Scp160p NNP O
, , O
a DT O
multiple JJ O
KH NN O
- HYPH O
domain NN O
protein NN O
, , O
is VBZ O
a DT O
component NN O
of IN O
mRNP NN O
complexes NNS O
in IN O
yeast NN B-Species

Abstract JJ O

Scp160p NN O
is VBZ O
a DT O
160 CD O
kDa NN O
protein NN O
in IN O
the DT O
yeast NN B-Species
Saccharomyces NNP B-Species
cerevisiae NN I-Species
that WDT O
contains VBZ O
14 CD O
repeats NNS O
of IN O
the DT O
hnRNP NNP O
K NNP O
- HYPH O
homology NN O
( , O
KH NNP O
) -RRB- O
domain NN O
, , O
and CC O
demonstrates VBZ O
significant JJ O
sequence NN O
homology NN O
to IN O
a DT O
family NN O
of IN O
proteins NNS O
collectively RB O
known VBN O
as IN O
vigilins NNS O
. . O

As IN O
a DT O
first JJ O
step NN O
towards IN O
defining VBG O
the DT O
function NN O
of IN O
Scp160p NN O
, , O
we PRP O
have VBP O
characterized VBN O
the DT O
subcellular JJ O
distribution NN O
and CC O
in IN O
vivo NN O
interactions NNS O
of IN O
this DT O
protein NN O
. . O

Using VBG O
sucrose JJ O
gradient NN O
fractionation NN O
studies NNS O
we PRP O
have VBP O
demonstrated VBN O
that IN O
Scp160p NN O
in IN O
cytoplasmic JJ O
lysates NNS O
is VBZ O
predominantly RB O
associated VBN O
with IN O
polyribosomes NNS O
. . O

Furthermore RB O
, , O
we PRP O
have VBP O
found VBN O
that IN O
Scp160p NN O
is VBZ O
released VBN O
from IN O
polyribosomes NNS O
by IN O
EDTA NNP O
in IN O
the DT O
form NN O
of IN O
a DT O
large JJ O
complex NN O
of IN O
> SYM O
= SYM O
1300 CD O
kDa NN O
that WDT O
is VBZ O
sensitive JJ O
both CC O
to IN O
RNase NNP O
and CC O
NaCl NNP O
. . O

Using VBG O
affinity NN O
- HYPH O
chromatography NN O
to TO O
isolate VB O
these DT O
complexes NNS O
, , O
we PRP O
have VBP O
identified VBN O
two CD O
protein NN O
components NNS O
other JJ O
than IN O
Scp160p NN O
: : O
poly NN O
( : O
A NN O
) -RRB- O
binding NN O
protein NN O
, , O
Pab1p NNP O
, , O
and CC O
Bfr1p NNP O
. . O

The DT O
presence NN O
of IN O
Pab1p NNP O
confirms VBZ O
these DT O
complexes NNS O
to TO O
be VB O
mRNPs NNS O
. . O

The DT O
presence NN O
of IN O
Bfr1p NNP O
is VBZ O
intriguing JJ O
because IN O
the DT O
null JJ O
phenotype NN O
for IN O
this DT O
gene NN O
is VBZ O
essentially RB O
the DT O
same JJ O
as IN O
that DT O
reported VBN O
for IN O
scp160 NN O
- HYPH O
null JJ O
cells NNS O
: : O
increased VBN O
cell NN O
size NN O
and CC O
aberrant JJ O
DNA NN O
content NN O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
Scp160p NN O
associates VBZ O
with IN O
polyribosome NN O
- HYPH O
bound VBN O
mRNP NN O
complexes NNS O
in IN O
vivo NN O
, , O
implicating VBG O
a DT O
role NN O
for IN O
this DT O
protein NN O
in IN O
one CD O
or CC O
more JJR O
levels NNS O
of IN O
mRNA NN O
metabolism NN O
in IN O
yeast NN B-Species
. . O

INTRODUCTION NN O

Scp160p NN O
is VBZ O
a DT O
1222 CD O
amino NN O
acid NN O
Saccharomyces NNP B-Species
cerevisiae NN I-Species
protein NN O
that WDT O
contains VBZ O
14 CD O
copies NNS O
of IN O
the DT O
hnRNP NNP O
K NNP O
homology NN O
( , O
KH NNP O
) -RRB- O
domain NN O
, , O
a DT O
highly RB O
conserved VBN O
motif NN O
found VBN O
in IN O
many JJ O
proteins NNS O
involved VBN O
in IN O
RNA NNP O
metabolism NN O
( : O
1 CD O
) -RRB- O
. . O

KH NNP O
domain NN O
- HYPH O
containing VBG O
proteins NNS O
appear VBP O
to TO O
have VB O
diverse JJ O
functions NNS O
and CC O
have VBP O
been VBN O
identified VBN O
in IN O
all DT O
kingdoms NNS O
of IN O
life NN O
, , O
including VBG O
the DT O
ribosomal JJ O
protein NN O
S3 NN O
from IN O
Escherichia NNP B-Species
coli NN I-Species
( , O
1 CD O
) -RRB- O
, , O
Mer1p NNP O
from IN O
S NNP B-Species
. . I-Species
cerevisiae NN I-Species
, , O
a DT O
meiosis NN O
- HYPH O
specific JJ O
splicing VBG O
factor NN O
( , O
1 CD O
) -RRB- O
, , O
MEX NNP O
- HYPH O
3 CD O
from IN O
Caenorhabditis NNP B-Species
elegans NNS I-Species
, , O
presumably RB O
involved VBN O
in IN O
mRNA NN O
localization NN O
during IN O
development NN O
( , O
2 CD O
) -RRB- O
, , O
and CC O
FMRP NNP O
, , O
the DT O
fragile JJ O
- HYPH O
X NN O
mental JJ O
retardation NN O
protein NN O
in IN O
humans NNS B-Species
( , O
3 CD O
) -RRB- O
. . O

A DT O
partial JJ O
clone NN O
of IN O
Scp160p NNP O
, , O
known VBN O
as IN O
HX NNP O
, , O
was VBD O
one CD O
of IN O
the DT O
first JJ O
multiple JJ O
- HYPH O
KH NNP O
proteins NNS O
identified VBN O
( : O
1 CD O
) -RRB- O
. . O

Whole JJ O
cell NN O
immunofluorescence NN O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
Scp160p NNP O
localizes VBZ O
to IN O
the DT O
cytoplasm NN O
, , O
with IN O
enrichment NN O
around IN O
the DT O
nuclear JJ O
envelope NN O
, , O
and CC O
what WP O
appears VBZ O
to TO O
be VB O
the DT O
endoplasmic JJ O
reticulum NN O
( , O
3 CD O
) -RRB- O
. . O

Deletion NN O
of IN O
the DT O
SCP160 NNP O
locus NN O
in IN O
yeast NN B-Species
is VBZ O
not RB O
lethal JJ O
, , O
but CC O
results VBZ O
in IN O
a DT O
complex JJ O
phenotype NN O
, , O
including VBG O
increased VBN O
DNA NN O
content NN O
per IN O
cell NN O
, , O
missegregation NN O
of IN O
genetic JJ O
markers NNS O
during IN O
sporulation NN O
, , O
and CC O
abnormal JJ O
cell NN O
morphology NN O
, , O
including VBG O
increased VBN O
size NN O
and CC O
irregular JJ O
shape NN O
( , O
4 CD O
) -RRB- O
. . O

Observation NN O
of IN O
this DT O
phenotype NN O
led VBD O
to IN O
the DT O
hypothesis NN O
that IN O
Scp160p NNP O
may MD O
function VB O
in IN O
regulating VBG O
ploidy NN O
during IN O
cell NN O
division NN O
. . O

More RBR O
recently RB O
, , O
Weber NNP O
and CC O
colleagues NNS O
demonstrated VBD O
in FW O
vitro FW O
RNA NNP O
binding NN O
activity NN O
of IN O
Scp160p NNP O
using VBG O
northwestern JJ O
blot NN O
analyses NNS O
; : O
the DT O
protein NN O
was VBD O
found VBN O
to TO O
bind VB O
efficiently RB O
to IN O
ribohomopolymers NNS O
and CC O
rRNA NN O
, , O
but CC O
not RB O
to IN O
tRNA NNP O
( SYM O
5 CD O
) -RRB- O
. . O

Cell NN O
fractionation NN O
studies NNS O
revealed VBD O
that IN O
a DT O
large JJ O
percentage NN O
of IN O
Scp160p NN O
associates NNS O
with IN O
membrane NN O
- HYPH O
pellets NNS O
, , O
and CC O
is VBZ O
released VBN O
by IN O
treatment NN O
with IN O
either CC O
10 CD O
mM NN O
EDTA NNP O
or CC O
500 CD O
mM NN O
NaCl NNP O
( SYM O
5 CD O
) -RRB- O
. . O

While IN O
these DT O
authors NNS O
interpreted VBD O
these DT O
results NNS O
to TO O
suggest VB O
that IN O
the DT O
nuclear JJ O
envelope NN O
/ SYM O
ER NNP O
localization NN O
of IN O
Scp160p NNP O
was VBD O
due JJ O
primarily RB O
to IN O
interactions NNS O
of IN O
the DT O
protein NN O
with IN O
membrane NN O
- HYPH O
bound VBN O
polyribosomes NNS O
, , O
clear JJ O
evidence NN O
of IN O
this DT O
association NN O
has VBZ O
not RB O
been VBN O
reported VBN O
( : O
5 CD O
) -RRB- O
. . O

Currently RB O
, , O
the DT O
relationship NN O
between IN O
the DT O
phenotype NN O
of IN O
scp160 NN O
null JJ O
mutants NNS O
and CC O
the DT O
RNA NNP O
- HYPH O
binding VBG O
activity NN O
of IN O
Scp160p NNP O
remains VBZ O
unclear JJ O
. . O

Scp160p NN O
demonstrates VBZ O
significant JJ O
sequence NN O
homology NN O
( : O
~ NFP O
23 CD O
% NN O
identity NN O
and CC O
~ $ O
40 CD O
% NN O
similarity NN O
at IN O
the DT O
amino NN O
acid NN O
level NN O
) -RRB- O
to IN O
a DT O
class NN O
of IN O
vertebrate JJ O
KH NN O
- HYPH O
domain NN O
proteins NNS O
collectively RB O
known VBN O
as IN O
vigilins NNS O
. . O

First RB O
identified VBN O
in IN O
chicken NN B-Species
, , O
vigilin NN O
homologues NNS O
have VBP O
now RB O
been VBN O
found VBN O
in IN O
human NN B-Species
( , O
6 CD O
) , O
, , O
Xenopus NNP B-Species
laevis NNP I-Species
( , O
7 CD O
) , O
, , O
Drosophila NNP B-Species
melanogaster NN I-Species
( , O
8 CD O
) -RRB- O
, , O
C NN B-Species
. . I-Species
elegans NNS I-Species
( , O
5 CD O
) -RRB- O
and CC O
Schizosaccharomyces NNS B-Species
pombe NN I-Species
. . O

While IN O
all DT O
of IN O
the DT O
vigilin NN O
proteins NNS O
studied VBN O
to IN O
date NN O
are VBP O
reported VBN O
to TO O
bind VB O
nucleic JJ O
acid NN O
, , O
both CC O
the DT O
type NN O
of IN O
nucleic JJ O
acid NN O
bound VBN O
and CC O
the DT O
functional JJ O
significance NN O
of IN O
these DT O
interactions NNS O
remain VBP O
unclear JJ O
. . O

For IN O
example NN O
, , O
Kruse NNP O
and CC O
colleagues NNS O
reported VBD O
from IN O
their PRP$ O
work NN O
with IN O
human JJ B-Species
cells NNS O
in IN O
culture NN O
that WDT O
vigilin NN O
may MD O
be VB O
involved VBN O
in IN O
the DT O
binding NN O
and CC O
transport NN O
of IN O
tRNA NNP O
( : O
9 CD O
- SYM O
11 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
Dodson NNP O
and CC O
Shapiro NNP O
concluded VBD O
from IN O
their PRP$ O
work NN O
with IN O
Xenopus NNP O
vigilin NN O
that IN O
, , O
in IN O
response NN O
to IN O
estrogen NN O
, , O
the DT O
protein NN O
bound VBN O
specifically RB O
to IN O
the DT O
3 CD O
' '' O
UTR NN O
of IN O
vitellogenin NN O
mRNA NNP O
( , O
7 CD O
, , O
12 CD O
) -RRB- O
, , O
potentially RB O
stabilizing VBG O
the DT O
message NN O
( SYM O
13 CD O
) -RRB- O
. . O

Lastly RB O
, , O
DDP1 NNP O
, , O
the DT O
Drosophila NNP O
homolog NN O
of IN O
vigilin NN O
, , O
was VBD O
reported VBN O
recently RB O
to TO O
interact VB O
with IN O
the DT O
dodeca NN O
- HYPH O
satellite NN O
repeat NN O
regions NNS O
of IN O
centromeric JJ O
heterochromatin NN O
in IN O
embryonic JJ O
and CC O
larval JJ O
cell NN O
nuclei NNS O
, , O
suggesting VBG O
a DT O
possible JJ O
role NN O
for IN O
this DT O
protein NN O
in IN O
heterochromatin NN O
structure NN O
( SYM O
8 CD O
) -RRB- O
. . O

The DT O
goal NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
begin VB O
elucidating VBG O
the DT O
function NN O
of IN O
Scp160p NN O
in IN O
yeast NN B-Species
by IN O
characterizing VBG O
the DT O
subcellular JJ O
distribution NN O
and CC O
macromolecular JJ O
interactions NNS O
of IN O
this DT O
protein NN O
. . O

We PRP O
have VBP O
demonstrated VBN O
that IN O
Scp160p NN O
in IN O
cytoplasmic JJ O
lysates NNS O
is VBZ O
associated VBN O
predominantly RB O
with IN O
polyribosomes NNS O
, , O
and CC O
that IN O
following VBG O
treatment NN O
with IN O
EDTA NNP O
, , O
Scp160p NN O
remains VBZ O
in IN O
an DT O
RNase NNP O
/ SYM O
NaCl NN O
- HYPH O
sensitive JJ O
complex NN O
of IN O
apparent JJ O
molecular JJ O
weight NN O
approximately RB O
> SYM O
= SYM O
1300 CD O
kDa FW O
. . O

Affinity NN O
purification NN O
of IN O
this DT O
complex NN O
revealed VBD O
the DT O
presence NN O
of IN O
poly JJ O
( HYPH O
A NNP O
) NFP O
- HYPH O
binding VBG O
protein NN O
( , O
Pab1p NNP O
) -RRB- O
, , O
a DT O
well RB O
- HYPH O
characterized VBN O
component NN O
of IN O
eukaryotic JJ O
mRNPs NNS O
( : O
14 CD O
, , O
15 CD O
) -RRB- O
. . O

Finally RB O
, , O
a DT O
third JJ O
abundant JJ O
protein NN O
component NN O
of IN O
this DT O
complex NN O
was VBD O
identified VBN O
as IN O
Bfr1p NNP O
, , O
a DT O
protein NN O
not RB O
previously RB O
reported VBN O
to TO O
associate VB O
with IN O
mRNPs NNS O
. . O

While IN O
the DT O
function NN O
of IN O
Bfr1p NNP O
remains VBZ O
unknown JJ O
, , O
gene NN O
deletion NN O
reportedly RB O
leads VBZ O
to IN O
a DT O
phenotype NN O
remarkably RB O
similar JJ O
to IN O
that DT O
of IN O
scp160 NN O
deletion NN O
( : O
16 CD O
) -RRB- O
. . O

These DT O
results NNS O
indicate VBP O
a DT O
role NN O
for IN O
Scp160p NNP O
in IN O
mRNA NNP O
metabolism NN O
in IN O
yeast NN B-Species
, , O
and CC O
by IN O
extension NN O
, , O
support VB O
results NNS O
seen VBN O
with IN O
Xenopus NNP O
vigilin NN O
in IN O
its PRP$ O
interactions NNS O
with IN O
mRNA NNP O
. . O

To IN O
our PRP$ O
knowledge NN O
, , O
the DT O
data NNS O
reported VBN O
here RB O
demonstrate VB O
Scp160p NN O
to TO O
be VB O
the DT O
first JJ O
example NN O
of IN O
a DT O
KH NNP O
- HYPH O
domain NN O
protein NN O
that WDT O
functions VBZ O
as IN O
a DT O
component NN O
of IN O
polyribosome NN O
- HYPH O
associated VBN O
mRNP NN O
complexes NNS O
in IN O
the DT O
yeast NN B-Species
, , O
S NNP B-Species
. . I-Species
cerevisiae NN I-Species
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Plasmids NNS O
, , O
yeast NN B-Species
strains NNS O
and CC O
culture NN O
conditions NNS O

All DT O
recombinant JJ O
DNA NN O
manipulations NNS O
were VBD O
performed VBN O
according VBG O
to IN O
standard JJ O
techniques NNS O
and CC O
utilized VBN O
E NN B-Species
. . I-Species
coli NN I-Species
strain NN O
XL1 NNP O
- HYPH O
Blue NNP O
( : O
Stratagene NNP O
) -RRB- O
. . O

The DT O
yeast NN B-Species
strain NN O
JFy1511 NNP O
, , O
expressing VBG O
FLAG NN O
- HYPH O
Scp160p NNP O
, , O
was VBD O
derived VBN O
by IN O
two CD O
- HYPH O
step NN O
gene NN O
replacement NN O
from IN O
strain NN O
yJJ52 CD O
( SYM O
MAT NNP O
alpha NN O
gal7 NN O
Delta NNP O
102 CD O
ura3 CD O
- HYPH O
52 CD O
trp1 CD O
- HYPH O
289 CD O
ade1 CD O
lys1 NN O
leu2 CD O
- HYPH O
3 CD O
, , O
112 CD O
; : O
generously RB O
donated VBN O
by IN O
Drs NNP O
Mark NNP O
Parthun NNP O
and CC O
Judith NNP O
Jaehning NNP O
, , O
University NNP O
of IN O
Colorado NNP O
Health NNP O
Sciences NNPS O
Center NNP O
) -RRB- O
, , O
and CC O
confirmed VBN O
by IN O
PCR NNP O
. . O

The DT O
wild JJ O
- HYPH O
type NN O
SCP160 NN O
coding VBG O
sequence NN O
was VBD O
obtained VBN O
by IN O
PCR NNP O
amplification NN O
from IN O
a DT O
genomic JJ O
DNA NN O
preparation NN O
from IN O
yJFK1 NNP O
( , O
MAT NNP O
alpha NN O
gal7 NN O
Delta NNP O
102 CD O
ura3 CD O
- HYPH O
52 CD O
trp1 CD O
- HYPH O
289 CD O
ade1 CD O
lys1 NN O
leu2 CD O
- HYPH O
3 CD O
, , O
112 CD O
Delta NNP O
GAL80 NNP O
: : O
: : O
URA3 NNP O
) -RRB- O
, , O
using VBG O
a DT O
16 CD O
: SYM O
1 CD O
mixture NN O
of IN O
Taq NNP O
( : O
Fisher NNP O
Biotech NNP O
) -RRB- O
and CC O
Pfu NNP O
( , O
Stratagene NNP O
) , O
DNA NN O
polymerases NNS O
and CC O
the DT O
following VBG O
primers NNS O
: : O
Scp160F1 NNP O
( : O
5 CD O
' '' O
- HYPH O
GCCGGTCGA NNP O
- HYPH O
CTAACTGCAATGTCTGAAGA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
Scp160R1 NNP O
( : O
5 CD O
' '' O
- HYPH O
GCGCGTCGACGAGCTTGTCT NNP O
- HYPH O
CTTAAGG NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
. . O

A DT O
wild JJ O
- HYPH O
type NN O
SCP160 NN O
genomic JJ O
clone NN O
, , O
containing VBG O
1 CD O
kb NN O
upstream NN O
and CC O
300 CD O
bp NN O
downstream NN O
sequence NN O
was VBD O
PCR NN O
amplified VBN O
from IN O
yJFK1 NNP O
genomic JJ O
DNA NN O
using VBG O
the DT O
primers NNS O
Scp160F0 NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
GCCGAGCTCACACCAGCTTT NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
Scp160R2 NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
GCGCAAGCTTGTGCGGTA NNP O
- HYPH O
TCCCAGTCTATG NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
. . O

The DT O
resultant JJ O
clone NN O
was VBD O
confirmed VBN O
by IN O
dideoxy NN O
sequencing NN O
. . O

The DT O
N NNP O
- HYPH O
terminal NN O
FLAG NNP O
and CC O
HA NNP O
tags NNS O
were VBD O
added VBN O
using VBG O
PCR NNP O
with IN O
the DT O
primers NNS O
ScpFLAGF1 NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
CCAT NNP O
- HYPH O
TATAACTGCAATGGACTACA NNP O
- HYPH O
AAGATGTCTGAAGAACAAAC NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
ScpHAF1 NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
CCCCCTCCTGTCGACATTAT NNP O
- HYPH O
TCACCATCACCATTCTGAAG NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
respectively RB O
. . O

For IN O
integration NN O
, , O
constructs NNS O
containing VBG O
the DT O
1 CD O
kb NN O
upstream NN O
and CC O
300 CD O
bp NN O
downstream NN O
sequence NN O
were VBD O
subcloned VBN O
into IN O
the DT O
plasmid NN O
YIplac211 NNP O
( SYM O
17 CD O
) -RRB- O
using VBG O
SacI NNP O
and CC O
HindIII NNP O
restriction NN O
sites NNS O
. . O

The DT O
HA NNP O
- HYPH O
tagged VBN O
construct NN O
was VBD O
subcloned VBN O
into IN O
the DT O
low JJ O
copy NN O
number NN O
plasmid NN O
, , O
YCplac22 NNP O
using VBG O
SacI NNP O
and CC O
HindIII NNP O
restriction NN O
sites NNS O
. . O

The DT O
SCP160 NNP O
deletion NN O
construct NN O
was VBD O
made VBN O
by IN O
removal NN O
of IN O
a DT O
3 CD O
. . O
4 CD O
kb NN O
ApaI NNP O
- HYPH O
KpnI NNP O
fragment NN O
from IN O
the DT O
coding VBG O
region NN O
of IN O
this DT O
construct NN O
, , O
followed VBN O
by IN O
treatment NN O
with IN O
Klenow NNP O
fragment NN O
and CC O
re NN O
- HYPH O
ligation NN O
following VBG O
attachment NN O
of IN O
BamHI NNP O
linker NN O
oligonucleotides NNS O
. . O

Genomic JJ O
integration NN O
of IN O
the DT O
plasmid NN O
sequences NNS O
and CC O
subsequent JJ O
removal NN O
of IN O
the DT O
endogenous JJ O
SCP160 NNP O
allele NN O
were VBD O
achieved VBN O
by IN O
standard JJ O
two CD O
- HYPH O
step NN O
gene NN O
replacement NN O
techniques NNS O
( , O
18 CD O
) -RRB- O
and CC O
confirmed VBN O
by IN O
PCR NNP O
. . O

The DT O
N NNP O
- HYPH O
terminally RB O
HA NNP O
- HYPH O
tagged VBN O
allele NN O
of IN O
BFR1 NNP O
was VBD O
generated VBN O
by IN O
PCR NNP O
- HYPH O
amplifiction NN O
of IN O
the DT O
BFR1 NNP O
locus NN O
from IN O
wild JJ O
- HYPH O
type NN O
( -LRB- O
W303 CD O
) -RRB- O
yeast NN B-Species
genomic JJ O
DNA NN O
using VBG O
the DT O
primers NNS O
BFR1HAF1 NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
CCGCGGATCCATGTACC NNP O
- HYPH O
CATACGACGTCCCAGACTAC NNP O
- HYPH O
AACACAA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
BFR1HINDR1 NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
CCGCAAGCTTGTCG NN O
- HYPH O
ACTATTTCATATGCCACAGG NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
, , O
and CC O
subcloned VBN O
into IN O
YIPlac211 NNP O
. . O

The DT O
BFR1 NNP O
promoter NN O
region NN O
was VBD O
PCR NN O
- HYPH O
amplified VBN O
in IN O
a DT O
similar JJ O
manner NN O
using VBG O
the DT O
primers NNS O
BFR1SACF1 NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
CCGCGAG NNP O
- HYPH O
CTCAGCATTAAGCATTCACG NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
BFR1BAMR1 NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
CCGCGGATCCGGCAATGGCT NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
subcloned VBN O
into IN O
the DT O
appropriate JJ O
position NN O
upstream RB O
of IN O
the DT O
HA NNP O
- HYPH O
Bfr1p NNP O
open JJ O
reading NN O
frame NN O
in IN O
the DT O
plasmid JJ O
backbone NN O
. . O

The DT O
entire JJ O
open JJ O
reading NN O
frame NN O
was VBD O
confirmed VBN O
by IN O
dideoxy NN O
sequencing NN O
. . O

Finally RB O
, , O
the DT O
HA NNP O
- HYPH O
BFR1 NNP O
allele NN O
was VBD O
substituted VBN O
into IN O
the DT O
yeast NN B-Species
genome NN O
in IN O
place NN O
of IN O
the DT O
native JJ O
allele NN O
using VBG O
linearization NN O
with IN O
SphI NNP O
and CC O
standard JJ O
two CD O
- HYPH O
step NN O
gene NN O
replacement NN O
techniques NNS O
. . O

All DT O
yeast NN B-Species
transformations NNS O
and CC O
culture NN O
manipulations NNS O
were VBD O
performed VBN O
according VBG O
to IN O
standard JJ O
protocols NNS O
as IN O
described VBN O
elsewhere RB O
( : O
19 CD O
) -RRB- O
. . O

Confirmation NN O
of IN O
genomic JJ O
integrations NNS O

All DT O
genomic JJ O
integrations NNS O
were VBD O
confirmed VBN O
by IN O
PCR NNP O
amplifications NNS O
from IN O
purified JJ O
yeast NN B-Species
genomic JJ O
DNA NNP O
. . O

For IN O
scp160 CD O
deletion NN O
mutants NNS O
, , O
the DT O
primers NNS O
Scp160PF NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
GATTTCCTAACTTTCC NNP O
- HYPH O
GTCTA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
Scp160R5 NNP O
( : O
5 CD O
' '' O
- HYPH O
GCGCAAGCTTCACCGCCTTA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
that WDT O
flanked VBD O
the DT O
deleted VBN O
region NN O
were VBD O
used VBN O
. . O

Similarly RB O
, , O
epitope NN O
tags NNS O
on IN O
Scp160p NNP O
were VBD O
confirmed VBN O
by IN O
PCR NNP O
using VBG O
primers NNS O
that WDT O
flanked VBD O
the DT O
tag NN O
sequence NN O
. . O

Positive JJ O
clones NNS O
were VBD O
further RB O
confirmed VBN O
by IN O
western JJ O
blot NN O
analysis NN O
of IN O
crude JJ O
cell NN O
lysates NNS O
using VBG O
the DT O
appropriate JJ O
anti JJ O
- HYPH O
tag NN O
antibodies NNS O
. . O

The DT O
presence NN O
of IN O
HA NNP O
- HYPH O
Bfr1p NNP O
in IN O
cells NNS O
was VBD O
confirmed VBN O
by IN O
western JJ O
blot NN O
analysis NN O
of IN O
soluble JJ O
cell NN O
lysates NNS O
using VBG O
12CA5 CD O
mAb NN O
( , O
Boehringer NNP O
Mannheim NNP O
) -RRB- O
. . O

Polyribosome NN O
isolation NN O

Polyribosomes NNS O
were VBD O
isolated VBN O
using VBG O
a DT O
combination NN O
of IN O
protocols NNS O
described VBN O
by IN O
Stansfield NNP O
and CC O
colleagues NNS O
( , O
20 CD O
) -RRB- O
and CC O
by IN O
Dr NNP O
Maurice NNP O
Swanson NNP O
( , O
personal JJ O
communication NN O
) -RRB- O
. . O

In IN O
brief NN O
, , O
a DT O
100 CD O
ml NN O
culture NN O
of IN O
yeast NN B-Species
was VBD O
grown VBN O
in IN O
either CC O
YEPD NNP O
or CC O
Hartwell NNP O
synthetic JJ O
medium NN O
, , O
to IN O
early JJ O
- HYPH O
log NN O
phase NN O
( : O
OD600 CD O
= SYM O
1 CD O
. . O
0 CD O
) -RRB- O
, , O
at IN O
which WDT O
time NN O
cyclohexamide NN O
( , O
Sigma NNP O
) -RRB- O
was VBD O
added VBN O
directly RB O
to IN O
the DT O
culture NN O
to IN O
a DT O
final JJ O
concentration NN O
of IN O
100 CD O
micro NN O
g NN O
/ SYM O
ml NN O
. . O

The DT O
culture NN O
was VBD O
incubated VBN O
on IN O
ice NN O
for IN O
15 CD O
min NN O
, , O
and CC O
cells NNS O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
( : O
4000 CD O
r NN O
. . O
p NN O
. . O
m NN O
. . O
/ SYM O
10 CD O
min NN O
) -RRB- O
. . O

Following VBG O
two CD O
washes NNS O
in IN O
10 CD O
ml NNS O
of IN O
water NN O
containing VBG O
100 CD O
micro JJ O
g NN O
/ SYM O
ml NN O
cyclohexamide NN O
, , O
cells NNS O
were VBD O
lysed VBN O
by IN O
vortex NN O
agitation NN O
with IN O
an DT O
equal JJ O
volume NN O
of IN O
glass NN O
beads NNS O
in IN O
1 CD O
ml CD O
lysis NN O
buffer NN O
( , O
25 CD O
mM NN O
Tris NNS O
pH NN O
7 CD O
. . O
2 CD O
, , O
50 CD O
mM NN O
KCl NNP O
, , O
30 CD O
mM NN O
MgCl2 NN O
, , O
5 CD O
mM NN O
beta NN O
- HYPH O
mercaptoethanol NN O
, , O
200 CD O
micro NN O
g NN O
/ SYM O
ml NN O
cyclohexamide NN O
, , O
2 CD O
micro NN O
g NN O
/ SYM O
ml NN O
aprotonin NN O
, , O
1 CD O
mM NN O
PMSF NN O
, , O
0 CD O
. . O
5 CD O
micro NN O
g NN O
/ SYM O
ml NN O
leupeptin NN O
, , O
2 CD O
. . O
9 CD O
micro NN O
g NN O
/ SYM O
ml NN O
E64 CD O
, , O
1 CD O
micro NN O
g NN O
/ SYM O
ml NN O
antipain NN O
, , O
0 CD O
. . O
2 CD O
micro NN O
g NN O
/ SYM O
ml NN O
chymostatin NN O
) -RRB- O
. . O

Lysate NNP O
was VBD O
transferred VBN O
to IN O
a DT O
clean JJ O
microfuge NN O
tube NN O
, , O
and CC O
centrifuged VBN O
10 CD O
min NN O
at IN O
3000 CD O
g NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

The DT O
supernatant NN O
was VBD O
again RB O
transferred VBN O
to IN O
a DT O
clean JJ O
microfuge NN O
tube NN O
and CC O
centrifuged VBN O
at IN O
12 CD O
0 CD O
g CD O
for IN O
15 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
, , O
and CC O
then RB O
assayed VBN O
for IN O
absorbance NN O
at IN O
260 CD O
nm NN O
. . O

Approximately RB O
12 CD O
OD260 CD O
units NNS O
were VBD O
loaded VBN O
onto IN O
a DT O
11 CD O
ml CD O
15 CD O
- SYM O
45 CD O
% NN O
sucrose NN O
gradient NN O
made VBN O
in IN O
10 CD O
mM NN O
Tris NNP O
, , O
pH NN O
7 CD O
. . O
4 CD O
, , O
70 CD O
mM NN O
NH4Cl NNP O
, , O
4 CD O
mM NN O
MgOAc NNP O
, , O
using VBG O
a DT O
Gradient NNP O
Master NNP O
automatic JJ O
system NN O
, , O
and CC O
the DT O
gradient NN O
was VBD O
centrifuged VBN O
in IN O
a DT O
SW41ti NNP O
rotor NN O
( : O
Beckman NNP O
) -RRB- O
at IN O
39 CD O
0 CD O
r NN O
. . O
p NN O
. . O
m NN O
. . O
for IN O
2 CD O
. . O
5 CD O
h NN O
. . O

0 NFP O
. . O
5 CD O
ml NNS O
fractions NNS O
were VBD O
collected VBN O
using VBG O
an DT O
Isco NNP O
gradient NN O
fractionator NN O
, , O
and CC O
gradient NN O
profiles NNS O
were VBD O
determined VBN O
by IN O
monitoring VBG O
absorbance NN O
at IN O
254 CD O
nm NN O
. . O

For IN O
EDTA NNP O
controls NNS O
, , O
lysis NN O
buffer NN O
containing VBG O
5 CD O
mM NN O
MgCl2 NNP O
was VBD O
used VBN O
, , O
and CC O
30 CD O
mM NN O
EDTA NNP O
was VBD O
added VBN O
to IN O
the DT O
sample NN O
before IN O
loading VBG O
onto IN O
the DT O
gradient NN O
. . O

Where WRB O
indicated VBD O
, , O
addition NN O
of IN O
50 CD O
U NNP O
/ SYM O
ml NNP O
of IN O
RNase NNP O
One NNP O
( -LRB- O
Promega NNP O
) -RRB- O
was VBD O
performed VBN O
prior RB O
to IN O
loading VBG O
the DT O
sample NN O
onto IN O
the DT O
gradient NN O
. . O

Gel NN O
filtration NN O
chromatography NN O

Gel NN O
filtration NN O
chromatography NN O
was VBD O
performed VBN O
using VBG O
a DT O
120 CD O
ml CD O
Hi NNP O
- HYPH O
Prep NNP O
S NNP O
- HYPH O
300 CD O
Sephacryl NNP O
column NN O
( , O
Pharmacia NNP O
) -RRB- O
with IN O
a DT O
cut NN O
- HYPH O
off NN O
of IN O
1300 CD O
kDa NN O
, , O
attached VBN O
to IN O
an DT O
FPLC NNP O
system NN O
( , O
Pharmacia NNP O
) -RRB- O
. . O

The DT O
column NN O
had VBD O
been VBN O
calibrated VBN O
previously RB O
using VBG O
the DT O
following VBG O
molecular JJ O
weight NN O
standards NNS O
( -LRB- O
Sigma NNP O
) -RRB- O
: : O
blue JJ O
dextran NN O
( , O
2000 CD O
kDa NN O
) -RRB- O
, , O
thyroglobulin NN O
( , O
669 CD O
kDa FW O
) -RRB- O
, , O
apoferritin NN O
( , O
443 CD O
kDa FW O
) -RRB- O
, , O
alcohol NN O
dehydrogenase NN O
( , O
150 CD O
kDa NN O
) -RRB- O
, , O
and CC O
bovine JJ B-Species
serum NN O
albumin NN O
( SYM O
66 CD O
kDa NN O
) -RRB- O
. . O

Yeast NN B-Species
were VBD O
lysed VBN O
as IN O
described VBN O
for IN O
polyribosome NN O
analysis NN O
, , O
with IN O
an DT O
additional JJ O
clarification NN O
by IN O
passage NN O
through IN O
a DT O
0 CD O
. . O
2 CD O
micro NN O
m NN O
syringe NN O
- HYPH O
tip NN O
filter NN O
( : O
Acrodisc NNP O
) -RRB- O
and CC O
run VB O
over IN O
the DT O
column NN O
at IN O
a DT O
rate NN O
of IN O
0 CD O
. . O
5 CD O
ml NN O
/ SYM O
min NN O
in IN O
polyribosome NN O
lysis NN O
buffer NN O
following VBG O
treatment NN O
with IN O
the DT O
indicated VBN O
reagents NNS O
. . O

Fractions NNS O
( , O
2 CD O
. . O
0 CD O
ml CD O
) -RRB- O
were VBD O
collected VBN O
, , O
from IN O
which WDT O
12 CD O
micro NN O
l NN O
were VBD O
combined VBN O
with IN O
sample NN O
buffer NN O
( , O
2 CD O
% NN O
SDS NN O
, , O
10 CD O
% NN O
glycerol NN O
, , O
100 CD O
mM NN O
dithiothreitol NN O
, , O
60 CD O
mM NN O
Tris NNS O
pH NN O
6 CD O
. . O
8 CD O
, , O
0 CD O
. . O
1 CD O
% NN O
bromophenol NN O
blue NN O
) , O
and CC O
analyzed VBN O
by IN O
western JJ O
blot NN O
using VBG O
the DT O
indicated VBN O
antibodies NNS O
. . O

alpha NN O
- HYPH O
FLAG NNP O
affinity NN O
chromatography NN O

For IN O
most JJS O
experiments NNS O
, , O
one CD O
liter NN O
yeast NN B-Species
cultures NNS O
were VBD O
grown VBN O
to IN O
early JJ O
log NN O
- HYPH O
phase NN O
and CC O
harvested VBN O
by IN O
centrifugation NN O
. . O

Cells NNS O
were VBD O
washed VBN O
twice RB O
in IN O
T75 CD O
buffer NN O
( SYM O
25 CD O
mM NN O
Tris NNS O
pH NN O
7 CD O
. . O
5 CD O
, , O
75 CD O
mM NN O
NaCl NNP O
) -RRB- O
and CC O
then RB O
were VBD O
lysed VBN O
by IN O
vortex NN O
agitation NN O
with IN O
an DT O
equal JJ O
volume NN O
of IN O
glass NN O
beads NNS O
in IN O
4 CD O
ml NN O
T75 CD O
buffer NN O
containing VBG O
30 CD O
mM NN O
EDTA NNP O
. . O

Lysate NNP O
was VBD O
transferred VBN O
to IN O
a DT O
clean JJ O
microfuge NN O
tube NN O
, , O
and CC O
centrifuged VBN O
for IN O
10 CD O
min NN O
at IN O
3000 CD O
g NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

The DT O
supernatant NN O
was VBD O
again RB O
transferred VBN O
to IN O
a DT O
clean JJ O
microfuge NN O
tube NN O
and CC O
centrifuged VBN O
at IN O
12 CD O
0 CD O
g CD O
for IN O
15 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
, , O
and CC O
finally RB O
passed VBD O
through IN O
a DT O
0 CD O
. . O
2 CD O
micro NN O
m NN O
syringe NN O
filter NN O
. . O

Lysate NNP O
was VBD O
then RB O
pre NN O
- HYPH O
purified VBN O
by IN O
running VBG O
over IN O
the DT O
S NNP O
- HYPH O
300 CD O
gel NN O
- HYPH O
filtration NN O
column NN O
in IN O
T75 CD O
buffer NN O
, , O
with IN O
pooling NN O
of IN O
the DT O
void NN O
volume NN O
fractions NNS O
( : O
~ $ O
10 CD O
ml NN O
total NN O
) -RRB- O
. . O

For IN O
several JJ O
experiments NNS O
( , O
Fig NNP O
. . O
5A NN O
, , O
B NNP O
, , O
E NNP O
and CC O
F NNP O
) -RRB- O
, , O
a DT O
low JJ O
concentration NN O
( , O
< SYM O
10 CD O
micro NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
of IN O
FLAG NNP O
peptide NN O
( , O
N NNP O
- HYPH O
DYKDDDDK NNP O
- HYPH O
C NNP O
) -RRB- O
was VBD O
added VBN O
to IN O
this DT O
sample NN O
. . O

This DT O
void NN O
material NN O
was VBD O
then RB O
loaded VBN O
onto IN O
a DT O
1 CD O
ml CD O
M2 NNP O
alpha NN O
- HYPH O
FLAG NN O
column NN O
( : O
Sigma NNP O
) -RRB- O
; : O
column NN O
flow NN O
- HYPH O
through RP O
was VBD O
passed VBN O
over IN O
the DT O
column NN O
a DT O
second JJ O
time NN O
. . O

The DT O
column NN O
was VBD O
then RB O
washed VBN O
extensively RB O
with IN O
75 CD O
ml NN O
T75 CD O
buffer NN O
; : O
material NN O
bound VBN O
to IN O
the DT O
column NN O
was VBD O
eluted VBN O
with IN O
5 CD O
ml NN O
T75 CD O
containing VBG O
184 CD O
mg NN O
/ SYM O
ml NN O
FLAG NN O
peptide NN O
. . O

The DT O
peptide NN O
solution NN O
was VBD O
allowed VBN O
to TO O
incubate VB O
on IN O
the DT O
column NN O
for IN O
20 CD O
min NN O
prior RB O
to IN O
collection NN O
of IN O
the DT O
first JJ O
1 CD O
ml CD O
fraction NN O
; : O
subsequent JJ O
fractions NNS O
were VBD O
collected VBN O
every DT O
10 CD O
min NN O
. . O

Samples NNS O
of IN O
crude JJ O
material NN O
, , O
S NNP O
- HYPH O
300 CD O
void NN O
, , O
alpha NN O
- HYPH O
FLAG NNP O
flow NN O
- HYPH O
through RP O
, , O
first JJ O
and CC O
last JJ O
wash NN O
, , O
and CC O
eluate NN O
fractions NNS O
were VBD O
analyzed VBN O
by IN O
western JJ O
blot NN O
using VBG O
the DT O
indicated VBN O
antibodies NNS O
. . O

For IN O
Figure NNP O
5A NNP O
and CC O
E NNP O
, , O
samples NNS O
of IN O
first JJ O
and CC O
last JJ O
wash NN O
and CC O
eluate NN O
fractions NNS O
were VBD O
concentrated VBN O
, , O
run VBN O
on IN O
SDS NNP O
- HYPH O
PAGE NN O
and CC O
stained VBN O
with IN O
colloidal JJ O
G250 NNP O
Coomassie NNP O
. . O

Concentration NN O
of IN O
samples NNS O

Where WRB O
indicated VBD O
, , O
samples NNS O
were VBD O
concentrated VBN O
using VBG O
the DT O
method NN O
of IN O
Traub NNP O
et FW O
al NNP O
. . O

( SYM O
21 CD O
) -RRB- O
. . O

400 CD O
micro NN O
l NN O
of IN O
sample NN O
were VBD O
transferred VBN O
to IN O
a DT O
microfuge NN O
tube NN O
, , O
and CC O
combined VBN O
with IN O
400 CD O
micro NN O
l NN O
of IN O
methanol NN O
, , O
and CC O
100 CD O
micro JJ O
l NN O
of IN O
chloroform NN O
. . O

Samples NNS O
were VBD O
then RB O
vortexed VBN O
vigorously RB O
, , O
and CC O
centrifuged VBN O
for IN O
5 CD O
min NN O
at IN O
12 CD O
0 CD O
g NN O
. . O

The DT O
supernatant NN O
was VBD O
discarded VBN O
, , O
leaving VBG O
the DT O
interface NN O
intact JJ O
, , O
and CC O
an DT O
additional JJ O
400 CD O
micro NN O
l NN O
of IN O
methanol NN O
was VBD O
added VBN O
to IN O
each DT O
tube NN O
. . O

Samples NNS O
were VBD O
then RB O
inverted VBN O
several JJ O
times NNS O
, , O
and CC O
centrifuged VBN O
again RB O
for IN O
5 CD O
min NN O
. . O

The DT O
supernatant NN O
was VBD O
discarded VBN O
, , O
and CC O
the DT O
protein NN O
pellet NN O
was VBD O
air NN O
- HYPH O
dried VBN O
and CC O
resuspended VBN O
in IN O
1 CD O
x NN O
sample NN O
buffer NN O
. . O

Western JJ O
blot NN O
analysis NN O

Western JJ O
blot NN O
analysis NN O
was VBD O
performed VBN O
essentially RB O
as IN O
described VBN O
previously RB O
( : O
19 CD O
) -RRB- O
. . O

Briefly RB O
, , O
samples NNS O
to TO O
be VB O
analyzed VBN O
were VBD O
mixed VBN O
with IN O
sample NN O
buffer NN O
, , O
boiled VBN O
, , O
electrophoresed VBN O
through IN O
a DT O
10 CD O
% NN O
SDS NN O
- HYPH O
polyacrylamide NN O
gel NN O
, , O
and CC O
electro NN O
- HYPH O
blotted VBN O
onto IN O
nitrocellulose NN O
( -LRB- O
Bio NNP O
- HYPH O
Rad NNP O
) -RRB- O
. . O

FLAG NN O
- HYPH O
Scp160p NN O
fusion NN O
protein NN O
was VBD O
detected VBN O
by IN O
incubation NN O
of IN O
the DT O
filter NN O
with IN O
mouse NN B-Species
M2 NN O
anti JJ O
- HYPH O
FLAG NN O
monoclonal JJ O
antibody NN O
( , O
10 CD O
micro JJ O
g NN O
/ SYM O
ml NN O
final JJ O
concentration NN O
) -RRB- O
, , O
followed VBN O
by IN O
HRP NNP O
- HYPH O
conjugated VBN O
sheep JJ B-Species
anti JJ O
- HYPH O
mouse NN B-Species
secondary JJ O
antibody NN O
( -LRB- O
Amersham NNP O
) -RRB- O
, , O
diluted VBN O
1 CD O
: : O
5000 CD O
as IN O
per IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
, , O
and CC O
ECL NNP O
reagent NN O
( , O
Amersham NNP O
) -RRB- O
, , O
followed VBN O
by IN O
exposure NN O
to IN O
X NN O
- HYPH O
ray NN O
film NN O
. . O

HA NN O
- HYPH O
tagged VBN O
Scp160p NNP O
and CC O
HA NN O
- HYPH O
tagged VBN O
Bfr1p NNP O
were VBD O
detected VBN O
using VBG O
the DT O
12CA5 CD O
mAb NN O
( , O
Boehringer NNP O
Mannheim NNP O
) -RRB- O
at IN O
a DT O
final JJ O
concentration NN O
of IN O
0 CD O
. . O
8 CD O
micro NN O
g NN O
/ SYM O
ml NN O
; : O
Pab1p NNP O
and CC O
Pub1p NNP O
were VBD O
detected VBN O
using VBG O
1G1 CD O
mAb NN O
at IN O
1 CD O
: SYM O
5000 CD O
, , O
and CC O
4C3 CD O
mAb NN O
at IN O
1 CD O
: : O
1000 CD O
, , O
respectively RB O
, , O
both CC O
generous JJ O
gifts NNS O
from IN O
Dr NNP O
Maurice NNP O
Swanson NNP O
( : O
22 CD O
, , O
23 CD O
) -RRB- O
. . O

Where WRB O
appropriate JJ O
, , O
films NNS O
were VBD O
analyzed VBN O
by IN O
scanning VBG O
densitometry NN O
( , O
Molecular NNP O
Dynamics NNP O
) -RRB- O
, , O
and CC O
quantitated VBN O
using VBG O
ImageQuant NNP O
software NN O
( : O
Molecular NNP O
Dynamics NNPS O
) -RRB- O
. . O

Colloidal JJ O
G250 NN O
coomassie NN O
staining VBG O

Procedure NN O
used VBN O
was VBD O
that DT O
of IN O
Neuhoff NNP O
( SYM O
24 CD O
) -RRB- O
. . O

Briefly RB O
, , O
a DT O
one CD O
liter NN O
stock NN O
of IN O
staining NN O
solution NN O
was VBD O
prepared VBN O
containing VBG O
1 CD O
g NNP O
Coomassie NNP O
brilliant JJ O
blue JJ O
G NNP O
- HYPH O
250 CD O
( SYM O
Sigma NNP O
) -RRB- O
, , O
100 CD O
g NN O
ammonium NN O
sulfate NN O
( , O
Sigma NNP O
) -RRB- O
, , O
and CC O
11 CD O
. . O
76 CD O
ml NN O
85 CD O
% NN O
phosphoric JJ O
acid NN O
( -LRB- O
Fisher NN O
) -RRB- O
. . O

Following VBG O
SDS NNP O
- HYPH O
PAGE NNP O
, , O
gels NNS O
were VBD O
fixed VBN O
in IN O
40 CD O
% NN O
methanol NN O
, , O
10 CD O
% NN O
acetic JJ O
acid NN O
for IN O
10 CD O
min NN O
. . O

Gels NNS O
were VBD O
then RB O
rinsed VBN O
several JJ O
times NNS O
in IN O
water NN O
, , O
then RB O
stained VBN O
using VBG O
40 CD O
ml NNS O
of IN O
the DT O
stock NN O
staining VBG O
solution NN O
mixed VBN O
with IN O
10 CD O
ml NN O
methanol NN O
, , O
for IN O
2 CD O
h NNS O
at IN O
room NN O
temperature NN O
. . O

Stain NN O
was VBD O
then RB O
poured VBN O
off RP O
, , O
and CC O
residual JJ O
stain NN O
was VBD O
removed VBN O
by IN O
rinsing VBG O
in IN O
water NN O
. . O

By IN O
performing VBG O
a DT O
standard JJ O
analysis NN O
using VBG O
bovine JJ B-Species
serum NN O
albumin NN O
, , O
the DT O
stain NN O
was VBD O
able JJ O
to TO O
detect VB O
~ $ O
15 CD O
ng CD O
total JJ O
protein NN O
per IN O
lane NN O
. . O

Pichia NNP O
expression NN O
system NN O

An DT O
N NNP O
- HYPH O
terminally RB O
HIS6 NNP O
/ SYM O
FLAG NNP O
- HYPH O
tagged VBN O
allele NN O
of IN O
the DT O
SCP160 NNP O
coding VBG O
sequence NN O
was VBD O
blunt JJ O
- HYPH O
end NN O
sub NN O
- HYPH O
cloned VBN O
into IN O
the DT O
BamHI NNP O
/ SYM O
SnaBI NNP O
sites NNS O
of IN O
the DT O
Pichia NNP O
expression NN O
vector NN O
pPIC3 NNP O
. . O
5K CD O
( , O
Invitrogen NNP O
) -RRB- O
. . O

The DT O
construct NN O
was VBD O
then RB O
linearized VBN O
using VBG O
SalI NNP O
and CC O
integrated VBN O
into IN O
the DT O
genome NN O
of IN O
the DT O
Pichia NNP O
strain NN O
GS115 NNP O
( , O
Invitrogen NNP O
) -RRB- O
. . O

High JJ O
expression NN O
transformants NNS O
were VBD O
selected VBN O
initially RB O
on IN O
histidine NN O
- HYPH O
deficient JJ O
medium NN O
followed VBN O
by IN O
selection NN O
on IN O
increasing VBG O
concentrations NNS O
of IN O
G418 CD O
( : O
US NNP O
Biological NNP O
) -RRB- O
. . O

Crude JJ O
lysates NNS O
of IN O
the DT O
resultant JJ O
transformants NNS O
were VBD O
then RB O
confirmed VBN O
by IN O
western JJ O
blot NN O
analysis NN O
with IN O
the DT O
anti AFX O
- HYPH O
FLAG NNP O
antibody NN O
M2 NNP O
, , O
and CC O
the DT O
best RBS O
expressing VBG O
strain NN O
was VBD O
cultured VBN O
in IN O
a DT O
fermenter NN O
, , O
harvested VBN O
, , O
and CC O
lysed VBN O
by IN O
agitation NN O
with IN O
glass NN O
beads NNS O
. . O

To TO O
purify VB O
Scp160p NN O
, , O
2 CD O
ml NNS O
of IN O
crude JJ O
lysate NN O
was VBD O
first RB O
diluted VBN O
to IN O
10 CD O
ml NNS O
with IN O
25 CD O
mM NN O
Tris NNS O
, , O
pH NN O
7 CD O
. . O
5 CD O
, , O
1 CD O
M NN O
NaCl NNP O
, , O
then RB O
twice RB O
passed VBN O
over RP O
a DT O
1 CD O
ml CD O
alpha NN O
- HYPH O
FLAG NN O
affinity NN O
column NN O
. . O

The DT O
column NN O
was VBD O
then RB O
washed VBN O
with IN O
75 CD O
ml NNS O
of IN O
25 CD O
mM NN O
Tris NNS O
, , O
pH NN O
7 CD O
. . O
5 CD O
, , O
1 CD O
M NNP O
NaCl NNP O
, , O
and CC O
then RB O
eluted VBN O
with IN O
184 CD O
micro JJ O
g NN O
/ SYM O
ml NN O
FLAG NN O
peptide NN O
prepared VBN O
in IN O
the DT O
same JJ O
buffer NN O
. . O

RESULTS NNS O

Expression NN O
of IN O
tagged VBN O
Scp160p NN O
in IN O
yeast NN B-Species

An DT O
N NN O
- HYPH O
terminal JJ O
FLAG NN O
- HYPH O
tagged VBN O
form NN O
of IN O
Scp160p NNP O
was VBD O
created VBN O
to TO O
facilitate VB O
detection NN O
of IN O
the DT O
protein NN O
in IN O
cells NNS O
and CC O
extracts NNS O
( , O
Fig NNP O
. . O
1A NN O
) -RRB- O
. . O

To TO O
probe VB O
functionality NN O
of IN O
this DT O
fusion NN O
protein NN O
, , O
we PRP O
used VBD O
two CD O
- HYPH O
step NN O
gene NN O
replacement NN O
( HYPH O
18 CD O
) -RRB- O
to TO O
substitute VB O
the DT O
modified VBN O
allele NN O
into IN O
the DT O
SCP160 NNP O
locus NN O
of IN O
haploid NN O
yeast NN B-Species
, , O
and CC O
then RB O
tested VBD O
the DT O
morphological JJ O
phenotype NN O
of IN O
the DT O
resultant JJ O
cells NNS O
. . O

All DT O
strains NNS O
were VBD O
confirmed VBN O
by IN O
PCR NNP O
analysis NN O
of IN O
the DT O
SCP160 NNP O
locus NN O
with IN O
appropriate JJ O
primers NNS O
( , O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
, , O
and CC O
expression NN O
of IN O
the DT O
tagged VBN O
protein NN O
was VBD O
confirmed VBN O
by IN O
western JJ O
blot NN O
analysis NN O
with IN O
the DT O
appropriate JJ O
antibody NN O
( , O
M2 NNP O
alpha NNP O
FLAG NNP O
) -RRB- O
( , O
Fig NNP O
. . O
1B NN O
) -RRB- O
. . O

In IN O
all DT O
cases NNS O
, , O
yeast NN B-Species
expressing VBG O
tagged VBN O
Scp160p NN O
in IN O
place NN O
of IN O
the DT O
native JJ O
protein NN O
appeared VBD O
indistinguishable JJ O
from IN O
the DT O
corresponding VBG O
wild JJ O
- HYPH O
type NN O
strains NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

As IN O
a DT O
negative JJ O
control NN O
, , O
we PRP O
also RB O
deleted VBD O
almost RB O
the DT O
entire JJ O
SCP160 NNP O
coding VBG O
region NN O
from IN O
the DT O
genomes NNS O
of IN O
these DT O
yeast NN B-Species
strains NNS O
( -LRB- O
Fig NNP O
. . O
1A NNP O
) -RRB- O
, , O
and CC O
confirmed VBD O
the DT O
expected VBN O
mutant JJ O
phenotype NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

Scp160p NN O
associates NNS O
with IN O
polyribosomes NNS O

To TO O
test VB O
the DT O
hypothesis NN O
that IN O
Scp160p NN O
associates NNS O
with IN O
polyribosomes NNS O
we PRP O
used VBD O
sucrose NN O
gradient NN O
ultracentrifugation NN O
to IN O
size NN O
- HYPH O
fractionate JJ O
subcellular JJ O
components NNS O
of IN O
lysates NNS O
prepared VBN O
from IN O
yeast NN B-Species
expressing VBG O
the DT O
N NN O
- HYPH O
terminal JJ O
FLAG NN O
- HYPH O
tagged VBN O
Scp160p NNP O
protein NN O
. . O

Western JJ O
blot NN O
analyses NNS O
of IN O
gradient JJ O
fractions NNS O
with IN O
an DT O
alpha NN O
- HYPH O
FLAG NNP O
antibody NN O
( , O
M2 NNP O
, , O
Boehringer NNP O
Mannheim NNP O
) -RRB- O
, , O
revealed VBD O
a DT O
160 CD O
kDa NN O
band NN O
that WDT O
was VBD O
most RBS O
abundant JJ O
in IN O
the DT O
denser JJ O
fractions NNS O
, , O
consistent JJ O
with IN O
the DT O
location NN O
of IN O
polyribosomes NNS O
( : O
> SYM O
80S CD O
) -RRB- O
( , O
Fig NNP O
. . O
2A NN O
, , O
solid JJ O
arrow NN O
) -RRB- O
. . O

A DT O
convenient JJ O
internal JJ O
control NN O
for IN O
these DT O
gradients NNS O
was VBD O
provided VBN O
by IN O
an DT O
unknown JJ O
endogenous JJ O
yeast NN B-Species
cross NN O
- HYPH O
reacting VBG O
protein NN O
at IN O
~ $ O
100 CD O
kDa NN O
, , O
that WDT O
exemplified VBD O
the DT O
migration NN O
pattern NN O
of IN O
a DT O
free JJ O
protein NN O
, , O
appearing VBG O
only RB O
in IN O
the DT O
upper JJ O
fractions NNS O
of IN O
the DT O
gradient NN O
( , O
Fig NNP O
. . O
2A NN O
, , O
open JJ O
arrow NN O
) -RRB- O
. . O

To TO O
determine VB O
whether IN O
the DT O
migration NN O
pattern NN O
of IN O
Scp160p NNP O
in IN O
these DT O
sucrose JJ O
gradients NNS O
truly RB O
reflected VBD O
association NN O
with IN O
yeast NN B-Species
polyribosomes NNS O
, , O
lysates NNS O
were VBD O
pre NN O
- HYPH O
treated VBN O
with IN O
either CC O
30 CD O
mM NN O
EDTA NNP O
or CC O
50 CD O
U NN O
/ SYM O
ml NNP O
RNase NNP O
One CD O
( HYPH O
Promega NNP O
) -RRB- O
immediately RB O
prior RB O
to IN O
sucrose JJ O
gradient NN O
fractionation NN O
. . O

EDTA NNP O
chelates VBZ O
Mg2 NNP O
+ CC O
cations NNS O
, , O
resulting VBG O
in IN O
the DT O
dissociation NN O
of IN O
the DT O
small JJ O
and CC O
large JJ O
ribosomal JJ O
subunits NNS O
, , O
reflected VBN O
in IN O
gradient NN O
profiles NNS O
( -LRB- O
OD254 NN O
) -RRB- O
by IN O
the DT O
disappearance NN O
of IN O
80S CD O
monosomes NNS O
and CC O
polyribosomes NNS O
along IN O
with IN O
a DT O
marked JJ O
increase NN O
in IN O
the DT O
abundance NN O
of IN O
free JJ O
ribosomal JJ O
subunits NNS O
( , O
Fig NNP O
. . O
2B NN O
) -RRB- O
. . O

Under IN O
these DT O
conditions NNS O
, , O
the DT O
greatest JJS O
intensity NN O
of IN O
FLAG NNP O
- HYPH O
Scp160p NNP O
signal NN O
was VBD O
seen VBN O
only RB O
in IN O
the DT O
upper JJ O
- HYPH O
most JJS O
fractions NNS O
of IN O
the DT O
gradient NN O
( , O
Fig NNP O
. . O
2B NN O
) -RRB- O
. . O

Alternatively RB O
, , O
pre JJ O
- HYPH O
treatment NN O
of IN O
lysates NNS O
with IN O
RNase NNP O
, , O
which WDT O
results VBZ O
in IN O
inter JJ O
- HYPH O
ribosomal JJ O
severing NN O
of IN O
translating VBG O
messages NNS O
, , O
gave VBD O
rise NN O
to IN O
a DT O
large JJ O
pool NN O
of IN O
single JJ O
80S NNS O
ribosomes NNS O
( -LRB- O
Fig NNP O
. . O
2C NNP O
) -RRB- O
. . O

Again RB O
, , O
FLAG NNP O
- HYPH O
Scp160p NNP O
was VBD O
shifted VBN O
to IN O
the DT O
uppermost JJ O
fractions NNS O
of IN O
these DT O
gradients NNS O
. . O

Although IN O
some DT O
of IN O
the DT O
Scp160p NNP O
signal NN O
was VBD O
detected VBN O
in IN O
fractions NNS O
larger JJR O
than IN O
40S NNS O
, , O
the DT O
migration NN O
pattern NN O
of IN O
the DT O
100 CD O
kDa NNP O
cross NN O
- HYPH O
reacting VBG O
protein NN O
in IN O
these DT O
experiments NNS O
indicated VBD O
that IN O
RNase NNP O
treatment NN O
caused VBD O
an DT O
apparent JJ O
diffusion NN O
of IN O
material NN O
in IN O
the DT O
upper JJ O
portion NN O
of IN O
the DT O
gradient NN O
. . O

Characterization NN O
of IN O
Scp160p NN O
- HYPH O
containing VBG O
complexes NNS O
following VBG O
EDTA NNP O
and CC O
RNase NNP O
treatment NN O

Gel NN O
- HYPH O
filtration NN O
chromatography NN O
was VBD O
used VBN O
to TO O
determine VB O
the DT O
apparent JJ O
molecular JJ O
weight NN O
of IN O
Scp160p NNP O
following VBG O
its PRP$ O
release NN O
from IN O
polyribosomes NNS O
by IN O
both CC O
EDTA NNP O
and CC O
RNase NNP O
treatment NN O
. . O

Lysates NNS O
were VBD O
prepared VBN O
as IN O
described VBN O
above RB O
for IN O
sucrose NN O
gradient NN O
analysis NN O
, , O
but CC O
were VBD O
instead RB O
size NN O
fractionated VBN O
over IN O
a DT O
Sephacryl NNP O
S NNP O
- HYPH O
300 CD O
Hi NNP O
- HYPH O
Prep NNP O
column NN O
, , O
with IN O
an DT O
inclusion NN O
cut VBN O
- HYPH O
off NN O
of IN O
1300 CD O
kDa NN O
. . O

As IN O
expected VBN O
, , O
Scp160p NNP O
from IN O
untreated JJ O
lysates NNS O
eluted VBN O
in IN O
the DT O
void NN O
volume NN O
, , O
confirming VBG O
its PRP$ O
association NN O
with IN O
large JJ O
complexes NNS O
, , O
ostensibly RB O
polyribosomes NNS O
( , O
Fig NNP O
. . O
3A NN O
, , O
solid JJ O
arrow NN O
) -RRB- O
. . O

In IN O
EDTA NNP O
treated VBN O
lysates NNS O
, , O
all DT O
Scp160p NNP O
signal NN O
was VBD O
still RB O
detected VBN O
in IN O
the DT O
void NN O
volume NN O
, , O
indicating VBG O
it PRP O
remained VBD O
in IN O
a DT O
complex NN O
of IN O
> SYM O
1300 CD O
kDa NN O
( : O
Fig NNP O
. . O
3B NN O
, , O
solid JJ O
arrow NN O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
limited JJ O
RNase NNP O
treatment NN O
( : O
10 CD O
min NN O
) -RRB- O
resulted VBD O
in IN O
the DT O
appearance NN O
of IN O
an DT O
Scp160p NN O
- HYPH O
containing VBG O
species NNS O
of IN O
~ $ O
450 CD O
kDa NN O
, , O
in IN O
addition NN O
to IN O
a DT O
fraction NN O
still RB O
visible JJ O
in IN O
the DT O
void NN O
( : O
Fig NNP O
. . O
3C NNP O
, , O
solid JJ O
arrow NN O
) -RRB- O
. . O

More RBR O
extensive JJ O
RNase NNP O
treatment NN O
( : O
30 CD O
min NN O
) -RRB- O
led VBN O
to IN O
complete JJ O
conversion NN O
to IN O
the DT O
450 CD O
kDa NN O
species NN O
( , O
Fig NNP O
. . O
3D NN O
, , O
solid JJ O
arrow NN O
) -RRB- O
. . O

Sequential JJ O
treatment NN O
, , O
first RB O
with IN O
RNase NNP O
, , O
then RB O
with IN O
EDTA NNP O
, , O
also RB O
resulted VBD O
in IN O
a DT O
450 CD O
kDa NN O
species NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
suggesting VBG O
that IN O
all DT O
components NNS O
of IN O
this DT O
apparent JJ O
450 CD O
kDa NN O
complex NN O
were VBD O
also RB O
present JJ O
following VBG O
EDTA NNP O
treatment NN O
alone RB O
. . O

As IN O
before RB O
, , O
the DT O
100 CD O
kDa NN O
, , O
endogenous JJ O
alpha NN O
- HYPH O
FLAG NNP O
cross NN O
- HYPH O
reacting VBG O
protein NN O
( , O
Fig NNP O
. . O
3 CD O
, , O
open JJ O
arrows NNS O
) -RRB- O
served VBD O
as IN O
a DT O
convenient JJ O
internal JJ O
control NN O
, , O
eluting VBG O
from IN O
the DT O
column NN O
at IN O
a DT O
volume NN O
consistent JJ O
with IN O
its PRP$ O
expected VBN O
monomeric JJ O
size NN O
. . O

To TO O
characterize VB O
further RB O
the DT O
stability NN O
of IN O
the DT O
large JJ O
( , O
apparent JJ O
molecular JJ O
weight NN O
> SYM O
1300 CD O
kDa NN O
) -RRB- O
, , O
EDTA NNP O
- HYPH O
resistant JJ O
complex NN O
, , O
lysates NNS O
were VBD O
treated VBN O
with IN O
increasing VBG O
concentrations NNS O
of IN O
NaCl NNP O
prior RB O
to IN O
size NN O
fractionation NN O
( , O
Fig NNP O
. . O
3 CD O
, , O
panels NNS O
E NN O
, , O
F NN O
and CC O
G NNP O
) -RRB- O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
3E CD O
, , O
at IN O
75 CD O
mM NN O
NaCl NNP O
, , O
the DT O
large JJ O
complex NN O
remained VBD O
intact JJ O
. . O

However RB O
, , O
at IN O
a DT O
NaCl NNP O
concentration NN O
of IN O
150 CD O
mM NN O
, , O
the DT O
Scp160p NNP O
complex NN O
was VBD O
partially RB O
reduced VBN O
to IN O
450 CD O
kDa NNS O
, , O
with IN O
some DT O
signal NN O
still RB O
remaining VBG O
in IN O
the DT O
void NN O
( , O
Fig NNP O
. . O
3F NNP O
, , O
solid JJ O
arrow NN O
) -RRB- O
. . O

Following VBG O
treatment NN O
with IN O
1 CD O
M NNP O
NaCl NNP O
, , O
Scp160p NNP O
was VBD O
only RB O
visible JJ O
as IN O
the DT O
450 CD O
kDa NN O
species NN O
( , O
Fig NNP O
. . O
3G NNP O
, , O
solid JJ O
arrow NN O
) -RRB- O
. . O

The DT O
fact NN O
that IN O
RNase NNP O
treatment NN O
and CC O
high JJ O
salt NN O
both DT O
generated VBN O
Scp160p NNP O
species NNS O
of IN O
similar JJ O
apparent JJ O
molecular JJ O
weight NN O
suggests VBZ O
that IN O
these DT O
high JJ O
salt NN O
concentrations NNS O
resulted VBD O
in IN O
the DT O
disassociation NN O
of IN O
RNA NN O
, , O
and CC O
perhaps RB O
other JJ O
components NNS O
, , O
from IN O
Scp160p NNP O
. . O

Pab1p NNP O
and CC O
Bfr1p NNP O
are VBP O
present JJ O
in IN O
EDTA NNP O
- HYPH O
resistant JJ O
Scp160p NNP O
- HYPH O
containing VBG O
complexes NNS O

To TO O
determine VB O
if IN O
the DT O
> SYM O
1300 CD O
kDa NN O
Scp160p NN O
- HYPH O
containing VBG O
complexes NNS O
remaining VBG O
after IN O
EDTA NNP O
treatment NN O
were VBD O
mRNPs NNS O
, , O
we PRP O
assayed VBD O
for IN O
the DT O
presence NN O
of IN O
the DT O
yeast NN B-Species
poly NN O
( , O
A NN O
) -RRB- O
binding NN O
protein NN O
, , O
Pab1p NNP O
, , O
following VBG O
alpha NN O
- HYPH O
FLAG NN O
affinity NN O
purification NN O
as IN O
illustrated VBN O
in IN O
Figure NN O
4 CD O
. . O

Pab1p NNP O
is VBZ O
an DT O
abundant JJ O
and CC O
well RB O
- HYPH O
characterized VBN O
component NN O
of IN O
mRNP NN O
complexes NNS O
in IN O
yeast NN B-Species
, , O
as RB O
well RB O
as IN O
higher JJR O
eukaryotes NNS O
( , O
14 CD O
, , O
15 CD O
, , O
25 CD O
) -RRB- O
. . O

As IN O
seen VBN O
in IN O
Figure NNP O
5A NN O
and CC O
B NN O
, , O
Pab1p NNP O
did VBD O
co VB O
- HYPH O
purify VB O
with IN O
FLAG NNP O
- HYPH O
Scp160p NNP O
; : O
moreover RB O
, , O
treatment NN O
with IN O
RNase NNP O
immediately RB O
prior RB O
to IN O
FLAG NNP O
- HYPH O
purification NN O
completely RB O
abolished VBD O
this DT O
interaction NN O
( -LRB- O
Fig NNP O
. . O
5C NNP O
) -RRB- O
, , O
indicating VBG O
an DT O
RNA NN O
- HYPH O
dependant JJ O
association NN O
between IN O
these DT O
two CD O
proteins NNS O
. . O

We PRP O
also RB O
probed VBD O
the DT O
isolated VBN O
complexes NNS O
for IN O
the DT O
presence NN O
of IN O
another DT O
abundant JJ O
mRNP NN O
- HYPH O
component NN O
protein NN O
, , O
Pub1p NNP O
( , O
23 CD O
, , O
26 CD O
) -RRB- O
. . O

Pub1p NNP O
, , O
as IN O
opposed VBN O
to IN O
Pab1p NNP O
, , O
is VBZ O
not RB O
reported VBN O
to TO O
associate VB O
with IN O
polyribosomes NNS O
, , O
and CC O
is VBZ O
hypothesized VBN O
to TO O
bind VB O
a DT O
pool NN O
of IN O
non AFX O
- HYPH O
translatable JJ O
mRNAs NNS O
( SYM O
23 CD O
) -RRB- O
. . O

As IN O
predicted VBN O
, , O
Pub1p NNP O
did VBD O
not RB O
co VB O
- HYPH O
purify VB O
with IN O
Scp160p NNP O
( : O
Fig NNP O
. . O
5D CD O
) -RRB- O
. . O

The DT O
absence NN O
of IN O
Pub1p NNP O
in IN O
Scp160p NNP O
- HYPH O
containing VBG O
complexes NNS O
served VBD O
as IN O
a DT O
negative JJ O
control NN O
, , O
demonstrating VBG O
that IN O
abundant JJ O
RNA NN O
- HYPH O
binding VBG O
proteins NNS O
did VBD O
not RB O
co VB O
- HYPH O
purify VB O
non NN O
- HYPH O
specifically RB O
by IN O
this DT O
protocol NN O
. . O

In IN O
addition NN O
, , O
we PRP O
performed VBD O
mock JJ O
purifications NNS O
using VBG O
lysates NNS O
from IN O
yeast NN B-Species
expressing VBG O
the DT O
wild JJ O
- HYPH O
type NN O
allele NN O
of IN O
SCP160 NNP O
without IN O
the DT O
FLAG NNP O
epitope NN O
( , O
Fig NNP O
. . O
5F NNP O
) -RRB- O
, , O
or CC O
with IN O
an DT O
unrelated JJ O
FLAG NN O
- HYPH O
tagged VBN O
protein NN O
, , O
human JJ B-Species
galactose NN O
1 CD O
- HYPH O
phosphate NN O
uridylyltransferase NN O
( -LRB- O
GALT NNP O
) -RRB- O
( , O
Fig NNP O
. . O
5G NNP O
, , O
lower JJR O
panel NN O
) -RRB- O
. . O

In IN O
neither DT O
case NN O
did VBD O
Pab1p NNP O
bind VB O
and CC O
elute VB O
from IN O
the DT O
FLAG NNP O
affinity NN O
column NN O
. . O

Finally RB O
, , O
no DT O
bands NNS O
were VBD O
visible JJ O
by IN O
colloidal JJ O
G250 NNP O
Coomassie NNP O
staining NN O
of IN O
samples NNS O
from IN O
the DT O
mock JJ O
( , O
wild JJ O
- HYPH O
type NN O
) -RRB- O
preparations NNS O
( , O
Fig NNP O
. . O
5E CD O
) -RRB- O
, , O
further RB O
demonstrating VBG O
the DT O
specificity NN O
of IN O
this DT O
procedure NN O
. . O

By IN O
colloidal JJ O
G250 NNP O
Coomassie NNP O
staining NN O
( , O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
of IN O
the DT O
FLAG NNP O
- HYPH O
purified VBN O
complex NN O
, , O
we PRP O
observed VBD O
in IN O
addition NN O
to IN O
Scp160p NNP O
, , O
two CD O
major JJ O
bands NNS O
, , O
at IN O
~ $ O
70 CD O
kDa NN O
and CC O
~ $ O
55 CD O
kDa NN O
, , O
which WDT O
ostensibly RB O
represent VBP O
co NN O
- HYPH O
purifying VBG O
proteins NNS O
( , O
Fig NNP O
. . O
5A NN O
, , O
bottom NN O
panel NN O
) -RRB- O
. . O

Western JJ O
blot NN O
analysis NN O
suggested VBD O
that IN O
the DT O
~ $ O
70 CD O
kDa NN O
species NN O
is VBZ O
Pab1p NNP O
. . O

To TO O
identify VB O
the DT O
55 CD O
kDa NN O
protein NN O
, , O
that DT O
band NN O
was VBD O
excised VBN O
from IN O
the DT O
gel NN O
, , O
and CC O
sent VBN O
to IN O
the DT O
Keck NNP O
microchemical NN O
facility NN O
at IN O
Yale NNP O
University NNP O
for IN O
analysis NN O
by IN O
in IN O
gel NN O
tryptic JJ O
digestion NN O
, , O
followed VBN O
by IN O
MALDI NNP O
- HYPH O
mass NN O
spectrometry NN O
. . O

The DT O
results NNS O
of IN O
these DT O
analyses NNS O
clearly RB O
identified VBD O
the DT O
unknown JJ O
protein NN O
as IN O
Bfr1p NNP O
. . O

To TO O
confirm VB O
this DT O
result NN O
, , O
an DT O
N CD O
- HYPH O
terminal JJ O
HA NN O
tag NN O
was VBD O
engineered VBN O
onto IN O
the DT O
genomic JJ O
BFR1 NNP O
locus NN O
in IN O
strains NNS O
expressing VBG O
FLAG NN O
- HYPH O
tagged VBN O
or CC O
wild JJ O
- HYPH O
type NN O
Scp160p NN O
. . O

Scp160p NN O
complexes NNS O
were VBD O
then RB O
isolated VBN O
from IN O
both DT O
of IN O
these DT O
strains NNS O
using VBG O
the DT O
protocol NN O
described VBN O
above RB O
. . O

As IN O
seen VBN O
in IN O
Figure NNP O
6 CD O
, , O
an DT O
HA NN O
- HYPH O
tagged VBN O
protein NN O
of IN O
~ $ O
55 CD O
kDa NN O
( HYPH O
center NN O
panel NN O
) -RRB- O
appears VBZ O
in IN O
alpha NN O
- HYPH O
FLAG NN O
column NN O
elutions NNS O
only RB O
when WRB O
FLAG NNP O
- HYPH O
Scp160p NNP O
is VBZ O
also RB O
present JJ O
( , O
top JJ O
panel NN O
) -RRB- O
. . O

No DT O
signal NN O
is VBZ O
visible JJ O
in IN O
mock JJ O
purifications NNS O
of IN O
extracts NNS O
where WRB O
Scp160p NN O
is VBZ O
not RB O
FLAG NN O
- HYPH O
tagged VBN O
( : O
bottom JJ O
panel NN O
) -RRB- O
. . O

Monomeric NNP O
Scp160p NNP O
migrates VBZ O
as IN O
a DT O
~ $ O
450 CD O
kDa NN O
protein NN O
under IN O
native JJ O
conditions NNS O

As IN O
a DT O
first JJ O
step NN O
to TO O
characterize VB O
the DT O
post NN O
RNase NNP O
/ SYM O
NaCl NNP O
450 CD O
kDa NNP O
Scp160p NNP O
species NN O
we PRP O
compared VBD O
it PRP O
with IN O
Scp160p NNP O
over RB O
- HYPH O
expressed VBN O
and CC O
purified VBN O
from IN O
an DT O
exogenous JJ O
host NN O
, , O
the DT O
yeast NN B-Species
Pichia NNP B-Species
pastoris NN I-Species
. . O

The DT O
purified JJ O
N NNP O
- HYPH O
terminal NN O
FLAG NNP O
/ SYM O
hexahistidine NN O
- HYPH O
tagged VBN O
Scp160p NNP O
was VBD O
run VBN O
over IN O
an DT O
S300 CD O
gel NN O
filtration NN O
column NN O
; , O
2 CD O
ml NNS O
fractions NNS O
were VBD O
collected VBN O
and CC O
analyzed VBN O
by IN O
alpha NN O
- HYPH O
FLAG NNP O
western JJ O
blot NN O
. . O

As IN O
seen VBN O
in IN O
Figure NNP O
7A NNP O
, , O
purified JJ O
Scp160p NN O
eluted VBN O
at IN O
a DT O
volume NN O
consistent JJ O
with IN O
a DT O
> SYM O
443 CD O
kDa NN O
protein NN O
. . O

To TO O
confirm VB O
that IN O
no DT O
other JJ O
proteins NNS O
were VBD O
associated VBN O
with IN O
the DT O
purified VBN O
Scp160p NNP O
, , O
12 CD O
micro JJ O
l NN O
of IN O
the DT O
protein NN O
was VBD O
run VBN O
on IN O
SDS NNP O
- HYPH O
PAGE NNP O
and CC O
subjected VBN O
to IN O
colloidal JJ O
G250 NNP O
Coomassie NNP O
staining VBG O
before IN O
loading VBG O
on IN O
the DT O
S NNP O
- HYPH O
300 CD O
column NN O
( : O
Fig NNP O
. . O
7B NN O
) -RRB- O
. . O

As IN O
shown VBN O
, , O
no DT O
bands NNS O
other JJ O
than IN O
Scp160p NNP O
were VBD O
visible JJ O
. . O

Several JJ O
KH NNP O
- HYPH O
domain NN O
proteins NNS O
, , O
including VBG O
Sam68 NNP O
and CC O
FMRP NNP O
, , O
have VBP O
been VBN O
reported VBN O
to TO O
form VB O
homodimers NNS O
in IN O
vivo NN O
( SYM O
27 CD O
) -RRB- O
. . O

Therefore RB O
, , O
we PRP O
explored VBD O
the DT O
possibility NN O
that IN O
the DT O
~ $ O
450 CD O
kDa NN O
Scp160p NNP O
species NN O
might MD O
contain VB O
two CD O
or CC O
more JJR O
copies NNS O
of IN O
Scp160p NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
yeast NN B-Species
expressing VBG O
FLAG NN O
- HYPH O
Scp160p NNP O
were VBD O
transfected VBN O
with IN O
a DT O
centromeric JJ O
plasmid NN O
, , O
YCplac22 NNP O
- HYPH O
HA NNP O
- HYPH O
Scp160p NNP O
, , O
encoding VBG O
a DT O
distinct JJ O
, , O
HA NN O
- HYPH O
tagged VBN O
allele NN O
of IN O
the DT O
protein NN O
. . O

The DT O
functionality NN O
of IN O
this DT O
tagged VBN O
protein NN O
had VBD O
previously RB O
been VBN O
demonstrated VBN O
by IN O
polyribosome NN O
association NN O
as RB O
well RB O
as IN O
complementation NN O
of IN O
the DT O
null JJ O
morphological JJ O
phenotype NN O
in IN O
cells NNS O
expressing VBG O
only RB O
HA NNP O
- HYPH O
Scp160p NNP O
( : O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

As IN O
seen VBN O
in IN O
Figure NNP O
7C NNP O
, , O
when WRB O
yeast NN B-Species
co NN O
- HYPH O
expressing VBG O
the DT O
two CD O
alleles NNS O
were VBD O
lysed VBN O
and CC O
the DT O
FLAG NNP O
- HYPH O
tagged VBN O
protein NN O
was VBD O
isolated VBN O
as IN O
described VBN O
above RB O
, , O
no DT O
HA NN O
- HYPH O
Scp160p NN O
co NN O
- HYPH O
purified VBN O
with IN O
the DT O
FLAG NNP O
- HYPH O
Scp160p NNP O
. . O

These DT O
data NNS O
strongly RB O
suggest VBP O
that IN O
Scp160p NNP O
does VBZ O
not RB O
form VB O
homo NN O
- HYPH O
dimers NNS O
or CC O
higher JJR O
- HYPH O
order NN O
multimers NNS O
in IN O
vivo NN O
, , O
and CC O
that IN O
the DT O
~ $ O
450 CD O
kDa NN O
species NN O
of IN O
Scp160p NNP O
observed VBN O
is VBZ O
simply RB O
the DT O
monomeric JJ O
protein NN O
. . O

DISCUSSION NN O

The DT O
data NNS O
presented VBN O
here RB O
demonstrate VBP O
two CD O
main JJ O
points NNS O
regarding VBG O
the DT O
biochemical JJ O
associations NNS O
and CC O
function NN O
of IN O
Scp160p NN O
in IN O
yeast NN B-Species
. . O

First RB O
, , O
the DT O
sucrose JJ O
gradient NN O
fractionation NN O
data NNS O
clearly RB O
demonstrate VBP O
that IN O
Scp160p NNP O
exists VBZ O
primarily RB O
associated VBN O
with IN O
large JJ O
complexes NNS O
, , O
likely JJ O
to TO O
be VB O
polyribosomes NNS O
. . O

To IN O
our PRP$ O
knowledge NN O
, , O
this DT O
is VBZ O
the DT O
first JJ O
time NN O
a DT O
vigilin NN O
family NN O
member NN O
has VBZ O
been VBN O
shown VBN O
to TO O
associate VB O
with IN O
polyribosomes NNS O
in IN O
this DT O
manner NN O
. . O

Interestingly RB O
, , O
Weber NNP O
and CC O
colleagues NNS O
did VBD O
not RB O
observe VB O
sucrose NN O
gradient NN O
fractionation NN O
data NNS O
consistent JJ O
with IN O
polyribosome NN O
association NN O
of IN O
Scp160p NNP O
( SYM O
5 CD O
) -RRB- O
. . O

These DT O
authors NNS O
hypothesized VBD O
that IN O
Scp160p NN O
associates VBZ O
only RB O
with IN O
membrane NN O
- HYPH O
bound VBN O
polyribosomes NNS O
, , O
and CC O
that IN O
Scp160p NNP O
is VBZ O
not RB O
found VBN O
complexed VBN O
with IN O
cytosolic JJ O
polyribosomes NNS O
( , O
5 CD O
) -RRB- O
. . O

Our PRP$ O
data NNS O
do VBP O
not RB O
support VB O
this DT O
hypothesis NN O
, , O
since IN O
unlike IN O
Weber NNP O
and CC O
colleagues NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
detect VB O
significant JJ O
amounts NNS O
of IN O
Scp160p NN O
associated VBN O
with IN O
polyribosomes NNS O
without IN O
using VBG O
detergents NNS O
during IN O
preparation NN O
. . O

There EX O
are VBP O
several JJ O
possible JJ O
explanations NNS O
for IN O
this DT O
discrepancy NN O
. . O

First RB O
, , O
the DT O
lysate NN O
buffer NN O
utilized VBN O
by IN O
that DT O
group NN O
contained VBD O
100 CD O
mM NN O
NaCl NNP O
, , O
whereas IN O
our PRP$ O
buffer NN O
contained VBD O
50 CD O
mM NN O
KCl NNP O
. . O

Our PRP$ O
data NNS O
shown VBN O
in IN O
Figure NN O
3 CD O
suggest VBP O
that IN O
100 CD O
mM NN O
NaCl NNP O
may MD O
have VB O
caused VBN O
an DT O
instability NN O
in IN O
the DT O
Scp160p NNP O
- HYPH O
RNA NNP O
interaction NN O
, , O
leading VBG O
to IN O
release NN O
from IN O
polyribosomes NNS O
during IN O
their PRP$ O
procedure NN O
. . O

Secondly RB O
, , O
Weber NNP O
' POS O
s POS O
lysate NN O
buffer NN O
reportedly RB O
contained VBD O
heparin NN O
to TO O
inhibit VB O
ribonucleases NNS O
; : O
a DT O
number NN O
of IN O
reports NNS O
( , O
28 CD O
, , O
29 CD O
) -RRB- O
suggest VBP O
that IN O
heparin NN O
can MD O
disrupt VB O
RNA NN O
- HYPH O
protein NN O
interactions NNS O
. . O

Although IN O
we PRP O
have VBP O
not RB O
in IN O
the DT O
past NN O
included VBN O
heparin NN O
in IN O
any DT O
of IN O
our PRP$ O
experiments NNS O
, , O
we PRP O
have VBP O
observed VBN O
disruption NN O
of IN O
the DT O
polyribosome NN O
association NN O
in IN O
buffer NN O
containing VBG O
residual JJ O
diethylpyrocarbonate NN O
, , O
another DT O
inhibitor NN O
of IN O
ribonucleases NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Second RB O
, , O
our PRP$ O
data NNS O
provide VBP O
compelling JJ O
evidence NN O
that IN O
Scp160p NNP O
is VBZ O
released VBN O
from IN O
polyribosomes NNS O
as IN O
a DT O
component NN O
of IN O
an DT O
mRNP NNP O
complex NN O
. . O

Since IN O
Scp160p NNP O
does VBZ O
not RB O
remain VB O
associated VBN O
with IN O
either CC O
single JJ O
ribosomes NNS O
or CC O
ribosomal JJ O
subunits NNS O
following VBG O
treatment NN O
with IN O
EDTA NNP O
or CC O
RNase NNP O
, , O
it PRP O
seems VBZ O
unlikely JJ O
that IN O
Scp160p NNP O
is VBZ O
a DT O
constitutive JJ O
component NN O
of IN O
the DT O
translational JJ O
machinery NN O
. . O

Partial JJ O
purification NN O
of IN O
the DT O
EDTA NNP O
- HYPH O
resistant JJ O
Scp160p NNP O
complexes NNS O
allowed VBD O
us PRP O
to TO O
demonstrate VB O
the DT O
presence NN O
of IN O
Pab1p NNP O
but CC O
not RB O
Pub1p NNP O
in IN O
these DT O
preparations NNS O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
the DT O
idea NN O
that IN O
Scp160p NN O
associates VBZ O
with IN O
polyribosomes NNS O
as IN O
a DT O
component NN O
of IN O
mRNP NNP O
complexes NNS O
. . O

Previously RB O
, , O
Scp160p NNP O
had VBD O
been VBN O
shown VBN O
to TO O
bind VB O
ribohomopolymers NNS O
and CC O
rRNA NNP O
in IN O
vitro NN O
, , O
although IN O
the DT O
in IN O
vivo NN O
nucleic JJ O
acid NN O
targets NNS O
of IN O
Scp160p NNP O
were VBD O
unknown JJ O
( : O
5 CD O
) -RRB- O
. . O

The DT O
presence NN O
of IN O
Pab1p NNP O
in IN O
RNase NNP O
- HYPH O
sensitive JJ O
Scp160p NNP O
complexes NNS O
indicates VBZ O
that IN O
Scp160p NNP O
is VBZ O
primarily RB O
bound VBN O
to IN O
polyadenylated JJ O
RNAs NNS O
. . O

Whether IN O
or CC O
not RB O
Scp160p NN O
binds VBZ O
only RB O
specific JJ O
sets NNS O
of IN O
mRNAs NNS O
will MD O
be VB O
the DT O
subject NN O
of IN O
future JJ O
studies NNS O
. . O

In IN O
addition NN O
to IN O
Scp160p NNP O
and CC O
Pab1p NNP O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
third JJ O
component NN O
of IN O
the DT O
complex NN O
, , O
the DT O
protein NN O
Bfr1p NNP O
. . O

The DT O
gene NN O
, , O
BFR1 NNP O
, , O
was VBD O
originally RB O
identified VBN O
in IN O
a DT O
screen NN O
for IN O
high JJ O
- HYPH O
copy NN O
suppressors NNS O
of IN O
Brefeldin NNP O
- HYPH O
A NNP O
induced VBN O
lethality NN O
, , O
suggesting VBG O
a DT O
role NN O
in IN O
the DT O
secretory NN O
pathway NN O
( , O
16 CD O
) -RRB- O
. . O

Interestingly RB O
, , O
however RB O
, , O
bfr1 NNP O
null JJ O
mutants NNS O
do VBP O
not RB O
demonstrate VB O
any DT O
defects NNS O
in IN O
the DT O
secretory NN O
pathway NN O
, , O
but CC O
rather RB O
display VBP O
similar JJ O
phenotypes NNS O
to IN O
scp160 CD O
null JJ O
mutants NNS O
, , O
most RBS O
notably RB O
increased VBN O
ploidy JJ O
and CC O
increased VBN O
cell NN O
size NN O
( SYM O
16 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
therefore RB O
unclear JJ O
whether IN O
Bfr1p NNP O
is VBZ O
capable JJ O
of IN O
functioning VBG O
in IN O
both CC O
RNA NNP O
metabolism NN O
and CC O
secretion NN O
directly RB O
, , O
or CC O
if IN O
the DT O
Scp160p NNP O
- HYPH O
Bfr1p NNP O
complex NN O
regulates VBZ O
the DT O
expression NN O
of IN O
one CD O
or CC O
more JJR O
secretory JJ O
genes NNS O
at IN O
the DT O
post NN O
- HYPH O
transcriptional JJ O
level NN O
. . O

Additionally RB O
, , O
two CD O
- HYPH O
hybrid NN O
analysis NN O
indicated VBD O
an DT O
interaction NN O
of IN O
Bfr1p NNP O
with IN O
the DT O
protein NN O
Bbp1p NNP O
, , O
a DT O
component NN O
of IN O
the DT O
mitotic JJ O
spindle NN O
apparatus NN O
( SYM O
30 CD O
) -RRB- O
. . O

While IN O
Bbp1p NNP O
is VBZ O
an DT O
essential JJ O
gene NN O
, , O
overexpression NN O
leads VBZ O
to IN O
a DT O
phenotype NN O
similar JJ O
to IN O
both DT O
bfr1 NN O
and CC O
scp160 NN O
null JJ O
strains NNS O
( SYM O
30 CD O
) -RRB- O
. . O

Future JJ O
work NN O
will MD O
address VB O
the DT O
functional JJ O
relationship NN O
between IN O
Scp160p NNP O
and CC O
Bfr1p NNP O
including VBG O
the DT O
possibility NN O
that IN O
these DT O
proteins NNS O
represent VBP O
a DT O
regulatory JJ O
mechanism NN O
connecting VBG O
the DT O
translational JJ O
machinery NN O
with IN O
cell NN O
division NN O
and CC O
/ SYM O
or CC O
the DT O
secretory NN O
pathway NN O
. . O

Following VBG O
treatment NN O
with IN O
either CC O
RNase NNP O
or CC O
> SYM O
150 CD O
mM NN O
NaCl NNP O
, , O
Scp160p NNP O
remained VBD O
as IN O
an DT O
apparent JJ O
~ $ O
450 CD O
kDa NN O
species NNS O
. . O

Considering VBG O
that IN O
purified JJ O
Scp160p NNP O
alone RB O
also RB O
migrates VBZ O
at IN O
this DT O
size NN O
, , O
we PRP O
conclude VBP O
that IN O
this DT O
apparent JJ O
complex NN O
may MD O
consist VB O
only RB O
of IN O
Scp160p NNP O
, , O
although IN O
the DT O
presence NN O
of IN O
other JJ O
small JJ O
components NNS O
cannot MD O
be VB O
ruled VBN O
out RP O
at IN O
this DT O
time NN O
. . O

Furthermore RB O
, , O
by IN O
utilizing VBG O
yeast NN B-Species
co NN O
- HYPH O
expressing VBG O
two CD O
distinct JJ O
epitope NN O
- HYPH O
tagged VBN O
versions NNS O
of IN O
Scp160p NN O
, , O
we PRP O
have VBP O
ruled VBN O
out RP O
the DT O
possibility NN O
of IN O
self NN O
- HYPH O
association NN O
of IN O
Scp160p NN O
. . O

Although IN O
both DT O
tagged VBN O
proteins NNS O
appear VBP O
functional JJ O
, , O
it PRP O
remains VBZ O
a DT O
formal JJ O
possibility NN O
that IN O
the DT O
tags NNS O
somehow RB O
prevented VBD O
formation NN O
of IN O
FLAG NNP O
- HYPH O
HA NNP O
hetero NN O
- HYPH O
complexes NNS O
. . O

Nonetheless RB O
, , O
it PRP O
seems VBZ O
most RBS O
likely JJ O
that IN O
native JJ O
Scp160p NNP O
monomers NNS O
may MD O
simply RB O
migrate VB O
aberrantly RB O
under IN O
native JJ O
conditions NNS O
due IN O
to IN O
an DT O
unusual JJ O
shape NN O
or CC O
some DT O
other JJ O
physical JJ O
property NN O
. . O

In IN O
conclusion NN O
we PRP O
have VBP O
shown VBN O
convincing JJ O
evidence NN O
that IN O
Scp160p NNP O
exists VBZ O
in IN O
yeast NN B-Species
cytoplasmic JJ O
extracts NNS O
primarily RB O
associated VBN O
with IN O
polyribosomes NNS O
. . O

We PRP O
have VBP O
purified VBN O
Scp160p NNP O
following VBG O
disruption NN O
of IN O
polyribosomes NNS O
with IN O
EDTA NNP O
, , O
and CC O
identified VBN O
two CD O
associated VBN O
proteins NNS O
: : O
Pab1p NNP O
and CC O
Bfr1p NNP O
. . O

The DT O
presence NN O
of IN O
Pab1p NNP O
suggests VBZ O
that IN O
Scp160p NN O
associates VBZ O
with IN O
polyribosomes NNS O
as IN O
a DT O
component NN O
of IN O
an DT O
mRNP NN O
, , O
demonstrating VBG O
Scp160p NN O
to TO O
be VB O
the DT O
first JJ O
S NN B-Species
. . I-Species
cerevisiae JJ I-Species
multiple JJ O
- HYPH O
KH NN O
domain NN O
protein NN O
characterized VBN O
to TO O
function VB O
in IN O
this DT O
way NN O
. . O

HP1 NN O
modulates VBZ O
the DT O
transcription NN O
of IN O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
in IN O
Drosophila NNP B-Species
melanogaster NN I-Species

Abstract JJ O

Heterochromatin NN O
protein NN O
1 CD O
( , O
HP1 NN O
) -RRB- O
was VBD O
originally RB O
described VBN O
as IN O
a DT O
non AFX O
- HYPH O
histone NN O
chromosomal JJ O
protein NN O
and CC O
is VBZ O
required VBN O
for IN O
transcriptional JJ O
gene NN O
silencing NN O
and CC O
the DT O
formation NN O
of IN O
heterochromatin NN O
. . O

Although IN O
it PRP O
is VBZ O
localized VBN O
primarily RB O
at IN O
pericentric JJ O
heterochromatin NN O
, , O
a DT O
scattered JJ O
distribution NN O
over IN O
a DT O
large JJ O
number NN O
of IN O
euchromatic JJ O
loci NN O
is VBZ O
also RB O
evident JJ O
. . O

Here RB O
, , O
we PRP O
provide VBP O
evidence NN O
that IN O
Drosophila NNP B-Species
HP1 NNP O
is VBZ O
essential JJ O
for IN O
the DT O
maintenance NN O
of IN O
active JJ O
transcription NN O
of IN O
euchromatic JJ O
genes NNS O
functionally RB O
involved VBN O
in IN O
cell NN O
- HYPH O
cycle NN O
progression NN O
, , O
including VBG O
those DT O
required VBN O
for IN O
DNA NN O
replication NN O
and CC O
mitosis NN O
. . O

Depletion NN O
of IN O
HP1 NN O
in IN O
proliferating VBG O
embryonic JJ O
cells NNS O
caused VBD O
aberrant JJ O
progression NN O
of IN O
the DT O
cell NN O
cycle NN O
at IN O
S NNP O
phase NN O
and CC O
G2 NNP O
/ SYM O
M NNP O
phase NN O
, , O
linked VBN O
to IN O
aberrant JJ O
chromosome NN O
segregation NN O
, , O
cytokinesis NN O
, , O
and CC O
an DT O
increase NN O
in IN O
apoptosis NN O
. . O

The DT O
chromosomal JJ O
distribution NN O
of IN O
Aurora NNP O
B NNP O
, , O
and CC O
the DT O
level NN O
of IN O
phosphorylation NN O
of IN O
histone NN O
H3 NN O
serine NN O
10 CD O
were VBD O
also RB O
altered VBN O
in IN O
the DT O
absence NN O
of IN O
HP1 NN O
. . O

Using VBG O
chromatin NN O
immunoprecipitation NN O
analysis NN O
, , O
we PRP O
further RB O
demonstrate VBP O
that IN O
the DT O
promoters NNS O
of IN O
a DT O
number NN O
of IN O
cell NN O
- HYPH O
cycle NN O
regulator NN O
genes NNS O
are VBP O
bound VBN O
to IN O
HP1 NNP O
, , O
supporting VBG O
a DT O
direct JJ O
role NN O
for IN O
HP1 NN O
in IN O
their PRP$ O
active JJ O
transcription NN O
. . O

Overall RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
HP1 NN O
is VBZ O
essential JJ O
for IN O
the DT O
maintenance NN O
of IN O
cell NN O
- HYPH O
cycle NN O
progression NN O
and CC O
the DT O
transcription NN O
of IN O
cell NN O
- HYPH O
cycle NN O
regulatory JJ O
genes NNS O
. . O

The DT O
results NNS O
also RB O
support VBP O
the DT O
view NN O
that IN O
HP1 NNP O
is VBZ O
a DT O
positive JJ O
regulator NN O
of IN O
transcription NN O
in IN O
euchromatin NN O
. . O

INTRODUCTION NN O

Chromatin NN O
in IN O
higher JJR O
eukaryotes NNS O
is VBZ O
subdivided VBN O
into IN O
different JJ O
functional JJ O
compartments NNS O
termed VBN O
heterochromatin NN O
and CC O
euchromatin NN O
( , O
1 CD O
) -RRB- O
. . O

Heterochromatin NN O
differs VBZ O
from IN O
euchromatin NN O
in IN O
its PRP$ O
DNA NN O
composition NN O
, , O
replication NN O
timing NN O
, , O
condensation NN O
throughout IN O
the DT O
cell NN O
cycle NN O
, , O
and CC O
its PRP$ O
ability NN O
to TO O
silence VB O
euchromatic JJ O
genes NNS O
placed VBN O
adjacent JJ O
to IN O
or CC O
within IN O
its PRP$ O
territory NN O
, , O
often RB O
described VBN O
as IN O
position NN O
- HYPH O
effect NN O
- HYPH O
variegation NN O
( -LRB- O
PEV NNP O
) -RRB- O
( , O
2 CD O
) -RRB- O
. . O

Heterochromatin NN O
protein NN O
1 CD O
( -LRB- O
HP1 NN O
) -RRB- O
was VBD O
the DT O
first JJ O
protein NN O
identified VBN O
in IN O
Drosophila NNP B-Species
melanogaster NN I-Species
as IN O
a DT O
heterochromatin NN O
- HYPH O
associated VBN O
protein NN O
( , O
3 CD O
) -RRB- O
; , O
the DT O
corresponding VBG O
gene NN O
has VBZ O
been VBN O
cloned VBN O
from IN O
a DT O
number NN O
of IN O
organisms NNS O
and CC O
is VBZ O
highly RB O
conserved VBN O
from IN O
yeast NN B-Species
to IN O
human NN B-Species
( , O
4 CD O
) -RRB- O
. . O

Polytene NN O
chromosome NN O
staining NN O
showed VBD O
that IN O
, , O
in IN O
Drosophila NNP B-Species
, , O
HP1 NN O
is VBZ O
distributed VBN O
mainly RB O
in IN O
pericentric JJ O
heterochromatin NN O
, , O
telomeric JJ O
heterochromatin NN O
, , O
the DT O
banded JJ O
small JJ O
fourth JJ O
chromosome NN O
( , O
5 CD O
- SYM O
8 CD O
) -RRB- O
, , O
as RB O
well RB O
as IN O
~ $ O
200 CD O
individual JJ O
loci NN O
scattered VBN O
throughout IN O
the DT O
euchromatic JJ O
chromosomal JJ O
arms NNS O
( SYM O
5 CD O
) -RRB- O
. . O

The DT O
gene NN O
encoding VBG O
HP1 NN O
in IN O
D NNP B-Species
. . I-Species
melanogaster NN I-Species
, , O
Su NNP O
( , O
var NNP O
) -RRB- O
2 CD O
- HYPH O
5 CD O
, , O
was VBD O
isolated VBN O
as IN O
a DT O
suppressor NN O
of IN O
PEV NNP O
( , O
9 CD O
- SYM O
11 CD O
) -RRB- O
. . O

The DT O
protein NN O
contains VBZ O
a DT O
highly RB O
conserved VBN O
motif NN O
, , O
the DT O
chromo NN O
( , O
chromatin NN O
organization NN O
modifier NN O
) -RRB- O
domain NN O
, , O
similar JJ O
to IN O
Polycomb NNP O
( -LRB- O
Pc NNP O
) -RRB- O
, , O
a DT O
repressor NN O
of IN O
homeotic JJ O
genes NNS O
( SYM O
12 CD O
) -RRB- O
. . O

The DT O
association NN O
between IN O
HP1 NN O
and CC O
pericentric JJ O
heterochromatin NN O
is VBZ O
believed VBN O
to TO O
occur VB O
via IN O
the DT O
chromo NN O
domain NN O
of IN O
HP1 NNP O
and CC O
the DT O
N NNP O
- HYPH O
terminal JJ O
tail NN O
of IN O
histone NN O
H3 NN O
methylated VBN O
at IN O
lysine NN O
9 CD O
( SYM O
13 CD O
, , O
14 CD O
) -RRB- O
, , O
generated VBN O
by IN O
histone NN O
methyltransferase NN O
- HYPH O
Su NNP O
( HYPH O
var NN O
) SYM O
3 CD O
- HYPH O
9 CD O
, , O
a DT O
partner NN O
of IN O
HP1 NN O
in IN O
pericentric NN O
heterochromatin NN O
( SYM O
15 CD O
) -RRB- O
. . O

The DT O
C NNP O
- HYPH O
terminal JJ O
chromo NN O
' `` O
shadow NN O
' '' O
domain NN O
of IN O
HP1 NNP O
interacts VBZ O
with IN O
other JJ O
silencing NN O
complexes NNS O
to TO O
suppress VB O
local JJ O
transcriptional JJ O
activity NN O
( : O
15 CD O
- SYM O
18 CD O
) -RRB- O
. . O

However RB O
, , O
studies NNS O
of IN O
HP1 NNP O
chromosomal JJ O
distribution NN O
also RB O
showed VBD O
that IN O
HP1 NNP O
does VBZ O
not RB O
always RB O
co VB O
- HYPH O
localize VB O
with IN O
lysine NN O
9 CD O
methylated JJ O
histone NN O
H3 NNP O
or CC O
Su NNP O
( HYPH O
var NNP O
) SYM O
3 CD O
- SYM O
9 CD O
, , O
especially RB O
in IN O
euchromatic JJ O
regions NNS O
( , O
19 CD O
- SYM O
21 CD O
) -RRB- O
; : O
in IN O
some DT O
cases NNS O
, , O
HP1 NNP O
is VBZ O
found VBN O
directly RB O
bound VBN O
to IN O
DNA NNP O
( SYM O
22 CD O
, , O
23 CD O
) -RRB- O
. . O

All PDT O
these DT O
features NNS O
argue VBP O
for IN O
distinct JJ O
roles NNS O
for IN O
HP1 NN O
in IN O
chromatin NN O
and CC O
in IN O
epigenetic JJ O
gene NN O
regulation NN O
. . O

HP1 NN O
is VBZ O
believed VBN O
to TO O
be VB O
an DT O
essential JJ O
structural JJ O
protein NN O
protecting VBG O
the DT O
integrity NN O
of IN O
chromosomes NNS O
during IN O
cell NN O
division NN O
( : O
8 CD O
, , O
24 CD O
) -RRB- O
. . O

Swi6 NNP O
, , O
the DT O
homolog NN O
of IN O
HP1 NN O
in IN O
fission NN B-Species
yeast NN I-Species
, , O
is VBZ O
dispensable JJ O
for IN O
survival NN O
, , O
but CC O
its PRP$ O
deletion NN O
results VBZ O
in IN O
lagging VBG O
chromosomes NNS O
during IN O
anaphase NN O
, , O
and CC O
a DT O
high JJ O
rate NN O
of IN O
chromosome NN O
loss NN O
( : O
25 CD O
, , O
26 CD O
) -RRB- O
. . O

Mutations NNS O
of IN O
HP1 NN O
in IN O
D NN B-Species
. . I-Species
melanogaster NN I-Species
result VBP O
in IN O
late JJ O
larval JJ O
lethality NN O
, , O
chromosome NN O
breakages NNS O
/ SYM O
loss NN O
, , O
telomere NN O
fusion NN O
and CC O
a DT O
high JJ O
frequency NN O
of IN O
cells NNS O
with IN O
abnormal JJ O
anaphase NN O
( , O
8 CD O
, , O
27 CD O
) -RRB- O
. . O

Null JJ O
alleles NNS O
of IN O
the DT O
HP1 NNP O
functional JJ O
partner NN O
in IN O
mice NNS B-Species
( -LRB- O
SUVAR39 NN O
) -RRB- O
also RB O
showed VBD O
various JJ O
chromosomal JJ O
defects NNS O
( SYM O
28 CD O
) -RRB- O
, , O
supporting VBG O
a DT O
conserved JJ O
role NN O
for IN O
heterochromatin NN O
proteins NNS O
in IN O
the DT O
regulation NN O
of IN O
chromosome NN O
dynamics NNS O
during IN O
cell NN O
- HYPH O
cycle NN O
progression NN O
. . O

However RB O
, , O
the DT O
mechanism NN O
( , O
s NNS O
) -RRB- O
involved VBN O
remains VBZ O
to TO O
be VB O
understood VBN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
utilized VBD O
Drosophila NNP B-Species
embryonic JJ O
Kc NN O
cells NNS O
and CC O
an DT O
RNA NNP O
interference NN O
( , O
RNAi NNP O
) NN O
- HYPH O
based VBN O
approach NN O
to TO O
demonstrate VB O
that IN O
HP1 NNP O
plays VBZ O
an DT O
important JJ O
role NN O
at IN O
S NNP O
phase NN O
and CC O
G2 NNP O
/ SYM O
M NNP O
phases NNS O
during IN O
the DT O
cell NN O
cycle NN O
. . O

We PRP O
further RB O
show VBP O
that IN O
nearly RB O
one CD O
- HYPH O
third NN O
of IN O
known VBN O
/ SYM O
predicted VBN O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
require VBP O
HP1 NN O
to TO O
maintain VB O
their PRP$ O
active JJ O
transcription NN O
. . O

These DT O
genes NNS O
include VBP O
MCMs NNP O
, , O
Orc4 NNP O
, , O
CDC45L NNP O
, , O
INCENP NNP O
, , O
Aurora NNP O
B NNP O
, , O
CAF1 NNP O
, , O
Bub1 NNP O
, , O
Bub3 NNP O
and CC O
a DT O
few JJ O
other JJ O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
. . O

ChIP NN O
analysis NN O
suggests VBZ O
that IN O
HP1 NNP O
plays VBZ O
a DT O
direct JJ O
role NN O
in IN O
their PRP$ O
transcription NN O
. . O

Therefore RB O
, , O
the DT O
results NNS O
of IN O
this DT O
study NN O
provide VBP O
an DT O
alternative JJ O
explanation NN O
for IN O
the DT O
specific JJ O
role NN O
of IN O
HP1 NN O
in IN O
the DT O
regulation NN O
of IN O
chromatin NN O
dynamics NNS O
and CC O
in IN O
cell NN O
- HYPH O
cycle NN O
progression NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

RNAi NNP O
in IN O
Kc NNP O
cells NNS O

Drosophila NNP B-Species
Kc NNP O
cells NNS O
were VBD O
routinely RB O
cultured VBN O
at IN O
25 CD O
degrees NNS O
C NN O
in IN O
Schneider NNP O
Drosophila NNP B-Species
medium NN O
( , O
GIBCO NNP O
) -RRB- O
supplemented VBN O
with IN O
10 CD O
% NN O
fetal JJ O
calf NN O
serum NN O
, , O
160 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
penicillin NN O
, , O
250 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
streptomycin NN O
, , O
and CC O
4 CD O
mM NN O
l NN O
- HYPH O
glutamine NN O
. . O

Double JJ O
- HYPH O
stranded VBN O
RNA NNP O
( : O
dsRNA NNP O
) -RRB- O
of IN O
HP1 NN O
was VBD O
generated VBN O
by IN O
incubation NN O
of IN O
single JJ O
- HYPH O
stranded VBN O
RNA NNP O
in IN O
annealing VBG O
buffer NN O
( , O
100 CD O
mM NN O
potassium NN O
acetate NN O
, , O
30 CD O
mM NN O
HEPES NNP O
- HYPH O
KOH NNP O
, , O
pH NN O
7 CD O
. . O
4 CD O
, , O
2 CD O
mM NN O
magnesium NN O
acetate NN O
) -RRB- O
for IN O
3 CD O
min NN O
at IN O
95 CD O
degrees NNS O
C NNS O
and CC O
then RB O
placed VBN O
in IN O
a DT O
beaker NN O
with IN O
water NN O
at IN O
75 CD O
degrees NNS O
C NN O
and CC O
allowed VBN O
to TO O
cool VB O
slowly RB O
to IN O
room NN O
temperature NN O
. . O

The DT O
detailed JJ O
procedure NN O
of IN O
RNAi NNP O
was VBD O
carried VBN O
out RP O
according VBG O
to IN O
the DT O
established VBN O
protocols NNS O
( , O
) -RRB- O
. . O

Briefly RB O
, , O
Kc NNP O
cells NNS O
were VBD O
seeded VBN O
in IN O
a DT O
six CD O
- HYPH O
well NN O
dish NN O
using VBG O
serum NN O
- HYPH O
free JJ O
medium NN O
at IN O
1 CD O
x SYM O
106 CD O
cells NNS O
/ SYM O
ml NNS O
. . O

HP1 NNP O
dsRNA NNP O
( : O
5 CD O
mu NN O
g NNS O
/ SYM O
ml NN O
) -RRB- O
was VBD O
added VBN O
to IN O
the DT O
cultured VBN O
Kc NNP O
cells NNS O
. . O

After IN O
60 CD O
min NN O
at IN O
room NN O
temperature NN O
, , O
2 CD O
ml NNS O
of IN O
medium NN O
containing VBG O
10 CD O
% NN O
serum NN O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
the DT O
plates NNS O
transferred VBN O
to IN O
25 CD O
degrees NNS O
C NN O
for IN O
up IN O
to TO O
8 CD O
days NNS O
. . O

Western JJ O
blotting NN O
and CC O
RT NNP O
- HYPH O
PCR NNP O
were VBD O
carried VBN O
out RP O
using VBG O
the DT O
extract NN O
/ SYM O
total JJ O
RNA NNP O
isolated VBN O
from IN O
control NN O
and CC O
dsRNA NN O
- HYPH O
treated VBN O
cells NNS O
on IN O
days NNS O
2 CD O
, , O
6 CD O
and CC O
8 CD O
. . O

Cell NN O
- HYPH O
cycle NN O
and CC O
apoptosis NN O
analysis NN O

The DT O
procedure NN O
for IN O
flow NN O
cytometric JJ O
analysis NN O
of IN O
Kc NNP O
cells NNS O
followed VBD O
that DT O
in IN O
the DT O
manual NN O
provided VBN O
with IN O
the DT O
BrdU NNP O
flow NN O
kit NN O
( -LRB- O
BD NNP O
PharMingen NNP O
) -RRB- O
. . O

The DT O
cells NNS O
were VBD O
fed VBN O
with IN O
BrdU NNP O
for IN O
4 CD O
h NN O
, , O
then RB O
scraped VBN O
and CC O
collected VBN O
. . O

Fluorescence NN O
was VBD O
measured VBN O
using VBG O
a DT O
FACSCalibur NNP O
( , O
Becton NNP O
Dickinson NNP O
) -RRB- O
. . O

Data NN O
collection NN O
and CC O
analysis NN O
were VBD O
performed VBN O
using VBG O
CellQuest NNP O
software NN O
. . O

Electrophoresis NN O
and CC O
immunoblotting NN O

Cell NN O
extracts NNS O
( , O
15 CD O
mu NNS O
g NN O
) -RRB- O
were VBD O
fractionated VBN O
by IN O
10 CD O
% NN O
SDS NNP O
- HYPH O
PAGE NN O
, , O
then RB O
transferred VBN O
to IN O
Hybond NNP O
- HYPH O
P NNP O
PVDF NNP O
membranes NNS O
( , O
Amersham NNP O
) -RRB- O
and CC O
probed VBN O
with IN O
primary JJ O
antibodies NNS O
( , O
CIA9 NNP O
) -RRB- O
, , O
and CC O
secondary JJ O
antibodies NNS O
( , O
anti JJ O
- HYPH O
rabbit NN B-Species
or CC O
anti JJ O
- HYPH O
mouse NN B-Species
horseradish NN B-Species
peroxidase NN O
- HYPH O
conjugated VBN O
IgG NNP O
) -RRB- O
, , O
obtained VBN O
from IN O
Jackson NNP O
Immunoresearch NNP O
Laboratories NNPS O
. . O

Enhanced VBN O
chemiluminescence NN O
reagents NNS O
( -LRB- O
Amersham NNP O
Pharmacia NNP O
Biotech NNP O
) -RRB- O
were VBD O
used VBN O
for IN O
signal NN O
detection NN O
. . O

For IN O
the DT O
analysis NN O
of IN O
H3 NNP O
ser10 NN O
phosphorylation NN O
, , O
we PRP O
used VBD O
whole JJ O
- HYPH O
cell NN O
extracts NNS O
from IN O
700 CD O
0 CD O
Kc NNP O
cells NNS O
( -LRB- O
control NN O
and CC O
RNAi NNP O
at IN O
day NN O
8 CD O
) -RRB- O
. . O

Western JJ O
blotting NN O
was VBD O
performed VBN O
using VBG O
polyclonal JJ O
antibodies NNS O
against IN O
ser10 NN O
- HYPH O
phosphorylated VBN O
histone NN O
H3 CD O
at IN O
a DT O
dilution NN O
of IN O
1 CD O
: SYM O
1000 CD O
( SYM O
Upstate NNP O
) -RRB- O
. . O

Kc NNP O
control NN O
cells NNS O
arrested VBN O
in IN O
mitosis NN O
by IN O
incubation NN O
in IN O
25 CD O
micro JJ O
M NN O
colchicine NN O
( , O
Sigma NNP O
) -RRB- O
for IN O
24 CD O
h NN O
were VBD O
also RB O
analyzed VBN O
for IN O
comparison NN O
. . O

Immunofluorescence NN O

Kc NNP O
cells NNS O
were VBD O
seeded VBN O
onto IN O
polylysine NN O
slides NNS O
, , O
fixed VBN O
with IN O
4 CD O
% NN O
formaldehyde NN O
for IN O
15 CD O
min NN O
and CC O
permeabilized VBN O
with IN O
0 CD O
. . O
5 CD O
% NN O
Triton NNP O
X NNP O
- HYPH O
100 CD O
for IN O
5 CD O
min NN O
. . O

The DT O
incubation NN O
with IN O
primary JJ O
antibodies NNS O
was VBD O
carried VBN O
out RP O
in IN O
blocking NN O
solution NN O
for IN O
1 CD O
h NN O
. . O

For IN O
staining VBG O
of IN O
mitotic JJ O
cells NNS O
, , O
the DT O
cells NNS O
were VBD O
permeabilized VBN O
using VBG O
PBST NNP O
( , O
PBS NNP O
containing VBG O
0 CD O
. . O
3 CD O
% NN O
Triton NNP O
X NNP O
- SYM O
100 CD O
) -RRB- O
and CC O
stained VBN O
with IN O
polyclonal JJ O
antibody NN O
against IN O
Drosophila NNP B-Species
Aurora NNP O
B NNP O
at IN O
1 CD O
: SYM O
200 CD O
dilution NN O
and CC O
monoclonal JJ O
mouse NN B-Species
at IN O
anti JJ O
- HYPH O
beta NN O
- HYPH O
tubulin NN O
1 CD O
: : O
300 CD O
dilution NN O
( -LRB- O
Chemicon NNP O
International NNP O
) -RRB- O
as IN O
primary JJ O
antibodies NNS O
. . O

Secondary JJ O
antibodies NNS O
were VBD O
anti JJ O
- HYPH O
rabbit NN B-Species
coupled VBN O
with IN O
Alexa NNP O
488 CD O
( SYM O
1 CD O
: SYM O
500 CD O
) -RRB- O
and CC O
anti JJ O
- HYPH O
mouse NN B-Species
coupled VBN O
to IN O
Alexa NNP O
546 CD O
( SYM O
1 CD O
: SYM O
500 CD O
) -RRB- O
( : O
Molecular NNP O
Probes NNPS O
, , O
Eugene NNP O
, , O
Oregon NNP O
) -RRB- O
. . O

Images NNS O
were VBD O
acquired VBN O
using VBG O
a DT O
confocal JJ O
LSM510 NNP O
META NNP O
microscope NN O
( , O
Zeiss NNP O
) -RRB- O
. . O

Stacks NNS O
of IN O
images NNS O
were VBD O
analyzed VBN O
using VBG O
the DT O
IMARIS NNP O
4 CD O
. . O
0 NFP O
program NN O
( : O
Media NNP O
cybernetics NN O
, , O
Carlsbad NNP O
, , O
CA NNP O
) -RRB- O
. . O

Antibodies NNS O

Affinity NN O
- HYPH O
purified VBN O
polyclonal JJ O
antibodies NNS O
of IN O
HP1 NNP O
( -LRB- O
rabbit NN B-Species
# NN O
192 CD O
and CC O
# NN O
187 CD O
, , O
5 CD O
mu NNS O
g NN O
) -RRB- O
and CC O
5 CD O
mu NN O
g NN O
of IN O
polyclonal JJ O
anti JJ O
- HYPH O
HA NN O
antibodies NNS O
( -LRB- O
Sigma NNP O
) -RRB- O
were VBD O
used VBN O
in IN O
each DT O
ChIP NN O
reaction NN O
. . O

The DT O
specificity NN O
of IN O
the DT O
HP1 NNP O
polyclonal JJ O
antibodies NNS O
was VBD O
determined VBN O
using VBG O
various JJ O
approaches NNS O
, , O
including VBG O
western JJ O
blotting NN O
assay NN O
, , O
immunofluorescence NN O
staining NN O
and CC O
immunoprecipitation NN O
to TO O
pull VB O
down RB O
HP1 NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

The DT O
monoclonal JJ O
antibody NN O
HP1 NNP O
- HYPH O
CIA9 NNP O
( -LRB- O
5 CD O
) -RRB- O
was VBD O
used VBN O
at IN O
a DT O
dilution NN O
of IN O
1 CD O
: SYM O
20 CD O
in IN O
immunoblotting NN O
assays NNS O
. . O

Microarray NNP O
analysis NN O
and CC O
RT NNP O
- HYPH O
PCR NNP O

Total JJ O
RNA NNP O
was VBD O
isolated VBN O
from IN O
control NN O
and CC O
HP1 NN O
- HYPH O
depleted VBN O
Kc NNP O
cells NNS O
at IN O
day NN O
8 CD O
using VBG O
an DT O
RNeasy NNP O
kit NN O
( , O
Qiagen NNP O
) -RRB- O
. . O

RNA NNP O
labeling NN O
and CC O
microarray NN O
data NNS O
analysis NN O
followed VBD O
the DT O
standard JJ O
protocol NN O
from IN O
Affymetrix NNP O
. . O

We PRP O
used VBD O
ANOVA NNP O
( : O
P NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
to TO O
assess VB O
the DT O
expression NN O
confidence NN O
for IN O
each DT O
gene NN O
. . O

For IN O
RT NNP O
- HYPH O
PCR NN O
analysis NN O
, , O
poly NN O
( , O
A NNP O
) -RRB- O
+ SYM O
mRNA NNP O
was VBD O
purified VBN O
with IN O
the DT O
Oligotex NNP O
Direct NNP O
mRNA NNP O
kit NN O
( : O
Qiagen NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

The DT O
purified JJ O
poly NN O
( , O
A NNP O
) NFP O
+ SYM O
RNA NNP O
was VBD O
reverse RB O
transcribed VBN O
using VBG O
the DT O
Thermoscript NNP O
kit NN O
( , O
Invitrogen NNP O
) -RRB- O
. . O

The DT O
cDNA NNP O
was VBD O
then RB O
used VBN O
for IN O
PCR NNP O
amplification NN O
for IN O
35 CD O
cycles NNS O
with IN O
gene NN O
- HYPH O
specific JJ O
primers NNS O
. . O

PCR NNP O
products NNS O
were VBD O
scanned VBN O
after IN O
electrophoretic JJ O
separation NN O
with IN O
a DT O
Typhoon NNP O
Scanner NNP O
, , O
quantified VBN O
using VBG O
ImageQuant NNP O
software NN O
( , O
Amersham NNP O
Biosciences NNP O
) -RRB- O
and CC O
normalized VBN O
for IN O
amplification NN O
of IN O
the DT O
Actin5c NNP O
transcript NN O
. . O

The DT O
sequence NN O
of IN O
primers NNS O
used VBN O
for IN O
RT NNP O
- HYPH O
PCR NNP O
and CC O
ChIP NNP O
analysis NN O
are VBP O
provided VBN O
in IN O
the DT O
Supplementary NNP O
Material NNP O
. . O

ChIP NN O

ChIP NNP O
was VBD O
performed VBN O
according VBG O
to IN O
Orlando NNP O
et FW O
al NNP O
. . O

( : O
29 CD O
) , O
and CC O
the DT O
protocol NN O
provided VBN O
by IN O
Upstate NNP O
( : O
) -RRB- O
with IN O
some DT O
modifications NNS O
. . O

In IN O
brief JJ O
, , O
1 CD O
- SYM O
2 CD O
x SYM O
108 CD O
Kc NNP O
cells NNS O
were VBD O
prepared VBN O
and CC O
fixed VBN O
in IN O
1 CD O
% NN O
formaldehyde NN O
. . O

Nuclei NNP O
were VBD O
isolated VBN O
according VBG O
to IN O
a DT O
standard JJ O
procedure NN O
in IN O
Current NNP O
Protocols NNPS O
( : O
) -RRB- O
, , O
then RB O
resuspended VBN O
in IN O
1 CD O
. . O
7 CD O
ml CD O
of IN O
lysis NN O
buffer NN O
( : O
50 CD O
mM NN O
Tris NNS O
, , O
pH NN O
8 CD O
. . O
0 CD O
, , O
10 CD O
mM NN O
EDTA NNP O
, , O
1 CD O
% NN O
SDS NN O
and CC O
protease NN O
inhibitors NNS O
) -RRB- O
and CC O
sonicated VBN O
using VBG O
a DT O
Branson NNP O
sonifier NN O
250 CD O
. . O

Chromatin NN O
fractions NNS O
in IN O
the DT O
size NN O
range NN O
0 CD O
. . O
2 CD O
- SYM O
0 CD O
. . O
8 CD O
kb NNS O
were VBD O
used VBN O
to TO O
perform VB O
immunoprecipitation NN O
experiments NNS O
. . O

We PRP O
used VBD O
5 CD O
mu NN O
g NN O
affinity NN O
- HYPH O
purified VBN O
polyclonal JJ O
antibodies NNS O
( , O
# $ O
192 CD O
and CC O
# NN O
182 CD O
for IN O
HP1 NN O
; : O
HA NN O
antibody NN O
for IN O
control NN O
) -RRB- O
and CC O
1 CD O
ml NNS O
of IN O
salmon NN O
sperm NN O
DNA NN O
/ SYM O
protein NN O
- HYPH O
A NN O
- HYPH O
agarose NN O
( : O
Upstate NN O
) -RRB- O
pre NN O
- HYPH O
cleared VBN O
chromatin NN O
lysate NN O
in IN O
each DT O
reaction NN O
. . O

The DT O
mixture NN O
was VBD O
then RB O
rotated VBN O
at IN O
4 CD O
degrees NNS O
C NNP O
overnight RB O
and CC O
the DT O
recovered VBN O
beads NNS O
were VBD O
washed VBN O
twice RB O
with IN O
1 CD O
ml NNS O
of IN O
Low NNP O
salt NN O
buffer NN O
( , O
Upstate NNP O
) -RRB- O
, , O
once RB O
with IN O
High JJ O
salt NN O
buffer NN O
( , O
Upstate NNP O
) -RRB- O
, , O
once RB O
with IN O
LiCl NNP O
buffer NN O
( , O
Upstate NNP O
) -RRB- O
and CC O
twice RB O
with IN O
TE NNP O
at IN O
4 CD O
degrees NNS O
C NN O
for IN O
8 CD O
min NN O
. . O

ChIP NNP O
DNA NNP O
was VBD O
extracted VBN O
according VBG O
to IN O
the DT O
standard JJ O
procedures NNS O
( SYM O
29 CD O
) -RRB- O
. . O

RESULTS NNS O

Depletion NN O
of IN O
HP1 NN O
in IN O
Drosophila NNP B-Species
Kc NNP O
cells NNS O

Various JJ O
chromosomal JJ O
defects NNS O
in IN O
the DT O
cell NN O
cycle NN O
have VBP O
been VBN O
observed VBN O
in IN O
embryos NNS O
or CC O
larval JJ O
tissues NNS O
of IN O
Drosophila NNP B-Species
HP1 NNP O
mutants NNS O
( , O
8 CD O
, , O
27 CD O
) -RRB- O
. . O

However RB O
, , O
the DT O
presence NN O
of IN O
maternally RB O
loaded VBN O
HP1 NN O
in IN O
embryos NNS O
and CC O
the DT O
lethality NN O
of IN O
HP1 NNP O
mutants NNS O
at IN O
late JJ O
larval JJ O
stages NNS O
have VBP O
so RB O
far RB O
precluded VBN O
a DT O
systematic JJ O
study NN O
of IN O
the DT O
role NN O
of IN O
HP1 NN O
in IN O
cell NN O
- HYPH O
cycle NN O
regulation NN O
. . O

Therefore RB O
, , O
we PRP O
used VBD O
Drosophila NNP B-Species
Kc NNP O
cells NNS O
, , O
a DT O
cell NN O
line NN O
derived VBN O
from IN O
Drosophila NNP B-Species
embryos NNS O
, , O
as IN O
a DT O
model NN O
system NN O
to TO O
address VB O
this DT O
problem NN O
. . O

HP1 NN O
transcripts NNS O
were VBD O
depleted VBN O
using VBG O
an DT O
RNAi NNP O
- HYPH O
based VBN O
approach NN O
( , O
see VB O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
. . O

The DT O
reduction NN O
in IN O
HP1 NNP O
expression NN O
was VBD O
measured VBN O
both CC O
by IN O
RT NNP O
- HYPH O
PCR NNP O
and CC O
by IN O
western JJ O
blotting NN O
analysis NN O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
. . O

A DT O
significant JJ O
reduction NN O
in IN O
the DT O
HP1 NNP O
expression NN O
was VBD O
already RB O
evident JJ O
after IN O
2 CD O
days NNS O
treatment NN O
with IN O
HP1 NNP O
dsRNA NNP O
. . O

Cells NNS O
at IN O
day NN O
8 CD O
showed VBD O
a DT O
reduction NN O
in IN O
HP1 NN O
of IN O
~ $ O
90 CD O
% NN O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
and CC O
were VBD O
therefore RB O
used VBN O
in IN O
all DT O
subsequent JJ O
experiments NNS O
. . O

Cell NN O
- HYPH O
cycle NN O
progression NN O
at IN O
S NNP O
and CC O
G2 NNP O
/ SYM O
M NNP O
phase NN O
is VBZ O
altered VBN O
in IN O
the DT O
absence NN O
of IN O
HP1 NNP O

The DT O
impact NN O
of IN O
HP1 NNP O
loss NN O
on IN O
the DT O
cell NN O
cycle NN O
of IN O
Kc NNP O
cells NNS O
was VBD O
determined VBN O
using VBG O
cell NN O
- HYPH O
cycle NN O
profile NN O
analysis NN O
of IN O
HP1 NN O
- HYPH O
depleted VBN O
and CC O
control NN O
cells NNS O
. . O

The DT O
percentage NN O
of IN O
cells NNS O
in IN O
S NNP O
phase NN O
was VBD O
determined VBN O
by IN O
BrdU NNP O
incorporation NN O
, , O
and CC O
total JJ O
DNA NN O
content NN O
by IN O
7 CD O
- HYPH O
amino NN O
- HYPH O
actinomycin NN O
( : O
7 CD O
- HYPH O
AAD NN O
) -RRB- O
. . O

The DT O
results NNS O
showed VBD O
that IN O
the DT O
depletion NN O
of IN O
HP1 NNP O
( HYPH O
day NN O
8 CD O
) -RRB- O
caused VBD O
a DT O
decrease NN O
in IN O
S NN O
- HYPH O
phase NN O
cells NNS O
of IN O
at RB O
least RBS O
4 CD O
- HYPH O
fold NN O
, , O
and CC O
a DT O
2 CD O
- HYPH O
fold NN O
decrease NN O
in IN O
G2 NNP O
/ SYM O
M NNP O
- HYPH O
phase NN O
cells NNS O
( -LRB- O
Figure NNP O
1B NNP O
) -RRB- O
, , O
although IN O
no DT O
significant JJ O
effect NN O
was VBD O
found VBN O
at IN O
the DT O
G1 NNP O
phase NN O
. . O

In IN O
addition NN O
, , O
depletion NN O
of IN O
HP1 NNP O
caused VBD O
a DT O
greater JJR O
than IN O
7 CD O
- HYPH O
fold NN O
increase NN O
in IN O
the DT O
number NN O
of IN O
apoptotic JJ O
cells NNS O
. . O

These DT O
results NNS O
, , O
therefore RB O
, , O
confirm VBP O
that IN O
HP1 NN O
is VBZ O
an DT O
important JJ O
regulator NN O
during IN O
the DT O
cell NN O
cycle NN O
, , O
especially RB O
at IN O
the DT O
S NNP O
and CC O
G2 NNP O
/ SYM O
M NNP O
phases NNS O
. . O

Cell NN O
- HYPH O
cycle NN O
regulators NNS O
require VBP O
HP1 NNP O
to TO O
maintain VB O
their PRP$ O
active JJ O
transcription NN O

To TO O
ask VB O
whether IN O
the DT O
cell NN O
- HYPH O
cycle NN O
defects NNS O
were VBD O
due IN O
to IN O
changes NNS O
in IN O
the DT O
transcription NN O
of IN O
genes NNS O
functionally RB O
involved VBN O
in IN O
S NNP O
phase NN O
and CC O
the DT O
G2 NNP O
/ SYM O
M NNP O
phase NN O
, , O
we PRP O
next RB O
assessed VBD O
global JJ O
changes NNS O
in IN O
gene NN O
transcription NN O
following VBG O
depletion NN O
of IN O
HP1 NNP O
. . O

Expression NN O
profile NN O
analysis NN O
was VBD O
performed VBN O
using VBG O
total JJ O
RNA NNP O
isolated VBN O
from IN O
both CC O
HP1 NN O
- HYPH O
depleted VBN O
Kc NNP O
cells NNS O
and CC O
control NN O
Kc NNP O
cells NNS O
, , O
and CC O
an DT O
Affymetrix NNP O
Drosophila NNP B-Species
chip NN O
. . O

For IN O
each DT O
experiment NN O
, , O
we PRP O
used VBD O
total JJ O
RNA NNP O
isolated VBN O
from IN O
two CD O
independent JJ O
HP1 NN O
- HYPH O
depleted VBN O
and CC O
control NN O
samples NNS O
, , O
and CC O
at RB O
least RBS O
two CD O
independent JJ O
experiments NNS O
were VBD O
performed VBN O
. . O

The DT O
microarray NN O
analysis NN O
showed VBD O
that IN O
loss NN O
of IN O
HP1 NN O
function NN O
in IN O
Kc NNP O
cells NNS O
resulted VBD O
in IN O
alterations NNS O
in IN O
transcription NN O
of IN O
> SYM O
500 CD O
genes NNS O
: : O
~ $ O
400 CD O
genes NNS O
were VBD O
down RB O
- HYPH O
regulated VBN O
and CC O
~ $ O
120 CD O
genes NNS O
were VBD O
up RB O
- HYPH O
regulated VBN O
( : O
> SYM O
1 CD O
. . O
5 CD O
- HYPH O
fold NN O
, , O
ANOVA NNP O
) -RRB- O
. . O

The DT O
function NN O
of IN O
these DT O
genes NNS O
ranged VBD O
from IN O
cellular JJ O
enzymes NNS O
, , O
signal NN O
transduction NN O
molecules NNS O
, , O
and CC O
membrane NN O
and CC O
cell NN O
structural JJ O
proteins NNS O
, , O
to IN O
nucleic JJ O
acid NN O
- HYPH O
binding VBG O
proteins NNS O
and CC O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

At IN O
the DT O
chromosomal JJ O
level NN O
, , O
the DT O
genes NNS O
targeted VBN O
by IN O
HP1 NNP O
appeared VBD O
to TO O
be VB O
distributed VBN O
along IN O
all DT O
euchromatic JJ O
chromosomal JJ O
arms NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
supporting VBG O
a DT O
global JJ O
role NN O
of IN O
HP1 NN O
in IN O
euchromatic JJ O
gene NN O
regulation NN O
( SYM O
20 CD O
) -RRB- O
. . O

Among IN O
60 CD O
known VBN O
/ SYM O
predicted VBN O
genes NNS O
associated VBN O
with IN O
DNA NNP O
replication NN O
function NN O
, , O
15 CD O
were VBD O
down RB O
- HYPH O
regulated VBN O
in IN O
the DT O
absence NN O
of IN O
HP1 NN O
( -LRB- O
Figure NNP O
2B NN O
) -RRB- O
. . O

These DT O
included VBD O
McM2 NNP O
, , O
McM5 NNP O
, , O
McM6 NNP O
and CC O
CDC45L NNP O
, , O
which WDT O
are VBP O
required VBN O
for IN O
processive JJ O
DNA NN O
replication NN O
and CC O
correct JJ O
chromosome NN O
condensation NN O
( : O
30 CD O
- SYM O
32 CD O
) -RRB- O
. . O

Other JJ O
genes NNS O
involved VBN O
in IN O
DNA NN O
replication NN O
, , O
such JJ O
as IN O
components NNS O
of IN O
the DT O
origin NN O
recognition NN O
complex NN O
( -LRB- O
Orc NNP O
) -RRB- O
- : O
- : O
Orc4 NNP O
, , O
Caf1 NNP O
, , O
Gnf1 NNP O
, , O
Dref1 NNP O
, , O
DNA NNP O
polymerase NN O
- HYPH O
gamma NN O
and CC O
Tam NNP O
- HYPH O
- , O
were VBD O
also RB O
down RB O
- HYPH O
regulated VBN O
( -LRB- O
Figure NNP O
2B NNP O
) -RRB- O
. . O

Aurora NNP O
B NNP O
and CC O
inner JJ O
centromere NN O
protein NN O
( , O
INCENP NNP O
) -RRB- O
, , O
known VBN O
to TO O
be VB O
required VBN O
for IN O
kinetochore NN O
assembly NN O
, , O
chromosome NN O
condensation NN O
and CC O
bipolar JJ O
chromosome NN O
attachment NN O
during IN O
mitosis NN O
( SYM O
33 CD O
) -RRB- O
, , O
also RB O
showed VBD O
a DT O
reduction NN O
in IN O
transcription NN O
. . O

A DT O
similar JJ O
loss NN O
of IN O
transcription NN O
was VBD O
observed VBN O
in IN O
Bub1 NNP O
and CC O
Bub3 NNP O
( -LRB- O
Figure NNP O
2B NNP O
) -RRB- O
, , O
encoding VBG O
mitotic JJ O
checkpoint NN O
control NN O
proteins NNS O
( , O
34 CD O
, , O
35 CD O
) -RRB- O
. . O

Loss NN O
function NN O
of IN O
Bub1 NNP O
has VBZ O
been VBN O
shown VBN O
to TO O
cause VB O
chromatin NN O
bridges NNS O
to TO O
extend VB O
between IN O
the DT O
two CD O
separating VBG O
groups NNS O
of IN O
chromosomes NNS O
, , O
and CC O
extensive JJ O
chromosome NN O
fragmentation NN O
in IN O
anaphase NN O
cells NNS O
( SYM O
35 CD O
) -RRB- O
. . O

We PRP O
confirmed VBD O
the DT O
changes NNS O
in IN O
the DT O
transcription NN O
of IN O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
using VBG O
semi JJ O
- HYPH O
quantitative JJ O
RT NNP O
- HYPH O
PCR NNP O
, , O
which WDT O
gave VBD O
results NNS O
consistent JJ O
with IN O
the DT O
microarray NN O
analysis NN O
. . O

In IN O
addition NN O
, , O
cell NN O
- HYPH O
cycle NN O
regulator NN O
genes NNS O
, , O
such JJ O
as IN O
McM3 NNP O
, , O
McM7 NNP O
and CC O
Asp NNP O
( , O
abnormal JJ O
spindle NN O
) -RRB- O
, , O
were VBD O
also RB O
confirmed VBN O
to TO O
be VB O
down RB O
- HYPH O
regulated VBN O
( -LRB- O
Figure NNP O
2C NNP O
) -RRB- O
. . O

Collectively RB O
, , O
these DT O
results NNS O
demonstrate VBP O
that IN O
HP1 NNP O
is VBZ O
indeed RB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
transcription NN O
of IN O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
. . O

HP1 NN O
is VBZ O
required VBN O
for IN O
Aurora NNP O
B NNP O
distribution NN O
and CC O
histone NN O
H3 NN O
phosphorylation NN O

INCENP NNP O
is VBZ O
localized VBN O
to IN O
the DT O
centromeric JJ O
region NN O
of IN O
chromosomes NNS O
at IN O
metaphase NN O
and CC O
the DT O
spindle JJ O
midzone NN O
at IN O
anaphase NN O
, , O
which WDT O
then RB O
targets VBZ O
Aurora NNP O
B NNP O
, , O
a DT O
kinase NN O
essential JJ O
for IN O
histone NN O
H3 NN O
ser10 NN O
phosphorylation NN O
, , O
to IN O
these DT O
sites NNS O
( SYM O
36 CD O
) -RRB- O
. . O

Loss NN O
of IN O
function NN O
of IN O
both PDT O
these DT O
' `` O
chromosomal JJ O
passenger NN O
' '' O
proteins NNS O
causes VBZ O
abnormal JJ O
chromosomal JJ O
segregation NN O
at IN O
metaphase NN O
, , O
as RB O
well RB O
as IN O
certain JJ O
cytokinesis NN O
defects NNS O
( , O
36 CD O
, , O
37 CD O
) -RRB- O
. . O

The DT O
loss NN O
of IN O
transcription NN O
of IN O
both CC O
INCENP NNP O
and CC O
Aurora NNP O
B NNP O
after IN O
depletion NN O
of IN O
HP1 NNP O
, , O
therefore RB O
, , O
raised VBD O
the DT O
possibility NN O
that IN O
localization NN O
of IN O
Aurora NNP O
B NNP O
( -LRB- O
Figure NNP O
3 CD O
and CC O
data NNS O
not RB O
shown VBN O
) -RRB- O
may MD O
be VB O
altered VBN O
. . O

Staining VBG O
of IN O
HP1 NN O
- HYPH O
depleted VBN O
Kc NNP O
cells NNS O
with IN O
anti JJ O
- HYPH O
Aurora NNP O
B NNP O
antibodies NNS O
indeed RB O
revealed VBD O
an DT O
altered JJ O
localization NN O
of IN O
Aurora NNP O
B NNP O
and CC O
, , O
in IN O
a DT O
number NN O
of IN O
cases NNS O
, , O
a DT O
complete JJ O
loss NN O
of IN O
Aurora NNP O
B NNP O
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
. . O

Consistent JJ O
with IN O
the DT O
loss NN O
function NN O
of IN O
Aurora NNP O
B NNP O
, , O
the DT O
spindles NNS O
in IN O
the DT O
metaphase NN O
cells NNS O
were VBD O
also RB O
disorganized VBN O
, , O
with IN O
a DT O
large JJ O
number NN O
of IN O
cells NNS O
showing VBG O
an DT O
altered JJ O
prometaphase NN O
chromosome NN O
alignment NN O
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
. . O

Some DT O
showed VBD O
extensive JJ O
chromosome NN O
fragmentation NN O
( -LRB- O
Figure NNP O
3B NNP O
) -RRB- O
, , O
or CC O
the DT O
presence NN O
of IN O
a DT O
third JJ O
spindle NN O
pole NN O
- HYPH O
like JJ O
structure NN O
as IN O
indicated VBN O
by IN O
beta NN O
- HYPH O
tubulin NN O
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
. . O

At IN O
telophase NN O
, , O
we PRP O
observed VBD O
defective JJ O
separating VBG O
cells NNS O
with IN O
an DT O
extra JJ O
cell NN O
envelope NN O
- HYPH O
like JJ O
structure NN O
without IN O
nuclei NN O
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
. . O

Chromatin NN O
bridges NNS O
or CC O
lagging VBG O
chromatids NNS O
at IN O
telophase NN O
were VBD O
also RB O
evident JJ O
in IN O
some DT O
cells NNS O
( -LRB- O
Figure NNP O
3C NNP O
) -RRB- O
; : O
however RB O
, , O
in IN O
some DT O
cases NNS O
, , O
localization NN O
of IN O
Aurora NNP O
B NNP O
appeared VBD O
not RB O
to TO O
be VB O
affected VBN O
, , O
arguing VBG O
that IN O
other JJ O
pathways NNS O
are VBP O
possibly RB O
involved VBN O
. . O

We PRP O
next RB O
analyzed VBD O
changes NNS O
in IN O
histone NN O
H3 NN O
serine NN O
10 CD O
phosphorylation NN O
, , O
since IN O
the DT O
loss NN O
of IN O
transcription NN O
of IN O
INCENP NNP O
is VBZ O
known VBN O
to TO O
affect VB O
localization NN O
of IN O
Aurora NNP O
B NNP O
( SYM O
33 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
essential JJ O
in IN O
the DT O
regulation NN O
of IN O
histone NN O
H3 NN O
phosphorylation NN O
( SYM O
36 CD O
) -RRB- O
. . O

Total JJ O
cell NN O
extracts NNS O
from IN O
HP1 NNP O
- HYPH O
depleted VBN O
Kc NNP O
cells NNS O
were VBD O
analyzed VBN O
by IN O
western JJ O
blotting NN O
( -LRB- O
Figure NNP O
3D NNP O
) -RRB- O
. . O

The DT O
results NNS O
indeed RB O
showed VBD O
a DT O
severalfold JJ O
reduction NN O
in IN O
H3 NN O
ser10 NN O
phosphorylation NN O
after IN O
depletion NN O
of IN O
HP1 NN O
, , O
consistent JJ O
with IN O
the DT O
functional JJ O
disruption NN O
of IN O
INCENP NNP O
and CC O
Aurora NNP O
B NNP O
in IN O
the DT O
absence NN O
of IN O
HP1 NNP O
. . O

HP1 NNP O
directly RB O
targets VBZ O
genes NNS O
encoding VBG O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
in IN O
euchromatin NN O

To TO O
test VB O
whether IN O
the DT O
loss NN O
of IN O
transcription NN O
of IN O
genes NNS O
involved VBN O
in IN O
DNA NN O
replication NN O
and CC O
mitosis NN O
was VBD O
a DT O
direct JJ O
effect NN O
of IN O
the DT O
loss NN O
of IN O
HP1 NN O
, , O
we PRP O
performed VBD O
a DT O
ChIP NN O
analysis NN O
to TO O
determine VB O
whether IN O
HP1 NN O
is VBZ O
physically RB O
associated VBN O
with IN O
these DT O
genes NNS O
. . O

Chromatin NN O
lysates NNS O
from IN O
formaldehyde NN O
- HYPH O
fixed VBN O
Kc NNP O
cells NNS O
were VBD O
sonicated VBN O
into IN O
small JJ O
chromatin NN O
fragments NNS O
( : O
0 CD O
. . O
2 CD O
- SYM O
0 CD O
. . O
8 CD O
kb NN O
) -RRB- O
and CC O
immunoprecipitated VBN O
with IN O
polyclonal JJ O
antibodies NNS O
against IN O
Drosophila NNP B-Species
HP1 NNP O
. . O

As IN O
a DT O
control NN O
, , O
we PRP O
used VBD O
a DT O
mock JJ O
precipitation NN O
( , O
beads NNS O
only RB O
) , O
and CC O
polyclonal JJ O
antibodies NNS O
against IN O
HA NNP O
. . O

Our PRP$ O
ChIP NN O
results NNS O
showed VBD O
that IN O
known VBN O
transposable JJ O
elements NNS O
distributed VBN O
in IN O
heterochromatin NN O
, , O
such JJ O
as IN O
F NNP O
- HYPH O
element NN O
, , O
TART NNP O
and CC O
1360 CD O
( SYM O
7 CD O
, , O
38 CD O
) -RRB- O
, , O
were VBD O
all DT O
enriched VBN O
in IN O
HP1 NN O
binding NN O
( : O
Figure NNP O
4 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
also RB O
consistent JJ O
with IN O
a DT O
previous JJ O
study NN O
( , O
20 CD O
) -RRB- O
. . O

Using VBG O
the DT O
same JJ O
ChIP NNP O
DNA NNP O
material NN O
, , O
we PRP O
then RB O
attempted VBD O
to TO O
determine VB O
whether IN O
HP1 NNP O
was VBD O
enriched VBN O
in IN O
genes NNS O
involved VBN O
in IN O
DNA NNP O
replication NN O
. . O

Primers NNS O
were VBD O
designed VBN O
to TO O
cover VB O
the DT O
promoter NN O
regions NNS O
of IN O
selected VBN O
genes NNS O
. . O

The DT O
results NNS O
showed VBD O
that IN O
McM3 NNP O
, , O
McM5 NNP O
and CC O
Tam NNP O
were VBD O
all DT O
enriched VBN O
in IN O
HP1 NNP O
binding NN O
( : O
Figure NN O
4 CD O
) -RRB- O
. . O

However RB O
, , O
McM7 NNP O
appeared VBD O
to TO O
be VB O
HP1 NN O
- HYPH O
negative JJ O
, , O
although IN O
its PRP$ O
transcription NN O
was VBD O
also RB O
affected VBN O
by IN O
the DT O
loss NN O
of IN O
HP1 NN O
function NN O
. . O

Genes NNS O
essential JJ O
for IN O
mitosis NN O
, , O
such JJ O
as IN O
Aurora NNP O
B NNP O
, , O
were VBD O
also RB O
HP1 NN O
- HYPH O
positive JJ O
( : O
Figure NN O
4 CD O
) -RRB- O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
these DT O
cell NN O
- HYPH O
cycle NN O
regulator NN O
genes NNS O
are VBP O
directly RB O
targeted VBN O
by IN O
HP1 NNP O
in IN O
their PRP$ O
promoter NN O
regions NNS O
. . O

DISCUSSION NN O

In IN O
this DT O
study NN O
, , O
we PRP O
used VBD O
microarray NN O
and CC O
RT NNP O
- HYPH O
PCR NNP O
techniques NNS O
to TO O
demonstrate VB O
that IN O
transcription NN O
of IN O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
is VBZ O
misregulated VBN O
in IN O
the DT O
absence NN O
of IN O
HP1 NNP O
. . O

Certain JJ O
defects NNS O
in IN O
S NNP O
phase NN O
may MD O
be VB O
a DT O
direct JJ O
consequence NN O
of IN O
the DT O
loss NN O
of IN O
transcription NN O
of IN O
DNA NN O
replication NN O
genes NNS O
such JJ O
as IN O
McM2 NNP O
, , O
McM5 NNP O
, , O
McM6 NNP O
, , O
CDC45L NNP O
, , O
Orc4 NNP O
and CC O
others NNS O
, , O
since IN O
these DT O
genes NNS O
have VBP O
been VBN O
functionally RB O
implicated VBN O
in IN O
the DT O
initiation NN O
of IN O
DNA NN O
replication NN O
and CC O
/ SYM O
or CC O
the DT O
progression NN O
of IN O
replication NN O
forks NNS O
( SYM O
39 CD O
) -RRB- O
. . O

Depletion NN O
or CC O
mutation NN O
of IN O
these DT O
genes NNS O
has VBZ O
been VBN O
shown VBN O
to TO O
result VB O
in IN O
DNA NN O
damage NN O
( : O
32 CD O
) NN O
, , O
the DT O
blockage NN O
of IN O
replication NN O
forks NNS O
( , O
39 CD O
) -RRB- O
, , O
increased VBN O
chromosome NN O
loss NN O
/ SYM O
genome NN O
instability NN O
, , O
and CC O
defective JJ O
condensation NN O
( SYM O
30 CD O
) -RRB- O
. . O

The DT O
reduction NN O
in IN O
the DT O
number NN O
of IN O
cells NNS O
in IN O
G2 NNP O
/ SYM O
M NNP O
phase NN O
may MD O
be VB O
a DT O
consequence NN O
of IN O
the DT O
reduction NN O
in IN O
transcription NN O
or CC O
functional JJ O
disruption NN O
of IN O
INCENP NNP O
, , O
Aurora NNP O
B NNP O
, , O
Bub1 NNP O
, , O
and CC O
Bub3 NNP O
( SYM O
34 CD O
, , O
36 CD O
) -RRB- O
. . O

Chromosome NN O
segregation NN O
defects NNS O
, , O
such JJ O
as IN O
chromosome NN O
fragmentation NN O
and CC O
chromatin NN O
bridges NNS O
in IN O
anaphase NN O
/ SYM O
telophase NN O
cells NNS O
, , O
and CC O
certain JJ O
cytokinesis NN O
defects NNS O
in IN O
HP1 NN O
- HYPH O
depleted VBN O
cells NNS O
, , O
mimic VBP O
the DT O
phenotype NN O
of IN O
cells NNS O
with IN O
loss NN O
function NN O
of IN O
INCENP NNP O
, , O
Aurora NNP O
B NNP O
or CC O
Bub1 NNP O
( SYM O
35 CD O
- HYPH O
37 CD O
) -RRB- O
. . O

The DT O
mislocalization NN O
of IN O
Aurora NNP O
B NNP O
in IN O
the DT O
absence NN O
of IN O
HP1 NN O
is VBZ O
also RB O
consistent JJ O
with IN O
the DT O
loss NN O
of IN O
transcription NN O
and CC O
functional JJ O
disruption NN O
of IN O
INCENP NNP O
( : O
37 CD O
) -RRB- O
, , O
and CC O
the DT O
reduction NN O
in IN O
Aurora NNP O
B NNP O
transcription NN O
may MD O
be VB O
partially RB O
responsible JJ O
for IN O
the DT O
observed VBN O
chromosomal JJ O
defects NNS O
, , O
including VBG O
loss NN O
of IN O
histone NN O
H3 NN O
phosphorylation NN O
at IN O
serine NN O
10 CD O
. . O

HP1 NN O
is VBZ O
also RB O
known VBN O
to TO O
physically RB O
interact VB O
with IN O
certain JJ O
components NNS O
of IN O
replication NN O
complexes NNS O
such JJ O
as IN O
ORCs NNPS O
and CC O
MCMs NNPS O
( , O
30 CD O
, , O
40 CD O
, , O
41 CD O
) -RRB- O
, , O
with IN O
the DT O
inner JJ O
centromere NN O
protein NN O
INCENP NNP O
( SYM O
42 CD O
) -RRB- O
and CC O
the DT O
chromatin NN O
assembly NN O
factor NN O
CAF1 NNP O
( -LRB- O
43 CD O
) -RRB- O
promoting VBG O
delivery NN O
of IN O
HP1 NN O
to IN O
heterochromatin NN O
sites NNS O
( SYM O
44 CD O
) -RRB- O
. . O

Loss NN O
of IN O
HP1 NNP O
is VBZ O
, , O
therefore RB O
, , O
expected VBN O
to TO O
cause VB O
disruption NN O
to IN O
such JJ O
HP1 NN O
- HYPH O
associated VBN O
complexes NNS O
, , O
and CC O
will MD O
partially RB O
contribute VB O
to IN O
the DT O
chromatin NN O
/ SYM O
chromosomal JJ O
defects NNS O
in IN O
HP1 NNP O
mutants NNS O
( : O
8 CD O
, , O
27 CD O
) , O
and CC O
HP1 NN O
- HYPH O
depleted VBN O
Kc NNP O
cells NNS O
. . O

It PRP O
is VBZ O
therefore RB O
well RB O
possible JJ O
that IN O
the DT O
loss NN O
of IN O
transcription NN O
of IN O
these DT O
cell NN O
- HYPH O
cycle NN O
regulator NN O
genes NNS O
, , O
and CC O
consequent JJ O
disruption NN O
of IN O
HP1 NNP O
functional JJ O
complexes NNS O
or CC O
heterochromatin NN O
structure NN O
, , O
all DT O
contributed VBD O
to IN O
the DT O
cell NN O
- HYPH O
cycle NN O
defects NNS O
observed VBN O
. . O

The DT O
ChIP NNP O
assay NN O
supports VBZ O
the DT O
hypothesis NN O
that IN O
the DT O
loss NN O
of IN O
transcription NN O
of IN O
cell NN O
- HYPH O
cycle NN O
regulator NN O
genes NNS O
is VBZ O
a DT O
direct JJ O
effect NN O
of IN O
the DT O
lack NN O
of IN O
HP1 NNP O
. . O

Aurora NNP O
B NNP O
, , O
McM3 NNP O
, , O
and CC O
McM5 NNP O
were VBD O
all DT O
bound VBN O
by IN O
HP1 NNP O
at IN O
their PRP$ O
promoter NN O
regions NNS O
, , O
although IN O
other JJ O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
, , O
such JJ O
as IN O
McM7 NNP O
, , O
were VBD O
HP1 NN O
- HYPH O
negative JJ O
, , O
implying VBG O
that IN O
the DT O
altered VBN O
transcription NN O
in IN O
these DT O
genes NNS O
might MD O
be VB O
a DT O
secondary JJ O
effect NN O
of IN O
the DT O
loss NN O
of IN O
HP1 NN O
. . O

A DT O
previous JJ O
study NN O
in IN O
Drosophila NNP B-Species
Kc NNP O
cells NNS O
( , O
20 CD O
) -RRB- O
employed VBD O
an DT O
approach NN O
based VBN O
on IN O
the DT O
ectopic JJ O
expression NN O
of IN O
a DT O
fusion NN O
protein NN O
of IN O
HP1 NN O
with IN O
a DT O
prokaryotic JJ O
DNA NN O
adenine NN O
methyltransferase NN O
and CC O
identified VBD O
a DT O
number NN O
of IN O
methylated JJ O
targets NNS O
in IN O
the DT O
genome NN O
. . O

In IN O
this DT O
study NN O
, , O
MCM3 NNP O
and CC O
MCM5 NNP O
were VBD O
not RB O
found VBN O
to TO O
be VB O
methylated VBN O
, , O
indicating VBG O
lack NN O
of IN O
association NN O
with IN O
HP1 NNP O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
heterochromatin NN O
repeats NNS O
, , O
such JJ O
F NN O
- HYPH O
element NN O
and CC O
1360 CD O
, , O
were VBD O
consistently RB O
found VBN O
to TO O
be VB O
HP1 NN O
- HYPH O
enriched VBN O
both CC O
here RB O
and CC O
in IN O
the DT O
previous JJ O
study NN O
. . O

It PRP O
remains VBZ O
to TO O
be VB O
determined VBN O
whether IN O
these DT O
discrepancies NNS O
are VBP O
due IN O
to IN O
the DT O
different JJ O
experimental JJ O
systems NNS O
used VBN O
. . O

However RB O
, , O
we PRP O
note VBP O
that IN O
the DT O
previous JJ O
study NN O
was VBD O
performed VBN O
using VBG O
a DT O
cDNA NN O
array NN O
, , O
while IN O
we PRP O
observe VBP O
binding NN O
of IN O
endogenous JJ O
HP1 NN O
at IN O
the DT O
promoter NN O
of IN O
these DT O
genes NNS O
. . O

Similarly RB O
, , O
another DT O
study NN O
using VBG O
chromatin NN O
immunoprecipitation NN O
in IN O
larvae NN O
also RB O
showed VBD O
few JJ O
HP1 NNP O
- HYPH O
positive JJ O
genes NNS O
that WDT O
were VBD O
not RB O
detected VBN O
in IN O
Kc NNP O
cells NNS O
by IN O
the DT O
Dam NNP O
ID NNP O
approach NN O
( : O
21 CD O
) -RRB- O
. . O

A DT O
large JJ O
number NN O
of IN O
genes NNS O
affected VBN O
by IN O
the DT O
loss NN O
of IN O
D NN B-Species
. , I-Species
melanogaster NN I-Species
HP1 NN O
in IN O
larval JJ O
tissues NNS O
( SYM O
21 CD O
) -RRB- O
seem VBP O
to TO O
be VB O
different JJ O
from IN O
that DT O
in IN O
embryonic JJ O
Kc NNP O
cells NNS O
. . O

The DT O
change NN O
in IN O
the DT O
transcription NN O
of IN O
Aurora NNP O
B NNP O
and CC O
few JJ O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
reported VBN O
in IN O
this DT O
study NN O
is VBZ O
also RB O
not RB O
found VBN O
among IN O
the DT O
HP1 NN O
- HYPH O
affected VBN O
genes NNS O
at IN O
larval NN O
stage NN O
( SYM O
21 CD O
) -RRB- O
. . O

This DT O
may MD O
be VB O
due IN O
to IN O
specific JJ O
role NN O
( , O
s NNS O
) -RRB- O
of IN O
HP1 NN O
in IN O
different JJ O
stages NNS O
of IN O
development NN O
. . O

Alternatively RB O
, , O
it PRP O
is VBZ O
also RB O
possible JJ O
that IN O
the DT O
impact NN O
of IN O
HP1 NN O
in IN O
the DT O
transcription NN O
of IN O
cell NN O
- HYPH O
cycle NN O
regulators NNS O
in IN O
proliferating VBG O
cells NNS O
is VBZ O
underestimated VBN O
when WRB O
performing VBG O
the DT O
analyses NNS O
on IN O
larval JJ O
tissues NNS O
, , O
and CC O
thus RB O
on IN O
mixed JJ O
populations NNS O
of IN O
both CC O
proliferating VBG O
and CC O
differentiating VBG O
/ SYM O
differentiated VBN O
cells NNS O
. . O

HP1 NNP O
is VBZ O
generally RB O
known VBN O
as IN O
a DT O
transcriptional JJ O
repressor NN O
, , O
as IN O
supported VBN O
by IN O
several JJ O
lines NNS O
of IN O
evidence NN O
: : O
silencing NN O
of IN O
a DT O
euchromatic JJ O
reporter NN O
gene NN O
in IN O
heterochromatin NN O
requires VBZ O
HP1 NNP O
( SYM O
10 CD O
, , O
11 CD O
) -RRB- O
, , O
tethering NN O
of IN O
HP1 NN O
next RB O
to IN O
a DT O
euchromatic JJ O
reporter NN O
gene NN O
causes VBZ O
silencing NN O
( SYM O
45 CD O
) -RRB- O
, , O
and CC O
the DT O
repression NN O
of IN O
genes NNS O
within IN O
euchromatic JJ O
region NN O
31 CD O
bound VBN O
by IN O
HP1 NNP O
is VBZ O
relieved VBN O
in IN O
the DT O
absence NN O
of IN O
HP1 NNP O
( SYM O
46 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
genes NNS O
in IN O
heterochromatin NN O
, , O
known VBN O
as IN O
heterochromatic JJ O
genes NNS O
, , O
such JJ O
as IN O
light JJ O
and CC O
rolled VBN O
, , O
seem VBP O
to TO O
require VB O
HP1 NNP O
to TO O
maintain VB O
their PRP$ O
active JJ O
transcription NN O
( : O
47 CD O
, , O
48 CD O
) -RRB- O
. . O

The DT O
level NN O
of IN O
transcription NN O
of IN O
heterochromatic JJ O
genes NNS O
was VBD O
dramatically RB O
reduced VBN O
in IN O
a DT O
mutated VBN O
HP1 NNP O
background NN O
( : O
47 CD O
- HYPH O
49 CD O
) -RRB- O
. . O

It PRP O
was VBD O
therefore RB O
proposed VBN O
that IN O
HP1 NNP O
may MD O
function VB O
as IN O
a DT O
positive JJ O
regulator NN O
of IN O
transcription NN O
of IN O
these DT O
genes NNS O
( : O
50 CD O
, , O
51 CD O
) -RRB- O
, , O
although IN O
the DT O
exact JJ O
regulation NN O
mechanism NN O
remains VBZ O
unclear JJ O
. . O

A DT O
study NN O
of IN O
heat NN O
- HYPH O
shock NN O
genes NNS O
found VBD O
that IN O
HP1 NNP O
is VBZ O
associated VBN O
with IN O
RNA NNP O
transcripts NNS O
in IN O
the DT O
coding VBG O
region NN O
, , O
and CC O
is VBZ O
also RB O
a DT O
positive JJ O
regulator NN O
of IN O
their PRP$ O
transcription NN O
( SYM O
52 CD O
, , O
53 CD O
) -RRB- O
. . O

The DT O
chromatin NN O
association NN O
of IN O
HP1 NN O
at IN O
the DT O
promoter NN O
region NN O
of IN O
active JJ O
euchromatic JJ O
genes NNS O
demonstrated VBN O
from IN O
this DT O
work NN O
and CC O
others NNS O
, , O
and CC O
its PRP$ O
independence NN O
from IN O
histone NN O
H3K9 NNP O
methylation NN O
( SYM O
21 CD O
) -RRB- O
, , O
all DT O
suggest VBP O
that IN O
mechanism NN O
whereby WRB O
HP1 NNP O
modulates VBZ O
transcription NN O
of IN O
euchromatic JJ O
genes NNS O
is VBZ O
potentially RB O
distinct JJ O
from IN O
its PRP$ O
role NN O
in IN O
heterochromatin NN O
formation NN O
. . O

Collectively RB O
, , O
the DT O
results NNS O
of IN O
this DT O
study NN O
demonstrate VBP O
that IN O
HP1 NNP O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
cell NN O
- HYPH O
cycle NN O
progression NN O
, , O
and CC O
support VBP O
the DT O
view NN O
that IN O
HP1 NNP O
, , O
in IN O
addition NN O
to IN O
its PRP$ O
role NN O
in IN O
heterochromatin NN O
, , O
can MD O
act VB O
as IN O
a DT O
positive JJ O
transcriptional JJ O
regulator NN O
of IN O
euchromatic JJ O
genes NNS O
. . O

SUPPLEMENTARY JJ O
MATERIAL NN O

Supplementary JJ O
Material NN O
is VBZ O
available JJ O
at IN O
NAR NNP O
Online NNP O
. . O

Supplementary JJ O
Material NN O

Structural JJ O
organization NN O
and CC O
interactions NNS O
of IN O
transmembrane NN O
domains NNS O
in IN O
tetraspanin NN O
proteins NNS O

Abstract JJ O

Background NN O

Proteins NNS O
of IN O
the DT O
tetraspanin JJ O
family NN O
contain VBP O
four CD O
transmembrane JJ O
domains NNS O
( , O
TM1 NNP O
- HYPH O
4 CD O
) -RRB- O
linked VBN O
by IN O
two CD O
extracellular JJ O
loops NNS O
and CC O
a DT O
short JJ O
intracellular JJ O
loop NN O
, , O
and CC O
have VBP O
short JJ O
intracellular JJ O
N NN O
- HYPH O
and CC O
C NN O
- HYPH O
termini NN O
. . O

While IN O
structure NN O
and CC O
function NN O
analysis NN O
of IN O
the DT O
larger JJR O
extracellular JJ O
loop NN O
has VBZ O
been VBN O
performed VBN O
, , O
the DT O
organization NN O
and CC O
role NN O
of IN O
transmembrane NN O
domains NNS O
have VBP O
not RB O
been VBN O
systematically RB O
assessed VBN O
. . O

Results NNS O

Among IN O
28 CD O
human JJ B-Species
tetraspanin JJ O
proteins NNS O
, , O
the DT O
TM1 NNP O
- HYPH O
3 CD O
sequences NNS O
display VBP O
a DT O
distinct JJ O
heptad NN O
repeat NN O
motif NN O
( , O
abcdefg FW O
) -RRB- O
n -RRB- O
. . O

In IN O
TM1 NNP O
, , O
position NN O
a DT O
is VBZ O
occupied VBN O
by IN O
structurally RB O
conserved VBN O
bulky JJ O
residues NNS O
and CC O
position NN O
d NN O
contains VBZ O
highly RB O
conserved VBN O
Asn NNP O
and CC O
Gly NNP O
residues NNS O
. . O

In IN O
TM2 NNP O
, , O
position NN O
a DT O
is VBZ O
occupied VBN O
by IN O
conserved VBN O
small JJ O
residues NNS O
( , O
Gly NNP O
/ SYM O
Ala NNP O
/ , O
Thr NNP O
) -RRB- O
, , O
and CC O
position NN O
d VBN O
has VBZ O
a DT O
conserved VBN O
Gly NNP O
and CC O
two CD O
bulky JJ O
aliphatic JJ O
residues NNS O
. . O

In IN O
TM3 NNP O
, , O
three CD O
a DT O
positions NNS O
of IN O
the DT O
heptad NN O
repeat NN O
are VBP O
filled VBN O
by IN O
two CD O
leucines NNS O
and CC O
a DT O
glutamate NN O
/ SYM O
glutamine NN O
residue NN O
, , O
and CC O
two CD O
d JJ O
positions NNS O
are VBP O
occupied VBN O
by IN O
either CC O
Phe NNP O
/ SYM O
Tyr NNP O
or CC O
Val NNP O
/ SYM O
Ile NNP O
/ SYM O
Leu NNP O
residues NNS O
. . O

No DT O
heptad NN O
motif NN O
is VBZ O
apparent JJ O
in IN O
TM4 NNP O
sequences NNS O
. . O

Mutations NNS O
of IN O
conserved VBN O
glycines NNS O
in IN O
human JJ B-Species
CD9 NN O
( , O
Gly25 NN O
and CC O
Gly32 NN O
in IN O
TM1 NN O
; : O
Gly67 NN O
and CC O
Gly74 NN O
in IN O
TM2 NN O
) -RRB- O
caused VBD O
aggregation NN O
of IN O
mutant JJ O
proteins NNS O
inside IN O
the DT O
cell NN O
. . O

Modeling VBG O
of IN O
the DT O
TM1 NNP O
- HYPH O
TM2 NNP O
interface NN O
in IN O
CD9 NNP O
, , O
using VBG O
a DT O
novel JJ O
algorithm NN O
, , O
predicts VBZ O
tight JJ O
packing NN O
of IN O
conserved VBN O
bulky JJ O
residues NNS O
against IN O
conserved VBN O
Gly NNP O
residues NNS O
along IN O
the DT O
two CD O
helices NNS O
. . O

The DT O
homodimeric JJ O
interface NN O
of IN O
CD9 NNP O
was VBD O
mapped VBN O
, , O
by IN O
disulfide JJ O
cross NN O
- HYPH O
linking NN O
of IN O
single JJ O
- HYPH O
cysteine NN O
mutants NNS O
, , O
to IN O
the DT O
vicinity NN O
of IN O
residues NNS O
Leu14 NNP O
and CC O
Phe17 NNP O
in IN O
TM1 NNP O
( , O
positions NNS O
g NNP O
and CC O
c NN O
) -RRB- O
and CC O
Gly77 NNP O
, , O
Gly80 NNP O
and CC O
Ala81 NNP O
in IN O
TM2 NNP O
( , O
positions NNS O
d NN O
, , O
g NN O
and CC O
a DT O
, , O
respectively RB O
) -RRB- O
. . O

Mutations NNS O
of IN O
a DT O
and CC O
d JJ O
residues NNS O
in IN O
both CC O
TM1 NNP O
and CC O
TM2 NNP O
( , O
Gly25 NNP O
, , O
Gly32 NNP O
, , O
Gly67 NNP O
and CC O
Gly74 NNP O
) -RRB- O
, , O
involved VBN O
in IN O
intramolecular JJ O
TM1 NN O
- HYPH O
TM2 NNP O
interaction NN O
, , O
also RB O
strongly RB O
diminished VBN O
intermolecular JJ O
interaction NN O
, , O
as IN O
assessed VBN O
by IN O
cross NN O
- HYPH O
linking NN O
of IN O
Cys80 NNP O
. . O

Conclusion NN O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
tetraspanin JJ O
intra NN O
- HYPH O
and CC O
intermolecular JJ O
interactions NNS O
are VBP O
mediated VBN O
by IN O
conserved VBN O
residues NNS O
in IN O
adjacent JJ O
, , O
but CC O
distinct JJ O
regions NNS O
of IN O
TM1 NNP O
and CC O
TM2 NNP O
. . O

A DT O
key JJ O
structural JJ O
element NN O
that WDT O
defines VBZ O
TM1 NNP O
- HYPH O
TM2 NNP O
interaction NN O
in IN O
tetraspanins NN O
is VBZ O
the DT O
specific JJ O
packing NN O
of IN O
bulky JJ O
residues NNS O
against IN O
small JJ O
residues NNS O
. . O

Background NN O

Tetraspanins NNP O
constitute VBP O
a DT O
large JJ O
family NN O
of IN O
integral JJ O
membrane NN O
proteins NNS O
, , O
characteristically RB O
containing VBG O
4 CD O
, , O
6 CD O
or CC O
8 CD O
conserved VBN O
cysteine NN O
residues NNS O
in IN O
the DT O
large JJ O
extracellular JJ O
loop NN O
( , O
including VBG O
the DT O
CCG NNP O
and CC O
PxxCC NNP O
motifs NNS O
) -RRB- O
, , O
which WDT O
form VBP O
disulfide NN O
bonds NNS O
, , O
and CC O
several JJ O
conserved VBN O
polar JJ O
residues NNS O
in IN O
the DT O
intracellular JJ O
loop NN O
and CC O
transmembrane NN O
regions NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

There EX O
are VBP O
32 CD O
putative JJ O
tetraspanin NN O
family NN O
members NNS O
in IN O
mammals NNS O
, , O
37 CD O
in IN O
Drosophila NNP B-Species
melanogaster NN I-Species
and CC O
20 CD O
in IN O
Caenorhabditis NNP B-Species
elegans NNS I-Species
. . O

Tetraspanins NNP O
play VBP O
diverse JJ O
roles NNS O
in IN O
cell NN O
adhesion NN O
, , O
migration NN O
and CC O
fusion NN O
processes NNS O
, , O
cellular JJ O
activation NN O
and CC O
signaling NN O
( , O
reviewed VBN O
in IN O
refs NNS O
. . O
[ -LRB- O
2 CD O
- SYM O
4 CD O
] -RRB- O
) -RRB- O
. . O

Mammalian JJ O
tetraspanins NNS O
such JJ O
as IN O
CD9 NNP O
, , O
CD63 NNP O
, , O
CD81 NNP O
, , O
CD82 NNP O
, , O
CD151 NNP O
, , O
rds NNS O
/ SYM O
peripherin NN O
, , O
and CC O
uroplakins NNS O
Ia NNP O
and CC O
Ib NNP O
have VBP O
been VBN O
most RBS O
extensively RB O
studied VBN O
, , O
with IN O
mouse NN B-Species
knock VB O
- HYPH O
out RP O
models NNS O
available JJ O
for IN O
CD9 NNP O
[ -LRB- O
5 CD O
- SYM O
7 CD O
] -RRB- O
, , O
CD81 NNP O
[ -LRB- O
8 CD O
, , O
9 CD O
] -RRB- O
, , O
CD151 NNP O
[ -LRB- O
10 CD O
] -RRB- O
and CC O
a DT O
few JJ O
others NNS O
. . O

However RB O
, , O
the DT O
majority NN O
of IN O
tetraspanins NNS O
are VBP O
characterized VBN O
very RB O
little JJ O
, , O
if IN O
at RB O
all RB O
, , O
at IN O
genetic JJ O
, , O
biochemical JJ O
or CC O
structural JJ O
levels NNS O
. . O

The DT O
large JJ O
extracellular JJ O
loop NN O
( , O
LEL NNP O
) -RRB- O
of IN O
tetraspanins NNS O
has VBZ O
received VBN O
most JJS O
attention NN O
, , O
since IN O
it PRP O
contains VBZ O
functionally RB O
important JJ O
sites NNS O
. . O

Sequence NN O
QRD NNP O
( : O
194 CD O
- HYPH O
196 CD O
) -RRB- O
in IN O
CD151 NN O
is VBZ O
important JJ O
for IN O
association NN O
with IN O
integrins NNS O
, , O
which WDT O
has VBZ O
functional JJ O
consequences NNS O
for IN O
integrin NN O
- HYPH O
dependent JJ O
cell NN O
spreading NN O
and CC O
multicellular JJ O
cable NN O
formation NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

A DT O
site NN O
in IN O
the DT O
LEL NNP O
of IN O
CD9 NNP O
, , O
SFQ NNP O
( , O
residues NNS O
173 CD O
- HYPH O
175 CD O
) -RRB- O
, , O
is VBZ O
essential JJ O
for IN O
CD9 NN O
function NN O
in IN O
sperm NN O
- HYPH O
egg NN O
fusion NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

The DT O
crystal NN O
structure NN O
of IN O
tetraspanin NN O
CD81 NNP O
LEL NNP O
revealed VBD O
five CD O
alpha NN O
- HYPH O
helixes NNS O
, , O
A NN O
- HYPH O
E NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Helices NNS O
A NN O
, , O
B NN O
and CC O
E NN O
form VBP O
a DT O
relatively RB O
conserved JJ O
region NN O
in IN O
tetraspanins NNS O
, , O
whereas IN O
the DT O
region NN O
between IN O
helices NNS O
B NN O
and CC O
E NNP O
is VBZ O
the DT O
most RBS O
variable JJ O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
the DT O
variable JJ O
region NN O
contains VBZ O
most JJS O
of IN O
the DT O
functionally RB O
important JJ O
sites NNS O
involved VBN O
in IN O
tetraspanin NN O
protein NN O
- HYPH O
protein NN O
interactions NNS O
. . O

A DT O
remarkable JJ O
biochemical JJ O
property NN O
of IN O
tetraspanin JJ O
molecules NNS O
is VBZ O
their PRP$ O
ability NN O
to TO O
associate VB O
with IN O
a DT O
large JJ O
number NN O
of IN O
other JJ O
transmembrane NN O
proteins NNS O
, , O
including VBG O
integrins NNS O
, , O
membrane NN O
- HYPH O
associated VBN O
growth NN O
factors NNS O
and CC O
receptors NNS O
, , O
MHC NNP O
class NN O
II NN O
molecules NNS O
, , O
Ig NNP O
superfamily NN O
proteins NNS O
, , O
and CC O
each DT O
other JJ O
[ -LRB- O
2 CD O
, , O
3 CD O
, , O
15 CD O
] -RRB- O
. . O

Several JJ O
of IN O
these DT O
lateral JJ O
associations NNS O
of IN O
tetraspanins NNS O
are VBP O
detected VBN O
in IN O
"""" `` O
mild JJ O
"""" '' O
detergents NNS O
( , O
Brij NNP O
series NN O
, , O
CHAPS NNP O
) -RRB- O
, , O
but CC O
are VBP O
disrupted VBN O
by IN O
"""" `` O
strong JJ O
"""" '' O
detergents NNS O
such JJ O
as IN O
Triton NNP O
X NNP O
- HYPH O
100 CD O
or CC O
SDS NNP O
. . O

Multiprotein JJ O
complexes NNS O
of IN O
tetraspanins NNS O
and CC O
associated VBN O
molecules NNS O
, , O
also RB O
called VBN O
the DT O
"""" `` O
tetraspanin JJ O
web NN O
"""" '' O
[ -LRB- O
16 CD O
] -RRB- O
, , O
may MD O
represent VB O
a DT O
distinct JJ O
tetraspanin NN O
- HYPH O
enriched VBN O
membrane NN O
microdomain NN O
[ -LRB- O
17 CD O
, , O
18 CD O
] -RRB- O
. . O

The DT O
formation NN O
of IN O
this DT O
microdomain NN O
is VBZ O
influenced VBN O
by IN O
palmitoylation NN O
of IN O
several JJ O
conserved VBN O
juxtamembrane NN O
cysteine NN O
residues NNS O
in IN O
tetraspanins NNS O
[ -LRB- O
19 CD O
- HYPH O
21 CD O
] -RRB- O
. . O

The DT O
transmembrane NN O
domains NNS O
, , O
encompassing VBG O
nearly RB O
half NN O
of IN O
a DT O
tetraspanin NN O
protein NN O
, , O
are VBP O
the DT O
most RBS O
conserved JJ O
part NN O
of IN O
the DT O
molecule NN O
( , O
Stipp NNP O
et NN O
al NNP O
. . O
[ -LRB- O
1 CD O
] -RRB- O
and CC O
this DT O
study NN O
) -RRB- O
. . O

However RB O
, , O
very RB O
little JJ O
functional JJ O
information NN O
is VBZ O
available JJ O
on IN O
these DT O
domains NNS O
. . O

The DT O
differential JJ O
detergent NN O
sensitivity NN O
of IN O
tetraspanin NN O
- HYPH O
tetraspanin NN O
associations NNS O
suggests VBZ O
that IN O
hydrophobic JJ O
interactions NNS O
between IN O
TM NNP O
helices NNS O
may MD O
play VB O
a DT O
role NN O
. . O

Indeed RB O
, , O
when WRB O
the DT O
large JJ O
extracellular JJ O
loop NN O
( , O
LEL NNP O
) -RRB- O
of IN O
CD151 NN O
is VBZ O
deleted VBN O
, , O
the DT O
molecule NN O
is VBZ O
still RB O
able JJ O
to TO O
associate VB O
with IN O
other JJ O
tetraspanins NNS O
[ -LRB- O
22 CD O
] -RRB- O
. . O

Thus RB O
, , O
TM NNP O
domains NNS O
are VBP O
strong JJ O
candidates NNS O
for IN O
mediating VBG O
tetraspanin NN O
- HYPH O
tetraspanin NN O
interactions NNS O
. . O

The DT O
importance NN O
of IN O
TM NNP O
domain NN O
interactions NNS O
in IN O
intramolecular JJ O
organization NN O
was VBD O
demonstrated VBN O
in IN O
a DT O
study NN O
showing VBG O
that IN O
CD82 NNP O
fragment NN O
TM2 NNP O
- HYPH O
4 CD O
, , O
lacking VBG O
TM1 NNP O
, , O
was VBD O
retained VBN O
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
, , O
but CC O
was VBD O
transported VBN O
to IN O
the DT O
cell NN O
surface NN O
upon IN O
co NN O
- HYPH O
expression NN O
of IN O
TM1 NNP O
[ -LRB- O
23 CD O
] -RRB- O
. . O

This DT O
in IN O
vivo NN O
reconstitution NN O
experiment NN O
demonstrated VBD O
a DT O
strong JJ O
interaction NN O
between IN O
TM1 NNP O
and CC O
the DT O
rest NN O
of IN O
the DT O
molecule NN O
. . O

Expression NN O
of IN O
a DT O
truncated VBN O
CD9 NNP O
molecule NN O
( , O
TM3 NNP O
- HYPH O
LEL NNP O
- HYPH O
TM4 NNP O
) , O
results VBZ O
in IN O
intracellular JJ O
accumulation NN O
of IN O
the DT O
protein NN O
and CC O
significant JJ O
misfolding NN O
of IN O
the DT O
LEL NNP O
, , O
as IN O
judged VBN O
by IN O
inappropriate JJ O
disulfide JJ O
formation NN O
and CC O
diminished VBN O
antibody NN O
reactivity NN O
( , O
our PRP$ O
unpublished JJ O
data NNS O
) -RRB- O
. . O

Similarly RB O
, , O
a DT O
CD9 NNP O
epitope NN O
in IN O
the DT O
LEL NNP O
is VBZ O
lost VBN O
in IN O
molecules NNS O
lacking VBG O
either CC O
TM2 NNP O
+ CC O
TM3 NNP O
or CC O
just RB O
TM4 NNP O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Thus RB O
, , O
TM NNP O
domain NN O
interactions NNS O
and CC O
packing NN O
are VBP O
crucial JJ O
for IN O
proper JJ O
folding NN O
, , O
stability NN O
and CC O
transport NN O
of IN O
tetraspanin JJ O
molecules NNS O
. . O

In IN O
a DT O
previous JJ O
study NN O
, , O
we PRP O
showed VBD O
that IN O
covalent JJ O
cross NN O
- HYPH O
linking NN O
of IN O
membrane NN O
- HYPH O
proximal JJ O
cysteine NN O
residues NNS O
can MD O
be VB O
used VBN O
as IN O
a DT O
tool NN O
for IN O
detection NN O
of IN O
tetraspanin NN O
- HYPH O
tetraspanin NN O
associations NNS O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Inhibition NN O
of IN O
cysteine NN O
palmitoylation NN O
by IN O
2 CD O
- HYPH O
bromopalmitate NN O
( -LRB- O
2 CD O
- HYPH O
BP NN O
) -RRB- O
made VBD O
cysteines NNS O
available JJ O
for IN O
cross NN O
- HYPH O
linking VBG O
and CC O
enabled VBN O
demonstration NN O
of IN O
specific JJ O
tetraspanin NN O
homodimerization NN O
and CC O
low JJ O
levels NNS O
of IN O
heterodimerization NN O
. . O

We PRP O
concluded VBD O
that IN O
tetraspanin NN O
homodimers NNS O
, , O
formed VBN O
in IN O
the DT O
Golgi NNP O
, , O
may MD O
be VB O
a DT O
fundamental JJ O
structural JJ O
unit NN O
within IN O
tetraspanin NN O
microdomains NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
carried VBD O
out RP O
detailed JJ O
sequence NN O
analysis NN O
of IN O
human JJ B-Species
tetraspanin NN O
TM NN O
domains NNS O
. . O

We PRP O
show VBP O
that IN O
a DT O
heptad NN O
repeat NN O
containing VBG O
conserved VBN O
glycine NN O
, , O
asparagine NN O
and CC O
large JJ O
hydrophobic JJ O
residues NNS O
occurs VBZ O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
domains NNS O
, , O
and CC O
predict VBP O
tight JJ O
intramolecular JJ O
association NN O
of IN O
these DT O
two CD O
domains NNS O
by IN O
packing NN O
of IN O
the DT O
large JJ O
residues NNS O
against IN O
the DT O
small JJ O
residues NNS O
. . O

Moreover RB O
, , O
by IN O
using VBG O
cysteine NN O
cross NN O
- HYPH O
linking VBG O
we PRP O
map VBP O
a DT O
dimerization NN O
interface NN O
in IN O
the DT O
human JJ B-Species
CD9 NN O
protein NN O
, , O
and CC O
show VBP O
that IN O
conserved VBN O
heptad NN O
motif NN O
glycine NN O
residues NNS O
are VBP O
also RB O
important JJ O
for IN O
intermolecular JJ O
CD9 NNP O
associations NNS O
. . O

Results NNS O

Sequence NN O
analysis NN O
of IN O
tetraspanin NN O
transmembrane NN O
domains NNS O
: : O
presence NN O
of IN O
the DT O
heptad NN O
repeat NN O
motif NN O

We PRP O
focused VBD O
our PRP$ O
attention NN O
on IN O
28 CD O
human JJ B-Species
tetraspanins NNS O
identified VBN O
from IN O
the DT O
SWISS NNP O
- HYPH O
PROT NNP O
and CC O
GenBank NNP O
databases NNS O
. . O

All DT O
tetraspanins NNS O
have VBP O
in IN O
common JJ O
four CD O
hydrophobic JJ O
stretches NNS O
( , O
TM NNP O
domains NNS O
) -RRB- O
of IN O
20 CD O
- SYM O
25 CD O
residues NNS O
, , O
and CC O
contain VBP O
highly RB O
conserved VBN O
residues NNS O
in IN O
the DT O
second JJ O
extracellular JJ O
loop NN O
, , O
in IN O
particular JJ O
the DT O
Cys NNP O
- HYPH O
Cys NNP O
- HYPH O
Gly NNP O
( : O
CCG NNP O
) -RRB- O
motif NN O
. . O

Detailed JJ O
analysis NN O
of IN O
the DT O
large JJ O
extracellular JJ O
loop NN O
sequences NNS O
[ -LRB- O
14 CD O
] -RRB- O
, , O
and CC O
dendrograms NNS O
based VBN O
on IN O
full JJ O
- HYPH O
length NN O
alignment NN O
can MD O
be VB O
found VBN O
in IN O
earlier JJR O
studies NNS O
[ -LRB- O
26 CD O
, , O
27 CD O
] -RRB- O
. . O

The DT O
length NN O
of IN O
each DT O
transmembrane NN O
domain NN O
was VBD O
established VBN O
based VBN O
on IN O
previous JJ O
sequence NN O
analysis NN O
of IN O
tetraspanin NN O
sequences NNS O
[ -LRB- O
27 CD O
, , O
28 CD O
] -RRB- O
, , O
and CC O
on IN O
annotations NNS O
to IN O
the DT O
database NN O
entries NNS O
. . O

Manual JJ O
adjustments NNS O
based VBN O
on IN O
sequence NN O
homology NN O
and CC O
hydrophobicity NN O
profiles NNS O
were VBD O
done VBN O
to TO O
fully RB O
delineate VB O
the DT O
TM NNP O
domains NNS O
. . O

The DT O
resulting VBG O
lengths NNS O
of IN O
TM NNP O
domains NNS O
were VBD O
: : O
TM1 NNP O
- HYPH O
23 CD O
residues NNS O
; : O
TM2 NNP O
- HYPH O
21 CD O
residues NNS O
; : O
TM3 NNP O
- HYPH O
25 CD O
residues NNS O
; : O
TM4 NNP O
- HYPH O
25 CD O
residues NNS O
. . O

Two CD O
more JJR O
residues NNS O
could MD O
be VB O
added VBN O
onto IN O
the DT O
N NNP O
- HYPH O
terminal JJ O
part NN O
of IN O
TM2 NNP O
; : O
however RB O
, , O
relatively RB O
small JJ O
sequence NN O
conservation NN O
of IN O
these DT O
residues NNS O
among IN O
tetraspanins NNS O
and CC O
occurrence NN O
of IN O
polar JJ O
/ SYM O
charged VBN O
side NN O
chains NNS O
in IN O
some DT O
tetraspanins NNS O
precluded VBD O
us PRP O
from IN O
doing VBG O
so RB O
for IN O
the DT O
global JJ O
alignment NN O
. . O

Figures NNS O
1 CD O
and CC O
2 CD O
show VBP O
a DT O
multiple JJ O
sequence NN O
alignment NN O
of IN O
four CD O
TM NNP O
domains NNS O
of IN O
28 CD O
human JJ B-Species
tetraspanins NNS O
. . O

For IN O
each DT O
position NN O
within IN O
the DT O
domains NNS O
, , O
consensus NN O
residues NNS O
were VBD O
determined VBN O
and CC O
classified VBN O
( , O
with IN O
individual JJ O
color NN O
code NN O
) -RRB- O
in IN O
4 CD O
categories NNS O
: : O
1 CD O
) SYM O
large JJ O
hydrophobic JJ O
residues NNS O
( , O
including VBG O
Val NNP O
, , O
Met NNP O
, , O
Leu NNP O
, , O
Ile NNP O
, , O
Phe NNP O
, , O
Tyr NNP O
, , O
Trp NNP O
) -RRB- O
, , O
2 CD O
) SYM O
small JJ O
residues NNS O
( , O
Gly NNP O
, , O
Ala NNP O
, , O
Ser NNP O
and CC O
Thr NNP O
) -RRB- O
, , O
3 CD O
) SYM O
Cys NNS O
, , O
and CC O
4 CD O
) SYM O
Asn NNP O
. . O

When WRB O
more JJR O
than IN O
two CD O
types NNS O
of IN O
residues NNS O
occupied VBD O
a DT O
given VBN O
position NN O
in IN O
a DT O
TM NN O
, , O
a DT O
dual JJ O
- HYPH O
color NN O
pattern NN O
that WDT O
reflected VBD O
the DT O
prevalence NN O
of IN O
the DT O
particular JJ O
residue NN O
type NN O
was VBD O
used VBN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

Cysteine NN O
residues NNS O
were VBD O
shown VBN O
separately RB O
due IN O
to IN O
their PRP$ O
importance NN O
as IN O
palmitoylation NN O
target NN O
sites NNS O
. . O

The DT O
highly RB O
conserved VBN O
asparagine NN O
residue NN O
in IN O
TM1 NNP O
was VBD O
considered VBN O
separately RB O
. . O

No DT O
proline JJ O
residues NNS O
are VBP O
found VBN O
in IN O
TM NNP O
domains NNS O
1 CD O
- SYM O
3 CD O
of IN O
human JJ B-Species
tetraspanins NNS O
. . O

An DT O
inspection NN O
of IN O
the DT O
multiple JJ O
sequence NN O
alignment NN O
reveals VBZ O
a DT O
repeating VBG O
heptad NN O
amino NN O
acid NN O
pattern NN O
, , O
( , O
abcdefg FW O
) -RRB- O
n CD O
, , O
in IN O
TM1 NNP O
, , O
2 CD O
and CC O
3 CD O
( SYM O
Figure NNP O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Heptad NNP O
repeats VBZ O
promote VBP O
helical JJ O
coiled VBN O
coil NN O
interactions NNS O
in IN O
multiple JJ O
soluble JJ O
and CC O
membrane NN O
- HYPH O
spanning VBG O
proteins NNS O
[ -LRB- O
29 CD O
- SYM O
31 CD O
] -RRB- O
. . O

In IN O
the DT O
heptad JJ O
repeat NN O
, , O
hydrophobic JJ O
residues NNS O
in IN O
positions NNS O
a DT O
and CC O
d NN O
are VBP O
of IN O
special JJ O
importance NN O
, , O
as IN O
they PRP O
directly RB O
mediate VBP O
interhelical JJ O
contacts NNS O
by IN O
creating VBG O
a DT O
tight JJ O
knobs NNS O
- HYPH O
into IN O
- HYPH O
holes NNS O
packing VBG O
in IN O
the DT O
coiled VBN O
coil NN O
structure NN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

For IN O
instance NN O
, , O
in IN O
the DT O
leucine NN O
zipper NN O
of IN O
the DT O
yeast NN B-Species
transcription NN O
factor NN O
GCN4 NNP O
, , O
positions NNS O
a DT O
and CC O
d NN O
contain VBP O
Val NNP O
and CC O
Leu NNP O
residues NNS O
, , O
respectively RB O
, , O
with IN O
an DT O
Asn NNP O
residue NN O
in IN O
a DT O
single JJ O
a DT O
position NN O
forming VBG O
a DT O
hydrogen NN O
bond NN O
across IN O
the DT O
GCN4 NNP O
dimer NN O
interface NN O
[ -LRB- O
33 CD O
] -RRB- O
. . O

In IN O
TM1 NNP O
of IN O
tetraspanins NNS O
, , O
highly RB O
conserved VBN O
Asn NNP O
, , O
Gly NNP O
and CC O
Gly JJ O
residues NNS O
( , O
numbers NNS O
18 CD O
, , O
25 CD O
and CC O
32 CD O
in IN O
the DT O
CD9 NNP O
sequence NN O
) -RRB- O
appear VBP O
at IN O
d VBN O
positions NNS O
of IN O
the DT O
heptad NN O
repeats NNS O
, , O
and CC O
residues NNS O
14 CD O
, , O
21 CD O
and CC O
28 CD O
are VBP O
at IN O
a DT O
positions NNS O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

In IN O
TM2 NNP O
, , O
residues NNS O
67 CD O
, , O
74 CD O
and CC O
81 CD O
( , O
consensus NN O
Gly NNP O
, , O
Gly NNP O
and CC O
Ala NNP O
, , O
respectively RB O
) , O
occupy VBP O
a DT O
positions NNS O
, , O
whereas IN O
residues NNS O
63 CD O
, , O
70 CD O
and CC O
77 CD O
are VBP O
at IN O
d VBN O
positions NNS O
. . O

Another DT O
highly RB O
conserved VBN O
glycine NN O
, , O
Gly80 NNP O
, , O
occupies VBZ O
the DT O
3rd JJ O
g NN O
position NN O
in IN O
TM2 NNP O
. . O

In IN O
TM3 NNP O
, , O
the DT O
conserved VBN O
pattern NN O
consists VBZ O
of IN O
two CD O
leucine NN O
residues NNS O
( , O
Leu89 NNP O
and CC O
Leu96 NNP O
) -RRB- O
and CC O
a DT O
glutamate NN O
/ SYM O
glutamine NN O
residue NN O
( , O
Glu NNP O
/ SYM O
Gln103 NNP O
) -RRB- O
in IN O
a DT O
positions NNS O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Two CD O
d JJ O
positions NNS O
are VBP O
also RB O
conserved VBN O
- : O
Phe NNP O
/ SYM O
Tyr92 NNP O
and CC O
Ile NNP O
/ SYM O
Val NNP O
/ SYM O
Leu99 NNP O
. . O

TM4 NNP O
lacks VBZ O
a DT O
conserved JJ O
heptad NN O
pattern NN O
and CC O
has VBZ O
only RB O
a DT O
single JJ O
conserved VBN O
position NN O
, , O
Glu NNP O
/ SYM O
Gln209 NNP O
( , O
with IN O
four CD O
exceptions NNS O
) -RRB- O
. . O

These DT O
features NNS O
of IN O
TM1 NNP O
- HYPH O
4 CD O
of IN O
tetraspanins NNS O
are VBP O
displayed VBN O
on IN O
helical JJ O
wheel NN O
diagrams NNS O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

Analysis NN O
of IN O
TM1 NNP O
sequences NNS O

The DT O
conserved VBN O
Asn NNP O
- HYPH O
Gly NNP O
- HYPH O
Gly NNP O
motif NN O
, , O
occupying VBG O
designated VBN O
d JJ O
positions NNS O
of IN O
the DT O
heptad NN O
repeat NN O
, , O
is VBZ O
the DT O
most RBS O
prominent JJ O
structural JJ O
feature NN O
of IN O
TM1 NNP O
. . O

We PRP O
also RB O
compared VBD O
sequences NNS O
of IN O
CD9 NNP O
orthologs NNS O
from IN O
10 CD O
different JJ O
organisms NNS O
( , O
the DT O
most RBS O
available JJ O
for IN O
any DT O
tetraspanin NN O
) -RRB- O
to TO O
gain VB O
further JJ O
insight NN O
into IN O
conservation NN O
and CC O
variability NN O
of IN O
the DT O
TM1 NNP O
sequence NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4 CD O
, , O
positions NNS O
a DT O
, , O
d NN O
and CC O
g NN O
in IN O
TM1 NN O
are VBP O
among IN O
the DT O
most RBS O
conserved VBN O
( , O
0 CD O
, , O
1 CD O
and CC O
1 CD O
substitution NN O
, , O
respectively RB O
) -RRB- O
, , O
while IN O
interspecies NNS O
variability NN O
tends VBZ O
to TO O
occur VB O
in IN O
other JJ O
positions NNS O
: : O
b LS O
( , O
5 CD O
substitutions NNS O
) -RRB- O
, , O
c NN O
( , O
4 CD O
substitutions NNS O
) -RRB- O
, , O
e FW O
( , O
4 CD O
substitutions NNS O
) -RRB- O
and CC O
f LS O
( , O
4 CD O
substitutions NNS O
) -RRB- O
. . O

Thus RB O
, , O
the DT O
positions NNS O
typically RB O
involved VBN O
in IN O
coiled VBN O
coil NN O
interactions NNS O
( , O
a DT O
and CC O
d NN O
) -RRB- O
are VBP O
the DT O
most RBS O
conserved JJ O
. . O

When WRB O
residues NNS O
of IN O
TM1 NNP O
are VBP O
plotted VBN O
as IN O
a DT O
helical JJ O
wheel NN O
, , O
additional JJ O
structural JJ O
features NNS O
are VBP O
revealed VBN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

There EX O
are VBP O
highly RB O
conserved VBN O
aliphatic JJ O
and CC O
aromatic JJ O
residues NNS O
in IN O
the DT O
first JJ O
three CD O
a DT O
positions NNS O
of IN O
the DT O
heptad NN O
motif NN O
( , O
Phe15 NNP O
, , O
Trp22 NNP O
and CC O
Leu29 NNP O
in IN O
CD9 NNP O
) -RRB- O
, , O
as RB O
well RB O
as IN O
in IN O
g JJ O
positions NNS O
( , O
Leu14 NNP O
, , O
Phe21 NNP O
, , O
Val28 NNP O
in IN O
CD9 NNP O
) -RRB- O
. . O

The DT O
"""" `` O
ridges NNS O
"""" '' O
formed VBN O
by IN O
these DT O
bulky JJ O
residues NNS O
are VBP O
flanking VBG O
the DT O
"""" `` O
groove NN O
"""" '' O
- , O
forming VBG O
Gly JJ O
residues NNS O
of IN O
the DT O
Asn NNP O
- HYPH O
Gly NNP O
- HYPH O
Gly NNP O
position NN O
d NN O
motif NN O
. . O

In IN O
contrast NN O
, , O
b NN O
, , O
c NN O
, , O
e `` O
and CC O
f NN O
positions NNS O
show VBP O
an DT O
overall JJ O
higher JJR O
variability NN O
among IN O
tetraspanins NNS O
, , O
as IN O
also RB O
seen VBN O
in IN O
the DT O
comparison NN O
of IN O
CD9 NNP O
orthologs NNS O
described VBN O
above RB O
. . O

Analysis NN O
of IN O
TM2 NNP O
sequences NNS O

A DT O
landmark JJ O
feature NN O
of IN O
TM2 NNP O
in IN O
tetraspanins NN O
is VBZ O
the DT O
presence NN O
of IN O
highly RB O
conserved VBN O
glycine NN O
residues NNS O
( , O
Gly67 NNP O
, , O
74 CD O
, , O
77 CD O
and CC O
80 CD O
in IN O
CD9 NN O
, , O
Figure NN O
1 CD O
) -RRB- O
. . O

Other JJ O
substitutions NNS O
at IN O
these DT O
positions NNS O
are VBP O
almost RB O
exclusively RB O
small JJ O
residues NNS O
, , O
such JJ O
as IN O
Ala NNP O
or CC O
Ser NNP O
. . O

In IN O
addition NN O
, , O
Ala NNP O
, , O
Ser NNP O
or CC O
Thr NNP O
occupy VBP O
position NN O
81 CD O
. . O

This DT O
residue NN O
, , O
together RB O
with IN O
Gly67 NNP O
and CC O
Gly74 NNP O
, , O
forms VBZ O
face NN O
a DT O
of IN O
the DT O
helix NN O
. . O

Residue NNP O
Gly77 NNP O
( -LRB- O
position NN O
d VBN O
) -RRB- O
is VBZ O
preceded VBN O
by IN O
conserved VBN O
, , O
chiefly RB O
large JJ O
hydrophobic JJ O
residues NNS O
on IN O
the DT O
same JJ O
helical JJ O
face NN O
( , O
Leu63 NNP O
and CC O
Met70 NNP O
in IN O
CD9 NNP O
) -RRB- O
. . O

Extremely RB O
conserved VBN O
Gly80 NNP O
falls VBZ O
into IN O
heptad NN O
position NN O
g NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

Among IN O
CD9 NNP O
orthologs NNS O
, , O
heptad NN O
positions NNS O
a DT O
and CC O
d CC O
are VBP O
absolutely RB O
conserved JJ O
, , O
whereas IN O
other JJ O
positions NNS O
have VBP O
the DT O
following VBG O
number NN O
of IN O
substitutions NNS O
: : O
b NN O
- HYPH O
3 CD O
; : O
c NN O
- HYPH O
2 CD O
; : O
e CD O
- HYPH O
1 CD O
; : O
f CD O
- HYPH O
3 CD O
; : O
g NNP O
- HYPH O
1 CD O
( : O
Figure NN O
4 CD O
) -RRB- O
. . O

Two CD O
of IN O
the DT O
f CD O
position NN O
residues NNS O
in IN O
TM2 NNP O
( : O
65 CD O
and CC O
79 CD O
) -RRB- O
also RB O
show VBP O
higher JJR O
variability NN O
among IN O
different JJ O
tetraspanins NNS O
( -LRB- O
Figures NNS O
1 CD O
, , O
3 CD O
) -RRB- O
. . O

Cysteine NN O
residues NNS O
are VBP O
frequently RB O
found VBN O
near IN O
the DT O
cytoplasmic JJ O
end NN O
of IN O
TM2 NNP O
helix NN O
at IN O
positions NNS O
78 CD O
and CC O
79 CD O
; : O
these DT O
cysteines NNS O
are VBP O
likely JJ O
to TO O
be VB O
palmitoylated VBN O
. . O

Analysis NN O
of IN O
TM3 NNP O
and CC O
TM4 NNP O
sequences NNS O

The DT O
TM3 NNP O
domain NN O
provides VBZ O
another DT O
example NN O
of IN O
the DT O
heptad NN O
repeat NN O
pattern NN O
. . O

Position NN O
a DT O
is VBZ O
occupied VBN O
by IN O
two CD O
highly RB O
conserved VBN O
leucine NN O
and CC O
a DT O
glutamate NN O
/ SYM O
glutamine NN O
residue NN O
( , O
Leu89 NNP O
, , O
Leu96 NNP O
and CC O
Glu NNP O
/ SYM O
Gln103 CD O
in IN O
CD9 NNP O
) -RRB- O
. . O

Furthermore RB O
, , O
two CD O
d JJ O
positions NNS O
are VBP O
conserved VBN O
- HYPH O
Phe NNP O
/ SYM O
Tyr92 NNP O
( , O
aromatic JJ O
residue NN O
) -RRB- O
and CC O
Ile NNP O
/ SYM O
Val99 NNP O
( , O
beta NN O
- HYPH O
branched JJ O
aliphatic JJ O
residue NN O
; : O
Figures NNS O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
residue NN O
100 CD O
in IN O
position NN O
e FW O
is VBZ O
generally RB O
Phe NNP O
or CC O
Leu NNP O
. . O

Among IN O
CD9 NNP O
orthologs NNS O
, , O
position NN O
a DT O
has VBZ O
1 CD O
substitution NN O
, , O
positions NNS O
b NN O
, , O
c NN O
and CC O
f NN O
each DT O
have VBP O
6 CD O
, , O
positions NNS O
d NN O
and CC O
e VB O
each DT O
have VB O
2 CD O
, , O
and CC O
g VB O
has VBZ O
4 CD O
. . O

Thus RB O
, , O
as IN O
for IN O
TM1 NNP O
and CC O
TM2 NNP O
, , O
positions NNS O
a DT O
and CC O
d NN O
are VBP O
among IN O
the DT O
most RBS O
conserved JJ O
, , O
but CC O
overall JJ O
TM3 NNP O
has VBZ O
more RBR O
variable JJ O
positions NNS O
than IN O
TM1 NNP O
or CC O
TM2 NNP O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
. . O

Less JJR O
than IN O
half NN O
of IN O
TM3 NNP O
sequences NNS O
contain VBP O
cysteine NN O
residues NNS O
, , O
and CC O
those DT O
tend VBP O
to TO O
occur VB O
at IN O
the DT O
internal JJ O
positions NNS O
of IN O
the DT O
helix NN O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

TM4 NNP O
shows VBZ O
less JJR O
conservation NN O
among IN O
various JJ O
tetraspanin JJ O
family NN O
members NNS O
than IN O
the DT O
other JJ O
TM NNP O
domains NNS O
( , O
Figures NNS O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

The DT O
only JJ O
highly RB O
conserved VBN O
feature NN O
is VBZ O
the DT O
glutamate NN O
/ SYM O
glutamine NN O
residue NN O
in IN O
position NN O
209 CD O
. . O

In IN O
addition NN O
, , O
one CD O
or CC O
two CD O
cysteine NN O
residues NNS O
can MD O
be VB O
found VBN O
at IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
end NN O
of IN O
TM4 NNP O
in IN O
some DT O
tetraspanins NNS O
( , O
e LS O
. . O
g LS O
. . O
CD9 NNP O
, , O
CD81 NNP O
, , O
CD151 NNP O
) -RRB- O
, , O
and CC O
many JJ O
sequences NNS O
contain VBP O
additional JJ O
polar JJ O
residues NNS O
( , O
Arg NNP O
, , O
Lys NNP O
, , O
His NNP O
, , O
Asn NNP O
, , O
Gln NNP O
) -RRB- O
. . O

No DT O
conserved VBN O
heptad NN O
motif NN O
was VBD O
identified VBN O
in IN O
TM4 NNP O
, , O
as IN O
also RB O
confirmed VBN O
by IN O
analysis NN O
of IN O
substitutions NNS O
in IN O
CD9 NNP O
orthologs NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Mutational JJ O
analysis NN O
of IN O
conserved VBN O
glycine NN O
residues NNS O
in IN O
TM1 NNP O
and CC O
TM2 NNP O

The DT O
conserved JJ O
nature NN O
of IN O
the DT O
Asn NNP O
and CC O
Gly NNP O
residues NNS O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
prompted VBD O
an DT O
analysis NN O
of IN O
their PRP$ O
functional JJ O
role NN O
. . O

To IN O
this DT O
end NN O
, , O
we PRP O
have VBP O
probed VBN O
whether IN O
mutations NNS O
of IN O
these DT O
residues NNS O
destabilize VBP O
the DT O
protein NN O
molecule NN O
. . O

We PRP O
expressed VBD O
a DT O
construct NN O
of IN O
the DT O
first JJ O
and CC O
second JJ O
TMs NNS O
of IN O
CD9 NNP O
, , O
connected VBN O
by IN O
the DT O
small JJ O
extracellular JJ O
loop NN O
, , O
and CC O
tagged VBN O
with IN O
a DT O
C NN O
- HYPH O
terminal JJ O
green JJ O
fluorescent NN O
protein NN O
( , O
TM NN O
( , O
1 CD O
+ SYM O
2 CD O
) SYM O
- HYPH O
GFP NN O
molecule NN O
) -RRB- O
. . O

In IN O
human JJ B-Species
rhabdomyosarcoma NN O
RD NN O
cells NNS O
, , O
the DT O
wild JJ O
- HYPH O
type NN O
fusion NN O
protein NN O
localized VBN O
mostly RB O
in IN O
a DT O
reticular JJ O
, , O
intracellular JJ O
pattern NN O
, , O
without IN O
forming VBG O
any DT O
large JJ O
aggregates NNS O
( -LRB- O
Figure NN O
5 CD O
, , O
panel NN O
A NN O
) -RRB- O
. . O

Remarkably RB O
, , O
when WRB O
double JJ O
mutants NNS O
Gly25Leu NNP O
+ CC O
Gly32Leu NNP O
and CC O
Gly67Leu NNP O
+ CC O
Gly74Leu NNP O
were VBD O
expressed VBN O
, , O
the DT O
protein NN O
formed VBD O
distinct JJ O
large JJ O
aggregates NNS O
in IN O
a DT O
high JJ O
proportion NN O
of IN O
cells NNS O
( -LRB- O
Figure NNP O
5 CD O
, , O
panels NNS O
C NN O
and CC O
E NN O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
double JJ O
mutant NN O
Gly77Leu NNP O
+ SYM O
Gly80Leu NNP O
did VBD O
not RB O
form VB O
such JJ O
aggregates NNS O
( -LRB- O
Figure NNP O
5 CD O
, , O
panel NN O
G NN O
) -RRB- O
. . O

Results NNS O
with IN O
respective JJ O
single JJ O
mutants NNS O
were VBD O
similar JJ O
to IN O
that DT O
with IN O
double JJ O
mutants NNS O
, , O
with IN O
the DT O
aggregation NN O
being VBG O
somewhat RB O
more RBR O
pronounced JJ O
for IN O
Leu NNP O
substitutions NNS O
of IN O
Gly67 NNP O
and CC O
Gly74 NNP O
compared VBN O
to IN O
Gly25 NNP O
and CC O
Gly32 NNP O
mutations NNS O
. . O

No DT O
aggregation NN O
was VBD O
observed VBN O
for IN O
Asn18Ser NNP O
and CC O
Asn18Tyr NNP O
mutants NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Also RB O
, , O
nearly RB O
identical JJ O
results NNS O
were VBD O
obtained VBN O
with IN O
human JJ B-Species
HT1080 NN O
cells NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

We PRP O
interpret VBP O
these DT O
results NNS O
as IN O
an DT O
indication NN O
that IN O
aggregating VBG O
mutants NNS O
are VBP O
destabilized VBN O
or CC O
misfolded VBN O
while IN O
non RB O
- HYPH O
aggregating VBG O
mutants NNS O
retain VBP O
the DT O
wild JJ O
- HYPH O
type NN O
conformation NN O
. . O

Intriguingly RB O
, , O
mutations NNS O
to IN O
the DT O
conserved VBN O
GG7 NNP O
motifs NNS O
caused VBD O
protein NN O
aggregation NN O
while IN O
the DT O
mutation NN O
of IN O
other JJ O
glycines NNS O
had VBD O
no DT O
detectable JJ O
effect NN O
. . O

These DT O
results NNS O
also RB O
suggest VBP O
that IN O
wild JJ O
- HYPH O
type NN O
GFP NNP O
, , O
which WDT O
has VBZ O
weak JJ O
tendency NN O
to IN O
self NN O
- HYPH O
associate NN O
, , O
could MD O
enhance VB O
non RB O
- HYPH O
specific JJ O
interactions NNS O
of IN O
destabilized VBN O
mutant JJ O
TM NN O
( , O
1 CD O
+ SYM O
2 CD O
) SYM O
CD9 NN O
moieties NNS O
, , O
leading VBG O
to IN O
their PRP$ O
aggregation NN O
. . O

Consistent JJ O
with IN O
this DT O
hypothesis NN O
, , O
the DT O
aggregation NN O
of IN O
Gly25Leu NNP O
+ CC O
Gly32Leu NNP O
and CC O
Gly67Leu NNP O
+ CC O
Gly74Leu NNP O
double JJ O
mutants NNS O
was VBD O
suppressed VBN O
when WRB O
monomeric JJ O
GFP NNP O
molecule NN O
, , O
Leu221Lys NNP O
[ -LRB- O
34 CD O
] -RRB- O
was VBD O
used VBN O
( : O
Figure NNP O
5 CD O
, , O
panels NNS O
D NN O
and CC O
F NN O
) -RRB- O
. . O

The DT O
use NN O
of IN O
monomeric JJ O
GFP NNP O
did VBD O
not RB O
affect VB O
intercellular JJ O
localization NN O
of IN O
wild JJ O
- HYPH O
type NN O
CD9 NN O
TM NN O
( : O
1 CD O
+ SYM O
2 CD O
) -RRB- O
( -LRB- O
Figure NN O
5 CD O
, , O
panel NN O
B NN O
) -RRB- O
, , O
or CC O
a DT O
Gly77Leu NNP O
+ SYM O
Gly80Leu NNP O
double JJ O
mutant NN O
( -LRB- O
Figure NNP O
5 CD O
, , O
panel NN O
H NN O
) -RRB- O
. . O

In IN O
summary NN O
, , O
Leu NNP O
substitutions NNS O
of IN O
Gly JJ O
residues NNS O
that WDT O
are VBP O
part NN O
of IN O
the DT O
Asn NNP O
- HYPH O
Gly NNP O
- HYPH O
Gly NNP O
( HYPH O
NGG7 NNP O
) -RRB- O
motif NN O
in IN O
TM1 NNP O
, , O
or CC O
Gly NNP O
- HYPH O
Gly NNP O
- HYPH O
Ala NNP O
( , O
GGA7 NNP O
) -RRB- O
motif NN O
in IN O
TM2 NNP O
, , O
resulted VBD O
in IN O
destabilization NN O
and CC O
aggregation NN O
of IN O
GFP NNP O
- HYPH O
fused VBN O
TM NNP O
( , O
1 CD O
+ SYM O
2 CD O
) -RRB- O
proteins NNS O
, , O
whereas IN O
substitutions NNS O
of IN O
Gly77 NNP O
or CC O
Gly80 NNP O
, , O
which WDT O
are VBP O
not RB O
part NN O
of IN O
these DT O
motifs NNS O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
, , O
failed VBD O
to TO O
show VB O
such JJ O
aggregation NN O
. . O

Prediction NN O
and CC O
modelling NN O
of IN O
interaction NN O
between IN O
TM1 NNP O
and CC O
TM2 NNP O

Consecutive JJ O
helices NNS O
in IN O
polytopic JJ O
membrane NN O
proteins NNS O
frequently RB O
interact VBP O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Sequence NN O
analysis NN O
of IN O
TM1 NNP O
and CC O
TM2 NNP O
helices NNS O
of IN O
tetraspanins NNS O
reveals VBZ O
a DT O
remarkable JJ O
complementarity NN O
in IN O
the DT O
distribution NN O
of IN O
large JJ O
and CC O
small JJ O
residues NNS O
at IN O
heptad NN O
positions NNS O
a DT O
and CC O
d RB O
along IN O
the DT O
helical JJ O
axis NN O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
, , O
suggesting VBG O
that IN O
these DT O
residues NNS O
may MD O
interact VB O
. . O

To TO O
further RB O
elucidate VB O
the DT O
potential NN O
for IN O
TM1 NNP O
- HYPH O
TM2 NNP O
interaction NN O
, , O
the DT O
putative JJ O
interface NN O
was VBD O
modeled VBN O
using VBG O
a DT O
novel JJ O
algorithm NN O
that WDT O
considers VBZ O
mutational JJ O
data NNS O
during IN O
each DT O
step NN O
of IN O
a DT O
Monte NNP O
Carlo NNP O
simulated VBN O
annealing NN O
cycle NN O
( , O
see VB O
Methods NNPS O
for IN O
details NNS O
) -RRB- O
. . O

Specifically RB O
, , O
Gly25Leu NNP O
, , O
Gly32Leu NNP O
, , O
Gly67Leu NNP O
and CC O
Gly74Leu NNP O
were VBD O
scored VBN O
as IN O
disruptive JJ O
mutations NNS O
, , O
while IN O
Asn18Ser NNP O
, , O
Gly77Leu NNP O
and CC O
Gly80Leu NNP O
were VBD O
scored VBN O
as IN O
silent JJ O
mutations NNS O
, , O
based VBN O
on IN O
their PRP$ O
effects NNS O
on IN O
protein NN O
stability NN O
( -LRB- O
Figure NN O
5 CD O
and CC O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

The DT O
resulting VBG O
model NN O
predicts VBZ O
left RB O
- HYPH O
handed JJ O
crossing NN O
of IN O
TM1 NNP O
and CC O
TM2 NNP O
helices NNS O
at IN O
an DT O
angle NN O
of IN O
+ SYM O
28 CD O
degrees NNS O
. . O

The DT O
key JJ O
element NN O
of IN O
the DT O
structure NN O
is VBZ O
the DT O
apposition NN O
of IN O
bulky JJ O
and CC O
small JJ O
heptad NN O
position NN O
a DT O
and CC O
d NN O
residues NNS O
, , O
as IN O
follows VBZ O
: : O
Gly32 NNP O
- HYPH O
Leu63 NNP O
; : O
Gly67 NNP O
- HYPH O
Leu29 NNP O
; : O
Gly25 NNP O
- HYPH O
Met70 NNP O
; : O
Gly74 NNP O
- HYPH O
Trp22 CD O
; : O
Asn18 NNP O
- : O
Gly77 CD O
; : O
Ala81 NNP O
- HYPH O
Phe15 NNP O
( : O
Figure NN O
6 CD O
) -RRB- O
. . O

Our PRP$ O
model NN O
predicts VBZ O
that IN O
each DT O
of IN O
these DT O
residue NN O
pairs NNS O
are VBP O
in IN O
van NNP O
der NNP O
Waals NNP O
contact NN O
. . O

Additionally RB O
, , O
two CD O
potential JJ O
H NN O
- HYPH O
bonds NNS O
are VBP O
predicted VBN O
in IN O
this DT O
model NN O
, , O
indicating VBG O
close JJ O
packing NN O
: : O
Gly67 CD O
C NN O
alpha NN O
to IN O
Gly25 NN O
carbonyl NN O
oxygen NN O
, , O
and CC O
Trp22 NN O
C NN O
alpha NN O
to IN O
Met70 NNP O
carbonyl NN O
oxygen NN O
. . O

The DT O
packing NN O
is VBZ O
tighter JJR O
in IN O
the DT O
ectodomain NN O
- HYPH O
proximal JJ O
portion NN O
of IN O
the DT O
helices NNS O
( -LRB- O
Figure NNP O
6 CD O
, , O
panel NN O
B NN O
) -RRB- O
, , O
as IN O
determined VBN O
by IN O
C NNP O
alpha NN O
- HYPH O
C NN O
alpha NN O
distances NNS O
between IN O
interacting VBG O
residue NN O
pairs NNS O
. . O

The DT O
key JJ O
elements NNS O
of IN O
the DT O
model NN O
are VBP O
corroborated VBN O
by IN O
the DT O
presence NN O
of IN O
apparently RB O
complementary JJ O
substitutions NNS O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
sequences NNS O
of IN O
different JJ O
tetraspanins NNS O
( -LRB- O
Figure NNP O
1 CD O
, , O
boxed VBN O
residues NNS O
) -RRB- O
. . O

For IN O
example NN O
, , O
Gly74 NNP O
is VBZ O
predicted VBN O
to TO O
interact VB O
with IN O
Trp22 NNP O
. . O

In IN O
8 CD O
of IN O
the DT O
10 CD O
tetraspanins NNS O
that WDT O
contain VBP O
a DT O
substitution NN O
for IN O
Gly74 NNP O
, , O
a DT O
compensatory JJ O
substitution NN O
occurs VBZ O
at IN O
the DT O
Trp22 NNP O
position NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

Thus RB O
, , O
a DT O
larger JJR O
non AFX O
- HYPH O
glycine NN O
side NN O
chain NN O
at IN O
position NN O
74 CD O
may MD O
necessitate VB O
a DT O
less RBR O
bulky JJ O
non JJ O
- HYPH O
Trp NN O
side NN O
chain NN O
in IN O
position NN O
22 CD O
. . O

Likewise RB O
, , O
the DT O
presence NN O
of IN O
a DT O
C NN O
beta NN O
at IN O
position NN O
25 CD O
, , O
typically RB O
occupied VBN O
by IN O
glycine NN O
, , O
necessitates VBZ O
a DT O
non JJ O
- HYPH O
beta NN O
- HYPH O
branched JJ O
amino NN O
acid NN O
at IN O
position NN O
70 CD O
, , O
which WDT O
is VBZ O
occupied VBN O
by IN O
a DT O
beta NN O
- HYPH O
branched VBN O
residue NN O
in IN O
nearly RB O
half NN O
of IN O
all DT O
cases NNS O
. . O

Indeed RB O
, , O
we PRP O
find VBP O
that IN O
in IN O
each DT O
of IN O
5 CD O
cases NNS O
in IN O
which WDT O
position NN O
25 CD O
contains VBZ O
a DT O
C NN O
beta NN O
, , O
a DT O
leucine NN O
residue NN O
occurs VBZ O
in IN O
position NN O
70 CD O
. . O

This DT O
analysis NN O
is VBZ O
consistent JJ O
with IN O
our PRP$ O
molecular JJ O
model NN O
that WDT O
suggests VBZ O
Leu70 NNP O
will MD O
pack VB O
most RBS O
favorably RB O
against IN O
a DT O
C NN O
beta NN O
at IN O
position NN O
25 CD O
than IN O
a DT O
beta NN O
- HYPH O
branched VBN O
residue NN O
or CC O
a DT O
methionine NN O
. . O

Role NNP O
of IN O
TM1 NNP O
and CC O
TM2 NN O
heptad NN O
motif NN O
residues NNS O
in IN O
CD9 NN O
dimerization NN O

To TO O
probe VB O
CD9 NN O
dimerization NN O
, , O
we PRP O
used VBD O
a DT O
cysteine NN O
- HYPH O
mediated VBN O
cross NN O
- HYPH O
linking VBG O
approach NN O
. . O

We PRP O
established VBD O
previously RB O
a DT O
simple JJ O
and CC O
efficient JJ O
method NN O
for IN O
cysteine NN O
- HYPH O
mediated VBN O
cross NN O
- HYPH O
linking VBG O
[ -LRB- O
25 CD O
] -RRB- O
. . O

After IN O
cells NNS O
are VBP O
pre NN O
- HYPH O
treated VBN O
with IN O
2 CD O
- HYPH O
BP NN O
for IN O
16 CD O
- SYM O
24 CD O
hours NNS O
to TO O
expose VB O
normally RB O
palmitoylated VBN O
cysteines NNS O
, , O
the DT O
cysteines NNS O
can MD O
be VB O
cross NN O
- HYPH O
linked VBN O
using VBG O
any DT O
of IN O
the DT O
following VBG O
methods NNS O
: : O
a LS O
) NFP O
Spontaneous JJ O
oxidation NN O
in IN O
Brij97 NNP O
lysates NNS O
( , O
a DT O
condition NN O
that WDT O
preserves VBZ O
tetraspanin NN O
- HYPH O
tetraspanin NN O
associations NNS O
) -RRB- O
, , O
b NN O
) , O
In IN O
situ NN O
cross NN O
- HYPH O
linking VBG O
, , O
by IN O
pre NN O
- HYPH O
lysis NN O
oxidation NN O
of IN O
cells NNS O
with IN O
Cu2 NNP O
+ SYM O
- HYPH O
phenanthroline NN O
( -LRB- O
CuP NN O
) -RRB- O
to TO O
promote VB O
disulfide NN O
bond NN O
formation NN O
. . O

c LS O
) -RRB- O
In IN O
situ NN O
cross NN O
- HYPH O
linking VBG O
with IN O
thiol NN O
- HYPH O
reactive JJ O
cross NN O
- HYPH O
linking VBG O
agents NNS O
of IN O
defined VBN O
length NN O
( : O
e UH O
. . O
g LS O
. . O
DTME NNP O
, , O
BMB NNP O
) -RRB- O
. . O

The DT O
first JJ O
two CD O
approaches NNS O
produce VBP O
in IN O
essence NN O
"""" `` O
zero CD O
- HYPH O
length NN O
"""" '' O
disulfides NNS O
, , O
indicative JJ O
of IN O
close JJ O
proximity NN O
of IN O
target NN O
cysteines NNS O
and CC O
presumably RB O
high JJ O
specificity NN O
of IN O
interaction NN O
. . O

In IN O
contrast NN O
, , O
chemical JJ O
cross NN O
- HYPH O
linkers NNS O
with IN O
6 CD O
- SYM O
20 CD O
A NN O
spacer NN O
arm NN O
may MD O
cross VB O
- HYPH O
link NN O
with IN O
higher JJR O
efficiency NN O
, , O
but CC O
not RB O
necessarily RB O
higher JJR O
specificity NN O
. . O

However RB O
, , O
they PRP O
provide VBP O
advantages NNS O
such JJ O
as IN O
variable JJ O
membrane NN O
permeability NN O
, , O
and CC O
potential JJ O
linkage NN O
cleavability NN O
. . O

For IN O
tetraspanins NNS O
such JJ O
as IN O
CD9 NNP O
, , O
membrane NN O
- HYPH O
permeable JJ O
cross NN O
- HYPH O
linker NN O
DTME NNP O
( : O
13 CD O
. . O
3 CD O
A NN O
- HYPH O
long JJ O
, , O
reducible JJ O
) -RRB- O
provides VBZ O
highly RB O
specific JJ O
and CC O
efficient JJ O
cross NN O
- HYPH O
linking NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Here RB O
we PRP O
have VBP O
used VBN O
a DT O
cysteine NN O
cross NN O
- HYPH O
linking VBG O
strategy NN O
, , O
in IN O
combination NN O
with IN O
cysteine NN O
- HYPH O
scanning VBG O
mutagenesis NN O
, , O
to TO O
map VB O
the DT O
residues NNS O
from IN O
TM1 NNP O
and CC O
TM2 NNP O
contributing VBG O
to IN O
the DT O
CD9 NNP O
dimerization NN O
interface NN O
. . O

For IN O
subsequent JJ O
cross NN O
- HYPH O
linking VBG O
experiments NNS O
using VBG O
CD9 NNP O
TM NNP O
( , O
1 CD O
+ SYM O
2 CD O
) SYM O
- HYPH O
GFP NN O
protein NN O
, , O
the DT O
non AFX O
- HYPH O
dimerizing JJ O
form NN O
of IN O
GFP NNP O
was VBD O
used VBN O
. . O

This DT O
avoids VBZ O
potential JJ O
GFP NNP O
- HYPH O
dependent JJ O
dimerization NN O
and CC O
aggregation NN O
that WDT O
can MD O
be VB O
observed VBN O
with IN O
wild JJ O
- HYPH O
type NN O
GFP NN O
, , O
especially RB O
when WRB O
fusions NNS O
with IN O
transmembrane NN O
proteins NNS O
are VBP O
studied VBN O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Importantly RB O
, , O
the DT O
Leu221Lys NNP O
mutation NN O
in IN O
GFP NNP O
prevented VBD O
aggregation NN O
of IN O
mutant JJ O
forms NNS O
of IN O
CD9 NNP O
TM NNP O
( SYM O
1 CD O
+ SYM O
2 CD O
) -RRB- O
, , O
which WDT O
was VBD O
observed VBN O
with IN O
wild JJ O
- HYPH O
type NN O
GFP NN O
fusion NN O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

The DT O
TM NNP O
( , O
1 CD O
+ SYM O
2 CD O
) -RRB- O
fragment NN O
of IN O
CD9 NN O
contains VBZ O
three CD O
native JJ O
cysteines NNS O
- : O
Cys9 NNP O
, , O
Cys78 NNP O
and CC O
Cys79 NNP O
. . O

Single JJ O
- HYPH O
cysteine NN O
mutants NNS O
of IN O
TM NN O
( , O
1 CD O
+ SYM O
2 CD O
) -RRB- O
were VBD O
constructed VBN O
, , O
in IN O
which WDT O
a DT O
cysteine NN O
was VBD O
placed VBN O
at IN O
various JJ O
faces NNS O
of IN O
TM1 NNP O
or CC O
TM2 NNP O
while IN O
all DT O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
cysteines NNS O
were VBD O
simultaneously RB O
replaced VBN O
by IN O
serines NNS O
. . O

The DT O
mutant JJ O
proteins NNS O
were VBD O
transiently RB O
expressed VBN O
in IN O
RD NN O
cells NNS O
( , O
having VBG O
little JJ O
endogenous JJ O
CD9 NNP O
) -RRB- O
, , O
which WDT O
were VBD O
then RB O
treated VBN O
for IN O
16 CD O
- SYM O
18 CD O
hours NNS O
with IN O
2 CD O
- HYPH O
BP NN O
. . O

To TO O
achieve VB O
maximal JJ O
specificity NN O
in IN O
cross NN O
- HYPH O
linking VBG O
we PRP O
used VBD O
a DT O
"""" `` O
zero CD O
- HYPH O
length NN O
"""" '' O
agent NN O
, , O
CuP NNP O
. . O

First JJ O
, , O
single JJ O
- HYPH O
cysteine NN O
replacements NNS O
were VBD O
constructed VBN O
for IN O
residues NNS O
Leu14 NNP O
, , O
Phe15 NNP O
, , O
Gly16 NNP O
, , O
Phe17 NNP O
and CC O
Asn18 NNP O
, , O
covering VBG O
just RB O
over IN O
one CD O
complete JJ O
helical NN O
turn NN O
at IN O
the DT O
beginning NN O
of IN O
TM1 NNP O
. . O

While IN O
residue NN O
Asn18 NNP O
is VBZ O
highly RB O
conserved VBN O
, , O
positions NNS O
14 CD O
, , O
15 CD O
and CC O
17 CD O
are VBP O
occupied VBN O
by IN O
bulky JJ O
hydrophobic JJ O
residues NNS O
in IN O
most JJS O
tetraspanins NNS O
, , O
whereas IN O
position NN O
16 CD O
shows VBZ O
less JJR O
conservation NN O
( , O
Figures NNS O
1 CD O
, , O
4 CD O
) -RRB- O
. . O

All DT O
of IN O
the DT O
single JJ O
- HYPH O
cysteine NN O
mutants NNS O
showed VBD O
diffused JJ O
pattern NN O
of IN O
protein NN O
localization NN O
, , O
without IN O
any DT O
signs NNS O
of IN O
aggregation NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
7A CD O
, , O
the DT O
highest JJS O
level NN O
of IN O
intermolecular JJ O
cross NN O
- HYPH O
linking NN O
was VBD O
observed VBN O
for IN O
Leu14Cys NNP O
and CC O
Phe17Cys NNP O
mutants NNS O
, , O
a DT O
lower JJR O
level NN O
for IN O
Phe15Cys NNP O
and CC O
Gly16Cys NNP O
mutants NNS O
, , O
and CC O
very RB O
little JJ O
cross NN O
- HYPH O
linking VBG O
for IN O
Asn18Cys NNP O
substitution NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
: : O
a DT O
) , O
the DT O
first JJ O
two CD O
transmembrane NN O
domains NNS O
of IN O
CD9 NN O
alone RB O
can MD O
mediate VB O
its PRP$ O
dimerization NN O
, , O
and CC O
b NN O
) , O
the DT O
g NN O
and CC O
c NN O
residues NNS O
of IN O
TM1 NN O
( : O
e ADD O
. . O
g LS O
. . O
Leu14 NNP O
and CC O
Phe17 NNP O
, , O
Figure NN O
3 CD O
) -RRB- O
are VBP O
likely JJ O
to TO O
be VB O
part NN O
of IN O
the DT O
intermolecular JJ O
interface NN O
. . O

Similarly RB O
, , O
single JJ O
- HYPH O
cysteine NN O
substitutions NNS O
were VBD O
made VBN O
for IN O
residues NNS O
Gly77 NNP O
, , O
Gly80 NNP O
and CC O
Ala81 NNP O
in IN O
TM2 NNP O
; : O
in IN O
addition NN O
, , O
proteins NNS O
carrying VBG O
a DT O
single JJ O
wild JJ O
- HYPH O
type NN O
cysteine NN O
, , O
Cys9 NNP O
, , O
Cys78 NNP O
or CC O
Cys79 NNP O
, , O
were VBD O
tested VBN O
. . O

No DT O
protein NN O
aggregation NN O
was VBD O
observed VBN O
for IN O
any DT O
of IN O
these DT O
single JJ O
- HYPH O
cysteine NN O
mutants NNS O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
7B NNP O
, , O
the DT O
relatively RB O
low JJ O
level NN O
of IN O
intermolecular JJ O
cross NN O
- HYPH O
linking NN O
of IN O
wild JJ O
- HYPH O
type NN O
CD9 NN O
TM NN O
( , O
1 CD O
+ SYM O
2 CD O
) SYM O
- HYPH O
GFP NNP O
protein NN O
was VBD O
enhanced VBN O
dramatically RB O
in IN O
single JJ O
- HYPH O
cysteine NN O
TM2 NNP O
mutants NNS O
Gly80Cys NNP O
and CC O
Ala81Cys NNP O
. . O

The DT O
Gly77Cys NNP O
mutant NN O
also RB O
had VBD O
an DT O
elevated VBN O
level NN O
of IN O
cross NN O
- HYPH O
linking VBG O
. . O

In IN O
contrast NN O
, , O
any DT O
of IN O
the DT O
three CD O
native JJ O
cysteines NNS O
( , O
9 CD O
, , O
78 CD O
and CC O
79 CD O
) -RRB- O
produced VBD O
level NN O
of IN O
cross NN O
- HYPH O
linking VBG O
not RB O
much RB O
greater JJR O
than IN O
the DT O
wild JJ O
- HYPH O
type NN O
TM NN O
( : O
1 CD O
+ SYM O
2 CD O
) SYM O
protein NN O
. . O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
with IN O
cysteine NN O
- HYPH O
reactive JJ O
cross NN O
- HYPH O
linker NN O
BMB NNP O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Likewise RB O
, , O
comparable JJ O
results NNS O
were VBD O
obtained VBN O
with IN O
single JJ O
- HYPH O
cysteine NN O
mutants NNS O
of IN O
untagged JJ O
, , O
full JJ O
- HYPH O
length NN O
CD9 NNP O
, , O
using VBG O
CuP NNP O
( -LRB- O
Figure NNP O
7C NNP O
) -RRB- O
as RB O
well RB O
as IN O
DTME NNP O
cross NN O
- HYPH O
linker NN O
( : O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

These DT O
cross NN O
- HYPH O
linking VBG O
results NNS O
for IN O
TM1 NNP O
and CC O
TM2 NNP O
are VBP O
consistent JJ O
with IN O
our PRP$ O
model NN O
that WDT O
places VBZ O
residues NNS O
Leu14 NNP O
, , O
Phe17 NNP O
and CC O
Gly80 NNP O
on IN O
the DT O
same JJ O
side NN O
of IN O
the DT O
TM1 NNP O
- HYPH O
TM2 NNP O
pair NN O
( -LRB- O
Figure NNP O
6 CD O
, , O
panel NN O
C NN O
) -RRB- O
. . O

The DT O
strong JJ O
cross NN O
- HYPH O
linking VBG O
with IN O
Leu14Cys NNP O
, , O
Phe17Cys NNP O
and CC O
Gly80Cys NNP O
places VBZ O
the DT O
intermolecular JJ O
interface NN O
toward IN O
the DT O
c NN O
and CC O
g NN O
phases NNS O
of IN O
the DT O
TM1 NNP O
helix NN O
, , O
and CC O
the DT O
g NN O
phase NN O
of IN O
the DT O
TM2 NNP O
helix NN O
, , O
away RB O
from IN O
its PRP$ O
e NN O
and CC O
f NN O
faces VBZ O
containing VBG O
wild JJ O
- HYPH O
type NN O
cysteines NNS O
78 CD O
and CC O
79 CD O
. . O

Critical JJ O
residues NNS O
at IN O
the DT O
TM1 NNP O
- HYPH O
TM2 NNP O
interface NN O
also RB O
affect VBP O
dimerization NN O
indirectly RB O
. . O

To TO O
assess VB O
specific JJ O
CD9 NN O
dimerization NN O
, , O
we PRP O
used VBD O
a DT O
Gly80Cys NNP O
substitution NN O
at IN O
the DT O
intermolecular JJ O
interface NN O
for IN O
cross NN O
- HYPH O
linking VBG O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
8A NNP O
, , O
single JJ O
replacements NNS O
of IN O
conserved VBN O
heptad NN O
residues NNS O
in IN O
positions NNS O
18 CD O
, , O
25 CD O
, , O
32 CD O
, , O
67 CD O
and CC O
74 CD O
( , O
Asn18Ser NNP O
, , O
Gly25 NNP O
/ SYM O
32 CD O
/ SYM O
67 CD O
/ SYM O
74 CD O
- SYM O
- HYPH O
> SYM O
Leu NNP O
) -RRB- O
strongly RB O
decreased VBD O
the DT O
cross NN O
- HYPH O
linking VBG O
mediated VBN O
by IN O
Cys80 NNP O
. . O

The DT O
effect NN O
was VBD O
most RBS O
pronounced VBN O
for IN O
mutations NNS O
of IN O
residues NNS O
, , O
Gly32 NNP O
and CC O
Gly67 NNP O
, , O
located VBN O
in IN O
the DT O
tightly RB O
packed VBN O
extracellular JJ O
end NN O
of IN O
TM NNP O
helices NNS O
( -LRB- O
Figure NNP O
6 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
mutations NNS O
of IN O
residues NNS O
closer JJR O
to IN O
the DT O
cytoplasmic JJ O
end NN O
of IN O
TM2 NNP O
( , O
Gly74 NNP O
and CC O
especially RB O
Ala81 NNP O
) -RRB- O
had VBD O
only RB O
modest JJ O
to IN O
very RB O
little JJ O
effect NN O
on IN O
cross NN O
- HYPH O
linking VBG O
. . O

Relatively RB O
low JJ O
efficiency NN O
of IN O
intermolecular JJ O
cross NN O
- HYPH O
linking VBG O
via IN O
native JJ O
residues NNS O
Cys9 NNP O
, , O
78 CD O
, , O
and CC O
79 CD O
( , O
Figures NNS O
7B NNP O
, , O
C NNP O
) -RRB- O
correlates VBZ O
well RB O
with IN O
the DT O
predicted VBN O
location NN O
of IN O
Cys78 NNP O
and CC O
79 CD O
away RB O
from IN O
the DT O
dimeric JJ O
interface NN O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
, , O
and CC O
suggests VBZ O
that IN O
the DT O
extramembrane JJ O
N NN O
- HYPH O
terminal JJ O
part NN O
of IN O
CD9 NNP O
( : O
residues NNS O
1 CD O
- HYPH O
13 CD O
) -RRB- O
does VBZ O
not RB O
self NN O
- HYPH O
associate NN O
. . O

We PRP O
next RB O
examined VBD O
whether IN O
mutations NNS O
of IN O
conserved VBN O
Asn NNP O
and CC O
Gly NNP O
residues NNS O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
decreased VBD O
low JJ O
- HYPH O
level NN O
background NN O
cross NN O
- HYPH O
linking NN O
via IN O
native JJ O
cysteines NNS O
. . O

As IN O
expected VBN O
, , O
these DT O
mutations NNS O
had VBD O
virtually RB O
no DT O
effect NN O
on IN O
dimer NN O
formation NN O
of IN O
CD9 NNP O
TM NNP O
( : O
1 CD O
+ SYM O
2 CD O
) SYM O
- HYPH O
GFP NN O
( -LRB- O
Figure NN O
8B NN O
) -RRB- O
. . O

The DT O
level NN O
of IN O
covalent JJ O
dimer NN O
formed VBD O
was VBD O
not RB O
diminished VBN O
for IN O
triple JJ O
Asn18Ser NN O
+ CC O
Gly25Leu NNP O
+ CC O
Gly32Leu NNP O
and CC O
double JJ O
Gly67Leu NNP O
+ CC O
Gly74Leu NNP O
mutants NNS O
, , O
compared VBN O
to IN O
wild JJ O
- HYPH O
type NN O
TM NN O
( : O
1 CD O
+ SYM O
2 CD O
) SYM O
CD9 NN O
molecule NN O
. . O

Similarly RB O
, , O
the DT O
same JJ O
triple JJ O
and CC O
double JJ O
mutations NNS O
in IN O
the DT O
context NN O
of IN O
full JJ O
- HYPH O
length NN O
CD9 NNP O
- HYPH O
GFP NNP O
protein NN O
( , O
with IN O
six CD O
cysteines NNS O
) -RRB- O
produced VBN O
wild JJ O
- HYPH O
type NN O
levels NNS O
of IN O
cross NN O
- HYPH O
linking NN O
( -LRB- O
Figure NNP O
8C NNP O
) -RRB- O
. . O

We PRP O
interpret VBP O
these DT O
findings NNS O
as IN O
evidence NN O
for IN O
at IN O
least JJS O
two CD O
types NNS O
of IN O
associations NNS O
between IN O
CD9 NNP O
molecules NNS O
: : O
primary JJ O
, , O
involving VBG O
residues NNS O
14 CD O
, , O
17 CD O
and CC O
80 CD O
, , O
and CC O
dependent JJ O
on IN O
integrity NN O
of IN O
conserved VBN O
heptad NN O
residues NNS O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
, , O
and CC O
less RBR O
efficient JJ O
secondary JJ O
interactions NNS O
, , O
probably RB O
representing VBG O
random JJ O
collision NN O
events NNS O
, , O
and CC O
independent JJ O
of IN O
the DT O
heptad NN O
residues NNS O
( , O
see VB O
Discussion NN O
for IN O
more JJR O
details NNS O
) -RRB- O
. . O

TM3 NNP O
and CC O
TM4 NNP O
cysteine NN O
residues NNS O
in IN O
CD9 NN O
dimerization NN O

After IN O
identifying VBG O
the DT O
roles NNS O
of IN O
conserved VBN O
TM1 NNP O
and CC O
TM2 NNP O
residues NNS O
in IN O
CD9 NNP O
dimerization NN O
, , O
we PRP O
next RB O
probed VBD O
whether IN O
residues NNS O
proximal JJ O
to IN O
TM NNP O
domains NNS O
3 CD O
and CC O
4 CD O
are VBP O
also RB O
involved JJ O
. . O

To IN O
this DT O
end NN O
, , O
disulfide JJ O
cross NN O
- HYPH O
linking VBG O
of IN O
full JJ O
- HYPH O
length NN O
CD9 NN O
molecules NNS O
containing VBG O
3 CD O
C NN O
- HYPH O
terminal JJ O
cysteines NNS O
( : O
87 CD O
, , O
just RB O
before IN O
TM3 NNP O
; : O
218 CD O
and CC O
219 CD O
in IN O
TM4 CD O
) -RRB- O
or CC O
3 CD O
N CD O
- HYPH O
terminal NN O
cysteines NNS O
( : O
9 CD O
, , O
78 CD O
and CC O
79 CD O
) -RRB- O
was VBD O
compared VBN O
( -LRB- O
Figure NN O
9 CD O
) -RRB- O
. . O

We PRP O
found VBD O
that IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
cysteines NNS O
were VBD O
only RB O
slightly RB O
better JJR O
than IN O
N NNP O
- HYPH O
terminal JJ O
cysteines NNS O
with IN O
respect NN O
to IN O
detection NN O
of IN O
CD9 NNP O
dimers NNS O
. . O

However RB O
, , O
markedly RB O
more JJR O
trimers NNS O
and CC O
tetramers NNS O
were VBD O
detected VBN O
using VBG O
C NN O
- HYPH O
terminal JJ O
cysteines NNS O
. . O

Thus RB O
, , O
residues NNS O
87 CD O
, , O
218 CD O
and CC O
219 CD O
at IN O
TM3 NNP O
and CC O
TM4 NNP O
in IN O
CD9 NNP O
can MD O
together RB O
form VB O
contacts NNS O
across IN O
the DT O
dimeric JJ O
interface NN O
and CC O
also RB O
additional JJ O
contacts NNS O
with IN O
other JJ O
neighboring VBG O
CD9 NNP O
molecules NNS O
. . O

Discussion NN O

Here RB O
we PRP O
provide VBP O
the DT O
first JJ O
detailed JJ O
analysis NN O
of IN O
tetraspanin NN O
protein NN O
transmembrane NN O
domains NNS O
. . O

First RB O
, , O
we PRP O
show VBP O
1 CD O
) -RRB- O
the DT O
presence NN O
of IN O
a DT O
heptad JJ O
repeat NN O
motif NN O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
, , O
containing VBG O
highly RB O
conserved VBN O
Asn NNP O
and CC O
Gly NNP O
residues NNS O
, , O
2 CD O
) SYM O
a DT O
leucine NN O
and CC O
glutamate NN O
/ SYM O
glutamine NN O
- HYPH O
containing VBG O
heptad NN O
motif NN O
in IN O
TM3 NNP O
, , O
and CC O
3 CD O
) -RRB- O
high JJ O
variability NN O
and CC O
absence NN O
of IN O
heptad NN O
repeats NNS O
in IN O
TM4 NNP O
sequences NNS O
. . O

Second RB O
, , O
we PRP O
provide VBP O
evidence NN O
for IN O
a DT O
specific JJ O
, , O
intramolecular JJ O
interaction NN O
between IN O
TM1 NNP O
and CC O
TM2 NNP O
domains NNS O
, , O
in IN O
which WDT O
bulky JJ O
hydrophobic JJ O
residues NNS O
pack VBP O
against IN O
GG7 NNP O
motif NN O
, , O
and CC O
present VBP O
a DT O
molecular JJ O
model NN O
for IN O
this DT O
interaction NN O
. . O

Third RB O
, , O
experimental JJ O
mapping NN O
of IN O
the DT O
CD9 NNP O
dimerization NN O
interface NN O
firmly RB O
establishes VBZ O
an DT O
additional JJ O
role NN O
for IN O
conserved VBN O
TM1 NNP O
and CC O
TM2 NNP O
residues NNS O
in IN O
dimeric JJ O
intermolecular JJ O
interactions NNS O
. . O

Fourth JJ O
, , O
preliminary JJ O
evidence NN O
is VBZ O
provided VBN O
to TO O
suggest VB O
that IN O
TM3 NNP O
and CC O
TM4 NNP O
domains NNS O
contribute VBP O
to IN O
expansion NN O
of IN O
CD9 NNP O
dimers NNS O
into IN O
higher JJR O
order NN O
multimers NNS O
. . O

Conserved VBN O
residues NNS O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
of IN O
tetraspanins NNS O
: : O
role NN O
in IN O
intramolecular JJ O
packing NN O

We PRP O
hypothesized VBD O
that IN O
the DT O
first JJ O
two CD O
transmembrane NN O
domains NNS O
of IN O
tetraspanins NNS O
might MD O
interact VB O
with IN O
each DT O
other JJ O
because IN O
: : O
a DT O
) , O
consecutive JJ O
TM NNP O
domains NNS O
frequently RB O
associate VBP O
in IN O
known VBN O
protein NN O
3D NN O
structures NNS O
[ -LRB- O
35 CD O
] -RRB- O
, , O
and CC O
b LS O
) -RRB- O
they PRP O
both DT O
contain VBP O
a DT O
series NN O
of IN O
highly RB O
conserved VBN O
amino NN O
acids NNS O
- , O
several JJ O
Gly NNP O
residues NNS O
and CC O
an DT O
Asn NNP O
residue NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

Conserved VBN O
Gly JJ O
residues NNS O
are VBP O
a DT O
frequent JJ O
theme NN O
in IN O
the DT O
organization NN O
of IN O
interacting VBG O
transmembrane NN O
domains NNS O
. . O

Analysis NN O
of IN O
3D JJ O
helix NN O
packing NN O
in IN O
polytopic JJ O
membrane NN O
proteins NNS O
reveals VBZ O
that IN O
Gly NNP O
residues NNS O
tend VBP O
to TO O
localize VB O
in IN O
buried VBN O
positions NNS O
, , O
especially RB O
at IN O
the DT O
helix NN O
- HYPH O
helix NN O
interfaces NNS O
and CC O
helix NN O
crossing NN O
points NNS O
[ -LRB- O
37 CD O
, , O
38 CD O
] -RRB- O
. . O

Due IN O
to IN O
the DT O
absence NN O
of IN O
a DT O
side NN O
chain NN O
, , O
Gly NNP O
provides VBZ O
a DT O
flat JJ O
surface NN O
for IN O
packing NN O
of IN O
a DT O
side NN O
chain NN O
from IN O
another DT O
residue NN O
, , O
without IN O
loss NN O
of IN O
side NN O
- HYPH O
chain NN O
entropy NN O
upon IN O
interaction NN O
. . O

The DT O
most RBS O
common JJ O
Gly NNP O
- HYPH O
containing VBG O
motif NN O
is VBZ O
GxxxG NNP O
[ -LRB- O
39 CD O
, , O
40 CD O
] -RRB- O
. . O

In IN O
glycophorin NN O
A NN O
( , O
GpA NNP O
) -RRB- O
, , O
the DT O
major JJ O
glycoprotein NN O
in IN O
erythrocyte NN O
cell NN O
membranes NNS O
, , O
Gly79 NNP O
and CC O
Gly83 NNP O
are VBP O
part NN O
of IN O
the DT O
LIxxGVxxGVxxT NNP O
sequence NN O
that WDT O
promotes VBZ O
homodimerization NN O
of IN O
parallel JJ O
transmembrane NN O
alpha NN O
- HYPH O
helixes NNS O
[ -LRB- O
41 CD O
, , O
42 CD O
] -RRB- O
. . O

In IN O
the DT O
GpA NNP O
dimerization NN O
motif NN O
, , O
Gly NNP O
residues NNS O
allow VBP O
for IN O
tight JJ O
packing NN O
in IN O
the DT O
right RB O
- HYPH O
handed JJ O
helical JJ O
crossing NN O
[ -LRB- O
43 CD O
] -RRB- O
. . O

There EX O
are VBP O
also RB O
examples NNS O
of IN O
left RB O
- HYPH O
handed JJ O
helical JJ O
crossing NN O
in IN O
the DT O
context NN O
of IN O
a DT O
GxxxG NNP O
motif NN O
[ -LRB- O
44 CD O
] -RRB- O
. . O

Other JJ O
membrane NN O
proteins NNS O
that WDT O
use VBP O
the DT O
GxxxG NNP O
motif NN O
for IN O
homo NN O
- HYPH O
or CC O
heterodimerization NN O
include VBP O
bacteriophage NN B-Species
M13 NNP I-Species
coat NN O
proteins NNS O
[ -LRB- O
45 CD O
] -RRB- O
, , O
yeast NN B-Species
alpha NN O
factor NN O
receptor NN O
[ -LRB- O
46 CD O
] -RRB- O
, , O
integrin NN O
alpha NN O
IIb NN O
subunit NN O
[ -LRB- O
47 CD O
] -RRB- O
, , O
and CC O
ErbB1 NNP O
receptor NN O
tyrosine NN O
kinase NN O
[ -LRB- O
48 CD O
] -RRB- O
. . O

Other JJ O
small JJ O
residues NNS O
, , O
such JJ O
as IN O
Ala NNP O
and CC O
Ser NNP O
, , O
can MD O
substitute VB O
for IN O
Gly NNP O
in IN O
this DT O
motif NN O
[ -LRB- O
49 CD O
] -RRB- O
. . O

A DT O
protein NN O
motif NN O
in IN O
which WDT O
Gly NNP O
residues NNS O
are VBP O
separated VBN O
by IN O
6 CD O
other JJ O
residues NNS O
( -LRB- O
GG7 NNP O
) -RRB- O
is VBZ O
also RB O
common JJ O
in IN O
transmembrane NN O
helices NNS O
, , O
especially RB O
in IN O
transporter NN O
/ SYM O
channel NN O
- HYPH O
like JJ O
membrane NN O
proteins NNS O
[ -LRB- O
50 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
structural JJ O
features NNS O
associated VBN O
with IN O
this DT O
motif NN O
are VBP O
not RB O
well RB O
known VBN O
. . O

In IN O
particular JJ O
, , O
it PRP O
is VBZ O
unclear JJ O
whether IN O
left RB O
- HYPH O
handed JJ O
GG7 NNP O
heptad NN O
repeat NN O
motif NN O
( , O
as IN O
opposed VBN O
to IN O
the DT O
"""" `` O
classic JJ O
"""" '' O
right RB O
- HYPH O
handed JJ O
GxxxG NNP O
motif NN O
) , O
can MD O
drive VB O
membrane NN O
helix NN O
association NN O
. . O

In IN O
a DT O
recent JJ O
work NN O
addressing VBG O
this DT O
issue NN O
, , O
Lear NNP O
et FW O
al NNP O
. . O

[ -LRB- O
51 CD O
] -RRB- O
showed VBD O
that IN O
a DT O
synthetic JJ O
peptide NN O
containing VBG O
Gly NNP O
at IN O
heptad NN O
positions NNS O
a DT O
and CC O
d VBD O
could MD O
self NN O
- HYPH O
associate VB O
in IN O
vitro NN O
, , O
likely JJ O
in IN O
an DT O
antiparallel JJ O
orientation NN O
. . O

Heptad NNP O
repeats VBZ O
containing VBG O
conserved VBN O
Gly NNP O
residues NNS O
occur VBP O
in IN O
TM NNP O
domains NNS O
of IN O
alpha NN O
and CC O
beta NN O
chains NNS O
of IN O
MHC NNP O
class NN O
II NN O
proteins NNS O
, , O
and CC O
mutations NNS O
of IN O
the DT O
Gly NNP O
residues NNS O
disrupt VBP O
the DT O
alpha NN O
beta NN O
heterodimer NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

These DT O
examples NNS O
demonstrate VBP O
that IN O
Gly NNP O
- HYPH O
based VBN O
heptad NN O
motifs NN O
may MD O
be VB O
used VBN O
for IN O
both CC O
intra JJ O
- HYPH O
and CC O
intermolecular JJ O
associations NNS O
. . O

In IN O
this DT O
work NN O
, , O
we PRP O
identified VBD O
a DT O
highly RB O
conserved VBN O
GG7 NNP O
motif NN O
in IN O
the DT O
first JJ O
two CD O
tetraspanin JJ O
TM NN O
domains NNS O
. . O

The DT O
GG7 NNP O
sequence NN O
in IN O
tetraspanins NN O
is VBZ O
a DT O
part NN O
of IN O
a DT O
larger JJR O
motif NN O
that WDT O
also RB O
includes VBZ O
a DT O
conserved VBN O
Asn NNP O
residue NN O
in IN O
TM1 NNP O
( -LRB- O
NGG7 NNP O
) -RRB- O
and CC O
an DT O
Ala NNP O
/ SYM O
Ser NNP O
/ SYM O
Thr NNP O
residue NN O
in IN O
TM2 NNP O
( , O
GGA7 NNP O
) -RRB- O
. . O

The DT O
seven CD O
- HYPH O
residue NN O
periodicity NN O
of IN O
these DT O
motifs NNS O
strongly RB O
suggests VBZ O
their PRP$ O
involvement NN O
in IN O
left RB O
- HYPH O
handed JJ O
coiled JJ O
coil NN O
packing NN O
reminiscent JJ O
of IN O
the DT O
leucine NN O
zipper NN O
, , O
rather RB O
than IN O
right RB O
- HYPH O
handed JJ O
packing NN O
of IN O
the DT O
GpA NNP O
- HYPH O
like JJ O
GxxxG NNP O
motif NN O
. . O

For IN O
antiparallel JJ O
helices NNS O
, , O
the DT O
left JJ O
- HYPH O
handed JJ O
crossing NN O
is VBZ O
in IN O
fact NN O
predominant JJ O
over IN O
the DT O
right RB O
- HYPH O
handed JJ O
in RP O
known VBN O
TM NNP O
domain NN O
structures NNS O
[ -LRB- O
44 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
model NN O
, , O
heptad NNP O
Gly NNP O
residues NNS O
in IN O
NGG7 NNP O
and CC O
GGA7 NNP O
sequences NNS O
provide VBP O
specific JJ O
packing NN O
between IN O
antiparallel JJ O
tetraspanin NN O
TM1 NNP O
and CC O
TM2 NNP O
helices NNS O
by IN O
allowing VBG O
tight JJ O
van FW O
der FW O
Waals NNP O
interactions NNS O
with IN O
large JJ O
hydrophobic JJ O
residues NNS O
( -LRB- O
Figure NNP O
6 CD O
) -RRB- O
. . O

Highly RB O
efficient JJ O
packing NN O
of IN O
bulky JJ O
side NN O
chains NNS O
against IN O
glycine NN O
residues NNS O
is VBZ O
observed VBN O
in IN O
known VBN O
transmembrane NN O
protein NN O
3D NN O
structures NNS O
[ -LRB- O
38 CD O
, , O
53 CD O
, , O
54 CD O
] -RRB- O
. . O

An DT O
example NN O
includes VBZ O
packing NN O
of IN O
helices NNS O
M1 NNP O
and CC O
M2 NNP O
in IN O
potassium NN O
channel NN O
KcsA NNP O
, , O
where WRB O
Val91 NNP O
in IN O
M2 NNP O
is VBZ O
paired VBN O
with IN O
Gly43 NNP O
in IN O
M1 NNP O
, , O
and CC O
Leu36 NNP O
in IN O
M1 NNP O
contacts NNS O
Ala98 NNP O
and CC O
Gly99 NNP O
in IN O
helix NN O
M2 NNP O
[ -LRB- O
54 CD O
, , O
55 CD O
] -RRB- O
. . O

In IN O
addition NN O
to IN O
facilitating VBG O
helix NN O
- HYPH O
helix NN O
packing NN O
, , O
Gly NNP O
residues NNS O
frequently RB O
provide VBP O
additional JJ O
C NN O
alpha NN O
H NN O
. . O
. . O
. . O
O NN O
hydrogen NN O
bonds NNS O
between IN O
two CD O
helices NNS O
[ -LRB- O
44 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
model NN O
, , O
two CD O
C NN O
alpha NN O
- HYPH O
backbone NN O
carbonyl NN O
H NN O
- HYPH O
bonds NNS O
are VBP O
predicted VBN O
- : O
between IN O
residues NNS O
Gly27 NNP O
- HYPH O
Gly67 NNP O
, , O
and CC O
Trp22 NNP O
- HYPH O
Met70 NNP O
. . O

Although IN O
polar JJ O
and CC O
charged JJ O
amino NN O
acid NN O
residues NNS O
( , O
such JJ O
as IN O
Asn NNP O
in IN O
the DT O
TM1 NNP O
heptad NN O
motif NN O
) -RRB- O
are VBP O
infrequent JJ O
in IN O
transmembrane NN O
domains NNS O
, , O
they PRP O
are VBP O
functionally RB O
important JJ O
. . O

Polar JJ O
residues NNS O
such JJ O
as IN O
glutamine NN O
, , O
glutamic JJ O
acid NN O
, , O
aspartic JJ O
acid NN O
and CC O
asparagine NN O
can MD O
promote VB O
strong JJ O
oligomerization NN O
of IN O
model NN O
membrane NN O
- HYPH O
associated VBN O
helices NNS O
[ -LRB- O
56 CD O
- HYPH O
58 CD O
] -RRB- O
. . O

Ruan NNP O
et FW O
al NNP O
. . O

[ -LRB- O
59 CD O
] -RRB- O
used VBD O
asparagine NN O
scanning NN O
mutagenesis NN O
to TO O
probe VB O
the DT O
interface NN O
of IN O
self NN O
- HYPH O
associating VBG O
polyleucine NN O
helices NNS O
by IN O
detecting VBG O
their PRP$ O
enhanced VBN O
self NN O
- HYPH O
interaction NN O
in IN O
vitro NN O
and CC O
in IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
- HYPH O
based VBN O
ToxR NNP O
assay NN O
. . O

Thus RB O
, , O
a DT O
hydrogen NN O
bond NN O
in IN O
an DT O
apolar JJ O
environment NN O
can MD O
result VB O
in IN O
strong JJ O
, , O
though IN O
not RB O
necessarily RB O
specific JJ O
, , O
association NN O
of IN O
transmembrane NN O
helices NNS O
. . O

In IN O
fact NN O
, , O
mutations NNS O
to IN O
polar JJ O
residues NNS O
in IN O
transmembrane NN O
proteins NNS O
are VBP O
commonly RB O
associated VBN O
with IN O
disease NN O
[ -LRB- O
60 CD O
] -RRB- O
. . O

Because IN O
of IN O
this DT O
potential NN O
for IN O
non AFX O
- HYPH O
specific JJ O
interactions NNS O
, , O
polar JJ O
residues NNS O
tend VBP O
to TO O
localize VB O
at IN O
buried VBN O
positions NNS O
in IN O
TM NNP O
domains NNS O
. . O

In IN O
our PRP$ O
case NN O
, , O
the DT O
conserved VBN O
Asn18 NNP O
residue NN O
in IN O
CD9 NNP O
is VBZ O
predicted VBN O
to TO O
be VB O
a DT O
part NN O
of IN O
the DT O
TM1 NNP O
- HYPH O
TM2 NNP O
interface NN O
, , O
though IN O
our PRP$ O
model NN O
does VBZ O
not RB O
predict VB O
any DT O
electrostatic JJ O
interaction NN O
between IN O
Asn18 NNP O
and CC O
TM2 NNP O
( -LRB- O
Figure NNP O
6 CD O
) -RRB- O
. . O

Consistently RB O
, , O
substitution NN O
such JJ O
as IN O
Asn18Tyr NNP O
( , O
and CC O
Gly77Leu NNP O
) , O
in IN O
TM NNP O
( , O
1 CD O
+ SYM O
2 CD O
) SYM O
- HYPH O
GFP NNP O
protein NN O
was VBD O
not RB O
destabilizing VBG O
as IN O
analyzed VBN O
by IN O
protein NN O
aggregation NN O
. . O

Curiously RB O
, , O
the DT O
full JJ O
- HYPH O
length NN O
Asn18Ser NNP O
CD9 NNP O
migrated VBD O
slightly RB O
slower JJR O
on IN O
SDS NNP O
- HYPH O
PAGE NNP O
gel NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
suggesting VBG O
that IN O
Asn18 NNP O
does VBZ O
play VB O
a DT O
role NN O
in IN O
maintaining VBG O
conformation NN O
of IN O
the DT O
molecule NN O
. . O

The DT O
Asn18Cys NNP O
single JJ O
- HYPH O
cysteine NN O
mutant NN O
shows VBZ O
very RB O
little JJ O
intermolecular JJ O
cross NN O
- HYPH O
linking VBG O
( , O
Figure NNP O
7A NNP O
) -RRB- O
, , O
supporting VBG O
the DT O
proposed VBN O
location NN O
of IN O
this DT O
residue NN O
at IN O
the DT O
intramolecular JJ O
interface NN O
. . O

It PRP O
is VBZ O
tempting JJ O
to TO O
speculate VB O
that IN O
the DT O
"""" `` O
pocket NN O
"""" '' O
between IN O
TM1 NNP O
and CC O
TM2 NNP O
lined VBN O
by IN O
Asn18 NNP O
and CC O
Gly77 NNP O
might MD O
be VB O
important JJ O
for IN O
accommodating VBG O
palmitate JJ O
moieties NNS O
that WDT O
target VBP O
Cys78 NNP O
and CC O
Cys79 NNP O
residues NNS O
, , O
and CC O
/ SYM O
or CC O
important JJ O
for IN O
access NN O
by IN O
the DT O
putative JJ O
palmitoyl NN O
transferase NN O
to IN O
those DT O
residues NNS O
. . O

Understanding VBG O
the DT O
exact JJ O
role NN O
of IN O
these DT O
highly RB O
conserved VBN O
Asn18 NNP O
and CC O
Gly77 NNP O
residues NNS O
in IN O
tetraspanins NNS O
awaits VBZ O
further JJ O
investigation NN O
. . O

In IN O
summary NN O
, , O
we PRP O
identified VBD O
conserved VBN O
glycine NN O
residues NNS O
of IN O
TM1 NN O
and CC O
TM2 NNP O
of IN O
tetraspanins NNS O
as IN O
key JJ O
elements NNS O
required VBN O
for IN O
intramolecular JJ O
packing NN O
. . O

Mutations NNS O
of IN O
these DT O
key JJ O
residues NNS O
( , O
Gly25 NNP O
, , O
Gly32 NNP O
, , O
Gly67 NNP O
and CC O
Gly74 NNP O
in IN O
CD9 NNP O
) -RRB- O
resulted VBD O
in IN O
protein NN O
destabilization NN O
and CC O
aggregation NN O
. . O

There EX O
is VBZ O
ample JJ O
evidence NN O
in IN O
the DT O
literature NN O
for IN O
mutations NNS O
in IN O
transmembrane NN O
proteins NNS O
that WDT O
lead VBP O
to IN O
protein NN O
destabilization NN O
, , O
misassembly NN O
and CC O
pathologic JJ O
conditions NNS O
[ -LRB- O
61 CD O
] -RRB- O
. . O

Thus RB O
, , O
we PRP O
have VBP O
identified VBN O
conserved VBN O
heptad NN O
Gly NNP O
residues NNS O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
of IN O
tetraspanins NNS O
as IN O
plausible JJ O
targets NNS O
of IN O
destabilizing JJ O
mutations NNS O
with IN O
potential JJ O
functional JJ O
consequences NNS O
. . O

Intermolecular JJ O
interactions NNS O
in IN O
tetraspanins NNS O

Tetraspanin NNP O
CD9 NNP O
forms VBZ O
mostly RB O
homodimers NNS O
, , O
but CC O
also RB O
a DT O
low JJ O
level NN O
of IN O
heterodimers NNS O
with IN O
CD81 NN O
and CC O
CD151 NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Thus RB O
, , O
mapping VBG O
the DT O
dimerization NN O
interface NN O
is VBZ O
an DT O
important JJ O
next JJ O
step NN O
in IN O
structure NN O
- HYPH O
function NN O
analysis NN O
of IN O
tetraspanins NNS O
. . O

Disulfide NN O
- HYPH O
mediated VBN O
cross NN O
- HYPH O
linking VBG O
, , O
often RB O
in IN O
combination NN O
with IN O
cysteine NN O
- HYPH O
scanning VBG O
mutagenesis NN O
, , O
is VBZ O
a DT O
common JJ O
strategy NN O
to TO O
probe VB O
oligomerization NN O
or CC O
intersubunit NN O
interactions NNS O
of IN O
transmembrane NN O
proteins NNS O
such JJ O
as IN O
histidine NN O
kinase NN O
EnvZ NNP O
[ -LRB- O
62 CD O
] -RRB- O
, , O
M NN O
( , O
3 CD O
) -RRB- O
muscarinic JJ O
acetylcholine NN O
receptor NN O
[ -LRB- O
63 CD O
] -RRB- O
, , O
E NN B-Species
. . I-Species
coli NN I-Species
lactose NN O
permease NN O
[ -LRB- O
64 CD O
] -RRB- O
, , O
synaptobrevin NN O
[ -LRB- O
65 CD O
] -RRB- O
, , O
integrins NNS O
[ -LRB- O
66 CD O
] -RRB- O
and CC O
many JJ O
others NNS O
. . O

In IN O
tetraspanins NNS O
such JJ O
as IN O
CD9 NNP O
, , O
membrane NN O
- HYPH O
proximal JJ O
cysteine NN O
residues NNS O
are VBP O
especially RB O
useful JJ O
targets NNS O
for IN O
disulfide NN O
trapping NN O
, , O
as IN O
their PRP$ O
linkage NN O
can MD O
be VB O
enhanced VBN O
by IN O
pre NN O
- HYPH O
treating VBG O
cells NNS O
with IN O
2 CD O
- HYPH O
BP NN O
. . O

While IN O
the DT O
ability NN O
of IN O
wild JJ O
- HYPH O
type NN O
cysteines NNS O
in IN O
CD9 NNP O
to TO O
be VB O
cross NN O
- HYPH O
linked VBN O
may MD O
indicate VB O
that IN O
they PRP O
are VBP O
close JJ O
to IN O
the DT O
dimerization NN O
interface NN O
, , O
more RBR O
precise JJ O
mapping NN O
was VBD O
achieved VBN O
here RB O
using VBG O
cysteine NN O
- HYPH O
scanning VBG O
mutagenesis NN O
. . O

Our PRP$ O
data NNS O
clearly RB O
identify VBP O
regions NNS O
, , O
near IN O
the DT O
cytoplasmic JJ O
face NN O
of IN O
TM1 NN O
and CC O
TM2 NNP O
, , O
important JJ O
for IN O
dimerization NN O
. . O

Intermolecular JJ O
zero CD O
- HYPH O
length NN O
cross NN O
- HYPH O
linking NN O
was VBD O
highest JJS O
when WRB O
single JJ O
cysteines NNS O
were VBD O
placed VBN O
in IN O
positions NNS O
14 CD O
, , O
17 CD O
, , O
77 CD O
, , O
80 CD O
and CC O
81 CD O
in IN O
TM NN O
( , O
1 CD O
+ SYM O
2 CD O
) SYM O
- HYPH O
GFP NN O
molecule NN O
, , O
or CC O
at IN O
positions NNS O
77 CD O
, , O
80 CD O
or CC O
81 CD O
in IN O
the DT O
full JJ O
- HYPH O
length NN O
CD9 NN O
protein NN O
. . O

Positions NNS O
14 CD O
, , O
17 CD O
and CC O
80 CD O
are VBP O
distinct JJ O
from IN O
the DT O
intramolecular JJ O
interface NN O
and CC O
are VBP O
on IN O
the DT O
same JJ O
side NN O
of IN O
the DT O
TM1 NNP O
- HYPH O
TM2 NNP O
pair NN O
( -LRB- O
Figure NNP O
6 CD O
) -RRB- O
. . O

Thus RB O
, , O
they PRP O
are VBP O
well RB O
- HYPH O
positioned VBN O
to TO O
participate VB O
in IN O
an DT O
interaction NN O
with IN O
another DT O
molecule NN O
. . O

At IN O
the DT O
same JJ O
time NN O
, , O
the DT O
model NN O
predicts VBZ O
that IN O
wild JJ O
- HYPH O
type NN O
cysteines NNS O
( -LRB- O
Cys78 NNP O
, , O
79 CD O
) -RRB- O
, , O
which WDT O
do VBP O
not RB O
yield VB O
very RB O
efficient JJ O
zero CD O
- HYPH O
length NN O
cross NN O
- HYPH O
linking NN O
, , O
are VBP O
on IN O
the DT O
other JJ O
side NN O
of IN O
TM1 NNP O
- HYPH O
TM2 NNP O
pair NN O
. . O

While IN O
using VBG O
the DT O
cysteine NN O
at IN O
position NN O
80 CD O
as IN O
the DT O
dimeric JJ O
interface NN O
probe NN O
, , O
mutations NNS O
of IN O
conserved VBN O
residues NNS O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
( : O
especially RB O
Gly32 NNP O
and CC O
Gly67 NNP O
to IN O
Leu NNP O
) -RRB- O
clearly RB O
reduced VBD O
intermolecular JJ O
cross NN O
- HYPH O
linking VBG O
. . O

We PRP O
do VBP O
not RB O
suggest VB O
that IN O
those DT O
residues NNS O
are VBP O
directly RB O
involved VBN O
in IN O
intermolecular JJ O
interaction NN O
. . O

Rather RB O
, , O
we PRP O
propose VBP O
that IN O
destabilization NN O
of IN O
the DT O
intramolecular JJ O
TM1 NNP O
- HYPH O
TM2 NNP O
interaction NN O
by IN O
Gly NNP O
to IN O
Leu NNP O
substitutions NNS O
( , O
discussed VBN O
above RB O
) , O
causes VBZ O
an DT O
overall JJ O
conformational JJ O
change NN O
that WDT O
reduces VBZ O
dimer NN O
formation NN O
. . O

An DT O
Ala81Leu NNP O
mutation NN O
did VBD O
not RB O
reduce VB O
cross NN O
- HYPH O
linking VBG O
via IN O
Cys80 NNP O
, , O
even RB O
though IN O
single JJ O
- HYPH O
cysteine NN O
Ala81Cys NNP O
molecules NNS O
themselves PRP O
produced VBD O
a DT O
high JJ O
level NN O
of IN O
cross NN O
- HYPH O
linking NN O
. . O

These DT O
results NNS O
, , O
together RB O
with IN O
data NNS O
on IN O
Gly32Leu NNP O
and CC O
Gly67Leu NNP O
mutations NNS O
, , O
are VBP O
consistent JJ O
with IN O
our PRP$ O
model NN O
predicting VBG O
that IN O
helices NNS O
1 CD O
and CC O
2 CD O
interact VBP O
more RBR O
tightly RB O
near IN O
the DT O
extracellular JJ O
end NN O
and CC O
less JJR O
at IN O
the DT O
cytoplasmic JJ O
end NN O
. . O

This DT O
would MD O
give VB O
more JJR O
flexibility NN O
to IN O
a DT O
cysteine NN O
at IN O
position NN O
81 CD O
and CC O
also RB O
limit VB O
the DT O
effect NN O
of IN O
an DT O
Ala81Leu NNP O
mutation NN O
. . O

Location NN O
of IN O
this DT O
residue NN O
at IN O
the DT O
membrane NN O
/ SYM O
cytoplasmic JJ O
border NN O
could MD O
also RB O
make VB O
it PRP O
more RBR O
accessible JJ O
to IN O
CuP NNP O
reagent NN O
as IN O
compared VBN O
to IN O
residues NNS O
buried VBN O
in IN O
TM NNP O
domain NN O
, , O
thus RB O
elevating VBG O
the DT O
efficiency NN O
of IN O
disulfide JJ O
formation NN O
of IN O
the DT O
Ala81Cys NNP O
mutant NN O
. . O

Multiple JJ O
interfaces NNS O
in IN O
tetraspanin NN O
molecules NNS O

In IN O
the DT O
full JJ O
- HYPH O
length NN O
CD9 NNP O
molecules NNS O
, , O
the DT O
3 CD O
C NN O
- HYPH O
terminal NN O
cysteines NNS O
( -LRB- O
Cys87 NNP O
, , O
218 CD O
and CC O
219 CD O
) -RRB- O
located VBN O
at IN O
or CC O
in IN O
TM3 NNP O
and CC O
TM4 NNP O
promoted VBD O
efficient JJ O
dimer NN O
and CC O
even RB O
more RBR O
efficient JJ O
oligomer NN O
formation NN O
compared VBN O
to IN O
the DT O
3 CD O
N NN O
- HYPH O
terminal JJ O
cysteines NNS O
( -LRB- O
Figure NN O
9 CD O
) -RRB- O
. . O

Cys87 NNP O
alone RB O
can MD O
be VB O
used VBN O
to TO O
capture VB O
CD9 NN O
dimers NNS O
[ -LRB- O
25 CD O
] -RRB- O
. . O

These DT O
results NNS O
suggest VBP O
the DT O
existence NN O
of IN O
two CD O
dimeric JJ O
interfaces NNS O
in IN O
CD9 NNP O
molecule NN O
- : O
the DT O
TM NNP O
1 CD O
- HYPH O
2 CD O
/ SYM O
1 CD O
- HYPH O
2 CD O
interface NN O
and CC O
the DT O
TM NN O
3 CD O
- HYPH O
4 CD O
/ SYM O
3 CD O
- HYPH O
4 CD O
interface NN O
( -LRB- O
Figure NNP O
10 CD O
) -RRB- O
. . O

In IN O
a DT O
TM NN O
( : O
1 CD O
+ SYM O
2 CD O
) -RRB- O
molecule NN O
, , O
the DT O
destabilization NN O
of IN O
1 CD O
- SYM O
2 CD O
interaction NN O
, , O
e UH O
. . O
g LS O
. . O
by IN O
Gly NNP O
- HYPH O
- : O
> NFP O
Leu NNP O
mutations NNS O
, , O
would MD O
affect VB O
the DT O
1 CD O
- SYM O
2 CD O
/ SYM O
1 CD O
- HYPH O
2 CD O
interface NN O
, , O
as IN O
discussed VBN O
above RB O
. . O

However RB O
, , O
these DT O
mutations NNS O
would MD O
not RB O
interfere VB O
with IN O
the DT O
3 CD O
- SYM O
4 CD O
/ SYM O
3 CD O
- HYPH O
4 CD O
interface NN O
in IN O
a DT O
full JJ O
- HYPH O
length NN O
molecule NN O
, , O
which WDT O
includes VBZ O
Cys87 NNP O
, , O
218 CD O
and CC O
219 CD O
. . O

Thus RB O
, , O
cross VB O
- HYPH O
linking VBG O
of IN O
full JJ O
- HYPH O
length NN O
molecules NNS O
, , O
containing VBG O
all DT O
6 CD O
cysteine NN O
residues NNS O
, , O
would MD O
be VB O
unaffected JJ O
, , O
as IN O
seen VBN O
in IN O
Figure NNP O
8C NNP O
. . O

Furthermore RB O
, , O
wild JJ O
- HYPH O
type NN O
Cys9 NNP O
, , O
Cys78 NNP O
and CC O
Cys79 NNP O
are VBP O
apparently RB O
not RB O
at IN O
the DT O
primary JJ O
1 CD O
- HYPH O
2 CD O
/ SYM O
1 CD O
- HYPH O
2 CD O
interface NN O
. . O

Their PRP$ O
relative JJ O
inefficiency NN O
in IN O
cross NN O
- HYPH O
linking VBG O
CD9 NNP O
TM NNP O
( , O
1 CD O
+ SYM O
2 CD O
) -RRB- O
protein NN O
likely RB O
reflects VBZ O
weak JJ O
secondary JJ O
contacts NNS O
between IN O
the DT O
molecules NNS O
, , O
or CC O
possibly RB O
random JJ O
collision NN O
events NNS O
. . O

Such JJ O
events NNS O
should MD O
be VB O
independent JJ O
of IN O
mutations NNS O
in IN O
the DT O
conserved VBN O
Gly NNP O
residues NNS O
in IN O
TM1 NNP O
and CC O
TM2 NNP O
, , O
as IN O
was VBD O
demonstrated VBN O
in IN O
Figure NNP O
8B NNP O
. . O

The DT O
potential JJ O
existence NN O
of IN O
two CD O
interfaces NNS O
in IN O
tetraspanin JJ O
molecules NNS O
, , O
1 CD O
- HYPH O
2 CD O
/ SYM O
1 CD O
- SYM O
2 CD O
and CC O
3 CD O
- HYPH O
4 CD O
/ SYM O
3 CD O
- HYPH O
4 CD O
, , O
should MD O
provide VB O
enhanced VBN O
flexibility NN O
for IN O
forming VBG O
additional JJ O
intermolecular JJ O
contacts NNS O
. . O

Current JJ O
understanding NN O
of IN O
tetraspanin JJ O
microdomains NNS O
assumes VBZ O
a DT O
few JJ O
strong JJ O
, , O
primary JJ O
homotypic JJ O
and CC O
heterotypic JJ O
tetraspanin NN O
complexes NNS O
( , O
e LS O
. . O
g LS O
. . O
CD9 NNP O
- HYPH O
CD9 NNP O
, , O
CD9 NNP O
- HYPH O
CD81 CD O
, , O
CD151 CD O
- HYPH O
alpha NN O
3 CD O
integrin NN O
, , O
CD81 NN O
- HYPH O
EWI2 NN O
) -RRB- O
that WDT O
help VBP O
bring VB O
together RB O
various JJ O
other JJ O
proteins NNS O
, , O
forming VBG O
secondary JJ O
- HYPH O
type NN O
associations NNS O
. . O

Such JJ O
properties NNS O
of IN O
tetraspanins NNS O
may MD O
bring VB O
signaling VBG O
molecules NNS O
such JJ O
as IN O
protein NN O
kinase NN O
C NN O
or CC O
phosphatidylinositol NN O
4 CD O
- HYPH O
kinase NN O
to IN O
the DT O
vicinity NN O
of IN O
integrins NNS O
[ -LRB- O
67 CD O
, , O
68 CD O
] -RRB- O
. . O

The DT O
organization NN O
of IN O
the DT O
TM3 NNP O
domain NN O
points VBZ O
to IN O
a DT O
potential JJ O
role NN O
in IN O
protein NN O
- HYPH O
protein NN O
interactions NNS O
. . O

A DT O
motif NN O
of IN O
Leu NNP O
- HYPH O
Leu NNP O
- HYPH O
Glu NNP O
( , O
Gln NNP O
) -RRB- O
spaced VBD O
7 CD O
residues NNS O
apart RB O
( , O
heptad NN O
positions VBZ O
a DT O
) -RRB- O
, , O
with IN O
highly RB O
conserved VBN O
residues NNS O
in IN O
two CD O
consecutive JJ O
positions NNS O
d NN O
, , O
poses VBZ O
as IN O
a DT O
likely JJ O
interaction NN O
module NN O
. . O

If IN O
responsible JJ O
for IN O
heterologous JJ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
, , O
it PRP O
would MD O
form VB O
another DT O
distinct JJ O
interface NN O
of IN O
tetraspanin NN O
molecule NN O
. . O

Our PRP$ O
preliminary JJ O
data NNS O
indicate VBP O
that IN O
replacing VBG O
the DT O
Leu NNP O
and CC O
Glu NNP O
residues NNS O
in IN O
TM3 NNP O
of IN O
CD9 NNP O
with IN O
Ala NNP O
has VBZ O
no DT O
effect NN O
on IN O
cell NN O
surface NN O
expression NN O
of IN O
the DT O
protein NN O
and CC O
its PRP$ O
dimerization NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

It PRP O
remains VBZ O
to TO O
be VB O
tested VBN O
if IN O
interactions NNS O
with IN O
other JJ O
proteins NNS O
will MD O
be VB O
affected VBN O
. . O

Similarly RB O
, , O
the DT O
TM4 NNP O
domain NN O
may MD O
provide VB O
additional JJ O
contributions NNS O
to IN O
lateral JJ O
tetraspanin NN O
associations NNS O
. . O

Much RB O
higher JJR O
sequence NN O
variability NN O
, , O
and CC O
the DT O
lack NN O
of IN O
a DT O
distinct JJ O
heptad NN O
pattern NN O
suggests VBZ O
that IN O
TM4 NNP O
is VBZ O
a DT O
major JJ O
contributor NN O
to IN O
diversity NN O
among IN O
tetraspanin NN O
complexes NNS O
. . O

Structure NN O
- HYPH O
function NN O
analysis NN O
of IN O
TM3 NNP O
and CC O
TM4 NNP O
domains NNS O
in IN O
tetraspanins NNS O
is VBZ O
the DT O
subject NN O
of IN O
ongoing JJ O
investigation NN O
. . O

Conclusion NN O

We PRP O
have VBP O
defined VBN O
the DT O
TM1 NNP O
- HYPH O
TM2 NNP O
intramolecular JJ O
interface NN O
in IN O
tetraspanin NN O
CD9 NNP O
, , O
providing VBG O
evidence NN O
for IN O
glycines NNS O
( , O
Gly25 NN O
and CC O
Gly32 NNP O
in IN O
TM1 NNP O
, , O
Gly67 NN O
and CC O
Gly74 NN O
in IN O
TM2 NN O
) -RRB- O
packing VBG O
against IN O
apposing VBG O
bulky JJ O
aliphatic JJ O
residues NNS O
. . O

Second RB O
, , O
we PRP O
mapped VBD O
an DT O
intermolecular JJ O
CD9 NN O
interface NN O
( , O
involved VBN O
in IN O
CD9 NN O
homodimer NN O
formation NN O
) , O
to IN O
the DT O
vicinity NN O
of IN O
residues NNS O
Leu14 NNP O
and CC O
Phe17 NNP O
in IN O
TM1 NNP O
and CC O
Gly77 NNP O
, , O
Gly80 NNP O
and CC O
Ala81 NNP O
in IN O
TM2 NNP O
. . O

Finally RB O
, , O
we PRP O
provide VBP O
preliminary JJ O
evidence NN O
that IN O
TM3 NNP O
and CC O
TM4 NNP O
in IN O
CD9 NNP O
may MD O
contribute VB O
to IN O
a DT O
second JJ O
intermolecular JJ O
interface NN O
. . O

Key JJ O
CD9 NN O
residues NNS O
involved VBN O
in IN O
intra NN O
- HYPH O
and CC O
intermolecular JJ O
interactions NNS O
are VBP O
highly RB O
conserved VBN O
throughout IN O
the DT O
tetraspanin JJ O
family NN O
, , O
thus RB O
suggesting VBG O
that IN O
our PRP$ O
findings NNS O
will MD O
apply VB O
to IN O
most JJS O
tetraspanins NNS O
. . O

Methods NNS O

Materials NNS O

Cell NN O
culture NN O
reagents NNS O
were VBD O
from IN O
Invitrogen NNP O
( : O
Carlsbad NNP O
, , O
CA NNP O
) -RRB- O
. . O

2 LS O
- HYPH O
bromopalmitate NN O
was VBD O
from IN O
Fluka NNP O
( , O
Milwaukee NNP O
, , O
WI NNP O
) -RRB- O
, , O
N NNP O
- HYPH O
ethylmaleimide NN O
( , O
NEM NNP O
) -RRB- O
and CC O
1 CD O
, , O
10 CD O
- HYPH O
phenanthroline NN O
were VBD O
from IN O
Sigma NNP O
- HYPH O
Aldrich NNP O
( : O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
) -RRB- O
, , O
and CC O
chemical JJ O
cross NN O
- HYPH O
linkers NNS O
dithio NN O
- HYPH O
bis NN O
- HYPH O
maleimidoethane NN O
( , O
DTME NNP O
) -RRB- O
and CC O
1 CD O
, , O
4 CD O
- HYPH O
Bis NN O
- HYPH O
maleimidobutane NN O
( , O
BMB NNP O
) -RRB- O
were VBD O
purchased VBN O
from IN O
Pierce NNP O
Endogen NNP O
( : O
Rockford NNP O
, , O
IL NNP O
) -RRB- O
. . O

Triton NNP O
X NNP O
- HYPH O
100 CD O
, , O
protease NN O
inhibitor NN O
cocktail NN O
and CC O
FuGENE NNP O
6 CD O
transfection NN O
reagent NN O
were VBD O
obtained VBN O
from IN O
Roche NNP O
( : O
Indianapolis NNP O
, , O
IN NNP O
) -RRB- O
. . O

Restriction NN O
endonucleases NNS O
and CC O
Pfu NNP O
DNA NNP O
polymerase NN O
were VBD O
obtained VBN O
New NNP O
England NNP O
Biolabs NNP O
( : O
Beverly NNP O
, , O
MA NNP O
) -RRB- O
and CC O
Stratagene NNP O
( : O
Carlsbad NNP O
, , O
CA NNP O
) -RRB- O
, , O
respectively RB O
. . O

All DT O
other JJ O
chemicals NNS O
were VBD O
purchased VBN O
from IN O
Sigma NNP O
- HYPH O
Aldrich NNP O
or CC O
Fisher NNP O
Scientific NNP O
( : O
Pittsburg NNP O
, , O
PA NNP O
) -RRB- O
. . O

Sequence NN O
analysis NN O

Tetraspanin NNP O
sequences NNS O
were VBD O
obtained VBN O
from IN O
SWISS NNP O
- HYPH O
PROT NNP O
and CC O
GenBank NNP O
databases NNS O
. . O

Locus NNP O
designations NNS O
, , O
accession NN O
numbers NNS O
and CC O
the DT O
most RBS O
commonly RB O
used VBN O
protein NN O
names NNS O
are VBP O
summarized VBN O
in IN O
Tables NNP O
1 CD O
and CC O
2 CD O
. . O

TM NNP O
segments NNS O
were VBD O
delineated VBN O
by IN O
inspection NN O
of IN O
hydrophobicity NN O
profiles NNS O
, , O
using VBG O
database NN O
annotations NNS O
and CC O
previous JJ O
analyses NNS O
of IN O
TM NNP O
sequences NNS O
as IN O
a DT O
guide NN O
( , O
[ -LRB- O
28 CD O
] -RRB- O
, , O
M NNP O
. . O
Hemler NNP O
, , O
unpublished JJ O
) -RRB- O
, , O
and CC O
aligned VBN O
manually RB O
. . O

Residue NN O
numbers NNS O
in IN O
human JJ B-Species
CD9 NN O
sequence NN O
are VBP O
used VBN O
a DT O
reference NN O
point NN O
throughout IN O
the DT O
study NN O
. . O

DNA NN O
cloning NN O
and CC O
mutagenesis NN O

Sequence NN O
encoding VBG O
CD9 NN O
protein NN O
was VBD O
cloned VBN O
into IN O
vector NN O
pcDNA3 NN O
( , O
Invitrogen NNP O
, , O
Carlsbad NNP O
, , O
CA NNP O
) -RRB- O
and CC O
pEGFP NNP O
- HYPH O
N1 NNP O
( , O
Clontech NNP O
, , O
Palo NNP O
Alto NNP O
, , O
CA NNP O
) -RRB- O
, , O
for IN O
expression NN O
of IN O
untagged JJ O
and CC O
C NN O
- HYPH O
terminally RB O
GFP NNP O
- HYPH O
tagged VBN O
CD9 NNP O
, , O
respectively RB O
. . O

pEGFP NNP O
- HYPH O
N1 NN O
encoding VBG O
CD9 NNP O
TM NN O
( , O
1 CD O
+ SYM O
2 CD O
) NFP O
- HYPH O
GFP NNP O
fusion NN O
protein NN O
was VBD O
constructed VBN O
by IN O
subcloning VBG O
DNA NN O
for IN O
residues NNS O
1 CD O
- HYPH O
83 CD O
of IN O
CD9 NNP O
into IN O
HindIII NNP O
and CC O
PstI NNP O
sites NNS O
of IN O
the DT O
vector NN O
; : O
to TO O
introduce VB O
the DT O
PstI NNP O
site NN O
, , O
codon NN O
GTG NNP O
for IN O
Val82 NNP O
was VBD O
changed VBN O
to IN O
CTG NNP O
( , O
coding VBG O
for IN O
Ala NNP O
) -RRB- O
. . O

In IN O
the DT O
resulting VBG O
fusion NN O
protein NN O
, , O
there EX O
is VBZ O
a DT O
13 CD O
- HYPH O
amino NN O
acid NN O
linker NN O
( , O
with IN O
no DT O
cysteines NNS O
) , O
between IN O
CD9 NNP O
and CC O
GFP NNP O
. . O

To TO O
minimize VB O
the DT O
low JJ O
inherent JJ O
ability NN O
of IN O
GFP NNP O
to TO O
homodimerize VB O
, , O
which WDT O
could MD O
potentially RB O
influence VB O
the DT O
results NNS O
of IN O
CD9 NNP O
cross NN O
- HYPH O
linking VBG O
, , O
we PRP O
used VBD O
a DT O
monomeric JJ O
GFP NNP O
mutant NN O
, , O
Leu221 NNP O
- HYPH O
- : O
> : O
Lys NNP O
[ -LRB- O
34 CD O
] -RRB- O
, , O
for IN O
cross NN O
- HYPH O
linking VBG O
experiments NNS O
. . O

Mutations NNS O
were VBD O
introduced VBN O
in IN O
full JJ O
- HYPH O
length NN O
and CC O
TM NN O
( , O
1 CD O
+ SYM O
2 CD O
) SYM O
CD9 NN O
proteins NNS O
by IN O
a DT O
PCR NN O
- HYPH O
based VBN O
strategy NN O
using VBG O
mutagenic JJ O
primers NNS O
and CC O
Pfu NNP O
DNA NNP O
polymerase NN O
. . O

All DT O
mutations NNS O
were VBD O
confirmed VBN O
by IN O
DNA NNP O
sequencing NN O
. . O

Protein NN O
expression NN O
, , O
microscopy NN O
, , O
cysteine NN O
disulfide NN O
cross NN O
- HYPH O
linking NN O
and CC O
Western JJ O
blotting NN O

DNA NN O
constructs NNS O
encoding VBG O
TM NNP O
( , O
1 CD O
+ SYM O
2 CD O
) SYM O
- HYPH O
GFP NN O
or CC O
full JJ O
- HYPH O
length NN O
CD9 NN O
proteins NNS O
were VBD O
transfected VBN O
into IN O
human JJ B-Species
rhabdomyosarcoma NN O
RD NN O
cells NNS O
using VBG O
the DT O
FuGENE NNP O
6 CD O
reagent NN O
. . O

Cells NNS O
expressing VBG O
GFP NNP O
fusion NN O
proteins NNS O
were VBD O
analysed VBN O
by IN O
fluorescence NN O
microscopy NN O
18 CD O
- SYM O
28 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
. . O

Images NNS O
were VBD O
captured VBN O
using VBG O
Spot NNP O
1 CD O
. . O
4 CD O
. . O
0 CD O
camera NN O
( -LRB- O
Diagnostic NNP O
Instruments NNPS O
, , O
Sterling NNP O
Heights NNPS O
, , O
MI NNP O
) -RRB- O
attached VBN O
to IN O
Nikon NNP O
Eclipse NNP O
TE300 NNP O
microscope NN O
. . O

For IN O
experiments NNS O
involving VBG O
cysteine NN O
- HYPH O
mediated VBN O
cross NN O
- HYPH O
linking VBG O
, , O
cells NNS O
were VBD O
treated VBN O
with IN O
50 CD O
mu NN O
M NNP O
2 CD O
- HYPH O
BP NNP O
starting VBG O
24 CD O
- SYM O
26 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
and CC O
continuing VBG O
for IN O
16 CD O
- SYM O
18 CD O
hours NNS O
. . O

Cross NN O
- HYPH O
linking VBG O
was VBD O
carried VBN O
out RP O
by IN O
incubating VBG O
cells NNS O
in IN O
HBSM NNP O
buffer NN O
( , O
25 CD O
mM NN O
Hepes NNP O
- HYPH O
NaOH NNP O
, , O
pH NN O
7 CD O
. . O
2 CD O
, , O
150 CD O
mM NN O
NaCl NN O
, , O
2 CD O
mM NN O
MgCl2 NN O
) -RRB- O
containing VBG O
either CC O
a DT O
) SYM O
0 CD O
. . O
6 CD O
mM NN O
CuSO4 NN O
and CC O
1 CD O
. . O
8 CD O
mM NN O
1 CD O
, , O
10 CD O
- HYPH O
phenanthroline NN O
( : O
CuP NN O
complex NN O
) -RRB- O
or CC O
b NN O
) SYM O
0 CD O
. . O
2 CD O
mg NN O
/ SYM O
ml NN O
homobifunctional JJ O
cysteine NN O
- HYPH O
reactive JJ O
cross NN O
- HYPH O
linker NN O
( : O
e LS O
. . O
g LS O
. . O
DTME NNP O
) -RRB- O
, , O
diluted VBN O
from IN O
fresh JJ O
10 CD O
mg NN O
/ SYM O
ml NN O
solution NN O
in IN O
DMSO NNP O
. . O

After IN O
incubation NN O
for IN O
10 CD O
- SYM O
15 CD O
minutes NNS O
( , O
with IN O
CuP NNP O
) -RRB- O
or CC O
30 CD O
- SYM O
45 CD O
minutes NNS O
( , O
with IN O
cross NN O
- HYPH O
linker NN O
) -RRB- O
, , O
cells NNS O
were VBD O
washed VBN O
twice RB O
for IN O
10 CD O
minutes NNS O
with IN O
HBSM NNP O
containing VBG O
10 CD O
mM NN O
NEM NN O
to TO O
block VB O
residual JJ O
free JJ O
cysteines NNS O
. . O

Cells NNS O
were VBD O
lysed VBN O
in IN O
HBSM NNP O
containing VBG O
1 CD O
% NN O
Triton NNP O
X NNP O
- SYM O
100 CD O
, , O
0 CD O
. . O
1 CD O
% NN O
SDS NN O
and CC O
a DT O
cocktail NN O
of IN O
protease NN O
inhibitors NNS O
with IN O
1 CD O
mM NN O
EDTA NNP O
at IN O
4 CD O
degrees NNS O
C NN O
for IN O
45 CD O
- SYM O
60 CD O
minutes NNS O
. . O

Cell NN O
lysate NN O
was VBD O
clarified VBN O
by IN O
centrifugation NN O
at IN O
14 CD O
, , O
0 CD O
x SYM O
g NN O
for IN O
15 CD O
minutes NNS O
, , O
an DT O
aliquot NN O
was VBD O
removed VBN O
, , O
and CC O
proteins NNS O
from IN O
it PRP O
were VBD O
precipitated VBN O
by IN O
addition NN O
of IN O
trichloroacetic JJ O
acid NN O
to IN O
10 CD O
% NN O
on IN O
ice NN O
followed VBN O
by IN O
centrifugation NN O
at IN O
14 CD O
, , O
0 CD O
x SYM O
g NN O
for IN O
10 CD O
minutes NNS O
. . O

After IN O
two CD O
washes NNS O
with IN O
ice NN O
- HYPH O
cold JJ O
acetone NN O
, , O
protein NN O
pellet NN O
was VBD O
solubilized VBN O
in IN O
SDS NNP O
- HYPH O
PAGE NN O
sample NN O
buffer NN O
without IN O
a DT O
reducing VBG O
agent NN O
( : O
50 CD O
mM NN O
Tris NN O
- HYPH O
HCl NNP O
, , O
pH NN O
6 CD O
. . O
8 CD O
, , O
1 CD O
% NN O
SDS NN O
, , O
8 CD O
% NN O
glycerol NN O
) -RRB- O
. . O

In IN O
some DT O
experiments NNS O
, , O
CD9 NNP O
protein NN O
was VBD O
immunoprecipitated VBN O
using VBG O
monoclonal JJ O
antibody NN O
Alb6 NNP O
( , O
Immunotech NNP O
, , O
Marseille NNP O
, , O
France NNP O
) -RRB- O
. . O

Proteins NNS O
were VBD O
separated VBN O
by IN O
SDS NNP O
- HYPH O
PAGE NNP O
and CC O
analyzed VBN O
by IN O
Western JJ O
blotting NN O
using VBG O
monoclonal JJ O
antibody NN O
JL NNP O
- HYPH O
8 CD O
( HYPH O
Clontech NNP O
) -RRB- O
for IN O
GFP NNP O
or CC O
Alb6 NNP O
for IN O
CD9 NNP O
. . O

Bands NNS O
from IN O
X NN O
- HYPH O
ray NN O
films NNS O
were VBD O
quantitated VBN O
using VBG O
GeneTools NNP O
( -LRB- O
TM NNP O
) , O
software NN O
from IN O
Syngene NNP O
( : O
Frederick NNP O
, , O
MD NNP O
) -RRB- O
. . O

Modeling VBG O
of IN O
TM1 NN O
- HYPH O
TM2 NNP O
interaction NN O

An DT O
atomic JJ O
model NN O
of IN O
the DT O
CD9 NNP O
TM1 NNP O
- HYPH O
TM2 NNP O
dimer NN O
was VBD O
constructed VBN O
with IN O
a DT O
Monte NNP O
Carlo NNP O
- HYPH O
simulated VBN O
annealing NN O
( , O
MCSA NNP O
) , O
algorithm NN O
[ -LRB- O
69 CD O
] -RRB- O
. . O

Two CD O
idealized JJ O
alpha NN O
- HYPH O
helices NNS O
corresponding VBG O
to IN O
TM1 NNP O
residues NNS O
Tyr12 NNP O
through IN O
Leu35 NNP O
and CC O
TM2 NNP O
residues NNS O
Gly59 NNP O
through IN O
Val82 NNP O
were VBD O
docked VBN O
with IN O
six CD O
orthogonal JJ O
parameters NNS O
: : O
three CD O
rigid JJ O
body NN O
translations NNS O
and CC O
three CD O
rotations NNS O
. . O

During IN O
each DT O
step NN O
of IN O
a DT O
MCSA NNP O
cycle NN O
, , O
there EX O
was VBD O
an DT O
equal JJ O
probability NN O
of IN O
changing VBG O
either CC O
one CD O
parameter NN O
or CC O
all DT O
six CD O
parameters NNS O
to IN O
random JJ O
values NNS O
. . O

A DT O
conformation NN O
' '' O
s NN O
energy NN O
was VBD O
calculated VBN O
in IN O
vacuo NN O
with IN O
the DT O
AMBER NNP O
united JJ O
- HYPH O
atom NN O
force NN O
field NN O
for IN O
van FW O
der FW O
Waals NNP O
interactions NNS O
[ -LRB- O
70 CD O
] -RRB- O
. . O

The DT O
van NNP O
der NNP O
Waals NNP O
term NN O
was VBD O
modified VBN O
as IN O
described VBN O
by IN O
Kuhlman NNP O
and CC O
Baker NNP O
[ -LRB- O
71 CD O
] -RRB- O
. . O

If IN O
a DT O
structure NN O
had VBD O
favorable JJ O
dimerization NN O
energy NN O
, , O
the DT O
energies NNS O
of IN O
select JJ O
mutants NNS O
were VBD O
calculated VBN O
. . O

Structures NNS O
were VBD O
selected VBN O
with IN O
a DT O
novel JJ O
scoring NN O
function NN O
that WDT O
maximizes VBZ O
the DT O
Boltzmann NNP O
probability NN O
of IN O
dimerization NN O
for IN O
silent JJ O
mutations NNS O
while IN O
minimizing VBG O
the DT O
probability NN O
for IN O
disruptive JJ O
mutations NNS O
. . O

Asn18Ser NNP O
, , O
Gly77Leu NNP O
, , O
and CC O
Gly80Leu NNP O
were VBD O
scored VBN O
as IN O
silent JJ O
mutations NNS O
while IN O
Gly25Leu NNP O
, , O
Gly32Leu NNP O
, , O
Gly67Leu NNP O
, , O
and CC O
Gly74Leu NNP O
were VBD O
considered VBN O
to TO O
be VB O
disruptive JJ O
. . O

Each DT O
MCSA NNP O
cycle NN O
consisted VBD O
of IN O
50 CD O
, , O
0 CD O
steps NNS O
with IN O
an DT O
exponential JJ O
temperature NN O
decay NN O
from IN O
10 CD O
, , O
0 CD O
to IN O
10 CD O
K NN O
. . O

Ten CD O
MCSA NNP O
cycles NNS O
through IN O
global JJ O
sample NN O
space NN O
were VBD O
used VBN O
to TO O
restrict VB O
the DT O
search NN O
area NN O
. . O

Parameters NNS O
were VBD O
restricted VBN O
to IN O
+ SYM O
/ SYM O
- SYM O
2 CD O
standard JJ O
deviations NNS O
from IN O
their PRP$ O
mean JJ O
value NN O
for IN O
structures NNS O
within IN O
10 CD O
kcal NN O
of IN O
the DT O
best JJS O
structure NN O
. . O

MCSA NNP O
cycles NNS O
were VBD O
repeated VBN O
as IN O
described VBN O
above RB O
with IN O
additional JJ O
optimization NN O
of IN O
chi NN O
values NNS O
: : O
rotamers NNS O
at IN O
the DT O
protein NN O
- HYPH O
protein NN O
interface NN O
were VBD O
optimized VBN O
with IN O
Dead NNP O
End NNP O
Elimination NNP O
[ -LRB- O
72 CD O
] -RRB- O
, , O
and CC O
chi NN O
values NNS O
were VBD O
further RB O
optimized VBN O
with IN O
Monte NNP O
Carlo NNP O
. . O

All DT O
MCSA NNP O
cycles NNS O
converged VBD O
upon IN O
structures NNS O
that WDT O
were VBD O
within IN O
a DT O
root NN O
mean JJ O
squared JJ O
deviation NN O
( , O
RMSD NN O
) -RRB- O
of IN O
1 CD O
. . O
5 CD O
A NN O
with IN O
the DT O
best JJS O
structure NN O
, , O
and CC O
structures NNS O
that WDT O
scored VBD O
within IN O
5 CD O
kcal NN O
of IN O
the DT O
best JJS O
score NN O
had VBD O
an DT O
RMSD NN O
of IN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
A NN O
with IN O
the DT O
best JJS O
structure NN O
. . O

List NN O
of IN O
abbreviations NNS O

2 CD O
- HYPH O
BP NN O
, , O
2 CD O
- HYPH O
bromopalmitate NN O
; : O
CuP NN O
, , O
Cu2 NNP O
+ SYM O
- HYPH O
phenanthroline NN O
; : O
DTME NNP O
, , O
dithio NN O
- HYPH O
bis NN O
- HYPH O
maleimidoethane NN O
; : O
LEL NNP O
, , O
large JJ O
extracellular JJ O
loop NN O
; , O
NEM NNP O
, , O
N NNP O
- HYPH O
ethylmaleimide NN O
; : O
TM NN O
, , O
transmembrane NN O
( , O
domain NN O
) -RRB- O
. . O

Authors NNS O
' POS O
contributions NNS O

OVK NNP O
carried VBD O
out RP O
sequence NN O
comparisons NNS O
, , O
mutational JJ O
analysis NN O
and CC O
cross NN O
- HYPH O
linking VBG O
experiments NNS O
, , O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

DGM NNP O
built VBD O
the DT O
TM1 NNP O
- HYPH O
TM2 NNP O
interaction NN O
model NN O
and CC O
contributed VBD O
to IN O
the DT O
manuscript NN O
. . O

WFD NNP O
supervised VBD O
DGM NNP O
' POS O
s NNS O
work NN O
. . O

MEH NNP O
coordinated VBD O
the DT O
whole JJ O
study NN O
and CC O
prepared VBD O
the DT O
final JJ O
manuscript NN O
. . O

Epigenetic JJ O
inactivation NN O
and CC O
aberrant JJ O
transcription NN O
of IN O
CSMD1 NNP O
in IN O
squamous JJ O
cell NN O
carcinoma NN O
cell NN O
lines NNS O

Abstract JJ O

Background NN O

The DT O
p23 NN O
. . O
2 CD O
region NN O
of IN O
human JJ B-Species
chromosome NN O
8 CD O
is VBZ O
frequently RB O
deleted VBN O
in IN O
several JJ O
types NNS O
of IN O
epithelial JJ O
cancer NN O
and CC O
those DT O
deletions NNS O
appear VBP O
to TO O
be VB O
associated VBN O
with IN O
poor JJ O
prognosis NN O
. . O

Cub NNP O
and CC O
Sushi NNP O
Multiple NNP O
Domains NNPS O
1 CD O
( SYM O
CSMD1 NNP O
) -RRB- O
was VBD O
positionally RB O
cloned VBN O
as IN O
a DT O
candidate NN O
for IN O
the DT O
8p23 CD O
suppressor NN O
but CC O
point NN O
mutations NNS O
in IN O
this DT O
gene NN O
are VBP O
rare JJ O
relative JJ O
to IN O
the DT O
frequency NN O
of IN O
allelic JJ O
loss NN O
. . O

In IN O
an DT O
effort NN O
to TO O
identify VB O
alternative JJ O
mechanisms NNS O
of IN O
inactivation NN O
, , O
we PRP O
have VBP O
characterized VBN O
CSMD1 NNP O
expression NN O
and CC O
epigenetic JJ O
modifications NNS O
in IN O
head NN O
and CC O
neck NN O
squamous JJ O
cell NN O
carcinoma NN O
cell NN O
lines NNS O
. . O

Results NNS O

Only RB O
one CD O
of IN O
the DT O
20 CD O
cell NN O
lines NNS O
examined VBN O
appears VBZ O
to TO O
express VB O
a DT O
structurally RB O
normal JJ O
CSMD1 NNP O
transcript NN O
. . O

The DT O
rest NN O
express VBP O
transcripts NNS O
which WDT O
either CC O
lack VBP O
internal JJ O
exons NNS O
, , O
terminate VBP O
abnormally RB O
or CC O
initiate VBP O
at IN O
cryptic JJ O
promoters NNS O
. . O

None NN O
of IN O
these DT O
truncated VBN O
transcripts NNS O
is VBZ O
predicted VBN O
to TO O
encode VB O
a DT O
functional JJ O
CSMD1 NN O
protein NN O
. . O

Cell NN O
lines NNS O
that WDT O
express VBP O
little JJ O
or CC O
no DT O
CSMD1 NNP O
RNA NNP O
exhibit VBP O
DNA NN O
methylation NN O
of IN O
a DT O
specific JJ O
region NN O
of IN O
the DT O
CpG NNP O
island NN O
surrounding VBG O
CSMD1 NNP O
' POS O
s NN O
first JJ O
exon NN O
. . O

Conclusion NN O

Correlating VBG O
methylation NN O
patterns NNS O
and CC O
expression NN O
suggests VBZ O
that IN O
it PRP O
is VBZ O
modification NN O
of IN O
the DT O
genomic JJ O
DNA NN O
preceding VBG O
the DT O
first JJ O
exon NN O
that WDT O
is VBZ O
associated VBN O
with IN O
gene NN O
silencing NN O
and CC O
that IN O
methylation NN O
of IN O
CpG NN O
dinucleotides NNS O
further RB O
3 CD O
' '' O
does VBZ O
not RB O
contribute VB O
to IN O
inactivation NN O
of IN O
the DT O
gene NN O
. . O

Taken VBN O
together RB O
, , O
the DT O
cell NN O
line NN O
data NNS O
suggest VBP O
that IN O
epigenetic JJ O
silencing NN O
and CC O
aberrant JJ O
splicing NN O
rather RB O
than IN O
point NN O
mutations NNS O
may MD O
be VB O
contributing VBG O
to IN O
the DT O
reduction NN O
in IN O
CSMD1 NN O
expression NN O
in IN O
squamous JJ O
cancers NNS O
. . O

These DT O
mechanisms NNS O
can MD O
now RB O
serve VB O
as IN O
a DT O
focus NN O
for IN O
further JJ O
analysis NN O
of IN O
primary JJ O
squamous JJ O
cancers NNS O
. . O

Background NN O

CUB NNP O
and CC O
Sushi NNP O
Multiple NNP O
Domains NNPS O
1 CD O
( SYM O
CSMD1 NNP O
) -RRB- O
was VBD O
cloned VBN O
as IN O
a DT O
candidate NN O
tumor NN O
suppressor NN O
or CC O
progression NN O
gene NN O
from IN O
a DT O
region NN O
of IN O
human JJ B-Species
chromosome NN O
8 CD O
deleted VBN O
in IN O
tumors NNS O
of IN O
the DT O
upper JJ O
aerodigestive NN O
tract NN O
, , O
prostate NN O
, , O
ovary NN O
and CC O
bladder NN O
[ -LRB- O
1 CD O
- SYM O
7 CD O
] -RRB- O
. . O

Deletion NN O
of IN O
8p23 CD O
. . O
2 CD O
or CC O
reduced VBN O
expression NN O
of IN O
CSMD1 NNP O
has VBZ O
been VBN O
associated VBN O
with IN O
poor JJ O
prognosis NN O
in IN O
head NN O
and CC O
neck NN O
squamous JJ O
cell NN O
carcinomas NNS O
and CC O
in IN O
prostate NN O
cancers NNS O
[ -LRB- O
2 CD O
, , O
5 CD O
, , O
8 CD O
] -RRB- O
. . O

CSMD1 NNP O
, , O
consisting VBG O
of IN O
70 CD O
exons NNS O
spread VBN O
over IN O
two CD O
megabases NNS O
of IN O
8p23 CD O
. . O
2 CD O
, , O
encodes VBZ O
a DT O
rare JJ O
11 CD O
. . O
5 CD O
kb NN O
transcript NN O
most RBS O
abundantly RB O
expressed VBN O
in IN O
the DT O
brain NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
the DT O
founding VBG O
member NN O
of IN O
a DT O
novel JJ O
, , O
evolutionarily RB O
highly RB O
conserved VBN O
gene NN O
family NN O
whose WP$ O
proteins NNS O
contain VBP O
multiple JJ O
domains NNS O
thought VBN O
to TO O
be VB O
sites NNS O
of IN O
protein NN O
- HYPH O
protein NN O
or CC O
protein NN O
- HYPH O
ligand NN O
interactions NNS O
and CC O
whose WP$ O
structure NN O
suggests VBZ O
that IN O
they PRP O
may MD O
be VB O
transmembrane NN O
receptors NNS O
or CC O
adhesion NN O
proteins NNS O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
. . O

Tumor NN O
suppressor NN O
genes NNS O
are VBP O
expected VBN O
to TO O
be VB O
inactivated VBN O
in IN O
cancers NNS O
either CC O
genetically RB O
by IN O
mutations NNS O
or CC O
epigenetically RB O
by IN O
modification NN O
of IN O
their PRP$ O
promoters NNS O
. . O

While IN O
CSMD1 NNP O
transcripts NNS O
are VBP O
detectable JJ O
in IN O
upper JJ O
aerodigestive NN O
tract NN O
epithelium NN O
, , O
preliminary JJ O
analysis NN O
of IN O
several JJ O
head NN O
and CC O
neck NN O
squamous NN O
cell NN O
carcinoma NN O
cell NN O
lines NNS O
suggested VBD O
that IN O
CSMD1 NNP O
expression NN O
was VBD O
lost VBN O
in IN O
these DT O
lines NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Although IN O
the DT O
region NN O
containing VBG O
CSMD1 NNP O
is VBZ O
frequently RB O
deleted VBN O
in IN O
head NN O
and CC O
neck NN O
squamous JJ O
cell NN O
carcinomas NNS O
and CC O
prostatic JJ O
adenocarcinomas NNS O
[ -LRB- O
3 CD O
, , O
11 CD O
- SYM O
15 CD O
] -RRB- O
, , O
point NN O
mutations NNS O
in IN O
the DT O
gene NN O
are VBP O
relatively RB O
rare JJ O
in IN O
primary JJ O
squamous JJ O
cancers NNS O
[ -LRB- O
16 CD O
] -RRB- O
and CC O
in IN O
squamous JJ O
cell NN O
carcinoma NN O
cell NN O
lines NNS O
( , O
Schmidt NNP O
, , O
Richter NNP O
and CC O
Scholnick NNP O
, , O
unpublished JJ O
) -RRB- O
. . O

Nonsense NN O
or CC O
splice NN O
junction NN O
mutations NNS O
in IN O
CSMD1 NNP O
have VBP O
not RB O
been VBN O
reported VBN O
and CC O
not RB O
enough JJ O
is VBZ O
known VBN O
about IN O
the DT O
function NN O
of IN O
the DT O
protein NN O
to TO O
accurately RB O
assess VB O
the DT O
effect NN O
of IN O
the DT O
few JJ O
missense NN O
mutations NNS O
that WDT O
have VBP O
been VBN O
detected VBN O
. . O

Thus RB O
, , O
if IN O
CSMD1 NNP O
is VBZ O
inactivated VBN O
in IN O
tumors NNS O
, , O
alternative JJ O
mechanisms NNS O
for IN O
gene NN O
silencing NN O
must MD O
be VB O
operating VBG O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
demonstrate VBP O
that IN O
while IN O
most JJS O
squamous JJ O
cell NN O
carcinoma NN O
cell NN O
lines NNS O
do VBP O
not RB O
express VB O
full JJ O
length NN O
CSMD1 NN O
transcripts NNS O
, , O
nearly RB O
all DT O
produce VBP O
abnormal JJ O
transcripts NNS O
unlikely JJ O
to TO O
encode VB O
functional JJ O
CSMD1 NN O
proteins NNS O
. . O

Methylation NN O
of IN O
the DT O
DNA NNP O
preceding VBG O
CSMD1 NNP O
' POS O
s NNS O
first JJ O
exon NN O
is VBZ O
correlated VBN O
with IN O
reduction NN O
in IN O
the DT O
level NN O
of IN O
expression NN O
and CC O
cell NN O
lines NNS O
expressing VBG O
at IN O
low JJ O
levels NNS O
do VBP O
not RB O
appear VB O
to TO O
elongate VB O
the DT O
full JJ O
11 CD O
. . O
5 CD O
kb NN O
transcript NN O
. . O

Other JJ O
anomalies NNS O
of IN O
expression NN O
include VBP O
incorrect JJ O
splicing NN O
and CC O
the DT O
use NN O
of IN O
cryptic JJ O
promoters NNS O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
activation NN O
of IN O
these DT O
promoters NNS O
may MD O
result VB O
from IN O
the DT O
global JJ O
demethylation NN O
of IN O
the DT O
genome NN O
associated VBN O
with IN O
tumorigenesis NN O
( , O
reviewed VBN O
by IN O
Ehrlich NNP O
[ -LRB- O
17 CD O
] -RRB- O
) -RRB- O
. . O

Taken VBN O
together RB O
these DT O
data NNS O
demonstrate VBP O
that IN O
mechanisms NNS O
other JJ O
than IN O
point NN O
mutation NN O
are VBP O
responsible JJ O
for IN O
the DT O
aberrant JJ O
CSMD1 NN O
expression NN O
in IN O
head NN O
and CC O
neck NN O
squamous JJ O
cell NN O
carcinoma NN O
cell NN O
lines NNS O
, , O
and CC O
these DT O
data NNS O
suggest VBP O
potential JJ O
targets NNS O
for IN O
further JJ O
investigation NN O
in IN O
primary JJ O
tumors NNS O
. . O

Results NNS O

CSMD1 NN O
promoter NN O
methylation NN O
in IN O
HNSCC NNP O
cell NN O
lines NNS O
is VBZ O
correlated VBN O
with IN O
expression NN O
levels NNS O

Preliminary JJ O
evidence NN O
suggested VBD O
that IN O
CSMD1 NNP O
expression NN O
is VBZ O
lost VBN O
in IN O
head NN O
and CC O
neck NN O
squamous JJ O
cell NN O
carcinomas NNS O
[ -LRB- O
1 CD O
] -RRB- O
but CC O
that DT O
point NN O
mutations NNS O
were VBD O
rare JJ O
[ -LRB- O
[ -LRB- O
16 CD O
] -RRB- O
, , O
and CC O
Schmidt NNP O
, , O
Richter NNP O
and CC O
Scholnick NNP O
, , O
unpublished JJ O
] -RRB- O
. . O

To IN O
date NN O
, , O
only RB O
two CD O
of IN O
the DT O
20 CD O
cell NN O
lines NNS O
we PRP O
have VBP O
tested VBN O
for IN O
CSMD1 NNP O
expression NN O
, , O
UPCI NNP O
: : O
SCC066 NNP O
and CC O
PCI NNP O
- HYPH O
13 CD O
, , O
express VBP O
large JJ O
transcripts NNS O
initiated VBN O
at IN O
the DT O
normal JJ O
CSMD1 NNP O
promoter NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
a DT O
mechanism NN O
( , O
s VBZ O
) -RRB- O
other JJ O
than IN O
point NN O
mutation NN O
must MD O
be VB O
responsible JJ O
for IN O
the DT O
loss NN O
of IN O
expression NN O
. . O

CSMD1 NNP O
' POS O
s POS O
first JJ O
exon NN O
is VBZ O
embedded VBN O
in IN O
a DT O
3 CD O
. . O
7 CD O
kb NN O
CpG NNP O
island NN O
( , O
data NNS O
from IN O
the DT O
UCSC NNP O
genome NN O
browser NN O
[ -LRB- O
18 CD O
] -RRB- O
) , O
suggesting VBG O
that IN O
promoter NN O
methylation NN O
might MD O
epigenetically RB O
silence VB O
the DT O
gene NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
we PRP O
surveyed VBD O
32 CD O
head NN O
and CC O
neck NN O
cancer NN O
cell NN O
lines NNS O
for IN O
CSMD1 NNP O
promoter NN O
methylation NN O
using VBG O
the DT O
Combined NNP O
Bisulfite NNP O
Restriction NNP O
Analysis NNP O
( , O
COBRA NNP O
) -RRB- O
technique NN O
described VBN O
by IN O
Xiong NNP O
and CC O
Laird NNP O
( : O
Methods NNP O
) -RRB- O
[ -LRB- O
19 CD O
] -RRB- O
. . O

COBRA NNP O
analysis NN O
of IN O
the DT O
three CD O
amplicons NNS O
diagrammed VBN O
in IN O
Figure NNP O
1 CD O
suggested VBD O
that IN O
28 CD O
of IN O
the DT O
cell NN O
lines NNS O
( : O
87 CD O
% NN O
) -RRB- O
had VBD O
more JJR O
promoter NN O
methylation NN O
than IN O
did VBD O
normal JJ O
upper JJ O
aerodigestive JJ O
epithelium NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

We PRP O
selected VBD O
nine CD O
of IN O
these DT O
cell NN O
lines NNS O
for IN O
high JJ O
resolution NN O
analysis NN O
of IN O
promoter NN O
methylation NN O
by IN O
sequencing VBG O
of IN O
clones NNS O
from IN O
bisulfite NN O
converted VBN O
genomic JJ O
DNA NNP O
. . O

This DT O
approach NN O
has VBZ O
the DT O
distinct JJ O
advantage NN O
of IN O
allowing VBG O
determination NN O
of IN O
the DT O
state NN O
of IN O
all PDT O
the DT O
CpG NNP O
dinucleotides NNS O
within IN O
an DT O
amplicon NN O
on IN O
an DT O
allele NN O
by IN O
allele JJ O
basis NN O
. . O

Amplicons NNS O
1 CD O
and CC O
2 CD O
have VBP O
19 CD O
and CC O
20 CD O
CpG NN O
dinucleotides NNS O
, , O
respectively RB O
. . O

Amplicon NNP O
3 CD O
could MD O
not RB O
be VB O
examined VBN O
by IN O
this DT O
technique NN O
because IN O
it PRP O
is VBZ O
unclonable JJ O
after IN O
bisulfite NN O
conversion NN O
. . O

The DT O
methylation NN O
data NNS O
were VBD O
correlated VBN O
to IN O
CSMD1 NNP O
expression NN O
levels NNS O
as IN O
measured VBN O
by IN O
quantitative JJ O
RT NNP O
- HYPH O
PCR NN O
using VBG O
an DT O
amplicon NN O
spanning VBG O
exons NNS O
1 CD O
and CC O
2 CD O
( SYM O
Methods NNPS O
) -RRB- O
. . O

A DT O
pool NN O
of IN O
cDNA NNP O
from IN O
five CD O
normal JJ O
oropharyngeal JJ O
epithelium NN O
specimens NNS O
served VBD O
as IN O
a DT O
basis NN O
for IN O
comparison NN O
to IN O
the DT O
cell NN O
lines NNS O
. . O

Our PRP$ O
data NNS O
from IN O
amplicon NN O
1 CD O
demonstrate VBP O
a DT O
clear JJ O
relationship NN O
between IN O
methylation NN O
and CC O
the DT O
level NN O
of IN O
expression NN O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

The DT O
bisulfite NN O
sequencing NN O
data NNS O
confirm VBP O
that IN O
there EX O
is VBZ O
relatively RB O
little JJ O
promoter NN O
methylation NN O
in IN O
normal JJ O
tissue NN O
( , O
clones NNS O
1 CD O
- SYM O
20 CD O
, , O
Figure NNP O
2A NNP O
) -RRB- O
. . O

This DT O
is VBZ O
also RB O
the DT O
case NN O
in IN O
cell NN O
line NN O
UPCI NNP O
: : O
SCC066 NNP O
which WDT O
expresses VBZ O
a DT O
large JJ O
CSMD1 NNP O
transcript NN O
from IN O
the DT O
normal JJ O
promoter NN O
at IN O
a DT O
level NN O
approximately RB O
33 CD O
% NN O
of IN O
that DT O
of IN O
normal JJ O
tissue NN O
( , O
clones NNS O
32 CD O
- HYPH O
39 CD O
, , O
Figure NNP O
2B NNP O
) -RRB- O
. . O

PCI NNP O
- HYPH O
13 CD O
, , O
our PRP$ O
highest JJS O
expressing VBG O
line NN O
at IN O
125 CD O
% NN O
of IN O
normal JJ O
epithelium NN O
, , O
displays VBZ O
two CD O
distinct JJ O
patterns NNS O
of IN O
promoter NN O
methylation NN O
with IN O
some DT O
clones NNS O
heavily RB O
methylated VBN O
( , O
clones NNS O
21 CD O
- HYPH O
24 CD O
, , O
and CC O
30 CD O
) -RRB- O
and CC O
others NNS O
with IN O
no DT O
methylation NN O
( , O
clones NNS O
25 CD O
- HYPH O
39 CD O
and CC O
31 CD O
; : O
Figure NN O
2B NN O
) -RRB- O
. . O

This DT O
pattern NN O
is VBZ O
consistent JJ O
with IN O
either CC O
heterozygosity NN O
for IN O
methylation NN O
or CC O
the DT O
co NN O
- HYPH O
existence NN O
of IN O
2 CD O
distinct JJ O
populations NNS O
within IN O
the DT O
cell NN O
line NN O
, , O
one CD O
heavily RB O
methylated JJ O
and CC O
one CD O
unmethylated JJ O
. . O

We PRP O
cannot MD O
distinguish VB O
between IN O
these DT O
two CD O
possibilities NNS O
using VBG O
the DT O
currently RB O
available JJ O
data NNS O
. . O

The DT O
remaining VBG O
cell NN O
lines NNS O
express VBP O
CSMD1 NNP O
at IN O
a DT O
level NN O
half PDT O
that DT O
of IN O
UPCI NNP O
: : O
SCC066 NNP O
or CC O
less JJR O
( , O
ranging VBG O
from IN O
17 CD O
% NN O
to IN O
1 CD O
% NN O
of IN O
normal JJ O
epithelium NN O
) -RRB- O
and CC O
they PRP O
exhibit VBP O
considerably RB O
greater JJR O
methylation NN O
of IN O
amplicon NN O
1 CD O
( SYM O
clones NNS O
40 CD O
- HYPH O
76 CD O
, , O
Figure NNP O
2C NNP O
) -RRB- O
. . O

Cell NN O
lines NNS O
with IN O
more JJR O
amplicon NN O
1 CD O
methylation NN O
tend VBP O
to TO O
express VB O
the DT O
gene NN O
at IN O
lower JJR O
levels NNS O
but CC O
the DT O
relationship NN O
is VBZ O
not RB O
strictly RB O
quantitative JJ O
( : O
Figure NNP O
2C NNP O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
our PRP$ O
data NNS O
revealed VBD O
no DT O
relationship NN O
between IN O
expression NN O
level NN O
and CC O
methylation NN O
of IN O
amplicon NN O
2 CD O
( , O
located VBN O
towards IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
exon NN O
1 CD O
, , O
Figure NN O
1 CD O
) -RRB- O
. . O

For IN O
example NN O
, , O
all DT O
of IN O
the DT O
10 CD O
clones NNS O
of IN O
amplicon NN O
2 CD O
sequenced VBN O
from IN O
PCI NNP O
- HYPH O
13 CD O
were VBD O
methylated VBN O
at IN O
19 CD O
or CC O
20 CD O
of IN O
their PRP$ O
20 CD O
CpG NN O
dinucleotides NNS O
. . O

UPCI NNP O
: : O
SCC066 NNP O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
has VBZ O
nearly RB O
no DT O
methylation NN O
in IN O
amplicon NN O
2 CD O
with IN O
only RB O
a DT O
single JJ O
methylated JJ O
CpG NN O
dinucleotide NN O
detected VBN O
in IN O
one CD O
clone NN O
out IN O
of IN O
the DT O
nine CD O
sequenced VBN O
. . O

Amplicon NNP O
2 CD O
ranges VBZ O
from IN O
completely RB O
unmethylated JJ O
to IN O
heavily RB O
methylated VBN O
in IN O
the DT O
seven CD O
remaining VBG O
cell NN O
lines NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Low JJ O
transcript NN O
levels NNS O
are VBP O
accompanied VBN O
by IN O
a DT O
failure NN O
to TO O
elongate VB O
the DT O
full JJ O
CSMD1 NNP O
transcript NN O

On IN O
the DT O
surface NN O
, , O
the DT O
quantitative JJ O
RT NNP O
- HYPH O
PCR NNP O
data NNS O
presented VBN O
in IN O
Figure NN O
2 CD O
suggest VBP O
that IN O
the DT O
cell NN O
lines NNS O
we PRP O
consider VBP O
low JJ O
expressing VBG O
might MD O
still RB O
have VB O
up IN O
to TO O
17 CD O
% NN O
of IN O
the DT O
normal JJ O
level NN O
of IN O
CSMD1 NN O
transcript NN O
. . O

A DT O
survey NN O
of IN O
20 CD O
cell NN O
lines NNS O
using VBG O
a DT O
battery NN O
of IN O
RT NNP O
- HYPH O
PCR NNP O
primer NN O
pairs NNS O
located VBN O
throughout IN O
the DT O
11 CD O
. . O
5 CD O
kb NN O
transcript NN O
reveals VBZ O
that IN O
this DT O
is VBZ O
not RB O
the DT O
case NN O
. . O

These DT O
lines NNS O
included VBD O
OKF6 NNP O
- HYPH O
TERT1 NNP O
, , O
a DT O
TERT NNP O
immortalized VBN O
, , O
p16 NN O
deficient JJ O
but CC O
untransformed JJ O
oral JJ O
keratinocyte NN O
cell NN O
line NN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
low JJ O
expressing VBG O
cell NN O
lines NNS O
shown VBN O
in IN O
Figure NNP O
2C NNP O
express VB O
considerably RB O
more JJR O
of IN O
the DT O
5 CD O
' '' O
end NN O
of IN O
the DT O
11 CD O
. . O
5 CD O
kb NN O
transcript NN O
than IN O
they PRP O
do VBP O
exons VBZ O
further RB O
3 CD O
' '' O
, , O
a DT O
phenomenon NN O
well RB O
illustrated VBN O
by IN O
cell NN O
line NN O
PCI NNP O
- HYPH O
100 CD O
. . O

This DT O
line NN O
expresses VBZ O
the DT O
exon NN O
1 CD O
/ SYM O
exon NN O
2 CD O
amplicon NN O
at IN O
approximately RB O
15 CD O
% NN O
of IN O
the DT O
level NN O
of IN O
normal JJ O
epithelium NN O
. . O

In IN O
contrast NN O
, , O
we PRP O
had VBD O
previously RB O
reported VBN O
that IN O
CSMD1 NNP O
transcripts NNS O
were VBD O
not RB O
detectable JJ O
in IN O
this DT O
line NN O
by IN O
combined VBN O
RT NNP O
- HYPH O
PCR NN O
and CC O
Southern JJ O
blotting NN O
using VBG O
three CD O
sets NNS O
of IN O
intron NN O
spanning VBG O
primers NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
most RBS O
5 CD O
' '' O
of IN O
those DT O
amplicons NNS O
spans VBZ O
exons NNS O
9 CD O
through IN O
26 CD O
. . O

Analysis NN O
with IN O
additional JJ O
primer NN O
pairs NNS O
resolves VBZ O
this DT O
apparent JJ O
paradox NN O
by IN O
demonstrating VBG O
that IN O
the DT O
amount NN O
of IN O
transcript NN O
declines VBZ O
sharply RB O
and CC O
reproducibly RB O
as IN O
one CD O
examines VBZ O
progressively RB O
more JJR O
3 CD O
' '' O
exons NNS O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

The DT O
same JJ O
effect NN O
is VBZ O
seen VBN O
using VBG O
either CC O
oligo NN O
- HYPH O
dT NN O
or CC O
random JJ O
hexamer NN O
primed VBN O
cDNA NNP O
. . O

No DT O
transcript NN O
of IN O
this DT O
structure NN O
has VBZ O
been VBN O
detected VBN O
in IN O
normal JJ O
epithelium NN O
nor CC O
have VBP O
we PRP O
detected VBN O
any DT O
sequence NN O
alterations NNS O
in IN O
PCI NNP O
- : O
100 CD O
that WDT O
would MD O
explain VB O
why WRB O
the DT O
full JJ O
transcript NN O
is VBZ O
not RB O
expressed VBN O
. . O

It PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
PCI NNP O
- HYPH O
100 CD O
produces VBZ O
a DT O
small JJ O
number NN O
of IN O
discrete JJ O
size NN O
classes NNS O
of IN O
transcript NN O
, , O
if IN O
individual JJ O
transcripts NNS O
terminate VBP O
at IN O
random JJ O
points NNS O
within IN O
the DT O
very RB O
large JJ O
introns NNS O
in IN O
this DT O
part NN O
of IN O
the DT O
gene NN O
( , O
the DT O
first JJ O
10 CD O
introns NNS O
average JJ O
~ $ O
150 CD O
kb NN O
in IN O
length NN O
) -RRB- O
, , O
or CC O
if IN O
the DT O
short JJ O
transcripts NNS O
result VBP O
from IN O
the DT O
elevated JJ O
activity NN O
of IN O
a DT O
previously RB O
undetected JJ O
posttranscriptional JJ O
control NN O
mechanism NN O
. . O

Inactivation NN O
of IN O
CSMD1 NNP O
by IN O
aberrant JJ O
splicing NN O

Two CD O
cell NN O
lines NNS O
, , O
UPCI NNP O
: : O
SCC066 NNP O
and CC O
PCI NNP O
- HYPH O
13 CD O
, , O
express VBP O
large JJ O
CSMD1 NNP O
transcripts NNS O
initiated VBN O
at IN O
the DT O
normal JJ O
promoter NN O
. . O

Subsequent JJ O
finer NN O
scale NN O
analysis NN O
demonstrates VBZ O
that IN O
PCI NNP O
- HYPH O
13 CD O
' '' O
s NNS O
transcript NN O
lacks VBZ O
exons NNS O
4 CD O
and CC O
5 CD O
, , O
resulting VBG O
in IN O
a DT O
frameshift NN O
- HYPH O
induced VBN O
nonsense NN O
codon NN O
in IN O
exon NN O
6 CD O
( HYPH O
Figure NN O
4 CD O
) -RRB- O
. . O

Sequencing VBG O
of IN O
the DT O
PCI NNP O
- HYPH O
13 CD O
RT NNP O
- HYPH O
PCR NNP O
product NN O
demonstrates VBZ O
the DT O
direct JJ O
juxtaposition NN O
of IN O
wildtype JJ O
exons NNS O
3 CD O
and CC O
6 CD O
and CC O
that IN O
the DT O
transcript NN O
contains VBZ O
no DT O
novel JJ O
sequences NNS O
or CC O
splices NNS O
that WDT O
would MD O
prevent VB O
the DT O
frameshift NN O
. . O

UPCI NNP O
: : O
SCC066 NNP O
produces VBZ O
two CD O
transcripts NNS O
, , O
a DT O
normal JJ O
one NN O
that WDT O
includes VBZ O
exons NNS O
4 CD O
and CC O
5 CD O
and CC O
another DT O
that WDT O
lacks VBZ O
them PRP O
( -LRB- O
Figure NN O
4 CD O
) -RRB- O
. . O

RT NNP O
- HYPH O
PCR NN O
of IN O
human JJ B-Species
fetal JJ O
brain NN O
cDNA NN O
reveals VBZ O
very RB O
low JJ O
levels NNS O
of IN O
an DT O
RT NNP O
- HYPH O
PCR NNP O
product NN O
corresponding VBG O
in IN O
size NN O
to IN O
that DT O
expected VBN O
from IN O
the DT O
internally RB O
deleted VBN O
transcript NN O
. . O

This DT O
band NN O
is VBZ O
not RB O
readily RB O
visible JJ O
at IN O
the DT O
exposure NN O
used VBN O
for IN O
Figure NNP O
4A NNP O
. . O

We PRP O
have VBP O
not RB O
detected VBN O
a DT O
similar JJ O
sized JJ O
PCR NN O
product NN O
in IN O
RNA NNP O
from IN O
oropharyngeal JJ O
epithelium NN O
but CC O
this DT O
may MD O
reflect VB O
the DT O
fact NN O
that IN O
CSMD1 NNP O
transcripts NNS O
are VBP O
~ : O
10x CD O
less RBR O
abundant JJ O
in IN O
oropharyngeal JJ O
epithelium NN O
than IN O
they PRP O
are VBP O
in IN O
fetal JJ O
brain NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

The DT O
transcripts NNS O
lacking VBG O
exons NNS O
4 CD O
and CC O
5 CD O
appear VBP O
to TO O
result VB O
from IN O
aberrant JJ O
splicing NN O
rather RB O
than IN O
somatic JJ O
deletion NN O
of IN O
these DT O
two CD O
exons NNS O
or CC O
mutations NNS O
of IN O
their PRP$ O
splicing VBG O
consensus NN O
sequences NNS O
. . O

Exons NNP O
4 CD O
and CC O
5 CD O
can MD O
be VB O
amplified VBN O
from IN O
PCI NNP O
- HYPH O
13 CD O
genomic JJ O
DNA NN O
and CC O
sequencing NN O
of IN O
those DT O
PCR NNP O
products NNS O
demonstrates VBZ O
that IN O
both PDT O
their PRP$ O
coding VBG O
sequences NNS O
and CC O
consensus NN O
splice NN O
sites NNS O
are VBP O
wildtype JJ O
. . O

Activation NN O
of IN O
cryptic JJ O
promoters NNS O
in IN O
cancer NN O
cell NN O
lines NNS O

The DT O
RT NNP O
- HYPH O
PCR NNP O
survey NN O
revealed VBD O
a DT O
second JJ O
transcriptional JJ O
anomaly NN O
exhibited VBN O
by IN O
4 CD O
cell NN O
lines NNS O
: : O
SCC9 NNP O
, , O
41 CD O
, , O
PCI NNP O
- HYPH O
1 CD O
and CC O
PCI NNP O
- HYPH O
2 CD O
. . O

Like IN O
PCI NNP O
- HYPH O
100 CD O
, , O
these DT O
lines NNS O
express VBP O
low JJ O
levels NNS O
of IN O
the DT O
very RB O
5 CD O
' '' O
end NN O
of IN O
the DT O
transcript NN O
and CC O
even RB O
lower JJR O
levels NNS O
of IN O
more JJR O
3 CD O
' '' O
exons NNS O
within IN O
the DT O
first JJ O
half NN O
of IN O
the DT O
transcript NN O
. . O

However RB O
, , O
these DT O
lines NNS O
are VBP O
distinct JJ O
in IN O
expressing VBG O
higher JJR O
levels NNS O
of IN O
the DT O
3 CD O
' '' O
half NN O
of IN O
the DT O
transcript NN O
, , O
suggesting VBG O
that IN O
alternative JJ O
promoters NNS O
in IN O
the DT O
middle NN O
of IN O
the DT O
gene NN O
may MD O
be VB O
used VBN O
. . O

SCC9 NNP O
was VBD O
chosen VBN O
for IN O
further JJ O
study NN O
because IN O
it PRP O
expresses VBZ O
the DT O
3 CD O
' '' O
half NN O
of IN O
the DT O
transcript NN O
at IN O
a DT O
level NN O
dramatically RB O
higher JJR O
than IN O
normal JJ O
for IN O
oropharyngeal JJ O
epithelium NN O
. . O

Northern JJ O
blotting NN O
detects VBZ O
a DT O
comparatively RB O
abundant JJ O
6 CD O
. . O
4 CD O
kb NN O
truncated VBN O
transcript NN O
as RB O
well RB O
as IN O
smaller JJR O
amounts NNS O
of IN O
an DT O
8 CD O
. . O
7 CD O
kb NN O
transcript NN O
in IN O
SCC9 NNP O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

The DT O
other JJ O
three CD O
cell NN O
lines NNS O
express VBP O
their PRP$ O
truncated VBN O
CSMD1 NNP O
transcripts NNS O
at IN O
lower JJR O
levels NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Sequence NN O
analysis NN O
of IN O
CSMD1 NNP O
cDNA NNP O
clones NNS O
from IN O
SCC9 NNP O
demonstrates VBZ O
that IN O
many JJ O
transcripts NNS O
are VBP O
improperly RB O
spliced VBN O
, , O
resulting VBG O
in IN O
retention NN O
of IN O
intronic JJ O
sequences NNS O
and CC O
/ SYM O
or CC O
deletion NN O
of IN O
exonic JJ O
sequences NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

In IN O
particular JJ O
, , O
retention NN O
of IN O
sequences NNS O
from IN O
intron NN O
40 CD O
is VBZ O
common JJ O
. . O

The DT O
high JJ O
frequency NN O
of IN O
faulty JJ O
splicing NN O
may MD O
explain VB O
the DT O
broadness NN O
of IN O
the DT O
6 CD O
. . O
4 CD O
kb NN O
CSMD1 NN O
band NN O
in IN O
Figure NNP O
5A NN O
and CC O
suggests VBZ O
that IN O
the DT O
8 CD O
. . O
7 CD O
kb NN O
transcript NN O
may MD O
also RB O
be VB O
incompletely RB O
or CC O
improperly RB O
spliced VBN O
. . O

5 CD O
' '' O
RACE NN O
[ -LRB- O
21 CD O
] -RRB- O
reveals VBZ O
that IN O
the DT O
SCC9 NNP O
message NN O
is VBZ O
initiated VBN O
just RB O
upstream RB O
of IN O
an DT O
Alu NNP O
element NN O
in IN O
intron NN O
36 CD O
( -LRB- O
Figure NN O
5B NN O
) -RRB- O
. . O

Only RB O
the DT O
5 CD O
' '' O
- HYPH O
most RBS O
120 CD O
base NN O
pairs NNS O
of IN O
the DT O
Alu NNP O
element NN O
are VBP O
present JJ O
in IN O
the DT O
genome NN O
. . O

RT NNP O
- HYPH O
PCR NNP O
using VBG O
a DT O
forward JJ O
primer NN O
specific NN O
for IN O
the DT O
novel JJ O
sequences NNS O
of IN O
the DT O
SCC9 NNP O
transcript NN O
( , O
prm1904 CD O
, , O
cgtttagttcgacacacttc NNP O
) -RRB- O
demonstrates VBZ O
that IN O
cell NN O
lines NNS O
41 CD O
, , O
PCI NNP O
- HYPH O
1 CD O
and CC O
PCI NNP O
- HYPH O
2 CD O
do VBP O
not RB O
initiate VB O
their PRP$ O
CSMD1 NNP O
transcripts NNS O
at IN O
the DT O
same JJ O
point NN O
, , O
suggesting VBG O
that IN O
other JJ O
cryptic JJ O
promoters NNS O
are VBP O
active JJ O
in IN O
these DT O
lines NNS O
. . O

The DT O
sequence NN O
of IN O
this DT O
novel NN O
exon NN O
has VBZ O
been VBN O
entered VBN O
in IN O
Genbank NNP O
as IN O
accession NN O
number NN O
DQ093422 NN O
. . O

DNA NN O
methyltransferase NN O
inhibitors NNS O
activate VBP O
the DT O
same JJ O
cryptic JJ O
promoter NN O
used VBN O
in IN O
cell NN O
line NN O
SCC9 NNP O

Expression NN O
from IN O
epigenetically RB O
silenced VBN O
promoters NNS O
can MD O
sometimes RB O
be VB O
restored VBN O
by IN O
treatment NN O
with IN O
inhibitors NNS O
of IN O
DNA NN O
methyltransferase NN O
or CC O
histone NN O
deacetylase NN O
activity NN O
( : O
[ -LRB- O
22 CD O
] -RRB- O
) -RRB- O
. . O

We PRP O
selected VBD O
two CD O
low JJ O
expressing VBG O
cell NN O
lines NNS O
with IN O
promoter NN O
methylation NN O
, , O
UPCI NNP O
: : O
SCC104 NNP O
and CC O
94 CD O
, , O
for IN O
treatment NN O
with IN O
various JJ O
concentrations NNS O
of IN O
5 CD O
- HYPH O
azacytidine NN O
or CC O
5 CD O
- HYPH O
aza NN O
- HYPH O
2 CD O
' '' O
- HYPH O
deoxycytidine NN O
( -LRB- O
5 CD O
- HYPH O
aza NN O
- HYPH O
dC NNP O
) -RRB- O
as RB O
well RB O
as IN O
combinations NNS O
of IN O
either DT O
of IN O
those DT O
drugs NNS O
with IN O
the DT O
histone NN O
deacetylase NN O
inhibitor NN O
trichostatin NN O
A NN O
. . O

These DT O
treatments NNS O
did VBD O
not RB O
reactivate VB O
the DT O
silenced VBN O
CSMD1 NNP O
promoter NN O
. . O

COBRA NNP O
analysis NN O
of IN O
genomic JJ O
DNA NN O
from IN O
the DT O
treated VBN O
cells NNS O
suggested VBD O
that IN O
the DT O
drugs NNS O
did VBD O
not RB O
robustly RB O
affect VB O
methylation NN O
of IN O
the DT O
CSMD1 NNP O
promoter NN O
even RB O
at IN O
levels NNS O
high JJ O
enough RB O
to TO O
be VB O
toxic JJ O
to IN O
the DT O
cells NNS O
. . O

These DT O
experiments NNS O
did VBD O
however RB O
shed VB O
light NN O
on IN O
the DT O
cryptic JJ O
promoter NN O
used VBN O
in IN O
SCC9 NNP O
cells NNS O
and CC O
on IN O
the DT O
interpretation NN O
of IN O
experiments NNS O
using VBG O
methyltransferase NN O
inhibitors NNS O
. . O

Treatment NN O
of IN O
cell NN O
line NN O
94 CD O
with IN O
relatively RB O
high JJ O
doses NNS O
of IN O
5aza NNP O
- HYPH O
dC NN O
results VBZ O
in IN O
the DT O
expression NN O
of IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
the DT O
CSMD1 NNP O
transcript NN O
. . O

This DT O
transcript NN O
was VBD O
not RB O
detected VBN O
in IN O
control NN O
94 CD O
cells NNS O
undergoing VBG O
mock JJ O
drug NN O
treatment NN O
( -LRB- O
Figure NN O
6 CD O
) , O
nor CC O
was VBD O
it PRP O
detected VBN O
in IN O
94 CD O
cells NNS O
growing VBG O
under IN O
normal JJ O
culture NN O
conditions NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

RT NNP O
- HYPH O
PCR NNP O
of IN O
cDNA NNP O
from IN O
drug NN O
- HYPH O
treated VBN O
94 CD O
cells NNS O
using VBG O
the DT O
primer NN O
developed VBN O
from IN O
the DT O
novel NN O
5 CD O
' '' O
exon NN O
of IN O
SCC9 NNP O
' '' O
s NNS O
truncated VBN O
transcript NN O
( , O
prm1904 CD O
, , O
see VB O
above RB O
) -RRB- O
yielded VBD O
a DT O
product NN O
identical JJ O
in IN O
size NN O
to IN O
that DT O
amplified VBN O
from IN O
SCC9 NNP O
cDNA NNP O
( -LRB- O
Figure NN O
6 CD O
) -RRB- O
. . O

The DT O
identity NN O
of IN O
the DT O
product NN O
was VBD O
confirmed VBN O
by IN O
DNA NNP O
sequencing NN O
which WDT O
also RB O
revealed VBD O
that IN O
the DT O
drug NN O
- HYPH O
induced VBN O
94 CD O
transcript NN O
was VBD O
more RBR O
faithfully RB O
spliced VBN O
than IN O
the DT O
transcript NN O
expressed VBN O
in IN O
SCC9 NNP O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Discussion NN O

Our PRP$ O
data NNS O
clearly RB O
demonstrate VBP O
that IN O
expression NN O
of IN O
normal JJ O
CSMD1 NNP O
transcripts NNS O
is VBZ O
rare JJ O
in IN O
head NN O
and CC O
neck NN O
squamous JJ O
cell NN O
carcinoma NN O
cell NN O
lines NNS O
. . O

Of IN O
the DT O
HNSCC NNP O
cell NN O
lines NNS O
examined VBN O
, , O
only RB O
UPCI NNP O
: : O
SCC066 NNP O
appears VBZ O
to TO O
express VB O
a DT O
normal JJ O
transcript NN O
from IN O
the DT O
expected JJ O
promoter NN O
. . O

Even RB O
that DT O
cell NN O
line NN O
produces VBZ O
a DT O
second JJ O
species NN O
of IN O
aberrantly RB O
spliced VBN O
transcript NN O
lacking VBG O
internal JJ O
exons NNS O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
epigenetic JJ O
modification NN O
of IN O
the DT O
DNA NNP O
5 CD O
' '' O
of IN O
the DT O
transcription NN O
start NN O
site NN O
may MD O
contribute VB O
to IN O
the DT O
down NN O
- HYPH O
regulation NN O
of IN O
CSMD1 NNP O
. . O

In IN O
addition NN O
, , O
a DT O
low JJ O
level NN O
of IN O
expression NN O
appears VBZ O
to TO O
be VB O
associated VBN O
with IN O
production NN O
of IN O
prematurely RB O
terminated VBN O
transcripts NNS O
. . O

This DT O
degree NN O
of IN O
complexity NN O
might MD O
be VB O
expected VBN O
from IN O
a DT O
2 CD O
megabase NN O
, , O
70 CD O
exon NN O
gene NN O
. . O

Methylation NN O
of IN O
a DT O
specific JJ O
region NN O
of IN O
the DT O
CpG NNP O
island NN O
, , O
- HYPH O
395 CD O
to IN O
- HYPH O
112 CD O
bp NN O
relative JJ O
to IN O
the DT O
transcriptional JJ O
start NN O
site NN O
( , O
amplicon NN O
1 CD O
) -RRB- O
, , O
appears VBZ O
to TO O
be VB O
correlated VBN O
with IN O
the DT O
activity NN O
of IN O
the DT O
normal JJ O
CSMD1 NNP O
promoter NN O
. . O

In IN O
contrast NN O
, , O
methylation NN O
of IN O
amplicon NN O
2 CD O
, , O
located VBN O
within IN O
the DT O
first JJ O
exon NN O
, , O
shows VBZ O
no DT O
such JJ O
relationship NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
relationship NN O
between IN O
the DT O
amount NN O
of IN O
methylation NN O
in IN O
amplicon NN O
1 CD O
and CC O
the DT O
level NN O
of IN O
expression NN O
may MD O
not RB O
be VB O
strictly RB O
quantitative JJ O
. . O

Differences NNS O
between IN O
cell NN O
lines NNS O
with IN O
amplicon NN O
1 CD O
methylation NN O
could MD O
arise VB O
through IN O
a DT O
number NN O
of IN O
mechanisms NNS O
, , O
for IN O
example NN O
, , O
variations NNS O
in IN O
the DT O
levels NNS O
of IN O
transcription NN O
factors NNS O
between IN O
cell NN O
lines NNS O
. . O

In IN O
cases NNS O
where WRB O
there EX O
is VBZ O
considerable JJ O
heterogeneity NN O
in IN O
the DT O
methylation NN O
pattern NN O
within IN O
a DT O
cell NN O
line NN O
like IN O
PCI NNP O
- HYPH O
100 CD O
, , O
alleles NNS O
with IN O
less JJR O
methylation NN O
may MD O
be VB O
expressed VBN O
at IN O
higher JJR O
levels NNS O
than IN O
those DT O
more RBR O
heavily RB O
methylated JJ O
( , O
compare VBP O
clones NNS O
51 CD O
and CC O
52 CD O
to TO O
clone VB O
58 CD O
in IN O
Figure NNP O
2C NNP O
) -RRB- O
. . O

Alternatively RB O
, , O
the DT O
presence NN O
of IN O
methylation NN O
in IN O
amplicon NN O
1 CD O
could MD O
be VB O
a DT O
qualitative JJ O
but CC O
not RB O
strictly RB O
quantitative JJ O
indicator NN O
of IN O
methylation NN O
of IN O
a DT O
critical JJ O
segment NN O
of IN O
the DT O
promoter NN O
not RB O
discovered VBN O
in IN O
this DT O
study NN O
. . O

The DT O
normal JJ O
CSMD1 NNP O
promoter NN O
was VBD O
not RB O
reactivated VBN O
by IN O
drugs NNS O
that WDT O
inhibit VBP O
DNA NN O
methyltransferases NNS O
and CC O
histone NN O
deacetylases NNS O
, , O
nor CC O
did VBD O
the DT O
drugs NNS O
abolish VB O
CSMD1 NN O
promoter NN O
methylation NN O
, , O
even RB O
at IN O
toxic JJ O
doses NNS O
. . O

Not RB O
all DT O
genes NNS O
with IN O
promoter NN O
methylation NN O
respond VBP O
to IN O
such JJ O
treatments NNS O
[ -LRB- O
23 CD O
] -RRB- O
. . O

These DT O
drug NN O
treatments NNS O
did VBD O
, , O
however RB O
, , O
provide VB O
a DT O
potential JJ O
explanation NN O
for IN O
the DT O
use NN O
of IN O
a DT O
normally RB O
cryptic JJ O
promoter NN O
by IN O
cell NN O
line NN O
SCC9 NNP O
. . O

The DT O
CSMD1 NNP O
transcript NN O
in IN O
this DT O
line NN O
is VBZ O
initiated VBN O
near IN O
a DT O
partial JJ O
Alu NNP O
element NN O
. . O

5 LS O
- HYPH O
aza NNP O
- HYPH O
dC NNP O
treatment NN O
of IN O
cell NN O
line NN O
94 CD O
activates VBZ O
the DT O
same JJ O
cryptic JJ O
promoter NN O
. . O

This DT O
suggests VBZ O
that IN O
cryptic JJ O
promoters NNS O
may MD O
be VB O
naturally RB O
activated VBN O
by IN O
general JJ O
hypomethylation NN O
of IN O
the DT O
genome NN O
in IN O
cancer NN O
cells NNS O
and CC O
the DT O
subsequent JJ O
release NN O
of IN O
repetitive JJ O
elements NNS O
from IN O
epigenetic JJ O
repression NN O
( , O
reviewed VBN O
by IN O
Ehrlich NNP O
[ -LRB- O
17 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
SCC9 NNP O
transcript NN O
does VBZ O
not RB O
appear VB O
to TO O
encode VB O
a DT O
functional JJ O
protein NN O
but CC O
, , O
with IN O
a DT O
very RB O
large JJ O
gene NN O
like IN O
CSMD1 NNP O
, , O
there EX O
is VBZ O
a DT O
potential NN O
for IN O
some DT O
abnormally RB O
initiated VBN O
transcripts NNS O
to TO O
encode VB O
truncated VBN O
proteins NNS O
with IN O
dominant JJ O
negative JJ O
properties NNS O
. . O

The DT O
second JJ O
ramification NN O
of IN O
this DT O
finding NN O
is VBZ O
for IN O
the DT O
interpretation NN O
of IN O
data NNS O
obtained VBN O
by IN O
treating VBG O
cells NNS O
with IN O
methyltransferase NN O
inhibitors NNS O
. . O

Detection NN O
of IN O
CSMD1 NNP O
transcripts NNS O
solely RB O
with IN O
primers NNS O
mapping VBG O
to IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
the DT O
gene NN O
could MD O
have VB O
been VBN O
erroneously RB O
interpreted VBN O
as IN O
representing VBG O
reactivation NN O
of IN O
the DT O
normal JJ O
promoter NN O
. . O

It PRP O
seems VBZ O
imperative JJ O
that IN O
such JJ O
experiments NNS O
demonstrate VBP O
that IN O
transcripts NNS O
detected VBN O
after IN O
drug NN O
treatment NN O
are VBP O
actually RB O
initiated VBN O
at IN O
the DT O
normal JJ O
promoter NN O
. . O

Aberrant JJ O
splicing NN O
also RB O
appears VBZ O
to TO O
play VB O
a DT O
role NN O
in IN O
the DT O
production NN O
of IN O
defective JJ O
CSMD1 NNP O
transcripts NNS O
. . O

Loss NN O
of IN O
splicing VBG O
fidelity NN O
has VBZ O
been VBN O
proposed VBN O
as IN O
a DT O
characteristic NN O
of IN O
cancer NN O
cells NNS O
[ -LRB- O
24 CD O
, , O
25 CD O
] -RRB- O
and CC O
this DT O
would MD O
be VB O
consistent JJ O
with IN O
the DT O
variety NN O
of IN O
misspliced JJ O
transcripts NNS O
we PRP O
detected VBD O
from IN O
SCC9 NNP O
. . O

However RB O
, , O
the DT O
removal NN O
of IN O
exons NNS O
4 CD O
and CC O
5 CD O
from IN O
the DT O
CSMD1 NNP O
transcript NN O
in IN O
PCI NNP O
- HYPH O
13 CD O
may MD O
reflect VB O
a DT O
more RBR O
specific JJ O
phenomenon NN O
than IN O
a DT O
general JJ O
inability NN O
to TO O
splice VB O
large JJ O
introns NNS O
; : O
this DT O
line NN O
is VBZ O
still RB O
capable JJ O
of IN O
splicing VBG O
large JJ O
introns NNS O
as IN O
evidenced VBN O
by IN O
its PRP$ O
successful JJ O
splicing NN O
of IN O
exon NN O
3 CD O
to IN O
exon NN O
6 CD O
, , O
eliminating VBG O
an DT O
intron NN O
of IN O
over IN O
666 CD O
kb NN O
. . O

The DT O
failure NN O
to TO O
include VB O
exons NNS O
4 CD O
and CC O
5 CD O
may MD O
be VB O
due IN O
to IN O
inactivation NN O
of IN O
a DT O
splicing VBG O
enhancer NN O
in IN O
intron NN O
3 CD O
, , O
or CC O
to IN O
less RBR O
efficient JJ O
splicing NN O
due IN O
to IN O
the DT O
fact NN O
that IN O
exons NNS O
4 CD O
and CC O
5 CD O
do VBP O
not RB O
begin VB O
with IN O
the DT O
consensus NN O
G NN O
residue NN O
( -LRB- O
Figure NNP O
4B NNP O
) -RRB- O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Conclusion NN O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
CSMD1 NN O
function NN O
is VBZ O
lost VBN O
in IN O
head NN O
and CC O
neck NN O
squamous JJ O
cell NN O
carcinoma NN O
cell NN O
lines NNS O
through IN O
a DT O
variety NN O
of IN O
mechanisms NNS O
other JJ O
than IN O
point NN O
mutagenesis NN O
. . O

Epigenetic JJ O
modifications NNS O
of IN O
amplicon NN O
1 CD O
and CC O
defective JJ O
splicing NN O
appear VBP O
to TO O
be VB O
fruitful JJ O
areas NNS O
to TO O
explore VB O
in IN O
primary JJ O
head NN O
and CC O
neck NN O
squamous JJ O
cancers NNS O
. . O

Methods NNS O

Cell NN O
lines NNS O
and CC O
tissue NN O
samples NNS O

DNA NNP O
from IN O
HNSCC NNP O
cell NN O
lines NNS O
UMSCC9 NNP O
, , O
UMSCC35 NNP O
, , O
UMSCC37 NNP O
, , O
UMSCC38 NNP O
, , O
UMSCC45 NNP O
, , O
UMSCC49 NNP O
, , O
UMSCC65 NNP O
, , O
UMSCC68 NNP O
, , O
and CC O
UMSCC76 NNP O
was VBD O
provided VBN O
by IN O
Dr NNP O
. . O
Thomas NNP O
Carey NNP O
, , O
University NNP O
of IN O
Michigan NNP O
[ -LRB- O
27 CD O
] -RRB- O
. . O

Dr NNP O
. . O
Ruud NNP O
Brakenhoff NNP O
, , O
Vrije NNP O
Universitat NNP O
, , O
provided VBD O
cell NN O
lines NNS O
40 CD O
, , O
41 CD O
, , O
and CC O
94 CD O
[ -LRB- O
28 CD O
] -RRB- O
; : O
Dr NNP O
. . O
Theresa NNP O
Whiteside NNP O
, , O
University NNP O
of IN O
Pittsburgh NNP O
, , O
provided VBN O
cell NN O
lines NNS O
PCI NNP O
- HYPH O
1 CD O
, , O
PCI NNP O
- HYPH O
2 CD O
, , O
PCI NNP O
- HYPH O
4B NNP O
, , O
PCI NNP O
- HYPH O
13 CD O
, , O
PCI NNP O
- HYPH O
30 CD O
, , O
PCI NNP O
- HYPH O
50 CD O
, , O
PCI NNP O
- HYPH O
51 CD O
, , O
PCI NNP O
- HYPH O
52 CD O
, , O
PCI NNP O
- HYPH O
100 CD O
[ -LRB- O
29 CD O
] -RRB- O
, , O
SCC4 NNP O
, , O
SCC9 NNP O
[ -LRB- O
30 CD O
, , O
31 CD O
] -RRB- O
, , O
and CC O
UPCI NNP O
: : O
SCC068 NNP O
, , O
UPCI NNP O
: : O
SCC74 NNP O
, , O
UPCI NNP O
: : O
SCC104 NNP O
, , O
UPCI NNP O
: : O
SCC182 NNP O
, , O
UPCI NNP O
: : O
SCC203 NNP O
, , O
and CC O
UPCI NNP O
: : O
SCC220 NNP O
[ -LRB- O
developed VBN O
by IN O
Dr NNP O
. . O
Susanne NNP O
Gollin NNP O
, , O
University NNP O
of IN O
Pittsburgh NNP O
, , O
32 CD O
] -RRB- O
. . O

Dr NNP O
. . O
Gollin NNP O
provided VBD O
cell NN O
lines NNS O
UPCI NNP O
: : O
SCC056 NNP O
, , O
UPCI NNP O
: : O
SCC066 NNP O
, , O
and CC O
UPCI NNP O
: : O
SCC114 NNP O
[ -LRB- O
14 CD O
, , O
16 CD O
, , O
32 CD O
] -RRB- O
. . O

The DT O
immortal JJ O
but CC O
untransformed JJ O
keratinocyte NN O
line NN O
OKF6 NNP O
- HYPH O
TERT1 NNP O
was VBD O
obtained VBN O
from IN O
Dr NNP O
. . O
James NNP O
Rheinwald NNP O
, , O
Harvard NNP O
University NNP O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Normal JJ O
oropharyngeal JJ O
epithelium NN O
was VBD O
isolated VBN O
from IN O
discarded VBN O
tissue NN O
from IN O
uvulopalatopharyngop NN O
( , O
UPPP NNP O
) , O
collected VBN O
anonymously RB O
with IN O
the DT O
approval NN O
of IN O
the DT O
Washington NNP O
University NNP O
Human NNP B-Species
Studies NNPS O
Committee NNP O
. . O

Cell NN O
Culture NN O
and CC O
Tissue NN O
Preparation NN O

Squamous JJ O
cell NN O
carcinoma NN O
cell NN O
lines NNS O
were VBD O
grown VBN O
in IN O
DMEM NNP O
or CC O
DMEM NNP O
: : O
F NNP O
- HYPH O
12 CD O
, , O
1 CD O
: : O
1 CD O
Mixture NN O
( : O
BioWhittaker NNP O
) -RRB- O
containing VBG O
10 CD O
% NN O
fetal JJ O
bovine JJ B-Species
serum NN O
( , O
Sigma NNP O
) -RRB- O
. . O

DMEM NNP O
medium NN O
was VBD O
supplemented VBN O
with IN O
1X NNP O
MEM NNP O
Nonessential NNP O
Amino NNP O
Acids NNP O
( -LRB- O
BioWhittaker NNP O
) -RRB- O
. . O

Upper JJ O
aerodigestive JJ O
tract NN O
epithelium NN O
was VBD O
separated VBN O
from IN O
the DT O
rest NN O
of IN O
the DT O
UPPP NNP O
specimen NN O
by IN O
digestion NN O
with IN O
Dispase NNP O
II NNP O
( , O
Roche NNP O
) -RRB- O
using VBG O
a DT O
protocol NN O
adapted VBN O
from IN O
Oda NNP O
and CC O
Watson NNP O
[ -LRB- O
33 CD O
] -RRB- O
. . O

Nucleic JJ O
acid NN O
preparation NN O
and CC O
bisulfite NN O
conversion NN O

Genomic JJ O
DNA NNP O
was VBD O
isolated VBN O
by IN O
using VBG O
either CC O
Nucleospin NNP O
Tissue NNP O
kits NNS O
( , O
Clontech NNP O
) -RRB- O
, , O
QIAamp NNP O
DNA NNP O
Blood NNP O
Mini NNP O
kits NNS O
( , O
Qiagen NNP O
) -RRB- O
or CC O
Trizol NNP O
( , O
Invitrogen NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturers NNS O
' POS O
instructions NNS O
. . O

Total JJ O
RNA NNP O
isolation NN O
, , O
synthesis NN O
of IN O
first JJ O
strand NN O
cDNA NN O
, , O
RT NNP O
- HYPH O
PCR NN O
and CC O
5 CD O
' POS O
RACE NN O
PCR NN O
were VBD O
performed VBN O
essentially RB O
as IN O
previously RB O
described VBN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Poly NNP O
- HYPH O
A NN O
+ SYM O
RNA NN O
for IN O
Northern JJ O
blotting NN O
was VBD O
selected VBN O
from IN O
total JJ O
RNA NNP O
using VBG O
Oligotex NNP O
beads NNS O
( , O
Qiagen NNP O
) -RRB- O
. . O

Northern JJ O
blotting NN O
and CC O
hybridization NN O
were VBD O
performed VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

cDNA NNP O
synthesis NN O
was VBD O
primed VBN O
using VBG O
oligo JJ O
dT NN O
or CC O
random JJ O
primers NNS O
and CC O
extended VBN O
by IN O
either CC O
Thermoscript NNP O
or CC O
Superscript NNP O
III NNP O
reverse JJ O
transcriptase NN O
( : O
Invitrogen NNP O
) -RRB- O
. . O

PCR NNP O
was VBD O
run VBN O
in IN O
Perkin NNP O
- HYPH O
Elmer NNP O
480 CD O
or CC O
Applied NNP O
Biosystems NNP O
9700 CD O
thermal JJ O
cyclers NNS O
for IN O
35 CD O
cycles NNS O
unless IN O
otherwise RB O
noted VBN O
. . O

Images NNS O
of IN O
ethidium NN O
bromide NN O
stained VBN O
gels NNS O
were VBD O
captured VBN O
with IN O
a DT O
Gel NNP O
- HYPH O
Doc NNP O
imaging NN O
station NN O
( , O
Biorad NNP O
) -RRB- O
. . O

Quantitative JJ O
PCR NN O
was VBD O
run VBN O
in IN O
an DT O
Applied NNP O
Biosystems NNP O
5700 CD O
thermal JJ O
cycler NN O
using VBG O
SYBR NNP O
Green NNP O
Master NNP O
Mix NNP O
( , O
Applied NNP O
Biosystems NNPS O
) -RRB- O
. . O

Primers NNP O
prm2426 CD O
( SYM O
gtgtggagtatctgcagaca NNP O
) -RRB- O
and CC O
prm2427 CD O
( , O
ctggactaagcctccacagt NN O
) -RRB- O
were VBD O
used VBN O
to TO O
amplify VB O
a DT O
132 CD O
base NN O
segment NN O
spanning VBG O
CSMD1 NNP O
' POS O
s NNS O
first JJ O
and CC O
second JJ O
exons NNS O
. . O

An DT O
amplicon NN O
from IN O
human JJ B-Species
18S NNP O
RNA NNP O
was VBD O
used VBN O
as IN O
a DT O
basis NN O
for IN O
comparisons NNS O
across IN O
cell NN O
lines NNS O
( : O
primers NNS O
prm2396 CD O
, , O
ttcggaactgaggccatgat ADD O
and CC O
prm2397 NN O
, , O
tttcgctctggtccgtcttg ADD O
) -RRB- O
. . O

Calculations NNS O
were VBD O
performed VBN O
using VBG O
the DT O
Delta NNP O
Delta NNP O
Ct NNP O
method NN O
in IN O
GeneAmp NNP O
5700 CD O
SDS NNP O
software NN O
( : O
version NN O
1 CD O
. . O
3 CD O
) -RRB- O
and CC O
Microsoft NNP O
Excel NNP O
. . O

Quantitation NN O
was VBD O
based VBN O
on IN O
the DT O
average JJ O
values NNS O
obtained VBN O
from IN O
duplicate JJ O
reactions NNS O
. . O

The DT O
level NN O
of IN O
CSMD1 NN O
expression NN O
in IN O
normal JJ O
oropharyngeal JJ O
epithelium NN O
was VBD O
determined VBN O
from IN O
pooled VBN O
cDNA NN O
from IN O
five CD O
UPPP NNP O
specimens NNS O
. . O

We PRP O
used VBD O
the DT O
CpGenome NNP O
DNA NNP O
Modification NNP O
kit NN O
( -LRB- O
Intergen NNP O
) -RRB- O
for IN O
bisulfite NN O
conversion NN O
of IN O
the DT O
genomic JJ O
DNA NN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
, , O
with IN O
the DT O
following VBG O
exception NN O
. . O

Incubation NN O
of IN O
the DT O
conversion NN O
reaction NN O
was VBD O
carried VBN O
out RP O
in IN O
a DT O
thermal JJ O
cycler NN O
for IN O
six CD O
cycles NNS O
each DT O
consisting VBG O
of IN O
three CD O
minutes NNS O
at IN O
94 CD O
degrees NNS O
C NN O
followed VBN O
by IN O
three CD O
hours NNS O
at IN O
50 CD O
degrees NNS O
C NNP O
( , O
Christina NNP O
Menke NNP O
and CC O
Paul NNP O
Goodfellow NNP O
, , O
personal JJ O
communication NN O
) -RRB- O
. . O

Analysis NN O
of IN O
CSMD1 NNP O
Promoter NNP O
Methylation NNP O

Methylation NN O
of IN O
three CD O
segments NNS O
of IN O
the DT O
CSMD1 NNP O
CpG NNP O
island NN O
was VBD O
examined VBN O
using VBG O
the DT O
Combined NNP O
Bisulfite NNP O
Restriction NNP O
Analysis NNP O
technique NN O
( , O
COBRA NNP O
) -RRB- O
[ -LRB- O
19 CD O
] -RRB- O
. . O

All DT O
three CD O
segments NNS O
were VBD O
amplified VBN O
by IN O
using VBG O
the DT O
nested VBN O
primers NNS O
and CC O
PCR NN O
conditions NNS O
listed VBN O
in IN O
Table NNP O
1 CD O
. . O

Amplicon NNP O
1 CD O
extends VBZ O
from IN O
- HYPH O
395 CD O
to IN O
- HYPH O
112 CD O
bp NN O
, , O
amplicon NN O
2 CD O
from IN O
+ SYM O
175 CD O
to IN O
+ NN O
396 CD O
bp NN O
, , O
and CC O
amplicon NN O
3 CD O
from IN O
+ SYM O
398 CD O
to IN O
+ $ O
718 CD O
bp NN O
relative JJ O
to IN O
the DT O
first JJ O
base NN O
of IN O
the DT O
transcript NN O
. . O

A DT O
small JJ O
region NN O
surrounding VBG O
the DT O
transcription NN O
start NN O
site NN O
( : O
- : O
111 CD O
to TO O
+ SYM O
174 CD O
bp NN O
) -RRB- O
could MD O
not RB O
be VB O
examined VBN O
because IN O
no DT O
PCR NN O
primers NNS O
could MD O
be VB O
designed VBN O
from IN O
its PRP$ O
extremely RB O
GC JJ O
- HYPH O
rich JJ O
sequence NN O
. . O

The DT O
first JJ O
round NN O
PCR NNP O
used VBD O
2 CD O
mu NN O
l NN O
of IN O
bisulfite NN O
converted VBN O
genomic JJ O
DNA NN O
in IN O
a DT O
final JJ O
volume NN O
of IN O
10 CD O
mu NNS O
l -RRB- O
. . O

Subsequent JJ O
amplifications NNS O
with IN O
nested VBN O
primers NNS O
used VBD O
4 CD O
mu NNS O
l NN O
of IN O
first JJ O
round NN O
product NN O
as IN O
template NN O
in IN O
reactions NNS O
with IN O
a DT O
final JJ O
volume NN O
of IN O
20 CD O
mu NNS O
l -RRB- O
. . O

All DT O
PCR NNP O
was VBD O
carried VBN O
out RP O
for IN O
35 CD O
cycles NNS O
. . O

A DT O
portion NN O
of IN O
the DT O
second JJ O
round NN O
PCR NNP O
product NN O
was VBD O
run VBN O
on IN O
a DT O
1 CD O
. . O
5 CD O
% NN O
agarose NN O
gel NN O
, , O
stained VBN O
with IN O
ethidium NN O
bromide NN O
, , O
and CC O
quantified VBN O
using VBG O
the DT O
ImageQuant NNP O
software NN O
package NN O
( , O
v1 NN O
. . O
2 CD O
for IN O
Macintosh NNP O
, , O
Molecular NNP O
Dynamics NNPS O
) -RRB- O
so IN O
that IN O
equal JJ O
amounts NNS O
of IN O
each DT O
could MD O
be VB O
used VBN O
in IN O
restriction NN O
digests NNS O
. . O

Restriction NN O
digests NNS O
for IN O
COBRA NNP O
were VBD O
performed VBN O
with IN O
either CC O
BstU NNP O
I NNP O
or CC O
Taq NNP O
alpha NNP O
I NNP O
( , O
5 CD O
or CC O
10 CD O
units NNS O
per IN O
reaction NN O
, , O
respectively RB O
; : O
New NNP O
England NNP O
Biolabs NNP O
) -RRB- O
for IN O
4 CD O
hours NNS O
in IN O
a DT O
final JJ O
volume NN O
of IN O
10 CD O
mu NNS O
l NN O
. . O

Taq NNP O
alpha NN O
I PRP O
digests VBZ O
were VBD O
performed VBN O
only RB O
when WRB O
no DT O
methylation NN O
was VBD O
detected VBN O
with IN O
BstU NNP O
I NNP O
. . O

BstU NNP O
I PRP O
digests VBZ O
also RB O
included VBD O
an DT O
internal JJ O
control NN O
DNA NN O
fragment NN O
to TO O
confirm VB O
complete JJ O
digestion NN O
. . O

This DT O
DNA NNP O
fragment NN O
contains VBZ O
a DT O
single JJ O
BstU NNP O
I NNP O
site NN O
and CC O
was VBD O
amplified VBN O
from IN O
a DT O
cloned VBN O
CSMD1 NN O
cDNA NN O
using VBG O
primers NNS O
prm2020 NN O
( -LRB- O
agatcccccagtgtctccct NN O
) -RRB- O
and CC O
prm2021 NN O
( , O
actgctggtgccgtggtaat NN O
) -RRB- O
. . O

The DT O
control NN O
PCR NNP O
product NN O
is VBZ O
1019 CD O
bp NN O
long JJ O
and CC O
is VBZ O
digested VBN O
to IN O
two CD O
fragments NNS O
of IN O
605 CD O
and CC O
414 CD O
bp NN O
by IN O
BstU NNP O
I NNP O
. . O

Digestion NN O
products NNS O
were VBD O
fractionated VBN O
on IN O
a DT O
10 CD O
% NN O
polyacrylamide NN O
gel NN O
, , O
stained VBN O
with IN O
ethidium NN O
bromide NN O
, , O
and CC O
visualized VBN O
with IN O
a DT O
Gel NNP O
- HYPH O
Doc NNP O
video NN O
imaging NN O
workstation NN O
( -LRB- O
Bio NNP O
- HYPH O
Rad NNP O
) -RRB- O
. . O

High JJ O
resolution NN O
analysis NN O
of IN O
methylation NN O
was VBD O
performed VBN O
by IN O
sequence NN O
analysis NN O
of IN O
individual JJ O
clones NNS O
from IN O
amplicons NNS O
1 CD O
and CC O
2 CD O
. . O

DNA NN O
from IN O
amplicon NN O
3 CD O
proved VBD O
unclonable JJ O
and CC O
gel NN O
electrophoresis NN O
suggests VBZ O
that IN O
its PRP$ O
very JJ O
AT NN O
rich JJ O
sequence NN O
results VBZ O
in IN O
a DT O
bent JJ O
DNA NN O
configuration NN O
. . O

PCR NNP O
products NNS O
were VBD O
purified VBN O
using VBG O
the DT O
Nucleospin NNP O
Extraction NNP O
columns NNS O
( , O
Clontech NNP O
) -RRB- O
and CC O
inserted VBN O
into IN O
the DT O
pCR2 NN O
. . O
1 CD O
- HYPH O
TOPO NNP O
vector NN O
using VBG O
the DT O
TOPO NNP O
TA NNP O
Cloning NNP O
kit NN O
( : O
Invitrogen NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

Plasmid NNP O
DNA NN O
from IN O
individual JJ O
colonies NNS O
was VBD O
isolated VBN O
using VBG O
the DT O
Nucleospin NNP O
Plus NNP O
Plasmid NNP O
Miniprep NNP O
kit NN O
( , O
Clontech NNP O
) -RRB- O
and CC O
sequenced VBN O
with IN O
a DT O
reverse JJ O
vector NN O
primer NN O
( -LRB- O
agcggataacaatttcacac NN O
) -RRB- O
using VBG O
fluorescence NN O
based VBN O
sequencing NN O
with IN O
Big NNP O
Dye NNP O
Terminator NNP O
mix NN O
( , O
Applied NNP O
Biosystems NNPS O
) -RRB- O
. . O

Treatment NN O
of IN O
cultured VBN O
cells NNS O
with IN O
DNA NNP O
methyltransferase NN O
inhibitors NNS O

Cell NN O
line NN O
94 CD O
was VBD O
treated VBN O
with IN O
5 CD O
- HYPH O
aza NN O
- HYPH O
2 CD O
' '' O
- HYPH O
deoxycytidine NN O
( HYPH O
5aza NNP O
- HYPH O
dC NNP O
) -RRB- O
( , O
Sigma NNP O
) -RRB- O
dissolved VBN O
in IN O
DMSO NNP O
. . O

Two CD O
100 CD O
mm NN O
cell NN O
culture NN O
dishes NNS O
containing VBG O
5 CD O
x SYM O
105 CD O
cells NNS O
were VBD O
established VBN O
for IN O
each DT O
of IN O
the DT O
drug NN O
concentrations NNS O
tested VBN O
. . O

Cells NNS O
were VBD O
grown VBN O
for IN O
72 CD O
hours NNS O
in IN O
media NNS O
containing VBG O
DMEM NNP O
: : O
F NNP O
- HYPH O
12 CD O
, , O
1 CD O
: : O
1 CD O
Mixture NNP O
( -LRB- O
BioWhittaker NNP O
) -RRB- O
with IN O
1X NNP O
MEM NNP O
Nonessential NNP O
Amino NNP O
Acids NNPS O
( -LRB- O
BioWhittaker NNP O
) -RRB- O
and CC O
10 CD O
% NN O
fetal JJ O
bovine JJ B-Species
serum NN O
and CC O
then RB O
switched VBN O
to IN O
media NNS O
containing VBG O
5aza NNP O
- HYPH O
dC NNP O
at IN O
concentrations NNS O
of IN O
0 CD O
mu NNS O
m NN O
, , O
5 CD O
mu NNS O
M NNP O
, , O
25 CD O
mu NNS O
M NNP O
, , O
or CC O
100 CD O
mu NNS O
M NN O
. . O

Cells NNS O
were VBD O
fed VBN O
daily RB O
for IN O
4 CD O
- SYM O
5 CD O
days NNS O
and CC O
then RB O
both DT O
plates NNS O
were VBD O
harvested VBN O
in IN O
3 CD O
ml NNS O
of IN O
Trizol NNP O
( , O
Invitrogen NNP O
) -RRB- O
for IN O
isolation NN O
of IN O
RNA NN O
and CC O
DNA NN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

RT NNP O
- HYPH O
PCR NNP O
used VBN O
for IN O
detection NN O
of IN O
CSMD1 NNP O
transcripts NNS O
in IN O
these DT O
treated VBN O
cells NNS O
was VBD O
run VBN O
for IN O
40 CD O
cycles NNS O
. . O

Abbreviations NNS O

5aza NNP O
- HYPH O
dC NN O
= : O
5 CD O
- HYPH O
aza NN O
- HYPH O
2 CD O
' '' O
deoxycytidine NN O
, , O
COBRA NN O
= , O
Combined VBN O
Bisulfite NNP O
Restriction NNP O
Analysis NNP O
, , O
CSMD1 NN O
= : O
Cub NN O
and CC O
sushi NN O
multiple JJ O
domains NNS O
1 CD O
, , O
HNSCC NNP O
= SYM O
head NN O
& CC O
neck NN O
squamous JJ O
cell NN O
carcinoma NN O
, , O
RT NN O
- HYPH O
PCR NN O
= : O
reverse JJ O
transcription NN O
- HYPH O
polymerase NN O
chain NN O
reaction NN O
, , O
SCC NNP O
= , O
squamous JJ O
cell NN O
carcinoma NN O
, , O
UPPP NNP O
= SYM O
uvulopalatopharyngop NN O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O

Authors NNS O
' POS O
contributions NNS O

TMR NNP O
performed VBD O
the DT O
DNA NN O
methylation NN O
analysis NN O
, , O
and CC O
parts NNS O
of IN O
the DT O
transcript NN O
survey NN O
. . O

BDT NNP O
cloned VBD O
and CC O
characterized VBD O
the DT O
novel JJ O
first JJ O
exon NN O
expressed VBN O
in IN O
cell NN O
line NN O
SCC9 NNP O
. . O

SBS NNP O
performed VBD O
parts NNS O
of IN O
the DT O
transcript NN O
survey NN O
and CC O
characterized VBD O
the DT O
deletion NN O
of IN O
exons NNS O
4 CD O
and CC O
5 CD O
in IN O
PCI NNP O
- HYPH O
13 CD O
. . O

All DT O
three CD O
authors NNS O
participated VBD O
in IN O
the DT O
analysis NN O
of IN O
the DT O
data NNS O
and CC O
in IN O
the DT O
writing NN O
of IN O
the DT O
manuscript NN O
. . O

Plasma NN O
D NN O
- HYPH O
dimer NN O
concentration NN O
in IN O
patients NNS B-Species
with IN O
systemic JJ O
sclerosis NN O

Abstract JJ O

Background NN O

Systemic JJ O
sclerosis NN O
( : O
SSc NNP O
) -RRB- O
is VBZ O
an DT O
autoimmune JJ O
disorder NN O
of IN O
the DT O
connective JJ O
tissue NN O
characterized VBN O
by IN O
widespread JJ O
vascular JJ O
lesions NNS O
and CC O
fibrosis NN O
. . O

Little RB O
is VBZ O
known VBN O
so RB O
far RB O
on IN O
the DT O
activation NN O
of IN O
the DT O
hemostatic JJ O
and CC O
fibrinolytic JJ O
systems NNS O
in IN O
SSc NNP O
, , O
and CC O
most JJS O
preliminary JJ O
evidences NNS O
are VBP O
discordant JJ O
. . O

Methods NNS O

To TO O
verify VB O
whether IN O
SSc NNP O
patients NNS B-Species
might MD O
display VB O
a DT O
prothrombotic JJ O
condition NN O
, , O
plasma NN O
D NN O
- HYPH O
dimer NN O
was VBD O
assessed VBN O
in IN O
28 CD O
consecutive JJ O
SSc NNP O
patients NNS B-Species
and CC O
in IN O
33 CD O
control NN O
subjects NNS O
, , O
matched VBN O
for IN O
age NN O
, , O
sex NN O
and CC O
environmental JJ O
habit NN O
. . O

Results NNS O
and CC O
discussion NN O

When WRB O
compared VBN O
to IN O
healthy JJ O
controls NNS O
, , O
geometric JJ O
mean NN O
and CC O
95 CD O
% NN O
confidence NN O
interval JJ O
( , O
IC95 CD O
% NN O
) -RRB- O
of IN O
plasma NN O
D NN O
- HYPH O
dimer NN O
were VBD O
significantly RB O
increased VBN O
in IN O
SSc NNP O
patients NNS B-Species
( , O
362 CD O
ng CD O
/ SYM O
mL NNP O
, , O
IC NN O
95 CD O
% NN O
: : O
361 CD O
- SYM O
363 CD O
ng CD O
/ SYM O
mL NN O
vs IN O
229 CD O
ng CD O
/ SYM O
mL NN O
, , O
IC95 CD O
% NN O
: : O
228 CD O
- SYM O
231 CD O
ng CD O
/ SYM O
mL NN O
, , O
p NN O
= SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

After IN O
stratifying VBG O
SSc NNP O
patients NNS B-Species
according VBG O
to IN O
disease NN O
subset NN O
, , O
no DT O
significant JJ O
differences NNS O
were VBD O
observed VBN O
between IN O
those DT O
with IN O
limited JJ O
cutaneous JJ O
pattern NN O
and CC O
controls NNS O
, , O
whereas IN O
patients NNS B-Species
with IN O
diffuse JJ O
cutaneous JJ O
pattern NN O
displayed VBD O
substantially RB O
increased VBN O
values NNS O
. . O

No DT O
correlation NN O
was VBD O
found VBN O
between IN O
plasma NN O
D NN O
- HYPH O
dimer NN O
concentration NN O
and CC O
age NN O
, , O
sex NN O
, , O
autoantibody NN O
pattern NN O
, , O
serum NN O
creatinine NN O
, , O
erythrosedimentation NN O
rate NN O
, , O
nailfold NN O
videocapillaroscopic JJ O
pattern NN O
and CC O
pulmonary JJ O
involvement NN O
. . O

Conclusion NN O

We PRP O
demonstrated VBD O
that IN O
SSc NNP O
patients NNS B-Species
with IN O
diffuse JJ O
subset NN O
are VBP O
characterized VBN O
by IN O
increased VBN O
plasma NN O
D NN O
- HYPH O
dimer NN O
values NNS O
, , O
reflecting VBG O
a DT O
potential JJ O
activation NN O
of IN O
both CC O
the DT O
hemostatic JJ O
and CC O
fibrinolytic JJ O
cascades NNS O
, , O
which WDT O
might MD O
finally RB O
predispose VB O
these DT O
patients NNS B-Species
to IN O
thrombotic JJ O
complications NNS O
. . O

Background NN O

Systemic JJ O
sclerosis NN O
( : O
SSc NNP O
) -RRB- O
is VBZ O
an DT O
autoimmune JJ O
disorder NN O
of IN O
the DT O
connective JJ O
tissue NN O
characterized VBN O
by IN O
widespread JJ O
vascular JJ O
lesions NNS O
and CC O
fibrosis NN O
. . O

In IN O
SSc NNP O
, , O
vasospasm NN O
causes VBZ O
frequent JJ O
episodes NNS O
of IN O
reperfusion NN O
injury NN O
and CC O
free JJ O
radical JJ O
- HYPH O
mediated VBN O
endothelial JJ O
dysfunction NN O
, , O
which WDT O
might MD O
finally RB O
influence VB O
the DT O
onset NN O
of IN O
local JJ O
thrombotic JJ O
complications NNS O
. . O

The DT O
characteristic JJ O
vascular JJ O
involvement NN O
affects VBZ O
primarily RB O
small JJ O
arteries NNS O
and CC O
capillaries NNS O
, , O
causing VBG O
reduced VBN O
blood NN O
flow NN O
and CC O
tissue NN O
ischemia NN O
and CC O
supporting VBG O
the DT O
typical JJ O
clinical JJ O
manifestations NNS O
of IN O
this DT O
unique JJ O
autoimmune JJ O
disorder NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

However RB O
, , O
mechanisms NNS O
involved VBN O
in IN O
the DT O
endothelial JJ O
injury NN O
are VBP O
as RB O
yet RB O
elusive JJ O
and CC O
most JJS O
biochemical JJ O
evidences NNS O
are VBP O
often RB O
inconclusive JJ O
or CC O
controversial JJ O
. . O

Some DT O
earlier JJR O
investigations NNS O
suggested VBD O
that IN O
SSc NNP O
patients NNS B-Species
might MD O
be VB O
characterized VBN O
by IN O
a DT O
procoagulant JJ O
state NN O
, , O
reporting VBG O
depressed VBN O
basal JJ O
and CC O
stimulated JJ O
fibrinolytic JJ O
activity NN O
, , O
while IN O
others NNS O
studies NNS O
have VBP O
reported VBN O
normal JJ O
plasma NN O
fibrinolytic JJ O
activity NN O
and CC O
normal JJ O
skin NN O
and CC O
plasma NN O
tissue NN O
plasminogen NN O
activator NN O
( -LRB- O
tPA NNP O
) -RRB- O
levels NNS O
[ -LRB- O
2 CD O
- SYM O
4 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
also RB O
reported VBN O
that IN O
the DT O
lack NN O
of IN O
a DT O
consistent JJ O
and CC O
homogenous JJ O
increase NN O
of IN O
some DT O
fibrinolytic JJ O
markers NNS O
, , O
in IN O
the DT O
presence NN O
of IN O
normal JJ O
levels NNS O
of IN O
antithrombin NN O
, , O
might MD O
indirectly RB O
highlight VB O
an DT O
impairment NN O
of IN O
the DT O
heparan NN O
sulphate NN O
- HYPH O
antithrombin NN O
system NN O
, , O
which WDT O
would MD O
finally RB O
promote VB O
thrombin NN O
generation NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Conversely RB O
, , O
Cerinic NNP O
and CC O
colleagues NNS O
provided VBD O
evidence NN O
that IN O
fibrinolysis NN O
might MD O
be VB O
impaired VBN O
in IN O
SSc NNP O
, , O
as IN O
shown VBN O
by IN O
reduced VBN O
D NN O
- HYPH O
dimer NN O
and CC O
decreased VBN O
levels NNS O
of IN O
plasminogen NN O
activator NN O
inhibitor NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

In IN O
synthesis NN O
, , O
there EX O
are VBP O
no DT O
conclusive JJ O
evidences NNS O
on IN O
the DT O
activity NN O
of IN O
the DT O
hemostatic JJ O
and CC O
fibrinolytic JJ O
pathways NNS O
in IN O
SSc NNP O
so RB O
far RB O
. . O

D NNP O
- HYPH O
dimer NNP O
, , O
a DT O
breakdown NN O
product NN O
of IN O
cross NN O
- HYPH O
linked VBN O
fibrin NN O
, , O
was VBD O
proven VBN O
useful JJ O
for IN O
the DT O
diagnostic JJ O
evaluation NN O
of IN O
several JJ O
thrombotic JJ O
disorders NNS O
. . O

Moreover RB O
, , O
an DT O
increased JJ O
D NN O
- HYPH O
dimer NN O
value NN O
in IN O
plasma NN O
is VBZ O
a DT O
reliable JJ O
marker NN O
of IN O
a DT O
systemic JJ O
prothrombotic JJ O
state NN O
, , O
likely RB O
superior JJ O
to IN O
alternative JJ O
fibrinolytic NN O
markers NNS O
, , O
and CC O
its PRP$ O
measurement NN O
might MD O
be VB O
helpful JJ O
in IN O
predicting VBG O
or CC O
preventing VBG O
thrombotic JJ O
events NNS O
in IN O
the DT O
single JJ O
patient NN B-Species
[ -LRB- O
5 CD O
] -RRB- O
. . O

Therefore RB O
, , O
to TO O
investigate VB O
whether IN O
SSc NNP O
patients NNS B-Species
might MD O
be VB O
characterized VBN O
by IN O
a DT O
potential JJ O
prothrombotic JJ O
condition NN O
, , O
plasma NN O
D NN O
- HYPH O
dimer NN O
vales NNS O
were VBD O
measured VBN O
in IN O
a DT O
subset NN O
of IN O
SSc NNP O
patients NNS B-Species
, , O
compared VBN O
with IN O
those DT O
of IN O
a DT O
healthy JJ O
matched VBN O
control NN O
population NN O
and CC O
further RB O
associated VBN O
with IN O
SSc NNP O
disease NN O
subset NN O
. . O

Methods NNS O

Plasma NN O
D NN O
- HYPH O
dimer NN O
was VBD O
measured VBN O
in IN O
28 CD O
consecutive JJ O
SSc NNP O
patients NNS B-Species
( , O
2 CD O
males NNS O
and CC O
26 CD O
females NNS O
; : O
mean JJ O
age NN O
50 CD O
+ SYM O
/ SYM O
- HYPH O
15 CD O
years NNS O
, , O
17 CD O
with IN O
limited JJ O
and CC O
11 CD O
with IN O
diffuse JJ O
disease NN O
patterns NNS O
) -RRB- O
, , O
who WP O
fulfilled VBD O
the DT O
American NNP O
Rheumatism NNP O
Association NNP O
' POS O
s POS O
criteria NNS O
for IN O
the DT O
diagnosis NN O
of IN O
SSc NNP O
[ -LRB- O
6 CD O
] -RRB- O
and CC O
in IN O
33 CD O
control NN O
subjects NNS O
, , O
matched VBN O
for IN O
age NN O
( , O
48 CD O
+ CD O
/ SYM O
- SYM O
13 CD O
years NNS O
) -RRB- O
, , O
sex NN O
( , O
3 CD O
males NNS O
, , O
30 CD O
females NNS O
) , O
and CC O
environmental JJ O
habit NN O
, , O
recruited VBN O
among IN O
healthy JJ O
hospital NN O
personnel NNS O
. . O

Samples NNS O
were VBD O
collected VBN O
in IN O
the DT O
morning NN O
; : O
all DT O
subjects NNS O
were VBD O
in IN O
a DT O
fasted VBN O
state NN O
. . O

The DT O
research NN O
was VBD O
carried VBN O
out RP O
according VBG O
to IN O
the DT O
principles NNS O
of IN O
the DT O
Declaration NNP O
of IN O
Helsinki NNP O
and CC O
an DT O
informed JJ O
consent NN O
for IN O
testing NN O
was VBD O
received VBN O
from IN O
all DT O
individuals NNS O
recruited VBN O
to IN O
the DT O
study NN O
. . O

Blood NN O
was VBD O
collected VBN O
after IN O
an DT O
overnight RB O
fast RB O
into IN O
siliconized JJ O
vacuum NN O
tubes NNS O
, , O
containing VBG O
0 CD O
. . O
105 CD O
mol NN O
/ SYM O
l NN O
sodium NN O
citrate NN O
( , O
Becton NNP O
- HYPH O
Dickinson NNP O
, , O
Oxford NNP O
, , O
UK NNP O
) -RRB- O
. . O

Samples NNS O
were VBD O
gently RB O
mixed JJ O
and CC O
centrifuged VBN O
for IN O
10 CD O
min NN O
at IN O
15 CD O
degrees NNS O
C NN O
at IN O
1500 CD O
x NN O
g NN O
; : O
plasma NN O
was VBD O
separated VBN O
and CC O
stored VBN O
in IN O
aliquots NNS O
at IN O
- SYM O
70 CD O
degrees NNS O
C NN O
until IN O
measurement NN O
. . O

Plasma NNP O
D NN O
- HYPH O
dimer NN O
was VBD O
measured VBN O
employing VBG O
Vidas NNP O
DD NNP O
, , O
a DT O
rapid JJ O
and CC O
quantitative JJ O
automated JJ O
enzyme NN O
linked VBN O
immunosorbent JJ O
assay NN O
with IN O
fluorescent JJ O
detection NN O
, , O
on IN O
the DT O
Mini NNP O
Vidas NNP O
immunoanalyzer NN O
( , O
bioMerieux NN O
, , O
Marcy NNP O
l FW O
' '' O
Etoile NNP O
, , O
France NNP O
) -RRB- O
. . O

Analytical JJ O
imprecision NN O
, , O
expressed VBN O
in IN O
terms NNS O
of IN O
mean JJ O
inter JJ O
- HYPH O
assay NN O
coefficient NN O
of IN O
variation NN O
( -LRB- O
CV NN O
) -RRB- O
, , O
was VBD O
quoted VBN O
by IN O
the DT O
manufacturer NN O
as IN O
being VBG O
lower JJR O
than IN O
5 CD O
% NN O
. . O

Significance NN O
of IN O
differences NNS O
between IN O
samples NNS O
was VBD O
assessed VBN O
, , O
following VBG O
logarithmic JJ O
conversion NN O
of IN O
data NNS O
, , O
by IN O
parametric JJ O
tests NNS O
( -LRB- O
Student NN O
' '' O
s POS O
t NN O
- HYPH O
test NN O
, , O
ANOVA NNP O
test NN O
, , O
Pearson NNP O
' '' O
s NN O
correlation NN O
) -RRB- O
; , O
the DT O
level NN O
of IN O
statistical JJ O
significance NN O
was VBD O
set VBN O
at IN O
p NN O
< NN O
0 CD O
. . O
5 CD O
. . O

Results NNS O
and CC O
discussion NN O

When WRB O
compared VBN O
to IN O
healthy JJ O
controls NNS O
, , O
geometric JJ O
mean NN O
and CC O
95 CD O
% NN O
confidence NN O
interval JJ O
( , O
IC95 CD O
% NN O
) -RRB- O
of IN O
plasma NN O
D NN O
- HYPH O
dimer NN O
concentration NN O
appeared VBD O
significantly RB O
increased VBN O
in IN O
SSc NNP O
patients NNS B-Species
( , O
362 CD O
ng CD O
/ SYM O
mL NNP O
, , O
IC NN O
95 CD O
% NN O
: : O
361 CD O
- SYM O
363 CD O
ng CD O
/ SYM O
mL NN O
vs IN O
229 CD O
ng CD O
/ SYM O
mL NN O
, , O
IC95 CD O
% NN O
: : O
228 CD O
- SYM O
231 CD O
ng CD O
/ SYM O
mL NN O
, , O
p NN O
= SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

After IN O
stratifying VBG O
SSc NNP O
patients NNS B-Species
according VBG O
to IN O
disease NN O
subset NN O
, , O
no DT O
significant JJ O
differences NNS O
were VBD O
observed VBN O
between IN O
those DT O
with IN O
limited JJ O
cutaneous JJ O
pattern NN O
( , O
lcSSc NNP O
) -RRB- O
and CC O
controls NNS O
( , O
geometric JJ O
mean JJ O
plasma NN O
D NN O
- HYPH O
dimer NN O
: : O
283 CD O
ng CD O
/ SYM O
mL NN O
, , O
IC95 CD O
% NN O
: : O
282 CD O
- HYPH O
285 CD O
ng NNS O
/ SYM O
mL NN O
; : O
p NN O
= SYM O
0 CD O
. . O
61 CD O
) -RRB- O
, , O
whereas IN O
patients NNS B-Species
with IN O
diffuse JJ O
cutaneous JJ O
pattern NN O
( , O
dcSSc NNP O
) -RRB- O
displayed VBD O
substantially RB O
increased VBN O
values NNS O
( , O
geometric JJ O
mean JJ O
plasma NN O
D NN O
- HYPH O
dimer NN O
: : O
538 CD O
ng CD O
/ SYM O
mL CD O
, , O
IC95 CD O
% NN O
: : O
536 CD O
- SYM O
539 CD O
ng CD O
/ SYM O
mL NN O
; : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Additionally RB O
, , O
patients NNS B-Species
with IN O
active JJ O
disease NN O
, , O
as IN O
evaluated VBN O
according VBG O
to IN O
the DT O
European NNP O
Scleroderma NNP O
Study NNP O
Group NNP O
criteria NNS O
[ -LRB- O
7 CD O
] -RRB- O
, , O
displayed VBD O
higher JJR O
D NN O
- HYPH O
dimer NN O
levels NNS O
as IN O
compared VBN O
to IN O
patients NNS B-Species
with IN O
inactive JJ O
disease NN O
( : O
p NN O
= SYM O
0 CD O
. . O
27 CD O
) -RRB- O
. . O

As IN O
further RB O
shown VBN O
in IN O
table NN O
1 CD O
, , O
D NN O
- HYPH O
dimer NN O
concentration NN O
correlated VBD O
significantly RB O
with IN O
the DT O
modified VBN O
Rodnan NNP O
total JJ O
skin NN O
score NN O
( -LRB- O
TSS NNP O
) -RRB- O
and CC O
the DT O
forced JJ O
vital JJ O
capacity NN O
( -LRB- O
FVC NNP O
) -RRB- O
. . O

No DT O
correlation NN O
was VBD O
observed VBN O
between IN O
plasma NN O
D NN O
- HYPH O
dimer NN O
concentration NN O
and CC O
age NN O
, , O
sex NN O
, , O
autoantibody NN O
pattern NN O
, , O
serum NN O
creatinine NN O
, , O
erythrosedimentation NN O
rate NN O
, , O
nailfold NN O
videocapillaroscopic JJ O
pattern NN O
and CC O
pulmonary JJ O
involvement NN O
, , O
ascertained VBN O
according VBG O
to IN O
the DT O
score NN O
proposed VBN O
by IN O
Medsger NNP O
et FW O
al NNP O
[ -LRB- O
8 CD O
] -RRB- O
. . O

The DT O
pathogenesis NN O
of IN O
the DT O
endothelial JJ O
injury NN O
in IN O
SSc NNP O
is VBZ O
as RB O
yet RB O
elusive JJ O
and CC O
most JJS O
biochemical JJ O
evidences NNS O
are VBP O
often RB O
inconclusive JJ O
or CC O
controversial JJ O
. . O

Although IN O
endothelial JJ O
cell NN O
apoptosis NN O
and CC O
impaired JJ O
angiogenesis NN O
have VBP O
received VBN O
major JJ O
attention NN O
among IN O
the DT O
mechanisms NNS O
involved VBN O
in IN O
the DT O
characteristic JJ O
vascular JJ O
dysfunction NN O
, , O
recent JJ O
studies NNS O
provided VBD O
clear JJ O
evidence NN O
of IN O
a DT O
significant JJ O
activation NN O
of IN O
the DT O
coagulation NN O
cascade NN O
, , O
resulting VBG O
in IN O
a DT O
procoagulant JJ O
state NN O
that WDT O
might MD O
finally RB O
raise VB O
the DT O
relative JJ O
risk NN O
of IN O
thrombotic JJ O
events NNS O
in IN O
these DT O
patients NNS B-Species
. . O

In IN O
SSc NNP O
, , O
the DT O
peculiar JJ O
vascular JJ O
lesions NNS O
and CC O
fibrosis NN O
were VBD O
claimed VBN O
to TO O
impair VB O
endothelial JJ O
function NN O
, , O
as IN O
suggested VBN O
by IN O
impairment NN O
of IN O
fibrinolysis NN O
and CC O
activation NN O
of IN O
the DT O
coagulation NN O
pathway NN O
. . O

The DT O
following VBG O
loss NN O
of IN O
the DT O
balance NN O
between IN O
fibrinolysis NN O
and CC O
coagulation NN O
might MD O
finally RB O
contribute VB O
to IN O
vessel NN O
engulfment NN O
with IN O
fibrin NN O
and CC O
breakdown NN O
of IN O
vessel NN O
patency NN O
, , O
symptomatic JJ O
of IN O
a DT O
tendency NN O
to IN O
the DT O
development NN O
of IN O
thrombotic JJ O
complications NNS O
in IN O
this DT O
particular JJ O
autoimmune JJ O
disorder NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

D NN O
- HYPH O
dimer NN O
is VBZ O
a DT O
heterogeneous JJ O
class NN O
of IN O
end NN O
- HYPH O
stage NN O
degradation NN O
products NNS O
that WDT O
directly RB O
reflect VBP O
the DT O
level NN O
of IN O
lysed VBN O
cross NN O
- HYPH O
linked VBN O
fibrin NN O
, , O
occurring VBG O
in IN O
vivo NN O
with IN O
a DT O
wide JJ O
range NN O
of IN O
molecular JJ O
weights NNS O
. . O

Therefore RB O
, , O
D NN O
- HYPH O
dimer NN O
is VBZ O
a DT O
well RB O
- HYPH O
recognized VBN O
marker NN O
of IN O
a DT O
systemic JJ O
prothrombotic JJ O
state NN O
[ -LRB- O
5 CD O
, , O
9 CD O
] -RRB- O
and CC O
appears VBZ O
a DT O
strong JJ O
, , O
consistent JJ O
predictor NN O
of IN O
cardiovascular JJ O
events NNS O
in IN O
the DT O
general JJ O
population NN O
, , O
in IN O
patients NNS B-Species
with IN O
cardiovascular JJ O
disease NN O
and CC O
in IN O
other JJ O
pathologies NNS O
characterized VBN O
by IN O
an DT O
increased VBN O
risk NN O
of IN O
thrombosis NN O
[ -LRB- O
10 CD O
- SYM O
12 CD O
] -RRB- O
. . O

Accordingly RB O
, , O
D NN O
- HYPH O
dimer NN O
measurement NN O
could MD O
be VB O
reliably RB O
used VBN O
as IN O
an DT O
initial JJ O
screening NN O
test NN O
in IN O
patients NNS B-Species
with IN O
clinically RB O
suspected VBN O
thrombosis NN O
, , O
as IN O
its PRP$ O
high JJ O
negative JJ O
predictive JJ O
value NN O
enables VBZ O
to TO O
validly RB O
rule VB O
out RP O
ongoing JJ O
thrombotic JJ O
complications NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Little RB O
is VBZ O
known VBN O
on IN O
the DT O
thrombotic JJ O
tendency NN O
of IN O
SSc NNP O
patients NNS B-Species
so RB O
far RB O
[ -LRB- O
13 CD O
] -RRB- O
. . O

At IN O
variance NN O
with IN O
previous JJ O
investigations NNS O
[ -LRB- O
2 CD O
- SYM O
4 CD O
] -RRB- O
, , O
we PRP O
demonstrated VBD O
that IN O
SSc NNP O
patients NNS B-Species
with IN O
diffuse JJ O
subset NN O
are VBP O
characterized VBN O
by IN O
increased VBN O
plasma NN O
D NN O
- HYPH O
dimer NN O
values NNS O
, , O
reflecting VBG O
a DT O
potential JJ O
activation NN O
of IN O
both CC O
the DT O
coagulation NN O
and CC O
fibrinolytic JJ O
pathways NNS O
. . O

Conclusion NN O

Although IN O
increased JJ O
D NN O
- HYPH O
dimer NN O
values NNS O
in IN O
SSc NNP O
patients NNS B-Species
were VBD O
occasionally RB O
observed VBN O
in IN O
earlier JJR O
studies NNS O
, , O
the DT O
association NN O
between IN O
plasma NN O
D NN O
- HYPH O
dimer NN O
and CC O
disease NN O
subset NN O
is VBZ O
likely RB O
an DT O
original JJ O
and CC O
innovative JJ O
issue NN O
. . O

The DT O
significant JJ O
correlation NN O
observed VBN O
with IN O
disease NN O
activity NN O
, , O
cutaneous JJ O
involvement NN O
and CC O
forced JJ O
vital JJ O
capacity NN O
, , O
further RB O
suggests VBZ O
that IN O
SSc NNP O
patients NNS B-Species
, , O
especially RB O
those DT O
with IN O
diffuse JJ O
subset NN O
, , O
display VBP O
a DT O
hypercoagulable JJ O
state NN O
, , O
which WDT O
might MD O
finally RB O
predispose VB O
this DT O
peculiar JJ O
subset NN O
of IN O
patients NNS B-Species
to IN O
the DT O
development NN O
of IN O
thrombotic JJ O
complications NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

GL NNP O
: : O
conceived VBN O
of IN O
the DT O
study NN O
, , O
participated VBD O
in IN O
its PRP$ O
design NN O
and CC O
coordination NN O
and CC O
drafted VBD O
the DT O
manuscript NN O
; , O
AV NN O
: : O
participated VBD O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
, , O
performed VBD O
the DT O
statistical JJ O
analysis NN O
and CC O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
; : O
PC NN O
: : O
participated VBD O
in IN O
the DT O
design NN O
and CC O
coordination NN O
of IN O
the DT O
study NN O
; , O
GLS NNP O
: : O
participated VBN O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
; , O
MM NN O
: : O
participated VBD O
in IN O
the DT O
design NN O
and CC O
coordination NN O
of IN O
the DT O
study NN O
and CC O
performed VBD O
the DT O
measurement NN O
; , O
GCG NNP O
: : O
participated VBD O
in IN O
the DT O
design NN O
and CC O
coordination NN O
of IN O
the DT O
study NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Enp1 NNP O
, , O
a DT O
yeast NN B-Species
protein NN O
associated VBN O
with IN O
U3 NNP O
and CC O
U14 NNP O
snoRNAs NNS O
, , O
is VBZ O
required VBN O
for IN O
pre JJ O
- HYPH O
rRNA NN O
processing NN O
and CC O
40S NN O
subunit NN O
synthesis NN O

Abstract JJ O

ENP1 NNP O
is VBZ O
an DT O
essential JJ O
Saccharomyces NNP B-Species
cerevisiae NN I-Species
gene NN O
encoding VBG O
a DT O
483 CD O
amino NN O
acid NN O
polypeptide NN O
. . O

Enp1 NN O
protein NN O
is VBZ O
localized VBN O
in IN O
the DT O
nucleus NN O
and CC O
concentrated VBN O
in IN O
the DT O
nucleolus NN O
. . O

An DT O
enp1 NN O
- HYPH O
1 CD O
temperature NN O
- HYPH O
sensitive JJ O
mutant JJ O
inhibited VBN O
35S NNP O
pre NN O
- HYPH O
rRNA NNP O
early JJ O
processing NN O
at IN O
sites NNS O
A0 NNP O
, , O
A1 NNP O
and CC O
A2 CD O
as IN O
shown VBN O
by IN O
northern JJ O
analysis NN O
of IN O
steady JJ O
state NN O
levels NNS O
of IN O
rRNA NNP O
precursors NNS O
. . O

Pulse NN O
- HYPH O
chase NN O
analysis NN O
further RB O
revealed VBD O
that IN O
the DT O
enp1 NN O
- HYPH O
1 CD O
strain NN O
was VBD O
defective JJ O
in IN O
the DT O
synthesis NN O
of IN O
20S CD O
pre NN O
- HYPH O
rRNA NN O
and CC O
hence RB O
18S NNP O
rRNA NNP O
, , O
which WDT O
led VBD O
to IN O
reduced VBN O
formation NN O
of IN O
40S CD O
ribosomal JJ O
subunits NNS O
. . O

Co NN O
- HYPH O
precipitation NN O
analysis NN O
revealed VBD O
that IN O
Enp1 NNP O
was VBD O
associated VBN O
with IN O
Nop1 NNP O
protein NN O
, , O
as RB O
well RB O
as IN O
with IN O
U3 NNP O
and CC O
U14 NNP O
RNAs NNS O
, , O
two CD O
snoRNAs NNS O
implicated VBN O
in IN O
early JJ O
pre JJ O
- HYPH O
rRNA NN O
processing NN O
steps NNS O
. . O

These DT O
results NNS O
suggest VBP O
a DT O
direct JJ O
role NN O
for IN O
Enp1 NNP O
in IN O
the DT O
early JJ O
steps NNS O
of IN O
rRNA NNP O
processing NN O
. . O

INTRODUCTION NN O

Ribosome NN O
biogenesis NN O
is VBZ O
one CD O
of IN O
the DT O
major JJ O
cellular JJ O
activities NNS O
in IN O
eukaryotic JJ O
cells NNS O
. . O

It PRP O
takes VBZ O
place NN O
primarily RB O
in IN O
a DT O
specialized JJ O
subnuclear JJ O
compartment NN O
, , O
the DT O
nucleolus NN O
( , O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

In IN O
the DT O
yeast NN B-Species
Saccharomyces NNP B-Species
cerevisiae NN I-Species
, , O
each DT O
rRNA NNP O
gene NN O
is VBZ O
transcribed VBN O
by IN O
RNA NNP O
polymerase NN O
I NNP O
into IN O
a DT O
35S CD O
rRNA NNP O
precursor NN O
, , O
consisting VBG O
of IN O
18S CD O
, , O
5 CD O
. . O
8S NNS O
and CC O
25S NNP O
rRNA NNP O
sequences NNS O
flanked VBN O
by IN O
two CD O
external JJ O
transcribed VBN O
spacers NNS O
( -LRB- O
ETS NNP O
) -RRB- O
and CC O
separated VBN O
by IN O
two CD O
internal JJ O
transcribed VBN O
spacers NNS O
( , O
ITS NNP O
) -RRB- O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

This DT O
35S CD O
precursor NN O
goes VBZ O
through IN O
a DT O
series NN O
of IN O
modifications NNS O
and CC O
processing NN O
steps NNS O
to TO O
generate VB O
the DT O
mature JJ O
18S NNS O
, , O
5 CD O
. . O
8S CD O
and CC O
25S CD O
rRNAs NNS O
. . O

The DT O
processing NN O
occurs VBZ O
first RB O
at IN O
sites NNS O
A0 NNP O
, , O
A1 NNP O
and CC O
A2 NNP O
, , O
resulting VBG O
in IN O
the DT O
20S CD O
pre NN O
- HYPH O
rRNA NNP O
and CC O
27SA2 CD O
pre NN O
- HYPH O
rRNA NN O
. . O

The DT O
20S NNP O
pre NNP O
- HYPH O
rRNA NNP O
is VBZ O
then RB O
cleaved VBN O
, , O
leading VBG O
to IN O
the DT O
mature JJ O
18S NNP O
rRNA NNP O
found VBN O
in IN O
the DT O
40S CD O
ribosomal NN O
subunit NN O
. . O

The DT O
27SA2 CD O
pre NN O
- HYPH O
rRNA NNP O
is VBZ O
processed VBN O
through IN O
two CD O
alternative JJ O
pathways NNS O
. . O

The DT O
majority NN O
of IN O
27SA2 CD O
pre NN O
- HYPH O
rRNA NNP O
is VBZ O
cleaved VBN O
at IN O
sites NNS O
A3 NN O
and CC O
B2 NNP O
to TO O
form VB O
the DT O
27SA3 CD O
pre NN O
- HYPH O
rRNA NN O
, , O
which WDT O
is VBZ O
subsequently RB O
processed VBN O
to TO O
produce VB O
27SBS NNP O
. . O

Alternatively RB O
, , O
27SA2 CD O
pre NN O
- HYPH O
rRNA NN O
can MD O
be VB O
processed VBN O
at IN O
sites NNS O
B1L NNP O
and CC O
B2 NNP O
to TO O
generate VB O
27SBL NNP O
pre NN O
- HYPH O
rRNA NN O
. . O

Both CC O
27SBS NNP O
and CC O
27SBL NNP O
pre NN O
- HYPH O
rRNAs NNS O
are VBP O
then RB O
cleaved VBN O
at IN O
sites NNS O
C1 NN O
and CC O
C2 NNP O
to TO O
generate VB O
the DT O
mature JJ O
25S NNP O
rRNA NNP O
, , O
and CC O
7SS NNP O
or CC O
7SL NNP O
intermediates NNS O
, , O
which WDT O
are VBP O
then RB O
processed VBN O
to TO O
mature VB O
5 CD O
. . O
8SS NN O
or CC O
5 CD O
. . O
8SL NN O
rRNAs NNS O
( : O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

The DT O
25S NNP O
rRNA NNP O
and CC O
5 CD O
. , O
8S NNP O
rRNA NNP O
are VBP O
the DT O
RNA NNP O
components NNS O
of IN O
the DT O
60S CD O
ribosomal NN O
subunit NN O
( , O
3 CD O
) -RRB- O
. . O

During IN O
the DT O
course NN O
of IN O
rRNA NNP O
modification NN O
and CC O
processing NN O
, , O
many JJ O
of IN O
the DT O
ribosomal JJ O
proteins NNS O
are VBP O
assembled VBN O
onto IN O
the DT O
rRNA NNP O
molecules NNS O
to TO O
form VB O
the DT O
ribosome NN O
complex NN O
. . O

Ribosome JJ O
biogenesis NN O
needs VBZ O
a DT O
large JJ O
number NN O
of IN O
trans NNS O
- HYPH O
acting VBG O
factors NNS O
, , O
including VBG O
small JJ O
nucleolar JJ O
RNAs NNS O
( , O
snoRNAs NNS O
) -RRB- O
, , O
protein NN O
components NNS O
of IN O
the DT O
snoRNP NNP O
complexes NNS O
, , O
rRNA NNP O
modifying VBG O
enzymes NNS O
, , O
endo NN O
- HYPH O
and CC O
exonucleases NNS O
, , O
putative JJ O
RNA NN O
helicases NNS O
and CC O
other JJ O
protein NN O
factors NNS O
( : O
3 CD O
, , O
4 CD O
) -RRB- O
. . O

In IN O
yeast NN B-Species
cells NNS O
there EX O
are VBP O
more JJR O
than IN O
100 CD O
different JJ O
snoRNAs NNS O
playing VBG O
important JJ O
roles NNS O
in IN O
rRNA NNP O
modification NN O
and CC O
processing NN O
. . O

On IN O
the DT O
basis NN O
of IN O
their PRP$ O
structure NN O
, , O
the DT O
snoRNAs NNS O
can MD O
be VB O
divided VBN O
into IN O
two CD O
groups NNS O
: : O
the DT O
box NN O
C NN O
/ SYM O
D NN O
family NN O
and CC O
box NN O
H NN O
/ SYM O
ACA NNP O
family NN O
. . O

Only RB O
one CD O
snoRNA NN O
, , O
MRP NNP O
RNA NNP O
, , O
belongs VBZ O
to IN O
neither DT O
family NN O
( , O
5 CD O
- HYPH O
7 CD O
) -RRB- O
. . O

While IN O
the DT O
majority NN O
of IN O
the DT O
snoRNAs NNS O
participate VBP O
in IN O
RNA NN O
pseudouridylation NN O
and CC O
2 CD O
' '' O
- HYPH O
O NN O
- HYPH O
ribose NN O
methylation NN O
, , O
a DT O
few JJ O
of IN O
them PRP O
, , O
including VBG O
MRP NNP O
snoRNA NN O
, , O
box NN O
C NNP O
/ SYM O
D NN O
snoRNAs NNS O
U3 NNP O
and CC O
U14 NNP O
, , O
and CC O
box NN O
H NN O
/ SYM O
ACA NN O
snoRNAs NNS O
snR10 NN O
and CC O
snR30 NN O
, , O
are VBP O
required VBN O
for IN O
processing NN O
of IN O
the DT O
pre NN O
- HYPH O
rRNA NNP O
( SYM O
8 CD O
- HYPH O
12 CD O
) -RRB- O
. . O

Not RB O
only RB O
are VBP O
U3 NNP O
, , O
U14 NNP O
, , O
snR10 NN O
and CC O
snR30 NN O
essential JJ O
for IN O
early JJ O
cleavages NNS O
of IN O
35S CD O
pre NN O
- HYPH O
rRNA NN O
to IN O
18S NNP O
rRNA NNP O
, , O
the DT O
proteins NNS O
associated VBN O
with IN O
them PRP O
, , O
including VBG O
Nop1 NNP O
, , O
Nop5 NNP O
, , O
Gar1 NNP O
and CC O
Nop10 NNP O
, , O
have VBP O
also RB O
been VBN O
shown VBN O
to TO O
be VB O
required VBN O
for IN O
18S NNP O
rRNA NNP O
synthesis NN O
( : O
13 CD O
- HYPH O
16 CD O
) -RRB- O
. . O

The DT O
ENP1 NNP O
( -LRB- O
Essential NNP O
Nuclear NNP O
Protein NNP O
1 CD O
) -RRB- O
gene NN O
was VBD O
identified VBN O
in IN O
a DT O
genetic JJ O
screen NN O
for IN O
suppressors NNS O
of IN O
an DT O
ost4 NN O
mutation NN O
( , O
oligosaccharide NN O
transferase NN O
4 CD O
) -RRB- O
( SYM O
17 CD O
) -RRB- O
. . O

However RB O
, , O
in IN O
subsequent JJ O
studies NNS O
it PRP O
was VBD O
found VBN O
not RB O
to TO O
be VB O
involved VBN O
in IN O
OST4 NN O
function NN O
( : O
18 CD O
) -RRB- O
. . O

ENP1 NNP O
is VBZ O
an DT O
essential JJ O
gene NN O
encoding VBG O
a DT O
483 CD O
amino NN O
acid NN O
polypeptide NN O
. . O

The DT O
Enp1 NNP O
protein NN O
is VBZ O
highly RB O
conserved JJ O
and CC O
homologs NNS O
are VBP O
found VBN O
in IN O
all DT O
eukaryotes NNS O
. . O

The DT O
yeast NN B-Species
protein NN O
was VBD O
localized VBN O
to IN O
the DT O
nucleus NN O
in IN O
a DT O
previous JJ O
study NN O
( : O
18 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
an DT O
Enp1 NNP O
human JJ B-Species
homolog NN O
, , O
called VBN O
bystin NN O
, , O
was VBD O
reported VBN O
to TO O
localize VB O
to IN O
the DT O
cytoplasm NN O
and CC O
was VBD O
proposed VBN O
to TO O
be VB O
involved VBN O
in IN O
cell NN O
adhesion NN O
( SYM O
19 CD O
) -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
report VBP O
that IN O
the DT O
Enp1 NNP O
protein NN O
not RB O
only RB O
is VBZ O
nuclear JJ O
but CC O
is VBZ O
enriched VBN O
in IN O
the DT O
nucleolus NN O
. . O

We PRP O
also RB O
found VBD O
that IN O
Enp1 NNP O
is VBZ O
required VBN O
for IN O
the DT O
synthesis NN O
of IN O
40S CD O
ribosomal JJ O
subunits NNS O
, , O
and CC O
its PRP$ O
presence NN O
is VBZ O
necessary JJ O
for IN O
the DT O
pre NN O
- HYPH O
rRNA NNP O
processing NN O
to TO O
form VB O
20S CD O
pre NN O
- HYPH O
rRNA NN O
and CC O
18S NNP O
rRNA NNP O
. . O

An DT O
association NN O
between IN O
Enp1 NNP O
and CC O
U3 NNP O
and CC O
U14 NNP O
snoRNAs NNS O
, , O
and CC O
with IN O
the DT O
nucleolar JJ O
protein NN O
Nop1 NNP O
, , O
was VBD O
established VBN O
. . O

We PRP O
also RB O
found VBD O
that IN O
human JJ B-Species
Enp1 NNP O
, , O
expressed VBN O
in IN O
yeast NN B-Species
, , O
was VBD O
located VBN O
in IN O
the DT O
nucleus NN O
and CC O
the DT O
nucleolus NN O
, , O
suggesting VBG O
that IN O
the DT O
function NN O
of IN O
this DT O
protein NN O
is VBZ O
conserved VBN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Yeast NN B-Species
strains NNS O
and CC O
media NNS O

The DT O
S NNP B-Species
. , I-Species
cerevisiae NN I-Species
strains NNS O
used VBN O
in IN O
this DT O
study NN O
are VBP O
all RB O
derivatives NNS O
of IN O
a DT O
wild JJ O
- HYPH O
type NN O
diploid NN O
strain NN O
W303 CD O
( , O
MATa NNP O
/ SYM O
MAT NNP O
alpha NNP O
ura3 NNP O
- HYPH O
1 CD O
/ SYM O
ura3 CD O
- HYPH O
1 CD O
leu2 CD O
- HYPH O
3 CD O
, , O
112 CD O
/ SYM O
leu2 CD O
- HYPH O
3 CD O
, , O
112 CD O
trp1 CD O
- HYPH O
1 CD O
/ SYM O
trp1 CD O
- HYPH O
1 CD O
his3 CD O
- HYPH O
11 CD O
, , O
15 CD O
/ SYM O
his3 CD O
- HYPH O
11 CD O
, , O
15 CD O
ade2 CD O
- HYPH O
1 CD O
/ SYM O
ade2 CD O
- HYPH O
1 CD O
can1 NN O
- HYPH O
100 CD O
/ SYM O
can1 NN O
- HYPH O
100 CD O
) -RRB- O
except IN O
for IN O
strain NN O
RS1938 NN O
. . O

Strain NNP O
JBY45 NNP O
( : O
MATa NNP O
/ SYM O
MAT NNP O
alpha NN O
ENP1 NN O
/ SYM O
Delta NNP O
enp1 CD O
: : O
: : O
his5 CD O
+ NFP O
) -RRB- O
was VBD O
constructed VBN O
by IN O
replacing VBG O
one CD O
copy NN O
of IN O
the DT O
ENP1 NNP O
open JJ O
reading NN O
frame NN O
( -LRB- O
ORF NNP O
) -RRB- O
with IN O
the DT O
Schizosaccharomyces NNP B-Species
pombe NN I-Species
his5 CD O
+ SYM O
gene NN O
( SYM O
18 CD O
) -RRB- O
. . O

Strain NNP O
JBY46 NNP O
[ -LRB- O
MATa NNP O
Delta NNP O
enp1 CD O
: : O
: : O
his5 NNP O
+ NFP O
/ SYM O
pJB23 NNP O
( , O
ENP1 NNP O
, , O
URA3 NNP O
, , O
CEN6 NNP O
) -RRB- O
] -RRB- O
is VBZ O
a DT O
haploid NN O
strain NN O
derived VBN O
from IN O
JBY45 NNP O
with IN O
wild JJ O
- HYPH O
type NN O
ENP1 NN O
on IN O
a DT O
low JJ O
copy NN O
number NN O
plasmid NN O
. . O

Strain NN O
JBY48 NNP O
[ -LRB- O
MATa NNP O
Delta NNP O
enp1 CD O
: : O
: : O
his5 NNP O
+ NFP O
/ SYM O
pJB19 NNP O
( , O
enp1 CD O
- HYPH O
1 CD O
, , O
TRP1 NNP O
, , O
CEN6 NNP O
) -RRB- O
] -RRB- O
and CC O
strain NN O
JBY49 NNP O
[ -LRB- O
MATa NNP O
Delta NNP O
enp1 CD O
: : O
: : O
his5 NNP O
+ NFP O
/ SYM O
pJB39 NNP O
( -LRB- O
enp1 NN O
- HYPH O
2 CD O
, , O
TRP1 NNP O
, , O
CEN6 NNP O
) -RRB- O
] -RRB- O
have VBP O
plasmids NNS O
with IN O
enp1 NN O
temperature NN O
- HYPH O
sensitive JJ O
( : O
ts NN O
) -RRB- O
mutations NNS O
. . O

Strain NN O
JBY51 NNP O
( : O
MATa NNP O
Delta NNP O
enp1 CD O
: : O
: : O
his5 CD O
+ SYM O
TRP1 NN O
: : O
: : O
enp1 CD O
- HYPH O
1 CD O
) -RRB- O
is VBZ O
an DT O
enp1 NN O
ts IN O
strain NN O
generated VBN O
by IN O
integrating VBG O
the DT O
enp1 NN O
- HYPH O
1 CD O
gene NN O
at IN O
the DT O
chromosomal JJ O
trp1 NN O
- HYPH O
1 CD O
locus NN O
. . O

Strain NN O
CWY13 NN O
[ -LRB- O
MATa NNP O
Delta NNP O
enp1 CD O
: : O
: : O
his5 NNP O
+ NFP O
/ SYM O
pJB24 NNP O
( , O
pMET25 NNP O
- HYPH O
GFP NNP O
- HYPH O
ENP1 NNP O
, , O
URA3 NNP O
, , O
CEN6 NNP O
) -RRB- O
] -RRB- O
has VBZ O
GFP NN O
- HYPH O
ENP1 NN O
under IN O
control NN O
of IN O
the DT O
MET25 NNP O
promoter NN O
. . O

Strain NN O
CWY14 NN O
( , O
MATa NNP O
ENP1 NNP O
- HYPH O
TAP NNP O
) -RRB- O
was VBD O
created VBN O
by IN O
fusing VBG O
sequences NNS O
encoding VBG O
a DT O
Tandem NNP O
Affinity NNP O
Purification NNP O
( , O
TAP NNP O
) -RRB- O
tag NN O
( , O
20 CD O
, , O
21 CD O
) -RRB- O
to IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
ENP1 NNP O
. . O

Strain NNP O
YRH39 NNP O
( -LRB- O
MAT NNP O
alpha NNP O
HST2 NNP O
- HYPH O
TAP NNP O
) -RRB- O
was VBD O
created VBN O
by IN O
fusing VBG O
sequences NNS O
encoding VBG O
a DT O
TAP NN O
tag NN O
to IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
HST2 NNP O
. . O

Strain NN O
RS1938 CD O
( : O
Delta NNP O
nop1 NN O
: : O
: : O
URA3 NNP O
pUN100 NNP O
- HYPH O
ProtA NNP O
- HYPH O
NOP1 NNP O
) -RRB- O
was VBD O
created VBN O
by IN O
transforming VBG O
RS1935 NNP O
( SYM O
MATa NNP O
/ SYM O
alpha NNP O
leu2 NNP O
/ SYM O
leu2 CD O
ura3 NN O
/ SYM O
ura3 NN O
lys2 NN O
/ SYM O
lys2 NN O
ade2 CD O
/ SYM O
ade2 CD O
Delta NNP O
nop1 NN O
: : O
: : O
URA3 NNP O
/ SYM O
NOP1 NNP O
) -RRB- O
with IN O
pUN100 NN O
- HYPH O
ProtA NNP O
- HYPH O
NOP1 NNP O
( , O
strain NN O
and CC O
plasmid NN O
supplied VBN O
by IN O
T NNP O
. . O
Schafer NNP O
) -RRB- O
, , O
followed VBN O
by IN O
tetrad NN O
dissection NN O
. . O

Strain NNP O
CWY15 NNP O
[ -LRB- O
MATa NNP O
/ SYM O
pCW109 NNP O
( , O
pMET25 NNP O
- HYPH O
GFP NNP O
- HYPH O
hENP1 NNP O
, , O
URA3 NNP O
, , O
CEN6 NNP O
) -RRB- O
] -RRB- O
has VBZ O
a DT O
human JJ B-Species
homolog NN O
of IN O
Enp1 NNP O
expressed VBN O
in IN O
W303 CD O
- HYPH O
1a CD O
. . O

The DT O
media NNS O
used VBD O
were VBD O
prepared VBN O
as IN O
described VBN O
( SYM O
22 CD O
) -RRB- O
. . O

Cloning NN O
of IN O
ENP1 NNP O

pRS426 NNP O
- : O
MEG1 NNP O
( : O
The DT O
original JJ O
name NN O
of IN O
ENP1 NNP O
) -RRB- O
was VBD O
a DT O
gift NN O
from IN O
Dr NNP O
William NNP O
J NNP O
. . O
Lennarz NNP O
. . O

It PRP O
contains VBZ O
the DT O
ENP1 NNP O
gene NN O
within IN O
a DT O
2 CD O
. . O
6 CD O
kb NN O
EcoRI NNP O
genomic JJ O
fragment NN O
cloned VBN O
into IN O
pRS426 CD O
( SYM O
18 CD O
) -RRB- O
. . O

The DT O
EcoRI NNP O
fragment NN O
was VBD O
subsequently RB O
cloned VBN O
into IN O
pRS314 NN O
( : O
TRP1 NNP O
, , O
CEN6 NNP O
) -RRB- O
, , O
pRS316 NNP O
( , O
URA3 NNP O
, , O
CEN6 NNP O
) -RRB- O
and CC O
pRS424 NN O
( , O
TRP1 NNP O
, , O
2 CD O
micro NN O
) -RRB- O
to TO O
create VB O
pJB20 NN O
, , O
pJB23 NNP O
and CC O
pJB21 NN O
, , O
respectively RB O
. . O

pGFP NNP O
- HYPH O
N NNP O
- HYPH O
FUS NNP O
is VBZ O
a DT O
centromeric JJ O
plasmid NN O
for IN O
fusing VBG O
green JJ O
fluorescence NN O
protein NN O
( , O
GFP NNP O
) -RRB- O
to IN O
a DT O
polypeptide NN O
' '' O
s NN O
N NN O
- HYPH O
terminus NN O
under IN O
control NN O
of IN O
the DT O
MET25 NNP O
promoter NN O
( SYM O
23 CD O
) -RRB- O
. . O

Cloning VBG O
the DT O
ENP1 NN O
ORF NNP O
into IN O
pGFP NNP O
- HYPH O
N NNP O
- HYPH O
FUS NNP O
via IN O
XbaI NNP O
and CC O
SalI NNP O
sites NNS O
generated VBN O
plasmid NN O
pJB24 NN O
. . O

pJB19 NNP O
( , O
enp1 CD O
- HYPH O
1 CD O
, , O
TRP1 NNP O
, , O
CEN6 NNP O
) -RRB- O
contains VBZ O
the DT O
enp1 NN O
- HYPH O
1 CD O
mutant NN O
gene NN O
. . O

The DT O
human JJ B-Species
homolog NN O
of IN O
yeast NN B-Species
Enp1 NNP O
was VBD O
PCR NN O
amplified VBN O
from IN O
a DT O
human JJ B-Species
cDNA NN O
clone NN O
BC007340 NNP O
( , O
Research NNP O
Genetics NNP O
) -RRB- O
, , O
then RB O
cloned VBN O
into IN O
pGFP NNP O
- HYPH O
N NNP O
- HYPH O
FUS NNP O
, , O
p415 CD O
- HYPH O
ADH NNP O
, , O
p415 CD O
- HYPH O
GPD NNP O
and CC O
p415 CD O
- HYPH O
TEF NNP O
( -LRB- O
24 CD O
) -RRB- O
via IN O
XbaI NNP O
and CC O
SalI NNP O
sites NNS O
to TO O
generate VB O
pCW109 NN O
, , O
pCW113 NN O
, , O
pCW115 NN O
and CC O
pCW117 NN O
, , O
respectively RB O
. . O

The DT O
fragment NN O
of IN O
the DT O
human JJ B-Species
Enp1 NN O
homolog NN O
( , O
amino NN O
acids NN O
152 CD O
- HYPH O
437 CD O
) -RRB- O
was VBD O
also RB O
cloned VBN O
into IN O
these DT O
vectors NNS O
to TO O
generate VB O
pCW110 NN O
, , O
pCW114 NN O
, , O
pCW116 NN O
and CC O
pCW118 NN O
. . O

Random JJ O
mutagenesis NN O
of IN O
ENP1 NNP O
to TO O
generate VB O
enp1 NN O
ts VBZ O
mutants NNS O

The DT O
enp1 NN O
ts IN O
mutants NNS O
were VBD O
generated VBN O
with IN O
a DT O
protocol NN O
introducing VBG O
random JJ O
mutations NNS O
by IN O
PCR NNP O
( SYM O
25 CD O
) -RRB- O
. . O

The DT O
PCR NNP O
was VBD O
performed VBN O
with IN O
oligonucleotides NNS O
ENP1 NNP O
- HYPH O
MUT5 NNP O
' '' O
( -LRB- O
5 CD O
' '' O
- HYPH O
GGTGGTGTCAGT NNP O
AGGGGA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
, , O
ENP1 NNP O
- HYPH O
MUT3 NNP O
' '' O
( -LRB- O
5 CD O
' '' O
- HYPH O
CAGTCTGCAATATA NNP O
TGGAC NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
plasmid NN O
template NN O
pJB20 NN O
( -LRB- O
see VB O
above RB O
) -RRB- O
. . O

The DT O
nucleotide NN O
concentrations NNS O
in IN O
the DT O
reaction NN O
were VBD O
1 CD O
mM NN O
each DT O
for IN O
dATP NNP O
, , O
dGTP NNP O
, , O
dCTP NNP O
and CC O
dTTP NNP O
. . O

After IN O
strain NN O
JBY46 NNP O
was VBD O
transformed VBN O
with IN O
the DT O
PCR NNP O
product NN O
and CC O
with IN O
pJB20 NN O
gapped VBN O
by IN O
NheI NNP O
and CC O
NsiI NNP O
, , O
the DT O
transformants NNS O
were VBD O
replica NN O
- HYPH O
plated VBN O
onto IN O
two CD O
plates NNS O
containing VBG O
5 CD O
- HYPH O
FOA NNP O
synthetic JJ O
medium NN O
without IN O
tryptophan NN O
; : O
one CD O
replica NN O
was VBD O
incubated VBN O
at IN O
23 CD O
degrees NNS O
C NN O
and CC O
the DT O
other JJ O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Colonies NNS O
growing VBG O
at IN O
23 CD O
degrees NNS O
C NN O
but CC O
not RB O
at IN O
37 CD O
degrees NNS O
C NNS O
were VBD O
picked VBN O
as IN O
candidates NNS O
. . O

Since IN O
approximately RB O
10 CD O
% NN O
of IN O
the DT O
colonies NNS O
were VBD O
inviable JJ O
at IN O
both DT O
temperatures NNS O
, , O
we PRP O
knew VBD O
that IN O
10 CD O
% NN O
of IN O
the DT O
ENP1 NNP O
PCR NNP O
products NNS O
lost VBD O
their PRP$ O
function NN O
after IN O
the DT O
PCR NNP O
mutagenesis NN O
. . O

This DT O
confirmed VBD O
the DT O
effectiveness NN O
of IN O
the DT O
mutagenesis NN O
procedure NN O
. . O

Two CD O
candidates NNS O
showed VBD O
good JJ O
growth NN O
at IN O
23 CD O
degrees NNS O
C NN O
but CC O
no DT O
growth NN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

They PRP O
were VBD O
named VBN O
strains NNS O
JBY48 NNP O
and CC O
JBY49 NNP O
and CC O
contained VBD O
plasmids NNS O
with IN O
the DT O
enp1 NN O
- HYPH O
1 CD O
and CC O
enp1 NN O
- HYPH O
2 CD O
mutations NNS O
, , O
respectively RB O
. . O

The DT O
mutated VBN O
enp1 NN O
- HYPH O
1 CD O
gene NN O
on IN O
pJB19 NN O
was VBD O
cloned VBN O
into IN O
an DT O
integration NN O
vector NN O
, , O
pRS304 NN O
, , O
as IN O
an DT O
EcoRI NNP O
fragment NN O
. . O

The DT O
plasmid NN O
was VBD O
subsequently RB O
linearized VBN O
with IN O
SnaBI NNP O
within IN O
the DT O
TRP1 NN O
marker NN O
and CC O
was VBD O
integrated VBN O
at IN O
the DT O
chromosomal JJ O
trp1 NN O
- HYPH O
1 CD O
locus NN O
of IN O
strain NN O
JBY46 NNP O
. . O

Selection NN O
on IN O
5 CD O
- HYPH O
FOA NNP O
was VBD O
used VBN O
to TO O
remove VB O
plasmid NN O
pJB23 NN O
, , O
creating VBG O
strain NN O
JBY51 NNP O
. . O

Sucrose JJ O
gradient NN O
analysis NN O

Polyribosome NN O
preparation NN O
and CC O
analysis NN O
were VBD O
carried VBN O
out RP O
essentially RB O
as IN O
described VBN O
( SYM O
26 CD O
) -RRB- O
. . O

Cells NNS O
grown VBN O
in IN O
YPD NNP O
were VBD O
collected VBN O
at IN O
mid JJ O
- HYPH O
log NN O
phase NN O
( : O
OD600 NN O
0 CD O
. . O
8 CD O
- SYM O
1 CD O
. . O
0 CD O
) -RRB- O
and CC O
were VBD O
broken VBN O
with IN O
glass NN O
beads NNS O
. . O

The DT O
lysate NN O
was VBD O
frozen VBN O
immediately RB O
in IN O
liquid NN O
N2 CD O
and CC O
was VBD O
stored VBN O
at IN O
- SYM O
80 CD O
degrees NNS O
C NN O
. . O

Lysate NNP O
( : O
30 CD O
U NN O
of IN O
absorbance NN O
at IN O
OD260 CD O
) -RRB- O
was VBD O
layered VBN O
over IN O
a DT O
7 CD O
- SYM O
47 CD O
% NN O
( HYPH O
w NN O
/ SYM O
v NN O
) SYM O
sucrose NN O
gradient NN O
, , O
which WDT O
was VBD O
centrifuged VBN O
at IN O
28 CD O
0 CD O
r NN O
. . O
p NN O
. . O
m UH O
. . O
for IN O
5 CD O
h NNS O
at IN O
4 CD O
degrees NNS O
C NN O
in IN O
a DT O
SW28 NN O
rotor NN O
and CC O
was VBD O
analyzed VBN O
with IN O
an DT O
ISCO NNP O
UA NNP O
- HYPH O
5 CD O
gradient NN O
UV NN O
detection NN O
system NN O
on IN O
absorbency NN O
at IN O
254 CD O
nm NN O
. . O

Immunofluorescence NN O

Immunofluorescence NN O
analysis NN O
was VBD O
carried VBN O
out RP O
essentially RB O
as IN O
described VBN O
( SYM O
27 CD O
) -RRB- O
. . O

Cells NNS O
were VBD O
fixed VBN O
with IN O
3 CD O
. . O
7 CD O
% NN O
formaldehyde NN O
at IN O
room NN O
temperature NN O
for IN O
1 CD O
. . O
5 CD O
h NN O
. . O

Antibodies NNS O
included VBD O
a DT O
mouse NN B-Species
monoclonal JJ O
anti JJ O
- HYPH O
Nop1 NNP O
( : O
a DT O
gift NN O
from IN O
John NNP O
P NNP O
. . O
Aris NNP O
, , O
University NNP O
of IN O
Florida NNP O
, , O
Gainesville NNP O
, , O
Florida NNP O
) , O
and CC O
a DT O
Texas NNP O
- HYPH O
red JJ O
- HYPH O
conjugated JJ O
donkey NN B-Species
- HYPH O
anti JJ O
- HYPH O
mouse NN B-Species
antibody NN O
( -LRB- O
Jackson NNP O
Lab NNP O
) -RRB- O
, , O
both DT O
used VBN O
at IN O
1 CD O
: SYM O
500 CD O
dilution NN O
. . O

Images NNS O
were VBD O
taken VBN O
on IN O
a DT O
Zeiss NNP O
Axioplan2 NNP O
microscope NN O
equipped VBN O
with IN O
a DT O
Zeiss NNP O
AxioCam NNP O
camera NN O
. . O

Pulse NN O
- HYPH O
chase NN O
labeling NN O
analysis NN O
of IN O
rRNA NNP O

For IN O
[ -LRB- O
methyl NN O
- HYPH O
3H NN O
] -RRB- O
methionine NN O
pulse NN O
- HYPH O
chase NN O
analysis NN O
, , O
cells NNS O
were VBD O
grown VBN O
in IN O
synthetic JJ O
medium NN O
without IN O
methionine NN O
at IN O
room NN O
temperature NN O
or CC O
37 CD O
degrees NNS O
C NN O
for IN O
2 CD O
h NNS O
. . O

When WRB O
the DT O
OD600 NNP O
reached VBD O
1 CD O
. . O
0 CD O
, , O
6 CD O
ml NNS O
of IN O
the DT O
culture NN O
were VBD O
pulse NN O
- HYPH O
labeled VBN O
with IN O
250 CD O
micro NN O
Ci NN O
[ -LRB- O
methyl NN O
- HYPH O
3H CD O
] -RRB- O
methionine NN O
( , O
Amersham NNP O
Pharmacia NNP O
) -RRB- O
for IN O
3 CD O
min NN O
and CC O
chased VBN O
with IN O
cold JJ O
methionine NN O
( : O
500 CD O
micro NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
for IN O
2 CD O
, , O
4 CD O
or CC O
12 CD O
min NN O
. . O

For IN O
each DT O
time NN O
point NN O
of IN O
the DT O
chase NN O
1 CD O
. . O
25 CD O
ml NNS O
of IN O
culture NN O
was VBD O
mixed VBN O
with IN O
ice NN O
and CC O
collected VBN O
. . O

The DT O
pellets NNS O
were VBD O
frozen VBN O
immediately RB O
in IN O
liquid NN O
N2 CD O
and CC O
stored VBN O
at IN O
- HYPH O
80 CD O
degrees NNS O
C NN O
before IN O
total JJ O
RNA NNP O
was VBD O
purified VBN O
using VBG O
a DT O
hot JJ O
phenol NN O
method NN O
( SYM O
28 CD O
) -RRB- O
. . O

The DT O
RNAs NNS O
were VBD O
separated VBN O
on IN O
a DT O
1 CD O
. . O
2 CD O
% NN O
agarose NN O
formaldehyde NN O
gel NN O
and CC O
transferred VBN O
onto IN O
Hybond NNP O
- HYPH O
N NNP O
+ CC O
nylon NN O
membranes NNS O
( -LRB- O
Amersham NNP O
Pharmacia NNP O
) -RRB- O
. . O

After IN O
being VBG O
sprayed VBN O
with IN O
EN3HANCE NNP O
( -LRB- O
Du NNP O
Pont NNP O
) -RRB- O
, , O
the DT O
membranes NNS O
were VBD O
exposed VBN O
to IN O
film NN O
at IN O
- HYPH O
80 CD O
degrees NNS O
C NN O
( SYM O
29 CD O
) -RRB- O
. . O

Northern JJ O
analysis NN O

Cells NNS O
were VBD O
grown VBN O
inYPD NN O
at IN O
room NN O
temperature NN O
or CC O
37 CD O
degrees NNS O
C NN O
for IN O
2 CD O
- SYM O
4 CD O
h NN O
. . O

When WRB O
the DT O
OD600 NNP O
reached VBD O
1 CD O
. . O
0 CD O
, , O
10 CD O
ml NNS O
of IN O
cells NNS O
were VBD O
collected VBN O
and CC O
frozen VBN O
immediately RB O
. . O

Total JJ O
RNA NNP O
was VBD O
extracted VBN O
as IN O
described VBN O
( SYM O
28 CD O
) -RRB- O
. . O

Five CD O
micrograms NNS O
of IN O
RNA NNP O
were VBD O
separated VBN O
on IN O
1 CD O
. . O
2 CD O
% NN O
agarose JJ O
formaldehyde NN O
gels NNS O
( , O
for IN O
high JJ O
molecular JJ O
weight NN O
RNA NN O
) -RRB- O
or CC O
on IN O
6 CD O
% NN O
polyacrylamide NN O
7 CD O
M NN O
urea NN O
denaturing VBG O
gels NNS O
( , O
for IN O
low JJ O
molecular JJ O
weight NN O
RNA NNP O
) -RRB- O
for IN O
each DT O
sample NN O
. . O

The DT O
RNA NNP O
was VBD O
then RB O
transferred VBN O
to IN O
Zeta NNP O
- HYPH O
Probe NNP O
GT NNP O
nylon NN O
membranes NNS O
( -LRB- O
Bio NNP O
- HYPH O
Rad NNP O
) -RRB- O
. . O

Probes NNS O
for IN O
hybridyzation NN O
were VBD O
specific JJ O
oligonucleotides NNS O
end NN O
- HYPH O
labeled VBN O
using VBG O
[ -LRB- O
gamma NN O
- HYPH O
32P NN O
] -RRB- O
ATP NNP O
. . O

After IN O
hybridization NN O
and CC O
washes NNS O
, , O
membranes NNS O
were VBD O
exposed VBN O
to IN O
phosphorimager NN O
screens NNS O
or CC O
X NN O
- HYPH O
ray NN O
films NNS O
( SYM O
29 CD O
) -RRB- O
. . O

Oligonucleotides NNS O
specific JJ O
for IN O
various JJ O
regions NNS O
of IN O
35S NNP O
pre NNP O
- HYPH O
rRNA NNP O
are VBP O
: : O
1 CD O
, , O
GGTCTCTCTGCTGCCG NNP O
GAAATG NNP O
; : O
3 CD O
, , O
AATGAGCCATTCGCAGTTTC NNP O
; : O
4 CD O
, , O
GCTCTCATGCTCTTGCCAAA NNP O
; : O
5 CD O
, , O
TGTTTGTTACCT NNP O
CTGGGCCCCG NNP O
; : O
6 CD O
, , O
TCCAGTTACGAAAATTCTTG NNP O
; : O
7 CD O
, , O
CGTATCGCATTTCGCTGCGT NNP O
; : O
8 CD O
, , O
GTTCGCCTAGAC NNP O
GCTCTCTCTTC NNP O
; : O
9 CD O
, , O
GCGAGATTCCCCTACCCAC NNP O
. . O

The DT O
regions NNS O
complementary JJ O
to IN O
these DT O
oligonucleotides NNS O
are VBP O
shown VBN O
in IN O
Figure NNP O
6A NNP O
. . O

The DT O
oligonucleotides NNS O
probing VBG O
box NN O
C NN O
/ SYM O
D NN O
snoRNAs NNS O
are VBP O
: : O
U3 NNP O
, , O
TTCGGTTTCTCACTCACTCT NNP O
; : O
U14 NNP O
, , O
GGAACCAGTCTTTCATCACC NNP O
. . O

The DT O
oligonucleotides NNS O
probing VBG O
box NN O
H NN O
/ SYM O
ACA NN O
snoRNAs NNS O
are VBP O
: : O
snoRNA10 NNP O
, , O
CCTTG NNP O
CAACGGTCCTCATCCGGG NNP O
; : O
snoRNA30 NNP O
, , O
GTCCGAAGC NNP O
GCCATCTAGATGA NNP O
. . O

RNA NN O
and CC O
protein NN O
precipitation NN O
analysis NN O

Cells NNS O
were VBD O
grown VBN O
in IN O
YPD NNP O
( SYM O
1 CD O
l SYM O
) CD O
to IN O
OD600 CD O
1 CD O
. . O
0 CD O
, , O
then RB O
collected VBN O
, , O
washed VBN O
once RB O
in IN O
ice NN O
- HYPH O
cold JJ O
PBS NNP O
and CC O
broken VBN O
using VBG O
glass NN O
beads NNS O
in IN O
10 CD O
ml NN O
IPP150 CD O
buffer NN O
( SYM O
10 CD O
mM NN O
Tris NN O
pH NN O
8 CD O
. . O
0 CD O
, , O
150 CD O
mM NN O
NaCl NN O
and CC O
0 CD O
. . O
1 CD O
% NN O
NP NN O
- HYPH O
40 CD O
) , O
with IN O
protease NN O
inhibitors NNS O
. . O

The DT O
lysates NNS O
were VBD O
mixed VBN O
with IN O
200 CD O
micro NN O
l NN O
IgG NNP O
agarose NN O
beads NNS O
for IN O
2 CD O
h NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

After IN O
several JJ O
washes NNS O
with IN O
50 CD O
ml NN O
IPP150 NN O
buffer NN O
, , O
the DT O
IgG NNP O
beads NNS O
were VBD O
collected VBN O
and CC O
the DT O
RNA NNP O
associated VBN O
with IN O
the DT O
beads NNS O
extracted VBN O
by IN O
the DT O
hot JJ O
phenol NN O
method NN O
( SYM O
28 CD O
) -RRB- O
. . O

One CD O
- HYPH O
tenth NN O
of IN O
the DT O
precipitated VBN O
RNA NNP O
was VBD O
then RB O
separated VBN O
on IN O
6 CD O
% NN O
polyacrylamide NN O
7 CD O
M NN O
urea NN O
denaturing NN O
gels NNS O
and CC O
electro NN O
- HYPH O
transferred VBN O
to IN O
Zeta NNP O
- HYPH O
Probe NNP O
GT NNP O
nylon NN O
membranes NNS O
. . O

They PRP O
were VBD O
probed VBN O
with IN O
[ -LRB- O
gamma NN O
- HYPH O
32P CD O
] -RRB- O
ATP NNP O
labeled VBN O
oligonucleotides NNS O
. . O

For IN O
the DT O
lanes NNS O
showing VBG O
total JJ O
RNA NNP O
, , O
2 CD O
micro JJ O
g NN O
RNA NNP O
prepared VBN O
from IN O
exponentially RB O
growing VBG O
cultures NNS O
were VBD O
loaded VBN O
. . O

For IN O
co NN O
- HYPH O
precipitation NN O
analysis NN O
of IN O
proteins NNS O
, , O
the DT O
IgG NNP O
beads NNS O
were VBD O
resuspended VBN O
in IN O
2 CD O
x SYM O
Laemmli NNP O
sample NN O
buffer NN O
, , O
boiled VBN O
for IN O
5 CD O
min NN O
and CC O
separated VBN O
by IN O
SDS NNP O
- HYPH O
polyacrylamide NN O
gel NN O
electrophoresis NN O
. . O

Approximately RB O
1 CD O
% NN O
of IN O
the DT O
precipitate JJ O
was VBD O
loaded VBN O
onto IN O
each DT O
lane NN O
. . O

For IN O
the DT O
total JJ O
protein NN O
, , O
0 CD O
. . O
1 CD O
% NN O
of IN O
the DT O
extract NN O
prior RB O
to IN O
precipitation NN O
was VBD O
loaded VBN O
onto IN O
each DT O
lane NN O
. . O

Following VBG O
electrophoresis NN O
, , O
the DT O
proteins NNS O
were VBD O
transferred VBN O
to IN O
nitrocellulose NN O
membranes NNS O
and CC O
detected VBN O
using VBG O
anti JJ O
- HYPH O
Nop1 NN O
antibody NN O
at IN O
1 CD O
: SYM O
3000 CD O
dilution NN O
( : O
provided VBN O
by IN O
J NNP O
. . O
Aris NNP O
) -RRB- O
and CC O
anti JJ O
- HYPH O
L3 NN O
antibody NN O
( , O
provided VBN O
by IN O
J NNP O
. . O
Warner NNP O
) -RRB- O
at IN O
1 CD O
: SYM O
3000 CD O
dilution NN O
followed VBN O
by IN O
peroxidase NN O
- HYPH O
conjugated VBN O
anti JJ O
- HYPH O
mouse NN B-Species
secondary JJ O
antibody NN O
at IN O
1 CD O
: SYM O
5000 CD O
dilution NN O
. . O

The DT O
antibody NN O
complexes NNS O
were VBD O
detected VBN O
using VBG O
ECL NNP O
- HYPH O
Plus CC O
reagents NNS O
( -LRB- O
Amersham NNP O
Pharmacia NNP O
) -RRB- O
as IN O
specified VBN O
by IN O
the DT O
manufacturer NN O
. . O

RESULTS NNS O

Construction NN O
and CC O
analysis NN O
of IN O
ENP1 NNP O
temperature NN O
- HYPH O
sensitive JJ O
alleles NNS O

ENP1 NNP O
is VBZ O
an DT O
essential JJ O
yeast NN B-Species
gene NN O
conserved VBN O
among IN O
eukaryotes NNS O
( SYM O
18 CD O
) -RRB- O
. . O

To TO O
study VB O
its PRP$ O
functions NNS O
, , O
we PRP O
first RB O
created VBD O
a DT O
diploid NN O
strain NN O
, , O
JBY45 NNP O
, , O
heterozygous JJ O
for IN O
the DT O
Delta NNP O
enp1 NN O
mutation NN O
. . O

Then RB O
two CD O
enp1 NN O
ts IN O
mutant JJ O
alleles NNS O
( , O
enp1 CD O
- HYPH O
1 CD O
and CC O
enp1 CD O
- HYPH O
2 CD O
) -RRB- O
were VBD O
generated VBN O
by IN O
random JJ O
PCR NNP O
mutagenesis NN O
, , O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

Both DT O
mutant JJ O
alleles NNS O
were VBD O
recessive JJ O
to IN O
the DT O
wild JJ O
- HYPH O
type NN O
ENP1 NN O
gene NN O
. . O

The DT O
enp1 NN O
- HYPH O
1 CD O
gene NN O
was VBD O
integrated VBN O
into IN O
the DT O
chromosomal JJ O
trp1 NN O
- HYPH O
1 CD O
locus NN O
to TO O
create VB O
strain NN O
JBY51 NNP O
and CC O
all DT O
subsequent JJ O
experiments NNS O
were VBD O
done VBN O
with IN O
this DT O
enp1 NN O
allele NN O
. . O

At IN O
23 CD O
degrees NNS O
C NN O
the DT O
growth NN O
of IN O
JBY51 NNP O
was VBD O
comparable JJ O
to IN O
that DT O
of IN O
W303 CD O
- HYPH O
1a CD O
( SYM O
ENP1 NNP O
) -RRB- O
, , O
but CC O
at IN O
37 CD O
degrees NNS O
C NN O
it PRP O
did VBD O
not RB O
grow VB O
( : O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

Sequence NN O
analysis NN O
revealed VBD O
that IN O
enp1 NN O
- HYPH O
1 CD O
contains VBZ O
two CD O
point NN O
mutations NNS O
, , O
resulting VBG O
in IN O
substitutions NNS O
of IN O
two CD O
amino NN O
acids NNS O
: : O
W242 CD O
- HYPH O
- : O
> : O
G NN O
and CC O
V415 CD O
- HYPH O
- : O
> : O
A NN O
. . O

No DT O
attempt NN O
was VBD O
made VBN O
to TO O
determine VB O
whether IN O
both DT O
mutations NNS O
were VBD O
required VBN O
for IN O
the DT O
ts VBZ O
phenotype NN O
. . O

Flow NN O
cytometry NN O
of IN O
strain NN O
JBY51 NNP O
showed VBD O
DNA NN O
content NN O
profiles NNS O
similar JJ O
to IN O
those DT O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
strain NN O
at IN O
the DT O
non JJ O
- HYPH O
permissive JJ O
temperature NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
suggesting VBG O
that IN O
ENP1 NNP O
is VBZ O
not RB O
involved VBN O
in IN O
cell NN O
cycle NN O
regulation NN O
. . O

Enp1 NNP O
is VBZ O
enriched VBN O
in IN O
the DT O
nucleolus NN O

Enp1 NNP O
tagged VBD O
at IN O
the DT O
C NNP O
- HYPH O
terminus NN O
with IN O
the DT O
myc NN O
epitope NN O
was VBD O
previously RB O
found VBN O
to TO O
localize VB O
to IN O
the DT O
nucleus NN O
( HYPH O
18 CD O
) -RRB- O
. . O

To TO O
expand VB O
this DT O
analysis NN O
, , O
we PRP O
fused VBD O
GFP NNP O
to IN O
the DT O
N NNP O
- HYPH O
terminus NN O
of IN O
Enp1 NNP O
, , O
and CC O
expressed VBD O
the DT O
tagged VBN O
Enp1 NNP O
protein NN O
under IN O
control NN O
of IN O
the DT O
MET25 NNP O
promoter NN O
as IN O
the DT O
sole JJ O
source NN O
of IN O
Enp1 NNP O
protein NN O
in IN O
the DT O
cells NNS O
. . O

Cells NNS O
of IN O
strain NN O
CWY13 NNP O
( -LRB- O
pMET25 NN O
- HYPH O
GFP NNP O
- HYPH O
ENP1 NNP O
) -RRB- O
were VBD O
grown VBN O
in IN O
media NNS O
with IN O
methionine NN O
( , O
transcription NN O
partially RB O
repressed VBN O
) , O
or CC O
without IN O
methionine NN O
( , O
transcription NN O
not RB O
repressed VBN O
) -RRB- O
. . O

Growth NN O
of IN O
CWY13 NNP O
was VBD O
comparable JJ O
to IN O
that DT O
of IN O
wild JJ O
- HYPH O
type NN O
cells NNS O
in IN O
both DT O
media NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
indicating VBG O
that IN O
the DT O
GFP NNP O
tagged VBD O
Enp1 NNP O
protein NN O
was VBD O
functional JJ O
. . O

In IN O
cells NNS O
cultured VBN O
in IN O
medium NN O
without IN O
methionine NN O
, , O
in IN O
which WDT O
the DT O
ENP NNP O
transcription NN O
was VBD O
not RB O
repressed VBN O
, , O
the DT O
GFP NNP O
- HYPH O
Enp1 NNP O
protein NN O
was VBD O
expressed VBN O
at IN O
a DT O
high JJ O
level NN O
and CC O
showed VBD O
strong JJ O
green JJ O
fluorescence NN O
distributed VBN O
throughout IN O
the DT O
nucleus NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
consistent JJ O
with IN O
the DT O
original JJ O
observation NN O
( : O
18 CD O
) -RRB- O
. . O

With IN O
methionine NN O
added VBN O
to IN O
the DT O
medium JJ O
, , O
however RB O
, , O
the DT O
fluorescent JJ O
signal NN O
of IN O
GFP NNP O
- HYPH O
Enp1 NNP O
was VBD O
weaker JJR O
and CC O
surprisingly RB O
showed VBD O
crescent NN O
or CC O
cap NN O
- HYPH O
like JJ O
patterns NNS O
typical JJ O
of IN O
nucleolar JJ O
proteins NNS O
( , O
Fig NNP O
. . O
3A NNP O
) -RRB- O
. . O

This DT O
nucleolar JJ O
enrichment NN O
was VBD O
confirmed VBN O
by IN O
its PRP$ O
co NN O
- HYPH O
localization NN O
with IN O
the DT O
nucleolar JJ O
protein NN O
Nop1 NNP O
( : O
Fig NNP O
. . O
3B NN O
) -RRB- O
. . O

ENP1 NNP O
mutation NN O
leads VBZ O
to IN O
reduced VBN O
levels NNS O
of IN O
40S CD O
ribosomal JJ O
subunits NNS O

The DT O
nucleolar JJ O
enrichment NN O
suggested VBD O
that IN O
Enp1 NNP O
might MD O
play VB O
some DT O
role NN O
in IN O
ribosome NN O
synthesis NN O
. . O

To TO O
test VB O
this DT O
possibility NN O
, , O
cells NNS O
of IN O
W303 CD O
- HYPH O
1a CD O
( , O
ENP1 NNP O
) -RRB- O
, , O
JBY51 NNP O
( , O
enp1 NN O
- HYPH O
1 CD O
) -RRB- O
and CC O
a DT O
top2 NN O
ts NNS O
strain NN O
RS191 CD O
( SYM O
30 CD O
) -RRB- O
were VBD O
grown VBN O
in IN O
YPD NNP O
at IN O
23 CD O
or CC O
37 CD O
degrees NNS O
C NN O
and CC O
their PRP$ O
ribosome NN O
profiles NNS O
analyzed VBN O
after IN O
separation NN O
on IN O
sucrose JJ O
gradients NNS O
. . O

At IN O
23 CD O
degrees NNS O
C NN O
, , O
enp1 NN O
- HYPH O
1 CD O
cells NNS O
showed VBD O
polysome NN O
profiles NNS O
similar JJ O
to IN O
those DT O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
and CC O
top2 NN O
- HYPH O
1 CD O
strains NNS O
( -LRB- O
Fig NNP O
. . O
4A NN O
- HYPH O
C NN O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
after IN O
incubation NN O
at IN O
the DT O
non JJ O
- HYPH O
permissive JJ O
temperature NN O
( : O
37 CD O
degrees NNS O
C NN O
) -RRB- O
for IN O
40 CD O
min NN O
( , O
data NNS O
not RB O
shown VBN O
) , O
and CC O
2 CD O
h NN O
, , O
enp1 NN O
- HYPH O
1 CD O
cells NNS O
had VBD O
reduced VBN O
levels NNS O
of IN O
40S CD O
ribosomal JJ O
subunits NNS O
, , O
80S NNS O
monosomes NNS O
and CC O
polysomes NNS O
, , O
along IN O
with IN O
a DT O
dramatic JJ O
increase NN O
in IN O
the DT O
free JJ O
60S CD O
subunit NN O
peak NN O
( , O
Fig NNP O
. . O
4F CD O
) -RRB- O
, , O
while IN O
the DT O
wild JJ O
- HYPH O
type NN O
and CC O
top2 NN O
- HYPH O
1 CD O
cells NNS O
showed VBD O
little JJ O
change NN O
in IN O
polysome JJ O
profile NN O
at IN O
37 CD O
degrees NNS O
C NN O
( , O
Fig NNP O
. . O
4D CD O
and CC O
E NN O
) -RRB- O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
the DT O
changes NNS O
of IN O
the DT O
enp1 NN O
- HYPH O
1 CD O
polysome JJ O
profile NN O
were VBD O
due IN O
to IN O
specific JJ O
defects NNS O
caused VBN O
by IN O
the DT O
enp1 NN O
- HYPH O
1 CD O
mutation NN O
, , O
and CC O
not RB O
due JJ O
simply RB O
to IN O
the DT O
shift NN O
to IN O
37 CD O
degrees NNS O
C NN O
for IN O
a DT O
wild JJ O
- HYPH O
type NN O
or CC O
ts VBZ O
strain NN O
. . O

The DT O
processing NN O
of IN O
pre NN O
- HYPH O
rRNA NN O
for IN O
18S NNP O
rRNA NNP O
is VBZ O
impaired VBN O
in IN O
enp1 CD O
mutants NNS O

In IN O
most JJS O
cases NNS O
reductions NNS O
in IN O
ribosomal JJ O
subunit NN O
levels NNS O
are VBP O
the DT O
results NNS O
of IN O
defects NNS O
in IN O
pre NN O
- HYPH O
rRNA NN O
processing NN O
or CC O
ribosome NN O
assembly NN O
or CC O
both DT O
( , O
3 CD O
) -RRB- O
. . O

To TO O
study VB O
the DT O
mechanism NN O
by IN O
which WDT O
Enp1 NNP O
affects VBZ O
the DT O
40S NNP O
subunit NN O
, , O
we PRP O
analyzed VBD O
the DT O
effects NNS O
of IN O
enp1 NN O
mutations NNS O
on IN O
processing NN O
of IN O
the DT O
pre NN O
- HYPH O
rRNA NNP O
using VBG O
pulse NN O
- HYPH O
chase NN O
labeling NN O
. . O

[ -LRB- O
methyl NN O
- HYPH O
3H CD O
] -RRB- O
methionine NN O
is VBZ O
preferred VBN O
for IN O
labeling VBG O
rRNAs NNS O
in IN O
pulse NN O
- HYPH O
chase NN O
analysis NN O
because IN O
rRNAs NNS O
are VBP O
specifically RB O
methylated VBN O
during IN O
the DT O
early JJ O
steps NNS O
of IN O
the DT O
processing NN O
. . O

Cells NNS O
of IN O
W303 CD O
- HYPH O
1a CD O
( SYM O
ENP1 NNP O
) -RRB- O
and CC O
JBY51 NNP O
( , O
enp1 CD O
- HYPH O
1 CD O
) -RRB- O
were VBD O
grown VBN O
at IN O
23 CD O
or CC O
37 CD O
degrees NNS O
C NN O
for IN O
2 CD O
h NNS O
before IN O
they PRP O
were VBD O
labeled VBN O
with IN O
[ -LRB- O
methyl NN O
- HYPH O
3H CD O
] -RRB- O
methionine NN O
for IN O
3 CD O
min NN O
and CC O
chased VBN O
with IN O
cold JJ O
methionine NN O
for IN O
2 CD O
, , O
4 CD O
and CC O
12 CD O
min NN O
. . O

In IN O
wild JJ O
- HYPH O
type NN O
cells NNS O
, , O
the DT O
labeled VBN O
35S NNP O
rRNA NNP O
precursor NN O
, , O
27S NNP O
and CC O
20S NNP O
rRNA NNP O
intermediates NNS O
were VBD O
rapidly RB O
chased VBN O
into IN O
mature JJ O
25S NNS O
and CC O
18S CD O
rRNAs NNS O
( -LRB- O
Fig NNP O
. . O
5 CD O
) -RRB- O
, , O
at IN O
23 CD O
or CC O
37 CD O
degrees NNS O
C NN O
. . O

In IN O
contrast NN O
, , O
enp1 NN O
- HYPH O
1 CD O
cells NNS O
showed VBD O
dramatic JJ O
changes NNS O
after IN O
incubation NN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Although IN O
at IN O
23 CD O
degrees NNS O
C NN O
the DT O
synthesis NN O
and CC O
processing NN O
were VBD O
comparable JJ O
to IN O
those DT O
of IN O
wild JJ O
- HYPH O
type NN O
cells NNS O
, , O
cells NNS O
cultured VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
2 CD O
h NN O
had VBD O
neither CC O
20S CD O
pre NN O
- HYPH O
rRNA NNP O
nor CC O
18S NNP O
rRNA NNP O
, , O
while IN O
25S NNP O
rRNA NNP O
was VBD O
generated VBN O
at IN O
normal JJ O
levels NNS O
. . O

The DT O
37 CD O
degrees NNS O
C NN O
grown VBN O
enp1 NN O
- HYPH O
1 CD O
cells NNS O
also RB O
had VBD O
low JJ O
levels NNS O
of IN O
aberrant JJ O
23S NNS O
and CC O
possibly RB O
21S CD O
intermediates NNS O
( , O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

The DT O
defect NN O
in IN O
18S NNP O
rRNA NNP O
synthesis NN O
was VBD O
further RB O
supported VBN O
by IN O
pulse NN O
- HYPH O
chase NN O
experiments NNS O
carried VBN O
out RP O
using VBG O
[ -LRB- O
5 CD O
, , O
6 CD O
- HYPH O
3H CD O
] -RRB- O
uracil NN O
. . O

The DT O
results NNS O
obtained VBN O
were VBD O
essentially RB O
the DT O
same JJ O
; : O
no DT O
20S CD O
pre NN O
- HYPH O
rRNA NN O
or CC O
18S NNP O
rRNA NNP O
was VBD O
produced VBN O
, , O
while IN O
processing NN O
to IN O
25S NNP O
rRNA NNP O
was VBD O
not RB O
affected VBN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
suggested VBD O
that IN O
the DT O
enp1 NN O
mutation NN O
leads VBZ O
to IN O
specific JJ O
defects NNS O
in IN O
the DT O
processing NN O
pathway NN O
for IN O
20S NNP O
pre NN O
- HYPH O
rRNA NNP O
and CC O
18S NNP O
rRNA NNP O
, , O
resulting VBG O
in IN O
reduced VBN O
40S NNP O
subunit NN O
synthesis NN O
and CC O
a DT O
lowered VBN O
level NN O
of IN O
the DT O
40S NNP O
subunit NN O
. . O

Enp1 NNP O
is VBZ O
required VBN O
for IN O
pre JJ O
- HYPH O
rRNA NN O
processing NN O
at IN O
A0 NNP O
, , O
A1 NNP O
and CC O
A2 NNP O
sites NNS O

To TO O
define VB O
the DT O
processing NN O
steps NNS O
affected VBN O
by IN O
the DT O
enp1 NN O
mutation NN O
, , O
the DT O
steady JJ O
state NN O
levels NNS O
of IN O
rRNA NNP O
precursors NNS O
and CC O
mature JJ O
RNAs NNS O
were VBD O
analyzed VBN O
by IN O
northern JJ O
blotting NN O
. . O

Total JJ O
RNAs NNS O
were VBD O
isolated VBN O
from IN O
cells NNS O
of IN O
W303 CD O
- HYPH O
1a CD O
( SYM O
ENP1 NNP O
) -RRB- O
and CC O
JBY51 NNP O
( -LRB- O
enp1 NN O
- HYPH O
1 CD O
) -RRB- O
grown VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
2 CD O
or CC O
4 CD O
h NNS O
. . O

After IN O
separation NN O
on IN O
formaldehyde NN O
agarose NN O
, , O
RNAs NNS O
were VBD O
transferred VBN O
onto IN O
nylon NN O
membranes NNS O
and CC O
probed VBN O
with IN O
radiolabeled VBN O
oligonucleotides NNS O
specific JJ O
to IN O
various JJ O
regions NNS O
of IN O
the DT O
35S NNP O
pre NNP O
- HYPH O
rRNA NNP O
( : O
Fig NNP O
. . O
6A NNP O
) -RRB- O
. . O

After IN O
incubation NN O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
enp1 NN O
- HYPH O
1 CD O
cells NNS O
had VBD O
wild JJ O
- HYPH O
type NN O
levels NNS O
of IN O
25S NNP O
rRNA NNP O
, , O
but CC O
reduced VBN O
levels NNS O
of IN O
18S NNP O
rRNA NNP O
( : O
Fig NNP O
. . O
6B NN O
) -RRB- O
. . O

A DT O
probe NN O
specific JJ O
to IN O
ITS1 NNP O
( -LRB- O
P5 NNP O
) -RRB- O
further RB O
revealed VBD O
that IN O
enp1 NN O
- HYPH O
1 CD O
cells NNS O
incubated VBN O
at IN O
the DT O
non JJ O
- HYPH O
permissive JJ O
temperature NN O
accumulated VBD O
two CD O
aberrant JJ O
rRNAs NNS O
, , O
23S NNPS O
and CC O
21S NNS O
( SYM O
Fig NNP O
. . O
6C NNP O
) -RRB- O
. . O

Aberrant NNP O
rRNA NNP O
processing NN O
products NNS O
of IN O
similar JJ O
sizes NNS O
have VBP O
been VBN O
described VBN O
in IN O
numerous JJ O
studies NNS O
( , O
14 CD O
, , O
31 CD O
- HYPH O
34 CD O
) -RRB- O
and CC O
result VBP O
from IN O
defects NNS O
in IN O
processing NN O
at IN O
A0 NNP O
, , O
A1 NNP O
and CC O
A2 NNP O
. . O

Additional JJ O
probes NNS O
were VBD O
used VBN O
to TO O
verify VB O
the DT O
origins NNS O
of IN O
the DT O
23S NNP O
and CC O
21S CD O
RNAs NNS O
in IN O
the DT O
enp1 NN O
- HYPH O
1 CD O
strain NN O
. . O

The DT O
23S CD O
product NN O
was VBD O
detected VBN O
by IN O
oligos NNS O
1 CD O
, , O
2 CD O
, , O
4 CD O
and CC O
5 CD O
, , O
but CC O
not RB O
by IN O
oligos NNS O
6 CD O
, , O
7 CD O
or CC O
8 CD O
( SYM O
Fig NNP O
. . O
6D CD O
, , O
E NNP O
, , O
C NNP O
, , O
F NNP O
, , O
G NNP O
and CC O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Thus RB O
this DT O
RNA NNP O
extends VBZ O
from IN O
the DT O
5 CD O
' '' O
end NN O
of IN O
the DT O
35S NNP O
rRNA NNP O
to IN O
the DT O
A3 NNP O
site NN O
. . O

The DT O
21S CD O
product NN O
was VBD O
detected VBN O
by IN O
oligos NNS O
4 CD O
and CC O
5 CD O
, , O
but CC O
not RB O
by IN O
oligos NNS O
1 CD O
, , O
2 CD O
, , O
6 CD O
, , O
7 CD O
and CC O
8 CD O
( SYM O
Fig NNP O
. . O
6E CD O
, , O
C NNP O
, , O
D NNP O
, , O
F NNP O
, , O
G NNP O
and CC O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
indicating VBG O
that IN O
it PRP O
extends VBZ O
from IN O
the DT O
A1 NNP O
to IN O
the DT O
A3 NNP O
site NN O
. . O

At IN O
37 CD O
degrees NNS O
C NN O
the DT O
enp1 NN O
- HYPH O
1 CD O
cells NNS O
also RB O
had VBD O
less JJR O
32S NNS O
and CC O
20S NNS O
rRNA NNP O
intermediates NNS O
( -LRB- O
Fig NNP O
. . O
6B NN O
and CC O
E NN O
) -RRB- O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
enp1 NN O
mutation NN O
led VBN O
to IN O
complete JJ O
or CC O
nearly RB O
complete JJ O
inhibition NN O
of IN O
processing NN O
at IN O
site NN O
A0 NN O
and CC O
A2 NNP O
, , O
and CC O
partial JJ O
inhibition NN O
of IN O
processing NN O
at IN O
site NN O
A1 NN O
. . O

As IN O
a DT O
consequence NN O
, , O
the DT O
35S CD O
pre NN O
- HYPH O
rRNA NNP O
was VBD O
cleaved VBN O
at IN O
site NN O
A3 NNP O
instead RB O
, , O
producing VBG O
23S NNP O
and CC O
21S NNP O
rRNA NNP O
products NNS O
. . O

Consistent JJ O
with IN O
this DT O
theory NN O
, , O
the DT O
27SA2 NNP O
rRNA NNP O
intermediate JJ O
level NN O
was VBD O
greatly RB O
reduced VBN O
in IN O
enp1 NN O
cells NNS O
at IN O
37 CD O
degrees NNS O
C NN O
( , O
Fig NNP O
. . O
6C NNP O
) -RRB- O
due IN O
to IN O
the DT O
inhibition NN O
of IN O
processing NN O
at IN O
A2 NNP O
, , O
while IN O
the DT O
27SB NNP O
pre NN O
- HYPH O
rRNA NN O
level NN O
was VBD O
similar JJ O
to IN O
wild JJ O
- HYPH O
type NN O
cells NNS O
( : O
Fig NNP O
. . O
6G NNP O
) -RRB- O
. . O

Moreover RB O
, , O
no DT O
difference NN O
in IN O
the DT O
5 CD O
. . O
8 CD O
rRNA NN O
level NN O
was VBD O
observed VBN O
between IN O
the DT O
wild JJ O
- HYPH O
type NN O
cells NNS O
and CC O
enp1 NN O
cells NNS O
( -LRB- O
Fig NNP O
. . O
6H CD O
) -RRB- O
. . O

Enp1 NNP O
is VBZ O
associated VBN O
with IN O
U3 NNP O
and CC O
U14 NNP O
snoRNAs NNS O
and CC O
with IN O
Nop1 NNP O

It PRP O
has VBZ O
previously RB O
been VBN O
shown VBN O
that IN O
mutations NNS O
in IN O
the DT O
U3 NNP O
, , O
U14 NNP O
, , O
snR10 NN O
and CC O
snR30 NN O
snoRNAs NNS O
and CC O
in IN O
their PRP$ O
associated VBN O
proteins NNS O
affect VBP O
processing NN O
of IN O
35S CD O
pre NN O
- HYPH O
rRNA NNP O
at IN O
A0 NNP O
, , O
A1 NNP O
and CC O
A2 NNP O
. . O

Because IN O
of IN O
the DT O
similarity NN O
with IN O
the DT O
processing NN O
defects NNS O
of IN O
enp1 NN O
- HYPH O
1 CD O
strains NNS O
, , O
we PRP O
tested VBD O
the DT O
association NN O
between IN O
Enp1 NNP O
and CC O
snoRNAs NNS O
. . O

To TO O
do VB O
this DT O
, , O
we PRP O
created VBD O
a DT O
strain NN O
in IN O
which WDT O
a DT O
TAP NNP O
tag NN O
was VBD O
fused VBN O
to IN O
the DT O
C NNP O
- HYPH O
terminus NN O
of IN O
Enp1 NNP O
. . O

The DT O
TAP NNP O
tag NN O
contains VBZ O
Staphylococcus NNP B-Species
aureus NN I-Species
Protein NNP O
A NNP O
as RB O
well RB O
as IN O
calmodulin NN O
- HYPH O
binding VBG O
peptide NN O
sequences NNS O
, , O
so IN O
the DT O
tagged VBN O
Enp1 NN O
binds VBZ O
IgG NN O
beads NNS O
with IN O
high JJ O
specificity NN O
. . O

Cells NNS O
grew VBD O
well RB O
with IN O
the DT O
TAP NNP O
- HYPH O
tagged VBN O
Enp1 NNP O
as IN O
the DT O
only JJ O
source NN O
of IN O
Enp1 NNP O
protein NN O
, , O
showing VBG O
that IN O
it PRP O
was VBD O
functional JJ O
. . O

As IN O
a DT O
control NN O
, , O
we PRP O
used VBD O
a DT O
TAP NNP O
tag NN O
on IN O
an DT O
unrelated JJ O
cytoplasmic JJ O
protein NN O
, , O
Hst2 NNP O
. . O

Strain NN O
CWY14 NNP O
( -LRB- O
ENP1 NNP O
- HYPH O
TAP NNP O
) -RRB- O
and CC O
the DT O
Hst2 NNP O
- HYPH O
TAP NN O
tagged VBN O
strain NN O
were VBD O
grown VBN O
in IN O
YPD NNP O
to IN O
mid JJ O
- HYPH O
exponential JJ O
phase NN O
before IN O
being VBG O
harvested VBN O
. . O

Extracts NNS O
were VBD O
prepared VBN O
and CC O
mixed VBN O
with IN O
IgG NNP O
agarose NN O
beads NNS O
to TO O
precipitate VB O
Enp1 NNP O
- HYPH O
TAP NNP O
and CC O
associated VBN O
RNAs NNPS O
. . O

Total JJ O
RNAs NNS O
were VBD O
extracted VBN O
from IN O
washed VBN O
IgG NNP O
beads NNS O
, , O
separated VBN O
on IN O
6 CD O
% NN O
polyacrylamide NN O
denaturing NN O
gels NNS O
, , O
transferred VBN O
to IN O
nylon NN O
membranes NNS O
and CC O
probed VBN O
with IN O
radiolabeled VBN O
oligonucleotides NNS O
. . O

Northern JJ O
analysis NN O
revealed VBD O
that IN O
Enp1 NNP O
- HYPH O
TAP NNP O
precipitates VBZ O
were VBD O
enriched VBN O
with IN O
U3 NNP O
and CC O
U14 NNP O
snoRNAs NNS O
relative JJ O
to IN O
precipitates NNS O
from IN O
the DT O
Hst2 NNP O
- HYPH O
tagged VBN O
strain NN O
( , O
Fig NNP O
. . O
7A NN O
) -RRB- O
. . O

The DT O
Enp1 NNP O
- HYPH O
TAP NNP O
samples NNS O
were VBD O
not RB O
enriched VBN O
with IN O
snR30 NNP O
snoRNA NNP O
( -LRB- O
Fig NNP O
. . O
7A NNP O
) -RRB- O
, , O
nor CC O
with IN O
U24 NNP O
or CC O
U18 NNP O
snoRNAs NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

We PRP O
found VBD O
no DT O
change NN O
in IN O
the DT O
levels NNS O
of IN O
U3 NNP O
, , O
U14 NNP O
, , O
snR10 NN O
and CC O
snR30 NN O
snoRNAs NNS O
in IN O
the DT O
enp1 NN O
mutant NN O
, , O
indicating VBG O
that IN O
the DT O
mutation NN O
did VBD O
not RB O
affect VB O
snoRNAs NN O
levels NNS O
( : O
Fig NNP O
. . O
6I CD O
) -RRB- O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
Enp1 NNP O
associates NNS O
in IN O
vivo NN O
with IN O
U3 NNP O
and CC O
U14 NNP O
snoRNAs NNS O
. . O

Much RB O
less JJR O
U3 NNP O
RNA NNP O
co NN O
- HYPH O
immunoprecipitated VBN O
with IN O
Enp1 NNP O
- HYPH O
TAP NNP O
than IN O
with IN O
Protein NNP O
A NNP O
- HYPH O
tagged VBN O
Nop1 NNP O
, , O
which WDT O
is VBZ O
known VBN O
to TO O
associate VB O
with IN O
U3 NNP O
and CC O
U14 NNP O
snoRNAs NNS O
( : O
Fig NNP O
. . O
7A NNP O
) -RRB- O
. . O

However RB O
, , O
Protein NNP O
A NNP O
- HYPH O
Nop1 NNP O
was VBD O
much RB O
more RBR O
efficiently RB O
precipitated VBN O
than IN O
was VBD O
the DT O
Enp1 NNP O
- HYPH O
TAP NN O
protein NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
similar JJ O
amounts NNS O
of IN O
RNAs NNS O
are VBP O
associated VBN O
with IN O
the DT O
two CD O
proteins NNS O
and CC O
that IN O
the DT O
proteins NNS O
are VBP O
part NN O
of IN O
the DT O
same JJ O
complex NN O
. . O

To TO O
address VB O
this DT O
further RB O
, , O
we PRP O
checked VBD O
for IN O
the DT O
presence NN O
of IN O
Nop1 NNP O
in IN O
the DT O
Enp1 NNP O
- HYPH O
TAP NNP O
immunoprecipitates VBZ O
. . O

Figure NN O
7B NN O
shows VBZ O
that IN O
Nop1 NNP O
indeed RB O
is VBZ O
in IN O
the DT O
Enp1 NNP O
precipitate JJ O
but CC O
not RB O
in IN O
the DT O
Hst2 NNP O
control NN O
, , O
whereas IN O
an DT O
abundant JJ O
ribosomal JJ O
protein NN O
, , O
L3 NNP O
, , O
is VBZ O
in IN O
neither CC O
precipitate JJ O
. . O

U3 NNP O
and CC O
U14 NNP O
snoRNAs NNS O
have VBP O
been VBN O
shown VBN O
to TO O
interact VB O
with IN O
rRNA NNP O
precursors NNS O
and CC O
these DT O
interactions NNS O
are VBP O
required VBN O
for IN O
pre JJ O
- HYPH O
rRNA NN O
processing NN O
( : O
35 CD O
- HYPH O
37 CD O
) -RRB- O
. . O

Using VBG O
an DT O
in FW O
vitro FW O
system NN O
, , O
U3 NNP O
was VBD O
also RB O
shown VBN O
to TO O
be VB O
associated VBN O
with IN O
its PRP$ O
rRNA NNP O
substrate NN O
and CC O
processing NN O
product NN O
( SYM O
38 CD O
) -RRB- O
. . O

This DT O
raised VBD O
the DT O
possibility NN O
that IN O
Enp1 NNP O
might MD O
also RB O
be VB O
associated VBN O
with IN O
rRNAs NNS O
since IN O
its PRP$ O
function NN O
in IN O
rRNA NNP O
processing NN O
appeared VBD O
linked VBN O
to IN O
those DT O
of IN O
U3 NNP O
and CC O
U14 NNP O
snoRNAs NNS O
. . O

To TO O
test VB O
this DT O
possibility NN O
, , O
we PRP O
further RB O
analyzed VBD O
the DT O
RNAs NNS O
that WDT O
co VBP O
- HYPH O
precipiate JJ O
with IN O
TAP NNP O
- HYPH O
tagged VBN O
Enp1 NNP O
. . O

The DT O
RNAs NNS O
were VBD O
separated VBN O
on IN O
1 CD O
. . O
2 CD O
% NN O
agarose JJ O
formaldehyde NN O
gels NNS O
or CC O
on IN O
polyacrylamide NN O
denaturing NN O
gels NNS O
, , O
transferred VBN O
to IN O
nylon NN O
membranes NNS O
and CC O
probed VBN O
with IN O
radiolabeled VBN O
oligonucleotides NNS O
for IN O
pre NN O
- HYPH O
rRNAs NNS O
. . O

A DT O
probe NN O
( -LRB- O
P4 NN O
; : O
see VB O
Fig NNP O
. . O
6 CD O
) -RRB- O
specific NN O
to IN O
20s NNS O
and CC O
its PRP$ O
precursors NNS O
revealed VBN O
that IN O
pre FW O
- HYPH O
rRNAs NNP O
35S NNPS O
, , O
33S NNPS O
, , O
32S NNS O
and CC O
20S NNS O
specifically RB O
co NN O
- HYPH O
precipitated VBN O
with IN O
Enp1 NNP O
- HYPH O
TAP NNP O
( : O
Fig NNP O
. . O
7C NNP O
) -RRB- O
. . O

No DT O
such JJ O
enrichment NN O
was VBD O
found VBN O
using VBG O
a DT O
probe NN O
( , O
P8 NN O
; : O
see VB O
Fig NNP O
. . O
6 CD O
) -RRB- O
specific JJ O
for IN O
27S CD O
RNAs NNS O
or CC O
a DT O
probe NN O
for IN O
5 CD O
. . O
8S NNP O
RNA NNP O
( -LRB- O
Fig NNP O
. . O
7C NNP O
) -RRB- O
. . O

These DT O
results NNS O
clearly RB O
demonstrated VBD O
that IN O
Enp1 NNP O
is VBZ O
associated VBN O
with IN O
substrates NNS O
and CC O
products NNS O
of IN O
the DT O
early JJ O
steps NNS O
of IN O
18S NNP O
rRNA NNP O
processing NN O
. . O

Comparison NN O
of IN O
Enp1 NNP O
with IN O
homologs NNS O
in IN O
other JJ O
organisms NNS O

Homologs NNS O
of IN O
Enp1 NNP O
protein NN O
in IN O
human NN B-Species
, , O
Drosophila NNP B-Species
and CC O
Caenorhabditis NNP B-Species
elegans NNS I-Species
have VBP O
been VBN O
reported VBN O
( : O
18 CD O
) -RRB- O
. . O

A DT O
previously RB O
described VBN O
human JJ B-Species
homolog NN O
, , O
bystin NN O
, , O
was VBD O
only RB O
306 CD O
amino NN O
acids NNS O
in IN O
length NN O
, , O
and CC O
lacked VBD O
sequences NNS O
corresponding VBG O
to IN O
the DT O
N NNP O
- HYPH O
terminal JJ O
163 CD O
amino NN O
acids NNS O
of IN O
yeast NN B-Species
Enp1 NNP O
( HYPH O
19 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
we PRP O
identified VBD O
a DT O
human NN B-Species
expressed VBN O
sequence NN O
tag NN O
( , O
EST NNP O
) -RRB- O
, , O
BC007340 NNP O
in IN O
a DT O
Blast NNP O
search NN O
that WDT O
revealed VBD O
an DT O
ORF NNP O
of IN O
1311 CD O
nucleotides NNS O
encoding VBG O
a DT O
437 CD O
amino NN O
acid NN O
polypeptide NN O
( SYM O
39 CD O
) -RRB- O
. . O

Comparison NN O
of IN O
this DT O
437 CD O
amino JJ O
acid NN O
polypeptide NN O
with IN O
human JJ B-Species
bystin NN O
( SYM O
19 CD O
) -RRB- O
showed VBD O
that IN O
they PRP O
were VBD O
encoded VBN O
by IN O
the DT O
same JJ O
gene NN O
on IN O
human JJ B-Species
chromosome NN O
6 CD O
. . O

The DT O
reported JJ O
sequence NN O
for IN O
human JJ B-Species
bystin NN O
is VBZ O
a DT O
fragment NN O
of IN O
the DT O
437 CD O
amino NN O
acid NN O
human JJ B-Species
Enp1 NN O
protein NN O
, , O
due IN O
to IN O
a DT O
truncated VBN O
cDNA NN O
sequence NN O
. . O

Also RB O
, , O
a DT O
sequence NN O
discrepancy NN O
at IN O
the DT O
C NNP O
- HYPH O
terminus NN O
is VBZ O
due JJ O
to IN O
inaccurate JJ O
DNA NN O
sequence NN O
of IN O
the DT O
human JJ B-Species
bystin NN O
, , O
as IN O
confirmed VBN O
by IN O
available JJ O
human JJ B-Species
genome NN O
and CC O
EST NNP O
sequences NNS O
. . O

Searches NNS O
of IN O
the DT O
database NN O
of IN O
other JJ O
organisms NNS O
identified VBN O
Enp1 NNP O
homologs NNS O
in IN O
S NNP B-Species
. . I-Species
pombe NN I-Species
, , O
Arabidopsis NNP B-Species
thaliana NN I-Species
, , O
C NNP B-Species
. . I-Species
elegans NNS I-Species
, , O
Drosophila NNP B-Species
melanogaster NN I-Species
and CC O
mouse NN B-Species
. . O

The DT O
alignment NN O
of IN O
the DT O
homologs NNS O
showed VBD O
that IN O
they PRP O
shared VBD O
homology NN O
from IN O
the DT O
N NNP O
- HYPH O
terminus NN O
to IN O
the DT O
C NNP O
- HYPH O
terminus NN O
, , O
with IN O
the DT O
C NN O
- HYPH O
terminal NN O
half NN O
extremely RB O
well RB O
conserved VBN O
, , O
with IN O
close JJ O
to TO O
90 CD O
% NN O
similarity NN O
( : O
Fig NNP O
. . O
8 CD O
) -RRB- O
. . O

One CD O
interesting JJ O
observation NN O
is VBZ O
that IN O
the DT O
two CD O
amino NN O
acids NNS O
changed VBD O
in IN O
the DT O
enp1 NN O
- HYPH O
1 CD O
mutant NN O
, , O
W242 NNP O
and CC O
V415 CD O
, , O
are VBP O
conserved VBN O
among IN O
all DT O
homologs NNS O
. . O

The DT O
human JJ B-Species
Enp1 NNP O
homolog NN O
was VBD O
cloned VBN O
and CC O
expressed VBN O
in IN O
yeast NN B-Species
and CC O
tested VBN O
for IN O
function NN O
. . O

Expressed VBN O
under IN O
the DT O
control NN O
of IN O
ADH NNP O
, , O
TEF NNP O
or CC O
GPD NNP O
promoter NN O
, , O
the DT O
human JJ B-Species
Enp1 NNP O
homolog NN O
did VBD O
not RB O
complement VB O
a DT O
yeast NN B-Species
enp1 NN O
null JJ O
mutant NN O
. . O

However RB O
, , O
a DT O
GFP NNP O
fusion NN O
to IN O
the DT O
N NN O
- HYPH O
terminus NN O
of IN O
human JJ B-Species
Enp1 NNP O
homolog NN O
localized VBD O
to IN O
the DT O
nucleus NN O
and CC O
was VBD O
enriched VBN O
in IN O
the DT O
nucleolus NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

DISCUSSION NN O

ENP1 NNP O
is VBZ O
a DT O
yeast NN B-Species
gene NN O
first RB O
identified VBN O
in IN O
a DT O
genetic JJ O
screen NN O
for IN O
complementation NN O
of IN O
mutations NNS O
in IN O
ost4 NN O
, , O
which WDT O
encodes VBZ O
a DT O
subunit NN O
of IN O
oligosaccharide NN O
transferase NN O
( SYM O
17 CD O
) -RRB- O
, , O
although IN O
subsequent JJ O
work NN O
showed VBD O
that IN O
it PRP O
is VBZ O
unlikely JJ O
that IN O
Enp1 NNP O
has VBZ O
any DT O
connection NN O
to IN O
oligosaccharide NN O
transferase NN O
( SYM O
18 CD O
) -RRB- O
. . O

ENP1 NNP O
was VBD O
shown VBN O
to TO O
be VB O
essential JJ O
for IN O
viability NN O
and CC O
the DT O
Enp1 NNP O
protein NN O
localized VBN O
to IN O
the DT O
nucleus NN O
( SYM O
18 CD O
) -RRB- O
. . O

When WRB O
we PRP O
re RB O
- HYPH O
examined VBD O
the DT O
localization NN O
of IN O
Enp1 NNP O
, , O
we PRP O
observed VBD O
that IN O
the DT O
protein NN O
was VBD O
enriched VBN O
in IN O
the DT O
nucleolus NN O
. . O

This DT O
finding NN O
led VBD O
us PRP O
to TO O
test VB O
for IN O
a DT O
role NN O
of IN O
Enp1 NNP O
in IN O
ribosome NN O
synthesis NN O
. . O

Using VBG O
an DT O
enp1 NN O
ts VBZ O
mutant JJ O
, , O
we PRP O
found VBD O
that IN O
depletion NN O
of IN O
Enp1 NNP O
caused VBD O
a DT O
40S CD O
ribosomal JJ O
subunit NN O
deficiency NN O
. . O

Further JJ O
analysis NN O
revealed VBD O
that IN O
this DT O
deficiency NN O
was VBD O
not RB O
due JJ O
to IN O
a DT O
change NN O
of IN O
the DT O
subunit NN O
' '' O
s NN O
stability NN O
, , O
but CC O
to IN O
a DT O
defect NN O
in IN O
the DT O
synthesis NN O
of IN O
the DT O
subunit NN O
' POS O
s NN O
18S NNP O
rRNA NNP O
component NN O
. . O

Pulse NN O
- HYPH O
chase NN O
analysis NN O
of IN O
RNA NNP O
synthesis NN O
in IN O
an DT O
enp1 NN O
- HYPH O
1 CD O
strain NN O
revealed VBD O
that IN O
no DT O
20S CD O
pre NN O
- HYPH O
rRNA NN O
or CC O
18S NNP O
rRNA NNP O
was VBD O
made VBN O
at IN O
the DT O
non AFX O
- HYPH O
permissive JJ O
temperature NN O
, , O
while IN O
levels NNS O
of IN O
25S NNP O
rRNA NNP O
appeared VBD O
normal JJ O
. . O

Low JJ O
levels NNS O
of IN O
precursors NNS O
to IN O
18S NNP O
rRNA NNP O
were VBD O
detected VBN O
in IN O
the DT O
mutants NNS O
, , O
and CC O
they PRP O
were VBD O
extremely RB O
unstable JJ O
. . O

Northern JJ O
analysis NN O
of IN O
steady JJ O
state NN O
RNA NNP O
levels NNS O
demonstrated VBD O
that IN O
the DT O
enp1 NN O
mutation NN O
specifically RB O
inhibited VBD O
the DT O
pre NN O
- HYPH O
rRNA NNP O
early JJ O
cleavages NNS O
at IN O
sites NNS O
A0 NNP O
, , O
A1 NNP O
and CC O
A2 NNP O
, , O
which WDT O
are VBP O
required VBN O
for IN O
the DT O
production NN O
of IN O
the DT O
20S NNP O
pre NNP O
- HYPH O
rRNA NNP O
and CC O
the DT O
18S NNP O
rRNA NNP O
. . O

These DT O
defects NNS O
of IN O
the DT O
enp1 NN O
mutation NN O
on IN O
rRNA NNP O
processing NN O
are VBP O
very RB O
similar JJ O
to IN O
those DT O
caused VBN O
by IN O
mutation NN O
of IN O
KRR1 NNP O
, , O
another DT O
essential JJ O
nucleolar NN O
gene NN O
required VBN O
for IN O
synthesis NN O
of IN O
the DT O
40S NNS O
, , O
but CC O
not RB O
the DT O
60S NNS O
subunit NN O
( SYM O
40 CD O
) -RRB- O
. . O

Co NN O
- HYPH O
precipitation NN O
analyses NNS O
provided VBD O
strong JJ O
evidence NN O
that IN O
Enp1 NNP O
is VBZ O
directly RB O
involved VBN O
in IN O
pre NN O
- HYPH O
rRNA NN O
processing NN O
. . O

In IN O
these DT O
experiments NNS O
, , O
TAP NNP O
- HYPH O
tagged VBN O
Enp1 NNP O
bound VBN O
to IN O
IgG NNP O
beads NNS O
specifically RB O
co NN O
- HYPH O
precipitated VBN O
with IN O
two CD O
snoRNAs NNS O
, , O
U3 NNP O
and CC O
U14 NNP O
, , O
and CC O
with IN O
the DT O
35S NNP O
, , O
33S NNPS O
, , O
32S NNPS O
and CC O
20S CD O
pre NN O
- HYPH O
rRNAs NNS O
. . O

Among IN O
the DT O
more JJR O
than IN O
100 CD O
snoRNAs NNS O
in IN O
yeast NN B-Species
cells NNS O
, , O
U3 NNP O
, , O
U14 NNP O
, , O
snR10 NNP O
, , O
snR30 NNP O
and CC O
MRP NNP O
RNA NNP O
are VBP O
the DT O
only JJ O
ones NNS O
required VBN O
for IN O
rRNA NNP O
processing NN O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
mutations NNS O
in IN O
U3 NNP O
, , O
U14 NNP O
, , O
snR10 NN O
and CC O
snR30 NN O
snoRNAs NNS O
and CC O
protein NN O
components NNS O
of IN O
the DT O
snoRNPs NNS O
affect VBP O
processing NN O
at IN O
sites NNS O
A0 NNP O
, , O
A1 NNP O
or CC O
A2 NNP O
( , O
15 CD O
, , O
16 CD O
, , O
41 CD O
, , O
42 CD O
) -RRB- O
. . O

Enp1 NNP O
' POS O
s POS O
interaction NN O
with IN O
U3 NNP O
and CC O
U14 NNP O
snoRNAs NNS O
suggests VBZ O
that IN O
Enp1 NNP O
' '' O
s NNS O
function NN O
in IN O
rRNA NNP O
processing NN O
involves VBZ O
these DT O
two CD O
snoRNAs NNS O
. . O

The DT O
fact NN O
that IN O
the DT O
nucleolar JJ O
protein NN O
, , O
Nop1 NNP O
, , O
known VBN O
to TO O
bind VB O
to IN O
U3 NNP O
and CC O
U14 NNP O
RNAs NNS O
, , O
also RB O
was VBD O
found VBN O
in IN O
the DT O
Enp1 NNP O
precipitate NN O
, , O
provides VBZ O
additional JJ O
evidence NN O
that IN O
Enp1 NNP O
is VBZ O
part NN O
of IN O
a DT O
complex NN O
involved VBN O
in IN O
processing NN O
of IN O
rRNA NNP O
. . O

Recently RB O
, , O
a DT O
genome NN O
- HYPH O
wide JJ O
study NN O
of IN O
yeast NN B-Species
protein NN O
complexes NNS O
, , O
using VBG O
a DT O
TAP NNP O
tag NN O
method NN O
similar JJ O
to IN O
ours PRP O
, , O
reported VBD O
a DT O
number NN O
of IN O
proteins NNS O
that WDT O
co RB O
- HYPH O
immunoprecipitated VBN O
with IN O
Enp1 NNP O
( SYM O
43 CD O
) -RRB- O
. . O

These DT O
proteins NNS O
included VBD O
Imp4 NNP O
, , O
Kre31 NNP O
, , O
Kre33 NNP O
, , O
Mpp10 NNP O
, , O
Nop1 NNP O
, , O
Nop14 NNP O
and CC O
Sof1 NNP O
, , O
all DT O
of IN O
which WDT O
have VBP O
been VBN O
implicated VBN O
in IN O
18S NNP O
RNA NNP O
processing NN O
or CC O
40S NN O
biogenesis NN O
. . O

Very RB O
recently RB O
( , O
after IN O
the DT O
studies NNS O
in IN O
this DT O
manuscript NN O
were VBD O
concluded VBN O
) , O
Grandi NNP O
et FW O
al NNP O
. , O
published VBD O
an DT O
analysis NN O
of IN O
components NNS O
of IN O
the DT O
90s NNS O
preribosomal JJ O
particle NN O
, , O
which WDT O
include VBP O
the DT O
35S CD O
pre NN O
- HYPH O
rRNA NNP O
, , O
U3 NNP O
snoRNP NNP O
and CC O
rRNA NNP O
processing NN O
factors NNS O
for IN O
the DT O
40S CD O
subunit NN O
( SYM O
44 CD O
) -RRB- O
. . O

In IN O
agreement NN O
with IN O
our PRP$ O
findings NNS O
, , O
they PRP O
found VBD O
that IN O
Enp1 NNP O
is VBZ O
a DT O
component NN O
of IN O
this DT O
90s NNS O
complex NN O
and CC O
also RB O
of IN O
a DT O
smaller JJR O
complex NN O
containing VBG O
the DT O
20S CD O
pre NN O
- HYPH O
rRNA NNP O
. . O

Surprisingly RB O
, , O
none NN O
of IN O
the DT O
other JJ O
proteins NNS O
involved VBN O
in IN O
processing NN O
of IN O
pre NN O
- HYPH O
rRNAs NNS O
that WDT O
were VBD O
tested VBN O
associated VBN O
with IN O
the DT O
20S NNP O
rRNA NNP O
, , O
suggesting VBG O
that IN O
those DT O
proteins NNS O
, , O
but CC O
not RB O
Enp1 NNP O
, , O
are VBP O
released VBN O
prior RB O
to IN O
20S CD O
pre IN O
- HYPH O
rRNA NN O
formation NN O
( SYM O
44 CD O
) -RRB- O
. . O

The DT O
authors NNS O
also RB O
showed VBD O
co NN O
- HYPH O
precipitation NN O
of IN O
Enp1 NNP O
with IN O
dimethylated JJ O
20S CD O
pre NN O
- HYPH O
rRNA NN O
, , O
which WDT O
is VBZ O
formed VBN O
after IN O
export NN O
of IN O
20S NNS O
to IN O
the DT O
cytoplasm NN O
. . O

These DT O
results NNS O
of IN O
Grandi NNP O
et FW O
al NNP O
. . O
suggest VBP O
that IN O
Enp1 NNP O
may MD O
also RB O
be VB O
involved VBN O
in IN O
later JJ O
steps NNS O
of IN O
processing NN O
or CC O
nuclear JJ O
export NN O
. . O

A DT O
previous JJ O
study NN O
on IN O
the DT O
Enp1 NNP O
human JJ B-Species
homolog NN O
, , O
bystin NN O
, , O
reported VBD O
that IN O
the DT O
protein NN O
was VBD O
localized VBN O
in IN O
the DT O
cytoplasm NN O
of IN O
mammalian JJ O
cells NNS O
and CC O
might MD O
be VB O
involved VBN O
in IN O
cell NN O
adhesion NN O
( : O
19 CD O
) -RRB- O
. . O

Our PRP$ O
discovery NN O
of IN O
the DT O
437 CD O
amino NN O
acid NN O
human JJ B-Species
Enp1 NNP O
homolog NN O
revealed VBD O
that IN O
the DT O
bystin NN O
studied VBD O
previously RB O
was VBD O
from IN O
a DT O
truncated VBN O
library NN O
cDNA NN O
encoding VBG O
only RB O
the DT O
C NN O
- HYPH O
terminal NN O
306 CD O
amino NN O
acids NNS O
. . O

Although IN O
the DT O
human JJ B-Species
homolog NN O
of IN O
Enp1 NNP O
did VBD O
not RB O
complement VB O
a DT O
yeast NN B-Species
Delta NNP O
enp1 NN O
mutant NN O
, , O
we PRP O
did VBD O
show VB O
that IN O
it PRP O
was VBD O
localized VBN O
to IN O
the DT O
nucleus NN O
and CC O
enriched VBN O
in IN O
the DT O
nucleolus NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

This DT O
strongly RB O
suggests VBZ O
that IN O
the DT O
conserved VBN O
function NN O
of IN O
Enp1 NNP O
is VBZ O
in IN O
rRNA NNP O
processing NN O
. . O

The DT O
cytoplasmic JJ O
localization NN O
of IN O
bystin NN O
and CC O
its PRP$ O
proposed VBN O
function NN O
in IN O
cell NN O
adhesion NN O
are VBP O
unlikely JJ O
to TO O
reflect VB O
the DT O
actual JJ O
function NN O
of IN O
the DT O
human JJ B-Species
Enp1 NNP O
homolog NN O
. . O

It PRP O
will MD O
be VB O
important JJ O
to TO O
study VB O
the DT O
nature NN O
of IN O
the DT O
associations NNS O
between IN O
Enp1 NNP O
and CC O
U3 NNP O
and CC O
U14 NNP O
snoRNPs NNS O
, , O
and CC O
to TO O
learn VB O
more JJR O
about IN O
the DT O
exact JJ O
role NN O
of IN O
Enp1 NNP O
in IN O
ribosomal JJ O
RNA NNP O
processing NN O
. . O

Piezoelectric JJ O
osteotomy NN O
in IN O
hand NN O
surgery NN O
: : O
first JJ O
experiences NNS O
with IN O
a DT O
new JJ O
technique NN O

Abstract JJ O

Background NN O

In IN O
hand NN O
and CC O
spinal JJ O
surgery NN O
nerve NN O
lesions NNS O
are VBP O
feared VBN O
complications NNS O
with IN O
the DT O
use NN O
of IN O
standard JJ O
oscillating NN O
saws NNS O
. . O

Oral JJ O
surgeons NNS O
have VBP O
started VBN O
using VBG O
a DT O
newly RB O
developed VBN O
ultrasound NN O
bone NN O
scalpel NN O
when WRB O
performing VBG O
precise JJ O
osteotomies NNS O
. . O

By IN O
using VBG O
a DT O
frequency NN O
of IN O
25 CD O
- SYM O
29 CD O
kHz NN O
only RB O
mineralized VBN O
tissue NN O
is VBZ O
cut VBN O
, , O
sparing VBG O
the DT O
soft JJ O
tissue NN O
. . O

This DT O
reduces VBZ O
the DT O
risk NN O
of IN O
nerve NN O
lesions NNS O
. . O

As IN O
there EX O
is VBZ O
a DT O
lack NN O
of IN O
experience NN O
with IN O
this DT O
technique NN O
in IN O
the DT O
field NN O
of IN O
orthopaedic JJ O
bone NN O
surgery NN O
, , O
we PRP O
performed VBD O
the DT O
first JJ O
ultrasound NN O
osteotomy NN O
in IN O
hand NN O
surgery NN O
. . O

Method NN O

While IN O
performing VBG O
a DT O
correctional JJ O
osteotomy NN O
of IN O
the DT O
5th JJ O
metacarpal NN O
bone NN O
we PRP O
used VBD O
the DT O
Piezosurgery NNP O
( , O
R NNP O
) -RRB- O
Device NNP O
from IN O
Mectron NNP O
[ -LRB- O
Italy NNP O
] -RRB- O
instead RB O
of IN O
the DT O
usual JJ O
oscillating VBG O
saw NN O
. . O

We PRP O
will MD O
report VB O
on IN O
our PRP$ O
experience NN O
with IN O
one CD O
case NN O
, , O
with IN O
a DT O
follow NN O
up RP O
time NN O
of IN O
one CD O
year NN O
. . O

Results NNS O

The DT O
cut NN O
was VBD O
highly RB O
precise JJ O
and CC O
there EX O
were VBD O
no DT O
vibrations NNS O
of IN O
the DT O
bone NN O
. . O

The DT O
time NN O
needed VBN O
for IN O
the DT O
operation NN O
was VBD O
slightly RB O
longer JJR O
than IN O
the DT O
time NN O
needed VBN O
while IN O
using VBG O
the DT O
usual JJ O
saw NN O
. . O

Bone NN O
healing NN O
was VBD O
good JJ O
and CC O
at IN O
no DT O
point NN O
were VBD O
there EX O
any DT O
neurovascular JJ O
disturbances NNS O
. . O

Conclusion NN O

The DT O
Piezosurgery NNP O
( -LRB- O
R NN O
) -RRB- O
Device NN O
is VBZ O
useful JJ O
for IN O
small JJ O
long JJ O
bone NN O
osteotomies NNS O
. . O

Using VBG O
the DT O
fine JJ O
tip NN O
enables VBZ O
curved JJ O
cutting NN O
and CC O
provides VBZ O
an DT O
opportunity NN O
for IN O
new JJ O
osteotomy NN O
techniques NNS O
. . O

As IN O
the DT O
device NN O
selectively RB O
cuts VBZ O
bone NN O
we PRP O
feel VBP O
that IN O
this DT O
device NN O
has VBZ O
great JJ O
potential NN O
in IN O
the DT O
field NN O
of IN O
hand NN O
- HYPH O
and CC O
spinal JJ O
surgery NN O
. . O

Background NN O

For IN O
osteotomies NNS O
of IN O
the DT O
hand NN O
oscillating VBG O
saws NNS O
are VBP O
usually RB O
used VBN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Even RB O
though IN O
they PRP O
are VBP O
varied JJ O
in IN O
size NN O
, , O
they PRP O
are VBP O
not RB O
very RB O
precise JJ O
for IN O
use NN O
in IN O
the DT O
vicinity NN O
of IN O
nerves NNS O
and CC O
arteries NNS O
. . O

They PRP O
also RB O
pose VBP O
problems NNS O
while IN O
being VBG O
used VBN O
in IN O
conjunction NN O
with IN O
magnification NN O
, , O
as IN O
one CD O
' '' O
s POS O
range NN O
of IN O
sight NN O
and CC O
focus NN O
is VBZ O
restricted VBN O
when WRB O
wearing VBG O
magnifying VBG O
glasses NNS O
. . O

For IN O
that DT O
reason NN O
oral JJ O
surgeons NNS O
have VBP O
moved VBN O
to IN O
using VBG O
the DT O
newly RB O
developed VBN O
piezoelectrical JJ O
bone NN O
scalpel NN O
when WRB O
operating VBG O
in IN O
the DT O
near JJ O
vicinity NN O
of IN O
nerves NNS O
or CC O
arteries NNS O
. . O

The DT O
tip NN O
of IN O
this DT O
instrument NN O
oscillates VBZ O
in IN O
the DT O
frequency NN O
of IN O
ultrasound NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

The DT O
mechanism NN O
of IN O
this DT O
device NN O
is VBZ O
based VBN O
on IN O
the DT O
so RB O
called VBN O
Piezo NNP O
- HYPH O
Effect NNP O
. . O

French NNP O
Physicists NNPS O
Jean NNP O
and CC O
Marie NNP O
Curie NNP O
first RB O
mentioned VBD O
the DT O
direct JJ O
Piezo NNP O
- HYPH O
Effect NNP O
1880 CD O
, , O
whereby WRB O
certain JJ O
crystals NNS O
produce VBP O
electrical JJ O
current NN O
while IN O
under IN O
mechanical JJ O
pressure NN O
. . O

The DT O
reciprocal JJ O
effect NN O
, , O
by IN O
which WDT O
the DT O
crystals NNS O
are VBP O
deformed VBN O
when WRB O
under IN O
electrical JJ O
current NN O
, , O
was VBD O
then RB O
discovered VBN O
a DT O
while NN O
later RB O
. . O

This DT O
is VBZ O
the DT O
effect NN O
being VBG O
used VBN O
by IN O
the DT O
Piezosurgery NNP O
Device NNP O
( -LRB- O
R NNP O
) -RRB- O
. . O

In IN O
this DT O
device NN O
, , O
the DT O
electrical JJ O
field NN O
is VBZ O
located VBN O
in IN O
the DT O
handle NN O
of IN O
the DT O
saw NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Due IN O
to IN O
the DT O
deformation NN O
caused VBN O
by IN O
the DT O
electrical JJ O
current NN O
, , O
a DT O
cutting VBG O
- HYPH O
hammering VBG O
movement NN O
is VBZ O
produced VBN O
at IN O
the DT O
tip NN O
of IN O
the DT O
instrument NN O
. . O

These DT O
micro JJ O
movements NNS O
are VBP O
in IN O
the DT O
frequency NN O
range NN O
of IN O
25 CD O
to TO O
29 CD O
kHz NN O
and CC O
, , O
depending VBG O
on IN O
the DT O
insert NN O
, , O
with IN O
an DT O
amplitude NN O
of IN O
60 CD O
to TO O
210 CD O
mu NNS O
m NN O
. . O

This DT O
way NN O
only RB O
mineralized VBN O
tissue NN O
is VBZ O
selectively RB O
cut VBN O
. . O

Neurovascular JJ O
tissue NN O
and CC O
other JJ O
soft JJ O
tissue NN O
would MD O
only RB O
be VB O
cut VBN O
by IN O
a DT O
frequency NN O
of IN O
above IN O
50 CD O
kHz NN O
[ -LRB- O
3 CD O
- SYM O
5 CD O
] -RRB- O
. . O

Depending VBG O
on IN O
the DT O
strength NN O
of IN O
the DT O
bone NN O
and CC O
the DT O
blade NN O
geometry NN O
, , O
the DT O
efficiency NN O
of IN O
the DT O
cutting NN O
can MD O
be VB O
regulated VBN O
by IN O
the DT O
frequency NN O
modulator NN O
and CC O
the DT O
power NN O
level NN O
. . O

For IN O
cooling NN O
there EX O
is VBZ O
an DT O
integrated VBN O
pump NN O
with IN O
five CD O
different JJ O
working VBG O
levels NNS O
. . O

This DT O
pump NN O
automatically RB O
washes VBZ O
physiological JJ O
solution NN O
to IN O
the DT O
area NN O
being VBG O
cut VBN O
. . O

The DT O
cost NN O
of IN O
the DT O
device NN O
is VBZ O
about IN O
7 CD O
. . O
0 CD O
USD NN O
. . O

Additional JJ O
costs NNS O
per IN O
operation NN O
are VBP O
for IN O
the DT O
cooling NN O
liquid NN O
and CC O
are VBP O
in IN O
the DT O
range NN O
of IN O
a DT O
few JJ O
dollars NNS O
. . O

We PRP O
have VBP O
used VBN O
the DT O
Piezosurgery NNP O
Device NNP O
( -LRB- O
R NNP O
) -RRB- O
by IN O
Mectron NNP O
[ -LRB- O
Italy NNP O
] -RRB- O
[ -LRB- O
3 CD O
] -RRB- O
for IN O
the DT O
first JJ O
time NN O
in IN O
osteotomies NNS O
of IN O
the DT O
long JJ O
bone NN O
in IN O
the DT O
field NN O
of IN O
hand NN O
surgery NN O
. . O

We PRP O
will MD O
report VB O
on IN O
our PRP$ O
experience NN O
with IN O
one CD O
case NN O
, , O
with IN O
a DT O
follow NN O
up RP O
time NN O
of IN O
one CD O
year NN O
. . O

Method NN O

The DT O
correctional JJ O
osteotomy NN O
was VBD O
performed VBN O
on IN O
a DT O
23 CD O
year NN O
old JJ O
worker NN O
who WP O
suffered VBD O
a DT O
malunited JJ O
metacarpal NN O
bone NN O
fracture NN O
of IN O
the DT O
fifth JJ O
finger NN O
on IN O
his PRP$ O
dominant JJ O
hand NN O
. . O

The DT O
X NNP O
- HYPH O
ray NNP O
revealed VBD O
a DT O
45 CD O
degree NN O
angular JJ O
deformity NN O
of IN O
the DT O
fifth JJ O
metacarpal NN O
neck NN O
with IN O
internal JJ O
rotation NN O
. . O

( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
operation NN O
was VBD O
performed VBN O
under IN O
regional JJ O
anesthesia NN O
. . O

A DT O
longitudinal JJ O
incision NN O
was VBD O
made VBN O
over IN O
the DT O
fifth JJ O
metacarpal NN O
. . O

The DT O
tendon NN O
of IN O
the DT O
extensor NN O
digiti NN O
minimi NN O
was VBD O
found VBN O
and CC O
on IN O
its PRP$ O
radial JJ O
side NN O
the DT O
periosteum NN O
of IN O
metacarpal NN O
five CD O
was VBD O
reached VBN O
. . O

The DT O
periosteum NN O
was VBD O
opened VBN O
longitudinally RB O
over IN O
the DT O
defect NN O
as IN O
usual JJ O
. . O

For IN O
the DT O
correction NN O
of IN O
the DT O
defect NN O
of IN O
45 CD O
degrees NNS O
, , O
a DT O
bone NN O
wedge NN O
was VBD O
excised VBN O
. . O

Instead RB O
of IN O
using VBG O
the DT O
traditional JJ O
oscillating VBG O
saw NN O
, , O
the DT O
Piezosurgery NNP O
Device NNP O
( -LRB- O
R NNP O
) -RRB- O
[ -LRB- O
3 CD O
] -RRB- O
was VBD O
used VBN O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
. . O

We PRP O
used VBD O
a DT O
sharp JJ O
hardened VBN O
saw NN O
coated VBN O
with IN O
titannitrid NN O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
. . O

For IN O
most JJS O
of IN O
the DT O
surgery NN O
the DT O
highest JJS O
power NN O
level NN O
, , O
the DT O
boosted VBN O
burst NN O
c NN O
, , O
was VBD O
used VBN O
. . O

We PRP O
set VBP O
the DT O
automatic JJ O
cooling NN O
of IN O
the DT O
area NN O
with IN O
water NN O
to IN O
its PRP$ O
highest JJS O
level NN O
. . O

The DT O
angulation NN O
and CC O
rotation NN O
was VBD O
corrected VBN O
and CC O
fixed VBN O
with IN O
a DT O
1 CD O
. . O
5 CD O
mm NN O
titanium NN O
five CD O
- HYPH O
hole NN O
plate NN O
and CC O
four CD O
screws NNS O
. . O

Closure NN O
of IN O
the DT O
wound NN O
was VBD O
done VBN O
in IN O
layers NNS O
. . O

Mobilization NN O
was VBD O
started VBN O
on IN O
the DT O
10th JJ O
postoperative JJ O
day NN O
. . O

The DT O
overall JJ O
time NN O
of IN O
observation NN O
was VBD O
one CD O
year NN O
. . O

Results NNS O
and CC O
discussion NN O

The DT O
Piezosurgery NNP O
( -LRB- O
R NNP O
) -RRB- O
Device NNP O
is VBZ O
ideally RB O
sized VBN O
for IN O
hand NN O
surgery NN O
. . O

The DT O
cutting NN O
was VBD O
very RB O
precise JJ O
. . O

The DT O
edges NNS O
of IN O
the DT O
osteotomy NN O
were VBD O
all RB O
sharp JJ O
to IN O
the DT O
edge NN O
, , O
there EX O
was VBD O
no DT O
need NN O
to TO O
split VB O
the DT O
bone NN O
with IN O
a DT O
chisel NN O
, , O
nor CC O
was VBD O
there EX O
the DT O
danger NN O
of IN O
a DT O
break NN O
out RP O
. . O

During IN O
the DT O
osteotomy NN O
there EX O
were VBD O
no DT O
disturbing JJ O
vibrations NNS O
in IN O
the DT O
area NN O
of IN O
operation NN O
. . O

This DT O
absence NN O
of IN O
vibration NN O
is VBZ O
very RB O
practical JJ O
for IN O
operations NNS O
using VBG O
a DT O
magnifier NN O
. . O

Vercellotti NNP O
mentions VBZ O
that IN O
to TO O
overcome VB O
any DT O
problems NNS O
during IN O
surgery NN O
, , O
instead RB O
of IN O
increasing VBG O
pressure NN O
on IN O
the DT O
hand NN O
piece NN O
, , O
as IN O
in IN O
traditional JJ O
techniques NNS O
, , O
it PRP O
is VBZ O
necessary JJ O
to TO O
find VB O
the DT O
correct JJ O
pressure NN O
to TO O
achieve VB O
the DT O
desired VBN O
result NN O
. . O

With IN O
piezoelectric JJ O
surgery NN O
, , O
increasing VBG O
the DT O
working VBG O
pressure NN O
above IN O
a DT O
certain JJ O
limit NN O
impedes VBZ O
the DT O
vibrations NNS O
of IN O
the DT O
insert NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

We PRP O
have VBP O
also RB O
experienced VBN O
this DT O
in IN O
our PRP$ O
study NN O
. . O

The DT O
instrument NN O
can MD O
be VB O
moved VBN O
in IN O
all DT O
directions NNS O
comparable JJ O
to IN O
a DT O
pen NN O
. . O

The DT O
tip NN O
of IN O
the DT O
instrument NN O
is VBZ O
exchangeable JJ O
. . O

Using VBG O
the DT O
fine JJ O
tip NN O
enables VBZ O
multiplanar NN O
as RB O
well RB O
as IN O
curved VBN O
cutting NN O
. . O

Because IN O
of IN O
the DT O
automatic JJ O
water NN O
cooling NN O
during IN O
the DT O
whole JJ O
procedure NN O
, , O
there EX O
is VBZ O
always RB O
a DT O
clear JJ O
view NN O
onto IN O
the DT O
object NN O
. . O

This DT O
is VBZ O
something NN O
oral JJ O
surgeons NNS O
found VBD O
especially RB O
useful JJ O
[ -LRB- O
6 CD O
] -RRB- O
. . O

The DT O
authors NNS O
mention VBP O
that IN O
the DT O
downside NN O
of IN O
the DT O
device NN O
is VBZ O
the DT O
relative JJ O
slow JJ O
sawing NN O
process NN O
. . O

We PRP O
needed VBD O
about RB O
30 CD O
seconds NNS O
for IN O
one CD O
cut NN O
of IN O
the DT O
relatively RB O
small JJ O
bone NN O
. . O

This DT O
is VBZ O
about RB O
20 CD O
seconds NNS O
longer JJR O
than IN O
the DT O
time NN O
needed VBN O
for IN O
cutting VBG O
with IN O
the DT O
usual JJ O
saw NN O
. . O

Although IN O
the DT O
power NN O
can MD O
be VB O
regulated VBN O
with IN O
the DT O
power NN O
box NN O
and CC O
the DT O
use NN O
of IN O
different JJ O
scalpels NNS O
, , O
we PRP O
agree VBP O
with IN O
other JJ O
authors NNS O
that IN O
the DT O
optimal JJ O
use NN O
of IN O
this DT O
device NN O
is VBZ O
in IN O
surgeries NNS O
of IN O
small JJ O
bones NNS O
where WRB O
precise JJ O
and CC O
soft JJ O
tissue NN O
friendly JJ O
cutting NN O
is VBZ O
required VBN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

As IN O
other JJ O
literature NN O
has VBZ O
shown VBN O
, , O
the DT O
device NN O
selectively RB O
cuts VBZ O
bone NN O
while IN O
sparing VBG O
nerves NNS O
and CC O
other JJ O
soft JJ O
tissue NN O
[ -LRB- O
2 CD O
, , O
3 CD O
] -RRB- O
. . O

This DT O
allows VBZ O
for IN O
minimal JJ O
invasive JJ O
surgeries NNS O
with IN O
limited JJ O
retraction NN O
of IN O
soft JJ O
tissue NN O
and CC O
minimal JJ O
stripping NN O
of IN O
the DT O
periosteum NN O
, , O
saves VBZ O
time NN O
and CC O
might MD O
have VB O
a DT O
positive JJ O
effect NN O
on IN O
the DT O
healing NN O
process NN O
. . O

Our PRP$ O
aim NN O
of IN O
the DT O
first JJ O
time NN O
use NN O
of IN O
the DT O
Piezosurgery NNP O
( -LRB- O
R NNP O
) , O
Device NN O
in IN O
hand NN O
surgery NN O
was VBD O
to TO O
check VB O
its PRP$ O
usability NN O
in IN O
osteotomies NNS O
of IN O
tubular JJ O
bones NNS O
. . O

The DT O
preparation NN O
of IN O
the DT O
bone NN O
was VBD O
done VBN O
in IN O
the DT O
usual JJ O
manner NN O
as IN O
is VBZ O
done VBN O
when WRB O
cutting VBG O
with IN O
an DT O
oscillating JJ O
saw NN O
. . O

The DT O
reason NN O
for IN O
this DT O
was VBD O
to TO O
fully RB O
visualize VB O
the DT O
cutting NN O
process NN O
using VBG O
this DT O
new JJ O
device NN O
, , O
although IN O
in IN O
the DT O
future NN O
, , O
it PRP O
should MD O
be VB O
possible JJ O
to TO O
minimize VB O
the DT O
bony JJ O
exposure NN O
. . O

In IN O
our PRP$ O
patient NN B-Species
the DT O
postoperative JJ O
healing NN O
of IN O
the DT O
wound NN O
and CC O
the DT O
bone NN O
consolidation NN O
( -LRB- O
Figure NN O
4 CD O
) -RRB- O
were VBD O
smooth JJ O
. . O

The DT O
duration NN O
of IN O
postoperative JJ O
sick NN O
leave NN O
was VBD O
four CD O
weeks NNS O
which WDT O
is VBZ O
more RBR O
rapid JJ O
than IN O
the DT O
usual JJ O
recovery NN O
period NN O
. . O

The DT O
patient NN B-Species
regained VBD O
full JJ O
use NN O
of IN O
his PRP$ O
finger NN O
according VBG O
to IN O
the DT O
state NN O
before IN O
the DT O
fracture NN O
. . O

At IN O
no DT O
point NN O
was VBD O
there EX O
any DT O
loss NN O
of IN O
sensitivity NN O
. . O

The DT O
patient NN B-Species
as RB O
well RB O
as IN O
the DT O
surgeons NNS O
were VBD O
fully RB O
satisfied JJ O
with IN O
the DT O
result NN O
. . O

Conclusion NN O

The DT O
Piezosurgery NNP O
( -LRB- O
R NNP O
) -RRB- O
Device NNP O
is VBZ O
a DT O
useful JJ O
device NN O
for IN O
small JJ O
long JJ O
bone NN O
osteotomies NNS O
. . O

We PRP O
feel VBP O
that IN O
this DT O
device NN O
has VBZ O
great JJ O
potential NN O
in IN O
the DT O
field NN O
of IN O
hand NN O
- HYPH O
and CC O
spinal JJ O
surgery NN O
. . O

As IN O
the DT O
device NN O
selectively RB O
cuts VBZ O
bone NN O
, , O
considerable JJ O
nerve NN O
lesions NNS O
can MD O
be VB O
avoided VBN O
and CC O
minimal JJ O
invasive JJ O
surgeries NNS O
are VBP O
possible JJ O
. . O

Using VBG O
the DT O
fine JJ O
tip NN O
enables VBZ O
curved JJ O
cutting NN O
and CC O
provides VBZ O
an DT O
opportunity NN O
for IN O
new JJ O
osteotomy NN O
techniques NNS O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

DJH NNP O
initiated VBD O
and CC O
coordinated VBD O
the DT O
new JJ O
application NN O
of IN O
Piezosurgery NNP O
( : O
R NNP O
) -RRB- O
device NN O
and CC O
wrote VBD O
the DT O
publication NN O
. . O

StSt NNP O
lead VB O
the DT O
osteotomy NN O
as IN O
he PRP O
was VBD O
experienced VBN O
with IN O
this DT O
tool NN O
from IN O
oral JJ O
surgery NN O
. . O

He PRP O
played VBD O
a DT O
major JJ O
part NN O
in IN O
writing VBG O
the DT O
technical JJ O
aspects NNS O
. . O

OVK NNP O
was VBD O
the DT O
treating VBG O
surgeon NN O
, , O
performed VBD O
the DT O
operation NN O
and CC O
evaluated VBD O
the DT O
new JJ O
tool NN O
. . O

SS NNP O
performed VBD O
a DT O
literature NN O
review NN O
and CC O
wrote VBD O
part NN O
of IN O
the DT O
publication NN O
. . O

PH NNP O
was VBD O
the DT O
treating VBG O
chief JJ O
surgeon NN O
, , O
evaluated VBD O
the DT O
new JJ O
tool NN O
and CC O
lead VB O
the DT O
treatment NN O
in IN O
all DT O
aspects NNS O
. . O

Consent NN O

We PRP O
obtained VBD O
oral JJ O
consent NN O
from IN O
the DT O
patient NN B-Species
but CC O
could MD O
not RB O
obtain VB O
written JJ O
consent NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

Molecular JJ O
cloning NN O
of IN O
four CD O
novel JJ O
murine NN B-Species
ribonuclease NN O
genes NNS O
: : O
unusual JJ O
expansion NN O
within IN O
the DT O
ribonuclease NN O
A NN O
gene NN O
family NN O
. . O

Abstract JJ O

We PRP O
have VBP O
characterized VBN O
four CD O
novel NN O
murine NN B-Species
ribonuclease NN O
genes NNS O
that WDT O
, , O
together RB O
with IN O
the DT O
murine NN B-Species
eosinophil NN O
- HYPH O
associated VBN O
ribonucleases NNS O
1 CD O
and CC O
2 CD O
, , O
form VBP O
a DT O
distinct JJ O
and CC O
unusual JJ O
cluster NN O
within IN O
the DT O
RNase NNP O
A NNP O
gene NN O
superfamily NN O
. . O

Three CD O
of IN O
these DT O
genes NNS O
( , O
mR NNP O
- HYPH O
3 CD O
, , O
mR NN O
- HYPH O
4 CD O
, , O
mR NN O
- HYPH O
5 CD O
) -RRB- O
include VBP O
complete JJ O
open JJ O
reading NN O
frames NNS O
, , O
encoding VBG O
ribonucleases NNS O
with IN O
eight CD O
cysteines NNS O
and CC O
appropriately RB O
spaced VBN O
histidines NNS O
( -LRB- O
His11 NN O
and CC O
His124 CD O
) -RRB- O
and CC O
lysine NN O
( -LRB- O
Lys35 NNP O
) -RRB- O
that WDT O
are VBP O
characteristic JJ O
of IN O
this DT O
enlarging VBG O
protein NN O
family NN O
; , O
the DT O
fourth JJ O
sequence NN O
encodes VBZ O
a DT O
non JJ O
- HYPH O
functional JJ O
pseudogene NN O
( , O
mR NN O
- HYPH O
6P NN O
) -RRB- O
. . O

Although IN O
the DT O
amino JJ O
acid NN O
sequence NN O
similarities NNS O
among IN O
these DT O
murine JJ B-Species
ribonucleases NNS O
varies VBZ O
from IN O
60 CD O
to IN O
94 CD O
% NN O
, , O
they PRP O
form VBP O
a DT O
unique JJ O
cluster NN O
, , O
as IN O
each DT O
sequence NN O
is VBZ O
found VBN O
to TO O
be VB O
more RBR O
closely RB O
related JJ O
to IN O
another DT O
of IN O
this DT O
group NN O
than IN O
to IN O
either CC O
murine JJ B-Species
angiogenin NN O
or CC O
to IN O
murine NN B-Species
pancreatic JJ O
ribonuclease NN O
. . O

Interestingly RB O
, , O
the DT O
relationship NN O
between IN O
the DT O
six CD O
genes NNS O
in IN O
this DT O
' `` O
mR NN O
cluster NN O
' '' O
and CC O
the DT O
defined VBN O
lineages NNS O
of IN O
the DT O
RNase NNP O
A NNP O
gene NN O
family NN O
could MD O
not RB O
be VB O
determined VBN O
by IN O
amino NN O
acid NN O
sequence NN O
homology NN O
, , O
suggesting VBG O
the DT O
possibility NN O
that IN O
there EX O
are VBP O
one CD O
or CC O
more JJR O
additional JJ O
ribonuclease NN O
lineages NNS O
that WDT O
have VBP O
yet RB O
to TO O
be VB O
defined VBN O
. . O

Although IN O
the DT O
nature NN O
of IN O
the DT O
evolutionary JJ O
constraints NNS O
promoting VBG O
this DT O
unusual JJ O
expansion NN O
and CC O
diversification NN O
remain VBP O
unclear JJ O
, , O
the DT O
implications NNS O
with IN O
respect NN O
to IN O
function NN O
are VBP O
intriguing JJ O
. . O

< NFP O
FFFD NNP O
> SYM O
1997 CD O
Oxford NNP O
University NNP O
Press NNP O

Nucleic NNP O
Acids NNP O
Research NNP O
, , O
1997 CD O
, , O
Vol NNP O
. . O

25 CD O
, , O
No UH O
. . O
21 CD O

4235 CD O
< SYM O
FFFD NN O
> SYM O
4239 CD O

Molecular JJ O
cloning NN O
of IN O
four CD O
novel JJ O
murine NN B-Species
ribonuclease NN O
genes NNS O
: : O
unusual JJ O
expansion NN O
within IN O
the DT O
Ribonuclease NNP O
A NNP O
gene NN O
family NN O
Dean NNP O
Batten NNP O
+ NNP O
, , O
Kimberly NNP O
D NNP O
. . O
Dyer NNP O
, , O
Joseph NNP O
B NNP O
. . O
Domachowske NNP O
< , O
FFFD NNP O
> : O
and CC O
Helene NNP O
F NNP O
. , O
Rosenberg NNP O
* NFP O
The DT O
Laboratory NNP O
of IN O
Host NNP O
Defenses NNPS O
, , O
Building NNP O
10 CD O
, , O
Room NNP O
11N104 CD O
, , O
National NNP O
Institute NNP O
of IN O
Allergy NNP O
and CC O
Infectious NNP O
Diseases NNPS O
, , O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
, , O
9000 CD O
Rockville NNP O
Pike NNP O
, , O
Bethesda NNP O
, , O
MD NNP O
20892 CD O
, , O
USA NNP O
Received VBN O
August NNP O
4 CD O
, , O
1997 CD O
; : O
Revised NNP O
and CC O
Accepted VBN O
September NNP O
17 CD O
, , O
1997 CD O
DDBJ NNP O
/ SYM O
EMBL NNP O
/ SYM O
GenBank NNP O
accession NN O
numbers NNS O
: : O
U72031 CD O
, , O
U72032 CD O
, , O
AF017258 NN O
< : O
FFFD NN O
> SYM O
AF017261 CD O

ABSTRACT NN O
We PRP O
have VBP O
characterized VBN O
four CD O
novel JJ O
murine NN B-Species
ribonuclease NN O
genes NNS O
that WDT O
, , O
together RB O
with IN O
the DT O
murine NN B-Species
eosinophilassociated VBN O
ribonucleases NNS O
1 CD O
and CC O
2 CD O
, , O
form VBP O
a DT O
distinct JJ O
and CC O
unusual JJ O
cluster NN O
within IN O
the DT O
RNase NNP O
A NNP O
gene NN O
superfamily NN O
. . O

Three CD O
of IN O
these DT O
genes NNS O
( , O
mR NNP O
- HYPH O
3 CD O
, , O
mR NN O
- HYPH O
4 CD O
, , O
mR NN O
- HYPH O
5 CD O
) -RRB- O
include VBP O
complete JJ O
open JJ O
reading NN O
frames NNS O
, , O
encoding VBG O
ribonucleases NNS O
with IN O
eight CD O
cysteines NNS O
and CC O
appropriately RB O
spaced VBN O
histidines NNS O
( -LRB- O
His11 NN O
and CC O
His124 CD O
) -RRB- O
and CC O
lysine NN O
( -LRB- O
Lys35 NNP O
) -RRB- O
that WDT O
are VBP O
characteristic JJ O
of IN O
this DT O
enlarging VBG O
protein NN O
family NN O
; , O
the DT O
fourth JJ O
sequence NN O
encodes VBZ O
a DT O
non JJ O
- HYPH O
functional JJ O
pseudogene NN O
( , O
mR NN O
- HYPH O
6P NN O
) -RRB- O
. . O

Although IN O
the DT O
amino JJ O
acid NN O
sequence NN O
similarities NNS O
among IN O
these DT O
murine JJ B-Species
ribonucleases NNS O
varies VBZ O
from IN O
60 CD O
to IN O
94 CD O
% NN O
, , O
they PRP O
form VBP O
a DT O
unique JJ O
cluster NN O
, , O
as IN O
each DT O
sequence NN O
is VBZ O
found VBN O
to TO O
be VB O
more RBR O
closely RB O
related JJ O
to IN O
another DT O
of IN O
this DT O
group NN O
than IN O
to IN O
either CC O
murine JJ B-Species
angiogenin NN O
or CC O
to IN O
murine NN B-Species
pancreatic JJ O
ribonuclease NN O
. . O

Interestingly RB O
, , O
the DT O
relationship NN O
between IN O
the DT O
six CD O
genes NNS O
in IN O
this DT O
` `` O
mR NN O
cluster NN O
' '' O
and CC O
the DT O
defined VBN O
lineages NNS O
of IN O
the DT O
RNase NNP O
A NNP O
gene NN O
family NN O
could MD O
not RB O
be VB O
determined VBN O
by IN O
amino NN O
acid NN O
sequence NN O
homology NN O
, , O
suggesting VBG O
the DT O
possibility NN O
that IN O
there EX O
are VBP O
one CD O
or CC O
more JJR O
additional JJ O
ribonuclease NN O
lineages NNS O
that WDT O
have VBP O
yet RB O
to TO O
be VB O
defined VBN O
. . O

Although IN O
the DT O
nature NN O
of IN O
the DT O
evolutionary JJ O
constraints NNS O
promoting VBG O
this DT O
unusual JJ O
expansion NN O
and CC O
diversification NN O
remain VBP O
unclear JJ O
, , O
the DT O
implications NNS O
with IN O
respect NN O
to IN O
function NN O
are VBP O
intriguing JJ O
. . O

INTRODUCTION NN O
Ribonuclease NNP O
A NNP O
( , O
RNase NNP O
A NNP O
, , O
bovine JJ B-Species
pancreatic JJ O
ribonuclease NN O
) -RRB- O
is VBZ O
the DT O
prototype NN O
of IN O
an DT O
enlarging JJ O
family NN O
of IN O
proteins NNS O
defined VBN O
by IN O
distinctive JJ O
elements NNS O
of IN O
conserved VBN O
primary JJ O
structure NN O
and CC O
enzymatic JJ O
activity NN O
( : O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

The DT O
features NNS O
shared VBN O
by IN O
all DT O
members NNS O
of IN O
the DT O
RNase NNP O
A NNP O
family NN O
include VBP O
six CD O
to TO O
eight CD O
cysteines NNS O
and CC O
specific JJ O
histidine NN O
and CC O
lysine NN O
residues NNS O
that WDT O
form VBP O
the DT O
ribonuclease NN O
active JJ O
site NN O
. . O

To IN O
date NN O
, , O
several JJ O
distinct JJ O
lineages NNS O
within IN O
the DT O
RNase NNP O
A NNP O
superfamily NN O
have VBP O
been VBN O
identified VBN O
. . O

Pancreatic JJ O
ribonucleases NNS O
( -LRB- O
RNases NNS O
1 CD O
) -RRB- O
have VBP O
been VBN O
isolated VBN O
from IN O
an DT O
extensive JJ O
array NN O
of IN O
mammalian JJ O
species NNS O
( , O
3 CD O
, , O
4 CD O
) -RRB- O
, , O
and CC O
mRNA NN O
encoding VBG O
human JJ B-Species
pancreatic JJ O
ribonuclease NN O
has VBZ O
been VBN O
detected VBN O
in IN O

numerous JJ O
somatic JJ O
tissues NNS O
in IN O
addition NN O
to IN O
pancreas NN O
( , O
5 CD O
) -RRB- O
. . O

RNases NNP O
2 CD O
and CC O
3 CD O
, , O
eosinophil NN O
- HYPH O
derived VBN O
neurotoxin NN O
( , O
EDN NNP O
) -RRB- O
and CC O
eosinophil NN O
cationic JJ O
protein NN O
( -LRB- O
ECP NNP O
) -RRB- O
, , O
respectively RB O
, , O
have VBP O
been VBN O
characterized VBN O
primarily RB O
with IN O
respect NN O
to IN O
eosinophil NN O
function NN O
( , O
6 CD O
, , O
7 CD O
) -RRB- O
, , O
although IN O
expression NN O
of IN O
EDN NNP O
[ -LRB- O
also RB O
known VBN O
as IN O
RNase NNP O
Us NNP O
( , O
8 CD O
) , O
or CC O
human JJ B-Species
liver NN O
ribonuclease NN O
( , O
9 CD O
) -RRB- O
] -RRB- O
is VBZ O
also RB O
widespread JJ O
( , O
5 CD O
) -RRB- O
. . O

Angiogenin NNP O
( , O
RNase NNP O
5 CD O
) -RRB- O
, , O
a DT O
structurally RB O
atypical JJ O
member NN O
of IN O
this DT O
family NN O
, , O
was VBD O
originally RB O
identified VBN O
as IN O
an DT O
agent NN O
promoting VBG O
blood NN O
vessel NN O
growth NN O
and CC O
development NN O
( , O
10 CD O
, , O
11 CD O
) -RRB- O
. . O

RNase NNP O
4 CD O
( SYM O
12 CD O
, , O
13 CD O
) -RRB- O
and CC O
RNase NNP O
k6 CD O
( SYM O
14 CD O
) -RRB- O
are VBP O
also RB O
members NNS O
of IN O
the DT O
RNase NNP O
A NNP O
superfamily NN O
, , O
although IN O
their PRP$ O
functions NNS O
are VBP O
currently RB O
obscure JJ O
. . O

Recently RB O
, , O
Larson NNP O
and CC O
colleagues NNS O
( , O
15 CD O
) -RRB- O
described VBD O
cDNAs NNS O
encoding VBG O
two CD O
highly RB O
homologous JJ O
murine NN B-Species
ribonucleases NNS O
, , O
the DT O
murine NN B-Species
eosinophil NN O
- HYPH O
associated VBN O
ribonucleases NNS O
( -LRB- O
mEAR NNP O
) -RRB- O
1 CD O
and CC O
2 CD O
, , O
which WDT O
were VBD O
cloned VBN O
and CC O
identified VBN O
via IN O
tryptic JJ O
peptides NNS O
isolated VBN O
from IN O
murine JJ B-Species
eosinophil NN O
proteins NNS O
. . O

Although IN O
Southern JJ O
analysis NN O
demonstrated VBD O
that IN O
multiple JJ O
copies NNS O
of IN O
sequence NN O
homologous NN O
to IN O
mEAR NN O
- HYPH O
1 CD O
and CC O
mEAR NN O
- HYPH O
2 CD O
were VBD O
present JJ O
in IN O
murine JJ B-Species
genomic JJ O
DNA NN O
, , O
the DT O
precise JJ O
nature NN O
of IN O
these DT O
copies NNS O
- : O
- : O
as IN O
pseudogenes NNS O
, , O
polymorphisms NNS O
, , O
or CC O
distinct JJ O
functional JJ O
genes NNS O
- , O
- : O
was VBD O
unclear JJ O
. . O

In IN O
this DT O
work NN O
, , O
we PRP O
have VBP O
identified VBN O
four CD O
of IN O
these DT O
homologous JJ O
sequences NNS O
, , O
three CD O
encoding VBG O
novel NN O
ribonucleases NNS O
, , O
and CC O
one CD O
encoding VBG O
a DT O
pseudogene NN O
. . O

Together RB O
with IN O
mEAR NNP O
- HYPH O
1 CD O
and CC O
mEAR NN O
- HYPH O
2 CD O
, , O
these DT O
six CD O
ribonuclease NN O
genes NNS O
form VBP O
an DT O
` `` O
mR NN O
cluster NN O
, , O
' '' O
whose WP$ O
members NNS O
are VBP O
more RBR O
closely RB O
related JJ O
to IN O
one CD O
another DT O
than IN O
they PRP O
are VBP O
to IN O
other JJ O
murine NN B-Species
ribonucleases NNS O
, , O
yet CC O
whose WP$ O
position NN O
with IN O
respect NN O
to IN O
the DT O
defined VBN O
RNase NNP O
A NNP O
lineages NNS O
remains VBZ O
unclear JJ O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O
Isolation NN O
of IN O
genomic JJ O
fragments NNS O
encoding VBG O
murine NN B-Species
ribonucleases NNS O
by IN O
polymerase NN O
chain NN O
reaction NN O
( -LRB- O
PCR NN O
) -RRB- O
Genomic NNP O
DNA NNP O
was VBD O
isolated VBN O
from IN O
cells NNS O
of IN O
the DT O
murine NN B-Species
3T3 CD O
fibroblast NN O
cell NN O
line NN O
. . O

The DT O
mR NNP O
- HYPH O
3 CD O
, , O
mR NN O
- HYPH O
5 CD O
and CC O
mR NN O
- HYPH O
6P NN O
sequences NNS O
were VBD O
amplified VBN O
using VBG O
oligonucleotide NN O
primers NNS O
derived VBN O
from IN O
the DT O
published VBN O
coding VBG O
sequence NN O
of IN O
mEAR NNP O
- HYPH O
1 CD O
as IN O
follows VBZ O
: : O
5 CD O
- HYPH O
CAA NN O
ACC NNP O
CTT NNP O
TCC NNP O
CAG NNP O
AAG NNP O
TTT NNP O
GCC NNP O
- HYPH O
3 CD O
( HYPH O
amino NN O
acids NNS O
28 CD O
< SYM O
FFFD NNP O
> SYM O
33 CD O
) -RRB- O
; : O
5 CD O
- HYPH O
AAA NN O
TGT NNP O
CCC NNP O
ATC NNP O
CAA NN O
GTG NNP O
AAC NNP O
TGG NNP O
ACC NNP O
- HYPH O
3 CD O
( SYM O
amino NN O
acids NNS O
156 CD O
< SYM O
FFFD NN O
> SYM O
148 CD O
) -RRB- O
( SYM O
15 CD O
) -RRB- O
. . O

The DT O
PCR NNP O
reactions NNS O
were VBD O
performed VBN O
as IN O
described VBN O
previously RB O
( : O
14 CD O
) -RRB- O
, , O
and CC O
the DT O
multiple JJ O
products NNS O
present JJ O
in IN O
the DT O
single JJ O
400 CD O
bp NN O
product NN O
were VBD O
identified VBN O
by IN O
dideoxy NN O

* NFP O
To TO O
whom WP O
correspondence NN O
should MD O
be VB O
addressed VBN O
. . O

Tel NN O
: : O
+ SYM O
1 CD O
301 CD O
402 CD O
9131 CD O
; : O
Fax NN O
: : O
+ CD O
1 CD O
301 CD O
402 CD O
4369 CD O
; : O
Email NN O
: : O
hr2k ADD O
@ IN O
nih NNP O
. . O
gov NN O
Present NN O
addresses NNS O
: : O
+ SYM O
Duke NNP O
University NNP O
School NNP O
of IN O
Medicine NNP O
, , O
Durham NNP O
, , O
NC NNP O
27701 CD O
, , O
USA NNP O
and CC O
< IN O
FFFD NNP O
> SYM O
Department NNP O
of IN O
Pediatrics NNP O
, , O
State NNP O
University NNP O
of IN O
New NNP O
York NNP O
- HYPH O
Health NNP O
Sciences NNPS O
Center NNP O
at IN O
Syracuse NNP O
, , O
Syracuse NNP O
, , O
NY NNP O
13210 CD O
, , O
USA NNP O

4236 CD O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
1997 CD O
, , O
Vol NNP O
. . O

25 CD O
, , O
No UH O
. . O
21 CD O

Figure NN O
1 CD O
. . O

( : O
A DT O
) NFP O
Alignment NN O
of IN O
amino NN O
acid NN O
sequences NNS O
encoded VBN O
by IN O
six CD O
related JJ O
murine NN B-Species
ribonuclease NN O
genes NNS O
. . O

Regions NNS O
of IN O
amino JJ O
acid NN O
sequence NN O
identity NN O
among IN O
the DT O
five CD O
functional JJ O
genes NNS O
are VBP O
enclosed VBN O
in IN O
boxes NNS O
; : O
the DT O
boxes NNS O
enclosing VBG O
the DT O
active JJ O
site NN O
residues NNS O
( -LRB- O
His11 NNP O
, , O
Lys35 NNP O
, , O
His124 CD O
) -RRB- O
and CC O
eight CD O
cysteines NNS O
conserved VBN O
in IN O
all DT O
members NNS O
of IN O
the DT O
RNase NNP O
A DT O
superfamily NN O
are VBP O
shaded VBN O
. . O

( : O
B NN O
) NFP O
Percent NN O
similarities NNS O
between IN O
amino NN O
acid NN O
sequences NNS O
determined VBN O
via IN O
the DT O
BESTFIT NNP O
algorithm NN O
of IN O
the DT O
Wisconsin NNP O
Genetics NNP O
Computer NNP O
Group NNP O
( -LRB- O
WGCG NNP O
) -RRB- O
program NN O
on IN O
- HYPH O
line NN O
at IN O
the DT O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
. . O

GenBank NNP O
accession NN O
numbers NNS O
: : O
mEAR NNP O
( , O
murine NN B-Species
eosinophil NN O
- HYPH O
associated VBN O
ribonuclease NN O
) -RRB- O
- : O
1 CD O
, , O
U72032 CD O
; : O
mEAR NNP O
- HYPH O
2 CD O
, , O
U72031 CD O
; : O
mR NNP O
( -LRB- O
murine NN B-Species
ribonuclease NNP O
) -RRB- O
- HYPH O
3 CD O
, , O
AF017258 CD O
; : O
mR NNP O
- HYPH O
4 CD O
, , O
AF017259 CD O
; : O
mR NNP O
- HYPH O
5 CD O
, , O
AF017260 NNP O
; : O
mR NN O
- HYPH O
6P NNP O
( -LRB- O
pseudogene NN O
) -RRB- O
, , O
AF017261 NN O
. . O

sequencing NN O
of IN O
individual JJ O
plasmids NNS O
after IN O
subcloning VBG O
into IN O
the DT O
pCR NNP O
II NNP O
TA NNP O
cloning NN O
vector NN O
( : O
Invitrogen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
. . O

The DT O
complete JJ O
open JJ O
reading NN O
frames NNS O
were VBD O
obtained VBN O
by IN O
extension NN O
in IN O
both CC O
5 CD O
and CC O
3 CD O
directions NNS O
by IN O
uni JJ O
- HYPH O
directional JJ O
PCR NNP O
( , O
Genome NNP O
Walker NNP O
kit NN O
, , O
Clontech NNP O
, , O
Palo NNP O
Alto NNP O
, , O
CA NNP O
) -RRB- O
, , O
involving VBG O
two CD O
amplifications NNS O
with IN O
nested VBN O
primers NNS O
and CC O
Tth NNP O
polymerase NN O
as IN O
described VBN O
previously RB O
( : O
14 CD O
) -RRB- O
. . O

The DT O
nested VBN O
gene NN O
- HYPH O
specific JJ O
primer NN O
pairs NNS O
were VBD O
as IN O
follows VBZ O
: : O
for IN O
5 CD O
extension NN O
of IN O
mR NN O
- HYPH O
3 CD O
, , O
5 CD O
- HYPH O
CTG NN O
GAA NNP O
CCA NNP O
CTG NNP O
GAT NNP O
ACG NNP O
TGG NNP O
GAC NNP O
TGT NNP O
CCT NNP O
- HYPH O
3 CD O
and CC O
5 CD O
- HYPH O
ACG NN O
TGG NNP O
GAC NNP O
TGT NNP O
CCT NNP O
GTG NNP O
GAG NNP O
TTC NNP O
TGG NNP O
GTT NNP O
- HYPH O
3 CD O
; : O
for IN O
3 CD O
extension NN O
of IN O
mR NNP O
- HYPH O
3 CD O
, , O
5 CD O
- HYPH O
ATG NNP O
CTG NNP O
TTG NNP O
GTG NNP O
TGT NNP O
GTG NNP O
GAA NNP O
ATC NNP O
CAA NNP O
GTG NNP O
- HYPH O
3 CD O
and CC O
5 CD O
- HYPH O
GCT NNP O
TGT NNP O
GCA NNP O
GTG NNP O
ACA NNP O
ATA NNP O
TAA NNP O
GTC NNP O
AAA NNP O
ACT NNP O
- HYPH O
3 CD O
; : O
for IN O
5 CD O
extension NN O
of IN O
mR NNP O
- HYPH O
5 CD O
, , O
5 CD O
- HYPH O
GGT NNP O
GGG NNP O
ACG NNP O
GTC NNP O
CTT NNP O
TGG NNP O
AGT NNP O
TCT NNP O
GGG NNP O
GTT NNP O
ACA NNP O
- HYPH O
3 CD O
and CC O
5 CD O
- HYPH O
GGG NNP O
GTT NNP O
ACA NNP O
GGC NNP O
AAC NNP O
TGT NNP O
GTA NNP O
GGA NNP O
CTT NNP O
CTT NNP O
TCC NNP O
- HYPH O
3 CD O
; : O
for IN O
3 CD O
extension NN O
of IN O
mR NNP O
- HYPH O
5 CD O
, , O
5 CD O
- HYPH O
GAT NNP O
GTT NNP O
GTC NNP O
CGT NNP O
GTG NNP O
TGT NNP O
CAC NNP O
AAT NNP O
CCA NNP O
CCC NNP O
- HYPH O
3 CD O
and CC O
5 CD O
- HYPH O
AAG NNP O
ACT NNP O
TGC NNP O
AAA NNP O
GAC NNP O
GGG NNP O
ACA NNP O
AGT NNP O
CCA NNP O
AAT NNP O
- HYPH O
3 CD O
; : O
for IN O
5 CD O
extension NN O
of IN O
mR NNP O
- HYPH O
6P NNP O
, , O
5 CD O
- HYPH O
TTG NNP O
TTG NNP O
TTT NNP O
TGC NNP O
ATC NNP O
TGC NNP O
ATT NNP O
GTG NNP O
CAT NNP O
AAC NNP O
TGC NNP O
- HYPH O
3 CD O
and CC O
5 CD O
- HYPH O
TTC NNP O
TGC NNP O
ATA NNP O
ACT NNP O
GCT NNP O
TGC NNP O
TGA NNP O
ACT NNP O
TGT NNP O
GAG NNP O
TGA NNP O
- HYPH O
3 CD O
; : O
for IN O
3 CD O
extension NN O
of IN O
mR NNP O
- HYPH O
6P NNP O
, , O
5 CD O
- HYPH O
ATG NNP O
TGA NNP O
TAA NNP O
TGC NNP O
AAT NNP O
GCT NNP O
GTC NNP O
TCT NNP O
TAG NNP O
CAG NNP O
TTA NNP O
- HYPH O
3 CD O
and CC O
5 CD O
- HYPH O
TAC NNP O
AAG NNP O

AGT NN O
ATG NNP O
TAA NNP O
GCC NNP O
ATT NNP O
GAA NNP O
TCA NNP O
TTT NNP O
TCT NNP O
- HYPH O
3 CD O
. . O

The DT O
products NNS O
of IN O
these DT O
reactions NNS O
were VBD O
likewise RB O
subcloned VBN O
into IN O
the DT O
PCR NNP O
II NNP O
TA NNP O
vector NN O
and CC O
evaluated VBN O
by IN O
dideoxy NN O
- HYPH O
sequencing NN O
. . O

The DT O
mR NNP O
- HYPH O
4 CD O
sequence NN O
was VBD O
amplified VBN O
with IN O
a DT O
36 CD O
bp NN O
primer NN O
derived VBN O
from IN O
sequence NN O
encoding VBG O
the DT O
amino JJ O
- HYPH O
terminal JJ O
signal NN O
sequence NN O
of IN O
mEAR NN O
- HYPH O
1 CD O
; : O
5 CD O
- HYPH O
ATG NN O
GGT NN O
CCG NN O
AAG NNP O
CTG NNP O
CTT NNP O
GAG NNP O
TCC NNP O
CGA NNP O
CTT NNP O
TGT NNP O
CTC NNP O
- HYPH O
3 CD O
with IN O
the DT O
carboxy NN O
- HYPH O
primer NN O
described VBN O
above RB O
. . O

Northern JJ O
analysis NN O
The DT O
murine JJ B-Species
multi JJ O
- HYPH O
tissue NN O
Northern JJ O
blot NN O
was VBD O
purchased VBN O
from IN O
Clontech NNP O
, , O
and CC O
pre NN O
- HYPH O
hybridized VBN O
and CC O
hybridized VBN O
as IN O
per IN O
manufacturer NN O
' POS O
s NN O
instructions NNS O
with IN O
radiolabelled JJ O
oligonucleotide NN O
probes NNS O
. . O

The DT O
membrane NN O
was VBD O
washed VBN O
with IN O
5 CD O
< SYM O
FFFD NN O
> SYM O
SSPE NNP O
with IN O
0 CD O
. . O
1 CD O
% NN O
SDS NN O
for IN O
1 CD O
h NN O
at IN O
37 CD O
_ CC O
C NN O
and CC O
the DT O
autoradiogram NN O
developed VBN O
after IN O
exposure NN O
to IN O
film NN O
at IN O
< SYM O
FFFD NN O
> SYM O
80 CD O
_ SYM O
C NN O
. . O

The DT O
mEAR NNP O
- HYPH O
1 CD O
/ SYM O
mEAR NNP O
- HYPH O
2 CD O
/ SYM O
mR NN O
- HYPH O
3 CD O
probe NN O
: : O
5 CD O
- HYPH O
CTC NNP O
TTG NNP O
TCA NNP O
CTG NNP O
CAC NNP O
AAG NNP O
CCA NNP O
CTT NNP O
GGA NNP O
TTT NNP O
CC NNP O
- HYPH O
3 CD O
, , O
the DT O
mR NN O
- HYPH O
5 CD O
probe NN O
: : O
5 CD O
- HYPH O
GTC NNP O
CCG NNP O
TCT NNP O
TTG NNP O
CAA NNP O
GTC NNP O
TTG NNP O
GGT NNP O
GGA NNP O
TTG NNP O
TG NNP O
- HYPH O
3 CD O
, , O
and CC O
the DT O
actin NN O
probe NN O
: : O
5 CD O
- HYPH O
GCA NNP O
CAT NNP O
GCC NNP O
GGA NNP O
GCC NNP O
GTT NNP O
GTC NNP O
GAC NNP O
GAC NNP O
GAG NNP O
CGC NNP O
GGC NNP O
GAT NNP O
ATC NNP O
ATC NNP O
ATC NNP O
- HYPH O
3 CD O
( SYM O
16 CD O
) -RRB- O
. . O

4237 CD O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
1997 CD O
, , O
Vol NNP O
. . O

25 CD O
, , O
No UH O
. . O

Nucleic NNP O
Acids NNP O
Research NNP O
, , O
1994 CD O
, , O
Vol NNP O
. . O

22 CD O
, , O
No UH O
. . O
121 CD O
4237 CD O

Figure NN O
2 CD O
. . O

( : O
A DT O
) : O
Dendrogram NNP O
depicting VBG O
relationships NNS O
among IN O
the DT O
eight CD O
characterized VBN O
murine NN B-Species
ribonucleases NNS O
as IN O
determined VBN O
by IN O
a DT O
modified VBN O
UPGMA NNP O
method NN O
( SYM O
17 CD O
) -RRB- O
. . O

Abbreviations NNS O
are VBP O
as IN O
in IN O
Figure NNP O
1A NNP O
, , O
also RB O
mPR NN O
( , O
murine NN B-Species
pancreatic JJ O
ribonuclease NN O
, , O
sw NN O
: : O
rnp NN O
_ HYPH O
mouse NNP B-Species
) -RRB- O
, , O
mANG NNP O
( , O
murine NN B-Species
angiogenin NN O
, , O
U72672 NNP O
) -RRB- O
, , O
hEDN NNP O
( , O
human JJ B-Species
eosinophil NN O
- HYPH O
derived VBN O
neurotoxin NN O
, , O
M24157 NNP O
) -RRB- O
, , O
hECP NNP O
( , O
human JJ B-Species
eosinophil NN O
cationic JJ O
protein NN O
, , O
X15161 NNP O
) -RRB- O
, , O
hRK6 NN O
( , O
human JJ B-Species
ribonuclease NN O
k6 CD O
, , O
U64998 NNP O
) -RRB- O
, , O
pRK6 NN O
( , O
porcine NN O
kidney NN O
ribonuclease NN O
( , O
24 CD O
) -RRB- O
, , O
and CC O
bRK6 NN O
( , O
bovine JJ B-Species
kidney NN O
ribonuclease NN O
, , O
sw FW O
: : O
rnkd NN O
_ HYPH O
bovin NN O
) -RRB- O
. . O

( : O
B NN O
) , O
Calculated VBN O
isoelectric JJ O
points NNS O
from IN O
amino NN O
acid NN O
sequences NNS O
in IN O
( -LRB- O
A NN O
) -RRB- O
as IN O
determined VBN O
via IN O
the DT O
PEPTIDESORT NNP O
algorithm NN O
of IN O
WGCG NNP O
. . O

Table NN O
1 CD O
. . O

Amino JJ O
acid NN O
sequence NN O
comparisons NNS O
of IN O
murine NN B-Species
and CC O
human JJ B-Species
ribonucleases NNS O

Sequence NN O
analysis NN O
All DT O
DNA NN O
sequence NN O
analysis NN O
and CC O
comparisons NNS O
were VBD O
performed VBN O
with IN O
the DT O
assistance NN O
of IN O
the DT O
Wisconsin NNP O
Genetics NNP O
Computer NNP O
Group NNP O
and CC O
Sequencher NNP O
( -LRB- O
Gene NNP O
Codes NNP O
Corporation NNP O
) -RRB- O
programs NNS O
available JJ O
at IN O
the DT O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
. . O

The DT O
dendrogram NN O
in IN O
Figure NNP O
2A NNP O
was VBD O
constructed VBN O
by IN O
a DT O
modified VBN O
version NN O
of IN O
the DT O
unweighted JJ O
pair NN O
group NN O
method NN O
with IN O
arithmetic JJ O
mean NN O
( , O
UPGMA NNP O
) -RRB- O
( , O
17 CD O
) -RRB- O
, , O
constructed VBN O
using VBG O
four CD O
initial JJ O
pairings NNS O
, , O
mEAR NN O
- HYPH O
2 CD O
to IN O
mR NN O
- HYPH O
3 CD O
, , O
mR NN O
- HYPH O
5 CD O
to IN O
mR NN O
- HYPH O
6P NN O
, , O
hEDN NN O
to IN O
hECP NN O
and CC O
bRK6 NN O
to IN O
pRK6 NN O
. . O

RESULTS NNS O
Isolation NN O
of IN O
genomic JJ O
fragments NNS O
encoding VBG O
novel JJ O
murine NN B-Species
ribonucleases NNS O
The DT O
alignment NN O
in IN O
Figure NN O
1A NN O
displays VBZ O
the DT O
amino JJ O
acid NN O
sequences NNS O
encoded VBN O
by IN O
the DT O
six CD O
related JJ O
ribonuclease NN O
genes NNS O
. . O

Murine NNP B-Species
eosinophil NN O
- HYPH O
associated VBN O
ribonucleases NN O
- HYPH O
1 CD O
and CC O
- HYPH O
2 CD O
( HYPH O
mEAR NN O
- HYPH O
1 CD O
and CC O
mEAR NN O
- HYPH O
2 CD O
) -RRB- O
are VBP O
the DT O
predicted VBN O
amino JJ O
acid NN O
sequences NNS O
from IN O
two CD O
genes NNS O
described VBN O
previously RB O
by IN O
Larson NNP O
and CC O
colleagues NNS O
( , O
15 CD O
) -RRB- O
; , O
murine JJ B-Species
ribonucleases NNS O
3 CD O
, , O
4 CD O
, , O
5 CD O
and CC O
6 CD O
- HYPH O
pseudogene NN O
( , O
mR NN O
- HYPH O
3 CD O
, , O
mR NN O
- HYPH O
4 CD O
, , O
mR NN O
- HYPH O
5 CD O
and CC O
mR NN O
- HYPH O
6P CD O
) -RRB- O
, , O
are VBP O
the DT O
predicted VBN O
amino JJ O
acid NN O
sequences NNS O
encoded VBN O
by IN O
novel JJ O
DNA NNP O

hEDN NNP O
mEAR NNP O
- HYPH O
1 CD O
mEAR NN O
- HYPH O
2 CD O
mR CD O
- HYPH O
3 CD O
mR CD O
- HYPH O
4 CD O
mR CD O
- HYPH O
5 CD O
mANG NN O
mPR NN O
56 CD O
56 CD O
54 CD O
60 CD O
60 CD O
43 CD O
53 CD O

hECP NNP O
59 CD O
59 CD O
57 CD O
59 CD O
58 CD O
49 CD O
52 CD O

hRK6 CD O
58 CD O
59 CD O
59 CD O
53 CD O
56 CD O
49 CD O
59 CD O

hPR NNP O
47 CD O
48 CD O
49 CD O
48 CD O
57 CD O
55 CD O
79 CD O

hR4 CD O
50 CD O
53 CD O
51 CD O
52 CD O
54 CD O
57 CD O
66 CD O

hANG NNP O
49 CD O
48 CD O
51 CD O
47 CD O
47 CD O
80 CD O
60 CD O

Values NNS O
are VBP O
expressed VBN O
as IN O
percent NN O
similarity NN O
between IN O
pairs NNS O
of IN O
amino NN O
acid NN O
sequences NNS O
as IN O
determined VBN O
by IN O
the DT O
BESTFIT NNP O
algorithm NN O
of IN O
the DT O
Wisconsin NNP O
Genetics NNP O
Computer NNP O
Group NNP O
program NN O
on IN O
- HYPH O
line NN O
at IN O
the DT O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
. . O

Value NN O
representing VBG O
the DT O
highest JJS O
degree NN O
of IN O
sequence NN O
homology NN O
in IN O
each DT O
row NN O
is VBZ O
indicated VBN O
in IN O
boldface NN O
. . O

Abbreviations NNS O
are VBP O
as IN O
defined VBN O
in IN O
Figures NNP O
1 CD O
and CC O
2 CD O
, , O
and CC O
also RB O
include VBP O
hR4 NNP O
( , O
human JJ B-Species
ribonuclease NN O
4 CD O
, , O
sw NN O
: : O
rnl4 NN O
_ : O
human JJ B-Species
) -RRB- O
, , O
hANG NNP O
( , O
human JJ B-Species
angiogenin NN O
, , O
M11567 NNP O
) -RRB- O
, , O
and CC O
hPR NN O
( , O
human JJ B-Species
pancreatic JJ O
ribonuclease NN O
, , O
X62946 CD O
) -RRB- O
. . O

4238 CD O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
1997 CD O
, , O
Vol NNP O
. . O

25 CD O
, , O
No UH O
. . O
21 CD O
fragments NNS O
amplified VBN O
from IN O
murine JJ B-Species
genomic JJ O
DNA NNP O
. . O

All DT O
five CD O
functional JJ O
genes NNS O
encode VBP O
amino JJ O
acid NN O
sequences NNS O
with IN O
eight CD O
cysteines NNS O
and CC O
appropriately RB O
spaced VBN O
catalytic JJ O
histidines NNS O
and CC O
lysine NN O
that WDT O
are VBP O
conserved VBN O
among IN O
the DT O
members NNS O
of IN O
the DT O
RNase NNP O
A NNP O
superfamily NN O
. . O

The DT O
predicted VBN O
coding VBG O
sequence NN O
of IN O
the DT O
non JJ O
- HYPH O
functional JJ O
pseudogene NN O
( , O
mR NN O
- HYPH O
6P NN O
) -RRB- O
includes VBZ O
two CD O
aberrant JJ O
stop NN O
codons NNS O
( , O
positions NNS O
19 CD O
and CC O
100 CD O
) , O
as RB O
well RB O
as IN O
a DT O
point NN O
mutation NN O
resulting VBG O
in IN O
the DT O
destruction NN O
of IN O
the DT O
cysteine NN O
at IN O
position NN O
78 CD O
. . O

Each DT O
genomic JJ O
fragment NN O
also RB O
encodes VBZ O
a DT O
28 CD O
residue NN O
amino JJ O
terminal NN O
signal NN O
sequence NN O
( , O
not RB O
shown VBN O
) NFP O
. . O

The DT O
amino NN O
acid NN O
sequences NNS O
are VBP O
displayed VBN O
in IN O
order NN O
of IN O
decreasing VBG O
similarity NN O
to IN O
mEAR NN O
- HYPH O
1 CD O
( HYPH O
Fig NNP O
. . O
1B NN O
) -RRB- O
. . O

Genomic JJ O
fragments NNS O
encoding VBG O
mEAR NN O
- HYPH O
1 CD O
and CC O
mEAR NN O
- HYPH O
2 CD O
were VBD O
also RB O
detected VBN O
. . O

Relationships NNS O
among IN O
the DT O
murine NN B-Species
ribonucleases NNS O
A DT O
dendrogram NN O
depicting VBG O
the DT O
relationships NNS O
among IN O
several JJ O
of IN O
the DT O
murine NN B-Species
and CC O
human JJ B-Species
ribonucleases NNS O
is VBZ O
shown VBN O
in IN O
Figure NNP O
2A NNP O
. . O

The DT O
mEAR NN O
- HYPH O
1 CD O
, , O
mEAR NNP O
- HYPH O
2 CD O
, , O
and CC O
mR NN O
- HYPH O
3 CD O
sequences NNS O
form VBP O
a DT O
closely RB O
related VBN O
sub NN O
- HYPH O
group NN O
, , O
with IN O
only RB O
nine CD O
amino JJ O
acid NN O
sequence NN O
differences NNS O
noted VBN O
between IN O
mEAR NNP O
- HYPH O
2 CD O
and CC O
mR NN O
- HYPH O
3 CD O
, , O
and CC O
12 CD O
and CC O
17 CD O
between IN O
these DT O
two CD O
and CC O
mEAR NN O
- HYPH O
1 CD O
, , O
respectively RB O
. . O

The DT O
mR NNP O
- HYPH O
4 CD O
, , O
mR NNP O
- HYPH O
5 CD O
, , O
and CC O
mR NN O
- HYPH O
6P NN O
sequences NNS O
diverge VBP O
from IN O
this DT O
subgroup NN O
and CC O
from IN O
one NN O
another DT O
as RB O
well RB O
. . O

These DT O
six CD O
sequences NNS O
are VBP O
more RBR O
closely RB O
related VBN O
to IN O
one CD O
another DT O
than IN O
they PRP O
are VBP O
to IN O
either CC O
murine JJ B-Species
pancreatic JJ O
ribonuclease NN O
( , O
mPR NN O
) , O
or CC O
to IN O
murine NN B-Species
angiogenin NN O
( , O
mANG NNP O
) -RRB- O
or CC O
to IN O
any DT O
of IN O
the DT O
three CD O
human JJ B-Species
ribonucleases NNS O
shown VBN O
( : O
hEDN NNP O
, , O
hECP NNP O
or CC O
hRK6 NNP O
) -RRB- O
. . O

Isoelectric JJ O
points NNS O
The DT O
isoelectric JJ O
points NNS O
of IN O
all DT O
six CD O
related JJ O
ribonucleases NNS O
range VBP O
from IN O
8 CD O
< SYM O
FFFD NNP O
> SYM O
11 CD O
, , O
as IN O
is VBZ O
typical JJ O
for IN O
members NNS O
of IN O
the DT O
RNase NNP O
A NNP O
superfamily NN O
( : O
Fig NNP O
. . O
2B NN O
) -RRB- O
. . O

Interestingly RB O
, , O
the DT O
isoelectric JJ O
points NNS O
within IN O
the DT O
mEAR NNP O
- HYPH O
1 CD O
/ SYM O
mEAR NN O
- HYPH O
2 CD O
/ SYM O
mR NN O
- HYPH O
3 CD O
subgroup NN O
vary VBP O
by IN O
a DT O
full JJ O
1 CD O
. . O
0 CD O
unit NN O
( , O
mEAR NN O
- HYPH O
1 CD O
at IN O
9 CD O
. . O
2 CD O
to IN O
mEAR NN O
- HYPH O
2 CD O
at IN O
10 CD O
. . O
2 CD O
) -RRB- O
in IN O
response NN O
to IN O
only RB O
12 CD O
discrepancies NNS O
in IN O
amino NN O
acid NN O
sequence NN O
. . O

As IN O
increased VBN O
charge NN O
has VBZ O
been VBN O
associated VBN O
with IN O
increased VBN O
toxicity NN O
in IN O
other JJ O
branches NNS O
of IN O
the DT O
RNase NNP O
A NNP O
gene NN O
family NN O
( : O
18 CD O
) -RRB- O
, , O
this DT O
finding NN O
has VBZ O
potential JJ O
consequences NNS O
with IN O
respect NN O
to IN O
the DT O
function NN O
of IN O
these DT O
proteins NNS O
( , O
see VB O
Discussion NNP O
) -RRB- O
. . O

Northern JJ O
analysis NN O
Tissue NNP O
- HYPH O
specific JJ O
expression NN O
of IN O
mRNA NN O
encoding VBG O
these DT O
murine NN B-Species
ribonucleases NNS O
is VBZ O
shown VBN O
in IN O
Figure NN O
3 CD O
. . O

The DT O
probe NN O
complementary JJ O
to IN O
all DT O
three CD O
sequences NNS O
of IN O
the DT O
mEAR NN O
- HYPH O
1 CD O
/ SYM O
mEAR NN O
- HYPH O
2 CD O
/ SYM O
mR NN O
- HYPH O
3 CD O
subgroup NN O
hybridizes NNS O
to IN O
an DT O
1 CD O
. . O
4 CD O
kb NN O
mRNA NN O
isolated VBN O
from IN O
renal JJ O
tissue NN O
( , O
Fig NNP O
. . O
3A NN O
) -RRB- O
. . O

As IN O
the DT O
probe NN O
cannot MD O
distinguish VB O
among IN O
the DT O
three CD O
genes NNS O
, , O
it PRP O
is VBZ O
not RB O
possible JJ O
to TO O
conclude VB O
whether IN O
the DT O
band NN O
detected VBN O
represents VBZ O
mRNA NNP O
encoding VBG O
one CD O
, , O
two CD O
, , O
or CC O
all DT O
three CD O
of IN O
the DT O
ribonucleases NNS O
of IN O
this DT O
subgroup NN O
. . O

In IN O
contrast NN O
, , O
the DT O
probe NN O
complementary JJ O
to IN O
the DT O
mR NNP O
- HYPH O
5 CD O
genomic JJ O
fragment NN O
hybridizes VBZ O
to IN O
two CD O
prominent JJ O
mRNA NNP O
species NNS O
in IN O
hepatic JJ O
tissue NN O
, , O
one CD O
at IN O
1 CD O
. . O
4 CD O
kb NN O
, , O
and CC O
a DT O
second NN O
at IN O
2 CD O
. . O
0 CD O
kb NN O
. . O

A DT O
prominent JJ O
mRNA NNP O
of IN O
1 CD O
. . O
8 CD O
kb NN O
was VBD O
also RB O
detected VBN O
in IN O
mRNA NNP O
isolated VBN O
from IN O
murine JJ B-Species
testicular JJ O
tissue NN O
; : O
fainter NN O
hybridizing VBG O
mRNAs NNS O
of IN O
varying VBG O
size NN O
were VBD O
detected VBN O
in IN O
lung NN O
and CC O
skeletal JJ O
muscle NN O
. . O

The DT O
size NN O
variation NN O
may MD O
represent VB O
differential JJ O
splicing NN O
of IN O
the DT O
mR NNP O
- HYPH O
5 CD O
- HYPH O
encoding VBG O
mRNA NNP O
, , O
or CC O
may MD O
represent VB O
mRNAs NNS O
encoding VBG O
one CD O
or CC O
more JJR O
as IN O
yet RB O
undiscovered JJ O
murine NN B-Species
ribonucleases NNS O
that WDT O
are VBP O
more RBR O
closely RB O
related VBN O
to IN O
mR NNP O
- HYPH O
5 CD O
than IN O
those DT O
whose WP$ O
sequences NNS O
are VBP O
reported VBN O
here RB O
. . O

Figure NN O
3 CD O
. . O

( : O
A DT O
) : O
Murine NNP B-Species
RNA NNP O
probed VBD O
with IN O
a DT O
32 CD O
bp NN O
oligonucleotide NN O
complementary JJ O
to IN O
mEAR NN O
- HYPH O
1 CD O
, , O
mEAR NN O
- HYPH O
2 CD O
and CC O
mR NN O
- HYPH O
3 CD O
coding NN O
sequences NNS O
. . O

Tissue NN O
source NN O
of IN O
each DT O
RNA NNP O
is VBZ O
indicated VBN O
above IN O
each DT O
lane NN O
. . O

( -LRB- O
B NN O
) : O
Same JJ O
as IN O
in IN O
( HYPH O
A NN O
) -RRB- O
, , O
probed VBN O
with IN O
a DT O
32 CD O
bp NN O
oligonucleotide NN O
complementary JJ O
to IN O
mR NN O
- HYPH O
5 CD O
. . O

( : O
C NN O
) : O
Same JJ O
as IN O
in IN O
( HYPH O
A NN O
) -RRB- O
, , O
probed VBN O
with IN O
a DT O
48 CD O
bp NN O
oligonucleotide NN O
complementary JJ O
to IN O
human JJ B-Species
actin NN O
( SYM O
16 CD O
) -RRB- O
, , O
demonstrating VBG O
relative JJ O
loading NN O
of IN O
each DT O
lane NN O
. . O

Relationship NN O
to IN O
human JJ B-Species
ribonucleases NNS O
The DT O
data NNS O
in IN O
Table NNP O
1 CD O
denote VBP O
the DT O
amino JJ O
acid NN O
sequence NN O
similarity NN O
between IN O
pairs NNS O
of IN O
murine NN B-Species
and CC O
human JJ B-Species
ribonucleases NNS O
of IN O
the DT O
RNase NNP O
A NNP O
superfamily NN O
. . O

Overall RB O
, , O
the DT O
similarities NNS O
within IN O
the DT O
identified VBN O
cluster NN O
range VBP O
from IN O
47 CD O
to IN O
60 CD O
% NN O
, , O
with IN O
remarkably RB O
little JJ O
variation NN O
among IN O
the DT O
pairs NNS O
. . O

Although IN O
the DT O
sequences NNS O
of IN O
the DT O
mEAR NNP O
- HYPH O
1 CD O
/ SYM O
mEAR NN O
- HYPH O
2 CD O
/ SYM O
mR NN O
- HYPH O
3 CD O
subgroup NN O
are VBP O
slightly RB O
more RBR O
similar JJ O
to IN O
ECP NNP O
and CC O
RNase NNP O
k6 CD O
, , O
and CC O
mR NNP O
- HYPH O
4 CD O
and CC O
mR NN O
- HYPH O
5 CD O
, , O
to IN O
EDN NNP O
and CC O
ECP NNP O
, , O
the DT O
orthologous JJ O
relationships NNS O
of IN O
these DT O
murine NN B-Species
ribonucleases NNS O
cannot MD O
be VB O
discerned VBN O
from IN O
these DT O
data NNS O
. . O

This DT O
stands VBZ O
in IN O
direct JJ O
contrast NN O
to IN O
mPR NNP O
and CC O
mANG NNP O
, , O
whose WP$ O
human JJ B-Species
orthologs NNS O
can MD O
be VB O
clearly RB O
distinguished VBN O
on IN O
the DT O
basis NN O
of IN O
their PRP$ O
amino JJ O
acid NN O
sequence NN O
homologies NNS O
. . O

DISCUSSION NN O
In IN O
this DT O
work NN O
, , O
we PRP O
have VBP O
identified VBN O
four CD O
novel JJ O
murine NN B-Species
ribonuclease NN O
genes NNS O
that WDT O
, , O
together RB O
with IN O
mEAR NNP O
- HYPH O
1 CD O
and CC O
mEAR NN O
- HYPH O
2 CD O
defined VBN O
by IN O
Larson NNP O
and CC O
colleagues NNS O
( , O
15 CD O
) -RRB- O
, , O
form VBP O
an DT O
unusual JJ O
cluster NN O
within IN O
the DT O
RNase NNP O
A NNP O
gene NN O
superfamily NN O
. . O

The DT O
six CD O
genes NNS O
within IN O
this DT O
cluster NN O
have VBP O
varying VBG O
amino NN O
acid NN O
sequence NN O
homologies NNS O
to IN O
one CD O
another DT O
, , O
but CC O
are VBP O
clearly RB O
more RBR O
closely RB O
related JJ O
to IN O
one CD O
another DT O
than IN O
to IN O
either CC O
murine JJ B-Species
pancreatic JJ O
ribonuclease NN O
( , O
mPR NN O
) , O
or CC O
angiogenin NN O
( , O
mANG NNP O
) -RRB- O
, , O
or CC O
to IN O
any DT O
of IN O
the DT O
human JJ B-Species
ribonucleases NNS O
of IN O
the DT O
RNase NNP O
A NNP O
family NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
` `` O
mR NN O
cluster NN O
' '' O
emerged VBD O
via IN O
multiple JJ O
duplications NNS O
of IN O
a DT O
gene NN O
that WDT O
had VBD O
already RB O
diverged VBN O
from IN O
those DT O
encoding VBG O
the DT O
other JJ O
murine NN B-Species
ribonucleases NNS O
. . O

Although IN O
this DT O
type NN O
of IN O
expansion NN O
is VBZ O
unusual JJ O
in IN O
this DT O
gene NN O
family NN O
, , O
it PRP O
is VBZ O
actually RB O
not RB O
unique JJ O
; : O
similar JJ O
expansion NN O
has VBZ O
occurred VBN O
in IN O
bovine JJ B-Species
species NNS O
, , O
with IN O
gene NN O
duplication NN O
resulting VBG O
in IN O
the DT O
three CD O
closely RB O
- HYPH O
related VBN O
bovine JJ B-Species
pancreatic JJ O
, , O
bovine JJ B-Species
brain NN O
( , O
19 CD O
, , O
20 CD O
) -RRB- O
and CC O
bovine JJ B-Species
seminal JJ O
( , O
21 CD O
) , O
ribonucleases NNS O
. . O

One CD O
interesting JJ O
feature NN O
of IN O
the DT O
mR NNP O
cluster NN O
is VBZ O
that IN O
its PRP$ O
relationship NN O
to IN O
any DT O
of IN O
to IN O
the DT O
six CD O
known VBN O
human JJ B-Species
RNase NNP O
A NNP O
- HYPH O
type NN O
genes NNS O
cannot MD O
be VB O

4239 CD O
Nucleic NNP O
Acids NNP O
Research NNP O
, , O
1997 CD O
, , O
Vol NNP O
. . O

25 CD O
, , O
No UH O
. . O

Nucleic NNP O
Acids NNP O
Research NNP O
, , O
1994 CD O
, , O
Vol NNP O
. . O

22 CD O
, , O
No UH O
. . O
121 CD O
determined VBN O
from IN O
their PRP$ O
respective JJ O
amino JJ O
acid NN O
sequence NN O
homologies NNS O
. . O

Although IN O
the DT O
amino NN O
acid NN O
sequences NNS O
encoded VBN O
by IN O
mEAR NNP O
- HYPH O
1 CD O
and CC O
mEAR NN O
- HYPH O
2 CD O
match VBP O
those DT O
of IN O
tryptic JJ O
peptides NNS O
derived VBN O
from IN O
murine JJ B-Species
eosinophil NN O
proteins NNS O
( , O
15 CD O
) -RRB- O
, , O
the DT O
homology NN O
data NNS O
do VBP O
not RB O
stand VB O
in IN O
overwhelming JJ O
support NN O
of IN O
a DT O
unique JJ O
relationship NN O
between IN O
any DT O
of IN O
the DT O
mR JJ O
cluster NN O
ribonucleases NNS O
and CC O
the DT O
human JJ B-Species
eosinophil NN O
ribonucleases NNS O
EDN NNP O
and CC O
ECP NNP O
. . O

The DT O
existence NN O
of IN O
an DT O
additional JJ O
, , O
as IN O
yet RB O
unidentified JJ O
human JJ B-Species
ribonuclease NN O
( , O
or CC O
ribonucleases NNS O
) , O
more RBR O
closely RB O
related VBN O
to IN O
those DT O
of IN O
the DT O
mR NNP O
cluster NN O
cannot MD O
be VB O
ruled VBN O
out RP O
. . O

Perhaps RB O
the DT O
most RBS O
important JJ O
issue NN O
raised VBN O
by IN O
this DT O
work NN O
is VBZ O
the DT O
question NN O
of IN O
why WRB O
so RB O
much JJ O
evolutionary JJ O
energy NN O
has VBZ O
been VBN O
devoted VBN O
to IN O
enlarging VBG O
and CC O
diversifying VBG O
the DT O
RNase NNP O
A NNP O
gene NN O
superfamily NN O
. . O

To IN O
date NN O
, , O
this DT O
superfamily NN O
now RB O
includes VBZ O
several JJ O
distinct JJ O
lineages NNS O
, , O
two CD O
species NN O
- HYPH O
limited VBN O
clusters NNS O
, , O
and CC O
the DT O
two CD O
most RBS O
rapidly RB O
evolving VBG O
functional JJ O
coding VBG O
sequences NNS O
known VBN O
among IN O
primates NNS O
( , O
22 CD O
) -RRB- O
. . O

The DT O
question NN O
of IN O
evolutionary JJ O
energy NN O
takes VBZ O
on RP O
particular JJ O
significance NN O
here RB O
, , O
where WRB O
five CD O
functional JJ O
ribonucleases NNS O
have VBP O
emerged VBN O
in IN O
what WP O
appears VBZ O
to TO O
be VB O
a DT O
remarkably RB O
short JJ O
period NN O
of IN O
evolutionary JJ O
time NN O
( , O
15 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
conceivable JJ O
that IN O
each DT O
of IN O
these DT O
ribonucleases NNS O
might MD O
serve VB O
a DT O
unique JJ O
but CC O
related JJ O
function NN O
. . O

On IN O
this DT O
point NN O
, , O
a DT O
number NN O
of IN O
studies NNS O
have VBP O
suggested VBN O
a DT O
distinct JJ O
role NN O
for IN O
the DT O
human JJ B-Species
ribonuclease NN O
ECP NNP O
in IN O
eosinophil NN O
- HYPH O
mediated VBN O
host NN O
defense NN O
( , O
6 CD O
, , O
7 CD O
) -RRB- O
; , O
in IN O
addition NN O
, , O
we PRP O
have VBP O
recently RB O
shown VBN O
that IN O
eosinophil NN O
ribonucleases NNS O
can MD O
inhibit VB O
retroviral JJ O
transduction NN O
of IN O
human JJ B-Species
target NN O
cells NNS O
( SYM O
23 CD O
) -RRB- O
. . O

The DT O
possibility NN O
that IN O
certain JJ O
ribonucleases NNS O
have VBP O
diverged VBN O
to TO O
promote VB O
distinct JJ O
and CC O
specific JJ O
host NN O
defense NN O
- HYPH O
related VBN O
activities NNS O
remains VBZ O
an DT O
intriguing JJ O
hypothesis NN O
. . O

ACKNOWLEDGEMENTS NNS O
We PRP O
would MD O
like VB O
to TO O
thank VB O
Dr NNP O
Jianzhi NNP O
Zhang NNP O
for IN O
helpful JJ O
discussions NNS O
, , O
and CC O
Drs NNP O
Harry NNP O
L NNP O
. . O
Malech NNP O
and CC O
John NNP O
I NNP O
. . O
Gallin NNP O
for IN O
their PRP$ O
ongoing JJ O
suppport NN O
of IN O
the DT O
work NN O
in IN O
our PRP$ O
laboratory NN O
. . O

D NN O
. . O
B NN O
. . O

is VBZ O
a DT O
Howard NNP O
Hughes NNP O
Medical NNP O
Institute NNP O
- : O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
Research NNP O
Scholar NNP O
REFERENCES NNPS O
1 CD O
D NNP O
' '' O
Alessio NNP O
, , O
G NNP O
. . O
and CC O
Riordan NNP O
, , O
J NNP O
. . O
F NNP O
. . O

( NFP O
1997 CD O
) : O
In IN O
D NN O
' '' O
Alessio NNP O
, , O
G NNP O
. . O
and CC O
Riordan NNP O
, , O
J NNP O
. . O
F NNP O
. . O

( : O
eds NN O
) -RRB- O
Ribonucleases NNS O
: : O
structure NN O
and CC O
function NN O
. . O

Academic NNP O
Press NNP O
, , O
Inc NNP O
. . O
, , O
New NNP O
York NNP O
, , O
NY NNP O
. . O

2 LS O
Sorrentino NNP O
, , O
S NNP O
. . O
and CC O
Libonati NNP O
, , O
M NNP O
. . O

( -LRB- O
1997 CD O
) SYM O
FEBS NNP O
Lett NNP O
. . O

404 CD O
, , O
1 CD O
< SYM O
FFFD NNP O
> SYM O
5 CD O
. . O

21 CD O
22 CD O
23 CD O
24 CD O
3 CD O
4 CD O
5 CD O
6 CD O
7 CD O
8 CD O
9 CD O
10 CD O
11 CD O
12 CD O
13 CD O
14 CD O
15 CD O
16 CD O
17 CD O
18 CD O
19 CD O
20 CD O

4239 CD O

Beintema NNP O
, , O
J NNP O
. . O
J NNP O
. . O
, , O
Breukelman NNP O
, , O
H NNP O
. . O
J NNP O
, , O
Carsana NNP O
, , O
A NNP O
. . O
, , O
and CC O
Furia NNP O
, , O
A NNP O
. . O

( NFP O
1997 CD O
) : O
In IN O
D NN O
' '' O
Alessio NNP O
, , O
G NNP O
. . O
and CC O
Riordan NNP O
, , O
J NNP O
. . O
F NNP O
. . O

( : O
eds NN O
) -RRB- O
Ribonucleases NNS O
: : O
structure NN O
and CC O
function NN O
. . O

Academic NNP O
Press NNP O
, , O
Inc NNP O
. . O
, , O
New NNP O
York NNP O
, , O
NY NNP O
. . O

Confalone NNP O
, , O
E NNP O
. . O
, , O
Beintema NNP O
, , O
J NNP O
. . O
J NNP O
. . O
, , O
Sasso NNP O
, , O
M NNP O
. . O
P NN O
. . O

Carsana NNP O
, , O
A NNP O
. . O
, , O
Palmieria NNP O
, , O
M NNP O
. . O
, , O
Vento NNP O
, , O
M NNP O
. . O
T NNP O
. . O
and CC O
Furia NNP O
A NNP O
. . O

( -LRB- O
1995 CD O
) SYM O
J NN O
. . O

Mol NNP O
. . O

Evol NNP O
. . O

41 CD O
, , O
850 CD O
< SYM O
FFFD NNP O
> SYM O
858 CD O
. . O

Futami NNP O
, , O
J NNP O
. . O
, , O
Tsushima NNP O
, , O
Y NNP O
. . O
, , O
Murato NNP O
, , O
U NNP O
, , O
Tada NNP O
, , O
H NNP O
. . O
, , O
Sasaki NNP O
, , O
J NNP O
. . O
, , O
Seno NNP O
, , O
M NNP O
. . O
, , O
and CC O
Yamada NNP O
, , O
H NNP O
. . O

( -LRB- O
1997 CD O
) SYM O
DNA NNP O
Cell NNP O
Biol NNP O
. . O

16 CD O
, , O
413 CD O
< SYM O
FFFD NNP O
> SYM O
419 CD O
. . O

Ackerman NNP O
, , O
S NNP O
. . O
J NNP O
. . O

( -LRB- O
1993 CD O
) -RRB- O
In IN O
Makino NNP O
, , O
S NNP O
. . O
and CC O
Fukuda NNP O
, , O
T NNP O
. . O

( : O
eds NNS O
) -RRB- O
Eosinophils NNP O
: : O
biological JJ O
and CC O
clinical JJ O
aspects NNS O
. . O

CRC NNP O
Press NNP O
, , O
Inc NNP O
. . O
, , O
Boca NNP O
Raton NNP O
, , O
FL NNP O
Spry NNP O
, , O
C NNP O
. . O
J NNP O
. . O
F NN O
. . O

( : O
1988 CD O
) SYM O
Eosinophils NNP O
: : O
a DT O
comprehensive JJ O
review NN O
and CC O
guide NN O
to IN O
the DT O
scientific JJ O
and CC O
medical JJ O
literature NN O
. . O

Oxford NNP O
University NNP O
Press NNP O
, , O
Oxford NNP O
, , O
UK NNP O
. . O

Beintema NNP O
, , O
J NNP O
. . O
J NNP O
. . O
, , O
Hofsteenge NNP O
, , O
J NNP O
. . O
, , O
Iwama NNP O
, , O
M NNP O
. . O
, , O
Morita NNP O
, , O
T NNP O
. . O
, , O
Ohgi NNP O
, , O
K NNP O
. . O
, , O
Irie NNP O
, , O
M NNP O
. . O
, , O
Sugiyama NNP O
, , O
R NNP O
. . O
H NNP O
. . O
, , O
Schieven NNP O
G NNP O
. . O
L NNP O
. . O
, , O
Dekker NNP O
, , O
C NNP O
. . O
A NNP O
. . O
, , O
and CC O
Glitz NNP O
, , O
D NNP O
. . O
G NNP O
. . O

( : O
1988 CD O
) SYM O
Biochemistry NNP O
27 CD O
, , O
4530 CD O
< , O
FFFD NN O
> SYM O
4538 CD O
. . O

Sorrentino NNP O
, , O
S NNP O
. . O
, , O
Tucker NNP O
, , O
G NNP O
. . O
K NNP O
. . O
, , O
and CC O
Glitz NNP O
, , O
D NNP O
. . O
G NNP O
. . O

( : O
1988 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

263 CD O
, , O
16125 CD O
< : O
FFFD NN O
> SYM O
16131 CD O
. . O

Vallee NNP O
, , O
B NNP O
. . O
L NNP O
. . O
and CC O
Riordan NNP O
, , O
J NNP O
. . O
F NN O
. . O

( -LRB- O
1988 CD O
) SYM O
Adv NNP O
. . O

Exp UH O
. . O

Med NNP O
. . O

Biol NNP O
. . O

234 CD O
, , O
41 CD O
< SYM O
FFFD NNP O
> SYM O
53 CD O
. . O

Moroianu NNP O
, , O
J NNP O
. . O
and CC O
Riordan NNP O
, , O
J NNP O
. . O
F NNP O
. . O

( -LRB- O
1994 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
91 CD O
, , O
1677 CD O
< SYM O
FFFD NN O
> SYM O
1681 CD O
. . O

Seno NNP O
, , O
M UH O
. . O
, , O
Futami NNP O
, , O
J NNP O
. . O
, , O
Tsushima NNP O
, , O
Y NNP O
. . O
, , O
Akutagawa NNP O
, , O
K NNP O
. . O
, , O
Kosaka NNP O
, , O
M NNP O
. . O
, , O
Tada NNP O
, , O
H NNP O
. . O
and CC O
Yamada NNP O
, , O
H NNP O
. . O

( -LRB- O
1995 CD O
) SYM O
Bioch NNP O
. . O

Biophys NNP O
. . O

Acta NNP O
1261 CD O
, , O
424 CD O
< SYM O
FFFD NN O
> SYM O
426 CD O
. . O

Rosenberg NNP O
, , O
H NNP O
. . O
F XX O
. . O
and CC O
Dyer NNP O
, , O
K NNP O
. . O
D NN O
. . O

( NFP O
1995 CD O
) SYM O
Nucleic JJ O
Acids NNS O
Res NNP O
. . O

23 CD O
, , O
4290 CD O
< SYM O
FFFD NNP O
> SYM O
4295 CD O
. . O

Rosenberg NNP O
, , O
H NNP O
. . O
F XX O
. . O
and CC O
Dyer NNP O
, , O
K NNP O
. . O
D NN O
. . O

( NFP O
1996 CD O
) SYM O
Nucleic JJ O
Acids NNS O
Res NNP O
. . O

24 CD O
, , O
3507 CD O
< SYM O
FFFD NNP O
> SYM O
3513 CD O
. . O

Larson NNP O
, , O
K UH O
. . O
A NNP O
. . O
, , O
Olson NNP O
, , O
E NNP O
. . O
V NN O
. . O
, , O
Madden NNP O
, , O
B NNP O
. . O
J NNP O
. . O
, , O
Gleich NNP O
, , O
G NNP O
. . O
J NNP O
. . O
, , O
Lee NNP O
, , O
N NNP O
. . O
A NNP O
. . O
and CC O
Lee NNP O
, , O
J NNP O
. . O
J NNP O
. . O

( -LRB- O
1997 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
93 CD O
, , O
12370 CD O
< SYM O
FFFD NN O
> SYM O
12375 CD O
. . O

Nakajima NNP O
- HYPH O
Iyima NNP O
, , O
S NNP O
. . O
, , O
Hamada NNP O
, , O
H NNP O
. . O
, , O
Reddy NNP O
, , O
P NNP O
. . O
and CC O
Kakanaga NNP O
, , O
T NNP O
. . O

( -LRB- O
1985 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
82 CD O
, , O
6133 CD O
< SYM O
FFFD NNP O
> SYM O
6137 CD O
. . O

Li NNP O
, , O
W NNP O
. . O
- HYPH O
H NN O
. . O
and CC O
Graur NNP O
, , O
D NNP O
. . O

( : O
1991 CD O
) -RRB- O
Fundamentals NNS O
of IN O
Molecular NNP O
Evolution NNP O
. . O

Sinauer NNP O
Associates NNP O
, , O
Sunderland NNP O
, , O
MA NNP O
. . O

Rosenberg NNP O
, , O
H NNP O
. . O
F XX O
. . O
and CC O
Dyer NNP O
, , O
K NNP O
. . O
D NN O
. . O

( -LRB- O
1995 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

270 CD O
, , O
21539 CD O
< SYM O
FFFD NN O
> SYM O
21544 CD O
. . O

Watanabe NNP O
, , O
H NNP O
. . O
, , O
Katoh NNP O
, , O
H NNP O
, , O
Ishii NNP O
, , O
M NNP O
. . O
, , O
Komoda NNP O
, , O
Y NNP O
. . O
, , O
Sanda NNP O
, , O
A NNP O
. . O
, , O
Takizawa NNP O
, , O
Y NNP O
. . O
, , O
Ohgi NNP O
, , O
K NNP O
. . O
and CC O
Irie NNP O
, , O
M NNP O
. . O

( : O
1988 CD O
) SYM O
J NN O
. . O

Biochem NNP O
. . O

104 CD O
, , O
939 CD O
< SYM O
FFFD NNP O
> SYM O
945 CD O
. . O

Sasso NNP O
, , O
M NNP O
. . O
P NN O
. . O
, , O
Carsana NNP O
, , O
A NNP O
. . O
, , O
Confalone NNP O
, , O
E NNP O
. . O
, , O
Cosi NNP O
, , O
C NNP O
. . O
, , O
Sorrentino NNP O
, , O
S NNP O
. . O
, , O
Viola NNP O
, , O
M NNP O
. . O
, , O
Palmieri NNP O
, , O
M NNP O
. . O
, , O
Russo NNP O
, , O
E NNP O
. . O
and CC O
Furia NNP O
, , O
A NNP O
. . O

( NFP O
1991 CD O
) SYM O
Nucleic JJ O
Acids NNS O
Res NNP O
. . O

19 CD O
, , O
6469 CD O
< SYM O
FFFD NNP O
> SYM O
6474 CD O
. . O

Palmieri NNP O
, , O
M NNP O
. . O
, , O
Carsana NNP O
, , O
A NNP O
. . O
, , O
Furia NNP O
, , O
A NNP O
. . O
and CC O
Libonati NNP O
, , O
M NNP O
. . O

( -LRB- O
1985 CD O
) SYM O
Eur NNP O
. . O

J NNP O
. . O

Biochem NNP O
. . O

152 CD O
, , O
275 CD O
< SYM O
FFFD NNP O
> SYM O
277 CD O
. . O

Rosenberg NNP O
, , O
H NNP O
. . O
F NNP O
. . O
, , O
Dyer NNP O
, , O
K NNP O
. . O
D NNP O
. . O
, , O
Tiffany NNP O
, , O
H NNP O
. . O
L NNP O
. . O
and CC O
Gonzalez NNP O
, , O
M NNP O
. . O

( -LRB- O
1995 CD O
) SYM O
Nature NNP O
Genet NNP O
. . O

10 CD O
, , O
219 CD O
< SYM O
FFFD NNP O
> SYM O
223 CD O
. . O

Domachowske NNP O
, , O
J NNP O
. . O
B NNP O
. . O
and CC O
Rosenberg NNP O
, , O
H NN O
. . O
F NN O
. . O

( -LRB- O
1997 CD O
) SYM O
J NN O
. . O

Leukoc NNP O
. . O

Biol NNP O
. . O
, , O
62 CD O
, , O
363 CD O
< SYM O
FFFD NNP O
> : O
368 CD O
. . O

Iwama NNP O
, , O
M NNP O
. . O
, , O
Sanda NNP O
, , O
A NNP O
. . O
, , O
Ohgi NNP O
, , O
K NNP O
. . O
, , O
Hofsteenge NNP O
, , O
J NNP O
. . O
, , O
and CC O
Irie NNP O
, , O
M NNP O
. . O

( -LRB- O
1993 CD O
) : O
Biosci NNP O
. . O

Biotech NN O
. . O

Biochem NNP O
. . O

57 CD O
, , O
2133 CD O
< SYM O
FFFD NNP O
> SYM O
2138 CD O
. . O

Physiological JJ O
and CC O
chemical JJ O
characterization NN O
of IN O
cyanobacterial JJ B-Species
metallothioneins NNS O
. . O

Abstract JJ O

Techniques NNS O
have VBP O
been VBN O
developed VBN O
for IN O
detection NN O
, , O
quantitation NN O
, , O
and CC O
isolation NN O
of IN O
bacterial JJ O
metallothioneins NNS O
( , O
MTs NNP O
) -RRB- O
from IN O
cyanobacterial JJ O
species NNS O
. . O

These DT O
methods NNS O
involve VBP O
differential JJ O
pulse NN O
polarography NN O
and CC O
reverse JJ O
- HYPH O
phase NN O
high JJ O
- HYPH O
performance NN O
liquid NN O
chromatography NN O
( -LRB- O
HPLC NNP O
) -RRB- O
and CC O
have VBP O
allowed VBN O
detection NN O
of IN O
picomole NN O
quantities NNS O
of IN O
these DT O
high JJ O
sulfhydryl NN O
content NN O
proteins NNS O
. . O

The DT O
prokaryotic JJ O
molecule NN O
was VBD O
found VBN O
to TO O
be VB O
induced VBN O
in IN O
the DT O
presence NN O
of IN O
Cd NN O
or CC O
Zn NN O
salts NNS O
with IN O
regulation NN O
at IN O
the DT O
level NN O
of IN O
transcription NN O
. . O

Cu NNP O
was VBD O
not RB O
found VBN O
to TO O
induce VB O
synthesis NN O
of IN O
the DT O
prokaryotic JJ O
MT NNP O
. . O

Exposure NN O
to IN O
the DT O
former JJ O
metals NNS O
resulted VBD O
in IN O
a DT O
growth NN O
lag NN O
followed VBN O
by IN O
simultaneous JJ O
induction NN O
of IN O
MT NNP O
synthesis NN O
and CC O
onset NN O
of IN O
growth NN O
. . O

Amino JJ O
acid NN O
analysis NN O
and CC O
N NN O
- HYPH O
terminal JJ O
sequence NN O
analysis NN O
indicated VBD O
that IN O
the DT O
bacterial JJ O
MTs NNS O
from IN O
cyanobacteria NN O
are VBP O
unique JJ O
, , O
having VBG O
many JJ O
aromatic JJ O
and CC O
aliphatic JJ O
residues NNS O
and CC O
no DT O
apparent JJ O
association NN O
of IN O
hydroxylated JJ O
or CC O
basic JJ O
amino NN O
acids NNS O
with IN O
cysteines NNS O
. . O

Although IN O
the DT O
characteristic JJ O
Cys NNP O
- HYPH O
X NNP O
- HYPH O
Cys NNP O
sequences NNS O
were VBD O
present JJ O
, , O
no DT O
apparent JJ O
amino NN O
acid NN O
sequence NN O
homology NN O
with IN O
the DT O
eukaryotic JJ O
MTs NNS O
was VBD O
found VBN O
in IN O
the DT O
first JJ O
42 CD O
residues NNS O
. . O

Environmental NNP O
Health NNP O
Perspectives NNPS O
Vol NNP O
. . O

65 CD O
, , O
pp UH O
. . O

71 CD O
- SYM O
75 CD O
, , O
1986 CD O

Physiological JJ O
and CC O
Chemical NNP O

Characterization NN O
of IN O
Cyanobacterial NNP O
Metallothioneins NNP O

by IN O
Robert NNP O
W NNP O
. . O
Olafson NNP O
* NFP O

Techniques NNS O
have VBP O
been VBN O
developed VBN O
for IN O
detection NN O
, , O
quantitation NN O
, , O
and CC O
isolation NN O
of IN O
bacterial JJ O
metallothioneins NNS O
( , O
MTs NNP O
) -RRB- O
from IN O
cyanobacterial JJ O
species NNS O
. . O

These DT O
methods NNS O
involve VBP O
differential JJ O
pulse NN O
polarography NN O
and CC O
reverse JJ O
- HYPH O
phase NN O
high JJ O
- HYPH O
performance NN O
liquid NN O
chromatography NN O
( -LRB- O
HPLC NNP O
) -RRB- O
and CC O
have VBP O
allowed VBN O
detection NN O
of IN O
picomole NN O
quantities NNS O
of IN O
these DT O
high JJ O
sulfhydryl NN O
content NN O
proteins NNS O
. . O

The DT O
prokaryotic JJ O
molecule NN O
was VBD O
found VBN O
to TO O
be VB O
induced VBN O
in IN O
the DT O
presence NN O
of IN O
Cd NN O
or CC O
Zn NN O
salts NNS O
with IN O
regulation NN O
at IN O
the DT O
level NN O
of IN O
transcription NN O
. . O

Cu NNP O
was VBD O
not RB O
found VBN O
to TO O
induce VB O
synthesis NN O
of IN O
the DT O
prokaryotic JJ O
MT NNP O
. . O

Exposure NN O
to IN O
the DT O
former JJ O
metals NNS O
resulted VBD O
in IN O
a DT O
growth NN O
lag NN O
followed VBN O
by IN O
simultaneous JJ O
induction NN O
of IN O
MT NNP O
synthesis NN O
and CC O
onset NN O
of IN O
growth NN O
. . O

Amino JJ O
acid NN O
analysis NN O
and CC O
N NN O
- HYPH O
terminal JJ O
sequence NN O
analysis NN O
indicated VBD O
that IN O
the DT O
bacterial JJ O
MTs NNS O
from IN O
cyanobacteria NN O
are VBP O
unique JJ O
, , O
having VBG O
many JJ O
aromatic JJ O
and CC O
aliphatic JJ O
residues NNS O
and CC O
no DT O
apparent JJ O
association NN O
of IN O
hydroxylated JJ O
or CC O
basic JJ O
amino NN O
acids NNS O
with IN O
cysteines NNS O
. . O

Although IN O
the DT O
characteristic JJ O
CysX NNP O
- HYPH O
Cys NNP O
sequences NNS O
were VBD O
present JJ O
, , O
no DT O
apparent JJ O
amino NN O
acid NN O
sequence NN O
homology NN O
with IN O
the DT O
eukaryotic JJ O
MTs NNS O
was VBD O
found VBN O
in IN O
the DT O
first JJ O
42 CD O
residues NNS O
. . O

Introduction NN O

Metallothioneins NNS O
have VBP O
now RB O
been VBN O
isolated VBN O
and CC O
characterized VBN O
from IN O
a DT O
large JJ O
variety NN O
of IN O
eukaryotic JJ O
organisms NNS O
( , O
1 CD O
) , O
and CC O
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
heavy JJ O
metal NN O
detoxification NN O
and CC O
/ SYM O
or CC O
homeostasis NN O
( , O
2 CD O
- HYPH O
4 CD O
) -RRB- O
. . O

These DT O
proteins NNS O
are VBP O
highly RB O
homologous JJ O
with IN O
respect NN O
to IN O
amino NN O
acid NN O
sequence NN O
and CC O
complex JJ O
metals NNS O
in IN O
characteristic JJ O
metal NN O
- HYPH O
thiolate NN O
cluster NN O
arrangements NNS O
, , O
the DT O
structures NNS O
of IN O
which WDT O
have VBP O
been VBN O
recently RB O

investigated VBN O
by IN O
113Cd NNP O
- HYPH O
NMR NNP O
( SYM O
6 CD O
) -RRB- O
. . O

Although IN O
metallothionein NN O
( , O
MT NNP O
) -RRB- O
is VBZ O
found VBN O
throughout IN O
the DT O
eukaryotic JJ O
world NN O
, , O
few JJ O
reports NNS O
of IN O
the DT O
presence NN O
of IN O
this DT O
type NN O
of IN O
high JJ O
sulfhydryl NN O
content NN O
metal NN O
- HYPH O
binding VBG O
protein NN O
exist VBP O
for IN O
prokaryotes NNS O
. . O

We PRP O
earlier RBR O
reported VBD O
the DT O
presence NN O
of IN O
a DT O
prokaryotic JJ O
MT NNP O
in IN O
cyanobacteria NN O
( , O
7 CD O
, , O
8 CD O
) -RRB- O
and CC O
have VBP O
recently RB O
provided VBN O
primary JJ O
sequence NN O
evidence NN O
substantiating VBG O
these DT O
data NNS O
. . O

This DT O
manuscript NN O
is VBZ O
intended VBN O
to TO O
summarize VB O
the DT O
present JJ O
state NN O
of IN O
knowledge NN O
regarding VBG O
the DT O
physiological JJ O
and CC O
chemical JJ O
characterization NN O
of IN O
these DT O
bacterial JJ O
MTs NNS O
, , O
with IN O
an DT O
emphasis NN O
on IN O
the DT O
techniques NNS O
employed VBN O
in IN O
such JJ O
studies NNS O
. . O

Analytical JJ O
Procedure NN O

In IN O
order NN O
to TO O
facilitate VB O
rapid JJ O
detection NN O
, , O
isolation NN O
, , O
and CC O
quantitation NN O
of IN O
MT NNP O
from IN O
various JJ O
sources NNS O
, , O
we PRP O
have VBP O
routinely RB O
employed VBN O
a DT O
differential JJ O
pulse NN O
polarographic JJ O
tech NN O

* NFP O
Department NNP O
of IN O
Biochemistry NNP O
and CC O
Microbiology NNP O
, , O
University NNP O
of IN O
Victoria NNP O
, , O
Victoria NNP O
, , O
British NNP O
Columbia NNP O
V8W NNP O
2Y2 NNP O
, , O
Canada NNP O
. . O

nique NNP O
first RB O
described VBN O
by IN O
Brdicka NNP O
( : O
9 CD O
- HYPH O
11 CD O
) -RRB- O
. . O

This DT O
procedure NN O
avoids VBZ O
use NN O
of IN O
radioisotopes NNS O
and CC O
circumvents VBZ O
problems NNS O
such JJ O
as IN O
species NNS O
specificity NN O
and CC O
metal NN O
stoichiometric JJ O
assumptions NNS O
associated VBN O
with IN O
radioimmunoassays NNS O
and CC O
metal NN O
binding NN O
assays NNS O
. . O

Figure NN O
1 CD O
shows VBZ O
a DT O
typical JJ O
polarographic JJ O
wave NN O
for IN O
MT NNP O
using VBG O
the DT O
Brdicka NNP O
procedure NN O
. . O

Measurement NN O
of IN O
the DT O
wave NN O
height NN O
can MD O
be VB O
performed VBN O
from IN O
either CC O
the DT O

0 NFP O
. . O
20 CD O

glJ NNP O
MT NNP O
- HYPH O
1 CD O

O NN O
0 CD O
. . O
15 CD O

E NN O

0 NFP O
0 CD O
. . O
10 CD O
0 CD O

E NN O
0 CD O
. . O
5 CD O
_ NFP O
_ NFP O

- : O
1 CD O
. . O
35 CD O
- SYM O
1 CD O
. . O
45 CD O
- SYM O
1 CD O
. . O
55 CD O
- SYM O
1 CD O
. . O
65 CD O

V NN O
vs IN O
Agt NNP O
/ SYM O
AgC1 NNP O

FIGURE NN O
1 CD O
. . O

Differential JJ O
pulse NN O
polarographic JJ O
wave NN O
for IN O
murine NN B-Species
MT NNP O
- HYPH O
1 CD O
. . O

Wave NN O
heights NNS O
were VBD O
calculated VBN O
from IN O
the DT O
broken VBN O
tangent NN O
line NN O
between IN O
minima NN O
rather RB O
than IN O
the DT O
supporting VBG O
electrolyte JJ O
baseline NN O
at IN O
the DT O
bottom NN O
of IN O
the DT O
figure NN O
. . O

R NN O
. . O

W NNP O
OLAFSON NNP O

supporting VBG O
electrolyte NN O
baseline NN O
or CC O
a DT O
tangent NN O
to IN O
the DT O
minima NN O
as IN O
shown VBN O
in IN O
the DT O
preceding VBG O
figure NN O
. . O

In IN O
the DT O
cobalt NN O
hexaminechloride NN O
supporting VBG O
electrolyte NN O
, , O
the DT O
half JJ O
- HYPH O
wave NN O
potential NN O
for IN O
all DT O
MTs NNPS O
studied VBN O
to IN O
date NN O
is VBZ O
approximately RB O
- HYPH O
1 CD O
. . O
45 CD O
V NN O
versus IN O
a DT O
Ag NNP O
/ SYM O
AgCl NNP O
reference NN O
electrode NN O
. . O

This DT O
electrochemical JJ O
reaction NN O
results VBZ O
in IN O
highly RB O
reproducible JJ O
and CC O
linear JJ O
current JJ O
responses NNS O
which WDT O
can MD O
be VB O
used VBN O
with IN O
samples NNS O
containing VBG O
picomole NN O
levels NNS O
of IN O
MT NNP O
( , O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

Since IN O
this DT O
is VBZ O
an DT O
exceedingly RB O
sensitive JJ O
instrument NN O
, , O
attention NN O
to IN O
detail NN O
is VBZ O
particularly RB O
important JJ O
for IN O
successful JJ O
use NN O
of IN O
the DT O
Brdicka NNP O
procedure NN O
( SYM O
11 CD O
) -RRB- O
. . O

Routine JJ O
use NN O
of IN O
a DT O
reference NN O
standard NN O
MT NNP O
is VBZ O
highly RB O
recommended VBN O
to TO O
compensate VB O
for IN O
small JJ O
day NN O
- HYPH O
today NN O
variations NNS O
in IN O
response NN O
. . O

For IN O
absolute JJ O
values NNS O
, , O
standards NNS O
must MD O
be VB O
identical JJ O
to IN O
the DT O
species NNS O
of IN O
protein NN O
quantitated VBN O
; , O
otherwise RB O
commercially RB O
available JJ O
standard NN O
is VBZ O
adequate JJ O
. . O

Although IN O
certain JJ O
tissues NNS O
and CC O
cellular JJ O
types NNS O
can MD O
be VB O
shown VBN O
to TO O
have VB O
no DT O
other JJ O
polarographically RB O
active JJ O
material NN O
other JJ O
than IN O
MT NNP O
, , O
with IN O
samples NNS O
from IN O
new JJ O
species NNS O
, , O
it PRP O
is VBZ O
necessary JJ O
to TO O
evaluate VB O
this DT O
potential JJ O
problem NN O
by IN O
gelperneation NN O
chromatography NN O
and CC O
, , O
if IN O
necessary JJ O
, , O
take VB O
steps NNS O
to TO O
remove VB O
contaminants NNS O
before IN O
assaying VBG O
. . O

In IN O
most JJS O
cases NNS O
, , O

0 NFP O

E NN O
i NN O

m UH O
0 NFP O

0 NFP O
E NN O

0 NFP O
. . O
31 CD O

0 NFP O
. . O
11 CD O

O NN O
0 CD O
. . O
1 CD O
0 CD O
. . O
3 CD O
0 CD O
. . O
5 CD O

MT NNP O
( , O
nanomoles NNS O
) -RRB- O

FIGURE NN O
2 CD O
. . O

Standard JJ O
curve NN O
for IN O
polarographic JJ O
determination NN O
of IN O
me PRP O

tallothionein NN O
. . O

FIGURE NN O
3 CD O
. . O

Cyclic JJ O
voltamogram NN O
obtained VBN O
by IN O
equilibration NN O
at IN O
- HYPH O
1 CD O
. . O
0 CD O
V NN O

for IN O
4 CD O
min NN O
followed VBN O
by IN O
cyclic JJ O
scanning NN O
to IN O
OV NN O
and CC O
- HYPH O
1 CD O
. . O
4 CD O
V NN O
at IN O
a DT O
scan NN O
rate NN O
of IN O
200 CD O
mV NN O
/ SYM O
sec NN O
with IN O
a DT O
PAR NNP O
Model NNP O
303 CD O
static JJ O
mercury NN O
drop NN O
electrode NN O
in IN O
the DT O
hanging NN O
drop NN O
mode NN O
. . O

The DT O
mercury NN O
drop NN O
electrode NN O
was VBD O
set VBN O
in IN O
the DT O
large JJ O
drop NN O
position NN O
producing VBG O
a DT O
drop NN O
of IN O
0 CD O
. . O
226 CD O
cm3 NN O
. . O

The DT O
supporting VBG O
electrolyte NN O
was VBD O
20 CD O
mM NN O
HEPES NNP O
buffer NN O
, , O
pH NN O
7 CD O
. . O
3 CD O
. . O

The DT O
dotted JJ O
line NN O
is VBZ O
the DT O
equilibrium NN O
trace NN O
. . O

Adapted VBN O
Olafson NNP O
and CC O
Sim NNP O
( SYM O
10 CD O
) -RRB- O
. . O

this DT O
is VBZ O
easily RB O
managed VBN O
by IN O
heat NN O
denaturation NN O
, , O
if IN O
care NN O
is VBZ O
taken VBN O
to TO O
assess VB O
the DT O
degree NN O
of IN O
MT NNP O
losses NNS O
due IN O
to IN O
coprecipitation NN O
. . O

Such JJ O
losses NNS O
later RB O
can MD O
usually RB O
be VB O
minimized VBN O
to IN O
less JJR O
than IN O
10 CD O
% NN O
by IN O
adjustment NN O
of IN O
the DT O
tissue NN O
homogenate NN O
density NN O
prior RB O
to IN O
denaturation NN O
. . O

It PRP O
should MD O
be VB O
indicated VBN O
that IN O
additional JJ O
utility NN O
can MD O
be VB O
found VBN O
with IN O
a DT O
polarographic JJ O
analyzer NN O
beyond IN O
application NN O
of IN O
the DT O
Brdicka NNP O
procedure NN O
. . O

For IN O
example NN O
, , O
metal NN O
levels NNS O
can MD O
be VB O
readily RB O
determined VBN O
by IN O
using VBG O
differential JJ O
pulse NN O
or CC O
anodic JJ O
stripping NN O
voltametry NN O
procedures NNS O
( SYM O
10 CD O
) -RRB- O
, , O
while IN O
Figure NN O
3 CD O
shows VBZ O
a DT O
cyclic JJ O
voltamogram NN O
of IN O
bacterial JJ O
MT NNP O
. . O

The DT O
latter JJ O
technique NN O
is VBZ O
potentially RB O
useful JJ O
in IN O
assessing VBG O
metal NN O
speciation NN O
and CC O
integrity NN O
of IN O
the DT O
protein NN O
tertiary JJ O
structure NN O
near IN O
metal NN O
clusters NNS O
, , O
particularly RB O
after IN O
metal NN O
reconstitution NN O
studies NNS O
. . O

E NN O

' '' O
C2A NN O
- HYPH O
E NN O
24 CD O

0 CD O
30 CD O
40 CD O
E0 CD O

* NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O

o LS O
C NN O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
C NN O

Fraction NN O
Number NN O
( : O
18ml CD O
) -RRB- O

FIGURE NN O
4 CD O
. . O

Sephadex NNP O
G NNP O
- HYPH O
75 CD O
chromatography NN O
profile NN O
of IN O
bacterial JJ O
cell NN O

lysate NNP O
applied VBD O
to IN O
a DT O
5 CD O
x SYM O
100 CD O
cm NN O
column NN O
and CC O
eluted VBN O
with IN O
10 CD O
mM NN O
anunoium NN O
bicarbonate NN O
, , O
5 CD O
mM NN O
mercaptoethanol NN O
( , O
7 CD O
) -RRB- O
. . O

Elution NNP O
Time NNP O
( -LRB- O
min NNP O
) -RRB- O

FIGURE NN O
5 CD O
. . O

Reverse JJ O
- HYPH O
phase NN O
high JJ O
- HYPH O
performance NN O
chromatography NN O
profile NN O

of IN O
Sephadex NNP O
G NNP O
- HYPH O
75 CD O
fractionated VBN O
bacterial JJ O
MT NNP O
. . O

The DT O
300 CD O
A DT O
pore NN O
size NN O
propyl NN O
column NN O
was VBD O
eluted VBN O
with IN O
20 CD O
mM NN O
triethylamine NN O
phosphate NN O
, , O
pH NN O
7 CD O
. . O
0 CD O
, , O
by IN O
using VBG O
an DT O
acetonitrile NN O
organic JJ O
modifier NN O
( , O
phase NN O
B NN O
) -RRB- O
. . O

Column NN O
effluent NN O
was VBD O
monitored VBN O
at IN O
250 CD O
nm NN O
with IN O
a DT O
sensitivity NN O
of IN O
1 CD O
. . O
0 CD O
AUFS NNS O
( SYM O
12 CD O
) -RRB- O
. . O

72 CD O

CYANOBACTERIAL JJ B-Species
METALLOTHIONEINS NNS O

Isolation NN O
of IN O
Cyanobacterial JJ O
MT NNP O

Synechococcus NNP B-Species
strain NN I-Species
Tx NNP I-Species
- HYPH I-Species
20 CD I-Species
cyanobacteria NN O
were VBD O
maintained VBN O
in IN O
axenic JJ O
culture NN O
on IN O
BG NNP O
- HYPH O
11 CD O
medium JJ O
( , O
7 CD O
) -RRB- O
and CC O
harvested VBN O
from IN O
aerated VBN O
20 CD O
L NN O
cultures NNS O
grown VBN O
at IN O
280C CD O
under IN O
fluorescent JJ O
light NN O
. . O

Cells NNS O
were VBD O
broken VBN O
in IN O
a DT O
French JJ O
pressure NN O
cell NN O
at IN O
0 CD O
? . O
C NN O
in IN O
0 CD O
. . O
5 CD O
M NN O
Tris NNP O
- HYPH O
HCI NNP O
, , O
pH NN O
8 CD O
. . O
6 CD O
, , O
and CC O
the DT O
lysate NN O
exposed VBN O
to IN O
10 CD O
, , O
uCi NNP O
of IN O
109CdCl NNP O
. . O

The DT O
40 CD O
, , O
000g NNP O
supernatant NN O
was VBD O
applied VBN O
to IN O
a DT O
Sephadex NNP O
G NNP O
- HYPH O
75 CD O
column NN O
developed VBN O
with IN O
10 CD O
mM NN O
ammonium NN O
bicarbonate NN O
and CC O
5 CD O
mM NN O
mercaptoethanol NN O
resulting VBG O
in IN O
the DT O
profile NN O
shown VBN O
in IN O
Figure NNP O
4 CD O
. . O

Polarographic JJ O
activity NN O
and CC O
radionuclide NN O
binding NN O
were VBD O
coincident JJ O
with IN O
a DT O
10 CD O
, , O
0 CD O
MW NN O
ultraviolet NN O
absorbing VBG O
fraction NN O
. . O

Further JJ O
purification NN O
of IN O
this DT O
material NN O
could MD O
be VB O
undertaken VBN O
by IN O
DEAE NNP O
- HYPH O
cellulose NN O
chromatography NN O
or CC O
isoelectric JJ O
focusing NN O
but CC O
maximum JJ O
resolution NN O
of IN O
isoproteins NNS O
was VBD O
best RBS O
attained VBN O
by IN O
reverse JJ O
- HYPH O
phase NN O
high JJ O
- HYPH O
performance NN O
liquid NN O
chromatogra NN O

0 NFP O
5 CD O

DAYS NNS O

I0 NN O

5 CD O

phy UH O
. . O

Figure NN O
5 CD O
shows VBZ O
such PDT O
a DT O
separation NN O
performed VBN O
on IN O
a DT O
300 CD O
A NN O
pore NN O
size NN O
C NN O
- HYPH O
3 CD O
column NN O
( : O
Beckman NNP O
Instruments NNPS O
) -RRB- O
. . O

Four CD O
baseline NN O
resolved VBN O
MT NNP O
peaks NNS O
appear VBP O
between IN O
40 CD O
and CC O
70 CD O
min NN O
. . O

Peaks NNS O
eluting VBG O
at IN O
80 CD O
min NN O
contain VBP O
at IN O
least JJS O
four CD O
additional JJ O
MT NNP O
components NNS O
resolvable JJ O
by IN O
adjustment NN O
of IN O
the DT O
applied VBN O
organic JJ O
modifier NN O
ramp NN O
. . O

Preliminary JJ O
evidence NN O
indicates VBZ O
that IN O
these DT O
isoproteins NNS O
are VBP O
microheterogeneous JJ O
with IN O
respect NN O
to IN O
both CC O
amino JJ O
acid NN O
composition NN O
and CC O
metal NN O
speciation NN O
resulting VBG O
in IN O
the DT O
observed VBN O
reverse JJ O
- HYPH O
phase NN O
separation NN O
. . O

Physiological JJ O
Characteristics NNS O
of IN O
Cyanobacterial JJ O
MT NNP O

Using VBG O
the DT O
Brdicka NNP O
polarographic JJ O
procedure NN O
, , O
it PRP O
is VBZ O
possible JJ O
to TO O
measure VB O
basal JJ O
MT NNP O
levels NNS O
in IN O
Synechococcus NNP O
strain NN O

5 CD O

DAYS NNS O

10 CD O

15 CD O

FIGURE NN O
6 CD O
. . O

Cell NN O
numbers NNS O
and CC O
MT NNP O
concentrations NNS O
as IN O
a DT O
function NN O
of IN O
time NN O
after IN O
inoculation NN O
of IN O
wild JJ O
- HYPH O
type NN O
cyanobacteria NN O
in IN O
the DT O
presence NN O
and CC O
absence NN O

of IN O
( : O
A NNP O
) SYM O
22 CD O
. . O
5 CD O
, , O
uM UH O
CdCl2 NNP O
; : O
( : O
B NNP O
) -RRB- O
control NN O
; : O
( : O
C NNP O
) -RRB- O
50 CD O
, , O
uM NNP O
ZnSO4 NNP O
; : O
( : O
D NNP O
) SYM O
50 CD O
, , O
uM NNP O
CuCl2 NNP O
( SYM O
8 CD O
) -RRB- O
. . O

73 CD O

74 CD O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
R NFP O
. . O

W NNP O
OLAFSON NNP O

Table NN O
1 CD O
. . O

Amino JJ O
acid NN O
compositions NNS O
of IN O
cyanobacterial JJ O

metallothioneins NNS O
compared VBN O
with IN O
eukaryotic JJ O
metallothioneins NNS O
. . O

Nearest JJ O
integer NN O
residues NNS O
per IN O
molecule NN O
Human JJ B-Species
( , O
MT NNP O
- HYPH O
2 CD O
) SYM O
Crab NNP O
( , O
MT NNP O
- HYPH O
2 CD O
) SYM O
Tx NN O
- HYPH O
20t CD O
CysA NN O
20 CD O
18 CD O
9 CD O
. . O
5 CD O
Asx NN O
4 CD O
6 CD O
5 CD O
. . O
7 CD O
Thr CD O
2 CD O
3 CD O
4 CD O
. . O
8 CD O
Ser NN O
8 CD O
5 CD O
3 CD O
. . O
8 CD O
Glx NN O
2 CD O
5 CD O
2 CD O
. . O
0 CD O
Gly CD O
5 CD O
3 CD O
8 CD O
. . O
0 CD O
Ala NN O
7 CD O
1 CD O
4 CD O
. . O
0 CD O
Val NN O
1 CD O
- SYM O
2 CD O
. . O
3 CD O
Met NN O
1 CD O
- HYPH O

Ile NNP O
1 CD O
- SYM O
1 CD O
. . O
1 CD O

Leu NNP O
Tyr NNP O
Phe NNP O
His PRP$ O
Lys NNP O
Arg NNP O
Pro NNP O

8 CD O
2 CD O

8 CD O
2 CD O
6 CD O

2 LS O
. . O
9 CD O
2 CD O
. . O
3 CD O

2 LS O
. . O
8 CD O
2 CD O
. . O
6 CD O
1 CD O
. . O
0 CD O
1 CD O
. . O
9 CD O

RRIMP NNP O
NI NNP O
cells NNS O
cultured VBN O
in IN O
the DT O
absence NN O
of IN O
added VBN O
metal NN O
, , O
as IN O
shown VBN O
in IN O
Figure NNP O
6B NNP O
( SYM O
8 CD O
) -RRB- O
. . O

Comparison NN O
with IN O
cultures NNS O
exposed VBN O
to IN O
cadmium NN O
chloride NN O
( , O
Fig NNP O
. . O
6A NN O
) -RRB- O
or CC O
zinc NN O
sulfate NN O
( , O
Fig NNP O
. . O
6C NNP O
) -RRB- O
showed VBD O
that IN O
introduction NN O
of IN O
metal NN O
salts NNS O
resulted VBD O
in IN O
a DT O
growth NN O
lag NN O
and CC O
that IN O
resumption NN O
of IN O
growth NN O
occurred VBD O
coincident JJ O
with IN O
an DT O
increase NN O
in IN O
cellular JJ O
levels NNS O
of IN O
MT NNP O
. . O

In IN O
addition NN O
, , O
it PRP O
should MD O
be VB O
noted VBN O
that IN O
, , O
like IN O
mammalian JJ O
MT NNP O
, , O
cadmium NN O
appears VBZ O
to TO O
be VB O
a DT O
more RBR O
potent JJ O
inducer NN O
than IN O
zinc NN O
. . O

Twice RB O
as RB O
much JJ O
cadmium NN O
- HYPH O
thionein NN O
was VBD O
synthesized VBN O
on IN O
exposure NN O
to IN O
half PDT O
as RB O
much JJ O
metal NN O
as IN O
was VBD O
used VBN O
in IN O
the DT O
zinc NN O
induction NN O
experiment NN O
. . O

A DT O
further JJ O
interesting JJ O
finding NN O
was VBD O
that IN O
copper NN O
exposure NN O
resulted VBD O
in IN O
an DT O
even RB O
greater JJR O
growth NN O
lag NN O
than IN O
observed VBN O
with IN O
cadmium NN O
, , O
but CC O
on IN O
resumption NN O
of IN O
growth NN O
in IN O
the DT O
presence NN O
copper NN O
, , O
MT NNP O
synthesis NN O
was VBD O
not RB O
noted VBN O
( : O
Fig NNP O
. . O
6D CD O
) -RRB- O
. . O

Recent JJ O
results NNS O
suggest VBP O
that IN O
this DT O
copper NN O
resistance NN O
is VBZ O
manifest JJ O
via IN O
a DT O
membrane NN O
exclusion NN O
mechanism NN O
( , O
unpublished JJ O
results NNS O
) -RRB- O
. . O

HOURS NNS O

FIGURE NN O
7 CD O
. . O

Inhibition NN O
of IN O
cadmium NN O
induced VBN O
synthesis NN O
by IN O
actinomycin NN O

D NN O
( HYPH O
hatched VBN O
bar NN O
) -RRB- O
and CC O
chloramphenicol NN O
( , O
solid JJ O
bar NN O
) -RRB- O
. . O

Control NN O
cells NNS O
are VBP O
shown VBN O
by IN O
unmarked JJ O
bars NNS O
. . O

In IN O
order NN O
that IN O
the DT O
level NN O
of IN O
regulation NN O
of IN O
metal NN O
induction NN O
be VB O
determined VBN O
for IN O
cyanobacteria NN O
, , O
logarithmically RB O
growing VBG O
cultures NNS O
were VBD O
exposed VBN O
to IN O
cadmium NN O
and CC O
MT NNP O
concentrations NNS O
measured VBN O
at IN O
several JJ O
time NN O
intervals NNS O
thereafter RB O
. . O

Two CD O
cultures NNS O
were VBD O
exposed VBN O
to IN O
either CC O
chloramphenicol NN O
or CC O
actinomycin NN O
D NN O
30 CD O
min NN O
prior RB O
to IN O
introduction NN O
of IN O
metal NN O
, , O
while IN O
a DT O
third JJ O
culture NN O
was VBD O
used VBN O
as IN O
a DT O
control NN O
. . O

The DT O
results NNS O
of IN O
this DT O
experiment NN O
are VBP O
shown VBN O
in IN O
Figure NN O
7 CD O
and CC O
indicate VB O
induction NN O
at IN O
the DT O
level NN O
of IN O
transcription NN O
, , O
as IN O
was VBD O
found VBN O
in IN O
eukaryotic JJ O
organisms NNS O
. . O

The DT O
assumption NN O
at IN O
this DT O
stage NN O
in IN O
these DT O
investigations NNS O
was VBD O
that IN O
the DT O
growth NN O
lag NN O
observed VBN O
in IN O
cultures NNS O
exposed VBN O
to IN O

Table NN O
2 CD O
. . O

Amino NN O
acid NN O
sequence NN O
analysis NN O
. . O

Amino JJ O
acid NN O

1 CD O
10 CD O
20 CD O
30 CD O
Cyanobacteria NN O
T NN O
S NN O
T NN O
T NN O
L NN O
V NN O
K NN O
C NN O
A NN O
C NN O
E NN O
P NN O
C NN O
L NN O
C NN O
N NN O
V NN O
D NN O
P NN O
S NN O
K NN O
A NN O
I NN O
D NN O
R NN O
N NN O
G NN O
L NN O
Y NN O
Y NN O
Scylla NN O
P NN O
DP NN O
C NN O
C NN O
NDK NN O
C NN O
DC NN O
K NN O
EG NN O
EC NN O
KT NN O
GC NN O
K NN O
CT NN O
S NN O
C NN O
Human NN B-Species
Ac NN O
MD NN O
P NN O
NC NN O
S NN O
C NN O
AA NN O
G NN O
DS NN O
CT NN O
C NN O
AG NN O
S NN O
C NN O
KC NN O
KE NN O
C NN O
KC NN O
T NN O
S NN O
C NN O

Neurospora NNP O

G NN O
D NN O
C NN O
G NN O
C NN O
S NN O
G NN O
A NN O
S NN O
S NN O
C NN O
N NN O
C NN O
G NN O
S NN O
G NN O
C NN O
S NN O
C NN O
S NN O
N NN O

C NN O
G NN O
S NN O
K NN O

Table NN O
2 CD O
. . O

Continued VBN O
. . O

Amino JJ O
acid NN O

40 CD O
50 CD O
60 CD O
C NN O
C NN O
EAC NN O
A NN O
H NN O
GHT NN O
G NN O
G NN O

R NN O
CP NN O
PC NN O
EQ NN O
C NN O
S NN O
SGC NN O
K NN O
CA NN O
NK NN O
E NN O
DC NN O
RK NN O
TC NN O
SK NN O
PC NN O
SCC NN O
P NN O
K NN O
K NN O
SCC NN O
S NN O
CCP NN O
V NN O
GC NN O
A NN O
KCA NN O
Q NN O
BC NN O
I NN O
C NN O
K NN O
GA NN O
SDK NN O
C NN O
S NN O
CC NN O
A NN O

74 CD O

I PRP O

II NNP O

I PRP O
I PRP O

CYANOBACTERIAL JJ B-Species
METALLOTHIONEINS NNS O
75 CD O

cadmium NN O
or CC O
zinc NN O
was VBD O
due JJ O
to IN O
a DT O
rather RB O
protracted JJ O
time NN O
of IN O
MT NNP O
induction NN O
, , O
perhaps RB O
associated VBN O
with IN O
toxic JJ O
burden NN O
. . O

If IN O
the DT O
above JJ O
cadmium NN O
- HYPH O
resistant JJ O
cells NNS O
were VBD O
transferred VBN O
into IN O
fresh JJ O
media NNS O
in IN O
the DT O
absence NN O
of IN O
cadmium NN O
and CC O
allowed VBN O
to TO O
grow VB O
up RP O
between IN O
three CD O
successive JJ O
transfers NNS O
, , O
levels NNS O
of IN O
MT NNP O
dropped VBD O
to IN O
near IN O
basal JJ O
values NNS O
as IN O
synthesis NN O
was VBD O
repressed VBN O
in IN O
the DT O
absence NN O
of IN O
metal NN O
. . O

However RB O
, , O
when WRB O
these DT O
cells NNS O
were VBD O
now RB O
transferred VBN O
into IN O
cadmium NN O
- , O
containing VBG O
media NNS O
, , O
instead RB O
of IN O
the DT O
predicted VBN O
growth NN O
lag NN O
, , O
they PRP O
grew VBD O
immediately RB O
. . O

Thus RB O
, , O
these DT O
cells NNS O
were VBD O
truly RB O
cadmium NN O
resistant JJ O
. . O

Since IN O
50 CD O
tubes NNS O
of IN O
wild JJ O
- HYPH O
type NN O
cells NNS O
at IN O
a DT O
dilution NN O
of IN O
104 CD O
grew VBD O
, , O
after IN O
the DT O
usual JJ O
lag NN O
on IN O
exposure NN O
to IN O
cadmium NN O
- HYPH O
containing VBG O
media NNS O
, , O
the DT O
acquisition NN O
of IN O
cadmium NN O
resistance NN O
in IN O
this DT O
strain NN O
of IN O
Synechococcus NNP O
was VBD O
therefore RB O
considered VBN O
unlikely JJ O
to TO O
be VB O
related VBN O
to IN O
a DT O
chromosomal JJ O
mutational JJ O
event NN O
. . O

Such PDT O
a DT O
mutation NN O
frequency NN O
would MD O
be VB O
unreasonably RB O
high JJ O
. . O

Although IN O
no DT O
direct JJ O
evidence NN O
exists VBZ O
at IN O
this DT O
time NN O
, , O
this DT O
metal NN O
resistance NN O
phenomenon NN O
is VBZ O
best RBS O
explained VBN O
by IN O
the DT O
amplification NN O
of IN O
an DT O
extrachromosomal JJ O
gene NN O
, , O
especially RB O
since IN O
this DT O
strain NN O
is VBZ O
known VBN O
to TO O
have VB O
plasmids NNS O
. . O

Structure NN O
of IN O
Cyanobacterial JJ O
MT NNP O

The DT O
structural JJ O
determination NN O
of IN O
cyanobacterial JJ B-Species
MT NNP O
is VBZ O
not RB O
yet RB O
complete JJ O
, , O
although IN O
a DT O
substantial JJ O
amount NN O
of IN O
information NN O
is VBZ O
now RB O
known VBN O
. . O

For IN O
example NN O
, , O
Table NNP O
1 CD O
compares VBZ O
the DT O
amino JJ O
acid NN O
composition NN O
of IN O
a DT O
Synechococcus NNP B-Species
TX NNP I-Species
- HYPH I-Species
20 CD I-Species
isoprotein NN O
with IN O
two CD O
eukaryotic JJ O
MTs NNS O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
bacterial JJ O
form NN O
is VBZ O
unique JJ O
. . O

While IN O
cysteine NN O
was VBD O
still RB O
the DT O
predominant JJ O
amino NN O
acid NN O
in IN O
this DT O
protein NN O
, , O
levels NNS O
of IN O
the DT O
amino NN O
acid NN O
were VBD O
half PDT O
that DT O
seen VBN O
in IN O
the DT O
eukaryotes NNS O
. . O

In IN O
addition NN O
, , O
the DT O
bacterial JJ O
protein NN O
had VBD O
two CD O
tyrosines NNS O
, , O
three CD O
histidines NNS O
, , O
and CC O
five CD O
long JJ O
- HYPH O
chain NN O
aliphatics NNS O
- , O
all DT O
residues NNS O
rarely RB O
found VBN O
in IN O
eukaryotic JJ O
MTs NNS O
. . O

Thus RB O
, , O
the DT O
amino JJ O
acid NN O
composition NN O
indicates VBZ O
that IN O
prokaryotic JJ O
MTs NNS O
are VBP O
not RB O
as RB O
structurally RB O
homologous JJ O
with IN O
eukaryotes NNS O
as IN O
they PRP O
are VBP O
physiologically RB O
homologous JJ O
. . O

This DT O
was VBD O
further RB O
exemplified VBN O
on IN O
amino JJ O
terminal JJ O
amino NN O
acid NN O
sequence NN O
analysis NN O
( : O
12 CD O
) -RRB- O
. . O

With IN O
the DT O
exception NN O
of IN O
the DT O
typical JJ O
Cys NNP O
- HYPH O
X NNP O
- HYPH O
Cys NNP O
sequences NNS O
, , O
the DT O
first JJ O
42 CD O
residues NNS O
of IN O
the DT O
prokaryotic JJ O
MT NNP O
were VBD O
essentially RB O
without IN O
homology NN O
on IN O
comparison NN O
with IN O
the DT O
crab NN B-Species
( -LRB- O
Scylla NNP B-Species
) -RRB- O
, , O
human JJ B-Species
, , O
or CC O
Neurospora NNP B-Species
crassa NN I-Species
MTs NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

Of IN O
the DT O
above RB O
- HYPH O
mentioned VBN O
uncommon JJ O
MT NNP O
residues NNS O
, , O
two CD O
tyrosines NNS O
were VBD O
found VBN O
together RB O
in IN O
positions NNS O
29 CD O
and CC O
30 CD O
, , O
all DT O
five CD O
of IN O
the DT O
long JJ O
- HYPH O
chain NN O
aliphatic JJ O
amino NN O
acids NNS O
were VBD O
located VBN O
in IN O
the DT O
first JJ O
28 CD O
residues NNS O
, , O
and CC O
two CD O
histidines NNS O
were VBD O
situated VBN O
at IN O
positions NNS O
37 CD O
and CC O
39 CD O
. . O

Perhaps RB O
of IN O
greater JJR O
interest NN O
was VBD O
the DT O
complete JJ O
lack NN O
of IN O
association NN O
of IN O
basic JJ O
residues NNS O
or CC O
hydroxylated JJ O
residues NNS O
with IN O
cysteines NNS O
, , O
as IN O
is VBZ O
found VBN O
in IN O
eukaryotes NNS O
( , O
11 CD O
) -RRB- O
. . O

Instead RB O
, , O
a DT O
block NN O
of IN O
four CD O
hydroxylated JJ O
amino NN O
acids NNS O
was VBD O
found VBN O
at IN O
the DT O
amino JJ O
terminus NN O
. . O

The DT O
sequence NN O
of IN O
this DT O
unique JJ O
MT NNP O
is VBZ O
now RB O
nearing VBG O
completion NN O
, , O
opening VBG O
the DT O
way NN O
for IN O
an DT O
X NN O
- HYPH O
ray NN O
crystallographic JJ O
investigation NN O
. . O

However RB O
, , O
the DT O
degree NN O
of IN O
similarity NN O
between IN O
the DT O
metal NN O
cluster NN O
arrangement NN O
of IN O
these DT O
bacterial JJ O
molecules NNS O
with IN O
the DT O
eukaryotic JJ O
structures NNS O
will MD O
initially RB O
be VB O
undertaken VBN O
spectroscopically RB O
. . O

Reliable JJ O
interpretation NN O
of IN O
the DT O
113Cd NNP O
- HYPH O
NMR NNP O
data NNS O
for IN O
this DT O
molecule NN O
will MD O
be VB O
dependent JJ O
upon IN O
adequate JJ O
isolation NN O
of IN O
isoproteins NNS O
using VBG O
RP NN O
- HYPH O
HPLC NNP O
and CC O
assessment NN O
of IN O
conformational JJ O
integrity NN O
of IN O
metal NN O
reconstituted VBN O
molecules NNS O
, , O
using VBG O
procedures NNS O
such JJ O
as IN O
cyclic JJ O
voltametry NN O
. . O

Studies NNS O
along IN O
these DT O
lines NNS O
are VBP O
presently RB O
underway JJ O
in IN O
this DT O
laboratory NN O

The DT O
author NN O
gratefully RB O
acknowledges VBZ O
the DT O
financial JJ O
support NN O
of IN O
the DT O
Australian NNP O
Institute NNP O
of IN O
Marine NNP O
Science NNP O
and CC O
the DT O
National NNP O
Science NNP O
and CC O
Engineering NNP O
Research NNP O
Council NNP O
of IN O
Canada NNP O
. . O

Excellent JJ O
technical JJ O
assistance NN O
was VBD O
provided VBN O
by IN O
R NNP O
. . O

G NNP O
. . O

Sim NNP O
and CC O
S NNP O
. . O

Kielland NNP O
in IN O
carrying VBG O
out RP O
the DT O
polarographic JJ O
and CC O
sequence NN O
analyses NNS O
, , O
respectively RB O
. . O

REFERENCES NNS O

1 LS O
. . O

Kagi NNP O
, , O
J NNP O
. . O

H NN O
. . O

R NNP O
. . O
, , O
and CC O
Nordberg NNP O
, , O
M NNP O
. . O

( : O
Eds NNP O
. . O
) -RRB- O
. . O

Metallothionein NNP O
. . O

Birk NNP O

hauser NNP O
Verlag NNP O
, , O
Basel NNP O
, , O
1979 CD O
, , O
pp NN O
. . O

5 CD O
- SYM O
55 CD O
. . O

2 LS O
. . O

Olafson NNP O
, , O
R NNP O
. . O

W NN O
Differential JJ O
pulse NN O
polarographic JJ O
determination NN O
of IN O

murine JJ B-Species
metallothionein NN O
induction NN O
kinetics NNS O
. . O

J NNP O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

256 CD O
: : O
12631268 CD O
( : O
1981 CD O
) -RRB- O
. . O

3 LS O
. . O

Olafson NNP O
, , O
R NNP O
. . O

W NNP O
Intestinal JJ O
metallothionein NN O
: : O
effect NN O
of IN O
parenteral NN O
and CC O

enteral JJ O
zinc NN O
exposure NN O
on IN O
tissue NN O
levels NNS O
of IN O
mice NNS B-Species
on IN O
controlled VBN O
zinc NN O
diets NNS O
. . O

J NNP O
. . O

Nutr NNP O
. . O

113 CD O
: : O
268 CD O
- HYPH O
275 CD O
( SYM O
1983 CD O
) -RRB- O
. . O

4 LS O
. . O

McCarter NNP O
, , O
J NNP O
. . O
A NNP O
. . O
, , O
and CC O
Roch NNP O
, , O
M NNP O
. . O

Chronic JJ O
exposure NN O
of IN O
Coho NNP B-Species
salmon NN I-Species

to IN O
sublethal JJ O
concentrations NNS O
of IN O
copper NN O
. . O

III NNP O
. . O

Kinetics NNS O
of IN O
metabolism NN O
of IN O
metallothionein NN O
. . O

Comp UH O
. . O

Biochem NNP O
. . O

Physiol NN O
. . O

77C CD O
: : O
83 CD O
- HYPH O
87 CD O
( SYM O
1984 CD O
) -RRB- O
. . O

5 LS O
. . O

Lerch NNP O
, , O
K NNP O
. . O
, , O
Ammer NNP O
, , O
D NNP O
. . O
, , O
and CC O
Olafson NNP O
, , O
R NNP O
. . O

W NN O
Crab NN O
metallothionein NN O

primary JJ O
structures NNS O
of IN O
metallothioneins NNS O
1 CD O
and CC O
2 CD O
. . O

J NNP O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

257 CD O
: : O
2420 CD O
- HYPH O
2426 CD O
( SYM O
1982 CD O
) -RRB- O
. . O

6 LS O
. . O

Otvos NNP O
, , O
J NNP O
. . O

D NNP O
. . O
, , O
Olafson NNP O
, , O
R NNP O
. . O
W UH O
, , O
and CC O
Armitage NNP O
, , O
I PRP O
. . O

M UH O
. . O

Structure NN O
of IN O
an DT O

invertebrate NN O
metallothionein NN O
from IN O
Scylla NNP B-Species
serrata NN I-Species
. . O

J NNP O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

257 CD O
: : O
2427 CD O
- HYPH O
2431 CD O
( SYM O
1982 CD O
) -RRB- O
. . O

7 LS O
. . O

Olafson NNP O
, , O
R NNP O
. . O

W UH O
, , O
Abel NNP O
, , O
K NNP O
. . O
, , O
and CC O
Sim NNP O
, , O
R NNP O
. . O

G NNP O
. . O

Prokaryotic JJ O
metallothi NN O

onein NN O
: : O
preliminary JJ O
characteristics NNS O
of IN O
a DT O
blue JJ O
- HYPH O
green JJ O
alga NN O
heavy JJ O
metalbinding NN O
protein NN O
. . O

Biochem NNP O
. . O

Biophys NNP O
. . O

Res NNS O
. . O

Commun NNP O
. . O

89 CD O
: : O
36 CD O
- HYPH O
40 CD O
( SYM O
1979 CD O
) -RRB- O
. . O

8 LS O
. . O

Olafson NNP O
, , O
R NNP O
. . O

W UH O
, , O
Loya NNP O
, , O
S NNP O
. . O
, , O
and CC O
Sim NNP O
, , O
R NNP O
. . O

G NNP O
. . O

Physiological JJ O
parameters NNS O

of IN O
prokaryotic JJ O
metallothionein NN O
induction NN O
. . O

Biochem NNP O
. . O

Biophys NNP O
. . O

Res NNS O
. . O

Commun NNP O
. . O

95 CD O
: : O
1495 CD O
- SYM O
1503 CD O
( SYM O
1980 CD O
) -RRB- O
. . O

9 LS O
. . O

Brdicka NNP O
, , O
R NNP O
. . O

Pblarographic JJ O
studies NNS O
with IN O
the DT O
dropping VBG O
mercury NN O
ka NN O

thode NNP O
. . O
- : O
Part NNP O
XXXI NNP O
. . O
- : O
A DT O
new JJ O
test NN O
for IN O
proteins NNS O
in IN O
the DT O
presence NN O
of IN O
cobalt NN O
salts NNS O
in IN O
ammoniacal JJ O
solutions NNS O
of IN O
ammonium NN O
chloride NN O
. . O

Collect VB O
. . O

Czech NNP O
. . O

Chem NNP O
. . O

Commun NNP O
. . O

5 CD O
: : O
112 CD O
- HYPH O
128 CD O
( SYM O
1933 CD O
) -RRB- O
. . O

10 CD O
. . O

Olafson NNP O
, , O
R NNP O
. . O

W UH O
, , O
and CC O
Sim NNP O
, , O
R NNP O
. . O

G NNP O
. . O

An DT O
electrochemical JJ O
approach NN O
to IN O

quantitation NN O
and CC O
characterization NN O
of IN O
metallothionein NN O
. . O

Anal NNP O
. . O

Biochem NNP O
. . O

100 CD O
: : O
343 CD O
- HYPH O
351 CD O
( SYM O
1979 CD O
) -RRB- O
. . O

11 CD O
. . O

Olafson NNP O
, , O
R NNP O
. . O

W NN O
Differential JJ O
pulse NN O
polarographic JJ O
determination NN O
of IN O

murine JJ B-Species
metallothionein NN O
induction NN O
kinetics NNS O
. . O

J NNP O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

256 CD O
: : O
12631268 CD O
( : O
1981 CD O
) -RRB- O
. . O

12 CD O
. . O

Olafson NNP O
, , O
R NNP O
. . O

W NNP O
Prokaryotic JJ O
metallothionein NN O
: : O
amino JJ O
terminal NN O
se NN O

quence NN O
analysis NN O
of IN O
a DT O
unique JJ O
metallothionein NN O
. . O

Int NNP O
. . O

J NNP O
. . O

Peptide NN O
Protein NN O
Res NNS O
. . O

24 CD O
: : O
303 CD O
- HYPH O
308 CD O
( SYM O
1984 CD O
) -RRB- O
. . O

Peculiarities NNS O
of IN O
carcinogenesis NN O
under IN O
simultaneous JJ O
oral JJ O
administration NN O
of IN O
benzo NN O
( , O
a DT O
) -RRB- O
pyrene NN O
and CC O
o NN O
- HYPH O
cresol NN O
in IN O
mice NNS B-Species
. . O

Abstract JJ O

A DT O
modifying VBG O
influence NN O
of IN O
ortho NN O
- HYPH O
cresol NN O
( HYPH O
o NN O
- HYPH O
cresol NN O
) -RRB- O
on IN O
the DT O
carcinogenic JJ O
effect NN O
of IN O
benzo NN O
( , O
a DT O
) -RRB- O
pyrene NN O
( , O
BaP NN O
) -RRB- O
with IN O
combined VBN O
oral JJ O
administration NN O
to IN O
CC57Br NNP O
mice NNS B-Species
had VBD O
been VBN O
found VBN O
. . O

During IN O
simultaneous JJ O
administration NN O
of IN O
o NNP O
- HYPH O
cresol NN O
( , O
1 CD O
mg NN O
) -RRB- O
and CC O
BaP NN O
( SYM O
1 CD O
mg NN O
) -RRB- O
, , O
the DT O
incidence NN O
of IN O
tumors NNS O
, , O
the DT O
multiplicity NN O
of IN O
tumors NNS O
, , O
and CC O
the DT O
degree NN O
of IN O
malignancy NN O
all DT O
increased VBD O
, , O
but CC O
the DT O
latency NN O
was VBD O
shortened VBN O
. . O

When WRB O
o JJ O
- HYPH O
cresol NN O
was VBD O
administered VBN O
before IN O
or CC O
after IN O
BaP NNP O
( , O
in IN O
identical JJ O
doses NNS O
) -RRB- O
, , O
the DT O
carcinogenic JJ O
effect NN O
was VBD O
weakened VBN O
. . O

When WRB O
o NNP O
- HYPH O
cresol NN O
( , O
10 CD O
mg NN O
) -RRB- O
and CC O
BaP NNP O
( SYM O
5 CD O
mg NN O
) -RRB- O
were VBD O
administered VBN O
simultaneously RB O
, , O
the DT O
incidence NN O
of IN O
malignant JJ O
tumors NNS O
was VBD O
similar JJ O
to IN O
controls NNS O
receiving VBG O
BaP NNP O
only RB O
( : O
13 CD O
. . O
8 CD O
% NN O
) -RRB- O
, , O
indicating VBG O
inhibition NN O
of IN O
carcinogenesis NN O
. . O

Environnmental NNP O
Health NNP O
Perspectives NNPS O
Supplements NNPS O
Vol NNP O
. . O

101 CD O
( , O
Suppl NNP O
. . O
3 CD O
) NFP O
: : O
341 CD O
- HYPH O
344 CD O
( SYM O
1993 CD O
) -RRB- O

Peculiarities NNS O
of IN O
Carcinogenesis NN O
under IN O
Simultaneous JJ O
Oral NNP O
Administration NNP O
of IN O

Benzo NNP O
( , O
a DT O
) NFP O
Pyrene NN O
and CC O
o NN O
- HYPH O
Cresol NN O
in IN O
Mice NNP B-Species

by IN O
N NNP O
. . O

Ya UH O
. . O

Yanysheva NNP O
, , O
' '' O
N NNP O
. . O

V NN O
. . O

Balenko NNP O
, , O
1 CD O
. . O

A DT O
. . O

Chernichenko NNP O
, , O
1 CD O
and CC O
V NN O
. . O

F NNP O
. . O

Babiy NNP O
' '' O

A DT O
modifying VBG O
influence NN O
of IN O
ortho NN O
- HYPH O
cresol NN O
( HYPH O
o NN O
- HYPH O
cresol NN O
) -RRB- O
on IN O
the DT O
carcinogenic JJ O
effect NN O
of IN O
benzo NN O
( , O
a DT O
) -RRB- O
pyrene NN O
( , O
BaP NN O
) -RRB- O
with IN O
combined VBN O
oral JJ O
administration NN O
to IN O
CC57Br NNP O
mice NNS B-Species
had VBD O
been VBN O
found VBN O
. . O

During IN O
simultaneous JJ O
administration NN O
of IN O
o NNP O
- HYPH O
cresol NN O
( , O
1 CD O
mg NN O
) -RRB- O
and CC O
BaP NN O
( SYM O
1 CD O
mg NN O
) -RRB- O
, , O
the DT O
incidence NN O
of IN O
tumors NNS O
, , O
the DT O
multiplicity NN O
of IN O
tumors NNS O
, , O
and CC O
the DT O
degree NN O
of IN O
malignancy NN O
all DT O
increased VBD O
, , O
but CC O
the DT O
latency NN O
was VBD O
shortened VBN O
. . O

When WRB O
o JJ O
- HYPH O
cresol NN O
was VBD O
administered VBN O
before IN O
or CC O
after IN O
BaP NNP O
( , O
in IN O
identical JJ O
doses NNS O
) -RRB- O
, , O
the DT O
carcinogenic JJ O
effect NN O
was VBD O
weakened VBN O
. . O

When WRB O
o NNP O
- HYPH O
cresol NN O
( , O
10 CD O
mg NN O
) -RRB- O
and CC O
BaP NNP O
( SYM O
5 CD O
mg NN O
) -RRB- O
were VBD O
administered VBN O
simultaneously RB O
, , O
the DT O
incidence NN O
of IN O
malignant JJ O
tumors NNS O
was VBD O
similar JJ O
to IN O
controls NNS O
receiving VBG O
BaP NNP O
only RB O
( : O
13 CD O
. . O
8 CD O
% NN O
) -RRB- O
, , O
indicating VBG O
inhibition NN O
of IN O
carcinogenesis NN O
. . O

Introduction NN O

Numerous JJ O
experiments NNS O
have VBP O
shown VBN O
a DT O
modifying VBG O
influence NN O
of IN O
different JJ O
chemicals NNS O
on IN O
benzo NN O
( , O
a DT O
) , O
pyrene NN O
( , O
BaP NN O
) -RRB- O
induced VBN O
carcinogenic JJ O
effects NNS O
. . O

Both CC O
enhancing VBG O
or CC O
weakening VBG O
effects NNS O
have VBP O
been VBN O
seen VBN O
( SYM O
1 CD O
- SYM O
12 CD O
) -RRB- O
. . O

In IN O
some DT O
experiments NNS O
ubiquitious JJ O
environmental JJ O
carcinogenic JJ O
and CC O
toxic JJ O
chemical NN O
pollutants NNS O
were VBD O
used VBN O
( SYM O
13 CD O
- SYM O
17 CD O
) -RRB- O
. . O

The DT O
stimulating VBG O
effect NN O
of IN O
phenol NN O
, , O
nitrogen NN O
oxides NNS O
, , O
and CC O
sulfur NN O
dioxide NN O
upon IN O
BaP NNP O
' POS O
s POS O
blastogenic JJ O
action NN O
on IN O
the DT O
respiratory JJ O
tract NN O
and CC O
phenol NN O
on IN O
the DT O
digestive JJ O
tract NN O
( , O
forestomach NN O
) -RRB- O
have VBP O
been VBN O
reported VBN O
( : O
12 CD O
- SYM O
18 CD O
) -RRB- O
. . O

We PRP O
have VBP O
established VBN O
the DT O
relationship NN O
between IN O
the DT O
doses NNS O
of IN O
carcinogenic JJ O
and CC O
toxic JJ O
agents NNS O
and CC O
their PRP$ O
modifying JJ O
effects NNS O
( : O
17 CD O
, , O
18 CD O
) -RRB- O
. . O

The DT O
maximal JJ O
enhancing VBG O
effect NN O
was VBD O
observed VBN O
after IN O
BaP NNP O
( : O
2 CD O
. . O
5 CD O
mg NN O
) -RRB- O
and CC O
NO2 NNP O
( SYM O
0 CD O
. . O
87 CD O
mg CD O
/ SYM O
m3 CD O
) -RRB- O
were VBD O
exposed VBN O
to IN O
rat NN B-Species
respiratory JJ O
tract NN O
. . O

The DT O
effect NN O
weakened VBD O
with IN O
decreasing VBG O
dose NN O
. . O

At IN O
concentrations NNS O
at IN O
the DT O
MPC NNP O
level NN O
( , O
MPC NNP O
BaP NNP O
, , O
1 CD O
ng CD O
/ SYM O
m3 CD O
, , O
MPC NNP O
NO2 NNP O
, , O
0 CD O
. . O
4 CD O
mg NN O
/ SYM O
m3 CD O
) -RRB- O
no DT O
effect NN O
was VBD O
seen VBN O
. . O

Phenol NN O
at IN O
1 CD O
mg NN O
orally RB O
to IN O
CC57Br NN O
mice NN B-Species
enhanced VBN O
the DT O
BaP NNP O
( SYM O
1 CD O
mg NN O
) -RRB- O
effect NN O
, , O
but CC O
no DT O
effect NN O
was VBD O
seen VBN O
at IN O
0 CD O
. . O
2 CD O
mg NN O
. . O

Phenolic JJ O
compounds NNS O
showed VBD O
either CC O
enhancing VBG O
or CC O
inhibiting VBG O
effects NNS O
on IN O
carcinogenesis NN O
depending VBG O
on IN O
their PRP$ O
chemical JJ O
structure NN O
( : O
16 CD O
, , O
18 CD O
- SYM O
25 CD O
) -RRB- O
. . O

This DT O
report NN O
presents VBZ O
the DT O
results NNS O
of IN O
combined VBN O
oral JJ O
administration NN O
of IN O
BaP NNP O
and CC O
artho NN O
- HYPH O
cresol NN O
( HYPH O
o NN O
- HYPH O
cresol NN O
) -RRB- O
in IN O
mice NNS B-Species
, , O

' POS O
Ukrainian JJ O
State NNP O
Medical NNP O
Center NNP O
for IN O
Environmental NNP O
Health NNP O
, , O
Kiev NNP O
, , O
Ukraine NNP O
. . O

Address NN O
reprint NN O
requests NNS O
to IN O
N NNP O
. . O

Y UH O
. . O

Yanysheva NNP O
, , O
Ukrainian NNP O
State NNP O
Medical NNP O
Center NNP O
for IN O
Environmental NNP O
Health NNP O
, , O
Popudrenko NNP O
St NNP O
. . O

50 CD O
, , O
253660 CD O
Kiev NNP O
- HYPH O
94 CD O
, , O
Ukraine NNP O
. . O

chemicals NNS O
commonly RB O
found VBN O
in IN O
ambient JJ O
water NN O
because IN O
of IN O
their PRP$ O
industrial JJ O
use NN O
( , O
coke NN O
chemistry NN O
, , O
oil NN O
processing NN O
, , O
shale NN O
processing NN O
, , O
and CC O
other JJ O
industries NNS O
) -RRB- O
( , O
27 CD O
- SYM O
30 CD O
) -RRB- O
. . O

Materials NNS O
and CC O
Methods NNS O

The DT O
experiment NN O
was VBD O
conducted VBN O
on IN O
CC57Br NNP O
female JJ O
mice NNS B-Species
weighing VBG O
12 CD O
- SYM O
14 CD O
g NN O
. . O

Animals NNS O
were VBD O
divided VBN O
in IN O
15 CD O
groups NNS O
. . O

This DT O
experiment NN O
included VBD O
three CD O
types NNS O
of IN O
sequential JJ O
combinations NNS O
for IN O
the DT O
introduction NN O
of IN O
compounds NNS O
: : O
a DT O
) -RRB- O
simultaneous JJ O
BaP NNP O
and CC O
o DT O
- HYPH O
cresol NN O
administration NN O
; : O
b LS O
) -RRB- O
BaP NN O
after IN O
o FW O
- HYPH O
cresol NN O
( , O
stage NN O
1 CD O
) -RRB- O
; : O
and CC O
c NN O
) NFP O
BaP NN O
before IN O
o NN O
- HYPH O
cresol NN O
( , O
stage NN O
2 CD O
) -RRB- O
. . O

Appropriate JJ O
controls NNS O
were VBD O
included VBN O
( : O
Table NNP O
1 CD O
) -RRB- O
. . O

The DT O
chemicals NNS O
were VBD O
administered VBN O
twice RB O
per IN O
week NN O
( : O
for IN O
a DT O
total NN O
of IN O
10 CD O
, , O
20 CD O
, , O
and CC O
40 CD O
doses NNS O
) , O
using VBG O
a DT O
syringe NN O
and CC O
a DT O
needle NN O
with IN O
a DT O
soldered VBN O
olive NN O
on IN O
its PRP$ O
tip NN O
. . O

BaP NNP O
( : O
1 CD O
or CC O
5 CD O
mg NN O
) -RRB- O
or CC O
o CD O
- HYPH O
cresol NN O
( , O
0 CD O
. . O
2 CD O
, , O
1 CD O
, , O
or CC O
10 CD O
mg NN O
) -RRB- O
was VBD O
placed VBN O
in IN O
triethylene NN O
glycol NN O
( , O
TEG NNP O
) -RRB- O
and CC O
administered VBN O
as IN O
0 CD O
. . O
1 CD O
- HYPH O
mL NN O
water NN O
solutions NNS O
. . O

The DT O
evaluation NN O
of IN O
o IN O
- HYPH O
cresol NN O
' '' O
s NNS O
modifying VBG O
effect NN O
on IN O
the DT O
incidence NN O
of IN O
tumors NNS O
, , O
especially RB O
malignant JJ O
tumors NNS O
, , O
the DT O
tumor NN O
latency NN O
period NN O
( , O
tl NN O
) -RRB- O
, , O
and CC O
the DT O
average JJ O
time NN O
( , O
ta NN O
) -RRB- O
of IN O
the DT O
appearance NN O
of IN O
tumors NNS O
, , O
as RB O
well RB O
as IN O
the DT O
multiplicity NN O
index NN O
, , O
M NNP O
( , O
the DT O
average JJ O
number NN O
of IN O
tumors NNS O
per IN O
animal NN O
for IN O
tumor NN O
- HYPH O
bearing VBG O
animals NNS O
) -RRB- O
was VBD O
recorded VBN O
. . O

Because IN O
the DT O
M NNP O
could MD O
be VB O
identified VBN O
at IN O
the DT O
initial JJ O
stage NN O
of IN O
carcinogenesis NN O
by IN O
the DT O
third JJ O
month NN O
after IN O
the DT O
beginning NN O
of IN O
the DT O
trial NN O
when WRB O
neoplasms NNS O
began VBD O
to TO O
emerge VB O
, , O
moribund JJ O
animals NNS O
were VBD O
killed VBN O
by IN O
ether JJ O
inhalation NN O
if IN O
they PRP O
did VBD O
not RB O
die VB O
spontaneously RB O
. . O

The DT O
experiments NNS O
with IN O
large JJ O
chemical JJ O
doses NNS O
( : O
BaP NNP O
, , O
5 CD O
mg NN O
; : O
o CD O
- HYPH O
cresol NN O
, , O
10 CD O
mg NN O
) -RRB- O
lasted VBD O
for IN O
30 CD O
weeks NNS O
. . O

Some DT O
animals NNS O
were VBD O
killed VBN O
after IN O
the DT O
1st JJ O
, , O
3rd JJ O
, , O
5th JJ O
, , O
and CC O
10th JJ O
procedures NNS O
for IN O
the DT O

YANYSHEVA NNP O
ET NNP O
AL NNP O
. . O

evaluation NN O
of IN O
initial JJ O
stages NNS O
of IN O
carcinogenesis NN O
; : O
others NNS O
were VBD O
killed VBN O
at IN O
26 CD O
and CC O
30 CD O
weeks NNS O
. . O

The DT O
stomachs NNS O
were VBD O
distended VBN O
with IN O
formalin JJ O
solution NN O
and CC O
the DT O
mucosa NN O
examined VBN O
macroscopically RB O
. . O

All DT O
tumors NNS O
> : O
1 CD O
mm NN O
in IN O
diameter NN O
were VBD O
recorded VBN O
. . O

Organs NNS O
and CC O
tissues NNS O
were VBD O
fised VBN O
in IN O
10 CD O
% NN O
neutral JJ O
formalin JJ O
solution NN O
, , O
embedded VBN O
in IN O
paraffin NN O
and CC O
routine JJ O
histological JJ O
slides NNS O
prepared VBN O
. . O

Microscopic JJ O
data NNS O
were VBD O
processed VBN O
according VBG O
to IN O
Mostkovoy NNP O
( : O
30 CD O
) -RRB- O
. . O

Results NNS O

The DT O
data NNS O
from IN O
this DT O
study NN O
demonstrate VBP O
the DT O
modifying VBG O
influence NN O
of IN O
o NN O
- HYPH O
cresol NN O
on IN O
BaP NNP O
- HYPH O
induced VBN O
carcinogenesis NN O
with IN O
combined VBN O
oral JJ O
exposure NN O
. . O

The DT O
combined VBN O
exposure NN O
and CC O
BaP NNP O
alone RB O
caused VBD O
benign JJ O
and CC O
malignant JJ O
epithelial JJ O
tumors NNS O
of IN O
the DT O
forestomach NN O
. . O

The DT O
benign JJ O
neoplasms NNS O
were VBD O
papillomas NNS O
, , O
and CC O
the DT O
malignant JJ O
neoplasms NNS O
were VBD O
invasive JJ O
carcinomas NNS O
. . O

The DT O
combined VBN O
administration NN O
of IN O
BaP NNP O
and CC O
o NN O
- HYPH O
cresol NN O
showed VBD O
different JJ O
results NNS O
depending VBG O
on IN O
doses NNS O
and CC O
sequential JJ O
combinations NNS O
of IN O
both DT O
chemicals NNS O
. . O

As IN O
shown VBN O
in IN O
Table NNP O
2 CD O
, , O
the DT O
simultaneous JJ O
administration NN O
of IN O
BaP NNP O
( : O
1 CD O
mg NN O
) -RRB- O
and CC O
o NN O
- HYPH O
cresol NN O
( , O
1 CD O
mg NN O
) -RRB- O
affected VBD O
all DT O
parameters NNS O
of IN O
carcinogenesis NN O
that WDT O
were VBD O
measured VBN O
. . O

This DT O
included VBD O
a DT O
significant JJ O
increase NN O
in IN O
the DT O
incidence NN O
of IN O
tumors NNS O
, , O
shortening NN O
of IN O
the DT O
time NN O
to IN O
the DT O
appearance NN O
of IN O
the DT O
first JJ O
tumor NN O
, , O
and CC O
the DT O
mean JJ O
time NN O
of IN O
tumor NN O

development NN O
as IN O
compared VBN O
to IN O
animals NNS O
that WDT O
received VBD O
1 CD O
mg NN O
of IN O
BaP NNP O
alone RB O
and CC O
had VBD O
tumors NNS O
. . O

One CD O
hundred CD O
percent NN O
of IN O
the DT O
mice NN B-Species
that WDT O
received VBD O
5 CD O
mg NN O
of IN O
BaP NNP O
alone RB O
had VBD O
tumors NNS O
. . O

Shortening VBG O
of IN O
the DT O
time NN O
to IN O
appearance NN O
of IN O
malignant JJ O
tumors NNS O
was VBD O
also RB O
observed VBN O
: : O
the DT O
mice NNS B-Species
with IN O
forestomach NN O
cancer NN O
died VBD O
between IN O
23 CD O
and CC O
26 CD O
. . O
2 CD O
weeks NNS O
after IN O
the DT O
beginning NN O
of IN O
experiment NN O
, , O
but CC O
the DT O
controls NNS O
survived VBD O
to IN O
58 CD O
. . O
5 CD O
weeks NNS O
. . O

Muliple JJ O
small JJ O
metastases NNS O
in IN O
the DT O
lungs NNS O
and CC O
mediastinum NN O
were VBD O
found VBN O
in IN O
42 CD O
. . O
8 CD O
% NN O
of IN O
mice NNS B-Species
, , O
which WDT O
signifies VBZ O
a DT O
high JJ O
degree NN O
of IN O
malignancy NN O
. . O

o LS O
- : O
Cresol NNP O
at IN O
0 CD O
. . O
2 CD O
mg NN O
did VBD O
not RB O
modify VB O
carcinogenesis NN O
in IN O
comparison NN O
to IN O
the DT O
control NN O
. . O

o LS O
- HYPH O
Cresol NNP O
administration NN O
before IN O
or CC O
after IN O
BaP NNP O
did VBD O
not RB O
modify VB O
tumor NN O
incidence NN O
or CC O
the DT O
multiplicity NN O
index NN O
as IN O
compared VBN O
to IN O
control NN O
, , O
but CC O
the DT O
latency NN O
period NN O
was VBD O
longer JJR O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

When WRB O
o JJ O
- HYPH O
cresol NN O
was VBD O
administered VBN O
after IN O
BaP NNP O
( HYPH O
stage NN O
2 CD O
) -RRB- O
, , O
there EX O
was VBD O
an DT O
absence NN O
of IN O
malignant JJ O
tumors NNS O
. . O

Besides IN O
the DT O
quantitative JJ O
aspects NNS O
, , O
other JJ O
peculiarities NNS O
of IN O
carcinogenesis NN O
in IN O
mice NNS B-Species
simultaneously RB O
administered VBN O
BaP NNP O
and CC O
o NN O
- HYPH O
cresol NN O
should MD O
be VB O
noted VBN O
. . O

The DT O
combined JJ O
chemical NN O
administration NN O
resulted VBD O
in IN O
diffuse JJ O
verrucosa NN O
vegetations NNS O
over IN O
the DT O
forestomach NN O
surface NN O
, , O
especially RB O
near IN O
the DT O
greater JJR O
curvature NN O
. . O

Highly RB O
aggressive JJ O
malignant JJ O
neoplasms NNS O
developed VBD O
earlier RBR O
with IN O
more JJR O
metastases NNS O
as IN O
compared VBN O
to IN O
control NN O
. . O

Many JJ O
mice NNS B-Species
were VBD O
emaciated VBN O
, , O
and CC O
the DT O
tumors NNS O
could MD O
be VB O

Table NN O
1 CD O
. . O

Scheme NN O
of IN O
BaP NNP O
and CC O
o DT O
- HYPH O
cresol NN O
combined VBN O
action NN O
under IN O
different JJ O
regimes NNS O
of IN O
oral JJ O
administration NN O
. . O

Theatmenta NNP O

No UH O
. . O
of IN O
mice NN B-Species
Stage NN O
1 CD O
Stage NN O
2 CD O

Groups NNS O
of IN O
in IN O
each DT O
No UH O
. . O
of IN O
No UH O
. . O
of IN O

animals NNS O
group NN O
Substances NNS O
Dose NN O
, , O
mg NN O
applications NNS O
Substances NNS O
Dose NN O
, , O
mg NN O
applications NNS O

1 CD O
55 CD O
BaP NN O
, , O
o CD O
- HYPH O
cresol NN O
5 CD O
+ SYM O
10 CD O
10 CD O
- HYPH O
- HYPH O
2 CD O
45 CD O
BaP NN O
5 CD O
10 CD O
- HYPH O
- HYPH O
3 CD O
40 CD O
TEG NN O
la NN O
10 CD O
- HYPH O
- HYPH O
4 CD O
45 CD O
TEG NN O
, , O
o CD O
- HYPH O
cresol NN O
1b CD O
+ NN O
10 CD O
10 CD O
- HYPH O
- HYPH O
5 CD O
30 CD O
BaP NN O
, , O
o CD O
- HYPH O
cresol NN O
1 CD O
+ SYM O
1 CD O
20 CD O
- HYPH O
- HYPH O
6 CD O
30 CD O
BaP NN O
, , O
o CD O
- HYPH O
cresol NN O
1 CD O
+ SYM O
0 CD O
. . O
2 CD O
20 CD O
- HYPH O
- HYPH O
7 CD O
30 CD O
o CD O
- HYPH O
Cresol NN O
1 CD O
20 CD O
BaP NN O
1 CD O
20 CD O
8 CD O
30 CD O
BaP NN O
1 CD O
20 CD O
o CD O
- HYPH O
Cresol NN O
1 CD O
20 CD O
9 CD O
30 CD O
BaP NN O
1 CD O
20 CD O
- HYPH O
10 CD O
30 CD O
- HYPH O
- HYPH O
- HYPH O
BaP NN O
1 CD O
20 CD O
11 CD O
30 CD O
o CD O
- HYPH O
Cresol NN O
1 CD O
20 CD O
- HYPH O
12 CD O
30 CD O
- HYPH O
- HYPH O
- HYPH O
o CD O
- HYPH O
Cresol NN O
1 CD O
20 CD O
13 CD O
30 CD O
o CD O
- HYPH O
Cresol NN O
+ CC O
TEG NN O
1 CD O
+ SYM O
2 CD O
' NN O
20 CD O
- HYPH O
14 CD O
30 CD O
o SYM O
- HYPH O
Cresol NN O
+ CC O
TEG NN O
0 CD O
. . O
2 CD O
+ SYM O
2b CD O
20 CD O

15 CD O
30 CD O
TEG NN O
2b CD O
20 CD O
- : O
- : O
Abbreviations NNS O
: : O
BaP NNP O
, , O
benzo NN O
[ -LRB- O
a DT O
] -RRB- O
pyrene NN O
; : O
TEG NN O
, , O
triethylene NN O
glycol NN O
. . O

Table NN O
2 CD O
. . O

Occurrence NN O
of IN O
forestomach NN O
tumors NNS O
in IN O
CC57Br NN O
mice NN B-Species
after IN O
combined VBN O
oral JJ O
administration NN O
of IN O
BaP NNP O
and CC O
o NN O
- HYPH O
cresol NN O
. . O

Number NN O
of IN O
animals NNS O
with IN O
forestomach NN O
tumors NNS O

Order NN O
of IN O
administration NN O
of IN O
substances NNS O
Total NNP O
Benign NNP O
Malignant NNP O

( : O
dose NN O
, , O
mg NN O
) : O
Absolute JJ O
% NN O
% NN O
M NN O
t NN O
, , O
ta NN O
% NN O
t NN O
, , O
ta IN O
BaP NN O
( : O
5 CD O
) -RRB- O
, , O
o CD O
- HYPH O
cresol NN O
( , O
10 CD O
) SYM O
29 CD O
100 CD O
. . O
0 CD O
86 CD O
. . O
2 CD O
ND NN O
ND NN O
ND NN O
13 CD O
. . O
8 CD O
ND NN O
ND NN O
BaP NN O
( SYM O
1 CD O
) -RRB- O
, , O
o CD O
- HYPH O
cresol NN O
( : O
1 CD O
) SYM O
19 CD O
95 CD O
. . O
0 CD O
60 CD O
. . O
0 CD O
9 CD O
. . O
6 CD O
10 CD O
. . O
7 CD O
16 CD O
. . O
3 CD O
35 CD O
. . O
0 CD O
23 CD O
. . O
0 CD O
25 CD O
. . O
2 CD O
BaP NN O
( : O
1 CD O
) -RRB- O
, , O
o CD O
- HYPH O
cresol NN O
( : O
0 CD O
. . O
2 CD O
) SYM O
7 CD O
35 CD O
. . O
0 CD O
30 CD O
. . O
0 CD O
1 CD O
. . O
6 CD O
13 CD O
. . O
5 CD O
19 CD O
. . O
8 CD O
5 CD O
. . O
0 CD O
56 CD O
. . O
8 CD O
56 CD O
. . O
8 CD O
BaP NN O
( : O
1 CD O
) -RRB- O
, , O
stage NN O
1 CD O
, , O
o CD O
- HYPH O
cresol NN O
( , O
1 CD O
) NFP O
, , O
stage NN O
2 CD O
7 CD O
31 CD O
. . O
8 CD O
31 CD O
. . O
8 CD O
1 CD O
. . O
4 CD O
16 CD O
. . O
2 CD O
31 CD O
. . O
1 CD O
0 CD O
0 CD O
0 CD O

BaP NNP O
( : O
1 CD O
) -RRB- O
, , O
stage NN O
2 CD O
6 CD O
35 CD O
. . O
3 CD O
29 CD O
. . O
4 CD O
2 CD O
. . O
8 CD O
15 CD O
. . O
8 CD O
41 CD O
. . O
2 CD O
5 CD O
. . O
9 CD O
24 CD O
. . O
8 CD O
24 CD O
. . O
8 CD O
BaP NN O
( SYM O
5 CD O
) -RRB- O
, , O
stage NN O
1 CD O
18 CD O
100 CD O
. . O
0 CD O
50 CD O
. . O
0 CD O
ND NN O
ND NN O
ND NN O
50 CD O
. . O
0 CD O
ND NN O
ND NN O
BaP NN O
( SYM O
1 CD O
) -RRB- O
, , O
stage NN O
1 CD O
8 CD O
33 CD O
. . O
3 CD O
28 CD O
. . O
7 CD O
1 CD O
. . O
4 CD O
14 CD O
. . O
0 CD O
21 CD O
. . O
3 CD O
4 CD O
. SYM O
6 CD O
58 CD O
. . O
5 CD O
58 CD O
. . O
5 CD O
BaP NN O
( SYM O
1 CD O
) -RRB- O
, , O
stage NN O
2 CD O
7 CD O
36 CD O
. . O
8 CD O
31 CD O
. . O
6 CD O
2 CD O
. . O
8 CD O
10 CD O
. . O
0 CD O
13 CD O
. . O
3 CD O
5 CD O
. . O
2 CD O
55 CD O
. . O
7 CD O
55 CD O
. . O
7 CD O

Abbreviations NNS O
: : O
BaP NNP O
, , O
benzo NNP O
[ -LRB- O
a DT O
] -RRB- O
pyrene NN O
; , O
0 CD O
, , O
not RB O
observed VBN O
; : O
ND NN O
, , O
not RB O
determined VBN O
; : O
t1 CD O
, , O
time NN O
of IN O
the DT O
first JJ O
tumor NN O
appearance NN O
in IN O
weeks NNS O
; : O
ta NN O
, , O
mean JJ O
time NN O
of IN O
tumor NN O
development NN O
in IN O
weeks NNS O
; : O
M NNP O
, , O
multiplicity NN O
. . O

342 CD O

CARCINOGENESIS NN O
OF IN O
BaP NNP O
AND CC O
o NFP O
- HYPH O
CRESOL NN O
343 CD O

palpated VBN O
through IN O
the DT O
abdominal JJ O
wall NN O
. . O

At IN O
autopsy NN O
, , O
enlargement NN O
of IN O
the DT O
stomach NN O
with IN O
tuberculous JJ O
white JJ O
superficial JJ O
vegetations NNS O
were VBD O
observed VBN O
. . O

The DT O
forestomach NN O
and CC O
glandular JJ O
part NN O
of IN O
the DT O
stomach NN O
was VBD O
often RB O
obliterated VBN O
by IN O
tumor NN O
masses NNS O
. . O

The DT O
stomach NN O
was VBD O
often RB O
adhered VBN O
to IN O
the DT O
pancreas NN O
, , O
liver NN O
, , O
and CC O
mesentery NN O
. . O

Hemmorrhage NN O
and CC O
inflammation NN O
were VBD O
found VBN O
in IN O
tumors NNS O
foci FW O
. . O

When WRB O
o JJ O
- HYPH O
cresol NN O
was VBD O
introduced VBN O
before IN O
BaP NNP O
, , O
the DT O
tumors NNS O
were VBD O
more RBR O
frequently RB O
found VBN O
closer JJR O
to IN O
the DT O
small JJ O
curvature NN O
of IN O
the DT O
stomach NN O
between IN O
the DT O
forestomach NN O
and CC O
esophageal JJ O
entrance NN O
. . O

Over IN O
the DT O
large JJ O
curvature NN O
less RBR O
prominent JJ O
mucosal JJ O
folds NNS O
were VBD O
observed VBN O
. . O

Microscopically RB O
, , O
a DT O
decrease NN O
in IN O
mucosa NN O
papillae NN O
, , O
epithelial JJ O
atrophy NN O
( , O
one CD O
to IN O
two CD O
cullular JJ O
layers NNS O
) -RRB- O
, , O
decreased VBD O
keratonization NN O
, , O
and CC O
nuclear JJ O
pycnosis NN O
were VBD O
observed VBN O
. . O

With IN O
the DT O
simultaneous JJ O
administration NN O
of IN O
large JJ O
doses NNS O
of IN O
o NN O
- HYPH O
cresol NN O
and CC O
BaP NNP O
, , O
the DT O
final JJ O
carcinogenic JJ O
effect NN O
( , O
30 CD O
weeks NNS O
after IN O
the DT O
first JJ O
dose NN O
) , O
was VBD O
similar JJ O
to IN O
BaP NNP O
alone RB O
but CC O
differences NNS O
were VBD O
observed VBN O
at IN O
the DT O
earlier JJR O
stages NNS O
( , O
after IN O
the DT O
1st JJ O
, , O
3rd JJ O
, , O
5th JJ O
, , O
and CC O
10th JJ O
exposures NNS O
) -RRB- O
. . O

In IN O
the DT O
BaP NNP O
control NN O
, , O
multiple JJ O
forestomach NN O
epithelial JJ O
proliferative JJ O
and CC O
hyperplastic JJ O
changes NNS O
were VBD O
found VBN O
after IN O
the DT O
third JJ O
dose NN O
. . O

Multiple JJ O
papillomas NNS O
occurred VBD O
( : O
9 CD O
- SYM O
15 CD O
in IN O
each DT O
mouse NN B-Species
) -RRB- O
. . O

The DT O
stomach NN O
' '' O
s POS O
mucosal JJ O
folds NNS O
appeared VBD O
thickened VBN O
diffusely RB O
, , O
then RB O
papillomas NNS O
appeared VBD O
and CC O
finally RB O
merged VBD O
together RB O
. . O

Approximately RB O
half NN O
of IN O
the DT O
tumors NNS O
were VBD O
malignant JJ O
. . O

The DT O
neoplasms NNS O
filled VBD O
almost RB O
the DT O
whole JJ O
forestomach NN O
cavity NN O
and CC O
infiltrated VBD O
the DT O
wall NN O
with IN O
tuberculous JJ O
vegetations NNS O
, , O
which WDT O
were VBD O
visible JJ O
on IN O
the DT O
serosal JJ O
surface NN O
. . O

Thmor NN O
infiltration NN O
in IN O
the DT O
liver NN O
, , O
pancreas NN O
, , O
and CC O
wide JJ O
dissemination NN O
of IN O
peritoneum NN O
were VBD O
also RB O
observed VBN O
. . O

In IN O
mice NNS B-Species
simultaneously RB O
administered VBN O
BaP NNP O
and CC O
o NN O
- HYPH O
cresol NN O
, , O
the DT O
proliferative JJ O
alterations NNS O
of IN O
forestomach NN O
epithelium NN O
were VBD O
seen VBN O
after IN O
the DT O
third JJ O
dose NN O
. . O

However RB O
, , O
they PRP O
occurred VBD O
as IN O
the DT O
single JJ O
foci NN O
at IN O
damaged VBN O
mucosa NN O
and CC O
even RB O
in IN O
the DT O
later JJ O
stages NNS O
were VBD O
not RB O
diffuse JJ O
. . O

Adjacent JJ O
to IN O
the DT O
hyperplastic JJ O
foci NN O
, , O
the DT O
mucosa NN O
was VBD O
atrophied VBN O
with IN O
decreased VBN O
keratonization NN O
. . O

The DT O
epithelial JJ O
cells NNS O
also RB O
showed VBD O
cytoplasm NN O
coagulation NN O
and CC O
nuclear JJ O
pycnosis NN O
. . O

Edema NNP O
, , O
inflammation NN O
of IN O
the DT O
mucosa NN O
, , O
submucosa NN O
microabscesses NNS O
, , O
and CC O
erosion NN O
were VBD O
seen VBN O
. . O

There EX O
were VBD O
fewer JJR O
papillomas NNS O
per IN O
mouse NN B-Species
( : O
four CD O
to TO O
eight CD O
in IN O
each DT O
mouse NN B-Species
) , O
than IN O
in IN O
the DT O
control NN O
group NN O
. . O

Even RB O
in IN O
the DT O
late JJ O
stages NNS O
the DT O
papillomas NNS O
were VBD O
isolated VBN O
and CC O
elevated VBN O
on IN O
the DT O
atrophied VBN O
mucosal JJ O
folds NNS O
. . O

In IN O
the DT O
final JJ O
experiment NN O
the DT O
papillomas NNS O
prevailed VBD O
as IN O
compared VBN O
to IN O
the DT O
previous JJ O
experiments NNS O
. . O

Only RB O
4 CD O
out IN O
of IN O
29 CD O
mice NNS B-Species
( , O
13 CD O
. . O
8 CD O
% NN O
) -RRB- O
developed VBD O
malignant JJ O
tumors NNS O
. . O

Neoplasms NNS O
were VBD O
smaller JJR O
and CC O
appeared VBD O
as IN O
single JJ O
verrucosa NN O
vegetations NNS O
5 CD O
- SYM O
10 CD O
mm NN O
in IN O
diameter NN O
. . O

Thus RB O
, , O
the DT O
toxic JJ O
dose NN O
of IN O
o NN O
- HYPH O
cresol NN O
inhibits VBZ O
the DT O
carcinogenic JJ O
process NN O
of IN O
induced VBN O
forestomach NN O
tumors NNS O
by IN O
decreasing VBG O
multiplicity NN O
, , O
frequency NN O
, , O
and CC O
percentage NN O
of IN O
malignant JJ O
tumors NNS O
. . O

Discussion NN O

Our PRP$ O
results NNS O
and CC O
the DT O
literature NN O
suggest VBP O
a DT O
hypothesis NN O
on IN O
modifying VBG O
carcinogenesis NN O
mechanisms NNS O
. . O

The DT O
primary JJ O
effect NN O
of IN O
the DT O
toxic JJ O
agents NNS O
, , O
including VBG O
carcinogenic JJ O
agents NNS O
, , O
may MD O
relate VB O
to IN O
cellular JJ O
membrane NN O
damage NN O
with IN O
the DT O
subsequent JJ O
increased JJ O
permeability NN O
( : O
31 CD O
- SYM O
35 CD O
) -RRB- O
, , O
which WDT O
may MD O
be VB O
the DT O
mechanism NN O
of IN O
the DT O
o NN O
- HYPH O
cresol NN O
. . O

With IN O
simultaneous JJ O
introduction NN O
of IN O
o NN O
- HYPH O
cresol NN O
at IN O
low JJ O
toxic JJ O
doses NNS O
and CC O
BaP NNP O
there EX O
may MD O
be VB O
increased VBN O
carcinogen NN O
penetration NN O
to IN O
the DT O
target NN O
cells NNS O
. . O

In IN O
addition NN O
, , O
membrane NN O
damage NN O
may MD O
alter VB O
other JJ O
cellular JJ O
systems NNS O
responsible JJ O
for IN O
energy NN O
and CC O
xenobiotic JJ O
detoxication NN O
. . O

Damage NN O
of IN O
these DT O
processes NNS O
may MD O
activate VB O
free JJ O
- HYPH O
radical JJ O
reactions NNS O
, , O
glycolysis NN O
, , O
or CC O
alter VB O
carcinogenic JJ O
metabolism NN O
, , O
which WDT O
promotes VBZ O
the DT O
oncogenic JJ O
effect NN O
. . O

The DT O
o IN O
- HYPH O
cresol NN O
effect NN O
on IN O
these DT O
systems NNS O
was VBD O
confirmed VBN O
by IN O
our PRP$ O
previous JJ O
investigations NNS O
on IN O
cytochrome NN O
P450 NN O
, , O
ferrosulfuric JJ O
nonhemic JJ O
proteins NNS O
, , O
and CC O
semiquinon NN O
radical JJ O
content NN O
affected VBN O
by IN O
the DT O
combined VBN O
action NN O
of IN O
BaP NNP O
and CC O
o CD O
- HYPH O
cresol NN O
( SYM O
36 CD O
) -RRB- O
. . O

Another DT O
effect NN O
was VBD O
obtained VBN O
with IN O
BaP NNP O
exposure NN O
after IN O
o FW O
- HYPH O
cresol NN O
. . O

The DT O
atrophic JJ O
alterations NNS O
in IN O
the DT O
stomach NN O
induced VBN O
by IN O
2 CD O
. . O
5 CD O
months NNS O
of IN O
o JJ O
- HYPH O
cresol NN O
administration NN O
might MD O
decrease VB O
the DT O
natural JJ O
conditions NNS O
of IN O
retention NN O
( , O
muscosal JJ O
folds NNS O
, , O
frontier NN O
torn VBN O
) -RRB- O
, , O
and CC O
thus RB O
shorten VB O
the DT O
contact NN O
of IN O
BaP NNP O
with IN O
the DT O
forestomach NN O
. . O

In IN O
our PRP$ O
opinion NN O
, , O
this DT O
explains VBZ O
the DT O
decreased VBN O
carcinogenic JJ O
effect NN O
seen VBN O
after IN O
o JJ O
- HYPH O
cresol NN O
exposure NN O
. . O

Considering VBG O
the DT O
toxic JJ O
effect NN O
of IN O
o NN O
- HYPH O
cresol NN O
at IN O
low JJ O
toxic JJ O
doses NNS O
( : O
1 CD O
mg NN O
) -RRB- O
after IN O
BaP NNP O
and CC O
the DT O
effect NN O
of IN O
a DT O
super JJ O
toxic JJ O
dose NN O
( : O
10 CD O
mg NN O
) -RRB- O
simultaneously RB O
with IN O
BaP NNP O
administration NN O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
the DT O
inhibition NN O
of IN O
carcinogenesis NN O
in IN O
both DT O
trials NNS O
was VBD O
related VBN O
to IN O
the DT O
toxic JJ O
effects NNS O
of IN O
o NN O
- HYPH O
cresol NN O
. . O

Cytotoxicity NN O
may MD O
not RB O
only RB O
hamper VB O
tumor NN O
growth NN O
, , O
but CC O
also RB O
promote VB O
the DT O
regression NN O
of IN O
inducible JJ O
and CC O
spontaneous JJ O
neoplasms NNS O
( : O
37 CD O
- SYM O
39 CD O
) -RRB- O
. . O

There EX O
is VBZ O
also RB O
a DT O
possibility NN O
that IN O
BaP NNP O
damages VBZ O
metabolic JJ O
systems NNS O
and CC O
decreases VBZ O
resistance NN O
to IN O
carcinogenesis NN O
. . O

Conclusions NNS O

The DT O
data NNS O
obtained VBN O
demonstrate VBP O
that IN O
simultaneous JJ O
administration NN O
of IN O
BaP NNP O
modifies VBZ O
the DT O
induced VBN O
carcinogenesis NN O
depending VBG O
on IN O
the DT O
dose NN O
and CC O
the DT O
sequence NN O
of IN O
administration NN O
. . O

Administered VBN O
with IN O
BaP NNP O
( : O
1 CD O
mg NN O
) -RRB- O
, , O
a DT O
low JJ O
toxic JJ O
o NN O
- HYPH O
cresol NN O
dose NN O
( , O
about RB O
minimally RB O
effective JJ O
) , O
produces VBZ O
an DT O
enhanced VBN O
cocarcinogenic JJ O
effect NN O
reflected VBN O
in IN O
the DT O
incidence NN O
, , O
frequency NN O
, , O
multiplicity NN O
, , O
and CC O
degree NN O
of IN O
malignancy NN O
of IN O
forestomach NN O
tumors NNS O
. . O

o LS O
- HYPH O
Cresol NNP O
administration NN O
at IN O
low JJ O
toxic JJ O
doses NNS O
before IN O
or CC O
after IN O
BaP NNP O
at IN O
the DT O
same JJ O
dose NN O
level NN O
( : O
1 CD O
mg NN O
) -RRB- O
and CC O
its PRP$ O
administration NN O
at IN O
super JJ O
toxic JJ O
doses NNS O
( : O
10 CD O
mg NN O
) -RRB- O
with IN O
the DT O
BaP NNP O
optimal JJ O
dose NN O
( : O
5 CD O
mg NN O
) -RRB- O
may MD O
inhibit VB O
carcinogenesis NN O
. . O

Simultaneous JJ O
introduction NN O
of IN O
a DT O
noneffective JJ O
o JJ O
- HYPH O
cresol NN O
dose NN O
( , O
0 CD O
. . O
2 CD O
mg NN O
) -RRB- O
with IN O
the DT O
BaP NNP O
( SYM O
1 CD O
mg NN O
) -RRB- O
does VBZ O
not RB O
change VB O
its PRP$ O
carcinogenic JJ O
activity NN O
. . O

Controlling VBG O
both DT O
chemicals NNS O
in IN O
the DT O
environment NN O
is VBZ O
the DT O
most RBS O
effective JJ O
measure NN O
of IN O
preventing VBG O
potential JJ O
risk NN O
and CC O
is VBZ O
undoubtedly RB O
of IN O
paramount JJ O
significance NN O
. . O

REFERENCES NNS O

1 LS O
. . O

Bingham NNP O
, , O
E NNP O
. . O
, , O
and CC O
Falk NNP O
, , O
H NNP O
. . O

L NN O
. . O

Environmental JJ O
carcinogenesis NN O
. . O

The DT O

modifying VBG O
effect NN O
of IN O
cocarcinogens NNS O
on IN O
the DT O
threshold NN O
response NN O
. . O

Arch NNP O
. . O

Environ NNP O
. . O

Health NN O
19 CD O
: : O
779 CD O
- HYPH O
783 CD O
( SYM O
1969 CD O
) -RRB- O
. . O

2 LS O
. . O

Goldschmidt NNP O
, , O
B NNP O
. . O

M UH O
. . O
, , O
Katz NNP O
, , O
C NNP O
. . O
, , O
and CC O
Van NNP O
Duuren NNP O
, , O
B NNP O
. . O

L NN O
. . O

The DT O
cocar NN O

cinogenic JJ O
activity NN O
of IN O
non JJ O
- HYPH O
carcinogenic JJ O
aromatic JJ O
hydrocarbons NNS O
. . O

Proc NNP O
. . O

Am UH O
. . O

Assoc NNP O
. . O

Cancer NNP O
Res NNP O
. . O

17 CD O
: : O
84 CD O
( SYM O
1973 CD O
) -RRB- O
. . O

3 LS O
. . O

Kaufman NNP O
, , O
D NNP O
. . O

C NNP O
. . O
, , O
and CC O
Madison NNP O
, , O
R NNP O
. . O

M UH O
. . O

Synergistic JJ O
effects NNS O
of IN O

benzo NNP O
( , O
a DT O
) -RRB- O
pyrene NN O
and CC O
N NN O
- HYPH O
methyl NN O
- HYPH O
N NN O
- HYPH O
nitrosourea NN O
respirators NNS O
carcinogenesis NN O
in IN O
Syrian JJ B-Species
golden JJ I-Species
hamsters NNS I-Species
. . O

In IN O
: : O
Proceedings NNS O
of IN O
the DT O
Sym NNP O

344 CD O
YANYSHEVA NNP O
ET NNP O
AL NNP O
. . O

posium NN O
on IN O
Epithelial NNP O
Respiratory NNP O
Carcinogenesis NNP O
and CC O
Bioassays NNP O
. . O

Batelle NNP O
Seattle NNP O
Research NNP O
Center NNP O
, , O
Seattle NNP O
, , O
WA NNP O
, , O
1974 CD O
, , O
p NN O
. . O

17 CD O
. . O

4 LS O
. . O

Montesano NNP O
, , O
R NNP O
. . O
, , O
Saffiotti NNP O
, , O
U NNP O
, , O
Ferrero NNP O
, , O
A NNP O
, , O
and CC O
Kaufman NNP O
, , O
D NNP O
. . O

Synergistic JJ O

effects NNS O
of IN O
benzo NN O
( : O
a DT O
) -RRB- O
pyrene NN O
and CC O
diethylnitrosamine NN O
on IN O
respiratory JJ O
carcinogenesis NN O
in IN O
hamsters NNS O
. . O

J NNP O
. . O

Natl NNP O
. . O

Cancer NN O
. . O

Inst RB O
. . O

5 CD O
: : O
1395 CD O
- SYM O
1397 CD O
( SYM O
1974 CD O
) -RRB- O
. . O

5 LS O
. . O

Pfeiffer NNP O
, , O
E UH O
. . O

H NN O
. . O

Investigations NNS O
of IN O
the DT O
carcinogenic JJ O
burden NN O
by IN O
air NN O

pollution NN O
in IN O
man NN B-Species
. . O

VII NNP O
. . O

Studies NNS O
on IN O
the DT O
ontogenetic JJ O
interaction NN O
of IN O
polycyclic JJ O
aromatic JJ O
hydrocarbons NNS O
. . O

Zbl NNP O
. . O

Bakteriol NNP O
. . O

Parasitenk NNP O
. . O

Infektion NN O
. . O

Hyg UH O
. . O

Abt NNP O
. . O

B NNP O
158 CD O
( SYM O
1 CD O
) SYM O
: : O
69 CD O
- HYPH O
83 CD O
( SYM O
1973 CD O
) -RRB- O
. . O

6 LS O
. . O

Slaga NNP O
, , O
T NNP O
. . O

J NNP O
. . O
, , O
Jecker NNP O
, , O
L NNP O
. . O
, , O
Bracken NNP O
, , O
W NNP O
. . O

M UH O
. . O
, , O
and CC O
Weeks NNPS O
, , O
C NNP O
. . O

E UH O
. . O

The DT O
effects NNS O
of IN O

weak JJ O
or CC O
non JJ O
- HYPH O
carcinogenic JJ O
polycyclic JJ O
hydrocarbons NNS O
on IN O
7 CD O
, , O
12 CD O
- HYPH O
dimethylbenz NN O
( : O
a DT O
) -RRB- O
anthracene NN O
and CC O
benzo NN O
( , O
a DT O
) -RRB- O
pyrene NN O
skin NN O
tumor NN O
- HYPH O
initiation NN O
. . O

Cancer NNP O
Lett NNP O
. . O

7 CD O
: : O
51 CD O
- SYM O
59 CD O
( SYM O
1979 CD O
) -RRB- O
. . O

7 LS O
. . O

Topping VBG O
, , O
D NNP O
. . O

C UH O
. . O
, , O
Martin NNP O
, , O
D NNP O
. . O

H UH O
. . O
, , O
and CC O
Nettesheim NNP O
, , O
P NN O
. . O

Determination NN O
of IN O

cocarcinogenic JJ O
activity NN O
of IN O
benzo NN O
( : O
a DT O
) NFP O
pyrene NN O
for IN O
respiratory JJ O
tract NN O
mucosa NN O
. . O

Cancer NNP O
Lett NNP O
. . O

11 CD O
: : O
315 CD O
- HYPH O
321 CD O
( SYM O
1981 CD O
) -RRB- O
. . O

8 LS O
. . O

Ilnitsky NNP O
, , O
A NNP O
. . O

P UH O
. . O
, , O
Voronin NNP O
, , O
V NN O
. . O

M NNP O
. . O
, , O
and CC O
Solenova NNP O
, , O
M NNP O
. . O

G NNP O
. . O

Carcinogenic JJ O
effect NN O

of IN O
benzo FW O
( , O
a DT O
) -RRB- O
pyrene NN O
and CC O
its PRP$ O
combinations NNS O
with IN O
other JJ O
carbohydrates NNS O
at IN O
their PRP$ O
oral JJ O
intake NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Voprosy NNP O
Onkol NNP O
. . O

10 CD O
: : O
71 CD O
- HYPH O
75 CD O
( SYM O
1974 CD O
) -RRB- O
. . O

9 LS O
. . O

Kurljandsky NNP O
, , O
B NNP O
. . O

A UH O
. . O
, , O
Medvedovsky NNP O
, , O
A NNP O
. . O

G NNP O
. . O
, , O
and CC O
Mashbits NNP O
, , O
F NNP O
. . O

D NNP O
. . O

On IN O

cocarcinogenic JJ O
effect NN O
of IN O
toxic JJ O
factors NNS O
of IN O
low JJ O
intensity NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Gig UH O
. . O

Sanit NNP O
. . O

10 CD O
: : O
83 CD O
- HYPH O
85 CD O
( SYM O
1972 CD O
) -RRB- O
. . O

10 CD O
. . O

Thrusov NNP O
, , O
V NN O
. . O

S NNP O
. . O
, , O
and CC O
Andrianov NNP O
, , O
L NNP O
. . O

A DT O
. . O

On IN O
combined VBN O
effect NN O
on IN O
the DT O
skin NN O
of IN O

single JJ O
application NN O
of IN O
7 CD O
, , O
12 CD O
- HYPH O
dimethylbenz NN O
( : O
a DT O
) -RRB- O
anthracene NN O
and CC O
repeated VBN O
applications NNS O
of IN O
benz NN O
( , O
a DT O
) -RRB- O
pyrene NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Bull NNP O
. . O

Eksper NNP O
. . O

Biol NNP O
. . O

Med NNP O
. . O

3 CD O
: : O
80 CD O
- SYM O
83 CD O
( SYM O
1972 CD O
) -RRB- O
. . O

11 CD O
. . O

Yanysheva NNP O
, , O
N NNP O
. . O

Ya UH O
. . O
, , O
Chernichenko NNP O
, , O
I PRP O
. . O

A UH O
. . O
, , O
Balenko NNP O
, , O
N NNP O
. . O

V NN O
, , O
and CC O
Kireeva NNP O
, , O

I PRP O
. . O

S UH O
. . O

Carcinogenic JJ O
substances NNS O
and CC O
their PRP$ O
hygienic JJ O
standardization NN O
in IN O
the DT O
environment NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Zdorovja NNP O
, , O
Kiev NNP O
, , O
1977 CD O
. . O

12 CD O
. . O

Laskin NNP O
, , O
S NNP O
. . O
, , O
Kushner NNP O
, , O
M NNP O
. . O
, , O
and CC O
Drew NNP O
, , O
R NNP O
. . O

T NNP O
. . O

Studies NNS O
in IN O
pulmonary JJ O

careinogenesis NN O
. . O

In IN O
: : O
Inhalation NNP O
Carcinogenesis NNP O
( , O
M NNP O
. . O
G NNP O
. . O
Hanna NNP O
, , O
P NN O
. . O
Nettesheim NNP O
, , O
and CC O
J NNP O
. . O
R NN O
. . O
Gillbert NNP O
, , O
Eds NNP O
. . O
) -RRB- O
U NN O
. . O
S NN O
. . O

Atomic NNP O
Energy NNP O
Commission NNP O
Symposium NNP O
, , O
Series NN O
18 CD O
, , O
1970 CD O
, , O
p NN O
. . O

321 CD O
. . O

13 CD O
. . O

Laskin NNP O
, , O
S NNP O
. . O
, , O
Kuschner NNP O
, , O
M NNP O
. . O
, , O
and CC O
Drew NNP O
, , O
R NNP O
. . O

T NNP O
. . O

Inhalation NN O
exposure NN O
to IN O

sulphur NN O
dioxide NN O
and CC O
benzo NN O
( : O
a DT O
) -RRB- O
pyrene NN O
. . O

Oak NNP O
Ridge NNP O
National NNP O
Laboratory NNP O
, , O
Gatlinburg NNP O
, , O
TN NNP O
, , O
1970 CD O
, , O
pp NN O
. . O

322 CD O
- HYPH O
351 CD O
. . O

14 CD O
. . O

Kuschner NNP O
, , O
M NNP O
. . O
, , O
and CC O
Laskin NNP O
, , O
S NNP O
. . O

Experimental JJ O
models NNS O
in IN O
environmental JJ O

carcinogenesis NN O
. . O

Am UH O
. . O

J NNP O
. . O

Pathol NNP O
. . O

1 CD O
: : O
183 CD O
- HYPH O
196 CD O
( SYM O
1971 CD O
) -RRB- O
. . O

15 CD O
. . O

Komine NNP O
, , O
T NNP O
. . O

Influences NNS O
of IN O
sulfur NN O
dioxide NN O
and CC O
3 CD O
, , O
4 CD O
- HYPH O
benzpyrene NN O
on IN O
the DT O

respiratory JJ O
organ NN O
of IN O
rats NNS B-Species
. . O

Hokkaido NNP O
Igaku NNP O
Zasshi NNP O
3 CD O
: : O
189 CD O
- SYM O
203 CD O
( SYM O
1977 CD O
) -RRB- O
. . O

16 CD O
. . O

Skvortsova NNP O
, , O
N NNP O
. . O

N NNP O
. . O

Role NN O
of IN O
some DT O
common JJ O
atmospheric JJ O
pollutions NNS O
in IN O

lung NN O
blastomogenesis NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

In IN O
: : O
Handbook NNP O
of IN O
Hygiene NN O
of IN O
Atmospheric NNP O
Air NNP O
( , O
K NNP O
. . O
A NNP O
. . O
Bushtueva NNP O
, , O
Ed NNP O
. . O
) -RRB- O
, , O
Meditsina NNP O
, , O
Moscow NNP O
, , O
1976 CD O
, , O
pp NN O
. . O

384 CD O
- HYPH O
391 CD O
. . O

17 CD O
. . O

Yanysheva NNP O
, , O
N NNP O
. . O

Ya UH O
. . O
, , O
Balenko NNP O
, , O
N NNP O
. . O

V NN O
, , O
Chernichenko NNP O
, , O
I PRP O
. . O

A DT O
, , O
and CC O
Babiy NNP O
, , O
V NN O
. . O

F NNP O
. . O

Quantitation NN O
of IN O
modified VBN O
effects NNS O
of IN O
nitrogen NN O
oxides NNS O
on IN O
carcinogenicity NN O
of IN O
benz NN O
( , O
a DT O
) -RRB- O
pyrene NN O
effect NN O
[ -LRB- O
in IN O
Rusian NNP O
] -RRB- O
. . O

Gig UH O
. . O

Sanit NNP O
. . O

7 CD O
: : O
7 CD O
- SYM O
9 CD O
( SYM O
1986 CD O
) -RRB- O
. . O

18 CD O
. . O

Yanysheva NNP O
, , O
N NNP O
. . O

Ya UH O
. . O
, , O
Balenko NNP O
, , O
N NNP O
. . O

V NN O
. . O
, , O
Chernichenko NNP O
, , O
I PRP O
. . O

A DT O
. . O
, , O
Babiy NNP O
, , O
V NNP O
. . O

F NNP O
. . O
, , O

Bakanova NNP O
, , O
G NNP O
. . O

N UH O
. . O
, , O
and CC O
Lemeshko NNP O
, , O
L NNP O
. . O

P NN O
. . O

Peculiarities NNS O
of IN O
manifestation NN O
of IN O
carcinogenesis NN O
at IN O
combined VBN O
effect NN O
of IN O
benz NN O
( , O
a DT O
) -RRB- O
pyrene NN O
and CC O
phenol NN O
depending VBG O
on IN O
regimen NN O
of IN O
intake NN O
into IN O
the DT O
organism NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Gig UH O
. . O

Sanit NNP O
. . O

4 CD O
: : O
29 CD O
- HYPH O
33 CD O
( SYM O
1988 CD O
) -RRB- O
. . O

19 CD O
. . O

Van NNP O
Duuren NNP O
, , O
B NNP O
. . O

L NNP O
. . O
, , O
Katz NNP O
, , O
C NNP O
. . O
, , O
and CC O
Goldschmidt NNP O
, , O
B NNP O
. . O

M UH O
. . O

Brief JJ O
communica NN O

tion NN O
: : O
cocarcinogenic JJ O
agents NNS O
in IN O
tobacco NN B-Species
carcinogenesis NN O
. . O

J NNP O
. . O

Natl NNP O
. . O

Cancer NNP O
Inst NNP O
. . O

51 CD O
: : O
703 CD O
- HYPH O
705 CD O
( SYM O
1973 CD O
) -RRB- O
. . O

20 CD O
. . O

Van NNP O
Duuren NNP O
, , O
B NNP O
. . O

L NNP O
. . O
, , O
and CC O
Goldschmidt NNP O
, , O
B NNP O
. . O

M UH O
. . O

Cocarcinogenic JJ O
and CC O

tumor NN O
- HYPH O
promoting VBG O
agents NNS O
in IN O
tobacco NN B-Species
carcinogenesis NN O
. . O

J NNP O
. . O

Natl NNP O
. . O

Cancer NNP O
Inst NNP O
. . O

56 CD O
: : O
1237 CD O
- HYPH O
1242 CD O
( SYM O
1976 CD O
) -RRB- O
. . O

21 CD O
. . O

Wattenberg NNP O
, , O
L NNP O
. . O

W UH O
. . O
, , O
Coccia NNP O
, , O
J NNP O
. . O

B NNP O
. . O
, , O
and CC O
Lam NNP O
, , O
L NNP O
. . O

K UH O
. . O

Inhibitory JJ O
effects NNS O
of IN O

phenolic JJ O
compounds NNS O
on IN O
benzo NN O
( , O
a DT O
) NFP O
pyrene NN O
- HYPH O
induced VBN O
neoplasia NN O
. . O

Cancer NNP O
Res NNP O
. . O

8 CD O
: : O
2820 CD O
- SYM O
2823 CD O
( SYM O
1980 CD O
) -RRB- O
. . O

22 CD O
. . O

Bogovski NNP O
, , O
P NN O
. . O

A DT O
, , O
and CC O
Mirme NNP O
, , O
H NNP O
. . O

Yu NNP O
. . O

Cocarcinogenicity NN O
of IN O
phenols NNS O
from IN O

Estonian JJ O
shale NN O
tars NNS O
( , O
oils NNS O
) -RRB- O
. . O

Environ NNP O
. . O

Health NNP O
Perspect NNP O
. . O

30 CD O
: : O
177 CD O
- HYPH O
178 CD O
( SYM O
1979 CD O
) -RRB- O
. . O

23 CD O
. . O

Gubergritz NNP O
, , O
M NNP O
. . O

Ya NNP O
. . O
, , O
and CC O
Kirso NNP O
, , O
U NN O
. . O

E UH O
. . O

Carcinogenic JJ O
properties NNS O
, , O
struc NN O

ture NN O
and CC O
reactive JJ O
capacity NN O
of IN O
phenols NNS O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Voprosy NNP O
Onkol NNP O
. . O

8 CD O
: : O
96 CD O
- SYM O
100 CD O
( SYM O
1970 CD O
) -RRB- O
. . O

24 CD O
. . O

Mirme NNP O
, , O
H NNP O
. . O

Yu NNP O
. . O

Modifying VBG O
effect NN O
of IN O
water NN O
- HYPH O
soluble JJ O
shale NN O
phenols NNS O
upon IN O

carcinogenesis NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

In IN O
: : O
Problems NNS O
of IN O
Prevention NNP O
of IN O
Pollution NN O
of IN O
Environment NN O
by IN O
Carcinogenic NNP O
Substances NNPS O
( , O
M NNP O
. . O
M NNP O
. . O
Shabad NNP O
, , O
Ed NNP O
. . O
) -RRB- O
, , O
Tallinn NNP O
, , O
Valgus NNP O
, , O
1972 CD O
, , O
pp NN O
. . O

16 CD O
- SYM O
18 CD O
. . O

25 CD O
. . O

Kirso NNP O
, , O
U NN O
. . O

E UH O
. . O
, , O
Pashin NNP O
, , O
Yu NNP O
. . O

V NN O
. . O
, , O
Bakhitova NNP O
, , O
L NNP O
. . O

M NNP O
. . O
, , O
and CC O
Kjung NNP O
, , O
A NNP O
. . O

I PRP O
. . O

Effect NN O

of IN O
antioxidants NNS O
on IN O
carcinogenic JJ O
and CC O
mutagenic JJ O
activity NN O
of IN O
benzo NN O
( : O
a DT O
) -RRB- O
pyrene NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Voprosy NNP O
Onkol NNP O
. . O

4 CD O
: : O
70 CD O
- SYM O
75 CD O
( SYM O
1985 CD O
) -RRB- O
. . O

26 CD O
. . O

Veldre NNP O
, , O
I PRP O
. . O

A DT O
. . O

Comparative JJ O
assessment NN O
of IN O
toxic JJ O
effect NN O
of IN O
some DT O
water NN O

soluble JJ O
phenols NNS O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

In IN O
: : O
Proceedings NNS O
of IN O
the DT O
Scientific JJ O
Conference NN O
on IN O
Urgent JJ O
Problems NNS O
Related VBN O
with IN O
Decrease NN O
of IN O
Infectious JJ O
Diseases NNS O
Morbidity NN O
and CC O
with IN O
Hygienic JJ O
Problems NNS O
. . O

Tallinn NNP O
, , O
1968 CD O
, , O
pp NN O
. . O

200 CD O
- SYM O
202 CD O
. . O

27 CD O
. . O

Substances NNS O
possessing VBG O
cocarcinogenic JJ O
effect NN O
. . O

In IN O
: : O
Carcinogenic JJ O
Sub NNP O

stances NNS O
in IN O
the DT O
Environment NNP O
of IN O
Man NNP B-Species
( , O
L NNP O
. . O
M NNP O
. . O
Shabad NNP O
and CC O
A NNP O
. . O
P NN O
. . O
Ilnitsky NNP O
, , O
Eds NNP O
. . O
) -RRB- O
, , O
Budapest NNP O
, , O
1979 CD O
, , O
pp NN O
. . O

111 CD O
- SYM O
113 CD O
. . O

28 CD O
. . O

Djatlovitskaya NNP O
, , O
F NNP O
. . O

G NNP O
. . O
, , O
and CC O
Maktas NNP O
, , O
E NNP O
. . O

D NNP O
. . O

Separate JJ O
determination NN O
of IN O
fly NN O

phenols NNS O
in IN O
water NN O
using VBG O
thin JJ O
- HYPH O
layer NN O
chromatography NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Gig UH O
. . O

Sanit NNP O
. . O

6 CD O
: : O
60 CD O
- SYM O
63 CD O
( SYM O
1965 CD O
) -RRB- O
. . O

29 CD O
. . O

Kostovetsky NNP O
, , O
Ya NNP O
. . O

I PRP O
. . O
, , O
and CC O
Zholdakova NNP O
, , O
Z NNP O
. . O

I PRP O
. . O

About IN O
hygienic JJ O
rate NN O
setting NN O

of IN O
phenol NN O
in IN O
the DT O
water NN O
of IN O
waterpools NNS O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Gig UH O
. . O

Sanit NNP O
. . O

7 CD O
: : O
7 CD O
- SYM O
10 CD O
( SYM O
1971 CD O
) -RRB- O
. . O

30 CD O
. . O

Mostkovoy NNP O
, , O
M NNP O
. . O

I PRP O
. . O

Practicum NN O
on IN O
variational JJ O
- HYPH O
statistical JJ O
processing NN O
of IN O

clinical JJ O
material NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Ashkhabad NNP O
, , O
1954 CD O
, , O
p NN O
. . O

132 CD O
. . O

31 CD O
. . O

Weinstein NNP O
, , O
I PRP O
. . O

B NN O
. . O

The DT O
scientific JJ O
basis NN O
for IN O
carcinogen NN O
detection NN O
and CC O

primary JJ O
cancer NN O
prevention NN O
. . O

Cancer NN O
47 CD O
: : O
1133 CD O
- HYPH O
1141 CD O
( SYM O
1981 CD O
) -RRB- O
. . O

32 CD O
. . O

Merkulov NNP O
, , O
A NNP O
. . O

I PRP O
, , O
and CC O
Skvortsova NNP O
, , O
R NNP O
. . O

I PRP O
. . O

About IN O
toxic JJ O
effect NN O
of IN O
phenol NN O
[ -LRB- O
in IN O

Russian JJ O
] -RRB- O
. . O

Gig UH O
. . O

Sanit NNP O
. . O

1 CD O
: : O
79 CD O
- SYM O
80 CD O
( SYM O
1984 CD O
) -RRB- O
. . O

33 CD O
. . O

Weinstein NNP O
, , O
I PRP O
. . O

B NNP O
. . O
, , O
Mufson NNP O
, , O
R NN O
. . O

A UH O
. . O
, , O
Lee NNP O
, , O
L NNP O
. . O

S UH O
. . O
, , O
et FW O
al NNP O
. . O

Membrane NN O
and CC O
other JJ O

biochemical JJ O
effects NNS O
of IN O
the DT O
phorbol NN O
esters NNS O
and CC O
their PRP$ O
relevance NN O
to IN O
tumor NN O
promotion NN O
. . O

In IN O
: : O
Carcinogenesis NNP O
. . O

Fundamental NNP O
Mechanisms NNPS O
and CC O
Environmental NNP O
Effects NNPS O
. . O

London NNP O
, , O
1980 CD O
, , O
pp NN O
. . O

543 CD O
- HYPH O
563 CD O
. . O

34 CD O
. . O

Yamasaki NNP O
, , O
H NNP O
. . O
, , O
and CC O
Weinstein NNP O
, , O
I PRP O
. . O

B NN O
. . O

Cellular JJ O
and CC O
molecular JJ O
mecha NN O

nisms NNS O
of IN O
tumor NN O
promotion NN O
and CC O
their PRP$ O
implications NNS O
for IN O
risk NN O
assessment NN O
. . O

In IN O
: : O
Methods NNS O
for IN O
Estimating VBG O
Risk NN O
of IN O
Chemical JJ O
Injury NN O
: : O
Human JJ B-Species
and CC O
Non NNP O
- HYPH O
human JJ B-Species
Biota NN O
and CC O
Ecosystems NNPS O
( , O
V NN O
. . O
B NN O
. . O
Vouk NNP O
, , O
G NNP O
. . O
C NN O
. . O
Butler NNP O
, , O
D NNP O
. . O
G NNP O
. . O
Hoel NNP O
, , O
and CC O
D NNP O
. . O
B NNP O
. . O
Peakall NNP O
, , O
Eds NNP O
. . O
) -RRB- O
, , O
SCOPE NNP O
, , O
1985 CD O
, , O
pp NN O
. . O

155 CD O
- SYM O
180 CD O
. . O

35 CD O
. . O

Karu NNP O
, , O
T NNP O
, , O
Kirso NNP O
, , O
U NN O
. . O

E NNP O
. . O
, , O
and CC O
Andrianov NNP O
, , O
L NNP O
. . O

A DT O
. . O

Dynamics NNS O
of IN O
resorption NN O
of IN O

3 CD O
, , O
4 CD O
- HYPH O
benzpyrene NN O
with IN O
phenols NNS O
from IN O
mouse NN B-Species
skin NN O
[ -LRB- O
in IN O
Russian NNP O
] -RRB- O
. . O

Voprosy NNP O
Onkol NNP O
. . O

5 CD O
: : O
80 CD O
- SYM O
84 CD O
( SYM O
1973 CD O
) -RRB- O
. . O

36 CD O
. . O

Yanysheva NNP O
, , O
N NNP O
. . O

Ya UH O
. . O
, , O
Yurkovskaya NNP O
, , O
T NNP O
. . O

N UH O
. . O
, , O
Beregovskaya NNP O
, , O
N NNP O
. . O

N UH O
. . O
, , O
et FW O
al NNP O
. . O

Metalloenzymic JJ O
complexes NNS O
of IN O
energetic JJ O
and CC O
detoxicating JJ O
systems NNS O
of IN O
cell NN O
during IN O
benz NN O
( , O
a DT O
) -RRB- O
pyrene NN O
- HYPH O
induced VBN O
carcinogenesis NN O
. . O

In IN O
: : O
Proceedings NNP O
of IN O
the DT O
4th JJ O
National NNP O
Congress NNP O
of IN O
Oncology NNP O
with IN O
International NNP O
Participation NNP O
. . O

Sofia NNP O
, , O
1985 CD O
, , O
p NN O
. . O

102 CD O
. . O

37 CD O
. . O

Mizell NNP O
, , O
M NNP O
. . O

Anuran NNP O
( , O
Lucke NNP O
) , O
tumor NN O
breakdown NN O
in IN O
regenerating VBG O
anuran NN O

tadpole NN O
tails NNS O
. . O

Anat NNP O
. . O

Res NNS O
. . O

137 CD O
: : O
382 CD O
- HYPH O
383 CD O
( SYM O
1960 CD O
) -RRB- O
. . O

38 CD O
. . O

Sheremetieva NNP O
, , O
E UH O
. . O

N NNP O
. . O

Spontaneous JJ O
melanoma NN O
in IN O
regenerating VBG O
tails NNS O
of IN O

axolotis NN O
. . O

J NNP O
. . O

Exp UH O
. . O

Zool NN O
. . O

158 CD O
: : O
101 CD O
- HYPH O
122 CD O
( SYM O
1965 CD O
) -RRB- O
. . O

39 CD O
. . O

Tsonis NNP O
, , O
P NN O
. . O

A DT O
, , O
and CC O
Eguchi NNP O
, , O
G NNP O
. . O

Carcinogens NNS O
on IN O
regeneration NN O
. . O

Effects NNS O
on IN O

N NN O
- HYPH O
methyl NN O
- HYPH O
N NN O
- HYPH O
nitro NN O
- HYPH O
N NN O
- HYPH O
nitrosoguanidine NN O
and CC O
4 CD O
- HYPH O
nitrogninoline NN O
- HYPH O
1 CD O
- HYPH O
oxide NN O
on IN O
limb NN O
regeneration NN O
in IN O
adult NN O
newts NNS O
. . O

Differentiation NN O
20 CD O
: : O
52 CD O
- HYPH O
60 CD O
( SYM O
1981 CD O
) -RRB- O
. . O

B NN O
lymphocyte NN O
stimulator NN O
( -LRB- O
BLyS NNP O
) -RRB- O
isoforms NNS O
in IN O
systemic JJ O
lupus NN O
erythematosus NN O
: : O
disease NN O
activity NN O
correlates VBZ O
better RBR O
with IN O
blood NN O
leukocyte NN O
BLyS NNP O
mRNA NNP O
levels NNS O
than IN O
with IN O
plasma NN O
BLyS NNP O
protein NN O
levels NNS O

Abstract JJ O

Considerable JJ O
evidence NN O
points VBZ O
to IN O
a DT O
role NN O
for IN O
B NN O
lymphocyte NN O
stimulator NN O
( -LRB- O
BLyS NNP O
) -RRB- O
overproduction NN O
in IN O
murine NN B-Species
and CC O
human JJ B-Species
systemic JJ O
lupus NN O
erythematosus NN O
( -LRB- O
SLE NNP O
) -RRB- O
. . O

Nevertheless RB O
, , O
the DT O
correlation NN O
between IN O
circulating VBG O
levels NNS O
of IN O
BLyS NNP O
protein NN O
and CC O
disease NN O
activity NN O
in IN O
human JJ B-Species
SLE NNP O
is VBZ O
modest JJ O
at RB O
best RBS O
. . O

This DT O
may MD O
be VB O
due IN O
to IN O
an DT O
inadequacy NN O
of IN O
the DT O
former JJ O
to TO O
reflect VB O
endogenous JJ O
BLyS NNP O
overproduction NN O
faithfully RB O
, , O
in IN O
that IN O
steady JJ O
- HYPH O
state NN O
protein NN O
levels NNS O
are VBP O
affected VBN O
not RB O
just RB O
by IN O
production NN O
rates NNS O
but CC O
also RB O
by IN O
rates NNS O
of IN O
peripheral JJ O
utilization NN O
and CC O
excretion NN O
. . O

Increased JJ O
levels NNS O
of IN O
BLyS NNP O
mRNA NNP O
may MD O
better RBR O
reflect VB O
increased VBN O
in IN O
vivo NN O
BLyS NNP O
production NN O
, , O
and CC O
therefore RB O
they PRP O
may MD O
correlate VB O
better RBR O
with IN O
biologic JJ O
and CC O
clinical JJ O
sequelae NN O
of IN O
BLyS NNP O
overexpression NN O
than IN O
do VBP O
circulating VBG O
levels NNS O
of IN O
BLyS NNP O
protein NN O
. . O

Accordingly RB O
, , O
we PRP O
assessed VBD O
peripheral JJ O
blood NN O
leukocyte NN O
levels NNS O
of IN O
BLyS NNP O
mRNA NNP O
isoforms NNS O
( , O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
) -RRB- O
and CC O
plasma NN O
BLyS NNP O
protein NN O
levels NNS O
in IN O
patients NNS B-Species
with IN O
SLE NNP O
, , O
and CC O
correlated VBD O
these DT O
levels NNS O
with IN O
laboratory NN O
and CC O
clinical JJ O
features NNS O
. . O

BLyS NNP O
protein NN O
, , O
full JJ O
- HYPH O
length NN O
BLyS NNP O
mRNA NNP O
, , O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
were VBD O
greater JJR O
in IN O
SLE NNP O
patients NNS B-Species
( , O
n CD O
= SYM O
60 CD O
) -RRB- O
than IN O
in IN O
rheumatoid JJ O
arthritis NN O
patients NNS B-Species
( : O
n CD O
= SYM O
60 CD O
) -RRB- O
or CC O
normal JJ O
control NN O
individuals NNS O
( : O
n CD O
= SYM O
30 CD O
) -RRB- O
. . O

Although IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
correlated VBD O
significantly RB O
with IN O
BLyS NNP O
protein NN O
levels NNS O
in IN O
the DT O
SLE NNP O
cohort NN O
, , O
BLyS NNP O
mRNA NNP O
levels NNS O
were VBD O
more RBR O
closely RB O
associated VBN O
with IN O
serum NN O
immunoglobulin NN O
levels NNS O
and CC O
SLE NNP O
Disease NNP O
Activity NNP O
Index NNP O
scores NNS O
than IN O
were VBD O
BLyS NNP O
protein NN O
levels NNS O
. . O

Moreover RB O
, , O
changes NNS O
in IN O
SLE NNP O
Disease NNP O
Activity NNP O
Index NNP O
scores NNS O
were VBD O
more RBR O
closely RB O
associated VBN O
with IN O
changes NNS O
in IN O
BLyS NNP O
mRNA NNP O
levels NNS O
than IN O
with IN O
changes NNS O
in IN O
BLyS NNP O
protein NN O
levels NNS O
among IN O
the DT O
37 CD O
SLE NNP O
patients NNS B-Species
from IN O
whom WP O
repeat NN O
blood NN O
samples NNS O
were VBD O
obtained VBN O
. . O

Thus RB O
, , O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
are VBP O
elevated VBN O
in IN O
SLE NNP O
and CC O
are VBP O
more RBR O
closely RB O
associated VBN O
with IN O
disease NN O
activity NN O
than IN O
are VBP O
BLyS NNP O
protein NN O
levels NNS O
. . O

BLyS NNP O
mRNA NNP O
levels NNS O
may MD O
be VB O
a DT O
helpful JJ O
biomarker NN O
in IN O
the DT O
clinical JJ O
monitoring NN O
of IN O
SLE NNP O
patients NNS B-Species
. . O

Introduction NN O

B NN O
lymphocyte NN O
stimulator NN O
( , O
BLyS NNP O
; : O
a DT O
trademark NN O
of IN O
Human NNP B-Species
Genome NNP O
Sciences NNPS O
, , O
Inc NNP O
. . O
, , O
Rockville NNP O
, , O
MD NNP O
, , O
USA NNP O
) -RRB- O
is VBZ O
a DT O
285 CD O
- HYPH O
amino NN O
- HYPH O
acid NN O
member NN O
of IN O
the DT O
tumor NN O
necrosis NN O
factor NN O
ligand NN O
superfamily NN O
[ -LRB- O
1 CD O
- HYPH O
3 CD O
] -RRB- O
. . O

A DT O
causal JJ O
relation NN O
between IN O
constitutive JJ O
overproduction NN O
of IN O
BLyS NNS O
and CC O
development NN O
of IN O
systemic JJ O
lupus NN O
erythematosus NN O
( , O
SLE NNP O
) -RRB- O
- HYPH O
like JJ O
illness NN O
has VBZ O
incontrovertibly RB O
been VBN O
established VBN O
in IN O
mice NNS B-Species
. . O

BLyS NNP O
- HYPH O
transgenic JJ O
mice NNS B-Species
often RB O
develop VBP O
SLE NN O
- HYPH O
like JJ O
features NNS O
as IN O
they PRP O
age VBP O
[ -LRB- O
3 CD O
- HYPH O
5 CD O
] -RRB- O
, , O
and CC O
SLE NNP O
- HYPH O
prone JJ O
( , O
NZB NNP O
x NNP O
NZW NNP O
) -RRB- O
F1 NNP O
( -LRB- O
BWF1 NNP O
) -RRB- O
and CC O
MRL NN O
- HYPH O
lpr NNP O
/ SYM O
lpr NN O
mice NN B-Species
respond VBP O
clinically RB O
to IN O
treatment NN O
with IN O
BLyS NNP O
antagonists NNS O
( , O
decreased VBN O
disease NN O
progression NN O
and CC O
improved JJ O
survival NN O
) -RRB- O
[ -LRB- O
3 CD O
, , O
6 CD O
] -RRB- O
. . O

Considerable JJ O
inferential JJ O
evidence NN O
points VBZ O
to IN O
a DT O
role NN O
for IN O
BLyS NNP O
overproduction NN O
in IN O
human JJ B-Species
SLE NN O
as RB O
well RB O
. . O

Cross JJ O
- HYPH O
sectional JJ O
studies NNS O
have VBP O
demonstrated VBN O
elevated VBN O
circulating VBG O
levels NNS O
of IN O
BLyS NNP O
in IN O
20 CD O
- SYM O
30 CD O
% NN O
of IN O
human JJ B-Species
SLE NNP O
patients NNS B-Species
tested VBN O
at IN O
a DT O
single JJ O
point NN O
in IN O
time NN O
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
. . O

Moreover RB O
, , O
a DT O
12 CD O
- HYPH O
month NN O
longitudinal JJ O
study NN O
documented VBD O
persistently RB O
elevated VBN O
serum NN O
BLyS NNP O
levels NNS O
in IN O
about RB O
25 CD O
% NN O
of IN O
SLE NNP O
patients NNS B-Species
and CC O
intermittently RB O
elevated VBN O
serum NN O
BLyS NNP O
levels NNS O
in IN O
an DT O
additional JJ O
25 CD O
% NN O
of IN O
patients NNS B-Species
[ -LRB- O
9 CD O
] -RRB- O
. . O

Remarkably RB O
, , O
circulating VBG O
BLyS NNP O
levels NNS O
did VBD O
not RB O
correlate VB O
with IN O
disease NN O
activity NN O
( , O
measured VBN O
using VBG O
the DT O
SLE NNP O
Disease NNP O
Activity NNP O
Index NNP O
[ -LRB- O
SLEDAI NNP O
] -RRB- O
) -RRB- O
in IN O
these DT O
cross JJ O
- HYPH O
sectional JJ O
or CC O
longitudinal JJ O
studies NNS O
[ -LRB- O
7 CD O
- SYM O
9 CD O
] -RRB- O
. . O

Although IN O
a DT O
statistically RB O
significant JJ O
correlation NN O
between IN O
circulating VBG O
BLyS NNP O
levels NNS O
and CC O
SLEDAI NNP O
has VBZ O
been VBN O
appreciated VBN O
in IN O
a DT O
more RBR O
recent JJ O
24 CD O
- HYPH O
month NN O
longitudinal JJ O
study NN O
of IN O
245 CD O
SLE NNP O
patients NNS B-Species
( , O
with IN O
> SYM O
1 CD O
, , O
700 CD O
plasma NN O
samples NNS O
analyzed VBN O
) -RRB- O
[ -LRB- O
10 CD O
] -RRB- O
, , O
the DT O
correlation NN O
remains VBZ O
weak JJ O
. . O

The DT O
limited VBN O
correlation NN O
between IN O
circulating VBG O
BLyS NNP O
protein NN O
levels NNS O
and CC O
disease NN O
activity NN O
in IN O
these DT O
studies NNS O
may MD O
have VB O
exposed VBN O
an DT O
inadequacy NN O
of IN O
the DT O
former JJ O
to TO O
reflect VB O
faithfully RB O
endogenous JJ O
BLyS NNP O
overproduction NN O
. . O

In IN O
addition NN O
to IN O
the DT O
rate NN O
of IN O
BLyS NNP O
protein NN O
production NN O
, , O
several JJ O
other JJ O
factors NNS O
( , O
for IN O
example NN O
, , O
utilization NN O
and CC O
excretion NN O
) , O
can MD O
affect VB O
circulating VBG O
BLyS NNP O
protein NN O
levels NNS O
. . O

Although IN O
there EX O
are VBP O
no DT O
practicable JJ O
means NNS O
of IN O
directly RB O
measuring VBG O
in IN O
vivo NN O
BLyS NNP O
production NN O
per IN O
se FW O
in IN O
humans NNS B-Species
, , O
the DT O
level NN O
of IN O
BLyS NNP O
mRNA NNP O
may MD O
serve VB O
as IN O
a DT O
better JJR O
surrogate NN O
marker NN O
of IN O
in IN O
vivo NN O
BLyS NNP O
production NN O
than IN O
does VBZ O
the DT O
level NN O
of IN O
BLyS NNP O
protein NN O
. . O

Candidate NN O
BLyS NNP O
mRNA NNP O
isoforms NNS O
include VBP O
the DT O
full JJ O
- HYPH O
length NN O
BLyS NNP O
mRNA NN O
isoform NN O
, , O
which WDT O
encodes VBZ O
the DT O
full JJ O
- HYPH O
length NN O
protein NN O
, , O
and CC O
the DT O
alternatively RB O
spliced VBN O
Delta NNP O
BLyS NNP O
mRNA NNP O
isoform NN O
, , O
which WDT O
encodes VBZ O
a DT O
protein NN O
with IN O
a DT O
small JJ O
peptide NN O
deletion NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

( : O
Delta NNP O
BLyS NNP O
does VBZ O
not RB O
bind VB O
to IN O
cells NNS O
expressing VBG O
BLyS NNP O
receptors NNS O
, , O
and CC O
therefore RB O
it PRP O
has VBZ O
no DT O
agonistic JJ O
activity NN O
. , O
Moreover RB O
, , O
Delta NNP O
BLyS NNP O
can MD O
form VB O
heterotrimers NNS O
with IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
, , O
thereby RB O
actually RB O
functioning VBG O
as IN O
a DT O
dominant JJ O
- HYPH O
negative JJ O
antagonist NN O
of IN O
BLyS NNP O
activity NN O
. . O
) -RRB- O

In IN O
this DT O
report NN O
we PRP O
demonstrate VBP O
that IN O
peripheral JJ O
blood NN O
leukocytes NNS O
from IN O
SLE NNP O
patients NNS B-Species
express VBP O
elevated VBN O
mRNA NNP O
levels NNS O
of IN O
both DT O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
relative JJ O
to IN O
those DT O
levels NNS O
expressed VBN O
by IN O
patients NNS B-Species
with IN O
rheumatoid JJ O
arthritis NN O
( , O
RA NN O
) -RRB- O
or CC O
by IN O
normal JJ O
control NN O
individuals NNS O
. . O

In IN O
the DT O
SLE NNP O
patients NNS B-Species
, , O
both CC O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
are VBP O
more RBR O
closely RB O
associated VBN O
with IN O
disease NN O
activity NN O
( -LRB- O
SLEDAI NNP O
) -RRB- O
than IN O
are VBP O
BLyS NNP O
protein NN O
levels NNS O
. . O

Accordingly RB O
, , O
BLyS NNP O
mRNA NNP O
levels NNS O
may MD O
be VB O
a DT O
helpful JJ O
biomarker NN O
in IN O
the DT O
clinical JJ O
monitoring NN O
of IN O
SLE NNP O
patients NNS B-Species
. . O

Materials NNS O
and CC O
methods NNS O

General JJ O
details NNS O

This DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
institutional JJ O
review NN O
boards NNS O
of IN O
the DT O
University NNP O
of IN O
Southern NNP O
California NNP O
and CC O
the DT O
Scripps NNP O
Research NNP O
Institute NNP O
. . O

All DT O
participants NNS B-Species
gave VBD O
their PRP$ O
written VBN O
informed VBN O
consent NN O
before IN O
participation NN O
in IN O
this DT O
study NN O
. . O

Participants NNS B-Species

Patients NNS B-Species
receiving VBG O
outpatient JJ O
medical JJ O
care NN O
at IN O
the DT O
rheumatology NN O
clinics NNS O
of IN O
the DT O
Los NNP O
Angeles NNP O
County NNP O
+ SYM O
University NNP O
of IN O
Southern NNP O
California NNP O
Medical NNP O
Center NNP O
were VBD O
recruited VBN O
into IN O
the DT O
study NN O
. . O

Diagnoses NNS O
of IN O
SLE NNP O
( , O
n CD O
= SYM O
60 CD O
) -RRB- O
or CC O
RA NN O
( , O
n CD O
= SYM O
60 CD O
) -RRB- O
were VBD O
based VBN O
on IN O
established VBN O
clinical JJ O
criteria NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Healthy JJ O
control NN O
individuals NNS O
( , O
n CD O
= SYM O
30 CD O
) -RRB- O
were VBD O
recruited VBN O
from IN O
Los NNP O
Angeles NNP O
County NNP O
+ SYM O
University NNP O
of IN O
Southern NNP O
California NNP O
Medical NNP O
Center NNP O
and CC O
University NNP O
of IN O
Southern NNP O
California NNP O
Keck NNP O
School NNP O
of IN O
Medicine NNP O
personnel NNS O
. . O

No DT O
exclusions NNS O
were VBD O
made VBN O
on IN O
any DT O
basis NN O
other JJ O
than IN O
an DT O
inability NN O
to TO O
give VB O
informed JJ O
consent NN O
. . O

Each DT O
patient NN B-Species
' POS O
s POS O
sex NN O
, , O
race NN O
, , O
age NN O
, , O
and CC O
medications NNS O
at IN O
the DT O
time NN O
of IN O
the DT O
phlebotomy NN O
were VBD O
recorded VBN O
( , O
Table NNP O
1 CD O
) -RRB- O
. . O

Based VBN O
solely RB O
on IN O
the DT O
patient NN B-Species
' '' O
s POS O
willingness NN O
to TO O
donate VB O
a DT O
second JJ O
blood NN O
sample NN O
, , O
repeat NN O
blood NN O
samples NNS O
were VBD O
collected VBN O
from IN O
37 CD O
of IN O
the DT O
SLE NNP O
patients NNS B-Species
147 CD O
- SYM O
511 CD O
days NNS O
( : O
median JJ O
371 CD O
days NNS O
) -RRB- O
after IN O
collection NN O
of IN O
the DT O
first JJ O
samples NNS O
. . O

These DT O
patients NNS B-Species
were VBD O
not RB O
selected VBN O
on IN O
the DT O
basis NN O
of IN O
any DT O
demographic JJ O
, , O
clinical JJ O
, , O
or CC O
laboratory JJ O
feature NN O
. . O

Clinical JJ O
disease NN O
activity NN O
for IN O
the DT O
SLE NNP O
patients NNS B-Species
was VBD O
assessed VBN O
using VBG O
the DT O
SLEDAI NNP O
[ -LRB- O
13 CD O
] -RRB- O
and CC O
using VBG O
a DT O
modified VBN O
SLEDAI NNP O
that WDT O
excludes VBZ O
the DT O
contribution NN O
of IN O
anti JJ O
- HYPH O
double JJ O
- HYPH O
stranded VBN O
DNA NNP O
( , O
anti JJ O
- HYPH O
dsDNA NNP O
) -RRB- O
antibodies NNS O
from IN O
the DT O
total JJ O
score NN O
. . O

Each DT O
patient NN B-Species
' POS O
s POS O
medical JJ O
chart NN O
was VBD O
reviewed VBN O
for IN O
results NNS O
of IN O
standard JJ O
clinical JJ O
laboratory NN O
tests NNS O
within IN O
the DT O
previous JJ O
or CC O
subsequent JJ O
1 CD O
- HYPH O
month NN O
period NN O
. . O

Plasma NN O
BLyS NNP O
determination NN O

Whole JJ O
venous JJ O
blood NN O
was VBD O
centrifuged VBN O
to TO O
yield VB O
plasma NN O
and CC O
a DT O
buffy JJ O
coat NN O
. . O

The DT O
plasma NN O
was VBD O
harvested VBN O
, , O
stored VBN O
at IN O
- SYM O
70 CD O
degrees NNS O
C NN O
, , O
and CC O
assayed VBN O
for IN O
BLyS NNP O
levels NNS O
by IN O
ELISA NNP O
[ -LRB- O
8 CD O
, , O
14 CD O
] -RRB- O
using VBG O
Fab JJ O
fragments NNS O
of IN O
the DT O
capture NN O
antibody NN O
rather RB O
than IN O
the DT O
whole JJ O
antibody NN O
to TO O
reduce VB O
assay JJ O
interference NN O
by IN O
rheumatoid JJ O
factor NN O
. . O

The DT O
lower JJR O
limit NN O
of IN O
detection NN O
in IN O
this DT O
assay NN O
is VBZ O
0 CD O
. . O
3 CD O
ng CD O
/ SYM O
ml NN O
. . O

For IN O
statistical JJ O
purposes NNS O
, , O
plasma NN O
samples NNS O
with IN O
BLyS NNP O
concentrations NNS O
below IN O
the DT O
lower JJR O
limit NN O
of IN O
detection NN O
were VBD O
assigned VBN O
a DT O
value NN O
of IN O
0 CD O
. . O
25 CD O
ng CD O
/ SYM O
ml NN O
. . O

Blood NN O
BLyS NNP O
mRNA NNP O
determination NN O

The DT O
buffy JJ O
coat NN O
from IN O
centrifuged JJ O
whole JJ O
blood NN O
was VBD O
harvested VBN O
, , O
added VBN O
to IN O
RNAlater NNP O
( -LRB- O
TM NNP O
) -RRB- O
( , O
Ambion NNP O
, , O
Austin NNP O
, , O
TX NNP O
, , O
USA NNP O
) -RRB- O
at IN O
a DT O
1 CD O
: SYM O
4 CD O
vol NN O
/ SYM O
vol NN O
ratio NN O
for IN O
RNA NNP O
stabilization NN O
, , O
stored VBN O
at IN O
- SYM O
70 CD O
degrees NNS O
C NN O
, , O
and CC O
assayed VBN O
for IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
by IN O
real JJ O
- HYPH O
time NN O
PCR NNP O
. . O

Total JJ O
RNA NNP O
was VBD O
purified VBN O
from IN O
buffy JJ O
coat NN O
samples NNS O
using VBG O
RNAeasy NNP O
miniprep NN O
kits NNS O
( , O
Qiagen NNP O
, , O
Valencia NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
, , O
and CC O
contaminating VBG O
genomic JJ O
DNA NNP O
was VBD O
removed VBN O
by IN O
DNAse NNP O
- HYPH O
I NNP O
digestion NN O
. . O

One CD O
- HYPH O
tenth NN O
volume NN O
of IN O
total JJ O
RNA NNP O
was VBD O
used VBN O
as IN O
template NN O
in IN O
the DT O
first JJ O
- HYPH O
strand NN O
cDNA NN O
reaction NN O
using VBG O
oligo NN O
- HYPH O
dT NN O
and CC O
the DT O
Superscript NNP O
III NNP O
first JJ O
- HYPH O
strand NN O
synthesis NN O
system NN O
( , O
Invitrogen NNP O
, , O
Carlsbad NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Duplicate NN O
samples NNS O
of IN O
cDNA NNP O
were VBD O
amplified VBN O
with IN O
primers NNS O
against IN O
beta NN O
- HYPH O
actin NN O
, , O
full JJ O
- HYPH O
length NN O
BLyS NNP O
, , O
or CC O
Delta NNP O
BLyS NNP O
: : O
beta NN O
- HYPH O
actin NN O
sense NN O
5 CD O
' '' O
- : O
CGAGAAGATGACCCAGATCA NNP O
- HYPH O
3 CD O
' '' O
; : O
beta NN O
- HYPH O
actin JJ O
anti JJ O
- HYPH O
sense NN O
5 CD O
' '' O
- HYPH O
GGCATACCCCTCGTAGATGG NNP O
- HYPH O
3 CD O
' '' O
; : O
full JJ O
- HYPH O
length NN O
BLyS NN O
sense NN O
5 CD O
' '' O
- : O
GCAGACAGTGAAACACCAAC NNP O
- HYPH O
3 CD O
' '' O
; : O
Delta NNP O
BLyS NNP O
sense NN O
5 CD O
' '' O
- : O
CAGAAGAAACAGGATCTTAC NN O
- HYPH O
3 CD O
' '' O
; : O
and CC O
full JJ O
- HYPH O
length NN O
BLyS NNP O
/ SYM O
Delta NNP O
BLyS NNP O
anti JJ O
- HYPH O
sense NN O
5 CD O
' '' O
- HYPH O
TGCCAGCTGAATAGCAGGAA NNP O
- HYPH O
3 CD O
' '' O
. . O

A DT O
165 CD O
bp NN O
amplicon NN O
for IN O
beta NN O
- HYPH O
actin NN O
was VBD O
PCR NN O
- HYPH O
amplified VBN O
using VBG O
the DT O
7900 CD O
HT NNP O
ABI NNP O
Prism NNP O
machine NN O
( : O
Qiagen NNP O
) -RRB- O
with IN O
annealing VBG O
at IN O
65 CD O
degrees NNS O
C NN O
. . O

A DT O
296 CD O
bp IN O
amplicon NN O
for IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
was VBD O
PCR NN O
- HYPH O
amplified VBN O
, , O
with IN O
annealing VBG O
at IN O
64 CD O
degrees NNS O
C NN O
. . O

A DT O
270 CD O
bp IN O
amplicon NN O
for IN O
Delta NNP O
BLyS NNP O
was VBD O
PCR NN O
- HYPH O
amplified VBN O
with IN O
annealing VBG O
at IN O
61 CD O
degrees NNS O
C NN O
. . O

The DT O
annealing VBG O
conditions NNS O
for IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
were VBD O
determined VBN O
so IN O
that IN O
each DT O
primer NN O
set NN O
remained VBD O
specific JJ O
to IN O
the DT O
respective JJ O
BLyS NNP O
isoform NN O
and CC O
yielded VBD O
a DT O
PCR NN O
efficiency NN O
similar JJ O
to IN O
those DT O
of IN O
cloned VBN O
cDNA NNP O
standards NNS O
. . O

Melting VBG O
curve NN O
analysis NN O
revealed VBD O
a DT O
single JJ O
peak NN O
for IN O
each DT O
gene NN O
amplified VBN O
. . O

The DT O
threshold NN O
cycle NN O
( -LRB- O
Ct NNP O
) -RRB- O
values NNS O
for IN O
each DT O
reaction NN O
were VBD O
determined VBN O
using VBG O
Sequence NNP O
Detection NNP O
System NNP O
software NN O
( , O
Applied NNP O
Biosystems NNP O
, , O
Foster NNP O
City NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Results NNS O
are VBP O
presented VBN O
as IN O
ratios NNS O
of IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
or CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
to IN O
beta NN O
- HYPH O
actin NN O
mRNA NNP O
, , O
which WDT O
were VBD O
calculated VBN O
using VBG O
the DT O
following VBG O
formulae NN O
: : O

2 CD O
exp NN O
( : O
Ct NN O
beta NN O
- HYPH O
actin NN O
- HYPH O
Ctfull NNP O
- HYPH O
length NN O
BLyS NNP O
) -RRB- O

2 CD O
exp NN O
( : O
Ct NN O
beta NN O
- HYPH O
actin NN O
- : O
Ct NNP O
Delta NNP O
BLyS NNP O
) -RRB- O

Determination NN O
of IN O
anti JJ O
- HYPH O
BLyS NN O
autoantibodies NNS O

BLyS NNP O
was VBD O
bound VBN O
to IN O
microtiter NN O
plates NNS O
by IN O
first RB O
coating VBG O
the DT O
plates NNS O
with IN O
streptavidin NN O
and CC O
then RB O
adding VBG O
biotinylated JJ O
recombinant JJ O
BLyS NNP O
. . O

Using VBG O
these DT O
plates NNS O
as IN O
the DT O
capture NN O
reagent NN O
, , O
plasma NN O
samples NNS O
were VBD O
incubated VBN O
, , O
and CC O
horseradish JJ B-Species
peroxidase NN O
- HYPH O
conjugated VBN O
anti JJ O
- HYPH O
human JJ B-Species
IgA NNP O
/ SYM O
IgM NNP O
/ SYM O
IgG NNP O
( , O
Southern NNP O
Biotechnology NNP O
Associates NNPS O
, , O
Birmingham NNP O
, , O
AL NNP O
, , O
USA NNP O
; : O
1 CD O
: : O
20 CD O
, , O
0 CD O
final JJ O
dilution NN O
) -RRB- O
or CC O
horseradish JJ B-Species
peroxidase NN O
- HYPH O
conjugated VBN O
anti JJ O
- HYPH O
human JJ B-Species
IgG NN O
( , O
Southern NNP O
Biotechnology NNP O
; : O
1 CD O
: : O
10 CD O
, , O
0 CD O
final JJ O
dilution NN O
) -RRB- O
were VBD O
used VBN O
as IN O
the DT O
detector NN O
reagents NNS O
. . O

Statistical JJ O
analysis NN O

All DT O
analyses NNS O
were VBD O
performed VBN O
using VBG O
SigmaStat NNP O
software NN O
( : O
SPSS NNP O
, , O
Chicago NNP O
, , O
IL NNP O
, , O
USA NNP O
) -RRB- O
. . O

Results NNS O
that WDT O
did VBD O
not RB O
follow VB O
a DT O
normal JJ O
distribution NN O
were VBD O
log NN O
- HYPH O
transformed VBN O
to TO O
achieve VB O
normality NN O
. . O

Parametric JJ O
testing NN O
between IN O
two CD O
matched VBN O
or CC O
unmatched JJ O
groups NNS O
was VBD O
performed VBN O
using VBG O
the DT O
paired JJ O
or CC O
unpaired JJ O
t NN O
test NN O
, , O
respectively RB O
. . O

Parametric JJ O
testing NN O
among IN O
three CD O
or CC O
more JJR O
groups NNS O
was VBD O
performed VBN O
using VBG O
one CD O
- HYPH O
way NN O
analysis NN O
of IN O
variance NN O
. . O

When WRB O
log NN O
- HYPH O
transformation NN O
failed VBD O
to TO O
generate VB O
normally RB O
distributed VBN O
data NNS O
or CC O
the DT O
equal JJ O
variance NN O
test NN O
was VBD O
not RB O
satisfied VBN O
, , O
nonparametric JJ O
testing NN O
was VBD O
performed VBN O
using VBG O
the DT O
Mann NNP O
- HYPH O
Whitney NNP O
rank NN O
sum NN O
test NN O
between IN O
two CD O
groups NNS O
and CC O
by IN O
Kruskal NNP O
- HYPH O
Wallis NNP O
one CD O
- HYPH O
way NN O
analysis NN O
of IN O
variance NN O
on IN O
ranks NNS O
among IN O
three CD O
or CC O
more JJR O
groups NNS O
. . O

Correlations NNS O
were VBD O
determined VBN O
using VBG O
Pearson NNP O
product NN O
moment NN O
correlation NN O
for IN O
interval JJ O
data NNS O
and CC O
using VBG O
Spearman NNP O
rank NN O
order NN O
correlation NN O
for IN O
ordinal JJ O
data NNS O
or CC O
for IN O
interval JJ O
data NNS O
that WDT O
did VBD O
not RB O
follow VB O
a DT O
normal JJ O
distribution NN O
. . O

Nominal JJ O
data NNS O
were VBD O
analyzed VBN O
using VBG O
chi NN O
2 CD O
analysis NN O
- HYPH O
of IN O
- HYPH O
contingency NN O
tables NNS O
. . O

Results NNS O

Elevated JJ O
plasma NN O
BLyS NNP O
levels NNS O
and CC O
blood NN O
levels NNS O
of IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
isoforms NNS O
in IN O
systemic JJ O
lupus NN O
erythematosus NN O
patients NNS B-Species

Previous JJ O
reports NNS O
of IN O
elevated VBN O
circulating VBG O
BLyS NNP O
levels NNS O
in IN O
SLE NNP O
patients NNS B-Species
were VBD O
based VBN O
on IN O
a DT O
BLyS NNP O
ELISA NNP O
that WDT O
utilized VBD O
a DT O
whole JJ O
( HYPH O
unfragmented JJ O
) NFP O
capture NN O
anti JJ O
- HYPH O
BLyS NN O
monoclonal JJ O
antibody NN O
[ -LRB- O
7 CD O
- SYM O
9 CD O
] -RRB- O
. . O

Since IN O
the DT O
publication NN O
of IN O
these DT O
reports NNS O
, , O
it PRP O
has VBZ O
been VBN O
recognized VBN O
that IN O
the DT O
presence NN O
of IN O
rheumatoid JJ O
factor NN O
can MD O
potentially RB O
interfere VB O
with IN O
the DT O
assay NN O
and CC O
lead VB O
to IN O
spurious JJ O
overestimation NN O
of IN O
the DT O
true JJ O
circulating VBG O
BLyS NNP O
levels NNS O
( , O
Human NNP B-Species
Genome NNP O
Sciences NNPS O
, , O
Inc NNP O
. . O
; : O
unpublished JJ O
observations NNS O
) -RRB- O
. . O

To TO O
mitigate VB O
potential JJ O
interference NN O
from IN O
rheumatoid JJ O
factor NN O
, , O
the DT O
BLyS NNP O
ELISA NNP O
has VBZ O
been VBN O
modified VBN O
and CC O
the DT O
capture JJ O
anti JJ O
- HYPH O
BLyS NN O
monoclonal JJ O
antibody NN O
is VBZ O
now RB O
utilized VBN O
as IN O
a DT O
Fab NNP O
fragment NN O
. . O

Despite IN O
the DT O
changes NNS O
in IN O
the DT O
ELISA NNP O
format NN O
, , O
our PRP$ O
findings NNS O
are VBP O
entirely RB O
consistent JJ O
with IN O
those DT O
of IN O
the DT O
previous JJ O
reports NNS O
. . O

Plasma NNP O
BLyS NNP O
levels NNS O
were VBD O
significantly RB O
greater JJR O
in IN O
the DT O
SLE NNP O
group NN O
than IN O
in IN O
either CC O
RA NNP O
or CC O
normal JJ O
control NN O
group NN O
( : O
P NN O
< SYM O
0 CD O
. . O
1 CD O
; : O
Figure NNP O
1a CD O
) -RRB- O
. . O

Arbitrary JJ O
assignment NN O
of IN O
the DT O
95th JJ O
percentile NN O
value NN O
among IN O
the DT O
normal JJ O
control NN O
individuals NNS O
as IN O
the DT O
upper JJ O
limit NN O
of IN O
' `` O
normal JJ O
' '' O
revealed VBD O
that IN O
two CD O
of IN O
the DT O
30 CD O
normal JJ O
control NN O
individuals NNS O
, , O
15 CD O
of IN O
the DT O
60 CD O
RA NN O
patients NNS B-Species
, , O
and CC O
29 CD O
of IN O
the DT O
60 CD O
SLE NNP O
patients NNS B-Species
harbored VBD O
elevated VBN O
plasma NN O
BLyS NNP O
levels NNS O
( : O
P NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Overexpression NN O
of IN O
BLyS NNP O
in IN O
SLE NNP O
patients NNS B-Species
was VBD O
also RB O
established VBN O
by IN O
measuring VBG O
BLyS NNP O
mRNA NNP O
levels NNS O
normalized VBN O
to IN O
beta NN O
- HYPH O
actin NN O
mRNA NN O
levels NNS O
in IN O
peripheral JJ O
blood NN O
leukocytes NNS O
( , O
buffy JJ O
coats NNS O
) -RRB- O
. . O

The DT O
geometric JJ O
mean JJ O
full JJ O
- HYPH O
length NN O
BLyS NNP O
mRNA NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
among IN O
the DT O
SLE NNP O
patients NNS B-Species
were VBD O
each DT O
significantly RB O
greater JJR O
than IN O
those DT O
among IN O
the DT O
RA NN O
patients NNS B-Species
and CC O
normal JJ O
control NN O
individuals NNS O
, , O
respectively RB O
( : O
P NN O
< SYM O
0 CD O
. . O
1 CD O
for IN O
each DT O
; : O
Figure NN O
1b CD O
, , O
c NN O
) -RRB- O
. . O

Arbitrary JJ O
assignment NN O
of IN O
the DT O
95th JJ O
percentile NN O
values NNS O
for IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
among IN O
the DT O
normal JJ O
control NN O
individuals NNS O
as IN O
the DT O
upper JJ O
limits NNS O
of IN O
' `` O
normal JJ O
' '' O
revealed VBD O
that IN O
two CD O
of IN O
the DT O
30 CD O
normal JJ O
control NN O
individuals NNS O
, , O
four CD O
of IN O
the DT O
60 CD O
RA NN O
patients NNS B-Species
, , O
and CC O
20 CD O
of IN O
the DT O
60 CD O
SLE NNP O
patients NNS B-Species
had VBD O
elevated VBN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
mRNA NNP O
levels NNS O
( -LRB- O
P NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
, , O
and CC O
that IN O
two CD O
of IN O
the DT O
30 CD O
normal JJ O
control NN O
individuals NNS O
, , O
three CD O
of IN O
the DT O
60 CD O
RA NN O
patients NNS B-Species
, , O
and CC O
19 CD O
of IN O
the DT O
60 CD O
SLE NNP O
patients NNS B-Species
had VBD O
elevated VBN O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
( : O
P NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Levels NNS O
of IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
strongly RB O
correlated VBN O
with IN O
each DT O
other JJ O
( , O
r NN O
= SYM O
0 CD O
. . O
703 CD O
; : O
P NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
in IN O
the DT O
SLE NNP O
cohort NN O
, , O
and CC O
plasma NN O
BLyS NNP O
levels NNS O
also RB O
correlated VBD O
significantly RB O
with IN O
levels NNS O
of IN O
each DT O
BLyS NNP O
isoform NN O
( , O
r NN O
= SYM O
0 CD O
. . O
429 CD O
, , O
P NN O
< NN O
0 CD O
. . O
1 CD O
; : O
and CC O
r NN O
= SYM O
0 CD O
. . O
290 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
24 CD O
, , O
respectively RB O
) -RRB- O
. . O

Among IN O
these DT O
SLE NNP O
patients NNS B-Species
, , O
none NN O
of IN O
the DT O
measured VBN O
BLyS NNP O
parameters NNS O
correlated VBN O
with IN O
patient JJ B-Species
age NN O
, , O
sex NN O
, , O
race NN O
, , O
or CC O
daily JJ O
dose NN O
of IN O
corticosteroids NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Because IN O
the DT O
racial JJ O
composition NN O
of IN O
the DT O
normal JJ O
cohort NN O
was VBD O
not RB O
as RB O
predominantly RB O
Hispanic JJ O
as IN O
were VBD O
those DT O
of IN O
the DT O
RA NNP O
and CC O
SLE NNP O
cohorts NNS O
, , O
we PRP O
assessed VBD O
the DT O
BLyS NNP O
parameters NNS O
in IN O
the DT O
respective JJ O
Hispanic JJ O
subpopulations NNS O
. . O

As IN O
for IN O
the DT O
entire JJ O
populations NNS O
, , O
values NNS O
for IN O
SLE NNP O
were VBD O
significantly RB O
greater JJR O
than IN O
those DT O
for IN O
either CC O
RA NNP O
or CC O
normal JJ O
controls NNS O
( : O
P NN O
< SYM O
= SYM O
0 CD O
. . O
4 CD O
; : O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Correlations NNS O
between IN O
BLyS NNP O
parameters NNS O
and CC O
plasma NN O
immunoglobulin NN O
levels NNS O

BLyS NNP O
is VBZ O
a DT O
potent JJ O
B NN O
cell NN O
survival NN O
factor NN O
[ -LRB- O
15 CD O
- HYPH O
21 CD O
] -RRB- O
, , O
and CC O
administration NN O
of IN O
exogenous JJ O
BLyS NNP O
to IN O
mice NNS B-Species
leads VBZ O
to IN O
B NN O
cell NN O
expansion NN O
and CC O
hypergammaglobulinem NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Previous JJ O
studies NNS O
with IN O
numbers NNS O
of IN O
SLE NNP O
patients NNS B-Species
greater JJR O
than IN O
were VBD O
included VBN O
in IN O
the DT O
present JJ O
study NN O
documented VBD O
a DT O
modest JJ O
but CC O
significant JJ O
correlation NN O
between IN O
serum JJ O
levels NNS O
of IN O
BLyS NNP O
and CC O
IgG NNP O
[ -LRB- O
8 CD O
, , O
10 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
SLE NNP O
cohort NN O
of IN O
limited JJ O
size NN O
, , O
plasma NN O
BLyS NNP O
levels NNS O
failed VBD O
to TO O
show VB O
significant JJ O
correlations NNS O
with IN O
plasma NN O
levels NNS O
of IN O
total JJ O
immunoglobulin NN O
, , O
IgG NNP O
, , O
or CC O
IgA NNP O
. . O

In IN O
contrast NN O
, , O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
correlated VBN O
significantly RB O
with IN O
each DT O
( : O
Figure NNP O
2 CD O
) -RRB- O
. . O

( : O
None NN O
of IN O
the DT O
BLyS NNP O
parameters NNS O
correlated VBN O
with IN O
plasma NN O
IgM NNP O
levels NNS O
. , O
) -RRB- O
The DT O
absence NN O
of IN O
significant JJ O
correlation NN O
between IN O
plasma NN O
BLyS NNP O
levels NNS O
and CC O
the DT O
immunoglobulin NN O
parameters NNS O
also RB O
persisted VBD O
when WRB O
just RB O
the DT O
53 CD O
patients NNS B-Species
with IN O
detectable JJ O
plasma NN O
BLyS NNP O
levels NNS O
were VBD O
considered VBN O
( : O
r NFP O
= SYM O
- HYPH O
0 CD O
. . O
133 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
346 CD O
for IN O
total JJ O
immunoglobulin NN O
; : O
r NN O
= SYM O
- HYPH O
0 CD O
. . O
48 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
734 CD O
for IN O
IgG NN O
; : O
and CC O
r NN O
= SYM O
0 CD O
. . O
33 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
817 CD O
for IN O
IgA NNP O
) -RRB- O
. . O

Correlations NNS O
between IN O
BLyS NNP O
parameters NNS O
and CC O
disease NN O
activity NN O

Previous JJ O
studies NNS O
either CC O
have VBP O
failed VBN O
to TO O
demonstrate VB O
a DT O
significant JJ O
correlation NN O
between IN O
disease NN O
activity NN O
and CC O
circulating VBG O
BLyS NNP O
levels NNS O
[ -LRB- O
7 CD O
- SYM O
9 CD O
] -RRB- O
or CC O
have VBP O
detected VBN O
only RB O
a DT O
weak JJ O
correlation NN O
between IN O
the DT O
two CD O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Consonant JJ O
with IN O
those DT O
studies NNS O
, , O
we PRP O
identified VBD O
no DT O
significant JJ O
correlation NN O
between IN O
plasma NN O
BLyS NNP O
levels NNS O
and CC O
SLEDAI NNP O
in IN O
our PRP$ O
cohort NN O
of IN O
60 CD O
SLE NNP O
patients NNS B-Species
( -LRB- O
Figure NNP O
3a CD O
) -RRB- O
. . O

The DT O
failure NN O
to TO O
demonstrate VB O
a DT O
significant JJ O
correlation NN O
cannot MD O
be VB O
attributed VBN O
to IN O
a DT O
skewing NN O
of IN O
the DT O
results NNS O
by IN O
the DT O
patients NNS B-Species
in IN O
whom WP O
plasma NN O
BLyS NNP O
levels NNS O
were VBD O
below IN O
the DT O
limit NN O
of IN O
detection NN O
, , O
because IN O
no DT O
significant JJ O
correlation NN O
was VBD O
detected VBN O
among IN O
the DT O
53 CD O
SLE NN O
patients NNS B-Species
in IN O
whom WP O
plasma NN O
BLyS NNP O
levels NNS O
were VBD O
in IN O
the DT O
detectable JJ O
range NN O
( : O
r NN O
= SYM O
0 CD O
. . O
185 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
183 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
a DT O
significant JJ O
correlation NN O
between IN O
SLEDAI NNP O
and CC O
full JJ O
- HYPH O
length NN O
BLyS NNP O
mRNA NNP O
levels NNS O
was VBD O
readily RB O
discernible JJ O
( -LRB- O
Figure NN O
3b NN O
) -RRB- O
. . O

A DT O
trend NN O
toward IN O
a DT O
correlation NN O
between IN O
SLEDAI NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
was VBD O
also RB O
observed VBN O
, , O
although IN O
it PRP O
did VBD O
not RB O
achieve VB O
statistical JJ O
significance NN O
( : O
Figure NNP O
3c NNP O
) -RRB- O
. . O

A DT O
component NN O
of IN O
the DT O
SLEDAI NNP O
is VBZ O
the DT O
presence NN O
of IN O
circulating VBG O
anti JJ O
- HYPH O
dsDNA NN O
antibodies NNS O
. . O

Because IN O
circulating VBG O
BLyS NNP O
levels NNS O
may MD O
affect VB O
the DT O
presence NN O
and CC O
/ SYM O
or CC O
titers NNS O
of IN O
circulating VBG O
anti JJ O
- HYPH O
dsDNA NN O
antibodies NNS O
[ -LRB- O
7 CD O
- SYM O
10 CD O
] -RRB- O
, , O
we PRP O
assessed VBD O
correlations NNS O
between IN O
the DT O
individual JJ O
BLyS NNP O
parameters NNS O
and CC O
a DT O
modified VBN O
SLEDAI NNP O
that WDT O
excludes VBZ O
any DT O
consideration NN O
of IN O
anti JJ O
- HYPH O
dsDNA NN O
antibodies NNS O
. . O

As IN O
with IN O
the DT O
unmodified JJ O
SLEDAI NNP O
, , O
the DT O
modified VBN O
SLEDAI NNP O
did VBD O
not RB O
correlate VB O
with IN O
plasma NN O
BLyS NNP O
levels NNS O
( -LRB- O
Figure NNP O
3d CD O
) -RRB- O
either CC O
among IN O
the DT O
SLE NNP O
cohort NN O
overall JJ O
or CC O
among IN O
the DT O
53 CD O
patients NNS B-Species
in IN O
whom WP O
plasma NN O
BLyS NNS O
levels NNS O
were VBD O
in IN O
the DT O
detectable JJ O
range NN O
( : O
r NN O
= SYM O
0 CD O
. . O
160 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
252 CD O
) -RRB- O
, , O
but CC O
it PRP O
significantly RB O
correlated VBD O
with IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
mRNA NNP O
levels NNS O
( -LRB- O
Figure NNP O
3e CD O
) -RRB- O
and CC O
exhibited VBD O
a DT O
trend NN O
toward IN O
correlation NN O
with IN O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
( -LRB- O
Figure NNP O
3f CD O
) -RRB- O
. . O

Thus RB O
, , O
the DT O
stronger JJR O
correlations NNS O
between IN O
BLyS NNP O
mRNA NNP O
levels NNS O
and CC O
disease NN O
activity NN O
cannot MD O
solely RB O
be VB O
explained VBN O
by IN O
any DT O
effects NNS O
that WDT O
BLyS NNP O
may MD O
have VB O
on IN O
anti JJ O
- HYPH O
dsDNA NN O
antibodies NNS O
per FW O
se FW O
. . O

Moreover RB O
, , O
among IN O
the DT O
37 CD O
SLE NNP O
patients NNS B-Species
who WP O
were VBD O
evaluated VBN O
on IN O
two CD O
separate JJ O
occasions NNS O
, , O
trends NNS O
toward IN O
correlation NN O
were VBD O
appreciated VBN O
between IN O
changes NNS O
in IN O
the DT O
unmodified JJ O
or CC O
modified VBN O
SLEDAI NN O
and CC O
changes NNS O
in IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
or CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
but CC O
not RB O
changes NNS O
in IN O
plasma NN O
BLyS NNP O
levels NNS O
( -LRB- O
Figure NN O
4 CD O
) -RRB- O
. . O

These DT O
results NNS O
cannot MD O
be VB O
ascribed VBN O
to IN O
changes NNS O
in IN O
medications NNS O
taken VBN O
by IN O
the DT O
patients NNS B-Species
, , O
because IN O
changes NNS O
in IN O
neither CC O
disease NN O
activity NN O
nor CC O
in IN O
any DT O
of IN O
the DT O
BLyS NNP O
parameters NNS O
correlated VBN O
with IN O
changes NNS O
in IN O
the DT O
doses NNS O
of IN O
corticosteroids NNS O
or CC O
cytotoxics NNS O
taken VBN O
by IN O
the DT O
patients NNS B-Species
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

The DT O
failure NN O
to TO O
demonstrate VB O
a DT O
meaningful JJ O
association NN O
between IN O
changes NNS O
in IN O
SLEDAI NNP O
score NN O
and CC O
changes NNS O
in IN O
plasma NN O
BLyS NNP O
protein NN O
levels NNS O
cannot MD O
be VB O
attributed VBN O
to IN O
a DT O
skewing NN O
of IN O
the DT O
results NNS O
by IN O
the DT O
patients NNS B-Species
in IN O
whom WP O
plasma NN O
BLyS NNP O
levels NNS O
were VBD O
below IN O
the DT O
limit NN O
of IN O
detection NN O
, , O
because IN O
the DT O
absence NN O
of IN O
association NN O
between IN O
the DT O
two CD O
persisted VBD O
among IN O
the DT O
27 CD O
SLE NNP O
patients NNS B-Species
in IN O
whom WP O
plasma NN O
BLyS NNP O
levels NNS O
were VBD O
in IN O
the DT O
detectable JJ O
range NN O
in IN O
both DT O
samples NNS O
( , O
r NN O
= SYM O
- HYPH O
0 CD O
. . O
69 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
727 CD O
for IN O
plasma NN O
BLyS NNP O
versus IN O
unmodified JJ O
SLEDAI NNP O
; : O
r CC O
= SYM O
- HYPH O
0 CD O
. . O
20 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
919 CD O
for IN O
plasma NN O
BLyS NNS O
versus IN O
modified VBN O
SLEDAI NNP O
) -RRB- O
. . O

Lack NN O
of IN O
correlation NN O
between IN O
levels NNS O
of IN O
BLyS NNP O
mRNA NNP O
isoforms NNS O
and CC O
percentages NNS O
of IN O
individual JJ O
leukocyte NN O
cell NN O
types NNS O

Among IN O
cells NNS O
in IN O
peripheral JJ O
blood NN O
, , O
BLyS NNP O
is VBZ O
predominantly RB O
expressed VBN O
by IN O
cells NNS O
of IN O
the DT O
myeloid NN O
lineage NN O
( , O
monocytes NNS O
and CC O
neutrophils NNS O
) -RRB- O
[ -LRB- O
1 CD O
, , O
14 CD O
, , O
22 CD O
, , O
23 CD O
] -RRB- O
. . O

Accordingly RB O
, , O
a DT O
shift NN O
in IN O
the DT O
differential JJ O
leukocyte NN O
count NN O
away RB O
from IN O
lymphocytes NNS O
to IN O
monocytes NNS O
and CC O
/ SYM O
or CC O
neutrophils NNS O
could MD O
substantially RB O
alter VB O
BLyS NNP O
mRNA NNP O
results NNS O
. . O

Because IN O
of IN O
the DT O
limited JJ O
amount NN O
of IN O
blood NN O
we PRP O
were VBD O
permitted VBN O
to TO O
obtain VB O
from IN O
the DT O
SLE NNP O
patients NNS B-Species
( , O
consequent JJ O
to IN O
the DT O
high JJ O
prevalence NN O
of IN O
anemia NN O
among IN O
these DT O
patients NNS B-Species
) -RRB- O
, , O
we PRP O
were VBD O
unable JJ O
to TO O
purify VB O
the DT O
individual JJ O
leukocyte NN O
populations NNS O
for IN O
BLyS NNP O
mRNA NNP O
analysis NN O
. . O

Nevertheless RB O
, , O
to TO O
demonstrate VB O
that IN O
the DT O
elevated JJ O
BLyS NNP O
mRNA NNP O
levels NNS O
in IN O
SLE NNP O
did VBD O
not RB O
simply RB O
reflect VB O
a DT O
shift NN O
in IN O
differential JJ O
leukocyte NN O
count NN O
, , O
we PRP O
assessed VBD O
the DT O
correlations NNS O
between IN O
the DT O
individual JJ O
BLyS NNS O
parameters NNS O
on IN O
the DT O
one CD O
hand NN O
and CC O
the DT O
percentages NNS O
of IN O
blood NN O
neutrophils NNS O
, , O
monocytes NNS O
, , O
and CC O
lymphocytes NNS O
on IN O
the DT O
other JJ O
. . O

No DT O
correlations NNS O
were VBD O
appreciated VBN O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Presence NN O
of IN O
anti JJ O
- HYPH O
BLyS NNP O
autoantibodies NNS O
in IN O
patients NNS B-Species
with IN O
systemic JJ O
lupus NN O
erythematosus NN O

The DT O
poorer JJR O
correlation NN O
between IN O
plasma NN O
BLyS NNP O
protein NN O
levels NNS O
and CC O
disease NN O
activity NN O
compared VBN O
with IN O
that DT O
between IN O
BLyS NNP O
mRNA NNP O
levels NNS O
and CC O
disease NN O
activity NN O
was VBD O
striking JJ O
. . O

Patients NNS B-Species
with IN O
SLE NNP O
frequently RB O
develop VBP O
autoantibodies NNS O
against IN O
self NN O
- HYPH O
antigens NNS O
, , O
and CC O
so IN O
some DT O
of IN O
the DT O
SLE NNP O
patients NNS B-Species
might MD O
have VB O
harbored VBN O
autoantibodies NNS O
to IN O
BLyS NNP O
. . O

Such JJ O
autoantibodies NNS O
could MD O
have VB O
complexed VBN O
with IN O
BLyS NNP O
and CC O
enhanced VBN O
its PRP$ O
clearance NN O
, , O
thereby RB O
masking VBG O
BLyS NNP O
overproduction NN O
. . O

Alternatively RB O
, , O
such JJ O
autoantibodies NNS O
might MD O
have VB O
sterically RB O
blocked VBN O
the DT O
epitopes NNS O
recognized VBN O
by IN O
the DT O
detecting VBG O
antibodies NNS O
in IN O
the DT O
in FW O
vitro FW O
ELISA NNP O
. . O

In IN O
this DT O
case NN O
, , O
measured VBN O
BLyS NNP O
levels NNS O
would MD O
have VB O
been VBN O
spuriously RB O
reduced VBN O
, , O
again RB O
masking VBG O
BLyS NNP O
overproduction NN O
. . O

In IN O
our PRP$ O
cohort NN O
, , O
IgA NNP O
/ SYM O
IgM NNP O
/ SYM O
IgG NNP O
anti JJ O
- HYPH O
BLyS NNP O
antibodies NNS O
were VBD O
detected VBN O
in IN O
six CD O
out IN O
of IN O
the DT O
60 CD O
SLE NNP O
patients NNS B-Species
. . O

Such JJ O
autoantibodies NNS O
were VBD O
also RB O
detected VBN O
in IN O
two CD O
out IN O
of IN O
60 CD O
RA NN O
patients NNS B-Species
and CC O
in IN O
one CD O
out IN O
of IN O
30 CD O
normal JJ O
control NN O
individuals NNS O
, , O
demonstrating VBG O
that IN O
anti JJ O
- HYPH O
BLyS NN O
autoantibodies NNS O
are VBP O
not RB O
restricted VBN O
to IN O
SLE NNP O
patients NNS B-Species
. . O

IgG NN O
anti JJ O
- HYPH O
BLyS NNP O
autoantibodies NNS O
were VBD O
detected VBN O
in IN O
3 CD O
SLE NNP O
patients NNS B-Species
but CC O
in IN O
no DT O
RA NN O
patients NNS B-Species
or CC O
normal JJ O
control NN O
individuals NNS O
. . O

Discussion NN O

Elevated VBN O
blood NN O
levels NNS O
of IN O
BLyS NNP O
protein NN O
and CC O
mRNA NN O
are VBP O
well RB O
described VBN O
features NNS O
of IN O
human JJ B-Species
SLE NNP O
[ -LRB- O
7 CD O
- SYM O
9 CD O
] -RRB- O
. . O

We PRP O
confirmed VBD O
these DT O
observations NNS O
in IN O
our PRP$ O
study NN O
and CC O
extended VBD O
them PRP O
by IN O
documenting VBG O
increases NNS O
not RB O
just RB O
in IN O
levels NNS O
of IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
mRNA NNP O
but CC O
also RB O
in IN O
levels NNS O
of IN O
Delta NNP O
BLyS NNP O
mRNA NNP O
( -LRB- O
Figure NNP O
1 CD O
) -RRB- O
. . O

Of IN O
note NN O
, , O
BLyS NNP O
mRNA NNP O
levels NNS O
were VBD O
elevated VBN O
in IN O
SLE NNP O
but CC O
not RB O
in IN O
RA NNP O
, , O
raising VBG O
the DT O
possibility NN O
that IN O
BLyS NNP O
overproduction NN O
in IN O
SLE NNP O
is VBZ O
systemic JJ O
whereas IN O
BLyS NNP O
overproduction NN O
in IN O
RA NNP O
may MD O
be VB O
more RBR O
focused JJ O
to IN O
the DT O
affected VBN O
arthritic JJ O
joints NNS O
[ -LRB- O
24 CD O
] -RRB- O
. . O

The DT O
modestly RB O
elevated VBN O
plasma NN O
BLyS NNP O
protein NN O
levels NNS O
in IN O
RA NNP O
patients NNS B-Species
may MD O
reflect VB O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
release NN O
of IN O
locally RB O
overproduced VBN O
BLyS NNP O
into IN O
the DT O
circulation NN O
. . O

The DT O
relationship NN O
between IN O
circulating VBG O
BLyS NNP O
protein NN O
levels NNS O
and CC O
disease NN O
activity NN O
was VBD O
addressed VBN O
in IN O
several JJ O
previous JJ O
studies NNS O
, , O
but CC O
significant JJ O
correlations NNS O
between IN O
the DT O
two CD O
measures NNS O
did VBD O
not RB O
emerge VB O
[ -LRB- O
7 CD O
- SYM O
9 CD O
] -RRB- O
. . O

In IN O
the DT O
largest JJS O
study NN O
to IN O
date NN O
, , O
a DT O
2 CD O
- HYPH O
year NN O
longitudinal JJ O
study NN O
of IN O
245 CD O
patients NNS B-Species
in IN O
which WDT O
more JJR O
than IN O
1 CD O
, , O
700 CD O
plasma NN O
samples NNS O
were VBD O
analyzed VBN O
, , O
a DT O
significant JJ O
but CC O
weak JJ O
correlation NN O
between IN O
the DT O
two CD O
was VBD O
appreciated VBN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
a DT O
significant JJ O
correlation NN O
between IN O
plasma NN O
BLyS NNP O
protein NN O
levels NNS O
and CC O
disease NN O
activity NN O
was VBD O
again RB O
not RB O
realized VBN O
( : O
Figure NNP O
3a CD O
, , O
d NN O
) -RRB- O
. . O

The DT O
weak JJ O
, , O
at IN O
best JJS O
, , O
correlation NN O
between IN O
circulating VBG O
BLyS NNP O
levels NNS O
and CC O
disease NN O
activity NN O
is VBZ O
seemingly RB O
rather RB O
surprising JJ O
. . O

There EX O
is VBZ O
a DT O
clear RB O
- HYPH O
cut VBN O
association NN O
in IN O
BlyS NNP O
transgenic JJ O
mice NNS B-Species
between IN O
BLyS NNP O
overexpression NN O
and CC O
development NN O
of IN O
SLE NNP O
- HYPH O
like JJ O
features NNS O
[ -LRB- O
3 CD O
- HYPH O
5 CD O
] -RRB- O
, , O
and CC O
treatment NN O
of IN O
SLE NN O
- HYPH O
prone JJ O
mice NNS B-Species
with IN O
BLyS NNP O
antagonists NNS O
retards VBZ O
the DT O
progression NN O
of IN O
disease NN O
and CC O
improves VBZ O
survival NN O
[ -LRB- O
3 CD O
, , O
6 CD O
] -RRB- O
. . O

Moreover RB O
, , O
development NN O
of IN O
precocious JJ O
glomerular JJ O
pathology NN O
in IN O
autoimmune NN O
- HYPH O
prone JJ O
mice NN B-Species
correlates VBZ O
strongly RB O
with IN O
circulating VBG O
BLyS NNP O
levels NNS O
[ -LRB- O
25 CD O
] -RRB- O
. . O

The DT O
likely JJ O
explanation NN O
for IN O
the DT O
weak JJ O
correlation NN O
between IN O
circulating VBG O
BLyS NNP O
levels NNS O
and CC O
disease NN O
activity NN O
in IN O
human JJ B-Species
SLE NNP O
is VBZ O
not RB O
that IN O
disease NN O
activity NN O
in IN O
SLE NNP O
patients NNS B-Species
is VBZ O
insensitive JJ O
to IN O
the DT O
degree NN O
of IN O
BLyS NNP O
overproduction NN O
. . O

Rather RB O
, , O
a DT O
more RBR O
tenable JJ O
explanation NN O
is VBZ O
that IN O
circulating VBG O
BLyS NNP O
levels NNS O
in IN O
human JJ B-Species
SLE NN O
do VBP O
not RB O
always RB O
accurately RB O
reflect VB O
excessive JJ O
endogenous JJ O
BLyS NNP O
production NN O
. . O

We PRP O
can MD O
identify VB O
at IN O
least JJS O
three CD O
nonmutually RB O
exclusive JJ O
mechanisms NNS O
to TO O
explain VB O
a DT O
dissociation NN O
between IN O
the DT O
two CD O
. . O

First RB O
, , O
SLE NNP O
patients NNS B-Species
frequently RB O
develop VBP O
autoantibodies NNS O
to IN O
a DT O
myriad NN O
of IN O
self NN O
- HYPH O
targets NNS O
( , O
for IN O
example NN O
, , O
erythrocytes NNS O
, , O
lymphocytes NNS O
) -RRB- O
. . O

Indeed RB O
, , O
we PRP O
detected VBD O
circulating VBG O
IgA NNP O
/ SYM O
IgM NNP O
/ SYM O
IgG NN O
anti AFX O
- HYPH O
BLyS NN O
autoantibodies NNS O
in IN O
10 CD O
% NN O
( SYM O
6 CD O
/ SYM O
60 CD O
) -RRB- O
of IN O
the DT O
tested VBN O
SLE NNP O
patients NNS B-Species
, , O
and CC O
we PRP O
detected VBD O
circulating VBG O
IgG NN O
anti AFX O
- HYPH O
BLyS NN O
autoantibodies NNS O
in IN O
5 CD O
% NN O
( SYM O
3 CD O
/ SYM O
60 CD O
) -RRB- O
. . O

These DT O
percentages NNS O
may MD O
be VB O
underestimates NNS O
of IN O
the DT O
true JJ O
prevalence NN O
of IN O
anti JJ O
- HYPH O
BLyS NN O
autoantibodies NNS O
, , O
because IN O
some DT O
of IN O
these DT O
autoantibodies NNS O
may MD O
be VB O
saturated VBN O
in IN O
vivo NN O
with IN O
circulating VBG O
BLyS NNP O
, , O
rendering VBG O
them PRP O
incapable JJ O
of IN O
binding VBG O
to IN O
BLyS NNP O
in IN O
the DT O
in FW O
vitro FW O
detection NN O
assay NN O
. . O

We PRP O
do VBP O
not RB O
yet RB O
know VB O
whether IN O
the DT O
anti AFX O
- HYPH O
BLyS NNP O
autoantibodies NNS O
are VBP O
functionally RB O
neutralizing VBG O
but CC O
, , O
regardless RB O
, , O
such JJ O
autoantibodies NNS O
could MD O
enhance VB O
the DT O
clearance NN O
of IN O
BLyS NNS O
and CC O
/ SYM O
or CC O
interfere VB O
with IN O
in FW O
vitro FW O
detection NN O
of IN O
BLyS NNP O
, , O
thereby RB O
masking VBG O
endogenous JJ O
BLyS NNP O
overproduction NN O
. . O

Second RB O
, , O
increased VBN O
urinary JJ O
excretion NN O
of IN O
BLyS NNP O
has VBZ O
been VBN O
reported VBN O
in IN O
SLE NNP O
patients NNS B-Species
, , O
especially RB O
among IN O
those DT O
with IN O
clinically RB O
overt VBN O
renal JJ O
involvement NN O
[ -LRB- O
26 CD O
] -RRB- O
. . O

At IN O
least JJS O
four CD O
of IN O
the DT O
patients NNS B-Species
we PRP O
studied VBD O
manifested VBD O
nephrotic JJ O
- HYPH O
range NN O
proteinuria NN O
( : O
> NFP O
= SYM O
3 CD O
g NN O
/ SYM O
24 CD O
hours NNS O
) -RRB- O
, , O
and CC O
so RB O
urinary JJ O
loss NN O
of IN O
BLyS NNP O
was VBD O
probably RB O
substantial JJ O
in IN O
at IN O
least JJS O
these DT O
patients NNS B-Species
. . O

A DT O
validated JJ O
assay NN O
for IN O
urinary JJ O
BLyS NNP O
detection NN O
has VBZ O
not RB O
yet RB O
been VBN O
developed VBN O
so CC O
we PRP O
were VBD O
unable JJ O
to TO O
quantify VB O
urinary JJ O
BLyS NNP O
levels NNS O
. . O

Once RB O
an DT O
assay NN O
for IN O
urinary JJ O
BLyS NNP O
levels NNS O
is VBZ O
validated VBN O
, , O
we PRP O
should MD O
be VB O
able JJ O
to TO O
assess VB O
the DT O
effect NN O
of IN O
urinary JJ O
BLyS NNP O
excretion NN O
on IN O
circulating VBG O
BLyS NNP O
levels NNS O
. . O

Third RB O
, , O
BLyS NNP O
promotes VBZ O
in IN O
vivo NN O
expansion NN O
of IN O
B NN O
cells NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Freshly RB O
isolated VBN O
SLE NNP O
B NNP O
cells NNS O
, , O
despite IN O
intact JJ O
surface NN O
expression NN O
of IN O
BLyS NNP O
receptors NNS O
, , O
bind VBP O
less RBR O
biotinylated JJ O
BLyS NNS O
ex FW O
vivo NN O
than IN O
do VBP O
freshly RB O
isolated VBN O
normal JJ O
B NN O
cells NNS O
[ -LRB- O
27 CD O
] -RRB- O
. . O

Although IN O
other JJ O
interpretations NNS O
are VBP O
possible JJ O
, , O
the DT O
most RBS O
likely JJ O
explanation NN O
is VBZ O
that IN O
BLyS NNP O
receptors NNS O
on IN O
B NN O
cells NNS O
in IN O
SLE NNP O
patients NNS B-Species
are VBP O
occupied VBN O
in IN O
vivo NN O
by IN O
soluble JJ O
BLyS NNS O
. . O

Accordingly RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
BLyS NNP O
receptors NNS O
expressed VBN O
by IN O
the DT O
expanded VBN O
B NNP O
cell NN O
population NN O
do VBP O
bind VB O
BLyS NNP O
and CC O
remove VB O
it PRP O
from IN O
the DT O
circulation NN O
, , O
resulting VBG O
in IN O
a DT O
homeostatic JJ O
pathway NN O
that WDT O
modulates VBZ O
the DT O
effects NNS O
of IN O
BLyS NNP O
overproduction NN O
on IN O
circulating VBG O
BLyS NNP O
levels NNS O
. . O

Indeed RB O
, , O
circulating VBG O
levels NNS O
of IN O
BLyS NNP O
rise NN O
with IN O
peripheral JJ O
blood NN O
B NN O
cell NN O
depletion NN O
and CC O
fall VBP O
with IN O
re NN O
- HYPH O
emergence NN O
of IN O
peripheral JJ O
blood NN O
B NNP O
cells NNS O
in IN O
rituximab NN O
- HYPH O
treated VBN O
RA NNP O
or CC O
SLE NNP O
patients NNS B-Species
[ -LRB- O
28 CD O
, , O
29 CD O
] -RRB- O
, , O
highlighting VBG O
this DT O
inverse JJ O
relationship NN O
between IN O
circulating VBG O
BLyS NNP O
levels NNS O
and CC O
B NN O
cell NN O
load NN O
. . O

Moreover RB O
, , O
one CD O
of IN O
the DT O
hallmarks NNS O
of IN O
active JJ O
disease NN O
in IN O
human NN B-Species
SLE NNP O
is VBZ O
the DT O
increased VBN O
percentages NNS O
of IN O
activated VBN O
B NN O
cells NNS O
and CC O
plasma NN O
cells NNS O
in IN O
peripheral JJ O
blood NN O
[ -LRB- O
30 CD O
- SYM O
34 CD O
] -RRB- O
, , O
probably RB O
reflecting VBG O
increased VBN O
systemic JJ O
numbers NNS O
of IN O
activated VBN O
B NN O
cells NNS O
and CC O
plasma NN O
cells NNS O
. . O

Although IN O
not RB O
yet RB O
formally RB O
tested VBN O
, , O
differential JJ O
BLyS NNP O
receptor NN O
expression NN O
by IN O
these DT O
cells NNS O
compared VBN O
with IN O
expression NN O
by IN O
nonactivated JJ O
B NN O
cells NNS O
may MD O
result VB O
in IN O
increased VBN O
peripheral JJ O
BLyS NNP O
utilization NN O
, , O
further RB O
dampening VBG O
the DT O
effects NNS O
of IN O
BLyS NNP O
overproduction NN O
on IN O
circulating VBG O
protein NN O
levels NNS O
. . O

To TO O
circumvent VB O
these DT O
confounding VBG O
processes NNS O
, , O
we PRP O
used VBD O
BLyS NNP O
mRNA NNP O
levels NNS O
as IN O
a DT O
surrogate NN O
marker NN O
of IN O
endogenous JJ O
BLyS NNP O
production NN O
. . O

Overall RB O
, , O
the DT O
correlations NNS O
between IN O
disease NN O
activity NN O
and CC O
either CC O
full JJ O
- HYPH O
length NN O
BLyS NNP O
or CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
were VBD O
much RB O
stronger JJR O
than IN O
that DT O
between IN O
disease NN O
activity NN O
and CC O
BLyS NNP O
protein NN O
levels NNS O
( -LRB- O
Figures NNS O
3 CD O
and CC O
4 CD O
) -RRB- O
. . O

This DT O
was VBD O
the DT O
case NN O
regardless RB O
of IN O
whether IN O
we PRP O
used VBD O
the DT O
standard JJ O
SLEDAI NNP O
or CC O
the DT O
modified VBN O
SLEDAI NNP O
as IN O
a DT O
measure NN O
of IN O
disease NN O
activity NN O
. . O

These DT O
correlations NNS O
were VBD O
not RB O
spurious JJ O
ones NNS O
consequent JJ O
to IN O
shifts NNS O
in IN O
percentages NNS O
of IN O
leukocyte NN O
subpopulations NNS O
in IN O
peripheral JJ O
blood NN O
, , O
because IN O
BLyS NNP O
mRNA NNP O
levels NNS O
did VBD O
not RB O
correlate VB O
with IN O
percentages NNS O
of IN O
blood NN O
neutrophils NNS O
, , O
monocytes NNS O
, , O
or CC O
lymphocytes NNS O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

A DT O
similar JJ O
pattern NN O
was VBD O
observed VBN O
between IN O
plasma NN O
immunoglobulin NN O
levels NNS O
and CC O
the DT O
BLyS NNP O
parameters NNS O
, , O
with IN O
plasma NN O
levels NNS O
of IN O
total JJ O
immunoglobulin NN O
, , O
IgG NNP O
, , O
and CC O
IgA NNP O
correlating VBG O
significantly RB O
with IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
but CC O
not RB O
with IN O
plasma NN O
BLyS NNP O
levels NNS O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

These DT O
significant JJ O
correlations NNS O
between IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
or CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
and CC O
plasma NN O
immunoglobulin NN O
levels NNS O
again RB O
highlight VBP O
the DT O
greater JJR O
ability NN O
of IN O
BLyS NNP O
mRNA NNP O
levels NNS O
, , O
compared VBN O
with IN O
plasma NN O
BLyS NNP O
protein NN O
levels NNS O
, , O
to TO O
reflect VB O
ongoing JJ O
BLyS NNP O
overproduction NN O
. . O

At IN O
present NN O
, , O
it PRP O
is VBZ O
not RB O
known VBN O
whether IN O
soluble JJ O
Delta NNP O
BLyS NNP O
protein NN O
is VBZ O
present JJ O
in IN O
the DT O
circulation NN O
of IN O
SLE NNP O
patients NNS B-Species
or CC O
of IN O
normal JJ O
individuals NNS O
. . O

Although IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
protein NN O
is VBZ O
readily RB O
cleaved VBN O
and CC O
released VBN O
from IN O
cells NNS O
transfected VBN O
with IN O
a DT O
vector NN O
containing VBG O
murine NN B-Species
full JJ O
- HYPH O
length NN O
BLyS NNP O
, , O
Delta NNP O
BLyS NNP O
protein NN O
is VBZ O
not RB O
cleaved VBN O
or CC O
released VBN O
from IN O
murine JJ B-Species
Delta NNP O
BLyS NNP O
transfectants NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Given VBN O
the DT O
strong JJ O
similarities NNS O
between IN O
murine NN B-Species
and CC O
human JJ B-Species
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
Delta NNP O
BLyS NNP O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
human JJ B-Species
soluble JJ O
Delta NNP O
BLyS NNP O
protein NN O
is VBZ O
also RB O
not RB O
cleaved VBN O
from IN O
the DT O
cell NN O
surface NN O
and CC O
released VBN O
into IN O
the DT O
circulation NN O
. . O

Moreover RB O
, , O
soluble JJ O
Delta NNP O
BLyS NNP O
protein NN O
is VBZ O
not RB O
released VBN O
from IN O
cells NNS O
transfected VBN O
with IN O
a DT O
vector NN O
containing VBG O
just RB O
the DT O
extracellular JJ O
domain NN O
of IN O
human JJ B-Species
Delta NNP O
BLyS NNP O
( : O
which WDT O
encodes VBZ O
the DT O
soluble JJ O
protein NN O
; : O
A NN O
. . O
L NN O
. . O
Gavin NNP O
, , O
unpublished JJ O
observations NNS O
) -RRB- O
. . O

Whether IN O
this DT O
reflects VBZ O
rapid JJ O
intracellular JJ O
degradation NN O
of IN O
soluble JJ O
Delta NNP O
BLyS NNP O
or CC O
some DT O
other JJ O
impediment NN O
to IN O
its PRP$ O
release NN O
remains VBZ O
unknown JJ O
. . O

Regardless RB O
, , O
if IN O
the DT O
inability NN O
to TO O
release VB O
soluble JJ O
Delta NNP O
BLyS NNP O
in IN O
vitro FW O
faithfully RB O
recapitulates VBZ O
in IN O
vivo NN O
biology NN O
, , O
then RB O
the DT O
stronger JJR O
associations NNS O
between IN O
SLE NNP O
disease NN O
activity NN O
and CC O
full JJ O
- HYPH O
length NN O
BLyS NNP O
or CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
compared VBN O
with IN O
that DT O
between IN O
SLE NNP O
disease NN O
activity NN O
and CC O
BLyS NNP O
protein NN O
levels NNS O
could MD O
not RB O
be VB O
attributable JJ O
to IN O
interference NN O
by IN O
biologically RB O
inactive JJ O
( , O
inhibitory JJ O
) , O
Delta NNP O
BLyS NNP O
protein NN O
in IN O
the DT O
BLyS NNP O
protein NN O
detection NN O
ELISA NNP O
. . O

Importantly RB O
, , O
even RB O
if IN O
soluble JJ O
Delta NNP O
BLyS NNP O
protein NN O
is VBZ O
present JJ O
in IN O
the DT O
circulation NN O
and CC O
is VBZ O
detected VBN O
by IN O
the DT O
BLyS NNP O
protein NN O
detection NN O
ELISA NNP O
, , O
then RB O
the DT O
stronger JJR O
correlations NNS O
between IN O
SLE NNP O
disease NN O
activity NN O
and CC O
full JJ O
- HYPH O
length NN O
BLyS NNP O
or CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
than IN O
that DT O
between IN O
disease NN O
activity NN O
and CC O
total JJ O
BLyS NNP O
( -LRB- O
including VBG O
Delta NNP O
BLyS NNP O
) -RRB- O
protein NN O
levels NNS O
suggest VBP O
that IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
/ SYM O
or CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
may MD O
operationally RB O
serve VB O
as IN O
useful JJ O
biomarkers NNS O
of IN O
disease NN O
activity NN O
in IN O
SLE NNP O
. . O

Although IN O
the DT O
complexity NN O
and CC O
labor NN O
intensiveness NN O
associated VBN O
with IN O
quantitative JJ O
real JJ O
- HYPH O
time NN O
PCR NNP O
may MD O
render VB O
measurement NN O
of IN O
BLyS NNP O
mRNA NNP O
levels NNS O
impracticable JJ O
for IN O
routine JJ O
clinical JJ O
practice NN O
, , O
such JJ O
measurement NN O
could MD O
readily RB O
be VB O
incorporated VBN O
into IN O
clinical JJ O
trials NNS O
and CC O
yield VB O
valuable JJ O
information NN O
. . O

Longitudinal JJ O
observations NNS O
in IN O
large JJ O
numbers NNS O
of IN O
SLE NNP O
patients NNS B-Species
will MD O
be VB O
necessary JJ O
to TO O
establish VB O
or CC O
refute VB O
the DT O
utility NN O
of IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
/ SYM O
or CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
to TO O
subserve VB O
this DT O
clinically RB O
vital JJ O
function NN O
. . O

Although IN O
expression NN O
of IN O
the DT O
two CD O
major JJ O
BLyS NNP O
isoforms NNS O
was VBD O
highly RB O
coordinate JJ O
among IN O
SLE NNP O
patients NNS B-Species
, , O
there EX O
were VBD O
several JJ O
patients NNS B-Species
in IN O
whom WP O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
were VBD O
markedly RB O
greater JJR O
than IN O
or CC O
less JJR O
than IN O
the DT O
expected VBN O
values NNS O
based VBN O
on IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
mRNA NN O
levels NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

This DT O
raises VBZ O
the DT O
possibility NN O
that IN O
dysregulation NN O
of IN O
Delta NNP O
BLyS NNP O
may MD O
contribute VB O
to IN O
overall JJ O
BLyS NNP O
dysregulation NN O
in IN O
at IN O
least JJS O
some DT O
SLE NNP O
patients NNS B-Species
. . O

It PRP O
is VBZ O
known VBN O
that IN O
interferon NN O
- HYPH O
gamma NN O
, , O
interleukin NN O
- HYPH O
10 CD O
, , O
interferon NN O
- HYPH O
alpha NN O
, , O
and CC O
CD154 NN O
can MD O
upregulate VB O
full JJ O
- HYPH O
length NN O
BLyS NNP O
mRNA NNP O
levels NNS O
[ -LRB- O
14 CD O
, , O
22 CD O
, , O
35 CD O
] -RRB- O
, , O
but CC O
it PRP O
is VBZ O
not RB O
known VBN O
what WP O
effects VBZ O
these DT O
or CC O
other JJ O
cytokines NNS O
/ SYM O
cell NN O
- HYPH O
surface NN O
structures NNS O
have VBP O
on IN O
Delta NNP O
BLyS NNP O
expression NN O
. . O

Further JJ O
investigation NN O
of IN O
the DT O
regulation NN O
of IN O
Delta NNP O
BLyS NNP O
and CC O
the DT O
differential JJ O
expression NN O
of IN O
BLyS NNP O
isoforms NNS O
is VBZ O
certainly RB O
warranted VBN O
. . O

Although IN O
the DT O
associations NNS O
between IN O
full JJ O
- HYPH O
length NN O
BLyS NNP O
and CC O
/ SYM O
or CC O
Delta NNP O
BLyS NNP O
mRNA NNP O
levels NNS O
and CC O
disease NN O
activity NN O
in IN O
SLE NNP O
were VBD O
usually RB O
strong JJ O
when WRB O
the DT O
SLE NNP O
cohort NN O
was VBD O
analyzed VBN O
in IN O
aggregate NN O
, , O
there EX O
were VBD O
several JJ O
SLE NNP O
patients NNS B-Species
in IN O
whom WP O
BLyS NNP O
mRNA NNP O
levels NNS O
were VBD O
quite RB O
high JJ O
despite IN O
little JJ O
objective JJ O
ongoing JJ O
disease NN O
activity NN O
, , O
and CC O
there EX O
were VBD O
several JJ O
SLE NNP O
patients NNS B-Species
in IN O
whom WP O
BLyS NNP O
mRNA NNP O
levels NNS O
were VBD O
low JJ O
despite IN O
considerable JJ O
ongoing JJ O
disease NN O
activity NN O
. . O

One PRP O
must MD O
recognize VB O
that IN O
the DT O
bulk NN O
of IN O
the DT O
pathogenic JJ O
autoimmune NN O
responses NNS O
probably RB O
takes VBZ O
place NN O
in IN O
the DT O
spleen NN O
and CC O
lymph NN O
nodes NNS O
, , O
rather RB O
than IN O
in IN O
the DT O
peripheral JJ O
blood NN O
, , O
where WRB O
myeloid NN O
lineage NN O
cells NNS O
( , O
for IN O
example NN O
, , O
dendritic JJ O
cells NNS O
) -RRB- O
produce VBP O
BLyS NNS O
and CC O
support VBP O
B NN O
cell NN O
survival NN O
and CC O
expansion NN O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Local JJ O
BLyS NNP O
production NN O
in IN O
the DT O
secondary JJ O
lymphoid NN O
tissues NNS O
will MD O
be VB O
more RBR O
important JJ O
to IN O
the DT O
development NN O
and CC O
maintenance NN O
of IN O
an DT O
autoimmune JJ O
response NN O
than IN O
will MD O
remote VB O
BLyS NNP O
levels NNS O
in IN O
the DT O
circulation NN O
. . O

Because IN O
at RB O
least RBS O
some DT O
autoreactive JJ O
B NN O
cells NNS O
may MD O
be VB O
more RBR O
sensitive JJ O
to IN O
BLyS NNP O
- HYPH O
mediated VBN O
survival NN O
signals NNS O
than IN O
non JJ O
- HYPH O
autoreactive JJ O
B NN O
cells NNS O
[ -LRB- O
37 CD O
, , O
38 CD O
] -RRB- O
, , O
local JJ O
increases NNS O
in IN O
BLyS NNP O
production NN O
could MD O
preferentially RB O
promote VB O
expansion NN O
of IN O
autoreactive JJ O
B NN O
cells NNS O
. . O

These DT O
cells NNS O
, , O
in IN O
turn NN O
, , O
could MD O
activate VB O
autoreactive JJ O
T NN O
cells NNS O
by IN O
presenting VBG O
autoantigen NN O
to IN O
them PRP O
, , O
and CC O
some DT O
of IN O
the DT O
autoreactive JJ O
B NN O
cells NNS O
would MD O
respond VB O
to IN O
T NN O
cell NN O
derived VBN O
signals NNS O
and CC O
mature VB O
into IN O
( : O
pathogenic JJ O
) , O
autoantibody NN O
secreting VBG O
plasma NN O
cells NNS O
. . O

In IN O
contrast NN O
to IN O
murine NN B-Species
studies NNS O
, , O
in IN O
which WDT O
investigators NNS O
can MD O
readily RB O
harvest VB O
and CC O
analyze VB O
lymphoid NN O
and CC O
myeloid NN O
lineage NN O
cells NNS O
from IN O
any DT O
site NN O
( , O
for IN O
example NN O
, , O
spleen NN O
, , O
bone NN O
marrow NN O
) -RRB- O
, , O
such JJ O
is VBZ O
not RB O
the DT O
case NN O
for IN O
human JJ B-Species
studies NNS O
. . O

Peripheral JJ O
blood NN O
is VBZ O
the DT O
only JJ O
site NN O
readily RB O
accessible JJ O
for IN O
human JJ B-Species
studies NNS O
, , O
and CC O
it PRP O
is VBZ O
possible JJ O
that IN O
, , O
at IN O
least JJS O
in IN O
some DT O
patients NNS B-Species
, , O
BLyS NNP O
mRNA NNP O
levels NNS O
in IN O
circulating VBG O
leukocytes NNS O
do VBP O
not RB O
reflect VB O
local JJ O
BLyS NNP O
production NN O
in IN O
the DT O
secondary JJ O
lymphoid NN O
tissues NNS O
. . O

One PRP O
must MD O
also RB O
recognize VB O
that IN O
disease NN O
activity NN O
in IN O
SLE NNP O
is VBZ O
not RB O
solely RB O
driven VBN O
by IN O
B NNP O
cells NNS O
. . O

Systemic JJ O
inflammation NN O
and CC O
SLE NN O
flares NNS O
can MD O
be VB O
triggered VBN O
via IN O
B NN O
cell NN O
independent JJ O
means NNS O
. . O

Not RB O
all DT O
SLE NNP O
patients NNS B-Species
treated VBN O
with IN O
a DT O
B NN O
cell NN O
depleting VBG O
course NN O
of IN O
rituximab NN O
experience NN O
clinical JJ O
remission NN O
[ -LRB- O
39 CD O
] -RRB- O
, , O
strongly RB O
pointing VBG O
to IN O
the DT O
importance NN O
of IN O
non NN O
- HYPH O
B NN O
cells NNS O
in IN O
disease NN O
pathogenesis NN O
/ SYM O
maintenance NN O
. . O

Conversely RB O
, , O
not RB O
all DT O
pathogenic JJ O
B NN O
cells NNS O
necessarily RB O
require VBP O
high JJ O
levels NNS O
of IN O
BLyS NNS O
to TO O
effect VB O
their PRP$ O
pathogenicity NN O
. . O

Murine NNP O
studies NNS O
have VBP O
unequivocally RB O
documented VBN O
B NNP O
cell NN O
subpopulations NNS O
that WDT O
do VBP O
not RB O
depend VB O
upon IN O
BLyS NNP O
for IN O
their PRP$ O
survival NN O
[ -LRB- O
40 CD O
- SYM O
42 CD O
] -RRB- O
. . O

Although IN O
mice NNS B-Species
completely RB O
devoid JJ O
of IN O
BLyS NNP O
have VBP O
reduced VBN O
numbers NNS O
of IN O
mature JJ O
B NN O
cells NNS O
and CC O
harbor VBP O
reduced VBN O
levels NNS O
of IN O
immunoglobulin NN O
, , O
these DT O
reductions NNS O
are VBP O
incomplete JJ O
. . O

Thus RB O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
some DT O
SLE NNP O
patients NNS B-Species
harbor VBP O
pathogenic JJ O
B NN O
cells NNS O
that WDT O
are VBP O
relatively RB O
insensitive JJ O
to IN O
BLyS NNP O
and CC O
could MD O
drive VB O
considerable JJ O
disease NN O
activity NN O
even RB O
in IN O
the DT O
context NN O
of IN O
low JJ O
endogenous JJ O
BLyS NNP O
production NN O
. . O

Conversely RB O
, , O
patients NNS B-Species
with IN O
high JJ O
BLyS NNP O
mRNA NN O
levels NNS O
may MD O
be VB O
those DT O
patients NNS B-Species
whose WP$ O
disease NN O
is VBZ O
strongly RB O
driven VBN O
by IN O
BLyS NNP O
and CC O
may MD O
be VB O
especially RB O
helped VBN O
by IN O
BLyS NNP O
antagonist NN O
therapy NN O
. . O

Future JJ O
clinical JJ O
trials NNS O
should MD O
be VB O
able JJ O
to TO O
establish VB O
whether IN O
the DT O
BLyS NNP O
mRNA NNP O
levels NNS O
are VBP O
good JJ O
predictors NNS O
of IN O
response NN O
to IN O
such JJ O
agents NNS O
. . O

Conclusion NN O

Plasma NN O
total JJ O
immunoglobulin NN O
, , O
IgG NNP O
, , O
and CC O
IgA NNP O
levels NNS O
and CC O
disease NN O
activity NN O
( , O
as IN O
measured VBN O
by IN O
SLEDAI NNP O
) -RRB- O
in IN O
SLE NNP O
patients NNS B-Species
correlate VBP O
more RBR O
closely RB O
with IN O
peripheral JJ O
blood NN O
leukocyte NN O
levels NNS O
of IN O
BLyS NNP O
mRNA NNP O
than IN O
with IN O
plasma NN O
levels NNS O
of IN O
BLyS NNP O
protein NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
BLyS NNP O
mRNA NNP O
levels NNS O
better RBR O
reflect VBP O
in IN O
vivo NN O
BLyS NNP O
production NN O
than IN O
do VBP O
circulating VBG O
BLyS NNP O
protein NN O
levels NNS O
, , O
and CC O
may MD O
be VB O
a DT O
useful JJ O
biomarker NN O
in IN O
the DT O
clinical JJ O
monitoring NN O
of IN O
SLE NNP O
patients NNS B-Species
. . O

These DT O
findings NNS O
also RB O
support VBP O
the DT O
premise NN O
that IN O
BLyS NNP O
overexpression NN O
not RB O
only RB O
promotes VBZ O
development NN O
of IN O
disease NN O
but CC O
also RB O
actively RB O
contributes VBZ O
to IN O
the DT O
ongoing JJ O
maintenance NN O
of IN O
disease NN O
in IN O
SLE NNP O
patients NNS B-Species
. . O

This DT O
reinforces VBZ O
the DT O
rationale NN O
underlying VBG O
clinical JJ O
trials NNS O
with IN O
BLyS NNP O
antagonists NNS O
in IN O
SLE NNP O
. . O

Abbreviations NNS O

anti JJ O
- HYPH O
dsDNA NNP O
= : O
anti JJ O
- HYPH O
double JJ O
- HYPH O
stranded VBN O
DNA NN O
; : O
BLyS NNP O
= SYM O
B NN O
lymphocyte NN O
stimulator NN O
; : O
bp NN O
= HYPH O
base NN O
pairs NNS O
; : O
Ct NN O
= HYPH O
threshold NN O
cycle NN O
; : O
ELISA NNP O
= HYPH O
enzyme NN O
- HYPH O
linked VBN O
immunosorbent JJ O
assay NN O
; : O
PCR NN O
= : O
polymerase NN O
chain NN O
reaction NN O
; : O
RA NN O
= : O
rheumatoid NN O
arthritis NN O
; : O
SLE NN O
= : O
systemic JJ O
lupus NN O
erythematosus NN O
; : O
SLEDAI NN O
= SYM O
SLE NNP O
Disease NNP O
Activity NNP O
Index NNP O
. . O

Competing VBG O
interests NNS O

TSM NNP O
and CC O
DMH NNP O
were VBD O
employees NNS O
of IN O
Human NNP B-Species
Genome NNP O
Sciences NNPS O
( : O
HGS NNP O
) -RRB- O
at IN O
the DT O
time NN O
the DT O
investigation NN O
was VBD O
conducted VBN O
. . O

( : O
DMH NNP O
has VBZ O
since RB O
left VBN O
the DT O
company NN O
. . O
) -RRB- O
WS NNP O
has VBZ O
received VBN O
research NN O
support NN O
from IN O
HGS NNP O
and CC O
has VBZ O
served VBN O
as IN O
a DT O
consultant NN O
to IN O
HGS NNP O
( : O
< : O
$ $ O
10 CD O
, , O
0 CD O
) -RRB- O
. . O

CEC NNP O
, , O
ALG NNP O
, , O
and CC O
DN NNP O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

CEC NNP O
identified VBD O
and CC O
recruited VBD O
all DT O
participants NNS B-Species
; , O
collected VBD O
all PDT O
the DT O
blood NN O
samples NNS O
and CC O
reviewed VBD O
all PDT O
the DT O
medical JJ O
charts NNS O
; , O
and CC O
wrote VBD O
the DT O
initial JJ O
working VBG O
draft NN O
of IN O
this DT O
manuscript NN O
. . O

ALG NNP O
developed VBD O
and CC O
performed VBD O
all PDT O
the DT O
real JJ O
- HYPH O
time NN O
PCR NN O
assays NNS O
and CC O
assisted VBD O
in IN O
the DT O
interpretation NN O
of IN O
the DT O
results NNS O
and CC O
in IN O
writing VBG O
the DT O
final JJ O
version NN O
of IN O
the DT O
manuscript NN O
. . O

TSM NNP O
performed VBD O
the DT O
plasma NN O
BLyS NNP O
protein NN O
and CC O
anti JJ O
- HYPH O
BLyS NNP O
assays NNS O
and CC O
assisted VBD O
in IN O
the DT O
interpretation NN O
of IN O
the DT O
results NNS O
and CC O
in IN O
writing VBG O
the DT O
final JJ O
version NN O
of IN O
the DT O
manuscript NN O
. . O

DMH NNP O
assisted VBD O
in IN O
the DT O
design NN O
in IN O
the DT O
study NN O
, , O
in IN O
the DT O
interpretation NN O
of IN O
the DT O
results NNS O
, , O
and CC O
in IN O
writing VBG O
the DT O
final JJ O
version NN O
of IN O
the DT O
manuscript NN O
. . O

DN NNP O
assisted VBD O
in IN O
the DT O
design NN O
in IN O
the DT O
study NN O
, , O
in IN O
the DT O
interpretation NN O
of IN O
the DT O
results NNS O
, , O
and CC O
in IN O
writing VBG O
the DT O
final JJ O
version NN O
of IN O
the DT O
manuscript NN O
. . O

WS NNP O
conceived VBD O
the DT O
study NN O
, , O
supervised VBD O
the DT O
recruitment NN O
of IN O
participants NNS B-Species
, , O
performed VBD O
the DT O
statistical JJ O
analyses NNS O
, , O
assisted VBN O
in IN O
the DT O
interpretation NN O
of IN O
the DT O
results NNS O
, , O
and CC O
supervised VBD O
the DT O
editing NN O
of IN O
the DT O
manuscript NN O
to IN O
its PRP$ O
final JJ O
form NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
version NN O
. . O

Travel NN O
- HYPH O
Related VBN O
Venous NNP O
Thrombosis NNP O
: : O
Results NNS O
from IN O
a DT O
Large JJ O
Population NN O
- HYPH O
Based VBN O
Case NNP O
Control NNP O
Study NNP O
( , O
MEGA NNP O
Study NN O
) -RRB- O

Abstract JJ O

Background NN O

Recent JJ O
studies NNS O
have VBP O
indicated VBN O
an DT O
increased VBN O
risk NN O
of IN O
venous JJ O
thrombosis NN O
after IN O
air NN O
travel NN O
. . O

Nevertheless RB O
, , O
questions NNS O
on IN O
the DT O
magnitude NN O
of IN O
risk NN O
, , O
the DT O
underlying VBG O
mechanism NN O
, , O
and CC O
modifying VBG O
factors NNS O
remain VBP O
unanswered JJ O
. . O

Methods NNS O
and CC O
Findings NNS O

We PRP O
studied VBD O
the DT O
effect NN O
of IN O
various JJ O
modes NNS O
and CC O
duration NN O
of IN O
travel NN O
on IN O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
in IN O
a DT O
large JJ O
ongoing JJ O
case NN O
- HYPH O
control NN O
study NN O
on IN O
risk NN O
factors NNS O
for IN O
venous JJ O
thrombosis NN O
in IN O
an DT O
unselected JJ O
population NN O
( , O
MEGA NNP O
study NN O
) -RRB- O
. . O

We PRP O
also RB O
assessed VBD O
the DT O
combined VBN O
effect NN O
of IN O
travel NN O
and CC O
prothrombotic JJ O
mutations NNS O
, , O
body NN O
mass NN O
index NN O
, , O
height NN O
, , O
and CC O
oral JJ O
contraceptive JJ O
use NN O
. . O

Since IN O
March NNP O
1999 CD O
, , O
consecutive JJ O
patients NNS B-Species
younger JJR O
than IN O
70 CD O
y VBP O
with IN O
a DT O
first JJ O
venous JJ O
thrombosis NN O
have VBP O
been VBN O
invited VBN O
to TO O
participate VB O
in IN O
the DT O
study NN O
, , O
with IN O
their PRP$ O
partners NNS O
serving VBG O
as IN O
matched VBN O
control NN O
individuals NNS O
. . O

Information NN O
has VBZ O
been VBN O
collected VBN O
on IN O
acquired VBN O
and CC O
genetic JJ O
risk NN O
factors NNS O
for IN O
venous JJ O
thrombosis NN O
. . O

Of IN O
1 CD O
, , O
906 CD O
patients NNS B-Species
, , O
233 CD O
had VBD O
traveled VBN O
for IN O
more JJR O
than IN O
4 CD O
h NNS O
in IN O
the DT O
8 CD O
wk NN O
preceding VBG O
the DT O
event NN O
. . O

Traveling VBG O
in IN O
general JJ O
was VBD O
found VBN O
to TO O
increase VB O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
2 CD O
- HYPH O
fold NN O
( HYPH O
odds NNS O
ratio NN O
[ -LRB- O
OR CC O
] -RRB- O
2 CD O
. . O
1 CD O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
[ -LRB- O
CI NN O
] -RRB- O
1 CD O
. . O
5 CD O
- SYM O
3 CD O
. . O
0 CD O
) -RRB- O
. . O

The DT O
risk NN O
of IN O
flying NN O
was VBD O
similar JJ O
to IN O
the DT O
risks NNS O
of IN O
traveling VBG O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
. . O

The DT O
risk NN O
was VBD O
highest JJS O
in IN O
the DT O
first JJ O
week NN O
after IN O
traveling VBG O
. . O

Travel NN O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
led VBD O
to IN O
a DT O
high JJ O
relative JJ O
risk NN O
of IN O
thrombosis NN O
in IN O
individuals NNS O
with IN O
factor NN O
V NN O
Leiden NNP O
( : O
OR NN O
8 CD O
. . O
1 CD O
; : O
95 CD O
% NN O
CI NN O
2 CD O
. . O
7 CD O
- SYM O
24 CD O
. . O
7 CD O
) -RRB- O
, , O
in IN O
those DT O
who WP O
had VBD O
a DT O
body NN O
mass NN O
index NN O
of IN O
more JJR O
than IN O
30 CD O
kg NNS O
/ SYM O
m2 CD O
( , O
OR CC O
9 CD O
. . O
9 CD O
; : O
95 CD O
% NN O
CI NN O
3 CD O
. . O
6 CD O
- SYM O
27 CD O
. . O
6 CD O
) -RRB- O
, , O
in IN O
those DT O
who WP O
were VBD O
more JJR O
than IN O
1 CD O
. . O
90 CD O
m NN O
tall JJ O
( : O
OR CC O
4 CD O
. . O
7 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
4 CD O
- SYM O
15 CD O
. . O
4 CD O
) -RRB- O
, , O
and CC O
in IN O
those DT O
who WP O
used VBD O
oral JJ O
contraceptives NNS O
( , O
estimated VBN O
OR NN O
> SYM O
20 CD O
) -RRB- O
. . O

For IN O
air NN O
travel NN O
these DT O
synergistic JJ O
findings NNS O
were VBD O
more RBR O
apparent JJ O
, , O
while IN O
people NNS B-Species
shorter JJR O
than IN O
1 CD O
. . O
60 CD O
m NN O
had VBD O
an DT O
increased VBN O
risk NN O
of IN O
thrombosis NN O
after IN O
air NN O
travel NN O
( , O
OR CC O
4 CD O
. . O
9 CD O
; : O
95 CD O
% NN O
CI NN O
0 CD O
. . O
9 CD O
- SYM O
25 CD O
. . O
6 CD O
) -RRB- O
as RB O
well RB O
. . O

Conclusions NNS O

The DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
after IN O
travel NN O
is VBZ O
moderately RB O
increased VBN O
for IN O
all DT O
modes NNS O
of IN O
travel NN O
. . O

Subgroups NNS O
exist VBP O
in IN O
which WDT O
the DT O
risk NN O
is VBZ O
highly RB O
increased VBN O
. . O

Background NN O
. . O

Recently RB O
there EX O
has VBZ O
been VBN O
increasing VBG O
concern NN O
that IN O
blood NN O
clots NNS O
( -LRB- O
thromboses NNS O
) -RRB- O
in IN O
the DT O
leg NN O
or CC O
lungs NNS O
occur VBP O
with IN O
greater JJR O
frequency NN O
after IN O
air NN O
travel NN O
. . O

Several JJ O
theories NNS O
have VBP O
been VBN O
put VBN O
forward RB O
to TO O
explain VB O
why WRB O
this DT O
increase NN O
might MD O
happen VB O
, , O
including VBG O
the DT O
fact NN O
that IN O
air NN O
passengers NNS O
tend VBP O
to TO O
not RB O
move VB O
around RB O
much RB O
, , O
or CC O
possibly RB O
that IN O
reduced VBN O
amounts NNS O
of IN O
oxygen NN O
in IN O
the DT O
blood NN O
make VBP O
the DT O
blood NN O
more RBR O
likely JJ O
to TO O
clot VB O
. . O

Understanding VBG O
what WP O
causes VBZ O
such JJ O
clots NNS O
is VBZ O
important JJ O
as IN O
it PRP O
would MD O
help VB O
us PRP O
come VB O
up RP O
with IN O
suggestions NNS O
of IN O
ways NNS O
to TO O
prevent VB O
them PRP O
. . O

Why WRB O
Was VBD O
This DT O
Study NN O
Done VBN O
? . O

It PRP O
is VBZ O
not RB O
possible JJ O
to TO O
test VB O
in IN O
a DT O
controlled VBN O
trial NN O
whether IN O
travel NN O
causes VBZ O
an DT O
increase NN O
in IN O
blood NN O
clots NNS O
, , O
so IN O
the DT O
next JJ O
best JJS O
way NN O
of IN O
studying VBG O
this DT O
problem NN O
is VBZ O
to TO O
do VB O
a DT O
case NN O
- HYPH O
control NN O
study NN O
, , O
in IN O
which WDT O
people NNS B-Species
with IN O
blood NN O
clots NNS O
( , O
cases NNS O
) -RRB- O
are VBP O
compared VBN O
with IN O
similar JJ O
people NNS B-Species
who WP O
don VBP O
' `` O
t RB O
have VB O
a DT O
blood NN O
clot NN O
( , O
controls NNS O
- : O
- : O
in IN O
this DT O
case NN O
, , O
the DT O
partners NNS O
of IN O
the DT O
cases NNS O
) -RRB- O
, , O
and CC O
the DT O
differences NNS O
in IN O
a DT O
number NN O
of IN O
contributing VBG O
factors NNS O
are VBP O
assessed VBN O
. . O

What WP O
Did VBD O
the DT O
Researchers NNS O
Do VB O
and CC O
Find VB O
? . O

Since IN O
1999 CD O
, , O
the DT O
MEGA NNP O
( , O
Multiple NNP O
Environmental NNP O
and CC O
Genetic NNP O
Assessment NNP O
of IN O
Risk NNP O
Factors NNPS O
for IN O
Venous NNP O
Thrombosis NNP O
) , O
study NN O
has VBZ O
aimed VBN O
to TO O
identify VB O
all DT O
people NNS B-Species
in IN O
an DT O
area NN O
of IN O
the DT O
Netherlands NNP O
who WP O
develop VBP O
a DT O
blood NN O
clot NN O
for IN O
the DT O
first JJ O
time NN O
, , O
by IN O
seeking VBG O
out RP O
people NNS B-Species
who WP O
receive VBP O
treatment NN O
for IN O
blood NN O
clots NNS O
. . O

At IN O
the DT O
time NN O
of IN O
this DT O
report NN O
, , O
1 CD O
, , O
906 CD O
people NNS B-Species
with IN O
clots NNS O
had VBD O
been VBN O
found VBN O
; : O
of IN O
these DT O
, , O
233 CD O
had VBD O
traveled VBN O
for IN O
more JJR O
than IN O
four CD O
hours NNS O
in IN O
the DT O
eight CD O
weeks NNS O
preceding VBG O
the DT O
event NN O
. . O

Traveling VBG O
in IN O
general JJ O
was VBD O
found VBN O
to TO O
increase VB O
the DT O
risk NN O
of IN O
clots NNS O
two CD O
- HYPH O
fold NN O
, , O
and CC O
the DT O
risk NN O
was VBD O
highest JJS O
in IN O
the DT O
week NN O
after IN O
traveling VBG O
. . O

The DT O
risk NN O
of IN O
flying NN O
was VBD O
similar JJ O
to IN O
the DT O
risk NN O
of IN O
traveling VBG O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
, , O
and CC O
was VBD O
highest JJS O
in IN O
the DT O
first JJ O
week NN O
after IN O
traveling VBG O
. . O

Certain JJ O
other JJ O
factors NNS O
increased VBD O
the DT O
risk NN O
of IN O
a DT O
blood NN O
clot NN O
even RB O
more RBR O
, , O
such JJ O
as IN O
having VBG O
a DT O
particular JJ O
mutation NN O
( , O
known VBN O
as IN O
factor NN O
V NN O
Leiden NNP O
) , O
in IN O
a DT O
gene NN O
involved VBN O
in IN O
blood NN O
clotting NN O
, , O
having VBG O
a DT O
body NN O
mass NN O
index NN O
of IN O
more JJR O
than IN O
30 CD O
kg NNS O
/ SYM O
m2 CD O
( , O
over IN O
30 CD O
kg NNS O
/ SYM O
m2 CD O
is VBZ O
defined VBN O
as IN O
being VBG O
obese JJ O
) -RRB- O
, , O
being VBG O
more JJR O
than IN O
1 CD O
. . O
90 CD O
meters NNS O
tall JJ O
, , O
and CC O
using VBG O
oral JJ O
contraceptives NNS O
. . O

All PDT O
these DT O
factors NNS O
made VBD O
the DT O
risk NN O
of IN O
clots NNS O
especially RB O
after IN O
air NN O
travel NN O
worse JJR O
; : O
in IN O
addition NN O
, , O
people NNS B-Species
shorter JJR O
than IN O
1 CD O
. . O
60 CD O
meters NNS O
also RB O
had VBD O
an DT O
increased VBN O
risk NN O
of IN O
thrombosis NN O
after IN O
air NN O
travel NN O
. . O

However RB O
, , O
it PRP O
should MD O
be VB O
borne VBN O
in IN O
mind NN O
that IN O
the DT O
number NN O
of IN O
cases NNS O
in IN O
each DT O
of IN O
these DT O
various JJ O
groups NNS O
was VBD O
quite RB O
small JJ O
, , O
and CC O
the DT O
overall JJ O
risk NN O
of IN O
getting VBG O
a DT O
thrombosis NN O
is VBZ O
still RB O
low JJ O
. . O

What WP O
Do VBP O
These DT O
Findings NNS O
Mean VB O
? . O

Since IN O
the DT O
risks NNS O
of IN O
thrombosis NN O
are VBP O
increased VBN O
for IN O
all DT O
types NNS O
of IN O
long JJ O
travel NN O
, , O
it PRP O
seems VBZ O
that IN O
the DT O
main JJ O
factor NN O
causing VBG O
the DT O
thrombosis NN O
is VBZ O
immobility NN O
. . O

However RB O
, , O
since IN O
the DT O
risk NN O
is VBZ O
even RB O
higher JJR O
for IN O
air NN O
travel NN O
, , O
the DT O
relative JJ O
lack NN O
of IN O
oxygen NN O
may MD O
also RB O
play VB O
a DT O
part NN O
. . O

One CD O
interesting JJ O
aspect NN O
of IN O
this DT O
study NN O
is VBZ O
that IN O
the DT O
researchers NNS O
used VBD O
partners NNS O
as IN O
controls NNS O
; : O
in IN O
order NN O
to TO O
be VB O
sure JJ O
that IN O
doing VBG O
this DT O
did VBD O
not RB O
make VB O
the DT O
results NNS O
invalid JJ O
, , O
the DT O
researchers NNS O
had VBD O
to TO O
carefully RB O
adjust VB O
for IN O
differences NNS O
between IN O
the DT O
cases NNS O
and CC O
controls NNS O
, , O
such JJ O
as IN O
the DT O
fact NN O
that IN O
partners NNS O
were VBD O
generally RB O
of IN O
the DT O
opposite JJ O
sex NN O
. . O

In IN O
a DT O
related JJ O
Perspective NN O
( : O
DOI NNP O
: : O
10 CD O
. . O
1371 CD O
/ SYM O
journal NN O
. . O
pmed NN O
. . O
30300 CD O
) -RRB- O
, , O
Kenneth NNP O
Rothman NNP O
discusses VBZ O
the DT O
study NN O
further RB O
. . O

Additional JJ O
Information NN O
. . O

Please UH O
access VB O
these DT O
Web NN O
sites NNS O
via IN O
the DT O
online JJ O
version NN O
of IN O
this DT O
summary NN O
at IN O
http NN O
: : O
/ : O
/ : O
dx ADD O
. . O
doi NN O
. . O
org NN O
/ SYM O
10 CD O
. . O
1371 CD O
/ SYM O
journal NN O
. . O
pmed NN O
. . O
30307 CD O
. . O

Introduction NN O

Interest NN O
in IN O
the DT O
role NN O
of IN O
air NN O
travel NN O
in IN O
the DT O
pathogenesis NN O
of IN O
venous JJ O
thrombosis NN O
has VBZ O
heightened VBN O
in IN O
the DT O
past JJ O
5 CD O
y CD O
[ SYM O
1 CD O
- SYM O
5 CD O
] -RRB- O
. . O

Venous JJ O
thrombosis NN O
was VBD O
first RB O
linked VBN O
to IN O
air NN O
travel NN O
in IN O
1954 CD O
[ -LRB- O
6 CD O
] -RRB- O
, , O
and CC O
as IN O
air NN O
travel NN O
has VBZ O
become VBN O
more RBR O
and CC O
more RBR O
common JJ O
, , O
many JJ O
case NN O
reports NNS O
and CC O
case NN O
series NN O
have VBP O
been VBN O
published VBN O
since RB O
. . O

Several JJ O
clinical JJ O
studies NNS O
have VBP O
shown VBN O
an DT O
association NN O
between IN O
air NN O
travel NN O
and CC O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
. . O

In IN O
a DT O
series NN O
of IN O
individuals NNS O
who WP O
died VBD O
suddenly RB O
at IN O
Heathrow NNP O
Airport NNP O
, , O
death NN O
occurred VBD O
far RB O
more RBR O
often RB O
in IN O
the DT O
arrival NN O
than IN O
in IN O
the DT O
departure NN O
area NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Two CD O
similar JJ O
studies NNS O
described VBD O
a DT O
"""" `` O
dose NN O
- HYPH O
response NN O
"""" '' O
relation NN O
: : O
the DT O
risk NN O
of IN O
pulmonary JJ O
embolism NN O
in IN O
air NN O
travelers NNS O
increased VBD O
with IN O
the DT O
distance NN O
traveled VBN O
[ -LRB- O
5 CD O
, , O
8 CD O
] -RRB- O
. . O

A DT O
number NN O
of IN O
case NN O
- HYPH O
control NN O
studies NNS O
, , O
however RB O
, , O
have VBP O
shown VBN O
conflicting JJ O
results NNS O
[ -LRB- O
9 CD O
- SYM O
11 CD O
] -RRB- O
. . O

More RBR O
recently RB O
, , O
a DT O
2 CD O
- HYPH O
fold NN O
increased VBN O
risk NN O
in IN O
patients NNS B-Species
who WP O
had VBD O
traveled VBN O
by IN O
air NN O
was VBD O
described VBN O
in IN O
a DT O
case NN O
- HYPH O
control NN O
study NN O
among IN O
210 CD O
patients NNS B-Species
and CC O
210 CD O
controls NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

A DT O
case NN O
- HYPH O
crossover NN O
study NN O
based VBN O
on IN O
record NN O
linking NN O
in IN O
Australia NNP O
described VBD O
a DT O
4 CD O
- HYPH O
fold NN O
increased VBN O
risk NN O
of IN O
venous JJ O
thrombosis NN O
in IN O
the DT O
first JJ O
2 CD O
wk NN O
after IN O
a DT O
long JJ O
- HYPH O
haul NN O
flight NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

In IN O
terms NNS O
of IN O
absolute JJ O
risk NN O
, , O
two CD O
studies NNS O
found VBD O
similar JJ O
results NNS O
: : O
one CD O
performed VBN O
in IN O
New NNP O
Zealand NNP O
found VBD O
a DT O
frequency NN O
of IN O
1 CD O
% NN O
of IN O
venous JJ O
thrombosis NN O
in IN O
878 CD O
individuals NNS O
who WP O
had VBD O
traveled VBN O
by IN O
air NN O
for IN O
at RB O
least RBS O
10 CD O
h NN O
[ -LRB- O
2 CD O
] -RRB- O
, , O
and CC O
a DT O
German JJ O
study NN O
found VBD O
venous JJ O
thrombotic JJ O
events NNS O
in IN O
2 CD O
. . O
8 CD O
% NN O
of IN O
964 CD O
individuals NNS O
who WP O
had VBD O
traveled VBN O
for IN O
more JJR O
than IN O
8 CD O
h CD O
in IN O
an DT O
airplane NN O
, , O
as IN O
compared VBN O
to IN O
1 CD O
% NN O
in IN O
1 CD O
, , O
213 CD O
controls NNS O
[ -LRB- O
4 CD O
] -RRB- O
. . O

The DT O
events NNS O
in IN O
both DT O
studies NNS O
were VBD O
mostly RB O
asymptomatic JJ O
. . O

The DT O
available JJ O
evidence NN O
suggests VBZ O
that IN O
the DT O
overall JJ O
risk NN O
of IN O
venous JJ O
thrombosis NN O
is VBZ O
moderately RB O
increased VBN O
after IN O
air NN O
travel NN O
. . O

Nevertheless RB O
, , O
many JJ O
questions NNS O
remain VBP O
unanswered JJ O
: : O
the DT O
exact JJ O
underlying VBG O
mechanism NN O
is VBZ O
still RB O
unknown JJ O
, , O
and CC O
, , O
related VBN O
to IN O
this DT O
, , O
it PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
the DT O
risk NN O
is VBZ O
increased VBN O
after IN O
air NN O
travel NN O
only RB O
or CC O
after IN O
long JJ O
- HYPH O
distance NN O
travel NN O
in IN O
general JJ O
. . O

Furthermore RB O
, , O
the DT O
effect NN O
of IN O
the DT O
combination NN O
of IN O
other JJ O
risk NN O
factors NNS O
for IN O
venous JJ O
thrombosis NN O
and CC O
travel NN O
has VBZ O
not RB O
yet RB O
been VBN O
systematically RB O
studied VBN O
, , O
with IN O
the DT O
exception NN O
of IN O
a DT O
study NN O
by IN O
Martinelli NNP O
et FW O
al NNP O
. , O
, , O
who WP O
found VBD O
an DT O
additionally RB O
increased VBN O
risk NN O
in IN O
patients NNS B-Species
with IN O
thrombophilia NN O
and CC O
patients NNS B-Species
who WP O
used VBD O
oral JJ O
contraceptives NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

The DT O
Multiple NNP O
Environmental NNP O
and CC O
Genetic NNP O
Assessment NNP O
( , O
MEGA NNP O
) -RRB- O
study NN O
of IN O
risk NN O
factors NNS O
for IN O
venous JJ O
thrombosis NN O
is VBZ O
a DT O
large JJ O
ongoing JJ O
case NN O
- HYPH O
control NN O
study NN O
aimed VBN O
at IN O
assessing VBG O
the DT O
combined VBN O
effect NN O
of IN O
genetic JJ O
and CC O
acquired VBN O
risk NN O
factors NNS O
for IN O
venous JJ O
thrombosis NN O
. . O

Cases NNS O
and CC O
control NN O
individuals NNS O
are VBP O
questioned VBN O
about IN O
- : O
- : O
among IN O
many JJ O
other JJ O
items NNS O
- : O
- : O
travel NN O
that WDT O
occurred VBD O
shortly RB O
before IN O
the DT O
event NN O
. . O

This DT O
provides VBZ O
an DT O
opportunity NN O
to TO O
assess VB O
the DT O
effect NN O
of IN O
travel NN O
on IN O
the DT O
risk NN O
of IN O
thrombosis NN O
in IN O
an DT O
unselected JJ O
population NN O
, , O
as RB O
well RB O
as IN O
the DT O
effect NN O
of IN O
the DT O
combination NN O
of IN O
travel NN O
with IN O
several JJ O
other JJ O
risk NN O
factors NNS O
for IN O
thrombosis NN O
. . O

Methods NNS O

Study VB O
Design NN O

Since IN O
March NNP O
1999 CD O
, , O
consecutive JJ O
patients NNS B-Species
younger JJR O
than IN O
70 CD O
y VBP O
with IN O
a DT O
first JJ O
deep JJ O
- HYPH O
vein NN O
thrombosis NN O
( , O
DVT NNP O
) -RRB- O
or CC O
pulmonary JJ O
embolism NN O
( -LRB- O
PE NN O
) -RRB- O
have VBP O
been VBN O
identified VBN O
at IN O
six CD O
regional JJ O
anticoagulation JJ O
clinics NNS O
in IN O
the DT O
Netherlands NNP O
. . O

Anticoagulant JJ O
clinics NNS O
monitor VBP O
the DT O
anticoagulant JJ O
therapy NN O
of IN O
all DT O
patients NNS B-Species
in IN O
a DT O
well RB O
- HYPH O
defined VBN O
geographical JJ O
area NN O
, , O
allowing VBG O
us PRP O
to TO O
identify VB O
consecutive JJ O
and CC O
unselected JJ O
patients NNS B-Species
with IN O
thrombosis NN O
. . O

Patients NNS B-Species
who WP O
were VBD O
unable JJ O
to TO O
fill VB O
in RP O
the DT O
questionnaire NN O
( , O
because IN O
of IN O
language NN O
or CC O
severe JJ O
psychiatric JJ O
problems NNS O
) -RRB- O
, , O
as RB O
well RB O
as IN O
those DT O
who WP O
died VBD O
soon RB O
after IN O
the DT O
venous JJ O
thrombosis NN O
or CC O
who WP O
were VBD O
in IN O
the DT O
end NN O
stage NN O
of IN O
a DT O
disease NN O
and CC O
for IN O
that DT O
reason NN O
did VBD O
not RB O
participate VB O
, , O
were VBD O
not RB O
included VBN O
. . O

All DT O
others NNS O
were VBD O
considered VBN O
eligible JJ O
. . O

Partners NNS O
of IN O
these DT O
patients NNS B-Species
were VBD O
invited VBN O
as IN O
control NN O
individuals NNS O
, , O
and CC O
the DT O
same JJ O
exclusion NN O
criteria NNS O
were VBD O
applied VBN O
. . O

All DT O
participants NNS B-Species
filled VBD O
in RP O
a DT O
detailed JJ O
standardized VBN O
questionnaire NN O
on IN O
general JJ O
demographic JJ O
and CC O
anthropomorphic JJ O
characteristics NNS O
, , O
as RB O
well RB O
as IN O
risk NN O
factors NNS O
for IN O
venous JJ O
thrombosis NN O
. . O

The DT O
questionnaire NN O
was VBD O
sent VBN O
to IN O
all DT O
participants NNS B-Species
within IN O
a DT O
few JJ O
weeks NNS O
after IN O
the DT O
event NN O
and CC O
covered VBD O
the DT O
period NN O
of IN O
1 CD O
y NN O
prior RB O
to IN O
the DT O
date NN O
of IN O
the DT O
thrombotic JJ O
event NN O
( HYPH O
index NN O
date NN O
) -RRB- O
. . O

When WRB O
the DT O
participant NN B-Species
was VBD O
unable JJ O
to TO O
fill VB O
in RP O
the DT O
questionnaire NN O
we PRP O
asked VBD O
questions NNS O
by IN O
phone NN O
, , O
using VBG O
a DT O
standardized JJ O
mini JJ O
- HYPH O
questionnaire NN O
. . O

Three CD O
months NNS O
after IN O
the DT O
patients NNS B-Species
had VBD O
discontinued VBN O
their PRP$ O
oral JJ O
anticoagulant JJ O
therapy NN O
, , O
they PRP O
were VBD O
invited VBN O
with IN O
their PRP$ O
partners NNS O
to IN O
the DT O
anticoagulation NN O
clinic NN O
for IN O
a DT O
blood NN O
sample NN O
. . O

In IN O
those DT O
patients NNS B-Species
who WP O
continued VBD O
to TO O
take VB O
oral JJ O
anticoagulant JJ O
therapy NN O
for IN O
more JJR O
than IN O
1 CD O
y NN O
after IN O
the DT O
event NN O
, , O
blood NN O
was VBD O
drawn VBN O
during IN O
therapy NN O
. . O

If IN O
participants NNS B-Species
were VBD O
unable JJ O
to TO O
come VB O
to IN O
the DT O
clinic NN O
, , O
a DT O
buccal NN O
swab NN O
was VBD O
sent VBN O
by IN O
mail NN O
to TO O
replace VB O
the DT O
blood NN O
sample NN O
for IN O
DNA NN O
extraction NN O
. . O

The DT O
study NN O
protocol NN O
was VBD O
approved VBN O
by IN O
the DT O
Ethics NNP O
Committee NNP O
of IN O
the DT O
Leiden NNP O
University NNP O
Medical NNP O
Center NNP O
. . O

Written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
all DT O
participants NNS B-Species
[ -LRB- O
12 CD O
] -RRB- O
. . O

Validation NN O
Study NN O
of IN O
Thrombosis NNP O
Diagnosis NNP O

Discharge NN O
letters NNS O
or CC O
diagnostic JJ O
reports NNS O
of IN O
the DT O
venous JJ O
thrombotic JJ O
event NN O
were VBD O
obtained VBN O
for IN O
a DT O
sample NN O
of IN O
742 CD O
patients NNS B-Species
who WP O
had VBD O
their PRP$ O
first JJ O
thrombosis NN O
between IN O
March NNP O
1999 CD O
and CC O
March NNP O
2000 CD O
. . O

The DT O
diagnostic JJ O
management NN O
of IN O
the DT O
patients NNS B-Species
was VBD O
compared VBN O
to IN O
the DT O
diagnostic JJ O
procedure NN O
as IN O
described VBN O
in IN O
the DT O
Dutch JJ O
consensus NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Diagnosis NN O
of IN O
clinically RB O
suspected VBN O
DVT NNP O
of IN O
the DT O
leg NN O
is VBZ O
based VBN O
on IN O
a DT O
clinical JJ O
score NN O
, , O
serial JJ O
compression NN O
ultrasonography NN O
, , O
and CC O
D NN O
- HYPH O
dimer NN O
assay NN O
. . O

Objective JJ O
testing NN O
of IN O
clinically RB O
suspected VBN O
pulmonary JJ O
embolism NN O
is VBZ O
based VBN O
on IN O
perfusion NN O
and CC O
ventilation NN O
scintigraphy NN O
, , O
ultrasonography NN O
of IN O
the DT O
leg NN O
veins NNS O
, , O
pulmonary JJ O
angiography NN O
, , O
or CC O
helical NN O
computed VBN O
tomography NN O
. . O

Out IN O
of IN O
395 CD O
patients NNS B-Species
with IN O
DVT NNP O
of IN O
the DT O
leg NN O
, , O
384 CD O
( SYM O
97 CD O
% NN O
) CD O
were VBD O
objectively RB O
diagnosed VBN O
, , O
while IN O
out IN O
of IN O
347 CD O
patients NNS B-Species
with IN O
PE NNP O
, , O
271 CD O
( SYM O
78 CD O
% NN O
) -RRB- O
were VBD O
confirmed VBN O
with IN O
objective JJ O
testing NN O
as IN O
certainly RB O
having VBG O
PE NNP O
. . O

Since IN O
the DT O
diagnosis NN O
appears VBZ O
to TO O
be VB O
made VBN O
by IN O
objective JJ O
methods NNS O
in IN O
virtually RB O
all DT O
cases NNS O
of IN O
DVT NNP O
, , O
while IN O
being VBG O
more RBR O
ambiguous JJ O
for IN O
PE NNP O
, , O
we PRP O
also RB O
analyzed VBD O
these DT O
two CD O
manifestations NNS O
of IN O
venous JJ O
thrombosis NN O
separately RB O
. . O

Current JJ O
Analysis NNP O

For IN O
the DT O
current JJ O
analysis NN O
we PRP O
were VBD O
interested JJ O
in IN O
the DT O
effects NNS O
of IN O
travel NN O
, , O
and CC O
its PRP$ O
combined VBN O
effect NN O
with IN O
other JJ O
common JJ O
risk NN O
factors NNS O
for IN O
venous JJ O
thrombosis NN O
. . O

Patients NNS B-Species
with IN O
a DT O
solitary JJ O
arm NN O
thrombosis NN O
were VBD O
excluded VBN O
from IN O
this DT O
analysis NN O
. . O

Of IN O
3 CD O
, , O
902 CD O
eligible JJ O
cases NNS O
, , O
diagnosed VBN O
up IN O
to IN O
May NNP O
2002 CD O
, , O
656 CD O
did VBD O
not RB O
participate VB O
for IN O
various JJ O
reasons NNS O
( : O
such JJ O
as IN O
not RB O
willing JJ O
or CC O
not RB O
reachable JJ O
) -RRB- O
, , O
leading VBG O
to IN O
a DT O
response NN O
of IN O
83 CD O
% NN O
. . O

A DT O
further JJ O
3 CD O
% NN O
responded VBD O
only RB O
to IN O
the DT O
mini JJ O
- HYPH O
questionnaire NN O
, , O
taken VBN O
by IN O
phone NN O
, , O
which WDT O
did VBD O
not RB O
contain VB O
questions NNS O
about IN O
travel NN O
. . O

Of IN O
the DT O
remaining VBG O
3 CD O
, , O
111 CD O
cases NNS O
, , O
78 CD O
% NN O
had VBD O
a DT O
partner NN O
, , O
77 CD O
% NN O
of IN O
whom WP O
were VBD O
willing JJ O
to TO O
participate VB O
, , O
which WDT O
left VBD O
1 CD O
, , O
867 CD O
couples NNS O
. . O

Additionally RB O
, , O
229 CD O
partners NNS O
were VBD O
identified VBN O
for IN O
whom WP O
the DT O
corresponding VBG O
patient NN B-Species
originally RB O
participated VBD O
but CC O
was VBD O
later RB O
found VBN O
not RB O
to TO O
be VB O
eligible JJ O
( , O
aged VBN O
over IN O
70 CD O
y NN O
, , O
or CC O
not RB O
a DT O
first JJ O
thrombotic JJ O
event NN O
) -RRB- O
. . O

These DT O
control NN O
individuals NNS O
were VBD O
matched VBN O
on IN O
sex NN O
and CC O
5 CD O
- HYPH O
y NN O
age NN O
groups NNS O
to IN O
one CD O
of IN O
the DT O
557 CD O
patients NNS B-Species
whose WP$ O
partner NN O
did VBD O
not RB O
want VB O
to TO O
participate VB O
, , O
so CC O
an DT O
extra JJ O
229 CD O
pairs NNS O
were VBD O
included VBN O
, , O
making VBG O
a DT O
total NN O
of IN O
4 CD O
, , O
192 CD O
participants NNS B-Species
( , O
2 CD O
, , O
96 CD O
pairs NNS O
) -RRB- O
. . O

As IN O
part NN O
of IN O
the DT O
general JJ O
questionnaire NN O
, , O
questions NNS O
had VBD O
been VBN O
asked VBN O
about IN O
whether IN O
or CC O
not RB O
respondents NNS O
had VBD O
traveled VBN O
for IN O
more JJR O
than IN O
4 CD O
h NN O
in IN O
the DT O
3 CD O
mo NN O
before IN O
the DT O
index NN O
date NN O
, , O
about IN O
the DT O
travel NN O
date NN O
, , O
and CC O
about IN O
mode NN O
and CC O
duration NN O
of IN O
travel NN O
. . O

We PRP O
assessed VBD O
the DT O
occurrence NN O
of IN O
thrombosis NN O
in IN O
relation NN O
to IN O
the DT O
period NN O
of IN O
time NN O
that WDT O
had VBD O
passed VBN O
since IN O
traveling VBG O
. . O

Travel NN O
was VBD O
defined VBN O
in IN O
the DT O
analysis NN O
as IN O
at RB O
least RBS O
one CD O
journey NN O
with IN O
a DT O
duration NN O
of IN O
at RB O
least RBS O
four CD O
uninterrupted JJ O
hours NNS O
during IN O
the DT O
8 CD O
- HYPH O
wk NN O
period NN O
before IN O
the DT O
event NN O
. . O

During IN O
the DT O
analysis NN O
it PRP O
appeared VBD O
that IN O
some DT O
individuals NNS O
had VBD O
provided VBN O
dates NNS O
of IN O
travel NN O
after IN O
the DT O
event NN O
instead RB O
of IN O
before RB O
. . O

As IN O
there EX O
was VBD O
only RB O
one CD O
opportunity NN O
to TO O
fill VB O
in RP O
such PDT O
a DT O
date NN O
, , O
we PRP O
had VBD O
no DT O
information NN O
about IN O
the DT O
period NN O
before IN O
the DT O
event NN O
. . O

This DT O
was VBD O
the DT O
case NN O
in IN O
88 CD O
cases NNS O
and CC O
146 CD O
controls NNS O
. . O

We PRP O
excluded VBD O
these DT O
individuals NNS O
and CC O
their PRP$ O
partners NNS O
, , O
which WDT O
left VBD O
3 CD O
, , O
812 CD O
participants NNS B-Species
( , O
1 CD O
, , O
906 CD O
pairs NNS O
) , O
for IN O
the DT O
analysis NN O
. . O

Because IN O
we PRP O
selected VBD O
the DT O
partners NNS O
of IN O
the DT O
cases NNS O
as IN O
control NN O
individuals NNS O
, , O
and CC O
because IN O
it PRP O
turned VBD O
out RP O
, , O
as IN O
expected VBN O
, , O
that IN O
couples NNS O
tend VBP O
to TO O
travel VB O
together RB O
, , O
we PRP O
performed VBD O
a DT O
conditional JJ O
logistic JJ O
regression NN O
analysis NN O
to TO O
calculate VB O
odds NNS O
ratios NNS O
( -LRB- O
ORs NNS O
) -RRB- O
for IN O
the DT O
relation NN O
between IN O
travel NN O
and CC O
venous NN O
thrombosis NN O
. . O

This DT O
method NN O
fully RB O
takes VBZ O
this DT O
matching NN O
into IN O
account NN O
, , O
and CC O
leads VBZ O
to IN O
unbiased JJ O
estimates NNS O
, , O
with IN O
adjustment NN O
for IN O
all DT O
factors NNS O
in IN O
which WDT O
cases NNS O
and CC O
controls NNS O
tend VBP O
to TO O
be VB O
similar JJ O
, , O
e UH O
. . O
g LS O
. . O
, , O
socioeconomic JJ O
class NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Details NNS O
of IN O
this DT O
method NN O
can MD O
be VB O
found VBN O
in IN O
Protocol NNP O
S1 NNP O
. . O

The DT O
95 CD O
% NN O
confidence NN O
intervals NNS O
( -LRB- O
CIs NNS O
) -RRB- O
were VBD O
derived VBN O
from IN O
the DT O
model NN O
. . O

We PRP O
assessed VBD O
the DT O
combined VBN O
effect NN O
of IN O
traveling VBG O
and CC O
the DT O
following VBG O
risk NN O
factors NNS O
for IN O
thrombosis NN O
: : O
factor NN O
V NN O
Leiden NNP O
mutation NN O
, , O
prothrombin NN O
G20210A NN O
mutation NN O
, , O
body NN O
mass NN O
index NN O
( , O
BMI NNP O
, , O
as IN O
kg NN O
/ SYM O
m2 CD O
) -RRB- O
, , O
and CC O
height NN O
. . O

We PRP O
were VBD O
also RB O
interested JJ O
in IN O
the DT O
combined VBN O
effect NN O
of IN O
oral JJ O
contraceptive NN O
use NN O
and CC O
travel NN O
. . O

However RB O
, , O
as IN O
the DT O
control NN O
individuals NNS O
were VBD O
nearly RB O
always RB O
of IN O
the DT O
opposite JJ O
sex NN O
( , O
partners NNS O
of IN O
the DT O
cases NNS O
were VBD O
recruited VBN O
as IN O
controls NNS O
) -RRB- O
, , O
it PRP O
was VBD O
not RB O
possible JJ O
to TO O
perform VB O
a DT O
matched JJ O
analysis NN O
for IN O
the DT O
combination NN O
of IN O
oral JJ O
contraceptive NN O
use NN O
and CC O
travel NN O
. . O

Therefore RB O
, , O
we PRP O
performed VBD O
a DT O
case NN O
- HYPH O
only RB O
analysis NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

This DT O
method NN O
allows VBZ O
one CD O
to TO O
examine VB O
the DT O
association NN O
between IN O
two CD O
exposures NNS O
among IN O
case NN O
individuals NNS O
only RB O
. . O

ORs NNS O
are VBP O
interpreted VBN O
as IN O
a DT O
synergy NN O
index NN O
( -LRB- O
SI NNP O
) -RRB- O
on IN O
a DT O
multiplicative JJ O
scale NN O
, , O
with IN O
independence NN O
assumed VBN O
between IN O
the DT O
exposures NNS O
. . O

As IN O
this DT O
analysis NN O
depends VBZ O
only RB O
on IN O
cases NNS O
, , O
it PRP O
was VBD O
possible JJ O
to TO O
perform VB O
it PRP O
in IN O
all DT O
consecutive JJ O
cases NNS O
, , O
therefore RB O
also RB O
including VBG O
those DT O
without IN O
a DT O
partner NN O
. . O

Laboratory NN O
Measurements NNS O

Blood NN O
was VBD O
collected VBN O
from IN O
the DT O
antecubital JJ O
vein NN O
into IN O
vacuum NN O
tubes NNS O
containing VBG O
0 CD O
. . O
106 CD O
mol NN O
/ SYM O
l NN O
trisodium NN O
citrate NN O
. . O

High JJ O
molecular JJ O
weight NN O
DNA NN O
was VBD O
isolated VBN O
from IN O
leukocytes NNS O
using VBG O
a DT O
standard JJ O
salting NN O
- HYPH O
out RP O
procedure NN O
[ -LRB- O
16 CD O
] -RRB- O
and CC O
stored VBN O
at IN O
- HYPH O
20 CD O
degrees NNS O
C NN O
. . O

When WRB O
a DT O
blood NN O
sample NN O
was VBD O
not RB O
available JJ O
, , O
DNA NNP O
was VBD O
extracted VBN O
from IN O
buccal NN O
swabs NNS O
. . O

Three CD O
large JJ O
cotton NN B-Species
swabs NNS O
in IN O
a DT O
total NN O
of IN O
6 CD O
ml NNS O
of IN O
SDS NNP O
- HYPH O
proteinase NN O
K NN O
solution NN O
( : O
100 CD O
mM NN O
NaCl NNP O
, , O
10 CD O
mM NN O
EDTA NNP O
, , O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
[ -LRB- O
pH NN O
8 CD O
. . O
0 CD O
] -RRB- O
, , O
0 CD O
. . O
5 CD O
% NN O
SDS NN O
, , O
0 CD O
. . O
1 CD O
mg NN O
/ SYM O
ml NN O
proteinase NN O
K NN O
) -RRB- O
were VBD O
obtained VBN O
. . O

Upon IN O
arrival NN O
, , O
the DT O
proteinase NN O
K NN O
concentration NN O
was VBD O
raised VBN O
to IN O
0 CD O
. . O
2 CD O
mg NN O
/ SYM O
ml NN O
, , O
and CC O
the DT O
sample NN O
was VBD O
incubated VBN O
for IN O
2 CD O
h NNS O
at IN O
65 CD O
degrees NNS O
C NN O
. . O

Subsequently RB O
, , O
the DT O
solute NN O
was VBD O
recovered VBN O
by IN O
centrifugation NN O
. . O

Potassium NN O
acetate NN O
was VBD O
added VBN O
to IN O
the DT O
supernatant NN O
to IN O
a DT O
final JJ O
concentration NN O
of IN O
1 CD O
. . O
6 CD O
M NN O
. . O

After IN O
15 CD O
min NN O
incubation NN O
on IN O
ice NN O
, , O
proteins NNS O
were VBD O
removed VBN O
using VBG O
chloroform NN O
/ SYM O
isomylalcohol NN O
( , O
24 CD O
: SYM O
1 CD O
) -RRB- O
treatment NN O
. . O

The DT O
DNA NN O
in IN O
the DT O
water NN O
phase NN O
was VBD O
subsequently RB O
ethanol NN O
precipitated VBN O
. . O

After IN O
centrifugation NN O
, , O
the DT O
pellet NN O
was VBD O
resuspended VBN O
in IN O
200 CD O
mu NNS O
l NN O
of IN O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
and CC O
10 CD O
mM NN O
EDTA NNP O
( , O
pH NN O
8 CD O
. . O
0 CD O
) -RRB- O
, , O
and CC O
frozen VBN O
at IN O
- HYPH O
20 CD O
degrees NNS O
C NN O
until IN O
further JJ O
analysis NN O
. . O

The DT O
factor NN O
V NN O
Leiden NNP O
mutation NN O
( -LRB- O
G1691A NNP O
) -RRB- O
and CC O
the DT O
prothrombin NN O
mutation NN O
( -LRB- O
G20210A NNP O
) -RRB- O
were VBD O
simultaneously RB O
detected VBN O
by IN O
duplex JJ O
polymerase NN O
chain NN O
reaction NN O
[ -LRB- O
17 CD O
, , O
18 CD O
] -RRB- O
. . O

The DT O
technician NN O
was VBD O
blinded VBN O
concerning VBG O
the DT O
origin NN O
of IN O
the DT O
sample NN O
, , O
i PRP O
. . O
e UH O
. . O
, , O
whether IN O
it PRP O
was VBD O
from IN O
a DT O
patient NN B-Species
or CC O
from IN O
a DT O
control NN O
individual NN O
. . O

Results NNS O

Venous JJ O
Thrombosis NN O
in IN O
Relation NN O
to IN O
Travel NN O

Table NNP O
1 CD O
shows VBZ O
general JJ O
characteristics NNS O
of IN O
the DT O
1 CD O
, , O
906 CD O
patients NNS B-Species
. . O

They PRP O
ranged VBD O
in IN O
age NN O
from IN O
18 CD O
to IN O
69 CD O
y NN O
( , O
median JJ O
50 CD O
. . O
4 CD O
y NN O
) CD O
; : O
51 CD O
% NN O
were VBD O
men NNS B-Species
. . O

Diagnosis NN O
was VBD O
DVT NNP O
in IN O
57 CD O
% NN O
of IN O
the DT O
cases NNS O
, , O
PE NN O
in IN O
32 CD O
% NN O
, , O
and CC O
both DT O
in IN O
11 CD O
% NN O
. . O

As IN O
partners NNS O
of IN O
the DT O
cases NNS O
were VBD O
included VBN O
as IN O
control NN O
individuals NNS O
, , O
the DT O
sex NN O
distribution NN O
of IN O
the DT O
control NN O
individuals NNS O
was VBD O
the DT O
opposite JJ O
; : O
the DT O
age NN O
distribution NN O
differed VBD O
only RB O
trivially RB O
. . O

Of IN O
the DT O
patients NNS B-Species
, , O
233 CD O
individuals NNS O
( : O
12 CD O
% NN O
) , O
had VBD O
traveled VBN O
for IN O
at RB O
least RBS O
4 CD O
h CD O
by IN O
air NN O
, , O
bus NN O
, , O
car NN O
, , O
or CC O
train NN O
within IN O
the DT O
8 CD O
wk NN O
preceding VBG O
the DT O
index NN O
date NN O
, , O
as IN O
compared VBN O
to IN O
182 CD O
of IN O
the DT O
control NN O
individuals NNS O
( : O
9 CD O
. . O
5 CD O
% NN O
) -RRB- O
. . O

As IN O
the DT O
cases NNS O
and CC O
control NN O
individuals NNS O
were VBD O
selected VBN O
as IN O
couples NNS O
, , O
many JJ O
pairs NNS O
( , O
135 CD O
) -RRB- O
had VBD O
traveled VBN O
together RB O
and CC O
were VBD O
uninformative JJ O
: : O
as IN O
a DT O
consequence NN O
, , O
145 CD O
pairs NNS O
in IN O
which WDT O
either CC O
the DT O
patient NN B-Species
( SYM O
98 CD O
) -RRB- O
or CC O
the DT O
control NN O
( $ O
47 CD O
) -RRB- O
had VBD O
traveled VBN O
could MD O
be VB O
used VBN O
for IN O
the DT O
matched VBN O
analysis NN O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

This DT O
analysis NN O
showed VBD O
a DT O
2 CD O
- HYPH O
fold NN O
increased VBN O
risk NN O
of IN O
venous JJ O
thrombosis NN O
for IN O
all DT O
modes NNS O
of IN O
travel NN O
combined VBN O
( : O
OR CC O
2 CD O
. . O
1 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
5 CD O
- SYM O
3 CD O
. . O
0 CD O
) , O
compared VBN O
to IN O
not RB O
traveling VBG O
. . O

For IN O
air NN O
travel NN O
alone RB O
, , O
49 CD O
individuals NNS O
( , O
31 CD O
cases NNS O
and CC O
18 CD O
controls NNS O
) , O
had VBD O
traveled VBN O
without IN O
their PRP$ O
partner NN O
, , O
and CC O
the DT O
analysis NN O
yielded VBD O
an DT O
OR CC O
of IN O
1 CD O
. . O
7 CD O
( SYM O
95 CD O
% NN O
CI NN O
1 CD O
. . O
0 CD O
- HYPH O
3 CD O
. . O
1 CD O
) -RRB- O
. . O

For IN O
the DT O
other JJ O
modes NNS O
of IN O
travel NN O
( , O
car NN O
, , O
bus NN O
, , O
and CC O
train NN O
) , O
the DT O
relative JJ O
risks NNS O
were VBD O
essentially RB O
similar JJ O
to IN O
each DT O
other JJ O
and CC O
to IN O
that DT O
of IN O
air NN O
travel NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

The DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
was VBD O
not RB O
clearly RB O
related VBN O
to IN O
increased VBN O
duration NN O
of IN O
travel NN O
( , O
Table NNP O
2 CD O
) -RRB- O
. . O

Of IN O
the DT O
233 CD O
events NNS O
that WDT O
occurred VBD O
within IN O
8 CD O
wk NN O
after IN O
traveling VBG O
, , O
68 CD O
( SYM O
29 CD O
% NN O
) -RRB- O
were VBD O
diagnosed VBN O
in IN O
the DT O
first JJ O
week NN O
, , O
after IN O
which WDT O
the DT O
incidence NN O
gradually RB O
decreased VBD O
( : O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
Effect NN O
of IN O
Other JJ O
Risk NN O
Factors NNS O
Combined VBN O
with IN O
Travel NN O

Prothrombotic JJ O
mutations NNS O
. . O

Information NN O
on IN O
the DT O
factor NN O
V NN O
Leiden NNP O
mutation NN O
and CC O
prothrombin NN O
G20210A NN O
genotype NN O
was VBD O
available JJ O
for IN O
1 CD O
, , O
713 CD O
patients NNS B-Species
( : O
90 CD O
% NN O
) -RRB- O
and CC O
for IN O
1 CD O
, , O
629 CD O
of IN O
the DT O
control NN O
individuals NNS O
( : O
85 CD O
% NN O
) -RRB- O
. . O

Factor NN O
V NN O
Leiden NNP O
was VBD O
present JJ O
in IN O
259 CD O
cases NNS O
( : O
14 CD O
% NN O
) -RRB- O
and CC O
84 CD O
control NN O
individuals NNS O
( : O
4 CD O
% NN O
) -RRB- O
( : O
OR CC O
3 CD O
. . O
1 CD O
; : O
95 CD O
% NN O
CI NN O
2 CD O
. . O
4 CD O
- SYM O
4 CD O
. . O
1 CD O
) -RRB- O
. . O

The DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
was VBD O
8 CD O
- HYPH O
fold NN O
increased VBD O
in IN O
people NNS B-Species
with IN O
factor NN O
V NN O
Leiden NNP O
who WP O
had VBD O
traveled VBN O
by IN O
bus NN O
, , O
car NN O
, , O
or CC O
train NN O
( HYPH O
modes NNS O
combined VBN O
) , O
as IN O
compared VBN O
to IN O
noncarriers NNS O
who WP O
did VBD O
not RB O
travel VB O
( : O
OR CC O
8 CD O
. . O
1 CD O
; : O
95 CD O
% NN O
CI NN O
2 CD O
. . O
7 CD O
- SYM O
24 CD O
. . O
7 CD O
) -RRB- O
. . O

For IN O
the DT O
combined VBN O
effect NN O
of IN O
air NN O
travel NN O
and CC O
factor NN O
V NN O
Leiden NNP O
, , O
the DT O
risk NN O
seemed VBD O
even RB O
slightly RB O
higher JJR O
( : O
OR CC O
13 CD O
. . O
6 CD O
; : O
95 CD O
% NN O
CI NN O
2 CD O
. . O
9 CD O
- SYM O
64 CD O
. . O
2 CD O
) -RRB- O
. . O

The DT O
prothrombin NN O
G20210A NN O
mutation NN O
was VBD O
found VBN O
in IN O
83 CD O
cases NNS O
( : O
4 CD O
% NN O
) -RRB- O
and CC O
in IN O
29 CD O
control NN O
individuals NNS O
( : O
2 CD O
% NN O
) -RRB- O
( , O
OR CC O
2 CD O
. . O
7 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
7 CD O
- SYM O
4 CD O
. . O
2 CD O
) -RRB- O
. . O

The DT O
risk NN O
in IN O
individuals NNS O
with IN O
this DT O
mutation NN O
who WP O
had VBD O
traveled VBN O
was VBD O
difficult JJ O
to TO O
interpret VB O
because IN O
of IN O
the DT O
small JJ O
numbers NNS O
but CC O
appeared VBD O
not RB O
to TO O
increase VB O
more RBR O
than IN O
additively RB O
( : O
Table NNP O
3 CD O
) -RRB- O
. . O

BMI NNP O
. . O

The DT O
effect NN O
of IN O
BMI NNP O
was VBD O
studied VBN O
by IN O
dividing VBG O
individuals NNS O
into IN O
three CD O
categories NNS O
with IN O
the DT O
following VBG O
BMI NNP O
values NNS O
: : O
< $ O
25 CD O
, , O
25 CD O
- HYPH O
30 CD O
, , O
and CC O
> SYM O
30 CD O
kg NNS O
/ SYM O
m2 CD O
[ -LRB- O
19 CD O
] -RRB- O
. . O

A DT O
BMI NNP O
of IN O
25 CD O
- SYM O
30 CD O
kg NNS O
/ SYM O
m2 CD O
was VBD O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
venous JJ O
thrombosis NN O
( , O
OR CC O
1 CD O
. . O
4 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
2 CD O
- SYM O
1 CD O
. . O
7 CD O
) -RRB- O
, , O
and CC O
the DT O
risk NN O
was VBD O
slightly RB O
higher JJR O
in IN O
patients NNS B-Species
with IN O
a DT O
BMI NN O
of IN O
30 CD O
kg NNS O
/ SYM O
m2 CD O
or CC O
more JJR O
( , O
OR CC O
1 CD O
. . O
7 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
4 CD O
- SYM O
2 CD O
. . O
1 CD O
) -RRB- O
. . O

The DT O
combined VBN O
effect NN O
of IN O
a DT O
higher JJR O
BMI NNP O
and CC O
travel NN O
was VBD O
the DT O
sum NN O
of IN O
the DT O
individual JJ O
risks NNS O
( -LRB- O
Table NNP O
3 CD O
) -RRB- O
, , O
with IN O
the DT O
exception NN O
of IN O
people NNS B-Species
with IN O
a DT O
BMI NNP O
of IN O
more JJR O
than IN O
30 CD O
kg NNS O
/ SYM O
m2 NNS O
who WP O
traveled VBD O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
, , O
for IN O
whom WP O
the DT O
risk NN O
was VBD O
10 CD O
- HYPH O
fold NN O
increased VBN O
( : O
OR CC O
9 CD O
. . O
9 CD O
; : O
95 CD O
% NN O
CI NN O
3 CD O
. . O
6 CD O
- SYM O
27 CD O
. . O
6 CD O
) -RRB- O
. . O

This DT O
increase NN O
in IN O
risk NN O
was VBD O
not RB O
found VBN O
in IN O
people NNS B-Species
who WP O
traveled VBD O
by IN O
air NN O
. . O

Height NN O
. . O

Particularly RB O
short JJ O
or CC O
tall JJ O
people NNS B-Species
may MD O
be VB O
subjected VBN O
during IN O
travel NN O
to IN O
even RB O
more RBR O
unnatural JJ O
sitting NN O
positions NNS O
than IN O
individuals NNS O
with IN O
average JJ O
height NN O
. . O

Therefore RB O
, , O
we PRP O
assessed VBD O
the DT O
effect NN O
of IN O
extremes NNS O
of IN O
heights NNS O
in IN O
combination NN O
with IN O
travel NN O
on IN O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
by IN O
comparing VBG O
short JJ O
( HYPH O
less JJR O
than IN O
1 CD O
. . O
60 CD O
m NN O
) -RRB- O
and CC O
tall JJ O
individuals NNS O
( , O
more JJR O
than IN O
1 CD O
. . O
90 CD O
m NN O
) -RRB- O
with IN O
people NNS B-Species
of IN O
average JJ O
height NN O
( : O
1 CD O
. . O
60 CD O
- SYM O
1 CD O
. . O
90 CD O
m NN O
) -RRB- O
. . O

Compared VBN O
to IN O
people NNS B-Species
of IN O
average JJ O
height NN O
, , O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
was VBD O
lower JJR O
for IN O
short JJ O
people NNS B-Species
( -LRB- O
OR CC O
0 CD O
. . O
7 CD O
; : O
95 CD O
% NN O
CI NN O
0 CD O
. . O
5 CD O
- SYM O
0 CD O
. . O
9 CD O
) -RRB- O
and CC O
did VBD O
not RB O
differ VB O
for IN O
very RB O
tall JJ O
individuals NNS O
( : O
OR CC O
0 CD O
. . O
9 CD O
; : O
95 CD O
% NN O
CI NN O
0 CD O
. . O
7 CD O
- SYM O
1 CD O
. . O
1 CD O
) -RRB- O
. . O

The DT O
risk NN O
was VBD O
found VBN O
to TO O
be VB O
increased VBN O
in IN O
people NNS B-Species
of IN O
more JJR O
than IN O
1 CD O
. . O
90 CD O
m NN O
who WP O
traveled VBD O
( : O
OR CC O
4 CD O
. . O
7 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
4 CD O
- SYM O
15 CD O
. . O
4 CD O
for IN O
travel NN O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
; : O
OR CC O
6 CD O
. . O
8 CD O
; : O
95 CD O
% NN O
CI NN O
0 CD O
. . O
8 CD O
- SYM O
60 CD O
. . O
6 CD O
for IN O
air NN O
travel NN O
) , O
compared VBN O
to IN O
non NN O
- HYPH O
traveling VBG O
people NNS B-Species
of IN O
average JJ O
height NN O
. . O

Interestingly RB O
, , O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
was VBD O
also RB O
increased VBN O
in IN O
short JJ O
people NNS B-Species
but CC O
only RB O
after IN O
air NN O
travel NN O
( : O
OR CC O
4 CD O
. . O
9 CD O
; : O
95 CD O
% NN O
CI NN O
0 CD O
. . O
9 CD O
- SYM O
25 CD O
. . O
6 CD O
) -RRB- O
, , O
not RB O
after IN O
other JJ O
modes NNS O
of IN O
travel NN O
( : O
OR CC O
1 CD O
. . O
0 CD O
; : O
95 CD O
% NN O
CI NN O
0 CD O
. . O
3 CD O
- SYM O
2 CD O
. . O
8 CD O
, , O
all DT O
relative JJ O
to IN O
non NN O
- HYPH O
traveling VBG O
people NNS B-Species
of IN O
average JJ O
height NN O
) -RRB- O
. . O

Oral JJ O
contraception NN O
. . O

To TO O
study VB O
the DT O
association NN O
between IN O
oral JJ O
contraceptive JJ O
use NN O
, , O
travel NN O
, , O
and CC O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
, , O
we PRP O
performed VBD O
a DT O
case NN O
- HYPH O
only RB O
analysis NN O
in IN O
all DT O
female JJ O
patients NNS B-Species
who WP O
were VBD O
less JJR O
than IN O
50 CD O
y NN O
of IN O
age NN O
. . O

As IN O
we PRP O
needed VBD O
only RB O
cases NNS O
, , O
it PRP O
was VBD O
also RB O
possible JJ O
to TO O
include VB O
women NNS B-Species
without IN O
a DT O
partner NN O
for IN O
this DT O
analysis NN O
, , O
which WDT O
led VBD O
to IN O
a DT O
total NN O
of IN O
1 CD O
, , O
25 CD O
women NNS B-Species
aged VBN O
under IN O
50 CD O
. . O

Non NNP O
- HYPH O
users NNS O
who WP O
did VBD O
not RB O
travel VB O
were VBD O
used VBN O
as IN O
the DT O
reference NN O
group NN O
. . O

The DT O
case NN O
- HYPH O
only RB O
estimate NN O
of IN O
the DT O
SI NNP O
for IN O
women NNS B-Species
who WP O
traveled VBD O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
was VBD O
2 CD O
. . O
4 CD O
( SYM O
95 CD O
% NN O
CI NN O
1 CD O
. . O
5 CD O
- HYPH O
3 CD O
. . O
7 CD O
) -RRB- O
. . O

This DT O
indicates VBZ O
that IN O
the DT O
OR NNP O
for IN O
the DT O
combination NN O
of IN O
travel NN O
and CC O
oral JJ O
contraceptive NN O
use NN O
is VBZ O
2 CD O
. . O
4 CD O
times NNS O
the DT O
product NN O
of IN O
the DT O
separate JJ O
ORs NNS O
. . O

As IN O
oral JJ O
contraceptive NN O
use NN O
generally RB O
increases VBZ O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
about IN O
4 CD O
- HYPH O
fold NN O
[ -LRB- O
20 CD O
] -RRB- O
, , O
the DT O
combination NN O
with IN O
travel NN O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
would MD O
lead VB O
to IN O
an DT O
estimated VBN O
OR CC O
of IN O
about IN O
20 CD O
( SYM O
4 CD O
x SYM O
2 CD O
x SYM O
2 CD O
. . O
4 CD O
) -RRB- O
. . O

A DT O
clearly RB O
stronger JJR O
interaction NN O
of IN O
travel NN O
by IN O
air NN O
with IN O
oral JJ O
contraceptive NN O
use NN O
was VBD O
found VBN O
: : O
the DT O
case NN O
- HYPH O
only RB O
estimate NN O
of IN O
the DT O
SI NNP O
was VBD O
4 CD O
. . O
9 CD O
( SYM O
95 CD O
% NN O
CI NN O
2 CD O
. . O
1 CD O
- SYM O
11 CD O
. . O
4 CD O
) -RRB- O
, , O
which WDT O
would MD O
result VB O
in IN O
an DT O
OR NNP O
of IN O
about IN O
40 CD O
( SYM O
4 CD O
x SYM O
2 CD O
x SYM O
4 CD O
. . O
9 CD O
) -RRB- O
. . O

Effect NN O
of IN O
Risk NN O
Factors NNS O
in IN O
DVT NN O
Patients NNS B-Species
Only RB O

Of IN O
the DT O
1 CD O
, , O
906 CD O
cases NNS O
, , O
1 CD O
, , O
82 CD O
were VBD O
diagnosed VBN O
with IN O
DVT NNP O
. . O

As IN O
the DT O
diagnosis NN O
was VBD O
more RBR O
unambiguous JJ O
in IN O
these DT O
patients NNS B-Species
( , O
97 CD O
% NN O
objectively RB O
diagnosed VBN O
as IN O
compared VBN O
to IN O
78 CD O
% NN O
of IN O
the DT O
PE NN O
patients NNS B-Species
) -RRB- O
, , O
we PRP O
repeated VBD O
the DT O
analysis NN O
in IN O
these DT O
patients NNS B-Species
only RB O
. . O

In IN O
this DT O
analysis NN O
, , O
the DT O
overall JJ O
effect NN O
of IN O
travel NN O
on IN O
the DT O
risk NN O
of IN O
DVT NNP O
was VBD O
equal JJ O
to IN O
the DT O
effect NN O
on IN O
all DT O
venous JJ O
thrombosis NN O
( , O
DVT NNP O
and CC O
PE NN O
combined VBN O
) -RRB- O
. . O

However RB O
, , O
here RB O
we PRP O
found VBD O
a DT O
stronger JJR O
risk NN O
for IN O
travel NN O
by IN O
air NN O
( , O
OR CC O
3 CD O
. . O
0 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
3 CD O
- SYM O
7 CD O
. . O
1 CD O
) : O
then RB O
for IN O
travel NN O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
( , O
OR CC O
1 CD O
. . O
9 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
1 CD O
- SYM O
3 CD O
. . O
2 CD O
) -RRB- O
( : O
Table NN O
4 CD O
) -RRB- O
. . O

Also RB O
, , O
the DT O
analysis NN O
of IN O
the DT O
combination NN O
of IN O
other JJ O
risk NN O
factors NNS O
with IN O
travel NN O
resulted VBD O
in IN O
more RBR O
clear RB O
- HYPH O
cut VBN O
effects NNS O
, , O
despite IN O
the DT O
smaller JJR O
number NN O
of IN O
cases NNS O
: : O
the DT O
risk NN O
of IN O
DVT NNP O
was VBD O
still RB O
clearly RB O
synergistically RB O
increased VBN O
in IN O
patients NNS B-Species
with IN O
factor NN O
V NN O
Leiden NNP O
who WP O
traveled VBD O
, , O
whereas IN O
the DT O
prothrombin NN O
G20210A NN O
mutation NN O
did VBD O
not RB O
further RB O
increase VB O
the DT O
risk NN O
of IN O
travel NN O
( , O
Table NNP O
4 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
a DT O
BMI NNP O
of IN O
more JJR O
than IN O
30 CD O
kg NNS O
/ SYM O
m2 CD O
in IN O
combination NN O
with IN O
travel NN O
yielded VBD O
high JJ O
ORs NNS O
for IN O
DVT NN O
both CC O
in IN O
people NNS B-Species
who WP O
traveled VBD O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
and CC O
in IN O
those DT O
who WP O
flew VBD O
. . O

Being VBG O
more JJR O
than IN O
1 CD O
. . O
90 CD O
m NN O
tall JJ O
in IN O
combination NN O
with IN O
travel NN O
resulted VBD O
in IN O
higher JJR O
ORs NNS O
for IN O
DVT NNP O
; : O
the DT O
risk NN O
for IN O
short JJ O
people NNS B-Species
was VBD O
more RBR O
increased VBN O
after IN O
travel NN O
by IN O
air NN O
( , O
OR CC O
6 CD O
. . O
8 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
1 CD O
- SYM O
43 CD O
. . O
5 CD O
) -RRB- O
( -LRB- O
Table NN O
4 CD O
) -RRB- O
. . O

The DT O
effect NN O
of IN O
oral JJ O
contraceptive NN O
use NN O
in IN O
combination NN O
with IN O
travel NN O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
on IN O
the DT O
risk NN O
of IN O
DVT NNP O
was VBD O
studied VBN O
in IN O
589 CD O
women NNS B-Species
and CC O
was VBD O
somewhat RB O
lower JJR O
than IN O
the DT O
effect NN O
on IN O
the DT O
risk NN O
of IN O
all DT O
venous JJ O
thrombosis NN O
( -LRB- O
SI NN O
1 CD O
. . O
9 CD O
; : O
95 CD O
% NN O
CI NN O
0 CD O
. . O
9 CD O
- SYM O
4 CD O
. . O
2 CD O
) -RRB- O
. . O

In IN O
those DT O
who WP O
traveled VBD O
by IN O
air NN O
it PRP O
was VBD O
also RB O
a DT O
bit NN O
lower JJR O
( , O
SI NNP O
3 CD O
. . O
4 CD O
; : O
95 CD O
% NN O
CI NN O
1 CD O
. . O
3 CD O
- SYM O
8 CD O
. . O
8 CD O
) -RRB- O
, , O
but CC O
still RB O
indicative JJ O
of IN O
a DT O
strong JJ O
synergistic JJ O
effect NN O
. . O

Discussion NN O

In IN O
this DT O
population NN O
- HYPH O
based VBN O
case NN O
- HYPH O
control NN O
study NN O
, , O
long JJ O
- HYPH O
distance NN O
traveling NN O
increased VBD O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
2 CD O
- HYPH O
fold NN O
. . O

Travel NN O
by IN O
air NN O
increased VBD O
the DT O
risk NN O
to IN O
the DT O
same JJ O
extent NN O
as IN O
travel NN O
by IN O
car NN O
, , O
bus NN O
, , O
or CC O
train NN O
. . O

The DT O
risk NN O
was VBD O
highest JJS O
in IN O
the DT O
first JJ O
week NN O
after IN O
traveling VBG O
. . O

As IN O
venous JJ O
thrombosis NN O
is VBZ O
a DT O
disease NN O
in IN O
which WDT O
many JJ O
factors NNS O
( , O
genetic JJ O
and CC O
acquired VBN O
) , O
interact VBP O
[ -LRB- O
21 CD O
] -RRB- O
, , O
we PRP O
identified VBD O
groups NNS O
with IN O
additional JJ O
risk NN O
factors NNS O
in IN O
which WDT O
the DT O
risk NN O
was VBD O
further RB O
increased VBN O
. . O

This DT O
was VBD O
the DT O
case NN O
for IN O
individuals NNS O
with IN O
factor NN O
V NN O
Leiden NNP O
, , O
obese JJ O
people NNS B-Species
( , O
BMI NNP O
> SYM O
30 CD O
kg NNS O
/ SYM O
m2 CD O
) -RRB- O
, , O
and CC O
short JJ O
( , O
only RB O
for IN O
travel NN O
by IN O
air NN O
) , O
and CC O
tall JJ O
people NNS B-Species
, , O
as RB O
well RB O
as IN O
for IN O
women NNS B-Species
using VBG O
oral JJ O
contraceptives NNS O
. . O

Some DT O
of IN O
these DT O
synergistic JJ O
effects NNS O
were VBD O
more RBR O
apparent JJ O
for IN O
air NN O
travel NN O
. . O

Although IN O
the DT O
studies NNS O
that WDT O
have VBP O
been VBN O
published VBN O
so RB O
far RB O
have VBP O
not RB O
yielded VBN O
entirely RB O
consistent JJ O
results NNS O
, , O
those DT O
that WDT O
did VBD O
report VB O
an DT O
increased VBN O
risk NN O
of IN O
venous JJ O
thrombosis NN O
in IN O
air NN O
travelers NNS O
showed VBD O
similar JJ O
risk NN O
estimates NNS O
of IN O
a DT O
2 CD O
- HYPH O
to IN O
3 CD O
- HYPH O
fold NN O
increased VBN O
risk NN O
( , O
even RB O
in IN O
one CD O
with IN O
asymptomatic JJ O
events NNS O
only RB O
[ -LRB- O
4 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
occurrence NN O
of IN O
venous JJ O
thrombosis NN O
was VBD O
highest JJS O
in IN O
the DT O
first JJ O
week NN O
after IN O
travel NN O
, , O
and CC O
slowly RB O
declined VBD O
afterwards RB O
, , O
a DT O
pattern NN O
that WDT O
was VBD O
also RB O
described VBN O
in IN O
a DT O
recent JJ O
record NN O
- HYPH O
linking VBG O
study NN O
from IN O
Australia NNP O
[ -LRB- O
1 CD O
] -RRB- O
, , O
supporting VBG O
a DT O
causal JJ O
relation NN O
. . O

As IN O
a DT O
possible JJ O
mechanism NN O
for IN O
an DT O
extra JJ O
risk NN O
in IN O
travelers NNS O
who WP O
fly VBP O
, , O
an DT O
effect NN O
of IN O
hypobaric JJ O
hypoxia NN O
on IN O
the DT O
coagulation NN O
system NN O
was VBD O
postulated VBN O
, , O
which WDT O
has VBZ O
already RB O
been VBN O
studied VBN O
a DT O
number NN O
of IN O
times NNS O
, , O
mainly RB O
in IN O
hypobaric JJ O
chambers NNS O
, , O
with IN O
unclear JJ O
results NNS O
so RB O
far RB O
. . O

Our PRP$ O
study NN O
showed VBD O
an DT O
increased VBN O
risk NN O
in IN O
all DT O
types NNS O
of IN O
travel NN O
, , O
which WDT O
suggests VBZ O
that IN O
the DT O
increased VBN O
risk NN O
of IN O
flying NN O
is VBZ O
caused VBN O
mainly RB O
by IN O
immobilization NN O
. . O

Additionally RB O
, , O
the DT O
risk NN O
is VBZ O
further RB O
increased VBN O
in IN O
short JJ O
and CC O
tall JJ O
people NNS B-Species
, , O
who WP O
are VBP O
likely JJ O
to TO O
experience VB O
more JJR O
immobilization NN O
and CC O
venous JJ O
compression NN O
than IN O
other JJ O
travelers NNS O
. . O

However RB O
, , O
as IN O
some DT O
of IN O
our PRP$ O
findings NNS O
were VBD O
more RBR O
pronounced VBN O
for IN O
air NN O
travel NN O
, , O
we PRP O
cannot MD O
exclude VB O
an DT O
additional JJ O
effect NN O
of IN O
hypobaric JJ O
hypoxia NN O
, , O
possibly RB O
in IN O
risk NN O
groups NNS O
only RB O
. . O

This DT O
possibility NN O
is VBZ O
supported VBN O
by IN O
a DT O
recent JJ O
study NN O
of IN O
our PRP$ O
group NN O
[ -LRB- O
22 CD O
] -RRB- O
in IN O
which WDT O
we PRP O
found VBD O
that IN O
thrombin NN O
generation NN O
occurred VBD O
in IN O
some DT O
healthy JJ O
volunteers NNS O
after IN O
flying VBG O
for IN O
8 CD O
h NNS O
but CC O
happened VBD O
to IN O
a DT O
far RB O
lesser JJR O
extent NN O
after IN O
being VBG O
immobilized VBN O
for IN O
8 CD O
h NN O
in IN O
a DT O
cinema NN O
. . O

The DT O
high JJ O
response NN O
in IN O
the DT O
fliers NNS O
was VBD O
associated VBN O
with IN O
the DT O
presence NN O
of IN O
risk NN O
factors NNS O
for IN O
thrombosis NN O
, , O
i LS O
. . O
e LS O
. . O
, , O
oral JJ O
contraceptive NN O
use NN O
, , O
the DT O
factor NN O
V NN O
Leiden NNP O
mutation NN O
, , O
and CC O
the DT O
combination NN O
of IN O
the DT O
two CD O
. . O

This DT O
finding NN O
indicates VBZ O
an DT O
effect NN O
of IN O
an DT O
additional JJ O
factor NN O
in IN O
an DT O
airplane NN O
, , O
such JJ O
as IN O
hypobaric JJ O
hypoxia NN O
, , O
to IN O
which WDT O
mainly RB O
individuals NNS O
with IN O
risk NN O
factors NNS O
respond VBP O
. . O

None NN O
of IN O
the DT O
studies NNS O
published VBN O
so RB O
far RB O
have VBP O
systematically RB O
studied VBN O
the DT O
effect NN O
of IN O
traveling VBG O
in IN O
combination NN O
with IN O
other JJ O
risk NN O
factors NNS O
, , O
with IN O
the DT O
exception NN O
of IN O
the DT O
study NN O
by IN O
Martinelli NNP O
et FW O
al NNP O
. . O

[ -LRB- O
3 CD O
] -RRB- O
. . O

In IN O
an DT O
analysis NN O
of IN O
210 CD O
patients NNS B-Species
, , O
they PRP O
found VBD O
a DT O
16 CD O
- HYPH O
fold NN O
increased VBN O
risk NN O
for IN O
patients NNS B-Species
who WP O
traveled VBD O
by IN O
air NN O
and CC O
had VBD O
some DT O
form NN O
of IN O
thrombophilia NN O
, , O
as RB O
well RB O
as IN O
a DT O
14 CD O
- HYPH O
fold NN O
increased VBN O
risk NN O
in IN O
women NNS B-Species
who WP O
flew VBD O
and CC O
used VBD O
oral JJ O
contraceptives NNS O
, , O
findings NNS O
that WDT O
confirm VBP O
both DT O
the DT O
results NNS O
of IN O
the DT O
present JJ O
study NN O
and CC O
our PRP$ O
finding NN O
of IN O
activated VBN O
coagulation NN O
in IN O
individuals NNS O
with IN O
risk NN O
factors NNS O
after IN O
flying VBG O
[ -LRB- O
22 CD O
] -RRB- O
. . O

The DT O
finding NN O
that IN O
taller JJR O
and CC O
shorter JJR O
people NNS B-Species
had VBD O
an DT O
increased VBN O
risk NN O
of IN O
venous JJ O
thrombosis NN O
after IN O
traveling VBG O
should MD O
be VB O
interpreted VBN O
with IN O
some DT O
caution NN O
, , O
as IN O
the DT O
numbers NNS O
were VBD O
small JJ O
in IN O
these DT O
strata NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
it PRP O
is VBZ O
biologically RB O
plausible JJ O
: : O
very RB O
tall JJ O
people NNS B-Species
are VBP O
subjected VBN O
to IN O
even RB O
more RBR O
cramped JJ O
seating NN O
than IN O
average JJ O
- HYPH O
height NN O
individuals NNS O
, , O
and CC O
very RB O
short JJ O
people NNS B-Species
' POS O
s POS O
feet NNS O
may MD O
not RB O
touch VB O
the DT O
floor NN O
, , O
which WDT O
would MD O
lead VB O
to IN O
extra JJ O
compression NN O
of IN O
the DT O
popliteal JJ O
veins NNS O
. . O

Interestingly RB O
, , O
the DT O
increased VBN O
risk NN O
for IN O
short JJ O
people NNS B-Species
was VBD O
only RB O
found VBN O
in IN O
people NNS B-Species
who WP O
traveled VBD O
by IN O
air NN O
. . O

This DT O
may MD O
have VB O
to TO O
do VB O
with IN O
the DT O
fact NN O
that IN O
seats NNS O
in IN O
cars NNS O
are VBP O
generally RB O
lower JJR O
, , O
and CC O
more RBR O
individually RB O
adjustable JJ O
, , O
than IN O
those DT O
in IN O
airplanes NNS O
. . O

As IN O
the DT O
diagnosis NN O
of IN O
DVT NNP O
is VBZ O
usually RB O
more RBR O
unambiguous JJ O
than IN O
that DT O
of IN O
PE NNP O
[ -LRB- O
23 CD O
] -RRB- O
, , O
as IN O
was VBD O
the DT O
case NN O
in IN O
our PRP$ O
study NN O
population NN O
as RB O
well RB O
, , O
we PRP O
repeated VBD O
the DT O
analysis NN O
using VBG O
only RB O
DVT NNP O
as IN O
the DT O
outcome NN O
of IN O
interest NN O
( : O
97 CD O
% NN O
objectively RB O
diagnosed VBN O
) -RRB- O
. . O

In IN O
this DT O
analysis NN O
, , O
despite IN O
using VBG O
smaller JJR O
numbers NNS O
, , O
most JJS O
findings NNS O
were VBD O
either CC O
similar JJ O
or CC O
appeared VBD O
more RBR O
evident JJ O
, , O
and CC O
inconsistencies NNS O
that WDT O
were VBD O
found VBN O
when WRB O
using VBG O
both CC O
DVT NNP O
and CC O
PE NN O
as IN O
endpoints NNS O
disappeared VBD O
. . O

To IN O
our PRP$ O
knowledge NN O
, , O
this DT O
is VBZ O
the DT O
first JJ O
large JJ O
population NN O
- HYPH O
based VBN O
case NN O
- HYPH O
control NN O
study NN O
in IN O
which WDT O
the DT O
effect NN O
of IN O
travel NN O
on IN O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
has VBZ O
been VBN O
studied VBN O
. . O

Because IN O
the DT O
control NN O
individuals NNS O
were VBD O
closely RB O
matched VBN O
, , O
being VBG O
partners NNS O
of IN O
the DT O
cases NNS O
, , O
and CC O
couples NNS O
tend VBP O
to TO O
travel VB O
together RB O
, , O
only RB O
the DT O
cases NNS O
and CC O
control NN O
individuals NNS O
who WP O
had VBD O
not RB O
traveled VBN O
together RB O
could MD O
be VB O
used VBN O
for IN O
the DT O
analysis NN O
. . O

Also RB O
because IN O
of IN O
this DT O
design NN O
, , O
the DT O
effect NN O
of IN O
sex NN O
and CC O
age NN O
could MD O
not RB O
be VB O
studied VBN O
. . O

It PRP O
has VBZ O
to TO O
be VB O
noted VBN O
, , O
however RB O
, , O
that IN O
for IN O
all DT O
other JJ O
research NN O
questions NNS O
on IN O
the DT O
effect NN O
of IN O
genetic JJ O
and CC O
acquired VBN O
risk NN O
factors NNS O
on IN O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
, , O
this DT O
design NN O
has VBZ O
no DT O
limitations NNS O
and CC O
the DT O
close JJ O
matching NN O
of IN O
cases NNS O
and CC O
controls NNS O
renders VBZ O
confounding JJ O
by IN O
, , O
for IN O
instance NN O
, , O
lifestyle NN O
and CC O
socioeconomic JJ O
class NN O
less RBR O
likely JJ O
than IN O
in IN O
previous JJ O
unmatched JJ O
studies NNS O
( , O
see VB O
also RB O
Protocol NNP O
S1 NNP O
) -RRB- O
. . O

Another DT O
advantage NN O
of IN O
this DT O
approach NN O
is VBZ O
the DT O
minimization NN O
of IN O
recall NN O
bias NN O
, , O
as IN O
the DT O
cases NNS O
and CC O
controls NNS O
would MD O
generally RB O
fill VB O
in RP O
the DT O
questionnaire NN O
together RB O
. . O

Many JJ O
questions NNS O
are VBP O
still RB O
left VBN O
unanswered JJ O
that WDT O
necessitate VBP O
more JJR O
research NN O
. . O

First RB O
of IN O
all DT O
, , O
our PRP$ O
study NN O
results NNS O
apply VBP O
only RB O
to IN O
people NNS B-Species
younger JJR O
than IN O
70 CD O
y NN O
of IN O
age NN O
. . O

Furthermore RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
other JJ O
characteristics NNS O
exist VBP O
that WDT O
also RB O
increase VBP O
the DT O
risk NN O
- HYPH O
- HYPH O
person NN B-Species
- HYPH O
specific JJ O
( : O
e LS O
. . O
g LS O
. . O
, , O
other JJ O
drug NN O
use NN O
) -RRB- O
, , O
behavioral JJ O
( , O
e LS O
. . O
g LS O
. . O
, , O
use NN O
of IN O
sleeping NN O
pills NNS O
or CC O
alcohol NN O
consumption NN O
) -RRB- O
, , O
and CC O
flight NN O
- HYPH O
specific NN O
( : O
e LS O
. . O
g LS O
. . O
, , O
class NN O
or CC O
seating NN O
) -RRB- O
- : O
- : O
that WDT O
need VBP O
to TO O
be VB O
identified VBN O
. . O

These DT O
further JJ O
variables NNS O
are VBP O
part NN O
of IN O
our PRP$ O
ongoing JJ O
study NN O
as IN O
part NN O
of IN O
the DT O
World NNP O
Health NNP O
Organization NNP O
Research NNP O
Initiative NNP O
into IN O
the DT O
Global NNP O
Hazards NNPS O
of IN O
Travel NNP O
( , O
WRIGHT NNP O
study NN O
) -RRB- O
. . O

For IN O
those DT O
who WP O
have VBP O
an DT O
increased JJ O
risk NN O
, , O
such JJ O
as IN O
oral JJ O
contraceptive JJ O
users NNS O
and CC O
individuals NNS O
with IN O
factor NN O
V NN O
Leiden NNP O
, , O
prevention NN O
may MD O
be VB O
warranted VBN O
. . O

Prevention NN O
may MD O
vary VB O
from IN O
simple JJ O
measures NNS O
, , O
such JJ O
as IN O
exercises NNS O
during IN O
the DT O
flight NN O
, , O
to IN O
measures NNS O
that WDT O
carry VBP O
a DT O
risk NN O
themselves PRP O
, , O
such JJ O
as IN O
anticoagulants NNS O
. . O

Specific JJ O
studies NNS O
are VBP O
needed VBN O
to TO O
assess VB O
the DT O
efficacy NN O
of IN O
these DT O
measures NNS O
and CC O
their PRP$ O
risk NN O
- HYPH O
benefit NN O
ratio NN O
. . O

It PRP O
can MD O
be VB O
concluded VBN O
that IN O
the DT O
risk NN O
of IN O
venous JJ O
thrombosis NN O
is VBZ O
2 CD O
- HYPH O
fold NN O
increased VBN O
for IN O
all DT O
travelers NNS O
and CC O
to IN O
the DT O
same JJ O
extent NN O
for IN O
all DT O
modes NNS O
of IN O
travel NN O
. . O

In IN O
individuals NNS O
who WP O
use VBP O
oral JJ O
contraceptives NNS O
, , O
are VBP O
carriers NNS O
of IN O
the DT O
factor NN O
V NN O
Leiden NNP O
mutation NN O
, , O
or CC O
are VBP O
particularly RB O
tall JJ O
, , O
short JJ O
, , O
or CC O
obese JJ O
, , O
this DT O
risk NN O
is VBZ O
considerably RB O
higher JJR O
, , O
to IN O
such PDT O
an DT O
extent NN O
that IN O
studies NNS O
into IN O
the DT O
efficacy NN O
of IN O
prophylactic JJ O
measures NNS O
are VBP O
required VBN O
. . O

Supporting VBG O
Information NN O

The DT O
role NN O
of IN O
the DT O
muscarinic JJ O
system NN O
in IN O
regulating VBG O
estradiol NN O
secretion NN O
varies VBZ O
during IN O
the DT O
estrous JJ O
cycle NN O
: : O
the DT O
hemiovariectomized JJ O
rat NN B-Species
model NN O

Abstract JJ O

There EX O
is VBZ O
evidence NN O
that IN O
one CD O
gonad NN O
has VBZ O
functional JJ O
predominance NN O
. . O

The DT O
present JJ O
study NN O
analyzed VBD O
the DT O
acute JJ O
effects NNS O
of IN O
unilateral JJ O
ovariectomy NN O
( , O
ULO NNP O
) -RRB- O
and CC O
blocking VBG O
the DT O
cholinergic JJ O
system NN O
, , O
by IN O
injecting VBG O
atropine NN O
sulfate NN O
( -LRB- O
ATR NNP O
) -RRB- O
, , O
on IN O
estradiol NN O
( -LRB- O
E2 NNP O
) -RRB- O
serum NN O
concentrations NNS O
during IN O
the DT O
estrous JJ O
cycle NN O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
ULO NNP O
effects NNS O
on IN O
E2 NNP O
concentrations NNS O
are VBP O
asymmetric JJ O
, , O
vary VBP O
during IN O
the DT O
estrous JJ O
cycle NN O
, , O
and CC O
partially RB O
depend VBP O
on IN O
the DT O
cholinergic JJ O
innervation NN O
. . O

Background NN O

Estradiol NNP O
secretion NN O
is VBZ O
regulated VBN O
by IN O
pituitary NN O
[ -LRB- O
follicle NN O
stimulating VBG O
hormone NN O
( , O
FSH NNP O
) -RRB- O
and CC O
luteinizing VBG O
hormones NNS O
( , O
LH NNP O
) -RRB- O
, , O
prolactin NN O
, , O
and CC O
adrenocorticotropin NN O
( , O
ACTH NNP O
) -RRB- O
] -RRB- O
. . O

The DT O
effects NNS O
of IN O
these DT O
hormones NNS O
are VBP O
modulated VBN O
by IN O
neurotransmitters NNS O
released VBN O
by IN O
the DT O
intrinsic JJ O
ovarian JJ O
innervation NN O
near IN O
the DT O
follicular JJ O
wall NN O
. . O

Acetylcholine NN O
produced VBN O
by IN O
the DT O
follicle NN O
may MD O
be VB O
one CD O
of IN O
the DT O
neurotransmitters NNS O
participating VBG O
in IN O
modulating VBG O
the DT O
effects NNS O
of IN O
pituitary JJ O
hormones NNS O
on IN O
the DT O
follicle NN O
[ -LRB- O
1 CD O
- HYPH O
3 CD O
] -RRB- O
. . O

Evidence NN O
suggesting VBG O
that IN O
one CD O
gonad NN O
has VBZ O
functional JJ O
predominance NN O
in IN O
mammals NNS O
and CC O
birds NNS O
have VBP O
been VBN O
published VBN O
[ -LRB- O
1 CD O
, , O
4 CD O
- HYPH O
8 CD O
] -RRB- O
. . O

In IN O
previous JJ O
studies NNS O
we PRP O
have VBP O
shown VBN O
that IN O
unilateral JJ O
ovariectomy NN O
( , O
ULO NNP O
) -RRB- O
modifies VBZ O
progesterone NN O
and CC O
/ SYM O
or CC O
testosterone NN O
serum NN O
concentrations NNS O
, , O
and CC O
that IN O
the DT O
effects NNS O
of IN O
ULO NNP O
depend VBP O
on IN O
both DT O
, , O
the DT O
stage NN O
of IN O
the DT O
estrous JJ O
cycle NN O
when WRB O
ULO NNP O
was VBD O
performed VBN O
and CC O
the DT O
ovary NN O
( , O
left VBN O
or CC O
right RB O
) -RRB- O
remaining VBG O
in IN O
situ NN O
[ -LRB- O
9 CD O
- SYM O
11 CD O
] -RRB- O
. . O

Asymmetry NN O
in IN O
ovarian JJ O
functions NNS O
has VBZ O
been VBN O
explained VBN O
by IN O
differences NNS O
in IN O
the DT O
ovarian JJ O
innervation NN O
participating VBG O
in IN O
modulating VBG O
the DT O
effects NNS O
of IN O
gonadotropin NN O
on IN O
the DT O
ovarian JJ O
follicles NNS O
[ -LRB- O
1 CD O
, , O
6 CD O
] -RRB- O
. . O

Kawakami NNP O
et FW O
al NNP O
[ -LRB- O
12 CD O
] -RRB- O
showed VBD O
that IN O
electrical JJ O
stimulation NN O
of IN O
the DT O
medial JJ O
basal JJ O
pre NN O
- HYPH O
chiasmatic JJ O
area NN O
, , O
the DT O
ventro NN O
- HYPH O
medial JJ O
hypothalamus NN O
, , O
and CC O
the DT O
areas NNS O
in IN O
the DT O
mesencephalon NN O
of IN O
hypophysectomized JJ O
and CC O
adrenalectomized VBN O
female JJ O
rats NNS B-Species
resulted VBD O
in IN O
a DT O
significant JJ O
increase NN O
of IN O
estradiol NN O
( , O
E2 NN O
) -RRB- O
and CC O
progesterone NN O
( -LRB- O
P4 NN O
) -RRB- O
plasma NN O
concentrations NNS O
in IN O
the DT O
contra JJ O
- HYPH O
lateral JJ O
ovarian JJ O
venous JJ O
blood NN O
. . O

In IN O
turn NN O
, , O
stimulating VBG O
the DT O
dorsal JJ O
hippocampus NN O
, , O
the DT O
lateral JJ O
amygdala NN O
, , O
and CC O
the DT O
mesencephalic JJ O
areas NNS O
resulted VBD O
in IN O
lower JJR O
E2 NN O
and CC O
P4 NN O
concentrations NNS O
. . O

Ovarian JJ O
denervation NN O
of IN O
rats NNS B-Species
in IN O
proestrus NN O
stage NN O
blocks VBZ O
E2 NNP O
secretion NN O
induced VBN O
by IN O
stimulating VBG O
the DT O
medial JJ O
basal JJ O
pre NN O
- HYPH O
chiasmatic JJ O
area NN O
. . O

In IN O
addition NN O
, , O
the DT O
electrochemical JJ O
stimulation NN O
in IN O
proestrus NN O
day NN O
of IN O
the DT O
medial JJ O
basal JJ O
pre NN O
- HYPH O
chiasmatic JJ O
area NN O
of IN O
untreated JJ O
rats NNS B-Species
increased VBD O
E2 NN O
and CC O
P4 NN O
concentrations NNS O
in IN O
serum NN O
. . O

This DT O
effect NN O
was VBD O
not RB O
observed VBN O
when WRB O
stimulation NN O
was VBD O
applied VBN O
to IN O
the DT O
pre JJ O
- HYPH O
optic JJ O
supra NN O
- HYPH O
chiasmatic JJ O
area NN O
. . O

According VBG O
to IN O
the DT O
authors NNS O
' POS O
interpretation NN O
of IN O
the DT O
results NNS O
, , O
the DT O
efferent JJ O
neural JJ O
system NN O
connecting VBG O
the DT O
brain NN O
and CC O
the DT O
ovaries NNS O
is VBZ O
supplementary JJ O
to IN O
the DT O
brain NN O
- HYPH O
pituitary JJ O
- HYPH O
ovarian JJ O
hormonal JJ O
mechanisms NNS O
regulating VBG O
ovarian JJ O
steroid NN O
secretion NN O
, , O
and CC O
the DT O
system NN O
may MD O
be VB O
required VBN O
for IN O
adjusting VBG O
ovarian JJ O
responsiveness NN O
and CC O
sensitivity NN O
to IN O
gonadotropins NNS O
[ -LRB- O
12 CD O
, , O
13 CD O
] -RRB- O
. . O

Gerendai NNP O
et FW O
al FW O
. . O

[ -LRB- O
14 CD O
] -RRB- O
described VBD O
a DT O
multi JJ O
- HYPH O
synaptic JJ O
neural JJ O
pathway NN O
between IN O
the DT O
central JJ O
nervous JJ O
system NN O
and CC O
the DT O
ovaries NNS O
, , O
with IN O
the DT O
vagus JJ O
nerve NN O
being VBG O
one CD O
of IN O
the DT O
main JJ O
neural JJ O
pathways NNS O
. . O

In IN O
ULO NNP O
treated VBN O
rats NNS B-Species
, , O
bi NN O
- HYPH O
lateral JJ O
sectioning VBG O
the DT O
vagus JJ O
nerve NN O
( , O
ventral JJ O
or CC O
dorsal NN O
) , O
results VBZ O
in IN O
lower JJR O
compensatory JJ O
ovarian JJ O
hypertrophy NN O
. . O

The DT O
effects NNS O
of IN O
sectioning VBG O
the DT O
left JJ O
vagus JJ O
nerve NN O
depend VBP O
on IN O
the DT O
remaining VBG O
ovary NN O
in IN O
situ NN O
: : O
rats NNS B-Species
with IN O
the DT O
left JJ O
ovary NN O
in IN O
situ NN O
had VBD O
a DT O
larger JJR O
proportion NN O
of IN O
ovulating VBG O
animals NNS O
, , O
compensatory JJ O
ovarian JJ O
hypertrophy NN O
and CC O
number NN O
of IN O
ova NN O
shed NN O
. . O

In IN O
turn NN O
, , O
rats NNS B-Species
with IN O
the DT O
right JJ O
ovary NN O
in IN O
situ NN O
showed VBD O
a DT O
decrease NN O
in IN O
all DT O
parameters NNS O
studied VBN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Based VBN O
on IN O
available JJ O
information NN O
, , O
the DT O
present JJ O
study NN O
aims VBZ O
to TO O
analyze VB O
if IN O
changes NNS O
in IN O
E2 NNP O
secretion NN O
by IN O
the DT O
left JJ O
and CC O
right JJ O
ovaries NNS O
vary VBP O
during IN O
the DT O
estrous JJ O
cycle NN O
, , O
using VBG O
the DT O
unilateral JJ O
ovariectomized JJ O
animal NN O
as IN O
a DT O
model NN O
of IN O
study NN O
. . O

We PRP O
also RB O
investigated VBD O
if IN O
, , O
throughout IN O
estrous JJ O
cycle NN O
diestrus NN O
1 CD O
( , O
D1 NNP O
) -RRB- O
, , O
diestrus NN O
2 CD O
( , O
D2 NN O
) -RRB- O
and CC O
proestrus NN O
( , O
P NN O
) -RRB- O
, , O
the DT O
cholinergic JJ O
system NN O
modulates VBZ O
E2 NNP O
secretion NN O
in IN O
an DT O
asymmetric JJ O
way NN O
. . O

For IN O
this DT O
purpose NN O
, , O
we PRP O
analyzed VBD O
the DT O
effects NNS O
of IN O
injecting VBG O
ATR NNP O
at IN O
13 CD O
. . O
0 CD O
h NN O
to IN O
rats NNS B-Species
on IN O
D1 NNP O
, , O
D2 NN O
or CC O
P NN O
with IN O
or CC O
without IN O
unilateral JJ O
or CC O
bilateral JJ O
ovariectomy NN O
. . O

Materials NNS O
and CC O
methods NNS O

The DT O
study NN O
was VBD O
performed VBN O
with IN O
virgin JJ O
adult NN O
female JJ O
rats NNS B-Species
( : O
195 CD O
- SYM O
225 CD O
- HYPH O
g NN O
body NN O
weight NN O
) -RRB- O
of IN O
the DT O
CIIZ NNP O
- HYPH O
V NN O
strain NN O
from IN O
our PRP$ O
own JJ O
stock NN O
. . O

Animals NNS O
were VBD O
kept VBN O
under IN O
controlled VBN O
lighting NN O
conditions NNS O
( , O
lights NNS O
on IN O
from IN O
5 CD O
: SYM O
0 CD O
to IN O
19 CD O
: SYM O
0 CD O
h NN O
) -RRB- O
, , O
with IN O
free JJ O
access NN O
to IN O
food NN O
( , O
Purina NNP O
S NNP O
. . O
A NNP O
. . O
, , O
Mexico NNP O
) -RRB- O
and CC O
tap NN O
water NN O
; , O
following VBG O
NIH NNP O
Guide NNP O
parameters NNS O
for IN O
the DT O
care NN O
of IN O
laboratory NN O
animals NNS O
. . O

The DT O
Committee NNP O
of IN O
the DT O
Facultad NNP O
de NNP O
Estudios NNP O
Superiores NNP O
Zaragoza NNP O
approved VBD O
the DT O
experimental JJ O
protocols NNS O
. . O

Estrous JJ O
cycles NNS O
were VBD O
monitored VBN O
by IN O
daily JJ O
vaginal JJ O
smears NNS O
. . O

Only RB O
rats NNS B-Species
showing VBG O
at IN O
least JJS O
two CD O
consecutive JJ O
4 CD O
- HYPH O
day NN O
cycles NNS O
were VBD O
used VBN O
in IN O
the DT O
experiment NN O
. . O

All DT O
surgeries NNS O
were VBD O
performed VBN O
under IN O
ether JJ O
anesthesia NN O
, , O
between IN O
13 CD O
: SYM O
0 CD O
- SYM O
13 CD O
: SYM O
15 CD O
hours NNS O
. . O

Rats NNS B-Species
were VBD O
sacrificed VBN O
by IN O
decapitation NN O
one CD O
hour NN O
after IN O
treatment NN O
. . O

Experimental JJ O
groups NNS O

Rats NNS B-Species
were VBD O
randomly RB O
allotted VBN O
to IN O
one CD O
of IN O
the DT O
experimental JJ O
groups NNS O
described VBN O
below RB O
. . O

Animals NNS O
from IN O
different JJ O
experimental JJ O
groups NNS O
were VBD O
treated VBN O
simultaneously RB O
and CC O
sacrificed VBN O
one CD O
hour NN O
after IN O
surgery NN O
. . O

The DT O
number NN O
of IN O
animals NNS O
used VBN O
in IN O
each DT O
experimental JJ O
group NN O
is VBZ O
presented VBN O
in IN O
Tables NNP O
1 CD O
, , O
2 CD O
and CC O
3 CD O
. . O

Control NN O
group NN O
( : O
N NNP O
= SYM O
48 CD O
) -RRB- O
. . O

Non RB O
- HYPH O
treated VBN O
cyclic JJ O
rats NNS B-Species
sacrificed VBD O
at IN O
14 CD O
: SYM O
0 CD O
h CD O
on IN O
D1 NNP O
( , O
17 CD O
rats NNS B-Species
) -RRB- O
, , O
D2 NNP O
( , O
19 CD O
rats NNS B-Species
) -RRB- O
and CC O
P NN O
( SYM O
12 CD O
rats NNS B-Species
) -RRB- O
. . O

Ether NNP O
anesthesia NN O
( : O
N NNP O
= SYM O
24 CD O
) -RRB- O
: : O
Groups NNS O
of IN O
rats NNS B-Species
, , O
on IN O
specific JJ O
stages NNS O
( -LRB- O
D1 NNP O
, , O
D2 NNP O
or CC O
P NNP O
) -RRB- O
of IN O
the DT O
estrous JJ O
cycle NN O
, , O
were VBD O
anesthetized VBN O
for IN O
10 CD O
min NN O
and CC O
sacrificed VBN O
one CD O
hour NN O
later RB O
. . O

Unilateral JJ O
peritoneal JJ O
perforation NN O
( : O
sham NN O
operation NN O
) -RRB- O
( , O
N NNP O
= SYM O
53 CD O
) -RRB- O
: : O
A DT O
unilateral JJ O
incision NN O
was VBD O
performed VBN O
2 CD O
- HYPH O
cm NN O
below IN O
the DT O
last JJ O
rib NN O
; , O
affecting VBG O
skin NN O
, , O
muscle NN O
, , O
and CC O
peritoneum NN O
. . O

The DT O
ovaries NNS O
were VBD O
not RB O
injured VBN O
or CC O
manipulated VBN O
. . O

After IN O
surgical JJ O
procedures NNS O
the DT O
wound NN O
was VBD O
sealed VBN O
. . O

Bilateral JJ O
peritoneal JJ O
perforation NN O
( : O
sham NN O
operation NN O
2 CD O
) -RRB- O
( , O
N NNP O
= SYM O
27 CD O
) -RRB- O
. . O

A DT O
bilateral JJ O
incision NN O
below IN O
the DT O
last JJ O
rib NN O
, , O
including VBG O
skin NN O
and CC O
muscle NN O
, , O
was VBD O
performed VBN O
. . O

The DT O
ovaries NNS O
were VBD O
not RB O
injured VBN O
or CC O
manipulated VBN O
. . O

After IN O
surgical JJ O
procedures NNS O
the DT O
wound NN O
was VBD O
sealed VBN O
. . O

Unilateral JJ O
ovariectomy NN O
( , O
ULO NNP O
) -RRB- O
( , O
N NNP O
= SYM O
50 CD O
) -RRB- O
: : O
A DT O
unilateral JJ O
incision NN O
below IN O
the DT O
last JJ O
rib NN O
, , O
including VBG O
skin NN O
and CC O
muscle NN O
was VBD O
performed VBN O
, , O
and CC O
the DT O
right JJ O
or CC O
left JJ O
ovary NN O
was VBD O
extirpated VBN O
. . O

The DT O
wound NN O
was VBD O
subsequently RB O
sealed VBN O
. . O

Bilateral JJ O
ovariectomy NN O
( : O
N NNP O
= SYM O
23 CD O
) -RRB- O
: : O
A DT O
bilateral JJ O
incision NN O
below IN O
the DT O
last JJ O
rib NN O
, , O
including VBG O
skin NN O
and CC O
muscle NN O
was VBD O
performed VBN O
, , O
and CC O
the DT O
ovaries NNS O
removed VBN O
. . O

The DT O
wound NN O
was VBD O
subsequently RB O
sealed VBN O
. . O

Blocking VBG O
the DT O
cholinergic JJ O
system NN O

To TO O
analyze VB O
the DT O
effects NNS O
of IN O
blocking VBG O
the DT O
cholinergic JJ O
system NN O
, , O
groups NNS O
of IN O
animals NNS O
were VBD O
injected VBN O
with IN O
atropine NN O
sulfate NN O
( , O
ATR NNP O
, , O
Sigma NNP O
Chem NNP O
. . O
Co NNP O
. . O
St NNP O
. . O
Louis NNP O
, , O
Mo NNP O
. . O
) -RRB- O
. . O

ATR NNP O
was VBD O
injected VBN O
one CD O
hour NN O
before IN O
surgery NN O
at IN O
doses NNS O
known VBN O
to TO O
block VB O
ovulation NN O
: : O
in IN O
D1 NNP O
, , O
100 CD O
mg NN O
/ SYM O
kg NN O
body NN O
weight NN O
( : O
b NN O
. . O
w UH O
. . O
) -RRB- O
; : O
in IN O
D2 CD O
, , O
300 CD O
mg NN O
/ SYM O
kg NN O
b NN O
. . O
w UH O
. . O
; : O
and CC O
in IN O
P NN O
, , O
700 CD O
mg NN O
/ SYM O
kg NN O
b NN O
. . O
w -RRB- O
. . O

[ -LRB- O
16 CD O
] -RRB- O
. . O

One CD O
hour NN O
after IN O
ATR NNP O
treatment NN O
, , O
rats NNS B-Species
were VBD O
randomly RB O
allotted VBN O
to IN O
one CD O
of IN O
the DT O
following VBG O
treatments NNS O
: : O
unilateral JJ O
peritoneal JJ O
perforation NN O
, , O
bilateral JJ O
peritoneal JJ O
perforation NN O
, , O
ULO NNP O
, , O
or CC O
bilateral JJ O
ovariectomy NN O
. . O

All DT O
animals NNS O
were VBD O
sacrificed VBN O
one CD O
hour NN O
after IN O
surgery NN O
. . O

For IN O
control NN O
purposes NNS O
, , O
untreated JJ O
rats NNS B-Species
, , O
on IN O
D1 NNP O
, , O
D2 NNP O
or CC O
P NNP O
, , O
were VBD O
injected VBN O
with IN O
ATR NNP O
in IN O
the DT O
same JJ O
dose NN O
as IN O
in IN O
their PRP$ O
corresponding JJ O
treatment NN O
group NN O
. . O

The DT O
animals NNS O
were VBD O
sacrificed VBN O
two CD O
hours NNS O
after IN O
treatment NN O
. . O

Autopsy NN O
procedures NNS O

Animals NNS O
were VBD O
sacrificed VBN O
by IN O
decapitation NN O
. . O

The DT O
blood NN O
of IN O
the DT O
trunk NN O
was VBD O
collected VBN O
in IN O
a DT O
test NN O
tube NN O
, , O
allowed VBN O
to TO O
clot VB O
at IN O
room NN O
temperature NN O
for IN O
30 CD O
minutes NNS O
and CC O
centrifuged VBN O
at IN O
3 CD O
, , O
0 CD O
rpm NN O
for IN O
15 CD O
minutes NNS O
. . O

Serum NNP O
was VBD O
stored VBN O
at IN O
- SYM O
20 CD O
degrees NNS O
C NN O
, , O
until IN O
E2 NNP O
concentrations NNS O
were VBD O
measured VBN O
. . O

Hormone NN O
assay NN O

Concentrations NNS O
of IN O
E2 NNP O
in IN O
serum NN O
were VBD O
measured VBN O
by IN O
Radio NNP O
- HYPH O
Immuno NNP O
- HYPH O
Assay NNP O
( , O
RIA NNP O
) -RRB- O
; , O
using VBG O
kits NNS O
purchased VBN O
from IN O
Diagnostic NNP O
Products NNP O
( , O
Los NNP O
Angeles NNP O
, , O
CA NNP O
) -RRB- O
. . O

Results NNS O
are VBP O
expressed VBN O
in IN O
pg NN O
/ SYM O
ml NNP O
. . O

The DT O
Intra NNP O
- HYPH O
and CC O
inter JJ O
- HYPH O
assay NN O
variation NN O
coefficients NNS O
were VBD O
6 CD O
. . O
9 CD O
% NN O
and CC O
10 CD O
. . O
8 CD O
% NN O
, , O
respectively RB O
. . O

Statistics NNS O

Data NNS O
on IN O
hormonal JJ O
concentrations NNS O
in IN O
serum NN O
were VBD O
analyzed VBN O
using VBG O
multivariate JJ O
analysis NN O
of IN O
variance NN O
( , O
MANOVA NNP O
) -RRB- O
followed VBN O
by IN O
Tukey NNP O
' POS O
s NN O
test NN O
. . O

Differences NNS O
in IN O
serum NN O
hormone NN O
concentrations NNS O
between IN O
two CD O
groups NNS O
were VBD O
analyzed VBN O
by IN O
Student NNP O
' '' O
s POS O
t NN O
- HYPH O
test NN O
. . O

A DT O
probability NN O
value NN O
of IN O
less JJR O
than IN O
5 CD O
% NN O
was VBD O
considered VBN O
significant JJ O
. . O

Results NNS O

Effects NNS O
of IN O
ether JJ O
anesthesia NN O
and CC O
unilateral JJ O
or CC O
bilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O

In IN O
the DT O
control NN O
group NN O
, , O
animals NNS O
sacrificed VBN O
on IN O
P NNP O
showed VBD O
significantly RB O
higher JJR O
E2 NNP O
serum NN O
concentration NN O
than IN O
animals NNS O
sacrificed VBN O
on IN O
D1 NNP O
or CC O
D2 NNP O
( , O
D1 CD O
: : O
55 CD O
. . O
3 CD O
+ SYM O
/ SYM O
- SYM O
8 CD O
. . O
0 CD O
; : O
D2 CD O
: : O
59 CD O
. . O
1 CD O
+ SYM O
/ SYM O
- HYPH O
7 CD O
. . O
9 CD O
; : O
P NN O
: : O
158 CD O
. . O
4 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
. . O
8 CD O
) -RRB- O
. . O

Compared VBN O
to IN O
the DT O
control NN O
group NN O
, , O
ether JJ O
anesthesia NN O
treatment NN O
did VBD O
not RB O
modify VB O
E2 NNP O
serum NN O
concentrations NNS O
( : O
D1 CD O
: : O
62 CD O
. . O
9 CD O
+ SYM O
/ SYM O
- SYM O
8 CD O
. . O
4 CD O
; : O
D2 CD O
: : O
69 CD O
. . O
5 CD O
+ SYM O
/ SYM O
- HYPH O
12 CD O
. . O
0 CD O
; : O
P NN O
: : O
164 CD O
. . O
1 CD O
+ SYM O
/ SYM O
- HYPH O
17 CD O
. . O
6 CD O
) -RRB- O
. . O

Since IN O
ether JJ O
anesthesia NN O
did VBD O
not RB O
modify VB O
E2 NNP O
serum NN O
concentrations NNS O
, , O
treatment NN O
results NNS O
are VBP O
compared VBN O
to IN O
their PRP$ O
respective JJ O
control NN O
group NN O
. . O

The DT O
effects NNS O
on IN O
E2 NNP O
serum NN O
concentrations NNS O
of IN O
unilaterally RB O
or CC O
bilaterally RB O
perforating VBG O
the DT O
peritoneum NN O
depended VBD O
on IN O
the DT O
side NN O
of IN O
the DT O
peritoneum NN O
and CC O
the DT O
stage NN O
of IN O
the DT O
estrous JJ O
cycle NN O
when WRB O
perforation NN O
surgery NN O
was VBD O
performed VBN O
. . O

Perforating VBG O
the DT O
left JJ O
peritoneum NN O
on IN O
D1 NNP O
resulted VBD O
in IN O
lower JJR O
E2 NNP O
serum NN O
concentrations NNS O
( , O
55 CD O
% NN O
) -RRB- O
, , O
while IN O
bilateral JJ O
perforation NN O
, , O
or CC O
perforating VBG O
the DT O
right JJ O
side NN O
of IN O
the DT O
peritoneum NN O
, , O
had VBD O
no DT O
apparent JJ O
effects NNS O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

Perforating VBG O
the DT O
right JJ O
side NN O
of IN O
the DT O
peritoneum NN O
on IN O
D2 NNP O
day NN O
resulted VBD O
in IN O
E2 NNP O
concentration NN O
increases NNS O
( : O
184 CD O
% NN O
) -RRB- O
, , O
while IN O
perforating VBG O
the DT O
left JJ O
side NN O
resulted VBD O
in IN O
a DT O
decrease NN O
( , O
51 CD O
% NN O
) -RRB- O
of IN O
E2 NNP O
serum NN O
concentrations NNS O
. . O

Bilateral JJ O
perforation NN O
had VBD O
no DT O
apparent JJ O
effects NNS O
on IN O
hormone NN O
concentrations NNS O
. . O

Perforating VBG O
the DT O
peritoneum NN O
on IN O
P NN O
phase NN O
( , O
left JJ O
, , O
right JJ O
or CC O
bilateral JJ O
) -RRB- O
resulted VBD O
in IN O
hormone NN O
serum NN O
concentration NN O
decreases NNS O
( -LRB- O
Left VBN O
30 CD O
% NN O
; : O
Right JJ O
50 CD O
% NN O
; : O
Bilateral JJ O
41 CD O
% NN O
) -RRB- O
. . O

Results NNS O
are VBP O
summarized VBN O
in IN O
Table NNP O
1 CD O
. . O

Effects NNS O
of IN O
unilateral JJ O
or CC O
bilateral JJ O
ovariectomy NN O

When WRB O
surgery NN O
was VBD O
performed VBN O
on IN O
D1 NNP O
, , O
no DT O
significant JJ O
differences NNS O
in IN O
E2 NNP O
serum NN O
concentrations NNS O
were VBD O
observed VBN O
between IN O
rats NNS B-Species
with IN O
ULO NNP O
( , O
animals NNS O
with IN O
intact JJ O
left JJ O
or CC O
right JJ O
ovary NN O
in IN O
situ NN O
) , O
or CC O
perforation NN O
of IN O
the DT O
peritoneum NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

Animals NNS O
with IN O
the DT O
left JJ O
intact JJ O
ovary NN O
in IN O
situ NN O
showed VBD O
significantly RB O
higher JJR O
E2 NNP O
serum NN O
concentrations NNS O
than IN O
animals NNS O
with IN O
the DT O
right JJ O
intact JJ O
ovary NN O
in IN O
situ NN O
( , O
61 CD O
. . O
5 CD O
+ SYM O
/ SYM O
- HYPH O
9 CD O
. . O
4 CD O
vs NN O
. . O
17 CD O
. . O
3 CD O
+ SYM O
/ SYM O
- HYPH O
4 CD O
. . O
3 CD O
, , O
p NN O
< NN O
0 CD O
. . O
5 CD O
Student NN O
' '' O
s NN O
t NN O
test NN O
) -RRB- O
. . O

Compared VBN O
to IN O
animals NNS O
with IN O
unilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O
, , O
animals NNS O
with IN O
right JJ O
ULO NNP O
( , O
left JJ O
ovary NN O
in IN O
situ NN O
) -RRB- O
performed VBN O
on IN O
D2 NNP O
had VBD O
lower JJR O
E2 NNP O
serum NN O
concentrations NNS O
( : O
55 CD O
% NN O
) -RRB- O
. . O

Such JJ O
differences NNS O
were VBD O
not RB O
observed VBN O
in IN O
rats NNS B-Species
with IN O
left JJ O
ULO NNP O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

As IN O
in IN O
rats NNS B-Species
treated VBN O
on IN O
D1 NNP O
, , O
E2 NNP O
serum NN O
concentrations NNS O
were VBD O
significantly RB O
higher JJR O
in IN O
animals NNS O
treated VBN O
on IN O
D2 NNP O
with IN O
the DT O
left JJ O
ovary NN O
in IN O
situ NN O
( , O
right JJ O
ULO NNP O
) -RRB- O
than IN O
in IN O
animals NNS O
with IN O
the DT O
right JJ O
ovary NN O
in IN O
situ NN O
( , O
49 CD O
. . O
5 CD O
+ SYM O
/ SYM O
- HYPH O
10 CD O
. . O
8 CD O
vs NN O
. . O
26 CD O
. . O
0 CD O
+ SYM O
/ SYM O
- HYPH O
6 CD O
. . O
9 CD O
) -RRB- O
. . O

In IN O
animals NNS O
treated VBN O
on IN O
P NNP O
, , O
right JJ O
ULO NNP O
( , O
left JJ O
ovary NN O
in IN O
situ NN O
) , O
resulted VBD O
in IN O
higher JJR O
E2 NN O
( : O
180 CD O
% NN O
) SYM O
serum JJ O
concentrations NNS O
than IN O
in IN O
animals NNS O
with IN O
unilateral JJ O
peritoneum NN O
perforation NN O
. . O

ULO NNP O
performed VBD O
on IN O
the DT O
left JJ O
side NN O
( , O
right JJ O
ovary NN O
in IN O
situ NN O
) , O
, , O
resulted VBD O
in IN O
significantly RB O
lower JJR O
( : O
45 CD O
% NN O
) SYM O
E2 CD O
serum JJ O
concentrations NNS O
compared VBN O
to IN O
rats NNS B-Species
with IN O
a DT O
unilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

As IN O
observed VBN O
in IN O
rats NNS B-Species
treated VBN O
on IN O
D1 NNP O
or CC O
D2 NNP O
, , O
when WRB O
the DT O
intact JJ O
left JJ O
ovary NN O
remains VBZ O
in IN O
situ NN O
, , O
estradiol NN O
serum NN O
concentrations NNS O
were VBD O
significantly RB O
higher JJR O
than IN O
in IN O
animals NNS O
with IN O
the DT O
intact JJ O
right JJ O
ovary NN O
in IN O
situ NN O
( , O
142 CD O
. . O
0 CD O
+ SYM O
/ SYM O
- HYPH O
14 CD O
. . O
1 CD O
vs NN O
. . O
61 CD O
. . O
5 CD O
+ SYM O
/ SYM O
- HYPH O
6 CD O
. . O
0 CD O
) -RRB- O
. . O

Compared VBN O
to IN O
animals NNS O
with IN O
a DT O
bilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O
, , O
bilateral JJ O
ovariectomy NN O
resulted VBD O
in IN O
significantly RB O
lower JJR O
E2 NNP O
serum NN O
concentrations NNS O
, , O
regardless RB O
of IN O
the DT O
stage NN O
of IN O
the DT O
estrous JJ O
cycle NN O
surgery NN O
performed VBN O
( : O
D1 NN O
74 CD O
% NN O
; : O
D2 NN O
73 CD O
% NN O
; : O
P NN O
84 CD O
% NN O
) -RRB- O
. . O

Results NNS O
are VBP O
summarized VBN O
in IN O
Table NNP O
2 CD O
. . O

Effects NNS O
of IN O
blocking VBG O
the DT O
cholinergic JJ O
system NN O

Injecting VBG O
ATR NNP O
on IN O
D1 NNP O
or CC O
P NN O
resulted VBD O
in IN O
E2 NNP O
serum NN O
concentrations NNS O
decreases VBZ O
( : O
84 CD O
% NN O
and CC O
67 CD O
% NN O
, , O
respectively RB O
) -RRB- O
, , O
and CC O
had VBD O
no DT O
apparent JJ O
effects NNS O
on IN O
E2 NNP O
serum NN O
concentrations NNS O
when WRB O
injected VBN O
on IN O
D2 NNP O
( , O
Table NNP O
3 CD O
) -RRB- O
. . O

Figure NN O
2 CD O
shows VBZ O
that IN O
the DT O
effects NNS O
of IN O
blocking VBG O
the DT O
cholinergic JJ O
system NN O
of IN O
rats NNS B-Species
with IN O
unilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O
depended VBD O
on IN O
both DT O
, , O
the DT O
side NN O
( , O
left JJ O
or CC O
right JJ O
) -RRB- O
and CC O
the DT O
phase NN O
of IN O
the DT O
estrous NN O
when WRB O
surgery NN O
was VBD O
performed VBN O
. . O

Injecting VBG O
ATR NNP O
on IN O
D1 NNP O
or CC O
D2 NNP O
resulted VBD O
in IN O
a DT O
significant JJ O
drop NN O
in IN O
E2 NNP O
serum NN O
concentrations NNS O
in IN O
animals NNS O
with IN O
sham NN O
treatment NN O
on IN O
the DT O
right JJ O
side NN O
. . O

Blocking VBG O
the DT O
cholinergic JJ O
system NN O
of IN O
rats NNS B-Species
with IN O
left JJ O
side NN O
peritoneum NN O
perforation NN O
on IN O
D1 NNP O
or CC O
P NN O
resulted VBD O
in IN O
a DT O
drop NN O
in IN O
E2 NNP O
serum NN O
concentrations NNS O
( , O
52 CD O
% NN O
; : O
47 CD O
% NN O
, , O
respectively RB O
) -RRB- O
, , O
while IN O
the DT O
same JJ O
treatment NN O
performed VBN O
on IN O
D2 NNP O
resulted VBD O
in IN O
a DT O
significant JJ O
E2 NNP O
concentrations NNS O
increase NN O
( : O
157 CD O
% NN O
) -RRB- O
. . O

Figure NN O
3 CD O
shows VBZ O
the DT O
effects NNS O
of IN O
blocking VBG O
the DT O
cholinergic JJ O
system NN O
of IN O
rats NNS B-Species
with IN O
ULO NNP O
. . O

ATR NNP O
treatment NN O
on IN O
D1 NNP O
or CC O
P NN O
stages NNS O
performed VBN O
on IN O
rats NNS B-Species
with IN O
the DT O
left JJ O
ovary NN O
in IN O
situ NN O
resulted VBD O
in IN O
a DT O
significant JJ O
drop NN O
of IN O
E2 NNP O
serum NN O
concentrations NNS O
( : O
65 CD O
% NN O
; : O
62 CD O
% NN O
respectively RB O
) -RRB- O
. . O

Such JJ O
effects NNS O
were VBD O
not RB O
observed VBN O
in IN O
rats NNS B-Species
treated VBN O
on IN O
D2 NNP O
. . O

When WRB O
ATR NNP O
treatment NN O
was VBD O
performed VBN O
on IN O
rats NNS B-Species
with IN O
the DT O
right JJ O
ovary NN O
in IN O
situ NN O
on IN O
D1 NNP O
, , O
E2 NNP O
serum NN O
concentrations NNS O
were VBD O
lower JJR O
( : O
48 CD O
% NN O
) -RRB- O
than IN O
in IN O
ULO NNP O
animals NNS O
. . O

Blocking VBG O
the DT O
cholinergic JJ O
system NN O
on IN O
D2 NNP O
resulted VBD O
in IN O
E2 NNP O
serum NN O
concentrations NNS O
increase NN O
( : O
159 CD O
% NN O
) -RRB- O
. . O

When WRB O
the DT O
treatment NN O
was VBD O
performed VBN O
on IN O
P NNP O
, , O
no DT O
significant JJ O
differences NNS O
in IN O
E2 NNP O
serum JJ O
concentrations NNS O
were VBD O
observed VBN O
. . O

Compared VBN O
to IN O
bilateral JJ O
treatment NN O
, , O
perforation NN O
of IN O
the DT O
peritoneum NN O
or CC O
bilateral JJ O
ovariectomy NN O
, , O
ATR NNP O
treatment NN O
on IN O
D1 NNP O
resulted VBD O
in IN O
significant JJ O
E2 NNP O
serum NN O
concentrations NNS O
decreases NNS O
, , O
90 CD O
% NN O
in IN O
bilateral JJ O
peritoneal JJ O
perforation NN O
and CC O
60 CD O
% NN O
in IN O
bilateral JJ O
ovariectomized JJ O
animals NNS O
. . O

Blocking VBG O
the DT O
cholinergic JJ O
system NN O
on IN O
D2 NNP O
, , O
to IN O
rats NNS B-Species
with IN O
bilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O
or CC O
bilateral JJ O
ovariectomy NN O
resulted VBD O
in IN O
E2 NNP O
serum NN O
concentrations NNS O
increases VBZ O
( , O
159 CD O
% NN O
and CC O
253 CD O
% NN O
respectively RB O
) -RRB- O
, , O
while IN O
injecting VBG O
ATR NNP O
to IN O
animals NNS O
treated VBN O
on IN O
P NN O
had VBD O
no DT O
apparent JJ O
effects NNS O
( -LRB- O
Figure NN O
4 CD O
) -RRB- O
. . O

Discussion NN O

The DT O
results NNS O
obtained VBN O
in IN O
the DT O
present JJ O
study NN O
suggest VBP O
that IN O
the DT O
ability NN O
to TO O
compensate VB O
the DT O
secretion NN O
of IN O
E2 NNP O
by IN O
the DT O
missing VBG O
ovary NN O
is VBZ O
different JJ O
between IN O
the DT O
right JJ O
and CC O
left JJ O
ovaries NNS O
and CC O
varies VBZ O
during IN O
the DT O
estrous JJ O
cycle NN O
. . O

Similarly RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
cholinergic JJ O
system NN O
participates VBZ O
in IN O
regulating VBG O
E2 NNP O
secretion NN O
by IN O
the DT O
ovary NN O
, , O
and CC O
that IN O
such JJ O
participation NN O
varies VBZ O
depending VBG O
on IN O
the DT O
ovary NN O
remaining VBG O
in IN O
situ NN O
and CC O
the DT O
stage NN O
of IN O
the DT O
estrous JJ O
cycle NN O
when WRB O
the DT O
surgical JJ O
procedure NN O
was VBD O
performed VBN O
. . O

Previously RB O
, , O
we PRP O
suggested VBD O
the DT O
existence NN O
of IN O
a DT O
neural JJ O
pathway NN O
arising VBG O
from IN O
the DT O
peritoneum NN O
that WDT O
participates VBZ O
in IN O
regulating VBG O
E2 NNP O
[ -LRB- O
9 CD O
] -RRB- O
, , O
P4 NN O
[ -LRB- O
10 CD O
] -RRB- O
and CC O
testosterone NN O
secretion NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

In IN O
the DT O
rat NN B-Species
, , O
the DT O
sensory JJ O
information NN O
arising VBG O
from IN O
the DT O
peritoneum NN O
is VBZ O
sent VBN O
to IN O
the DT O
nucleus NN O
tractus NN O
solitarius NN O
and CC O
stimulates VBZ O
neurokinine NN O
- HYPH O
B NN O
receptors NNS O
[ -LRB- O
17 CD O
] -RRB- O
. . O

Since IN O
perforating VBG O
the DT O
peritoneum NN O
unilaterally RB O
on IN O
each DT O
day NN O
of IN O
the DT O
estrous JJ O
cycle NN O
changed VBN O
E2 NNP O
serum NN O
concentrations NNS O
, , O
we PRP O
think VBP O
that IN O
each DT O
side NN O
of IN O
the DT O
peritoneum NN O
sends VBZ O
different JJ O
neural JJ O
information NN O
through IN O
the DT O
superior JJ O
ovarian JJ O
nerve NN O
( , O
SON NNP O
) -RRB- O
to IN O
the DT O
ovary NN O
and CC O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
perhaps RB O
reaching VBG O
nuclei NNS O
related VBN O
to IN O
the DT O
vagus JJ O
nerve NN O
. . O

A DT O
study NN O
analyzing VBG O
the DT O
distribution NN O
of IN O
sensory JJ O
neurons NNS O
innervating VBG O
the DT O
peritoneum NN O
showed VBD O
that IN O
when WRB O
tracer NN O
was VBD O
placed VBN O
on IN O
the DT O
area NN O
where WRB O
the DT O
peritoneum NN O
covers VBZ O
the DT O
abdominal JJ O
wall NN O
, , O
labeled VBN O
neurons NNS O
were VBD O
observed VBN O
only RB O
in IN O
the DT O
ipsilateral JJ O
dorsal JJ O
root NN O
ganglia NN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

The DT O
authors NNS O
suggest VBP O
that IN O
most JJS O
of IN O
the DT O
parietal JJ O
peritoneum NN O
receives VBZ O
sensory JJ O
nerves NNS O
from IN O
dorsal JJ O
root NN O
ganglia NN O
, , O
and CC O
visceral JJ O
peritoneum NN O
from IN O
both DT O
, , O
the DT O
spinal JJ O
and CC O
vagus JJ O
nerves NNS O
. . O

According VBG O
to IN O
Stener NNP O
- HYPH O
Victorin NNP O
et FW O
al NNP O
. . O

( : O
19 CD O
) , O
repeated VBN O
electro JJ O
- HYPH O
acupunture NN O
treatments NNS O
in IN O
rats NNS B-Species
with IN O
polycystic JJ O
ovary NN O
syndrome NN O
( , O
PCO NN O
) -RRB- O
, , O
induced VBN O
by IN O
a DT O
single JJ O
injection NN O
of IN O
estradiol NN O
valerate NN O
, , O
resulted VBN O
in IN O
lower JJR O
nerve JJ O
growth NN O
factor NN O
( , O
NGF NNP O
) -RRB- O
concentrations NNS O
at IN O
the DT O
ovarian JJ O
level NN O
than IN O
in IN O
non JJ O
- HYPH O
electro NN O
- HYPH O
acupunture NN O
treated VBN O
PCO NN O
rats NNS B-Species
. . O

In IN O
our PRP$ O
experiments NNS O
, , O
perforating VBG O
the DT O
peritoneum NN O
affected VBD O
the DT O
same JJ O
somatic JJ O
segments NNS O
employed VBN O
by IN O
Stener NNP O
- HYPH O
Victorin NNP O
et FW O
. . O

al NNP O
. . O

[ -LRB- O
19 CD O
] -RRB- O
. . O

We PRP O
presume VBP O
that IN O
peritoneum NN O
surgery NN O
resulted VBD O
in IN O
an DT O
increase NN O
of IN O
NGF NNP O
concentrations NNS O
at IN O
the DT O
ovarian JJ O
level NN O
, , O
which WDT O
in IN O
turn NN O
induced VBD O
hyper NN O
- HYPH O
androgenism NN O
, , O
as IN O
observed VBN O
in IN O
women NNS O
with IN O
PCO NNP O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Previously RB O
, , O
we PRP O
showed VBD O
that IN O
the DT O
unilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O
results VBZ O
in IN O
a DT O
significant JJ O
increase NN O
in IN O
testosterone NN O
serum NN O
concentrations NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Because IN O
E2 NNP O
serum NN O
concentrations NNS O
did VBD O
not RB O
increase VB O
after IN O
left JJ O
or CC O
bilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O
, , O
we PRP O
suppose VBP O
that IN O
the DT O
neural JJ O
information NN O
originating VBG O
from IN O
the DT O
peritoneum NN O
inhibits VBZ O
the DT O
mechanisms NNS O
regulating VBG O
aromatase NN O
activity NN O
within IN O
the DT O
follicle NN O
. . O

One CD O
of IN O
the DT O
ovaries NNS O
' POS O
sources NNS O
of IN O
catecholamines NNS O
arrives VBZ O
through IN O
the DT O
SON NNP O
. . O

In IN O
the DT O
ovary NN O
, , O
the DT O
SON NNP O
fibers NNS O
are VBP O
mainly RB O
distributed VBN O
in IN O
the DT O
peri NN O
- HYPH O
follicular JJ O
theca NN O
layer NN O
, , O
and CC O
in IN O
close JJ O
relation NN O
with IN O
the DT O
cells NNS O
of IN O
the DT O
theca NN O
interna NN O
[ -LRB- O
21 CD O
, , O
22 CD O
] -RRB- O
. . O

Sectioning VBG O
the DT O
SON NNP O
of IN O
rats NNS B-Species
in IN O
P NN O
results VBZ O
in IN O
a DT O
sudden JJ O
drop NN O
of IN O
P4 NN O
and CC O
E2 NN O
concentrations NNS O
in IN O
the DT O
ovarian JJ O
vein NN O
effluent NN O
[ -LRB- O
23 CD O
] -RRB- O
, , O
while IN O
the DT O
same JJ O
procedure NN O
on IN O
estrus NN O
did VBD O
not RB O
modify VB O
E2 NN O
concentrations NNS O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
perforating VBG O
the DT O
peritoneum NN O
modifies VBZ O
the DT O
type NN O
and CC O
/ SYM O
or CC O
rate NN O
of IN O
information NN O
arriving VBG O
to IN O
the DT O
ovary NN O
via IN O
the DT O
SON NNP O
. . O

Another DT O
possibility NN O
is VBZ O
that IN O
perforating VBG O
the DT O
left JJ O
side NN O
of IN O
the DT O
peritoneum NN O
results VBZ O
in IN O
an DT O
increase NN O
release NN O
of IN O
ovarian JJ O
gamma NN O
amino NN O
butyric NN O
acid NN O
( -LRB- O
GABA NNP O
) -RRB- O
, , O
and CC O
a DT O
subsequent JJ O
increase NN O
of IN O
E2 NNP O
concentrations NNS O
. . O

According VBG O
to IN O
Erd NNP O
o UH O
, , O
et UH O
. . O

al NNP O
. . O

[ -LRB- O
25 CD O
] -RRB- O
and CC O
Laszlo NNP O
, , O
et UH O
. . O

al NNP O
. . O

[ -LRB- O
26 CD O
] -RRB- O
, , O
injecting VBG O
GABA NNP O
into IN O
pseudo NN O
- HYPH O
pregnant JJ O
rats NNS B-Species
increases VBZ O
E2 NNP O
concentration NN O
in IN O
the DT O
blood NN O
. . O

Present JJ O
results NNS O
indicate VBP O
that IN O
injecting VBG O
ATR NNP O
, , O
before IN O
unilateral JJ O
or CC O
bilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O
, , O
to IN O
rats NNS B-Species
in IN O
D1 NNP O
or CC O
P NNP O
, , O
results VBZ O
in IN O
lower JJR O
E2serum NN O
concentrations NNS O
; , O
leading VBG O
us PRP O
to TO O
think VB O
that IN O
some DT O
of IN O
the DT O
neural JJ O
fibers NNS O
present JJ O
in IN O
the DT O
peritoneum NN O
are VBP O
muscarinic JJ O
. . O

It PRP O
is VBZ O
also RB O
possible JJ O
that IN O
blocking VBG O
the DT O
cholinergic JJ O
innervation NN O
, , O
by IN O
ATR NNP O
treatment NN O
, , O
results VBZ O
in IN O
lower JJR O
adrenaline NN O
and CC O
norepinephrine NN O
release NN O
by IN O
the DT O
adrenal JJ O
medulla NN O
. . O

Our PRP$ O
results NNS O
, , O
and CC O
those DT O
of IN O
others NNS O
, , O
suggest VBP O
that IN O
stimulating VBG O
on IN O
D2 NNP O
the DT O
sensory NN O
receptors NNS O
located VBN O
on IN O
the DT O
left JJ O
side NN O
of IN O
the DT O
peritoneum NN O
triggers VBZ O
an DT O
E2 NN O
secretion NN O
inhibitory NN O
mechanism NN O
, , O
that IN O
the DT O
sensory JJ O
pathway NN O
arising VBG O
from IN O
the DT O
right JJ O
side NN O
has VBZ O
a DT O
stimulatory JJ O
effect NN O
, , O
and CC O
that IN O
both DT O
are VBP O
mediated VBN O
by IN O
the DT O
cholinergic JJ O
muscarinic JJ O
system NN O
. . O

Previously RB O
, , O
we PRP O
showed VBD O
that IN O
injecting VBG O
ATR NNP O
to IN O
rats NNS B-Species
in IN O
D2 NNP O
results VBZ O
in IN O
increases NNS O
of IN O
P4 NN O
serum NN O
concentrations NNS O
originating VBG O
from IN O
the DT O
adrenals NNS O
[ -LRB- O
8 CD O
] -RRB- O
, , O
without IN O
having VBG O
apparent JJ O
effects NNS O
on IN O
testosterone NN O
serum NN O
concentrations NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Since IN O
P4 NN O
and CC O
androgens NNS O
are VBP O
precursors NNS O
in IN O
the DT O
synthesis NN O
of IN O
E2 NNP O
, , O
we PRP O
presume VBP O
that IN O
this DT O
mechanism NN O
may MD O
explain VB O
the DT O
increase NN O
in IN O
E2 NNP O
serum NN O
concentrations NNS O
observed VBN O
in IN O
rats NNS B-Species
with IN O
peritoneum NN O
perforation NN O
previously RB O
injected VBN O
with IN O
ATR NNP O
. . O

Another DT O
possibility NN O
explaining VBG O
the DT O
differences NNS O
on IN O
E2 NNP O
secretion NN O
regulation NN O
during IN O
the DT O
estrous JJ O
cycle NN O
is VBZ O
that IN O
the DT O
effects NNS O
of IN O
the DT O
cholinergic JJ O
system NN O
take VBP O
place NN O
through IN O
changes NNS O
at IN O
the DT O
celiac JJ O
ganglion NN O
level NN O
. . O

According VBG O
to IN O
Aguado NNP O
and CC O
Ojeda NNP O
[ -LRB- O
23 CD O
] -RRB- O
, , O
acetylcholine NN O
inhibits VBZ O
P4 NN O
secretion NN O
in IN O
the DT O
celiac JJ O
ganglion NN O
- HYPH O
SON NNP O
- HYPH O
ovary NN O
preparation NN O
obtained VBN O
from IN O
rats NNS B-Species
in IN O
D1 NNP O
or CC O
D2 NNP O
, , O
while IN O
the DT O
preparation NN O
obtained VBN O
from IN O
rats NNS B-Species
in IN O
P NNP O
resulted VBD O
in IN O
only RB O
a DT O
moderate JJ O
stimulation NN O
. . O

Since IN O
there EX O
is VBZ O
evidence NN O
that IN O
fibers NNS O
from IN O
the DT O
vagus JJ O
nerve NN O
innervate VBP O
neurons NNS O
in IN O
the DT O
celiac JJ O
ganglion NN O
[ -LRB- O
27 CD O
] -RRB- O
, , O
we PRP O
presume VBP O
that IN O
the DT O
cholinergic JJ O
system NN O
modulates VBZ O
the DT O
sympathetic JJ O
post NN O
- HYPH O
ganglionar NN O
activity NN O
and CC O
the DT O
secretory JJ O
ability NN O
of IN O
the DT O
ovaries NNS O
through IN O
the DT O
SON NNP O
. . O

Conclusion NN O

Based VBN O
on IN O
the DT O
differences NNS O
in IN O
E2 NNP O
serum NN O
concentrations NNS O
in IN O
rats NNS B-Species
with IN O
ULO NNP O
, , O
present JJ O
results NNS O
suggest VBP O
that IN O
the DT O
capacity NN O
to TO O
release VB O
E2 NN O
by IN O
the DT O
left JJ O
and CC O
right JJ O
ovaries NNS O
varies VBZ O
during IN O
the DT O
estrous JJ O
cycle NN O
. . O

We PRP O
presume VBP O
that IN O
the DT O
left JJ O
ovary NN O
releases VBZ O
more JJR O
E2 NN O
than IN O
the DT O
right JJ O
one NN O
. . O

As IN O
previously RB O
proposed VBN O
, , O
another DT O
possibility NN O
is VBZ O
that IN O
neural JJ O
communication NN O
between IN O
the DT O
ovaries NNS O
modulates VBZ O
E2 NNP O
secretion NN O
. . O

Case NN O
report NN O
: : O
rapidly RB O
fatal JJ O
bowel NN O
ischaemia NN O
on IN O
clozapine NN O
treatment NN O

Abstract JJ O

Background NN O

There EX O
have VBP O
been VBN O
previous JJ O
reported VBN O
deaths NNS O
due IN O
to IN O
clozapine NN O
- HYPH O
induced VBN O
constipation NN O
. . O

In IN O
all PDT O
these DT O
cases NNS O
patients NNS B-Species
have VBP O
experienced VBN O
prior JJ O
abdominal JJ O
symptoms NNS O
over IN O
a DT O
period NN O
of IN O
weeks NNS O
or CC O
months NNS O
. . O

Case NN O
presentation NN O

We PRP O
report VBP O
the DT O
sudden JJ O
death NN O
due IN O
to IN O
constipation NN O
of IN O
a DT O
healthy JJ O
young JJ O
male JJ O
patient NN B-Species
on IN O
clozapine NN O
without IN O
any DT O
known JJ O
history NN O
of IN O
prior JJ O
abdominal JJ O
symptoms NNS O
. . O

Conclusion NN O

Psychiatrists NNS O
need VBP O
to TO O
be VB O
alert JJ O
to IN O
the DT O
medical JJ O
emergencies NNS O
which WDT O
can MD O
occur VB O
in IN O
the DT O
context NN O
of IN O
clozapine NN O
treatment NN O
and CC O
also RB O
need VBP O
to TO O
make VB O
other JJ O
clinicians NNS O
who WP O
may MD O
have VB O
contact NN O
with IN O
their PRP$ O
patients NNS B-Species
aware JJ O
of IN O
these DT O
. . O

Background NN O

There EX O
have VBP O
been VBN O
six CD O
previously RB O
published VBN O
cases NNS O
of IN O
death NN O
secondary JJ O
to IN O
clozapine NN O
- HYPH O
induced VBN O
constipation NN O
[ -LRB- O
1 CD O
- HYPH O
3 CD O
] -RRB- O
. . O

Of IN O
these DT O
, , O
two CD O
patients NNS B-Species
died VBD O
from IN O
faecal JJ O
peritonitis NN O
, , O
two CD O
from IN O
aspiration NN O
of IN O
faeculent JJ O
vomitus NN O
as IN O
a DT O
result NN O
of IN O
bowel NN O
obstruction NN O
and CC O
two CD O
from IN O
bowel NN O
necrosis NN O
. . O

In IN O
all PDT O
these DT O
cases NNS O
there EX O
had VBD O
been VBN O
prior JJ O
complaints NNS O
of IN O
constipation NN O
and CC O
/ SYM O
or CC O
other JJ O
abdominal JJ O
symptoms NNS O
for IN O
weeks NNS O
to IN O
months NNS O
before IN O
the DT O
fatal JJ O
event NN O
. . O

Here RB O
we PRP O
describe VBP O
a DT O
case NN O
of IN O
constipation NN O
, , O
presumably RB O
clozapine NN O
- HYPH O
induced VBN O
, , O
where WRB O
death NN O
from IN O
bowel NN O
ischaemia NN O
occured VBD O
within IN O
2 CD O
days NNS O
from IN O
the DT O
first JJ O
complaint NN O
of IN O
constipation NN O
and CC O
without IN O
any DT O
prior JJ O
reported JJ O
abdominal JJ O
symptoms NNS O
which WDT O
might MD O
have VB O
provided VBN O
a DT O
warning NN O
to IN O
the DT O
clinicians NNS O
involved VBN O
. . O

Case NN O
presentation NN O

A DT O
20 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
male NN O
with IN O
a DT O
year NN O
long JJ O
history NN O
of IN O
schizophrenia NN O
which WDT O
had VBD O
been VBN O
unresponsive JJ O
to IN O
trials NNS O
of IN O
two CD O
atypical JJ O
antipsychotic JJ O
drugs NNS O
was VBD O
commenced VBN O
on IN O
clozapine NN O
. . O

The DT O
dose NN O
was VBD O
titrated VBN O
over IN O
the DT O
next JJ O
year NN O
to IN O
900 CD O
mg NN O
daily RB O
. . O

Due IN O
to IN O
persisting VBG O
negative JJ O
symptoms NNS O
amisulpiride NN O
400 CD O
mg NN O
twice RB O
daily RB O
was VBD O
added VBN O
with IN O
good JJ O
response NN O
after IN O
one CD O
month NN O
. . O

The DT O
patient NN B-Species
was VBD O
reviewed VBN O
regularly RB O
over IN O
the DT O
next JJ O
year NN O
, , O
continued VBD O
to TO O
improve VB O
and CC O
did VBD O
not RB O
report VB O
any DT O
side NN O
effects NNS O
to IN O
members NNS O
of IN O
the DT O
multidisciplinary JJ O
mental JJ O
health NN O
team NN O
working VBG O
to TO O
support VB O
him PRP O
in IN O
the DT O
community NN O
. . O

He PRP O
appeared VBD O
to TO O
be VB O
fit JJ O
and CC O
healthy JJ O
. . O

Although IN O
he PRP O
usually RB O
lived VBD O
in IN O
supported JJ O
accommodation NN O
he PRP O
was VBD O
staying VBG O
temporarily RB O
with IN O
his PRP$ O
family NN O
and CC O
from IN O
their PRP$ O
account NN O
he PRP O
complained VBD O
of IN O
having VBG O
constipation NN O
for IN O
2 CD O
days NNS O
before IN O
presenting VBG O
to IN O
his PRP$ O
GP NNP O
with IN O
severe JJ O
abdominal JJ O
pain NN O
. . O

He PRP O
was VBD O
prescribed VBN O
medication NN O
and CC O
returned VBD O
home RB O
but CC O
his PRP$ O
condition NN O
deteriorated VBD O
further RBR O
and CC O
a DT O
few JJ O
hours NNS O
later RB O
an DT O
ambulance NN O
was VBD O
called VBN O
. . O

He PRP O
collapsed VBD O
and CC O
died VBD O
before IN O
reaching VBG O
hospital NN O
. . O

Post JJ O
mortem NN O
examination NN O
revealed VBD O
that IN O
he PRP O
had VBD O
impacted VBN O
faeces NNS O
which WDT O
had VBD O
pressed VBN O
against IN O
the DT O
bowel NN O
wall NN O
causing VBG O
ischaemia NN O
. . O

This DT O
had VBD O
led VBN O
to IN O
infarction NN O
of IN O
this DT O
part NN O
of IN O
the DT O
bowel NN O
. . O

Conclusion NN O

This DT O
case NN O
demonstrates VBZ O
that IN O
death NN O
can MD O
occur VB O
over IN O
a DT O
very RB O
short JJ O
time NN O
course NN O
from IN O
constipation NN O
, , O
in IN O
this DT O
case NN O
presumably RB O
induced VBN O
by IN O
clozapine NN O
. . O

Death NN O
from IN O
constipation NN O
and CC O
subsequent JJ O
bowel NN O
infarction NN O
is VBZ O
relatively RB O
common JJ O
in IN O
elderly JJ O
patients NNS B-Species
and CC O
infarction NN O
causes VBZ O
a DT O
far RB O
more RBR O
rapid JJ O
and CC O
dangerous JJ O
deterioration NN O
than IN O
does VBZ O
intestinal JJ O
obstruction NN O
. . O

In IN O
the DT O
present JJ O
case NN O
this DT O
meant VBD O
that IN O
this DT O
patient NN B-Species
did VBD O
not RB O
have VB O
any DT O
contact NN O
with IN O
psychiatric JJ O
services NNS O
between IN O
the DT O
onset NN O
of IN O
his PRP$ O
symptoms NNS O
and CC O
his PRP$ O
rapid JJ O
demise NN O
, , O
in IN O
spite NN O
of IN O
regular JJ O
follow NN O
- HYPH O
up NN O
. . O

Although IN O
the DT O
risk NN O
of IN O
neutropenia NN O
is VBZ O
relatively RB O
well RB O
- HYPH O
known VBN O
, , O
it PRP O
should MD O
be VB O
borne VBN O
in IN O
mind NN O
that IN O
clozapine NN O
is VBZ O
reported VBN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
number NN O
of IN O
other JJ O
syndromes NNS O
which WDT O
may MD O
be VB O
rapidly RB O
fatal JJ O
including VBG O
not RB O
only RB O
constipation NN O
and CC O
obstruction NN O
but CC O
also RB O
cardiovascular JJ O
collapse NN O
, , O
seizures NNS O
and CC O
ketoacidosis NN O
. . O

Psychiatrists NNS O
working VBG O
with IN O
such JJ O
patients NNS B-Species
should MD O
not RB O
only RB O
themselves PRP O
be VB O
vigilant JJ O
regarding VBG O
such JJ O
complications NNS O
but CC O
should MD O
take VB O
steps NNS O
to TO O
see VB O
that IN O
other JJ O
clinicians NNS O
to TO O
whom WP O
the DT O
patient NN B-Species
may MD O
present VB O
are VBP O
also RB O
aware JJ O
of IN O
them PRP O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

Both DT O
authors NNS O
were VBD O
equally RB O
involved VBN O
in IN O
the DT O
preparation NN O
of IN O
this DT O
manuscript NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

A DT O
disease NN O
- HYPH O
specific JJ O
measure NN O
of IN O
health NN O
- HYPH O
related VBN O
quality NN O
of IN O
life NN O
for IN O
use NN O
in IN O
adults NNS O
with IN O
immune JJ O
thrombocytopenic JJ O
purpura NN O
: : O
Its PRP$ O
development NN O
and CC O
validation NN O

Abstract JJ O

Background NN O

No DT O
validated JJ O
disease NN O
- HYPH O
specific JJ O
measures NNS O
are VBP O
available JJ O
to TO O
assess VB O
health NN O
- HYPH O
related VBN O
quality NN O
of IN O
life NN O
( , O
HRQoL NNP O
) -RRB- O
in IN O
adult NN O
subjects NNS O
with IN O
immune JJ O
thrombocytopenic JJ O
purpura NN O
( , O
ITP NNP O
) -RRB- O
. . O

Therefore RB O
, , O
we PRP O
sought VBD O
to TO O
develop VB O
and CC O
validate VB O
the DT O
ITP NNP O
- HYPH O
Patient NNP B-Species
Assessment NNP O
Questionnaire NNP O
( -LRB- O
ITP NNP O
- HYPH O
PAQ NNP O
) -RRB- O
for IN O
adult NN O
subjects NNS O
with IN O
ITP NNP O
. . O

Methods NNS O

Information NN O
from IN O
literature NN O
reviews NNS O
, , O
focus NN O
groups NNS O
with IN O
subjects NNS O
, , O
and CC O
clinicians NNS O
were VBD O
used VBN O
to TO O
develop VB O
50 CD O
ITP NNP O
- HYPH O
PAQ NNP O
items NNS O
. . O

Factor NN O
analyses NNS O
were VBD O
conducted VBN O
to TO O
develop VB O
the DT O
scale NN O
structure NN O
and CC O
reduce VB O
the DT O
number NN O
of IN O
items NNS O
. . O

The DT O
final JJ O
44 CD O
- HYPH O
item NN O
ITP NNP O
- HYPH O
PAQ NNP O
, , O
which WDT O
includes VBZ O
ten CD O
scales NNS O
[ -LRB- O
Symptoms NNS O
( -LRB- O
S NNP O
) -RRB- O
, , O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
( , O
B NNP O
) -RRB- O
, , O
Fatigue NNP O
/ SYM O
Sleep NNP O
( , O
FT NNP O
) -RRB- O
, , O
Activity NNP O
( , O
A NNP O
) -RRB- O
, , O
Fear NNP O
( , O
FR NNP O
) -RRB- O
, , O
Psychological NNP O
Health NNP O
( , O
PH NNP O
) -RRB- O
, , O
Work NNP O
( , O
W NNP O
) -RRB- O
, , O
Social NNP O
Activity NNP O
( , O
SA NNP O
) -RRB- O
, , O
Women NNPS B-Species
' POS O
s POS O
Reproductive NNP O
Health NNP O
( , O
RH NNP O
) -RRB- O
, , O
and CC O
Overall NNP O
( -LRB- O
QoL NNP O
) -RRB- O
] -RRB- O
, , O
was VBD O
self NN O
- HYPH O
administered VBN O
to IN O
adult NN O
ITP NNP O
subjects NNS O
at IN O
baseline NN O
and CC O
7 CD O
- SYM O
10 CD O
days NNS O
later RB O
. . O

Test NN O
- HYPH O
retest NN O
reliability NN O
, , O
internal JJ O
consistency NN O
reliability NN O
, , O
construct NN O
and CC O
known VBN O
groups NNS O
validity NN O
of IN O
the DT O
final JJ O
ITP NNP O
- HYPH O
PAQ NNP O
were VBD O
evaluated VBN O
. . O

Results NNS O

Seventy CD O
- HYPH O
three CD O
subjects NNS O
with IN O
ITP NNP O
completed VBD O
the DT O
questionnaire NN O
twice RB O
. . O

Test NN O
- HYPH O
retest NN O
reliability NN O
, , O
as IN O
measured VBN O
by IN O
the DT O
intra JJ O
- HYPH O
class NN O
correlation NN O
, , O
ranged VBN O
from IN O
0 CD O
. . O
52 CD O
- SYM O
0 CD O
. . O
90 CD O
. . O

Internal JJ O
consistency NN O
reliability NN O
was VBD O
demonstrated VBN O
with IN O
Cronbach NNP O
' POS O
s POS O
alpha NN O
for IN O
all DT O
scales NNS O
above IN O
the DT O
acceptable JJ O
level NN O
of IN O
0 CD O
. . O
70 CD O
( HYPH O
range NN O
: : O
0 CD O
. . O
71 CD O
- HYPH O
0 CD O
. . O
92 CD O
) -RRB- O
, , O
except IN O
for IN O
RH NNP O
( : O
0 CD O
. . O
66 CD O
) -RRB- O
. . O

Construct NN O
validity NN O
, , O
assessed VBN O
by IN O
correlating VBG O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
with IN O
established VBN O
measures NNS O
( , O
Short NNP O
Form NN O
- HYPH O
36 CD O
v NN O
. . O
1 CD O
, , O
SF NNP O
- HYPH O
36 CD O
and CC O
Center NNP O
for IN O
Epidemiologic NNP O
Studies NNPS O
Depression NNP O
Scale NNP O
, , O
CES NNP O
- HYPH O
D NNP O
) -RRB- O
, , O
was VBD O
demonstrated VBN O
through IN O
moderate JJ O
correlations NNS O
between IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
SA NNP O
and CC O
SF NNP O
- HYPH O
36 CD O
Social NNP O
Function NNP O
scales NNS O
( , O
r NN O
= SYM O
0 CD O
. . O
67 CD O
) -RRB- O
, , O
and CC O
between IN O
ITP NNP O
- HYPH O
PAQ NNP O
PH NNP O
and CC O
SF NNP O
- HYPH O
36 CD O
Mental NNP O
Health NNP O
Scales NNPS O
( : O
r NN O
= SYM O
0 CD O
. . O
63 CD O
) -RRB- O
. . O

Moderate JJ O
to IN O
strong JJ O
inter JJ O
- HYPH O
scale NN O
correlations NNS O
were VBD O
reported VBN O
between IN O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
and CC O
the DT O
CES NNP O
- HYPH O
D NNP O
, , O
except IN O
for IN O
the DT O
RH NNP O
scale NN O
. . O

Known VBN O
groups NNS O
validity NN O
was VBD O
evaluated VBN O
by IN O
comparing VBG O
mean JJ O
scores NNS O
for IN O
groups NNS O
that WDT O
differed VBD O
clinically RB O
. . O

Statistically RB O
significant JJ O
differences NNS O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
were VBD O
observed VBN O
when WRB O
subjects NNS O
were VBD O
categorized VBN O
by IN O
treatment NN O
status NN O
[ -LRB- O
S NNP O
, , O
FT NNP O
, , O
B NNP O
, , O
A NNP O
, , O
PH NNP O
, , O
and CC O
QoL NNP O
, , O
perceived VBN O
effectiveness NN O
of IN O
ITP NNP O
treatment NN O
[ -LRB- O
S NN O
] -RRB- O
, , O
and CC O
time NN O
elapsed VBD O
since IN O
ITP NNP O
diagnosis NN O
[ -LRB- O
PH NN O
] -RRB- O
. . O

Conclusion NN O

Results NNS O
provide VBP O
preliminary JJ O
evidence NN O
of IN O
the DT O
reliability NN O
and CC O
validity NN O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
in IN O
adult NN O
subjects NNS O
with IN O
ITP NNP O
. . O

Further JJ O
work NN O
should MD O
be VB O
conducted VBN O
to TO O
assess VB O
the DT O
responsiveness NN O
and CC O
to TO O
estimate VB O
the DT O
minimal JJ O
clinical JJ O
important JJ O
difference NN O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
to TO O
more RBR O
fully RB O
understand VB O
the DT O
impact NN O
of IN O
ITP NNP O
and CC O
its PRP$ O
treatments NNS O
on IN O
HRQoL NNP O
. . O

Background NN O

Immune JJ O
thrombocytopenic JJ O
purpura NN O
( , O
ITP NNP O
) -RRB- O
is VBZ O
a DT O
disorder NN O
characterized VBN O
by IN O
autoimmune NN O
- HYPH O
mediated VBN O
platelet NN O
destruction NN O
and CC O
suboptimal JJ O
platelet NN O
production NN O
[ -LRB- O
1 CD O
- HYPH O
3 CD O
] -RRB- O
that WDT O
results VBZ O
in IN O
a DT O
decrease NN O
in IN O
the DT O
number NN O
of IN O
circulating VBG O
platelets NNS O
and CC O
increases VBZ O
the DT O
risk NN O
of IN O
bleeding VBG O
events NNS O
. . O

The DT O
estimated VBN O
prevalence NN O
rate NN O
for IN O
ITP NNP O
in IN O
the DT O
United NNP O
States NNP O
is VBZ O
9 CD O
. . O
5 CD O
/ SYM O
100 CD O
, , O
0 CD O
[ SYM O
4 CD O
] -RRB- O
. . O

Adult NN O
women NNS B-Species
are VBP O
disproportionately RB O
affected VBN O
by IN O
the DT O
disorder NN O
, , O
with IN O
a DT O
female JJ O
to IN O
male JJ O
ratio NN O
of IN O
nearly RB O
two CD O
to TO O
one CD O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
disorder NN O
rarely RB O
remits VBZ O
spontaneously RB O
in IN O
adult NN O
subjects NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
mortality NN O
rate NN O
is VBZ O
relatively RB O
low JJ O
( : O
< : O
1 CD O
% NN O
) -RRB- O
[ -LRB- O
6 CD O
] -RRB- O
in IN O
adults NNS O
less JJR O
than IN O
65 CD O
years NNS O
of IN O
age NN O
. . O

Morbidity NN O
increases VBZ O
above IN O
age NN O
65 CD O
, , O
primarily RB O
as IN O
a DT O
result NN O
of IN O
an DT O
increase NN O
in IN O
age NN O
- HYPH O
related VBN O
major JJ O
bleeding NN O
events NNS O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Initial JJ O
therapy NN O
for IN O
ITP NNP O
consists VBZ O
of IN O
some DT O
combination NN O
of IN O
glucocorticoids NNS O
, , O
intravenous JJ O
immune JJ O
globulin NN O
( , O
IVIg NNP O
) -RRB- O
or CC O
anti JJ O
- HYPH O
D NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Splenectomy NN O
is VBZ O
often RB O
considered VBN O
if IN O
these DT O
therapies NNS O
fail VBP O
. . O

Approximately RB O
two CD O
- HYPH O
thirds NNS O
of IN O
patients NNS B-Species
treated VBN O
with IN O
splenectomy NN O
achieve VBP O
a DT O
sustained JJ O
remission NN O
[ -LRB- O
1 CD O
, , O
5 CD O
, , O
9 CD O
] -RRB- O
. . O

Patients NNS B-Species
who WP O
fail VBP O
splenectomy NN O
are VBP O
treated VBN O
with IN O
a DT O
wide JJ O
variety NN O
of IN O
agents NNS O
including VBG O
corticosteroids NNS O
, , O
danazol NN O
, , O
and CC O
chemotherapeutic JJ O
agents NNS O
. . O

Morbidity NN O
and CC O
mortality NN O
in IN O
these DT O
refractory JJ O
patients NNS B-Species
are VBP O
substantial JJ O
[ -LRB- O
1 CD O
, , O
6 CD O
, , O
8 CD O
] -RRB- O
. . O

Patient NN B-Species
- HYPH O
reported VBN O
outcomes NNS O
( -LRB- O
PRO NNP O
) -RRB- O
, , O
including VBG O
health NN O
- HYPH O
related VBN O
quality NN O
of IN O
life NN O
( , O
HRQoL NNP O
) -RRB- O
measures NNS O
, , O
are VBP O
critical JJ O
components NNS O
for IN O
evaluating VBG O
and CC O
understanding VBG O
treatment NN O
effects NNS O
from IN O
the DT O
subject NN O
' POS O
s POS O
perspective NN O
. . O

The DT O
Food NNP O
and CC O
Drug NNP O
Administration NNP O
( -LRB- O
FDA NNP O
) -RRB- O
indicates VBZ O
that IN O
PRO NNP O
measures NNS O
are VBP O
important JJ O
to TO O
assess VB O
because IN O
they PRP O
may MD O
: : O
1 CD O
) -RRB- O
detect VB O
treatment NN O
effects NNS O
known VBN O
only RB O
to IN O
the DT O
subject NN O
; : O
2 LS O
) -RRB- O
understand VB O
the DT O
subject NN O
' '' O
s POS O
perspective NN O
regarding VBG O
treatment NN O
effect NN O
; : O
or CC O
3 LS O
) -RRB- O
provide VB O
information NN O
not RB O
included VBN O
in IN O
a DT O
clinician NN O
' POS O
s NNS O
subject JJ O
notes NNS O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
the DT O
Committee NNP O
for IN O
Medicinal NNP O
Products NNPS O
for IN O
Human NNP B-Species
Use NNP O
of IN O
the DT O
European NNP O
Medicines NNPS O
Agency NNP O
defines VBZ O
HRQoL NNP O
as IN O
"""" `` O
the DT O
subject NN O
' '' O
s POS O
subjective JJ O
perception NN O
of IN O
the DT O
impact NN O
of IN O
his PRP$ O
disease NN O
and CC O
its PRP$ O
treatment NN O
( , O
s VBZ O
) -RRB- O
on IN O
his PRP$ O
daily JJ O
life NN O
, , O
physical JJ O
, , O
psychological JJ O
and CC O
social JJ O
functioning NN O
and CC O
well RB O
- HYPH O
being NN O
"""" '' O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Currently RB O
, , O
limited JJ O
data NNS O
are VBP O
available JJ O
on IN O
the DT O
assessment NN O
of IN O
the DT O
impact NN O
of IN O
symptoms NNS O
in IN O
adult NN O
subjects NNS O
with IN O
ITP NNP O
. . O

Symptoms NNS O
of IN O
ITP NNP O
, , O
such JJ O
as IN O
spontaneous JJ O
bruising NN O
, , O
menorrhagia NN O
, , O
mucosal JJ O
bleeding NN O
and CC O
prolonged VBN O
bleeding NN O
with IN O
injury NN O
, , O
may MD O
significantly RB O
affect VB O
HRQoL NNP O
in IN O
ITP NNP O
subjects NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Treatments NNS O
for IN O
chronic JJ O
ITP NNP O
can MD O
also RB O
be VB O
associated VBN O
with IN O
substantial JJ O
side NN O
effects NNS O
[ -LRB- O
5 CD O
, , O
8 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
subjects NNS O
who WP O
are VBP O
resistant JJ O
to IN O
current JJ O
therapies NNS O
are VBP O
likely JJ O
to TO O
experience VB O
an DT O
even RB O
greater JJR O
decrement NN O
to IN O
their PRP$ O
HRQoL NN O
than IN O
responders NNS O
to IN O
treatment NN O
. . O

Thus RB O
, , O
restoring VBG O
and CC O
/ SYM O
or CC O
maintaining VBG O
quality NN O
of IN O
life NN O
should MD O
be VB O
an DT O
important JJ O
goal NN O
of IN O
treatment NN O
. . O

While IN O
the DT O
primary JJ O
markers NNS O
for IN O
ITP NNP O
include VBP O
hematologic JJ O
measures NNS O
such JJ O
as IN O
platelet NN O
counts NNS O
, , O
clinical JJ O
measures NNS O
typically RB O
do VBP O
not RB O
assess VB O
a DT O
subject NN O
' '' O
s POS O
functioning NN O
and CC O
well RB O
- HYPH O
being NN O
. . O

Therefore RB O
, , O
subjects NNS O
and CC O
physicians NNS O
may MD O
want VB O
to TO O
weigh VB O
the DT O
impact NN O
of IN O
ITP NNP O
therapies NNS O
on IN O
HRQoL NNP O
endpoints NNS O
when WRB O
making VBG O
treatment NN O
decisions NNS O
. . O

Previously RB O
, , O
no DT O
validated JJ O
disease NN O
- HYPH O
specific JJ O
measures NNS O
were VBD O
available JJ O
to TO O
evaluate VB O
quality NN O
of IN O
life NN O
in IN O
adult NN O
ITP NNP O
subjects NNS O
; : O
however RB O
, , O
two CD O
disease NN O
- HYPH O
specific JJ O
HRQoL NNP O
questionnaires NNS O
have VBP O
been VBN O
developed VBN O
for IN O
use NN O
in IN O
children NNS B-Species
with IN O
ITP NNP O
[ -LRB- O
13 CD O
, , O
14 CD O
] -RRB- O
. . O

Thus RB O
, , O
we PRP O
sought VBD O
to TO O
develop VB O
a DT O
questionnaire NN O
that WDT O
would MD O
be VB O
appropriate JJ O
to TO O
assess VB O
the DT O
impact NN O
of IN O
ITP NNP O
symptoms NNS O
and CC O
its PRP$ O
treatments NNS O
on IN O
HRQoL NNP O
in IN O
adult NN O
subjects NNS O
. . O

The DT O
objective NN O
of IN O
this DT O
current JJ O
manuscript NN O
is VBZ O
to TO O
describe VB O
the DT O
development NN O
and CC O
initial JJ O
validation NN O
of IN O
a DT O
newly RB O
developed VBN O
HRQoL NNP O
questionnaire NN O
for IN O
use NN O
in IN O
adult NN O
subjects NNS O
with IN O
ITP NNP O
. . O

Methods NNS O

Overview NN O

A DT O
newly RB O
developed VBN O
questionnaire NN O
, , O
which WDT O
assesses VBZ O
issues NNS O
of IN O
importance NN O
to IN O
ITP NNP O
subjects NNS O
, , O
was VBD O
developed VBN O
based VBN O
on IN O
available JJ O
published VBN O
literature NN O
, , O
existing VBG O
questionnaires NNS O
, , O
expert JJ O
clinical JJ O
opinion NN O
, , O
and CC O
input NN O
from IN O
subjects NNS O
with IN O
ITP NNP O
. . O

Subjects NNS O
and CC O
Procedures NNS O

To TO O
develop VB O
the DT O
questionnaire NN O
, , O
three CD O
focus NN O
groups NNS O
with IN O
ITP NNP O
subjects NNS O
were VBD O
conducted VBN O
in IN O
geographically RB O
diverse JJ O
locations NNS O
( , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
New NNP O
York NNP O
, , O
NY NNP O
, , O
and CC O
Oklahoma NNP O
City NNP O
, , O
OK NNP O
) -RRB- O
. . O

Each DT O
of IN O
the DT O
three CD O
sites NNS O
recruited VBD O
a DT O
convenience NN O
sample NN O
of IN O
five CD O
to TO O
eight CD O
ITP NNP O
subjects NNS O
who WP O
were VBD O
being VBG O
treated VBN O
on IN O
an DT O
outpatient JJ O
basis NN O
. . O

To TO O
be VB O
eligible JJ O
, , O
subjects NNS O
were VBD O
required VBN O
to TO O
have VB O
active JJ O
disease NN O
and CC O
be VB O
> SYM O
= SYM O
18 CD O
years NNS O
of IN O
age NN O
. . O

Although IN O
platelet NN O
count NN O
data NNS O
were VBD O
not RB O
required VBN O
for IN O
participation NN O
in IN O
the DT O
focus NN O
groups NNS O
, , O
clinicians NNS O
at IN O
each DT O
site NN O
considered VBD O
the DT O
subjects NNS O
to TO O
have VB O
active JJ O
disease NN O
, , O
usually RB O
an DT O
indication NN O
that IN O
platelet NN O
levels NNS O
have VBP O
dropped VBN O
below IN O
120 CD O
x SYM O
109L CD O
and CC O
the DT O
subject NN O
requires VBZ O
treatment NN O
and CC O
/ SYM O
or CC O
more RBR O
frequent JJ O
monitoring NN O
. . O

In IN O
total NN O
, , O
23 CD O
ITP NNP O
subjects NNS O
participated VBD O
in IN O
the DT O
focus NN O
groups NNS O
after IN O
providing VBG O
their PRP$ O
informed JJ O
consent NN O
. . O

To TO O
validate VB O
the DT O
questionnaire NN O
, , O
a DT O
convenience NN O
sample NN O
of IN O
subjects NNS O
was VBD O
recruited VBN O
from IN O
the DT O
same JJ O
three CD O
clinical JJ O
sites NNS O
in IN O
New NNP O
York NNP O
, , O
NY NNP O
, , O
Oklahoma NNP O
City NNP O
, , O
OK NNP O
, , O
and CC O
La NNP O
Jolla NNP O
, , O
CA NNP O
. . O

Subjects NNS O
were VBD O
eligible JJ O
if IN O
they PRP O
were VBD O
> SYM O
= SYM O
18 CD O
years NNS O
of IN O
age NN O
, , O
had VBD O
active JJ O
disease NN O
, , O
and CC O
were VBD O
willing JJ O
to TO O
complete VB O
a DT O
self NN O
- HYPH O
administered VBN O
questionnaire NN O
at IN O
two CD O
time NN O
points NNS O
. . O

Target NNP O
enrollment NN O
was VBD O
roughly RB O
72 CD O
subjects NNS O
( , O
24 CD O
subjects NNS O
from IN O
each DT O
site NN O
) -RRB- O
. . O

The DT O
study NN O
protocol NN O
was VBD O
approved VBN O
by IN O
a DT O
local JJ O
institutional JJ O
review NN O
board NN O
at IN O
each DT O
site NN O
and CC O
was VBD O
carried VBN O
out RP O
in IN O
accordance NN O
with IN O
Good NNP O
Clinical NNP O
Practice NNP O
and CC O
International NNP O
Conference NNP O
on IN O
Harmonization NNP O
guidelines NNS O
and CC O
the DT O
Declaration NNP O
of IN O
Helsinki NNP O
. . O

Written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
each DT O
subject NN O
prior RB O
to IN O
enrollment NN O
. . O

Creation NN O
of IN O
Questionnaire NNP O
/ SYM O
Item NNP O
Selection NNP O

A DT O
trained VBN O
moderator NN O
led VBD O
all DT O
focus NN O
groups NNS O
using VBG O
a DT O
detailed VBN O
discussion NN O
guide NN O
. . O

Subjects NNS O
discussed VBD O
their PRP$ O
ITP NNP O
history NN O
, , O
treatment NN O
, , O
ITP NNP O
symptoms NNS O
, , O
and CC O
the DT O
impact NN O
of IN O
ITP NNP O
on IN O
daily JJ O
activities NNS O
. . O

Each DT O
focus NN O
group NN O
lasted VBD O
approximately RB O
three CD O
hours NNS O
, , O
and CC O
subjects NNS O
were VBD O
provided VBN O
with IN O
an DT O
honorarium NN O
for IN O
their PRP$ O
time NN O
. . O

Following VBG O
the DT O
focus NN O
group NN O
session NN O
, , O
all DT O
subjects NNS O
completed VBD O
a DT O
questionnaire NN O
which WDT O
included VBD O
the DT O
SF NNP O
- HYPH O
36 CD O
v1 NNP O
[ -LRB- O
15 CD O
] -RRB- O
and CC O
ITP NNP O
- HYPH O
specific JJ O
questions NNS O
. . O

The DT O
ITP NNP O
- HYPH O
specific JJ O
items NNS O
were VBD O
developed VBN O
based VBN O
on IN O
clinical JJ O
input NN O
[ -LRB- O
12 CD O
, , O
16 CD O
- HYPH O
18 CD O
] -RRB- O
. . O

The DT O
ITP NNP O
- HYPH O
specific JJ O
items NNS O
assessed VBD O
the DT O
impact NN O
of IN O
ITP NNP O
on IN O
the DT O
subject NN O
' POS O
s POS O
overall JJ O
quality NN O
of IN O
life NN O
, , O
relationships NNS O
, , O
ability NN O
to TO O
sleep VB O
, , O
menstruation NN O
/ SYM O
gynecological JJ O
history NN O
, , O
and CC O
sexual JJ O
activity NN O
. . O

The DT O
ITP NNP O
- HYPH O
specific JJ O
questions NNS O
also RB O
assessed VBD O
the DT O
subject NN O
' POS O
s POS O
response NN O
to IN O
ITP NNP O
treatments NNS O
and CC O
any DT O
side NN O
effects NNS O
. . O

Transcripts NNS O
of IN O
the DT O
focus NN O
groups NNS O
were VBD O
summarized VBN O
and CC O
reviewed VBN O
by IN O
the DT O
study NN O
team NN O
. . O

The DT O
initial JJ O
draft NN O
of IN O
the DT O
ITP NNP O
Subject NNP O
Assessment NNP O
Questionnaire NNP O
( , O
ITP NNP O
- HYPH O
PAQ NNP O
) -RRB- O
was VBD O
developed VBN O
after IN O
reviewing VBG O
information NN O
from IN O
the DT O
literature NN O
searches NNS O
, , O
existing VBG O
questionnaires NNS O
, , O
expert NN O
opinion NN O
, , O
focus NN O
group NN O
transcripts NNS O
, , O
and CC O
the DT O
questionnaire NN O
responses NNS O
from IN O
the DT O
focus NN O
group NN O
subjects NNS O
. . O

The DT O
initial JJ O
ITP NNP O
- HYPH O
PAQ NNP O
consisted VBD O
of IN O
50 CD O
items NNS O
that WDT O
assesses VBZ O
the DT O
impact NN O
of IN O
ITP NNP O
in IN O
the DT O
areas NNS O
of IN O
physical JJ O
health NN O
, , O
mental JJ O
health NN O
, , O
work NN O
, , O
social JJ O
activity NN O
, , O
reproductive JJ O
health NN O
( , O
relevant JJ O
for IN O
women NNS B-Species
only RB O
) , O
, , O
and CC O
overall JJ O
quality NN O
of IN O
life NN O
. . O

Factor NN O
analyses NNS O
were VBD O
conducted VBN O
which WDT O
yielded VBD O
six CD O
unique JJ O
domains NNS O
. . O

The DT O
impact NN O
of IN O
ITP NNP O
on IN O
physical JJ O
health NN O
was VBD O
measured VBN O
by IN O
four CD O
scales NNS O
that WDT O
evaluated VBD O
ITP NNP O
- HYPH O
related VBN O
symptoms NNS O
, , O
Fatigue NNP O
/ SYM O
Sleep NNP O
, , O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
, , O
and CC O
Activity NNP O
. . O

Its PRP$ O
impact NN O
on IN O
mental JJ O
health NN O
was VBD O
measured VBN O
by IN O
two CD O
scales NNS O
that WDT O
evaluated VBD O
psychological JJ O
distress NN O
and CC O
fear NN O
. . O

A DT O
copy NN O
of IN O
the DT O
questionnaire NN O
can MD O
be VB O
obtained VBN O
by IN O
contacting VBG O
Janet NNP O
L NNP O
. . O
Nichol NNP O
and CC O
sample NN O
items NNS O
are VBP O
included VBN O
Table NNP O
2 CD O
. . O

Statistical NNP O
Analyses NNPS O

A DT O
validation NN O
study NN O
was VBD O
conducted VBN O
to TO O
evaluate VB O
the DT O
psychometric JJ O
properties NNS O
of IN O
the DT O
newly RB O
developed VBN O
ITP NNP O
- HYPH O
PAQ NNP O
questionnaire NN O
so IN O
that IN O
it PRP O
could MD O
be VB O
used VBN O
to TO O
measure VB O
the DT O
impact NN O
of IN O
ITP NNP O
in IN O
adult NN O
subjects NNS O
in IN O
future JJ O
studies NNS O
. . O

Standard JJ O
psychometric JJ O
methods NNS O
were VBD O
used VBN O
to TO O
evaluate VB O
the DT O
reliability NN O
and CC O
validity NN O
of IN O
the DT O
questionnaire NN O
[ -LRB- O
19 CD O
, , O
20 CD O
] -RRB- O
. . O

Eligible JJ O
subjects NNS O
completed VBD O
the DT O
baseline NN O
questionnaire NN O
at IN O
the DT O
site NN O
or CC O
by IN O
mail NN O
after IN O
providing VBG O
telephone NN O
consent NN O
. . O

An DT O
informed JJ O
consent NN O
form NN O
and CC O
baseline NN O
questionnaire NN O
was VBD O
mailed VBN O
to IN O
those DT O
subjects NNS O
who WP O
gave VBD O
their PRP$ O
initial JJ O
consent NN O
via IN O
telephone NN O
. . O

These DT O
completed VBN O
documents NNS O
were VBD O
returned VBN O
by IN O
mail NN O
to IN O
the DT O
investigators NNS O
. . O

At IN O
follow NN O
up RP O
, , O
each DT O
subject NN O
was VBD O
mailed VBN O
the DT O
same JJ O
questionnaire NN O
and CC O
asked VBN O
to TO O
complete VB O
it PRP O
a DT O
second JJ O
time NN O
( , O
for IN O
evaluating VBG O
test NN O
- HYPH O
retest NN O
reliability NN O
) -RRB- O
approximately RB O
two CD O
weeks NNS O
later RB O
. . O

Additionally RB O
, , O
subjects NNS O
completed VBD O
the DT O
SF NNP O
- HYPH O
36 CD O
and CC O
the DT O
CES NNP O
- HYPH O
D NNP O
[ -LRB- O
21 CD O
] -RRB- O
for IN O
validation NN O
purposes NNS O
at IN O
both DT O
assessments NNS O
. . O

Demographic JJ O
and CC O
clinical JJ O
characteristics NNS O
were VBD O
also RB O
solicited VBN O
in IN O
order NN O
to TO O
more RBR O
fully RB O
describe VB O
the DT O
study NN O
population NN O
. . O

Each DT O
study NN O
subject NN O
received VBD O
an DT O
honorarium NN O
for IN O
completing VBG O
the DT O
questionnaires NNS O
. . O

Scale NN O
creation NN O
and CC O
confirmatory JJ O
factor NN O
analysis NN O

Confirmatory JJ O
factor NN O
analyses NNS O
were VBD O
conducted VBN O
to TO O
test VB O
the DT O
hypothesized JJ O
structure NN O
of IN O
the DT O
scales NNS O
. . O

Two CD O
models NNS O
using VBG O
LISREL NNP O
version NN O
8 CD O
were VBD O
tested VBN O
[ -LRB- O
22 CD O
] -RRB- O
. . O

The DT O
first JJ O
model NN O
consisted VBD O
of IN O
all DT O
50 CD O
HRQoL NNP O
items NNS O
and CC O
10 CD O
factors NNS O
, , O
whereas IN O
the DT O
second JJ O
model NN O
consisted VBD O
of IN O
a DT O
subset NN O
of IN O
the DT O
50 CD O
- HYPH O
item NN O
correlation NN O
matrix NN O
. . O

Only RB O
women NNS B-Species
respond VBP O
to IN O
the DT O
six CD O
items NNS O
comprising VBG O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
, , O
so IN O
the DT O
items NNS O
were VBD O
not RB O
included VBN O
in IN O
the DT O
second JJ O
LISREL NNP O
model NN O
to TO O
avoid VB O
estimation NN O
biases NNS O
. . O

The DT O
remaining VBG O
44 CD O
items NNS O
were VBD O
analyzed VBN O
. . O

Model JJ O
fit NN O
was VBD O
evaluated VBN O
using VBG O
the DT O
goodness NN O
- HYPH O
of IN O
- HYPH O
fit NN O
( HYPH O
GFI NNP O
) -RRB- O
, , O
the DT O
normed VBN O
fit NN O
index NN O
( -LRB- O
NFI NNP O
) -RRB- O
, , O
the DT O
non AFX O
- HYPH O
normed VBN O
fit NN O
index NN O
( -LRB- O
NNFI NNP O
) -RRB- O
, , O
the DT O
comparative JJ O
fit NN O
index NN O
( -LRB- O
CIF NNP O
) -RRB- O
, , O
and CC O
the DT O
root NN O
mean JJ O
square JJ O
error NN O
of IN O
approximation NN O
( : O
RMSEA NNP O
) -RRB- O
. . O

For IN O
the DT O
confirmatory JJ O
models NNS O
, , O
index NN O
values NNS O
greater JJR O
than IN O
0 CD O
. . O
95 CD O
indicate VBP O
better JJR O
fit NN O
, , O
and CC O
RMSEA NNP O
values NNS O
less JJR O
than IN O
0 CD O
. . O
5 CD O
are VBP O
considered VBN O
evidence NN O
of IN O
adequate JJ O
fit NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Reliability NN O
and CC O
stability NN O

Two CD O
forms NNS O
of IN O
reliability NN O
were VBD O
assessed VBN O
: : O
test NN O
- HYPH O
retest NN O
reliability NN O
and CC O
internal JJ O
consistency NN O
reliability NN O
. . O

Test NN O
- HYPH O
retest NN O
reliability NN O
, , O
a DT O
measure NN O
of IN O
the DT O
degree NN O
to TO O
which WDT O
the DT O
questionnaire NN O
yields VBZ O
stable JJ O
scores NNS O
over IN O
a DT O
short JJ O
period NN O
of IN O
time NN O
( , O
assuming VBG O
there EX O
is VBZ O
no DT O
underlying VBG O
change NN O
) -RRB- O
, , O
was VBD O
measured VBN O
by IN O
the DT O
intra JJ O
- HYPH O
class NN O
correlation NN O
coefficient JJ O
( -LRB- O
ICC NNP O
) -RRB- O
[ -LRB- O
24 CD O
, , O
25 CD O
] -RRB- O
. . O

An DT O
ICC NNP O
of IN O
> NFP O
= SYM O
0 CD O
. . O
70 CD O
was VBD O
considered VBN O
acceptable JJ O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Internal JJ O
consistency NN O
reliability NN O
, , O
the DT O
extent NN O
to IN O
which WDT O
items NNS O
within IN O
each DT O
scale NN O
correlate VBP O
with IN O
each DT O
other JJ O
to TO O
form VB O
a DT O
multi JJ O
- HYPH O
item NN O
scale NN O
, , O
was VBD O
assessed VBN O
using VBG O
Cronbach NNP O
' POS O
s POS O
alpha NN O
[ -LRB- O
25 CD O
, , O
27 CD O
] -RRB- O
. . O

Data NNS O
from IN O
both DT O
assessments NNS O
were VBD O
used VBN O
to TO O
evaluate VB O
internal JJ O
consistency NN O
reliability NN O
. . O

An DT O
alpha NN O
coefficient NN O
of IN O
> SYM O
= SYM O
0 CD O
. . O
70 CD O
was VBD O
considered VBN O
acceptable JJ O
, , O
which WDT O
is VBZ O
the DT O
commonly RB O
accepted VBN O
minimal JJ O
standard NN O
for IN O
reliability NN O
coefficients NNS O
endorsed VBN O
by IN O
the DT O
Scientific NNP O
Advisory NNP O
Committee NNP O
of IN O
the DT O
Medical NNP O
Outcomes NNPS O
Trust NNP O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Construct VB O
Validity NN O

Construct NN O
validity NN O
was VBD O
assessed VBN O
by IN O
examining VBG O
the DT O
inter JJ O
- HYPH O
scale NN O
correlations NNS O
between IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
and CC O
the DT O
CES NNP O
- HYPH O
D NNP O
and CC O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
with IN O
the DT O
SF NNP O
- HYPH O
36 CD O
and CC O
by IN O
examining VBG O
the DT O
strength NN O
of IN O
the DT O
within IN O
ITP NNP O
- HYPH O
PAQ NNP O
scale NN O
correlations NNS O
[ -LRB- O
25 CD O
, , O
28 CD O
] -RRB- O
. . O

For IN O
both CC O
inter JJ O
- HYPH O
scale NN O
and CC O
intra JJ O
- HYPH O
scale NN O
correlations NNS O
, , O
we PRP O
made VBD O
a DT O
priori JJ O
hypotheses NNS O
about IN O
the DT O
directionality NN O
and CC O
magnitude NN O
of IN O
the DT O
correlation NN O
and CC O
observed VBD O
the DT O
extent NN O
to IN O
which WDT O
hypothesized JJ O
relationships NNS O
held VBD O
. . O

For IN O
example NN O
, , O
we PRP O
hypothesized VBD O
that IN O
the DT O
scales NNS O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
would MD O
be VB O
negatively RB O
correlated VBN O
with IN O
the DT O
CES NNP O
- HYPH O
D NNP O
and CC O
positively RB O
correlated VBN O
with IN O
those DT O
of IN O
the DT O
SF NNP O
- HYPH O
36 CD O
. . O

We PRP O
expected VBD O
the DT O
Pearson NNP O
correlations NNS O
to TO O
be VB O
moderate JJ O
in IN O
size NN O
. . O

Known VBN O
Groups NNS O

Known VBN O
groups NNS O
validity NN O
evaluates VBZ O
the DT O
ability NN O
of IN O
the DT O
measure NN O
to TO O
discriminate VB O
between IN O
groups NNS O
known VBN O
to TO O
be VB O
clinically RB O
different JJ O
[ -LRB- O
28 CD O
] -RRB- O
. . O

We PRP O
only RB O
collected VBD O
patient NN B-Species
- HYPH O
reported VBN O
information NN O
using VBG O
the DT O
questionnaire NN O
and CC O
did VBD O
not RB O
collect VB O
clinical JJ O
information NN O
such JJ O
as IN O
platelet NN O
counts NNS O
. . O

Therefore RB O
, , O
the DT O
following VBG O
four CD O
criteria NNS O
were VBD O
identified VBN O
as IN O
proxies NNS O
for IN O
severity NN O
: : O

* NFP O
Currently RB O
on IN O
treatment NN O

* NFP O
Splenectomy NN O
status NN O

* NFP O
Subjects NNS O
' POS O
self NN O
- HYPH O
perception NN O
of IN O
the DT O
effectiveness NN O
of IN O
current JJ O
medication NN O

* NFP O
Length NN O
of IN O
time NN O
since IN O
diagnosis NN O

It PRP O
was VBD O
hypothesized VBN O
that IN O
subjects NNS O
not RB O
being VBG O
treated VBN O
, , O
who WP O
did VBD O
not RB O
have VB O
a DT O
splenectomy NN O
, , O
who WP O
perceived VBD O
their PRP$ O
medication NN O
to TO O
be VB O
more RBR O
effective JJ O
, , O
and CC O
who WP O
had VBD O
been VBN O
diagnosed VBN O
with IN O
ITP NNP O
for IN O
a DT O
longer JJR O
time NN O
would MD O
be VB O
healthier JJR O
and CC O
therefore RB O
report VBP O
higher JJR O
HRQoL NNP O
scores NNS O
. . O

In IN O
contrast NN O
, , O
subjects NNS O
on IN O
any DT O
treatment NN O
, , O
who WP O
had VBD O
received VBN O
a DT O
splenectomy NN O
, , O
who WP O
perceived VBD O
their PRP$ O
medication NN O
to TO O
be VB O
less RBR O
effective JJ O
, , O
and CC O
who WP O
were VBD O
diagnosed VBN O
more RBR O
recently RB O
would MD O
report VB O
worse JJR O
HRQoL NNP O
. . O

In IN O
addition NN O
, , O
subjects NNS O
were VBD O
also RB O
categorized VBN O
by IN O
gender NN O
. . O

Subjects NNS O
were VBD O
categorized VBN O
into IN O
two CD O
groups NNS O
for IN O
each DT O
of IN O
the DT O
analyses NNS O
: : O
female JJ O
vs IN O
. , O
male JJ O
, , O
intact JJ O
spleen NN O
vs CC O
. , O
removed VBN O
spleen NN O
, , O
currently RB O
on IN O
ITP NNP O
treatment NN O
vs IN O
. , O
not RB O
currently RB O
on IN O
ITP NNP O
treatment NN O
, , O
subject NN O
' '' O
s POS O
perception NN O
of IN O
the DT O
effectiveness NN O
of IN O
their PRP$ O
current JJ O
ITP NNP O
medication NN O
( : O
extremely RB O
/ SYM O
moderately RB O
effective JJ O
vs IN O
. , O
not RB O
at RB O
all RB O
effective JJ O
) -RRB- O
, , O
and CC O
ITP NNP O
diagnosis NN O
less JJR O
than IN O
one CD O
year NN O
ago RB O
vs IN O
. . O
ITP NNP O
diagnosis NN O
more JJR O
than IN O
one CD O
year NN O
ago RB O
. . O

Results NNS O

Demographics NNS O
and CC O
clinical JJ O
characteristics NNS O

Table NNP O
1 CD O
describes VBZ O
the DT O
demographic JJ O
and CC O
clinical JJ O
characteristics NNS O
of IN O
the DT O
73 CD O
subjects NNS O
included VBN O
in IN O
the DT O
validation NN O
analyses NNS O
. . O

The DT O
majority NN O
were VBD O
female JJ O
( : O
77 CD O
% NN O
) -RRB- O
and CC O
Caucasian JJ O
( : O
84 CD O
% NN O
) -RRB- O
. . O

The DT O
mean JJ O
age NN O
was VBD O
45 CD O
years NNS O
( , O
SD NN O
= SYM O
15 CD O
. . O
7 CD O
) -RRB- O
, , O
and CC O
most JJS O
of IN O
the DT O
subjects NNS O
had VBD O
been VBN O
diagnosed VBN O
with IN O
ITP NNP O
for IN O
at RB O
least RBS O
five CD O
years NNS O
( : O
57 CD O
% NN O
) -RRB- O
. . O

Fifty CD O
- HYPH O
two CD O
percent NN O
of IN O
the DT O
subjects NNS O
reported VBD O
that IN O
they PRP O
were VBD O
currently RB O
taking VBG O
medications NNS O
for IN O
their PRP$ O
ITP NNP O
. . O

Furthermore RB O
, , O
58 CD O
% NN O
indicated VBD O
that IN O
they PRP O
had VBD O
a DT O
splenectomy NN O
. . O

Among IN O
the DT O
42 CD O
subjects NNS O
who WP O
had VBD O
a DT O
splenectomy NN O
, , O
55 CD O
% NN O
reported VBD O
that IN O
the DT O
removal NN O
of IN O
their PRP$ O
spleen NN O
did VBD O
not RB O
cure VB O
their PRP$ O
ITP NNP O
. . O

With IN O
one CD O
exception NN O
, , O
the DT O
remaining VBG O
subjects NNS O
did VBD O
not RB O
provide VB O
a DT O
response NN O
. . O

Confirmatory JJ O
factor NN O
analysis NN O

The DT O
first JJ O
confirmatory JJ O
factor NN O
analysis NN O
of IN O
the DT O
50 CD O
- HYPH O
item NN O
and CC O
ten CD O
factors NNS O
model NN O
converged VBD O
in IN O
28 CD O
iterations NNS O
. . O

However RB O
, , O
neither CC O
the DT O
inter JJ O
- HYPH O
item NN O
correlation NN O
matrix NN O
nor CC O
the DT O
inter JJ O
- HYPH O
factor NN O
correlation NN O
matrix NN O
was VBD O
positive JJ O
- HYPH O
definite JJ O
, , O
which WDT O
suggests VBZ O
that IN O
the DT O
proposed VBN O
model NN O
is VBZ O
wrong JJ O
for IN O
the DT O
data NNS O
or CC O
the DT O
data NNS O
are VBP O
inadequate JJ O
for IN O
the DT O
model NN O
[ -LRB- O
22 CD O
] -RRB- O
. . O

The DT O
chi JJ O
- HYPH O
square JJ O
value NN O
of IN O
the DT O
model NN O
was VBD O
316 CD O
. . O
64 CD O
with IN O
1129 CD O
degrees NNS O
of IN O
freedom NN O
( : O
p NN O
= SYM O
1 CD O
. . O
0 CD O
) -RRB- O
, , O
which WDT O
does VBZ O
not RB O
support VB O
the DT O
hypothesized JJ O
scale NN O
structure NN O
of IN O
the DT O
initial JJ O
ITP NNP O
- HYPH O
PAQ NNP O
. . O

The DT O
confirmatory JJ O
analysis NN O
of IN O
this DT O
LISREL NNP O
model NN O
indicate VBP O
that IN O
computing NN O
domain NN O
scores NNS O
for IN O
the DT O
Physical NNP O
Health NNP O
and CC O
Mental NNP O
Health NNP O
domains NNS O
is VBZ O
not RB O
appropriate JJ O
for IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
. . O

The DT O
second JJ O
LISREL NNP O
model NN O
was VBD O
analyzed VBN O
to TO O
confirm VB O
the DT O
scale NN O
structure NN O
, , O
excluding VBG O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
. . O

For IN O
this DT O
model NN O
, , O
126 CD O
parameters NNS O
were VBD O
estimated VBN O
: : O
46 CD O
factor NN O
loadings NNS O
, , O
44 CD O
error NN O
terms NNS O
, , O
and CC O
36 CD O
inter JJ O
- HYPH O
factor NN O
correlations NNS O
. . O

The DT O
model NN O
converged VBD O
in IN O
39 CD O
iterations NNS O
, , O
with IN O
a DT O
chi JJ O
- HYPH O
square NN O
value NN O
of IN O
1043 CD O
. . O
10 CD O
with IN O
864 CD O
degrees NNS O
of IN O
freedom NN O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

The DT O
Goodness NNP O
of IN O
Fit NNP O
Index NNP O
( -LRB- O
GFI NNP O
) -RRB- O
, , O
Normed NNP O
Fit NNP O
Index NNP O
( , O
NFI NNP O
) -RRB- O
, , O
Non NNP O
- HYPH O
normed VBN O
Fit NNP O
Index NNP O
( : O
NNFI NNP O
) -RRB- O
, , O
and CC O
Comparative NNP O
Fit NNP O
Index NNP O
( : O
CFI NNP O
) -RRB- O
was VBD O
0 CD O
. . O
60 CD O
, , O
0 CD O
. . O
63 CD O
, , O
0 CD O
. . O
91 CD O
, , O
and CC O
0 CD O
. . O
92 CD O
, , O
respectively RB O
, , O
and CC O
the DT O
RMSEA NNP O
was VBD O
0 CD O
. . O
5 CD O
[ -LRB- O
90 CD O
% NN O
CI NN O
, , O
0 CD O
. . O
4 CD O
- HYPH O
0 CD O
. . O
65 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
the DT O
inter JJ O
- HYPH O
factor NN O
correlations NNS O
ranged VBN O
form NN O
0 CD O
. . O
33 CD O
between IN O
the DT O
Symptoms NNS O
and CC O
Work NNP O
scales NNS O
to IN O
0 CD O
. . O
96 CD O
between IN O
the DT O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
and CC O
Overall NNP O
QoL NNP O
scales NNS O
. . O

In IN O
addition NN O
to IN O
the DT O
confirmatory JJ O
factor NN O
analyses NNS O
, , O
Cronbach NNP O
' POS O
s NN O
alphas NNS O
and CC O
item NN O
- HYPH O
to IN O
- HYPH O
total JJ O
correlations NNS O
were VBD O
used VBN O
for IN O
item NN O
reduction NN O
. . O

Items NNS O
with IN O
low JJ O
factor NN O
loadings NNS O
and CC O
item NN O
- HYPH O
to IN O
- HYPH O
total JJ O
correlations NNS O
that WDT O
reduced VBD O
the DT O
internal JJ O
consistency NN O
were VBD O
eliminated VBN O
. . O

Although IN O
initial JJ O
factor NN O
analyses NNS O
identified VBD O
six CD O
domains NNS O
for IN O
future JJ O
use NN O
, , O
the DT O
final JJ O
version NN O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
contained VBD O
44 CD O
items NNS O
that WDT O
included VBD O
the DT O
following VBG O
ten CD O
scales NNS O
: : O
Symptoms NNS O
, , O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
, , O
Fatigue NNP O
/ SYM O
Sleep NNP O
, , O
Activity NNP O
, , O
Fear NNP O
, , O
Psychological NNP O
Health NNP O
, , O
Work NNP O
, , O
Social NNP O
Activity NNP O
, , O
Women NNPS B-Species
' POS O
s POS O
Reproductive NNP O
Health NNP O
, , O
and CC O
Overall NNP O
QoL NNP O
. . O

Table NN O
2 CD O
provides VBZ O
information NN O
on IN O
the DT O
number NN O
of IN O
items NNS O
, , O
item NN O
variability NN O
and CC O
sample VB O
items NNS O
from IN O
each DT O
scale NN O
of IN O
the DT O
questionnaire NN O
. . O

Each DT O
scale NN O
is VBZ O
scored VBN O
from IN O
0 CD O
to IN O
100 CD O
, , O
with IN O
higher JJR O
scores NNS O
representing VBG O
better JJR O
quality NN O
of IN O
life NN O
. . O

Test NN O
- HYPH O
retest NN O
reliability NN O

Of IN O
the DT O
73 CD O
subjects NNS O
who WP O
completed VBD O
the DT O
first JJ O
administration NN O
of IN O
the DT O
questionnaire NN O
, , O
most JJS O
of IN O
the DT O
subjects NNS O
completed VBD O
the DT O
second JJ O
questionnaire NN O
within IN O
a DT O
15 CD O
- HYPH O
day NN O
period NN O
( : O
75 CD O
% NN O
) -RRB- O
, , O
during IN O
which WDT O
subjects NNS O
were VBD O
expected VBN O
to TO O
remain VB O
clinically RB O
stable JJ O
. . O

However RB O
, , O
20 CD O
% NN O
of IN O
the DT O
73 CD O
subjects NNS O
completed VBD O
the DT O
questionnaire NN O
within IN O
three CD O
weeks NNS O
following VBG O
the DT O
first JJ O
administration NN O
. . O

The DT O
remaining VBG O
5 CD O
% NN O
of IN O
subjects NNS O
completed VBD O
it PRP O
between IN O
four CD O
and CC O
nine CD O
weeks NNS O
after IN O
the DT O
first JJ O
"""" `` O
test NN O
. , O
"""" '' O
ICC NNP O
' '' O
s POS O
were VBD O
computed VBN O
for IN O
the DT O
entire JJ O
sample NN O
( , O
n CD O
= SYM O
73 CD O
) -RRB- O
and CC O
for IN O
a DT O
sub NN O
- HYPH O
sample NN O
of IN O
respondents NNS O
who WP O
completed VBD O
the DT O
second JJ O
questionnaire NN O
within IN O
three CD O
weeks NNS O
( : O
n CD O
= SYM O
69 CD O
) -RRB- O
. . O

With IN O
the DT O
exception NN O
of IN O
the DT O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
and CC O
Activity NNP O
scales NNS O
, , O
all DT O
scales NNS O
had VBD O
acceptable JJ O
test NN O
- HYPH O
retest NN O
reliability NN O
( : O
ICC NNP O
> SYM O
= SYM O
0 CD O
. . O
70 CD O
) -RRB- O
as IN O
measured VBN O
by IN O
the DT O
ICC NNP O
( -LRB- O
Table NNP O
3 CD O
) -RRB- O
. . O

For IN O
the DT O
entire JJ O
sample NN O
, , O
ICC NNP O
values NNS O
ranged VBN O
from IN O
0 CD O
. . O
52 CD O
- SYM O
0 CD O
. . O
90 CD O
, , O
while IN O
ICC NNP O
values NNS O
for IN O
the DT O
sub NN O
- HYPH O
sample NN O
ranged VBD O
from IN O
0 CD O
. . O
56 CD O
- SYM O
0 CD O
. . O
89 CD O
. . O

Internal JJ O
consistency NN O
reliability NN O

Internal JJ O
consistency NN O
reliability NN O
, , O
measured VBN O
by IN O
Cronbach NNP O
' POS O
s POS O
alpha NN O
, , O
ranged VBD O
from IN O
0 CD O
. . O
66 CD O
to IN O
0 CD O
. . O
92 CD O
( , O
Table NN O
3 CD O
) -RRB- O
. . O

With IN O
the DT O
exception NN O
of IN O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
, , O
Cronbach NNP O
' POS O
s POS O
alpha NN O
coefficients NNS O
exceeded VBD O
the DT O
acceptable JJ O
level NN O
of IN O
0 CD O
. . O
70 CD O
. . O

Cronbach NNP O
' POS O
s POS O
alpha NN O
for IN O
the DT O
Symptoms NNS O
, , O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
, , O
Fatigue NNP O
/ , O
Sleep NNP O
, , O
and CC O
Activity NN O
scales NNS O
ranged VBD O
from IN O
0 CD O
. . O
71 CD O
- SYM O
0 CD O
. . O
89 CD O
, , O
while IN O
Cronbach NNP O
' POS O
s POS O
alpha NN O
for IN O
the DT O
Psychological NNP O
Health NNP O
and CC O
Fear NNP O
scales NNS O
ranged VBD O
from IN O
0 CD O
. . O
87 CD O
- SYM O
0 CD O
. . O
92 CD O
. . O

Additionally RB O
, , O
Cronbach NNP O
' POS O
s POS O
alphas NNS O
for IN O
the DT O
Social NNP O
Activity NNP O
, , O
Work NNP O
, , O
Reproductive NNP O
Health NNP O
, , O
and CC O
Overall NNP O
QoL NNP O
scales NNS O
were VBD O
0 CD O
. . O
72 CD O
, , O
0 CD O
. . O
86 CD O
, , O
0 CD O
. . O
66 CD O
, , O
and CC O
0 CD O
. . O
89 CD O
, , O
respectively RB O
. . O

Construct VB O
validity NN O

Table NN O
4 CD O
displays VBZ O
the DT O
results NNS O
of IN O
inter JJ O
- HYPH O
scale NN O
Pearson NNP O
correlation NN O
coefficients NNS O
for IN O
the DT O
initial JJ O
test NN O
administration NN O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
. . O

As IN O
expected VBN O
, , O
the DT O
Symptoms NNS O
, , O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
, , O
Fatigue NNP O
/ SYM O
Sleep NNP O
, , O
and CC O
Activity NNP O
scales NNS O
were VBD O
moderately RB O
to IN O
strongly RB O
inter VB O
- HYPH O
correlated VBN O
based VBN O
on IN O
the DT O
data NNS O
from IN O
the DT O
initial JJ O
administration NN O
( , O
correlation NN O
coefficients NNS O
ranged VBN O
from IN O
0 CD O
. . O
56 CD O
- SYM O
0 CD O
. . O
75 CD O
; : O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

The DT O
Overall NNP O
QoL NNP O
scale NN O
was VBD O
moderately RB O
to IN O
strongly RB O
correlated VBN O
with IN O
the DT O
other JJ O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
, , O
with IN O
the DT O
exception NN O
of IN O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
. . O

In IN O
addition NN O
to IN O
examining VBG O
the DT O
correlations NNS O
within IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
, , O
construct NN O
validity NN O
was VBD O
also RB O
assessed VBN O
by IN O
comparing VBG O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scale NN O
scores NNS O
with IN O
those DT O
of IN O
the DT O
CES NNP O
- HYPH O
D NNP O
and CC O
the DT O
SF NNP O
- HYPH O
36 CD O
. . O

The DT O
CES NNP O
- HYPH O
D NNP O
was VBD O
negatively RB O
correlated VBN O
with IN O
all DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
, , O
except IN O
for IN O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
. . O

Other RB O
than IN O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
, , O
Pearson NNP O
correlations NNS O
ranged VBD O
from IN O
- HYPH O
0 CD O
. . O
37 CD O
to IN O
- HYPH O
0 CD O
. . O
70 CD O
( , O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Most JJS O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
were VBD O
moderately RB O
correlated VBN O
with IN O
the DT O
SF NNP O
- HYPH O
36 CD O
scales NNS O
; : O
however RB O
, , O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
was VBD O
not RB O
significantly RB O
correlated VBN O
with IN O
any DT O
of IN O
the DT O
SF NNP O
- HYPH O
36 CD O
scales NNS O
. . O

The DT O
mean JJ O
SF NNP O
- HYPH O
36 CD O
scores NNS O
of IN O
the DT O
subjects NNS O
with IN O
ITP NNP O
were VBD O
compared VBN O
to IN O
those DT O
of IN O
the DT O
general JJ O
U NN O
. . O
S NNP O
. . O
population NN O
norms NNS O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Results NNS O
from IN O
t NN O
- HYPH O
tests NNS O
indicate VBP O
that IN O
there EX O
were VBD O
statistically RB O
significant JJ O
differences NNS O
( -LRB- O
p NN O
< SYM O
0 CD O
. . O
5 CD O
) -RRB- O
in IN O
SF NNP O
- HYPH O
36 CD O
mean JJ O
scores NNS O
between IN O
subjects NNS O
with IN O
ITP NNP O
( HYPH O
range NN O
, , O
43 CD O
. . O
4 CD O
- HYPH O
72 CD O
. . O
86 CD O
) -RRB- O
and CC O
the DT O
general JJ O
U NN O
. . O
S NN O
. . O
population NN O
( : O
range NN O
, , O
60 CD O
. . O
86 CD O
- SYM O
84 CD O
. . O
15 CD O
) -RRB- O
. . O

Subjects NNS O
with IN O
ITP NNP O
reported VBD O
lower JJR O
scores NNS O
on IN O
each DT O
SF NNP O
- HYPH O
36 CD O
scale NN O
compared VBN O
to IN O
the DT O
US NNP O
norm NN O
( : O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Known VBN O
groups NNS O
validity NN O

Subjects NNS O
were VBD O
categorized VBN O
into IN O
two CD O
groups NNS O
according VBG O
to IN O
gender NN O
, , O
splenectomy NN O
status NN O
, , O
current JJ O
ITP NNP O
treatment NN O
status NN O
, , O
subject NN O
' '' O
s POS O
perception NN O
of IN O
the DT O
effectiveness NN O
of IN O
ITP NNP O
treatment NN O
, , O
and CC O
time NN O
elapsed VBN O
since IN O
ITP NNP O
diagnosis NN O
. . O

When WRB O
subjects NNS O
were VBD O
grouped VBN O
according VBG O
to IN O
gender NN O
or CC O
splenectomy NN O
status NN O
, , O
no DT O
statistically RB O
significant JJ O
differences NNS O
were VBD O
observed VBN O
for IN O
any DT O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Subjects NNS O
who WP O
were VBD O
currently RB O
receiving VBG O
treatment NN O
for IN O
ITP NNP O
reported VBD O
lower JJR O
scores NNS O
on IN O
all DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
compared VBN O
to IN O
subjects NNS O
who WP O
were VBD O
not RB O
currently RB O
receiving VBG O
treatment NN O
. . O

Statistically RB O
significant JJ O
differences NNS O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
were VBD O
reported VBN O
for IN O
the DT O
following VBG O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
when WRB O
subjects NNS O
were VBD O
categorized VBN O
by IN O
treatment NN O
status NN O
: : O
Symptoms NNS O
, , O
Fatigue NNP O
/ SYM O
Sleep NNP O
, , O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
, , O
Activity NNP O
, , O
Psychological NNP O
Health NNP O
, , O
and CC O
Overall NNP O
QoL NNP O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

When WRB O
subjects NNS O
were VBD O
categorized VBN O
by IN O
effectiveness NN O
of IN O
ITP NNP O
treatment NN O
, , O
statistically RB O
significant JJ O
differences NNS O
( , O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
were VBD O
observed VBN O
for IN O
the DT O
Symptoms NNS O
and CC O
Activity NNP O
scales NNS O
( -LRB- O
Figure NNP O
1 CD O
) -RRB- O
, , O
while IN O
statistically RB O
significant JJ O
differences NNS O
were VBD O
only RB O
found VBN O
for IN O
the DT O
Psychological NNP O
Health NNP O
scale NN O
when WRB O
subjects NNS O
were VBD O
categorized VBN O
according VBG O
to IN O
time NN O
elapsed VBN O
since IN O
ITP NNP O
diagnosis NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Subjects NNS O
who WP O
had VBD O
been VBN O
diagnosed VBN O
with IN O
ITP NNP O
for IN O
< SYM O
1 CD O
year NN O
had VBD O
a DT O
lower JJR O
mean JJ O
score NN O
on IN O
the DT O
Psychological NNP O
Health NNP O
scale NN O
compared VBN O
to IN O
subjects NNS O
who WP O
had VBD O
been VBN O
diagnosed VBN O
with IN O
ITP NNP O
for IN O
at RB O
least RBS O
one CD O
year NN O
( : O
50 CD O
. . O
38 CD O
vs NNS O
. . O
66 CD O
. . O
46 CD O
, , O
respectively RB O
; : O
p NN O
= SYM O
0 CD O
. . O
2 CD O
) -RRB- O
( , O
data NN O
not RB O
shown VBN O
) -RRB- O
. . O

Discussion NN O

The DT O
goal NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
develop VB O
and CC O
undertake VB O
initial JJ O
validation NN O
analyses NNS O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
as IN O
a DT O
tool NN O
for IN O
measuring VBG O
HRQoL NNP O
specifically RB O
related VBN O
to IN O
adult NN O
subjects NNS O
with IN O
ITP NNP O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
provide VBP O
preliminary JJ O
evidence NN O
of IN O
the DT O
reliability NN O
and CC O
validity NN O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
in IN O
this DT O
population NN O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
, , O
with IN O
the DT O
exception NN O
of IN O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
, , O
the DT O
questionnaire NN O
has VBZ O
good JJ O
internal JJ O
consistency NN O
. . O

The DT O
Reproductive NNP O
Health NNP O
scale NN O
may MD O
not RB O
have VB O
reached VBN O
an DT O
acceptable JJ O
level NN O
because IN O
the DT O
items NNS O
could MD O
in IN O
fact NN O
be VB O
measuring VBG O
slightly RB O
different JJ O
concepts NNS O
. . O

For IN O
example NN O
, , O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
includes VBZ O
items NNS O
that WDT O
assess VBP O
symptom NN O
bother VBP O
related VBN O
to IN O
menstruation NN O
in IN O
addition NN O
to IN O
items NNS O
that WDT O
ask VBP O
how WRB O
ITP NNP O
impacts VBZ O
reproductive JJ O
choices NNS O
, , O
such JJ O
as IN O
becoming VBG O
pregnant JJ O
, , O
giving VBG O
birth NN O
, , O
and CC O
adopting VBG O
children NNS B-Species
. . O

Perhaps RB O
, , O
the DT O
symptom NN O
bother NN O
items NNS O
in IN O
this DT O
scale NN O
may MD O
fit VB O
more RBR O
appropriately RB O
with IN O
the DT O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
scale NN O
, , O
and CC O
the DT O
reproductive JJ O
choice NN O
items NNS O
could MD O
comprise VB O
a DT O
separate JJ O
scale NN O
. . O

Most JJS O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
also RB O
demonstrated VBD O
acceptable JJ O
test NN O
- HYPH O
retest NN O
reliability NN O
, , O
even RB O
though IN O
the DT O
time NN O
interval NN O
between IN O
test NN O
and CC O
retest NN O
administrations NNS O
of IN O
the DT O
questionnaire NN O
exceeded VBD O
the DT O
targeted VBN O
time NN O
interval NN O
of IN O
seven CD O
to TO O
ten CD O
days NNS O
. . O

However RB O
, , O
two CD O
scales NNS O
, , O
the DT O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
and CC O
Activity NNP O
scales NNS O
, , O
reported VBD O
ICC NNP O
values NNS O
below IN O
the DT O
acceptable JJ O
value NN O
of IN O
0 CD O
. . O
70 CD O
. . O

In IN O
addition NN O
to IN O
the DT O
lag NN O
between IN O
the DT O
two CD O
administrations NNS O
of IN O
the DT O
questionnaire NN O
, , O
subjects NNS O
may MD O
have VB O
experienced VBN O
an DT O
increase NN O
in IN O
bother NN O
and CC O
/ SYM O
or CC O
a DT O
decrease NN O
in IN O
activity NN O
due IN O
to IN O
ITP NNP O
during IN O
the DT O
extended JJ O
time NN O
interval NN O
. . O

Additionally RB O
, , O
the DT O
comparatively RB O
low JJ O
ICC NNP O
values NNS O
of IN O
the DT O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
and CC O
Activity NNP O
scales NNS O
may MD O
be VB O
due IN O
in IN O
part NN O
to IN O
the DT O
relatively RB O
low JJ O
number NN O
of IN O
items NNS O
contained VBN O
in IN O
each DT O
of IN O
these DT O
scales NNS O
( : O
four CD O
and CC O
two CD O
items NNS O
, , O
respectively RB O
) , O
compared VBN O
to IN O
the DT O
Symptoms NNS O
scale NN O
which WDT O
contains VBZ O
six CD O
items NNS O
. . O

In IN O
general JJ O
, , O
the DT O
construct NN O
validity NN O
of IN O
the DT O
questionnaire NN O
was VBD O
supported VBN O
by IN O
inter JJ O
- HYPH O
scale NN O
correlations NNS O
. . O

As IN O
expected VBN O
, , O
the DT O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
, , O
Symptoms NNP O
, , O
Fatigue NNP O
/ SYM O
Sleep NNP O
, , O
and CC O
Activity NNP O
scales NNS O
were VBD O
more RBR O
strongly RB O
correlated VBN O
to IN O
one CD O
another DT O
than IN O
with IN O
other JJ O
scales NNS O
. . O

However RB O
, , O
the DT O
Reproductive NNP O
Health NNP O
scale NN O
had VBD O
a DT O
lower JJR O
internal JJ O
consistency NN O
reliability NN O
and CC O
it PRP O
was VBD O
weakly RB O
correlated VBN O
with IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
, , O
the DT O
SF NNP O
- HYPH O
36 CD O
, , O
and CC O
the DT O
CES NNP O
- HYPH O
D NNP O
, , O
possibly RB O
due IN O
to IN O
the DT O
differing VBG O
concepts NNS O
measured VBN O
by IN O
the DT O
items NNS O
within IN O
this DT O
scale NN O
or CC O
the DT O
all DT O
- HYPH O
female JJ O
sample NN O
. . O

Most JJS O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
were VBD O
moderately RB O
correlated VBN O
with IN O
the DT O
SF NNP O
- HYPH O
36 CD O
scales NNS O
and CC O
the DT O
CES NNP O
- HYPH O
D NNP O
; : O
however RB O
, , O
correlations NNS O
between IN O
some DT O
of IN O
the DT O
scales NNS O
were VBD O
< : O
0 CD O
. . O
40 CD O
( : O
e LS O
. . O
g LS O
. . O
, , O
Fear NNP O
and CC O
SF NNP O
- HYPH O
36 CD O
Mental JJ O
Health NN O
, , O
0 CD O
. . O
30 CD O
; : O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

This DT O
low JJ O
correlation NN O
could MD O
be VB O
due IN O
to IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
assessing VBG O
fear NN O
associated VBN O
with IN O
ITP NNP O
( : O
e LS O
. . O
g LS O
. . O
, , O
fear NN O
of IN O
having VBG O
a DT O
bleeding VBG O
episode NN O
) -RRB- O
, , O
while IN O
the DT O
SF NNP O
- HYPH O
36 CD O
provides VBZ O
a DT O
more RBR O
general JJ O
assessment NN O
of IN O
mental JJ O
health NN O
issues NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
felt VBD O
downhearted JJ O
and CC O
blue JJ O
) -RRB- O
. . O

The DT O
known VBN O
- HYPH O
groups NNS O
validity NN O
results NNS O
indicate VBP O
that IN O
some DT O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
( -LRB- O
Symptoms NNP O
, , O
Fatigue NNP O
/ SYM O
Sleep NNP O
, , O
Bother NNP O
- HYPH O
Physical NNP O
Health NNP O
, , O
Activity NNP O
, , O
Psychological NNP O
Health NNP O
, , O
and CC O
Overall NNP O
QoL NNP O
scales NNS O
) -RRB- O
were VBD O
able JJ O
to TO O
differentiate VB O
ITP NNP O
subjects NNS O
who WP O
were VBD O
currently RB O
receiving VBG O
ITP NNP O
treatment NN O
from IN O
those DT O
who WP O
were VBD O
not RB O
receiving VBG O
treatment NN O
for IN O
ITP NNP O
, , O
providing VBG O
preliminary JJ O
evidence NN O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
' POS O
s NN O
ability NN O
to TO O
distinguish VB O
between IN O
groups NNS O
known VBN O
to TO O
be VB O
different JJ O
. . O

However RB O
, , O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
were VBD O
generally RB O
unable JJ O
to TO O
distinguish VB O
between IN O
subjects NNS O
when WRB O
they PRP O
were VBD O
grouped VBN O
by IN O
gender NN O
, , O
splenectomy NN O
status NN O
, , O
perceived VBN O
effectiveness NN O
of IN O
treatment NN O
and CC O
length NN O
of IN O
time NN O
since IN O
ITP NNP O
diagnosis NN O
. . O

The DT O
ITP NNP O
- HYPH O
PAQ NNP O
may MD O
not RB O
be VB O
able JJ O
to TO O
differentiate VB O
between IN O
female JJ O
and CC O
male JJ O
subjects NNS O
because IN O
the DT O
disorder NN O
may MD O
affect VB O
females NNS O
and CC O
males NNS O
similarly RB O
. . O

Additionally RB O
, , O
significant JJ O
differences NNS O
may MD O
not RB O
have VB O
been VBN O
observed VBN O
between IN O
subjects NNS O
who WP O
have VBP O
undergone VBN O
splenectomy NN O
and CC O
subjects NNS O
who WP O
have VBP O
not RB O
because IN O
55 CD O
% NN O
of IN O
subjects NNS O
who WP O
had VBD O
a DT O
splenectomy NN O
indicated VBD O
that IN O
it PRP O
did VBD O
not RB O
cure VB O
their PRP$ O
ITP NNP O
. . O

Specifically RB O
, , O
the DT O
known VBN O
- HYPH O
groups NNS O
could MD O
be VB O
defined VBN O
as IN O
' `` O
subjects NNS O
without IN O
a DT O
splenectomy NN O
' '' O
versus IN O
' '' O
subjects NNS O
with IN O
a DT O
failed VBN O
splenectomy NN O
' '' O
( , O
for IN O
whom WP O
QoL NNP O
likely RB O
worsened VBD O
) , O
versus IN O
' `` O
subjects NNS O
with IN O
a DT O
successful JJ O
splenectomy NN O
' '' O
( : O
for IN O
whom WP O
QoL NNP O
may MD O
have VB O
improved VBN O
) -RRB- O
. . O

In IN O
the DT O
future NN O
, , O
to TO O
assess VB O
whether IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
can MD O
differentiate VB O
between IN O
groups NNS O
of IN O
subjects NNS O
, , O
it PRP O
may MD O
be VB O
worthwhile JJ O
to TO O
categorize VB O
subjects NNS O
by IN O
a DT O
more RBR O
clinically RB O
relevant JJ O
measure NN O
, , O
such JJ O
as IN O
platelet NN O
count NN O
. . O

Several JJ O
limitations NNS O
should MD O
be VB O
considered VBN O
when WRB O
interpreting VBG O
our PRP$ O
findings NNS O
. . O

Subjects NNS O
were VBD O
drawn VBN O
from IN O
a DT O
convenience NN O
sample NN O
. . O

The DT O
study NN O
population NN O
was VBD O
fairly RB O
homogeneous JJ O
, , O
comprised VBN O
primarily RB O
of IN O
Caucasian JJ O
female JJ O
subjects NNS O
. . O

The DT O
data NNS O
was VBD O
validated VBN O
using VBG O
only RB O
patient NN B-Species
- HYPH O
reported VBN O
data NNS O
collected VBN O
via IN O
questionnaire NN O
. . O

The DT O
lack NN O
of IN O
clinical JJ O
data NNS O
in IN O
this DT O
initial JJ O
validation NN O
study NN O
will MD O
be VB O
addressed VBN O
in IN O
on IN O
- HYPH O
going VBG O
pivotal JJ O
trials NNS O
that WDT O
will MD O
collect VB O
clinical JJ O
data NNS O
such JJ O
as IN O
platelet NN O
counts NNS O
and CC O
platelet NN O
response NN O
. . O

In IN O
addition NN O
, , O
the DT O
time NN O
interval NN O
between IN O
the DT O
initial JJ O
and CC O
retest NN O
administration NN O
of IN O
the DT O
questionnaire NN O
may MD O
have VB O
been VBN O
too RB O
lengthy JJ O
to TO O
properly RB O
evaluate VB O
the DT O
test NN O
- HYPH O
retest NN O
reliability NN O
. . O

Because IN O
25 CD O
% NN O
of IN O
subjects NNS O
did VBD O
not RB O
complete VB O
the DT O
questionnaire NN O
within IN O
the DT O
targeted JJ O
fifteen CD O
day NN O
interval NN O
, , O
those DT O
subjects NNS O
may MD O
have VB O
undergone VBN O
clinical JJ O
changes NNS O
that WDT O
may MD O
have VB O
affected VBN O
their PRP$ O
responses NNS O
. . O

In IN O
future JJ O
validation NN O
studies NNS O
platelet NN O
counts NNS O
or CC O
type NN O
of IN O
platelet NN O
response NN O
should MD O
be VB O
used VBN O
to TO O
identify VB O
a DT O
stable JJ O
cohort NN O
for IN O
the DT O
test NN O
- HYPH O
retest NN O
analyses NNS O
. . O

Furthermore RB O
, , O
the DT O
criteria NNS O
used VBN O
to TO O
categorize VB O
the DT O
subjects NNS O
for IN O
the DT O
known VBN O
groups NNS O
validity NN O
evaluation NN O
may MD O
not RB O
have VB O
been VBN O
sufficient JJ O
to TO O
allow VB O
for IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
scales NNS O
to TO O
detect VB O
differences NNS O
between IN O
groups NNS O
. . O

Grouping VBG O
the DT O
subjects NNS O
by IN O
a DT O
different JJ O
criterion NN O
, , O
such JJ O
as IN O
a DT O
relevant JJ O
clinical JJ O
measure NN O
, , O
may MD O
bolster VB O
the DT O
findings NNS O
for IN O
its PRP$ O
known VBN O
groups NNS O
validity NN O
. . O

Conclusion NN O

The DT O
primary JJ O
goal NN O
of IN O
this DT O
manuscript NN O
was VBD O
to TO O
describe VB O
the DT O
development NN O
of IN O
a DT O
new JJ O
ITP NNP O
- HYPH O
specific JJ O
HRQoL NNP O
questionnaire NN O
for IN O
adults NNS O
with IN O
ITP NNP O
and CC O
to TO O
present VB O
our PRP$ O
initial JJ O
findings NNS O
on IN O
the DT O
psychometric JJ O
properties NNS O
of IN O
this DT O
questionnaire NN O
. . O

The DT O
results NNS O
of IN O
this DT O
initial JJ O
validation NN O
study NN O
indicate VBP O
that IN O
the DT O
questionnaire NN O
generally RB O
has VBZ O
acceptable JJ O
reliability NN O
and CC O
validity NN O
. . O

We PRP O
plan VBP O
to TO O
conduct VB O
additional JJ O
analyses NNS O
using VBG O
more RBR O
objective JJ O
clinical JJ O
measures NNS O
such JJ O
as IN O
platelet NN O
counts NNS O
as IN O
a DT O
criterion NN O
for IN O
known VBN O
groups NNS O
validity NN O
. . O

Further JJ O
validation NN O
work NN O
should MD O
also RB O
be VB O
conducted VBN O
to TO O
assess VB O
its PRP$ O
responsiveness NN O
and CC O
to TO O
estimate VB O
its PRP$ O
minimal JJ O
clinical JJ O
important JJ O
difference NN O
value NN O
so IN O
that IN O
it PRP O
can MD O
become VB O
a DT O
more RBR O
widely RB O
used VBN O
HRQoL NNP O
measure NN O
in IN O
the DT O
ITP NNP O
population NN O
. . O

Competing VBG O
interests NNS O

The DT O
validation NN O
study NN O
design NN O
, , O
analysis NN O
, , O
interpretation NN O
of IN O
results NNS O
, , O
and CC O
the DT O
writing NN O
of IN O
the DT O
manuscript NN O
represent VBP O
the DT O
joint JJ O
collaboration NN O
of IN O
all DT O
authors NNS O
of IN O
this DT O
study NN O
, , O
which WDT O
was VBD O
funded VBN O
solely RB O
by IN O
Amgen NNP O
, , O
Inc NNP O
, , O
Thousand NNP O
Oaks NNP O
, , O
California NNP O
, , O
USA NNP O
. . O

Ovation NNP O
Research NNP O
Group NNP O
provided VBD O
no DT O
additional JJ O
funding NN O
for IN O
this DT O
study NN O
. . O

The DT O
decision NN O
to TO O
submit VB O
this DT O
manuscript NN O
for IN O
publication NN O
was VBD O
subject JJ O
to IN O
the DT O
approval NN O
of IN O
Amgen NNP O
, , O
Inc NNP O
. . O
and CC O
all DT O
authors NNS O
. . O

Gary NNP O
Okano NNP O
and CC O
Janet NNP O
Nichol NNP O
are VBP O
employees NNS O
of IN O
Amgen NNP O
, , O
Inc NNP O
. . O

James NNP O
Bussel NNP O
is VBZ O
an DT O
employee NN O
of IN O
Weill NNP O
Cornell NNP O
Medical NNP O
Center NNP O
. . O

James NNP O
George NNP O
is VBZ O
employed VBN O
by IN O
the DT O
University NNP O
of IN O
Oklahoma NNP O
Health NNP O
Sciences NNPS O
Center NNP O
. . O

Robert NNP O
McMillan NNP O
is VBZ O
a DT O
Professor NNP O
Emeritus NNP O
of IN O
the DT O
Scripps NNPS O
Research NNP O
Institute NNP O
. . O

Susan NNP O
Mathias NNP O
is VBZ O
an DT O
employee NN O
of IN O
Ovation NNP O
Research NNP O
Group NNP O
. . O

Authors NNS O
' POS O
contributions NNS O

SDM NNP O
supervised VBD O
the DT O
interpretation NN O
of IN O
the DT O
results NNS O
from IN O
the DT O
validation NN O
study NN O
, , O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

JBB NNP O
, , O
JNG NNP O
, , O
RM NNP O
, , O
and CC O
JLN NNP O
provided VBD O
clinical JJ O
expertise NN O
in IN O
the DT O
development NN O
of IN O
the DT O
questionnaire NN O
, , O
and CC O
participated VBD O
in IN O
the DT O
design NN O
and CC O
execution NN O
of IN O
the DT O
study NN O
. . O

GJO NNP O
assisted VBD O
in IN O
interpreting VBG O
the DT O
results NNS O
and CC O
drafting VBG O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Estrogen NN O
receptor NN O
alpha NN O
( -LRB- O
ER NN O
alpha NN O
) -RRB- O
mRNA NN O
copy NN O
numbers NNS O
in IN O
immunohistochemicall JJ O
ER NN O
alpha NN O
- HYPH O
positive JJ O
- HYPH O
, , O
and CC O
negative JJ O
breast NN O
cancer NN O
tissues NNS O

Abstract JJ O

Background NN O

The DT O
presence NN O
of IN O
ER NNP O
alpha NN O
is VBZ O
the DT O
basis NN O
for IN O
treating VBG O
breast NN O
cancer NN O
patients NNS B-Species
with IN O
targeted VBN O
molecular JJ O
therapies NNS O
that WDT O
block VBP O
estrogen NN O
stimulation NN O
of IN O
breast NN O
cancer NN O
cell NN O
division NN O
. . O

To TO O
select VB O
patients NNS B-Species
for IN O
the DT O
above JJ O
therapies NNS O
, , O
currently RB O
, , O
the DT O
ER NNP O
alpha NN O
presence NN O
in IN O
breast NN O
cancer NN O
tissues NNS O
is VBZ O
determined VBN O
in IN O
clinical JJ O
laboratories NNS O
by IN O
microscopically RB O
scoring VBG O
the DT O
slides NNS O
subjected VBN O
to IN O
immunohistochemistry NN O
( -LRB- O
IHC NNP O
) -RRB- O
. . O

This DT O
method NN O
is VBZ O
not RB O
quantitative JJ O
, , O
highly RB O
subjective JJ O
and CC O
requires VBZ O
large JJ O
amount NN O
of IN O
tumor NN O
tissue NN O
, , O
therefore RB O
, , O
cannot MD O
be VB O
applied VBN O
to IN O
sterotactic JJ O
and CC O
ultrasound NN O
guided VBN O
biopsy NN O
samples NNS O
. . O

To TO O
circumvent VB O
these DT O
problems NNS O
, , O
we PRP O
previously RB O
developed VBD O
quantitative JJ O
real JJ O
- HYPH O
time NN O
PCR NNP O
based VBN O
molecular JJ O
assay NN O
that WDT O
can MD O
be VB O
applied VBN O
to TO O
determine VB O
mRNA NNP O
copies NNS O
of IN O
ER NNP O
alpha NN O
in IN O
picogram NN O
amounts NNS O
of IN O
total JJ O
RNA NNP O
from IN O
tumor NN O
samples NNS O
. . O

However RB O
, , O
it PRP O
is VBZ O
not RB O
known VBN O
how WRB O
the DT O
mRNA NNP O
copy NN O
numbers NNS O
correlate VBP O
to IN O
IHC NNP O
positive JJ O
and CC O
negative JJ O
status NN O
. . O

Methods NNS O

In IN O
the DT O
current JJ O
study NN O
we PRP O
determined VBD O
the DT O
copy NN O
numbers NNS O
of IN O
ER NNP O
alpha NN O
mRNA NN O
by IN O
Q NNP O
RTPCR NNP O
in IN O
breast NN O
cancer NN O
tissues NNS O
that WDT O
were VBD O
graded VBN O
as IN O
ER NNP O
alpha NN O
- HYPH O
positive JJ O
and CC O
negative JJ O
by IN O
1 CD O
) SYM O
IHC NNP O
and CC O
2 CD O
) -RRB- O
functional JJ O
estrogen NN O
binding NN O
assay NN O
and CC O
statistically RB O
analyzed VBD O
the DT O
data NNS O
. . O

Results NNS O

We PRP O
demonstrate VBP O
here RB O
that IN O
ER NNP O
alpha NN O
mRNA NN O
copy NN O
numbers NNS O
are VBP O
not RB O
significantly RB O
different JJ O
in IN O
tissues NNS O
that WDT O
are VBP O
graded VBN O
as IN O
positive JJ O
by IN O
IHC NNP O
and CC O
ligand JJ O
binding NN O
assays NNS O
. . O

We PRP O
establish VBP O
here RB O
a DT O
cut NN O
of IN O
value NN O
of IN O
5 CD O
x SYM O
106 CD O
copies NNS O
per IN O
1010 CD O
mRNA NNP O
copies NNS O
of IN O
GAPDH NNP O
with IN O
an DT O
Odds NNPS O
Radio NNP O
of IN O
39 CD O
. . O
4 CD O
, , O
Sensitivity NN O
of IN O
0 CD O
. . O
81 CD O
and CC O
Specificity NN O
of IN O
0 CD O
. . O
90 CD O
in IN O
breast NN O
cancer NN O
tissues NNS O
that WDT O
are VBP O
negative JJ O
for IN O
ER NNP O
alpha NN O
protein NN O
by IN O
IHC NNP O
and CC O
estrogen NN O
binding NN O
assays NNS O
. . O

ROC NNP O
analysis NN O
of IN O
the DT O
data NNS O
gave VBD O
an DT O
area NN O
of IN O
0 CD O
. . O
8967 CD O
under IN O
the DT O
curve NN O
. . O

Conclusion NN O

We PRP O
expect VBP O
that IN O
the DT O
cut NN O
off RP O
values NNS O
determined VBN O
here RB O
will MD O
be VB O
highly RB O
significant JJ O
for IN O
applying VBG O
molecular JJ O
assay NN O
in IN O
the DT O
place NN O
of IN O
IHC NNP O
in IN O
clinical JJ O
laboratories NNS O
for IN O
evaluating VBG O
the DT O
presence NN O
of IN O
ER NNP O
alpha NN O
for IN O
prognostic JJ O
and CC O
therapeutic JJ O
purposes NNS O
. . O

Background NN O

Breast NN O
cancer NN O
is VBZ O
the DT O
most RBS O
diagnosed VBN O
and CC O
the DT O
second JJ O
leading JJ O
cause NN O
of IN O
cancer NN O
deaths NNS O
for IN O
women NNS B-Species
in IN O
the DT O
United NNP O
States NNP O
striking VBG O
about RB O
300 CD O
, , O
0 CD O
and CC O
killing VBG O
about RB O
40 CD O
, , O
0 CD O
women NNS B-Species
a DT O
year NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

A DT O
substantial JJ O
body NN O
of IN O
epidemiological JJ O
, , O
experimental JJ O
and CC O
clinical JJ O
evidence NN O
indicated VBD O
that IN O
unopposed JJ O
stimulation NN O
of IN O
breast NN O
epithelial JJ O
cells NNS O
by IN O
the DT O
natural JJ O
hormone NN O
, , O
estrogen NN O
, , O
plays VBZ O
a DT O
major JJ O
role NN O
in IN O
the DT O
progression NN O
of IN O
breast NN O
cancers NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Because IN O
endogenous JJ O
estrogens NNS O
directly RB O
promote VBP O
the DT O
growth NN O
of IN O
breast NN O
cancer NN O
cells NNS O
, , O
estrogen NN O
deprivation NN O
either CC O
by IN O
inhibiting VBG O
its PRP$ O
biosynthesis NN O
( , O
aromatase NN O
inhibitors NNS O
) , O
or CC O
blocking VBG O
estrogen NN O
- HYPH O
mediated VBN O
gene NN O
transcription NN O
( , O
tamoxifen NN O
) , O
through IN O
its PRP$ O
high JJ O
affinity NN O
receptor NN O
, , O
the DT O
estrogen NN O
receptor NN O
alpha NN O
( -LRB- O
ER NN O
alpha NN O
) -RRB- O
, , O
are VBP O
the DT O
primary JJ O
lines NNS O
of IN O
therapy NN O
for IN O
breast NN O
cancer NN O
patients NNS B-Species
. . O

In IN O
most JJS O
cases NNS O
, , O
the DT O
efficacy NN O
of IN O
the DT O
above JJ O
treatments NNS O
has VBZ O
correlated VBN O
with IN O
the DT O
presence NN O
of IN O
ER NN O
alpha NN O
in IN O
the DT O
tumor NN O
tissues NNS O
. . O

Currently RB O
, , O
only RB O
those DT O
patients NNS B-Species
who WP O
express VBP O
ER NNP O
alpha NN O
in IN O
their PRP$ O
tumors NNS O
are VBP O
chosen VBN O
for IN O
aromatase NN O
inhibitor NN O
or CC O
tamoxifen NN O
therapies NNS O
. . O

In IN O
addition NN O
to IN O
being VBG O
a DT O
therapeutic JJ O
target NN O
, , O
ER NNP O
alpha NN O
was VBD O
also RB O
shown VBN O
to TO O
be VB O
the DT O
most RBS O
important JJ O
factor NN O
to TO O
predict VB O
breast NN O
cancer NN O
prognosis NN O
. . O

The DT O
patients NNS B-Species
who WP O
express VBP O
ER NNP O
alpha NN O
in IN O
their PRP$ O
tumors NNS O
have VBP O
an DT O
overall JJ O
longer JJR O
cancer NN O
- HYPH O
free JJ O
survival NN O
and CC O
lower JJR O
recurrence NN O
rates NNS O
than IN O
patients NNS B-Species
who WP O
do VBP O
not RB O
express VB O
this DT O
receptor NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

To TO O
predict VB O
prognosis NN O
and CC O
identify VB O
patients NNS B-Species
for IN O
the DT O
above JJ O
two CD O
anti AFX O
- HYPH O
estrogen NN O
therapies NNS O
, , O
every DT O
breast NN O
cancer NN O
tissue NN O
is VBZ O
currently RB O
screened VBN O
for IN O
the DT O
presence NN O
of IN O
ER NNP O
alpha NN O
before IN O
a DT O
treatment NN O
regimen NN O
is VBZ O
selected VBN O
for IN O
any DT O
breast NN O
cancer NN O
patient NN B-Species
. . O

The DT O
presence NN O
of IN O
ER NN O
alpha NN O
in IN O
breast NN O
tumors NNS O
was VBD O
originally RB O
determined VBN O
in IN O
clinical JJ O
labs NNS O
by IN O
estrogen NN O
binding VBG O
assay NN O
for IN O
about RB O
20 CD O
years NNS O
. . O

However RB O
, , O
when WRB O
the DT O
tumors NNS O
were VBD O
detected VBN O
at IN O
comparatively RB O
smaller JJR O
sizes NNS O
and CC O
highly RB O
specific JJ O
monoclonal JJ O
antibodies NNS O
were VBD O
developed VBN O
that WDT O
could MD O
detect VB O
ER NN O
alpha NN O
both DT O
in IN O
the DT O
fresh JJ O
frozen VBN O
as RB O
well RB O
as IN O
formalin NN O
fixed VBN O
paraffin NN O
- HYPH O
embedded VBN O
tissues NNS O
, , O
the DT O
clinical JJ O
labs NNS O
switched VBD O
to IN O
immunohistochemistry NN O
( , O
IHC NNP O
) -RRB- O
from IN O
estrogen NN O
binding NN O
assay NN O
for IN O
determining VBG O
the DT O
presence NN O
of IN O
ER NNP O
alpha NN O
. . O

Currently RB O
ER NNP O
alpha NN O
is VBZ O
determined VBN O
in IN O
the DT O
clinical JJ O
laboratories NNS O
from IN O
rough JJ O
estimates NNS O
yielded VBN O
by IN O
microscopically RB O
scoring VBG O
the DT O
slides NNS O
subjected VBN O
to IN O
IHC NNP O
technique NN O
using VBG O
antibodies NNS O
against IN O
the DT O
N NNP O
- HYPH O
terminal JJ O
A NN O
/ SYM O
B NN O
region NN O
of IN O
ER NNP O
alpha NN O
. . O

Although IN O
this DT O
procedure NN O
is VBZ O
used VBN O
for IN O
over IN O
ten CD O
years NNS O
, , O
it PRP O
has VBZ O
several JJ O
limitations NNS O
including VBG O
not RB O
quantitative JJ O
, , O
highly RB O
subjective JJ O
, , O
variations NNS O
due IN O
to IN O
antibody NN O
preparations NNS O
, , O
variations NNS O
from IN O
one CD O
clinical JJ O
lab NN O
to IN O
other JJ O
and CC O
comparatively RB O
large JJ O
sample NN O
size NN O
requirement NN O
. . O

In IN O
recent JJ O
times NNS O
, , O
due IN O
to IN O
increased JJ O
awareness NN O
and CC O
substantially RB O
improved VBN O
screening NN O
methods NNS O
, , O
breast NN O
cancers NNS O
are VBP O
detected VBN O
at IN O
very RB O
early JJ O
stages NNS O
and CC O
excised VBN O
, , O
in IN O
a DT O
large JJ O
majority NN O
of IN O
cases NNS O
, , O
by IN O
stereotactic JJ O
and CC O
ultrasound NN O
guided VBN O
techniques NNS O
. . O

In IN O
these DT O
cases NNS O
the DT O
limited JJ O
amount NN O
of IN O
tumor NN O
tissue NN O
that WDT O
remains VBZ O
after IN O
histological JJ O
testing NN O
restricts VBZ O
determining VBG O
ER NNP O
alpha NN O
status NN O
for IN O
prognostic JJ O
and CC O
therapeutic JJ O
purposes NNS O
by IN O
IHC NNP O
. . O

In IN O
many JJ O
cases NNS O
, , O
ER NNP O
alpha NN O
status NN O
is VBZ O
not RB O
determined VBN O
due IN O
to IN O
insufficient JJ O
amount NN O
of IN O
tumor NN O
tissue NN O
. . O

For IN O
these DT O
reasons NNS O
there EX O
is VBZ O
an DT O
urgent JJ O
need NN O
to TO O
switch VB O
to IN O
a DT O
procedure NN O
that WDT O
can MD O
detect VB O
ER NN O
alpha NN O
in IN O
a DT O
very RB O
small JJ O
amount NN O
of IN O
tumor NN O
tissue NN O
obtained VBN O
by IN O
the DT O
above JJ O
methods NNS O
. . O

There EX O
is VBZ O
a DT O
general JJ O
consensus NN O
that IN O
ER NNP O
alpha NN O
mRNA NN O
quantification NN O
is VBZ O
a DT O
more RBR O
suited JJ O
technique NN O
for IN O
detecting VBG O
its PRP$ O
presence NN O
in IN O
tumor NN O
tissues NNS O
. . O

Several JJ O
PCR NN O
based VBN O
approaches NNS O
have VBP O
been VBN O
described VBN O
for IN O
detecting VBG O
the DT O
presence NN O
of IN O
ER NN O
alpha NN O
in IN O
breast NN O
cancer NN O
tissues NNS O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
. . O

We PRP O
recently RB O
developed VBD O
a DT O
highly RB O
sensitive JJ O
real JJ O
- HYPH O
time NN O
PCR NN O
based VBN O
quantitative JJ O
molecular JJ O
assay NN O
that WDT O
can MD O
detect VB O
and CC O
quantify VB O
as RB O
low JJ O
as IN O
50 CD O
- SYM O
100 CD O
copies NNS O
of IN O
ER NNP O
alpha NN O
mRNA NN O
from IN O
as RB O
small JJ O
as IN O
40 CD O
picograms NNS O
of IN O
total JJ O
RNA NN O
from IN O
breast NN O
cancer NN O
tissues NNS O
. . O

Because IN O
quantitative JJ O
real JJ O
- HYPH O
time NN O
PCR NN O
is VBZ O
a DT O
high RB O
through RB O
- HYPH O
put NN O
method NN O
, , O
it PRP O
could MD O
be VB O
automated VBN O
to TO O
apply VB O
in IN O
clinical JJ O
laboratories NNS O
. . O

However RB O
, , O
it PRP O
is VBZ O
not RB O
known VBN O
how WRB O
the DT O
ER NNP O
alpha NN O
mRNA NNP O
copy NN O
numbers NNS O
correlate VBP O
to IN O
ER NNP O
alpha NN O
positivity NN O
and CC O
negativity NN O
by IN O
IHC NNP O
assay NN O
. . O

Establishing VBG O
a DT O
cut NN O
off RP O
value NN O
in IN O
IHC NNP O
negative JJ O
tissues NNS O
is VBZ O
required VBN O
for IN O
the DT O
application NN O
of IN O
molecular JJ O
assay NN O
in IN O
the DT O
place NN O
of IN O
IHC NNP O
assay NN O
. . O

To TO O
determine VB O
the DT O
cut NN O
off RP O
value NN O
, , O
we PRP O
have VBP O
profiled VBN O
ER NNP O
alpha NN O
mRNA NN O
copy NN O
numbers NNS O
in IN O
breast NN O
cancer NN O
tissues NNS O
which WDT O
have VBP O
been VBN O
graded VBN O
as IN O
ER NNP O
alpha NN O
positive JJ O
and CC O
negative JJ O
by IN O
IHC NNP O
and CC O
estrogen NN O
binding NN O
assays NNS O
. . O

We PRP O
demonstrate VBP O
here RB O
that IN O
ER NNP O
alpha NN O
mRNA NN O
copy NN O
numbers NNS O
are VBP O
not RB O
significantly RB O
different JJ O
in IN O
tissues NNS O
that WDT O
were VBD O
graded VBN O
as IN O
positive JJ O
by IN O
IHC NNP O
and CC O
ligand JJ O
binding NN O
assays NNS O
. . O

However RB O
, , O
ER NNP O
alpha NN O
positive JJ O
tissues NNS O
, , O
either CC O
by IN O
IHC NNP O
or CC O
estrogen NN O
binding NN O
assays NNS O
, , O
express VBP O
significantly RB O
higher JJR O
mRNA NN O
copy NN O
numbers NNS O
than IN O
the DT O
negative JJ O
tissues NNS O
. . O

We PRP O
have VBP O
determined VBN O
the DT O
cut NN O
off RP O
values NNS O
of IN O
ER NNP O
alpha NNP O
mRNA NNP O
copy NN O
numbers NNS O
by IN O
molecular JJ O
assay NN O
that WDT O
correlate VBP O
to IN O
ER NNP O
alpha NN O
negativity NN O
by IN O
both CC O
IHC NNP O
and CC O
ligand JJ O
binding NN O
assays NNS O
using VBG O
CART NNP O
program NN O
( -LRB- O
Classification NNP O
And CC O
Regression NNP O
Tree NNP O
) -RRB- O
. . O

We PRP O
expect VBP O
that IN O
the DT O
cut NN O
off RP O
values NNS O
determined VBN O
here RB O
will MD O
be VB O
highly RB O
significant JJ O
for IN O
applying VBG O
molecular JJ O
assay NN O
in IN O
the DT O
place NN O
of IN O
IHC NNP O
in IN O
clinical JJ O
laboratories NNS O
for IN O
determining VBG O
the DT O
ER NNP O
alpha NN O
status NN O
for IN O
prognostic JJ O
and CC O
therapeutic JJ O
purposes NNS O
. . O

Methods NNS O

All PDT O
the DT O
primers NNS O
used VBN O
in IN O
the DT O
current JJ O
study NN O
were VBD O
synthesized VBN O
by IN O
Gibco NNP O
- HYPH O
BRL NNP O
Life NNP O
Technologies NNPS O
. . O

TaqMan NNP O
Universal NNP O
PCR NNP O
Master NNP O
Mix NNP O
( , O
Cat NNP O
# NN O
4304437 CD O
) -RRB- O
was VBD O
from IN O
Applied NNP O
Biosystems NNPS O
. . O

5 CD O
' '' O
FAM NNP O
and CC O
3 CD O
' '' O
TAMARA NNP O
labeled VBD O
oligonucleotide NN O
probes NNS O
were VBD O
synthesized VBN O
by IN O
Applied NNP O
Biosystems NNP O
and CC O
available JJ O
from IN O
previous JJ O
studies NNS O
. . O

PCR NN O
quality NN O
water NN O
and CC O
Tris NNP O
- HYPH O
EDTA NNP O
buffer NN O
were VBD O
from IN O
BioWhittaker NNP O
. . O

Breast NN O
tumor NN O
samples NNS O

Breast NN O
cancer NN O
tissues NNS O
with IN O
known VBN O
ER NN O
alpha NN O
status NN O
by IN O
IHC NNP O
and CC O
ligand NN O
binding NN O
assay NN O
were VBD O
available JJ O
from IN O
previous JJ O
studies NNS O
[ -LRB- O
6 CD O
- SYM O
9 CD O
] -RRB- O
. . O

Briefly RB O
, , O
the DT O
tumor NN O
samples NNS O
were VBD O
collected VBN O
from IN O
either CC O
biopsy NN O
or CC O
mastectomies NNS O
immediately RB O
after IN O
surgery NN O
and CC O
stored VBN O
at IN O
- HYPH O
80 CD O
degrees NNS O
C NN O
until IN O
use NN O
. . O

Fresh JJ O
tumor NN O
tissue NN O
samples NNS O
for IN O
ER NNP O
alpha NN O
quantification NN O
were VBD O
routinely RB O
harvested VBN O
immediately RB O
adjacent JJ O
to IN O
the DT O
histologic JJ O
/ SYM O
diagnostic JJ O
sections NNS O
and CC O
considered VBN O
to TO O
be VB O
representative JJ O
of IN O
the DT O
tissue NN O
used VBN O
for IN O
diagnosis NN O
. . O

All PDT O
the DT O
samples NNS O
were VBD O
examined VBN O
by IN O
a DT O
pathologist NN O
and CC O
tissues NNS O
containing VBG O
> SYM O
80 CD O
% NN O
cancer NN O
cells NNS O
were VBD O
excised VBN O
and CC O
used VBN O
for IN O
ER NNP O
alpha NN O
mRNA NN O
quantification NN O
. . O

The DT O
ER NNP O
alpha NN O
- HYPH O
status NN O
for IN O
the DT O
samples NNS O
used VBN O
in IN O
this DT O
study NN O
was VBD O
determined VBN O
either CC O
by IN O
IHC NNP O
using VBG O
monoclonal JJ O
antibodies NNS O
against IN O
NH2 NNP O
- HYPH O
terminal JJ O
portion NN O
of IN O
the DT O
molecule NN O
at IN O
Oncotech NNP O
Laboratories NNP O
, , O
Irwine NNP O
, , O
CA NNP O
, , O
or CC O
by IN O
ligand JJ O
binding NN O
assay NN O
as IN O
described VBN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

The DT O
tumor NN O
tissues NNS O
were VBD O
considered VBN O
positive JJ O
for IN O
ER NNP O
alpha NN O
by IN O
IHC NNP O
if IN O
> SYM O
5 CD O
% NN O
of IN O
cancer NN O
cells NNS O
showed VBD O
positive JJ O
nuclear JJ O
staining NN O
. . O

The DT O
tumor NN O
tissues NNS O
that WDT O
were VBD O
diagnosed VBN O
as IN O
ER NNP O
alpha NN O
positive JJ O
by IN O
estrogen NN O
binding NN O
assay NN O
had VBD O
> SYM O
3 CD O
fmol NN O
of IN O
ER NN O
/ SYM O
mg NN O
of IN O
total JJ O
tissue NN O
extract NN O
. . O

A DT O
total NN O
of IN O
70 CD O
samples NNS O
positive JJ O
by IN O
IHC NNP O
, , O
33 CD O
positive JJ O
by IN O
estrogen NN O
binding NN O
assay NN O
, , O
43 CD O
negative JJ O
by IN O
IHC NNP O
and CC O
20 CD O
negative JJ O
by IN O
estrogen NN O
binding NN O
assay NN O
were VBD O
included VBN O
in IN O
the DT O
current JJ O
study NN O
( , O
Tables NNP O
1 CD O
, , O
2 CD O
, , O
3 CD O
and CC O
4 CD O
respectively RB O
) -RRB- O
. . O

The DT O
tumor NN O
tissues NNS O
were VBD O
processed VBN O
to TO O
isolate VB O
total JJ O
RNA NN O
and CC O
cDNAs NNS O
prepared VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
6 CD O
- SYM O
9 CD O
] -RRB- O
. . O

Howard NNP O
University NNP O
Institutional NNP O
Review NNP O
Board NNP O
granted VBD O
the DT O
ethical JJ O
approval NN O
of IN O
Tumor NNP O
collection NN O
procedures NNS O
for IN O
the DT O
study NN O
. . O

Absolute JJ O
quantification NN O
of IN O
ER NNP O
alpha NN O
mRNA NN O
copy NN O
numbers NNS O
by IN O
quantitative JJ O
real JJ O
- HYPH O
time NN O
PCR NN O

Absolute JJ O
quantification NN O
of IN O
ER NNP O
alpha NN O
transcript NN O
copy NN O
numbers NNS O
was VBD O
achieved VBN O
by IN O
quantitative JJ O
real JJ O
- HYPH O
time NN O
PCR NN O
in IN O
ABI NNP O
Prism NNP O
GeneAmp NNP O
7900 CD O
HT NNP O
Sequence NNP O
Detection NNP O
System NNP O
as IN O
described VBN O
previously RB O
( : O
9 CD O
) -RRB- O
. . O

Briefly RB O
, , O
a DT O
typical JJ O
real JJ O
- HYPH O
time NN O
PCR NN O
reaction NN O
mixture NN O
contained VBD O
cDNA NNP O
prepared VBN O
from IN O
reverse JJ O
transcription NN O
of IN O
0 CD O
. . O
5 CD O
- SYM O
5 CD O
nanograms NNS O
of IN O
tumor NN O
tissue NN O
total JJ O
RNA NN O
, , O
0 CD O
. . O
4 CD O
micromolar NN O
each DT O
of IN O
sense NN O
and CC O
anti JJ O
- HYPH O
sense NN O
primers NNS O
, , O
0 CD O
. . O
5 CD O
micromolar NN O
5 CD O
' '' O
FAM NN O
and CC O
3 CD O
' '' O
TAMARA NN O
labeled VBN O
oligonucleotide NN O
probe NN O
and CC O
1 CD O
x SYM O
Taqman NNP O
Universal NNP O
PCR NNP O
Mix NNP O
in IN O
a DT O
total JJ O
volume NN O
of IN O
25 CD O
mu NNS O
l -RRB- O
. . O

PCR NN O
conditions NNS O
were VBD O
initial JJ O
hold NN O
at IN O
50 CD O
degrees NNS O
C NN O
for IN O
two CD O
minutes NNS O
, , O
followed VBN O
by IN O
denaturation NN O
for IN O
ten CD O
minutes NNS O
at IN O
95 CD O
degrees NNS O
C NN O
, , O
and CC O
denaturation NN O
for IN O
15 CD O
seconds NNS O
at IN O
95 CD O
degrees NNS O
C NN O
in IN O
the DT O
subsequent JJ O
cycles NNS O
and CC O
annealing NN O
and CC O
extension NN O
for IN O
1 CD O
min NN O
at IN O
60 CD O
degrees NNS O
C NN O
for IN O
40 CD O
cycles NNS O
. . O

The DT O
ER NNP O
alpha NN O
mRNA NN O
copy NN O
numbers NNS O
in IN O
tumor NN O
tissues NNS O
were VBD O
determined VBN O
in IN O
comparison NN O
with IN O
a DT O
standard JJ O
graph NN O
constructed VBN O
simultaneously RB O
using VBG O
102 CD O
, , O
103 CD O
, , O
104 CD O
, , O
105 CD O
, , O
106 CD O
, , O
107 CD O
, , O
108 CD O
, , O
and CC O
109 CD O
copies NNS O
of IN O
reverse RB O
transcribed VBN O
cRNA NN O
of IN O
ER NNP O
alpha NN O
. . O

All PDT O
the DT O
samples NNS O
were VBD O
amplified VBN O
in IN O
triplicate JJ O
and CC O
real JJ O
- HYPH O
time NN O
PCRs NNS O
were VBD O
repeated VBN O
four CD O
times NNS O
. . O

The DT O
ER NNP O
alpha NN O
mRNA NN O
copy NN O
numbers NNS O
in IN O
tumor NN O
tissues NNS O
were VBD O
normalized VBN O
to IN O
mRNA NNP O
copy NN O
numbers NNS O
of IN O
the DT O
house NN O
keeping NN O
gene NN O
, , O
glyceraldehyde NN O
3 CD O
- HYPH O
phosphate NN O
dehydrogenase NN O
( -LRB- O
GAPDH NNP O
) -RRB- O
. . O

GAPDH NNP O
copy NN O
numbers NNS O
were VBD O
determined VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
11 CD O
, , O
12 CD O
] -RRB- O
. . O

The DT O
sense NN O
, , O
and CC O
anti JJ O
- HYPH O
sense NN O
primers NNS O
and CC O
probe NN O
for IN O
quantifying VBG O
the DT O
mRNA NNP O
copy NN O
numbers NNS O
of IN O
ER NNP O
alpha NN O
were VBD O
5 CD O
' `` O
caagcccgctcatgatcaa NN O
3 CD O
' '' O
( , O
position NN O
, , O
exon FW O
4 CD O
, , O
bp NN O
1110 CD O
- HYPH O
1128 CD O
) -RRB- O
, , O
5 CD O
' '' O
ctgatcatggagggtcaaat NN O
' '' O
( , O
position NN O
, , O
exon NN O
5 CD O
, , O
bp NN O
1358 CD O
- HYPH O
1338 CD O
) -RRB- O
and CC O
FAM NNP O
5 CD O
' '' O
agaacagcctggccttgtcc NNP O
' POS O
TAMARA NNP O
( -LRB- O
position NN O
, , O
exon NN O
4 CD O
, , O
bp NN O
1140 CD O
- SYM O
1162 CD O
) -RRB- O
respectively RB O
. . O

The DT O
sense NN O
and CC O
anti JJ O
- HYPH O
sense NN O
primers NNS O
and CC O
probe NN O
for IN O
quantifying VBG O
GAPDH NNP O
mRNA NNP O
copy NN O
numbers NNS O
were VBD O
5 CD O
' `` O
ttccagg FW O
agcgag FW O
atccct3 FW O
' '' O
( , O
position NN O
, , O
bp IN O
304 CD O
- HYPH O
322 CD O
) -RRB- O
, , O
5 CD O
' `` O
ggctgttgtcatacttctca NN O
' '' O
( , O
position NN O
, , O
bp IN O
483 CD O
- HYPH O
505 CD O
) -RRB- O
and CC O
FAM NNP O
5 CD O
' '' O
tgctggcgctgagtacgtcg NNP O
' '' O
TAMARA NNP O
( -LRB- O
position NN O
, , O
bp IN O
342 CD O
- HYPH O
363 CD O
) -RRB- O
respectively RB O
. . O

Primer NN O
positions NNS O
of IN O
ER NNP O
alpha NN O
and CC O
GAPDH NNP O
nucleotide NN O
sequences NNS O
were VBD O
as IN O
described VBN O
[ -LRB- O
13 CD O
, , O
14 CD O
] -RRB- O
. . O

Statistical JJ O
analysis NN O

Wilcoxon NNP O
- HYPH O
rank NN O
- HYPH O
sum NN O
test NN O
and CC O
standard JJ O
two CD O
- HYPH O
sample NN O
t NN O
- HYPH O
test NN O
were VBD O
used VBN O
to TO O
determine VB O
whether IN O
the DT O
mRNA NNP O
copy NN O
numbers NNS O
were VBD O
significantly RB O
different JJ O
in IN O
breast NN O
cancer NN O
tissues NNS O
that WDT O
were VBD O
1 CD O
) SYM O
ER JJ O
alpha NN O
- HYPH O
positive JJ O
and CC O
ER NN O
alpha NN O
- HYPH O
negative JJ O
by IN O
IHC NNP O
, , O
2 CD O
) SYM O
ER NN O
alpha NN O
- HYPH O
positive JJ O
and CC O
ER NN O
alpha NN O
- HYPH O
negative JJ O
by IN O
estrogen NN O
binding NN O
assays NNS O
, , O
3 CD O
) SYM O
ER NN O
alpha NN O
positive JJ O
by IN O
IHC NNP O
and CC O
estrogen NN O
binding NN O
assays NNS O
, , O
and CC O
4 CD O
) SYM O
ER NN O
alpha NN O
- HYPH O
negative JJ O
by IN O
IHC NNP O
and CC O
estrogen NN O
binding NN O
assays NNS O
. . O

Test NN O
results NNS O
were VBD O
considered VBN O
significant JJ O
if IN O
P NN O
< SYM O
= SYM O
0 CD O
. . O

5 NFP O
. . O

To TO O
determine VB O
the DT O
cut VBN O
- HYPH O
off RP O
value NN O
/ SYM O
maximum JJ O
level NN O
of IN O
mRNA NNP O
copy NN O
numbers NNS O
in IN O
the DT O
samples NNS O
which WDT O
were VBD O
negative JJ O
by IN O
IHC NNP O
and CC O
estrogen NN O
binding NN O
assays NNS O
, , O
we PRP O
used VBD O
CART NNP O
( -LRB- O
Classification NNP O
Regression NNP O
Tree NNP O
) -RRB- O
[ -LRB- O
15 CD O
, , O
16 CD O
] -RRB- O
program NN O
. . O

The DT O
data NNS O
consisting VBG O
of IN O
103 CD O
ER NN O
alpha NN O
positive JJ O
and CC O
63 CD O
ER NN O
alpha NN O
negative JJ O
samples NNS O
which WDT O
had VBD O
a DT O
predictive JJ O
variable JJ O
, , O
mRNA NNP O
copy NN O
numbers NNS O
, , O
were VBD O
partitioned VBN O
into IN O
two CD O
groups NNS O
using VBG O
CART NNP O
program NN O
. . O

This DT O
program NN O
determines VBZ O
the DT O
best JJS O
cut VBN O
- HYPH O
off RP O
value NN O
copy NN O
numbers NNS O
in IN O
the DT O
sense NN O
that IN O
the DT O
OR NNP O
( HYPH O
Odds NNS O
Ratio NN O
, , O
ER NN O
alpha NN O
positive JJ O
to IN O
ER NNP O
alpha NN O
negative JJ O
in IN O
our PRP$ O
case NN O
) -RRB- O
of IN O
the DT O
two CD O
groups NNS O
( , O
with IN O
copy NN O
number NN O
greater JJR O
than IN O
the DT O
cut VBN O
- HYPH O
off RP O
value NN O
in IN O
one CD O
group NN O
and CC O
less JJR O
or CC O
equal JJ O
to IN O
the DT O
cut VBN O
- HYPH O
off NN O
value NN O
in IN O
the DT O
other JJ O
) -RRB- O
is VBZ O
maximized VBN O
. . O

Receiver NNP O
Operating NNP O
Characteristic NNP O
( -LRB- O
ROC NNP O
) -RRB- O
analysis NN O
was VBD O
performed VBN O
to TO O
determine VB O
the DT O
sensitivity NN O
and CC O
specificity NN O
of IN O
the DT O
RNA NNP O
based VBN O
molecular JJ O
assay NN O
. . O

The DT O
ROC NNP O
curves NNS O
were VBD O
generated VBN O
by IN O
connecting VBG O
all PDT O
the DT O
points NNS O
determined VBN O
by IN O
the DT O
copy NN O
numbers NNS O
in IN O
all PDT O
the DT O
samples NNS O
in IN O
an DT O
increasing VBG O
order NN O
. . O

Since IN O
data NNS O
on IN O
IHC NNP O
grading NN O
as IN O
percent NN O
positive JJ O
cells NNS O
were VBD O
available JJ O
on IN O
some DT O
of IN O
the DT O
samples NNS O
, , O
the DT O
correlation NN O
between IN O
the DT O
IHC NNP O
grading NN O
and CC O
the DT O
mRNA NNP O
copy NN O
number NN O
was VBD O
determined VBN O
both CC O
in IN O
the DT O
original JJ O
scale NN O
and CC O
in IN O
logarithmic JJ O
transformations NNS O
scale NN O
using VBG O
S NNP O
- HYPH O
PLUS NNP O
software NN O
. . O

Results NNS O

We PRP O
have VBP O
undertaken VBN O
the DT O
current JJ O
study NN O
to TO O
determine VB O
ER NN O
alpha NN O
mRNA NN O
copy NN O
numbers NNS O
in IN O
breast NN O
cancer NN O
tissues NNS O
that WDT O
were VBD O
positive JJ O
and CC O
negative JJ O
by IN O
two CD O
conventional JJ O
methods NNS O
of IN O
assaying VBG O
ER NN O
alpha NN O
protein NN O
, , O
IHC NNP O
and CC O
estrogen NN O
binding NN O
. . O

The DT O
rational JJ O
for IN O
undertaking VBG O
this DT O
study NN O
is VBZ O
that IN O
once IN O
we PRP O
establish VBP O
a DT O
threshold NN O
value NN O
in IN O
IHC NNP O
negative JJ O
tissues NNS O
, , O
then RB O
the DT O
molecular JJ O
assay NN O
could MD O
be VB O
applied VBN O
in IN O
clinical JJ O
laboratories NNS O
in IN O
the DT O
place NN O
of IN O
currently RB O
used VBN O
IHC NNP O
assay NN O
for IN O
determining VBG O
the DT O
status NN O
of IN O
ER NNP O
alpha NN O
for IN O
prognostic JJ O
and CC O
therapeutic JJ O
purposes NNS O
. . O

Our PRP$ O
rational JJ O
for IN O
establishing VBG O
a DT O
cut NN O
off RP O
value NN O
is VBZ O
that IN O
any DT O
patient NN B-Species
who WP O
expresses VBZ O
above IN O
the DT O
cut NN O
off IN O
level NN O
could MD O
be VB O
selected VBN O
as IN O
a DT O
candidate NN O
for IN O
anti JJ O
- HYPH O
estrogen NN O
therapies NNS O
and CC O
could MD O
be VB O
considered VBN O
to TO O
have VB O
good JJ O
prognosis NN O
. . O

We PRP O
first RB O
profiled VBD O
ER NNP O
alpha NNP O
mRNA NNP O
copy NN O
numbers NNS O
in IN O
70 CD O
samples NNS O
positive JJ O
by IN O
IHC NNP O
, , O
43 CD O
negative JJ O
by IN O
IHC NNP O
, , O
33 CD O
positive JJ O
by IN O
estrogen NN O
binding NN O
assay NN O
and CC O
20 CD O
negative JJ O
by IN O
estrogen NN O
binding NN O
assay NN O
. . O

The DT O
data NNS O
are VBP O
presented VBN O
in IN O
Tables NNP O
1 CD O
, , O
3 CD O
, , O
2 CD O
and CC O
4 CD O
respectively RB O
. . O

A DT O
box NN O
plot NN O
drawn VBN O
for IN O
the DT O
copy NN O
numbers NNS O
( -LRB- O
logarithm NN O
base NN O
2 CD O
scale NN O
) -RRB- O
in IN O
the DT O
four CD O
groups NNS O
( , O
positive JJ O
and CC O
negative JJ O
by IN O
IHC NNP O
and CC O
by IN O
estrogen NN O
binding NN O
assay NN O
) -RRB- O
using VBG O
S NN O
- HYPH O
PLUS NNP O
software NN O
is VBZ O
shown VBN O
in IN O
Figure NNP O
1 CD O
. . O

We PRP O
next RB O
compared VBD O
the DT O
quantitative JJ O
data NNS O
on IN O
mRNA NNP O
copy NN O
numbers NNS O
among IN O
samples NNS O
as IN O
described VBN O
below RB O
. . O

1 LS O
) -RRB- O
We PRP O
tested VBD O
whether IN O
the DT O
two CD O
conventional JJ O
assays NNS O
, , O
the DT O
IHC NNP O
and CC O
estrogen NN O
binding NN O
assays NNS O
, , O
correlate VBP O
in IN O
terms NNS O
of IN O
mRNA NNP O
copy NN O
numbers NNS O
in IN O
70 CD O
and CC O
33 CD O
positive JJ O
tissues NNS O
( -LRB- O
Tables NNS O
1 CD O
and CC O
2 CD O
respectively RB O
) -RRB- O
using VBG O
Wilcoxon NNP O
- HYPH O
rank NN O
- HYPH O
sum NN O
test NN O
and CC O
standard JJ O
two CD O
- HYPH O
sample NN O
t NN O
- HYPH O
tests NNS O
. . O

By IN O
these DT O
two CD O
tests NNS O
, , O
we PRP O
did VBD O
not RB O
find VB O
significant JJ O
differences NNS O
in IN O
the DT O
ER NNP O
alpha NNP O
mRNA NNP O
copy NN O
numbers NNS O
in IN O
samples NNS O
that WDT O
were VBD O
ER NNP O
alpha NN O
positive JJ O
by IN O
IHC NNP O
and CC O
estrogen NN O
binding NN O
assays NNS O
( : O
p NN O
> SYM O
0 CD O
. . O
28 CD O
by IN O
both DT O
tests NNS O
) -RRB- O
. . O

2 LS O
) -RRB- O
We PRP O
also RB O
compared VBD O
the DT O
mRNA NNP O
copy NN O
numbers NNS O
in IN O
43 CD O
samples NNS O
negative JJ O
by IN O
IHC NNP O
with IN O
20 CD O
samples NNS O
negative JJ O
by IN O
estrogen NN O
binding VBG O
assay NN O
and CC O
did VBD O
not RB O
find VB O
significant JJ O
differences NNS O
( -LRB- O
Tables NNS O
3 CD O
and CC O
4 CD O
respectively RB O
) -RRB- O
( : O
p NN O
> SYM O
0 CD O
. . O
25 CD O
by IN O
the DT O
above JJ O
two CD O
tests NNS O
) -RRB- O
. . O

However RB O
, , O
3 CD O
) , O
we PRP O
found VBD O
significant JJ O
differences NNS O
in IN O
mRNA NNP O
copy NN O
numbers NNS O
in IN O
the DT O
breast NN O
tumors NNS O
that WDT O
were VBD O
IHC NNP O
positive JJ O
from IN O
those DT O
which WDT O
were VBD O
IHC NNP O
negative JJ O
( : O
Tables NNS O
1 CD O
and CC O
3 CD O
respectively RB O
) -RRB- O
( : O
p NN O
= SYM O
1 CD O
. . O
3e CD O
- HYPH O
6 CD O
by IN O
standard JJ O
two CD O
- HYPH O
sample NN O
t NN O
- HYPH O
test NN O
and CC O
p NN O
= SYM O
2 CD O
. . O
7e CD O
- HYPH O
18 CD O
by IN O
Wilcoxon NNP O
- HYPH O
rank NN O
- HYPH O
sum NN O
test NN O
) -RRB- O
. . O

And CC O
4 CD O
) -RRB- O
we PRP O
also RB O
found VBD O
significant JJ O
differences NNS O
in IN O
the DT O
samples NNS O
that WDT O
were VBD O
positive JJ O
and CC O
negative JJ O
by IN O
estrogen NN O
binding NN O
assay NN O
( : O
Tables NNS O
2 CD O
and CC O
4 CD O
respectively RB O
) -RRB- O
( : O
p NN O
= SYM O
7 CD O
. . O
6e CD O
- HYPH O
3 CD O
by IN O
standard JJ O
two CD O
- HYPH O
sample NN O
t NN O
- HYPH O
test NN O
and CC O
p NN O
= SYM O
3 CD O
. . O
6e CD O
- HYPH O
7 CD O
by IN O
Wilcoxon NNP O
- HYPH O
rank NN O
- HYPH O
sum NN O
test NN O
) -RRB- O
. . O

After IN O
establishing VBG O
that IN O
ER NNP O
alpha NN O
- HYPH O
positive JJ O
tissues NNS O
express VBP O
significantly RB O
higher JJR O
levels NNS O
of IN O
mRNA NNP O
copy NN O
numbers NNS O
compared VBN O
to IN O
negative JJ O
tumor NN O
samples NNS O
, , O
we PRP O
next RB O
determined VBD O
the DT O
maximum JJ O
level NN O
of IN O
expression NN O
in IN O
ER NNP O
alpha NN O
- HYPH O
negative JJ O
samples NNS O
using VBG O
CART NNP O
program NN O
. . O

By IN O
using VBG O
this DT O
program NN O
, , O
we PRP O
found VBD O
the DT O
maximum JJ O
level NN O
of IN O
expression NN O
of IN O
mRNA NNP O
copy NN O
numbers NNS O
/ SYM O
cut VBN O
- HYPH O
off NN O
value NN O
to TO O
be VB O
5 CD O
x SYM O
106 CD O
per IN O
1010copies NNS O
of IN O
GAPDH NNP O
mRNA NNP O
. . O

Of IN O
the DT O
total JJ O
106 CD O
positive JJ O
( : O
70 CD O
by IN O
IHC NNP O
and CC O
33 CD O
by IN O
estrogen NN O
binding VBG O
assay NN O
) , O
samples NNS O
in IN O
our PRP$ O
study NN O
, , O
83 CD O
samples NNS O
showed VBD O
higher JJR O
level NN O
of IN O
expression NN O
than IN O
5 CD O
x SYM O
106 CD O
copies NNS O
per IN O
1010 CD O
copies NNS O
of IN O
GAPDH NNP O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
the DT O
samples NNS O
that WDT O
showed VBD O
less JJR O
than IN O
the DT O
above JJ O
cut VBN O
off RP O
value NN O
copy NN O
numbers NNS O
could MD O
be VB O
due IN O
to IN O
false JJ O
positivity NN O
by IN O
the DT O
above JJ O
methods NNS O
. . O

In IN O
a DT O
total NN O
of IN O
63 CD O
negative JJ O
samples NNS O
( : O
43 CD O
by IN O
IHC NNP O
and CC O
20 CD O
by IN O
estrogen NN O
binding NN O
assay NN O
) , O
only RB O
6 CD O
samples NNS O
showed VBD O
higher JJR O
expression NN O
than IN O
5 CD O
x SYM O
106 CD O
copies NNS O
per IN O
1010GAPDH CD O
copies NNS O
. . O

It PRP O
is VBZ O
also RB O
possible JJ O
that IN O
the DT O
samples NNS O
that WDT O
showed VBD O
higher JJR O
than IN O
the DT O
cut NN O
off RP O
copy NN O
numbers NNS O
could MD O
be VB O
false JJ O
negative JJ O
. . O

The DT O
OR NNP O
( HYPH O
Odds NNP O
Ratio NNP O
) -RRB- O
in IN O
the DT O
two CD O
groups NNS O
is VBZ O
about RB O
39 CD O
. . O
4 CD O
, , O
an DT O
extremely RB O
high JJ O
OR NN O
value NN O
. . O

The DT O
counts NNS O
of IN O
the DT O
ER NNP O
alpha NN O
- HYPH O
positive JJ O
( : O
80 CD O
, , O
23 CD O
) -RRB- O
and CC O
ER NN O
alpha NN O
- HYPH O
negative JJ O
( , O
6 CD O
, , O
66 CD O
) -RRB- O
in IN O
the DT O
two CD O
groups NNS O
produce VBP O
a DT O
chi JJ O
- HYPH O
square JJ O
value NN O
of IN O
88 CD O
. , O
2544 CD O
with IN O
1 CD O
degree NN O
of IN O
freedom NN O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
our PRP$ O
T NN O
- HYPH O
test NN O
and CC O
Wilcoxon NNP O
- HYPH O
rank NN O
- HYPH O
sum NN O
test NN O
results NNS O
. . O

We PRP O
applied VBD O
the DT O
above JJ O
cut NN O
off RP O
value NN O
and CC O
determined VBD O
the DT O
Sensitivity NNP O
( HYPH O
percentage NN O
of IN O
samples NNS O
that WDT O
showed VBD O
higher JJR O
copy NN O
numbers NNS O
than IN O
the DT O
cut NN O
off RP O
value NN O
of IN O
5 CD O
x SYM O
106 CD O
copies NNS O
per IN O
1010 CD O
GAPDH NNP O
copies NNS O
in IN O
IHC NNP O
positive JJ O
tissues NNS O
) -RRB- O
and CC O
Specificity NNP O
( , O
percentage NN O
of IN O
samples NNS O
that WDT O
showed VBD O
less JJR O
than IN O
5 CD O
x SYM O
106 CD O
copies NNS O
per IN O
1010 CD O
GAPDH NNP O
copies NNS O
in IN O
IHC NNP O
negative JJ O
tissues NNS O
) , O
and CC O
the DT O
values NNS O
obtained VBN O
were VBD O
0 CD O
. . O
81 CD O
and CC O
0 CD O
. . O
90 CD O
respectively RB O
. . O

We PRP O
also RB O
determined VBD O
Receiver NNP O
Operating NNP O
Characteristics NNP O
using VBG O
S NNP O
- HYPH O
PLUS NNP O
software NN O
and CC O
the DT O
ROC NNP O
curve NN O
generated VBN O
is VBZ O
shown VBN O
in IN O
Figure NNP O
2 CD O
. . O

The DT O
area NN O
under IN O
the DT O
ROC NNP O
curve NN O
, , O
0 CD O
. . O
89675 CD O
, , O
shows VBZ O
that IN O
the DT O
molecular JJ O
assay NN O
clearly RB O
distinguishes VBZ O
the DT O
positives NNS O
by IN O
IHC NNP O
or CC O
estrogen NN O
binding NN O
from IN O
the DT O
negative JJ O
tissues NNS O
. . O

Since IN O
we PRP O
have VBP O
the DT O
grading NN O
score NN O
as IN O
percent NN O
positive JJ O
cells NNS O
for IN O
about RB O
50 CD O
samples NNS O
( , O
Table NNP O
1 CD O
) -RRB- O
, , O
we PRP O
tested VBD O
if IN O
a DT O
correlation NN O
exits VBZ O
between IN O
the DT O
percent NN O
positive JJ O
cells NNS O
by IN O
IHC NNP O
and CC O
the DT O
mRNA NNP O
copy NN O
numbers NNS O
using VBG O
S NN O
- HYPH O
PLUS NNP O
software NN O
. . O

We PRP O
obtained VBD O
a DT O
correlation NN O
coefficient NN O
of IN O
0 CD O
. . O
2 CD O
. . O

When WRB O
we PRP O
used VBD O
the DT O
logarithmic JJ O
transformations NNS O
scale NN O
, , O
we PRP O
obtained VBD O
a DT O
correlation NN O
coefficient NN O
of IN O
0 CD O
. . O
37 CD O
. . O

These DT O
results NNS O
indicated VBD O
that IN O
there EX O
is VBZ O
no DT O
correlation NN O
between IN O
the DT O
percent NN O
positive JJ O
cells NNS O
and CC O
the DT O
level NN O
of IN O
ER NNP O
alpha NN O
mRNA NN O
copy NN O
numbers NNS O
. . O

These DT O
observations NNS O
could MD O
be VB O
due IN O
to IN O
qualitative JJ O
nature NN O
of IN O
IHC NNP O
assay NN O
. . O

The DT O
IHC NNP O
data NNS O
only RB O
show VBP O
the DT O
number NN O
of IN O
positive JJ O
cells NNS O
but CC O
not RB O
quantitative JJ O
to TO O
determine VB O
the DT O
level NN O
of IN O
ER NNP O
alpha NN O
expression NN O
. . O

The DT O
molecular JJ O
assay NN O
based VBN O
on IN O
RNA NNP O
is VBZ O
quantitative JJ O
to TO O
determine VB O
the DT O
level NN O
of IN O
ER NNP O
alpha NN O
expression NN O
. . O

Discussion NN O
and CC O
conclusion NN O

Previously RB O
ER NNP O
alpha NN O
mRNA NN O
levels NNS O
in IN O
immunohistochemicall JJ O
positive JJ O
and CC O
negative JJ O
tissues NNS O
were VBD O
evaluated VBN O
in IN O
breast NN O
cancer NN O
tissues NNS O
by IN O
several JJ O
groups NNS O
using VBG O
conventional JJ O
RT NNP O
PCR NNP O
. . O

Cullen NNP O
et FW O
al NNP O
[ -LRB- O
17 CD O
] -RRB- O
determined VBD O
mRNA NNP O
levels NNS O
by IN O
conventional JJ O
PCR NN O
in IN O
107 CD O
breast NN O
cancer NN O
tissues NNS O
. . O

They PRP O
reported VBD O
that IN O
ER NNP O
alpha NN O
mRNA NNP O
was VBD O
more RBR O
frequently RB O
detected VBN O
in IN O
ER NNP O
alpha NN O
protein NN O
positive JJ O
tissues NNS O
than IN O
ER NNP O
alpha NN O
protein NN O
negative JJ O
tissues NNS O
. . O

Jarzabek NNP O
et FW O
al NNP O
[ -LRB- O
18 CD O
] -RRB- O
studied VBD O
ER NNP O
alpha NN O
mRNA NN O
levels NNS O
and CC O
protein NN O
levels NNS O
in IN O
41 CD O
primary JJ O
breast NN O
cancer NN O
tissues NNS O
. . O

They PRP O
reported VBD O
the DT O
presence NN O
of IN O
ER NNP O
alpha NN O
mRNA NN O
in IN O
all PDT O
the DT O
tissues NNS O
, , O
where WRB O
as IN O
the DT O
protein NN O
was VBD O
present JJ O
only RB O
in IN O
70 CD O
% NN O
of IN O
tumor NN O
tissues NNS O
by IN O
Western JJ O
blotting NN O
and CC O
67 CD O
% NN O
showed VBD O
positive JJ O
by IN O
immunohistochemistry NN O
. . O

They PRP O
concluded VBD O
that IN O
lack NN O
of IN O
ER NNP O
alpha NN O
protein NN O
is VBZ O
not RB O
due JJ O
to IN O
lack NN O
of IN O
ER NNP O
alpha NN O
gene NN O
expression NN O
or CC O
methylation NN O
of IN O
its PRP$ O
promoter NN O
, , O
but CC O
may MD O
be VB O
due JJ O
to IN O
post NN O
- HYPH O
transcriptional JJ O
or CC O
post NN O
- HYPH O
translational JJ O
mechanisms NNS O
. . O

Alkarain NNP O
et FW O
al NNP O
[ -LRB- O
19 CD O
] -RRB- O
reported VBD O
the DT O
presence NN O
of IN O
ER NNP O
alpha NN O
mRNA NN O
in IN O
immunohistochemicall JJ O
ER NN O
alpha NN O
- HYPH O
negative JJ O
tissues NNS O
. . O

However RB O
, , O
none NN O
of IN O
the DT O
above JJ O
studies NNS O
has VBZ O
evaluated VBN O
the DT O
threshold NN O
levels NNS O
of IN O
ER NNP O
alpha NN O
mRNA NN O
levels NNS O
in IN O
immunohistochemicall JJ O
negative JJ O
tissues NNS O
or CC O
those DT O
negative JJ O
by IN O
ligand JJ O
binding NN O
assays NNS O
. . O

Our PRP$ O
quantitative JJ O
analysis NN O
of IN O
ER NNP O
alpha NN O
mRNA NN O
copy NN O
numbers NNS O
demonstrate VBP O
that IN O
breast NN O
cancer NN O
tissues NNS O
that WDT O
are VBP O
negative JJ O
by IN O
both CC O
IHC NNP O
and CC O
ligand NN O
binding NN O
express VBP O
significant JJ O
levels NNS O
of IN O
ER NNP O
alpha NN O
mRNA NN O
. . O

The DT O
reasons NNS O
why WRB O
the DT O
mRNA NNP O
is VBZ O
not RB O
translated VBN O
to IN O
detectable JJ O
protein NN O
are VBP O
not RB O
clear JJ O
. . O

Our PRP$ O
previous JJ O
studies NNS O
on IN O
ER NN O
beta JJ O
mRNA NN O
copy NN O
numbers NNS O
[ -LRB- O
9 CD O
] -RRB- O
in IN O
breast NN O
cancer NN O
tissues NNS O
have VBP O
shown VBN O
that IN O
at IN O
the DT O
5 CD O
x SYM O
106 CD O
copies NNS O
per IN O
1010 CD O
mRNA NNP O
copies NNS O
of IN O
GAPDH NNP O
levels NNS O
ER NN O
beta NN O
protein NN O
is VBZ O
translated VBN O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
either CC O
ER NNP O
alpha NN O
mRNA NN O
is VBZ O
not RB O
translated VBN O
or CC O
the DT O
translated VBN O
protein NN O
is VBZ O
degraded VBN O
to IN O
undetectable JJ O
levels NNS O
in IN O
these DT O
tissues NNS O
. . O

The DT O
results NNS O
and CC O
the DT O
analysis NN O
presented VBN O
above RB O
clearly RB O
demonstrate VBP O
that IN O
the DT O
ER NNP O
alpha NN O
positive JJ O
tissues NNS O
by IN O
IHC NNP O
or CC O
estrogen NN O
binding NN O
assay NN O
express VBP O
significantly RB O
higher JJR O
mRNA NNP O
copy NN O
numbers NNS O
than IN O
5 CD O
x SYM O
106 CD O
copies NNS O
per IN O
1010 CD O
GAPDH NNP O
copies NNS O
. . O

An DT O
extremely RB O
high JJ O
Odds NNPS O
Ratio NN O
, , O
high JJ O
sensitivity NN O
and CC O
specificity NN O
demonstrate VBP O
that IN O
the DT O
molecular JJ O
assay NN O
could MD O
be VB O
used VBN O
in IN O
the DT O
place NN O
of IN O
currently RB O
used VBN O
IHC NNP O
in IN O
the DT O
clinical JJ O
laboratories NNS O
. . O

Based VBN O
on IN O
our PRP$ O
data NNS O
above IN O
any DT O
patient NN B-Species
who WP O
has VBZ O
more JJR O
than IN O
5 CD O
x SYM O
106 CD O
copies NNS O
per IN O
1010 CD O
GAPDH NNP O
copies NNS O
in IN O
her PRP$ O
tumor NN O
tissue NN O
could MD O
be VB O
considered VBN O
positive JJ O
for IN O
ER NNP O
alpha NN O
, , O
could MD O
be VB O
selected VBN O
for IN O
anti JJ O
- HYPH O
estrogen NN O
therapies NNS O
and CC O
considered VBN O
to TO O
have VB O
good JJ O
prognosis NN O
. . O

However RB O
, , O
the DT O
above JJ O
described VBN O
approach NN O
has VBZ O
some DT O
limitations NNS O
in IN O
that IN O
it PRP O
needs VBZ O
to TO O
be VB O
verified VBN O
on IN O
a DT O
defined JJ O
set NN O
of IN O
biopsy NN O
samples NNS O
and CC O
with IN O
reference NN O
to IN O
another DT O
house NN O
keeping NN O
gene NN O
. . O

Therefore RB O
, , O
the DT O
results NNS O
should MD O
be VB O
interpreted VBN O
with IN O
caution NN O
and CC O
undoubtedly RB O
will MD O
require VB O
confirmation NN O
by IN O
a DT O
larger JJR O
prospective JJ O
multi NN O
- HYPH O
centered VBN O
clinical JJ O
study NN O
with IN O
a DT O
more RBR O
accurate JJ O
design NN O
to TO O
bring VB O
the DT O
technology NN O
to IN O
the DT O
clinic NN O
. . O

The DT O
current JJ O
study NN O
is VBZ O
a DT O
first JJ O
step NN O
in IN O
that DT O
direction NN O
. . O

We PRP O
expect VBP O
that IN O
the DT O
cost NN O
effective JJ O
, , O
extremely RB O
sensitive JJ O
, , O
high JJ O
though RB O
- HYPH O
put VBN O
molecular JJ O
assay NN O
which WDT O
requires VBZ O
only RB O
a DT O
few JJ O
cancer NN O
cells NNS O
could MD O
be VB O
an DT O
assay NN O
of IN O
choice NN O
to TO O
replace VB O
IHC NNP O
in IN O
clinical JJ O
labs NNS O
for IN O
determining VBG O
ER NNP O
alpha NN O
status NN O
in IN O
breast NN O
cancer NN O
tissues NNS O
once RB O
established VBN O
in IN O
a DT O
multi NN O
- HYPH O
centered VBN O
prospective JJ O
clinical JJ O
study NN O
. . O

Abbreviations NNS O

FAM NNP O
, , O
carboxy NN O
- HYPH O
fluorescein NN O
; : O
TAMARA NNP O
, , O
6 CD O
- HYPH O
carboxy NN O
tetraethyl NN O
- HYPH O
rhodamine NN O
; : O
GAPDH NNP O
, , O
Glyceraldehyde NN O
- HYPH O
3 CD O
phosphate NN O
dehydrogenase NN O
; , O
ER NN O
alpha NN O
, , O
estrogen NN O
receptor NN O
alpha NN O
; , O
IHC NNP O
, , O
Immunohistochemistry NNP O
; : O
CART NNP O
, , O
Classification NNP O
And CC O
Regression NNP O
Tree NNP O
; : O
and CC O
OR NNP O
, , O
Odds NNPS O
Ratio NNP O
and CC O
ROC NNP O
, , O
Receiver NNP O
Operating NNP O
Characteristics NNPS O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

I PRP O
. . O

P NN O
conceived VBD O
the DT O
study NN O
, , O
participated VBD O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
, , O
performed VBD O
the DT O
real JJ O
- HYPH O
time NN O
PCR NN O
quantifications NNS O
of IN O
ERalph NNP O
mRNA NNP O
copy NN O
numbers NNS O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

Q NNP O
. . O
Y PRP O
participated VBD O
in IN O
performing VBG O
the DT O
statistical JJ O
analysis NN O
of IN O
the DT O
data NNS O
. . O

Both DT O
authors NNS O
read VBD O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

Molecular JJ O
Basis NN O
for IN O
a DT O
Lack NN O
of IN O
Correlation NN O
between IN O
Viral JJ O
Fitness NN O
and CC O
Cell NN O
Killing NN O
Capacity NN O

Abstract JJ O

The DT O
relationship NN O
between IN O
parasite NN O
fitness NN O
and CC O
virulence NN O
has VBZ O
been VBN O
the DT O
object NN O
of IN O
experimental JJ O
and CC O
theoretical JJ O
studies NNS O
often RB O
with IN O
conflicting JJ O
conclusions NNS O
. . O

Here RB O
, , O
we PRP O
provide VBP O
direct JJ O
experimental JJ O
evidence NN O
that IN O
viral JJ O
fitness NN O
and CC O
virulence NN O
, , O
both DT O
measured VBN O
in IN O
the DT O
same JJ O
biological JJ O
environment NN O
provided VBN O
by IN O
host NN O
cells NNS O
in IN O
culture NN O
, , O
can MD O
be VB O
two CD O
unrelated JJ O
traits NNS O
. . O

A DT O
biological JJ O
clone NN O
of IN O
foot NN B-Species
- HYPH I-Species
and CC I-Species
- HYPH I-Species
mouth NN I-Species
disease NN I-Species
virus NN I-Species
acquired VBD O
high JJ O
fitness NN O
and CC O
virulence NN O
( , O
cell NN O
killing NN O
capacity NN O
) , O
upon IN O
large JJ O
population NN O
passages NNS O
in IN O
cell NN O
culture NN O
. . O

However RB O
, , O
subsequent JJ O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
resulted VBD O
in IN O
profound JJ O
fitness NN O
loss NN O
, , O
but CC O
only RB O
a DT O
minimal JJ O
decrease NN O
of IN O
virulence NN O
. . O

While IN O
fitness NN O
- HYPH O
decreasing VBG O
mutations NNS O
have VBP O
been VBN O
mapped VBN O
throughout IN O
the DT O
genome NN O
, , O
virulence NN O
determinants NNS O
- , O
- , O
studied VBN O
here RB O
with IN O
mutant JJ O
and CC O
chimeric JJ O
viruses NNS O
- , O
- , O
were VBD O
multigenic JJ O
, , O
but CC O
concentrated VBN O
on IN O
some DT O
genomic JJ O
regions NNS O
. . O

Therefore RB O
, , O
we PRP O
propose VBP O
a DT O
model NN O
in IN O
which WDT O
viral JJ O
virulence NN O
is VBZ O
more RBR O
robust JJ O
to IN O
mutation NN O
than IN O
viral JJ O
fitness NN O
. . O

As IN O
a DT O
consequence NN O
, , O
depending VBG O
on IN O
the DT O
passage NN O
regime NN O
, , O
viral JJ O
fitness NN O
and CC O
virulence NN O
can MD O
follow VB O
different JJ O
evolutionary JJ O
trajectories NNS O
. . O

This DT O
lack NN O
of IN O
correlation NN O
is VBZ O
relevant JJ O
to IN O
current JJ O
models NNS O
of IN O
attenuation NN O
and CC O
virulence NN O
in IN O
that DT O
virus NN O
de IN O
- HYPH O
adaptation NN O
need MD O
not RB O
entail VB O
a DT O
decrease NN O
of IN O
virulence NN O
. . O

Virulence NN O
expresses VBZ O
the DT O
harm NN O
that WDT O
parasites NNS O
inflict VBP O
upon IN O
their PRP$ O
hosts NNS O
. . O

Many JJ O
studies NNS O
have VBP O
addressed VBN O
the DT O
basis NN O
of IN O
virulence NN O
and CC O
its PRP$ O
effect NN O
on IN O
host NN O
and CC O
parasite NN O
survival NN O
. . O

It PRP O
has VBZ O
generally RB O
been VBN O
accepted VBN O
that IN O
one CD O
of IN O
the DT O
components NNS O
of IN O
parasite NN O
virulence NN O
is VBZ O
fitness NN O
, , O
or CC O
the DT O
capacity NN O
of IN O
the DT O
parasite NN O
to TO O
multiply VB O
in IN O
its PRP$ O
host NN O
. . O

Some DT O
models NNS O
have VBP O
equated VBN O
virulence NN O
with IN O
fitness NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
use VBP O
foot NN B-Species
- HYPH I-Species
and CC I-Species
- HYPH I-Species
mouth NN I-Species
disease NN I-Species
virus NN I-Species
( , O
FMDV NNP B-Species
) -RRB- O
to TO O
document VB O
that IN O
virulence NN O
and CC O
fitness NN O
- HYPH O
- , O
measured VBN O
in IN O
the DT O
same JJ O
biological JJ O
environment NN O
provided VBN O
by IN O
cells NNS O
in IN O
culture NN O
- , O
- : O
can MD O
be VB O
unrelated JJ O
traits NNS O
. . O

This DT O
has VBZ O
been VBN O
achieved VBN O
by IN O
multiplying VBG O
the DT O
virus NN O
in IN O
a DT O
manner NN O
that IN O
mutations NNS O
accumulated VBN O
in IN O
its PRP$ O
genome NN O
. . O

Mutations NNS O
decreased VBD O
fitness NN O
dramatically RB O
, , O
but CC O
not RB O
virulence NN O
. . O

Chimeric NNP O
and CC O
mutant JJ O
viruses NNS O
were VBD O
constructed VBN O
to TO O
show VB O
that IN O
virulence NN O
is VBZ O
influenced VBN O
by IN O
only RB O
some DT O
of IN O
the DT O
FMDV NNP B-Species
genes NNS O
, , O
while IN O
fitness NN O
is VBZ O
influenced VBN O
by IN O
the DT O
entire JJ O
genome NN O
. . O

For IN O
this DT O
reason NN O
, , O
virulence NN O
is VBZ O
more RBR O
robust JJ O
( , O
"""" `` O
resistant JJ O
"""" '' O
) -RRB- O
than IN O
fitness NN O
to IN O
the DT O
effects NNS O
of IN O
deleterious JJ O
mutations NNS O
. . O

The DT O
fact NN O
that IN O
virulence NN O
can MD O
be VB O
unrelated JJ O
to IN O
fitness NN O
has VBZ O
implications NNS O
for IN O
the DT O
design NN O
of IN O
anti JJ O
- HYPH O
viral JJ O
vaccines NNS O
because IN O
it PRP O
suggests VBZ O
that IN O
it PRP O
may MD O
be VB O
possible JJ O
to TO O
design VB O
high JJ O
fitness NN O
, , O
low JJ O
virulence NN O
strains NNS O
to TO O
stimulate VB O
the DT O
host NN O
immune JJ O
response NN O
. . O

Furthermore RB O
, , O
in IN O
modelling VBG O
studies NNS O
it PRP O
cannot MD O
be VB O
assumed VBN O
that IN O
virulence NN O
is VBZ O
equal JJ O
to IN O
fitness NN O
. . O

Introduction NN O

The DT O
relationship NN O
between IN O
fitness NN O
and CC O
virulence NN O
is VBZ O
an DT O
unsettled JJ O
question NN O
, , O
and CC O
sometimes RB O
fitness NN O
is VBZ O
considered VBN O
a DT O
component NN O
of IN O
the DT O
virulence NN O
phenotype NN O
of IN O
parasites NNS O
. . O

RNA NNP O
viruses NNS O
are VBP O
ideal JJ O
systems NNS O
to TO O
address VB O
this DT O
important JJ O
question NN O
because IN O
of IN O
their PRP$ O
high JJ O
mutability NN O
and CC O
fecundity NN O
, , O
which WDT O
result VBP O
in IN O
a DT O
potential NN O
for IN O
rapid JJ O
evolution NN O
, , O
and CC O
also RB O
because IN O
of IN O
the DT O
availability NN O
of IN O
quantitative JJ O
fitness NN O
and CC O
virulence NN O
assays NNS O
. . O

RNA NNP O
viruses NNS O
replicate VBP O
as IN O
complex JJ O
and CC O
dynamic JJ O
mutant JJ O
spectra NN O
, , O
termed VBN O
viral JJ O
quasispecies NNS O
. . O

Key NN O
to IN O
quasispecies NNS O
dynamics NNS O
are VBP O
mutation NN O
rates NNS O
in IN O
the DT O
range NN O
of IN O
10 CD O
- SYM O
3 CD O
to TO O
10 CD O
- SYM O
5 CD O
substitutions NNS O
per IN O
nucleotide NN O
copied VBN O
, , O
and CC O
competition NN O
among IN O
continuously RB O
arising VBG O
variant JJ O
genomes NNS O
[ -LRB- O
1 CD O
- SYM O
4 CD O
] -RRB- O
, , O
which WDT O
prompt VBP O
rapid JJ O
movements NNS O
in IN O
sequence NN O
space NN O
, , O
with IN O
corresponding VBG O
changes NNS O
of IN O
position NN O
in IN O
the DT O
fitness NN O
landscape NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Indeed RB O
, , O
large JJ O
population NN O
passages NNS O
of IN O
RNA NNP O
viruses NNS O
in IN O
cell NN O
culture NN O
permit VBP O
competitive JJ O
optimization NN O
of IN O
mutant JJ O
distributions NNS O
that WDT O
generally RB O
result VBP O
in IN O
fitness NN O
gain NN O
[ -LRB- O
6 CD O
, , O
7 CD O
] -RRB- O
, , O
while IN O
repeated JJ O
bottleneck NN O
events NNS O
( , O
experimentally RB O
realized VBN O
as IN O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
) , O
lead VBP O
to IN O
random JJ O
accumulation NN O
of IN O
deleterious JJ O
mutations NNS O
( , O
operation NN O
of IN O
Muller NNP O
' POS O
s NN O
ratchet NN O
[ -LRB- O
8 CD O
] -RRB- O
) -RRB- O
and CC O
result VB O
in IN O
average JJ O
fitness NN O
decreases NNS O
[ -LRB- O
9 CD O
- SYM O
13 CD O
] -RRB- O
. . O

Fitness NN O
recovery NN O
of IN O
low JJ O
fitness NN O
foot NN B-Species
- HYPH I-Species
and CC I-Species
- HYPH I-Species
mouth NN I-Species
disease NN I-Species
virus NN I-Species
( -LRB- O
FMDV NNP B-Species
) -RRB- O
clones NNS O
occurs VBZ O
mainly RB O
with IN O
introduction NN O
of IN O
mutations NNS O
along IN O
the DT O
genome NN O
, , O
with IN O
very RB O
few JJ O
true JJ O
reversions NNS O
. . O

An DT O
understanding NN O
of IN O
the DT O
consequences NNS O
of IN O
fitness NN O
variation NN O
for IN O
viral JJ O
virulence NN O
is VBZ O
a DT O
key JJ O
question NN O
for IN O
viral JJ O
pathogenesis NN O
and CC O
evolution NN O
. . O

Here RB O
, , O
we PRP O
approach VBP O
this DT O
issue NN O
with IN O
FMDV NNP B-Species
, , O
an DT O
important JJ O
viral JJ O
pathogen NN O
in IN O
veterinary JJ O
medicine NN O
[ -LRB- O
14 CD O
] -RRB- O
, , O
and CC O
one CD O
that WDT O
fully RB O
participates VBZ O
of IN O
quasispecies NNS O
dynamics NNS O
. . O

Our PRP$ O
laboratory NN O
has VBZ O
characterized VBN O
multiple JJ O
FMDV NNP B-Species
variants NNS O
that WDT O
derive VBP O
from IN O
one CD O
original JJ O
biological JJ O
clone NN O
, , O
and CC O
that WDT O
occupy VBP O
widely RB O
different JJ O
fitness NN O
levels NNS O
when WRB O
replicating VBG O
in IN O
a DT O
defined JJ O
environment NN O
in IN O
cell NN O
culture NN O
. . O

We PRP O
define VBP O
fitness NN O
as IN O
the DT O
replication NN O
capacity NN O
of IN O
a DT O
mutant JJ O
FMDV NN B-Species
, , O
relative JJ O
to IN O
a DT O
reference NN O
FMDV NN B-Species
, , O
in IN O
direct JJ O
growth NN O
- HYPH O
competition NN O
upon IN O
coinfection NN O
of IN O
baby NN O
hamster NN B-Species
kidney NN O
21 CD O
( , O
BHK NNP O
- HYPH O
21 CD O
) -RRB- O
cells NNS O
[ -LRB- O
15 CD O
- SYM O
17 CD O
] -RRB- O
. . O

Fitness NN O
of IN O
FMDV NNP B-Species
in IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
is VBZ O
a DT O
multigenic JJ O
trait NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
define VBP O
virulence NN O
of IN O
FMDV NNP B-Species
as IN O
the DT O
capacity NN O
of IN O
the DT O
virus NN O
to TO O
kill VB O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
under IN O
a DT O
standard JJ O
set NN O
of IN O
cell NN O
culture NN O
conditions NNS O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Thus RB O
, , O
the DT O
FMDV NNP B-Species
- HYPH O
BHK NNP O
- HYPH O
21 CD O
system NN O
offered VBD O
a DT O
means NN O
to TO O
investigate VB O
in IN O
a DT O
direct JJ O
and CC O
comparative JJ O
fashion NN O
the DT O
relationship NN O
between IN O
fitness NN O
and CC O
virulence NN O
of IN O
a DT O
virus NN O
, , O
measured VBN O
in IN O
the DT O
same JJ O
biological JJ O
environment NN O
provided VBN O
by IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
. . O

We PRP O
describe VBP O
the DT O
behavior NN O
of IN O
an DT O
FMDV NNP B-Species
clone NN O
( : O

) NFP O
, , O
which WDT O
has VBZ O
a DT O
history NN O
of IN O
repeated VBN O
serial JJ O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
in IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
[ -LRB- O
11 CD O
] -RRB- O
, , O
that WDT O
attained VBD O
a DT O
very RB O
low JJ O
fitness NN O
value NN O
relative JJ O
to IN O
its PRP$ O
parental JJ O
reference NN O
virus NN O
( , O
C NNP O
- HYPH O
S8c1 NNP O
) -RRB- O
, , O
and CC O
yet RB O
, , O
its PRP$ O
virulence NN O
for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
was VBD O
significantly RB O
higher JJR O
than IN O
that DT O
of IN O
C NN O
- HYPH O
S8c1 NN O
. . O

A DT O
comparative JJ O
study NN O
of IN O
the DT O
capacity NN O
to TO O
kill VB O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
of IN O
chimeric JJ O
FMDVs NNS B-Species
constructed VBN O
with IN O
cDNA NN O
copies NNS O
of IN O
the DT O
two CD O
parental JJ O
FMDVs NNPS B-Species
indicates VBZ O
that IN O
the DT O
enhanced VBN O
virulence NN O
for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
of IN O
the DT O
low JJ O
fitness NN O
clone NN O
is VBZ O
a DT O
polygenic JJ O
trait NN O
, , O
with IN O
participation NN O
of IN O
the DT O
regions NNS O
encoding VBG O
capsid JJ O
proteins NNS O
and CC O
non JJ O
- HYPH O
structural JJ O
proteins NNS O
2A NN O
, , O
2B NN O
, , O
and CC O
2C NN O
as IN O
virulence NN O
determinants NNS O
. . O

Three CD O
specific JJ O
amino NN O
acid NN O
replacements NNS O
in IN O
2C NNP O
have VBP O
been VBN O
identified VBN O
as IN O
redundant JJ O
virulence NN O
determinants NNS O
of IN O
FMDV NNP B-Species
for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
. . O

Thus RB O
, , O
while IN O
large JJ O
population NN O
passages NNS O
of IN O
the DT O
virus NN O
resulted VBD O
in IN O
a DT O
gain NN O
of IN O
both CC O
fitness NN O
and CC O
virulence NN O
, , O
subsequent JJ O
bottleneck NN O
passages NNS O
resulted VBD O
in IN O
a DT O
decrease NN O
of IN O
fitness NN O
but CC O
not RB O
of IN O
virulence NN O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
fitness NN O
is VBZ O
very RB O
vulnerable JJ O
to IN O
mutation NN O
in IN O
any DT O
genomic JJ O
region NN O
. . O

In IN O
contrast NN O
, , O
because IN O
of IN O
the DT O
involvement NN O
of IN O
several JJ O
( , O
but CC O
not RB O
all DT O
) , O
viral JJ O
genes NNS O
in IN O
virulence NN O
, , O
and CC O
the DT O
redundant JJ O
effect NN O
of IN O
three CD O
2C NNP O
substitutions NNS O
, , O
virulence NN O
is VBZ O
a DT O
more RBR O
robust JJ O
phenotypic JJ O
trait NN O
than IN O
fitness NN O
, , O
and CC O
less RBR O
vulnerable JJ O
to IN O
accumulation NN O
of IN O
mutations NNS O
. . O

Therefore RB O
, , O
we PRP O
provide VBP O
direct JJ O
evidence NN O
that IN O
viral JJ O
fitness NN O
and CC O
capacity NN O
to TO O
kill VB O
cells NNS O
can MD O
( -LRB- O
in IN O
some DT O
cases NNS O
) -RRB- O
be VB O
unrelated JJ O
traits NNS O
. . O

Furthermore RB O
, , O
the DT O
relationship NN O
between IN O
fitness NN O
and CC O
virulence NN O
, , O
of IN O
being VBG O
either CC O
linked VBN O
or CC O
unrelated JJ O
traits NNS O
, , O
depends VBZ O
on IN O
the DT O
evolutionary JJ O
history NN O
of IN O
the DT O
virus NN O
. . O

This DT O
observation NN O
has VBZ O
implications NNS O
for IN O
viral JJ O
pathogenesis NN O
, , O
and CC O
sheds VBZ O
light NN O
on IN O
models NNS O
of IN O
virulence NN O
proposed VBN O
on IN O
the DT O
basis NN O
of IN O
theoretical JJ O
and CC O
experimental JJ O
studies NNS O
with IN O
cellular JJ O
organisms NNS O
. . O

Results NNS O

Inability NN O
of IN O
FMDV NNP B-Species

to TO O
Establish VB O
a DT O
Persistent JJ O
Infection NN O
in IN O
BHK NNP O
- HYPH O
21 CD O
Cells NNS O

Several JJ O
biological JJ O
clones NNS O
and CC O
populations NNS O
were VBD O
obtained VBN O
by IN O
passaging VBG O
FMDV NNP B-Species
biological JJ O
clone NN O
C NNP O
- HYPH O
S8c1 NNP O
[ -LRB- O
19 CD O
- HYPH O
22 CD O
] -RRB- O
in IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
, , O
either CC O
as IN O
large JJ O
population NN O
passages NNS O
or CC O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
biological JJ O
clones NNS O
and CC O
populations NNS O
differed VBD O
up IN O
to IN O
236 CD O
- HYPH O
fold NN O
in IN O
relative JJ O
fitness NN O
( : O
Table NN O
1 CD O
) -RRB- O
. . O

The DT O
fitness NN O
differences NNS O
found VBN O
are VBP O
expected VBN O
from IN O
previous JJ O
results NNS O
on IN O
fitness NN O
gain NN O
upon IN O
large JJ O
population NN O
passages NNS O
of IN O
RNA NNP O
viruses NNS O
[ -LRB- O
6 CD O
, , O
7 CD O
] -RRB- O
and CC O
fitness NN O
decrease NN O
upon IN O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
( -LRB- O
bottleneck NN O
) -RRB- O
transfers NNS O
[ -LRB- O
9 CD O
- SYM O
13 CD O
] -RRB- O
. . O

The DT O
initial JJ O
experiment NN O
was VBD O
aimed VBN O
at IN O
testing VBG O
whether IN O

, , O
because IN O
of IN O
its PRP$ O
low JJ O
fitness NN O
( : O
0 CD O
. . O
11 CD O
times NNS O
that DT O
of IN O
its PRP$ O
parental JJ O
C NNP O
- HYPH O
S8c1 NNP O
[ -LRB- O
12 CD O
, , O
23 CD O
, , O
24 CD O
] -RRB- O
[ -LRB- O
Table NNP O
1 CD O
] -RRB- O
) -RRB- O
, , O
had VBD O
an DT O
advantage NN O
in IN O
establishing VBG O
a DT O
persistent JJ O
non JJ O
- HYPH O
cytopathic JJ O
infection NN O
in IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
as IN O
compared VBN O
with IN O
its PRP$ O
parental JJ O
clone NN O
, , O
C NN O
- HYPH O
S8c1 NNP O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

A DT O
persistent JJ O
FMDV NNP B-Species
infection NN O
is VBZ O
established VBN O
by IN O
growing VBG O
the DT O
cells NNS O
that WDT O
survive VBP O
a DT O
standard JJ O
cytolytic JJ O
infection NN O
with IN O
FMDV NNP B-Species
[ -LRB- O
25 CD O
] -RRB- O
. . O

Confluent JJ O
monolayers NNS O
of IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
were VBD O
infected VBN O
either CC O
with IN O
C NN O
- HYPH O
S8c1 NN O
or CC O
with IN O

at IN O
a DT O
multiplicity NN O
of IN O
infection NN O
( : O
MOI NNP O
) -RRB- O
of IN O
0 CD O
. . O
2 CD O
- HYPH O
0 CD O
. . O
1 CD O
plaque NN O
- HYPH O
forming VBG O
units NNS O
( -LRB- O
PFU NNP O
) -RRB- O
/ SYM O
cell NN O
( : O
2 CD O
x SYM O
106 CD O
cells NNS O
infected VBN O
with IN O
4 CD O
x SYM O
104 CD O
- SYM O
2 CD O
x SYM O
105 CD O
PFU NN O
) -RRB- O
. . O

Unexpectedly RB O
, , O
at IN O
24 CD O
h CD O
postinfection NN O
, , O
the DT O
cells NNS O
infected VBN O
with IN O

showed VBD O
extensive JJ O
cytopathology NN O
, , O
and CC O
at IN O
48 CD O
h NN O
postinfection NN O
, , O
no DT O
surviving VBG O
cells NNS O
were VBD O
observed VBN O
. . O

The DT O
frequency NN O
of IN O
surviving VBG O
cells NNS O
in IN O
parallel JJ O
infections NNS O
with IN O
C NN O
- HYPH O
S8c1 NN O
was VBD O
5 CD O
x SYM O
10 CD O
- SYM O
3 CD O
- SYM O
9 CD O
x SYM O
10 CD O
- SYM O
3 CD O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
previous JJ O
determinations NNS O
[ -LRB- O
25 CD O
] -RRB- O
. . O

No DT O
persistently RB O
infected VBN O
BHK NNP O
- HYPH O
21 CD O
cell NN O
cultures NNS O
could MD O
be VB O
established VBN O
with IN O

, , O
despite IN O
several JJ O
attempts NNS O
. . O

Thus RB O
, , O
C NNP O
- HYPH O
S8c1 NNP O
, , O
which WDT O
displays VBZ O
a DT O
9 CD O
- HYPH O
fold NN O
higher JJR O
relative JJ O
fitness NN O
than IN O

in IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
, , O
showed VBD O
a DT O
capacity NN O
to TO O
kill VB O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
that WDT O
was VBD O
at IN O
least JJS O
103 CD O
- HYPH O
fold NN O
lower JJR O
than IN O
the DT O
killing NN O
capacity NN O
of IN O

in IN O
the DT O
infectivity NN O
assay NN O
intended VBN O
to TO O
establish VB O
a DT O
persistent JJ O
FMDV NNP B-Species
infection NN O
. . O

FMDV NN B-Species
Fitness NN O
and CC O
Capacity NN O
to TO O
Kill VB O
BHK NN O
- HYPH O
21 CD O
Cells NNS O
May MD O
Not RB O
Be VB O
Positively RB O
Correlated VBN O

The DT O
capacity NN O
of IN O

to TO O
kill VB O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
despite IN O
its PRP$ O
low JJ O
fitness NN O
in IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
led VBD O
us PRP O
to TO O
quantitatively RB O
examine VB O
the DT O
relationship NN O
between IN O
fitness NN O
of IN O
FMDV NNP B-Species
and CC O
its PRP$ O
capacity NN O
to TO O
kill VB O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
. . O

To IN O
this DT O
aim NN O
, , O
FMDV NNP B-Species
clones NNS O
or CC O
populations NNS O
were VBD O
compared VBN O
in IN O
a DT O
cell NN O
killing NN O
assay NN O
, , O
consisting VBG O
in IN O
determining VBG O
the DT O
time NN O
required VBN O
to TO O
kill VB O
104 CD O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
as IN O
a DT O
function NN O
of IN O
the DT O
PFU NNP O
added VBN O
( HYPH O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
. . O

The DT O
results NNS O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
indicate VBP O
that IN O
over IN O
the DT O
time NN O
range NN O
of IN O
12 CD O
h CD O
to IN O
48 CD O
h NN O
postinfection NN O
, , O
the DT O
number NN O
of IN O
PFUs NNS O
needed VBN O
to TO O
kill VB O
104 CD O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
varied VBD O
logarithmically RB O
as IN O
a DT O
function NN O
of IN O
time NN O
. . O

Similar JJ O
quantifications NNS O
of IN O
relative JJ O
virulence NN O
were VBD O
obtained VBN O
by IN O
measuring VBG O
the DT O
PFU NNP O
needed VBN O
to TO O
kill VB O
104 CD O
cells NNS O
in IN O
24 CD O
h NN O
, , O
and CC O
then RB O
by IN O
extrapolating VBG O
the DT O
PFU NNP O
values NNS O
to IN O
0 CD O
h NN O
postinfection NN O
( : O
Tables NN O
1 CD O
and CC O
S1 NNP O
) -RRB- O
. . O

Virulence NN O
of IN O

was VBD O
29 CD O
to TO O
35 CD O
times NNS O
higher JJR O
than IN O
virulence NN O
of IN O
C NNP O
- HYPH O
S8c1 NNP O
, , O
despite IN O
the DT O
latter JJ O
displaying VBG O
a DT O
9 CD O
- HYPH O
fold NN O
higher JJR O
fitness NN O
( : O
Tables NN O
1 CD O
and CC O
S1 NNP O
) -RRB- O
. . O

The DT O
high JJ O
virulence NN O
of IN O

was VBD O
not RB O
due JJ O
to IN O
the DT O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
, , O
since IN O
a DT O
high JJ O
virulence NN O
was VBD O
also RB O
quantitated VBN O
for IN O
its PRP$ O
parental JJ O
clone NN O
, , O

, , O
and CC O
for IN O
population NN O
C NN O
- HYPH O
S8p113 CD O
( : O
Figure NN O
2B NN O
; : O
Tables NN O
1 CD O
, , O
2 CD O
, , O
and CC O
S1 NN O
) -RRB- O
. . O

deviated VBN O
from IN O
a DT O
line NN O
that WDT O
correlated VBD O
relative JJ O
fitness NN O
of IN O
FMDV NNP B-Species
and CC O
the DT O
logarithm NN O
of IN O
cell NN O
killing NN O
capacity NN O
, , O
as IN O
reflected VBN O
in IN O
the DT O
decrease NN O
of IN O
the DT O
regression NN O
coefficient NN O
( -LRB- O
R2 NN O
) -RRB- O
( , O
inset NN O
in IN O
Figure NNP O
2A NNP O
) -RRB- O
. . O

Probably RB O
, , O
this DT O
deviation NN O
is VBZ O
due JJ O
to IN O
the DT O
fact NN O
that IN O

lost VBN O
fitness NN O
due IN O
to IN O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
, , O
and CC O
the DT O
other JJ O
viruses NNS O
were VBD O
not RB O
subjected VBN O
to IN O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
virulence NN O
determinants NNS O
were VBD O
acquired VBN O
during IN O
the DT O
large JJ O
population NN O
passages NNS O
done VBN O
between IN O
C NN O
- HYPH O
S8c1 NN O
and CC O
C NN O
- HYPH O
S8c1p113 CD O
. . O

The DT O
29 CD O
- HYPH O
to TO O
35 CD O
- HYPH O
fold VBP O
higher JJR O
virulence NN O
of IN O

with IN O
respect NN O
to IN O
C NNP O
- HYPH O
S8c1 NNP O
( , O
Tables NN O
1 CD O
and CC O
S1 NNP O
) -RRB- O
, , O
despite IN O
its PRP$ O
low JJ O
fitness NN O
, , O
indicates VBZ O
that IN O
viral JJ O
fitness NN O
and CC O
virulence NN O
can MD O
be VB O
two CD O
unrelated JJ O
traits NNS O
. . O

Mapping VBG O
Virulence NN O
Determinants NNS O
in IN O
the DT O

Genome NNP O

The DT O
comparison NN O
of IN O
the DT O
consensus NN O
nucleotide NN O
sequence NN O
of IN O
the DT O

genome NN O
with IN O
that DT O
of IN O
C NNP O
- HYPH O
S8c1 NNP O
revealed VBD O
a DT O
total NN O
of IN O
47 CD O
mutations NNS O
( -LRB- O
Table NNP O
S2 NNP O
) -RRB- O
, , O
leading VBG O
to IN O
21 CD O
amino NN O
acid NN O
replacements NNS O
affecting VBG O
structural JJ O
and CC O
non JJ O
- HYPH O
structural JJ O
proteins NNS O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

To TO O
identify VB O
the DT O
genomic JJ O
regions NNS O
associated VBN O
with IN O
the DT O
increased VBN O
virulence NN O
of IN O

with IN O
respect NN O
to IN O
C NNP O
- HYPH O
S8c1 NNP O
, , O
we PRP O
measured VBD O
the DT O
BHK NNP O
- HYPH O
21 CD O
cell NN O
killing NN O
capacity NN O
of IN O
nine CD O
chimeric JJ O
viruses NNS O
rescued VBN O
from IN O
constructs NNS O
obtained VBN O
by IN O
introducing VBG O
fragments NNS O
of IN O
cDNA NN O
of IN O
the DT O

genome NN O
into IN O
plasmid NN O
pMT28 CD O
, , O
which WDT O
encodes VBZ O
infectious JJ O
C NN O
- HYPH O
S8c1 NNP O
RNA NNP O
[ -LRB- O
21 CD O
] -RRB- O
( -LRB- O
Figure NN O
4 CD O
) -RRB- O
. . O

The DT O
results NNS O
( -LRB- O
Figure NN O
5 CD O
; : O
Tables NN O
2 CD O
and CC O
S1 NNP O
) -RRB- O
show VBP O
that IN O
several JJ O
genomic JJ O
regions NNS O
contribute VBP O
to IN O
the DT O
virulence NN O
of IN O

for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
, , O
and CC O
that IN O
the DT O
major JJ O
contributors NNS O
map VBP O
within IN O
genomic JJ O
positions NNS O
2046 CD O
to IN O
3760 CD O
( , O
residues NNS O
encoding VBG O
part NN O
of IN O
VP2 NN O
, , O
VP3 NN O
, , O
and CC O
part NN O
of IN O
VP1 NN O
, , O
Figure NNP O
5A NNP O
) -RRB- O
and CC O
3760 CD O
to IN O
5839 CD O
( , O
residues NNS O
encoding VBG O
2A CD O
, , O
2B NN O
, , O
2C NN O
, , O
and CC O
3A NN O
, , O
Figure NNP O
5B NN O
) -RRB- O
. . O

The DT O
results NNS O
exclude VBP O
the DT O
internal JJ O
ribosome NN O
entry NN O
site NN O
and CC O
the DT O
3C NN O
- HYPH O
and CC O
3D NN O
- HYPH O
coding VBG O
regions NNS O
as IN O
significant JJ O
virulence NN O
determinants NNS O
of IN O

for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
( , O
virulence NN O
of IN O
the DT O
relevant JJ O
chimeric JJ O
viruses NNS O
< : O
= SYM O
2 CD O
. . O
5 CD O
, , O
relative JJ O
to IN O
C NN O
- HYPH O
S8c1 NN O
; : O
Tables NN O
2 CD O
and CC O
S1 NN O
) -RRB- O
. . O

Infectious JJ O
progeny NN O
production NN O
by IN O
each DT O
chimeric JJ O
virus NN O
was VBD O
intermediate JJ O
between IN O
the DT O
production NN O
of IN O
the DT O
parental JJ O
viruses NNS O
pMT28 NN O
and CC O

, , O
with IN O
no DT O
significant JJ O
differences NNS O
that WDT O
could MD O
be VB O
correlated VBN O
with IN O
virulence NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

Non NNP O
- HYPH O
Structural JJ O
Protein NN O
2C NN O
Is VBZ O
a DT O
Determinant NN O
of IN O
the DT O
Virulence NN O
of IN O
FMDV NNP B-Species
for IN O
BHK NNP O
- HYPH O
21 CD O
Cells NNS O

Amino JJ O
acid NN O
substitutions NNS O
in IN O
human JJ B-Species
rhinovirus NN I-Species
protein NN O
2C NNP O
promoted VBD O
cytopathology NN O
for IN O
mouse NN B-Species
L NNP O
cells NNS O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Remarkably RB O
, , O

shares NNS O
with IN O
other JJ O
FMDV NNP B-Species
clones NNS O
and CC O
populations NNS O
, , O
notably RB O
, , O
MARLS NNP O
and CC O
C NNP O
- HYPH O
S8p260p3d NNP O
( , O
the DT O
two CD O
viruses NNS O
showing VBG O
the DT O
highest JJS O
virulence NN O
for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
; : O
Figure NNP O
2A NNP O
; : O
Tables NNP O
1 CD O
and CC O
S1 NNP O
) -RRB- O
, , O
three CD O
amino NN O
acid NN O
substitutions NNS O
in IN O
2C NNP O
: : O
S80N NNP O
, , O
T256A NNP O
, , O
and CC O
Q263H NNP O
. . O

In IN O
addition NN O
, , O
MARLS NNP O
and CC O
CS8p260p3d NNP O
include VBP O
replacement NN O
M283V NN O
in IN O
2C CD O
, , O
relative NN O
to IN O
C NN O
- HYPH O
S8c1 NNP O
[ -LRB- O
27 CD O
, , O
28 CD O
] -RRB- O
. . O

To TO O
test VB O
whether IN O
any DT O
( , O
or CC O
a DT O
combination NN O
) -RRB- O
of IN O
the DT O
three CD O
shared VBN O
amino NN O
acid NN O
substitutions NNS O
in IN O
2C NNP O
contributed VBD O
to IN O
the DT O
increased VBN O
virulence NN O
of IN O
FMDV NNP B-Species
, , O
each DT O
of IN O
the DT O
mutations NNS O
was VBD O
introduced VBN O
individually RB O
into IN O
plasmid NN O
pMT28 NN O
by IN O
site NN O
- HYPH O
directed VBN O
mutagenesis NN O
, , O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

Transcripts NNS O
of IN O
the DT O
three CD O
mutants NNS O
, , O
termed VBN O
pMT28 NN O
( , O
SN NNP O
) -RRB- O
, , O
pMT28 NNP O
( , O
TA NNP O
) -RRB- O
, , O
and CC O
pMT28 NN O
( -LRB- O
QH NNP O
) -RRB- O
( -LRB- O
Figure NNP O
4 CD O
) -RRB- O
, , O
were VBD O
used VBN O
to TO O
transfect VB O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
, , O
and CC O
the DT O
viruses NNS O
obtained VBN O
were VBD O
tested VBN O
with IN O
the DT O
BHK NNP O
- HYPH O
21 CD O
cell NN O
killing NN O
assay NN O
. . O

Viruses NNS O
having VBG O
any DT O
of IN O
the DT O
substitutions NNS O
in IN O
2C NNP O
have VB O
a DT O
virulence NN O
intermediate JJ O
between IN O
that DT O
of IN O
C NN O
- HYPH O
S8c1 NNP O
and CC O

( -LRB- O
Figure NN O
6A NN O
) -RRB- O
. . O

To TO O
test VB O
whether IN O
the DT O
combination NN O
of IN O
the DT O
three CD O
substitutions NNS O
in IN O
2C NNP O
could MD O
produce VB O
an DT O
additional JJ O
increase NN O
of IN O
virulence NN O
, , O
the DT O
three CD O
mutations NNS O
were VBD O
introduced VBN O
in IN O
pMT28 NN O
to TO O
rescue VB O
the DT O
triple JJ O
mutant NN O
pMT28 NN O
( , O
SN NNP O
, , O
TA NNP O
, , O
QH NNP O
) -RRB- O
( -LRB- O
Figure NN O
4 CD O
) -RRB- O
. . O

The DT O
results NNS O
( -LRB- O
Figure NNP O
6B NNP O
) -RRB- O
show VBP O
that IN O
the DT O
virulence NN O
of IN O
the DT O
triple JJ O
2C NNP O
mutant NN O
is VBZ O
similar JJ O
to IN O
the DT O
virulence NN O
of IN O
the DT O
individual JJ O
2C NNP O
mutants NNS O
. . O

The DT O
2C NNP O
mutations NNS O
did VBD O
not RB O
significantly RB O
affect VB O
the DT O
infectious JJ O
progeny NN O
production NN O
( : O
Table NNP O
2 CD O
) -RRB- O
. . O

A DT O
testable JJ O
prediction NN O
of IN O
this DT O
result NN O
is VBZ O
that IN O
the DT O
introduction NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
2C NNP O
- HYPH O
3A NN O
- HYPH O
coding VBG O
region NN O
in IN O
the DT O
genetic JJ O
background NN O
of IN O

should MD O
produce VB O
a DT O
virus NN O
with IN O
lower JJR O
virulence NN O
than IN O

. , O
Indeed RB O
, , O
the DT O
results NNS O
with IN O
such PDT O
a DT O
chimeric JJ O
virus NN O
( -LRB- O
Figure NNP O
5D NNP O
) -RRB- O
indicate VBP O
that IN O
the DT O
presence NN O
of IN O
the DT O
2C NN O
- HYPH O
and CC O
3A NN O
- HYPH O
coding VBG O
region NN O
as IN O
the DT O
only JJ O
genetic JJ O
region NN O
of IN O
the DT O
pMT28 NN O
in IN O
the DT O
genetic JJ O
background NN O
of IN O

resulted VBD O
in IN O
an DT O
FMDV NNP B-Species
with IN O
a DT O
2 CD O
. . O
4 CD O
- HYPH O
to IN O
4 CD O
. . O
8 CD O
- HYPH O
fold NN O
lower JJR O
virulence NN O
than IN O

. , O
We PRP O
conclude VBP O
that IN O
mutations NNS O
in IN O
2C NNP O
contribute VBP O
to IN O
virulence NN O
of IN O
FMDV NNP B-Species
for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
. . O

Thus RB O
, , O
a DT O
virus NN O
that WDT O
evolves VBZ O
towards IN O
low JJ O
fitness NN O
levels NNS O
due IN O
to IN O
the DT O
operation NN O
of IN O
Muller NNP O
' POS O
s POS O
ratchet NN O
may MD O
nevertheless RB O
maintain VB O
its PRP$ O
capacity NN O
to TO O
kill VB O
the DT O
same JJ O
cells NNS O
in IN O
which WDT O
it PRP O
displays VBZ O
low JJ O
fitness NN O
. . O

In IN O
FMDV NNP B-Species
, , O
the DT O
enhanced VBN O
capacity NN O
to TO O
kill VB O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
was VBD O
multigenic JJ O
, , O
including VBG O
participation NN O
of IN O
non JJ O
- HYPH O
structural JJ O
protein NN O
2C NN O
with IN O
three CD O
amino NN O
acid NN O
substitutions NNS O
acting VBG O
in IN O
a DT O
redundant JJ O
fashion NN O
. . O

In IN O
conclusion NN O
, , O
the DT O
results NNS O
provide VBP O
a DT O
molecular JJ O
interpretation NN O
of IN O
why WRB O
fitness NN O
and CC O
virulence NN O
of IN O
an DT O
animal NN O
virus NN O
can MD O
follow VB O
disparate JJ O
evolutionary JJ O
trajectories NNS O
, , O
culminating VBG O
in IN O
two CD O
unrelated JJ O
traits NNS O
. . O

Discussion NN O

The DT O
capacity NN O
of IN O
a DT O
virus NN O
to TO O
kill VB O
cells NNS O
is VBZ O
probably RB O
influenced VBN O
by IN O
several JJ O
steps NNS O
in IN O
the DT O
virus NN O
life NN O
cycle NN O
, , O
including VBG O
receptor NN O
affinity NN O
( , O
which WDT O
may MD O
trigger VB O
signalling NN O
pathways NNS O
and CC O
alter NN O
cell NN O
functions NNS O
) -RRB- O
and CC O
intracellular JJ O
viral JJ O
replication NN O
that WDT O
may MD O
lead VB O
to IN O
metabolic JJ O
alterations NNS O
such JJ O
as IN O
transcriptional JJ O
or CC O
translational JJ O
shut NN O
- HYPH O
off NN O
[ -LRB- O
29 CD O
] -RRB- O
. . O

A DT O
parallel JJ O
increase NN O
of IN O
virulence NN O
and CC O
fitness NN O
as IN O
a DT O
virus NN O
improves VBZ O
its PRP$ O
adaptation NN O
to IN O
a DT O
host NN O
cell NN O
type NN O
is VBZ O
expected VBN O
, , O
since IN O
a DT O
key JJ O
parameter NN O
that WDT O
should MD O
contribute VB O
to IN O
the DT O
fitness NN O
level NN O
of IN O
a DT O
cytophatic JJ O
virus NN O
is VBZ O
the DT O
accumulation NN O
of IN O
infectious JJ O
particles NNS O
and CC O
its PRP$ O
release NN O
from IN O
cells NNS O
, , O
which WDT O
are VBP O
events NNS O
often RB O
associated VBN O
with IN O
cell NN O
killing NN O
. . O

This DT O
expectation NN O
was VBD O
fulfilled VBN O
in IN O
our PRP$ O
experiments NNS O
( , O
increase NN O
of IN O
both CC O
fitness NN O
and CC O
cell NN O
killing NN O
following VBG O
large JJ O
population NN O
passages NNS O
of IN O
C NNP O
- HYPH O
S8c1 NNP O
[ -LRB- O
Figure NN O
2 CD O
] -RRB- O
) -RRB- O
, , O
and CC O
also RB O
in IN O
other JJ O
virus NN O
- HYPH O
host NN O
systems NNS O
. . O

In IN O
a DT O
comparison NN O
of IN O
two CD O
genetically RB O
divergent JJ O
isolates NNS O
of IN O
the DT O
whispovirus NN O
white JJ O
spot NN O
syndrome NN O
virus NN O
, , O
whose WP$ O
virulence NN O
for IN O
the DT O
shrimp NN B-Species
host NN O
Penaeus NNP B-Species
monodon NN I-Species
was VBD O
measured VBN O
by IN O
in IN O
vivo NN O
cumulative JJ O
mortality NN O
rates NNS O
, , O
virulence NN O
correlated VBN O
with IN O
competitive JJ O
fitness NN O
in IN O
vivo NN O
[ -LRB- O
30 CD O
] -RRB- O
. . O

The DT O
onset NN O
of IN O
type NN O
1 CD O
diabetes NNS O
by IN O
coxsackievirus NN O
B NNP O
strains NNS O
was VBD O
linked VBN O
to IN O
the DT O
viral JJ O
replication NN O
rate NN O
and CC O
to IN O
the DT O
infectious JJ O
dose NN O
[ -LRB- O
31 CD O
] -RRB- O
. . O

In IN O
engineered JJ O
alphavirus NN O
replicons NNS O
, , O
a DT O
direct JJ O
correlation NN O
between IN O
the DT O
level NN O
of IN O
RNA NN O
replication NN O
and CC O
cytopathogenicity NN O
was VBD O
observed VBN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

At IN O
an DT O
epidemiological JJ O
level NN O
, , O
a DT O
greater JJR O
replicative JJ O
fitness NN O
of IN O
historical JJ O
versus IN O
current JJ O
human JJ B-Species
immunodeficiency NN I-Species
virus NN I-Species
type NN I-Species
1 CD I-Species
( , O
HIV NNP B-Species
- HYPH I-Species
1 CD I-Species
) -RRB- O
isolates NNS O
was VBD O
taken VBN O
as IN O
evidence NN O
of IN O
HIV NNP B-Species
- HYPH I-Species
1 CD I-Species
attenuation NN O
over IN O
time NN O
, , O
assuming VBG O
a DT O
direct JJ O
connection NN O
between IN O
fitness NN O
and CC O
virulence NN O
[ -LRB- O
33 CD O
] -RRB- O
. . O

In IN O
vivo NN O
, , O
viral JJ O
fitness NN O
may MD O
vary VB O
among IN O
specific JJ O
organs NNS O
, , O
and CC O
virulence NN O
may MD O
be VB O
affected VBN O
only RB O
when WRB O
fitness NN O
for IN O
some DT O
specific JJ O
target NN O
tissues NNS O
is VBZ O
affected VBN O
[ -LRB- O
34 CD O
] -RRB- O
. . O

Replicative JJ O
fitness NN O
is VBZ O
, , O
however RB O
, , O
but CC O
one CD O
of IN O
several JJ O
factors NNS O
which WDT O
influence VBP O
the DT O
progression NN O
of IN O
a DT O
viral JJ O
infection NN O
in IN O
vivo NN O
. . O

In IN O
a DT O
comparative JJ O
analysis NN O
, , O
R5 NNP O
- HYPH O
tropic JJ O
and CC O
X4 NN O
- HYPH O
tropic JJ O
clones NNS O
of IN O
HIV NNP B-Species
- HYPH I-Species
1 CD I-Species
showed VBD O
similar JJ O
replication NN O
capacity NN O
in IN O
mitogen NN O
- HYPH O
activated VBN O
T NNP O
cells NNS O
. . O

However RB O
, , O
X4 NNP O
clones NNS O
were VBD O
transferred VBN O
more RBR O
efficiently RB O
than IN O
R5 NNP O
clones NNS O
from IN O
dendritic JJ O
cells NNS O
to IN O
CD4 NNP O
( -LRB- O
+ SYM O
) -RRB- O
T NN O
cells NNS O
, , O
a DT O
fact NN O
that WDT O
can MD O
contribute VB O
to IN O
the DT O
competitive JJ O
advantage NN O
of IN O
X4 NN O
viruses NNS O
in IN O
AIDS NNP O
patients NNS B-Species
[ -LRB- O
35 CD O
] -RRB- O
. . O

Simian JJ B-Species
immunodeficiency NN I-Species
virus NN I-Species
SIVmac239 NN B-Species
infects VBZ O
both CC O
the DT O
sooty JJ B-Species
mangabey NN I-Species
and CC O
the DT O
rhesus NN B-Species
macaque NN I-Species
, , O
reaching VBG O
high JJ O
viral JJ O
loads NNS O
in IN O
both DT O
hosts NNS O
, , O
yet CC O
it PRP O
is VBZ O
only RB O
virulent JJ O
for IN O
the DT O
rhesus NN B-Species
macaque NN I-Species
[ -LRB- O
36 CD O
] -RRB- O
. . O

Deviations NNS O
of IN O
a DT O
positive JJ O
correlation NN O
between IN O
viral JJ O
fitness NN O
and CC O
virulence NN O
were VBD O
observed VBN O
also RB O
in IN O
the DT O
plant NN O
viruses NNS O
cucumber NN B-Species
mosaic NN I-Species
virus NN I-Species
[ -LRB- O
37 CD O
] -RRB- O
and CC O
barley NN B-Species
stripe NN I-Species
mosaic NN I-Species
virus NN I-Species
[ -LRB- O
38 CD O
] -RRB- O
. . O

A DT O
study NN O
of IN O
the DT O
effect NN O
of IN O
lysis NN O
timing NN O
on IN O
bacteriophage NN B-Species
fitness NN O
revealed VBD O
that IN O
a DT O
strain NN O
with IN O
an DT O
intermediate JJ O
lysis NN O
time NN O
had VBD O
the DT O
highest JJS O
fitness NN O
[ -LRB- O
39 CD O
] -RRB- O
. . O

The DT O
time NN O
of IN O
transmission NN O
may MD O
also RB O
affect VB O
virulence NN O
. . O

Nuclear JJ O
polyhedrosis NN O
virus NN O
transmitted VBN O
early RB O
to IN O
its PRP$ O
host NN O
, , O
the DT O
moth NN O
Lymantria NNP B-Species
dispar NN I-Species
, , O
was VBD O
more RBR O
virulent JJ O
than IN O
virus NN O
transmitted VBN O
late RB O
, , O
although IN O
the DT O
latter NN O
was VBD O
more RBR O
productive JJ O
because IN O
the DT O
virus NN O
could MD O
use VB O
more JJR O
host NN O
tissue NN O
for IN O
replication NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

In IN O
a DT O
study NN O
of IN O
the DT O
susceptibility NN O
of IN O
North JJ O
American JJ O
and CC O
non JJ O
- HYPH O
North JJ O
American JJ O
breeds NNS O
of IN O
Lymantria NNP O
to IN O
several JJ O
isolates NNS O
of IN O
the DT O
fungus NN O
Entomaphaga NNP B-Species
maimaiga NN I-Species
, , O
mortality NN O
was VBD O
scored VBN O
in IN O
all DT O
cases NNS O
. . O

However RB O
, , O
virulence NN O
of IN O
the DT O
fungus NN O
, , O
quantitated VBN O
by IN O
the DT O
time NN O
of IN O
death NN O
of IN O
Lymantria NNP O
, , O
was VBD O
, , O
in IN O
some DT O
cases NNS O
, , O
inversely RB O
proportional JJ O
to IN O
fitness NN O
, , O
quantitated VBN O
by IN O
fungal JJ O
reproduction NN O
in IN O
the DT O
moth NN B-Species
[ -LRB- O
41 CD O
] -RRB- O
. . O

In IN O
all PDT O
these DT O
cases NNS O
, , O
the DT O
molecular JJ O
basis NN O
of IN O
the DT O
lack NN O
of IN O
positive JJ O
correlation NN O
between IN O
fitness NN O
and CC O
virulence NN O
is VBZ O
not RB O
understood VBN O
. . O

Model NN O
for IN O
a DT O
Lack NN O
of IN O
Correlation NN O
between IN O
Viral NNP O
Fitness NNP O
and CC O
Virulence NNP O

The DT O
results NNS O
with IN O
FMDV NNP B-Species
clones NNS O
H5 NNP O
have VBP O
documented VBN O
that IN O
both CC O
fitness NN O
- HYPH O
enhancing NN O
and CC O
virulence NN O
- HYPH O
enhancing VBG O
mutations NNS O
can MD O
be VB O
incorporated VBN O
in IN O
the DT O
viral JJ O
genome NN O
in IN O
such PDT O
a DT O
fashion NN O
that IN O
subsequent JJ O
fitness NN O
- HYPH O
decreasing VBG O
mutations NNS O
associated VBN O
with IN O
bottleneck NN O
( , O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
) -RRB- O
transfers NNS O
produce VBP O
only RB O
minimal JJ O
effects NNS O
on IN O
virulence NN O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

The DT O
dissection NN O
of IN O
accompanying JJ O
molecular JJ O
events NNS O
, , O
achieved VBN O
through IN O
quantification NN O
of IN O
virulence NN O
of IN O
recombinant JJ O
and CC O
mutant JJ O
genomes NNS O
( , O
Tables NNP O
2 CD O
and CC O
S1 NNP O
) -RRB- O
, , O
provides VBZ O
an DT O
interpretation NN O
of IN O
the DT O
lack NN O
of IN O
positive JJ O
correlation NN O
between IN O
virulence NN O
and CC O
fitness NN O
. . O

Multiple JJ O
fitness NN O
- HYPH O
decreasing VBG O
mutations NNS O
occur VBP O
in IN O
the DT O
course NN O
of IN O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
, , O
distributed VBN O
throughout IN O
the DT O
FMDV NNP B-Species
genome NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

In IN O
contrast NN O
, , O
determinants NNS O
of IN O
virulence NN O
for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
are VBP O
multigenic JJ O
, , O
but CC O
concentrated VBN O
mainly RB O
in IN O
some DT O
FMDV NNP B-Species
genomic JJ O
regions NNS O
. . O

Similar JJ O
multigenic JJ O
but CC O
discrete JJ O
virulence NN O
determinants NNS O
have VBP O
been VBN O
described VBN O
also RB O
in IN O
other JJ O
virus NN O
- HYPH O
host NN O
systems NNS O
[ -LRB- O
42 CD O
, , O
43 CD O
] -RRB- O
. . O

To TO O
decrease VB O
virulence NN O
, , O
mutations NNS O
occurring VBG O
randomly RB O
in IN O
the DT O
course NN O
of IN O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
should MD O
affect VB O
specific JJ O
genomic JJ O
sites NNS O
, , O
and CC O
this DT O
will MD O
occur VB O
with IN O
a DT O
lower JJR O
probability NN O
than IN O
fitness NN O
- HYPH O
decreasing VBG O
mutations NNS O
, , O
which WDT O
can MD O
hit VB O
any DT O
of IN O
the DT O
multifunctional JJ O
picornaviral JJ O
proteins NNS O
and CC O
regulatory JJ O
regions NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

This DT O
model NN O
is VBZ O
reinforced VBN O
by IN O
the DT O
observation NN O
that IN O
three CD O
amino NN O
acid NN O
substitutions NNS O
in IN O
2C NNP O
( -LRB- O
S80N NNP O
, , O
T256A NNP O
, , O
and CC O
Q263H NNP O
) -RRB- O
had VBD O
a DT O
similar JJ O
effect NN O
in IN O
enhancing VBG O
FMDV NNP B-Species
virulence NN O
, , O
and CC O
the DT O
three CD O
mutations NNS O
in IN O
the DT O
same JJ O
genome NN O
had VBD O
an DT O
effect NN O
comparable JJ O
to IN O
each DT O
mutation NN O
individually RB O
( : O
Figure NNP O
6 CD O
; : O
Tables NN O
2 CD O
and CC O
S1 NNP O
) -RRB- O
. . O

It PRP O
is VBZ O
not RB O
clear JJ O
what WP O
the DT O
basis NN O
of IN O
the DT O
contribution NN O
of IN O
2C NNP O
to IN O
virulence NN O
for IN O
BHK NNP O
- HYPH O
21 CD O
could MD O
be VB O
. . O

2C NNP O
is VBZ O
involved VBN O
in IN O
RNA NNP O
synthesis NN O
and CC O
contains VBZ O
a DT O
nucleotide NN O
- HYPH O
binding VBG O
domain NN O
, , O
although IN O
none NN O
of IN O
the DT O
substitutions NNS O
found VBN O
in IN O

and CC O

lie VB O
within IN O
such PDT O
a DT O
domain NN O
. . O

An DT O
unlikely JJ O
triple JJ O
reversion NN O
would MD O
be VB O
required VBN O
to TO O
eliminate VB O
the DT O
virulence NN O
- HYPH O
enhancing VBG O
effect NN O
of IN O
the DT O
three CD O
mutations NNS O
in IN O
2C CD O
. . O

We PRP O
propose VBP O
that IN O
a DT O
higher JJR O
robustness NN O
of IN O
the DT O
FMDV NNP B-Species
genome NN O
with IN O
regard NN O
to IN O
virulence NN O
for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
, , O
rather RB O
than IN O
to IN O
replicative JJ O
fitness NN O
in IN O
the DT O
same JJ O
cells NNS O
, , O
underlies VBZ O
the DT O
different JJ O
trajectories NNS O
followed VBN O
by IN O
fitness NN O
and CC O
virulence NN O
upon IN O
subjecting VBG O
the DT O
virus NN O
to IN O
repeated VBN O
bottleneck NN O
transfers NNS O
. . O

Obviously RB O
, , O
we PRP O
cannot MD O
exclude VB O
that IN O
parameters NNS O
of IN O
the DT O
virus NN O
life NN O
cycle NN O
, , O
other JJ O
than IN O
fitness NN O
as IN O
measured VBN O
in IN O
our PRP$ O
experiments NNS O
, , O
could MD O
correlate VB O
with IN O
virulence NN O
for IN O
BHK NNP O
- HYPH O
21 CD O
. . O

The DT O
comparative JJ O
analysis NN O
of IN O
FMDV NNP B-Species
clones NNS O
and CC O
populations NNS O
shows VBZ O
that IN O
shifts NNS O
in IN O
virulence NN O
can MD O
occur VB O
even RB O
through IN O
the DT O
evolution NN O
of IN O
a DT O
single JJ O
viral JJ O
clone NN O
( -LRB- O
C NNP O
- HYPH O
S8c1 NNP O
) -RRB- O
, , O
with IN O
its PRP$ O
restricted VBN O
genetic JJ O
diversity NN O
prompted VBN O
by IN O
different JJ O
replication NN O
regimes NNS O
in IN O
the DT O
same JJ O
host NN O
cells NNS O
, , O
which WDT O
also RB O
have VBP O
a DT O
clonal JJ O
origin NN O
( , O
see VBP O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
. . O

We PRP O
conjecture VBP O
that IN O
the DT O
demonstration NN O
that IN O
fitness NN O
and CC O
virulence NN O
can MD O
follow VB O
different JJ O
evolutionary JJ O
courses NNS O
has VBZ O
been VBN O
possible JJ O
thanks NNS O
to IN O
the DT O
consequences NNS O
of IN O
the DT O
extreme JJ O
passage NN O
regimes NNS O
to TO O
which WDT O
the DT O
viral JJ O
populations NNS O
were VBD O
subjected VBN O
: : O
competitive JJ O
evolution NN O
of IN O
an DT O
ample JJ O
mutant JJ O
spectra NN O
during IN O
repeated VBN O
large JJ O
population NN O
passages NNS O
, , O
and CC O
accumulation NN O
of IN O
deleterious JJ O
( , O
with IN O
regard NN O
to IN O
fitness NN O
, , O
but CC O
not RB O
with IN O
regard NN O
to IN O
virulence NN O
) , O
mutations NNS O
upon IN O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
( , O
predominance NN O
of IN O
genetic JJ O
drift NN O
and CC O
operation NN O
of IN O
Muller NNP O
' POS O
s NN O
ratchet NN O
) -RRB- O
[ -LRB- O
12 CD O
, , O
15 CD O
] -RRB- O
. . O

Implications NNS O
for IN O
Models NNPS O
of IN O
Virulence NNP O

It PRP O
must MD O
be VB O
emphasized VBN O
that IN O
fitness NN O
and CC O
virulence NN O
are VBP O
relative JJ O
values NNS O
that WDT O
pertain VBP O
to IN O
a DT O
defined VBN O
physical JJ O
and CC O
biological JJ O
environment NN O
. . O

Virulence NN O
determinants NNS O
of IN O
FMDV NNP B-Species
, , O
identified VBN O
here RB O
for IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
, , O
need VBP O
not RB O
apply VB O
to IN O
virulence NN O
for IN O
the DT O
natural JJ O
animal NN O
hosts NNS O
of IN O
FMDV NNP B-Species
[ -LRB- O
44 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
observation NN O
of IN O
a DT O
lack NN O
of IN O
correlation NN O
between IN O
fitness NN O
and CC O
virulence NN O
in IN O
a DT O
FMDV NNP B-Species
clone NN O
is VBZ O
relevant JJ O
to IN O
current JJ O
models NNS O
of IN O
attenuation NN O
and CC O
virulence NN O
, , O
since IN O
it PRP O
shows VBZ O
that IN O
more RBR O
virulent JJ O
forms NNS O
of IN O
a DT O
virus NN O
need VBP O
not RB O
have VB O
a DT O
reproductive JJ O
advantage NN O
, , O
and CC O
that IN O
viral JJ O
virulence NN O
is VBZ O
not RB O
necessarily RB O
a DT O
byproduct NN O
of IN O
viral JJ O
fitness NN O
. . O

Even RB O
if IN O
virulence NN O
is VBZ O
regarded VBN O
as IN O
an DT O
unavoidable JJ O
consequence NN O
of IN O
parasite NN O
adaptation NN O
[ -LRB- O
45 CD O
] -RRB- O
, , O
virus NN O
de FW O
- HYPH O
adaptation NN O
( , O
fitness NN O
loss NN O
) -RRB- O
need MD O
not RB O
entail VB O
a DT O
decrease NN O
of IN O
virulence NN O
. . O

Most JJS O
current JJ O
definitions NNS O
of IN O
virulence NN O
include VBP O
both DT O
the DT O
ability NN O
of IN O
the DT O
pathogen NN O
to TO O
multiply VB O
and CC O
to TO O
cause VB O
harm NN O
to IN O
its PRP$ O
host NN O
; : O
some DT O
authors NNS O
, , O
however RB O
, , O
assume VBP O
a DT O
direct JJ O
relationship NN O
between IN O
fitness NN O
and CC O
capacity NN O
to TO O
produce VB O
disease NN O
[ -LRB- O
46 CD O
- SYM O
48 CD O
] -RRB- O
. . O

In IN O
relating VBG O
the DT O
results NNS O
with IN O
FMDV NNP B-Species
to IN O
general JJ O
models NNS O
of IN O
virulence NN O
in IN O
host NN O
- HYPH O
parasite NN O
systems NNS O
, , O
it PRP O
must MD O
be VB O
considered VBN O
that IN O
in IN O
the DT O
FMDV NNP B-Species
system NN O
, , O
evolution NN O
of IN O
the DT O
host NN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
could MD O
not RB O
influence VB O
FMDV NNP B-Species
evolution NN O
, , O
because IN O
clonal JJ O
cell NN O
populations NNS O
with IN O
a DT O
controlled VBN O
passage NN O
history NN O
were VBD O
supplied VBN O
in IN O
constant JJ O
numbers NNS O
at IN O
each DT O
infection NN O
event NN O
( , O
see VB O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
. . O

Therefore RB O
, , O
changes NNS O
in IN O
host NN O
density NN O
, , O
or CC O
mobility NN O
, , O
as RB O
well RB O
as IN O
pathogen NN O
survival NN O
in IN O
the DT O
external JJ O
environment NN O
, , O
all DT O
of IN O
which WDT O
are VBP O
relevant JJ O
parameters NNS O
in IN O
virulence NN O
models NNS O
[ -LRB- O
48 CD O
, , O
49 CD O
] -RRB- O
, , O
cannot MD O
play VB O
a DT O
role NN O
in IN O
our PRP$ O
system NN O
. . O

A DT O
consistent JJ O
finding NN O
in IN O
serial JJ O
passage NN O
experiments NNS O
is VBZ O
that IN O
virulence NN O
of IN O
a DT O
parasite NN O
increases VBZ O
with IN O
passage NN O
number NN O
in IN O
a DT O
new JJ O
host NN O
[ -LRB- O
50 CD O
] -RRB- O
. . O

The DT O
results NNS O
with IN O
FMDV NNP B-Species
infecting VBG O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
cytolytically RB O
imply VBP O
that IN O
the DT O
increase NN O
of IN O
virulence NN O
can MD O
be VB O
conditioned VBN O
to IN O
the DT O
history NN O
of IN O
passage NN O
regimes NNS O
undergone VBN O
by IN O
a DT O
virus NN O
. . O

The DT O
invariance NN O
of IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
in IN O
the DT O
course NN O
of IN O
serial JJ O
cytolytic JJ O
passages NNS O
of IN O
FMDV NNP B-Species
is VBZ O
in IN O
contrast NN O
with IN O
the DT O
parallel JJ O
system NN O
consisting VBG O
of IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
persistently RB O
infected VBN O
with IN O
FMDV NNP B-Species
C NNP O
- HYPH O
S8c1 NNP O
[ -LRB- O
25 CD O
] -RRB- O
, , O
in IN O
which WDT O
the DT O
cells NNS O
are VBP O
passaged VBN O
and CC O
coevolve VBP O
with IN O
the DT O
resident JJ O
virus NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

Host NN O
- HYPH O
virus NN O
coevolution NN O
has VBZ O
generally RB O
favored VBN O
a DT O
decrease NN O
of IN O
viral JJ O
virulence NN O
in IN O
the DT O
field NN O
, , O
a DT O
classical JJ O
example NN O
being VBG O
myxoma NN B-Species
virus NN I-Species
and CC O
myxomatosis NN O
in IN O
rabbits NNS B-Species
[ -LRB- O
52 CD O
] -RRB- O
. . O

Our PRP$ O
comparison NN O
of IN O
FMDV NNP B-Species
clones NNS O
did VBD O
not RB O
provide VB O
evidence NN O
of IN O
clones NNS O
with IN O
high JJ O
fitness NN O
and CC O
low JJ O
virulence NN O
, , O
which WDT O
, , O
with IN O
regard NN O
to IN O
natural JJ O
hosts NNS O
, , O
is VBZ O
an DT O
aim NN O
of IN O
biomedicine NN O
to TO O
obtain VB O
vaccine NN O
strains NNS O
. . O

Yet CC O
, , O
the DT O
existence NN O
of IN O
specific JJ O
mutations NNS O
that WDT O
differentially RB O
affect VBP O
fitness NN O
and CC O
virulence NN O
opens VBZ O
the DT O
way NN O
to IN O
engineer NN O
candidate NN O
vaccine NN O
strains NNS O
unable JJ O
to TO O
kill VB O
the DT O
host NN O
, , O
while IN O
maintaining VBG O
replicative JJ O
competence NN O
. . O

Virulence NN O
is VBZ O
, , O
however RB O
, , O
a DT O
feature NN O
of IN O
the DT O
host NN O
- HYPH O
parasite NN O
relationship NN O
[ -LRB- O
46 CD O
] -RRB- O
, , O
and CC O
the DT O
mutations NNS O
needed VBN O
to TO O
impair VB O
virulence NN O
are VBP O
expected VBN O
to TO O
be VB O
host NN O
- HYPH O
dependent JJ O
[ -LRB- O
53 CD O
, , O
54 CD O
] -RRB- O
. . O

Materials NNS O
and CC O
Methods NNS O

Cells NNS O
, , O
viruses NNS O
, , O
and CC O
infections NNS O
. . O

The DT O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
used VBN O
in IN O
the DT O
present JJ O
study NN O
were VBD O
cloned VBN O
by IN O
end JJ O
- HYPH O
point NN O
dilution NN O
, , O
followed VBN O
by IN O
preparation NN O
of IN O
a DT O
cell NN O
stock NN O
from IN O
a DT O
single JJ O
cell NN O
; : O
they PRP O
were VBD O
passaged VBN O
a DT O
maximum NN O
of IN O
30 CD O
times NNS O
before IN O
being VBG O
used VBN O
for IN O
FMDV NNP B-Species
infection NN O
[ -LRB- O
25 CD O
, , O
51 CD O
] -RRB- O
. . O

Procedures NNS O
for IN O
cell NN O
growth NN O
, , O
infection NN O
of IN O
BHK NNP O
- HYPH O
21 CD O
cell NN O
monolayers NNS O
with IN O
FMDV NNP B-Species
in IN O
liquid JJ O
medium NN O
, , O
and CC O
plaque NN O
assays NNS O
in IN O
semi JJ O
- HYPH O
solid JJ O
agar NN O
medium NN O
were VBD O
carried VBN O
out RP O
as IN O
previously RB O
described VBN O
[ -LRB- O
11 CD O
, , O
19 CD O
, , O
25 CD O
, , O
27 CD O
] -RRB- O
. . O

Mock NNP O
- HYPH O
infected VBN O
cells NNS O
were VBD O
handled VBN O
in IN O
parallel NN O
in IN O
all DT O
infectivity NN O
and CC O
plaque NN O
assays NNS O
to TO O
monitor VB O
absence NN O
of IN O
viral JJ O
contamination NN O
. . O

The DT O
FMDVs NNPS B-Species
used VBN O
in IN O
the DT O
present JJ O
study NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
are VBP O
( , O
i PRP O
) -RRB- O
the DT O
reference NN O
clone NN O
C NN O
- HYPH O
S8c1 NNP O
, , O
which WDT O
has VBZ O
been VBN O
assigned VBN O
a DT O
relative JJ O
fitness NN O
of IN O
1 CD O
. . O
0 CD O
[ SYM O
11 CD O
] -RRB- O
. . O

( : O
ii NNP O
) NFP O
MARLS NNP O
, , O
a DT O
monoclonal JJ O
antibody NN O
escape NN O
mutant NN O
isolated VBN O
from IN O
population NN O
C NNP O
- HYPH O
S8c1p213 NNP O
[ -LRB- O
55 CD O
] -RRB- O
; : O
MARLS NNP O
has VBZ O
a DT O
fitness NN O
of IN O
25 CD O
relative JJ O
to IN O
C NN O
- HYPH O
S8c1 NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

( -LRB- O
iii NNP O
) , O
C NNP O
- HYPH O
S8p260p3d NNP O
, , O
a DT O
standard JJ O
FMDV NNP B-Species
virus NN O
rescued VBN O
by IN O
low JJ O
MOI NNP O
passage NN O
of IN O
C NN O
- HYPH O
S8p260 CD O
. . O

The DT O
latter JJ O
is VBZ O
a DT O
virus NN O
that WDT O
evolved VBD O
by IN O
passage NN O
of IN O
C NNP O
- HYPH O
S8c1 NNP O
at IN O
a DT O
high JJ O
MOI NNP O
, , O
which WDT O
resulted VBD O
in IN O
dominance NN O
of IN O
two CD O
defective JJ O
FMDV NNP B-Species
genomes NNS O
( , O
both DT O
including VBG O
internal JJ O
deletions NNS O
) , O
that WDT O
were VBD O
infectious JJ O
by IN O
complementation NN O
, , O
in IN O
the DT O
absence NN O
of IN O
standard JJ O
virus NN O
[ -LRB- O
22 CD O
, , O
24 CD O
, , O
28 CD O
] -RRB- O
; : O
C NNP O
- HYPH O
S8p260p3d NN O
has VBZ O
a DT O
relative JJ O
fitness NN O
of IN O
20 CD O
[ SYM O
24 CD O
] -RRB- O
. . O

( : O
iv IN O
) NFP O
REDpt60 NN O
, , O
obtained VBN O
after IN O
60 CD O
successive JJ O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
of IN O
RED NNP O
( : O
a DT O
monoclonal JJ O
antibody NN O
escape NN O
mutant NN O
isolated VBN O
from IN O
population NN O
C NN O
- HYPH O
S8c1p100 CD O
) -RRB- O
[ -LRB- O
20 CD O
] -RRB- O
; : O
REDpt60 NN O
has VBZ O
a DT O
fitness NN O
of IN O
1 CD O
. . O
9 CD O
relative NN O
to IN O
C NN O
- HYPH O
S8c1 NN O
. . O

( : O
v LS O
) : O
C NN O
- HYPH O
S8c1p113 CD O
, , O
a DT O
viral JJ O
population NN O
obtained VBN O
after IN O
113 CD O
serial JJ O
cytolytic JJ O
passages NNS O
of IN O
C NN O
- HYPH O
S8c1 NN O
at IN O
a DT O
high JJ O
MOI NNP O
in IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
( , O
2 CD O
x SYM O
106 CD O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
infected VBN O
with IN O
the DT O
virus NN O
contained VBN O
in IN O
200 CD O
mu NNS O
l NN O
of IN O
the DT O
supernatant NN O
from IN O
the DT O
previous JJ O
infection NN O
) -RRB- O
. . O

( NFP O
vi FW O
) FW O
Clone NNP O

, , O
a DT O
biological JJ O
clone NN O
isolated VBN O
from IN O
population NN O
C NNP O
- HYPH O
S8c1p113 NNP O
[ -LRB- O
11 CD O
] -RRB- O
; : O
its PRP$ O
relative JJ O
fitness NN O
is VBZ O
26 CD O
( , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

( -LRB- O
vii NNP O
) -RRB- O
Clone NNP O

, , O
obtained VBN O
after IN O
95 CD O
successive JJ O
plaque NN O
- HYPH O
to IN O
- HYPH O
plaque NN O
transfers NNS O
of IN O

[ -LRB- O
11 CD O
] -RRB- O
; : O
its PRP$ O
relative JJ O
fitness NN O
is VBZ O
0 CD O
. . O
11 CD O
[ SYM O
23 CD O
] -RRB- O
. . O

Cell NN O
killing NN O
assay NN O
. . O

The DT O
capacity NN O
of IN O
FMDV NNP B-Species
to TO O
kill VB O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
was VBD O
measured VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
18 CD O
, , O
22 CD O
] -RRB- O
. . O

The DT O
assay NN O
consists VBZ O
in IN O
determining VBG O
the DT O
minimum JJ O
number NN O
of IN O
PFU NNP O
required VBN O
to TO O
kill VB O
104 CD O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
after IN O
variable JJ O
times NNS O
of IN O
infection NN O
. . O

The DT O
assay NN O
was VBD O
performed VBN O
in IN O
M96 NNP O
multiwell JJ O
plates NNS O
with IN O
monolayers NNS O
of IN O
104 CD O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
per IN O
well RB O
infected VBN O
with IN O
serial JJ O
dilutions NNS O
of IN O
virus NN O
. . O

At IN O
different JJ O
times NNS O
postinfection NN O
, , O
cells NNS O
were VBD O
fixed VBN O
with IN O
2 CD O
% NN O
formaldehyde NN O
and CC O
stained VBN O
with IN O
2 CD O
% NN O
crystal NN O
violet NN O
in IN O
2 CD O
% NN O
formaldehyde NN O
. . O

Results NNS O
are VBP O
expressed VBN O
as IN O
the DT O
logarithm NN O
of IN O
the DT O
number NN O
of IN O
PFUs NNS O
needed VBN O
for IN O
complete JJ O
cell NN O
killing NN O
( , O
as IN O
judged VBN O
by IN O
cell NN O
staining VBG O
with IN O
crystal NN O
violet NN O
, , O
with IN O
series NNS O
of IN O
control NN O
wells NNS O
with IN O
known VBN O
numbers NNS O
of IN O
cells NNS O
) -RRB- O
as IN O
a DT O
function NN O
of IN O
time NN O
postinfection NN O
[ -LRB- O
18 CD O
, , O
22 CD O
] -RRB- O
. . O

Determination NN O
of IN O
relative JJ O
fitness NN O
of IN O

. . O

The DT O
relative JJ O
fitness NN O
of IN O
FMDV NNP B-Species

was VBD O
determined VBN O
by IN O
growth NN O
competition NN O
in IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
as IN O
previously RB O
described VBN O
[ -LRB- O
7 CD O
, , O
10 CD O
, , O
11 CD O
, , O
24 CD O
, , O
56 CD O
] -RRB- O
. . O

FMDV NNP B-Species

was VBD O
mixed VBN O
with IN O
appropriate JJ O
proportions NNS O
of IN O

, , O
which WDT O
was VBD O
used VBN O
as IN O
reference NN O
virus NN O
. . O

This DT O
virus NN O
has VBZ O
a DT O
fitness NN O
8 CD O
. . O
5 CD O
- HYPH O
fold NN O
higher JJR O
than IN O
that DT O
of IN O
the DT O
reference NN O
clone NN O
of IN O
C NNP O
- HYPH O
S8c1 NNP O
in IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
[ -LRB- O
7 CD O
, , O
10 CD O
, , O
11 CD O
, , O
24 CD O
, , O
56 CD O
] -RRB- O
. . O

Four CD O
serial JJ O
infections NNS O
were VBD O
carried VBN O
out RP O
at IN O
MOI NNP O
of IN O
0 CD O
. . O
1 CD O
PFU NNP O
/ SYM O
cell NN O
. . O

The DT O
proportion NN O
of IN O
the DT O
two CD O
competing VBG O
genomes NNS O
at IN O
different JJ O
passages NNS O
was VBD O
determined VBN O
by IN O
real JJ O
- HYPH O
time NN O
reverse NN O
transcription NN O
( , O
RT NNP O
) -RRB- O
- HYPH O
PCR NN O
, , O
employing VBG O
primers NNS O
5531wtnew CD O
and CC O

, , O
which WDT O
are VBP O
able JJ O
to TO O
discriminate VB O
FMDV NNP B-Species

RNA NNP O
from IN O

RNA NNP O
. . O

The DT O
nucleotide NN O
sequences NNS O
of IN O
the DT O
primers NNS O
will MD O
be VB O
provided VBN O
upon IN O
request NN O
. . O

The DT O
fitness NN O
vector NN O
obtained VBD O
for IN O

corresponded VBD O
to IN O
the DT O
equation NN O
y NN O
= NFP O
0 CD O
, , O
2060 CD O
, , O
1074x CD O
; : O
R2 CD O
= SYM O
0 CD O
. . O
9507 CD O
. . O

The DT O
antilogarithm NN O
( HYPH O
base NN O
e NN O
) -RRB- O
of IN O
the DT O
vector NN O
slope NN O
is VBZ O
the DT O
fitness NN O
of IN O
the DT O
assayed VBN O
virus NN O
relative JJ O
to IN O
the DT O
reference NN O
virus NN O
[ -LRB- O
56 CD O
] -RRB- O
. . O

cDNA NNP O
synthesis NN O
, , O
molecular JJ O
cloning NN O
, , O
and CC O
nucleotide NN O
sequencing NN O
. . O

Viral JJ O
RNA NNP O
was VBD O
extracted VBN O
by IN O
treatment NN O
with IN O
Trizol NNP O
as IN O
previously RB O
described VBN O
[ -LRB- O
57 CD O
] -RRB- O
. . O

Reverse JJ O
transcription NN O
of IN O
FMDV NNP B-Species
RNA NNP O
was VBD O
carried VBN O
out RP O
with IN O
avian JJ B-Species
myeloblastosis NN I-Species
virus NN I-Species
reverse NN O
transcriptase NN O
( , O
Promega NN O
, , O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
promega NN O
. . O
com NN O
) -RRB- O
or CC O
Transcriptor NN O
reverse JJ O
transcriptase NN O
( : O
Roche NNP O
, , O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
roche NN O
. . O
com NN O
) -RRB- O
, , O
and CC O
PCR NN O
amplification NN O
was VBD O
performed VBN O
by IN O
using VBG O
either CC O
Ampli NNP O
- HYPH O
Taq NNP O
polymerase NN O
( : O
PerkinElmer NNP O
, , O
http NNP O
: : O
/ : O
/ : O
las ADD O
. . O
perkinelmer ADD O
. . O
com NN O
) -RRB- O
or CC O
an DT O
Expand NNP O
High NNP O
Fidelity NNP O
polymerase NN O
system NN O
( -LRB- O
Roche NNP O
) -RRB- O
, , O
as IN O
instructed VBN O
by IN O
the DT O
manufacturers NNS O
. . O

The DT O
FMDV NNP B-Species
genome NN O
- HYPH O
specific JJ O
oligonucleotide NN O
primers NNS O
used VBN O
have VBP O
been VBN O
previously RB O
described VBN O
[ -LRB- O
22 CD O
, , O
58 CD O
] -RRB- O
. . O

In IN O
all DT O
RT NNP O
- HYPH O
PCR NNP O
amplifications NNS O
, , O
negative JJ O
amplification NN O
controls NNS O
, , O
including VBG O
all DT O
reaction NN O
components NNS O
except IN O
template NN O
RNA NNP O
, , O
were VBD O
run VBN O
in IN O
parallel NN O
to TO O
monitor VB O
absence NN O
of IN O
contamination NN O
. . O

Chimeric JJ O
viruses NNS O
containing VBG O
selected VBN O
regions NNS O
of IN O

in IN O
the DT O
genetic JJ O
background NN O
of IN O
C NNP O
- HYPH O
S8c1 NNP O
( -LRB- O
Figure NN O
4 CD O
) -RRB- O
were VBD O
obtained VBN O
by IN O
replacing VBG O
the DT O
corresponding VBG O
DNA NN O
fragment NN O
of IN O
pMT28 NN O
by IN O
a DT O
cDNA NN O
copy NN O
of IN O

RNA NNP O
, , O
using VBG O
specific JJ O
restriction NN O
sites NNS O
. . O

To TO O
obtain VB O
pMT28 NN O
/ , O

( : O
436 CD O
- HYPH O
2046 CD O
) -RRB- O
, , O
a DT O
chimera NN O
that WDT O
included VBD O
nucleotides NNS O
436 CD O
to IN O
2046 CD O
of IN O

( : O
the DT O
residue NN O
numbering NN O
of IN O
the DT O
FMDV NNP B-Species
genome NN O
is VBZ O
as IN O
in IN O
[ -LRB- O
11 CD O
] -RRB- O
) -RRB- O
, , O

RNA NNP O
was VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
primers NNS O
NR2 NNP O
and CC O
JH2 NNP O
, , O
and CC O
the DT O
cDNA NN O
was VBD O
digested VBN O
with IN O
Hpa NNP O
I NNP O
( -LRB- O
position NN O
436 CD O
) -RRB- O
and CC O
Xba NNP O
I NNP O
( SYM O
2046 CD O
) -RRB- O
, , O
and CC O
ligated VBD O
into IN O
pMT28 NN O
DNA NN O
digested VBN O
with IN O
the DT O
same JJ O
enzymes NNS O
. . O

To TO O
obtain VB O
pMT28 NN O
/ , O

( : O
2046 CD O
- HYPH O
3760 CD O
) -RRB- O
, , O

RNA NNP O
was VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
primers NNS O
2R1New NNP O
and CC O
pU NN O
, , O
and CC O
then RB O
the DT O
cDNA NNP O
was VBD O
digested VBN O
with IN O
Xba NNP O
I NNP O
( SYM O
2046 CD O
) -RRB- O
and CC O
Avr NNP O
II NNP O
( : O
3760 CD O
) -RRB- O
. . O

To TO O
obtain VB O
pMT28 NN O
/ , O

( : O
3760 CD O
- HYPH O
5839 CD O
) -RRB- O
, , O

RNA NNP O
was VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
primers NNS O
3R2New NNP O
and CC O
3CD1 CD O
, , O
and CC O
then RB O
the DT O
cDNA NNP O
was VBD O
digested VBN O
with IN O
Avr NNP O
II NNP O
( : O
3760 CD O
) -RRB- O
and CC O
Rsr NNP O
II NNP O
( SYM O
5839 CD O
) -RRB- O
. . O

To TO O
obtain VB O
pMT28 NN O
/ , O

( : O
5839 CD O
- HYPH O
7427 CD O
) -RRB- O
, , O

RNA NNP O
was VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
primers NNS O
5531 CD O
wt NN O
new JJ O
and CC O
C NNP O
- HYPH O
Not NNP O
- HYPH O
Pol NNP O
, , O
and CC O
then RB O
the DT O
cDNA NNP O
was VBD O
digested VBN O
with IN O
Rsr NNP O
II NNP O
( , O
5839 CD O
) -RRB- O
and CC O
Bam NNP O
HI NNP O
( SYM O
7427 CD O
) -RRB- O
. . O

To TO O
obtain VB O
pMT28 NN O
/ , O

( : O
436 CD O
- HYPH O
3760 CD O
) -RRB- O
, , O

RNA NNP O
was VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
primers NNS O
NR2 NNP O
and CC O
JH2 NNP O
, , O
and CC O
then RB O
the DT O
cDNA NNP O
was VBD O
digested VBN O
with IN O
Hpa NNP O
I NNP O
( -LRB- O
position NN O
436 CD O
) -RRB- O
and CC O
Xba NNP O
I NNP O
( SYM O
2046 CD O
) -RRB- O
, , O
and CC O
ligated VBD O
into IN O
pMT28 NN O
/ , O

( : O
2046 CD O
- HYPH O
3760 CD O
) -RRB- O
DNA NN O
digested VBN O
with IN O
the DT O
same JJ O
enzymes NNS O
. . O

To TO O
obtain VB O
pMT28 NN O
/ , O

( : O
3760 CD O
- HYPH O
7427 CD O
) -RRB- O
, , O

RNA NNP O
was VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
primers NNS O
3R2New NNP O
and CC O
3CD1 CD O
, , O
and CC O
then RB O
the DT O
cDNA NNP O
was VBD O
digested VBN O
with IN O
Avr NNP O
II NNP O
( : O
3760 CD O
) -RRB- O
and CC O
Rsr NNP O
II NNP O
( SYM O
5839 CD O
) -RRB- O
, , O
and CC O
ligated VBD O
into IN O
pMT28 NN O
/ , O

( : O
5839 CD O
- HYPH O
7427 CD O
) -RRB- O
DNA NN O
digested VBN O
with IN O
the DT O
same JJ O
enzymes NNS O
. . O

To TO O
obtain VB O
pMT28 NN O
/ , O

( : O
2046 CD O
- HYPH O
7427 CD O
) -RRB- O
, , O

RNA NNP O
was VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
primers NNS O
2R1New NNP O
and CC O
pU NN O
, , O
and CC O
then RB O
the DT O
cDNA NNP O
was VBD O
digested VBN O
with IN O
Xba NNP O
I NNP O
( SYM O
2046 CD O
) -RRB- O
and CC O
Avr NNP O
II NNP O
( : O
3760 CD O
) -RRB- O
, , O
and CC O
ligated VBD O
into IN O
pMT28 NN O
/ , O

( : O
3760 CD O
- HYPH O
7427 CD O
) -RRB- O
DNA NN O
digested VBN O
with IN O
the DT O
same JJ O
enzymes NNS O
. . O

To TO O
obtain VB O
pMT28 NN O
/ , O

( : O
436 CD O
- HYPH O
7427 CD O
) -RRB- O
, , O

RNA NNP O
was VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
primers NNS O
NR2 NNP O
and CC O
JH2 NNP O
; : O
the DT O
cDNA NNP O
was VBD O
digested VBN O
with IN O
Hpa NNP O
I NNP O
( -LRB- O
position NN O
436 CD O
) -RRB- O
and CC O
Xba NNP O
I NNP O
( SYM O
2046 CD O
) -RRB- O
, , O
and CC O
ligated VBD O
into IN O
pMT28 NN O
/ , O

( : O
2046 CD O
- HYPH O
7427 CD O
) -RRB- O
DNA NN O
digested VBN O
with IN O
the DT O
same JJ O
enzymes NNS O
. . O

To TO O
obtain VB O

/ SYM O
2C NNP O
- HYPH O
3A NN O
( , O
pMT28 CD O
) -RRB- O
, , O
pMT28 NN O
was VBD O
digested VBN O
with IN O
Bgl NNP O
II NNP O
( : O
4201 CD O
) -RRB- O
and CC O
Rsr NNP O
II NNP O
( : O
5839 CD O
) -RRB- O
, , O
and CC O
a DT O
DNA NN O
fragment NN O
including VBG O
wild JJ O
- HYPH O
type NN O
2C NNP O
- HYPH O
3A NNP O
- HYPH O
coding VBG O
region NN O
was VBD O
inserted VBN O
into IN O
pMT28 NN O
/ , O

( : O
436 CD O
- HYPH O
7427 CD O
) -RRB- O
DNA NN O
digested VBN O
with IN O
the DT O
same JJ O
enzymes NNS O
. . O

DNA NN O
ligation NN O
, , O
transformation NN O
of IN O
Escherichia NNP B-Species
coli NN I-Species
DH5 NNP O
alpha NN O
, , O
isolation NN O
of IN O
DNA NN O
from IN O
bacterial JJ O
colonies NNS O
, , O
and CC O
characterization NN O
of IN O
DNA NN O
by IN O
restriction NN O
enzyme NN O
digestion NN O
were VBD O
performed VBN O
by IN O
standard JJ O
procedures NNS O
[ -LRB- O
59 CD O
] -RRB- O
. . O

The DT O
primers NNS O
used VBN O
for IN O
molecular JJ O
cloning NN O
and CC O
site NN O
- HYPH O
directed VBN O
mutagenesis NN O
are VBP O
described VBN O
in IN O
Table NNP O
S3 NNP O
. . O

To TO O
obtain VB O
FMDV NNP B-Species
C NNP O
- HYPH O
S8c1 NNP O
containing VBG O
the DT O
mutations NNS O
found VBN O
in IN O
gene NN O
2C NN O
of IN O

, , O
plasmid NN O
pMT28 NN O
was VBD O
subjected VBN O
to IN O
site NN O
- HYPH O
directed VBN O
mutagenesis NN O
using VBG O
an DT O
oligonucleotide NN O
including VBG O
the DT O
required VBN O
nucleotide NN O
replacement NN O
, , O
and CC O
3R2New NNP O
or CC O
3CD1 CD O
as IN O
external JJ O
oligonucleotide NN O
primer NN O
( -LRB- O
Table NNP O
S3 NNP O
; : O
Figure NNP O
4 CD O
) -RRB- O
. . O

A DT O
DNA NNP O
fragment NN O
termed VBD O
A NNP O
was VBD O
obtained VBN O
by IN O
subjecting VBG O
plasmid NN O
pMT28 NN O
to IN O
site NN O
- HYPH O
directed VBN O
mutagenesis NN O
using VBG O
primers NNS O
( -LRB- O
reverse NN O
) -RRB- O
mutSNu NNP O
, , O
mutTAu NNP O
, , O
and CC O
mutQHu NNP O
( , O
to TO O
introduce VB O
mutations NNS O
S80N NNP O
, , O
T256A NNP O
, , O
and CC O
Q263H NNP O
, , O
respectively RB O
) -RRB- O
and CC O
an DT O
external JJ O
oligonucleotide NN O
primer NN O
( , O
3R2New NNP O
, , O
forward RB O
) -RRB- O
. . O

A DT O
DNA NNP O
fragment NN O
termed VBD O
B NNP O
was VBD O
obtained VBN O
amplifying VBG O
pMT28 NN O
with IN O
primers NNS O
( , O
forward RB O
) -RRB- O
mutSNd NNP O
, , O
mutTAd NN O
, , O
and CC O
mutQHd NN O
( , O
to TO O
introduce VB O
mutations NNS O
S80N NNP O
, , O
T256A NNP O
, , O
and CC O
Q263H NNP O
, , O
respectively RB O
) -RRB- O
and CC O
an DT O
external JJ O
oligonucleotide NN O
primer NN O
( , O
3CD1 CD O
, , O
reverse NN O
) -RRB- O
. . O

DNA NN O
fragments NNS O
A NN O
and CC O
B NN O
, , O
including VBG O
the DT O
desired VBN O
mutations NNS O
, , O
were VBD O
recombined VBN O
by IN O
shuffling VBG O
PCR NN O
using VBG O
equimolar JJ O
amounts NNS O
of IN O
DNA NN O
fragments NNS O
and CC O
two CD O
external JJ O
primers NNS O
( -LRB- O
3R2New NNP O
and CC O
3CD1 CD O
) -RRB- O
. . O

The DT O
DNA NN O
with IN O
the DT O
desired VBN O
mutation NN O
( , O
s VBZ O
) -RRB- O
in IN O
the DT O
2C NNP O
gene NN O
was VBD O
digested VBN O
with IN O
Avr NNP O
II NNP O
( , O
genomic JJ O
position NN O
3760 CD O
) -RRB- O
and CC O
Rsr NNP O
II NNP O
( -LRB- O
position NN O
5839 CD O
) -RRB- O
, , O
and CC O
cloned VBN O
into IN O
pMT28 NN O
to TO O
generate VB O
pMT28 NN O
( : O
SN NNP O
) -RRB- O
, , O
pMT28 NN O
( , O
TA NNP O
) -RRB- O
, , O
and CC O
pMT28 NN O
( -LRB- O
QH NNP O
) -RRB- O
. . O

To TO O
obtain VB O
pMT28 NNP O
( -LRB- O
SN NNP O
, , O
TA NNP O
, , O
QH NNP O
) -RRB- O
, , O
plasmid NN O
pMT28 NN O
( , O
SN NNP O
) -RRB- O
was VBD O
subjected VBN O
to IN O
site NN O
- HYPH O
directed VBN O
mutagenesis NN O
to TO O
introduce VB O
mutation NN O
T256A NN O
in IN O
a DT O
similar JJ O
way NN O
as IN O
described VBN O
above RB O
, , O
and CC O
then RB O
, , O
plasmid NN O
pMT28 NN O
( , O
SN NNP O
, , O
TA NNP O
) -RRB- O
was VBD O
subjected VBN O
to IN O
site NN O
- HYPH O
directed VBN O
mutagenesis NN O
to TO O
introduce VB O
mutation NN O
Q263H NN O
. . O

All DT O
chimeric JJ O
viruses NNS O
and CC O
mutants NNS O
were VBD O
analyzed VBN O
by IN O
nucleotide NN O
sequencing NN O
using VBG O
Big NNP O
Dye NNP O
Terminator NNP O
Cycle NNP O
Sequencing NNP O
kit NN O
( : O
Abi NNP O
Prism NNP O
; : O
PerkinElmer NNP O
) -RRB- O
and CC O
sequencer NN O
ABI373 NN O
as IN O
previously RB O
described VBN O
[ -LRB- O
58 CD O
] -RRB- O
. . O

Sequences NNS O
were VBD O
analyzed VBN O
using VBG O
DNASTAR NNP O
4 CD O
. . O
0 NFP O
( : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
dnastar NN O
. . O
com NN O
) -RRB- O
, , O
GeneDoc NNP O
, , O
and CC O
GCC NNP O
( , O
University NNP O
of IN O
Wisconsin NNP O
) -RRB- O
. . O

Each DT O
sequence NN O
was VBD O
determined VBN O
at IN O
least JJS O
twice RB O
, , O
with IN O
products NNS O
obtained VBN O
using VBG O
different JJ O
oligonucleotide NN O
primers NNS O
. . O

DNA NN O
from IN O
pMT28 NNP O
or CC O
its PRP$ O
recombinant JJ O
and CC O
mutant JJ O
derivatives NNS O
was VBD O
linearized VBN O
with IN O
Nde NNP O
I NNP O
and CC O
transcribed VBN O
with IN O
SP6 NNP O
RNA NNP O
polymerase NN O
as IN O
previously RB O
described VBN O
[ -LRB- O
22 CD O
, , O
27 CD O
] -RRB- O
. . O

Transcript NN O
RNA NN O
integrity NN O
and CC O
concentration NN O
were VBD O
estimated VBN O
by IN O
agarose JJ O
gel NN O
electrophoresis NN O
, , O
in IN O
parallel JJ O
runs NNS O
with IN O
known VBN O
amounts NNS O
of IN O
standard JJ O
C NNP O
- HYPH O
S8c1 NNP O
RNA NNP O
. . O

BHK NNP O
- HYPH O
21 CD O
cell NN O
monolayers NNS O
( : O
70 CD O
% NN O
confluent JJ O
, , O
about RB O
1 CD O
x SYM O
106 CD O
cells NNS O
) -RRB- O
were VBD O
transfected VBN O
with IN O
RNA NNP O
transcripts NNS O
( , O
1 CD O
mu NNS O
g NNP O
RNA NNP O
) -RRB- O
using VBG O
lipofectin NN O
as IN O
previously RB O
described VBN O
[ -LRB- O
59 CD O
] -RRB- O
. . O

Virus NNP O
was VBD O
collected VBN O
from IN O
the DT O
culture NN O
supernatant NN O
at IN O
72 CD O
h NN O
post NN O
- HYPH O
transfection NN O
. . O

The DT O
virus NN O
obtained VBN O
by IN O
transfection NN O
was VBD O
passaged VBN O
twice RB O
before IN O
using VBG O
it PRP O
in IN O
biological JJ O
studies NNS O
. . O

RNA NNP O
was VBD O
extracted VBN O
and CC O
sequenced VBN O
to TO O
ascertain VB O
that IN O
the DT O
virus NN O
maintained VBD O
the DT O
genomic JJ O
structure NN O
and CC O
mutations NNS O
of IN O
the DT O
initial JJ O
transcript NN O
. . O

Consensus NN O
genomic JJ O
nucleotide NN O
sequences NNS O
of IN O
FMDV NNP B-Species
clones NNS O
were VBD O
obtained VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
amplification NN O
of IN O
virion NN O
RNA NNP O
using VBG O
specific JJ O
primers NNS O
[ -LRB- O
7 CD O
, , O
22 CD O
, , O
28 CD O
] -RRB- O
. . O

Supporting VBG O
Information NN O

Accession NN O
Numbers NNS O

The DT O
GenBank NNP O
accession NN O
numbers NNS O
for IN O
the DT O
C NNP O
- HYPH O
S8c1 NNP O
, , O

, , O

, , O
CS8p260p3d NNP O
, , O
and CC O
MARLS NNP O
genomic JJ O
sequences NNS O
are VBP O
AJ133357 NNP O
, , O
AM409190 NNP O
, , O
AM409325 NNP O
, , O
DQ409185 NNP O
, , O
and CC O
AF274010 NNP O
, , O
respectively RB O
. . O

Nucleotide NN O
and CC O
amino NN O
acid NN O
sequences NNS O
for IN O
picornaviruses NNS O
can MD O
be VB O
found VBN O
at IN O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
iah UH O
. . O
bbsrc NN O
. . O
ac ADD O
. . O
uk NN O
/ SYM O
virus NN O
/ SYM O
picornaviridae NN O
/ SYM O
SequenceDatabase NNP O
/ SYM O
3Ddatabase NN O
/ SYM O
3D NN O
. . O
HTM NN O
. . O

Human JJ B-Species
growth NN O
hormone NN O
( -LRB- O
GH1 NNP O
) -RRB- O
gene NN O
polymorphism NN O
map NN O
in IN O
a DT O
normal JJ O
- HYPH O
statured VBN O
adult NN O
population NN O

Abstract JJ O

Objective NN O

GH1 NNP O
gene NN O
presents VBZ O
a DT O
complex JJ O
map NN O
of IN O
single JJ O
nucleotide JJ O
polymorphisms NNS O
( -LRB- O
SNPs NNPS O
) -RRB- O
in IN O
the DT O
entire JJ O
promoter NN O
, , O
coding VBG O
and CC O
noncoding JJ O
regions NNS O
. . O

The DT O
aim NN O
of IN O
the DT O
study NN O
was VBD O
to TO O
establish VB O
the DT O
complete JJ O
map NN O
of IN O
GH1 NNP O
gene NN O
SNPs NNS O
in IN O
our PRP$ O
control NN O
normal JJ O
population NN O
and CC O
to TO O
analyse VB O
its PRP$ O
association NN O
with IN O
adult NN O
height NN O
. . O

Design NN O
, , O
subjects NNS O
and CC O
measurements NNS O

A DT O
systematic JJ O
GH1 NNP O
gene NN O
analysis NN O
was VBD O
designed VBN O
in IN O
a DT O
control NN O
population NN O
of IN O
307 CD O
adults NNS O
of IN O
both DT O
sexes NNS O
with IN O
height NN O
normally RB O
distributed VBN O
within IN O
normal JJ O
range NN O
for IN O
the DT O
same JJ O
population NN O
: : O
- : O
2 CD O
standard JJ O
deviation NN O
scores NNS O
( : O
SDS NNP O
) -RRB- O
to IN O
+ SYM O
2 CD O
SDS NNS O
. . O

An DT O
analysis NN O
was VBD O
performed VBN O
on IN O
individual JJ O
and CC O
combined VBN O
genotype NN O
associations NNS O
with IN O
adult NN O
height NN O
. . O

Results NNS O

Twenty CD O
- HYPH O
five CD O
SNPs NNPS O
presented VBD O
a DT O
frequency NN O
over IN O
1 CD O
% NN O
: : O
11 CD O
in IN O
the DT O
promoter NN O
( , O
P1 NN O
to IN O
P11 NNP O
) -RRB- O
, , O
three CD O
in IN O
the DT O
5 CD O
' '' O
UTR NNP O
region NN O
( , O
P12 NN O
to IN O
P14 CD O
) -RRB- O
, , O
one CD O
in IN O
exon NN O
1 CD O
( SYM O
P15 CD O
) -RRB- O
, , O
three CD O
in IN O
intron NN O
1 CD O
( SYM O
P16 CD O
to IN O
P18 CD O
) -RRB- O
, , O
two CD O
in IN O
intron NN O
2 CD O
( SYM O
P19 CD O
and CC O
P20 NN O
) -RRB- O
, , O
two CD O
in IN O
exon NN O
4 CD O
( SYM O
P21 NN O
and CC O
P22 NN O
) -RRB- O
and CC O
three CD O
in IN O
intron NN O
4 CD O
( SYM O
P23 CD O
to IN O
P25 CD O
) -RRB- O
. . O

Twenty CD O
- HYPH O
nine CD O
additional JJ O
changes NNS O
with IN O
frequencies NNS O
under IN O
1 CD O
% NN O
were VBD O
found VBN O
in IN O
29 CD O
subjects NNS O
. . O

P8 NN O
, , O
P19 NNP O
, , O
P20 NNP O
and CC O
P25 NNP O
had VBD O
not RB O
been VBN O
previously RB O
described VBN O
. . O

P6 NNP O
, , O
P12 NNP O
, , O
P17 CD O
and CC O
P25 NN O
accounted VBD O
for IN O
6 CD O
. . O
2 CD O
% NN O
of IN O
the DT O
variation NN O
in IN O
adult NN O
height NN O
( : O
P NN O
= SYM O
0 CD O
. . O
7 CD O
) -RRB- O
in IN O
this DT O
population NN O
with IN O
genotypes NNS O
A NN O
/ SYM O
G NN O
at IN O
P6 NN O
, , O
G NNP O
/ SYM O
G NNP O
at IN O
P6 NN O
and CC O
A NN O
/ SYM O
G NN O
at IN O
P12 NN O
decreasing VBG O
height NN O
SDS NN O
( : O
- HYPH O
0 CD O
. . O
63 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
31 CD O
, , O
- HYPH O
0 CD O
. . O
693 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
350 CD O
and CC O
- HYPH O
0 CD O
. . O
489 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
265 CD O
, , O
Mean NN O
+ CC O
/ : O
- HYPH O
SE NN O
) -RRB- O
and CC O
genotypes NNS O
A NN O
/ SYM O
T NN O
at IN O
P17 NN O
and CC O
T NN O
/ SYM O
G NN O
at IN O
P25 NN O
increasing VBG O
height NN O
SDS NN O
( : O
+ SYM O
1 CD O
. . O
94 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
456 CD O
and CC O
+ SYM O
1 CD O
. . O
184 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
432 CD O
) -RRB- O
. . O

Conclusions NNS O

This DT O
study NN O
established VBD O
the DT O
GH1 NNP O
gene NN O
sequence NN O
variation NN O
map NN O
in IN O
a DT O
normal JJ O
adult NN O
height NN O
control NN O
population NN O
confirming VBG O
the DT O
high JJ O
density NN O
of IN O
SNPs NNS O
in IN O
a DT O
relatively RB O
small JJ O
gene NN O
. . O

Our PRP$ O
study NN O
shows VBZ O
that IN O
the DT O
more RBR O
frequent JJ O
SNPs NNPS O
did VBD O
not RB O
significantly RB O
contribute VB O
to IN O
height NN O
determination NN O
, , O
while IN O
only RB O
one CD O
promoter NN O
and CC O
two CD O
intronic JJ O
SNPs NNPS O
contributed VBD O
significantly RB O
to IN O
it PRP O
. . O

Studies NNS O
in IN O
larger JJR O
populations NNS O
will MD O
have VB O
to TO O
confirm VB O
the DT O
associations NNS O
and CC O
in IN O
vitro FW O
functional JJ O
studies NNS O
will MD O
elucidate VB O
the DT O
mechanisms NNS O
involved VBN O
. . O

Systematic JJ O
GH1 NN O
gene NN O
analysis NN O
in IN O
patients NNS B-Species
with IN O
growth NN O
delay NN O
and CC O
suspected VBN O
GH NN O
deficiency NN O
/ SYM O
insufficiency NN O
will MD O
clarify VB O
whether IN O
different JJ O
SNP NNP O
frequencies NNS O
and CC O
/ SYM O
or CC O
the DT O
presence NN O
of IN O
different JJ O
sequence NN O
changes NNS O
may MD O
be VB O
associated VBN O
with IN O
phenotypes NNS O
in IN O
them PRP O
. . O

Introduction NN O

Human JJ B-Species
skeletal JJ O
growth NN O
and CC O
final JJ O
height NN O
attainment NN O
are VBP O
a DT O
result NN O
of IN O
a DT O
multifactorial JJ O
regulation NN O
involving VBG O
systemic JJ O
and CC O
local JJ O
hormones NNS O
, , O
growth NN O
and CC O
nutritional JJ O
factors NNS O
, , O
lifestyle NN O
and CC O
genetic JJ O
factors NNS O
. . O

Heritability NN O
estimates1 NN O
and CC O
genome NN O
- HYPH O
wide JJ O
linkage NN O
analysis2 NN O
have VBP O
shown VBN O
that IN O
genetic JJ O
factors NNS O
play VBP O
a DT O
major JJ O
role NN O
in IN O
determining VBG O
stature NN O
. . O

Among IN O
these DT O
factors NNS O
, , O
the DT O
GH NNP O
- HYPH O
IGF NNP O
- HYPH O
I NNP O
axis VBZ O
plays VBZ O
an DT O
important JJ O
role NN O
during IN O
postnatal JJ O
life NN O
, , O
and CC O
associations NNS O
between IN O
structural JJ O
variations NNS O
in IN O
its PRP$ O
genes NNS O
and CC O
height NN O
are VBP O
currently RB O
under IN O
study NN O
. . O
3 LS O
Although IN O
growth NN O
hormone NN O
( , O
GH NN O
) -RRB- O
deficiency NN O
is VBZ O
a DT O
well RB O
- HYPH O
known VBN O
cause NN O
of IN O
growth NN O
retardation NN O
, , O
which WDT O
responds VBZ O
to IN O
GH NNP O
replacement NN O
therapy NN O
, , O
the DT O
diagnosis NN O
and CC O
physiopathological JJ O
mechanisms NNS O
for IN O
the DT O
so RB O
- HYPH O
called VBN O
' `` O
idiopathic JJ O
isolated VBN O
GH NNP O
deficiency NN O
' '' O
( : O
IIGHD NNP O
) -RRB- O
require VBP O
further JJ O
clarification NN O
. . O

In IN O
addition NN O
, , O
GH NNP O
secretion NN O
levels NNS O
and CC O
markers NNS O
of IN O
GH NN O
biological JJ O
activity NN O
have VBP O
been VBN O
demonstrated VBN O
to TO O
be VB O
specific JJ O
and CC O
sensitive JJ O
only RB O
in IN O
major JJ O
deficiency NN O
states NNS O
. , O
4 CD O
, , O
5 CD O
Genetic JJ O
causes NNS O
of IN O
GH NN O
deficiency NN O
within IN O
the DT O
GH1 NNP O
gene NN O
have VBP O
been VBN O
established VBN O
; , O
however RB O
, , O
they PRP O
are VBP O
rarely RB O
recognized VBN O
and CC O
only RB O
sought VBN O
in IN O
major JJ O
GH NNP O
deficiency NN O
states NNS O
during IN O
childhood NN O
and CC O
in IN O
family NN O
studies NNS O
. , O
3 CD O
GH1 NN O
gene NN O
, , O
located VBN O
at IN O
17q22 CD O
- HYPH O
24 CD O
, , O
is VBZ O
a DT O
component NN O
of IN O
the DT O
GH NNP O
gene NN O
cluster NN O
in IN O
which WDT O
five CD O
genes NNS O
evolving VBG O
from IN O
a DT O
common JJ O
ancestor NN O
are VBP O
91 CD O
- SYM O
99 CD O
% NN O
sequence NN O
conserved VBN O
( , O
paralogues NNS O
) -RRB- O
. , O
6 CD O
GH1 NN O
is VBZ O
more RBR O
abundantly RB O
expressed VBN O
in IN O
pituitary JJ O
cells NNS O
, , O
while IN O
the DT O
other JJ O
four CD O
genes NNS O
are VBP O
expressed VBN O
in IN O
placental JJ O
tissue NN O
. . O

Large JJ O
deletions NNS O
within IN O
the DT O
GH1 NNP O
gene NN O
cluster NN O
were VBD O
described VBN O
first RB O
followed VBN O
by IN O
point NN O
mutations NNS O
, , O
the DT O
majority NN O
of IN O
which WDT O
affect VBP O
introns NN O
3 CD O
or CC O
4 CD O
, , O
provoke VBP O
skipping NN O
of IN O
exon NN O
3 CD O
product NN O
and CC O
exert VBP O
a DT O
dominant JJ O
effect NN O
. . O
3 CD O
, , O
7 CD O
, , O
8 CD O
More RBR O
recently RB O
, , O
the DT O
presence NN O
of IN O
single JJ O
nucleotide JJ O
polymorphic JJ O
points NNS O
( -LRB- O
SNPs NNP O
) -RRB- O
in IN O
the DT O
promoter NN O
region NN O
or CC O
in IN O
intron NN O
4 CD O
of IN O
the DT O
GH1 NNP O
gene NN O
have VBP O
been VBN O
described9 VBN O
- HYPH O
12 CD O
and CC O
associations NNS O
with IN O
promoter NN O
allele NN O
activities NNS O
or CC O
with IN O
GH NN O
secretion NN O
efficacy NN O
and CC O
circulating VBG O
IGF NNP O
- HYPH O
I NN O
levels NNS O
in IN O
growth NN O
- HYPH O
retarded VBN O
patients NNS B-Species
have VBP O
also RB O
been VBN O
described VBN O
. , O
11 CD O
, , O
12 CD O
Other JJ O
studies NNS O
have VBP O
analysed VBN O
several JJ O
GH1 NNP O
gene NN O
SNP NNP O
genotypes NNS O
as IN O
related VBN O
to IN O
the DT O
incidence NN O
of IN O
neoplasia NN O
, , O
with IN O
a DT O
positive JJ O
association NN O
with IN O
colorectal JJ O
neoplasia NN O
for IN O
intron NN O
4 CD O
SNP NNP O
, , O
13 CD O
a DT O
negative JJ O
result NN O
for IN O
breast NN O
carcinoma14 NN O
, , O
15 CD O
or CC O
a DT O
positive JJ O
one CD O
for IN O
breast NN O
cancer NN O
risk NN O
. . O
16 CD O
, , O
17 CD O
In IN O
addition NN O
, , O
a DT O
recent JJ O
study NN O
in IN O
a DT O
cohort NN O
of IN O
adults NNS O
over IN O
ages NNS O
60 CD O
years NNS O
detected VBD O
a DT O
significant JJ O
association NN O
between IN O
genotypes NNS O
at IN O
one CD O
SNP NNP O
in IN O
the DT O
GH1 NNP O
gene NN O
promoter NN O
region NN O
and CC O
at IN O
the DT O
intron NN O
4 CD O
SNP NN O
described VBN O
by IN O
Hasegawa NNP O
et FW O
al NNP O
. , O
11 CD O
with IN O
baseline NN O
bone NN O
density NN O
and CC O
accelerated VBN O
bone NN O
loss NN O
together RB O
with IN O
an DT O
interaction NN O
with IN O
weight NN O
at IN O
1 CD O
year NN O
. , O
18 CD O
Intron NN O
4 CD O
SNP NN O
described VBN O
by IN O
Hasegawa NNP O
et FW O
al NNP O
. . O
11 CD O
has VBZ O
also RB O
been VBN O
associated VBN O
, , O
in IN O
women NNS B-Species
, , O
with IN O
shorter JJR O
body NN O
height NN O
and CC O
reduced VBN O
mortality NN O
, , O
19 CD O
whereas IN O
another DT O
intron NN O
4 CD O
SNP NNP O
( -LRB- O
T1169A NN O
) -RRB- O
has VBZ O
been VBN O
associated VBN O
in IN O
both DT O
sexes NNS O
with IN O
a DT O
favourable JJ O
metabolic JJ O
profile NN O
. , O
20 CD O
A DT O
systematic JJ O
SNP NNP O
study NN O
was VBD O
conducted VBN O
by IN O
Adkins NNP O
et NN O
al NNP O
. . O
21 CD O
in IN O
GH1 NN O
promoter NN O
, , O
coding VBG O
and CC O
noncoding JJ O
regions NNS O
in IN O
DNAs NNS O
from IN O
placental JJ O
tissues NNS O
, , O
and CC O
analysis NN O
of IN O
associations NNS O
between IN O
genotypes NNS O
and CC O
birth NN O
weight NN O
revealed VBD O
an DT O
association NN O
between IN O
an DT O
alternate JJ O
nucleotide NN O
at IN O
- HYPH O
1 CD O
and CC O
+ SYM O
3 CD O
of IN O
translation NN O
initiation NN O
site NN O
and CC O
fetal JJ O
growth NN O
restriction NN O
. . O

However RB O
, , O
no DT O
systematic JJ O
GH1 NN O
gene NN O
analysis NN O
in IN O
the DT O
entire JJ O
promoter NN O
, , O
coding VBG O
and CC O
noncoding JJ O
regions NNS O
has VBZ O
been VBN O
conducted VBN O
in IN O
adults NNS O
to TO O
establish VB O
the DT O
map NN O
of IN O
structural JJ O
variation NN O
and CC O
its PRP$ O
possible JJ O
association NN O
with IN O
height NN O
. . O

The DT O
relatively RB O
short JJ O
size NN O
of IN O
the DT O
entire JJ O
gene NN O
permits VBZ O
a DT O
complete JJ O
analysis NN O
which WDT O
is VBZ O
, , O
nevertheless RB O
, , O
hampered VBN O
by IN O
the DT O
need NN O
to TO O
avoid VB O
amplification NN O
of IN O
any DT O
other JJ O
of IN O
the DT O
GH NNP O
cluster NN O
genes NNS O
( , O
paralogues NNS O
) -RRB- O
and CC O
the DT O
high JJ O
density NN O
of IN O
sequence NN O
variations NNS O
. . O

To TO O
obtain VB O
normative JJ O
data NNS O
for IN O
subsequent JJ O
analysis NN O
of IN O
GH1 NNP O
gene NN O
contribution NN O
to IN O
IIGHD NN O
in IN O
children NNS B-Species
, , O
a DT O
systematic JJ O
GH1 NN O
gene NN O
structural JJ O
analysis NN O
was VBD O
designed VBN O
in IN O
a DT O
normal JJ O
adult NN O
control NN O
population NN O
to TO O
establish VB O
the DT O
GH1 NNP O
gene NN O
SNP NN O
map NN O
in IN O
adults NNS O
from IN O
our PRP$ O
population NN O
with IN O
heights NNS O
within IN O
the DT O
normal JJ O
range NN O
, , O
determine VB O
the DT O
genotype NN O
frequencies NNS O
and CC O
analyse VB O
possible JJ O
associations NNS O
between IN O
individual JJ O
and CC O
combined VBN O
SNPs NNPS O
with IN O
height NN O
. . O

Subjects NNS O
and CC O
methods NNS O

Subjects NNS O

A DT O
total NN O
of IN O
307 CD O
adult NN O
subjects NNS O
of IN O
both DT O
sexes NNS O
( , O
164 CD O
women NNS B-Species
and CC O
143 CD O
men NNS B-Species
) -RRB- O
were VBD O
recruited VBN O
from IN O
hospital NN O
personnel NNS O
and CC O
parents NNS O
of IN O
patients NNS B-Species
with IN O
no DT O
history NN O
of IN O
growth NN O
retardation NN O
. . O

Subjects NNS O
had VBD O
to TO O
fulfil VB O
the DT O
following VBG O
criteria NNS O
: : O
Iberian NNP O
Peninsular NNP O
( , O
except IN O
Basque JJ O
) -RRB- O
family NN O
origin NN O
and CC O
no DT O
family NN O
history NN O
of IN O
pathological JJ O
short JJ O
stature NN O
. . O

A DT O
single JJ O
subject NN O
per IN O
family NN O
was VBD O
included VBN O
. . O

The DT O
protocol NN O
was VBD O
approved VBN O
by IN O
the DT O
Hospital NNP O
Vall NNP O
d NNP O
' POS O
Hebron NNP O
Ethics NNP O
Committee NNP O
and CC O
written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
each DT O
participant NN B-Species
. . O

Height NN O
standard JJ O
deviation NN O
scores NNS O
( -LRB- O
height NN O
SDS NNP O
) -RRB- O
were VBD O
calculated VBN O
according VBG O
to IN O
sex NN O
- HYPH O
specific JJ O
reference NN O
growth NN O
charts NNS O
for IN O
the DT O
Spanish JJ O
population NN O
( , O
Carrascosa NNP O
et FW O
al NNP O
. , O
22 CD O
charts NNS O
were VBD O
used VBN O
for IN O
subjects NNS O
under IN O
ages NNS O
30 CD O
years NNS O
and CC O
Hern NNP O
a DT O
ndez NN O
et NN O
al NNP O
. . O
23 CD O
for IN O
subjects NNS O
aged VBN O
30 CD O
- SYM O
50 CD O
years NNS O
) -RRB- O
. . O

Only RB O
individuals NNS O
with IN O
height NN O
SDS NNP O
between IN O
- HYPH O
2 CD O
and CC O
+ SYM O
2 CD O
SDS NNS O
were VBD O
included VBN O
in IN O
the DT O
study NN O
( , O
mean JJ O
- HYPH O
0 CD O
. . O
16 CD O
; : O
32 CD O
women NNS B-Species
and CC O
28 CD O
men NNS B-Species
between IN O
- HYPH O
2 CD O
. . O
0 CD O
and CC O
- HYPH O
1 CD O
. , O
10 CD O
; : O
99 CD O
women NNS B-Species
and CC O
80 CD O
men NNS B-Species
between IN O
- HYPH O
1 CD O
. . O
0 CD O
and CC O
+ SYM O
0 CD O
. . O
910 CD O
; : O
33 CD O
women NNS B-Species
and CC O
35 CD O
men NNS B-Species
between IN O
+ SYM O
1 CD O
. . O
10 CD O
and CC O
+ SYM O
1 CD O
. . O
980 CD O
) -RRB- O
and CC O
sample NN O
size NN O
was VBD O
adjusted VBN O
for IN O
normal JJ O
sex NN O
and CC O
height NN O
SDS NN O
distribution NN O
. . O

Height NN O
and CC O
weight NN O
were VBD O
recorded VBN O
in IN O
the DT O
morning NN O
by IN O
a DT O
single JJ O
observer NN O
. . O

Height NN O
was VBD O
measured VBN O
with IN O
a DT O
Harpenden NNP O
stadiometer NN O
. . O

Four CD O
millilitres NNS O
of IN O
peripheral JJ O
venous JJ O
blood NN O
were VBD O
drawn VBN O
into IN O
EDTA NNP O
- HYPH O
containing VBG O
tubes NNS O
for IN O
molecular JJ O
genetic JJ O
analysis NN O
. . O

Genomic JJ O
DNA NNP O
study NN O

Genomic JJ O
DNA NNP O
was VBD O
obtained VBN O
from IN O
peripheral JJ O
blood NN O
following VBG O
the DT O
method NN O
described VBN O
by IN O
Lahiri NNP O
and CC O
Nurnberger NNP O
. . O
24 CD O
DNA NNP O
was VBD O
amplified VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
( -LRB- O
PCR NNP O
) -RRB- O
using VBG O
a DT O
nested VBN O
strategy NN O
. . O

Briefly RB O
, , O
50 CD O
ng NN O
of IN O
genomic JJ O
DNA NNP O
were VBD O
added VBN O
to IN O
a DT O
10 CD O
micro JJ O
l NN O
reaction NN O
mixture NN O
of IN O
1 CD O
mm NN O
Mg NNS O
( -LRB- O
OAc NNP O
) SYM O
2 CD O
, , O
0 CD O
. . O
6 CD O
mm NN O
dNTPs NNS O
, , O
0 CD O
. . O
3 CD O
micro NN O
m NN O
of IN O
each DT O
primer NN O
, , O
and CC O
0 CD O
. . O
4 CD O
U NN O
r NN O
Tth NNP O
DNA NNP O
polymerase NN O
XL NNP O
( , O
Applied NNP O
Biosystems NNP O
, , O
Foster NNP O
City NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
sense NN O
and CC O
antisense NN O
primers NNS O
used VBD O
corresponded VBN O
to IN O
nucleotides NNS O
4156 CD O
- HYPH O
5 CD O
' '' O
ACGGTCCGCCACTACGCCCA NNP O
- HYPH O
3 CD O
' '' O
and CC O
the DT O
complement NN O
of IN O
6948 CD O
- SYM O
5 CD O
' `` O
TGCAGTGAGCCAAGATTGTG NNP O
- HYPH O
3 CD O
' '' O
of IN O
the DT O
GH NNP O
gene NN O
cluster NN O
. . O
6 LS O
The DT O
PCR NNP O
reaction NN O
mix NN O
was VBD O
denatured VBN O
for IN O
5 CD O
min NN O
at IN O
94 CD O
degrees NNS O
C NN O
and CC O
cycled VBN O
40 CD O
times NNS O
( : O
94 CD O
degrees NNS O
C NN O
, , O
1 CD O
min NN O
; : O
72 CD O
degrees NNS O
C NN O
, , O
3 CD O
min NN O
30 CD O
s NNS O
) , O
followed VBN O
by IN O
a DT O
7 CD O
- HYPH O
min NN O
extension NN O
at IN O
72 CD O
degrees NNS O
C NN O
. . O

The DT O
resulting VBG O
GH1 NNP O
PCR NNP O
products NNS O
( -LRB- O
2893 CD O
bp NN O
) -RRB- O
were VBD O
used VBN O
as IN O
templates NNS O
for IN O
five CD O
nested VBN O
reactions NNS O
( , O
AN NNP O
, , O
BL NNP O
, , O
CK NNP O
, , O
DI NNP O
, , O
FP NNP O
) -RRB- O
, , O
carried VBN O
out RP O
as IN O
follows VBZ O
: : O
1 CD O
micro JJ O
l NN O
of IN O
each DT O
GH1 NNP O
PCR NNP O
product NN O
was VBD O
added VBN O
to IN O
a DT O
20 CD O
micro JJ O
l NN O
reaction NN O
mixture NN O
of IN O
1 CD O
. . O
5 CD O
mm NN O
MgCl2 CD O
, , O
0 CD O
. . O
2 CD O
mm NN O
dNTPs NNS O
, , O
0 CD O
. . O
3 CD O
micro NN O
m NN O
of IN O
each DT O
primer NN O
and CC O
0 CD O
. . O
4 CD O
U NN O
Eco NNP O
Taq NNP O
DNA NNP O
polymerase NN O
( : O
Ecogen NNP O
S NNP O
. . O
R NNP O
. . O
L NNP O
. . O
, , O
Barcelona NNP O
, , O
Spain NNP O
) -RRB- O
. . O

Reaction NN O
mixtures NNS O
were VBD O
denatured VBN O
for IN O
5 CD O
min NN O
at IN O
94 CD O
degrees NNS O
C NN O
, , O
cycled VBN O
40 CD O
times NNS O
( : O
94 CD O
degrees NNS O
C NN O
, , O
1 CD O
min NN O
; : O
58 CD O
degrees NNS O
C NN O
, , O
1 CD O
min NN O
; : O
and CC O
72 CD O
degrees NNS O
C NN O
, , O
1 CD O
min NN O
) -RRB- O
, , O
followed VBN O
by IN O
a DT O
7 CD O
- HYPH O
min NN O
extension NN O
at IN O
72 CD O
degrees NNS O
C NN O
. . O

Sense NN O
and CC O
antisense NN O
primers NNS O
were VBD O
as IN O
follows VBZ O
: : O

Sequencing VBG O
from IN O
both DT O
ends NNS O
was VBD O
performed VBN O
by IN O
the DT O
dideoxy NN O
method NN O
using VBG O
ABI NNP O
PRISM NNP O
BigDye NNP O
Terminator NNP O
version NN O
3 CD O
. . O
1 CD O
Cycle NNP O
Sequencing NNP O
Kit NNP O
( , O
Applied NNP O
Biosystems NNP O
, , O
Foster NNP O
City NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

GH1 NNP O
gene NN O
nucleotide NN O
sequence NN O
published VBN O
by IN O
Chen NNP O
et FW O
al NNP O
. . O
6 CD O
was VBD O
used VBN O
as IN O
control NN O
. . O

For IN O
each DT O
DNA NN O
, , O
the DT O
five CD O
segments NNS O
from IN O
the DT O
nested VBN O
PCR NNP O
were VBD O
assembled VBN O
with IN O
the DT O
SeqEscape NNP O
programme NN O
( , O
Applied NNP O
Biosystems NNP O
) -RRB- O
and CC O
interpretation NN O
was VBD O
made VBN O
visually RB O
and CC O
simultaneously RB O
by IN O
two CD O
observers NNS O
. . O

Antisense JJ O
sequencing NN O
was VBD O
performed VBN O
to TO O
confirm VB O
each DT O
nucleotide NN O
sequence NN O
change NN O
up IN O
to IN O
the DT O
establishment NN O
of IN O
the DT O
more RBR O
frequent JJ O
SNP NNP O
map NN O
( , O
frequency NN O
over IN O
1 CD O
% NN O
) -RRB- O
, , O
whereas IN O
less RBR O
frequent JJ O
single JJ O
or CC O
multiple JJ O
nucleotide JJ O
changes NNS O
were VBD O
reconfirmed VBN O
in IN O
each DT O
DNA NN O
by IN O
antisense NN O
sequence NN O
and CC O
resequencing NN O
after IN O
a DT O
new JJ O
nested VBN O
PCR NNP O
from IN O
original JJ O
DNA NNP O
was VBD O
performed VBN O
. . O

Single JJ O
nucleotide NN O
polymorphism NN O
( -LRB- O
SNP NNP O
) -RRB- O
genotyping NN O

The DT O
sequences NNS O
for IN O
the DT O
five CD O
genes NNS O
of IN O
the DT O
GH NNP O
cluster NN O
identified VBN O
by IN O
Chen NNP O
et FW O
al NNP O
. , O
6 CD O
and CC O
reported VBD O
as IN O
the DT O
GI NNP O
sequence NN O
183148 CD O
were VBD O
aligned VBN O
using VBG O
the DT O
Multalin NNP O
program NN O
. , O
25 CD O
SNPs NNPS O
and CC O
other JJ O
sequence NN O
changes NNS O
identified VBN O
were VBD O
indicated VBN O
using VBG O
their PRP$ O
position NN O
corresponding VBG O
to IN O
GH1 NNP O
. . O

Genotypes NNS O
were VBD O
deduced VBN O
by IN O
the DT O
combination NN O
of IN O
genetic JJ O
variation NN O
at IN O
the DT O
polymorphic JJ O
positions NNS O
. . O

Statistical JJ O
analysis NN O

Standardized JJ O
height NN O
was VBD O
investigated VBN O
for IN O
normal JJ O
distribution NN O
( : O
Kolmogorov NNP O
- HYPH O
Smirnov NNP O
test NN O
: : O
c2 CD O
= SYM O
2 CD O
. . O
882 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
4733 CD O
) -RRB- O
. . O

Hardy NNP O
- HYPH O
Weinberg NNP O
equilibrium NN O
was VBD O
tested VBN O
for IN O
SNPs NNPS O
presenting VBG O
three CD O
alternate JJ O
genotypes NNS O
according VBG O
to IN O
standard JJ O
procedures NNS O
using VBG O
chi NN O
2 CD O
- HYPH O
analysis NN O
. , O
anova NN O
test NN O
was VBD O
applied VBN O
to TO O
investigate VB O
individual JJ O
and CC O
combined VBN O
SNP NN O
association NN O
with IN O
adult NN O
height NN O
SDS NN O
; : O
significance NN O
assessment NN O
was VBD O
adjusted VBN O
for IN O
multiple JJ O
testing NN O
using VBG O
Fisher NNP O
' POS O
s NN O
PLSD NN O
test NN O
setting NN O
Pcritical NN O
= SYM O
0 CD O
. . O
5 CD O
or CC O
the DT O
Bonferroni NNP O
- HYPH O
Dunn NNP O
test NN O
setting NN O
Pcritical NN O
= SYM O
0 CD O
. . O
5 CD O
/ SYM O
n CD O
( : O
n NN O
= SYM O
number NN O
of IN O
comparisons NNS O
carried VBN O
out RP O
) -RRB- O
. . O

Stepwise JJ O
regression NN O
analysis NN O
was VBD O
applied VBN O
to TO O
predict VB O
the DT O
contribution NN O
of IN O
SNPs NNPS O
to IN O
adult NN O
height NN O
SDS NNP O
. . O

Statview NNP O
4 CD O
. . O
5 CD O
program NN O
( : O
Abacus NNP O
Concepts NNP O
Inc NNP O
. . O
, , O
Berkeley NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
was VBD O
used VBN O
for IN O
statistical JJ O
analyses NNS O
. . O

Results NNS O

GH1 NNP O
gene NN O
sequence NN O
variation NN O

GH1 NNP O
gene NN O
sequence NN O
comparison NN O
with IN O
the DT O
GI NNP O
- HYPH O
183148 CD O
sequence NN O
published VBN O
by IN O
Chen NNP O
et FW O
al NNP O
. . O
6 CD O
yielded VBD O
a DT O
total NN O
of IN O
54 CD O
single JJ O
or CC O
multiple JJ O
nucleotide JJ O
changes NNS O
. . O

Twenty CD O
- HYPH O
five CD O
SNPs NNPS O
presented VBD O
a DT O
frequency NN O
over IN O
1 CD O
% NN O
( , O
genotypes NNS O
and CC O
frequencies NNS O
are VBP O
listed VBN O
in IN O
Table NNP O
1 CD O
) -RRB- O
. . O

SNPs NNS O
which WDT O
presented VBD O
the DT O
three CD O
alternate JJ O
genotypes NNS O
( -LRB- O
P2 NN O
to IN O
P4 NNP O
, , O
P6 NNP O
, , O
P7 NNP O
, , O
P10 NNP O
and CC O
P24 CD O
) -RRB- O
were VBD O
in IN O
Hardy NNP O
- HYPH O
Weinberg NNP O
equilibrium NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Twenty CD O
- HYPH O
nine CD O
additional JJ O
changes NNS O
were VBD O
found VBN O
with IN O
a DT O
frequency NN O
under IN O
1 CD O
% NN O
or CC O
involving VBG O
more JJR O
than IN O
one CD O
nucleotide NN O
and CC O
thus RB O
could MD O
be VB O
considered VBN O
as IN O
rare JJ O
variant JJ O
SNPs NNS O
( -LRB- O
R1 CD O
to IN O
R29 CD O
) -RRB- O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

These DT O
changes NNS O
were VBD O
found VBN O
in IN O
29 CD O
of IN O
307 CD O
subjects NNS O
( : O
9 CD O
. . O
4 CD O
% NN O
) -RRB- O
, , O
all DT O
in IN O
heterozygosity NN O
. . O

GH1 NNP O
- HYPH O
paralogue NN O
alignment NN O

A DT O
sequence NN O
alignment NN O
was VBD O
performed VBN O
to TO O
study VB O
possible JJ O
sequence NN O
recombinations NNS O
among IN O
paralogues NNS O
of IN O
the DT O
five CD O
GH1 NNP O
- HYPH O
gene NN O
cluster NN O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

This DT O
alignment NN O
showed VBD O
that IN O
9 CD O
of IN O
25 CD O
SNPs NNS O
( : O
36 CD O
% NN O
) -RRB- O
in IN O
the DT O
GH1 NNP O
gene NN O
did VBD O
not RB O
correspond VB O
to IN O
any DT O
of IN O
the DT O
paralogues NNS O
. . O

Among IN O
the DT O
29 CD O
rare JJ O
SNPs NNPS O
found VBD O
, , O
six CD O
( SYM O
20 CD O
. . O
7 CD O
% NN O
) -RRB- O
did VBD O
not RB O
correspond VB O
to IN O
any DT O
of IN O
the DT O
paralogues NNS O
: : O
two CD O
were VBD O
located VBN O
in IN O
the DT O
5 CD O
' '' O
UTR NNP O
region NN O
( , O
R9 NNP O
and CC O
R10 CD O
) -RRB- O
, , O
two CD O
in IN O
intron NN O
1 CD O
( HYPH O
positions NNS O
5300 CD O
= SYM O
R14 CD O
and CC O
5302 CD O
= SYM O
R17 CD O
) -RRB- O
, , O
one CD O
in IN O
intron NN O
2 CD O
( SYM O
position NN O
5679 CD O
= SYM O
R21 CD O
) -RRB- O
and CC O
one CD O
in IN O
intron NN O
4 CD O
( SYM O
position NN O
6344 CD O
= SYM O
R23 CD O
) -RRB- O
( : O
Table NN O
2 CD O
) -RRB- O
. . O

Equivalence NN O
with IN O
previously RB O
reported VBN O
GH1 NNP O
changes NNS O

Equivalence NN O
with IN O
changes NNS O
and CC O
SNPs NNS O
previously RB O
reported VBN O
by IN O
other JJ O
authors NNS O
are VBP O
shown VBN O
in IN O
Table NNP O
3 CD O
. . O

The DT O
majority NN O
found VBD O
a DT O
high JJ O
density NN O
of IN O
SNPs NNS O
in IN O
the DT O
promoter NN O
and CC O
5 CD O
' POS O
UTR NNP O
regions NNS O
in IN O
control NN O
populations NNS O
. , O
10 CD O
, , O
12 CD O
, , O
21 CD O
Several JJ O
sequence NN O
changes NNS O
have VBP O
been VBN O
reported VBN O
in IN O
patients NNS B-Species
with IN O
familial JJ O
or CC O
idiopathic JJ O
short JJ O
stature NN O
, , O
11 CD O
, , O
26 CD O
, , O
27 CD O
whereas IN O
P8 NNP O
, , O
P19 NNP O
, , O
P20 NNP O
and CC O
P25 NNP O
( , O
at IN O
positions NNS O
5165 CD O
, , O
5681 CD O
, , O
5686 CD O
and CC O
6358 CD O
, , O
respectively RB O
, , O
in IN O
the DT O
Genebank NNP O
accession NN O
GI NNP O
183148 CD O
) -RRB- O
located VBN O
in IN O
the DT O
promoter NN O
, , O
intron NN O
2 CD O
and CC O
intron NN O
4 CD O
regions NNS O
, , O
respectively RB O
, , O
had VBD O
not RB O
been VBN O
previously RB O
described VBN O
. . O

GH1 NNP O
genotypes NNS O
and CC O
associations NNS O
with IN O
height NN O
SDS NNP O

Associations NNS O
between IN O
genotypes NNS O
and CC O
standardized VBN O
height NN O
were VBD O
first RB O
studied VBN O
in IN O
the DT O
subpopulation NN O
of IN O
278 CD O
controls NNS O
carrying VBG O
only RB O
the DT O
25 CD O
most RBS O
frequent JJ O
SNPs NNPS O
in IN O
the DT O
GH1 NNP O
gene NN O
( : O
c2 CD O
= SYM O
2 CD O
. . O
59 CD O
; : O
P NN O
= SYM O
0 CD O
. . O
5458 CD O
for IN O
normality NN O
of IN O
height NN O
distribution NN O
) -RRB- O
. . O

Three CD O
individual JJ O
SNPs NNPS O
showed VBD O
a DT O
statistically RB O
significant JJ O
association NN O
with IN O
height NN O
SDS NNP O
: : O
at IN O
positions NNS O
5286 CD O
( SYM O
P16 CD O
) -RRB- O
, , O
5290 CD O
( SYM O
P17 CD O
) -RRB- O
and CC O
6358 CD O
( SYM O
P25 CD O
) -RRB- O
. . O

Subjects NNS O
with IN O
heterozygous JJ O
genotypes NNS O
presented VBD O
statistically RB O
significant JJ O
taller JJR O
stature NN O
than IN O
the DT O
corresponding JJ O
homozygous JJ O
genotypes NNS O
( , O
P NN O
= SYM O
0 CD O
. . O
16 CD O
for IN O
P16 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
15 CD O
for IN O
P17 CD O
and CC O
P NN O
= SYM O
0 CD O
. . O
23 CD O
for IN O
P25 CD O
) -RRB- O
( : O
Fig NNP O
. . O
2a CD O
, , O
b NN O
, , O
c NN O
) -RRB- O
. . O

P16 NN O
and CC O
P17 CD O
were VBD O
in IN O
linkage NN O
disequilibrium NN O
( -LRB- O
LD NNP O
) -RRB- O
( , O
r2 CD O
= SYM O
0 CD O
. . O
831 CD O
) -RRB- O
, , O
while IN O
P25 NN O
was VBD O
carried VBN O
by IN O
six CD O
subjects NNS O
homozygous JJ O
at IN O
P16 NNP O
and CC O
P17 NN O
. . O

GH1 NNP O
gene NN O
genotypes NNS O
were VBD O
defined VBN O
by IN O
genetic JJ O
variation NN O
in IN O
the DT O
25 CD O
polymorphic JJ O
positions NNS O
. . O

We PRP O
found VBD O
163 CD O
different JJ O
combinations NNS O
. . O

Only RB O
two CD O
genotypes NNS O
presented VBD O
a DT O
frequency NN O
over IN O
5 CD O
% NN O
( -LRB- O
Table NN O
4 CD O
) -RRB- O
. . O

Height NN O
SDS NN O
in IN O
the DT O
two CD O
more JJR O
frequent JJ O
genotypes NNS O
did VBD O
not RB O
differ VB O
significantly RB O
and CC O
covered VBD O
the DT O
whole JJ O
height NN O
range NN O
. . O

Genotype NNP O
1 CD O
presented VBD O
four CD O
heterozygous JJ O
variations NNS O
and CC O
Genotype NNP O
2 CD O
was VBD O
the DT O
corresponding VBG O
homozygous JJ O
genotype NN O
. . O

Heterozygous NNP O
positions NNS O
corresponded VBD O
to IN O
SNPs NNPS O
with IN O
the DT O
highest JJS O
frequency NN O
variation NN O
( , O
4886 CD O
( SYM O
P4 CD O
) -RRB- O
, , O
5107 CD O
( SYM O
P7 CD O
) -RRB- O
, , O
5157 CD O
( SYM O
P10 CD O
) -RRB- O
and CC O
6331 CD O
( SYM O
P24 CD O
) -RRB- O
) -RRB- O
. . O

In IN O
addition NN O
, , O
DNAs NNPS O
exhibited VBD O
a DT O
different JJ O
genotype NN O
in IN O
each DT O
of IN O
129 CD O
subjects NNS O
( : O
46 CD O
. . O
4 CD O
% NN O
) -RRB- O
. . O

The DT O
11 CD O
SNPs NNPS O
found VBN O
in IN O
the DT O
promoter NN O
region NN O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
were VBD O
grouped VBN O
in IN O
94 CD O
genotypes NNS O
and CC O
analysed VBN O
for IN O
association NN O
with IN O
adult NN O
height NN O
SDS NNP O
. . O

The DT O
four CD O
more JJR O
frequent JJ O
combinations NNS O
are VBP O
listed VBN O
in IN O
Table NNP O
4 CD O
: : O
height NN O
SDS NNP O
of IN O
these DT O
four CD O
genotypes NNS O
did VBD O
not RB O
differ VB O
statistically RB O
although IN O
Genotype NNP O
3 CD O
tended VBD O
to TO O
have VB O
a DT O
shorter JJR O
height NN O
. . O

Genotype NN O
3 CD O
differed VBD O
from IN O
Genotype NNP O
1 CD O
in IN O
the DT O
SNP NNP O
located VBN O
at IN O
position NN O
5089 CD O
( SYM O
P6 CD O
) -RRB- O
, , O
corresponding VBG O
to IN O
Pit NN O
1 CD O
proximal JJ O
responsive JJ O
element NN O
for IN O
GH1 NNP O
gene NN O
promoter NN O
. . O

Genotype NNP O
4 CD O
is VBZ O
heterozygous JJ O
at IN O
positions NNS O
4856 CD O
( SYM O
P2 CD O
) -RRB- O
, , O
4863 CD O
( SYM O
P3 CD O
) -RRB- O
and CC O
5107 CD O
( SYM O
P7 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
19 CD O
% NN O
of IN O
cases NNS O
exhibited VBD O
a DT O
genotype NN O
in IN O
the DT O
promoter NN O
region NN O
carried VBN O
by IN O
only RB O
one CD O
subject NN O
. . O

Combination NN O
of IN O
the DT O
three CD O
SNPs NNS O
in IN O
the DT O
5 CD O
' '' O
UTR NNP O
region NN O
of IN O
GH1 NNP O
gene NN O
resulted VBD O
in IN O
five CD O
different JJ O
genotypes NNS O
. . O

SNPs NNS O
at IN O
positions NNS O
5178 CD O
( SYM O
P12 CD O
) -RRB- O
and CC O
5187 CD O
( SYM O
P13 CD O
) -RRB- O
were VBD O
in IN O
LD NNP O
( , O
r2 CD O
= SYM O
0 CD O
. . O
88 CD O
) -RRB- O
. . O

Mean JJ O
height NN O
SDS NNP O
comparison NN O
among IN O
these DT O
genotypes NNS O
was VBD O
not RB O
statistically RB O
significant JJ O
, , O
although IN O
mean JJ O
height NN O
SDS NNP O
of IN O
alternate JJ O
nucleotide NN O
carriers NNS O
at IN O
position NN O
5178 CD O
( SYM O
P12 CD O
) -RRB- O
tended VBD O
to TO O
be VB O
shorter JJR O
( -LRB- O
Table NN O
4 CD O
) -RRB- O
. . O

An DT O
anova NN O
analysis NN O
was VBD O
conducted VBN O
to TO O
investigate VB O
the DT O
interaction NN O
between IN O
two CD O
or CC O
more JJR O
SNPs NNS O
and CC O
height NN O
SDS NNP O
. . O

SNPs NNS O
at IN O
positions NNS O
5286 CD O
( SYM O
P16 CD O
) -RRB- O
and CC O
5290 CD O
( SYM O
P17 CD O
) -RRB- O
were VBD O
in IN O
LD NNP O
( : O
r2 CD O
= SYM O
0 CD O
. . O
83 CD O
) -RRB- O
: : O
the DT O
heterozygous JJ O
genotype NN O
AG NN O
/ , O
AT NN O
for IN O
these DT O
SNPs NNPS O
was VBD O
associated VBN O
with IN O
taller JJR O
stature NN O
( , O
shown VBN O
above RB O
) -RRB- O
. . O

SNP NNP O
at IN O
position NN O
6358 CD O
( SYM O
P25 CD O
) -RRB- O
increased VBD O
the DT O
expected JJ O
height NN O
SDS NNP O
for IN O
individual JJ O
carriers NNS O
of IN O
the DT O
G NNP O
allele NN O
at IN O
5089 CD O
( SYM O
P6 CD O
) -RRB- O
SNP NNP O
as IN O
shown VBN O
in IN O
Fig NNP O
. . O

2 CD O
( , O
d LS O
) -RRB- O
: : O
subjects NNS O
heterozygous JJ O
at IN O
6358 CD O
( SYM O
P25 CD O
) -RRB- O
were VBD O
taller JJR O
than IN O
the DT O
mean JJ O
, , O
and CC O
mean JJ O
height NN O
SDS NNS O
of IN O
subjects NNS O
with IN O
GG NNP O
/ SYM O
TG NNP O
combined VBN O
genotype NN O
was VBD O
significantly RB O
higher JJR O
than IN O
the DT O
corresponding JJ O
GG NNP O
/ SYM O
TT NNP O
genotype NN O
( : O
P NN O
= SYM O
0 CD O
. . O
21 CD O
) -RRB- O
, , O
suggesting VBG O
an DT O
interaction NN O
between IN O
these DT O
two CD O
SNPs NNS O
as IN O
they PRP O
were VBD O
not RB O
in IN O
LD NNP O
. . O

Analysis NN O
of IN O
height NN O
SDS NNP O
association NN O
with IN O
the DT O
most RBS O
frequent JJ O
single JJ O
and CC O
combined VBN O
SNPs NNPS O
and CC O
with IN O
rare JJ O
variant JJ O
SNPs NNPS O
was VBD O
performed VBN O
in IN O
the DT O
29 CD O
individuals NNS O
carrying VBG O
the DT O
rare JJ O
SNPs NNPS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

None NN O
of IN O
them PRP O
carried VBD O
any DT O
of IN O
the DT O
three CD O
SNPs NNPS O
( -LRB- O
P16 NNP O
, , O
P17 NNP O
and CC O
P25 CD O
) -RRB- O
related VBN O
to IN O
taller JJR O
stature NN O
in IN O
the DT O
population NN O
of IN O
278 CD O
controls NNS O
with IN O
only RB O
the DT O
frequent JJ O
SNPs NNPS O
. . O

In IN O
these DT O
29 CD O
, , O
mean JJ O
height NN O
SDS NNP O
( : O
0 CD O
. . O
0 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
987 CD O
, , O
from IN O
- HYPH O
1 CD O
. . O
930 CD O
to TO O
+ SYM O
1 CD O
. . O
870 CD O
) -RRB- O
did VBD O
not RB O
differ VB O
from IN O
that DT O
of IN O
the DT O
278 CD O
controls NNS O
( : O
- HYPH O
0 CD O
. . O
18 CD O
+ NFP O
/ SYM O
- HYPH O
1 CD O
. . O
41 CD O
, , O
from IN O
- HYPH O
2 CD O
. . O
0 CD O
to TO O
+ SYM O
1 CD O
. . O
980 CD O
) -RRB- O
. . O

Analysis NN O
of IN O
associations NNS O
between IN O
individual JJ O
SNP NNP O
genotypes NNS O
and CC O
height NN O
SDS NNP O
revealed VBD O
that IN O
SNPs NNS O
at IN O
positions NNS O
5089 CD O
( SYM O
P6 CD O
) -RRB- O
, , O
5178 CD O
( SYM O
P12 CD O
) -RRB- O
and CC O
5187 CD O
( SYM O
P13 CD O
) -RRB- O
were VBD O
associated VBN O
with IN O
significantly RB O
shorter JJR O
stature NN O
( : O
Fig NNP O
. . O
2e CD O
) -RRB- O
. . O

Only RB O
two CD O
sequence NN O
changes NNS O
considered VBD O
as IN O
rare JJ O
SNPs NNPS O
were VBD O
carried VBN O
by IN O
individuals NNS O
in IN O
the DT O
lower JJR O
normal JJ O
height NN O
range NN O
( , O
between IN O
- HYPH O
1 CD O
. . O
500 CD O
and CC O
- HYPH O
2 CD O
. . O
0 CD O
SDS NN O
) -RRB- O
( : O
Table NN O
2 CD O
) -RRB- O
: : O
R4 CD O
( SYM O
4979 CD O
C NN O
> : O
T NN O
) -RRB- O
in IN O
the DT O
promoter NN O
region NN O
and CC O
R14 CD O
( SYM O
5300 CD O
C NN O
> SYM O
T NN O
) -RRB- O
in IN O
intron NN O
1 CD O
. . O

Predicted VBN O
single JJ O
amino NN O
acid NN O
changes NNS O
located VBN O
in IN O
exon NN O
5 CD O
( SYM O
R25 CD O
to IN O
R27 CD O
) -RRB- O
were VBD O
not RB O
associated VBN O
with IN O
short JJ O
stature NN O
. . O

In IN O
the DT O
entire JJ O
population NN O
of IN O
307 CD O
controls NNS O
, , O
stepwise JJ O
regression NN O
analysis NN O
between IN O
height NN O
SDS NNS O
and CC O
genotypes NNS O
at IN O
the DT O
25 CD O
SNPs NNPS O
showed VBD O
that IN O
genotypes NNS O
at IN O
5089 CD O
( SYM O
P6 CD O
) -RRB- O
, , O
5178 CD O
( , O
P12 CD O
) -RRB- O
, , O
5290 CD O
( SYM O
P17 CD O
) -RRB- O
and CC O
6358 CD O
( SYM O
P25 CD O
) -RRB- O
were VBD O
significantly RB O
correlated VBN O
with IN O
height NN O
SDS NNP O
( : O
r2 CD O
= SYM O
0 CD O
. . O
62 CD O
, , O
P NN O
= SYM O
0 CD O
. . O
7 CD O
) -RRB- O
with IN O
genotypes NNS O
A NN O
/ SYM O
G NN O
at IN O
P6 NN O
, , O
G NNP O
/ SYM O
G NNP O
at IN O
P6 NN O
and CC O
A NN O
/ SYM O
G NN O
at IN O
P12 NN O
decreasing VBG O
height NN O
SDS NNP O
( : O
- HYPH O
0 CD O
. . O
63 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
31 CD O
, , O
- HYPH O
0 CD O
. . O
693 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
350 CD O
and CC O
- HYPH O
0 CD O
. . O
489 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
265 CD O
, , O
respectively RB O
, , O
Mean NNP O
+ CC O
/ : O
- HYPH O
SE NN O
) -RRB- O
and CC O
genotypes NNS O
A NN O
/ SYM O
T NN O
at IN O
P17 NN O
and CC O
T NN O
/ SYM O
G NN O
at IN O
P25 NN O
increasing VBG O
height NN O
SDS NN O
( : O
+ SYM O
1 CD O
. . O
94 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
456 CD O
and CC O
+ SYM O
1 CD O
. . O
184 CD O
+ NFP O
/ SYM O
- HYPH O
0 CD O
. . O
432 CD O
, , O
respectively RB O
) -RRB- O
. . O

Discussion NN O

Genetic JJ O
variations NNS O
within IN O
human JJ B-Species
GH1 NN O
gene NN O
have VBP O
been VBN O
described VBN O
by IN O
several JJ O
authors NNS O
. , O
9 CD O
- SYM O
12 CD O
, , O
21 CD O
The DT O
populations NNS O
described VBN O
to IN O
date NN O
comprised VBD O
small JJ O
numbers NNS O
of IN O
normal JJ O
- HYPH O
stature NN O
individuals NNS O
, , O
9 CD O
male JJ O
adults NNS O
with IN O
narrow JJ O
height NN O
range12 NN O
or CC O
growth NN O
- HYPH O
retarded VBN O
patients NNS B-Species
with IN O
/ SYM O
without IN O
GHD NNP O
before IN O
achievement NN O
of IN O
adult NN O
height NN O
. . O
9 CD O
, , O
11 CD O
, , O
12 CD O
Our PRP$ O
study NN O
was VBD O
designed VBN O
to TO O
characterize VB O
the DT O
GH1 NNP O
gene NN O
sequence NN O
variation NN O
in IN O
individuals NNS O
within IN O
the DT O
whole JJ O
range NN O
of IN O
normal JJ O
adult NN O
height NN O
( , O
between IN O
- HYPH O
2 CD O
and CC O
+ SYM O
2 CD O
SDS NN O
) , O
according VBG O
to IN O
the DT O
standards NNS O
for IN O
our PRP$ O
population NN O
. . O

Height NN O
was VBD O
normally RB O
distributed VBN O
, , O
both DT O
sexes NNS O
were VBD O
equally RB O
represented VBN O
and CC O
the DT O
GI NNP O
- HYPH O
183148 CD O
homozygous NN O
sequence6 NN O
was VBD O
used VBN O
for IN O
comparison NN O
. . O

A DT O
nested VBN O
PCR NNP O
with IN O
specific JJ O
primers NNS O
for IN O
GH1 NNP O
gene NN O
was VBD O
designed VBN O
, , O
thus RB O
avoiding VBG O
amplification NN O
of IN O
any DT O
other JJ O
GH NN O
gene NN O
paralogue NN O
of IN O
the DT O
GH NNP O
gene NN O
cluster NN O
. . O

Our PRP$ O
results NNS O
establish VBP O
a DT O
map NN O
of IN O
25 CD O
SNPs NNPS O
as IN O
present JJ O
in IN O
over IN O
1 CD O
% NN O
of IN O
individuals NNS O
, , O
whereas IN O
29 CD O
other JJ O
sequence NN O
changes NNS O
( , O
single JJ O
or CC O
multiple JJ O
nucleotide NN O
) -RRB- O
are VBP O
present JJ O
in IN O
less JJR O
than IN O
1 CD O
% NN O
of IN O
subjects NNS O
. . O

More JJR O
than IN O
50 CD O
% NN O
( , O
n CD O
= SYM O
14 CD O
) -RRB- O
of IN O
SNPs NNS O
are VBP O
located VBN O
in IN O
the DT O
promoter NN O
and CC O
5 CD O
' POS O
UTR NNP O
regions NNS O
, , O
thus RB O
confirming VBG O
previous JJ O
reports NNS O
: : O
Giordano NNP O
et FW O
al NNP O
. , O
9 CD O
reported VBD O
eight CD O
SNPs NNS O
in IN O
the DT O
promoter NN O
and CC O
5 CD O
' POS O
UTR NNP O
regions NNS O
, , O
Wagner NNP O
et FW O
al NNP O
. . O
10 CD O
16 CD O
SNPs NNPS O
from IN O
the DT O
promoter NN O
to IN O
intron NN O
1 CD O
and CC O
Horan NNP O
et FW O
al NNP O
. . O
12 CD O
identified VBD O
36 CD O
haplotypes NNS O
in IN O
control NN O
subjects NNS O
of IN O
the DT O
British JJ O
population NN O
, , O
which WDT O
would MD O
result VB O
from IN O
the DT O
combination NN O
of IN O
15 CD O
of IN O
the DT O
previously RB O
reported VBN O
SNPs NNPS O
. . O

Our PRP$ O
results NNS O
confirm VBP O
the DT O
presence NN O
of IN O
13 CD O
of IN O
those DT O
points NNS O
; : O
SNP NNP O
at IN O
5165 CD O
( SYM O
R11 CD O
in IN O
the DT O
present JJ O
study NN O
and CC O
+ SYM O
3 CD O
in IN O
references9 NN O
, , O
12 CD O
) -RRB- O
was VBD O
present JJ O
in IN O
less JJR O
than IN O
1 CD O
% NN O
of IN O
subjects NNS O
and CC O
a DT O
new JJ O
SNP NNP O
is VBZ O
described VBN O
( : O
P8 NN O
at IN O
5116 CD O
in IN O
the DT O
VDR NNP O
/ SYM O
RA NN O
/ SYM O
T3 NN O
responsive JJ O
element NN O
sequence NN O
) -RRB- O
. . O

The DT O
remaining VBG O
SNPs NNPS O
( -LRB- O
from IN O
P15 CD O
to IN O
P25 CD O
, , O
n CD O
= SYM O
11 CD O
) -RRB- O
are VBP O
distributed VBN O
in IN O
introns NNS O
1 CD O
, , O
2 CD O
and CC O
4 CD O
, , O
and CC O
among IN O
coding VBG O
regions NNS O
only RB O
exon NN O
1 CD O
and CC O
exon NN O
4 CD O
bear VBP O
a DT O
total NN O
of IN O
three CD O
SNPs NNS O
, , O
two CD O
of IN O
which WDT O
predict VBP O
an DT O
amino NN O
acid NN O
change NN O
( -LRB- O
P15 NN O
and CC O
P21 NN O
) -RRB- O
. . O

These DT O
two CD O
latter JJ O
SNPs NNS O
had VBD O
been VBN O
described VBN O
by IN O
Millar NNP O
et FW O
al NNP O
. . O
26 CD O
and CC O
the DT O
more RBR O
frequent JJ O
SNP NNP O
in IN O
intron NN O
4 CD O
( SYM O
P24 CD O
) -RRB- O
has VBZ O
been VBN O
described VBN O
by IN O
Hasegawa NNP O
et FW O
al NNP O
. . O
11 CD O
together RB O
with IN O
the DT O
two CD O
more JJR O
frequent JJ O
SNPs NNPS O
in IN O
the DT O
promoter NN O
region NN O
( : O
P4 NN O
and CC O
P7 NN O
in IN O
our PRP$ O
map NN O
) -RRB- O
. . O

Three CD O
new JJ O
SNPs NNS O
are VBP O
described VBN O
( : O
P19 NN O
and CC O
P20 NN O
in IN O
intron NN O
2 CD O
and CC O
P25 NN O
in IN O
intron NN O
4 CD O
) -RRB- O
, , O
all DT O
outside IN O
the DT O
splice NN O
sites NNS O
. . O

Only RB O
SNPs NNPS O
presenting VBG O
high JJ O
frequency NN O
are VBP O
present JJ O
in IN O
homozygous JJ O
alternate JJ O
state NN O
and CC O
this DT O
accounts NNS O
mostly RB O
for IN O
the DT O
majority NN O
of IN O
the DT O
promoter NN O
and CC O
5 CD O
' '' O
UTR NNP O
SNPs NNPS O
and CC O
in IN O
the DT O
intron NN O
4 CD O
more JJR O
frequent JJ O
SNP NNP O
( , O
P24 CD O
) -RRB- O
described VBN O
by IN O
Hasegawa NNP O
et FW O
al NNP O
. . O
11 CD O
In IN O
conclusion NN O
, , O
in IN O
the DT O
entire JJ O
coding VBG O
and CC O
noncoding JJ O
GH1 NN O
gene NN O
sequence NN O
, , O
only RB O
P24 NN O
is VBZ O
present JJ O
in IN O
homozygous JJ O
alternate JJ O
state NN O
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
the DT O
GI NNP O
183148 CD O
homozygous NN O
sequence NN O
is VBZ O
present JJ O
in IN O
our PRP$ O
population NN O
except IN O
for IN O
SNP NNP O
P14 NNP O
in IN O
the DT O
5 CD O
' '' O
UTR NNP O
region NN O
which WDT O
is VBZ O
only RB O
present JJ O
as IN O
the DT O
alternate JJ O
nucleotide NN O
in IN O
homozygous JJ O
or CC O
heterozygous JJ O
states NNS O
. . O

As IN O
described VBN O
by IN O
several JJ O
authors9 NN O
, , O
10 CD O
, , O
12 CD O
, , O
21 CD O
several JJ O
promoter NN O
SNPs NNS O
affected VBD O
functional JJ O
sequences NNS O
and CC O
P6 NN O
is VBZ O
located VBN O
in IN O
the DT O
Pit NNP O
1 CD O
proximal JJ O
responsive JJ O
element NN O
, , O
P7 NN O
and CC O
P8 NN O
in IN O
the DT O
VDR NNP O
/ SYM O
RA NNP O
/ SYM O
T3 NN O
responsive JJ O
element NN O
and CC O
P9 NN O
( HYPH O
G NNP O
del NN O
) -RRB- O
in IN O
the DT O
TATA NNP O
box NN O
. . O

The DT O
mechanisms NNS O
by IN O
which WDT O
the DT O
high JJ O
density NN O
of IN O
SNPs NNS O
in IN O
the DT O
GH1 NNP O
gene NN O
is VBZ O
generated VBN O
has VBZ O
been VBN O
proposed VBN O
to TO O
be VB O
recombination NN O
and CC O
gene NN O
conversion NN O
with IN O
any DT O
other JJ O
( , O
s NNP O
) -RRB- O
of IN O
the DT O
GH NNP O
cluster NN O
genes NNS O
. , O
9 CD O
, , O
12 CD O
, , O
28 CD O
Alignment NNP O
of IN O
the DT O
25 CD O
SNPs NNPS O
with IN O
the DT O
other JJ O
GH1 NNP O
gene NN O
paralogues NNS O
demonstrated VBN O
in IN O
our PRP$ O
results NNS O
that IN O
this DT O
mechanism NN O
is VBZ O
possible JJ O
for IN O
64 CD O
% NN O
of IN O
SNPs NNPS O
. . O

Familial JJ O
SNP NNP O
transmission NN O
pattern NN O
analysis NN O
will MD O
be VB O
of IN O
interest NN O
to TO O
support VB O
the DT O
hypothesis NN O
of IN O
GH NNP O
gene NN O
recombination NN O
. . O

In IN O
addition NN O
, , O
29 CD O
of IN O
307 CD O
individuals NNS O
( , O
9 CD O
. . O
4 CD O
% NN O
) -RRB- O
bore VBD O
additional JJ O
GH1 NN O
sequence NN O
changes NNS O
with IN O
frequencies NNS O
under IN O
1 CD O
% NN O
. . O

As IN O
for IN O
SNPs NNPS O
, , O
they PRP O
are VBP O
located VBN O
along IN O
the DT O
whole JJ O
gene NN O
with IN O
higher JJR O
density NN O
in IN O
the DT O
promoter NN O
and CC O
5 CD O
' POS O
UTR NNP O
regions NNS O
. . O

Interestingly RB O
, , O
intron NN O
3 CD O
and CC O
exon NN O
5 CD O
present VBP O
several JJ O
of IN O
these DT O
less JJR O
frequent JJ O
changes NNS O
. . O

Intron NNP O
3 CD O
has VBZ O
been VBN O
shown VBN O
to TO O
carry VB O
the DT O
majority NN O
of IN O
single JJ O
nucleotide NN O
mutations NNS O
causing VBG O
the DT O
dominant JJ O
form NN O
of IN O
GH NN O
deficiency NN O
. , O
3 LS O
The DT O
two CD O
single JJ O
nucleotide JJ O
changes NNS O
detected VBN O
in IN O
intron NN O
3 CD O
( SYM O
R15 CD O
at IN O
6056 CD O
and CC O
R16 CD O
at IN O
6061 CD O
) -RRB- O
are VBP O
in IN O
perfect JJ O
LD NNP O
( , O
r2 CD O
= SYM O
1 CD O
. . O
0 CD O
) -RRB- O
and CC O
located VBN O
within IN O
the DT O
enhancer NN O
splice NN O
site NN O
element NN O
( -LRB- O
ESE NNP O
) -RRB- O
described VBN O
by IN O
Ryther NNP O
et FW O
al NNP O
. . O
29 CD O
, , O
30 CD O
Studies NNS O
in IN O
additional JJ O
normal JJ O
or CC O
growth NN O
- HYPH O
retarded VBN O
populations NNS O
will MD O
permit VB O
description NN O
of IN O
their PRP$ O
possible JJ O
clinical JJ O
implications NNS O
. . O

Five CD O
single JJ O
nucleotide NN O
changes NNS O
are VBP O
located VBN O
in IN O
exon NN O
5 CD O
; , O
of IN O
these DT O
five CD O
, , O
three CD O
predict VBP O
an DT O
amino JJ O
acid NN O
change NN O
, , O
and CC O
one CD O
of IN O
the DT O
three CD O
( , O
Ile179Met NNP O
) -RRB- O
has VBZ O
been VBN O
described VBN O
by IN O
Lewis NNP O
et FW O
al NNP O
. . O
27 CD O
in IN O
a DT O
paediatric JJ O
patient NN B-Species
with IN O
familial JJ O
short JJ O
stature NN O
and CC O
the DT O
other JJ O
two CD O
, , O
as RB O
yet RB O
undescribed JJ O
, , O
are VBP O
contiguous JJ O
in IN O
a DT O
single JJ O
individual NN O
( -LRB- O
Pro133Hys NNPS O
and CC O
Arg134Leu NNP O
) -RRB- O
. . O

Polynucleotide NN O
changes NNS O
are VBP O
mostly RB O
located VBN O
in IN O
the DT O
promoter NN O
region NN O
corresponding VBG O
to IN O
the DT O
VDR NNP O
/ SYM O
RA NNP O
/ SYM O
T3 NN O
response NN O
element NN O
. . O

As IN O
for IN O
frequent JJ O
SNPs NNPS O
, , O
the DT O
majority NN O
of IN O
the DT O
sequence NN O
changes NNS O
with IN O
frequencies NNS O
under IN O
1 CD O
% NN O
may MD O
have VB O
been VBN O
generated VBN O
by IN O
recombination NN O
within IN O
the DT O
GH NNP O
gene NN O
cluster NN O
as IN O
19 CD O
of IN O
24 CD O
( SYM O
79 CD O
% NN O
) -RRB- O
may MD O
correspond VB O
to IN O
one CD O
or CC O
more JJR O
of IN O
the DT O
GH1 NNP O
gene NN O
paralogues NNS O
. . O

Our PRP$ O
results NNS O
now RB O
show VBP O
the DT O
diversity NN O
and CC O
complexity NN O
of IN O
SNP NNP O
genotypes NNS O
, , O
as IN O
previously RB O
highlighted VBN O
by IN O
other JJ O
authors9 NN O
, , O
10 CD O
, , O
12 CD O
, , O
21 CD O
in IN O
a DT O
normal JJ O
adult NN O
height NN O
control NN O
population NN O
. . O

Our PRP$ O
initial JJ O
aim NN O
when WRB O
designing VBG O
the DT O
present JJ O
study NN O
was VBD O
to TO O
establish VB O
the DT O
map NN O
of IN O
GH1 NNP O
gene NN O
SNPs NNS O
in IN O
our PRP$ O
adult NN O
control NN O
population NN O
with IN O
heights NNS O
normally RB O
distributed VBN O
within IN O
the DT O
entire JJ O
normal JJ O
range NN O
for IN O
further JJ O
comparison NN O
with IN O
genotypes NNS O
in IN O
our PRP$ O
paediatric JJ O
population NN O
with IN O
growth NN O
delay NN O
, , O
variable JJ O
response NN O
to IN O
GH NN O
secretion NN O
tests NNS O
and CC O
adequate JJ O
response NN O
to IN O
GH NNP O
therapy NN O
. . O

Analysis NN O
of IN O
SNP NNP O
association NN O
with IN O
adult NN O
height NN O
was VBD O
subsequently RB O
performed VBN O
to TO O
establish VB O
a DT O
body NN O
of IN O
knowledge NN O
useful JJ O
for IN O
comparing VBG O
patient NN B-Species
genotypes NNS O
and CC O
phenotypes NNS O
. . O

This DT O
analysis NN O
was VBD O
first RB O
performed VBN O
in IN O
controls NNS O
bearing VBG O
only JJ O
frequent JJ O
SNPs NNPS O
( : O
90 CD O
. . O
5 CD O
% NN O
of IN O
the DT O
total JJ O
population NN O
) -RRB- O
. . O

We PRP O
demonstrate VBP O
that IN O
the DT O
four CD O
SNPs NNPS O
with IN O
the DT O
highest JJS O
allelic JJ O
variation NN O
frequencies NNS O
( -LRB- O
P4 NNP O
, , O
P7 NNP O
, , O
P10 NNP O
and CC O
P24 NN O
) -RRB- O
do VBP O
not RB O
significantly RB O
contribute VB O
to IN O
adult NN O
height NN O
determination NN O
, , O
with IN O
the DT O
heterozygous JJ O
genotype NN O
being VBG O
the DT O
most RBS O
frequent JJ O
followed VBN O
by IN O
the DT O
corresponding VBG O
homozygous JJ O
genotype NN O
in IN O
the DT O
whole JJ O
sequence NN O
, , O
and CC O
heights NNS O
are VBP O
normally RB O
distributed VBN O
over IN O
the DT O
entire JJ O
height NN O
range NN O
. . O

The DT O
third JJ O
most RBS O
frequent JJ O
combined VBN O
genotype NN O
in IN O
the DT O
promoter NN O
region NN O
in IN O
our PRP$ O
population NN O
presented VBD O
, , O
in IN O
addition NN O
, , O
in IN O
heterozygosity NN O
, , O
the DT O
SNP NNP O
at IN O
P6 NN O
in IN O
the DT O
sequence NN O
regulated VBN O
by IN O
Pit NNP O
1 CD O
and CC O
although IN O
mean JJ O
height NN O
of IN O
individuals NNS O
( , O
6 CD O
. . O
1 CD O
% NN O
) -RRB- O
bearing VBG O
this DT O
genotype NN O
was VBD O
around IN O
- HYPH O
0 CD O
. . O
5 CD O
SDS NN O
, , O
this DT O
was VBD O
not RB O
statistically RB O
significant JJ O
. . O

Analysis NN O
of IN O
single JJ O
SNP NNP O
genotype NN O
association NN O
with IN O
adult NN O
height NN O
yielded VBD O
few JJ O
clues NNS O
as IN O
to IN O
the DT O
contribution NN O
of IN O
GH1 NNP O
gene NN O
variation NN O
to IN O
adult NN O
height NN O
determination NN O
. . O

Only RB O
three CD O
SNPs NNPS O
( -LRB- O
P16 NNP O
, , O
P17 NNP O
and CC O
P25 CD O
) -RRB- O
, , O
present JJ O
with IN O
low JJ O
frequency NN O
and CC O
only RB O
in IN O
heterozygous JJ O
state NN O
, , O
were VBD O
individually RB O
significantly RB O
associated VBN O
with IN O
taller JJR O
stature NN O
and CC O
none NN O
was VBD O
individually RB O
associated VBN O
with IN O
shorter JJR O
stature NN O
. . O

P16 NN O
and CC O
P17 CD O
( , O
in IN O
LD NNP O
, , O
r2 CD O
= SYM O
0 CD O
. . O
83 CD O
) -RRB- O
are VBP O
located VBN O
in IN O
intron NN O
1 CD O
and CC O
P25 NN O
in IN O
intron NN O
4 CD O
. . O

The DT O
resulting VBG O
sequence NN O
for IN O
the DT O
presence NN O
of IN O
P16 NNP O
and CC O
P17 NNP O
corresponded VBD O
to IN O
the DT O
paralogue NN O
GH2 NNP O
and CC O
generated VBD O
a DT O
responsive JJ O
element NN O
for IN O
a DT O
core NN O
- HYPH O
binding VBG O
protein NN O
( , O
Matinspector NNP O
Programme NNP O
, , O
Geometrix NNP O
Software NNP O
GmbH NNP O
, , O
M NNP O
u NNP O
nchen NNP O
, , O
Germany NNP O
) , O
with IN O
three CD O
Kruppel NNP O
- HYPH O
type NN O
zinc NN O
fingers NNS O
which WDT O
could MD O
increase VB O
the DT O
efficacy NN O
of IN O
GH1 NNP O
gene NN O
transcription NN O
; : O
31 CD O
, , O
32 CD O
moreover RB O
, , O
Kruppel NNP O
- HYPH O
like JJ O
proteins NNS O
have VBP O
recently RB O
been VBN O
described VBN O
in IN O
the DT O
brain NN O
. . O
33 CD O
Stepwise JJ O
regression NN O
analysis NN O
demonstrated VBD O
that IN O
P17 NNP O
and CC O
P25 NNP O
contribute VBP O
, , O
separately RB O
, , O
to IN O
an DT O
increase NN O
of IN O
almost RB O
1 CD O
. . O
0 CD O
height NN O
SDS NN O
. . O

P16 NN O
and CC O
P17 CD O
had VBD O
been VBN O
described VBN O
by IN O
Adkins NNP O
et FW O
al NNP O
. . O
21 CD O
although IN O
they PRP O
found VBD O
no DT O
association NN O
with IN O
fetal JJ O
growth NN O
, , O
whereas IN O
P25 NN O
had VBD O
not RB O
previously RB O
been VBN O
described VBN O
. . O

The DT O
mechanisms NNS O
by IN O
which WDT O
they PRP O
may MD O
determine VB O
taller JJR O
final JJ O
height NN O
should MD O
be VB O
established VBN O
by IN O
in FW O
vitro FW O
studies NNS O
analysing VBG O
GH1 NN O
gene NN O
transcription NN O
and CC O
GH NN O
protein NN O
translation NN O
efficiencies NNS O
. . O

Analysis NN O
of IN O
interaction NN O
effect NN O
between IN O
SNPs NNPS O
detected VBD O
that IN O
variation NN O
at IN O
P25 NNP O
masked VBD O
an DT O
effect NN O
of IN O
P6 NNP O
. . O

Individuals NNS O
homozygous JJ O
at IN O
P25 NNP O
( -LRB- O
TT NNP O
) -RRB- O
present VBP O
a DT O
significant JJ O
association NN O
between IN O
P6 NN O
genotype NN O
and CC O
height NN O
with IN O
the DT O
homozygous JJ O
alternate JJ O
genotype NN O
at IN O
P6 NNP O
( -LRB- O
GG NNP O
) -RRB- O
being VBG O
associated VBN O
with IN O
shorter JJR O
stature NN O
. . O

This DT O
was VBD O
further RB O
confirmed VBN O
in IN O
the DT O
subpopulation NN O
of IN O
29 CD O
individuals NNS O
bearing VBG O
rare JJ O
SNPs NNPS O
who WP O
, , O
in IN O
the DT O
absence NN O
of IN O
heterozygous JJ O
change NN O
at IN O
P25 NNP O
, , O
presented VBD O
significantly RB O
shorter JJR O
stature NN O
in IN O
the DT O
heterozygous JJ O
alternate JJ O
nucleotide NN O
change NN O
at IN O
P6 NNP O
( -LRB- O
AG NNP O
) -RRB- O
. . O

P6 NN O
, , O
located VBN O
at IN O
Pit NN O
1 CD O
proximal JJ O
responsive JJ O
element NN O
of IN O
the DT O
GH1 NNP O
gene NN O
promoter NN O
, , O
was VBD O
first RB O
described VBN O
by IN O
Wagner NNP O
et FW O
al NNP O
. . O
10 CD O
and CC O
Giordano NNP O
et FW O
al NNP O
. . O
9 CD O
and CC O
further RB O
by IN O
Horan NNP O
et FW O
al NNP O
. . O
12 CD O
Six CD O
of IN O
nine CD O
GH1 CD O
gene NN O
promoter NN O
haplotypes NNS O
bearing VBG O
the DT O
alternate NN O
G NN O
at IN O
P6 NN O
presented VBD O
lower JJR O
transcriptional JJ O
activities NNS O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
( -LRB- O
EMSA NNP O
) -RRB- O
detected VBN O
differential JJ O
protein NN O
binding VBG O
strength NN O
, , O
although IN O
in IN O
vitro FW O
studies NNS O
were VBD O
unable JJ O
to TO O
identify VB O
this DT O
SNP NNP O
as IN O
a DT O
major JJ O
determinant NN O
of IN O
GH1 NNP O
gene NN O
expression NN O
level NN O
. . O
12 CD O
A DT O
recent JJ O
study NN O
from IN O
Giordano NNP O
et FW O
al NNP O
. . O
34 CD O
has VBZ O
shown VBN O
a DT O
twofold JJ O
reduced VBN O
luciferase JJ O
activity NN O
for IN O
the DT O
G NNP O
nucleotide NN O
bearing NN O
promoter NN O
haplotype NN O
in IN O
transfected VBN O
rat JJ B-Species
pituitary NN O
cells NNS O
. . O

Genotypes NNS O
at IN O
P6 NN O
had VBD O
also RB O
been VBN O
associated VBN O
with IN O
decreased VBN O
breast NN O
cancer NN O
risk NN O
through IN O
its PRP$ O
association NN O
with IN O
lower JJR O
GH NN O
secretion NN O
and CC O
IGF NNP O
- HYPH O
I PRP O
circulating VBG O
levels NNS O
. . O
16 CD O
, , O
17 CD O

In IN O
our PRP$ O
results NNS O
, , O
GH1 NNP O
gene NN O
polymorphic JJ O
structural JJ O
variation NN O
accounted VBD O
for IN O
only RB O
6 CD O
. . O
2 CD O
% NN O
of IN O
adult NN O
height NN O
determination NN O
in IN O
the DT O
entire JJ O
adult NN O
population NN O
studied VBN O
and CC O
genome NN O
- HYPH O
wide JJ O
linkage NN O
analysis NN O
of IN O
stature NN O
in IN O
multiple JJ O
populations NNS O
revealed VBN O
no DT O
linkage NN O
with IN O
chromosome NN O
17 CD O
GH NN O
gene NN O
cluster NN O
. . O
2 CD O
, , O
35 CD O
As IN O
only RB O
some DT O
of IN O
the DT O
less JJR O
frequent JJ O
SNPs NNS O
are VBP O
statistically RB O
associated VBN O
with IN O
height NN O
, , O
and CC O
in IN O
view NN O
of IN O
the DT O
high JJ O
density NN O
of IN O
SNPs NNS O
, , O
our PRP$ O
study NN O
may MD O
be VB O
hampered VBN O
by IN O
selection NN O
bias36 NN O
and CC O
would MD O
ideally RB O
have VB O
required VBN O
a DT O
wider JJR O
sampling NN O
of IN O
some DT O
2 CD O
0 CD O
individuals NNS O
; : O
however RB O
, , O
this DT O
was VBD O
a DT O
highly RB O
laborious JJ O
strategy NN O
when WRB O
the DT O
complete JJ O
sequencing NN O
technique NN O
is VBZ O
applied VBN O
. . O

The DT O
high JJ O
density NN O
of IN O
SNPs NNPS O
and CC O
their PRP$ O
proximity NN O
hamper VBP O
other JJ O
genotyping JJ O
strategies NNS O
for IN O
rapid JJ O
determination NN O
of IN O
the DT O
complete JJ O
GH1 NNP O
SNP NNP O
map NN O
in IN O
large JJ O
control NN O
and CC O
patient JJ B-Species
populations NNS O
. . O

Individual JJ O
SNP NNP O
associations NNS O
with IN O
height NN O
or CC O
other JJ O
GH NN O
secretion NN O
- HYPH O
related VBN O
phenotypic JJ O
traits NNS O
will MD O
require VB O
further JJ O
confirmation NN O
by IN O
studies NNS O
in IN O
larger JJR O
populations NNS O
and CC O
by IN O
in FW O
vitro FW O
functional JJ O
studies NNS O
. . O

In IN O
conclusion NN O
, , O
our PRP$ O
study NN O
established VBD O
the DT O
GH1 NNP O
gene NN O
sequence NN O
variation NN O
map NN O
in IN O
an DT O
adult NN O
control NN O
population NN O
with IN O
heights NNS O
normally RB O
distributed VBN O
within IN O
the DT O
normal JJ O
range NN O
. . O

SNPs NNS O
and CC O
other JJ O
sequence NN O
change NN O
contributions NNS O
to IN O
skeletal JJ O
growth NN O
as IN O
observed VBN O
at IN O
adult NN O
height NN O
demonstrated VBD O
that IN O
, , O
despite IN O
the DT O
high JJ O
frequency NN O
of IN O
variation NN O
and CC O
diversity NN O
and CC O
complexity NN O
of IN O
combinations NNS O
, , O
only RB O
some DT O
of IN O
the DT O
less JJR O
frequent JJ O
SNPs NNPS O
were VBD O
associated VBN O
with IN O
taller JJR O
stature NN O
( : O
P17 NN O
in IN O
intron NN O
1 CD O
and CC O
P25 NN O
in IN O
intron NN O
4 CD O
) -RRB- O
, , O
even RB O
masking VBG O
the DT O
SNP NNP O
contribution NN O
to IN O
a DT O
shorter JJR O
one CD O
( HYPH O
P6 NN O
in IN O
the DT O
promoter NN O
and CC O
P12 NN O
in IN O
the DT O
5 CD O
' '' O
UTR NNP O
regions NNS O
, , O
respectively RB O
) -RRB- O
. . O

Systematic JJ O
GH1 NN O
gene NN O
analysis NN O
in IN O
patients NNS B-Species
with IN O
growth NN O
delay NN O
and CC O
suspected VBN O
GH NN O
deficiency NN O
/ SYM O
insufficiency NN O
will MD O
clarify VB O
whether IN O
different JJ O
SNP NNP O
frequencies NNS O
and CC O
/ SYM O
or CC O
the DT O
presence NN O
of IN O
different JJ O
sequence NN O
changes NNS O
may MD O
be VB O
associated VBN O
with IN O
phenotypes NNS O
in IN O
them PRP O
. . O

Elevated JJ O
Blood NN O
Lead NN O
Levels NNS O
of IN O
Children NNS B-Species
in IN O
Guiyu NNP O
, , O
an DT O
Electronic NNP O
Waste NNP O
Recycling NNP O
Town NNP O
in IN O
China NNP O

Abstract JJ O

Background NN O

Electronic JJ O
waste NN O
( , O
e IN O
- HYPH O
waste NN O
) , O
recycling NN O
has VBZ O
remained VBN O
primitive JJ O
in IN O
Guiyu NNP O
, , O
China NNP O
, , O
and CC O
thus RB O
may MD O
contribute VB O
to IN O
the DT O
elevation NN O
of IN O
blood NN O
lead NN O
levels NNS O
( , O
BLLs NNS O
) -RRB- O
in IN O
children NNS B-Species
living VBG O
in IN O
the DT O
local JJ O
environment NN O
. . O

Objectives NNS O

We PRP O
compared VBD O
the DT O
BLLs NNS O
in IN O
children NNS B-Species
living VBG O
in IN O
the DT O
e JJ O
- HYPH O
waste NN O
recycling NN O
town NN O
of IN O
Guiyu NNP O
with IN O
those DT O
living VBG O
in IN O
the DT O
neighboring VBG O
town NN O
of IN O
Chendian NNP O
. . O

Methods NNS O

We PRP O
observed VBD O
the DT O
processing NN O
of IN O
e NN O
- HYPH O
waste NN O
recycling NN O
in IN O
Guiyu NNP O
and CC O
studied VBD O
BLLs NNS O
in IN O
a DT O
cluster NN O
sample NN O
of IN O
226 CD O
children NNS B-Species
< SYM O
6 CD O
years NNS O
of IN O
age NN O
who WP O
lived VBD O
in IN O
Guiyu NNP O
and CC O
Chendian NNP O
. . O

BLLs NNS O
were VBD O
determined JJ O
with IN O
atomic JJ O
absorption NN O
spectrophotometry NN O
. . O

Hemoglobin NNP O
( , O
Hgb NNP O
) -RRB- O
and CC O
physical JJ O
indexes NNS O
( , O
height NN O
and CC O
weight NN O
, , O
head NN O
and CC O
chest NN O
circumferences NNS O
) -RRB- O
were VBD O
also RB O
measured VBN O
. . O

Results NNS O

BLLs NNS O
in IN O
165 CD O
children NNS B-Species
of IN O
Guiyu NNP O
ranged VBD O
from IN O
4 CD O
. . O
40 CD O
to IN O
32 CD O
. . O
67 CD O
mu NN O
g NN O
/ SYM O
dL NN O
with IN O
a DT O
mean NN O
of IN O
15 CD O
. . O
3 CD O
mu NN O
g NN O
/ SYM O
dL NN O
, , O
whereas IN O
BLLs NNS O
in IN O
61 CD O
children NNS B-Species
of IN O
Chendian NNP O
were VBD O
from IN O
4 CD O
. . O
9 CD O
to IN O
23 CD O
. . O
10 CD O
mu NN O
g NN O
/ SYM O
dL NN O
with IN O
a DT O
mean NN O
of IN O
9 CD O
. . O
94 CD O
mu NN O
g NN O
/ SYM O
dL NN O
. . O

Statistical JJ O
analyses NNS O
showed VBD O
that IN O
children NNS B-Species
living VBG O
in IN O
Guiyu NNP O
had VBD O
significantly RB O
higher JJR O
BLLs NNS O
compared VBN O
with IN O
those DT O
living VBG O
in IN O
Chendian NNP O
( , O
p NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Of IN O
children NNS B-Species
in IN O
Guiyu NNP O
, , O
81 CD O
. . O
8 CD O
% NN O
( , O
135 CD O
of IN O
165 CD O
) -RRB- O
had VBD O
BLLs NNS O
> SYM O
10 CD O
mu NNS O
g NN O
/ SYM O
dL NN O
, , O
compared VBN O
with IN O
37 CD O
. . O
7 CD O
% NN O
of IN O
children NNS B-Species
( : O
23 CD O
of IN O
61 CD O
) -RRB- O
in IN O
Chendian NNP O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
we PRP O
observed VBD O
a DT O
significant JJ O
increasing VBG O
trend NN O
in IN O
BLLs NNS O
with IN O
increasing VBG O
age NN O
in IN O
Guiyu NNP O
( , O
p NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

It PRP O
appeared VBD O
that IN O
there EX O
was VBD O
correlation NN O
between IN O
the DT O
BLLs NNS O
in IN O
children NNS B-Species
and CC O
numbers NNS O
of IN O
e JJ O
- HYPH O
waste NN O
workshops NNS O
. . O

However RB O
, , O
no DT O
significant JJ O
difference NN O
in IN O
Hgb NN O
level NN O
or CC O
physical JJ O
indexes NNS O
was VBD O
found VBN O
between IN O
the DT O
two CD O
towns NNS O
. . O

Conclusions NNS O

The DT O
primitive JJ O
e NN O
- HYPH O
waste NN O
recycling NN O
activities NNS O
may MD O
contribute VB O
to IN O
the DT O
elevated VBN O
BLLs NNS O
in IN O
children NNS B-Species
living VBG O
in IN O
Guiyu NNP O
. . O

Disposal NN O
of IN O
electronic JJ O
waste NN O
, , O
or CC O
e NN O
- HYPH O
waste NN O
, , O
is VBZ O
an DT O
emerging VBG O
global JJ O
environmental JJ O
issue NN O
, , O
as IN O
these DT O
wastes NNS O
have VBP O
become VBN O
the DT O
most RBS O
rapidly RB O
growing VBG O
segment NN O
of IN O
the DT O
municipal JJ O
waste NN O
stream NN O
in IN O
the DT O
world NN O
[ -LRB- O
Dahl NNP O
2002 CD O
; : O
Halluite NNP O
et FW O
al NNP O
. . O
2005 CD O
; , O
Jang NNP O
and CC O
Townsend NNP O
2003 CD O
; : O
Schmidt NNP O
2002 CD O
; : O
Silicon NNP O
Valley NNP O
Toxics NNPS O
Coalition NNP O
( : O
SVTC NNP O
) -RRB- O
2001 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
reported VBN O
that IN O
approximately RB O
500 CD O
million CD O
computers NNS O
became VBD O
obsolete JJ O
between IN O
1997 CD O
and CC O
2007 CD O
in IN O
the DT O
United NNP O
States NNP O
( , O
National NNP O
Safety NNP O
Council NNP O
1999 CD O
) -RRB- O
. . O

Up IN O
to TO O
80 CD O
% NN O
of IN O
e NN O
- HYPH O
waste NN O
from IN O
the DT O
United NNP O
States NNP O
has VBZ O
seeped VBN O
into IN O
Asia NNP O
and CC O
Africa NNP O
( , O
Johnson NNP O
2006 CD O
; : O
Puckett NNP O
et FW O
al NNP O
. . O
2002 CD O
; : O
Schmidt NNP O
2002 CD O
, , O
2006 CD O
; : O
SVTC NNP O
2001 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
noteworthy JJ O
that IN O
the DT O
United NNP O
States NNP O
is VBZ O
the DT O
only RB O
developed JJ O
country NN O
today NN O
that WDT O
has VBZ O
not RB O
ratified VBN O
the DT O
United NNP O
Nations NNP O
Basel NNP O
Convention NNP O
, , O
which WDT O
bans VBZ O
the DT O
export NN O
of IN O
hazardous JJ O
wastes NNS O
to IN O
developing VBG O
countries NNS O
( , O
United NNP O
Nations NNP O
Environment NNP O
Programme NNP O
1992 CD O
, , O
2006 CD O
; , O
USA NNP O
Today NNP O
2002 CD O
) -RRB- O
. . O

Together RB O
with IN O
New NNP O
Delhi NNP O
in IN O
India NNP O
, , O
Guiyu NNP O
in IN O
Shantou NNP O
, , O
Guangdong NNP O
Province NNP O
, , O
China NNP O
( , O
Figure NNP O
1 CD O
) -RRB- O
, , O
is VBZ O
one CD O
of IN O
the DT O
popular JJ O
destinations NNS O
of IN O
e NNP O
- HYPH O
waste NN O
( , O
Brigden NNP O
et FW O
al NNP O
. . O
2005 CD O
; : O
Puckett NNP O
et FW O
al NNP O
. . O
2002 CD O
) -RRB- O
. . O

Within IN O
a DT O
total JJ O
area NN O
of IN O
52 CD O
km2 NN O
and CC O
local JJ O
population NN O
of IN O
132 CD O
, , O
0 CD O
( , O
in IN O
2003 CD O
) -RRB- O
, , O
Guiyu NNP O
has VBZ O
accommodated VBN O
millions NNS O
of IN O
tons NNS O
of IN O
e NN O
- HYPH O
waste NN O
from IN O
overseas JJ O
and CC O
domestic JJ O
a DT O
year NN O
. . O

Nearly RB O
60 CD O
- SYM O
80 CD O
% NN O
of IN O
families NNS O
in IN O
the DT O
town NN O
have VBP O
engaged VBN O
in IN O
e JJ O
- HYPH O
waste NN O
recycling NN O
operations NNS O
conducted VBN O
by IN O
small JJ O
scale NN O
family NN O
- HYPH O
run VBN O
workshops NNS O
, , O
with IN O
approximately RB O
100 CD O
, , O
0 CD O
migrant JJ O
workers NNS O
employed VBN O
in IN O
processing NN O
e NN O
- HYPH O
waste NN O
. . O

Because IN O
the DT O
implementation NN O
of IN O
a DT O
clean JJ O
and CC O
safe JJ O
high JJ O
- HYPH O
tech NN O
recovery NN O
process NN O
was VBD O
very RB O
expensive JJ O
( : O
Allsopp NNP O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
, , O
the DT O
processes NNS O
and CC O
techniques NNS O
used VBN O
during IN O
the DT O
recycling NN O
activities NNS O
in IN O
Guiyu NNP O
were VBD O
very RB O
primitive JJ O
. . O

The DT O
result NN O
was VBD O
that IN O
many JJ O
tons NNS O
of IN O
e NN O
- HYPH O
waste NN O
material NN O
and CC O
process NN O
residues NNS O
were VBD O
dumped VBN O
in IN O
workshops NNS O
, , O
yards NNS O
, , O
roadsides NNS O
, , O
open JJ O
fields NNS O
, , O
irrigation NN O
canals NNS O
, , O
riverbanks NNS O
, , O
ponds NNS O
, , O
and CC O
rivers NNS O
. . O

Hazardous JJ O
chemicals NNS O
can MD O
be VB O
released VBN O
from IN O
e NN O
- HYPH O
wastes NNS O
through IN O
disposal NN O
or CC O
recycling NN O
processes NNS O
, , O
threatening VBG O
the DT O
health NN O
of IN O
local JJ O
residents NNS O
. . O

Several JJ O
studies NNS O
have VBP O
reported VBN O
the DT O
soaring VBG O
levels NNS O
of IN O
toxic JJ O
heavy JJ O
metals NNS O
and CC O
organic JJ O
contaminants NNS O
in IN O
samples NNS O
of IN O
dust NN O
, , O
soil NN O
, , O
river NN O
sediment NN O
, , O
surface NN O
water NN O
, , O
and CC O
groundwater NN O
of IN O
Guiyu NNP O
( , O
Brigden NNP O
et FW O
al NNP O
. . O
2005 CD O
; : O
Puckett NNP O
et FW O
al NNP O
. . O
2002 CD O
; , O
Wang NNP O
and CC O
Guo NNP O
2006 CD O
; , O
Wang NNP O
et FW O
al NNP O
. . O
2005 CD O
; : O
Wong NNP O
et FW O
al NNP O
. . O
2006 CD O
; : O
Yu NNP O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
. . O

Previously RB O
, , O
we PRP O
have VBP O
shown VBN O
that IN O
the DT O
residents NNS O
in IN O
Guiyu NNP O
had VBD O
high JJ O
incidence NN O
of IN O
skin NN O
damage NN O
, , O
headaches NNS O
, , O
vertigo NN O
, , O
nausea NN O
, , O
chronic JJ O
gastritis NN O
, , O
and CC O
gastric JJ O
and CC O
duodenal JJ O
ulcers NNS O
, , O
all DT O
of IN O
which WDT O
may MD O
be VB O
caused VBN O
by IN O
the DT O
primitive JJ O
recycling NN O
processing NN O
of IN O
e NN O
- HYPH O
waste NN O
( , O
Qiu NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

Of IN O
many JJ O
toxic JJ O
heavy JJ O
metals NNS O
, , O
lead NN O
is VBZ O
the DT O
most RBS O
widely RB O
used VBN O
in IN O
electronic JJ O
devices NNS O
for IN O
various JJ O
purposes NNS O
, , O
resulting VBG O
in IN O
a DT O
variety NN O
of IN O
health NN O
hazards NNS O
due JJ O
to IN O
environmental JJ O
contamination NN O
( , O
Jang NNP O
and CC O
Townsend NNP O
2003 CD O
; : O
Musson NNP O
et FW O
al NNP O
. . O
2006 CD O
; : O
Vann NNP O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
. . O

Lead NN O
enters VBZ O
biological JJ O
systems NNS O
via IN O
food NN O
, , O
water NN O
, , O
air NN O
, , O
and CC O
soil NN O
. . O

Children NNS B-Species
are VBP O
particularly RB O
vulnerable JJ O
to IN O
lead NN O
poisoning NN O
- : O
- : O
more RBR O
so RB O
than IN O
adults NNS O
because IN O
they PRP O
absorb VBP O
more JJR O
lead NN O
from IN O
their PRP$ O
environments NNS O
( , O
Baghurst NNP O
et FW O
al NNP O
. . O
1992 CD O
; : O
Grigg NNP O
2004 CD O
; : O
Guilarte NNP O
et FW O
al NNP O
. . O
2003 CD O
; : O
Jain NNP O
and CC O
Hu NNP O
2006 CD O
; : O
Needleman NNP O
2004 CD O
; : O
Safi NNP O
et FW O
al NNP O
. . O
2006 CD O
; : O
Wasserman NNP O
et FW O
al NNP O
. . O
1998 CD O
) -RRB- O
. . O

The DT O
U NNP O
. . O
S NNP O
. . O

Centers NNPS O
for IN O
Disease NNP O
Control NNP O
and CC O
Prevention NNP O
( -LRB- O
CDC NNP O
) -RRB- O
defined VBD O
elevated VBN O
blood NN O
lead NN O
levels NNS O
( -LRB- O
BLLs NNS O
) -RRB- O
as IN O
those DT O
> : O
= SYM O
10 CD O
mu NNS O
g NN O
/ SYM O
dL NN O
in IN O
children NNS B-Species
< SYM O
= SYM O
6 CD O
years NNS O
of IN O
age NN O
( -LRB- O
CDC NNP O
1991 CD O
) -RRB- O
. . O

Nevertheless RB O
, , O
studies NNS O
have VBP O
increasingly RB O
shown VBN O
that IN O
low JJ O
blood NN O
lead NN O
concentrations NNS O
, , O
even RB O
< , O
10 CD O
mu NN O
g NN O
/ SYM O
dL NN O
, , O
were VBD O
inversely RB O
associated VBN O
with IN O
children NNS B-Species
' POS O
s NNS O
IQ NN O
scores NNS O
and CC O
academic JJ O
skills NNS O
( , O
Canfield NNP O
et FW O
al NNP O
. . O
2003 CD O
; : O
Lanphear NNP O
et FW O
al NNP O
. . O
2000 CD O
, , O
2005 CD O
; : O
Nevin NNP O
2000 CD O
; : O
Schnaas NNP O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
. . O

Therefore RB O
, , O
no DT O
safety NN O
margin NN O
at IN O
existing VBG O
exposures NNS O
has VBZ O
been VBN O
identified VBN O
( , O
Chiodo NNP O
et FW O
al NNP O
. . O
2004 CD O
; : O
Koller NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

Considering VBG O
the DT O
potential JJ O
heavy JJ O
metal NN O
contamination NN O
in IN O
the DT O
local JJ O
living NN O
environment NN O
of IN O
Guiyu NNP O
, , O
we PRP O
hypothesized VBD O
that IN O
children NNS B-Species
living VBG O
in IN O
Guiyu NNP O
may MD O
have VB O
elevated VBN O
BLLs NNS O
and CC O
thus RB O
their PRP$ O
physical JJ O
and CC O
mental JJ O
development NN O
may MD O
have VB O
been VBN O
affected VBN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
evaluated VBD O
the DT O
mean JJ O
BLLs NNS O
in IN O
children NNS B-Species
1 CD O
- SYM O
6 CD O
years NNS O
of IN O
age NN O
living VBG O
in IN O
Guiyu NNP O
and CC O
compared VBD O
them PRP O
with IN O
those DT O
living VBG O
in IN O
the DT O
neighboring VBG O
town NN O
of IN O
Chendian NNP O
, , O
where WRB O
no DT O
e NN O
- HYPH O
waste NN O
processing NN O
was VBD O
taken VBN O
. . O

Materials NNS O
and CC O
Methods NNS O

Geographic JJ O
location NN O
and CC O
site NN O
description NN O

There EX O
are VBP O
28 CD O
villages NNS O
with IN O
a DT O
total JJ O
area NN O
of IN O
52 CD O
km2 NNS O
and CC O
a DT O
resident JJ O
population NN O
of IN O
132 CD O
, , O
0 CD O
and CC O
around RB O
100 CD O
, , O
0 CD O
migrant JJ O
workers NNS O
in IN O
Guiyu NNP O
( : O
Figure NNP O
1 CD O
) -RRB- O
. . O

We PRP O
chose VBD O
four CD O
villages NNS O
for IN O
their PRP$ O
differences NNS O
in IN O
the DT O
scale NN O
and CC O
type NN O
of IN O
e NN O
- HYPH O
waste NN O
processing NN O
. . O

Beilin NNP O
village NN O
has VBZ O
dense JJ O
e JJ O
- HYPH O
waste NN O
workshops NNS O
mainly RB O
involved VBN O
in IN O
equipment NN O
dismantling NN O
, , O
circuit NN O
board NN O
baking NN O
, , O
and CC O
acid NN O
baths NNS O
; , O
Dutou NNP O
village NN O
specializes VBZ O
in IN O
plastics NNS O
sorting NN O
, , O
including VBG O
manually RB O
stripping VBG O
plastic NN O
materials NNS O
from IN O
electronic JJ O
products NNS O
and CC O
then RB O
crudely RB O
classifying VBG O
them PRP O
; : O
Huamei NNP O
village NN O
had VBD O
workshops NNS O
similar JJ O
to IN O
those DT O
of IN O
Beilin NNP O
, , O
but CC O
they PRP O
are VBP O
fewer JJR O
and CC O
scattered VBN O
; , O
and CC O
Longgang NNP O
village NN O
was VBD O
involved VBN O
in IN O
plastic JJ O
reprocessing NN O
in IN O
which WDT O
plastics NNS O
collected VBN O
from IN O
Dutou NNP O
and CC O
other JJ O
villages NNS O
were VBD O
washed VBN O
and CC O
smashed VBN O
into IN O
tiny JJ O
pieces NNS O
of IN O
recycled VBN O
plastic NN O
. . O

We PRP O
used VBD O
the DT O
neighboring VBG O
town NN O
of IN O
Chendian NNP O
as IN O
a DT O
control NN O
because IN O
the DT O
local JJ O
residents NNS O
work VBP O
mainly RB O
in IN O
the DT O
textiles NNS O
industry NN O
, , O
not RB O
in IN O
e NN O
- HYPH O
waste NN O
processing NN O
. . O

The DT O
population NN O
, , O
traffic NN O
density NN O
, , O
lifestyle NN O
, , O
and CC O
socioeconomic JJ O
status NN O
were VBD O
very RB O
similar JJ O
to IN O
those DT O
of IN O
Guiyu NNP O
. . O

Study NN O
population NN O

The DT O
study NN O
population NN O
was VBD O
composed VBN O
of IN O
children NNS B-Species
< : O
= SYM O
6 CD O
years NNS O
of IN O
age NN O
. . O

No DT O
children NNS B-Species
involved VBN O
in IN O
the DT O
study NN O
had VBD O
any DT O
occupational JJ O
exposure NN O
to IN O
e DT O
- HYPH O
waste NN O
. . O

A DT O
cluster NN O
sample NN O
of IN O
165 CD O
children NNS B-Species
with IN O
a DT O
median JJ O
age NN O
of IN O
5 CD O
. . O
0 CD O
years NNS O
lived VBD O
in IN O
the DT O
four CD O
villages NNS O
of IN O
Guiyu NNP O
( : O
Figure NNP O
1 CD O
) -RRB- O
. . O

Sixty CD O
- HYPH O
one CD O
children NNS B-Species
with IN O
a DT O
median JJ O
age NN O
of IN O
4 CD O
. . O
0 CD O
years NNS O
resided VBN O
in IN O
Chendian NNP O
were VBD O
included VBN O
in IN O
the DT O
study NN O
for IN O
comparison NN O
. . O

After IN O
written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
the DT O
parents NNS O
or CC O
guardians NNS O
, , O
blood NN O
samples NNS O
were VBD O
collected VBN O
from IN O
the DT O
children NNS B-Species
at IN O
village NN O
kindergartens NNS O
. . O

To TO O
facilitate VB O
the DT O
counseling NN O
process NN O
, , O
advice NN O
on IN O
dietary JJ O
and CC O
eating NN O
habits NNS O
to TO O
minimize VB O
lead JJ O
exposure NN O
were VBD O
provided VBN O
to IN O
the DT O
local JJ O
residents NNS O
. . O

All DT O
children NNS B-Species
found VBD O
to TO O
have VB O
high JJ O
BLLs NNS O
were VBD O
advised VBN O
to TO O
get VB O
further JJ O
hospital NN O
treatment NN O
. . O

The DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
Human NNP O
Ethics NNP O
Committee NNP O
of IN O
Shantou NNP O
University NNP O
Medical NNP O
College NNP O
. . O

Measurement NN O
of IN O
BLLs NNS O
and CC O
hemoglobin NN O

Venipuncture NN O
blood NN O
samples NNS O
were VBD O
obtained VBN O
from IN O
each DT O
volunteer NN O
at IN O
the DT O
kindergarten NN O
, , O
and CC O
collected VBN O
in IN O
lead NN O
- HYPH O
free JJ O
tubes NNS O
by IN O
trained VBN O
nurses NNS O
. . O

Lead NN O
in IN O
total JJ O
blood NN O
was VBD O
analyzed VBN O
by IN O
graphite NN O
furnace NN O
atomic JJ O
absorption NN O
spectrometry NN O
( -LRB- O
GFAAS NNP O
) -RRB- O
, , O
which WDT O
consisted VBD O
of IN O
a DT O
Shimadzu NNP O
AA NNP O
- HYPH O
660 CD O
AAS NNP O
and CC O
GFA NNP O
- HYPH O
4B NN O
graphite NN O
furnace NN O
atomizer NN O
and CC O
an DT O
ACS NNP O
- HYPH O
60G NNP O
autosampler NN O
( HYPH O
Shimadzu NNP O
Corporation NNP O
, , O
Kyoto NNP O
, , O
Japan NNP O
) -RRB- O
. . O

The DT O
main JJ O
parameters NNS O
used VBN O
for IN O
the DT O
determination NN O
were VBD O
a DT O
wavelength NN O
of IN O
283 CD O
. . O
3 CD O
nm NN O
, , O
current NN O
of IN O
8 CD O
mA NN O
, , O
a DT O
slit JJ O
width NN O
of IN O
1 CD O
. . O
0 CD O
nm NN O
, , O
drying VBG O
at IN O
150 CD O
degrees NNS O
C NN O
, , O
ashing VBG O
at IN O
325 CD O
degrees NNS O
C NN O
, , O
and CC O
atomization NN O
at IN O
1 CD O
, , O
400 CD O
degrees NNS O
C NN O
. . O

The DT O
accuracy NN O
of IN O
the DT O
method NN O
was VBD O
controlled VBN O
by IN O
recoveries NNS O
between IN O
95 CD O
% NN O
and CC O
107 CD O
% NN O
from IN O
the DT O
spiked VBN O
blood NN O
samples NNS O
. . O

Repeated VBN O
analyses NNS O
of IN O
standard JJ O
solutions NNS O
confirmed VBD O
the DT O
method NN O
' POS O
s NN O
precision NN O
. . O

The DT O
BLLs NNS O
were VBD O
expressed VBN O
in IN O
micrograms NNS O
per IN O
deciliter NN O
( , O
1 CD O
mu NNS O
g FW O
/ SYM O
dL NNP O
= SYM O
0 CD O
. . O
484 CD O
mu NN O
mol NN O
/ SYM O
L NNP O
) -RRB- O
. . O

Meanwhile RB O
, , O
we PRP O
assessed VBD O
hemoglobin NN O
( , O
Hgb NNP O
) -RRB- O
levels NNS O
by IN O
hemoglobin NN O
cyanide NN O
method NN O
with IN O
hemoglobinometer NN O
( , O
XK NNP O
- HYPH O
2 CD O
, , O
JiangSu NNP O
, , O
China NNP O
) -RRB- O
. . O

Evaluation NN O
of IN O
physical JJ O
developmental JJ O
indexes NNS O

Children NNS B-Species
' POS O
s POS O
physical JJ O
growth NN O
and CC O
development NN O
, , O
such JJ O
as IN O
body NN O
height NN O
, , O
weight NN O
, , O
and CC O
head NN O
and CC O
chest NN O
circumferences NNS O
were VBD O
measured VBN O
when WRB O
blood NN O
samples NNS O
were VBD O
collected VBN O
. . O

Weight NN O
and CC O
height NN O
were VBD O
measured VBN O
using VBG O
a DT O
weighing NN O
and CC O
height NN O
scale NN O
( -LRB- O
TZ120 NNP O
; : O
Yuyao NNP O
Balance NNP O
Instrument NNP O
Factory NNP O
, , O
Yuyao NNP O
, , O
China NNP O
) , O
with IN O
maximum JJ O
weight NN O
of IN O
120 CD O
kg NNS O
( , O
minimum NN O
scale NN O
, , O
50 CD O
g NN O
) -RRB- O
and CC O
minimum JJ O
height NN O
of IN O
70 CD O
cm NNS O
( , O
minimum NN O
scale NN O
, , O
0 CD O
. . O
5 CD O
cm NN O
) -RRB- O
. . O

Head NN O
and CC O
chest NN O
circumferences NNS O
were VBD O
measured VBN O
using VBG O
graduated VBN O
anthropometric JJ O
tapes NNS O
. . O

Statistical JJ O
analyses NNS O

We PRP O
performed VBD O
statistical JJ O
analyses NNS O
using VBG O
SPSS NNP O
version NN O
10 CD O
. . O
0 CD O
software NN O
( : O
SPSS NNP O
, , O
Chicago NNP O
, , O
IL NNP O
, , O
USA NNP O
) -RRB- O
. . O

We PRP O
used VBD O
independent JJ O
sample NN O
t NN O
- HYPH O
tests NNS O
or CC O
covariance NN O
analyses NNS O
for IN O
comparisons NNS O
of IN O
mean JJ O
, , O
chi NN O
- HYPH O
square JJ O
analyses NNS O
for IN O
test NN O
of IN O
frequency NN O
data NNS O
, , O
and CC O
linear JJ O
regression NN O
analysis NN O
for IN O
the DT O
association NN O
between IN O
BLLs NNS O
and CC O
age NN O
. . O

Differences NNS O
were VBD O
considered VBN O
significant JJ O
with IN O
a DT O
p NN O
- HYPH O
value NN O
< SYM O
0 CD O
. . O
5 CD O
. . O

Results NNS O

Observation NN O
of IN O
e NN O
- HYPH O
waste NN O
processing NN O

The DT O
primitive JJ O
e NN O
- HYPH O
waste NN O
recycling NN O
procedures NNS O
in IN O
Guiyu NNP O
were VBD O
mainly RB O
as IN O
follows VBZ O
: : O
a DT O
) NFP O
Old JJ O
electronic JJ O
equipment NN O
was VBD O
dismantled VBN O
( : O
Figure NNP O
2 CD O
) -RRB- O
with IN O
electric JJ O
drill NN O
, , O
cutter NN O
, , O
hammer NN O
, , O
and CC O
screwdriver NN O
into IN O
component NN O
parts NNS O
such JJ O
as IN O
monitor NN O
, , O
hard JJ O
drive NN O
, , O
CD NN O
driver NN O
, , O
wires NNS O
, , O
cables NNS O
, , O
circuit NN O
boards NNS O
, , O
transformer NN O
, , O
charger NN O
, , O
battery NN O
, , O
and CC O
plastic NN O
or CC O
metal NN O
frame NN O
that WDT O
are VBP O
sold VBN O
for IN O
reuse NN O
or CC O
to IN O
other JJ O
workshops NNS O
for IN O
further JJ O
recycling NN O
. . O

b LS O
) : O
Circuit NN O
boards NNS O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
of IN O
computers NNS O
and CC O
other JJ O
large JJ O
appliances NNS O
were VBD O
heated VBN O
over IN O
coal NN O
fires NNS O
to TO O
melt VB O
the DT O
solder NN O
to TO O
release VB O
valuable JJ O
electronic JJ O
components NNS O
, , O
such JJ O
as IN O
diodes NNS O
, , O
resistors NNS O
, , O
and CC O
microchips NNS O
. . O

c LS O
) , O
Circuit NN O
boards NNS O
of IN O
cell NN O
phones NNS O
and CC O
other JJ O
hand NN O
- HYPH O
held VBN O
devices NNS O
were VBD O
taken VBN O
apart RB O
by IN O
a DT O
electrothermal JJ O
machine NN O
( -LRB- O
Figure NNP O
4 CD O
) -RRB- O
, , O
which WDT O
was VBD O
a DT O
particular JJ O
environmental JJ O
and CC O
human JJ B-Species
health NN O
concern NN O
in IN O
the DT O
processing NN O
of IN O
e NN O
- HYPH O
waste NN O
in IN O
Guiyu NNP O
. . O

d LS O
) : O
In IN O
acid NN O
baths NNS O
( -LRB- O
Figure NNP O
5 CD O
) -RRB- O
, , O
some DT O
microchips NNS O
and CC O
computer NN O
parts NNS O
were VBD O
soaked VBN O
to TO O
extract VB O
precious JJ O
gold NN O
and CC O
palladium NN O
, , O
from IN O
which WDT O
the DT O
waste NN O
acids NNS O
were VBD O
discharged VBN O
into IN O
nearby JJ O
fields NNS O
and CC O
streams NNS O
. . O

e LS O
) NFP O
Wires NNS O
and CC O
cables NNS O
were VBD O
stripped VBN O
or CC O
simply RB O
burnt VBN O
in IN O
open JJ O
air NN O
to TO O
recover VB O
metals NNS O
. . O

f LS O
) , O
Printer NN O
cartridges NNS O
were VBD O
ripped VBN O
apart RB O
for IN O
their PRP$ O
toner NN O
and CC O
recyclable JJ O
aluminum NN O
, , O
steel NN O
, , O
and CC O
plastic NN O
parts NNS O
. . O

g LS O
) NFP O
Plastic NNP O
[ -LRB- O
e NN O
. . O
g NN O
. . O
, , O
polyvinyl NN O
chloride NN O
( , O
PVC NN O
) -RRB- O
, , O
acrylonitrile NN O
butadiene NN O
styrene NN O
copolymer NN O
( , O
ABS NNP O
) -RRB- O
, , O
high JJ O
- HYPH O
density NN O
polyethylene NN O
( , O
HDPE NNP O
) -RRB- O
] -RRB- O
was VBD O
sorted VBN O
by IN O
workers NNS O
according VBG O
to IN O
rigidity NN O
, , O
color NN O
, , O
and CC O
luster NN O
. . O

Plastic JJ O
scraps NNS O
that WDT O
cannot MD O
be VB O
sorted VBN O
visually RB O
must MD O
be VB O
burned VBN O
and CC O
classified VBN O
by IN O
burning VBG O
odor NN O
. . O

Another DT O
way NN O
to TO O
sort VB O
different JJ O
plastics NNS O
was VBD O
gravitational JJ O
separation NN O
into IN O
ceramic JJ O
jugs NNS O
with IN O
brine NN O
( -LRB- O
Figure NNP O
6 CD O
) -RRB- O
, , O
after IN O
which WDT O
the DT O
pieces NNS O
were VBD O
spread VBN O
on IN O
the DT O
sidewalk NN O
to IN O
dry VB O
; : O
h LS O
) -RRB- O
For IN O
reprocessing NN O
, , O
after IN O
sorting VBG O
plastic NN O
scraps NNS O
were VBD O
fed VBN O
into IN O
grinders NNS O
that WDT O
spit VBD O
out RP O
tiny JJ O
pieces NNS O
of IN O
plastic NN O
. . O

i LS O
) -RRB- O
For IN O
metals NNS O
sorting NN O
and CC O
reprocessing NN O
, , O
transformers NNS O
, , O
chargers NNS O
, , O
batteries NNS O
, , O
and CC O
cathode NN O
- HYPH O
ray NN O
tubes NNS O
were VBD O
separated VBN O
and CC O
hammered VBN O
open JJ O
for IN O
recycling VBG O
metals NNS O
such JJ O
as IN O
copper NN O
, , O
steel NN O
, , O
silver NN O
, , O
aluminum NN O
, , O
which WDT O
were VBD O
then RB O
reprocessed VBN O
to IN O
raw JJ O
material NN O
. . O

Although IN O
the DT O
methods NNS O
for IN O
processing VBG O
e NN O
- HYPH O
waste NN O
were VBD O
primitive JJ O
, , O
the DT O
coordination NN O
of IN O
e NN O
- HYPH O
waste NN O
recycling NN O
in IN O
Guiyu NNP O
was VBD O
very RB O
well RB O
organized VBN O
into IN O
specific JJ O
tasks NNS O
. . O

Workshops NNS O
specializing VBG O
in IN O
dismantled VBN O
equipment NN O
would MD O
not RB O
conduct VB O
circuit NN O
board NN O
baking NN O
or CC O
plastics NNS O
and CC O
metals NNS O
reprocessing NN O
. . O

The DT O
chain NN O
of IN O
recycling NN O
components NNS O
from IN O
each DT O
type NN O
of IN O
e NN O
- HYPH O
waste NN O
was VBD O
well RB O
established VBN O
in IN O
the DT O
town NN O
. . O

BLLs NNS O
in IN O
children NNS B-Species

We PRP O
collected VBD O
blood NN O
from IN O
165 CD O
children NNS B-Species
in IN O
Guiyu NNP O
and CC O
61 CD O
children NNS B-Species
in IN O
Chendian NNP O
and CC O
measured VBD O
the DT O
BLLs NNS O
in IN O
these DT O
children NNS B-Species
. . O

Table NNP O
1 CD O
shows VBZ O
that IN O
the DT O
BLLs NNS O
corresponded VBD O
to IN O
the DT O
children NNS B-Species
' POS O
s POS O
age NN O
, , O
sex NN O
, , O
and CC O
town NN O
of IN O
residence NN O
. . O

As IN O
expected VBN O
, , O
BLLs NNS O
among IN O
Guiyu NNP O
children NNS B-Species
were VBD O
much RB O
higher JJR O
than IN O
those DT O
in IN O
the DT O
children NNS B-Species
of IN O
Chendian NNP O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Among IN O
Guiyu NNP O
children NNS B-Species
, , O
135 CD O
( SYM O
81 CD O
. . O
8 CD O
% NN O
) -RRB- O
had VBD O
BLLs NNS O
> SYM O
10 CD O
mu NNS O
g FW O
/ SYM O
dL NN O
, , O
whereas IN O
23 CD O
( SYM O
37 CD O
. . O
7 CD O
% NN O
) -RRB- O
in IN O
Chendian NNP O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
had VBD O
high JJ O
levels NNS O
. . O

Among IN O
135 CD O
( SYM O
81 CD O
. . O
8 CD O
% NN O
) -RRB- O
Guiyu NNP O
children NNS B-Species
with IN O
elevated JJ O
BLLs NNS O
, , O
61 CD O
. . O
8 CD O
% NN O
and CC O
20 CD O
% NN O
had VBD O
BLLs NNS O
> SYM O
10 CD O
mu NNS O
g NNP O
/ SYM O
dL NN O
and CC O
20 CD O
mu NNS O
g NN O
/ SYM O
dL NN O
respectively RB O
, , O
but CC O
lead JJ O
levels NNS O
> SYM O
45 CD O
mu NNS O
g NN O
/ SYM O
dL CD O
were VBD O
not RB O
found VBN O
. . O

And CC O
BLLs NNS O
of IN O
Guiyu NNP O
increased VBD O
somewhat RB O
with IN O
age NN O
( : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
; : O
older JJR O
children NNS B-Species
tended VBD O
to TO O
have VB O
higher JJR O
BLLs NNS O
than IN O
younger JJR O
ones NNS O
. . O

We PRP O
found VBD O
no DT O
evidence NN O
for IN O
the DT O
association NN O
in IN O
lead NN O
concentrations NNS O
or CC O
prevalence NN O
of IN O
elevated VBN O
BLLs NNS O
differentiated VBN O
by IN O
sex NN O
( : O
both DT O
p NN O
> SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Table NNP O
2 CD O
presents VBZ O
BLLs NNS O
for IN O
165 CD O
exposed VBN O
children NNS B-Species
in IN O
the DT O
four CD O
villages NNS O
. . O

The DT O
findings NNS O
showed VBD O
that IN O
BLLs NNS O
from IN O
different JJ O
villages NNS O
were VBD O
in IN O
the DT O
following JJ O
descending VBG O
order NN O
: : O
Beilin NNP O
, , O
19 CD O
. . O
34 CD O
mu NN O
g NN O
/ SYM O
dL NNP O
> SYM O
Dutou NNP O
, , O
17 CD O
. . O
86 CD O
mu NN O
g NN O
/ : O
dL NNP O
> SYM O
Huamei NNP O
, , O
14 CD O
. . O
23 CD O
mu NN O
g NN O
/ : O
dL NN O
> SYM O
Longgang NNP O
, , O
13 CD O
. . O
13 CD O
mu NN O
g NN O
/ : O
dL NN O
( : O
Table NN O
2 CD O
) -RRB- O
. . O

Children NNS B-Species
living VBG O
in IN O
Beilin NNP O
, , O
where WRB O
the DT O
number NN O
of IN O
e JJ O
- HYPH O
waste NN O
workshops NNS O
specializing VBG O
in IN O
equipment NN O
dismantling NN O
, , O
circuit NN O
board NN O
baking NN O
, , O
and CC O
acid NN O
baths NNS O
, , O
had VBD O
the DT O
highest JJS O
BLLs NNS O
. . O

Dutou NNP O
, , O
which WDT O
had VBD O
many JJ O
workshops NNS O
specializing VBG O
in IN O
plastics NNS O
sorting NN O
, , O
including VBG O
strip NN O
plastic NN O
materials NNS O
from IN O
e NN O
- HYPH O
waste NN O
, , O
had VBD O
the DT O
second JJ O
highest JJS O
BLLs NNS O
in IN O
children NNS B-Species
. . O

Huamei NNP O
had VBD O
e DT O
- HYPH O
waste NN O
workshops NNS O
similar JJ O
to IN O
those DT O
of IN O
Beilin NNP O
, , O
but CC O
fewer RBR O
and CC O
less RBR O
centralized JJ O
; : O
the DT O
BLLs NNS O
of IN O
Huamei NNP O
children NNS B-Species
were VBD O
much RB O
lower JJR O
than IN O
those DT O
of IN O
Beilin NNP O
and CC O
Dutou NNP O
. . O

Longgang NNP O
, , O
a DT O
village NN O
specializing VBG O
in IN O
reprocessing VBG O
plastics NNS O
collected VBN O
from IN O
other JJ O
villages NNS O
that WDT O
had VBD O
no DT O
workshops NNS O
directly RB O
processing VBG O
e NN O
- HYPH O
waste NN O
, , O
had VBD O
the DT O
lowest JJS O
BLLs NNS O
. . O

There EX O
was VBD O
a DT O
significant JJ O
difference NN O
in IN O
BLLs NNS O
among IN O
the DT O
children NNS B-Species
of IN O
the DT O
four CD O
villages NNS O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

In IN O
Beilin NNP O
and CC O
Dutou NNP O
, , O
88 CD O
. . O
8 CD O
% NN O
and CC O
100 CD O
% NN O
children NNS B-Species
had VBD O
elevated VBN O
BLLs NNS O
> SYM O
10 CD O
mu NNS O
g NN O
/ SYM O
dL NN O
, , O
respectively RB O
. . O

As RB O
far RB O
as IN O
physical JJ O
indexes NNS O
and CC O
Hgb NN O
levels NNS O
were VBD O
concerned VBN O
, , O
there EX O
was VBD O
no DT O
significant JJ O
difference NN O
between IN O
Guiyu NNP O
and CC O
Chendian NNP O
( : O
p NN O
> SYM O
0 CD O
. . O
5 CD O
, , O
Table NN O
3 CD O
) -RRB- O
. . O

Discussion NN O

In IN O
this DT O
study NN O
, , O
we PRP O
observed VBD O
that IN O
the DT O
processing NN O
of IN O
e NN O
- HYPH O
waste NN O
in IN O
Guiyu NNP O
was VBD O
very RB O
primitive JJ O
and CC O
the DT O
recycling NN O
industry NN O
depended VBD O
mainly RB O
on IN O
manual JJ O
processing NN O
methods NNS O
. . O

Despite IN O
the DT O
fact NN O
that IN O
the DT O
coordination NN O
of IN O
the DT O
e JJ O
- HYPH O
waste NN O
recycling NN O
is VBZ O
well RB O
organized JJ O
in IN O
family NN O
- HYPH O
based VBN O
small JJ O
business NN O
units NNS O
, , O
the DT O
manual JJ O
processing NN O
methods NNS O
and CC O
the DT O
deposition NN O
of IN O
the DT O
e NN O
- HYPH O
waste NN O
have VBP O
contributed VBN O
to IN O
the DT O
contamination NN O
by IN O
heavy JJ O
metals NNS O
in IN O
the DT O
living NN O
environment NN O
. . O

Examination NN O
of IN O
the DT O
possible JJ O
impact NN O
of IN O
the DT O
e NN O
- HYPH O
waste NN O
industry NN O
on IN O
the DT O
BLLs NNS O
of IN O
children NNS B-Species
living VBG O
in IN O
Guiyu NNP O
revealed VBD O
that IN O
Guiyu NNP O
children NNS B-Species
had VBD O
significantly RB O
higher JJR O
BLLs NNS O
than IN O
Chendian JJ O
children NNS B-Species
. . O

Of IN O
children NNS B-Species
tested VBN O
in IN O
Guiyu NNP O
, , O
81 CD O
. . O
8 CD O
% NN O
had VBD O
BLLs NNS O
> SYM O
10 CD O
mu NNS O
g NN O
/ SYM O
dL NN O
, , O
indicating VBG O
a DT O
correlation NN O
between IN O
the DT O
BLLs NNS O
in IN O
children NNS B-Species
and CC O
the DT O
numbers NNS O
of IN O
e JJ O
- HYPH O
waste NN O
workshops NNS O
. . O

We PRP O
speculated VBD O
that IN O
the DT O
elevated VBN O
BLLs NNS O
in IN O
Guiyu NNP O
children NNS B-Species
may MD O
be VB O
directly RB O
caused VBN O
by IN O
the DT O
contamination NN O
of IN O
the DT O
lead NN O
during IN O
e NN O
- HYPH O
waste NN O
recycling NN O
. . O

However RB O
, , O
further JJ O
study NN O
should MD O
be VB O
conducted VBN O
to TO O
determine VB O
the DT O
relationship NN O
between IN O
BLLs NNS O
in IN O
Children NNPS B-Species
and CC O
the DT O
actual JJ O
lead NN O
contamination NN O
in IN O
the DT O
environment NN O
. . O

Lead NN O
is VBZ O
considered VBN O
one CD O
of IN O
the DT O
major JJ O
heavy JJ O
metal NN O
contaminants NNS O
during IN O
the DT O
process NN O
of IN O
e NN O
- HYPH O
waste NN O
recycling NN O
. . O

A DT O
cathode NN O
ray NN O
tube NN O
inside IN O
a DT O
television NN O
set NN O
or CC O
a DT O
computer NN O
monitor NN O
contains VBZ O
an DT O
average NN O
of IN O
4 CD O
- SYM O
8 CD O
lb NN O
lead NN O
; : O
monitor NN O
glass NN O
contains VBZ O
about RB O
20 CD O
% NN O
lead NN O
by IN O
weight NN O
; : O
a DT O
typical JJ O
battery NN O
weighs VBZ O
36 CD O
lb NN O
and CC O
contains VBZ O
about RB O
18 CD O
lb NN O
of IN O
lead NN O
. . O

For IN O
decades NNS O
, , O
lead NN O
as IN O
a DT O
major JJ O
component NN O
of IN O
solders NNS O
has VBZ O
been VBN O
used VBN O
to TO O
attach VB O
electronic JJ O
components NNS O
to IN O
printed VBN O
circuit NN O
boards NNS O
. . O

Lead NN O
compounds NNS O
have VBP O
also RB O
been VBN O
used VBN O
as IN O
stabilizers NNS O
in IN O
some DT O
PVC NNP O
cables NNS O
and CC O
other JJ O
products NNS O
. . O

Our PRP$ O
study NN O
demonstrated VBD O
in IN O
Guiyu NNP O
a DT O
significant JJ O
increasing VBG O
trend NN O
in IN O
BLLs NNS O
with IN O
increasing VBG O
age NN O
; : O
older JJR O
children NNS B-Species
tended VBD O
to TO O
have VB O
higher JJR O
BLLs NNS O
than IN O
younger JJR O
ones NNS O
. . O

This DT O
might MD O
be VB O
the DT O
result NN O
of IN O
increasing VBG O
exposure NN O
risk NN O
because IN O
older JJR O
children NNS B-Species
might MD O
have VB O
more JJR O
outdoor JJ O
activities NNS O
. . O

In IN O
addition NN O
, , O
it PRP O
may MD O
also RB O
be VB O
attributed VBN O
to IN O
the DT O
fact NN O
that IN O
the DT O
heaviest JJS O
lead NN O
- HYPH O
contaminated VBN O
zone NN O
in IN O
air NN O
after IN O
the DT O
burning NN O
of IN O
the DT O
e NN O
- HYPH O
waste NN O
was VBD O
75 CD O
- SYM O
100 CD O
cm NNS O
above IN O
the DT O
ground NN O
( , O
Wang NNP O
and CC O
Zhang NNP O
2006 CD O
) -RRB- O
, , O
which WDT O
was VBD O
the DT O
height NN O
range NN O
for IN O
normal JJ O
Chinese JJ O
children NNS B-Species
5 CD O
- SYM O
6 CD O
years NNS O
of IN O
age NN O
. . O

In IN O
China NNP O
, , O
the DT O
mean JJ O
BLL NN O
of IN O
children NNS B-Species
was VBD O
9 CD O
. . O
29 CD O
mu NN O
g NN O
/ SYM O
dL NN O
, , O
and CC O
33 CD O
. . O
8 CD O
% NN O
of IN O
the DT O
subjects NNS O
had VBD O
BLLs NNS O
> SYM O
10 CD O
mu NNS O
g NN O
/ SYM O
dL NN O
; : O
boys NNS B-Species
' POS O
mean JJ O
BLL NNP O
was VBD O
9 CD O
. . O
64 CD O
mu NN O
g NN O
/ SYM O
dL NN O
, , O
significantly RB O
higher JJR O
than IN O
the DT O
girls NNS B-Species
' POS O
mean JJ O
BLL NN O
of IN O
8 CD O
. . O
94 CD O
mu NNS O
g NN O
/ SYM O
dL NN O
( : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
( , O
Wang NNP O
and CC O
Zhang NNP O
2006 CD O
) -RRB- O
. . O

Generally RB O
in IN O
China NNP O
, , O
BLLs NNS O
of IN O
children NNS B-Species
living VBG O
in IN O
industrial JJ O
and CC O
urban JJ O
areas NNS O
were VBD O
significantly RB O
higher JJR O
than IN O
those DT O
of IN O
children NNS B-Species
in IN O
suburbs NNS O
and CC O
rural JJ O
areas NNS O
( : O
Wang NNP O
and CC O
Zhang NNP O
2006 CD O
) -RRB- O
. . O

In IN O
Guiyu NNP O
, , O
the DT O
BLLs NNPS O
of IN O
children NNS B-Species
were VBD O
higher JJR O
than IN O
the DT O
mean JJ O
level NN O
in IN O
China NNP O
, , O
and CC O
there EX O
were VBD O
no DT O
significant JJ O
different JJ O
between IN O
boys NNS B-Species
and CC O
girls NNS B-Species
. . O

Although IN O
Guiyu NNP O
is VBZ O
rural JJ O
, , O
the DT O
children NNS B-Species
' POS O
s NNS O
BLLs NNS O
were VBD O
nearly RB O
double PDT O
those DT O
of IN O
a DT O
nearby JJ O
urban JJ O
area NN O
, , O
Shantou NNP O
City NNP O
( , O
7 CD O
. . O
9 CD O
mu NN O
g NN O
/ SYM O
dL NNP O
; : O
Luo NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
. . O

Compared VBN O
with IN O
results NNS O
from IN O
studies NNS O
conducted VBN O
in IN O
some DT O
other JJ O
part NN O
of IN O
Guangdong NNP O
province NN O
, , O
such JJ O
as IN O
Zhongshan NNP O
City NNP O
( , O
7 CD O
. . O
45 CD O
mu NN O
g NN O
/ : O
dL NNP O
; , O
Huang NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
and CC O
Shenzhen NNP O
City NNP O
( , O
9 CD O
. . O
6 CD O
mu NN O
g NN O
/ : O
dL NN O
; , O
Wang NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
, , O
we PRP O
observed VBD O
higher JJR O
BLLs NNS O
not RB O
only RB O
in IN O
Guiyu NNP O
children NNS B-Species
, , O
but CC O
also RB O
in IN O
Chendian JJ O
children NNS B-Species
( , O
9 CD O
. . O
94 CD O
mu NN O
g NN O
/ SYM O
dL NN O
) -RRB- O
. . O

The DT O
lead JJ O
contamination NN O
may MD O
have VB O
spread VBN O
from IN O
Guiyu NNP O
to IN O
nearby JJ O
Chendian NNP O
by IN O
dust NN O
, , O
river NN O
, , O
and CC O
air NN O
and CC O
contributed VBN O
to IN O
the DT O
elevation NN O
of IN O
Chendian JJ O
children NNS B-Species
' POS O
s NN O
BLLs NNS O
. . O

In IN O
conclusion NN O
, , O
elevated VBN O
BLLs NNS O
in IN O
Guiyu NNP O
children NNS B-Species
are VBP O
common JJ O
as IN O
a DT O
result NN O
of IN O
exposure NN O
to IN O
lead NN O
contamination NN O
caused VBN O
by IN O
primitive JJ O
e NN O
- HYPH O
waste NN O
recycling NN O
activities NNS O
. . O

Lead NN O
contamination NN O
from IN O
e JJ O
- HYPH O
waste NN O
processing NN O
appears VBZ O
to TO O
have VB O
reached VBN O
the DT O
level NN O
considered VBN O
to TO O
be VB O
a DT O
serious JJ O
threat NN O
to IN O
children NNS B-Species
' POS O
s NNS O
health NN O
around IN O
the DT O
e JJ O
- HYPH O
waste NN O
recycling NN O
area NN O
. . O

Based VBN O
on IN O
these DT O
threats NNS O
, , O
it PRP O
is VBZ O
necessary JJ O
to TO O
increase VB O
public JJ O
awareness NN O
about IN O
the DT O
effects NNS O
of IN O
exposure NN O
to IN O
lead NN O
from IN O
e NN O
- HYPH O
waste NN O
and CC O
arouse VB O
local JJ O
governments NNS O
' POS O
interest NN O
in IN O
public JJ O
health NN O
and CC O
safety NN O
, , O
so IN O
that IN O
an DT O
infrastructure NN O
for IN O
safe JJ O
management NN O
of IN O
e NN O
- HYPH O
waste NN O
can MD O
be VB O
established VBN O
. . O

More RBR O
important JJ O
, , O
responsible JJ O
management NN O
strategies NNS O
should MD O
be VB O
undertaken VBN O
to TO O
minimize VB O
e NN O
- HYPH O
waste NN O
production NN O
and CC O
make VB O
e NN O
- HYPH O
waste NN O
components NNS O
more RBR O
easily RB O
recycled VBN O
and CC O
reused VBN O
. . O

Correction NN O

In IN O
the DT O
Abstract NNP O
and CC O
Discussion NNP O
, , O
the DT O
percentage NN O
of IN O
Guiyu NNP O
children NNS B-Species
with IN O
BLLs NNS O
> SYM O
10 CD O
mu NNS O
g NN O
/ SYM O
dL NN O
has VBZ O
been VBN O
corrected VBN O
from IN O
88 CD O
% NN O
in IN O
the DT O
original JJ O
manuscript NN O
published VBN O
online RB O
to IN O
81 CD O
. . O
8 CD O
% NN O
. . O

Dynein NNP O
Modifiers NNP O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
: : O
Light JJ O
Chains NNS O
Suppress VBP O
Conditional JJ O
Heavy NNP O
Chain NNP O
Mutants NNS O

Abstract JJ O

Cytoplasmic JJ O
dynein NN O
is VBZ O
a DT O
microtubule NN O
- HYPH O
dependent JJ O
motor NN O
protein NN O
that WDT O
functions VBZ O
in IN O
mitotic JJ O
cells NNS O
during IN O
centrosome NN O
separation NN O
, , O
metaphase NN O
chromosome NN O
congression NN O
, , O
anaphase NN O
spindle NN O
elongation NN O
, , O
and CC O
chromosome NN O
segregation NN O
. . O

Dynein NNP O
is VBZ O
also RB O
utilized VBN O
during IN O
interphase NN O
for IN O
vesicle NN O
transport NN O
and CC O
organelle NN O
positioning NN O
. . O

While IN O
numerous JJ O
cellular JJ O
processes NNS O
require VBP O
cytoplasmic JJ O
dynein NN O
, , O
the DT O
mechanisms NNS O
that WDT O
target VBP O
and CC O
regulate VBP O
this DT O
microtubule NN O
motor NN O
remain VBP O
largely RB O
unknown JJ O
. . O

By IN O
screening VBG O
a DT O
conditional JJ O
Caenorhabditis NNP B-Species
elegans NNS I-Species
cytoplasmic JJ O
dynein NN O
heavy JJ O
chain NN O
mutant NN O
at IN O
a DT O
semipermissive JJ O
temperature NN O
with IN O
a DT O
genome NN O
- HYPH O
wide JJ O
RNA NNP O
interference NN O
library NN O
to TO O
reduce VB O
gene NN O
functions NNS O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
characterized VBN O
twenty CD O
dynein NN O
- HYPH O
specific JJ O
suppressor NN O
genes NNS O
. . O

When WRB O
reduced VBN O
in IN O
function NN O
, , O
these DT O
genes NNS O
suppress VBP O
dynein NN O
mutants NNS O
but CC O
not RB O
other JJ O
conditionally RB O
mutant JJ O
loci NN O
, , O
and CC O
twelve CD O
of IN O
the DT O
20 CD O
specific JJ O
suppressors NNS O
do VBP O
not RB O
exhibit VB O
sterile JJ O
or CC O
lethal JJ O
phenotypes NNS O
when WRB O
their PRP$ O
function NN O
is VBZ O
reduced VBN O
in IN O
wild JJ O
- HYPH O
type NN O
worms NNS B-Species
. . O

Many JJ O
of IN O
the DT O
suppressor NN O
proteins NNS O
, , O
including VBG O
two CD O
dynein NN O
light JJ O
chains NNS O
, , O
localize VBP O
to IN O
subcellular JJ O
sites NNS O
that WDT O
overlap VBP O
with IN O
those DT O
reported VBN O
by IN O
others NNS O
for IN O
the DT O
dynein NN O
heavy JJ O
chain NN O
. . O

Furthermore RB O
, , O
knocking VBG O
down RP O
any DT O
one CD O
of IN O
four CD O
putative JJ O
dynein NN O
accessory NN O
chains NNS O
suppresses VBZ O
the DT O
conditional JJ O
heavy JJ O
chain NN O
mutants NNS O
, , O
suggesting VBG O
that IN O
some DT O
accessory NN O
chains NNS O
negatively RB O
regulate VBP O
heavy JJ O
chain NN O
function NN O
. . O

We PRP O
also RB O
identified VBD O
29 CD O
additional JJ O
genes NNS O
that WDT O
, , O
when WRB O
reduced VBN O
in IN O
function NN O
, , O
suppress VBP O
conditional JJ O
mutations NNS O
not RB O
only RB O
in IN O
dynein NN O
but CC O
also RB O
in IN O
loci NN O
required VBN O
for IN O
unrelated JJ O
essential JJ O
processes NNS O
. . O

In IN O
conclusion NN O
, , O
we PRP O
have VBP O
identified VBN O
twenty CD O
genes NNS O
that WDT O
in IN O
many JJ O
cases NNS O
are VBP O
not RB O
essential JJ O
themselves PRP O
but CC O
are VBP O
conserved VBN O
and CC O
when WRB O
reduced VBN O
in IN O
function NN O
can MD O
suppress VB O
conditionally RB O
lethal JJ O
C NN B-Species
. . I-Species
elegans NNS I-Species
cytoplasmic JJ O
dynein NN O
heavy JJ O
chain NN O
mutants NNS O
. . O

We PRP O
conclude VBP O
that IN O
conserved JJ O
but CC O
nonessential JJ O
genes NNS O
contribute VBP O
to IN O
dynein NN O
function NN O
during IN O
the DT O
essential JJ O
process NN O
of IN O
mitosis NN O
. . O

Microtubules NN O
and CC O
microtubule NN O
- HYPH O
dependent JJ O
motor NN O
proteins NNS O
segregate VBP O
chromosomes NNS O
during IN O
mitosis NN O
and CC O
also RB O
promote VBP O
cellular JJ O
organization NN O
in IN O
nondividing JJ O
cells NNS O
. . O

An DT O
essential JJ O
motor NN O
protein NN O
complex NN O
called VBN O
cytoplasmic JJ O
dynein NN O
powers VBZ O
many JJ O
aspects NNS O
of IN O
microtubule NN O
- HYPH O
dependent JJ O
transport NN O
, , O
but CC O
it PRP O
is VBZ O
currently RB O
unclear JJ O
how WRB O
dynein NN O
is VBZ O
regulated VBN O
such JJ O
that IN O
it PRP O
can MD O
execute VB O
different JJ O
processes NNS O
. . O

We PRP O
have VBP O
performed VBN O
a DT O
genome NN O
- HYPH O
wide JJ O
screen NN O
to TO O
isolate VB O
genes NNS O
that WDT O
are VBP O
involved VBN O
in IN O
dynein NN O
- HYPH O
dependent JJ O
processes NNS O
. . O

We PRP O
determined VBD O
that IN O
20 CD O
of IN O
the DT O
49 CD O
genes NNS O
we PRP O
identified VBD O
specifically RB O
influenced VBD O
the DT O
viability NN O
of IN O
dynein NN O
mutant JJ O
strains NNS O
but CC O
not RB O
the DT O
viability NN O
of IN O
other JJ O
C NN B-Species
. . I-Species
elegans NNS I-Species
mutants NNS O
. . O

Many JJ O
of IN O
the DT O
proteins NNS O
that WDT O
specifically RB O
influence VBP O
dynein NN O
localized VBN O
to IN O
subcellular JJ O
sites NNS O
where WRB O
the DT O
dynein NN O
heavy JJ O
chain NN O
has VBZ O
been VBN O
reported VBN O
by IN O
others NNS O
to TO O
be VB O
found VBN O
. . O

Additionally RB O
, , O
we PRP O
identified VBD O
four CD O
dynein NN O
components NNS O
that WDT O
appear VBP O
to TO O
negatively RB O
regulate VB O
the DT O
force NN O
- HYPH O
generating VBG O
dynein NN O
heavy JJ O
chain NN O
. . O

The DT O
identification NN O
and CC O
initial JJ O
characterization NN O
of IN O
this DT O
group NN O
of IN O
genes NNS O
represents VBZ O
a DT O
route NN O
to TO O
identify VB O
genes NNS O
that WDT O
are VBP O
not RB O
themselves PRP O
essential JJ O
but CC O
do VBP O
participate VB O
in IN O
essential JJ O
processes NNS O
. . O

Introduction NN O

The DT O
microtubule NN O
motor NN O
called VBN O
cytoplasmic JJ O
dynein NN O
has VBZ O
roles NNS O
in IN O
diverse JJ O
cellular JJ O
processes NNS O
including VBG O
meiotic JJ O
and CC O
mitotic JJ O
spindle NN O
assembly NN O
and CC O
function NN O
, , O
neuronal JJ O
transport NN O
, , O
and CC O
organelle NN O
positioning NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Cytoplasmic JJ O
dynein NN O
is VBZ O
composed VBN O
of IN O
a DT O
dimer NN O
of IN O
heavy JJ O
chains NNS O
( , O
HCs NNP O
) -RRB- O
, , O
along IN O
with IN O
several JJ O
accessory NN O
chains NNS O
( : O
ACs NNS O
: : O
intermediate JJ O
, , O
light JJ O
intermediate NN O
, , O
and CC O
light JJ O
chains NNS O
) -RRB- O
. . O

Other JJ O
dynein NN O
- HYPH O
interacting VBG O
proteins NNS O
, , O
such JJ O
as IN O
dynactin NN O
and CC O
LIS1 NN O
, , O
are VBP O
likely RB O
present JJ O
at IN O
substoichiometric JJ O
levels NNS O
and CC O
further RB O
modulate VBP O
dynein NN O
function NN O
. . O

The DT O
HCs NNPS O
contain VBP O
both CC O
ATPase NNP O
and CC O
microtubule NN O
binding NN O
activities NNS O
and CC O
are VBP O
sufficient JJ O
for IN O
microtubule NN O
- HYPH O
based VBN O
motility NN O
in IN O
vitro NN O
, , O
moving VBG O
toward IN O
the DT O
minus NN O
, , O
or CC O
slow RB O
- HYPH O
growing VBG O
, , O
end NN O
of IN O
microtubules NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

The DT O
dynein NN O
ACs NNS O
provide VBP O
cargo NN O
docking NN O
sites NNS O
and CC O
often RB O
are VBP O
encoded VBN O
by IN O
multigene NN O
families NNS O
in IN O
any DT O
one CD O
species NN O
[ -LRB- O
reviewed VBN O
in IN O
1 CD O
, , O
3 CD O
] -RRB- O
. . O

In IN O
C NNP B-Species
. . I-Species
elegans NNS I-Species
, , O
a DT O
single JJ O
gene NN O
called VBN O
dhc NN O
- HYPH O
1 CD O
encodes VBZ O
a DT O
cytoplasmic JJ O
dynein NN O
1 CD O
HC NN O
, , O
while IN O
11 CD O
other JJ O
genes NNS O
encode VBP O
five CD O
classes NNS O
of IN O
predicted VBN O
dynein NN O
ACs NNS O
[ -LRB- O
3 CD O
, , O
4 CD O
] -RRB- O
. . O

The DT O
early JJ O
C NN B-Species
. , I-Species
elegans NNS I-Species
embryo NN O
is VBZ O
an DT O
excellent JJ O
system NN O
for IN O
investigating VBG O
gene NN O
contributions NNS O
for IN O
essential JJ O
cellular JJ O
processes NNS O
, , O
including VBG O
cytoskeletal JJ O
functions NNS O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
C NN B-Species
. . I-Species
elegans NN I-Species
dynein NN O
HC NNP O
DHC NNP O
- HYPH O
1 CD O
is VBZ O
essential JJ O
and CC O
required VBN O
for IN O
multiple JJ O
microtubule NN O
- HYPH O
dependent JJ O
events NNS O
during IN O
early JJ O
embryogenesis NN O
[ -LRB- O
6 CD O
- SYM O
9 CD O
] -RRB- O
. . O

Depletion NN O
of IN O
DHC NNP O
- HYPH O
1 CD O
by IN O
RNA NNP O
interference NN O
( -LRB- O
RNAi NNP O
) -RRB- O
in IN O
early JJ O
C NN B-Species
. , I-Species
elegans NN I-Species
embryos NNS O
produces VBZ O
defects NNS O
in IN O
female JJ O
meiotic JJ O
divisions NNS O
, , O
migration NN O
of IN O
the DT O
oocyte NN O
and CC O
sperm NN O
pronuclei NN O
after IN O
fertilization NN O
, , O
and CC O
centrosome NN O
separation NN O
during IN O
mitotic JJ O
spindle NN O
assembly NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Analysis NN O
of IN O
fast RB O
- HYPH O
acting VBG O
dhc NN O
- HYPH O
1 CD O
temperature NN O
- HYPH O
sensitive JJ O
( , O
ts VBZ O
) -RRB- O
mutants NNS O
has VBZ O
further RB O
revealed VBN O
that IN O
dynein NN O
is VBZ O
required VBN O
for IN O
chromosome NN O
congression NN O
to IN O
the DT O
metaphase NN O
plate NN O
during IN O
mitosis NN O
, , O
as RB O
well RB O
as IN O
for IN O
mitotic JJ O
spindle NN O
positioning NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

While IN O
many JJ O
requirements NNS O
for IN O
cytoplasmic JJ O
dynein NN O
are VBP O
known VBN O
, , O
our PRP$ O
knowledge NN O
of IN O
the DT O
molecular JJ O
mechanisms NNS O
that WDT O
target VBP O
and CC O
regulate VBP O
dynein NN O
remains VBZ O
limited JJ O
. . O

Clearly RB O
, , O
the DT O
multiple JJ O
ACs NNS O
can MD O
couple VB O
the DT O
dynein NN O
HC NNP O
to IN O
particular JJ O
substrates NNS O
[ -LRB- O
11 CD O
] -RRB- O
, , O
including VBG O
vesicles NNS O
, , O
nuclei NNS O
, , O
viruses NNS O
, , O
kinetochores NNS O
, , O
and CC O
rhodopsin NN O
[ -LRB- O
see VB O
table NN O
in IN O
1 CD O
] -RRB- O
. . O

However RB O
, , O
reducing VBG O
the DT O
function NN O
of IN O
only RB O
four CD O
of IN O
the DT O
eleven CD O
dynein NN O
ACs NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
produces VBZ O
lethal JJ O
phenotypes NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Thus RB O
, , O
it PRP O
remains VBZ O
unclear JJ O
how WRB O
ACs NNS O
influence VBP O
the DT O
different JJ O
essential JJ O
requirements NNS O
for IN O
dynein NN O
. . O

Another DT O
potential JJ O
route NN O
for IN O
dynein NN O
regulation NN O
involves VBZ O
the DT O
phosphorylation NN O
state NN O
of IN O
the DT O
different JJ O
dynein NN O
chains NNS O
, , O
which WDT O
in IN O
some DT O
cases NNS O
confers VBZ O
distinctive JJ O
functional JJ O
properties NNS O
to IN O
the DT O
motor NN O
. . O

While IN O
many JJ O
examples NNS O
of IN O
dynein NN O
phosphorylation NN O
exist VBP O
, , O
and CC O
cell NN O
cycle NN O
dependent JJ O
changes NNS O
in IN O
phosphorylation NN O
have VBP O
been VBN O
described VBN O
[ -LRB- O
13 CD O
- SYM O
15 CD O
] -RRB- O
, , O
few JJ O
if IN O
any DT O
studies NNS O
have VBP O
demonstrated VBN O
a DT O
requirement NN O
for IN O
such JJ O
modification NN O
during IN O
mitosis NN O
. . O

Large JJ O
- HYPH O
scale NN O
forward JJ O
genetic JJ O
screens NNS O
have VBP O
identified VBN O
genes NNS O
with IN O
requirements NNS O
similar JJ O
to IN O
those DT O
for IN O
dynein NN O
, , O
but CC O
many JJ O
of IN O
these DT O
encode VBP O
core NN O
components NNS O
of IN O
the DT O
microtubule NN O
cytoskeleton NN O
and CC O
few JJ O
are VBP O
known VBN O
to TO O
directly RB O
influence VB O
dynein NN O
itself PRP O
[ -LRB- O
12 CD O
, , O
16 CD O
] -RRB- O
. . O

Genes NNS O
that WDT O
do VBP O
influence VB O
dynein NN O
function NN O
might MD O
also RB O
have VB O
other JJ O
essential JJ O
roles NNS O
, , O
leading VBG O
to IN O
pleiotropic JJ O
mutant JJ O
phenotypes NNS O
that WDT O
obscure VBP O
their PRP$ O
relationship NN O
to IN O
dynein NN O
[ -LRB- O
17 CD O
- HYPH O
19 CD O
] -RRB- O
. . O

Moreover RB O
, , O
redundancy NN O
within IN O
the DT O
multigene NN O
dynein NN O
subunit NN O
families NNS O
, , O
and CC O
also RB O
perhaps RB O
between IN O
the DT O
different JJ O
ACs NNS O
, , O
may MD O
complicate VB O
the DT O
identification NN O
of IN O
single JJ O
gene NN O
requirements NNS O
that WDT O
are VBP O
important JJ O
for IN O
dynein NN O
function NN O
. . O

Thus RB O
far RB O
, , O
reducing VBG O
the DT O
function NN O
of IN O
individual JJ O
genes NNS O
has VBZ O
not RB O
provided VBN O
substantial JJ O
insight NN O
into IN O
the DT O
mechanisms NNS O
that WDT O
regulate VBP O
and CC O
mediate VBP O
the DT O
many JJ O
different JJ O
requirements NNS O
for IN O
cytoplasmic JJ O
dynein NN O
during IN O
mitosis NN O
. . O

To TO O
identify VB O
potential JJ O
regulators NNS O
of IN O
cytoplasmic JJ O
dynein NN O
, , O
we PRP O
have VBP O
used VBN O
a DT O
sensitized JJ O
genetic JJ O
background NN O
to TO O
conduct VB O
a DT O
genome NN O
- HYPH O
wide JJ O
screen NN O
for IN O
modifiers NNS O
of IN O
dynein NN O
function NN O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
. . O

Other JJ O
groups NNS O
have VBP O
successfully RB O
used VBN O
RNAi NNP O
modifier NN O
screens NNS O
to TO O
identify VB O
genes NNS O
that WDT O
function VBP O
in IN O
particular JJ O
pathways NNS O
[ -LRB- O
20 CD O
- SYM O
23 CD O
] -RRB- O
; , O
we PRP O
have VBP O
used VBN O
RNAi NNP O
to TO O
screen VB O
for IN O
genes NNS O
that WDT O
, , O
when WRB O
reduced VBN O
in IN O
function NN O
, , O
suppress VB O
the DT O
embryonic JJ O
lethality NN O
associated VBN O
with IN O
a DT O
temperature NN O
- HYPH O
sensitive JJ O
( , O
ts VBZ O
) -RRB- O
allele NN O
of IN O
the DT O
dhc NN O
- HYPH O
1 CD O
dynein NN O
HC NN O
gene NN O
. . O

Using VBG O
the DT O
dhc NN O
- HYPH O
1ts NNS O
genetic JJ O
background NN O
, , O
we PRP O
found VBD O
49 CD O
genes NNS O
that WDT O
, , O
when WRB O
depleted VBN O
, , O
suppress VBP O
the DT O
partial JJ O
loss NN O
of IN O
HC NN O
function NN O
. . O

Twenty CD O
of IN O
these DT O
genes NNS O
suppress VBP O
conditional JJ O
dynein NN O
HC NNP O
mutants NNS O
but CC O
not RB O
other JJ O
conditional JJ O
mutants NNS O
with IN O
unrelated JJ O
defects NNS O
. . O

Finally RB O
, , O
we PRP O
show VBP O
that IN O
some DT O
of IN O
these DT O
dynein NN O
- HYPH O
specific JJ O
suppressors NNS O
encode VBP O
proteins NNS O
that WDT O
may MD O
overlap VB O
with IN O
the DT O
dynein NN O
HC NNP O
in IN O
subcellular JJ O
localization NN O
. . O

Results NNS O

To TO O
identify VB O
dynein NN O
suppressors NNS O
, , O
we PRP O
used VBD O
three CD O
different JJ O
conditional JJ O
and CC O
recessive JJ O
dhc NN O
- HYPH O
1 CD O
mutants NNS O
that WDT O
were VBD O
identified VBN O
previously RB O
[ -LRB- O
7 CD O
] -RRB- O
. . O

These DT O
ts NNS O
alleles NNS O
of IN O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
, , O
or283 CD O
, , O
and CC O
or352 CD O
) -RRB- O
produce VBP O
similar JJ O
defects NNS O
at IN O
the DT O
restrictive JJ O
temperature NN O
of IN O
26 CD O
degrees NNS O
C NN O
, , O
including VBG O
incomplete JJ O
mitotic JJ O
spindle NN O
assembly NN O
in IN O
one CD O
- HYPH O
cell NN O
embryos NNS O
and CC O
embryonic JJ O
lethality NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

We PRP O
sequenced VBD O
the DT O
dhc NN O
- HYPH O
1 CD O
locus NN O
in IN O
the DT O
three CD O
mutants NNS O
. . O

The DT O
independently RB O
isolated VBN O
or195 CD O
and CC O
or283 CD O
alleles NNS O
each DT O
change VBP O
a DT O
conserved VBN O
serine NN O
to IN O
leucine NN O
at IN O
codon NN O
3200 CD O
, , O
within IN O
the DT O
coiled VBN O
- HYPH O
coil NN O
region NN O
of IN O
the DT O
microtubule NN O
- HYPH O
binding VBG O
stalk NN O
domain NN O
( -LRB- O
Figure NNP O
1A NN O
and CC O
1C NN O
) -RRB- O
. . O

The DT O
or352 CD O
allele NN O
replaces VBZ O
a DT O
conserved VBN O
glycine NN O
with IN O
aspartic JJ O
acid NN O
at IN O
codon NN O
2158 CD O
, , O
in IN O
the DT O
ATP NNP O
- HYPH O
binding VBG O
walker NN O
A DT O
motif NN O
of IN O
the DT O
second JJ O
AAA NNP O
ATPase NNP O
domain NN O
( -LRB- O
Figure NNP O
1B NN O
and CC O
1C NN O
) -RRB- O
. . O

As IN O
both DT O
missense JJ O
mutations NNS O
affect VBP O
conserved JJ O
residues NNS O
, , O
they PRP O
may MD O
prove VB O
useful JJ O
for IN O
engineering NN O
ts VBZ O
alleles NNS O
in IN O
other JJ O
organisms NNS O
. . O

The DT O
temperature NN O
versus IN O
viability NN O
curves NNS O
of IN O
the DT O
dynein NN O
ts POS O
mutants NNS O
feature VBP O
a DT O
steep JJ O
central JJ O
transition NN O
zone NN O
ideal JJ O
for IN O
modifier NN O
screening NN O
because IN O
subtle JJ O
changes NNS O
in IN O
temperature NN O
produce VBP O
large JJ O
changes NNS O
in IN O
embryonic JJ O
viability NN O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

To TO O
identify VB O
genes NNS O
that WDT O
, , O
when WRB O
reduced VBN O
in IN O
function NN O
, , O
can MD O
suppress VB O
conditional JJ O
dhc NN O
- HYPH O
1 CD O
mutants NNS O
, , O
we PRP O
developed VBD O
a DT O
high JJ O
- HYPH O
throughput NN O
RNAi NN O
- HYPH O
based VBN O
screen NN O
( -LRB- O
Figure NNP O
2B NN O
) -RRB- O
. . O

To TO O
reduce VB O
gene NN O
function NN O
we PRP O
used VBD O
a DT O
library NN O
of IN O
16 CD O
, , O
757 CD O
bacterial JJ O
strains NNS O
that WDT O
each DT O
express VBP O
a DT O
dsRNA NN O
corresponding VBG O
to IN O
exon NN O
- HYPH O
rich JJ O
gene NN O
sequences NNS O
[ -LRB- O
17 CD O
, , O
19 CD O
] -RRB- O
. . O

We PRP O
then RB O
tested VBD O
over IN O
99 CD O
% NN O
of IN O
the DT O
bacterial JJ O
strains NNS O
in IN O
this DT O
library NN O
for IN O
RNAi NNP O
- HYPH O
mediated VBN O
suppression NN O
of IN O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) SYM O
embryonic JJ O
lethality NN O
at IN O
23 CD O
degrees NNS O
C NN O
, , O
after IN O
raising VBG O
synchronized VBN O
L1 NNP O
larvae NN O
to IN O
adulthood NN O
on IN O
dsRNA NN O
- HYPH O
expressing VBG O
bacterial JJ O
lawns NNS O
in IN O
48 CD O
- HYPH O
well RB O
agar JJ O
plates NNS O
. . O

This DT O
screening NN O
procedure NN O
should MD O
work VB O
to TO O
identify VB O
nonessential JJ O
and CC O
essential JJ O
suppressor NN O
genes NNS O
, , O
because IN O
RNAi NNP O
does VBZ O
not RB O
always RB O
fully RB O
reduce VB O
gene NN O
function NN O
[ -LRB- O
24 CD O
, , O
25 CD O
] -RRB- O
, , O
and CC O
even RB O
if IN O
RNAi NNP O
does VBZ O
produce VB O
lethality NN O
, , O
cosuppression NN O
could MD O
restore VB O
viability NN O
. . O

Nevertheless RB O
, , O
essential JJ O
genes NNS O
may MD O
be VB O
missed VBN O
due IN O
to IN O
earlier JJR O
requirements NNS O
that WDT O
produce VBP O
strong JJ O
larval JJ O
arrest NN O
, , O
sterile JJ O
, , O
or CC O
embryonic JJ O
lethal JJ O
phenotypes NNS O
. . O

Using VBG O
this DT O
screening NN O
procedure NN O
, , O
we PRP O
identified VBD O
49 CD O
bacterial JJ O
clones NNS O
that WDT O
consistently RB O
increased VBD O
embryonic JJ O
viability NN O
at IN O
the DT O
semipermissive JJ O
temperature NN O
. . O

The DT O
dsRNA NN O
- HYPH O
producing VBG O
plasmids NNS O
were VBD O
then RB O
sequenced VBN O
to TO O
verify VB O
gene NN O
identity NN O
. . O

Quantification NN O
of IN O
embryonic JJ O
viability NN O
using VBG O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
animals NNS O
showed VBD O
that IN O
the DT O
RNAi NNP O
- HYPH O
mediated VBN O
depletion NN O
of IN O
suppressor NN O
gene NN O
function NN O
increased VBD O
viability NN O
to IN O
5 CD O
% NN O
- SYM O
100 CD O
% NN O
, , O
compared VBN O
to IN O
less JJR O
than IN O
2 CD O
% NN O
in IN O
unsuppressed JJ O
controls NNS O
( -LRB- O
Figure NN O
3A CD O
; : O
Table NNP O
S1 NNP O
) -RRB- O
. . O

The DT O
proteins NNS O
encoded VBN O
by IN O
the DT O
suppressor NN O
genes NNS O
we PRP O
identified VBD O
are VBP O
summarized VBN O
in IN O
Figure NNP O
4 CD O
. . O

As IN O
a DT O
more RBR O
direct JJ O
assay NN O
for IN O
dynein NN O
activity NN O
in IN O
the DT O
suppressed JJ O
dhc NN O
- HYPH O
1 CD O
embryos NNS O
, , O
we PRP O
measured VBD O
spindle NN O
length NN O
and CC O
cytokinesis NN O
success NN O
: : O
dhc FW O
- HYPH O
1 CD O
mutant JJ O
embryos NNS O
have VBP O
severe JJ O
spindle NN O
assembly NN O
defects NNS O
and CC O
subsequent JJ O
cytokinesis NN O
failures NNS O
[ -LRB- O
6 CD O
, , O
7 CD O
, , O
10 CD O
] -RRB- O
. . O

We PRP O
shifted VBD O
dhc NN O
- HYPH O
1 CD O
adult NN O
hermaphrodites NNS O
from IN O
23 CD O
degrees NNS O
C NN O
to IN O
the DT O
fully RB O
restrictive JJ O
temperature NN O
of IN O
26 CD O
degrees NNS O
C NN O
for IN O
3 CD O
- SYM O
5 CD O
hours NNS O
and CC O
made VBN O
time NN O
- HYPH O
lapse NN O
video NN O
micrographs NNS O
using VBG O
Nomarski NNP O
optics NNS O
to TO O
monitor VB O
the DT O
first JJ O
embryonic JJ O
cell NN O
division NN O
. . O

This DT O
procedure NN O
results VBZ O
in IN O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
embryos NNS O
with IN O
P0 NN O
spindles NNS O
30 CD O
% NN O
the DT O
length NN O
of IN O
wild JJ O
- HYPH O
type NN O
spindles NNS O
( -LRB- O
Figure NNP O
S1 NNP O
) -RRB- O
. . O

In IN O
the DT O
suppressed JJ O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
backgrounds NNS O
, , O
spindle NN O
lengths NNS O
ranged VBD O
from IN O
30 CD O
% NN O
- SYM O
83 CD O
% NN O
of IN O
wild JJ O
- HYPH O
type NN O
lengths NNS O
( -LRB- O
Figure NNP O
S1 NNP O
) -RRB- O
. . O

Similarly RB O
, , O
cytokinesis NN O
failed VBD O
in IN O
unsuppressed JJ O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) SYM O
embryos NNS O
89 CD O
% NN O
of IN O
the DT O
time NN O
, , O
but CC O
most JJS O
of IN O
the DT O
suppressors NNS O
rescued VBD O
this DT O
phenotype NN O
( -LRB- O
Figure NNP O
S1 NNP O
) -RRB- O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
most JJS O
of IN O
the DT O
suppressors NNS O
influence VBP O
dynein NN O
- HYPH O
dependent JJ O
cellular JJ O
processes NNS O
, , O
as IN O
expected VBN O
given VBN O
their PRP$ O
ability NN O
to TO O
restore VB O
viability NN O
when WRB O
reduced VBN O
in IN O
function NN O
. . O

Specificity NN O
of IN O
Suppression NN O

Because IN O
RNAi NNP O
can MD O
reduce VB O
the DT O
function NN O
of IN O
unintended JJ O
targets NNS O
( , O
so RB O
- HYPH O
called VBN O
"""" `` O
off JJ O
- HYPH O
target NN O
effects NNS O
"""" '' O
[ -LRB- O
26 CD O
, , O
27 CD O
] -RRB- O
) -RRB- O
, , O
we PRP O
also RB O
used VBD O
available JJ O
mutations NNS O
in IN O
some DT O
of IN O
the DT O
suppressor NN O
genes NNS O
we PRP O
identified VBD O
to TO O
reduce VB O
their PRP$ O
function NN O
. . O

We PRP O
constructed VBD O
double JJ O
mutant JJ O
strains NNS O
using VBG O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
and CC O
viable JJ O
deletion NN O
alleles NNS O
for IN O
two CD O
suppressor NN O
genes NNS O
, , O
dylt NN O
- HYPH O
1 CD O
( HYPH O
ok417 CD O
) -RRB- O
and CC O
ufd NN O
- HYPH O
2 CD O
( SYM O
tm1380 CD O
) -RRB- O
, , O
and CC O
examined VBN O
embryonic JJ O
viability NN O
( -LRB- O
Figure NN O
3B NN O
) -RRB- O
. . O

The DT O
deletion NN O
alleles NNS O
of IN O
dylt NN O
- HYPH O
1 CD O
( HYPH O
encoding VBG O
a DT O
Tctex1 NNP O
- HYPH O
type NN O
dynein NN O
light JJ O
chain NN O
) -RRB- O
, , O
and CC O
ufd NN O
- HYPH O
2 CD O
( HYPH O
encoding VBG O
a DT O
ubiquitin NN O
conjugating VBG O
enzyme NN O
) , O
both DT O
recapitulated VBD O
the DT O
suppression NN O
produced VBN O
by IN O
RNAi NNP O
knockdown NN O
( -LRB- O
Figure NN O
3B NN O
) -RRB- O
. . O

The DT O
dpy JJ O
- HYPH O
3 CD O
( HYPH O
e27 CD O
) -RRB- O
and CC O
dpy NN O
- HYPH O
10 CD O
( HYPH O
e128 CD O
) -RRB- O
point NN O
mutation NN O
alleles NNS O
[ -LRB- O
28 CD O
] -RRB- O
also RB O
suppressed VBD O
embryonic JJ O
lethality NN O
in IN O
double JJ O
mutants NNS O
( -LRB- O
Figure NNP O
3B NNP O
) -RRB- O
. . O

Based VBN O
on IN O
this DT O
small JJ O
sampling NN O
, , O
and CC O
because IN O
RNAi NNP O
in IN O
C NNP B-Species
. . I-Species
elegans NNS I-Species
appears VBZ O
to TO O
be VB O
highly RB O
gene NN O
specific JJ O
in IN O
the DT O
absence NN O
of IN O
close JJ O
paralogs NNS O
[ -LRB- O
12 CD O
, , O
19 CD O
] -RRB- O
, , O
we PRP O
conclude VBP O
that IN O
many JJ O
of IN O
the DT O
suppressors NNS O
we PRP O
have VBP O
identified VBN O
will MD O
prove VB O
to TO O
be VB O
suppressor NN O
locus NN O
specific JJ O
. . O

The DT O
dsRNA NN O
- HYPH O
expressing VBG O
bacterial JJ O
clones NNS O
we PRP O
used VBD O
to TO O
deplete VB O
two CD O
of IN O
the DT O
dynein NN O
suppressors NNS O
( -LRB- O
tag NN O
- HYPH O
300 CD O
and CC O
ZK1127 NN O
. . O
10 CD O
) -RRB- O
probably RB O
also RB O
knock VBP O
down RP O
expression NN O
of IN O
one CD O
close JJ O
paralog NN O
for IN O
each DT O
locus NN O
[ -LRB- O
29 CD O
] -RRB- O
. . O

We PRP O
next RB O
asked VBD O
whether IN O
the DT O
suppressors NNS O
are VBP O
specific JJ O
for IN O
dynein NN O
function NN O
or CC O
if IN O
their PRP$ O
depletion NN O
more RBR O
generally RB O
stabilizes VBZ O
ts POS O
proteins NNS O
. . O

We PRP O
tested VBD O
for IN O
specificity NN O
using VBG O
two CD O
conditional JJ O
mutants NNS O
with IN O
cell NN O
fate NN O
patterning NN O
defects NNS O
unrelated JJ O
to IN O
dynein NN O
function NN O
, , O
lit VBN O
- HYPH O
1 CD O
( SYM O
or131 CD O
) -RRB- O
and CC O
spn NN O
- HYPH O
4 CD O
( SYM O
or191 CD O
) -RRB- O
. . O

The DT O
lit NN O
- HYPH O
1 CD O
gene NN O
encodes VBZ O
a DT O
MAP NN O
kinase NN O
- HYPH O
related VBN O
protein NN O
[ -LRB- O
30 CD O
] -RRB- O
, , O
while IN O
spn NN O
- HYPH O
4 CD O
encodes VBZ O
a DT O
protein NN O
with IN O
an DT O
RNA NNP O
binding NN O
motif NN O
[ -LRB- O
31 CD O
] -RRB- O
. . O

We PRP O
found VBD O
that IN O
ten CD O
of IN O
the DT O
dhc NN O
- HYPH O
1 CD O
- HYPH O
interacting VBG O
genes NNS O
significantly RB O
increased VBD O
embryonic JJ O
viability NN O
in IN O
both DT O
lit NN O
- HYPH O
1 CD O
and CC O
spn CD O
- HYPH O
4 CD O
mutants NNS O
, , O
while IN O
18 CD O
others NNS O
suppressed VBD O
one CD O
or CC O
the DT O
other JJ O
of IN O
these DT O
two CD O
conditional JJ O
mutants NNS O
when WRB O
reduced VBN O
in IN O
function NN O
using VBG O
the DT O
same JJ O
RNAi NNP O
protocol NN O
as IN O
that DT O
used VBN O
for IN O
dhc NNP O
- HYPH O
1ts NNP O
mutants NNS O
( -LRB- O
Figure NNP O
4 CD O
, , O
right JJ O
two CD O
columns NNS O
; : O
Table NNP O
S1 NNP O
) -RRB- O
. . O

Therefore RB O
, , O
about RB O
half NN O
of IN O
the DT O
suppressors NNS O
appear VBP O
to TO O
act VB O
nonspecifically RB O
on IN O
multiple JJ O
ts IN O
mutants NNS O
to TO O
restore VB O
embryonic JJ O
viability NN O
. . O

From IN O
here RB O
on RB O
, , O
we PRP O
will MD O
refer VB O
to IN O
the DT O
suppressors NNS O
that WDT O
only RB O
acted VBD O
on IN O
dhc NN O
- HYPH O
1 CD O
, , O
and CC O
not RB O
on IN O
lit NN O
- HYPH O
1 CD O
and CC O
spn NN O
- HYPH O
4 CD O
ts NNS O
mutants NNS O
, , O
as IN O
dynein NN O
- HYPH O
specific JJ O
suppressors NNS O
. . O

Because IN O
many JJ O
ts IN O
mutations NNS O
exert VBP O
their PRP$ O
effect NN O
via IN O
protein NN O
assembly NN O
or CC O
unfolding VBG O
mechanisms NNS O
[ -LRB- O
32 CD O
] -RRB- O
, , O
suppressor NN O
genes NNS O
reduced VBN O
in IN O
function NN O
by IN O
RNAi NNP O
might MD O
not RB O
be VB O
expected VBN O
to TO O
exhibit VB O
allele JJ O
specificity NN O
with IN O
most JJS O
ts NNS O
mutations NNS O
. . O

To TO O
determine VB O
if IN O
the DT O
dynein NN O
suppressors NNS O
are VBP O
either CC O
allele JJ O
or CC O
strain NN O
specific JJ O
, , O
we PRP O
tested VBD O
the DT O
two CD O
other JJ O
conditional JJ O
dhc NN O
- HYPH O
1 CD O
strains NNS O
( , O
containing VBG O
the DT O
or283 CD O
and CC O
or352 CD O
alleles NNS O
) -RRB- O
. . O

Although IN O
the DT O
or283 CD O
allele NN O
is VBZ O
identical JJ O
to IN O
or195 CD O
, , O
it PRP O
provides VBZ O
a DT O
useful JJ O
control NN O
for IN O
the DT O
presence NN O
of IN O
background NN O
mutations NNS O
because IN O
the DT O
two CD O
strains NNS O
were VBD O
isolated VBN O
independently RB O
. . O

In IN O
most JJS O
cases NNS O
, , O
depletion NN O
of IN O
the DT O
dynein NN O
- HYPH O
specific JJ O
suppressors NNS O
also RB O
restored VBD O
viability NN O
to IN O
the DT O
other JJ O
two CD O
ts IN O
dhc NN O
- HYPH O
1 CD O
alleles NNS O
. . O

Y40B1B NNP O
. . O
5 CD O
, , O
a DT O
putative JJ O
translation NN O
initiation NN O
factor NN O
, , O
suppressed VBD O
only RB O
one CD O
conditional JJ O
dhc NN O
- HYPH O
1 CD O
strain NN O
, , O
and CC O
we PRP O
consider VBP O
this DT O
as IN O
an DT O
example NN O
of IN O
a DT O
nonspecific JJ O
interaction NN O
( -LRB- O
Figure NN O
4 CD O
, , O
left VBN O
three CD O
columns NNS O
; : O
Table NNP O
S1 NNP O
) -RRB- O
. . O

Two CD O
dsRNAs NNS O
that WDT O
do VBP O
not RB O
suppress VB O
lit VBN O
- HYPH O
1 CD O
or CC O
spn CD O
- HYPH O
4 CD O
mutants NNS O
produced VBN O
suppression NN O
in IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
and CC O
dhc NN O
- HYPH O
1 CD O
( SYM O
or283 CD O
) SYM O
strains NNS O
, , O
but CC O
not RB O
in IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or352 CD O
) NN O
strain NN O
, , O
perhaps RB O
indicating VBG O
allele JJ O
specificity NN O
or CC O
variability NN O
in IN O
the DT O
RNAi NNP O
treatments NNS O
. . O

We PRP O
conclude VBP O
that IN O
strain NN O
background NN O
differences NNS O
are VBP O
relatively RB O
rare JJ O
, , O
and CC O
that IN O
the DT O
majority NN O
of IN O
the DT O
suppressors NNS O
are VBP O
allele JJ O
- HYPH O
independent JJ O
. . O

To TO O
summarize VB O
, , O
we PRP O
have VBP O
identified VBN O
20 CD O
genes NNS O
that WDT O
when WRB O
reduced VBN O
in IN O
function NN O
specifically RB O
suppress VBP O
multiple JJ O
dynein NN O
ts POS O
strains NNS O
but CC O
not RB O
unrelated JJ O
ts IN O
loci NN O
. . O

Survey NN O
of IN O
Putative NNP O
Dynein NNP O
Accessory NNP O
Chains NNPS O

We PRP O
were VBD O
surprised JJ O
to TO O
discover VB O
that IN O
depleting VBG O
two CD O
predicted VBN O
dynein NN O
ACs NNS O
specifically RB O
suppressed VBD O
the DT O
partial JJ O
loss NN O
of IN O
HC NN O
function NN O
, , O
because IN O
most JJS O
dynein NN O
accessory NN O
subunits NNS O
are VBP O
presumed VBN O
to TO O
promote VB O
dynein NN O
function NN O
by IN O
aiding VBG O
dynein NN O
complex JJ O
formation NN O
or CC O
mediating VBG O
cargo NN O
attachment NN O
[ -LRB- O
3 CD O
, , O
11 CD O
, , O
33 CD O
] -RRB- O
. . O

Depletion NN O
of IN O
either CC O
dylt NN O
- HYPH O
1 CD O
( HYPH O
encoding VBG O
a DT O
Tctex1 NNP O
- HYPH O
type NN O
light JJ O
chain NN O
) -RRB- O
or CC O
dyrb NN O
- HYPH O
1 CD O
( HYPH O
encoding VBG O
a DT O
roadblock NN O
- HYPH O
type NN O
light JJ O
chain NN O
) -RRB- O
suppressed VBN O
embryonic JJ O
lethality NN O
in IN O
all DT O
three CD O
ts IN O
dynein NN O
HC NNP O
mutant JJ O
strains NNS O
( -LRB- O
Figure NN O
4 CD O
) -RRB- O
. . O

To TO O
extend VB O
this DT O
observation NN O
, , O
we PRP O
surveyed VBD O
all DT O
genes NNS O
encoding VBG O
predicted VBN O
dynein NN O
components NNS O
for IN O
suppression NN O
of IN O
the DT O
three CD O
ts IN O
dhc NN O
- HYPH O
1 CD O
mutants NNS O
( -LRB- O
Figure NNP O
5A NN O
; : O
Table NNP O
S2 NNP O
) -RRB- O
. . O

We PRP O
reasoned VBD O
that IN O
some DT O
dynein NN O
subunit NN O
genes NNS O
could MD O
have VB O
been VBN O
missed VBN O
in IN O
the DT O
primary JJ O
screening NN O
and CC O
several JJ O
dynein NN O
AC NNP O
genes NNS O
were VBD O
not RB O
represented VBN O
in IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
RNAi NNP O
library NN O
. . O

After IN O
using VBG O
RNAi NNP O
to TO O
reduce VB O
their PRP$ O
function NN O
, , O
we PRP O
found VBD O
that IN O
one CD O
of IN O
three CD O
Tctex1 NNP O
homologs NNS O
( : O
dylt NN O
- HYPH O
1 CD O
) -RRB- O
, , O
one CD O
of IN O
four CD O
LC8 NNP O
homologs NNS O
( , O
dlc NNP O
- HYPH O
1 CD O
) -RRB- O
, , O
one CD O
of IN O
two CD O
light JJ O
intermediate JJ O
chains NNS O
( -LRB- O
dli NN O
- HYPH O
1 CD O
) -RRB- O
, , O
as RB O
well RB O
as IN O
the DT O
sole JJ O
roadblock NN O
homolog NN O
( , O
dyrb NN O
- HYPH O
1 CD O
) -RRB- O
each DT O
strongly RB O
suppressed VBD O
the DT O
three CD O
conditional JJ O
dynein NN O
mutants NNS O
. . O

Lower JJR O
- HYPH O
level NN O
suppression NN O
was VBD O
also RB O
seen VBN O
for IN O
the DT O
second JJ O
light JJ O
intermediate JJ O
chain NN O
, , O
xbx NN O
- HYPH O
1 CD O
, , O
when WRB O
its PRP$ O
function NN O
was VBD O
reduced VBN O
. . O

Thus RB O
, , O
one CD O
gene NN O
of IN O
each DT O
of IN O
four CD O
subunit NN O
classes NNS O
restores VBZ O
viability NN O
to IN O
the DT O
three CD O
dhc NN O
- HYPH O
1 CD O
mutant JJ O
strains NNS O
when WRB O
depleted VBN O
by IN O
RNAi NNP O
. . O

The DT O
only JJ O
subunit NN O
class NN O
not RB O
found VBN O
to TO O
suppress VB O
was VBD O
the DT O
intermediate JJ O
chain NN O
, , O
encoded VBN O
by IN O
a DT O
single JJ O
gene NN O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
, , O
dyci NN O
- HYPH O
1 CD O
. . O

When WRB O
reduced VBN O
in IN O
function NN O
by IN O
RNAi NNP O
, , O
dyci NN O
- HYPH O
1 CD O
produces VBZ O
a DT O
larval JJ O
arrest NN O
phenotype NN O
like IN O
that DT O
observed VBN O
for IN O
dhc NN O
- HYPH O
1 CD O
( HYPH O
RNAi NNP O
) -RRB- O
; , O
this DT O
phenotype NN O
precludes VBZ O
any DT O
suppression NN O
of IN O
the DT O
conditional JJ O
embryonic JJ O
lethality NN O
( , O
shown VBN O
as IN O
"""" `` O
la FW O
"""" '' O
in IN O
Figure NNP O
5A NNP O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
knockdown NN O
of IN O
either CC O
dlc NN O
- HYPH O
1 CD O
or CC O
dli NN O
- HYPH O
1 CD O
suppresses VBZ O
embryonic JJ O
lethality NN O
in IN O
the DT O
dhc NN O
- HYPH O
1ts NNS O
mutants NNS O
, , O
even RB O
though IN O
reducing VBG O
their PRP$ O
function NN O
in IN O
otherwise RB O
wild JJ O
- HYPH O
type NN O
embryos NNS O
produces VBZ O
dhc NN O
- HYPH O
1 CD O
- HYPH O
like JJ O
defects NNS O
, , O
including VBG O
embryonic JJ O
lethality NN O
[ -LRB- O
12 CD O
, , O
34 CD O
] -RRB- O
( , O
see VB O
Figure NN O
5B NN O
and CC O
Discussion NNP O
) -RRB- O
. . O

The DT O
suppressing VBG O
cytoplasmic JJ O
dynein NN O
subunits NNS O
and CC O
DYCI NNP O
- HYPH O
1 CD O
are VBP O
shown VBN O
in IN O
a DT O
putative JJ O
complex NN O
in IN O
Figure NNP O
5E CD O
. . O

We PRP O
performed VBD O
several JJ O
genetic JJ O
assays NNS O
to TO O
better RBR O
understand VB O
how WRB O
the DT O
suppressor NN O
genes NNS O
may MD O
be VB O
operating VBG O
. . O

First RB O
, , O
suppression NN O
of IN O
dhc NN O
- HYPH O
1 CD O
lethality NN O
by IN O
reducing VBG O
AC NN O
function NN O
may MD O
indicate VB O
that IN O
our PRP$ O
dhc NN O
- HYPH O
1 CD O
alleles NNS O
express VBP O
a DT O
neomorphic JJ O
and CC O
toxic JJ O
DHC NNP O
- HYPH O
1 CD O
protein NN O
: : O
if IN O
the DT O
suppressor NN O
dynein NN O
AC NN O
subunits NNS O
positively RB O
function VBP O
in IN O
dynein NN O
processes NNS O
, , O
depleting VBG O
them PRP O
might MD O
suppress VB O
any DT O
neomorphic JJ O
effects NNS O
. . O

This DT O
explanation NN O
is VBZ O
perhaps RB O
unlikely JJ O
, , O
because IN O
the DT O
dhc NN O
- HYPH O
1ts NNS O
alleles NNS O
are VBP O
all DT O
recessive JJ O
, , O
but CC O
remained VBD O
a DT O
possibility NN O
in IN O
dhc NN O
- HYPH O
1 CD O
homozygotes NNS O
. . O

We PRP O
therefore RB O
reduced VBD O
dynein NN O
function NN O
using VBG O
RNAi NN O
in IN O
animals NNS O
that WDT O
had VBD O
passed VBN O
through IN O
the DT O
larval JJ O
arrest NN O
points NNS O
for IN O
dhc NNP O
- HYPH O
1 CD O
( HYPH O
RNAi NNP O
) -RRB- O
and CC O
dyci NN O
- HYPH O
1 CD O
( HYPH O
RNAi NNP O
) -RRB- O
. . O

Specifically RB O
, , O
we PRP O
transferred VBD O
dhc NNP O
- HYPH O
1 CD O
( SYM O
or195 CD O
) SYM O
L4 CD O
hermaphrodites NNS O
to IN O
plates NNS O
with IN O
bacteria NNS O
expressing VBG O
dhc NN O
- HYPH O
1 CD O
or CC O
dyci NN O
- HYPH O
1 CD O
dsRNA NN O
. . O

As IN O
control NN O
we PRP O
performed VBD O
dylt NN O
- HYPH O
1 CD O
( SYM O
RNAi NNP O
) -RRB- O
using VBG O
the DT O
same JJ O
procedure NN O
. . O

We PRP O
observed VBD O
substantial JJ O
suppression NN O
with IN O
dylt NN O
- HYPH O
1 CD O
in IN O
this DT O
assay NN O
, , O
but CC O
we PRP O
saw VBD O
no DT O
suppression NN O
with IN O
the DT O
heavy JJ O
or CC O
intermediate JJ O
chains NNS O
( -LRB- O
Figure NNP O
5C NNP O
) -RRB- O
. . O

This DT O
suggests VBZ O
that IN O
the DT O
DHC NNP O
- HYPH O
1ts NNP O
protein NN O
is VBZ O
not RB O
toxic JJ O
and CC O
that IN O
dyci NN O
- HYPH O
1 CD O
acts VBZ O
more RBR O
like IN O
dhc NN O
- HYPH O
1 CD O
than IN O
the DT O
other JJ O
suppressing VBG O
ACs NNS O
because IN O
it PRP O
does VBZ O
not RB O
suppress VB O
the DT O
heavy JJ O
chain NN O
mutant NN O
. . O

To TO O
further RB O
examine VB O
the DT O
nature NN O
of IN O
the DT O
AC NNP O
suppression NN O
, , O
we PRP O
asked VBD O
if IN O
depletion NN O
of IN O
the DT O
suppressor NN O
chains NNS O
could MD O
bypass VB O
the DT O
requirement NN O
for IN O
dhc NN O
- HYPH O
1 CD O
. . O

We PRP O
transferred VBD O
wild JJ O
- HYPH O
type NN O
L4 NN O
larvae NN O
to IN O
plates NNS O
with IN O
bacteria NNS O
expressing VBG O
dsRNA NNP O
corresponding VBG O
to IN O
both CC O
the DT O
suppressor NN O
ACs NNS O
and CC O
dhc NN O
- HYPH O
1 CD O
. . O

We PRP O
did VBD O
not RB O
observe VB O
any DT O
suppression NN O
in IN O
these DT O
double JJ O
RNAi NNP O
assays NNS O
( -LRB- O
Figure NNP O
5D NNP O
) -RRB- O
, , O
suggesting VBG O
that IN O
dhc NN O
- HYPH O
1ts NNS O
suppression NN O
requires VBZ O
the DT O
residual JJ O
activity NN O
of IN O
the DT O
defective JJ O
DHC NNP O
- HYPH O
1 CD O
protein NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
dynein NN O
AC NNP O
suppressors NNS O
inhibit VBP O
or CC O
somehow RB O
oppose VBP O
the DT O
function NN O
of IN O
the DT O
DHC NNP O
- HYPH O
1ts NNS O
protein NN O
, , O
and CC O
that IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( HYPH O
or195ts NNS O
) , O
mutation NN O
does VBZ O
not RB O
produce VB O
a DT O
toxic JJ O
gene NN O
product NN O
but CC O
simply RB O
reduces VBZ O
DHC NNP O
- HYPH O
1 CD O
activity NN O
to IN O
a DT O
low JJ O
, , O
but CC O
non JJ O
- HYPH O
null JJ O
, , O
level NN O
. . O

Localization NN O
of IN O
the DT O
Dynein NNP O
Suppressor NNP O
Proteins NNP O

To TO O
further RB O
explore VB O
how WRB O
the DT O
suppressor NN O
proteins NNS O
function VBP O
, , O
we PRP O
examined VBD O
the DT O
subcellular JJ O
localization NN O
of IN O
nine CD O
of IN O
them PRP O
as IN O
stably RB O
expressed VBN O
N NNP O
- HYPH O
terminal JJ O
GFP NNP O
: : O
: : O
S NNP O
fusions NNS O
. . O

We PRP O
chose VBD O
to TO O
first RB O
focus VB O
on IN O
the DT O
suppressor NN O
genes NNS O
that WDT O
were VBD O
conserved VBN O
but CC O
poorly RB O
characterized VBN O
in IN O
any DT O
system NN O
, , O
or CC O
were VBD O
conserved VBN O
but CC O
uncharacterized JJ O
during IN O
early JJ O
C NN B-Species
. . I-Species
elegans NNS I-Species
embryogenesis NN O
. . O

Prior JJ O
dynein NN O
immunocytochemistry NN O
- HYPH O
based VBN O
localization NN O
studies NNS O
serve VBP O
as IN O
a DT O
comparison NN O
[ -LRB- O
6 CD O
, , O
10 CD O
, , O
35 CD O
] -RRB- O
. . O

As IN O
in IN O
other JJ O
species NNS O
, , O
C NNP B-Species
. . I-Species
elegans NNS I-Species
DHC NNP O
- HYPH O
1 CD O
is VBZ O
associated VBN O
with IN O
mitotic JJ O
spindles NNS O
, , O
centrosomes NNS O
, , O
the DT O
nuclear JJ O
envelope NN O
, , O
the DT O
cell NN O
cortex NN O
, , O
the DT O
midbody NN O
, , O
and CC O
throughout IN O
the DT O
cytoplasm NN O
. . O

Most JJS O
of IN O
the DT O
suppressor NN O
proteins NNS O
we PRP O
examined VBD O
localized VBN O
to IN O
sites NNS O
where WRB O
DHC NNP O
- HYPH O
1 CD O
is VBZ O
known VBN O
to TO O
act VB O
or CC O
localize VB O
( -LRB- O
Figure NN O
6 CD O
) -RRB- O
. . O

However RB O
, , O
the DT O
nearly RB O
ubiquitous JJ O
distribution NN O
of IN O
DHC NNP O
- HYPH O
1 CD O
in IN O
early JJ O
embryonic JJ O
cells NNS O
makes VBZ O
colocalization NN O
likely JJ O
but CC O
not RB O
necessarily RB O
meaningful JJ O
, , O
and CC O
biochemical JJ O
studies NNS O
are VBP O
needed VBN O
to TO O
conclusively RB O
address VB O
any DT O
direct JJ O
or CC O
indirect JJ O
physical JJ O
associations NNS O
. . O

Four CD O
suppressor NN O
GFP NNP O
fusion NN O
proteins NNS O
localized VBN O
to IN O
nuclear JJ O
membranes NNS O
and CC O
to TO O
spindle VB O
poles NNS O
or CC O
pericentrosomal JJ O
regions NNS O
. . O

The DT O
DYLT NNP O
- HYPH O
1 CD O
and CC O
DYRB NNP O
- HYPH O
1 CD O
dynein NN O
light JJ O
chains NNS O
were VBD O
associated VBN O
with IN O
nuclear JJ O
envelopes NNS O
and CC O
centrosomes NNS O
, , O
as RB O
well RB O
as IN O
meiotic JJ O
and CC O
mitotic JJ O
spindle NN O
poles NNS O
( -LRB- O
Figure NNP O
6A NNP O
- HYPH O
6H CD O
; : O
Videos NNP O
S1 NNP O
and CC O
S2 NNP O
) -RRB- O
. . O

The DT O
potential JJ O
coiled VBN O
- HYPH O
coil NN O
protein NN O
K04F10 NNP O
. . O
3 CD O
was VBD O
present JJ O
on IN O
the DT O
nuclear JJ O
envelope NN O
and CC O
in IN O
a DT O
pericentrosomal JJ O
position NN O
during IN O
mitosis NN O
, , O
similar JJ O
to IN O
endoplasmic JJ O
reticulum NN O
proteins NNS O
[ -LRB- O
36 CD O
] -RRB- O
( , O
Figure NNP O
6I CD O
- HYPH O
6L NN O
; : O
Video NNP O
S3 NNP O
) -RRB- O
. . O

K04F10 NNP O
. . O
3 CD O
was VBD O
also RB O
highly RB O
enriched VBN O
at IN O
meiotic JJ O
spindle NN O
poles NNS O
( -LRB- O
Figure NNP O
6I CD O
) -RRB- O
, , O
which WDT O
has VBZ O
been VBN O
observed VBN O
for IN O
other JJ O
endoplasmic JJ O
reticulum NN O
proteins NNS O
[ -LRB- O
36 CD O
] -RRB- O
. . O

The DT O
NPP NNP O
- HYPH O
22 CD O
transmembrane NN O
nucleoporin NN O
was VBD O
found VBN O
at IN O
nuclear JJ O
envelopes NNS O
( , O
Figure NNP O
6M NNP O
- HYPH O
6P NNP O
; : O
Video NNP O
S4 NNP O
) -RRB- O
, , O
as IN O
previously RB O
reported VBN O
for IN O
later JJ O
stage NN O
embryos NNS O
[ -LRB- O
37 CD O
] -RRB- O
, , O
and CC O
it PRP O
also RB O
surrounded VBD O
centrosomes NNS O
during IN O
mitosis NN O
. . O

Two CD O
splice NN O
isoforms NNS O
of IN O
the DT O
pleckstrin NN O
homology NN O
domain NN O
- HYPH O
containing VBG O
EFA NNP O
- HYPH O
6 CD O
/ SYM O
Y55D9A NNP O
. . O
1 CD O
, , O
an DT O
ARF NN O
guanine NN O
nucleotide NN O
exchange NN O
factor NN O
, , O
were VBD O
enriched VBN O
cortically RB O
both DT O
in IN O
the DT O
anterior JJ O
portion NN O
of IN O
the DT O
one CD O
- HYPH O
cell NN O
zygote NN O
and CC O
at IN O
the DT O
blastomere NN O
boundary NN O
in IN O
two CD O
- HYPH O
cell NN O
embryos NNS O
( -LRB- O
Figure NNP O
6Q NNP O
- HYPH O
6T NN O
; : O
Videos NNP O
S5 NNP O
and CC O
S6 NNP O
) -RRB- O
. . O

The DT O
conserved VBN O
Mo25 NNP O
homolog NN O
MOP NNP O
- HYPH O
25 CD O
. . O
2 CD O
/ SYM O
Y53C12A NN O
. . O
4 CD O
was VBD O
found VBN O
enriched VBN O
in IN O
a DT O
single JJ O
spot NN O
after IN O
cytokinesis NN O
that WDT O
appears VBZ O
to TO O
correspond VB O
to IN O
the DT O
midbody NN O
( -LRB- O
Figure NNP O
6U NNP O
- HYPH O
6X NN O
; : O
Video NNP O
S7 NNP O
) -RRB- O
. . O

F10E7 NNP O
. . O
8 CD O
, , O
a DT O
highly RB O
conserved VBN O
ortholog NN O
of IN O
S NN B-Species
. . I-Species
cerevisiae NN I-Species
Far11 NN O
, , O
appears VBZ O
nuclear JJ O
( , O
Figure NNP O
6Y NNP O
- HYPH O
6B NN O
' '' O
and CC O
Video NNP O
S8 NNP O
) -RRB- O
. . O

Finally RB O
, , O
the DT O
nonspecific JJ O
suppressor NN O
protein NN O
STAR NNP O
- HYPH O
2 CD O
, , O
a DT O
predicted VBN O
RNA NNP O
binding VBG O
protein NN O
, , O
appears VBZ O
to TO O
be VB O
associated VBN O
with IN O
P NN O
- HYPH O
granules NNS O
( , O
like IN O
its PRP$ O
homolog NN O
GLD NN O
- HYPH O
1 CD O
) -RRB- O
, , O
where WRB O
dynein NN O
is VBZ O
neither CC O
localized VBN O
nor CC O
known VBN O
to TO O
function VB O
( : O
Figure NNP O
6C NNP O
' '' O
- HYPH O
6F NN O
' '' O
) -RRB- O
. . O

DLYT NNP O
- HYPH O
1 CD O
and CC O
DYRB NNP O
- HYPH O
1 CD O
: : O
Dynein NNP O
Light NNP O
Chain NNP O
Localization NNP O

The DT O
C NN B-Species
. . I-Species
elegans NNS I-Species
dynein NN O
HC NN O
protein NN O
weakly RB O
localizes VBZ O
to TO O
spindle VB O
poles NNS O
during IN O
early JJ O
embryonic JJ O
cell NN O
cycles NNS O
[ -LRB- O
6 CD O
, , O
10 CD O
] -RRB- O
, , O
and CC O
so RB O
did VBD O
DYRB NNP O
- HYPH O
1 CD O
and CC O
DYLT NNP O
- HYPH O
1 CD O
( : O
Videos NNS O
S9 NN O
and CC O
S10 NN O
) -RRB- O
. . O

However RB O
, , O
ts VBZ O
mutant JJ O
forms NNS O
of IN O
the DT O
DHC NNP O
- HYPH O
1 CD O
protein NN O
( , O
including VBG O
DHC NNP O
- HYPH O
1 CD O
encoded VBN O
by IN O
the DT O
or195 CD O
allele NN O
) -RRB- O
strongly RB O
localize VBP O
to IN O
centrosomes NNS O
when WRB O
shifted VBN O
to IN O
the DT O
non NN O
- HYPH O
permissive JJ O
temperature NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

The DT O
mechanism NN O
underlying VBG O
this DT O
enhanced VBN O
localization NN O
is VBZ O
not RB O
known VBN O
, , O
but CC O
it PRP O
may MD O
represent VB O
trapping NN O
of IN O
the DT O
defective JJ O
protein NN O
at IN O
a DT O
normally RB O
transient JJ O
location NN O
. . O

We PRP O
exploited VBD O
this DT O
behavior NN O
of IN O
the DT O
mutant JJ O
DHC NNP O
- HYPH O
1 CD O
protein NN O
to TO O
determine VB O
whether IN O
redistribution NN O
of IN O
the DT O
putative JJ O
DYRB NNP O
- HYPH O
1 CD O
and CC O
DYLT NNP O
- HYPH O
1 CD O
dynein NN O
light NN O
chains NNS O
also RB O
occurred VBD O
in IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) SYM O
background NN O
. . O

We PRP O
found VBD O
that IN O
the DT O
cellular JJ O
distributions NNS O
of IN O
DYRB NNP O
- HYPH O
1 CD O
and CC O
DYLT NNP O
- HYPH O
1 CD O
were VBD O
dramatically RB O
altered VBN O
in IN O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) SYM O
mutant JJ O
embryos NNS O
. . O

After IN O
shifting VBG O
the DT O
parental JJ O
worms NNS B-Species
to IN O
the DT O
restrictive JJ O
temperature NN O
for IN O
3 CD O
- SYM O
5 CD O
h NN O
prior RB O
to IN O
collecting VBG O
embryos NNS O
, , O
these DT O
two CD O
proteins NNS O
were VBD O
prominently RB O
localized VBN O
to IN O
centrosomes NNS O
and CC O
to TO O
spindle VB O
poles NNS O
that WDT O
did VBD O
not RB O
separate VB O
in IN O
one CD O
- HYPH O
cell NN O
stage NN O
embryos NNS O
( -LRB- O
Figure NNP O
7 CD O
; : O
Videos NNS O
S11 CD O
and CC O
S12 CD O
) -RRB- O
. . O

The DT O
spindle JJ O
pole NN O
to IN O
cytoplasmic JJ O
fluorescence NN O
ratio NN O
during IN O
late JJ O
anaphase NN O
was VBD O
5 CD O
- HYPH O
fold NN O
higher RBR O
in IN O
both DT O
of IN O
the DT O
dhc NN O
- HYPH O
1 CD O
homozygous JJ O
mutant JJ O
strains NNS O
when WRB O
compared VBN O
to IN O
wild JJ O
- HYPH O
type NN O
embryos NNS O
expressing VBG O
the DT O
GFP NNP O
fusions NNS O
. . O

We PRP O
also RB O
assayed VBD O
localization NN O
of IN O
the DT O
two CD O
putative JJ O
dynein NN O
light NN O
chains NNS O
after IN O
short JJ O
temperature NN O
shifts VBZ O
to IN O
the DT O
nonpermissive JJ O
temperature NN O
in IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) SYM O
mutant JJ O
background NN O
, , O
which WDT O
yields VBZ O
mitotic JJ O
spindles NNS O
with IN O
an DT O
overall JJ O
wild JJ O
- HYPH O
type NN O
appearance NN O
and CC O
function NN O
. . O

These DT O
short JJ O
temperature NN O
shifts NNS O
also RB O
resulted VBD O
in IN O
robust JJ O
localization NN O
of IN O
these DT O
two CD O
dynein NN O
light JJ O
chains NNS O
to IN O
centrosomes NNS O
( , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

Finally RB O
, , O
we PRP O
examined VBD O
the DT O
localization NN O
of IN O
GFP NNP O
: : O
: : O
DYRB NNP O
- HYPH O
1 CD O
and CC O
GFP NNP O
: : O
: : O
DYLT NNP O
- HYPH O
1 CD O
in IN O
embryos NNS O
from IN O
dhc NNP O
- HYPH O
1 CD O
( SYM O
or195 CD O
) SYM O
- HYPH O
/ SYM O
+ CC O
worms NNS B-Species
grown VBN O
at IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) SYM O
permissive JJ O
temperature NN O
of IN O
15 CD O
degrees NNS O
C NN O
. . O

Even RB O
though IN O
embryos NNS O
from IN O
mothers NNS O
heterozygous JJ O
for IN O
this DT O
recessive JJ O
mutation NN O
are VBP O
viable JJ O
and CC O
develop VBP O
normally RB O
, , O
even RB O
at IN O
26 CD O
degrees NNS O
C NN O
[ -LRB- O
7 CD O
] -RRB- O
, , O
we PRP O
observed VBD O
a DT O
substantial JJ O
increase NN O
in IN O
both CC O
GFP NNP O
fusion NN O
proteins NNS O
at IN O
the DT O
mitotic JJ O
spindle NN O
poles NNS O
in IN O
early JJ O
embryos NNS O
( -LRB- O
Figure NNP O
7 CD O
; : O
Videos NNS O
S13 CD O
and CC O
S14 CD O
) -RRB- O
. . O

Importantly RB O
, , O
localization NN O
of IN O
DYLT NNP O
- HYPH O
1 CD O
and CC O
DYRB NNP O
- HYPH O
1 CD O
to IN O
centrosomes NNS O
does VBZ O
not RB O
occur VB O
in IN O
embryos NNS O
depleted VBN O
for IN O
DHC NNP O
- HYPH O
1 CD O
with IN O
RNAi NNP O
( : O
our PRP$ O
unpublished JJ O
results NNS O
) -RRB- O
, , O
indicating VBG O
that IN O
these DT O
proteins NNS O
require VBP O
the DT O
mutant JJ O
DHC NNP O
- HYPH O
1 CD O
polypeptide NN O
for IN O
centrosomal JJ O
targeting NN O
in IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
embryos NNS O
. . O

In IN O
summary NN O
, , O
the DT O
DYRB NNP O
- HYPH O
1 CD O
and CC O
DYLT NNP O
- HYPH O
1 CD O
proteins NNS O
localize VBP O
to IN O
sites NNS O
where WRB O
the DT O
DHC NNP O
- HYPH O
1 CD O
HC NNP O
is VBZ O
also RB O
found VBN O
in IN O
wild JJ O
- HYPH O
type NN O
embryos NNS O
, , O
and CC O
all DT O
three CD O
proteins NNS O
respond VBP O
similarly RB O
to IN O
mutational JJ O
alterations NNS O
in IN O
DHC NNP O
- HYPH O
1 CD O
. . O

Genetic JJ O
Characterization NN O
of IN O
the DT O
DYLT NNP O
- HYPH O
1 CD O
and CC O
DYRB NNP O
- HYPH O
1 CD O
Dynein NNP O
Light NNP O
Chains NNPS O

We PRP O
obtained VBD O
putative JJ O
null NN O
alleles NNS O
to TO O
determine VB O
if IN O
dylt NN O
- HYPH O
1 CD O
and CC O
dyrb NN O
- HYPH O
1 CD O
function NN O
in IN O
dynein NN O
- HYPH O
dependent JJ O
processes NNS O
. . O

DYLT NNP O
- HYPH O
1 CD O
is VBZ O
40 CD O
% NN O
identical JJ O
to IN O
human JJ B-Species
DYNLT3 NNP O
and CC O
38 CD O
% NN O
identical JJ O
to IN O
Drosophila NNP B-Species
Dlc90F NNP O
( , O
see VB O
alignment NN O
in IN O
Figure NN O
8A CD O
) -RRB- O
. . O

Two CD O
other JJ O
C NN B-Species
. . I-Species
elegans NNS I-Species
genes NNS O
, , O
dylt NN O
- HYPH O
2 CD O
and CC O
dylt NN O
- HYPH O
3 CD O
, , O
encode VBP O
more RBR O
divergent JJ O
members NNS O
of IN O
this DT O
protein NN O
family NN O
. . O

DYRB NNP O
- HYPH O
1 CD O
is VBZ O
49 CD O
% NN O
identical JJ O
to IN O
both CC O
human JJ B-Species
DYNLRB1 NNP O
and CC O
Drosophila NNP B-Species
Robl NNP O
( , O
see VB O
alignment NN O
in IN O
Figure NN O
8A CD O
) -RRB- O
. . O

There EX O
do VBP O
not RB O
appear VB O
to TO O
be VB O
other JJ O
Roadblock NNP O
genes NNS O
in IN O
the DT O
C NNP B-Species
. . I-Species
elegans NNS I-Species
genome NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Deletion NN O
alleles NNS O
for IN O
both DT O
dylt NN O
- HYPH O
1 CD O
and CC O
dyrb NN O
- HYPH O
1 CD O
have VBP O
been VBN O
isolated VBN O
( -LRB- O
Figure NNP O
8B NNP O
) -RRB- O
. . O

The DT O
dylt NN O
- HYPH O
1 CD O
( HYPH O
ok417 CD O
) -RRB- O
deletion NN O
removes VBZ O
the DT O
entire JJ O
DYLT NNP O
- HYPH O
1 CD O
open JJ O
reading NN O
frame NN O
and CC O
does VBZ O
not RB O
affect VB O
adjacent JJ O
coding VBG O
regions NNS O
. . O

The DT O
dyrb NN O
- HYPH O
1 CD O
( SYM O
tm2645 CD O
) -RRB- O
deletion NN O
removes VBZ O
69 CD O
% NN O
of IN O
the DT O
dyrb NN O
- HYPH O
1 CD O
coding VBG O
region NN O
, , O
leaving VBG O
29 CD O
predicted VBN O
N NNP O
- HYPH O
terminal JJ O
amino NN O
acids NNS O
, , O
and CC O
does VBZ O
not RB O
affect VB O
adjacent JJ O
coding VBG O
regions NNS O
. . O

Both DT O
deletions NNS O
are VBP O
currently RB O
annotated VBN O
as IN O
homozygous JJ O
viable JJ O
[ -LRB- O
29 CD O
] -RRB- O
. . O

However RB O
, , O
we PRP O
found VBD O
that IN O
the DT O
dyrb NN O
- HYPH O
1 CD O
( SYM O
tm2645 CD O
) -RRB- O
strain NN O
was VBD O
in IN O
fact NN O
heterozygous JJ O
for IN O
the DT O
deletion NN O
and CC O
that IN O
most JJS O
embryos NNS O
produced VBN O
by IN O
dyrb NN O
- HYPH O
1 CD O
( SYM O
tm2645 CD O
) -RRB- O
homozygous JJ O
animals NNS O
failed VBD O
to TO O
hatch VB O
( -LRB- O
Figure NNP O
8C NNP O
) -RRB- O
. . O

Homozygous NNP O
dyrb NNP O
- HYPH O
1 CD O
( SYM O
tm2645 CD O
) -RRB- O
worms NNS B-Species
also RB O
showed VBD O
an DT O
egg NN O
- HYPH O
laying VBG O
defect NN O
and CC O
produced VBD O
small JJ O
broods NNS O
( , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

To TO O
determine VB O
if IN O
the DT O
dyrb NN O
- HYPH O
1 CD O
deletion NN O
was VBD O
responsible JJ O
for IN O
the DT O
embryonic JJ O
lethality NN O
, , O
we PRP O
crossed VBD O
the DT O
GFP NNP O
: : O
: : O
dyrb NN O
- HYPH O
1 CD O
transgene NN O
into IN O
the DT O
deletion NN O
background NN O
. . O

The DT O
presence NN O
of IN O
the DT O
transgene NN O
fully RB O
rescued VBD O
the DT O
embryonic JJ O
lethality NN O
( -LRB- O
Figure NNP O
8C NNP O
) -RRB- O
, , O
but CC O
not RB O
the DT O
egg NN O
- HYPH O
laying VBG O
defect NN O
: : O
the DT O
transgene NN O
is VBZ O
driven VBN O
from IN O
a DT O
germline NN O
- HYPH O
specific JJ O
promoter NN O
and CC O
so RB O
would MD O
not RB O
be VB O
expected VBN O
to TO O
rescue VB O
zygotic JJ O
phenotypes NNS O
. . O

The DT O
embryonic JJ O
lethality NN O
exhibited VBN O
by IN O
dyrb NN O
- HYPH O
1 CD O
( HYPH O
tm2645 CD O
) -RRB- O
mutants NNS O
is VBZ O
consistent JJ O
with IN O
RNAi NNP O
studies NNS O
performed VBN O
by IN O
injection NN O
or CC O
soaking NN O
[ -LRB- O
12 CD O
, , O
38 CD O
] -RRB- O
. . O

In IN O
contrast NN O
, , O
homozygous JJ O
dylt NN O
- HYPH O
1 CD O
deletion NN O
mutants NNS O
did VBD O
not RB O
exhibit VB O
any DT O
larval JJ O
or CC O
embryonic JJ O
lethality NN O
( -LRB- O
Figure NNP O
8C NNP O
) -RRB- O
. . O

To TO O
determine VB O
if IN O
these DT O
dynein NN O
light JJ O
chain NN O
mutants NNS O
exhibit VBP O
dynein NN O
HC NNP O
- HYPH O
like JJ O
phenotypes NNS O
, , O
we PRP O
observed VBD O
the DT O
completion NN O
of IN O
meiotic JJ O
polar JJ O
body NN O
extrusion NN O
and CC O
the DT O
first JJ O
two CD O
mitotic JJ O
cell NN O
divisions NNS O
in IN O
mutant JJ O
embryos NNS O
( -LRB- O
Figure NN O
8D NN O
) -RRB- O
. . O

The DT O
dylt NN O
- HYPH O
1 CD O
embryos NNS O
appeared VBD O
wild JJ O
type NN O
for IN O
completion NN O
of IN O
meiosis NN O
, , O
pronuclear JJ O
migration NN O
, , O
and CC O
spindle JJ O
assembly NN O
and CC O
function NN O
. . O

However RB O
, , O
the DT O
dyrb NN O
- HYPH O
1 CD O
embryos NNS O
occasionally RB O
contained VBD O
extra JJ O
female JJ O
pronuclei NN O
( , O
observed VBN O
in IN O
four CD O
of IN O
12 CD O
recordings NNS O
, , O
Figure NNP O
8D NNP O
) -RRB- O
, , O
suggesting VBG O
that IN O
polar JJ O
body NN O
extrusion NN O
was VBD O
defective JJ O
, , O
and CC O
pronuclear JJ O
migration NN O
was VBD O
often RB O
slow JJ O
compared VBN O
to IN O
wild JJ O
- HYPH O
type NN O
embryos NNS O
. . O

Once RB O
formed VBN O
, , O
spindles NNS O
appeared VBD O
functional JJ O
using VBG O
Nomarski NNP O
optics NNS O
, , O
although IN O
they PRP O
were VBD O
frequently RB O
positioned VBN O
improperly RB O
and CC O
had VBD O
large JJ O
spindle NN O
poles NNS O
, , O
as IN O
has VBZ O
also RB O
been VBN O
observed VBN O
after IN O
RNAi NNP O
knockdown NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Thus RB O
, , O
these DT O
two CD O
genes NNS O
are VBP O
not RB O
strictly RB O
essential JJ O
, , O
but CC O
the DT O
DYRB NNP O
- HYPH O
1 CD O
protein NN O
clearly RB O
is VBZ O
required VBN O
for IN O
dynein NN O
- HYPH O
dependent JJ O
processes NNS O
. . O

Discussion NN O

By IN O
using VBG O
the DT O
suppressor NN O
screening NN O
method NN O
outlined VBN O
in IN O
Figure NNP O
2B NNP O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
characterized VBN O
49 CD O
genes NNS O
that IN O
when WRB O
reduced VBN O
in IN O
function NN O
can MD O
suppress VB O
a DT O
partial JJ O
loss NN O
of IN O
dynein NN O
HC NN O
function NN O
. . O

This DT O
screening NN O
procedure NN O
takes VBZ O
advantage NN O
of IN O
sensitized JJ O
genetic JJ O
backgrounds NNS O
using VBG O
conditional JJ O
mutants NNS O
, , O
can MD O
be VB O
completed VBN O
for IN O
one CD O
mutant NN O
in IN O
less JJR O
than IN O
5 CD O
wk NN O
, , O
and CC O
is VBZ O
scalable JJ O
so IN O
that IN O
many JJ O
mutants NNS O
can MD O
be VB O
screened VBN O
in IN O
parallel NN O
. . O

In IN O
fact NN O
, , O
we PRP O
have VBP O
performed VBN O
15 CD O
such JJ O
screens NNS O
in IN O
different JJ O
sensitized JJ O
backgrounds NNS O
( , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

By IN O
using VBG O
three CD O
dhc NN O
- HYPH O
1ts NNS O
mutant JJ O
strains NNS O
, , O
we PRP O
found VBD O
that IN O
strain NN O
background NN O
differences NNS O
and CC O
allele NN O
specificity NN O
are VBP O
minimal JJ O
because IN O
most JJS O
of IN O
these DT O
genes NNS O
suppress VBP O
all DT O
three CD O
dynein NN O
mutants NNS O
when WRB O
reduced VBN O
in IN O
function NN O
using VBG O
RNAi NNP O
. . O

Furthermore RB O
, , O
by IN O
using VBG O
two CD O
unrelated JJ O
ts VBG O
mutants NNS O
to TO O
assay VB O
for IN O
specificity NN O
, , O
we PRP O
found VBD O
that IN O
57 CD O
% NN O
of IN O
the DT O
suppressor NN O
genes NNS O
suppress VBP O
multiple JJ O
unrelated JJ O
mutant JJ O
loci NN O
. . O

Thus RB O
, , O
it PRP O
is VBZ O
clear JJ O
that IN O
assaying VBG O
the DT O
specificity NN O
of IN O
suppression NN O
is VBZ O
critical JJ O
for IN O
evaluating VBG O
the DT O
functional JJ O
significance NN O
of IN O
these DT O
RNAi NNP O
interactions NNS O
. . O

Eliminating VBG O
the DT O
analysis NN O
of IN O
these DT O
nonspecific JJ O
genes NNS O
in IN O
future JJ O
screens NNS O
will MD O
save VB O
time NN O
and CC O
resources NNS O
. . O

Most JJS O
of IN O
the DT O
specific JJ O
suppressor NN O
proteins NNS O
we PRP O
examined VBD O
appear VBP O
to TO O
overlap VB O
in IN O
subcellular JJ O
localization NN O
with IN O
the DT O
dynein NN O
HC NNP O
, , O
based VBN O
on IN O
previous JJ O
studies NNS O
of IN O
DHC NNP O
- HYPH O
1 CD O
, , O
while IN O
one CD O
nonspecific JJ O
suppressor NN O
protein NN O
, , O
STAR NNP O
- HYPH O
2 CD O
, , O
localized VBN O
to IN O
germline NN O
P NN O
- HYPH O
granules NNS O
, , O
where WRB O
dynein NN O
is VBZ O
not RB O
known VBN O
to TO O
function VB O
. . O

Many JJ O
of IN O
the DT O
20 CD O
genes NNS O
that WDT O
specifically RB O
suppress VBP O
multiple JJ O
dhc NN O
- HYPH O
1ts NNS O
alleles NNS O
are VBP O
nonessential JJ O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
but CC O
well RB O
conserved JJ O
nonetheless RB O
. . O

Six CD O
of IN O
eight CD O
deletion NN O
alleles NNS O
available JJ O
for IN O
the DT O
20 CD O
specific JJ O
suppressor NN O
genes NNS O
are VBP O
homozygous JJ O
viable JJ O
, , O
and CC O
six CD O
additional JJ O
specific JJ O
genes NNS O
do VBP O
not RB O
display VB O
lethal JJ O
phenotypes NNS O
when WRB O
reduced VBN O
in IN O
function NN O
by IN O
RNAi NNP O
in IN O
wild JJ O
- HYPH O
type NN O
worms NNS B-Species
[ -LRB- O
29 CD O
] -RRB- O
. . O

Thus RB O
, , O
our PRP$ O
genetic JJ O
screening NN O
has VBZ O
identified VBN O
roles NNS O
in IN O
an DT O
essential JJ O
process NN O
for IN O
at RB O
least RBS O
12 CD O
apparently RB O
nonessential JJ O
genes NNS O
. . O

Fourteen CD O
of IN O
the DT O
specific JJ O
dynein NN O
suppressor NN O
genes NNS O
have VBP O
human JJ B-Species
orthologs NNS O
as IN O
determined VBN O
by IN O
best JJS O
reciprocal JJ O
BLAST NNP O
hits NNS O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
, , O
while IN O
mop NN O
- HYPH O
25 CD O
. . O
2 CD O
has VBZ O
a DT O
conserved VBN O
human JJ B-Species
homolog NN O
but CC O
also RB O
a DT O
paralog NN O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
. . O

Eleven CD O
of IN O
these DT O
conserved VBN O
genes NNS O
are VBP O
nonessential JJ O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
. . O

Interestingly RB O
, , O
eight CD O
of IN O
the DT O
conserved VBN O
genes NNS O
in IN O
Table NNP O
1 CD O
have VBP O
been VBN O
implicated VBN O
in IN O
human JJ B-Species
disease NN O
etiology NN O
, , O
with IN O
three CD O
of IN O
them PRP O
identified VBN O
as IN O
the DT O
causative JJ O
gene NN O
[ -LRB- O
39 CD O
- HYPH O
41 CD O
] -RRB- O
. . O

Thus RB O
, , O
using VBG O
sensitized VBN O
genetic JJ O
backgrounds NNS O
for IN O
genome NN O
- HYPH O
wide JJ O
modifier NN O
screens NNS O
can MD O
identify VB O
roles NNS O
for IN O
nonessential JJ O
but CC O
conserved VBN O
genes NNS O
and CC O
thereby RB O
provide VB O
insights NNS O
into IN O
human JJ B-Species
disease NN O
. . O

Nonspecific JJ O
Suppression NN O
of IN O
Conditional JJ O
Mutants NNS O

We PRP O
examined VBD O
the DT O
predicted VBN O
molecular JJ O
functions NNS O
of IN O
the DT O
suppressor NN O
proteins NNS O
to TO O
better RBR O
understand VB O
the DT O
basis NN O
for IN O
the DT O
nonspecific JJ O
suppression NN O
phenomenon NN O
. . O

Strikingly RB O
, , O
many JJ O
of IN O
the DT O
nonspecific JJ O
suppressor NN O
genes NNS O
encode VBP O
proteins NNS O
with IN O
predicted VBN O
roles NNS O
in IN O
mitochondrial JJ O
, , O
ribosomal JJ O
, , O
and CC O
collagen NN O
function NN O
( , O
18 CD O
of IN O
29 CD O
genes NNS O
, , O
or CC O
62 CD O
% NN O
) -RRB- O
, , O
while IN O
only RB O
two CD O
such JJ O
genes NNS O
appeared VBD O
to TO O
specifically RB O
suppress VB O
dhc NN O
- HYPH O
1 CD O
( SYM O
2 CD O
of IN O
20 CD O
genes NNS O
or CC O
10 CD O
% NN O
) -RRB- O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
stress NN O
produced VBN O
by IN O
RNAi NNP O
knockdown NN O
of IN O
these DT O
suppressor NN O
genes NNS O
triggers VBZ O
the DT O
activity NN O
of IN O
molecular JJ O
chaperones NNS O
that WDT O
can MD O
generally RB O
restore VB O
function NN O
to IN O
ts IN O
proteins NNS O
. . O

Indeed RB O
, , O
mutation NN O
of IN O
dpy NN O
- HYPH O
10 CD O
is VBZ O
known VBN O
to TO O
suppress VB O
three CD O
other JJ O
ts NNS O
mutants NNS O
: : O
glp NN O
- HYPH O
1 CD O
, , O
emb NN O
- HYPH O
5 CD O
, , O
and CC O
mup NN O
- HYPH O
1 CD O
[ SYM O
42 CD O
- HYPH O
44 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
RNAi NNP O
reduction NN O
of IN O
dpy JJ O
- HYPH O
10 CD O
, , O
star NN O
- HYPH O
2 CD O
, , O
osr NN O
- HYPH O
1 CD O
, , O
or CC O
C50D2 NNP O
. . O
1 CD O
( , O
all DT O
suppressors NNS O
of IN O
dhc NN O
- HYPH O
1 CD O
, , O
lit VBN O
- HYPH O
1 CD O
, , O
and CC O
spn NN O
- HYPH O
4 CD O
ts NN O
alleles NNS O
) -RRB- O
induces VBZ O
the DT O
glycerol NN O
biosynthetic JJ O
gene NN O
gpdh NN O
- HYPH O
2 CD O
, , O
while IN O
dpy NN O
- HYPH O
10 CD O
and CC O
osr NN O
- HYPH O
1 CD O
mutants NNS O
exhibit VBP O
increased VBD O
glycerol NN O
levels NNS O
, , O
a DT O
condition NN O
that WDT O
promotes VBZ O
protein NN O
stability NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

We PRP O
suggest VBP O
that IN O
partial JJ O
loss NN O
of IN O
central JJ O
metabolic JJ O
processes NNS O
can MD O
invoke VB O
stress NN O
responses NNS O
that WDT O
nonspecifically RB O
alleviate VBP O
protein NN O
- HYPH O
folding VBG O
problems NNS O
in IN O
ts VBG O
proteins NNS O
. . O

Filtering VBG O
out RP O
these DT O
nonspecific JJ O
interactions NNS O
by IN O
testing VBG O
unrelated JJ O
conditional JJ O
mutants NNS O
increases VBZ O
the DT O
likelihood NN O
that IN O
the DT O
remaining VBG O
suppressor NN O
genes NNS O
are VBP O
more RBR O
directly RB O
involved VBN O
with IN O
dynein NN O
function NN O
. . O

However RB O
, , O
ts VBZ O
mutants NNS O
likely RB O
differ VBP O
in IN O
their PRP$ O
susceptibility NN O
to IN O
nonspecific JJ O
suppression NN O
mechanisms NNS O
, , O
and CC O
some DT O
apparently RB O
unrelated JJ O
ts IN O
mutants NNS O
might MD O
share VB O
common JJ O
cofactors NNS O
such JJ O
that IN O
both DT O
mutants NNS O
are VBP O
suppressed VBN O
by IN O
depletion NN O
of IN O
the DT O
same JJ O
cofactor NN O
. . O

Nevertheless RB O
, , O
we PRP O
expect VBP O
that IN O
more JJR O
extensive JJ O
testing NN O
for IN O
specificity NN O
will MD O
prove VB O
very RB O
useful JJ O
for IN O
judging VBG O
the DT O
significance NN O
of IN O
modifier NN O
interactions NNS O
. . O

Possible JJ O
Relevance NN O
of IN O
Suppressor NN O
Proteins NNS O
to IN O
Dynein NN O
Function NN O

We PRP O
examined VBD O
the DT O
localization NN O
of IN O
a DT O
number NN O
of IN O
GFP NNP O
fusions NNS O
to IN O
suppressor NN O
proteins NNS O
to TO O
gain VB O
insight NN O
into IN O
their PRP$ O
functional JJ O
relationship NN O
to IN O
dynein NN O
. . O

In IN O
several JJ O
cases NNS O
, , O
the DT O
subcellular JJ O
distribution NN O
of IN O
the DT O
suppressor NN O
proteins NNS O
overlapped VBD O
in IN O
different JJ O
ways NNS O
with IN O
the DT O
known VBN O
and CC O
nearly RB O
ubiquitous JJ O
distribution NN O
of IN O
cytoplasmic JJ O
dynein NN O
in IN O
the DT O
early JJ O
C NN B-Species
. . I-Species
elegans NNS I-Species
embryo NN O
. . O

In IN O
fact NN O
, , O
the DT O
only JJ O
specific JJ O
suppressor NN O
that WDT O
did VBD O
not RB O
display VB O
dynein NN O
- HYPH O
like JJ O
localization NN O
was VBD O
F10E7 CD O
. . O
8 CD O
, , O
a DT O
homolog NN O
of IN O
yeast NN B-Species
Far11 NNP O
of IN O
unknown JJ O
function NN O
[ -LRB- O
46 CD O
] -RRB- O
, , O
which WDT O
was VBD O
nuclear JJ O
. . O

The DT O
one CD O
nonspecific JJ O
suppressor NN O
protein NN O
we PRP O
examined VBD O
did VBD O
not RB O
show VB O
any DT O
dynein NN O
- HYPH O
like JJ O
localization NN O
patterns NNS O
. . O

The DT O
subcellular JJ O
localizations NNS O
of IN O
the DT O
GFP NNP O
: : O
: : O
suppressor NN O
protein NN O
fusions NNS O
are VBP O
intriguing JJ O
. . O

However RB O
, , O
given VBN O
the DT O
nearly RB O
ubiquitous JJ O
distribution NN O
of IN O
dynein NN O
in IN O
early JJ O
embryonic JJ O
cells NNS O
, , O
biochemical JJ O
tests NNS O
for IN O
direct JJ O
association NN O
are VBP O
needed VBN O
to TO O
address VB O
the DT O
significance NN O
of IN O
any DT O
colocalization NN O
detected VBN O
using VBG O
light JJ O
microscopy NN O
. . O

We PRP O
are VBP O
particularly RB O
interested JJ O
in IN O
suppressor NN O
proteins NNS O
that WDT O
localize VBP O
to IN O
mitotic JJ O
spindle NN O
poles NNS O
: : O
the DT O
association NN O
of IN O
the DT O
DYLT NNP O
- HYPH O
1 CD O
and CC O
DYRB NNP O
- HYPH O
1 CD O
predicted VBN O
dynein NN O
light JJ O
chains NNS O
with IN O
centrosomes NNS O
and CC O
spindle NN O
poles NNS O
suggests VBZ O
that IN O
they PRP O
may MD O
be VB O
components NNS O
of IN O
cytoplasmic JJ O
dynein NN O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
. . O

Localization NN O
of IN O
cytoplasmic JJ O
dynein NN O
to IN O
centrosomes NNS O
and CC O
spindle NN O
poles NNS O
is VBZ O
well RB O
established VBN O
[ -LRB- O
47 CD O
, , O
48 CD O
] -RRB- O
, , O
and CC O
the DT O
inhibition NN O
of IN O
dynein NN O
function NN O
prevents VBZ O
centrosome NN O
separation NN O
, , O
centrosome NN O
attachment NN O
to IN O
nuclei NNS O
, , O
and CC O
the DT O
formation NN O
of IN O
bipolar JJ O
spindles NNS O
[ -LRB- O
6 CD O
, , O
10 CD O
, , O
49 CD O
, , O
50 CD O
] -RRB- O
. . O

Moreover RB O
, , O
the DT O
centrosomal JJ O
localization NN O
of IN O
DHC NNP O
- HYPH O
1 CD O
, , O
DYLT NNP O
- HYPH O
1 CD O
, , O
and CC O
DYRB NNP O
- HYPH O
1 CD O
are VBP O
all RB O
greatly RB O
enhanced VBN O
in IN O
dhc NN O
- HYPH O
1ts NNS O
mutant JJ O
embryos NNS O
: : O
this DT O
dependence NN O
of IN O
the DT O
light JJ O
chain NN O
distribution NN O
on IN O
the DT O
HC NNP O
further RB O
suggests VBZ O
they PRP O
reside VBP O
in IN O
the DT O
same JJ O
motor NN O
complex NN O
( -LRB- O
Figure NNP O
7 CD O
and CC O
[ -LRB- O
10 CD O
] -RRB- O
) -RRB- O
. . O

Furthermore RB O
, , O
roadblock NN O
light NN O
chains NNS O
are VBP O
well RB O
- HYPH O
established VBN O
components NNS O
of IN O
dynein NN O
, , O
and CC O
all DT O
of IN O
the DT O
roadblock NN O
protein NN O
in IN O
mammalian JJ O
liver NN O
extracts NNS O
is VBZ O
dynein NN O
associated VBN O
[ -LRB- O
51 CD O
, , O
52 CD O
] -RRB- O
. . O

Finally RB O
, , O
a DT O
DYLT NNP O
- HYPH O
1 CD O
homolog NN O
in IN O
vertebrates NNS O
is VBZ O
a DT O
stoichiometric JJ O
subunit NN O
of IN O
cytoplasmic JJ O
dynein NN O
[ -LRB- O
53 CD O
] -RRB- O
. . O

The DT O
presence NN O
of IN O
these DT O
two CD O
light JJ O
chains NNS O
in IN O
a DT O
dynein NN O
complex NN O
is VBZ O
consistent JJ O
with IN O
them PRP O
having VBG O
either CC O
positive JJ O
or CC O
negative JJ O
roles NNS O
in IN O
the DT O
regulation NN O
of IN O
HC NNP O
function NN O
( , O
see VB O
below RB O
) -RRB- O
. . O

Cytoplasmic JJ O
dynein NN O
is VBZ O
found VBN O
on IN O
the DT O
nuclear JJ O
envelope NN O
where WRB O
it PRP O
is VBZ O
thought VBN O
to TO O
regulate VB O
nuclear JJ O
membrane NN O
breakdown NN O
during IN O
mitosis NN O
[ -LRB- O
54 CD O
] -RRB- O
, , O
and CC O
dynein NN O
plays VBZ O
roles NNS O
during IN O
the DT O
trafficking NN O
of IN O
endoplasmic JJ O
reticulum NN O
components NNS O
[ -LRB- O
55 CD O
, , O
56 CD O
] -RRB- O
. . O

Therefore RB O
, , O
the DT O
nuclear JJ O
envelope NN O
/ SYM O
endoplasmic JJ O
reticulum NN O
proteins NNS O
NPP NNP O
- HYPH O
22 CD O
and CC O
K04F10 NNP O
. . O
3 CD O
could MD O
couple VB O
dynein NN O
activity NN O
to IN O
either DT O
of IN O
these DT O
structures NNS O
. . O

The DT O
anc NN O
- HYPH O
1 CD O
gene NN O
was VBD O
also RB O
isolated VBN O
in IN O
our PRP$ O
screening NN O
and CC O
ANC NNP O
- HYPH O
1 CD O
is VBZ O
localized VBN O
to IN O
the DT O
nuclear JJ O
envelope NN O
where WRB O
it PRP O
maintains VBZ O
nuclear JJ O
positioning NN O
in IN O
postembryonic JJ O
cells NNS O
[ -LRB- O
57 CD O
] -RRB- O
. . O

Reducing VBG O
the DT O
function NN O
of IN O
these DT O
three CD O
genes NNS O
may MD O
suppress VB O
partial JJ O
loss NN O
of IN O
dynein NN O
HC NNP O
mutants NNS O
by IN O
reducing VBG O
the DT O
need NN O
for IN O
dynein NN O
during IN O
nuclear JJ O
envelope NN O
breakdown NN O
, , O
through IN O
constitutive JJ O
partial JJ O
destabilization NN O
of IN O
the DT O
nuclear JJ O
envelope NN O
. . O

The DT O
distribution NN O
of IN O
the DT O
cytoplasmic JJ O
dynein NN O
HC NNP O
includes VBZ O
sites NNS O
other JJ O
than IN O
spindle JJ O
poles NNS O
and CC O
nuclear JJ O
envelopes NNS O
in IN O
C NNP B-Species
. . I-Species
elegans NNS I-Species
, , O
for IN O
example NN O
, , O
at IN O
the DT O
cell NN O
cortex NN O
and CC O
at IN O
the DT O
cell NN O
division NN O
remnant NN O
called VBN O
the DT O
midbody NN O
[ -LRB- O
6 CD O
, , O
10 CD O
] -RRB- O
. . O

The DT O
MOP NNP O
- HYPH O
25 CD O
. . O
2 CD O
protein NN O
was VBD O
found VBN O
at IN O
the DT O
midbody NN O
and CC O
faintly RB O
at IN O
spindle NN O
poles NNS O
. . O

The DT O
MOP NNP O
- HYPH O
25 CD O
. . O
2 CD O
ortholog NN O
in IN O
S NNP B-Species
. . I-Species
pombe NN I-Species
, , O
Pmo25 NNP O
, , O
is VBZ O
also RB O
present JJ O
at IN O
the DT O
cell NN O
division NN O
site NN O
and CC O
on IN O
spindle JJ O
poles NNS O
[ -LRB- O
58 CD O
] -RRB- O
. . O

Mammalian NNP O
MOP NNP O
- HYPH O
25 CD O
. . O
2 CD O
homologs NNS O
stimulate VBP O
the DT O
kinase NN O
activity NN O
of IN O
the DT O
LKB1 NNP O
tumor NN O
suppressor NN O
( : O
the DT O
C NN B-Species
. . I-Species
elegans NNS I-Species
ortholog NN O
is VBZ O
PAR NNP O
- HYPH O
4 CD O
) -RRB- O
, , O
which WDT O
in IN O
turn NN O
activates VBZ O
MARK NNP O
microtubule NN O
- HYPH O
destabilizing VBG O
kinases NNS O
[ -LRB- O
59 CD O
, , O
60 CD O
] -RRB- O
. . O

The DT O
C NN B-Species
. . I-Species
elegans NNS I-Species
MARK NNP O
ortholog NN O
, , O
PAR NNP O
- HYPH O
1 CD O
, , O
controls VBZ O
cell NN O
polarity NN O
during IN O
embryogenesis NN O
, , O
and CC O
orthologs NNS O
have VBP O
been VBN O
implicated VBN O
in IN O
regulation NN O
of IN O
microtubule NN O
dynamics NNS O
from IN O
yeast NN B-Species
to IN O
humans NNS B-Species
[ -LRB- O
61 CD O
- SYM O
64 CD O
] -RRB- O
. . O

Lastly RB O
, , O
the DT O
two CD O
splice NN O
isoforms NNS O
of IN O
EFA NNP O
- HYPH O
6 CD O
were VBD O
associated VBN O
with IN O
the DT O
anterior JJ O
cell NN O
cortex NN O
in IN O
late JJ O
one CD O
- HYPH O
cell NN O
embryos NNS O
. . O

Cortically RB O
localized VBN O
dynein NN O
may MD O
have VB O
important JJ O
roles NNS O
in IN O
applying VBG O
forces NNS O
to IN O
astral JJ O
microtubules NNS O
that WDT O
influence VBP O
mitotic JJ O
spindle NN O
positioning NN O
and CC O
chromosome NN O
separation NN O
during IN O
anaphase NN O
[ -LRB- O
10 CD O
, , O
65 CD O
, , O
66 CD O
] -RRB- O
. . O

EFA6 NNP O
ARF NNP O
guanine NN O
nucleotide NN O
exchange NN O
factors NNS O
require VBP O
their PRP$ O
pleckstrin NN O
homology NN O
domain NN O
for IN O
cortical JJ O
targeting NN O
, , O
and CC O
are VBP O
known VBN O
to TO O
regulate VB O
cortical JJ O
actin NN O
dynamics NNS O
in IN O
vertebrate JJ O
cells NNS O
by IN O
promoting VBG O
guanine NN O
nucleotide NN O
exchange NN O
on IN O
ARF6 NNP O
[ -LRB- O
67 CD O
, , O
68 CD O
] -RRB- O
. . O

Our PRP$ O
results NNS O
identifying VBG O
efa NN O
- HYPH O
6 CD O
as IN O
a DT O
dynein NN O
HC NN O
suppressor NN O
suggest VBP O
a DT O
functional JJ O
linkage NN O
of IN O
the DT O
actin NN O
and CC O
microtubule NN O
cytoskeletons NNS O
at IN O
the DT O
cell NN O
cortex NN O
. . O

Interestingly RB O
, , O
two CD O
yeast NN B-Species
pleckstrin NN O
homology NN O
domain NN O
proteins NNS O
, , O
Num1 NNP O
and CC O
mcp5 NN O
+ CC O
, , O
localize VBP O
to IN O
the DT O
cell NN O
cortex NN O
and CC O
direct JJ O
astral JJ O
microtubule NN O
and CC O
dynein NN O
function NN O
, , O
although IN O
they PRP O
do VBP O
not RB O
contain VB O
a DT O
Sec7 NNP O
domain NN O
like IN O
EFA NNP O
- HYPH O
6 CD O
does VBZ O
[ -LRB- O
69 CD O
- HYPH O
71 CD O
] -RRB- O
. . O

Function NN O
of IN O
Dynein NNP O
Intermediate NNP O
, , O
Light NNP O
Intermediate NNP O
, , O
and CC O
Light NNP O
Chains NNPS O

The DT O
dynein NN O
chains NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
exhibit VBP O
strikingly RB O
different JJ O
functional JJ O
requirements NNS O
. . O

The DT O
DYRB NNP O
- HYPH O
1 CD O
roadblock NN O
light JJ O
chain NN O
is VBZ O
required VBN O
for IN O
completion NN O
of IN O
meiosis NN O
and CC O
pronuclear JJ O
migration NN O
, , O
but CC O
an DT O
at IN O
least JJS O
partially RB O
functional JJ O
mitotic JJ O
spindle NN O
forms NNS O
in IN O
the DT O
absence NN O
of IN O
DYRB NNP O
- HYPH O
1 CD O
( HYPH O
Figure NN O
8 CD O
) -RRB- O
. . O

The DT O
DLI NNP O
- HYPH O
1 CD O
light JJ O
intermediate JJ O
chain NN O
is VBZ O
required VBN O
for IN O
multiple JJ O
dynein NN O
- HYPH O
dependent JJ O
functions NNS O
: : O
pronuclear JJ O
migration NN O
, , O
centrosome NN O
separation NN O
, , O
and CC O
meiotic JJ O
and CC O
mitotic JJ O
spindle NN O
function NN O
[ -LRB- O
12 CD O
, , O
34 CD O
] -RRB- O
. . O

DLI NNP O
- HYPH O
1 CD O
may MD O
promote VB O
nuclear JJ O
envelope NN O
targeting NN O
of IN O
both DT O
centrosomes NNS O
and CC O
DHC NNP O
- HYPH O
1 CD O
by IN O
interacting VBG O
with IN O
the DT O
nuclear JJ O
envelope NN O
protein NN O
ZYG NNP O
- HYPH O
12 CD O
[ SYM O
35 CD O
] -RRB- O
. . O

The DT O
second JJ O
worm NN O
light JJ O
intermediate JJ O
chain NN O
gene NN O
, , O
xbx NN O
- HYPH O
1 CD O
, , O
is VBZ O
required VBN O
for IN O
cilia NN O
function NN O
but CC O
not RB O
early JJ O
embryonic JJ O
development NN O
[ -LRB- O
12 CD O
, , O
72 CD O
] -RRB- O
. . O

RNAi NNP O
knockdown NN O
of IN O
DLC NNP O
- HYPH O
1 CD O
, , O
one CD O
of IN O
three CD O
LC8 NNP O
proteins NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
, , O
produces VBZ O
defects NNS O
similar JJ O
to IN O
dli NN O
- HYPH O
1 CD O
but CC O
knockdown NN O
of IN O
the DT O
other JJ O
two CD O
LC8 NN O
- HYPH O
related VBN O
genes NNS O
does VBZ O
not RB O
result VB O
in IN O
any DT O
phenotypes NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

RNAi NNP O
depletion NN O
of IN O
dyci NN O
- HYPH O
1 CD O
results NNS O
in IN O
severe JJ O
meiotic JJ O
, , O
pronuclear JJ O
migration NN O
, , O
and CC O
mitotic JJ O
spindle NN O
assembly NN O
defects NNS O
[ -LRB- O
12 CD O
] -RRB- O
and CC O
in IN O
our PRP$ O
feeding NN O
RNAi NNP O
regimen NN O
dyci NN O
- HYPH O
1 CD O
( , O
RNAi NNP O
) -RRB- O
produces VBZ O
a DT O
larval JJ O
arrest NN O
phenotype NN O
similar JJ O
to IN O
that DT O
observed VBN O
for IN O
dhc NN O
- HYPH O
1 CD O
. . O

Finally RB O
, , O
the DT O
three CD O
Tctex1 NNP O
proteins NNS O
in IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
, , O
DYLT NNP O
- HYPH O
1 CD O
, , O
2 CD O
, , O
and CC O
3 CD O
, , O
are VBP O
not RB O
essential JJ O
for IN O
dynein NN O
- HYPH O
related VBN O
functions NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

As IN O
the DT O
dyrb NN O
- HYPH O
1 CD O
, , O
dlc NN O
- HYPH O
1 CD O
, , O
and CC O
dli NN O
- HYPH O
1 CD O
dynein NN O
AC NN O
genes NNS O
display VBP O
some DT O
dhc NN O
- HYPH O
1 CD O
- HYPH O
like JJ O
requirements NNS O
, , O
they PRP O
positively RB O
influence VBP O
dynein NN O
function NN O
. . O

However RB O
, , O
because IN O
reducing VBG O
their PRP$ O
function NN O
suppresses VBZ O
dhc NNP O
- HYPH O
1ts NNS O
mutants NNS O
, , O
they PRP O
may MD O
also RB O
exert VB O
negative JJ O
regulation NN O
( , O
along IN O
with IN O
dylt NN O
- HYPH O
1 CD O
) -RRB- O
on IN O
the DT O
heavy JJ O
chain NN O
. . O

Negative JJ O
Regulation NN O
of IN O
Dynein NNP O
HC NNP O
by IN O
Light NNP O
Chain NNP O
Subunits NNP O

Finding VBG O
that IN O
reducing VBG O
the DT O
function NN O
of IN O
light NN O
and CC O
light JJ O
intermediate JJ O
dynein NN O
chains NNS O
suppressed VBD O
the DT O
partial JJ O
loss NN O
of IN O
HC NNP O
function NN O
was VBD O
a DT O
striking JJ O
result NN O
. . O

One CD O
member NN O
of IN O
each DT O
of IN O
four CD O
subunit NN O
classes NNS O
can MD O
suppress VB O
the DT O
embryonic JJ O
lethality NN O
associated VBN O
with IN O
three CD O
dhc NN O
- HYPH O
1 CD O
ts IN O
mutants NNS O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

We PRP O
have VBP O
considered VBN O
two CD O
different JJ O
models NNS O
to TO O
explain VB O
how WRB O
RNAi NNP O
- HYPH O
mediated VBN O
depletion NN O
of IN O
these DT O
dynein NN O
ACs NNS O
can MD O
suppress VB O
reduced VBN O
HC NNP O
function NN O
. . O

First RB O
, , O
these DT O
dynein NN O
subunits NNS O
could MD O
be VB O
in IN O
functional JJ O
complexes NNS O
with IN O
, , O
and CC O
exert VB O
negative JJ O
regulation NN O
on IN O
, , O
the DT O
DHC NNP O
- HYPH O
1 CD O
HC NNP O
( -LRB- O
Figure NN O
5B NN O
) -RRB- O
. . O

The DT O
suppression NN O
mechanism NN O
in IN O
this DT O
case NN O
proposes VBZ O
that IN O
removal NN O
of IN O
the DT O
suppressing VBG O
ACs NNP O
increases VBZ O
residual JJ O
mutant JJ O
DHC NNP O
- HYPH O
1 CD O
activity NN O
. . O

The DT O
other JJ O
, , O
nonsuppressing JJ O
, , O
accessory NN O
subunits NNS O
might MD O
then RB O
function VB O
in IN O
nonmitotic JJ O
cellular JJ O
processes NNS O
such JJ O
as IN O
neuronal JJ O
transport NN O
or CC O
organelle NN O
positioning NN O
. . O

In IN O
support NN O
of IN O
this DT O
view NN O
, , O
physical JJ O
removal NN O
of IN O
the DT O
intermediate JJ O
chains NNS O
of IN O
rat NN B-Species
cytoplasmic JJ O
dynein NN O
increased VBD O
HC NNP O
ATPase NNP O
activity NN O
by IN O
about RB O
4 CD O
- HYPH O
fold NN O
( , O
light JJ O
chains NNS O
were VBD O
not RB O
monitored VBN O
in IN O
this DT O
study NN O
but CC O
were VBD O
likely RB O
removed VBN O
as RB O
well RB O
) : O
[ -LRB- O
73 CD O
] -RRB- O
. . O

Thus RB O
, , O
at IN O
least JJS O
with IN O
respect NN O
to IN O
ATPase NNP O
activity NN O
, , O
some DT O
dynein NN O
ACs NNS O
do VBP O
act VB O
as IN O
biochemical JJ O
negative JJ O
regulators NNS O
of IN O
HC NNP O
function NN O
. . O

An DT O
Assortment NNP O
of IN O
Essential JJ O
and CC O
Nonessential JJ O
Dynein NNP O
Complexes NNPS O

Alternatively RB O
, , O
an DT O
assortment NN O
of IN O
dynein NN O
complexes NNS O
( , O
with IN O
different JJ O
ACs NNS O
) -RRB- O
could MD O
coexist VB O
within IN O
early JJ O
embryonic JJ O
cells NNS O
, , O
with IN O
only RB O
a DT O
subset NN O
required VBN O
for IN O
the DT O
essential JJ O
mitotic JJ O
functions NNS O
that WDT O
require VBP O
DHC NNP O
- HYPH O
1 CD O
. . O

In IN O
this DT O
case NN O
, , O
suppression NN O
might MD O
result VB O
from IN O
the DT O
release NN O
of IN O
DHC NNP O
- HYPH O
1 CD O
HCs NNPS O
from IN O
less RBR O
essential JJ O
motor NN O
complexes NNS O
, , O
allowing VBG O
more JJR O
of IN O
the DT O
functionally RB O
compromised VBN O
HCs NNPS O
to TO O
participate VB O
in IN O
the DT O
essential JJ O
process NN O
of IN O
mitosis NN O
. . O

We PRP O
currently RB O
disfavor VBP O
this DT O
hypothesis NN O
because IN O
two CD O
of IN O
the DT O
suppressing VBG O
light JJ O
chains NNS O
( , O
DYLT NNP O
- HYPH O
1 CD O
and CC O
DYRB NNP O
- HYPH O
1 CD O
) -RRB- O
can MD O
indeed RB O
localize VB O
to IN O
meiotic JJ O
and CC O
mitotic JJ O
spindles NNS O
( -LRB- O
Figures NNS O
6 CD O
and CC O
7 CD O
) -RRB- O
, , O
sites NNS O
where WRB O
DHC NNP O
- HYPH O
1 CD O
has VBZ O
been VBN O
shown VBN O
by IN O
others NNS O
to TO O
localize VB O
and CC O
function VB O
. . O

Furthermore RB O
, , O
the DT O
distribution NN O
of IN O
DYRB NNP O
- HYPH O
1 CD O
and CC O
DYLT NNP O
- HYPH O
1 CD O
closely RB O
resembles VBZ O
the DT O
distribution NN O
of IN O
the DT O
HC NNP O
in IN O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
embryos NNS O
, , O
suggesting VBG O
that IN O
these DT O
two CD O
light JJ O
chains NNS O
associate VBP O
with IN O
the DT O
HC NNP O
during IN O
mitosis NN O
( -LRB- O
Figure NN O
7 CD O
and CC O
[ -LRB- O
10 CD O
] -RRB- O
) -RRB- O
. . O

Finally RB O
, , O
dhc NN O
- HYPH O
1 CD O
- HYPH O
like JJ O
phenotypes NNS O
result VBP O
from IN O
mutation NN O
or CC O
RNAi NNP O
knockdown NN O
of IN O
three CD O
suppressing VBG O
ACs NNS O
in IN O
otherwise RB O
wild JJ O
- HYPH O
type NN O
worms NNS B-Species
, , O
indicating VBG O
that IN O
they PRP O
share VBP O
at IN O
least JJS O
some DT O
common JJ O
and CC O
essential JJ O
requirements NNS O
. . O

Regardless RB O
of IN O
the DT O
suppression NN O
mechanism NN O
, , O
our PRP$ O
identification NN O
of IN O
ACs NNS O
that WDT O
genetically RB O
interact VBP O
with IN O
the DT O
DHC NNP O
- HYPH O
1 CD O
HC NNP O
provides VBZ O
a DT O
basis NN O
for IN O
functionally RB O
classifying VBG O
the DT O
paralogs NNS O
of IN O
these DT O
dynein NN O
subunit NN O
gene NN O
families NNS O
, , O
and CC O
for IN O
further JJ O
investigation NN O
of IN O
dynein NN O
composition NN O
and CC O
function NN O
. . O

Nonessential JJ O
Dynein NNP O
Subunits NNPS O
and CC O
Negative JJ O
Regulation NN O
of IN O
the DT O
HC NNP O

Some DT O
ACs NNS O
are VBP O
nonessential JJ O
, , O
supporting VBG O
the DT O
view NN O
that IN O
some DT O
cytoplasmic JJ O
dynein NN O
subunits NNS O
could MD O
function VB O
by IN O
exerting VBG O
negative JJ O
regulation NN O
on IN O
the DT O
HC NNP O
, , O
rather RB O
than IN O
positively RB O
influencing VBG O
essential JJ O
HC NNP O
function NN O
. . O

For IN O
example NN O
, , O
DYRB NNP O
- HYPH O
1 CD O
is VBZ O
not RB O
absolutely RB O
required VBN O
for IN O
viability NN O
because IN O
worms NNS B-Species
lacking VBG O
this DT O
protein NN O
can MD O
be VB O
propagated VBN O
, , O
although IN O
they PRP O
are VBP O
extremely RB O
sick JJ O
and CC O
do VBP O
exhibit VB O
two CD O
dhc NN O
- HYPH O
1 CD O
- HYPH O
like JJ O
phenotypes NNS O
( -LRB- O
Figure NN O
8 CD O
) -RRB- O
. . O

Also RB O
, , O
homozygous JJ O
dylt NN O
- HYPH O
1 CD O
deletion NN O
mutants NNS O
appear VBP O
fully RB O
viable JJ O
( : O
Figure NN O
8 CD O
) -RRB- O
. . O

The DT O
two CD O
additional JJ O
Tctex1 NNP O
C NNP B-Species
. , I-Species
elegans NNS I-Species
genes NNS O
could MD O
be VB O
functionally RB O
redundant JJ O
with IN O
DYLT NNP O
- HYPH O
1 CD O
, , O
but CC O
simultaneously RB O
reducing VBG O
the DT O
function NN O
of IN O
DYLT NNP O
- HYPH O
2 CD O
and CC O
DYLT NNP O
- HYPH O
3 CD O
by IN O
RNAi NNP O
in IN O
the DT O
dylt NN O
- HYPH O
1 CD O
deletion NN O
strain NN O
did VBD O
not RB O
cause VB O
lethality NN O
( , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

Because IN O
RNAi NNP O
does VBZ O
not RB O
always RB O
completely RB O
reduce VB O
function NN O
, , O
the DT O
question NN O
of IN O
redundancy NN O
in IN O
the DT O
Tctex1 NNP O
C NNP B-Species
. . I-Species
elegans NNS I-Species
gene NN O
family NN O
remains VBZ O
unresolved JJ O
. . O

However RB O
, , O
Drosophila NNP B-Species
contains VBZ O
only RB O
a DT O
single JJ O
Tctex1 NNP O
gene NN O
, , O
Dlc90F NNP O
[ -LRB- O
74 CD O
, , O
75 CD O
] -RRB- O
. . O

A DT O
Dlc90F NNP O
null NN O
allele NN O
that WDT O
deletes VBZ O
80 CD O
% NN O
of IN O
the DT O
open JJ O
reading NN O
frame NN O
is VBZ O
essential JJ O
only RB O
for IN O
sperm NN O
production NN O
but CC O
not RB O
for IN O
viability NN O
of IN O
male JJ O
or CC O
female JJ O
flies NNS O
, , O
despite IN O
the DT O
wild JJ O
- HYPH O
type NN O
protein NN O
being VBG O
incorporated VBN O
into IN O
dynein NN O
motors NNS O
and CC O
expressed VBN O
in IN O
various JJ O
Drosophila NNP B-Species
tissues NNS O
[ -LRB- O
74 CD O
] -RRB- O
. . O

Thus RB O
, , O
at IN O
least JJS O
in IN O
Drosophila NNP B-Species
, , O
the DT O
Tctex1 NNP O
dynein NN O
light JJ O
chain NN O
family NN O
is VBZ O
not RB O
required VBN O
for IN O
cell NN O
division NN O
processes NNS O
like IN O
the DT O
HC NNP O
is VBZ O
. . O

Interestingly RB O
, , O
budding VBG O
yeast NN B-Species
does VBZ O
not RB O
possess VB O
genes NNS O
for IN O
the DT O
Tctex1 NNP O
or CC O
roadblock NN O
ACs NNS O
, , O
indicating VBG O
that IN O
functional JJ O
cytoplasmic JJ O
dynein NN O
does VBZ O
not RB O
require VB O
these DT O
subunits NNS O
that WDT O
are VBP O
conserved VBN O
in IN O
many JJ O
other JJ O
organisms NNS O
. . O

The DT O
AC NNP O
genes NNS O
that WDT O
yeast NN B-Species
does VBZ O
posses VB O
are VBP O
not RB O
required VBN O
for IN O
HC NNP O
motility NN O
in IN O
vitro FW O
because IN O
dynein NN O
purified VBD O
from IN O
yeast NN B-Species
with IN O
mutations NNS O
in IN O
these DT O
genes NNS O
remains VBZ O
fully RB O
active JJ O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Thus RB O
, , O
dynein NN O
function NN O
in IN O
several JJ O
contexts NNS O
does VBZ O
not RB O
require VB O
AC NNP O
subunits NNS O
, , O
and CC O
we PRP O
suggest VBP O
that IN O
in IN O
some DT O
cases NNS O
they PRP O
may MD O
have VB O
negative JJ O
regulatory JJ O
roles NNS O
. . O

Negative JJ O
regulation NN O
of IN O
cytoplasmic JJ O
dynein NN O
may MD O
be VB O
redundant JJ O
with IN O
other JJ O
modes NNS O
of IN O
HC NN O
regulation NN O
or CC O
only RB O
required VBN O
during IN O
special JJ O
circumstances NNS O
. . O

Further JJ O
studies NNS O
of IN O
subunit NN O
localization NN O
, , O
and CC O
in IN O
vitro FW O
studies NNS O
of IN O
C NN B-Species
. . I-Species
elegans NNS I-Species
dynein NN O
motility NN O
, , O
may MD O
provide VB O
further JJ O
insight NN O
into IN O
the DT O
modes NNS O
of IN O
AC NN O
regulation NN O
and CC O
function NN O
. . O

Materials NNS O
and CC O
Methods NNS O

C NN B-Species
. . I-Species
elegans NNS I-Species
strains NNS O
and CC O
culture NN O
. . O

Strains NNS O
were VBD O
cultured VBN O
according VBG O
to IN O
standard JJ O
procedures NNS O
[ -LRB- O
28 CD O
] -RRB- O
. . O

ts IN O
mutants NNS O
were VBD O
maintained VBN O
at IN O
15 CD O
degrees NNS O
C NN O
and CC O
GFP NNP O
- HYPH O
expressing VBG O
strains NNS O
in IN O
a DT O
wild JJ O
- HYPH O
type NN O
background NN O
were VBD O
maintained VBN O
in IN O
a DT O
23 CD O
degrees NNS O
C NN O
incubator NN O
. . O

dhc NNP O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
was VBD O
outcrossed VBN O
six CD O
times NNS O
to IN O
the DT O
N2 NNP O
Bristol NNP O
wild JJ O
- HYPH O
type NN O
strain NN O
and CC O
the DT O
or283 CD O
and CC O
or352 CD O
dhc FW O
- HYPH O
1 CD O
mutants NNS O
were VBD O
each DT O
outcrossed VBN O
four CD O
times NNS O
with IN O
N2 NNP O
. . O

For IN O
sequencing VBG O
mutant JJ O
dhc NN O
- HYPH O
1 CD O
loci NN O
, , O
genomic JJ O
DNA NNP O
was VBD O
amplified VBN O
as IN O
overlapping JJ O
~ SYM O
1 CD O
- HYPH O
kb NN O
fragments NNS O
from IN O
the DT O
start NN O
codon NN O
to IN O
the DT O
stop NN O
codon NN O
and CC O
sequenced VBN O
at IN O
the DT O
University NNP O
of IN O
Oregon NNP O
DNA NNP O
sequencing NN O
laboratory NN O
. . O

For IN O
double JJ O
mutant JJ O
constructions NNS O
, , O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
mutation NN O
was VBD O
monitored VBN O
by IN O
sequencing NN O
or CC O
by IN O
assaying VBG O
a DT O
restriction NN O
fragment NN O
length NN O
polymorphism NN O
caused VBN O
by IN O
the DT O
mutation NN O
with IN O
Hpy188I NNP O
( : O
New NNP O
England NNP O
Biolabs NNPS O
, , O
http NN O
: : O
/ SYM O
/ SYM O
www NN O
. . O
neb NN O
. . O
com NN O
) -RRB- O
, , O
following VBG O
PCR NNP O
amplification NN O
of IN O
the DT O
mutated VBN O
region NN O
. . O

The DT O
dylt NN O
- HYPH O
1 CD O
( HYPH O
ok417 CD O
) -RRB- O
and CC O
ufd NN O
- HYPH O
2 CD O
( SYM O
tm1380 CD O
) -RRB- O
alleles NNS O
were VBD O
monitored VBN O
by IN O
PCR NN O
amplification NN O
of IN O
genomic JJ O
sequence NN O
encompassing VBG O
the DT O
deletions NNS O
and CC O
assaying VBG O
product NN O
size NN O
by IN O
agarose JJ O
gel NN O
electrophoresis NN O
. . O

GFP NNP O
imaging NN O
. . O

Visualization NN O
of IN O
GFP NNP O
fusion NN O
protein NN O
localization NN O
was VBD O
accomplished VBN O
by IN O
mounting VBG O
embryos NNS O
on IN O
M9 NNP O
+ SYM O
3 CD O
% NN O
agarose JJ O
pads NNS O
on IN O
microscope NN O
slides NNS O
covered VBN O
with IN O
a DT O
coverslip NN O
. . O

Time NN O
- HYPH O
lapse NN O
videos NNS O
were VBD O
obtained VBN O
on IN O
a DT O
spinning JJ O
disk NN O
Nikon NNP O
Eclipse NNP O
TE2000 NNP O
- HYPH O
U NN O
microscope NN O
( : O
Nikon NNP O
Instruments NNP O
, , O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
nikon NN O
. . O
com NN O
) -RRB- O
fitted VBN O
with IN O
an DT O
ORCA NNP O
- HYPH O
ER NN O
digital JJ O
camera NN O
( , O
Hamamatsu NNP O
Photonics NNP O
, , O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
hamamatsu NN O
. . O
com NN O
) -RRB- O
using VBG O
a DT O
Nikon NNP O
60 CD O
x NN O
, , O
1 CD O
. . O
4 CD O
null NN O
Plan NN O
Apo NN O
oil NN O
objective JJ O
lens NN O
. . O

Videos NNS O
were VBD O
adjusted VBN O
for IN O
contrast NN O
in IN O
ImageJ NNP O
( : O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
, , O
http NNP O
: : O
/ : O
/ SYM O
rsb NNP O
. . O
info NN O
. . O
nih NNP O
. . O
gov NN O
/ SYM O
ij NN O
/ : O
) -RRB- O
[ -LRB- O
76 CD O
] -RRB- O
, , O
images NNS O
were VBD O
adjusted VBN O
for IN O
levels NNS O
in IN O
Adobe NNP O
Photoshop NNP O
( : O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
adobe NN O
. . O
com NN O
/ , O
) -RRB- O
. . O

RNAi NNP O
screening NN O
. . O

After IN O
obtaining VBG O
the DT O
E NNP B-Species
. . I-Species
coli NN I-Species
RNAi NNP O
library NN O
from IN O
the DT O
MRC NNP O
Geneservice NNP O
( , O
Cambridge NNP O
, , O
UK NNP O
) -RRB- O
[ -LRB- O
17 CD O
, , O
19 CD O
] -RRB- O
, , O
we PRP O
rearrayed VBD O
it PRP O
into IN O
a DT O
48 CD O
- HYPH O
well NN O
microplate NN O
format NN O
using VBG O
a DT O
liquid NN O
- HYPH O
handling VBG O
Qiagen NNP O
BioRobot NNP O
8000 CD O
( : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
qiagen NN O
. . O
com NN O
) -RRB- O
. . O

E NN B-Species
. . I-Species
coli NN I-Species
strains NNS O
were VBD O
thawed VBN O
from IN O
- : O
80 CD O
degrees NNS O
C NN O
storage NN O
and CC O
inoculated VBN O
into IN O
1 CD O
ml NNS O
of IN O
LB NNP O
+ SYM O
100 CD O
mg NN O
/ SYM O
ml NN O
ampicillin NN O
- HYPH O
containing VBG O
96 CD O
- HYPH O
well NN O
growth NN O
plates NNS O
( , O
Whatman NNP O
, , O
http NN O
: : O
/ SYM O
/ SYM O
www NN O
. . O
whatman NN O
. . O
com NN O
) NFP O
and CC O
covered VBN O
with IN O
microporous JJ O
sealing NN O
film NN O
( , O
USA NNP O
Scientific NNP O
, , O
http NN O
: : O
/ : O
/ : O
www NN O
. . O
usascientific NN O
. . O
com NN O
) -RRB- O
. . O

Only RB O
48 CD O
wells NNS O
of IN O
the DT O
96 CD O
- HYPH O
well NN O
growth NN O
plates NNS O
were VBD O
filled VBN O
with IN O
media NNS O
, , O
corresponding VBG O
to IN O
the DT O
rearrayed JJ O
E NNP B-Species
. . I-Species
coli NN I-Species
library NN O
. . O

After IN O
overnight JJ O
shaking NN O
incubation NN O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
20 CD O
mu NNS O
l NN O
of IN O
the DT O
cultures NNS O
were VBD O
dispensed VBN O
with IN O
a DT O
24 CD O
- HYPH O
channel NN O
electronic JJ O
repeating NN O
pipette NN O
( , O
Rainin NNP O
, , O
http NN O
: : O
/ NFP O
/ SYM O
www NN O
. . O
rainin NN O
. . O
com NN O
) -RRB- O
onto IN O
48 CD O
- HYPH O
well NN O
plates NNS O
( , O
Nunc NNP O
, , O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
nuncbrand NN O
. . O
com NN O
/ , O
) -RRB- O
containing VBG O
NGM NNP O
agar NN O
, , O
100 CD O
mu NN O
g NN O
/ SYM O
ml NN O
ampicillin NN O
, , O
and CC O
1 CD O
mM NN O
IPTG NN O
and CC O
allowed VBN O
to TO O
dry VB O
and CC O
induce VB O
dsRNA NN O
at IN O
37 CD O
degrees NNS O
C NN O
overnight RB O
. . O

The DT O
48 CD O
- HYPH O
well RB O
agar JJ O
plates NNS O
were VBD O
filled VBN O
with IN O
a DT O
Wheaton NNP O
Unispense NNP O
peristaltic JJ O
pump NN O
( , O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
wheaton NN O
. . O
com NN O
) -RRB- O
equipped VBN O
with IN O
a DT O
custom RB O
- HYPH O
made VBN O
adaptor NN O
( , O
University NNP O
of IN O
Oregon NNP O
Technical NNP O
Science NNP O
Administration NNP O
) -RRB- O
that WDT O
allowed VBD O
simultaneous JJ O
filling NN O
of IN O
eight CD O
wells NNS O
with IN O
the DT O
agar NN O
solution NN O
. . O

Approximately RB O
15 CD O
hypochlorite NN O
- HYPH O
synchronized VBN O
L1 NNP O
mutant JJ O
larvae NN O
were VBD O
pipetted VBN O
into IN O
each DT O
well NN O
of IN O
the DT O
48 CD O
- HYPH O
well NN O
plates NNS O
with IN O
a DT O
multichannel JJ O
pipette NN O
and CC O
allowed VBN O
to TO O
produce VB O
broods NNS O
. . O

Screening NN O
for IN O
F1 NN O
viability NN O
was VBD O
performed VBN O
by IN O
visual JJ O
examination NN O
with IN O
a DT O
dissecting VBG O
microscope NN O
. . O

Phenotypes NNS O
were VBD O
recorded VBN O
on IN O
an DT O
Excel NNP O
spreadsheet NN O
( : O
http NN O
: : O
/ : O
/ SYM O
www ADD O
. . O
microsoft NN O
. . O
com NN O
) -RRB- O
and CC O
organized VBN O
in IN O
a DT O
FileMaker NNP O
Pro NNP O
( : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
filemaker NN O
. . O
com NN O
) -RRB- O
database NN O
. . O

We PRP O
qualitatively RB O
identified VBD O
295 CD O
initial JJ O
positive JJ O
suppressing VBG O
E NN B-Species
. . I-Species
coli NN I-Species
strains NNS O
, , O
for IN O
which WDT O
we PRP O
repeated VBD O
the DT O
assay NN O
on IN O
60 CD O
- HYPH O
mm NN O
plates NNS O
with IN O
E NN B-Species
. . I-Species
coli NN I-Species
again RB O
thawed VBD O
from IN O
the DT O
library NN O
( , O
not RB O
streak NN O
purified VBN O
) -RRB- O
. . O

If IN O
the DT O
observed VBN O
phenotypes NNS O
reproduced VBD O
, , O
the DT O
assay NN O
was VBD O
performed VBN O
with IN O
three CD O
streak NN O
- HYPH O
purified VBN O
E NNP B-Species
. . I-Species
coli NN I-Species
colonies NNS O
, , O
and CC O
a DT O
single JJ O
isolate NN O
that WDT O
again RB O
displayed VBD O
the DT O
interaction NN O
was VBD O
kept VBN O
for IN O
further JJ O
analysis NN O
. . O

Embryonic JJ O
viability NN O
quantitation NN O
methods NNS O
. . O

To TO O
quantitate VB O
embryonic JJ O
viability NN O
we PRP O
used VBD O
the DT O
following VBG O
procedure NN O
. . O

Cultures NNS O
of IN O
dsRNA NN O
- HYPH O
producing VBG O
bacteria NNS O
were VBD O
grown VBN O
overnight RB O
in IN O
LB NNP O
+ SYM O
100 CD O
mu NN O
g NN O
/ SYM O
ml NN O
ampicillin NN O
. . O

Cultures NNS O
( , O
0 CD O
. . O
2 CD O
ml NN O
) -RRB- O
were VBD O
seeded VBN O
onto IN O
60 CD O
- HYPH O
mm NN O
NGM NNP O
agar NN O
plates NNS O
containing VBG O
100 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
ampicillin NN O
and CC O
1 CD O
mM NN O
IPTG NN O
and CC O
allowed VBN O
to TO O
induce VB O
dsRNAs NNS O
overnight RB O
at IN O
room NN O
temperature NN O
. . O

The DT O
L4440 NNP O
control NN O
vector NN O
- HYPH O
containing VBG O
strain NN O
was VBD O
used VBN O
as IN O
the DT O
bacterial JJ O
lawn NN O
for IN O
the DT O
experiments NNS O
shown VBN O
in IN O
Figures NNS O
2A NN O
and CC O
3B NN O
. . O

Approximately RB O
80 CD O
synchronized VBN O
L1 NNP O
larvae NN O
( , O
obtained VBN O
from IN O
hypochlorite NN O
- HYPH O
treated VBN O
worms NNS B-Species
) -RRB- O
were VBD O
pipetted VBN O
onto IN O
the DT O
plates NNS O
and CC O
allowed VBN O
to TO O
grow VB O
to IN O
young JJ O
adulthood NN O
. . O

Five CD O
gravid NN O
worms NNS B-Species
were VBD O
transferred VBN O
to IN O
prepared VBN O
NGM NNP O
agar NN O
plates NNS O
supplemented VBN O
with IN O
100 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
ampicillin NN O
and CC O
1 CD O
mM NN O
IPTG NNP O
containing VBG O
a DT O
small JJ O
RNAi NNP O
bacterial JJ O
lawn NN O
produced VBN O
from IN O
~ $ O
5 CD O
mu NNS O
l NN O
of IN O
overnight JJ O
E NN B-Species
. . I-Species
coli NN I-Species
culture NN O
. . O

After IN O
producing VBG O
broods NNS O
, , O
the DT O
adult NN O
worms NNS B-Species
were VBD O
removed VBN O
and CC O
the DT O
embryos NNS O
were VBD O
allowed VBN O
to TO O
develop VB O
for IN O
at RB O
least RBS O
24 CD O
h NN O
. . O

Embryos NNS O
and CC O
larvae NN O
were VBD O
then RB O
counted VBN O
immediately RB O
or CC O
after IN O
storage NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

We PRP O
considered VBD O
only RB O
suppressor NN O
dsRNAs NNS O
that WDT O
increased VBD O
embryonic JJ O
viability NN O
greater JJR O
than IN O
3 CD O
- HYPH O
fold NN O
above IN O
the DT O
background NN O
viability NN O
observed VBN O
with IN O
the DT O
L4440 NNP O
control NN O
vector NN O
( , O
in IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) NN O
) -RRB- O
screen NN O
to TO O
be VB O
significant JJ O
enough RB O
for IN O
continued JJ O
study NN O
. . O

Molecular JJ O
biology NN O
. . O

We PRP O
introduced VBD O
a DT O
polylinker NN O
site NN O
containing VBG O
six CD O
unique JJ O
restriction NN O
enzyme NN O
recognition NN O
sites NNS O
into IN O
the DT O
pIC26 NN O
GFP NNP O
- HYPH O
S NN O
protein NN O
plasmid NN O
by IN O
using VBG O
phosphorylated VBN O
and CC O
PAGE NN O
- HYPH O
purified VBN O
synthetic JJ O
oligonucleotides NNS O
[ -LRB- O
77 CD O
] -RRB- O
. . O

Following VBG O
ligation NN O
, , O
the DT O
new JJ O
plasmid NN O
was VBD O
sequence NN O
verified VBN O
. . O

The DT O
modified VBN O
vector NN O
, , O
pSO26 NN O
, , O
allows VBZ O
the DT O
use NN O
of IN O
additional JJ O
restriction NN O
enzymes NNS O
and CC O
directional JJ O
cloning NN O
for IN O
inserting VBG O
genes NNS O
of IN O
interest NN O
( -LRB- O
Figure NNP O
S2 NNP O
) -RRB- O
. . O

The DT O
SpeI NNP O
site NN O
was VBD O
recreated VBN O
at IN O
the DT O
5 CD O
' '' O
end NN O
of IN O
the DT O
polylinker NN O
but CC O
not RB O
at IN O
the DT O
3 CD O
' '' O
end NN O
. . O

We PRP O
amplified VBD O
N2 NNP O
genomic JJ O
DNA NN O
or CC O
cDNA NN O
( , O
Invitrogen NNP O
, , O
http NN O
: : O
/ : O
/ : O
www NN O
. . O
invitrogen NN O
. . O
com NN O
) -RRB- O
with IN O
Pfu NNP O
Turbo NNP O
polymerase NN O
( , O
Stratagene NN O
, , O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
stratagene NN O
. . O
com NN O
) -RRB- O
, , O
and CC O
cloned VBN O
A NN O
- HYPH O
tailed VBN O
PCR NN O
products NNS O
into IN O
either CC O
pGEM NNP O
- HYPH O
T NNP O
or CC O
pGEM NNP O
- HYPH O
T NNP O
- HYPH O
easy JJ O
shuttle NN O
vectors NNS O
( : O
Promega NNP O
, , O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
promega NN O
. . O
com NN O
) -RRB- O
. . O

Inserted VBN O
genes NNS O
were VBD O
sequence NN O
verified VBN O
at IN O
the DT O
University NNP O
of IN O
Oregon NNP O
DNA NNP O
sequencing NN O
laboratory NN O
prior RB O
to IN O
cleavage NN O
and CC O
ligation NN O
to IN O
pSO26 NN O
( , O
see VB O
Table NNP O
S3 NNP O
for IN O
restriction NN O
sites NNS O
and CC O
primer NN O
sequences NNS O
used VBN O
) -RRB- O
. . O

All DT O
of IN O
the DT O
constructs NNS O
used VBN O
in IN O
this DT O
study NN O
were VBD O
cloned VBN O
as IN O
SpeI NNP O
- HYPH O
AsiSI NNP O
or CC O
AscI NNP O
- HYPH O
AsiSI NNP O
fragments NNS O
, , O
except IN O
for IN O
the DT O
STAR NNP O
- HYPH O
2 CD O
gene NN O
, , O
which WDT O
was VBD O
amplified VBN O
as IN O
a DT O
SpeI NNP O
fragment NN O
and CC O
cloned VBN O
into IN O
pIC26 NN O
. . O

To TO O
construct VB O
dynein NN O
subunit NN O
dsRNA NN O
- HYPH O
expressing VBG O
plasmids NNS O
not RB O
available JJ O
in IN O
the DT O
RNAi NNP O
library NN O
, , O
gene NN O
fragments NNS O
were VBD O
amplified VBN O
from IN O
N2 NNP O
genomic JJ O
DNA NN O
with IN O
the DT O
following VBG O
primers NNS O
: : O
F41G4 NNP O
. . O
1 CD O
: : O
5 CD O
' '' O
- : O
AAGATATCACCCAAAATGGT NN O
- HYPH O
3 CD O
' '' O
and CC O
5 CD O
' '' O
- : O
CGGATATCTCGACTGAAGCT NNP O
- HYPH O
3 CD O
' '' O
, , O
xbx NN O
- HYPH O
1 CD O
: : O
5 CD O
' '' O
- : O
AAGATATCTACGACGATGGA NNP O
- HYPH O
3 CD O
' '' O
and CC O
5 CD O
' '' O
- : O
CGGATATCCGTGCCTCTGCA NNP O
- HYPH O
3 CD O
' '' O
, , O
dlc NNP O
- HYPH O
3 CD O
: : O
5 CD O
' '' O
- : O
AAGATATCAATTTCAGGTGG NN O
- HYPH O
3 CD O
' '' O
and CC O
5 CD O
' '' O
- : O
CGGATATCAGCACACTTGCA NNP O
- HYPH O
3 CD O
' '' O
. . O

The DT O
PCR NNP O
products NNS O
were VBD O
cut VBN O
with IN O
EcoRV NNP O
, , O
ligated VBN O
to IN O
EcoRV NN O
- HYPH O
digested VBN O
L4440 CD O
, , O
and CC O
sequence NN O
verified VBN O
. . O

Isolation NN O
of IN O
transgenic JJ O
worms NNS B-Species
. . O

GFP NNP O
fusion NN O
plasmids NNS O
were VBD O
bombarded VBN O
into IN O
unc NNP O
- HYPH O
119 CD O
( HYPH O
ed3 NN O
) -RRB- O
worms NNS B-Species
as IN O
previously RB O
described VBN O
except IN O
with IN O
the DT O
following VBG O
two CD O
changes NNS O
[ -LRB- O
78 CD O
] -RRB- O
. . O

Three CD O
milligrams NNS O
of IN O
gold NN O
particles NNS O
were VBD O
used VBN O
per IN O
hepta NN O
adaptor NN O
bombardment NN O
. . O

Also RB O
, , O
we PRP O
briefly RB O
sonicated VBD O
the DT O
gold JJ O
particles NNS O
( , O
prior RB O
to IN O
DNA NN O
coating NN O
and CC O
while IN O
suspended VBN O
in IN O
50 CD O
% NN O
glycerol NN O
) , O
with IN O
a DT O
Branson NNP O
sonifier NN O
450 CD O
( , O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
sonifier NN O
. . O
com NN O
/ , O
) -RRB- O
fitted VBN O
with IN O
a DT O
small JJ O
tip NN O
set VBN O
to IN O
power NN O
level NN O
1 CD O
, , O
to TO O
disrupt VB O
gold NN O
aggregates NNS O
. . O

Non NNP O
- HYPH O
Unc NNP O
worms NNS B-Species
were VBD O
picked VBN O
to IN O
new JJ O
plates NNS O
and CC O
allowed VBN O
to TO O
produce VB O
broods NNS O
, , O
which WDT O
were VBD O
assayed VBN O
for IN O
GFP NNP O
fluorescence NN O
with IN O
a DT O
Zeiss NNP O
axioskop NN O
microscope NN O
( , O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
zeiss NNP O
. . O
com NN O
/ , O
) -RRB- O
fitted VBN O
with IN O
an DT O
X NNP O
- HYPH O
Cite NN O
120 CD O
illumination NN O
system NN O
( , O
EXFO NNP O
life NN O
sciences NNS O
, , O
Mississauga NNP O
, , O
Ontario NNP O
, , O
Canada NNP O
) -RRB- O
. . O

For IN O
each DT O
fluorescent JJ O
line NN O
, , O
12 CD O
GFP NNP O
- HYPH O
positive JJ O
worms NNS B-Species
were VBD O
singled VBN O
to IN O
new JJ O
plates NNS O
to TO O
determine VB O
if IN O
the DT O
constructs NNS O
were VBD O
integrated VBN O
or CC O
were VBD O
carried VBN O
as IN O
extrachromosomal JJ O
arrays NNS O
. . O

Supporting VBG O
Information NN O

Accession NN O
Numbers NNS O

The DT O
National NNP O
Center NNP O
for IN O
Biotechnology NNP O
Information NNP O
( : O
NCBI NNP O
) -RRB- O
database NN O
( , O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
ncbi ADD O
. . O
nlm UH O
. . O
nih NN O
. . O
gov NN O
/ : O
gquery NN O
/ SYM O
gquery NN O
. . O
fcgi NN O
? , O
itool NN O
= : O
toolbar NN O
) -RRB- O
accession NN O
numbers NNS O
for IN O
the DT O
dhc NN O
- HYPH O
1 CD O
homologs NNS O
discussed VBN O
in IN O
this DT O
paper NN O
are VBP O
C NN B-Species
. . I-Species
elegans NNS I-Species
, , O
NP NNP O
_ : O
491363 CD O
; : O
Dictyostelium NN B-Species
discoideum NN I-Species
, , O
XP NN O
_ : O
643185 CD O
; : O
Drosophila NNP B-Species
melanogaster NN I-Species
, , O
AAA60323 NN O
; : O
Homo NNP B-Species
sapiens NNP I-Species
, , O
NP NNP O
_ : O
1367 CD O
; : O
Mus NNP B-Species
musculus NNP I-Species
, , O
NP NNP O
_ : O
84514 CD O
; : O
Saccharomyces NNP B-Species
cerevisiae NN I-Species
, , O
NP NNP O
_ : O
12980 CD O
; : O
and CC O
Schizosaccharomyces NN B-Species
pombe NN I-Species
, , O
NP NNP O
_ : O
1018285 CD O
. . O

The DT O
NCBI NNP O
accession NN O
numbers NNS O
for IN O
the DT O
Drosophila NNP B-Species
and CC O
human JJ B-Species
DYLT NNP O
- HYPH O
1 CD O
and CC O
DYRB NNP O
- HYPH O
1 CD O
protein NN O
homologues NNS O
, , O
respectively RB O
, , O
are VBP O
Dlc90F NNP O
, , O
NP NNP O
_ : O
477356 CD O
; : O
DYNLT3 NNP O
, , O
NP NNP O
_ : O
6511 CD O
; : O
DYNLRB1 NNP O
, , O
NP NNP O
_ : O
54902 CD O
; : O
and CC O
robl NN O
, , O
NP NNP O
_ : O
523771 CD O
. . O

Identification NN O
of IN O
Two CD O
Independent JJ O
Risk NNP O
Factors NNPS O
for IN O
Lupus NNP O
within IN O
the DT O
MHC NNP O
in IN O
United NNP O
Kingdom NNP O
Families NNPS O

Abstract JJ O

The DT O
association NN O
of IN O
the DT O
major JJ O
histocompatibility NN O
complex NN O
( , O
MHC NNP O
) -RRB- O
with IN O
SLE NNP O
is VBZ O
well RB O
established VBN O
yet RB O
the DT O
causal JJ O
variants NNS O
arising VBG O
from IN O
this DT O
region NN O
remain VBP O
to TO O
be VB O
identified VBN O
, , O
largely RB O
due IN O
to IN O
inadequate JJ O
study NN O
design NN O
and CC O
the DT O
strong JJ O
linkage NN O
disequilibrium NN O
demonstrated VBN O
by IN O
genes NNS O
across IN O
this DT O
locus NN O
. . O

The DT O
majority NN O
of IN O
studies NNS O
thus RB O
far RB O
have VBP O
identified VBN O
strong JJ O
association NN O
with IN O
classical JJ O
class NN O
II NN O
alleles NNS O
, , O
in IN O
particular JJ O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
and CC O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
. . O

Additional JJ O
associations NNS O
have VBP O
been VBN O
reported VBN O
with IN O
class NN O
III NNP O
alleles NNS O
; : O
specifically RB O
, , O
complement VB O
C4 NN O
null NN O
alleles NNS O
and CC O
a DT O
tumor NN O
necrosis NN O
factor NN O
promoter NN O
SNP NNP O
( -LRB- O
TNF NNP O
- HYPH O
308G CD O
/ SYM O
A NNP O
) -RRB- O
. . O

However RB O
, , O
the DT O
relative JJ O
effects NNS O
of IN O
these DT O
class NN O
II NN O
and CC O
class NN O
III NNP O
variants NNS O
have VBP O
not RB O
been VBN O
determined VBN O
. . O

We PRP O
have VBP O
thus RB O
used VBN O
a DT O
family NN O
- HYPH O
based VBN O
approach NN O
to IN O
map NN O
association NN O
signals NNS O
across IN O
the DT O
MHC NNP O
class NN O
II NN O
and CC O
class NN O
III NNP O
regions NNS O
in IN O
a DT O
cohort NN O
of IN O
314 CD O
complete JJ O
United NNP O
Kingdom NNP O
Caucasian JJ O
SLE NNP O
trios NNS O
by IN O
typing VBG O
tagging NN O
SNPs NNPS O
together RB O
with IN O
classical JJ O
typing NN O
of IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
locus NN O
. . O

Using VBG O
TDT NNP O
and CC O
conditional JJ O
regression NN O
analyses NNS O
, , O
we PRP O
have VBP O
demonstrated VBN O
the DT O
presence NN O
of IN O
two CD O
distinct JJ O
and CC O
independent JJ O
association NN O
signals NNS O
in IN O
SLE NNP O
: : O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
( : O
nominal JJ O
p NN O
= SYM O
4 CD O
. . O
9 CD O
x SYM O
10 CD O
- HYPH O
8 CD O
, , O
permuted VBN O
p NN O
< SYM O
0 CD O
. . O
1 CD O
, , O
OR CC O
= SYM O
2 CD O
. . O
3 CD O
) -RRB- O
and CC O
the DT O
T NN O
allele NN O
of IN O
SNP NN O
rs419788 CD O
( : O
nominal JJ O
p NN O
= SYM O
4 CD O
. . O
3 CD O
x SYM O
10 CD O
- HYPH O
8 CD O
, , O
permuted VBN O
p NN O
< NN O
0 CD O
. . O
1 CD O
, , O
OR CC O
= SYM O
2 CD O
. . O
0 CD O
) -RRB- O
in IN O
intron NN O
6 CD O
of IN O
the DT O
class NN O
III NNP O
region NN O
gene NN O
SKIV2L NNP O
. . O

Assessment NN O
of IN O
genotypic JJ O
risk NN O
demonstrates VBZ O
a DT O
likely RB O
dominant JJ O
model NN O
of IN O
inheritance NN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
, , O
while IN O
rs419788 CD O
- HYPH O
T NN O
confers VBZ O
susceptibility NN O
in IN O
an DT O
additive JJ O
manner NN O
. . O

Furthermore RB O
, , O
by IN O
comparing VBG O
transmitted VBN O
and CC O
untransmitted JJ O
parental JJ O
chromosomes NNS O
, , O
we PRP O
have VBP O
delimited VBN O
our PRP$ O
class NN O
II NN O
signal NN O
to IN O
a DT O
180 CD O
kb NN O
region NN O
encompassing VBG O
the DT O
alleles FW O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
- HYPH O
HLA NNP O
- HYPH O
DQA1 NNP O
* NFP O
501 CD O
- HYPH O
HLA NN O
- HYPH O
DQB1 NNP O
* NFP O
201 CD O
alone RB O
. . O

Our PRP$ O
class NN O
III NNP O
signal NN O
importantly RB O
excludes VBZ O
independent JJ O
association NN O
at IN O
the DT O
TNF NNP O
promoter NN O
polymorphism NN O
, , O
TNF NNP O
- HYPH O
308G NNP O
/ SYM O
A NNP O
, , O
in IN O
our PRP$ O
SLE NNP O
cohort NN O
and CC O
provides VBZ O
a DT O
potentially RB O
novel JJ O
locus NN O
for IN O
future JJ O
genetic JJ O
and CC O
functional JJ O
studies NNS O
. . O

Systemic JJ O
lupus NN O
erythematosus NN O
( , O
SLE NNP O
/ SYM O
lupus NN O
) -RRB- O
is VBZ O
a DT O
complex JJ O
autoimmune JJ O
disease NN O
in IN O
which WDT O
the DT O
body NN O
' POS O
s POS O
immune JJ O
system NN O
attacks VBZ O
its PRP$ O
own JJ O
tissues NNS O
, , O
causing VBG O
inflammation NN O
in IN O
a DT O
variety NN O
of IN O
different JJ O
organs NNS O
such JJ O
as IN O
the DT O
skin NN O
, , O
joints NNS O
, , O
and CC O
kidneys NNS O
. . O

The DT O
cause NN O
of IN O
lupus NN O
is VBZ O
not RB O
known VBN O
, , O
but CC O
genes NNS O
play VBP O
a DT O
significant JJ O
role NN O
in IN O
the DT O
predisposition NN O
to IN O
disease NN O
. . O

The DT O
major JJ O
histocompatibility NN O
complex NN O
( , O
MHC NNP O
) -RRB- O
on IN O
Chromosome NNP O
6 CD O
contains VBZ O
at RB O
least RBS O
100 CD O
different JJ O
genes NNS O
that WDT O
affect VBP O
the DT O
immune JJ O
system NN O
, , O
including VBG O
the DT O
genes NNS O
with IN O
the DT O
strongest JJS O
effect NN O
on IN O
lupus NN O
susceptibility NN O
. . O

Despite IN O
the DT O
importance NN O
of IN O
the DT O
MHC NNP O
in IN O
SLE NNP O
, , O
the DT O
identity NN O
of IN O
the DT O
actual JJ O
genes NNS O
in IN O
the DT O
MHC NNP O
region NN O
that WDT O
cause VBP O
SLE NNP O
has VBZ O
remained VBN O
elusive JJ O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
used VBD O
the DT O
latest JJS O
set NN O
of IN O
genetic JJ O
markers NNS O
present JJ O
at IN O
the DT O
MHC NNP O
in IN O
lupus NN O
families NNS O
to TO O
identify VB O
the DT O
actual JJ O
genes NNS O
that WDT O
affect VBP O
the DT O
disease NN O
. . O

To IN O
our PRP$ O
knowledge NN O
, , O
we PRP O
have VBP O
shown VBN O
for IN O
the DT O
first JJ O
time NN O
that IN O
two CD O
separate JJ O
groups NNS O
of IN O
genes NNS O
are VBP O
involved VBN O
in IN O
SLE NNP O
. . O

One CD O
group NN O
of IN O
genes NNS O
alters VBZ O
how WRB O
the DT O
immune JJ O
system NN O
may MD O
inappropriately RB O
target VB O
its PRP$ O
own JJ O
tissues NNS O
in IN O
the DT O
disease NN O
. . O

How WRB O
the DT O
second JJ O
set NN O
of IN O
genes NNS O
predisposes VBZ O
to IN O
SLE NNP O
is VBZ O
the DT O
subject NN O
of IN O
ongoing JJ O
study NN O
. . O

Introduction NN O

Since IN O
the DT O
early JJ O
1970s CD O
, , O
the DT O
human JJ B-Species
major JJ O
histocompatibility NN O
complex NN O
( -LRB- O
MHC NNP O
) -RRB- O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
number NN O
of IN O
autoimmune JJ O
, , O
inflammatory JJ O
, , O
and CC O
infectious JJ O
diseases NNS O
, , O
and CC O
it PRP O
continues VBZ O
to TO O
be VB O
the DT O
focus NN O
of IN O
intense JJ O
research NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
recently RB O
defined VBN O
extended VBN O
MHC NNP O
( -LRB- O
xMHC NNP O
) -RRB- O
encompasses VBZ O
7 CD O
. . O
6 CD O
Mb NN O
of IN O
genome NN O
on IN O
6p21 CD O
. . O
3 CD O
and CC O
is VBZ O
divided VBN O
into IN O
five CD O
subregions NNS O
from IN O
telomere NN O
to IN O
centromere NN O
: : O
extended VBN O
class NN O
I NNP O
, , O
classical JJ O
class NN O
I NNP O
, , O
classical JJ O
class NN O
III NNP O
, , O
classical JJ O
class NN O
II NN O
, , O
and CC O
extended VBN O
class NN O
II CD O
. . O

In IN O
addition NN O
, , O
the DT O
MHC NNP O
contains VBZ O
two CD O
hypervariable JJ O
regions NNS O
, , O
the DT O
RCCX NNP O
module NN O
in IN O
class NN O
III NNP O
( , O
spanning VBG O
complement NN O
C4 NNP O
) -RRB- O
and CC O
the DT O
HLA NNP O
- HYPH O
DRB NNP O
genes NNS O
in IN O
class NN O
II CD O
, , O
that WDT O
both CC O
exhibit VBP O
copy NN O
number NN O
polymorphism NN O
. . O

Examination NN O
of IN O
the DT O
sequence NN O
across IN O
the DT O
extended JJ O
MHC NNP O
reveals VBZ O
the DT O
presence NN O
of IN O
421 CD O
genes NNS O
, , O
and CC O
over IN O
252 CD O
( SYM O
60 CD O
% NN O
) -RRB- O
are VBP O
thought VBN O
to TO O
be VB O
expressed VBN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Around RB O
40 CD O
% NN O
of IN O
genes NNS O
expressed VBN O
within IN O
the DT O
classical JJ O
MHC NNP O
encode NN O
proteins NNS O
with IN O
putative JJ O
immunomodulatory JJ O
function NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

The DT O
classical JJ O
class NN O
I PRP O
and CC O
class NN O
II NN O
loci NN O
encode VBP O
the DT O
human JJ B-Species
leucocyte NN O
antigen NN O
( , O
HLA NNP O
) -RRB- O
proteins NNS O
involved VBN O
in IN O
antigen NN O
presentation NN O
to IN O
T NN O
cells NNS O
, , O
initiating VBG O
the DT O
adaptive JJ O
immune JJ O
response NN O
. . O

The DT O
class NN O
III NNP O
region NN O
contains VBZ O
the DT O
greatest JJS O
density NN O
of IN O
genes NNS O
in IN O
the DT O
genome NN O
( , O
58 CD O
expressed VBN O
genes NNS O
) -RRB- O
, , O
which WDT O
are VBP O
often RB O
found VBN O
in IN O
functionally RB O
related VBN O
clusters NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

A DT O
major JJ O
obstacle NN O
in IN O
the DT O
identification NN O
of IN O
disease NN O
- HYPH O
specific JJ O
causal NN O
variants NNS O
within IN O
the DT O
MHC NNP O
has VBZ O
been VBN O
the DT O
strong JJ O
linkage NN O
disequilibrium NN O
( -LRB- O
LD NNP O
) -RRB- O
exhibited VBN O
by IN O
certain JJ O
alleles NNS O
in IN O
this DT O
region NN O
, , O
resulting VBG O
in IN O
the DT O
existence NN O
of IN O
long JJ O
- HYPH O
range NN O
, , O
conserved VBN O
, , O
extended VBN O
haplotypes NNS O
[ -LRB- O
4 CD O
] -RRB- O
, , O
also RB O
known VBN O
as IN O
ancestral JJ O
haplotypes NNS O
[ -LRB- O
5 CD O
] -RRB- O
, , O
sometimes RB O
spanning VBG O
more JJR O
than IN O
2 CD O
Mb NNS O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Thus RB O
, , O
for IN O
many JJ O
MHC NNP O
- HYPH O
associated VBN O
diseases NNS O
, , O
it PRP O
has VBZ O
only RB O
been VBN O
possible JJ O
to TO O
delimit VB O
association NN O
signals NNS O
to IN O
a DT O
particular JJ O
extended JJ O
haplotype NN O
or CC O
segment NN O
of IN O
one CD O
. . O

Systemic JJ O
lupus NN O
erythematosus NN O
( , O
SLE NN O
/ SYM O
lupus NN O
, , O
[ -LRB- O
Online NNP O
Mendelian NNP O
Inheritance NNP O
in IN O
Man NNP B-Species
152700 CD O
, , O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
ncbi ADD O
. . O
nlm UH O
. . O
nih NN O
. . O
gov NN O
/ SYM O
sites NNS O
/ SYM O
entrez NN O
? , O
db NN O
= : O
OMIM NN O
& CC O
TabCmd NNP O
= SYM O
Limits NNS O
] -RRB- O
) -RRB- O
is VBZ O
a DT O
chronic JJ O
, , O
multi JJ O
- HYPH O
system NN O
autoimmune JJ O
disease NN O
affecting VBG O
young JJ O
women NNS B-Species
ten CD O
times NNS O
more RBR O
commonly RB O
than IN O
men NNS B-Species
. . O

The DT O
worldwide JJ O
prevalence NN O
of IN O
SLE NNP O
is VBZ O
estimated VBN O
at IN O
between IN O
12 CD O
and CC O
124 CD O
cases NNS O
per IN O
100 CD O
, , O
0 CD O
individuals NNS O
[ -LRB- O
7 CD O
] -RRB- O
. . O

SLE NNP O
is VBZ O
characterized VBN O
by IN O
the DT O
presence NN O
of IN O
pathogenic JJ O
autoantibodies NNS O
to IN O
nuclear JJ O
and CC O
cell NN O
- HYPH O
surface NN O
antigens NNS O
that WDT O
show VBP O
affinity NN O
maturation NN O
. . O

The DT O
consequent JJ O
immune JJ O
complexes NNS O
deposit VBP O
in IN O
tissues NNS O
, , O
causing VBG O
inflammation NN O
and CC O
damage NN O
. . O

It PRP O
is VBZ O
well RB O
established VBN O
that IN O
there EX O
is VBZ O
a DT O
complex JJ O
genetic JJ O
component NN O
to IN O
lupus NN O
aetiology NN O
, , O
with IN O
hormonal JJ O
and CC O
environmental JJ O
influences NNS O
also RB O
contributing VBG O
to IN O
disease NN O
susceptibility NN O
[ -LRB- O
8 CD O
, , O
9 CD O
] -RRB- O
. . O

The DT O
MHC NNP O
has VBZ O
been VBN O
the DT O
most RBS O
consistently RB O
confirmed VBN O
genetic JJ O
risk NN O
factor NN O
for IN O
SLE NNP O
, , O
and CC O
multiple JJ O
different JJ O
genes NNS O
within IN O
the DT O
region NN O
have VBP O
been VBN O
significantly RB O
implicated VBN O
with IN O
disease NN O
susceptibility NN O
. . O

For IN O
example NN O
, , O
hereditary JJ O
and CC O
acquired VBN O
deficiencies NNS O
of IN O
the DT O
early JJ O
classical JJ O
complement NN O
component NN O
C4 NNP O
, , O
located VBN O
within IN O
the DT O
MHC NNP O
class NN O
III NNP O
locus NN O
, , O
leads VBZ O
to IN O
a DT O
lupus NN O
- HYPH O
like JJ O
syndrome NN O
. . O

A DT O
role NN O
for IN O
another DT O
class NN O
III NNP O
gene NN O
, , O
tumour NN O
necrosis NN O
factor NN O
alpha NN O
( , O
TNF NNP O
) -RRB- O
, , O
in IN O
SLE NNP O
was VBD O
suggested VBN O
following VBG O
the DT O
observation NN O
that IN O
the DT O
lupus NN O
- HYPH O
prone JJ O
New NNP O
Zealand NNP O
F1 NNP O
mouse NN B-Species
hybrid NN O
exhibits VBZ O
constitutively RB O
low JJ O
TNF NNP O
expression NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Recently RB O
, , O
the DT O
development NN O
of IN O
antinuclear JJ O
antibodies NNS O
in IN O
patients NNS B-Species
treated VBN O
with IN O
TNF NNP O
antagonists NNS O
has VBZ O
also RB O
stimulated VBN O
interest NN O
in IN O
the DT O
possible JJ O
role NN O
of IN O
TNF NNP O
in IN O
SLE NNP O
[ -LRB- O
11 CD O
- SYM O
13 CD O
] -RRB- O
. . O

Murine NN O
and CC O
human JJ B-Species
candidate NN O
gene NN O
studies NNS O
, , O
together RB O
with IN O
genome NN O
- HYPH O
wide JJ O
linkage NN O
screens NNS O
, , O
provide VBP O
further JJ O
support NN O
that IN O
multiple JJ O
genetic JJ O
loci NN O
, , O
including VBG O
the DT O
mouse NN B-Species
MHC NNP O
complex NN O
H2 NN O
and CC O
the DT O
human JJ B-Species
MHC NNP O
locus NN O
, , O
contribute VBP O
to IN O
disease NN O
susceptibility NN O
[ -LRB- O
14 CD O
- SYM O
17 CD O
] -RRB- O
. . O

It PRP O
should MD O
be VB O
noted VBN O
that IN O
the DT O
human JJ B-Species
MHC NNP O
was VBD O
first RB O
associated VBN O
with IN O
SLE NNP O
in IN O
1971 CD O
, , O
when WRB O
studies NNS O
demonstrated VBD O
that IN O
lupus NN O
probands NNS O
were VBD O
enriched VBN O
for IN O
the DT O
class NN O
I PRP O
alleles VBZ O
HL NNP O
- HYPH O
A8 NNP O
( , O
now RB O
known VBN O
as IN O
HLA NNP O
- HYPH O
B8 NNP O
) -RRB- O
and CC O
HLA NNP O
- HYPH O
W15 NNP O
( , O
now RB O
known VBN O
as IN O
HLA NNP O
- HYPH O
B15 NNP O
) -RRB- O
when WRB O
compared VBN O
with IN O
healthy JJ O
controls NNS O
[ -LRB- O
18 CD O
, , O
19 CD O
] -RRB- O
. . O

Further JJ O
case NN O
control NN O
association NN O
studies NNS O
were VBD O
small JJ O
, , O
performed VBN O
in IN O
ethnically RB O
diverse JJ O
populations NNS O
, , O
and CC O
tested VBD O
only RB O
a DT O
small JJ O
number NN O
of IN O
the DT O
classical JJ O
HLA NNP O
and CC O
complement VBP O
C4 NN O
alleles NNS O
. . O

The DT O
most RBS O
consistent JJ O
findings NNS O
reported VBN O
to IN O
date NN O
are VBP O
associations NNS O
with IN O
the DT O
class NN O
II NNP O
alleles NNP O
HLA NNP O
- HYPH O
DR2 NNP O
( -LRB- O
DRB1 NNP O
* NFP O
1501 CD O
) -RRB- O
and CC O
HLA NNP O
- HYPH O
DR3 NNP O
( -LRB- O
DRB1 NNP O
* NFP O
301 CD O
) -RRB- O
and CC O
their PRP$ O
respective JJ O
haplotypes NNS O
in IN O
Caucasian JJ O
populations NNS O
. . O

The DT O
complement NN O
C4A NNP O
null NN O
allele NN O
( , O
C4A NNP O
* NFP O
Q0 NNP O
) -RRB- O
has VBZ O
shown VBN O
inconsistent JJ O
association NN O
with IN O
lupus NN O
in IN O
a DT O
number NN O
of IN O
studies NNS O
- : O
- : O
a DT O
situation NN O
that WDT O
may MD O
reflect VB O
genetic JJ O
heterogeneity NN O
in IN O
disease NN O
susceptibility NN O
[ -LRB- O
20 CD O
- SYM O
23 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
a DT O
recent JJ O
study NN O
has VBZ O
demonstrated VBN O
that IN O
low JJ O
C4A NN O
copy NN O
number NN O
is VBZ O
a DT O
risk NN O
factor NN O
for IN O
lupus NN O
in IN O
a DT O
European JJ O
American JJ O
cohort NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
C4A NNP O
null NN O
allele NN O
lies VBZ O
on IN O
the DT O
lupus NN O
- HYPH O
associated VBN O
DR3 NN O
"""" `` O
autoimmune JJ O
"""" '' O
extended VBN O
haplotype NN O
( : O
AH8 NNP O
. . O
1 CD O
) -RRB- O
, , O
which WDT O
exhibits VBZ O
extremely RB O
strong JJ O
LD NNP O
[ -LRB- O
6 CD O
] -RRB- O
. . O

It PRP O
therefore RB O
remains VBZ O
to TO O
be VB O
definitively RB O
established VBN O
whether IN O
this DT O
locus NN O
constitutes VBZ O
a DT O
distinct JJ O
susceptibility NN O
allele NN O
to IN O
that DT O
of IN O
the DT O
class NN O
II NNP O
association NN O
or CC O
is VBZ O
merely RB O
in IN O
LD NNP O
with IN O
it PRP O
. . O

Similarly RB O
, , O
certain JJ O
TNF NNP O
promoter NN O
polymorphisms NNS O
, , O
including VBG O
the DT O
much RB O
- HYPH O
studied VBN O
SNP NNP O
TNF NNP O
- HYPH O
308G NNP O
/ SYM O
A NNP O
, , O
have VBP O
shown VBN O
association NN O
with IN O
SLE NNP O
; : O
but CC O
again RB O
, , O
many JJ O
of IN O
these DT O
variants NNS O
are VBP O
carried VBN O
on IN O
the DT O
highly RB O
conserved VBN O
8 CD O
. . O
1 CD O
ancestral JJ O
haplotype NN O
, , O
thus RB O
restricting VBG O
interpretation NN O
of IN O
these DT O
data NNS O
. . O

In IN O
2002 CD O
, , O
a DT O
family NN O
- HYPH O
based VBN O
study NN O
employing VBG O
microsatellites NNS O
as IN O
surrogate NN O
markers NNS O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
haplotypes NNS O
in IN O
Caucasian JJ O
lupus NN O
families NNS O
demonstrated VBD O
association NN O
with IN O
DR3 NNP O
- HYPH O
, , O
DR2 NNP O
- , O
, , O
and CC O
DR8 NNP O
( -LRB- O
DRB1 NNP O
* NFP O
801 CD O
) -RRB- O
- , O
containing VBG O
haplotypes NNS O
. . O

In IN O
that DT O
study NN O
, , O
Graham NNP O
and CC O
colleagues NNS O
reported VBD O
that IN O
, , O
taking VBG O
advantage NN O
of IN O
recombinant JJ O
chromosomes NNS O
, , O
the DT O
disease NN O
risk NN O
region NN O
could MD O
be VB O
limited VBN O
to IN O
a DT O
1 CD O
Mb NN O
region NN O
encompassing VBG O
classical JJ O
class NN O
II NN O
and CC O
class NN O
III NNP O
[ -LRB- O
25 CD O
] -RRB- O
. . O

We PRP O
have VBP O
performed VBN O
a DT O
medium JJ O
resolution NN O
association NN O
mapping VBG O
study NN O
of IN O
the DT O
MHC NNP O
in IN O
lupus NN O
families NNS O
, , O
utilizing VBG O
a DT O
combination NN O
of IN O
SNPs NNS O
and CC O
four CD O
- HYPH O
digit NN O
typing NN O
at IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
locus NN O
in IN O
order NN O
to TO O
anchor VB O
haplotypes NNS O
. . O

Sixty CD O
- HYPH O
eight CD O
SNPs NNS O
were VBD O
successfully RB O
genotyped VBN O
across IN O
a DT O
2 CD O
. SYM O
4 CD O
Mb NN O
region NN O
of IN O
the DT O
MHC NNP O
, , O
from IN O
the DT O
class NN O
I NNP O
locus NN O
KIAA1949 NNP O
to IN O
the DT O
class NN O
II NNP O
gene NN O
HLA NNP O
- HYPH O
DPB2 NNP O
, , O
in IN O
314 CD O
UK NNP O
Caucasian NNP O
SLE NNP O
trios NNS O
. . O

We PRP O
used VBD O
these DT O
data NNS O
to TO O
perform VB O
a DT O
family NN O
- HYPH O
based VBN O
association NN O
study NN O
in IN O
an DT O
attempt NN O
to TO O
distinguish VB O
the DT O
relative JJ O
effects NNS O
of IN O
the DT O
class NN O
II NN O
and CC O
class NN O
III NNP O
regions NNS O
of IN O
the DT O
MHC NNP O
in IN O
lupus NN O
susceptibility NN O
. . O

In IN O
addition NN O
, , O
we PRP O
employed VBD O
the DT O
long JJ O
- HYPH O
range NN O
haplotype NN O
test NN O
to TO O
search VB O
for IN O
the DT O
presence NN O
of IN O
high JJ O
- HYPH O
frequency NN O
, , O
extended VBN O
haplotypes NNS O
indicative JJ O
of IN O
recent JJ O
positive JJ O
selection NN O
[ -LRB- O
26 CD O
] -RRB- O
. . O

We PRP O
have VBP O
also RB O
used VBN O
family NN O
- HYPH O
based VBN O
and CC O
case NN O
- HYPH O
control NN O
strategies NNS O
to TO O
examine VB O
genotypic JJ O
risk NN O
at IN O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
rs419788 CD O
. . O

Results NNS O

Association NNP O
Testing NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
MHC NNP O
Region NNP O
SNPs NNPS O

In IN O
order NN O
to TO O
define VB O
the DT O
causal JJ O
variation NN O
within IN O
the DT O
MHC NNP O
region NN O
, , O
we PRP O
typed VBD O
314 CD O
complete JJ O
SLE NNP O
trios NNS O
for IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
gene NN O
as RB O
well RB O
as IN O
for IN O
86 CD O
SNPs NNS O
across IN O
a DT O
2 CD O
. . O
4 CD O
Mb NN O
region NN O
encompassing VBG O
the DT O
HLA NNP O
class NN O
I PRP O
locus VBP O
HLA NNP O
- HYPH O
B NNP O
to IN O
HLA NNP O
- HYPH O
DPB2 NNP O
. . O

High JJ O
- HYPH O
quality NN O
genotype NN O
data NNS O
was VBD O
obtained VBN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
68 CD O
MHC NNP O
SNPs NNPS O
( , O
see VB O
Table NNP O
S1 NNP O
for IN O
quality NN O
control NN O
data NNS O
) -RRB- O
. . O

Association NN O
testing NN O
of IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
gene NN O
revealed VBD O
a DT O
significant JJ O
association NN O
with IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
( : O
nominal JJ O
p NN O
= SYM O
4 CD O
. . O
9 CD O
x SYM O
10 CD O
- HYPH O
8 CD O
, , O
permuted VBN O
p NN O
< NN O
0 CD O
. . O
1 CD O
, , O
T NN O
: : O
U NN O
= SYM O
129 CD O
: : O
55 CD O
) -RRB- O
in IN O
our PRP$ O
lupus NN O
cohort NN O
( : O
Table NN O
1 CD O
) -RRB- O
. . O

There EX O
was VBD O
also RB O
a DT O
trend NN O
for IN O
under IN O
transmission NN O
of IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
701 CD O
allele NN O
( : O
nominal JJ O
p NN O
= SYM O
0 CD O
. . O
13 CD O
, , O
T NN O
: : O
U NNP O
42 CD O
: : O
77 CD O
) -RRB- O
; : O
however RB O
, , O
this DT O
association NN O
was VBD O
no RB O
longer RBR O
significant JJ O
after IN O
correction NN O
for IN O
multiple JJ O
testing NN O
as IN O
determined VBN O
by IN O
10 CD O
, , O
0 CD O
permutations NNS O
of IN O
the DT O
dataset NN O
( , O
permuted VBN O
p NN O
= SYM O
0 CD O
. . O
9 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
we PRP O
did VBD O
not RB O
find VB O
evidence NN O
of IN O
association NN O
with IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
( , O
nominal JJ O
p NN O
= SYM O
1 CD O
. . O
0 CD O
, , O
T NN O
: : O
U NN O
70 CD O
: : O
70 CD O
) -RRB- O
or CC O
HLA NN O
- HYPH O
DRB1 NNP O
* NFP O
801 CD O
( : O
nominal JJ O
p NN O
= SYM O
1 CD O
. . O
0 CD O
, , O
T NN O
: : O
U NN O
= SYM O
11 CD O
: : O
11 CD O
) -RRB- O
in IN O
our PRP$ O
cohort NN O
( , O
see VB O
Table NNP O
S2 NNP O
for IN O
complete JJ O
HLA NNP O
- HYPH O
DRB1 NNP O
association NN O
data NNS O
) -RRB- O
; : O
alleles NNS O
previously RB O
suggested VBN O
by IN O
microsatellite NN O
typing NN O
of IN O
a DT O
US NNP O
lupus NN O
cohort NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Association NN O
testing NN O
of IN O
the DT O
MHC NNP O
region NN O
SNPs NNPS O
also RB O
identified VBD O
significant JJ O
evidence NN O
of IN O
association NN O
to IN O
SLE NNP O
( -LRB- O
Table NNP O
1 CD O
for IN O
associated JJ O
markers NNS O
and CC O
Table NNP O
S3 NNP O
for IN O
all DT O
MHC NNP O
SNPs NNPS O
) -RRB- O
. . O

The DT O
SNP NNP O
with IN O
the DT O
most RBS O
significant JJ O
association NN O
, , O
rs419788 CD O
( , O
nominal JJ O
p NN O
= SYM O
4 CD O
. . O
3 CD O
x SYM O
10 CD O
- HYPH O
8 CD O
, , O
permuted VBN O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
was VBD O
of IN O
similar JJ O
strength NN O
to IN O
that DT O
of IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
allele NN O
, , O
with IN O
odds NNS O
ratios NNS O
( , O
ORs NNS O
) -RRB- O
and CC O
95 CD O
% NN O
confidence NN O
intervals NNS O
( , O
CIs NNS O
) -RRB- O
of IN O
2 CD O
. . O
0 CD O
( SYM O
1 CD O
. . O
6 CD O
- SYM O
2 CD O
. . O
6 CD O
) SYM O
and CC O
2 CD O
. . O
3 CD O
( SYM O
1 CD O
. . O
7 CD O
- SYM O
3 CD O
. . O
2 CD O
) -RRB- O
, , O
respectively RB O
. . O

This DT O
SNP NNP O
is VBZ O
located VBN O
within IN O
intron NN O
6 CD O
of IN O
the DT O
class NN O
III NNP O
gene NN O
, , O
superkiller NN O
viralicidic JJ O
activity NN O
2 CD O
- HYPH O
like JJ O
( , O
Saccharomyces NNP B-Species
cerevisiae NN I-Species
) -RRB- O
( , O
SKIV2L NN O
) -RRB- O
, , O
and CC O
is VBZ O
located VBN O
approximately RB O
500 CD O
kb NN O
telomeric JJ O
to IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
gene NN O
. . O

Of IN O
the DT O
other JJ O
12 CD O
SNPs NNPS O
that WDT O
were VBD O
significantly RB O
associated VBN O
with IN O
SLE NNP O
( , O
nominal JJ O
p NN O
= SYM O
4 CD O
. . O
0 CD O
x SYM O
10 CD O
- SYM O
4 CD O
to TO O
2 CD O
. . O
5 CD O
x SYM O
10 CD O
- SYM O
7 CD O
; : O
permuted VBN O
p NN O
= SYM O
0 CD O
. . O
3 CD O
to IN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
, , O
one CD O
was VBD O
located VBN O
in IN O
the DT O
class NN O
I NN O
region NN O
between IN O
HLA NNP O
- HYPH O
B NNP O
and CC O
MICA NNP O
, , O
seven CD O
were VBD O
located VBN O
in IN O
the DT O
class NN O
III NNP O
region NN O
, , O
and CC O
four CD O
were VBD O
situated VBN O
in IN O
the DT O
class NN O
II NNP O
region NN O
( : O
Table NNP O
1 CD O
; : O
Figure NNP O
S1 NNP O
) -RRB- O
. . O

Specifically RB O
, , O
the DT O
seven CD O
associated VBN O
class NN O
III NNP O
SNPs NNPS O
were VBD O
located VBN O
in IN O
or CC O
close RB O
to IN O
the DT O
following VBG O
genes NNS O
: : O
the DT O
TNF NNP O
promoter NN O
, , O
BAT3 NNP O
, , O
SLC44A4 NNP O
, , O
EHMT2 NNP O
, , O
TNXB NNP O
, , O
GPSM3 NNP O
, , O
and CC O
NOTCH4 NNP O
. . O

One CD O
of IN O
the DT O
four CD O
class NN O
II NN O
associated VBN O
SNPs NNPS O
was VBD O
close JJ O
to IN O
HLA NNP O
- HYPH O
DRA NNP O
, , O
two CD O
were VBD O
between IN O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
HLA NNP O
- HYPH O
DQA1 NNP O
and CC O
one CD O
was VBD O
in IN O
intron NN O
1 CD O
of IN O
HLA NNP O
- HYPH O
DQA1 NNP O
. . O

The DT O
correlation NN O
between IN O
all DT O
68 CD O
SNPs NNPS O
and CC O
HLA NNP O
- HYPH O
DRB1 NNP O
in IN O
our PRP$ O
UK NNP O
SLE NNP O
cohort NN O
is VBZ O
illustrated VBN O
in IN O
Figure NN O
1 CD O
. . O

The DT O
markers NNS O
showing VBG O
significant JJ O
association NN O
are VBP O
highlighted VBN O
. . O

Conditional JJ O
Analyses NNS O
Identify VBP O
Two CD O
Independent NNP O
Association NNP O
Signals NNS O
in IN O
the DT O
MHC NNP O

In IN O
order NN O
to TO O
establish VB O
whether IN O
the DT O
two CD O
most RBS O
associated VBN O
signals NNS O
identified VBN O
in IN O
this DT O
association NN O
- HYPH O
mapping NN O
experiment NN O
are VBP O
likely JJ O
to TO O
represent VB O
a DT O
single JJ O
causal JJ O
allele NN O
or CC O
independent JJ O
risk NN O
factors NNS O
, , O
we PRP O
first RB O
examined VBD O
the DT O
association NN O
data NNS O
conditioned VBN O
upon IN O
the DT O
presence NN O
of IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
allele NN O
. . O

We PRP O
found VBD O
that IN O
four CD O
of IN O
the DT O
13 CD O
associated VBN O
SNPs NNPS O
showed VBD O
evidence NN O
of IN O
signals NNS O
independent JJ O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
in IN O
our PRP$ O
dataset NN O
, , O
the DT O
strongest JJS O
of IN O
which WDT O
was VBD O
rs419788 CD O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

We PRP O
therefore RB O
conditioned VBD O
the DT O
three CD O
remaining VBG O
SNPs NNPS O
( , O
rs2523589 CD O
, , O
rs1052486 CD O
, , O
and CC O
rs605203 CD O
) -RRB- O
on IN O
rs419788 CD O
to TO O
assess VB O
whether IN O
these DT O
signals NNS O
are VBP O
truly RB O
independent JJ O
of IN O
each DT O
other JJ O
or CC O
show VBP O
association NN O
due IN O
to IN O
LD NNP O
with IN O
rs419788 NN O
. . O

In IN O
addition NN O
, , O
we PRP O
included VBD O
HLA NNP O
- HYPH O
DRB1 NNP O
in IN O
stepwise JJ O
conditional JJ O
regression NN O
analyses NNS O
performed VBN O
on IN O
the DT O
SNPs NNPS O
showing VBG O
association NN O
independent JJ O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
( , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

These DT O
analyses NNS O
demonstrated VBD O
that IN O
the DT O
observed VBN O
association NN O
signals VBZ O
at IN O
rs2523589 CD O
, , O
rs1052486 CD O
, , O
and CC O
rs605203 CD O
were VBD O
predominantly RB O
dependent JJ O
upon IN O
the DT O
association NN O
at IN O
rs419788 CD O
, , O
and CC O
suggested VBD O
that IN O
there EX O
are VBP O
two CD O
major JJ O
independent JJ O
association NN O
signals NNS O
in IN O
the DT O
MHC NNP O
in IN O
UK NNP O
SLE NNP O
: : O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
rs419788 CD O
. . O

The DT O
independence NN O
of IN O
the DT O
association NN O
signals VBZ O
at IN O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
rs419788 CD O
is VBZ O
further RBR O
supported VBN O
by IN O
the DT O
observation NN O
that IN O
there EX O
is VBZ O
only RB O
modest JJ O
LD NN O
between IN O
these DT O
two CD O
( , O
r2 CD O
= SYM O
0 CD O
. . O
24 CD O
) -RRB- O
. . O

There EX O
was VBD O
no DT O
association NN O
with IN O
any DT O
other JJ O
HLA NNP O
- HYPH O
DRB1 NNP O
allele NN O
and CC O
the DT O
four CD O
SNPs NNPS O
independent JJ O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
( , O
TRANSMIT NNP O
, , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

The DT O
association NN O
of IN O
the DT O
tumour NN O
necrosis NN O
factor NN O
gene NN O
promoter NN O
SNP NNP O
TNF NNP O
- HYPH O
308G NNP O
/ SYM O
A NNP O
with IN O
SLE NNP O
is VBZ O
lost VBN O
after IN O
conditioning NN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
in IN O
our PRP$ O
cohort NN O
. . O

If IN O
we PRP O
perform VBP O
the DT O
reverse JJ O
analysis NN O
and CC O
condition NN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
on IN O
the DT O
presence NN O
of IN O
the DT O
TNF NNP O
promoter NN O
SNP NNP O
, , O
we PRP O
find VBP O
that IN O
the DT O
association NN O
remains VBZ O
, , O
confirming VBG O
that IN O
our PRP$ O
TNF NNP O
association NN O
is VBZ O
secondary JJ O
to IN O
that DT O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
. . O

Genotypic JJ O
Risk NN O
for IN O
Class NN O
II NNP O
and CC O
Class NNP O
III NNP O
Association NNP O
Signals NNS O

Having VBG O
established VBN O
independent JJ O
association NN O
at IN O
the DT O
allelic JJ O
level NN O
with IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
and CC O
rs419788 CD O
- HYPH O
T NNP O
in IN O
our PRP$ O
UK NNP O
SLE NNP O
cohort NN O
, , O
we PRP O
wanted VBD O
to TO O
further RB O
determine VB O
the DT O
genotypic JJ O
risk NN O
conferred VBN O
by IN O
these DT O
variants NNS O
and CC O
hence RB O
gain VB O
insight NN O
into IN O
their PRP$ O
underlying VBG O
mode NN O
of IN O
inheritance NN O
in IN O
lupus NN O
. . O

We PRP O
used VBD O
case NN O
- HYPH O
control NN O
and CC O
family NN O
- HYPH O
based VBN O
analyses NNS O
to TO O
assess VB O
genotypic JJ O
risk NN O
at IN O
HLA NNP O
- HYPH O
DRB1 NNP O
, , O
while IN O
the DT O
family NN O
- HYPH O
based VBN O
test NN O
alone RB O
was VBD O
used VBN O
for IN O
rs419788 CD O
. . O

Common JJ O
family NN O
- HYPH O
based VBN O
tests NNS O
of IN O
LD NNP O
, , O
such JJ O
as IN O
those DT O
used VBN O
in IN O
this DT O
study NN O
( , O
Genehunter NNP O
) -RRB- O
, , O
measure VB O
transmission NN O
distortion NN O
based VBN O
on IN O
allele JJ O
counts NNS O
rather RB O
than IN O
genotype NN O
counts NNS O
; : O
the DT O
former JJ O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
more RBR O
powerful JJ O
under IN O
additive JJ O
models NNS O
, , O
while IN O
the DT O
latter JJ O
has VBZ O
greater JJR O
power NN O
under IN O
recessive JJ O
or CC O
dominant JJ O
genetic JJ O
models NNS O
[ -LRB- O
27 CD O
] -RRB- O
. . O

The DT O
genotype NN O
- HYPH O
pedigree NN O
disequilibrium NN O
test NN O
( , O
geno NN O
- HYPH O
PDT NNP O
) -RRB- O
determines VBZ O
LD NNP O
between IN O
a DT O
locus NN O
genotype NN O
and CC O
disease NN O
by IN O
comparing VBG O
genotypes NNS O
that WDT O
are VBP O
transmitted VBN O
from IN O
parent NN O
to TO O
proband VB O
with IN O
those DT O
that WDT O
are VBP O
not RB O
[ -LRB- O
27 CD O
] -RRB- O
. . O

We PRP O
used VBD O
the DT O
geno NN O
- HYPH O
PDT NNP O
to TO O
assess VB O
genotypic JJ O
risk NN O
for IN O
our PRP$ O
class NN O
II NN O
and CC O
class NN O
III NNP O
association NN O
signals NNS O
: : O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
the DT O
SNP NNP O
rs419788 NN O
. . O

In IN O
the DT O
case NN O
- HYPH O
control NN O
analysis NN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
, , O
ORs NNS O
with IN O
95 CD O
% NN O
CI NN O
were VBD O
calculated VBN O
and CC O
Fisher NNP O
' POS O
s POS O
exact JJ O
test NN O
employed VBN O
to TO O
assess VB O
statistically RB O
significant JJ O
differences NNS O
between IN O
HLA NNP O
- HYPH O
DRB1 NNP O
genotypes NNS O
in IN O
lupus NN O
probands NNS O
and CC O
healthy JJ O
controls NNS O
. . O

For IN O
HLA NNP O
- HYPH O
DRB1 NNP O
, , O
the DT O
alleles NNS O
were VBD O
coded VBN O
as IN O
follows VBZ O
: : O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
, , O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
, , O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
X NNP O
where WRB O
X NNP O
represents VBZ O
all DT O
HLA NNP O
- HYPH O
DRB1 NNP O
alleles NNS O
other JJ O
than IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
, , O
and CC O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
. . O

We PRP O
included VBD O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
in IN O
the DT O
analysis NN O
, , O
even RB O
though IN O
we PRP O
find VBP O
no DT O
allelic JJ O
association NN O
in IN O
our PRP$ O
cohort NN O
, , O
because IN O
previous JJ O
studies NNS O
have VBP O
shown VBN O
a DT O
greater JJR O
risk NN O
for IN O
lupus NN O
in IN O
individuals NNS O
who WP O
are VBP O
compound JJ O
heterozygotes NNS O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
- HYPH O
and CC O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
1501 CD O
- HYPH O
containing VBG O
haplotypes NNS O
[ -LRB- O
25 CD O
, , O
28 CD O
] -RRB- O
. . O

Overall RB O
the DT O
results NNS O
are VBP O
consistent JJ O
with IN O
a DT O
dominant JJ O
effect NN O
from IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
( : O
Table NN O
2 CD O
) -RRB- O
and CC O
a DT O
dose NN O
- HYPH O
dependent JJ O
( , O
additive JJ O
) -RRB- O
effect NN O
from IN O
rs419788 CD O
- HYPH O
T NN O
( -LRB- O
Table NN O
3 CD O
) -RRB- O
. . O

Specifically RB O
, , O
both DT O
case NN O
- HYPH O
control NN O
and CC O
geno NN O
- HYPH O
PDT NN O
demonstrate VBP O
that IN O
there EX O
is VBZ O
no DT O
dose NN O
- HYPH O
dependent JJ O
increase NN O
in IN O
disease NN O
risk NN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
. . O

Rather RB O
, , O
it PRP O
appears VBZ O
that IN O
the DT O
presence NN O
of IN O
a DT O
single JJ O
copy NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
alone RB O
is VBZ O
sufficient JJ O
to TO O
increase VB O
susceptibility NN O
to IN O
disease NN O
. . O

Moreover RB O
the DT O
301 CD O
/ SYM O
X NNP O
genotypes NNS O
constitute VBP O
the DT O
greatest JJS O
risk NN O
in IN O
our PRP$ O
cohort NN O
rather RB O
than IN O
the DT O
301 CD O
/ SYM O
1501 CD O
heterozygotes NNS O
. . O

Genotypes NNS O
containing VBG O
HLA NNP O
- HYPH O
DRB1 NNP O
* CC O
1501 CD O
in IN O
the DT O
absence NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
revealed VBD O
no DT O
significant JJ O
association NN O
in IN O
our PRP$ O
cohort NN O
. . O

All DT O
three CD O
rs419788 CD O
genotypes NNS O
demonstrated VBD O
significant JJ O
association NN O
in IN O
our PRP$ O
lupus NN O
families NNS O
( -LRB- O
Table NNP O
3 CD O
) -RRB- O
. . O

The DT O
common JJ O
CC NNP O
genotype NN O
was VBD O
significantly RB O
under IN O
transmitted VBN O
, , O
while IN O
the DT O
rare JJ O
T NN O
allele NN O
displayed VBD O
dose NN O
- HYPH O
dependent JJ O
over IN O
transmission NN O
to IN O
lupus NN O
probands NNS O
. . O

Characterization NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
Risk NN O
Haplotype NNP O

Next RB O
, , O
we PRP O
wanted VBD O
to TO O
further RB O
delimit VB O
the DT O
MHC NNP O
class NN O
II NN O
association NN O
signal NN O
that WDT O
we PRP O
have VBP O
detected VBN O
at IN O
HLA NNP O
- HYPH O
DRB1 NNP O
. . O

We PRP O
used VBD O
phased VBN O
parental JJ O
genotype NN O
data NNS O
to TO O
compare VB O
the DT O
allelic JJ O
composition NN O
of IN O
HLA NN O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
- HYPH O
bearing VBG O
haplotypes NNS O
that WDT O
were VBD O
transmitted VBN O
( , O
T NNP O
) -RRB- O
to IN O
affected VBN O
probands NNS O
to IN O
those DT O
that WDT O
were VBD O
not RB O
transmitted VBN O
( , O
or CC O
untransmitted JJ O
, , O
UT NNP O
) -RRB- O
with IN O
the DT O
aim NN O
of IN O
identifying VBG O
differences NNS O
that WDT O
could MD O
delineate VB O
the DT O
lupus NN O
susceptibility NN O
interval NN O
( , O
s NNS O
) , O
arising VBG O
from IN O
this DT O
haplotype NN O
( , O
summarized VBN O
in IN O
Figures NNPS O
2A NNP O
, , O
2B NN O
, , O
and CC O
S2 NNP O
) -RRB- O
. . O

We PRP O
observed VBD O
a DT O
striking JJ O
difference NN O
between IN O
transmitted VBN O
and CC O
untransmitted JJ O
chromosomes NNS O
within IN O
the DT O
class NN O
II NNP O
region NN O
: : O
nearly RB O
all DT O
transmitted VBN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
haplotypes NNS O
( : O
99 CD O
% NN O
) -RRB- O
are VBP O
identical JJ O
across IN O
a DT O
180 CD O
kb NN O
region NN O
defined VBN O
by IN O
eight CD O
SNPs NNS O
, , O
whereas IN O
the DT O
corresponding VBG O
region NN O
within IN O
untransmitted JJ O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
haplotypes NNS O
exhibits VBZ O
significant JJ O
recombination NN O
. . O

These DT O
data NNS O
strongly RB O
suggest VBP O
the DT O
existence NN O
of IN O
a DT O
risk NN O
haplotype NN O
that WDT O
, , O
interestingly RB O
, , O
contains VBZ O
only RB O
three CD O
expressed VBN O
genes NNS O
: : O
HLA NNP O
- HYPH O
DRB1 NNP O
, , O
HLA NNP O
- HYPH O
DQA1 NNP O
, , O
and CC O
HLA NNP O
- HYPH O
DQB1 NNP O
. . O

Furthermore RB O
, , O
we PRP O
can MD O
confidently RB O
define VB O
the DT O
allelic JJ O
composition NN O
of IN O
this DT O
risk NN O
haplotype NN O
, , O
as IN O
these DT O
three CD O
genes NNS O
are VBP O
in IN O
strong JJ O
LD NN O
and CC O
occur VBP O
in IN O
one CD O
common JJ O
haplotype NN O
in IN O
Caucasians NNPS O
: : O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
- HYPH O
HLA NNP O
- HYPH O
DQA1 NNP O
* NFP O
501 CD O
- HYPH O
HLA NN O
- HYPH O
DQB1 NNP O
* NFP O
201 CD O
. . O

Thus RB O
, , O
we PRP O
hypothesize VBP O
that IN O
the DT O
specific JJ O
combination NN O
of IN O
all DT O
three CD O
alleles NNS O
is VBZ O
required VBN O
to TO O
confer VB O
disease NN O
risk NN O
in IN O
lupus NN O
or CC O
that IN O
disease NN O
susceptibility NN O
lies VBZ O
with IN O
either CC O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
or CC O
the DT O
HLA NNP O
- HYPH O
DQ NNP O
alleles NNS O
. . O

We PRP O
do VBP O
not RB O
have VB O
sufficient JJ O
numbers NNS O
of IN O
recombinant JJ O
chromosomes NNS O
in IN O
this DT O
risk NN O
region NN O
to TO O
further RB O
delimit VB O
this DT O
signal NN O
: : O
2 CD O
/ SYM O
176 CD O
( SYM O
1 CD O
. . O
1 CD O
% NN O
) -RRB- O
transmitted VBN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
haplotypes NNS O
are VBP O
recombinant JJ O
at IN O
HLA NNP O
- HYPH O
DQA1 NNP O
- HYPH O
HLA NNP O
- HYPH O
DQB1 NNP O
; : O
3 CD O
/ SYM O
178 CD O
( SYM O
1 CD O
. . O
7 CD O
% NN O
) -RRB- O
transmitted VBN O
haplotypes NNS O
identical JJ O
across IN O
HLA NNP O
- HYPH O
DQA1 NNP O
- HYPH O
HLA NNP O
- HYPH O
DQB1 NNP O
do VBP O
not RB O
possess VB O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
. . O

The DT O
composite JJ O
relative JJ O
extended VBN O
haplotype NN O
homozygosity NN O
( , O
REHH NNP O
) -RRB- O
versus IN O
frequency NN O
plot NN O
for IN O
UK NNP O
SLE NNP O
; , O
Utah NNP O
residents NNS O
with IN O
ancestry NN O
from IN O
northern JJ O
and CC O
western JJ O
Europe NNP O
( , O
CEPH NNP O
) -RRB- O
; , O
and CC O
Yoruba NNP O
in IN O
Ibadan NNP O
, , O
Nigeria NNP O
( , O
Yoruba NNP O
) -RRB- O
populations NNS O
is VBZ O
shown VBN O
in IN O
Figure NNP O
3A NNP O
. . O

We PRP O
can MD O
only RB O
comment VB O
on IN O
evidence NN O
for IN O
positive JJ O
selection NN O
in IN O
CEPH NNP O
individuals NNS O
, , O
as IN O
we PRP O
have VBP O
used VBN O
this DT O
population NN O
alone RB O
to TO O
assess VB O
background NN O
variation NN O
on IN O
Chromosome NNP O
6 CD O
. . O

The DT O
SLE NNP O
and CC O
Yoruba NNP O
cohorts NNS O
are VBP O
shown VBN O
for IN O
comparative JJ O
purposes NNS O
. . O

We PRP O
find VBP O
no DT O
evidence NN O
of IN O
positive JJ O
selection NN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
in IN O
the DT O
CEPH NNP O
population NN O
. . O

However RB O
, , O
this DT O
allele NN O
is VBZ O
enriched VBN O
in IN O
our PRP$ O
lupus NN O
cohort NN O
( : O
21 CD O
% NN O
of IN O
parental JJ O
chromosomes NNS O
) , O
and CC O
displays VBZ O
greater JJR O
extended VBN O
homozygosity NN O
when WRB O
compared VBN O
with IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
- HYPH O
bearing VBG O
haplotypes NNS O
in IN O
CEPH NNP O
and CC O
Yoruba NNP O
. . O

Hence RB O
, , O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
allele NN O
in IN O
lupus NN O
is VBZ O
observed VBN O
as IN O
an DT O
outlier NN O
on IN O
the DT O
plot NN O
when WRB O
compared VBN O
to IN O
background NN O
variation NN O
in IN O
CEPH NNP O
. . O

These DT O
data NNS O
support VBP O
our PRP$ O
previous JJ O
observations NNS O
( , O
outlined VBN O
above RB O
) , O
of IN O
the DT O
highly RB O
conserved VBN O
nature NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
haplotypes NNS O
in IN O
lupus NN O
. . O

In IN O
addition NN O
, , O
the DT O
haplotype NN O
bifurcation NN O
plots NNS O
centered VBN O
on IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
for IN O
UK NNP O
SLE NNP O
, , O
CEPH NNP O
, , O
and CC O
Yoruba NNP O
populations NNS O
in IN O
Figure NNP O
3B NNP O
illustrate VBP O
preservation NN O
of IN O
the DT O
common JJ O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
haplotype NN O
in IN O
CEPH NNP O
and CC O
UK NNP O
SLE NNP O
, , O
while IN O
that DT O
seen VBN O
in IN O
the DT O
Yoruba NNP O
is VBZ O
significantly RB O
different JJ O
. . O

The DT O
class NN O
II NNP O
regions NNS O
of IN O
all DT O
three CD O
populations NNS O
are VBP O
essentially RB O
identical JJ O
across IN O
our PRP$ O
chosen VBN O
SNPs NNPS O
; : O
the DT O
main JJ O
differences NNS O
lie VBP O
in IN O
class NN O
III NNP O
. . O

The DT O
difference NN O
in IN O
African JJ O
populations NNS O
in IN O
the DT O
class NN O
III NNP O
region NN O
is VBZ O
one CD O
possible JJ O
explanation NN O
for IN O
the DT O
lack NN O
of IN O
evidence NN O
for IN O
an DT O
association NN O
between IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
and CC O
SLE NN O
in IN O
African JJ O
or CC O
African JJ O
American JJ O
populations NNS O
. . O

However RB O
, , O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
has VBZ O
a DT O
lower JJR O
frequency NN O
( : O
~ $ O
7 CD O
% NN O
- SYM O
10 CD O
% NN O
) -RRB- O
in IN O
African JJ O
populations NNS O
compared VBN O
with IN O
Europeans NNPS O
( , O
~ $ O
13 CD O
% NN O
) -RRB- O
, , O
and CC O
the DT O
number NN O
of IN O
HLA NNP O
association NN O
studies NNS O
conducted VBN O
in IN O
African JJ O
populations NNS O
is VBZ O
very RB O
limited JJ O
. . O

Characterization NN O
of IN O
Class NNP O
III NNP O
Region NN O
Risk NN O
Haplotype NNP O

Our PRP$ O
data NNS O
reveal VBP O
a DT O
second JJ O
independent JJ O
signal NN O
at IN O
the DT O
MHC NNP O
in IN O
SLE NNP O
arising VBG O
from IN O
the DT O
T NN O
allele NN O
of IN O
SNP NNP O
rs419788 CD O
in IN O
intron NN O
6 CD O
of IN O
the DT O
class NN O
III NNP O
gene NN O
, , O
SKIV2L NNP O
. . O

Further JJ O
evidence NN O
supporting VBG O
the DT O
independence NN O
of IN O
the DT O
rs419788 NNP O
- HYPH O
T NNP O
and CC O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
alleles NNS O
is VBZ O
provided VBN O
by IN O
the DT O
moderate JJ O
LD NNP O
between IN O
these DT O
two CD O
variants NNS O
( , O
r2 CD O
= SYM O
0 CD O
. . O
24 CD O
) -RRB- O
coupled VBN O
with IN O
our PRP$ O
data NNS O
demonstrating VBG O
that IN O
only RB O
47 CD O
% NN O
of IN O
rs419788 CD O
- HYPH O
T NN O
allele NN O
- HYPH O
bearing VBG O
haplotypes NNS O
contain VBP O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
. . O

The DT O
structure NN O
and CC O
composition NN O
of IN O
T NNP O
and CC O
UT NNP O
haplotypes NNS O
anchored VBN O
at IN O
rs419788 CD O
- HYPH O
T NNP O
were VBD O
essentially RB O
identical JJ O
( , O
Figures NNPS O
2C NNP O
, , O
2D NN O
, , O
and CC O
S2 NNP O
) -RRB- O
, , O
and CC O
hence RB O
not RB O
informative JJ O
in IN O
delimiting VBG O
our PRP$ O
class NN O
III NNP O
signal NN O
. . O

Therefore RB O
, , O
we PRP O
examined VBD O
the DT O
LD NNP O
structure NN O
around IN O
our PRP$ O
associated VBN O
class NN O
III NNP O
SNP NNP O
to TO O
better RBR O
define VB O
our PRP$ O
disease NN O
risk NN O
interval NN O
. . O

In IN O
our PRP$ O
lupus NN O
dataset NN O
the DT O
rs419788 CD O
- HYPH O
T NN O
allele NN O
resides VBZ O
on IN O
three CD O
of IN O
seven CD O
haplotypes NNS O
present JJ O
within IN O
a DT O
large JJ O
block NN O
of IN O
six CD O
SNPs NNS O
exhibiting VBG O
strong JJ O
LD NNP O
. . O

This DT O
haplotype NN O
block NN O
encompasses VBZ O
roughly RB O
270 CD O
kb NN O
containing VBG O
class NN O
III NNP O
genes NNS O
from IN O
SLC44A4 NNP O
to IN O
AGER NNP O
, , O
including VBG O
the DT O
RCCX NNP O
module NN O
. . O

Next RB O
, , O
we PRP O
analyzed VBD O
the DT O
haplotype NN O
block NN O
structure NN O
of IN O
this DT O
region NN O
in IN O
CEPH NNP O
families NNS O
using VBG O
SNP NNP O
data NNS O
dumped VBN O
from IN O
the DT O
International NNP O
HapMap NNP O
Project NNP O
( : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
hapmap NN O
. . O
org NN O
/ : O
) -RRB- O
. . O

The DT O
greater JJR O
density NN O
of IN O
SNP NNP O
typing NN O
available JJ O
in IN O
the DT O
HapMap NNP O
CEPH NNP O
population NN O
compared VBN O
to IN O
our PRP$ O
current JJ O
UK NNP O
SLE NNP O
map NN O
allowed VBD O
us PRP O
to TO O
potentially RB O
refine VB O
our PRP$ O
signal NN O
by IN O
exploring VBG O
correlations NNS O
between IN O
our PRP$ O
associated JJ O
SNP NNP O
and CC O
those DT O
surrounding VBG O
it PRP O
. . O

Analysis NN O
of IN O
these DT O
data NNS O
( -LRB- O
Figure NNP O
4 CD O
) -RRB- O
suggests VBZ O
the DT O
presence NN O
of IN O
short JJ O
- HYPH O
range NN O
LD NN O
around IN O
our PRP$ O
associated JJ O
variant NN O
, , O
rs419788 CD O
, , O
in IN O
CEPH NNP O
families NNS O
, , O
encompassing VBG O
approximately RB O
40 CD O
kb NN O
of IN O
the DT O
genome NN O
which WDT O
includes VBZ O
the DT O
five CD O
genes NNS O
: : O
complement NN O
factor NN O
B NNP O
( : O
CFB NNP O
) -RRB- O
, , O
RD NNP O
RNA NNP O
binding NN O
protein NN O
( , O
RDBP NNP O
) -RRB- O
, , O
SKIV2L NN O
, , O
dom NN O
- HYPH O
3 CD O
homolg NN O
Z NN O
( HYPH O
C NN B-Species
. . I-Species
elegans NNS I-Species
) -RRB- O
( , O
DOM3Z NNP O
) -RRB- O
, , O
and CC O
serine NN O
/ SYM O
threonine NN O
kinase NN O
19 CD O
( -LRB- O
STK19 NN O
) -RRB- O
, , O
and CC O
does VBZ O
not RB O
include VB O
the DT O
complement NN O
C4 NN O
locus NN O
. . O

Furthermore RB O
, , O
assessment NN O
of IN O
marker NN O
association NN O
in IN O
our PRP$ O
lupus NN O
dataset NN O
demonstrates VBZ O
that IN O
after IN O
conditioning NN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
, , O
the DT O
only JJ O
markers NNS O
that WDT O
retain VBP O
association NN O
signals NNS O
are VBP O
telomeric JJ O
of IN O
SKIV2L NNP O
, , O
suggesting VBG O
that IN O
complement NN O
C4 NNP O
, , O
which WDT O
is VBZ O
centromeric JJ O
to IN O
this DT O
gene NN O
, , O
may MD O
not RB O
be VB O
responsible JJ O
for IN O
our PRP$ O
independent JJ O
class NN O
III NNP O
signal NN O
. . O

Subphenotype NNP O
Analysis NNP O

In IN O
order NN O
to TO O
gain VB O
further JJ O
insight NN O
into IN O
disease NN O
pathogenesis NN O
, , O
we PRP O
examined VBD O
common JJ O
lupus NN O
subphenotypes NNS O
. . O

Such JJ O
subsets NNS O
are VBP O
more RBR O
homogeneous JJ O
than IN O
lupus NN O
per FW O
se FW O
and CC O
thus RB O
maybe RB O
enriched VBN O
for IN O
specific JJ O
predisposing VBG O
variants NNS O
. . O

In IN O
addition NN O
, , O
one PRP O
might MD O
expect VB O
a DT O
close JJ O
association NN O
between IN O
MHC NNP O
class NN O
II NN O
alleles NNS O
and CC O
autoantibody NN O
subsets NNS O
in IN O
lupus NN O
if IN O
these DT O
are VBP O
indeed RB O
causal JJ O
variants NNS O
, , O
given VBN O
their PRP$ O
role NN O
in IN O
antigen NN O
presentation NN O
and CC O
subsequent JJ O
humoral JJ O
immunity NN O
. . O

We PRP O
therefore RB O
tested VBD O
our PRP$ O
two CD O
main JJ O
MHC NNP O
association NN O
signals NNS O
, , O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
and CC O
rs419788 CD O
, , O
for IN O
association NN O
with IN O
renal JJ O
disease NN O
and CC O
autoantibody NN O
subsets NNS O
in IN O
our PRP$ O
lupus NN O
cohort NN O
. . O

We PRP O
found VBD O
that IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
was VBD O
associated VBN O
with IN O
the DT O
presence NN O
of IN O
anti JJ O
- HYPH O
Ro NN O
and CC O
anti JJ O
- HYPH O
La NN O
antibodies NNS O
in IN O
our PRP$ O
UK NNP O
SLE NNP O
cohort NN O
, , O
with IN O
the DT O
latter JJ O
showing VBG O
the DT O
greatest JJS O
evidence NN O
of IN O
association NN O
( , O
anti JJ O
- HYPH O
La NN O
nominal JJ O
p NN O
< SYM O
0 CD O
. . O
1 CD O
compared VBN O
with IN O
anti JJ O
- HYPH O
Ro NN O
nominal JJ O
p NN O
< NN O
0 CD O
. . O
25 CD O
) -RRB- O
. . O

We PRP O
found VBD O
no DT O
association NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
with IN O
renal JJ O
disease NN O
or CC O
any DT O
other JJ O
autoantibody NN O
subsets NNS O
in IN O
our PRP$ O
dataset NN O
( , O
see VB O
Table NNP O
S4 NNP O
for IN O
detailed JJ O
results NNS O
) -RRB- O
. . O

Genotypes NNS O
of IN O
the DT O
SNP NNP O
rs419788 CD O
were VBD O
not RB O
associated VBN O
with IN O
any DT O
of IN O
the DT O
tested VBN O
lupus NN O
subphenotypes NNS O
after IN O
controlling VBG O
for IN O
the DT O
effect NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
( , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

Discussion NN O

We PRP O
present VBP O
the DT O
first JJ O
family NN O
- HYPH O
based VBN O
SNP NNP O
association NN O
study NN O
of IN O
the DT O
MHC NNP O
in IN O
SLE NNP O
. . O

We PRP O
have VBP O
genotyped VBN O
69 CD O
markers NNS O
( , O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
68 CD O
SNPs NNPS O
) -RRB- O
across IN O
2 CD O
. . O
4 CD O
Mb NNP O
of IN O
the DT O
MHC NNP O
, , O
encompassing VBG O
class NN O
III NNP O
and CC O
class NN O
II CD O
, , O
in IN O
a DT O
cohort NN O
of IN O
314 CD O
UK NNP O
Caucasian JJ O
SLE NNP O
trios NNS O
. . O

Transmission NN O
disequilibrium NN O
testing NN O
of IN O
these DT O
data NNS O
has VBZ O
shown VBN O
predominant JJ O
association NN O
with IN O
the DT O
alleles FW O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
and CC O
rs419788 CD O
- HYPH O
T NNP O
, , O
together RB O
with IN O
12 CD O
other JJ O
MHC NNP O
SNPs NNPS O
. . O

Moreover RB O
, , O
using VBG O
conditional JJ O
analyses NNS O
, , O
we PRP O
have VBP O
shown VBN O
that IN O
the DT O
two CD O
primary JJ O
signals NNS O
of IN O
association NN O
at IN O
the DT O
MHC NNP O
are VBP O
independent JJ O
of IN O
each DT O
other JJ O
. . O

Specifically RB O
, , O
one CD O
signal NN O
arises VBZ O
from IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
in IN O
class NN O
II NN O
and CC O
the DT O
other JJ O
from IN O
the DT O
T NN O
allele NN O
of IN O
SNP NNP O
rs419788 CD O
in IN O
the DT O
class NN O
III NNP O
gene NN O
SKIV2L NNP O
. . O

Examination NN O
of IN O
bifurcation NN O
plots NNS O
for IN O
T NNP O
and CC O
UT NNP O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
- HYPH O
containing VBG O
haplotypes NNS O
has VBZ O
enabled VBN O
delineation NN O
of IN O
our PRP$ O
class NN O
II NN O
association NN O
signal NN O
to IN O
a DT O
180 CD O
kb NN O
region NN O
encompassing VBG O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
- HYPH O
HLA NNP O
- HYPH O
DQA1 NNP O
* NFP O
501 CD O
- HYPH O
HLA NN O
- HYPH O
DQB1 NNP O
* NFP O
201 CD O
. . O

These DT O
data NNS O
substantially RB O
refine VBP O
that DT O
previously RB O
published VBN O
by IN O
Graham NNP O
et FW O
al NNP O
. , O
in IN O
2002 CD O
[ -LRB- O
25 CD O
] -RRB- O
, , O
where WRB O
the DT O
lupus NN O
susceptibility NN O
interval NN O
within IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
- HYPH O
containing VBG O
haplotypes NNS O
could MD O
only RB O
be VB O
delimited VBN O
to IN O
a DT O
1 CD O
Mb NN O
region NN O
encompassing VBG O
class NN O
II NN O
and CC O
class NN O
III NNP O
. . O

The DT O
precise JJ O
causal JJ O
variant NN O
( , O
s VBZ O
) -RRB- O
within IN O
this DT O
region NN O
remains VBZ O
to TO O
be VB O
determined VBN O
, , O
as IN O
the DT O
three CD O
implicated VBN O
alleles NNS O
exhibit VBP O
strong JJ O
LD NN O
with IN O
few JJ O
recombination NN O
events NNS O
separating VBG O
them PRP O
( , O
two CD O
out IN O
of IN O
176 CD O
transmitted VBN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
chromosomes NNS O
in IN O
our PRP$ O
dataset NN O
) -RRB- O
. . O

However RB O
, , O
all DT O
three CD O
allelic JJ O
variants NNS O
represent VBP O
attractive JJ O
functional JJ O
candidates NNS O
in IN O
lupus NN O
susceptibility NN O
for IN O
their PRP$ O
role NN O
in IN O
antigen NN O
presentation NN O
and CC O
stimulation NN O
of IN O
the DT O
adaptive JJ O
immune JJ O
response NN O
. . O

Our PRP$ O
association NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
with IN O
lupus NN O
concurs VBZ O
with IN O
published VBN O
data NNS O
in IN O
Caucasian JJ O
cohorts NNS O
and CC O
is VBZ O
well RB O
established VBN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

While IN O
our PRP$ O
lack NN O
of IN O
association NN O
with IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
and CC O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
801 CD O
is VBZ O
consistent JJ O
with IN O
previous JJ O
data NNS O
from IN O
the DT O
UK NNP O
[ -LRB- O
29 CD O
] -RRB- O
, , O
Spain NNP O
[ -LRB- O
30 CD O
] -RRB- O
, , O
the DT O
Netherlands NNP O
[ -LRB- O
31 CD O
] -RRB- O
, , O
Sweden NNP O
[ -LRB- O
32 CD O
] -RRB- O
, , O
Mexico NNP O
[ -LRB- O
33 CD O
] -RRB- O
, , O
and CC O
the DT O
US NNP O
[ -LRB- O
34 CD O
] -RRB- O
, , O
it PRP O
conflicts VBZ O
with IN O
that DT O
of IN O
other JJ O
US NNP O
groups NNS O
[ -LRB- O
25 CD O
, , O
35 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
we PRP O
demonstrate VBP O
a DT O
trend NN O
, , O
though IN O
not RB O
statistically RB O
significant JJ O
, , O
for IN O
undertransmission NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
701 CD O
- : O
- : O
a DT O
result NN O
also RB O
observed VBN O
in IN O
prior JJ O
UK NNP O
and CC O
Canadian JJ O
lupus NN O
studies NNS O
[ -LRB- O
29 CD O
, , O
36 CD O
] -RRB- O
. . O

Moreover RB O
, , O
a DT O
negative JJ O
association NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
701 CD O
has VBZ O
been VBN O
reported VBN O
in IN O
other JJ O
autoimmune JJ O
diseases NNS O
including VBG O
Graves NNP O
disease NN O
[ -LRB- O
37 CD O
, , O
38 CD O
] -RRB- O
, , O
type NN O
1 CD O
diabetes NNS O
[ -LRB- O
39 CD O
] -RRB- O
, , O
and CC O
rheumatoid NN O
arthritis NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

It PRP O
appears VBZ O
that IN O
the DT O
conflicting VBG O
results NNS O
between IN O
UK NNP O
SLE NNP O
and CC O
previous JJ O
US NNP O
( , O
Minnesota NNP O
[ -LRB- O
MN NNP O
] -RRB- O
) -RRB- O
[ -LRB- O
25 CD O
] -RRB- O
SLE NNP O
data NNS O
stem VBP O
from IN O
differences NNS O
in IN O
HLA NNP O
- HYPH O
DRB1 NNP O
allele NN O
frequency NN O
in IN O
the DT O
probands NNS O
of IN O
each DT O
cohort NN O
. . O

The DT O
reason NN O
for IN O
this DT O
is VBZ O
unclear JJ O
. . O

A DT O
comparison NN O
between IN O
UK NNP O
and CC O
MN NNP O
SLE NNP O
cohorts NNS O
( -LRB- O
Table NNP O
4 CD O
) -RRB- O
reveals VBZ O
that IN O
UK NNP O
SLE NNP O
cases NNS O
are VBP O
enriched VBN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
but CC O
not RB O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
801 CD O
or CC O
HLA NNP O
- HYPH O
DRB1 NNP O
* CC O
1501 CD O
when WRB O
compared VBN O
to IN O
a DT O
UK NNP O
control NN O
population NN O
. . O

In IN O
contrast NN O
, , O
MN NNP O
SLE NNP O
cases NNS O
are VBP O
enriched VBN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
- HYPH O
DQB1 NNP O
* NFP O
201 CD O
, , O
DRB1 NNP O
* NFP O
801 CD O
- HYPH O
DQB1 NNP O
* NFP O
402 CD O
, , O
and CC O
DRB1 NNP O
* NFP O
1501 CD O
- HYPH O
DQB1 NNP O
* NFP O
602 CD O
inferred VBN O
haplotypes NNS O
when WRB O
compared VBN O
to IN O
MN NNP O
controls NNS O
[ -LRB- O
25 CD O
] -RRB- O
. . O

There EX O
is VBZ O
no DT O
statistically RB O
significant JJ O
difference NN O
in IN O
the DT O
aforementioned JJ O
HLA NNP O
class NN O
II NN O
alleles NNS O
/ SYM O
haplotypes NNS O
between IN O
UK NNP O
and CC O
MN NNP O
control NN O
populations NNS O
that WDT O
could MD O
account VB O
for IN O
the DT O
disparity NN O
seen VBN O
in IN O
the DT O
respective JJ O
lupus NN O
cohorts NNS O
. . O

Differences NNS O
in IN O
disease NN O
severity NN O
and CC O
subphenotype NN O
frequency NN O
between IN O
the DT O
two CD O
populations NNS O
could MD O
account VB O
for IN O
the DT O
observed VBN O
discrepancy NN O
. . O

From IN O
the DT O
limited VBN O
data NNS O
available JJ O
we PRP O
found VBD O
that IN O
the DT O
presence NN O
of IN O
renal JJ O
disease NN O
appears VBZ O
to TO O
be VB O
similar JJ O
in IN O
both DT O
cohorts NNS O
( , O
UK NNP O
SLE NNP O
36 CD O
% NN O
compared VBN O
with IN O
MN NNP O
SLE NNP O
40 CD O
% NN O
) -RRB- O
, , O
while IN O
the DT O
gender NN O
ratios NNS O
are VBP O
significantly RB O
different JJ O
( : O
female JJ O
: : O
male JJ O
UK NNP O
SLE NNP O
11 CD O
: : O
1 CD O
compared VBN O
with IN O
MN NNP O
SLE NNP O
57 CD O
: : O
1 CD O
, , O
Chi NNP O
square JJ O
p NN O
value NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

We PRP O
were VBD O
unable JJ O
to TO O
compare VB O
other JJ O
lupus NN O
subphenotypes NNS O
. . O

Furthermore RB O
, , O
closer JJR O
inspection NN O
of IN O
these DT O
data NNS O
reveals VBZ O
that IN O
microsatellite NN O
- HYPH O
inference NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
alleles NNS O
in IN O
the DT O
MN NNP O
SLE NNP O
dataset NN O
may MD O
underestimate VB O
the DT O
frequency NN O
of IN O
HLA NN O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
and CC O
overestimate VB O
that DT O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
1501 CD O
, , O
thus RB O
diminishing VBG O
the DT O
effect NN O
of IN O
the DT O
former JJ O
and CC O
enhancing VBG O
that DT O
of IN O
the DT O
latter JJ O
. . O

It PRP O
is VBZ O
also RB O
possible JJ O
that IN O
the DT O
MN NNP O
SLE NNP O
cohort NN O
shows VBZ O
greater JJR O
racial JJ O
heterogeneity NN O
in IN O
comparison NN O
to IN O
our PRP$ O
UK NNP O
SLE NNP O
cohort NN O
, , O
despite IN O
both DT O
being VBG O
characterized VBN O
as IN O
Caucasian JJ O
. . O

Previous JJ O
studies NNS O
have VBP O
demonstrated VBN O
increased VBN O
risk NN O
for IN O
lupus NN O
in IN O
individuals NNS O
carrying VBG O
particular JJ O
combinations NNS O
of IN O
microsatellite NN O
- HYPH O
inferred VBN O
HLA NNP O
- HYPH O
DRB1 NNP O
- HYPH O
HLA NNP O
- HYPH O
DQB1 NNP O
haplotypes NNS O
[ -LRB- O
25 CD O
, , O
28 CD O
] -RRB- O
. . O

The DT O
highest JJS O
risk NN O
genotype NN O
was VBD O
found VBN O
to TO O
be VB O
the DT O
compound NN O
heterozygote NN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
- HYPH O
DQB1 NNP O
* SYM O
201 CD O
/ SYM O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
1501 CD O
- HYPH O
DQB1 NNP O
* SYM O
602 CD O
, , O
while IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
- HYPH O
DQB1 NNP O
* NFP O
201 CD O
- HYPH O
containing VBG O
genotypes NNS O
demonstrated VBD O
a DT O
dose NN O
- HYPH O
dependent JJ O
effect NN O
in IN O
increasing VBG O
lupus NN O
susceptibility NN O
[ -LRB- O
25 CD O
, , O
28 CD O
] -RRB- O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
examined VBN O
genotypic JJ O
risk NN O
at IN O
the DT O
classically RB O
typed VBN O
HLA NNP O
- HYPH O
DRB1 NNP O
locus NN O
and CC O
in IN O
contrast NN O
to IN O
the DT O
aforementioned JJ O
data NNS O
of IN O
Graham NNP O
et FW O
al NN O
. . O

[ -LRB- O
25 CD O
, , O
28 CD O
] -RRB- O
we PRP O
have VBP O
shown VBN O
a DT O
likely JJ O
dominant JJ O
effect NN O
of IN O
the DT O
associated JJ O
allele NN O
, , O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
. . O

The DT O
case NN O
- HYPH O
control NN O
and CC O
family NN O
- HYPH O
based VBN O
analyses NNS O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
also RB O
show VBP O
the DT O
greater JJR O
power NN O
of IN O
the DT O
former JJ O
to TO O
detect VB O
significant JJ O
association NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

Specifically RB O
, , O
all DT O
genotypes NNS O
containing VBG O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
show VBP O
increased VBN O
transmission NN O
to IN O
lupus JJ O
probands NNS O
; : O
however RB O
, , O
homozygotes NNS O
show VBP O
no DT O
greater JJR O
risk NN O
compared VBN O
with IN O
heterozygotes NNS O
, , O
as IN O
would MD O
be VB O
expected VBN O
under IN O
additive JJ O
or CC O
multiplicative JJ O
models NNS O
. . O

Thus RB O
, , O
a DT O
dominant JJ O
model NN O
of IN O
inheritance NN O
, , O
requiring VBG O
the DT O
presence NN O
of IN O
a DT O
single JJ O
copy NN O
of IN O
the DT O
disease NN O
- HYPH O
predisposing VBG O
variant NN O
alone RB O
, , O
likely RB O
underlies VBZ O
the DT O
susceptibility NN O
conferred VBN O
by IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
in IN O
UK NNP O
SLE NNP O
. . O

Such PDT O
a DT O
model NN O
would MD O
fit VB O
an DT O
antigen NN O
presentation NN O
hypothesis NN O
where WRB O
susceptible JJ O
individuals NNS O
carrying VBG O
an DT O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
allele NN O
are VBP O
able JJ O
to TO O
present VB O
auto NN O
- HYPH O
antigens NNS O
to IN O
CD4 NNP O
+ CC O
lymphocytes NNS O
, , O
thus RB O
stimulating VBG O
an DT O
autoimmune JJ O
response NN O
. . O

The DT O
differences NNS O
between IN O
our PRP$ O
UK NNP O
SLE NNP O
and CC O
the DT O
previously RB O
published VBN O
US NNP O
SLE NNP O
data NNS O
may MD O
reflect VB O
disease NN O
, , O
ethnic JJ O
, , O
and CC O
haplotypic JJ O
heterogeneity NN O
. . O

Interestingly RB O
, , O
analysis NN O
of IN O
genotypic JJ O
risk NN O
at IN O
the DT O
associated JJ O
class NN O
III NNP O
marker NN O
, , O
rs419788 CD O
, , O
suggests VBZ O
an DT O
additive NN O
( HYPH O
dose NN O
- HYPH O
dependent JJ O
) , O
pattern NN O
of IN O
inheritance NN O
for IN O
the DT O
rare JJ O
T NN O
allele NN O
, , O
where WRB O
one CD O
copy NN O
confers VBZ O
a DT O
low JJ O
risk NN O
of IN O
disease NN O
and CC O
two CD O
copies NNS O
results VBZ O
in IN O
greater JJR O
susceptibility NN O
. . O

The DT O
different JJ O
inheritance NN O
patterns NNS O
for IN O
our PRP$ O
class NN O
II NN O
and CC O
class NN O
III NNP O
association NN O
signals NNS O
provide VBP O
further JJ O
evidence NN O
for IN O
their PRP$ O
independence NN O
. . O

A DT O
variety NN O
of IN O
HLA NNP O
- HYPH O
DR NNP O
and CC O
HLA NNP O
- HYPH O
DQ NNP O
alleles NNS O
have VBP O
been VBN O
associated VBN O
with IN O
autoantibody NN O
subsets NNS O
in IN O
ethnically RB O
diverse JJ O
populations NNS O
of IN O
lupus NN O
. . O

The DT O
strongest JJS O
associations NNS O
have VBP O
been VBN O
demonstrated VBN O
between IN O
anti AFX O
- HYPH O
Ro NN O
and CC O
anti JJ O
- HYPH O
La NNP O
antibodies NNS O
and CC O
HLA NNP O
- HYPH O
DR3 NNP O
and CC O
HLA NNP O
- HYPH O
DQ2 NNP O
( , O
HLA NNP O
- HYPH O
DQB1 NNP O
* SYM O
201 CD O
) -RRB- O
, , O
which WDT O
are VBP O
in IN O
strong JJ O
LD NNP O
[ -LRB- O
41 CD O
- HYPH O
45 CD O
] -RRB- O
in IN O
case NN O
- HYPH O
control NN O
studies NNS O
. . O

Here RB O
, , O
we PRP O
confirm VBP O
the DT O
association NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
with IN O
anti AFX O
- HYPH O
Ro NN O
and CC O
anti JJ O
- HYPH O
La NN O
antibody NN O
production NN O
in IN O
our PRP$ O
family NN O
- HYPH O
based VBN O
cohort NN O
. . O

Examination NN O
of IN O
LD NNP O
structure NN O
around IN O
our PRP$ O
second JJ O
independent JJ O
association NN O
, , O
rs419788 CD O
- HYPH O
T NN O
in IN O
class NN O
III NNP O
, , O
coupled VBN O
with IN O
the DT O
results NNS O
of IN O
our PRP$ O
conditional JJ O
analysis NN O
, , O
suggests VBZ O
that IN O
this DT O
signal NN O
could MD O
also RB O
be VB O
delimited VBN O
to IN O
a DT O
relatively RB O
narrow JJ O
genomic JJ O
interval NN O
of IN O
about RB O
40 CD O
kb NN O
given VBN O
further JJ O
SNP NNP O
mapping NN O
in IN O
our PRP$ O
cohort NN O
. . O

This DT O
region NN O
includes VBZ O
the DT O
genes NNS O
CFB NNP O
, , O
RDBP NNP O
, , O
SKIV2L NNP O
, , O
DOM3Z NNP O
, , O
and CC O
STK19 NNP O
, , O
but CC O
does VBZ O
not RB O
include VB O
complement NN O
C4 NN O
. . O

Thus RB O
, , O
complement VB O
C4 NN O
null JJ O
alleles NNS O
, , O
which WDT O
have VBP O
been VBN O
implicated VBN O
in IN O
lupus NN O
pathogenesis NN O
, , O
may MD O
not RB O
be VB O
responsible JJ O
for IN O
our PRP$ O
class NN O
III NNP O
signal NN O
. . O

We PRP O
conclude VBP O
, , O
therefore RB O
, , O
that IN O
our PRP$ O
family NN O
- HYPH O
based VBN O
mapping NN O
study NN O
has VBZ O
potentially RB O
revealed VBN O
a DT O
hitherto RB O
unknown JJ O
lupus NN O
susceptibility NN O
interval NN O
in IN O
the DT O
class NN O
III NNP O
region NN O
of IN O
the DT O
MHC NNP O
. . O

However RB O
, , O
we PRP O
cannot MD O
conclusively RB O
exclude VB O
association NN O
at IN O
complement NN O
C4 NNP O
/ SYM O
RCCX NNP O
without IN O
direct JJ O
determination NN O
of IN O
C4 NN O
polymorphism NN O
/ SYM O
copy NN O
number NN O
in IN O
our PRP$ O
cohort NN O
. . O

With IN O
respect NN O
to IN O
the DT O
genes NNS O
implicated VBN O
in IN O
our PRP$ O
study NN O
, , O
CFB NNP O
is VBZ O
a DT O
vital JJ O
component NN O
of IN O
the DT O
alternate JJ O
complement NN O
pathway NN O
and CC O
disregulation NN O
may MD O
clearly RB O
affect VB O
the DT O
inflammatory JJ O
response NN O
[ -LRB- O
46 CD O
] -RRB- O
. . O

RD NNP O
and CC O
Skiv2l NNP O
are VBP O
proteins NNS O
potentially RB O
involved VBN O
in IN O
RNA NNP O
processing NN O
. . O

The DT O
RD NN O
protein NN O
forms VBZ O
part NN O
of IN O
a DT O
negative JJ O
elongation NN O
factor NN O
( -LRB- O
NELF NNP O
) -RRB- O
complex NN O
that WDT O
represses VBZ O
RNA NNP O
polymerase NN O
II NN O
transcript NN O
elongation NN O
, , O
while IN O
Skiv2l NNP O
is VBZ O
a DT O
DEAD JJ O
box NN O
protein NN O
with IN O
possible JJ O
function NN O
as IN O
an DT O
RNA NNP O
helicase NN O
. . O

The DT O
function NN O
of IN O
Dom3z NNP O
is VBZ O
currently RB O
unknown JJ O
, , O
although IN O
the DT O
homologous JJ O
yeast NN B-Species
protein NN O
binds VBZ O
nuclear JJ O
exoribonuclease NN O
. . O

Moreover RB O
, , O
its PRP$ O
ubiquitous JJ O
expression NN O
suggests VBZ O
a DT O
housekeeping NN O
role NN O
. . O

STK19 NN O
is VBZ O
a DT O
protein NN O
kinase NN O
of IN O
unknown JJ O
function NN O
with IN O
primary JJ O
nuclear JJ O
localization NN O
[ -LRB- O
47 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
RDBP NNP O
and CC O
SKIV2L NNP O
are VBP O
found VBN O
to TO O
be VB O
highly RB O
expressed VBN O
in IN O
T NNP O
lymphocytes NNS O
, , O
B NN O
lymphocytes NNS O
, , O
and CC O
dendritic JJ O
cells NNS O
( , O
SymAtlas NNP O
, , O
http NN O
: : O
/ : O
/ : O
symatlas NNS O
. . O
gnf ADD O
. . O
org NN O
/ SYM O
SymAtlas NNP O
/ , O
) -RRB- O
. . O

A DT O
number NN O
of IN O
studies NNS O
have VBP O
demonstrated VBN O
conflicting JJ O
evidence NN O
for IN O
and CC O
against IN O
association NN O
with IN O
various JJ O
TNF NNP O
locus NN O
polymorphisms NNS O
in IN O
SLE NNP O
[ -LRB- O
48 CD O
] -RRB- O
. . O

A DT O
recent JJ O
meta JJ O
- HYPH O
analysis NN O
of IN O
the DT O
TNF NNP O
- HYPH O
308G NNP O
/ SYM O
A NN O
promoter NN O
polymorphism NN O
in IN O
SLE NNP O
[ -LRB- O
48 CD O
] -RRB- O
revealed VBD O
evidence NN O
of IN O
association NN O
for IN O
the DT O
minor JJ O
allele NN O
( , O
A NN O
) -RRB- O
in IN O
European JJ O
populations NNS O
; : O
however RB O
, , O
this DT O
study NN O
did VBD O
not RB O
account VB O
for IN O
LD NNP O
with IN O
class NN O
II NNP O
alleles NNS O
. . O

On IN O
conditioning VBG O
our PRP$ O
dataset NN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
, , O
we PRP O
find VBP O
that IN O
the DT O
TNF NNP O
promoter NN O
signal NN O
is VBZ O
lost VBN O
, , O
suggesting VBG O
that IN O
this DT O
association NN O
is VBZ O
not RB O
independent JJ O
and CC O
is VBZ O
due JJ O
to IN O
LD NNP O
with IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
( , O
or CC O
another DT O
variant NN O
in IN O
LD NNP O
with IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
) -RRB- O
. . O

In IN O
summary NN O
, , O
we PRP O
have VBP O
found VBN O
association NN O
with IN O
two CD O
distinct JJ O
and CC O
independent JJ O
variants NNS O
within IN O
the DT O
class NN O
II NNP O
( -LRB- O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
) -RRB- O
and CC O
class NN O
III NNP O
( -LRB- O
SKIV2L NNP O
) -RRB- O
regions NNS O
of IN O
the DT O
MHC NNP O
in IN O
UK NNP O
SLE NNP O
trios NNS O
. . O

We PRP O
can MD O
delimit VB O
our PRP$ O
class NN O
II NN O
signal NN O
in IN O
lupus NN O
to IN O
three CD O
genetic JJ O
variants NNS O
( : O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
- HYPH O
HLA NNP O
- HYPH O
DQA1 NNP O
* NFP O
501 CD O
- HYPH O
HLA NN O
- HYPH O
DQB1 NNP O
* NFP O
201 CD O
) -RRB- O
that WDT O
may MD O
confer VB O
disease NN O
risk NN O
in IN O
combination NN O
or CC O
as IN O
separate JJ O
signals NNS O
. . O

Our PRP$ O
class NN O
III NNP O
signal NN O
importantly RB O
excludes VBZ O
independent JJ O
association NN O
at IN O
the DT O
TNF NNP O
promoter NN O
polymorphism NN O
TNF NNP O
- HYPH O
308G NNP O
/ SYM O
A NNP O
and CC O
potentially RB O
provides VBZ O
a DT O
novel JJ O
locus NN O
for IN O
further JJ O
study NN O
. . O

Materials NNS O
and CC O
Methods NNS O

Study NN O
cohorts NNS O
. . O

SLE NNP O
families NNS O
. . O

The DT O
cohort NN O
comprises VBZ O
314 CD O
complete JJ O
SLE NNP O
trios NNS O
( : O
that RB O
is RB O
, , O
mother NN O
, , O
father NN O
, , O
and CC O
affected VBN O
lupus NN O
proband NN O
) -RRB- O
collected VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
49 CD O
] -RRB- O
. . O

All DT O
study NN O
participants NNS B-Species
are VBP O
European JJ O
Caucasian NNP O
on IN O
the DT O
basis NN O
of IN O
grandparental JJ O
origin NN O
. . O

All DT O
314 CD O
lupus NN O
probands NNS O
( -LRB- O
288 CD O
female JJ O
, , O
26 CD O
male NN O
) -RRB- O
fulfill VBP O
the DT O
revised JJ O
American NNP O
College NNP O
of IN O
Rheumatology NNP O
( : O
ACR NNP O
) -RRB- O
criteria NNS O
for IN O
SLE NNP O
[ -LRB- O
50 CD O
] -RRB- O
, , O
36 CD O
% NN O
of IN O
whom WP O
have VBP O
a DT O
diagnosis NN O
of IN O
lupus NN O
nephritis NN O
. . O

Written JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
all DT O
study NN O
participants NNS B-Species
and CC O
ethical JJ O
approval NN O
for IN O
this DT O
study NN O
was VBD O
obtained VBN O
from IN O
the DT O
Multi NNP O
- HYPH O
Centre NNP O
Research NNP O
Ethics NNP O
Committee NNP O
( -LRB- O
MREC NNP O
2 CD O
June NNP O
1998 CD O
) -RRB- O
. . O

Healthy JJ O
controls NNS O
. . O

The DT O
control NN O
population NN O
for IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
genotypic JJ O
risk NN O
case NN O
- HYPH O
control NN O
analysis NN O
constitutes VBZ O
1 CD O
, , O
667 CD O
healthy JJ O
males NNS O
of IN O
Northern JJ O
European JJ O
origin NN O
. . O

The DT O
individuals NNS O
are VBP O
potential JJ O
hematopoietic JJ O
stem NN O
cell NN O
donors NNS O
and CC O
were VBD O
typed VBN O
to IN O
four CD O
digits NNS O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
at IN O
the DT O
Anthony NNP O
Nolan NNP O
Trust NNP O
, , O
UK NNP O
for IN O
this DT O
purpose NN O
. . O

The DT O
level NN O
of IN O
resolution NN O
used VBN O
for IN O
the DT O
typing NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
15 CD O
alleles NNS O
in IN O
these DT O
healthy JJ O
controls NNS O
resulted VBD O
in IN O
the DT O
ambiguous JJ O
allele NN O
string NN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
1501 CD O
/ SYM O
1502 CD O
/ SYM O
1504 CD O
/ SYM O
1506 CD O
. . O

However RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
the DT O
great JJ O
majority NN O
are VBP O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
. . O

There EX O
is VBZ O
no DT O
gender NN O
bias NN O
in IN O
HLA NNP O
- HYPH O
DRB1 NNP O
allele NN O
frequencies NNS O
, , O
so CC O
although IN O
we PRP O
have VBP O
used VBN O
a DT O
male JJ O
control NN O
cohort NN O
, , O
the DT O
frequencies NNS O
would MD O
be VB O
expected VBN O
to TO O
be VB O
the DT O
same JJ O
in IN O
a DT O
similar JJ O
female JJ O
cohort NN O
( , O
Steven NNP O
Marsh NNP O
, , O
personal JJ O
communication NN O
) -RRB- O
. . O

SNP NNP O
genotyping NN O
. . O

Eighty CD O
- HYPH O
six CD O
SNPs NNS O
were VBD O
chosen VBN O
for IN O
genotyping NN O
in IN O
our PRP$ O
mapping NN O
study NN O
. . O

Specifically RB O
, , O
we PRP O
selected VBD O
40 CD O
MHC NNP O
class NN O
II NN O
and CC O
class NN O
III NNP O
haplotype NN O
tagging NN O
SNPs NNPS O
from IN O
a DT O
preliminary JJ O
MHC NNP O
SNP NNP O
map NN O
[ -LRB- O
51 CD O
] -RRB- O
that WDT O
had VBD O
previously RB O
shown VBN O
robust JJ O
genotyping NN O
efficacy NN O
. . O

In IN O
addition NN O
, , O
we PRP O
typed VBD O
36 CD O
MHC NNP O
class NN O
II NN O
tag NN O
SNPs NNS O
from IN O
a DT O
subsequent JJ O
high JJ O
- HYPH O
resolution NN O
MHC NNP O
study NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

We PRP O
also RB O
included VBD O
the DT O
TNF NNP O
- HYPH O
308G NNP O
/ SYM O
A NN O
promoter NN O
SNP NNP O
, , O
together RB O
with IN O
nine CD O
further JJ O
SNPs NNPS O
in IN O
the DT O
region NN O
of IN O
HLA NNP O
- HYPH O
B NNP O
and CC O
MICA NNP O
obtained VBN O
from IN O
the DT O
database NN O
, , O
dbSNP NNP O
( : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
ncbi ADD O
. . O
nlm UH O
. . O
nih NN O
. . O
gov NN O
/ SYM O
projects NNS O
/ SYM O
SNP NN O
/ SYM O
) -RRB- O
. . O

The DT O
latter JJ O
SNPs NNPS O
had VBD O
not RB O
been VBN O
well RB O
characterized VBN O
. . O

All DT O
variants NNS O
were VBD O
typed VBN O
in IN O
the DT O
entire JJ O
cohort NN O
( : O
n CD O
= SYM O
942 CD O
) -RRB- O
. . O

The DT O
SNPs NNPS O
span VBP O
approximately RB O
2 CD O
. . O
4 CD O
Mb NN O
of IN O
the DT O
MHC NNP O
from IN O
the DT O
class NN O
I NN O
gene NN O
, , O
KIAA1949 NNP O
to IN O
the DT O
class NN O
II NNP O
pseudogene NN O
, , O
HLA NNP O
- HYPH O
DPB2 NNP O
and CC O
thus RB O
encompass VBP O
MHC NNP O
class NN O
III NNP O
and CC O
class NN O
II CD O
. . O

SNP NNP O
genotyping NN O
was VBD O
performed VBN O
at IN O
the DT O
Broad NNP O
Institute NNP O
of IN O
MIT NNP O
and CC O
Harvard NNP O
and CC O
at IN O
Imperial NNP O
College NNP O
London NNP O
by IN O
matrix NN O
- HYPH O
assisted VBN O
laser NN O
desorption NN O
/ SYM O
ionisation NN O
time NN O
- HYPH O
of IN O
- HYPH O
flight NN O
( -LRB- O
MALDI NNP O
- HYPH O
TOF NNP O
) -RRB- O
mass NN O
spectrometry NN O
using VBG O
the DT O
Sequenom NNP O
MassARRAY NNP O
platform NN O
as IN O
previously RB O
described VBN O
[ -LRB- O
53 CD O
] -RRB- O
. . O

SNPs NNS O
that WDT O
failed VBD O
Sequenom NNP O
typing NN O
were VBD O
retyped VBN O
by IN O
KBiosciences NNP O
( : O
http JJ O
: : O
/ NFP O
/ SYM O
www ADD O
. . O
kbioscience NN O
. . O
co NN O
. . O
uk IN O
/ SYM O
) -RRB- O
using VBG O
their PRP$ O
in IN O
- HYPH O
house NN O
SNP NNP O
genotyping NN O
methodology NN O
, , O
KASPar NNP O
( : O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
kbioscience NN O
. . O
co NN O
. . O
uk NN O
/ SYM O
genotyping NN O
/ SYM O
index NN O
. . O
htm NNP O
) -RRB- O
, , O
a DT O
competitive JJ O
allele NN O
- HYPH O
specific JJ O
PCR NN O
technique NN O
. . O

HLA NNP O
- HYPH O
DRB1 NNP O
genotyping VBG O
. . O

HLA NNP O
- HYPH O
DRB1 NNP O
typing NN O
was VBD O
performed VBN O
at IN O
the DT O
Anthony NNP O
Nolan NNP O
Trust NNP O
, , O
UK NNP O
. . O

All DT O
samples NNS O
( , O
n CD O
= SYM O
942 CD O
UK NNP O
SLE NNP O
trios NNS O
and CC O
n CD O
= SYM O
1 CD O
, , O
667 CD O
controls NNS O
) -RRB- O
were VBD O
genotyped VBN O
using VBG O
LABType NNP O
SSO NNP O
( , O
sequence NN O
- HYPH O
specific JJ O
oligonucleotide NN O
) -RRB- O
typing NN O
technology NN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NNS O
written VBN O
recommendations NNS O
( : O
http NN O
: : O
/ NFP O
/ SYM O
www NN O
. . O
onelambda NN O
. . O
com NN O
) -RRB- O
. . O

Briefly RB O
, , O
a DT O
locus NN O
- HYPH O
specific JJ O
biotinylated JJ O
PCR NNP O
amplicon NN O
is VBZ O
produced VBN O
, , O
denatured VBN O
, , O
and CC O
rehybridized VBN O
to IN O
complementary JJ O
oligonucleotide NN O
probes NNS O
conjugated VBN O
to IN O
fluorescently RB O
coded VBN O
beads NNS O
. . O

The DT O
bound VBN O
biotinylated JJ O
PCR NN O
product NN O
can MD O
be VB O
detected VBN O
using VBG O
R NN O
- HYPH O
phycoerythrin NN O
- HYPH O
conjugated VBN O
streptavidin NN O
. . O

A DT O
flow NN O
analyzer NN O
identifies VBZ O
the DT O
fluorescent JJ O
intensity NN O
of IN O
phycoerythrin NN O
on IN O
each DT O
bead NN O
. . O

The DT O
assignment NN O
of IN O
HLA NNP O
type NN O
is VBZ O
based VBN O
on IN O
the DT O
reaction NN O
pattern NN O
compared VBN O
to IN O
patterns NNS O
associated VBN O
with IN O
known VBN O
sequences NNS O
. . O

High JJ O
resolution NN O
testing NN O
was VBD O
performed VBN O
using VBG O
the DT O
Dynal NNP O
AllSet NNP O
+ SYM O
SSP NNP O
( HYPH O
sequence NN O
- HYPH O
specific JJ O
primers NNS O
) -RRB- O
DRB1 NNP O
assay NN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
( , O
Invitrogen NNP O
) -RRB- O
for IN O
SLE NNP O
families NNS O
only RB O
. . O

The DT O
presence NN O
or CC O
absence NN O
of IN O
PCR NNP O
amplification NN O
was VBD O
detected VBN O
in IN O
a DT O
gel NN O
electrophoresis NN O
step NN O
using VBG O
visualization NN O
by IN O
ethidium NN O
bromide NN O
incorporation NN O
. . O

Genotypes NNS O
were VBD O
determined VBN O
using VBG O
SSPTool NNP O
software NN O
. . O

Samples NNS O
that WDT O
could MD O
not RB O
be VB O
resolved VBN O
to IN O
four CD O
digits NNS O
using VBG O
SSO NNP O
and CC O
PCR NNP O
- HYPH O
SSP NNP O
were VBD O
analyzed VBN O
by IN O
DNA NNP O
sequencing NN O
of IN O
exon NN O
2 CD O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
. . O

Primers NNS O
, , O
reagents NNS O
, , O
and CC O
protocols NNS O
were VBD O
provided VBN O
by IN O
The DT O
Anthony NNP O
Nolan NNP O
Trust NNP O
, , O
UK NNP O
( , O
primer NN O
sequences NNS O
are VBP O
available JJ O
on IN O
request NN O
) -RRB- O
. . O

Specific JJ O
HLA NNP O
- HYPH O
DRB1 NNP O
alleles NNS O
were VBD O
assigned VBN O
by IN O
comparing VBG O
the DT O
resultant JJ O
sequence NN O
with IN O
reference NN O
sequence NN O
from IN O
the DT O
IMGT NNP O
/ SYM O
HLA NNP O
Database NNP O
[ -LRB- O
54 CD O
] -RRB- O
. . O

Data NNS O
analysis NN O
. . O

Mendelian JJ O
inconsistencies NNS O
were VBD O
removed VBN O
using VBG O
PedCheck NNP O
[ -LRB- O
55 CD O
] -RRB- O
. . O

Families NNS O
in IN O
which WDT O
more JJR O
than IN O
eight CD O
markers NNS O
demonstrated VBD O
Mendel NNP O
errors NNS O
were VBD O
removed VBN O
from IN O
further JJ O
analysis NN O
. . O

Markers NNS O
with IN O
less JJR O
than IN O
80 CD O
% NN O
genotyping NN O
efficiency NN O
and CC O
markers NNS O
where WRB O
more JJR O
than IN O
eight CD O
families NNS O
showed VBD O
Mendel NNP O
errors NNS O
were VBD O
also RB O
excluded VBN O
from IN O
analysis NN O
. . O

Two CD O
markers NNS O
located VBN O
within IN O
the DT O
SLE NNP O
associated VBN O
class NN O
II NN O
region NN O
( , O
rs2239802 CD O
in IN O
intron NN O
4 CD O
of IN O
HLA NNP O
- HYPH O
DRA NNP O
and CC O
rs6457594 CD O
in IN O
the DT O
region NN O
between IN O
HLA NNP O
- HYPH O
DRB9 NNP O
and CC O
HLA NNP O
- HYPH O
DRB5 NNP O
) -RRB- O
show VBP O
deviation NN O
from IN O
Hardy NNP O
- HYPH O
Weinberg NNP O
equilibrium NN O
( : O
HWE NNP O
) -RRB- O
, , O
which WDT O
may MD O
reflect VB O
an DT O
undetected JJ O
SLE NNP O
association NN O
or CC O
systematic JJ O
genotyping NN O
error NN O
. . O

HWE NNP O
was VBD O
assessed VBN O
in IN O
parental JJ O
samples NNS O
in IN O
our PRP$ O
cohort NN O
. . O

There EX O
is VBZ O
currently RB O
no DT O
uniform JJ O
opinion NN O
in IN O
the DT O
community NN O
regarding VBG O
the DT O
inclusion NN O
or CC O
exclusion NN O
of IN O
SNPs NNPS O
that WDT O
show VBP O
deviation NN O
from IN O
HWE NNP O
, , O
hence RB O
we PRP O
elected VBD O
to TO O
include VB O
these DT O
markers NNS O
in IN O
the DT O
final JJ O
analysis NN O
. . O

Sixty CD O
- HYPH O
eight CD O
out IN O
of IN O
the DT O
total JJ O
86 CD O
SNPs NNPS O
passed VBD O
our PRP$ O
quality NN O
- HYPH O
control NN O
measures NNS O
( , O
see VB O
Table NNP O
S1 NNP O
for IN O
details NNS O
) -RRB- O
. . O

In IN O
summary NN O
, , O
one CD O
SNP NNP O
was VBD O
monomorphic JJ O
in IN O
our PRP$ O
dataset NN O
, , O
four CD O
SNPs NNPS O
yielded VBD O
low JJ O
genotyping NN O
efficiency NN O
, , O
and CC O
13 CD O
SNPs NNS O
were VBD O
excluded VBN O
for IN O
unacceptable JJ O
Mendel NNP O
error NN O
rate NN O
. . O

The DT O
mean JJ O
call NN O
rate NN O
for IN O
all DT O
markers NNS O
post NN O
- HYPH O
quality NN O
control NN O
was VBD O
94 CD O
% NN O
( , O
range NN O
83 CD O
% NN O
to TO O
99 CD O
% NN O
) -RRB- O
. . O

Family NN O
- HYPH O
based VBN O
association NN O
testing NN O
was VBD O
performed VBN O
using VBG O
Genehunter NNP O
TDT NNP O
( , O
version NN O
2 CD O
. . O
1 CD O
) -RRB- O
[ -LRB- O
56 CD O
] -RRB- O
and CC O
TRANSMIT NN O
( : O
version NN O
2 CD O
. . O
5 CD O
) -RRB- O
[ -LRB- O
57 CD O
] -RRB- O
. . O

Haplotypes NNS O
were VBD O
constructed VBN O
and CC O
permutation NN O
testing NN O
performed VBN O
using VBG O
Haploview NNP O
( , O
version NN O
3 CD O
. . O
32 CD O
) -RRB- O
[ -LRB- O
58 CD O
] -RRB- O
. . O

Significance NN O
of IN O
association NN O
signals NNS O
in IN O
all DT O
analyses NNS O
was VBD O
based VBN O
on IN O
permutation NN O
testing NN O
( , O
10 CD O
, , O
0 CD O
permutations NNS O
) -RRB- O
. . O

The DT O
data NNS O
are VBP O
represented VBN O
both CC O
as IN O
nominal JJ O
and CC O
permuted VBN O
p NN O
values NNS O
. . O

ORs NNS O
with IN O
95 CD O
% NN O
CI NN O
for IN O
family NN O
- HYPH O
based VBN O
analyses NNS O
were VBD O
calculated VBN O
in IN O
PLINK NNP O
( : O
http NN O
: : O
/ : O
/ : O
pngu NNP O
. . O
mgh UH O
. . O
harvard NN O
. . O
edu NNP O
/ SYM O
purcell NN O
/ SYM O
plink NN O
/ : O
) -RRB- O
[ -LRB- O
59 CD O
] -RRB- O
. . O

Conditional JJ O
regression NN O
analyses NNS O
were VBD O
undertaken VBN O
using VBG O
WHAP NNP O
[ -LRB- O
60 CD O
] -RRB- O
. . O

The DT O
geno NN O
- HYPH O
PDT NNP O
was VBD O
performed VBN O
using VBG O
PDT NNP O
version NN O
5 CD O
. . O
1 CD O
with IN O
default NN O
settings NNS O
[ -LRB- O
27 CD O
] -RRB- O
. . O

The DT O
HLA NNP O
- HYPH O
DRB1 NNP O
alleles NNS O
were VBD O
coded VBN O
into IN O
three CD O
groups NNS O
for IN O
the DT O
geno NN O
- HYPH O
PDT NNP O
and CC O
the DT O
case NN O
- HYPH O
control NN O
analysis NN O
: : O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
, , O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
and CC O
HLA NNP O
- HYPH O
DRX NNP O
where WRB O
HLA NNP O
- HYPH O
DRX NNP O
includes VBZ O
all DT O
HLA NNP O
- HYPH O
DRB1 NNP O
alleles NNS O
other JJ O
than IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
or CC O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
. . O

The DT O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
code NN O
in IN O
the DT O
healthy JJ O
controls NNS O
represents VBZ O
the DT O
allele NN O
string NN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
1501 CD O
/ SYM O
1502 CD O
/ SYM O
1504 CD O
/ SYM O
1506 CD O
, , O
as IN O
described VBN O
previously RB O
. . O

The DT O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
1501 CD O
code NN O
in IN O
the DT O
lupus NN O
probands NNS O
represents VBZ O
the DT O
alleles NNS O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
1501 CD O
( SYM O
84 CD O
out IN O
of IN O
91 CD O
* SYM O
1501 CD O
and CC O
* NFP O
1502 CD O
alleles NNS O
) -RRB- O
and CC O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
1502 CD O
( SYM O
7 CD O
/ SYM O
91 CD O
* SYM O
1501 CD O
and CC O
* SYM O
1502 CD O
alleles NNS O
) -RRB- O
, , O
as IN O
* SYM O
1504 CD O
and CC O
* SYM O
1506 CD O
were VBD O
not RB O
present JJ O
in IN O
this DT O
population NN O
. . O

Fisher NNP O
' POS O
s POS O
exact JJ O
test NN O
was VBD O
used VBN O
to TO O
assess VB O
significance NN O
of IN O
association NN O
in IN O
the DT O
case NN O
- HYPH O
control NN O
analysis NN O
. . O

Subphenotype NN O
analysis NN O
. . O

We PRP O
looked VBD O
for IN O
association NN O
of IN O
the DT O
HLA NNP O
- HYPH O
DRB1 NNP O
* NFP O
301 CD O
allele NN O
with IN O
autoantibody NN O
subsets NNS O
and CC O
renal JJ O
disease NN O
in IN O
our PRP$ O
cohort NN O
using VBG O
the DT O
Chi NNP O
- HYPH O
square JJ O
test NN O
. . O

We PRP O
compared VBD O
cases NNS O
with IN O
and CC O
without IN O
the DT O
subphenotype NN O
of IN O
interest NN O
with IN O
DRB1 NNP O
* NFP O
301 CD O
homozygosity NN O
, , O
heterozygosity NN O
, , O
combined VBN O
homozygosity NN O
and CC O
heterozygosity NN O
, , O
and CC O
non JJ O
- HYPH O
DRB1 NN O
* SYM O
301 CD O
status NN O
. . O

We PRP O
performed VBD O
the DT O
same JJ O
analyses NNS O
for IN O
homozygous JJ O
and CC O
heterozygous JJ O
genotypes NNS O
of IN O
the DT O
associated VBN O
SNP NNP O
rs419788 NN O
. . O

The DT O
autoantibody NN O
subsets NNS O
compared VBN O
were VBD O
anti JJ O
- HYPH O
C1q NNP O
, , O
IgG NNP O
, , O
and CC O
IgM NNP O
anti JJ O
- HYPH O
cardiolipin NN O
antibodies NNS O
( , O
ACLG NNP O
and CC O
ACLM NNP O
) -RRB- O
, , O
anti JJ O
- HYPH O
Ro NN O
, , O
anti JJ O
- HYPH O
La NN O
, , O
anti JJ O
- HYPH O
RNP NN O
, , O
anti JJ O
- HYPH O
Sm NN O
, , O
and CC O
anti JJ O
- HYPH O
dsDNA NN O
. . O

Delineation NN O
of IN O
associated VBN O
MHC NNP O
haplotypes NNS O
and CC O
evidence NN O
for IN O
positive JJ O
selection NN O
. . O

We PRP O
looked VBD O
for IN O
positively RB O
selected VBN O
alleles NNS O
in IN O
our PRP$ O
dataset NN O
using VBG O
the DT O
long JJ O
- HYPH O
range NN O
haplotype NN O
test NN O
as IN O
measured VBN O
by IN O
extended VBN O
haplotype NN O
homozygosity NN O
( , O
EHH NNP O
) -RRB- O
, , O
previously RB O
described VBN O
by IN O
Sabeti NNP O
et FW O
al NNP O
. . O

[ -LRB- O
26 CD O
] -RRB- O
. . O

Essentially RB O
, , O
such PDT O
an DT O
analysis NN O
allows VBZ O
assessment NN O
of IN O
positive JJ O
selection NN O
by IN O
mining VBG O
datasets NNS O
for IN O
high JJ O
frequency NN O
extended VBN O
haplotypes NNS O
in IN O
comparison NN O
to IN O
the DT O
other JJ O
core NN O
haplotypes NNS O
at IN O
a DT O
locus NN O
. . O

EHH NNP O
is VBZ O
defined VBN O
as IN O
the DT O
probability NN O
that IN O
two CD O
randomly RB O
chosen VBN O
chromosomes NNS O
carrying VBG O
the DT O
core NN O
haplotype NN O
of IN O
interest NN O
will MD O
be VB O
identical JJ O
by IN O
descent NN O
( : O
homozygosity NN O
at IN O
all DT O
SNPs NNPS O
) -RRB- O
for IN O
the DT O
entire JJ O
interval NN O
from IN O
the DT O
core NN O
to IN O
a DT O
distance NN O
x NN O
. . O

The DT O
REHH NNP O
is VBZ O
the DT O
ratio NN O
of IN O
the DT O
EHH NN O
on IN O
the DT O
tested VBN O
core NN O
haplotype NN O
compared VBN O
with IN O
the DT O
combined JJ O
EHH NN O
of IN O
all PDT O
the DT O
other JJ O
core NN O
haplotypes NNS O
at IN O
the DT O
region NN O
excluding VBG O
the DT O
tested VBN O
core NN O
; : O
as IN O
such JJ O
, , O
REHH NNP O
accounts VBZ O
for IN O
local JJ O
variation NN O
in IN O
recombination NN O
rate NN O
while IN O
EHH NNP O
does VBZ O
not RB O
[ -LRB- O
26 CD O
] -RRB- O
. . O

The DT O
program NN O
emphase NN O
was VBD O
employed VBN O
to TO O
assign VB O
the DT O
phase NN O
of IN O
parental JJ O
genotype NN O
data NNS O
and CC O
reconstruct VB O
missing VBG O
information NN O
. . O

Emphase NN O
is VBZ O
a DT O
simple JJ O
phaser NN O
similar JJ O
to IN O
the DT O
phaser NN O
of IN O
Excoffier NNP O
and CC O
Slatkin NNP O
[ -LRB- O
61 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
very RB O
fast JJ O
, , O
especially RB O
on IN O
large JJ O
datasets NNS O
, , O
and CC O
sufficiently RB O
accurate JJ O
for IN O
most JJS O
genetic JJ O
applications NNS O
. . O

EHH NNP O
analysis NN O
was VBD O
performed VBN O
on IN O
the DT O
phased VBN O
parental JJ O
data NNS O
using VBG O
the DT O
software NN O
program NN O
SWEEP NN O
( : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
broad JJ O
. . O
mit NN O
. . O
edu NNP O
/ SYM O
mpg NN O
/ SYM O
sweep NN O
/ SYM O
index NN O
. . O
html ADD O
) -RRB- O
. . O

Haplotype NN O
bifurcation NN O
plots NNS O
. . O

We PRP O
represent VBP O
the DT O
breakdown NN O
of IN O
LD NN O
on IN O
core NN O
haplotypes NNS O
using VBG O
haplotype NN O
bifurcation NN O
diagrams NNS O
generated VBN O
in IN O
the DT O
program NN O
TREE NNP O
[ -LRB- O
62 CD O
] -RRB- O
( , O
also RB O
explained VBN O
in IN O
[ $ O
52 CD O
] -RRB- O
) -RRB- O
. . O

REHH NNP O
versus IN O
frequency NN O
plots NNS O
. . O

Fifty CD O
- HYPH O
three CD O
SNPs NNS O
( , O
identified VBN O
in IN O
Figure NNP O
1 CD O
) -RRB- O
are VBP O
common JJ O
to IN O
our PRP$ O
dataset NN O
and CC O
the DT O
CEPH NNP O
and CC O
Yoruba NNP O
HapMap NNP O
[ -LRB- O
63 CD O
] -RRB- O
populations NNS O
. . O

These DT O
three CD O
datasets NNS O
, , O
together RB O
with IN O
CEPH NNP O
SNP NNP O
data NNS O
for IN O
Chromosome NNP O
6 CD O
in IN O
its PRP$ O
entirety NN O
, , O
were VBD O
used VBN O
to TO O
generate VB O
separate JJ O
REHH NNP O
versus IN O
frequency NN O
plots NNS O
in IN O
SWEEP NNP O
. . O

The DT O
plots NNS O
from IN O
the DT O
four CD O
cohorts NNS O
were VBD O
combined VBN O
for IN O
visual JJ O
, , O
not RB O
statistical JJ O
, , O
comparison NN O
. . O

Evidence NN O
for IN O
positive JJ O
selection NN O
was VBD O
quantitatively RB O
assessed VBN O
in IN O
CEPH NNP O
individuals NNS O
, , O
as IN O
this DT O
population NN O
alone RB O
was VBD O
used VBN O
to TO O
assess VB O
background NN O
variation NN O
on IN O
Chromosome NNP O
6 CD O
. . O

The DT O
UK NNP O
SLE NNP O
and CC O
Yoruba NNP O
cohort NN O
data NNS O
are VBP O
shown VBN O
for IN O
comparison NN O
. . O

The DT O
95th JJ O
percentile NN O
based VBN O
on IN O
total JJ O
CEPH NNP O
Chromosome NNP O
6 CD O
SNP NNP O
data NNS O
is VBZ O
shown VBN O
. . O

Supporting VBG O
Information NN O

Accession NN O
Numbers NNS O

The DT O
Online NNP O
Mendelian NNP O
Inheritance NNP O
in IN O
Man NNP B-Species
( , O
OMIM NNP O
, , O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
ncbi ADD O
. . O
nlm UH O
. . O
nih NNP O
. , O
gov NN O
/ SYM O
sites NNS O
/ SYM O
entrez FW O
? , O
db NN O
= : O
omim NN O
) -RRB- O
accession NN O
numbers NNS O
for IN O
the DT O
genes NNS O
described VBN O
in IN O
this DT O
study NN O
are VBP O
as IN O
follows VBZ O
: : O
AGER NNP O
, , O
600214 CD O
; : O
BAT3 NNP O
, , O
142590 CD O
; : O
C4A NNP O
, , O
120810 CD O
; : O
C4B NNP O
, , O
120820 CD O
; : O
CFB NNP O
, , O
138470 CD O
; : O
DOM3Z NNP O
, , O
605996 CD O
; : O
DOM3Z NNP O
, , O
605996 CD O
; : O
EHMT2 NNP O
, , O
604599 CD O
; : O
HLA NNP O
- HYPH O
B NNP O
, , O
142830 CD O
; : O
HLA NNP O
- HYPH O
DPB2 NNP O
, , O
120290 CD O
; : O
HLA NNP O
- HYPH O
DQA1 NNP O
, , O
146880 CD O
; : O
HLA NNP O
- HYPH O
DQB1 NNP O
, , O
604305 CD O
; : O
HLA NNP O
- HYPH O
DRA NNP O
, , O
142860 CD O
; : O
HLA NNP O
- HYPH O
DRB1 NNP O
, , O
142857 CD O
; : O
KIAA1949 NNP O
, , O
610990 CD O
; : O
MICA NNP O
, , O
600169 CD O
; : O
NOTCH4 NNP O
, , O
164951 CD O
; : O
RDBP NNP O
, , O
154040 CD O
; : O
RDBP NNP O
, , O
154040 CD O
; : O
SKIV2L NNP O
, , O
600478 CD O
; : O
SLC44A4 NNP O
, , O
606107 CD O
; : O
STK19 NNP O
, , O
604977 CD O
; : O
STK19 NNP O
, , O
604977 CD O
; : O
TNF NNP O
, , O
191160 CD O
; : O
and CC O
TNXB NNP O
, , O
600985 CD O
. . O

SuperCAT NNP O
: : O
a DT O
supertree NN O
database NN O
for IN O
combined VBN O
and CC O
integrative JJ O
multilocus NN O
sequence NN O
typing VBG O
analysis NN O
of IN O
the DT O
Bacillus NNP B-Species
cereus NN I-Species
group NN I-Species
of IN O
bacteria NNS O
( , O
including VBG O
B NN B-Species
. . I-Species
cereus NN I-Species
, , O
B NN B-Species
. . I-Species
anthracis NN I-Species
and CC O
B NN B-Species
. . I-Species
thuringiensis NN I-Species
) -RRB- O

Abstract JJ O

The DT O
Bacillus NNP B-Species
cereus NN I-Species
group NN I-Species
of IN O
bacteria NNS O
is VBZ O
an DT O
important JJ O
group NN O
including VBG O
mammalian JJ O
and CC O
insect NN O
pathogens NNS O
, , O
such JJ O
as IN O
B NN B-Species
. . I-Species
anthracis NN I-Species
, , O
the DT O
anthrax NN B-Species
bacterium NN O
, , O
B NN B-Species
. . I-Species
thuringiensis NN I-Species
, , O
used VBN O
as IN O
a DT O
biological JJ O
pesticide NN O
and CC O
B NN B-Species
. . I-Species
cereus NN I-Species
, , O
often RB O
involved VBN O
in IN O
food NN O
poisoning NN O
incidents NNS O
. . O

To TO O
characterize VB O
the DT O
population NN O
structure NN O
and CC O
epidemiology NN O
of IN O
these DT O
bacteria NNS O
, , O
five CD O
separate JJ O
multilocus JJ O
sequence NN O
typing NN O
( , O
MLST NNP O
) -RRB- O
schemes NNS O
have VBP O
been VBN O
developed VBN O
, , O
which WDT O
makes VBZ O
results NNS O
difficult JJ O
to TO O
compare VB O
. . O

Therefore RB O
, , O
we PRP O
have VBP O
developed VBN O
a DT O
database NN O
that WDT O
compiles VBZ O
and CC O
integrates VBZ O
MLST NNP O
data NNS O
from IN O
all DT O
five CD O
schemes NNS O
for IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
, , O
accessible JJ O
at IN O
http NN O
: : O
/ NFP O
/ SYM O
mlstoslo ADD O
. . O
uio NNP O
. . O
no UH O
/ , O
. . O

Supertree NN O
techniques NNS O
were VBD O
used VBN O
to TO O
combine VB O
the DT O
phylogenetic JJ O
information NN O
from IN O
analysis NN O
of IN O
all DT O
schemes NNS O
and CC O
datasets NNS O
, , O
in IN O
order NN O
to TO O
produce VB O
an DT O
integrated VBN O
view NN O
of IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
population NN O
. . O

The DT O
database NN O
currently RB O
contains VBZ O
strain NN O
information NN O
and CC O
sequence NN O
data NNS O
for IN O
1029 CD O
isolates NNS O
and CC O
26 CD O
housekeeping NN O
gene NN O
fragments NNS O
, , O
which WDT O
can MD O
be VB O
searched VBN O
by IN O
keywords NNS O
, , O
MLST NNP O
scheme NN O
, , O
or CC O
sequence NN O
similarity NN O
. . O

Supertrees NNS O
can MD O
be VB O
browsed VBN O
according VBG O
to IN O
various JJ O
criteria NNS O
such JJ O
as IN O
species NNS O
, , O
isolate JJ O
source NN O
, , O
or CC O
genetic JJ O
distance NN O
, , O
and CC O
subtrees NNS O
containing VBG O
strains NNS O
of IN O
interest NN O
can MD O
be VB O
extracted VBN O
. . O

Besides IN O
analysis NN O
of IN O
the DT O
available JJ O
data NNS O
, , O
the DT O
user NN O
has VBZ O
the DT O
possibility NN O
to TO O
enter VB O
her PRP$ O
/ SYM O
his PRP$ O
own JJ O
sequences NNS O
and CC O
compare VB O
them PRP O
to IN O
the DT O
database NN O
and CC O
/ SYM O
or CC O
include VB O
them PRP O
into IN O
the DT O
supertree NN O
reconstructions NNS O
. . O

INTRODUCTION NN O

Multilocus NNP O
sequence NN O
typing NN O
( , O
MLST NNP O
) -RRB- O
is VBZ O
a DT O
tool NN O
that WDT O
is VBZ O
widely RB O
used VBN O
for IN O
phylogenetic JJ O
typing NN O
of IN O
bacteria NNS O
. . O

MLST NNP O
is VBZ O
based VBN O
on IN O
polymerase NN O
chain NN O
reaction NN O
( , O
PCR NN O
) -RRB- O
amplification NN O
and CC O
sequencing NN O
of IN O
internal JJ O
fragments NNS O
of IN O
usually RB O
seven CD O
essential JJ O
or CC O
housekeeping NN O
genes NNS O
spread VBN O
around IN O
the DT O
bacterial JJ O
chromosome NN O
. . O

The DT O
genetic JJ O
relatedness NN O
among IN O
isolates NNS O
is VBZ O
then RB O
determined VBN O
by IN O
comparison NN O
of IN O
the DT O
nucleotide NN O
sequence NN O
types NNS O
( : O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

MLST NNP O
is VBZ O
thus RB O
a DT O
method NN O
that WDT O
is VBZ O
unambiguous JJ O
and CC O
truly RB O
portable JJ O
among IN O
laboratories NNS O
. . O

Since IN O
the DT O
initial JJ O
development NN O
of IN O
this DT O
technique NN O
for IN O
Neisseria NNP B-Species
meningitidis NNS I-Species
in IN O
1998 CD O
, , O
MLST NNP O
schemes NNS O
have VBP O
been VBN O
developed VBN O
for IN O
about IN O
30 CD O
species NNS O
including VBG O
some DT O
of IN O
the DT O
most RBS O
important JJ O
bacterial JJ O
pathogens NNS O
, , O
e UH O
. . O
g LS O
. . O
Streptococcus NNP B-Species
pneumoniae NN I-Species
, , O
Streptococcus NNP B-Species
pyogenes NN I-Species
, , O
Haemophilus NNP B-Species
influenzae NN I-Species
, , O
Staphylococcus NNP B-Species
aureus NN I-Species
, , O
Campylobacter NNP B-Species
jejuni NN I-Species
, , O
Enterococcus NNP B-Species
faecium NN I-Species
, , O
Burkholderia NNP B-Species
pseudomallei NN I-Species
, , O
Escherichia NNP B-Species
coli NN I-Species
, , O
Salmonella NNP B-Species
enterica NN I-Species
and CC O
the DT O
Bacillus NNP B-Species
cereus NN I-Species
group NN I-Species
( , O
see VB O
( , O
1 CD O
) -RRB- O
for IN O
a DT O
recent JJ O
review NN O
) -RRB- O
. . O

These DT O
MLST NNP O
schemes NNS O
have VBP O
been VBN O
used VBN O
successfully RB O
to TO O
explore VB O
the DT O
population NN O
structure NN O
of IN O
bacteria NNS O
, , O
to TO O
study VB O
the DT O
evolution NN O
of IN O
their PRP$ O
virulence NN O
properties NNS O
, , O
to TO O
identify VB O
antibiotic JJ O
- HYPH O
resistant JJ O
strains NNS O
and CC O
epidemic JJ O
clones NNS O
, , O
and CC O
for IN O
epidemiological JJ O
surveillance NN O
. . O

The DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
includes VBZ O
bacterial JJ O
species NNS O
that WDT O
are VBP O
of IN O
medical JJ O
and CC O
/ SYM O
or CC O
economic JJ O
importance NN O
, , O
such JJ O
as IN O
B NN B-Species
. . I-Species
anthracis NN I-Species
, , O
an DT O
obligate JJ O
mammalian JJ O
pathogen NN O
causing VBG O
the DT O
lethal JJ O
disease NN O
anthrax NN B-Species
, , O
B NN B-Species
. . I-Species
cereus NN I-Species
, , O
an DT O
opportunistic JJ O
human JJ B-Species
pathogen NN O
involved VBN O
in IN O
food NN O
- HYPH O
poisoning VBG O
incidents NNS O
and CC O
contaminations NNS O
in IN O
hospitals NNS O
, , O
B NN B-Species
. . I-Species
thuringiensis NN I-Species
, , O
an DT O
insect NN O
pathogen NN O
and CC O
one CD O
of IN O
the DT O
world NN O
' '' O
s POS O
most RBS O
widely RB O
used VBN O
biopesticide NN O
and CC O
B NN B-Species
. . I-Species
weihenstephanensis NNP I-Species
, , O
a DT O
cold JJ O
- HYPH O
tolerant JJ O
species NN O
known VBN O
for IN O
contaminating VBG O
dairies NNS O
. . O

These DT O
species NNS O
are VBP O
genetically RB O
very RB O
closely RB O
related JJ O
and CC O
may MD O
be VB O
considered VBN O
as IN O
one CD O
species NN O
based VBN O
on IN O
genetic JJ O
and CC O
genomic JJ O
evidence NN O
( , O
3 CD O
- SYM O
5 CD O
) -RRB- O
. . O

Unlike IN O
other JJ O
bacterial JJ O
species NNS O
that WDT O
are VBP O
typed VBN O
using VBG O
a DT O
single JJ O
MLST NNP O
scheme NN O
, , O
five CD O
separate JJ O
schemes NNS O
have VBP O
been VBN O
developed VBN O
for IN O
the DT O
B NNP B-Species
. . I-Species
cereus NNP I-Species
group NN I-Species
, , O
based VBN O
on IN O
different JJ O
sets NNS O
of IN O
genes NNS O
and CC O
isolates NNS O
( : O
5 CD O
- SYM O
10 CD O
) -RRB- O
. . O

The DT O
Priest NNP O
scheme NN O
( -LRB- O
8 CD O
) -RRB- O
is VBZ O
currently RB O
the DT O
most RBS O
widely RB O
used VBN O
. . O

Studies NNS O
with IN O
the DT O
various JJ O
schemes NNS O
have VBP O
independently RB O
indicated VBN O
that IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
population NN O
is VBZ O
divided VBN O
into IN O
three CD O
main JJ O
phylogenetic JJ O
clusters NNS O
and CC O
that IN O
species NNS O
are VBP O
usually RB O
intermixed VBN O
within IN O
the DT O
groups NNS O
. . O

One CD O
cluster NN O
contains VBZ O
the DT O
monomorphic JJ O
B NN B-Species
. . I-Species
anthracis NN I-Species
isolates NNS O
and CC O
a DT O
number NN O
of IN O
B NN B-Species
. . I-Species
cereus NN I-Species
and CC O
B NN B-Species
. . I-Species
thuringiensis NN I-Species
strains NNS O
, , O
many JJ O
of IN O
which WDT O
are VBP O
from IN O
clinical JJ O
sources NNS O
. . O

A DT O
second JJ O
heterogeneous JJ O
cluster NN O
includes VBZ O
B NN B-Species
. . I-Species
cereus NN I-Species
and CC O
B NN B-Species
. . I-Species
thuringiensis NN I-Species
isolates VBZ O
from IN O
various JJ O
origins NNS O
, , O
while IN O
cold JJ O
- HYPH O
tolerant JJ O
B NN B-Species
. . I-Species
weihenstephanensis NN I-Species
and CC O
B NN B-Species
. . I-Species
cereus NN I-Species
isolates NNS O
belong VBP O
to IN O
the DT O
third JJ O
group NN O
. . O

The DT O
separate JJ O
MLST NNP O
analyses NNS O
have VBP O
also RB O
revealed VBN O
that IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
population NN O
is VBZ O
weakly RB O
clonal JJ O
overall JJ O
due IN O
to IN O
numerous JJ O
clinical JJ O
and CC O
virulent JJ O
isolates NNS O
emerging VBG O
from IN O
different JJ O
phylogenetic JJ O
positions NNS O
( , O
5 CD O
- SYM O
8 CD O
, , O
11 CD O
- HYPH O
14 CD O
) -RRB- O
, , O
with IN O
the DT O
exception NN O
of IN O
the DT O
' `` O
cold JJ O
- HYPH O
tolerant JJ O
' '' O
cluster NN O
that WDT O
seems VBZ O
to TO O
exhibit VB O
a DT O
panmictic JJ O
( , O
or CC O
sexual JJ O
) , O
population NN O
structure NN O
, , O
i LS O
. . O
e LS O
. . O
with IN O
frequent JJ O
genetic JJ O
exchanges NNS O
between IN O
strains NNS O
( , O
9 CD O
) -RRB- O
. . O

Despite IN O
the DT O
overall JJ O
congruence NN O
between IN O
the DT O
various JJ O
MLST NNP O
studies NNS O
, , O
the DT O
use NN O
of IN O
separate JJ O
schemes NNS O
with IN O
no DT O
gene NN O
overlap NN O
and CC O
very RB O
little JJ O
strain NN O
overlap NN O
has VBZ O
produced VBN O
a DT O
confusing JJ O
situation NN O
and CC O
makes VBZ O
the DT O
results NNS O
difficult JJ O
to TO O
compare VB O
directly RB O
. . O

Therefore RB O
, , O
we PRP O
recently RB O
proposed VBD O
a DT O
combined VBN O
scheme NN O
based VBN O
on IN O
genes NNS O
taken VBN O
from IN O
three CD O
of IN O
the DT O
four CD O
schemes NNS O
available JJ O
by IN O
then RB O
and CC O
for IN O
which WDT O
we PRP O
created VBD O
a DT O
web NN O
- HYPH O
based VBN O
database NN O
accessible JJ O
at IN O
the DT O
University NNP O
of IN O
Oslo NNP O
' POS O
s POS O
MLST NNP O
server NN O
, , O
http NN O
: : O
/ : O
/ : O
mlstoslo ADD O
. . O
uio NNP O
. . O
no UH O
/ , O
( SYM O
5 CD O
) -RRB- O
. . O

Here RB O
, , O
in IN O
order NN O
to TO O
provide VB O
the DT O
B NN B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
research NN O
community NN O
with IN O
a DT O
common JJ O
MLST NNP O
resource NN O
, , O
we PRP O
have VBP O
developed VBN O
on IN O
the DT O
same JJ O
website NN O
a DT O
database NN O
, , O
SuperCAT NNP O
, , O
that WDT O
compiles VBZ O
and CC O
integrates VBZ O
MLST NNP O
data NNS O
from IN O
all PDT O
the DT O
published JJ O
B NN B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
schemes NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
applied VBD O
supertree NN O
reconstruction NN O
methods NNS O
to TO O
build VB O
an DT O
integrated JJ O
view NN O
of IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
population NN O
and CC O
phylogeny NN O
. . O

Below RB O
we PRP O
describe VBP O
the DT O
content NN O
and CC O
main JJ O
features NNS O
of IN O
the DT O
new JJ O
database NN O
as RB O
well RB O
as IN O
the DT O
process NN O
of IN O
supertree NN O
building NN O
. . O

DATABASE NN O
CONTENT NN O
AND CC O
IMPLEMENTATION NN O

The DT O
SuperCAT NNP O
database NN O
provides VBZ O
information NN O
, , O
sequence NN O
and CC O
phylogenetic JJ O
data NNS O
for IN O
all DT O
bacterial JJ O
isolates NNS O
that WDT O
have VBP O
been VBN O
typed VBN O
using VBG O
any DT O
of IN O
the DT O
five CD O
published VBN O
MLST NNP O
schemes NNS O
for IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
( : O
Table NNP O
1 CD O
) -RRB- O
. . O

Strain NN O
information NN O
, , O
when WRB O
known VBN O
, , O
includes VBZ O
isolate JJ O
description NN O
, , O
source NN O
and CC O
geographical JJ O
location NN O
of IN O
isolation NN O
, , O
and CC O
the DT O
scheme NN O
( , O
s NNS O
) -RRB- O
used VBN O
for IN O
typing NN O
. . O

The DT O
sequence NN O
data NNS O
include VBP O
the DT O
nucleotide NN O
sequences NNS O
of IN O
the DT O
MLST NNP O
loci NN O
examined VBN O
in IN O
a DT O
given VBN O
strain NN O
. . O

SuperCAT NNP O
also RB O
contains VBZ O
the DT O
phylogenetic JJ O
supertree NN O
of IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
reconstructed VBN O
by IN O
combining VBG O
the DT O
sequence NN O
data NNS O
from IN O
all DT O
five CD O
schemes NNS O
, , O
as RB O
well RB O
as IN O
supertrees NNS O
built VBN O
for IN O
individual JJ O
schemes NNS O
. . O

Information NN O
and CC O
sequences NNS O
for IN O
isolates NNS O
typed VBN O
by IN O
the DT O
Priest NNP O
and CC O
Tourasse NNP O
- HYPH O
Helgason NNP O
schemes NNS O
were VBD O
retrieved VBN O
from IN O
the DT O
databases NNS O
devoted VBN O
to IN O
these DT O
schemes NNS O
at IN O
http JJ O
: : O
/ SYM O
/ SYM O
pubmlst ADD O
. . O
org NN O
/ SYM O
bcereus NNP O
and CC O
http NN O
: : O
/ NFP O
/ : O
mlstoslo ADD O
. . O
uio NNP O
. . O
no UH O
/ , O
, , O
respectively RB O
. . O

MLST NNP O
data NNS O
for IN O
additional JJ O
strains NNS O
not RB O
available JJ O
in IN O
the DT O
pubmlst NN O
. , O
org NN O
repository NN O
( , O
strains NNS O
from IN O
( , O
15 CD O
) -RRB- O
are VBP O
missing VBG O
therein RB O
) , O
and CC O
for IN O
the DT O
Helgason NNP O
, , O
Ko NNP O
, , O
and CC O
Candelon NNP O
- HYPH O
Sorokin NNP O
schemes NNS O
were VBD O
taken VBN O
from IN O
the DT O
published JJ O
literature NN O
and CC O
the DT O
Genbank NNP O
nucleotide NN O
sequence NN O
database NN O
( , O
Table NNP O
1 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
sequences NNS O
of IN O
all DT O
MLST NNP O
loci NN O
were VBD O
extracted VBN O
from IN O
the DT O
complete JJ O
genomes NNS O
of IN O
the DT O
21 CD O
sequenced VBN O
B NN B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
strains NNS O
available JJ O
in IN O
Genbank NNP O
. . O

Altogether RB O
, , O
SuperCAT NNP O
currently RB O
contains VBZ O
data NNS O
for IN O
1029 CD O
isolates NNS O
and CC O
26 CD O
gene NN O
fragments NNS O
from IN O
25 CD O
different JJ O
genes NNS O
. . O

However RB O
, , O
since IN O
most JJS O
strains NNS O
have VBP O
been VBN O
typed VBN O
using VBG O
only RB O
6 CD O
or CC O
7 CD O
of IN O
the DT O
26 CD O
loci NN O
, , O
about RB O
one CD O
- HYPH O
third NN O
of IN O
the DT O
complete JJ O
set NN O
of IN O
sequences NNS O
are VBP O
included VBN O
. . O

The DT O
26 CD O
loci NN O
, , O
only RB O
available JJ O
for IN O
the DT O
completely RB O
sequenced VBN O
strains NNS O
, , O
sum NN O
up IN O
to IN O
10 CD O
619 CD O
bp NN O
. . O

All PDT O
these DT O
genes NNS O
are VBP O
located VBN O
on IN O
the DT O
chromosome NN O
, , O
thus RB O
the DT O
database NN O
provides VBZ O
no DT O
information NN O
about IN O
extrachromosomal JJ O
plasmids NNS O
even RB O
though IN O
most JJS O
of IN O
the DT O
strains NNS O
do VBP O
carry VB O
one CD O
or CC O
several JJ O
small JJ O
and CC O
/ SYM O
or CC O
large JJ O
plasmids NNS O
. . O

Unlike IN O
scheme NN O
- HYPH O
specific JJ O
MLST NNP O
databases NNS O
, , O
SuperCAT NNP O
does VBZ O
not RB O
contain VB O
allele NN O
and CC O
sequence NN O
type NN O
( -LRB- O
ST NNP O
) -RRB- O
numbers NNS O
. . O

Since IN O
isolates NNS O
in IN O
SuperCAT NNP O
have VBP O
been VBN O
typed VBN O
by IN O
different JJ O
subsets NNS O
of IN O
loci NN O
, , O
complete JJ O
allelic JJ O
profiles NNS O
are VBP O
unavailable JJ O
and CC O
therefore RB O
STs NNP O
cannot MD O
be VB O
assigned VBN O
for IN O
most JJS O
strains NNS O
, , O
except IN O
the DT O
fully RB O
sequenced VBN O
ones NNS O
. . O

Table NNP O
1 CD O
. , O
The DT O
five CD O
MLST NNP O
schemes NNS O
designed VBN O
for IN O
typing VBG O
bacteria NNS O
of IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
groupSchemeGenesTota NN I-Species
sequence NN O
length NN O
( , O
bp NN O
) -RRB- O
Total JJ O
number NN O
of IN O
isolateseUsed VBN O
in IN O
( , O
references NNS O
) , O
Helgasonadk NNP O
, , O
ccpA NNP O
, , O
ftsA NN O
, , O
glpT NN O
, , O
pyre NN O
, , O
recF NN O
and CC O
sucC2 NN O
938120 CD O
( SYM O
6 CD O
, , O
12 CD O
, , O
46 CD O
) SYM O
Candelon NNP O
- HYPH O
Sorokina NNP O
, , O
cclpC NN O
, , O
dinB NN O
, , O
gdpD NN O
, , O
panC NN O
, , O
purF NN O
and CC O
yhfL2 NNP O
850149 CD O
( SYM O
9 CD O
, , O
10 CD O
) SYM O
Kob NNP O
, , O
cgyrB NN O
, , O
mbl NN O
, , O
mdh NN O
, , O
mutS NN O
, , O
pycA NN O
( , O
1 CD O
) -RRB- O
and CC O
rpoB2 NN O
265 CD O
( SYM O
7 CD O
) SYM O
Priesta NNP O
, , O
bglpF NN O
, , O
gmk NN O
, , O
ilvD NN O
, , O
pta NN O
, , O
purH NN O
, , O
pycA NN O
( , O
2 CD O
) , O
and CC O
tpi2 NN O
829721 CD O
( SYM O
8 CD O
, , O
11 CD O
, , O
13 CD O
- HYPH O
15 CD O
, , O
46 CD O
- HYPH O
48 CD O
) : O
Tourasse NN O
- HYPH O
Helgasona NNP O
, , O
b NN O
, , O
dadk NN O
, , O
ccpA NN O
, , O
glpF NN O
, , O
glpT NN O
, , O
panC NN O
, , O
pta NN O
and CC O
pycA NN O
( , O
2 CD O
) SYM O
2 CD O
658172 CD O
( SYM O
5 CD O
) SYM O
aSpecific JJ O
databases NNS O
for IN O
the DT O
Priest NNP O
and CC O
Tourasse NNP O
- HYPH O
Helgason NNP O
schemes NNS O
are VBP O
accessible JJ O
at IN O
http NN O
: : O
/ SYM O
/ SYM O
pubmlst ADD O
. . O
org NN O
/ SYM O
bcereus NN O
/ SYM O
and CC O
http NN O
: : O
/ NFP O
/ : O
mlstoslo ADD O
. . O
uio NNP O
. . O
no UH O
/ , O
, , O
respectively RB O
. . O

A DT O
BLAST NN O
database NN O
for IN O
the DT O
Candelon NNP O
- HYPH O
Sorokin NNP O
scheme NN O
is VBZ O
available JJ O
at IN O
http NN O
: : O
/ : O
/ SYM O
spock NN O
. . O
jouy NNP O
. . O
inra FW O
. . O
fr NN O
/ : O
cgi NN O
- HYPH O
bin NN O
/ : O
bacilliMLSopen ADD O
. . O
cgi NNP O
. . O
bWhile IN O
the DT O
Tourasse NNP O
- HYPH O
Helgason NNP O
and CC O
Priest NNP O
schemes NNS O
use VBP O
the DT O
same JJ O
gene NN O
fragment NN O
for IN O
the DT O
pycA NN O
gene NN O
, , O
the DT O
Ko NNP O
scheme NN O
is VBZ O
based VBN O
on IN O
a DT O
different JJ O
and CC O
non RB O
- HYPH O
overlapping VBG O
gene NN O
region NN O
. . O
cThe NN O
B NN B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
- HYPH O
specific JJ O
transcriptional JJ O
regulator NN O
plcR NN O
was VBD O
originally RB O
included VBN O
in IN O
the DT O
Candelon NNP O
- HYPH O
Sorokin NNP O
and CC O
Ko NNP O
schemes NNS O
. . O

However RB O
, , O
plcR NN O
follows VBZ O
a DT O
phylogeny NN O
different JJ O
from IN O
the DT O
other JJ O
MLST NNP O
loci NN O
( , O
7 CD O
, , O
10 CD O
) -RRB- O
and CC O
is VBZ O
no RB O
longer RBR O
used VBN O
for IN O
MLST NNP O
; : O
therefore RB O
, , O
it PRP O
is VBZ O
not RB O
included VBN O
in IN O
SuperCAT NNP O
. , O
dThe NNP O
Tourasse NNP O
- HYPH O
Helgason NNP O
scheme NN O
is VBZ O
a DT O
combined VBN O
scheme NN O
based VBN O
on IN O
3 CD O
genes NNS O
from IN O
the DT O
Helgason NNP O
scheme NN O
( , O
adk NN O
, , O
ccpA NN O
, , O
and CC O
glpT NN O
) -RRB- O
, , O
3 CD O
genes NNS O
from IN O
the DT O
Priest NNP O
scheme NN O
( , O
glpF NN O
, , O
pta NN O
and CC O
pycA NN O
( , O
2 CD O
) , O
) -RRB- O
, , O
and CC O
the DT O
panC NN O
gene NN O
from IN O
the DT O
Candelon NNP O
- HYPH O
Sorokin NNP O
scheme NN O
. , O
eIncluding VBG O
strains NNS O
with IN O
fully RB O
sequenced VBN O
genomes NNS O
. . O

SuperCAT NNP O
is VBZ O
built VBN O
as IN O
a DT O
relational JJ O
database NN O
using VBG O
the DT O
PostgreSQL NNP O
management NN O
system NN O
, , O
and CC O
data NNS O
are VBP O
accessible JJ O
through IN O
a DT O
graphical JJ O
web NN O
interface NN O
. . O

User NN O
queries NNS O
and CC O
results NNS O
pages NNS O
are VBP O
processed VBN O
and CC O
created VBN O
on IN O
- HYPH O
the DT O
- HYPH O
fly NN O
via IN O
a DT O
highly RB O
modified VBN O
version NN O
of IN O
the DT O
mlstdbNet NN O
software NN O
( -LRB- O
16 CD O
) -RRB- O
written VBN O
in IN O
PERL NNP O
and CC O
based VBN O
on IN O
the DT O
DataBase NNP O
Interface NNP O
( -LRB- O
DBI NNP O
) -RRB- O
and CC O
Common NNP O
Gateway NNP O
Interface NNP O
( -LRB- O
CGI NNP O
) -RRB- O
modules NNS O
. . O

The DT O
database NN O
is VBZ O
implemented VBN O
on IN O
a DT O
Linux NNP O
Apache NNP O
web NN O
server NN O
maintained VBN O
through IN O
the DT O
facilities NNS O
and CC O
support NN O
provided VBN O
by IN O
the DT O
Norwegian NNP O
EMBnet NNP O
node NN O
. . O

Some DT O
large JJ O
supertree NN O
computations NNS O
are VBP O
run VBN O
on IN O
a DT O
Linux NNP O
supercomputer NN O
at IN O
the DT O
University NNP O
of IN O
Oslo NNP O
. . O

The DT O
ATV NNP O
( , O
A NNP O
Tree NNP O
Viewer NNP O
) -RRB- O
Java NNP O
applet NN O
is VBZ O
used VBN O
for IN O
phylogenetic JJ O
tree NN O
display NN O
( , O
17 CD O
) -RRB- O
. . O

ATV NN O
notably RB O
supports VBZ O
horizontal JJ O
and CC O
vertical JJ O
zooming NN O
capabilities NNS O
that WDT O
are VBP O
suitable JJ O
for IN O
browsing VBG O
large JJ O
trees NNS O
. . O

The DT O
Jalview NNP O
editor NN O
Java NNP O
applet NN O
is VBZ O
also RB O
implemented VBN O
in IN O
SuperCAT NNP O
for IN O
advanced JJ O
multiple JJ O
sequence NN O
alignment NN O
display NN O
( : O
18 CD O
) -RRB- O
. . O

SUPERTREE NN O
RECONSTRUCTION NN O

Supertree NNP O
techniques NNS O
allow VBP O
to TO O
combine VB O
the DT O
phylogenetic JJ O
information NN O
from IN O
different JJ O
datasets NNS O
into IN O
a DT O
common JJ O
phylogenetic JJ O
tree NN O
and CC O
several JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
meaningful JJ O
supertrees NNS O
can MD O
be VB O
obtained VBN O
even RB O
when WRB O
taxon NN O
overlap NN O
is VBZ O
very RB O
sparse JJ O
( , O
see VB O
( : O
19 CD O
, , O
20 CD O
) -RRB- O
for IN O
reviews NNS O
) -RRB- O
. . O

Supertree NN O
analysis NN O
has VBZ O
thus RB O
become VBN O
increasingly RB O
popular JJ O
for IN O
taking VBG O
advantage NN O
and CC O
combining VBG O
the DT O
massive JJ O
amount NN O
of IN O
sequence NN O
data NNS O
available JJ O
in IN O
public JJ O
databases NNS O
for IN O
reconstructing VBG O
large JJ O
- HYPH O
scale NN O
organismal JJ O
phylogenies NNS O
with IN O
the DT O
ultimate JJ O
goal NN O
of IN O
building VBG O
the DT O
tree NN O
of IN O
life NN O
( : O
21 CD O
- SYM O
24 CD O
) -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
21 CD O
B NN B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
strains NNS O
that WDT O
have VBP O
been VBN O
completely RB O
sequenced VBN O
, , O
and CC O
for IN O
which WDT O
the DT O
sequences NNS O
at IN O
all DT O
26 CD O
MLST NNP O
loci NN O
are VBP O
thus RB O
available JJ O
, , O
can MD O
be VB O
used VBN O
to TO O
join VB O
all DT O
five CD O
schemes NNS O
and CC O
provide VB O
the DT O
strain NN O
overlap RB O
necessary JJ O
for IN O
supertree NN O
analysis NN O
. . O

The DT O
global JJ O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
supertree NN O
, , O
containing VBG O
1029 CD O
isolates NNS O
, , O
was VBD O
reconstructed VBN O
according VBG O
to IN O
the DT O
widely RB O
used VBN O
matrix NN O
representation NN O
by IN O
parsimony NN O
( , O
MRP NNP O
) -RRB- O
procedure NN O
( -LRB- O
Figure NNP O
1 CD O
; : O
( SYM O
19 CD O
, , O
25 CD O
, , O
26 CD O
) -RRB- O
) -RRB- O
. . O

Scheme NN O
- HYPH O
specific JJ O
supertrees NNS O
were VBD O
also RB O
reconstructed VBN O
for IN O
each DT O
of IN O
the DT O
five CD O
MLST NNP O
schemes NNS O
by IN O
the DT O
same JJ O
technique NN O
. . O

Briefly RB O
, , O
a DT O
phylogenetic JJ O
tree NN O
is VBZ O
built VBN O
for IN O
every DT O
gene NN O
separately RB O
by IN O
the DT O
maximum JJ O
likelihood NN O
method NN O
with IN O
the DT O
PHYML NNP O
_ HYPH O
aLRT NNP O
program NN O
( SYM O
27 CD O
) -RRB- O
. . O

Then RB O
, , O
each DT O
gene NN O
tree NN O
is VBZ O
recoded VBN O
into IN O
a DT O
binary JJ O
matrix NN O
representing VBG O
the DT O
branching NN O
order NN O
( : O
i PRP O
. . O
e -RRB- O
. . O
the DT O
phylogenetic JJ O
groupings NNS O
) , O
following VBG O
standard JJ O
MRP NNP O
coding NN O
using VBG O
the DT O
SuperMRP NNP O
. . O
pl NN O
script NN O
( SYM O
28 CD O
) -RRB- O
. . O

All DT O
gene NN O
tree NN O
matrices NNS O
are VBP O
concatenated VBN O
into IN O
a DT O
supermatrix NN O
, , O
in IN O
which WDT O
isolates NNS O
missing VBG O
from IN O
a DT O
particular JJ O
tree NN O
are VBP O
coded VBN O
using VBG O
the DT O
' '' O
? . O
' '' O
character NN O
representing VBG O
unknown JJ O
data NNS O
. . O

In IN O
this DT O
supermatrix NN O
, , O
the DT O
sequence NN O
of IN O
0 CD O
' '' O
s NNS O
, , O
1 CD O
' '' O
s NNS O
and CC O
? . O
' '' O
s VBZ O
defines VBZ O
the DT O
branching NN O
profile NN O
of IN O
a DT O
strain NN O
. . O

Closely RB O
related VBN O
strains NNS O
have VBP O
similar JJ O
branching NN O
profiles NNS O
. . O

Supertrees NNS O
are VBP O
then RB O
generated VBN O
from IN O
the DT O
supermatrix NN O
by IN O
the DT O
maximum JJ O
parsimony NN O
technique NN O
using VBG O
the DT O
program NN O
MIX NNP O
from IN O
the DT O
PHYLIP NNP O
package NN O
( : O
29 CD O
) -RRB- O
run VBN O
with IN O
default NN O
parameters NNS O
. . O

The DT O
maximum JJ O
parsimony NN O
step NN O
infers VBZ O
the DT O
trees NNS O
that WDT O
would MD O
require VB O
the DT O
minimum JJ O
number NN O
of IN O
changes NNS O
between IN O
the DT O
branching NN O
profiles NNS O
of IN O
all DT O
isolates NNS O
, , O
where WRB O
the DT O
unknown JJ O
characters NNS O
can MD O
take VB O
any DT O
of IN O
the DT O
two CD O
possible JJ O
states NNS O
0 CD O
or CC O
1 CD O
( : O
they PRP O
are VBP O
not RB O
treated VBN O
as IN O
missing VBG O
gaps NNS O
) -RRB- O
. . O

As IN O
many JJ O
trees NNS O
were VBD O
equally RB O
parsimonious JJ O
, , O
the DT O
final JJ O
supertree NN O
was VBD O
taken VBN O
as IN O
the DT O
strict JJ O
consensus NN O
of IN O
all DT O
parsimony NN O
trees NNS O
with IN O
the DT O
CONSENSE NNP O
program NN O
of IN O
PHYLIP NNP O
. . O

In IN O
order NN O
to TO O
obtain VB O
branch NN O
lengths NNS O
that WDT O
are VBP O
proportional JJ O
to IN O
the DT O
amount NN O
of IN O
nucleotide NN O
changes NNS O
, , O
we PRP O
added VBD O
an DT O
additional JJ O
step NN O
in IN O
which WDT O
branch NN O
lengths NNS O
and CC O
statistical JJ O
support NN O
for IN O
groupings NNS O
are VBP O
estimated VBN O
from IN O
the DT O
concatenated JJ O
sequences NNS O
by IN O
the DT O
maximum JJ O
likelihood NN O
method NN O
employing VBG O
approximate JJ O
likelihood NN O
- HYPH O
ratio NN O
tests NNS O
( , O
aLRTs NNS O
) -RRB- O
for IN O
branches NNS O
using VBG O
PHYML NNP O
_ : O
aLRT NNP O
with IN O
Shimodaira NNP O
- HYPH O
Hasegawa NNP O
- HYPH O
like JJ O
support NN O
values NNS O
( SYM O
27 CD O
, , O
30 CD O
) -RRB- O
. . O

aLRTs NNS O
provide VBP O
a DT O
fast JJ O
way NN O
of IN O
testing VBG O
branch NN O
support NN O
without IN O
requirement NN O
of IN O
multiple JJ O
replicates NNS O
like IN O
traditional JJ O
bootstrap NN O
procedures NNS O
. . O

The DT O
Felsenstein NNP O
- HYPH O
1984 CD O
nucleotide NN O
substitution NN O
model NN O
supplemented VBN O
with IN O
a DT O
gamma NN O
distribution NN O
( , O
F84 CD O
+ CC O
Gamma NNP O
) -RRB- O
was VBD O
used VBN O
in IN O
maximum JJ O
likelihood NN O
computations NNS O
for IN O
individual JJ O
gene NN O
trees NNS O
and CC O
the DT O
supertree NN O
( SYM O
31 CD O
) -RRB- O
. . O

This DT O
model NN O
allows VBZ O
for IN O
unequal JJ O
base NN O
frequencies NNS O
, , O
transition NN O
/ SYM O
transversion NN O
rate NN O
bias NN O
, , O
and CC O
gamma NN O
- HYPH O
distributed VBN O
substitution NN O
rate NN O
variation NN O
among IN O
sites NNS O
. . O

It PRP O
was VBD O
empirically RB O
chosen VBN O
as IN O
a DT O
consensus NN O
from IN O
exploratory JJ O
model NN O
testing NN O
using VBG O
ModelTest NNP O
( , O
32 CD O
, , O
33 CD O
) -RRB- O
, , O
which WDT O
indicated VBD O
that IN O
models NNS O
including VBG O
these DT O
three CD O
factors NNS O
were VBD O
most RBS O
appropriate JJ O
for IN O
the DT O
MLST NNP O
loci NN O
studied VBN O
, , O
although IN O
models NNS O
for IN O
individual JJ O
loci NN O
differed VBD O
slightly RB O
. . O

Note VB O
that IN O
the DT O
maximum JJ O
likelihood NN O
technique NN O
also RB O
allows VBZ O
for IN O
uneven JJ O
rates NNS O
of IN O
nucleotide NN O
substitution NN O
between IN O
strains NNS O
, , O
which WDT O
allows VBZ O
to TO O
accommodate VB O
slow JJ O
- HYPH O
and CC O
fast RB O
- HYPH O
evolving VBG O
isolates NNS O
. . O

To TO O
reduce VB O
the DT O
size NN O
of IN O
the DT O
binary JJ O
supermatrix NN O
and CC O
speed VB O
up RP O
computations NNS O
, , O
individual JJ O
gene NN O
trees NNS O
and CC O
the DT O
supertree NN O
were VBD O
built VBN O
using VBG O
only RB O
one CD O
representative NN O
from IN O
a DT O
set NN O
of IN O
strains NNS O
having VBG O
identical JJ O
sequences NNS O
. . O

The DT O
remaining VBG O
identical JJ O
isolates NNS O
were VBD O
graphically RB O
added VBN O
to IN O
the DT O
tree NN O
afterwards RB O
when WRB O
drawing VBG O
the DT O
final JJ O
supertree NN O
. . O

Figure NN O
1 CD O
. . O
Schematic JJ O
overview NN O
of IN O
the DT O
B NN B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
supertree NN O
reconstruction NN O
procedure NN O
using VBG O
Matrix NNP O
Representation NNP O
by IN O
Parsimony NNP O
( : O
MRP NNP O
) -RRB- O
. . O

See VB O
text NN O
for IN O
details NNS O
. . O

It PRP O
should MD O
be VB O
noted VBN O
that IN O
the DT O
global JJ O
1029 CD O
- HYPH O
strain NN O
supertree NN O
retains VBZ O
the DT O
phylogenetic JJ O
signals NNS O
from IN O
the DT O
individual JJ O
schemes NNS O
and CC O
contains VBZ O
the DT O
three CD O
main JJ O
clusters NNS O
of IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
population NN O
described VBN O
in IN O
the DT O
section NN O
' '' O
Introduction NN O
' '' O
. . O

The DT O
integrated VBN O
SuperCAT NNP O
system NN O
may MD O
also RB O
allow VB O
to TO O
infer VB O
new JJ O
relationships NNS O
between IN O
strains NNS O
that WDT O
were VBD O
analyzed VBN O
with IN O
different JJ O
gene NN O
sets NNS O
. . O

Even RB O
though IN O
the DT O
26 CD O
loci NN O
sequences NNS O
are VBP O
available JJ O
for IN O
only RB O
21 CD O
isolates NNS O
, , O
they PRP O
apparently RB O
provide VBP O
enough JJ O
overlap NN O
information NN O
for IN O
building VBG O
the DT O
main JJ O
branches NNS O
of IN O
the DT O
supertree NN O
. . O

These DT O
21 CD O
isolates NNS O
cover VBP O
all DT O
three CD O
clusters NNS O
, , O
although IN O
the DT O
majority NN O
of IN O
them PRP O
are VBP O
B NN B-Species
. . I-Species
anthracis NN I-Species
strains NNS O
or CC O
clinical JJ O
strains NNS O
closely RB O
related VBN O
to IN O
B NNP B-Species
. . I-Species
anthracis NN I-Species
due IN O
to IN O
the DT O
focus NN O
of IN O
genome NN O
sequencing NN O
projects NNS O
, , O
making VBG O
the DT O
part NN O
of IN O
the DT O
supertree NN O
containing VBG O
these DT O
isolates NNS O
likely JJ O
to TO O
be VB O
more RBR O
accurate JJ O
than IN O
the DT O
rest NN O
of IN O
the DT O
tree NN O
. . O

Furthermore RB O
, , O
111 CD O
other JJ O
isolates NNS O
have VBP O
been VBN O
typed VBN O
by IN O
10 CD O
genes NNS O
or CC O
more JJR O
, , O
providing VBG O
additional JJ O
overlap NN O
( , O
see VB O
the DT O
' `` O
Gene NNP O
Distribution NN O
' '' O
page NN O
) -RRB- O
. . O

Although IN O
about RB O
two CD O
- HYPH O
thirds NNS O
of IN O
the DT O
sequence NN O
data NNS O
are VBP O
missing VBG O
overall RB O
, , O
it PRP O
has VBZ O
been VBN O
shown VBN O
for IN O
other JJ O
organisms NNS O
that IN O
relevant JJ O
supertrees NNS O
could MD O
be VB O
reconstructed VBN O
with IN O
datasets NNS O
containing VBG O
more JJR O
than IN O
90 CD O
% NN O
of IN O
missing VBG O
data NNS O
, , O
especially RB O
when WRB O
the DT O
characters NNS O
that WDT O
are VBP O
present JJ O
are VBP O
informative JJ O
( , O
20 CD O
, , O
22 CD O
, , O
23 CD O
, , O
34 CD O
) -RRB- O
. . O

Empirical JJ O
and CC O
simulation NN O
studies NNS O
have VBP O
indicated VBN O
that IN O
this DT O
behavior NN O
may MD O
be VB O
due IN O
to IN O
the DT O
fact NN O
that IN O
the DT O
characters NNS O
which WDT O
are VBP O
present JJ O
are VBP O
more RBR O
important JJ O
for IN O
the DT O
tree NN O
- HYPH O
building NN O
process NN O
than IN O
those DT O
which WDT O
are VBP O
absent JJ O
( , O
see VB O
( : O
20 CD O
, , O
34 CD O
) -RRB- O
and CC O
references NNS O
therein RB O
) -RRB- O
. . O

Precise JJ O
within IN O
- HYPH O
cluster NN O
groupings NNS O
may MD O
contain VB O
more JJR O
uncertainty NN O
, , O
as IN O
indicated VBN O
by IN O
the DT O
large JJ O
number NN O
of IN O
unresolved JJ O
multifurcations NNS O
in IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
supertree NN O
. . O

Finally RB O
, , O
it PRP O
is VBZ O
also RB O
worth JJ O
mentioning VBG O
that IN O
the DT O
branching NN O
orders NNS O
of IN O
the DT O
scheme NN O
- HYPH O
specific JJ O
MRP NNP O
supertrees NNS O
are VBP O
highly RB O
correlated VBN O
to IN O
those DT O
of IN O
the DT O
published VBN O
trees NNS O
built VBN O
with IN O
concatenated JJ O
sequences NNS O
and CC O
other JJ O
phylogenetic JJ O
algorithms NNS O
. . O

DATA NN O
ACCESS NN O
AND CC O
MANIPULATION NN O

The DT O
complete JJ O
list NN O
of IN O
isolates NNS O
included VBN O
in IN O
SuperCAT NNP O
( , O
currently RB O
1029 CD O
) -RRB- O
with IN O
strain NN O
description NN O
, , O
source NN O
and CC O
country NN O
of IN O
origin NN O
is VBZ O
available JJ O
at IN O
the DT O
database NN O
home NN O
page NN O
. . O

By IN O
default NN O
all DT O
isolates NNS O
in IN O
the DT O
database NN O
are VBP O
used VBN O
in IN O
the DT O
analysis NN O
tools NNS O
provided VBN O
, , O
but CC O
the DT O
user NN O
can MD O
select VB O
strains NNS O
of IN O
interest NN O
by IN O
keywords NNS O
, , O
MLST NNP O
scheme NN O
, , O
entering VBG O
a DT O
list NN O
of IN O
strain NN O
identifiers NNS O
, , O
or CC O
choosing VBG O
isolates NNS O
individually RB O
via IN O
checkboxes NNS O
. . O

All DT O
subsequent JJ O
analyses NNS O
will MD O
be VB O
based VBN O
on IN O
the DT O
selected VBN O
strain NN O
subset NN O
and CC O
their PRP$ O
loci NN O
. . O

The DT O
keyword NN O
search NN O
will MD O
look VB O
for IN O
matches NNS O
in IN O
any DT O
of IN O
the DT O
strain NN O
, , O
description NN O
, , O
source NN O
, , O
location NN O
and CC O
scheme NN O
fields NNS O
. . O

Complex JJ O
keyword NN O
queries NNS O
with IN O
several JJ O
logical JJ O
operators NNS O
can MD O
be VB O
formulated VBN O
in IN O
the DT O
' `` O
advanced JJ O
search NN O
' '' O
page NN O
. . O

Note VB O
that IN O
many JJ O
isolates NNS O
were VBD O
referred VBN O
by IN O
alternative JJ O
names NNS O
in IN O
different JJ O
MLST NNP O
schemes NNS O
and CC O
publications NNS O
, , O
therefore RB O
synonyms NNS O
have VBP O
been VBN O
included VBN O
in IN O
the DT O
strain NN O
descriptions NNS O
that WDT O
allow VBP O
a DT O
particular JJ O
isolate NN O
to TO O
be VB O
looked VBN O
up IN O
using VBG O
any DT O
of IN O
its PRP$ O
alternative JJ O
identifiers NNS O
. . O

A DT O
sequence NN O
search NN O
is VBZ O
also RB O
possible JJ O
using VBG O
BLASTN NNP O
( -LRB- O
35 CD O
) -RRB- O
, , O
in IN O
order NN O
to TO O
select VB O
isolates NNS O
that WDT O
have VBP O
allele NN O
sequences NNS O
identical JJ O
to IN O
user NN O
- HYPH O
entered VBN O
query NN O
sequences NNS O
. . O

Throughout IN O
SuperCAT NNP O
, , O
clicking VBG O
on IN O
a DT O
strain NN O
name NN O
will MD O
pop VB O
up RP O
an DT O
isolate NN O
- HYPH O
specific JJ O
window NN O
showing VBG O
all DT O
relevant JJ O
information NN O
and CC O
giving VBG O
access NN O
to IN O
the DT O
nucleotide JJ O
sequences NNS O
of IN O
individual JJ O
loci NN O
for IN O
that DT O
isolate NN O
. . O

Detailed JJ O
information NN O
about IN O
the DT O
MLST NNP O
schemes NNS O
( , O
e LS O
. . O
g LS O
. . O
loci NN O
names NNS O
and CC O
lengths NNS O
, , O
genomic JJ O
coordinates NNS O
, , O
literature NN O
references NNS O
) -RRB- O
and CC O
their PRP$ O
overlap NN O
, , O
the DT O
distribution NN O
of IN O
available JJ O
loci NN O
among IN O
the DT O
isolates NNS O
, , O
and CC O
the DT O
supertree NN O
reconstruction NN O
procedure NN O
can MD O
be VB O
obtained VBN O
by IN O
clicking VBG O
the DT O
relevant JJ O
links NNS O
in IN O
the DT O
header NN O
line NN O
present JJ O
at IN O
the DT O
top NN O
of IN O
every DT O
page NN O
. . O

Apart RB O
from IN O
the DT O
basic JJ O
functions NNS O
for IN O
selecting VBG O
and CC O
accessing VBG O
strain NN O
information NN O
and CC O
sequence NN O
data NNS O
for IN O
all DT O
five CD O
B NN B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
MLST NNP O
schemes NNS O
, , O
the DT O
main JJ O
features NNS O
of IN O
SuperCAT NNP O
relate VBP O
to IN O
the DT O
manipulation NN O
of IN O
the DT O
supertrees NNS O
constructed VBN O
by IN O
the DT O
MRP NNP O
approach NN O
. . O

The DT O
global JJ O
supertree NN O
based VBN O
on IN O
the DT O
combination NN O
of IN O
all DT O
five CD O
B NN B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
MLST NNP O
schemes NNS O
as RB O
well RB O
as IN O
the DT O
five CD O
scheme NN O
- HYPH O
specific JJ O
supertrees NNS O
can MD O
be VB O
browsed VBN O
according VBG O
to IN O
various JJ O
user NN O
- HYPH O
chosen VBN O
criteria NNS O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
. . O

Isolates NNS O
in IN O
the DT O
supertrees NNS O
can MD O
be VB O
colored VBN O
by IN O
species NNS O
or CC O
source NN O
of IN O
isolation NN O
. . O

It PRP O
is VBZ O
also RB O
possible JJ O
to TO O
specifically RB O
mark VB O
in IN O
red JJ O
the DT O
current JJ O
subset NN O
of IN O
strains NNS O
that WDT O
has VBZ O
been VBN O
selected VBN O
by IN O
the DT O
user NN O
and CC O
to TO O
extract VB O
from IN O
the DT O
supertrees NNS O
the DT O
subtree NN O
containing VBG O
only RB O
those DT O
isolates NNS O
. . O

In IN O
the DT O
case NN O
of IN O
the DT O
multi JJ O
- HYPH O
scheme NN O
supertree NN O
highlighting NN O
of IN O
the DT O
strains NNS O
can MD O
be VB O
based VBN O
on IN O
genetic JJ O
distance NN O
. . O

With IN O
this DT O
option NN O
the DT O
user NN O
can MD O
mark VB O
on IN O
and CC O
/ SYM O
or CC O
extract VB O
from IN O
the DT O
tree NN O
the DT O
isolates NNS O
that WDT O
are VBP O
genetically RB O
closely RB O
related VBN O
to IN O
strains NNS O
of IN O
her PRP O
/ SYM O
his PRP$ O
choice NN O
. . O

The DT O
user NN O
can MD O
either CC O
select VB O
strains NNS O
that WDT O
share VBP O
one CD O
or CC O
several JJ O
identical JJ O
allele JJ O
sequences NNS O
with IN O
her PRP$ O
/ SYM O
his PRP$ O
query NN O
isolate NN O
( , O
s LS O
) -RRB- O
or CC O
that WDT O
are VBP O
at IN O
a DT O
specified VBN O
genetic JJ O
distance NN O
. . O

Distances NNS O
between IN O
isolates NNS O
are VBP O
computed VBN O
by IN O
summing VBG O
up RP O
the DT O
lengths NNS O
of IN O
the DT O
branches NNS O
( , O
in IN O
average JJ O
number NN O
of IN O
nucleotide NN O
substitutions NNS O
per IN O
site NN O
) -RRB- O
connecting VBG O
the DT O
isolates NNS O
in IN O
the DT O
supertree NN O
( , O
known VBN O
as IN O
patristic JJ O
distances NNS O
; : O
( , O
36 CD O
) -RRB- O
) -RRB- O
. . O

The DT O
genetic JJ O
relatedness NN O
search NN O
functions NNS O
are VBP O
also RB O
available JJ O
in IN O
a DT O
separate JJ O
page NN O
for IN O
the DT O
user NN O
to TO O
find VB O
closely RB O
related VBN O
isolates NNS O
without IN O
tree NN O
manipulation NN O
. . O

SuperCAT NNP O
allows VBZ O
to TO O
compare VB O
the DT O
scheme NN O
- HYPH O
specific JJ O
MLST NNP O
supertrees NNS O
with IN O
each DT O
other JJ O
and CC O
with IN O
the DT O
global JJ O
supertree NN O
by IN O
using VBG O
the DT O
subset NN O
of IN O
isolates NNS O
that WDT O
are VBP O
common JJ O
to IN O
all DT O
selected VBN O
schemes NNS O
. . O

Common JJ O
isolates NNS O
can MD O
either CC O
be VB O
highlighted VBN O
in IN O
red JJ O
or CC O
be VB O
extracted VBN O
as IN O
subtrees NNS O
from IN O
each DT O
supertree NN O
, , O
which WDT O
can MD O
be VB O
used VBN O
for IN O
comparing VBG O
the DT O
positions NNS O
of IN O
the DT O
common JJ O
strains NNS O
in IN O
the DT O
various JJ O
MLST NNP O
trees NNS O
. . O

For IN O
all DT O
supertree NN O
- HYPH O
related VBN O
options NNS O
, , O
detailed JJ O
tree NN O
navigation NN O
can MD O
be VB O
achieved VBN O
using VBG O
the DT O
various JJ O
functions NNS O
in IN O
the DT O
ATV NNP O
tree NN O
window NN O
when WRB O
the DT O
trees NNS O
are VBP O
displayed VBN O
( SYM O
17 CD O
) -RRB- O
. . O

Figure NN O
2 CD O
. . O
Examples NNS O
of IN O
supertree NN O
browsing NN O
and CC O
manipulation NN O
in IN O
SuperCAT NNP O
. . O

A DT O
, , O
supertree NN O
colored VBN O
by IN O
species NNS O
; : O
B NN O
, , O
specific JJ O
highlighting NN O
of IN O
user NN O
- HYPH O
selected VBN O
strains NNS O
( , O
in IN O
red JJ O
) -RRB- O
; , O
C NNP O
, , O
extracted VBN O
subtree NN O
containing VBG O
only RB O
the DT O
strains NNS O
highlighted VBN O
in IN O
B NNP O
. . O

Trees NNS O
are VBP O
displayed VBN O
using VBG O
ATV NNP O
( SYM O
17 CD O
) -RRB- O
. . O

Besides IN O
the DT O
manipulation NN O
of IN O
the DT O
precomputed VBN O
supertrees NNS O
, , O
SuperCAT NNP O
offers VBZ O
the DT O
user NN O
the DT O
possibility NN O
to TO O
compute VB O
new JJ O
supertrees NNS O
by IN O
MRP NNP O
using VBG O
any DT O
combination NN O
of IN O
strains NNS O
, , O
schemes NNS O
and CC O
genes NNS O
. . O

Supertree NN O
computations NNS O
may MD O
be VB O
extremely RB O
time NN O
consuming VBG O
, , O
ranging VBG O
from IN O
a DT O
few JJ O
minutes NNS O
to IN O
2 CD O
- SYM O
3 CD O
days NNS O
with IN O
the DT O
complete JJ O
database NN O
. . O

Users NNS O
are VBP O
therefore RB O
requested VBN O
to TO O
enter VB O
their PRP$ O
e NN O
- HYPH O
mail NN O
addresses NNS O
and CC O
will MD O
receive VB O
a DT O
notification NN O
containing VBG O
a DT O
link NN O
to IN O
the DT O
results NNS O
page NN O
when WRB O
the DT O
supertree NN O
is VBZ O
ready JJ O
. . O

Note VB O
that IN O
when WRB O
building VBG O
a DT O
supertree NN O
for IN O
a DT O
user NN O
- HYPH O
selected VBN O
subset NN O
of IN O
strains NNS O
, , O
the DT O
computation NN O
will MD O
first RB O
include VB O
all DT O
database NN O
isolates NNS O
. . O

A DT O
subtree NN O
containing VBG O
only RB O
the DT O
user NN O
- HYPH O
selected VBN O
isolates NNS O
will MD O
then RB O
be VB O
extracted VBN O
from IN O
the DT O
supertree NN O
of IN O
all DT O
strains NNS O
. . O

Although IN O
more JJR O
time NN O
consuming VBG O
, , O
this DT O
strategy NN O
allows VBZ O
: : O
( : O
i PRP O
) -RRB- O
to TO O
avoid VB O
sampling VBG O
artefacts NNS O
as IN O
phylogenies NNS O
built VBN O
with IN O
different JJ O
isolate NN O
sets NNS O
may MD O
vary VB O
and CC O
( , O
ii FW O
) -RRB- O
to TO O
obtain VB O
relationships NNS O
even RB O
if IN O
the DT O
selected VBN O
isolates NNS O
have VBP O
been VBN O
typed VBN O
using VBG O
non AFX O
- HYPH O
overlapping VBG O
gene NN O
sets NNS O
, , O
as IN O
the DT O
supertree NN O
of IN O
all DT O
isolates NNS O
can MD O
always RB O
be VB O
built VBN O
owing VBG O
to IN O
the DT O
completely RB O
sequenced VBN O
strains NNS O
that WDT O
are VBP O
common JJ O
to IN O
all DT O
schemes NNS O
. . O

Another DT O
main JJ O
feature NN O
of IN O
the DT O
SuperCAT NNP O
database NN O
is VBZ O
that IN O
the DT O
user NN O
can MD O
enter VB O
her PRP$ O
/ SYM O
his PRP$ O
own JJ O
private JJ O
sequences NNS O
and CC O
conduct VB O
several JJ O
sequence NN O
analyses NNS O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
. . O

These DT O
analyses NNS O
include VBP O
: : O
( : O
a DT O
) -RRB- O
building VBG O
new JJ O
supertrees NNS O
containing VBG O
user NN O
isolates NNS O
and CC O
sequences NNS O
; : O
( , O
b NN O
) -RRB- O
finding NN O
database NN O
isolates NNS O
having VBG O
sequences NNS O
most RBS O
similar JJ O
to IN O
the DT O
user NN O
' POS O
s NNS O
query NN O
sequences NNS O
using VBG O
an DT O
on IN O
- HYPH O
line NN O
BLASTN NNP O
( -LRB- O
35 CD O
) -RRB- O
service NN O
; : O
and CC O
( : O
c NN O
) -RRB- O
aligning VBG O
user NN O
sequences NNS O
to IN O
database NN O
genes NNS O
using VBG O
the DT O
multiple JJ O
sequence NN O
alignment NN O
program NN O
CLUSTALW NNP O
( SYM O
37 CD O
) -RRB- O
. . O

For IN O
the DT O
last JJ O
option NN O
, , O
the DT O
Jalview NNP O
editor NN O
( , O
18 CD O
) -RRB- O
is VBZ O
provided VBN O
for IN O
advanced JJ O
multiple JJ O
alignment NN O
display NN O
. . O

All DT O
user NN O
- HYPH O
entered VBN O
data NNS O
must MD O
be VB O
in IN O
FASTA NNP O
format NN O
and CC O
can MD O
be VB O
either CC O
copied VBN O
and CC O
pasted VBN O
into IN O
the DT O
query NN O
forms NNS O
or CC O
uploaded VBN O
from IN O
text NN O
files NNS O
stored VBN O
locally RB O
on IN O
the DT O
user NN O
' POS O
s NNS O
computer NN O
. . O

Figure NN O
3 CD O
. . O
Examples NNS O
of IN O
query NN O
results NNS O
in IN O
SuperCAT NNP O
. . O

A DT O
, , O
multi JJ O
- HYPH O
scheme NN O
BLAST NN O
search NN O
with IN O
sequence NN O
alignment NN O
; : O
B NN O
, , O
multi JJ O
- HYPH O
scheme NN O
genetic JJ O
search NN O
showing VBG O
the DT O
list NN O
of IN O
isolates NNS O
sharing VBG O
one CD O
or CC O
more JJR O
sequences NNS O
with IN O
a DT O
query NN O
strain NN O
; : O
C NN O
, , O
multiple JJ O
sequence NN O
alignment NN O
using VBG O
Jalview NNP O
( HYPH O
18 CD O
) -RRB- O
. . O

All DT O
strain NN O
information NN O
data NNS O
, , O
sequences NNS O
and CC O
phylogenetic JJ O
trees NNS O
, , O
including VBG O
user NN O
- HYPH O
made VBN O
supertrees NNS O
and CC O
extracted VBN O
subtrees NNS O
, , O
can MD O
be VB O
saved VBN O
and CC O
downloaded VBN O
freely RB O
from IN O
the DT O
database NN O
. . O

Users NNS O
wishing VBG O
to TO O
have VB O
their PRP$ O
MLST NNP O
data NNS O
included VBN O
as IN O
part NN O
of IN O
the DT O
SuperCAT NNP O
release NN O
( : O
and CC O
/ SYM O
or CC O
the DT O
Tourasse NNP O
- HYPH O
Helgason NNP O
scheme NN O
- HYPH O
specific JJ O
database NN O
) -RRB- O
are VBP O
welcome JJ O
to TO O
contact VB O
N NNP O
. . O
J NNP O
. . O
T NNP O
. . O
or CC O
A NN O
. . O
- HYPH O
B NN O
. . O
K NN O
. . O
at IN O
the DT O
e JJ O
- HYPH O
mail NN O
addresses NNS O
given VBN O
on IN O
the DT O
Oslo NNP O
MLST NNP O
server NN O
front JJ O
page NN O
. . O

DISCUSSION NN O
AND CC O
FUTURE JJ O
DEVELOPMENTS NNS O

SuperCAT NNP O
is VBZ O
a DT O
newly RB O
created VBN O
database NN O
devoted VBN O
to IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
of IN O
bacteria NNS O
whose WP$ O
main JJ O
objectives NNS O
are VBP O
to TO O
provide VB O
a DT O
common JJ O
MLST NN O
repository NN O
and CC O
means NNS O
for IN O
building VBG O
a DT O
comprehensive JJ O
genetic JJ O
analysis NN O
of IN O
the DT O
group NN O
that WDT O
has VBZ O
been VBN O
typed VBN O
by IN O
five CD O
separate JJ O
schemes NNS O
. . O

The DT O
database NN O
is VBZ O
publicly RB O
and CC O
freely RB O
available JJ O
at IN O
http JJ O
: : O
/ NFP O
/ NFP O
mlstoslo ADD O
. . O
uio NNP O
. . O
no UH O
/ , O
, , O
along IN O
with IN O
the DT O
database NN O
specific NN O
for IN O
the DT O
combined VBN O
scheme NN O
of IN O
( : O
5 CD O
) -RRB- O
. . O

We PRP O
plan VBP O
to TO O
update VB O
SuperCAT NNP O
quarterly RB O
. . O

Future JJ O
developments NNS O
of IN O
the DT O
database NN O
may MD O
deal VB O
with IN O
refining VBG O
the DT O
supertree NN O
- HYPH O
building VBG O
procedure NN O
. . O

In IN O
particular JJ O
, , O
a DT O
new JJ O
improved JJ O
method NN O
has VBZ O
recently RB O
been VBN O
developed VBN O
for IN O
taking VBG O
into IN O
account NN O
both CC O
nucleotide NN O
substitutions NNS O
and CC O
recombination NN O
events NNS O
in IN O
phylogenies NNS O
, , O
as IN O
part NN O
of IN O
the DT O
ClonalFrame NNP O
software NN O
, , O
which WDT O
has VBZ O
been VBN O
applied VBN O
to IN O
the DT O
B NNP B-Species
. . I-Species
cereus NNP I-Species
group NN I-Species
and CC O
the DT O
Priest NNP O
scheme NN O
( : O
38 CD O
) -RRB- O
. . O

It PRP O
would MD O
therefore RB O
be VB O
of IN O
interest NN O
to TO O
examine VB O
the DT O
suitability NN O
of IN O
ClonalFrame NNP O
in IN O
the DT O
supertree NN O
context NN O
. . O

It PRP O
is VBZ O
also RB O
tempting JJ O
to TO O
extend VB O
the DT O
supertree NN O
analysis NN O
beyond IN O
MLST NNP O
data NNS O
, , O
by IN O
incorporating VBG O
the DT O
phylogenies NNS O
obtained VBN O
previously RB O
from IN O
large JJ O
- HYPH O
scale NN O
multilocus NN O
enzyme NN O
electrophoresis NN O
( , O
MLEE NNP O
; : O
( , O
3 CD O
, , O
39 CD O
- HYPH O
41 CD O
) -RRB- O
) -RRB- O
and CC O
amplified VBN O
fragment NN O
length NN O
polymorphism NN O
( , O
AFLP NNP O
; : O
( : O
42 CD O
- HYPH O
45 CD O
) -RRB- O
) -RRB- O
studies NNS O
. . O

The DT O
MRP NNP O
framework NN O
is VBZ O
ideal JJ O
since IN O
it PRP O
allows VBZ O
to TO O
integrate VB O
trees NNS O
that WDT O
can MD O
be VB O
built VBN O
from IN O
different JJ O
methods NNS O
and CC O
data NNS O
. . O

As IN O
MLEE NNP O
, , O
AFLP NNP O
and CC O
MLST NNP O
have VBP O
different JJ O
levels NNS O
of IN O
resolution NN O
, , O
one PRP O
can MD O
hope VB O
that IN O
combining VBG O
them PRP O
might MD O
provide VB O
an DT O
even RB O
more RBR O
robust JJ O
supertree NN O
for IN O
the DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
. . O

Discovery NN O
of IN O
genes NNS O
implicated VBN O
in IN O
whirling VBG O
disease NN O
infection NN O
and CC O
resistance NN O
in IN O
rainbow NN B-Species
trout NN I-Species
using VBG O
genome NN O
- HYPH O
wide JJ O
expression NN O
profiling NN O

Abstract JJ O

Background NN O

Whirling VBG O
disease NN O
, , O
caused VBN O
by IN O
the DT O
pathogen NN O
Myxobolus NNP B-Species
cerebralis NN I-Species
, , O
afflicts VBZ O
several JJ O
salmonid NN O
species NNS O
. . O

Rainbow NN B-Species
trout NN I-Species
are VBP O
particularly RB O
susceptible JJ O
and CC O
may MD O
suffer VB O
high JJ O
mortality NN O
rates NNS O
. . O

The DT O
disease NN O
is VBZ O
persistent JJ O
and CC O
spreading VBG O
in IN O
hatcheries NNS O
and CC O
natural JJ O
waters NNS O
of IN O
several JJ O
countries NNS O
, , O
including VBG O
the DT O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
, , O
and CC O
the DT O
economic JJ O
losses NNS O
attributed VBN O
to IN O
whirling VBG O
disease NN O
are VBP O
substantial JJ O
. . O

In IN O
this DT O
study NN O
, , O
genome NN O
- HYPH O
wide JJ O
expression NN O
profiling NN O
using VBG O
cDNA NN O
microarrays NNS O
was VBD O
conducted VBN O
for IN O
resistant JJ O
Hofer NNP O
and CC O
susceptible JJ O
Trout NNP O
Lodge NNP O
rainbow NN B-Species
trout NN I-Species
strains NNS O
following VBG O
pathogen NN O
exposure NN O
with IN O
the DT O
primary JJ O
objective NN O
of IN O
identifying VBG O
specific JJ O
genes NNS O
implicated VBN O
in IN O
whirling VBG O
disease NN O
resistance NN O
. . O

Results NNS O

Several JJ O
genes NNS O
were VBD O
significantly RB O
up RB O
- HYPH O
regulated VBN O
in IN O
skin NN O
following VBG O
pathogen NN O
exposure NN O
for IN O
both CC O
the DT O
resistant JJ O
and CC O
susceptible JJ O
rainbow NN B-Species
trout NN I-Species
strains NNS O
. . O

For IN O
both DT O
strains NNS O
, , O
response NN O
to IN O
infection NN O
appears VBZ O
to TO O
be VB O
linked VBN O
with IN O
the DT O
interferon NN O
system NN O
. . O

Expression NN O
profiles NNS O
for IN O
three CD O
genes NNS O
identified VBN O
with IN O
microarrays NNS O
were VBD O
confirmed VBN O
with IN O
qRT NNP O
- HYPH O
PCR NNP O
. . O

Ubiquitin NN O
- HYPH O
like JJ O
protein NN O
1 CD O
was VBD O
up RB O
- HYPH O
regulated VBN O
over IN O
100 CD O
fold NN O
and CC O
interferon NN O
regulating VBG O
factor NN O
1 CD O
was VBD O
up RB O
- HYPH O
regulated VBN O
over IN O
15 CD O
fold NN O
following VBG O
pathogen NN O
exposure NN O
for IN O
both DT O
strains NNS O
. . O

Expression NN O
of IN O
metallothionein NN O
B NN O
, , O
which WDT O
has VBZ O
known VBN O
roles NNS O
in IN O
inflammation NN O
and CC O
immune JJ O
response NN O
, , O
was VBD O
up RB O
- HYPH O
regulated VBN O
over IN O
5 CD O
fold NN O
in IN O
the DT O
resistant JJ O
Hofer NNP O
strain NN O
but CC O
was VBD O
unchanged JJ O
in IN O
the DT O
susceptible JJ O
Trout NNP O
Lodge NNP O
strain NN O
following VBG O
pathogen NN O
exposure NN O
. . O

Conclusion NN O

The DT O
present JJ O
study NN O
has VBZ O
provided VBN O
an DT O
initial JJ O
view NN O
into IN O
the DT O
genetic JJ O
basis NN O
underlying VBG O
immune JJ O
response NN O
and CC O
resistance NN O
of IN O
rainbow NN B-Species
trout NN I-Species
to IN O
the DT O
whirling VBG O
disease NN O
parasite NN O
. . O

The DT O
identified VBN O
genes NNS O
have VBP O
allowed VBN O
us PRP O
to TO O
gain VB O
insight NN O
into IN O
the DT O
molecular JJ O
mechanisms NNS O
implicated VBN O
in IN O
salmonid JJ O
immune JJ O
response NN O
and CC O
resistance NN O
to IN O
whirling VBG O
disease NN O
infection NN O
. . O

Background NN O

Whirling VBG O
disease NN O
was VBD O
first RB O
described VBN O
among IN O
farmed VBN O
rainbow NN B-Species
trout NN I-Species
( , O
Oncorhynchus NNP B-Species
mykiss NNP I-Species
) -RRB- O
, , O
a DT O
native JJ O
North JJ O
American JJ O
salmonid NN O
species NN O
, , O
introduced VBN O
to IN O
Germany NNP O
as IN O
a DT O
food NN O
fish NN O
in IN O
the DT O
late JJ O
1800s NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Whirling VBG O
disease NN O
is VBZ O
associated VBN O
with IN O
systemic JJ O
infections NNS O
by IN O
the DT O
myxozoan NN O
Myxobolus NNP B-Species
cerebralis NN I-Species
, , O
a DT O
parasite NN O
with IN O
presumed VBN O
origins NNS O
among IN O
salmonid NN O
fish NN O
in IN O
Eurasia NNP O
[ -LRB- O
2 CD O
, , O
3 CD O
] -RRB- O
. . O

Rainbow NN B-Species
trout NN I-Species
are VBP O
highly RB O
susceptible JJ O
to IN O
whirling VBG O
disease NN O
and CC O
the DT O
introduction NN O
of IN O
the DT O
parasite NN O
to IN O
the DT O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
in IN O
the DT O
1950s CD O
had VBD O
immediate JJ O
economic JJ O
impacts NNS O
on IN O
salmonid JJ O
hatcheries NNS O
in IN O
both DT O
eastern JJ O
and CC O
western JJ O
states NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

The DT O
parasite NN O
has VBZ O
a DT O
broad JJ O
worldwide JJ O
distribution NN O
and CC O
has VBZ O
been VBN O
identified VBN O
in IN O
25 CD O
states NNS O
in IN O
the DT O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
where WRB O
salmonid NN O
fish NN O
are VBP O
present JJ O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Salmonid NN O
hatcheries NNS O
throughout IN O
the DT O
U NNP O
. . O
S NNP O
. . O
A NNP O
have VBP O
suffered VBN O
drastic JJ O
economic JJ O
losses NNS O
due IN O
to IN O
whirling VBG O
disease NN O
outbreaks NNS O
. . O

The DT O
disease NN O
has VBZ O
more RBR O
recently RB O
been VBN O
recognized VBN O
as IN O
the DT O
principal JJ O
cause NN O
of IN O
major JJ O
population NN O
declines NNS O
among IN O
wild JJ O
rainbow NN B-Species
trout NN I-Species
populations NNS O
in IN O
the DT O
intermountain JJ O
region NN O
of IN O
the DT O
U NNP O
. . O
S NNP O
. . O
A DT O
with IN O
serious JJ O
negative JJ O
impacts NNS O
on IN O
sportfishing NN O
and CC O
allied JJ O
industries NNS O
[ -LRB- O
5 CD O
- SYM O
7 CD O
] -RRB- O
. . O

Additionally RB O
, , O
concerns NNS O
continue VBP O
over IN O
the DT O
potential JJ O
negative JJ O
ecologic JJ O
impacts NNS O
of IN O
whirling VBG O
disease NN O
on IN O
wild JJ O
salmonid NN O
populations NNS O
, , O
particularly RB O
threatened VBN O
or CC O
endangered JJ O
salmonids NNS O
such JJ O
as IN O
bull NN B-Species
trout NN I-Species
( , O
Salvelinus NNP B-Species
confluentus NN I-Species
) -RRB- O
, , O
cutthroat JJ B-Species
trout NN I-Species
( , O
Oncorhynchus NNP B-Species
clarki NN I-Species
) -RRB- O
, , O
and CC O
steelhead NN B-Species
( , O
Oncorhynchus NNP B-Species
mykiss NNP I-Species
) -RRB- O
[ -LRB- O
8 CD O
, , O
9 CD O
] -RRB- O
. . O

Myxobolus NNP B-Species
cerebralis NN I-Species
has VBZ O
a DT O
complex JJ O
life NN O
cycle NN O
that WDT O
includes VBZ O
two CD O
alternate JJ O
hosts NNS O
, , O
a DT O
salmonid NN O
fish NN O
and CC O
an DT O
oligochaete NN O
worm NN O
, , O
Tubifex NNP B-Species
tubifex NN I-Species
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
. . O

Infection NN O
in IN O
the DT O
salmonid NN O
host NN O
begins VBZ O
when WRB O
microscopic JJ O
waterborne NN O
actinospore NN O
stages NNS O
of IN O
M NNP B-Species
. . I-Species
cerebralis NN I-Species
are VBP O
released VBN O
from IN O
the DT O
worm NN O
and CC O
contact VBP O
the DT O
skin NN O
of IN O
the DT O
fish NN O
host NN O
. . O

Actinospores NNP O
, , O
also RB O
referred VBD O
to IN O
as IN O
triactinomyxons NNS O
for IN O
M NNP B-Species
. . I-Species
cerebralis NN I-Species
, , O
attach VBP O
preferentially RB O
to IN O
fins NNS O
and CC O
the DT O
buccal JJ O
cavity NN O
where WRB O
they PRP O
release VBP O
one CD O
or CC O
more JJR O
of IN O
three CD O
coiled VBN O
polar JJ O
filaments NNS O
which WDT O
penetrate VBP O
and CC O
then RB O
anchor VBP O
them PRP O
to IN O
the DT O
epidermis NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Within IN O
minutes NNS O
the DT O
sporoplasm NN O
, , O
which WDT O
contains VBZ O
64 CD O
internal JJ O
cells NNS O
, , O
migrates VBZ O
from IN O
the DT O
triactinomxyon NN O
to IN O
deeper JJR O
layers NNS O
of IN O
the DT O
epidermis NN O
, , O
an DT O
action NN O
that WDT O
may MD O
be VB O
facilitated VBN O
by IN O
parasite NN O
proteases NNS O
[ -LRB- O
13 CD O
- SYM O
15 CD O
] -RRB- O
. . O

Aggregates NNS O
and CC O
single JJ O
cells NNS O
from IN O
the DT O
sporoplasm NN O
then RB O
begin VBP O
mitotic JJ O
replication NN O
within IN O
two CD O
h NN O
of IN O
initial JJ O
infection NN O
, , O
alternating VBG O
between IN O
inter JJ O
and CC O
intracellular JJ O
locations NNS O
, , O
a DT O
process NN O
that WDT O
may MD O
also RB O
depend VB O
upon IN O
parasite NN O
coded VBN O
protease NN O
activity NN O
[ -LRB- O
15 CD O
, , O
16 CD O
] -RRB- O
. . O

Over IN O
the DT O
next JJ O
10 CD O
h NN O
at IN O
water NN O
temperatures NNS O
of IN O
15 CD O
degrees NNS O
C NN O
, , O
parasites NNS O
within IN O
host NN O
epithelial JJ O
cells NNS O
further RB O
divide VBP O
by IN O
the DT O
process NN O
of IN O
endogeny NN O
or CC O
cell NN O
within IN O
cell NN O
replication NN O
prior RB O
to IN O
release NN O
and CC O
then RB O
penetration NN O
of IN O
new JJ O
host NN O
cells NNS O
. . O

Between IN O
12 CD O
and CC O
20 CD O
h CD O
post NN O
infection NN O
, , O
the DT O
number NN O
of IN O
parasite NN O
cells NNS O
present JJ O
in IN O
the DT O
epidermis NN O
steadily RB O
declines VBZ O
until IN O
new JJ O
stages NNS O
are VBP O
observed VBN O
in IN O
the DT O
subcutis NN O
at IN O
48 CD O
h NN O
. . O

Degenerative JJ O
stages NNS O
observed VBN O
in IN O
the DT O
epidermis NN O
between IN O
12 CD O
and CC O
20 CD O
h NN O
are VBP O
suspected VBN O
to TO O
be VB O
a DT O
result NN O
of IN O
the DT O
action NN O
of IN O
the DT O
host NN O
immune JJ O
response NN O
, , O
although IN O
the DT O
cellular JJ O
and CC O
or CC O
humoral JJ O
factors NNS O
involved VBN O
are VBP O
not RB O
currently RB O
known VBN O
. . O

After IN O
a DT O
brief JJ O
residence NN O
in IN O
the DT O
subcutis NN O
, , O
parasite NN O
stages NNS O
are VBP O
presumed VBN O
to TO O
migrate VB O
to IN O
proximal JJ O
nervous JJ O
tissues NNS O
, , O
initially RB O
in IN O
peripheral JJ O
and CC O
then RB O
more RBR O
central JJ O
locations NNS O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Migration NN O
and CC O
potential JJ O
replication NN O
of IN O
parasite NN O
stages NNS O
in IN O
nervous JJ O
tissue NN O
ensues VBZ O
over IN O
the DT O
next JJ O
16 CD O
d NN O
with IN O
the DT O
first JJ O
parasites NNS O
exiting VBG O
to TO O
invade VB O
cartilage NN O
observed VBN O
at IN O
20 CD O
d NN O
post NN O
infection NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Feeding VBG O
on IN O
cartilage NN O
may MD O
induce VB O
a DT O
host NN O
inflammatory JJ O
response NN O
that WDT O
constricts VBZ O
the DT O
spinal JJ O
cord NN O
, , O
brain NN O
stem NN O
, , O
and CC O
caudal JJ O
nerves NNS O
resulting VBG O
in IN O
the DT O
erratic JJ O
swimming NN O
behavior NN O
( , O
whirling NN O
) , O
and CC O
black JJ O
tail NN O
observed VBN O
among IN O
fish NN O
with IN O
acute JJ O
whirling VBG O
disease NN O
[ -LRB- O
17 CD O
] -RRB- O
. . O

An DT O
additional JJ O
impact NN O
of IN O
cartilage NN O
destruction NN O
are VBP O
permanent JJ O
deformities NNS O
to IN O
the DT O
skeletal JJ O
system NN O
that WDT O
may MD O
increase VB O
vulnerability NN O
to IN O
predation NN O
and CC O
impair VB O
ability NN O
to TO O
forage VB O
for IN O
food NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
final JJ O
developmental JJ O
stages NNS O
of IN O
the DT O
parasite NN O
in IN O
the DT O
fish NN O
are VBP O
environmentally RB O
resistant JJ O
spore NN O
stages NNS O
( , O
myxospores NNS O
) , O
which WDT O
remained VBD O
trapped VBN O
in IN O
cartilage NN O
or CC O
bone NN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Death NN O
of IN O
infected JJ O
fish NN O
or CC O
ingestion NN O
by IN O
fish NN O
or CC O
avian JJ O
predators NNS O
releases VBZ O
myxospores NNS O
from IN O
the DT O
fish NN O
tissues NNS O
and CC O
they PRP O
may MD O
be VB O
ingested VBN O
by IN O
the DT O
second JJ O
host NN O
, , O
the DT O
benthic JJ O
dwelling NN O
oligochaete NN O
T NN B-Species
. . I-Species
tubifex NN I-Species
[ -LRB- O
19 CD O
] -RRB- O
. . O

A DT O
second JJ O
developmental JJ O
cycle NN O
then RB O
occurs VBZ O
under IN O
the DT O
mucosal JJ O
lining NN O
of IN O
the DT O
intestine NN O
that WDT O
results VBZ O
in IN O
the DT O
release NN O
of IN O
thousands NNS O
of IN O
the DT O
actinospore NN O
( -LRB- O
triactinomyxon NN O
) , O
stages NNS O
potentially RB O
over IN O
the DT O
entire JJ O
lifetime NN O
of IN O
the DT O
individual JJ O
oligochaete NN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Susceptibility NN O
to IN O
whirling VBG O
disease NN O
in IN O
U NN O
. . O
S NN O
. . O
rainbow NN B-Species
trout NN I-Species
strains NNS O
is VBZ O
pervasive JJ O
with IN O
only RB O
two CD O
of IN O
the DT O
tested VBN O
native JJ O
strains NNS O
displaying VBG O
any DT O
degree NN O
of IN O
resistance NN O
, , O
which WDT O
may MD O
be VB O
inconsistent JJ O
and CC O
relatively RB O
moderate JJ O
[ -LRB- O
21 CD O
, , O
22 CD O
] -RRB- O
. . O

Hatchery NN O
rainbow NN B-Species
trout NN I-Species
in IN O
Germany NNP O
( -LRB- O
Hofer NNP O
strain NN O
) -RRB- O
, , O
however RB O
, , O
have VBP O
acquired VBN O
a DT O
degree NN O
of IN O
resistance NN O
to IN O
whirling VBG O
disease NN O
that WDT O
is VBZ O
consistently RB O
much RB O
higher JJR O
than IN O
any DT O
domestic JJ O
rainbow NN O
strains NNS O
and CC O
comparable JJ O
to IN O
that DT O
of IN O
brown JJ B-Species
trout NN I-Species
( , O
Salmon NN B-Species
trutta NN I-Species
) -RRB- O
, , O
which WDT O
are VBP O
native JJ O
to IN O
Europe NNP O
and CC O
typically RB O
asymptomatic JJ O
following VBG O
infection NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Laboratory NN O
tests NNS O
comparing VBG O
rainbow NN B-Species
trout NN I-Species
strains NNS O
under IN O
the DT O
same JJ O
environmental JJ O
conditions NNS O
and CC O
pathogen NN O
exposure NN O
indicate VBP O
that IN O
the DT O
Hofer NNP O
strain NN O
' POS O
s POS O
ability NN O
to TO O
combat VB O
M NNP B-Species
. . I-Species
cerebralis NN I-Species
infection NN O
has VBZ O
a DT O
genetic JJ O
basis NN O
. . O

Recently RB O
, , O
controlled VBN O
crosses NNS O
of IN O
the DT O
Hofer NNP O
strain NN O
and CC O
a DT O
susceptible JJ O
strain NN O
( , O
Colorado NNP O
River NNP O
rainbow NN B-Species
trout NN I-Species
[ -LRB- O
CRR NNP O
] -RRB- O
) -RRB- O
demonstrated VBD O
that IN O
resistance NN O
to IN O
whirling VBG O
disease NN O
was VBD O
inherited VBN O
by IN O
progeny NN O
[ -LRB- O
24 CD O
] -RRB- O
and CC O
heritability NN O
estimates NNS O
are VBP O
currently RB O
underway JJ O
. . O

The DT O
discovery NN O
of IN O
the DT O
resistant JJ O
Hofer NNP O
strain NN O
allowed VBD O
us PRP O
to TO O
conduct VB O
an DT O
intraspecific JJ O
comparison NN O
of IN O
susceptible JJ O
and CC O
resistant JJ O
rainbow NN B-Species
trout NN I-Species
in IN O
order NN O
to TO O
gain VB O
insight NN O
into IN O
the DT O
genetic JJ O
basis NN O
underlying VBG O
whirling VBG O
disease NN O
susceptibility NN O
for IN O
this DT O
species NNS O
. . O

Gene NN O
expression NN O
profiling NN O
, , O
through IN O
the DT O
use NN O
of IN O
microarrays NNS O
, , O
is VBZ O
an DT O
extremely RB O
high JJ O
- HYPH O
throughput NN O
method NN O
to TO O
discover VB O
specific JJ O
genes NNS O
and CC O
pathways NNS O
involved VBN O
in IN O
a DT O
disease NN O
phenotype NN O
without IN O
the DT O
bias NN O
of IN O
a DT O
candidate NN O
gene NN O
approach NN O
. . O

In IN O
this DT O
study NN O
, , O
microarray JJ O
analysis NN O
was VBD O
used VBN O
to TO O
examine VB O
expression NN O
changes NNS O
in IN O
a DT O
resistant JJ O
and CC O
susceptible JJ O
strain NN O
of IN O
rainbow NN B-Species
trout NN I-Species
following VBG O
exposure NN O
to IN O
M NNP B-Species
. . I-Species
cerebralis NN I-Species
, , O
the DT O
pathogen NN O
causing VBG O
whirling VBG O
disease NN O
. . O

We PRP O
have VBP O
found VBN O
several JJ O
genes NNS O
significantly RB O
up RB O
- HYPH O
regulated VBN O
in IN O
both CC O
the DT O
resistant JJ O
and CC O
susceptible JJ O
strain NN O
that WDT O
appear VBP O
to TO O
be VB O
involved VBN O
in IN O
host NN O
response NN O
to IN O
infection NN O
. . O

We PRP O
have VBP O
also RB O
found VBN O
a DT O
gene NN O
which WDT O
is VBZ O
significantly RB O
up RB O
- HYPH O
regulated VBN O
in IN O
the DT O
resistant JJ O
but CC O
remains VBZ O
unchanged JJ O
in IN O
the DT O
susceptible JJ O
rainbow NN B-Species
trout NN I-Species
strain NN O
following VBG O
pathogen NN O
exposure NN O
that WDT O
is VBZ O
a DT O
likely JJ O
candidate NN O
gene NN O
for IN O
involvement NN O
in IN O
conferring VBG O
whirling VBG O
disease NN O
resistance NN O
. . O

Results NNS O
and CC O
Discussion NN O

Quantitative JJ O
PCR NN O
conducted VBN O
on IN O
caudal JJ O
fin NN O
tissues NNS O
at IN O
two CD O
hours NNS O
post NN O
exposure NN O
to IN O
M NNP B-Species
. . I-Species
cerebralis NN I-Species
demonstrated VBD O
each DT O
fish NN O
strain NN O
had VBD O
similar JJ O
initial JJ O
pathogen NN O
loads NNS O
, , O
although IN O
there EX O
was VBD O
substantial JJ O
variation NN O
between IN O
individual JJ O
fish NN O
within IN O
each DT O
strain NN O
. . O

The DT O
mean JJ O
parasite NN O
copy NN O
numbers NNS O
per IN O
host NN O
cell NN O
were VBD O
1 CD O
. . O
20 CD O
x SYM O
106 CD O
( SYM O
SD NN O
1 CD O
. . O
53 CD O
x SYM O
106 CD O
) -RRB- O
for IN O
the DT O
Hofer NNP O
and CC O
1 CD O
. . O
4 CD O
x SYM O
106 CD O
( SYM O
SD NN O
0 CD O
. . O
91 CD O
x SYM O
106 CD O
) -RRB- O
for IN O
the DT O
Trout NNP O
Lodge NNP O
. . O

These DT O
mean JJ O
values NNS O
and CC O
standard JJ O
deviations NNS O
are VBP O
similar JJ O
to IN O
those DT O
obtained VBN O
in IN O
additional JJ O
studies NNS O
of IN O
susceptible JJ O
rainbow NN B-Species
trout NN I-Species
when WRB O
examined VBN O
at IN O
early JJ O
time NN O
points NNS O
post VBP O
TAM NNP O
exposure NN O
( , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

In IN O
order NN O
to TO O
study VB O
genes NNS O
involved VBN O
in IN O
whirling VBG O
disease NN O
response NN O
, , O
resistant JJ O
and CC O
susceptible JJ O
rainbow NN B-Species
trout NN I-Species
strains NNS O
were VBD O
exposed VBN O
to IN O
M NNP B-Species
. . I-Species
cerebralis NN I-Species
and CC O
RNA NN O
from IN O
skin NN O
tissue NN O
was VBD O
converted VBN O
to IN O
cDNA NNP O
and CC O
hybridized VBN O
onto IN O
microarrays NNS O
. . O

Relative JJ O
gene NN O
expression NN O
for IN O
exposed VBN O
and CC O
unexposed JJ O
controls NNS O
for IN O
each DT O
strain NN O
was VBD O
compared VBN O
and CC O
the DT O
list NN O
of IN O
differentially RB O
expressed VBN O
genes NNS O
for IN O
both DT O
strains NNS O
is VBZ O
found VBN O
in IN O
Table NNP O
1 CD O
. . O

A DT O
combined VBN O
total NN O
of IN O
17 CD O
genes NNS O
or CC O
features NNS O
( , O
14 CD O
annotated VBN O
genes NNS O
, , O
3 CD O
unknown JJ O
features NNS O
) , O
were VBD O
differentially RB O
expressed VBN O
in IN O
one CD O
or CC O
both DT O
strains NNS O
following VBG O
pathogen NN O
exposure NN O
and CC O
are VBP O
involved VBN O
with IN O
rainbow NN B-Species
trout NN I-Species
infection NN O
response NN O
to IN O
whirling VBG O
disease NN O
exposure NN O
. . O

Several JJ O
of IN O
these DT O
genes NNS O
were VBD O
found VBN O
in IN O
different JJ O
locations NNS O
on IN O
the DT O
array NN O
as IN O
unique JJ O
expressed VBN O
sequence NN O
tag NN O
( , O
EST NNP O
) -RRB- O
clones NNS O
and CC O
their PRP$ O
repeated VBN O
presence NN O
on IN O
the DT O
significance NN O
gene NN O
lists NNS O
provides VBZ O
additional JJ O
support NN O
for IN O
their PRP$ O
involvement NN O
in IN O
the DT O
whirling VBG O
disease NN O
phenotype NN O
. . O

The DT O
small JJ O
number NN O
of IN O
genes NNS O
found VBN O
potentially RB O
indicates VBZ O
that IN O
only RB O
a DT O
few JJ O
genes NNS O
contribute VBP O
to IN O
the DT O
phenotypic JJ O
differences NNS O
found VBN O
between IN O
resistant JJ O
Hofer NNP O
and CC O
susceptible JJ O
Trout NNP O
Lodge NNP O
, , O
at IN O
least JJS O
in IN O
terms NNS O
of IN O
differential JJ O
gene NN O
expression NN O
, , O
during IN O
early JJ O
disease NN O
progression NN O
in IN O
the DT O
skin NN O
. . O

In IN O
the DT O
microarray JJ O
statistical JJ O
analysis NN O
, , O
when WRB O
the DT O
delta NN O
value NN O
was VBD O
adjusted VBN O
even RB O
slightly RB O
lower JJR O
, , O
the DT O
FDR NNP O
estimate NN O
increases VBZ O
from IN O
0 CD O
% NN O
to IN O
~ $ O
78 CD O
% NN O
. . O

Since IN O
increasing VBG O
the DT O
FDR NNP O
cut NN O
- HYPH O
off NN O
to IN O
such PDT O
a DT O
high JJ O
percentage NN O
would MD O
dramatically RB O
reduce VB O
power NN O
, , O
we PRP O
chose VBD O
to TO O
leave VB O
the DT O
gene NN O
list NN O
small JJ O
with IN O
an DT O
estimated VBN O
FDR NNP O
of IN O
0 CD O
% NN O
. . O

This DT O
type NN O
of IN O
dramatic JJ O
increase NN O
in IN O
FDR NNP O
estimation NN O
is VBZ O
additional JJ O
support NN O
that IN O
there EX O
are VBP O
not RB O
many JJ O
genes NNS O
differentially RB O
expressed VBN O
in IN O
response NN O
to IN O
whirling VBG O
disease NN O
infection NN O
for IN O
our PRP$ O
chosen VBN O
tissue NN O
and CC O
time NN O
points NNS O
. . O

Different JJ O
salmonid NN O
microarray NN O
platforms NNS O
, , O
such JJ O
as IN O
those DT O
available JJ O
from IN O
Oregon NNP O
State NNP O
University NNP O
and CC O
Michigan NNP O
State NNP O
University NNP O
, , O
or CC O
different JJ O
tissues NNS O
and CC O
time NN O
points NNS O
may MD O
produce VB O
additional JJ O
candidate NN O
genes NNS O
. . O

A DT O
recent JJ O
time NN O
course NN O
study NN O
used VBD O
a DT O
candidate NN O
gene NN O
approach NN O
to TO O
identify VB O
four CD O
genes NNS O
( -LRB- O
TGF NNP O
- HYPH O
beta NN O
, , O
IL NN O
- HYPH O
1 CD O
beta NN O
1 CD O
, , O
IL NN O
- HYPH O
1 CD O
beta NN O
2 CD O
, , O
and CC O
COX NN O
- HYPH O
2 CD O
) -RRB- O
that WDT O
were VBD O
significantly RB O
up RB O
- HYPH O
regulated VBN O
by IN O
both CC O
Hofer NNP O
and CC O
Trout NNP O
Lodge NNP O
in IN O
response NN O
to IN O
whirling VBG O
disease NN O
infection NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

These DT O
genes NNS O
and CC O
their PRP$ O
downstream JJ O
effectors NNS O
were VBD O
not RB O
identified VBN O
in IN O
the DT O
current JJ O
microarray NN O
study NN O
, , O
likely JJ O
due IN O
to IN O
many JJ O
differences NNS O
in IN O
experimental JJ O
design NN O
between IN O
the DT O
two CD O
studies NNS O
( , O
e LS O
. . O
g LS O
. . O
, , O
pathogen NN O
exposure NN O
levels NNS O
, , O
tissue NN O
types NNS O
, , O
water NN O
temperatures NNS O
, , O
age NN O
of IN O
fish NN O
at IN O
exposure NN O
, , O
etc FW O
. . O
) -RRB- O
. . O

While IN O
downstream JJ O
effectors NNS O
of IN O
these DT O
genes NNS O
were VBD O
present JJ O
on IN O
the DT O
microarray NN O
, , O
only RB O
one CD O
of IN O
the DT O
four CD O
genes NNS O
( -LRB- O
COX NN O
- HYPH O
2 CD O
) -RRB- O
was VBD O
actually RB O
present JJ O
on IN O
the DT O
microarray NN O
. . O

It PRP O
is VBZ O
our PRP$ O
hope NN O
that IN O
future JJ O
genome NN O
sequencing NN O
will MD O
enable VB O
the DT O
construction NN O
of IN O
more RBR O
comprehensive JJ O
microarray JJ O
platforms NNS O
for IN O
economically RB O
important JJ O
aquaculture NN O
species NNS O
, , O
such JJ O
as IN O
Atlantic NNP B-Species
salmon NN I-Species
and CC O
rainbow NN B-Species
trout NN I-Species
. . O

All DT O
significant JJ O
genes NNS O
identified VBN O
by IN O
the DT O
current JJ O
microarray NN O
study NN O
were VBD O
up RB O
- HYPH O
regulated VBN O
following VBG O
pathogen NN O
exposure NN O
for IN O
one CD O
or CC O
both DT O
strains NNS O
. . O

Therefore RB O
, , O
it PRP O
appears VBZ O
that IN O
both DT O
strains NNS O
are VBP O
undergoing VBG O
transcriptional JJ O
activation NN O
to TO O
defend VB O
against IN O
whirling VBG O
disease NN O
infection NN O
and CC O
thus RB O
, , O
are VBP O
exclusively RB O
employing VBG O
positive JJ O
regulation NN O
for IN O
the DT O
genes NNS O
examined VBN O
in IN O
skin NN O
during IN O
early JJ O
disease NN O
progression NN O
. . O

The DT O
normal JJ O
caveats NNS O
that WDT O
apply VBP O
for IN O
microarray JJ O
studies NNS O
( , O
gene NN O
discovery NN O
is VBZ O
limited VBN O
by IN O
transcripts NNS O
on IN O
arrays NNS O
, , O
differences NNS O
at IN O
transcriptional JJ O
level NN O
may MD O
not RB O
cause VB O
phenotypic JJ O
differences NNS O
, , O
results NNS O
are VBP O
dependent JJ O
upon IN O
tissue NN O
type NN O
and CC O
time NN O
point NN O
chosen VBN O
, , O
etc FW O
. . O
) -RRB- O
apply VBP O
for IN O
this DT O
study NN O
. . O

Additionally RB O
, , O
the DT O
comparison NN O
of IN O
two CD O
rainbow NN B-Species
trout NN I-Species
strains NNS O
( , O
i LS O
. . O
e -RRB- O
. . O
, , O
resistant JJ O
versus IN O
susceptible JJ O
) -RRB- O
added VBD O
another DT O
layer NN O
of IN O
complexity NN O
to IN O
the DT O
analysis NN O
. . O

We PRP O
chose VBD O
to TO O
not RB O
directly RB O
compare VB O
the DT O
two CD O
strains NNS O
because IN O
there EX O
could MD O
be VB O
expression NN O
differences NNS O
between IN O
them PRP O
, , O
due IN O
to IN O
divergence NN O
following VBG O
strain NN O
isolation NN O
, , O
that WDT O
are VBP O
unrelated JJ O
to IN O
the DT O
whirling VBG O
disease NN O
phenotype NN O
. . O

With IN O
that DT O
in IN O
mind NN O
, , O
the DT O
two CD O
strains NNS O
were VBD O
first RB O
compared VBN O
entirely RB O
separately RB O
from IN O
each DT O
other JJ O
to TO O
discover VB O
expression NN O
differences NNS O
in IN O
response NN O
to IN O
pathogen NN O
exposure NN O
for IN O
each DT O
strain NN O
. . O

Only RB O
the DT O
genes NNS O
responding VBG O
to IN O
infection NN O
, , O
and CC O
therefore RB O
implicated VBN O
in IN O
the DT O
whirling NN O
disease NN O
phenotype NN O
, , O
were VBD O
compared VBN O
between IN O
the DT O
two CD O
strains NNS O
for IN O
differential JJ O
gene NN O
expression NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

A DT O
limitation NN O
of IN O
this DT O
approach NN O
to IN O
our PRP$ O
study NN O
is VBZ O
that IN O
constitutively RB O
expressed VBN O
transcripts NNS O
which WDT O
are VBP O
differentially RB O
expressed VBN O
between IN O
the DT O
two CD O
strains NNS O
that WDT O
contribute VBP O
to IN O
the DT O
whirling VBG O
disease NN O
phenotype NN O
cannot MD O
be VB O
identified VBN O
. . O

Microarray NNP O
analysis NN O
of IN O
genes NNS O
differentially RB O
expressed VBN O
in IN O
the DT O
resistant JJ O
Hofer NNP O
strain NN O
in IN O
response NN O
to IN O
pathogen NN O
exposure NN O

A DT O
total NN O
of IN O
16 CD O
genes NNS O
or CC O
features NNS O
( , O
13 CD O
annotated VBN O
genes NNS O
, , O
3 CD O
unknown JJ O
features NNS O
) , O
were VBD O
up RB O
- HYPH O
regulated VBN O
in IN O
the DT O
resistant JJ O
Hofer NNP O
strain NN O
following VBG O
pathogen NN O
exposure NN O
. . O

All DT O
13 CD O
annotated VBN O
genes NNS O
have VBP O
been VBN O
previously RB O
implicated VBN O
in IN O
host NN O
immune JJ O
response NN O
for IN O
other JJ O
infectious JJ O
diseases NNS O
. . O

Viral NNP B-Species
Hemorrhagic NNP I-Species
Septicemia NNP I-Species
Virus NNP I-Species
( -LRB- O
VHSV NNP B-Species
) -RRB- O
induced VBN O
protein NN O
and CC O
neighbor NN O
of IN O
COX NNP O
- HYPH O
4 CD O
are VBP O
the DT O
only RB O
annotated VBN O
genes NNS O
without IN O
known VBN O
molecular JJ O
functions NNS O
. . O

A DT O
common JJ O
link NN O
between IN O
the DT O
majority NN O
of IN O
annotated VBN O
genes NNS O
with IN O
known VBN O
molecular JJ O
functions NNS O
is VBZ O
an DT O
involvement NN O
in IN O
the DT O
interferon NN O
system NN O
. . O

The DT O
interferon NN O
system NN O
is VBZ O
one CD O
of IN O
the DT O
first JJ O
lines NNS O
of IN O
host NN O
defense NN O
against IN O
invading VBG O
pathogens NNS O
for IN O
vertebrates NNS O
( , O
for IN O
review NN O
see VB O
[ -LRB- O
26 CD O
] -RRB- O
) -RRB- O
, , O
including VBG O
teleost NN B-Species
fish NN I-Species
( , O
for IN O
review NN O
see VB O
[ -LRB- O
27 CD O
] -RRB- O
) -RRB- O
. . O

Other JJ O
economically RB O
important JJ O
salmonid NN O
pathogens NNS O
, , O
such JJ O
as IN O
infectious JJ B-Species
pancreatic JJ I-Species
necrosis NN I-Species
virus NN I-Species
and CC O
infectious JJ B-Species
salmon NN I-Species
anaemia NN I-Species
virus NN I-Species
have VBP O
been VBN O
found VBN O
to TO O
activate VB O
both CC O
type NN O
I NN O
and CC O
type NN O
II NN O
interferon NN O
( -LRB- O
IFN NNP O
) -RRB- O
responses NNS O
in IN O
the DT O
Atlantic NNP B-Species
salmon NN I-Species
host NN O
following VBG O
infection NN O
[ -LRB- O
28 CD O
] -RRB- O
. . O

Interferons NNS O
are VBP O
cytokine NN O
proteins NNS O
that WDT O
are VBP O
secreted VBN O
following VBG O
infection NN O
and CC O
play VBP O
a DT O
critical JJ O
role NN O
in IN O
both CC O
innate JJ O
and CC O
adaptive JJ O
immunity NN O
. . O

The DT O
IFN NNP O
system NN O
has VBZ O
been VBN O
most RBS O
widely RB O
researched VBN O
in IN O
mammals NNS O
and CC O
studies NNS O
have VBP O
found VBN O
that IN O
type NN O
I NNP O
IFN NNP O
( , O
mammalian JJ O
IFN NN O
- HYPH O
alpha NNP O
/ SYM O
beta NN O
) -RRB- O
are VBP O
secreted VBN O
by IN O
the DT O
pathogen NN O
- HYPH O
infected VBN O
cells NNS O
as IN O
part NN O
of IN O
a DT O
rapid JJ O
initial JJ O
immune JJ O
response NN O
while IN O
Type NNP O
II NNP O
IFN NNP O
( , O
mammalian JJ O
IFN NN O
- HYPH O
gamma NN O
) -RRB- O
is VBZ O
secreted VBN O
by IN O
natural JJ O
killer NN O
( , O
NK NNP O
) -RRB- O
and CC O
T NN O
cells NNS O
and CC O
plays VBZ O
a DT O
more RBR O
central JJ O
role NN O
in IN O
the DT O
second JJ O
wave NN O
of IN O
immune JJ O
response NN O
. . O

To TO O
cope VB O
with IN O
the DT O
myriad NN O
of IN O
host NN O
infections NNS O
, , O
the DT O
interferon NN O
system NN O
is VBZ O
highly RB O
complex JJ O
and CC O
involves VBZ O
the DT O
regulation NN O
of IN O
hundreds NNS O
of IN O
genes NNS O
[ -LRB- O
29 CD O
, , O
30 CD O
] -RRB- O
. . O

Specifically RB O
, , O
type NN O
I NN O
IFN NNP O
acts VBZ O
to TO O
increase VB O
MHC NNP O
class NN O
I NN O
expression NN O
for IN O
antigen NN O
presentation NN O
[ -LRB- O
31 CD O
] -RRB- O
, , O
promote VBP O
T NN O
cell NN O
survival NN O
[ -LRB- O
32 CD O
] -RRB- O
, , O
inhibit VBP O
cell NN O
proliferation NN O
[ -LRB- O
33 CD O
] -RRB- O
, , O
mediate VBP O
apoptosis NN O
[ -LRB- O
26 CD O
] -RRB- O
, , O
and CC O
increase VBP O
NK NNP O
cell NN O
activity NN O
[ -LRB- O
34 CD O
] -RRB- O
. . O

Type NNP O
II NNP O
IFN NNP O
acts VBZ O
to TO O
increase VB O
both CC O
MHC NNP O
class NN O
I NN O
and CC O
II NN O
expression NN O
for IN O
antigen NN O
presentation NN O
[ -LRB- O
29 CD O
] -RRB- O
, , O
stimulate VB O
macrophages NNS O
to TO O
kill VB O
engulfed VBN O
pathogens NNS O
[ -LRB- O
35 CD O
] -RRB- O
, , O
induce VB O
apoptosis NN O
[ -LRB- O
36 CD O
] -RRB- O
, , O
and CC O
regulate VB O
leukocyte NN O
- HYPH O
endothelium NN O
interactions NNS O
[ -LRB- O
37 CD O
] -RRB- O
in IN O
addition NN O
to IN O
many JJ O
other JJ O
immune NN O
- HYPH O
related VBN O
activities NNS O
. . O

It PRP O
is VBZ O
informative JJ O
to TO O
examine VB O
the DT O
functional JJ O
roles NNS O
of IN O
each DT O
gene NN O
' '' O
s NNS O
encoded VBN O
protein NN O
specifically RB O
to TO O
better RBR O
understand VB O
the DT O
part NN O
each DT O
plays NNS O
, , O
both CC O
individually RB O
and CC O
as IN O
interconnected JJ O
components NNS O
, , O
in IN O
host NN O
immune JJ O
response NN O
. . O

Expression NN O
of IN O
the DT O
interferon NN O
- HYPH O
induced VBN O
35 CD O
kDa NN O
protein NN O
is VBZ O
induced VBN O
by IN O
IFN NNP O
and CC O
it PRP O
is VBZ O
involved VBN O
in IN O
cytokine NN O
signalling NN O
[ -LRB- O
38 CD O
] -RRB- O
. . O

Interferon NN O
regulatory JJ O
factor NN O
1 CD O
( , O
IRF NNP O
- HYPH O
1 CD O
) -RRB- O
and CC O
interferon NN O
regulatory JJ O
factor NN O
7 CD O
( , O
IRF NNP O
- HYPH O
7 CD O
) -RRB- O
are VBP O
transcription NN O
factors NNS O
that WDT O
induce VBP O
expression NN O
of IN O
IFN NNP O
responsive JJ O
genes NNS O
[ -LRB- O
39 CD O
, , O
40 CD O
] -RRB- O
. . O

Additionally RB O
, , O
IRF NNP O
- HYPH O
1 CD O
is VBZ O
involved VBN O
in IN O
apoptosis NN O
and CC O
cell NN O
cycle NN O
regulation NN O
related VBN O
to IN O
tumor NN O
suppression NN O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Similarly RB O
, , O
cyclin NN O
- HYPH O
dependent JJ O
kinase NN O
4 CD O
inhibitor NN O
B NNP O
( , O
p15 CD O
- HYPH O
INK4b NNP O
) -RRB- O
plays VBZ O
a DT O
role NN O
in IN O
apoptosis NN O
[ -LRB- O
42 CD O
] -RRB- O
, , O
cell NN O
cycle NN O
regulation NN O
[ -LRB- O
42 CD O
] -RRB- O
, , O
and CC O
tumor NN O
suppression NN O
[ -LRB- O
43 CD O
] -RRB- O
and CC O
can MD O
be VB O
induced VBN O
by IN O
the DT O
cytokine NN O
TGF NNP O
- HYPH O
beta NN O
[ -LRB- O
44 CD O
] -RRB- O
. . O

Gig2 NNP O
is VBZ O
an DT O
interferon NN O
- HYPH O
inducible JJ O
protein NN O
that WDT O
is VBZ O
likely JJ O
part NN O
of IN O
the DT O
JAK NNP O
- HYPH O
STAT NNP O
signal NN O
transduction NN O
pathway NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

Ubiquitin NNP O
and CC O
the DT O
proteasome NN O
subunit NN O
beta NN O
type NN O
8 CD O
precursor NN O
are VBP O
both DT O
members NNS O
of IN O
the DT O
ubiquitin NN O
- HYPH O
proteasome NN O
system NN O
( : O
for IN O
review NN O
see VB O
[ -LRB- O
26 CD O
] -RRB- O
) -RRB- O
, , O
which WDT O
serves VBZ O
to TO O
degrade VB O
proteins NNS O
via IN O
proteolysis NN O
. . O

These DT O
degraded VBN O
proteins NNS O
can MD O
originate VB O
from IN O
an DT O
invading VBG O
pathogen NN O
and CC O
are VBP O
displayed VBN O
on IN O
MHC NNP O
class NN O
I NNP O
proteins NNS O
. . O

The DT O
beta JJ O
- HYPH O
2 CD O
- HYPH O
microglobulin NN O
is VBZ O
an DT O
integral JJ O
component NN O
of IN O
MHC NNP O
class NN O
I NN O
proteins NNS O
and CC O
is VBZ O
therefore RB O
involved VBN O
in IN O
antigen NN O
processing NN O
and CC O
presentation NN O
to IN O
cytotoxic JJ O
T NN O
cells NNS O
[ -LRB- O
46 CD O
] -RRB- O
. . O

Haptoglobin NNP O
binds VBZ O
hemoglobin NN O
and CC O
limits VBZ O
its PRP$ O
availability NN O
to IN O
infectious JJ O
bacteria NNS O
, , O
thus RB O
preventing VBG O
bacterial JJ O
proliferation NN O
in IN O
a DT O
wound NN O
[ -LRB- O
47 CD O
] -RRB- O
. . O

The DT O
PPAR NNP O
- HYPH O
alpha NN O
- HYPH O
interacting VBG O
complex NN O
protein NN O
285 CD O
is VBZ O
a DT O
transcriptional JJ O
co NN O
- HYPH O
activator NN O
with IN O
helicase NN O
activity NN O
[ -LRB- O
48 CD O
] -RRB- O
and CC O
has VBZ O
sequence NN O
similarity NN O
to IN O
a DT O
rainbow NN B-Species
trout NN I-Species
VHSV NN B-Species
- HYPH O
induced VBN O
protein NN O
. . O

Gene NN O
expression NN O
of IN O
metallothionein NN O
B NN O
( , O
MT NNP O
- HYPH O
B NNP O
) -RRB- O
is VBZ O
induced VBN O
by IN O
several JJ O
metal NN O
ions NNS O
[ -LRB- O
49 CD O
] -RRB- O
, , O
cytokines NNS O
[ -LRB- O
50 CD O
- HYPH O
52 CD O
] -RRB- O
, , O
and CC O
stress NN O
hormones NNS O
[ -LRB- O
53 CD O
- SYM O
55 CD O
] -RRB- O
. . O

MT NN O
proteins NNS O
are VBP O
believed VBN O
to TO O
play VB O
diverse JJ O
functional JJ O
roles NNS O
in IN O
inflammation NN O
, , O
immune JJ O
response NN O
, , O
apoptosis NN O
, , O
tumor NN O
suppression NN O
, , O
and CC O
detoxification NN O
( , O
for IN O
reviews NNS O
see VB O
[ -LRB- O
55 CD O
, , O
56 CD O
] -RRB- O
) -RRB- O
. . O

Microarray NNP O
analysis NN O
of IN O
genes NNS O
differentially RB O
expressed VBN O
in IN O
the DT O
susceptible JJ O
Trout NNP O
Lodge NNP O
strain NN O
in IN O
response NN O
to IN O
pathogen NN O
exposure NN O

A DT O
total NN O
of IN O
six CD O
genes NNS O
or CC O
features NNS O
( , O
five CD O
annotated VBN O
genes NNS O
, , O
one CD O
unknown JJ O
feature NN O
) , O
were VBD O
up RB O
- HYPH O
regulated VBN O
in IN O
the DT O
susceptible JJ O
Trout NNP O
Lodge NNP O
strain NN O
following VBG O
pathogen NN O
exposure NN O
. . O

Only RB O
one CD O
of IN O
the DT O
significant JJ O
genes NNS O
for IN O
Trout NNP O
Lodge NNP O
, , O
which WDT O
has VBZ O
sequence NN O
similarity NN O
to IN O
CC NN O
chemokine NN O
SCYA113 NN O
, , O
was VBD O
not RB O
also RB O
differentially RB O
expressed VBN O
in IN O
Hofer NNP O
in IN O
response NN O
to IN O
pathogen NN O
exposure NN O
. . O

The DT O
CC NNP O
chemokine NN O
SCYA113 NN O
gene NN O
is VBZ O
a DT O
member NN O
of IN O
the DT O
CC NNP O
chemokine NN O
family NN O
, , O
which WDT O
guides VBZ O
leukocytes NNS O
to IN O
sites NNS O
of IN O
infection NN O
and CC O
inflammation NN O
( , O
for IN O
review NN O
see VB O
[ -LRB- O
57 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
fewer JJR O
number NN O
of IN O
significant JJ O
genes NNS O
found VBN O
for IN O
Trout NNP O
Lodge NNP O
relative JJ O
to IN O
Hofer NNP O
may MD O
indicate VB O
a DT O
decrease NN O
in IN O
transcriptional JJ O
activation NN O
for IN O
this DT O
susceptible JJ O
strain NN O
. . O

There EX O
is VBZ O
, , O
however RB O
, , O
likely RB O
some DT O
degree NN O
of IN O
overlap NN O
in IN O
both DT O
strains NNS O
' POS O
response NN O
to IN O
pathogen NN O
exposure NN O
due IN O
to IN O
the DT O
fact NN O
that IN O
several JJ O
genes NNS O
were VBD O
up RB O
- HYPH O
regulated VBN O
in IN O
both CC O
Hofer NNP O
and CC O
Trout NNP O
Lodge NNP O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
ubiquitin NN O
- HYPH O
like JJ O
protein NN O
1 CD O
, , O
IRF NNP O
- HYPH O
1 CD O
, , O
and CC O
PPAR NNP O
- HYPH O
alpha NN O
- HYPH O
interacting VBG O
protein NN O
Gig2 NNP O
) -RRB- O
. . O

A DT O
critical JJ O
phase NN O
in IN O
the DT O
early JJ O
stages NNS O
of IN O
M NN B-Species
. . I-Species
cerebralis NN I-Species
infection NN O
in IN O
trout NN O
is VBZ O
invasion NN O
and CC O
intracellular JJ O
replication NN O
, , O
processes NNS O
that WDT O
begin VBP O
as RB O
early RB O
as IN O
one CD O
hour NN O
post NN O
exposure NN O
to IN O
triactinomyxons NNS O
[ -LRB- O
16 CD O
] -RRB- O
. . O

A DT O
role NN O
for IN O
accumulated VBN O
ubiquinated JJ O
proteins NNS O
in IN O
the DT O
lysosome NN O
in IN O
the DT O
killing NN O
of IN O
Mycobacterium NN B-Species
tuberculosis NN I-Species
has VBZ O
recently RB O
been VBN O
described VBN O
that WDT O
has VBZ O
implications NNS O
for IN O
a DT O
range NN O
of IN O
intracellular JJ O
infections NNS O
[ -LRB- O
58 CD O
] -RRB- O
and CC O
some DT O
similar JJ O
responses NNS O
to IN O
infection NN O
may MD O
be VB O
occurring VBG O
for IN O
both CC O
resistant JJ O
and CC O
susceptible JJ O
strains NNS O
. . O

Microarray NNP O
analysis NN O
of IN O
genes NNS O
differentially RB O
expressed VBN O
between IN O
resistant JJ O
and CC O
susceptible JJ O
strains NNS O
in IN O
response NN O
to IN O
pathogen NN O
exposure NN O

Of IN O
the DT O
genes NNS O
differentially RB O
expressed VBN O
in IN O
response NN O
to IN O
pathogen NN O
exposure NN O
for IN O
both DT O
strains NNS O
, , O
only RB O
metallothionein NN O
B NNP O
shows VBZ O
a DT O
statistically RB O
significant JJ O
difference NN O
in IN O
expression NN O
between IN O
the DT O
two CD O
strains NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

MT NNP O
- HYPH O
B NNP O
was VBD O
found VBN O
to TO O
be VB O
up RB O
- HYPH O
regulated VBN O
in IN O
the DT O
resistant JJ O
Hofer NNP O
strain NN O
following VBG O
pathogen NN O
exposure NN O
but CC O
remained VBD O
unchanged JJ O
in IN O
the DT O
susceptible JJ O
Trout NNP O
Lodge NNP O
strain NN O
. . O

As IN O
previously RB O
noted VBN O
, , O
metallothionein NN O
has VBZ O
been VBN O
implicated VBN O
in IN O
a DT O
broad JJ O
range NN O
of IN O
functional JJ O
capacities NNS O
, , O
including VBG O
inflammatory JJ O
and CC O
immune JJ O
responses NNS O
. . O

Several JJ O
cytokines NNS O
can MD O
induce VB O
metallothionein NN O
expression NN O
including VBG O
IFN NNP O
[ -LRB- O
59 CD O
- HYPH O
61 CD O
] -RRB- O
, , O
interleukin NN O
- HYPH O
1 CD O
[ -LRB- O
50 CD O
] -RRB- O
, , O
interleukin NN O
- HYPH O
6 CD O
[ -LRB- O
51 CD O
] -RRB- O
, , O
and CC O
tumor NN O
necrosis NN O
factor NN O
- HYPH O
alpha NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

Metallothionein NNP O
has VBZ O
been VBN O
shown VBN O
to TO O
mediate VB O
leukocyte NN O
chemotaxis NN O
and CC O
has VBZ O
been VBN O
hypothesized VBN O
to TO O
serve VB O
as IN O
an DT O
early JJ O
"""" `` O
danger NN O
signal NN O
"""" '' O
during IN O
times NNS O
of IN O
stress NN O
or CC O
infection NN O
to TO O
activate VB O
an DT O
immune JJ O
response NN O
[ -LRB- O
62 CD O
] -RRB- O
. . O

The DT O
functional JJ O
similarities NNS O
between IN O
metallothionein NN O
and CC O
CC NN O
chemokine NN O
SCYA113 NNP O
, , O
at IN O
least JJS O
in IN O
terms NNS O
of IN O
leukocyte NN O
chemotaxis NN O
, , O
are VBP O
certainly RB O
of IN O
interest NN O
since IN O
these DT O
genes NNS O
displayed VBD O
quite RB O
distinct JJ O
expression NN O
profiles NNS O
. . O

Metallothionein NNP O
was VBD O
up RB O
- HYPH O
regulated VBN O
in IN O
the DT O
resistant JJ O
Hofer NNP O
strain NN O
and CC O
CC NN O
chemokine NN O
SCYA113 NN O
was VBD O
up RB O
- HYPH O
regulated VBN O
in IN O
the DT O
susceptible JJ O
Trout NNP O
Lodge NNP O
strain NN O
( , O
although IN O
CC NN O
chemokine NN O
SCYA113 NN O
did VBD O
not RB O
pass VB O
the DT O
significance NN O
cut VBN O
- HYPH O
off NN O
to TO O
be VB O
considered VBN O
differentially RB O
expressed VBN O
between IN O
the DT O
two CD O
strains NNS O
) -RRB- O
. . O

This DT O
distinction NN O
between IN O
two CD O
genes NNS O
, , O
capable JJ O
of IN O
similar JJ O
biological JJ O
roles NNS O
, , O
may MD O
indicate VB O
that IN O
leukocyte NN O
movements NNS O
to IN O
, , O
and CC O
their PRP$ O
activities NNS O
once RB O
at IN O
, , O
the DT O
infection NN O
site NN O
are VBP O
key JJ O
factors NNS O
in IN O
determining VBG O
resistance NN O
versus IN O
susceptibility NN O
to IN O
whirling VBG O
disease NN O
. . O

Evaluations NNS O
by IN O
light JJ O
microscopy NN O
and CC O
qPCR NN O
for IN O
M NN B-Species
. . I-Species
cerebralis NN I-Species
genomic JJ O
DNA NN O
of IN O
Hofer NNP O
and CC O
Trout NNP O
Lodge NNP O
rainbow NN B-Species
trout NN I-Species
exposed VBN O
to IN O
triactinomyxons NNS O
demonstrates VBZ O
Hofer NNP O
more RBR O
efficiently RB O
eliminates VBZ O
invading VBG O
parasites NNS O
in IN O
the DT O
skin NN O
( , O
M NN O
. . O
Adkison NNP O
, , O
pers FW O
. . O
comm NN O
. . O
) -RRB- O
. . O

While IN O
the DT O
parasite NN O
effectively RB O
penetrates VBZ O
the DT O
epidermis NN O
in IN O
both DT O
strains NNS O
, , O
significantly RB O
fewer JJR O
parasites NNS O
survive VBP O
the DT O
migration NN O
from IN O
the DT O
skin NN O
to IN O
the DT O
nerves NNS O
as IN O
evaluated VBN O
at IN O
10 CD O
d NN O
post NN O
exposure NN O
. . O

A DT O
role NN O
for IN O
host NN O
immune JJ O
factors NNS O
in IN O
the DT O
elimination NN O
of IN O
invading VBG O
parasites NNS O
, , O
even RB O
in IN O
susceptible JJ O
rainbow NN B-Species
trout NN I-Species
strains NNS O
, , O
is VBZ O
suggested VBN O
by IN O
several JJ O
prior JJ O
light JJ O
and CC O
electron NN O
microscopy NN O
studies NNS O
that WDT O
demonstrate VBP O
an DT O
increase NN O
in IN O
degenerative JJ O
stages NNS O
in IN O
the DT O
skin NN O
beginning VBG O
as RB O
early RB O
as IN O
12 CD O
h NN O
and CC O
then RB O
their PRP$ O
elimination NN O
by IN O
24 CD O
h CD O
post NN O
- HYPH O
exposure NN O
to IN O
triactinomyxons NNS O
[ -LRB- O
12 CD O
, , O
16 CD O
, , O
63 CD O
] -RRB- O
. . O

The DT O
difference NN O
in IN O
metallothionein NN O
expression NN O
may MD O
be VB O
due IN O
to IN O
an DT O
alternative JJ O
immune JJ O
response NN O
pathway NN O
since IN O
the DT O
protein NN O
has VBZ O
known VBN O
involvement NN O
in IN O
diverse JJ O
functional JJ O
capacities NNS O
. . O

For IN O
instance NN O
, , O
metallothionein NN O
' '' O
s NN O
role NN O
as IN O
a DT O
zinc NN O
- HYPH O
finger NN O
transcriptional JJ O
regulator NN O
[ -LRB- O
64 CD O
] -RRB- O
may MD O
dramatically RB O
alter VB O
the DT O
expression NN O
profiles NNS O
between IN O
resistant JJ O
and CC O
susceptible JJ O
rainbow NN B-Species
trout NN I-Species
. . O

All DT O
biological JJ O
roles NNS O
of IN O
this DT O
diverse JJ O
protein NN O
should MD O
be VB O
considered VBN O
when WRB O
examining VBG O
the DT O
complexities NNS O
of IN O
host NN O
immune JJ O
response NN O
. . O

Additionally RB O
, , O
upstream JJ O
regulators NNS O
of IN O
metallothionein NN O
expression NN O
could MD O
be VB O
the DT O
true JJ O
underlying VBG O
cause NN O
of IN O
the DT O
whirling VBG O
disease NN O
phenotype NN O
since IN O
a DT O
gene NN O
expression NN O
study NN O
alone RB O
cannot MD O
determine VB O
if IN O
a DT O
gene NN O
is VBZ O
directly RB O
contributing VBG O
to IN O
a DT O
phenotype NN O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
cause NN O
versus IN O
downstream NN O
effect NN O
) -RRB- O
. . O

Validation NN O
of IN O
microarray NN O
results NNS O
by IN O
qRT NNP O
- HYPH O
PCR NNP O

Quantitative NNP O
RT NNP O
- HYPH O
PCR NNP O
( -LRB- O
qRT NNP O
- HYPH O
PCR NNP O
) -RRB- O
confirmed VBD O
the DT O
microarrays NNS O
results NNS O
for IN O
two CD O
of IN O
the DT O
genes NNS O
up RB O
- HYPH O
regulated VBN O
in IN O
both CC O
Hofer NNP O
and CC O
Trout NNP O
Lodge NNP O
following VBG O
infection NN O
, , O
ubiquitin NN O
and CC O
IRF NNP O
- HYPH O
1 CD O
, , O
and CC O
the DT O
metallothionein NN O
gene NN O
( -LRB- O
MT NNP O
- HYPH O
B NNP O
) -RRB- O
, , O
which WDT O
was VBD O
up RB O
- HYPH O
regulated VBN O
in IN O
Hofer NNP O
but CC O
remained VBD O
unchanged JJ O
in IN O
Trout NNP O
Lodge NNP O
following VBG O
infection NN O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

The DT O
qRT NNP O
- HYPH O
PCR NNP O
results NNS O
for IN O
IRF NNP O
- HYPH O
1 CD O
and CC O
metallothionein NN O
were VBD O
quite RB O
similar JJ O
to IN O
the DT O
microarray JJ O
results NNS O
for IN O
each DT O
gene NN O
, , O
in IN O
terms NNS O
of IN O
relative JJ O
expression NN O
changes NNS O
in IN O
response NN O
to IN O
infection NN O
. . O

MT NNP O
- HYPH O
B NNP O
was VBD O
found VBN O
to TO O
once RB O
again RB O
be VB O
significantly RB O
up RB O
- HYPH O
regulated VBN O
in IN O
the DT O
resistant JJ O
Hofer NNP O
strain NN O
following VBG O
pathogen NN O
exposure NN O
but CC O
remained VBD O
unchanged JJ O
in IN O
the DT O
susceptible JJ O
Trout NNP O
Lodge NNP O
. . O

This DT O
difference NN O
in IN O
MT NNP O
- HYPH O
B NNP O
gene NN O
expression NN O
between IN O
the DT O
two CD O
strains NNS O
was VBD O
statistically RB O
significant JJ O
( : O
P NN O
~ SYM O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

The DT O
relative JJ O
degree NN O
of IN O
up IN O
- HYPH O
regulation NN O
for IN O
ubiquitin NN O
following VBG O
pathogen NN O
exposure NN O
was VBD O
considerably RB O
higher JJR O
in IN O
the DT O
qRT NNP O
- HYPH O
PCR NNP O
( : O
~ SYM O
9 CD O
- HYPH O
17 CD O
fold NN O
greater JJR O
up IN O
- HYPH O
regulation NN O
in IN O
qRT NNP O
- HYPH O
PCR NNP O
versus IN O
microarrays NNS O
) -RRB- O
. . O

Many JJ O
other JJ O
studies NNS O
have VBP O
also RB O
observed VBN O
this DT O
pattern NN O
of IN O
greater JJR O
sensitivity NN O
in IN O
qRT NN O
- HYPH O
PCR NN O
versus IN O
microarray NN O
results NNS O
( , O
for IN O
examples NNS O
see VB O
[ -LRB- O
65 CD O
, , O
66 CD O
] -RRB- O
, , O
which WDT O
is VBZ O
often RB O
attributed VBN O
to IN O
the DT O
more JJR O
gene NN O
- HYPH O
specific JJ O
optimized VBN O
conditions NNS O
of IN O
the DT O
qRT NNP O
- HYPH O
PCR NNP O
approach NN O
. . O

Given VBN O
the DT O
high JJ O
degree NN O
of IN O
statistical JJ O
support NN O
and CC O
biological JJ O
relevance NN O
of IN O
the DT O
candidate NN O
genes NNS O
, , O
we PRP O
believe VBP O
this DT O
study NN O
provides VBZ O
initial JJ O
insight NN O
into IN O
rainbow NN B-Species
trout NN I-Species
genes NNS O
and CC O
pathways NNS O
responding VBG O
to IN O
whirling VBG O
disease NN O
infection NN O
and CC O
identifies VBZ O
the DT O
first JJ O
candidate NN O
genes NNS O
for IN O
whirling VBG O
disease NN O
resistance NN O
. . O

Potential JJ O
future JJ O
studies NNS O

While IN O
the DT O
interferon NN O
system NN O
appears VBZ O
to TO O
be VB O
a DT O
likely JJ O
candidate NN O
system NN O
for IN O
further JJ O
study NN O
, , O
many JJ O
of IN O
the DT O
significant JJ O
genes NNS O
are VBP O
found VBN O
in IN O
alternative JJ O
pathways NNS O
and CC O
have VBP O
distinct JJ O
roles NNS O
and CC O
functions NNS O
in IN O
other JJ O
systems NNS O
. . O

Furthermore RB O
, , O
it PRP O
is VBZ O
increasingly RB O
apparent JJ O
that IN O
epistatic JJ O
interactions NNS O
and CC O
the DT O
interplay NN O
between IN O
pathways NNS O
/ SYM O
networks NNS O
previously RB O
classified VBN O
as IN O
discrete JJ O
can MD O
have VB O
enormous JJ O
phenotypic JJ O
effects NNS O
on IN O
quantitative JJ O
traits NNS O
[ -LRB- O
67 CD O
] -RRB- O
. . O

Multiple JJ O
avenues NNS O
of IN O
research NN O
should MD O
be VB O
examined VBN O
in IN O
future JJ O
studies NNS O
, , O
using VBG O
the DT O
candidate NN O
genes NNS O
presented VBN O
here RB O
as IN O
an DT O
initial JJ O
guide NN O
, , O
due IN O
to IN O
the DT O
complex JJ O
relationships NNS O
between IN O
hosts NNS O
and CC O
pathogens NNS O
. . O

For IN O
instance NN O
, , O
the DT O
migration NN O
of IN O
leukocytes NNS O
and CC O
their PRP$ O
subsequent JJ O
activity NN O
in IN O
the DT O
skin NN O
are VBP O
likely RB O
a DT O
critical JJ O
part NN O
of IN O
the DT O
early JJ O
immune JJ O
and CC O
inflammatory JJ O
host NN O
response NN O
after IN O
pathogen NN O
infection NN O
. . O

Additionally RB O
, , O
it PRP O
is VBZ O
quite RB O
feasible JJ O
that IN O
the DT O
difference NN O
in IN O
metallothionein NN O
expression NN O
is VBZ O
due JJ O
to IN O
an DT O
alternative JJ O
immune JJ O
response NN O
pathway NN O
since IN O
the DT O
protein NN O
has VBZ O
known VBN O
involvement NN O
in IN O
diverse JJ O
functional JJ O
capacities NNS O
. . O

For IN O
instance NN O
, , O
metallothionein NN O
' '' O
s NN O
role NN O
as IN O
a DT O
zinc NN O
- HYPH O
finger NN O
transcriptional JJ O
regulator NN O
[ -LRB- O
64 CD O
] -RRB- O
may MD O
dramatically RB O
alter VB O
the DT O
expression NN O
profiles NNS O
between IN O
resistant JJ O
and CC O
susceptible JJ O
rainbow NN B-Species
trout NN I-Species
. . O

All DT O
biological JJ O
roles NNS O
of IN O
this DT O
diverse JJ O
protein NN O
should MD O
be VB O
considered VBN O
when WRB O
examining VBG O
the DT O
complexities NNS O
of IN O
host NN O
immune JJ O
response NN O
. . O

Finally RB O
, , O
upstream JJ O
regulators NNS O
of IN O
metallothionein NN O
expression NN O
could MD O
be VB O
the DT O
true JJ O
underlying VBG O
cause NN O
of IN O
the DT O
whirling VBG O
disease NN O
phenotype NN O
since IN O
a DT O
gene NN O
expression NN O
study NN O
alone RB O
cannot MD O
determine VB O
if IN O
a DT O
gene NN O
is VBZ O
directly RB O
contributing VBG O
to IN O
a DT O
phenotype NN O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
cause NN O
versus IN O
downstream NN O
effect NN O
) -RRB- O
. . O

The DT O
expression NN O
profiles NNS O
of IN O
a DT O
variety NN O
of IN O
metallothionein NN O
upstream NN O
regulators NNS O
, , O
such JJ O
as IN O
cytokines NNS O
and CC O
metal NN O
transcription NN O
factor NN O
( , O
MTF NNP O
- HYPH O
1 CD O
) -RRB- O
, , O
could MD O
be VB O
evaluated VBN O
in IN O
a DT O
time NN O
course NN O
study NN O
during IN O
early JJ O
disease NN O
progression NN O
to TO O
identify VB O
additional JJ O
candidate NN O
genes NNS O
. . O

A DT O
QTL NNP O
mapping NN O
approach NN O
could MD O
also RB O
be VB O
used VBN O
to TO O
identify VB O
particular JJ O
chromosomal JJ O
regions NNS O
directly RB O
contributing VBG O
to IN O
the DT O
disease NN O
phenotype NN O
. . O

Conclusion NN O

The DT O
present JJ O
study NN O
has VBZ O
provided VBN O
the DT O
first JJ O
examination NN O
into IN O
the DT O
genetic JJ O
basis NN O
underlying VBG O
rainbow NN B-Species
trout NN I-Species
' POS O
s NN O
immune JJ O
response NN O
and CC O
resistance NN O
to IN O
the DT O
whirling VBG O
disease NN O
pathogen NN O
. . O

Several JJ O
genes NNS O
were VBD O
significantly RB O
up RB O
- HYPH O
regulated VBN O
in IN O
skin NN O
following VBG O
pathogen NN O
exposure NN O
for IN O
both CC O
the DT O
resistant JJ O
Hofer NNP O
and CC O
susceptible JJ O
Trout NNP O
Lodge NNP O
rainbow NN B-Species
trout NN I-Species
strains NNS O
. . O

For IN O
both DT O
strains NNS O
, , O
response NN O
to IN O
infection NN O
appears VBZ O
to TO O
be VB O
linked VBN O
with IN O
the DT O
interferon NN O
system NN O
. . O

Metallothionein NNP O
B NNP O
is VBZ O
differentially RB O
expressed VBN O
between IN O
the DT O
resistant JJ O
and CC O
susceptible JJ O
strains NNS O
and CC O
is VBZ O
a DT O
good JJ O
candidate NN O
for IN O
future JJ O
whirling NN O
disease NN O
resistance NN O
studies NNS O
. . O

The DT O
identified VBN O
genes NNS O
have VBP O
allowed VBN O
us PRP O
to TO O
gain VB O
initial JJ O
insight NN O
into IN O
the DT O
molecular JJ O
mechanisms NNS O
involved VBN O
in IN O
a DT O
salmonid JJ O
host NN O
' POS O
s NN O
immune JJ O
response NN O
and CC O
resistance NN O
to IN O
whirling VBG O
disease NN O
infection NN O
. . O

Methods NNS O

Animal NN O
care NN O
, , O
pathogen NN O
exposure NN O
, , O
and CC O
RNA NN O
preparation NN O

Hofer NNP O
and CC O
Trout NNP O
Lodge NNP O
rainbow NN B-Species
trout NN I-Species
strains NNS O
were VBD O
reared VBN O
in IN O
35 CD O
gallon NN O
aquaria NNS O
with IN O
15 CD O
degrees NNS O
C NN O
flow NN O
- , O
through IN O
well NN O
water NN O
for IN O
nine CD O
weeks NNS O
post NN O
- HYPH O
hatch NN O
, , O
with IN O
each DT O
fish NN O
weighing VBG O
approximately RB O
6 CD O
. . O
5 CD O
grams NNS O
prior RB O
to IN O
pathogen NN O
exposure NN O
. . O

Individuals NNS O
from IN O
each DT O
strain NN O
( , O
n CD O
= SYM O
60 CD O
) -RRB- O
were VBD O
exposed VBN O
to IN O
2 CD O
, , O
0 CD O
triactinomyxons NNS O
( , O
TAMs NNS O
) -RRB- O
per IN O
fish NN O
for IN O
one CD O
hour NN O
. . O

Additional JJ O
fish NN O
( , O
n CD O
= SYM O
60 CD O
) -RRB- O
from IN O
both DT O
strains NNS O
served VBD O
as IN O
unexposed JJ O
controls NNS O
, , O
which WDT O
were VBD O
treated VBN O
identically RB O
to IN O
exposed VBN O
fish NN O
at IN O
all DT O
experimental JJ O
stages NNS O
other JJ O
than IN O
their PRP$ O
lack NN O
of IN O
pathogen NN O
exposure NN O
. . O

Fish NNS O
were VBD O
then RB O
kept VBN O
under IN O
standard JJ O
aquaculture NN O
conditions NNS O
until IN O
euthanized VBN O
. . O

TaqMan NNP O
PCR NNP O
for IN O
the DT O
quantitative JJ O
evaluation NN O
of IN O
genomic JJ O
parasite NN O
DNA NNP O
was VBD O
employed VBN O
to TO O
confirm VB O
that IN O
fish NN O
in IN O
both CC O
the DT O
Hofer NNP O
and CC O
Trout NNP O
Lodge NNP O
groups NNS O
received VBD O
equal JJ O
amounts NNS O
of IN O
parasite NN O
exposure NN O
. . O

At IN O
two CD O
hours NNS O
post NN O
TAM NNP O
exposure NN O
, , O
6 CD O
fish NN O
in IN O
each DT O
exposed JJ O
group NN O
were VBD O
removed VBN O
and CC O
euthanized VBN O
with IN O
an DT O
overdose NN O
of IN O
benzocaine NN O
at IN O
a DT O
concentration NN O
of IN O
500 CD O
mg NNS O
/ SYM O
L NN O
. . O

Caudal JJ O
fins NNS O
were VBD O
removed VBN O
posterior NN O
to IN O
the DT O
peduncle NN O
and CC O
used VBN O
as IN O
the DT O
tissue NN O
for IN O
a DT O
quantiative JJ O
TaqMan NNP O
assay NN O
following VBG O
procedures NNS O
described VBN O
by IN O
Kelley NNP O
et FW O
al NNP O
. . O

[ -LRB- O
68 CD O
] -RRB- O
. . O

Microarray NN O
studies NNS O
examining VBG O
skin NN O
four CD O
hours NNS O
after IN O
pathogen NN O
exposure NN O
did VBD O
not RB O
identify VB O
any DT O
genes NNS O
differentially RB O
expressed VBN O
between IN O
Trout NNP O
Lodge NNP O
and CC O
Hofer NNP O
strains NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Therefore RB O
, , O
we PRP O
chose VBD O
a DT O
later JJ O
time NN O
point NN O
( , O
24 CD O
hours NNS O
after IN O
exposure NN O
) , O
so IN O
that IN O
early JJ O
host NN O
immune JJ O
response NN O
was VBD O
more RBR O
likely JJ O
to TO O
be VB O
fully RB O
underway JJ O
and CC O
significant JJ O
expression NN O
changes NNS O
could MD O
be VB O
detected VBN O
. . O

After IN O
the DT O
24 CD O
hour NN O
incubation NN O
period NN O
, , O
all DT O
fish NN O
were VBD O
euthanized VBN O
with IN O
an DT O
overdose NN O
of IN O
benzocaine NN O
at IN O
a DT O
concentration NN O
of IN O
500 CD O
mg NNS O
/ SYM O
L NN O
. . O

Each DT O
fish NN O
was VBD O
euthanized VBN O
individually RB O
and CC O
the DT O
caudal JJ O
fin NN O
( , O
largely RB O
comprised VBN O
of IN O
skin NN O
tissue NN O
) , O
was VBD O
removed VBN O
posterior NN O
to IN O
the DT O
peduncle NN O
. . O

The DT O
fin NNP O
was VBD O
immediately RB O
placed VBN O
into IN O
2 CD O
x SYM O
Nucleic NNP O
Acid NNP O
Purification NNP O
Lysis NNP O
Solution NNP O
supplied VBN O
with IN O
ABI NNP O
' POS O
s POS O
TransPrep NNP O
Chemistry NNP O
kit NN O
( : O
Applied NNP O
Biosystems NNP O
, , O
Foster NNP O
City NNP O
, , O
CA NNP O
) -RRB- O
to TO O
stop VB O
further JJ O
gene NN O
expression NN O
changes NNS O
. . O

Total JJ O
RNA NNP O
was VBD O
extracted VBN O
from IN O
the DT O
fin NN O
of IN O
each DT O
individual NN O
using VBG O
the DT O
ABI NNP O
Prism NNP O
( -LRB- O
TM NNP O
) -RRB- O
TransPrep NNP O
system NN O
with IN O
the DT O
ABI NNP O
Prism NNP O
( -LRB- O
TM NNP O
) SYM O
6100 CD O
Nucleic NNP O
Acid NNP O
PrepStation NNP O
according VBG O
to IN O
manufacturer NN O
instructions NNS O
. . O

RNA NNP O
quality NN O
was VBD O
assessed VBN O
by IN O
agarose JJ O
gel NN O
electrophoresis NN O
and CC O
RNA NN O
concentrations NNS O
were VBD O
measured VBN O
using VBG O
a DT O
ND NNP O
- HYPH O
1000 CD O
spectrophotometer NN O
( HYPH O
NanoDrop NNP O
Technologies NNP O
, , O
Wilmington NNP O
, , O
DE NNP O
) -RRB- O
. . O

Starting VBG O
total JJ O
RNA NNP O
yields NNS O
were VBD O
not RB O
sufficient JJ O
for IN O
microarray JJ O
hybridizations NNS O
due IN O
to IN O
the DT O
small JJ O
amount NN O
of IN O
caudal JJ O
fin NN O
tissue NN O
present JJ O
on IN O
these DT O
young JJ O
fish NNS O
. . O

Therefore RB O
, , O
250 CD O
- SYM O
1000 CD O
ng NN O
of IN O
total JJ O
RNA NNP O
was VBD O
used VBN O
as IN O
the DT O
starting VBG O
material NN O
to TO O
create VB O
amplified VBN O
RNA NNP O
( -LRB- O
aRNA NNP O
) -RRB- O
indirectly RB O
labeled VBN O
with IN O
Cy3 NNP O
or CC O
Cy5 NNP O
fluorescent NN O
dyes NNS O
( -LRB- O
GE NNP O
Healthcare NNP O
, , O
Buckinghamshire NNP O
, , O
UK NNP O
) , O
using VBG O
the DT O
Amino NNP O
Allyl NNP O
MessageAmp NNP O
( -LRB- O
TM NNP O
) -RRB- O
II NNP O
aRNA NNP O
Amplification NNP O
kit NN O
according VBG O
to IN O
manufacturer NN O
instructions NNS O
( : O
Ambion NNP O
, , O
Austin NNP O
, , O
TX NNP O
) -RRB- O
. . O

Microarray NN O
hybridization NN O
and CC O
data NN O
analysis NN O

Salmonid NNP O
cDNA NNP O
microarrays NN O
( , O
GRASP16k NNP O
v2 NN O
. . O
0 CD O
) -RRB- O
were VBD O
obtained VBN O
from IN O
consortium NN O
for IN O
Genomic NNP O
Research NNP O
on IN O
Atlantic NNP O
Salmon NNP O
( : O
cGRASP NNP O
) -RRB- O
and CC O
details NNS O
of IN O
microarray JJ O
development NN O
and CC O
fabrication NN O
can MD O
be VB O
found VBN O
in IN O
von NNP O
Schalburg NNP O
et FW O
al NNP O
. . O

[ -LRB- O
69 CD O
] -RRB- O
. . O

These DT O
arrays NNS O
contain VBP O
13 CD O
, , O
421 CD O
Atlantic NNP B-Species
salmon NN I-Species
and CC O
2 CD O
, , O
576 CD O
rainbow NN B-Species
trout NN I-Species
cDNA NN O
features NNS O
and CC O
have VBP O
been VBN O
successfully RB O
used VBN O
for IN O
several JJ O
previous JJ O
rainbow NN B-Species
trout NN I-Species
gene NN O
expression NN O
studies NNS O
[ -LRB- O
70 CD O
- SYM O
73 CD O
] -RRB- O
. . O

For IN O
each DT O
rainbow NN B-Species
trout NN I-Species
strain NN O
, , O
competitive JJ O
hybridization NN O
was VBD O
conducted VBN O
on IN O
every DT O
array NN O
using VBG O
equal JJ O
amounts NNS O
( , O
8 CD O
mu NN O
g NN O
) -RRB- O
of IN O
differentially RB O
labeled VBN O
aRNA NN O
from IN O
one CD O
control NN O
fish NN O
and CC O
one CD O
exposed VBN O
fish NN O
. . O

Four CD O
biological JJ O
replicates NNS O
were VBD O
performed VBN O
for IN O
each DT O
experimental JJ O
condition NN O
and CC O
dye NN O
- HYPH O
sample NN O
coupling NN O
was VBD O
swapped VBN O
between IN O
biological JJ O
replicates NNS O
in IN O
a DT O
balanced JJ O
block NN O
design NN O
. . O

Prehybridization NN O
washes VBZ O
for IN O
all DT O
microarrays NNS O
included VBN O
: : O
2 CD O
x SYM O
5 CD O
min NN O
in IN O
0 CD O
. . O
1 CD O
% NN O
SDS NN O
, , O
5 CD O
x SYM O
1 CD O
min NN O
in IN O
NANOpure NNP O
H2O NNP O
with IN O
0 CD O
. . O
5 CD O
mM NN O
dithiothreotol NN O
, , O
1 CD O
min NN O
in IN O
near IN O
boiling VBG O
nanopure NN O
H2O NN O
, , O
centrifugation NN O
for IN O
2 CD O
min NN O
at IN O
1500 CD O
RPM NN O
. . O

To TO O
reduce VB O
background NN O
, , O
the DT O
microarrays NNS O
were VBD O
next JJ O
incubated VBN O
for IN O
90 CD O
min NN O
in IN O
5 CD O
x SYM O
SSC NNP O
, , O
0 CD O
. . O
1 CD O
% NN O
SDS NNP O
, , O
3 CD O
% NN O
BSA NNP O
( -LRB- O
Fraction NN O
V NN O
) -RRB- O
at IN O
49 CD O
degrees NNS O
C NN O
, , O
washed VBN O
3 CD O
x SYM O
20 CD O
s NNS O
in IN O
nanopure NN O
H2O NN O
, , O
and CC O
dried VBN O
by IN O
centrifugation NN O
for IN O
5 CD O
min NN O
at IN O
1500 CD O
RPM NN O
. . O

The DT O
labeled VBN O
aRNA NNP O
samples NNS O
were VBD O
competitively RB O
hybridized VBN O
to IN O
microarrays NNS O
prewarmed VBN O
to IN O
49 CD O
degrees NNS O
C NN O
for IN O
16 CD O
hours NNS O
in IN O
a DT O
formamide NN O
- HYPH O
based VBN O
buffer NN O
( , O
Genisphere NNP O
, , O
Hatfield NNP O
, , O
PA NNP O
) , O
with IN O
LNA NNP O
dT NN O
blocker NN O
( , O
Genisphere NNP O
) -RRB- O
. . O

Posthybridization NN O
washes VBZ O
for IN O
all DT O
microarrays NNS O
included VBN O
: : O
1 CD O
x SYM O
10 CD O
min NN O
in IN O
2 CD O
x SYM O
SSC NN O
, , O
0 CD O
. . O
1 CD O
% NN O
SDS NN O
prewarmed VBN O
to IN O
49 CD O
degrees NNS O
C NN O
, , O
2 CD O
x SYM O
5 CD O
min NN O
in IN O
2 CD O
x SYM O
SSC NN O
, , O
0 CD O
. . O
1 CD O
% NN O
SDS NN O
at IN O
room NN O
temperature NN O
, , O
2 CD O
x SYM O
5 CD O
min NN O
1 CD O
x SYM O
SSC NN O
at IN O
room NN O
temperature NN O
, , O
2 CD O
x SYM O
5 CD O
min NN O
0 CD O
. . O
1 CD O
x SYM O
SSC NN O
at IN O
room NN O
temperature NN O
. . O

Slides NNS O
were VBD O
then RB O
dried VBN O
by IN O
centrifugation NN O
and CC O
immediately RB O
scanned VBN O
using VBG O
an DT O
Agilent NNP O
G2565BA NNP O
Microarray NNP O
Scanner NNP O
( : O
Agilent NNP O
Technologies NNP O
, , O
Santa NNP O
Clara NNP O
, , O
CA NNP O
) -RRB- O
. . O

Data NNS O
underwent VBD O
local JJ O
background NN O
subtraction NN O
and CC O
LOWESS NNP O
normalization NN O
using VBG O
Agilent NNP O
' POS O
s NNPS O
Feature NNP O
Extraction NNP O
software NN O
. . O

Raw JJ O
and CC O
processed JJ O
gene NN O
expression NN O
data NNS O
have VBP O
been VBN O
deposited VBN O
into IN O
the DT O
NCBI NNP O
Gene NNP O
Expression NNP O
Omnibus NNP O
[ -LRB- O
74 CD O
] -RRB- O
( , O
series NN O
GSE8631 NN O
) -RRB- O
and CC O
are VBP O
in IN O
compliance NN O
with IN O
MIAME NNP O
guidelines NNS O
. . O

The DT O
Significance NNP O
Analysis NNP O
of IN O
Microarrays NNP O
( -LRB- O
SAM NNP O
) -RRB- O
software NN O
package NN O
[ -LRB- O
75 CD O
] -RRB- O
was VBD O
used VBN O
to TO O
identify VB O
differentially RB O
expressed VBN O
genes NNS O
between IN O
exposed VBN O
and CC O
unexposed JJ O
control NN O
fish NN O
for IN O
each DT O
rainbow NN B-Species
trout NN I-Species
strain NN O
. . O

Both DT O
a DT O
Wilcoxon NNP O
rank NN O
sum NN O
and CC O
a DT O
modified JJ O
t NN O
- HYPH O
test NN O
were VBD O
conducted VBN O
with IN O
1 CD O
, , O
0 CD O
permutations NNS O
and CC O
the DT O
minimum JJ O
fold NN O
change NN O
cut VBN O
- HYPH O
off NN O
was VBD O
set VBN O
to IN O
2 CD O
. . O
0 CD O
up IN O
- HYPH O
or CC O
down RB O
- HYPH O
regulated VBN O
. . O

A DT O
false JJ O
discovery NN O
rate NN O
( -LRB- O
FDR NNP O
) -RRB- O
of IN O
0 CD O
. . O
0 CD O
% NN O
was VBD O
estimated VBN O
for IN O
both DT O
strains NNS O
. . O

To TO O
determine VB O
statistically RB O
significant JJ O
differences NNS O
between IN O
the DT O
Hofer NNP O
and CC O
Trout NNP O
Lodge NNP O
strains NNS O
, , O
a DT O
Welch NNP O
' '' O
s NN O
t NN O
- HYPH O
test NN O
( HYPH O
P NN O
- HYPH O
value NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
was VBD O
implemented VBN O
in IN O
Microsoft NNP O
Excel NNP O
between IN O
the DT O
log NN O
ratios NNS O
( , O
exposed VBN O
/ SYM O
control NN O
) -RRB- O
for IN O
each DT O
strain NN O
for IN O
all DT O
genes NNS O
that WDT O
were VBD O
significant JJ O
for IN O
at RB O
least RBS O
one CD O
strain NN O
in IN O
the DT O
SAM NNP O
program NN O
. . O

Quantitative JJ O
RT NNP O
- HYPH O
PCR NN O

Microarray NNP O
expression NN O
results NNS O
were VBD O
validated VBN O
by IN O
qRT NN O
- HYPH O
PCR NNP O
for IN O
several JJ O
identified VBN O
genes NNS O
. . O

Prior RB O
to IN O
qRT NNP O
- HYPH O
PCR NNP O
, , O
80 CD O
ng NNS O
of IN O
total JJ O
RNA NNP O
was VBD O
reverse RB O
transcribed VBN O
from IN O
each DT O
biological JJ O
replicate NN O
used VBN O
for IN O
the DT O
microarray NN O
study NN O
along IN O
with IN O
two CD O
additional JJ O
samples NNS O
( , O
total JJ O
n NN O
= SYM O
6 CD O
per IN O
experimental JJ O
condition NN O
) , O
using VBG O
the DT O
QuantiScript NNP O
Reverse NNP O
Transcriptase NNP O
kit NN O
( , O
Qiagen NNP O
, , O
Valencia NNP O
, , O
CA NNP O
) , O
according VBG O
to IN O
manufacturer NN O
instructions NNS O
. . O

In IN O
contrast NN O
to IN O
the DT O
microarray JJ O
experiments NNS O
, , O
the DT O
template NN O
RNA NNP O
was VBD O
not RB O
amplified VBN O
before IN O
cDNA NNP O
synthesis NN O
. . O

EST NNP O
clone NN O
sequences NNS O
from IN O
the DT O
cGRASP NNP O
microarray NN O
were VBD O
used VBN O
to TO O
design VB O
primers NNS O
for IN O
genes NNS O
undergoing VBG O
validation NN O
, , O
along IN O
with IN O
a DT O
beta NN O
- HYPH O
actin NN O
reference NN O
gene NN O
used VBN O
for IN O
normalization NN O
, , O
with IN O
Primer3 NNP O
software NN O
[ -LRB- O
76 CD O
] -RRB- O
and CC O
the DT O
sequence NN O
for IN O
each DT O
primer NN O
pair NN O
is VBZ O
shown VBN O
in IN O
Table NNP O
3 CD O
. . O

The DT O
Quantitect NNP O
( -LRB- O
TM NNP O
) -RRB- O
SYBR NNP O
( -LRB- O
R NNP O
) -RRB- O
Green NNP O
RT NNP O
- HYPH O
PCR NN O
kit NN O
( , O
Qiagen NNP O
) -RRB- O
was VBD O
used VBN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
instructions NNS O
except IN O
the DT O
final JJ O
PCR NN O
volume NN O
was VBD O
reduced VBN O
to IN O
25 CD O
mu NNS O
l NN O
. . O

The DT O
PCR NNP O
conditions NNS O
used VBN O
on IN O
a DT O
Chromo4 NNP O
Real NNP O
Time NNP O
PCR NNP O
Detection NNP O
System NNP O
( -LRB- O
Bio NNP O
- HYPH O
Rad NNP O
, , O
Hercules NNP O
, , O
CA NNP O
) -RRB- O
were VBD O
as IN O
follows VBZ O
: : O
HotStarTaq NNP O
DNA NNP O
polymerase NN O
activation NN O
at IN O
95 CD O
degrees NNS O
C NN O
for IN O
15 CD O
min NN O
, , O
45 CD O
cycles NNS O
of IN O
15 CD O
s NNS O
denaturation NN O
at IN O
94 CD O
degrees NNS O
C NN O
, , O
30 CD O
s NNS O
annealing VBG O
at IN O
58 CD O
degrees NNS O
C NN O
, , O
30 CD O
s NNS O
extension NN O
at IN O
72 CD O
degrees NNS O
C NN O
, , O
followed VBN O
by IN O
a DT O
melting NN O
curve NN O
to TO O
ensure VB O
that IN O
a DT O
single JJ O
PCR NNP O
product NN O
was VBD O
produced VBN O
for IN O
each DT O
reaction NN O
. . O

For IN O
each DT O
gene NN O
, , O
the DT O
relative JJ O
amount NN O
of IN O
gene NN O
expression NN O
was VBD O
calculated VBN O
using VBG O
the DT O
Delta NNP O
Delta NNP O
CT NNP O
method NN O
[ -LRB- O
77 CD O
] -RRB- O
and CC O
significance NN O
was VBD O
determined VBN O
using VBG O
a DT O
nonparametric JJ O
Mann NNP O
- HYPH O
Whitney NNP O
U NNP O
test NN O
and CC O
multiple JJ O
linear JJ O
regression NN O
in IN O
JMP NNP O
. . O

Authors NNS O
' POS O
contributions NNS O

MRB NNP O
participated VBD O
in IN O
study NN O
conception NN O
and CC O
design NN O
, , O
conducted VBD O
gene NN O
expression NN O
experiments NNS O
and CC O
data NN O
analysis NN O
, , O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

ABW NNP O
participated VBD O
in IN O
study NN O
design NN O
, , O
data NN O
analysis NN O
, , O
and CC O
manuscript NN O
revision NN O
. . O

RPH NNP O
and CC O
BPM NNP O
participated VBD O
in IN O
study NN O
conception NN O
and CC O
design NN O
, , O
supervision NN O
of IN O
research NN O
activities NNS O
, , O
and CC O
manuscript NN O
revision NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

The DT O
comparative JJ O
analysis NN O
of IN O
statistics NNS O
, , O
based VBN O
on IN O
the DT O
likelihood NN O
ratio NN O
criterion NN O
, , O
in IN O
the DT O
automated JJ O
annotation NN O
problem NN O

Abstract JJ O

Background NN O

This DT O
paper NN O
discusses VBZ O
the DT O
problem NN O
of IN O
automated JJ O
annotation NN O
. . O

It PRP O
is VBZ O
a DT O
continuation NN O
of IN O
the DT O
previous JJ O
work NN O
on IN O
the DT O
A4 NNP O
- HYPH O
algorithm NN O
( , O
Adaptive JJ O
algorithm NN O
of IN O
automated JJ O
annotation NN O
) , O
developed VBN O
by IN O
Leontovich NNP O
and CC O
others NNS O
. . O

Results NNS O

A DT O
number NN O
of IN O
new JJ O
statistics NNS O
for IN O
the DT O
automated JJ O
annotation NN O
of IN O
biological JJ O
sequences NNS O
is VBZ O
introduced VBN O
. . O

All PDT O
these DT O
statistics NNS O
are VBP O
based VBN O
on IN O
the DT O
likelihood NN O
ratio NN O
criterion NN O
. . O

Conclusion NN O

Some DT O
of IN O
the DT O
statistics NNS O
yield VBP O
a DT O
prediction NN O
quality NN O
that WDT O
is VBZ O
significantly RB O
higher JJR O
( : O
up IN O
to TO O
1 CD O
. . O
5 CD O
times NNS O
higher JJR O
) , O
in IN O
comparison NN O
with IN O
the DT O
results NNS O
obtained VBN O
with IN O
the DT O
A4 NNP O
- HYPH O
procedure NN O
. . O

Background NN O

Many JJ O
biological JJ O
databanks NNS O
, , O
both DT O
dealing VBG O
with IN O
protein NN O
sequences NNS O
( , O
e LS O
. . O
g LS O
. . O
, , O
SWISS NNP O
- HYPH O
PROT NN O
) -RRB- O
and CC O
nucleotide NN O
sequences NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
GeneBank NNP O
) -RRB- O
, , O
contain VBP O
not RB O
only RB O
primary JJ O
structures NNS O
of IN O
sequences NNS O
( , O
i LS O
. . O
e -RRB- O
. . O
, , O
sequences NNS O
of IN O
letters NNS O
- HYPH O
amino NN O
acids NNS O
or CC O
nucleotides NNS O
) -RRB- O
, , O
but CC O
also RB O
information NN O
about IN O
functions NNS O
and CC O
properties NNS O
of IN O
these DT O
sequences NNS O
. . O

This DT O
information NN O
is VBZ O
stored VBN O
in IN O
so RB O
called VBN O
description NN O
fields NNS O
of IN O
the DT O
sequences NNS O
. . O

There EX O
exist VBP O
different JJ O
types NNS O
of IN O
description NN O
fields NNS O
- : O
KW NNP O
( , O
KeyWords NNP O
) -RRB- O
, , O
DE NNP O
( , O
Descriptions NNPS O
) -RRB- O
, , O
. . O
. , O
. . O
, , O
FT NNP O
( , O
Feature NNP O
Table NNP O
) -RRB- O
, , O
. . O
. , O
. , O
; : O
elements NNS O
of IN O
description NN O
fields NNS O
are VBP O
referred VBN O
to IN O
as IN O
words NNS O
. . O

Words NNS O
from IN O
KW NNP O
, , O
DE NNP O
, , O
. . O
. , O
. , O
fields NNS O
describe VBP O
a DT O
sequence NN O
as IN O
a DT O
whole NN O
, , O
while IN O
words NNS O
from IN O
FT NNP O
fields NNS O
correspond VBP O
to IN O
certain JJ O
positions NNS O
( , O
letters NNS O
) -RRB- O
of IN O
a DT O
sequence NN O
. . O

The DT O
automated JJ O
annotation NN O
problem NN O
can MD O
be VB O
described VBN O
as IN O
follows VBZ O
. . O

Consider VB O
a DT O
biological JJ O
sequence NN O
( , O
referred VBD O
to IN O
as IN O
a DT O
query NN O
sequence NN O
) , O
with IN O
known VBN O
primary JJ O
structure NN O
( , O
i LS O
. . O
e -RRB- O
. . O
letter NN O
sequence NN O
) -RRB- O
but CC O
unknown JJ O
properties NNS O
and CC O
functions NNS O
( , O
i LS O
. . O
e -RRB- O
. . O
, , O
description NN O
fields NNS O
) -RRB- O
. . O

The DT O
task NN O
is VBZ O
to TO O
determine VB O
functions NNS O
and CC O
properties NNS O
of IN O
this DT O
sequence NN O
( , O
in IN O
other JJ O
words NNS O
, , O
to TO O
restore VB O
its PRP$ O
description NN O
fields NNS O
) -RRB- O
on IN O
the DT O
basis NN O
of IN O
the DT O
primary JJ O
structure NN O
. . O

The DT O
annotation NN O
should MD O
be VB O
fully RB O
automated VBN O
. . O

This DT O
is VBZ O
the DT O
subject NN O
of IN O
the DT O
current JJ O
paper NN O
. . O

There EX O
are VBP O
two CD O
main JJ O
approaches NNS O
to IN O
the DT O
solution NN O
of IN O
this DT O
problem NN O
. . O

In IN O
the DT O
first JJ O
approach NN O
( : O
it PRP O
can MD O
be VB O
called VBN O
a DT O
static JJ O
one NN O
) , O
a DT O
certain JJ O
fixed VBN O
protein NN O
classification NN O
( , O
grouping VBG O
proteins NNS O
according VBG O
to IN O
similarity NN O
in IN O
structure NN O
and CC O
/ SYM O
or CC O
functions NNS O
) -RRB- O
, , O
specified VBN O
beforehand RB O
, , O
is VBZ O
used VBN O
: : O
for IN O
a DT O
query NN O
protein NN O
the DT O
search NN O
of IN O
a DT O
relative JJ O
group NN O
( , O
super JJ O
family NN O
) -RRB- O
is VBZ O
performed VBN O
on IN O
the DT O
basis NN O
of IN O
primary JJ O
structures NNS O
, , O
and CC O
properties NNS O
/ SYM O
functions NNS O
of IN O
this DT O
group NN O
are VBP O
extended VBN O
to IN O
the DT O
query NN O
protein NN O
. . O

An DT O
example NN O
of IN O
this DT O
approach NN O
is VBZ O
described VBN O
in IN O
the DT O
paper NN O
by IN O
W NNP O
. . O

Fleischmann NNP O
et FW O
al FW O
. . O

[ -LRB- O
1 LS O
] -RRB- O
, , O
it PRP O
uses VBZ O
the DT O
protein NN O
classification NN O
( , O
more JJR O
than IN O
1000 CD O
families NNS O
) -RRB- O
, , O
stored VBN O
in IN O
the DT O
Prosite NNP O
databank NN O
. . O

The DT O
second JJ O
approach NN O
( , O
it PRP O
can MD O
be VB O
called VBN O
a DT O
dynamic JJ O
or CC O
an DT O
adaptive JJ O
one NN O
) -RRB- O
does VBZ O
not RB O
use VB O
protein NN O
classification NN O
. . O

Instead RB O
, , O
a DT O
"""" `` O
dynamic JJ O
"""" '' O
collection NN O
of IN O
bank NN O
sequences NNS O
that WDT O
are VBP O
similar JJ O
to IN O
a DT O
query NN O
sequence NN O
is VBZ O
generated VBN O
, , O
and CC O
then RB O
common JJ O
properties NNS O
/ SYM O
functions NNS O
of IN O
these DT O
bank NN O
sequences NNS O
are VBP O
extended VBN O
to IN O
the DT O
query NN O
sequence NN O
. . O

One CD O
of IN O
the DT O
first JJ O
examples NNS O
of IN O
this DT O
approach NN O
was VBD O
described VBN O
by IN O
M NNP O
. . O
A NNP O
. . O

Andrade NNP O
et FW O
al FW O
. . O

[ -LRB- O
2 LS O
] -RRB- O
. . O

In IN O
this DT O
paper NN O
the DT O
prediction NN O
was VBD O
based VBN O
on IN O
so RB O
called VBN O
word NN O
reliability NN O
function NN O
- : O
a DT O
function NN O
depending VBG O
on IN O
the DT O
degree NN O
of IN O
similarity NN O
between IN O
a DT O
query NN O
sequence NN O
and CC O
corresponding VBG O
bank NN O
sequences NNS O
. . O

In IN O
other JJ O
examples NNS O
of IN O
annotation NN O
procedures NNS O
based VBN O
on IN O
the DT O
dynamic JJ O
approach NN O
prediction NN O
was VBD O
performed VBN O
in IN O
a DT O
"""" `` O
naive JJ O
"""" '' O
way NN O
- : O
all DT O
properties NNS O
/ SYM O
functions NNS O
of IN O
similar JJ O
proteins NNS O
were VBD O
extended VBN O
to IN O
a DT O
query NN O
protein NN O
, , O
or CC O
using VBG O
stochastic JJ O
methods NNS O
- : O
only RB O
properties NNS O
/ SYM O
functions NNS O
that WDT O
are VBP O
most RBS O
frequent JJ O
for IN O
the DT O
collection NN O
of IN O
similar JJ O
proteins NNS O
were VBD O
extended VBN O
( : O
see VB O
[ -LRB- O
3 CD O
, , O
4 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
current JJ O
paper NN O
uses VBZ O
the DT O
dynamic JJ O
approach NN O
. . O

This DT O
paper NN O
is VBZ O
a DT O
sequel NN O
to IN O
paper NN O
[ -LRB- O
5 CD O
] -RRB- O
that WDT O
describes VBZ O
the DT O
A4 NNP O
algorithm NN O
( , O
the DT O
Adaptive NNP O
Algorithm NNP O
of IN O
Automated NNP O
Annotation NNP O
) -RRB- O
, , O
so IN O
results NNS O
of IN O
the DT O
paper NN O
[ -LRB- O
5 CD O
] -RRB- O
are VBP O
constantly RB O
used VBN O
here RB O
. . O

The DT O
A4 NNP O
algorithm NN O
is VBZ O
based VBN O
on IN O
a DT O
stochastic JJ O
approach NN O
. . O

More RBR O
precisely RB O
, , O
it PRP O
is VBZ O
based VBN O
on IN O
the DT O
notion NN O
of IN O
transfer NN O
probabilities NNS O
. . O

Transfer NN O
probabilities NNS O
are VBP O
the DT O
probabilities NNS O
of IN O
word NN O
transfer NN O
( , O
extension NN O
) -RRB- O
from IN O
description NN O
fields NNS O
of IN O
one CD O
sequence NN O
to IN O
description NN O
fields NNS O
of IN O
another DT O
sequence NN O
; : O
they PRP O
depend VBP O
on IN O
the DT O
measure NN O
of IN O
similarity NN O
between IN O
sequences NNS O
. . O

Transfer NN O
probabilities NNS O
are VBP O
evaluated VBN O
on IN O
the DT O
basis NN O
of IN O
word NN O
transfer NN O
frequencies NNS O
in IN O
the DT O
found VBN O
collection NN O
of IN O
sequences NNS O
similar JJ O
to IN O
a DT O
query NN O
sequence NN O
. . O

For IN O
each DT O
word NN O
from IN O
description NN O
fields NNS O
of IN O
sequences NNS O
included VBN O
in IN O
the DT O
collection NN O
the DT O
prediction NN O
of IN O
the DT O
fact NN O
that IN O
this DT O
word NN O
belongs VBZ O
( , O
or CC O
does VBZ O
not RB O
belong VB O
) -RRB- O
to IN O
the DT O
description NN O
field NN O
of IN O
a DT O
query NN O
sequence NN O
is VBZ O
performed VBN O
; : O
this DT O
prediction NN O
is VBZ O
based VBN O
on IN O
transfer NN O
probabilities NNS O
. . O

In IN O
the DT O
current JJ O
paper NN O
we PRP O
introduce VBP O
and CC O
analyze VBP O
a DT O
number NN O
of IN O
new JJ O
statistics NNS O
for IN O
the DT O
prediction NN O
. . O

All DT O
of IN O
them PRP O
are VBP O
based VBN O
on IN O
the DT O
likelihood NN O
ratio NN O
criterion NN O
[ -LRB- O
6 CD O
] -RRB- O
( , O
which WDT O
is VBZ O
the DT O
most RBS O
powerful JJ O
criterion NN O
) -RRB- O
. . O

As IN O
in IN O
[ -LRB- O
5 CD O
] -RRB- O
, , O
all PDT O
these DT O
statistics NNS O
are VBP O
evaluated VBN O
using VBG O
transfer NN O
probabilities NNS O
. . O

Two CD O
approaches NNS O
to IN O
statistics NNS O
definition NN O
are VBP O
introduced VBN O
: : O
a DT O
"""" `` O
discrete JJ O
"""" '' O
approach NN O
and CC O
a DT O
"""" `` O
continuous JJ O
"""" '' O
approach NN O
. . O

A DT O
detailed JJ O
analysis NN O
and CC O
comparison NN O
of IN O
introduced VBN O
statistics NNS O
are VBP O
performed VBN O
and CC O
the DT O
best JJS O
statistics NNS O
are VBP O
selected VBN O
. . O

The DT O
emphasis NN O
is VBZ O
on IN O
a DT O
precise JJ O
description NN O
of IN O
the DT O
way NN O
these DT O
statistics NNS O
can MD O
be VB O
constructed VBN O
using VBG O
well RB O
- HYPH O
known VBN O
concepts NNS O
from IN O
statistical JJ O
decision NN O
theory NN O
. . O

The DT O
current JJ O
A4 NN O
algorithm NN O
uses VBZ O
SPKW NNP O
as IN O
a DT O
language NN O
of IN O
annotation NN O
. . O

Of RB O
course RB O
, , O
it PRP O
is VBZ O
possible JJ O
to TO O
use VB O
GO NNP O
terms NNS O
in IN O
A4 NNP O
as RB O
well RB O
. . O

That DT O
would MD O
facilitate VB O
comparison NN O
with IN O
other JJ O
approaches NNS O
. . O

However RB O
, , O
at IN O
the DT O
current JJ O
stage NN O
of IN O
our PRP$ O
research NN O
we PRP O
test VBP O
and CC O
choose VBP O
"""" `` O
the DT O
best JJS O
decision NN O
making NN O
algorithm NN O
"""" '' O
, , O
not RB O
"""" `` O
the DT O
best JJS O
annotation NN O
terminology NN O
"""" '' O
. . O

Obviously RB O
, , O
which WDT O
annotation NN O
is VBZ O
used VBN O
hardly RB O
matters VBZ O
for IN O
the DT O
problem NN O
of IN O
finding VBG O
the DT O
optimal JJ O
"""" `` O
decision NN O
making NN O
algorithm NN O
"""" '' O

Results NNS O

Algorithm NN O
description NN O

Generation NN O
of IN O
a DT O
collection NN O
of IN O
similar JJ O
sequences NNS O

First RB O
, , O
we PRP O
introduce VBP O
some DT O
notation NN O
. . O

For IN O
the DT O
sake NN O
of IN O
brevity NN O
we PRP O
write VBP O
"""" `` O
a DT O
word NN O
omega NN O
belongs VBZ O
to IN O
a DT O
sequence NN O
pi NN O
"""" '' O
instead RB O
of IN O
"""" `` O
a DT O
word NN O
omega NN O
belongs VBZ O
to IN O
description NN O
fields NNS O
of IN O
a DT O
sequence NN O
pi NN O
"""" '' O
. . O

If IN O
omega NN O
is VBZ O
a DT O
KW NN O
- HYPH O
type NN O
word NN O
( , O
to TO O
be VB O
definite JJ O
, , O
further RB O
in IN O
the DT O
paper NN O
we PRP O
consider VBP O
only RB O
amino NN O
- HYPH O
acid NN O
sequences NNS O
and CC O
KW NN O
- HYPH O
type NN O
words NNS O
) -RRB- O
, , O
we PRP O
write VBP O
omega NN O
in IN O
KW NNP O
[ -LRB- O
pi NN O
] -RRB- O
. . O

The DT O
application NN O
of IN O
an DT O
annotation NN O
procedure NN O
to IN O
an DT O
unannotated JJ O
amino NN O
- HYPH O
acid NN O
query NN O
sequence NN O
( , O
i LS O
. . O
e UH O
. . O
, , O
the DT O
prediction NN O
of IN O
description NN O
fields NNS O
) -RRB- O
starts VBZ O
with IN O
generating VBG O
a DT O
collection NN O
of IN O
sequences NNS O
similar JJ O
to IN O
this DT O
query NN O
sequence NN O
with IN O
known VBN O
description NN O
fields NNS O
. . O

These DT O
similar JJ O
sequences NNS O
are VBP O
selected VBN O
from IN O
a DT O
certain JJ O
databank NN O
that WDT O
contains VBZ O
annotated JJ O
amino NN O
- HYPH O
acid NN O
sequences NNS O
, , O
e UH O
. . O
g LS O
. . O
, , O
SWISS NNP O
- HYPH O
PROT NN O
. . O

There EX O
exist VBP O
different JJ O
approaches NNS O
to IN O
the DT O
generation NN O
of IN O
a DT O
collection NN O
of IN O
similar JJ O
sequences NNS O
( , O
see VB O
[ -LRB- O
7 CD O
] -RRB- O
) -RRB- O
. . O

This DT O
collections NNS O
can MD O
be VB O
generated VBN O
on IN O
the DT O
basis NN O
of IN O
global JJ O
alignments NNS O
between IN O
a DT O
query NN O
sequence NN O
and CC O
bank NN O
sequences NNS O
( , O
global JJ O
alignments NNS O
can MD O
be VB O
constructed VBN O
, , O
e LS O
. . O
g LS O
. . O
, , O
by IN O
CLUSTAL NNP O
procedure NN O
) , O
using VBG O
an DT O
identity NN O
percentage NN O
or CC O
, , O
more RBR O
generally RB O
, , O
a DT O
similarity NN O
percentage NN O
as IN O
a DT O
similarity NN O
measure NN O
. . O

Another DT O
variant NN O
is VBZ O
to TO O
use VB O
local JJ O
alignments NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
alignments NNS O
of IN O
most RBS O
similar JJ O
fragments NNS O
of IN O
compared VBN O
sequences NNS O
, , O
see VB O
[ -LRB- O
7 CD O
] -RRB- O
) -RRB- O
instead RB O
of IN O
global JJ O
alignments NNS O
. . O

Local JJ O
alignments NNS O
can MD O
be VB O
constructed VBN O
, , O
for IN O
example NN O
, , O
by IN O
a DT O
well RB O
- HYPH O
known VBN O
BLAST NN O
procedure NN O
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
, , O
in IN O
which WDT O
sum NN O
of IN O
weights NNS O
or CC O
a DT O
corresponding JJ O
e NN O
- HYPH O
value NN O
serves VBZ O
as IN O
a DT O
measure NN O
of IN O
similarity NN O
between IN O
fragments NNS O
( , O
and CC O
thus RB O
between IN O
compared VBN O
sequences NNS O
) -RRB- O
. . O

Other JJ O
alignment NN O
procedures NNS O
are VBP O
also RB O
acceptable JJ O
; , O
alignment NN O
procedure NN O
selection NN O
does VBZ O
not RB O
play VB O
a DT O
critical JJ O
role NN O
. . O

Since IN O
we PRP O
build VBP O
on IN O
the DT O
A4 NNP O
procedure NN O
, , O
we PRP O
briefly RB O
summarize VBP O
that DT O
approach NN O
. . O

In IN O
the DT O
A4 NNP O
procedure NN O
a DT O
collection NN O
of IN O
similar JJ O
sequences NNS O
is VBZ O
generated VBN O
on IN O
the DT O
basis NN O
of IN O
local JJ O
alignments NNS O
of IN O
a DT O
special JJ O
type NN O
. . O

These DT O
alignments NNS O
are VBP O
constructed VBN O
by IN O
the DT O
DotHelix NNP O
procedure NN O
( , O
[ -LRB- O
9 CD O
] -RRB- O
) -RRB- O
, , O
in IN O
which WDT O
the DT O
"""" `` O
power NN O
"""" '' O
( , O
sum NN O
of IN O
weights NNS O
divided VBN O
by IN O
the DT O
root NN O
of IN O
the DT O
length NN O
of IN O
the DT O
local JJ O
alignment NN O
, , O
see VBP O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
for IN O
details NNS O
) -RRB- O
serves VBZ O
as IN O
a DT O
similarity NN O
measure NN O
. . O

Each DT O
local JJ O
alignment NN O
constructed VBN O
by IN O
DotHelix NNP O
procedure NN O
is VBZ O
a DT O
chain NN O
of IN O
closely RB O
located VBN O
gapless JJ O
local JJ O
alignments NNS O
. . O

Local JJ O
alignments NNS O
that WDT O
are VBP O
generated VBN O
during IN O
the DT O
construction NN O
of IN O
a DT O
collection NN O
of IN O
similar JJ O
sequences NNS O
are VBP O
referred VBN O
to IN O
as IN O
primary JJ O
local JJ O
alignments NNS O
. . O

Each DT O
sequence NN O
from IN O
a DT O
collection NN O
of IN O
similar JJ O
sequences NNS O
pi NN O
1 CD O
, , O
. . O
. , O
. , O
, , O
pi FW O
n FW O
can MD O
have VB O
several JJ O
corresponding VBG O
primary JJ O
local JJ O
alignments NNS O
, , O
but CC O
for IN O
the DT O
sake NN O
of IN O
simplicity NN O
we PRP O
assume VBP O
that IN O
each DT O
similar JJ O
sequence NN O
pi NN O
i PRP O
has VBZ O
exactly RB O
one CD O
corresponding VBG O
primary JJ O
local JJ O
alignment NN O
, , O
the DT O
one NN O
with IN O
the DT O
maximum JJ O
similarity NN O
measure NN O
. . O

Let VB O
mu PRP O
i PRP O
denote VB O
the DT O
similarity NN O
measure NN O
( , O
power NN O
) -RRB- O
of IN O
a DT O
primary JJ O
alignment NN O
that WDT O
corresponds VBZ O
to IN O
pi NN O
i PRP O
. . O

The DT O
value NN O
of IN O
mu NN O
i PRP O
characterizes VBZ O
the DT O
measure NN O
of IN O
similarity NN O
between IN O
fragments NNS O
that WDT O
constitute VBP O
this DT O
alignment NN O
; , O
at IN O
the DT O
same JJ O
time NN O
mu UH O
i PRP O
can MD O
be VB O
treated VBN O
as IN O
a DT O
measure NN O
of IN O
similarity NN O
between IN O
the DT O
whole JJ O
query NN O
sequence NN O
pi NN O
0 CD O
and CC O
the DT O
whole JJ O
similar JJ O
sequence NN O
pi NN O
i PRP O
. . O

We PRP O
assume VBP O
that IN O
similar JJ O
sequences NNS O
are VBP O
ordered VBN O
in IN O
such PDT O
a DT O
way NN O
that IN O
mu NN O
1 CD O
> SYM O
= SYM O
mu NNP O
2 CD O
> NFP O
= NFP O
. . O
. . O
. . O
> NFP O
= NFP O
mu FW O
n FW O
. . O

The DT O
exact JJ O
stochastic JJ O
formulation NN O
of IN O
the DT O
problem NN O

Let VB O
pi NN O
0 CD O
be VB O
an DT O
unannotated JJ O
amino NN O
- HYPH O
acid NN O
query NN O
sequence NN O
, , O
pi NN O
1 CD O
, , O
. . O
. . O
. . O
, , O
pi NN O
n RB O
be VB O
a DT O
collection NN O
of IN O
sequences NNS O
similar JJ O
to IN O
pi NN O
0 CD O
, , O
and CC O
omega NN O
be VB O
a DT O
word NN O
that WDT O
belongs VBZ O
to IN O
some DT O
similar JJ O
sequences NNS O
( : O
i PRP O
. . O
e LS O
. . O
, , O
omega NN O
in IN O
KW NNP O
[ -LRB- O
pi NN O
i PRP O
] -RRB- O
. . O
for IN O
at RB O
least RBS O
one CD O
similar JJ O
sequence NN O
pi NN O
i PRP O
) -RRB- O
. . O

The DT O
task NN O
is VBZ O
to TO O
predict VB O
whether IN O
this DT O
word NN O
omega NN O
belongs VBZ O
to IN O
the DT O
query NN O
sequence NN O
pi NN O
0 CD O
or CC O
not RB O
. . O

Let VB O
us PRP O
put VB O

xi NNP O
i NN O
= SYM O
1 CD O
, , O
if IN O
omega NN O
in IN O
KW NNP O
[ -LRB- O
pi NN O
i NN O
] -RRB- O
, , O
and CC O
xi NN O
i PRP O
= NFP O
0 CD O
, , O
if IN O
omega NN O
not RB O
- HYPH O
in IN O
KW NNP O
[ -LRB- O
pi NN O
i PRP O
] -RRB- O
( : O
i PRP O
= SYM O
1 CD O
, , O
. . O
. . O
. . O
, , O
n CD O
) -RRB- O
. . O

we PRP O
also RB O
put VBD O

xi NN O
0 CD O
= SYM O
1 CD O
, , O
if IN O
omega NN O
in IN O
KW NNP O
[ -LRB- O
pi NN O
0 CD O
] -RRB- O
, , O
and CC O
xi NN O
0 CD O
= SYM O
0 CD O
, , O
if IN O
omega NN O
not RB O
- HYPH O
in IN O
KW NNP O
[ -LRB- O
pi NN O
0 CD O
] -RRB- O
. . O

Variables NNS O
xi VBP O
i PRP O
can MD O
be VB O
treated VBN O
as IN O
random JJ O
variates NNS O
Actually RB O
, , O
they PRP O
depend VBP O
on IN O
omega NN O
. . O

For IN O
the DT O
sake NN O
of IN O
brevity NN O
we PRP O
write VBP O
xi NN O
i PRP O
instead RB O
of IN O
xi NN O
i NN O
( , O
omega NN O
) -RRB- O
. . O

In IN O
this DT O
notation NN O
the DT O
problem NN O
can MD O
be VB O
stated VBN O
as IN O
follows VBZ O
. . O

Measures NNS O
of IN O
similarity NN O
mu NN O
i VBZ O
between IN O
the DT O
query NN O
sequence NN O
pi NN O
0 NFP O
and CC O
similar JJ O
sequences NNS O
pi NN O
i PRP O
and CC O
values NNS O
of IN O
random JJ O
variates NNS O
xi VBP O
i PRP O
, , O
i PRP O
= NFP O
1 CD O
, , O
. . O
. . O
. . O
, , O
n UH O
, , O
are VBP O
given VBN O
. . O

The DT O
task NN O
is VBZ O
to TO O
determine VB O
whether IN O
the DT O
word NN O
omega NN O
belongs VBZ O
to IN O
the DT O
query NN O
sequence NN O
pi NN O
0 CD O
or CC O
not RB O
. . O

In IN O
other JJ O
words NNS O
, , O
two CD O
hypotheses NNS O
are VBP O
considered VBN O
, , O
H1 NN O
: : O
xi NN O
0 CD O
= SYM O
1 CD O
( : O
i LS O
. . O
e NN O
. . O
, , O
omega NN O
in IN O
KW NNP O
[ -LRB- O
pi NN O
0 CD O
] -RRB- O
) -RRB- O
, , O
and CC O
H0 NN O
: : O
xi NN O
0 CD O
= SYM O
0 CD O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
omega NN O
not RB O
- HYPH O
in IN O
KW NNP O
[ -LRB- O
pi NN O
0 CD O
] -RRB- O
) -RRB- O
, , O
and CC O
the DT O
task NN O
is VBZ O
to TO O
construct VB O
a DT O
procedure NN O
that WDT O
allows VBZ O
to TO O
decide VB O
which WDT O
hypothesis NN O
is VBZ O
true JJ O
on IN O
the DT O
basis NN O
of IN O
xi NN O
= : O
( : O
xi FW O
1 CD O
, , O
. . O
. . O
. . O
, , O
xi NN O
n NN O
) -RRB- O
. . O

As IN O
announced VBN O
in IN O
the DT O
introduction NN O
, , O
we PRP O
base VBP O
our PRP$ O
procedures NNS O
on IN O
the DT O
likelihood NN O
ratio NN O
. . O

Let VB O
us PRP O
recall VB O
the DT O
famous JJ O
Bayes NNP O
' POS O
Theorem NNP O
that WDT O
can MD O
be VB O
written VBN O
as IN O

P NN O
{ NN O
H1 NN O
| : O
xi NN O
} NFP O
P NN O
{ NN O
H0 NN O
| : O
xi NN O
} NN O
= SYM O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
1 CD O
| : O
xi NN O
} : O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
0 CD O
| SYM O
xi NN O
} NFP O
= SYM O
P NN O
{ SYM O
xi NN O
0 CD O
= SYM O
1 CD O
, , O
xi NN O
} NN O
/ : O
P NN O
{ NN O
xi NN O
} : O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
0 CD O
, , O
xi NN O
} NN O
/ SYM O
P NN O
{ SYM O
xi NN O
} NFP O
= SYM O
P NN O
{ SYM O
xi NN O
| : O
xi NN O
0 CD O
= SYM O
1 CD O
} SYM O
P NN O
{ SYM O
xi NN O
| : O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
. . O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
1 CD O
} SYM O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
. . O

Here RB O
the DT O
left JJ O
part NN O
is VBZ O
the DT O
posterior JJ O
odds NNS O
, , O
that DT O
is VBZ O
the DT O
ratio NN O
of IN O
a DT O
posteriori JJ O
probabilities NNS O
of IN O
hypotheses NNS O
H1 NN O
and CC O
H0 CD O
( , O
a DT O
posteriori NN O
means VBZ O
that IN O
values NNS O
xi VBP O
1 CD O
, , O
. , O
. , O
. , O
, , O
xi NN O
n CC O
are VBP O
known VBN O
) -RRB- O
. . O

It PRP O
is VBZ O
equal JJ O
to IN O
the DT O
product NN O
of IN O
the DT O
likelihood NN O
ratio NN O
P NN O
{ NN O
xi NN O
| : O
xi NN O
0 CD O
= SYM O
1 CD O
} SYM O
P NN O
{ SYM O
xi NN O
| : O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
( : O
i LS O
. . O
e LS O
. . O
, , O
the DT O
ratio NN O
of IN O
probabilities NNS O
that IN O
the DT O
set NN O
of IN O
values NNS O
xi NN O
= : O
xi NN O
( , O
omega NN O
) -RRB- O
is VBZ O
realized VBN O
for IN O
the DT O
word NN O
omega NN O
given VBN O
the DT O
conditions NNS O
xi NN O
0 CD O
= SYM O
1 CD O
and CC O
xi NN O
0 CD O
= SYM O
0 CD O
respectively RB O
) -RRB- O
and CC O
the DT O
prior JJ O
odds NNS O
, , O
that DT O
is VBZ O
the DT O
ratio NN O
of IN O
a DT O
priori JJ O
probabilities NNS O
of IN O
hypotheses NNS O
H1 NN O
and CC O
H0 NN O
. . O

Statistical JJ O
decision NN O
theory NN O
tells VBZ O
us PRP O
that IN O
the DT O
optimal JJ O
prediction NN O
procedure NN O
should MD O
be VB O
based VBN O
on IN O
the DT O
statistic NN O
P NN O
{ NN O
H1 NN O
| : O
xi NN O
} : O
P NN O
{ NN O
H0 CD O
| HYPH O
xi NN O
} -RRB- O
or CC O
equivalently RB O
on IN O
the DT O
likelihood NN O
ratio NN O
. . O

For IN O
any DT O
statistic NN O
a DT O
threshold NN O
value NN O
should MD O
be VB O
specified VBN O
for IN O
the DT O
procedure NN O
: : O
if IN O
the DT O
value NN O
of IN O
the DT O
statistic NN O
is VBZ O
greater JJR O
than IN O
the DT O
threshold NN O
, , O
hypothesis NN O
H1 NN O
is VBZ O
accepted VBN O
, , O
otherwise RB O
hypothesis NN O
H0 NNP O
is VBZ O
accepted VBN O
. . O

The DT O
threshold NN O
value NN O
should MD O
be VB O
selected VBN O
in IN O
such PDT O
a DT O
way NN O
that IN O
the DT O
total JJ O
number NN O
of IN O
incorrect JJ O
predictions NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
the DT O
sum NN O
of IN O
the DT O
number NN O
of IN O
type NN O
1 CD O
errors NNS O
and CC O
the DT O
number NN O
of IN O
type NN O
2 CD O
errors NNS O
) -RRB- O
would MD O
be VB O
minimal JJ O
. . O

It PRP O
is VBZ O
clear JJ O
that IN O
if IN O
the DT O
prior JJ O
odds NNS O
are VBP O
equal JJ O
to IN O
1 CD O
, , O
then RB O
a DT O
threshold NN O
value NN O
of IN O
one CD O
should MD O
be VB O
selected VBN O
for IN O
the DT O
likelihood NN O
ratio NN O
; : O
total JJ O
number NN O
of IN O
errors NNS O
would MD O
( -LRB- O
theoretically RB O
) , O
be VB O
minimal JJ O
for IN O
this DT O
threshold NN O
. . O

Surely RB O
, , O
the DT O
assumption NN O
that IN O
the DT O
ratio NN O
of IN O
a DT O
priori JJ O
hypothesis NN O
probabilities NNS O
equals VBZ O
1 CD O
does VBZ O
not RB O
seem VB O
to TO O
be VB O
natural JJ O
. . O

Indeed RB O
, , O
the DT O
number NN O
of IN O
considered VBN O
words NNS O
that WDT O
do VBP O
not RB O
belong VB O
to IN O
a DT O
query NN O
sequence NN O
is VBZ O
much RB O
greater JJR O
( , O
approximately RB O
8 CD O
times NNS O
greater JJR O
) -RRB- O
than IN O
the DT O
number NN O
of IN O
considered VBN O
words NNS O
that WDT O
belong VBP O
to IN O
a DT O
query NN O
sequence NN O
. . O

But CC O
statistics NNS O
that WDT O
are VBP O
obtained VBN O
from IN O
the DT O
assumption NN O
that IN O
this DT O
a DT O
priori JJ O
ratio NN O
equals VBZ O
1 CD O
, , O
and CC O
the DT O
assumption NN O
that IN O
this DT O
a DT O
priori JJ O
ratio NN O
does VBZ O
not RB O
equal VB O
1 CD O
, , O
but CC O
is VBZ O
constant JJ O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
it PRP O
does VBZ O
not RB O
depend VB O
on IN O
a DT O
word NN O
omega NN O
) -RRB- O
are VBP O
equivalent JJ O
. . O

Essentially RB O
these DT O
are VBP O
the DT O
same JJ O
statistics NNS O
( : O
only RB O
the DT O
threshold NN O
value NN O
should MD O
be VB O
changed VBN O
: : O
a DT O
value NN O
P NN O
{ SYM O
xi FW O
0 CD O
= SYM O
0 CD O
} SYM O
P NN O
{ SYM O
xi NN O
0 CD O
= SYM O
1 CD O
} SYM O
should MD O
be VB O
taken VBN O
instead RB O
of IN O
1 CD O
; : O
as IN O
it PRP O
was VBD O
noted VBN O
, , O
this DT O
value NN O
approximately RB O
equals VBZ O
8 CD O
in IN O
our PRP$ O
data NNS O
) -RRB- O
. . O

Therefore RB O
, , O
we PRP O
assume VBP O
from IN O
now RB O
on RB O
that IN O
the DT O
ratio NN O
of IN O
a DT O
priori JJ O
hypothesis NN O
probabilities NNS O
equals VBZ O
1 CD O
. . O

Thus RB O
all DT O
considered VBN O
statistics NNS O
are VBP O
based VBN O
on IN O
the DT O
likelihood NN O
ratio NN O

( : O
1 CD O
) SYM O
P NN O
{ NFP O
xi NN O
| : O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
P NN O
{ NN O
xi NN O
| : O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O

Assumption NN O
of IN O
independence NN O
of IN O
variables NNS O
xi NN O
i -RRB- O
. . O

Transfer NN O
probabilities NNS O

By IN O
virtue NN O
of IN O
equation NN O
( : O
1 CD O
) -RRB- O
we PRP O
need VBP O
to TO O
estimate VB O
conditional JJ O
probabilities NNS O
P NN O
{ , O
xi NN O
| : O
xi NN O
0 CD O
= SYM O
epsilon NN O
} NFP O
, , O
where WRB O
epsilon NN O
= SYM O
1 CD O
or CC O
0 CD O
in IN O
order NN O
to TO O
calculate VB O
the DT O
likelihood NN O
ratio NN O
. . O

Our PRP$ O
derivation NN O
of IN O
these DT O
estimates NNS O
uses VBZ O
the DT O
assumption NN O
that IN O
variables NNS O
xi FW O
i FW O
, , O
i PRP O
= NFP O
1 CD O
, , O
. . O
. , O
. . O
, , O
n UH O
, , O
are VBP O
independent JJ O
in IN O
the DT O
aggregate NN O
. . O

Surely RB O
, , O
this DT O
assumption NN O
is VBZ O
false JJ O
. . O

In IN O
reality NN O
variables NNS O
xi VBP O
i PRP O
are VBP O
dependent JJ O
, , O
and CC O
the DT O
dependence NN O
is VBZ O
considerably RB O
strong JJ O
. . O

Nevertheless RB O
, , O
in IN O
our PRP$ O
definition NN O
of IN O
the DT O
likelihood NN O
ratio NN O
statistic NN O
( , O
and CC O
the DT O
statistic NN O
that DT O
is VBZ O
the DT O
logarithm NN O
of IN O
the DT O
likelihood NN O
ratio NN O
) , O
we PRP O
use VBP O
the DT O
independence NN O
assumption NN O
. . O

Since IN O
variables NNS O
xi VBP O
i PRP O
are VBP O
not RB O
independent JJ O
, , O
one PRP O
can MD O
not RB O
assert VB O
that IN O
the DT O
obtained VBN O
statistics NNS O
are VBP O
the DT O
most RBS O
powerful JJ O
, , O
but CC O
these DT O
statistics NNS O
can MD O
be VB O
still RB O
quite RB O
good JJ O
. . O

In IN O
decision NN O
theory NN O
, , O
this DT O
approach NN O
is VBZ O
known VBN O
as IN O
the DT O
naive JJ O
Bayes NNP O
procedure NN O
. . O

The DT O
independence NN O
of IN O
variables NNS O
xi NN O
i PRP O
implies VBZ O
the DT O
equality NN O

( : O
2 CD O
) SYM O
P NN O
{ NFP O
xi NN O
| : O
xi NN O
0 CD O
= NFP O
epsilon NN O
} NFP O
= NFP O
product NN O
i NN O
= NFP O
1nP NN O
{ NFP O
xi NN O
i NN O
| NFP O
xi NN O
0 CD O
= SYM O
epsilon NN O
} NFP O
, , O
epsilon NN O
= SYM O
1 CD O
, , O
0 CD O

Each DT O
variable JJ O
xi NN O
i NN O
has VBZ O
exactly RB O
two CD O
possible JJ O
values NNS O
: : O
1 CD O
and CC O
0 CD O
. . O

Thus RB O
, , O
everything NN O
is VBZ O
reduced VBN O
to IN O
the DT O
following VBG O
four CD O
conditional JJ O
probabilities NNS O
: : O

( : O
3 CD O
) SYM O
P NN O
{ NFP O
xi NN O
i NN O
= NFP O
1 CD O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
, , O
P NN O
{ NN O
xi NN O
i NN O
= NFP O
0 CD O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
, , O
P NN O
{ NN O
xi NN O
i NN O
= SYM O
1 CD O
| NFP O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
, , O
P NN O
{ NN O
xi NN O
i NN O
= NFP O
0 CD O
| NFP O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
. . O

In IN O
addition NN O
, , O
it PRP O
is VBZ O
clear JJ O
that IN O

( : O
4 CD O
) SYM O
P NN O
{ NFP O
xi NN O
i NN O
= NFP O
1 CD O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
+ NN O
P NN O
{ NN O
xi NN O
i NN O
= NFP O
0 CD O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
= SYM O
1 CD O
, , O
P NN O
{ NFP O
xi NN O
i NN O
= SYM O
1 CD O
| NFP O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
+ CC O
P NN O
{ NFP O
xi NN O
i NN O
= SYM O
0 CD O
| NFP O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
= SYM O
1 CD O
, . O

so RB O
actually RB O
everything NN O
is VBZ O
reduced VBN O
to IN O
two CD O
conditional JJ O
probabilities NNS O

P NN O
{ NFP O
xi NN O
i NN O
= NFP O
1 CD O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
, , O
P NN O
{ NN O
xi NN O
i NN O
= NFP O
1 CD O
| NFP O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
. . O

Conditional JJ O
probabilities NNS O
( -LRB- O
3 CD O
) -RRB- O
are VBP O
a DT O
special JJ O
case NN O
of IN O
conditional JJ O
probabilities NNS O
of IN O
the DT O
type NN O

P NN O
{ NFP O
xi NN O
i NN O
= NFP O
epsilon NN O
1 CD O
| NFP O
xi FW O
j NN O
= : O
epsilon NN O
2 CD O
} NFP O
, , O
where WRB O
epsilon NN O
1 CD O
, , O
epsilon NN O
2 CD O
= SYM O
1 CD O
or CC O
0 CD O
, , O
i PRP O
, , O
j NN O
= , O
0 CD O
, , O
1 CD O
, , O
. . O
. . O
. . O
, , O
n CD O

( : O
above IN O
special JJ O
case NN O
corresponds VBZ O
to IN O
j NNP O
= SYM O
0 CD O
) -RRB- O
. . O

We PRP O
call VBP O
all PDT O
this DT O
conditional JJ O
probabilities NNS O
transfer VBP O
probabilities NNS O
and CC O
denote VBP O
them PRP O
by IN O

P NN O
{ NFP O
xi NN O
i NN O
= NFP O
epsilon NN O
1 CD O
| NFP O
xi NN O
j NN O
= NFP O
epsilon NN O
2 CD O
} NFP O
= SYM O
p NN O
epsilon NN O
1 CD O
| SYM O
epsilon NN O
2 CD O
. . O

Transfer NN O
probabilities NNS O
depend VBP O
on IN O
i PRP O
, , O
j UH O
( , O
and CC O
certainly RB O
on IN O
the DT O
word NN O
omega NN O
) -RRB- O
: : O

p NN O
epsilon NN O
1 CD O
| : O
epsilon NN O
2 CD O
= SYM O
p NN O
epsilon NN O
1 CD O
| : O
epsilon NN O
2 CD O
( : O
i PRP O
, , O
j NN O
; : O
omega NN O
) -RRB- O
. . O

Conditional JJ O
probabilities NNS O
play VBP O
a DT O
central JJ O
role NN O
in IN O
our PRP$ O
procedure NN O
. . O

According VBG O
to IN O
equation NN O
( : O
4 CD O
) -RRB- O
, , O
it PRP O
suffices VBZ O
to TO O
explain VB O
how WRB O
transfer NN O
probabilities NNS O
p1 NN O
| SYM O
1 CD O
, , O
p1 NN O
| SYM O
0 CD O
are VBP O
evaluated VBN O
. . O

We PRP O
suppose VBP O
that IN O
transfer NN O
probabilities NNS O
satisfy VBP O
the DT O
following VBG O
assumptions NNS O
( : O
"""" `` O
axioms NNS O
"""" '' O
) -RRB- O
( , O
the DT O
sense NN O
of IN O
these DT O
assumptions NNS O
is VBZ O
obvious JJ O
) -RRB- O
. . O

Assumption NN O
1 CD O
) -RRB- O
For IN O
a DT O
fixed VBN O
word NN O
omega NN O
and CC O
for IN O
sequences NNS O
pi NN O
0 CD O
, , O
pi NN O
1 CD O
, , O
. . O
. . O
. . O
, , O
pi NN O
n NN O
( : O
i ADD O
. . O
e -RRB- O
. . O
, , O
for IN O
the DT O
sequence NN O
pi NN O
0 CD O
and CC O
sequences NNS O
similar JJ O
to IN O
pi NN O
0 CD O
) -RRB- O
transfer NN O
probabilities NNS O
depend VBP O
only RB O
on IN O
the DT O
measure NN O
of IN O
similarity NN O
between IN O
sequences NNS O
. . O

Thus RB O
, , O
we PRP O
have VBP O
: : O

p1 NN O
| : O
1 CD O
= SYM O
p1 CD O
| SYM O
1 CD O
( : O
i PRP O
, , O
j NN O
; : O
omega NN O
) NFP O
= SYM O
p1 CD O
| SYM O
1 CD O
( : O
mu NN O
ij UH O
; : O
omega NN O
) NFP O
= SYM O
p1 CD O
| SYM O
1 CD O
( : O
mu NN O
ij CD O
) NFP O
= SYM O
1 CD O
- HYPH O
p0 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
ij CC O
) -RRB- O
, , O

p1 NN O
| : O
0 CD O
= SYM O
p1 CD O
| SYM O
0 CD O
( : O
i PRP O
, , O
j NN O
; : O
omega NN O
) NFP O
= SYM O
p1 CD O
| : O
0 CD O
( : O
mu NN O
ij UH O
; : O
omega NN O
) NFP O
= SYM O
p1 CD O
| SYM O
0 CD O
( : O
mu NN O
ij CD O
) NFP O
= NFP O
1 CD O
- HYPH O
p0 NN O
| : O
0 CD O
( HYPH O
mu NN O
ij RB O
) -RRB- O
, , O

where WRB O
mu UH O
ij UH O
is VBZ O
the DT O
measure NN O
of IN O
similarity NN O
between IN O
sequences NNS O
pi FW O
i PRP O
, , O
pi NN O
j NNP O
( , O
i PRP O
, , O
j NN O
= SYM O
0 CD O
, , O
1 CD O
, , O
. . O
. . O
. . O
, , O
n CD O
) -RRB- O
. . O

Particularly RB O
, , O
if IN O
one CD O
of IN O
these DT O
sequences NNS O
is VBZ O
the DT O
query NN O
sequence NN O
pi NN O
0 CD O
and CC O
mu NN O
j NN O
is VBZ O
the DT O
measure NN O
of IN O
similarity NN O
between IN O
pi NN O
j NN O
, , O
pi NN O
0 NFP O
, , O
we PRP O
have VBP O

( : O
5 CD O
) SYM O
P NN O
{ NFP O
xi NN O
j NN O
= SYM O
1 CD O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
= SYM O
p1 CD O
| SYM O
1 CD O
( HYPH O
mu NN O
j NN O
) NFP O
, , O
P NN O
{ NN O
xi NN O
j NN O
= SYM O
1 CD O
| NFP O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
= SYM O
p1 CD O
| SYM O
0 CD O
( HYPH O
mu NN O
j NN O
) -RRB- O
. . O

Assumption NN O
2 CD O
) -RRB- O
Transfer NN O
probabilities NNS O
( : O
for IN O
an DT O
arbitrary JJ O
fixed VBN O
word NN O
omega NN O
) -RRB- O
depend VBP O
on IN O
similarity NN O
measure NN O
mu NNS O
monotonically RB O
: : O
the DT O
probability NN O
p1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
) -RRB- O
increases VBZ O
( : O
does VBZ O
not RB O
decrease VB O
) -RRB- O
and CC O
the DT O
probability NN O
p1 NN O
| : O
0 CD O
( HYPH O
mu NN O
) -RRB- O
decreases VBZ O
( : O
does VBZ O
not RB O
increase VB O
) -RRB- O
as IN O
mu NNS O
increases VBZ O
. . O

Assumption NN O
3 CD O
) -RRB- O
The DT O
inequality NN O

( -LRB- O
6 CD O
) SYM O
p1 CD O
| SYM O
1 CD O
( HYPH O
mu NNS O
) NFP O
> NFP O
p1 CD O
| SYM O
0 CD O
( HYPH O
mu NN O
) -RRB- O

always RB O
holds VBZ O
( : O
if IN O
mu PRP O
> NFP O
0 CD O
) -RRB- O
. . O

Transfer NN O
probabilities NNS O
are VBP O
evaluated VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
measure NN O
of IN O
similarity NN O
between IN O
similar JJ O
sequences NNS O
for IN O
which WDT O
it PRP O
is VBZ O
known VBN O
whether IN O
omega NN O
in IN O
KW NNP O
[ -LRB- O
pi NN O
i NN O
] -RRB- O
using VBG O
the DT O
so RB O
called VBN O
isotonic JJ O
regression NN O
procedure NN O
( , O
see VB O
[ -LRB- O
11 CD O
] -RRB- O
) -RRB- O
. . O

( : O
In IN O
[ -LRB- O
5 CD O
] -RRB- O
this DT O
procedure NN O
was VBD O
referred VBN O
to IN O
as IN O
monotonization NN O
procedure NN O
) -RRB- O
. . O

Results NNS O
of IN O
this DT O
procedure NN O
are VBP O
piecewise JJ O
- HYPH O
constant JJ O
monotonous JJ O
functions NNS O
of IN O
the DT O
similarity NN O
measure VBP O
mu NN O
that WDT O
increase VBP O
( , O
do VBP O
not RB O
decrease VB O
) , O
for IN O
probabilities NNS O
p1 CD O
| SYM O
1 CD O
( HYPH O
mu NN O
) -RRB- O
and CC O
decrease VBP O
( , O
do VBP O
not RB O
increase VB O
) -RRB- O
for IN O
probabilities NNS O
p1 CD O
| SYM O
0 CD O
( HYPH O
mu NN O
) -RRB- O
. . O

We PRP O
briefly RB O
recall VBP O
the DT O
isotonic JJ O
regression NN O
problem NN O
. . O

Let VB O
one PRP O
have VB O
two CD O
number NN O
sets NNS O
( : O
i PRP O
. . O
e UH O
. . O
, , O
a DT O
set NN O
of IN O
points NNS O
in IN O
the DT O
plain NN O
) , O
xi NN O
, , O
yi UH O
, , O
i PRP O
= . O
1 CD O
, , O
. . O
. . O
. . O
, , O
n NFP O
, , O
for IN O
which WDT O
x1 CD O
< SYM O
= SYM O
x2 CD O
< NFP O
= NFP O
. . O
. . O
. . O
< NFP O
= : O
xn ADD O
. . O

The DT O
task NN O
is VBZ O
to TO O
find VB O
values NNS O
z1 NN O
, , O
z2 CD O
, , O
. . O
. . O
. . O
, , O
zn FW O
, , O
z1 NN O
< NFP O
= NFP O
z2 CD O
< NFP O
= NFP O
. . O
. . O
. . O
< NFP O
= NFP O
zn FW O
, , O
that WDT O
minimize VB O
the DT O
deviation NN O
sum NN O
i CD O
= SYM O
1n CD O
( HYPH O
zi FW O
- HYPH O
yi FW O
) SYM O
2 CD O
. . O

This DT O
is VBZ O
the DT O
monotone NN O
- HYPH O
increasing VBG O
isotonic JJ O
regression NN O
problem NN O
. . O

The DT O
monotone NN O
- HYPH O
decreasing VBG O
isotonic JJ O
regression NN O
problem NN O
is VBZ O
similar JJ O
; : O
the DT O
only JJ O
difference NN O
is VBZ O
that IN O
here RB O
z1 CD O
> : O
= SYM O
z2 CD O
> NFP O
= : O
. . O
. . O
. . O
> XX O
= NFP O
zn FW O
. . O

The DT O
isotonic JJ O
regression NN O
procedure NN O
constructs VBZ O
a DT O
monotonic JJ O
number NN O
sequence NN O
z1 CD O
, , O
. , O
. , O
. , O
, , O
zn NN O
( , O
while IN O
in IN O
linear JJ O
regression NN O
values NNS O
of IN O
zi NN O
are VBP O
linearly RB O
expressed VBN O
in IN O
terms NNS O
of IN O
xi NN O
: : O
zi NN O
= : O
alpha NN O
xi NN O
+ CC O
beta NN O
) -RRB- O
. . O

An DT O
algorithm NN O
for IN O
the DT O
solution NN O
of IN O
isotonic JJ O
regression NN O
problem NN O
can MD O
be VB O
easily RB O
constructed VBN O
. . O

We PRP O
do VBP O
not RB O
describe VB O
it PRP O
here RB O
. . O

We PRP O
only RB O
note VBP O
that IN O
each DT O
zi NN O
is VBZ O
the DT O
mean JJ O
value NN O
of IN O
{ SYM O
yj XX O
} NFP O
over IN O
a DT O
window NN O
of IN O
variable JJ O
length NN O
: : O
Li NNP O
: : O
zi NNP O
= : O
( : O
sum NN O
j NN O
= : O
t NN O
( : O
i PRP O
) : O
t NN O
( , O
i XX O
) NFP O
+ CC O
L NN O
( HYPH O
i NN O
) NFP O
- HYPH O
1yi NN O
) NFP O
/ SYM O
Li NNP O
. . O

For IN O
different JJ O
indices NNS O
these DT O
windows NNS O
either CC O
coincide VBP O
or CC O
do VBP O
not RB O
overlap VB O
, , O
and CC O
the DT O
i DT O
- HYPH O
th DT O
window NN O
contains VBZ O
i PRP O
. . O

We PRP O
also RB O
note VBP O
that IN O
the DT O
values NNS O
of IN O
xi NN O
are VBP O
not RB O
essential JJ O
in IN O
the DT O
isotonic JJ O
regression NN O
problem NN O
, , O
only RB O
the DT O
order NN O
of IN O
values NNS O
of IN O
yi NN O
is VBZ O
essential JJ O
. . O

To TO O
obtain VB O
the DT O
transfer NN O
probabilities NNS O
using VBG O
isotonic JJ O
regression NN O
we PRP O
proceed VBP O
as IN O
follows VBZ O
. . O

For IN O
the DT O
evaluation NN O
of IN O
p1 NN O
| SYM O
1 CD O
we PRP O
consider VBP O
pairs NNS O
of IN O
similar JJ O
sequences NNS O
pi NN O
i PRP O
, , O
pi NN O
j NN O
that WDT O
satisfy VBP O
the DT O
condition NN O
omega NN O
in IN O
KW NNP O
[ -LRB- O
pi NN O
i PRP O
] -RRB- O
. . O

Let VB O
mu PRP O
ij RB O
denote VB O
the DT O
measure NN O
of IN O
similarity NN O
between IN O
sequences NNS O
pi FW O
i PRP O
, , O
pi FW O
j FW O
. . O

We PRP O
put VBP O
xi NN O
ij IN O
= SYM O
1 CD O
if IN O
the DT O
word NN O
omega NN O
belongs VBZ O
to IN O
the DT O
sequence NN O
pi NN O
j NN O
, , O
and CC O
put VBD O
xi NN O
ij IN O
= SYM O
0 CD O
if IN O
omega NN O
does VBZ O
not RB O
belong VB O
to IN O
pi NN O
j NN O
( : O
recall VB O
that IN O
the DT O
word NN O
omega NN O
belongs VBZ O
to IN O
pi NN O
i PRP O
) -RRB- O
. . O

Then RB O
we PRP O
apply VBP O
the DT O
monotone NN O
- HYPH O
increasing VBG O
isotonic JJ O
regression NN O
procedure NN O
to IN O
the DT O
collection NN O
of IN O
points NNS O
( , O
mu FW O
ij FW O
, , O
xi FW O
ij FW O
) -RRB- O
, , O
where WRB O
mu NNS O
ij RB O
are VBP O
in IN O
ascending VBG O
order NN O
. . O

The DT O
resulting VBG O
values NNS O
are VBP O
the DT O
estimates NNS O
of IN O
the DT O
transfer NN O
probabilities NNS O
p1 CD O
| SYM O
1 CD O
( SYM O
mu FW O
ij FW O
) -RRB- O
. . O

Similarly RB O
, , O
applying VBG O
the DT O
monotone NN O
- HYPH O
decreasing VBG O
isotonic JJ O
regression NN O
procedure NN O
to IN O
the DT O
collection NN O
of IN O
points NNS O
( , O
mu FW O
ij FW O
, , O
xi FW O
ij FW O
) -RRB- O
that WDT O
correspond VBP O
to IN O
pairs NNS O
of IN O
similar JJ O
sequences NNS O
pi NN O
i PRP O
, , O
pi NN O
j NN O
for IN O
which WDT O
omega NN O
does VBZ O
not RB O
belong VB O
to IN O
pi NN O
i PRP O
, , O
we PRP O
obtain VBP O
values NNS O
of IN O
the DT O
transfer NN O
probabilities NNS O
p1 CD O
| SYM O
0 CD O
( HYPH O
mu NN O
ij CC O
) -RRB- O
. . O

As IN O
we PRP O
noted VBD O
, , O
the DT O
probabilities NNS O
p1 NN O
| SYM O
1 CD O
, , O
p1 CD O
| SYM O
0 CD O
are VBP O
supposed VBN O
to TO O
satisfy VB O
condition NN O
( : O
6 CD O
) -RRB- O
. . O

Therefore RB O
, , O
if IN O
it PRP O
turns VBZ O
out RP O
that IN O
functions NNS O
p1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
) -RRB- O
, , O
p1 NN O
| SYM O
0 CD O
( HYPH O
mu NN O
) -RRB- O
obtained VBN O
after IN O
the DT O
application NN O
of IN O
isotonic JJ O
regression NN O
procedure NN O
do VBP O
not RB O
satisfy VB O
this DT O
condition NN O
for IN O
some DT O
values NNS O
of IN O
mu NN O
, , O
then RB O
we PRP O
consider VBP O
that IN O
probabilities NNS O
p1 NN O
| SYM O
1 CD O
, , O
p1 CD O
| SYM O
0 CD O
are VBP O
not RB O
defined VBN O
for IN O
these DT O
values NNS O
of IN O
mu NNS O
. . O

Hence RB O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
transfer NN O
probabilities NNS O
are VBP O
defined VBN O
only RB O
for IN O
sufficiently RB O
large JJ O
values NNS O
of IN O
mu NN O
, , O
but CC O
not RB O
for IN O
all DT O
mu NNS O
. . O

In IN O
particular JJ O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
for IN O
some DT O
words NNS O
there EX O
are VBP O
no DT O
values NNS O
of IN O
mu NN O
such JJ O
that IN O
inequality NN O
( : O
6 CD O
) -RRB- O
holds VBZ O
. . O

These DT O
words NNS O
are VBP O
referred VBN O
to IN O
as IN O
degenerate JJ O
words NNS O
. . O

Statistics NNS O
description NN O

All DT O
statistics NNS O
considered VBN O
in IN O
this DT O
paper NN O
are VBP O
based VBN O
on IN O
the DT O
likelihood NN O
ratio NN O
criterion NN O
, , O
that DT O
is VBZ O
on IN O
formula NN O
( , O
1 CD O
) -RRB- O
under IN O
the DT O
assumption NN O
of IN O
independence NN O
of IN O
variables NNS O
xi NN O
i NN O
( , O
formula NN O
( -LRB- O
2 CD O
) -RRB- O
) -RRB- O
. . O

Two CD O
approaches NNS O
are VBP O
used VBN O
in IN O
the DT O
definitions NNS O
of IN O
these DT O
statistics NNS O
. . O

One CD O
of IN O
them PRP O
can MD O
be VB O
called VBN O
a DT O
"""" `` O
discrete JJ O
"""" '' O
approach NN O
; : O
the DT O
other JJ O
can MD O
be VB O
called VBN O
a DT O
"""" `` O
continuous JJ O
"""" '' O
approach NN O
. . O

The DT O
discrete JJ O
approach NN O
is VBZ O
based VBN O
directly RB O
on IN O
formulae NN O
( , O
1 CD O
) -RRB- O
, , O
( , O
2 CD O
) -RRB- O
and CC O
the DT O
definition NN O
of IN O
transfer NN O
probabilities NNS O
. . O

It PRP O
follows VBZ O
from IN O
( : O
5 CD O
) , O
that IN O
the DT O
following VBG O
formulae NN O
for IN O
conditional JJ O
probabilities NNS O
hold VBP O
: : O

P NN O
{ NFP O
xi NN O
i NN O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
= NFP O
p1 CD O
| SYM O
1 CD O
( : O
mu NN O
i NN O
) -RRB- O
, , O
if IN O
xi NN O
i NN O
= SYM O
1 CD O
, , O

P NN O
{ NFP O
xi NN O
i NN O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
= NFP O
p0 CD O
| SYM O
1 CD O
( : O
mu NN O
i NN O
) NFP O
= SYM O
1 CD O
- HYPH O
p1 NN O
| SYM O
1 CD O
( : O
mu NN O
i NN O
) -RRB- O
, , O
if IN O
xi NN O
i NN O
= SYM O
0 CD O
, , O

and CC O
hence RB O

( : O
7 CD O
) SYM O
P NN O
{ NFP O
xi NN O
i NN O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
= NFP O
( SYM O
1 CD O
- HYPH O
p1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
i NN O
) NFP O
) -RRB- O
. . O
( : O
p1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
i CD O
) SYM O
1 CD O
- HYPH O
p1 CD O
| SYM O
1 CD O
( HYPH O
mu NN O
i NN O
) NFP O
) NFP O
) -RRB- O
xi NN O
i -RRB- O
. . O

Similarly RB O
, , O

( : O
8 CD O
) SYM O
P NN O
{ NFP O
xi NN O
i NN O
| NFP O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
= NFP O
( SYM O
1 CD O
- HYPH O
p1 NN O
| : O
0 CD O
( HYPH O
mu NN O
i NN O
) NFP O
) NFP O
. . O
( : O
p1 NN O
| : O
0 CD O
( HYPH O
mu NN O
i NN O
) SYM O
1 CD O
- HYPH O
p1 NN O
| : O
0 CD O
( HYPH O
mu NN O
i NN O
) NFP O
) NFP O
xi FW O
i FW O
. . O

Relations NNS O
( : O
7 CD O
) -RRB- O
, , O
( , O
8 CD O
) SYM O
together RB O
with IN O
( : O
1 CD O
) -RRB- O
, , O
( , O
2 CD O
) -RRB- O
imply VBP O
the DT O
following VBG O
formula NN O
for IN O
the DT O
logarithm NN O
of IN O
the DT O
likelihood NN O
ratio NN O
: : O

( : O
9 CD O
) SYM O
T NN O
( : O
1 CD O
) NFP O
( : O
xi NN O
; : O
omega NN O
) -RRB- O
= : O
T NN O
( : O
1 CD O
) NFP O
( : O
xi NN O
) -RRB- O
= NFP O
ln NNS O
( : O
product NN O
i NN O
= NFP O
1nP NN O
{ NFP O
xi NN O
i NN O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} SYM O
P NN O
{ SYM O
xi NN O
i NN O
| NFP O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
) NFP O
= SYM O
alpha NN O
0 CD O
+ SYM O
sum NN O
i NN O
= SYM O
1n CD O
alpha NN O
i NN O
. . O
xi NN O
i PRP O
, , O

where WRB O

( : O
10 CD O
) SYM O
alpha NN O
0 CD O
= SYM O
sum NN O
i NN O
= SYM O
1n CD O
alpha NN O
0i NN O
, , O
alpha NN O
0i NN O
= SYM O
ln NN O
1 CD O
- HYPH O
p1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
i CD O
) SYM O
1 CD O
- HYPH O
p1 NN O
| SYM O
0 CD O
( HYPH O
mu NN O
i CD O
) -RRB- O
< NFP O
0 CD O

( : O
11 CD O
) SYM O
alpha NN O
i NN O
= NFP O
ln NN O
p1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
i CD O
) NFP O
( : O
1 CD O
- HYPH O
p1 CD O
| SYM O
0 CD O
( HYPH O
mu NN O
i CD O
) NFP O
) NFP O
p1 CD O
| SYM O
0 CD O
( HYPH O
mu NN O
i CD O
) -RRB- O
( : O
1 CD O
- HYPH O
p1 CD O
| SYM O
1 CD O
( HYPH O
mu NN O
i NN O
) NFP O
) NFP O
> NFP O
0 NFP O
. . O

One PRP O
can MD O
see VB O
that IN O
the DT O
statistic NN O
T NNP O
( -LRB- O
1 CD O
) -RRB- O
can MD O
be VB O
expressed VBN O
as IN O
a DT O
linear JJ O
combination NN O
of IN O
the DT O
xi NN O
i NN O
. . O

As IN O
we PRP O
noted VBD O
, , O
theoretically RB O
the DT O
best JJS O
threshold NN O
value NN O
for IN O
the DT O
statistic NN O
T NN O
( : O
1 CD O
) -RRB- O
is VBZ O
equal JJ O
to IN O
1n1 CD O
= SYM O
0 CD O
. . O

However RB O
, , O
that DT O
is VBZ O
only RB O
theoretical JJ O
. . O

As IN O
the DT O
assumption NN O
of IN O
independence NN O
of IN O
variables NNS O
xi FW O
i FW O
is VBZ O
incorrect JJ O
and CC O
the DT O
statistic NN O
T NNP O
( , O
1 CD O
) -RRB- O
is VBZ O
only RB O
a DT O
rough JJ O
estimate NN O
of IN O
logarithm NN O
of IN O
the DT O
likelihood NN O
ratio NN O
, , O
the DT O
best JJS O
threshold NN O
value NN O
is VBZ O
not RB O
necessarily RB O
equal JJ O
to IN O
zero CD O
( : O
and CC O
this DT O
threshold NN O
does VBZ O
not RB O
really RB O
equal VB O
zero CD O
in IN O
practice NN O
) -RRB- O
. . O

Let VB O
us PRP O
put VB O
eta NN O
= : O
eta NN O
( : O
omega JJ O
) NFP O
= : O
T NN O
( SYM O
1 CD O
) SYM O
- HYPH O
alpha NN O
0 CD O
sum NN O
i NN O
= SYM O
1n CD O
alpha NN O
i NFP O
. . O

From IN O
the DT O
definition NN O
of IN O
eta NN O
and CC O
relations NNS O
( , O
9 CD O
) SYM O
- HYPH O
( SYM O
11 CD O
) -RRB- O
it PRP O
follows VBZ O
that DT O

( : O
12 CD O
) SYM O
eta NN O
= : O
sum NN O
i NN O
= SYM O
1na NN O
^ NFP O
i NN O
xi NN O
i CD O
, , O

where WRB O

( : O
13 CD O
) SYM O
a DT O
^ SYM O
i NN O
= SYM O
ln JJ O
p1 CD O
| SYM O
1 CD O
( HYPH O
mu NN O
i CD O
) -RRB- O
( , O
1 CD O
- HYPH O
p1 NN O
| SYM O
0 CD O
( HYPH O
mu NN O
i NN O
) NFP O
) NFP O
p1 CD O
| SYM O
0 CD O
( HYPH O
mu NN O
i CD O
) -RRB- O
( , O
1 CD O
- HYPH O
p1 CD O
| SYM O
1 CD O
( HYPH O
mu NN O
i NN O
) NFP O
) -RRB- O
sum NN O
i NN O
= SYM O
1nln CD O
p1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
i NN O
) -RRB- O
( , O
1 CD O
- HYPH O
p1 NN O
| SYM O
0 CD O
( HYPH O
mu NN O
i NN O
) -RRB- O
) NFP O
p1 CD O
| SYM O
0 CD O
( HYPH O
mu NN O
i CD O
) -RRB- O
( , O
1 CD O
- HYPH O
p1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
i NN O
) NFP O
) NFP O
> NFP O
0 NFP O
. . O

We PRP O
note VBP O
that DT O

( : O
14 CD O
) SYM O
sum NN O
i NN O
= SYM O
1na NN O
^ NFP O
i CD O
= SYM O
1 CD O
. . O

The DT O
variable JJ O
eta NN O
( , O
omega NN O
) -RRB- O
can MD O
be VB O
treated VBN O
as IN O
a DT O
second JJ O
statistic NN O
. . O

Its PRP$ O
values NNS O
lie VBP O
between IN O
0 CD O
and CC O
1 CD O
. . O

Statistics NNP O
T NNP O
( , O
1 CD O
) -RRB- O
and CC O
eta FW O
are VBP O
linearly RB O
dependent JJ O
, , O
and CC O
hence RB O
for IN O
a DT O
fixed VBN O
word NN O
omega NN O
these DT O
statistics NNS O
are VBP O
equivalent JJ O
. . O

However RB O
, , O
the DT O
coefficients NNS O
alpha NN O
0 CD O
and CC O
alpha NN O
i NN O
( , O
i CD O
= SYM O
1 CD O
, , O
. . O
. , O
. . O
, , O
n LS O
) -RRB- O
are VBP O
different JJ O
for IN O
different JJ O
words NNS O
omega NN O
, , O
so IN O
the DT O
relation NN O
between IN O
thresholds NNS O
, , O
used VBN O
in IN O
the DT O
prediction NN O
, , O
is VBZ O
different JJ O
for IN O
different JJ O
words NNS O
; : O
consequently RB O
, , O
the DT O
statistics NNS O
T NN O
( , O
1 CD O
) -RRB- O
and CC O
eta FW O
are VBP O
not RB O
equivalent JJ O
for IN O
the DT O
whole JJ O
totality NN O
of IN O
words NNS O
( , O
We PRP O
will MD O
see VB O
later RB O
that IN O
if IN O
thresholds NNS O
are VBP O
well RB O
- HYPH O
chosen VBN O
, , O
then RB O
eta FW O
leads VBZ O
to IN O
better JJR O
results NNS O
than IN O
T NNP O
( SYM O
1 CD O
) -RRB- O
) -RRB- O
. . O

The DT O
other JJ O
approach NN O
to IN O
the DT O
definition NN O
of IN O
statistics NNS O
, , O
used VBN O
in IN O
the DT O
annotation NN O
procedure NN O
, , O
starts VBZ O
from IN O
a DT O
linear JJ O
combination NN O
eta NN O
= : O
sum NN O
i NN O
= SYM O
1nai FW O
xi FW O
i CD O
of IN O
the DT O
xi NN O
i NN O
as IN O
in IN O
formula NN O
( : O
12 CD O
) -RRB- O
. . O

Here RB O
coefficients NNS O
alpha NN O
i PRP O
are VBP O
not RB O
necessarily RB O
given VBN O
by IN O
( , O
13 CD O
) -RRB- O
, , O
but CC O
should MD O
be VB O
positive JJ O
and CC O
satisfy VB O
the DT O
relation NN O
( : O
14 CD O
) -RRB- O
. . O

This DT O
approach NN O
uses VBZ O
the DT O
assumption NN O
that IN O
eta NNP O
has VBZ O
the DT O
normal JJ O
distribution NN O
. . O

Certainly RB O
this DT O
assumption NN O
is VBZ O
not RB O
correct JJ O
( : O
at IN O
least JJS O
because IN O
the DT O
inequality NN O
0 CD O
< SYM O
= SYM O
eta FW O
< CC O
= SYM O
1 CD O
always RB O
holds VBZ O
) -RRB- O
. . O

Nevertheless RB O
, , O
we PRP O
use VBP O
this DT O
assumption NN O
( , O
and CC O
, , O
similarly RB O
to IN O
the DT O
discrete JJ O
approach NN O
, , O
the DT O
assumption NN O
of IN O
independence NN O
of IN O
variables NNS O
xi NN O
i NN O
( , O
omega NN O
) -RRB- O
) -RRB- O
. . O

( : O
As IN O
the DT O
normal JJ O
distribution NN O
is VBZ O
continuous JJ O
, , O
this DT O
approach NN O
can MD O
be VB O
called VBN O
"""" `` O
continuous JJ O
"""" '' O
) -RRB- O
. . O

Thus RB O
, , O
we PRP O
consider VBP O
a DT O
random JJ O
variable NN O

( : O
15 CD O
) : O
eta NN O
= : O
sum NN O
i NN O
= NFP O
1nai NNP O
xi CD O
i NN O

and CC O
assume VB O
that IN O
it PRP O
has VBZ O
a DT O
normal JJ O
distribution NN O
. . O

Denote NN O
by IN O

M1 NNP O
eta NNP O
= : O
M NNP O
( -LRB- O
eta NN O
| : O
xi NN O
0 CD O
= SYM O
1 CD O
) -RRB- O
, , O
D1 NN O
eta NN O
= : O
D NN O
( , O
eta NN O
| : O
xi NN O
0 CD O
= SYM O
1 CD O
) -RRB- O
= SYM O
sigma NN O
12 CD O
, , O
M0 CD O
eta NN O
= : O
M NN O
( , O
eta NN O
| : O
xi NN O
0 CD O
= SYM O
0 CD O
) -RRB- O
, , O
D0 NN O
eta NN O
= : O
D NN O
( , O
eta NN O
| : O
xi NN O
0 CD O
= SYM O
0 CD O
) NFP O
= SYM O
sigma NN O
2 CD O

the DT O
conditional JJ O
expectations NNS O
and CC O
dispersions NNS O
of IN O
eta FW O
given VBN O
that DT O
xi NN O
0 CD O
= SYM O
1 CD O
or CC O
0 CD O
respectively RB O
. . O

We PRP O
have VBP O

M1 NNP O
eta NN O
= : O
sum NN O
aiM NN O
( : O
xi NN O
i NN O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
) NFP O
= SYM O
sum NN O
aip1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
i NN O
) -RRB- O
, , O
M0 NN O
eta NN O
= : O
sum NN O
aip1 NN O
| SYM O
0 CD O
( HYPH O
mu NN O
i NN O
) -RRB- O
. . O

Further RB O
, , O
the DT O
assumption NN O
of IN O
independence NN O
of IN O
xi NN O
i NN O
( , O
omega NN O
) -RRB- O
implies VBZ O
that IN O

D1 NN O
eta NN O
= : O
sigma NN O
12 CD O
= SYM O
sum NN O
iai2 NN O
. . O
p1 CD O
| SYM O
1 CD O
( HYPH O
mu NN O
i NN O
) -RRB- O
. . O
( : O
1 CD O
- HYPH O
p1 NN O
| SYM O
1 CD O
( HYPH O
mu NN O
i NN O
) NFP O
) NFP O
, , O
D0 NN O
eta NN O
= SYM O
sigma NN O
2 CD O
= SYM O
sum NN O
iai2 NN O
. . O
p1 NN O
| SYM O
0 CD O
( HYPH O
mu NN O
i NN O
) -RRB- O
. . O
( , O
1 CD O
- HYPH O
p1 NN O
| SYM O
0 CD O
( HYPH O
mu NN O
i NN O
) -RRB- O
) -RRB- O
. . O

( NFP O
We PRP O
note VBP O
that IN O
it PRP O
is VBZ O
the DT O
only JJ O
place NN O
where WRB O
the DT O
independence NN O
of IN O
xi NN O
i NN O
is VBZ O
used VBN O
; , O
therefore RB O
, , O
the DT O
assumption NN O
of IN O
independence NN O
of IN O
xi NN O
i PRP O
is VBZ O
not RB O
as RB O
essential JJ O
in IN O
this DT O
approach NN O
as IN O
it PRP O
was VBD O
in IN O
the DT O
definition NN O
of IN O
the DT O
statistic NN O
T NNP O
( -LRB- O
1 CD O
) -RRB- O
) -RRB- O
. . O

It PRP O
follows VBZ O
from IN O
the DT O
assumption NN O
of IN O
a DT O
normal JJ O
distribution NN O
that IN O
in IN O
cases NNS O
xi NN O
0 CD O
= SYM O
1 CD O
and CC O
0 CD O
the DT O
variables NNS O

( : O
16 CD O
) , O
eta FW O
- HYPH O
M1 NN O
eta NN O
sigma NN O
1 CD O
and CC O
eta NNP O
- HYPH O
M0 NN O
eta NN O
sigma NN O
0 CD O
have VBP O
standard JJ O
normal JJ O
distribution NN O
N NN O
( , O
0 CD O
, , O
1 CD O
) NFP O

As IN O
above RB O
, , O
we PRP O
use VBP O
the DT O
logarithm NN O
of IN O
the DT O
likelihood NN O
ratio NN O
as IN O
a DT O
statistic NN O
and CC O
in IN O
addition NN O
assume VBP O
that IN O
the DT O
ratio NN O
of IN O
a DT O
priori JJ O
hypothesis NN O
probabilities NNS O
is VBZ O
equal JJ O
to IN O
1 CD O
. . O

Let VB O
us PRP O
denote VB O
this DT O
statistic NN O
by IN O
T NNP O
( SYM O
2 CD O
) -RRB- O
. . O

Relation NN O
( SYM O
16 CD O
) -RRB- O
implies VBZ O
that IN O

T NN O
( , O
2 CD O
) SYM O
( : O
lambda FW O
) -RRB- O
= : O
ln NN O
P NN O
{ NN O
lambda NN O
< NN O
= NFP O
eta FW O
< SYM O
= : O
lambda NN O
+ CC O
d NN O
lambda NN O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} SYM O
P NN O
{ NN O
lambda NN O
< NN O
= NFP O
eta NN O
< : O
= : O
lambda NN O
+ CC O
d NN O
lambda NN O
| NFP O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
= SYM O
ln NN O
( , O
1 CD O
/ SYM O
2 CD O
pi NN O
. . O
sigma NN O
1 CD O
) -RRB- O
. , O
exp NN O
{ CD O
- HYPH O
12 CD O
. . O
( : O
( : O
lambda NN O
- HYPH O
M1 NNP O
eta FW O
) -RRB- O
/ : O
sigma NN O
1 CD O
) SYM O
2 CD O
} SYM O
( SYM O
1 CD O
/ SYM O
2 CD O
pi NN O
. . O
sigma NN O
0 CD O
) -RRB- O
. , O
exp NN O
{ NN O
12 CD O
. . O
( : O
( : O
lambda NN O
- HYPH O
M0 NNP O
eta FW O
) -RRB- O
/ : O
sigma NN O
0 CD O
) SYM O
2 CD O
} SYM O
= SYM O
12 CD O
. . O
{ NFP O
( , O
( : O
lambda NN O
- HYPH O
M0 NNP O
eta FW O
) -RRB- O
/ : O
sigma NN O
0 CD O
) SYM O
2 CD O
- HYPH O
( , O
( : O
lambda NN O
- HYPH O
M1 NN O
eta NN O
) -RRB- O
/ : O
sigma NN O
1 CD O
) SYM O
2 CD O
} SYM O
+ CC O
ln NN O
( HYPH O
sigma NN O
0 CD O
/ SYM O
sigma NN O
1 CD O
) -RRB- O
. . O

Another DT O
variant NN O
of IN O
this DT O
statistic NN O
- : O
statistic NN O
T NN O
^ , O
( -LRB- O
2 CD O
) -RRB- O
- , O
was VBD O
used VBN O
in IN O
the DT O
paper NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
statistic NN O
T NN O
^ NFP O
( SYM O
2 CD O
) -RRB- O
is VBZ O
the DT O
ratio NN O
of IN O
type NN O
1 CD O
error NN O
to IN O
type NN O
2 CD O
error NN O
: : O

( : O
17 CD O
) SYM O
T NN O
^ NFP O
( SYM O
2 CD O
) -RRB- O
( -LRB- O
lambda NN O
) NFP O
= SYM O
ln NNP O
P NNP O
( SYM O
1 CD O
) -RRB- O
( , O
lambda NN O
) : O
P NN O
( SYM O
2 CD O
) -RRB- O
( : O
lambda NN O
) -RRB- O
= , O
ln FW O
Phi NNP O
( , O
( , O
lambda NN O
- HYPH O
M1 NNP O
eta NNP O
) -RRB- O
/ : O
sigma NN O
1 CD O
) SYM O
1 CD O
- HYPH O
Phi NN O
( : O
( : O
lambda NN O
- HYPH O
M0 NNP O
eta FW O
) -RRB- O
/ : O
sigma NN O
0 CD O
) -RRB- O
, , O

where WRB O
Phi NNP O
( , O
x NNP O
) -RRB- O
is VBZ O
the DT O
cumulative JJ O
normal JJ O
distribution NN O
function NN O
: : O
Phi NNP O
( : O
x NNP O
) -RRB- O
= SYM O
12 CD O
pi NN O
integral JJ O
- HYPH O
infinity NN O
xe NN O
- HYPH O
z22dz NN O
. . O

The DT O
statistics NNS O
eta NN O
and CC O
T NN O
^ SYM O
( SYM O
2 CD O
) -RRB- O
are VBP O
equivalent JJ O
for IN O
an DT O
arbitrary JJ O
fixed VBN O
word NN O
omega NN O
( , O
although IN O
not RB O
equivalent JJ O
for IN O
the DT O
whole JJ O
totality NN O
of IN O
words NNS O
) -RRB- O
. . O

At IN O
the DT O
same JJ O
time NN O
, , O
the DT O
statistics NNS O
eta NN O
and CC O
T NNP O
( SYM O
2 CD O
) -RRB- O
are VBP O
not RB O
necessarily RB O
equivalent JJ O
, , O
as IN O
the DT O
dependence NN O
of IN O
T NNP O
( SYM O
2 CD O
) -RRB- O
on IN O
eta FW O
may MD O
turn VB O
out RP O
to TO O
be VB O
not RB O
monotonic JJ O
. . O

Moreover RB O
, , O
it PRP O
is VBZ O
never RB O
monotonic JJ O
for IN O
all DT O
values NNS O
of IN O
eta NN O
. . O

However RB O
, , O
we PRP O
are VBP O
interested JJ O
only RB O
in IN O
values NNS O
0 NFP O
< SYM O
= SYM O
eta FW O
< SYM O
= SYM O
1 CD O
, , O
and CC O
usually RB O
( , O
though IN O
not RB O
always RB O
) , O
the DT O
dependence NN O
of IN O
T NN O
( SYM O
2 CD O
) -RRB- O
on IN O
eta FW O
is VBZ O
monotonous JJ O
for IN O
these DT O
values NNS O
of IN O
eta NN O
, , O
and CC O
in IN O
this DT O
case NN O
the DT O
statistics NNS O
eta VBP O
and CC O
T NN O
( , O
2 CD O
) -RRB- O
are VBP O
equivalent JJ O
( , O
for IN O
a DT O
fixed VBN O
word NN O
omega NN O
) -RRB- O
. . O

Furthermore RB O
, , O
even RB O
in IN O
the DT O
case NN O
where WRB O
the DT O
dependence NN O
is VBZ O
not RB O
monotonic JJ O
, , O
the DT O
monotonicity NN O
is VBZ O
violated VBN O
only RB O
for IN O
the DT O
values NNS O
of IN O
eta NNP O
close JJ O
either CC O
to IN O
0 CD O
or CC O
to IN O
1 CD O
, , O
and CC O
the DT O
lack NN O
of IN O
monotonicity NN O
can MD O
be VB O
disregarded VBN O
. . O

We PRP O
still RB O
have VBP O
to TO O
discuss VB O
the DT O
question NN O
of IN O
the DT O
choice NN O
of IN O
coefficients NNS O
ai VBP O
in IN O
( HYPH O
15 CD O
) -RRB- O
. . O

One CD O
of IN O
the DT O
variants NNS O
was VBD O
described VBN O
above IN O
: : O
formula NN O
( : O
13 CD O
) -RRB- O
can MD O
be VB O
applied VBN O
. . O

Another DT O
variant NN O
was VBD O
introduced VBN O
in IN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

This DT O
variant NN O
can MD O
be VB O
described VBN O
as IN O
follows VBZ O
. . O

As IN O
above RB O
, , O
we PRP O
assume VBP O
that IN O
the DT O
variate NN O
eta FW O
= : O
sum NN O
ai NN O
xi NN O
i PRP O
has VBZ O
a DT O
normal JJ O
distribution NN O
. . O

Each DT O
set NN O
of IN O
coefficients NNS O
ai VBP O
and CC O
each DT O
threshold NN O
value NN O
lambda NN O
have VBP O
corresponding VBG O
theoretical JJ O
frequencies NNS O
of IN O
type NN O
1 CD O
and CC O
type NN O
2 CD O
errors NNS O
P NNP O
( , O
1 CD O
) -RRB- O
( , O
lambda NN O
) -RRB- O
, , O
P NNP O
( , O
2 CD O
) -RRB- O
( , O
lambda NN O
) -RRB- O
. . O

The DT O
idea NN O
is VBZ O
to TO O
take VB O
the DT O
set NN O
of IN O
coefficients NNS O
{ : O
ai NN O
} , O
that WDT O
gives VBZ O
the DT O
minimum JJ O
sum NN O
P NN O
( -LRB- O
1 CD O
) -RRB- O
( , O
lambda NN O
) -RRB- O
+ CC O
P NN O
( SYM O
2 CD O
) -RRB- O
( , O
lambda NN O
) -RRB- O
, , O
where WRB O
lambda NN O
is VBZ O
the DT O
best JJS O
threshold NN O
value NN O
for IN O
this DT O
coefficient JJ O
set NN O
. . O

However RB O
, , O
analytically RB O
it PRP O
is VBZ O
very RB O
cumbersome JJ O
, , O
so RB O
the DT O
following VBG O
simplification NN O
was VBD O
implemented VBN O
. . O

For IN O
a DT O
fixed VBN O
set NN O
of IN O
coefficients NNS O
{ , O
ai NN O
} NFP O
we PRP O
select VBP O
the DT O
threshold NN O
value NN O
lambda NN O
such JJ O
that IN O
the DT O
frequency NN O
of IN O
type NN O
1 CD O
errors NNS O
is VBZ O
equal JJ O
to IN O
the DT O
frequency NN O
of IN O
type NN O
2 CD O
errors NNS O
: : O
P NN O
( : O
1 CD O
) -RRB- O
( , O
lambda NN O
) NFP O
= SYM O
P NNP O
( SYM O
2 CD O
) -RRB- O
( : O
lambda NN O
) -RRB- O
. . O

Then RB O
we PRP O
find VBP O
the DT O
set NN O
of IN O
coefficients NNS O
that WDT O
minimizes VBZ O
these DT O
frequencies NNS O
P NN O
( : O
1 CD O
) -RRB- O
( , O
lambda NN O
) NFP O
= SYM O
P NNP O
( SYM O
2 CD O
) -RRB- O
( , O
lambda NN O
) -RRB- O
. . O

Here RB O
the DT O
search NN O
of IN O
the DT O
coefficient JJ O
set NN O
can MD O
be VB O
reduced VBN O
to IN O
a DT O
conditional JJ O
extremum JJ O
problem NN O
. . O

The DT O
A4 NNP O
algorithm NN O
uses VBZ O
an DT O
iterated JJ O
procedure NN O
for IN O
the DT O
solution NN O
of IN O
this DT O
problem NN O
( , O
see VB O
[ -LRB- O
5 CD O
] -RRB- O
) -RRB- O
. . O

In IN O
order NN O
to TO O
optimize VB O
the DT O
automated JJ O
annotation NN O
procedure NN O
, , O
that DT O
is VBZ O
to TO O
increase VB O
the DT O
prediction NN O
quality NN O
, , O
certain JJ O
modifications NNS O
of IN O
the DT O
procedure NN O
were VBD O
introduced VBN O
. . O

For IN O
each DT O
statistic NN O
( , O
eta FW O
, , O
T NNP O
( , O
1 CD O
) -RRB- O
, , O
T NNP O
( , O
2 CD O
) -RRB- O
, , O
T NNP O
^ SYM O
( SYM O
2 CD O
) -RRB- O
) , O
many JJ O
variants NNS O
( , O
up IN O
to IN O
36 CD O
) -RRB- O
, , O
including VBG O
the DT O
variant NN O
that WDT O
was VBD O
described VBN O
above RB O
, , O
were VBD O
considered VBN O
- : O
each DT O
variant NN O
corresponds VBZ O
to IN O
a DT O
certain JJ O
combination NN O
of IN O
these DT O
modifications NNS O
. . O

Some DT O
variants NNS O
really RB O
turned VBD O
out RP O
to TO O
be VB O
better JJR O
than IN O
the DT O
variants NNS O
described VBN O
above RB O
. . O

A DT O
simplified JJ O
scheme NN O
of IN O
modifications NNS O
( , O
and CC O
thereby RB O
of IN O
statistic JJ O
variants NNS O
) -RRB- O
can MD O
be VB O
described VBN O
as IN O
follows VBZ O
. . O

1 LS O
) : O
What WDT O
primary JJ O
local JJ O
alignments NNS O
are VBP O
considered VBN O
? . O

In IN O
the DT O
described VBN O
variant NN O
of IN O
statistics NNS O
only RB O
one CD O
primary JJ O
local JJ O
alignment NN O
( : O
the DT O
one NN O
with IN O
the DT O
maximum JJ O
power NN O
) -RRB- O
was VBD O
considered VBN O
. . O

Meanwhile RB O
, , O
all DT O
constructed VBN O
local JJ O
alignments NNS O
with IN O
sufficiently RB O
high JJ O
power NN O
can MD O
be VB O
considered VBN O
, , O
as IN O
it PRP O
was VBD O
done VBN O
in IN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

In IN O
this DT O
case NN O
indices NNS O
i PRP O
in IN O
( : O
9 CD O
) -RRB- O
, , O
( , O
12 CD O
) -RRB- O
, , O
( , O
15 CD O
) -RRB- O
correspond VBP O
not RB O
to IN O
individual JJ O
similar JJ O
sequences NNS O
, , O
but CC O
to IN O
primary JJ O
local JJ O
alignments NNS O
of IN O
this DT O
sequences NNS O
. . O

2 LS O
) : O
Are VBP O
the DT O
lengths NNS O
of IN O
primary JJ O
local JJ O
alignments NNS O
taken VBN O
into IN O
consideration NN O
? . O

In IN O
the DT O
described VBN O
variant JJ O
lengths NNS O
of IN O
primary JJ O
local JJ O
alignments NNS O
were VBD O
not RB O
taken VBN O
into IN O
consideration NN O
, , O
but CC O
these DT O
lengths NNS O
can MD O
be VB O
considered VBN O
as RB O
well RB O
. . O

In IN O
this DT O
case NN O
indices NNS O
i PRP O
in IN O
( : O
9 CD O
) -RRB- O
, , O
( , O
12 CD O
) -RRB- O
, , O
( , O
15 CD O
) -RRB- O
correspond VBP O
not RB O
to IN O
similar JJ O
sequences NNS O
or CC O
primary JJ O
local JJ O
alignments NNS O
, , O
but CC O
to IN O
individual JJ O
positions NNS O
of IN O
these DT O
primary JJ O
local JJ O
alignments NNS O
( : O
as IN O
in IN O
case NN O
of IN O
FT NNP O
- HYPH O
type NN O
words NNS O
) -RRB- O
. . O

In IN O
this DT O
case NN O
the DT O
total JJ O
number NN O
of IN O
variates NNS O
xi NN O
i PRP O
is VBZ O
equal JJ O
to IN O
the DT O
overall JJ O
length NN O
of IN O
all DT O
primary JJ O
local JJ O
alignments NNS O
. . O

For IN O
these DT O
variants NNS O
of IN O
statistics NNS O
long JJ O
local JJ O
alignments NNS O
turn VBP O
out RP O
to TO O
be VB O
more RBR O
significant JJ O
than IN O
short JJ O
local JJ O
alignments NNS O
with IN O
the DT O
same JJ O
power NN O
. . O

3 LS O
) : O
How WRB O
are VBP O
the DT O
coefficients NNS O
ai VBP O
calculated VBN O
? . O

The DT O
coefficients NNS O
ai VBP O
in IN O
( SYM O
15 CD O
) -RRB- O
can MD O
be VB O
calculated VBN O
using VBG O
different JJ O
methods NNS O
- : O
either CC O
formula NN O
( , O
13 CD O
) -RRB- O
can MD O
be VB O
used VBN O
, , O
or CC O
an DT O
iterative JJ O
method NN O
( , O
described VBN O
in IN O
[ -LRB- O
5 CD O
] -RRB- O
) -RRB- O
can MD O
be VB O
applied VBN O
. . O

( : O
For IN O
the DT O
statistic NN O
T NNP O
( , O
1 CD O
) -RRB- O
the DT O
coefficients NNS O
ai VBP O
are VBP O
always RB O
calculated VBN O
using VBG O
formula NN O
( SYM O
13 CD O
) -RRB- O
) -RRB- O
. . O

As IN O
there EX O
are VBP O
3 CD O
modifications NNS O
, , O
the DT O
total JJ O
number NN O
of IN O
basic JJ O
variants NNS O
( , O
in IN O
the DT O
described VBN O
simplified JJ O
scheme NN O
) -RRB- O
equals VBZ O
23 CD O
= SYM O
8 CD O
( , O
and CC O
for IN O
the DT O
statistic NN O
T NNP O
( SYM O
1 CD O
) -RRB- O
it PRP O
equals VBZ O
4 CD O
) -RRB- O
. . O

So CC O
, , O
variants NNS O
of IN O
the DT O
statistics NNS O
eta FW O
, , O
T NNP O
( , O
1 CD O
) -RRB- O
, , O
T NNP O
( , O
2 CD O
) -RRB- O
, , O
T NN O
^ SYM O
( SYM O
2 CD O
) -RRB- O
are VBP O
considered VBN O
in IN O
this DT O
paper NN O
. . O

Moreover RB O
, , O
for IN O
the DT O
purpose NN O
of IN O
comparison NN O
( , O
as IN O
in IN O
the DT O
paper NN O
[ -LRB- O
5 CD O
] -RRB- O
) -RRB- O
the DT O
simple JJ O
statistic NN O

( : O
18 CD O
) SYM O
q NN O
= SYM O
q NN O
( : O
omega NN O
) -RRB- O
= : O
sum NN O
in IN O
xi NN O
in IN O

( : O
the DT O
frequency NN O
of IN O
occurrence NN O
of IN O
a DT O
word NN O
omega NN O
in IN O
the DT O
collection NN O
of IN O
similar JJ O
sequences NNS O
) -RRB- O
is VBZ O
also RB O
considered VBN O
. . O

Finally RB O
we PRP O
quote VBP O
a DT O
scheme NN O
of IN O
the DT O
A4 NNP O
algorithm NN O
in IN O
Figure NNP O
1 CD O
( : O
this DT O
scheme NN O
is VBZ O
essentially RB O
taken VBN O
from IN O
[ -LRB- O
5 CD O
] -RRB- O
) -RRB- O
. . O

A DT O
short JJ O
description NN O
of IN O
each DT O
stage NN O
can MD O
be VB O
found VBN O
in IN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Here RB O
we PRP O
only RB O
note VBP O
that IN O
the DT O
most JJS O
time NN O
- HYPH O
consuming VBG O
stage NN O
is VBZ O
the DT O
first JJ O
one CD O
- , O
the DT O
generation NN O
of IN O
a DT O
collection NN O
of IN O
similar JJ O
sequences NNS O
. . O

We PRP O
also RB O
note VBP O
that IN O
in IN O
the DT O
current JJ O
investigation NN O
regions NNS O
were VBD O
not RB O
determined VBN O
, , O
and CC O
the DT O
prediction NN O
was VBD O
performed VBN O
for IN O
the DT O
whole JJ O
query NN O
sequence NN O
. . O

Testing NN O
results NNS O

Testing NN O
scheme NN O

A DT O
collection NN O
of IN O
518 CD O
sequences NNS O
, , O
randomly RB O
selected VBN O
from IN O
SWISS NNP O
- HYPH O
PROT NNP O
databank NN O
, , O
was VBD O
generated VBN O
. . O

Note VB O
that IN O
only RB O
initially RB O
annotated VBN O
sequences NNS O
( : O
i PRP O
. . O
e UH O
. . O
, , O
sequences NNS O
whose WP$ O
description NN O
fields NNS O
were VBD O
not RB O
obtained VBN O
by IN O
the DT O
extension NN O
from IN O
similar JJ O
sequences NNS O
) -RRB- O
were VBD O
selected VBN O
. . O

The DT O
prediction NN O
was VBD O
performed VBN O
for IN O
KW NNP O
- HYPH O
type NN O
words NNS O
. . O

All DT O
selected VBN O
sequences NNS O
were VBD O
divided VBN O
into IN O
two CD O
groups NNS O
. . O

The DT O
first JJ O
group NN O
contained VBD O
210 CD O
sequences NNS O
. . O

This DT O
group NN O
was VBD O
used VBN O
during IN O
the DT O
"""" `` O
learning VBG O
stage NN O
"""" '' O
: : O
the DT O
procedure NN O
was VBD O
applied VBN O
to IN O
all DT O
sequences NNS O
from IN O
the DT O
group NN O
, , O
and CC O
values NNS O
of IN O
procedure NN O
parameters NNS O
( , O
including VBG O
optimal JJ O
threshold NN O
values NNS O
) -RRB- O
that WDT O
minimize VBP O
the DT O
total JJ O
number NN O
of IN O
errors NNS O
for IN O
the DT O
first JJ O
group NN O
were VBD O
selected VBN O
. . O

The DT O
remaining VBG O
308 CD O
sequences NNS O
were VBD O
used VBN O
for IN O
the DT O
"""" `` O
main JJ O
testing NN O
"""" '' O
that WDT O
was VBD O
performed VBN O
using VBG O
parameter NN O
values NNS O
obtained VBN O
on IN O
the DT O
basis NN O
of IN O
"""" `` O
learning VBG O
"""" '' O
results NNS O
. . O

A DT O
list NN O
of IN O
all PDT O
these DT O
308 CD O
sequences NNS O
is VBZ O
given VBN O
in IN O
Additional JJ O
file NN O
1 CD O
. . O

The DT O
total JJ O
number NN O
of IN O
KW NNP O
- HYPH O
type NN O
words NNS O
in IN O
the DT O
description NN O
fields NNS O
of IN O
308 CD O
selected VBN O
sequences NNS O
, , O
used VBN O
as IN O
query NN O
sequences NNS O
, , O
was VBD O
equal JJ O
to IN O
1176 CD O
( , O
the DT O
positive JJ O
prediction NN O
was VBD O
preferable JJ O
for IN O
these DT O
words NNS O
) -RRB- O
. . O

As IN O
it PRP O
was VBD O
noted VBN O
, , O
a DT O
collection NN O
of IN O
similar JJ O
sequences NNS O
was VBD O
generated VBN O
for IN O
each DT O
query NN O
sequence NN O
; : O
the DT O
number NN O
of IN O
sequences NNS O
in IN O
these DT O
collections NNS O
equaled VBD O
100 CD O
. . O

Then RB O
the DT O
list NN O
of IN O
all DT O
KW NNP O
- HYPH O
type NN O
words NNS O
from IN O
description NN O
fields NNS O
of IN O
similar JJ O
sequences NNS O
was VBD O
formed VBN O
. . O

The DT O
majority NN O
of IN O
these DT O
words NNS O
belonged VBD O
only RB O
to IN O
one CD O
similar JJ O
sequence NN O
. . O

All DT O
such JJ O
words NNS O
are VBP O
degenerate JJ O
, , O
transfer NN O
probabilities NNS O
are VBP O
not RB O
defined VBN O
for IN O
them PRP O
. . O

At IN O
the DT O
same JJ O
time NN O
nearly RB O
all PDT O
these DT O
words NNS O
did VBD O
not RB O
belong VB O
to IN O
the DT O
query NN O
sequence NN O
. . O

Hence RB O
it PRP O
was VBD O
sensible JJ O
to TO O
perform VB O
prediction NN O
only RB O
for IN O
words NNS O
that WDT O
belonged VBD O
to IN O
at RB O
least RBS O
two CD O
similar JJ O
sequences NNS O
. . O

For IN O
all PDT O
these DT O
words NNS O
transfer NN O
probabilities NNS O
were VBD O
evaluated VBN O
, , O
non JJ O
- HYPH O
degenerate JJ O
words NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
words NNS O
with IN O
defined VBN O
transfer NN O
probabilities NNS O
) -RRB- O
were VBD O
determined VBN O
, , O
and CC O
the DT O
prediction NN O
was VBD O
performed VBN O
( : O
for IN O
both CC O
degenerate JJ O
and CC O
non JJ O
- HYPH O
degenerate JJ O
words NNS O
) -RRB- O
. . O

Table NNP O
1 CD O
shows VBZ O
certain JJ O
characteristics NNS O
of IN O
sequences NNS O
used VBN O
for IN O
the DT O
testing NN O
. . O

The DT O
average JJ O
number NN O
of IN O
words NNS O
considered VBN O
per IN O
query NN O
sequence NN O
equals VBZ O
30 CD O
and CC O
the DT O
entire JJ O
range NN O
was VBD O
from IN O
3 CD O
to IN O
67 CD O
. . O

Final JJ O
results NNS O

Testing NN O
results NNS O
are VBP O
presented VBN O
in IN O
Table NNP O
2 CD O
. . O

The DT O
table NN O
contains VBZ O
testing NN O
results NNS O
for IN O
the DT O
basic JJ O
statistics NNS O
eta FW O
, , O
T NNP O
( , O
1 CD O
) -RRB- O
, , O
T NNP O
( , O
2 CD O
) -RRB- O
, , O
T NNP O
^ SYM O
( SYM O
2 CD O
) -RRB- O
as RB O
well RB O
as IN O
for IN O
the DT O
statistics NNS O
q NNS O
and CC O
SAnd NNP O
, , O
included VBN O
into IN O
the DT O
table NN O
for IN O
the DT O
purpose NN O
of IN O
comparison NN O
( , O
See VB O
the DT O
Discussion NNP O
section NN O
) -RRB- O
. . O

Each DT O
line NN O
of IN O
the DT O
table NN O
corresponds VBZ O
to IN O
a DT O
certain JJ O
variant NN O
of IN O
studied VBN O
statistics NNS O
. . O

The DT O
first JJ O
column NN O
shows VBZ O
which WDT O
statistic NN O
and CC O
which WDT O
variant NN O
of IN O
this DT O
statistic NN O
corresponds VBZ O
to IN O
a DT O
line NN O
. . O

Variants NNS O
are VBP O
given VBN O
in IN O
square JJ O
brackets NNS O
: : O
the DT O
first JJ O
number NN O
equals VBZ O
0 CD O
if IN O
lengths NNS O
of IN O
primary JJ O
local JJ O
alignments NNS O
are VBP O
not RB O
considered VBN O
, , O
and CC O
1 CD O
otherwise RB O
; : O
the DT O
second JJ O
number NN O
equals VBZ O
0 CD O
if IN O
the DT O
coefficients NNS O
ai VBP O
are VBP O
calculated VBN O
using VBG O
formula NN O
( , O
13 CD O
) -RRB- O
, , O
and CC O
1 CD O
if IN O
the DT O
coefficients NNS O
ai VBP O
are VBP O
calculated VBN O
using VBG O
the DT O
iterative JJ O
procedure NN O
( , O
for IN O
the DT O
statistic NN O
T NN O
( SYM O
1 CD O
) -RRB- O
the DT O
second JJ O
number NN O
is VBZ O
always RB O
0 CD O
) -RRB- O
. . O

The DT O
second JJ O
column NN O
contains VBZ O
the DT O
number NN O
N1 CD O
of IN O
type NN O
1 CD O
errors NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
number NN O
of IN O
cases NNS O
when WRB O
the DT O
prediction NN O
for IN O
a DT O
word NN O
that WDT O
belongs VBZ O
to IN O
description NN O
fields NNS O
of IN O
a DT O
query NN O
sequence NN O
is VBZ O
negative JJ O
) -RRB- O
. . O

The DT O
third JJ O
column NN O
contains VBZ O
the DT O
number NN O
N2 CD O
of IN O
type NN O
2 CD O
errors NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
number NN O
of IN O
cases NNS O
when WRB O
the DT O
prediction NN O
for IN O
a DT O
word NN O
that WDT O
does VBZ O
not RB O
belong VB O
to IN O
description NN O
fields NNS O
of IN O
a DT O
query NN O
sequence NN O
is VBZ O
positive JJ O
) -RRB- O
. . O

The DT O
forth NN O
column NN O
contains VBZ O
the DT O
total JJ O
number NN O
of IN O
errors NNS O
Nall NNP O
= SYM O
N1 CD O
+ SYM O
N2 CD O
. . O

The DT O
next JJ O
columns NNS O
contain VBP O
sums NNS O
P NNP O
( , O
1 CD O
) SYM O
+ CC O
P NN O
( SYM O
2 CD O
) -RRB- O
and CC O
P NN O
( SYM O
1 CD O
) SYM O
+ SYM O
P NN O
( -LRB- O
+ CC O
) -RRB- O
, , O
where WRB O
P NN O
( , O
1 CD O
) -RRB- O
is VBZ O
the DT O
proportion NN O
of IN O
type NN O
1 CD O
errors NNS O
, , O
P NN O
( , O
2 CD O
) -RRB- O
is VBZ O
the DT O
proportion NN O
of IN O
type NN O
2 CD O
errors NNS O
, , O
and CC O
P NN O
( , O
+ CC O
) -RRB- O
is VBZ O
the DT O
ratio NN O
of IN O
false JJ O
positive JJ O
predictions NNS O
to IN O
the DT O
total JJ O
number NN O
of IN O
predictions NNS O
: : O
P NN O
( : O
1 CD O
) -RRB- O
= SYM O
N1nq NNP O
, , O
P NN O
( , O
2 CD O
) SYM O
= SYM O
N2nall NNP O
- HYPH O
nq NN O
, , O
P NN O
( : O
+ SYM O
) NFP O
= SYM O
N2n CD O
+ SYM O
( HYPH O
nall NN O
is VBZ O
the DT O
total JJ O
number NN O
of IN O
words NNS O
for IN O
which WDT O
the DT O
prediction NN O
is VBZ O
performed VBN O
, , O
i LS O
. . O
e -RRB- O
. , O
, , O
total JJ O
number NN O
of IN O
KW NNP O
- HYPH O
type NN O
words NNS O
in IN O
description NN O
fields NNS O
of IN O
all DT O
sequences NNS O
, , O
similar JJ O
to IN O
at RB O
least RBS O
one CD O
query NN O
sequence NN O
, , O
nq NN O
is VBZ O
the DT O
number NN O
of IN O
words NNS O
( , O
from IN O
the DT O
list NN O
of IN O
these DT O
nall JJ O
words NNS O
) -RRB- O
that WDT O
belong VBP O
to IN O
query NN O
sequences NNS O
, , O
n LS O
+ NFP O
is VBZ O
the DT O
total JJ O
number NN O
of IN O
words NNS O
for IN O
which WDT O
the DT O
prediction NN O
is VBZ O
positive JJ O
; : O
here RB O
nall NN O
= : O
9236 CD O
, , O
nq NN O
= SYM O
1176 CD O
, , O
nall NN O
- HYPH O
nq NN O
= SYM O
8060 CD O
; : O
the DT O
value NN O
of IN O
n DT O
+ NN O
of IN O
depends VBZ O
on IN O
the DT O
threshold NN O
evaluated VBN O
for IN O
the DT O
given VBN O
version NN O
of IN O
statistic NN O
at IN O
the DT O
"""" `` O
learning VBG O
stage NN O
"""" '' O
) -RRB- O
. . O

Lines NNS O
are VBP O
ordered VBN O
according VBG O
to IN O
the DT O
prediction NN O
quality NN O
: : O
higher JJR O
lines NNS O
correspond VBP O
to IN O
statistic JJ O
variants NNS O
with IN O
lower JJR O
total JJ O
number NN O
of IN O
errors NNS O
. . O

For IN O
a DT O
fixed VBN O
statistic NN O
, , O
lines NNS O
that WDT O
correspond VBP O
to IN O
the DT O
best JJS O
variant NN O
of IN O
this DT O
statistic NN O
( , O
i LS O
. . O
e -RRB- O
. . O
, , O
for IN O
the DT O
variant NN O
that WDT O
leads VBZ O
to IN O
the DT O
lowest JJS O
total JJ O
number NN O
of IN O
errors NNS O
) -RRB- O
are VBP O
marked VBN O
. . O

Recall VB O
that IN O
the DT O
statistic NN O
T NNP O
^ NFP O
( SYM O
2 CD O
) -RRB- O
[ -LRB- O
1 CD O
, , O
0 CD O
] -RRB- O
is VBZ O
exactly RB O
the DT O
statistic NN O
that WDT O
was VBD O
considered VBN O
in IN O
[ -LRB- O
5 CD O
] -RRB- O
( , O
note VB O
that IN O
it PRP O
is VBZ O
the DT O
best JJS O
variant NN O
for IN O
the DT O
statistic NN O
T NN O
^ NFP O
( SYM O
2 CD O
) -RRB- O
) -RRB- O
. . O

The DT O
results NNS O
could MD O
also RB O
have VB O
been VBN O
presented VBN O
as IN O
a DT O
confusion NN O
table NN O
as IN O
laid VBN O
out RP O
in IN O
Table NNP O
3 CD O
, , O
but CC O
doing VBG O
so RB O
for IN O
all DT O
variants NNS O
would MD O
take VB O
a DT O
lot NN O
of IN O
space NN O
. . O

The DT O
testing NN O
results NNS O
showed VBD O
that IN O
the DT O
first JJ O
modification NN O
( , O
consideration NN O
of IN O
all DT O
primary JJ O
local JJ O
alignments NNS O
or CC O
only RB O
one CD O
primary JJ O
local JJ O
alignment NN O
with IN O
the DT O
maximum JJ O
power NN O
) -RRB- O
did VBD O
not RB O
significantly RB O
affect VB O
the DT O
prediction NN O
quality NN O
, , O
so CC O
results NNS O
are VBP O
only RB O
presented VBN O
for IN O
one CD O
case NN O
( , O
all DT O
local JJ O
alignments NNS O
are VBP O
considered VBN O
, , O
similarly RB O
to IN O
[ -LRB- O
5 CD O
] -RRB- O
) -RRB- O
. . O

Note VB O
that IN O
the DT O
results NNS O
presented VBN O
in IN O
the DT O
Table NNP O
correspond VBP O
to IN O
the DT O
whole JJ O
totality NN O
of IN O
words NNS O
including VBG O
degenerate JJ O
words NNS O
( , O
though IN O
statistics NNS O
eta FW O
, , O
T NNP O
( , O
1 CD O
) -RRB- O
, , O
T NNP O
( , O
2 CD O
) -RRB- O
, , O
T NNP O
^ NFP O
( SYM O
2 CD O
) -RRB- O
, , O
T NNP O
( , O
nik CD O
) -RRB- O
were VBD O
evaluated VBN O
only RB O
for IN O
non AFX O
- HYPH O
degenerate JJ O
words NNS O
, , O
for IN O
degenerate JJ O
words NNS O
the DT O
prediction NN O
was VBD O
performed VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
statistic NN O
q NN O
, , O
i LS O
. . O
e -RRB- O
. . O
, , O
on IN O
the DT O
basis NN O
of IN O
word NN O
frequency NN O
) -RRB- O
. . O

In IN O
particular JJ O
, , O
the DT O
total JJ O
number NN O
of IN O
errors NNS O
includes VBZ O
errors NNS O
for IN O
degenerate JJ O
words NNS O
. . O

It PRP O
is VBZ O
worth JJ O
noticing VBG O
that IN O
the DT O
total JJ O
number NN O
of IN O
errors NNS O
for IN O
degenerate JJ O
words NNS O
in IN O
case NN O
of IN O
the DT O
best JJS O
choice NN O
of IN O
threshold NN O
q0 NN O
for IN O
the DT O
frequency NN O
q NN O
( , O
omega NN O
) -RRB- O
turned VBD O
out RP O
to TO O
be VB O
surprisingly RB O
small JJ O
: : O
only RB O
13 CD O
( , O
whereas IN O
the DT O
number NN O
of IN O
errors NNS O
for IN O
the DT O
whole JJ O
totality NN O
of IN O
words NNS O
was VBD O
220 CD O
) -RRB- O
; , O
these DT O
errors NNS O
included VBD O
twelve CD O
type NN O
1 CD O
errors NNS O
and CC O
one CD O
type NN O
2 CD O
error NN O
( , O
recall VB O
that IN O
the DT O
prediction NN O
was VBD O
performed VBN O
for IN O
2029 CD O
degenerate JJ O
words NNS O
, , O
and CC O
the DT O
prediction NN O
was VBD O
incorrect JJ O
only RB O
in IN O
13 CD O
cases NNS O
) -RRB- O
. . O

Such PDT O
a DT O
small JJ O
number NN O
of IN O
errors NNS O
can MD O
seemingly RB O
be VB O
explained VBN O
by IN O
the DT O
fact NN O
that IN O
for IN O
degenerate JJ O
words NNS O
the DT O
frequency NN O
q NN O
( , O
omega NN O
) -RRB- O
is VBZ O
nearly RB O
always RB O
close JJ O
either CC O
to IN O
1 CD O
or CC O
to IN O
0 CD O
, , O
otherwise RB O
in IN O
almost RB O
all DT O
cases NNS O
transfer NN O
probabilities NNS O
p1 CD O
| SYM O
1 CD O
, , O
p1 NN O
| SYM O
0 CD O
can MD O
be VB O
defined VBN O
for IN O
at IN O
least JJS O
some DT O
values NNS O
of IN O
similarity NN O
measure NN O
mu NN O
and CC O
hence RB O
a DT O
word NN O
omega NN O
turns VBZ O
out RP O
to TO O
be VB O
non RB O
- HYPH O
degenerate JJ O
. . O

We PRP O
also RB O
note VBP O
that IN O
along IN O
with IN O
type NN O
1 CD O
and CC O
type NN O
2 CD O
errors NNS O
other JJ O
errors NNS O
can MD O
occur VB O
, , O
as IN O
it PRP O
is VBZ O
possible JJ O
that IN O
some DT O
words NNS O
from IN O
description NN O
fields NNS O
of IN O
a DT O
query NN O
sequence NN O
do VBP O
not RB O
belong VB O
to IN O
description NN O
fields NNS O
of IN O
similar JJ O
sequences NNS O
and CC O
hence RB O
the DT O
prediction NN O
is VBZ O
not RB O
performed VBN O
for IN O
these DT O
words NNS O
at RB O
all RB O
. . O

However RB O
, , O
we PRP O
used VBD O
a DT O
large JJ O
number NN O
of IN O
similar JJ O
sequences NNS O
( : O
100 CD O
) -RRB- O
for IN O
the DT O
prediction NN O
, , O
so IN O
such JJ O
errors NNS O
were VBD O
extremely RB O
rare JJ O
( : O
only RB O
two CD O
words NNS O
for IN O
the DT O
whole JJ O
test NN O
set NN O
of IN O
518 CD O
sequences NNS O
, , O
whereas IN O
the DT O
number NN O
of IN O
words NNS O
for IN O
which WDT O
the DT O
prediction NN O
was VBD O
performed VBN O
equaled VBD O
9236 CD O
) -RRB- O
. . O

Hence RB O
, , O
in IN O
our PRP$ O
case NN O
these DT O
errors NNS O
can MD O
be VB O
disregarded VBN O
. . O

Statistical JJ O
analysis NN O
showed VBD O
that IN O
the DT O
precision NN O
of IN O
the DT O
evaluation NN O
of IN O
N1 NNP O
, , O
N2 NNP O
, , O
Nall NNP O
is VBZ O
reasonable JJ O
: : O
it PRP O
can MD O
be VB O
checked VBN O
that IN O
the DT O
relative JJ O
precision NN O
of IN O
Nall NNP O
( , O
the DT O
standard JJ O
error NN O
of IN O
ln NN O
( -LRB- O
Nall NNP O
) -RRB- O
) -RRB- O
is VBZ O
in IN O
the DT O
order NN O
of IN O
7 CD O
- SYM O
10 CD O
% NN O
which WDT O
is VBZ O
in IN O
line NN O
with IN O
the DT O
relative JJ O
precision NN O
of IN O
a DT O
Poisson NNP O
random JJ O
variable NN O
that WDT O
is VBZ O
given VBN O
by IN O
1 CD O
/ SYM O
Nall NNP O
. . O

However RB O
, , O
since IN O
the DT O
"""" `` O
methods NNS O
"""" '' O
( , O
the DT O
statistics NNS O
and CC O
their PRP$ O
variants NNS O
) , O
are VBP O
compared VBN O
on IN O
the DT O
same JJ O
sequences NNS O
, , O
the DT O
standard JJ O
error NN O
for IN O
the DT O
comparison NN O
between IN O
methods NNS O
is VBZ O
much RB O
smaller JJR O
due IN O
to IN O
the DT O
high JJ O
correlation NN O
of IN O
results NNS O
for IN O
the DT O
same JJ O
sequence NN O
and CC O
is VBZ O
in IN O
the DT O
order NN O
of IN O
2 CD O
- SYM O
4 CD O
% NN O
. . O

This DT O
implies VBZ O
that IN O
"""" `` O
methods NNS O
"""" '' O
for IN O
which WDT O
Nall NNP O
differ VBP O
by IN O
more JJR O
than IN O
10 CD O
% NN O
can MD O
considered VBN O
to TO O
be VB O
significantly RB O
different JJ O
. . O

This DT O
shows VBZ O
that IN O
size NN O
of IN O
the DT O
experiment NN O
with IN O
210 CD O
randomly RB O
selected VBN O
sequences NNS O
in IN O
the DT O
learning NN O
stage NN O
and CC O
308 CD O
sequences NNS O
in IN O
the DT O
testing NN O
stage NN O
is VBZ O
large JJ O
enough RB O
to TO O
obtain VB O
valid JJ O
statements NNS O
about IN O
the DT O
accuracy NN O
of IN O
the DT O
proposed JJ O
methodology NN O
and CC O
allows VBZ O
statistical JJ O
comparisons NNS O
of IN O
different JJ O
statistics NNS O
and CC O
variants NNS O
. . O

When WRB O
the DT O
set NN O
of IN O
tested VBN O
sequences NNS O
is VBZ O
fixed VBN O
, , O
the DT O
total JJ O
number NN O
of IN O
errors NNS O
Nall NNP O
is VBZ O
an DT O
objective JJ O
characteristic NN O
of IN O
prediction NN O
quality NN O
, , O
and CC O
the DT O
optimal JJ O
threshold NN O
values NNS O
( , O
selected VBN O
during IN O
the DT O
"""" `` O
learning VBG O
stage NN O
"""" '' O
) -RRB- O
provide VBP O
exactly RB O
the DT O
minimum NN O
of IN O
the DT O
total JJ O
number NN O
of IN O
errors NNS O
. . O

However RB O
, , O
if IN O
different JJ O
testing NN O
results NNS O
( , O
based VBN O
on IN O
different JJ O
sets NNS O
of IN O
query NN O
sequences NNS O
) , O
are VBP O
compared VBN O
, , O
then RB O
absolute JJ O
numbers NNS O
of IN O
errors NNS O
can MD O
not RB O
be VB O
treated VBN O
as IN O
a DT O
procedure NN O
quality NN O
measure NN O
, , O
and CC O
relative JJ O
quantities NNS O
( , O
proportions NNS O
) -RRB- O
should MD O
be VB O
considered VBN O
instead RB O
of IN O
absolute JJ O
quantities NNS O
. . O

Usually RB O
a DT O
sum NN O
of IN O
the DT O
proportion NN O
of IN O
type NN O
1 CD O
errors NNS O
and CC O
the DT O
proportion NN O
of IN O
type NN O
2 CD O
errors NNS O
P NN O
( SYM O
1 CD O
) SYM O
+ SYM O
P NN O
( SYM O
2 CD O
) -RRB- O
is VBZ O
used VBN O
as IN O
a DT O
quality NN O
measure NN O
; , O
values NNS O
of IN O
this DT O
sum NN O
are VBP O
presented VBN O
in IN O
the DT O
fifth JJ O
column NN O
of IN O
Table NNP O
2 CD O
. . O

However RB O
, , O
in IN O
our PRP$ O
situation NN O
the DT O
number NN O
of IN O
words NNS O
nall JJ O
- HYPH O
nq NNS O
that WDT O
do VBP O
not RB O
belong VB O
to IN O
query NN O
sequences NNS O
is VBZ O
much RB O
larger JJR O
than IN O
nq UH O
, , O
and CC O
for IN O
the DT O
majority NN O
of IN O
these DT O
words NNS O
it PRP O
is VBZ O
obvious JJ O
that IN O
they PRP O
do VBP O
not RB O
belong VB O
to IN O
a DT O
query NN O
sequence NN O
. . O

Consequently RB O
, , O
in IN O
case NN O
of IN O
optimal JJ O
parameter NN O
values NNS O
the DT O
proportion NN O
of IN O
type NN O
2 CD O
errors NNS O
P NN O
( SYM O
2 CD O
) -RRB- O
is VBZ O
small JJ O
, , O
it PRP O
is VBZ O
considerably RB O
smaller JJR O
than IN O
P NN O
( SYM O
1 CD O
) -RRB- O
. . O

Thus RB O
the DT O
quantity NN O
P NN O
( : O
1 CD O
) SYM O
+ SYM O
P NN O
( -LRB- O
2 CD O
) -RRB- O
is VBZ O
not RB O
representative JJ O
in IN O
our PRP$ O
case NN O
( , O
see VB O
[ -LRB- O
5 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
ratio NN O
P NN O
( -LRB- O
+ CC O
) -RRB- O
of IN O
the DT O
number NN O
of IN O
wrong JJ O
positive JJ O
predictions NNS O
to IN O
the DT O
total JJ O
number NN O
of IN O
positive JJ O
predictions NNS O
is VBZ O
more RBR O
representative JJ O
than IN O
P NN O
( SYM O
2 CD O
) -RRB- O
. . O

Hence RB O
, , O
it PRP O
is VBZ O
natural JJ O
to TO O
measure VB O
procedure NN O
quality NN O
by IN O
the DT O
sum NN O
P NN O
( SYM O
1 CD O
) SYM O
+ SYM O
P NN O
( -LRB- O
+ CC O
) -RRB- O
. . O

Exactly RB O
this DT O
procedure NN O
quality NN O
measure NN O
was VBD O
used VBN O
in IN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

In IN O
medical JJ O
decision NN O
making NN O
( , O
diagnostic JJ O
testing NN O
) , O
the DT O
terms NNS O
sensitivity NN O
( , O
sens NNS O
= SYM O
1 CD O
- HYPH O
P NN O
( SYM O
1 CD O
) -RRB- O
) -RRB- O
and CC O
specificity NN O
( -LRB- O
spec NN O
= SYM O
1 CD O
- HYPH O
P NN O
( SYM O
2 CD O
) -RRB- O
) , O
are VBP O
frequently RB O
used VBN O
to TO O
quantify VB O
the DT O
accuracy NN O
of IN O
a DT O
procedure NN O
, , O
while IN O
the DT O
quantity NN O
1 CD O
- HYPH O
P NN O
( , O
+ CC O
) -RRB- O
is VBZ O
known VBN O
as IN O
the DT O
positive JJ O
predictive JJ O
value NN O
. . O

Alternative JJ O
terminology NN O
is VBZ O
discussed VBN O
in IN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

The DT O
ROC NNP O
curve NN O
plotting VBG O
sens NNS O
against IN O
1 CD O
- HYPH O
spec NN O
is VBZ O
a DT O
popular JJ O
way NN O
of IN O
showing VBG O
the DT O
overall JJ O
performance NN O
of IN O
a DT O
diagnostic JJ O
test NN O
without IN O
specification NN O
of IN O
a DT O
cut NN O
off RP O
value NN O
. . O

It PRP O
is VBZ O
also RB O
used VBN O
and CC O
discussed VBN O
in IN O
[ -LRB- O
12 CD O
] -RRB- O
, , O
but CC O
with IN O
different JJ O
labels NNS O
for IN O
the DT O
axes NNS O
. . O

Figure NN O
2 CD O
contains VBZ O
ROC NNP O
curves NNS O
for IN O
the DT O
best JJS O
variants NNS O
of IN O
the DT O
statistics NNS O
( : O
i PRP O
. . O
e -RRB- O
. . O
, , O
for IN O
variants NNS O
that WDT O
were VBD O
marked VBN O
in IN O
Table NNP O
2 CD O
) -RRB- O
applied VBN O
to IN O
the DT O
non AFX O
- HYPH O
degenerate JJ O
words NNS O
. . O

Discussion NN O

Overall JJ O
comparison NN O
of IN O
the DT O
statistics NNS O
T NNP O
( , O
1 CD O
) -RRB- O
, , O
eta FW O
, , O
T NNP O
( , O
2 CD O
) -RRB- O
, , O
T NN O
^ SYM O
( SYM O
2 CD O
) -RRB- O

Mean JJ O
values NNS O
of IN O
Nall NNP O
( : O
where WRB O
averaging NN O
is VBZ O
performed VBN O
over IN O
all DT O
variants NNS O
presented VBN O
in IN O
Table NNP O
2 CD O
) -RRB- O
for IN O
different JJ O
statistics NNS O
are VBP O
the DT O
following VBG O
: : O
241 CD O
for IN O
eta FW O
, , O
310 CD O
for IN O
T NNP O
( SYM O
1 CD O
) -RRB- O
, , O
320 CD O
for IN O
T NNP O
( SYM O
2 CD O
) -RRB- O
, , O
and CC O
356 CD O
for IN O
T NN O
^ SYM O
( HYPH O
2 CD O
) -RRB- O
( , O
recall VB O
that IN O
differences NNS O
in IN O
the DT O
order NN O
of IN O
10 CD O
% NN O
can MD O
be VB O
considered VBN O
to TO O
be VB O
significant JJ O
) -RRB- O
. . O

These DT O
numbers NNS O
show VBP O
that IN O
the DT O
statistics NNS O
can MD O
clearly RB O
be VB O
ordered VBN O
with IN O
respect NN O
to IN O
the DT O
prediction NN O
quality NN O
: : O
the DT O
best JJS O
statistic NN O
is VBZ O
eta FW O
, , O
then RB O
comes VBZ O
T NNP O
( SYM O
1 CD O
) -RRB- O
, , O
then RB O
T NNP O
( SYM O
2 CD O
) -RRB- O
, , O
and CC O
finally RB O
T NN O
^ SYM O
( SYM O
2 CD O
) -RRB- O
. . O

For IN O
the DT O
comparison NN O
of IN O
the DT O
statistics NNS O
eta FW O
, , O
T NNP O
( , O
1 CD O
) -RRB- O
, , O
as RB O
well RB O
as IN O
for IN O
the DT O
comparison NN O
of IN O
statistics NNS O
the DT O
T NNP O
( , O
2 CD O
) -RRB- O
, , O
T NNP O
^ SYM O
( SYM O
2 CD O
) , O
this DT O
conclusion NN O
is VBZ O
obvious JJ O
. . O

For IN O
the DT O
comparison NN O
of IN O
the DT O
statistics NNS O
T NNP O
( , O
1 CD O
) -RRB- O
, , O
T NNP O
( , O
2 CD O
) -RRB- O
it PRP O
seems VBZ O
to TO O
be VB O
less RBR O
obvious JJ O
, , O
but CC O
the DT O
consideration NN O
of IN O
variants NNS O
in IN O
which WDT O
the DT O
calculation NN O
of IN O
coefficients NNS O
ai NN O
is VBZ O
performed VBN O
using VBG O
formula NN O
( : O
13 CD O
) -RRB- O
( : O
i LS O
. . O
e LS O
. . O
, , O
variants NNS O
[ -LRB- O
0 CD O
, , O
0 CD O
] -RRB- O
and CC O
[ -LRB- O
1 CD O
, , O
0 CD O
] -RRB- O
; , O
recall VB O
that IN O
the DT O
statistic NN O
T NNP O
( -LRB- O
1 CD O
) -RRB- O
has VBZ O
only RB O
such JJ O
variants NNS O
) -RRB- O
clearly RB O
shows VBZ O
that IN O
the DT O
statistic NN O
T NN O
( , O
1 CD O
) -RRB- O
is VBZ O
considerably RB O
better JJR O
than IN O
T NNP O
( SYM O
2 CD O
) -RRB- O
. . O

The DT O
same JJ O
conclusion NN O
can MD O
be VB O
drawn VBN O
from IN O
the DT O
comparison NN O
of IN O
ROC NNP O
curves NNS O
presented VBN O
in IN O
Fig NNP O
. . O

2 LS O
. . O

Testing NN O
results NNS O
show VBP O
that IN O
the DT O
prediction NN O
quality NN O
for IN O
the DT O
best JJS O
variant NN O
of IN O
the DT O
statistic NN O
eta NN O
( , O
see VB O
the DT O
first JJ O
line NN O
of IN O
Table NNP O
2 CD O
) -RRB- O
is VBZ O
much RB O
higher JJR O
( : O
higher JJR O
by IN O
50 CD O
% NN O
) -RRB- O
in IN O
comparison NN O
with IN O
results NNS O
of IN O
[ -LRB- O
5 CD O
] -RRB- O
( , O
see VB O
the DT O
line NN O
of IN O
Table NNP O
2 CD O
that WDT O
corresponds VBZ O
to IN O
T NNP O
^ SYM O
( SYM O
2 CD O
) -RRB- O
[ -LRB- O
0 CD O
, , O
1 CD O
] -RRB- O
) -RRB- O
. . O

That DT O
is VBZ O
the DT O
most RBS O
striking JJ O
finding NN O
of IN O
the DT O
current JJ O
paper NN O
. . O

It PRP O
is VBZ O
interesting JJ O
to TO O
see VB O
that IN O
the DT O
statistic NN O
eta NN O
turned VBD O
out RP O
to TO O
be VB O
better JJR O
than IN O
T NNP O
( SYM O
1 CD O
) -RRB- O
: : O
the DT O
latter JJ O
would MD O
be VB O
expected VBN O
to TO O
be VB O
better JJR O
as IN O
it PRP O
equals VBZ O
the DT O
logarithm NN O
of IN O
the DT O
likelihood NN O
ratio NN O
( , O
in IN O
reality NN O
, , O
it PRP O
does VBZ O
not RB O
equal VB O
this DT O
logarithm NN O
because IN O
the DT O
xi NN O
i PRP O
are VBP O
not RB O
independent JJ O
) -RRB- O
. . O

We PRP O
suppose VBP O
that IN O
this DT O
fact NN O
can MD O
be VB O
explained VBN O
as IN O
follows VBZ O
. . O

Recall VB O
that IN O
T NNP O
( SYM O
1 CD O
) -RRB- O
and CC O
eta NN O
are VBP O
equivalent JJ O
for IN O
an DT O
arbitrary JJ O
fixed VBN O
word NN O
omega NN O
. . O

These DT O
statistics NNS O
turn VBP O
out RP O
to TO O
be VB O
not RB O
equivalent JJ O
only RB O
if IN O
they PRP O
are VBP O
compared VBN O
on IN O
the DT O
whole JJ O
totality NN O
of IN O
words NNS O
. . O

It PRP O
is VBZ O
worth JJ O
noting VBG O
that IN O
the DT O
variation NN O
of IN O
the DT O
values NNS O
of IN O
the DT O
statistic NN O
T NN O
( : O
1 CD O
) -RRB- O
( , O
i LS O
. . O
e -RRB- O
. . O
, , O
the DT O
difference NN O
between IN O
values NNS O
of IN O
T NNP O
( , O
1 CD O
) -RRB- O
in IN O
cases NNS O
xi NN O
1 CD O
= SYM O
. . O
. . O
. . O
. . O
= : O
xi NN O
n NN O
= SYM O
0 CD O
and CC O
xi NN O
1 CD O
= : O
. . O
. . O
. . O
. . O
= : O
xi NN O
n NN O
= SYM O
1 CD O
) -RRB- O
significantly RB O
depends VBZ O
on IN O
a DT O
word NN O
omega NN O
: : O
for IN O
some DT O
words NNS O
these DT O
values NNS O
vary VBP O
from IN O
- : O
700 CD O
to IN O
700 CD O
, , O
for IN O
some DT O
other JJ O
from IN O
- HYPH O
0 CD O
. . O
1 CD O
to IN O
0 CD O
. . O
1 CD O
. . O

In IN O
principle NN O
, , O
the DT O
optimal JJ O
threshold NN O
value NN O
is VBZ O
different JJ O
for IN O
different JJ O
words NNS O
. . O

As IN O
the DT O
ranges NNS O
of IN O
T NNP O
( SYM O
1 CD O
) -RRB- O
values NNS O
essentially RB O
vary VBP O
, , O
then RB O
it PRP O
is VBZ O
probable JJ O
that IN O
optimal JJ O
thresholds NNS O
also RB O
essentially RB O
vary VBP O
. . O

The DT O
optimal JJ O
threshold NN O
for IN O
the DT O
whole JJ O
totality NN O
of IN O
words NNS O
is VBZ O
a DT O
certain JJ O
mean JJ O
value NN O
of IN O
thresholds NNS O
over IN O
individual JJ O
words NNS O
omega NN O
. . O

Since IN O
the DT O
optimal JJ O
thresholds NNS O
are VBP O
significantly RB O
different JJ O
for IN O
different JJ O
words NNS O
, , O
the DT O
quality NN O
of IN O
the DT O
mean NN O
is VBZ O
low JJ O
: : O
for IN O
certain JJ O
words NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
words NNS O
with IN O
small JJ O
variation NN O
of IN O
T NNP O
( , O
1 CD O
) -RRB- O
) -RRB- O
this DT O
mean VBP O
is VBZ O
completely RB O
unrepresentative JJ O
. . O

In IN O
the DT O
same JJ O
time NN O
, , O
the DT O
range NN O
of IN O
values NNS O
of IN O
eta NN O
is VBZ O
the DT O
same JJ O
for IN O
all DT O
words NNS O
( : O
these DT O
values NNS O
lie VBP O
between IN O
0 CD O
and CC O
1 CD O
) -RRB- O
. . O

Consequently RB O
, , O
the DT O
difference NN O
between IN O
optimal JJ O
thresholds NNS O
for IN O
individual JJ O
words NNS O
is VBZ O
probably RB O
not RB O
so RB O
significant JJ O
, , O
and CC O
the DT O
mean NN O
gives VBZ O
better JJR O
quality NN O
for IN O
individual JJ O
words NNS O
in IN O
comparison NN O
with IN O
T NNP O
( SYM O
1 CD O
) -RRB- O
. . O

From IN O
the DT O
point NN O
of IN O
view NN O
of IN O
prediction NN O
quality NN O
the DT O
statistic NN O
T NNP O
( SYM O
2 CD O
) -RRB- O
turned VBD O
out RP O
to TO O
be VB O
worse JJR O
than IN O
T NNP O
( HYPH O
1 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
not RB O
surprising JJ O
, , O
because IN O
during IN O
the DT O
derivation NN O
of IN O
the DT O
formula NN O
for IN O
T NNP O
( , O
2 CD O
) , O
along IN O
with IN O
the DT O
incorrect JJ O
assumption NN O
of IN O
independence NN O
of IN O
xi NN O
i , O
we PRP O
also RB O
made VBD O
the DT O
incorrect JJ O
assumption NN O
of IN O
the DT O
normal JJ O
distribution NN O
of IN O
eta FW O
. . O

This DT O
consideration NN O
is VBZ O
applicable JJ O
to IN O
T NNP O
^ SYM O
( SYM O
2 CD O
) -RRB- O
as RB O
well RB O
. . O

Since IN O
the DT O
cut NN O
- HYPH O
off RP O
points NNS O
for IN O
these DT O
statistics NNS O
are VBP O
determined VBN O
empirically RB O
in IN O
the DT O
test NN O
set VBN O
and CC O
validated VBN O
in IN O
the DT O
training NN O
set NN O
, , O
the DT O
violation NN O
of IN O
the DT O
normality NN O
assumption NN O
does VBZ O
not RB O
invalidate VB O
the DT O
procedures NNS O
as IN O
such JJ O
, , O
but CC O
might MD O
affect VB O
their PRP$ O
performance NN O
. . O

Effect NN O
of IN O
procedure NN O
modifications NNS O

The DT O
next JJ O
issue NN O
is VBZ O
the DT O
dependence NN O
of IN O
prediction NN O
quality NN O
on IN O
procedure NN O
modifications NNS O
. . O

One PRP O
can MD O
see VB O
that IN O
for IN O
a DT O
fixed VBN O
statistic NN O
the DT O
prediction NN O
quality NN O
significantly RB O
depends VBZ O
on IN O
the DT O
choice NN O
of IN O
the DT O
variant NN O
. . O

Thus RB O
, , O
the DT O
introduction NN O
of IN O
modifications NNS O
turned VBD O
out RP O
to TO O
be VB O
effective JJ O
. . O

It PRP O
is VBZ O
interesting JJ O
that IN O
all DT O
statistics NNS O
for IN O
which WDT O
coefficients NNS O
aj IN O
can MD O
be VB O
calculated VBN O
in IN O
different JJ O
ways NNS O
( : O
these DT O
are VBP O
the DT O
statistics NNS O
eta FW O
, , O
T NNP O
( , O
2 CD O
) SYM O
T NN O
^ SYM O
( SYM O
2 CD O
) -RRB- O
) , O
prediction NN O
quality NN O
was VBD O
better JJR O
in IN O
case NN O
when WRB O
these DT O
coefficients NNS O
were VBD O
calculated VBN O
using VBG O
the DT O
iterative JJ O
procedure NN O
. . O

At IN O
the DT O
same JJ O
time NN O
the DT O
dependence NN O
of IN O
prediction NN O
quality NN O
on IN O
the DT O
modification NN O
related VBN O
to IN O
the DT O
consideration NN O
of IN O
lengths NNS O
of IN O
primary JJ O
local JJ O
alignments NNS O
is VBZ O
more RBR O
intricate JJ O
: : O
for IN O
the DT O
statistic NN O
eta NN O
, , O
and CC O
to IN O
a DT O
lesser JJR O
extent NN O
for IN O
the DT O
statistics NNS O
T NNP O
( , O
1 CD O
) -RRB- O
, , O
T NNP O
( , O
2 CD O
) -RRB- O
, , O
the DT O
results NNS O
are VBP O
better JJR O
if IN O
lengths NNS O
of IN O
primary JJ O
local JJ O
alignments NNS O
are VBP O
considered VBN O
, , O
but CC O
for IN O
the DT O
statistic NN O
T NN O
^ SYM O
( SYM O
2 CD O
) -RRB- O
results NNS O
are VBP O
better JJR O
when WRB O
lengths NNS O
of IN O
primary JJ O
local JJ O
alignments NNS O
are VBP O
not RB O
considered VBN O
. . O

Currently RB O
reasons NNS O
of IN O
this DT O
fact NN O
are VBP O
not RB O
clear JJ O
for IN O
us PRP O
. . O

As IN O
it PRP O
was VBD O
noted VBN O
, , O
the DT O
dependence NN O
of IN O
results NNS O
on IN O
modifications NNS O
dealing VBG O
with IN O
the DT O
number NN O
of IN O
considered VBN O
primary JJ O
local JJ O
alignments NNS O
for IN O
similar JJ O
sequences NNS O
is VBZ O
not RB O
essential JJ O
. . O

( : O
However RB O
, , O
we PRP O
note VBP O
that IN O
for IN O
nearly RB O
all DT O
variants NNS O
that WDT O
were VBD O
described VBN O
above RB O
as RB O
well RB O
as IN O
variants NNS O
that WDT O
were VBD O
not RB O
described VBN O
, , O
prediction NN O
quality NN O
is VBZ O
better JJR O
in IN O
case NN O
when WRB O
all DT O
primary JJ O
local JJ O
alignments NNS O
are VBP O
considered VBN O
) -RRB- O
. . O

Comparison NN O
with IN O
other JJ O
procedures NNS O

For IN O
the DT O
purpose NN O
of IN O
comparison NN O
we PRP O
compared VBD O
our PRP$ O
findings NNS O
with IN O
the DT O
simple JJ O
statistic NN O
q NN O
( , O
omega NN O
) -RRB- O
( , O
the DT O
frequency NN O
of IN O
word NN O
occurrence NN O
in IN O
the DT O
list NN O
of IN O
similar JJ O
sequences NNS O
, , O
see VB O
( , O
18 CD O
) -RRB- O
) , O
was VBD O
also RB O
considered VBN O
, , O
using VBG O
a DT O
threshold NN O
of IN O
q NN O
= SYM O
0 CD O
. . O
422 CD O
. . O

As IN O
expected VBN O
, , O
q NNS O
( , O
omega NN O
) -RRB- O
gave VBD O
essentially RB O
worse JJR O
results NNS O
in IN O
comparison NN O
with IN O
T NNP O
( SYM O
1 CD O
) -RRB- O
, , O
eta FW O
, , O
T NNP O
( , O
2 CD O
) -RRB- O
, , O
T NNP O
^ SYM O
( SYM O
2 CD O
) -RRB- O
( , O
see VB O
Table NN O
2 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
we PRP O
compared VBD O
our PRP$ O
results NNS O
with IN O
the DT O
results NNS O
, , O
which WDT O
predicts VBZ O
all DT O
of IN O
the DT O
words NNS O
for IN O
which WDT O
there EX O
is VBZ O
among IN O
similar JJ O
sequences NNS O
at IN O
least JJS O
one CD O
sequence NN O
with IN O
a DT O
power NN O
above IN O
a DT O
certain JJ O
threshold NN O
. . O

Such PDT O
an DT O
approach NN O
was VBD O
used VBN O
by IN O
Andrade NNP O
M NNP O
. . O

et FW O
al NNP O
. . O

[ -LRB- O
2 LS O
] -RRB- O
. . O

This DT O
is VBZ O
the DT O
statistics NNS O
SAnd NNP O
as IN O
already RB O
mentioned VBN O
in IN O
Table NNP O
2 CD O
. . O

It PRP O
is VBZ O
defined VBN O
as IN O
SAnd NNP O
( -LRB- O
omega NN O
) -RRB- O
= : O
max NN O
mu NN O
j NN O
, , O
where WRB O
mu NN O
j NN O
is VBZ O
the DT O
measure NN O
of IN O
similarity NN O
between IN O
sequences NNS O
pi NN O
0 CD O
, , O
pi NN O
j NN O
, , O
and CC O
the DT O
maximum NN O
is VBZ O
taken VBN O
on IN O
the DT O
j NN O
for IN O
which WDT O
xi NN O
j NN O
( : O
omega NN O
) NFP O
= SYM O
1 CD O
( : O
i LS O
. . O
e LS O
. . O
the DT O
word NN O
belongs VBZ O
to IN O
these DT O
sequences NNS O
) -RRB- O
. . O

In IN O
our PRP$ O
application NN O
similarity NN O
is VBZ O
measured VBN O
by IN O
the DT O
power NN O
value NN O
( , O
see VB O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
) -RRB- O
as IN O
used VBN O
in IN O
the DT O
other JJ O
statistics NNS O
in IN O
this DT O
paper NN O
and CC O
mentioned VBN O
before RB O
, , O
while IN O
[ -LRB- O
2 LS O
] -RRB- O
used VBD O
the DT O
E NN O
- HYPH O
value NN O
. . O

That DT O
makse VBP O
the DT O
cut NN O
- HYPH O
offs NNS O
hard JJ O
to TO O
compare VB O
. . O

The DT O
results NNS O
for IN O
these DT O
statistics NNS O
are VBP O
given VBN O
in IN O
the DT O
same JJ O
Table NNP O
2 CD O
. . O

The DT O
results NNS O
were VBD O
better JJR O
than IN O
in IN O
the DT O
statistics NNS O
q NNS O
( , O
omega NN O
) -RRB- O
, , O
but CC O
worse JJR O
than IN O
in IN O
any DT O
of IN O
our PRP$ O
statistics NNS O
. . O

Surprisingly RB O
, , O
it PRP O
turned VBD O
out RP O
that IN O
the DT O
prediction NN O
quality NN O
is VBZ O
better JJR O
when WRB O
only RB O
some DT O
similar JJ O
sequences NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
10 CD O
from IN O
100 CD O
) -RRB- O
are VBP O
used VBN O
for IN O
the DT O
evaluation NN O
of IN O
a DT O
statistic NN O
( , O
but CC O
not RB O
for IN O
the DT O
evaluation NN O
of IN O
transfer NN O
probabilities NNS O
! . O
) -RRB- O
. . O

It PRP O
means VBZ O
that IN O
a DT O
large JJ O
part NN O
of IN O
similar JJ O
sequences NNS O
only RB O
leads VBZ O
to IN O
an DT O
increase NN O
of IN O
"""" `` O
noise NN O
"""" '' O
. . O

( : O
See VB O
[ -LRB- O
13 CD O
] -RRB- O
for IN O
details NNS O
. . O
) -RRB- O

We PRP O
would MD O
also RB O
like VB O
to TO O
mention VB O
the DT O
work NN O
[ -LRB- O
14 CD O
] -RRB- O
on IN O
FunCat NNP O
categories NNS O
containing VBG O
a DT O
set NN O
of IN O
about RB O
7 CD O
, , O
500 CD O
well RB O
annotated VBN O
proteins NNS O
and CC O
providing VBG O
a DT O
benchmarking NN O
for IN O
different JJ O
methods NNS O
of IN O
automated JJ O
annotation NN O
. . O

It PRP O
would MD O
be VB O
interesting JJ O
to TO O
apply VB O
our PRP$ O
procedure NN O
to IN O
this DT O
database NN O
, , O
but CC O
that DT O
has VBZ O
not RB O
been VBN O
realized VBN O
yet RB O
. . O

We PRP O
did VBD O
not RB O
attempt VB O
at IN O
this DT O
stage NN O
to TO O
apply VB O
our PRP$ O
approach NN O
to IN O
the DT O
GO NNP O
annotation NN O
. . O

It PRP O
would MD O
be VB O
interesting JJ O
further JJ O
research NN O
to TO O
switch VB O
to IN O
GO NNP O
data NNS O
and CC O
to TO O
compare VB O
our PRP$ O
approach NN O
with IN O
other JJ O
approaches NNS O
in IN O
the DT O
literature NN O
. . O

There EX O
is VBZ O
a DT O
similarity NN O
with IN O
the DT O
approach NN O
of IN O
Kajan NNP O
et FW O
al NNP O
. . O

[ -LRB- O
15 CD O
] -RRB- O
. . O

They PRP O
also RB O
base VBP O
their PRP$ O
procedures NNS O
on IN O
the DT O
likelihood NN O
ratio NN O
, , O
but CC O
use VBP O
approximations NNS O
based VBN O
on IN O
maximal JJ O
similarity NN O
( , O
or CC O
minimal JJ O
distance NN O
) -RRB- O
, , O
while IN O
we PRP O
attempt VBP O
to TO O
estimate VB O
the DT O
likelihood NN O
ratio NN O
from IN O
pairwise JJ O
comparisons NNS O
within IN O
the DT O
set NN O
of IN O
similar JJ O
sequences NNS O
. . O

There EX O
is VBZ O
also RB O
an DT O
interesting JJ O
relation NN O
with IN O
the DT O
GOPET NNP O
tool NN O
presented VBN O
in IN O
[ -LRB- O
16 CD O
] -RRB- O
based VBN O
on IN O
earlier JJR O
work NN O
by IN O
the DT O
same JJ O
authors NNS O
[ -LRB- O
17 CD O
] -RRB- O
. . O

These DT O
authors NNS O
use VBP O
a DT O
number NN O
of IN O
characteristics NNS O
of IN O
the DT O
set NN O
of IN O
found VBN O
similar JJ O
sequences NNS O
for IN O
term NN O
( : O
word NN O
) -RRB- O
, , O
such JJ O
as IN O
maximal JJ O
e NN O
- HYPH O
value NN O
, , O
frequency NN O
of IN O
the DT O
term NN O
etc FW O
. . O
, , O
as IN O
a DT O
coordinates NNS O
of IN O
decision NN O
making NN O
space NN O
. . O

They PRP O
use VBP O
more JJR O
features NNS O
while IN O
we PRP O
concentrate VBP O
on IN O
the DT O
similarity NN O
. . O

That DT O
might MD O
be VB O
an DT O
advantage NN O
for IN O
their PRP$ O
method NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
we PRP O
try VBP O
to TO O
use VB O
the DT O
information NN O
from IN O
all DT O
similar JJ O
sequences NNS O
in IN O
an DT O
optimal JJ O
way NN O
relying VBG O
on IN O
statistical JJ O
decision NN O
theory NN O
by IN O
means NNS O
of IN O
the DT O
use NN O
of IN O
transfer NN O
probabilities NNS O
and CC O
the DT O
concept NN O
of IN O
likelihood NN O
ratio NN O
. . O

It PRP O
is VBZ O
an DT O
interesting JJ O
topic NN O
of IN O
further JJ O
research NN O
to TO O
compare VB O
the DT O
two CD O
methods NNS O
. . O

So RB O
far RB O
we PRP O
only RB O
predicted VBD O
the DT O
presence NN O
of IN O
a DT O
key JJ O
word NN O
. . O

It PRP O
is VBZ O
quite RB O
a DT O
challenge NN O
to TO O
obtain VB O
a DT O
true JJ O
prediction NN O
of IN O
function NN O
. . O

Conclusion NN O

The DT O
main JJ O
conclusion NN O
of IN O
the DT O
paper NN O
is VBZ O
that IN O
the DT O
introduction NN O
of IN O
the DT O
concept NN O
of IN O
likelihood NN O
ratio NN O
coming VBG O
from IN O
statistical JJ O
decision NN O
theory NN O
is VBZ O
very RB O
helpful JJ O
in IN O
the DT O
development NN O
of IN O
automated JJ O
annotation NN O
procedures NNS O
. . O

We PRP O
obtained VBD O
a DT O
substantial JJ O
improvement NN O
when WRB O
compared VBN O
with IN O
our PRP$ O
previous JJ O
results NNS O
. . O

We PRP O
are VBP O
sure JJ O
that IN O
there EX O
is VBZ O
room NN O
for IN O
further JJ O
improvement NN O
. . O

Issues NNS O
for IN O
further JJ O
research NN O
are VBP O
the DT O
size NN O
of IN O
the DT O
set NN O
of IN O
similar JJ O
sequences NNS O
and CC O
the DT O
combination NN O
of IN O
different JJ O
statistics NNS O
into IN O
a DT O
"""" `` O
super JJ O
- HYPH O
predictor NN O
"""" '' O
. . O

Authors NNS O
' POS O
contributions NNS O

A DT O
. . O
M NN O
. . O

Leontovich NNP O
and CC O
H NNP O
. . O
C NNP O
. . O
van NNP O
Houwelingen NNP O
developed VBD O
the DT O
approach NN O
. . O

A DT O
. . O
M NN O
. . O

Leontovich NNP O
developed VBD O
the DT O
methodology NN O
and CC O
the DT O
algorithms NNS O
in IN O
cooperation NN O
with IN O
K NNP O
. . O
Y UH O
. . O

Tokmachev NNP O
and CC O
H NNP O
. . O
C NNP O
. . O
van NNP O
Houwelingen NNP O
. . O

K UH O
. . O
Y UH O
. . O

Tokmachev NNP O
carried VBD O
out RP O
all DT O
computations NNS O
. . O

Supplementary JJ O
Material NN O

Borrelia NNP B-Species
burgdorferi NN I-Species
membranes NNS O
are VBP O
the DT O
primary JJ O
targets NNS O
of IN O
reactive JJ O
oxygen NN O
species NNS O

Abstract JJ O

Spirochetes NNS O
living VBG O
in IN O
an DT O
oxygen NN O
- HYPH O
rich JJ O
environment NN O
or CC O
when WRB O
challenged VBN O
by IN O
host NN O
immune JJ O
cells NNS O
are VBP O
exposed VBN O
to IN O
reactive JJ O
oxygen NN O
species NNS O
( , O
ROS NNP O
) -RRB- O
. . O

These DT O
species NNS O
can MD O
harm VB O
/ SYM O
destroy VB O
cysteinyl NN O
residues NNS O
, , O
iron NN O
- HYPH O
sulphur NN O
clusters NNS O
, , O
DNA NN O
and CC O
polyunsaturated VBN O
lipids NNS O
, , O
leading VBG O
to IN O
inhibition NN O
of IN O
growth NN O
or CC O
cell NN O
death NN O
. . O

Because IN O
Borrelia NNP B-Species
burgdorferi NN I-Species
contains VBZ O
no DT O
intracellular JJ O
iron NN O
, , O
DNA NNP O
is VBZ O
most RBS O
likely RB O
not RB O
a DT O
major JJ O
target NN O
for IN O
ROS NNP O
via IN O
Fenton NNP O
reaction NN O
. . O

In IN O
support NN O
of IN O
this DT O
, , O
growth NN O
of IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
in IN O
the DT O
presence NN O
of IN O
5 CD O
mM NN O
H2O2 NN O
had VBD O
no DT O
effect NN O
on IN O
the DT O
DNA NN O
mutation NN O
rate NN O
( , O
spontaneous JJ O
coumermycin NN O
A1 NN O
resistance NN O
) -RRB- O
, , O
and CC O
cells NNS O
treated VBN O
with IN O
10 CD O
mM NN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
or CC O
10 CD O
mM NN O
H2O2 NN O
show VBP O
no DT O
increase NN O
in IN O
DNA NN O
damage NN O
. . O

Unlike IN O
most JJS O
bacteria NNS O
, , O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
incorporates VBZ O
ROS NNP O
- HYPH O
susceptible JJ O
polyunsaturated JJ O
fatty NN O
acids NNS O
from IN O
the DT O
environment NN O
into IN O
their PRP$ O
membranes NNS O
. . O

Analysis NN O
of IN O
lipoxidase NN O
- HYPH O
treated VBN O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
cells NNS O
by IN O
Electron NNP O
Microscopy NNP O
showed VBD O
significant JJ O
irregularities NNS O
indicative JJ O
of IN O
membrane NN O
damage NN O
. . O

Fatty JJ O
acid NN O
analysis NN O
of IN O
cells NNS O
treated VBN O
with IN O
lipoxidase NN O
indicated VBD O
that IN O
host NN O
- HYPH O
derived VBN O
linoleic JJ O
acid NN O
had VBD O
been VBN O
dramatically RB O
reduced VBN O
( : O
50 CD O
- HYPH O
fold NN O
) -RRB- O
in IN O
these DT O
cells NNS O
, , O
with IN O
a DT O
corresponding VBG O
increase NN O
in IN O
the DT O
levels NNS O
of IN O
malondialdehyde NN O
by IN O
- HYPH O
product NN O
( , O
fourfold RB O
) -RRB- O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
membrane NN O
lipids NNS O
are VBP O
targets NNS O
for IN O
attack NN O
by IN O
ROS NNP O
encountered VBN O
in IN O
the DT O
various JJ O
stages NNS O
of IN O
the DT O
infective JJ O
cycle NN O
. . O

Introduction NN O

Borrelia NNP B-Species
burgdorferi NNP I-Species
, , O
the DT O
causative JJ O
agent NN O
of IN O
Lyme NNP O
disease NN O
, , O
survives VBZ O
and CC O
proliferates VBZ O
in IN O
distinctly RB O
different JJ O
niches NNS O
, , O
including VBG O
its PRP$ O
arthropod JJ O
vector NN O
and CC O
various JJ O
mammalian JJ O
hosts NNS O
. . O

These DT O
' `` O
micro JJ O
' '' O
environments NNS O
provide VBP O
their PRP$ O
own JJ O
distinct JJ O
sets NNS O
of IN O
advantages NNS O
and CC O
challenges NNS O
to IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
. . O

For IN O
example NN O
, , O
during IN O
the DT O
initial JJ O
stages NNS O
of IN O
infection NN O
of IN O
the DT O
mammalian JJ O
host NN O
, , O
immune JJ O
cells NNS O
attempt VBP O
to TO O
prevent VB O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
from IN O
establishing VBG O
an DT O
infection NN O
using VBG O
several JJ O
systems NNS O
including VBG O
those DT O
generating VBG O
bacteriocidal JJ O
reactive JJ O
oxygen NN O
species NNS O
( , O
ROS NNP O
) -RRB- O
[ -LRB- O
e LS O
. . O
g LS O
. . O
superoxide NN O
radicals NNS O
( , O
O2 NNP O
- HYPH O
) -RRB- O
, , O
hydrogen NN O
peroxide NN O
( , O
H2O2 NN O
) -RRB- O
and CC O
hydroxyl NN O
radicals NNS O
( , O
OH NN O
) -RRB- O
] -RRB- O
and CC O
reactive JJ O
nitrogen NN O
species NNS O
( , O
RNS NNP O
) -RRB- O
[ -LRB- O
e LS O
. . O
g LS O
. . O
nitric JJ O
oxide NN O
( , O
NO NNP O
) -RRB- O
and CC O
peroxynitrite NN O
] -RRB- O
( , O
Storz NNP O
and CC O
Imlay NNP O
, , O
1999 CD O
) -RRB- O
. . O

In IN O
order NN O
for IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
to TO O
successfully RB O
colonize VB O
a DT O
new JJ O
host NN O
and CC O
cause VB O
disease NN O
, , O
they PRP O
must MD O
overcome VB O
the DT O
challenges NNS O
posed VBN O
by IN O
the DT O
innate JJ O
immune JJ O
system NN O
including VBG O
the DT O
deleterious JJ O
effects NNS O
of IN O
ROS NNP O
/ SYM O
RNS NNP O
compounds NNS O
. . O

The DT O
effects NNS O
of IN O
ROS NNP O
/ SYM O
RNS NNP O
on IN O
cells NNS O
have VBP O
been VBN O
extensively RB O
investigated VBN O
. . O

These DT O
highly RB O
reactive JJ O
compounds NNS O
have VBP O
been VBN O
shown VBN O
to TO O
damage VB O
cellular JJ O
macromolecules NNS O
including VBG O
DNA NN O
, , O
proteins NNS O
and CC O
cellular JJ O
membranes NNS O
. . O

The DT O
damage NN O
to IN O
membranes NNS O
can MD O
arise VB O
through IN O
either CC O
lipid NN O
or CC O
membrane NN O
protein NN O
damage NN O
. . O

In IN O
eukaryotes NNS O
, , O
membrane NN O
lipids NNS O
are VBP O
a DT O
major JJ O
target NN O
of IN O
ROS NNP O
. . O

Free JJ O
radicals NNS O
attack VBP O
polyunsaturated JJ O
fatty NN O
acids NNS O
in IN O
membranes NNS O
and CC O
initiate VBP O
lipid JJ O
peroxidation NN O
. . O

A DT O
primary JJ O
effect NN O
of IN O
this DT O
is VBZ O
a DT O
decrease NN O
in IN O
membrane NN O
fluidity NN O
which WDT O
affects VBZ O
the DT O
physical JJ O
properties NNS O
of IN O
the DT O
membrane NN O
altering VBG O
the DT O
function NN O
of IN O
membrane NN O
- HYPH O
associated VBN O
proteins NNS O
. . O

Once IN O
lipid NN O
peroxides NNS O
form VBP O
, , O
they PRP O
react VBP O
with IN O
adjacent JJ O
polyunsaturated JJ O
lipids NNS O
causing VBG O
an DT O
amplification NN O
of IN O
the DT O
damage NN O
. . O

Lipid JJ O
peroxides NNS O
undergo VBP O
further JJ O
oxidation NN O
to IN O
a DT O
variety NN O
of IN O
products NNS O
, , O
including VBG O
aldehydes NNS O
, , O
which WDT O
subsequently RB O
react VBP O
with IN O
and CC O
damage VBP O
membrane NN O
proteins NNS O
. . O

However RB O
, , O
in IN O
bacteria NNS O
, , O
it PRP O
is VBZ O
assumed VBN O
that IN O
lipids NNS O
are VBP O
not RB O
subject JJ O
to IN O
the DT O
oxidative JJ O
damage NN O
observed VBN O
in IN O
eukaryotic JJ O
cells NNS O
. . O

Only RB O
certain JJ O
polyunsaturated JJ O
lipids NNS O
, , O
such JJ O
as IN O
linoleic JJ O
acid NN O
and CC O
linolenic NN O
acid NN O
, , O
are VBP O
susceptible JJ O
to IN O
oxidation NN O
( , O
Gutteridge NNP O
and CC O
Halliwell NNP O
, , O
1990 CD O
) -RRB- O
, , O
and CC O
it PRP O
is VBZ O
clear JJ O
that IN O
most JJS O
bacteria NNS O
do VBP O
not RB O
synthesize VB O
or CC O
incorporate VB O
these DT O
types NNS O
of IN O
lipids NNS O
in IN O
their PRP$ O
cell NN O
membrane NN O
. . O

Two CD O
notable JJ O
exceptions NNS O
are VBP O
the DT O
photosynthetic JJ O
bacteria NNS O
which WDT O
synthesize VBP O
and CC O
incorporate VBP O
significant JJ O
levels NNS O
of IN O
linoleic JJ O
acid NN O
in IN O
their PRP$ O
membrane NN O
( , O
Tasaka NNP O
et NN O
al NNP O
. . O
, , O
1996 CD O
) -RRB- O
and CC O
Helicobacter NNP B-Species
pylori NN I-Species
membranes NNS O
which WDT O
contain VBP O
between IN O
0 CD O
. . O
5 CD O
% NN O
and CC O
3 CD O
% NN O
linoleic NN O
acid NN O
( , O
Ursini NNP O
and CC O
Bindoli NNP O
, , O
1987 CD O
) -RRB- O
. . O

Instead RB O
, , O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
the DT O
most RBS O
damaging JJ O
effects NNS O
of IN O
ROS NNP O
in IN O
bacteria NNS O
result VBP O
from IN O
the DT O
interactions NNS O
of IN O
H2O2 NN O
with IN O
' `` O
free JJ O
' '' O
Fe2 NNP O
+ CC O
( , O
Imlay NNP O
, , O
2003 CD O
) -RRB- O
, , O
generating VBG O
very RB O
reactive JJ O
OH NN O
( HYPH O
Fenton NNP O
reaction NN O
) -RRB- O
. . O

Because IN O
of IN O
this DT O
reactivity NN O
, , O
the DT O
effect NN O
on IN O
any DT O
given VBN O
biomolecule NN O
will MD O
depend VB O
largely RB O
upon IN O
proximity NN O
to IN O
the DT O
target NN O
. . O

Because IN O
Fe2 NNP O
+ CC O
localizes VBZ O
along IN O
the DT O
phosphodiester NN O
backbone NN O
of IN O
nucleic JJ O
acid NN O
, , O
DNA NNP O
is VBZ O
a DT O
major JJ O
target NN O
of IN O
OH NNP O
. . O

This DT O
reactive JJ O
species NN O
can MD O
pull VB O
electrons NNS O
from IN O
either CC O
the DT O
base NN O
or CC O
sugar NN O
moieties NNS O
, , O
producing VBG O
a DT O
variety NN O
of IN O
lesions NNS O
including VBG O
single JJ O
- HYPH O
and CC O
double RB O
- HYPH O
stranded VBN O
breaks NNS O
in IN O
the DT O
backbone NN O
and CC O
chemical JJ O
cross NN O
- HYPH O
links NNS O
to IN O
other JJ O
molecules NNS O
. . O

These DT O
strand NN O
breaks NNS O
and CC O
other JJ O
lesions NNS O
block VBP O
DNA NN O
replication NN O
and CC O
contribute VBP O
to IN O
OH NN O
toxicity NN O
and CC O
cell NN O
death NN O
. . O

Other JJ O
base NN O
damage NN O
, , O
which WDT O
does VBZ O
not RB O
hinder VB O
replication NN O
, , O
may MD O
result VB O
in IN O
a DT O
significant JJ O
increase NN O
in IN O
mutation NN O
rates NNS O
. . O

The DT O
intracellular JJ O
biochemistry NN O
of IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
suggests VBZ O
that IN O
the DT O
primary JJ O
cellular JJ O
target NN O
of IN O
ROS NNP O
may MD O
be VB O
distinct JJ O
from IN O
that DT O
described VBN O
in IN O
other JJ O
bacteria NNS O
such JJ O
as IN O
Escherichia NNP B-Species
coli NN I-Species
. . O

In IN O
E NNP B-Species
. . I-Species
coli NN I-Species
, , O
the DT O
extent NN O
of IN O
DNA NN O
damage NN O
due IN O
to IN O
H2O2 NN O
and CC O
Fenton NNP O
chemistry NN O
is VBZ O
directly RB O
proportional JJ O
to IN O
Fe NNP O
metabolism NN O
and CC O
the DT O
free JJ O
Fe NN O
concentration NN O
within IN O
the DT O
cell NN O
( , O
10 CD O
micro NN O
M NNP O
) -RRB- O
( , O
Keyer NNP O
and CC O
Imlay NNP O
, , O
1996 CD O
) -RRB- O
. . O

As IN O
the DT O
intracellular JJ O
Fe NN O
concentrations NNS O
of IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
are VBP O
estimated VBN O
to TO O
be VB O
< IN O
10 CD O
atoms NNS O
per IN O
cell NN O
( : O
Posey NNP O
and CC O
Gherardini NNP O
, , O
2000 CD O
) -RRB- O
, , O
it PRP O
seems VBZ O
unlikely JJ O
that IN O
DNA NNP O
is VBZ O
a DT O
primary JJ O
target NN O
for IN O
ROS NNP O
. . O

Therefore RB O
, , O
the DT O
purpose NN O
of IN O
this DT O
study NN O
is VBZ O
to TO O
determine VB O
the DT O
biochemical JJ O
effects NNS O
of IN O
ROS NNP O
on IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
, , O
including VBG O
growth NN O
effects NNS O
and CC O
biological JJ O
/ SYM O
physical JJ O
damage NN O
. . O

Results NNS O

Effect NN O
of IN O
ROS NNP O
on IN O
B NNP B-Species
. . I-Species
burgdorferi NNP I-Species
cells NNS O

In IN O
order NN O
to TO O
determine VB O
what WP O
the DT O
cellular JJ O
targets NNS O
of IN O
ROS NNP O
in IN O
B NNP B-Species
. . I-Species
burgdorferi NNS I-Species
are VBP O
, , O
we PRP O
first RB O
needed VBD O
to TO O
determine VB O
the DT O
sensitivity NN O
of IN O
Borrelia NNP O
cells NNS O
to IN O
various JJ O
oxidants NNS O
. . O

Microaerobic JJ O
cultures NNS O
of IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
were VBD O
grown VBN O
to IN O
a DT O
cell NN O
density NN O
of IN O
5 CD O
x SYM O
107 CD O
cells NNS O
ml NN O
- HYPH O
1 CD O
, , O
treated VBN O
with IN O
varying VBG O
concentrations NNS O
of IN O
H2O2 NNP O
( , O
0 CD O
- SYM O
50 CD O
mM NN O
) -RRB- O
or CC O
t VBN O
- HYPH O
butyl NN O
hydroperoxide NN O
( , O
0 CD O
- SYM O
50 CD O
mM NN O
) -RRB- O
and CC O
the DT O
number NN O
of IN O
surviving VBG O
cells NNS O
determined VBN O
by IN O
plating NN O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Fig NNP O
. . O

1 LS O
. . O

When WRB O
cells NNS O
were VBD O
exposed VBN O
to IN O
10 CD O
mM NN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
, , O
approximately RB O
50 CD O
% NN O
of IN O
the DT O
cells NNS O
survive VBP O
( , O
Fig NNP O
. . O
1A CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
when WRB O
E NNP B-Species
. . I-Species
coli NN I-Species
cells NNS O
were VBD O
exposed VBN O
to IN O
1 CD O
mM NN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
, , O
approximately RB O
1 CD O
% NN O
of IN O
the DT O
cells NNS O
survive VBP O
. . O

B NN B-Species
. . I-Species
burgdorferi NN I-Species
cells NNS O
were VBD O
much RB O
more RBR O
resistant JJ O
to IN O
t JJ O
- HYPH O
butyl NN O
hydroperoxide NN O
than IN O
E NN B-Species
. . I-Species
coli NN I-Species
cells NNS O
, , O
with IN O
a DT O
survival NN O
rate NN O
of IN O
approximately RB O
100 CD O
% NN O
at IN O
1 CD O
mM NN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
. . O

This DT O
trend NN O
was VBD O
observed VBN O
when WRB O
cells NNS O
were VBD O
exposed VBN O
to IN O
H2O2 NNP O
. . O

E NN B-Species
. . I-Species
coli NN I-Species
cells NNS O
exposed VBN O
to IN O
1 CD O
mM NN O
H2O2 CD O
have VBP O
approximately RB O
10 CD O
% NN O
survivability NN O
, , O
while IN O
100 CD O
% NN O
of IN O
the DT O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
cells NNS O
survive VBP O
at IN O
this DT O
concentration NN O
, , O
and CC O
approximately RB O
80 CD O
% NN O
survive VBP O
when WRB O
exposed VBN O
to IN O
10 CD O
mM NN O
H2O2 NN O
( , O
Fig NN O
. . O
1B NN O
) -RRB- O
. . O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
when WRB O
cells NNS O
were VBD O
exposed VBN O
in IN O
HN NNP O
( , O
Hepes NNP O
- HYPH O
NaCl NNP O
) -RRB- O
buffer NN O
, , O
suggesting VBG O
that IN O
the DT O
high JJ O
- HYPH O
level NN O
resistance NN O
to IN O
ROS NNP O
was VBD O
not RB O
due JJ O
to IN O
the DT O
interaction NN O
of IN O
ROS NNP O
with IN O
components NNS O
of IN O
Barbour NNP O
- HYPH O
Stoenner NNP O
- HYPH O
Kelly NNP O
( : O
BSK NNP O
- HYPH O
II NNP O
) -RRB- O
growth NN O
medium NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
indicated VBD O
that IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
was VBD O
highly RB O
resistant JJ O
to IN O
exposure NN O
to IN O
both CC O
t VBN O
- HYPH O
butyl NN O
peroxide NN O
and CC O
H2O2 NN O
. . O

Borrelia NNP B-Species
burgdorferi NNP I-Species
DNA NNP O
is VBZ O
not RB O
the DT O
primary JJ O
target NN O
of IN O
ROS NNP O

For IN O
most JJS O
bacteria NNS O
, , O
DNA NNP O
is VBZ O
the DT O
major JJ O
target NN O
of IN O
ROS NNP O
causing VBG O
a DT O
wide JJ O
variety NN O
of IN O
DNA NNP O
lesions NNS O
. . O

This DT O
is VBZ O
in IN O
part NN O
due IN O
to IN O
the DT O
localization NN O
of IN O
' `` O
free JJ O
' '' O
Fe2 NNP O
+ CC O
along IN O
the DT O
phosphodiester NN O
backbone NN O
of IN O
nucleic JJ O
acids NNS O
, , O
putting VBG O
the DT O
DNA NN O
in IN O
close JJ O
proximity NN O
to IN O
the DT O
active JJ O
species NNS O
formed VBN O
via IN O
the DT O
Fenton NNP O
reaction NN O
. . O

However RB O
, , O
B NNP B-Species
. . I-Species
burgdorferi NNP I-Species
has VBZ O
been VBN O
shown VBN O
to TO O
harbour VB O
few JJ O
genes NNS O
encoding VBG O
orthologues NNS O
of IN O
known VBN O
iron NN O
- HYPH O
containing VBG O
proteins NNS O
, , O
does VBZ O
not RB O
require VB O
Fe NN O
for IN O
growth NN O
and CC O
has VBZ O
intracellular JJ O
Fe NN O
concentrations NNS O
estimated VBN O
to TO O
be VB O
< $ O
10 CD O
atoms NNS O
per IN O
cell NN O
( : O
Posey NNP O
and CC O
Gherardini NNP O
, , O
2000 CD O
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
these DT O
observations NNS O
strongly RB O
suggest VBP O
that IN O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
DNA NNP O
is VBZ O
not RB O
a DT O
major JJ O
target NN O
for IN O
ROS NNP O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
different JJ O
techniques NNS O
were VBD O
used VBN O
to TO O
measure VB O
DNA NN O
damage NN O
in IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
cells NNS O
after IN O
exposure NN O
to IN O
ROS NNP O
. . O

One CD O
reliable JJ O
indicator NN O
of IN O
DNA NNP O
damage NN O
by IN O
ROS NNP O
in IN O
a DT O
cell NN O
is VBZ O
an DT O
increase NN O
in IN O
the DT O
spontaneous JJ O
mutation NN O
rate NN O
. . O

In IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
, , O
mutations NNS O
that WDT O
confer VBP O
resistance NN O
to IN O
coumermycin NN O
A1 NN O
, , O
which WDT O
targets VBZ O
the DT O
beta JJ O
subunit NN O
of IN O
DNA NN O
gyrase NN O
, , O
have VBP O
been VBN O
mapped VBN O
to IN O
gyrB NN O
, , O
the DT O
gene NN O
encoding VBG O
DNA NNP O
gyrase NN O
B NNP O
( , O
Samuels NNP O
et FW O
al NNP O
. . O
, , O
1994 CD O
) -RRB- O
. . O

In IN O
each DT O
case NN O
, , O
a DT O
single JJ O
point NN O
mutation NN O
correlated VBD O
with IN O
this DT O
drug NN O
resistance NN O
. . O

To TO O
determine VB O
if IN O
exposure NN O
to IN O
oxidants NNS O
increases VBZ O
DNA NN O
damage NN O
by IN O
increasing VBG O
point NN O
mutations NNS O
, , O
B NN B-Species
. , I-Species
burgdorferi NN I-Species
B31A3 NN O
cells NNS O
grown VBN O
under IN O
microaerobic JJ O
conditions NNS O
were VBD O
treated VBN O
with IN O
5 CD O
mM NN O
H2O2 NN O
and CC O
plated VBN O
in IN O
the DT O
presence NN O
and CC O
absence NN O
of IN O
250 CD O
ng CD O
ml NN O
- HYPH O
1 CD O
coumermycin NN O
A1 NN O
. . O

The DT O
mutation NN O
frequency NN O
was VBD O
calculated VBN O
as IN O
the DT O
number NN O
of IN O
colonies NNS O
that WDT O
are VBP O
CouR NNP O
per IN O
total JJ O
number NN O
of IN O
cells NNS O
plated VBN O
. . O

The DT O
spontaneous JJ O
resistance NN O
frequency NN O
of IN O
treated VBN O
cells NNS O
was VBD O
approximately RB O
equivalent JJ O
to IN O
that DT O
of IN O
untreated JJ O
cells NNS O
, , O
8 CD O
. . O
8 CD O
x SYM O
10 CD O
- SYM O
8 CD O
and CC O
1 CD O
. . O
33 CD O
x SYM O
10 CD O
- HYPH O
7 CD O
, , O
respectively RB O
, , O
indicating VBG O
no DT O
increase NN O
in IN O
the DT O
number NN O
of IN O
point NN O
mutations NNS O
( , O
Fig NNP O
. . O
2A CD O
) -RRB- O
. . O

Also RB O
, , O
no DT O
increase NN O
in IN O
point NN O
mutations NNS O
was VBD O
observed VBN O
when WRB O
cells NNS O
were VBD O
treated VBN O
with IN O
higher JJR O
concentrations NNS O
of IN O
H2O2 NNP O
( SYM O
10 CD O
mM NN O
) -RRB- O
or CC O
when WRB O
treated VBN O
with IN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
( , O
5 CD O
and CC O
10 CD O
mM NN O
) -RRB- O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Another DT O
effective JJ O
way NN O
to TO O
determine VB O
DNA NN O
damage NN O
is VBZ O
by IN O
measuring VBG O
the DT O
number NN O
of IN O
apurinic JJ O
/ SYM O
apyrimidinic JJ O
sites NNS O
( -LRB- O
AP NNP O
) -RRB- O
. . O

AP NNP O
sites NNS O
in IN O
DNA NNP O
, , O
where WRB O
the DT O
DNA NNP O
base NN O
is VBZ O
lost VBN O
, , O
can MD O
be VB O
generated VBN O
spontaneously RB O
under IN O
physiological JJ O
conditions NNS O
by IN O
hydrolysis NN O
of IN O
the DT O
N NNP O
- HYPH O
glycosylic JJ O
bond NN O
, , O
or CC O
can MD O
also RB O
be VB O
formed VBN O
by IN O
DNA NN O
- HYPH O
damaging VBG O
agents NNS O
( : O
Lindahl NNP O
and CC O
Nyberg NNP O
, , O
1972 CD O
) -RRB- O
, , O
such JJ O
as IN O
UV NN O
, , O
alkylating NN O
agents NNS O
or CC O
OH NN O
. . O

They PRP O
are VBP O
also RB O
intermediates NNS O
in IN O
the DT O
base NN O
excision NN O
repair NN O
pathway NN O
( , O
BER NNP O
) -RRB- O
( , O
Weiss NNP O
and CC O
Grossman NNP O
, , O
1987 CD O
; : O
Friedberg NNP O
and CC O
Hanawalt NNP O
, , O
1988 CD O
; : O
Wallace NNP O
, , O
1988 CD O
) -RRB- O
. . O

Thus RB O
, , O
the DT O
cellular JJ O
steady JJ O
state NN O
level NN O
of IN O
AP NNP O
sites NNS O
would MD O
increase VB O
as IN O
a DT O
consequence NN O
of IN O
base NN O
modifications NNS O
and CC O
their PRP$ O
subsequent JJ O
repair NN O
. . O

As IN O
AP NNP O
sites NNS O
are VBP O
bypassed VBN O
inefficiently RB O
by IN O
DNA NNP O
polymerase NN O
in IN O
bacterial JJ O
cells NNS O
, , O
DNA NN O
lesions NNS O
can MD O
result VB O
in IN O
a DT O
significant JJ O
block NN O
in IN O
DNA NN O
replication NN O
. . O

Therefore RB O
, , O
the DT O
number NN O
of IN O
AP NNP O
sites NNS O
can MD O
serve VB O
as IN O
a DT O
sensitive JJ O
indicator NN O
of IN O
DNA NN O
damage NN O
resulting VBG O
from IN O
oxidative JJ O
stress NN O
( , O
Kubo NNP O
et FW O
al NNP O
. . O
, , O
1992 CD O
) -RRB- O
. . O

To TO O
determine VB O
whether IN O
ROS NNP O
can MD O
damage VB O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
DNA NN O
, , O
strain NN O
B31A3 NN O
cells NNS O
grown VBN O
under IN O
microaerobic JJ O
conditions NNS O
were VBD O
treated VBN O
with IN O
H2O2 NNP O
( , O
1 CD O
or CC O
10 CD O
mM NN O
) -RRB- O
, , O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
( , O
1 CD O
or CC O
10 CD O
mM NN O
) -RRB- O
or CC O
lipoxidase NN O
( , O
an DT O
enzyme NN O
which WDT O
specifically RB O
catalyses VBZ O
the DT O
hydroperoxidation NN O
of IN O
lipids NNS O
containing VBG O
a DT O
cis NN O
, , O
cis NN O
- HYPH O
pentadiene NN O
structure NN O
, , O
such JJ O
as IN O
linoleic NN O
acid NN O
) -RRB- O
. . O

The DT O
DNA NNP O
was VBD O
isolated VBN O
and CC O
assayed VBN O
for IN O
AP NNP O
sites NNS O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Fig NNP O
. . O

2B NN O
. . O

In IN O
all DT O
cases NNS O
, , O
the DT O
numbers NNS O
of IN O
AP NNP O
sites NNS O
per IN O
105 CD O
bp IN O
DNA NNP O
were VBD O
equivalent JJ O
, , O
indicating VBG O
that IN O
the DT O
addition NN O
of IN O
oxidants NNS O
did VBD O
not RB O
increase VB O
the DT O
number NN O
of IN O
DNA NN O
base NN O
lesions NNS O
. . O

In IN O
contrast NN O
, , O
when WRB O
E NN B-Species
. . I-Species
coli NN I-Species
strain NN O
TA4315 CD O
cells NNS O
( -LRB- O
ahpCF NNP O
) -RRB- O
( , O
Storz NNP O
et NN O
al NNP O
. . O
, , O
1989 CD O
) -RRB- O
were VBD O
treated VBN O
with IN O
100 CD O
micro NN O
M NNP O
H2O2 NNP O
, , O
the DT O
number NN O
of IN O
AP NNP O
sites NNS O
increased VBN O
~ $ O
10 CD O
- HYPH O
fold NN O
over IN O
untreated JJ O
cells NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
B NNP B-Species
. . I-Species
burgdorferi NNP I-Species
DNA NNP O
was VBD O
not RB O
a DT O
major JJ O
target NN O
for IN O
oxidative JJ O
damage NN O
under IN O
these DT O
conditions NNS O
. . O

It PRP O
is VBZ O
of IN O
note NN O
to TO O
mention VB O
that IN O
the DT O
total JJ O
number NN O
of IN O
AP NNP O
sites NNS O
per IN O
105 CD O
bp NN O
DNA NNP O
is VBZ O
approximately RB O
10 CD O
- HYPH O
fold NN O
higher JJR O
in IN O
untreated JJ O
Borrelia NNP O
B31A3 NNP O
DNA NNP O
than IN O
in IN O
untreated JJ O
E NN B-Species
. . I-Species
coli NN I-Species
DNA NNP O
. . O

The DT O
Borrelia NNP O
genome NN O
consists VBZ O
of IN O
a DT O
linear JJ O
chromosome NN O
and CC O
multiple JJ O
linear JJ O
and CC O
circular JJ O
plasmids NNS O
. . O

Numerous JJ O
observations NNS O
indicate VBP O
that IN O
functional JJ O
telomeres NNS O
require VBP O
interaction NN O
with IN O
DNA NN O
damage NN O
repair NN O
proteins NNS O
, , O
suggesting VBG O
that IN O
the DT O
DNA NN O
damage NN O
repair NN O
machinery NN O
, , O
including VBG O
the DT O
BER NNP O
, , O
is VBZ O
involved VBN O
in IN O
replication NN O
of IN O
telomeres NNS O
and CC O
protection NN O
of IN O
functional JJ O
chromosome NN O
ends NNS O
( , O
Verdun NNP O
and CC O
Karlseder NNP O
, , O
2007 CD O
) -RRB- O
. . O

An DT O
important JJ O
intermediate NN O
in IN O
BER NNP O
is VBZ O
the DT O
apurinic JJ O
or CC O
abasic JJ O
site NN O
. . O

Therefore RB O
, , O
it PRP O
was VBD O
possible JJ O
that IN O
the DT O
higher JJR O
numbers NNS O
of IN O
AP NNP O
sites NNS O
in IN O
untreated JJ O
Borrelia NNP O
DNA NNP O
was VBD O
due JJ O
to IN O
the DT O
number NN O
of IN O
telomeres NNS O
present JJ O
in IN O
the DT O
genome NN O
. . O

The DT O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
harbours VBZ O
11 CD O
linear JJ O
plasmids NNS O
and CC O
a DT O
linear JJ O
chromosome NN O
with IN O
~ $ O
100 CD O
unpaired JJ O
bases NNS O
in IN O
the DT O
telomere NN O
loops NNS O
per IN O
genome NN O
or CC O
10 CD O
bases NNS O
per IN O
105 CD O
bp NN O
DNA NNP O
( , O
Hinnebusch NNP O
and CC O
Barbour NNP O
, , O
1991 CD O
; : O
Chaconas NNP O
, , O
2005 CD O
) -RRB- O
. . O

Untreated JJ O
Borrelia NNP O
B31A3 NNP O
contains VBZ O
11 CD O
+ SYM O
/ SYM O
- HYPH O
3 CD O
. . O
8 CD O
AP NN O
sites NNS O
per IN O
105 CD O
bp NN O
DNA NN O
, , O
suggesting VBG O
that IN O
the DT O
elevated JJ O
number NN O
of IN O
AP NNP O
sites NNS O
in IN O
Borrelia NNP O
was VBD O
due JJ O
to IN O
the DT O
number NN O
of IN O
telomeres NNS O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
the DT O
AP NNP O
sites NNS O
were VBD O
measured VBN O
in IN O
DNA NN O
isolated VBN O
from IN O
untreated JJ O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
strain NN O
B314 CD O
which WDT O
harbours VBZ O
no DT O
linear JJ O
plasmids NNS O
( , O
Sadziene NNP O
et FW O
al NNP O
. . O
, , O
1993 CD O
) -RRB- O
. . O

The DT O
number NN O
of IN O
unpaired JJ O
bases NNS O
in IN O
the DT O
telomere NN O
loops NNS O
per IN O
genome NN O
was VBD O
estimated VBN O
to TO O
be VB O
10 CD O
, , O
which WDT O
corresponds VBZ O
to IN O
1 CD O
base NN O
per IN O
105 CD O
bp NN O
DNA NN O
, , O
and CC O
only RB O
3 CD O
. . O
6 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
2 CD O
AP NN O
sites NNS O
per IN O
105 CD O
bp IN O
DNA NNP O
were VBD O
detected VBN O
, , O
supporting VBG O
the DT O
hypothesis NN O
that IN O
the DT O
high JJ O
number NN O
of IN O
AP NNP O
sites NNS O
in IN O
untreated JJ O
Borrelia NNP O
DNA NNP O
was VBD O
due JJ O
to IN O
the DT O
number NN O
of IN O
unpaired JJ O
bases NNS O
in IN O
the DT O
telomeres NNS O
. . O

The DT O
analyses NNS O
of IN O
the DT O
AP NNP O
sites NNS O
strongly RB O
suggested VBD O
that IN O
B NNP B-Species
. . I-Species
burgdorferi NNP I-Species
DNA NNP O
was VBD O
not RB O
the DT O
major JJ O
target NN O
for IN O
oxidative JJ O
damage NN O
. . O

In IN O
addition NN O
to IN O
the DT O
generation NN O
of IN O
abasic JJ O
sites NNS O
, , O
oxygen NN O
radicals NNS O
often RB O
damage VBP O
DNA NN O
through IN O
the DT O
formation NN O
of IN O
8 CD O
- HYPH O
oxoguanine NN O
lesions NNS O
( , O
Nakamura NNP O
et FW O
al NNP O
. . O
, , O
2000 CD O
) -RRB- O
. . O

8 NNP O
- HYPH O
Oxoguanine NNP O
, , O
through IN O
its PRP$ O
ability NN O
to TO O
mispair VB O
with IN O
bases NNS O
other JJ O
than IN O
cytosine NN O
, , O
likely RB O
plays VBZ O
a DT O
role NN O
in IN O
DNA NN O
mutagenesis NN O
. . O

Consequently RB O
, , O
8 CD O
- HYPH O
oxoguanine NN O
is VBZ O
often RB O
used VBN O
as IN O
a DT O
marker NN O
of IN O
oxidized VBN O
DNA NNP O
damage NN O
. . O

To TO O
determine VB O
whether IN O
ROS NNP O
can MD O
damage VB O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
DNA NN O
and CC O
cause VB O
8 CD O
- HYPH O
oxoguanine JJ O
lesions NNS O
, , O
strain NN O
B31A3 NN O
cells NNS O
grown VBN O
under IN O
microaerobic JJ O
conditions NNS O
were VBD O
treated VBN O
with IN O
H2O2 NNP O
( , O
5 CD O
or CC O
10 CD O
mM NN O
) -RRB- O
, , O
t IN O
- HYPH O
butyl NN O
hydroperoxide NN O
( , O
5 CD O
or CC O
10 CD O
mM NN O
) -RRB- O
or CC O
lipoxidase NN O
. . O

The DT O
DNA NNP O
was VBD O
isolated VBN O
and CC O
assayed VBN O
for IN O
8 CD O
- HYPH O
oxoguanine NN O
using VBG O
an DT O
Enzyme NN O
- HYPH O
Linked VBN O
ImmunoSorbent NNP O
Assay NNP O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Fig NNP O
. . O

2C NN O
. . O

In IN O
all DT O
cases NNS O
, , O
the DT O
amount NN O
of IN O
8 CD O
- HYPH O
oxoguanine NN O
in IN O
Borrelia NNP O
cells NNS O
was VBD O
below IN O
the DT O
detection NN O
limit NN O
of IN O
the DT O
assay NN O
. . O

In IN O
contrast NN O
, , O
when WRB O
a DT O
MutM NNP O
( , O
the DT O
specific JJ O
glycosylase NN O
that WDT O
removes VBZ O
the DT O
8 CD O
- HYPH O
oxoguanine NN O
) NFP O
- HYPH O
deficient JJ O
E NN B-Species
. . I-Species
coli NN I-Species
strain NN O
was VBD O
treated VBN O
with IN O
100 CD O
micro NN O
M NNP O
H2O2 NNP O
, , O
the DT O
amount NN O
of IN O
8 CD O
- HYPH O
oxoguanine NN O
sites NNS O
increased VBD O
~ : O
fivefold RB O
over IN O
untreated JJ O
cells NNS O
. . O

It PRP O
is VBZ O
important JJ O
to TO O
point VB O
out RP O
that IN O
no DT O
MutM NNP O
homologue NN O
has VBZ O
been VBN O
identified VBN O
in IN O
the DT O
genome NN O
of IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
suggested VBD O
that IN O
B NNP B-Species
. . I-Species
burgdorferi NNP I-Species
DNA NNP O
was VBD O
not RB O
a DT O
major JJ O
target NN O
for IN O
oxidative JJ O
damage NN O
under IN O
these DT O
conditions NNS O
. . O

The DT O
membranes NNS O
of IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
are VBP O
targeted VBN O
during IN O
oxidative JJ O
stress NN O

In IN O
eukaryotes NNS O
, , O
membrane NN O
lipids NNS O
are VBP O
a DT O
major JJ O
target NN O
of IN O
ROS NNP O
. . O

Free JJ O
radicals NNS O
can MD O
attack VB O
polyunsaturated JJ O
fatty NN O
acids NNS O
, , O
such JJ O
as IN O
linoleic JJ O
acid NN O
and CC O
linolenic NN O
acid NN O
, , O
in IN O
membranes NNS O
and CC O
initiate VB O
lipid NN O
peroxidation NN O
. . O

This DT O
reaction NN O
can MD O
cascade VB O
throughout IN O
the DT O
membrane NN O
to IN O
adjacent JJ O
polyunsaturated JJ O
fatty NN O
acids NNS O
, , O
decreasing VBG O
membrane NN O
fluidity NN O
and CC O
generating VBG O
more RBR O
toxic JJ O
products NNS O
such JJ O
as IN O
aldehydes NNS O
( , O
Imlay NNP O
, , O
2003 CD O
) -RRB- O
. . O

Because IN O
most JJS O
bacterial JJ O
membranes NNS O
contain VBP O
saturated JJ O
and CC O
monounsaturated JJ O
fatty NN O
acids NNS O
rather RB O
than IN O
' `` O
reactive JJ O
' '' O
polyunsaturated JJ O
lipids NNS O
, , O
peroxidation NN O
of IN O
lipids NNS O
in IN O
bacterial JJ O
membranes NNS O
is VBZ O
not RB O
considered VBN O
a DT O
problem NN O
. . O

As IN O
B NN B-Species
. . I-Species
burgdorferi NNS I-Species
cannot MD O
synthesize VB O
their PRP$ O
own JJ O
lipids NNS O
, , O
they PRP O
must MD O
instead RB O
scavenge VB O
them PRP O
. . O

Therefore RB O
, , O
it PRP O
seems VBZ O
likely JJ O
that IN O
their PRP$ O
membrane NN O
composition NN O
would MD O
reflect VB O
the DT O
host NN O
' '' O
s POS O
lipid NN O
profile NN O
or CC O
that DT O
of IN O
their PRP$ O
growth NN O
medium NN O
( , O
Barbour NNP O
, , O
1984 CD O
; : O
Fraser NNP O
et FW O
al NNP O
. . O
, , O
1997 CD O
) -RRB- O
and CC O
would MD O
contain VB O
some DT O
polyunsaturated JJ O
fatty NN O
acids NNS O
. . O

To TO O
determine VB O
if IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
contains VBZ O
polyunsaturated JJ O
lipids NNS O
, , O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
was VBD O
grown VBN O
under IN O
anaerobic JJ O
conditions NNS O
and CC O
analysed VBN O
for IN O
fatty JJ O
acid NN O
composition NN O
by IN O
Lipid NNP O
Technologies NNP O
( : O
Austin NNP O
, , O
MN NNP O
) -RRB- O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Table NNP O
1 CD O
and CC O
are VBP O
reported VBN O
as IN O
percentage NN O
of IN O
total JJ O
fatty JJ O
acid NN O
content NN O
. . O

Linoleic NNP O
acid NN O
comprised VBD O
~ $ O
10 CD O
% NN O
of IN O
the DT O
total JJ O
lipid JJ O
content NN O
and CC O
the DT O
linolenic JJ O
acid NN O
content NN O
was VBD O
measured VBN O
to TO O
be VB O
~ $ O
1 CD O
% NN O
, , O
indicating VBG O
that IN O
Borrelia NNP O
cells NNS O
do VBP O
contain VB O
lipids NNS O
that WDT O
are VBP O
susceptible JJ O
to IN O
ROS NNP O
damage NN O
. . O

The DT O
amount NN O
of IN O
linoleic JJ O
acid NN O
and CC O
linolenic NN O
acid NN O
present JJ O
in IN O
Borrelia NNP O
reflected VBD O
the DT O
amount NN O
present JJ O
in IN O
the DT O
media NNS O
. . O

Therefore RB O
, , O
these DT O
results NNS O
suggested VBD O
that IN O
the DT O
amount NN O
of IN O
these DT O
fatty NN O
acids NNS O
in IN O
the DT O
membranes NNS O
would MD O
vary VB O
as IN O
availability NN O
varies VBZ O
. . O

To TO O
determine VB O
if IN O
Borrelia NNP O
polyunsaturated JJ O
lipids NNS O
can MD O
undergo VB O
lipid NN O
peroxidation NN O
, , O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
B31A3 NN O
cells NNS O
grown VBN O
microaerobically RB O
were VBD O
treated VBN O
with IN O
1 CD O
mM NN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
or CC O
250 CD O
mg NN O
of IN O
lipoxidase NN O
, , O
and CC O
the DT O
cell NN O
pellets NNS O
were VBD O
analysed VBN O
for IN O
fatty JJ O
acid NN O
composition NN O
( -LRB- O
Industrial NNP O
Laboratory NNP O
) -RRB- O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Table NNP O
2 CD O
and CC O
are VBP O
reported VBN O
as IN O
the DT O
percentage NN O
of IN O
total JJ O
cell NN O
mass NN O
. . O

The DT O
per NN O
cent NN O
of IN O
linoleic JJ O
acid NN O
in IN O
the DT O
total JJ O
cell NN O
mass NN O
decreased VBD O
with IN O
treatment NN O
, , O
while IN O
the DT O
levels NNS O
of IN O
oleic NN O
acid NN O
( : O
c18 CD O
: : O
1n9 CD O
) -RRB- O
and CC O
pentadecanoic NN O
acid NN O
( : O
c15 CD O
: : O
0 CD O
) -RRB- O
remained VBD O
relatively RB O
constant JJ O
. . O

Untreated JJ O
cells NNS O
contained VBD O
0 CD O
. . O
4 CD O
% NN O
linoleic NN O
acid NN O
, , O
while IN O
cells NNS O
treated VBN O
with IN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
contained VBD O
10 CD O
- HYPH O
fold NN O
less JJR O
( : O
0 CD O
. . O
4 CD O
% NN O
) SYM O
linoleic JJ O
acid NN O
and CC O
cells NNS O
treated VBN O
with IN O
lipoxidase NN O
had VBD O
no DT O
detectable JJ O
linoleic JJ O
acid NN O
present JJ O
in IN O
the DT O
sample NN O
. . O

These DT O
data NNS O
indicated VBD O
that IN O
the DT O
linoleic JJ O
acid NN O
present JJ O
in IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
membranes NNS O
can MD O
be VB O
oxidized VBN O
by IN O
ROS NNP O
. . O

Malondialdehyde NNP O
( , O
MDA NNP O
) -RRB- O
is VBZ O
generated VBN O
as IN O
a DT O
relatively RB O
stable JJ O
end NN O
- HYPH O
product NN O
from IN O
the DT O
oxidative JJ O
degradation NN O
of IN O
polyunsaturated VBN O
fatty NN O
acids NNS O
. . O

MDA NNP O
has VBZ O
thus RB O
been VBN O
used VBN O
as IN O
an DT O
indicator NN O
of IN O
lipid JJ O
peroxidation NN O
( , O
Gutteridge NNP O
and CC O
Halliwell NNP O
, , O
1990 CD O
; , O
Esterbauer NNP O
et FW O
al NNP O
. . O
, , O
1991 CD O
) -RRB- O
. . O

To TO O
further RB O
demonstrate VB O
that IN O
Borrelia NNP O
lipids NNS O
can MD O
undergo VB O
lipid NN O
peroxidation NN O
, , O
B31A3 NN O
cells NNS O
grown VBN O
microaerobically RB O
were VBD O
treated VBN O
with IN O
5 CD O
mM NN O
AAPH NN O
( , O
free JJ O
radical JJ O
generator NN O
) , O
or CC O
250 CD O
mg NN O
of IN O
lipoxidase NN O
and CC O
MDA NNP O
measured VBN O
( -LRB- O
Seljeskog NNP O
et NN O
al NNP O
. . O
, , O
2006 CD O
) -RRB- O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Fig NNP O
. . O

3 LS O
. . O

Untreated JJ O
cells NNS O
contained VBD O
~ $ O
16 CD O
. . O
5 CD O
micro NN O
M NN O
of IN O
MDA NN O
per IN O
mg NN O
of IN O
protein NN O
. . O

When WRB O
the DT O
cells NNS O
were VBD O
treated VBN O
with IN O
AAPH NNP O
or CC O
lipoxidase NN O
, , O
the DT O
amount NN O
of IN O
MDA NNP O
increased VBD O
~ $ O
1 CD O
. . O
5 CD O
- HYPH O
fold NN O
( : O
27 CD O
. . O
3 CD O
micro NN O
M NN O
of IN O
MDA NNP O
per IN O
mg NN O
of IN O
protein NN O
) -RRB- O
and CC O
approximately RB O
twofold JJ O
( : O
33 CD O
micro NN O
M NN O
of IN O
MDA NNP O
per IN O
mg NN O
of IN O
protein NN O
) -RRB- O
respectively RB O
( : O
Fig NNP O
. . O
3A CD O
) -RRB- O
. . O

As IN O
a DT O
control NN O
, , O
eukaryotic JJ O
cells NNS O
( , O
mouse NN B-Species
myeloma NN O
cells NNS O
SP2 NNP O
) -RRB- O
were VBD O
treated VBN O
with IN O
AAPH NNP O
and CC O
MDA NNP O
measured VBN O
( : O
Fig NNP O
. . O
3B NN O
) -RRB- O
. . O

Mouse NNP B-Species
myeloma NN O
cells NNS O
have VBP O
been VBN O
used VBN O
as IN O
a DT O
model NN O
system NN O
for IN O
the DT O
determination NN O
of IN O
phospholipid NN O
hydroperoxides NNS O
( , O
Chotimarkorn NNP O
et FW O
al NNP O
. . O
, , O
2005 CD O
) -RRB- O
. . O

In IN O
this DT O
case NN O
, , O
the DT O
amount NN O
of IN O
MDA NNP O
increased VBD O
approximately RB O
threefold RB O
( SYM O
36 CD O
. . O
3 CD O
micro NN O
M NN O
of IN O
MDA NN O
per IN O
mg NN O
of IN O
protein NN O
) -RRB- O
in IN O
the DT O
treated VBN O
cells NNS O
versus IN O
untreated JJ O
cells NNS O
( , O
11 CD O
. . O
7 CD O
micro NN O
M NN O
of IN O
MDA NNP O
per IN O
mg NN O
of IN O
protein NN O
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
suggested VBD O
that IN O
, , O
like IN O
eukaryotic JJ O
membranes NNS O
, , O
Borrelia NNP O
membrane NN O
lipids NNS O
were VBD O
capable JJ O
of IN O
undergoing VBG O
lipid NN O
peroxidation NN O
. . O

As IN O
shown VBN O
in IN O
Fig NNP O
. . O

3A NN O
, , O
there EX O
is VBZ O
a DT O
measurable JJ O
quantity NN O
of IN O
MDA NNP O
present JJ O
even RB O
in IN O
untreated JJ O
cells NNS O
, , O
suggesting VBG O
that IN O
the DT O
membrane NN O
lipids NNS O
are VBP O
damaged VBN O
without IN O
the DT O
addition NN O
of IN O
exogenous JJ O
ROS NNP O
. . O

Oxidative JJ O
damage NN O
is VBZ O
an DT O
unavoidable JJ O
by IN O
- HYPH O
product NN O
of IN O
growth NN O
in IN O
an DT O
oxygen NN O
environment NN O
because IN O
superoxide NN O
anions NNS O
and CC O
H2O2 NN O
are VBP O
formed VBN O
whenever WRB O
molecular JJ O
oxygen NN O
chemically RB O
oxidizes VBZ O
electron NN O
carriers NNS O
. . O

To TO O
determine VB O
if IN O
the DT O
Borrelia NNP O
lipids NNS O
are VBP O
damaged VBN O
from IN O
growth NN O
in IN O
an DT O
oxygen NN O
environment NN O
, , O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
B31A3 NN O
cells NNS O
were VBD O
grown VBN O
under IN O
anaerobic JJ O
, , O
microaerobic JJ O
and CC O
aerobic JJ O
conditions NNS O
and CC O
MDA NNP O
measured VBN O
. . O

Figure NN O
3C NNP O
demonstrates VBZ O
that IN O
as IN O
the DT O
oxygen NN O
concentration NN O
increased VBD O
, , O
the DT O
amount NN O
of IN O
MDA NNP O
increased VBD O
. . O

Cells NNS O
grown VBN O
under IN O
anaerobic JJ O
conditions NNS O
contained VBD O
the DT O
lowest JJS O
amount NN O
of IN O
MDA NNP O
( SYM O
7 CD O
. . O
6 CD O
micro NN O
M NN O
of IN O
MDA NNP O
per IN O
mg NN O
of IN O
protein NN O
) -RRB- O
, , O
approximately RB O
twofold RB O
less JJR O
than IN O
the DT O
measured VBN O
amount NN O
in IN O
microaerobic JJ O
cells NNS O
( : O
16 CD O
. . O
5 CD O
micro NN O
M NN O
of IN O
MDA NNP O
per IN O
mg NN O
of IN O
protein NN O
) -RRB- O
. . O

Aerobically RB O
grown VBN O
cells NNS O
contained VBD O
the DT O
highest JJS O
amount NN O
of IN O
MDA NNP O
, , O
~ $ O
1 CD O
. . O
5 CD O
- HYPH O
fold NN O
greater JJR O
than IN O
that DT O
observed VBN O
in IN O
microaerobic JJ O
cells NNS O
( : O
28 CD O
. . O
8 CD O
micro NN O
M NN O
of IN O
MDA NNP O
per IN O
mg NN O
of IN O
protein NN O
) -RRB- O
and CC O
~ $ O
3 CD O
. . O
7 CD O
- HYPH O
fold NN O
greater JJR O
than IN O
that DT O
observed VBN O
in IN O
anaerobically RB O
grown VBN O
cells NNS O
. . O

These DT O
data NNS O
suggested VBD O
that IN O
Borrelia NNP O
lipids NNS O
can MD O
be VB O
damaged VBN O
during IN O
aerobic JJ O
growth NN O
. . O

Our PRP$ O
High NNP O
Performance NNP O
Liquid NNP O
Chromatography NNP O
analyses NNS O
of IN O
the DT O
MDA NNP O
present JJ O
in IN O
anaerobically RB O
grown VBN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
cells NNS O
showed VBD O
a DT O
small JJ O
peak NN O
with IN O
a DT O
retention NN O
time NN O
similar JJ O
to IN O
that DT O
of IN O
the DT O
MDA NNP O
standard NN O
. . O

This DT O
was VBD O
puzzling JJ O
as IN O
little JJ O
or CC O
no DT O
lipid JJ O
peroxidation NN O
should MD O
occur VB O
under IN O
these DT O
conditions NNS O
. . O

To TO O
further RB O
characterize VB O
this DT O
' `` O
MDA NNP O
' '' O
peak NN O
, , O
a DT O
three CD O
- HYPH O
dimensional JJ O
diode NN O
array NN O
spectra NN O
was VBD O
generated VBN O
by IN O
scanning VBG O
each DT O
sample NN O
during IN O
the DT O
elution NN O
of IN O
the DT O
peak NN O
( , O
Fig NNP O
. . O
4 CD O
, , O
lower JJR O
sections NNS O
) -RRB- O
. . O

An DT O
authentic JJ O
MDA NNP O
standard NN O
was VBD O
also RB O
scanned VBN O
as IN O
a DT O
control NN O
( HYPH O
Fig NNP O
. . O
4A NN O
, , O
lower JJR O
section NN O
) -RRB- O
. . O

In IN O
the DT O
anaerobically RB O
grown JJ O
cells NNS O
, , O
the DT O
spectrum NN O
shows VBZ O
that IN O
two CD O
compounds NNS O
with IN O
different JJ O
absorbance NN O
maximums NNS O
( , O
Fig NNP O
. . O
4B NNP O
, , O
lower JJR O
section NN O
) -RRB- O
comprised VBD O
the DT O
single JJ O
retention NN O
time NN O
peak NN O
from IN O
the DT O
HPLC NNP O
chromatogram NN O
( , O
Fig NNP O
. . O
4B NNP O
, , O
upper JJ O
section NN O
) -RRB- O
. . O

Based VBN O
on IN O
this DT O
spectrum NN O
, , O
the DT O
amount NN O
of IN O
actual JJ O
MDA NNP O
contributed VBN O
< : O
15 CD O
% NN O
of IN O
the DT O
total JJ O
amount NN O
of IN O
material NN O
detected VBN O
in IN O
the DT O
HPLC NNP O
peak NN O
while IN O
the DT O
second JJ O
contaminating VBG O
peak NN O
contributed VBD O
> : O
85 CD O
% NN O
. . O

Therefore RB O
, , O
the DT O
amount NN O
of IN O
MDA NNP O
in IN O
untreated JJ O
anaerobically RB O
grown VBN O
cells NNS O
was VBD O
considerably RB O
less JJR O
than IN O
the DT O
7 CD O
. . O
6 CD O
micro NN O
M NN O
of IN O
MDA NNP O
per IN O
mg NN O
of IN O
protein NN O
actually RB O
measured VBN O
. . O

However RB O
, , O
in IN O
cells NNS O
grown VBN O
under IN O
microaerobic JJ O
conditions NNS O
, , O
the DT O
MDA NNP O
peak NN O
contributed VBD O
more JJR O
to IN O
the DT O
overall JJ O
retention NN O
time NN O
peak NN O
when WRB O
compared VBN O
with IN O
the DT O
anaerobic JJ O
spectrum NN O
, , O
while IN O
the DT O
second JJ O
contaminating VBG O
peak NN O
stays VBZ O
relatively RB O
constant JJ O
( : O
Fig NNP O
. . O
4C NNP O
, , O
lower JJR O
section NN O
) -RRB- O
. . O

These DT O
spectra NNS O
demonstrated VBD O
that IN O
the DT O
increase NN O
in IN O
the DT O
MDA NNP O
retention NN O
time NN O
peak NN O
between IN O
anaerobically RB O
and CC O
aerobically RB O
grown VBN O
cells NNS O
was VBD O
due JJ O
to IN O
the DT O
increase NN O
in IN O
the DT O
amount NN O
of IN O
authentic JJ O
MDA NNP O
present JJ O
. . O

The DT O
fluorescent JJ O
probe NN O
diphenyl NN O
- HYPH O
1 CD O
- HYPH O
pyrenylphophine NN O
( -LRB- O
DPPP NNP O
) -RRB- O
has VBZ O
been VBN O
used VBN O
for IN O
detection NN O
of IN O
lipid JJ O
hydroperoxides NNS O
in IN O
cell NN O
membranes NNS O
( , O
Okimoto NNP O
et NN O
al NNP O
. . O
, , O
2000 CD O
; , O
Takahashi NNP O
et FW O
al NNP O
. . O
, , O
2001 CD O
) -RRB- O
. . O

In IN O
this DT O
method NN O
, , O
the DT O
hydroperoxides NNS O
are VBP O
reduced VBN O
with IN O
DPPP NNP O
, , O
resulting VBG O
in IN O
the DT O
formation NN O
of IN O
the DT O
fluorescent NN O
arylphosphine NN O
oxide NN O
. . O

To TO O
visualize VB O
the DT O
lipid JJ O
hydroperoxides NNS O
, , O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
B31A3 NN O
cells NNS O
were VBD O
labelled VBN O
with IN O
DPPP NNP O
and CC O
observed VBN O
by IN O
fluorescence NN O
microscopy NN O
( , O
Fig NNP O
. . O
5B NN O
) -RRB- O
. . O

E NN B-Species
. . I-Species
coli NN I-Species
Top10 NN O
cells NNS O
and CC O
mouse NN B-Species
myeloma NN O
SP2 NNP O
cells NNS O
were VBD O
also RB O
labelled VBN O
and CC O
visualized VBN O
to TO O
serve VB O
as IN O
negative JJ O
and CC O
positive JJ O
controls NNS O
respectively RB O
( : O
Fig NNP O
. . O
5A NN O
and CC O
C NN O
) -RRB- O
. . O

Red JJ O
Fluorescent NN O
dye NN O
was VBD O
used VBN O
to TO O
visualize VB O
the DT O
cell NN O
membranes NNS O
. . O

A DT O
strong JJ O
fluorescence NN O
of IN O
DPPP NNP O
was VBD O
observed VBN O
for IN O
B31A3 NNP O
cells NNS O
( -LRB- O
Fig NNP O
. . O
5B NN O
) -RRB- O
and CC O
for IN O
the DT O
mouse NN B-Species
myeloma NN O
cells NNS O
( , O
Fig NNP O
. . O
5C NN O
) -RRB- O
, , O
but CC O
not RB O
for IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
cells NNS O
( -LRB- O
Fig NNP O
. . O
5A NN O
) -RRB- O
. . O

An DT O
overlay NN O
of IN O
the DT O
two CD O
dyes NNS O
demonstrates VBZ O
that IN O
the DT O
DPPP NNP O
fluorescence NN O
of IN O
both CC O
the DT O
Borrelia NNP O
and CC O
myeloma NN O
cells NNS O
corresponds VBZ O
to IN O
the DT O
areas NNS O
of IN O
red JJ O
fluorescence NN O
. . O

This DT O
indicated VBD O
that IN O
lipid JJ O
hydroperoxides NNS O
were VBD O
present JJ O
on IN O
the DT O
Borrelia NNP O
cell NN O
membranes NNS O
and CC O
suggested VBD O
that IN O
the DT O
membranes NNS O
were VBD O
damaged VBN O
. . O

To TO O
further RB O
demonstrate VB O
Borrelia NNP O
membrane NN O
damage NN O
, , O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
B31A3 NN O
cells NNS O
were VBD O
grown VBN O
under IN O
anaerobic JJ O
and CC O
microaerobic JJ O
conditions NNS O
and CC O
visualized VBN O
by IN O
negative JJ O
stain NN O
using VBG O
an DT O
electron NN O
microscope NN O
. . O

Additionally RB O
, , O
cells NNS O
grown VBN O
under IN O
microaerobic JJ O
conditions NNS O
were VBD O
treated VBN O
with IN O
250 CD O
mg NN O
of IN O
lipoxidase NN O
and CC O
visualized VBN O
by IN O
Electron NNP O
Microscopy NNP O
. . O

Intact JJ O
membranes NNS O
were VBD O
observed VBN O
in IN O
cultures NNS O
of IN O
B31A3 NNP O
grown VBN O
under IN O
anaerobic JJ O
and CC O
microaerobic JJ O
conditions NNS O
( , O
Fig NNP O
. . O
6A NN O
and CC O
B NN O
respectively RB O
) -RRB- O
. . O

However RB O
, , O
in IN O
cultures NNS O
treated VBN O
with IN O
lipoxidase NN O
( , O
Fig NNP O
. . O
6C NNP O
) -RRB- O
, , O
a DT O
significant JJ O
number NN O
of IN O
membrane NN O
blebs NNS O
were VBD O
seen VBN O
surrounding VBG O
the DT O
spirochetes NNS O
, , O
indicating VBG O
membrane NN O
damage NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
indicated VBD O
that IN O
Borrelia NNP O
membranes NNS O
were VBD O
a DT O
target NN O
for IN O
oxidative JJ O
stress NN O
. . O

Discussion NN O

Most JJS O
bacterial JJ O
pathogens NNS O
are VBP O
faced VBN O
with IN O
the DT O
challenge NN O
of IN O
overcoming VBG O
ROS NNP O
generated VBN O
by IN O
the DT O
host NN O
immune JJ O
system NN O
. . O

These DT O
radicals NNS O
can MD O
cause VB O
a DT O
great JJ O
deal NN O
of IN O
damage NN O
to IN O
biological JJ O
molecules NNS O
both CC O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

The DT O
potential JJ O
cellular JJ O
targets NNS O
for IN O
ROS NNP O
damage NN O
in IN O
bacteria NNS O
include VBP O
DNA NN O
, , O
RNA NN O
, , O
proteins NNS O
and CC O
lipids NNS O
, , O
and CC O
extensive JJ O
work NN O
has VBZ O
been VBN O
done VBN O
to TO O
determine VB O
the DT O
cellular JJ O
targets NNS O
of IN O
ROS NNP O
that WDT O
affect VBP O
bacterial JJ O
survival NN O
. . O

To IN O
date NN O
, , O
the DT O
most RBS O
definitive JJ O
work NN O
has VBZ O
been VBN O
done VBN O
on IN O
E NN B-Species
. . I-Species
coli NN I-Species
. . O

It PRP O
seems VBZ O
clear JJ O
from IN O
several JJ O
studies NNS O
that IN O
the DT O
most RBS O
physiologically RB O
relevant JJ O
target NN O
of IN O
ROS NNP O
in IN O
E NNP B-Species
. . I-Species
coli NN I-Species
is VBZ O
DNA NNP O
. . O

The DT O
exposure NN O
to IN O
micro NN O
M NN O
concentrations NNS O
of IN O
ROS NNP O
( : O
i LS O
. . O
e -RRB- O
. . O
H2O2 NN O
) -RRB- O
is VBZ O
sufficient JJ O
to TO O
cause VB O
DNA NN O
damage NN O
, , O
inhibit VB O
DNA NN O
replication NN O
, , O
increase VB O
the DT O
mutation NN O
rate NN O
and CC O
often RB O
lead VB O
to IN O
cell NN O
death NN O
. . O

This DT O
process NN O
leading VBG O
to IN O
DNA NN O
damage NN O
begins VBZ O
with IN O
formation NN O
of IN O
O2 NN O
- HYPH O
and CC O
H2O2 NN O
from IN O
the DT O
oxidation NN O
of IN O
flavoproteins NNS O
and CC O
/ SYM O
or CC O
the DT O
diffusion NN O
of IN O
these DT O
reactive JJ O
species NNS O
from IN O
the DT O
extracellular JJ O
milieu NN O
. . O

The DT O
subsequent JJ O
oxidation NN O
of IN O
Fe NNP O
- HYPH O
S NNP O
proteins NNS O
by IN O
ROS NNP O
( : O
e LS O
. . O
g LS O
. . O
O2 CD O
- HYPH O
) -RRB- O
leads VBZ O
to IN O
an DT O
increase NN O
in IN O
intracellular JJ O
' `` O
free JJ O
' '' O
Fe2 NN O
+ CC O
which WDT O
triggers VBZ O
the DT O
reduction NN O
of IN O
H2O2 NN O
to IN O
OH NN O
( : O
Fenton NNP O
reaction NN O
) -RRB- O
. . O

The DT O
highly RB O
reactive JJ O
nature NN O
of IN O
OH NNP O
limits VBZ O
its PRP$ O
diffusion NN O
so IN O
that IN O
it PRP O
generally RB O
reacts VBZ O
with IN O
molecules NNS O
in IN O
close JJ O
proximity NN O
to IN O
its PRP$ O
origin NN O
( , O
e LS O
. . O
g LS O
. . O
the DT O
Fe2 NN O
+ CC O
associated VBN O
with IN O
DNA NNP O
) -RRB- O
. . O

In IN O
DNA NN O
, , O
OH NNP O
oxidizes VBZ O
sugar NN O
and CC O
base NN O
moieties NNS O
, , O
producing VBG O
radicals NNS O
which WDT O
ultimately RB O
generate VBP O
lesions NNS O
, , O
including VBG O
base NN O
modifications NNS O
, , O
strand NN O
breaks NNS O
and CC O
chemical JJ O
cross NN O
- HYPH O
links NNS O
to IN O
other JJ O
molecules NNS O
. . O

Base NN O
modifications NNS O
lead VBP O
to IN O
mismatching NN O
and CC O
increased VBN O
mutation NN O
frequencies NNS O
while IN O
more RBR O
severe JJ O
damage NN O
, , O
such JJ O
as IN O
strand NN O
breaks NNS O
, , O
prevents VBZ O
DNA NN O
replication NN O
, , O
contributing VBG O
to IN O
OH NN O
toxicity NN O
and CC O
cell NN O
death NN O
. . O

Critical JJ O
to IN O
this DT O
chemical JJ O
process NN O
in IN O
vivo NN O
is VBZ O
the DT O
presence NN O
of IN O
iron NN O
. . O

No DT O
other JJ O
metal NN O
or CC O
non JJ O
- HYPH O
metal NN O
electron NN O
carrier NN O
appears VBZ O
to TO O
be VB O
able JJ O
to TO O
univalently RB O
reduce VB O
H2O2 NN O
to IN O
OH NNP O
in IN O
vivo NN O
( : O
Macomber NNP O
et NN O
al NNP O
. . O
, , O
2007 CD O
) -RRB- O
. . O

These DT O
observations NNS O
are VBP O
critical JJ O
in IN O
beginning VBG O
to TO O
understand VB O
the DT O
oxidative JJ O
damage NN O
/ SYM O
targets NNS O
in IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
in IN O
E NNP B-Species
. . I-Species
coli NN I-Species
that IN O
the DT O
free JJ O
- HYPH O
iron NN O
pool NN O
size NN O
determines VBZ O
the DT O
rate NN O
of IN O
oxidative JJ O
DNA NN O
damage NN O
. . O

For IN O
example NN O
, , O
in IN O
wild JJ O
- HYPH O
type NN O
E NN B-Species
. . I-Species
coli NN I-Species
, , O
free JJ O
iron NN O
levels NNS O
are VBP O
estimated VBN O
to TO O
be VB O
10 CD O
micro NN O
M NN O
, , O
yet CC O
H2O2 NN O
is VBZ O
only RB O
mildly RB O
genotoxic JJ O
( , O
Keyer NNP O
and CC O
Imlay NNP O
, , O
1996 CD O
) -RRB- O
. . O

However RB O
, , O
in IN O
E NNP B-Species
. . I-Species
coli NN I-Species
Fur NNP O
- HYPH O
mutants NNS O
, , O
intracellular JJ O
iron NN O
concentration NN O
increases VBZ O
eightfold NN O
while IN O
survival NN O
is VBZ O
10 CD O
- HYPH O
fold NN O
lower JJR O
when WRB O
cells NNS O
are VBP O
exposed VBN O
to IN O
H2O2 NNP O
. . O

Because IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
cells NNS O
do VBP O
not RB O
contain VB O
detectable JJ O
levels NNS O
of IN O
intracellular JJ O
Fe NNP O
, , O
it PRP O
seems VBZ O
unlikely JJ O
that IN O
DNA NNP O
is VBZ O
a DT O
major JJ O
target NN O
for IN O
damage NN O
via IN O
the DT O
Fenton NNP O
reaction NN O
in IN O
this DT O
bacterium NN O
( : O
Posey NNP O
and CC O
Gherardini NNP O
, , O
2000 CD O
) -RRB- O
. . O

The DT O
experimental JJ O
data NNS O
present JJ O
in IN O
this DT O
report NN O
suggested VBD O
that IN O
this DT O
was VBD O
the DT O
case NN O
. . O

When WRB O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
cells NNS O
were VBD O
exposed VBN O
to IN O
high JJ O
concentrations NNS O
of IN O
ROS NNP O
( : O
e LS O
. . O
g LS O
. . O
H2O2 NN O
) -RRB- O
, , O
there EX O
was VBD O
no DT O
effect NN O
on IN O
the DT O
spontaneous JJ O
mutation NN O
rate NN O
( , O
Fig NNP O
. . O
2A NN O
) -RRB- O
or CC O
the DT O
number NN O
of IN O
DNA NN O
lesions NNS O
( , O
AP NNP O
sites NNS O
or CC O
8 CD O
- HYPH O
oxoguanine NN O
) -RRB- O
( , O
Fig NN O
. . O
2B NN O
and CC O
C NN O
) -RRB- O
. . O

It PRP O
should MD O
be VB O
noted VBN O
that IN O
in IN O
these DT O
experiments NNS O
, , O
a DT O
wild JJ O
- HYPH O
type NN O
strain NN O
of IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
was VBD O
used VBN O
and CC O
presumably RB O
all DT O
of IN O
the DT O
endogenous JJ O
oxidative JJ O
stress NN O
enzymes NNS O
were VBD O
expressed VBN O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
no DT O
DNA NNP O
damage NN O
was VBD O
observed VBN O
because IN O
these DT O
enzymes NNS O
are VBP O
capable JJ O
of IN O
detoxifying VBG O
the DT O
cell NN O
and CC O
protecting VBG O
nucleic JJ O
acids NNS O
from IN O
oxidation NN O
via IN O
the DT O
Fenton NNP O
reaction NN O
. . O

However RB O
, , O
we PRP O
do VBP O
not RB O
believe VB O
this DT O
to TO O
be VB O
the DT O
case NN O
as IN O
the DT O
concentration NN O
of IN O
oxidants NNS O
used VBN O
in IN O
these DT O
experiments NNS O
were VBD O
significantly RB O
higher JJR O
than IN O
concentrations NNS O
known VBN O
to TO O
cause VB O
DNA NN O
damage NN O
in IN O
E NN B-Species
. . I-Species
coli NN I-Species
and CC O
other JJ O
pathogenic JJ O
bacteria NNS O
. . O

The DT O
lack NN O
of IN O
detectable JJ O
DNA NN O
damage NN O
in IN O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
cells NNS O
under IN O
the DT O
conditions NNS O
tested VBN O
could MD O
be VB O
the DT O
result NN O
of IN O
very RB O
efficient JJ O
DNA NNP O
repair NN O
systems NNS O
. . O

Bacteria NNS O
, , O
such JJ O
as IN O
E NNP B-Species
. . I-Species
coli NN I-Species
, , O
harbour VBP O
genes NNS O
encoding VBG O
repair NN O
enzymes NNS O
( , O
i LS O
. . O
e -RRB- O
. . O
MutM NNP O
, , O
MutY NNP O
, , O
Ung NNP O
, , O
AlkA NNP O
, , O
MutS NNP O
, , O
MutL NNP O
, , O
ExoIII NNP O
, , O
EndoVIII NNP O
, , O
PolI NNP O
, , O
RecJ NNP O
) -RRB- O
. . O

Key JJ O
enzymes NNS O
in IN O
the DT O
repair NN O
of IN O
8 CD O
- HYPH O
oxoguanine NN O
lesions NNS O
resulting VBG O
from IN O
the DT O
oxidation NN O
of IN O
DNA NNP O
are VBP O
the DT O
bifunctional JJ O
glycosylases NNS O
, , O
such JJ O
as IN O
MutM NNP O
, , O
MutY NNP O
or CC O
EndoVIII NNP O
. . O

The DT O
first JJ O
activity NN O
of IN O
these DT O
enzymes NNS O
is VBZ O
to TO O
remove VB O
oxidized VBN O
or CC O
ring NN O
- HYPH O
saturated VBN O
bases NNS O
while IN O
the DT O
second JJ O
activity NN O
is VBZ O
to TO O
remove VB O
the DT O
resulting VBG O
deoxyribose NN O
residue NN O
, , O
generating VBG O
a DT O
3 CD O
' '' O
- HYPH O
phosphate NN O
end NN O
( , O
Krwawicz NNP O
et FW O
al NNP O
. . O
, , O
2007 CD O
) -RRB- O
. . O

This DT O
3 CD O
' NN O
- HYPH O
P NN O
is VBZ O
converted VBN O
to IN O
a DT O
3 CD O
' '' O
- HYPH O
OH NN O
by IN O
various JJ O
enzymes NNS O
/ SYM O
pathways NNS O
and CC O
the DT O
lesion NN O
is VBZ O
repaired VBN O
by IN O
enzymes NNS O
( , O
e LS O
. . O
g LS O
. . O
ExoIII NNP O
, , O
PolI NNP O
, , O
LigI NNP O
etc FW O
. . O
) -RRB- O
in IN O
the DT O
short JJ O
or CC O
long JJ O
BER NNP O
pathways NNS O
( -LRB- O
S NNP O
- HYPH O
BER NNP O
, , O
L NNP O
- HYPH O
BER NNP O
) -RRB- O
. . O

Interestingly RB O
, , O
the DT O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
genome NN O
does VBZ O
not RB O
contain VB O
genes NNS O
encoding VBG O
homologues NNS O
of IN O
MutM NNP O
, , O
MutY NNP O
or CC O
EndoVIII NNP O
, , O
suggesting VBG O
that IN O
it PRP O
would MD O
be VB O
difficult JJ O
for IN O
the DT O
cells NNS O
to TO O
efficiently RB O
repair VB O
8 CD O
- HYPH O
oxoguanine NN O
sites NNS O
using VBG O
this DT O
pathway NN O
. . O

B NN B-Species
. . I-Species
burgdorferi NN I-Species
does VBZ O
harbour VB O
the DT O
genes NNS O
encoding VBG O
the DT O
enzymes NNS O
Ung NNP O
( , O
monofunctional JJ O
gylcosylase NN O
, , O
BB0053 NNP O
) -RRB- O
, , O
MutS NNP O
( , O
BB0797 NNP O
, , O
BB0098 NNP O
) -RRB- O
, , O
MutL NNP O
( , O
BB0211 NNP O
) -RRB- O
, , O
ExoIII NNP O
( -LRB- O
BB0114 NNP O
) -RRB- O
, , O
PolI NNP O
( , O
BB0548 NNP O
) -RRB- O
, , O
LigI NNP O
( -LRB- O
BB0552 NN O
) -RRB- O
and CC O
RecJ NNP O
( -LRB- O
BB0254 NN O
) -RRB- O
( , O
Fraser NN O
et NN O
al NNP O
. . O
, , O
1997 CD O
) -RRB- O
which WDT O
are VBP O
involved VBN O
in IN O
excision NN O
and CC O
repair NN O
, , O
via IN O
S NN O
- HYPH O
BER NNP O
or CC O
L NNP O
- HYPH O
BER NNP O
, , O
of IN O
deaminated VBN O
, , O
alkylated VBN O
, , O
methylated JJ O
or CC O
mismatched VBN O
bases NNS O
. . O

Clearly RB O
, , O
these DT O
repair NN O
systems NNS O
in IN O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
do VBP O
not RB O
seem VB O
as RB O
robust JJ O
at IN O
defending VBG O
against IN O
oxidation NN O
of IN O
DNA NNP O
as IN O
those DT O
described VBN O
in IN O
E NN B-Species
. . I-Species
coli NNP I-Species
. . O

The DT O
lack NN O
of IN O
key JJ O
repair NN O
enzymes NNS O
in IN O
this DT O
system NN O
may MD O
indicate VB O
that IN O
B NNP B-Species
. . I-Species
burgdorferi NNP I-Species
DNA NNP O
is VBZ O
not RB O
subjected VBN O
to IN O
the DT O
same JJ O
challenge NN O
from IN O
ROS NNP O
as IN O
is VBZ O
E NN B-Species
. . I-Species
coli NN I-Species
. . O

In IN O
most JJS O
bacteria NNS O
, , O
ROS NNP O
- HYPH O
mediated VBN O
damage NN O
to IN O
lipids NNS O
( , O
lipid JJ O
peroxidation NN O
) -RRB- O
is VBZ O
very RB O
unlikely JJ O
because IN O
of IN O
the DT O
lack NN O
of IN O
polyunsaturated VBN O
fatty NN O
acids NNS O
( : O
e LS O
. . O
g LS O
. . O
linoleic NN O
acid NN O
) -RRB- O
( , O
Imlay NNP O
, , O
2003 CD O
) -RRB- O
. . O

When WRB O
it PRP O
does VBZ O
occur VB O
, , O
lipid NN O
peroxidation NN O
is VBZ O
initiated VBN O
by IN O
the DT O
attack NN O
of IN O
free JJ O
radicals NNS O
on IN O
polyunsaturated JJ O
fatty NN O
acids NNS O
which WDT O
decreases VBZ O
the DT O
membrane NN O
fluidity NN O
and CC O
, , O
if IN O
these DT O
reactions NNS O
propagate VBP O
, , O
lipid JJ O
peroxides NNS O
and CC O
their PRP$ O
degradation NN O
products NNS O
( , O
e LS O
. . O
g LS O
. . O
aldehydes NN O
) -RRB- O
in IN O
turn NN O
could MD O
damage VB O
proteins NNS O
( , O
Gutteridge NNP O
and CC O
Halliwell NNP O
, , O
1990 CD O
) -RRB- O
. . O

This DT O
would MD O
dramatically RB O
affect VB O
the DT O
function NN O
of IN O
transmembrane NN O
proteins NNS O
and CC O
membrane NN O
- HYPH O
bound VBN O
lipoproteins NNS O
involved VBN O
in IN O
the DT O
maintenance NN O
of IN O
membrane NN O
potential NN O
and CC O
solute JJ O
transport NN O
, , O
decreasing VBG O
cell NN O
survivability NN O
. . O

In IN O
contrast NN O
to IN O
most JJS O
bacteria NNS O
, , O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
membranes NNS O
contained VBD O
significant JJ O
levels NNS O
of IN O
unsaturated JJ O
fatty NN O
acids NNS O
, , O
such JJ O
as IN O
linoleic JJ O
acid NN O
and CC O
linolenic JJ O
acid NN O
, , O
which WDT O
were VBD O
derived VBN O
from IN O
the DT O
growth NN O
media NN O
( , O
Table NNP O
1 CD O
) -RRB- O
. . O

Thus RB O
, , O
it PRP O
seemed VBD O
possible JJ O
that IN O
lipids NNS O
and CC O
/ SYM O
or CC O
proteins NNS O
rather RB O
than IN O
DNA NNP O
are VBP O
the DT O
primary JJ O
targets NNS O
of IN O
ROS NNP O
in IN O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
. . O

When WRB O
Borrelia NNP O
cells NNS O
are VBP O
treated VBN O
with IN O
oxidants NNS O
, , O
the DT O
levels NNS O
of IN O
linoleic JJ O
acid NN O
decreased VBD O
while IN O
other JJ O
fatty NN O
acids NNS O
remain VBP O
unaffected JJ O
( : O
Table NNP O
2 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
HPLC NNP O
- HYPH O
based VBN O
assays NNS O
demonstrated VBD O
that IN O
, , O
as IN O
linoleic JJ O
acid NN O
concentrations NNS O
decrease VBP O
, , O
MDA NNP O
( , O
a DT O
toxic JJ O
lipid NN O
peroxide NN O
intermediate NN O
) , O
increased VBN O
( : O
Fig NNP O
. . O
3 CD O
) -RRB- O
. . O

When WRB O
these DT O
cells NNS O
were VBD O
examined VBN O
by IN O
electron NN O
microscopy NN O
, , O
damage NN O
to IN O
the DT O
membranes NNS O
( -LRB- O
membrane NN O
' '' O
blebs NNS O
' '' O
) -RRB- O
was VBD O
observed VBN O
( : O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

These DT O
data NNS O
indicated VBD O
that IN O
unlike IN O
most JJS O
other JJ O
bacteria NNS O
, , O
Borrelia NNP O
membranes NNS O
were VBD O
damaged VBN O
by IN O
oxygen NN O
radicals NNS O
. . O

As IN O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
may MD O
be VB O
exposed VBN O
to IN O
potentially RB O
harmful JJ O
oxygen NN O
species NNS O
at IN O
different JJ O
stages NNS O
of IN O
the DT O
infective JJ O
cycle NN O
, , O
the DT O
ability NN O
to TO O
protect VB O
its PRP$ O
membrane NN O
lipids NNS O
from IN O
ROS NNP O
should MD O
be VB O
required VBN O
for IN O
survival NN O
in IN O
the DT O
different JJ O
host NN O
environments NNS O
. . O

In IN O
eukaryotic JJ O
cells NNS O
, , O
where WRB O
lipid NN O
peroxidation NN O
is VBZ O
a DT O
major JJ O
consequence NN O
of IN O
oxidative JJ O
attack NN O
, , O
proteins NNS O
which WDT O
protect VBP O
membranes NNS O
have VBP O
been VBN O
well RB O
studied VBN O
. . O

For IN O
example NN O
, , O
phospholipid NN O
hydroperoxide NN O
glutathione NN O
peroxidase NN O
, , O
a DT O
member NN O
of IN O
the DT O
glutathione NN O
peroxidase NN O
family NN O
, , O
has VBZ O
been VBN O
identified VBN O
in IN O
a DT O
variety NN O
of IN O
higher JJR O
organisms NNS O
. . O

These DT O
enzymes NNS O
are VBP O
capable JJ O
of IN O
reducing VBG O
an DT O
assortment NN O
of IN O
hydroperoxy NN O
lipids NNS O
, , O
including VBG O
oxidized JJ O
phospholipids NNS O
and CC O
cholesterol NN O
esters NNS O
( , O
Ursini NNP O
and CC O
Bindoli NNP O
, , O
1987 CD O
) -RRB- O
, , O
and CC O
protect VB O
complex JJ O
membranes NNS O
from IN O
oxidative JJ O
damage NN O
. . O

Much RB O
less RBR O
is VBZ O
known VBN O
about IN O
the DT O
enzyme NN O
( , O
s NN O
) -RRB- O
responsible JJ O
for IN O
protecting VBG O
unsaturated JJ O
lipids NNS O
from IN O
ROS NNP O
in IN O
prokaryotes NNS O
. . O

In IN O
H NN B-Species
. . I-Species
pylori NN I-Species
, , O
lipid NN O
hydroperoxide NN O
levels NNS O
in IN O
ahpC NN O
mutants NNS O
are VBP O
approximately RB O
three CD O
times NNS O
higher JJR O
than IN O
in IN O
wild JJ O
- HYPH O
type NN O
cells NNS O
, , O
suggesting VBG O
a DT O
role NN O
for IN O
AhpC NNP O
in IN O
reducing VBG O
organic JJ O
peroxides NNS O
( , O
Wang NNP O
et FW O
al NNP O
. . O
, , O
2006a CD O
, , O
b NN O
) -RRB- O
. . O

In IN O
addition NN O
, , O
purified JJ O
AhpC NNP O
has VBZ O
been VBN O
shown VBN O
to TO O
reduce VB O
linoleic JJ O
acid NN O
hydroperoxide NN O
in IN O
vitro FW O
( , O
Baker NNP O
et FW O
al NNP O
. . O
, , O
2001 CD O
) -RRB- O
. . O

Because IN O
these DT O
antioxidant JJ O
enzymes NNS O
promote VBP O
the DT O
in IN O
vivo NN O
survival NN O
of IN O
cells NNS O
when WRB O
challenged VBN O
with IN O
ROS NNP O
, , O
enzymes NNS O
for IN O
the DT O
reduction NN O
of IN O
lipid JJ O
peroxides NNS O
in IN O
Borrelia NNP O
need VBP O
to TO O
be VB O
identified VBN O
. . O

Interestingly RB O
, , O
Borrelia NNP O
cells NNS O
grown VBN O
aerobically RB O
showed VBD O
signs NNS O
of IN O
membrane NN O
damage NN O
similar JJ O
to IN O
those DT O
observed VBN O
in IN O
cells NNS O
exposed VBN O
to IN O
various JJ O
oxidants NNS O
. . O

The DT O
amount NN O
of IN O
MDA NNP O
in IN O
untreated JJ O
aerobically RB O
grown VBN O
cells NNS O
was VBD O
equivalent JJ O
to IN O
that DT O
observed VBN O
in IN O
treated VBN O
cells NNS O
( , O
Fig NNP O
. . O
3 CD O
) -RRB- O
. . O

Also RB O
, , O
EM NNP O
indicated VBD O
that IN O
cells NNS O
grown VBN O
microaerobically RB O
or CC O
aerobically RB O
had VBD O
significantly RB O
more JJR O
membrane NN O
damage NN O
than IN O
cells NNS O
grown VBN O
anaerobically RB O
( : O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

This DT O
indicated VBD O
that IN O
Borrelia NNP O
membranes NNS O
can MD O
be VB O
damaged VBN O
simply RB O
by IN O
exposure NN O
to IN O
physiologically RB O
relevant JJ O
concentrations NNS O
of IN O
dissolved VBN O
oxygen NN O
. . O

In IN O
exponentially RB O
growing VBG O
E NNP B-Species
. . I-Species
coli NN I-Species
, , O
Imlay NNP O
and CC O
Fridovich NNP O
( : O
1991 CD O
) -RRB- O
have VBP O
shown VBN O
that IN O
both CC O
O2 NNP O
- HYPH O
and CC O
H2O2 NNP O
are VBP O
generated VBN O
by IN O
the DT O
autoxidation NN O
of IN O
components NNS O
of IN O
the DT O
respiratory JJ O
chain NN O
during IN O
oxygen NN O
metabolism NN O
. . O

In IN O
contrast NN O
, , O
B NNP B-Species
. . I-Species
burgdorferi NNP I-Species
is VBZ O
very RB O
metabolically RB O
limited JJ O
and CC O
has VBZ O
no DT O
enzymes NNS O
for IN O
the DT O
TCA NNP O
cycle NN O
or CC O
respiration NN O
. . O

Therefore RB O
, , O
it PRP O
seems VBZ O
more RBR O
likely JJ O
that IN O
sources NNS O
of IN O
ROS NNP O
are VBP O
exogenous JJ O
( , O
e LS O
. . O
g LS O
. . O
innate JJ O
immune JJ O
response NN O
in IN O
the DT O
mammalian JJ O
host NN O
) -RRB- O
rather RB O
than IN O
endogenous JJ O
. . O

In IN O
addition NN O
, , O
the DT O
current JJ O
practice NN O
of IN O
growing VBG O
B NN B-Species
. . I-Species
burgdorferi NNS I-Species
under IN O
atmospheric JJ O
oxygen NN O
could MD O
itself PRP O
be VB O
unintentionally RB O
compromising VBG O
cell NN O
integrity NN O
during IN O
in FW O
vitro FW O
manipulations NNS O
. . O

Analyses NNS O
of IN O
the DT O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
genome NN O
indicates VBZ O
that IN O
only RB O
a DT O
few JJ O
genes NNS O
encoding VBG O
putative JJ O
oxidative JJ O
stress NN O
/ SYM O
intracellular JJ O
redox NN O
proteins NNS O
( , O
SodA NNP O
, , O
NapA NNP O
, , O
BosR NNP O
, , O
CoADR NNP O
, , O
Trx NNP O
and CC O
TrxR NNP O
) -RRB- O
( , O
Fraser NNP O
et FW O
al NNP O
. , O
, , O
1997 CD O
) -RRB- O
are VBP O
present JJ O
, , O
compared VBN O
with IN O
other JJ O
bacterial JJ O
pathogens NNS O
, , O
including VBG O
other JJ O
pathogenic JJ O
spirochetes NNS O
( , O
e LS O
. . O
g LS O
. . O
Treponema NNP O
, , O
Leptospira NNP O
) -RRB- O
. . O

Despite IN O
this DT O
apparent JJ O
' `` O
deficiency NN O
' '' O
in IN O
the DT O
number NN O
of IN O
ROS NNP O
- HYPH O
protective JJ O
enzymes NNS O
, , O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
cells NNS O
appear VBP O
to TO O
be VB O
able JJ O
to TO O
cope VB O
with IN O
physiologically RB O
relevant JJ O
levels NNS O
of IN O
ROS NNP O
. . O

There EX O
are VBP O
several JJ O
factors NNS O
that WDT O
would MD O
contribute VB O
to IN O
this DT O
phenomenon NN O
: : O
( : O
i PRP O
) -RRB- O
as IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
does VBZ O
not RB O
harbour VB O
the DT O
genes NNS O
encoding VBG O
respiratory JJ O
enzymes NNS O
nor CC O
metabolize VB O
oxygen NN O
, , O
it PRP O
seems VBZ O
unlikely JJ O
that IN O
significant JJ O
levels NNS O
of IN O
ROS NNP O
are VBP O
generated VBN O
via IN O
the DT O
incomplete JJ O
reduction NN O
of IN O
O2 NN O
during IN O
cellular JJ O
metabolism NN O
. . O

This DT O
would MD O
suggest VB O
that IN O
potential JJ O
ROS NNP O
challenges NNS O
to IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
would MD O
come VB O
almost RB O
completely RB O
from IN O
extracellular JJ O
sources NNS O
with IN O
little JJ O
contribution NN O
from IN O
intracellularly RB O
generated VBN O
ROS NNP O
; : O
( : O
ii FW O
) -RRB- O
owing VBG O
to IN O
a DT O
lack NN O
of IN O
understanding NN O
of IN O
the DT O
physiological JJ O
conditions NNS O
in IN O
vector NN O
and CC O
host NN O
tissues NNS O
infected VBN O
with IN O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
, , O
it PRP O
is VBZ O
difficult JJ O
to TO O
assess VB O
the DT O
levels NNS O
and CC O
/ SYM O
or CC O
sites NNS O
of IN O
the DT O
potential JJ O
ROS NNP O
challenge NN O
during IN O
the DT O
infective JJ O
cycle NN O
and CC O
( , O
iii NN O
) -RRB- O
most RBS O
importantly RB O
, , O
analyses NNS O
of IN O
the DT O
potential JJ O
targets NNS O
for IN O
ROS NNP O
in IN O
B NNP B-Species
. . I-Species
burgdorferi NNS I-Species
strongly RB O
suggested VBD O
that IN O
the DT O
major JJ O
targets NNS O
of IN O
oxidative JJ O
damage NN O
are VBP O
different JJ O
and CC O
perhaps RB O
less RBR O
extensive JJ O
in IN O
this DT O
bacterium NN O
than IN O
in IN O
other JJ O
bacterial JJ O
pathogens NNS O
( : O
e LS O
. . O
g LS O
. . O
E NN B-Species
. . I-Species
coli NN I-Species
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
this DT O
suggests VBZ O
that IN O
B NNP B-Species
. . I-Species
burgdorferi NN I-Species
would MD O
be VB O
innately RB O
more RBR O
resistant JJ O
to IN O
ROS NNP O
and CC O
require VB O
a DT O
less RBR O
extensive JJ O
repertoire NN O
of IN O
enzymes NNS O
to TO O
protect VB O
the DT O
cells NNS O
from IN O
oxidative JJ O
damage NN O
. . O

Experimental JJ O
procedures NNS O

Strains NNS O
, , O
growth NN O
conditions NNS O
and CC O
reagents NNS O

Borrelia NNP B-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
and CC O
strain NN O
B314 CD O
( -LRB- O
Sadziene NNP O
et NN O
al NNP O
. , O
, , O
1993 CD O
) -RRB- O
were VBD O
grown VBN O
in IN O
modified JJ O
BSK NNP O
- HYPH O
II NNP O
( , O
Barbour NNP O
, , O
1984 CD O
) -RRB- O
medium NN O
at IN O
34 CD O
degrees NNS O
C NN O
under IN O
an DT O
atmosphere NN O
of IN O
0 CD O
- SYM O
20 CD O
% NN O
O2 NN O
with IN O
5 CD O
% NN O
CO2 NN O
and CC O
the DT O
balance NN O
N2 CD O
. . O

Cells NNS O
density NN O
was VBD O
determined VBN O
using VBG O
a DT O
dark JJ O
- HYPH O
field NN O
microscope NN O
. . O

All DT O
reagents NNS O
were VBD O
purchased VBN O
from IN O
Sigma NNP O
Chemicals NNP O
, , O
St NNP O
. . O

Louis NNP O
, , O
MO NNP O
unless IN O
stated VBN O
otherwise RB O
. . O

E NN B-Species
. . I-Species
coli NN I-Species
strain NN O
Top10 NNP O
, , O
strain NN O
TA4315 CD O
( , O
ahpCF NNP O
) -RRB- O
( , O
Storz NNP O
et NN O
al NNP O
. . O
, , O
1989 CD O
) -RRB- O
and CC O
CM1319 NNP O
( -LRB- O
mutM NN O
) -RRB- O
( , O
Bridges NNS O
et FW O
al NNP O
. . O
, , O
1996 CD O
) -RRB- O
were VBD O
grown VBN O
in IN O
Luria NNP O
- HYPH O
Bertani NNP O
( HYPH O
LB NNP O
) -RRB- O
at IN O
37 CD O
degrees NNS O
C NN O
with IN O
shaking NN O
. . O

Per IN O
cent NN O
survivability NN O
assays NNS O

Borrelia NNP B-Species
burgdorferi NN I-Species
strain NN O
B31A3 NNP O
was VBD O
grown VBN O
to IN O
a DT O
cell NN O
density NN O
of IN O
5 CD O
x SYM O
107 CD O
cells NNS O
ml CD O
- HYPH O
1 CD O
in IN O
BSK NNP O
II NNP O
under IN O
microaerobic JJ O
( , O
3 CD O
% NN O
O2 NN O
) -RRB- O
conditions NNS O
, , O
the DT O
culture NN O
split NN O
and CC O
the DT O
cells NNS O
treated VBN O
with IN O
varying VBG O
concentrations NNS O
of IN O
oxidants NNS O
( , O
0 CD O
- SYM O
50 CD O
mM NN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
or CC O
H2O2 NN O
) -RRB- O
at IN O
34 CD O
degrees NNS O
C NN O
for IN O
4 CD O
h NN O
. . O

After IN O
the DT O
incubation NN O
, , O
cells NNS O
were VBD O
diluted VBN O
in IN O
fresh JJ O
BSK NNP O
II NNP O
, , O
plated VBN O
on IN O
BSK NNP O
plates NNS O
and CC O
incubated VBN O
7 CD O
- SYM O
14 CD O
days NNS O
at IN O
34 CD O
degrees NNS O
C NN O
. . O

Per IN O
cent NN O
survivability NN O
was VBD O
calculated VBN O
as IN O
the DT O
number NN O
of IN O
colonies NNS O
on IN O
the DT O
treated VBN O
plates NNS O
versus IN O
the DT O
number NN O
of IN O
colonies NNS O
on IN O
the DT O
untreated JJ O
plates NNS O
. . O

Determination NN O
of IN O
the DT O
spontaneous JJ O
mutation NN O
rate NN O

To TO O
determine VB O
spontaneous JJ O
resistance NN O
to IN O
coumermycin NN O
A1 NN O
, , O
B NNP B-Species
. , I-Species
burgdorferi NN I-Species
B31A3 NN O
cells NNS O
were VBD O
grown VBN O
under IN O
microaerobic JJ O
conditions NNS O
to IN O
a DT O
cell NN O
density NN O
of IN O
5 CD O
x SYM O
107 CD O
cells NNS O
ml NN O
- HYPH O
1 CD O
and CC O
treated VBN O
with IN O
5 CD O
mM NN O
H2O2 NN O
for IN O
1 CD O
h NNS O
at IN O
34 CD O
degrees NNS O
C NN O
. . O

The DT O
cells NNS O
were VBD O
plated VBN O
on IN O
BSK NNP O
plates NNS O
containing VBG O
0 CD O
or CC O
250 CD O
ng CD O
ml NN O
- HYPH O
1 CD O
coumermycin NN O
A1 NN O
and CC O
incubated VBN O
7 CD O
- SYM O
14 CD O
days NNS O
at IN O
34 CD O
degrees NNS O
C NN O
. . O

The DT O
resistance NN O
frequency NN O
was VBD O
calculated VBN O
as IN O
the DT O
number NN O
of IN O
colonies NNS O
that WDT O
are VBP O
CouR NNP O
per IN O
total JJ O
number NN O
of IN O
cells NNS O
plated VBN O
. . O

Measurement NN O
of IN O
DNA NN O
base NN O
lesions NNS O

Borrelia NNP B-Species
burgdorferi NNP I-Species
B31A3 NNP O
cells NNS O
were VBD O
grown VBN O
in IN O
BSK NNP O
- HYPH O
II NNP O
under IN O
microaerobic JJ O
conditions NNS O
to IN O
a DT O
cell NN O
density NN O
of IN O
5 CD O
x SYM O
107 CD O
cells NNS O
ml NN O
- HYPH O
1 CD O
, , O
treated VBN O
with IN O
various JJ O
oxidants NNS O
( , O
1 CD O
or CC O
10 CD O
mM NN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
, , O
1 CD O
or CC O
10 CD O
mM NN O
H2O2 NN O
, , O
10 CD O
mM NN O
paraquat NN O
or CC O
lipoxidase NN O
) -RRB- O
for IN O
4 CD O
h NN O
and CC O
total JJ O
DNA NNP O
was VBD O
isolated VBN O
using VBG O
Wizard NNP O
Genomic NNP O
DNA NNP O
Purification NNP O
Kit NNP O
( : O
Promega NNP O
Corp NNP O
. . O
, , O
Madison NNP O
, , O
WI NNP O
) -RRB- O
. . O

The DT O
number NN O
of IN O
base NN O
lesions NNS O
was VBD O
determined VBN O
using VBG O
the DT O
DNA NNP O
Damage NNP O
Quantification NNP O
Colorimetric NNP O
Assay NNP O
kit NN O
( : O
Oxford NNP O
Biomedical NNP O
Research NNP O
, , O
Oxford NNP O
, , O
MI NNP O
) -RRB- O
following VBG O
the DT O
manufacturer NN O
' POS O
s POS O
protocol NN O
. . O

Briefly RB O
, , O
500 CD O
ng NN O
of IN O
DNA NNP O
was VBD O
mixed VBN O
with IN O
an DT O
equal JJ O
volume NN O
of IN O
10 CD O
mM NN O
biotinylated JJ O
aldehyde NN O
reactive JJ O
probe NN O
( , O
ARP NN O
) -RRB- O
reagent NN O
and CC O
incubated VBN O
for IN O
1 CD O
h NN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

The DT O
DNA NNP O
- HYPH O
ARP NNP O
product NN O
was VBD O
ethanol NN O
- HYPH O
precipitated VBN O
using VBG O
glycogen NN O
as IN O
a DT O
carrier NN O
, , O
washed VBN O
three CD O
times NNS O
with IN O
70 CD O
% NN O
ethanol NN O
and CC O
resuspended VBN O
in IN O
Tris NNP O
- HYPH O
EDTA NNP O
to TO O
give VB O
a DT O
final JJ O
concentration NN O
of IN O
0 CD O
. . O
5 CD O
micro NN O
g NN O
ml NN O
- HYPH O
1 CD O
. . O

The DT O
DNA NNP O
- HYPH O
ARP NNP O
product NN O
was VBD O
allowed VBN O
to TO O
bind VB O
to IN O
the DT O
wells NNS O
of IN O
96 CD O
- HYPH O
well NN O
microplate NN O
overnight RB O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

After IN O
the DT O
binding NN O
, , O
the DT O
wells NNS O
were VBD O
washed VBN O
four CD O
times NNS O
with IN O
TPBS NNP O
( , O
137 CD O
mM NN O
NaCl NNP O
, , O
2 CD O
. . O
7 CD O
mM NN O
KCl NNP O
, , O
10 CD O
mM NN O
Na3HPO4 NN O
, , O
2 CD O
mM NN O
KH2PO4 NN O
, , O
0 CD O
. . O
5 CD O
% NN O
Tween NNP O
20 CD O
, , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
. . O

The DT O
HRP NNP O
- HYPH O
streptavidin NNP O
conjugate NN O
was VBD O
diluted VBN O
to IN O
0 CD O
. . O
5 CD O
micro NN O
g NN O
ml NN O
- HYPH O
1 CD O
in IN O
Assay NNP O
Buffer NNP O
( : O
0 CD O
. . O
15 CD O
M NN O
NaCl NNP O
, , O
10 CD O
mM NN O
NasHPO4 CD O
, , O
1 CD O
. . O
5 CD O
mM NN O
KH2PO4 CD O
, , O
2 CD O
. . O
5 CD O
mM NN O
KCl NN O
, , O
5 CD O
mg NN O
ml CD O
- HYPH O
1 CD O
BSA NN O
, , O
0 CD O
. . O
1 CD O
% NN O
Tween NN O
, , O
pH NN O
7 CD O
. . O
5 CD O
) -RRB- O
, , O
100 CD O
micro NN O
l NN O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
the DT O
plate NN O
incubated VBN O
at IN O
100 CD O
r NN O
. . O
p NN O
. . O
m UH O
. . O
for IN O
1 CD O
h NNS O
at IN O
room NN O
temperature NN O
( , O
RT NN O
) -RRB- O
. . O

After IN O
incubation NN O
, , O
the DT O
wells NNS O
were VBD O
washed VBN O
four CD O
times NNS O
with IN O
TPBS NNP O
, , O
100 CD O
micro NN O
l NN O
of IN O
substrate NN O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
incubated VBN O
for IN O
1 CD O
h NN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

The DT O
reaction NN O
was VBD O
then RB O
quenched VBN O
with IN O
100 CD O
micro NN O
l NN O
of IN O
1 CD O
M NN O
sulphuric NN O
acid NN O
and CC O
the DT O
reaction NN O
was VBD O
monitored VBN O
at IN O
450 CD O
nm NN O
. . O

The DT O
number NN O
of IN O
aldehyde NN O
reactive JJ O
probe NN O
( , O
DNA NN O
base NN O
lesions NNS O
) -RRB- O
per IN O
105 CD O
bp IN O
DNA NNP O
was VBD O
determined VBN O
using VBG O
a DT O
standard JJ O
curve NN O
. . O

As IN O
a DT O
control NN O
, , O
E NN B-Species
. . I-Species
coli NN I-Species
TA4315 CD O
cells NNS O
were VBD O
grown VBN O
in IN O
minimal JJ O
media NNS O
to IN O
OD600 NN O
of IN O
0 CD O
. . O
4 CD O
, , O
treated VBN O
with IN O
0 CD O
or CC O
100 CD O
micro NN O
M NN O
H2O2 NN O
for IN O
30 CD O
min NN O
and CC O
DNA NN O
isolated VBN O
. . O

The DT O
number NN O
of IN O
base NN O
lesions NNS O
was VBD O
determined VBN O
as IN O
described VBN O
above RB O
. . O

B NN B-Species
. . I-Species
burgdorferi NN I-Species
strain NN O
B314 CD O
cells NNS O
were VBD O
grown VBN O
under IN O
microaerobic JJ O
conditions NNS O
and CC O
DNA NN O
isolated VBN O
. . O

The DT O
number NN O
of IN O
DNA NNP O
lesions NNS O
was VBD O
determined VBN O
as IN O
described VBN O
. . O

To TO O
determine VB O
the DT O
amount NN O
of IN O
8 CD O
- HYPH O
oxoguanine NN O
in IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
DNA NN O
, , O
cells NNS O
were VBD O
grown VBN O
and CC O
treated VBN O
as IN O
described VBN O
above RB O
and CC O
DNA NN O
isolated VBN O
. . O

The DT O
DNA NNP O
was VBD O
converted VBN O
to IN O
single JJ O
- HYPH O
stranded VBN O
DNA NN O
by IN O
boiling VBG O
the DT O
sample NN O
for IN O
5 CD O
min NN O
followed VBN O
by IN O
rapid JJ O
chill NN O
on IN O
ice NN O
. . O

The DT O
DNA NNP O
was VBD O
then RB O
digested VBN O
with IN O
nuclease JJ O
P1 NN O
for IN O
2 CD O
h NN O
and CC O
then RB O
treated VBN O
with IN O
alkaline NN O
phosphatase NN O
for IN O
1 CD O
h NNS O
following VBG O
manufacturer NN O
' POS O
s NNS O
protocols NNS O
. . O

The DT O
resultant JJ O
mixture NN O
was VBD O
then RB O
centrifuged VBN O
for IN O
5 CD O
min NN O
at IN O
6000 CD O
g NN O
and CC O
the DT O
supernatant NN O
used VBN O
for IN O
the DT O
8 CD O
- HYPH O
oxoguanine NN O
ELISA NNP O
assay NN O
( : O
Oxford NNP O
Biomedical NNP O
Research NNP O
, , O
Oxford NNP O
, , O
MI NNP O
) -RRB- O
. . O

As IN O
a DT O
control NN O
, , O
E NNP B-Species
. . I-Species
coli NNP I-Species
CM1319 NNP O
( -LRB- O
mutM NN O
) -RRB- O
cells NNS O
were VBD O
grown VBN O
in IN O
LB NNP O
to IN O
OD600 NNP O
of IN O
0 CD O
. . O
4 CD O
, , O
treated VBN O
with IN O
0 CD O
or CC O
100 CD O
micro NN O
M NN O
H2O2 NN O
for IN O
1 CD O
h NNS O
and CC O
DNA NN O
isolated VBN O
. . O

The DT O
concentration NN O
of IN O
8 CD O
- HYPH O
oxoguanine NN O
was VBD O
determined VBN O
as IN O
above RB O
. . O

Lipid NNP O
analyses NNS O

To TO O
determine VB O
fatty JJ O
acid NN O
content NN O
in IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
total JJ O
membranes NNS O
, , O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
was VBD O
grown VBN O
under IN O
anaerobic JJ O
conditions NNS O
to IN O
a DT O
cell NN O
density NN O
of IN O
5 CD O
x SYM O
107 CD O
cells NNS O
ml CD O
- HYPH O
1 CD O
, , O
harvested VBN O
by IN O
centrifugation NN O
( , O
5000 CD O
g NN O
, , O
15 CD O
min NN O
, , O
4 CD O
degrees NNS O
C NN O
) -RRB- O
and CC O
washed VBN O
two CD O
times NNS O
with IN O
HN NNP O
( , O
20 CD O
mM NN O
NaCl NNP O
, , O
50 CD O
mM NN O
Hepes NNS O
, , O
pH NN O
7 CD O
. . O
6 CD O
) -RRB- O
buffer NN O
. . O

Cell NN O
pellets NNS O
were VBD O
analysed VBN O
for IN O
fatty JJ O
acid NN O
composition NN O
by IN O
fatty JJ O
acid NN O
methyl NN O
ester NN O
( , O
FAME NNP O
) -RRB- O
gas NN O
chromatography NN O
( : O
Lipid NNP O
Technologies NNPS O
, , O
Austin NNP O
, , O
MN NNP O
) -RRB- O
and CC O
results NNS O
are VBP O
reported VBN O
as IN O
percentage NN O
of IN O
total JJ O
fatty JJ O
acid NN O
content NN O
. . O

To TO O
determine VB O
the DT O
effects NNS O
of IN O
oxidants NNS O
on IN O
fatty JJ O
acid NN O
composition NN O
, , O
a DT O
1 CD O
. . O
5 CD O
l NN O
culture NN O
of IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
was VBD O
grown VBN O
under IN O
microaerobic JJ O
conditions NNS O
to IN O
a DT O
cell NN O
density NN O
of IN O
5 CD O
x SYM O
107 CD O
cells NNS O
ml CD O
- HYPH O
1 CD O
. . O

The DT O
culture NN O
was VBD O
split VBN O
into IN O
500 CD O
ml NNS O
aliquots NNS O
, , O
the DT O
first JJ O
was VBD O
treated VBN O
with IN O
1 CD O
mM NN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
, , O
the DT O
second JJ O
with IN O
0 CD O
. . O
25 CD O
mg NN O
of IN O
lipoxidase NN O
( : O
17 CD O
700 CD O
units NNS O
) -RRB- O
and CC O
the DT O
third JJ O
was VBD O
untreated JJ O
. . O

All DT O
cultures NNS O
were VBD O
incubated VBN O
for IN O
12 CD O
h NNS O
at IN O
34 CD O
degrees NNS O
C NN O
. . O

Cells NNS O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
( , O
5000 CD O
g NN O
, , O
4 CD O
degrees NNS O
C NN O
, , O
15 CD O
min NN O
) -RRB- O
and CC O
washed VBD O
three CD O
times NNS O
with IN O
HN NNP O
buffer NN O
. . O

The DT O
fatty NN O
acids NNS O
present JJ O
in IN O
the DT O
cell NN O
pellets NNS O
were VBD O
analysed VBN O
by IN O
FAME NNP O
gas NN O
chromatography NN O
( : O
Industrial NNP O
Laboratory NNP O
, , O
Wheat NNP O
Ridge NNP O
, , O
CO NNP O
) -RRB- O
. . O

Fatty JJ O
acids NNS O
were VBD O
reported VBN O
as IN O
percentage NN O
of IN O
total JJ O
cell NN O
mass NN O
. . O

Measurement NN O
of IN O
MDA NNP O

Borrelia NNP B-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
was VBD O
grown VBN O
aerobically RB O
, , O
microaerobically RB O
and CC O
anaerobically RB O
as IN O
described VBN O
above IN O
to IN O
a DT O
cell NN O
density NN O
of IN O
5 CD O
x SYM O
107 CD O
cells NNS O
ml NNS O
- HYPH O
1 CD O
. . O

The DT O
microaerobic JJ O
culture NN O
was VBD O
split VBN O
and CC O
treated VBN O
with IN O
either CC O
5 CD O
mM NN O
AAPH NN O
[ -LRB- O
2 CD O
, , O
2 CD O
' '' O
- HYPH O
azobis NN O
( , O
2 CD O
- HYPH O
methylpropionamidine NN O
) -RRB- O
dihydrochloride NN O
] -RRB- O
or CC O
250 CD O
mg NN O
of IN O
lipoxidase NN O
for IN O
4 CD O
h NNS O
at IN O
34 CD O
degrees NNS O
C NN O
. . O

To TO O
measure VB O
the DT O
amount NN O
of IN O
MDA NNP O
, , O
the DT O
cells NNS O
were VBD O
derivatized VBN O
with IN O
thiobarbituric JJ O
acid NN O
and CC O
analysed VBN O
by IN O
HPLC NNP O
as IN O
described VBN O
by IN O
Seljeskog NNP O
et FW O
al NNP O
. . O

( : O
2006 CD O
) -RRB- O
. . O

After IN O
the DT O
incubation NN O
, , O
all DT O
cells NNS O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
( : O
1000 CD O
g NN O
, , O
5 CD O
min NN O
, , O
4 CD O
degrees NNS O
C NN O
) -RRB- O
and CC O
washed VBN O
three CD O
times NNS O
with IN O
HN NNP O
buffer NN O
. . O

Each DT O
sample NN O
was VBD O
resuspended VBN O
in IN O
50 CD O
micro NN O
l NN O
of IN O
HN NNP O
, , O
mixed VBN O
with IN O
150 CD O
micro NN O
l NN O
of IN O
0 CD O
. . O
1 CD O
N NN O
perchloric NN O
acid NN O
, , O
150 CD O
micro NN O
l NN O
of IN O
40 CD O
mM NN O
thiobarbituric JJ O
acid NN O
and CC O
35 CD O
micro NN O
l NN O
of IN O
20 CD O
% NN O
SDS NN O
, , O
vortexed VBN O
and CC O
heated VBN O
at IN O
97 CD O
degrees NNS O
C NN O
for IN O
60 CD O
min NN O
. . O

After IN O
cooling VBG O
at IN O
- HYPH O
20 CD O
degrees NNS O
C NN O
for IN O
20 CD O
min NN O
, , O
300 CD O
micro NN O
l NN O
of IN O
methanol NN O
and CC O
100 CD O
micro NN O
l NN O
of IN O
20 CD O
% NN O
trichloroacetic JJ O
acid NN O
was VBD O
added VBN O
and CC O
the DT O
samples NNS O
were VBD O
mixed VBN O
vigorously RB O
and CC O
centrifuged VBN O
( : O
13 CD O
0 CD O
g NN O
, , O
6 CD O
min NN O
) -RRB- O
. . O

The DT O
samples NNS O
( , O
10 CD O
micro NN O
l NN O
) -RRB- O
were VBD O
then RB O
analysed VBN O
with IN O
an DT O
Agilent NNP O
Technologies NNP O
1200 CD O
series NN O
HPLC NNP O
system NN O
using VBG O
a DT O
C18 CD O
4 CD O
. . O
6 CD O
x SYM O
150 CD O
mm NN O
column NN O
with IN O
mobile JJ O
phase NN O
72 CD O
: : O
17 CD O
: : O
11 CD O
( SYM O
50 CD O
mM NN O
KPO4 NN O
, , O
pH NN O
6 CD O
. . O
8 CD O
: : O
methanol NN O
: : O
acetonitrile NN O
) -RRB- O
. . O

Absorbance NN O
was VBD O
monitored VBN O
at IN O
532 CD O
nm NN O
. . O

Pure JJ O
MDA NNP O
standards NNS O
( : O
0 CD O
- SYM O
10 CD O
micro NN O
M NNP O
) -RRB- O
were VBD O
prepared VBN O
in IN O
methanol NN O
for IN O
comparison NN O
. . O

As IN O
a DT O
negative JJ O
control NN O
, , O
E NNP B-Species
. . I-Species
coli NN I-Species
Top10 CD O
cells NNS O
were VBD O
grown VBN O
to IN O
OD600 CD O
of IN O
0 CD O
. . O
4 CD O
, , O
treated VBN O
with IN O
0 CD O
or CC O
5 CD O
mM NN O
AAPH NN O
for IN O
30 CD O
min NN O
and CC O
MDA NNP O
measured VBN O
as IN O
above RB O
. . O

As IN O
a DT O
positive JJ O
control NN O
, , O
mouse NN B-Species
myeloma NN O
SP2 NNP O
/ SYM O
O NN O
cells NNS O
were VBD O
cultured VBN O
with IN O
HYQ NNP O
- HYPH O
CCM1 NNP O
( -LRB- O
HyClone NN O
) -RRB- O
medium NN O
at IN O
37 CD O
degrees NNS O
C NN O
in IN O
a DT O
humidified VBN O
5 CD O
% NN O
CO2 NN O
atmosphere NN O
, , O
treated VBN O
with IN O
1 CD O
mM NN O
AAPH NN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
4 CD O
h NNS O
( , O
Chotimarkorn NNP O
et NN O
al NNP O
. , O
, , O
2005 CD O
) -RRB- O
and CC O
MDA NNP O
measured VBN O
as IN O
above RB O
. . O

Identification NN O
of IN O
lipid JJ O
damage NN O
using VBG O
Diphenyl NNP O
- HYPH O
1 CD O
- HYPH O
pyrenylphosphine NN O
fluorescent NN O
stain NN O

Borrelia NNP B-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
cells NNS O
were VBD O
grown VBN O
microaerobically RB O
as IN O
described VBN O
above IN O
until IN O
a DT O
cell NN O
density NN O
of IN O
5 CD O
x SYM O
107 CD O
cells NNS O
ml NNS O
- HYPH O
1 CD O
was VBD O
obtained VBN O
. . O

The DT O
culture NN O
was VBD O
divided VBN O
into IN O
two CD O
equal JJ O
aliquots NNS O
and CC O
the DT O
cells NNS O
treated VBN O
with IN O
5 CD O
mM NN O
AAPH NN O
for IN O
4 CD O
h NN O
at IN O
34 CD O
degrees NNS O
C NN O
. . O

After IN O
the DT O
incubation NN O
, , O
all DT O
cells NNS O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
( : O
1000 CD O
g NN O
, , O
5 CD O
min NN O
, , O
4 CD O
degrees NNS O
C NN O
) -RRB- O
and CC O
washed VBN O
three CD O
times NNS O
with IN O
HN NNP O
buffer NN O
. . O

To TO O
visualize VB O
Borrelia NNP O
cells NNS O
, , O
the DT O
cells NNS O
were VBD O
stained VBN O
with IN O
PKH26 NNP O
Red NNP O
Fluorescent NNP O
Cell NNP O
Linker NNP O
Dye NNP O
( : O
Sigma NNP O
Aldrich NNP O
) , O
following VBG O
the DT O
manufacturer NN O
' POS O
s POS O
protocol NN O
. . O

To TO O
visualize VB O
the DT O
lipid JJ O
hydroperoxides NNS O
in IN O
the DT O
cell NN O
membrane NN O
, , O
the DT O
cells NNS O
were VBD O
counterstained VBN O
with IN O
DPPP NNP O
( : O
Cayman NNP O
Chemicals NNPS O
, , O
MI NNP O
) -RRB- O
( , O
Okimoto NNP O
et NN O
al NNP O
. . O
, , O
2000 CD O
) -RRB- O
. . O

Briefly RB O
, , O
after IN O
cells NNS O
were VBD O
stained VBN O
with IN O
the DT O
Red NNP O
Fluorescent NNP O
dye NN O
, , O
2 CD O
ml NNS O
of IN O
rabbit NN B-Species
serum NN O
was VBD O
added VBN O
to TO O
stop VB O
the DT O
reaction NN O
and CC O
the DT O
mixture NN O
incubated VBN O
for IN O
1 CD O
min NN O
at IN O
RT NNP O
. . O

Next JJ O
, , O
4 CD O
ml NNS O
of IN O
HN NNP O
buffer NN O
was VBD O
added VBN O
, , O
the DT O
cells NNS O
harvested VBN O
by IN O
centrifugation NN O
( , O
1000 CD O
g NN O
, , O
10 CD O
min NN O
, , O
RT NNP O
) -RRB- O
and CC O
washed VBD O
three CD O
times NNS O
with IN O
HN NNP O
buffer NN O
. . O

The DT O
cells NNS O
were VBD O
then RB O
resuspended VBN O
in IN O
1 CD O
ml NNS O
of IN O
HN NNP O
buffer NN O
, , O
incubated VBN O
at IN O
34 CD O
degrees NNS O
C NN O
for IN O
5 CD O
min CD O
and CC O
30 CD O
micro NN O
l NN O
of IN O
2 CD O
. . O
5 CD O
mM NN O
DPPP NNP O
was VBD O
added VBN O
. . O

The DT O
incubation NN O
was VBD O
then RB O
continued VBN O
at IN O
34 CD O
degrees NNS O
C NN O
for IN O
5 CD O
min NN O
in IN O
the DT O
dark NN O
. . O

After IN O
incubation NN O
, , O
the DT O
mixture NN O
was VBD O
centrifuged VBN O
( , O
1000 CD O
g NN O
, , O
10 CD O
min NN O
, , O
RT NNP O
) -RRB- O
and CC O
the DT O
cells NNS O
washed VBD O
three CD O
times NNS O
with IN O
HN NNP O
buffer NN O
. . O

The DT O
cells NNS O
were VBD O
then RB O
resuspended VBN O
in IN O
100 CD O
micro JJ O
l NN O
HN NN O
buffer NN O
and CC O
observed VBN O
by IN O
fluorescence NN O
microscopy NN O
with IN O
excitation NN O
wavelengths NNS O
551 CD O
nm NNS O
( SYM O
Red NNP O
Fluorescent NNP O
) -RRB- O
and CC O
351 CD O
nm NN O
( , O
DPPP NNP O
) -RRB- O
, , O
and CC O
emission NN O
wavelengths NNS O
567 CD O
nm NN O
( -LRB- O
Red NNP O
Fluorescent NNP O
) -RRB- O
and CC O
380 CD O
nm NN O
( -LRB- O
DPPP NNP O
) -RRB- O
. . O

As IN O
a DT O
positive JJ O
control NN O
, , O
mouse NN B-Species
myeloma NN O
SP2 NNP O
/ SYM O
O NN O
cells NNS O
were VBD O
cultured VBN O
with IN O
HYQ NNP O
- HYPH O
CCM1 NNP O
( -LRB- O
HyClone NN O
) -RRB- O
medium NN O
at IN O
37 CD O
degrees NNS O
C NN O
in IN O
a DT O
humidified VBN O
5 CD O
% NN O
CO2 NN O
atmosphere NN O
, , O
treated VBN O
with IN O
1 CD O
mM NN O
AAPH NN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
4 CD O
h NNS O
( , O
Chotimarkorn NNP O
et NN O
al NNP O
. . O
, , O
2005 CD O
) -RRB- O
and CC O
stained VBN O
as IN O
described VBN O
above RB O
. . O

As IN O
a DT O
negative JJ O
control NN O
, , O
E NN B-Species
. . I-Species
coli NN I-Species
Top10 CD O
cells NNS O
were VBD O
grown VBN O
to IN O
OD600 CD O
of IN O
0 CD O
. . O
4 CD O
, , O
treated VBN O
with IN O
0 CD O
or CC O
5 CD O
mM NN O
AAPH NN O
for IN O
30 CD O
min NN O
and CC O
stained VBN O
as IN O
described VBN O
above RB O
. . O

Electron NN O
microscopy NN O

Borrelia NNP B-Species
burgdorferi NN I-Species
cells NNS O
were VBD O
grown VBN O
under IN O
microaerobic JJ O
or CC O
anaerobic JJ O
conditions NNS O
to IN O
a DT O
cell NN O
density NN O
of IN O
5 CD O
x SYM O
107 CD O
cells NNS O
ml NNS O
- HYPH O
1 CD O
. . O

The DT O
microaerobic JJ O
cultures NNS O
were VBD O
split VBN O
and CC O
treated VBN O
with IN O
lipoxidase NN O
for IN O
4 CD O
h NN O
at IN O
34 CD O
degrees NNS O
C NN O
. . O

Cells NNS O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
( : O
5000 CD O
g NN O
, , O
10 CD O
min NN O
, , O
4 CD O
degrees NNS O
C NN O
) -RRB- O
, , O
washed VBN O
and CC O
resuspended VBN O
in IN O
HBSS NNP O
( : O
Lonza NNP O
Group NNP O
Ltd NNP O
, , O
Switzerland NNP O
) -RRB- O
. . O

The DT O
cells NNS O
were VBD O
fixed VBN O
with IN O
Karnovsky NNP O
' POS O
s NN O
phosphate NN O
for IN O
5 CD O
min NN O
at IN O
RT NNP O
adsorbed VBN O
to IN O
Formvar NNP O
/ SYM O
carbon NN O
- HYPH O
coated VBN O
grids NNS O
( , O
Ted NNP O
Pella NNP O
, , O
Redding NNP O
, , O
CA NNP O
) -RRB- O
for IN O
5 CD O
min NN O
and CC O
washed VBD O
three CD O
times NNS O
in IN O
H2O NNP O
. . O

The DT O
grids NNS O
were VBD O
stained VBN O
with IN O
1 CD O
% NN O
ammonium NN O
molybdate NN O
and CC O
allowed VBN O
to TO O
air NN O
- HYPH O
dry NN O
. . O

Samples NNS O
were VBD O
examined VBN O
using VBG O
a DT O
Hitachi NNP O
H7500 NNP O
electron NN O
microscope NN O
( , O
Hitachi NNP O
High NNP O
Technologies NNPS O
America NNP O
, , O
Pleasanton NNP O
, , O
CA NNP O
) -RRB- O
. . O

Cytotoxic JJ O
Activity NN O
of IN O
Silyl NNP O
- : O
and CC O
Germyl NNP O
- HYPH O
Substituted VBN O
4 CD O
, , O
4 CD O
- HYPH O
Dioxo NNP O
- HYPH O
3a CD O
, , O
6a CD O
- HYPH O
Dihydrothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d NN O
] -RRB- O
isoxazolines FW O
- HYPH O
2 CD O

Abstract JJ O

The DT O
[ -LRB- O
2 CD O
+ SYM O
3 CD O
] -RRB- O
dipolar JJ O
cycloaddition NN O
of IN O
nitrile NN O
oxides NNS O
to IN O
the DT O
double JJ O
C NN O
= SYM O
C NN O
bonds NNS O
of IN O
thiophene NN O
- HYPH O
1 CD O
, , O
1 CD O
- HYPH O
dioxides NNS O
leads VBZ O
to IN O
formation NN O
of IN O
the DT O
fused VBN O
isoxazolines NNS O
- HYPH O
2 CD O
( SYM O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Tumor NN O
growth NN O
inhibition NN O
of IN O
these DT O
compounds NNS O
strongly RB O
depends VBZ O
on IN O
the DT O
nature NN O
of IN O
group NN O
IV NN O
A NN O
element NN O
increasing VBG O
from IN O
slightly RB O
active JJ O
tert NN O
- HYPH O
butyl NN O
derivatives NNS O
to IN O
silicon NN O
and CC O
germanium NN O
containing VBG O
analogues NNS O
. . O

The DT O
products NNS O
of IN O
benzonitrile NN O
oxide NN O
cycloaddition NN O
have VBP O
greater JJR O
cytotoxic JJ O
effect NN O
than IN O
the DT O
compounds NNS O
obtained VBN O
from IN O
the DT O
cycloaddition NN O
reaction NN O
of IN O
2 CD O
, , O
5 CD O
- HYPH O
disubstituted JJ O
thiophene NN O
- HYPH O
1 CD O
, , O
1 CD O
- HYPH O
dioxides NNS O
with IN O
acetonitrile NN O
oxide NN O
. . O

Fused VBN O
silyl NN O
substituted VBN O
isoxazolines NNS O
- : O
2 CD O
are VBP O
stronger JJR O
NO NNP O
- HYPH O
inducers NNS O
than IN O
their PRP$ O
germyl JJ O
and CC O
tert NN O
- HYPH O
butyl NN O
analogues NNS O
. . O

CYTOTOXIC JJ O
ACTIVITY NN O
OF IN O
SILYL NNP O
- : O
AND CC O
GERMYL NNP O
- HYPH O
SUBSTITUTED VBN O
4 CD O
, , O
4 CD O
- HYPH O
DIOXO NNP O
- HYPH O
3a CD O
, , O
6a CD O
- HYPH O
DIHYDROTHIENO NNP O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d CD O
] -RRB- O
ISOXAZOLINES NNP O
- HYPH O
2 CD O

E UH O
. . O

Lukevics NNP O
* NFP O
, , O
P NN O
. . O

Arsenyan NNP O
, , O
I PRP O
. . O

Shestakova NNP O
, , O
O UH O
. . O

Zharkova NNP O
, , O
I PRP O
. . O

Kanepe NNP O
, , O
R NNP O
. . O

Mezapuke NNP O
, , O
and CC O
O UH O
. . O

Pudova NNP O
Latvian NNP O
Institute NNP O
of IN O
Organic NNP O
Synthesis NNP O
, , O
Aizkraukles NNP O
21 CD O
, , O
Riga NNP O
, , O
LV NNP O
- HYPH O
1006 CD O
, , O
Latvia NNP O

ABSTRACT NN O
The DT O
[ -LRB- O
2 CD O
+ SYM O
3 CD O
] -RRB- O
dipolar JJ O
cycloaddition NN O
of IN O
nitrile NN O
oxides NNS O
to IN O
the DT O
double JJ O
( , O
3 CD O
= SYM O
( SYM O
3 CD O
bonds NNS O
of IN O
thiophene NN O
- HYPH O
l NN O
, , O
l NN O
- HYPH O
dioides NNS O
leads VBZ O
to IN O
formation NN O
of IN O
the DT O
fused VBN O
isoxazolines NNS O
- HYPH O
2 CD O
( SYM O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Tumor NN O
growth NN O
inhibition NN O
of IN O
these DT O
compounds NNS O
strongly RB O
depends VBZ O
on IN O
the DT O
nature NN O
of IN O
group NN O
IV NN O
A NN O
element NN O
increasing VBG O
from IN O
slightly RB O
active JJ O
ert NN O
- HYPH O
butyl NN O
derivatives NNS O
to IN O
silicon NN O
and CC O
germanium NN O
containing VBG O
analogues NNS O
. . O

The DT O
products NNS O
of IN O
benzonitdle NN O
oxide NN O
cycloaddition NN O
have VBP O
greater JJR O
cytotoic JJ O
effect NN O
than IN O
the DT O
compounds NNS O
obtained VBN O
from IN O
he PRP O
cycloaddition NN O
reaction NN O
of IN O
2 CD O
, , O
5 CD O
- HYPH O
disubstituted JJ O
thiophene NN O
- HYPH O
l NN O
, , O
l FW O
- HYPH O
dioxides NNS O
with IN O
acetonitrile NN O
oxide NN O
. . O

Fused VBN O
silyl NN O
substituted VBN O
isoxazolines NNS O
- : O
2 CD O
are VBP O
stronger JJR O
NO NNP O
- HYPH O
inducers NNS O
than IN O
their PRP$ O
germyl JJ O
and CC O
tert NN O
- HYPH O
butyl NN O
analogues NNS O
. . O

INTRODUCTION NN O
The DT O
interest NN O
in IN O
silyl NN O
substituted VBN O
thiophene NN O
- HYPH O
l NN O
, , O
l NN O
- HYPH O
dioxides NNS O
stems VBZ O
from IN O
the DT O
fact NN O
that IN O
they PRP O
are VBP O
useful JJ O
synthetic JJ O
intermediates NNS O
for IN O
the DT O
preparation NN O
of IN O
various JJ O
types NNS O
of IN O
organic JJ O
compounds NNS O
by IN O
Diels NNP O
- HYPH O
Alder NN O
cycloaddition NN O
[ -LRB- O
1 CD O
] -RRB- O
, , O
amine NN O
induced VBN O
ring NN O
- HYPH O
opening VBG O
reaction NN O
[ -LRB- O
2 CD O
] -RRB- O
, , O
or CC O
coupling NN O
of IN O
bromothiophene NN O
- HYPH O
l NN O
, , O
l FW O
- HYPH O
dioxides NNS O
with IN O
thienyl NN O
stannanes NNS O
in IN O
the DT O
presence NN O
of IN O
a DT O
palladium NN O
( , O
0 CD O
) -RRB- O
catalyst NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
unsubstituted JJ O
thiophene NN O
- HYPH O
l NN O
, , O
l NN O
- HYPH O
dioxide NN O
prepared VBN O
in IN O
situ NN O
is VBZ O
a DT O
quite RB O
reactive JJ O
dipolarophile NN O
in IN O
the DT O
[ -LRB- O
2 CD O
+ SYM O
3 CD O
] -RRB- O
cycloaddition NN O
reactions NNS O
with IN O
N NNP O
, , O
o FW O
- HYPH O
diphenylnitrone NN O
[ -LRB- O
4 CD O
] -RRB- O
, , O
benzonitrile NN O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
and CC O
mesitonitrile NN O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
oxides NNS O
yielding VBG O
mono NN O
- HYPH O
and CC O
diisoxazolines NNS O
- HYPH O
2 CD O
and CC O
N NN O
- HYPH O
substituted VBN O
isoxazolidines NNS O
. . O

Moreover RB O
, , O
our PRP$ O
recent JJ O
studies NNS O
indicate VBP O
that IN O
silyl NN O
- HYPH O
and CC O
germylcontaining VBG O
isoxazolines NNS O
have VBP O
gained VBN O
a DT O
great JJ O
deal NN O
of IN O
attention NN O
as IN O
compounds NNS O
possessing VBG O
a DT O
wide JJ O
spectrum NN O
of IN O
the DT O
biological JJ O
properties NNS O
. . O

The DT O
vasodilating VBG O
, , O
anticoagulant JJ O
and CC O
cardioprotective JJ O
activity NN O
of IN O
5 CD O
- HYPH O
Si NNP O
- HYPH O
( , O
Ge NNP O
) -RRB- O
substituted VBN O
isoxazolines NNS O
- HYPH O
2 CD O
has VBZ O
been VBN O
studied VBN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
[ -LRB- O
6 CD O
, , O
7 CD O
] -RRB- O
. . O

The DT O
most RBS O
active JJ O
isoxazoline NN O
- HYPH O
3 CD O
- HYPH O
( -LRB- O
5 CD O
"""" '' O
- HYPH O
triethylgermyl NN O
- HYPH O
3 CD O
"""" '' O
- HYPH O
isoxazolino NN O
) , O
pyridine NN O
hydrochloride NN O
protected VBD O
the DT O
heart NN O
from IN O
rhythm NN O
disturbances NNS O
and CC O
lethality NN O
during IN O
ischemiareperfusion NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
silylisoxazolines NNS O
- : O
2 CD O
are VBP O
more RBR O
potent JJ O
in IN O
protection NN O
against IN O
hypoxia NN O
and CC O
corazole NN O
convulsions NNS O
than IN O
germanium NN O
analogues NNS O
. . O

However RB O
, , O
germylisoxazolines NNS O
- HYPH O
2 CD O
are VBP O
stronger JJR O
tumor NN O
growth NN O
inhibitors NNS O
and CC O
NO NNP O
- HYPH O
inducers NNS O
than IN O
their PRP$ O
silicon NN O
analogue NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

This DT O
work NN O
presents VBZ O
the DT O
results NNS O
of IN O
cytotoxic JJ O
activity NN O
for IN O
fused VBN O
isoxazolines NNS O
- : O
2 CD O
bearing VBG O
a DT O
group NN O
14 CD O
element NN O
as IN O
substituent NN O
( , O
1 CD O
, , O
2 CD O
) -RRB- O
in IN O
function NN O
of IN O
the DT O
nature NN O
of IN O
the DT O
group NN O
14 CD O
element NN O
. . O

M NN O

e3M NN O
. . O
CH3 NN O
N NN O

- : O
0 CD O
\ SYM O
R NN O

O NN O
\ NFP O
M NN O

e3M NN O
S NN O

N NN O

2 NFP O

2 CD O
2 CD O

1 NFP O

MATERIALS NNS O
AND CC O
METHODS NNS O
CHEMISTRY NN O
Seven CD O
tert NN O
- HYPH O
butyl NN O
- HYPH O
, , O
trimethylsilyl NN O
- , O
, , O
and CC O
trimethylgermyl NN O
- HYPH O
substituted VBN O
4 CD O
, , O
4 CD O
- HYPH O
dioxo NN O
- HYPH O
3a CD O
, , O
6adihydrothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d NN O
] -RRB- O
isoxazoline NN O
- HYPH O
2 CD O
1 CD O
and CC O
2 CD O
( SYM O
Table NN O
1 CD O
) -RRB- O
were VBD O
prepared VBN O
by IN O
the DT O
[ -LRB- O
2 CD O
+ SYM O
3 CD O
] -RRB- O
dipolar NN O
63 CD O

Vol NNP O
. . O

7 CD O
, , O
No UH O
. . O
2 CD O
, , O
2000 CD O

Cytotoxic NNP O
Activity NNP O
ofSilyl NNP O
- : O
and CC O
Germyl NNP O
- HYPH O
Substituted VBN O
4 CD O
, , O
4 CD O
- HYPH O
dioxo NNP O
- HYPH O
3a CD O
, , O
6a CD O
- HYPH O
Dihydrothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d NN O
] -RRB- O
Isoxazolines NNPS O
- HYPH O
2 CD O

cycloaddition NN O
of IN O
aceto NN O
- HYPH O
and CC O
benzonitrile NN O
oxides NNS O
to IN O
2 CD O
, , O
5 CD O
- HYPH O
disubstituted JJ O
thiophene NN O
- HYPH O
l NN O
, , O
l NN O
- HYPH O
dioxides NNS O
. . O

Their PRP$ O
synthesis NN O
and CC O
characterization NN O
are VBP O
given VBN O
in IN O
ref NN O
. . O

[ -LRB- O
9 CD O
] -RRB- O
. . O

_ NFP O
, , O
, , O
/ NFP O
0 NFP O
\ NFP O
N NN O
Me3M NN O
M NN O
' '' O
Me3 NN O

Me3M NNP O

2 CD O
M NN O
, , O
M NNP O
' '' O
= : O
C NNP O
, , O
Si NNP O
, , O
Ge NNP O
; : O
R NNP O
= , O
Me NNP O
, , O
Ph NNP O
; : O
R NN O
' '' O
= NFP O
H NN O
, , O
Me3Ge NNP O
Table NNP O
1 CD O
. . O

Me3C NNP O
, , O
MeSi NNP O
, , O
Investigated NNP O
dihydrothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d NN O
] -RRB- O
isoxazolines NNS O
- : O
2 CD O

2 CD O
Me3Ge NNP O
substituted VBD O

% UH O
, , O
\ NFP O
R NN O
4 CD O
, , O
4 CD O
- HYPH O
dioxo NN O
- HYPH O
3a CD O
, , O
6a CD O

Compound NN O

' '' O
Type NNP O
la NNP O

M NN O

R NN O
H NN O
Me3Ge NNP O
Me3Ge NNP O

Yield NN O

4 CD O
, , O
4 CD O
- HYPH O
dioxo NN O
- HYPH O
3 CD O
methyl NN O
"""" `` O
5 CD O
- HYPH O
tert NN O
- HYPH O
butyl NN O
- HYPH O
3a NNP O
, , O
6adihydrothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d NN O
] -RRB- O
isoxazoline NN O
- HYPH O
2 CD O

( : O
3 CD O
' '' O
C NN O
Si NN O

( : O
% NN O
) NFP O
80 CD O

4 CD O
, , O
4 CD O
- HYPH O
dioxo NN O
- HYPH O
3 CD O
- HYPH O
methyl NN O
- HYPH O
3a CD O
- HYPH O
trimethylgermyl NN O
- HYPH O
5 CD O
- HYPH O
tert NN O
- HYPH O
butyl3a NN O
, , O
6a CD O
- HYPH O
d NN O
ihyd NN O
rothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d FW O
] FW O
isoxazoli FW O
ne FW O
- HYPH O
2 CD O
4 CD O
, , O
4 CD O
- HYPH O
dioxo NN O
- HYPH O
3 CD O
- HYPH O
methyl NN O
- HYPH O
3a CD O
- HYPH O
trimethyigermyl NN O
- HYPH O
5tri CD O
methylsilyl NN O
- HYPH O
3a CD O
, , O
6a CD O
- HYPH O
d FW O
hyd FW O
roth FW O
ien FW O
o FW O
[ -LRB- O
2 CD O
, , O
3d CD O
] -RRB- O
isoxazoline NN O
- HYPH O
2 CD O
4 CD O
, , O
4 CD O
- HYPH O
d FW O
io FW O
x FW O
o FW O
- HYPH O
3 CD O
- HYPH O
meth NN O
y , O
I NN O
- HYPH O
3a CD O
, , O
5 CD O
- HYPH O
b NN O
s NN O
tri NN O
m NN O
ethy NN O
Ig NN O
e NN O
rmy NNP O
I NNP O
) SYM O
3a CD O
, , O
6a CD O
- HYPH O
d FW O
hyd FW O
rothieno FW O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d FW O
] FW O
isoxazo FW O
ne FW O
- HYPH O
2 CD O
4 CD O
, , O
4 CD O
- HYPH O
d NN O
ioxo NN O
- HYPH O
3 CD O
- HYPH O
ph FW O
en FW O
y FW O
I NNP O
- HYPH O
5 CD O
- HYPH O
tert NN O
- HYPH O
b NN O
uty JJ O
I NN O
- HYPH O
3a CD O
, , O
6adihydrothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d NN O
] -RRB- O
isoxazoline NN O
- HYPH O
2 CD O
4 CD O
, , O
4 CD O
- HYPH O
d NN O
ioxo NN O
- HYPH O
3 CD O
- HYPH O
p NN O
h NN O
e NN O
ny JJ O
I NN O
- HYPH O
5 CD O
- HYPH O
tri NN O
meth NN O
y , O
si NN O
ly IN O
I NNP O
- HYPH O
3a CD O
, , O
6adihydrothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d NN O
] -RRB- O
isoxazoline NN O
- HYPH O
2 CD O
4 CD O
, , O
4 CD O
- HYPH O
d NN O
ioxo NN O
- HYPH O
3 CD O
- HYPH O
p NN O
h NN O
e NN O
n NN O
y JJ O
I NN O
- HYPH O
5 CD O
- HYPH O
tri NN O
methy NN O
Ig NN O
e NN O
rmy NNP O
I NNP O
- HYPH O
3a CD O
, , O
6adi NN O
, , O
hydr0thieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
, , O
d NN O
] -RRB- O
isoxazoline NN O
- HYPH O
2 CD O

lb NNP O
lc NNP O

58 CD O
45 CD O
67 CD O
84 CD O

ld NN O
2a CD O
2b NN O

Ge NNP O

Me3Ge NNP O

C NN O
Si NNP O

77 CD O
85 CD O

2c NN O

Ge NNP O

IN FW O
VITRO FW O
CYTOTOXITY NN O
ASSAY NNP O
Monolayer NNP O
cells NNS O
lines NNS O
were VBD O
cultivated VBN O
for IN O
72 CD O
h NN O
in IN O
DMEM NNP O
standard JJ O
medium NN O
without IN O
an DT O
indicator NN O
and CC O
antibiotics NNS O
. . O

After IN O
the DT O
ampoule NN O
was VBD O
defreezed VBN O
not RB O
more JJR O
than IN O
four CD O
passa4ges NNS O
were VBD O
performed VBN O
. . O

The DT O
control NN O
cells NNS O
and CC O
cells NNS O
with IN O
tested VBN O
substances NNS O
in IN O
the DT O
range NN O
of IN O
2 CD O
- SYM O
5 CD O
10 CD O
cell NN O
/ SYM O
mL NN O
concentration NN O
( , O
depending VBG O
on IN O
line NN O
nature NN O
) -RRB- O
were VBD O
placed VBN O
on IN O
a DT O
separate JJ O
96 CD O
wells NNS O
plates NNS O
. . O

Solutions NNS O
containing VBG O
test NN O
compounds NNS O
were VBD O
diluted VBN O
and CC O
added VBN O
in IN O
wells NNS O
to TO O
give VB O
the DT O
final JJ O
concentrations NNS O
of IN O
50 CD O
, , O
25 CD O
, , O
12 CD O
. , O
5 CD O
, , O
and CC O
6 CD O
. . O
25 CD O
# NN O
g CD O
/ SYM O
mL NNP O
Control NN O
cells NNS O
were VBD O
treated VBN O
in IN O
the DT O
same JJ O
manner NN O
only RB O
in IN O
the DT O
absence NN O
of IN O
test NN O
compounds NNS O
. . O

Plates NNS O
were VBD O
cultivated VBN O
for IN O
72 CD O
h NN O
. . O

A DT O
quantity NN O
of IN O
survived VBN O
cells NNS O
was VBD O
determined VBN O
using VBG O
crystal NN O
violet NN O
( , O
CV NN O
) , O
or CC O
3 CD O
- HYPH O
( SYM O
4 CD O
, , O
5 CD O
- HYPH O
dimethylthiazol NN O
- HYPH O
2 CD O
- HYPH O
yl NN O
) SYM O
- HYPH O
2 CD O
, , O
5diphenyltetrazolini NN O
bromide NN O
( -LRB- O
MTT NNP O
) -RRB- O
coloration NN O
which WDT O
was VBD O
assayed VBN O
by IN O
multiscan NN O
spectrofotometer NN O
. . O

The DT O
quantity NN O
of IN O
alive JJ O
cells NNS O
on IN O
control NN O
plate NN O
was VBD O
taken VBN O
in IN O
calculations NNS O
for IN O
100 CD O
% NN O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
. . O

Concentration NN O
of IN O
NO NNP O
was VBD O
determined VBN O
according VBG O
to IN O
[ $ O
10 CD O
] -RRB- O
. . O

RESULTS NNS O
AND CC O
DISCUSSION NN O
Potential JJ O
cytotoxic JJ O
activity NN O
of IN O
synthesized VBN O
fused VBN O
isoxazolines NNS O
1 CD O
and CC O
2 CD O
was VBD O
tested VBN O
in IN O
vitro NN O
on IN O
four CD O
monolayer NN O
tumor NN O
cell NN O
lines NNS O
: : O
MG NNP O
- HYPH O
22A CD O
( HYPH O
mouse NN B-Species
hepatoma NN O
) -RRB- O
, , O
HT NNP O
- HYPH O
1080 CD O
( , O
human JJ B-Species
fibroblastoma NN O
) -RRB- O
, , O
B16 NNP O
( , O
mouse NN B-Species
melanoma NN O
) -RRB- O
, , O
Neuro NNP O
2A NNP O
( , O
mouse NN B-Species
neiroblastoma NN O
) -RRB- O
. . O

Concentrations NNS O
providing VBG O
50 CD O
% NN O
of IN O
tumor NN O
death NN O
effect NN O
were VBD O
determined VBN O
according VBG O
to IN O
the DT O
known VBN O
procedure NN O
[ -LRB- O
12 CD O
] -RRB- O
using VBG O
96 CD O
well JJ O
plates NNS O
. . O

The DT O
experimental JJ O
evaluation NN O
of IN O
cytotoxicity NN O
properties NNS O
is VBZ O
presented VBN O
in IN O
Table NNP O
2 CD O
. . O

A DT O
preliminary JJ O
analysis NN O
of IN O
the DT O
structure NN O
- HYPH O
activity NN O
relationship NN O
for IN O
the DT O
cytotoxic JJ O
action NN O
clearly RB O
indicates VBZ O
the DT O
strong JJ O
influence NN O
of IN O
the DT O
MeM NNP O
( , O
M NNP O
= , O
C NNP O
, , O
Si NNP O
, , O
Ge NNP O
) -RRB- O
group NN O
in IN O
position NN O
5 CD O
of IN O
fused VBN O
isoxazolines NNS O
1 CD O
and CC O
2 CD O
. . O

Derivatives NNS O
bearing VBG O
tert NN O
- HYPH O
butyl NN O
substituent NN O
( : O
la FW O
, , O
b NN O
and CC O
2a CD O
) -RRB- O
have VBP O
a DT O
slight JJ O
cytotoxic JJ O
effect NN O
( : O
> SYM O
10 CD O
# NN O
g CD O
/ SYM O
mL NN O
) -RRB- O
. . O

The DT O
substitution NN O
of IN O
the DT O
tert NN O
- HYPH O
butyl NN O
group NN O
by IN O
trimethylsilyl NN O
or CC O
64 CD O

E UH O
. . O

Lukevics NNP O
et FW O
al FW O
. . O

Metal NN O
- HYPH O
Based VBN O
Drugs NNS O

A DT O

oO UH O

{ NFP O
D NN O

0 NFP O

0 NFP O

65 CD O

Vol NNP O
. . O

7 CD O
, , O
No UH O
. . O
2 CD O
, , O
2000 CD O

Cytotoxic NNP O
Activity NNP O
ofSilyl NNP O
- : O
and CC O
Germyl NNP O
- HYPH O
Substituted VBN O
4 CD O
, , O
4 CD O
- HYPH O
dioxo NNP O
- HYPH O
3a CD O
, , O
6a CD O
- HYPH O
Dihydrothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d NN O
] -RRB- O
Isoxazolines NNPS O
- HYPH O
2 CD O

trimethylgermyl NN O
ones NNS O
leads VBZ O
to IN O
considerable JJ O
increase NN O
of IN O
cytotoxicity NN O
. . O

It PRP O
must MD O
be VB O
noted VBN O
that IN O
the DT O
activity NN O
of IN O
silicon NN O
- HYPH O
and CC O
germanium NN O
- HYPH O
containing VBG O
compounds NNS O
( , O
1 CD O
and CC O
l NN O
d NN O
) -RRB- O
depends VBZ O
on IN O
the DT O
tumor NN O
type NN O
. . O

5 CD O
- HYPH O
Trimethylsilyl NN O
- HYPH O
substituted VBN O
fused VBN O
isoxazoline NN O
le NN O
is VBZ O
more RBR O
active JJ O
than IN O
the DT O
germanium NN O
analogue NN O
l '' O
d -RRB- O
in IN O
tests NNS O
on IN O
HP NNP O
- HYPH O
1080 CD O
and CC O
MG NNP O
- HYPH O
22A CD O
cell NN O
lines NNS O
. . O

However RB O
, , O
the DT O
germanium NN O
compound NN O
ld NN O
has VBZ O
greater JJR O
cytotoxic JJ O
effect NN O
on IN O
Neuro NNP O
2A NNP O
and CC O
B16 NNP O
cell NN O
lines NNS O
than IN O
the DT O
silicon NN O
derivative JJ O
lc NN O
. . O

Comparison NN O
of IN O
the DT O
tumor NN O
growth NN O
inhibition NN O
for IN O
derivatives NNS O
1 CD O
and CC O
2 CD O
shows VBZ O
a DT O
higher JJR O
activity NN O
of IN O
the DT O
condensed VBN O
isoxazolines NNS O
2 CD O
containing VBG O
a DT O
phenyl NN O
group NN O
in IN O
position NN O
3 CD O
with IN O
respect NN O
to IN O
4 CD O
, , O
4 CD O
- HYPH O
dioxo NN O
- HYPH O
3 CD O
- HYPH O
methyl NN O
- HYPH O
3a CD O
- HYPH O
trimethylgermyl NN O
- HYPH O
5 CD O
- HYPH O
MeM NN O
- HYPH O
3a CD O
, , O
6a CD O
- HYPH O
dihyd NN O
rothieno NN O
[ -LRB- O
2 CD O
, , O
3d CD O
] -RRB- O
isoxazolines FW O
l FW O
b FW O
- HYPH O
d NN O
. . O

Silyl NNP O
- HYPH O
and CC O
germyl NN O
- HYPH O
substituted VBN O
fused VBN O
isoxazolines NNS O
have VBP O
a DT O
medium JJ O
NOinduction NNP O
ability NN O
, , O
4 CD O
, , O
4 CD O
- HYPH O
dioxo NN O
- HYPH O
3 CD O
- HYPH O
phenyl NN O
- HYPH O
5 CD O
- HYPH O
trimethylsilyl NN O
- HYPH O
3a CD O
, , O
6a CD O
- HYPH O
dihydrothieno NN O
[ -LRB- O
2 CD O
, , O
3 CD O
- HYPH O
d NN O
] -RRB- O
isoxazoline NN O
- HYPH O
2 CD O
( SYM O
2b CD O
) NN O
being VBG O
the DT O
most RBS O
active JJ O
( , O
250 CD O
% NN O
in IN O
the DT O
MG NNP O
- HYPH O
22A NNP O
test NN O
) -RRB- O
. . O

ACKNOWLEGMENT NNP O
We PRP O
are VBP O
grateful JJ O
to IN O
Latvian NNP O
Taiho NNP O
Foundation NNP O
for IN O
financial JJ O
support NN O
. . O

REFERENCES NNS O
1 CD O
. . O

A DT O
. . O

R NN O
. . O

M UH O
. . O

Donovan NNP O
, , O
M NNP O
. . O

K UH O
. . O

Shepherd NNP O
, , O
Tetrahedron NNP O
Lett NNP O
. . O
, , O
35 CD O
( , O
1994 CD O
) SYM O
4425 CD O
. . O

2 LS O
. . O

S UH O
. . O

Gronowitz NNP O
, , O
A NN O
. . O
- HYPH O
B NN O
. . O

H0rnfeldt NNP O
, , O
E UH O
. . O

Lukevics NNP O
, , O
O UH O
. . O

Pudova NNP O
, , O
Synthesis NNP O
, , O
( , O
1994 CD O
) SYM O
40 CD O
. . O

3 LS O
. . O

G NNP O
. . O

Barbarella NNP O
, , O
L NNP O
. . O

Favaretto NNP O
, , O
G NNP O
. . O

Sotgiu NNP O
, , O
M NNP O
. . O

Zambianchi NNP O
, , O
L NNP O
. . O

Antolini NNP O
, , O
O UH O
. . O

Pudova NNP O
, , O
A NNP O
. . O

Bongini NNP O
, , O
J NNP O
. . O

Org NNP O
. . O

Chem NNP O
. . O
, , O
63 CD O
( , O
1998 CD O
) SYM O
5497 CD O
. . O

4 LS O
. . O

A DT O
. . O

Bened NNP O
, , O
R NN O
. . O

Durand NNP O
, , O
D NNP O
. . O

Pioch NNP O
, , O
P NN O
. . O

Geneste NNP O
, , O
J NNP O
. . O

P NN O
. . O

Declerq NNP O
, , O
G NNP O
. . O

Germain NNP O
, , O
J NNP O
. . O

Rambaud NNP O
, , O
R NNP O
. . O

Roques NNP O
, , O
J NNP O
. . O

Org NNP O
. . O

Chem NNP O
. . O
, , O
46 CD O
( , O
1981 CD O
) SYM O
3502 CD O
. . O

5 LS O
. . O

F NNP O
. . O

M UH O
. . O

Albini NNP O
, , O
P NN O
. . O

Ceva NNP O
, , O
A DT O
. . O

Mascherpa NNP O
, , O
E UH O
. . O

Albini NNP O
, , O
P NN O
. . O

Caramella NNP O
, , O
Tetrahedron NNP O
, , O
38 CD O
( , O
1982 CD O
) -RRB- O

6 LS O
. . O

7 LS O
. . O

8 LS O
. . O

9 LS O
. . O

10 CD O
. . O

11 CD O
. . O

12 CD O
. . O

3629 CD O
. . O

E UH O
. . O

Lukevics NNP O
, , O
M NNP O
. . O

Veveris NNP O
, , O
V NN O
. . O

Dirnens NNP O
, , O
Appl NNP O
. . O

Organomet NNP O
. . O

Chem NNP O
. . O
, , O
11 CD O
( , O
1997 CD O
) SYM O
805 CD O
. . O

E UH O
. . O

Lukevics NNP O
, , O
P NN O
. . O

Arsenyan NNP O
, , O
M NNP O
. . O

Veveris NNP O
, , O
Metal NNP O
Based NNP O
Drugs NNPS O
, , O
5 CD O
( SYM O
1998 CD O
) SYM O
251 CD O
. . O

E UH O
. . O

Lukevics NNP O
, , O
P NN O
. . O

Arsenyan NNP O
, , O
S NNP O
. . O

Germane NNP O
, , O
I PRP O
. . O

Shestakova NNP O
, , O
Applied NNP O
Organomet NNP O
. . O

Chem NNP O
. . O
, , O
13 CD O
( , O
1999 CD O
) SYM O
795 CD O
. . O

E UH O
. . O

Lukevics NNP O
, , O
P NN O
. . O

Arsenyan NNP O
, , O
S NNP O
. . O

Belyakov NNP O
, , O
J NNP O
. . O

Popelis NNP O
, , O
O UH O
. . O

Pudova NNP O
, , O
Organometallics NNP O
, , O
18 CD O
( , O
1999 CD O
) SYM O
3187 CD O
. . O

D NNP O
. . O
J NNP O
. . O

Fast JJ O
, , O
R NN O
. . O
C NN O
. . O

Lynch NNP O
, , O
R NNP O
. . O
W UH O
. . O

Leu NNP O
, , O
J NNP O
. . O

Leuckocyt NNP O
. . O

Biol NNP O
. . O
, , O
52 CD O
( , O
1992 CD O
) SYM O
255 CD O
. . O

P NN O
. . O
J NNP O
. . O

Freshney NNP O
, , O
Culture NNP O
of IN O
Animal NNP O
Cells NNPS O
( , O
A DT O
Manual NNP O
of IN O
Basic NNP O
Technique NNP O
) -RRB- O
, , O
Wiley NNP O
- HYPH O
Liss NNP O
, , O
New NNP O
York NNP O
, , O
1994 CD O
, , O
pp NN O
. . O

296 CD O
- SYM O
297 CD O
. . O

R NN O
. . O

J NNP O
. . O

Riddell NNP O
, , O
R NNP O
. . O

H NN O
. . O

Clothier NNP O
, , O
M NNP O
. . O

Fd UH O
. . O

Balls NNS O
, , O
Chem NNP O
. . O

Toxicol NNP O
. . O
, , O
24 CD O
( SYM O
1986 CD O
) SYM O
469 CD O
. . O

Received VBN O
: : O
January NNP O
21 CD O
, , O
2000 CD O
Accepted VBN O
: : O
February NNP O
1 CD O
, , O
2000 CD O
Received VBN O
in IN O
revised JJ O
camera NN O
- HYPH O
ready JJ O
format NN O
"""" `` O
February NNP O
2 CD O
, , O
2000 CD O

66 CD O

IL NN O
- HYPH O
5 CD O
drives VBZ O
eosinophils NNS O
from IN O
bone NN O
marrow NN O
to IN O
blood NN O
and CC O
tissues NNS O
in IN O
a DT O
guinea JJ B-Species
- HYPH I-Species
pig NN I-Species
model NN O
of IN O
visceral JJ O
larva NN O
migrans NN O
syndrome NN O

Abstract JJ O

This DT O
study NN O
was VBD O
undertaken VBN O
to TO O
evaluate VB O
the DT O
role NN O
of IN O
IL NN O
- HYPH O
5 CD O
in IN O
eosinophil NN O
migration NN O
and CC O
in IN O
the DT O
maintenance NN O
of IN O
eosinophilia NN O
in IN O
a DT O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species
model NN O
of IN O
visceral JJ O
larva NN O
migrans NNS O
syndrome NN O
. . O

The DT O
results NNS O
show VBP O
that IN O
the DT O
infection NN O
of IN O
animals NNS O
with IN O
Toxocara NNP B-Species
canis NN I-Species
induced VBD O
an DT O
early JJ O
increase NN O
in IN O
serum NN O
IL NN O
- HYPH O
5 CD O
levels NNS O
that WDT O
might MD O
be VB O
essential JJ O
for IN O
eosinophil NN O
differentiation NN O
and CC O
proliferation NN O
and CC O
for IN O
the DT O
development NN O
of IN O
eosinophilia NN O
. . O

When WRB O
infected JJ O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
were VBD O
treated VBN O
with IN O
mAb NN O
anti AFX O
- HYPH O
IL NN O
- HYPH O
5 CD O
( SYM O
TRFK NNP O
- HYPH O
5 CD O
) -RRB- O
given VBN O
at IN O
the DT O
same JJ O
time NN O
or CC O
1 CD O
or CC O
3 CD O
days NNS O
after IN O
infection NN O
, , O
there EX O
was VBD O
a DT O
high JJ O
percentage NN O
of IN O
reduction NN O
of IN O
eosinophil NN O
counts NNS O
18 CD O
days NNS O
after IN O
infection NN O
. . O

However RB O
, , O
when WRB O
the DT O
mAb NN O
was VBD O
administered VBN O
during IN O
the DT O
peak NN O
of IN O
eosinophilia NN O
, , O
there EX O
was VBD O
high JJ O
inhibition NN O
in IN O
blood NN O
, , O
no DT O
inhibition NN O
in IN O
bronchoalveolar JJ O
lavage NN O
fluid NN O
( , O
BALF NNP O
) -RRB- O
or CC O
peritoneum NN O
and CC O
an DT O
increase NN O
in IN O
eosinophil NN O
numbers NNS O
in IN O
bone NN O
marrow NN O
. . O

Thus RB O
, , O
a DT O
basic JJ O
level NN O
of IN O
IL NN O
- HYPH O
5 CD O
may MD O
be VB O
essential JJ O
to TO O
drive VB O
eosinophils NNS O
from IN O
bone NN O
marrow NN O
to IN O
blood NN O
and CC O
tissues NNS O
, , O
and CC O
for IN O
the DT O
maintenance NN O
of IN O
eosinophilia NN O
in IN O
infected JJ O
animals NNS O
. . O

We PRP O
may MD O
also RB O
conclude VB O
that IN O
when WRB O
eosinophils NNS O
have VBP O
already RB O
migrated VBN O
to IN O
the DT O
lungs NNS O
, , O
TRFK NNP O
- HYPH O
5 CD O
has VBZ O
no DT O
power NN O
to TO O
inhibit VB O
eosinophilia NN O
, , O
which WDT O
is VBZ O
also RB O
under IN O
control NN O
of IN O
local JJ O
lung NN O
cells NNS O
producing VBG O
IL NN O
- HYPH O
5 CD O
. . O

In IN O
this DT O
way NN O
, , O
only RB O
one CD O
later JJ O
TRFK NNP O
- HYPH O
5 CD O
treatment NN O
may MD O
not RB O
be VB O
sufficient JJ O
to TO O
modify VB O
the DT O
lung NN O
parenchyma NN O
microenvironment NN O
, , O
since IN O
T NNP B-Species
. . I-Species
canis NN I-Species
antigens NNS O
had VBD O
already RB O
stimulated VBN O
some DT O
cell NN O
populations NNS O
to TO O
produce VB O
IL NN O
- HYPH O
5 CD O
. . O

Research NNP O
Paper NNP O
Mediators NNPS O
of IN O
Inflammation NNP O
5 CD O
, , O
24 CD O
- SYM O
31 CD O
( SYM O
1996 CD O
) -RRB- O

Tins NNS O
study NN O
was VBD O
undertaken VBN O
to TO O
evaluate VB O
the DT O
role NN O
of IN O
11 CD O
- HYPH O
5 CD O
in IN O
eosinophil NN O
migration NN O
and CC O
in IN O
the DT O
maintenance NN O
of IN O
eosinophilia NN O
in IN O
a DT O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species
model NN O
of IN O
visceral JJ O
larva NN O
migrans NNS O
syndrome NN O
. . O

The DT O
results NNS O
show VBP O
that IN O
the DT O
infection NN O
of IN O
animals NNS O
with IN O
Toxocara NNP B-Species
canis NN I-Species
induced VBD O
an DT O
early JJ O
increase NN O
in IN O
serum NN O
11 CD O
- SYM O
5 CD O
levels NNS O
that WDT O
might MD O
be VB O
essential JJ O
for IN O
eosi NN O

IL NN O
- HYPH O
5 CD O
drives VBZ O
eosinophils NNS O
from IN O
bone NN O
marrow NN O
to IN O
blood NN O
and CC O
tissues NNS O
in IN O
a DT O
guinea JJ B-Species
- HYPH I-Species
pig NN I-Species
model NN O
of IN O
visceral JJ O
larva NN O
migrans NN O
syndrome NN O
L NNP O
. . O

H NN O
. . O

Faccioli NNP O
, , O
1 CD O
"""" `` O
cA NN O
V NN O
. . O

F NNP O
. . O

Mokwa NNP O
, , O
C NNP O
. . O

L NN O
. . O

Silva NNP O
, , O
G NNP O
. . O

M UH O
. . O

Rocha NNP O
, , O
J NNP O
. . O

I PRP O
. . O

Araujo NNP O
, , O
M NNP O
. . O

A DT O
. . O

Nahori NNP O
2 CD O
and CC O
B NN O
. . O

B NN O
. . O

Vargaftig NNP O
2 CD O

nophil NN O
differentiation NN O
and CC O
proliferation NN O
and CC O
for IN O
the DT O
development NN O
of IN O
eosinophilia NN O
. . O

When WRB O
infected JJ O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
were VBD O
treated VBN O
with IN O
mAb NN O
anti AFX O
- HYPH O
11 CD O
- HYPH O
5 CD O
( SYM O
TRFK NNP O
- HYPH O
5 CD O
) , O
given VBN O
at IN O
the DT O
same JJ O
time NN O
or CC O
1 CD O
or CC O
3 CD O
days NNS O
after IN O
infection NN O
, , O
there EX O
was VBD O
a DT O
high JJ O
percentage NN O
of IN O
reduction NN O
of IN O
eosinophil NN O
counts NNS O
18 CD O
days NNS O
after IN O
infection NN O
. . O

However RB O
, , O
when WRB O
the DT O
mAb NN O
was VBD O
administered VBN O
during IN O
the DT O
peak NN O
of IN O
eosinophilia NN O
, , O
there EX O
was VBD O
high JJ O
inhibition NN O
in IN O
blood NN O
, , O
no DT O
inhibition NN O
in IN O
bronchoalveolar JJ O
lavage NN O
fluid NN O
( , O
BALF NNP O
) -RRB- O
or CC O
peritoneum NN O
and CC O
an DT O
increase NN O
in IN O
eosinophil NN O
numbers NNS O
in IN O
bone NN O
marrow NN O
. . O

Thus RB O
, , O
a DT O
basic JJ O
level NN O
of IN O
11 CD O
- SYM O
5 CD O
may MD O
be VB O
essential JJ O
to TO O
drive VB O
eosinophils NNS O
from IN O
bone NN O
marrow NN O
to IN O
blood NN O
and CC O
tissues NNS O
, , O
and CC O
for IN O
the DT O
maintenance NN O
of IN O
eosinophilia NN O
in IN O
infected JJ O
animals NNS O
. . O

We PRP O
may MD O
also RB O
conclude VB O
that IN O
when WRB O
eosinophils NNS O
have VBP O
already RB O
migrated VBN O
to IN O
the DT O
lungs NNS O
, , O
TRFK NNP O
- HYPH O
5 CD O
has VBZ O
no DT O
power NN O
to TO O
inhibit VB O
eosinophilia NN O
, , O
which WDT O
is VBZ O
also RB O
under IN O
control NN O
of IN O
local JJ O
lung NN O
cells NNS O
producing VBG O
11 CD O
- SYM O
5 CD O
. . O

In IN O
this DT O
way NN O
, , O
only RB O
one CD O
later JJ O
TRFK NNP O
- HYPH O
5 CD O
treatment NN O
may MD O
not RB O
be VB O
sufficient JJ O
to TO O
modify VB O
the DT O
lung NN O
parenchyma NN O
microenvironment NN O
, , O
since IN O
T NNP B-Species
. . I-Species
canis NN I-Species
antigens NNS O
had VBD O
already RB O
stimulated VBN O
some DT O
cell NN O
populations NNS O
to TO O
produce VB O
11 CD O
- SYM O
5 CD O
. . O

1Department NNP O
of IN O
Parasitology NNP O
, , O
Microbiology NNP O
and CC O
Immunology NNP O
, , O
School NNP O
of IN O
Medicine NNP O
of IN O
Ribeir NNP O
, , O
5o NNP O
Preto NNP O
, , O
14049 CD O
- HYPH O
900 CD O
, , O
Ribeiro NNP O
Preto NNP O
, , O
SP NNP O
, , O
Brazil NNP O
. . O

Fax NN O
: : O
( : O
+ SYM O
55 CD O
) SYM O
16 CD O
633 CD O
6631 CD O
2Unit NN O
de NN O
Pharmacologie NNP O
Cellulaire NNP O
, , O
Unit NNP O
Associe NNP O
Institut NNP O
Pasteur NNP O
/ SYM O
INSERM NNP O
n -RRB- O
. . O

285 CD O
, , O
Paris NNP O
, , O

France NNP O
. . O

CACorresponding VBG O
Author NN O

Key JJ O
words NNS O
: : O
Eosinophil NNP O
, , O
Eosinophilia NNP O
by IN O
Toxocara NNP B-Species
canis NN I-Species
, , O
IL NN O
- HYPH O
5 CD O
in IN O
eosinophilia NN O
, , O
Toxocara NNP B-Species
canis NN I-Species

Introduction NN O

treatment NN O
in IN O
mice NNS B-Species
infected VBN O
with IN O

Eosinophilia NNP O
has VBZ O
been VBN O
associated VBN O
with IN O
parasitic JJ O
diseases NNS O
, , O
particularly RB O
when WRB O
the DT O
parasites NNS O
invade VBP O
the DT O
tissues NNS O
or CC O
injure VBP O
the DT O
mucosal JJ O
surfaces NNS O
. . O

Toxocara NNP B-Species
canis NN I-Species
is VBZ O
an DT O
intestinal JJ O
parasite NN O
of IN O
dogs NNS B-Species
, , O
and CC O
is VBZ O
the DT O
most RBS O
common JJ O
aetiologic JJ O
agent NN O
of IN O
visceral JJ O
larva NN O
migrans NN O
syndrome NN O
( , O
VLMS NNP O
) -RRB- O
. . O

In IN O
humans NNS B-Species
, , O
VLMS NNP O
results VBZ O
from IN O
the DT O
ingestion NN O
of IN O
embryonated VBN O
eggs NNS O
of IN O
T NN B-Species
. . I-Species
canis NN I-Species
, , O
that WDT O
eclode VBP O
in IN O
the DT O
small JJ O
intesfine NN O
. . O

The DT O
infective JJ O
larvae NN O
invade VBP O
the DT O
mucosa NN O
, , O
move VBP O
into IN O
the DT O
liver NN O
via IN O
the DT O
portal JJ O
circulation NN O
, , O
and CC O
from IN O
there RB O
to IN O
the DT O
lungs NNS O
. . O

2 LS O
Beaver NNP O
et FW O
al NNP O
. . O
, , O
3 CD O
who WP O
were VBD O
the DT O
first JJ O
to TO O
describe VB O
this DT O
syndrome NN O
, , O
noted VBD O
the DT O
intense JJ O
eosinophilia NN O
which WDT O
reaches VBZ O
more JJR O
than IN O
90 CD O
% NN O
of IN O
total JJ O
leucocyte NN O
counts NNS O
. . O

However RB O
, , O
there EX O
are VBP O
few JJ O
studies NNS O
regarding VBG O
the DT O
mechanisms NNS O
involved VBN O
in IN O
the DT O
blood NN O
and CC O
tissue NN O
eosinophilia NN O
obseeeed VBN O
in IN O
VLMS NNP O
. . O

Several JJ O
investigators NNS O
have VBP O
suggested VBN O
a DT O
direct JJ O
correlation NN O
between IN O
eosinophilia NN O
and CC O
interleukin5 NN O
( , O
IL NN O
- HYPH O
5 CD O
) -RRB- O
in IN O
human JJ B-Species
helminth NN O
infections4 NN O
' '' O
5 CD O
and CC O
in IN O
experimental JJ O
animal NN O
models NNS O
. . O

67 CD O
Inhibition NN O
of IN O
eosinophilia NN O
has VBZ O
been VBN O
demonstrated VBN O
by IN O
anti AFX O
- HYPH O
IL NN O
- HYPH O
5 CD O
24 CD O
Mediators NNS O
of IN O
Inflammation NN O
Vol NNP O
5 CD O

brasiliensis NNP O
, , O
8 CD O
$ SYM O
chistosoma NN O
mansoni NN O
, , O
Toxocara NNP B-Species
canis7 NN I-Species
and CC O
Heligmosomoidespolyg NNP B-Species
. . O

1 CD O
IL NN O
- HYPH O
5 CD O
has VBZ O
also RB O
been VBN O
shown VBN O
to TO O
support VB O
the DT O
terminal JJ O
differentiation NN O
, , O
proliferation NN O
of IN O
eosinophil NN O
precursors NNS O
11 CD O
' NN O
12 CD O
and CC O
eosinophil NN O
activation NN O
. . O

13 CD O
Although IN O
IL NN O
- HYPH O
5 CD O
does VBZ O
not RB O
demonstrate VB O
eosinophil NN O
chemotactic JJ O
activity NN O
in IN O
vivo14 NN O
there EX O
is VBZ O
some DT O
evidence NN O
suggesting VBG O
that IN O
this DT O
cytokine NN O
may MD O
modulate VB O
a DT O
selective JJ O
eosinophil NN O
accumulation NN O
at IN O
the DT O
site NN O
of IN O
inflammation NN O
. . O

Moreover RB O
, , O
Sehmi NNP O
et FW O
a FW O
/ SYM O
. . O
15 CD O
reported VBD O
that IN O
IL NN O
- HYPH O
5 CD O
has VBZ O
a DT O
selective JJ O
priming VBG O
effect NN O
on IN O
eosinophil NN O
migratory JJ O
response NN O
to IN O
nonselective JJ O
chemoattractant NN O
mediators NNS O
in IN O
vitro FW O
. . O

Also RB O
, , O
Moser NNP O
et FW O
a DT O
/ : O
. . O

16 CD O
have VBP O
demonstrated VBN O
that IN O
in IN O
order NN O
to TO O
acquire VB O
the DT O
ability NN O
to TO O
transmigrate VB O
, , O
eosinophils NNS O
must MD O
be VB O
primed VBN O
with IN O
IL NNP O
- HYPH O
5 CD O
, , O
IL NN O
- HYPH O
3 CD O
and CC O
GM NNP O
- HYPH O
CSF NNP O
. . O

Thus RB O
, , O
the DT O
involvement NN O
of IN O
IL NN O
- HYPH O
5 CD O
in IN O
eosinophilia NN O
is VBZ O
not RB O
fully RB O
understood VBN O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
have VBP O
used VBN O
a DT O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species
model NN O
of IN O
VLMS NNP O
to TO O
investigate VB O
the DT O
involvement NN O
of IN O
IL NN O
- HYPH O
5 CD O
in IN O
eosinophil NN O
migration NN O
and CC O
in IN O
the DT O
maintenance NN O
of IN O
eosinophilia NN O
in IN O
blood NN O
, , O
bone NN O
marrow NN O
, , O
lung NN O
and CC O
peritoneal JJ O
cavity NN O
. . O

( : O
C NNP O
) -RRB- O
1996 CD O
Rapid NNP O
Science NNP O
Publishers NNPS O

Nipostrongylus NNP O

1996 CD O

IL NN O
- HYPH O
5 CD O
drives VBZ O
eosinophils NNS O
in IN O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species

Materials NNS O
and CC O
Methods NNPS O
Animals NNPS O
: : O
Outbred NNP O
albino NN O
weighing VBG O
300 CD O
- SYM O
400g CD O
at IN O
the DT O
ments NNS O
were VBD O
obtained VBN O
from IN O
the DT O
School NNP O
of IN O
Medicine NNP O
of IN O
versity NN O
of IN O
So NNP O
Paulo NNP O
, , O
Brazil NNP O
. . O

female JJ O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
start VBP O
of IN O
the DT O
experi NN O

were VBD O
routinely RB O
processed VBN O
, , O
embedded VBN O
in IN O
paraffin NN O
, , O
sectioned VBN O
at IN O
4 CD O
- SYM O
61 CD O
. . O
tm NN O
, , O
and CC O
stained VBN O
with IN O
Chromothope NNP O
2R NN O
and CC O
haematoxylin NN O
, , O
for IN O
examination NN O
by IN O
light JJ O
microscopy NN O
. . O

Determination NN O
oflL NN O
- HYPH O
5 CD O
in IN O
serum NN O
: : O
The DT O
IL NN O
- HYPH O
5 CD O
level NN O
in IN O
the DT O
serum NN O
of IN O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
was VBD O
measured VBN O
using VBG O
an DT O
enzyme NN O
- HYPH O
linked VBN O
immunosorbent JJ O
assay NN O
( : O
ELISA NNP O
) -RRB- O
. . O

Briefly RB O
, , O
ELISA NNP O
plates NNS O
( : O
96 CD O
- HYPH O
well UH O
Immunoplate NNP O
MaxiSorp NNP O
, , O
Nunc NNP O
, , O
Roskilde NNP O
, , O
Denmark NNP O
) , O
were VBD O
coated VBN O
with IN O
IL NN O
- HYPH O
5 CD O
- HYPH O
specific JJ O
monoclonal JJ O
antibody NN O
( , O
TRFK NNP O
- HYPH O
5 CD O
, , O
5 CD O
lag NN O
/ SYM O
ml NN O
in IN O
phosphate NN O
buffered VBN O
saline NN O
, , O
pH NN O
7 CD O
. . O
4 CD O
, , O
PBS NN O
, , O
100 CD O
l NN O
. . O
tl NN O
/ SYM O
well NN O
) -RRB- O
. . O

After IN O
2 CD O
h NN O
of IN O
incubation NN O
at IN O
37C CD O
, , O
the DT O
wells NNS O
were VBD O
washed VBN O
four CD O
times NNS O
with IN O
PBS NNP O
containing VBG O
0 CD O
. . O
1 CD O
% NN O
Tween NNP O
20 CD O
( SYM O
PBS NNP O
- HYPH O
T NN O
) -RRB- O
. . O

Then RB O
, , O
100 CD O
btl NN O
of IN O
samples NNS O
or CC O
recombinant JJ O
murine NN B-Species
IL NN O
- HYPH O
5 CD O
standards NNS O
( : O
0 CD O
. . O
15 CD O
- HYPH O
200ng CD O
/ SYM O
ml NN O
) -RRB- O
in IN O
PBS NNP O
- HYPH O
T NNP O
and CC O
2 CD O
% NN O
BSA NNP O
( -LRB- O
PBSTBSA NNP O
) -RRB- O
were VBD O
added VBN O
to IN O
each DT O
well NN O
. . O

After IN O
incubation NN O
for IN O
l DT O
h NN O
at IN O
37C CD O
, , O
the DT O
wells NNS O
were VBD O
washed VBN O
three CD O
times NNS O
and CC O
100 CD O
l NN O
. . O
tl NN O
of IN O
biotinylated JJ O
rat JJ B-Species
anti JJ O
- HYPH O
murine NN B-Species
IL NN O
- HYPH O
5 CD O
( , O
biotinylated JJ O
- HYPH O
TRFK NNP O
- HYPH O
5 CD O
, , O
1 CD O
lag NN O
/ SYM O
ml CD O
in IN O
PBS NNP O
- HYPH O
TBSA NNP O
) -RRB- O
was VBD O
added VBN O
. . O

After IN O
incubation NN O
for IN O
1 CD O
h NN O
at IN O
37C CD O
, , O
the DT O
wells NNS O
were VBD O
washed VBN O
again RB O
three CD O
times NNS O
and CC O
100 CD O
of IN O
peroxidase NN O
- HYPH O
labelled VBN O
streptavidin NN O
( , O
1 CD O
/ SYM O
1000 CD O
, , O
Kirkegaard NNP O
& CC O
Perry NNP O
Laboratories NNP O
Inc NNP O
. . O
, , O
Maryland NNP O
, , O
USA NNP O
) -RRB- O
were VBD O
added VBN O
to IN O
each DT O
well NN O
. . O

Following VBG O
incubation NN O
for IN O
l DT O
h NN O
at IN O
37C CD O
and CC O
further JJ O
washing NN O
, , O
the DT O
enzyme NN O
was VBD O
developed VBN O
using VBG O
the DT O
TMB NNP O
substrate NN O
peroxidase NN O
for IN O
5 CD O
min NN O
. . O

The DT O
reaction NN O
was VBD O
stopped VBN O
by IN O
adding VBG O
501 CD O
. . O
tl -RRB- O
of IN O
2 CD O
. . O
0 CD O
N NN O
HCl NN O
, , O
and CC O
the DT O
optical JJ O
densities NNS O
were VBD O
read VBN O
at IN O
490nm CD O
using VBG O
an DT O
automated JJ O
plate NN O
reader NN O
. . O

The DT O
sensitivity NN O
of IN O
the DT O
assay NN O
was VBD O
0 CD O
. . O
15 CD O
ng CD O
/ SYM O
ml NN O
and CC O
the DT O
upper JJ O
limit NN O
100ng CD O
/ SYM O
ml NN O
. . O

the DT O
animal NN O
house NN O
of IN O
Ribeiro NNP O
Preto NNP O
, , O
Uni NNP O

Infection NN O
of IN O
animals NNS O
: : O
T NN B-Species
. . I-Species
canis NN I-Species
eggs NNS O
were VBD O
obtained VBN O
by IN O
the DT O
methods NNS O
of IN O
Olson NNP O
and CC O
Schulz NNP O
, , O
17 CD O
with IN O
minor JJ O
modifications NNS O
. . O

Briefly RB O
, , O
gravid JJ O
female JJ O
worms NNS O
were VBD O
recovered VBN O
from IN O
dogs NNS B-Species
, , O
and CC O
the DT O
eggs NNS O
were VBD O
rescued VBN O
from IN O
the DT O
uterus NN O
, , O
washed VBN O
and CC O
allowed VBN O
to TO O
develop VB O
to IN O
the DT O
infective JJ O
stage NN O
in IN O
shallow JJ O
dishes NNS O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
formalin NN O
at IN O
37C CD O
. . O

Under IN O
light JJ O
ether JJ O
anaesthesia NN O
, , O
the DT O
animals NNS O
were VBD O
infected VBN O
with IN O
I PRP O
ml UH O
saline NN O
containing VBG O
500 CD O
T NN B-Species
. . I-Species
canis NN I-Species
eggs NNS O
, , O
by IN O
gastric JJ O
intubation NN O
using VBG O
a DT O
metal NN O
cannula NN O
. . O

Blood NN O
cell NN O
counts NNS O
: : O
Guinea NNP B-Species
- HYPH I-Species
pigs NNS I-Species
were VBD O
anaesthetized VBN O
with IN O
sodium NN O
pentobarbitone NN O
( , O
30mg CD O
/ SYM O
kg NN O
, , O
i PRP O
. . O
v NN O
. . O
) -RRB- O
and CC O
blood NN O
samples NNS O
were VBD O
collected VBN O
by IN O
cardiac JJ O
puncture NN O
with IN O
10 CD O
% NN O
EDTA NNP O
. . O

Total JJ O
cell NN O
counts NNS O
were VBD O
carried VBN O
out RP O
using VBG O
diluting VBG O
fluid NN O
in IN O
a DT O
Neubauer NNP O
chamber NN O
. . O

Differential JJ O
countings NNS O
were VBD O
obtained VBN O
using VBG O
Rosenfeld NNP O
- HYPH O
stained VBN O
cytocentrifuge NN O
preparations NNS O
, , O

Bronchoalveolar NNP O
lavage NN O
fluid NN O
. . O

The DT O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
were VBD O
killed VBN O
by IN O
an DT O
overdose NN O
of IN O
sodium NN O
pentobarbitone NN O
and CC O
5ml NN O
of IN O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
( , O
PBS NNP O
) -RRB- O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
sodium NN O
citrate NN O
( , O
PBS NNP O
/ SYM O
SC NN O
) -RRB- O
, , O
at IN O
room NN O
temperature NN O
, , O
were VBD O
instilled VBN O
through IN O
a DT O
polyethylene NN O
cannula NN O
introduced VBN O
into IN O
the DT O
trachea NN O
. . O

The DT O
cells NNS O
present JJ O
in IN O
the DT O
bronchoalveolar JJ O
lavage NN O
fluid NN O
( -LRB- O
BALF NNP O
) -RRB- O
were VBD O
recovered VBN O
immediately RB O
. . O

The DT O
procedure NN O
was VBD O
repeated VBN O
once RB O
. . O

The DT O
leucocyte NN O
counts VBZ O
in IN O
the DT O
BAI NNP O
_ : O
were VBD O
determined VBN O
as IN O
described VBN O
above RB O
, , O
Peritoneal JJ O
cells NNS O
: : O
The DT O
cells NNS O
from IN O
the DT O
peritoneal JJ O
cavities NNS O
were VBD O
harvested VBN O
by IN O
injection NN O
of IN O
10ml CD O
of IN O
PBS NNP O
/ SYM O
SC NNP O
into IN O
the DT O
peritoneum NN O
. . O

Only RB O
5 CD O
- SYM O
8 CD O
ml NNS O
of IN O
the DT O

fluid NN O
was VBD O
withdrawn VBN O
for IN O
cell NN O
counts NNS O
, , O
as IN O
described VBN O
above RB O
, , O

Monoclonal JJ O
antibodies NNS O
: : O
The DT O
rat JJ B-Species
monoclonal JJ O
antibody NN O
TRFK NNP O
- HYPH O
5 CD O
was VBD O
a DT O
generous JJ O
gift NN O
from IN O
Dr NNP O
P NNP O
. . O

Minoprio NNP O
, , O
Institut NNP O
Pasteur NNP O
, , O
Paris NNP O
. . O

The DT O
neutralizing VBG O
antibody NN O
was VBD O
purified VBN O
by IN O
precipitation NN O
with IN O
ammonium NN O
sulfate NN O
( : O
45 CD O
% NN O
) -RRB- O
from IN O
ascites NNS O
prepared VBN O
in IN O
CD1 NNP O
nude JJ B-Species
mice NNS I-Species
( , O
Charles NNP O
River NNP O
, , O
St NNP O
Aubin NNP O
les FW O
Elbeuf NNP O
, , O
France NNP O
) , O
inoculated VBN O
1 CD O
week NN O
before IN O
the DT O
injection NN O
of IN O
hybridoma NN O
cells NNS O
, , O
with IN O
I NNP O
ml NNP O
of IN O
pristane NN O
( , O
Sigma NNP O
) -RRB- O
. . O

After IN O
precipitation NN O
and CC O
dialysis NN O
of IN O
the DT O
ascite NN O
fluid NN O
overnight RB O
against IN O
PBS NNP O
, , O
the DT O
dialysate NN O
was VBD O
further RB O
purified VBN O
on IN O
a DT O
Protein NNP O
G1 NNP O
column NN O
( , O
HiTrapTM NNP O
, , O
Pharmacia NNP O
Upsala NNP O
, , O
Sweden NNP O
) -RRB- O
. . O

Bone NN O
marrow NN O
cells NNS O
: : O
Bone NN O
marrow NN O
cells NNS O
were VBD O
collected VBN O
by IN O
flushing VBG O
the DT O
contents NNS O
of IN O
the DT O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species
femur NN O
with IN O
10 CD O
ml NNS O
of IN O
PBS NNP O
/ SYM O
SC NNP O
. . O

Total JJ O
cell NN O
numbers NNS O
were VBD O
determined VBN O
as IN O
above RB O
. . O

In IN O
the DT O
differential JJ O
cell NN O
counts VBZ O
the DT O
cell NN O
populations NNS O
were VBD O
divided VBN O
into IN O
mature JJ O
neutrophils NNS O
, , O
mature JJ O
eosinophils NNS O
and CC O
others NNS O
( , O
mainly RB O
precursors NNS O
and CC O
mononuclear NN O

cells NNS O
) -RRB- O
, , O
Histopathological JJ O
studies NNS O
: : O
Tissues NNS O
were VBD O
removed VBN O
from IN O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
at IN O
various JJ O
times NNS O
post NN O
- HYPH O
infection NN O
and CC O
immediately RB O
fixed VBN O
in IN O
10 CD O
% NN O
formalin NN O
. . O

Tissues NNS O

Eosinophil NN O
and CC O
cytokine NN O
depletion NN O
: : O
Guinea NNP B-Species
- HYPH I-Species
pigs NNS I-Species
were VBD O
injected VBN O
i PRP O
. . O
p LS O
. . O
with IN O
TRFK NNP O
- HYPH O
5 CD O
or CC O
with IN O
the DT O
irrelevant JJ O
antibody NN O
( -LRB- O
rat NN B-Species
IgG NN O
against IN O
total JJ O
anti JJ O
- HYPH O
human NN B-Species
IgG NNP O
) -RRB- O
once RB O
, , O
2mg CD O
/ SYM O
animal NN O
, , O
at IN O
the DT O
time NN O
of IN O
infection NN O
or CC O
at IN O
different JJ O
intervals NNS O
( , O
1 CD O
, , O
3 CD O
, , O
12 CD O
or CC O
17 CD O
days NNS O
) : O
thereafter RB O
. . O

The DT O
animals NNS O
in IN O
this DT O
group NN O
were VBD O
sacririced VBN O
18 CD O
days NNS O
after IN O
infection NN O
. , O
liver NN O
: : O
One CD O
lobule NN O
of IN O
was VBD O
used VBN O
to TO O
determine VB O
the DT O
larval JJ O
each DT O
liver NN O
counts VBZ O
from IN O
infected JJ O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
. . O

Larval NNP O
recovery NN O

Recovery NN O

of IN O
larvae NN O
from IN O

Mediators NNS O
of IN O
Inflammation NNP O
Vol NNP O
5 CD O

1996 CD O

25 CD O

L NN O
. . O

H NN O
. . O

Faccioli NNP O
et FW O
al NNP O
. . O

was VBD O
evaluated VBN O
as IN O
described VBN O
by IN O
Kayes NNP O
and CC O
Oaks NNP O
, , O
18 CD O
with IN O
minor JJ O
modifications NNS O
. . O

Briefly RB O
, , O
the DT O
tissue NN O
was VBD O
chopped VBN O
and CC O
digested VBN O
with IN O
pepsin NN O
- HYPH O
HC1 NNP O
( HYPH O
pH NN O
1 CD O
. . O
5 CD O

1 CD O
. . O
8 CD O
) -RRB- O
for IN O
2h CD O
at IN O
37C CD O
. . O

Larval NNP O
counts NNS O
for IN O
each DT O
sample NN O
were VBD O
performed VBN O
after IN O
centrifugation NN O
and CC O
examination NN O
of IN O
three CD O
100 CD O
- HYPH O
l CD O
. . O
tl CD O
samples NNS O
under IN O
the DT O
light JJ O
microscope NN O
. . O

Statistical JJ O
analysis NN O
: : O
Data NNS O
are VBP O
presented VBN O
as IN O
the DT O
mean NN O
_ : O
+ NFP O
S NN O
. . O
E NN O
. . O
M NN O
. . O
and CC O
were VBD O
analysed VBN O
statistically RB O
using VBG O
the DT O
Mann NNP O
- HYPH O
Whitney NNP O
test NN O
for IN O
unpaired JJ O
data NNS O
. . O

A DT O
p NN O
< SYM O
0 CD O
. . O
5 CD O
value NN O
was VBD O
considered VBN O
to TO O
be VB O
statistically RB O

significant JJ O
. . O

Results NNS O

of IN O
eosinophil NN O
counts NNS O
in IN O
blood NN O
bone NN O
marrow NN O
, , O
BALF NNP O
and CC O
peritoneum NN O
: : O
Guinea NNP B-Species
- HYPH I-Species
pigs NNS I-Species
infected VBN O
with IN O
T NNP B-Species
. . I-Species
canis NN I-Species
eggs NNS O
showed VBD O
a DT O
timedependent JJ O
blood NN O
, , O
bone NN O
- HYPH O
marrow NN O
, , O
BAUV NN O
and CC O
peritoneal JJ O
eosinophilia NN O
( : O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

The DT O
results NNS O
represent VBP O
the DT O
mean NN O
of IN O
nine CD O
animals NNS O
obtained VBN O
in IN O
three CD O
different JJ O
experiments NNS O
. . O

The DT O
eosinophil NN O
number NN O
Kinetics NNS O
16 CD O

increased VBD O
significantly RB O
from IN O
0 CD O
. . O
55 CD O
+ SYM O
_ SYM O
0 CD O
. . O
37 CD O
x SYM O
105 CD O
at IN O
the DT O
beginning NN O
of IN O
experiment NN O
to IN O
6 CD O
. . O
0 CD O
+ NFP O
_ NFP O
_ SYM O
1 CD O
. . O
3 CD O
x SYM O
105 CD O
at IN O
6 CD O
days NNS O
post NN O
- HYPH O
infection NN O
, , O
peaked VBN O
at IN O
day NN O
18 CD O
( SYM O
12 CD O
. . O
0 CD O
_ SYM O
+ SYM O
2 CD O
. . O
31 CD O
x SYM O
105 CD O
) -RRB- O
, , O
and CC O
decreased VBN O
by IN O
day NN O
24 CD O
( SYM O
8 CD O
. . O
11 CD O
2 CD O
. . O
85 CD O
x SYM O
105 CD O
) -RRB- O
( : O
Fig NNP O
. . O
1A CD O
) -RRB- O
. . O

A DT O
rise NN O
in IN O
the DT O
percentage NN O
of IN O
mature JJ O
eosinophils NNS O
in IN O
bone NN O
marrow NN O
"""" '' O
was VBD O
observed VBN O
12 CD O
days NNS O
after IN O
infection NN O
( , O
ranging VBG O
from IN O
6 CD O
2 CD O
% NN O
to IN O
14 CD O
2 CD O
% NN O
) -RRB- O
and CC O
peaked VBN O
at IN O
18 CD O
days NNS O
( : O
17 CD O
2 CD O
% NN O
) -RRB- O
( , O
Fig NNP O
. . O
1B NN O
) -RRB- O
. . O

As IN O
in IN O
blood NN O
, , O
the DT O
number NN O
of IN O
eosinophils NNS O
in IN O
BALF NNP O
increased VBD O
significantly RB O
from IN O
0 CD O
. . O
14 CD O
0 CD O
. . O
6 CD O
x SYM O
105 CD O
to TO O
1 CD O
. . O
37 CD O
_ SYM O
+ SYM O
0 CD O
. . O
35 CD O
x SYM O
105 CD O
at IN O
6 CD O
days NNS O
after IN O
infection NN O
, , O
reaching VBG O
a DT O
peak NN O
at IN O
18 CD O
days NNS O
( : O
10 CD O
. . O
23 CD O
2 CD O
. . O
62 CD O
x SYM O
105 CD O
) -RRB- O
with IN O
an DT O
increase NN O
in IN O
relative JJ O
number NN O
of IN O
as RB O
much JJ O
as IN O
90 CD O
% NN O
in IN O
eosinophil NN O
counts NNS O
in IN O
relation NN O
to IN O
controls NNS O
, , O
and CC O
was VBD O
still RB O
elevated VBN O
at IN O
day NN O
24 CD O
( SYM O
9 CD O
. . O
7 CD O
_ NFP O
_ NFP O
_ NFP O
3 CD O
. . O
47 CD O
x SYM O
10 CD O
s NN O
) -RRB- O
( : O
Fig NN O
. . O
1C NN O
) -RRB- O
. . O

The DT O
remaining VBG O
cells NNS O
in IN O
the DT O
BALF NNP O
were VBD O
alveolar JJ O
macrophages NNS O
, , O
lymphocytes NNS O
, , O
mast NN O
cells NNS O
and CC O
ciliated JJ O
cells NNS O
. . O

In IN O
contrast NN O
to IN O
blood NN O
and CC O
BALF NN O
, , O
the DT O
number NN O
of IN O
eosinophils NNS O
in IN O
the DT O
peritoneal JJ O
cavity NN O
increased VBD O
significantl JJ O
only RB O
at IN O
day NN O
12 CD O
post NN O
- HYPH O
infection NN O
( : O
onset NN O
, , O
2 CD O
. . O
6 CD O
1 CD O
. . O
4 CD O
x SYM O
105 CD O
; : O
day NN O
6 CD O
, , O
3 CD O
. . O
68 CD O
_ : O
+ SYM O
0 CD O
. . O
82 CD O
x SYM O
105 CD O
; : O
day NN O
12 CD O
, , O
5 CD O
. . O
77 CD O
+ NFP O
_ SYM O
1 CD O
. . O
12 CD O
x SYM O
10 CD O
> SYM O
; : O
and CC O
increased VBN O
progres NNS O

_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
. . O

( NFP O
B NN O
) -RRB- O

( : O
AI NNP O
Blood NN O

24 CD O
20 CD O
"""" '' O

Bone NNP O
Marrow NNP O

1612 CD O
8 CD O

4 CD O
O0 NN O

3 LS O

6 CD O

9 CD O

12 CD O

15 CD O

111 CD O

21 CD O

24 CD O

16 CD O

( : O
c NN O
) NFP O
BALF NNP O

16 CD O

ID NN O
) -RRB- O
Peritoneum NNP O

12 CD O

_ NFP O
_ NFP O
o NFP O

12 CD O

8 CD O

4 LS O

0 NFP O
3 CD O

O6 CD O
9 CD O

12 CD O

15 CD O

16 CD O

21 CD O

24 CD O

Days NNS O
postinfoction NN O

FIG NNP O
. . O

1 LS O
. . O

Number NN O
of IN O
eosinophils NNS O
in IN O
blood NN O
, , O
BALF NN O
and CC O
peritoneal JJ O
cavity NN O
, , O
and CC O
percentage NN O
, , O
of IN O
eosinophils NNS O
in IN O
bone NN O
marrow NN O
of IN O
T NN B-Species
. . I-Species
canisqnfected VBN I-Species
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
. . O

Values NNS O
are VBP O
the DT O
mean JJ O
- HYPH O
t NN O
- HYPH O
S NN O
. . O
E NN O
. . O
M NN O
. . O

( : O
n CD O
= SYM O
8 CD O
to IN O
9 CD O
) -RRB- O
. . O

Asterisks NNS O
indicate VBP O
a DT O
significant JJ O
difference NN O
between IN O
infected JJ O
and CC O
noninfected JJ O
animals NNS O
( , O
n SYM O
5 CD O
6 CD O
) -RRB- O
. . O

* NFP O
p NN O
< SYM O
0 CD O
. . O
5 CD O
and CC O
* NFP O
* NFP O
p NN O
< NN O
0 CD O
. . O
1 CD O
. . O

26 CD O
Mediators NNS O
of IN O
Inflammation NNP O
Vol NNP O
5 CD O

1996 CD O

IL NN O
- HYPH O
5 CD O
drives VBZ O
eosinophils NNS O
in IN O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species

sively RB O
until IN O
day NN O
24 CD O
, , O
12 CD O
. . O
44 CD O
4 CD O
- HYPH O
2 CD O
. . O
72 CD O
x SYM O
105 CD O
) -RRB- O
( : O
Fig NNP O
. . O
1D CD O
) -RRB- O
. . O

The DT O
percentage NN O
of IN O
eosinophils NNS O
in IN O
some DT O
animals NNS O
reached VBD O
55 CD O
% NN O
at IN O
the DT O
peak NN O
of IN O
infection NN O
. . O

No DT O
increase NN O
in IN O
the DT O
number NN O
of IN O
mononuclear JJ O
cells NNS O
was VBD O
seen VBN O
in IN O
any DT O
compartment NN O
analysed VBN O
. . O

Larval NNP O
counts NNS O
: : O
The DT O
percentage NN O
of IN O
inoculated VBN O
T NN B-Species
. . I-Species
canis NN I-Species
larvae NN O
recovered VBN O
by IN O
peptic NN O
digestion NN O
of IN O
the DT O
liver NN O
of IN O
experimental JJ O
animals NNS O
4 CD O
h NN O
and CC O
1 CD O
, , O
2 CD O
, , O
3 CD O
, , O
4 CD O
, , O
9 CD O
, , O
12 CD O
and CC O
18 CD O
days NNS O
after IN O
inoculation NN O
of IN O
500 CD O
eggs NNS O
per IN O
animal NN O
is VBZ O
shown VBN O
in IN O
Fig NNP O
. . O

2 LS O
. . O

Most JJS O
of IN O
the DT O
larvae NN O
were VBD O
recovered VBN O
2 CD O
to TO O
4 CD O
days NNS O
after IN O
infection NN O
and CC O
10 CD O
% NN O
recovery NN O
was VBD O
also RB O
observed VBN O
on IN O
day NN O
18 CD O
in IN O
the DT O
liver NN O
of IN O
the DT O
animals NNS O
. . O

150 CD O

120 CD O

IL NN O
- HYPH O
5 CD O
level NN O
in IN O
serum NN O
of IN O
infected JJ O
animals NNS O
: : O
IL NN O
- HYPH O
5 CD O
was VBD O
measured VBN O
in IN O
the DT O
serum NN O
of IN O
infected JJ O
and CC O
normal JJ O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
. . O

Each DT O
time NN O
point NN O
in IN O
Fig NNP O
. . O

3 CD O
represents VBZ O
the DT O
mean NN O
of IN O
results NNS O
from IN O
three CD O
to IN O
five CD O
infected JJ O
animals NNS O
, , O
and CC O
from IN O
six CD O
controls NNS O
. . O

Two CD O
peaks NNS O
of IN O
IL5 NNP O
were VBD O
present JJ O
in IN O
the DT O
serum NN O
of IN O
infected JJ O
guineapigs NNS B-Species
1 CD O
day NN O
after IN O
infection NN O
( : O
102 CD O
_ SYM O
_ : O
+ SYM O
22 CD O
pg NN O
/ SYM O
ml NN O
) -RRB- O
, , O
and CC O
18 CD O
days NNS O
later RB O
( : O
59 CD O
7 CD O
pg NN O
/ SYM O
ml NN O
) -RRB- O
. . O

The DT O
level NN O
of IN O
IL NN O
- HYPH O
5 CD O
in IN O
the DT O
controls NNS O
was VBD O
31 CD O
4 CD O
- SYM O
4 CD O
pg NN O
/ SYM O
ml NN O
. . O

Eosinophil NNP O
numbers NNS O
in IN O
infected JJ O
animals NNS O
treated VBN O
with IN O
TRFK NNP O
- HYPH O
5 CD O
: : O
When WRB O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
received VBD O
an DT O
i CD O
. . O
p NN O
. . O
injection NN O
of IN O
TRFK NNP O
- HYPH O
5 CD O
, , O
the DT O
monoclonal JJ O
antibody NN O
against IN O
IL NN O
- HYPH O
5 CD O
, , O
at IN O
the DT O
time NN O
of IN O
egg NN O
administration NN O
or CC O
1 CD O
day NN O
later RB O
, , O
the DT O
number NN O
of IN O
eosinophils NNS O
in IN O
blood NN O
, , O
BALF NNP O
, , O
peritoneal JJ O
cavity NN O
and CC O
bone NN O
marrow NN O
was VBD O

_ NFP O

30 CD O

0 NFP O

0 NFP O

3 LS O

6 CD O

12 CD O

18 CD O

Days NNS O
postinfection NN O

FIG NNP O
. . O

3 LS O
. . O

IL NN O
- HYPH O
5 CD O
concentration NN O
in IN O
serum NN O
of IN O
T NN B-Species
. . I-Species
caniinfected VBN I-Species
guineapigs NN B-Species
( : O
n SYM O
3 CD O
- HYPH O
5 CD O
) -RRB- O
. . O

Basal NNP O
IL NN O
- HYPH O
5 CD O
concentrations NNS O
were VBD O
of IN O
31 CD O
4 CD O
pg CD O
/ SYM O
ml CD O
( SYM O
n CD O
= SYM O
12 CD O
) -RRB- O
. . O

_ NFP O

24 CD O

60 CD O

50 CD O

40 CD O

0 NFP O

"""" `` O
T NNP O
"""" '' O

1 LS O
"""" '' O

0 NFP O

3 LS O

6 CD O

9 CD O

12 CD O

15 CD O

18 CD O

21 CD O

24 CD O

Days NNS O
postinfection NN O
FIG NN O
. . O

2 LS O
. . O

Percentage NN O
of IN O
T NNP B-Species
. . I-Species
canis NN I-Species
larvae NN O
recovered VBN O
from IN O
liver NN O
of IN O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
studied VBN O
at IN O
various JJ O
times NNS O
post NN O
- HYPH O
infection NN O
. . O

Data NNS O
obtained VBN O
from IN O
five CD O
animals NNS O
. . O

drastically RB O
reduced VBN O
, , O
even RB O
when WRB O
determined VBN O
18 CD O
days NNS O
after IN O
infection NN O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
. . O

No DT O
inhibition NN O
of IN O
eosinophil NN O
counts NNS O
was VBD O
observed VBN O
when WRB O
the DT O
animals NNS O
were VBD O
inoculated VBN O
with IN O
the DT O
irrelevant JJ O
antibody NN O
at IN O
the DT O
time NN O
of IN O
infection NN O
( : O
Table NNP O
1 CD O
) -RRB- O
. . O

Fig NN O
. . O

4 CD O
shows VBZ O
the DT O
comparative JJ O
results NNS O
of IN O
eosinophilia NN O
obtained VBN O
when WRB O
the DT O
antibody NN O
was VBD O
given VBN O
3 CD O
days NNS O
or CC O
17 CD O
days NNS O
after IN O
egg NN O
inoculation NN O
. . O

The DT O
antibody NN O
given VBN O
at IN O
3 CD O
days NNS O
after IN O
infection NN O
induced VBD O
a DT O
high JJ O
percentage NN O
of IN O
inhibition NN O
in IN O
eosinophil NN O
counts NNS O
in IN O
all PDT O
the DT O
compartments NNS O
analysed VBN O
18 CD O
days NNS O
after IN O
infection NN O
( : O
Fig NNP O
. . O
4A CD O
) -RRB- O
. . O

However RB O
, , O
when WRB O
TRFK NNP O
- HYPH O
5 CD O
was VBD O
administered VBN O
to IN O
the DT O
infected JJ O
animals NNS O
on IN O
day NN O
17 CD O
post NN O
- HYPH O
infection NN O
( , O
thus RB O
1 CD O
day NN O
before IN O
sacrifice NN O
) -RRB- O
, , O
a DT O
significant JJ O
inhibition NN O
in IN O
number NN O
and CC O
percentage NN O
of IN O
eosinophils NNS O
was VBD O
observed VBN O
only RB O
in IN O
the DT O
blood NN O
( , O
p NN O
= SYM O
0 CD O
. . O
30 CD O
) -RRB- O
( , O
Fig NNP O
. . O
4B NN O
) -RRB- O
. . O

A DT O
small JJ O
non NN O
- HYPH O
significant JJ O
decrease NN O
was VBD O
seen VBN O
in IN O
BALF NNP O
( : O
p NN O
0 CD O
. . O
790 CD O
) -RRB- O
and CC O
peritoneum NN O
( : O
p NN O
= SYM O
0 CD O
. . O
222 CD O
) -RRB- O
. . O

Moreover RB O
, , O
the DT O
number NN O
of IN O
mature JJ O
eosinophils NNS O
in IN O
bone NN O
marrow NN O
increased VBD O
by IN O
140 CD O
% NN O
( , O
p NN O
0 CD O
. . O
38 CD O
) -RRB- O
. . O

As IN O
demonstrated VBN O
in IN O
Fig NNP O
. . O

4B NN O
, , O
the DT O
behaviour NN O
of IN O
eosinotShilia NN O
in IN O
BALF NNP O
was VBD O
completely RB O
different JJ O
from IN O
that DT O
observed VBN O
in IN O
blood NN O
. . O

Thus RB O
, , O
to TO O
better RBR O
understand VB O
the DT O
eosinophilia NN O
in IN O
the DT O
lungs NNS O
of IN O
infected JJ O
animals NNS O
, , O
we PRP O
monitored VBD O
eosinophil JJ O
numbers NNS O
in IN O
BALF NNP O
after IN O
administration NN O
of IN O
TRFK NNP O
- HYPH O
5 CD O
at IN O
the DT O
same JJ O
time NN O
, , O
or CC O
1 CD O
, , O
3 CD O
, , O
12 CD O
or CC O
17 CD O
days NNS O
after IN O
infection NN O
. . O

The DT O
animals NNS O
were VBD O
sacrificed VBN O
18 CD O
days NNS O
after IN O
infection NN O
. . O

In IN O
another DT O
group NN O
, , O
TRFK NNP O
- HYPH O
5 CD O
was VBD O
administered VBN O
18 CD O
days NNS O
post NN O
- HYPH O
infection NN O
and CC O
the DT O
animals NNS O
were VBD O
sacrificed VBN O
6 CD O
days NNS O
later RB O
. . O

When WRB O
the DT O
mAb NN O
was VBD O
administered VBN O
at IN O
the DT O
same JJ O
time NN O
or CC O
1 CD O
or CC O
3 CD O
days NNS O
postinfection NN O
there EX O
was VBD O
a DT O
significant JJ O
inhibition NN O
in IN O
the DT O
number NN O
of IN O
eosinophils NNS O
( -LRB- O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

These DT O
data NNS O
show VBP O
Mediators NNS O
of IN O
Inflammation NNP O
Vol NNP O
5 CD O

1996 CD O

27 CD O

L NN O
. . O

H NN O
. . O

Faccioli NNP O
et FW O
al NNP O
. . O

Table NN O
1 CD O
. . O

Eosinophils NNS O
in IN O
T NNP O
. . O
caniinfected VBN O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
treated VBN O
or CC O
untreated JJ O
with IN O
TRFK NNP O
- HYPH O
5 CD O
Compartment NNP O

Time NN O
of IN O
sacrifice NN O

( : O
days NNS O
) -RRB- O

Non18 NNP O
24 CD O
18 CD O
24 CD O
18 CD O
24 CD O
18 CD O
24 CD O

treated VBN O

Blood NN O

12 CD O
. . O
18 CD O
5 CD O
. . O
28 CD O
10 CD O
. . O
8 CD O
- HYPH O
t CD O
- HYPH O
2 CD O
. . O
85 CD O
16 CD O
. . O
50 CD O
4 CD O
. . O
42 CD O
6 CD O
. . O
57 CD O
+ NFP O
_ NFP O
_ NFP O
1 CD O
. . O
68 CD O

BALF NNP O
Peritoneal JJ O
cavity NN O

12 CD O
. . O
31 CD O
- HYPH O
I CD O
- HYPH O
2 CD O
. . O
35 CD O
12 CD O
. . O
44 CD O
2 CD O
. . O
33 CD O
9 CD O
6 CD O

Bone NN O
marrow NN O

_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ : O
Days NNS O
of IN O
treatment NN O
with IN O
TRFK NNP O
- HYPH O
5 CD O
after IN O
egg NN O
administration NN O

Irrelevant JJ O
Ab NN O
at IN O
the DT O
time NN O
of IN O
infection NN O

0 NFP O

3 LS O

12 CD O

17 CD O

18 CD O

( : O
n NN O
6 CD O
) NFP O

( : O
n NFP O
= NFP O
4 CD O
) NFP O

( : O
n NFP O
= NFP O
4 CD O
) NFP O

( : O
n NN O
5 CD O
) NFP O

( : O
n NN O
5 CD O
) NFP O

( : O
n NFP O
= NFP O
4 CD O
) NFP O

0 NFP O
. . O
14 CD O
- HYPH O
t NN O
- : O
0 LS O
. . O
14 CD O
"""" '' O

0 NFP O
. . O
26 CD O
0 CD O
. . O
79 CD O

0 NFP O
. . O
26 CD O
* NFP O
0 CD O
. . O
24 CD O
* NFP O

0 NFP O
. . O
17 CD O
_ NFP O
- : O
t LS O
- : O
0 LS O
. . O
17 CD O
"""" '' O

0 NFP O
. . O
15 CD O

0 NFP O
. . O
15 CD O
"""" '' O

2 LS O
. . O
59 CD O

0 NFP O
. . O
80 CD O
* SYM O
4 CD O
. . O
36 CD O
2 CD O
. . O
21 CD O

13 CD O
. . O
32 CD O

4 LS O
. . O
54 CD O

O UH O
. . O

15 CD O

0 NFP O
. . O
15 CD O
* NFP O

0 NFP O
. . O
36 CD O

0 NFP O
. . O
10 CD O
"""" '' O

1 LS O
. . O
22 CD O
- : O
t LS O
- : O
0 CD O
. . O
50 CD O
* NFP O

7 LS O
. . O
7 CD O
- HYPH O
t NN O
- HYPH O
2 CD O
. . O
39 CD O

15 CD O
. . O
24 CD O

29 CD O
. . O
31 CD O
_ NFP O
+ SYM O
15 CD O
. . O
90 CD O
16 CD O
. . O
9 CD O

10 CD O
. . O
33 CD O
_ NFP O
+ SYM O
4 CD O
. . O
10 CD O
3 CD O
. . O
79 CD O

1 LS O
. . O
47 CD O
- HYPH O
t NN O
- HYPH O
0 CD O
. . O
76 CD O
* NFP O
3 CD O

0 NFP O
. . O
48 CD O

_ NFP O
+ NFP O
0 CD O
. . O
35 CD O
* NFP O

0 NFP O
. . O
46 CD O
2 CD O
. . O
6 CD O

0 NFP O
. . O
27 CD O
* NFP O
1 CD O
. . O
3 LS O
"""" '' O

2 LS O
. . O
89 CD O

0 NFP O
. . O
94 CD O
* NFP O

10 CD O
. . O
42 CD O

4 LS O
. . O
0 NFP O

1 LS O
. . O
58 CD O
"""" '' O

- : O
+ NFP O

1 LS O
"""" '' O

1 LS O
. . O
25 CD O
- HYPH O
I NN O
- HYPH O
0 CD O
. . O
25 CD O
* NFP O

+ NFP O

5 CD O

15 CD O
- HYPH O
t NN O
- HYPH O
2 CD O

9 CD O
_ SYM O
+ SYM O
1 CD O

2 LS O

0 NFP O
. . O
7 CD O
* NFP O

In IN O
blood NN O
BALF NN O
and CC O
peritoneal JJ O
cavity NN O
the DT O
values NNS O
represent VBP O
mean JJ O
- HYPH O
t NN O
- HYPH O
_ : O
S NN O
. . O
E NN O
. . O
M NN O
. . O

x SYM O
10 CD O
eosinophils NNS O
. . O

* NFP O
p NN O
< NN O
0 CD O
. . O
5 CD O
. . O

ml NNP O
- HYPH O
1 CD O

and CC O
in IN O
bone NN O
marrow NN O
mean NN O
- HYPH O
t NN O
- HYPH O
_ : O
S NN O
. . O
E NN O
. . O
M NN O
. . O
of IN O
the DT O
percentage NN O
of IN O
mature NN O

that IN O
the DT O
inhibition NN O
of IN O
the DT O
first JJ O
peak NN O
of IN O
IL NN O
- HYPH O
5 CD O
which WDT O
appeared VBD O
at IN O
1 CD O
to IN O
3 CD O
days NNS O
after IN O
infection NN O
as IN O
shown VBN O
in IN O
Fig NNP O
. . O

3 CD O
, , O
is VBZ O
also RB O
very RB O
important JJ O
for IN O
the DT O
establishment NN O
of IN O
eosinophilia NN O
in IN O
the DT O
lungs NNS O
. . O

However RB O
, , O
24 CD O
- HYPH O
( , O
A NN O
) , O

when WRB O
the DT O
mAb NN O
was VBD O
administered VBN O
12 CD O
, , O
17 CD O
or CC O
18 CD O
days NNS O
after IN O
infection NN O
there EX O
was VBD O
no DT O
significant JJ O
inhibition NN O
in IN O
the DT O
numbers NNS O
of IN O
eosinophils NNS O
in IN O
BALF NNP O
( , O
Fig NNP O
. . O
5 CD O
) -RRB- O
, , O
showing VBG O
that IN O
once RB O
established VBN O
, , O
the DT O
eosi18 NN O

15x CD O

16 CD O

12 CD O

. . O
_ NFP O
. . O

0 NFP O

12 CD O

o NFP O

BIo NNP O
o NFP O
d NN O

BALF NNP O

P NN O
e NN O
rit NN O
oneum NN O

Bone NN O
marrow NN O

24 CD O
- : O
( : O
Is VBZ O
) , O

1815 CD O

E NN O
x NN O

20 CD O

16 CD O

o NFP O

12 CD O
/ SYM O
/ SYM O
/ SYM O
. . O

o NFP O
= NFP O
o XX O

12 CD O

0 NFP O
Blood NN O

O UH O
"""" '' O

BALF NNP O

Peritoneum NN O

Bone NN O
marrow NN O
FIG NNP O
. . O

4 LS O
. . O

Number NN O
of IN O
eosinophils NNS O
in IN O
blood NN O
, , O
BALF NN O
and CC O
peritoneum NN O
and CC O
percentage NN O
of IN O
eosinophils NNS O
in IN O
bone NN O
marrow NN O
of IN O
T NNP B-Species
. . I-Species
caniinfected VBN I-Species
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
submitted VBN O
or CC O
not RB O
to IN O
treatment NN O
with IN O
TRFK NNP O
- HYPH O
5 CD O
. . O

( : O
A DT O
) : O
2 CD O
mg NN O
/ SYM O
animal NN O
at IN O
3 CD O
days NNS O
post NN O
- HYPH O
infection NN O
; : O
( : O
B NN O
) SYM O
2 CD O
mg NN O
/ SYM O
animal NN O
17 CD O
days NNS O
post NN O
- HYPH O
infection NN O
. . O

The DT O
treated VBN O
and CC O
control NN O
animals NNS O
were VBD O
sacrificed VBN O
18 CD O
days NNS O
after IN O
infection NN O
. . O

Asterisks NNS O
indicate VBP O
a DT O
significant JJ O
difference NN O
from IN O
infected JJ O
controls NNS O
( , O
n CD O
= SYM O
5 CD O
- HYPH O
6 CD O
) -RRB- O
and CC O
from IN O
animals NNS O
treated VBN O
with IN O
TRFK NNP O
- HYPH O
5 CD O
( SYM O
n CD O
= SYM O
4 CD O
- HYPH O
5 CD O
) -RRB- O
. . O

* NFP O
p NN O
< SYM O
0 CD O
. . O
5 CD O
and CC O
* NFP O
* NFP O
p NN O
< NN O
0 CD O
. . O
1 CD O
. . O

28 CD O
Mediators NNS O
of IN O
Inflammation NNP O
Vol NNP O
5 CD O

1996 CD O

IL NN O
- HYPH O
5 CD O
drives VBZ O
eosinophils NNS O
in IN O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species
24 CD O

E NN O

20 CD O

heart NN O
; : O
data NNS O
not RB O
shown VBN O
) , O
and CC O
muscle NN O
, , O
as IN O
reported VBN O
by IN O
other JJ O
investigators NNS O
, , O
8 CD O
were VBD O
infiltrated VBN O
. . O

The DT O
factors NNS O
responsible JJ O
for IN O
in FW O
vivo FW O
eosinophil NN O
accumulation NN O
at IN O
inflammatory JJ O
sites NNS O
have VBP O
been VBN O

0 NFP O

TRFK NNP O
- HYPH O
5 CD O
i NN O
. . O
p NN O
. . O

0 NFP O

3 LS O

12 CD O
17 CD O

A DT O

B NN O

FIG NNP O
. . O

5 LS O
. . O

Number NN O
of IN O
eosinophils NNS O
in IN O
BALF NNP O
of IN O
T NNP O
. . O
caniinfected VBN O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
submitted VBN O
or CC O
not RB O
to IN O
treatment NN O
with IN O
TRFK NNP O
- HYPH O
5 CD O
. . O

( : O
A DT O
) , O
animals NNS O
were VBD O
sacrificed VBN O
18 CD O
days NNS O
post NN O
- HYPH O
infection NN O
and CC O
( , O
B NN O
) -RRB- O
24 CD O
days NNS O
after IN O
infection NN O
. . O

Asterisks NNS O
indicate VBP O
a DT O
significant JJ O
difference NN O
from IN O
infected JJ O
control NN O
and CC O
from IN O
animals NNS O
treated VBN O
with IN O
TRFK NNP O
- HYPH O
5 CD O
( HYPH O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

nophilia NN O
persists VBZ O
in IN O
lungs NNS O
, , O
probably RB O
by IN O
the DT O
secretion NN O
of IN O
IL NN O
- HYPH O
5 CD O
from IN O
cells NNS O
localized VBN O
in IN O
the DT O
lung NN O
microenvironment NN O
, , O

Histopathological JJ O
analysis NN O
: : O
The DT O
treatment NN O
of IN O
T NNP B-Species
. . I-Species
canis NN I-Species
- HYPH O
infected VBN O
animals NNS O
with IN O
irrelevant JJ O
antibody NN O
showed VBD O
a DT O
widespread JJ O
eosinophilic JJ O
infiltration NN O
as IN O
in IN O
untreated JJ O
animals NNS O
( , O
Fig NNP O
. . O
6A NN O
, , O
B NN O
) -RRB- O
. . O

However RB O
, , O
the DT O
treatment NN O
of IN O
animals NNS O
with IN O
TRFK NNP O
- HYPH O
5 CD O
at IN O
the DT O
same JJ O
time NN O
of IN O
infection NN O
, , O
or CC O
1 CD O
day NN O
or CC O
3 CD O
days NNS O
later RB O
ted VBD O
to IN O
a DT O
complete JJ O
inhibition NN O
of IN O
eosinophil NN O
infiltration NN O
in IN O
the DT O
lung NN O
parenchyma NN O
( , O
Fig NNP O
. . O
6C NNP O
) -RRB- O
. . O

By IN O
contrast NN O
, , O
the DT O
mononuclear JJ O
cell NN O
infiltration NN O
in IN O
the DT O
lungs NNS O
was VBD O
not RB O
modified VBN O
. . O

When WRB O
the DT O
infected JJ O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
received VBD O
TRFK NNP O
- HYPH O
5 CD O
1 CD O
day NN O
before IN O
sacrifice NN O
( , O
or CC O
17 CD O
days NNS O
post NN O
- HYPH O
infection NN O
) -RRB- O
, , O
eosinophil NN O
infiltration NN O
in IN O
the DT O
lung NN O
parenchyma NN O
was VBD O
also RB O
inhibited VBN O
( : O
Fig NNP O
. . O
6D CD O
) -RRB- O
but CC O
not RB O
to IN O
the DT O
same JJ O
extent NN O
as IN O
observed VBN O
in IN O
the DT O
group NN O
receiving VBG O
TRFK NNP O
- HYPH O
5 CD O
given VBN O
at IN O
the DT O
time NN O
of IN O
infection NN O
or CC O
3 CD O
days NNS O
later RB O
. . O

Thus RB O
, , O
the DT O
histological JJ O
determination NN O
of IN O
eosinophil NN O
infiltration NN O
in IN O
these DT O
lungs NNS O
corroborates VBZ O
a DT O
reduction NN O
but CC O
not RB O
a DT O
sizeable JJ O
inhibition NN O
of IN O
eosinophil NN O
numbers NNS O
as IN O
observed VBN O
in IN O
the DT O
BALF NNP O
of IN O
the DT O
same JJ O
infected JJ O
animals NNS O
, . O

poorly RB O
defined VBN O
, , O
although IN O
T NNP O
lymphocytes NNS O
and CC O
mast NN O
cells NNS O
appear VBP O
to TO O
be VB O
involved VBN O
in IN O
eosinophilia NN O
. . O

9 CD O
' '' O
2 CD O
IL NN O
- HYPH O
5 CD O
, , O
a DT O
T NN O
cell NN O
- HYPH O
derived VBN O
factor NN O
that WDT O
regulates VBZ O
B NN O
cell NN O
functions NNS O
, , O
is VBZ O
an DT O
eosinophil NN O
differentiation NN O
factor11 NN O
as RB O
well RB O
as IN O
a DT O
stimulating VBG O
and CC O
survival NN O
- HYPH O
prolonging VBG O
factor NN O
specific JJ O
for IN O
eosinophils NNS O
in IN O
vitro FW O
. . O

2 LS O
Also RB O
, , O
several JJ O
investigators NNS O
have VBP O
demonstrated VBN O
that IN O
sTstemic JJ O
eosinophilia NN O
in IN O
mice NNS B-Species
infected VBN O
with IN O
parasites NNS O
is VBZ O
mediated VBN O
by IN O
IL NNP O
- HYPH O
5 CD O
produced VBN O
in IN O
response NN O
to IN O
the DT O
infection NN O
. . O

2 CD O
' '' O
22 CD O
In IN O
the DT O
present JJ O
study NN O
, , O
the DT O
i CD O
. . O
p NN O
. . O
administration NN O
of IN O
the DT O
TRFK NNP O
- HYPH O
5 CD O
antibody NN O
markedly RB O
inhibited VBD O
the DT O
widespread JJ O
eosinophilia NN O
observed VBN O
in IN O
T NNP B-Species
. . I-Species
canis NN I-Species
- HYPH O
infected VBN O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
, , O
indicating VBG O
that IN O
IL5 NNP O
participated VBD O
in IN O
a DT O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species
model NN O
of IN O
VLMS NNP O
eosinophJlia NNP O
. . O

Most JJS O
of IN O
the DT O
T NN B-Species
. . I-Species
canis NN I-Species
larvae NN O
which WDT O
penetrated VBD O
the DT O
intestinal JJ O
wall NN O
had VBD O
migrated VBN O
into IN O
the DT O
liver NN O
within IN O
72h CD O
after IN O
inoculation NN O
as IN O
demonstrated VBN O
here RB O
and CC O
elsewhere RB O
. . O

2 LS O
It PRP O
is VBZ O
apparently RB O
during IN O
this DT O
interval NN O
that IN O
the DT O
worm NN O
provides VBZ O
the DT O
signals NNS O
to IN O
cytokine NN O
- HYPH O
producing VBG O
cells NNS O
, , O
which WDT O
in IN O
turn NN O
trigger VBP O
increased VBN O
serum JJ O
levels NNS O
of IN O
specific JJ O
cytokine NN O
as IN O
demonstrated VBN O
here RB O
for IN O
IL NN O
- HYPH O
5 CD O
, , O
24 CD O
to TO O
72 CD O
h NN O
after IN O
infection NN O
. . O

The DT O
signals NNS O
may MD O
be VB O
provided VBN O
directly RB O
by IN O
the DT O
invading VBG O
parasite NN O
or CC O
by IN O
cells NNS O
in IN O
response NN O
to IN O
the DT O
parasite NN O
. . O

The DT O
cytokine NN O
pattern NN O
that WDT O
develops VBZ O
at IN O
this DT O
early JJ O
stage NN O
, , O
probably RB O
induced VBN O
by IN O
a DT O
T NNP O
- HYPH O
cell NN O
independent JJ O
pathway NN O
, , O
may MD O
also RB O
influence VB O
the DT O
pattern NN O
of IN O
T NN O
cell NN O
differentiation NN O
into IN O
a DT O
Th2 NNP O
type NN O
, , O
which WDT O
may MD O
be VB O
responsible JJ O
for IN O
the DT O
second JJ O
peak NN O
of IN O
IL NN O
- HYPH O
5 CD O
observed VBN O
in IN O
our PRP$ O
experimental JJ O
model NN O
( , O
Fig NNP O
. . O
3 CD O
) -RRB- O
, , O
although IN O
a DT O
second JJ O
cycle NN O
of IN O
larval JJ O
invasion NN O
( : O
Fig NNP O
. . O
2 CD O
) -RRB- O
with IN O
a DT O
rapid JJ O
peak NN O
of IN O
IL NN O
- HYPH O
5 CD O
liberation NN O
cannot MD O
be VB O
ruled VBN O
out RP O
. . O

Discussion NN O
The DT O
results NNS O
of IN O
the DT O
present JJ O
study NN O
show VBP O
that IN O
in IN O
our PRP$ O
experimental JJ O
model JJ O
widespread JJ O
eosinophilia NN O
follows VBZ O
the DT O
infection NN O
of IN O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
with IN O
second JJ O
stage NN O
eggs NNS O
from IN O
T NNP B-Species
. . I-Species
canis NN I-Species
, , O
as IN O
also RB O
noted VBN O
in IN O
humans NNS B-Species
and CC O
in IN O
other JJ O
experimental JJ O
animals NNS O
. . O

7 CD O
' '' O
7 CD O
T NN B-Species
. . I-Species
canis NN I-Species
is VBZ O
a DT O
potent JJ O
stimulus NN O
for IN O
systemic JJ O
eosinophilia NN O
, , O
since IN O
blood NN O
, , O
BALF NNP O
, , O
peritoneum NN O
and CC O
all DT O
tissues NNS O
examined VBN O
( : O
kidney NN O
, , O
eyes NNS O
, , O
spleen NN O
, , O
thymus NN O
, , O

Thus RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
eosinophilia NN O
against IN O
helminth NN O
larvae NN O
may MD O
be VB O
initiated VBN O
by IN O
the DT O
release NN O
of IN O
IL NN O
- HYPH O
5 CD O
when WRB O
the DT O
parasites NNS O
migrate VBP O
from IN O
the DT O
intestine NN O
to IN O
the DT O
liver NN O
by IN O
stimulation NN O
of IN O
specific JJ O
cell NN O
populations NNS O
. . O

Then RB O
, , O
an DT O
early JJ O
release NN O
of IN O
IL NN O
- HYPH O
5 CD O
quickly RB O
induces VBZ O
eosinophil NN O
recruitment NN O
, , O
probably RB O
first RB O
from IN O
the DT O
stored VBN O
mature JJ O
eosinophil NN O
pool NN O
from IN O
vascular JJ O
endothelium NN O
or CC O
by IN O
the DT O
mobilization NN O
of IN O
eosinophils NNS O
from IN O
extravascular JJ O
sites NNS O
to IN O
the DT O
blood NN O
. . O

This DT O
fact NN O
could MD O
explain VB O
why WRB O
we PRP O
found VBD O
increased JJ O
eosinophils NNS O
first RB O
in IN O
blood NN O
and CC O
later RB O
in IN O
other JJ O
compartments NNS O
. . O

The DT O
early JJ O
IL NN O
- HYPH O
5 CD O
release NN O
may MD O
also RB O
serve VB O
as IN O
a DT O
signal NN O
for IN O
eosinophil NN O
differentiation NN O
and CC O
maturation NN O
in IN O
bone NN O
marrow NN O
. . O

The DT O
time NN O

inteeeal JJ O
observed VBN O
between IN O
the DT O
first JJ O
peak NN O
of IN O
IL NN O
- HYPH O
5 CD O
release NN O
and CC O
the DT O
increase NN O
of IN O
eosinophils NNS O
in IN O
blood NN O
coincides VBZ O
with IN O
that DT O
reported VBN O
to TO O
be VB O
necessary JJ O
for IN O
eosinophil NN O
differentiation NN O
and CC O
maturation NN O
in IN O
vitro FW O
. . O

12Increased VBN O
eosinophil NN O
production NN O
and CC O
liberation NN O
into IN O
blood NN O
and CC O
other JJ O
tissues NNS O
occurs VBZ O
Mediators NNS O
of IN O
Inflammation NNP O
Vol NNP O
5 CD O

1996 CD O

29 CD O

L NN O
. . O

H NN O
. . O

Faccioli NNP O
et FW O
al NNP O
. . O

FIG NNP O
. . O

6 LS O
. . O

( : O
A DT O
) NFP O
photomicrographs NNS O
of IN O
lung NN O
parenchyma NN O
from IN O
guinea NN B-Species
- HYPH I-Species
pigs NNS I-Species
infected VBN O
for IN O
18 CD O
days NNS O
with IN O
T NN B-Species
. . I-Species
cani NN I-Species
, , O
, , O
( , O
B NN O
) -RRB- O
infected JJ O
animals NNS O
which WDT O
were VBD O
treated VBN O
with IN O
irrelevant JJ O
antibody NN O
at IN O
the DT O
time NN O
of IN O
infection NN O
; : O
( , O
C NNP O
) -RRB- O
infected JJ O
animals NNS O
which WDT O
were VBD O
treated VBN O
with IN O
the DT O
mAb NNP O
TRFK NNP O
- HYPH O
5 CD O
at IN O
3 CD O
days NNS O
after IN O
infection NN O
; : O
( : O
D NNP O
) -RRB- O
mAb NN O
administration NN O
17 CD O
days NNS O
after IN O
infection NN O
. . O

The DT O
animals NNS O
were VBD O
sacrificed VBN O
18 CD O
days NNS O
after IN O
infection NN O
. . O

Note VB O
the DT O
intense JJ O
eosinophil JJ O
infiltration NN O
into IN O
the DT O
lung NN O
in IN O
A NN O
and CC O
B NN O
, , O
the DT O
inhibition NN O
of IN O
eosinophils NNS O
in IN O
C NN O
and CC O
the DT O
reduction NN O
of IN O
eosinophils NNS O
in IN O
D NNP O
. . O

thereafter RB O
. . O

Thus RB O
, , O
early JJ O
and CC O
later JJ O
IL NN O
- HYPH O
5 CD O
release NN O
provides VBZ O
a DT O
necessary JJ O
level NN O
of IN O
this DT O
cytokine NN O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
the DT O
maintenance NN O
of IN O
eosinophilia NN O
. . O

We PRP O
may MD O
assume VB O
that IN O
the DT O
inhibition NN O
of IN O
the DT O
first JJ O
peak NN O
of IN O
IL NN O
- HYPH O
5 CD O
release NN O
by IN O
TRFK NNP O
- HYPH O
5 CD O
does VBZ O
not RB O
permit VB O
the DT O
subsequent JJ O
T NN O
cell NN O
stimulation NN O
and CC O
differentiation NN O
. . O

This DT O
may MD O
explain VB O
the DT O
long RB O
- HYPH O
lasting VBG O
effect NN O
of IN O
TRFK5 NNP O
treatment NN O
observed VBN O
here RB O
and CC O
also RB O
reported VBN O
by IN O
others NNS O
. . O

8 LS O
In IN O
agreement NN O
with IN O
our PRP$ O
results NNS O
, , O
there EX O
is VBZ O
an DT O
important JJ O
observation NN O
of IN O
Svetic NNP O
et FW O
al NNP O
. . O

24 CD O
showing VBG O
that IN O
a DT O
specific JJ O
and CC O
highly RB O
reproducible JJ O
IL NN O
- HYPH O
5 CD O
gene NN O
expression NN O
pattern NN O
is VBZ O
detectable JJ O
in IN O
Peyer NNP O
' POS O
s NN O
patches NNS O
by IN O
6 CD O
to IN O
12h CD O
after IN O
Heligmosomoides NNP B-Species
polygyrus NN I-Species
infection NN O
. . O

The DT O
early JJ O
increase NN O
in IN O
IL NN O
- HYPH O
5 CD O
gene NN O
expression NN O
after IN O
infection NN O
was VBD O
probably RB O
T NN O
cell NN O
- HYPH O
independent JJ O
, , O
inasmuch JJ O
as IN O
it PRP O
was VBD O
obseeeed VBN O
in IN O
Peyer NNP O
' POS O
s NN O
patches NNS O
of IN O
congenitally RB O
athymic JJ O
mice NNS B-Species
and CC O
of IN O
conventional JJ O
mice NNS B-Species
treated VBN O
with IN O
anti AFX O
- HYPH O
CD4 NN O
30 CD O
Mediators NNPS O
of IN O
Inflammation NNP O
Vol NNP O
5 CD O

and CC O
anti JJ O
- HYPH O
CD8 NN O
mAb NN O
. . O

Moreover RB O
, , O
Kusama NNP O
eta FW O
/ SYM O
. . O

25 CD O
have VBP O
observed VBN O
two CD O
peaks NNS O
of IN O
eosinophilia NN O
in IN O
normal JJ O
and CC O
athymic JJ O
mice NNS B-Species
, , O
and CC O
suggested VBN O
that IN O
IL NN O
- HYPH O
5 CD O
observed VBN O
in IN O
the DT O
first JJ O
peak NN O
was VBD O
produced VBN O
by IN O
cells NNS O
other JJ O
than IN O
CD4 NNP O
T NNP O
cells NNS O
, , O
since IN O
anti JJ O
- HYPH O
CD4 NN O
and CC O
anti JJ O
- HYPH O
CD3 NN O
mAb NN O
reduced VBD O
only RB O
the DT O
second JJ O
peak NN O
of IN O
eosinophilia NN O
in IN O
normal JJ O
mice NNS B-Species
and CC O
slightly RB O
reduced VBD O
the DT O
first JJ O
peak NN O
of IN O
eosinophilia NN O
in IN O
both DT O
normal JJ O
and CC O
nu NN O
/ SYM O
nu NN O
mice NNS B-Species
. . O

The DT O
local JJ O
lung NN O
cells NNS O
producing VBG O
IL NN O
- HYPH O
5 CD O
may MD O
also RB O
help VB O
us PRP O
to TO O
explain VB O
the DT O
reason NN O
why WRB O
12 CD O
, , O
17 CD O
or CC O
18 CD O
days NNS O
post NN O
- HYPH O
infection NN O
TRFK NNP O
- HYPH O
5 CD O
treatment NN O
only RB O
partially RB O
inhibits VBZ O
, , O
or CC O
does VBZ O
not RB O
inhibit VB O
eosinophil NN O
infiltration NN O
into IN O
the DT O
lungs NNS O
, , O
as IN O
demonstrated VBN O
in IN O
Figs NNP O
5 CD O
and CC O
6 CD O
. . O

We PRP O
may MD O
suggest VB O
that IN O
when WRB O
eosinophils NNS O
have VBP O
already RB O
migrated VBN O
to IN O
the DT O
lungs NNS O
, , O
TRFK NNP O
- HYPH O
5 CD O
has VBZ O
no DT O
power NN O
to TO O
inhibit VB O
eosinophilia NN O
, , O
which WDT O
is VBZ O
also RB O
under IN O
control NN O
of IN O
local JJ O
lung NN O
cells NNS O
producing VBG O
IL NN O
- HYPH O
5 CD O
. . O

In IN O
this DT O
way NN O
, , O
only RB O
one CD O
later RB O
TRFK NNP O

1996 CD O

IL NN O
- HYPH O
5 CD O
drives VBZ O
eosinophils NNS O
in IN O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species

5 CD O
treatment NN O
may MD O
not RB O
be VB O
sufficient JJ O
to TO O
modify VB O
the DT O
lung NN O
parenchyma NN O
microenvironment NN O
, , O
since IN O
T NN B-Species
. . I-Species
canis NN I-Species
antigens NNS O
have VBP O
already RB O
stimulated VBN O
some DT O
cell NN O
populations NNS O
to TO O
produce VB O
IL NN O
- HYPH O
5 CD O
, , O
as IN O
demonstrated VBN O
by IN O
Kusama NNP O
et FW O
aL25These FW O
results NNS O
suggest VBP O
that IN O
eosinophilia NN O
in IN O
lungs NNS O
is VBZ O
under IN O
the DT O
control NN O
of IN O
different JJ O
factors NNS O
when WRB O
compared VBN O
to IN O
that DT O
observed VBN O
in IN O
blood NN O
and CC O
the DT O
peritoneal JJ O
cavity NN O
. . O

One CD O
of IN O
the DT O
most RBS O
important JJ O
results NNS O
obtained VBN O
here RB O
was VBD O
the DT O
inhibition NN O
of IN O
circulating VBG O
eosinophil NN O
numbers NNS O
by IN O
the DT O
different JJ O
mAb NN O
treatments NNS O
, , O
even RB O
when WRB O
the DT O
antibody NN O
was VBD O
given VBN O
at IN O
the DT O
peak NN O
of IN O
blood NN O
eosinophilia NN O
, , O
which WDT O
was VBD O
accompanied VBN O
by IN O
an DT O
increase NN O
of IN O
mature JJ O
eosinophils NNS O
in IN O
bone NN O
marrow NN O
. . O

This DT O
suggests VBZ O
that IN O
IL NN O
- HYPH O
5 CD O
, , O
apart RB O
from IN O
being VBG O
required VBN O
for IN O
the DT O
terminal JJ O
differentiation NN O
of IN O
eosinophils NNS O
in IN O
bone NN O
marrow NN O
, , O
26 CD O
is VBZ O
also RB O
likely JJ O
to TO O
drive VB O
eosinophils NNS O
from IN O
the DT O
bone NN O
marrow NN O
to IN O
the DT O
blood NN O
and CC O
then RB O
to IN O
the DT O
tissues NNS O
, , O
probably RB O
by IN O
upregulating VBG O
VLA NNP O
- HYPH O
4 CD O
expression NN O
in IN O
eosinophils NNS O
. . O

Moser NNP O
et FW O
aL NNP O
have VBP O
demonstrated VBN O
that IN O
in IN O
order NN O
to TO O
acquire VB O
the DT O
ability NN O
to TO O
transmigrate VB O
, , O
eosinophils NNS O
must MD O
be VB O
primed VBN O
with IN O
cytokines NNS O
such JJ O
as IN O
IL NNP O
- HYPH O
5 CD O
, , O
IL NN O
- HYPH O
3 CD O
or CC O
GM NNP O
- HYPH O
CSF NNP O
for IN O
expression NN O
of IN O
adhesion NN O
molecules NNS O
such JJ O
as IN O
VI NNP O
- HYPH O
4 CD O
. . O

Recently RB O
, , O
Pretolani NNP O
et FW O
al NNP O
. . O

27 CD O
have VBP O
indeed RB O
shown VBN O
that IN O
an DT O
anti AFX O
- HYPH O
VLA NN O
- HYPH O
4 CD O
antibody NN O
suppresses VBZ O
eosinophil NN O
recruitment NN O
to IN O
lung NN O
in IN O
the DT O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species
and CC O
, , O
as IN O
a DT O
consequence NN O
, , O
inhibits VBZ O
the DT O
accompanying JJ O
bronchopulmonary JJ O
hyperresponsiveness NN O
. . O

tant NN O
in IN O
protective JJ O
immunity NN O
to IN O
a DT O
gastrointestinal JJ O
nematode NN O
infection NN O
in IN O
mice NNS B-Species
. . O

Proc NNP O
Natl NNP O
Acad NNP O
Sci NNP O
USA NNP O
1991 CD O
; : O
88 CD O
= SYM O
5513 CD O
- HYPH O
5517 CD O
. . O

11 CD O
. . O

Yamaguchi NNP O
A NNP O
, , O
Suda NNP O
T NNP O
, , O
Suda NNP O
J NNP O
, , O
et FW O
al NNP O
. . O

Purified JJ O
interleukin NN O
( , O
IL NN O
- HYPH O
5 CD O
) -RRB- O
supports VBZ O
the DT O
terminal JJ O
differentiation NN O
and CC O
proliferation NN O
of IN O
murine NN B-Species
eosinophilic JJ O

precursors NNS O
. . O

J NNP O
Exp NNP O
Med NNP O
1988 CD O
; : O
16 CD O
' '' O
7 CD O
: : O
43 CD O
- HYPH O
56 CD O
. . O

12 CD O
. . O

Yamaguchi NNP O
Y NNP O
, , O
Hayashi NNP O
Y NNP O
, , O
Sugama NNP O
Y NNP O
, , O
et FW O
al NNP O
. . O

Highly RB O
purified VBN O
murine NN B-Species
interleukin NN O
( , O
IL NN O
- HYPH O
5 CD O
) -RRB- O
stimulates VBZ O
eosinophil NN O
function NN O
and CC O
prolongs VBZ O
in FW O
vitro FW O
survival NN O
. . O

IL NN O
- HYPH O
5 CD O
as IN O
an DT O
eosinophil NN O
chemotactic JJ O
factor NN O
. . O

J NNP O
Exp NNP O
Med NNP O
1988 CD O
; : O
16 CD O
' NN O
7 CD O
: : O
17371752 CD O
. . O

13 CD O
. . O

Rothenberg NNP O
ME NNP O
, , O
Petersen NNP O
J NNP O
, , O
Stevens NNP O
RL NNP O
, , O
Silberstein NNP O
DS NNP O
, , O
McKenzie NNP O
DT NNP O
, , O
Austen NNP O
KF NNP O
, , O
Owen NNP O
WF NNP O
. . O

IL NN O
- HYPH O
5 CD O
- HYPH O
dependent JJ O
conversion NN O
of IN O
normodense JJ O
human JJ B-Species
eosinophils NNS O
to IN O
the DT O
hypodense NN O
phenotype NN O
uses VBZ O
3T3 CD O
fibroblasts NNS O
for IN O
enhanced VBN O
viability NN O
, , O
accelerated VBN O
hypodensity NN O
, , O
and CC O
sustained VBN O
antibodydependent JJ O
cytotoxicity NN O
. . O

J NNP O
Immuno11989 NNP O
; : O
143 CD O
; : O
2311 CD O
- HYPH O
2316 CD O
. . O

14 CD O
. . O

Collins NNP O
PD NNP O
, , O
Weg NNP O
VB NNP O
, , O
Faccioli NNP O
LH NNP O
, , O
Watson NNP O
ML NNP O
, , O
Moqbel NNP O
R NNP O
, , O
Williams NNP O
TJ NNP O
. . O

Eosinophil NNP O
accumulation NN O
induced VBN O
by IN O
human JJ B-Species
interleukin NN O
- HYPH O
8 CD O
in IN O
the DT O
guinea NN B-Species
pig NN I-Species
in IN O
vivo NN O
. . O

Immunology NN O
1993 CD O
; : O
' '' O
7 CD O
} SYM O
; : O
312 CD O
- SYM O
318 CD O
. . O

15 CD O
. . O

Sehmi NNP O
R NNP O
, , O
Wardlavo NNP O
AJ NNP O
, , O
Cromwell NNP O
O NNP O
, , O
Kurihara NNP O
K NNP O
, , O
Waltmann NNP O
P NNP O
, , O
Kay NNP O
AB NNP O
. . O

Interleukin NNP O
- HYPH O
5 CD O
selectively RB O
enhances VBZ O
the DT O
chemotactic JJ O
response NN O
of IN O
eosinophils NNS O
obtained VBN O
from IN O
normal JJ O
but CC O
not RB O
eosinophilic JJ O
subjects NNS O
. . O

Blood NN O
1992 CD O
; : O
' '' O
79 CD O
; : O
2952 CD O
- SYM O
2959 CD O
. . O

16 CD O
. . O

Moser NNP O
R NNP O
, , O
Fehr NNP O
J NNP O
, , O
Bruijnzeel NNP O
PLB NNP O
. . O

IL NN O
- HYPH O
4 CD O
controls VBZ O
the DT O
selective JJ O
endotheliumdriven JJ O
transmigration NN O
of IN O
eosinophils NNS O
from IN O
allergic JJ O
individuals NNS O
. . O

J NNP O
Immunol NNP O
1992 CD O
; : O
149 CD O
: : O
1432 CD O
- HYPH O
1438 CD O
. . O

17 CD O
. . O

Olson NNP O
LJ NNP O
, , O
Schulz NNP O
CW NNP O
. . O

Nematode NNP O
induced VBD O
hypersensitivity NN O
reactions NNS O
in IN O
guinea NN B-Species
pigs NNS I-Species
: : O
onset NN O
of IN O
eosinophilia NN O
and CC O
positive JJ O
Schultz NNP O
- HYPH O
Dale NNP O
reactions NNS O
following VBG O
graded VBN O
infection NN O
with IN O
Toxocara NNP B-Species
canis NN I-Species
. . O

Ann NNP O
N NNP O
Y NNP O
Acad NNP O
Sci NNP O
1963 CD O
; : O
113 CD O
; : O
440 CD O
- HYPH O
455 CD O
. . O

18 CD O
. . O

Kayes NNP O
SG NNP O
, , O
Oaks NNP O

JA NNP O
. . O

Development NN O

of IN O
the DT O
granulomatous JJ O
response NN O
in IN O

murine JJ B-Species
toxocariasis NN O
. . O

I PRP O
. . O

Initial JJ O
events NNS O
. . O

Am VBP O
J NNP O
Patho11978 NNP O
; : O
, , O
} SYM O
3 CD O
; : O

277 CD O
- SYM O
294 CD O
. . O

19 CD O
. . O

Basten NNP O
A NNP O
, , O
Beeson NNP O
PB NNP O
. . O

Mechanisms NNS O
of IN O
eosinophilia NN O
. . O

II NNP O
. . O

Role NN O
of IN O
the DT O
lymphocyte NN O
. . O

J NNP O
Exp NNP O
Med NNP O
1970 CD O
; : O
131 CD O
; : O
1288 CD O
- HYPH O
1305 CD O
. . O

20 CD O
. . O

Plaut NNP O
M NNP O
, , O
Pierce NNP O
JH NNP O
, , O
Watson NNP O
CJ NNP O
, , O
Hanley NNP O
- HYPH O
Hyde NNP O
J NNP O
, , O
Nordan NNP O
RP NNP O
, , O
Paul NNP O
WE NNP O
. . O

Mast JJ O
cell NN O
lines NNS O
produce VBP O
lymphokines NNS O
in IN O
response NN O
to IN O
cross JJ O
- HYPH O
linkage NN O
of IN O
Fc NNP O
epsilon NN O
RI NN O
or CC O
to IN O
calcium NN O
ionophoras NNS O
. . O

Nature NNP O
1989 CD O
; : O
339 CD O
: : O
64 CD O
- HYPH O
67 CD O
. . O

is VBZ O
21 CD O
. . O

Sher NNP O
A NNP O
, , O
Coffman NNP O
RL NNP O
, , O
Hieny NNP O
S NNP O
, , O
Scott NNP O
P NNP O
, , O
Cheever NNP O
AW NNP O
. . O

Interleukin NNP O
required VBD O
for IN O
the DT O
blood NN O
and CC O
tissue NN O
eosinophilia NN O
but CC O
not RB O
granuloma NN O
formation NN O
induced VBN O
by IN O
infection NN O
with IN O
Schistosoma NNP B-Species
mansoni NN I-Species
. . O

Proc NNP O
Natl NNP O
Acad NNP O
Sci NNP O
USA NNP O
1990 CD O
; : O
8 CD O
' '' O
7 CD O
; : O
61 CD O
- HYPH O
65 CD O
. . O

22 CD O
. . O

Herndon NNP O
FJ NNP O
, , O
Kayes NNP O
SG NNP O
. . O

Depletion NN O
of IN O
eosinophils NNS O
by IN O
anti JJ O
- HYPH O
IL NN O
- HYPH O
5 CD O
monoclonal JJ O
antibody NN O
treatment NN O
of IN O
mice NNS B-Species
infected VBN O
with IN O
Trichinella NNP B-Species
spiralis NNS I-Species
does VBZ O
not RB O
alter VB O
parasite NN O
burden NN O
or CC O
immunologic JJ O
resistance NN O
to IN O
reinfection NN O
. . O

J NNP O
Immuno11992 NNP O
; : O
149 CD O
: : O
3642 CD O
- HYPH O
3647 CD O
. . O

23 CD O
. . O

Oshima NNP O
T NNP O
. . O
Standardization NN O
of IN O
techniques NNS O
for IN O
infecting VBG O
mice NNS B-Species
with IN O
Tox24 NNP O
. . O
ocara NN O
canis NNS O
and CC O
observations NNS O
on IN O
the DT O
normal JJ O
migration NN O
routes NNS O
of IN O
the DT O
larvae NN O
. . O

J NNP O
Parasito11961 NNP O
; : O
4 CD O
' CD O
7 CD O
= SYM O
652 CD O
. . O

Svetic NNP O
A NN O
, , O
Madden NNP O
KB NNP O
, , O
Zhou NNP O
XD NNP O
, , O
et FW O
al NNP O
. . O

A DT O
primary JJ O
intestinal JJ O
helminthic JJ O
infection NN O
rapidly RB O
induces VBZ O
a DT O
gut NN O
- HYPH O
associated VBN O
elevation NN O
of IN O
Th2 NNP O
- HYPH O
associated VBN O
cytokines NNS O
and CC O
IL NN O
- HYPH O
3 CD O
. . O

J NNP O
Immuno11993 NNP O
; : O
150 CD O
: : O
3434 CD O
- HYPH O
3441 CD O
. . O

Kusama NNP O
Y NNP O
, , O
Takamoto NNP O
M NNP O
, , O
Kasahara NNP O
T NNP O
, , O
Takatsu NNP O
K NNP O
, , O
Nariuchi NNP O
H NNP O
, , O
Sugane NNP O
K NNP O
. , O
Mechanisms NNS O
of IN O
eosinophilia NN O
in IN O
BALB NNP O
/ SYM O
c NN O
- HYPH O
nu NN O
/ , O
+ CC O
and CC O
congenitally RB O
athymic JJ O
BALB NNP O
/ SYM O
c NN O
- HYPH O
nu NN O
/ SYM O
nu NN O
mice NN B-Species
infected VBN O
with IN O
Toxocara NNP B-Species
canis NNS I-Species
. . O

Immunology NN O
1995 CD O
; : O
84 CD O
; : O
461 CD O
- SYM O
468 CD O
. . O

Rennick NNP O
DM NNP O
, , O
Thompson NNP O
- HYPH O
Snipes NNP O
L NNP O
, , O
Coffman NNP O
RL NNP O
, , O
Seymour NNP O
BWP NNP O
, , O
Jackson NNP O
JD NNP O
, , O
Hudak NNP O
S NNP O
. . O

In IN O
vivo NN O
administration NN O
of IN O
antibody NN O
to IN O
interleukin NN O
- HYPH O
5 CD O
inhibits VBZ O
increased VBN O
generation NN O
of IN O
eosinophils NNS O
and CC O
their PRP$ O
progenitors NNS O
in IN O
bone NN O
marrow NN O
of IN O
parasitized JJ O
mice NNS B-Species
. . O

Blood NN O
1990 CD O
; : O
' '' O
76 CD O
: : O
312 CD O
- SYM O
316 CD O
. . O

Petrolani NNP O
M NNP O
, , O
Ruffle NNP O
C NNP O
, , O
Lapa NNP O
e NNP O
Silva NNP O
JR NNP O
, , O
Joseph NNP O
D NNP O
, , O
Lobb NNP O
RR NNP O
, , O
Boris NNP O
Vargaftig NNP O
B NNP O
. . O
Antibody NN O
to IN O
very RB O
late JJ O
activation NN O
antigen NN O
4 CD O
prevents VBZ O
antigen NN O
- HYPH O
induced VBN O
bronchial JJ O
hyperreactivity NN O
and CC O
cellular JJ O
infiltration NN O
in IN O
guinea NN B-Species
pig NN I-Species
airways NNS O
. . O

J NNP O
Exp NNP O
Med NNP O
1994 CD O
; : O
180 CD O
= SYM O
795 CD O
- HYPH O
805 CD O
. . O

References NNS O
25 CD O
. . O

1 LS O
. . O

Nutman NNP O

2 LS O
. . O

3 LS O
. . O

4 LS O
. . O

5 LS O
. . O

6 LS O
. . O

7 LS O
. . O

8 LS O
. . O

9 LS O
. . O

TB NNP O
, , O
Ottesen NNP O
EA NNP O
, , O
Cohen NNP O
SG NNP O
. . O

The DT O
eosinophil NN O
, , O
eosinophilia NN O
, , O
and CC O
eosinophil NN O
- HYPH O
related VBN O
disorders NNS O
. . O

Allergy NNP O
Proc NNP O
1989 CD O
; : O
10 CD O
; : O
47 CD O
- HYPH O
62 CD O
. . O

Glickman NNP O
LT NNP O
, , O
Schantz NNP O
PM NNP O
. . O

Epidemiology NN O
and CC O
pathogenesis NN O
of IN O
zoonotic JJ O
toxocariasis NN O
. . O

Epidem NNP O
Rev NNP O
1981 CD O
; : O
3 CD O
= SYM O
230 CD O
- HYPH O
250 CD O
. . O

Beaver NNP O
P NNP O
, , O
Snyder NNP O
H NNP O
, , O
Carrera NNP O
G NNP O
, , O
Dent NNP O
J NNP O
, , O
Lafferty NNP O
J NNP O
. . O
Chronic JJ O
eosinophilia NN O
due IN O
to IN O
visceral JJ O
larva NN O
migrans NNS O
. . O

Pediatrics NNP O
1952 CD O
; : O
9 CD O
: SYM O
7 CD O
- HYPH O
19 CD O
. . O

Limaye NNP O
AP NNP O
, , O
Abrams NNP O
JS NNP O
, , O
Silver NNP O
JE NNP O
, , O
Ottesen NNP O
EA NNP O
, , O
Nutman NNP O
TB NNP O
. . O

Regulation NN O
of IN O
parasite NN O
- HYPH O
induced VBN O
eosinophilia NN O
: : O
selectively RB O
increased VBN O
interleukin JJ O
production NN O
in IN O
helminth NN O
- HYPH O
infected VBN O
patients NNS B-Species
. . O

J NNP O
Exp NNP O
Med NNP O
1990 CD O
; : O
l CD O
' '' O
7 CD O
: : O
a DT O
; : O
399 CD O
- SYM O
402 CD O
. . O

Steel NNP O
C NNP O
, , O
Nutman NNP O
TB NNP O
. . O

Regulation NN O
of IN O
IL NN O
- HYPH O
5 CD O
in IN O
onchocerciasis NN O
: : O
a DT O
critical JJ O
role NN O
for IN O
IL NN O
- HYPH O
2 CD O
. . O

J NNP O
Immuno11993 NNP O
; : O
15 CD O
{ , O
} CD O
; : O
5511 CD O
- HYPH O
5518 CD O
. . O

Yamaguchi NNP O
Y NNP O
, , O
Matsui NNP O
T NNP O
, , O
Kasahara NNP O
T NNP O
, , O
et FW O
al NNP O
. . O

In IN O
vivo NN O
changes NNS O
of IN O
hemapoietic JJ O
progenitors NNS O
and CC O
the DT O
expression NN O
of IN O
the DT O
interleukin NN O
gene NN O
in IN O
eosinophilic JJ O
mice NNS B-Species
infected VBN O
with IN O
Toxocara NNP B-Species
canis NNS I-Species
. . O

Exp NNP O
Hemato11990 NNP O
; : O
18 CD O
; : O
1152 CD O
- HYPH O
1157 CD O
. . O

Parsons NNP O
JC NNP O
, , O
Coffman NNP O
RL NNP O
, , O
Grieve NNP O
RB NNP O
. . O

Antibody NN O
to IN O
interleukin NN O
prevents VBZ O
blood NN O
and CC O
tissue NN O
eosinophilia NN O
but CC O
not RB O
liver NN O
trapping NN O
in IN O
murine NN B-Species
larval JJ O
toxocariasis NNS O
. . O

Parasite NNP O
Immuno11993 NNP O
; : O
15 CD O
: : O
501 CD O
- HYPH O
508 CD O
. . O

Coffman NNP O
RL NNP O
, , O
Seymour NNP O
BWP NNP O
, , O
Hudak NNP O
S NNP O
, , O
Jackson NNP O
J NNP O
, , O
Rennick NNP O
D NNP O
. . O
Antibody NN O
to IN O
interleukin NN O
- HYPH O
5 CD O
inhibits VBZ O
helminth NN O
- HYPH O
induced VBN O
eosinophilia NN O
in IN O
mice NNS B-Species
. . O

Science NN O
1989 CD O
; : O
245 CD O
; : O
308 CD O
- SYM O
310 CD O
. . O

Sher NNP O
A NNP O
, , O
Coffman NNP O
RL NNP O
, , O
Hieny NNP O
S NNP O
, , O
Cheever NNP O
AW NNP O
. . O

Ablation NN O
of IN O
eosinophil NN O
and CC O
IgE NNP O
responses NNS O
with IN O
anti JJ O
- HYPH O
IL NN O
- HYPH O
5 CD O
or CC O
anti JJ O
- HYPH O
IL NN O
- HYPH O
4 CD O
antibodies NNS O
fails VBZ O
to TO O
affect VB O
immunity NN O
against IN O
Schistosoma NNP B-Species
mansoni NN I-Species
in IN O
the DT O
mouse NN B-Species
. . O

J NNP O
Immuno11990 NNP O
; : O
145 CD O
: : O
3911 CD O

26 CD O
. . O

27 CD O
. . O

ACKNOWLEDGEMENTS NNS O
. . O

This DT O
work NN O
was VBD O
funded VBN O
by IN O
grant NN O
300652 CD O
/ SYM O
85 CD O
- HYPH O
2 CD O
from IN O
Conselho NNP O
Nacional NNP O
de NNP O
Desenvolvimento NNP O
Cientifico NNP O
e NNP O
Tecnol6gico NNP O
( , O
CNPq NNP O
) -RRB- O
and CC O
Grant NNP O
92 CD O
/ SYM O
5105 CD O
- HYPH O
7 CD O
from IN O
Fundago NNP O
de NNP O
Amparo NNP O
ft IN O
Pesquisa NNP O
do VBP O
Estado NNP O
de NNP O
So NNP O
Paulo NNP O
( , O
FAPESP NNP O
) -RRB- O
. . O

We PRP O
wish VBP O
to TO O
thank VB O
Mrs NNP O
M NNP O
. . O
A DT O
. . O

Fernandes NNP O
for IN O
technical JJ O
assistance NN O
, , O
Mrs NNP O
M NNP O
. . O
M NNP O
. . O
O UH O
. . O

Rossi NNP O
for IN O
the DT O
histological JJ O
sections NNS O
, , O
M NNP O
. . O

Costa NNP O
Gongalves NNP O
for IN O
the DT O
photography NN O
artwork NN O
, , O
and CC O
Dr NNP O
P NNP O
. . O

Minoprio NNP O
, , O
Institut NNP O
Pasteur NNP O
, , O
for IN O
kindly RB O
providing VBG O
TRFK NNP O
- HYPH O
5 CD O
. . O

3916 CD O
. . O

10 CD O
. . O

Urban NNP O

Jr NNP O
JF NNP O
, , O

Katona NNP O
IM NNP O
, , O
Paul NNP O
WE NNP O
, , O
Finkelman NNP O
FD NNP O
. . O

Interleukin NNP O
4 CD O
is VBZ O
impor NN O

Received VBN O
12 CD O
October NNP O
1995 CD O
; : O
accepted VBN O
17 CD O
November NNP O
1995 CD O

Mediators NNS O
of IN O
Inflammation NNP O
Vol NNP O
5 CD O

1996 CD O

31 CD O

Modeling VBG O
the DT O
effect NN O
of IN O
PTPN22 NN O
in IN O
rheumatoid NN O
arthritis NN O

Abstract JJ O

In IN O
order NN O
to TO O
model VB O
the DT O
effect NN O
of IN O
PTPN22 NNP O
on IN O
rheumatoid JJ O
arthritis NN O
( -LRB- O
RA NNP O
) -RRB- O
, , O
we PRP O
determined VBD O
the DT O
combination NN O
of IN O
single JJ O
- HYPH O
nucleotide NN O
- HYPH O
polymorphisms NNS O
( -LRB- O
SNPs NNPS O
) -RRB- O
showing VBG O
the DT O
strongest JJS O
association NN O
with IN O
RA NNP O
. . O

Three CD O
SNPs NNS O
( , O
rs2476601 CD O
- HYPH O
rs12730735 CD O
- HYPH O
rs11102685 CD O
) -RRB- O
were VBD O
selected VBN O
for IN O
which WDT O
we PRP O
estimated VBD O
the DT O
genotypic JJ O
relative JJ O
risks NNS O
( , O
GRRs NNS O
) -RRB- O
of IN O
the DT O
corresponding VBG O
genotypes NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
these DT O
GRRs NNS O
we PRP O
defined VBD O
four CD O
at IN O
- HYPH O
risk NN O
genotypic JJ O
classes NNS O
. . O

Relative JJ O
to IN O
the DT O
class NN O
of IN O
reference NN O
risk NN O
, , O
individuals NNS O
had VBD O
a DT O
risk NN O
approximately RB O
multiplied VBN O
by IN O
two CD O
, , O
three CD O
, , O
or CC O
four CD O
. . O

This DT O
classification NN O
was VBD O
confirmed VBN O
by IN O
the DT O
excess NN O
of IN O
identity NN O
- HYPH O
by IN O
- HYPH O
descent NN O
( : O
IBD NNP O
) -RRB- O
sharing NN O
( , O
IBD NNP O
= SYM O
2 CD O
) -RRB- O
for IN O
the DT O
sibs NNS O
of IN O
an DT O
index NN O
in IN O
the DT O
high JJ O
- HYPH O
risk NN O
class NN O
and CC O
by IN O
excess NN O
of IN O
non JJ O
- HYPH O
IBD NN O
sharing NN O
( : O
IBD NNP O
= SYM O
0 CD O
) -RRB- O
when WRB O
the DT O
index NN O
belonged VBD O
to IN O
the DT O
low JJ O
- HYPH O
risk NN O
class NN O
. . O

The DT O
observed JJ O
data NN O
could MD O
not RB O
be VB O
explained VBN O
by IN O
the DT O
role NN O
of IN O
a DT O
single JJ O
variant NN O
but CC O
were VBD O
compatible JJ O
either CC O
with IN O
a DT O
joint JJ O
effect NN O
of IN O
the DT O
three CD O
typed VBN O
SNPs NNPS O
of IN O
PTPN22 NNP O
on IN O
RA NNP O
or CC O
with IN O
the DT O
role NN O
of IN O
two CD O
untyped JJ O
variants NNS O
. . O

Background NN O

The DT O
single JJ O
- HYPH O
nucleotide NN O
polymorphism NN O
( , O
SNP NNP O
) -RRB- O
R620W NNP O
, , O
also RB O
denoted VBN O
rs2476601 CD O
, , O
is VBZ O
located VBN O
within IN O
the DT O
hematopoietic JJ O
- HYPH O
specific JJ O
protein NN O
tyrosine NN O
phosphatase NN O
gene NN O
, , O
PTPN22 NNP O
. . O

This DT O
SNP NNP O
( , O
C NNP O
/ , O
T NNP O
) -RRB- O
codes NNS O
for IN O
an DT O
amino NN O
- HYPH O
acid NN O
change NN O
and CC O
the DT O
frequency NN O
of IN O
its PRP$ O
minor JJ O
allele NN O
T NNP O
has VBZ O
been VBN O
recently RB O
and CC O
repeatedly RB O
shown VBN O
to TO O
be VB O
increased VBN O
in IN O
patients NNS B-Species
with IN O
rheumatoid JJ O
arthritis NN O
( -LRB- O
RA NNP O
) -RRB- O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
allele NN O
T NNP O
confers VBZ O
1 CD O
. . O
7 CD O
- HYPH O
to IN O
1 CD O
. . O
9 CD O
- HYPH O
fold NN O
increased VBN O
risk NN O
to IN O
heterozygote NN O
and CC O
higher JJR O
risks NNS O
to IN O
homozygote NN O
carriers NNS O
[ -LRB- O
2 CD O
] -RRB- O
compared VBN O
to IN O
the DT O
non AFX O
- HYPH O
carrier NN O
individuals NNS O
. . O

This DT O
variant NN O
is VBZ O
also RB O
well RB O
known JJ O
to TO O
be VB O
associated VBN O
with IN O
several JJ O
other JJ O
autoimmune JJ O
diseases NNS O
[ -LRB- O
3 CD O
] -RRB- O
, , O
such JJ O
as IN O
systemic JJ O
lupus NN O
erythematosus NN O
and CC O
type NN O
1 CD O
diabetes NNS O
. . O

Recently RB O
, , O
Carlton NNP O
et FW O
al NNP O
. . O

[ -LRB- O
2 CD O
] -RRB- O
studied VBD O
the DT O
PTPN22 NNP O
genetic JJ O
variations NNS O
in IN O
the DT O
North NNP O
American NNP O
Rheumatoid NNP O
Arthritis NNP O
Consortium NNP O
( -LRB- O
NARAC NNP O
) -RRB- O
data NNS O
. . O

Using VBG O
the DT O
information NN O
on IN O
several JJ O
SNPs NNS O
typed VBN O
in IN O
PTPN22 NNP O
, , O
they PRP O
compared VBD O
the DT O
haplotype NN O
distributions NNS O
in IN O
NARAC NNP O
patients NNS B-Species
and CC O
controls NNS O
. . O

They PRP O
demonstrated VBD O
that IN O
SNP NNP O
R620W NNP O
does VBZ O
not RB O
fully RB O
explain VB O
the DT O
association NN O
between IN O
PTPN22 NNP O
and CC O
RA NNP O
and CC O
suggested VBD O
the DT O
effect NN O
of IN O
at RB O
least RBS O
one CD O
additional JJ O
variant NN O
in IN O
the DT O
PTPN22 NNP O
gene NN O
. . O

We PRP O
propose VBP O
here RB O
to TO O
reanalyze VB O
the DT O
NARAC NNP O
data NNS O
using VBG O
both CC O
association NN O
and CC O
linkage NN O
information NN O
for IN O
modeling VBG O
the DT O
role NN O
of IN O
PTPN22 NNP O
in IN O
RA NNP O
. . O

Methods NNS O

Data NNS O

We PRP O
selected VBD O
from IN O
the DT O
NARAC NNP O
data NNS O
the DT O
511 CD O
families NNS O
with IN O
affected JJ O
sib NN O
pairs NNS O
typed VBN O
for IN O
14 CD O
SNPs NNPS O
of IN O
PTPN22 NNP O
, , O
and CC O
1404 CD O
unrelated JJ O
controls NNS O
also RB O
typed VBN O
for IN O
all PDT O
these DT O
SNPs NNPS O
. . O

For IN O
each DT O
affected VBN O
sib NN O
pair NN O
we PRP O
considered VBD O
the DT O
proband NN O
as IN O
an DT O
index NN O
RA NN O
patient NN B-Species
. . O

The DT O
R620W NNP O
SNP NNP O
is VBZ O
one CD O
of IN O
the DT O
14 CD O
SNPs NNPS O
in IN O
PTPN22 NNP O
. . O

It PRP O
is VBZ O
located VBN O
at IN O
the DT O
ninth JJ O
position NN O
, , O
so IN O
it PRP O
will MD O
be VB O
subsequently RB O
denoted VBN O
as IN O
SNP NNP O
9 CD O
. . O

A DT O
preliminary JJ O
study NN O
of IN O
linkage NN O
disequilibrium NN O
( -LRB- O
LD NNP O
) -RRB- O
among IN O
the DT O
14 CD O
SNPs NNPS O
was VBD O
examined VBN O
in IN O
the DT O
1404 CD O
controls NNS O
. . O

The DT O
LD NNP O
analysis NN O
lead VBP O
us PRP O
to TO O
exclude VB O
3 CD O
SNPs NNS O
( -LRB- O
SNP NNP O
2 CD O
, , O
SNP NNP O
12 CD O
, , O
SNP NNP O
13 CD O
) -RRB- O
, , O
which WDT O
are VBP O
in IN O
complete JJ O
LD NNP O
with IN O
one CD O
( HYPH O
or CC O
more JJR O
) , O
other JJ O
SNP NNP O
( , O
s NNS O
) -RRB- O
. . O

Selection NN O
of IN O
associated VBN O
SNPs NNPS O

The DT O
combination NN O
test NN O
[ -LRB- O
4 CD O
] -RRB- O
was VBD O
used VBN O
on IN O
the DT O
11 CD O
remaining VBG O
SNPs NNPS O
to TO O
select VB O
the DT O
subset NN O
of IN O
SNPs NNS O
showing VBG O
a DT O
significant JJ O
difference NN O
in IN O
the DT O
genotypic JJ O
distribution NN O
between IN O
RA NNP O
index NN O
patients NNS B-Species
and CC O
controls NNS O
. . O

Its PRP$ O
principle NN O
consists VBZ O
in IN O
testing VBG O
all DT O
possible JJ O
combinations NNS O
of IN O
SNPs NNPS O
within IN O
a DT O
gene NN O
. . O

Here RB O
, , O
there EX O
are VBP O
( : O
211 CD O
- HYPH O
1 CD O
) SYM O
possible JJ O
combinations NNS O
. . O

Such PDT O
a DT O
systematic JJ O
testing NN O
of IN O
all DT O
SNPs NNPS O
and CC O
all DT O
SNP NNP O
combinations NNS O
raises VBZ O
the DT O
problem NN O
of IN O
multiple JJ O
and CC O
non JJ O
- HYPH O
independent JJ O
tests NNS O
. . O

This DT O
problem NN O
is VBZ O
generally RB O
solved VBN O
by IN O
the DT O
implementation NN O
of IN O
a DT O
permutation NN O
procedure NN O
that WDT O
allows VBZ O
estimation NN O
of IN O
corrected JJ O
p NN O
- HYPH O
values NNS O
. . O

Here RB O
, , O
associated VBN O
combinations NNS O
are VBP O
very RB O
significant JJ O
and CC O
the DT O
number NN O
of IN O
permutations NNS O
necessary JJ O
to TO O
discriminate VB O
them PRP O
would MD O
be VB O
extremely RB O
high JJ O
and CC O
almost RB O
unreachable JJ O
. . O

Nevertheless RB O
, , O
the DT O
chi JJ O
- HYPH O
square JJ O
values NNS O
of IN O
the DT O
genotypic JJ O
association NN O
test NN O
are VBP O
so RB O
high JJ O
that IN O
even RB O
the DT O
conservative JJ O
Bonferroni NNP O
correction NN O
can MD O
be VB O
used VBN O
. . O

We PRP O
selected VBD O
the DT O
most RBS O
associated JJ O
and CC O
parsimonious JJ O
subset NN O
of IN O
SNPs NNPS O
by IN O
nested VBN O
chi JJ O
- HYPH O
square NN O
tests NNS O
( , O
NCST NNP O
) -RRB- O
in IN O
a DT O
forward JJ O
procedure NN O
. . O

The DT O
NCST NNP O
compares VBZ O
the DT O
strength NN O
of IN O
association NN O
between IN O
nested VBN O
significant JJ O
subsets NNS O
. . O

Genotypic JJ O
relative JJ O
- HYPH O
risk NN O
estimation NN O

For IN O
the DT O
selected VBN O
subset NN O
of IN O
SNPs NNPS O
, , O
we PRP O
used VBD O
the DT O
marker NN O
association NN O
segregation NN O
chi NN O
- HYPH O
square NN O
( , O
MASC NNP O
) -RRB- O
method NN O
[ -LRB- O
5 CD O
] -RRB- O
to TO O
compute VB O
the DT O
genotypic JJ O
relative JJ O
risk NN O
( -LRB- O
GRR NNP O
) -RRB- O
of IN O
each DT O
genotype NN O
. . O

The DT O
genotype NN O
distributions NNS O
of IN O
index NN O
and CC O
controls NNS O
was VBD O
conditional JJ O
on IN O
the DT O
fact NN O
that IN O
the DT O
index NN O
has VBZ O
an DT O
affected VBN O
sib NN O
. . O

Stratified JJ O
sib NN O
pair NN O
IBD NN O
estimation NN O

Conditional JJ O
on IN O
each DT O
marker NN O
genotype NN O
of IN O
the DT O
index NN O
cases NNS O
, , O
the DT O
number NN O
of IN O
parental JJ O
alleles NNS O
identical JJ O
by IN O
descent NN O
( -LRB- O
IBD NNP O
) -RRB- O
shared VBN O
by IN O
the DT O
index NN O
case NN O
and CC O
one CD O
affected VBN O
sib NN O
were VBD O
estimated VBN O
on IN O
PTPN22 NNP O
with IN O
the DT O
MERLIN NNP O
software NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

MERLIN NNP O
is VBZ O
able JJ O
to TO O
take VB O
into IN O
account NN O
LD NN O
between IN O
SNPs NNPS O
during IN O
the DT O
IBD NNP O
computation NN O
. . O

So RB O
the DT O
estimated VBN O
IBD NNP O
distributions NNS O
are VBP O
computed VBN O
on IN O
the DT O
overall JJ O
set NN O
of IN O
SNPs NNPS O
even RB O
if IN O
they PRP O
are VBP O
in IN O
LD NNP O
. . O

The DT O
fit NN O
of IN O
a DT O
model NN O
to IN O
the DT O
IBD NN O
distributions NNS O
stratified VBN O
on IN O
index NN O
marker NN O
genotypes NNS O
[ -LRB- O
7 CD O
] -RRB- O
may MD O
then RB O
be VB O
tested VBN O
by IN O
the DT O
MASC NNP O
method NN O
. . O

Modeling VBG O
PTPN22 NNP O
effect NN O

We PRP O
applied VBD O
the DT O
MASC NNP O
method NN O
[ -LRB- O
5 CD O
] -RRB- O
to TO O
find VB O
the DT O
most RBS O
parsimonious JJ O
model NN O
explaining VBG O
the DT O
overall JJ O
observations NNS O
, , O
i PRP O
. . O
e LS O
. . O
, , O
the DT O
genotype NN O
and CC O
the DT O
stratified JJ O
sib NN O
- HYPH O
pair NN O
IBD NN O
distributions NNS O
. . O

To TO O
do VB O
this DT O
, , O
MASC NNP O
requires VBZ O
the DT O
haplotype NN O
frequencies NNS O
in IN O
the DT O
general JJ O
population NN O
, , O
which WDT O
were VBD O
estimated VBN O
on IN O
the DT O
unrelated JJ O
controls NNS O
by IN O
the DT O
MERLIN NNP O
software NN O
. . O

The DT O
MASC NNP O
method NN O
computes VBZ O
the DT O
expected JJ O
genotype NN O
marker NN O
distribution NN O
and CC O
the DT O
expected JJ O
sib NN O
- HYPH O
pair NN O
IBD NN O
distributions NNS O
stratified VBN O
on IN O
marker NN O
genotypes NNS O
for IN O
a DT O
given VBN O
genetic JJ O
model NN O
. . O

Here RB O
, , O
the DT O
computation NN O
of IN O
the DT O
genotypic JJ O
distribution NN O
is VBZ O
conditioned VBN O
on IN O
the DT O
fact NN O
that IN O
index NN O
cases NNS O
have VBP O
an DT O
affected VBN O
sib NN O
. . O

The DT O
global JJ O
expected VBN O
likelihood NN O
of IN O
the DT O
genetic JJ O
model NN O
given VBN O
the DT O
observed VBN O
data NNS O
is VBZ O
then RB O
computed VBN O
as IN O
the DT O
product NN O
of IN O
the DT O
likelihoods NNS O
of IN O
each DT O
expected VBN O
distribution NN O
, , O
and CC O
is VBZ O
maximized VBN O
on IN O
the DT O
model NN O
parameters NNS O
. . O

The DT O
fit NN O
of IN O
the DT O
model NN O
to IN O
the DT O
observed VBN O
data NNS O
is VBZ O
tested VBN O
by IN O
a DT O
likelihood NN O
ratio NN O
test NN O
( -LRB- O
LRT NNP O
) -RRB- O
between IN O
global JJ O
expected VBN O
likelihood NN O
and CC O
the DT O
likelihood NN O
of IN O
the DT O
saturated JJ O
model NN O
. . O

Results NNS O

Selection NN O
of IN O
associated VBN O
SNPs NNPS O

Many JJ O
subsets NNS O
of IN O
SNPs NNPS O
show VBP O
significant JJ O
associations NNS O
. . O

Table NNP O
1 CD O
presents VBZ O
a DT O
selection NN O
of IN O
the DT O
most RBS O
associated VBN O
combinations NNS O
of IN O
one CD O
, , O
two CD O
, , O
and CC O
three CD O
SNPs NNS O
. . O

When WRB O
considering VBG O
only RB O
the DT O
effect NN O
of IN O
a DT O
single JJ O
SNP NNP O
, , O
the DT O
only JJ O
significant JJ O
associated VBN O
one CD O
after IN O
correction NN O
for IN O
multiple JJ O
testing NN O
is VBZ O
SNP NNP O
9 CD O
. . O

The DT O
combination NN O
of IN O
SNPs NNPS O
9 CD O
- SYM O
10 CD O
is VBZ O
the DT O
one NN O
which WDT O
, , O
among IN O
the DT O
combination NN O
of IN O
two CD O
SNPs NNS O
, , O
best RBS O
improves VBZ O
the DT O
association NN O
shown VBN O
by IN O
the DT O
SNP NNP O
9 CD O
alone RB O
( : O
p NN O
= SYM O
0 CD O
. . O
17 CD O
) -RRB- O
. . O

The DT O
subset NN O
SNPs NNS O
9 CD O
- SYM O
10 CD O
- SYM O
11 CD O
( SYM O
rs2476601 CD O
- HYPH O
rs12730735 CD O
- HYPH O
rs11102685 CD O
) -RRB- O
is VBZ O
the DT O
only RB O
one CD O
that WDT O
improves VBZ O
significantly RB O
the DT O
association NN O
shown VBN O
by IN O
the DT O
SNPs NNPS O
9 CD O
- SYM O
10 CD O
( , O
p NN O
= SYM O
0 CD O
. . O
38 CD O
) -RRB- O
. . O

Adding VBG O
another DT O
SNP NNP O
to IN O
this DT O
subset NN O
does VBZ O
not RB O
significantly RB O
improve VB O
the DT O
association NN O
. . O

Consequently RB O
, , O
all PDT O
the DT O
subsequent JJ O
analyses NNS O
have VBP O
been VBN O
done VBN O
considering VBG O
SNPs NNP O
9 CD O
- SYM O
10 CD O
- SYM O
11 CD O
and CC O
their PRP$ O
ten CD O
corresponding VBG O
genotypes NNS O
. . O

GRR NNP O
estimation NN O

Table NNP O
2 CD O
displays VBZ O
the DT O
genotypes NNS O
and CC O
the DT O
corresponding VBG O
GRRs NNS O
for IN O
SNP NNP O
9 CD O
taken VBN O
alone RB O
( , O
columns NNS O
1 CD O
and CC O
2 CD O
) -RRB- O
and CC O
for IN O
the DT O
set NN O
of IN O
the DT O
three CD O
SNPs NNS O
9 CD O
- SYM O
10 CD O
- HYPH O
11 CD O
( , O
columns NNS O
3 CD O
and CC O
4 CD O
) -RRB- O
. . O

The DT O
GRRs NNS O
vary VBP O
from IN O
1 CD O
to IN O
2 CD O
. . O
7 CD O
when WRB O
considering VBG O
only RB O
SNP NNP O
9 CD O
, , O
whereas IN O
the DT O
variation NN O
ranges VBZ O
from IN O
1 CD O
to IN O
4 CD O
. . O
7 CD O
when WRB O
the DT O
information NN O
on IN O
the DT O
three CD O
SNPs NNS O
is VBZ O
taken VBN O
into IN O
account NN O
. . O

Interestingly RB O
, , O
the DT O
CC NNP O
genotype NN O
of IN O
the DT O
SNP NNP O
9 CD O
can MD O
be VB O
subdivided VBN O
in IN O
several JJ O
genotypes NNS O
when WRB O
taking VBG O
into IN O
account NN O
the DT O
genotypes NNS O
for IN O
SNPs NNS O
10 CD O
and CC O
11 CD O
( , O
rows NNS O
1 CD O
to IN O
6 CD O
) CD O
with IN O
GRRs NNS O
ranging VBG O
from IN O
1 CD O
( SYM O
CC NNP O
- HYPH O
GG NNP O
- HYPH O
AA NN O
) -RRB- O
to IN O
3 CD O
. . O
6 CD O
( SYM O
CC NN O
- HYPH O
AA NN O
- HYPH O
GG NNP O
) -RRB- O
. . O

This DT O
observation NN O
demonstrates VBZ O
the DT O
importance NN O
of IN O
using VBG O
the DT O
additional JJ O
information NN O
on IN O
SNPs NNP O
10 CD O
- SYM O
11 CD O
. . O

Sib NNP O
pair NN O
IBD NN O
estimation NN O

The DT O
proportion NN O
of IN O
RA NNP O
sibs NNS O
sharing VBG O
0 CD O
, , O
1 CD O
, , O
or CC O
2 CD O
parental JJ O
alleles NNS O
for IN O
PTPN22 NNP O
is VBZ O
0 CD O
. . O
26 CD O
( SYM O
181 CD O
pairs NNS O
) -RRB- O
, , O
0 CD O
. . O
51 CD O
( SYM O
362 CD O
pairs NNS O
) -RRB- O
, , O
and CC O
0 CD O
. . O
23 CD O
( SYM O
167 CD O
pairs NNS O
) -RRB- O
, , O
respectively RB O
, , O
and CC O
does VBZ O
not RB O
differ VB O
from IN O
the DT O
IBD NNP O
distribution NN O
0 CD O
. . O
25 CD O
; : O
0 CD O
. . O
5 CD O
; : O
0 CD O
. . O
25 CD O
expected VBN O
under IN O
no DT O
linkage NN O
. . O

However RB O
, , O
if IN O
our PRP$ O
GRRs NNS O
correctly RB O
reflect VBP O
the DT O
differential JJ O
risk NN O
of IN O
RA NN O
, , O
we PRP O
expect VBP O
to TO O
see VB O
differences NNS O
in IN O
the DT O
IBD NNP O
vectors NNS O
stratified VBN O
on IN O
the DT O
genotypes NNS O
of IN O
the DT O
subset NN O
of IN O
SNPs NNP O
9 CD O
- SYM O
10 CD O
- SYM O
11 CD O
[ -LRB- O
7 CD O
] -RRB- O
. . O

To TO O
avoid VB O
cells NNS O
with IN O
small JJ O
numbers NNS O
of IN O
individuals NNS O
we PRP O
pooled VBD O
sib NN O
pairs NNS O
with IN O
the DT O
index NN O
genotypes NNS O
( , O
SNP NNP O
9 CD O
- SYM O
10 CD O
- SYM O
11 CD O
) -RRB- O
that WDT O
have VBP O
similar JJ O
risk NN O
. . O

We PRP O
thus RB O
defined VBD O
four CD O
arbitrary JJ O
at IN O
risk NN O
genotypic JJ O
classes NNS O
: : O
the DT O
low JJ O
risk NN O
class NN O
( -LRB- O
L NNP O
; : O
GRR NNP O
= SYM O
1 CD O
; : O
19 CD O
pairs NNS O
) -RRB- O
, , O
the DT O
intermediate JJ O
risk NN O
class NN O
1 CD O
( SYM O
I1 CD O
; : O
1 CD O
< SYM O
GRR NN O
< CD O
= SYM O
2 CD O
; : O
295 CD O
pairs NNS O
) -RRB- O
, , O
the DT O
intermediate JJ O
risk NN O
class NN O
2 CD O
( SYM O
I2 CD O
; : O
2 CD O
< SYM O
GRR NN O
< SYM O
= SYM O
3 CD O
; : O
157 CD O
pairs NNS O
) -RRB- O
, , O
and CC O
the DT O
high JJ O
risk NN O
class NN O
( -LRB- O
H NN O
; : O
GRR NNP O
> SYM O
3 CD O
; : O
34 CD O
pairs NNS O
) -RRB- O
. . O

Table NNP O
3 CD O
shows VBZ O
that IN O
the DT O
proportion NN O
of IN O
IBD NN O
= SYM O
0 CD O
decreases NNS O
from IN O
0 CD O
. . O
47 CD O
to IN O
0 CD O
. . O
9 CD O
according VBG O
to IN O
the DT O
fact NN O
that IN O
the DT O
index NN O
belongs VBZ O
to IN O
class NN O
L NN O
or CC O
class NN O
H NN O
and CC O
conversely RB O
, , O
the DT O
proportion NN O
of IN O
IBD NN O
= SYM O
2 CD O
increases NNS O
from IN O
0 CD O
. . O
11 CD O
to IN O
0 CD O
. . O
26 CD O
. . O

These DT O
stratified VBN O
IBD NNP O
distributions NNS O
are VBP O
consistent JJ O
with IN O
the DT O
risk NN O
genotypic JJ O
classes NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
IBD NNP O
sharing NN O
distributions NNS O
stratified VBN O
only RB O
on IN O
SNP NNP O
9 CD O
genotypes NNS O
are VBP O
not RB O
consistent JJ O
with IN O
the DT O
GRR NNP O
estimates NNS O
on IN O
this DT O
SNP NNP O
( -LRB- O
Table NNP O
4 CD O
) -RRB- O
. . O

Modeling VBG O
PTPN22 NNP O
effect NN O

We PRP O
apply VBP O
the DT O
MASC NNP O
method NN O
in IN O
using VBG O
the DT O
genotype NN O
distribution NN O
only RB O
on IN O
the DT O
SNP NNP O
9 CD O
and CC O
the DT O
IBD NNP O
stratified VBN O
on IN O
the DT O
SNP NNP O
9 CD O
genotypes NNS O
. . O

In IN O
that DT O
case NN O
, , O
the DT O
single JJ O
and CC O
causal JJ O
effect NN O
of IN O
the DT O
SNP NNP O
9 CD O
is VBZ O
not RB O
rejected VBN O
( : O
p NN O
= SYM O
0 CD O
. . O
29 CD O
) -RRB- O
. . O

Then RB O
, , O
we PRP O
model VBP O
the DT O
effect NN O
of IN O
PTPN22 NNP O
using VBG O
the DT O
four CD O
genotypic JJ O
groups NNS O
of IN O
risk NN O
defined VBN O
on IN O
the DT O
genotypes NNS O
of IN O
the DT O
combination NN O
of IN O
the DT O
SNPs NNPS O
9 CD O
- SYM O
10 CD O
- SYM O
11 CD O
and CC O
the DT O
IBD NNP O
information NN O
stratified VBN O
on IN O
them PRP O
. . O

In IN O
this DT O
case NN O
, , O
we PRP O
reject VBP O
the DT O
direct JJ O
effect NN O
of IN O
SNP NNP O
9 CD O
( SYM O
p NN O
= SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

We PRP O
also RB O
reject VBP O
the DT O
effect NN O
of IN O
a DT O
single JJ O
untyped JJ O
SNP NNP O
( : O
p NN O
= SYM O
0 CD O
. . O
4 CD O
) -RRB- O
. . O

However RB O
, , O
we PRP O
do VBP O
not RB O
reject VB O
the DT O
interactive JJ O
effect NN O
of IN O
the DT O
3 CD O
SNPs NNS O
( : O
p NN O
= SYM O
0 CD O
. . O
53 CD O
) -RRB- O
or CC O
the DT O
interactive JJ O
effect NN O
of IN O
two CD O
untyped JJ O
SNPs NNPS O
. . O

Discussion NN O

The DT O
involvement NN O
of IN O
PTPN22 NNP O
and CC O
HLA NNP O
in IN O
RA NNP O
susceptibility NN O
is VBZ O
no RB O
longer RBR O
disputed VBN O
. . O

However RB O
, , O
as IN O
shown VBN O
by IN O
Carlton NNP O
et FW O
al NNP O
. , O
and CC O
confirmed VBN O
in IN O
this DT O
study NN O
, , O
the DT O
role NN O
of IN O
PTPN22 NNP O
cannot MD O
be VB O
explained VBN O
only RB O
by IN O
the DT O
R620W NNP O
SNP NNP O
. . O

A DT O
correct JJ O
modeling NN O
of IN O
PTPN22 NNP O
is VBZ O
important JJ O
and CC O
shows VBZ O
that IN O
the DT O
genotypic JJ O
risk NN O
varies VBZ O
much RB O
more RBR O
( : O
1 CD O
to TO O
4 CD O
. . O
7 CD O
) -RRB- O
than IN O
reported VBN O
in IN O
the DT O
literature NN O
( , O
1 CD O
to IN O
2 CD O
. . O
7 CD O
) -RRB- O
[ -LRB- O
4 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
we PRP O
proposed VBD O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
a DT O
model NN O
for IN O
the DT O
effect NN O
of IN O
PTPN22 NNP O
, , O
taking VBG O
into IN O
account NN O
both CC O
association NN O
and CC O
linkage NN O
information NN O
. . O

Another DT O
method NN O
, , O
called VBN O
LAMP NNP O
[ -LRB- O
8 CD O
] -RRB- O
was VBD O
recently RB O
proposed VBN O
for IN O
joint JJ O
modeling NN O
of IN O
linkage NN O
and CC O
association NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

The DT O
linkage NN O
information NN O
used VBN O
by IN O
the DT O
LAMP NNP O
method NN O
is VBZ O
the DT O
global JJ O
IBD NNP O
sharing NN O
of IN O
affected VBN O
sib NN O
pairs NNS O
. . O

However RB O
, , O
it PRP O
is VBZ O
very RB O
important JJ O
to TO O
note VB O
that IN O
the DT O
power NN O
of IN O
model NN O
discrimination NN O
strongly RB O
depends VBZ O
on IN O
the DT O
association NN O
and CC O
linkage NN O
information NN O
that WDT O
is VBZ O
used VBN O
. . O

As IN O
shown VBN O
here RB O
, , O
the DT O
information NN O
on IN O
SNP NNP O
9 CD O
alone RB O
and CC O
on IN O
the DT O
global JJ O
IBD NNP O
is VBZ O
very RB O
poor JJ O
as IN O
compared VBN O
with IN O
that DT O
of IN O
the DT O
three CD O
SNPs NNS O
9 CD O
- SYM O
10 CD O
- SYM O
11 CD O
and CC O
to IN O
the DT O
stratified JJ O
IBD NNP O
distributions NNS O
on IN O
the DT O
four CD O
at IN O
- HYPH O
risk NN O
genotype NN O
groups NNS O
. . O

In IN O
conclusion NN O
, , O
we PRP O
applied VBD O
a DT O
four CD O
- HYPH O
step NN O
strategy NN O
to TO O
model VB O
the DT O
effect NN O
of IN O
a DT O
candidate NN O
gene NN O
covered VBN O
by IN O
several JJ O
SNPs NNS O
: : O
1 CD O
) -RRB- O
to TO O
select VB O
the DT O
most RBS O
associated VBN O
set NN O
of IN O
SNPs NNPS O
; : O
2 CD O
) -RRB- O
to TO O
group VB O
the DT O
corresponding VBG O
genotypes NNS O
according VBG O
their PRP$ O
GRRs NNS O
; : O
3 CD O
) -RRB- O
to TO O
stratify VB O
IBD NN O
sharing VBG O
information NN O
on IN O
the DT O
at IN O
- HYPH O
risk NN O
genotype NN O
groups NNS O
; : O
4 LS O
) -RRB- O
to TO O
model VB O
the DT O
effect NN O
of IN O
the DT O
candidate NN O
gene NN O
while IN O
taking VBG O
into IN O
account NN O
both CC O
linkage NN O
and CC O
association NN O
information NN O
. . O

This DT O
strategy NN O
allowed VBD O
better JJR O
modeling NN O
of IN O
the DT O
effect NN O
of IN O
PTPN22 NNP O
in IN O
RA NNP O
susceptibility NN O
. . O

Recently RB O
, , O
du NNP O
Montcel NNP O
et FW O
al NNP O
. . O

[ -LRB- O
9 CD O
] -RRB- O
refined VBD O
the DT O
modeling NN O
of IN O
HLA NNP O
in IN O
RA NN O
susceptibility NN O
. . O

A DT O
next JJ O
step NN O
will MD O
be VB O
to TO O
use VB O
simultaneously RB O
the DT O
PTPN22 NNP O
and CC O
HLA NNP O
information NN O
to TO O
evaluate VB O
their PRP$ O
joint JJ O
effects NNS O
while IN O
taking VBG O
into IN O
account NN O
important JJ O
covariables NNS O
such JJ O
as IN O
age NN O
and CC O
gender NN O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Purinergic JJ O
signalling NN O
in IN O
the DT O
subretinal JJ O
space NN O
: : O
a DT O
role NN O
in IN O
the DT O
communication NN O
between IN O
the DT O
retina NN O
and CC O
the DT O
RPE NNP O

Abstract JJ O

The DT O
retinal JJ O
pigment NN O
epithelium NN O
( -LRB- O
RPE NNP O
) -RRB- O
is VBZ O
separated VBN O
from IN O
the DT O
photoreceptor NN O
outer JJ O
segments NNS O
by IN O
the DT O
subretinal JJ O
space NN O
. . O

While IN O
the DT O
actual JJ O
volume NN O
of IN O
this DT O
space NN O
is VBZ O
minimal JJ O
, , O
the DT O
communication NN O
that WDT O
occurs VBZ O
across IN O
this DT O
microenvironment NN O
is VBZ O
important JJ O
to IN O
the DT O
visual JJ O
process NN O
, , O
and CC O
accumulating VBG O
evidence NN O
suggests VBZ O
the DT O
purines NNS O
ATP NNP O
and CC O
adenosine NN O
contribute VBP O
to IN O
this DT O
communication NN O
. . O

P1 NN O
and CC O
P2 NN O
receptors NNS O
are VBP O
localized VBN O
to IN O
membranes NNS O
on IN O
both CC O
the DT O
photoreceptor NN O
outer JJ O
segments NNS O
and CC O
on IN O
the DT O
apical JJ O
membrane NN O
of IN O
the DT O
RPE NNP O
which WDT O
border NN O
subretinal JJ O
space NN O
. . O

ATP NNP O
is VBZ O
released VBN O
across IN O
the DT O
apical JJ O
membrane NN O
of IN O
the DT O
RPE NNP O
into IN O
this DT O
space NN O
in IN O
response NN O
to IN O
various JJ O
triggers NNS O
including VBG O
glutamate NN O
and CC O
chemical JJ O
ischemia NN O
. . O

This DT O
ATP NNP O
is VBZ O
dephosphorylated VBN O
into IN O
adenosine NN O
by IN O
a DT O
series NN O
of IN O
ectoenzymes NNS O
on IN O
the DT O
RPE NNP O
apical JJ O
membrane NN O
. . O

Regulation NN O
of IN O
release NN O
and CC O
ectoenzyme NN O
activity NN O
in IN O
response NN O
to IN O
light JJ O
- HYPH O
sensitive JJ O
signals NNS O
can MD O
alter VB O
the DT O
balance NN O
of IN O
purines NNS O
in IN O
subretinal JJ O
space NN O
, , O
and CC O
thus RB O
coordinate VB O
communication NN O
across IN O
subretinal JJ O
space NN O
with IN O
the DT O
visual JJ O
process NN O
. . O

Introduction NN O

The DT O
retinal JJ O
pigment NN O
epithelium NN O
( -LRB- O
RPE NNP O
) -RRB- O
lies VBZ O
between IN O
the DT O
outer JJ O
segments NNS O
of IN O
the DT O
photoreceptors NNS O
and CC O
the DT O
choroidal JJ O
blood NN O
supply NN O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

The DT O
RPE NNP O
combines VBZ O
the DT O
functions NNS O
of IN O
epithelial JJ O
and CC O
glial JJ O
cells NNS O
, , O
providing VBG O
a DT O
barrier NN O
while IN O
also RB O
supporting VBG O
the DT O
neural JJ O
photoreceptors NNS O
and CC O
modulating VBG O
their PRP$ O
function NN O
. . O

Tight JJ O
communication NN O
between IN O
photoreceptors NNS O
and CC O
the DT O
RPE NNP O
is VBZ O
critical JJ O
to TO O
coordinate VB O
the DT O
multiple JJ O
levels NNS O
of IN O
interaction NN O
, , O
and CC O
the DT O
purinergic JJ O
contribution NN O
to IN O
this DT O
communication NN O
is VBZ O
becoming VBG O
apparent JJ O
. . O

The DT O
relevance NN O
of IN O
this DT O
purinergic JJ O
input NN O
is VBZ O
emphasized VBN O
by IN O
the DT O
many JJ O
functional JJ O
effects NNS O
of IN O
P1 NN O
and CC O
P2 NN O
receptor NN O
stimulation NN O
and CC O
by IN O
the DT O
multiple JJ O
mechanisms NNS O
in IN O
place NN O
to TO O
regulate VB O
subretinal JJ O
levels NNS O
of IN O
purine NN O
agonists NNS O
. . O

As IN O
the DT O
dynamics NNS O
of IN O
ATP NNP O
release NN O
and CC O
extracellular JJ O
conversion NN O
into IN O
adenosine NN O
will MD O
modify VB O
agonist JJ O
availability NN O
, , O
the DT O
modulation NN O
of IN O
these DT O
processes NNS O
can MD O
exert VB O
a DT O
temporal JJ O
control NN O
on IN O
purinergic JJ O
signaling NN O
. . O

The DT O
following VBG O
review NN O
will MD O
outline VB O
the DT O
main JJ O
interactions NNS O
between IN O
the DT O
RPE NNP O
and CC O
photoreceptors NNS O
, , O
describe VB O
the DT O
effects NNS O
of IN O
stimulating VBG O
purinergic JJ O
receptors NNS O
on IN O
both DT O
sides NNS O
of IN O
subretinal JJ O
space NN O
, , O
and CC O
summarize VB O
how WRB O
levels NNS O
of IN O
ATP NNP O
, , O
ADP NNP O
, , O
and CC O
adenosine NN O
are VBP O
manipulated VBN O
in IN O
this DT O
microenvironment NN O
. . O

Fig NN O
. . O
1Schematic JJ O
illustration NN O
of IN O
the DT O
key JJ O
components NNS O
of IN O
purinergic JJ O
signaling NN O
in IN O
the DT O
subretinal JJ O
microenvironment NN O
. . O

Stimulation NN O
of IN O
P2 NN O
receptors NNS O
on IN O
the DT O
RPE NNP O
can MD O
enhance VB O
transepithelial JJ O
fluid NN O
absorption NN O
while IN O
P1 NN O
receptors NNS O
can MD O
modulate VB O
phagocytosis NN O
. . O

ATP NNP O
released VBD O
through IN O
CFTR NNP O
and CC O
other JJ O
Cl NN O
- HYPH O
channels NNS O
can MD O
stimulate VB O
P2 NN O
receptors NNS O
or CC O
be VB O
converted VBN O
to IN O
ADP NNP O
, , O
AMP NNP O
, , O
and CC O
adenosine NN O
( , O
Ado NNP O
) -RRB- O
by IN O
a DT O
series NN O
of IN O
ectonucleotidases NNS O
present JJ O
on IN O
the DT O
apical JJ O
membrane NN O
of IN O
the DT O
RPE NNP O
. . O

By IN O
controlling VBG O
the DT O
balance NN O
of IN O
extracellular JJ O
purines NNS O
available JJ O
to TO O
stimulate VB O
these DT O
receptors NNS O
these DT O
mechanisms NNS O
can MD O
control VB O
levels NNS O
of IN O
endogenous JJ O
purines NNS O
available JJ O
to TO O
activate VB O
the DT O
receptors NNS O
. . O

While IN O
theoretically RB O
possible JJ O
, , O
it PRP O
remains VBZ O
to TO O
be VB O
determined VBN O
whether IN O
these DT O
subretinal JJ O
purines NNS O
can MD O
actually RB O
stimulate VB O
photoreceptors NNS O

Purines NNS O
and CC O
subretinal JJ O
space NN O

RPE NN O
- HYPH O
photoreceptor NN O
interactions NNS O
across IN O
the DT O
subretinal JJ O
space NN O

The DT O
outer JJ O
segments NNS O
of IN O
the DT O
rods NNS O
and CC O
cones NNS O
are VBP O
responsible JJ O
for IN O
the DT O
initial JJ O
stages NNS O
of IN O
vision NN O
, , O
converting VBG O
photon NN O
energy NN O
into IN O
a DT O
series NN O
of IN O
enzymatic JJ O
reactions NNS O
that WDT O
close VBP O
the DT O
light JJ O
- HYPH O
sensitive JJ O
channels NNS O
on IN O
the DT O
photoreceptor NN O
plasma NN O
membrane NN O
, , O
hyperpolarize VBP O
the DT O
cells NNS O
, , O
and CC O
reduce VBP O
the DT O
release NN O
of IN O
glutamate NN O
from IN O
the DT O
synaptic JJ O
terminals NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

Efficient JJ O
photoreceptor NN O
function NN O
depends VBZ O
upon IN O
both CC O
short JJ O
- HYPH O
term NN O
and CC O
long JJ O
- HYPH O
term NN O
support NN O
from IN O
the DT O
RPE NNP O
. . O

The DT O
critical JJ O
nature NN O
of IN O
these DT O
interactions NNS O
is VBZ O
evident JJ O
from IN O
the DT O
rapid JJ O
degeneration NN O
of IN O
photoreceptors NNS O
in IN O
the DT O
absence NN O
of IN O
a DT O
healthy JJ O
RPE NNP O
layer NN O
and CC O
by IN O
the DT O
RPE NNP O
localization NN O
of IN O
defective JJ O
gene NN O
product NN O
in IN O
some DT O
forms NNS O
of IN O
hereditary JJ O
photoreceptor NN O
degeneration NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

The DT O
apical JJ O
membrane NN O
of IN O
the DT O
RPE NNP O
is VBZ O
separated VBN O
from IN O
the DT O
plasma NN O
membrane NN O
of IN O
the DT O
outer JJ O
segments NNS O
by IN O
an DT O
extracellular JJ O
space NN O
of IN O
only RB O
10 CD O
- SYM O
20 CD O
nm NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Although IN O
small JJ O
, , O
this DT O
subretinal JJ O
space NN O
contains VBZ O
a DT O
highly RB O
structured VBN O
matrix NN O
which WDT O
ensheathes VBZ O
the DT O
outer JJ O
segments NNS O
and CC O
extends VBZ O
to IN O
the DT O
RPE NNP O
[ -LRB- O
5 CD O
, , O
6 CD O
] -RRB- O
. . O

The DT O
presence NN O
of IN O
enzymes NNS O
within IN O
this DT O
interphotoreceptor NN O
matrix NN O
emphasizes VBZ O
that IN O
this DT O
extracellular JJ O
space NN O
itself PRP O
is VBZ O
functionally RB O
active JJ O
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
. . O

This DT O
intimate JJ O
anatomical JJ O
relationship NN O
between IN O
photoreceptors NNS O
and CC O
the DT O
RPE NNP O
reflects VBZ O
multiple JJ O
functional JJ O
interactions NNS O
. . O

For IN O
example NN O
, , O
the DT O
RPE NNP O
accepts VBZ O
, , O
recycles VBZ O
, , O
and CC O
exports VBZ O
central JJ O
components NNS O
of IN O
the DT O
phototransduction NN O
process NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

The DT O
outer JJ O
segments NNS O
are VBP O
continuously RB O
resynthesized VBN O
, , O
and CC O
the DT O
phagocytosis NN O
, , O
degradation NN O
, , O
and CC O
processing NN O
of IN O
shed NN O
outer JJ O
segment NN O
tips NNS O
by IN O
the DT O
RPE NNP O
cells NNS O
is VBZ O
central JJ O
to IN O
this DT O
renewal NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

The DT O
ion NN O
channels NNS O
and CC O
transporters NNS O
on IN O
the DT O
apical JJ O
membrane NN O
of IN O
the DT O
RPE NNP O
help VBP O
regulate VB O
the DT O
ionic JJ O
composition NN O
of IN O
the DT O
subretinal JJ O
space NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

As IN O
extracellular JJ O
levels NNS O
of IN O
ions NNS O
can MD O
modify VB O
the DT O
ionic JJ O
driving NN O
forces NNS O
across IN O
the DT O
photoreceptor NN O
plasma NN O
membrane NN O
, , O
these DT O
RPE NNP O
transporters NNS O
can MD O
influence VB O
the DT O
state NN O
of IN O
neural JJ O
activity NN O
. . O

The DT O
transport NN O
of IN O
fluid NN O
and CC O
ions NNS O
from IN O
the DT O
apical JJ O
membrane NN O
to IN O
basolateral JJ O
membrane NN O
of IN O
the DT O
RPE NNP O
is VBZ O
also RB O
one CD O
of IN O
the DT O
main JJ O
forces NNS O
keeping VBG O
the DT O
retina NN O
attached VBN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

The DT O
control NN O
of IN O
photoreceptor NN O
activity NN O
by IN O
light NN O
gives VBZ O
a DT O
rapid JJ O
temporal JJ O
dependence NN O
to IN O
some DT O
interactions NNS O
between IN O
the DT O
photoreceptors NNS O
and CC O
the DT O
RPE NNP O
. . O

The DT O
volume NN O
of IN O
subretinal JJ O
space NN O
increases VBZ O
in IN O
response NN O
to IN O
light JJ O
[ -LRB- O
13 CD O
] -RRB- O
, , O
linking VBG O
small JJ O
changes NNS O
in IN O
the DT O
ionic JJ O
composition NN O
of IN O
the DT O
subretinal JJ O
space NN O
with IN O
activity NN O
of IN O
the DT O
RPE NNP O
transport NN O
mechanisms NNS O
which WDT O
maintain VBP O
this DT O
volume NN O
[ -LRB- O
14 CD O
, , O
15 CD O
] -RRB- O
. . O

Other JJ O
processes NNS O
are VBP O
controlled VBN O
on IN O
a DT O
diurnal JJ O
cycle NN O
. . O

The DT O
shed NN O
tips NNS O
of IN O
the DT O
outer JJ O
segments NNS O
are VBP O
phagocytosed VBN O
by IN O
the DT O
RPE NNP O
soon RB O
after IN O
the DT O
onset NN O
of IN O
light NN O
[ -LRB- O
16 CD O
, , O
17 CD O
] -RRB- O
. . O

These DT O
processes NNS O
can MD O
both DT O
be VB O
modulated VBN O
by IN O
purine NN O
levels NNS O
in IN O
subretinal JJ O
space NN O
, , O
indicating VBG O
purinergic JJ O
regulation NN O
is VBZ O
important JJ O
over IN O
multiple JJ O
time NN O
scales NNS O
. . O

Purinergic JJ O
receptors NNS O
on IN O
photoreceptors NNS O

A2 NN O
adenosine NN O
receptors NNS O
were VBD O
localized VBN O
to IN O
both CC O
the DT O
inner JJ O
and CC O
outer JJ O
segments NNS O
of IN O
photoreceptor NN O
outer JJ O
segments NNS O
over IN O
a DT O
decade NN O
ago RB O
by IN O
Blazynski NNP O
and CC O
colleagues NNS O
[ -LRB- O
18 CD O
] -RRB- O
, , O
with IN O
more RBR O
recent JJ O
reports NNS O
emphasizing VBG O
their PRP$ O
functional JJ O
role NN O
. . O

A2 NN O
agonists NNS O
inhibit VBP O
the DT O
L NN O
- HYPH O
type NN O
Ca2 NN O
+ CC O
channel NN O
on IN O
rod NN O
outer JJ O
segments NNS O
[ -LRB- O
19 CD O
] -RRB- O
and CC O
can MD O
inhibit VB O
the DT O
synaptic JJ O
release NN O
of IN O
glutamate NN O
from IN O
rods NNS O
, , O
suggesting VBG O
changes NNS O
in IN O
adenosine NN O
levels NNS O
in IN O
subretinal JJ O
space NN O
could MD O
modulate VB O
light JJ O
sensitivity NN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

The DT O
A2 NNP O
agonist NN O
DPMA NNP O
and CC O
the DT O
adenosine JJ O
deaminase NN O
inhibitor NN O
EHNA NNP O
reduce VBP O
mRNA NN O
for IN O
opsin NN O
in IN O
rods NNS O
, , O
suggesting VBG O
that IN O
endogenous JJ O
levels NNS O
of IN O
adenosine NN O
can MD O
downregulate VB O
opsin NN O
message NN O
at IN O
night NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

EHNA NNP O
and CC O
the DT O
A2A NNP O
receptor NN O
agonist NN O
CGS21680 NNP O
also RB O
increase VBP O
the DT O
survival NN O
of IN O
chick JJ O
embryonic JJ O
photoreceptors NNS O
in IN O
culture NN O
[ -LRB- O
22 CD O
] -RRB- O
, , O
indicating VBG O
a DT O
long JJ O
- HYPH O
term NN O
neuroprotective JJ O
role NN O
for IN O
adenosine NN O
. . O

P2 NN O
receptors NNS O
are VBP O
also RB O
present JJ O
in IN O
the DT O
photoreceptors NNS O
. . O

mRNA NNP O
for IN O
the DT O
P2X2 NNP O
receptor NN O
is VBZ O
expressed VBN O
in IN O
the DT O
photoreceptor NN O
cell NN O
bodies NNS O
, , O
with IN O
immunohistochemical JJ O
localization NN O
of IN O
the DT O
protein NN O
to IN O
outer JJ O
segments NNS O
[ -LRB- O
23 CD O
] -RRB- O
. . O

In IN O
situ NN O
hybridization NN O
indicates VBZ O
the DT O
photoreceptor NN O
layer NN O
has VBZ O
the DT O
highest JJS O
level NN O
of IN O
P2Y2 NN O
receptor NN O
of IN O
any DT O
region NN O
in IN O
the DT O
rabbit NN B-Species
retina NN O
, , O
although IN O
staining VBG O
was VBD O
not RB O
pronounced VBN O
in IN O
monkey NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

P2X7 NN O
receptors NNS O
have VBP O
recently RB O
been VBN O
localized VBN O
to IN O
photoreceptor NN O
synaptic JJ O
terminals NNS O
, , O
with IN O
evidence NN O
for IN O
ecto NN O
- HYPH O
ATPase NN O
activity NN O
in IN O
the DT O
synapse NN O
, , O
and CC O
functional JJ O
evidence NN O
suggesting VBG O
ATP NNP O
augments VBZ O
transmission NN O
of IN O
the DT O
light JJ O
response NN O
by IN O
rods NNS O
[ -LRB- O
25 CD O
] -RRB- O
. . O

It PRP O
was VBD O
suggested VBN O
that IN O
ATP NNP O
might MD O
be VB O
co NN O
- HYPH O
released VBN O
from IN O
photoreceptors NNS O
with IN O
glutamate NN O
, , O
although IN O
this DT O
remains VBZ O
to TO O
be VB O
tested VBN O
directly RB O
. . O

Purinergic JJ O
receptors NNS O
on IN O
the DT O
RPE NNP O

Stimulation NN O
of IN O
P1 NN O
receptors NNS O
can MD O
have VB O
a DT O
considerable JJ O
impact NN O
on IN O
RPE NNP O
cells NNS O
. . O

A2 NN O
receptors NNS O
have VBP O
been VBN O
recognized VBN O
on IN O
cultured JJ O
and CC O
fresh JJ O
RPE NNP O
cells NNS O
for IN O
some DT O
time NN O
[ -LRB- O
26 CD O
, , O
27 CD O
] -RRB- O
, , O
with IN O
in IN O
situ NN O
hybridization NN O
confirming VBG O
the DT O
presence NN O
of IN O
A2A NN O
receptors NNS O
in IN O
rat NN B-Species
RPE NNP O
[ -LRB- O
28 CD O
] -RRB- O
. . O

Stimulation NN O
of IN O
A2 NN O
receptors NNS O
reduces VBZ O
the DT O
rate NN O
of IN O
rod NN O
outer JJ O
segment NN O
phagocytosis NN O
by IN O
RPE NNP O
cells NNS O
[ -LRB- O
29 CD O
] -RRB- O
, , O
while IN O
application NN O
of IN O
adenosine NN O
to IN O
the DT O
apical JJ O
membrane NN O
of IN O
chick NN O
RPE NNP O
cells NNS O
increases VBZ O
the DT O
basolateral JJ O
Cl NN O
- HYPH O
conductance NN O
, , O
the DT O
transepithelial JJ O
potential NN O
, , O
and CC O
the DT O
c NN O
- HYPH O
wave NN O
, , O
and CC O
decreases VBZ O
the DT O
hyperpolarization NN O
of IN O
the DT O
basal JJ O
membrane NN O
in IN O
response NN O
to IN O
light NN O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Although IN O
adenosine NN O
alone RB O
does VBZ O
not RB O
increase VB O
intracellular JJ O
Ca2 NN O
+ CC O
levels NNS O
[ -LRB- O
31 CD O
] -RRB- O
, , O
adenosine NN O
acts VBZ O
synergistically RB O
with IN O
ATP NNP O
to TO O
elevate VB O
Ca2 NN O
+ CC O
levels NNS O
in IN O
human JJ B-Species
RPE NNP O
cells NNS O
by IN O
stimulating VBG O
both CC O
A1 NNP O
and CC O
A2A NNP O
receptors NNS O
[ -LRB- O
32 CD O
, , O
33 CD O
] -RRB- O
. . O

Stimulation NN O
of IN O
A1 NN O
receptors NNS O
with IN O
high JJ O
doses NNS O
of IN O
NECA NNP O
increases VBZ O
the DT O
active JJ O
transport NN O
of IN O
fluorescein NN O
across IN O
the DT O
RPE NNP O
, , O
while IN O
activation NN O
of IN O
A2A NNP O
receptors NNS O
decreases VBZ O
this DT O
transport NN O
, , O
and CC O
by IN O
extension NN O
, , O
transport NN O
of IN O
the DT O
ions NNS O
that WDT O
underlie VBP O
fluid JJ O
movement NN O
[ -LRB- O
34 CD O
] -RRB- O
. . O

Stimulation NN O
of IN O
A1 NNP O
and CC O
A2A NNP O
receptors NNS O
produces VBZ O
analogous JJ O
increases NNS O
and CC O
decreases VBZ O
, , O
respectively RB O
, , O
in IN O
the DT O
absorption NN O
of IN O
subretinal JJ O
fluid NN O
blebs NNS O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
the DT O
negative JJ O
coupling NN O
of IN O
the DT O
A1 NNP O
receptor NN O
and CC O
the DT O
positive JJ O
coupling NN O
of IN O
the DT O
A2 NN O
receptors NNS O
to TO O
adenylate VB O
cyclase NN O
, , O
as IN O
increasing VBG O
cAMP NN O
inhibits VBZ O
the DT O
transport NN O
of IN O
fluid NN O
across IN O
the DT O
RPE NNP O
towards IN O
the DT O
choroid NN O
[ -LRB- O
35 CD O
- SYM O
37 CD O
] -RRB- O
. . O

The DT O
agonist NN O
2 CD O
- HYPH O
Cl NN O
adenosine NN O
reverses VBZ O
the DT O
deficit NN O
in IN O
phosphoinositide NN O
metabolism NN O
found VBN O
in IN O
diabetic JJ O
RPE NNP O
cells NNS O
[ -LRB- O
38 CD O
] -RRB- O
, , O
suggesting VBG O
effects NNS O
on IN O
metabolism NN O
in IN O
addition NN O
to IN O
transport NN O
and CC O
phagocytosis NN O
. . O

Multiple JJ O
P2 NN O
receptors NNS O
have VBP O
been VBN O
localized VBN O
to IN O
the DT O
RPE NNP O
. . O

The DT O
P2Y2 NNP O
receptor NN O
was VBD O
initially RB O
characterized VBN O
in IN O
cultured JJ O
human JJ B-Species
RPE NNP O
[ -LRB- O
31 CD O
] -RRB- O
, , O
with IN O
subsequent JJ O
reports NNS O
localizing VBG O
transcript NN O
for IN O
P2Y1 NNP O
, , O
P2Y2 NNP O
, , O
P2Y4 NNP O
, , O
and CC O
P2Y6 NN O
in IN O
the DT O
rat NN B-Species
RPE NN O
/ SYM O
choroid NN O
[ -LRB- O
39 CD O
] -RRB- O
and CC O
for IN O
P2Y1 NN O
and CC O
P2Y12 NN O
receptors NNS O
in IN O
ARPE NNP O
- HYPH O
19 CD O
cells NNS O
[ -LRB- O
40 CD O
] -RRB- O
, , O
and CC O
functionally RB O
identifying VBG O
a DT O
P2X NN O
receptor NN O
in IN O
rat NN B-Species
RPE NNP O
cells NNS O
[ -LRB- O
41 CD O
] -RRB- O
. . O

ATP NNP O
, , O
ADP NNP O
, , O
and CC O
UTP NNP O
induce VBP O
numerous JJ O
effects NNS O
on IN O
RPE NNP O
physiology NN O
[ -LRB- O
32 CD O
, , O
33 CD O
, , O
42 CD O
, , O
43 CD O
] -RRB- O
. . O

While IN O
these DT O
effects NNS O
likely RB O
involve VBP O
multiple JJ O
different JJ O
receptor NN O
types NNS O
, , O
the DT O
contributions NNS O
of IN O
the DT O
P2Y2 NNP O
receptor NN O
have VBP O
been VBN O
explored VBN O
in IN O
most JJS O
detail NN O
to IN O
date NN O
. . O

The DT O
P2Y2 NNP O
receptor NN O
has VBZ O
been VBN O
specifically RB O
localized VBN O
to IN O
the DT O
apical JJ O
membrane NN O
of IN O
fresh JJ O
bovine JJ B-Species
RPE NNP O
cells NNS O
, , O
and CC O
addition NN O
of IN O
ATP NN O
to IN O
this DT O
membrane NN O
transiently RB O
elevates VBZ O
Ca2 NN O
+ CC O
, , O
activates VBZ O
a DT O
basolateral JJ O
Cl NN O
- HYPH O
conductance NN O
, , O
inhibits VBZ O
an DT O
apical JJ O
K NN O
+ CC O
conductance NN O
, , O
and CC O
increases VBZ O
the DT O
apical JJ O
to IN O
basolateral JJ O
flow NN O
of IN O
fluid NN O
[ -LRB- O
43 CD O
] -RRB- O
. . O

This DT O
increased VBN O
absorption NN O
of IN O
fluid NN O
from IN O
the DT O
subretinal JJ O
space NN O
suggests VBZ O
P2Y2 NN O
receptor NN O
stimulation NN O
could MD O
reduce VB O
the DT O
excess JJ O
fluid NN O
that WDT O
accumulates VBZ O
in IN O
retinal JJ O
edemas NNS O
, , O
and CC O
several JJ O
reports NNS O
have VBP O
supported VBN O
this DT O
theory NN O
. . O

ATP NNP O
, , O
UTP NNP O
, , O
and CC O
the DT O
P2Y2 NNP O
receptor NN O
agonist NN O
INS37217 NNP O
decrease VBP O
the DT O
size NN O
of IN O
subretinal JJ O
fluid NN O
blebs NNS O
when WRB O
injected VBN O
into IN O
subretinal JJ O
space NN O
of IN O
rats NNS B-Species
[ -LRB- O
44 CD O
] -RRB- O
. . O

In IN O
both CC O
normal JJ O
and CC O
rds NNS O
+ CC O
/ SYM O
- HYPH O
mice NNS B-Species
with IN O
experimentally RB O
induced VBN O
detachment NN O
, , O
INS31217 NNP O
improves VBZ O
the DT O
ERG NNP O
recovery NN O
and CC O
decreased VBN O
cell NN O
death NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

INS37217 NNP O
also RB O
reduces VBZ O
subretinal JJ O
blebs NNS O
in IN O
rabbits NNS B-Species
[ -LRB- O
46 CD O
] -RRB- O
. . O

Injection NN O
of IN O
another DT O
P2Y2 NNP O
agonist NN O
, , O
INS542 NN O
, , O
increases VBZ O
the DT O
active JJ O
transport NN O
of IN O
fluorescein NN O
across IN O
the DT O
RPE NNP O
, , O
consistent JJ O
with IN O
this DT O
upregulation NN O
of IN O
ion NN O
and CC O
fluid NN O
transport NN O
across IN O
the DT O
tissue NN O
[ -LRB- O
47 CD O
] -RRB- O
. . O

Together RB O
these DT O
experiments NNS O
emphasize VBP O
the DT O
clinical JJ O
potential NN O
of IN O
treating VBG O
retinal JJ O
edema NN O
with IN O
P2Y2 NNP O
agonists NNS O
. . O

Regulation NN O
of IN O
purine NN O
levels NNS O
in IN O
subretinal JJ O
space NN O

While IN O
synthesized VBN O
purinergic JJ O
agonists NNS O
may MD O
prove VB O
useful JJ O
in IN O
treating VBG O
some DT O
ocular JJ O
disorders NNS O
, , O
the DT O
endogenous JJ O
activation NN O
of IN O
P1 NN O
and CC O
P2 NN O
receptors NNS O
in IN O
the DT O
subretinal JJ O
microenvironment NN O
will MD O
ultimately RB O
be VB O
determined VBN O
by IN O
availability NN O
of IN O
agonists NNS O
. . O

These DT O
levels NNS O
are VBP O
largely RB O
controlled VBN O
by IN O
the DT O
release NN O
of IN O
ATP NNP O
into IN O
the DT O
subretinal JJ O
space NN O
, , O
its PRP$ O
conversion NN O
into IN O
other JJ O
purines NNS O
including VBG O
adenosine NN O
, , O
and CC O
the DT O
manipulation NN O
of IN O
adenosine NN O
by IN O
enzymes NNS O
or CC O
transporters NNS O
. . O

Recent JJ O
work NN O
has VBZ O
increased VBN O
our PRP$ O
understanding NN O
of IN O
both CC O
the DT O
stimuli NNS O
that WDT O
initiate VBP O
changes NNS O
in IN O
subretinal JJ O
purine NN O
levels NNS O
and CC O
the DT O
mechanisms NNS O
that WDT O
mediate VBP O
these DT O
changes NNS O
. . O

Release NN O
of IN O
ATP NNP O
by IN O
the DT O
RPE NNP O

At IN O
least JJS O
some DT O
of IN O
the DT O
ATP NNP O
capable JJ O
of IN O
stimulating VBG O
the DT O
purinergic JJ O
receptors NNS O
on IN O
RPE NNP O
cells NNS O
is VBZ O
released VBN O
from IN O
the DT O
RPE NNP O
itself PRP O
. . O

The DT O
resulting VBG O
autocrine NN O
stimulation NN O
ensures VBZ O
local JJ O
delivery NN O
, , O
and CC O
control NN O
, , O
of IN O
purines NNS O
to TO O
initiate VB O
the DT O
physiologic JJ O
changes NNS O
in IN O
the DT O
RPE NNP O
. . O

The DT O
release NN O
of IN O
ATP NNP O
by IN O
RPE NNP O
cells NNS O
is VBZ O
triggered VBN O
by IN O
multiple JJ O
stimuli NNS O
including VBG O
osmotic JJ O
stress NN O
, , O
bFGF NNP O
, , O
UTP NNP O
, , O
NMDA NNP O
, , O
glutamate NN O
, , O
and CC O
ATP NNP O
[ -LRB- O
39 CD O
, , O
40 CD O
, , O
48 CD O
- HYPH O
51 CD O
] -RRB- O
. . O

The DT O
ATP NNP O
release NN O
following VBG O
activation NN O
of IN O
NMDA NNP O
receptors NNS O
by IN O
glutamate NN O
may MD O
have VB O
the DT O
most RBS O
interesting JJ O
implications NNS O
for IN O
communication NN O
across IN O
subretinal JJ O
space NN O
, , O
given VBN O
that IN O
glutamate NN O
confers VBZ O
the DT O
light JJ O
signal NN O
from IN O
photoreceptors NNS O
to IN O
the DT O
rest NN O
of IN O
the DT O
visual JJ O
system NN O
. . O

Glutamate NNP O
and CC O
the DT O
specific JJ O
receptor NN O
agonist NN O
NMDA NNP O
triggers VBZ O
ATP NNP O
release NN O
from IN O
ARPE NNP O
- HYPH O
19 CD O
cells NNS O
, , O
with IN O
the DT O
release NN O
inhibited VBN O
by IN O
NMDA NNP O
antagonist NN O
MK NNP O
- HYPH O
801 CD O
, , O
and CC O
by IN O
DCKA NNP O
, , O
which WDT O
inhibits VBZ O
the DT O
glycine NN O
B NN O
binding NN O
site NN O
on IN O
NMDA NNP O
receptors NNS O
[ -LRB- O
51 CD O
, , O
52 CD O
] -RRB- O
. . O

Although IN O
NMDA NNP O
raises VBZ O
intracellular JJ O
Ca2 NN O
+ CC O
levels NNS O
, , O
this DT O
increase NN O
is VBZ O
prevented VBN O
by IN O
eliminating VBG O
ATP NNP O
with IN O
apyrase NN O
, , O
indicating VBG O
autostimulation NN O
through IN O
released VBN O
ATP NNP O
is VBZ O
responsible JJ O
for IN O
this DT O
Ca2 NNP O
+ SYM O
signal NN O
. . O

NMDA NNP O
also RB O
triggers VBZ O
a DT O
release NN O
of IN O
ATP NNP O
when WRB O
applied VBN O
to IN O
the DT O
intact JJ O
bovine JJ B-Species
RPE NNP O
eyecup NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

The DT O
NMDA NNP O
receptors NNS O
and CC O
the DT O
ATP NNP O
release NN O
sites NNS O
have VBP O
been VBN O
functionally RB O
identified VBN O
to IN O
the DT O
apical JJ O
membrane NN O
of IN O
the DT O
bovine JJ B-Species
RPE NNP O
, , O
suggesting VBG O
the DT O
neurotransmitter NN O
interactions NNS O
could MD O
amplify VB O
the DT O
signal NN O
from IN O
any DT O
glutamate NN O
reaching VBG O
subretinal JJ O
space NN O
. . O

The DT O
ability NN O
of IN O
both CC O
UTP NNP O
and CC O
ATP NNP O
to TO O
stimulate VB O
release NN O
of IN O
ATP NNP O
from IN O
the DT O
RPE NNP O
supports VBZ O
the DT O
theory NN O
that IN O
the DT O
system NN O
acts VBZ O
to TO O
amplify VB O
signals NNS O
. . O

When WRB O
applied VBN O
at IN O
greater JJR O
than IN O
1 CD O
mu NNS O
M NN O
, , O
ATP NNP O
triggers VBZ O
a DT O
secondary JJ O
release NN O
of IN O
ATP NNP O
peaking VBG O
10 CD O
min NN O
after IN O
the DT O
initial JJ O
stimuli NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

UTP NNP O
also RB O
initiates VBZ O
a DT O
release NN O
in IN O
extracellular JJ O
ATP NNP O
with IN O
a DT O
similar JJ O
delay NN O
[ -LRB- O
48 CD O
] -RRB- O
. . O

The DT O
rise NN O
in IN O
ATP NNP O
triggered VBN O
by IN O
UTP NNP O
is VBZ O
inhibited VBN O
by IN O
the DT O
Cl NNP O
- HYPH O
channel NN O
blocker NN O
NPPB NNP O
, , O
and CC O
UDP NNP O
is VBZ O
much RB O
less RBR O
effective JJ O
at IN O
triggering VBG O
release NN O
than IN O
UTP NNP O
; : O
both DT O
observations NNS O
suggest VBP O
the DT O
P2Y2 NNP O
receptor NN O
contributes VBZ O
to IN O
the DT O
increase NN O
in IN O
ATP NNP O
more JJR O
than IN O
diphosphokinase NN O
, , O
although IN O
influence NN O
from IN O
the DT O
enzyme NN O
cannot MD O
be VB O
ruled VBN O
out RP O
[ -LRB- O
53 CD O
] -RRB- O
. . O

Recent JJ O
evidence NN O
suggests VBZ O
that IN O
ischemia NN O
may MD O
lead VB O
to IN O
the DT O
release NN O
of IN O
ATP NNP O
from IN O
RPE NNP O
cells NNS O
. . O

Chemical NN O
ischemia NN O
triggers VBZ O
a DT O
substantial JJ O
ATP NNP O
release NN O
from IN O
cardiac JJ O
myocytes NNS O
[ -LRB- O
54 CD O
] -RRB- O
, , O
while IN O
changes NNS O
in IN O
oxygen NN O
levels NNS O
trigger VBP O
ATP NN O
release NN O
in IN O
central JJ O
chemoreceptors NNS O
[ -LRB- O
55 CD O
] -RRB- O
. . O

We PRP O
found VBD O
that IN O
exposure NN O
to IN O
sodium NN O
cyanide NN O
led VBD O
to IN O
a DT O
rapid JJ O
release NN O
of IN O
ATP NNP O
from IN O
ARPE NNP O
- HYPH O
19 CD O
cells NNS O
( : O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

As IN O
hypoxic JJ O
and CC O
/ SYM O
or CC O
ischemic JJ O
challenge NN O
may MD O
lead VB O
to IN O
changes NNS O
in IN O
the DT O
expression NN O
of IN O
growth NN O
factors NNS O
in IN O
RPE NNP O
cells NNS O
during IN O
certain JJ O
ocular JJ O
disorders NNS O
such JJ O
as IN O
macular JJ O
degeneration NN O
[ -LRB- O
56 CD O
] -RRB- O
, , O
and CC O
as IN O
purines NNS O
can MD O
induce VB O
expression NN O
of IN O
VEGF NNP O
in IN O
other JJ O
cells NNS O
[ -LRB- O
57 CD O
] -RRB- O
, , O
this DT O
ATP NNP O
release NN O
may MD O
contribute VB O
to IN O
growth NN O
factor NN O
signaling NN O
by IN O
the DT O
diseased VBN O
RPE NNP O
. . O

Fig NN O
. . O
2Chemical JJ O
ischemia NN O
triggers VBZ O
ATP NNP O
release NN O
from IN O
ARPE NNP O
- HYPH O
19 CD O
cells NNS O
. . O

ATP NNP O
release NN O
was VBD O
measured VBN O
in IN O
the DT O
bath NN O
directly RB O
from IN O
cells NNS O
plated VBN O
in IN O
96 CD O
- HYPH O
well NN O
plates NNS O
to TO O
which WDT O
the DT O
luciferin JJ O
- HYPH O
luciferase NN O
reaction NN O
mixture NN O
was VBD O
added VBN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

Left VBN O
Levels NNS O
of IN O
ATP NNP O
in IN O
the DT O
bath NN O
after IN O
addition NN O
of IN O
5 CD O
mM NN O
NaCN NNP O
to IN O
the DT O
cells NNS O
. . O

Measurement NN O
began VBD O
1 CD O
min NN O
after IN O
addition NN O
of IN O
NaCN NNP O
or CC O
control NN O
solution NN O
to IN O
wells NNS O
. . O

Right JJ O
Levels NNS O
of IN O
ATP NNP O
measured VBN O
at IN O
the DT O
peak NN O
, , O
3 CD O
min NN O
after IN O
addition NN O
of IN O
NaCN NNP O
( : O
n CD O
= SYM O
12 CD O
) -RRB- O
. . O

Levels NNS O
were VBD O
normalized VBN O
to IN O
concurrent JJ O
levels NNS O
in IN O
control NN O
( : O
n NN O
= SYM O
14 CD O
) -RRB- O
. . O

Symbols NNS O
and CC O
bars NNS O
represent VBP O
mean JJ O
+ NFP O
/ SYM O
- HYPH O
SE NNP O
, , O
* NFP O
p NN O
< NN O
0 CD O
. . O
1 CD O

The DT O
particular JJ O
conduit NN O
for IN O
ATP NNP O
release NN O
varies VBZ O
with IN O
the DT O
stimuli NNS O
. . O

The DT O
release NN O
in IN O
response NN O
to IN O
hypotonic JJ O
challenge NN O
is VBZ O
largely RB O
dependent JJ O
upon IN O
CFTR NNP O
, , O
as IN O
it PRP O
was VBD O
prevented VBN O
by IN O
the DT O
specific JJ O
CFTR NNP O
inhibitor NN O
CFTR172 NN O
in IN O
addition NN O
to IN O
the DT O
more RBR O
general JJ O
blocker NN O
glybenclamide NN O
[ -LRB- O
50 CD O
] -RRB- O
. . O

While IN O
the DT O
precise JJ O
mechanisms NNS O
by IN O
which WDT O
CFTR NNP O
contributes VBZ O
to IN O
this DT O
release NN O
are VBP O
not RB O
yet RB O
known VBN O
, , O
a DT O
role NN O
for IN O
CFTR NNP O
in IN O
ATP NNP O
release NN O
into IN O
subretinal JJ O
space NN O
is VBZ O
consistent JJ O
with IN O
the DT O
reduction NN O
of IN O
certain JJ O
ERG NNP O
components NNS O
in IN O
cftr NN O
- HYPH O
/ SYM O
- HYPH O
mice NNS B-Species
[ -LRB- O
58 CD O
] -RRB- O
and CC O
with IN O
the DT O
ability NN O
of IN O
apical JJ O
ATP NNP O
to TO O
activate VB O
conductances NNS O
associated VBN O
with IN O
these DT O
ERG NNP O
components NNS O
[ -LRB- O
43 CD O
] -RRB- O
. . O

The DT O
release NN O
of IN O
ATP NNP O
is VBZ O
also RB O
largely RB O
blocked VBN O
by IN O
the DT O
vesicular JJ O
transport NN O
inhibitor NN O
brefeldin NN O
A NNP O
, , O
suggesting VBG O
the DT O
two CD O
processes NNS O
occurred VBD O
in IN O
series NN O
whereby IN O
ATP NNP O
efflux NN O
follows VBZ O
the DT O
insertion NN O
of IN O
vesicles NNS O
containing VBG O
CFTR NNP O
into IN O
the DT O
plasma NN O
membrane NN O
. . O

Although IN O
the DT O
Ca2 NNP O
+ CC O
chelator NN O
BAPTA NNP O
blocks VBZ O
this DT O
ATP NNP O
release NN O
[ -LRB- O
50 CD O
] -RRB- O
, , O
raising VBG O
Ca2 NN O
+ CC O
alone RB O
with IN O
ionophore NN O
ionomycin NN O
does VBZ O
not RB O
itself PRP O
initiate VB O
release NN O
[ -LRB- O
48 CD O
] -RRB- O
. . O

This DT O
necessary JJ O
but CC O
not RB O
sufficient JJ O
contribution NN O
of IN O
Ca2 NN O
+ CC O
also RB O
supports VBZ O
a DT O
role NN O
for IN O
vesicular JJ O
insertion NN O
. . O

In IN O
contrast NN O
to IN O
the DT O
release NN O
following VBG O
hypotonic JJ O
challenge NN O
, , O
the DT O
ATP NNP O
release NN O
in IN O
response NN O
to IN O
NMDA NNP O
does VBZ O
not RB O
involve VB O
CFTR NNP O
[ -LRB- O
51 CD O
] -RRB- O
. . O

Release NN O
is VBZ O
blocked VBN O
by IN O
NPPB NNP O
, , O
however RB O
, , O
suggesting VBG O
another DT O
type NN O
of IN O
anion NN O
channel NN O
could MD O
serve VB O
as IN O
a DT O
conduit NN O
for IN O
ATP NNP O
release NN O
. . O

The DT O
presence NN O
of IN O
parallel JJ O
mechanisms NNS O
coexisting VBG O
on IN O
the DT O
same JJ O
cell NN O
for IN O
ATP NN O
release NN O
triggered VBN O
by IN O
either CC O
agonists NNS O
or CC O
by IN O
cell NN O
swelling NN O
has VBZ O
also RB O
been VBN O
reported VBN O
in IN O
astrocytes NNS O
[ -LRB- O
59 CD O
] -RRB- O
and CC O
may MD O
reflect VB O
the DT O
multiple JJ O
roles NNS O
of IN O
purinergic JJ O
signaling NN O
within IN O
a DT O
given VBN O
tissue NN O
. . O

As IN O
both DT O
stimuli NNS O
lead VBP O
to IN O
release NN O
across IN O
the DT O
apical JJ O
membrane NN O
into IN O
subretinal JJ O
space NN O
, , O
both DT O
are VBP O
expected VBN O
to TO O
influence VB O
signaling NN O
in IN O
the DT O
microenvironment NN O
. . O

Interconversion NN O
of IN O
purines NNS O
in IN O
subretinal JJ O
space NN O

The DT O
interconversion NN O
of IN O
nucleotides NNS O
and CC O
nucleosides NNS O
each DT O
capable JJ O
of IN O
stimulating VBG O
distinct JJ O
receptors NNS O
makes VBZ O
the DT O
purinergic JJ O
signaling NN O
system NN O
of IN O
particular JJ O
interest NN O
in IN O
a DT O
confined JJ O
region NN O
such JJ O
as IN O
the DT O
subretinal JJ O
space NN O
. . O

The DT O
main JJ O
enzymes NNS O
responsible JJ O
for IN O
dephosphorylating VBG O
extracellular JJ O
ATP NN O
on IN O
the DT O
RPE NNP O
cells NNS O
have VBP O
been VBN O
analyzed VBN O
and CC O
a DT O
basic JJ O
understanding NN O
of IN O
their PRP$ O
regulation NN O
has VBZ O
begun VBN O
. . O

This DT O
section NN O
first RB O
describes VBZ O
the DT O
enzymes NNS O
that WDT O
act VBP O
on IN O
ATP NNP O
and CC O
ADP NNP O
, , O
followed VBN O
by IN O
enzymes NNS O
which WDT O
convert VBP O
AMP NNP O
into IN O
adenosine NN O
. . O

The DT O
dephosphorylation NN O
of IN O
extracellular JJ O
ATP NN O
by IN O
RPE NNP O
cells NNS O
involves VBZ O
enzymes NNS O
from IN O
multiple JJ O
families NNS O
[ -LRB- O
40 CD O
] -RRB- O
, , O
as IN O
found VBN O
in IN O
airway NN O
epithelial JJ O
cells NNS O
[ -LRB- O
60 CD O
] -RRB- O
. . O

Degradation NN O
of IN O
ATP NNP O
by IN O
the DT O
apical JJ O
membrane NN O
of IN O
the DT O
fresh JJ O
bovine JJ B-Species
eyecup NN O
and CC O
by IN O
ARPE NNP O
- HYPH O
19 CD O
cells NNS O
is VBZ O
inhibited VBN O
by IN O
ARL67156 NNP O
or CC O
beta JJ O
gamma NN O
mATP NNP O
. . O

Message NN O
for IN O
eNPP1 NNP O
, , O
eNPP2 NNP O
, , O
and CC O
eNPP3 NN O
is VBZ O
present JJ O
in IN O
ARPE NNP O
- HYPH O
19 CD O
cells NNS O
, , O
consistent JJ O
with IN O
the DT O
preference NN O
of IN O
beta NN O
gamma NN O
mATP NNP O
for IN O
members NNS O
of IN O
the DT O
eNPP NNP O
family NN O
[ -LRB- O
61 CD O
] -RRB- O
. . O

The DT O
cells NNS O
also RB O
express VBP O
NTPDase2 NNP O
, , O
and CC O
NTPDase3 NNP O
, , O
although IN O
the DT O
intermittent JJ O
presence NN O
of IN O
NTPDase1 NNP O
likely RB O
reflects VBZ O
a DT O
regulated JJ O
process NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

Ecto JJ O
- HYPH O
alkaline NN O
phosphatase NN O
has VBZ O
no DT O
effect NN O
on IN O
ATP NN O
degradation NN O
in IN O
RPE NNP O
cells NNS O
, , O
in IN O
contrast NN O
to IN O
its PRP$ O
considerable JJ O
contribution NN O
in IN O
airway NN O
epithelium NN O
[ -LRB- O
62 CD O
] -RRB- O
. . O

The DT O
putative JJ O
contribution NN O
from IN O
diphosphokinases NNS O
to IN O
interconversion NN O
of IN O
subretinal JJ O
purines NNS O
is VBZ O
presently RB O
unknown JJ O
. . O

Extracellular JJ O
AMP NN O
is VBZ O
rapidly RB O
dephosphorylated VBN O
into IN O
adenosine NN O
in IN O
subretinal JJ O
space NN O
. . O

The DT O
production NN O
of IN O
adenosine NN O
from IN O
ATP NNP O
at IN O
the DT O
apical JJ O
membrane NN O
of IN O
the DT O
bovine JJ B-Species
RPE NNP O
eyecup NN O
is VBZ O
inhibited VBN O
by IN O
the DT O
ecto NN O
- HYPH O
5 CD O
' '' O
- HYPH O
nucleotidase NN O
inhibitor NN O
alpha NN O
beta NN O
mADP NN O
, , O
confirming VBG O
a DT O
role NN O
for IN O
this DT O
enzyme NN O
[ -LRB- O
63 CD O
] -RRB- O
. . O

The DT O
enzyme NN O
is VBZ O
localized VBN O
to IN O
rat NN B-Species
RPE NNP O
and CC O
ARPE NNP O
- HYPH O
19 CD O
cells NNS O
immunohistochemicall NN O
. . O

Degradation NN O
of IN O
5 CD O
' '' O
AMP NN O
is VBZ O
highest JJS O
near IN O
the DT O
subretinal JJ O
space NN O
of IN O
rat NN B-Species
retina NN O
[ -LRB- O
63 CD O
] -RRB- O
, , O
although IN O
localization NN O
in IN O
mouse NN B-Species
indicated VBD O
larger JJR O
amounts NNS O
of IN O
ecto NN O
- HYPH O
5 CD O
' '' O
- HYPH O
nucleotidase NN O
at IN O
the DT O
tips NNS O
of IN O
adjacent JJ O
M NNP O
u NNP O
ller NNP O
cells NNS O
[ -LRB- O
64 CD O
] -RRB- O
. . O

Levamisole NNP O
does VBZ O
not RB O
inhibit VB O
the DT O
dephosphorylation NN O
of IN O
5 CD O
' '' O
AMP NN O
by IN O
the DT O
RPE NNP O
, , O
consistent JJ O
with IN O
the DT O
absence NN O
of IN O
substantial JJ O
ecto NN O
- HYPH O
alkaline NN O
phosphatase NN O
in IN O
subretinal JJ O
space NN O
. . O

The DT O
presence NN O
of IN O
light NN O
may MD O
alter VB O
the DT O
levels NNS O
of IN O
adenosine NN O
in IN O
subretinal JJ O
space NN O
. . O

Epinephrine NN O
is VBZ O
released VBN O
at IN O
the DT O
onset NN O
of IN O
light NN O
[ -LRB- O
65 CD O
] -RRB- O
and CC O
stimulation NN O
of IN O
the DT O
RPE NNP O
with IN O
epinephrine NN O
can MD O
decrease VB O
activity NN O
of IN O
ecto NN O
- HYPH O
5 CD O
' '' O
- HYPH O
nucleotidase NN O
[ -LRB- O
63 CD O
] -RRB- O
. . O

While IN O
norepinephrine NN O
and CC O
phenylephrine NN O
lead VBP O
to IN O
similar JJ O
decreases NNS O
in IN O
enzyme NN O
activity NN O
, , O
prazosin NN O
and CC O
corynanthine NN O
block VBP O
the DT O
effects NNS O
of IN O
norepinephrine NN O
, , O
implicating VBG O
the DT O
alpha NN O
1 CD O
epinephrine NN O
receptor NN O
in IN O
the DT O
inhibition NN O
of IN O
ecto NN O
- HYPH O
5 CD O
' '' O
- HYPH O
nucleotidase NN O
[ -LRB- O
63 CD O
] -RRB- O
. . O

The DT O
kinetics NNS O
of IN O
inhibition NN O
are VBP O
consistent JJ O
with IN O
cleavage NN O
of IN O
the DT O
nucleotidase NN O
from IN O
its PRP$ O
GPI NNP O
anchor NN O
. . O

The DT O
phagocytosis NN O
of IN O
rod JJ O
outer JJ O
segments NNS O
is VBZ O
maximal JJ O
shortly RB O
after IN O
light JJ O
onset NN O
[ -LRB- O
16 CD O
] -RRB- O
, , O
and CC O
this DT O
phagocytosis NN O
is VBZ O
inhibited VBN O
by IN O
adenosine NN O
[ -LRB- O
29 CD O
] -RRB- O
. . O

The DT O
ability NN O
of IN O
epinephrine NN O
released VBN O
by IN O
the DT O
illuminated JJ O
retina NN O
to TO O
reduce VB O
ecto NN O
- HYPH O
5 CD O
' '' O
- HYPH O
nucleotidase NN O
activity NN O
and CC O
consequently RB O
adenosine NN O
levels NNS O
may MD O
relieve VB O
this DT O
inhibition NN O
and CC O
enhance VB O
the DT O
rate NN O
of IN O
phagocytosis NN O
at IN O
light JJ O
onset NN O
. . O

Physiologic JJ O
effects NNS O
of IN O
subretinal JJ O
purines NNS O
on IN O
the DT O
RPE NN O
and CC O
photoreceptors NNS O

The DT O
number NN O
of IN O
purinergic JJ O
receptors NNS O
on IN O
both CC O
photoreceptor NN O
and CC O
RPE NN O
membranes NNS O
suggests VBZ O
purines NNS O
make VBP O
multiple JJ O
contributions NNS O
to IN O
the DT O
physiology NN O
of IN O
the DT O
outer JJ O
retina NN O
. . O

Our PRP$ O
increased JJ O
understanding NN O
of IN O
how WRB O
agonist JJ O
levels NNS O
in IN O
subretinal JJ O
space NN O
are VBP O
controlled VBN O
has VBZ O
begun VBN O
to TO O
indicate VB O
how WRB O
and CC O
when WRB O
this DT O
contribution NN O
may MD O
occur VB O
. . O

Future JJ O
research NN O
will MD O
involve VB O
applying VBG O
these DT O
findings NNS O
from IN O
isolated VBN O
systems NNS O
to IN O
intact JJ O
RPE NN O
- HYPH O
photoreceptor NN O
models NNS O
, , O
and CC O
pursuing VBG O
the DT O
role NN O
of IN O
defective JJ O
purinergic JJ O
regulation NN O
in IN O
ocular JJ O
disease NN O
. . O

While IN O
it PRP O
is VBZ O
unlikely JJ O
that IN O
ATP NNP O
released VBN O
across IN O
the DT O
apical JJ O
membrane NN O
of IN O
the DT O
RPE NNP O
can MD O
diffuse VB O
to IN O
these DT O
P2 NN O
receptors NNS O
in IN O
the DT O
outer JJ O
plexiform NN O
layer NN O
given VBN O
the DT O
ecto NN O
- HYPH O
ATPase NN O
activity NN O
in IN O
the DT O
synaptic JJ O
clef NN O
[ -LRB- O
25 CD O
] -RRB- O
, , O
stimulation NN O
of IN O
receptors NNS O
elsewhere RB O
on IN O
the DT O
photoreceptor NN O
membrane NN O
is VBZ O
possible JJ O
. . O

It PRP O
would MD O
be VB O
interesting JJ O
to TO O
determine VB O
whether IN O
ATP NNP O
released VBN O
from IN O
the DT O
RPE NNP O
and CC O
converted VBN O
to IN O
adenosine NN O
by IN O
ecto NN O
- HYPH O
nucleotidases NNS O
can MD O
actually RB O
modulate VB O
the DT O
response NN O
to IN O
light NN O
by IN O
stimulating VBG O
the DT O
A2A NNP O
receptors NNS O
on IN O
photoreceptor NN O
outer JJ O
segments NNS O
. . O

The DT O
impact NN O
of IN O
purinergic JJ O
signaling NN O
on IN O
chronic JJ O
ocular JJ O
diseases NNS O
is VBZ O
also RB O
of IN O
interest NN O
, , O
such JJ O
as IN O
the DT O
role NN O
of IN O
ischemia NN O
- HYPH O
driven VBN O
ATP NNP O
release NN O
in IN O
VEGF NNP O
production NN O
. . O

While IN O
the DT O
small JJ O
size NN O
of IN O
subretinal JJ O
space NN O
can MD O
complicate VB O
pharmacologic JJ O
manipulation NN O
within IN O
the DT O
intact JJ O
RPE NN O
- HYPH O
photoreceptor NN O
complex NN O
, , O
molecular JJ O
approaches NNS O
may MD O
provide VB O
new JJ O
insight NN O
into IN O
how WRB O
endogenous JJ O
purines NNS O
in IN O
subretinal JJ O
space NN O
affect VBP O
the DT O
physiology NN O
, , O
and CC O
pathophysiology NN O
, , O
of IN O
both CC O
RPE NNP O
and CC O
photoreceptors NNS O
. . O

Comparative JJ O
Genome NN O
Analysis NN O
of IN O
Filamentous JJ O
Fungi NN O
Reveals VBZ O
Gene NN O
Family NN O
Expansions NNS O
Associated VBN O
with IN O
Fungal NNP O
Pathogenesis NNP O

Abstract JJ O

Fungi NNS O
and CC O
oomycetes NNS O
are VBP O
the DT O
causal JJ O
agents NNS O
of IN O
many JJ O
of IN O
the DT O
most RBS O
serious JJ O
diseases NNS O
of IN O
plants NNS O
. . O

Here RB O
we PRP O
report VBP O
a DT O
detailed JJ O
comparative JJ O
analysis NN O
of IN O
the DT O
genome NN O
sequences NNS O
of IN O
thirty CD O
- HYPH O
six CD O
species NNS O
of IN O
fungi NNS O
and CC O
oomycetes NNS O
, , O
including VBG O
seven CD O
plant NN O
pathogenic JJ O
species NNS O
, , O
that WDT O
aims VBZ O
to TO O
explore VB O
the DT O
common JJ O
genetic JJ O
features NNS O
associated VBN O
with IN O
plant NN O
disease NN O
- HYPH O
causing VBG O
species NNS O
. . O

The DT O
predicted VBN O
translational JJ O
products NNS O
of IN O
each DT O
genome NN O
have VBP O
been VBN O
clustered VBN O
into IN O
groups NNS O
of IN O
potential JJ O
orthologues NNS O
using VBG O
Markov NNP O
Chain NNP O
Clustering NNP O
and CC O
the DT O
data NNS O
integrated VBN O
into IN O
the DT O
e NNP O
- HYPH O
Fungi NNP O
object NN O
- HYPH O
oriented VBN O
data NN O
warehouse NN O
( , O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
e LS O
- : O
fungi ADD O
. . O
org NN O
. . O
uk NN O
/ NFP O
) -RRB- O
. . O

Analysis NN O
of IN O
the DT O
species NNS O
distribution NN O
of IN O
members NNS O
of IN O
these DT O
clusters NNS O
has VBZ O
identified VBN O
proteins NNS O
that WDT O
are VBP O
specific JJ O
to IN O
filamentous JJ O
fungal JJ O
species NNS O
and CC O
a DT O
group NN O
of IN O
proteins NNS O
found VBN O
only RB O
in IN O
plant NN O
pathogens NNS O
. . O

By IN O
comparing VBG O
the DT O
gene NN O
inventories NNS O
of IN O
filamentous JJ O
, , O
ascomycetous JJ O
phytopathogenic JJ O
and CC O
free JJ O
- HYPH O
living VBG O
species NNS O
of IN O
fungi NN O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
set NN O
of IN O
gene NN O
families NNS O
that WDT O
appear VBP O
to TO O
have VB O
expanded VBN O
during IN O
the DT O
evolution NN O
of IN O
phytopathogens NNS O
and CC O
may MD O
therefore RB O
serve VB O
important JJ O
roles NNS O
in IN O
plant NN O
disease NN O
. . O

We PRP O
have VBP O
also RB O
characterised VBN O
the DT O
predicted VBN O
set NN O
of IN O
secreted VBN O
proteins NNS O
encoded VBN O
by IN O
each DT O
genome NN O
and CC O
identified VBN O
a DT O
set NN O
of IN O
protein NN O
families NNS O
which WDT O
are VBP O
significantly RB O
over RB O
- HYPH O
represented VBN O
in IN O
the DT O
secretomes NNS O
of IN O
plant NN O
pathogenic JJ O
fungi NN O
, , O
including VBG O
putative JJ O
effector NN O
proteins NNS O
that WDT O
might MD O
perturb VB O
host NN O
cell NN O
biology NN O
during IN O
plant NN O
infection NN O
. . O

The DT O
results NNS O
demonstrate VBP O
the DT O
potential NN O
of IN O
comparative JJ O
genome NN O
analysis NN O
for IN O
exploring VBG O
the DT O
evolution NN O
of IN O
eukaryotic JJ O
microbial JJ O
pathogenesis NN O
. . O

Introduction NN O

Fungi NNS O
and CC O
oomycetes NNS O
are VBP O
responsible JJ O
for IN O
many JJ O
of IN O
the DT O
world NN O
' '' O
s POS O
most RBS O
devastating JJ O
plant NN O
diseases NNS O
including VBG O
late JJ O
blight NN O
disease NN O
of IN O
potato NN B-Species
, , O
caused VBN O
by IN O
the DT O
oomycete NN O
pathogen NN O
Phytophthora NN B-Species
infestans NNS I-Species
and CC O
rice NN B-Species
blast NN O
disease NN O
caused VBN O
by IN O
the DT O
ascomycete NN O
fungus NN O
Magnaporthe NNP B-Species
grisea NN I-Species
, , O
both DT O
of IN O
which WDT O
are VBP O
responsible JJ O
for IN O
very RB O
significant JJ O
harvest NN O
losses NNS O
each DT O
year NN O
. . O

The DT O
enormous JJ O
diversity NN O
of IN O
crop NN O
diseases NNS O
caused VBN O
by IN O
these DT O
eukaryotic JJ O
micro NN O
- HYPH O
organisms NNS O
poses VBZ O
a DT O
difficult JJ O
challenge NN O
to IN O
the DT O
development NN O
of IN O
durable JJ O
disease NN O
control NN O
strategies NNS O
. . O

Identifying VBG O
common JJ O
underlying VBG O
molecular JJ O
mechanisms NNS O
necessary JJ O
for IN O
pathogenesis NN O
in IN O
a DT O
wide JJ O
range NN O
of IN O
pathogenic JJ O
species NNS O
is VBZ O
therefore RB O
a DT O
major JJ O
goal NN O
of IN O
current JJ O
research NN O
. . O

Approximately RB O
100 CD O
, , O
0 CD O
species NNS O
of IN O
fungi NNS O
have VBP O
so RB O
far RB O
been VBN O
described VBN O
, , O
but CC O
only RB O
a DT O
very RB O
small JJ O
proportion NN O
of IN O
these DT O
are VBP O
pathogenic JJ O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Phylogenetic JJ O
studies NNS O
have VBP O
, , O
meanwhile RB O
, , O
shown VBN O
that IN O
disease NN O
- HYPH O
causing VBG O
pathogens NNS O
are VBP O
not RB O
necessarily RB O
closely RB O
- HYPH O
related VBN O
to IN O
each DT O
other JJ O
, , O
and CC O
in IN O
fact NN O
are VBP O
spread VBN O
throughout IN O
all DT O
taxonomic JJ O
groups NNS O
of IN O
fungi NN O
, , O
often RB O
showing VBG O
a DT O
close JJ O
evolutionary JJ O
relationship NN O
to IN O
non NN O
- HYPH O
pathogenic JJ O
species NNS O
[ -LRB- O
2 CD O
] -RRB- O
, , O
[ -LRB- O
3 CD O
] -RRB- O
. . O

It PRP O
therefore RB O
seems VBZ O
likely JJ O
that IN O
phytopathogenicity NN O
has VBZ O
evolved VBN O
as IN O
a DT O
trait NN O
many JJ O
times NNS O
during IN O
fungal JJ O
and CC O
oomycete NN O
evolution NN O
[ -LRB- O
1 CD O
] -RRB- O
and CC O
in IN O
some DT O
groups NNS O
may MD O
be VB O
ancestral JJ O
to IN O
the DT O
more RBR O
recent JJ O
emergence NN O
of IN O
saprotrophic JJ O
species NNS O
. . O

A DT O
significant JJ O
effort NN O
has VBZ O
gone VBN O
into IN O
the DT O
identification NN O
of IN O
pathogenicity NN O
determinants NNS O
- : O
individual JJ O
genes NNS O
that WDT O
are VBP O
essential JJ O
for IN O
a DT O
pathogen NN O
to TO O
invade VB O
a DT O
host NN O
plant NN O
successfully RB O
, , O
but CC O
which WDT O
are VBP O
dispensable JJ O
for IN O
saprophytic JJ O
growth NN O
[ -LRB- O
4 CD O
] -RRB- O
, , O
[ -LRB- O
5 CD O
] -RRB- O
. . O

However RB O
, , O
far RB O
from IN O
being VBG O
novel JJ O
proteins NNS O
encoded VBN O
only RB O
by IN O
the DT O
genomes NNS O
of IN O
pathogenic JJ O
fungi NN O
, , O
many JJ O
of IN O
the DT O
genes NNS O
identified VBN O
so RB O
far RB O
encode VBP O
components NNS O
of IN O
conserved VBN O
signalling NN O
pathways NNS O
that WDT O
are VBP O
found VBN O
in IN O
all DT O
species NNS O
of IN O
fungi NN O
, , O
such JJ O
as IN O
the DT O
mitogen NN O
activated VBN O
protein NN O
( , O
MAP NNP O
) -RRB- O
kinases NNS O
[ -LRB- O
6 CD O
] -RRB- O
, , O
adenylate NN O
cyclase NN O
[ -LRB- O
7 CD O
] -RRB- O
and CC O
G NN O
- HYPH O
protein NN O
subunits NNS O
[ -LRB- O
8 CD O
] -RRB- O
. . O

The DT O
MAP NNP O
kinase NN O
pathways NNS O
, , O
for IN O
example NN O
, , O
have VBP O
been VBN O
studied VBN O
extensively RB O
in IN O
the DT O
budding VBG O
yeast NN B-Species
Saccharomyces NNP B-Species
cerevisiae NN I-Species
and CC O
trigger VB O
morphological JJ O
and CC O
biochemical JJ O
changes NNS O
in IN O
response NN O
to IN O
external JJ O
stimuli NN O
such JJ O
as IN O
starvation NN O
stress NN O
or CC O
hyperosmotic JJ O
conditions NNS O
[ -LRB- O
9 CD O
] -RRB- O
. . O

In IN O
pathogenic JJ O
fungi NN O
, , O
components NNS O
of IN O
these DT O
pathways NNS O
have VBP O
evolved VBN O
instead RB O
to TO O
regulate VB O
the DT O
morphological JJ O
changes NNS O
associated VBN O
with IN O
plant NN O
infection NN O
. . O

For IN O
example NN O
, , O
appressorium NN O
formation NN O
in IN O
the DT O
rice NN B-Species
blast NN I-Species
fungus NN I-Species
Magnaporthe NNP B-Species
grisea NN I-Species
, , O
stimulated VBN O
by IN O
hard JJ O
, , O
hydrophobic JJ O
surfaces NNS O
is VBZ O
regulated VBN O
by IN O
a DT O
MAP NNP O
kinase NN O
cascade NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

This DT O
pathway NN O
deploys VBZ O
novel JJ O
classes NNS O
of IN O
G NN O
- HYPH O
protein NN O
coupled VBN O
receptors NNS O
not RB O
found VBN O
in IN O
the DT O
genome NN O
of IN O
S NN B-Species
. . I-Species
cerevisiae NN I-Species
[ -LRB- O
11 CD O
] -RRB- O
, , O
but CC O
the DT O
inductive JJ O
signal NN O
is VBZ O
transmitted VBN O
via IN O
a DT O
MAP NNP O
kinase NN O
, , O
Pmk1 NNP O
, , O
that WDT O
is VBZ O
a DT O
functional JJ O
homologue NN O
of IN O
the DT O
yeast NN B-Species
Fus3 NNP O
MAP NNP O
kinase NN O
where WRB O
it PRP O
serves VBZ O
a DT O
role NN O
in IN O
pheromone NN O
signalling NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Similarly RB O
, , O
conserved VBN O
metabolic JJ O
pathways NNS O
such JJ O
as IN O
the DT O
glyoxylate JJ O
cycle NN O
and CC O
amino NN O
acid NN O
biosynthesis NN O
are VBP O
also RB O
important JJ O
for IN O
pathogenesis NN O
[ -LRB- O
12 CD O
] -RRB- O
- : O
[ -LRB- O
14 CD O
] -RRB- O
. . O

This DT O
may MD O
in IN O
some DT O
cases NNS O
reflect VB O
the DT O
nutritional JJ O
environment NN O
the DT O
pathogen NN O
encounters VBZ O
when WRB O
growing VBG O
in IN O
the DT O
host NN O
plant NN O
tissue NN O
, , O
and CC O
in IN O
others NNS O
shows VBZ O
the DT O
importance NN O
of IN O
simple JJ O
metabolites NNS O
for IN O
pathogenic JJ O
processes NNS O
, , O
such JJ O
as IN O
the DT O
role NN O
of IN O
glycerol NN O
as IN O
a DT O
compatible JJ O
solute NN O
for IN O
generating VBG O
turgor NN O
pressure NN O
in IN O
the DT O
appressorium NN O
of IN O
M NNP B-Species
. . I-Species
grisea NN I-Species
[ -LRB- O
15 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
undoubtedly RB O
the DT O
case NN O
, , O
however RB O
, , O
that IN O
identification NN O
of IN O
such JJ O
genes NNS O
has VBZ O
also RB O
been VBN O
a DT O
consequence NN O
of IN O
the DT O
manner NN O
in IN O
which WDT O
these DT O
studies NNS O
have VBP O
been VBN O
carried VBN O
out RP O
, , O
often RB O
using VBG O
yeast NN B-Species
as IN O
a DT O
model NN O
organism NN O
to TO O
test VB O
hypotheses NNS O
concerning VBG O
the DT O
developmental JJ O
biology NN O
and CC O
biochemistry NN O
of IN O
plant NN O
pathogenic JJ O
species NNS O
. . O

Other JJ O
pathogenicity NN O
factors NNS O
identified VBN O
to IN O
date NN O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
functions NNS O
associated VBN O
with IN O
host NN O
infection NN O
, , O
such JJ O
as IN O
plant NN O
cell NN O
wall NN O
degradation NN O
, , O
toxin NN O
biosynthesis NN O
and CC O
protection NN O
against IN O
plant NN O
defences NNS O
[ -LRB- O
reviewed VBN O
in IN O
5 CD O
] -RRB- O
. . O

Identification NN O
of IN O
a DT O
pathogenicity NN O
factor NN O
generally RB O
involves VBZ O
making VBG O
a DT O
mutant JJ O
fungal JJ O
strain NN O
with IN O
a DT O
non AFX O
- HYPH O
functioning VBG O
version NN O
of IN O
the DT O
gene NN O
by IN O
targeted VBN O
gene NN O
deletion NN O
and CC O
assaying VBG O
the DT O
ability NN O
of IN O
the DT O
mutant NN O
to TO O
cause VB O
disease NN O
. . O

Therefore RB O
, , O
most JJS O
pathogenicity NN O
factors NNS O
identified VBN O
so RB O
far RB O
, , O
have VBP O
been VBN O
validated VBN O
in IN O
only RB O
a DT O
small JJ O
number NN O
of IN O
genetically RB O
tractable JJ O
pathogenic JJ O
fungi NN O
, , O
such JJ O
as IN O
M NNP B-Species
. . I-Species
grisea NNP I-Species
and CC O
the DT O
corn NN B-Species
smut NN O
Ustilago NNP B-Species
maydis NN I-Species
and CC O
many JJ O
of IN O
the DT O
advances NNS O
in IN O
understanding VBG O
the DT O
developmental JJ O
biology NN O
of IN O
plant NN O
infection NN O
have VBP O
occurred VBN O
in IN O
these DT O
model NN O
pathogens NNS O
[ -LRB- O
16 CD O
] -RRB- O
, , O
[ -LRB- O
17 CD O
] -RRB- O
. . O

However RB O
, , O
there EX O
are VBP O
severe JJ O
limitations NNS O
to IN O
studying VBG O
pathogenicity NN O
by IN O
mutating VBG O
one CD O
gene NN O
at IN O
a DT O
time NN O
and CC O
working VBG O
predominantly RB O
with IN O
a DT O
hypothesis NN O
- HYPH O
driven VBN O
, , O
reverse JJ O
genetics NNS O
approach NN O
. . O

Many JJ O
virulence NN O
- HYPH O
associated VBN O
processes NNS O
, , O
for IN O
instance NN O
, , O
such JJ O
as IN O
the DT O
development NN O
of IN O
infection NN O
structures NNS O
and CC O
haustoria NN O
, , O
are VBP O
likely JJ O
to TO O
involve VB O
a DT O
large JJ O
number NN O
of IN O
gene NN O
products NNS O
and CC O
so IN O
there EX O
is VBZ O
likely JJ O
to TO O
be VB O
redundancy NN O
in IN O
gene NN O
function NN O
. . O

One CD O
example NN O
of IN O
this DT O
is VBZ O
cutinase NN O
, , O
a DT O
type NN O
of IN O
methyl NN O
esterase NN O
that WDT O
hydrolyses VBZ O
the DT O
protective JJ O
cutin NN O
layer NN O
present JJ O
on IN O
the DT O
outside NN O
of IN O
the DT O
plant NN O
epidermis NN O
. . O

Cutinase NNP O
was VBD O
excluded VBN O
as IN O
a DT O
pathogencity NN O
factor NN O
for IN O
M NNP B-Species
. . I-Species
grisea NNP I-Species
on IN O
the DT O
basis NN O
that IN O
a DT O
mutant JJ O
strain NN O
containing VBG O
a DT O
non AFX O
- HYPH O
functional JJ O
cutinase NN O
- HYPH O
encoding VBG O
gene NN O
was VBD O
still RB O
able JJ O
to TO O
cause VB O
rice NN B-Species
blast NN O
disease NN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

However RB O
, , O
sequencing NN O
of IN O
the DT O
M NNP B-Species
. . I-Species
grisea NN I-Species
genome NN O
has VBZ O
shown VBN O
the DT O
presence NN O
of IN O
eight CD O
potential JJ O
cutinase NN O
- HYPH O
encoding VBG O
genes NNS O
implicated VBN O
in IN O
virulence NN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Additionally RB O
, , O
targeted VBN O
gene NN O
deletion NN O
is VBZ O
not RB O
feasible JJ O
in IN O
many JJ O
important JJ O
pathogens NNS O
and CC O
the DT O
normal JJ O
definition NN O
of IN O
fungal JJ O
pathogenicity NN O
cannot MD O
be VB O
applied VBN O
in IN O
the DT O
case NN O
of IN O
obligate JJ O
biotrophs NNS O
, , O
such JJ O
as IN O
the DT O
powdery JJ O
mildew NN O
fungus NN O
Blumeria NNP B-Species
graminis NN I-Species
, , O
which WDT O
cannot MD O
be VB O
cultured VBN O
away RB O
from IN O
living JJ O
host NN O
plants NNS O
. . O

Therefore RB O
, , O
new JJ O
approaches NNS O
are VBP O
needed VBN O
to TO O
identify VB O
genes NNS O
that WDT O
are VBP O
vital JJ O
for IN O
the DT O
process NN O
of IN O
pathogenicity NN O
. . O

These DT O
include VBP O
high JJ O
- HYPH O
throughput NN O
methods NNS O
such JJ O
as IN O
microarray NN O
analysis NN O
, , O
serial JJ O
analysis NN O
of IN O
gene NN O
expression NN O
( , O
SAGE NNP O
) -RRB- O
, , O
insertional JJ O
mutagenesis NN O
, , O
proteomics NNS O
and CC O
metabolomics NNS O
[ -LRB- O
19 CD O
] -RRB- O
, , O
[ -LRB- O
20 CD O
] -RRB- O
and CC O
are VBP O
dependent JJ O
on IN O
the DT O
availability NN O
of IN O
genome NN O
sequence NN O
information NN O
. . O

After IN O
the DT O
initial JJ O
release NN O
of IN O
the DT O
genome NN O
of IN O
the DT O
budding VBG O
yeast NN B-Species
S NN B-Species
. . I-Species
cerevisiae NN I-Species
in IN O
1996 CD O
[ -LRB- O
21 CD O
] -RRB- O
, , O
the DT O
number NN O
of IN O
publicly RB O
available JJ O
sequenced VBN O
fungal JJ O
genomes NNS O
has VBZ O
recently RB O
risen VBN O
very RB O
quickly RB O
. . O

A DT O
large JJ O
number NN O
of IN O
fungal JJ O
genome NN O
sequences NNS O
are VBP O
now RB O
publicly RB O
available JJ O
, , O
including VBG O
those DT O
from IN O
several JJ O
phytopathogenic JJ O
fungi NN O
, , O
including VBG O
M NNP B-Species
. , I-Species
grisea NN I-Species
[ -LRB- O
22 CD O
] -RRB- O
, , O
Ustilago NNP B-Species
maydis NNP I-Species
[ -LRB- O
23 CD O
] -RRB- O
, , O
Gibberella NNP B-Species
zeae NN I-Species
[ -LRB- O
24 CD O
] -RRB- O
( , O
the DT O
causal JJ O
agent NN O
of IN O
head NN O
blight NN O
of IN O
wheat NN B-Species
and CC O
barley NN B-Species
) -RRB- O
, , O
Stagonospora NNP B-Species
nodorum NN I-Species
[ -LRB- O
25 CD O
] -RRB- O
( , O
the DT O
causal NN O
agent NN O
of IN O
glume NN O
blotch NN O
of IN O
wheat NN B-Species
) -RRB- O
, , O
the DT O
grey JJ O
mould NN O
fungus NN O
Botrytis NNP B-Species
cinerea NN I-Species
and CC O
the DT O
white JJ O
mould NN O
fungus NN O
Sclerotinia NNP B-Species
sclerotiorum NN I-Species
[ -LRB- O
reviewed VBN O
in IN O
19 CD O
] -RRB- O
. . O

Comparison NN O
of IN O
gene NN O
inventories NNS O
of IN O
pathogenic JJ O
and CC O
non JJ O
- HYPH O
pathogenic JJ O
organisms NNS O
offers VBZ O
the DT O
most RBS O
direct JJ O
means NN O
of IN O
providing VBG O
new JJ O
information NN O
concerning VBG O
the DT O
mechanisms NNS O
involved VBN O
in IN O
fungal JJ O
and CC O
oomycete NN O
pathogenicity NN O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
have VBP O
developed VBN O
and CC O
utilized VBN O
the DT O
e NNP O
- HYPH O
Fungi NNP O
object NN O
- HYPH O
oriented VBN O
data NN O
warehouse NN O
[ -LRB- O
26 CD O
] -RRB- O
, , O
which WDT O
contains VBZ O
data NNS O
from IN O
36 CD O
species NNS O
of IN O
fungi NNS O
and CC O
oomycetes NNS O
and CC O
deploys VBZ O
a DT O
range NN O
of IN O
querying VBG O
tools NNS O
to TO O
allow VB O
interrogation NN O
of IN O
a DT O
significant JJ O
amount NN O
of IN O
genome NN O
data NNS O
in IN O
unparalleled JJ O
detail NN O
. . O

We PRP O
report VBP O
the DT O
identification NN O
of IN O
new JJ O
gene NN O
families NNS O
that WDT O
are VBP O
over RB O
represented VBN O
in IN O
the DT O
genomes NNS O
of IN O
filamentous JJ O
ascomycete NN O
phytopathogens NNS O
and CC O
define VBP O
gene NN O
sets NNS O
that WDT O
are VBP O
specific JJ O
to IN O
diverse JJ O
fungal JJ O
pathogen NN O
species NNS O
. . O

We PRP O
also RB O
report VBP O
the DT O
putatively RB O
secreted VBN O
protein NN O
sets NNS O
which WDT O
are VBP O
produced VBN O
by IN O
plant NN O
pathogenic JJ O
fungi NNS O
and CC O
which WDT O
may MD O
play VB O
significant JJ O
roles NNS O
in IN O
plant NN O
infection NN O
. . O

Results NNS O

Identification NN O
of IN O
orthologous JJ O
gene NN O
sets NNS O
from IN O
fungal JJ O
and CC O
oomcyete NN O
genomes NNS O

Genome NN O
sequences NNS O
and CC O
sets NNS O
of IN O
predicted VBN O
proteins NNS O
were VBD O
analysed VBN O
from IN O
34 CD O
species NNS O
of IN O
fungi NNS O
and CC O
2 CD O
species NNS O
of IN O
oomycete NN O
( , O
Table NN O
1 CD O
) -RRB- O
. . O

In IN O
order NN O
to TO O
compare VB O
such PDT O
a DT O
large JJ O
number NN O
of IN O
genomes NNS O
, , O
an DT O
object NN O
- HYPH O
oriented VBN O
data NN O
warehouse NN O
has VBZ O
been VBN O
constructed VBN O
known VBN O
as IN O
e NNP O
- HYPH O
Fungi NNP O
[ -LRB- O
26 CD O
] -RRB- O
which WDT O
integrates VBZ O
genomic JJ O
data NNS O
with IN O
a DT O
variety NN O
of IN O
functional JJ O
data NNS O
and CC O
has VBZ O
a DT O
powerful JJ O
set NN O
of IN O
queries NNS O
that WDT O
enables VBZ O
sophisticated JJ O
, , O
whole JJ O
- HYPH O
genome NN O
comparisons NNS O
to TO O
be VB O
performed VBN O
. . O

To TO O
compare VB O
genome NN O
inventories NNS O
, , O
the DT O
entire JJ O
set NN O
of IN O
predicted VBN O
proteins NNS O
from IN O
the DT O
36 CD O
species NNS O
( , O
348 CD O
, , O
787 CD O
proteins NNS O
) -RRB- O
were VBD O
clustered VBN O
using VBG O
Markov NNP O
Chain NNP O
Clustering NNP O
[ -LRB- O
27 CD O
] -RRB- O
as IN O
described VBN O
previously RB O
[ -LRB- O
28 CD O
] -RRB- O
, , O
[ -LRB- O
29 CD O
] -RRB- O
. . O

A DT O
total NN O
of IN O
282 CD O
, , O
61 CD O
predicted VBN O
proteins NNS O
were VBD O
grouped VBN O
into IN O
23 CD O
, , O
724 CD O
clusters NNS O
, , O
each DT O
cluster NN O
representing VBG O
a DT O
group NN O
of IN O
putative JJ O
orthologues NNS O
. . O

The DT O
remaining VBG O
66 CD O
, , O
934 CD O
sequences NNS O
were VBD O
singletons NNS O
, , O
the DT O
products NNS O
of IN O
unique JJ O
genes NNS O
. . O

A DT O
total NN O
of IN O
165 CD O
clusters NNS O
contained VBD O
proteins NNS O
from IN O
all DT O
36 CD O
species NNS O
used VBN O
in IN O
this DT O
study NN O
( -LRB- O
Table NNP O
S1 NNP O
) -RRB- O
. . O

Not RB O
surprisingly RB O
, , O
they PRP O
included VBD O
many JJ O
proteins NNS O
involved VBN O
in IN O
basic JJ O
cellular JJ O
processes NNS O
, , O
such JJ O
as IN O
ribosomal JJ O
proteins NNS O
, , O
components NNS O
of IN O
transcription NN O
, , O
translation NN O
and CC O
DNA NN O
replication NN O
apparatus NN O
, , O
cytoskeletal JJ O
proteins NNS O
, , O
histones NNS O
, , O
proteins NNS O
involved VBN O
in IN O
the DT O
secretory NN O
pathway NN O
, , O
protein NN O
folding NN O
, , O
protein NN O
sorting NN O
and CC O
ubiquitin NN O
- HYPH O
mediated VBN O
proteolysis NN O
and CC O
enzymes NNS O
involved VBN O
in IN O
primary JJ O
metabolism NN O
. . O

Only RB O
16 CD O
clusters NNS O
contained VBD O
proteins NNS O
that WDT O
were VBD O
found VBN O
in IN O
all DT O
34 CD O
species NNS O
of IN O
fungi NN O
, , O
but CC O
which WDT O
were VBD O
absent JJ O
from IN O
the DT O
two CD O
species NNS O
of IN O
oomycete NN O
( , O
Table NNP O
S2 NNP O
) -RRB- O
. . O

This DT O
number NN O
of IN O
fungal JJ O
- HYPH O
specific JJ O
clusters NNS O
is VBZ O
surprisingly RB O
low JJ O
considering VBG O
the DT O
phylogenetic JJ O
distance NN O
between IN O
the DT O
oomycetes NNS O
and CC O
fungi NN O
[ -LRB- O
30 CD O
] -RRB- O
. . O

The DT O
list NN O
however RB O
, , O
is VBZ O
consistent JJ O
with IN O
the DT O
fundamental JJ O
differences NNS O
in IN O
biology NN O
between IN O
fungi NNS O
and CC O
oomycetes NN O
and CC O
included VBN O
proteins NNS O
involved VBN O
in IN O
fungal JJ O
septation NN O
, , O
glycosylation NN O
, , O
transcriptional JJ O
regulation NN O
, , O
cell NN O
signalling NN O
, , O
as RB O
well RB O
as IN O
two CD O
amino JJ O
- HYPH O
acyl NN O
tRNA NN O
synthetases NNS O
. . O

The DT O
obligate JJ O
mammalian JJ O
pathogen NN O
Encephalitozoon NN B-Species
cuniculi NN I-Species
, , O
a DT O
microsporidian JJ O
fungus NN O
, , O
has VBZ O
a DT O
reduced VBN O
genome NN O
that WDT O
codes VBZ O
only RB O
for IN O
1 CD O
, , O
997 CD O
proteins NNS O
and CC O
lacks VBZ O
genes NNS O
encoding VBG O
enzymes NNS O
of IN O
many JJ O
primary JJ O
metabolic JJ O
pathways NNS O
such JJ O
as IN O
the DT O
tricarboxylic JJ O
acid NN O
cycle NN O
, , O
fatty JJ O
acid NN O
beta NN O
- HYPH O
oxidation NN O
, , O
biosynthetic JJ O
enzymes NNS O
of IN O
the DT O
vast JJ O
majority NN O
of IN O
amino NN O
acids NNS O
, , O
fatty NN O
acids NNS O
and CC O
nucleotides NNS O
, , O
as RB O
well RB O
as IN O
components NNS O
of IN O
the DT O
respiratory JJ O
electron NN O
transport NN O
chain NN O
and CC O
F1 NNP O
- HYPH O
F0 NNP O
ATP NNP O
synthase NN O
. . O

It PRP O
also RB O
lacks VBZ O
mitochondria NN O
and CC O
peroxisomes NNS O
[ -LRB- O
31 CD O
] -RRB- O
. . O

Therefore RB O
, , O
we PRP O
reasoned VBD O
that IN O
the DT O
inclusion NN O
of IN O
this DT O
species NN O
in IN O
the DT O
analysis NN O
of IN O
MCL NNP O
clusters NNS O
is VBZ O
likely JJ O
to TO O
result VB O
in IN O
underestimation NN O
of IN O
the DT O
number NN O
of IN O
groups NNS O
of IN O
conserved VBN O
proteins NNS O
. . O

By IN O
discarding VBG O
E NNP B-Species
. . I-Species
cuniculi NNP I-Species
, , O
there EX O
are VBP O
377 CD O
clusters NNS O
that WDT O
contained VBD O
proteins NNS O
from IN O
35 CD O
species NNS O
of IN O
fungi NNS O
and CC O
oomycetes NN O
( , O
Table NNP O
S3 NNP O
) -RRB- O
. . O

This DT O
relatively RB O
small JJ O
number NN O
of IN O
fungal JJ O
- HYPH O
conserved VBN O
clusters NNS O
reflects VBZ O
the DT O
large JJ O
evolutionary JJ O
distance NN O
between IN O
members NNS O
of IN O
the DT O
fungal NN O
kingdom NN O
, , O
as RB O
well RB O
as IN O
complex JJ O
patterns NNS O
of IN O
gene NN O
gains NNS O
and CC O
losses NNS O
during IN O
the DT O
evolution NN O
of IN O
fungi NN O
. . O

Basidiomycetes NNS O
and CC O
ascomycetes NNS O
are VBP O
thought VBN O
to TO O
have VB O
diverged VBN O
nearly RB O
1 CD O
, , O
0 CD O
million CD O
years NNS O
ago RB O
[ -LRB- O
32 CD O
] -RRB- O
and CC O
the DT O
Saccharomycotina NNP O
alone RB O
are VBP O
more RBR O
evolutionarily RB O
diverged VBN O
than IN O
the DT O
Chordate NNP O
phylum NN O
of IN O
the DT O
animal NN O
kingdom NN O
[ -LRB- O
33 CD O
] -RRB- O
. . O

Since IN O
the DT O
divergence NN O
of IN O
Saccharomycotina NNP O
( , O
hemiascomycetes NNP O
) , O
and CC O
Pezizomycotina NNP O
( , O
euascomycetes FW O
) -RRB- O
, , O
the DT O
genomes NNS O
of IN O
the DT O
latter JJ O
have VBP O
greatly RB O
increased VBN O
in IN O
size NN O
, , O
partly RB O
due IN O
to IN O
the DT O
appearance NN O
of IN O
novel JJ O
genes NNS O
related VBN O
to IN O
the DT O
filamentous JJ O
lifestyle NN O
. . O

Lineage NN O
- HYPH O
specific JJ O
gene NN O
losses NNS O
have VBP O
also RB O
been VBN O
shown VBN O
in IN O
a DT O
number NN O
of IN O
hemiascomycete NN O
species NNS O
[ -LRB- O
34 CD O
] -RRB- O
. . O

As RB O
well RB O
as IN O
the DT O
groups NNS O
of IN O
proteins NNS O
mentioned VBN O
above RB O
( -LRB- O
Table NNP O
S1 NNP O
) -RRB- O
, , O
the DT O
fungal NN O
- HYPH O
conserved VBN O
clusters NNS O
included VBD O
those DT O
containing VBG O
enzymes NNS O
from IN O
primary JJ O
metabolic JJ O
pathways NNS O
not RB O
present JJ O
in IN O
E NNP B-Species
. . I-Species
cuniculi NNP I-Species
, , O
such JJ O
as IN O
the DT O
tricarboxylic NN O
acid NN O
cycle NN O
, , O
amino NN O
acid NN O
metabolism NN O
, , O
fatty JJ O
acid NN O
biosynthesis NN O
, , O
cholesterol NN O
biosynthesis NN O
and CC O
nucleotide NN O
metabolism NN O
, , O
as RB O
well RB O
as IN O
components NNS O
of IN O
the DT O
respiratory JJ O
electron NN O
transport NN O
chain NN O
and CC O
F1 NNP O
- HYPH O
F0 NNP O
ATP NNP O
synthase NN O
. . O

The DT O
conserved VBN O
protein NN O
clusters NNS O
also RB O
include VBP O
a DT O
number NN O
of IN O
transporters NNS O
( , O
including VBG O
mitochondrial JJ O
transporters NNS O
) -RRB- O
, , O
enzymes NNS O
involved VBN O
in IN O
haem NN O
biosynthesis NN O
, , O
autophagy NN O
- HYPH O
related VBN O
proteins NNS O
, , O
those DT O
involved VBN O
in IN O
protein NN O
targeting NN O
to IN O
the DT O
peroxisome NN O
and CC O
vacuole NN O
and CC O
additional JJ O
groups NNS O
of IN O
proteins NNS O
involved VBN O
in IN O
signal NN O
transduction NN O
that WDT O
are VBP O
not RB O
present JJ O
in IN O
E NNP B-Species
. . I-Species
cuniculi NNP I-Species
( , O
including VBG O
those DT O
involved VBN O
in IN O
inosine NN O
triphosphate NN O
and CC O
leukotriene NN O
metabolism NN O
) -RRB- O
. . O

The DT O
analysis NN O
also RB O
showed VBD O
there EX O
were VBD O
105 CD O
clusters NNS O
that WDT O
contained VBD O
proteins NNS O
from IN O
33 CD O
species NNS O
of IN O
fungi NN O
( , O
excluding VBG O
E NNP B-Species
. . I-Species
cuniculi NN I-Species
) -RRB- O
, , O
but CC O
not RB O
from IN O
the DT O
two CD O
species NNS O
of IN O
oomycete NN O
( , O
see VB O
Table NNP O
S4 NNP O
) -RRB- O
. . O

As RB O
well RB O
as IN O
those DT O
mentioned VBN O
previously RB O
( , O
Table NNP O
S2 NNP O
) -RRB- O
, , O
the DT O
group NN O
includes VBZ O
a DT O
number NN O
of IN O
clusters NNS O
of IN O
transporters NNS O
that WDT O
are VBP O
conserved VBN O
in IN O
fungi NN O
but CC O
not RB O
found VBN O
in IN O
oomycetes NNS O
, , O
as RB O
well RB O
as IN O
proteins NNS O
involved VBN O
in IN O
fungal JJ O
cell NN O
wall NN O
synthesis NN O
, , O
and CC O
lipid JJ O
metabolism NN O
. . O

It PRP O
may MD O
be VB O
the DT O
case NN O
that IN O
the DT O
genomes NNS O
of IN O
oomycete NN O
species NNS O
do VBP O
not RB O
possess VB O
orthologues NNS O
of IN O
the DT O
fungal JJ O
genes NNS O
in IN O
these DT O
clusters NNS O
, , O
or CC O
alternatively RB O
, , O
the DT O
large JJ O
evolutionary JJ O
distance NN O
between IN O
the DT O
oomycetes NNS O
and CC O
fungi NN O
mean VBP O
that IN O
the DT O
corresponding VBG O
orthologues NNS O
from IN O
each DT O
Kingdom NNP O
cluster NN O
separately RB O
. . O

Comparative JJ O
analysis NN O
of IN O
yeasts NNS O
and CC O
filamentous JJ O
fungi NNS O

One CD O
striking JJ O
difference NN O
in IN O
the DT O
morphology NN O
of IN O
species NNS O
of IN O
fungi NN O
is VBZ O
between IN O
those DT O
that WDT O
have VBP O
a DT O
filamentous JJ O
, , O
multi JJ O
- HYPH O
cellular JJ O
growth NN O
habit NN O
and CC O
those DT O
that WDT O
grow VBP O
as IN O
single JJ O
yeast NN B-Species
cells NNS O
. . O

There EX O
is VBZ O
some DT O
overlap NN O
between IN O
these DT O
two CD O
groups NNS O
; : O
because IN O
some DT O
fungi NNS O
are VBP O
dimorphic JJ O
or CC O
even RB O
pleiomorphic JJ O
, , O
switching VBG O
between IN O
different JJ O
growth NN O
forms NNS O
depending VBG O
on IN O
environmental JJ O
conditions NNS O
or CC O
the DT O
stage NN O
of IN O
their PRP$ O
life NN O
cycle NN O
. . O

For IN O
example NN O
, , O
the DT O
corn NN B-Species
- HYPH O
smut NN O
fungus NN O
Ustilago NNP B-Species
maydis NN I-Species
can MD O
exist VB O
saprophytically RB O
as IN O
haploid NN O
yeast NN B-Species
- HYPH O
like JJ O
cells NNS O
, , O
but CC O
needs VBZ O
to TO O
form VB O
a DT O
dikaryotic JJ O
filamentous JJ O
growth NN O
form NN O
in IN O
order NN O
to TO O
infect VB O
the DT O
host NN O
plant NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Generally RB O
the DT O
genomes NNS O
of IN O
the DT O
filamentous JJ O
fungi NN O
contain VBP O
more JJR O
protein NN O
- HYPH O
encoding VBG O
genes NNS O
( : O
9 CD O
, , O
0 CD O
- HYPH O
17 CD O
, , O
0 CD O
) -RRB- O
than IN O
those DT O
from IN O
unicellular JJ O
yeasts NNS O
( , O
5 CD O
, , O
0 CD O
- SYM O
7 CD O
, , O
0 CD O
) -RRB- O
, , O
perhaps RB O
reflecting VBG O
their PRP$ O
greater JJR O
morphological JJ O
complexity NN O
and CC O
secondary JJ O
metabolic JJ O
capacity NN O
. . O

U NN B-Species
. . I-Species
maydis NNP I-Species
, , O
however RB O
, , O
has VBZ O
6 CD O
, , O
522 CD O
protein NN O
encoding VBG O
genes NNS O
, , O
perhaps RB O
reflecting VBG O
its PRP$ O
lack NN O
of IN O
extensive JJ O
secondary JJ O
metabolic JJ O
pathways NNS O
and CC O
its PRP$ O
potential JJ O
usefulness NN O
in IN O
defining VBG O
the DT O
minimal JJ O
gene NN O
sets NNS O
associated VBN O
with IN O
biotrophic JJ O
growth NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

The DT O
increase NN O
in IN O
proteome NN O
size NN O
in IN O
filamentous JJ O
ascomycetes NNS O
may MD O
be VB O
due IN O
to IN O
the DT O
expansion NN O
of IN O
certain JJ O
gene NN O
families NNS O
or CC O
the DT O
presence NN O
of IN O
novel JJ O
genes NNS O
that WDT O
are VBP O
essential JJ O
for IN O
the DT O
filamentous JJ O
lifestyle NN O
. . O

For IN O
the DT O
purposes NNS O
of IN O
this DT O
study NN O
, , O
the DT O
filamentous JJ O
fungi NN O
were VBD O
defined VBN O
as IN O
the DT O
filamentous JJ O
ascomycetes NN O
( , O
subphylum NN O
Pezizomycotina NNP O
) -RRB- O
, , O
basidiomycetes NNS O
and CC O
zygomycetes NNS O
and CC O
the DT O
unicellular JJ O
fungi NN O
were VBD O
defined VBN O
as IN O
the DT O
budding VBG O
yeasts NNS O
( , O
order NN O
Saccharomycetales NNP O
) -RRB- O
, , O
the DT O
archiascomycete NN O
Schizosaccharomyces NN B-Species
pombe NN I-Species
and CC O
the DT O
microsporidian JJ O
fungus NN O
Encephalitozoon NNP B-Species
cuniculi NN I-Species
. . O

A DT O
total NN O
of IN O
37 CD O
MCL NNP O
clusters NNS O
contained VBD O
proteins NNS O
from IN O
all DT O
species NNS O
of IN O
filamentous JJ O
fungi NN O
, , O
but CC O
no DT O
species NNS O
of IN O
unicellular JJ O
fungi NN O
( , O
Table NNP O
2 CD O
) -RRB- O
. . O

Interestingly RB O
, , O
eight CD O
of IN O
these DT O
clusters NNS O
also RB O
contained VBD O
proteins NNS O
from IN O
both DT O
species NNS O
of IN O
oomycete NN O
represented VBN O
in IN O
e NNP O
- HYPH O
Fungi NNP O
. . O

The DT O
filamentous JJ O
- HYPH O
fungal JJ O
specific JJ O
clusters NNS O
included VBD O
a DT O
number NN O
of IN O
proteins NNS O
that WDT O
are VBP O
involved VBN O
in IN O
cytoskeletal JJ O
rearrangements NNS O
( , O
dedicator NN O
of IN O
cytokinesis NN O
protein NN O
, , O
integrin NN O
beta NN O
- HYPH O
1 CD O
- HYPH O
binding VBG O
protein NN O
, , O
dynactin NN O
p62 NN O
family NN O
, , O
dynein NN O
light JJ O
intermediate NN O
chain NN O
2 CD O
) -RRB- O
, , O
it PRP O
seems VBZ O
likely JJ O
that IN O
these DT O
are VBP O
required VBN O
for IN O
the DT O
complex JJ O
morphological JJ O
changes NNS O
that WDT O
filamentous JJ O
fungi NNS O
undergo VBP O
during IN O
their PRP$ O
lifecycle NN O
and CC O
the DT O
production NN O
of IN O
differentiated JJ O
cells NNS O
, , O
such JJ O
as IN O
spores NNS O
, , O
fruiting VBG O
bodies NNS O
and CC O
infection NN O
structures NNS O
. . O

The DT O
results NNS O
also RB O
suggest VBP O
that IN O
filamentous JJ O
fungal JJ O
species NNS O
make VBP O
a DT O
greater JJR O
use NN O
of IN O
lipids NNS O
as IN O
signalling VBG O
molecules NNS O
than IN O
yeast NN B-Species
species NNS O
. . O

For IN O
example NN O
, , O
the DT O
occurrence NN O
of IN O
filamentous JJ O
fungal NN O
- HYPH O
specific JJ O
clusters NNS O
representing VBG O
two CD O
groups NNS O
of IN O
lysophospholipases NNS O
, , O
as RB O
well RB O
as IN O
ceramidases NNS O
that WDT O
are VBP O
involved VBN O
in IN O
sphingolipid NN O
signalling NN O
[ -LRB- O
35 CD O
] -RRB- O
and CC O
linoleate NN O
diol NN O
synthases NNS O
that WDT O
can MD O
catalyse VB O
the DT O
formation NN O
of IN O
leukotrienes NNS O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
one CD O
of IN O
the DT O
products NNS O
of IN O
linoleate NN O
diol NN O
synthase NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
sporulation NN O
hormone NN O
in IN O
Aspergillus NNP B-Species
nidulans NNS I-Species
[ -LRB- O
37 CD O
] -RRB- O
. . O

There EX O
is VBZ O
also RB O
a DT O
cluster NN O
that WDT O
represents VBZ O
homologues NNS O
of IN O
a DT O
novel JJ O
human JJ B-Species
gene NN O
( , O
LRP16 NN O
) -RRB- O
that WDT O
acts VBZ O
downstream RB O
of IN O
a DT O
steroid NN O
receptor NN O
and CC O
promotes VBZ O
cell NN O
proliferation NN O
[ -LRB- O
38 CD O
] -RRB- O
. . O

Two CD O
clusters NNS O
of IN O
filamentous JJ O
fungal NN O
- HYPH O
specific JJ O
proteins NNS O
represent VBP O
enzymes NNS O
involved VBN O
in IN O
molypterin NN O
biosynthesis NN O
( , O
MCL2420 NNP O
, , O
MCL2581 NNP O
) -RRB- O
. . O

Molypterin NNP O
is VBZ O
a DT O
molybdenum NN O
- HYPH O
containing VBG O
co NN O
- HYPH O
factor NN O
for IN O
nitrate NN O
reductase NN O
, , O
an DT O
enzyme NN O
that WDT O
is VBZ O
known VBN O
to TO O
be VB O
absent JJ O
from IN O
the DT O
species NNS O
of IN O
yeast NN B-Species
used VBN O
in IN O
this DT O
study NN O
[ -LRB- O
39 CD O
] -RRB- O
. . O

Both PDT O
these DT O
clusters NNS O
are VBP O
also RB O
found VBN O
in IN O
oomycetes NNS O
. . O

There EX O
are VBP O
other JJ O
clusters NNS O
representing VBG O
proteins NNS O
important JJ O
for IN O
activities NNS O
specific JJ O
to IN O
filamentous JJ O
fungi NN O
, , O
such JJ O
as IN O
homologues NNS O
of IN O
Pro11 NNP O
( HYPH O
striatin NN O
) -RRB- O
which WDT O
regulates VBZ O
fruiting VBG O
body NN O
formation NN O
in IN O
Sordaria NNP B-Species
macrospora NN I-Species
[ -LRB- O
40 CD O
] -RRB- O
, , O
the DT O
vegetatible JJ O
incompatibility NN O
protein NN O
HET NN O
- HYPH O
E NN O
- HYPH O
1 CD O
, , O
which WDT O
prevents VBZ O
the DT O
formation NN O
of IN O
heterokaryons NNS O
between IN O
incompatible JJ O
fungal JJ O
strains NNS O
in IN O
Podospora NNP B-Species
anserina NN I-Species
[ -LRB- O
41 CD O
] -RRB- O
, , O
anucleate VBP O
primary JJ O
sterigmata NN O
protein NN O
A NN O
from IN O
Aspergillus NNP B-Species
nidulans NNS I-Species
, , O
which WDT O
is VBZ O
essential JJ O
for IN O
nuclear JJ O
migration NN O
and CC O
conidiophore NN O
development NN O
[ -LRB- O
42 CD O
] -RRB- O
and CC O
cytochrome NN O
P450 NN O
and CC O
polyketide NN O
synthase NN O
- HYPH O
encoding VBG O
genes NNS O
, , O
both DT O
of IN O
which WDT O
are VBP O
involved VBN O
in IN O
a DT O
number NN O
of IN O
secondary JJ O
metabolic JJ O
pathways NNS O
including VBG O
toxin NN O
biosynthesis NN O
[ -LRB- O
43 CD O
] -RRB- O
. . O

Pathogenicity NN O
- HYPH O
associated VBN O
gene NN O
functions NNS O
in IN O
fungi NN O

As IN O
the DT O
selected VBN O
set NN O
of IN O
fungi NN O
includes VBZ O
both CC O
saprotrophic JJ O
and CC O
pathogenic JJ O
species NNS O
, , O
this DT O
allows VBZ O
us PRP O
to TO O
compare VB O
the DT O
gene NN O
inventories NNS O
of IN O
phytopathogenic JJ O
and CC O
closely RB O
related VBN O
non JJ O
- HYPH O
pathogenic JJ O
fungi NN O
to TO O
look VB O
for IN O
genes NNS O
that WDT O
are VBP O
unique JJ O
to IN O
phytopathogens NNS O
. . O

Analysis NN O
of IN O
MCL NNP O
clusters NNS O
showed VBD O
that IN O
there EX O
were VBD O
no DT O
clusters NNS O
that WDT O
contained VBD O
proteins NNS O
from IN O
all DT O
species NNS O
of IN O
fungal JJ O
phytopathogen NN O
in IN O
e NN O
- HYPH O
Fungi NNP O
( , O
namely RB O
B NN B-Species
. . I-Species
cinerea NN I-Species
, , O
Eremothecium NN B-Species
gossypii NN I-Species
, , O
G NN B-Species
. . I-Species
zeae NN I-Species
, , O
M NN B-Species
. . I-Species
grisea NN I-Species
, , O
S NNP B-Species
. . I-Species
sclerotiorum NN I-Species
, , O
S NN B-Species
. . I-Species
nodorum NN I-Species
and CC O
U NN B-Species
. . I-Species
maydis NNP I-Species
) -RRB- O
but CC O
did VBD O
not RB O
contain VB O
proteins NNS O
from IN O
non JJ O
- HYPH O
pathogenic JJ O
species NNS O
. . O

There EX O
were VBD O
, , O
however RB O
, , O
four CD O
clusters NNS O
that WDT O
were VBD O
exclusive JJ O
to IN O
filamentous JJ O
ascomycete NN O
phytopathogens NNS O
( , O
namely RB O
B NN B-Species
. . I-Species
cinerea NN I-Species
, , O
G NNP B-Species
. . I-Species
zeae NN I-Species
, , O
M NNP B-Species
. . I-Species
grisea NN I-Species
, , O
S NNP B-Species
. . I-Species
sclerotiorum NN I-Species
, , O
S NN B-Species
. . I-Species
nodorum NN I-Species
as IN O
shown VBN O
in IN O
Table NN O
3 CD O
) -RRB- O
. . O

Significantly RB O
, , O
none NN O
of IN O
the DT O
members NNS O
of IN O
these DT O
clusters NNS O
had VBD O
homology NN O
to IN O
any DT O
known VBN O
proteins NNS O
or CC O
contained VBN O
motifs NNS O
from IN O
the DT O
Pfam NNP O
database NN O
[ -LRB- O
44 CD O
] -RRB- O
, , O
so CC O
we PRP O
were VBD O
unable JJ O
to TO O
predict VB O
their PRP$ O
function NN O
, , O
although IN O
two CD O
of IN O
the DT O
clusters NNS O
( -LRB- O
MCL4854 NNP O
and CC O
MCL8229 NNP O
) -RRB- O
consisted VBD O
entirely RB O
of IN O
proteins NNS O
that WDT O
were VBD O
predicted VBN O
to TO O
be VB O
secreted VBN O
. . O

Taken VBN O
together RB O
, , O
the DT O
observations NNS O
indicate VBP O
that IN O
a DT O
battery NN O
of IN O
completely RB O
novel JJ O
secreted VBN O
proteins NNS O
may MD O
be VB O
associated VBN O
with IN O
ascomycete NN O
fungal JJ O
pathogens NNS O
. . O

Pathogenicity NN O
factors NNS O
have VBP O
been VBN O
defined VBN O
as IN O
genes NNS O
that WDT O
are VBP O
essential JJ O
for IN O
successful JJ O
completion NN O
of IN O
the DT O
pathogen NN O
lifecycle NN O
but CC O
dispensable JJ O
for IN O
saprophytic JJ O
growth NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

This DT O
is VBZ O
an DT O
experimental JJ O
definition NN O
based VBN O
on IN O
whether IN O
null JJ O
mutations NNS O
of IN O
a DT O
given VBN O
gene NN O
reduce VBP O
the DT O
virulence NN O
of IN O
the DT O
pathogen NN O
on IN O
its PRP$ O
host NN O
. . O

We PRP O
wished VBD O
to TO O
ascertain VB O
whether IN O
homologues NNS O
of IN O
previously RB O
characterised VBN O
and CC O
experimentally RB O
- HYPH O
validated VBN O
pathogenicity NN O
factors NNS O
were VBD O
limited VBN O
to IN O
the DT O
genomes NNS O
of IN O
pathogenic JJ O
species NNS O
. . O

A DT O
search NN O
was VBD O
therefore RB O
made VBN O
for IN O
pathogenicity NN O
factors NNS O
that WDT O
have VBP O
been VBN O
identified VBN O
experimentally RB O
for IN O
the DT O
species NNS O
of IN O
phytopathogens NNS O
represented VBN O
in IN O
e NNP O
- HYPH O
Fungi NNP O
using VBG O
PHI NNP O
- HYPH O
base NN O
, , O
the DT O
plant NN O
- HYPH O
host NN O
interaction NN O
database NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

The DT O
matching NN O
locus NN O
was VBD O
identified VBN O
for IN O
each DT O
pathogenicity NN O
factor NN O
in IN O
the DT O
corresponding VBG O
genome NN O
sequence NN O
by IN O
comparing VBG O
a DT O
published VBN O
protein NN O
sequence NN O
with IN O
sets NNS O
of IN O
predicted VBN O
proteins NNS O
for IN O
each DT O
genome NN O
using VBG O
BLASTP NNP O
. . O

This DT O
produced VBD O
a DT O
list NN O
of IN O
105 CD O
pathogenicity NN O
factors NNS O
, , O
although IN O
corresponding VBG O
loci NN O
could MD O
not RB O
be VB O
found VBN O
in IN O
genome NN O
sequences NNS O
for IN O
all PDT O
the DT O
published VBN O
genes NNS O
( , O
see VB O
Table NNP O
S5 NNP O
) -RRB- O
. . O

MCL NNP O
clusters NNS O
containing VBG O
these DT O
proteins NNS O
were VBD O
identified VBN O
( : O
76 CD O
unique JJ O
clusters NNS O
) , O
and CC O
the DT O
species NNS O
distribution NN O
of IN O
members NNS O
of IN O
these DT O
clusters NNS O
analysed VBN O
. . O

In IN O
total NN O
, , O
29 CD O
of IN O
the DT O
MCL NNP O
clusters NNS O
contained VBD O
pathogenicity NN O
factors NNS O
with IN O
members NNS O
from IN O
at IN O
least JJS O
34 CD O
of IN O
the DT O
36 CD O
species NNS O
represented VBN O
in IN O
e NNP O
- HYPH O
Fungi NNP O
( -LRB- O
Table NNP O
4 CD O
) -RRB- O
. . O

Not RB O
surprisingly RB O
, , O
many JJ O
of IN O
these DT O
clusters NNS O
contain VBP O
conserved VBN O
components NNS O
of IN O
signalling VBG O
pathways NNS O
such JJ O
as IN O
protein NN O
kinases NNS O
, , O
adenylate NN O
cyclases NNS O
, , O
G NN O
- HYPH O
proteins NNS O
and CC O
cell NN O
cycle NN O
regulators NNS O
. . O

Cellular JJ O
morphogenesis NN O
is VBZ O
known VBN O
to TO O
be VB O
important JJ O
for IN O
infection NN O
of IN O
the DT O
host NN O
plant NN O
by IN O
many JJ O
phytopathogens NNS O
, , O
for IN O
example NN O
, , O
in IN O
appressorium NN O
formation NN O
in IN O
Magnaporthe NNP B-Species
grisea NN I-Species
[ -LRB- O
46 CD O
] -RRB- O
or CC O
the DT O
switch NN O
in IN O
the DT O
growth NN O
form NN O
of IN O
Ustilago NNP B-Species
maydis NN I-Species
from IN O
yeast NN B-Species
- HYPH O
like JJ O
growth NN O
to IN O
filamentous JJ O
invasive JJ O
growth NN O
[ -LRB- O
47 CD O
] -RRB- O
. . O

Links NNS O
between IN O
successful JJ O
plant NN O
infection NN O
and CC O
cell NN O
cycle NN O
control NN O
have VBP O
also RB O
been VBN O
demonstrated VBN O
[ -LRB- O
48 CD O
] -RRB- O
. . O

It PRP O
seems VBZ O
likely JJ O
that IN O
conserved VBN O
signalling NN O
pathways NNS O
that WDT O
control VBP O
activities NNS O
, , O
such JJ O
as IN O
mating NN O
and CC O
morphogenesis NN O
in IN O
all DT O
fungi NN O
, , O
have VBP O
evolved VBN O
to TO O
control VB O
processes NNS O
essential JJ O
for IN O
pathogencity NN O
in IN O
phytopathogens NNS O
. . O

Other JJ O
conserved JJ O
pathogenicity NN O
factors NNS O
encode VBP O
enzymes NNS O
of IN O
metabolic JJ O
pathways NNS O
that WDT O
are VBP O
present JJ O
in IN O
nearly RB O
all DT O
fungi NN O
, , O
but CC O
seem VBP O
to TO O
be VB O
important JJ O
for IN O
the DT O
life NN O
cycle NN O
of IN O
particular JJ O
pathogenic JJ O
species NNS O
, , O
for IN O
example NN O
, , O
enzymes NNS O
involved VBN O
in IN O
beta NN O
- HYPH O
oxidation NN O
of IN O
fatty NN O
acids NNS O
, , O
the DT O
glyoxylate JJ O
shunt NN O
, , O
amino NN O
acid NN O
metabolism NN O
and CC O
the DT O
utilisation NN O
of IN O
stored VBN O
sugars NNS O
. . O

When WRB O
considered VBN O
together RB O
, , O
this DT O
may MD O
indicate VB O
that IN O
nutritional JJ O
conditions NNS O
which WDT O
fungi NN O
encounter VBP O
when WRB O
invading VBG O
host NN O
plant NN O
tissue NN O
require VBP O
mobilisation NN O
of IN O
stored VBN O
lipids NNS O
prior RB O
to IN O
nutrition NN O
being VBG O
extracted VBN O
from IN O
the DT O
host NN O
plant NN O
. . O

Seventeen CD O
of IN O
the DT O
MCL NNP O
clusters NNS O
containing VBG O
pathogenicity NN O
factors NNS O
were VBD O
specific JJ O
to IN O
filamentous JJ O
ascomycetes NNS O
( -LRB- O
Table NNP O
5 CD O
) -RRB- O
. . O

These DT O
include VBP O
a DT O
number NN O
of IN O
enzymes NNS O
involved VBN O
in IN O
secondary JJ O
metabolism NN O
, , O
such JJ O
as IN O
those DT O
involved VBN O
in IN O
the DT O
synthesis NN O
of IN O
the DT O
fungal JJ O
toxin NN O
trichothecene NN O
in IN O
G NNP B-Species
. , I-Species
zeae NN I-Species
[ -LRB- O
43 CD O
] -RRB- O
and CC O
those DT O
involved VBN O
in IN O
melanin NN O
biosynthesis NN O
[ -LRB- O
49 CD O
] -RRB- O
, , O
as RB O
well RB O
as IN O
structural JJ O
proteins NNS O
, , O
some DT O
of IN O
which WDT O
are VBP O
components NNS O
of IN O
differentiated VBN O
cell NN O
types NNS O
not RB O
seen VBN O
in IN O
yeasts NNS O
, , O
for IN O
example NN O
, , O
hydrophobins NNS O
which WDT O
are VBP O
components NNS O
of IN O
aerial JJ O
structures NNS O
such JJ O
as IN O
fruiting VBG O
bodies NNS O
[ -LRB- O
50 CD O
] -RRB- O
but CC O
are VBP O
also RB O
involved VBN O
in IN O
pathogenicity NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

There EX O
also RB O
seems VBZ O
to TO O
be VB O
a DT O
number NN O
of IN O
filamentous JJ O
ascomycete NN O
specific JJ O
receptor NN O
proteins NNS O
( , O
transducin NN O
beta NN O
- HYPH O
subunit NN O
, , O
G NN O
- HYPH O
protein NN O
coupled VBN O
receptor NN O
, , O
tetraspanins NN O
) , O
that WDT O
have VBP O
evolved VBN O
in IN O
pathogens NNS O
to TO O
be VB O
used VBN O
in IN O
sensing VBG O
environmental JJ O
cues NNS O
that WDT O
are VBP O
essential JJ O
for IN O
successful JJ O
infection NN O
of IN O
the DT O
host NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

The DT O
Woronin NNP O
body NN O
is VBZ O
a DT O
structure NN O
found VBN O
only RB O
in IN O
filamentous JJ O
ascomycetes NNS O
, , O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
essential JJ O
for IN O
pathogenicity NN O
in IN O
M NNP B-Species
. . I-Species
grisea NN I-Species
[ -LRB- O
52 CD O
] -RRB- O
. . O

A DT O
major JJ O
constituent NN O
of IN O
the DT O
woronin NN O
body NN O
, , O
encoded VBN O
by IN O
MVP1 NNP O
, , O
is VBZ O
a DT O
pathogenicity NN O
factor NN O
for IN O
M NNP B-Species
. . I-Species
grisea NNP I-Species
, , O
but CC O
also RB O
has VBZ O
homologues NNS O
in IN O
nearly RB O
all DT O
species NNS O
of IN O
filamentous JJ O
ascomycetes NNS O
. . O

Two CD O
proteins NNS O
that WDT O
were VBD O
initially RB O
discovered VBN O
as IN O
being VBG O
highly RB O
expressed VBN O
in IN O
the DT O
appressoria NN O
of IN O
M NNP B-Species
. , I-Species
grisea NN I-Species
and CC O
essential JJ O
for IN O
pathogenicity NN O
( , O
Mas1 NNP O
and CC O
Mas3 NNP O
) -RRB- O
[ -LRB- O
53 CD O
] -RRB- O
also RB O
have VBP O
homologues NNS O
in IN O
a DT O
number NN O
of IN O
species NNS O
of IN O
filamentous JJ O
fungi NN O
( , O
Table NNP O
5 CD O
) -RRB- O
. . O

Thus RB O
, , O
many JJ O
innovations NNS O
that WDT O
have VBP O
allowed VBN O
filamentous JJ O
ascomycetes NNS O
to TO O
have VB O
a DT O
more RBR O
complex JJ O
morphology NN O
than IN O
unicellular JJ O
yeasts NNS O
have VBP O
also RB O
evolved VBN O
to TO O
be VB O
essential JJ O
for IN O
plant NN O
infection NN O
by IN O
phytopathogenic JJ O
species NNS O
. . O

Interestingly RB O
, , O
none NN O
of IN O
the DT O
MCL NNP O
clusters NNS O
containing VBG O
known VBN O
pathogenicity NN O
factors NNS O
contained VBD O
members NNS O
only RB O
from IN O
phytopathogenic JJ O
fungi NN O
, , O
apart RB O
from IN O
those DT O
that WDT O
were VBD O
restricted VBN O
to IN O
just RB O
one CD O
species NN O
. . O

These DT O
are VBP O
therefore RB O
likely JJ O
to TO O
represent VB O
highly RB O
- HYPH O
specialised VBN O
proteins NNS O
that WDT O
have VBP O
evolved VBN O
for IN O
the DT O
specific JJ O
lifecycle NN O
of IN O
just RB O
one CD O
species NN O
of IN O
phytopathogen NN O
, , O
for IN O
example NN O
the DT O
Pwl NNP O
proteins NNS O
involved VBN O
in IN O
determining VBG O
host NN O
range NN O
of IN O
different JJ O
strains NNS O
of IN O
M NNP B-Species
. . I-Species
grisea NN I-Species
[ -LRB- O
54 CD O
] -RRB- O
. . O

Two CD O
of IN O
the DT O
proteins NNS O
specific JJ O
to IN O
M NNP B-Species
. . I-Species
grisea NN I-Species
, , O
the DT O
metallothionein NN O
Mmt1 NNP O
[ -LRB- O
55 CD O
] -RRB- O
and CC O
the DT O
hydrophobin NN O
Mpg1 NNP O
[ -LRB- O
56 CD O
] -RRB- O
are VBP O
small JJ O
polypeptides NNS O
and CC O
are VBP O
members NNS O
of IN O
highly RB O
divergent JJ O
gene NN O
families NNS O
, , O
other JJ O
members NNS O
of IN O
which WDT O
do VBP O
not RB O
cluster VB O
together RB O
using VBG O
BLASTP NNP O
. . O

Comparative JJ O
analysis NN O
of IN O
plant NN O
- HYPH O
pathogenic JJ O
and CC O
saprotrophic JJ O
filamentous JJ O
ascomycetes NNS O

Based VBN O
on IN O
the DT O
analysis NN O
reported VBN O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
in IN O
general JJ O
there EX O
are VBP O
a DT O
large JJ O
number NN O
of IN O
differences NNS O
in IN O
gene NN O
inventories NNS O
between IN O
filamentous JJ O
and CC O
yeast NN B-Species
- HYPH O
like JJ O
fungi NN O
. . O

Therefore RB O
, , O
in IN O
order NN O
to TO O
compare VB O
the DT O
genomes NNS O
of IN O
phytopathogens NNS O
and CC O
saprotrophs NNS O
, , O
we PRP O
focused VBD O
on IN O
filamentous JJ O
ascomycetes NNS O
in IN O
order NN O
to TO O
resolve VB O
in IN O
greater JJR O
detail NN O
the DT O
distinct JJ O
differences NNS O
in IN O
gene NN O
sets NNS O
between IN O
these DT O
two CD O
ecologically RB O
separate JJ O
groups NNS O
of IN O
fungi NNS O
. . O

In IN O
this DT O
way NN O
differences NNS O
due IN O
to IN O
phylogeny NN O
between IN O
the DT O
species NNS O
would MD O
be VB O
minimised VBN O
. . O

We PRP O
compared VBD O
the DT O
gene NN O
inventories NNS O
of IN O
the DT O
phytopathogens NN O
B NN B-Species
. . I-Species
cinerea NN I-Species
, , O
G NNP B-Species
. . I-Species
zeae NN I-Species
, , O
M NN B-Species
. . I-Species
grisea NN I-Species
, , O
S NN B-Species
. . I-Species
sclerotiorum NN I-Species
, , O
S NN B-Species
. . I-Species
nodorum NN I-Species
with IN O
the DT O
non NN O
- HYPH O
pathogens NNS O
Aspergillus NNP B-Species
nidulans NNS I-Species
, , O
Chaetomium NNP B-Species
globosum NN I-Species
, , O
Neurospora NNP B-Species
crassa NN I-Species
and CC O
Trichoderma NNP B-Species
reesei NN I-Species
. . O

Phylogenetic JJ O
analysis NN O
suggests VBZ O
that IN O
the DT O
phytopathogenic JJ O
species NNS O
do VBP O
not RB O
form VB O
a DT O
separate JJ O
clade NN O
from IN O
the DT O
pathogenic JJ O
species NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
, , O
[ -LRB- O
3 CD O
] -RRB- O
and CC O
we PRP O
assumed VBD O
that IN O
differences NNS O
in IN O
gene NN O
inventory NN O
should MD O
therefore RB O
reflect VB O
lifestyle NN O
rather RB O
than IN O
evolutionary JJ O
distance NN O
. . O

In IN O
order NN O
for IN O
such PDT O
a DT O
comparison NN O
to TO O
be VB O
considered VBN O
valid JJ O
, , O
the DT O
completeness NN O
and CC O
quality NN O
of IN O
the DT O
fungal JJ O
genome NN O
sequences NNS O
used VBN O
should MD O
, , O
however RB O
, , O
also RB O
be VB O
comparable JJ O
. . O

Table NNP O
S6 NNP O
summarises VBZ O
the DT O
available JJ O
data NNS O
about IN O
genome NN O
sequence NN O
coverage NN O
, , O
genome NN O
size NN O
and CC O
the DT O
number NN O
of IN O
predicted VBN O
proteins NNS O
for IN O
each DT O
species NNS O
. . O

This DT O
shows VBZ O
that IN O
the DT O
genome NN O
coverage NN O
is VBZ O
greater JJR O
than IN O
5x CD O
and CC O
the DT O
number NN O
of IN O
predicted VBN O
proteins NNS O
in IN O
the DT O
range NN O
of IN O
10 CD O
, , O
0 CD O
- SYM O
16 CD O
, , O
0 CD O
for IN O
all DT O
genomes NNS O
used VBN O
, , O
suggesting VBG O
a DT O
high JJ O
level NN O
of IN O
equivalence NN O
between IN O
species NNS O
with IN O
regard NN O
to IN O
sequence NN O
quality NN O
. . O

From IN O
our PRP$ O
work NN O
it PRP O
seems VBZ O
unlikely JJ O
that IN O
there EX O
are VBP O
pathogenicity NN O
factors NNS O
conserved VBN O
in IN O
, , O
and CC O
specific JJ O
to IN O
, , O
all DT O
species NNS O
of IN O
phytopathogen NN O
. . O

It PRP O
may MD O
, , O
for IN O
instance NN O
, , O
be VB O
the DT O
case NN O
that IN O
differences NNS O
in IN O
the DT O
gene NN O
inventories NNS O
are VBP O
due IN O
to IN O
the DT O
expansion NN O
of IN O
certain JJ O
gene NN O
families NNS O
in IN O
the DT O
genomes NNS O
of IN O
phytopathogenic JJ O
species NNS O
associated VBN O
with IN O
functions NNS O
necessary JJ O
for IN O
pathogenesis NN O
. . O

To TO O
define VB O
protein NN O
families NNS O
, , O
we PRP O
used VBD O
the DT O
Pfam NNP O
database NN O
which WDT O
contains VBZ O
protein NN O
family NN O
models NNS O
based VBN O
on IN O
Hidden NNP O
Markov NNP O
Models NNPS O
[ -LRB- O
44 CD O
] -RRB- O
, , O
[ -LRB- O
57 CD O
] -RRB- O
. . O

Sets NNS O
of IN O
predicted VBN O
proteins NNS O
for IN O
each DT O
fungal JJ O
species NN O
in IN O
e NNP O
- HYPH O
Fungi NNP O
were VBD O
analysed VBN O
for IN O
the DT O
occurrence NN O
of IN O
Pfam NNP O
motifs NNS O
and CC O
the DT O
number NN O
of IN O
proteins NNS O
containing VBG O
each DT O
domain NN O
across IN O
fungal JJ O
species NNS O
ascertained VBN O
. . O

The DT O
sets NNS O
of IN O
predicted VBN O
protein NN O
sequences NNS O
used VBN O
in IN O
this DT O
study NN O
have VBP O
been VBN O
automatically RB O
predicted VBN O
as IN O
part NN O
of IN O
each DT O
individual JJ O
genome NN O
project NN O
and CC O
are VBP O
likely JJ O
to TO O
contain VB O
a DT O
number NN O
of IN O
artefactual JJ O
sequences NNS O
. . O

The DT O
use NN O
of IN O
Pfam NNP O
motifs NNS O
to TO O
define VB O
gene NN O
families NNS O
in IN O
this DT O
study NN O
reduces VBZ O
the DT O
likelihood NN O
of IN O
such JJ O
sequences NNS O
affecting VBG O
the DT O
data NNS O
, , O
since IN O
Pfam NNP O
motifs NNS O
are VBP O
based VBN O
on IN O
multiple JJ O
sequence NN O
alignments NNS O
of IN O
well RB O
- HYPH O
studied VBN O
proteins NNS O
. . O

A DT O
small JJ O
number NN O
of IN O
Pfam NNP O
motifs NNS O
were VBD O
not RB O
found VBN O
in IN O
the DT O
proteomes NNS O
of IN O
the DT O
filamentous JJ O
ascomycete NN O
non NN O
- HYPH O
pathogens NNS O
, , O
but CC O
were VBD O
found VBN O
in IN O
the DT O
proteomes NNS O
of IN O
at RB O
least RBS O
three CD O
species NNS O
of IN O
filamentous JJ O
ascomycete NN O
phytopathogens NNS O
( -LRB- O
Table NNP O
6 CD O
) -RRB- O
. . O

These DT O
include VBP O
the DT O
Cas1p NNP O
- HYPH O
like JJ O
motif NN O
( , O
PF07779 CD O
) -RRB- O
, , O
found VBN O
in IN O
4 CD O
species NNS O
of IN O
phytopathogen NN O
, , O
including VBG O
five CD O
copies NNS O
in IN O
G NNP B-Species
. . I-Species
zeae NN I-Species
, , O
and CC O
the DT O
Yeast NNP B-Species
cell NN O
wall NN O
synthesis NN O
protein NN O
KRE9 NNP O
/ SYM O
KNH1 NNP O
motif NN O
( , O
PF05390 NN O
) -RRB- O
, , O
which WDT O
was VBD O
found VBN O
in IN O
three CD O
species NNS O
of IN O
phytopathogen NN O
. . O

Cas1p NNP O
is VBZ O
a DT O
membrane NN O
protein NN O
necessary JJ O
for IN O
the DT O
O NNP O
- HYPH O
acetylation NN O
of IN O
the DT O
capsular JJ O
polysaccharide NN O
of IN O
the DT O
basidiomycete NN O
animal NN O
pathogen NN O
Cryptococcus NNP B-Species
neoformans NNS I-Species
[ -LRB- O
58 CD O
] -RRB- O
. . O

KRE9 NNP O
and CC O
KNH1 NNP O
are VBP O
involved VBN O
in IN O
the DT O
synthesis NN O
of IN O
cell NN O
surface NN O
polysaccharides NNS O
in IN O
S NNP B-Species
. . I-Species
cerevisiae NN I-Species
[ -LRB- O
59 CD O
] -RRB- O
. . O

Taken VBN O
together RB O
this DT O
suggests VBZ O
that IN O
synthesis NN O
of IN O
cell NN O
surface NN O
polysaccharides NNS O
is VBZ O
important JJ O
for IN O
phytopathogens NNS O
, , O
perhaps RB O
helping VBG O
to TO O
shroud VB O
the DT O
fungus NN O
from IN O
plant NN O
defences NNS O
. . O

The DT O
function NN O
of IN O
the DT O
YDG NNP O
/ SYM O
SRA NNP O
domain NN O
motif NN O
( , O
PF02182 CD O
) -RRB- O
is VBZ O
unknown JJ O
, , O
but CC O
is VBZ O
found VBN O
in IN O
a DT O
novel JJ O
mouse NN B-Species
cell NN O
proliferation NN O
protein NN O
Np95 NNP O
, , O
in IN O
which WDT O
the DT O
domain NN O
is VBZ O
important JJ O
both CC O
for IN O
the DT O
interaction NN O
with IN O
histones NNS O
and CC O
for IN O
chromatin NN O
binding NN O
in IN O
vivo NN O
[ -LRB- O
60 CD O
] -RRB- O
. . O

As RB O
well RB O
as IN O
domains NNS O
of IN O
unknown JJ O
function NN O
, , O
the DT O
list NN O
of IN O
phytopathogen NN O
- HYPH O
specific JJ O
Pfam NNP O
motifs NN O
includes VBZ O
Allophanate NNP O
hydrolase NN O
( : O
PF02682 CD O
) -RRB- O
which WDT O
is VBZ O
found VBN O
in IN O
an DT O
enzyme NN O
involved VBN O
in IN O
the DT O
ATP NNP O
- HYPH O
dependent JJ O
urea NN O
degradation NN O
pathway NN O
[ -LRB- O
61 CD O
] -RRB- O
, , O
a DT O
peptidase NN O
motif NN O
, , O
an DT O
opioid JJ O
growth NN O
receptor NN O
motif NN O
( , O
PF04664 NN O
) -RRB- O
and CC O
Mnd1 NNP O
( -LRB- O
PF03962 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
recombination NN O
and CC O
meiotic JJ O
nuclear JJ O
division NN O
[ -LRB- O
62 CD O
] -RRB- O
. . O

To TO O
detect VB O
potential JJ O
gene NN O
family NN O
expansion NN O
, , O
we PRP O
decided VBD O
to TO O
identify VB O
Pfam NNP O
motifs NNS O
that WDT O
were VBD O
present JJ O
in IN O
both CC O
phytopathogenic JJ O
and CC O
non JJ O
- HYPH O
pathogenic JJ O
species NNS O
of IN O
filamentous JJ O
ascomycetes NNS O
, , O
but CC O
that DT O
were VBD O
more RBR O
common JJ O
in IN O
the DT O
genomes NNS O
of IN O
the DT O
former JJ O
. . O

The DT O
Pfam NNP O
motifs NNS O
were VBD O
ranked VBN O
on IN O
the DT O
ratio NN O
of IN O
the DT O
mean JJ O
number NN O
of IN O
proteins NNS O
containing VBG O
each DT O
motif NN O
in IN O
phytopathogens NNS O
, , O
when WRB O
compared VBN O
to IN O
non NN O
- HYPH O
pathogens NNS O
( -LRB- O
Table NN O
7 CD O
) -RRB- O
. . O

The DT O
tables NNS O
only RB O
show VBP O
ratios NNS O
of IN O
greater JJR O
than IN O
or CC O
equal JJ O
to IN O
2 CD O
. . O
5 CD O
. . O

Pfam NNP O
motifs NNS O
that WDT O
were VBD O
more RBR O
common JJ O
in IN O
the DT O
proteomes NNS O
of IN O
pathogens NNS O
, , O
include VBP O
some DT O
found VBN O
in IN O
enzymes NNS O
involved VBN O
in IN O
secondary JJ O
metabolic JJ O
pathways NNS O
. . O

These DT O
include VBP O
novel JJ O
enzymes NNS O
that WDT O
have VBP O
only RB O
previously RB O
been VBN O
studied VBN O
in IN O
non JJ O
- HYPH O
fungal JJ O
species NNS O
, , O
such JJ O
as IN O
the DT O
chalcone NN O
synthases NNS O
; , O
type NN O
III NNP O
polyketide NN O
synthases NNS O
involved VBN O
in IN O
the DT O
biosynthesis NN O
of IN O
flavonoids NNS O
in IN O
plants NNS O
[ -LRB- O
63 CD O
] -RRB- O
and CC O
lipoxygenases NNS O
; , O
components NNS O
of IN O
metabolic JJ O
pathways NNS O
resulting VBG O
in IN O
the DT O
synthesis NN O
of IN O
physiologically RB O
- HYPH O
active JJ O
compounds NNS O
such JJ O
as IN O
eicosanoids NNS O
in IN O
mammals NNS O
[ -LRB- O
64 CD O
] -RRB- O
and CC O
jasmonic JJ O
acid NN O
in IN O
plants NNS O
[ -LRB- O
65 CD O
] -RRB- O
as RB O
well RB O
as IN O
antibiotic JJ O
synthesis NN O
monooxygenases NNS O
. . O

It PRP O
seems VBZ O
likely JJ O
that IN O
secondary JJ O
metabolism NN O
is VBZ O
essential JJ O
in IN O
phytopathogenic JJ O
species NNS O
for IN O
the DT O
synthesis NN O
of IN O
mycotoxins NNS O
, , O
antibiotics NNS O
, , O
siderophores NNS O
and CC O
pigments NNS O
[ -LRB- O
66 CD O
] -RRB- O
, , O
but CC O
it PRP O
may MD O
also RB O
offer VB O
fungal JJ O
pathogens NNS O
a DT O
distinct JJ O
alternative JJ O
means NN O
of IN O
perturbing VBG O
host NN O
metabolism NN O
, , O
cell NN O
signalling NN O
or CC O
plant NN O
defence NN O
, , O
in IN O
contrast NN O
to IN O
bacterial JJ O
pathogens NNS O
that WDT O
rely VBP O
on IN O
protein NN O
secretion NN O
to TO O
achieve VB O
this DT O
. . O

There EX O
also RB O
seems VBZ O
to TO O
be VB O
number NN O
of IN O
protease NN O
and CC O
peptidase NN O
domains NNS O
that WDT O
are VBP O
more RBR O
common JJ O
in IN O
the DT O
genomes NNS O
of IN O
phytopathogens NNS O
as RB O
well RB O
as IN O
domains NNS O
from IN O
two CD O
classes NNS O
of IN O
cell NN O
- HYPH O
wall NN O
degrading VBG O
enzymes NNS O
: : O
namely RB O
cutinase NN O
( , O
PF01083 NN O
) -RRB- O
and CC O
Glycosyl NNP O
hydrolase NN O
family NN O
53 CD O
( SYM O
PF07745 CD O
) -RRB- O
which WDT O
is VBZ O
found VBN O
in IN O
arabinogalactan NN O
endo NN O
- HYPH O
1 CD O
, , O
4 CD O
- HYPH O
beta NN O
- HYPH O
galactosidases NNS O
that WDT O
hydrolyze VBP O
the DT O
galactan NN O
side NN O
chains NNS O
that WDT O
form VBP O
part NN O
of IN O
the DT O
complex JJ O
carbohydrate NN O
structure NN O
of IN O
pectin NN O
[ -LRB- O
67 CD O
] -RRB- O
. . O

Two CD O
other JJ O
domains NNS O
found VBN O
in IN O
enzymes NNS O
involved VBN O
in IN O
pectin NN O
degradation NN O
, , O
pectinesterase NN O
( , O
PF01095 NN O
) -RRB- O
and CC O
Glycosyl NNP O
hydrolases NNS O
family NN O
28 CD O
( SYM O
PF00295 CD O
) -RRB- O
are VBP O
both DT O
more JJR O
than IN O
twice RB O
as RB O
common JJ O
in IN O
the DT O
genomes NNS O
of IN O
phytopathogens NNS O
than IN O
saprotrophs NNS O
. . O

In IN O
contrast NN O
, , O
domains NNS O
found VBN O
in IN O
cellulases NNS O
have VBP O
fairly RB O
equal JJ O
distribution NN O
between IN O
the DT O
proteomes NNS O
of IN O
phytopathogens NNS O
and CC O
non NN O
- HYPH O
pathogens NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Therefore RB O
, , O
for IN O
phytopathogens NNS O
the DT O
most RBS O
essential JJ O
enzymes NNS O
for IN O
pathogenesis NN O
may MD O
well RB O
be VB O
those DT O
that WDT O
allow VBP O
the DT O
fungus NN O
to TO O
penetrate VB O
the DT O
protective JJ O
cutin NN O
layer NN O
of IN O
the DT O
plant NN O
epidermis NN O
and CC O
disrupt VBP O
the DT O
pectin NN O
matrix NN O
of IN O
the DT O
plant NN O
cell NN O
wall NN O
in IN O
which WDT O
cellulose NN O
fibrils NNS O
are VBP O
embedded VBN O
. . O

Pectin NNP O
- HYPH O
degrading VBG O
enzymes NNS O
have VBP O
already RB O
been VBN O
shown VBN O
to TO O
be VB O
pathogenicity NN O
factors NNS O
in IN O
a DT O
number NN O
of IN O
fungi NN O
[ -LRB- O
68 CD O
] -RRB- O
. . O

NPP1 NN O
motifs NNS O
are VBP O
characteristic JJ O
of IN O
a DT O
group NN O
of IN O
proteins NNS O
called VBN O
NLPs NNP O
( , O
Nep1 NNP O
- HYPH O
like JJ O
proteins NNS O
) , O
that WDT O
trigger VBP O
defence NN O
responses NNS O
, , O
necrosis NN O
and CC O
cell NN O
death NN O
in IN O
plants NNS O
and CC O
may MD O
act VB O
as IN O
virulence NN O
factors NNS O
[ -LRB- O
69 CD O
] -RRB- O
. . O

The DT O
NLPs NNS O
are VBP O
more RBR O
common JJ O
in IN O
the DT O
genomes NNS O
of IN O
phytopathogenic JJ O
, , O
when WRB O
compared VBN O
to IN O
non JJ O
- HYPH O
pathogenic JJ O
ascomycetes NNS O
, , O
but CC O
are VBP O
even RB O
more RBR O
numerous JJ O
in IN O
the DT O
proteomes NNS O
of IN O
the DT O
oomycetes NNS O
( , O
64 CD O
proteins NNS O
in IN O
Phytophthora NNP B-Species
ramorum NN I-Species
and CC O
75 CD O
in IN O
Phytophthora NN B-Species
sojae NN I-Species
) -RRB- O
. . O

Proteins NNS O
containing VBG O
the DT O
Chitin NNP O
recognition NN O
protein NN O
domain NN O
( -LRB- O
PF00187 CD O
) -RRB- O
are VBP O
also RB O
very RB O
common JJ O
in IN O
the DT O
proteomes NNS O
of IN O
phytopathogens NNS O
( , O
18 CD O
in IN O
M NN B-Species
. . I-Species
grisea NN I-Species
and CC O
16 CD O
in IN O
S NN B-Species
. . I-Species
nodorum NN I-Species
) -RRB- O
. . O

A DT O
role NN O
for IN O
chitin NN O
- HYPH O
binding VBG O
proteins NNS O
has VBZ O
been VBN O
proposed VBN O
in IN O
protecting VBG O
the DT O
fungal JJ O
cell NN O
wall NN O
from IN O
chitinases NNS O
produced VBN O
by IN O
host NN O
plants NNS O
[ -LRB- O
70 CD O
] -RRB- O
. . O

There EX O
are VBP O
also RB O
two CD O
other JJ O
Pfam NNP O
motifs NNS O
, , O
which WDT O
are VBP O
more RBR O
common JJ O
in IN O
the DT O
proteomes NNS O
of IN O
phytopathogens NNS O
, , O
that WDT O
are VBP O
found VBN O
in IN O
enzymes NNS O
involved VBN O
in IN O
the DT O
catabolism NN O
of IN O
toxic JJ O
compounds NNS O
, , O
namely RB O
arylesterase NN O
( , O
PF01731 NN O
) -RRB- O
and CC O
EthD NN O
protein NN O
( -LRB- O
PF07110 NN O
) -RRB- O
which WDT O
breakdown NN O
organophosphorus NN O
esters NNS O
[ -LRB- O
71 CD O
] -RRB- O
and CC O
ethyl NN O
tert NN O
- HYPH O
butyl NN O
ether NN O
[ -LRB- O
72 CD O
] -RRB- O
, , O
respectively RB O
. . O

Comparative JJ O
secretome NN O
analysis NN O
of IN O
phytopathogenic JJ O
and CC O
saprotrophic JJ O
filamentous JJ O
ascomycetes NNS O

Studies NNS O
in IN O
bacterial JJ O
pathogens NNS O
and CC O
oomycetes NNS O
have VBP O
shown VBN O
that IN O
a DT O
range NN O
of IN O
secreted VBN O
proteins NNS O
known VBN O
as IN O
effectors NNS O
are VBP O
important JJ O
for IN O
establishing VBG O
infection NN O
of IN O
the DT O
host NN O
plant NN O
[ -LRB- O
73 CD O
] -RRB- O
, , O
[ -LRB- O
74 CD O
] -RRB- O
. . O

These DT O
secreted VBN O
proteins NNS O
may MD O
disable VB O
plant NN O
defences NNS O
and CC O
subvert VB O
cellular JJ O
processes NNS O
to TO O
suit VB O
the DT O
needs NNS O
of IN O
invading VBG O
pathogens NNS O
. . O

Therefore RB O
, , O
we PRP O
decided VBD O
also RB O
to TO O
compare VB O
gene NN O
family NN O
size NN O
in IN O
the DT O
secretomes NNS O
of IN O
phytopathogens NNS O
and CC O
non JJ O
- HYPH O
pathogens NNS O
. . O

There EX O
are VBP O
a DT O
number NN O
of IN O
programs NNS O
available JJ O
that WDT O
predict VBP O
whether IN O
a DT O
protein NN O
is VBZ O
likely JJ O
to TO O
be VB O
secreted VBN O
, , O
although IN O
the DT O
predictions NNS O
they PRP O
give VBP O
significantly RB O
differ VBP O
from IN O
each DT O
other JJ O
. . O

Therefore RB O
we PRP O
defined VBD O
the DT O
secretome NN O
of IN O
each DT O
fungal JJ O
species NN O
based VBN O
on IN O
those DT O
proteins NNS O
that WDT O
are VBP O
predicted VBN O
to TO O
be VB O
secreted VBN O
by IN O
two CD O
different JJ O
programs NNS O
: : O
SignalP NNP O
3 CD O
. . O
0 CD O
[ -LRB- O
75 CD O
] -RRB- O
and CC O
WoLFPSORT NNP O
[ -LRB- O
76 CD O
] -RRB- O
. . O

The DT O
size NN O
of IN O
each DT O
secretome NN O
is VBZ O
summarised VBN O
in IN O
Figure NNP O
2 CD O
. . O

Even RB O
when WRB O
using VBG O
two CD O
programs NNS O
, , O
the DT O
sizes NNS O
of IN O
predicted VBN O
secretomes NNS O
can MD O
vary VB O
greatly RB O
. . O

For IN O
example NN O
, , O
a DT O
similar JJ O
analysis NN O
for IN O
M NNP B-Species
. . I-Species
grisea NN I-Species
using VBG O
SignalP NNP O
and CC O
ProtComp NNP O
( : O
www NN O
. . O
Softberry NNP O
. . O
com NN O
) -RRB- O
predicted VBD O
only RB O
739 CD O
secreted VBN O
proteins NNS O
( , O
out IN O
of IN O
a DT O
proteome NN O
of IN O
11 CD O
, , O
109 CD O
) , O
compared VBN O
to IN O
our PRP$ O
prediction NN O
of IN O
1 CD O
, , O
546 CD O
secreted VBN O
proteins NNS O
( , O
out IN O
of IN O
a DT O
proteome NN O
of IN O
12 CD O
, , O
841 CD O
) -RRB- O
[ -LRB- O
22 CD O
] -RRB- O
. . O

The DT O
size NN O
of IN O
the DT O
secretomes NNS O
for IN O
each DT O
species NNS O
varied VBD O
from IN O
5 CD O
% NN O
- SYM O
12 CD O
% NN O
of IN O
the DT O
total JJ O
proteome NN O
. . O

Overall RB O
, , O
the DT O
size NN O
of IN O
the DT O
secretomes NNS O
from IN O
phytopathogens NNS O
did VBD O
not RB O
differ VB O
greatly RB O
from IN O
that DT O
of IN O
non NN O
- HYPH O
pathogens NNS O
. . O

Table NN O
8 CD O
shows VBZ O
a DT O
list NN O
of IN O
Pfam NNP O
motifs NNS O
, , O
not RB O
found VBN O
in IN O
the DT O
secretomes NNS O
of IN O
non NN O
- HYPH O
pathogenic JJ O
filamentous JJ O
ascomycetes NNS O
, , O
that WDT O
were VBD O
present JJ O
in IN O
at RB O
least RBS O
three CD O
phytopathogenic JJ O
fungal JJ O
species NNS O
. . O

The DT O
Isochorismatase NNP O
motif NN O
( , O
PF00857 CD O
) -RRB- O
was VBD O
found VBN O
in IN O
the DT O
secretomes NNS O
of IN O
all DT O
five CD O
species NNS O
of IN O
phytopathogen NN O
. . O

Isochorismatase NNP O
catalyses VBZ O
the DT O
conversion NN O
of IN O
isochorismate NN O
to IN O
2 CD O
, , O
3 CD O
- HYPH O
dihydroxybenzoate NN O
and CC O
pyruvate NN O
. . O

It PRP O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
synthesis NN O
of IN O
the DT O
anti JJ O
- HYPH O
microbial NN O
compound NN O
phenazine NN O
by IN O
Pseudomonas NNP B-Species
aeruginosa NN I-Species
[ -LRB- O
77 CD O
] -RRB- O
and CC O
the DT O
siderophore NN O
, , O
enterobactin NN O
, , O
by IN O
Escherichia NNP B-Species
coli NNP I-Species
[ -LRB- O
78 CD O
] -RRB- O
. . O

The DT O
isochorismatase JJ O
motif NN O
is VBZ O
also RB O
found VBN O
in IN O
a DT O
number NN O
of IN O
hydrolases NNS O
, , O
such JJ O
as IN O
nicotinamidase NN O
that WDT O
converts VBZ O
nicotinamide NN O
to IN O
nicotinic JJ O
acid NN O
[ -LRB- O
79 CD O
] -RRB- O
. . O

Members NNS O
of IN O
this DT O
family NN O
are VBP O
found VBN O
in IN O
all DT O
filamentous JJ O
ascomycetes NNS O
, , O
but CC O
interestingly RB O
they PRP O
are VBP O
only RB O
secreted VBN O
in IN O
phytopathogens NNS O
. . O

Salicylic NN O
acid NN O
is VBZ O
synthesised VBN O
in IN O
plants NNS O
in IN O
response NN O
to IN O
pathogen NN O
attack NN O
and CC O
mediates VBZ O
plant NN O
defences NNS O
. . O

As IN O
isochorismate NN O
is VBZ O
a DT O
precursor NN O
of IN O
salicyclic JJ O
acid NN O
[ -LRB- O
80 CD O
] -RRB- O
, , O
it PRP O
may MD O
be VB O
worth JJ O
speculating VBG O
that IN O
isochorismatases NNS O
secreted VBN O
by IN O
fungi NNS O
could MD O
act VB O
to TO O
reduce VB O
salicylic JJ O
acid NN O
accumulation NN O
in IN O
response NN O
to IN O
pathogen NN O
attack NN O
and CC O
thus RB O
inhibit VB O
plant NN O
defence NN O
responses NNS O
. . O

The DT O
secreted VBN O
isochorismatases NNS O
( , O
apart RB O
from IN O
one CD O
of IN O
the DT O
proteins NNS O
from IN O
S NNP B-Species
. . I-Species
nodorum NN I-Species
) -RRB- O
all DT O
show VBP O
sequence NN O
similarity NN O
to IN O
ycaC NN O
from IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
, , O
an DT O
octameric JJ O
hydrolase NN O
of IN O
unknown JJ O
function NN O
[ -LRB- O
81 CD O
] -RRB- O
. . O

Pfam NNP O
motifs NNS O
found VBN O
in IN O
the DT O
secretomes NNS O
of IN O
at RB O
least RBS O
three CD O
species NNS O
of IN O
phytopathogens NNS O
, , O
but CC O
not RB O
in IN O
any DT O
of IN O
the DT O
non NN O
- HYPH O
pathogens NNS O
also RB O
include VBP O
those DT O
found VBN O
in IN O
enzymes NNS O
potentially RB O
involved VBN O
in IN O
detoxification NN O
, , O
such JJ O
as IN O
arylesterase NN O
and CC O
amidohydrolase NN O
, , O
and CC O
also RB O
beta JJ O
- HYPH O
ketoacyl NN O
synthase NN O
, , O
which WDT O
catalyses VBZ O
the DT O
condensation NN O
of IN O
malonyl NN O
- HYPH O
ACP NN O
with IN O
a DT O
growing VBG O
fatty JJ O
acid NN O
chain NN O
and CC O
is VBZ O
found VBN O
as IN O
a DT O
component NN O
of IN O
a DT O
number NN O
of IN O
enzyme NN O
systems NNS O
, , O
including VBG O
fatty JJ O
acid NN O
synthases NNS O
and CC O
polyketide NN O
synthases NNS O
[ -LRB- O
82 CD O
] -RRB- O
, , O
[ -LRB- O
83 CD O
] -RRB- O
. . O

Table NN O
9 CD O
shows VBZ O
a DT O
list NN O
of IN O
Pfam NNP O
motifs NNS O
that WDT O
are VBP O
more RBR O
common JJ O
in IN O
the DT O
secretomes NNS O
of IN O
phytopathogens NNS O
as IN O
compared VBN O
to IN O
saprotrophs NNS O
. . O

These DT O
include VBP O
a DT O
number NN O
of IN O
secreted VBN O
proteases NNS O
, , O
transcription NN O
factors NNS O
and CC O
components NNS O
of IN O
signal NN O
transduction NN O
pathways NNS O
. . O

The DT O
Kelch NNP O
domain NN O
( : O
PF01344 CD O
) -RRB- O
shows VBZ O
the DT O
most RBS O
striking JJ O
difference NN O
in IN O
distribution NN O
between IN O
phytopathogenic JJ O
and CC O
non JJ O
- HYPH O
pathogenic JJ O
genomes NNS O
. . O

This DT O
50 CD O
- HYPH O
residue NN O
domain NN O
is VBZ O
found VBN O
in IN O
a DT O
number NN O
of IN O
actin NN O
- HYPH O
binding VBG O
proteins NNS O
[ -LRB- O
84 CD O
] -RRB- O
, , O
as RB O
well RB O
as IN O
enzymes NNS O
such JJ O
as IN O
galactose NN O
oxidase NN O
and CC O
neuraminidase NN O
. . O

The DT O
putative JJ O
function NN O
of IN O
each DT O
secreted VBN O
Kelch NNP O
domain NN O
- HYPH O
containing VBG O
protein NN O
was VBD O
ascertained VBN O
by IN O
performing VBG O
a DT O
BLAST NNP O
search NN O
against IN O
the DT O
NCBI NNP O
non AFX O
- HYPH O
redundant JJ O
protein NN O
database NN O
( -LRB- O
Table NNP O
10 CD O
) -RRB- O
. . O

A DT O
number NN O
of IN O
these DT O
seem VBP O
to TO O
be VB O
galactose NN O
oxidases NNS O
, , O
enzymes NNS O
which WDT O
catalyse VBP O
the DT O
oxidation NN O
of IN O
a DT O
range NN O
of IN O
primary JJ O
alcohols NNS O
, , O
including VBG O
galactose NN O
, , O
to IN O
the DT O
corresponding VBG O
aldehyde NN O
with IN O
the DT O
concomitant JJ O
reduction NN O
of IN O
oxygen NN O
to IN O
hydrogen NN O
peroxide NN O
( -LRB- O
H2O2 NN O
) -RRB- O
[ -LRB- O
85 CD O
] -RRB- O
. . O

Galactose JJ O
oxidase NN O
shares VBZ O
a DT O
copper NN O
radical JJ O
oxidase NN O
motif NN O
with IN O
the DT O
hydrogen NN O
peroxide NN O
- HYPH O
generating VBG O
glyoxal JJ O
oxidases NNS O
involved VBN O
in IN O
lignin NN O
- HYPH O
degradation NN O
in IN O
Phanerochaete NNP B-Species
chrysosporium NN I-Species
[ -LRB- O
86 CD O
] -RRB- O
. . O

H2O2 NNP O
- HYPH O
producing VBG O
copper NN O
oxidases NNS O
have VBP O
been VBN O
shown VBN O
to TO O
have VB O
roles NNS O
in IN O
morphogenesis NN O
, , O
in IN O
the DT O
corn NN B-Species
- HYPH O
smut NN O
fungus NN O
Ustilago NNP B-Species
maydis NNP I-Species
for IN O
example NN O
, , O
a DT O
glyoxal JJ O
oxidase NN O
is VBZ O
required VBN O
for IN O
filamentous JJ O
growth NN O
and CC O
pathogenicity NN O
[ -LRB- O
87 CD O
] -RRB- O
and CC O
a DT O
galactose NN O
oxidase NN O
is VBZ O
involved VBN O
in IN O
fruiting VBG O
body NN O
formation NN O
in IN O
the DT O
gram NN O
- HYPH O
negative JJ O
bacterium NN O
Stigmatella NNP B-Species
aurantiaca NNP I-Species
[ -LRB- O
88 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
the DT O
list NN O
of IN O
Pfam NNP O
motifs NNS O
more RBR O
common JJ O
in IN O
the DT O
secretomes NNS O
of IN O
phytopathogens NNS O
also RB O
includes VBZ O
those DT O
found VBN O
in IN O
copper NN O
amine NN O
oxidases NNS O
, , O
H2O2 NNP O
- HYPH O
generating VBG O
enzymes NNS O
that WDT O
catalyse VBP O
the DT O
oxidative JJ O
deamination NN O
of IN O
primary JJ O
amines NNS O
to IN O
the DT O
corresponding VBG O
aldehydes NNS O
[ -LRB- O
89 CD O
] -RRB- O
and CC O
peroxidases NNS O
, , O
haem NN O
- HYPH O
containing VBG O
enzymes NNS O
that WDT O
use VBP O
hydrogen NN O
peroxide NN O
as IN O
the DT O
electron NN O
acceptor NN O
to TO O
catalyse VB O
a DT O
number NN O
of IN O
oxidative JJ O
reactions NNS O
. . O

Secreted VBN O
fungal JJ O
peroxidases NNS O
include VBP O
enzymes NNS O
involved VBN O
in IN O
lignin NN O
breakdown NN O
by IN O
the DT O
white JJ O
rot NN O
fungus NN O
Phanerochaete NNP B-Species
chrysosporium NN I-Species
[ -LRB- O
90 CD O
] -RRB- O
, , O
but CC O
in IN O
plants NNS O
they PRP O
generate VBP O
reactive JJ O
oxygen NN O
species NNS O
and CC O
are VBP O
involved VBN O
in IN O
defence NN O
responses NNS O
and CC O
growth NN O
induction NN O
[ -LRB- O
91 CD O
] -RRB- O
. . O

A DT O
number NN O
of IN O
other JJ O
secreted VBN O
Kelch NNP O
domain NN O
- HYPH O
containing VBG O
proteins NNS O
have VBP O
similarity NN O
to IN O
proteins NNS O
of IN O
unknown JJ O
function NN O
from IN O
species NNS O
of IN O
the DT O
bacterial JJ O
phytopathogen NN O
Xanthomonas NNP O
. . O

Many JJ O
Kelch NNP O
domain NN O
- HYPH O
containing VBG O
proteins NNS O
are VBP O
involved VBN O
in IN O
cytoskeletal JJ O
rearrangement NN O
and CC O
cell NN O
morphology NN O
[ -LRB- O
92 CD O
] -RRB- O
, , O
[ -LRB- O
93 CD O
] -RRB- O
. . O

It PRP O
may MD O
be VB O
worth JJ O
speculating VBG O
that IN O
secreted VBN O
Kelch NNP O
domain NN O
- HYPH O
containing VBG O
proteins NNS O
could MD O
act VB O
as IN O
effectors NNS O
, , O
causing VBG O
changes NNS O
in IN O
the DT O
arrangement NN O
of IN O
the DT O
cytoskeleton NN O
of IN O
infected JJ O
plants NNS O
to TO O
aid VB O
the DT O
proliferation NN O
of IN O
fungal JJ O
hyphae NN O
. . O

It PRP O
has VBZ O
recently RB O
been VBN O
shown VBN O
, , O
for IN O
example NN O
, , O
that IN O
M NNP B-Species
. . I-Species
grisea NN I-Species
co NN O
- HYPH O
opts VBZ O
plasmodesmata NN O
to TO O
move VB O
from IN O
cell NN O
to IN O
cell NN O
in IN O
infected JJ O
rice NN B-Species
leaves NNS O
[ -LRB- O
94 CD O
] -RRB- O
and CC O
would MD O
therefore RB O
need VB O
to TO O
peturb VB O
cytoskeletal JJ O
organisation NN O
in IN O
rice NN B-Species
epidermal JJ O
cells NNS O
. . O

There EX O
are VBP O
other JJ O
Pfam NNP O
domains NNS O
that WDT O
are VBP O
more RBR O
common JJ O
in IN O
the DT O
secretomes NNS O
of IN O
phytopathogens NNS O
that WDT O
may MD O
potentially RB O
be VB O
found VBN O
in IN O
effectors NNS O
such JJ O
as IN O
the DT O
PAN NNP O
domain NN O
( , O
PF00024 NN O
) -RRB- O
, , O
that WDT O
mediates VBZ O
protein NN O
- HYPH O
protein NN O
and CC O
protein NN O
- HYPH O
carbohydrate NN O
interactions NNS O
[ -LRB- O
95 CD O
] -RRB- O
and CC O
the DT O
F5 NNP O
/ SYM O
8 CD O
type NN O
C NN O
domain NN O
( -LRB- O
PF00754 NN O
) -RRB- O
, , O
found VBN O
in IN O
the DT O
discoidin JJ O
family NN O
of IN O
proteins NNS O
involved VBN O
in IN O
cell NN O
- HYPH O
adhesion NN O
or CC O
developmental JJ O
processes NNS O
[ -LRB- O
96 CD O
] -RRB- O
. . O

Discussion NN O

One CD O
of IN O
the DT O
most RBS O
fundamental JJ O
aims NNS O
in IN O
plant NN O
pathology NN O
research NN O
is VBZ O
to TO O
define VB O
precisely RB O
the DT O
difference NN O
between IN O
pathogenic JJ O
and CC O
non JJ O
- HYPH O
pathogenic JJ O
microorganisms NNS O
. . O

The DT O
answer NN O
cannot MD O
be VB O
one CD O
of IN O
simple JJ O
phylogeny NN O
, , O
because IN O
phytopathogenic JJ O
species NNS O
are VBP O
found VBN O
in IN O
all DT O
taxonomic JJ O
divisions NNS O
of IN O
fungi NNS O
and CC O
are VBP O
often RB O
closely RB O
related JJ O
to IN O
non JJ O
- HYPH O
pathogenic JJ O
species NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Before IN O
the DT O
availability NN O
of IN O
genomic JJ O
sequences NNS O
and CC O
high JJ O
throughput NN O
approaches NNS O
to TO O
study VB O
gene NN O
function NN O
[ -LRB- O
20 CD O
] -RRB- O
, , O
research NN O
was VBD O
concentrated VBN O
on IN O
the DT O
search NN O
for IN O
single JJ O
pathogenicity NN O
factors NNS O
; , O
genes NNS O
that WDT O
are VBP O
dispensable JJ O
for IN O
saprophytic JJ O
growth NN O
but CC O
essential JJ O
for IN O
successful JJ O
infection NN O
of IN O
the DT O
host NN O
plant NN O
[ -LRB- O
4 CD O
] -RRB- O
, , O
[ -LRB- O
97 CD O
] -RRB- O
. . O

However RB O
, , O
rather RB O
than IN O
encoding VBG O
novel JJ O
proteins NNS O
found VBN O
only RB O
in IN O
phytopathogens NNS O
, , O
the DT O
majority NN O
of IN O
pathogenicity NN O
factors NNS O
discovered VBN O
in IN O
this DT O
way NN O
have VBP O
been VBN O
found VBN O
to TO O
be VB O
involved VBN O
in IN O
signalling VBG O
cascades NNS O
and CC O
metabolic JJ O
pathways NNS O
and CC O
hence RB O
are VBP O
conserved VBN O
in IN O
most JJS O
species NNS O
of IN O
fungi NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Components NNS O
of IN O
signalling NN O
cascades NNS O
that WDT O
in IN O
the DT O
budding VBG O
yeast NN B-Species
S NN B-Species
. . I-Species
cerevisiae NN I-Species
are VBP O
responsible JJ O
for IN O
responses NNS O
to IN O
pheromones NNS O
, , O
nutritional JJ O
starvation NN O
and CC O
osmotic JJ O
stress NN O
[ -LRB- O
9 CD O
] -RRB- O
have VBP O
in IN O
many JJ O
cases NNS O
evolved VBN O
different JJ O
roles NNS O
in IN O
the DT O
life NN O
cycle NN O
of IN O
pathogens NNS O
, , O
such JJ O
as IN O
controlling VBG O
appressorium NN O
formation NN O
, , O
dimorphism NN O
and CC O
growth NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Although IN O
the DT O
central JJ O
components NNS O
of IN O
signalling NN O
are VBP O
conserved VBN O
between IN O
phytopathogens NNS O
and CC O
S NN B-Species
. . I-Species
cerevisiae NN I-Species
, , O
the DT O
receptors NNS O
are VBP O
often RB O
different JJ O
, , O
reflecting VBG O
the DT O
different JJ O
environmental JJ O
cues NNS O
to TO O
which WDT O
the DT O
pathogen NN O
needs VBZ O
to TO O
respond VB O
[ -LRB- O
11 CD O
] -RRB- O
, , O
[ -LRB- O
98 CD O
] -RRB- O
. . O

Analysis NN O
of IN O
all DT O
available JJ O
genome NN O
sequences NNS O
from IN O
a DT O
wider JJR O
range NN O
of IN O
fungal JJ O
species NNS O
has VBZ O
for IN O
the DT O
first JJ O
time NN O
allowed VBN O
us PRP O
to TO O
address VB O
the DT O
differences NNS O
between IN O
phytopathogens NNS O
and CC O
non NN O
- HYPH O
pathogens NNS O
at IN O
a DT O
whole JJ O
genome NN O
level NN O
. . O

For IN O
this DT O
purpose NN O
, , O
the DT O
e NNP O
- HYPH O
Fungi NNP O
data NNS O
warehouse NN O
provides VBZ O
a DT O
means NN O
to TO O
interrogate VB O
the DT O
vast JJ O
amounts NNS O
of IN O
genomic JJ O
and CC O
functional JJ O
data NNS O
available JJ O
in IN O
a DT O
simple JJ O
integrated VBN O
manner NN O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Previous JJ O
research NN O
, , O
in IN O
which WDT O
EST NNP O
datasets NNS O
were VBD O
compared VBN O
with IN O
genomic JJ O
sequences NNS O
, , O
suggested VBD O
that IN O
the DT O
expressed VBN O
gene NN O
inventories NNS O
of IN O
phytopathogenic JJ O
species NNS O
were VBD O
not RB O
significantly RB O
more RBR O
similar JJ O
to IN O
one CD O
another DT O
than IN O
to IN O
those DT O
of IN O
saprotrophic JJ O
filamentous JJ O
fungi NN O
[ -LRB- O
99 CD O
] -RRB- O
. . O

We PRP O
clustered VBD O
sets NNS O
of IN O
predicted VBN O
proteins NNS O
from IN O
36 CD O
different JJ O
species NNS O
of IN O
fungi NNS O
and CC O
oomycetes NNS O
into IN O
groups NNS O
of IN O
potential JJ O
orthologues NNS O
and CC O
the DT O
species NNS O
distribution NN O
of IN O
members NNS O
of IN O
each DT O
cluster NN O
was VBD O
ascertained VBN O
. . O

There EX O
were VBD O
no DT O
clusters NNS O
that WDT O
were VBD O
completely RB O
specific JJ O
to IN O
phytopathogenic JJ O
species NNS O
across IN O
both DT O
fungi NNS O
and CC O
oomycetes NNS O
, , O
suggesting VBG O
that IN O
the DT O
presence NN O
of IN O
novel JJ O
, , O
universal JJ O
pathogenicity NN O
factors NNS O
in IN O
the DT O
genomes NNS O
of IN O
phytopathogens NNS O
is VBZ O
unlikely JJ O
. . O

This DT O
was VBD O
confirmed VBN O
by IN O
looking VBG O
at IN O
clusters NNS O
containing VBG O
empirically RB O
defined VBN O
pathogenicity NN O
factors NNS O
, , O
where WRB O
homologues NNS O
of IN O
many JJ O
of IN O
these DT O
were VBD O
found VBN O
in IN O
all DT O
species NNS O
studied VBN O
and CC O
none NN O
were VBD O
conserved VBN O
in IN O
the DT O
genomes NNS O
only RB O
of IN O
phytopathogens NNS O
. . O

A DT O
small JJ O
number NN O
were VBD O
only RB O
found VBN O
in IN O
a DT O
single JJ O
species NN O
of IN O
fungus NN O
and CC O
probably RB O
represented VBD O
proteins NNS O
that WDT O
are VBP O
highly RB O
specialised VBN O
for IN O
a DT O
particular JJ O
role NN O
in IN O
a DT O
specific JJ O
pathogenic JJ O
species NN O
, , O
for IN O
example NN O
in IN O
host NN O
- HYPH O
plant NN O
recognition NN O
[ -LRB- O
54 CD O
] -RRB- O
. . O

Previous JJ O
research NN O
also RB O
suggested VBD O
that IN O
the DT O
gene NN O
inventories NNS O
of IN O
filamentous JJ O
fungi NN O
were VBD O
more RBR O
similar JJ O
to IN O
each DT O
other JJ O
than IN O
to IN O
those DT O
of IN O
unicellular JJ O
yeasts NNS O
[ -LRB- O
99 CD O
] -RRB- O
. . O

Analysis NN O
of IN O
the DT O
clusters NNS O
of IN O
similar JJ O
proteins NNS O
show VBP O
some DT O
clusters NNS O
that WDT O
are VBP O
found VBN O
in IN O
all DT O
species NNS O
of IN O
filamentous JJ O
fungi NN O
( , O
including VBG O
ascomycetes NNS O
, , O
basidiomycetes NNS O
and CC O
zygomycetes NNS O
) , O
but CC O
are VBP O
not RB O
present JJ O
in IN O
the DT O
genomes NNS O
of IN O
yeasts NNS O
, , O
consistent JJ O
with IN O
the DT O
original JJ O
conclusion NN O
. . O

These DT O
contain VBP O
a DT O
number NN O
of IN O
proteins NNS O
that WDT O
are VBP O
likely JJ O
to TO O
be VB O
involved VBN O
in IN O
morphological JJ O
changes NNS O
associated VBN O
with IN O
the DT O
more RBR O
complex JJ O
filamentous JJ O
lifestyle NN O
, , O
as RB O
well RB O
those DT O
involved VBN O
in IN O
secondary JJ O
metabolism NN O
and CC O
signalling NN O
cascades NNS O
that WDT O
are VBP O
not RB O
found VBN O
in IN O
yeasts NNS O
. . O

In IN O
particular JJ O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
filamentous JJ O
fungi NN O
use VBP O
a DT O
wider JJR O
variety NN O
of IN O
lipid JJ O
molecules NNS O
for IN O
the DT O
purpose NN O
of IN O
signalling VBG O
. . O

Some DT O
of IN O
these DT O
may MD O
act VB O
as IN O
pheromones NNS O
, , O
or CC O
hormones NNS O
- : O
chemical JJ O
messengers NNS O
diffusing VBG O
from IN O
one CD O
cell NN O
to IN O
another DT O
to TO O
elicit VB O
a DT O
physiological JJ O
or CC O
developmental JJ O
response NN O
[ -LRB- O
37 CD O
] -RRB- O
. . O

A DT O
number NN O
of IN O
these DT O
innovations NNS O
to IN O
the DT O
filamentous JJ O
lifestyle NN O
may MD O
serve VB O
important JJ O
roles NNS O
in IN O
pathogenesis NN O
as RB O
well RB O
, , O
because IN O
homologues NNS O
of IN O
a DT O
number NN O
of IN O
pathogenicity NN O
factors NNS O
are VBP O
found VBN O
only RB O
in IN O
filamentous JJ O
ascomycetes NNS O
. . O

The DT O
distribution NN O
of IN O
filamentous JJ O
fungi NN O
- HYPH O
specific JJ O
proteins NNS O
, , O
such JJ O
as IN O
involved VBN O
in IN O
those DT O
cytoskeletal JJ O
rearrangements NNS O
and CC O
fruiting VBG O
body NN O
formation NN O
, , O
throughout IN O
the DT O
fungal JJ O
kingdom NN O
( , O
and CC O
in IN O
some DT O
cases NNS O
in IN O
oomycetes NNS O
as RB O
well RB O
) -RRB- O
, , O
suggests VBZ O
that IN O
the DT O
last JJ O
common JJ O
ancestral JJ O
fungus NN O
may MD O
well RB O
have VB O
been VBN O
multi NN O
- HYPH O
cellular JJ O
and CC O
the DT O
evolution NN O
of IN O
uni JJ O
- HYPH O
cellular JJ O
fungi NN O
was VBD O
likely RB O
associated VBN O
with IN O
massive JJ O
gene NN O
loss NN O
. . O

For IN O
example NN O
, , O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
early RB O
in IN O
ascomycete NN O
evolution NN O
there EX O
was VBD O
a DT O
proliferation NN O
of IN O
subtilase NN O
- HYPH O
type NN O
protease NN O
- HYPH O
encoding VBG O
genes NNS O
that WDT O
have VBP O
been VBN O
retained VBN O
in IN O
some DT O
filamentous JJ O
ascomycete NN O
lineages NNS O
, , O
but CC O
lost VBN O
in IN O
the DT O
yeast NN B-Species
lineage NN O
[ -LRB- O
100 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
previously RB O
been VBN O
speculated VBN O
that IN O
the DT O
evolution NN O
of IN O
phytopathogenesis NN O
was VBD O
associated VBN O
with IN O
the DT O
expansion NN O
of IN O
certain JJ O
gene NN O
families NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Duplication NN O
of IN O
an DT O
ancestral JJ O
gene NN O
, , O
followed VBN O
by IN O
mutation NN O
allows VBZ O
members NNS O
of IN O
the DT O
family NN O
to TO O
take VB O
on RP O
new JJ O
functions NNS O
[ -LRB- O
101 CD O
] -RRB- O
. . O

For IN O
example NN O
, , O
genomes NNS O
of IN O
the DT O
filamentous JJ O
ascomycetes NNS O
studied VBN O
here RB O
have VBP O
between IN O
40 CD O
and CC O
140 CD O
cytochrome NN O
P450 NN O
- HYPH O
encoding VBG O
genes NNS O
( , O
data NNS O
not RB O
shown VBN O
) , O
that WDT O
are VBP O
involved VBN O
in IN O
toxin NN O
biosynthesis NN O
, , O
lipid NN O
metabolism NN O
, , O
alkane NN O
assimilation NN O
and CC O
detoxification NN O
[ -LRB- O
102 CD O
] -RRB- O
and CC O
which WDT O
probably RB O
arose VBP O
via IN O
gene NN O
duplication NN O
and CC O
functional JJ O
diversification NN O
. . O

In IN O
contrast NN O
, , O
the DT O
genome NN O
of IN O
the DT O
budding VBG O
yeast NN B-Species
S NN B-Species
. . I-Species
cerevisiae NN I-Species
has VBZ O
only RB O
three CD O
cytochrome NN O
P450 NN O
- HYPH O
encoding VBG O
enzymes NNS O
. . O

We PRP O
have VBP O
shown VBN O
here RB O
that IN O
there EX O
are VBP O
likely JJ O
to TO O
be VB O
large JJ O
differences NNS O
in IN O
the DT O
gene NN O
inventories NNS O
of IN O
filamentous JJ O
fungi NN O
compared VBN O
to IN O
unicellular JJ O
yeasts NNS O
. . O

To TO O
study VB O
the DT O
differences NNS O
between IN O
phytopathogenic JJ O
and CC O
saprophytic JJ O
fungi NN O
, , O
we PRP O
concentrated VBD O
on IN O
the DT O
filamentous JJ O
ascomycetes NNS O
where WRB O
there EX O
are VBP O
a DT O
number NN O
of IN O
phytopathogenic JJ O
species NNS O
genomes NNS O
have VBP O
been VBN O
sequenced VBN O
along IN O
with IN O
closely RB O
related VBN O
non JJ O
- HYPH O
pathogens NNS O
. . O

Protein NN O
families NNS O
were VBD O
defined VBN O
using VBG O
Pfam NNP O
motifs NNS O
[ -LRB- O
57 CD O
] -RRB- O
and CC O
the DT O
predicted VBN O
protein NN O
sets NNS O
for IN O
each DT O
species NNS O
analysed VBN O
in IN O
order NN O
to TO O
identify VB O
domains NNS O
that WDT O
were VBD O
specific JJ O
to IN O
or CC O
more RBR O
common JJ O
in IN O
the DT O
genomes NNS O
of IN O
phytopathogens NNS O
. . O

Not RB O
surprisingly RB O
, , O
many JJ O
of IN O
the DT O
protein NN O
families NNS O
we PRP O
identified VBD O
are VBP O
likely JJ O
to TO O
be VB O
associated VBN O
with IN O
pathogenic JJ O
processes NNS O
such JJ O
as IN O
plant NN O
cell NN O
wall NN O
degradation NN O
, , O
toxin NN O
biosynthesis NN O
, , O
formation NN O
of IN O
reactive JJ O
oxygen NN O
species NNS O
and CC O
detoxification NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Studies NNS O
of IN O
bacterial JJ O
phytopathogens NNS O
have VBP O
shown VBN O
the DT O
importance NN O
of IN O
effectors NNS O
, , O
secreted VBN O
proteins NNS O
that WDT O
disable VBP O
plant NN O
defences NNS O
and CC O
subvert VBP O
metabolic JJ O
and CC O
morphological JJ O
processes NNS O
for IN O
the DT O
benefit NN O
of IN O
the DT O
invading VBG O
pathogen NN O
and CC O
which WDT O
require VBP O
delivery NN O
via IN O
a DT O
type NN O
III NNP O
secretion NN O
system NN O
that WDT O
are VBP O
often RB O
deployed VBN O
during IN O
pathogenesis NN O
[ -LRB- O
73 CD O
] -RRB- O
. . O

Bacterial JJ O
type NN O
III NNP O
secreted VBN O
effectors NNS O
( -LRB- O
T3SEs NNS O
) -RRB- O
have VBP O
been VBN O
shown VBN O
to TO O
target VB O
salicyclic JJ O
acid NN O
and CC O
abscisic JJ O
acid NN O
- HYPH O
dependent JJ O
defences NNS O
, , O
host NN O
vesicle NN O
trafficking NN O
, , O
transcription NN O
and CC O
RNA NN O
metabolism NN O
, , O
and CC O
several JJ O
components NNS O
of IN O
the DT O
plant NN O
defence NN O
signalling NN O
networks NNS O
[ -LRB- O
103 CD O
] -RRB- O
. . O

Very RB O
recently RB O
, , O
potential JJ O
effector NN O
- HYPH O
encoding VBG O
genes NNS O
have VBP O
been VBN O
identified VBN O
in IN O
the DT O
genomes NNS O
of IN O
several JJ O
species NNS O
of IN O
oomycete NN O
pathogens NNS O
and CC O
are VBP O
defined VBN O
by IN O
the DT O
presence NN O
of IN O
a DT O
conserved VBN O
RXLR NNP O
- HYPH O
EER NNP O
motif NN O
downstream NN O
of IN O
the DT O
signal NN O
peptide NN O
sequence NN O
[ -LRB- O
74 CD O
] -RRB- O
. . O

The DT O
RXLR NNP O
- HYPH O
EER NNP O
motif NN O
is VBZ O
necessary JJ O
for IN O
delivery NN O
of IN O
effector NN O
proteins NNS O
into IN O
host NN O
plant NN O
cells NNS O
and CC O
is VBZ O
therefore RB O
critical JJ O
to IN O
their PRP$ O
biological JJ O
activity NN O
[ -LRB- O
74 CD O
] -RRB- O
. . O

To TO O
identify VB O
potential JJ O
fungal JJ O
effectors NNS O
, , O
we PRP O
compared VBD O
Pfam NNP O
motif NN O
frequency NN O
between IN O
the DT O
secretomes NNS O
of IN O
phytopathogens NNS O
and CC O
non JJ O
- HYPH O
pathogens NNS O
. . O

This DT O
analysis NN O
identified VBD O
potential JJ O
effector NN O
- HYPH O
encoding VBG O
genes NNS O
, , O
including VBG O
secreted VBN O
proteases NNS O
, , O
transcription NN O
factors NNS O
and CC O
proteins NNS O
that WDT O
may MD O
be VB O
involved VBN O
in IN O
cytoskeletal JJ O
rearrangements NNS O
( , O
such JJ O
as IN O
Kelch NNP O
- HYPH O
domain NN O
containing VBG O
proteins NNS O
) , O
and CC O
protein NN O
- HYPH O
protein NN O
interactions NNS O
, , O
as RB O
well RB O
as IN O
a DT O
group NN O
of IN O
pathogen NN O
- HYPH O
specific JJ O
secreted VBN O
isochorisimatases NNS O
that WDT O
potentially RB O
could MD O
suppress VB O
salicyclic JJ O
acid NN O
- HYPH O
dependent JJ O
host NN O
plant NN O
defences NNS O
. . O

Bacterial JJ O
T3SEs NNS O
are VBP O
injected VBN O
directly RB O
into IN O
the DT O
host NN O
cytoplasm NN O
via IN O
the DT O
type NN O
III NNP O
secretion NN O
injection NN O
apparatus NN O
[ -LRB- O
73 CD O
] -RRB- O
. . O

In IN O
contrast NN O
, , O
the DT O
potential JJ O
fungal JJ O
effectors NNS O
identified VBN O
in IN O
this DT O
study NN O
appear VBP O
to TO O
be VB O
secreted VBN O
by IN O
the DT O
normal JJ O
cellular JJ O
secretory NN O
pathway NN O
via IN O
the DT O
endoplasmic JJ O
reticulum NN O
and CC O
the DT O
mechanism NN O
by IN O
which WDT O
fungal JJ O
effectors NNS O
might MD O
be VB O
taken VBN O
up RP O
by IN O
plant NN O
cells NNS O
and CC O
enter VB O
into IN O
the DT O
host NN O
cytoplasm NN O
is VBZ O
currently RB O
unknown JJ O
. . O

Although IN O
the DT O
evolution NN O
of IN O
phytopathogenicity NN O
is VBZ O
likely JJ O
to TO O
have VB O
happened VBN O
several JJ O
times NNS O
and CC O
the DT O
lifestyles NNS O
of IN O
these DT O
fungi NNS O
are VBP O
diverse JJ O
, , O
a DT O
comparison NN O
of IN O
gene NN O
inventories NNS O
of IN O
a DT O
number NN O
of IN O
species NNS O
using VBG O
a DT O
powerful JJ O
resource NN O
, , O
such JJ O
as IN O
e NNP O
- HYPH O
Fungi NNP O
, , O
has VBZ O
allowed VBN O
us PRP O
to TO O
pinpoint VB O
new JJ O
gene NN O
families NNS O
that WDT O
may MD O
serve VB O
important JJ O
roles NNS O
in IN O
the DT O
virulence NN O
of IN O
phytopathogens NNS O
, , O
allowing VBG O
their PRP$ O
selection NN O
for IN O
gene NN O
functional JJ O
studies NNS O
, , O
that WDT O
are VBP O
currently RB O
in IN O
progress NN O
. . O

The DT O
analyses NNS O
deployed VBN O
here RB O
may MD O
also RB O
offer VB O
a DT O
blueprint NN O
for IN O
the DT O
types NNS O
of IN O
larger JJR O
, , O
more RBR O
comprehensive JJ O
studies NNS O
that WDT O
will MD O
be VB O
necessary JJ O
to TO O
interpret VB O
the DT O
large JJ O
flow NN O
of IN O
genetic JJ O
data NNS O
that WDT O
will MD O
result VB O
from IN O
next JJ O
generation NN O
DNA NN O
sequence NN O
analysis NN O
utilizing VBG O
both CC O
a DT O
much RB O
wider JJR O
variety NN O
of IN O
fungal JJ O
pathogen NN O
species NNS O
and CC O
also RB O
large JJ O
sets NNS O
of IN O
individual JJ O
isolates NNS O
of IN O
existing JJ O
species NNS O
. . O

Materials NNS O
and CC O
Methods NNS O

Clustering VBG O
of IN O
sequences NNS O

Sets NNS O
of IN O
predicted VBN O
proteins NNS O
were VBD O
downloaded VBN O
for IN O
each DT O
of IN O
the DT O
36 CD O
genomes NNS O
from IN O
respective JJ O
sequencing NN O
project NN O
websites NNS O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
. . O

Proteins NNS O
less JJR O
than IN O
40 CD O
amino NN O
acids NNS O
in IN O
length NN O
were VBD O
not RB O
included VBN O
in IN O
this DT O
analysis NN O
. . O

Proteins NNS O
were VBD O
clustered VBN O
using VBG O
"""" `` O
all DT O
against IN O
all DT O
"""" `` O
BLASTP NNP O
[ -LRB- O
104 CD O
] -RRB- O
followed VBN O
by IN O
Markov NNP O
Chain NNP O
Clustering NNP O
( : O
MCL NNP O
) -RRB- O
[ -LRB- O
27 CD O
] -RRB- O
with IN O
2 CD O
. . O
5 CD O
as IN O
a DT O
moderate JJ O
inflation NN O
value NN O
and CC O
10 CD O
- SYM O
10 CD O
as IN O
an DT O
E NN O
- HYPH O
value NN O
cut NN O
- HYPH O
off NN O
, , O
as IN O
described VBN O
previously RB O
[ -LRB- O
28 CD O
] -RRB- O
, , O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Clusters NNS O
were VBD O
annotated VBN O
based VBN O
on IN O
best JJS O
hit NN O
against IN O
Swiss NNP O
- HYPH O
Prot NNP O
protein NN O
database NN O
[ -LRB- O
105 CD O
] -RRB- O
of IN O
members NNS O
of IN O
that DT O
cluster NN O
( , O
e CD O
- HYPH O
value NN O
< SYM O
10 CD O
- HYPH O
20 CD O
using VBG O
BLASTP NNP O
) -RRB- O
, , O
or CC O
Pfam NNP O
motifs NNS O
contained VBN O
in IN O
proteins NNS O
from IN O
the DT O
cluster NN O
in IN O
the DT O
absence NN O
of IN O
Swiss NNP O
- HYPH O
Prot NNP O
hits NNS O
. . O

Identification NN O
of IN O
Pfam NNP O
motifs NNS O

The DT O
Pfam NNP O
- HYPH O
A DT O
library NN O
from IN O
release NN O
18 CD O
. . O
0 CD O
of IN O
the DT O
Pfam NNP O
database NN O
was VBD O
downloaded VBN O
from IN O
the DT O
Pfam NNP O
website NN O
( : O
http NN O
: : O
/ NFP O
/ SYM O
www ADD O
. . O
sanger NN O
. . O
ac ADD O
. . O
uk IN O
/ SYM O
Software NNP O
/ SYM O
Pfam NN O
/ : O
) -RRB- O
. . O

This DT O
library NN O
contains VBZ O
7973 CD O
protein NN O
models NNS O
constructed VBN O
from IN O
manually RB O
curated VBN O
multiple JJ O
alignments NNS O
and CC O
covers VBZ O
75 CD O
% NN O
of IN O
proteins NNS O
in IN O
UniProt NNP O
[ -LRB- O
44 CD O
] -RRB- O
, , O
[ -LRB- O
57 CD O
] -RRB- O
. . O

This DT O
library NN O
was VBD O
used VBN O
to TO O
analyse VB O
the DT O
sequences NNS O
of IN O
predicted VBN O
proteins NNS O
for IN O
all DT O
36 CD O
fungal JJ O
genomes NNS O
to TO O
identify VB O
the DT O
Pfam NNP O
motifs NNS O
that WDT O
each DT O
protein NN O
contains VBZ O
. . O

The DT O
analysis NN O
was VBD O
performed VBN O
using VBG O
the DT O
"""" `` O
pfam NN O
_ HYPH O
scan NN O
"""" '' O
perl NN O
script NN O
( , O
version NN O
0 CD O
. . O
5 CD O
) -RRB- O
downloaded VBN O
from IN O
the DT O
Pfam NNP O
website NN O
and CC O
HMMER NNP O
software NN O
( , O
downloaded VBN O
from IN O
http NN O
: : O
/ : O
/ SYM O
hmmer NNP O
. . O
wustl NNP O
. . O
edu NNP O
/ , O
) -RRB- O
. . O

Default NN O
thresholds NNS O
were VBD O
used VBN O
, , O
which WDT O
are VBP O
hand NN O
- HYPH O
curated VBN O
for IN O
every DT O
family NN O
and CC O
designed VBN O
to TO O
minimise VB O
false JJ O
positives NNS O
[ -LRB- O
44 CD O
] -RRB- O
. . O

Identification NN O
of IN O
secreted VBN O
proteins NNS O

The DT O
N NNP O
- HYPH O
terminal JJ O
sequence NN O
of IN O
each DT O
predicted VBN O
protein NN O
from IN O
the DT O
36 CD O
fungal JJ O
genomes NNS O
used VBN O
in IN O
this DT O
study NN O
was VBD O
analysed VBN O
for IN O
the DT O
presence NN O
of IN O
a DT O
signal NN O
peptide NN O
using VBG O
SignalP NNP O
3 CD O
. . O
0 CD O
[ -LRB- O
75 CD O
] -RRB- O
and CC O
sub NN O
- HYPH O
cellular JJ O
localisation NN O
was VBD O
predicted VBN O
using VBG O
WoLF NNP O
PSORT NNP O
[ -LRB- O
76 CD O
] -RRB- O
. . O

Both PDT O
these DT O
programs NNS O
were VBD O
installed VBN O
locally RB O
. . O

SignalP NNP O
3 CD O
. . O
0 CD O
uses VBZ O
two CD O
different JJ O
algorithms NNS O
to TO O
identify VB O
signal NN O
sequences NNS O
. . O

The DT O
secretome NN O
for IN O
each DT O
fungal JJ O
species NN O
was VBD O
defined VBN O
as IN O
containing VBG O
those DT O
proteins NNS O
that WDT O
were VBD O
predicted VBN O
have VBP O
a DT O
signal NN O
peptide NN O
by IN O
both DT O
prediction NN O
algorithms NNS O
from IN O
SignalP NNP O
3 CD O
. . O
0 NFP O
and CC O
also RB O
predicted VBD O
to TO O
be VB O
extracellular JJ O
by IN O
WoLF NNP O
PSORT NNP O
. . O

Data NNS O
analysis NN O

All PDT O
the DT O
data NNS O
produced VBN O
, , O
as IN O
described VBN O
above RB O
, , O
was VBD O
stored VBN O
in IN O
the DT O
e NNP O
- HYPH O
Fungi NNP O
data NN O
warehouse NN O
[ -LRB- O
26 CD O
] -RRB- O
from IN O
which WDT O
it PRP O
can MD O
be VB O
accessed VBN O
via IN O
a DT O
web NN O
- HYPH O
interface NN O
( : O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
e LS O
- : O
fungi NN O
. . O
org NN O
. . O
uk NN O
/ NFP O
) -RRB- O
. . O

Analyses NNS O
described VBN O
in IN O
this DT O
study NN O
were VBD O
performed VBN O
using VBG O
the DT O
e NNP O
- HYPH O
Fungi NNP O
database NN O
. . O

Supporting VBG O
Information NN O

Emergence NN O
of IN O
Delayed VBN O
Methylmercury NN O
Toxicity NN O
after IN O
Perinatal JJ O
Exposure NN O
in IN O
Metallothionein NNP O
- HYPH O
Null NNP O
and CC O
Wild NNP O
- HYPH O
Type NN O
C57BL NNP O
Mice NNP B-Species

Abstract JJ O

Background NN O

Although IN O
a DT O
long JJ O
latency NN O
period NN O
of IN O
toxicity NN O
after IN O
exposure NN O
to IN O
methylmercury NN O
( , O
MeHg NNP O
) -RRB- O
is VBZ O
known VBN O
to TO O
exist VB O
in IN O
humans NNS B-Species
, , O
few JJ O
animal NN O
studies NNS O
have VBP O
addressed VBN O
this DT O
issue NN O
. . O

Substantiation NN O
of IN O
delayed VBN O
MeHg NNP O
toxicity NN O
in IN O
animals NNS O
would MD O
affect VB O
the DT O
risk NN O
evaluation NN O
of IN O
MeHg NNP O
. . O

Objectives NNS O

Our PRP$ O
goal NN O
in IN O
this DT O
study NN O
was VBD O
to TO O
demonstrate VB O
the DT O
existence NN O
of IN O
a DT O
latency NN O
period NN O
in IN O
a DT O
rodent JJ O
model NN O
in IN O
which WDT O
the DT O
toxicity NN O
of IN O
perinatal JJ O
MeHg NNP O
exposure NN O
becomes VBZ O
apparent JJ O
only RB O
later RB O
in IN O
life NN O
. . O

Our PRP$ O
study NN O
included VBD O
metallothionein NN O
( , O
MT NNP O
) -RRB- O
knockout NN O
mice NNS B-Species
because IN O
studies NNS O
have VBP O
suggested VBN O
the DT O
potential JJ O
susceptibility NN O
of IN O
this DT O
strain NN O
to IN O
the DT O
neurodevelopmental JJ O
toxicity NN O
of IN O
MeHg NNP O
. . O

Methods NNS O

Pregnant JJ O
MT NNP O
- HYPH O
null JJ O
and CC O
wild JJ O
- HYPH O
type NN O
C57Bl NNP O
/ SYM O
6J NNP O
mice NNS B-Species
were VBD O
exposed VBN O
to IN O
MeHg NNP O
through IN O
their PRP$ O
diet NN O
containing VBG O
5 CD O
mu NN O
g NN O
Hg NN O
/ SYM O
g NN O
during IN O
gestation NN O
and CC O
early JJ O
lactation NN O
. . O

We PRP O
examined VBD O
behavioral JJ O
functions NNS O
of IN O
the DT O
offspring NN O
using VBG O
frequently RB O
used VBN O
paradigms NNS O
, , O
including VBG O
open JJ O
field NN O
behavior NN O
( , O
OPF NNP O
) -RRB- O
, , O
passive JJ O
avoidance NN O
( , O
PA NNP O
) -RRB- O
, , O
and CC O
the DT O
Morris NNP O
water NN O
maze NN O
( , O
MM NN O
) -RRB- O
, , O
at IN O
ages NNS O
of IN O
12 CD O
- SYM O
13 CD O
and CC O
52 CD O
- SYM O
53 CD O
weeks NNS O
. . O

Results NNS O

At IN O
12 CD O
weeks NNS O
of IN O
age NN O
, , O
behavioral JJ O
effects NNS O
of IN O
MeHg NNP O
were VBD O
not RB O
detected VBN O
, , O
except IN O
for IN O
OPF NNP O
performance NN O
in IN O
MeHg NNP O
- HYPH O
exposed VBN O
MT NNP O
- HYPH O
null JJ O
females NNS O
. . O

At IN O
52 CD O
weeks NNS O
of IN O
age NN O
, , O
the DT O
MeHg NNP O
- HYPH O
exposed VBN O
groups NNS O
showed VBD O
poorer JJR O
performance NN O
both CC O
in IN O
PA NNP O
and CC O
MM NNP O
, , O
and CC O
their PRP$ O
OPF NNP O
activity NN O
differed VBD O
from IN O
controls NNS O
. . O

These DT O
effects NNS O
of IN O
MeHg NNP O
appeared VBD O
exaggerated JJ O
in IN O
the DT O
MT NNP O
- HYPH O
null JJ O
strain NN O
. . O

The DT O
brain NN O
Hg NN O
concentration NN O
had VBD O
leveled VBN O
off RP O
by IN O
13 CD O
weeks NNS O
of IN O
age NN O
. . O

Conclusions NNS O

The DT O
results NNS O
suggest VBP O
the DT O
existence NN O
of IN O
a DT O
long JJ O
latency NN O
period NN O
after IN O
perinatal JJ O
exposure NN O
to IN O
low JJ O
- HYPH O
level NN O
MeHg NNP O
, , O
in IN O
which WDT O
the DT O
behavioral JJ O
effects NNS O
emerged VBD O
long RB O
after IN O
the DT O
leveling NN O
- HYPH O
off NN O
of IN O
brain NN O
Hg NNP O
levels NNS O
. . O

Hence RB O
, , O
the DT O
initial JJ O
toxicologic JJ O
event NN O
responsible JJ O
for IN O
the DT O
late JJ O
effects NNS O
should MD O
have VB O
occurred VBN O
before IN O
this DT O
leveling NN O
- HYPH O
off NN O
of IN O
brain NN O
Hg NNP O
. . O

Methylmercury NNP O
( , O
MeHg NNP O
) -RRB- O
poses VBZ O
serious JJ O
and CC O
practical JJ O
concerns NNS O
for IN O
human JJ B-Species
populations NNS O
regarding VBG O
perinatal JJ O
exposure NN O
. . O

Fish NNS O
, , O
especially RB O
large JJ O
predator NN O
( , O
carnivore NN O
) , O
fish NN O
species NNS O
, , O
accumulate VBP O
high JJ O
concentrations NNS O
of IN O
MeHg NNP O
through IN O
the DT O
marine JJ O
food NN O
chain NN O
, , O
and CC O
exposure NN O
of IN O
pregnant JJ O
women NNS B-Species
to IN O
MeHg NNP O
through IN O
the DT O
consumption NN O
of IN O
fish NN O
has VBZ O
evoked VBN O
widespread JJ O
concern NN O
due IN O
to IN O
potential JJ O
effects NNS O
on IN O
offspring NN O
. . O

Two CD O
large JJ O
- HYPH O
scale NN O
cohort NN O
studies NNS O
in IN O
fish NN O
- HYPH O
eating VBG O
populations NNS O
of IN O
Seychelles NNP O
and CC O
Faroe NNP O
islanders NNS O
are VBP O
being VBG O
conducted VBN O
; , O
although IN O
the DT O
former JJ O
has VBZ O
not RB O
found VBN O
consistent JJ O
adverse JJ O
developmental JJ O
effects NNS O
of IN O
MeHg NNP O
( : O
Myers NNP O
et FW O
al NNP O
. . O
2007 CD O
) -RRB- O
, , O
the DT O
latter JJ O
has VBZ O
reported VBN O
adverse JJ O
effects NNS O
( , O
Debes FW O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
. . O

Fundamental JJ O
reasons NNS O
for IN O
this DT O
discrepancy NN O
have VBP O
not RB O
been VBN O
completely RB O
elucidated VBN O
, , O
and CC O
many JJ O
questions NNS O
remain VBP O
regarding VBG O
the DT O
neurotoxicity NN O
of IN O
MeHg NNP O
, , O
despite IN O
extensive JJ O
study NN O
. . O

Among IN O
the DT O
unanswered JJ O
questions NNS O
is VBZ O
whether IN O
there EX O
is VBZ O
a DT O
long JJ O
latency NN O
period NN O
for IN O
behavioral JJ O
manifestations NNS O
after IN O
exposure NN O
to IN O
MeHg NNP O
( : O
Clarkson NNP O
and CC O
Magos NNP O
2006 CD O
; : O
Landrigan NNP O
et FW O
al NNP O
. . O
2005 CD O
; : O
Rice NNP O
1996 CD O
; : O
Weiss NNP O
et FW O
al NNP O
. . O
2005a CD O
, , O
2005b CD O
) -RRB- O
. . O

Typical JJ O
examples NNS O
of IN O
latent JJ O
toxicity NN O
in IN O
humans NNS B-Species
, , O
including VBG O
both CC O
acute JJ O
and CC O
chronic JJ O
MeHg NNP O
exposures NNS O
, , O
have VBP O
been VBN O
described VBN O
in IN O
detail NN O
elsewhere RB O
( , O
Weiss NNP O
et FW O
al NNP O
. . O
2005a CD O
) -RRB- O
. . O

Davidson NNP O
et FW O
al NNP O
. . O

( : O
2006 CD O
) -RRB- O
recently RB O
suggested VBD O
that IN O
effects NNS O
of IN O
perinatal JJ O
exposure NN O
to IN O
MeHg NNP O
may MD O
emerge VB O
9 CD O
years NNS O
after IN O
birth NN O
in IN O
the DT O
Seychelles NNP O
cohort NN O
. . O

Consequently RB O
, , O
risk NN O
assessments NNS O
of IN O
MeHg NNP O
exposure NN O
could MD O
be VB O
inaccurate JJ O
because IN O
studies NNS O
( , O
human JJ B-Species
or CC O
animal NN O
) -RRB- O
usually RB O
do VBP O
not RB O
focus VB O
on IN O
later JJ O
stages NNS O
of IN O
life NN O
and CC O
therefore RB O
could MD O
miss VB O
delayed VBN O
effects NNS O
. . O

The DT O
possibility NN O
of IN O
delayed VBN O
toxicity NN O
is VBZ O
exemplified VBN O
by IN O
the DT O
expanded VBN O
Barker NNP O
hypothesis NN O
, , O
which WDT O
posits VBZ O
that IN O
the DT O
origin NN O
of IN O
some DT O
neurodegenerative JJ O
diseases NNS O
such JJ O
as IN O
Parkinson NNP O
and CC O
Alzheimer NNP O
diseases NNS O
lies VBZ O
in IN O
early JJ O
exposure NN O
to IN O
environmental JJ O
chemicals NNS O
( : O
Landrigan NNP O
et FW O
al NNP O
. . O
2005 CD O
) -RRB- O
. . O

Although IN O
epidemiologic JJ O
evidence NN O
would MD O
be VB O
ideal JJ O
for IN O
exploring VBG O
the DT O
possibility NN O
of IN O
delayed VBN O
toxicity NN O
( , O
and CC O
, , O
indeed RB O
, , O
data NNS O
from IN O
epidemiologic JJ O
studies NNS O
form VBP O
the DT O
basis NN O
of IN O
current JJ O
risk NN O
assessment NN O
for IN O
developmental JJ O
toxicity NN O
of IN O
MeHg NNP O
) -RRB- O
, , O
considering VBG O
the DT O
complex JJ O
effects NNS O
of IN O
numerous JJ O
potential JJ O
confounders NNS O
and CC O
the DT O
existence NN O
of IN O
multiple JJ O
exposures NNS O
in IN O
human JJ B-Species
populations NNS O
, , O
animal NN O
models NNS O
would MD O
likely RB O
make VB O
important JJ O
contributions NNS O
to IN O
this DT O
field NN O
. . O

Although IN O
numerous JJ O
animal NN O
studies NNS O
have VBP O
described VBN O
the DT O
developmental JJ O
neurotoxicity NN O
of IN O
MeHg NNP O
( , O
Watanabe NNP O
and CC O
Satoh NNP O
, , O
1996 CD O
) -RRB- O
, , O
few JJ O
have VBP O
addressed VBN O
the DT O
latency NN O
issue NN O
. . O

Few JJ O
studies NNS O
have VBP O
evaluated VBN O
the DT O
neurobehavioral JJ O
effects NNS O
in IN O
rodents NNS O
longitudinally RB O
beyond IN O
6 CD O
months NNS O
after IN O
perinatal JJ O
exposure NN O
. . O

Spyker NNP O
( , O
1975 CD O
) -RRB- O
addressed VBD O
this DT O
issue NN O
in IN O
her PRP$ O
pioneering JJ O
work NN O
, , O
reporting VBG O
the DT O
late JJ O
development NN O
of IN O
behavioral JJ O
toxicity NN O
in IN O
mice NNS B-Species
prenatally RB O
exposed VBN O
to IN O
MeHg NNP O
; : O
it PRP O
appeared VBD O
, , O
however RB O
, , O
that IN O
the DT O
substantial JJ O
mortality NN O
and CC O
retarded JJ O
growth NN O
among IN O
the DT O
exposed VBN O
mice NNS B-Species
were VBD O
apparent JJ O
before IN O
weaning VBG O
, , O
indicating VBG O
that IN O
the DT O
doses NNS O
used VBN O
( , O
even RB O
though IN O
some DT O
lower JJR O
dose NN O
levels NNS O
were VBD O
included VBN O
) -RRB- O
exerted VBD O
severe JJ O
toxicity NN O
. . O

Using VBG O
a DT O
relatively RB O
complex JJ O
schedule NN O
- HYPH O
controlled VBN O
operant JJ O
behavior NN O
method NN O
, , O
rats NNS B-Species
whose WP$ O
parents NNS O
were VBD O
exposed VBN O
to IN O
MeHg NNP O
( : O
0 CD O
. . O
5 CD O
or CC O
6 CD O
. . O
4 CD O
mg NN O
/ SYM O
L NNP O
) -RRB- O
from IN O
4 CD O
weeks NNS O
before IN O
mating NN O
and CC O
continuing VBG O
to IN O
postnatal JJ O
day NN O
( , O
PND NN O
) SYM O
16 CD O
were VBD O
shown VBN O
to TO O
be VB O
less RBR O
sensitive JJ O
to IN O
a DT O
change NN O
in IN O
the DT O
reinforcement NN O
schedule NN O
than IN O
were VBD O
their PRP$ O
nonexposed JJ O
counterparts NNS O
at IN O
28 CD O
- SYM O
32 CD O
months NNS O
of IN O
age NN O
( : O
Newland NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

Mice NNS B-Species
that WDT O
were VBD O
perinatally RB O
exposed VBN O
to IN O
1 CD O
or CC O
3 CD O
mg NNS O
/ SYM O
L NNP O
MeHg NNP O
in IN O
drinking NN O
water NN O
did VBD O
not RB O
show VB O
significant JJ O
deviation NN O
from IN O
controls NNS O
in IN O
behavioral JJ O
performance NN O
( , O
motor NN O
performance NN O
, , O
memory NN O
, , O
and CC O
learning NN O
) -RRB- O
at IN O
5 CD O
, , O
15 CD O
, , O
or CC O
26 CD O
months NNS O
of IN O
age NN O
, , O
but CC O
the DT O
lifetime NN O
- HYPH O
exposed VBN O
groups NNS O
did VBD O
show VB O
a DT O
significant JJ O
deviation NN O
( : O
Weiss NNP O
et FW O
al NNP O
. . O
2005c CD O
) -RRB- O
. . O

The DT O
existence NN O
of IN O
a DT O
latency NN O
period NN O
( : O
i PRP O
. . O
e LS O
. . O
, , O
the DT O
absence NN O
of IN O
effects NNS O
earlier RBR O
in IN O
life NN O
followed VBN O
by IN O
the DT O
emergence NN O
of IN O
effects NNS O
at IN O
a DT O
later JJ O
stage NN O
of IN O
life NN O
) , O
has VBZ O
not RB O
been VBN O
demonstrated VBN O
in IN O
any DT O
rodent JJ O
study NN O
. . O

In IN O
nonhuman JJ O
primates NNS O
, , O
delayed VBN O
emergence NN O
of IN O
the DT O
signs NNS O
of IN O
neurotoxicity NN O
was VBD O
observed VBN O
several JJ O
years NNS O
after IN O
the DT O
cessation NN O
of IN O
a DT O
7 CD O
- HYPH O
year NN O
postnatal JJ O
exposure NN O
( : O
Rice NNP O
1996 CD O
) -RRB- O
. . O

Metallothionein NNP O
( -LRB- O
MT NNP O
) -RRB- O
protects VBZ O
against IN O
the DT O
toxicities NNS O
of IN O
a DT O
variety NN O
of IN O
metals NNS O
. . O

We PRP O
examined VBD O
the DT O
neurotoxicity NN O
and CC O
developmental JJ O
toxicity NN O
of IN O
metallic JJ O
Hg NNP O
in IN O
MT NNP O
I NNP O
/ SYM O
II NNP O
- HYPH O
knockout NN O
mice NNS B-Species
( , O
Yoshida NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
and CC O
demonstrated VBD O
the DT O
susceptibility NN O
of IN O
this DT O
genetically RB O
manipulated VBN O
strain NN O
to IN O
the DT O
toxicity NN O
of IN O
metallic JJ O
Hg NNP O
. . O

In IN O
contrast NN O
to IN O
metallic JJ O
Hg NNP O
, , O
MeHg NNP O
does VBZ O
not RB O
induce VB O
MT NNP O
, , O
and CC O
MT NNP O
would MD O
not RB O
substantially RB O
influence VB O
the DT O
kinetics NNS O
of IN O
MeHg NNP O
( : O
Yasutake NNP O
et FW O
al NNP O
. . O
1998 CD O
) -RRB- O
. . O

Several JJ O
reports NNS O
, , O
however RB O
, , O
have VBP O
demonstrated VBN O
protective JJ O
effects NNS O
of IN O
MT NNP O
against IN O
MeHg NNP O
toxicity NN O
, , O
which WDT O
was VBD O
ascribed VBN O
to IN O
the DT O
radical JJ O
scavenging NN O
effect NN O
of IN O
MT NNP O
( , O
Yao NNP O
et FW O
al NNP O
. . O
2000 CD O
) -RRB- O
. . O

We PRP O
also RB O
showed VBD O
that IN O
perinatal JJ O
exposure NN O
to IN O
MeHg NNP O
results VBZ O
in IN O
altered JJ O
metabolism NN O
of IN O
thyroid NN O
hormones NNS O
in IN O
neonates NNS O
that WDT O
was VBD O
more RBR O
distinct JJ O
in IN O
MT NNP O
- HYPH O
null JJ O
strains NNS O
than IN O
their PRP$ O
wild JJ O
- HYPH O
type NN O
counterparts NNS O
( , O
Mori NNP O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
. . O

The DT O
vulnerability NN O
of IN O
the DT O
MT NNP O
- HYPH O
null JJ O
strain NN O
suggests VBZ O
that IN O
delayed VBN O
neurobehavioral JJ O
toxicity NN O
due IN O
to IN O
MeHg NNP O
, , O
if IN O
it PRP O
does VBZ O
exist VB O
, , O
might MD O
be VB O
more RBR O
distinctive JJ O
in IN O
this DT O
strain NN O
. . O

By IN O
utilizing VBG O
the DT O
MT NNP O
- HYPH O
null JJ O
strain NN O
, , O
we PRP O
aimed VBD O
to TO O
answer VB O
the DT O
following VBG O
two CD O
questions NNS O
: : O
First RB O
, , O
could MD O
we PRP O
generate VB O
a DT O
model NN O
in IN O
which WDT O
the DT O
toxicity NN O
of IN O
MeHg NNP O
would MD O
emerge VB O
or CC O
at IN O
least JJS O
become VB O
exaggerated JJ O
later RB O
in IN O
life NN O
as IN O
opposed VBN O
to IN O
earlier JJR O
in IN O
life NN O
( : O
i PRP O
. . O
e -RRB- O
. . O
, , O
at IN O
3 CD O
- SYM O
6 CD O
months NNS O
, , O
which WDT O
was VBD O
the DT O
timing NN O
for IN O
most JJS O
of IN O
the DT O
earlier JJR O
studies NNS O
that WDT O
used VBD O
behavioral JJ O
evaluations NNS O
) -RRB- O
? . O

Second RB O
, , O
would MD O
the DT O
MT NNP O
- HYPH O
null JJ O
strain NN O
be VB O
affected VBN O
more RBR O
than IN O
its PRP$ O
parent NN O
C57BL NN O
strain NN O
? . O

Answering VBG O
either DT O
of IN O
these DT O
questions NNS O
not RB O
only RB O
could MD O
influence VB O
the DT O
risk NN O
evaluation NN O
of IN O
MeHg NNP O
, , O
but CC O
it PRP O
could MD O
also RB O
lead VB O
to IN O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
mechanism NN O
of IN O
toxicity NN O
for IN O
perinatal JJ O
MeHg NNP O
exposure NN O
. . O

To TO O
address VB O
these DT O
issues NNS O
, , O
we PRP O
used VBD O
three CD O
behavioral JJ O
paradigms NNS O
, , O
the DT O
open JJ O
field NN O
( , O
OPF NNP O
) -RRB- O
, , O
passive JJ O
avoidance NN O
( , O
PA NNP O
) -RRB- O
, , O
and CC O
Morris NNP O
( -LRB- O
water NN O
) -RRB- O
maze NN O
( , O
MM NN O
) -RRB- O
tests NNS O
, , O
which WDT O
are VBP O
often RB O
used VBN O
in IN O
this DT O
field NN O
and CC O
which WDT O
we PRP O
used VBD O
in IN O
our PRP$ O
previous JJ O
studies NNS O
on IN O
the DT O
effects NNS O
of IN O
Hg NNP O
vapor NN O
( , O
Yoshida NNP O
et FW O
al NNP O
. . O
2004 CD O
, , O
2006 CD O
) -RRB- O
. . O

Performances NNS O
in IN O
the DT O
MM NNP O
and CC O
PA NNP O
are VBP O
said VBN O
to TO O
be VB O
the DT O
most RBS O
sensitive JJ O
to IN O
aging NN O
( , O
Gower NNP O
and CC O
Lamberty NNP O
1993 CD O
) -RRB- O
. . O

We PRP O
used VBD O
a DT O
dose NN O
of IN O
5 CD O
mu NN O
g NN O
MeHg NNP O
/ SYM O
g NN O
in IN O
the DT O
diet NN O
, , O
which WDT O
resulted VBD O
in IN O
a DT O
brain NN O
Hg NN O
level NN O
relevant JJ O
to IN O
human JJ B-Species
risk NN O
assessment NN O
. . O

We PRP O
evaluated VBD O
the DT O
behavioral JJ O
end NN O
points NNS O
twice RB O
, , O
once RB O
around IN O
3 CD O
months NNS O
of IN O
age NN O
and CC O
the DT O
other JJ O
time NN O
around IN O
1 CD O
year NN O
; , O
the DT O
latter JJ O
time NN O
roughly RB O
corresponds VBZ O
to IN O
the DT O
period NN O
when WRB O
many JJ O
behavioral JJ O
performances NNS O
, , O
including VBG O
OPF NNP O
( , O
Acevedoa NNP O
et FW O
al NNP O
. . O
2006 CD O
; : O
Carrie NNP O
et FW O
al NNP O
. . O
1999 CD O
; : O
Gower NNP O
and CC O
Lamberty NNP O
1993 CD O
) -RRB- O
, , O
PA NNP O
( , O
Gower NNP O
and CC O
Lamberty NNP O
1993 CD O
) -RRB- O
, , O
and CC O
MM NNP O
( , O
Bach NNP O
et FW O
al NNP O
. . O
1999 CD O
; : O
Carrie NNP O
et FW O
al NNP O
. . O
1999 CD O
) -RRB- O
, , O
show VBP O
alterations NNS O
in IN O
this DT O
mouse NN B-Species
strain NN O
. . O

Materials NNS O
and CC O
Methods NNS O

Animals NNS O
and CC O
MeHg NNP O
exposure NN O

OLA129 NNP O
/ SYM O
C57BL NNP O
/ SYM O
6J CD O
strain NN O
mice NN B-Species
( -LRB- O
wild JJ O
type NN O
) -RRB- O
and CC O
MT NNP O
I NNP O
/ SYM O
II NN O
- HYPH O
knockout NN O
mice NNS B-Species
( -LRB- O
MT NNP O
- HYPH O
null NN O
) -RRB- O
of IN O
this DT O
strain NN O
were VBD O
provided VBN O
by IN O
K NNP O
. . O
H NNP O
. . O

Choo NNP O
of IN O
the DT O
Murdoch NNP O
Institute NNP O
, , O
Parkville NNP O
, , O
Australia NNP O
( , O
Michalska NNP O
and CC O
Choo NNP O
1993 CD O
) -RRB- O
and CC O
were VBD O
of IN O
a DT O
mixed JJ O
genetic JJ O
background NN O
of IN O
129 CD O
/ SYM O
Ola NNP O
and CC O
C57BL NNP O
/ SYM O
6 CD O
strains NNS O
. . O

F1 NN O
hybrid NN O
mice NNS B-Species
were VBD O
mated VBN O
with IN O
C57BL NNP O
/ SYM O
6 CD O
mice NNS B-Species
for IN O
six CD O
generations NNS O
at IN O
the DT O
National NNP O
Institute NNP O
for IN O
Environmental NNP O
Studies NNPS O
( : O
Tsukuba NNP O
, , O
Japan NNP O
) -RRB- O
. . O

At IN O
10 CD O
weeks NNS O
of IN O
age NN O
, , O
single JJ O
male JJ O
and CC O
female JJ O
mice NNS B-Species
were VBD O
allowed VBN O
to TO O
cohabit VB O
; : O
every DT O
female JJ O
mouse NN B-Species
was VBD O
checked VBN O
each DT O
morning NN O
for IN O
the DT O
presence NN O
of IN O
a DT O
vaginal JJ O
plug NN O
. . O

When WRB O
a DT O
plug NN O
was VBD O
confirmed VBN O
, , O
the DT O
day NN O
was VBD O
designated VBN O
as IN O
day NN O
0 CD O
of IN O
gestation NN O
( : O
GD0 NNP O
) -RRB- O
. . O

The DT O
diet NN O
, , O
NIH NNP O
- HYPH O
07PLD NNP O
formula NN O
( , O
CLEA NNP O
Japan NNP O
, , O
Inc NNP O
. . O
, , O
Tokyo NNP O
, , O
Japan NNP O
) -RRB- O
, , O
contained VBD O
vitamins NNS O
and CC O
trace NN O
elements NNS O
as IN O
follows VBZ O
( : O
per IN O
kilogram NN O
diet NN O
) -RRB- O
: : O
3 CD O
. . O
2 CD O
mg NN O
CuSO4 NNP O
, , O
88 CD O
mg CD O
FeSO4 NNP O
, , O
149 CD O
mg NN O
MnSO4 NNP O
, , O
25 CD O
mg NN O
ZnCO3 NN O
, , O
1 CD O
. . O
6 CD O
mg NN O
Ca NN O
( , O
IO3 NN O
) SYM O
2 CD O
, , O
11 CD O
mg NN O
vitamin NN O
B1 NN O
, , O
4 CD O
. . O
7 CD O
mg NN O
vitamin NN O
B2 NN O
, , O
1 CD O
. . O
9 CD O
mg NN O
vitamin NN O
B6 NN O
, , O
44 CD O
mg NN O
vitamin NN O
E NN O
, , O
in IN O
addition NN O
to IN O
5 CD O
mu NNS O
g NN O
MeHg NN O
/ SYM O
g NN O
. . O

This DT O
diet NN O
was VBD O
fed VBN O
to IN O
the DT O
pregnant JJ O
mice NN B-Species
starting VBG O
from IN O
GD0 NNP O
through IN O
10 CD O
days NNS O
after IN O
delivery NN O
( : O
i PRP O
. . O
e -RRB- O
. . O
, , O
PND10 NN O
) -RRB- O
. . O

Thereafter RB O
, , O
we PRP O
switched VBD O
mice NNS B-Species
to IN O
a DT O
diet NN O
that WDT O
did VBD O
not RB O
contain VB O
MeHg NNP O
. . O

We PRP O
chose VBD O
GD0 NNP O
as IN O
the DT O
beginning NN O
of IN O
exposure NN O
because IN O
exposures NNS O
that WDT O
started VBD O
before IN O
conception NN O
often RB O
resulted VBD O
in IN O
fairly RB O
high JJ O
Hg NN O
concentrations NNS O
in IN O
fetal JJ O
/ SYM O
neonatal JJ O
brains NNS O
( , O
Kakita NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
, , O
and CC O
we PRP O
chose VBD O
PND10 NNP O
to TO O
cover VB O
the DT O
early JJ O
neonatal JJ O
period NN O
, , O
in IN O
which WDT O
considerable JJ O
brain NN O
growth NN O
occurs VBZ O
. . O

In IN O
our PRP$ O
experimental JJ O
setting NN O
, , O
the DT O
neonatal JJ O
mice NNS B-Species
started VBD O
to TO O
eat VB O
from IN O
the DT O
diet NN O
bucket NN O
and CC O
drink VB O
from IN O
the DT O
water NN O
bottle NN O
from IN O
PND10 NNP O
onward RB O
. . O

Control NN O
mice NNS B-Species
were VBD O
kept VBN O
on IN O
the DT O
same JJ O
diet NN O
but CC O
without IN O
MeHg NNP O
( : O
< SYM O
0 CD O
. . O
1 CD O
mu NN O
g NN O
Hg NN O
/ : O
g NN O
) -RRB- O
. . O

On IN O
PND1 NNP O
, , O
to TO O
avoid VB O
the DT O
confounding JJ O
effects NNS O
due JJ O
to IN O
different JJ O
litter NN O
size NN O
, , O
we PRP O
reduced VBD O
each DT O
litter NN O
to IN O
six CD O
pups NNS O
( , O
three CD O
males NNS O
and CC O
three CD O
females NNS O
when WRB O
possible JJ O
) -RRB- O
, , O
and CC O
on IN O
PND10 NNP O
, , O
two CD O
males NNS O
and CC O
two CD O
females NNS O
from IN O
each DT O
litter NN O
were VBD O
killed VBN O
for IN O
chemical JJ O
analyses NNS O
. . O

The DT O
remaining VBG O
male JJ O
and CC O
female JJ O
offspring NN O
per IN O
litter NN O
were VBD O
weaned VBN O
on IN O
PND28 NNP O
and CC O
used VBN O
for IN O
subsequent JJ O
behavioral JJ O
analyses NNS O
( , O
either CC O
at IN O
12 CD O
- SYM O
13 CD O
weeks NNS O
or CC O
52 CD O
- SYM O
53 CD O
weeks NNS O
, , O
depending VBG O
on IN O
the DT O
litter NN O
) -RRB- O
as IN O
described VBN O
below RB O
. . O

We PRP O
measured VBD O
body NN O
weights NNS O
of IN O
the DT O
weaned VBN O
mice NNS B-Species
every DT O
2 CD O
weeks NNS O
. . O

Thus RB O
, , O
four CD O
experimental JJ O
groups NNS O
were VBD O
used VBN O
( , O
with IN O
or CC O
without IN O
MeHg NNP O
exposure NN O
for IN O
two CD O
strains NNS O
) -RRB- O
, , O
and CC O
each DT O
group NN O
consisted VBD O
of IN O
12 CD O
- SYM O
13 CD O
litters NNS O
. . O

For IN O
half NN O
of IN O
the DT O
litters NNS O
, , O
the DT O
behavioral JJ O
analyses NNS O
were VBD O
conducted VBN O
at IN O
12 CD O
- SYM O
13 CD O
weeks NNS O
of IN O
age NN O
, , O
and CC O
upon IN O
completion NN O
of IN O
the DT O
behavioral JJ O
analyses NNS O
, , O
the DT O
animals NNS O
were VBD O
killed VBN O
under IN O
ether JJ O
anesthesia NN O
. . O

We PRP O
then RB O
dissected VBD O
the DT O
organs NNS O
( , O
brain NN O
, , O
liver NN O
, , O
and CC O
kidneys NNS O
) , O
for IN O
Hg NNP O
analyses NNS O
. . O

For IN O
the DT O
remaining VBG O
half NN O
of IN O
the DT O
litters NNS O
, , O
we PRP O
conducted VBD O
the DT O
behavioral JJ O
tests NNS O
at IN O
52 CD O
- SYM O
53 CD O
weeks NNS O
of IN O
age NN O
. . O

The DT O
mice NNS B-Species
were VBD O
treated VBN O
humanely RB O
and CC O
with IN O
regard NN O
to IN O
alleviation NN O
of IN O
suffering NN O
according VBG O
to IN O
the DT O
National NNP O
Institute NNP O
for IN O
Environmental NNP O
Studies NNPS O
' POS O
Guidelines NNPS O
for IN O
Animal NNP O
Welfare NNP O
and CC O
the DT O
guidelines NNS O
of IN O
St NNP O
. . O

Marianna NNP O
University NNP O
. . O

Behavioral JJ O
evaluations NNS O

The DT O
details NNS O
of IN O
each DT O
behavioral JJ O
procedure NN O
have VBP O
been VBN O
described VBN O
elsewhere RB O
( , O
Yoshida NNP O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
. . O

Brief JJ O
descriptions NNS O
follow VBP O
. . O

For IN O
the DT O
OPF NNP O
test NN O
, , O
we PRP O
used VBD O
an DT O
OPF NNP O
apparatus NN O
( , O
Ohara NNP O
Co NNP O
. . O
, , O
Ltd NNP O
. . O
, , O
Tokyo NNP O
, , O
Japan NNP O
) , O
with IN O
a DT O
60 CD O
x SYM O
60 CD O
- HYPH O
cm NN O
floor NN O
surrounded VBN O
by IN O
walls NNS O
60 CD O
cm NNS O
high JJ O
. . O

The DT O
experimental JJ O
room NN O
light NN O
was VBD O
turned VBN O
off RP O
, , O
and CC O
a DT O
dim JJ O
light NN O
of IN O
80 CD O
lux NN O
was VBD O
lit VBN O
during IN O
the DT O
experiment NN O
. . O

We PRP O
placed VBD O
a DT O
mouse NN B-Species
in IN O
the DT O
center NN O
of IN O
the DT O
floor NN O
and CC O
monitored VBD O
its PRP$ O
behavior NN O
for IN O
10 CD O
min NN O
using VBG O
a DT O
CCD NNP O
camera NN O
connected VBN O
to IN O
a DT O
computer NN O
. . O

The DT O
position NN O
of IN O
the DT O
center NN O
of IN O
gravity NN O
was VBD O
calculated VBN O
by IN O
image NN O
- HYPH O
analyzing VBG O
software NN O
, , O
which WDT O
was VBD O
used VBN O
to TO O
calculate VB O
the DT O
total JJ O
distance NN O
traveled VBN O
by IN O
the DT O
mouse NN B-Species
as RB O
well RB O
as IN O
the DT O
positional JJ O
preference NN O
( , O
either CC O
center NN O
or CC O
peripheral JJ O
, , O
where WRB O
peripheral JJ O
was VBD O
defined VBN O
as IN O
the DT O
area NN O
within IN O
10 CD O
cm NNS O
from IN O
the DT O
wall NN O
) -RRB- O
. . O

We PRP O
cleaned VBD O
the DT O
OPF NNP O
apparatus NN O
with IN O
70 CD O
% NN O
ethanol NN O
between IN O
trials NNS O
. . O

The DT O
apparatus NN O
for IN O
the DT O
PA NN O
test NN O
( : O
Ohara NNP O
Co NNP O
. . O
Ltd NNP O
. . O
) -RRB- O
consisted VBD O
of IN O
a DT O
light JJ O
compartment NN O
that WDT O
illuminated VBD O
by IN O
a DT O
400 CD O
- HYPH O
lux NN O
light NN O
and CC O
a DT O
dark JJ O
compartment NN O
with IN O
black JJ O
opaque JJ O
walls NNS O
and CC O
lids NNS O
. . O

The DT O
two CD O
compartments NNS O
were VBD O
separated VBN O
by IN O
a DT O
mobile JJ O
guillotine NN O
door NN O
. . O

On IN O
the DT O
first JJ O
day NN O
( , O
training NN O
trial NN O
) -RRB- O
, , O
we PRP O
placed VBD O
each DT O
mouse NN B-Species
in IN O
the DT O
light JJ O
compartment NN O
facing VBG O
away RB O
from IN O
the DT O
guillotine NN O
door NN O
, , O
which WDT O
was VBD O
closed JJ O
. . O

After IN O
30 CD O
sec NN O
of IN O
introduction NN O
, , O
the DT O
door NN O
was VBD O
opened VBN O
; : O
when WRB O
the DT O
mouse NN B-Species
entered VBD O
the DT O
dark JJ O
compartment NN O
, , O
a DT O
brief JJ O
electric JJ O
shock NN O
( , O
4 CD O
mA NN O
for IN O
2 CD O
sec NN O
) -RRB- O
was VBD O
delivered VBN O
through IN O
the DT O
metal NN O
grid NN O
floor NN O
. . O

This DT O
would MD O
force VB O
the DT O
mouse NN B-Species
back RB O
to IN O
the DT O
light JJ O
component NN O
. . O

The DT O
interval NN O
between IN O
the DT O
opening NN O
of IN O
the DT O
door NN O
and CC O
the DT O
entry NN O
to IN O
the DT O
dark JJ O
room NN O
( , O
in IN O
seconds NNS O
) , O
was VBD O
recorded VBN O
and CC O
defined VBN O
as IN O
the DT O
latency NN O
. . O

On IN O
the DT O
next JJ O
day NN O
, , O
the DT O
same JJ O
procedure NN O
was VBD O
repeated VBN O
, , O
but CC O
without IN O
the DT O
electric JJ O
shock NN O
( , O
retaining VBG O
trail NN O
) -RRB- O
. . O

In IN O
this DT O
PA NN O
paradigm NN O
, , O
aversive JJ O
learning NN O
was VBD O
assumed VBN O
to TO O
be VB O
established VBN O
in IN O
the DT O
training NN O
trial NN O
, , O
and CC O
we PRP O
used VBD O
its PRP$ O
retention NN O
in IN O
the DT O
retaining NN O
trail NN O
as IN O
the DT O
index NN O
of IN O
learning NN O
. . O

Between IN O
each DT O
individual JJ O
trial NN O
, , O
we PRP O
cleaned VBD O
the DT O
apparatus NN O
with IN O
ethanol NN O
. . O

The DT O
cutoff NN O
time NN O
of IN O
the DT O
retention NN O
session NN O
was VBD O
300 CD O
sec NN O
. . O

The DT O
MM NNP O
test NN O
apparatus NN O
( , O
Ohara NNP O
Co NNP O
. . O
, , O
Ltd NNP O
. . O
) -RRB- O
was VBD O
a DT O
round JJ O
- HYPH O
shaped JJ O
water NN O
pool NN O
with IN O
a DT O
diameter NN O
of IN O
120 CD O
cm NNS O
. . O

A DT O
small JJ O
platform NN O
was VBD O
submerged VBN O
in IN O
the DT O
water NN O
, , O
which WDT O
provided VBD O
a DT O
place NN O
for IN O
mice NNS B-Species
to TO O
escape VB O
from IN O
the DT O
water NN O
( : O
i PRP O
. . O
e UH O
. . O
, , O
an DT O
aversive JJ O
stimulus NN O
, , O
water NN O
temperature NN O
= SYM O
23 CD O
+ SYM O
/ SYM O
- SYM O
1 CD O
degrees NNS O
C NN O
) -RRB- O
. . O

The DT O
water NN O
was VBD O
made VBN O
opaque JJ O
by IN O
adding VBG O
white JJ O
paint NN O
so IN O
that IN O
the DT O
mouse NN B-Species
could MD O
not RB O
see VB O
the DT O
submerged JJ O
platform NN O
. . O

In IN O
each DT O
trial NN O
, , O
we PRP O
released VBD O
a DT O
mouse NN B-Species
into IN O
the DT O
pool NN O
from IN O
a DT O
determined JJ O
position NN O
along IN O
the DT O
wall NN O
, , O
and CC O
the DT O
performance NN O
of IN O
the DT O
mouse NN B-Species
was VBD O
monitored VBN O
by IN O
a DT O
CCD NNP O
camera NN O
/ SYM O
image NN O
analyzer NN O
. . O

The DT O
time NN O
required VBN O
to TO O
reach VB O
the DT O
platform NN O
was VBD O
recorded VBN O
. . O

If IN O
a DT O
mouse NN B-Species
could MD O
not RB O
find VB O
the DT O
platform NN O
within IN O
60 CD O
sec NN O
after IN O
release NN O
, , O
it PRP O
was VBD O
led VBN O
to IN O
the DT O
platform NN O
and CC O
placed VBN O
on IN O
it PRP O
for IN O
20 CD O
sec NNS O
before IN O
being VBG O
removed VBN O
. . O

In IN O
these DT O
cases NNS O
, , O
a DT O
latency NN O
of IN O
60 CD O
sec NN O
was VBD O
recorded VBN O
. . O

We PRP O
conducted VBD O
the DT O
trial NN O
once RB O
a DT O
day NN O
up IN O
to IN O
the DT O
fifth JJ O
day NN O
for IN O
each DT O
mouse NN B-Species
, , O
and CC O
the DT O
order NN O
of IN O
each DT O
mouse NN B-Species
was VBD O
counterbalanced VBN O
across IN O
the DT O
day NN O
. . O

On IN O
the DT O
sixth JJ O
day NN O
, , O
a DT O
transfer NN O
test NN O
( , O
or CC O
probe NN O
test NN O
) -RRB- O
, , O
which WDT O
is VBZ O
a DT O
trial NN O
without IN O
the DT O
platform NN O
, , O
was VBD O
conducted VBN O
; , O
in IN O
this DT O
procedure NN O
, , O
we PRP O
counted VBD O
the DT O
number NN O
of IN O
times NNS O
that IN O
the DT O
mouse NN B-Species
crossed VBD O
the DT O
position NN O
where WRB O
the DT O
platform NN O
had VBD O
been VBN O
. . O

Tissue NN O
Hg NNP O
concentration NN O

The DT O
tissue NN O
samples NNS O
were VBD O
homogenized VBN O
( : O
10 CD O
% NN O
weight NN O
/ SYM O
volume NN O
) -RRB- O
in IN O
distilled VBN O
water NN O
using VBG O
a DT O
Polytron NNP O
homogenizer NN O
( , O
Kinematica NNP O
GmbH NNP O
, , O
Littau NNP O
, , O
Switzerland NNP O
) -RRB- O
. . O

We PRP O
determined VBD O
Hg NNP O
levels NNS O
in IN O
the DT O
homogenates NNS O
by IN O
the DT O
oxygen NN O
combustion NN O
- HYPH O
gold NN O
amalgamation NN O
method NN O
( , O
Ohkawa NNP O
et FW O
al NNP O
. . O
1977 CD O
) -RRB- O
using VBG O
an DT O
atomic JJ O
absorption NN O
Hg NN O
detector NN O
MD NNP O
- HYPH O
1 CD O
( HYPH O
Nippon NNP O
Instruments NNPS O
, , O
Co NNP O
. . O
Ltd NNP O
. . O
, , O
Osaka NNP O
, , O
Japan NNP O
) -RRB- O
. . O

To TO O
ensure VB O
the DT O
accuracy NN O
of IN O
the DT O
measurement NN O
, , O
we PRP O
included VBD O
reference NN O
material NN O
from IN O
a DT O
dogfish NN O
( , O
DORM NNP O
- HYPH O
2 CD O
; : O
National NNP O
Research NNP O
Council NNP O
of IN O
Canada NNP O
, , O
Ottawa NNP O
, , O
Ontario NNP O
, , O
Canada NNP O
) -RRB- O
with IN O
a DT O
certified VBN O
value NN O
of IN O
4 CD O
. . O
64 CD O
+ NN O
/ SYM O
- HYPH O
0 CD O
. . O
26 CD O
mu NN O
g NN O
/ SYM O
g NN O
in IN O
the DT O
analyses NNS O
; : O
the DT O
observed JJ O
values NNS O
fell VBD O
within IN O
the DT O
certified JJ O
range NN O
. . O

The DT O
detection NN O
limit NN O
of IN O
the DT O
measurement NN O
was VBD O
0 CD O
. . O
1 CD O
ng CD O
Hg NNP O
. . O

Statistics NNS O

We PRP O
analyzed VBD O
behavioral JJ O
data NNS O
for IN O
OPF NNP O
and CC O
PA NNP O
by IN O
analysis NN O
of IN O
variance NN O
( , O
ANOVA NNP O
) -RRB- O
, , O
taking VBG O
sex NN O
, , O
strain NN O
, , O
and CC O
MeHg NNP O
exposure NN O
as IN O
the DT O
factors NNS O
. . O

All PDT O
the DT O
interactions NNS O
among IN O
these DT O
factors NNS O
were VBD O
put VBN O
into IN O
the DT O
model NN O
. . O

When WRB O
any DT O
of IN O
the DT O
interactions NNS O
was VBD O
highly RB O
significant JJ O
, , O
we PRP O
analyzed VBD O
the DT O
data NNS O
separately RB O
in IN O
an DT O
appropriate JJ O
way NN O
; , O
for IN O
example NN O
, , O
if IN O
sex NN O
x IN O
Hg NNP O
was VBD O
significant JJ O
, , O
the DT O
data NNS O
for IN O
males NNS O
and CC O
females NNS O
were VBD O
separately RB O
analyzed VBN O
for IN O
the DT O
effects NNS O
of IN O
strain NN O
and CC O
Hg NNP O
. . O

Whenever WRB O
appropriate JJ O
, , O
ANOVAs NNS O
were VBD O
followed VBN O
by IN O
Mann NNP O
- HYPH O
Whitney NNP O
U NNP O
or CC O
Student NNP O
' '' O
s POS O
t NN O
- HYPH O
tests NNS O
, , O
depending VBG O
on IN O
the DT O
nature NN O
and CC O
distribution NN O
of IN O
the DT O
variables NNS O
. . O

We PRP O
analyzed VBD O
data NNS O
for IN O
the DT O
MM NNP O
by IN O
repeated VBN O
- HYPH O
measures NNS O
ANOVA NNP O
, , O
taking VBG O
the DT O
exposure NN O
as IN O
between IN O
- HYPH O
group NN O
and CC O
trials NNS O
as IN O
within IN O
- HYPH O
group NN O
variables NNS O
. . O

The DT O
test NN O
was VBD O
performed VBN O
for IN O
each DT O
of IN O
the DT O
four CD O
sex NN O
and CC O
strain NN O
combinations NNS O
separately RB O
. . O

The DT O
significance NN O
level NN O
was VBD O
set VBN O
at IN O
p NN O
< SYM O
0 CD O
. . O
5 CD O
. . O

Results NNS O

Body NN O
weight NN O

Up IN O
to TO O
20 CD O
weeks NNS O
of IN O
age NN O
, , O
the DT O
body NN O
weight NN O
values NNS O
of IN O
the DT O
control NN O
and CC O
MeHg NNP O
- HYPH O
exposed VBN O
groups NNS O
were VBD O
not RB O
different JJ O
, , O
regardless RB O
of IN O
strain NN O
or CC O
sex NN O
. . O

After IN O
28 CD O
weeks NNS O
, , O
except IN O
for IN O
the DT O
wild JJ O
- HYPH O
type NN O
female JJ O
groups NNS O
, , O
the DT O
MeHg NNP O
- HYPH O
exposed VBN O
groups NNS O
weighed VBD O
significantly RB O
less JJR O
than IN O
the DT O
controls NNS O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

OPF NNP O

At IN O
12 CD O
weeks NNS O
of IN O
age NN O
, , O
a DT O
three CD O
- HYPH O
way NN O
ANOVA NN O
of IN O
the DT O
locomotion NN O
distance NN O
revealed VBD O
that IN O
only JJ O
strain NN O
was VBD O
a DT O
significant JJ O
factor NN O
( : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
, , O
reflecting VBG O
the DT O
longer JJR O
distance NN O
traveled VBN O
by IN O
the DT O
MT NNP O
- HYPH O
null JJ O
mice NN B-Species
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

Strain NN O
was VBD O
also RB O
a DT O
significant JJ O
factor NN O
for IN O
the DT O
proportion NN O
of IN O
the DT O
central JJ O
- HYPH O
area NN O
locomotion NN O
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
, , O
and CC O
Hg NNP O
exposure NN O
marginally RB O
affected VBD O
this DT O
outcome NN O
. . O

In IN O
MT NNP O
- HYPH O
null JJ O
females NNS O
, , O
the DT O
proportion NN O
of IN O
central JJ O
- HYPH O
area NN O
locomotion NN O
was VBD O
higher JJR O
in IN O
MeHg NNP O
- HYPH O
exposed VBN O
mice NNS B-Species
than IN O
in IN O
the DT O
controls NNS O
; : O
this DT O
difference NN O
was VBD O
not RB O
observed VBN O
in IN O
any DT O
other JJ O
strain NN O
- HYPH O
sex NN O
combination NN O
. . O

At IN O
52 CD O
weeks NNS O
of IN O
age NN O
, , O
the DT O
strain NN O
x NN O
Hg NN O
interaction NN O
was VBD O
highly RB O
significant JJ O
( : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
in IN O
an DT O
ANOVA NN O
of IN O
locomotion NN O
distance NN O
( -LRB- O
Figure NNP O
2B NN O
) -RRB- O
; , O
MeHg NNP O
exposure NN O
was VBD O
associated VBN O
with IN O
decreased VBN O
locomotion NN O
distance NN O
in IN O
wild JJ O
- HYPH O
type NN O
mice NN B-Species
and CC O
with IN O
increased VBN O
distance NN O
in IN O
MT NNP O
- HYPH O
null JJ O
mice NN B-Species
. . O

A DT O
strain NN O
- HYPH O
wise JJ O
two CD O
- HYPH O
way NN O
ANOVA NNP O
( : O
with IN O
sex NN O
and CC O
Hg NNP O
as IN O
the DT O
factors NNS O
) -RRB- O
revealed VBD O
that IN O
only RB O
Hg NNP O
was VBD O
significant JJ O
in IN O
both DT O
strains NNS O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Regarding VBG O
the DT O
proportion NN O
of IN O
the DT O
central JJ O
- HYPH O
area NN O
locomotion NN O
, , O
the DT O
effects NNS O
of IN O
MeHg NNP O
appeared VBD O
to TO O
depend VB O
on IN O
sex NN O
[ -LRB- O
i PRP O
. . O
e LS O
. . O
, , O
sex NN O
x CC O
Hg NNP O
was VBD O
highly RB O
significant JJ O
( : O
p NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
in IN O
the DT O
three CD O
- HYPH O
way NN O
ANOVA NN O
; : O
Figure NN O
3B NN O
] -RRB- O
. . O

Indeed RB O
, , O
a DT O
sex NN O
- HYPH O
wise JJ O
two CD O
- HYPH O
way NN O
ANOVA NNP O
showed VBD O
significant JJ O
effects NNS O
of IN O
Hg NNP O
only RB O
in IN O
females NNS O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

PA NN O

At IN O
12 CD O
weeks NNS O
of IN O
age NN O
, , O
all PDT O
the DT O
groups NNS O
showed VBD O
prolonged VBN O
latency NN O
in IN O
the DT O
second JJ O
( HYPH O
retention NN O
) -RRB- O
trial NN O
, , O
and CC O
no DT O
consistent JJ O
effect NN O
of IN O
MeHg NNP O
was VBD O
recognized VBN O
regardless RB O
of IN O
strain NN O
or CC O
sex NN O
( -LRB- O
Figure NNP O
4A NNP O
) -RRB- O
. . O

At IN O
52 CD O
weeks NNS O
of IN O
age NN O
, , O
a DT O
three CD O
- HYPH O
way NN O
ANOVA NNP O
revealed VBD O
a DT O
significant JJ O
interaction NN O
between IN O
strain NN O
and CC O
Hg NNP O
( , O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
; : O
strain NN O
- HYPH O
wise JJ O
two CD O
- HYPH O
way NN O
ANOVAs NNP O
revealed VBD O
a DT O
significant JJ O
effect NN O
of IN O
Hg NNP O
on IN O
learning VBG O
in IN O
MT NNP O
- HYPH O
null JJ O
mice NNS B-Species
of IN O
both DT O
sexes NNS O
; : O
these DT O
groups NNS O
of IN O
mice NNS B-Species
showed VBD O
significantly RB O
shorter JJR O
( , O
less JJR O
than IN O
half NN O
) , O
latency NN O
times NNS O
compared VBN O
to IN O
control NN O
mice NNS B-Species
( -LRB- O
Figure NNP O
4B NNP O
) -RRB- O
. . O

A DT O
notable JJ O
difference NN O
between IN O
the DT O
results NNS O
at IN O
52 CD O
weeks NNS O
of IN O
age NN O
and CC O
those DT O
at IN O
12 CD O
weeks NNS O
was VBD O
that IN O
many JJ O
of IN O
the DT O
tested VBN O
mice NNS B-Species
exceeded VBD O
the DT O
cutoff NN O
time NN O
in IN O
the DT O
retention NN O
trials NNS O
at IN O
52 CD O
weeks NNS O
, , O
except IN O
for IN O
the DT O
MT NNP O
- HYPH O
null JJ O
groups NNS O
. . O

MM NNP O

At IN O
13 CD O
weeks NNS O
of IN O
age NN O
, , O
repeated VBN O
- HYPH O
measures NNS O
ANOVA NNP O
did VBD O
not RB O
indicate VB O
any DT O
effects NNS O
of IN O
MeHg NNP O
( HYPH O
Figure NNP O
5A NNP O
) -RRB- O
. . O

At IN O
52 CD O
weeks NNS O
of IN O
age NN O
( : O
Figure NNP O
5B NNP O
) -RRB- O
, , O
wild JJ O
- HYPH O
type NN O
males NNS O
and CC O
MT NNP O
- HYPH O
null JJ O
females NNS O
shared VBD O
the DT O
same JJ O
statistical JJ O
results NNS O
; : O
Hg NNP O
as RB O
well RB O
as IN O
the DT O
Hg NNP O
x NN O
trial NN O
interaction NN O
were VBD O
statistically RB O
significant JJ O
. . O

Thus RB O
, , O
in IN O
both DT O
cases NNS O
, , O
the DT O
MeHg NNP O
groups NNS O
showed VBD O
a DT O
longer JJR O
latency NN O
, , O
hampering VBG O
learning NN O
performance NN O
. . O

Tissue NN O
Hg NNP O
concentration NN O

At IN O
PND10 NNP O
, , O
which WDT O
was VBD O
immediately RB O
after IN O
the DT O
exposure NN O
, , O
brain NN O
Hg NN O
concentrations NNS O
of IN O
the DT O
neonatal JJ O
mice NN B-Species
were VBD O
approximately RB O
< : O
= SYM O
0 CD O
. . O
5 CD O
mu NN O
g NN O
/ SYM O
g NN O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

Although IN O
the DT O
MT NNP O
- HYPH O
null JJ O
mice NN B-Species
and CC O
females NNS O
showed VBD O
slightly RB O
higher JJR O
brain NN O
Hg JJ O
concentrations NNS O
than IN O
the DT O
corresponding VBG O
wild JJ O
- HYPH O
type NN O
group NN O
and CC O
males NNS O
, , O
respectively RB O
, , O
neither CC O
of IN O
these DT O
differences NNS O
was VBD O
significant JJ O
. . O

At IN O
13 CD O
weeks NNS O
, , O
when WRB O
the DT O
behavioral JJ O
tests NNS O
were VBD O
completed VBN O
, , O
the DT O
brain NN O
Hg NN O
concentration NN O
was VBD O
comparable JJ O
to IN O
the DT O
control NN O
( , O
nonexposed JJ O
) , O
level NN O
( : O
approximately RB O
5 CD O
ng NN O
/ SYM O
g NN O
in IN O
both CC O
the DT O
exposed JJ O
and CC O
control NN O
brains NNS O
) -RRB- O
. . O

Interestingly RB O
, , O
MT NNP O
- HYPH O
null JJ O
mice NNS B-Species
had VBD O
a DT O
significantly RB O
lower JJR O
brain NN O
Hg JJ O
concentration NN O
than IN O
the DT O
corresponding VBG O
wild JJ O
- HYPH O
type NN O
groups NNS O
. . O

Discussion NN O

Results NNS O
of IN O
the DT O
present JJ O
study NN O
demonstrate VBP O
the DT O
delayed VBN O
emergence NN O
of IN O
neurobehavioral JJ O
toxicity NN O
due IN O
to IN O
perinatal JJ O
MeHg NNP O
exposure NN O
, , O
which WDT O
presumably RB O
developed VBD O
after IN O
brain NN O
MeHg NNP O
concentrations NNS O
had VBD O
leveled VBN O
off RP O
. . O

This DT O
emergent JJ O
toxicity NN O
was VBD O
exaggerated VBN O
in IN O
MT NNP O
- HYPH O
null NN O
mice NN B-Species
and CC O
was VBD O
more RBR O
distinct JJ O
in IN O
females NNS O
. . O

To IN O
our PRP$ O
knowledge NN O
, , O
our PRP$ O
findings NNS O
show VBP O
the DT O
first JJ O
clear RB O
- HYPH O
cut VBN O
demonstrations NNS O
of IN O
a DT O
long JJ O
latency NN O
period NN O
of IN O
MeHg NNP O
neurobehavioral JJ O
toxicity NN O
in IN O
rodents NNS O
and CC O
possible JJ O
genetic JJ O
susceptibility NN O
for IN O
the DT O
emergent JJ O
toxicity NN O
. . O

The DT O
exposure NN O
level NN O
should MD O
be VB O
considered VBN O
before IN O
discussing VBG O
the DT O
end NN O
points NNS O
. . O

On IN O
PND10 NNP O
, , O
immediately RB O
after IN O
the DT O
cessation NN O
of IN O
MeHg NNP O
exposure NN O
, , O
the DT O
brain NN O
Hg NN O
concentration NN O
was VBD O
approximately RB O
0 CD O
. . O
5 CD O
mu NN O
g NN O
/ SYM O
g NN O
, , O
regardless RB O
of IN O
the DT O
strain NN O
or CC O
sex NN O
. . O

In IN O
a DT O
previous JJ O
study NN O
, , O
the DT O
brain NN O
Hg NN O
concentration NN O
in IN O
mice NNS B-Species
perinatally RB O
exposed VBN O
to IN O
6 CD O
mg NN O
MeHg NNP O
/ SYM O
L NNP O
( , O
via IN O
water NN O
) , O
peaked VBD O
between IN O
PND0 NNP O
and CC O
PND4 NNP O
and CC O
was VBD O
approximately RB O
three CD O
times NNS O
higher JJR O
than IN O
on IN O
PND21 NNP O
( , O
Goulet NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
. . O

Therefore RB O
, , O
the DT O
peak NN O
brain NN O
Hg NN O
concentration NN O
, , O
which WDT O
is VBZ O
presumably RB O
observed VBN O
around IN O
birth NN O
, , O
can MD O
be VB O
estimated VBN O
as IN O
about RB O
3 CD O
- HYPH O
fold NN O
higher JJR O
than IN O
that DT O
on IN O
PND10 NN O
and CC O
would MD O
be VB O
approximately RB O
1 CD O
. . O
5 CD O
mu NN O
g NN O
/ SYM O
g NN O
( : O
0 CD O
. . O
5 CD O
mu NN O
g NN O
/ SYM O
g NN O
x SYM O
3 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
one CD O
of IN O
the DT O
lowest JJS O
levels NNS O
among IN O
recent JJ O
rodent NN O
studies NNS O
. . O

As IN O
shown VBN O
by IN O
Sakamoto NNP O
et FW O
al NNP O
. . O

( -LRB- O
2002 CD O
) -RRB- O
in IN O
their PRP$ O
Figure NN O
2 CD O
, , O
prenatal JJ O
exposure NN O
of IN O
rats NNS B-Species
to IN O
MeHg NNP O
showed VBD O
a DT O
peak NN O
brain NN O
Hg NN O
concentration NN O
around IN O
PND1 NNP O
that WDT O
was VBD O
four CD O
to TO O
five CD O
times NNS O
greater JJR O
than IN O
the DT O
level NN O
on IN O
PND10 NNP O
. . O

Also RB O
, , O
Newland NNP O
and CC O
Rasmussen NNP O
( : O
2000 CD O
) -RRB- O
reported VBD O
a DT O
slight JJ O
alteration NN O
of IN O
a DT O
complex JJ O
operant JJ O
behavior NN O
in IN O
rats NNS B-Species
at IN O
ages NNS O
< : O
2 CD O
years NNS O
at IN O
brain NN O
Hg NN O
concentrations NNS O
as RB O
low JJ O
as IN O
0 CD O
. . O
5 CD O
mu NN O
g NN O
/ SYM O
g NN O
at IN O
birth NN O
, , O
although IN O
statistical JJ O
significance NN O
of IN O
this DT O
particular JJ O
effect NN O
was VBD O
not RB O
clear JJ O
. . O

It PRP O
should MD O
be VB O
noted VBN O
that IN O
rats NNS B-Species
have VBP O
different JJ O
Hg NNP O
kinetics NNS O
( , O
Hirayama NNP O
and CC O
Yasutake NNP O
1986 CD O
; , O
Yasutake NNP O
and CC O
Hirayama NNP O
1990 CD O
) -RRB- O
due IN O
to IN O
the DT O
high JJ O
affinity NN O
of IN O
rat NN O
hemoglobin NN O
for IN O
MeHg NNP O
( : O
Clarkson NNP O
and CC O
Magos NNP O
2006 CD O
) -RRB- O
. . O

The DT O
most RBS O
important JJ O
observation NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
that IN O
the DT O
effects NNS O
of IN O
low JJ O
- HYPH O
level NN O
MeHg NNP O
exposure NN O
were VBD O
detected VBN O
only RB O
at IN O
later JJ O
stages NNS O
in IN O
the DT O
lives NNS O
of IN O
the DT O
mice NNS B-Species
. . O

Except IN O
for IN O
the DT O
central JJ O
- HYPH O
area NN O
occupancy NN O
in IN O
OPF NNP O
in IN O
MT NNP O
- HYPH O
null JJ O
females NNS O
, , O
no DT O
statistically RB O
significant JJ O
effects NNS O
of IN O
MeHg NNP O
were VBD O
observed VBN O
in IN O
any DT O
of IN O
the DT O
three CD O
behavioral JJ O
tests NNS O
at IN O
12 CD O
weeks NNS O
of IN O
age NN O
. . O

In IN O
contrast NN O
, , O
significant JJ O
effects NNS O
were VBD O
observed VBN O
in IN O
all DT O
three CD O
tests NNS O
at IN O
52 CD O
weeks NNS O
of IN O
age NN O
. . O

The DT O
brain NN O
Hg NNP O
concentration NN O
of IN O
the DT O
exposed VBN O
groups NNS O
had VBD O
leveled VBN O
off RP O
and CC O
was VBD O
not RB O
distinguishable JJ O
from IN O
the DT O
non AFX O
- HYPH O
exposed VBN O
group NN O
at IN O
13 CD O
weeks NNS O
of IN O
age NN O
, , O
immediately RB O
after IN O
the DT O
first JJ O
phase NN O
of IN O
the DT O
behavioral JJ O
testing NN O
. . O

Therefore RB O
, , O
in IN O
the DT O
present JJ O
study NN O
, , O
there EX O
was VBD O
a DT O
latency NN O
period NN O
in IN O
which WDT O
the DT O
dose NN O
and CC O
effects NNS O
could MD O
not RB O
be VB O
detected VBN O
, , O
although IN O
effects NNS O
were VBD O
observed VBN O
9 CD O
months NNS O
later RB O
. . O

Another DT O
notable JJ O
observation NN O
was VBD O
that IN O
the DT O
emergent JJ O
manifestation NN O
of IN O
toxicity NN O
was VBD O
also RB O
recognized VBN O
in IN O
the DT O
suppression NN O
of IN O
body NN O
weight NN O
( , O
except IN O
for IN O
wild JJ O
- HYPH O
type NN O
females NNS O
) -RRB- O
, , O
which WDT O
only RB O
became VBD O
apparent JJ O
on IN O
or CC O
after IN O
28 CD O
weeks NNS O
of IN O
age NN O
. . O

The DT O
existence NN O
of IN O
a DT O
latency NN O
period NN O
of IN O
as RB O
long JJ O
as IN O
several JJ O
years NNS O
after IN O
chronic JJ O
( , O
7 CD O
years NNS O
from IN O
birth NN O
) -RRB- O
, , O
low JJ O
- HYPH O
level NN O
exposure NN O
to IN O
MeHg NNP O
has VBZ O
been VBN O
described VBN O
in IN O
nonhuman JJ O
primates NNS O
( , O
Rice NNP O
1996 CD O
) -RRB- O
. . O

In IN O
that DT O
case NN O
, , O
however RB O
, , O
the DT O
Hg NNP O
concentration NN O
in IN O
the DT O
brain NN O
remained VBD O
elevated JJ O
, , O
presumably RB O
as IN O
a DT O
result NN O
of IN O
the DT O
long JJ O
exposure NN O
. . O

Indeed RB O
, , O
Rice NNP O
( : O
1996 CD O
) -RRB- O
argued VBD O
that IN O
the DT O
minute JJ O
amount NN O
of IN O
residual JJ O
brain NN O
Hg NNP O
could MD O
have VB O
caused VBN O
the DT O
delayed VBN O
toxicity NN O
. . O

This DT O
was VBD O
clearly RB O
not RB O
the DT O
case NN O
in IN O
the DT O
present JJ O
study NN O
because IN O
the DT O
Hg NNP O
concentration NN O
leveled VBD O
off RP O
around IN O
the DT O
time NN O
of IN O
the DT O
first JJ O
phase NN O
of IN O
the DT O
behavioral JJ O
study NN O
. . O

The DT O
absence NN O
of IN O
behavioral JJ O
effects NNS O
at IN O
12 CD O
weeks NNS O
of IN O
age NN O
ruled VBD O
out RP O
the DT O
possibility NN O
that IN O
the DT O
residual JJ O
behavioral JJ O
effects NNS O
were VBD O
due JJ O
to IN O
elevated JJ O
Hg NNP O
early RB O
in IN O
life NN O
. . O

Therefore RB O
, , O
the DT O
behavioral JJ O
toxicity NN O
that WDT O
surfaced VBD O
at IN O
52 CD O
weeks NNS O
of IN O
age NN O
must MD O
have VB O
had VBN O
its PRP$ O
origin NN O
before IN O
the DT O
brain NN O
Hg NN O
concentration NN O
leveled VBD O
off RP O
( , O
at IN O
or CC O
before IN O
13 CD O
weeks NNS O
of IN O
age NN O
) -RRB- O
, , O
although IN O
the DT O
redistribution NN O
of IN O
Hg NNP O
to IN O
the DT O
brain NN O
from IN O
other JJ O
sites NNS O
of IN O
deposition NN O
, , O
such JJ O
as IN O
the DT O
liver NN O
, , O
cannot MD O
be VB O
completely RB O
excluded VBN O
. . O

The DT O
long JJ O
silent JJ O
period NN O
before IN O
the DT O
manifestations NNS O
of IN O
toxicity NN O
emerged VBD O
suggests VBZ O
that IN O
a DT O
slow JJ O
process NN O
plays VBZ O
a DT O
role NN O
in IN O
this DT O
latent JJ O
toxicity NN O
. . O

Although IN O
an DT O
example NN O
of IN O
a DT O
slow JJ O
process NN O
is VBZ O
aging VBG O
, , O
52 CD O
weeks NNS O
of IN O
age NN O
might MD O
not RB O
be VB O
sufficiently RB O
old JJ O
for IN O
a DT O
mouse NN B-Species
to TO O
be VB O
considered VBN O
aged VBN O
in IN O
the DT O
physiologic JJ O
sense NN O
because IN O
C57BL NNP O
/ SYM O
6 CD O
mice NNS B-Species
have VBP O
a DT O
relatively RB O
long JJ O
life NN O
span NN O
among IN O
mouse NN B-Species
strains NNS O
[ -LRB- O
median JJ O
survival NN O
of IN O
27 CD O
- SYM O
31 CD O
months NNS O
( , O
Gower NNP O
and CC O
Lamberty NNP O
1993 CD O
) -RRB- O
] -RRB- O
and CC O
a DT O
survival NN O
rate NN O
at IN O
18 CD O
- SYM O
19 CD O
months NNS O
as RB O
high JJ O
as IN O
90 CD O
% NN O
( , O
Institute NNP O
on IN O
Aging NNP O
HP NNP O
) -RRB- O
( , O
National NNP O
Institute NNP O
on IN O
Aging NNP O
2008 CD O
) -RRB- O
. . O

Nevertheless RB O
, , O
various JJ O
behavioral JJ O
examinations NNS O
have VBP O
shown VBN O
age NN O
- HYPH O
related VBN O
changes NNS O
in IN O
the DT O
performance NN O
of IN O
mice NNS B-Species
at IN O
approximately RB O
1 CD O
year NN O
of IN O
age NN O
in IN O
the DT O
OPF NNP O
( : O
Acevedoa NNP O
et FW O
al NNP O
. . O
2006 CD O
; : O
Carrie NNP O
et FW O
al NNP O
. . O
1999 CD O
) -RRB- O
, , O
MM NNP O
( , O
Bach NNP O
et FW O
al NNP O
. . O
1999 CD O
; : O
Carrie NNP O
et FW O
al NNP O
. . O
1999 CD O
) -RRB- O
, , O
and CC O
PA NNP O
( , O
Gower NNP O
and CC O
Lamberty NNP O
1993 CD O
) -RRB- O
tests NNS O
. . O

The DT O
observed JJ O
effects NNS O
of IN O
MeHg NNP O
, , O
including VBG O
the DT O
deterioration NN O
in IN O
the DT O
PA NN O
and CC O
MM NN O
and CC O
suppression NN O
in IN O
the DT O
OPF NNP O
( , O
in IN O
wild JJ O
- HYPH O
type NN O
mice NN B-Species
) -RRB- O
, , O
were VBD O
consistent JJ O
with IN O
these DT O
reported VBN O
effects NNS O
of IN O
aging NN O
on IN O
behavioral JJ O
function NN O
( , O
in IN O
the DT O
sense NN O
described VBN O
above RB O
) -RRB- O
, , O
except IN O
for IN O
the DT O
increased VBN O
OPF NNP O
activity NN O
in IN O
the DT O
MT NNP O
- HYPH O
null NN O
mice NN B-Species
. . O

Regardless RB O
of IN O
its PRP$ O
neural JJ O
basis NN O
, , O
the DT O
basis NN O
of IN O
neurobehavioral JJ O
toxicity NN O
should MD O
be VB O
sought VBN O
in IN O
early JJ O
life NN O
stages NNS O
when WRB O
the DT O
brain NN O
Hg NN O
concentration NN O
is VBZ O
highly RB O
elevated VBN O
( : O
approximately RB O
1 CD O
. . O
5 CD O
mu NN O
g NN O
/ SYM O
g NN O
at IN O
its PRP$ O
peak NN O
) -RRB- O
. . O

Some DT O
in IN O
vivo NN O
experiments NNS O
have VBP O
demonstrated VBN O
several JJ O
candidate NN O
mechanisms NNS O
of IN O
perinatal JJ O
exposure NN O
to IN O
MeHg NNP O
, , O
including VBG O
abnormal JJ O
migration NN O
of IN O
neurons NNS O
and CC O
/ SYM O
or CC O
glias NN O
( , O
Kakita NNP O
et FW O
al NNP O
. . O
2003 CD O
; : O
Rodier NNP O
et FW O
al NNP O
. . O
1984 CD O
) -RRB- O
, , O
but CC O
at IN O
higher JJR O
Hg NNP O
concentrations NNS O
. . O

Using VBG O
exactly RB O
the DT O
same JJ O
exposure NN O
protocol NN O
as IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
found VBD O
suppressed JJ O
activity NN O
of IN O
type NN O
III NNP O
iodo NN O
- HYPH O
thyronine NN O
deiodinase NN O
, , O
a DT O
thyroid NN O
hormone NN O
- HYPH O
metabolizing VBG O
enzyme NN O
, , O
in IN O
the DT O
brains NNS O
of IN O
PND10 NNP O
mouse NN B-Species
neonates NNS O
( , O
Mori NNP O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
, , O
consistent JJ O
with IN O
our PRP$ O
previous JJ O
study NN O
of IN O
higher JJR O
MeHg NNP O
doses NNS O
( : O
Watanabe NNP O
et FW O
al NNP O
. . O
1999 CD O
) -RRB- O
. . O

This DT O
perturbation NN O
could MD O
be VB O
one CD O
of IN O
the DT O
candidate NN O
mechanisms NNS O
responsible JJ O
for IN O
the DT O
later JJ O
anomalous JJ O
behaviors NNS O
because IN O
even RB O
a DT O
transient JJ O
change NN O
in IN O
thyroid NN O
hormones NNS O
during IN O
the DT O
critical JJ O
period NN O
of IN O
perinatal JJ O
life NN O
exerts VBZ O
long JJ O
- HYPH O
term NN O
consequences NNS O
( : O
Auso NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

The DT O
effects NNS O
of IN O
MeHg NNP O
at IN O
52 CD O
weeks NNS O
of IN O
age NN O
were VBD O
influenced VBN O
by IN O
two CD O
potential JJ O
modifying VBG O
factors NNS O
, , O
sex NN O
and CC O
strain NN O
. . O

In IN O
the DT O
OPF NNP O
, , O
while IN O
the DT O
locomotion NN O
was VBD O
affected VBN O
in IN O
both DT O
strains NNS O
( , O
although IN O
the DT O
direction NN O
was VBD O
opposite JJ O
) -RRB- O
, , O
center NN O
occupancy NN O
was VBD O
significantly RB O
increased VBN O
only RB O
in IN O
the DT O
MT NNP O
- HYPH O
null JJ O
mice NN B-Species
. . O

In IN O
addition NN O
, , O
the DT O
effects NNS O
on IN O
PA NNP O
were VBD O
significant JJ O
only RB O
in IN O
MT NNP O
- HYPH O
null NN O
mice NNS B-Species
, , O
whereas IN O
MeHg NNP O
at IN O
a DT O
higher JJR O
dose NN O
was VBD O
reported VBN O
to TO O
worsen VB O
PA NN O
performance NN O
in IN O
rats NNS B-Species
( , O
6 CD O
- SYM O
8 CD O
weeks NNS O
of IN O
age NN O
; : O
Sakamoto NNP O
et FW O
al NNP O
. . O
2002 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
body NN O
weight NN O
gain NN O
was VBD O
suppressed VBN O
in IN O
both CC O
male JJ O
and CC O
female JJ O
MT NNP O
- HYPH O
null JJ O
mice NNS B-Species
, , O
whereas IN O
in IN O
wild JJ O
- HYPH O
type NN O
mice NNS B-Species
the DT O
suppression NN O
was VBD O
observed VBN O
only RB O
in IN O
males NNS O
. . O

Taken VBN O
together RB O
, , O
the DT O
MT NNP O
- HYPH O
null JJ O
strain NN O
appeared VBD O
to TO O
be VB O
slightly RB O
more RBR O
susceptible JJ O
to IN O
the DT O
late JJ O
- HYPH O
emergent JJ O
effects NNS O
of IN O
MeHg NNP O
. . O

Several JJ O
lines NNS O
of IN O
evidence NN O
have VBP O
shown VBN O
that IN O
MT NNP O
- HYPH O
I NNP O
, , O
II NNP O
is VBZ O
protective JJ O
against IN O
the DT O
toxicity NN O
of IN O
MeHg NNP O
( : O
Leiva NNP O
- HYPH O
Presa NNP O
et FW O
al NNP O
. . O
2004 CD O
; : O
Yao NNP O
et FW O
al NNP O
. . O
2000 CD O
) -RRB- O
, , O
and CC O
the DT O
present JJ O
results NNS O
were VBD O
basically RB O
consistent JJ O
with IN O
these DT O
reports NNS O
. . O

We PRP O
have VBP O
also RB O
reported VBN O
the DT O
susceptibility NN O
of IN O
the DT O
MT NNP O
- HYPH O
null JJ O
strain NN O
to IN O
the DT O
neurotoxic JJ O
effects NNS O
of IN O
metallic JJ O
Hg NNP O
( , O
Yoshida NNP O
et FW O
al NNP O
. . O
2004 CD O
, , O
2006 CD O
) -RRB- O
. . O

The DT O
difference NN O
in IN O
the DT O
susceptibility NN O
to IN O
MeHg NNP O
between IN O
sexes NNS O
is VBZ O
still RB O
debated VBN O
( : O
Clarkson NNP O
and CC O
Magos NNP O
2006 CD O
; : O
National NNP O
Research NNP O
Council NNP O
2000 CD O
; : O
Vahter NNP O
2007 CD O
) -RRB- O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
some DT O
responses NNS O
to IN O
MeHg NNP O
were VBD O
different JJ O
between IN O
the DT O
sexes NNS O
, , O
including VBG O
OPF NNP O
performance NN O
at IN O
12 CD O
and CC O
52 CD O
weeks NNS O
of IN O
age NN O
and CC O
MM NN O
performance NN O
at IN O
52 CD O
weeks NNS O
. . O

The DT O
fact NN O
that IN O
the DT O
MT NNP O
- HYPH O
null JJ O
female JJ O
group NN O
was VBD O
the DT O
only JJ O
group NN O
affected VBN O
by IN O
MeHg NNP O
at IN O
12 CD O
weeks NNS O
may MD O
suggest VB O
the DT O
particular JJ O
susceptibility NN O
of IN O
females NNS O
in IN O
this DT O
strain NN O
. . O

This DT O
point NN O
needs VBZ O
to TO O
be VB O
clarified VBN O
in IN O
further JJ O
experiments NNS O
. . O

The DT O
question NN O
remains VBZ O
of IN O
why WRB O
MT NNP O
- HYPH O
null NN O
mice NNS B-Species
are VBP O
susceptible JJ O
to IN O
the DT O
delayed VBN O
neurotoxicity NN O
of IN O
perinatal JJ O
MeHg NNP O
. . O

Apparently RB O
kinetics NNS O
play VBP O
only RB O
a DT O
minor JJ O
role NN O
because IN O
the DT O
strain NN O
did VBD O
not RB O
show VB O
distinct JJ O
effects NNS O
on IN O
the DT O
brain NN O
Hg NNP O
concentration NN O
at IN O
PND10 NNP O
. . O

The DT O
significantly RB O
lower JJR O
brain NN O
Hg NN O
concentration NN O
in IN O
MT NNP O
- HYPH O
null JJ O
mice NN B-Species
compared VBN O
with IN O
corresponding VBG O
wild JJ O
- HYPH O
type NN O
mice NNS B-Species
at IN O
13 CD O
weeks NNS O
of IN O
age NN O
indicated VBD O
that IN O
MT NNP O
- HYPH O
I PRP O
, , O
II NNP O
might MD O
play VB O
a DT O
significant JJ O
role NN O
in IN O
the DT O
retention NN O
of IN O
Hg NNP O
( , O
or CC O
MeHg NNP O
) -RRB- O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
the DT O
results NNS O
of IN O
studies NNS O
of IN O
metallic JJ O
Hg NNP O
exposure NN O
( , O
Yoshida NNP O
et FW O
al NNP O
. . O
2004 CD O
, , O
2005 CD O
) -RRB- O
; , O
a DT O
lower JJR O
brain NN O
Hg NN O
concentration NN O
may MD O
not RB O
guarantee VB O
lower JJR O
toxicity NN O
, , O
supporting VBG O
the DT O
protective JJ O
role NN O
of IN O
the DT O
protein NN O
. . O

Earlier JJR O
studies NNS O
suggest VBP O
that IN O
brain NN O
MT NNP O
- HYPH O
I NNP O
, , O
II NNP O
has VBZ O
an DT O
important JJ O
role NN O
both CC O
in IN O
the DT O
response NN O
to IN O
oxidative JJ O
injury NN O
( , O
Potter NNP O
et FW O
al NNP O
. . O
2007 CD O
) -RRB- O
and CC O
in IN O
the DT O
process NN O
of IN O
aging NN O
( , O
Kojima NNP O
et FW O
al NNP O
. . O
1999 CD O
) -RRB- O
. . O

Therefore RB O
, , O
the DT O
lack NN O
of IN O
MT NNP O
can MD O
exaggerate VB O
the DT O
toxicity NN O
of IN O
MeHg NNP O
by IN O
enhancing VBG O
the DT O
initial JJ O
effects NNS O
due IN O
to IN O
oxygen NN O
radicals NNS O
and CC O
/ SYM O
or CC O
by IN O
accelerating VBG O
functional JJ O
aging NN O
. . O

Apart RB O
from IN O
this DT O
, , O
an DT O
intriguing JJ O
possibility NN O
is VBZ O
that IN O
the DT O
brain NN O
- HYPH O
specific JJ O
isoform NN O
, , O
MT NNP O
- HYPH O
III NNP O
, , O
might MD O
contribute VB O
to IN O
the DT O
results NNS O
we PRP O
obtained VBD O
because IN O
the DT O
expression NN O
of IN O
MT NNP O
- HYPH O
III NNP O
, , O
together RB O
with IN O
MT NNP O
- HYPH O
I NNP O
, , O
is VBZ O
increased VBN O
in IN O
the DT O
brain NN O
of IN O
old JJ O
rats NNS B-Species
, , O
resulting VBG O
in IN O
the DT O
low JJ O
availability NN O
of IN O
free JJ O
zinc NN O
for IN O
synapses NNS O
( , O
Mocchegiani NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

The DT O
age NN O
- HYPH O
dependent JJ O
expressions NNS O
of IN O
MT NNP O
isoforms NNS O
might MD O
be VB O
modified VBN O
in IN O
MT NNP O
- HYPH O
null NNP O
mice NNS B-Species
. . O

Results NNS O
of IN O
the DT O
present JJ O
study NN O
might MD O
allow VB O
the DT O
possibility NN O
of IN O
alternative JJ O
interpretations NNS O
due IN O
to IN O
some DT O
potentially RB O
confounding JJ O
factors NNS O
. . O

For IN O
example NN O
, , O
except IN O
for IN O
the DT O
wild JJ O
- HYPH O
type NN O
females NNS O
, , O
we PRP O
observed VBD O
significant JJ O
differences NNS O
in IN O
body NN O
weight NN O
between IN O
MeHg NNP O
- HYPH O
exposed VBN O
and CC O
non RB O
- HYPH O
exposed VBN O
groups NNS O
. . O

Because IN O
these DT O
differences NNS O
only RB O
became VBD O
clear JJ O
later RB O
in IN O
life NN O
, , O
they PRP O
might MD O
be VB O
associated VBN O
with IN O
the DT O
toxicity NN O
that WDT O
also RB O
emerged VBD O
later RB O
in IN O
life NN O
. . O

Manipulation NN O
of IN O
body NN O
weight NN O
in IN O
rodents NNS O
alters VBZ O
activity NN O
levels NNS O
, , O
although IN O
the DT O
reported VBN O
results NNS O
are VBP O
not RB O
always RB O
consistent JJ O
with IN O
each DT O
other JJ O
( , O
Harrison NNP O
and CC O
Archer NNP O
1987 CD O
; : O
Samuelsson NNP O
et FW O
al NNP O
. . O
2008 CD O
) -RRB- O
. . O

Also RB O
, , O
the DT O
differential JJ O
performance NN O
in IN O
PA NNP O
could MD O
be VB O
related VBN O
with IN O
the DT O
potential JJ O
effects NNS O
of IN O
MeHg NNP O
on IN O
( : O
electric JJ O
) -RRB- O
shock NN O
sensitivity NN O
, , O
which WDT O
we PRP O
did VBD O
not RB O
examine VB O
. . O

At RB O
least RBS O
one CD O
high JJ O
- HYPH O
dose NN O
study NN O
with IN O
adult NN O
rats NNS B-Species
showed VBD O
reduced VBN O
electric JJ O
sensitivity NN O
due IN O
to IN O
mercury NN O
exposure NN O
( , O
Wu NNP O
et FW O
al NNP O
. . O
1985 CD O
) -RRB- O
. . O

These DT O
possibilities NNS O
need VBP O
to TO O
be VB O
addressed VBN O
in IN O
future JJ O
studies NNS O
. . O

To TO O
summarize VB O
, , O
the DT O
present JJ O
results NNS O
suggest VBP O
that IN O
an DT O
initial JJ O
( , O
or CC O
triggering NN O
) , O
toxicologic JJ O
event NN O
occurs VBZ O
before IN O
the DT O
brain NN O
Hg NN O
concentration NN O
stabilizes VBZ O
and CC O
that IN O
the DT O
nature NN O
of IN O
this DT O
event NN O
should MD O
be VB O
either CC O
an DT O
acceleration NN O
of IN O
the DT O
aging VBG O
process NN O
or CC O
interaction NN O
with IN O
the DT O
aging NN O
process NN O
. . O

Thus RB O
, , O
by IN O
identifying VBG O
the DT O
physiologic JJ O
events NNS O
associated VBN O
with IN O
the DT O
functional JJ O
aging NN O
of IN O
the DT O
examined VBN O
behavioral JJ O
tasks NNS O
, , O
the DT O
fundamental JJ O
toxicologic JJ O
scar NN O
might MD O
be VB O
revealed VBN O
. . O

A DT O
Novel JJ O
Role NN O
of IN O
the DT O
NRF2 NN O
Transcription NN O
Factor NN O
in IN O
the DT O
Regulation NN O
of IN O
Arsenite NN O
- HYPH O
Mediated VBN O
Keratin NN O
16 CD O
Gene NN O
Expression NN O
in IN O
Human JJ B-Species
Keratinocytes NNS O

Abstract JJ O

Background NN O

Inorganic JJ O
sodium NN O
arsenite NN O
( : O
iAs NN O
) -RRB- O
is VBZ O
a DT O
ubiquitous JJ O
environmental JJ O
contaminant NN O
and CC O
is VBZ O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
skin NN O
hyperkeratosis NN O
and CC O
cancer NN O
. . O

Objectives NNS O

We PRP O
investigated VBD O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
the DT O
regulation NN O
of IN O
the DT O
keratin NN O
16 CD O
( , O
K16 CD O
) -RRB- O
gene NN O
by IN O
iAs NNP O
in IN O
the DT O
human JJ B-Species
keratinocyte NN O
cell NN O
line NN O
HaCaT NNP O
. . O

Methods NNS O

We PRP O
performed VBD O
reverse JJ O
transcriptase NN O
polymerase NN O
chain NN O
reaction NN O
, , O
luciferase NN O
assays NNS O
, , O
Western JJ O
blots NNS O
, , O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
to TO O
determine VB O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
K16 CD O
gene NN O
by IN O
iAs NNP O
. . O

We PRP O
used VBD O
gene NN O
overexpression NN O
approaches NNS O
to TO O
elucidate VB O
the DT O
nuclear JJ O
factor NN O
erythroid NN O
- HYPH O
derived VBN O
2 CD O
related VBN O
factor NN O
2 CD O
( HYPH O
NRF2 NNP O
) -RRB- O
involved VBN O
in IN O
the DT O
K16 CD O
induction NN O
. . O

Results NNS O

iAs NNS O
induced VBD O
the DT O
mRNA NN O
and CC O
protein NN O
expression NN O
of IN O
K16 CD O
. . O

We PRP O
also RB O
found VBD O
that IN O
the DT O
expression NN O
of IN O
K16 NNP O
was VBD O
transcriptionally RB O
induced VBN O
by IN O
iAs NNS O
through IN O
activator NN O
protein NN O
- HYPH O
1 CD O
- HYPH O
like JJ O
sites NNS O
and CC O
an DT O
antioxidant JJ O
response NN O
element NN O
( -LRB- O
ARE NN O
) -RRB- O
in IN O
its PRP$ O
gene NN O
promoter NN O
region NN O
. . O

Treatment NN O
with IN O
iAs NNP O
also RB O
enhanced VBD O
the DT O
production NN O
and CC O
translocation NN O
of IN O
the DT O
NRF2 NNP O
transcription NN O
factor NN O
, , O
an DT O
ARE NNP O
- HYPH O
binding VBG O
protein NN O
, , O
into IN O
the DT O
nucleus NN O
without IN O
modification NN O
of IN O
its PRP$ O
mRNA NNP O
expression NN O
. . O

In IN O
addition NN O
, , O
iAs NNP O
elongated VBD O
the DT O
half JJ O
- HYPH O
life NN O
of IN O
the DT O
NRF2 NNP O
protein NN O
. . O

When WRB O
overexpressed VBN O
in IN O
HaCaT NNP O
cells NNS O
, , O
NRF2 NNP O
was VBD O
also RB O
directly RB O
involved VBN O
in IN O
not RB O
only RB O
the DT O
up JJ O
- HYPH O
regulation NN O
of IN O
the DT O
detoxification NN O
gene NN O
thioredoxin NN O
but CC O
also RB O
K16 CD O
gene NN O
expression NN O
. . O

Conclusions NNS O

Our PRP$ O
data NNS O
clearly RB O
indicate VBP O
that IN O
the DT O
K16 NNP O
gene NN O
is VBZ O
a DT O
novel JJ O
target NN O
of IN O
NRF2 NNP O
. . O

Furthermore RB O
, , O
our PRP$ O
findings NNS O
also RB O
suggest VBP O
that IN O
NRF2 NNP O
has VBZ O
opposing VBG O
roles NNS O
in IN O
the DT O
cell NN O
- HYPH O
- : O
in IN O
the DT O
activation NN O
of IN O
detoxification NN O
pathways NNS O
and CC O
in IN O
promoting VBG O
the DT O
development NN O
of IN O
skin NN O
disorders NNS O
. . O

Inorganic JJ O
sodium NN O
arsenite NN O
( : O
iAs NN O
) -RRB- O
, , O
a DT O
ubiquitous JJ O
element NN O
, , O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
toxic JJ O
metals NNS O
present JJ O
in IN O
the DT O
natural JJ O
environment NN O
( , O
Bagla NNP O
and CC O
Kaiser NNP O
1996 CD O
) -RRB- O
. . O

Arsenicals NNS O
are VBP O
found VBN O
as IN O
naturally RB O
occurring VBG O
constituents NNS O
of IN O
soil NN O
, , O
food NN O
, , O
and CC O
drinking NN O
water NN O
( , O
Wu NNP O
et FW O
al NNP O
. . O
1989 CD O
; : O
Yoshida NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
, , O
and CC O
exposure NN O
to IN O
iAs NNP O
has VBZ O
been VBN O
associated VBN O
with IN O
a DT O
variety NN O
of IN O
disease NN O
outcomes NNS O
, , O
including VBG O
disorders NNS O
of IN O
the DT O
skin NN O
, , O
urinary JJ O
bladder NN O
, , O
liver NN O
, , O
and CC O
lung NN O
( , O
Tchounwou NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

In IN O
particular JJ O
, , O
skin NN O
hyperkeratosis NN O
is VBZ O
a DT O
characteristic JJ O
dermatologic JJ O
lesion NN O
associated VBN O
with IN O
ingestion NN O
of IN O
arsenic NN O
from IN O
contaminated JJ O
groundwater NN O
( , O
McLellan NNP O
2002 CD O
; : O
Yoshida NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

There EX O
is VBZ O
also RB O
a DT O
significant JJ O
association NN O
between IN O
hyperkeratosis NN O
, , O
nonmelanoma NN O
skin NN O
cancer NN O
( , O
e LS O
. . O
g NN O
. . O
, , O
basal JJ O
cell NN O
carcinoma NN O
and CC O
squamous JJ O
cell NN O
carcinoma NN O
) -RRB- O
, , O
and CC O
Bowen NNP O
disease NN O
( , O
Col NNP O
et NN O
al NNP O
. . O
1999 CD O
; : O
Rossman NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
the DT O
pathologic JJ O
features NNS O
associated VBN O
with IN O
arsenic NN O
- HYPH O
induced VBN O
hyperkeratosis NN O
present JJ O
as IN O
typical JJ O
acanthotic JJ O
types NNS O
of IN O
psoriasis NN O
- : O
like IN O
keratosis NN O
, , O
characterized VBN O
by IN O
the DT O
aberrant JJ O
proliferation NN O
and CC O
terminal JJ O
differentiation NN O
of IN O
epidermal JJ O
keratinocytes NNS O
( , O
Lee NNP O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
. . O

Many JJ O
epidemiologic JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
hyperkeratoses NNS O
are VBP O
the DT O
most RBS O
frequent JJ O
precursor NN O
lesions NNS O
of IN O
some DT O
skin NN O
cancers NNS O
( -LRB- O
Bagla NNP O
and CC O
Kaiser NNP O
1996 CD O
; : O
Col NNP O
et FW O
al NNP O
. . O
1999 CD O
) -RRB- O
. . O

The DT O
keratins NNS O
are VBP O
the DT O
most RBS O
prominent JJ O
cytoskeletal JJ O
proteins NNS O
in IN O
keratinocytes NNS O
and CC O
comprise VBP O
a DT O
large JJ O
family NN O
of IN O
proteins NNS O
that WDT O
form VBP O
intermediate JJ O
filament NN O
networks NNS O
in IN O
all DT O
epithelial JJ O
cell NN O
types NNS O
( , O
Moll NNP O
et FW O
al NNP O
. . O
1982 CD O
) -RRB- O
. . O

Keratin NNP O
16 CD O
( SYM O
K16 CD O
) -RRB- O
and CC O
keratin NN O
6 CD O
( SYM O
K6 CD O
) -RRB- O
genes NNS O
are VBP O
constitutively RB O
expressed VBN O
in IN O
a DT O
number NN O
of IN O
stratified VBN O
epithelial JJ O
levels NNS O
, , O
including VBG O
the DT O
palmar NN O
and CC O
plantar NN O
epidermis NN O
( , O
Moll NNP O
et FW O
al NNP O
. . O
1982 CD O
) -RRB- O
. . O

In IN O
skin NN O
diseases NNS O
characterized VBN O
by IN O
aberrant JJ O
proliferation NN O
and CC O
differentiation NN O
, , O
such JJ O
as IN O
psoriasis NN O
and CC O
cancer NN O
, , O
K16 CD O
is VBZ O
detectable JJ O
at IN O
higher JJR O
levels NNS O
compared VBN O
with IN O
normal JJ O
tissue NN O
( , O
Haider NNP O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
the DT O
tissue NN O
- HYPH O
specific JJ O
overexpression NN O
of IN O
wild JJ O
- HYPH O
type NN O
K16 CD O
in IN O
the DT O
epidermis NN O
of IN O
transgenic JJ O
mice NN B-Species
results VBZ O
in IN O
the DT O
hyperproliferation NN O
of IN O
keratinocytes NNS O
and CC O
aberrant JJ O
keratinization NN O
of IN O
cornified VBN O
layers NNS O
, , O
leading VBG O
to IN O
hyperkeratosis NN O
of IN O
the DT O
skin NN O
( , O
Takahashi NNP O
et FW O
al NNP O
. . O
1994 CD O
) -RRB- O
. . O

Nuclear JJ O
factor NN O
erythoid NN O
- HYPH O
derived VBN O
2 CD O
related VBN O
factor NN O
2 CD O
( SYM O
NRF2 NNP O
) -RRB- O
, , O
a DT O
"""" `` O
cap NN O
' '' O
n NN O
' '' O
collar NN O
"""" '' O
basic JJ O
leucine NN O
zipper NN O
transcription NN O
factor NN O
, , O
regulates VBZ O
a DT O
transcriptional JJ O
program NN O
that WDT O
maintains VBZ O
cellular JJ O
redox NN O
homeostasis NN O
and CC O
protects VBZ O
cells NNS O
from IN O
oxidative JJ O
stress NN O
and CC O
xenobiotic JJ O
agents NNS O
( , O
Ishii NNP O
et FW O
al NNP O
. . O
2000 CD O
; : O
Moi NNP O
et FW O
al NNP O
. . O
1994 CD O
) -RRB- O
. . O

Several JJ O
detoxifying JJ O
and CC O
antioxidant JJ O
genes NNS O
, , O
including VBG O
glutathione NN O
- HYPH O
S NN O
- HYPH O
transferases NNS O
( -LRB- O
GSTs NNP O
) -RRB- O
, , O
heme NN O
oxygenase NN O
- HYPH O
1 CD O
( , O
HMOX1 NNP O
) -RRB- O
, , O
and CC O
thioredoxin NN O
( , O
TXN NNP O
) -RRB- O
, , O
are VBP O
regulated VBN O
by IN O
NRF2 NNP O
through IN O
the DT O
antioxidant JJ O
responsive JJ O
element NN O
( -LRB- O
ARE NN O
) -RRB- O
in IN O
the DT O
respective JJ O
promoter JJ O
regions NNS O
of IN O
these DT O
genes NNS O
( , O
McMahon NNP O
et FW O
al NNP O
. . O
2001 CD O
; : O
Wakabayashi NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

NRF2 NNP O
is VBZ O
held VBN O
in IN O
the DT O
cytoplasm NN O
by IN O
a DT O
cytoskeletal NN O
- HYPH O
associated VBN O
specific JJ O
inhibitory JJ O
protein NN O
( , O
kelch NN O
- HYPH O
like JJ O
ECH NNP O
- HYPH O
associated VBN O
protein NN O
1 CD O
; , O
KEAP1 NNP O
) -RRB- O
under IN O
normal JJ O
cellular JJ O
redox NN O
state NN O
conditions NNS O
, , O
where WRB O
it PRP O
is VBZ O
continuously RB O
targeted VBN O
by IN O
the DT O
proteasomal JJ O
degradation NN O
pathway NN O
( , O
McMahon NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
. . O

Upon IN O
exposure NN O
of IN O
the DT O
cell NN O
to IN O
oxidative JJ O
stress NN O
or CC O
electrophiles NNS O
, , O
NRF2 NNP O
can MD O
escape VB O
this DT O
KEAP1 NNP O
- HYPH O
mediated VBN O
repression NN O
, , O
translocate VB O
to IN O
the DT O
nucleus NN O
, , O
and CC O
activate VB O
the DT O
expression NN O
of IN O
its PRP$ O
target NN O
genes NNS O
( , O
Dinkova NNP O
- HYPH O
Kostova NNP O
et FW O
al NNP O
. . O
2002 CD O
; : O
McMahon NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
. . O

Recently RB O
, , O
studies NNS O
of IN O
Keap1 NNP O
- HYPH O
/ SYM O
- HYPH O
mice NNS B-Species
have VBP O
shown VBN O
that IN O
NRF2 NNP O
accumulates VBZ O
in IN O
the DT O
nucleus NN O
and CC O
constitutively RB O
activates VBZ O
the DT O
transcription NN O
of IN O
its PRP$ O
target NN O
genes NNS O
, , O
even RB O
in IN O
the DT O
absence NN O
of IN O
stress NN O
signals NNS O
( , O
Wakabayashi NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
. . O

Most RBS O
interestingly RB O
, , O
however RB O
, , O
the DT O
skin NN O
, , O
esophagus NN O
, , O
and CC O
forestomach NN O
of IN O
Keap1 NNP O
- HYPH O
deficient JJ O
mice NN B-Species
show VBP O
cornified JJ O
layer NN O
and CC O
hyperkeratosis NN O
phenotypes NNS O
. . O

In IN O
addition NN O
, , O
previous JJ O
studies NNS O
have VBP O
also RB O
shown VBN O
that IN O
the DT O
expression NN O
of IN O
NRF2 NNP O
and CC O
ARE NN O
- HYPH O
controlled VBN O
genes NNS O
is VBZ O
induced VBN O
by IN O
iAs NNS O
in IN O
some DT O
cell NN O
types NNS O
( , O
Pi NN O
et NN O
al NNP O
. . O
2003 CD O
; : O
Sakurai NNP O
et FW O
al NNP O
. . O
2005 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
histochemical JJ O
analyses NNS O
have VBP O
indicated VBN O
that IN O
the DT O
expression NN O
of IN O
K16 CD O
is VBZ O
increased VBN O
in IN O
Bowen NNP O
disease NN O
, , O
basal JJ O
cell NN O
carcinoma NN O
, , O
and CC O
squamous JJ O
cell NN O
carcinoma NN O
induced VBN O
by IN O
arsenicals NNS O
( , O
Yu NNP O
et FW O
al NNP O
. . O
1993 CD O
) -RRB- O
. . O

However RB O
, , O
it PRP O
remains VBZ O
to TO O
be VB O
determined VBN O
whether IN O
NRF2 NNP O
can MD O
regulate VB O
the DT O
transcriptional JJ O
activation NN O
of IN O
K16 CD O
upon IN O
iAs NNP O
exposure NN O
in IN O
human JJ B-Species
keratinocytes NNS O
. . O

Hence RB O
, , O
these DT O
findings NNS O
prompted VBD O
us PRP O
to TO O
investigate VB O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
the DT O
regulation NN O
of IN O
the DT O
K16 NNP O
gene NN O
by IN O
iAs NNP O
- HYPH O
induced VBN O
NRF2 NNP O
mediation NN O
. . O

Materials NNS O
and CC O
Methods NNS O

Chemicals NNS O
and CC O
reagents NNS O

A DT O
purified JJ O
preparation NN O
of IN O
inorganic JJ O
sodium NN O
arsenite NN O
( , O
iAs NNS O
; : O
NaAsO2 NNP O
; : O
Merck NNP O
, , O
Darmstadt NNP O
, , O
Germany NNP O
) -RRB- O
was VBD O
dissolved VBN O
in IN O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
( , O
PBS NNP O
) -RRB- O
and CC O
added VBD O
directly RB O
to IN O
the DT O
culture NN O
medium NN O
. . O

A DT O
fresh JJ O
iAs NNP O
solution NN O
was VBD O
prepared VBN O
for IN O
each DT O
new JJ O
experiment NN O
. . O

Cycloheximide NN O
( , O
CHX NNP O
) -RRB- O
, , O
dimethyl NN O
- HYPH O
sulfoxide NN O
( , O
DMSO NNP O
) -RRB- O
, , O
and CC O
a DT O
protease NN O
inhibitor NN O
cocktail NN O
were VBD O
purchased VBN O
from IN O
Sigma NNP O
( : O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
, , O
USA NNP O
) -RRB- O
. . O

CHX NNP O
was VBD O
dissolved VBN O
in IN O
DMSO NNP O
and CC O
stored VBN O
- SYM O
20 CD O
degrees NNS O
C NN O
until IN O
use NN O
. . O

Cells NNS O
and CC O
culture NN O
conditions NNS O

The DT O
human JJ B-Species
keratinocyte NN O
HaCaT NNP O
cell NN O
line NN O
was VBD O
obtained VBN O
from IN O
N NNP O
. . O
E NNP O
. . O

Fusenig NNP O
( : O
German NNP O
Cancer NNP O
Research NNP O
Center NNP O
, , O
Heidelberg NNP O
, , O
Germany NNP O
) -RRB- O
. . O

Cells NNS O
were VBD O
maintained VBN O
in IN O
monolayer NN O
cultures NNS O
in IN O
95 CD O
% NN O
air NN O
and CC O
5 CD O
% NN O
CO2 NN O
at IN O
37 CD O
degrees NNS O
C NN O
in IN O
Dulbecco NNP O
' POS O
s NNS O
modified VBN O
Eagles NNP O
medium NN O
( , O
DMEM NNP O
) , O
supplemented VBN O
with IN O
10 CD O
% NN O
fetal JJ O
bovine JJ O
serum NN O
( , O
FBS NNP O
) -RRB- O
, , O
50 CD O
U NN O
/ SYM O
mL NN O
penicillin NN O
and CC O
50 CD O
mg NN O
/ SYM O
mL NN O
streptomycin NN O
and CC O
nonessential JJ O
amino NN O
acids NNS O
( , O
Gibco NNP O
BRL NNP O
, , O
Paisley NNP O
, , O
UK NNP O
) -RRB- O
. . O

RNA NNP O
preparation NN O
and CC O
semiquantitative JJ O
reverse JJ O
transcriptase NN O
- HYPH O
polymerase NN O
chain NN O
reaction NN O
( , O
RT NNP O
- HYPH O
PCR NN O
) -RRB- O
analysis NN O

We PRP O
determined VBD O
RNA NNP O
expression NN O
levels NNS O
by IN O
semiquantitative JJ O
RT NNP O
- HYPH O
PCR NN O
analysis NN O
as IN O
described VBN O
previously RB O
( , O
Sugioka NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

Total JJ O
RNA NNP O
was VBD O
isolated VBN O
from IN O
HaCaT NNP O
cells NNS O
using VBG O
the DT O
GeneElute NNP O
Mammalian NNP O
Total NNP O
RNA NNP O
Kit NNP O
( -LRB- O
Sigma NNP O
) -RRB- O
. . O

The DT O
specific JJ O
primers NNS O
used VBN O
for IN O
first JJ O
- HYPH O
strand NN O
cDNA NN O
synthesis NN O
and CC O
PCR NN O
were VBD O
as IN O
follows VBZ O
: : O
K16 CD O
[ -LRB- O
forward JJ O
, , O
5 CD O
' '' O
- HYPH O
GAT NNP O
GCT NNP O
TGC NNP O
TCT NNP O
GAG NNP O
AGG NNP O
TC NNP O
- HYPH O
3 CD O
' '' O
, , O
and CC O
reverse VB O
, , O
5 CD O
' '' O
- HYPH O
CCA NN O
GCA NNP O
AGA NNP O
TCT NNP O
GGT NNP O
ACT NNP O
CC NNP O
- HYPH O
3 CD O
' '' O
; : O
Gene NNP O
Bank NNP O
accession NN O
no UH O
. , O
NM NN O
_ : O
5557 CD O
( : O
National NNP O
Center NNP O
for IN O
Biotechnology NNP O
Information NNP O
2007 CD O
) -RRB- O
] -RRB- O
; : O
c LS O
- HYPH O
Jun NNP O
( : O
forward JJ O
, , O
5 CD O
' '' O
- : O
CCT NNP O
GTT NNP O
GCG NNP O
GCC NNP O
CCG NNP O
AAA NNP O
CT NNP O
- HYPH O
3 CD O
' '' O
, , O
and CC O
reverse VB O
, , O
5 CD O
' '' O
- HYPH O
ACC NNP O
ATG NNP O
CCT NNP O
GCC NNP O
CCG NNP O
TTG NNP O
AC NNP O
- HYPH O
3 CD O
' '' O
; : O
NM NNP O
_ : O
2228 CD O
) -RRB- O
; : O
c NNP O
- HYPH O
Fos NNP O
( : O
forward RB O
, , O
5 CD O
' '' O
- HYPH O
TTT NNP O
GCC NNP O
TAA NNP O
CCG NNP O
CCA NNP O
CGA NNP O
TGA NNP O
T NNP O
- HYPH O
3 CD O
' '' O
, , O
and CC O
reverse VB O
, , O
5 CD O
' '' O
- HYPH O
TTG NNP O
CCG NNP O
CTT NNP O
TCT NNP O
GCC NNP O
ACC NNP O
TC NNP O
- HYPH O
3 CD O
' '' O
; : O
NM NNP O
_ : O
5252 CD O
) -RRB- O
; : O
NRF2 NNP O
( , O
forward JJ O
, , O
5 CD O
' '' O
- HYPH O
AGA NNP O
TTC NNP O
ACA NNP O
GGC NNP O
CTT NNP O
TCT NNP O
CG NNP O
- HYPH O
3 CD O
' '' O
, , O
and CC O
reverse VB O
, , O
5 CD O
' '' O
- HYPH O
CAG NNP O
CTC NNP O
TCC NNP O
CTA NNP O
CCG NNP O
TTG NNP O
GA NNP O
- HYPH O
3 CD O
' '' O
; : O
AF323119 NNP O
) -RRB- O
; : O
KEAP1 NNP O
( , O
forward JJ O
, , O
5 CD O
' '' O
- HYPH O
CAG NN O
AGG NN O
TGG NN O
TGG NNP O
TGT NNP O
TGC NNP O
TTA NNP O
T NNP O
- HYPH O
3 CD O
' '' O
, , O
and CC O
reverse VB O
, , O
5 CD O
' '' O
- HYPH O
AGC NNP O
TCG NNP O
TTC NNP O
ATG NNP O
ATG NNP O
CCA NNP O
AAG NNP O
- HYPH O
3 CD O
' '' O
; : O
NM NNP O
_ : O
12289 CD O
) -RRB- O
; : O
TXN NNP O
( : O
forward JJ O
, , O
5 CD O
' '' O
- HYPH O
CAG NN O
GGG NN O
AAT NNP O
GAA NNP O
AGA NNP O
AAG NNP O
G NNP O
- HYPH O
3 CD O
' '' O
, , O
and CC O
reverse VB O
, , O
5 CD O
' '' O
- HYPH O
CAA NN O
GGT NNP O
GAA NNP O
GCA NNP O
GAT NNP O
CG NNP O
- HYPH O
3 CD O
' '' O
; : O
NM NNP O
_ : O
3329 CD O
) -RRB- O
, , O
and CC O
glyceraldehyde NN O
3 CD O
- HYPH O
phosphate NN O
dehydrogenase NN O
( -LRB- O
GAPDH NNP O
) -RRB- O
as IN O
a DT O
loading NN O
control NN O
( , O
forward JJ O
, , O
5 CD O
' '' O
- HYPH O
ACC NNP O
ACA NNP O
GTC NNP O
CAT NNP O
GCC NNP O
ATC NNP O
AC NNP O
- HYPH O
3 CD O
' '' O
, , O
and CC O
reverse VB O
, , O
5 CD O
' '' O
- HYPH O
TCC NNP O
ACC NNP O
ACC NNP O
CTG NNP O
TTG NNP O
CTG NNP O
TA NNP O
- HYPH O
3 CD O
' '' O
, , O
NM NNP O
_ : O
2046 CD O
) -RRB- O
. . O

PCR NN O
products NNS O
were VBD O
separated VBN O
on IN O
a DT O
1 CD O
. . O
8 CD O
% NN O
agarose NN O
gel NN O
and CC O
stained VBN O
with IN O
ethidium NN O
bromide NN O
. . O

Western JJ O
blot NN O
analysis NN O

We PRP O
performed VBD O
Western JJ O
blot NN O
analysis NN O
as IN O
described VBN O
previously RB O
( , O
Sugioka NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

Briefly RB O
, , O
nuclear JJ O
and CC O
cytoplasmic JJ O
proteins NNS O
were VBD O
extracted VBN O
using VBG O
the DT O
NE NNP O
- HYPH O
PER NNP O
nuclear JJ O
and CC O
cytoplasmic JJ O
extraction NN O
kit NN O
( , O
Pierce NNP O
, , O
Rockford NNP O
, , O
IL NNP O
, , O
USA NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

For IN O
protein NN O
extraction NN O
, , O
the DT O
cells NNS O
were VBD O
lysed VBN O
in IN O
a DT O
buffer NN O
containing VBG O
complete JJ O
protease NN O
inhibitor NN O
cocktail NN O
. . O

We PRP O
measured VBD O
protein NN O
concentrations NNS O
using VBG O
the DT O
DC NNP O
Protein NNP O
Assay NNP O
Kit NNP O
( -LRB- O
Bio NNP O
- HYPH O
Rad NNP O
, , O
Richmond NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Equal JJ O
amounts NNS O
of IN O
protein NN O
were VBD O
then RB O
resolved VBN O
by IN O
sodium NN O
dodecyl NN O
sulfate NN O
- HYPH O
polyacrylamide NN O
gel NN O
electrophoresis NN O
( -LRB- O
SDS NNP O
- HYPH O
PAGE NNP O
) -RRB- O
and CC O
transferred VBN O
to IN O
a DT O
polyvinylidene NN O
fluoride NN O
membrane NN O
( , O
Amersham NNP O
Biosciences NNPS O
, , O
Bucks NNPS O
, , O
UK NNP O
) -RRB- O
. . O

Immunoblotting NN O
was VBD O
carried VBN O
out RP O
with IN O
specific JJ O
antibodies NNS O
in IN O
Tris NNP O
- HYPH O
buffered VBN O
saline NN O
with IN O
0 CD O
. . O
5 CD O
% NN O
Tween NN O
20 CD O
. . O

The DT O
primary JJ O
antibodies NNS O
were VBD O
as IN O
follows VBZ O
: : O
K16 CD O
( , O
Neomarkers NNPS O
, , O
Fremont NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
, , O
NRF2 NNP O
and CC O
KEAP1 NNP O
( , O
Santa NNP O
Cruz NNP O
Biotechnology NNP O
, , O
Santa NNP O
Cruz NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
, , O
c NN O
- HYPH O
Jun NNP O
( , O
Cell NNP O
Signaling NNP O
, , O
Beverly NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
, , O
and CC O
beta NN O
- HYPH O
actin NN O
( : O
Sigma NNP O
) -RRB- O
. . O

After IN O
washing VBG O
, , O
the DT O
membranes NNS O
were VBD O
probed VBN O
with IN O
horseradish JJ B-Species
peroxidase NN O
- HYPH O
conjugated VBN O
secondary JJ O
antibodies NNS O
and CC O
developed VBN O
by IN O
chemiluminescence NN O
using VBG O
the DT O
ECL NNP O
Plus NNP O
Detection NNP O
Kit NNP O
( : O
Amersham NNP O
Biosciences NNP O
) -RRB- O
. . O

Plasmids NNS O
, , O
transfections NNS O
, , O
and CC O
luciferase NN O
assays NNS O

Human NNP B-Species
K16 NNP O
promoter NN O
regions NNS O
of IN O
varying VBG O
lengths NNS O
( , O
pXK NN O
- HYPH O
1 CD O
, , O
3 CD O
, , O
4 CD O
, , O
5 CD O
- HYPH O
1 CD O
, , O
and CC O
5 CD O
- SYM O
2 CD O
) -RRB- O
were VBD O
provided VBN O
by IN O
Y NNP O
- HYPH O
N NNP O
Wang NNP O
( , O
National NNP O
Cheng NNP O
Kung NNP O
University NNP O
, , O
Taiwan NNP O
) -RRB- O
. . O

These DT O
DNA NN O
fragments NNS O
were VBD O
prepared VBN O
from IN O
HaCaT NNP O
cells NNS O
and CC O
were VBD O
ligated VBN O
into IN O
the DT O
pXP NNP O
- HYPH O
1 CD O
luciferase NN O
vector NN O
( , O
Wang NNP O
and CC O
Chang NNP O
2003 CD O
) -RRB- O
. . O

The DT O
p3xARE NNP O
/ SYM O
Luc NNP O
vector NN O
, , O
harboring VBG O
three CD O
tandem NN O
repeats NNS O
of IN O
ARE NNP O
, , O
was VBD O
donated VBN O
by IN O
X NNP O
. . O
L NNP O
. . O

Chen NNP O
( : O
Discovery NNP O
Research NNP O
, , O
AtheroGenics NNP O
Inc NNP O
. . O
, , O
Alpharetta NNP O
, , O
GA NNP O
, , O
USA NNP O
) -RRB- O
( , O
Chen NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
. . O

The DT O
wild JJ O
- HYPH O
type NN O
NRF2 NNP O
expression NN O
vector NN O
( , O
WT NNP O
- HYPH O
NRF2 NNP O
) -RRB- O
was VBD O
a DT O
gift NN O
from IN O
H NNP O
. . O
S NNP O
. . O

So RB O
( , O
Wonkwang NNP O
University NNP O
School NNP O
of IN O
Medicine NNP O
, , O
Korea NNP O
) -RRB- O
( , O
So RB O
et FW O
al NNP O
. . O
2006 CD O
) -RRB- O
. . O

NRF2 NNP O
cDNA NNP O
was VBD O
subcloned VBN O
into IN O
a DT O
pcDNA3 NN O
. . O
1 CD O
( SYM O
+ NFP O
) NFP O
vector NN O
( , O
Invitrogen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

For IN O
the DT O
transfection NN O
of IN O
reporter NN O
plasmids NNS O
, , O
we PRP O
seeded VBD O
HaCaT NNP O
cells NNS O
into IN O
six CD O
- HYPH O
well NN O
plates NNS O
at IN O
a DT O
density NN O
of IN O
80 CD O
% NN O
the DT O
previous JJ O
day NN O
. . O

Cells NNS O
were VBD O
then RB O
transfected VBN O
with IN O
a DT O
total NN O
of IN O
each DT O
luciferase NN O
reporter NN O
construct NN O
( , O
2 CD O
. . O
5 CD O
mu NN O
g NN O
) -RRB- O
using VBG O
LipofectAMINE NNP O
plus CC O
( , O
Invitrogen NNP O
) -RRB- O
. . O

To TO O
control VB O
for IN O
the DT O
efficiency NN O
of IN O
transfection NN O
, , O
Renilla NNP O
luciferase NN O
gene NN O
expression NN O
was VBD O
monitored VBN O
using VBG O
either CC O
the DT O
pRL NNP O
- HYPH O
CMV NNP O
or CC O
pRL NNP O
- HYPH O
TK NNP O
vectors NNS O
( : O
Promega NNP O
, , O
Madison NNP O
, , O
WI NNP O
, , O
USA NNP O
) -RRB- O
. . O

For IN O
overexpression NN O
of IN O
WT NNP O
- HYPH O
NRF2 NNP O
, , O
we PRP O
normalized VBD O
the DT O
total JJ O
plasmid JJ O
concentration NN O
using VBG O
the DT O
pcDNA3 NN O
. . O
1 CD O
( SYM O
+ NFP O
) NFP O
empty JJ O
vector NN O
. . O

Thirty CD O
- HYPH O
six CD O
hours NNS O
after IN O
transfection NN O
, , O
the DT O
medium NN O
was VBD O
replaced VBN O
with IN O
fresh JJ O
medium NN O
containing VBG O
either CC O
vehicle NN O
( , O
PBS NNP O
) -RRB- O
or CC O
iAs NNP O
for IN O
6 CD O
hr NNS O
. . O

After IN O
iAs NNP O
exposure NN O
, , O
we PRP O
harvested VBD O
cells NNS O
and CC O
analyzed VBD O
them PRP O
for IN O
luciferase NN O
activity NN O
using VBG O
a DT O
Dual NNP O
- HYPH O
Luciferase NNP O
Reporter NNP O
Assay NNP O
System NNP O
( -LRB- O
Promega NNP O
) -RRB- O
. . O

For IN O
the DT O
investigation NN O
of IN O
the DT O
role NN O
of IN O
NRF2 NNP O
in IN O
regulating VBG O
K16 NNP O
gene NN O
expression NN O
, , O
transfection NN O
of IN O
an DT O
NRF2 NNP O
expression NN O
plasmid NN O
into IN O
HaCaT NNP O
cells NNS O
was VBD O
carried VBN O
out RP O
using VBG O
LipofectAMINE NNP O
2000 CD O
( , O
Invitrogen NNP O
) -RRB- O
. . O

Cells NNS O
were VBD O
cultured VBN O
in IN O
100 CD O
- HYPH O
mm NN O
plates NNS O
24 CD O
hr NNS O
before IN O
transfection NN O
. . O

The DT O
expression NN O
plasmid NN O
WT NNP O
- HYPH O
NRF2 NNP O
( , O
15 CD O
mu NN O
g VBZ O
) -RRB- O
was VBD O
then RB O
transfected VBN O
into IN O
the DT O
cells NNS O
for IN O
48 CD O
- SYM O
60 CD O
hr NN O
. . O

As IN O
a DT O
negative JJ O
control NN O
, , O
we PRP O
used VBD O
15 CD O
mu NN O
g NN O
of IN O
the DT O
pcDNA3 NN O
. . O
1 CD O
( SYM O
+ NFP O
) NFP O
empty JJ O
vector NN O
. . O

Electrophoretic JJ O
mobility NN O
- HYPH O
shift NN O
assays NNS O
( -LRB- O
EMSA NNP O
) -RRB- O

We PRP O
extracted VBD O
and CC O
measured VBD O
nuclear JJ O
proteins NNS O
as IN O
described VBN O
above RB O
. . O

Nuclear JJ O
protein NN O
/ SYM O
DNA NN O
complexes NNS O
were VBD O
subjected VBN O
to IN O
electrophoresis NN O
in IN O
nondenaturing VBG O
5 CD O
% NN O
polyacrylamide NN O
gels NNS O
containing VBG O
2 CD O
% NN O
glycerol NN O
in IN O
0 CD O
. . O
25 CD O
% NN O
Tris NNP O
- HYPH O
borate NN O
/ SYM O
EDTA NNP O
buffer NN O
and CC O
transferred VBN O
to IN O
Hybond NNP O
- HYPH O
N NNP O
+ CC O
nylon NN O
transfer NN O
membranes NNS O
( , O
Amersham NNP O
Biosciences NNP O
) -RRB- O
for IN O
detection NN O
using VBG O
the DT O
Light NNP O
- HYPH O
Shift NNP O
EMSA NNP O
kit NN O
( : O
Pierce NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
, , O
with IN O
minor JJ O
modifications NNS O
. . O

We PRP O
incubated VBD O
10 CD O
- HYPH O
mu NNS O
g VBP O
aliquots NNS O
of IN O
nuclear JJ O
extract NN O
with IN O
the DT O
DNA NN O
probe NN O
in IN O
a DT O
binding VBG O
reaction NN O
buffer NN O
containing VBG O
10 CD O
mM NN O
Tris NNP O
/ SYM O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
6 CD O
) -RRB- O
, , O
50 CD O
mM NN O
KCl NN O
, , O
0 CD O
. . O
5 CD O
mM NN O
dithiothreitol NN O
, , O
0 CD O
. . O
25 CD O
mM NN O
EDTA NNP O
, , O
5 CD O
% NN O
glycerol NN O
, , O
2 CD O
. . O
5 CD O
mM NN O
MgCl2 NN O
, , O
0 CD O
. . O
5 CD O
% NN O
NP NN O
- HYPH O
40 CD O
detergent NN O
, , O
and CC O
2 CD O
mu NNS O
g NN O
of IN O
poly NN O
( HYPH O
dI NN O
- HYPH O
dC NN O
) -RRB- O
. . O
poly NN O
( HYPH O
dI NN O
- HYPH O
dC NN O
) -RRB- O
for IN O
30 CD O
min NN O
at IN O
room NN O
temperature NN O
. . O

For IN O
supershift NN O
assays NNS O
, , O
2 CD O
mu NN O
g NN O
of IN O
either CC O
a DT O
polyclonal JJ O
anti AFX O
- HYPH O
NRF2 NN O
or CC O
an DT O
anti AFX O
- HYPH O
c NN O
- HYPH O
Jun NNP O
antibody NN O
( , O
Santa NNP O
Cruz NNP O
Biotechnology NNP O
) -RRB- O
was VBD O
added VBN O
with IN O
the DT O
nuclear JJ O
protein NN O
for IN O
2 CD O
hr NN O
at IN O
4 CD O
degrees NNS O
C NN O
before IN O
the DT O
labeled VBN O
oligonucleotide NN O
probe NN O
was VBD O
added VBN O
. . O

Biotin NN O
- HYPH O
labeled VBN O
, , O
double JJ O
- HYPH O
stranded JJ O
oligonucleotides NNS O
WT NNP O
- HYPH O
K16ARE NNP O
( : O
- HYPH O
157 CD O
/ SYM O
- HYPH O
132 CD O
, , O
5 CD O
' '' O
- HYPH O
GGGGAACCTGGAGTCAGCAG NNP O
- HYPH O
TAGGA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
, , O
containing VBG O
an DT O
ARE NNP O
site NN O
( : O
- HYPH O
148 CD O
/ SYM O
- HYPH O
140 CD O
, , O
underlined VBN O
) -RRB- O
in IN O
the DT O
human JJ B-Species
K16 CD O
promoter NN O
region NN O
, , O
and CC O
Mut NNP O
- HYPH O
K16ARE NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
GGGGAA NNP O
- HYPH O
CCTGGAGTCAaaAGTTAGGA NNP O
- HYPH O
3 CD O
' '' O
, , O
mutated VBN O
GC NNP O
box NN O
in IN O
the DT O
ARE NNP O
) -RRB- O
were VBD O
prepared VBN O
by IN O
Fasmac NNP O
( , O
Kanagawa NNP O
, , O
Japan NNP O
) -RRB- O
. . O

A DT O
consensus NN O
ARE NNP O
probe NN O
was VBD O
purchased VBN O
from IN O
Panomics NNP O
, , O
Inc NNP O
. . O

( : O
Redwood NNP O
City NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

For IN O
competition NN O
binding NN O
of IN O
the DT O
K16 NNP O
ARE NNP O
- HYPH O
complexes NNS O
, , O
we PRP O
used VBD O
an DT O
unlabeled JJ O
AP NNP O
- HYPH O
1 CD O
consensus NN O
oligonucleotide NN O
( : O
5 CD O
' '' O
- HYPH O
TATC NNP O
- HYPH O
GATAAGCTATGAGTCATCCG NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
. . O

The DT O
binding VBG O
specificity NN O
was VBD O
confirmed VBN O
in IN O
each DT O
case NN O
by IN O
the DT O
addition NN O
of IN O
a DT O
100 CD O
- HYPH O
fold NN O
molar NN O
excess NN O
of IN O
unlabeled JJ O
oligonucleotide NN O
. . O

CHX NNP O
chase NN O
experiment NN O

We PRP O
investigated VBD O
the DT O
posttranscriptional JJ O
regulation NN O
of IN O
both CC O
the DT O
steady JJ O
- HYPH O
state NN O
levels NNS O
and CC O
half JJ O
- HYPH O
life NN O
of IN O
the DT O
NRF2 NNP O
protein NN O
by IN O
CHX NNP O
chase NN O
analysis NN O
. . O

Cells NNS O
were VBD O
incubated VBN O
in IN O
serum NN O
- HYPH O
free JJ O
medium NN O
in IN O
the DT O
absence NN O
or CC O
presence NN O
of IN O
iAs NNS O
for IN O
6 CD O
hr NN O
. . O

The DT O
culture NN O
medium NN O
was VBD O
then RB O
replaced VBN O
with IN O
serum NN O
- HYPH O
free JJ O
medium NN O
containing VBG O
CHX NNP O
( , O
100 CD O
mu NNS O
g NN O
/ SYM O
mL NN O
) -RRB- O
. . O

We PRP O
prepared VBD O
cell NN O
lysates NNS O
at IN O
0 CD O
, , O
10 CD O
, , O
30 CD O
, , O
60 CD O
, , O
120 CD O
, , O
and CC O
240 CD O
min NN O
after IN O
iAs NNP O
treatment NN O
. . O

Whole JJ O
- HYPH O
cell NN O
lysates NNS O
were VBD O
resolved VBN O
by IN O
SDS NNP O
- HYPH O
PAGE NNP O
and CC O
immunoblotted VBN O
with IN O
antibodies NNS O
against IN O
NRF2 NNP O
. . O

Statistics NNS O

All PDT O
the DT O
data NNS O
generated VBN O
from IN O
at RB O
least RBS O
three CD O
independent JJ O
experiments NNS O
and CC O
expressed VBD O
as IN O
the DT O
mean JJ O
+ SYM O
/ SYM O
- HYPH O
SD NN O
were VBD O
analyzed VBN O
by IN O
the DT O
Student NNP O
' '' O
s POS O
t NN O
- HYPH O
test NN O
. . O

Statistical JJ O
comparisons NNS O
were VBD O
made VBN O
by IN O
logarithmic JJ O
transformation NN O
of IN O
the DT O
normalized JJ O
values NNS O
. . O

We PRP O
considered VBD O
p NN O
- HYPH O
values NNS O
< SYM O
0 CD O
. . O
1 CD O
to TO O
be VB O
statistically RB O
significant JJ O
. . O

Results NNS O

K16 CD O
expression NN O
is VBZ O
induced VBN O
by IN O
iAs NNP O
in IN O
HaCaT NNP O
cells NNS O

We PRP O
wanted VBD O
to TO O
determine VB O
whether IN O
the DT O
K16 NNP O
mRNA NNP O
is VBZ O
transcriptionally RB O
regulated VBN O
by IN O
iAs NNP O
, , O
and CC O
treated VBN O
HaCaT NNP O
cells NNS O
with IN O
this DT O
compound NN O
for IN O
various JJ O
time NN O
periods NNS O
over IN O
a DT O
range NN O
of IN O
doses NNS O
. . O

After IN O
treatment NN O
of IN O
HaCaT NNP O
cells NNS O
with IN O
1 CD O
- SYM O
20 CD O
mu NNS O
M NN O
iAs NNS O
, , O
the DT O
expression NN O
of IN O
K16 CD O
mRNA NNP O
was VBD O
increased VBN O
compared VBN O
with IN O
the DT O
control NN O
at IN O
6 CD O
hr NN O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
but CC O
had VBD O
declined VBN O
to IN O
basal JJ O
levels NNS O
at IN O
24 CD O
hr NN O
. . O

The DT O
increase NN O
in IN O
the DT O
K16 CD O
protein NN O
levels NNS O
after IN O
6 CD O
hr NN O
of IN O
iAs NNP O
exposure NN O
was VBD O
just RB O
detectable JJ O
at IN O
10 CD O
- SYM O
20 CD O
mu NN O
M NN O
, , O
but CC O
a DT O
dose NN O
- HYPH O
dependent JJ O
increase NN O
was VBD O
more RBR O
evident JJ O
at IN O
10 CD O
hr NN O
( -LRB- O
Figure NNP O
1B NNP O
) -RRB- O
. . O

This DT O
enhancement NN O
of IN O
K16 CD O
expression NN O
had VBD O
declined VBN O
to IN O
basal JJ O
levels NNS O
at IN O
24 CD O
hr NN O
. . O

Identification NN O
of IN O
the DT O
iAs NNP O
responsive JJ O
region NN O
in IN O
the DT O
K16 NNP O
gene NN O
promoter NN O

To TO O
investigate VB O
the DT O
mechanisms NNS O
underlying VBG O
the DT O
transactivation NN O
of IN O
the DT O
K16 NNP O
gene NN O
by IN O
iAs NNP O
, , O
we PRP O
first RB O
examined VBD O
the DT O
response NN O
of IN O
the DT O
K16 NNP O
regulatory JJ O
region NN O
to IN O
this DT O
compound NN O
using VBG O
a DT O
luciferase NN O
reporter NN O
gene NN O
assay NN O
. . O

The DT O
dose NN O
- HYPH O
dependent JJ O
activation NN O
of IN O
K16 CD O
transcription NN O
after IN O
iAs NNP O
treatment NN O
was VBD O
observed VBN O
with IN O
a DT O
construct NN O
containing VBG O
a DT O
515 CD O
- HYPH O
bp NN O
fragment NN O
of IN O
the DT O
K16 NNP O
promoter NN O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

To TO O
further RB O
elucidate VB O
the DT O
region NN O
containing VBG O
the DT O
iAs NNP O
responsive JJ O
element NN O
, , O
we PRP O
examined VBD O
a DT O
series NN O
of IN O
deletions NNS O
of IN O
the DT O
5 CD O
' '' O
- HYPH O
flanking VBG O
region NN O
of IN O
K16 NNP O
gene NN O
. . O

The DT O
ARE NNP O
sequence NN O
in IN O
the DT O
pXK NNP O
- HYPH O
5 CD O
- HYPH O
1 CD O
vector NN O
contains VBZ O
an DT O
activator NN O
protein NN O
- HYPH O
1 CD O
( HYPH O
AP NNP O
- HYPH O
1 CD O
) SYM O
- HYPH O
like JJ O
element NN O
followed VBN O
by IN O
a DT O
GC NNP O
box NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
2B NNP O
, , O
an DT O
enhancement NN O
in IN O
the DT O
reporter NN O
activity NN O
levels NNS O
was VBD O
observed VBN O
for IN O
the DT O
promoter NN O
constructs NNS O
, , O
pXK NN O
- HYPH O
1 CD O
, , O
3 CD O
, , O
4 CD O
, , O
and CC O
5 CD O
- HYPH O
1 CD O
, , O
in IN O
response NN O
to IN O
20 CD O
mu NNS O
M NNP O
iAs NNP O
. . O

A DT O
decline NN O
in IN O
reporter NN O
activity NN O
, , O
however RB O
, , O
depended VBD O
on IN O
the DT O
number NN O
of IN O
AP NNP O
- HYPH O
1 CD O
- HYPH O
like JJ O
sites NNS O
, , O
and CC O
the DT O
results NNS O
for IN O
the DT O
pXK NNP O
- HYPH O
5 CD O
- HYPH O
1 CD O
construct NN O
show VBP O
also RB O
that IN O
ARE NNP O
is VBZ O
activated VBN O
by IN O
iAs NNP O
. . O

In IN O
contrast NN O
, , O
no DT O
significant JJ O
activation NN O
was VBD O
observed VBN O
using VBG O
a DT O
pXK NN O
- HYPH O
5 CD O
- HYPH O
2 CD O
construct NN O
in IN O
response NN O
to IN O
20 CD O
mu NNS O
M NNP O
iAs NNP O
. . O

Expression NN O
of IN O
AP NNP O
- HYPH O
1 CD O
transcriptions NNS O
factor NN O
and CC O
c NN O
- HYPH O
Jun NNP O
production NN O
following VBG O
iAs NNP O
treatment NN O

We PRP O
examined VBD O
AP NNP O
- HYPH O
1 CD O
transcription NN O
factors NNS O
c NN O
- HYPH O
Jun NNP O
and CC O
c NN O
- HYPH O
Fos NNP O
expression NN O
in IN O
iAs NNP O
- HYPH O
treated VBN O
HaCaT NNP O
cells NNS O
by IN O
semiquantitative JJ O
RT NNP O
- HYPH O
PCR NNP O
. . O

iAs NNS O
- HYPH O
induced VBN O
c NNP O
- HYPH O
Jun NNP O
expression NN O
was VBD O
observed VBN O
during IN O
the DT O
first JJ O
3 CD O
hr NN O
after IN O
treatment NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

An DT O
appreciable JJ O
induction NN O
of IN O
c NN O
- HYPH O
Jun NNP O
was VBD O
also RB O
confirmed VBN O
after IN O
6 CD O
hr NN O
, , O
but CC O
this DT O
was VBD O
down IN O
- HYPH O
regulated VBN O
by IN O
24 CD O
hr NN O
after IN O
iAs NNP O
treatment NN O
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
the DT O
expression NN O
of IN O
c NN O
- HYPH O
Fos NNP O
was VBD O
only RB O
transiently RB O
detectable JJ O
at IN O
3 CD O
hr NN O
( , O
data NNS O
not RB O
shown VBN O
) , O
but CC O
was VBD O
not RB O
observed VBN O
during IN O
the DT O
6 CD O
- SYM O
24 CD O
hr NN O
period NN O
of IN O
this DT O
experiment NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
3B NNP O
, , O
iAs NNP O
- HYPH O
enhanced VBN O
c NN O
- HYPH O
Jun NNP O
production NN O
can MD O
be VB O
observed VBN O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
manner NN O
at IN O
6 CD O
hr NN O
, , O
but CC O
it PRP O
declines VBZ O
from IN O
10 CD O
to IN O
24 CD O
hr NNS O
. . O

iAs NNS O
potently RB O
induces VBZ O
the DT O
translocation NN O
of IN O
NRF2 NNP O
and CC O
activates VBZ O
the DT O
ARE NN O
of IN O
the DT O
K16 NNP O
promoter NN O

The DT O
results NNS O
of IN O
our PRP$ O
reporter NN O
assays NNS O
suggested VBD O
that IN O
iAs NNP O
stimulates VBZ O
not RB O
only RB O
the DT O
AP NNP O
- HYPH O
1 CD O
- HYPH O
like JJ O
sites NNS O
but CC O
also RB O
the DT O
ARE NNP O
site NN O
within IN O
the DT O
K16 NNP O
gene NN O
promoter NN O
in IN O
HaCaT NNP O
cells NNS O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
several JJ O
oxidative JJ O
stress NN O
agents NNS O
and CC O
toxic JJ O
chemicals NNS O
, , O
including VBG O
iAs NNP O
, , O
have VBP O
been VBN O
reported VBN O
to TO O
induce VB O
the DT O
expression NN O
of IN O
ARE NNP O
- HYPH O
dependent JJ O
genes NNS O
in IN O
several JJ O
cell NN O
types NNS O
( : O
Pi NN O
et NN O
al NNP O
. . O
2003 CD O
; : O
Sakurai NNP O
et FW O
al NNP O
. . O
2005 CD O
) -RRB- O
. . O

On IN O
the DT O
basis NN O
of IN O
our PRP$ O
observations NNS O
and CC O
some DT O
recent JJ O
reports NNS O
, , O
we PRP O
thus RB O
hypothesized VBD O
that IN O
iAs NNP O
would MD O
have VB O
the DT O
ability NN O
to TO O
activate VB O
the DT O
ARE NNP O
of IN O
the DT O
K16 NNP O
gene NN O
promoter NN O
directly RB O
, , O
resulting VBG O
in IN O
the DT O
induction NN O
of IN O
K16 CD O
expression NN O
in IN O
HaCaT NNP O
cells NNS O
. . O

To TO O
confirm VB O
that IN O
the DT O
K16 NNP O
ARE NNP O
indeed RB O
functions VBZ O
as IN O
an DT O
iAs NN O
- HYPH O
responsive JJ O
transcriptional JJ O
control NN O
element NN O
, , O
we PRP O
performed VBD O
transient JJ O
transfections NNS O
of IN O
HaCaT NNP O
cells NNS O
with IN O
a DT O
p3xARE NNP O
/ SYM O
Luc NNP O
construct NN O
and CC O
then RB O
subjected VBD O
these DT O
cells NNS O
to IN O
iAs NNP O
for IN O
6 CD O
hr NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4A NNP O
, , O
treatment NN O
of IN O
HaCaT NNP O
cells NNS O
with IN O
iAs NNP O
results VBZ O
in IN O
a DT O
dramatic JJ O
increase NN O
in IN O
ARE NNP O
- HYPH O
driven VBN O
promoter NN O
activity NN O
. . O

Likewise RB O
, , O
EMSA NNP O
using VBG O
a DT O
consensus NN O
ARE NNP O
probe NN O
show VBP O
that IN O
iAs NN O
- HYPH O
induced VBN O
ARE NN O
- HYPH O
binding VBG O
complexes NNS O
increase VBP O
markedly RB O
, , O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
fashion NN O
( -LRB- O
Figure NNP O
4B NNP O
) -RRB- O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
iAs NNP O
has VBZ O
the DT O
ability NN O
to TO O
activate VB O
the DT O
ARE NNP O
- HYPH O
driven VBN O
genes NNS O
. . O

We PRP O
performed VBD O
further JJ O
EMSA NNP O
experiments NNS O
using VBG O
an DT O
ARE NNP O
probe NN O
specific JJ O
to IN O
the DT O
K16 NNP O
proximal JJ O
promoter NN O
region NN O
( , O
WT NNP O
- HYPH O
K16ARE NNP O
) -RRB- O
and CC O
found VBD O
that IN O
K16ARE NN O
- HYPH O
nuclear JJ O
protein NN O
complexes NNS O
formation NN O
is VBZ O
augmented VBN O
by IN O
iAs NNP O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NNP O
4C NNP O
) -RRB- O
. . O

Moreover RB O
, , O
the DT O
formation NN O
of IN O
these DT O
complexes NNS O
is VBZ O
specifically RB O
inhibited VBN O
by IN O
the DT O
addition NN O
of IN O
excess JJ O
unlabeled JJ O
oligonucleotide NN O
competitor NN O
( -LRB- O
Figure NNP O
4B NNP O
, , O
C NNP O
) -RRB- O
, , O
whereas IN O
an DT O
excess NN O
of IN O
an DT O
unlabeled JJ O
AP NNP O
- HYPH O
1 CD O
probe NN O
competes VBZ O
only RB O
marginally RB O
for IN O
K16ARE NNP O
binding NN O
( -LRB- O
Figure NNP O
4C NNP O
) -RRB- O
. . O

The DT O
NRF2 NNP O
transcription NN O
factor NN O
has VBZ O
been VBN O
shown VBN O
to TO O
bind VB O
to IN O
AREs NNS O
upon IN O
translocation NN O
into IN O
the DT O
nucleus NN O
, , O
resulting VBG O
in IN O
the DT O
induction NN O
of IN O
ARE NNP O
- HYPH O
mediated VBN O
genes NNS O
( , O
Wakabayashi NNP O
et FW O
al NNP O
. . O
2004 CD O
) -RRB- O
. . O

To TO O
examine VB O
whether IN O
iAs NNP O
induces VBZ O
and CC O
translocates VBZ O
NRF2 NNP O
into IN O
the DT O
nucleus NN O
in IN O
HaCaT NNP O
cells NNS O
, , O
we PRP O
treated VBD O
these DT O
cells NNS O
with IN O
iAs NNS O
for IN O
either CC O
3 CD O
or CC O
6 CD O
hr NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4D CD O
, , O
a DT O
dose NN O
- HYPH O
dependent JJ O
accumulation NN O
of IN O
NRF2 NNP O
protein NN O
was VBD O
observed VBN O
in IN O
the DT O
nucleus NN O
upon IN O
treatment NN O
with IN O
iAs NNP O
for IN O
6 CD O
hr CD O
. . O

This DT O
was VBD O
not RB O
observed VBN O
in IN O
the DT O
parallel JJ O
experiment NN O
performed VBN O
over IN O
the DT O
3 CD O
- HYPH O
hr NN O
time NN O
course NN O
. . O

Supershift NN O
EMSA NNP O
analysis NN O
using VBG O
an DT O
NRF2 NNP O
antibody NN O
showed VBD O
that IN O
the DT O
iAs NNS O
- HYPH O
induced VBN O
and CC O
iAs NN O
- HYPH O
translocated VBN O
NRF2 NNP O
protein NN O
binds NNS O
to IN O
the DT O
WT NNP O
- HYPH O
K16ARE NNP O
probe NN O
containing VBG O
the DT O
ARE NNP O
sequence NN O
of IN O
the DT O
K16 NNP O
proximal JJ O
promoter NN O
region NN O
( -LRB- O
5 CD O
' '' O
- HYPH O
GGAGTCAGC NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
that WDT O
comprises VBZ O
an DT O
AP NNP O
- HYPH O
1 CD O
- HYPH O
like JJ O
site NN O
and CC O
a DT O
GC NNP O
box NN O
, , O
whereas IN O
the DT O
supershift NN O
of IN O
c NN O
- HYPH O
Jun NNP O
was VBD O
not RB O
observed VBN O
( : O
Figure NN O
4E CD O
) -RRB- O
. . O

To TO O
identify VB O
whether IN O
the DT O
GC NNP O
box NN O
is VBZ O
dispensable JJ O
for IN O
the DT O
iAs NNP O
- HYPH O
stimulated VBN O
binding VBG O
activity NN O
of IN O
NRF2 NNP O
, , O
we PRP O
next RB O
performed VBD O
EMSA NNP O
analyses NNS O
with IN O
either CC O
WT NNP O
- HYPH O
or CC O
a DT O
Mut NNP O
- HYPH O
K16ARE NNP O
probe NN O
containing VBG O
an DT O
intact JJ O
AP NNP O
- HYPH O
1 CD O
- HYPH O
like JJ O
element NN O
but CC O
a DT O
mutated VBN O
GC NNP O
box NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4F CD O
, , O
the DT O
K16ARE NNP O
- HYPH O
nuclear JJ O
protein NN O
complexes NNS O
and CC O
supershifted VBN O
bands NNS O
that WDT O
were VBD O
enhanced VBN O
by IN O
iAs NNP O
treatment NN O
were VBD O
largely RB O
abolished VBN O
by IN O
the DT O
addition NN O
of IN O
the DT O
Mut NNP O
- HYPH O
K16ARE NNP O
probe NN O
. . O

iAs NNS O
stabilizes VBZ O
the DT O
NRF2 NNP O
protein NN O

We PRP O
examined VBD O
the DT O
effects NNS O
of IN O
iAs NNP O
treatment NN O
on IN O
the DT O
function NN O
of IN O
KEAP1 NNP O
in IN O
HaCaT NNP O
cells NNS O
. . O

Treatment NN O
with IN O
iAs NNP O
did VBD O
not RB O
alter VB O
the DT O
expression NN O
levels NNS O
of IN O
KEAP1 NNP O
mRNA NN O
or CC O
protein NN O
over IN O
either CC O
a DT O
3 CD O
or CC O
6 CD O
hr NN O
time NN O
course NN O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

Next RB O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
iAs NNS O
on IN O
the DT O
expression NN O
of IN O
NRF2 NNP O
mRNA NNP O
in IN O
HaCaT NNP O
cells NNS O
. . O

Exposure NN O
to IN O
iAs NNP O
did VBD O
not RB O
significantly RB O
alter VB O
the DT O
steady JJ O
- HYPH O
state NN O
levels NNS O
of IN O
NRF2 NNP O
mRNA NNP O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Production NN O
of IN O
NRF2 NNP O
protein NN O
, , O
however RB O
, , O
was VBD O
observed VBN O
to TO O
increase VB O
in IN O
both CC O
a DT O
dose NN O
- HYPH O
and CC O
time NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
4D NN O
) -RRB- O
. . O

To TO O
further RB O
examine VB O
the DT O
stabilization NN O
of IN O
NRF2 NNP O
protein NN O
by IN O
iAs NNP O
, , O
we PRP O
monitored VBD O
the DT O
decay NN O
of IN O
basal NN O
and CC O
iAs NN O
- HYPH O
induced VBN O
NRF2 NNP O
proteins NNS O
after IN O
inhibition NN O
of IN O
protein NN O
synthesis NN O
by IN O
CHX NNP O
( -LRB- O
Figure NNP O
5B NNP O
) -RRB- O
. . O

The DT O
results NNS O
of IN O
this DT O
analysis NN O
revealed VBD O
that IN O
the DT O
NRF2 NNP O
protein NN O
levels NNS O
decrease VBP O
by IN O
approximately RB O
50 CD O
% NN O
within IN O
30 CD O
min NN O
of IN O
treatment NN O
with IN O
CHX NNP O
in IN O
cells NNS O
that WDT O
had VBD O
not RB O
been VBN O
exposed VBN O
to IN O
iAs NNP O
. . O

Only JJ O
trace NN O
amounts NNS O
of IN O
NRF2 NN O
are VBP O
then RB O
detectable JJ O
after IN O
60 CD O
min NN O
of IN O
exposure NN O
to IN O
CHX NNP O
in IN O
these DT O
cells NNS O
. . O

The DT O
HaCaT NNP O
cells NNS O
were VBD O
then RB O
pretreated VBN O
with IN O
iAs NNS O
for IN O
6 CD O
hr NNS O
before IN O
their PRP$ O
exposure NN O
to IN O
CHX NNP O
in IN O
a DT O
similar JJ O
timecourse NN O
experiment NN O
. . O

The DT O
levels NNS O
of IN O
NRF2 NN O
in IN O
these DT O
iAs NNS O
- HYPH O
treated VBN O
cells NNS O
were VBD O
again RB O
found VBN O
to TO O
decrease VB O
by IN O
about RB O
50 CD O
% NN O
, , O
but CC O
only RB O
after IN O
120 CD O
min NN O
of IN O
CHX NNP O
exposure NN O
. . O

NRF2 NNP O
plays VBZ O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
K16 NNP O
gene NN O
expression NN O
in IN O
HaCaT NNP O
cells NNS O

To TO O
confirm VB O
the DT O
functional JJ O
role NN O
of IN O
NRF2 NNP O
in IN O
the DT O
induction NN O
of IN O
K16 CD O
gene NN O
expression NN O
by IN O
iAs NNP O
, , O
we PRP O
investigated VBD O
whether IN O
the DT O
expression NN O
of IN O
K16 NNP O
mRNA NNP O
is VBZ O
induced VBN O
by IN O
the DT O
overexpression NN O
of IN O
NRF2 NNP O
( -LRB- O
WT NNP O
- HYPH O
NRF2 NNP O
) -RRB- O
in IN O
HaCaT NNP O
cells NNS O
. . O

We PRP O
also RB O
investigated VBD O
the DT O
expression NN O
of IN O
the DT O
detoxification NN O
gene NN O
TXN NNP O
, , O
which WDT O
is VBZ O
highly RB O
induced VBN O
by IN O
a DT O
variety NN O
of IN O
oxidative JJ O
stimuli NN O
through IN O
NRF2 NNP O
- HYPH O
mediated VBN O
ARE NNP O
transactivation NN O
( , O
Kim NNP O
et FW O
al NNP O
. . O
2001 CD O
) -RRB- O
. . O

The DT O
expression NN O
of IN O
TXN NNP O
gene NN O
in IN O
untransfected JJ O
cells NNS O
after IN O
treatment NN O
with IN O
iAs NNP O
was VBD O
stronger JJR O
than IN O
that DT O
of IN O
the DT O
control NN O
cells NNS O
( -LRB- O
Figure NNP O
6A NNP O
) -RRB- O
. . O

When WRB O
the DT O
cells NNS O
were VBD O
transfected VBN O
with IN O
WT NNP O
- HYPH O
NRF2 NNP O
and CC O
then RB O
treated VBN O
with IN O
or CC O
without IN O
iAs NNP O
, , O
the DT O
expression NN O
of IN O
TXN NNP O
mRNA NNP O
was VBD O
augmented VBN O
markedly RB O
compared VBN O
with IN O
the DT O
empty JJ O
- HYPH O
vector NN O
control NN O
. . O

Similarly RB O
, , O
the DT O
expression NN O
of IN O
K16 NNP O
mRNA NNP O
was VBD O
also RB O
induced VBN O
in IN O
cells NNS O
transfected VBN O
with IN O
WT NNP O
- HYPH O
NRF2 NNP O
in IN O
the DT O
absence NN O
or CC O
presence NN O
of IN O
iAs NNS O
. . O

We PRP O
next RB O
performed VBD O
a DT O
transient JJ O
transfection NN O
of IN O
HaCaT NNP O
cells NNS O
with IN O
the DT O
pXK NNP O
- HYPH O
5 CD O
- HYPH O
1 CD O
luciferase NN O
vector NN O
together RB O
with IN O
the DT O
WT NNP O
- HYPH O
NRF2 NNP O
vector NN O
. . O

The DT O
overexpression NN O
of IN O
NRF2 NNP O
in IN O
increasing VBG O
concentrations NNS O
resulted VBD O
in IN O
significant JJ O
enhancement NN O
of IN O
the DT O
ARE NNP O
- HYPH O
mediated VBN O
K16 CD O
promoter NN O
activation NN O
( -LRB- O
Figure NNP O
6B NNP O
) -RRB- O
. . O

Discussion NN O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
showed VBD O
for IN O
the DT O
first JJ O
time NN O
that IN O
iAs NNP O
induces VBZ O
the DT O
transcriptional JJ O
activation NN O
of IN O
K16 CD O
in IN O
the DT O
human JJ B-Species
keratinocyte NN O
cell NN O
line NN O
, , O
HaCaT NNP O
, , O
through IN O
the DT O
ARE NNP O
present JJ O
in IN O
its PRP$ O
gene NN O
promoter NN O
. . O

It PRP O
has VBZ O
been VBN O
reported VBN O
previously RB O
that IN O
treatment NN O
with IN O
iAs NNP O
enhances VBZ O
the DT O
production NN O
and CC O
translocation NN O
of IN O
NRF2 NN O
into IN O
the DT O
nucleus NN O
in IN O
several JJ O
cell NN O
types NNS O
. . O

However RB O
, , O
until IN O
now RB O
it PRP O
has VBZ O
remained VBN O
uncertain JJ O
whether IN O
the DT O
induction NN O
of IN O
NRF2 NNP O
by IN O
iAs NNP O
mediates VBZ O
the DT O
transcriptional JJ O
activation NN O
of IN O
the DT O
K16 NNP O
gene NN O
in IN O
keratinocytes NNS O
. . O

In IN O
our PRP$ O
current JJ O
experiments NNS O
, , O
we PRP O
demonstrated VBD O
that IN O
iAs NNP O
elongates VBZ O
the DT O
half JJ O
- HYPH O
life NN O
of IN O
the DT O
NRF2 NNP O
protein NN O
, , O
which WDT O
results VBZ O
in IN O
its PRP$ O
increased VBN O
expression NN O
levels NNS O
. . O

Furthermore RB O
, , O
this DT O
iAs NN O
- HYPH O
induced VBN O
NRF2 NNP O
protein NN O
was VBD O
shown VBN O
to TO O
bind VB O
to IN O
the DT O
ARE NNP O
sequences NNS O
in IN O
the DT O
promoter NN O
region NN O
of IN O
the DT O
K16 NNP O
gene NN O
. . O

Finally RB O
, , O
by IN O
overexpressing VBG O
NRF2 NNP O
, , O
we PRP O
have VBP O
clarified VBN O
that IN O
its PRP$ O
induction NN O
is VBZ O
involved VBN O
in IN O
not RB O
only RB O
the DT O
gene NN O
expression NN O
of IN O
the DT O
detoxification NN O
gene NN O
TXN NNP O
, , O
but CC O
also RB O
in IN O
the DT O
upregulation NN O
of IN O
K16 CD O
expression NN O
in IN O
HaCaT NNP O
cells NNS O
through IN O
the DT O
ARE NNP O
in IN O
the DT O
K16 NNP O
gene NN O
promoter NN O
. . O

These DT O
experiments NNS O
indicate VBP O
an DT O
important JJ O
and CC O
novel JJ O
function NN O
for IN O
NRF2 NN O
in IN O
the DT O
regulation NN O
of IN O
K16 CD O
in IN O
keratinocytes NNS O
and CC O
also RB O
help VB O
to TO O
further RB O
explain VB O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
arsenic NN O
- HYPH O
mediated VBN O
epidermal JJ O
hyperkeratosis NN O
. . O

In IN O
our PRP$ O
present JJ O
experiments NNS O
, , O
the DT O
expression NN O
levels NNS O
of IN O
K16 NNP O
mRNA NNP O
and CC O
protein NN O
were VBD O
indeed RB O
found VBN O
to TO O
be VB O
enhanced VBN O
by IN O
iAs NNS O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
luciferase NN O
assays NNS O
of IN O
the DT O
K16 NNP O
promoter NN O
revealed VBD O
that IN O
iAs NNP O
enhances VBZ O
its PRP$ O
activity NN O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
fashion NN O
, , O
which WDT O
is VBZ O
stimulated VBN O
by IN O
AP NNP O
- HYPH O
1 CD O
- HYPH O
like JJ O
sites NNS O
and CC O
an DT O
ARE NN O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
. . O

The DT O
promoter NN O
of IN O
the DT O
human JJ B-Species
K16 CD O
gene NN O
was VBD O
recently RB O
cloned VBN O
and CC O
sequenced VBN O
, , O
and CC O
several JJ O
AP NNP O
- HYPH O
1 CD O
- HYPH O
like JJ O
sites NNS O
were VBD O
found VBN O
within IN O
the DT O
- HYPH O
515 CD O
- HYPH O
bp NN O
region NN O
of IN O
the DT O
gene NN O
( , O
Wang NNP O
and CC O
Chang NNP O
2003 CD O
) -RRB- O
. . O

AP NNP O
- HYPH O
1 CD O
transcription NN O
factor NN O
can MD O
be VB O
formed VBN O
by IN O
the DT O
dimerization NN O
of IN O
either CC O
Jun NNP O
or CC O
Jun NNP O
/ SYM O
Fos NNP O
family NN O
members NNS O
( : O
Eferl NNP O
and CC O
Wagner NNP O
2003 CD O
) -RRB- O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
the DT O
increased VBN O
expression NN O
of IN O
c NN O
- HYPH O
Jun NNP O
, , O
but CC O
not RB O
c NN O
- HYPH O
Fos NNP O
was VBD O
evident JJ O
in IN O
the DT O
nuclei NNS O
of IN O
HaCaT NNP O
cells NNS O
after IN O
iAs NNP O
treatment NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

Our PRP$ O
findings NNS O
thus RB O
suggest VBP O
that IN O
the DT O
activation NN O
of IN O
c NN O
- HYPH O
Jun NNP O
/ SYM O
AP NN O
- HYPH O
1 CD O
is VBZ O
one CD O
of IN O
the DT O
essential JJ O
steps NNS O
in IN O
the DT O
regulation NN O
of IN O
K16 CD O
gene NN O
expression NN O
by IN O
iAs NNP O
exposure NN O
in IN O
HaCaT NNP O
cells NNS O
. . O

It PRP O
has VBZ O
been VBN O
well RB O
documented VBN O
that IN O
the DT O
ARE NNP O
core NN O
sequence NN O
includes VBZ O
an DT O
AP NNP O
- HYPH O
1 CD O
- HYPH O
like JJ O
binding VBG O
site NN O
( , O
TGAC NNP O
/ SYM O
GTCA NNP O
) -RRB- O
, , O
followed VBN O
by IN O
a DT O
GC NNP O
box NN O
( , O
Rushmore NNP O
et FW O
al NNP O
. . O
1991 CD O
; : O
Xie NNP O
et FW O
al NNP O
. . O
1995 CD O
) -RRB- O
. . O

We PRP O
have VBP O
found VBN O
in IN O
our PRP$ O
current JJ O
analyses NNS O
that IN O
the DT O
AP NNP O
- HYPH O
1 CD O
- HYPH O
like JJ O
site NN O
within IN O
the DT O
K16 NNP O
promoter NN O
region NN O
from IN O
- HYPH O
148 CD O
to IN O
- HYPH O
140 CD O
bp NN O
( HYPH O
5 CD O
' '' O
- HYPH O
GGAGTCAGC NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
resembles VBZ O
a DT O
consensus NN O
ARE NN O
sequence NN O
. . O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
AREs NNS O
can MD O
be VB O
specifically RB O
bound VBN O
by IN O
complexes NNS O
of IN O
several JJ O
basic JJ O
- HYPH O
leucine NN O
zipper NN O
transcription NN O
factors NNS O
, , O
including VBG O
NRF2 NNP O
( , O
Ishii NNP O
et FW O
al NNP O
. . O
2000 CD O
; : O
Moi NNP O
et FW O
al NNP O
. . O
1994 CD O
) -RRB- O
. . O

NRF2 NNP O
heterodimerizes VBZ O
with IN O
either CC O
AP NNP O
- HYPH O
1 CD O
or CC O
small JJ O
MAF NNP O
( , O
MAFG NNP O
, , O
MAFK NNP O
, , O
and CC O
MAFF NNP O
) -RRB- O
proteins NNS O
( , O
MAF NNP O
, , O
v NN O
- HYPH O
maf NN O
musculoaponeurotic NN O
fibrosarcoma NN O
oncogene NN O
homolog NN O
) -RRB- O
and CC O
binds NNS O
to IN O
the DT O
ARE NN O
to TO O
induce VB O
the DT O
transcription NN O
of IN O
ARE NN O
- HYPH O
mediated VBN O
genes NNS O
( , O
Motohashi NNP O
et FW O
al NNP O
. . O
2002 CD O
) -RRB- O
. . O

In IN O
the DT O
present JJ O
investigation NN O
, , O
EMSA NNP O
and CC O
supershift NN O
assays NNS O
showed VBD O
that IN O
the DT O
NRF2 NNP O
proteins NNS O
in IN O
the DT O
nuclei NNS O
bind VBP O
to IN O
the DT O
ARE NNP O
sequences NNS O
of IN O
K16 NNP O
promoter NN O
region NN O
after IN O
iAs NNP O
exposure NN O
. . O

iAs NNS O
- HYPH O
induced VBN O
c NN O
- HYPH O
Jun NNP O
, , O
however RB O
, , O
does VBZ O
not RB O
bind VB O
to IN O
this DT O
ARE NNP O
( -LRB- O
Figure NNP O
4E CD O
) -RRB- O
. . O

c LS O
- HYPH O
Jun NNP O
may MD O
thus RB O
act VB O
on IN O
other JJ O
AP NNP O
- HYPH O
1 CD O
sites NNS O
within IN O
the DT O
K16 NNP O
promoter NN O
region NN O
. . O

These DT O
results NNS O
also RB O
suggest VBP O
that IN O
other JJ O
heterodimer NN O
partners NNS O
of IN O
NRF2 NNP O
are VBP O
involved VBN O
in IN O
the DT O
ARE NNP O
regulation NN O
of IN O
K16 NNP O
promoter NN O
region NN O
underlying VBG O
iAs NNP O
- HYPH O
mediated VBN O
the DT O
K16 NNP O
gene NN O
expression NN O
. . O

Gel NNP O
shifts VBZ O
with IN O
an DT O
K16Mut NNP O
- HYPH O
ARE NNP O
probe NN O
( , O
harboring VBG O
a DT O
mutation NN O
in IN O
the DT O
ARE NNP O
GC NNP O
box NN O
) -RRB- O
clearly RB O
show VBP O
that IN O
the DT O
ARE NN O
sequence NN O
in IN O
the DT O
K16 NNP O
promoter NN O
, , O
particularly RB O
the DT O
terminal JJ O
GC NNP O
dinucleotide NN O
, , O
is VBZ O
essential JJ O
for IN O
mediating VBG O
iAs NN O
- HYPH O
induced VBN O
K16 CD O
transactivation NN O
and CC O
NRF2 NNP O
binding NN O
( -LRB- O
Figure NNP O
4F NNP O
) -RRB- O
. . O

Several JJ O
investigations NNS O
have VBP O
suggested VBN O
that IN O
the DT O
GC NNP O
nucleotides NNS O
within IN O
the DT O
ARE NNP O
are VBP O
essential JJ O
for IN O
both CC O
the DT O
basal JJ O
and CC O
oxidative JJ O
stress NN O
- HYPH O
induced VBN O
activities NNS O
of IN O
the DT O
ARE NNP O
- HYPH O
related VBN O
genes NNS O
, , O
NAD NNP O
( , O
P NNP O
) -RRB- O
H NN O
dehydrogenase NN O
quinone NN O
1 CD O
( , O
NQO1 NN O
) -RRB- O
and CC O
glutamate NN O
- HYPH O
cysteine NN O
ligase NN O
catalytic JJ O
subunit NN O
( , O
GCLC NNP O
) -RRB- O
( , O
Wasserman NNP O
and CC O
Fahl NNP O
1997 CD O
; : O
Wild NNP O
et FW O
al NNP O
. . O
1998 CD O
) -RRB- O
. . O

Our PRP$ O
current JJ O
results NNS O
are VBP O
consistent JJ O
with IN O
these DT O
earlier JJR O
studies NNS O
in IN O
showing VBG O
that IN O
the DT O
formation NN O
of IN O
the DT O
iAs NN O
- HYPH O
responsive JJ O
NRF2 NNP O
/ SYM O
ARE NNP O
complexes NNS O
is VBZ O
reduced VBN O
by IN O
a DT O
mutation NN O
in IN O
the DT O
GC NNP O
box NN O
. . O

Collectively RB O
, , O
our PRP$ O
present JJ O
observations NNS O
reveal VBP O
a DT O
new JJ O
molecular JJ O
mechanism NN O
in IN O
which WDT O
iAs NN O
- HYPH O
induced VBN O
K16 CD O
gene NN O
expression NN O
is VBZ O
also RB O
regulated VBN O
by IN O
activation NN O
NRF2 NNP O
/ SYM O
ARE NNP O
pathways NNS O
. . O

It PRP O
has VBZ O
been VBN O
widely RB O
accepted VBN O
that IN O
oxidative JJ O
stress NN O
disrupts VBZ O
sequestration NN O
of IN O
NRF2 NNP O
by IN O
KEAP1 NNP O
, , O
permits VBZ O
NRF2 NN O
translocation NN O
to IN O
the DT O
nucleus NN O
, , O
and CC O
transactivates VBZ O
the DT O
expression NN O
of IN O
various JJ O
NRF2 NNP O
- HYPH O
mediated VBN O
genes NNS O
( , O
Dinkova NNP O
- HYPH O
Kostova NNP O
et FW O
al NNP O
. . O
2002 CD O
; : O
McMahon NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
. . O

Our PRP$ O
present JJ O
study NN O
showed VBD O
that IN O
iAs NNP O
elongates VBZ O
the DT O
half JJ O
- HYPH O
life NN O
of IN O
the DT O
NRF2 NNP O
protein NN O
but CC O
has VBZ O
no DT O
effects NNS O
upon IN O
KEAP1 NNP O
expression NN O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Other JJ O
studies NNS O
have VBP O
also RB O
demonstrated VBN O
that IN O
the DT O
production NN O
of IN O
NRF2 NN O
is VBZ O
increased VBN O
by IN O
various JJ O
inducers NNS O
via IN O
posttranscriptional JJ O
control NN O
( , O
Nguyen NNP O
et FW O
al NNP O
. . O
2003 CD O
; : O
Stewart NNP O
et FW O
al NNP O
. . O
2003 CD O
) -RRB- O
. . O

Several JJ O
earlier JJR O
reports NNS O
also RB O
indicated VBD O
that IN O
either CC O
oxidative JJ O
stress NN O
or CC O
antioxidant JJ O
substances NNS O
stabilize VBP O
the DT O
expression NN O
of IN O
the DT O
NRF2 NNP O
protein NN O
, , O
either CC O
by IN O
directly RB O
modifying VBG O
the DT O
cysteine NN O
residues NNS O
on IN O
KEAP1 NNP O
to TO O
disrupt VB O
the DT O
NRF2 NNP O
/ SYM O
KEAP1 NNP O
complex NN O
( : O
Dinkova NNP O
- HYPH O
Kostova NNP O
et FW O
al NNP O
. . O
2002 CD O
) -RRB- O
or CC O
by IN O
facilitating VBG O
the DT O
release NN O
of IN O
NRF2 NNP O
through IN O
the DT O
phosphorylation NN O
of IN O
the DT O
NRF2 NNP O
/ SYM O
KEAP1 NNP O
complex NN O
( : O
Bloom NNP O
and CC O
Jaiswal NNP O
2003 CD O
) -RRB- O
. . O

These DT O
findings NNS O
are VBP O
largely RB O
consistent JJ O
with IN O
our PRP$ O
present JJ O
finding NN O
that IN O
iAs NNP O
stabilizes VBZ O
the DT O
expression NN O
of IN O
NRF2 NNP O
in IN O
HaCaT NNP O
cells NNS O
by IN O
elongating VBG O
the DT O
protein NN O
half JJ O
- HYPH O
life NN O
. . O

Recently RB O
, , O
Wakabayashi NNP O
et FW O
al NNP O
. . O

( -LRB- O
2003 CD O
) -RRB- O
demonstrated VBD O
that IN O
NRF2 NNP O
accumulates VBZ O
in IN O
the DT O
nucleus NN O
at IN O
constitutively RB O
high JJ O
levels NNS O
and CC O
produces VBZ O
various JJ O
cytoprotective JJ O
genes NNS O
in IN O
embryonic JJ O
fibroblast NN O
- HYPH O
and CC O
liver NN O
- HYPH O
derived VBN O
Keap1 NNP O
- HYPH O
null NN O
mice NNS B-Species
. . O

Surprisingly RB O
, , O
these DT O
Keap1 NNP O
- HYPH O
deficient JJ O
mice NNS B-Species
also RB O
show VBP O
a DT O
thicker JJR O
stratum NN O
corneum NN O
epidermis NN O
, , O
abnormal JJ O
keratinization NN O
, , O
and CC O
cornification NN O
in IN O
the DT O
esophagus NN O
and CC O
forestomach NN O
( , O
hyperkeratosis NN O
) -RRB- O
. . O

K6 NNP O
was VBD O
found VBN O
to TO O
be VB O
strongly RB O
expressed VBN O
in IN O
the DT O
esophageal JJ O
epithelium NN O
of IN O
these DT O
mice NNS B-Species
. . O

These DT O
results NNS O
indicate VBP O
that IN O
K6 NNP O
is VBZ O
also RB O
a DT O
target NN O
gene NN O
of IN O
NRF2 NNP O
. . O

In IN O
addition NN O
, , O
the DT O
promoter NN O
of IN O
the DT O
K6 NNP O
gene NN O
bears VBZ O
a DT O
remarkable JJ O
sequence NN O
similarity NN O
to IN O
the DT O
K16 NNP O
promoter NN O
( , O
Jiang NNP O
et FW O
al NNP O
. . O
1993 CD O
) -RRB- O
. . O

Therefore RB O
, , O
we PRP O
examined VBD O
whether IN O
K16 CD O
gene NN O
expression NN O
is VBZ O
also RB O
regulated VBN O
by IN O
NRF2 NNP O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
the DT O
gene NN O
expression NN O
and CC O
transactivation NN O
of IN O
K16 CD O
were VBD O
dramatically RB O
induced VBN O
by IN O
transfection NN O
with IN O
WT NNP O
- HYPH O
NRF2 NNP O
via IN O
in IN O
HaCaT NNP O
cells NNS O
, , O
clearly RB O
demonstrating VBG O
that IN O
NRF2 NNP O
acts VBZ O
as IN O
a DT O
direct JJ O
transcriptional JJ O
regulator NN O
of IN O
the DT O
K16 NNP O
gene NN O
( -LRB- O
Figure NN O
6 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
we PRP O
also RB O
showed VBD O
that IN O
transfection NN O
of IN O
HaCaT NNP O
cells NNS O
with IN O
WT NNP O
- HYPH O
NRF2 NNP O
induces VBZ O
the DT O
expression NN O
of IN O
detoxification NN O
gene NN O
TXN NNP O
( -LRB- O
Figure NNP O
6A NNP O
) -RRB- O
. . O

NRF2 NNP O
may MD O
thus RB O
have VB O
a DT O
major JJ O
role NN O
to TO O
play VB O
in IN O
the DT O
development NN O
of IN O
hyperkeratosis NN O
, , O
whereas IN O
the DT O
expression NN O
and CC O
induction NN O
of IN O
NRF2 NNP O
is VBZ O
implicated VBN O
in IN O
cell NN O
protection NN O
against IN O
a DT O
variety NN O
of IN O
genotoxic JJ O
and CC O
cytotoxic JJ O
effects NNS O
. . O

Hence RB O
, , O
based VBN O
on IN O
these DT O
results NNS O
and CC O
on IN O
the DT O
findings NNS O
from IN O
studies NNS O
of IN O
Keap1 NNP O
knockout NN O
mice NNS B-Species
, , O
iAs NNS O
may MD O
both CC O
cause VB O
hyperkeratosis NN O
and CC O
induce VB O
detoxification NN O
enzymes NNS O
via IN O
the DT O
modification NN O
of IN O
NRF2 NNP O
. . O

Given VBN O
that IN O
there EX O
are VBP O
both CC O
beneficial JJ O
and CC O
adverse JJ O
effects NNS O
of IN O
NRF2 NNP O
activity NN O
, , O
caution NN O
will MD O
therefore RB O
be VB O
needed VBN O
when WRB O
using VBG O
antioxidants NNS O
for IN O
prevention NN O
and CC O
therapy NN O
. . O

Although IN O
further JJ O
investigations NNS O
are VBP O
needed VBN O
, , O
we PRP O
believe VBP O
that IN O
our PRP$ O
findings NNS O
provide VBP O
important JJ O
clues NNS O
for IN O
the DT O
design NN O
of IN O
future JJ O
therapies NNS O
for IN O
arsenic NN O
- HYPH O
mediated VBN O
hyperkeratosis NN O
and CC O
for IN O
treatments NNS O
involving VBG O
the DT O
molecular JJ O
targeting NN O
of IN O
NRF2 NNP O
. . O

Conclusion NN O

Our PRP$ O
findings NNS O
clearly RB O
demonstrate VBP O
that IN O
the DT O
induction NN O
of IN O
the DT O
K16 NNP O
gene NN O
in IN O
human JJ B-Species
keratinocytes NNS O
by IN O
iAs NNP O
depends VBZ O
on IN O
NRF2 NNP O
activation NN O
. . O

Our PRP$ O
results NNS O
thus RB O
represent VBP O
a DT O
valuable JJ O
initial JJ O
effort NN O
to TO O
elucidate VB O
the DT O
relationship NN O
between IN O
the DT O
K16 NNP O
gene NN O
and CC O
the DT O
NRF2 NNP O
transcription NN O
factor NN O
, , O
which WDT O
may MD O
be VB O
responsible JJ O
for IN O
hyperkeratosis NN O
. . O

Identification NN O
and CC O
Analysis NN O
of IN O
Co NNP O
- HYPH O
Occurrence NNP O
Networks NNPS O
with IN O
NetCutter NNP O

Abstract JJ O

Background NN O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
is VBZ O
a DT O
technique NN O
often RB O
applied VBN O
in IN O
text NN O
mining NN O
, , O
comparative JJ O
genomics NNS O
, , O
and CC O
promoter NN O
analysis NN O
. . O

The DT O
methodologies NNS O
and CC O
statistical JJ O
models NNS O
used VBN O
to TO O
evaluate VB O
the DT O
significance NN O
of IN O
association NN O
between IN O
co NN O
- HYPH O
occurring VBG O
entities NNS O
are VBP O
quite RB O
diverse JJ O
, , O
however RB O
. . O

Methodology NN O
/ SYM O
Principal JJ O
Findings NNS O

We PRP O
present VBP O
a DT O
general JJ O
framework NN O
for IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
based VBN O
on IN O
a DT O
bipartite JJ O
graph NN O
representation NN O
of IN O
the DT O
data NN O
, , O
a DT O
novel JJ O
co NN O
- HYPH O
occurrence NN O
statistic NN O
, , O
and CC O
software NN O
performing NN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
as RB O
well RB O
as IN O
generation NN O
and CC O
analysis NN O
of IN O
co NN O
- HYPH O
occurrence NN O
networks NNS O
. . O

We PRP O
show VBP O
that IN O
the DT O
overall JJ O
stringency NN O
of IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
depends VBZ O
critically RB O
on IN O
the DT O
choice NN O
of IN O
the DT O
null NN O
- HYPH O
model NN O
used VBN O
to TO O
evaluate VB O
the DT O
significance NN O
of IN O
co NN O
- HYPH O
occurrence NN O
and CC O
find VB O
that IN O
random JJ O
sampling NN O
from IN O
a DT O
complete JJ O
permutation NN O
set NN O
of IN O
the DT O
bipartite JJ O
graph NN O
permits VBZ O
co NN O
- HYPH O
occurrence NN O
analysis NN O
with IN O
optimal JJ O
stringency NN O
. . O

We PRP O
show VBP O
that IN O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
is VBZ O
the DT O
most RBS O
natural JJ O
co NN O
- HYPH O
occurrence NN O
probability NN O
distribution NN O
when WRB O
vertex JJ O
degrees NNS O
of IN O
the DT O
bipartite JJ O
graph NN O
are VBP O
variable JJ O
, , O
which WDT O
is VBZ O
usually RB O
the DT O
case NN O
. . O

Calculation NN O
of IN O
Poisson NNP O
- HYPH O
binomial JJ O
P NN O
- HYPH O
values NNS O
is VBZ O
difficult JJ O
, , O
however RB O
. . O

Therefore RB O
, , O
we PRP O
propose VBP O
a DT O
fast JJ O
bi NN O
- HYPH O
binomial JJ O
approximation NN O
for IN O
calculation NN O
of IN O
P NN O
- HYPH O
values NNS O
and CC O
show VBP O
that IN O
this DT O
statistic NN O
is VBZ O
superior JJ O
to IN O
other JJ O
measures NNS O
of IN O
association NN O
such JJ O
as IN O
the DT O
Jaccard NNP O
coefficient NN O
and CC O
the DT O
uncertainty NN O
coefficient JJ O
. . O

Furthermore RB O
, , O
co NN O
- HYPH O
occurrence NN O
analysis NN O
of IN O
more JJR O
than IN O
two CD O
entities NNS O
can MD O
be VB O
performed VBN O
using VBG O
the DT O
same JJ O
statistical JJ O
model NN O
, , O
which WDT O
leads VBZ O
to IN O
increased VBN O
signal NN O
- HYPH O
to IN O
- HYPH O
noise NN O
ratios NNS O
, , O
robustness NN O
towards IN O
noise NN O
, , O
and CC O
the DT O
identification NN O
of IN O
implicit JJ O
relationships NNS O
between IN O
co NN O
- HYPH O
occurring VBG O
entities NNS O
. . O

Using VBG O
NetCutter NNP O
, , O
we PRP O
identify VBP O
a DT O
novel JJ O
protein NN O
biosynthesis NN O
related VBN O
set NN O
of IN O
genes NNS O
that WDT O
are VBP O
frequently RB O
coordinately RB O
deregulated VBN O
in IN O
human JJ B-Species
cancer NN O
related VBN O
gene NN O
expression NN O
studies NNS O
. . O

NetCutter NNP O
is VBZ O
available JJ O
at IN O
http JJ O
: : O
/ NFP O
/ SYM O
bio NNP O
. . O
ifom NNP O
- HYPH O
ieo NN O
- HYPH O
campus NN O
. . O
it PRP O
/ SYM O
NetCutter NNP O
/ , O
) -RRB- O
. . O

Conclusion NN O

Our PRP$ O
approach NN O
can MD O
be VB O
applied VBN O
to IN O
any DT O
set NN O
of IN O
categorical JJ O
data NNS O
where WRB O
co NN O
- HYPH O
occurrence NN O
analysis NN O
might MD O
reveal VB O
functional JJ O
relationships NNS O
such JJ O
as IN O
clinical JJ O
parameters NNS O
associated VBN O
with IN O
cancer NN O
subtypes NNS O
or CC O
SNPs NNS O
associated VBN O
with IN O
disease NN O
phenotypes NNS O
. . O

The DT O
stringency NN O
of IN O
our PRP$ O
approach NN O
is VBZ O
expected VBN O
to TO O
offer VB O
an DT O
advantage NN O
in IN O
a DT O
variety NN O
of IN O
applications NNS O
. . O

Introduction NN O

Biological JJ O
research NN O
has VBZ O
experienced VBN O
a DT O
paradigm JJ O
shift NN O
in IN O
the DT O
last JJ O
decade NN O
catalyzed VBN O
by IN O
the DT O
availability NN O
of IN O
genome NN O
sequences NNS O
and CC O
the DT O
resulting VBG O
development NN O
of IN O
high JJ O
- HYPH O
throughput NN O
technologies NNS O
. . O

The DT O
large JJ O
data NN O
volumes NNS O
produced VBN O
by IN O
these DT O
novel JJ O
technologies NNS O
are VBP O
often RB O
published VBN O
as IN O
supplementary JJ O
material NN O
and CC O
/ SYM O
or CC O
stored VBN O
in IN O
extensive JJ O
data NN O
repositories NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Functional JJ O
interpretation NN O
of IN O
these DT O
data NNS O
is VBZ O
an DT O
ongoing JJ O
challenge NN O
. . O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
, , O
based VBN O
on IN O
the DT O
hypothesis NN O
that IN O
co NN O
- HYPH O
occurring VBG O
entities NNS O
are VBP O
functionally RB O
linked VBN O
, , O
is VBZ O
a DT O
technique NN O
that WDT O
has VBZ O
been VBN O
used VBN O
in IN O
three CD O
main JJ O
areas NNS O
of IN O
biological JJ O
research NN O
: : O

Co NN O
- HYPH O
occurrence NN O
of IN O
genes NNS O
in IN O
sequenced VBN O
genomes NNS O
relies VBZ O
on IN O
the DT O
fact NN O
that IN O
proteins NNS O
do VBP O
not RB O
function VB O
in IN O
isolation NN O
and CC O
are VBP O
dependent JJ O
on IN O
other JJ O
proteins NNS O
, , O
either CC O
as IN O
direct JJ O
binding NN O
partners NNS O
, , O
or CC O
as IN O
catalysts NNS O
of IN O
substrates NNS O
. . O

Thus RB O
, , O
when WRB O
two CD O
proteins NNS O
significantly RB O
co VBP O
- HYPH O
occur VBP O
in IN O
a DT O
large JJ O
number NN O
of IN O
genomes NNS O
or CC O
can MD O
be VB O
observed VBN O
as IN O
fusion NN O
proteins NNS O
in IN O
a DT O
subset NN O
of IN O
genomes NNS O
, , O
they PRP O
are VBP O
likely JJ O
to TO O
be VB O
binding VBG O
partners NNS O
or CC O
enzymes NNS O
needed VBN O
for IN O
a DT O
specific JJ O
metabolic JJ O
pathway NN O
. . O

Examples NNS O
of IN O
those DT O
studies NNS O
have VBP O
been VBN O
reported VBN O
by IN O
[ -LRB- O
2 LS O
] -RRB- O
- : O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Text NN O
mining NN O
is VBZ O
a DT O
quickly RB O
evolving VBG O
field NN O
that WDT O
aims VBZ O
at IN O
developing VBG O
technologies NNS O
helping VBG O
to TO O
cope VB O
with IN O
the DT O
functional JJ O
interpretation NN O
of IN O
large JJ O
volumes NNS O
of IN O
publications NNS O
. . O

Co NN O
- HYPH O
occurrence NN O
of IN O
gene NN O
names NNS O
in IN O
publication NN O
abstracts NNS O
, , O
entire JJ O
publications NNS O
, , O
or CC O
other JJ O
gene NN O
- HYPH O
related VBN O
databases NNS O
has VBZ O
been VBN O
used VBN O
to TO O
derive VB O
co NN O
- HYPH O
occurrence NN O
networks NNS O
with IN O
clear JJ O
evidence NN O
that IN O
edges NNS O
in IN O
those DT O
networks NNS O
are VBP O
reflecting VBG O
functionally RB O
relevant JJ O
relationships NNS O
[ -LRB- O
8 CD O
] -RRB- O
- : O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Gene NN O
names NNS O
have VBP O
also RB O
been VBN O
analyzed VBN O
for IN O
co NN O
- HYPH O
occurrence NN O
with IN O
other JJ O
entities NNS O
such JJ O
as IN O
mutations NNS O
[ -LRB- O
12 CD O
] -RRB- O
, , O
chemical JJ O
compounds NNS O
[ -LRB- O
13 CD O
] -RRB- O
, , O
and CC O
disease NN O
related VBN O
keywords NNS O
[ -LRB- O
14 CD O
] -RRB- O
. . O

From IN O
the DT O
resulting VBG O
networks NNS O
, , O
hypotheses NNS O
about IN O
candidate NN O
genes NNS O
involved VBN O
in IN O
inherited VBN O
diseases NNS O
and CC O
drug NN O
targets NNS O
can MD O
be VB O
derived VBN O
. . O

Clustering VBG O
of IN O
gene NN O
related VBN O
publications NNS O
using VBG O
keywords NNS O
has VBZ O
been VBN O
applied VBN O
to TO O
enhance VB O
the DT O
quality NN O
of IN O
gene NN O
expression NN O
clusters NNS O
[ -LRB- O
15 CD O
] -RRB- O
, , O
[ -LRB- O
16 CD O
] -RRB- O
. . O

More RBR O
general JJ O
( , O
non JJ O
gene NN O
- HYPH O
centric JJ O
) -RRB- O
approaches NNS O
try VBP O
to TO O
organize VB O
the DT O
literature NN O
into IN O
functional JJ O
areas NNS O
based VBN O
on IN O
co NN O
- HYPH O
occurrence NN O
of IN O
MeSH NNP O
terms NNS O
, , O
keywords NNS O
, , O
diseases NNS O
, , O
phenotypes NNS O
, , O
chemicals NNS O
, , O
and CC O
similar JJ O
objects NNS O
of IN O
biomedical JJ O
research NN O
interest NN O
[ -LRB- O
17 CD O
] -RRB- O
- : O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
of IN O
transcription NN O
factor NN O
binding NN O
motifs NNS O
has VBZ O
been VBN O
carried VBN O
out RP O
in IN O
a DT O
variety NN O
of IN O
slightly RB O
differing VBG O
ways NNS O
in IN O
a DT O
wide JJ O
range NN O
of IN O
organisms NNS O
, , O
including VBG O
humans NNS B-Species
. . O

[ -LRB- O
22 CD O
] -RRB- O
- : O
[ -LRB- O
33 CD O
] -RRB- O
. . O

The DT O
underlying VBG O
hypothesis NN O
is VBZ O
that IN O
co NN O
- HYPH O
regulated VBN O
genes NNS O
, , O
identified VBN O
usually RB O
by IN O
gene NN O
expression NN O
studies NNS O
, , O
should MD O
contain VB O
specific JJ O
combinations NNS O
of IN O
transcription NN O
factor NN O
binding NN O
motifs NNS O
in IN O
their PRP$ O
upstream JJ O
regulatory JJ O
regions NNS O
, , O
the DT O
identification NN O
of IN O
which WDT O
would MD O
allow VB O
the DT O
reverse NN O
- HYPH O
engineering NN O
of IN O
transcription NN O
regulatory JJ O
networks NNS O
[ -LRB- O
34 CD O
] -RRB- O
. . O

We PRP O
have VBP O
recently RB O
applied VBN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
to IN O
studying VBG O
published VBN O
gene NN O
expression NN O
signatures NNS O
and CC O
showed VBD O
that IN O
co NN O
- HYPH O
occurrence NN O
patterns NNS O
of IN O
genes NNS O
reflect VBP O
cancer NN O
signaling VBG O
pathways NNS O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Although IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
has VBZ O
a DT O
respectable JJ O
history NN O
, , O
the DT O
methodologies NNS O
used VBN O
in IN O
the DT O
studies NNS O
mentioned VBN O
above RB O
could MD O
not RB O
be VB O
easily RB O
applied VBN O
to IN O
studying VBG O
gene NN O
expression NN O
signatures NNS O
. . O

There EX O
are VBP O
three CD O
main JJ O
reasons NNS O
that WDT O
dictated VBD O
the DT O
use NN O
of IN O
a DT O
different JJ O
approach NN O
. . O

First RB O
, , O
gene NN O
expression NN O
signatures NNS O
can MD O
vary VB O
in IN O
size NN O
by IN O
orders NNS O
of IN O
magnitude NN O
. . O

Obviously RB O
, , O
the DT O
larger JJR O
a DT O
signature NN O
the DT O
more RBR O
likely JJ O
it PRP O
is VBZ O
to TO O
find VB O
two CD O
or CC O
more JJR O
genes NNS O
co NN O
- HYPH O
occurring VBG O
in IN O
that DT O
signature NN O
. . O

Thus RB O
, , O
the DT O
significance NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
must MD O
be VB O
evaluated VBN O
in IN O
the DT O
presence NN O
of IN O
considerable JJ O
heterogeneity NN O
of IN O
co NN O
- HYPH O
occurrence NN O
probabilities NNS O
among IN O
gene NN O
lists NNS O
. . O

As IN O
a DT O
consequence NN O
, , O
the DT O
statistics NNS O
used VBN O
to TO O
evaluate VB O
the DT O
significance NN O
of IN O
co NN O
- HYPH O
occurrence NN O
events NNS O
must MD O
reflect VB O
this DT O
heterogeneity NN O
. . O

In IN O
particular JJ O
, , O
it PRP O
must MD O
be VB O
based VBN O
on IN O
list NN O
- HYPH O
specific JJ O
co NN O
- HYPH O
occurrence NN O
probabilities NNS O
. . O

Second RB O
, , O
in IN O
the DT O
vast JJ O
majority NN O
of IN O
previous JJ O
studies NNS O
, , O
co NN O
- HYPH O
occurrence NN O
is VBZ O
analyzed VBN O
for IN O
pair NN O
- HYPH O
wise JJ O
combinations NNS O
of IN O
co NN O
- HYPH O
occurring VBG O
entities NNS O
. . O

We PRP O
found VBD O
that IN O
the DT O
resulting VBG O
stringency NN O
of IN O
this DT O
approach NN O
is VBZ O
not RB O
adequate JJ O
for IN O
the DT O
analysis NN O
of IN O
published VBN O
gene NN O
expression NN O
signatures NNS O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Third RB O
, , O
the DT O
null NN O
- HYPH O
model NN O
against IN O
which WDT O
the DT O
significance NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
is VBZ O
tested VBN O
does VBZ O
not RB O
work VB O
well RB O
for IN O
gene NN O
expression NN O
signatures NNS O
. . O

A DT O
common JJ O
procedure NN O
is VBZ O
to TO O
use VB O
generic JJ O
randomization NN O
of IN O
the DT O
entire JJ O
data NNS O
set VBN O
under IN O
analysis NN O
or CC O
to TO O
select VB O
subsets NNS O
of IN O
data NN O
entries NNS O
randomly RB O
for IN O
comparison NN O
purposes NNS O
. . O

However RB O
, , O
gene NN O
expression NN O
signatures NNS O
are VBP O
composed VBN O
of IN O
distinct JJ O
gene NN O
sets NNS O
and CC O
the DT O
null NN O
- HYPH O
model NN O
must MD O
maintain VB O
this DT O
property NN O
, , O
which WDT O
is VBZ O
not RB O
guaranteed VBN O
using VBG O
these DT O
approaches NNS O
. . O

Furthermore RB O
, , O
the DT O
list NN O
- HYPH O
specific JJ O
nature NN O
of IN O
co NN O
- HYPH O
occurrence NN O
probabilities NNS O
cannot MD O
be VB O
dealt VBN O
with IN O
properly RB O
. . O

NetCutter NNP O
was VBD O
developed VBN O
to TO O
address VB O
these DT O
challenges NNS O
and CC O
to TO O
provide VB O
a DT O
generic JJ O
tool NN O
for IN O
generating VBG O
and CC O
analyzing VBG O
co NN O
- HYPH O
occurrence NN O
networks NNS O
. . O

Although IN O
NetCutter NNP O
has VBZ O
been VBN O
developed VBN O
for IN O
the DT O
analysis NN O
of IN O
gene NN O
expression NN O
signatures NNS O
, , O
it PRP O
is VBZ O
based VBN O
on IN O
abstract JJ O
concepts NNS O
that WDT O
make VBP O
it PRP O
applicable JJ O
to IN O
a DT O
wide JJ O
variety NN O
of IN O
problems NNS O
. . O

The DT O
input NN O
is VBZ O
represented VBN O
by IN O
a DT O
bipartite JJ O
graph NN O
that WDT O
is VBZ O
composed VBN O
of IN O
list NN O
- HYPH O
entry NN O
pairs NNS O
, , O
which WDT O
are VBP O
stored VBN O
in IN O
tab NN O
- HYPH O
separated VBN O
text NN O
format NN O
. . O

Co NN O
- HYPH O
occurrence NN O
of IN O
entries NNS O
in IN O
lists NNS O
is VBZ O
analyzed VBN O
using VBG O
pair NN O
- HYPH O
wise JJ O
or CC O
higher JJR O
order NN O
combinations NNS O
of IN O
entries NNS O
. . O

The DT O
significance NN O
of IN O
co NN O
- HYPH O
occurrence NN O
is VBZ O
tested VBN O
using VBG O
a DT O
novel JJ O
bi NN O
- HYPH O
binomial JJ O
approximation NN O
of IN O
Poisson NNP O
- HYPH O
binomial JJ O
statistics NNS O
( , O
which WDT O
is VBZ O
a DT O
binomial JJ O
distribution NN O
with IN O
trial NN O
specific JJ O
probabilities NNS O
) -RRB- O
that WDT O
handles VBZ O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
properly RB O
and CC O
provides VBZ O
a DT O
novel JJ O
measure NN O
of IN O
association NN O
that WDT O
is VBZ O
found VBN O
to TO O
be VB O
superior JJ O
to IN O
the DT O
Jaccard NNP O
and CC O
the DT O
uncertainty NN O
coefficients NNS O
. . O

Occurrence NN O
probabilities NNS O
are VBP O
obtained VBN O
from IN O
an DT O
edge NN O
- HYPH O
swapping VBG O
procedure NN O
that WDT O
maintains VBZ O
vertex NN O
degrees NNS O
in IN O
the DT O
underlying VBG O
bipartite JJ O
graph NN O
and CC O
distinct JJ O
sets NNS O
of IN O
entries NNS O
per IN O
list NN O
. . O

As IN O
we PRP O
shall MD O
see VB O
below RB O
, , O
this DT O
procedure NN O
has VBZ O
a DT O
number NN O
of IN O
advantages NNS O
over IN O
other JJ O
possible JJ O
null NN O
- HYPH O
models NNS O
and CC O
permits NNS O
co NN O
- HYPH O
occurrence NN O
analysis NN O
with IN O
near IN O
maximum JJ O
stringency NN O
. . O

Last JJ O
but CC O
not RB O
least JJS O
, , O
NetCutter NNP O
is VBZ O
equipped VBN O
with IN O
a DT O
number NN O
of IN O
algorithms NNS O
for IN O
the DT O
identification NN O
of IN O
network NN O
communities NNS O
, , O
vertex NN O
ranking NN O
, , O
and CC O
convenience NN O
tools NNS O
needed VBN O
in IN O
the DT O
analysis NN O
of IN O
co NN O
- HYPH O
occurrence NN O
networks NNS O
, , O
or CC O
any DT O
undirected JJ O
graph NN O
. . O

We PRP O
illustrate VBP O
the DT O
utility NN O
of IN O
NetCutter NNP O
in IN O
the DT O
identification NN O
of IN O
corresponding VBG O
clusters NNS O
of IN O
genes NNS O
and CC O
publications NNS O
from IN O
the DT O
PubLiME NNP O
data NNS O
set NN O
. . O

PubLiME NNP O
( , O
Published NNP O
Lists NNPS O
of IN O
Microarray NNP O
Experiments NNPS O
) , O
is VBZ O
a DT O
repository NN O
of IN O
published VBN O
cancer NN O
related VBN O
gene NN O
expression NN O
signatures NNS O
( , O
http JJ O
: : O
/ : O
/ : O
bio NN O
. . O
ifom JJ O
- HYPH O
ieo NN O
- HYPH O
campus NN O
. . O
it PRP O
/ NFP O
Publime NNP O
) -RRB- O
. . O

The DT O
concept NN O
of IN O
cluster NN O
correspondence NN O
follows VBZ O
from IN O
the DT O
bipartite JJ O
graph NN O
representation NN O
of IN O
the DT O
data NNS O
. . O

Reversing VBG O
the DT O
list NN O
- HYPH O
entry NN O
order NN O
in IN O
the DT O
bipartite JJ O
graph NN O
permits NNS O
identifying VBG O
communities NNS O
of IN O
entries NNS O
as RB O
well RB O
as IN O
communities NNS O
of IN O
lists NNS O
. . O

We PRP O
show VBP O
that IN O
communities NNS O
of IN O
publications NNS O
corresponding VBG O
to IN O
communities NNS O
of IN O
genes NNS O
in IN O
the DT O
PubLiME NNP O
data NNS O
set NN O
can MD O
be VB O
used VBN O
to TO O
generate VB O
hypotheses NNS O
about IN O
the DT O
putative JJ O
function NN O
of IN O
gene NN O
communities NNS O
. . O

Results NNS O

The DT O
bipartite JJ O
graph NN O
model NN O
of IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
using VBG O
NetCutter NNP O
is VBZ O
based VBN O
on IN O
the DT O
abstraction NN O
of IN O
list NN O
- HYPH O
entry NN O
pairs NNS O
. . O

Any DT O
entity NN O
that WDT O
co VBP O
- HYPH O
occurs VBZ O
with IN O
some DT O
other JJ O
entity NN O
must MD O
be VB O
confined VBN O
to IN O
some DT O
sort NN O
of IN O
container NN O
where WRB O
co NN O
- HYPH O
occurrence NN O
is VBZ O
observed VBN O
. . O

For IN O
example NN O
, , O
in IN O
the DT O
case NN O
of IN O
gene NN O
name NN O
co NN O
- HYPH O
occurrence NN O
in IN O
PubMed NNP O
abstracts NNS O
, , O
the DT O
abstract JJ O
is VBZ O
the DT O
container NN O
and CC O
the DT O
gene NN O
names NNS O
are VBP O
the DT O
co NN O
- HYPH O
occurring VBG O
entities NNS O
. . O

Similarly RB O
, , O
co NN O
- HYPH O
occurrence NN O
of IN O
transcription NN O
factor NN O
binding NN O
motifs NNS O
is VBZ O
observed VBN O
in IN O
gene NN O
promoters NNS O
. . O

The DT O
promoters NNS O
are VBP O
the DT O
containers NNS O
where WRB O
motif NN O
entities NNS O
co VBP O
- HYPH O
occur VBP O
. . O

The DT O
containers NNS O
generally RB O
host VBP O
more JJR O
than IN O
one CD O
entity NN O
( , O
otherwise RB O
co NN O
- HYPH O
occurrence NN O
would MD O
be VB O
impossible JJ O
) -RRB- O
and CC O
can MD O
be VB O
conveniently RB O
interpreted VBN O
as IN O
lists NNS O
. . O

The DT O
co NN O
- HYPH O
occurring VBG O
entities NNS O
are VBP O
the DT O
list NN O
entries NNS O
. . O

Lists NNS O
and CC O
entries NNS O
form VBP O
a DT O
bipartite JJ O
graph NN O
with IN O
one CD O
part NN O
of IN O
the DT O
graph NN O
representing VBG O
lists NNS O
and CC O
the DT O
other JJ O
part NN O
representing VBG O
entries NNS O
. . O

The DT O
presence NN O
of IN O
a DT O
given VBN O
entry NN O
in IN O
a DT O
given VBN O
list NN O
is VBZ O
indicated VBN O
by IN O
an DT O
edge NN O
between IN O
the DT O
corresponding VBG O
list NN O
and CC O
entry NN O
vertices NNS O
. . O

It PRP O
is VBZ O
required VBN O
that IN O
each DT O
entry NN O
can MD O
be VB O
linked VBN O
to IN O
the DT O
same JJ O
list NN O
only RB O
once RB O
. . O

Without IN O
loss NN O
of IN O
generality NN O
, , O
let VB O
' '' O
s VBZ O
consider VB O
genes NNS O
as IN O
entries NNS O
and CC O
PubMedID NN O
_ : O
listIDs NNS O
as IN O
lists NNS O
in IN O
the DT O
following VBG O
, , O
unless IN O
otherwise RB O
specified VBN O
( , O
Fig NNP O
. . O
1A NN O
) -RRB- O
. . O

This DT O
interpretation NN O
of IN O
lists NNS O
and CC O
entries NNS O
has VBZ O
been VBN O
applied VBN O
in IN O
the DT O
co NN O
- HYPH O
occurrence NN O
analysis NN O
of IN O
published VBN O
gene NN O
expression NN O
signatures NNS O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Occurrence NN O
probabilities NNS O
and CC O
null NN O
- HYPH O
models NNS O

A DT O
prerequisite NN O
for IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
is VBZ O
the DT O
availability NN O
of IN O
occurrence NN O
probabilities NNS O
of IN O
genes NNS O
per IN O
list NN O
. . O

The DT O
occurrence NN O
probabilities NNS O
can MD O
be VB O
derived VBN O
from IN O
randomizing VBG O
the DT O
bipartite JJ O
graph NN O
and CC O
are VBP O
dependent JJ O
on IN O
the DT O
choice NN O
of IN O
the DT O
null NN O
- HYPH O
model NN O
. . O

A DT O
null NN O
- HYPH O
model NN O
creates VBZ O
an DT O
occurrence NN O
probability NN O
matrix NN O
where WRB O
the DT O
occurrence NN O
probability NN O
for IN O
each DT O
list NN O
- HYPH O
gene NN O
pair NN O
is VBZ O
listed VBN O
. . O

As IN O
a DT O
general JJ O
property NN O
of IN O
this DT O
matrix NN O
, , O
the DT O
sum NN O
of IN O
all DT O
matrix NN O
elements NNS O
must MD O
equal VB O
the DT O
number NN O
of IN O
edges NNS O
in IN O
the DT O
bipartite JJ O
graph NN O
. . O

This DT O
is VBZ O
because IN O
each DT O
edge NN O
is VBZ O
linked VBN O
to IN O
either DT O
side NN O
of IN O
the DT O
bipartite NN O
graph NN O
with IN O
certainty NN O
and CC O
therefore RB O
the DT O
sum NN O
of IN O
occurrence NN O
probabilities NNS O
over IN O
all DT O
lists NNS O
( , O
which WDT O
can MD O
be VB O
calculated VBN O
as IN O
the DT O
row NN O
sum NN O
if IN O
genes NNS O
are VBP O
listed VBN O
vertically RB O
or CC O
as IN O
the DT O
column NN O
sum NN O
if IN O
genes NNS O
are VBP O
listed VBN O
horizontally RB O
) , O
followed VBN O
by IN O
summing VBG O
the DT O
results NNS O
over IN O
all DT O
genes NNS O
must MD O
be VB O
1 CD O
for IN O
every DT O
edge NN O
. . O

The DT O
number NN O
of IN O
matrix NN O
elements NNS O
is VBZ O
given VBN O
by IN O
# NN O
genes NNS O
* NFP O
# NN O
lists NNS O
and CC O
therefore RB O
the DT O
average JJ O
occurrence NN O
probability NN O
for IN O
any DT O
null NN O
- HYPH O
model NN O
must MD O
be VB O
# $ O
edges NNS O
/ SYM O
( : O
# NN O
genes NNS O
* NFP O
# NN O
lists NNS O
) -RRB- O
. . O

As IN O
a DT O
consequence NN O
, , O
different JJ O
null NN O
- HYPH O
models NNS O
will MD O
only RB O
be VB O
distinguished VBN O
by IN O
the DT O
way NN O
they PRP O
attribute VBP O
occurrence NN O
probabilities NNS O
to IN O
vertices NNS O
with IN O
different JJ O
vertex NN O
degrees NNS O
but CC O
not RB O
by IN O
the DT O
average JJ O
occurrence NN O
probability NN O
. . O

We PRP O
consider VBP O
six CD O
different JJ O
strategies NNS O
to TO O
randomize VB O
the DT O
bipartite JJ O
graph NN O
. . O

First RB O
, , O
we PRP O
could MD O
reconnect VB O
all DT O
edges NNS O
of IN O
the DT O
graph NN O
randomly RB O
. . O

The DT O
probability NN O
of IN O
being VBG O
connected VBN O
by IN O
an DT O
edge NN O
for IN O
a DT O
given VBN O
list NN O
- HYPH O
gene NN O
pair NN O
is VBZ O
given VBN O
by IN O
( : O
1 CD O
/ SYM O
# NN O
genes NNS O
) -RRB- O
* NFP O
( , O
1 CD O
/ SYM O
# NN O
lists NNS O
) -RRB- O
. . O

Since IN O
there EX O
are VBP O
# $ O
edges NNS O
edges NNS O
to TO O
be VB O
reconnected VBN O
, , O
the DT O
occurrence NN O
probability NN O
for IN O
a DT O
single JJ O
list NN O
- HYPH O
gene NN O
pair NN O
is VBZ O
# NN O
edges NNS O
/ SYM O
( : O
# NN O
genes NNS O
* NFP O
# NN O
lists NNS O
) -RRB- O
, , O
i PRP O
. . O
e LS O
. . O
equal JJ O
to IN O
the DT O
average JJ O
occurrence NN O
probability NN O
. . O

Thus RB O
, , O
this DT O
model NN O
provides VBZ O
equal JJ O
occurrence NN O
probabilities NNS O
for IN O
all DT O
gene NN O
- HYPH O
list NN O
pairs NNS O
and CC O
does VBZ O
not RB O
consider VB O
vertex NN O
degrees NNS O
. . O

We PRP O
call VBP O
this DT O
model NN O
the DT O
generic JJ O
randomization NN O
( -LRB- O
GR NNP O
) -RRB- O
model NN O
in IN O
the DT O
following VBG O
. . O

Second RB O
, , O
we PRP O
could MD O
disconnect VB O
the DT O
edges NNS O
on IN O
only RB O
the DT O
list NN O
side NN O
of IN O
the DT O
bipartite JJ O
graph NN O
and CC O
reconnect VB O
them PRP O
randomly RB O
. . O

The DT O
occurrence NN O
probability NN O
of IN O
a DT O
gene NN O
vertex NN O
would MD O
be VB O
given VBN O
by IN O
( HYPH O
gene NN O
vertex NN O
degree NN O
) , O
/ SYM O
# NN O
lists NNS O
. . O

The DT O
sum NN O
of IN O
these DT O
probabilities NNS O
over IN O
all DT O
lists NNS O
is VBZ O
equal JJ O
to IN O
the DT O
gene NN O
vertex NN O
degree NN O
and CC O
the DT O
sum NN O
of IN O
all DT O
gene NN O
vertex NN O
degrees NNS O
is VBZ O
equal JJ O
to IN O
the DT O
total JJ O
number NN O
of IN O
edges NNS O
. . O

Thus RB O
, , O
the DT O
sum NN O
of IN O
all DT O
matrix NN O
elements NNS O
is VBZ O
equal JJ O
to IN O
the DT O
number NN O
of IN O
edges NNS O
, , O
as IN O
required VBN O
. . O

Since IN O
this DT O
model NN O
considers VBZ O
gene NN O
vertex NN O
degrees NNS O
, , O
we PRP O
call VBP O
it PRP O
the DT O
gene NN O
vertex NN O
degree NN O
( -LRB- O
GVD NNP O
) -RRB- O
model NN O
. . O

Third RB O
, , O
we PRP O
disconnect VBP O
the DT O
edges NNS O
on IN O
the DT O
gene NN O
side NN O
of IN O
the DT O
bipartite JJ O
graph NN O
and CC O
reconnect VBP O
them PRP O
randomly RB O
. . O

The DT O
probability NN O
of IN O
a DT O
list NN O
vertex NN O
being VBG O
connected VBN O
to IN O
a DT O
gene NN O
would MD O
be VB O
given VBN O
by IN O
( HYPH O
list NN O
vertex NN O
degree NN O
) -RRB- O
/ SYM O
# NN O
genes NNS O
. . O

The DT O
sum NN O
of IN O
these DT O
probabilities NNS O
over IN O
all DT O
genes NNS O
is VBZ O
equal JJ O
to IN O
the DT O
list NN O
vertex NN O
degree NN O
and CC O
the DT O
sum NN O
of IN O
all DT O
list NN O
vertex NN O
degrees NNS O
is VBZ O
equal JJ O
to IN O
the DT O
total JJ O
number NN O
of IN O
edges NNS O
. . O

Again RB O
, , O
the DT O
sum NN O
of IN O
all DT O
matrix NN O
elements NNS O
is VBZ O
equal JJ O
to IN O
the DT O
total JJ O
number NN O
of IN O
edges NNS O
. . O

Since IN O
this DT O
model NN O
considers VBZ O
list NN O
vertex NN O
degrees NNS O
, , O
we PRP O
call VBP O
it PRP O
the DT O
list NN O
vertex NN O
degree NN O
( -LRB- O
LVD NNP O
) -RRB- O
model NN O
. . O

In IN O
model NN O
four CD O
and CC O
five CD O
, , O
we PRP O
reconnect VBP O
edges NNS O
considering VBG O
both CC O
gene NN O
and CC O
list VBP O
vertex NN O
degrees NNS O
and CC O
allow VBP O
multiple JJ O
edges NNS O
between IN O
list NN O
- HYPH O
gene NN O
pairs NNS O
. . O

The DT O
occurrence NN O
probabilities NNS O
in IN O
model NN O
four CD O
are VBP O
calculated VBN O
according VBG O
to IN O
the DT O
binomial JJ O
distribution NN O
. . O

We PRP O
calculate VBP O
the DT O
probability NN O
of IN O
a DT O
list NN O
- HYPH O
gene NN O
pair NN O
for IN O
being VBG O
connected VBN O
as IN O
the DT O
cumulative JJ O
binomial JJ O
probability NN O
of IN O
the DT O
list NN O
- HYPH O
gene NN O
pair NN O
being VBG O
chosen VBN O
at IN O
least JJS O
once RB O
in IN O
the DT O
process NN O
of IN O
randomly RB O
reconnecting VBG O
the DT O
edges NNS O
. . O

This DT O
can MD O
be VB O
achieved VBN O
by IN O
setting VBG O
the DT O
number NN O
of IN O
trials NNS O
equal JJ O
to IN O
the DT O
gene NN O
vertex NN O
degree NN O
, , O
the DT O
probability NN O
of IN O
success NN O
equal JJ O
to IN O
the DT O
list NN O
vertex NN O
degree NN O
divided VBN O
by IN O
the DT O
total JJ O
number NN O
of IN O
edges NNS O
, , O
and CC O
the DT O
number NN O
of IN O
successes NNS O
equal JJ O
to IN O
0 CD O
. . O

The DT O
occurrence NN O
probability NN O
of IN O
a DT O
list NN O
- HYPH O
gene NN O
pair NN O
is VBZ O
then RB O
given VBN O
by IN O
the DT O
complement NN O
of IN O
this DT O
probability NN O
. . O

This DT O
model NN O
is VBZ O
called VBN O
the DT O
binomial NN O
( , O
BN NNP O
) -RRB- O
model NN O
. . O

In IN O
model NN O
five CD O
, , O
we PRP O
calculate VBP O
occurrence NN O
probabilities NNS O
according VBG O
to IN O
the DT O
hypergeometric JJ O
distribution NN O
. . O

The DT O
number NN O
of IN O
successes NNS O
in IN O
the DT O
sample NN O
is VBZ O
equal JJ O
to IN O
0 CD O
, , O
the DT O
sample NN O
size NN O
is VBZ O
equal JJ O
to IN O
the DT O
gene NN O
vertex NN O
degree NN O
, , O
the DT O
number NN O
of IN O
successes NNS O
in IN O
the DT O
population NN O
is VBZ O
set VBN O
to IN O
the DT O
list NN O
vertex NN O
degree NN O
, , O
and CC O
the DT O
population NN O
size NN O
is VBZ O
the DT O
total JJ O
number NN O
of IN O
edges NNS O
. . O

Again RB O
, , O
the DT O
occurrence NN O
probability NN O
of IN O
a DT O
list NN O
- HYPH O
gene NN O
pair NN O
is VBZ O
obtained VBN O
as IN O
the DT O
complement NN O
of IN O
this DT O
probability NN O
. . O

We PRP O
call VBP O
this DT O
model NN O
the DT O
hypergeometric JJ O
( , O
HG NNP O
) -RRB- O
model NN O
. . O

Calculating VBG O
occurrence NN O
probabilities NNS O
in IN O
this DT O
manner NN O
does VBZ O
not RB O
guarantee VB O
that IN O
the DT O
matrix NN O
elements NNS O
add VBP O
up RP O
to IN O
the DT O
total JJ O
number NN O
of IN O
edges NNS O
. . O

Therefore RB O
, , O
the DT O
matrices NNS O
are VBP O
normalized VBN O
such JJ O
that IN O
this DT O
condition NN O
is VBZ O
satisfied VBN O
by IN O
multiplying VBG O
each DT O
matrix NN O
element NN O
with IN O
the DT O
factor NN O
# NN O
edges NNS O
/ SYM O
( HYPH O
observed VBN O
matrix NN O
sum NN O
) -RRB- O
, , O
which WDT O
is VBZ O
generally RB O
quite RB O
close JJ O
to IN O
1 CD O
, , O
however RB O
. . O

In IN O
model NN O
six CD O
, , O
we PRP O
again RB O
consider VBP O
vertex NN O
degrees NNS O
, , O
but CC O
we PRP O
require VBP O
that IN O
each DT O
list NN O
is VBZ O
composed VBN O
of IN O
distinct JJ O
sets NNS O
of IN O
genes NNS O
. . O

Thus RB O
, , O
multiple JJ O
edges NNS O
are VBP O
forbidden VBN O
. . O

This DT O
condition NN O
is VBZ O
satisfied VBN O
by IN O
applying VBG O
an DT O
edge NN O
- HYPH O
swapping VBG O
procedure NN O
during IN O
graph NN O
randomization NN O
. . O

Edge NN O
- HYPH O
swapping VBG O
works NNS O
by IN O
randomly RB O
choosing VBG O
two CD O
list NN O
- HYPH O
gene NN O
pairs NNS O
from IN O
the DT O
bipartite JJ O
graph NN O
and CC O
prior RB O
to IN O
performing VBG O
the DT O
edge NN O
- HYPH O
swap NN O
, , O
a DT O
test NN O
is VBZ O
performed VBN O
to TO O
ensure VB O
that IN O
the DT O
two CD O
genes NNS O
are VBP O
not RB O
already RB O
linked VBN O
to IN O
the DT O
respective JJ O
target NN O
lists NNS O
. . O

This DT O
procedure NN O
is VBZ O
performed VBN O
a DT O
large JJ O
number NN O
of IN O
times NNS O
. . O

To TO O
ensure VB O
complete JJ O
randomization NN O
of IN O
the DT O
graph NN O
, , O
the DT O
number NN O
of IN O
swaps NNS O
performed VBN O
should MD O
be VB O
significantly RB O
larger JJR O
than IN O
the DT O
number NN O
of IN O
edges NNS O
. . O

After IN O
performing VBG O
R NN O
randomizations NNS O
of IN O
the DT O
graph NN O
and CC O
counting VBG O
the DT O
number NN O
of IN O
times NNS O
a DT O
gene NN O
has VBZ O
been VBN O
linked VBN O
to IN O
a DT O
particular JJ O
list NN O
, , O
division NN O
of IN O
this DT O
number NN O
by IN O
R NN O
gives VBZ O
the DT O
occurrence NN O
probability NN O
of IN O
a DT O
gene NN O
in IN O
a DT O
given VBN O
list NN O
. . O

As IN O
will MD O
be VB O
shown VBN O
below RB O
, , O
edge NN O
- HYPH O
swapping VBG O
produces VBZ O
occurrence NN O
probabilities NNS O
that WDT O
closely RB O
approximate VBP O
occurrence NN O
probabilities NNS O
obtained VBN O
by IN O
generating VBG O
a DT O
complete JJ O
permutation NN O
set VBN O
of IN O
the DT O
bipartite JJ O
graph NN O
, , O
counting VBG O
the DT O
number NN O
of IN O
times NNS O
a DT O
gene NN O
is VBZ O
found VBN O
part NN O
of IN O
a DT O
list NN O
, , O
and CC O
dividing VBG O
this DT O
number NN O
by IN O
the DT O
total JJ O
number NN O
of IN O
permutations NNS O
. . O

In IN O
the DT O
permutation NN O
model NN O
, , O
the DT O
sum NN O
of IN O
occurrence NN O
probabilities NNS O
of IN O
a DT O
gene NN O
over IN O
all DT O
lists NNS O
equals VBZ O
the DT O
gene NN O
vertex NN O
degree NN O
( , O
see VB O
below RB O
) -RRB- O
and CC O
thus RB O
the DT O
sum NN O
of IN O
all DT O
matrix NN O
elements NNS O
is VBZ O
the DT O
number NN O
of IN O
edges NNS O
. . O

Since IN O
permutation NN O
sets NNS O
of IN O
bipartite JJ O
graphs NNS O
are VBP O
difficult JJ O
to TO O
calculate VB O
, , O
we PRP O
use VBP O
the DT O
edge NN O
- HYPH O
swapping VBG O
procedure NN O
as IN O
a DT O
close JJ O
approximation NN O
and CC O
call VBP O
this DT O
model NN O
the DT O
edge NN O
- HYPH O
swapping NN O
( -LRB- O
ES NNP O
) -RRB- O
model NN O
. . O

Fig NN O
. . O

1 CD O
shows VBZ O
the DT O
occurrence NN O
probabilities NNS O
of IN O
the DT O
different JJ O
null NN O
- HYPH O
models NNS O
for IN O
the DT O
bipartite JJ O
graph NN O
shown VBN O
in IN O
Fig NNP O
. . O

1A NN O
. . O

The DT O
GR NNP O
model NN O
yields VBZ O
identical JJ O
occurrence NN O
probabilities NNS O
for IN O
all DT O
list NN O
- HYPH O
gene NN O
pairs NNS O
, , O
which WDT O
is VBZ O
equal JJ O
to IN O
the DT O
average JJ O
occurrence NN O
probability NN O
in IN O
all DT O
models NNS O
. . O

In IN O
the DT O
other JJ O
models NNS O
, , O
the DT O
occurrence NN O
probabilities NNS O
deviate VBP O
to IN O
varying VBG O
extent NN O
from IN O
the DT O
average JJ O
occurrence NN O
probability NN O
as IN O
a DT O
function NN O
of IN O
vertex NN O
degrees NNS O
. . O

In IN O
the DT O
GVD NNP O
model NN O
, , O
the DT O
deviations NNS O
are VBP O
a DT O
function NN O
of IN O
gene NN O
vertex NN O
degree NN O
and CC O
in IN O
the DT O
LVD NNP O
model NN O
the DT O
deviations NNS O
are VBP O
dependent JJ O
on IN O
list NN O
vertex NN O
degrees NNS O
. . O

In IN O
the DT O
remaining VBG O
models NNS O
, , O
the DT O
deviations NNS O
are VBP O
functions NNS O
of IN O
both CC O
the DT O
gene NN O
and CC O
the DT O
list NN O
vertex NN O
degrees NNS O
. . O

In IN O
all DT O
cases NNS O
, , O
larger JJR O
than IN O
average JJ O
occurrence NN O
probabilities NNS O
are VBP O
obtained VBN O
for IN O
larger JJR O
vertex NN O
degrees NNS O
at IN O
the DT O
expense NN O
of IN O
smaller JJR O
than IN O
average JJ O
occurrence NN O
probabilities NNS O
for IN O
smaller JJR O
vertex NN O
degrees NNS O
. . O

From IN O
these DT O
data NNS O
, , O
it PRP O
is VBZ O
difficult JJ O
to TO O
choose VB O
the DT O
most RBS O
effective JJ O
null NN O
- HYPH O
model NN O
. . O

A DT O
hint NN O
can MD O
be VB O
gleaned VBN O
from IN O
gene1 NN O
, , O
however RB O
. . O

Gene1 NNP O
is VBZ O
present JJ O
in IN O
all DT O
lists NNS O
. . O

Therefore RB O
, , O
the DT O
co NN O
- HYPH O
occurrence NN O
probability NN O
of IN O
gene1 NN O
with IN O
other JJ O
genes NNS O
, , O
which WDT O
is VBZ O
calculated VBN O
by IN O
multiplying VBG O
the DT O
occurrence NN O
probabilities NNS O
of IN O
gene1 NN O
and CC O
geneX NN O
for IN O
every DT O
list NN O
under IN O
study NN O
, , O
should MD O
depend VB O
only RB O
on IN O
the DT O
occurrence NN O
probability NN O
of IN O
this DT O
other JJ O
gene NN O
. . O

In IN O
other JJ O
words NNS O
, , O
the DT O
occurrence NN O
probability NN O
of IN O
gene1 NN O
in IN O
all DT O
lists NNS O
should MD O
be VB O
1 CD O
. . O
0 NFP O
. . O

Only RB O
two CD O
models NNS O
satisfy VBP O
this DT O
constraint NN O
: : O
The DT O
GVD NNP O
and CC O
the DT O
ES NNP O
models NNS O
. . O

Since IN O
the DT O
GVD NNP O
model NN O
does VBZ O
not RB O
consider VB O
list NN O
vertex NN O
degrees NNS O
, , O
it PRP O
seems VBZ O
that IN O
the DT O
ES NNP O
model NN O
is VBZ O
the DT O
preferred VBN O
null NN O
- HYPH O
model NN O
. . O

Expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O

As IN O
a DT O
general JJ O
criterion NN O
for IN O
comparing VBG O
the DT O
effectiveness NN O
of IN O
different JJ O
null NN O
- HYPH O
models NNS O
, , O
we PRP O
have VBP O
to TO O
compare VB O
them PRP O
for IN O
the DT O
number NN O
of IN O
expected VBN O
co NN O
- HYPH O
occurrences NNS O
. . O

The DT O
most RBS O
effective JJ O
null NN O
- HYPH O
model NN O
will MD O
be VB O
the DT O
one NN O
that WDT O
maximizes VBZ O
the DT O
expected JJ O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
. . O

If IN O
the DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
is VBZ O
larger JJR O
, , O
an DT O
observed JJ O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
in IN O
a DT O
real JJ O
bipartite JJ O
graph NN O
will MD O
be VB O
less RBR O
significant JJ O
and CC O
thus RB O
such PDT O
a DT O
null NN O
- HYPH O
model NN O
permits NNS O
co NN O
- HYPH O
occurrence NN O
analysis NN O
with IN O
higher JJR O
stringency NN O
. . O

The DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
depends VBZ O
in IN O
an DT O
obvious JJ O
fashion NN O
on IN O
the DT O
list NN O
vertex NN O
degree NN O
. . O

If IN O
pair NN O
- HYPH O
wise JJ O
co NN O
- HYPH O
occurrences NNS O
are VBP O
considered VBN O
, , O
the DT O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
in IN O
a DT O
list NN O
of IN O
vertex NN O
degree NN O
N NNP O
is VBZ O
given VBN O
by IN O
the DT O
binomial JJ O
coefficient JJ O
N NNP O
over IN O
2 CD O
. . O

Larger JJR O
lists NNS O
will MD O
give VB O
rise NN O
to IN O
more JJR O
co NN O
- HYPH O
occurrences NNS O
and CC O
the DT O
number NN O
increases VBZ O
quickly RB O
with IN O
list NN O
vertex NN O
degree NN O
. . O

The DT O
dependency NN O
of IN O
the DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
on IN O
the DT O
gene NN O
vertex NN O
degree NN O
is VBZ O
less RBR O
obvious JJ O
and CC O
depends VBZ O
strongly RB O
on IN O
the DT O
null NN O
- HYPH O
model NN O
. . O

A DT O
gene NN O
that WDT O
is VBZ O
part NN O
of IN O
a DT O
list NN O
with IN O
vertex NN O
degree NN O
N NNP O
will MD O
give VB O
rise NN O
to IN O
N NN O
- HYPH O
1 CD O
co NN O
- HYPH O
occurrences NNS O
in IN O
that DT O
list NN O
. . O

The DT O
null NN O
- HYPH O
model NN O
permits NNS O
calculating VBG O
the DT O
probability NN O
to TO O
find VB O
this DT O
gene NN O
in IN O
a DT O
given VBN O
list NN O
. . O

Thus RB O
, , O
the DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
of IN O
a DT O
gene NN O
is VBZ O
given VBN O
by IN O
the DT O
sum NN O
of IN O
expected VBN O
co NN O
- HYPH O
occurrences NNS O
in IN O
all DT O
lists NNS O
where WRB O
for IN O
a DT O
single JJ O
list NN O
the DT O
expected JJ O
co NN O
- HYPH O
occurrences NNS O
are VBP O
given VBN O
by IN O
( , O
Nl NNP O
- HYPH O
1 CD O
) -RRB- O
* NFP O
pl XX O
. . O

Nl NNP O
is VBZ O
the DT O
list NN O
vertex NN O
degree NN O
and CC O
pl NN O
is VBZ O
the DT O
occurrence NN O
probability NN O
of IN O
the DT O
gene NN O
in IN O
that DT O
list NN O
as IN O
determined VBN O
by IN O
the DT O
null NN O
- HYPH O
model NN O
. . O

We PRP O
used VBD O
the DT O
PubLiME NNP O
data NNS O
set VBN O
[ -LRB- O
35 CD O
] -RRB- O
to TO O
calculate VB O
the DT O
expected JJ O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
with IN O
different JJ O
null NN O
- HYPH O
models NNS O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Fig NNP O
2A NNP O
. . O

The DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
was VBD O
calculated VBN O
for IN O
all DT O
genes NNS O
in IN O
all DT O
lists NNS O
using VBG O
all DT O
null JJ O
- HYPH O
models NNS O
and CC O
the DT O
sum NN O
of IN O
expected VBN O
co NN O
- HYPH O
occurrences NNS O
per IN O
gene NN O
is VBZ O
shown VBN O
as IN O
a DT O
scatter NN O
plot NN O
with IN O
the DT O
gene NN O
vertex NN O
degree NN O
on IN O
the DT O
x NN O
- HYPH O
axis NN O
and CC O
the DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
on IN O
the DT O
y NN O
- HYPH O
axis NN O
. . O

The DT O
results NNS O
in IN O
Fig NNP O
. . O

2A NNP O
suggest VB O
the DT O
following VBG O
ranking NN O
of IN O
null JJ O
- HYPH O
models NNS O
: : O
GR NNP O
< : O
GVD NNP O
< SYM O
LVD NNP O
< SYM O
BN NNP O
= SYM O
HG NNP O
< SYM O
ES NNP O
. . O

The DT O
BN NNP O
and CC O
the DT O
HG NNP O
models NNS O
perform VBP O
in IN O
an DT O
essentially RB O
identical JJ O
way NN O
. . O

However RB O
, , O
the DT O
ES NNP O
model NN O
is VBZ O
the DT O
model NN O
that WDT O
yields VBZ O
the DT O
largest JJS O
estimates NNS O
of IN O
expected VBN O
co NN O
- HYPH O
occurrences NNS O
. . O

The DT O
results NNS O
are VBP O
also RB O
in IN O
line NN O
with IN O
the DT O
intuitive JJ O
expectation NN O
that IN O
genes NNS O
with IN O
higher JJR O
vertex NN O
degree NN O
give VBP O
rise NN O
to IN O
more JJR O
co NN O
- HYPH O
occurrences NNS O
. . O

However RB O
, , O
it PRP O
can MD O
be VB O
seen VBN O
that IN O
this DT O
is VBZ O
not RB O
true JJ O
for IN O
all DT O
null NN O
- HYPH O
models NNS O
. . O

In IN O
particular JJ O
, , O
it PRP O
is VBZ O
not RB O
true JJ O
for IN O
the DT O
GR NNP O
and CC O
the DT O
LVD NNP O
models NNS O
, , O
which WDT O
do VBP O
not RB O
consider VB O
gene NN O
vertex NN O
degrees NNS O
. . O

As IN O
outlined VBN O
above RB O
, , O
it PRP O
is VBZ O
expected VBN O
that IN O
the DT O
null NN O
- HYPH O
model NN O
that WDT O
yields VBZ O
the DT O
highest JJS O
estimates NNS O
of IN O
expected VBN O
co NN O
- HYPH O
occurrences NNS O
should MD O
permit VB O
co NN O
- HYPH O
occurrence NN O
analysis NN O
with IN O
the DT O
highest JJS O
stringency NN O
. . O

In IN O
Fig NNP O
. . O

2B NN O
, , O
this DT O
hypothesis NN O
is VBZ O
tested VBN O
directly RB O
again RB O
using VBG O
the DT O
PubLiME NNP O
data NNS O
set VBN O
[ -LRB- O
35 CD O
] -RRB- O
. . O

For IN O
all DT O
null JJ O
- HYPH O
models NNS O
, , O
co NN O
- HYPH O
occurrence NN O
analysis NN O
was VBD O
carried VBN O
out RP O
using VBG O
module NN O
size NN O
3 CD O
and CC O
support VB O
5 CD O
( HYPH O
co NN O
- HYPH O
occurrence NN O
modules NNS O
must MD O
be VB O
present JJ O
in IN O
at RB O
least RBS O
five CD O
publications NNS O
) -RRB- O
. . O

The DT O
choice NN O
of IN O
these DT O
parameters NNS O
has VBZ O
been VBN O
discussed VBN O
in IN O
[ -LRB- O
35 CD O
] -RRB- O
. . O

The DT O
number NN O
of IN O
co NN O
- HYPH O
occurrence NN O
modules NNS O
was VBD O
then RB O
determined VBN O
that WDT O
have VBP O
a DT O
Z NN O
- HYPH O
score NN O
higher JJR O
or CC O
equal JJ O
than IN O
the DT O
cut NN O
- HYPH O
off NN O
shown VBN O
in IN O
Fig NNP O
. . O

2B NN O
. . O

The DT O
Z NN O
- HYPH O
score NN O
is VBZ O
calculated VBN O
from IN O
the DT O
mean NN O
and CC O
variance NN O
of IN O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
as IN O
shown VBN O
in IN O
the DT O
Materials NNPS O
and CC O
Methods NNPS O
section NN O
and CC O
published VBN O
in IN O
[ -LRB- O
35 CD O
] -RRB- O
. . O

More JJR O
details NNS O
on IN O
the DT O
probability NN O
distribution NN O
will MD O
be VB O
provided VBN O
below RB O
. . O

The DT O
GR NNP O
and CC O
GVD NNP O
models NNS O
perform VBP O
very RB O
poorly RB O
and CC O
identify VBP O
large JJ O
numbers NNS O
of IN O
modules NNS O
with IN O
high JJ O
Z NN O
- HYPH O
scores NNS O
. . O

The DT O
LVD NNP O
model NN O
performs VBZ O
a DT O
little JJ O
better RBR O
and CC O
approximates VBZ O
the DT O
BN NNP O
and CC O
HG NNP O
models NNS O
at IN O
higher JJR O
Z NN O
- HYPH O
score NN O
cut NN O
- HYPH O
offs NNS O
. . O

The DT O
BN NNP O
and CC O
HG NNP O
models NNS O
give VBP O
essentially RB O
identical JJ O
results NNS O
. . O

However RB O
, , O
the DT O
ES NNP O
model NN O
is VBZ O
the DT O
model NN O
that WDT O
yields VBZ O
the DT O
fewest JJS O
number NN O
of IN O
significant JJ O
co NN O
- HYPH O
occurrence NN O
modules NNS O
and CC O
is VBZ O
thus RB O
the DT O
most RBS O
stringent JJ O
. . O

The DT O
increased VBN O
stringency NN O
of IN O
the DT O
ES NNP O
model NN O
over IN O
the DT O
BN NNP O
and CC O
HG NNP O
models NNS O
is VBZ O
also RB O
reflected VBN O
in IN O
a DT O
higher JJR O
signal NN O
- HYPH O
to IN O
- HYPH O
noise NN O
ratio NN O
calculated VBN O
as IN O
the DT O
number NN O
of IN O
significant JJ O
co NN O
- HYPH O
occurrence NN O
modules NNS O
in IN O
the DT O
real JJ O
bipartite NN O
graph NN O
divided VBN O
by IN O
the DT O
number NN O
of IN O
modules NNS O
found VBN O
in IN O
a DT O
randomized VBN O
bipartite JJ O
graph NN O
( HYPH O
Fig NNP O
. . O
2C NNP O
) -RRB- O
. . O

The DT O
reason NN O
for IN O
the DT O
superior JJ O
stringency NN O
of IN O
the DT O
ES NNP O
model NN O
over IN O
all DT O
other JJ O
models NNS O
can MD O
be VB O
explained VBN O
by IN O
examining VBG O
the DT O
average JJ O
occurrence NN O
probability NN O
per IN O
gene NN O
and CC O
list NN O
vertex NN O
degree NN O
. . O

Fig NN O
. . O

2D NN O
and CC O
E NNP O
show VBP O
the DT O
average JJ O
occurrence NN O
probability NN O
of IN O
genes NNS O
with IN O
the DT O
same JJ O
gene NN O
vertex NN O
degree NN O
as IN O
a DT O
function NN O
of IN O
the DT O
gene NN O
vertex NN O
degree NN O
. . O

It PRP O
can MD O
be VB O
seen VBN O
that IN O
the DT O
ES NNP O
model NN O
yields VBZ O
higher JJR O
occurrence NN O
probability NN O
estimates NNS O
for IN O
genes NNS O
with IN O
higher JJR O
vertex NN O
degrees NNS O
as IN O
compared VBN O
to IN O
the DT O
BN NNP O
and CC O
HG NNP O
models NNS O
. . O

In IN O
GR NN O
and CC O
LVD NNP O
models NNS O
, , O
gene NN O
vertex NN O
degrees NNS O
are VBP O
ignored VBN O
and CC O
occurrence NN O
probabilities NNS O
for IN O
genes NNS O
with IN O
large JJ O
vertex NN O
degree NN O
are VBP O
very RB O
small JJ O
, , O
which WDT O
is VBZ O
compensated VBN O
by IN O
larger JJR O
occurrence NN O
probabilities NNS O
for IN O
genes NNS O
with IN O
small JJ O
vertex NN O
degree NN O
. . O

The DT O
GVD NNP O
model NN O
is VBZ O
identical JJ O
to IN O
the DT O
ES NNP O
model NN O
in IN O
this DT O
setting NN O
. . O

Fig NN O
. . O

2E CD O
shows VBZ O
the DT O
average JJ O
occurrence NN O
probability NN O
of IN O
all DT O
lists NNS O
with IN O
the DT O
same JJ O
vertex NN O
degree NN O
as IN O
a DT O
function NN O
of IN O
list NN O
vertex NN O
degree NN O
. . O

It PRP O
can MD O
be VB O
seen VBN O
that IN O
the DT O
ES NNP O
model NN O
provides VBZ O
higher JJR O
occurrence NN O
probability NN O
estimates NNS O
for IN O
large JJ O
lists NNS O
as IN O
compared VBN O
to IN O
the DT O
BN NNP O
and CC O
HG NNP O
models NNS O
. . O

In IN O
this DT O
setting NN O
, , O
the DT O
LVD NNP O
model NN O
performs VBZ O
like IN O
the DT O
ES NNP O
model NN O
while IN O
the DT O
GR NNP O
and CC O
GVD NNP O
models NNS O
yield VBP O
small JJ O
occurrence NN O
probabilities NNS O
for IN O
large JJ O
lists NNS O
. . O

Since IN O
it PRP O
has VBZ O
been VBN O
shown VBN O
above IN O
that IN O
long JJ O
lists NNS O
and CC O
genes NNS O
with IN O
high JJ O
vertex NN O
degree NN O
are VBP O
responsible JJ O
for IN O
a DT O
large JJ O
part NN O
of IN O
the DT O
total JJ O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
for IN O
the DT O
most RBS O
stringent JJ O
null NN O
- HYPH O
models NNS O
, , O
the DT O
null NN O
- HYPH O
model NN O
that WDT O
provides VBZ O
larger JJR O
occurrence NN O
probability NN O
estimates NNS O
for IN O
genes NNS O
and CC O
lists NNS O
with IN O
high JJ O
vertex NN O
degree NN O
at IN O
the DT O
expense NN O
of IN O
lower JJR O
estimates NNS O
for IN O
smaller JJR O
degrees NNS O
will MD O
be VB O
the DT O
most RBS O
stringent JJ O
because IN O
large JJ O
occurrence NN O
probabilities NNS O
make VBP O
co NN O
- HYPH O
occurrence NN O
more RBR O
likely JJ O
and CC O
thus RB O
less RBR O
significant JJ O
. . O

By IN O
these DT O
criteria NNS O
, , O
the DT O
ES NNP O
model NN O
is VBZ O
the DT O
most RBS O
stringent JJ O
of IN O
all DT O
models NNS O
tested VBN O
. . O

The DT O
ES NNP O
model NN O
as IN O
an DT O
approximation NN O
of IN O
the DT O
permutation NN O
null NN O
- HYPH O
model NN O

The DT O
data NNS O
shown VBN O
above RB O
have VBP O
revealed VBN O
that IN O
the DT O
ES NNP O
model NN O
is VBZ O
the DT O
best JJS O
of IN O
the DT O
models NNS O
tested VBN O
. . O

One CD O
may MD O
wonder VB O
, , O
however RB O
, , O
whether IN O
yet RB O
more RBR O
effective JJ O
null NN O
- HYPH O
models NNS O
can MD O
be VB O
found VBN O
. . O

An DT O
obvious JJ O
choice NN O
would MD O
be VB O
the DT O
permutation NN O
model NN O
. . O

In IN O
the DT O
permutation NN O
model NN O
, , O
a DT O
complete JJ O
permutation NN O
set NN O
of IN O
the DT O
bipartite JJ O
graph NN O
is VBZ O
created VBN O
such JJ O
that IN O
each DT O
list NN O
is VBZ O
composed VBN O
of IN O
distinct JJ O
sets NNS O
of IN O
genes NNS O
. . O

The DT O
number NN O
of IN O
graphs NNS O
where WRB O
a DT O
gene NN O
is VBZ O
present JJ O
in IN O
a DT O
given VBN O
list NN O
divided VBN O
by IN O
the DT O
total JJ O
number NN O
of IN O
permutations NNS O
then RB O
provides VBZ O
the DT O
occurrence NN O
probability NN O
estimate NN O
. . O

The DT O
permutation NN O
model NN O
is VBZ O
the DT O
ideal JJ O
null NN O
- HYPH O
model NN O
because IN O
it PRP O
is VBZ O
exhaustive JJ O
. . O

The DT O
problem NN O
is VBZ O
that IN O
a DT O
complete JJ O
permutation NN O
set NN O
of IN O
bipartite JJ O
graphs NNS O
of IN O
some DT O
complexity NN O
is VBZ O
very RB O
time NN O
consuming VBG O
to TO O
calculate VB O
. . O

For IN O
example NN O
, , O
the DT O
simple JJ O
bipartite JJ O
graph NN O
from IN O
Fig NNP O
. . O

1A NN O
is VBZ O
part NN O
of IN O
a DT O
permutation NN O
set VBN O
of IN O
455 CD O
graphs NNS O
. . O

The DT O
number NN O
of IN O
permutations NNS O
is VBZ O
increasing VBG O
quickly RB O
as IN O
the DT O
numbers NNS O
of IN O
genes NNS O
and CC O
lists NNS O
grow VBP O
. . O

However RB O
, , O
since IN O
edge NN O
- HYPH O
swapping NN O
ensures VBZ O
that IN O
gene NN O
lists NNS O
are VBP O
composed VBN O
of IN O
distinct JJ O
sets NNS O
of IN O
genes NNS O
, , O
each DT O
edge NN O
- HYPH O
swap NN O
produces VBZ O
a DT O
graph NN O
that WDT O
is VBZ O
part NN O
of IN O
the DT O
permutation NN O
set NN O
of IN O
the DT O
bipartite JJ O
graph NN O
. . O

Edge NN O
- HYPH O
swapping VBG O
can MD O
thus RB O
be VB O
viewed VBN O
as IN O
a DT O
random JJ O
sampling NN O
procedure NN O
from IN O
the DT O
permutation NN O
set NN O
of IN O
the DT O
bipartite JJ O
graph NN O
. . O

Therefore RB O
, , O
occurrence NN O
probability NN O
estimates NNS O
derived VBN O
by IN O
edge NN O
- HYPH O
swapping NN O
should MD O
approximate VB O
those DT O
obtained VBN O
from IN O
the DT O
permutation NN O
model NN O
. . O

We PRP O
generated VBD O
a DT O
complete JJ O
permutation NN O
set VBN O
of IN O
the DT O
graph NN O
shown VBN O
in IN O
Fig NNP O
. . O

1A NN O
to TO O
verify VB O
this DT O
hypothesis NN O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Fig NNP O
. . O

3 LS O
. . O

Fig NN O
. . O

3A NNP O
shows VBZ O
how WRB O
the DT O
number NN O
of IN O
possible JJ O
permutations NNS O
can MD O
be VB O
calculated VBN O
. . O

Gene1 NNP O
is VBZ O
present JJ O
in IN O
all DT O
lists NNS O
and CC O
does VBZ O
not RB O
have VB O
an DT O
impact NN O
on IN O
the DT O
total JJ O
number NN O
of IN O
permutations NNS O
. . O

Gene2 NNP O
, , O
having VBG O
vertex NN O
degree NN O
two CD O
, , O
is VBZ O
present JJ O
in IN O
two CD O
out IN O
of IN O
three CD O
lists NNS O
in IN O
one CD O
out IN O
of IN O
three CD O
possible JJ O
ways NNS O
. . O

The DT O
remaining VBG O
genes NNS O
have VBP O
vertex NN O
degree NN O
1 CD O
and CC O
can MD O
be VB O
freely RB O
chosen VBN O
to TO O
fill VB O
the DT O
empty JJ O
slots NNS O
. . O

We PRP O
can MD O
now RB O
count VB O
exactly RB O
how WRB O
many JJ O
times NNS O
a DT O
gene NN O
is VBZ O
linked VBN O
to IN O
a DT O
list NN O
and CC O
divide VB O
these DT O
counts NNS O
by IN O
455 CD O
, , O
the DT O
size NN O
of IN O
the DT O
permutation NN O
set NN O
, , O
to TO O
obtain VB O
exact JJ O
occurrence NN O
probabilities NNS O
. . O

These DT O
numbers NNS O
are VBP O
shown VBN O
in IN O
graphical JJ O
form NN O
in IN O
Fig NNP O
. . O

3B NN O
and CC O
in IN O
numerical JJ O
form NN O
in IN O
Fig NNP O
. . O

3C NN O
. . O

Fig NN O
. . O

3B NNP O
also RB O
shows VBZ O
the DT O
occurrence NN O
probability NN O
estimates NNS O
obtained VBN O
by IN O
edge NN O
- HYPH O
swapping VBG O
side NN O
- HYPH O
by IN O
- HYPH O
side NN O
to IN O
the DT O
exact JJ O
occurrence NN O
probabilities NNS O
. . O

The DT O
graph NN O
in IN O
Fig NNP O
. . O

1A NN O
was VBD O
subjected VBN O
to IN O
edge NN O
- HYPH O
swapping VBG O
1000 CD O
times NNS O
and CC O
the DT O
number NN O
of IN O
times NNS O
a DT O
gene NN O
was VBD O
found VBN O
present JJ O
in IN O
a DT O
list NN O
was VBD O
divided VBN O
by IN O
1000 CD O
to TO O
obtain VB O
the DT O
occurrence NN O
probability NN O
. . O

At IN O
each DT O
run NN O
, , O
100 CD O
random JJ O
edge NN O
swaps NNS O
were VBD O
performed VBN O
to TO O
ensure VB O
complete JJ O
randomization NN O
of IN O
the DT O
graph NN O
. . O

This DT O
procedure NN O
was VBD O
repeated VBN O
10 CD O
times NNS O
and CC O
the DT O
mean JJ O
and CC O
standard JJ O
deviation NN O
of IN O
occurrence NN O
probability NN O
estimates NNS O
for IN O
each DT O
gene NN O
in IN O
each DT O
list NN O
are VBP O
shown VBN O
. . O

In IN O
all DT O
cases NNS O
, , O
the DT O
mean NN O
differs VBZ O
from IN O
the DT O
real JJ O
probability NN O
by IN O
less JJR O
than IN O
two CD O
standard JJ O
deviations NNS O
, , O
in IN O
most JJS O
cases NNS O
by IN O
less JJR O
than IN O
one CD O
standard JJ O
deviation NN O
. . O

Thus RB O
, , O
edge NN O
- HYPH O
swapping NN O
provides VBZ O
reliable JJ O
estimates NNS O
of IN O
exact JJ O
occurrence NN O
probabilities NNS O
as IN O
determined VBN O
from IN O
a DT O
complete JJ O
permutation NN O
set NN O
. . O

As IN O
an DT O
interesting JJ O
observation NN O
, , O
we PRP O
provide VBP O
evidence NN O
that IN O
occurrence NN O
probabilities NNS O
are VBP O
non RB O
- HYPH O
linear JJ O
functions NNS O
of IN O
vertex NN O
degrees NNS O
in IN O
the DT O
edge NN O
- HYPH O
swapping VBG O
model NN O
. . O

This DT O
is VBZ O
illustrated VBN O
in IN O
Fig NNP O
. . O

3C NN O
. . O

Individual JJ O
and CC O
average JJ O
occurrence NN O
probabilities NNS O
are VBP O
shown VBN O
as IN O
a DT O
function NN O
of IN O
gene NN O
and CC O
list NN O
vertex NN O
degrees NNS O
. . O

Non JJ O
- HYPH O
linearity NN O
of IN O
individual JJ O
occurrence NN O
probabilities NNS O
can MD O
be VB O
verified VBN O
from IN O
the DT O
counts NNS O
table NN O
underneath IN O
the DT O
plots NNS O
. . O

However RB O
, , O
the DT O
average JJ O
occurrence NN O
probability NN O
is VBZ O
found VBN O
to TO O
depend VB O
on IN O
vertex NN O
degrees NNS O
in IN O
a DT O
linear JJ O
fashion NN O
instead RB O
. . O

This DT O
is VBZ O
a DT O
consequence NN O
of IN O
the DT O
fact NN O
that IN O
occurrence NN O
probabilities NNS O
of IN O
a DT O
gene NN O
over IN O
all DT O
lists NNS O
add VBP O
up RP O
to IN O
the DT O
gene NN O
vertex NN O
degree NN O
and CC O
that IN O
the DT O
occurrence NN O
probabilities NNS O
of IN O
all DT O
genes NNS O
for IN O
a DT O
given VBN O
list NN O
add VBP O
up RP O
to IN O
the DT O
list NN O
vertex NN O
degree NN O
. . O

At IN O
the DT O
same JJ O
time NN O
, , O
since IN O
the DT O
most RBS O
stringent JJ O
permutation NN O
based VBN O
null NN O
- HYPH O
model NN O
predicts VBZ O
non AFX O
- HYPH O
linear JJ O
dependencies NNS O
of IN O
individual JJ O
occurrence NN O
probabilities NNS O
on IN O
vertex NN O
degrees NNS O
, , O
assuming VBG O
such JJ O
linearity NN O
in IN O
statistical JJ O
models NNS O
of IN O
co NN O
- HYPH O
occurrence NN O
will MD O
be VB O
linked VBN O
to IN O
loss NN O
of IN O
stringency NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
ES NNP O
null NN O
- HYPH O
model NN O
is VBZ O
the DT O
null NN O
- HYPH O
model NN O
that WDT O
permits VBZ O
co NN O
- HYPH O
occurrence NN O
analysis NN O
with IN O
the DT O
highest JJS O
stringency NN O
among IN O
the DT O
models NNS O
tested VBN O
and CC O
that IN O
it PRP O
closely RB O
approximates VBZ O
occurrence NN O
probabilities NNS O
derived VBN O
from IN O
an DT O
ideal JJ O
permutation NN O
model NN O
. . O

The DT O
increased VBN O
stringency NN O
of IN O
the DT O
ES NNP O
model NN O
over IN O
other JJ O
models NNS O
is VBZ O
a DT O
consequence NN O
of IN O
higher JJR O
occurrence NN O
probabilities NNS O
for IN O
genes NNS O
and CC O
list NN O
with IN O
high JJ O
vertex NN O
degrees NNS O
, , O
which WDT O
are VBP O
giving VBG O
rise NN O
to IN O
a DT O
large JJ O
part NN O
of IN O
all DT O
co NN O
- HYPH O
occurrences NNS O
in IN O
the DT O
bipartite JJ O
graph NN O
. . O

Since IN O
large JJ O
occurrence NN O
probabilities NNS O
make VBP O
co NN O
- HYPH O
occurrence NN O
more RBR O
likely RB O
, , O
the DT O
analysis NN O
becomes VBZ O
more RBR O
stringent JJ O
. . O

Co NN O
- HYPH O
occurrence NN O
probabilities NNS O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
can MD O
be VB O
thought VBN O
of IN O
as IN O
a DT O
Bernoulli NNP O
experiment NN O
with IN O
a DT O
binomial JJ O
outcome NN O
( , O
a DT O
given VBN O
combination NN O
of IN O
entries NNS O
is VBZ O
either CC O
present JJ O
or CC O
not RB O
present JJ O
in IN O
a DT O
given VBN O
list NN O
) -RRB- O
. . O

Thus RB O
, , O
the DT O
Binomial NNP O
distribution NN O
( , O
BD NNP O
) -RRB- O
is VBZ O
a DT O
natural JJ O
choice NN O
for IN O
judging VBG O
the DT O
significance NN O
of IN O
the DT O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
. . O

However RB O
, , O
the DT O
BD NNP O
is VBZ O
defined VBN O
for IN O
a DT O
probability NN O
of IN O
success NN O
which WDT O
is VBZ O
equal JJ O
in IN O
all DT O
trials NNS O
. . O

The DT O
list NN O
- HYPH O
specific JJ O
nature NN O
of IN O
occurrence NN O
probabilities NNS O
is VBZ O
not RB O
compatible JJ O
with IN O
this DT O
condition NN O
( , O
analysis NN O
of IN O
each DT O
list NN O
represents VBZ O
one CD O
trial NN O
) -RRB- O
, , O
which WDT O
means VBZ O
that IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
in IN O
the DT O
presence NN O
of IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
is VBZ O
better RBR O
described VBN O
as IN O
a DT O
series NN O
of IN O
Poisson NNP O
trials NNS O
, , O
where WRB O
the DT O
probability NN O
of IN O
success NN O
varies VBZ O
from IN O
trial NN O
to IN O
trial NN O
. . O

Therefore RB O
, , O
the DT O
significance NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
must MD O
be VB O
evaluated VBN O
using VBG O
a DT O
binomial JJ O
distribution NN O
with IN O
trial NN O
- HYPH O
specific JJ O
probabilities NNS O
, , O
i LS O
. . O
e LS O
. . O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
( -LRB- O
PBD NN O
) -RRB- O
. . O

The DT O
probability NN O
of IN O
success NN O
in IN O
a DT O
single JJ O
Poisson NNP O
trial NN O
can MD O
be VB O
calculated VBN O
by IN O
multiplying VBG O
the DT O
list NN O
- HYPH O
specific JJ O
occurrence NN O
probabilities NNS O
for IN O
the DT O
combination NN O
of IN O
genes NNS O
under IN O
study NN O
. . O

The DT O
number NN O
of IN O
occurrence NN O
probabilities NNS O
that WDT O
need VBP O
to TO O
be VB O
multiplied VBN O
is VBZ O
equal JJ O
to IN O
the DT O
module NN O
size NN O
, , O
i PRP O
. . O
e NFP O
. . O
the DT O
number NN O
of IN O
genes NNS O
whose WP$ O
combination NN O
is VBZ O
studied VBN O
. . O

An DT O
observed JJ O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
for IN O
a DT O
combination NN O
of IN O
genes NNS O
can MD O
then RB O
be VB O
evaluated VBN O
using VBG O
the DT O
PBD NNP O
, , O
which WDT O
is VBZ O
given VBN O
by IN O
the DT O
formula NN O
[ -LRB- O
36 CD O
] -RRB- O
: : O
( SYM O
18 CD O
) -RRB- O

The DT O
structure NN O
of IN O
this DT O
formula NN O
is VBZ O
very RB O
similar JJ O
to IN O
the DT O
structure NN O
of IN O
the DT O
formula NN O
used VBN O
to TO O
calculate VB O
the DT O
binomial JJ O
distribution NN O
, , O
except IN O
that IN O
multiplication NN O
with IN O
a DT O
binomial JJ O
coefficient NN O
is VBZ O
replaced VBN O
by IN O
summation NN O
over IN O
individual JJ O
terms NNS O
, , O
which WDT O
makes VBZ O
calculation NN O
of IN O
P NN O
- HYPH O
values NNS O
using VBG O
( : O
18 CD O
) -RRB- O
inefficient JJ O
( : O
note VB O
that IN O
equation NN O
numbering NN O
starts VBZ O
in IN O
the DT O
Materials NNPS O
and CC O
Methods NNPS O
section NN O
) -RRB- O
. . O

Here RB O
, , O
Ak NNP O
denotes VBZ O
the DT O
kth JJ O
set NN O
of IN O
indices NNS O
of IN O
the DT O
i DT O
lists NNS O
where WRB O
genes NNS O
are VBP O
co NN O
- HYPH O
occurring VBG O
( : O
"""" `` O
success NN O
"""" '' O
) -RRB- O
. . O

There EX O
are VBP O
possible JJ O
sets NNS O
and CC O
summation NN O
is VBZ O
carried VBN O
out RP O
accordingly RB O
. , O
denotes VBZ O
the DT O
set NN O
of IN O
indices NNS O
of IN O
N NNP O
- HYPH O
i NNP O
lists NNS O
where WRB O
genes NNS O
are VBP O
not RB O
co NN O
- HYPH O
occurring VBG O
( : O
"""" `` O
failure NN O
"""" '' O
) -RRB- O
. . O

[ -LRB- O
36 CD O
] -RRB- O
have VBP O
reported VBN O
two CD O
fast JJ O
procedures NNS O
for IN O
calculating VBG O
exact JJ O
PBD NNP O
P NNP O
- HYPH O
values NNS O
. . O

However RB O
, , O
both DT O
procedures NNS O
work VBP O
with IN O
probability NN O
ratios NNS O
and CC O
suffer VBP O
from IN O
numerical JJ O
overflow NN O
/ SYM O
underflow NN O
problems NNS O
for IN O
large JJ O
numbers NNS O
of IN O
trials NNS O
. . O

NetCutter NNP O
uses VBZ O
two CD O
workarounds NNS O
to TO O
circumvent VB O
this DT O
problem NN O
. . O

One CD O
is VBZ O
based VBN O
on IN O
using VBG O
Poisson NNP O
- HYPH O
binomial NNP O
Z NNP O
- HYPH O
scores NNS O
, , O
which WDT O
can MD O
be VB O
calculated VBN O
very RB O
easily RB O
instead RB O
( , O
see VB O
below RB O
) -RRB- O
. . O

The DT O
other JJ O
relies VBZ O
on IN O
a DT O
fast JJ O
approximation NN O
procedure NN O
for IN O
calculating VBG O
Poisson NNP O
- HYPH O
binomial JJ O
P NN O
- HYPH O
values NNS O
, , O
which WDT O
we PRP O
call VBP O
bi IN O
- HYPH O
binomial JJ O
approximation NN O
( , O
BBA NNP O
) -RRB- O
or CC O
bi IN O
- HYPH O
binomial NN O
distribution NN O
( -LRB- O
BBD NNP O
) -RRB- O
. . O

Z NN O
- HYPH O
scores NNS O
and CC O
P NN O
- HYPH O
values NNS O
of IN O
BBD NNP O

Given VBN O
the DT O
mean JJ O
mu NN O
( , O
1 CD O
) -RRB- O
and CC O
variance NN O
sigma NN O
2 CD O
( SYM O
2 CD O
) -RRB- O
of IN O
PBD NN O
( , O
see VB O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
, , O
the DT O
Z NN O
- HYPH O
score NN O
associated VBN O
with IN O
a DT O
given VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
x NN O
is VBZ O
obtained VBN O
as IN O
: : O
( : O
19 CD O
) NFP O

Considering VBG O
the DT O
structure NN O
of IN O
formulae NN O
( , O
1 CD O
) -RRB- O
and CC O
( , O
2 CD O
) -RRB- O
( -LRB- O
Materials NNPS O
and CC O
Methods NNPS O
section NN O
) -RRB- O
, , O
PBD NN O
Z NN O
- HYPH O
scores NNS O
can MD O
be VB O
calculated VBN O
very RB O
easily RB O
and CC O
provide VB O
a DT O
simple JJ O
estimate NN O
of IN O
the DT O
significance NN O
of IN O
co NN O
- HYPH O
occurrence NN O
modules NNS O
. . O

However RB O
, , O
in IN O
contrast NN O
to IN O
normally RB O
distributed VBN O
Z NNP O
- HYPH O
scores NNS O
, , O
binomial NN O
and CC O
Poisson NNP O
- HYPH O
binomial JJ O
Z NNP O
- HYPH O
scores NNS O
do VBP O
not RB O
correspond VB O
to IN O
the DT O
same JJ O
P NN O
- HYPH O
value NN O
for IN O
different JJ O
sets NNS O
of IN O
probabilities NNS O
of IN O
success NN O
. . O

To TO O
see VB O
this DT O
, , O
calculate VB O
for IN O
example NN O
the DT O
probability NN O
of IN O
success NN O
in IN O
a DT O
series NN O
of IN O
100 CD O
Bernoulli NNP O
trials NNS O
with IN O
success NN O
probability NN O
0 CD O
. . O
1 CD O
and CC O
0 CD O
. . O
9 CD O
for IN O
the DT O
expectation NN O
of IN O
10 CD O
and CC O
90 CD O
successes NNS O
, , O
respectively RB O
. . O

The DT O
Z NN O
- HYPH O
score NN O
will MD O
be VB O
0 CD O
in IN O
both DT O
cases NNS O
but CC O
the DT O
corresponding VBG O
cumulative JJ O
P NN O
- HYPH O
values NNS O
are VBP O
0 CD O
. . O
5832 CD O
and CC O
0 CD O
. . O
5487 CD O
. . O

Therefore RB O
, , O
exact JJ O
levels NNS O
of IN O
significance NN O
cannot MD O
be VB O
derived VBN O
from IN O
Z NN O
- HYPH O
scores NNS O
alone RB O
. . O

Thus RB O
, , O
a DT O
fast JJ O
and CC O
reliable JJ O
procedure NN O
for IN O
calculating VBG O
Poisson NNP O
- HYPH O
binomial JJ O
P NN O
- HYPH O
values NNS O
is VBZ O
needed VBN O
. . O

The DT O
BBD NNP O
approximation NN O
was VBD O
developed VBN O
to TO O
solve VB O
this DT O
problem NN O
. . O

The DT O
BBD NNP O
approximation NN O
of IN O
PBD NNP O
P NNP O
- HYPH O
values NNS O
follows VBZ O
from IN O
the DT O
relationship NN O
between IN O
the DT O
variance NN O
of IN O
PBD NN O
and CC O
the DT O
population NN O
variance NN O
of IN O
trial NN O
- HYPH O
specific JJ O
probabilities NNS O
of IN O
success NN O
. . O

This DT O
relationship NN O
is VBZ O
shown VBN O
in IN O
Materials NNPS O
and CC O
Methods NNS O
to TO O
be VB O
described VBN O
by IN O
( , O
4 CD O
) SYM O
: : O
( : O
4 CD O
) NFP O

This DT O
equation NN O
shows VBZ O
that IN O
there EX O
is VBZ O
an DT O
inverse JJ O
linear JJ O
relationship NN O
between IN O
the DT O
population NN O
variance NN O
S2 NNP O
of IN O
the DT O
N NNP O
trial NN O
probabilities NNS O
and CC O
the DT O
variance NN O
of IN O
PBD NN O
sigma NN O
2 CD O
, , O
which WDT O
means VBZ O
that IN O
PBD NN O
becomes VBZ O
increasingly RB O
narrow JJ O
as IN O
the DT O
variance NN O
of IN O
trial NN O
probabilities NNS O
grows VBZ O
. . O

It PRP O
also RB O
shows VBZ O
that IN O
, , O
for IN O
constant JJ O
mean NN O
mu NN O
and CC O
number NN O
of IN O
trials NNS O
N CD O
, , O
the DT O
shape NN O
of IN O
PBD NN O
depends VBZ O
only RB O
on IN O
the DT O
variance NN O
of IN O
trial NN O
probabilities NNS O
. . O

Therefore RB O
, , O
relationship NN O
( , O
4 CD O
) -RRB- O
suggests VBZ O
an DT O
easy JJ O
way NN O
to TO O
approximate VB O
PBD NNP O
P NNP O
- HYPH O
values NNS O
. . O

The DT O
P NN O
- HYPH O
value NN O
can MD O
be VB O
obtained VBN O
by IN O
constructing VBG O
a DT O
set NN O
of IN O
trial NN O
probabilities NNS O
with IN O
equal JJ O
variance NN O
as IN O
the DT O
original JJ O
set NN O
of IN O
trial NN O
probabilities NNS O
, , O
which WDT O
, , O
however RB O
, , O
are VBP O
not RB O
all RB O
different JJ O
. . O

In IN O
other JJ O
words NNS O
, , O
the DT O
series NN O
of IN O
Poisson NNP O
trials NNS O
can MD O
be VB O
replaced VBN O
by IN O
two CD O
sets NNS O
of IN O
Bernoulli NNP O
trials NNS O
with IN O
trial NN O
probabilities NNS O
p1 NN O
and CC O
p2 NN O
constructed VBN O
such JJ O
that IN O
the DT O
variance NN O
is VBZ O
equal JJ O
to IN O
the DT O
original JJ O
set NN O
of IN O
trial NN O
probabilities NNS O
. . O

This DT O
strategy NN O
is VBZ O
illustrated VBN O
in IN O
Fig NNP O
. . O

4 CD O
and CC O
explains VBZ O
why WRB O
this DT O
approximation NN O
is VBZ O
called VBN O
bi NN O
- HYPH O
binomial NN O
. . O

The DT O
details NNS O
on IN O
how WRB O
to TO O
obtain VB O
the DT O
values NNS O
of IN O
the DT O
two CD O
sets NNS O
of IN O
Bernoulli NNP O
trial NN O
probabilities NNS O
and CC O
the DT O
number NN O
of IN O
trials NNS O
with IN O
p1 NN O
and CC O
p2 NN O
as IN O
probabilities NNS O
of IN O
success NN O
are VBP O
provided VBN O
in IN O
the DT O
Materials NNPS O
and CC O
Methods NNPS O
section NN O
. . O

The DT O
precision NN O
of IN O
the DT O
BBD NNP O
approximation NN O
is VBZ O
discussed VBN O
in IN O
supplementary JJ O
material NN O
Simulation NNP O
S1 NNP O
. . O

In IN O
order NN O
to TO O
evaluate VB O
whether IN O
BBD NN O
P NN O
- HYPH O
values NNS O
as IN O
a DT O
significance NN O
measure NN O
of IN O
co NN O
- HYPH O
occurrence NN O
offer VBP O
an DT O
advantage NN O
over IN O
other JJ O
measures NNS O
such JJ O
as IN O
the DT O
Jaccard NNP O
coefficient NN O
or CC O
the DT O
uncertainty NN O
coefficient JJ O
, , O
pair NN O
- HYPH O
wise JJ O
co NN O
- HYPH O
occurrence NN O
of IN O
two CD O
genes NNS O
in IN O
200 CD O
lists NNS O
with IN O
and CC O
without IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
was VBD O
studied VBN O
( : O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

Each DT O
gene NN O
is VBZ O
assumed VBN O
to TO O
occur VB O
in IN O
100 CD O
lists NNS O
. . O

Therefore RB O
, , O
the DT O
occurrence NN O
probabilities NNS O
of IN O
both DT O
genes NNS O
over IN O
all DT O
200 CD O
lists NNS O
must MD O
add VB O
up IN O
to IN O
100 CD O
, , O
regardless RB O
of IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
. . O

For IN O
simplicity NN O
, , O
occurrence NN O
probabilities NNS O
of IN O
both DT O
genes NNS O
are VBP O
assumed VBN O
to TO O
be VB O
equal JJ O
in IN O
any DT O
particular JJ O
list NN O
. . O

The DT O
co NN O
- HYPH O
occurrence NN O
probability NN O
in IN O
a DT O
list NN O
is VBZ O
then RB O
given VBN O
by IN O
the DT O
square NN O
of IN O
the DT O
occurrence NN O
probability NN O
in IN O
that DT O
list NN O
. . O

For IN O
all DT O
possible JJ O
co NN O
- HYPH O
occurrences NNS O
from IN O
0 CD O
to IN O
100 CD O
, , O
the DT O
Jaccard NNP O
and CC O
uncertainty NN O
coefficients NNS O
were VBD O
calculated VBN O
as IN O
detailed VBN O
in IN O
the DT O
Materials NNPS O
and CC O
Methods NNPS O
section NN O
. . O

In IN O
addition NN O
, , O
cumulative JJ O
BBD NN O
P NN O
- HYPH O
values NNS O
were VBD O
calculated VBN O
using VBG O
the DT O
co NN O
- HYPH O
occurrence NN O
probabilities NNS O
as IN O
trial NN O
probabilities NNS O
. . O

To TO O
illustrate VB O
the DT O
advantage NN O
of IN O
BBD NNP O
over IN O
BD NN O
as IN O
co NN O
- HYPH O
occurrence NN O
probability NN O
distribution NN O
, , O
cumulative JJ O
BD NNP O
P NNP O
- HYPH O
values NNS O
of IN O
a DT O
BD NN O
with IN O
the DT O
same JJ O
mean NN O
as IN O
BBD NN O
but CC O
constant JJ O
trial NN O
probabilities NNS O
is VBZ O
shown VBN O
. . O

These DT O
trial NN O
probabilities NNS O
can MD O
be VB O
obtained VBN O
by IN O
dividing VBG O
the DT O
mean NN O
of IN O
BBD NNP O
by IN O
the DT O
number NN O
of IN O
lists NNS O
. . O

Three CD O
different JJ O
cases NNS O
of IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
are VBP O
considered VBN O
in IN O
Fig NNP O
. . O

5 LS O
: : O
No DT O
heterogeneity NN O
( , O
standard JJ O
deviation NN O
0 CD O
) -RRB- O
, , O
heterogeneity NN O
with IN O
standard JJ O
deviation NN O
0 CD O
. . O
283 CD O
and CC O
heterogeneity NN O
with IN O
standard JJ O
deviation NN O
0 CD O
. . O
401 CD O
in IN O
the DT O
occurrence NN O
probabilities NNS O
. . O

The DT O
Jaccard NNP O
and CC O
uncertainty NN O
coefficients NNS O
are VBP O
by IN O
definition NN O
insensitive JJ O
to TO O
list VB O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
because IN O
differences NNS O
in IN O
co NN O
- HYPH O
occurrence NN O
probabilities NNS O
in IN O
a DT O
given VBN O
list NN O
cannot MD O
be VB O
considered VBN O
in IN O
their PRP$ O
calculation NN O
. . O

This DT O
is VBZ O
because IN O
both DT O
coefficients NNS O
are VBP O
defined VBN O
by IN O
the DT O
counts NNS O
of IN O
the DT O
four CD O
list NN O
classes NNS O
: : O
both DT O
genes NNS O
absent JJ O
, , O
both DT O
genes NNS O
present JJ O
, , O
first JJ O
gene NN O
absent JJ O
second JJ O
gene NN O
present JJ O
, , O
and CC O
first JJ O
gene NN O
present JJ O
second JJ O
gene NN O
absent JJ O
, , O
i PRP O
. . O
e NFP O
. . O
by IN O
the DT O
corresponding VBG O
contingency NN O
table NN O
, , O
which WDT O
does VBZ O
not RB O
change VB O
with IN O
different JJ O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
. . O

In IN O
the DT O
absence NN O
of IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
, , O
the DT O
cumulative JJ O
P NN O
- HYPH O
values NNS O
of IN O
BD NNP O
and CC O
BBD NNP O
( , O
which WDT O
are VBP O
perfectly RB O
overlapping JJ O
as IN O
expected VBN O
) : O
assume VBP O
0 CD O
. . O
5 CD O
at IN O
50 CD O
co NN O
- HYPH O
occurrences NNS O
, , O
which WDT O
corresponds VBZ O
to IN O
the DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
calculated VBN O
as IN O
( : O
50 CD O
= SYM O
100 CD O
occurrences NNS O
per IN O
gene NN O
/ SYM O
200 CD O
lists NNS O
) SYM O
^ SYM O
2 CD O
* SYM O
200 CD O
lists NNS O
. . O

The DT O
uncertainty NN O
coefficient JJ O
is VBZ O
found VBN O
to TO O
be VB O
0 CD O
and CC O
the DT O
Jaccard NNP O
coefficient NN O
is VBZ O
0 CD O
. . O
33333 CD O
at IN O
that DT O
point NN O
. . O

When WRB O
there EX O
is VBZ O
modest JJ O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
( , O
standard JJ O
deviation NN O
0 CD O
. . O
283 CD O
) -RRB- O
, , O
the DT O
mean NN O
of IN O
BBD NN O
is VBZ O
shifting VBG O
to IN O
the DT O
right NN O
. . O

This DT O
is VBZ O
because IN O
the DT O
sum NN O
of IN O
squares NNS O
of IN O
varying VBG O
occurrence NN O
probabilities NNS O
( : O
i LS O
. . O
e LS O
. . O
the DT O
sum NN O
of IN O
co NN O
- HYPH O
occurrence NN O
probabilities NNS O
used VBN O
as IN O
trial JJ O
probabilities NNS O
, , O
which WDT O
is VBZ O
equal JJ O
to IN O
the DT O
mean NN O
of IN O
BBD NN O
) -RRB- O
is VBZ O
always RB O
larger JJR O
than IN O
the DT O
sum NN O
of IN O
squares NNS O
of IN O
constant JJ O
occurrence NN O
probabilities NNS O
with IN O
the DT O
same JJ O
average JJ O
occurrence NN O
probability NN O
( : O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

The DT O
corresponding VBG O
BD NN O
in IN O
the DT O
presence NN O
of IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
is VBZ O
obtained VBN O
by IN O
dividing VBG O
the DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
by IN O
the DT O
total JJ O
number NN O
of IN O
lists NNS O
, , O
which WDT O
means VBZ O
assuming VBG O
equal JJ O
co NN O
- HYPH O
occurrences NNS O
in IN O
all DT O
lists NNS O
. . O

This DT O
visualization NN O
is VBZ O
shown VBN O
to TO O
illustrate VB O
how WRB O
BBD NNP O
( : O
which WDT O
is VBZ O
narrower JJR O
than IN O
the DT O
corresponding VBG O
BD NNP O
) -RRB- O
gives VBZ O
rise NN O
to IN O
a DT O
steeper JJR O
cumulative JJ O
distribution NN O
of IN O
P NN O
- HYPH O
values NNS O
and CC O
as IN O
a DT O
consequence NN O
to IN O
more RBR O
significant JJ O
P NN O
- HYPH O
values NNS O
for IN O
numbers NNS O
of IN O
co NN O
- HYPH O
occurrence NN O
that WDT O
are VBP O
far RB O
from IN O
the DT O
expectation NN O
. . O

As IN O
the DT O
level NN O
of IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
grows VBZ O
( , O
standard JJ O
deviation NN O
of IN O
occurrence NN O
probabilities NNS O
0 CD O
. . O
401 CD O
) -RRB- O
, , O
the DT O
mean NN O
of IN O
BBD NN O
is VBZ O
shifted VBN O
even RB O
further RBR O
to IN O
the DT O
right JJ O
and CC O
BBD NN O
P NN O
- HYPH O
values NNS O
are VBP O
distributed VBN O
in IN O
a DT O
still RB O
steeper JJR O
fashion NN O
as IN O
compared VBN O
to IN O
corresponding JJ O
BD NN O
P NN O
- HYPH O
values NNS O
and CC O
the DT O
interval NN O
of IN O
non AFX O
- HYPH O
significant JJ O
co NN O
- HYPH O
occurrences NNS O
is VBZ O
shrinking VBG O
further RB O
. . O

With IN O
modest JJ O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
, , O
the DT O
expected JJ O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
is VBZ O
66 CD O
, , O
which WDT O
is VBZ O
associated VBN O
with IN O
a DT O
Jaccard NNP O
coefficient NN O
of IN O
0 CD O
. . O
49 CD O
and CC O
an DT O
uncertainty NN O
coefficient NN O
of IN O
0 CD O
. . O
75 CD O
. . O

In IN O
the DT O
case NN O
of IN O
large JJ O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
, , O
the DT O
expected JJ O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
is VBZ O
82 CD O
with IN O
J NNP O
= SYM O
0 CD O
. . O
69 CD O
and CC O
UC NN O
= SYM O
0 CD O
. . O
32 CD O
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
show VBP O
that IN O
the DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
varies VBZ O
strongly RB O
with IN O
the DT O
level NN O
of IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
and CC O
that IN O
the DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
is VBZ O
associated VBN O
with IN O
different JJ O
values NNS O
of IN O
UC NNP O
and CC O
J NNP O
. . O

To TO O
complicate VB O
matters NNS O
further RB O
, , O
66 CD O
co NN O
- HYPH O
occurrences NNS O
( , O
J NNP O
= SYM O
0 CD O
. . O
49 CD O
, , O
UC NN O
= SYM O
0 CD O
. . O
75 CD O
) -RRB- O
represent VBP O
significant JJ O
positive JJ O
association NN O
( : O
PBBD NNP O
= SYM O
0 CD O
. . O
996 CD O
) -RRB- O
with IN O
equal JJ O
list NN O
lengths NNS O
, , O
no DT O
significant JJ O
association NN O
with IN O
modest JJ O
differences NNS O
in IN O
list NN O
length NN O
( : O
PBBD NN O
= SYM O
0 CD O
. . O
536 CD O
) -RRB- O
and CC O
strongly RB O
negative JJ O
association NN O
( , O
meaning VBG O
one CD O
gene NN O
excludes VBZ O
the DT O
other JJ O
) -RRB- O
with IN O
strong JJ O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
( : O
PBBD NN O
= SYM O
0 CD O
. . O
16 CD O
) -RRB- O
. . O

Thus RB O
, , O
the DT O
same JJ O
J NNP O
and CC O
UC NNP O
association NN O
measure NN O
is VBZ O
obtained VBN O
for IN O
positive JJ O
, , O
negative JJ O
, , O
and CC O
absence NN O
of IN O
association NN O
. . O

Therefore RB O
, , O
the DT O
meaning NN O
of IN O
these DT O
measures NNS O
cannot MD O
be VB O
interpreted VBN O
properly RB O
in IN O
the DT O
absence NN O
of IN O
knowledge NN O
about IN O
the DT O
occurrence NN O
probabilities NNS O
of IN O
the DT O
co NN O
- HYPH O
occurring VBG O
entities NNS O
. . O

Furthermore RB O
, , O
the DT O
data NNS O
in IN O
Fig NNP O
. . O

5 CD O
also RB O
show VBP O
that IN O
neither CC O
J NNP O
nor CC O
UC NNP O
can MD O
distinguish VB O
between IN O
positive JJ O
and CC O
negative JJ O
association NN O
while IN O
this DT O
is VBZ O
easy JJ O
with IN O
cumulative JJ O
BBD NN O
P NN O
- HYPH O
values NNS O
: : O
Large JJ O
P NN O
- HYPH O
values NNS O
mean VBP O
positive JJ O
association NN O
and CC O
low JJ O
P NN O
- HYPH O
values NNS O
mean VBP O
negative JJ O
association NN O
. . O

In IN O
summary NN O
, , O
we PRP O
conclude VBP O
that IN O
BBD NNP O
provides VBZ O
a DT O
novel JJ O
association NN O
measure NN O
that WDT O
offers VBZ O
a DT O
number NN O
of IN O
advantages NNS O
over IN O
the DT O
existing VBG O
contingency NN O
table NN O
based VBN O
association NN O
measures VBZ O
Jaccard NNP O
coefficient JJ O
and CC O
uncertainty NN O
coefficient JJ O
. . O

The DT O
results NNS O
in IN O
Fig NNP O
. . O

5 CD O
also RB O
show VBP O
that IN O
significance NN O
of IN O
association NN O
depends VBZ O
critically RB O
on IN O
the DT O
specific JJ O
distribution NN O
of IN O
co NN O
- HYPH O
occurring VBG O
entities NNS O
over IN O
lists NNS O
of IN O
varying VBG O
length NN O
( , O
because IN O
this DT O
distribution NN O
determines VBZ O
the DT O
occurrence NN O
probabilities NNS O
) -RRB- O
and CC O
that IN O
contingency NN O
table NN O
based VBN O
methods NNS O
( , O
which WDT O
cannot MD O
capture VB O
this DT O
distribution NN O
) -RRB- O
should MD O
be VB O
avoided VBN O
in IN O
the DT O
presence NN O
of IN O
significant JJ O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
. . O

Generation NN O
of IN O
co NN O
- HYPH O
occurrence NN O
networks NNS O
and CC O
the DT O
identification NN O
of IN O
communities NNS O

The DT O
procedures NNS O
outlined VBN O
above RB O
allow VBP O
the DT O
identification NN O
of IN O
significant JJ O
co NN O
- HYPH O
occurrence NN O
modules NNS O
in IN O
any DT O
type NN O
of IN O
bipartite NN O
graph NN O
. . O

Three CD O
user NN O
defined VBN O
parameters NNS O
have VBP O
an DT O
impact NN O
on IN O
the DT O
stringency NN O
of IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
: : O
The DT O
module NN O
size NN O
, , O
the DT O
support NN O
, , O
and CC O
the DT O
Z NN O
- HYPH O
score NN O
/ SYM O
P NN O
- HYPH O
value NN O
cutoff NN O
. . O

The DT O
module NN O
size NN O
determines VBZ O
how WRB O
many JJ O
entries NNS O
will MD O
be VB O
tested VBN O
for IN O
co NN O
- HYPH O
occurrence NN O
, , O
the DT O
support NN O
sets VBZ O
a DT O
lower JJR O
boundary NN O
on IN O
the DT O
required JJ O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
, , O
and CC O
the DT O
Z NN O
- HYPH O
score NN O
/ SYM O
P NN O
- HYPH O
value NN O
cutoff NN O
sets VBZ O
the DT O
significance NN O
threshold NN O
. . O

In IN O
general JJ O
, , O
higher JJR O
module NN O
size NN O
leads VBZ O
to IN O
more RBR O
stringent JJ O
co NN O
- HYPH O
occurrence NN O
analysis NN O
at IN O
the DT O
cost NN O
of IN O
computational JJ O
complexity NN O
. . O

The DT O
support NN O
parameter NN O
allows VBZ O
limiting VBG O
this DT O
complexity NN O
by IN O
filtering VBG O
out RP O
co NN O
- HYPH O
occurrence NN O
modules NNS O
which WDT O
co VBP O
- HYPH O
occur VBP O
less RBR O
frequently RB O
than IN O
required VBN O
by IN O
the DT O
support NN O
. . O

The DT O
significance NN O
cutoff NN O
permits NNS O
adjusting VBG O
the DT O
signal NN O
- HYPH O
to IN O
- HYPH O
noise NN O
ratio NN O
, , O
which WDT O
is VBZ O
calculated VBN O
as IN O
the DT O
number NN O
of IN O
co NN O
- HYPH O
occurrence NN O
modules NNS O
observed VBN O
in IN O
the DT O
real JJ O
versus IN O
a DT O
randomized JJ O
bipartite JJ O
graph NN O
. . O

The DT O
impact NN O
of IN O
these DT O
parameters NNS O
on IN O
the DT O
stringency NN O
of IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
has VBZ O
been VBN O
reported VBN O
previously RB O
for IN O
the DT O
PubLiME NNP O
data NNS O
set VBN O
[ -LRB- O
35 CD O
] -RRB- O
and CC O
is VBZ O
illustrated VBN O
in IN O
a DT O
simulation NN O
study NN O
provided VBN O
as IN O
supplementary JJ O
material NN O
Simulation NNP O
S1 NNP O
. . O

From IN O
the DT O
set NN O
of IN O
significant JJ O
co NN O
- HYPH O
occurrence NN O
modules NNS O
, , O
a DT O
co NN O
- HYPH O
occurrence NN O
network NN O
is VBZ O
generated VBN O
by IN O
considering VBG O
each DT O
entry NN O
a DT O
vertex NN O
and CC O
drawing VBG O
an DT O
edge NN O
between IN O
any DT O
two CD O
vertices NNS O
, , O
which WDT O
have VBP O
been VBN O
part NN O
of IN O
the DT O
same JJ O
significant JJ O
co NN O
- HYPH O
occurrence NN O
module NN O
[ -LRB- O
35 CD O
] -RRB- O
. . O

An DT O
important JJ O
question NN O
in IN O
the DT O
analysis NN O
of IN O
co NN O
- HYPH O
occurrence NN O
networks NNS O
regards VBZ O
the DT O
presence NN O
of IN O
network NN O
communities NNS O
. . O

Communities NNS O
can MD O
be VB O
understood VBN O
as IN O
groups NNS O
of IN O
vertices NNS O
with IN O
the DT O
property NN O
that IN O
the DT O
number NN O
of IN O
edges NNS O
running VBG O
within IN O
groups NNS O
is VBZ O
larger JJR O
than IN O
expected VBN O
by IN O
chance NN O
and CC O
that IN O
the DT O
number NN O
of IN O
edges NNS O
running VBG O
between IN O
groups NNS O
is VBZ O
lower JJR O
than IN O
expected VBN O
by IN O
chance NN O
[ -LRB- O
37 CD O
] -RRB- O
. . O

This DT O
problem NN O
of IN O
partitioning VBG O
a DT O
graph NN O
is VBZ O
often RB O
referred VBN O
to IN O
as IN O
the DT O
graph NN O
- HYPH O
cut VBN O
problem NN O
( , O
hence RB O
the DT O
name NN O
NetCutter NNP O
) -RRB- O
. . O

NetCutter NNP O
is VBZ O
built VBN O
on IN O
the DT O
Java NNP O
Universal NNP O
Network NNP O
and CC O
Graph NNP O
framework NN O
( , O
JUNG NNP O
) , O
software NN O
package NN O
( : O
http NN O
: : O
/ : O
/ : O
jung NN O
. . O
sourceforge NN O
. . O
net NN O
) -RRB- O
, , O
which WDT O
provides VBZ O
algorithms NNS O
for IN O
solving VBG O
this DT O
problem NN O
. . O

In IN O
particular JJ O
, , O
NetCutter NNP O
implements VBZ O
the DT O
Bicomponent NNP O
clustering NN O
algorithm NN O
[ -LRB- O
38 CD O
] -RRB- O
, , O
the DT O
Edge NNP O
- HYPH O
Betweenness NNP O
clustering NN O
algorithm NN O
[ -LRB- O
39 CD O
] -RRB- O
, , O
and CC O
the DT O
Exact NNP O
Flow NNP O
Community NNP O
algorithm NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
there EX O
is VBZ O
a DT O
clustering VBG O
tool NN O
that WDT O
is VBZ O
not RB O
part NN O
of IN O
the DT O
JUNG NNP O
package NN O
, , O
namely RB O
an DT O
algorithm NN O
identifying VBG O
communities NNS O
using VBG O
eigenvectors NNS O
of IN O
the DT O
modularity NN O
matrix NN O
[ -LRB- O
37 CD O
] -RRB- O
. . O

The DT O
code NN O
for IN O
this DT O
algorithm NN O
was VBD O
kindly RB O
provided VBN O
by IN O
Mark NNP O
Newman NNP O
in IN O
C NNP O
+ CC O
+ NNP O
and CC O
ported VBN O
to IN O
Java NNP O
. . O

In IN O
addition NN O
to IN O
these DT O
tools NNS O
, , O
NetCutter NNP O
provides VBZ O
a DT O
number NN O
of IN O
convenience NN O
functions NNS O
for IN O
the DT O
analysis NN O
of IN O
co NN O
- HYPH O
occurrence NN O
networks NNS O
, , O
such JJ O
as IN O
testing VBG O
the DT O
significance NN O
of IN O
lists NNS O
reporting VBG O
a DT O
set NN O
of IN O
entries NNS O
making VBG O
up RP O
a DT O
network NN O
community NN O
, , O
ranking NN O
of IN O
vertices NNS O
, , O
random JJ O
graph NN O
generators NNS O
for IN O
topological JJ O
analysis NN O
of IN O
co NN O
- HYPH O
occurrence NN O
networks NNS O
, , O
and CC O
others NNS O
. . O

Details NNS O
on IN O
all DT O
functions NNS O
are VBP O
provided VBN O
in IN O
the DT O
NetCutter NNP O
software NN O
documentation NN O
. . O

One CD O
of IN O
the DT O
possible JJ O
applications NNS O
of IN O
NetCutter NNP O
is VBZ O
illustrated VBN O
below RB O
. . O

This DT O
application NN O
is VBZ O
tightly RB O
linked VBN O
to IN O
the DT O
bipartite JJ O
graph NN O
representation NN O
of IN O
the DT O
data NNS O
. . O

Namely RB O
, , O
NetCutter NNP O
can MD O
be VB O
used VBN O
to TO O
perform VB O
co NN O
- HYPH O
occurrence NN O
analysis NN O
of IN O
genes NNS O
or CC O
list NN O
derived VBN O
from IN O
the DT O
same JJ O
bipartite JJ O
graph NN O
. . O

The DT O
network NN O
communities NNS O
identified VBN O
in IN O
each DT O
both DT O
reflect VBP O
the DT O
same JJ O
underlying VBG O
structure NN O
of IN O
the DT O
bipartite JJ O
graph NN O
. . O

In IN O
the DT O
case NN O
of IN O
gene NN O
expression NN O
signatures NNS O
stored VBN O
in IN O
PubLiME NNP O
, , O
clusters NNS O
of IN O
genes NNS O
correspond VBP O
to IN O
clusters NNS O
of IN O
publications NNS O
, , O
which WDT O
can MD O
reveal VB O
possible JJ O
functions NNS O
of IN O
gene NN O
clusters NNS O
. . O

Cluster NN O
correspondence NN O
and CC O
association NN O
studies NNS O

The DT O
co NN O
- HYPH O
occurrence NN O
analysis NN O
of IN O
the DT O
PubLiME NNP O
data NNS O
set NN O
published VBN O
previously RB O
[ -LRB- O
35 CD O
] -RRB- O
identified VBD O
5 CD O
major JJ O
network NN O
communities NNS O
of IN O
genes NNS O
with IN O
consistent JJ O
functional JJ O
annotations NNS O
that WDT O
are VBP O
deregulated VBN O
in IN O
cancer NN O
related VBN O
gene NN O
expression NN O
signatures NNS O
. . O

This DT O
analysis NN O
was VBD O
performed VBN O
by IN O
considering VBG O
all DT O
genes NNS O
mentioned VBN O
in IN O
a DT O
particular JJ O
publication NN O
as IN O
a DT O
single JJ O
signature NN O
, , O
even RB O
though IN O
they PRP O
might MD O
have VB O
been VBN O
part NN O
of IN O
different JJ O
tables NNS O
and CC O
cluster NN O
analyses NNS O
. . O

Here RB O
we PRP O
present VBP O
an DT O
advanced JJ O
analysis NN O
of IN O
the DT O
PubLiME NNP O
data NNS O
set VBN O
where WRB O
each DT O
table NN O
and CC O
/ SYM O
or CC O
cluster NN O
identified VBD O
in IN O
a DT O
given VBN O
publication NN O
is VBZ O
considered VBN O
as IN O
a DT O
separate JJ O
signature NN O
. . O

This DT O
brings VBZ O
the DT O
total JJ O
number NN O
of IN O
signatures NNS O
to TO O
be VB O
analyzed VBN O
to IN O
1015 CD O
comprising VBG O
a DT O
total NN O
of IN O
7358 CD O
differentially RB O
regulated VBN O
genes NNS O
derived VBN O
from IN O
233 CD O
publications NNS O
reporting VBG O
cancer NN O
related VBN O
signatures NNS O
derived VBN O
from IN O
human JJ B-Species
samples NNS O
. . O

We PRP O
use VBP O
this DT O
analysis NN O
to TO O
illustrate VB O
three CD O
major JJ O
points NNS O
: : O
First RB O
, , O
the DT O
set NN O
of IN O
communities NNS O
reported VBN O
previously RB O
is VBZ O
reproduced VBN O
by IN O
this DT O
more RBR O
fine RB O
- HYPH O
grained JJ O
analysis NN O
. . O

Second RB O
, , O
the DT O
set NN O
of IN O
gene NN O
communities NNS O
corresponds VBZ O
to IN O
a DT O
set NN O
of IN O
publication NN O
communities NNS O
. . O

Third RB O
, , O
associations NNS O
between IN O
publications NNS O
and CC O
gene NN O
communities NNS O
can MD O
be VB O
calculated VBN O
with IN O
higher JJR O
stringency NN O
using VBG O
the DT O
edge NN O
- HYPH O
swapping VBG O
null NN O
- HYPH O
model NN O
in IN O
conjunction NN O
with IN O
bi NN O
- HYPH O
binomial JJ O
P NN O
- HYPH O
values NNS O
as IN O
compared VBN O
to IN O
binomial JJ O
or CC O
hypergeometric JJ O
statistics NNS O
. . O

The DT O
bipartite JJ O
graph NN O
to TO O
be VB O
analyzed VBN O
is VBZ O
composed VBN O
of IN O
PubMedID NNP O
_ HYPH O
listID NN O
- HYPH O
gene NN O
pairs NNS O
( , O
see VB O
supplementary JJ O
material NN O
Table NNP O
S1 NNP O
) -RRB- O
. . O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
was VBD O
carried VBN O
out RP O
in IN O
two CD O
ways NNS O
: : O
First JJ O
, , O
gene NN O
co NN O
- HYPH O
occurrence NN O
was VBD O
analyzed VBN O
and CC O
communities NNS O
of IN O
co NN O
- HYPH O
occurring VBG O
genes NNS O
were VBD O
defined VBN O
by IN O
edge NN O
- HYPH O
betweenness NN O
clustering NN O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

Second RB O
, , O
co NN O
- HYPH O
occurrence NN O
of IN O
PubMedID NN O
_ : O
listIDs NNS O
was VBD O
analyzed VBN O
. . O

To IN O
this DT O
end NN O
, , O
the DT O
order NN O
of IN O
PubMedID NNP O
_ : O
listID NN O
- HYPH O
gene NN O
pairs NNS O
was VBD O
reversed VBN O
to TO O
form VB O
GENE NNP O
- HYPH O
PUBMEDID NNP O
_ SYM O
LISTID NNP O
pairs NNS O
. . O

Thus RB O
, , O
the DT O
lists NNS O
in IN O
the DT O
resulting VBG O
bipartite JJ O
graph NN O
are VBP O
formed VBN O
by IN O
genes NNS O
and CC O
the DT O
entries NNS O
are VBP O
the DT O
PubMedID NNP O
_ HYPH O
listIDs NNS O
where WRB O
the DT O
genes NNS O
are VBP O
reported VBN O
as IN O
differentially RB O
regulated VBN O
. . O

Occurrence NN O
probabilities NNS O
for IN O
the DT O
reversed JJ O
bipartite JJ O
graph NN O
can MD O
be VB O
obtained VBN O
by IN O
transposing VBG O
the DT O
occurrence NN O
probability NN O
matrix NN O
of IN O
the DT O
original JJ O
bipartite JJ O
graph NN O
. . O

Since IN O
the DT O
gene NN O
communities NNS O
identified VBN O
in IN O
gene NN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
reflect VBP O
the DT O
structure NN O
inherent JJ O
in IN O
the DT O
bipartite JJ O
graph NN O
( , O
which WDT O
is VBZ O
not RB O
affected VBN O
by IN O
reversing VBG O
the DT O
list NN O
- HYPH O
entry NN O
order NN O
) -RRB- O
, , O
co NN O
- HYPH O
occurrence NN O
analysis NN O
of IN O
the DT O
reversed JJ O
bipartite JJ O
graph NN O
will MD O
result VB O
in IN O
PubMedID NNP O
_ HYPH O
listID NN O
communities NNS O
that WDT O
reflect VBP O
the DT O
same JJ O
underlying VBG O
structure NN O
in IN O
the DT O
bipartite JJ O
graph NN O
. . O

In IN O
other JJ O
words NNS O
, , O
PubMedID NNP O
_ HYPH O
listID NNP O
communities NNS O
correspond VBP O
to IN O
gene NN O
communities NNS O
. . O

In IN O
less RBR O
abstract JJ O
terms NNS O
, , O
the DT O
PubMedID NNP O
_ HYPH O
listID NNP O
communities NNS O
should MD O
correspond VB O
to IN O
sets NNS O
of IN O
publications NNS O
that WDT O
report VBP O
similar JJ O
sets NNS O
of IN O
genes NNS O
as IN O
differentially RB O
regulated VBN O
. . O

The DT O
identification NN O
of IN O
communities NNS O
of IN O
publications NNS O
can MD O
help VB O
the DT O
researcher NN O
to TO O
easily RB O
identify VB O
publications NNS O
studying VBG O
genes NNS O
in IN O
a DT O
gene NN O
community NN O
that WDT O
is VBZ O
of IN O
interest NN O
to IN O
the DT O
researcher NN O
. . O

The DT O
results NNS O
of IN O
both DT O
types NNS O
of IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
are VBP O
displayed VBN O
in IN O
Fig NNP O
. . O

6 LS O
. . O

Fig NN O
. . O

6A NNP O
shows VBZ O
the DT O
gene NN O
clusters NNS O
identified VBN O
. . O

The DT O
clusters NNS O
are VBP O
named VBN O
after IN O
significant JJ O
enrichments NNS O
of IN O
gene NN O
categories NNS O
as IN O
determined VBN O
by IN O
functional JJ O
category NN O
enrichment NN O
using VBG O
DAVID NNP O
[ -LRB- O
41 CD O
] -RRB- O
. . O

The DT O
P NNP O
- HYPH O
values NNS O
shown VBN O
are VBP O
Benjamini NNP O
corrected VBN O
for IN O
multiple JJ O
testing NN O
as IN O
reported VBN O
by IN O
DAVID NNP O
. . O

The DT O
clusters NNS O
are VBP O
very RB O
similar JJ O
to IN O
the DT O
clusters NNS O
published VBN O
previously RB O
[ -LRB- O
35 CD O
] -RRB- O
. . O

There EX O
is VBZ O
one CD O
new JJ O
cluster NN O
that WDT O
is VBZ O
strongly RB O
enriched VBN O
for IN O
ribosomal JJ O
proteins NNS O
( , O
"""" `` O
protein NN O
biosynthesis NN O
"""" '' O
cluster NN O
) -RRB- O
, , O
which WDT O
has VBZ O
not RB O
reached VBN O
significance NN O
in IN O
our PRP$ O
previous JJ O
analysis NN O
. . O

The DT O
"""" `` O
surface NN O
antigen NN O
"""" '' O
cluster NN O
contains VBZ O
many JJ O
genes NNS O
that WDT O
had VBD O
been VBN O
reported VBN O
as IN O
part NN O
of IN O
the DT O
"""" `` O
signal NN O
transduction NN O
"""" '' O
cluster NN O
. . O

Altogether RB O
, , O
however RB O
, , O
these DT O
results NNS O
strongly RB O
support VBP O
the DT O
notion NN O
that IN O
the DT O
gene NN O
clusters NNS O
in IN O
the DT O
PubLiME NNP O
data NNS O
set NN O
can MD O
be VB O
reproduced VBN O
by IN O
the DT O
more RBR O
fine RB O
- HYPH O
grained JJ O
analysis NN O
that WDT O
considers VBZ O
sublists NNS O
in IN O
each DT O
publication NN O
as IN O
separate JJ O
signatures NNS O
. . O

The DT O
corresponding VBG O
clusters NNS O
of IN O
PubMedID NNP O
_ : O
listIDs NNS O
are VBP O
shown VBN O
in IN O
Fig NNP O
. . O

6B NN O
. . O

There EX O
are VBP O
five CD O
clusters NNS O
, , O
which WDT O
have VBP O
been VBN O
named VBN O
after IN O
their PRP$ O
corresponding JJ O
gene NN O
cluster NN O
. . O

Only RB O
one CD O
cluster NN O
( , O
the DT O
"""" `` O
extracellular JJ O
matrix NN O
- HYPH O
immune JJ O
response NN O
cluster NN O
"""" '' O
) -RRB- O
cannot MD O
be VB O
separated VBN O
by IN O
edge NN O
- HYPH O
betweenness NN O
clustering VBG O
at IN O
the DT O
point NN O
of IN O
maximal JJ O
graph NN O
modularity NN O
. . O

To TO O
see VB O
that IN O
this DT O
naming NN O
is VBZ O
indeed RB O
justified VBN O
, , O
we PRP O
needed VBD O
to TO O
investigate VB O
how WRB O
strongly RB O
a DT O
given VBN O
PubMedID NNP O
_ HYPH O
listID NN O
is VBZ O
associated VBN O
with IN O
a DT O
given VBN O
gene NN O
cluster NN O
, , O
i PRP O
. . O
e NFP O
. . O
how WRB O
significant JJ O
is VBZ O
the DT O
overlap NN O
of IN O
the DT O
genes NNS O
reported VBN O
in IN O
a DT O
gene NN O
cluster NN O
and CC O
the DT O
genes NNS O
reported VBN O
in IN O
a DT O
PubMedID NN O
_ : O
listID NN O
. . O

Binomial JJ O
or CC O
hypergemetric JJ O
statistics NNS O
are VBP O
generally RB O
used VBN O
to TO O
calculate VB O
this DT O
significance NN O
. . O

However RB O
, , O
the DT O
bipartite JJ O
graph NN O
model NN O
in IN O
conjunction NN O
with IN O
the DT O
edge NN O
- HYPH O
swapping VBG O
null NN O
- HYPH O
model NN O
offers VBZ O
a DT O
more RBR O
fine RB O
- HYPH O
grained JJ O
approach NN O
based VBN O
on IN O
bi NN O
- HYPH O
binomial NN O
statistics NNS O
. . O

The DT O
edge NN O
- HYPH O
swapping VBG O
null NN O
- HYPH O
model NN O
determines VBZ O
occurrence NN O
probabilities NNS O
in IN O
such PDT O
a DT O
way NN O
that IN O
the DT O
number NN O
of IN O
genes NNS O
in IN O
a DT O
given VBN O
PubMedID NNP O
_ : O
listID NN O
is VBZ O
associated VBN O
with IN O
insignificant JJ O
P NN O
- HYPH O
values NNS O
in IN O
the DT O
context NN O
of IN O
the DT O
complete JJ O
bipartite JJ O
graph NN O
. . O

However RB O
, , O
when WRB O
a DT O
subset NN O
of IN O
genes NNS O
is VBZ O
analyzed VBN O
, , O
e UH O
. . O
g LS O
. . O
all PDT O
the DT O
genes NNS O
that WDT O
are VBP O
reported VBN O
in IN O
a DT O
particular JJ O
list NN O
, , O
the DT O
P NN O
- HYPH O
value NN O
associated VBN O
with IN O
the DT O
number NN O
of IN O
genes NNS O
contained VBN O
in IN O
this DT O
list NN O
will MD O
likely RB O
be VB O
highly RB O
significant JJ O
according VBG O
to IN O
how WRB O
unlikely JJ O
it PRP O
is VBZ O
to TO O
obtain VB O
all PDT O
the DT O
genes NNS O
contained VBN O
in IN O
a DT O
given VBN O
list NN O
in IN O
a DT O
random JJ O
draw NN O
from IN O
all DT O
genes NNS O
present JJ O
in IN O
the DT O
bipartite JJ O
graph NN O
. . O

Thus RB O
, , O
PubMedID NNP O
_ HYPH O
listID NN O
association NN O
with IN O
a DT O
set NN O
of IN O
genes NNS O
in IN O
the DT O
bipartite JJ O
graph NN O
model NN O
can MD O
be VB O
calculated VBN O
in IN O
the DT O
following VBG O
way NN O
: : O
The DT O
set NN O
of IN O
genes NNS O
that WDT O
is VBZ O
used VBN O
to TO O
analyze VB O
association NN O
is VBZ O
used VBN O
to TO O
extract VB O
a DT O
subgraph NN O
from IN O
the DT O
original JJ O
bipartite JJ O
graph NN O
where WRB O
occurrence NN O
probabilities NNS O
for IN O
each DT O
gene NN O
- HYPH O
PubMedID NN O
_ HYPH O
listID NN O
pair NN O
are VBP O
identical JJ O
to IN O
those DT O
in IN O
the DT O
original JJ O
bipartite JJ O
graph NN O
( , O
i LS O
. . O
e UH O
. . O
they PRP O
are VBP O
not RB O
recalculated VBN O
by IN O
edge NN O
- HYPH O
swapping NN O
) -RRB- O
. . O

The DT O
vertex JJ O
degree NN O
of IN O
the DT O
PubMedID NNP O
_ HYPH O
listID NN O
vertices NNS O
in IN O
the DT O
subgraph NN O
indicates VBZ O
the DT O
number NN O
of IN O
genes NNS O
contained VBN O
in IN O
each DT O
PubMedID NNP O
_ HYPH O
listID NN O
overlapping VBG O
with IN O
the DT O
set NN O
of IN O
genes NNS O
used VBN O
to TO O
extract VB O
the DT O
subgraph NN O
. . O

From IN O
the DT O
occurrence NN O
probabilities NNS O
of IN O
the DT O
genes NNS O
in IN O
a DT O
given VBN O
PubMedID NN O
_ : O
listID NN O
, , O
the DT O
bi NN O
- HYPH O
binomial JJ O
P NN O
- HYPH O
value NN O
can MD O
then RB O
be VB O
calculated VBN O
for IN O
every DT O
list NN O
vertex NN O
degree NN O
observed VBN O
in IN O
the DT O
subgraph NN O
. . O

In IN O
Fig NNP O
. . O

7 CD O
, , O
the DT O
significance NN O
of IN O
association NN O
of IN O
the DT O
PubMedID NNP O
_ : O
listIDs NNS O
( , O
see VB O
Fig NNP O
. . O
6B NNP O
) -RRB- O
with IN O
the DT O
cell NN O
cycle NN O
cluster NN O
of IN O
genes NNS O
( -LRB- O
Fig NNP O
. . O
6A CD O
) -RRB- O
is VBZ O
calculated VBN O
. . O

For IN O
comparison NN O
, , O
binomial JJ O
and CC O
hypergeometric JJ O
P NN O
- HYPH O
values NNS O
are VBP O
also RB O
shown VBN O
. . O

It PRP O
can MD O
be VB O
seen VBN O
that IN O
the DT O
bi NN O
- HYPH O
binomial JJ O
P NN O
- HYPH O
value NN O
is VBZ O
larger JJR O
than IN O
the DT O
binomial JJ O
and CC O
hypergeometric JJ O
P NN O
- HYPH O
values NNS O
, , O
which WDT O
means VBZ O
that IN O
the DT O
strength NN O
of IN O
association NN O
is VBZ O
evaluated VBN O
in IN O
a DT O
more RBR O
stringent JJ O
manner NN O
using VBG O
BBD NNP O
statistics NNS O
( , O
see VB O
Discussion NN O
for IN O
an DT O
explanation NN O
of IN O
this DT O
observation NN O
) -RRB- O
. . O

The DT O
analysis NN O
of IN O
significant JJ O
associations NNS O
between IN O
PubMedID NNP O
_ , O
listIDs NNS O
and CC O
gene NN O
clusters NNS O
now RB O
permit VBP O
answering VBG O
the DT O
question NN O
whether IN O
there EX O
is VBZ O
correspondence NN O
between IN O
gene NN O
clusters NNS O
and CC O
PubMedID NNP O
_ HYPH O
listID NN O
clusters NNS O
. . O

The DT O
naming NN O
of IN O
PubMedID NNP O
_ : O
listID NN O
clusters NNS O
shown VBN O
in IN O
Fig NNP O
. . O

6B NN O
is VBZ O
based VBN O
on IN O
the DT O
number NN O
of IN O
PubMedID NN O
_ : O
listID NN O
that WDT O
are VBP O
significantly RB O
associated VBN O
with IN O
gene NN O
clusters NNS O
shown VBN O
in IN O
Fig NNP O
. . O

6A NN O
. . O

First RB O
, , O
for IN O
each DT O
gene NN O
cluster NN O
, , O
all PDT O
the DT O
PubMedID NN O
_ : O
listIDs NNS O
that WDT O
are VBP O
associated VBN O
with IN O
that DT O
cluster NN O
with IN O
more JJR O
than IN O
95 CD O
% NN O
confidence NN O
( : O
i LS O
. . O
e LS O
. . O
cumulative JJ O
bi NN O
- HYPH O
binomial JJ O
P NN O
- HYPH O
values NNS O
> : O
= SYM O
0 CD O
. . O
95 CD O
) -RRB- O
were VBD O
identified VBN O
. . O

Second RB O
, , O
the DT O
number NN O
of IN O
significant JJ O
PubMedID NN O
_ : O
listIDs NNS O
in IN O
each DT O
PubMedID NNP O
_ HYPH O
listID NN O
cluster NN O
was VBD O
counted VBN O
for IN O
every DT O
gene NN O
cluster NN O
. . O

The DT O
significance NN O
of IN O
this DT O
number NN O
was VBD O
then RB O
calculated VBN O
using VBG O
binomial JJ O
statistics NNS O
. . O

The DT O
results NNS O
of IN O
this DT O
analysis NN O
are VBP O
shown VBN O
in IN O
Table NNP O
1 CD O
. . O

Negative JJ O
decadic JJ O
logarithms NNS O
of IN O
the DT O
binomial JJ O
P NN O
- HYPH O
value NN O
are VBP O
displayed VBN O
. . O

It PRP O
is VBZ O
apparent JJ O
that IN O
each DT O
PubMedID NNP O
_ HYPH O
listID NN O
cluster NN O
is VBZ O
strongly RB O
associated VBN O
with IN O
at RB O
least RBS O
one CD O
gene NN O
cluster NN O
, , O
except IN O
for IN O
the DT O
"""" `` O
extracellular JJ O
matrix NN O
- HYPH O
immune JJ O
response NN O
"""" '' O
cluster NN O
, , O
which WDT O
is VBZ O
associated VBN O
with IN O
two CD O
gene NN O
clusters NNS O
. . O

The DT O
strength NN O
of IN O
these DT O
associations NNS O
suggests VBZ O
that IN O
the DT O
PubMedID NNP O
_ HYPH O
listID NN O
clusters NNS O
are VBP O
indeed RB O
corresponding VBG O
to IN O
the DT O
gene NN O
clusters NNS O
and CC O
that IN O
both CC O
the DT O
gene NN O
and CC O
the DT O
PubMedID NNP O
_ HYPH O
listID NN O
clusters NNS O
reflect VBP O
the DT O
structure NN O
of IN O
the DT O
bipartite JJ O
graph NN O
representing VBG O
the DT O
PubLiME NNP O
data NNS O
set VBN O
. . O

Details NNS O
about IN O
all PDT O
the DT O
lists NNS O
analyzed VBN O
are VBP O
attached VBN O
as IN O
supplementary JJ O
material NN O
Table NNP O
S2 NNP O
. . O

Looking VBG O
at IN O
these DT O
lists NNS O
, , O
some DT O
general JJ O
conclusions NNS O
about IN O
the DT O
gene NN O
clusters NNS O
can MD O
be VB O
drawn VBN O
. . O

Cell NN O
cycle NN O
cluster NN O
genes NNS O
have VBP O
been VBN O
found VBN O
deregulated VBN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
tumor NN O
types NNS O
such JJ O
as IN O
colon NN O
cancer NN O
, , O
breast NN O
cancer NN O
, , O
in IN O
biliary JJ O
tract NN O
cancer NN O
, , O
pancreatic JJ O
cancer NN O
, , O
gastric JJ O
cancer NN O
, , O
prostate NN O
cancer NN O
, , O
T NN O
- HYPH O
cell NN O
leukemia NN O
, , O
glioma NN O
, , O
acute JJ O
lymphoblastic JJ O
and CC O
myeloblastic JJ O
leukemias NNS O
, , O
soft JJ O
tissue NN O
sarcoma NN O
, , O
neuroblastoma NN O
, , O
as RB O
well RB O
as IN O
in IN O
a DT O
number NN O
of IN O
cellular JJ O
model NN O
systems NNS O
in IN O
response NN O
to IN O
different JJ O
stimuli NNS O
. . O

Thus RB O
, , O
the DT O
cell NN O
cycle NN O
cluster NN O
seems VBZ O
to TO O
consist VB O
of IN O
genes NNS O
with IN O
a DT O
general JJ O
role NN O
in IN O
oncogenesis NN O
. . O

The DT O
surface NN O
antigen NN O
cluster NN O
instead RB O
seems VBZ O
to TO O
be VB O
derived VBN O
preferentially RB O
from IN O
studies NNS O
on IN O
leukemia NN O
. . O

The DT O
interferon NN O
cluster NN O
genes NNS O
are VBP O
found VBN O
deregulated VBN O
in IN O
virus NN O
induced VBN O
pathologies NNS O
such JJ O
as IN O
papilloma NN O
virus NN O
induced VBN O
cervical JJ O
cancer NN O
, , O
and CC O
viral JJ O
hepatitis NN O
. . O

Immune JJ O
response NN O
cluster NN O
genes NNS O
were VBD O
reported VBN O
as IN O
differentially RB O
regulated VBN O
in IN O
inflammatory JJ O
conditions NNS O
such JJ O
as IN O
ulcerative JJ O
colitis NN O
, , O
Crohn NNP O
' POS O
s NNP O
disease NN O
, , O
and CC O
Helicobacter NNP B-Species
pylori NN I-Species
infections NNS O
. . O

Genes NNS O
of IN O
the DT O
extracellular JJ O
matrix NN O
cluster NN O
seem VBP O
to TO O
be VB O
associated VBN O
with IN O
cancer NN O
progression NN O
studies NNS O
and CC O
metastatic JJ O
potential NN O
. . O

For IN O
the DT O
protein NN O
biosynthesis NN O
cluster NN O
, , O
there EX O
are VBP O
15 CD O
signatures NNS O
that WDT O
are VBP O
significantly RB O
enriched VBN O
for IN O
those DT O
genes NNS O
. . O

The DT O
cancers NNS O
studied VBN O
comprise VBP O
medulloblastoma NN O
, , O
glioblastoma NN O
, , O
pancreatic JJ O
cancer NN O
, , O
soft JJ O
tissue NN O
sarcoma NN O
, , O
lung NN O
carcinoma NN O
, , O
breast NN O
carcinoma NN O
, , O
prostate NN O
carcinoma NN O
, , O
multiple JJ O
myeloma NN O
, , O
and CC O
lymphocytic JJ O
leukemia NN O
. . O

The DT O
genes NNS O
are VBP O
also RB O
found VBN O
deregulated VBN O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
. . O

Although IN O
the DT O
number NN O
of IN O
signatures NNS O
is VBZ O
limited JJ O
, , O
the DT O
variation NN O
in IN O
conditions NNS O
where WRB O
the DT O
genes NNS O
are VBP O
deregulated VBN O
is VBZ O
compatible JJ O
with IN O
the DT O
hypothesis NN O
that IN O
protein NN O
biosynthesis NN O
genes NNS O
, , O
as IN O
cell NN O
cycle NN O
genes NNS O
, , O
are VBP O
deregulated VBN O
in IN O
many JJ O
cancer NN O
types NNS O
, , O
which WDT O
might MD O
reflect VB O
the DT O
general JJ O
property NN O
of IN O
cancer NN O
cells NNS O
to TO O
divide VB O
and CC O
grow VB O
in IN O
an DT O
uncontrolled JJ O
fashion NN O
. . O

Discussion NN O

Here RB O
we PRP O
have VBP O
investigated VBN O
basic JJ O
aspects NNS O
of IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
and CC O
present VB O
a DT O
software NN O
tool NN O
, , O
NetCutter NNP O
, , O
which WDT O
can MD O
be VB O
used VBN O
to TO O
identify VB O
and CC O
analyze VB O
generic JJ O
co NN O
- HYPH O
occurrence NN O
networks NNS O
. . O

In IN O
NetCutter NNP O
, , O
a DT O
co NN O
- HYPH O
occurrence NN O
data NNS O
set NN O
is VBZ O
represented VBN O
as IN O
a DT O
bipartite JJ O
graph NN O
with IN O
one CD O
part NN O
representing VBG O
lists NNS O
and CC O
the DT O
other JJ O
part NN O
list NN O
entries NNS O
whose WP$ O
co NN O
- HYPH O
occurrence NN O
patterns NNS O
are VBP O
studied VBN O
. . O

The DT O
bipartite JJ O
graph NN O
representation NN O
of IN O
co NN O
- HYPH O
occurrence NN O
data NNS O
sets VBZ O
allows VBZ O
the DT O
efficacy NN O
of IN O
different JJ O
null NN O
- HYPH O
models NNS O
to TO O
be VB O
tested VBN O
systematically RB O
. . O

We PRP O
have VBP O
shown VBN O
that IN O
an DT O
edge NN O
- HYPH O
swapping VBG O
procedure NN O
used VBN O
to TO O
randomize VB O
the DT O
bipartite JJ O
graph NN O
generates VBZ O
a DT O
null NN O
- HYPH O
model NN O
that WDT O
allows VBZ O
co NN O
- HYPH O
occurrence NN O
analysis NN O
with IN O
the DT O
highest JJS O
stringency NN O
. . O

The DT O
other JJ O
null NN O
- HYPH O
models NNS O
tested VBN O
here RB O
tend VBP O
to TO O
underestimate VB O
occurrence NN O
probabilities NNS O
of IN O
entries NNS O
per IN O
list NN O
for IN O
lists NNS O
and CC O
genes NNS O
with IN O
high JJ O
vertex NN O
degrees NNS O
, , O
i PRP O
. . O
e -RRB- O
. . O
for IN O
lists NNS O
and CC O
genes NNS O
where WRB O
most JJS O
co NN O
- HYPH O
occurrences NNS O
are VBP O
observed VBN O
. . O

As IN O
a DT O
result NN O
, , O
co NN O
- HYPH O
occurrences NNS O
are VBP O
judged VBN O
more RBR O
significant JJ O
than IN O
they PRP O
really RB O
are VBP O
. . O

Co NN O
- HYPH O
occurrence NN O
data NNS O
sets VBZ O
with IN O
exactly RB O
equal JJ O
lists NNS O
lengths NNS O
are VBP O
likely JJ O
to TO O
be VB O
the DT O
exception NN O
from IN O
the DT O
rule NN O
. . O

It PRP O
can MD O
be VB O
assumed VBN O
that IN O
some DT O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
will MD O
be VB O
present JJ O
in IN O
most JJS O
circumstances NNS O
. . O

An DT O
important JJ O
consequence NN O
of IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
regards VBZ O
the DT O
co NN O
- HYPH O
occurrence NN O
probability NN O
distribution NN O
used VBN O
to TO O
evaluate VB O
the DT O
significance NN O
of IN O
the DT O
observed VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
. . O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
in IN O
the DT O
presence NN O
of IN O
list NN O
- HYPH O
length NN O
- HYPH O
heterogeneity NN O
is VBZ O
best RBS O
performed VBN O
using VBG O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
( : O
a DT O
binomial JJ O
distribution NN O
with IN O
trial NN O
specific JJ O
probabilities NNS O
) -RRB- O
. . O

However RB O
, , O
calculating VBG O
Poisson NNP O
- HYPH O
binomial JJ O
P NN O
- HYPH O
values NNS O
for IN O
large JJ O
numbers NNS O
of IN O
lists NNS O
is VBZ O
difficult JJ O
using VBG O
existing VBG O
procedures NNS O
[ -LRB- O
36 CD O
] -RRB- O
. . O

We PRP O
have VBP O
presented VBN O
an DT O
approximation NN O
to IN O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
, , O
called VBN O
bi NN O
- HYPH O
binomial NN O
distribution NN O
, , O
which WDT O
is VBZ O
based VBN O
on IN O
replacing VBG O
the DT O
set NN O
of IN O
Poisson NNP O
trials NNS O
by IN O
two CD O
sets NNS O
of IN O
Bernoulli NNP O
trials NNS O
. . O

The DT O
resulting VBG O
distribution NN O
reproduces VBZ O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
nearly RB O
exactly RB O
and CC O
its PRP$ O
P NN O
- HYPH O
values NNS O
can MD O
be VB O
calculated VBN O
with IN O
ease NN O
even RB O
for IN O
thousands NNS O
of IN O
lists NNS O
( , O
see VB O
also RB O
supplementary JJ O
material NN O
Simulation NNP O
S1 NNP O
for IN O
details NNS O
on IN O
the DT O
precision NN O
of IN O
BBD NNP O
) -RRB- O
. . O

Importantly RB O
, , O
BBD NNP O
provides VBZ O
a DT O
novel JJ O
measure NN O
of IN O
association NN O
, , O
which WDT O
is VBZ O
shown VBN O
to TO O
be VB O
superior JJ O
to IN O
existing JJ O
measures NNS O
such JJ O
as IN O
the DT O
Jaccard NNP O
coefficient NN O
and CC O
the DT O
uncertainty NN O
coefficient JJ O
, , O
whose WP$ O
values NNS O
cannot MD O
be VB O
interpreted VBN O
properly RB O
in IN O
the DT O
absence NN O
of IN O
knowledge NN O
about IN O
the DT O
occurrence NN O
probabilities NNS O
of IN O
co NN O
- HYPH O
occurring VBG O
entities NNS O
. . O

It PRP O
is VBZ O
worth JJ O
noting VBG O
that IN O
Poisson NNP O
- HYPH O
binomial NNP O
Z NNP O
- HYPH O
scores NNS O
are VBP O
distinguished VBN O
from IN O
Gaussian NNP O
Z NNP O
- HYPH O
scores NNS O
by IN O
the DT O
fact NN O
that IN O
they PRP O
do VBP O
not RB O
correspond VB O
to IN O
the DT O
same JJ O
P NN O
- HYPH O
value NN O
for IN O
different JJ O
PBDs NNS O
, , O
BBDs NNPS O
, , O
and CC O
even RB O
BDs NNS O
. . O

This DT O
is VBZ O
because IN O
the DT O
Z NN O
- HYPH O
score NN O
is VBZ O
an DT O
explicit JJ O
part NN O
of IN O
the DT O
function NN O
defining VBG O
the DT O
normal JJ O
probability NN O
density NN O
while IN O
it PRP O
is VBZ O
not RB O
part NN O
of IN O
the DT O
definitions NNS O
of IN O
BD NNP O
, , O
PBD NNP O
, , O
and CC O
BBD NNP O
densities NNS O
. . O

As IN O
a DT O
consequence NN O
, , O
the DT O
simple JJ O
Poisson NNP O
- HYPH O
binomial JJ O
Z NN O
- HYPH O
score NN O
based VBN O
approach NN O
to IN O
evaluating VBG O
significance NN O
of IN O
co NN O
- HYPH O
occurrence NN O
must MD O
be VB O
complemented VBN O
with IN O
the DT O
BBD NNP O
to TO O
approximate VB O
Poisson NNP O
- HYPH O
binomial JJ O
P NN O
- HYPH O
values NNS O
in IN O
order NN O
to TO O
enable VB O
multiple JJ O
testing NN O
corrections NNS O
and CC O
to TO O
allow VB O
calculation NN O
of IN O
confidence NN O
levels NNS O
in IN O
association NN O
studies NNS O
precisely RB O
. . O

However RB O
, , O
NetCutter NNP O
is VBZ O
equipped VBN O
with IN O
a DT O
bipartite JJ O
graph NN O
randomization NN O
tool NN O
that WDT O
permits VBZ O
measuring VBG O
the DT O
number NN O
of IN O
false JJ O
positives NNS O
due IN O
to IN O
multiple JJ O
testing NN O
directly RB O
by IN O
comparing VBG O
the DT O
number NN O
of IN O
significant JJ O
co NN O
- HYPH O
occurrence NN O
modules NNS O
in IN O
the DT O
real JJ O
bipartite JJ O
graph NN O
to IN O
the DT O
corresponding JJ O
number NN O
in IN O
a DT O
randomized VBN O
version NN O
thereof RB O
. . O

Randomization NN O
is VBZ O
performed VBN O
by IN O
edge NN O
- HYPH O
swapping VBG O
in IN O
order NN O
to TO O
preserve VB O
vertex NN O
degrees NNS O
. . O

The DT O
resulting VBG O
signal NN O
- HYPH O
to IN O
- HYPH O
noise NN O
ratios NNS O
that WDT O
are VBP O
plotted VBN O
for IN O
each DT O
Z NN O
- HYPH O
score NN O
/ SYM O
P NN O
- HYPH O
value NN O
cutoff NN O
provide VBP O
a DT O
highly RB O
reliable JJ O
and CC O
visually RB O
intuitive JJ O
defense NN O
mechanism NN O
against IN O
false JJ O
positives NNS O
( , O
see VB O
also RB O
supplementary JJ O
material NN O
Simulation NNP O
S1 NNP O
) -RRB- O
. . O

In IN O
the DT O
vast JJ O
majority NN O
of IN O
co NN O
- HYPH O
occurrence NN O
studies NNS O
, , O
pair NN O
- HYPH O
wise JJ O
co NN O
- HYPH O
occurrences NNS O
have VBP O
been VBN O
analyzed VBN O
using VBG O
different JJ O
statistical JJ O
models NNS O
. . O

We PRP O
have VBP O
observed VBN O
that IN O
the DT O
stringency NN O
of IN O
pair NN O
- HYPH O
wise JJ O
co NN O
- HYPH O
occurrence NN O
analysis NN O
is VBZ O
far RB O
below IN O
the DT O
stringency NN O
of IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
using VBG O
higher JJR O
order NN O
combinations NNS O
of IN O
co NN O
- HYPH O
occurring VBG O
entities NNS O
[ -LRB- O
35 CD O
] -RRB- O
. . O

In IN O
NetCutter NNP O
, , O
co NN O
- HYPH O
occurrence NN O
analysis NN O
is VBZ O
preceded VBN O
by IN O
occurrence NN O
analysis NN O
, , O
i LS O
. . O
e LS O
. . O
the DT O
occurrence NN O
probability NN O
of IN O
each DT O
entry NN O
in IN O
each DT O
list NN O
is VBZ O
determined VBN O
. . O

Starting VBG O
from IN O
occurrence NN O
probabilities NNS O
, , O
co NN O
- HYPH O
occurrence NN O
probabilities NNS O
for IN O
any DT O
size NN O
of IN O
co NN O
- HYPH O
occurrence NN O
modules NNS O
under IN O
study NN O
can MD O
be VB O
obtained VBN O
by IN O
multiplying VBG O
the DT O
respective JJ O
list NN O
- HYPH O
specific JJ O
occurrence NN O
probabilities NNS O
. . O

Given VBN O
the DT O
list NN O
- HYPH O
specific JJ O
co NN O
- HYPH O
occurrence NN O
probabilities NNS O
, , O
bi NN O
- HYPH O
binomial JJ O
P NN O
- HYPH O
values NNS O
are VBP O
then RB O
calculated VBN O
in IN O
exactly RB O
the DT O
same JJ O
way NN O
for IN O
any DT O
module NN O
size NN O
. . O

As IN O
a DT O
consequence NN O
, , O
NetCutter NNP O
can MD O
perform VB O
co NN O
- HYPH O
occurrence NN O
analysis NN O
for IN O
higher JJR O
order NN O
combinations NNS O
of IN O
co NN O
- HYPH O
occurring VBG O
entries NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
larger JJR O
module NN O
sizes NNS O
) -RRB- O
using VBG O
the DT O
same JJ O
statistical JJ O
model NN O
. . O

One CD O
of IN O
the DT O
benefits NNS O
of IN O
using VBG O
higher JJR O
module NN O
sizes NNS O
is VBZ O
robustness NN O
of IN O
the DT O
analyses NNS O
in IN O
the DT O
presence NN O
of IN O
noise NN O
. . O

This DT O
is VBZ O
because IN O
each DT O
edge NN O
in IN O
the DT O
resulting VBG O
co NN O
- HYPH O
occurrence NN O
network NN O
is VBZ O
evaluated VBN O
many JJ O
times NNS O
since IN O
every DT O
pair NN O
of IN O
co NN O
- HYPH O
occurring VBG O
entries NNS O
can MD O
be VB O
part NN O
of IN O
many JJ O
higher JJR O
order NN O
co NN O
- HYPH O
occurrence NN O
modules NNS O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Another DT O
advantage NN O
is VBZ O
that IN O
implicit JJ O
relationships NNS O
between IN O
entries NNS O
, , O
which WDT O
have VBP O
never RB O
occurred VBN O
together RB O
[ -LRB- O
18 CD O
] -RRB- O
, , O
can MD O
be VB O
derived VBN O
as IN O
a DT O
natural JJ O
by IN O
- HYPH O
product NN O
of IN O
using VBG O
module NN O
sizes NNS O
larger JJR O
than IN O
2 CD O
. . O

As IN O
shown VBN O
in IN O
a DT O
simulation NN O
study NN O
( , O
supplementary JJ O
material NN O
Simulation NNP O
S1 NNP O
) -RRB- O
, , O
the DT O
result NN O
is VBZ O
a DT O
dramatic JJ O
reduction NN O
of IN O
misclassifications NNS O
at IN O
higher JJR O
module NN O
sizes NNS O
. . O

NetCutter NNP O
can MD O
be VB O
used VBN O
to TO O
calculate VB O
the DT O
strength NN O
of IN O
association NN O
between IN O
a DT O
subset NN O
of IN O
entries NNS O
and CC O
lists NNS O
reporting VBG O
those DT O
entries NNS O
. . O

In IN O
this DT O
case NN O
, , O
the DT O
analysis NN O
is VBZ O
performed VBN O
on IN O
a DT O
subgraph NN O
of IN O
the DT O
original JJ O
bipartite JJ O
graph NN O
. . O

The DT O
subgraph NN O
can MD O
correspond VB O
to IN O
communities NNS O
of IN O
entries NNS O
in IN O
the DT O
co NN O
- HYPH O
occurrence NN O
network NN O
, , O
or CC O
any DT O
set NN O
of IN O
entries NNS O
of IN O
interest NN O
. . O

NetCutter NNP O
will MD O
then RB O
calculate VB O
the DT O
significance NN O
of IN O
observing VBG O
a DT O
given VBN O
number NN O
of IN O
occurrences NNS O
of IN O
an DT O
entry NN O
in IN O
the DT O
user NN O
defined VBN O
subset NN O
of IN O
lists NNS O
using VBG O
bi NN O
- HYPH O
binomal NN O
statistics NNS O
. . O

This DT O
analysis NN O
mode NN O
corresponds VBZ O
to IN O
association NN O
studies NNS O
with IN O
the DT O
advantage NN O
that IN O
the DT O
structure NN O
of IN O
the DT O
underlying VBG O
bipartite JJ O
graph NN O
( , O
i LS O
. . O
e LS O
. . O
list NN O
length NN O
heterogeneity NN O
) -RRB- O
is VBZ O
considered VBN O
and CC O
handled VBN O
appropriately RB O
using VBG O
the DT O
bi NN O
- HYPH O
binomial NN O
distribution NN O
. . O

As IN O
a DT O
consequence NN O
, , O
association NN O
studies NNS O
can MD O
be VB O
performed VBN O
with IN O
higher JJR O
stringency NN O
. . O

This DT O
result NN O
can MD O
be VB O
understood VBN O
by IN O
examining VBG O
the DT O
occurrence NN O
probability NN O
matrix NN O
that WDT O
is VBZ O
implicitly RB O
assumed VBN O
in IN O
performing VBG O
binomial JJ O
or CC O
hypergeometric JJ O
tests NNS O
for IN O
the DT O
significance NN O
of IN O
overlaps NNS O
. . O

In IN O
both DT O
tests NNS O
, , O
a DT O
gene NN O
is VBZ O
assumed VBN O
to TO O
have VB O
an DT O
equal JJ O
opportunity NN O
to TO O
be VB O
present JJ O
in IN O
a DT O
list NN O
. . O

Therefore RB O
, , O
the DT O
probability NN O
of IN O
success NN O
for IN O
a DT O
gene NN O
to TO O
be VB O
part NN O
of IN O
a DT O
list NN O
is VBZ O
given VBN O
by IN O
the DT O
list NN O
vertex NN O
degree NN O
divided VBN O
by IN O
the DT O
total JJ O
number NN O
of IN O
genes NNS O
. . O

In IN O
other JJ O
words NNS O
, , O
both DT O
tests NNS O
are VBP O
implicitly RB O
based VBN O
on IN O
the DT O
list NN O
vertex NN O
degree NN O
model NN O
, , O
which WDT O
has VBZ O
been VBN O
shown VBN O
previously RB O
to TO O
underestimate VB O
the DT O
occurrence NN O
probability NN O
and CC O
the DT O
expected VBN O
number NN O
of IN O
co NN O
- HYPH O
occurrences NNS O
for IN O
genes NNS O
with IN O
high JJ O
vertex NN O
degree NN O
( , O
see VB O
Fig NNP O
. . O
2A CD O
) -RRB- O
. . O

Since IN O
the DT O
BBD NNP O
P NN O
- HYPH O
values NNS O
are VBP O
calculated VBN O
from IN O
the DT O
ES NNP O
- HYPH O
model NN O
, , O
which WDT O
assigns VBZ O
higher JJR O
occurrence NN O
probabilities NNS O
to IN O
genes NNS O
with IN O
higher JJR O
vertex JJ O
degree NN O
and CC O
more RBR O
expected JJ O
co NN O
- HYPH O
occurrences NNS O
, , O
the DT O
observed VBN O
number NN O
of IN O
overlaps NNS O
between IN O
a DT O
set NN O
of IN O
genes NNS O
of IN O
interest NN O
and CC O
the DT O
content NN O
of IN O
a DT O
given VBN O
list NN O
( , O
which WDT O
can MD O
be VB O
viewed VBN O
as IN O
co NN O
- HYPH O
occurrence NN O
of IN O
the DT O
overlapping VBG O
genes NNS O
in IN O
that DT O
list NN O
) , O
will MD O
be VB O
judged VBN O
less RBR O
significant JJ O
when WRB O
the DT O
overlapping VBG O
genes NNS O
are VBP O
of IN O
high JJ O
vertex NN O
degree NN O
( , O
and CC O
vice RB O
versa RB O
when WRB O
the DT O
overlapping VBG O
genes NNS O
are VBP O
of IN O
low JJ O
vertex NN O
degree NN O
) , O
as IN O
compared VBN O
to IN O
binomial JJ O
or CC O
hypergeometric JJ O
tests NNS O
. . O

Since IN O
the DT O
BBD NNP O
P NN O
- HYPH O
values NNS O
are VBP O
derived VBN O
from IN O
the DT O
most RBS O
stringent JJ O
ES NNP O
null NN O
- HYPH O
model NN O
, , O
BBD NNP O
P NNP O
- HYPH O
values NNS O
provide VBP O
a DT O
more RBR O
reliable JJ O
estimate NN O
for IN O
the DT O
significance NN O
of IN O
overlap NN O
. . O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
of IN O
data NNS O
represented VBN O
as IN O
bipartite NN O
graphs NNS O
permits VBZ O
visualizing VBG O
the DT O
structure NN O
of IN O
the DT O
bipartite JJ O
graph NN O
either CC O
as IN O
communities NNS O
of IN O
list NN O
entries NNS O
( , O
genes NNS O
) -RRB- O
or CC O
as IN O
communities NNS O
of IN O
lists NNS O
( -LRB- O
PubMedID NNP O
_ : O
ListID NNP O
) -RRB- O
in IN O
co NN O
- HYPH O
occurrence NN O
networks NNS O
. . O

We PRP O
have VBP O
analyzed VBN O
the DT O
PubLiME NNP O
data NNS O
set VBN O
for IN O
the DT O
presence NN O
of IN O
corresponding VBG O
gene NN O
and CC O
list NN O
clusters NNS O
. . O

In IN O
addition NN O
to IN O
previously RB O
published VBN O
clusters NNS O
of IN O
genes NNS O
, , O
we PRP O
describe VBP O
a DT O
novel JJ O
gene NN O
cluster NN O
that WDT O
is VBZ O
composed VBN O
of IN O
protein NN O
biosynthesis NN O
associated VBN O
genes NNS O
[ -LRB- O
35 CD O
] -RRB- O
. . O

We PRP O
found VBD O
that IN O
the DT O
corresponding VBG O
clusters NNS O
of IN O
PubMedID NNP O
_ : O
ListID NNP O
( , O
gene NN O
expression NN O
signatures NNS O
) -RRB- O
are VBP O
in IN O
general JJ O
strongly RB O
enriched VBN O
for IN O
genes NNS O
reported VBN O
in IN O
the DT O
corresponding VBG O
gene NN O
cluster NN O
and CC O
that IN O
interrogation NN O
of IN O
corresponding VBG O
clusters NNS O
can MD O
be VB O
used VBN O
to TO O
deduct VB O
hypotheses NNS O
about IN O
the DT O
putative JJ O
function NN O
of IN O
gene NN O
clusters NNS O
. . O

In IN O
addition NN O
to IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
, , O
NetCutter NNP O
offers VBZ O
a DT O
number NN O
of IN O
tools NNS O
for IN O
the DT O
analysis NN O
of IN O
co NN O
- HYPH O
occurrence NN O
networks NNS O
, , O
or CC O
any DT O
undirected JJ O
graph NN O
. . O

In IN O
particular JJ O
, , O
community NN O
identification NN O
is VBZ O
supported VBN O
by IN O
four CD O
different JJ O
community NN O
identification NN O
algorithms NNS O
. . O

NetCutter NNP O
also RB O
offers VBZ O
a DT O
range NN O
of IN O
convenience NN O
functions NNS O
that WDT O
are VBP O
of IN O
help NN O
in IN O
network NN O
analysis NN O
. . O

Worthy JJ O
of IN O
mentioning VBG O
are VBP O
the DT O
random JJ O
graph NN O
generators NNS O
that WDT O
can MD O
provide VB O
control NN O
graphs NNS O
for IN O
topological JJ O
studies NNS O
. . O

The DT O
complete JJ O
set NN O
of IN O
options NNS O
is VBZ O
described VBN O
in IN O
the DT O
software NN O
documentation NN O
. . O

In IN O
summary NN O
, , O
we PRP O
present VBP O
a DT O
general JJ O
framework NN O
for IN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
with IN O
many JJ O
potential JJ O
applications NNS O
. . O

We PRP O
illustrate VBP O
a DT O
number NN O
of IN O
advantages NNS O
of IN O
using VBG O
the DT O
bipartite JJ O
graph NN O
representation NN O
of IN O
data NNS O
and CC O
the DT O
associated VBN O
statistics NNS O
. . O

In IN O
particular JJ O
, , O
the DT O
identification NN O
of IN O
corresponding VBG O
clusters NNS O
permits VBZ O
the DT O
identification NN O
of IN O
functional JJ O
subunits NNS O
such JJ O
as IN O
gene NN O
clusters NNS O
on IN O
the DT O
one CD O
hand NN O
, , O
and CC O
the DT O
generation NN O
of IN O
hypotheses NNS O
about IN O
the DT O
function NN O
of IN O
those DT O
units NNS O
by IN O
analyzing VBG O
the DT O
corresponding VBG O
list NN O
clusters NNS O
on IN O
the DT O
other JJ O
hand NN O
. . O

Future JJ O
developments NNS O
will MD O
be VB O
directed VBN O
towards IN O
the DT O
analysis NN O
of IN O
data NN O
sets NNS O
that WDT O
are VBP O
considerably RB O
larger JJR O
than IN O
the DT O
data NNS O
sets NNS O
analyzed VBN O
so RB O
far RB O
. . O

For IN O
example NN O
, , O
co NN O
- HYPH O
occurrence NN O
analysis NN O
might MD O
be VB O
of IN O
interest NN O
for IN O
the DT O
analysis NN O
of IN O
single JJ O
nucleotide NN O
polymorphism NN O
( -LRB- O
SNP NNP O
) -RRB- O
data NN O
sets NNS O
and CC O
association NN O
studies NNS O
of IN O
genome NN O
variability NN O
with IN O
disease NN O
. . O

Each DT O
patient NN B-Species
is VBZ O
characterized VBN O
by IN O
a DT O
specific JJ O
range NN O
of IN O
SNPs NNPS O
. . O

Co NN O
- HYPH O
occurrence NN O
patterns NNS O
of IN O
patients NNS B-Species
according VBG O
to IN O
their PRP$ O
SNPs NNS O
could MD O
be VB O
compared VBN O
to IN O
clinical JJ O
parameters NNS O
with IN O
the DT O
aim NN O
of IN O
identifying VBG O
genomic JJ O
regions NNS O
associated VBN O
with IN O
disease NN O
. . O

The DT O
increased VBN O
stringency NN O
of IN O
association NN O
studies NNS O
offered VBN O
by IN O
NetCutter NNP O
may MD O
be VB O
of IN O
use NN O
in IN O
the DT O
analysis NN O
of IN O
polygenic JJ O
diseases NNS O
where WRB O
conventional JJ O
methods NNS O
fail VBP O
. . O

For IN O
being VBG O
useful JJ O
in IN O
this DT O
setting NN O
, , O
NetCutter NNP O
must MD O
be VB O
capable JJ O
of IN O
analyzing VBG O
bipartite JJ O
graphs NNS O
with IN O
millions NNS O
instead RB O
of IN O
thousands NNS O
of IN O
vertices NNS O
. . O

Materials NNS O
and CC O
Methods NNS O

Implementation NN O
of IN O
NetCutter NNP O

NetCutter NNP O
is VBZ O
written VBN O
in IN O
Java NNP O
using VBG O
NetBeans6 NNP O
software NN O
( : O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
netbeans NNS O
. . O
info IN O
/ SYM O
) -RRB- O
and CC O
tested VBN O
on IN O
the DT O
Java NNP O
Runtime NNP O
environment NN O
1 CD O
. . O
6 CD O
. . O
0 CD O
. . O
0 CD O
. . O
on IN O
a DT O
Windows NNP O
XP NNP O
Professional NNP O
computer NN O
. . O

The DT O
Java NNP O
Runtime NNP O
environment NN O
, , O
which WDT O
can MD O
be VB O
downloaded VBN O
from IN O
http NN O
: : O
/ SYM O
/ SYM O
java NNP O
. . O
sun NN O
. . O
com NN O
/ : O
, , O
must MD O
be VB O
installed VBN O
on IN O
a DT O
computer NN O
that WDT O
is VBZ O
intended VBN O
to TO O
run VB O
NetCutter NNP O
. . O

NetCutter NNP O
is VBZ O
provided VBN O
as IN O
a DT O
single JJ O
jar NN O
file NN O
and CC O
should MD O
run VB O
by IN O
double RB O
clicking VBG O
the DT O
jar NN O
file NN O
, , O
provided VBN O
that IN O
the DT O
Java NNP O
runtime NN O
environment NN O
is VBZ O
properly RB O
installed VBN O
. . O

NetCutter NNP O
makes VBZ O
use NN O
of IN O
the DT O
following VBG O
software NN O
packages NNS O
and CC O
classes NNS O
: : O
JUNG NNP O
version NN O
1 CD O
. . O
3 CD O
( : O
http NN O
: : O
/ : O
/ : O
jung NN O
. . O
sourceforge NN O
. . O
net NN O
/ SYM O
download NN O
. . O
html NN O
) -RRB- O
, , O
Apache NNP O
Jakarta NNP O
Commons NNPS O
Collections NNP O
3 CD O
. . O
1 CD O
( , O
http NN O
: : O
/ NFP O
/ NFP O
jakarta NNP O
. . O
apache NN O
. . O
org NN O
/ SYM O
commons NNS O
/ SYM O
collections NNS O
/ SYM O
) NFP O
, , O
Cern NNP O
Colt NNP O
Scientific NNP O
Library NNP O
1 CD O
. . O
2 CD O
. . O
0 CD O
( : O
http NN O
: : O
/ : O
/ : O
dsd NN O
. . O
lbl NNP O
. . O
gov NN O
/ SYM O
hoschek NN O
/ SYM O
colt NN O
/ : O
) NFP O
, , O
Xerces NN O
( : O
http NN O
: : O
/ : O
/ : O
xerces NNS O
. . O
apache NN O
. . O
org NN O
/ SYM O
xerces2 NN O
- HYPH O
j NN O
/ SYM O
index NN O
. . O
html NN O
) -RRB- O
, , O
Jama NNP O
( : O
http NN O
: : O
/ : O
/ SYM O
math NN O
. . O
nist NN O
. . O
gov NN O
/ SYM O
javanumerics NNP O
/ SYM O
jama NNP O
/ , O
) -RRB- O
, , O
Netlib NNP O
Java NNP O
LAPACK NNP O
( : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
netlib NN O
. . O
org NN O
/ SYM O
lapack NN O
/ : O
) NFP O
, , O
JFreeChart NNP O
( : O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
jfree NNP O
. . O
org NN O
/ SYM O
jfreechart NN O
/ : O
) NFP O
, , O
partition NN O
. . O
java NN O
( : O
http NN O
: : O
/ NFP O
/ NFP O
astro NNP O
. . O
u NN O
- HYPH O
strasbg NN O
. . O
fr ADD O
/ : O
fmurtagh ADD O
/ : O
mda NN O
- HYPH O
sw NN O
/ SYM O
java NN O
/ SYM O
partition NN O
. . O
java NN O
) -RRB- O
. . O

Bi JJ O
- HYPH O
binomial JJ O
approximation NN O
of IN O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O

The DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
( , O
binomial JJ O
distribution NN O
with IN O
trial NN O
specific JJ O
probabilities NNS O
) -RRB- O
has VBZ O
recently RB O
been VBN O
proposed VBN O
as IN O
a DT O
statistic NN O
that WDT O
properly RB O
handles VBZ O
largely RB O
differing VBG O
sizes NNS O
of IN O
gene NN O
expression NN O
signatures NNS O
in IN O
meta JJ O
- HYPH O
analysis NN O
of IN O
gene NN O
expression NN O
data NNS O
[ -LRB- O
35 CD O
] -RRB- O
. . O

Z NN O
- HYPH O
scores NNS O
have VBP O
been VBN O
used VBN O
to TO O
estimate VB O
the DT O
significance NN O
of IN O
co NN O
- HYPH O
occurrence NN O
because IN O
P NN O
- HYPH O
value NN O
calculation NN O
is VBZ O
cumbersome JJ O
and CC O
error NN O
prone JJ O
. . O

Two CD O
methods NNS O
reported VBN O
by IN O
[ -LRB- O
36 CD O
] -RRB- O
suffer VBP O
from IN O
numerical JJ O
overflow NN O
/ SYM O
underflow NN O
problems NNS O
when WRB O
large JJ O
numbers NNS O
of IN O
Poisson NNP O
trials NNS O
with IN O
probabilities NNS O
deviating VBG O
significantly RB O
from IN O
0 CD O
. . O
5 CD O
are VBP O
being VBG O
analyzed VBN O
. . O

Therefore RB O
, , O
we PRP O
propose VBP O
a DT O
fast JJ O
approximation NN O
of IN O
P NNP O
- HYPH O
values NNS O
based VBN O
on IN O
a DT O
bi JJ O
- HYPH O
binomial JJ O
distribution NN O
. . O

The DT O
bi JJ O
- HYPH O
binomial JJ O
distribution NN O
is VBZ O
a DT O
special JJ O
case NN O
of IN O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
where WRB O
the DT O
probability NN O
of IN O
success NN O
can MD O
assume VB O
only RB O
two CD O
values NNS O
. . O

In IN O
order NN O
to TO O
achieve VB O
a DT O
good JJ O
approximation NN O
of IN O
the DT O
underlying VBG O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
, , O
the DT O
values NNS O
of IN O
these DT O
two CD O
probabilities NNS O
and CC O
the DT O
number NN O
of IN O
trials NNS O
where WRB O
they PRP O
are VBP O
assumed VBN O
must MD O
be VB O
determined VBN O
carefully RB O
. . O

As IN O
is VBZ O
shown VBN O
in IN O
the DT O
following VBG O
, , O
the DT O
values NNS O
of IN O
the DT O
two CD O
trial NN O
probabilities NNS O
and CC O
their PRP$ O
number NN O
of IN O
occurrences NNS O
follow VBP O
from IN O
the DT O
formula NN O
used VBN O
to TO O
calculate VB O
the DT O
variance NN O
of IN O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
and CC O
from IN O
the DT O
formula NN O
yielding VBG O
the DT O
population NN O
variance NN O
of IN O
trial NN O
probabilities NNS O
of IN O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
to TO O
be VB O
approximated VBN O
. . O

The DT O
mean JJ O
mu NN O
and CC O
the DT O
variance NN O
sigma NN O
2 CD O
of IN O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
are VBP O
given VBN O
by IN O
equation NN O
( : O
1 CD O
) -RRB- O
and CC O
( , O
2 CD O
) -RRB- O
, , O
respectively RB O
. . O
( , O
1 CD O
) -RRB- O
( , O
2 CD O
) -RRB- O
pi NN O
is VBZ O
the DT O
trial NN O
- HYPH O
specific JJ O
probability NN O
of IN O
success NN O
and CC O
N NNP O
is VBZ O
the DT O
total JJ O
number NN O
of IN O
trials NNS O
. . O

For IN O
the DT O
sake NN O
of IN O
completeness NN O
, , O
a DT O
formal JJ O
proof NN O
of IN O
equation NN O
( -LRB- O
1 CD O
) -RRB- O
is VBZ O
reported VBN O
as IN O
supplementary JJ O
material NN O
Proof NNP O
S1 NNP O
and CC O
the DT O
proof NN O
of IN O
equation NN O
( -LRB- O
2 CD O
) -RRB- O
can MD O
be VB O
obtained VBN O
in IN O
an DT O
analogous JJ O
fashion NN O
. . O

The DT O
population NN O
variance NN O
S2 NN O
of IN O
trial NN O
probabilities NNS O
pi NN O
is VBZ O
given VBN O
by IN O
equation NN O
( : O
3 CD O
) -RRB- O
. . O
( , O
3 CD O
) -RRB- O

Rearranging VBG O
equation NN O
( : O
3 CD O
) -RRB- O
considering VBG O
( : O
1 CD O
) -RRB- O
and CC O
( : O
2 LS O
) -RRB- O
leads VBZ O
to IN O
( : O
4 CD O
) SYM O
and CC O
( SYM O
5 CD O
) -RRB- O
, , O
where WRB O
pa NN O
denotes VBZ O
the DT O
average JJ O
trial JJ O
probability NN O
of IN O
success NN O
and CC O
qa DT O
its PRP$ O
complement NN O
. . O
( : O
4 LS O
) -RRB- O
( : O
5 LS O
) -RRB- O
Now RB O
let VB O
' '' O
s VBZ O
define VB O
two CD O
trial NN O
probabilities NNS O
p1 CD O
and CC O
p2 NN O
, , O
which WDT O
are VBP O
used VBN O
N1 NNP O
and CC O
N2 CD O
times NNS O
during IN O
the DT O
Poisson NNP O
trials NNS O
, , O
respectively RB O
. . O

Thus RB O
, , O
N1 NNP O
and CC O
N2 CD O
add VBP O
up RP O
to IN O
N NNP O
. . O
( : O
6 CD O
) NN O

Considering VBG O
( : O
1 CD O
) -RRB- O
, , O
the DT O
average JJ O
trial NN O
probability NN O
pa NN O
can MD O
then RB O
be VB O
obtained VBN O
from IN O
( : O
7 CD O
) -RRB- O
. . O
( : O
7 CD O
) -RRB- O

Using VBG O
( : O
7 CD O
) -RRB- O
, , O
p1 NN O
can MD O
thus RB O
be VB O
calculated VBN O
as IN O
( SYM O
8 CD O
) -RRB- O
. . O
( : O
8 CD O
) NFP O

Similarly RB O
, , O
considering VBG O
( : O
2 CD O
) -RRB- O
, , O
the DT O
variance NN O
sigma NN O
2 CD O
is VBZ O
given VBN O
by IN O
( : O
9 CD O
) -RRB- O
. . O
( : O
9 CD O
) NFP O

Substituting VBG O
p1 NN O
in IN O
( SYM O
9 CD O
) , O
using VBG O
( , O
8 CD O
) , O
followed VBN O
by IN O
substituting VBG O
sigma NN O
2 CD O
in IN O
( SYM O
5 CD O
) SYM O
by IN O
( SYM O
9 CD O
) -RRB- O
leads VBZ O
to IN O
a DT O
quadratic JJ O
equation NN O
for IN O
p2 NN O
as IN O
a DT O
function NN O
of IN O
pa NN O
, , O
N NNP O
, , O
and CC O
S2 NNP O
, , O
as IN O
shown VBN O
in IN O
equation NN O
( : O
10 CD O
) -RRB- O
. . O
( : O
10 CD O
) -RRB- O

The DT O
solution NN O
to IN O
( SYM O
10 CD O
) -RRB- O
is VBZ O
given VBN O
by IN O
( SYM O
11 CD O
) -RRB- O
. . O
( : O
11 CD O
) -RRB- O

Setting VBG O
p2 CD O
to TO O
( SYM O
12 CD O
) CD O
p1 NN O
can MD O
be VB O
obtained VBN O
from IN O
( : O
8 CD O
) NFP O
and CC O
shown VBN O
to TO O
be VB O
given VBN O
by IN O
formula NN O
( : O
13 CD O
) -RRB- O
: : O
( : O
13 CD O
) SYM O
Choosing VBG O
p2 CD O
as IN O
( , O
12a CD O
) -RRB- O
leads VBZ O
to IN O
p1 CD O
( HYPH O
13a CD O
) -RRB- O

Comparing VBG O
( : O
13a CD O
) -RRB- O
to IN O
( SYM O
12 CD O
) -RRB- O
and CC O
( HYPH O
12a CD O
) -RRB- O
to IN O
( SYM O
13 CD O
) -RRB- O
, , O
it PRP O
can MD O
be VB O
seen VBN O
that IN O
the DT O
formulae NN O
are VBP O
identical JJ O
except IN O
for IN O
the DT O
fact NN O
that IN O
N1 NNP O
and CC O
N2 NNP O
are VBP O
reversed VBN O
. . O

Since IN O
the DT O
assignment NN O
of IN O
which WDT O
set NN O
of IN O
trials NNS O
is VBZ O
called VBN O
N1 NNP O
and CC O
which WDT O
set NN O
of IN O
trials NNS O
is VBZ O
called VBN O
N2 NNP O
is VBZ O
completely RB O
arbitrary JJ O
, , O
we PRP O
can MD O
limit VB O
the DT O
remaining VBG O
analysis NN O
on IN O
( SYM O
12 CD O
) -RRB- O
and CC O
( SYM O
13 CD O
) -RRB- O
without IN O
loss NN O
of IN O
generality NN O
. . O

Note VB O
that IN O
( : O
12 CD O
) -RRB- O
and CC O
( SYM O
13 CD O
) -RRB- O
do VBP O
not RB O
guarantee VB O
that IN O
p1 NN O
and CC O
p2 NN O
are VBP O
always RB O
confined VBN O
between IN O
0 CD O
and CC O
1 CD O
for IN O
any DT O
combination NN O
of IN O
N1 NNP O
and CC O
N2 CD O
. . O

While IN O
probabilities NNS O
smaller JJR O
than IN O
0 CD O
or CC O
bigger JJR O
than IN O
1 CD O
would MD O
still RB O
result VB O
in IN O
a DT O
distribution NN O
with IN O
the DT O
same JJ O
overall JJ O
variance NN O
as IN O
the DT O
original JJ O
distribution NN O
, , O
P NN O
- HYPH O
value NN O
calculation NN O
will MD O
be VB O
imprecise JJ O
because IN O
the DT O
tails NNS O
of IN O
the DT O
distribution NN O
will MD O
deviate VB O
significantly RB O
from IN O
the DT O
original JJ O
distribution NN O
. . O

Thus RB O
, , O
we PRP O
need VBP O
to TO O
define VB O
the DT O
values NNS O
N1 NNP O
and CC O
N2 NNP O
in IN O
such PDT O
a DT O
way NN O
that IN O
p2 NN O
< : O
= SYM O
1 CD O
and CC O
p1 CD O
> NFP O
= SYM O
0 NFP O
. . O

This DT O
can MD O
be VB O
achieved VBN O
by IN O
evaluating VBG O
( , O
12 CD O
) -RRB- O
and CC O
( SYM O
13 CD O
) -RRB- O
. . O

Evaluating VBG O
( : O
12 CD O
) -RRB- O
for IN O
the DT O
condition NN O
that IN O
p2 NN O
< : O
= SYM O
1 CD O
, , O
solving VBG O
the DT O
resulting VBG O
inequality NN O
for IN O
N2 CD O
, , O
and CC O
considering VBG O
( : O
5 CD O
) -RRB- O
, , O
which WDT O
relates VBZ O
S2 NN O
and CC O
sigma NN O
2 CD O
, , O
we PRP O
obtain VBP O
( $ O
14 CD O
) -RRB- O
. . O
( SYM O
14 CD O
) -RRB- O

Similarly RB O
, , O
evaluating VBG O
( , O
13 CD O
) -RRB- O
for IN O
the DT O
condition NN O
p1 CD O
> SYM O
= SYM O
0 CD O
, , O
solving VBG O
the DT O
resulting VBG O
inequality NN O
for IN O
N2 CD O
, , O
considering VBG O
( : O
5 CD O
) -RRB- O
, , O
which WDT O
relates VBZ O
S2 NN O
and CC O
sigma NN O
2 CD O
, , O
and CC O
defining VBG O
mu NN O
f IN O
the DT O
expected JJ O
number NN O
of IN O
failures NNS O
as IN O
N NNP O
* NFP O
( SYM O
1 CD O
- HYPH O
pa NN O
) -RRB- O
( SYM O
15 CD O
) -RRB- O
, , O
( SYM O
15 CD O
) -RRB- O
we PRP O
obtain VBP O
( SYM O
16 CD O
) -RRB- O
( SYM O
16 CD O
) -RRB- O

The DT O
meaning NN O
of IN O
these DT O
boundaries NNS O
is VBZ O
best RBS O
illustrated VBN O
by IN O
considering VBG O
a DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
whose WP$ O
variance NN O
is VBZ O
0 CD O
, , O
i PRP O
. . O
e ADD O
. . O
that WDT O
assumes VBZ O
1 CD O
at IN O
X NN O
= SYM O
mu NN O
and CC O
0 CD O
otherwise RB O
. . O

In IN O
this DT O
case NN O
( , O
14 CD O
) -RRB- O
requires VBZ O
N2 CD O
< : O
= SYM O
mu NNP O
while IN O
( SYM O
16 CD O
) -RRB- O
requires VBZ O
N2 CD O
> SYM O
= SYM O
mu NNP O
. . O

These DT O
conditions NNS O
can MD O
only RB O
be VB O
fulfilled VBN O
contemporaneously RB O
when WRB O
N2 NNP O
is VBZ O
set VBN O
to TO O
mu VB O
. . O

Intuitively RB O
, , O
this DT O
means VBZ O
that IN O
there EX O
are VBP O
mu JJ O
trials NNS O
with IN O
probability NN O
of IN O
success NN O
1 CD O
and CC O
N CD O
- HYPH O
mu NN O
trials NNS O
with IN O
probability NN O
of IN O
0 CD O
, , O
resulting VBG O
in IN O
a DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
with IN O
variance NN O
sigma NN O
2 CD O
= SYM O
0 CD O
and CC O
mean VB O
mu NNS O
. . O

When WRB O
sigma NN O
2 CD O
is VBZ O
larger JJR O
than IN O
0 CD O
, , O
the DT O
choice NN O
of IN O
N1 NNP O
and CC O
N2 NNP O
is VBZ O
more RBR O
flexible JJ O
. . O

However RB O
, , O
since IN O
the DT O
choice NN O
of IN O
N2 NNP O
= SYM O
mu NNP O
is VBZ O
valid JJ O
for IN O
all DT O
possible JJ O
values NNS O
of IN O
sigma NN O
2 CD O
, , O
this DT O
is VBZ O
how WRB O
NetCutter NNP O
determines VBZ O
N1 NNP O
and CC O
N2 NNP O
. . O

When WRB O
mu NNP O
is VBZ O
not RB O
an DT O
integer NN O
, , O
N2 NNP O
is VBZ O
set VBN O
to IN O
the DT O
integer NN O
closest JJS O
to IN O
mu NNP O
. . O

Having VBG O
determined VBN O
p2 CD O
( SYM O
12 CD O
) -RRB- O
and CC O
p1 CD O
( SYM O
13 CD O
) -RRB- O
as RB O
well RB O
a DT O
N1 CD O
and CC O
N2 CD O
( SYM O
14 CD O
, , O
16 CD O
, , O
6 CD O
) -RRB- O
, , O
we PRP O
can MD O
now RB O
calculate VB O
the DT O
bi NN O
- HYPH O
binomial JJ O
approximation NN O
of IN O
the DT O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O
in IN O
a DT O
fashion NN O
that WDT O
is VBZ O
very RB O
similar JJ O
to TO O
calculate VB O
the DT O
binomial JJ O
P NN O
- HYPH O
value NN O
. . O

With IN O
q1 CD O
= SYM O
1 CD O
- HYPH O
p1 CD O
and CC O
q2 CD O
= SYM O
1 CD O
- HYPH O
p2 NN O
we PRP O
obtain VBP O
: : O
( : O
17 CD O
) NN O

The DT O
summation NN O
is VBZ O
necessary JJ O
because IN O
i PRP O
successes NNS O
can MD O
be VB O
obtained VBN O
from IN O
any DT O
combination NN O
of IN O
j NN O
p1 NN O
and CC O
i CD O
- HYPH O
j NN O
p2 NN O
trials NNS O
, , O
where WRB O
j NN O
can MD O
assume VB O
any DT O
value NN O
from IN O
0 CD O
to IN O
i PRP O
. . O

Calculating VBG O
Jaccard NNP O
and CC O
uncertainty NN O
coefficients NNS O

For IN O
the DT O
purpose NN O
of IN O
comparing VBG O
the DT O
efficacy NN O
of IN O
the DT O
bi JJ O
- HYPH O
binomial JJ O
distribution NN O
as IN O
a DT O
significance NN O
measure NN O
of IN O
co NN O
- HYPH O
occurrence NN O
, , O
Jaccard NNP O
and CC O
uncertainty NN O
coefficients NNS O
( , O
which WDT O
are VBP O
also RB O
called VBN O
measures NNS O
of IN O
association NN O
) -RRB- O
were VBD O
calculated VBN O
using VBG O
the DT O
formulae NN O
: : O

The DT O
Jaccard NNP O
coefficient NN O
J NNP O
is VBZ O
calculated VBN O
as IN O
the DT O
number NN O
of IN O
times NNS O
A NN O
and CC O
B NN O
occur VBP O
together RB O
divided VBN O
by IN O
the DT O
number NN O
of IN O
times NNS O
A NN O
occurs VBZ O
without IN O
B NN O
plus CC O
the DT O
number NN O
of IN O
times NNS O
B NN O
occurs VBZ O
without IN O
A NN O
plus CC O
the DT O
number NN O
of IN O
times NNS O
A NN O
and CC O
B NN O
occur VBP O
together RB O
[ -LRB- O
42 CD O
] -RRB- O
. . O

The DT O
uncertainty NN O
coefficient JJ O
[ -LRB- O
42 CD O
] -RRB- O
is VBZ O
calculated VBN O
as IN O
: : O
H NN O
is VBZ O
the DT O
entropy NN O
associated VBN O
with IN O
A NN O
, , O
B NNP O
, , O
and CC O
AB NNP O
. . O

For IN O
A NN O
, , O
the DT O
entropy NN O
is VBZ O
calculated VBN O
from IN O
the DT O
probabilities NNS O
of IN O
A NN O
occurring VBG O
in IN O
n1 CD O
out IN O
of IN O
N NNP O
lists NNS O
( : O
n1 CD O
/ SYM O
N NNP O
) -RRB- O
and CC O
A NN O
not RB O
occurring VBG O
in IN O
n2 CD O
out IN O
of IN O
N NNP O
lists NNS O
( : O
n2 CD O
/ SYM O
N NNP O
) -RRB- O
. . O

Analogous JJ O
calculations NNS O
lead VBP O
to IN O
the DT O
entropy NN O
associated VBN O
with IN O
B NNP O
. . O

For IN O
H NN O
( , O
A NN O
, , O
B NNP O
) -RRB- O
, , O
the DT O
probabilities NNS O
of IN O
A NN O
occurring VBG O
without IN O
B NN O
, , O
B NNP O
occurring VBG O
without IN O
A NN O
, , O
A NN O
and CC O
B NN O
occurring VBG O
together RB O
, , O
and CC O
neither CC O
A NN O
nor CC O
B NN O
occurring VBG O
in IN O
the DT O
lists NNS O
are VBP O
used VBN O
. . O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
of IN O
the DT O
PubLiME NNP O
data NNS O
set VBN O

The DT O
bipartite JJ O
graph NN O
to TO O
be VB O
analyzed VBN O
is VBZ O
composed VBN O
of IN O
27619 CD O
PubMedID NN O
_ HYPH O
listID NN O
- HYPH O
gene NN O
pairs NNS O
( , O
see VB O
supplementary JJ O
material NN O
Table NNP O
S1 NNP O
) -RRB- O
. . O

Edge NN O
- HYPH O
swapping VBG O
( , O
1000 CD O
simulations NNS O
, , O
see VB O
above RB O
) -RRB- O
was VBD O
used VBN O
to TO O
determine VB O
occurrence NN O
probabilities NNS O
and CC O
gene NN O
co NN O
- HYPH O
occurrence NN O
was VBD O
analyzed VBN O
using VBG O
module NN O
size NN O
3 CD O
( HYPH O
co NN O
- HYPH O
occurrence NN O
of IN O
three CD O
genes NNS O
) -RRB- O
, , O
bi NN O
- HYPH O
binomial NN O
Z NN O
- HYPH O
score NN O
cutoff NN O
6 CD O
, , O
bi NN O
- HYPH O
binomial JJ O
P NN O
- HYPH O
value NN O
cutoff NN O
1 CD O
. . O
0E CD O
- HYPH O
5 CD O
, , O
and CC O
support VB O
5 CD O
. . O

Supplementary JJ O
material NN O
Simulation NN O
S1 NNP O
provides VBZ O
details NNS O
on IN O
why WRB O
module NN O
size NN O
3 CD O
is VBZ O
chosen VBN O
. . O

The DT O
support NN O
parameter NN O
ensures VBZ O
that IN O
each DT O
3 CD O
- HYPH O
gene NN O
co NN O
- HYPH O
occurrence NN O
module NN O
is VBZ O
present JJ O
in IN O
at RB O
least RBS O
5 CD O
signatures NNS O
. . O

We PRP O
identified VBD O
1654 CD O
significant JJ O
modules NNS O
in IN O
the DT O
test NN O
data NNS O
compared VBN O
to IN O
5 CD O
modules NNS O
in IN O
a DT O
randomized VBN O
bipartite JJ O
graph NN O
, , O
corresponding VBG O
to IN O
a DT O
signal NN O
- HYPH O
to IN O
- HYPH O
noise NN O
ratio NN O
of IN O
331 CD O
. . O

The DT O
co NN O
- HYPH O
occurrence NN O
network NN O
was VBD O
generated VBN O
from IN O
the DT O
significant JJ O
co NN O
- HYPH O
occurrence NN O
modules NNS O
by IN O
drawing VBG O
an DT O
edge NN O
between IN O
each DT O
pair NN O
wise JJ O
combination NN O
of IN O
genes NNS O
that WDT O
are VBP O
part NN O
of IN O
the DT O
same JJ O
co NN O
- HYPH O
occurrence NN O
module NN O
. . O

Gene NNP O
communities NNS O
were VBD O
identified VBN O
in IN O
this DT O
network NN O
by IN O
edge NN O
- HYPH O
betweenness NN O
clustering NN O
removing VBG O
4 CD O
edges NNS O
, , O
which WDT O
resulted VBD O
in IN O
a DT O
maximal JJ O
network NN O
modularity NN O
of IN O
0 CD O
. . O
63 CD O
. . O

Modularity NN O
is VBZ O
calculated VBN O
as IN O
described VBN O
by IN O
[ -LRB- O
43 CD O
] -RRB- O
. . O

For IN O
the DT O
identification NN O
of IN O
PubMedID NNP O
_ : O
listID NN O
clusters NNS O
, , O
the DT O
PubMedID NNP O
_ HYPH O
listID NN O
- HYPH O
gene NN O
pairs NNS O
in IN O
the DT O
original JJ O
bipartite JJ O
graph NN O
were VBD O
reversed VBN O
to TO O
form VB O
gene NN O
- HYPH O
PubMedID NN O
_ HYPH O
listID NN O
pairs NNS O
. . O

Occurrence NN O
probabilities NNS O
were VBD O
obtained VBN O
by IN O
transposing VBG O
the DT O
original JJ O
occurrence NN O
probability NN O
matrix NN O
determined VBN O
by IN O
edge NN O
- HYPH O
swapping NN O
as IN O
described VBN O
above RB O
. . O

PubMedID NN O
_ : O
listID NN O
co NN O
- HYPH O
occurrence NN O
was VBD O
analyzed VBN O
using VBG O
module NN O
size NN O
5 CD O
, , O
Z NN O
- HYPH O
score NN O
cutoff NN O
6 CD O
, , O
bi NN O
- HYPH O
binomial JJ O
P NN O
- HYPH O
value NN O
cutoff NN O
1 CD O
. . O
0E CD O
- HYPH O
5 CD O
, , O
and CC O
support VB O
3 CD O
. . O

Please UH O
note VB O
that IN O
the DT O
choice NN O
of IN O
these DT O
parameters NNS O
is VBZ O
dictated VBN O
by IN O
the DT O
parameters NNS O
used VBN O
in IN O
gene NN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
. . O

The DT O
reversal NN O
of IN O
the DT O
bipartite JJ O
graph NN O
necessitates VBZ O
the DT O
support NN O
parameter NN O
used VBN O
in IN O
gene NN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
( , O
5 CD O
) -RRB- O
to TO O
be VB O
used VBN O
as IN O
module NN O
size NN O
in IN O
PubMedID NN O
_ HYPH O
listID NN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
and CC O
the DT O
module NN O
size NN O
used VBN O
in IN O
gene NN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
( , O
3 CD O
) -RRB- O
to TO O
be VB O
used VBN O
as IN O
the DT O
support NN O
parameter NN O
in IN O
PubMedID NN O
_ HYPH O
listID NN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
if IN O
the DT O
scope NN O
of IN O
the DT O
analysis NN O
is VBZ O
the DT O
identification NN O
of IN O
PubMedID NNP O
_ HYPH O
listID NN O
clusters NNS O
that WDT O
correspond VBP O
to IN O
gene NN O
clusters NNS O
identified VBN O
before RB O
. . O

The DT O
significance NN O
cutoffs NNS O
remain VBP O
unchanged JJ O
. . O

PubMedID NN O
_ : O
listID NN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
revealed VBD O
448 CD O
significant JJ O
co NN O
- HYPH O
occurrence NN O
modules NNS O
in IN O
the DT O
real JJ O
bipartite JJ O
graph NN O
and CC O
6 CD O
significant JJ O
co NN O
- HYPH O
occurrence NN O
modules NNS O
in IN O
the DT O
randomized JJ O
bipartite JJ O
graph NN O
with IN O
a DT O
signal NN O
- HYPH O
to IN O
- HYPH O
noise NN O
ratio NN O
of IN O
75 CD O
. . O

Communities NNS O
in IN O
the DT O
resulting VBG O
co NN O
- HYPH O
occurrence NN O
network NN O
were VBD O
identified VBN O
by IN O
edge NN O
- HYPH O
betweenness NN O
clustering NN O
removing VBG O
130 CD O
edges NNS O
. . O

The DT O
resulting VBG O
maximal JJ O
network NN O
modularity NN O
was VBD O
found VBN O
to TO O
be VB O
0 CD O
. . O
47 CD O
. . O

Supporting VBG O
Information NN O

Personal JJ O
and CC O
environmental JJ O
correlates NNS O
of IN O
active JJ O
travel NN O
and CC O
physical JJ O
activity NN O
in IN O
a DT O
deprived JJ O
urban JJ O
population NN O

Abstract JJ O

Background NN O

Environmental JJ O
characteristics NNS O
may MD O
be VB O
associated VBN O
with IN O
patterns NNS O
of IN O
physical JJ O
activity NN O
in IN O
general JJ O
or CC O
with IN O
particular JJ O
types NNS O
of IN O
physical JJ O
activity NN O
such JJ O
as IN O
active JJ O
travel NN O
( , O
walking VBG O
or CC O
cycling VBG O
for IN O
transport NN O
) -RRB- O
. . O

However RB O
, , O
most JJS O
studies NNS O
in IN O
this DT O
field NN O
have VBP O
been VBN O
conducted VBN O
in IN O
North NNP O
America NNP O
and CC O
Australia NNP O
, , O
and CC O
hypotheses NNS O
about IN O
putative JJ O
correlates NNS O
should MD O
be VB O
tested VBN O
in IN O
a DT O
wider JJR O
range NN O
of IN O
sociospatial JJ O
contexts NNS O
. . O

We PRP O
therefore RB O
examined VBD O
the DT O
contribution NN O
of IN O
putative JJ O
personal JJ O
and CC O
environmental JJ O
correlates NNS O
of IN O
active JJ O
travel NN O
and CC O
overall JJ O
physical JJ O
activity NN O
in IN O
deprived JJ O
urban JJ O
neighbourhoods NNS O
in IN O
Glasgow NNP O
, , O
Scotland NNP O
as IN O
part NN O
of IN O
the DT O
baseline NN O
for IN O
a DT O
longitudinal JJ O
study NN O
of IN O
the DT O
effects NNS O
of IN O
opening VBG O
a DT O
new JJ O
urban JJ O
motorway NN O
( HYPH O
freeway NN O
) -RRB- O
. . O

Methods NNS O

We PRP O
conducted VBD O
a DT O
postal JJ O
survey NN O
of IN O
a DT O
random JJ O
sample NN O
of IN O
residents NNS O
( , O
n CD O
= SYM O
1322 CD O
) -RRB- O
, , O
collecting VBG O
data NNS O
on IN O
socioeconomic JJ O
status NN O
, , O
perceptions NNS O
of IN O
the DT O
local JJ O
environment NN O
, , O
travel NN O
behaviour NN O
, , O
physical JJ O
activity NN O
and CC O
general JJ O
health NN O
and CC O
wellbeing NN O
using VBG O
a DT O
new JJ O
14 CD O
- HYPH O
item NN O
neighbourhood NN O
rating NN O
scale NN O
, , O
a DT O
travel NN O
diary NN O
, , O
the DT O
short JJ O
form NN O
of IN O
the DT O
International NNP O
Physical NNP O
Activity NNP O
Questionnaire NNP O
( , O
IPAQ NNP O
) -RRB- O
and CC O
the DT O
SF NNP O
- HYPH O
8 CD O
. . O

We PRP O
analysed VBD O
the DT O
correlates NNS O
of IN O
active JJ O
travel NN O
and CC O
overall JJ O
physical JJ O
activity NN O
using VBG O
multivariate JJ O
logistic JJ O
regression NN O
, , O
first JJ O
building NN O
models NNS O
using VBG O
personal JJ O
( , O
individual JJ O
and CC O
household NN O
) , O
explanatory JJ O
variables NNS O
and CC O
then RB O
adding VBG O
environmental JJ O
variables NNS O
. . O

Results NNS O

Active JJ O
travel NN O
was VBD O
associated VBN O
with IN O
being VBG O
younger JJR O
, , O
living VBG O
in IN O
owner NN O
- HYPH O
occupied VBN O
accommodation NN O
, , O
not RB O
having VBG O
to TO O
travel VB O
a DT O
long JJ O
distance NN O
to IN O
work NN O
and CC O
not RB O
having VBG O
access NN O
to IN O
a DT O
car NN O
, , O
whereas IN O
overall JJ O
physical JJ O
activity NN O
was VBD O
associated VBN O
with IN O
living VBG O
in IN O
social JJ O
rented VBN O
accommodation NN O
and CC O
not RB O
being VBG O
overweight JJ O
. . O

After IN O
adjusting VBG O
for IN O
personal JJ O
characteristics NNS O
, , O
neither CC O
perceptions NNS O
of IN O
the DT O
local JJ O
environment NN O
nor CC O
the DT O
objective JJ O
proximity NN O
of IN O
respondents NNS O
' POS O
homes NNS O
to IN O
motorway NN O
or CC O
major JJ O
road NN O
infrastructure NN O
explained VBD O
much JJ O
of IN O
the DT O
variance NN O
in IN O
active JJ O
travel NN O
or CC O
overall JJ O
physical JJ O
activity NN O
, , O
although IN O
we PRP O
did VBD O
identify VB O
a DT O
significant JJ O
positive JJ O
association NN O
between IN O
active JJ O
travel NN O
and CC O
perceived VBN O
proximity NN O
to IN O
shops NNS O
. . O

Conclusion NN O

Apart RB O
from IN O
access NN O
to IN O
local JJ O
amenities NNS O
, , O
environmental JJ O
characteristics NNS O
may MD O
have VB O
limited JJ O
influence NN O
on IN O
active JJ O
travel NN O
in IN O
deprived JJ O
urban JJ O
populations NNS O
characterised VBN O
by IN O
a DT O
low JJ O
level NN O
of IN O
car NN O
ownership NN O
, , O
in IN O
which WDT O
people NNS B-Species
may MD O
have VB O
less JJR O
capacity NN O
for IN O
making VBG O
discretionary JJ O
travel NN O
choices NNS O
than IN O
the DT O
populations NNS O
studied VBN O
in IN O
most JJS O
published JJ O
research NN O
on IN O
the DT O
environmental JJ O
correlates NNS O
of IN O
physical JJ O
activity NN O
. . O

Background NN O

Until IN O
recently RB O
, , O
research NN O
on IN O
correlates NNS O
of IN O
physical JJ O
activity NN O
was VBD O
dominated VBN O
by IN O
studies NNS O
of IN O
individual JJ O
demographic JJ O
and CC O
psychosocial JJ O
characteristics NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

This DT O
reflected VBD O
an DT O
emphasis NN O
on IN O
promoting VBG O
sport NN O
, , O
recreation NN O
or CC O
health NN O
- HYPH O
directed VBN O
exercise NN O
using VBG O
techniques NNS O
to TO O
encourage VB O
individual JJ O
behaviour NN O
change NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

However RB O
, , O
there EX O
is VBZ O
little JJ O
evidence NN O
that IN O
such JJ O
approaches NNS O
are VBP O
effective JJ O
in IN O
increasing VBG O
physical JJ O
activity NN O
in IN O
the DT O
medium JJ O
- HYPH O
to IN O
- HYPH O
long JJ O
term NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

If IN O
habitual JJ O
patterns NNS O
of IN O
behaviour NN O
are VBP O
environmentally RB O
cued VBN O
, , O
sustained JJ O
change NN O
is VBZ O
likely JJ O
to TO O
require VB O
a DT O
supportive JJ O
environment NN O
in IN O
which WDT O
people NNS B-Species
can MD O
be VB O
active JJ O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
. . O

There EX O
is VBZ O
therefore RB O
increasing VBG O
interest NN O
in IN O
the DT O
influence NN O
of IN O
the DT O
social JJ O
and CC O
physical JJ O
environment NN O
on IN O
physical JJ O
activity NN O
. . O

With IN O
respect NN O
to IN O
the DT O
physical JJ O
( , O
natural JJ O
or CC O
built VBN O
) , O
environment NN O
, , O
a DT O
growing VBG O
body NN O
of IN O
evidence NN O
suggests VBZ O
that IN O
certain JJ O
environmental JJ O
characteristics NNS O
may MD O
be VB O
associated VBN O
with IN O
patterns NNS O
of IN O
physical JJ O
activity NN O
in IN O
general JJ O
or CC O
with IN O
particular JJ O
types NNS O
of IN O
physical JJ O
activity NN O
such JJ O
as IN O
walking VBG O
or CC O
cycling VBG O
as IN O
modes NNS O
of IN O
transport NN O
[ -LRB- O
4 CD O
- SYM O
10 CD O
] -RRB- O
. . O

Among IN O
the DT O
correlates NNS O
most RBS O
frequently RB O
identified VBN O
in IN O
such JJ O
reviews NNS O
- , O
some DT O
ascertained VBN O
using VBG O
' `` O
objective JJ O
' '' O
measures NNS O
, , O
and CC O
others NNS O
in IN O
terms NNS O
of IN O
people NNS B-Species
' POS O
s POS O
perceptions NNS O
- , O
are VBP O
the DT O
aesthetic JJ O
quality NN O
of IN O
the DT O
surroundings NNS O
, , O
the DT O
presence NN O
of IN O
pavements NNS O
( , O
sidewalks NNS O
) -RRB- O
, , O
the DT O
convenience NN O
of IN O
facilities NNS O
for IN O
being VBG O
active JJ O
, , O
the DT O
availability NN O
of IN O
green JJ O
space NN O
, , O
access NN O
to IN O
amenities NNS O
( , O
destinations NNS O
) -RRB- O
within IN O
walking NN O
or CC O
cycling NN O
distance NN O
, , O
safety NN O
from IN O
traffic NN O
and CC O
personal JJ O
attack NN O
, , O
and CC O
the DT O
lack NN O
of IN O
heavy JJ O
traffic NN O
. . O

Some DT O
of IN O
these DT O
local JJ O
characteristics NNS O
reflect VBP O
higher JJR O
- HYPH O
order NN O
aspects NNS O
of IN O
urban JJ O
design NN O
and CC O
spatial JJ O
policy NN O
such JJ O
as IN O
population NN O
density NN O
, , O
connectivity NN O
and CC O
mixed JJ O
land NN O
use NN O
[ -LRB- O
6 CD O
, , O
8 CD O
] -RRB- O
. . O

Importantly RB O
, , O
different JJ O
characteristics NNS O
may MD O
be VB O
associated VBN O
with IN O
different JJ O
types NNS O
of IN O
physical JJ O
activity NN O
; , O
for IN O
example NN O
, , O
Owen NNP O
and CC O
colleagues NNS O
found VBD O
that IN O
the DT O
aesthetic JJ O
quality NN O
of IN O
the DT O
surroundings NNS O
was VBD O
associated VBN O
with IN O
walking VBG O
for IN O
exercise NN O
or CC O
recreation NN O
and CC O
with IN O
walking VBG O
in IN O
general JJ O
, , O
but CC O
not RB O
with IN O
walking NN O
for IN O
transport NN O
, , O
whereas IN O
perceptions NNS O
of IN O
traffic NN O
were VBD O
associated VBN O
with IN O
walking VBG O
for IN O
transport NN O
and CC O
walking VBG O
in IN O
general JJ O
, , O
but CC O
not RB O
with IN O
walking VBG O
for IN O
exercise NN O
or CC O
recreation NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Despite IN O
the DT O
growing VBG O
volume NN O
of IN O
published JJ O
studies NNS O
in IN O
this DT O
field NN O
, , O
many JJ O
authors NNS O
remain VBP O
circumspect JJ O
in IN O
their PRP$ O
interpretation NN O
of IN O
the DT O
available JJ O
evidence NN O
. . O

Giles NNP O
- HYPH O
Corti NNP O
and CC O
Donovan NNP O
have VBP O
described VBN O
access NN O
to IN O
a DT O
supportive JJ O
physical JJ O
environment NN O
as IN O
a DT O
necessary JJ O
, , O
but CC O
insufficient JJ O
, , O
condition NN O
for IN O
an DT O
increase NN O
in IN O
physical JJ O
activity NN O
in IN O
the DT O
population NN O
[ -LRB- O
11 CD O
] -RRB- O
, , O
while IN O
Handy NNP O
found VBD O
' `` O
convincing JJ O
' '' O
evidence NN O
of IN O
an DT O
association NN O
between IN O
physical JJ O
activity NN O
and CC O
the DT O
built VBN O
environment NN O
in IN O
general JJ O
but CC O
' `` O
less RBR O
convincing JJ O
' '' O
evidence NN O
as IN O
to IN O
which WDT O
specific JJ O
environmental JJ O
characteristics NNS O
were VBD O
most RBS O
strongly RB O
associated VBN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

One CD O
limitation NN O
of IN O
the DT O
available JJ O
evidence NN O
is VBZ O
that IN O
most JJS O
research NN O
has VBZ O
been VBN O
conducted VBN O
in IN O
North NNP O
America NNP O
and CC O
Australia NNP O
[ -LRB- O
9 CD O
, , O
12 CD O
] -RRB- O
, , O
and CC O
it PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
associations NNS O
observed VBN O
in IN O
those DT O
countries NNS O
are VBP O
generalisable JJ O
to IN O
other JJ O
settings NNS O
with IN O
different JJ O
aggregate JJ O
socioeconomic JJ O
characteristics NNS O
( , O
e LS O
. . O
g LS O
. . O
wealth NN O
or CC O
access NN O
to IN O
private JJ O
cars NNS O
) , O
or CC O
environmental JJ O
characteristics NNS O
( : O
e LS O
. . O
g LS O
. . O
climate NN O
, , O
patterns NNS O
of IN O
land NN O
use NN O
, , O
or CC O
availability NN O
of IN O
public JJ O
transport NN O
) -RRB- O
. . O

For IN O
example NN O
, , O
North JJ O
American JJ O
researchers NNS O
are VBP O
often RB O
interested JJ O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
pavements NNS O
( , O
sidewalks NNS O
) -RRB- O
, , O
but CC O
it PRP O
is VBZ O
unusual JJ O
for IN O
streets NNS O
in IN O
the DT O
United NNP O
Kingdom NNP O
( -LRB- O
UK NNP O
) -RRB- O
not RB O
to TO O
have VB O
a DT O
pavement NN O
or CC O
footpath NN O
beside IN O
them PRP O
. . O

Hypotheses NNS O
about IN O
putative JJ O
environmental JJ O
correlates NNS O
of IN O
physical JJ O
activity NN O
therefore RB O
need VBP O
to TO O
be VB O
tested VBN O
in IN O
a DT O
wider JJR O
range NN O
of IN O
settings NNS O
. . O

A DT O
more RBR O
profound JJ O
limitation NN O
of IN O
the DT O
available JJ O
evidence NN O
is VBZ O
that IN O
identifying VBG O
a DT O
relationship NN O
between IN O
, , O
for IN O
example NN O
, , O
urban JJ O
form NN O
and CC O
walking VBG O
for IN O
transport NN O
is VBZ O
not RB O
the DT O
same JJ O
thing NN O
as IN O
showing VBG O
that IN O
changing VBG O
the DT O
built VBN O
environment NN O
will MD O
lead VB O
to IN O
a DT O
change NN O
in IN O
behaviour NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Few JJ O
researchers NNS O
have VBP O
taken VBN O
up RP O
the DT O
opportunity NN O
( : O
or CC O
challenge NN O
) , O
presented VBN O
by IN O
' `` O
natural JJ O
experiments NNS O
' '' O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
environmental JJ O
interventions NNS O
on IN O
physical JJ O
activity NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

We PRP O
therefore RB O
established VBD O
a DT O
longitudinal JJ O
study NN O
to TO O
examine VB O
changes NNS O
associated VBN O
with IN O
the DT O
opening NN O
of IN O
a DT O
new JJ O
urban JJ O
section NN O
of IN O
the DT O
M74 NNP O
motorway NN O
( , O
freeway NN O
) -RRB- O
currently RB O
under IN O
construction NN O
in IN O
Glasgow NNP O
, , O
Scotland NNP O
. . O

The DT O
rationale NN O
and CC O
design NN O
for IN O
this DT O
study NN O
have VBP O
been VBN O
described VBN O
previously RB O
[ -LRB- O
15 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
claimed VBN O
that IN O
the DT O
new JJ O
motorway NN O
, , O
which WDT O
will MD O
mostly RB O
pass VB O
through IN O
or CC O
close RB O
to IN O
densely RB O
- HYPH O
populated VBN O
urban JJ O
neighbourhoods NNS O
, , O
will MD O
contribute VB O
to IN O
the DT O
regeneration NN O
of IN O
a DT O
region NN O
which WDT O
includes VBZ O
some DT O
of IN O
the DT O
most RBS O
deprived VBN O
and CC O
least RBS O
healthy JJ O
working VBG O
- HYPH O
class NN O
communities NNS O
in IN O
Europe NNP O
[ -LRB- O
16 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
also RB O
claimed VBN O
that IN O
the DT O
new JJ O
motorway NN O
will MD O
divert VB O
traffic NN O
from IN O
local JJ O
streets NNS O
, , O
reduce VB O
traffic NN O
noise NN O
and CC O
bring VB O
new JJ O
local JJ O
employment NN O
opportunities NNS O
, , O
thereby RB O
improving VBG O
characteristics NNS O
of IN O
the DT O
local JJ O
environment NN O
held VBN O
to TO O
be VB O
associated VBN O
with IN O
active JJ O
travel NN O
. . O

Others NNS O
claim VBP O
that IN O
the DT O
new JJ O
motorway NN O
will MD O
encourage VB O
car NN O
use NN O
, , O
degrade VB O
the DT O
aesthetic JJ O
quality NN O
of IN O
the DT O
surroundings NNS O
and CC O
reduce VB O
the DT O
safety NN O
and CC O
attractiveness NN O
of IN O
routes NNS O
for IN O
pedestrians NNS O
and CC O
cyclists NNS O
across IN O
the DT O
line NN O
of IN O
the DT O
motorway NN O
- , O
all DT O
changes NNS O
which WDT O
may MD O
be VB O
expected VBN O
to TO O
discourage VB O
active JJ O
travel NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

The DT O
eventual JJ O
aim NN O
of IN O
the DT O
M74 NNP O
study NN O
will MD O
be VB O
to TO O
assess VB O
the DT O
effects NNS O
of IN O
this DT O
major JJ O
modification NN O
to IN O
the DT O
urban JJ O
built VBN O
environment NN O
and CC O
transport NN O
infrastructure NN O
on IN O
perceptions NNS O
of IN O
the DT O
local JJ O
environment NN O
and CC O
on IN O
population NN O
health NN O
and CC O
health NN O
- HYPH O
related VBN O
behaviour NN O
, , O
the DT O
primary JJ O
outcome NN O
of IN O
interest NN O
being VBG O
a DT O
change NN O
in IN O
the DT O
quantity NN O
of IN O
' `` O
active JJ O
travel NN O
' '' O
( , O
walking VBG O
and CC O
cycling VBG O
for IN O
transport NN O
) -RRB- O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
report VBP O
findings NNS O
from IN O
the DT O
cross JJ O
- HYPH O
sectional JJ O
( HYPH O
baseline NN O
) -RRB- O
phase NN O
of IN O
the DT O
study NN O
which WDT O
contribute VBP O
evidence NN O
on IN O
the DT O
environmental JJ O
correlates NNS O
of IN O
physical JJ O
activity NN O
in IN O
this DT O
comparatively RB O
deprived VBN O
urban JJ O
population NN O
. . O

We PRP O
focus VBP O
on IN O
two CD O
specific JJ O
hypotheses NNS O
: : O
first RB O
, , O
that IN O
levels NNS O
of IN O
active JJ O
travel NN O
and CC O
overall JJ O
physical JJ O
activity NN O
vary VBP O
with IN O
demographic JJ O
and CC O
socioeconomic JJ O
characteristics NNS O
, , O
but CC O
not RB O
necessarily RB O
in IN O
the DT O
same JJ O
way NN O
; : O
second LS O
, , O
that IN O
these DT O
relationships NNS O
may MD O
be VB O
partly RB O
explained VBN O
by IN O
the DT O
perceived VBN O
characteristics NNS O
of IN O
the DT O
local JJ O
environment NN O
in IN O
which WDT O
people NNS B-Species
live VBP O
and CC O
by IN O
their PRP$ O
objectively RB O
- HYPH O
assessed VBN O
proximity NN O
to IN O
motorway NN O
and CC O
major JJ O
road NN O
infrastructure NN O
. . O

Methods NNS O

Delineation NN O
of IN O
study NN O
areas NNS O

We PRP O
used VBD O
spatially RB O
referenced VBN O
census NN O
and CC O
transport NN O
infrastructure NN O
data NNS O
held VBN O
and CC O
analysed VBN O
in IN O
a DT O
geographical JJ O
information NN O
system NN O
( -LRB- O
GIS NNP O
) -RRB- O
, , O
combined VBN O
with IN O
field NN O
visits NNS O
, , O
to TO O
delineate VB O
three CD O
study NN O
areas NNS O
in IN O
Glasgow NNP O
with IN O
similar JJ O
aggregate JJ O
socioeconomic JJ O
characteristics NNS O
and CC O
broadly RB O
similar JJ O
topographical JJ O
characteristics NNS O
apart RB O
from IN O
their PRP$ O
proximity NN O
to IN O
urban JJ O
motorway NN O
infrastructure NN O
( , O
Table NNP O
1 CD O
, , O
Figure NNP O
1 CD O
) -RRB- O
. . O

All DT O
three CD O
study NN O
areas NNS O
extended VBD O
from IN O
inner JJ O
mixed JJ O
- HYPH O
use NN O
districts NNS O
close JJ O
to IN O
the DT O
city NN O
centre NN O
to IN O
residential JJ O
suburbs NNS O
, , O
contained VBD O
major JJ O
arterial JJ O
roads NNS O
other JJ O
than IN O
motorways NNS O
, , O
and CC O
contained VBD O
a DT O
mixture NN O
of IN O
housing NN O
stock NN O
including VBG O
traditional JJ O
high JJ O
- HYPH O
density NN O
tenements NNS O
, , O
high JJ O
- HYPH O
rise NN O
flats NNS O
and CC O
new JJ O
housing NN O
developments NNS O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
. . O

Sampling NN O
and CC O
survey NN O
administration NN O

We PRP O
used VBD O
the DT O
Royal NNP O
Mail NNP O
Postcode NNP O
Address NNP O
File NNP O
( : O
PAF NNP O
) -RRB- O
( , O
version NN O
2005 CD O
. . O
3 CD O
) -RRB- O
to TO O
identify VB O
all DT O
residential JJ O
addresses NNS O
whose WP$ O
unit NN O
postcode NN O
( HYPH O
zip NN O
code NN O
) -RRB- O
was VBD O
within IN O
one CD O
of IN O
the DT O
study NN O
areas NNS O
( , O
total JJ O
n -LRB- O
= SYM O
35601 CD O
) -RRB- O
and CC O
drew VBD O
a DT O
random JJ O
sample NN O
of IN O
3000 CD O
households NNS O
from IN O
each DT O
area NN O
. . O

Unit NN O
postcodes NNS O
( : O
e ADD O
. . O
g LS O
. . O
G12 CD O
8RZ NN O
) -RRB- O
are VBP O
the DT O
smallest JJS O
available JJ O
unit NN O
of IN O
postal JJ O
geography NN O
in IN O
the DT O
UK NNP O
; , O
residential JJ O
unit NN O
postcodes NNS O
cover VBP O
about IN O
15 CD O
addresses NNS O
on IN O
average JJ O
. . O

We PRP O
sent VBD O
the DT O
survey NN O
to IN O
all DT O
households NNS O
( , O
total JJ O
n CD O
= SYM O
9000 CD O
) -RRB- O
between IN O
28 CD O
September NNP O
and CC O
4 CD O
October NNP O
2005 CD O
and CC O
resent VB O
the DT O
survey NN O
to IN O
all DT O
non AFX O
- HYPH O
responding VBG O
households NNS O
between IN O
26 CD O
and CC O
31 CD O
October NNP O
2005 CD O
. . O

We PRP O
alerted VBD O
households NNS O
to IN O
the DT O
survey NN O
by IN O
means NNS O
of IN O
a DT O
postcard NN O
sent VBN O
a DT O
few JJ O
days NNS O
in IN O
advance NN O
, , O
used VBD O
coloured VBN O
paper NN O
for IN O
some DT O
of IN O
the DT O
survey NN O
materials NNS O
, , O
and CC O
posted VBD O
survey NN O
packs NNS O
in IN O
white JJ O
envelopes NNS O
printed VBN O
with IN O
the DT O
university NN O
crest NN O
; : O
these DT O
techniques NNS O
have VBP O
been VBN O
shown VBN O
in IN O
a DT O
meta JJ O
- HYPH O
analysis NN O
to TO O
be VB O
associated VBN O
with IN O
increased VBN O
response NN O
rates NNS O
to IN O
postal JJ O
surveys NNS O
[ -LRB- O
17 CD O
] -RRB- O
. . O

We PRP O
asked VBD O
householders NNS O
to TO O
ensure VB O
that IN O
the DT O
questionnaire NN O
was VBD O
completed VBN O
by IN O
a DT O
resident NN O
aged VBN O
16 CD O
or CC O
over RB O
; : O
if IN O
more JJR O
than IN O
one CD O
resident NN O
was VBD O
eligible JJ O
, , O
we PRP O
asked VBD O
householders NNS O
to TO O
select VB O
the DT O
person NN B-Species
with IN O
the DT O
most RBS O
recent JJ O
birthday NN O
. . O

Respondents NNS O
who WP O
consented VBD O
to TO O
follow VB O
- HYPH O
up NN O
were VBD O
entered VBN O
into IN O
a DT O
prize NN O
draw NN O
to TO O
win VB O
a DT O
pound NN O
50 CD O
( SYM O
euro CD O
63 CD O
; : O
US NNP O
$ $ O
92 CD O
) -RRB- O
gift NN O
voucher NN O
. . O

Responses NNS O
received VBD O
more JJR O
than IN O
three CD O
months NNS O
after IN O
the DT O
first JJ O
mailing NN O
wave NN O
were VBD O
disregarded VBN O
in IN O
analysis NN O
. . O

Data NN O
collection NN O

The DT O
questionnaire NN O
included VBD O
items NNS O
on IN O
demographic JJ O
and CC O
socioeconomic JJ O
characteristics NNS O
, , O
health NN O
and CC O
wellbeing NN O
( , O
including VBG O
the DT O
the DT O
SF NNP O
- HYPH O
8 CD O
scale NN O
) -RRB- O
, , O
perceptions NNS O
of IN O
the DT O
local JJ O
environment NN O
, , O
travel NN O
behaviour NN O
and CC O
the DT O
short JJ O
form NN O
of IN O
the DT O
International NNP O
Physical NNP O
Activity NNP O
Questionnaire NNP O
( , O
IPAQ NNP O
) -RRB- O
( , O
Additional JJ O
file NN O
1 CD O
) -RRB- O
. . O

We PRP O
developed VBD O
a DT O
new JJ O
' `` O
neighbourhood NN O
scale NN O
' '' O
to TO O
assess VB O
perceptions NNS O
of IN O
relevant JJ O
characteristics NNS O
of IN O
the DT O
local JJ O
environment NN O
( , O
aesthetics NNS O
, , O
green JJ O
space NN O
, , O
access NN O
to IN O
amenities NNS O
, , O
convenience NN O
of IN O
routes NNS O
, , O
traffic NN O
, , O
road NN O
safety NN O
and CC O
personal JJ O
safety NN O
) -RRB- O
. . O

The DT O
development NN O
, , O
principal JJ O
components NNS O
analysis NN O
and CC O
reliability NN O
of IN O
the DT O
items NNS O
in IN O
this DT O
scale NN O
and CC O
the DT O
derivation NN O
and CC O
reliability NN O
of IN O
summary JJ O
variables NNS O
are VBP O
reported VBN O
in IN O
an DT O
accompanying JJ O
paper NN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Data NN O
cleaning NN O
and CC O
derivation NN O
of IN O
variables NNS O

Demographic JJ O
and CC O
socioeconomic JJ O
characteristics NNS O

We PRP O
excluded VBD O
from IN O
analysis NN O
all DT O
respondents NNS O
who WP O
failed VBD O
to TO O
enter VB O
their PRP$ O
age NN O
or CC O
sex NN O
. . O

We PRP O
then RB O
examined VBD O
the DT O
distributions NNS O
of IN O
all DT O
raw JJ O
variables NNS O
and CC O
carried VBD O
out RP O
range NN O
and CC O
consistency NN O
checks NNS O
to TO O
identify VB O
any DT O
anomalous JJ O
values NNS O
or CC O
variables NNS O
with IN O
a DT O
high JJ O
proportion NN O
of IN O
missing VBG O
responses NNS O
. . O

As IN O
a DT O
consequence NN O
, , O
we PRP O
collapsed VBD O
responses NNS O
on IN O
distance NN O
to IN O
place NN O
of IN O
work NN O
or CC O
study NN O
, , O
housing NN O
tenure NN O
, , O
car NN O
access NN O
and CC O
working NN O
situation NN O
into IN O
fewer JJR O
categories NNS O
by IN O
merging VBG O
categories NNS O
with IN O
small JJ O
numbers NNS O
of IN O
responses NNS O
; : O
we PRP O
also RB O
disregarded VBD O
household NN O
composition NN O
and CC O
working VBG O
situation NN O
of IN O
spouse NN O
or CC O
partner NN O
in IN O
analysis NN O
because IN O
of IN O
the DT O
large JJ O
numbers NNS O
of IN O
missing VBG O
values NNS O
for IN O
these DT O
variables NNS O
. . O

Health NN O
and CC O
wellbeing NN O

We PRP O
calculated VBD O
body NN O
mass NN O
index NN O
( : O
BMI NNP O
) -RRB- O
by IN O
converting VBG O
, , O
where WRB O
necessary JJ O
, , O
self NN O
- HYPH O
reported VBN O
heights NNS O
and CC O
weights NNS O
from IN O
imperial JJ O
to IN O
metric JJ O
units NNS O
and CC O
dividing VBG O
the DT O
height NN O
in IN O
metres NNS O
by IN O
the DT O
square NN O
of IN O
the DT O
weight NN O
in IN O
kilograms NNS O
; , O
we PRP O
also RB O
categorised VBD O
respondents NNS O
into IN O
quintiles NNS O
of IN O
BMI NNP O
. . O

We PRP O
calculated VBD O
physical JJ O
( , O
PCS NNP O
- HYPH O
8 CD O
) -RRB- O
and CC O
mental JJ O
( , O
MCS NNP O
- HYPH O
8 CD O
) -RRB- O
health NN O
summary NN O
scores NNS O
from IN O
the DT O
SF NNP O
- HYPH O
8 CD O
data NNS O
and CC O
scaled VBD O
these DT O
to IN O
population NN O
norms NNS O
using VBG O
the DT O
method NN O
and CC O
coefficients NNS O
given VBN O
in IN O
the DT O
SF NNP O
- HYPH O
8 CD O
manual JJ O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Objective JJ O
environmental JJ O
characteristics NNS O

We PRP O
linked VBD O
each DT O
record NN O
to IN O
the DT O
unit NN O
postcode NN O
of IN O
residence NN O
. . O

We PRP O
then RB O
constructed VBD O
concentric JJ O
buffers NNS O
at IN O
100 CD O
- HYPH O
metre NN O
intervals NNS O
up IN O
to TO O
500 CD O
metres NNS O
around IN O
the DT O
routes NNS O
and CC O
access NN O
points NNS O
of IN O
existing JJ O
and CC O
planned JJ O
motorways NNS O
and CC O
around IN O
the DT O
network NN O
of IN O
other JJ O
major JJ O
( , O
A NNP O
- HYPH O
and CC O
B NNP O
- HYPH O
class NN O
) -RRB- O
roads NNS O
, , O
and CC O
assigned VBD O
each DT O
respondent NN O
to IN O
a DT O
category NN O
of IN O
proximity NN O
to IN O
each DT O
type NN O
of IN O
road NN O
infrastructure NN O
( , O
within IN O
100 CD O
metres NNS O
, , O
101 CD O
- SYM O
200 CD O
metres NNS O
, , O
etc FW O
. , O
) -RRB- O
based VBN O
on IN O
the DT O
location NN O
of IN O
the DT O
centroid NN O
of IN O
their PRP$ O
unit NN O
postcode NN O
. . O

Travel NN O
behaviour NN O

For IN O
travel NN O
time NN O
analysis NN O
we PRP O
included VBD O
travel NN O
diaries NNS O
which WDT O
recorded VBD O
no DT O
travel NN O
at RB O
all RB O
, , O
but CC O
we PRP O
disregarded VBD O
travel NN O
data NNS O
from IN O
respondents NNS O
who WP O
had VBD O
not RB O
been VBN O
at IN O
home NN O
on IN O
the DT O
day NN O
of IN O
the DT O
travel NN O
diary NN O
, , O
whose WP$ O
questionnaire NN O
had VBD O
been VBN O
misprinted VBN O
such JJ O
that IN O
the DT O
travel NN O
diary NN O
pages NNS O
were VBD O
unusable JJ O
, , O
who WP O
had VBD O
recorded VBN O
journeys NNS O
without IN O
reporting VBG O
valid JJ O
quantitative JJ O
data NNS O
on IN O
the DT O
durations NNS O
of IN O
those DT O
journeys NNS O
, , O
or CC O
whose WP$ O
completed VBN O
travel NN O
diary NN O
appeared VBD O
implausible JJ O
. . O

We PRP O
also RB O
disregarded VBD O
journeys NNS O
whose WP$ O
purpose NN O
was VBD O
not RB O
stated VBN O
or CC O
was VBD O
beyond IN O
the DT O
scope NN O
of IN O
the DT O
travel NN O
diary NN O
( , O
Additional JJ O
file NN O
1 CD O
, , O
page NN O
8 CD O
) -RRB- O
. . O

We PRP O
summed VBD O
the DT O
reported VBN O
travel NN O
time NN O
for IN O
each DT O
mode NN O
of IN O
transport NN O
, , O
calculated VBD O
a DT O
total JJ O
travel NN O
time NN O
by IN O
active JJ O
modes NNS O
( , O
walking VBG O
plus CC O
cycling NN O
) -RRB- O
and CC O
by IN O
all DT O
modes NNS O
combined VBN O
, , O
and CC O
calculated VBD O
the DT O
proportion NN O
of IN O
total JJ O
travel NN O
time NN O
contributed VBN O
by IN O
each DT O
mode NN O
of IN O
transport NN O
. . O

Physical JJ O
activity NN O

We PRP O
cleaned VBD O
and CC O
analysed VBD O
IPAQ NNP O
data NNS O
in IN O
accordance NN O
with IN O
the DT O
IPAQ NNP O
scoring NN O
protocol NN O
. . O

We PRP O
therefore RB O
disregarded VBD O
physical JJ O
activity NN O
data NNS O
from IN O
respondents NNS O
who WP O
had VBD O
reported VBN O
more JJR O
than IN O
16 CD O
hours NNS O
of IN O
physical JJ O
activity NN O
per IN O
day NN O
or CC O
who WP O
had VBD O
missing JJ O
or CC O
internally RB O
inconsistent JJ O
data NNS O
on IN O
the DT O
frequency NN O
or CC O
duration NN O
of IN O
any DT O
of IN O
the DT O
three CD O
categories NNS O
of IN O
physical JJ O
activity NN O
( , O
walking VBG O
, , O
moderate JJ O
- HYPH O
intensity NN O
activity NN O
or CC O
vigorous JJ O
activity NN O
) -RRB- O
. . O

We PRP O
also RB O
recoded VBD O
reported VBN O
durations NNS O
of IN O
activity NN O
of IN O
less JJR O
than IN O
ten CD O
minutes NNS O
to IN O
zero CD O
, , O
and CC O
of IN O
greater JJR O
than IN O
180 CD O
minutes NNS O
to IN O
180 CD O
minutes NNS O
. . O

We PRP O
calculated VBD O
the DT O
estimated VBN O
total JJ O
physical JJ O
activity NN O
energy NN O
expenditure NN O
for IN O
each DT O
respondent NN O
( -LRB- O
MET NNP O
- HYPH O
min NNP O
/ SYM O
week NN O
) -RRB- O
and CC O
used VBD O
a DT O
combination NN O
of IN O
frequency NN O
, , O
duration NN O
and CC O
total JJ O
energy NN O
expenditure NN O
to TO O
assign VB O
each DT O
respondent NN O
to IN O
a DT O
' `` O
high JJ O
' '' O
, , O
' `` O
moderate JJ O
' '' O
or CC O
' `` O
low JJ O
' '' O
category NN O
of IN O
overall JJ O
physical JJ O
activity NN O
in IN O
accordance NN O
with IN O
the DT O
prescribed VBN O
IPAQ NNP O
algorithm NN O
. . O

The DT O
' `` O
high JJ O
' '' O
category NN O
corresponds VBZ O
to IN O
a DT O
sufficient JJ O
level NN O
of IN O
physical JJ O
activity NN O
to TO O
meet VB O
current JJ O
public JJ O
health NN O
recommendations NNS O
for IN O
adults NNS O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Analysis NN O

We PRP O
considered VBD O
it PRP O
unlikely JJ O
that IN O
the DT O
statistical JJ O
assumptions NNS O
required VBN O
for IN O
linear JJ O
regression NN O
could MD O
be VB O
met VBN O
because IN O
the DT O
distributions NNS O
of IN O
time NN O
spent VBN O
walking NN O
and CC O
cycling NN O
and CC O
of IN O
estimated VBN O
total JJ O
physical JJ O
activity NN O
energy NN O
expenditure NN O
were VBD O
both DT O
strongly RB O
positively RB O
skewed VBN O
and CC O
dominated VBN O
by IN O
a DT O
large JJ O
number NN O
of IN O
zero CD O
values NNS O
which WDT O
meant VBD O
that IN O
the DT O
data NNS O
were VBD O
not RB O
amenable JJ O
to IN O
log NN O
- HYPH O
transformation NN O
. . O

We PRP O
therefore RB O
modelled VBD O
the DT O
correlates NNS O
of IN O
active JJ O
travel NN O
and CC O
physical JJ O
activity NN O
using VBG O
multivariate JJ O
logistic JJ O
regression NN O
. . O

We PRP O
defined VBD O
' `` O
active JJ O
travel NN O
' '' O
as IN O
a DT O
binary JJ O
condition NN O
achieved VBN O
by IN O
any DT O
respondent NN O
who WP O
had VBD O
reported VBN O
at RB O
least RBS O
30 CD O
minutes NNS O
of IN O
travel NN O
by IN O
walking VBG O
, , O
cycling VBG O
or CC O
both CC O
in IN O
their PRP$ O
travel NN O
diary NN O
, , O
reflecting VBG O
the DT O
current JJ O
recommendation NN O
that IN O
adults NNS O
should MD O
accumulate VB O
at RB O
least RBS O
30 CD O
minutes NNS O
of IN O
moderate JJ O
- HYPH O
intensity NN O
physical JJ O
activity NN O
on IN O
most JJS O
days NNS O
of IN O
the DT O
week NN O
[ -LRB- O
20 CD O
] -RRB- O
, , O
and CC O
we PRP O
defined VBD O
' `` O
physical JJ O
activity NN O
' '' O
as IN O
a DT O
binary JJ O
condition NN O
achieved VBN O
by IN O
any DT O
respondent NN O
whose WP$ O
overall JJ O
physical JJ O
activity NN O
was VBD O
categorised VBN O
as IN O
' `` O
high JJ O
' '' O
using VBG O
IPAQ NNP O
. . O

We PRP O
then RB O
built VBD O
separate JJ O
multivariate JJ O
models NNS O
for IN O
active JJ O
travel NN O
and CC O
physical JJ O
activity NN O
following VBG O
the DT O
method NN O
of IN O
Hosmer NNP O
and CC O
Lemeshow NNP O
[ -LRB- O
21 CD O
] -RRB- O
, , O
first RB O
including VBG O
only RB O
' `` O
personal JJ O
' '' O
( , O
individual JJ O
or CC O
household NN O
) -RRB- O
variables NNS O
and CC O
then RB O
adding VBG O
' `` O
environmental JJ O
' '' O
variables NNS O
( , O
Additional JJ O
file NN O
2 CD O
) -RRB- O
. . O

Results NNS O

Response NN O

We PRP O
received VBD O
1345 CD O
completed VBN O
questionnaires NNS O
. . O

After IN O
subtracting VBG O
from IN O
the DT O
numerator NN O
23 CD O
completed VBD O
questionnaires NNS O
with IN O
missing VBG O
critical JJ O
demographic JJ O
data NNS O
( , O
age NN O
or CC O
sex NN O
) -RRB- O
, , O
and CC O
after IN O
subtracting VBG O
from IN O
the DT O
denominator NN O
676 CD O
addresses NNS O
from IN O
which WDT O
survey NN O
packs NNS O
were VBD O
returned VBN O
as IN O
undeliverable JJ O
, , O
this DT O
left VBD O
1322 CD O
valid JJ O
responses NNS O
to TO O
be VB O
entered VBN O
into IN O
analysis NN O
- : O
a DT O
response NN O
rate NN O
of IN O
1322 CD O
/ SYM O
( SYM O
9000 CD O
- SYM O
676 CD O
) -RRB- O
= SYM O
15 CD O
. . O
9 CD O
% NN O
. . O

Characteristics NNS O
of IN O
study NN O
participants NNS B-Species

Demographic JJ O
and CC O
socioeconomic JJ O
characteristics NNS O

Respondents NNS O
were VBD O
aged VBN O
between IN O
16 CD O
and CC O
89 CD O
years NNS O
( , O
median JJ O
age NN O
48 CD O
years NNS O
) -RRB- O
. . O

804 CD O
( : O
61 CD O
% NN O
) -RRB- O
were VBD O
women NNS B-Species
. . O

Only RB O
136 CD O
( SYM O
26 CD O
% NN O
) -RRB- O
of IN O
the DT O
men NNS B-Species
and CC O
145 CD O
( , O
18 CD O
% NN O
) -RRB- O
of IN O
the DT O
women NNS B-Species
reported VBD O
having VBG O
access NN O
to IN O
a DT O
bicycle NN O
. . O

For IN O
those DT O
who WP O
usually RB O
travelled VBD O
to IN O
a DT O
place NN O
of IN O
work NN O
or CC O
study NN O
, , O
the DT O
median JJ O
reported VBN O
distance NN O
was VBD O
3 CD O
. . O
5 CD O
miles NNS O
( : O
about RB O
5 CD O
. . O
5 CD O
kilometres NNS O
) -RRB- O
. . O

Other JJ O
characteristics NNS O
of IN O
study NN O
participants NNS B-Species
are VBP O
summarised VBN O
in IN O
Table NNP O
2 CD O
. . O

Health NN O
and CC O
wellbeing NN O

25 CD O
% NN O
of IN O
respondents NNS O
reported VBD O
difficulty NN O
walking VBG O
for IN O
a DT O
quarter NN O
of IN O
a DT O
mile NN O
, , O
39 CD O
% NN O
reported VBD O
a DT O
long JJ O
- HYPH O
term NN O
health NN O
problem NN O
or CC O
disability NN O
, , O
and CC O
50 CD O
% NN O
were VBD O
overweight JJ O
( , O
median JJ O
BMI NNP O
25 CD O
. . O
1 CD O
kg NNS O
/ SYM O
m2 CD O
) -RRB- O
. . O

The DT O
median JJ O
mental JJ O
health NN O
summary NN O
score NN O
( -LRB- O
MCS NNP O
- HYPH O
8 CD O
) -RRB- O
was VBD O
significantly RB O
lower JJR O
( : O
i LS O
. . O
e LS O
. . O
poorer JJR O
) -RRB- O
than IN O
the DT O
population NN O
norm NN O
( : O
median NN O
47 CD O
. . O
3 CD O
, , O
95 CD O
% NN O
CI NN O
46 CD O
. . O
4 CD O
to TO O
48 CD O
. . O
1 CD O
) -RRB- O
; : O
the DT O
median JJ O
physical JJ O
health NN O
summary NN O
score NN O
( -LRB- O
PCS NNP O
- HYPH O
8 CD O
) -RRB- O
was VBD O
not RB O
significantly RB O
different JJ O
from IN O
the DT O
population NN O
norm NN O
( : O
median NN O
50 CD O
. . O
9 CD O
, , O
95 CD O
% NN O
CI NN O
49 CD O
. . O
6 CD O
to TO O
51 CD O
. . O
7 CD O
) -RRB- O
. . O

Descriptive JJ O
data NNS O
on IN O
travel NN O
behaviour NN O
and CC O
physical JJ O
activity NN O

Travel NN O
behaviour NN O

1099 CD O
travel NN O
diaries NNS O
were VBD O
suitable JJ O
for IN O
travel NN O
time NN O
analysis NN O
. . O

Men NNS B-Species
and CC O
women NNS B-Species
were VBD O
equally RB O
likely JJ O
to TO O
have VB O
returned VBN O
usable JJ O
travel NN O
time NN O
data NNS O
, , O
but CC O
respondents NNS O
who WP O
were VBD O
older JJR O
, , O
retired VBN O
, , O
or CC O
living VBG O
in IN O
social JJ O
rented VBN O
accommodation NN O
or CC O
who WP O
did VBD O
not RB O
have VB O
access NN O
to IN O
a DT O
car NN O
were VBD O
less RBR O
likely JJ O
to TO O
have VB O
returned VBN O
usable JJ O
data NNS O
. . O

On IN O
average JJ O
, , O
respondents NNS O
recorded VBD O
about IN O
an DT O
hour NN O
' POS O
s POS O
travel NN O
per IN O
day NN O
( , O
mean JJ O
61 CD O
. . O
5 CD O
minutes NNS O
, , O
median JJ O
50 CD O
. . O
0 CD O
minutes NNS O
) -RRB- O
, , O
of IN O
which WDT O
a DT O
minority NN O
was VBD O
spent VBN O
using VBG O
active JJ O
modes NNS O
of IN O
transport NN O
( , O
walking VBG O
or CC O
cycling NN O
: : O
mean VB O
20 CD O
. . O
0 CD O
minutes NNS O
, , O
median JJ O
10 CD O
. . O
0 CD O
minutes NNS O
) -RRB- O
( : O
Table NNP O
3 CD O
) -RRB- O
. . O

304 CD O
respondents NNS O
( : O
28 CD O
% NN O
) -RRB- O
recorded VBD O
at RB O
least RBS O
30 CD O
minutes NNS O
of IN O
active JJ O
travel NN O
, , O
of IN O
whom WP O
294 CD O
( SYM O
97 CD O
% NN O
) -RRB- O
recorded VBD O
at RB O
least RBS O
30 CD O
minutes NNS O
of IN O
walking NN O
. . O

Physical JJ O
activity NN O

833 CD O
respondents NNS O
returned VBD O
complete JJ O
physical JJ O
activity NN O
data NNS O
suitable JJ O
for IN O
analysis NN O
. . O

Women NNS B-Species
and CC O
respondents NNS O
who WP O
were VBD O
older JJR O
, , O
retired VBN O
, , O
or CC O
living VBG O
in IN O
social JJ O
rented VBN O
accommodation NN O
or CC O
who WP O
did VBD O
not RB O
have VB O
access NN O
to IN O
a DT O
car NN O
were VBD O
less RBR O
likely JJ O
to TO O
have VB O
returned VBN O
usable JJ O
data NNS O
. . O

Respondents NNS O
reported VBD O
a DT O
mean NN O
of IN O
318 CD O
minutes NNS O
' POS O
walking NN O
per IN O
week NN O
and CC O
a DT O
mean JJ O
estimated JJ O
total JJ O
physical JJ O
activity NN O
energy NN O
expenditure NN O
of IN O
3000 CD O
MET NN O
- HYPH O
minutes NNS O
per IN O
week NN O
( -LRB- O
Table NNP O
4 CD O
) -RRB- O
. . O

Only RB O
316 CD O
respondents NNS O
( : O
38 CD O
% NN O
) -RRB- O
were VBD O
categorised VBN O
as IN O
having VBG O
achieved VBN O
a DT O
' `` O
high JJ O
' '' O
( : O
i PRP O
. . O
e -RRB- O
. . O
sufficient JJ O
) -RRB- O
level NN O
of IN O
physical JJ O
activity NN O
. . O

Correlates NNS O
of IN O
active JJ O
travel NN O

Active JJ O
travel NN O
was VBD O
significantly RB O
associated VBN O
with IN O
being VBG O
younger JJR O
, , O
living VBG O
in IN O
owner NN O
- HYPH O
occupied VBN O
accommodation NN O
, , O
not RB O
having VBG O
to TO O
travel VB O
more JJR O
than IN O
four CD O
miles NNS O
to TO O
work VB O
, , O
having VBG O
access NN O
to IN O
a DT O
bicycle NN O
, , O
not RB O
having VBG O
access NN O
to IN O
a DT O
car NN O
, , O
and CC O
the DT O
absence NN O
of IN O
any DT O
difficulty NN O
walking VBG O
. . O

The DT O
final JJ O
best JJS O
model NN O
of IN O
the DT O
' `` O
personal JJ O
' '' O
correlates NNS O
of IN O
active JJ O
travel NN O
provided VBD O
satisfactory JJ O
goodness NN O
- HYPH O
of IN O
- HYPH O
fit NN O
( : O
Hosmer NNP O
and CC O
Lemeshow NNP O
test NN O
: : O
chi NN O
2 CD O
= SYM O
13 CD O
. . O
4 CD O
, , O
df IN O
= SYM O
8 CD O
; : O
P NN O
= SYM O
0 CD O
. . O
11 CD O
) -RRB- O
and CC O
explained VBN O
nearly RB O
one CD O
- HYPH O
fifth NN O
of IN O
the DT O
total JJ O
variance NN O
in IN O
active JJ O
travel NN O
( : O
Nagelkerke NNP O
' '' O
s NN O
R2 CD O
= SYM O
18 CD O
. . O
7 CD O
% NN O
) -RRB- O
( , O
Table NN O
5 CD O
) -RRB- O
. . O

Adding VBG O
' `` O
environmental JJ O
' '' O
variables NNS O
to IN O
the DT O
model NN O
showed VBD O
an DT O
additional JJ O
significant JJ O
positive JJ O
association NN O
between IN O
active JJ O
travel NN O
and CC O
perceived VBN O
proximity NN O
to IN O
shops NNS O
, , O
and CC O
an DT O
additional JJ O
significant JJ O
negative JJ O
association NN O
between IN O
active JJ O
travel NN O
and CC O
perceived VBN O
road NN O
safety NN O
for IN O
cyclists NNS O
. . O

The DT O
final JJ O
best JJS O
model NN O
of IN O
the DT O
personal JJ O
and CC O
environmental JJ O
correlates NNS O
of IN O
active JJ O
travel NN O
also RB O
provided VBD O
satisfactory JJ O
goodness NN O
- HYPH O
of IN O
- HYPH O
fit NN O
( : O
Hosmer NNP O
and CC O
Lemeshow NNP O
test NN O
: : O
chi NNP O
2 CD O
= SYM O
10 CD O
. . O
61 CD O
, , O
df IN O
= SYM O
8 CD O
; : O
P NN O
= SYM O
0 CD O
. . O
23 CD O
) -RRB- O
and CC O
explained VBD O
slightly RB O
more JJR O
of IN O
the DT O
total JJ O
variance NN O
in IN O
active JJ O
travel NN O
than IN O
did VBD O
the DT O
personal JJ O
model NN O
alone RB O
( : O
Nagelkerke NNP O
' POS O
s NN O
R2 CD O
= SYM O
20 CD O
. . O
1 CD O
% NN O
) -RRB- O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

In IN O
order NN O
to TO O
aid NN O
interpretation NN O
, , O
we PRP O
also RB O
partitioned VBD O
the DT O
dataset NN O
into IN O
two CD O
strata NN O
( , O
' `` O
No DT O
car NN O
available JJ O
' '' O
and CC O
' `` O
Car NN O
available JJ O
' '' O
) -RRB- O
and CC O
refitted VBD O
the DT O
final JJ O
model NN O
separately RB O
to IN O
each DT O
stratum NN O
of IN O
the DT O
dataset NN O
( -LRB- O
Table NNP O
6 CD O
) -RRB- O
. . O

This DT O
showed VBD O
that IN O
the DT O
subset NN O
of IN O
respondents NNS O
with IN O
no DT O
access NN O
to IN O
a DT O
car NN O
accounted VBD O
for IN O
the DT O
significant JJ O
overall JJ O
relationship NN O
between IN O
active JJ O
travel NN O
and CC O
access NN O
to IN O
a DT O
bicycle NN O
, , O
whereas IN O
those DT O
with IN O
access NN O
to IN O
a DT O
car NN O
accounted VBD O
for IN O
the DT O
significant JJ O
overall JJ O
relationships NNS O
with IN O
distance NN O
to IN O
place NN O
of IN O
work NN O
or CC O
study NN O
and CC O
perceptions NNS O
of IN O
the DT O
local JJ O
environment NN O
. . O

The DT O
relationship NN O
with IN O
difficulty NN O
walking NN O
was VBD O
also RB O
stronger JJR O
in IN O
this DT O
group NN O
than IN O
in IN O
those DT O
without IN O
access NN O
to IN O
a DT O
car NN O
. . O

Correlates NNS O
of IN O
physical JJ O
activity NN O

Physical JJ O
activity NN O
was VBD O
significantly RB O
associated VBN O
with IN O
living VBG O
in IN O
social JJ O
- HYPH O
rented VBN O
accommodation NN O
, , O
not RB O
being VBG O
overweight JJ O
, , O
and CC O
the DT O
absence NN O
of IN O
any DT O
difficulty NN O
walking VBG O
. . O

The DT O
final JJ O
best JJS O
model NN O
of IN O
the DT O
' `` O
personal JJ O
' '' O
correlates NNS O
of IN O
physical JJ O
activity NN O
provided VBD O
satisfactory JJ O
goodness NN O
- HYPH O
of IN O
- HYPH O
fit NN O
( : O
Hosmer NNP O
and CC O
Lemeshow NNP O
test NN O
: : O
chi NN O
2 CD O
= SYM O
3 CD O
. . O
89 CD O
, , O
df IN O
= SYM O
7 CD O
; : O
P NN O
= SYM O
0 CD O
. . O
89 CD O
) -RRB- O
and CC O
explained VBD O
about RB O
one CD O
- HYPH O
sixth NN O
of IN O
the DT O
total JJ O
variance NN O
in IN O
physical JJ O
activity NN O
( : O
Nagelkerke NNP O
' POS O
s NN O
R2 CD O
= SYM O
15 CD O
. . O
9 CD O
% NN O
) -RRB- O
( , O
Table NN O
7 CD O
) -RRB- O
. . O

Adding VBG O
' `` O
environmental JJ O
' '' O
variables NNS O
to IN O
the DT O
model NN O
showed VBD O
an DT O
additional JJ O
significant JJ O
negative JJ O
association NN O
between IN O
physical JJ O
activity NN O
and CC O
perception NN O
of IN O
traffic NN O
volume NN O
( : O
i LS O
. . O
e -RRB- O
. . O
respondents NNS O
who WP O
perceived VBD O
there EX O
to TO O
be VB O
a DT O
higher JJR O
volume NN O
of IN O
traffic NN O
were VBD O
more RBR O
likely JJ O
to TO O
report VB O
physical JJ O
activity NN O
) -RRB- O
. . O

The DT O
final JJ O
best JJS O
model NN O
of IN O
the DT O
personal JJ O
and CC O
environmental JJ O
correlates NNS O
of IN O
physical JJ O
activity NN O
also RB O
provided VBD O
satisfactory JJ O
goodness NN O
- HYPH O
of IN O
- HYPH O
fit NN O
( : O
Hosmer NNP O
and CC O
Lemeshow NNP O
test NN O
: : O
chi NN O
2 CD O
= SYM O
3 CD O
. . O
86 CD O
, , O
df IN O
= SYM O
8 CD O
; : O
P NN O
= SYM O
0 CD O
. . O
87 CD O
) -RRB- O
and CC O
explained VBD O
slightly RB O
more JJR O
of IN O
the DT O
total JJ O
variance NN O
in IN O
physical JJ O
activity NN O
than IN O
did VBD O
the DT O
personal JJ O
model NN O
alone RB O
( : O
Nagelkerke NNP O
' POS O
s NN O
16 CD O
. . O
6 CD O
% NN O
) -RRB- O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

Discussion NN O

Principal JJ O
findings NNS O

In IN O
this DT O
deprived JJ O
urban JJ O
population NN O
, , O
the DT O
likelihood NN O
of IN O
reporting VBG O
active JJ O
travel NN O
was VBD O
associated VBN O
with IN O
being VBG O
younger JJR O
, , O
living VBG O
in IN O
owner NN O
- HYPH O
occupied VBN O
accommodation NN O
, , O
not RB O
having VBG O
to TO O
travel VB O
a DT O
long JJ O
distance NN O
to IN O
work NN O
and CC O
not RB O
having VBG O
access NN O
to IN O
a DT O
car NN O
, , O
whereas IN O
overall JJ O
physical JJ O
activity NN O
was VBD O
associated VBN O
with IN O
living VBG O
in IN O
social RB O
- HYPH O
rented VBN O
accommodation NN O
and CC O
not RB O
being VBG O
overweight JJ O
. . O

After IN O
adjusting VBG O
for IN O
individual JJ O
and CC O
household NN O
characteristics NNS O
, , O
neither CC O
perceptions NNS O
of IN O
the DT O
local JJ O
environment NN O
nor CC O
the DT O
objective JJ O
proximity NN O
of IN O
respondents NNS O
' POS O
homes NNS O
to IN O
motorway NN O
or CC O
major JJ O
road NN O
infrastructure NN O
appeared VBD O
to TO O
explain VB O
much JJ O
of IN O
the DT O
variance NN O
in IN O
active JJ O
travel NN O
or CC O
overall JJ O
physical JJ O
activity NN O
, , O
although IN O
we PRP O
did VBD O
find VB O
a DT O
significant JJ O
positive JJ O
association NN O
between IN O
active JJ O
travel NN O
and CC O
perceived VBN O
proximity NN O
to IN O
shops NNS O
. . O

Representativeness NN O
and CC O
completeness NN O
of IN O
survey NN O
data NNS O

Our PRP$ O
difficulty NN O
in IN O
obtaining VBG O
a DT O
representative JJ O
sample NN O
of IN O
the DT O
resident JJ O
population NN O
is VBZ O
not RB O
unique JJ O
to IN O
our PRP$ O
study NN O
. . O

Although IN O
our PRP$ O
final JJ O
response NN O
rate NN O
was VBD O
low JJ O
, , O
it PRP O
was VBD O
almost RB O
identical JJ O
to IN O
that DT O
achieved VBN O
in IN O
a DT O
recent JJ O
population NN O
- HYPH O
based VBN O
intervention NN O
study NN O
elsewhere RB O
in IN O
Glasgow NNP O
[ -LRB- O
22 CD O
] -RRB- O
. . O

Some DT O
of IN O
the DT O
challenges NNS O
of IN O
recruiting VBG O
research NN O
participants NNS B-Species
in IN O
areas NNS O
of IN O
deprivation NN O
have VBP O
been VBN O
described VBN O
elsewhere RB O
[ -LRB- O
23 CD O
] -RRB- O
; , O
these DT O
are VBP O
superimposed VBN O
on IN O
a DT O
downward JJ O
trend NN O
in IN O
participation NN O
in IN O
even RB O
the DT O
best RBS O
- HYPH O
resourced VBN O
national JJ O
population NN O
surveys NNS O
[ -LRB- O
24 CD O
] -RRB- O
and CC O
an DT O
upward JJ O
( , O
and CC O
socially RB O
biased JJ O
) -RRB- O
trend NN O
in IN O
opt NN O
- HYPH O
outs NNS O
from IN O
the DT O
main JJ O
alternative JJ O
sampling NN O
frame NN O
, , O
the DT O
edited VBN O
electoral JJ O
register NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Although IN O
our PRP$ O
achieved VBN O
sample NN O
contained VBD O
a DT O
higher JJR O
proportion NN O
of IN O
respondents NNS O
from IN O
owner NN O
- HYPH O
occupied VBN O
and CC O
car NN O
- HYPH O
owning VBG O
households NNS O
than IN O
predicted VBN O
from IN O
2001 CD O
census NN O
data NNS O
for IN O
the DT O
same JJ O
census NN O
output NN O
areas NNS O
, , O
these DT O
differences NNS O
may MD O
be VB O
partly RB O
accounted VBN O
for IN O
by IN O
an DT O
upward JJ O
background NN O
trend NN O
in IN O
owner NN O
occupation NN O
and CC O
car NN O
access NN O
between IN O
2001 CD O
and CC O
2005 CD O
. . O

Our PRP$ O
achieved VBN O
sample NN O
is VBZ O
still RB O
clearly RB O
disadvantaged JJ O
overall RB O
, , O
in IN O
terms NNS O
of IN O
socioeconomic JJ O
and CC O
health NN O
status NN O
, , O
compared VBN O
with IN O
the DT O
country NN O
as IN O
a DT O
whole NN O
. . O

It PRP O
also RB O
contains VBZ O
sufficient JJ O
heterogeneity NN O
to TO O
enable VB O
us PRP O
to TO O
examine VB O
, , O
in IN O
time NN O
, , O
how WRB O
the DT O
effects NNS O
of IN O
the DT O
intervention NN O
are VBP O
distributed VBN O
between IN O
socioeconomic JJ O
groups NNS O
. . O

We PRP O
therefore RB O
consider VBP O
our PRP$ O
achieved VBN O
sample NN O
fit JJ O
for IN O
purpose NN O
. . O

We PRP O
had VBD O
to TO O
disregard VB O
a DT O
substantial JJ O
proportion NN O
of IN O
cases NNS O
in IN O
analysis NN O
because IN O
respondents NNS O
had VBD O
returned VBN O
unusable JJ O
travel NN O
time NN O
data NNS O
or CC O
had VBD O
returned VBN O
physical JJ O
activity NN O
data NNS O
that WDT O
were VBD O
incomplete JJ O
, , O
internally RB O
inconsistent JJ O
or CC O
included VBD O
a DT O
' '' O
Don NNP O
' '' O
t PRP O
know VBP O
' '' O
response NN O
and CC O
were VBD O
therefore RB O
unacceptable JJ O
according VBG O
to IN O
the DT O
IPAQ NNP O
scoring NN O
protocol NN O
. . O

Most JJS O
published VBN O
studies NNS O
using VBG O
the DT O
same JJ O
, , O
short JJ O
form NN O
of IN O
IPAQ NNP O
have VBP O
either CC O
not RB O
reported VBN O
the DT O
distribution NN O
of IN O
the DT O
continuous JJ O
summary JJ O
measures NNS O
or CC O
have VBP O
not RB O
reported VBN O
data NNS O
for IN O
the DT O
UK NNP O
separately RB O
from IN O
those DT O
for IN O
other JJ O
countries NNS O
where WRB O
higher JJR O
levels NNS O
of IN O
physical JJ O
activity NN O
are VBP O
reported VBN O
. . O

Despite IN O
the DT O
high JJ O
proportion NN O
of IN O
missing VBG O
physical JJ O
activity NN O
data NNS O
in IN O
our PRP$ O
dataset NN O
, , O
however RB O
, , O
the DT O
aggregate JJ O
continuous JJ O
data NNS O
we PRP O
obtained VBD O
were VBD O
broadly RB O
comparable JJ O
to IN O
those DT O
reported VBN O
in IN O
R NNP O
u NNP O
tten NN O
and CC O
colleagues NNS O
' POS O
study NN O
of IN O
a DT O
random JJ O
sample NN O
of IN O
UK NNP O
adults NNS O
[ -LRB- O
26 CD O
] -RRB- O
. . O

We PRP O
could MD O
have VB O
included VBN O
more JJR O
cases NNS O
in IN O
physical JJ O
activity NN O
analysis NN O
by IN O
, , O
for IN O
example NN O
, , O
imputing VBG O
missing VBG O
values NNS O
, , O
but CC O
the DT O
results NNS O
would MD O
not RB O
have VB O
been VBN O
comparable JJ O
with IN O
others NNS O
' POS O
owing VBG O
to IN O
the DT O
substantial JJ O
deviations NNS O
from IN O
the DT O
scoring NN O
protocol NN O
which WDT O
would MD O
have VB O
been VBN O
required VBN O
. . O

The DT O
frequency NN O
of IN O
unusable JJ O
responses NNS O
was VBD O
not RB O
reported VBN O
in IN O
the DT O
international JJ O
multi JJ O
- HYPH O
centre NN O
study NN O
which WDT O
originally RB O
established VBD O
the DT O
validity NN O
and CC O
reliability NN O
of IN O
IPAQ NNP O
[ -LRB- O
27 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
offering VBG O
a DT O
' `` O
Don NNP O
' '' O
t PRP O
know VB O
' '' O
option NN O
in IN O
the DT O
self NN O
- HYPH O
completed VBN O
IPAQ NNP O
questionnaire NN O
encourages VBZ O
respondents NNS O
to TO O
select VB O
this DT O
rather RB O
than IN O
to TO O
enter VB O
what WP O
may MD O
be VB O
a DT O
reasonably RB O
precise JJ O
estimate NN O
of IN O
the DT O
actual JJ O
time NN O
spent VBN O
in IN O
physical JJ O
activity NN O
; : O
the DT O
respondent NN O
has VBZ O
no DT O
way NN O
of IN O
knowing VBG O
that IN O
a DT O
single JJ O
' '' O
Don NNP O
' '' O
t PRP O
know VBP O
' '' O
response NN O
will MD O
result VB O
in IN O
all DT O
of IN O
their PRP$ O
physical JJ O
activity NN O
data NNS O
being VBG O
disregarded VBN O
in IN O
analysis NN O
. . O

This DT O
should MD O
be VB O
considered VBN O
in IN O
any DT O
future JJ O
revision NN O
of IN O
the DT O
IPAQ NNP O
questionnaire NN O
and CC O
scoring VBG O
protocol NN O
. . O

Contribution NN O
of IN O
active JJ O
travel NN O
to IN O
overall JJ O
physical JJ O
activity NN O

The DT O
explanatory JJ O
variables NNS O
that WDT O
were VBD O
significantly RB O
associated VBN O
with IN O
active JJ O
travel NN O
but CC O
not RB O
with IN O
physical JJ O
activity NN O
( , O
distance NN O
to IN O
place NN O
of IN O
work NN O
or CC O
study NN O
, , O
access NN O
to IN O
a DT O
bicycle NN O
, , O
access NN O
to IN O
a DT O
car NN O
, , O
perceived VBN O
proximity NN O
to IN O
shops NNS O
, , O
and CC O
perceived VBN O
road NN O
safety NN O
for IN O
cyclists NNS O
) , O
all DT O
have VBP O
an DT O
obvious JJ O
intuitive JJ O
relationship NN O
with IN O
the DT O
use NN O
of IN O
walking NN O
or CC O
cycling NN O
as IN O
modes NNS O
of IN O
transport NN O
. . O

That IN O
they PRP O
were VBD O
not RB O
significantly RB O
associated VBN O
with IN O
overall JJ O
physical JJ O
activity NN O
suggests VBZ O
either CC O
that IN O
active JJ O
travel NN O
contributes VBZ O
only RB O
a DT O
minority NN O
of IN O
respondents NNS O
' POS O
overall JJ O
physical JJ O
activity NN O
or CC O
that IN O
other JJ O
factors NNS O
not RB O
measured VBN O
in IN O
this DT O
study NN O
are VBP O
more RBR O
important JJ O
correlates NNS O
of IN O
overall JJ O
physical JJ O
activity NN O
than IN O
those DT O
which WDT O
determine VBP O
active JJ O
travel NN O
. . O

A DT O
crude JJ O
comparision NN O
of IN O
the DT O
quantity NN O
of IN O
active JJ O
travel NN O
reported VBN O
in IN O
the DT O
one CD O
- HYPH O
day NN O
travel NN O
diaries NNS O
with IN O
the DT O
quantities NNS O
of IN O
physical JJ O
activity NN O
reported VBN O
using VBG O
IPAQ NNP O
suggests VBZ O
that IN O
on IN O
average JJ O
, , O
active JJ O
travel NN O
may MD O
indeed RB O
make VB O
only RB O
a DT O
small JJ O
( : O
~ $ O
15 CD O
% NN O
) , O
contribution NN O
to IN O
overall JJ O
physical JJ O
activity NN O
in IN O
this DT O
study NN O
population NN O
. . O

However RB O
, , O
the DT O
real JJ O
contribution NN O
may MD O
be VB O
substantially RB O
greater JJR O
than IN O
this DT O
if IN O
, , O
as IN O
has VBZ O
been VBN O
shown VBN O
previously RB O
, , O
respondents NNS O
tend VBP O
to TO O
over RB O
- HYPH O
report VB O
their PRP$ O
physical JJ O
activity NN O
using VBG O
IPAQ NNP O
[ -LRB- O
28 CD O
] -RRB- O
. . O

There EX O
can MD O
be VB O
little JJ O
doubt NN O
that IN O
active JJ O
travel NN O
makes VBZ O
a DT O
substantial JJ O
contribution NN O
to IN O
the DT O
total JJ O
quantity NN O
of IN O
walking NN O
reported VBN O
in IN O
this DT O
study NN O
population NN O
. . O

Irrespective RB O
of IN O
the DT O
true JJ O
contribution NN O
of IN O
active JJ O
travel NN O
to IN O
overall JJ O
physical JJ O
activity NN O
, , O
however RB O
, , O
it PRP O
remains VBZ O
likely JJ O
that IN O
other JJ O
unmeasured JJ O
personal JJ O
and CC O
social JJ O
factors NNS O
beyond IN O
the DT O
scope NN O
of IN O
this DT O
study NN O
may MD O
be VB O
more RBR O
important JJ O
correlates NNS O
of IN O
overall JJ O
physical JJ O
activity NN O
. . O

Socio NN O
- HYPH O
spatial JJ O
patterning NN O
of IN O
active JJ O
travel NN O
and CC O
overall JJ O
physical JJ O
activity NN O

Respondents NNS O
living VBG O
in IN O
owner NN O
- HYPH O
occupied VBN O
households NNS O
were VBD O
more RBR O
likely JJ O
to TO O
report VB O
active JJ O
travel NN O
than IN O
those DT O
living VBG O
in IN O
social JJ O
- HYPH O
rented VBN O
accommodation NN O
, , O
but CC O
less RBR O
likely JJ O
to TO O
report VB O
sufficient JJ O
overall JJ O
physical JJ O
activity NN O
. . O

Since IN O
neither DT O
working NN O
situation NN O
nor CC O
perceived VBN O
financial JJ O
situation NN O
emerged VBD O
as IN O
significantly RB O
associated VBN O
with IN O
active JJ O
travel NN O
or CC O
overall JJ O
physical JJ O
activity NN O
, , O
housing NN O
tenure NN O
and CC O
car NN O
access NN O
are VBP O
the DT O
remaining VBG O
explanatory JJ O
variables NNS O
in IN O
this DT O
dataset NN O
which WDT O
can MD O
be VB O
interpreted VBN O
as IN O
markers NNS O
of IN O
socioeconomic JJ O
status NN O
. . O

Although IN O
having VBG O
access NN O
to IN O
a DT O
car NN O
clearly RB O
reflects VBZ O
the DT O
possession NN O
of IN O
a DT O
material JJ O
asset NN O
, , O
it PRP O
has VBZ O
been VBN O
argued VBN O
that IN O
this DT O
is VBZ O
a DT O
less RBR O
direct JJ O
marker NN O
of IN O
socioeconomic JJ O
status NN O
than IN O
some DT O
other JJ O
markers NNS O
because IN O
, , O
in IN O
Scotland NNP O
at IN O
least JJS O
, , O
access NN O
to IN O
a DT O
car NN O
is VBZ O
a DT O
more RBR O
- HYPH O
or CC O
- HYPH O
less RBR O
essential JJ O
requirement NN O
for IN O
living VBG O
in IN O
many JJ O
rural JJ O
areas NNS O
, , O
whereas IN O
it PRP O
is VBZ O
possible JJ O
to TO O
live VB O
in IN O
a DT O
dense JJ O
urban JJ O
settlement NN O
such JJ O
as IN O
Glasgow NNP O
without IN O
using VBG O
a DT O
car NN O
. . O

In IN O
the DT O
final JJ O
models NNS O
in IN O
this DT O
study NN O
, , O
therefore RB O
, , O
housing NN O
tenure NN O
may MD O
be VB O
regarded VBN O
as IN O
the DT O
primary JJ O
marker NN O
of IN O
socioeconomic JJ O
status NN O
. . O

The DT O
findings NNS O
consequently RB O
suggest VBP O
conflicting JJ O
socioeconomic JJ O
gradients NNS O
in IN O
prevalence NN O
: : O
more RBR O
advantaged JJ O
respondents NNS O
were VBD O
more RBR O
likely JJ O
to TO O
report VB O
active JJ O
travel NN O
, , O
but CC O
more RBR O
disadvantaged JJ O
respondents NNS O
were VBD O
more RBR O
likely JJ O
to TO O
report VB O
sufficient JJ O
overall JJ O
physical JJ O
activity NN O
. . O

The DT O
higher JJR O
prevalence NN O
of IN O
sufficient JJ O
overall JJ O
physical JJ O
activity NN O
among IN O
the DT O
more RBR O
disadvantaged JJ O
despite IN O
their PRP$ O
lower JJR O
propensity NN O
for IN O
active JJ O
travel NN O
is VBZ O
likely JJ O
to TO O
reflect VB O
higher JJR O
quantities NNS O
of IN O
physical JJ O
activity NN O
in IN O
other JJ O
domains NNS O
, , O
particularly RB O
occupational JJ O
and CC O
domestic JJ O
activities NNS O
, , O
since IN O
leisure NN O
- HYPH O
time NN O
physical JJ O
activity NN O
tends VBZ O
to TO O
be VB O
higher JJR O
among IN O
more RBR O
advantaged JJ O
groups NNS O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Environmental JJ O
characteristics NNS O
: : O
paradoxical JJ O
, , O
unmeasured JJ O
, , O
or CC O
irrelevant JJ O
? . O

The DT O
two CD O
environmental JJ O
variables NNS O
that WDT O
emerged VBD O
as IN O
significantly RB O
associated VBN O
with IN O
active JJ O
travel NN O
, , O
particularly RB O
among IN O
those DT O
without IN O
access NN O
to IN O
a DT O
car NN O
, , O
were VBD O
perceived VBN O
proximity NN O
to IN O
shops NNS O
and CC O
perceived VBN O
road NN O
safety NN O
for IN O
cyclists NNS O
. . O

The DT O
positive JJ O
association NN O
with IN O
perceived VBN O
proximity NN O
to IN O
shops NNS O
suggests VBZ O
that IN O
for IN O
active JJ O
travel NN O
to TO O
be VB O
undertaken VBN O
in IN O
this DT O
population NN O
, , O
it PRP O
may MD O
be VB O
more RBR O
important JJ O
that IN O
people NNS B-Species
live VBP O
close RB O
to IN O
the DT O
amenities NNS O
they PRP O
need VBP O
than IN O
that IN O
they PRP O
live VBP O
in IN O
an DT O
environment NN O
with IN O
more RBR O
favourable JJ O
subjective JJ O
or CC O
discretionary JJ O
considerations NNS O
such JJ O
as IN O
attractiveness NN O
or CC O
noise NN O
. . O

This DT O
would MD O
be VB O
consistent JJ O
with IN O
an DT O
understanding NN O
that IN O
walking VBG O
as IN O
a DT O
mode NN O
of IN O
transport NN O
is VBZ O
primarily RB O
a DT O
way NN O
of IN O
undertaking VBG O
journeys NNS O
which WDT O
have VBP O
to TO O
be VB O
made VBN O
anyway RB O
, , O
as IN O
opposed VBN O
to IN O
more RBR O
discretionary JJ O
( , O
recreational JJ O
) -RRB- O
forms NNS O
of IN O
walking NN O
which WDT O
may MD O
be VB O
more RBR O
susceptible JJ O
to IN O
the DT O
influence NN O
of IN O
less JJR O
- HYPH O
structural JJ O
characteristics NNS O
. . O

Although IN O
the DT O
negative JJ O
association NN O
with IN O
perceived VBN O
road NN O
safety NN O
for IN O
cyclists NNS O
appears VBZ O
counter RB O
- HYPH O
intuitive JJ O
, , O
similar JJ O
' `` O
paradoxical JJ O
inverse JJ O
relationships NNS O
' '' O
have VBP O
been VBN O
reported VBN O
elsewhere RB O
, , O
for IN O
example NN O
by IN O
Titze NNP O
and CC O
colleagues NNS O
in IN O
a DT O
study NN O
of IN O
the DT O
correlates NNS O
of IN O
cycling NN O
among IN O
students NNS O
[ -LRB- O
30 CD O
] -RRB- O
and CC O
by IN O
Humpel NNP O
and CC O
colleagues NNS O
in IN O
a DT O
study NN O
of IN O
correlates NNS O
of IN O
walking VBG O
for IN O
pleasure NN O
[ -LRB- O
31 CD O
] -RRB- O
. . O

Titze NNP O
and CC O
colleagues NNS O
suggest VBP O
that IN O
respondents NNS O
who WP O
cycle VBP O
regularly RB O
are VBP O
more RBR O
likely JJ O
to TO O
be VB O
aware JJ O
of IN O
, , O
and CC O
report VB O
, , O
the DT O
danger NN O
posed VBN O
by IN O
traffic NN O
than IN O
non JJ O
- HYPH O
cyclists NNS O
or CC O
infrequent JJ O
cyclists NNS O
. . O

A DT O
similar JJ O
phenomenon NN O
could MD O
explain VB O
the DT O
negative JJ O
association NN O
between IN O
physical JJ O
activity NN O
and CC O
perception NN O
of IN O
traffic NN O
volume NN O
. . O

Overall RB O
, , O
the DT O
influence NN O
of IN O
the DT O
putative JJ O
environmental JJ O
characteristics NNS O
examined VBN O
in IN O
this DT O
study NN O
on IN O
active JJ O
travel NN O
and CC O
physical JJ O
activity NN O
appeared VBD O
small JJ O
compared VBN O
with IN O
that DT O
of IN O
the DT O
personal JJ O
characteristics NNS O
found VBN O
to TO O
be VB O
significant JJ O
, , O
and CC O
including VBG O
environmental JJ O
characteristics NNS O
in IN O
the DT O
models NNS O
did VBD O
not RB O
substantially RB O
modify VB O
the DT O
influence NN O
of IN O
personal JJ O
characteristics NNS O
. . O

On IN O
the DT O
one CD O
hand NN O
, , O
this DT O
could MD O
reflect VB O
an DT O
artefact NN O
of IN O
the DT O
research NN O
methods NNS O
( , O
a DT O
false JJ O
negative JJ O
error NN O
) -RRB- O
, , O
which WDT O
could MD O
have VB O
arisen VBN O
in IN O
various JJ O
ways NNS O
. . O

In IN O
particular JJ O
, , O
the DT O
' `` O
wrong JJ O
' '' O
environmental JJ O
exposure NN O
may MD O
have VB O
been VBN O
measured VBN O
, , O
in IN O
that IN O
the DT O
environmental JJ O
characteristics NNS O
examined VBN O
were VBD O
those DT O
of IN O
the DT O
immediate JJ O
surroundings NNS O
of IN O
respondents NNS O
' POS O
homes NNS O
, , O
whereas IN O
the DT O
propensity NN O
to TO O
choose VB O
active JJ O
modes NNS O
of IN O
transport NN O
may MD O
be VB O
more RBR O
strongly RB O
influenced VBN O
by IN O
the DT O
characteristics NNS O
of IN O
the DT O
environment NN O
elsewhere RB O
on IN O
their PRP$ O
routes NNS O
[ -LRB- O
30 CD O
] -RRB- O
, , O
for IN O
example NN O
the DT O
perceived VBN O
danger NN O
of IN O
cycling NN O
in IN O
the DT O
city NN O
centre NN O
- : O
an DT O
association NN O
which WDT O
may MD O
be VB O
absent JJ O
, , O
or CC O
at IN O
least JJS O
diluted VBN O
, , O
when WRB O
the DT O
' `` O
exposure NN O
' '' O
examined VBN O
is VBZ O
limited JJ O
to IN O
the DT O
residential JJ O
environment NN O
. . O

It PRP O
could MD O
also RB O
be VB O
argued VBN O
that IN O
the DT O
apparently RB O
weak JJ O
influence NN O
of IN O
environmental JJ O
characteristics NNS O
in IN O
this DT O
study NN O
reflects VBZ O
a DT O
reliance NN O
on IN O
respondents NNS O
' POS O
perceptions NNS O
which WDT O
have VBP O
not RB O
been VBN O
objectively RB O
verified VBN O
and CC O
may MD O
therefore RB O
be VB O
a DT O
weak JJ O
proxy NN O
for IN O
the DT O
' `` O
true JJ O
' '' O
objectively RB O
- HYPH O
measured VBN O
characteristics NNS O
of IN O
their PRP$ O
surroundings NNS O
. . O

However RB O
, , O
as IN O
recent JJ O
reviews NNS O
have VBP O
pointed VBN O
out RP O
, , O
the DT O
current JJ O
weight NN O
of IN O
evidence NN O
for IN O
objective JJ O
environmental JJ O
correlates NNS O
of IN O
walking NN O
is VBZ O
no RB O
greater JJR O
than IN O
that DT O
for IN O
subjective JJ O
environmental JJ O
correlates NNS O
[ -LRB- O
5 CD O
] -RRB- O
and CC O
it PRP O
is VBZ O
entirely RB O
plausible JJ O
that IN O
people NNS B-Species
' POS O
s POS O
perceptions NNS O
of IN O
their PRP$ O
environment NN O
may MD O
be VB O
at IN O
least JJS O
as RB O
important JJ O
as IN O
their PRP$ O
objective JJ O
conditions NNS O
in IN O
influencing VBG O
their PRP$ O
behaviour NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
we PRP O
may MD O
have VB O
demonstrated VBN O
a DT O
real JJ O
absence NN O
of IN O
any DT O
major JJ O
association NN O
. . O

Although IN O
at IN O
first JJ O
sight NN O
this DT O
appears VBZ O
at IN O
odds NNS O
with IN O
the DT O
growing VBG O
body NN O
of IN O
review NN O
- HYPH O
level NN O
evidence NN O
for IN O
environmental JJ O
correlates NNS O
of IN O
physical JJ O
activity NN O
, , O
Wendel NNP O
- HYPH O
Vos NNP O
and CC O
colleagues NNS O
noted VBD O
that IN O
of IN O
all PDT O
the DT O
environmental JJ O
factors NNS O
examined VBN O
in IN O
all PDT O
the DT O
studies NNS O
included VBN O
in IN O
their PRP$ O
review NN O
, , O
analysis NN O
showed VBD O
a DT O
' `` O
null JJ O
association NN O
' '' O
in IN O
76 CD O
% NN O
of IN O
cases NNS O
[ -LRB- O
9 CD O
] -RRB- O
, , O
and CC O
our PRP$ O
finding NN O
that IN O
personal JJ O
factors NNS O
account VBP O
for IN O
a DT O
much RB O
larger JJR O
proportion NN O
of IN O
the DT O
variance NN O
in IN O
active JJ O
travel NN O
or CC O
physical JJ O
activity NN O
than IN O
is VBZ O
accounted VBN O
for IN O
by IN O
environmental JJ O
factors NNS O
is VBZ O
consistent JJ O
with IN O
those DT O
of IN O
some DT O
other JJ O
European JJ O
studies NNS O
[ -LRB- O
32 CD O
, , O
33 CD O
] -RRB- O
. . O

In IN O
the DT O
particular JJ O
context NN O
of IN O
this DT O
study NN O
, , O
residents NNS O
may MD O
simply RB O
have VB O
adapted VBN O
to IN O
adverse JJ O
conditions NNS O
in IN O
their PRP$ O
local JJ O
environment NN O
in IN O
the DT O
ways NNS O
identified VBN O
by IN O
Hedges NNP O
in IN O
a DT O
qualitative JJ O
study NN O
of IN O
people NNS B-Species
living VBG O
close RB O
to IN O
new JJ O
roads NNS O
built VBN O
in IN O
the DT O
UK NNP O
in IN O
the DT O
1970s NNS O
[ -LRB- O
34 CD O
] -RRB- O
- , O
particularly RB O
by IN O
attitudinal JJ O
adaptation NN O
, , O
which WDT O
Hedges NNP O
characterises VBZ O
as IN O
developing VBG O
an DT O
attitude NN O
that IN O
it PRP O
is VBZ O
futile JJ O
to TO O
resist VB O
. . O

One PRP O
can MD O
imagine VB O
that IN O
in IN O
the DT O
most RBS O
deprived JJ O
areas NNS O
of IN O
Glasgow NNP O
, , O
people NNS B-Species
may MD O
have VB O
become VBN O
resigned JJ O
to IN O
the DT O
nature NN O
of IN O
their PRP$ O
surroundings NNS O
, , O
seeing VBG O
them PRP O
as IN O
inevitable JJ O
and CC O
not RB O
amenable JJ O
to TO O
change VB O
either CC O
through IN O
environmental JJ O
improvement NN O
or CC O
through IN O
their PRP$ O
moving VBG O
to IN O
another DT O
area NN O
. . O

Conclusion NN O

After IN O
demographic JJ O
and CC O
socioeconomic JJ O
characteristics NNS O
were VBD O
taken VBN O
into IN O
account NN O
, , O
neither CC O
perceptions NNS O
of IN O
the DT O
local JJ O
environment NN O
nor CC O
objective JJ O
proximity NN O
to IN O
major JJ O
road NN O
infrastructure NN O
appeared VBD O
to TO O
explain VB O
much JJ O
of IN O
the DT O
variance NN O
in IN O
active JJ O
travel NN O
or CC O
overall JJ O
physical JJ O
activity NN O
in IN O
this DT O
study NN O
. . O

Our PRP$ O
study NN O
population NN O
may MD O
be VB O
both DT O
objectively RB O
constrained VBN O
by IN O
their PRP$ O
socioeconomic JJ O
circumstances NNS O
( , O
including VBG O
comparatively RB O
limited JJ O
access NN O
to IN O
private JJ O
cars NNS O
) -RRB- O
and CC O
adapted VBN O
to IN O
living VBG O
in IN O
conditions NNS O
which WDT O
others NNS O
would MD O
consider VB O
to TO O
pose VB O
a DT O
barrier NN O
to IN O
active JJ O
travel NN O
. . O

Under IN O
these DT O
circumstances NNS O
, , O
environmental JJ O
characteristics NNS O
which WDT O
have VBP O
been VBN O
found VBN O
to TO O
influence VB O
discretionary JJ O
active JJ O
travel NN O
in IN O
studies NNS O
in IN O
other JJ O
, , O
more RBR O
affluent JJ O
populations NNS O
may MD O
simply RB O
be VB O
irrelevant JJ O
in IN O
a DT O
population NN O
which WDT O
is VBZ O
more RBR O
captive JJ O
in IN O
its PRP$ O
travel NN O
choices NNS O
. . O

Environmental JJ O
correlates NNS O
of IN O
active JJ O
travel NN O
should MD O
not RB O
be VB O
assumed VBN O
to TO O
be VB O
generalisable JJ O
between IN O
populations NNS O
; : O
researchers NNS O
should MD O
continue VB O
to TO O
test VB O
hypotheses NNS O
about IN O
putative JJ O
environmental JJ O
correlates NNS O
in IN O
different JJ O
settings NNS O
, , O
and CC O
policymakers NNS O
should MD O
recognise VB O
that IN O
the DT O
effects NNS O
of IN O
interventions NNS O
to TO O
change VB O
the DT O
environment NN O
are VBP O
likely JJ O
to TO O
vary VB O
between IN O
populations NNS O
and CC O
between IN O
socioeconomic JJ O
groups NNS O
within IN O
populations NNS O
. . O

Competing VBG O
interests NNS O

This DT O
paper NN O
is VBZ O
based VBN O
on IN O
material NN O
contained VBN O
in IN O
the DT O
first JJ O
author NN O
' '' O
s POS O
PhD NN O
thesis NN O
. . O

Authors NNS O
' POS O
contributions NNS O

DO VB O
had VBD O
the DT O
original JJ O
idea NN O
for IN O
the DT O
study NN O
, , O
designed VBD O
the DT O
study NN O
and CC O
the DT O
survey NN O
materials NNS O
, , O
applied VBN O
for IN O
ethical JJ O
approval NN O
, , O
cleaned VBD O
and CC O
coded VBD O
the DT O
survey NN O
data NNS O
, , O
carried VBD O
out RP O
all PDT O
the DT O
geographical JJ O
and CC O
statistical JJ O
analyses NNS O
and CC O
wrote VBD O
the DT O
paper NN O
. . O

MP NNP O
was VBD O
DO NNP O
' POS O
s NN O
PhD NN O
supervisor NN O
. . O

RM NNP O
, , O
NM NNP O
, , O
MP NNP O
and CC O
SP NNP O
constituted VBD O
the DT O
steering NN O
group NN O
for IN O
the DT O
study NN O
, , O
contributed VBD O
to IN O
and CC O
advised VBD O
on IN O
the DT O
design NN O
of IN O
the DT O
study NN O
and CC O
the DT O
interpretation NN O
of IN O
the DT O
emerging VBG O
findings NNS O
, , O
and CC O
contributed VBD O
to IN O
the DT O
critical JJ O
revision NN O
of IN O
the DT O
paper NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Supplementary JJ O
Material NN O

Foamy JJ O
Macrophages NNS O
from IN O
Tuberculous JJ O
Patients NNS B-Species
' POS O
Granulomas NNS O
Constitute VBP O
a DT O
Nutrient NN O
- HYPH O
Rich JJ O
Reservoir NN O
for IN O
M NN B-Species
. . I-Species
tuberculosis NN I-Species
Persistence NN O

Abstract JJ O

Tuberculosis NN O
( , O
TB NNP O
) -RRB- O
is VBZ O
characterized VBN O
by IN O
a DT O
tight JJ O
interplay NN O
between IN O
Mycobacterium NN B-Species
tuberculosis NN I-Species
and CC O
host NN O
cells NNS O
within IN O
granulomas NNS O
. . O

These DT O
cellular JJ O
aggregates NNS O
restrict VBP O
bacterial JJ O
spreading NN O
, , O
but CC O
do VBP O
not RB O
kill VB O
all PDT O
the DT O
bacilli NN O
, , O
which WDT O
can MD O
persist VB O
for IN O
years NNS O
. . O

In IN O
- HYPH O
depth NN O
investigation NN O
of IN O
M NNP B-Species
. . I-Species
tuberculosis NN I-Species
interactions NNS O
with IN O
granuloma NN O
- HYPH O
specific JJ O
cell NN O
populations NNS O
are VBP O
needed VBN O
to TO O
gain VB O
insight NN O
into IN O
mycobacterial JJ O
persistence NN O
, , O
and CC O
to TO O
better RBR O
understand VB O
the DT O
physiopathology NN O
of IN O
the DT O
disease NN O
. . O

We PRP O
have VBP O
analyzed VBN O
the DT O
formation NN O
of IN O
foamy JJ O
macrophages NNS O
( , O
FMs NNS O
) -RRB- O
, , O
a DT O
granuloma NN O
- HYPH O
specific JJ O
cell NN O
population NN O
characterized VBN O
by IN O
its PRP$ O
high JJ O
lipid JJ O
content NN O
, , O
and CC O
studied VBD O
their PRP$ O
interaction NN O
with IN O
the DT O
tubercle NN O
bacillus NN O
. . O

Within IN O
our PRP$ O
in FW O
vitro FW O
human JJ B-Species
granuloma NN O
model NN O
, , O
M NNP B-Species
. , I-Species
tuberculosis NN I-Species
long JJ O
chain NN O
fatty NN O
acids NNS O
, , O
namely RB O
oxygenated VBN O
mycolic JJ O
acids NNS O
( , O
MA NNP O
) -RRB- O
, , O
triggered VBD O
the DT O
differentiation NN O
of IN O
human JJ B-Species
monocyte NN O
- HYPH O
derived VBN O
macrophages NNS O
into IN O
FMs NNPS O
. . O

In IN O
these DT O
cells NNS O
, , O
mycobacteria NN O
no RB O
longer RBR O
replicated VBD O
and CC O
switched VBD O
to IN O
a DT O
dormant JJ O
non AFX O
- HYPH O
replicative JJ O
state NN O
. . O

Electron NN O
microscopy NN O
observation NN O
of IN O
M NN B-Species
. . I-Species
tuberculosis NN I-Species
- HYPH O
infected VBN O
FMs NNPS O
showed VBD O
that IN O
the DT O
mycobacteria NN O
- HYPH O
containing VBG O
phagosomes NNS O
migrate VBP O
towards IN O
host NN O
cell NN O
lipid NN O
bodies NNS O
( -LRB- O
LB NNP O
) -RRB- O
, , O
a DT O
process NN O
which WDT O
culminates VBZ O
with IN O
the DT O
engulfment NN O
of IN O
the DT O
bacillus NN O
into IN O
the DT O
lipid NN O
droplets NNS O
and CC O
with IN O
the DT O
accumulation NN O
of IN O
lipids NNS O
within IN O
the DT O
microbe NN O
. . O

Altogether RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
oxygenated JJ O
mycolic NN O
acids NNS O
from IN O
M NNP B-Species
. . I-Species
tuberculosis NN I-Species
play VBP O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
differentiation NN O
of IN O
macrophages NNS O
into IN O
FMs NNPS O
. . O

These DT O
cells NNS O
might MD O
constitute VB O
a DT O
reservoir NN O
used VBN O
by IN O
the DT O
tubercle NN O
bacillus NN O
for IN O
long JJ O
- HYPH O
term NN O
persistence NN O
within IN O
its PRP$ O
human JJ B-Species
host NN O
, , O
and CC O
could MD O
provide VB O
a DT O
relevant JJ O
model NN O
for IN O
the DT O
screening NN O
of IN O
new JJ O
antimicrobials NNS O
against IN O
non NN O
- HYPH O
replicating VBG O
persistent JJ O
mycobacteria NN O
. . O

Introduction NN O

Tuberculosis NN O
caused VBN O
by IN O
Mycobacterium NNP B-Species
tuberculosis NN I-Species
( , O
M NNP B-Species
. . I-Species
tb NNP I-Species
) -RRB- O
remains VBZ O
one CD O
of IN O
the DT O
leading VBG O
causes NNS O
of IN O
mortality NN O
in IN O
the DT O
world NN O
, , O
with IN O
around RB O
2 CD O
million CD O
deaths NNS O
each DT O
year NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Most JJS O
individuals NNS O
remain VBP O
asymptomatic JJ O
after IN O
the DT O
primary JJ O
infection NN O
with IN O
only RB O
10 CD O
% NN O
at IN O
risk NN O
of IN O
developing VBG O
an DT O
active JJ O
disease NN O
during IN O
their PRP$ O
life NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

In IN O
asymptomatic JJ O
individuals NNS O
, , O
the DT O
bacilli NNS O
are VBP O
not RB O
cleared VBN O
but CC O
rather RB O
persist VBP O
in IN O
a DT O
dormant JJ O
state NN O
, , O
from IN O
which WDT O
they PRP O
may MD O
reactivate VB O
and CC O
induce VB O
clinical JJ O
disease NN O
at IN O
later JJR O
stages NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

The DT O
prognosis NN O
of IN O
the DT O
disease NN O
depends VBZ O
on IN O
the DT O
host NN O
' POS O
s NN O
efficiency NN O
to TO O
constrain VB O
the DT O
bacilli NN O
at IN O
the DT O
site NN O
of IN O
infection NN O
. . O

When WRB O
inhaled VBN O
M NNP B-Species
. . I-Species
tb `` I-Species
reach VBP O
the DT O
lungs NNS O
, , O
they PRP O
are VBP O
internalized VBN O
by IN O
lung NN O
macrophages NNS O
. . O

The DT O
latter JJ O
trigger VBP O
the DT O
accumulation NN O
at IN O
the DT O
infectious JJ O
site NN O
of IN O
macrophages NNS O
, , O
lymphocytes NNS O
and CC O
dendritic JJ O
cells NNS O
, , O
to TO O
form VB O
a DT O
granuloma NN O
, , O
which WDT O
is VBZ O
a DT O
major JJ O
histo NN O
- HYPH O
pathological JJ O
feature NN O
of IN O
TB NNP O
. . O

Within IN O
granulomas NNS O
, , O
macrophages NNS O
differentiate VBP O
into IN O
epithelio NN O
i HYPH O
d NN O
cells NNS O
( , O
differentiated VBN O
macrophages NNS O
) -RRB- O
, , O
and CC O
/ SYM O
or CC O
fuse VBP O
to TO O
form VB O
multinucleated JJ O
giant JJ O
cells NNS O
( -LRB- O
MGC NNP O
) -RRB- O
. . O

Macrophages NNS O
with IN O
large JJ O
numbers NNS O
of IN O
lipid NN O
- HYPH O
free JJ O
vacuoles NNS O
, , O
as RB O
well RB O
as IN O
macrophages NNS O
filled VBN O
with IN O
lipid NN O
- HYPH O
containing VBG O
bodies NNS O
, , O
also RB O
called VBN O
foamy JJ O
macrophages NNS O
( -LRB- O
FM NN O
) -RRB- O
are VBP O
also RB O
found VBN O
within IN O
granulomatous JJ O
structures NNS O
in IN O
both CC O
experimental JJ O
animal NN O
models NNS O
and CC O
human JJ B-Species
disease NN O
[ -LRB- O
4 CD O
] -RRB- O
, , O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
above JJ O
cells NNS O
are VBP O
surrounded VBN O
by IN O
a DT O
rim NN O
of IN O
lymphocytes NNS O
, , O
and CC O
at IN O
later JJ O
stages NNS O
, , O
a DT O
tight JJ O
coat NN O
of IN O
fibroblasts NNS O
encloses VBZ O
the DT O
structure NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Although IN O
the DT O
structure NN O
and CC O
cell NN O
composition NN O
of IN O
granulomas NNS O
are VBP O
well RB O
known VBN O
, , O
the DT O
biology NN O
of IN O
these DT O
inflammatory JJ O
structures NNS O
and CC O
, , O
more RBR O
specifically RB O
, , O
the DT O
role NN O
of IN O
granuloma NN O
- HYPH O
specific JJ O
cell NN O
types NNS O
, , O
remain VBP O
largely RB O
unknown JJ O
. . O

We PRP O
have VBP O
previously RB O
developed VBN O
an DT O
in FW O
vitro FW O
model NN O
of IN O
human JJ B-Species
tuberculous JJ O
granulomas NNS O
to TO O
gain VB O
insight NN O
into IN O
the DT O
survival NN O
strategies NNS O
of IN O
the DT O
tubercle JJ O
bacillus NN O
within IN O
its PRP$ O
human JJ B-Species
host NN O
. . O

This DT O
model NN O
now RB O
enables VBZ O
the DT O
characterization NN O
of IN O
granuloma NN O
- HYPH O
specific JJ O
cell NN O
types NNS O
, , O
and CC O
their PRP$ O
modulation NN O
by IN O
M NNP B-Species
. . I-Species
tb NNP I-Species
[ -LRB- O
7 CD O
] -RRB- O
. . O

The DT O
main JJ O
advantage NN O
of IN O
this DT O
model NN O
over IN O
in IN O
vivo NN O
animal NN O
models NNS O
or CC O
ex FW O
vivo NN O
human JJ B-Species
biopsy NN O
samples NNS O
, , O
is VBZ O
the DT O
availability NN O
of IN O
live JJ O
granuloma NN O
cells NNS O
which WDT O
facilitates VBZ O
analysis NN O
of IN O
their PRP$ O
cell NN O
biology NN O
. . O

Using VBG O
this DT O
model NN O
we PRP O
have VBP O
recently RB O
shown VBN O
that IN O
, , O
within IN O
granulomas NNS O
, , O
large JJ O
multinucleated JJ O
giant JJ O
cells NNS O
, , O
also RB O
known VBN O
as IN O
Langhans NNP O
giant JJ O
cells NNS O
, , O
result VBP O
from IN O
the DT O
induction NN O
of IN O
granuloma NN O
macrophage NN O
fusion NN O
by IN O
M NN B-Species
. . I-Species
tb NN I-Species
glycolipids NNS O
[ -LRB- O
8 CD O
] -RRB- O
. . O

We PRP O
have VBP O
shown VBN O
that IN O
these DT O
cells NNS O
have VBP O
lost VBN O
the DT O
ability NN O
to TO O
mediate VB O
bacterial JJ O
uptake NN O
upon IN O
maturation NN O
, , O
but CC O
have VBP O
conserved VBN O
their PRP$ O
ability NN O
to TO O
mediate VB O
antigen NN O
presentation NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

The DT O
differentiation NN O
of IN O
macrophages NNS O
into IN O
FMs NNPS O
has VBZ O
been VBN O
particularly RB O
well RB O
described VBN O
in IN O
individuals NNS O
developing VBG O
a DT O
postprimary JJ O
, , O
also RB O
known VBN O
as IN O
secondary JJ O
or CC O
adult NN O
, , O
TB NNP O
. . O

These DT O
postprimary JJ O
infections NNS O
are VBP O
considered VBN O
to TO O
be VB O
the DT O
result NN O
of IN O
re NN O
- HYPH O
infection NN O
or CC O
reactivation NN O
of IN O
a DT O
primary JJ O
TB NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

FMs NNS O
have VBP O
been VBN O
described VBN O
in IN O
leprosy JJ O
patients NNS B-Species
or CC O
M NNP B-Species
. . I-Species
avium NN I-Species
- HYPH O
infected VBN O
AIDS NNP O
( , O
Acquired NNP O
ImmunoDeficiency NNP O
Syndrome NNP O
) -RRB- O
patients NNS B-Species
, , O
and CC O
in IN O
chronic JJ O
stages NNS O
of IN O
M NN B-Species
. . I-Species
tb NN I-Species
infection NN O
in IN O
mice NNS B-Species
[ -LRB- O
4 CD O
] -RRB- O
, , O
[ -LRB- O
11 CD O
] -RRB- O
, , O
[ -LRB- O
12 CD O
] -RRB- O
. . O

The DT O
foamy JJ O
aspect NN O
of IN O
these DT O
macrophages NNS O
is VBZ O
the DT O
result NN O
of IN O
intracellular JJ O
lipid NN O
accumulation NN O
within IN O
lipid JJ O
bodies NNS O
, , O
also RB O
called VBN O
lipid NN O
droplets NNS O
or CC O
lipid JJ O
vacuoles NNS O
[ -LRB- O
13 CD O
] -RRB- O
, , O
[ -LRB- O
14 CD O
] -RRB- O
, , O
[ -LRB- O
15 CD O
] -RRB- O
. . O

In IN O
an DT O
experimental JJ O
model NN O
of IN O
leukocyte NN O
infection NN O
, , O
it PRP O
was VBD O
recently RB O
suggested VBN O
that IN O
BCG NNP O
( : O
Bacille NNP O
Calmette NNP O
Guerin NNP O
) , O
infection NN O
can MD O
induce VB O
, , O
in IN O
a DT O
TLR2 NNP O
- HYPH O
dependent JJ O
fashion NN O
, , O
the DT O
rapid JJ O
formation NN O
of IN O
lipid JJ O
bodies NNS O
carrying VBG O
out RP O
part NN O
of IN O
the DT O
eicosano NN O
i NN O
d NN O
biosynthesis NN O
that WDT O
usually RB O
accompanies VBZ O
the DT O
infection NN O
, , O
thus RB O
pointing VBG O
to IN O
an DT O
active JJ O
role NN O
for IN O
lipid JJ O
bodies NNS O
during IN O
the DT O
course NN O
of IN O
infection NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
mechanisms NNS O
regulating VBG O
this DT O
lipid NN O
accumulation NN O
during IN O
mycobacterial JJ O
infection NN O
and CC O
their PRP$ O
significance NN O
in IN O
the DT O
physiopathology NN O
of IN O
tuberculosis NN O
are VBP O
not RB O
understood VBN O
. . O

Most JJS O
of IN O
the DT O
studies NNS O
on IN O
TB NNP O
granulomas NNS O
have VBP O
focused VBN O
on IN O
the DT O
contribution NN O
of IN O
host NN O
components NNS O
, , O
but CC O
very RB O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
role NN O
played VBN O
by IN O
bacterial JJ O
constituents NNS O
in IN O
terms NNS O
of IN O
granuloma NN O
formation NN O
and CC O
progression NN O
. . O

The DT O
present JJ O
work NN O
was VBD O
aimed VBN O
at IN O
deciphering VBG O
the DT O
role NN O
of IN O
FMs NNPS O
in IN O
M NNP B-Species
. . I-Species
tb NN I-Species
survival NN O
within IN O
human JJ B-Species
granulomas NNS O
. . O

To TO O
test VB O
our PRP$ O
working VBG O
hypothesis NN O
according VBG O
to IN O
which WDT O
FMs NNS O
constitute VBP O
a DT O
nutrient NN O
- HYPH O
rich JJ O
reservoir NN O
for IN O
M NNP B-Species
. . I-Species
tb IN I-Species
persistence NN O
, , O
we PRP O
used VBD O
our PRP$ O
in FW O
vitro FW O
model NN O
of IN O
human JJ B-Species
granulomas NNS O
to TO O
analyze VB O
the DT O
formation NN O
of IN O
FMs NNS O
and CC O
their PRP$ O
role NN O
during IN O
M NNP B-Species
. . I-Species
tb NN I-Species
infection NN O
. . O

We PRP O
showed VBD O
that IN O
only RB O
highly RB O
virulent JJ O
mycobacteria NN O
( , O
M NNP B-Species
. . I-Species
tb NN I-Species
, , O
M NN B-Species
. . I-Species
avium NN I-Species
) -RRB- O
and CC O
not RB O
saprophytic JJ O
ones NNS O
( , O
M NN B-Species
. . I-Species
smegmatis NN I-Species
) -RRB- O
could MD O
induce VB O
the DT O
formation NN O
of IN O
FMs NNS O
in IN O
mature JJ O
granulomas NNS O
. . O

Moreover RB O
, , O
we PRP O
demonstrated VBD O
that IN O
oxygenated JJ O
mycolic JJ O
acids NNS O
specifically RB O
produced VBN O
by IN O
the DT O
above JJ O
pathogenic JJ O
species NNS O
were VBD O
responsible JJ O
for IN O
FMs NNP O
formation NN O
. . O

Once RB O
differentiated VBN O
, , O
FMs NNPS O
were VBD O
unable JJ O
to TO O
mediate VB O
phagocytosis NN O
of IN O
new JJ O
bacilli NN O
and CC O
their PRP$ O
microbicidal JJ O
activity NN O
was VBD O
reduced VBN O
. . O

M UH B-Species
. . I-Species
tb NNP I-Species
was VBD O
not RB O
killed VBN O
in IN O
FMs NNPS O
but CC O
instead RB O
persisted VBD O
in IN O
a DT O
non AFX O
- HYPH O
replicating VBG O
state NN O
, , O
and CC O
over RB O
- HYPH O
expressed VBN O
dormancy NN O
genes NNS O
. . O

Noteworthy JJ O
, , O
in IN O
foamy JJ O
macrophages NNS O
, , O
M NNP B-Species
. . I-Species
tb NN I-Species
- HYPH O
containing VBG O
phagosomes NNS O
were VBD O
shown VBN O
to TO O
migrate VB O
towards IN O
lipid JJ O
bodies NNS O
which WDT O
they PRP O
progressively RB O
surrounded VBD O
and CC O
engulfed VBD O
. . O

As IN O
a DT O
result NN O
, , O
bacteria NNS O
were VBD O
freed VBN O
into IN O
lipid JJ O
bodies NNS O
, , O
thus RB O
favoring VBG O
the DT O
bacilli NN O
' '' O
s NNS O
access NN O
to IN O
nutrients NNS O
. . O

From IN O
these DT O
data NNS O
, , O
we PRP O
propose VBP O
that IN O
FMs NNPS O
could MD O
form VB O
a DT O
secure JJ O
reservoir NN O
for IN O
the DT O
tubercle NN O
bacilli NN O
. . O

Methods NNS O

Human JJ B-Species
samples NNS O

Human JJ B-Species
blood NN O
samples NNS O
, , O
purchased VBN O
from IN O
the DT O
French JJ O
National NNP O
Blood NNP O
provider NN O
of IN O
Toulouse NNP O
, , O
were VBD O
collected VBN O
from IN O
fully RB O
anonymized VBN O
non AFX O
- HYPH O
tuberculous JJ O
control NN O
donors NNS O
, , O
an DT O
ethical JJ O
committee NN O
approval NN O
was VBD O
, , O
therefore RB O
, , O
not RB O
necessary JJ O
. . O

This DT O
study NN O
was VBD O
conducted VBN O
according VBG O
to IN O
the DT O
principles NNS O
expressed VBN O
in IN O
the DT O
Helsinki NNP O
Declaration NNP O
, , O
with IN O
informed JJ O
consent NN O
obtained VBN O
from IN O
each DT O
donor NN O
. . O

We PRP O
chose VBD O
to TO O
work VB O
on IN O
lymph NN O
node NN O
samples NNS O
rather RB O
than IN O
lung NN O
biopsies NNS O
, , O
which WDT O
are VBP O
usually RB O
only RB O
paraffin NN O
- HYPH O
embedded VBN O
, , O
because IN O
staining VBG O
for IN O
lipids NNS O
can MD O
only RB O
be VB O
performed VBN O
on IN O
frozen VBN O
samples NNS O
. . O

Lymph JJ O
node NN O
biopsies NNS O
were VBD O
taken VBN O
for IN O
diagnosis NN O
purposes NNS O
, , O
in IN O
ten CD O
non JJ O
- HYPH O
HIV NNP B-Species
patients NNS B-Species
. . O

For IN O
each DT O
biopsy NN O
, , O
a DT O
fragment NN O
was VBD O
sent VBN O
to IN O
the DT O
microbiology NN O
laboratory NN O
, , O
another DT O
was VBD O
frozen VBN O
in IN O
liquid NN O
nitrogen NN O
and CC O
the DT O
main JJ O
part NN O
was VBD O
fixed VBN O
in IN O
formalin NN O
and CC O
paraffin NN O
- HYPH O
embedded VBN O
for IN O
histological JJ O
examination NN O
. . O

M UH B-Species
. . I-Species
tb NN I-Species
was VBD O
identified VBN O
in IN O
9 CD O
lymph JJ O
node NN O
biopsies NNS O
and CC O
from IN O
the DT O
lung NN O
aspiration NN O
in IN O
the DT O
last JJ O
patient NN B-Species
. . O

This DT O
latter JJ O
case NN O
showed VBD O
no DT O
signs NNS O
of IN O
necrosis NN O
, , O
and CC O
no DT O
FMs NNS O
were VBD O
found VBN O
in IN O
the DT O
lymph JJ O
node NN O
biopsy NN O
. . O

This DT O
study NN O
complies VBZ O
with IN O
the DT O
guidelines NNS O
of IN O
the DT O
declaration NN O
of IN O
Helsinki NNP O
. . O

Bacterial JJ O
strains NNS O
and CC O
culture NN O
conditions NNS O

Wild JJ O
- HYPH O
type NN O
M NN B-Species
. . I-Species
smegmatis NN I-Species
and CC O
M NN B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NN O
strains NNS O
were VBD O
previously RB O
described VBN O
[ -LRB- O
17 CD O
] -RRB- O
, , O
M NNP B-Species
. . I-Species
tuberculosis NN I-Species
- HYPH O
GFP NNP O
were VBD O
a DT O
kind JJ O
gift NN O
from IN O
Dr NNP O
. . O
C NN O
. . O

Guilhot NNP O
( , O
CNRS NNP O
- HYPH O
IPBS NNP O
, , O
Toulouse NNP O
France NNP O
) -RRB- O
. . O

Bacilli NNP O
were VBD O
grown VBN O
in IN O
Middlebrook NNP O
7H9 CD O
medium NN O
( : O
Difco NNP O
) -RRB- O
supplemented VBN O
with IN O
10 CD O
% NN O
albumin NN O
- HYPH O
dextrose NN O
- HYPH O
catalase NN O
( : O
Difco NNP O
) -RRB- O
. . O

Fluorescent NN O
M NN B-Species
. . I-Species
smegmatis NN I-Species
and CC O
M NN B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NNP O
were VBD O
obtained VBN O
by IN O
FITC NNP O
labelling NN O
as IN O
described VBN O
in IN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Isolation NN O
of IN O
RNA NN O
from IN O
intraphagosomal JJ O
M NN B-Species
. . I-Species
tb XX I-Species

Six CD O
and CC O
12 CD O
days NNS O
post NN O
- HYPH O
infection NN O
( : O
MOI NNP O
10 CD O
) -RRB- O
, , O
macrophages NNS O
and CC O
FMs NNS O
( SYM O
5 CD O
x SYM O
106 CD O
) -RRB- O
were VBD O
washed VBN O
twice RB O
with IN O
PBS NNP O
, , O
scraped VBN O
off RP O
the DT O
cell NN O
dishes NNS O
and CC O
recovered VBN O
by IN O
centrifugation NN O
. . O

The DT O
cell NN O
pellets NNS O
were VBD O
lysed VBN O
with IN O
lysis NN O
buffer NN O
( , O
RNEasy NNP O
mini NN O
kit NN O
, , O
Quiagen NNP O
) -RRB- O
and CC O
transferred VBN O
to IN O
2 CD O
ml NNS O
Eppendorf NNP O
- HYPH O
tubes NNS O
containing VBG O
a DT O
0 CD O
. . O
5 CD O
ml NN O
suspension NN O
of IN O
0 CD O
. . O
1 CD O
mm NN O
- HYPH O
diameter NN O
glass NN O
beads NNS O
( -LRB- O
Biospec NN O
) -RRB- O
. . O

Mycobacteria NN O
were VBD O
disrupted VBN O
using VBG O
a DT O
bead NN O
beater NN O
( , O
Retsch NNP O
) , O
followed VBN O
by IN O
a DT O
5 CD O
min NN O
centrifugation NN O
at IN O
14 CD O
000g CD O
. . O

RNA NNP O
contained VBN O
in IN O
the DT O
supernatant NN O
was VBD O
then RB O
column NN O
- HYPH O
purified VBN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
conditions NNS O
using VBG O
the DT O
RNEasy NNP O
mini JJ O
kit NN O
( , O
Qiagen NNP O
) -RRB- O
and CC O
quantified VBD O
. . O

Quantitative JJ O
Real JJ O
- HYPH O
Time NNP O
RT NNP O
- HYPH O
PCR NNP O

In IN O
RNA NNP O
samples NNS O
DNA NN O
contamination NN O
was VBD O
excluded VBN O
by IN O
DNAse NNP O
I NNP O
treatment NN O
( -LRB- O
Ambion NNP O
) -RRB- O
. . O

1 CD O
micro NN O
g NN O
total JJ O
RNA NNP O
was VBD O
reverse RB O
- HYPH O
transcribed VBN O
using VBG O
random JJ O
hexamer NN O
primers NNS O
( , O
Ambion NNP O
) -RRB- O
and CC O
Superscript NNP O
III NNP O
reverse JJ O
transcriptase NN O
( , O
Invitrogen NNP O
) -RRB- O
. . O

Real JJ O
- HYPH O
time NN O
PCR NNP O
was VBD O
performed VBN O
on IN O
cDNA NNP O
using VBG O
the DT O
SYBR NNP O
green JJ O
essay NN O
( , O
Applied NNP O
Biosystems NNP O
) -RRB- O
. . O

Reverse VB O
and CC O
forward JJ O
primers NNS O
used VBD O
are VBP O
listed VBN O
below IN O
in IN O
Table NNP O
1 CD O
. . O

Fluorescence NN O
was VBD O
measured VBN O
by IN O
ABIPrism NNP O
7300 CD O
( , O
Applied NNP O
Biosystems NNPS O
) -RRB- O
. . O

The DT O
calculated JJ O
threshold NN O
cycle NN O
( -LRB- O
Ct NNP O
) -RRB- O
value NN O
for IN O
each DT O
gene NN O
of IN O
interest NN O
was VBD O
normalized VBN O
to IN O
the DT O
Ct NNP O
value NN O
for IN O
16S CD O
and CC O
the DT O
fold JJ O
expression NN O
was VBD O
calculated VBN O
using VBG O
the DT O
formula NN O
: : O
fold NN O
change NN O
= SYM O
2 CD O
- HYPH O
Delta NNP O
. . O
( : O
Delta NNP O
Ct NNP O
) -RRB- O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Real JJ O
- HYPH O
time NN O
PCR NNP O
conditions NNS O
include VBP O
initial JJ O
activation NN O
at IN O
94 CD O
degrees NNS O
C NN O
for IN O
5 CD O
min NN O
, , O
followed VBN O
by IN O
40 CD O
cycles NNS O
of IN O
denaturation NN O
at IN O
94 CD O
degrees NNS O
C NN O
for IN O
30 CD O
sec NN O
, , O
annealing NN O
and CC O
extension NN O
at IN O
65 CD O
degrees NNS O
C NN O
for IN O
1 CD O
min NN O
. . O

The DT O
gene NN O
induction NN O
ratios NNS O
were VBD O
obtained VBN O
by IN O
comparing VBG O
gene NN O
expression NN O
levels NNS O
in IN O
intracellular JJ O
bacilli NN O
with IN O
those DT O
of IN O
log NN O
- HYPH O
phase NN O
in IN O
vitro FW O
- HYPH O
grown VBN O
bacilli NN O
. . O

RNAs NNS O
were VBD O
isolated VBN O
from IN O
two CD O
independent JJ O
macrophage NN O
infections NNS O
. . O

In IN O
vitro FW O
human JJ B-Species
granuloma NN O
formation NN O

In IN O
vitro FW O
granulomas NNS O
were VBD O
obtained VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Briefly RB O
, , O
1 CD O
x SYM O
106 CD O
freshly RB O
isolated VBN O
Peripheral NNP O
Blood NNP O
Mononuclear NNP O
Cells NNPS O
( -LRB- O
PBMCs NNP O
) -RRB- O
were VBD O
incubated VBN O
with IN O
1 CD O
x SYM O
104 CD O
viable JJ O
M NN B-Species
. . I-Species
tb NN I-Species
, , O
or CC O
1 CD O
x SYM O
103 CD O
viable JJ O
M NN B-Species
. . I-Species
smegmatis NN I-Species
or CC O
M NN B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NNP O
. . O

The DT O
culture NN O
medium NN O
was VBD O
RPMI NNP O
- HYPH O
1640 CD O
+ SYM O
Glutamax NNP O
( : O
Difco NNP O
) -RRB- O
, , O
containing VBG O
7 CD O
. . O
5 CD O
% NN O
human JJ B-Species
AB NN O
serum NN O
( , O
Sigma NNP O
- HYPH O
Aldrich NNP O
) -RRB- O
. . O

Macrophage NN O
differentiation NN O

2 LS O
. . O
5 CD O
x SYM O
106 CD O
PBMCs NNS O
prepared VBN O
in IN O
RPMI NNP O
- HYPH O
1640 CD O
+ SYM O
Glutamax NNP O
( : O
Difco NNP O
) -RRB- O
were VBD O
plated VBN O
over IN O
coverslips NNS O
in IN O
24 CD O
- HYPH O
well NN O
plates NNS O
. . O

After IN O
2 CD O
h CD O
culture NN O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
cells NNS O
were VBD O
washed VBN O
3 CD O
times NNS O
with IN O
PBS NNP O
and CC O
then RB O
refed VBN O
with IN O
RPMI NNP O
- HYPH O
1640 CD O
+ SYM O
Glutamax NNP O
( : O
Difco NNP O
) -RRB- O
, , O
containing VBG O
7 CD O
. . O
5 CD O
% NN O
human JJ B-Species
AB NN O
serum NN O
. . O

After IN O
6 CD O
days NNS O
of IN O
culturing NN O
, , O
macrophages NNS O
were VBD O
differentiated VBN O
. . O

Respiratory JJ O
burst JJ O
assay NN O
with IN O
Nitroblue NNP O
tetrazolium NN O
( , O
NBT NNP O
) -RRB- O

Human JJ B-Species
monocyte NN O
derived VBN O
macrophages NNS O
were VBD O
stimulated VBN O
with IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NNP O
for IN O
2 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
washed VBN O
and CC O
reincubated VBN O
in IN O
mycobacterium NN O
- HYPH O
free JJ O
medium NN O
. . O

After IN O
2 CD O
days NNS O
of IN O
differentiation NN O
into IN O
FMs NNS O
, , O
macrophages NNS O
were VBD O
co RB O
- HYPH O
stained VBN O
with IN O
NBT NNP O
( : O
2 CD O
mg NN O
/ SYM O
ml NN O
Sigma NNP O
- HYPH O
Aldrich NNP O
) -RRB- O
and CC O
Nile NNP O
red JJ O
( HYPH O
Sigma NNP O
- HYPH O
Aldrich NNP O
) -RRB- O
for IN O
30 CD O
min NN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Stained VBN O
cells NNS O
were VBD O
fixed VBN O
and CC O
then RB O
analysed VBN O
with IN O
an DT O
inverted JJ O
microscope NN O
( , O
Nikon NNP O
TE NNP O
300 CD O
) -RRB- O
. . O

Phagocytosis NN O
and CC O
Survival NN O
test NN O

For IN O
phagocytosis NN O
assays NNS O
, , O
differentiated VBN O
macrophages NNS O
were VBD O
incubated VBN O
with IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NN O
mycolic JJ O
acids NNS O
for IN O
2 CD O
days NNS O
and CC O
then RB O
infected VBN O
with IN O
1 CD O
x SYM O
108 CD O
labeled VBN O
mycobacteria NN O
per IN O
well RB O
for IN O
90 CD O
min NN O
, , O
washed VBN O
3 CD O
times NNS O
with IN O
PBS NNP O
and CC O
chased VBN O
for IN O
3 CD O
h NNS O
in IN O
fresh JJ O
culture NN O
medium NN O
. . O

For IN O
survival NN O
experiments NNS O
, , O
macrophages NNS O
were VBD O
infected VBN O
with IN O
M NNP B-Species
. . I-Species
tuberculosis NN I-Species
- HYPH O
GFP NNP O
( , O
10 CD O
bacteria NNS O
/ SYM O
cell NN O
) -RRB- O
, , O
washed VBN O
3 CD O
times NNS O
with IN O
PBS NNP O
( , O
Gibco NNP O
) -RRB- O
and CC O
re NN O
- HYPH O
incubated VBN O
in IN O
fresh JJ O
culture NN O
medium NN O
. . O

At IN O
selected VBN O
time NN O
points NNS O
thereafter RB O
( , O
1 CD O
, , O
3 CD O
, , O
6 CD O
, , O
10 CD O
and CC O
14 CD O
days NNS O
) , O
cells NNS O
were VBD O
labeled VBN O
with IN O
Nile NNP O
red JJ O
( , O
Sigma NNP O
- HYPH O
Aldrich NNP O
) -RRB- O
, , O
fixed VBN O
and CC O
observed VBN O
under IN O
a DT O
confocal JJ O
microscope NN O
. . O

The DT O
amount NN O
of IN O
mycobacteria NN O
per IN O
cells NNS O
was VBD O
evaluated VBN O
. . O

( , O
100 CD O
cells NNS O
were VBD O
analyzed VBN O
for IN O
each DT O
time NN O
point NN O
) -RRB- O
. . O

Lipid JJ O
body NN O
staining NN O
and CC O
immunostaining VBG O

Granuloma NN O
cells NNS O
were VBD O
collected VBN O
and CC O
plated VBN O
onto IN O
glass NN O
coverslips NNS O
with IN O
a DT O
cytospin NN O
( , O
Thermo NNP O
Shandon NNP O
) , O
fixed VBN O
for IN O
30 CD O
min NN O
in IN O
PBS NNP O
- HYPH O
PFA NNP O
4 CD O
% NN O
and CC O
stained VBN O
with IN O
Oil NNP O
red JJ O
- HYPH O
O NNP O
( HYPH O
Sigma NNP O
- HYPH O
Aldrich NNP O
) -RRB- O
as IN O
described VBN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

The DT O
slides NNS O
were VBD O
then RB O
counterstained VBN O
with IN O
haematoxylin NN O
( , O
Dako NNP O
Cytomation NNP O
) -RRB- O
and CC O
observed VBN O
under IN O
an DT O
inverted JJ O
microscope NN O
( , O
Nikon NNP O
TE NNP O
300 CD O
) -RRB- O
. . O

For IN O
fluorescence NN O
analysis NN O
, , O
granuloma NN O
cells NNS O
or CC O
macrophages NNS O
were VBD O
collected VBN O
in IN O
PBS NNP O
, , O
lipid JJ O
bodies NNS O
were VBD O
stained VBN O
with IN O
Nile NNP O
red JJ O
( , O
Sigma NNP O
- HYPH O
Aldrich NNP O
, , O
0 CD O
. . O
1 CD O
micro NN O
g NN O
/ SYM O
ml NN O
, , O
from IN O
a DT O
stock NN O
solution NN O
in IN O
methanol NN O
) -RRB- O
for IN O
15 CD O
min NN O
washed VBN O
with IN O
PBS NNP O
, , O
fixed VBN O
for IN O
30 CD O
min NN O
in IN O
PBS NNP O
- HYPH O
PFA NNP O
4 CD O
% NN O
, , O
mounted VBN O
with IN O
the DT O
fluorescent NN O
mounting VBG O
medium NN O
( , O
Dako NNP O
Cytomation NNP O
) -RRB- O
and CC O
observed VBN O
under IN O
a DT O
confocal JJ O
microscope NN O
. . O

In IN O
order NN O
to TO O
distinguish VB O
the DT O
lipids NNS O
contained VBN O
within IN O
lipid JJ O
bodies NNS O
, , O
from IN O
those DT O
of IN O
the DT O
cell NN O
membrane NN O
, , O
we PRP O
used VBD O
the DT O
fluorescent JJ O
emission NN O
spectrum NN O
properties NNS O
of IN O
Nile NNP O
red JJ O
which WDT O
depend VBP O
upon IN O
the DT O
kind NN O
of IN O
lipid NN O
associated VBN O
with IN O
Nile NNP O
red JJ O
, , O
i PRP O
. . O
e NFP O
. . O
for IN O
triacylglycerol NN O
: : O
lambda NN O
max NN O
em NN O
= SYM O
590 CD O
nm NN O
, , O
for IN O
phospholipids NNS O
: : O
lambda NN O
max NN O
em NN O
= SYM O
640 CD O
nm NN O
( -LRB- O
Molecular JJ O
Probes NNS O
handbook NN O
) -RRB- O
. . O

On IN O
confocal JJ O
microscopy NN O
pictures NNS O
, , O
the DT O
phospholipid JJ O
background NN O
of IN O
both CC O
macrophages NNS O
and CC O
FM NNP O
appears VBZ O
in IN O
red JJ O
and CC O
the DT O
triacylglycerol NN O
- HYPH O
rich JJ O
lipid JJ O
bodies NNS O
appear VBP O
in IN O
white NN O
. . O

Cells NNS O
were VBD O
considered VBN O
to TO O
be VB O
positive JJ O
for IN O
Nile NNP O
red JJ O
staining NN O
when WRB O
more JJR O
than IN O
50 CD O
% NN O
of IN O
the DT O
cell NN O
surface NN O
was VBD O
stained VBN O
( , O
see VB O
Figure NNP O
S2 NNP O
) -RRB- O
. . O

Mycolic JJ O
acid NN O
isolation NN O

Bacterial JJ O
residues NNS O
obtained VBN O
after IN O
lipid NN O
extraction NN O
with IN O
organic JJ O
solvents NNS O
[ -LRB- O
17 CD O
] -RRB- O
were VBD O
saponified VBN O
with IN O
a DT O
mixture NN O
of IN O
40 CD O
% NN O
KOH NNP O
aqueous JJ O
solution NN O
and CC O
methoxyethanol NN O
( , O
1 CD O
: : O
7 CD O
, , O
v NN O
/ , O
v NN O
) -RRB- O
at IN O
110 CD O
degrees NNS O
C NN O
for IN O
3 CD O
hours NNS O
in IN O
a DT O
screw NN O
- HYPH O
capped VBN O
tube NN O
. . O

After IN O
acidification NN O
, , O
fatty JJ O
acids NNS O
were VBD O
extracted VBN O
with IN O
diethylether NN O
, , O
derivatised VBN O
into IN O
methyl NN O
esters NNS O
with IN O
diazomethane NN O
and CC O
analyzed VBN O
by IN O
analytical JJ O
thin JJ O
- HYPH O
layer NN O
chromatography NN O
on IN O
silica NN O
Gel NNP O
60 CD O
( , O
Silica NNP O
Gel NNP O
60 CD O
Macherey NNP O
- HYPH O
Nagel NNP O
) , O
using VBG O
either CC O
dicholoromethane NN O
or CC O
petroleum NN O
ether NN O
/ SYM O
diethylether NN O
( , O
9 CD O
: SYM O
1 CD O
, , O
v NN O
/ SYM O
v NN O
, , O
five CD O
runs NNS O
) -RRB- O
. . O

Visualization NN O
of IN O
lipid JJ O
spots NNS O
was VBD O
performed VBN O
by IN O
spraying VBG O
the DT O
plates NNS O
with IN O
molybdophosphoric JJ O
acid NN O
( : O
10 CD O
% NN O
in IN O
ethanol NN O
) -RRB- O
, , O
followed VBN O
by IN O
charring NN O
. . O

Processing NN O
for IN O
electron NN O
microscopy NN O

Granulomas NNP O
were VBD O
fixed VBN O
for IN O
1 CD O
hour NN O
at IN O
room NN O
temperature NN O
with IN O
2 CD O
. . O
5 CD O
% NN O
glutaraldehyde NN O
in IN O
0 CD O
. . O
1 CD O
M NN O
cacodylate NN O
buffer NN O
, , O
pH NN O
7 CD O
. . O
2 CD O
, , O
containing VBG O
0 CD O
. . O
1 CD O
M NN O
sucrose NN O
, , O
5 CD O
mM NN O
CaCl2 NN O
and CC O
5 CD O
mM NN O
MgCl2 NN O
. . O

After IN O
two CD O
successive JJ O
15 CD O
- HYPH O
min NN O
washes NNS O
with IN O
the DT O
same JJ O
buffer NN O
, , O
the DT O
granulomas NNS O
were VBD O
postfixed VBN O
for IN O
1 CD O
hour NN O
at IN O
RT NNP O
with IN O
1 CD O
% NN O
osmium NN O
tetroxide NN O
( -LRB- O
Electron NNP O
Microscopy NNP O
Science NNP O
) -RRB- O
in IN O
the DT O
same JJ O
buffer NN O
devoid JJ O
of IN O
sucrose NN O
. . O

The DT O
granulomas NNS O
were VBD O
scraped VBN O
off RP O
the DT O
culture NN O
dishes NNS O
with IN O
a DT O
rubber NN O
policeman NN O
and CC O
concentrated VBN O
in IN O
1 CD O
% NN O
agarose NN O
in IN O
the DT O
same JJ O
buffer NN O
. . O

After IN O
a DT O
one CD O
hour NN O
treatment NN O
at IN O
room NN O
temperature NN O
with IN O
1 CD O
% NN O
uranyl NN O
acetate NN O
in IN O
Veronal JJ O
buffer NN O
, , O
the DT O
samples NNS O
were VBD O
dehydrated VBN O
in IN O
a DT O
graded VBN O
series NN O
of IN O
ethanol NN O
and CC O
embedded VBN O
in IN O
Spurr NNP O
resin NN O
. . O

Thin JJ O
sections NNS O
were VBD O
stained VBN O
with IN O
uranyl NN O
acetate NN O
and CC O
lead NN O
citrate NN O
. . O

Image NN O
acquisition NN O
in IN O
confocal JJ O
microscopy NN O

The DT O
images NNS O
were VBD O
obtained VBN O
using VBG O
a DT O
Leica NNP O
confocal JJ O
fluorescence NN O
microscope NN O
( -LRB- O
SP2 NNP O
) -RRB- O
equipped VBN O
with IN O
a DT O
Plan NNP O
Apo NNP O
40 CD O
x SYM O
1 CD O
. . O
4 CD O
Ph NN O
6 CD O
objective NN O
( : O
Olympus NNP O
Optical NNP O
) -RRB- O
and CC O
CoolSNAP NNP O
- HYPH O
Pro NNP O
CF NNP O
digital JJ O
camera NN O
in IN O
conjunction NN O
with IN O
Image NNP O
- HYPH O
Pro NNP O
Plus CC O
version NN O
4 CD O
. . O
5 CD O
. . O
1 CD O
. . O
3 CD O
software NN O
( : O
Media NNP O
Cybernetics NNP O
) -RRB- O
. . O

The DT O
images NNS O
were VBD O
edited VBN O
using VBG O
Adobe NNP O
Photoshop NNP O
CS2 NNP O
9 CD O
software NN O
( , O
Adobe NNP O
Systems NNP O
) -RRB- O
. . O

Results NNS O

Foamy JJ O
macrophages NNS O
are VBP O
strongly RB O
associated VBN O
with IN O
necrotic JJ O
lesions NNS O
and CC O
often RB O
contain VBP O
M NN B-Species
. . I-Species
tuberculosis NN I-Species

We PRP O
analyzed VBD O
lymph JJ O
node NN O
biopsies NNS O
from IN O
10 CD O
tuberculous JJ O
patients NNS B-Species
as IN O
a DT O
first JJ O
step NN O
for IN O
evaluating VBG O
the DT O
role NN O
of IN O
FMs NNPS O
within IN O
tuberculous JJ O
granulomas NNS O
. . O

A DT O
section NN O
through IN O
a DT O
representative JJ O
biopsy NN O
is VBZ O
shown VBN O
in IN O
Figure NNP O
1 CD O
. . O

Well RB O
- HYPH O
circumscribed VBN O
and CC O
- HYPH O
differentiated VBN O
granulomatous JJ O
structures NNS O
were VBD O
observed VBN O
in IN O
all PDT O
the DT O
samples NNS O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
. . O

Classically RB O
, , O
lesions NNS O
display VBP O
a DT O
necrotic JJ O
center NN O
( , O
N NN O
) -RRB- O
, , O
an DT O
interface NN O
area NN O
between IN O
the DT O
necrotic JJ O
center NN O
and CC O
the DT O
histiocytes NNS O
( , O
I NNP O
) -RRB- O
, , O
and CC O
some DT O
peripheral JJ O
granulomas NNS O
( -LRB- O
G NN O
) -RRB- O
. . O

Only RB O
seven CD O
out IN O
of IN O
ten CD O
patients NNS B-Species
presented VBD O
lesions NNS O
displaying VBG O
central JJ O
necrosis NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

Staining VBG O
of IN O
the DT O
histology NN O
samples NNS O
with IN O
Oil NNP O
red JJ O
- HYPH O
O NNP O
, , O
a DT O
classic JJ O
lipid NN O
stain NN O
, , O
confirmed VBD O
the DT O
presence NN O
of IN O
FMs NNS O
within IN O
the DT O
granulomatous JJ O
structures NNS O
in IN O
six CD O
out IN O
of IN O
seven CD O
samples NNS O
presenting VBG O
necrosis NN O
( -LRB- O
Figure NNP O
1B NN O
) -RRB- O
, , O
whereas IN O
no DT O
FMs NNS O
were VBD O
found VBN O
in IN O
the DT O
three CD O
non JJ O
- HYPH O
necrotic JJ O
lesions NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

Noteworthy JJ O
, , O
in IN O
samples NNS O
with IN O
necrotic JJ O
areas NNS O
, , O
FMs NNPS O
were VBD O
always RB O
found VBN O
in IN O
the DT O
interface NN O
region NN O
flanking VBG O
the DT O
central JJ O
necrosis NN O
( -LRB- O
Figure NNP O
1B NN O
) -RRB- O
. . O

These DT O
observations NNS O
firstly RB O
confirmed VBD O
the DT O
presence NN O
of IN O
FMs NNS O
in IN O
most JJS O
TB NNP O
patients NNS B-Species
' POS O
lesions NNS O
thereby RB O
suggesting VBG O
that IN O
these DT O
cells NNS O
play VBP O
an DT O
important JJ O
role NN O
in IN O
the DT O
formation NN O
/ SYM O
maintenance NN O
of IN O
such JJ O
lesions NNS O
. . O

Second RB O
, , O
FMs NNS O
seem VBP O
to TO O
be VB O
associated VBN O
with IN O
necrosis NN O
, , O
which WDT O
is VBZ O
a DT O
hallmark NN O
of IN O
TB NNP O
lesions NNS O
, , O
since IN O
they PRP O
were VBD O
observed VBN O
only RB O
in IN O
lesions NNS O
with IN O
a DT O
necrotic JJ O
center NN O
and CC O
preferentially RB O
located VBN O
around IN O
the DT O
necrotic JJ O
area NN O
. . O

Interestingly RB O
, , O
staining VBG O
, , O
in IN O
parallel NN O
, , O
of IN O
serial JJ O
thin JJ O
sections NNS O
from IN O
a DT O
patient NN B-Species
' POS O
s NN O
lesion NN O
biopsy NN O
with IN O
Oil NNP O
red JJ O
- HYPH O
O NNP O
( -LRB- O
Figure NNP O
1C NNP O
) -RRB- O
and CC O
Ziehl NNP O
Nielsen NNP O
( -LRB- O
Figure NNP O
1D NNP O
) -RRB- O
, , O
showed VBD O
that IN O
most JJS O
of IN O
the DT O
bacilli NN O
( , O
arrow NN O
) -RRB- O
were VBD O
located VBN O
in IN O
the DT O
same JJ O
area NN O
as IN O
FMs NNS O
, , O
thus RB O
suggesting VBG O
a DT O
strong JJ O
association NN O
between IN O
the DT O
persisting VBG O
tubercle NN O
bacilli NN O
and CC O
FMs NNS O
within IN O
granulomas NNS O
. . O

M NN B-Species
. . I-Species
tuberculosis NN I-Species
induces VBZ O
the DT O
formation NN O
of IN O
FMs NNS O
within IN O
in FW O
vitro FW O
human JJ B-Species
tuberculous JJ O
granulomas NNS O

To TO O
further RB O
characterize VB O
the DT O
role NN O
of IN O
FMs NNPS O
in IN O
the DT O
granulomatous JJ O
response NN O
, , O
we PRP O
assessed VBD O
whether IN O
FM NNP O
formation NN O
in IN O
granulomatous JJ O
structures NNS O
was VBD O
triggered VBN O
only RB O
by IN O
pathogenic JJ O
mycobacterial JJ O
species NNS O
( , O
M NNP B-Species
. . I-Species
tb NN I-Species
) -RRB- O
, , O
or CC O
by IN O
low JJ O
virulent JJ O
ones NNS O
( , O
M NN B-Species
. . I-Species
smegmatis NN I-Species
) -RRB- O
as RB O
well RB O
. . O

PBMCs NNS O
from IN O
non JJ O
- HYPH O
tuberculous JJ O
control NN O
individuals NNS O
were VBD O
infected VBN O
with IN O
M NNP B-Species
. . I-Species
tb NN I-Species
or CC O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
, , O
following VBG O
the DT O
procedure NN O
previously RB O
described VBN O
for IN O
the DT O
induction NN O
of IN O
granulomatous JJ O
structures NNS O
( , O
[ -LRB- O
7 CD O
] -RRB- O
, , O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
Figure NNP O
S1 NNP O
) -RRB- O
. . O

Granuloma NN O
cells NNS O
collected VBN O
at IN O
days NNS O
3 CD O
and CC O
11 CD O
were VBD O
stained VBN O
with IN O
Oil NN O
red JJ O
- HYPH O
O NN O
to TO O
visualize VB O
the DT O
lipid NN O
droplets NNS O
within IN O
FMs NNS O
under IN O
the DT O
light JJ O
microscope NN O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
. . O

At IN O
day NN O
3 CD O
, , O
several JJ O
M NN B-Species
. . I-Species
tb NN I-Species
- HYPH O
induced VBN O
granuloma NN O
cells NNS O
already RB O
showed VBD O
lipid JJ O
bodies NNS O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
the DT O
cells NNS O
collected VBN O
from IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
- HYPH O
induced VBN O
granulomas NNS O
were VBD O
seldom RB O
( : O
5 CD O
% NN O
) -RRB- O
positively RB O
stained VBN O
( -LRB- O
Figure NN O
2B NN O
) -RRB- O
. . O

Interestingly RB O
, , O
M NNP B-Species
. . I-Species
avium NN I-Species
induced VBN O
FM NN O
formation NN O
in IN O
a DT O
similar JJ O
way NN O
to IN O
M NNP B-Species
. . I-Species
tb NN I-Species
( : O
not RB O
shown VBN O
) NFP O
. . O

By IN O
day NN O
11 CD O
, , O
the DT O
amount NN O
of IN O
positively RB O
stained VBN O
cells NNS O
had VBD O
increased VBN O
in IN O
M NNP B-Species
. . I-Species
tb NN I-Species
- HYPH O
induced VBN O
granulomas NNS O
, , O
but CC O
not RB O
in IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
- HYPH O
induced VBN O
ones NNS O
. . O

In IN O
addition NN O
, , O
the DT O
number NN O
of IN O
lipid JJ O
bodies NNS O
per IN O
cell NN O
increased VBD O
dramatically RB O
with IN O
time NN O
, , O
as IN O
depited VBN O
in IN O
the DT O
enlarged JJ O
views NNS O
( , O
Figures NNPS O
2A NNP O
, , O
C NNP O
) -RRB- O
. . O

The DT O
quantitative JJ O
evaluation NN O
of IN O
the DT O
percentage NN O
of IN O
FMs NNPS O
within IN O
granulomas NNS O
induced VBN O
by IN O
both DT O
strains NNS O
confirmed VBD O
the DT O
differences NNS O
observed VBN O
under IN O
the DT O
light JJ O
microscope NN O
, , O
and CC O
showed VBD O
a DT O
seven CD O
- HYPH O
fold NN O
difference NN O
( : O
44 CD O
% NN O
vs IN O
6 CD O
% NN O
respectively RB O
) -RRB- O
between IN O
M NN B-Species
. . I-Species
tb NN I-Species
and CC O
M NN B-Species
. . I-Species
smegmatis NN I-Species
in IN O
terms NNS O
of IN O
their PRP$ O
ability NN O
to TO O
induce VB O
FM NN O
formation NN O
( -LRB- O
Figure NN O
2D NN O
) -RRB- O
. . O

Our PRP$ O
results NNS O
therefore RB O
show VBP O
that IN O
virulent JJ O
species NNS O
such JJ O
as IN O
M NNP B-Species
. . I-Species
tb NNP I-Species
and CC O
M NNP B-Species
. . I-Species
avium NN I-Species
, , O
contrary JJ O
to IN O
poorly RB O
or CC O
avirulent JJ O
ones NNS O
such JJ O
as IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
, , O
are VBP O
able JJ O
to TO O
induce VB O
the DT O
formation NN O
of IN O
FMs NNPS O
within IN O
our PRP$ O
experimental JJ O
model NN O
. . O

Oxygenated JJ O
mycolic JJ O
acids NNS O
induce VBP O
the DT O
maturation NN O
of IN O
macrophages NNS O
into IN O
FMs NNP O

Mycolic JJ O
acids NNS O
from IN O
M NNP B-Species
. , I-Species
tb NN I-Species
incorporated VBD O
into IN O
liposomes NNS O
were VBD O
recently RB O
shown VBN O
to TO O
trigger VB O
the DT O
differentiation NN O
of IN O
mice NN B-Species
peritoneal JJ O
macrophages NNS O
into IN O
foamy JJ O
- HYPH O
like JJ O
cells NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
both CC O
M NNP B-Species
. . I-Species
tb NN I-Species
and CC O
M NN B-Species
. . I-Species
avium NN I-Species
, , O
which WDT O
induce VBP O
FM NN O
formation NN O
, , O
express VBP O
a DT O
family NN O
of IN O
oxygenated VBN O
mycolic JJ O
acids NNS O
, , O
especially RB O
ketomycolic JJ O
acids NNS O
, , O
which WDT O
are VBP O
not RB O
produced VBN O
by IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
. . O

In IN O
this DT O
context NN O
, , O
inactivation NN O
of IN O
the DT O
M NNP B-Species
. . I-Species
tb NNP I-Species
hma NN O
gene NN O
( , O
mmaA4 NNP O
- HYPH O
Rv0642c NN O
) -RRB- O
was VBD O
shown VBN O
to TO O
abolish VB O
the DT O
synthesis NN O
of IN O
oxygenated VBN O
keto NN O
- HYPH O
and CC O
hydroxyl NN O
- HYPH O
mycolic NN O
acid NN O
in IN O
the DT O
mutant JJ O
strain NN O
[ -LRB- O
17 CD O
] -RRB- O
. . O

Conversely RB O
, , O
transforming VBG O
M NNP B-Species
. . I-Species
smegmatis NNS I-Species
with IN O
the DT O
hma NN O
gene NN O
induced VBD O
the DT O
production NN O
of IN O
both DT O
keto NN O
- HYPH O
and CC O
hydroxyl NN O
- HYPH O
mycolic NN O
acids NNS O
[ -LRB- O
22 CD O
] -RRB- O
, , O
( , O
Figures NNS O
3B NN O
, , O
C NNP O
) -RRB- O
. . O

In IN O
the DT O
light NN O
of IN O
both DT O
data NNS O
, , O
we PRP O
anticipated VBD O
that IN O
oxygenated VBN O
mycolic JJ O
acids NNS O
specifically RB O
produced VBN O
by IN O
M NNP B-Species
. . I-Species
tb NNP I-Species
and CC O
M NNP B-Species
. , I-Species
avium NN I-Species
, , O
under IN O
the DT O
control NN O
of IN O
hma NN O
, , O
are VBP O
responsible JJ O
for IN O
FM NNP O
formation NN O
within IN O
human JJ B-Species
granulomas NNS O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
we PRP O
compared VBD O
FM NNP O
formation NN O
after IN O
infection NN O
of IN O
PBMCs NNS O
with IN O
either CC O
the DT O
wild JJ O
- HYPH O
type NN O
, , O
or CC O
the DT O
hma NN O
- HYPH O
expressing VBG O
M NN B-Species
. . I-Species
smegmatis NN I-Species
strain NN O
( , O
M NN B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NNP O
) -RRB- O
. . O

Granulomas NNP O
cells NNS O
were VBD O
collected VBN O
3 CD O
days NNS O
later RB O
and CC O
stained VBN O
with IN O
Oil NN O
red NN O
- HYPH O
O NN O
to TO O
visualize VB O
lipid JJ O
bodies NNS O
. . O

Wild JJ O
- HYPH O
type NN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
- HYPH O
induced VBN O
granulomas NNS O
displayed VBN O
only RB O
5 CD O
. . O
5 CD O
% NN O
of IN O
FM NNP O
, , O
whereas IN O
the DT O
hma NN O
gene NN O
- HYPH O
expressing VBG O
strain NN O
induced VBN O
granulomas NNS O
bearing VBG O
a DT O
majority NN O
( , O
67 CD O
% NN O
) , O
of IN O
brightly RB O
stained VBN O
Oil NN O
red JJ O
- HYPH O
O NN O
positive JJ O
cells NNS O
( -LRB- O
Figures NNS O
4A NN O
, , O
B NN O
, , O
C NNP O
) -RRB- O
. . O

Induction NN O
of IN O
FM NNP O
formation NN O
was VBD O
even RB O
greater JJR O
if IN O
isolated VBN O
macrophages NNS O
were VBD O
directly RB O
infected VBN O
with IN O
either DT O
strain NN O
. . O

After IN O
only RB O
4 CD O
hours NNS O
of IN O
infection NN O
, , O
M NN B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NNP O
had VBD O
already RB O
transformed VBN O
64 CD O
% NN O
of IN O
the DT O
infected VBN O
macrophages NNS O
into IN O
lipid JJ O
body NN O
- HYPH O
positive JJ O
cells NNS O
( , O
see VB O
Figure NNP O
S2 NNP O
for IN O
Nile NNP O
red JJ O
positive JJ O
cells NNS O
) -RRB- O
, , O
whereas IN O
only RB O
9 CD O
% NN O
of IN O
the DT O
cells NNS O
contained VBD O
lipid JJ O
bodies NNS O
after IN O
infection NN O
with IN O
the DT O
wild JJ O
- HYPH O
type NN O
strain NN O
( -LRB- O
Figures NNS O
4D NN O
, , O
E NNP O
, , O
F NNP O
) -RRB- O
. . O

To TO O
confirm VB O
the DT O
specific JJ O
role NN O
of IN O
hma NN O
- HYPH O
dependent JJ O
oxygenated VBN O
mycolic JJ O
acids NNS O
in IN O
FM NNP O
formation NN O
, , O
and CC O
to TO O
rule VB O
out RP O
a DT O
possible JJ O
combined VBN O
effect NN O
of IN O
oxygenated VBN O
mycolic NN O
- HYPH O
acids NNS O
with IN O
other JJ O
mycobacterial JJ O
components NNS O
, , O
mycolic JJ O
acids NNS O
isolated VBN O
from IN O
wild JJ O
- HYPH O
type NN O
M NN B-Species
. . I-Species
smegmatis NN I-Species
or CC O
M NN B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NNP O
were VBD O
incubated VBN O
with IN O
isolated VBN O
macrophages NNS O
. . O

With IN O
mycolic JJ O
acids NNS O
isolated VBN O
from IN O
the DT O
wild JJ O
- HYPH O
type NN O
strain NN O
, , O
only RB O
13 CD O
% NN O
of IN O
the DT O
macrophages NNS O
were VBD O
transformed VBN O
into IN O
FM NNP O
whereas IN O
66 CD O
% NN O
of IN O
the DT O
macrophages NNS O
incubated VBN O
with IN O
mycolic JJ O
acids NNS O
isolated VBN O
from IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NNP O
were VBD O
strongly RB O
stained VBN O
for IN O
lipid JJ O
bodies NNS O
( -LRB- O
Figures NNS O
4G NNP O
, , O
H NNP O
, , O
I NNP O
) -RRB- O
. . O

These DT O
results NNS O
therefore RB O
indicate VBP O
that IN O
oxygenated JJ O
mycolic JJ O
acids NNS O
play VBP O
a DT O
leading JJ O
role NN O
in IN O
M NNP B-Species
. . I-Species
tb NN I-Species
- HYPH O
induced VBN O
FM NN O
formation NN O
. . O

The DT O
phagocytic JJ O
and CC O
bactericidal JJ O
activities NNS O
are VBP O
arrested VBN O
in IN O
FMs NNP O

To TO O
assess VB O
the DT O
function NN O
of IN O
granuloma NN O
FM NN O
, , O
we PRP O
first RB O
evaluated VBD O
the DT O
ability NN O
of IN O
such JJ O
cells NNS O
to TO O
mediate VB O
phagocytosis NN O
. . O

For IN O
this DT O
purpose NN O
, , O
macrophages NNS O
isolated VBN O
from IN O
PBMCs NNPS O
were VBD O
exposed VBN O
to IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
/ SYM O
hma NN O
- HYPH O
derived VBN O
mycolic JJ O
acids NNS O
to TO O
induce VB O
FM NN O
formation NN O
. . O

Two CD O
days NNS O
later RBR O
, , O
the DT O
cell NN O
population NN O
contained VBD O
a DT O
mixture NN O
of IN O
FM NNP O
( , O
50 CD O
- SYM O
70 CD O
% NN O
) -RRB- O
and CC O
macrophages NNS O
( , O
30 CD O
- SYM O
50 CD O
% NN O
) -RRB- O
, , O
as IN O
assessed VBN O
by IN O
Nile NNP O
red JJ O
staining NN O
( , O
not RB O
shown VBN O
) NFP O
. . O

The DT O
mixed JJ O
cell NN O
population NN O
was VBD O
infected VBN O
with IN O
FITC NNP O
- HYPH O
labelled VBN O
M NNP B-Species
. . I-Species
smegmatis NNP I-Species
. . O

Intracellular JJ O
bacilli NN O
were VBD O
found VBN O
only RB O
within IN O
Nile NNP O
red JJ O
- HYPH O
negative JJ O
macrophages NNS O
thereby RB O
indicating VBG O
that IN O
FMs NNS O
are VBP O
unable JJ O
to TO O
ingest VB O
bacteria NNS O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

This DT O
result NN O
was VBD O
reproduced VBN O
using VBG O
other JJ O
mycobacterial JJ O
strains NNS O
, , O
such JJ O
as IN O
M NNP B-Species
. . I-Species
tb NN I-Species
and CC O
M NNP B-Species
. . I-Species
bovis NNP I-Species
BCG NNP I-Species
, , O
for IN O
infection NN O
( , O
not RB O
shown VBN O
) NFP O
. . O

These DT O
results NNS O
further RB O
suggest VBP O
that IN O
the DT O
bacilli NN O
found VBN O
in IN O
granuloma NN O
FMs NNS O
were VBD O
internalized VBN O
by IN O
macrophages NNS O
prior RB O
to IN O
their PRP$ O
transformation NN O
into IN O
FMs NNPS O
. . O

To TO O
assess VB O
whether IN O
FMs NNS O
are VBP O
able JJ O
to TO O
develop VB O
a DT O
respiratory JJ O
burst NN O
, , O
which WDT O
is VBZ O
a DT O
major JJ O
intracellular JJ O
bactericidal JJ O
activity NN O
, , O
the DT O
ability NN O
of IN O
Nile NNP O
red JJ O
positive JJ O
cells NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
FMs NNS O
) -RRB- O
to TO O
mediate VB O
NBT NNP O
reduction NN O
was VBD O
determined VBN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
5D CD O
, , O
only RB O
8 CD O
% NN O
of IN O
the DT O
NBT NNP O
- HYPH O
positive JJ O
cells NNS O
( -LRB- O
Figure NNP O
5B NNP O
) -RRB- O
were VBD O
Nile NNP O
red JJ O
positive JJ O
FMs NNS O
( -LRB- O
Figure NNP O
5C NNP O
) -RRB- O
. . O

This DT O
strongly RB O
suggests VBZ O
that IN O
once IN O
macrophages NNS O
have VBP O
differentiated VBN O
into IN O
FMs NNP O
, , O
they PRP O
lose VBP O
the DT O
ability NN O
to TO O
mediate VB O
intracellular JJ O
bactericidal JJ O
activity NN O
. . O

We PRP O
postulate VBP O
that IN O
FMs NNPS O
could MD O
, , O
therefore RB O
, , O
form VB O
a DT O
secure JJ O
reservoir NN O
for IN O
the DT O
tubercle NN O
bacilli NN O
. . O

M NN B-Species
. . I-Species
tuberculosis NN I-Species
persists VBZ O
in IN O
a DT O
dormant JJ O
non AFX O
- HYPH O
replicative JJ O
state NN O
in IN O
FMs NNP O

To TO O
evaluate VB O
the DT O
validity NN O
of IN O
the DT O
above JJ O
hypothesis NN O
, , O
we PRP O
analyzed VBD O
the DT O
ability NN O
of IN O
M NNP B-Species
. . I-Species
tb NN I-Species
to TO O
replicate VB O
within IN O
FMs NNP O
. . O

For IN O
this DT O
purpose NN O
, , O
isolated VBN O
macrophages NNS O
were VBD O
infected VBN O
with IN O
M NNP B-Species
. . I-Species
tb NNP I-Species
. . O

At IN O
selected VBN O
intervals NNS O
post NN O
- HYPH O
infection NN O
, , O
the DT O
amount NN O
of IN O
bacilli NN O
per IN O
cell NN O
was VBD O
compared VBN O
in IN O
both CC O
non NN O
- HYPH O
differentiated VBN O
macrophages NNS O
and CC O
FMs NNS O
( -LRB- O
Figure NNP O
5E CD O
) -RRB- O
. . O

Until IN O
day NN O
6 CD O
, , O
M NNP B-Species
. . I-Species
tb NN I-Species
replicated VBD O
in IN O
a DT O
similar JJ O
fashion NN O
in IN O
both DT O
cell NN O
types NNS O
. . O

In IN O
contrast NN O
, , O
after IN O
day NN O
6 CD O
post NN O
- HYPH O
infection NN O
, , O
the DT O
amount NN O
of IN O
bacilli NN O
remained VBD O
stationary JJ O
in IN O
FMs NNP O
, , O
whereas IN O
it PRP O
continued VBD O
to TO O
increase VB O
in IN O
macrophages NNS O
. . O

It PRP O
is VBZ O
interesting JJ O
to TO O
note VB O
that IN O
arrest NN O
of IN O
bacterial JJ O
replication NN O
coincided VBD O
with IN O
completion NN O
of IN O
macrophage NN O
differentiation NN O
into IN O
FM NN O
, , O
i LS O
. . O
e NFP O
. . O
starting VBG O
from IN O
day NN O
3 CD O
post NN O
- HYPH O
infection NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
, , O
that IN O
the DT O
bacilli NN O
found VBN O
in IN O
granuloma NN O
FMs NNS O
were VBD O
internalized VBN O
by IN O
macrophages NNS O
prior RB O
to IN O
their PRP$ O
differentiation NN O
into IN O
FMs NNS O
and CC O
also RB O
that IN O
bacilli NNS O
can MD O
terminate VB O
their PRP$ O
replication NN O
cycle NN O
while IN O
macrophages NNS O
are VBP O
being VBG O
transformed VBN O
into IN O
FM NNP O
, , O
but CC O
that DT O
replication NN O
comes VBZ O
to IN O
a DT O
halt NN O
as RB O
soon RB O
as IN O
the DT O
maturation NN O
process NN O
is VBZ O
complete JJ O
. . O

We PRP O
next RB O
determined VBD O
whether IN O
the DT O
non AFX O
- HYPH O
replicative JJ O
bacilli NN O
observed VBD O
in IN O
FMs NNPS O
were VBD O
still RB O
alive JJ O
. . O

For IN O
this DT O
purpose NN O
, , O
we PRP O
analyzed VBD O
the DT O
expression NN O
of IN O
a DT O
series NN O
of IN O
genes NNS O
known VBN O
to TO O
be VB O
up RB O
- HYPH O
regulated VBN O
when WRB O
bacilli NN O
are VBP O
in IN O
a DT O
persistent JJ O
non AFX O
- HYPH O
replicating VBG O
state NN O
[ -LRB- O
23 CD O
] -RRB- O
, , O
[ -LRB- O
24 CD O
] -RRB- O
. . O

RNA NNP O
was VBD O
, , O
therefore RB O
, , O
prepared VBN O
from IN O
both CC O
in IN O
vitro FW O
- HYPH O
grown VBN O
M NN B-Species
. . I-Species
tb NN I-Species
and CC O
intracellular JJ O
bacilli NN O
at IN O
day NN O
6 CD O
and CC O
12 CD O
post NN O
- HYPH O
infection NN O
. . O

The DT O
respective JJ O
amounts NNS O
of IN O
RNA NNP O
corresponding VBG O
to TO O
isocitrate VB O
lyase NN O
, , O
alpha NN O
- HYPH O
cristallin NN O
, , O
a DT O
very RB O
hypothetical JJ O
7 CD O
. . O
6 CD O
kDa NN O
protein NN O
, , O
CHP NNP O
and CC O
DosR NNP O
proteins NNS O
were VBD O
then RB O
quantified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
. . O

As IN O
shown VBN O
in IN O
Table NNP O
3 CD O
, , O
the DT O
dormancy JJ O
genes NNS O
were VBD O
all RB O
strongly RB O
up RB O
- HYPH O
regulated VBN O
in IN O
intracellular JJ O
bacilli NN O
at IN O
day NN O
12 CD O
post NN O
- HYPH O
infection NN O
. . O

These DT O
results NNS O
further RB O
demonstrate VBP O
that IN O
the DT O
bacilli NNS O
are VBP O
not RB O
killed VBN O
in IN O
FMs NNPS O
, , O
but CC O
rather RB O
persist VBP O
in IN O
a DT O
dormant JJ O
, , O
and CC O
therefore RB O
non RB O
- HYPH O
replicative JJ O
stage NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
the DT O
dormancy NN O
genes NNS O
were VBD O
not RB O
as RB O
strongly RB O
expressed VBN O
at IN O
day NN O
6 CD O
, , O
time NN O
at IN O
which WDT O
bacteria NNS O
were VBD O
still RB O
able JJ O
to TO O
replicate VB O
in IN O
macrophages NNS O
undergoing VBG O
differentiation NN O
into IN O
FMs NNPS O
. . O

Characterization NN O
of IN O
M NNP B-Species
. . I-Species
tb NN I-Species
survival NN O
within IN O
FMs NNS O
and CC O
interaction NN O
with IN O
lipid JJ O
bodies NNS O

To TO O
gain VB O
further JJ O
insight NN O
into IN O
the DT O
morphological JJ O
appearance NN O
of IN O
M NNP B-Species
. . I-Species
tb NN I-Species
within IN O
FM NNP O
and CC O
into IN O
the DT O
interactions NNS O
between IN O
FM NNP O
lipid NN O
bodies NNS O
( , O
LB NNP O
) -RRB- O
and CC O
M NNP B-Species
. . I-Species
tb NN I-Species
- HYPH O
containing VBG O
phagosomes NNS O
, , O
granulomas NNS O
were VBD O
fixed VBN O
and CC O
processed VBN O
for IN O
conventional JJ O
electron NN O
microscopy NN O
at IN O
days NNS O
3 CD O
and CC O
11 CD O
post NN O
- HYPH O
infection NN O
. . O

Whatever WDT O
the DT O
time NN O
point NN O
at IN O
which WDT O
granuloma NN O
cells NNS O
were VBD O
observed VBN O
, , O
bacteria NNS O
were VBD O
all DT O
enclosed VBN O
in IN O
phagosomes NNS O
, , O
most JJS O
of IN O
which WDT O
contained VBD O
a DT O
single JJ O
bacterium NN O
. . O

None NN O
of IN O
them PRP O
( , O
over IN O
a DT O
thousand CD O
which WDT O
were VBD O
examined VBN O
under IN O
the DT O
electron NN O
microscope NN O
) -RRB- O
were VBD O
free JJ O
in IN O
the DT O
cytoplasm NN O
and CC O
only RB O
one CD O
was VBD O
enclosed VBN O
in IN O
a DT O
classical JJ O
autophagic JJ O
vacuole NN O
. . O

At IN O
day NN O
3 CD O
post NN O
- HYPH O
infection NN O
, , O
FMs NNP O
profiles NNS O
( , O
thin JJ O
sections NNS O
) -RRB- O
were VBD O
scarce JJ O
, , O
representing VBG O
at IN O
most JJS O
9 CD O
% NN O
of IN O
the DT O
total JJ O
population NN O
of IN O
macrophage NN O
profiles NNS O
observed VBN O
under IN O
the DT O
electron NN O
microscope NN O
( -LRB- O
Figure NNP O
6A NNP O
) -RRB- O
. . O

In IN O
addition NN O
, , O
86 CD O
% NN O
of IN O
the DT O
FM NN O
profiles NNS O
displayed VBD O
at IN O
most JJS O
5 CD O
small JJ O
LBs NNP O
( -LRB- O
Figure NNP O
6B NNP O
) -RRB- O
. . O

At IN O
this DT O
stage NN O
of IN O
granuloma NN O
formation NN O
, , O
bacteria NNS O
were VBD O
infrequent JJ O
in IN O
FM NNP O
, , O
but CC O
were VBD O
found VBN O
in IN O
other JJ O
types NNS O
of IN O
macrophages NNS O
. . O

One CD O
of IN O
these DT O
displayed VBD O
large JJ O
numbers NNS O
of IN O
vacuoles NNS O
containing VBG O
flocculent JJ O
material NN O
and CC O
often RB O
one CD O
or CC O
two CD O
LBs NNS O
. . O

Over IN O
95 CD O
% NN O
of IN O
the DT O
bacteria NNS O
located VBN O
in IN O
the DT O
different JJ O
granuloma NN O
macrophages NNS O
were VBD O
morphologically RB O
intact JJ O
, , O
and CC O
therefore RB O
alive JJ O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Intact JJ O
bacteria NNS O
present VBP O
no DT O
breaks NNS O
in IN O
the DT O
cell NN O
wall NN O
or CC O
cytoplasmic JJ O
membrane NN O
and CC O
their PRP$ O
cytoplasm NN O
has VBZ O
preserved VBN O
its PRP$ O
ultrastructural JJ O
organization NN O
and CC O
electron NN O
opacity NN O
. . O

Furthermore RB O
, , O
they PRP O
display VBP O
no DT O
electron NN O
translucent JJ O
intracytoplasmic JJ O
lipid NN O
inclusions NNS O
( , O
ILI NNP O
) -RRB- O
. . O

Bacteria NNS O
were VBD O
also RB O
observed VBN O
in IN O
between IN O
cells NNS O
, , O
probably RB O
as IN O
a DT O
result NN O
of IN O
cell NN O
lysis NN O
within IN O
granulomas NNS O
. . O

These DT O
bacteria NNS O
were VBD O
also RB O
morphologically RB O
intact JJ O
and CC O
devoid JJ O
of IN O
ILI NNP O
( , O
not RB O
shown VBN O
) NFP O
. . O

At IN O
day NN O
11 CD O
post NN O
- HYPH O
infection NN O
, , O
M NNP B-Species
. . I-Species
tb NN I-Species
- HYPH O
containing VBG O
macrophages NNS O
displaying VBG O
large JJ O
numbers NNS O
of IN O
vacuoles NNS O
with IN O
flocculent JJ O
material NN O
were VBD O
less RBR O
frequently RB O
observed VBN O
. . O

Interestingly RB O
, , O
the DT O
amount NN O
of IN O
such JJ O
vacuoles NNS O
had VBD O
strongly RB O
decreased VBN O
in IN O
most JJS O
of IN O
these DT O
cells NNS O
while IN O
the DT O
number NN O
of IN O
LBs NNP O
had VBD O
increased VBN O
. . O

The DT O
percentage NN O
of IN O
FM NNP O
had VBD O
increased VBN O
to TO O
reach VB O
41 CD O
% NN O
of IN O
the DT O
total JJ O
population NN O
of IN O
macrophage NN O
profiles NNS O
within IN O
the DT O
granulomas NN O
( -LRB- O
Figure NNP O
6A NNP O
) -RRB- O
. . O

From IN O
these DT O
observations NNS O
, , O
it PRP O
is VBZ O
tempting JJ O
to TO O
assume VB O
that IN O
the DT O
highly RB O
vesiculated VBN O
macrophages NNS O
give VBP O
rise NN O
to IN O
FMs NNPS O
. . O

Within IN O
FMs NNP O
, , O
the DT O
size NN O
and CC O
amount NN O
of IN O
LBs NNPS O
had VBD O
also RB O
increased VBN O
with IN O
time NN O
since IN O
48 CD O
% NN O
of IN O
the DT O
FM NNP O
profiles NNS O
now RB O
displayed VBD O
more JJR O
than IN O
5 CD O
LB NN O
per IN O
FM NN O
thin JJ O
section NN O
( -LRB- O
Figure NNP O
6B NNP O
) -RRB- O
, , O
randomly RB O
distributed VBN O
within IN O
the DT O
cells NNS O
( -LRB- O
Figure NNP O
6C NNP O
) -RRB- O
. . O

About RB O
30 CD O
% NN O
of IN O
the DT O
FM NNP O
profiles NNS O
displayed VBD O
between IN O
1 CD O
and CC O
20 CD O
bacteria NNS O
, , O
which WDT O
were VBD O
morphologically RB O
intact JJ O
and CC O
enclosed VBN O
within IN O
phagosomes NNS O
( , O
Figure NNP O
6C NNP O
, , O
enlarged JJ O
view NN O
) -RRB- O
. . O

The DT O
interaction NN O
between IN O
these DT O
bacteria NNS O
and CC O
the DT O
cellular JJ O
LBs NNP O
was VBD O
next RB O
examined VBN O
at IN O
day NN O
11 CD O
. . O

Sixty CD O
percent NN O
of IN O
the DT O
bacilli NNS O
were VBD O
scattered VBN O
throughout IN O
the DT O
FMs NNPS O
and CC O
displayed VBD O
no DT O
obvious JJ O
signs NNS O
of IN O
interaction NN O
with IN O
the DT O
cellular JJ O
LBs NNP O
. . O

A DT O
small JJ O
fraction NN O
of IN O
the DT O
bacteria NNS O
( : O
21 CD O
% NN O
) -RRB- O
, , O
however RB O
, , O
were VBD O
observed VBN O
in IN O
the DT O
close JJ O
vicinity NN O
of IN O
cellular JJ O
LBs NNP O
. . O

The DT O
membrane NN O
of IN O
the DT O
phagosomes NNS O
in IN O
which WDT O
they PRP O
were VBD O
enclosed VBN O
clearly RB O
interacted VBD O
with IN O
cellular JJ O
LBs NNP O
( -LRB- O
Figures NNP O
6C NNP O
, , O
7A NNP O
, , O
7B NNP O
, , O
arrows NNS O
) -RRB- O
and CC O
became VBD O
tightly RB O
apposed VBN O
to IN O
an DT O
increasingly RB O
larger JJR O
surface NN O
area NN O
of IN O
the DT O
LB NNP O
. . O

As IN O
a DT O
result NN O
, , O
the DT O
phagosomes NNS O
started VBD O
to TO O
surround VB O
LBs NNP O
in IN O
a DT O
zippering VBG O
fashion NN O
( , O
Figures NNS O
7E CD O
, , O
F NNP O
) -RRB- O
. . O

Ultimately RB O
, , O
bacilli NN O
( : O
19 CD O
% NN O
) -RRB- O
were VBD O
translocated VBN O
to IN O
cellular JJ O
LBs NNP O
( -LRB- O
Figure NNP O
7C NNP O
) -RRB- O
. . O

From IN O
these DT O
observations NNS O
, , O
it PRP O
is VBZ O
tempting JJ O
to TO O
assume VB O
that IN O
M NNP B-Species
. . I-Species
tb NN I-Species
- HYPH O
containing VBG O
phagosomes NNS O
engulf VBP O
cellular JJ O
LBs NNS O
rather RB O
than IN O
fusing VBG O
with IN O
them PRP O
. . O

This DT O
process NN O
, , O
which WDT O
is VBZ O
reminiscent JJ O
of IN O
autophagy NN O
, , O
resulted VBD O
in IN O
the DT O
transfer NN O
of IN O
free JJ O
bacteria NNS O
into IN O
the DT O
lumen NN O
of IN O
cellular JJ O
LBs NNP O
( -LRB- O
Figure NNP O
7C NNP O
) -RRB- O
, , O
some DT O
of IN O
which WDT O
displayed VBD O
up IN O
to TO O
21 CD O
bacteria NNS O
( -LRB- O
Figure NNP O
7G NNP O
) -RRB- O
. . O

Interestingly RB O
, , O
only RB O
altered VBN O
M NNP B-Species
. . I-Species
tb NN I-Species
found VBN O
within IN O
FM NNP O
lipid NN O
bodies NNS O
exhibited VBN O
electron NN O
translucent JJ O
ILIs NNP O
( , O
Figures NNP O
7D NNP O
, , O
G NNP O
) -RRB- O
, , O
thereby RB O
suggesting VBG O
that IN O
they PRP O
are VBP O
able JJ O
to TO O
accumulate VB O
host NN O
cell NN O
lipids NNS O
. . O

In IN O
previous JJ O
work NN O
, , O
the DT O
term NN O
altered VBN O
bacteria NNS O
had VBD O
been VBN O
used VBN O
to TO O
define VB O
live JJ O
bacteria NNS O
that WDT O
had VBD O
acquired VBN O
ILIs NNP O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Since IN O
the DT O
presence NN O
of IN O
ILIs NNS O
within IN O
the DT O
cytoplasm NN O
of IN O
M NNP B-Species
. . I-Species
tb NN I-Species
is VBZ O
typical JJ O
for IN O
non NN O
- HYPH O
replicating VBG O
bacteria NNS O
in IN O
a DT O
state NN O
of IN O
dormancy NN O
[ -LRB- O
27 CD O
] -RRB- O
, , O
this DT O
further RB O
confirms VBZ O
that IN O
these DT O
bacteria NNS O
are VBP O
dormant JJ O
. . O

Discussion NN O

Studies NNS O
carried VBN O
out RP O
several JJ O
decades NNS O
ago RB O
suggested VBD O
that IN O
postprimary JJ O
tuberculosis NN O
starts VBZ O
as IN O
a DT O
lipid JJ O
pneumonia NN O
[ -LRB- O
28 CD O
] -RRB- O
, , O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Indeed RB O
, , O
following VBG O
a DT O
first JJ O
inflammatory JJ O
process NN O
leading VBG O
to IN O
exudates NNS O
of IN O
mononuclear JJ O
cells NNS O
within IN O
alveolar JJ O
spaces NNS O
, , O
early JJ O
pathologists NNS O
observed VBD O
an DT O
accumulation NN O
of IN O
lipid JJ O
droplets NNS O
in IN O
alveolar JJ O
macrophages NNS O
of IN O
TB NNP O
patients NNS B-Species
. . O

Tubercle NNP O
bacilli NN O
were VBD O
shown VBN O
to TO O
reside VB O
in IN O
these DT O
lipid JJ O
- HYPH O
rich JJ O
macrophages NNS O
which WDT O
were VBD O
named VBN O
foamy JJ O
macrophages NNS O
( , O
FMs NNS O
) -RRB- O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Recently RB O
, , O
histo JJ O
- HYPH O
pathological JJ O
analysis NN O
of IN O
biopsies NNS O
from IN O
patients NNS B-Species
with IN O
untreated JJ O
tuberculosis NN O
confirmed VBD O
the DT O
century NN O
- HYPH O
old JJ O
histological JJ O
descriptions NNS O
of IN O
postprimary JJ O
tuberculosis NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
Hunter NNP O
et VBD O
al NNP O
showed VBD O
that IN O
postprimary JJ O
tuberculosis NN O
begins VBZ O
as IN O
a DT O
lipid JJ O
pneumonia NN O
with IN O
the DT O
accumulation NN O
of IN O
large JJ O
amounts NNS O
of IN O
lipid JJ O
- HYPH O
rich JJ O
FMs NNS O
, , O
accompanied VBN O
by IN O
bronchial JJ O
obstruction NN O
. . O

It PRP O
was VBD O
also RB O
shown VBN O
that IN O
in IN O
alveolar JJ O
foamy JJ O
macrophages NNS O
, , O
the DT O
bacilli NNS O
were VBD O
mainly RB O
found VBN O
within IN O
lipid JJ O
droplets NNS O
. . O

All PDT O
these DT O
observations NNS O
underline VBP O
the DT O
important JJ O
, , O
yet CC O
often RB O
neglected VBN O
, , O
role NN O
of IN O
lipid NN O
accumulation NN O
, , O
and CC O
more RBR O
precisely RB O
FM NNP O
formation NN O
, , O
at IN O
the DT O
infectious JJ O
site NN O
in IN O
the DT O
physiopathology NN O
of IN O
TB NN O
. . O

In IN O
murine JJ O
experimental JJ O
models NNS O
, , O
FMs NNPS O
accumulate VBP O
within IN O
the DT O
outermost JJ O
layer NN O
of IN O
granulomatous JJ O
structures NNS O
occupying VBG O
the DT O
alveolar JJ O
spaces NNS O
during IN O
the DT O
chronic JJ O
phase NN O
of IN O
infection NN O
. . O

This DT O
strongly RB O
suggests VBZ O
that IN O
FMs NNPS O
could MD O
be VB O
involved VBN O
in IN O
lesion NN O
cleaning NN O
via IN O
phagocytic JJ O
uptake NN O
of IN O
cellular JJ O
debris NN O
generated VBN O
by IN O
the DT O
local JJ O
inflammatory JJ O
response NN O
. . O

Once RB O
filled VBN O
with IN O
debris NN O
, , O
FMs NNPS O
would MD O
leave VB O
the DT O
parenchyma NN O
through IN O
the DT O
alveolar JJ O
spaces NNS O
up IN O
to IN O
the DT O
superior JJ O
bronchial NN O
tree NN O
, , O
to TO O
be VB O
finally RB O
swallowed VBN O
and CC O
digested VBN O
in IN O
the DT O
stomach NN O
[ -LRB- O
31 CD O
] -RRB- O
. . O

In IN O
fact NN O
, , O
this DT O
process NN O
is VBZ O
very RB O
well RB O
known JJ O
, , O
and CC O
is VBZ O
a DT O
crucial JJ O
factor NN O
for IN O
TB NN O
diagnosis NN O
in IN O
children NNS B-Species
. . O

As IN O
infants NNS B-Species
do VBP O
not RB O
usually RB O
generate VB O
cavitary JJ O
lesions NNS O
, , O
and CC O
because IN O
it PRP O
is VBZ O
difficult JJ O
to TO O
detect VB O
bacilli NN O
in IN O
the DT O
sputum NN O
, , O
the DT O
diagnosis NN O
is VBZ O
linked VBN O
to IN O
the DT O
detection NN O
of IN O
bacilli NN O
in IN O
the DT O
gastrointestinal JJ O
lavage NN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

We PRP O
show VBP O
that IN O
M NNP B-Species
. . I-Species
tb NN I-Species
- HYPH O
induced VBN O
the DT O
transformation NN O
of IN O
in FW O
vitro FW O
- HYPH O
grown VBN O
human JJ B-Species
granuloma NN O
macrophages NNS O
into IN O
FMs NNS O
within IN O
6 CD O
days NNS O
, , O
and CC O
even RB O
more RBR O
rapidly RB O
( : O
3 CD O
- SYM O
4 CD O
hours NNS O
) -RRB- O
in IN O
cultured JJ O
macrophages NNS O
. . O

Although IN O
this DT O
event NN O
occurs VBZ O
more RBR O
quickly RB O
than IN O
in IN O
vivo NN O
, , O
or CC O
in IN O
animal NN O
models NNS O
, , O
our PRP$ O
data NNS O
are VBP O
consistent JJ O
with IN O
the DT O
above JJ O
in IN O
vivo NN O
observations NNS O
. . O

Within IN O
FMs NNS O
, , O
bacilli NNS O
and CC O
LBs NNP O
were VBD O
often RB O
tightly RB O
linked VBN O
, , O
to IN O
the DT O
point NN O
that IN O
a DT O
non AFX O
- HYPH O
negligible JJ O
amount NN O
of IN O
bacteria NNS O
were VBD O
ultimately RB O
observed VBN O
within IN O
LBs NNP O
. . O

Interestingly RB O
, , O
some DT O
of IN O
the DT O
bacilli NNS O
transferred VBN O
into IN O
lipid JJ O
bodies NNS O
displayed VBD O
their PRP$ O
own JJ O
intracytoplasmic JJ O
lipid NN O
inclusions NNS O
, , O
which WDT O
are VBP O
considered VBN O
to TO O
be VB O
one CD O
of IN O
the DT O
hallmarks NNS O
of IN O
non AFX O
- HYPH O
replicating VBG O
( , O
dormant JJ O
) , O
M NNP B-Species
. . I-Species
tb NN I-Species
[ -LRB- O
27 CD O
] -RRB- O
. . O

The DT O
recent JJ O
observation NN O
of IN O
persistent JJ O
ILI NNP O
- HYPH O
containing VBG O
tubercle NN O
bacilli NN O
within IN O
adipocyte NN O
LBs NNP O
[ -LRB- O
33 CD O
] -RRB- O
is VBZ O
in IN O
good JJ O
agreement NN O
with IN O
our PRP$ O
observations NNS O
. . O

Since IN O
bacilli NN O
residing VBG O
in IN O
phagosomes NNS O
that WDT O
do VBP O
not RB O
interact VB O
with IN O
cellular JJ O
lipid NN O
bodies NNS O
do VBP O
not RB O
display VB O
ILIs NNP O
, , O
it PRP O
is VBZ O
tempting JJ O
to TO O
assume VB O
that IN O
lipids NNS O
within IN O
ILIs NNS O
are VBP O
of IN O
cellular JJ O
origin NN O
. . O

The DT O
accumulation NN O
of IN O
lipids NNS O
within IN O
bacilli NN O
[ -LRB- O
47 CD O
] -RRB- O
, , O
via IN O
interaction NN O
with IN O
FM NNP O
lipid NN O
bodies NNS O
could MD O
, , O
therefore RB O
, , O
be VB O
crucial JJ O
to IN O
M NNP B-Species
. . I-Species
tb IN I-Species
persistence NN O
. . O

It PRP O
is VBZ O
indeed RB O
known VBN O
that IN O
M NNP B-Species
. . I-Species
tb NN I-Species
accumulates VBZ O
lipids NNS O
, , O
and CC O
more RBR O
precisely RB O
triacylglycerols NNS O
, , O
during IN O
dormancy NN O
[ -LRB- O
34 CD O
] -RRB- O
, , O
[ -LRB- O
35 CD O
] -RRB- O
from IN O
which WDT O
it PRP O
derives VBZ O
both CC O
carbon NN O
and CC O
energy NN O
for IN O
its PRP$ O
own JJ O
metabolism NN O
. . O

Intracellular JJ O
persistence NN O
of IN O
M NNP B-Species
. , I-Species
tb NN I-Species
is VBZ O
also RB O
critically RB O
linked VBN O
to IN O
the DT O
acquisition NN O
of IN O
host NN O
cholesterol NN O
through IN O
the DT O
Mce4 NNP O
transporter NN O
system NN O
[ -LRB- O
36 CD O
] -RRB- O
. . O

The DT O
question NN O
that WDT O
arises VBZ O
is VBZ O
how WRB O
do VBP O
bacteria NNS O
gain VB O
access NN O
to IN O
lipids NNS O
from IN O
LB NNP O
? . O

Direct JJ O
fusion NN O
of IN O
phagosomes NNS O
with IN O
FM NNP O
lipid NN O
bodies NNS O
seems VBZ O
unlikely JJ O
as IN O
the DT O
membranes NNS O
of IN O
both DT O
structures NNS O
are VBP O
quite RB O
different JJ O
from IN O
one NN O
another DT O
. . O

Our PRP$ O
observations NNS O
suggest VBP O
instead RB O
that IN O
once RB O
M NNP B-Species
. . I-Species
tb NN I-Species
- HYPH O
containing VBG O
phagosomes NNS O
have VBP O
established VBN O
close JJ O
contact NN O
with IN O
a DT O
lipid JJ O
body NN O
, , O
they PRP O
surround VBP O
and CC O
engulf VBP O
the DT O
latter JJ O
by IN O
a DT O
process NN O
that WDT O
remains VBZ O
to TO O
be VB O
deciphered VBN O
. . O

This DT O
phenomenon NN O
is VBZ O
somewhat RB O
reminiscent JJ O
of IN O
autophagy NN O
, , O
as IN O
observed VBN O
under IN O
conditions NNS O
of IN O
cholesterol NN O
depletion NN O
in IN O
macrophages NNS O
infected VBN O
with IN O
M NNP B-Species
. . I-Species
avium NN I-Species
[ -LRB- O
37 CD O
] -RRB- O
. . O

After IN O
degradation NN O
of IN O
the DT O
resulting VBG O
inner JJ O
membrane NN O
, , O
bacteria NNS O
would MD O
be VB O
freed VBN O
within IN O
the DT O
lipids NNS O
of IN O
the DT O
engulfed VBN O
LB NNP O
, , O
and CC O
therefore RB O
be VB O
in IN O
direct JJ O
contact NN O
with IN O
cellular JJ O
lipids NNS O
. . O

How WRB O
bacilli JJ O
translocate VBP O
the DT O
cellular JJ O
lipids NNS O
to IN O
their PRP$ O
own JJ O
cytoplasm NN O
remains VBZ O
to TO O
be VB O
established VBN O
. . O

Another DT O
important JJ O
phenomenon NN O
underlined VBD O
by IN O
our PRP$ O
study NN O
is VBZ O
the DT O
strong JJ O
correlation NN O
between IN O
the DT O
presence NN O
of IN O
FMs NNPS O
in IN O
the DT O
granulomatous JJ O
structures NNS O
and CC O
the DT O
development NN O
of IN O
necrosis NN O
within IN O
the DT O
lesion NN O
, , O
as IN O
suggested VBN O
by IN O
Pagel NNP O
over IN O
80 CD O
years NNS O
ago RB O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
FMs NNS O
were VBD O
systematically RB O
located VBN O
at IN O
the DT O
interface NN O
region NN O
between IN O
the DT O
histiocytes NNS O
and CC O
the DT O
central JJ O
necrosis NN O
area NN O
of IN O
the DT O
biopsied VBN O
lesions NNS O
. . O

Although IN O
necrosis JJ O
formation NN O
could MD O
depend VB O
on IN O
an DT O
indirect JJ O
effect NN O
of IN O
the DT O
global JJ O
immune JJ O
response NN O
, , O
our PRP$ O
data NNS O
indicate VBP O
that IN O
the DT O
formation NN O
of IN O
FMs NNPS O
is VBZ O
an DT O
important JJ O
factor NN O
favoring VBG O
the DT O
appearance NN O
of IN O
necrosis NN O
. . O

Analysis NN O
of IN O
larger JJR O
series NN O
of IN O
biopsy NN O
samples NNS O
are VBP O
, , O
however RB O
, , O
needed VBN O
to TO O
definitely RB O
demonstrate VB O
our PRP$ O
actual JJ O
hypothesis NN O
according VBG O
to IN O
which WDT O
FMs NNPS O
play VBP O
a DT O
direct JJ O
and CC O
unique JJ O
role NN O
in IN O
necrosis NN O
formation NN O
. . O

Consistent JJ O
with IN O
this DT O
hypothesis NN O
, , O
we PRP O
observed VBD O
that IN O
FMs NNPS O
induced VBD O
from IN O
M NNP B-Species
. . I-Species
tb NN I-Species
- HYPH O
infected VBN O
macrophages NNS O
displayed VBD O
permanent JJ O
TNF NNP O
- HYPH O
alpha NN O
secretion NN O
, , O
a DT O
potent JJ O
pro JJ O
- HYPH O
necrotic JJ O
factor NN O
, , O
whereas IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
- HYPH O
infected VBN O
macrophages NNS O
were VBD O
poor JJ O
producers NNS O
of IN O
TNF NNP O
- HYPH O
alpha NN O
. . O

At IN O
day NN O
4 CD O
post NN O
- HYPH O
infection NN O
, , O
TNF NNP O
- HYPH O
alpha NN O
secretion NN O
was VBD O
indeed RB O
twofold RB O
higher JJR O
in IN O
macrophages NNS O
( , O
of IN O
which WDT O
70 CD O
% NN O
had VBD O
differentiated VBN O
into IN O
FMs NNPS O
) , O
infected VBN O
with IN O
M NNP B-Species
. . I-Species
tb NN I-Species
than IN O
in IN O
those DT O
infected VBN O
with IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
, , O
as IN O
measured VBN O
both CC O
by IN O
ELISA NNP O
and CC O
RNA NNP O
quantification NN O
( , O
Peyron NNP O
, , O
unpublished JJ O
observations NNS O
) -RRB- O
. . O

However RB O
, , O
one PRP O
must MD O
keep VB O
in IN O
mind NN O
that IN O
the DT O
association NN O
of IN O
FMs NNS O
and CC O
necrosis NN O
may MD O
be VB O
the DT O
consequence NN O
of IN O
the DT O
FM NNP O
cleaning NN O
process NN O
of IN O
lipoproteins NNS O
released VBN O
into IN O
the DT O
necrotic JJ O
tissue NN O
, , O
as IN O
observed VBN O
in IN O
atherosclerosis NN O
lesions NNS O
[ -LRB- O
38 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
thus RB O
tempting JJ O
to TO O
propose VB O
that IN O
M NNP B-Species
. . I-Species
tb IN I-Species
mycolic JJ O
acids NNS O
may MD O
be VB O
responsible JJ O
for IN O
the DT O
development NN O
of IN O
necrotic JJ O
lesions NNS O
, , O
due IN O
to IN O
their PRP$ O
ability NN O
to TO O
induce VB O
TNF NNP O
- HYPH O
alpha NN O
production NN O
by IN O
FMs NNPS O
. . O

Whether IN O
mycolic JJ O
acids NNS O
are VBP O
directly RB O
involved VBN O
in IN O
TNF NNP O
- HYPH O
alpha NN O
production NN O
, , O
or CC O
only RB O
indirectly RB O
by IN O
inducing VBG O
FM NN O
formation NN O
, , O
remains VBZ O
a DT O
matter NN O
of IN O
debate NN O
currently RB O
under IN O
study NN O
. . O

Our PRP$ O
observations NNS O
are VBP O
strikingly RB O
similar JJ O
to IN O
the DT O
phenomena NN O
described VBN O
for IN O
postprimary JJ O
tuberculosis NN O
, , O
that WDT O
seems VBZ O
to TO O
begin VB O
as IN O
localized JJ O
foci NN O
of IN O
pneumonia NN O
followed VBN O
by IN O
massive JJ O
necrosis NN O
leading VBG O
to IN O
the DT O
formation NN O
of IN O
pulmonary JJ O
cavities NNS O
[ -LRB- O
10 CD O
] -RRB- O
. . O

If IN O
this DT O
proves VBZ O
to TO O
be VB O
the DT O
case NN O
, , O
then RB O
the DT O
traditionally RB O
admitted VBN O
phenomenon NN O
of IN O
cavitation NN O
arising VBG O
from IN O
the DT O
erosion NN O
of IN O
caseating VBG O
granulomatous JJ O
structures NNS O
from IN O
bronchi NN O
can MD O
be VB O
ruled VBN O
out RP O
[ -LRB- O
39 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
study NN O
, , O
we PRP O
successfully RB O
induced VBD O
FM NNP O
formation NN O
from IN O
isolated VBN O
macrophages NNS O
infected VBN O
with IN O
M NNP B-Species
. . I-Species
tb UH I-Species
, , O
i PRP O
. . O
e NFP O
. . O
outside IN O
a DT O
granulomatous JJ O
structure NN O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
Hunter NNP O
' POS O
s POS O
recent JJ O
proposal NN O
. . O

Until IN O
now RB O
, , O
mycolic JJ O
acids NNS O
have VBP O
been VBN O
considered VBN O
to TO O
be VB O
indirectly RB O
involved VBN O
in IN O
virulence NN O
mechanisms NNS O
as IN O
being VBG O
part NN O
of IN O
complex JJ O
molecules NNS O
of IN O
the DT O
mycobacterial JJ O
envelope NN O
. . O

The DT O
most RBS O
widely RB O
studied VBN O
mycolic JJ O
acid NN O
- HYPH O
containing VBG O
mycobacterial JJ O
compound NN O
trehalose NN O
6 CD O
, , O
6 CD O
' POS O
dimycolate NN O
( , O
TDM NNP O
) -RRB- O
, , O
has VBZ O
been VBN O
extensively RB O
analyzed VBN O
for IN O
its PRP$ O
role NN O
in IN O
virulence NN O
since IN O
the DT O
mid JJ O
- HYPH O
fifties NNS O
[ -LRB- O
40 CD O
] -RRB- O
. . O

Recently RB O
, , O
it PRP O
was VBD O
shown VBN O
to TO O
interfere VB O
with IN O
the DT O
host NN O
granulomatous JJ O
response NN O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Overall RB O
, , O
TDM NNP O
was VBD O
mainly RB O
shown VBN O
to TO O
mediate VB O
macrophage NN O
activation NN O
and CC O
a DT O
Th1 NN O
- HYPH O
type NN O
response NN O
to IN O
M NN B-Species
. . I-Species
tb NN I-Species
infection NN O
( , O
for IN O
review NN O
, , O
see VB O
[ -LRB- O
25 CD O
] -RRB- O
) -RRB- O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
a DT O
direct JJ O
role NN O
of IN O
oxygenated JJ O
mycolic JJ O
acids NNS O
for IN O
FM NN O
formation NN O
, , O
independently RB O
from IN O
the DT O
appearance NN O
and CC O
stage NN O
of IN O
the DT O
disease NN O
. . O

M NN B-Species
. . I-Species
tb NN I-Species
- HYPH O
specific JJ O
mycolic JJ O
acids NNS O
indeed RB O
trigger VBP O
the DT O
transformation NN O
of IN O
both CC O
isolated VBN O
and CC O
granuloma NN O
macrophages NNS O
, , O
into IN O
FM NN O
. . O

Given VBN O
the DT O
absence NN O
of IN O
FM NNP O
formation NN O
in IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
- HYPH O
induced VBN O
granulomas NNS O
, , O
despite IN O
the DT O
induction NN O
of IN O
a DT O
comparative JJ O
inflammatory JJ O
response NN O
, , O
ascertained VBN O
by IN O
the DT O
similar JJ O
induction NN O
of IN O
granulomas NNS O
, , O
this DT O
phenomenon NN O
clearly RB O
depends VBZ O
upon IN O
a DT O
direct JJ O
contact NN O
with IN O
the DT O
bacilli NN O
, , O
and CC O
not RB O
to IN O
the DT O
inflammatory JJ O
response NN O
. . O

Mycolic JJ O
acids NNS O
are VBP O
major JJ O
and CC O
hallmark JJ O
components NNS O
of IN O
the DT O
mycobacterial JJ O
cell NN O
wall NN O
. . O

They PRP O
constitute VBP O
40 CD O
- SYM O
60 CD O
% NN O
of IN O
dry JJ O
weight NN O
of IN O
the DT O
envelope NN O
[ -LRB- O
42 CD O
] -RRB- O
. . O

All DT O
members NNS O
of IN O
the DT O
complex NN O
( : O
e LS O
. . O
g LS O
. . O
M NN B-Species
. . I-Species
tb NN I-Species
, , O
Mycobacterium NN B-Species
africanum NN I-Species
, , O
Mycobacterium NN B-Species
bovis NN I-Species
and CC O
Mycobacterium NN B-Species
microti NN I-Species
) -RRB- O
are VBP O
able JJ O
to TO O
synthesize VB O
the DT O
same JJ O
combination NN O
of IN O
mycolic JJ O
acids NNS O
, , O
i LS O
. . O
e LS O
. . O
cyclopropanated VBN O
alpha NN O
- HYPH O
mycolic NN O
acids NNS O
, , O
ketomycolic NN O
and CC O
methoxymycolic NN O
acids NNS O
[ -LRB- O
17 CD O
] -RRB- O
, , O
which WDT O
are VBP O
not RB O
synthesized VBN O
by IN O
non JJ O
- HYPH O
pathogenic JJ O
mycobacterial JJ O
species NNS O
[ -LRB- O
43 CD O
] -RRB- O
. . O

These DT O
structural JJ O
specificities NNS O
probably RB O
account VBP O
for IN O
part NN O
of IN O
the DT O
pathogenicity NN O
of IN O
these DT O
species NNS O
, , O
as IN O
shown VBN O
by IN O
the DT O
impaired JJ O
virulence NN O
of IN O
mutant JJ O
strains NNS O
deprived VBN O
of IN O
keto NN O
and CC O
methoxyl NN O
groups NNS O
in IN O
experimental JJ O
infections NNS O
[ -LRB- O
17 CD O
] -RRB- O
, , O
[ -LRB- O
44 CD O
] -RRB- O
, , O
[ -LRB- O
45 CD O
] -RRB- O
. . O

Our PRP$ O
study NN O
, , O
therefore RB O
, , O
gives VBZ O
the DT O
first JJ O
proof NN O
of IN O
a DT O
direct JJ O
role NN O
of IN O
isolated VBN O
mycolic JJ O
acids NNS O
in IN O
the DT O
interplay NN O
between IN O
M NNP B-Species
. . I-Species
tb NN I-Species
and CC O
host NN O
cells NNS O
. . O

Interestingly RB O
, , O
this DT O
effect NN O
is VBZ O
expressed VBN O
both CC O
by IN O
whole JJ O
bacilli NN O
and CC O
isolated VBN O
lipids NNS O
, , O
suggesting VBG O
that IN O
oxygenated JJ O
mycolic JJ O
acids NNS O
are VBP O
either CC O
secreted VBN O
by IN O
the DT O
bacilli NN O
, , O
or CC O
exposed VBN O
at IN O
the DT O
cell NN O
wall NN O
surface NN O
in IN O
a DT O
manner NN O
enabling VBG O
their PRP$ O
bioactivity NN O
. . O

According VBG O
to IN O
our PRP$ O
results NNS O
, , O
mycolic JJ O
acids NNS O
trigger VBP O
the DT O
formation NN O
, , O
within IN O
granulomas NNS O
, , O
of IN O
FMs NNS O
in IN O
which WDT O
bacilli NN O
can MD O
hide VB O
and CC O
survive VB O
. . O

Oxygenated JJ O
mycolic JJ O
acids NNS O
, , O
either CC O
free JJ O
, , O
as IN O
constituents NNS O
of IN O
TDM NNP O
[ -LRB- O
44 CD O
] -RRB- O
, , O
or CC O
linked VBN O
to IN O
the DT O
cell NN O
wall NN O
arabinogalactan NN O
[ -LRB- O
46 CD O
] -RRB- O
, , O
[ -LRB- O
47 CD O
] -RRB- O
, , O
should MD O
, , O
therefore RB O
, , O
be VB O
considered VBN O
as IN O
major JJ O
virulence NN O
factors NNS O
enabling VBG O
M NNP B-Species
. . I-Species
tb NN I-Species
survival NN O
for IN O
long JJ O
periods NNS O
of IN O
time NN O
in IN O
a DT O
persistent JJ O
state NN O
. . O

Being VBG O
an DT O
inducer NN O
of IN O
host NN O
lipid NN O
accumulation NN O
, , O
and CC O
FM NN O
formation NN O
at IN O
the DT O
site NN O
of IN O
infection NN O
, , O
these DT O
oxygenated JJ O
mycolic JJ O
acids NNS O
could MD O
, , O
therefore RB O
, , O
also RB O
be VB O
responsible JJ O
for IN O
the DT O
induction NN O
of IN O
necrosis NN O
within IN O
lesions NNS O
, , O
thus RB O
favoring VBG O
M NNP B-Species
. . I-Species
tb NNP I-Species
dissemination NN O
. . O

Interestingly RB O
, , O
deletion NN O
of IN O
the DT O
mmaA4 NN O
( -LRB- O
Rv0642c NNP O
) -RRB- O
gene NN O
also RB O
drastically RB O
decreased VBD O
the DT O
ability NN O
of IN O
M NNP B-Species
. . I-Species
tb NN I-Species
to TO O
induce VB O
the DT O
differentiation NN O
of IN O
macrophages NNS O
into IN O
FMs NNPS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

However RB O
, , O
the DT O
residual JJ O
ability NN O
of IN O
this DT O
mutant NN O
to TO O
induce VB O
FMs NNP O
suggests VBZ O
that IN O
other JJ O
mycobacterial JJ O
factors NNS O
might MD O
partially RB O
trigger VB O
the DT O
formation NN O
of IN O
FM NN O
. . O

With IN O
regard NN O
to IN O
the DT O
mycolic JJ O
acid NN O
methyltransferases NNS O
, , O
given VBN O
that IN O
( , O
i PRP O
) , O
mmaA2 NN O
( -LRB- O
Rv0644c NNP O
) -RRB- O
and CC O
mmaA3 NN O
( -LRB- O
Rv0643c NNP O
) -RRB- O
are VBP O
pseudogenes NNS O
in IN O
M NNP B-Species
. . I-Species
leprae NN I-Species
and CC O
( , O
ii FW O
) -RRB- O
mmaA4 NN O
KO NN O
present JJ O
no DT O
trans NN O
cyclopropanation NN O
[ -LRB- O
45 CD O
] -RRB- O
, , O
thus RB O
excluding VBG O
the DT O
involvement NN O
of IN O
the DT O
cmaA2 NN O
( -LRB- O
Rv0503c NN O
) -RRB- O
gene NN O
, , O
we PRP O
expect VBP O
that IN O
at IN O
least JJS O
pcaA NN O
( , O
Rv0470c NNP O
) -RRB- O
, , O
which WDT O
introduces VBZ O
cis NN O
- HYPH O
cyclopropane NN O
, , O
may MD O
play VB O
the DT O
same JJ O
role NN O
. . O

Consistent JJ O
with IN O
this DT O
hypothesis NN O
, , O
a DT O
pcaA NN O
null JJ O
mutant NN O
is VBZ O
unable JJ O
to TO O
persist VB O
within IN O
infected JJ O
mice NNS B-Species
[ -LRB- O
46 CD O
] -RRB- O
, , O
thus RB O
demonstrating VBG O
the DT O
role NN O
of IN O
a DT O
mycolic JJ O
acid NN O
methyltransferase NN O
in IN O
the DT O
chronic JJ O
stage NN O
of IN O
infection NN O
. . O

Overall RB O
, , O
our PRP$ O
study NN O
has VBZ O
shed VBN O
light NN O
on IN O
a DT O
previously RB O
uncharacterized JJ O
cell NN O
population NN O
participating VBG O
in IN O
human JJ B-Species
tuberculous JJ O
granulomas NNS O
, , O
namely RB O
foamy JJ O
macrophages NNS O
. . O

We PRP O
propose VBP O
that IN O
the DT O
specific JJ O
induction NN O
of IN O
FM NNP O
by IN O
M NNP B-Species
. . I-Species
tb NNP I-Species
would MD O
create VB O
a DT O
favourable JJ O
environment NN O
for IN O
persistent JJ O
bacteria NNS O
. . O

In IN O
our PRP$ O
opinion NN O
, , O
FMs NNP O
could MD O
be VB O
a DT O
safe JJ O
shelter NN O
because IN O
they PRP O
preserve VBP O
bacilli NN O
from IN O
a DT O
direct JJ O
contact NN O
with IN O
granuloma NN O
lymphocytes NNS O
and CC O
histiocytes NNS O
, , O
they PRP O
lose VBP O
one CD O
of IN O
the DT O
major JJ O
macrophage NN O
bactericidal JJ O
activities NNS O
and CC O
they PRP O
constitute VBP O
an DT O
important JJ O
source NN O
of IN O
nutrients NNS O
for IN O
the DT O
bacilli NN O
thanks NNS O
to IN O
the DT O
fatty NN O
acids NNS O
accumulated VBN O
in IN O
their PRP$ O
lipid JJ O
granules NNS O
. . O

Supporting VBG O
Information NN O

A DT O
Case NN O
- HYPH O
Control NN O
Study NN O
to TO O
Assess VB O
the DT O
Relationship NN O
between IN O
Poverty NNP O
and CC O
Visual NNP O
Impairment NNP O
from IN O
Cataract NNP O
in IN O
Kenya NNP O
, , O
the DT O
Philippines NNPS O
, , O
and CC O
Bangladesh NNP O

Abstract JJ O

Background NN O

The DT O
link NN O
between IN O
poverty NN O
and CC O
health NN O
is VBZ O
central JJ O
to IN O
the DT O
Millennium NNP O
Development NNP O
Goals NNPS O
( -LRB- O
MDGs NNP O
) -RRB- O
. . O

Poverty NN O
can MD O
be VB O
both CC O
a DT O
cause NN O
and CC O
consequence NN O
of IN O
poor JJ O
health NN O
, , O
but CC O
there EX O
are VBP O
few JJ O
epidemiological JJ O
studies NNS O
exploring VBG O
this DT O
complex JJ O
relationship NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
examine VB O
the DT O
association NN O
between IN O
visual JJ O
impairment NN O
from IN O
cataract NN O
and CC O
poverty NN O
in IN O
adults NNS O
in IN O
Kenya NNP O
, , O
Bangladesh NNP O
, , O
and CC O
the DT O
Philippines NNPS O
. . O

Methods NNS O
and CC O
Findings NNS O

A DT O
population NN O
- HYPH O
based VBN O
case NN O
- HYPH O
control NN O
study NN O
was VBD O
conducted VBN O
in IN O
three CD O
countries NNS O
during IN O
2005 CD O
- SYM O
2006 CD O
. . O

Cases NNS O
were VBD O
persons NNS B-Species
aged VBN O
50 CD O
y NN O
or CC O
older JJR O
and CC O
visually RB O
impaired VBN O
due IN O
to IN O
cataract NN O
( , O
visual JJ O
acuity NN O
< : O
6 CD O
/ SYM O
24 CD O
in IN O
the DT O
better JJR O
eye NN O
) -RRB- O
. . O

Controls NNS O
were VBD O
persons NNS B-Species
age NN O
- HYPH O
and CC O
sex NN O
- HYPH O
matched VBN O
to IN O
the DT O
case NN O
participants NNS B-Species
with IN O
normal JJ O
vision NN O
selected VBN O
from IN O
the DT O
same JJ O
cluster NN O
. . O

Household NN O
expenditure NN O
was VBD O
assessed VBN O
through IN O
the DT O
collection NN O
of IN O
detailed JJ O
consumption NN O
data NNS O
, , O
and CC O
asset NN O
ownership NN O
and CC O
self NN O
- HYPH O
rated VBN O
wealth NN O
were VBD O
also RB O
measured VBN O
. . O

In IN O
total NN O
, , O
596 CD O
cases NNS O
and CC O
535 CD O
controls NNS O
were VBD O
included VBN O
in IN O
these DT O
analyses NNS O
( , O
Kenya NNP O
142 CD O
cases NNS O
, , O
75 CD O
controls NNS O
; : O
Bangladesh NNP O
216 CD O
cases NNS O
, , O
279 CD O
controls NNS O
; : O
Philippines NNP O
238 CD O
cases NNS O
, , O
180 CD O
controls NNS O
) -RRB- O
. . O

Case NN O
participants NNS B-Species
were VBD O
more RBR O
likely JJ O
to TO O
be VB O
in IN O
the DT O
lowest JJS O
quartile NN O
of IN O
per IN O
capita NN O
expenditure NN O
( , O
PCE NNP O
) -RRB- O
compared VBN O
to IN O
controls NNS O
in IN O
Kenya NNP O
( : O
odds NNS O
ratio NN O
= SYM O
2 CD O
. . O
3 CD O
, , O
95 CD O
% NN O
confidence NN O
interval NN O
0 CD O
. . O
9 CD O
- SYM O
5 CD O
. . O
5 CD O
) -RRB- O
, , O
Bangladesh NNP O
( : O
1 CD O
. . O
9 CD O
, , O
1 CD O
. . O
1 CD O
- SYM O
3 CD O
. . O
2 CD O
) -RRB- O
, , O
and CC O
the DT O
Philippines NNP O
( , O
3 CD O
. . O
1 CD O
, , O
1 CD O
. . O
7 CD O
- SYM O
5 CD O
. . O
7 CD O
) -RRB- O
, , O
and CC O
there EX O
was VBD O
significant JJ O
dose NN O
- HYPH O
response NN O
relationship NN O
across IN O
quartiles NNS O
of IN O
PCE NNP O
. . O

These DT O
associations NNS O
persisted VBD O
after IN O
adjustment NN O
for IN O
self NN O
- HYPH O
rated VBN O
health NN O
and CC O
social JJ O
support NN O
indicators NNS O
. . O

A DT O
similar JJ O
pattern NN O
was VBD O
observed VBN O
for IN O
the DT O
relationship NN O
between IN O
cataract NN O
visual JJ O
impairment NN O
with IN O
asset NN O
ownership NN O
and CC O
self NN O
- HYPH O
rated VBN O
wealth NN O
. . O

There EX O
was VBD O
no DT O
consistent JJ O
pattern NN O
of IN O
association NN O
between IN O
PCE NNP O
and CC O
level NN O
of IN O
visual JJ O
impairment NN O
due IN O
to IN O
cataract NN O
, , O
sex NN O
, , O
or CC O
age NN O
among IN O
the DT O
three CD O
countries NNS O
. . O

Conclusions NNS O

Our PRP$ O
data NNS O
show VBP O
that IN O
people NNS B-Species
with IN O
visual JJ O
impairment NN O
due JJ O
to IN O
cataract NN O
were VBD O
poorer JJR O
than IN O
those DT O
with IN O
normal JJ O
sight NN O
in IN O
all DT O
three CD O
low JJ O
- HYPH O
income NN O
countries NNS O
studied VBN O
. . O

The DT O
MDGs NNPS O
are VBP O
committed JJ O
to IN O
the DT O
eradication NN O
of IN O
extreme JJ O
poverty NN O
and CC O
provision NN O
of IN O
health NN O
care NN O
to IN O
poor JJ O
people NNS B-Species
, , O
and CC O
this DT O
study NN O
highlights VBZ O
the DT O
need NN O
for IN O
increased VBN O
provision NN O
of IN O
cataract NN O
surgery NN O
to IN O
poor JJ O
people NNS B-Species
, , O
as IN O
they PRP O
are VBP O
particularly RB O
vulnerable JJ O
to IN O
visual JJ O
impairment NN O
from IN O
cataract NN O
. . O

Background NN O
. . O

Globally RB O
, , O
about RB O
45 CD O
million CD O
people NNS B-Species
are VBP O
blind JJ O
. . O

As IN O
with IN O
many JJ O
other JJ O
conditions NNS O
, , O
avoidable JJ O
blindness NN O
( , O
preventable JJ O
or CC O
curable JJ O
blindness NN O
) -RRB- O
is VBZ O
a DT O
particular JJ O
problem NN O
for IN O
people NNS B-Species
in IN O
developing VBG O
countries NNS O
- : O
- : O
90 CD O
% NN O
of IN O
blind JJ O
people NNS B-Species
live VBP O
in IN O
poor JJ O
regions NNS O
of IN O
the DT O
world NN O
. . O

Although IN O
various JJ O
infections NNS O
and CC O
disorders NNS O
can MD O
cause VB O
blindness NN O
, , O
cataract NN O
is VBZ O
the DT O
most RBS O
common JJ O
cause NN O
. . O

In IN O
cataract NN O
, , O
which WDT O
is VBZ O
responsible JJ O
for IN O
half NN O
of IN O
all DT O
cases NNS O
of IN O
blindness NN O
in IN O
the DT O
world NN O
, , O
the DT O
lens NN O
of IN O
the DT O
eye NN O
gradually RB O
becomes VBZ O
cloudy JJ O
. . O

Because IN O
the DT O
lens NN O
focuses VBZ O
light NN O
to TO O
produce VB O
clear JJ O
, , O
sharp JJ O
images NNS O
, , O
as IN O
cataract NN O
develops VBZ O
, , O
vision NN O
becomes VBZ O
increasingly RB O
foggy JJ O
or CC O
fuzzy JJ O
, , O
colors NNS O
become VBP O
less RBR O
intense JJ O
, , O
and CC O
the DT O
ability NN O
to TO O
see VB O
shapes NNS O
against IN O
a DT O
background NN O
declines VBZ O
. . O

Eventually RB O
, , O
vision NN O
may MD O
be VB O
lost VBN O
completely RB O
. . O

Cataract NN O
can MD O
be VB O
treated VBN O
with IN O
an DT O
inexpensive JJ O
, , O
simple JJ O
operation NN O
in IN O
which WDT O
the DT O
cloudy JJ O
lens NN O
is VBZ O
surgically RB O
removed VBN O
and CC O
an DT O
artificial JJ O
lens NN O
is VBZ O
inserted VBN O
into IN O
the DT O
eye NN O
to TO O
restore VB O
vision NN O
. . O

In IN O
developed JJ O
countries NNS O
, , O
this DT O
operation NN O
is VBZ O
common JJ O
and CC O
easily RB O
accessible JJ O
but CC O
many JJ O
poor JJ O
countries NNS O
lack VBP O
the DT O
resources NNS O
to TO O
provide VB O
the DT O
operation NN O
to IN O
everyone NN O
who WP O
needs VBZ O
it PRP O
. . O

In IN O
addition NN O
, , O
blind JJ O
people NNS B-Species
often RB O
cannot MD O
afford VB O
to TO O
travel VB O
to IN O
the DT O
hospitals NNS O
where WRB O
the DT O
operation NN O
, , O
which WDT O
also RB O
may MD O
come VB O
with IN O
a DT O
fee NN O
, , O
is VBZ O
done VBN O
. . O

Why WRB O
Was VBD O
This DT O
Study NN O
Done VBN O
? . O

Because IN O
blindness NN O
may MD O
reduce VB O
earning VBG O
potential NN O
, , O
many JJ O
experts NNS O
believe VBP O
that IN O
poverty NN O
and CC O
blindness NN O
( , O
and CC O
, , O
more RBR O
generally RB O
, , O
poor JJ O
health NN O
) , O
are VBP O
inextricably RB O
linked VBN O
. . O

People NNS B-Species
become VBP O
ill RB O
more RBR O
often RB O
in IN O
poor JJ O
countries NNS O
than IN O
in IN O
wealthy JJ O
countries NNS O
because IN O
they PRP O
have VBP O
insufficient JJ O
food NN O
, , O
live VBP O
in IN O
substandard JJ O
housing NN O
, , O
and CC O
have VBP O
limited JJ O
access NN O
to IN O
health NN O
care NN O
, , O
education NN O
, , O
water NN O
, , O
and CC O
sanitation NN O
. . O

Once IN O
they PRP O
are VBP O
ill JJ O
, , O
their PRP$ O
ability NN O
to TO O
earn VB O
money NN O
may MD O
be VB O
reduced VBN O
, , O
which WDT O
increases VBZ O
their PRP$ O
personal JJ O
poverty NN O
and CC O
slows VBZ O
the DT O
economic JJ O
development NN O
of IN O
the DT O
whole JJ O
country NN O
. . O

Because IN O
of IN O
this DT O
potential JJ O
link NN O
between IN O
health NN O
and CC O
poverty NN O
, , O
improvements NNS O
in IN O
health NN O
are VBP O
at IN O
the DT O
heart NN O
of IN O
the DT O
United NNP O
Nations NNPS O
Millennium NNP O
Development NNP O
Goals NNPS O
, , O
a DT O
set NN O
of IN O
eight CD O
goals NNS O
established VBN O
in IN O
2000 CD O
with IN O
the DT O
primary JJ O
aim NN O
of IN O
reducing VBG O
world NN O
poverty NN O
. . O

However RB O
, , O
few JJ O
studies NNS O
have VBP O
actually RB O
investigated VBN O
the DT O
complex JJ O
relationship NN O
between IN O
poverty NN O
and CC O
health NN O
. . O

Here RB O
, , O
the DT O
researchers NNS O
investigate VBP O
the DT O
association NN O
between IN O
visual JJ O
impairment NN O
from IN O
cataract NN O
and CC O
poverty NN O
among IN O
adults NNS O
living VBG O
in IN O
three CD O
low JJ O
- HYPH O
income NN O
countries NNS O
. . O

What WP O
Did VBD O
the DT O
Researchers NNS O
Do VB O
and CC O
Find VB O
? . O

The DT O
researchers NNS O
identified VBD O
nearly RB O
600 CD O
people NNS B-Species
aged VBN O
50 CD O
y NN O
or CC O
more JJR O
with IN O
severe JJ O
cataract NN O
- HYPH O
induced VBN O
visual JJ O
impairment NN O
( , O
"""" `` O
cases NNS O
"""" '' O
) -RRB- O
primarily RB O
through IN O
a DT O
survey NN O
of IN O
the DT O
population NN O
in IN O
Kenya NNP O
, , O
Bangladesh NNP O
, , O
and CC O
the DT O
Philippines NNPS O
. . O

They PRP O
matched VBD O
each DT O
case NN O
to IN O
a DT O
normally RB O
sighted VBN O
( , O
"""" `` O
control NN O
"""" '' O
) -RRB- O
person NN B-Species
of IN O
similar JJ O
age NN O
and CC O
sex NN O
living VBG O
nearby RB O
. . O

They PRP O
then RB O
assessed VBD O
a DT O
proxy NN O
for IN O
the DT O
income NN O
level NN O
, , O
measured VBN O
as IN O
"""" `` O
per IN O
capita NN O
expenditure NN O
"""" '' O
( , O
PCE NNP O
) -RRB- O
, , O
of IN O
all PDT O
the DT O
study NN O
participants NNS B-Species
( , O
people NNS B-Species
with IN O
cataracts NNS O
and CC O
controls NNS O
) -RRB- O
by IN O
collecting VBG O
information NN O
about IN O
what WP O
their PRP$ O
households NNS O
consumed VBD O
. . O

The DT O
participants NNS B-Species
' POS O
housing NN O
conditions NNS O
and CC O
other JJ O
assets NNS O
and CC O
their PRP$ O
self NN O
- HYPH O
rated VBN O
wealth NN O
were VBD O
also RB O
measured VBN O
. . O

In IN O
all DT O
three CD O
countries NNS O
, , O
cases NNS O
were VBD O
more RBR O
likely JJ O
to TO O
be VB O
in IN O
the DT O
lowest JJS O
quarter NN O
( , O
quartile NN O
) -RRB- O
of IN O
the DT O
range NN O
of IN O
PCEs NNS O
for IN O
that DT O
country NN O
than IN O
controls NNS O
. . O

In IN O
the DT O
Philippines NNP O
, , O
for IN O
example NN O
, , O
people NNS B-Species
with IN O
cataract NN O
- HYPH O
affected VBN O
vision NN O
were VBD O
three CD O
times NNS O
more RBR O
likely JJ O
than IN O
normally RB O
sighted VBN O
controls NNS O
to TO O
have VB O
a DT O
PCE NN O
in IN O
the DT O
lowest JJS O
quartile NN O
than IN O
in IN O
the DT O
highest JJS O
quartile NN O
. . O

The DT O
risk NN O
of IN O
cataract NN O
- HYPH O
related VBN O
visual JJ O
impairment NN O
increased VBD O
as IN O
PCE NNP O
decreased VBD O
in IN O
all DT O
three CD O
countries NNS O
. . O

Similarly RB O
, , O
severe JJ O
cataract NN O
- HYPH O
induced VBN O
visual JJ O
impairment NN O
was VBD O
more RBR O
common JJ O
in IN O
those DT O
who WP O
owned VBD O
fewer JJR O
assets NNS O
and CC O
those DT O
with IN O
lower JJR O
self NN O
- HYPH O
rated VBN O
wealth NN O
. . O

However RB O
, , O
there EX O
was VBD O
no DT O
consistent JJ O
association NN O
between IN O
PCE NNP O
and CC O
the DT O
level NN O
of IN O
cataract NN O
- HYPH O
induced VBN O
visual JJ O
impairment NN O
. . O

What WP O
Do VBP O
These DT O
Findings NNS O
Mean VB O
? . O

These DT O
findings NNS O
show VBP O
that IN O
there EX O
is VBZ O
an DT O
association NN O
between IN O
visual JJ O
impairment NN O
caused VBN O
by IN O
cataract NN O
and CC O
poverty NN O
in IN O
Kenya NNP O
, , O
Bangladesh NNP O
, , O
and CC O
the DT O
Philippines NNPS O
. . O

However RB O
, , O
because IN O
the DT O
financial JJ O
circumstances NNS O
of IN O
the DT O
people NNS B-Species
in IN O
this DT O
study NN O
were VBD O
assessed VBN O
after IN O
cataracts NNS O
had VBD O
impaired VBN O
their PRP$ O
sight NN O
, , O
this DT O
study NN O
does VBZ O
not RB O
prove VB O
that IN O
poverty NN O
is VBZ O
a DT O
cause NN O
of IN O
visual JJ O
impairment NN O
. . O

A DT O
causal JJ O
connection NN O
between IN O
poverty NN O
and CC O
cataract NN O
can MD O
only RB O
be VB O
shown VBN O
by IN O
determining VBG O
the DT O
PCEs NNS O
of IN O
normally RB O
sighted VBN O
people NNS B-Species
and CC O
following VBG O
them PRP O
for IN O
several JJ O
years NNS O
to TO O
see VB O
who WP O
develops VBZ O
cataract NN O
. . O

Nevertheless RB O
, , O
by IN O
confirming VBG O
an DT O
association NN O
between IN O
poverty NN O
and CC O
blindness NN O
, , O
these DT O
findings NNS O
highlight VBP O
the DT O
need NN O
for IN O
increased VBN O
provision NN O
of IN O
cataract NN O
surgery NN O
to IN O
poor JJ O
people NNS B-Species
, , O
particularly RB O
since IN O
cataract NN O
surgery NN O
has VBZ O
the DT O
potential NN O
to TO O
improve VB O
the DT O
quality NN O
of IN O
life NN O
for IN O
many JJ O
people NNS B-Species
in IN O
developing VBG O
countries NNS O
at IN O
a DT O
relatively RB O
low JJ O
cost NN O
. . O

Additional JJ O
Information NN O
. . O

Please UH O
access VB O
these DT O
Web NN O
sites NNS O
via IN O
the DT O
online JJ O
version NN O
of IN O
this DT O
summary NN O
at IN O
http NN O
: : O
/ : O
/ : O
dx ADD O
. . O
doi NN O
. . O
org NN O
/ SYM O
10 CD O
. . O
1371 CD O
/ SYM O
journal NN O
. . O
pmed NN O
. . O
50244 CD O
. . O

Introduction NN O

Improvements NNS O
in IN O
health NN O
are VBP O
at IN O
the DT O
heart NN O
of IN O
the DT O
Millennium NNP O
Development NNP O
Goals NNPS O
, , O
with IN O
the DT O
recognition NN O
that IN O
better JJR O
health NN O
is VBZ O
central JJ O
to IN O
the DT O
primary JJ O
aim NN O
of IN O
reducing VBG O
poverty NN O
as RB O
well RB O
as IN O
important JJ O
in IN O
its PRP$ O
own JJ O
right NN O
. . O

Empirical JJ O
data NNS O
are VBP O
needed VBN O
to TO O
back VB O
up RP O
this DT O
claim NN O
. . O

Unravelling VBG O
the DT O
relationship NN O
between IN O
blindness NN O
and CC O
poverty NN O
therefore RB O
has VBZ O
important JJ O
implications NNS O
, , O
and CC O
may MD O
also RB O
be VB O
informative JJ O
for IN O
the DT O
association NN O
between IN O
poverty NN O
and CC O
other JJ O
disabilities NNS O
. . O

Blindness NN O
is VBZ O
a DT O
common JJ O
condition NN O
globally RB O
, , O
affecting VBG O
approximately RB O
45 CD O
million CD O
people NNS B-Species
, , O
and CC O
more JJR O
than IN O
a DT O
third NN O
of IN O
blindness NN O
is VBZ O
caused VBN O
by IN O
cataract NN O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

Globally RB O
, , O
the DT O
prevalence NN O
of IN O
blindness NN O
is VBZ O
five CD O
- HYPH O
fold NN O
higher JJR O
in IN O
poor JJ O
than IN O
rich JJ O
countries NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Limited JJ O
data NNS O
show VBP O
that IN O
within IN O
countries NNS O
the DT O
poor JJ O
are VBP O
also RB O
more RBR O
likely JJ O
to TO O
be VB O
blind JJ O
[ -LRB- O
3 CD O
, , O
4 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
frequently RB O
asserted VBN O
that IN O
blindness NN O
is VBZ O
both CC O
a DT O
cause NN O
and CC O
consequence NN O
of IN O
poverty NN O
, , O
but CC O
there EX O
are VBP O
few JJ O
empirical JJ O
data NNS O
to TO O
support VB O
this DT O
claim NN O
. . O

Poverty NN O
may MD O
cause VB O
cataract JJ O
blindness NN O
, , O
because IN O
access NN O
to IN O
cataract NN O
surgery NN O
is VBZ O
limited VBN O
in IN O
low JJ O
- HYPH O
income NN O
countries NNS O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
within IN O
poor JJ O
countries NNS O
some DT O
evidence NN O
suggests VBZ O
that IN O
lack NN O
of IN O
money NN O
is VBZ O
a DT O
major JJ O
barrier NN O
to IN O
uptake NN O
of IN O
cataract NN O
surgery NN O
by IN O
individuals NNS O
[ -LRB- O
6 CD O
- SYM O
8 CD O
] -RRB- O
. . O

Blindness NN O
may MD O
also RB O
cause VB O
poverty NN O
, , O
as IN O
the DT O
blind JJ O
individual NN O
, , O
or CC O
the DT O
household NN O
members NNS O
who WP O
care VBP O
for IN O
them PRP O
, , O
have VBP O
a DT O
reduced VBN O
earning NN O
potential NN O
[ -LRB- O
4 CD O
, , O
9 CD O
] -RRB- O
. . O

This DT O
complex JJ O
problem NN O
could MD O
have VB O
serious JJ O
implications NNS O
; : O
estimates NNS O
from IN O
The DT O
Gambia NNP O
suggest VBP O
that IN O
there EX O
is VBZ O
a DT O
substantial JJ O
economic JJ O
burden NN O
from IN O
lost VBN O
productivity NN O
among IN O
blind JJ O
people NNS B-Species
[ -LRB- O
10 CD O
] -RRB- O
. . O

Therefore RB O
, , O
blindness NN O
prevention NN O
may MD O
ultimately RB O
be VB O
cost NN O
saving NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Extrapolations NNS O
on IN O
a DT O
global JJ O
level NN O
indicate VBP O
that IN O
a DT O
successful JJ O
eye NN O
care NN O
programme NN O
could MD O
prevent VB O
more JJR O
than IN O
100 CD O
million CD O
cases NNS O
of IN O
blindness NN O
between IN O
2000 CD O
and CC O
2020 CD O
, , O
and CC O
consequently RB O
save VB O
at IN O
least JJS O
US NNP O
$ $ O
102 CD O
billion CD O
, , O
which WDT O
would MD O
otherwise RB O
be VB O
lost VBN O
to IN O
reductions NNS O
in IN O
productivity NN O
associated VBN O
with IN O
blindness NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

However RB O
, , O
these DT O
estimates NNS O
are VBP O
based VBN O
on IN O
extrapolations NNS O
from IN O
limited JJ O
data NNS O
and CC O
were VBD O
not RB O
based VBN O
on IN O
individual JJ O
- HYPH O
level NN O
data NNS O
. . O

It PRP O
is VBZ O
also RB O
difficult JJ O
to TO O
identify VB O
the DT O
component NN O
of IN O
productivity NN O
loss NN O
that WDT O
is VBZ O
due JJ O
to IN O
blindness NN O
, , O
as IN O
this DT O
condition NN O
mainly RB O
affects VBZ O
older JJR O
people NNS B-Species
, , O
who WP O
may MD O
suffer VB O
from IN O
other JJ O
comorbidities NNS O
that WDT O
restrict VBP O
their PRP$ O
employment NN O
opportunities NNS O
or CC O
make VBP O
them PRP O
dependent JJ O
on IN O
the DT O
care NN O
of IN O
others NNS O
. . O

The DT O
Cataract NNP O
Impact NNP O
Study NNP O
was VBD O
undertaken VBN O
to TO O
assess VB O
the DT O
relationship NN O
between IN O
cataract NN O
visual JJ O
impairment NN O
and CC O
"""" `` O
economic JJ O
poverty NN O
"""" '' O
and CC O
quality NN O
of IN O
life NN O
, , O
and CC O
to TO O
estimate VB O
the DT O
impact NN O
of IN O
cataract NN O
surgery NN O
on IN O
these DT O
factors NNS O
in IN O
three CD O
low JJ O
- HYPH O
income NN O
countries NNS O
. . O

The DT O
aim NN O
of IN O
the DT O
current JJ O
paper NN O
is VBZ O
to TO O
assess VB O
the DT O
association NN O
at IN O
baseline NN O
between IN O
visual JJ O
impairment NN O
from IN O
cataract NN O
and CC O
household NN O
poverty NN O
( , O
measured VBN O
through IN O
consumption NN O
, , O
asset NN O
ownership NN O
, , O
and CC O
self NN O
- HYPH O
rated VBN O
wealth NN O
) -RRB- O
in IN O
a DT O
population NN O
- HYPH O
based VBN O
case NN O
- HYPH O
control NN O
study NN O
in IN O
Kenya NNP O
, , O
the DT O
Philippines NNP O
, , O
and CC O
Bangladesh NNP O
. . O

Methods NNS O

Setting VBG O

Case NN O
and CC O
control NN O
participants NNS B-Species
were VBD O
recruited VBN O
from IN O
Nakuru NNP O
district NN O
, , O
Kenya NNP O
( , O
January NNP O
- HYPH O
February NNP O
, , O
2005 CD O
) -RRB- O
; , O
Negros NNP O
island NN O
( , O
May NNP O
- HYPH O
June NNP O
, , O
2005 CD O
) -RRB- O
and CC O
Antique NNP O
district NN O
( , O
April NNP O
- HYPH O
May NNP O
, , O
2006 CD O
) -RRB- O
, , O
Philippines NNPS O
; , O
and CC O
Satkhira NNP O
district NN O
, , O
Bangladesh NNP O
( , O
November NNP O
- HYPH O
December NNP O
, , O
2005 CD O
) -RRB- O
. . O

Selection NN O
of IN O
Cases NNPS O
and CC O
Controls NNS O

Persons NNS B-Species
with IN O
cataract NN O
visual JJ O
impairment NN O
( , O
cases NNS O
) , O
and CC O
persons NNS B-Species
without IN O
( , O
controls NNS O
) -RRB- O
were VBD O
primarily RB O
recruited VBN O
through IN O
a DT O
population NN O
- HYPH O
based VBN O
survey NN O
of IN O
adults NNS O
aged VBN O
> SYM O
= SYM O
50 CD O
y NN O
[ -LRB- O
6 CD O
- SYM O
8 CD O
] -RRB- O
. . O

Clusters NNS O
of IN O
50 CD O
people NNS B-Species
( , O
regardless RB O
of IN O
visual JJ O
impairment NN O
) , O
aged VBN O
> SYM O
= SYM O
50 CD O
y NN O
were VBD O
selected VBN O
through IN O
probability NN O
- HYPH O
proportionate JJ O
to IN O
size NN O
sampling NN O
, , O
using VBG O
either CC O
the DT O
census NN O
( , O
Philippines NNP O
and CC O
Bangladesh NNP O
) -RRB- O
or CC O
electoral JJ O
role NN O
( , O
Kenya NNP O
) -RRB- O
as IN O
the DT O
sampling JJ O
frame NN O
. . O

Households NNS O
within IN O
clusters NNS O
were VBD O
selected VBN O
through IN O
a DT O
modification NN O
of IN O
compact JJ O
segment NN O
sampling NN O
, , O
whereby WRB O
a DT O
map NN O
was VBD O
drawn VBN O
of IN O
the DT O
enumeration NN O
area NN O
that WDT O
was VBD O
divided VBN O
into IN O
segments NNS O
, , O
each DT O
including VBG O
approximately RB O
50 CD O
people NNS B-Species
aged VBN O
> SYM O
= SYM O
50 CD O
y NN O
, , O
and CC O
one CD O
segment NN O
was VBD O
chosen VBN O
at IN O
random JJ O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Households NNS O
in IN O
the DT O
segment NN O
were VBD O
included VBN O
sequentially RB O
until IN O
50 CD O
people NNS B-Species
aged VBN O
> SYM O
= SYM O
50 CD O
y NN O
were VBD O
identified VBN O
. . O

The DT O
surveys NNS O
included VBD O
3 CD O
, , O
503 CD O
( , O
93 CD O
% NN O
response NN O
rate NN O
) , O
people NNS B-Species
aged VBN O
> SYM O
= SYM O
50 CD O
y NN O
in IN O
Kenya NNP O
, , O
4 CD O
, , O
868 CD O
( , O
92 CD O
% NN O
) -RRB- O
in IN O
Bangladesh NNP O
, , O
2 CD O
, , O
774 CD O
( , O
76 CD O
% NN O
) , O
in IN O
Negros NNP O
, , O
and CC O
3 CD O
, , O
177 CD O
( , O
83 CD O
% NN O
) -RRB- O
in IN O
Antique NNP O
. . O

All DT O
people NNS B-Species
in IN O
the DT O
survey NN O
aged VBD O
> : O
= SYM O
50 CD O
y NN O
underwent VBD O
visual JJ O
acuity NN O
( , O
VA NNP O
) -RRB- O
testing NN O
and CC O
ophthalmic JJ O
examination NN O
. . O

VA NNP O
was VBD O
measured VBN O
in IN O
full JJ O
daylight NN O
with IN O
available JJ O
spectacle NN O
correction NN O
with IN O
a DT O
Snellen NNP O
tumbling VBG O
"""" `` O
E NNP O
"""" '' O
chart NN O
using VBG O
optotype NN O
size NN O
6 CD O
/ SYM O
18 CD O
( SYM O
20 CD O
/ SYM O
60 CD O
) -RRB- O
on IN O
one CD O
side NN O
and CC O
size NN O
6 CD O
/ SYM O
60 CD O
( SYM O
20 CD O
/ SYM O
200 CD O
) -RRB- O
on IN O
the DT O
other JJ O
side NN O
at IN O
6 CD O
or CC O
3 CD O
metres NNS O
. . O

If IN O
the DT O
VA NNP O
was VBD O
< SYM O
6 CD O
/ SYM O
18 CD O
in IN O
either DT O
eye NN O
then RB O
pinhole NN O
vision NN O
was VBD O
also RB O
measured VBN O
. . O

Participants NNS B-Species
with IN O
pinhole NN O
vision NN O
< CC O
6 CD O
/ SYM O
18 CD O
but CC O
> SYM O
6 CD O
/ SYM O
60 CD O
in IN O
the DT O
better JJR O
eye NN O
due JJ O
to IN O
age NN O
- HYPH O
related VBN O
cataract NN O
were VBD O
given VBN O
a DT O
second JJ O
VA NN O
test NN O
using VBG O
an DT O
"""" `` O
E NN O
"""" '' O
of IN O
size NN O
6 CD O
/ SYM O
24 CD O
. . O

The DT O
ophthalmologist NN O
examined VBD O
all DT O
eyes NNS O
with IN O
a DT O
presenting VBG O
VA NNP O
< SYM O
6 CD O
/ SYM O
18 CD O
with IN O
a DT O
torch NN O
( : O
i PRP O
. . O
e NN O
. . O
, , O
flashlight NN O
) -RRB- O
, , O
direct JJ O
ophthalmoscope NN O
, , O
and CC O
/ SYM O
or CC O
portable JJ O
slit NN O
lamp NN O
. . O

The DT O
principal JJ O
cause NN O
of IN O
blindness NN O
or CC O
visual JJ O
impairment NN O
was VBD O
recorded VBN O
, , O
according VBG O
to IN O
the DT O
WHO NNP O
convention NN O
in IN O
which WDT O
the DT O
major JJ O
cause NN O
is VBZ O
assigned VBN O
to IN O
the DT O
primary JJ O
disorder NN O
or CC O
, , O
if IN O
there EX O
are VBP O
two CD O
existing VBG O
primary JJ O
disorders NNS O
, , O
to IN O
the DT O
one NN O
that WDT O
is VBZ O
easiest JJS O
to TO O
treat VB O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Survey NN O
participants NNS B-Species
were VBD O
eligible JJ O
for IN O
inclusion NN O
as IN O
cases NNS O
if IN O
they PRP O
were VBD O
aged VBN O
> SYM O
= SYM O
50 CD O
y NN O
with IN O
best RBS O
corrected VBN O
visual JJ O
acuity NN O
< : O
6 CD O
/ SYM O
24 CD O
in IN O
the DT O
better JJR O
eye NN O
due IN O
to IN O
cataract NN O
, , O
as IN O
diagnosed VBN O
by IN O
an DT O
ophthalmologist NN O
. . O

All DT O
eligible JJ O
cases NNS O
identified VBN O
from IN O
these DT O
surveys NNS O
were VBD O
invited VBN O
to TO O
participate VB O
in IN O
the DT O
study NN O
. . O

Participants NNS B-Species
were VBD O
eligible JJ O
to TO O
be VB O
controls NNS O
if IN O
they PRP O
were VBD O
aged VBN O
> SYM O
= SYM O
50 CD O
y NN O
, , O
did VBD O
not RB O
have VB O
VA NN O
< SYM O
6 CD O
/ SYM O
24 CD O
in IN O
the DT O
better JJR O
eye NN O
due IN O
to IN O
cataract NN O
and CC O
did VBD O
not RB O
live VB O
in IN O
the DT O
same JJ O
household NN O
as IN O
a DT O
case NN O
. . O

During IN O
the DT O
survey NN O
a DT O
list NN O
was VBD O
maintained VBN O
of IN O
all DT O
eligible JJ O
controls NNS O
, , O
by IN O
age NN O
group NN O
( , O
50 CD O
- SYM O
54 CD O
, , O
55 CD O
- SYM O
59 CD O
, , O
60 CD O
- SYM O
64 CD O
, , O
65 CD O
- SYM O
69 CD O
, , O
and CC O
> SYM O
70 CD O
) -RRB- O
and CC O
sex NN O
. . O

Whenever WRB O
a DT O
case NN O
was VBD O
identified VBN O
, , O
one CD O
age NN O
- HYPH O
and CC O
sex NN O
- HYPH O
matched VBD O
control NN O
was VBD O
randomly RB O
selected VBN O
from IN O
the DT O
list NN O
for IN O
inclusion NN O
( , O
or CC O
up IN O
to TO O
two CD O
controls NNS O
in IN O
Bangladesh NNP O
) -RRB- O
. . O

If IN O
no DT O
matching VBG O
eligible JJ O
controls NNS O
had VBD O
been VBN O
identified VBN O
in IN O
that DT O
cluster NN O
at IN O
that DT O
stage NN O
of IN O
the DT O
survey NN O
, , O
then RB O
the DT O
next JJ O
eligible JJ O
control NN O
in IN O
the DT O
cluster NN O
was VBD O
recruited VBN O
. . O

Because IN O
of IN O
logistical JJ O
and CC O
time NN O
constraints NNS O
, , O
additional JJ O
cases NNS O
were VBD O
also RB O
included VBN O
through IN O
community NN O
- HYPH O
based VBN O
case NN O
detection NN O
. . O

In IN O
Kenya NNP O
and CC O
Negros NNP O
( , O
Philippines NNPS O
) -RRB- O
, , O
clusters NNS O
were VBD O
randomly RB O
selected VBN O
through IN O
probability NN O
proportionate JJ O
to IN O
size NN O
using VBG O
the DT O
same JJ O
cluster NN O
sampling NN O
procedure NN O
after IN O
completion NN O
of IN O
the DT O
population NN O
- HYPH O
based VBN O
survey NN O
. . O

Clusters NNS O
were VBD O
visited VBN O
in IN O
advance NN O
and CC O
asked VBN O
that IN O
all DT O
people NNS B-Species
> SYM O
= SYM O
50 CD O
y NN O
with IN O
vision NN O
problems NNS O
come VB O
to IN O
a DT O
central JJ O
point NN O
on IN O
a DT O
specified JJ O
day NN O
, , O
and CC O
that IN O
a DT O
list NN O
be VB O
made VBN O
of IN O
people NNS B-Species
unable JJ O
to TO O
attend VB O
( , O
e LS O
. . O
g LS O
. . O
, , O
due IN O
to IN O
blindness NN O
or CC O
other JJ O
physical JJ O
disability NN O
) -RRB- O
. . O

After IN O
examining VBG O
patients NNS B-Species
at IN O
the DT O
central JJ O
point NN O
, , O
the DT O
survey NN O
team NN O
then RB O
visited VBD O
those DT O
unable JJ O
to TO O
leave VB O
their PRP$ O
houses NNS O
. . O

Any DT O
identified VBN O
eligible JJ O
cases NNS O
that WDT O
agreed VBD O
to TO O
be VB O
part NN O
of IN O
the DT O
study NN O
were VBD O
interviewed VBN O
in IN O
their PRP$ O
homes NNS O
. . O

In IN O
Bangladesh NNP O
and CC O
Antique NNP O
( , O
Philippines NNPS O
) -RRB- O
, , O
community NN O
case NN O
detection NN O
was VBD O
carried VBN O
out RP O
simultaneously RB O
with IN O
the DT O
survey NN O
by IN O
two CD O
of IN O
the DT O
four CD O
teams NNS O
, , O
so IN O
that IN O
controls NNS O
were VBD O
included VBN O
for IN O
these DT O
cases NNS O
. . O

Within IN O
each DT O
cluster NN O
from IN O
the DT O
survey NN O
, , O
one CD O
interviewer NN O
was VBD O
asked VBN O
to TO O
be VB O
taken VBN O
to IN O
two CD O
community NN O
members NNS O
aged VBN O
> SYM O
= SYM O
50 CD O
y NN O
with IN O
eye NN O
problems NNS O
, , O
living VBG O
within IN O
the DT O
cluster NN O
boundaries NNS O
but CC O
not RB O
from IN O
the DT O
segments NNS O
selected VBN O
for IN O
the DT O
survey NN O
. . O

If IN O
VA NNP O
was VBD O
< : O
6 CD O
/ SYM O
24 CD O
with IN O
pinhole NN O
in IN O
the DT O
better JJR O
eye NN O
, , O
the DT O
ophthalmologist NN O
was VBD O
called VBN O
to TO O
carry VB O
out RP O
the DT O
full JJ O
eye NN O
examination NN O
, , O
and CC O
eligible JJ O
cases NNS O
were VBD O
included VBN O
in IN O
the DT O
study NN O
. . O

For IN O
the DT O
purposes NNS O
of IN O
the DT O
present JJ O
analyses NNS O
, , O
control NN O
individuals NNS O
with IN O
any DT O
visual JJ O
impairment NN O
( , O
VA NN O
< SYM O
6 CD O
/ SYM O
18 CD O
in IN O
the DT O
better JJR O
eye NN O
) -RRB- O
were VBD O
excluded VBN O
( : O
n CD O
= SYM O
14 CD O
in IN O
Kenya NNP O
, , O
n CD O
= SYM O
53 CD O
in IN O
Bangladesh NNP O
, , O
n CD O
= SYM O
24 CD O
in IN O
the DT O
Philippines NNPS O
) -RRB- O
. . O

Case NN O
and CC O
control NN O
participants NNS B-Species
who WP O
were VBD O
significantly RB O
communication NN O
impaired VBN O
( : O
e LS O
. . O
g LS O
. . O
deafness NN O
, , O
dementia NN O
, , O
or CC O
psychiatric JJ O
disease NN O
) -RRB- O
were VBD O
excluded VBN O
( : O
fewer JJR O
than IN O
five CD O
per IN O
country NN O
) -RRB- O
, , O
and CC O
one CD O
case NN O
was VBD O
excluded VBN O
in IN O
the DT O
Philippines NNP O
because IN O
of IN O
missing VBG O
age NN O
data NNS O
. . O

One CD O
household NN O
had VBD O
two CD O
eligible JJ O
cases NNS O
( : O
Kenya NNP O
) -RRB- O
, , O
and CC O
one CD O
of IN O
these DT O
participants NNS B-Species
was VBD O
excluded VBN O
for IN O
the DT O
poverty NN O
analyses NNS O
as IN O
poverty NN O
was VBD O
assessed VBN O
through IN O
household NN O
level NN O
indicators NNS O
( , O
see VB O
below RB O
) -RRB- O
. . O

In IN O
total NN O
, , O
147 CD O
cases NNS O
( , O
82 CD O
from IN O
the DT O
survey NN O
and CC O
65 CD O
from IN O
case NN O
detection NN O
) , O
and CC O
79 CD O
controls NNS O
were VBD O
included VBN O
in IN O
Kenya NNP O
; : O
217 CD O
cases NNS O
( , O
162 CD O
from IN O
survey NN O
and CC O
55 CD O
from IN O
case NN O
detection NN O
) -RRB- O
and CC O
280 CD O
controls NNS O
in IN O
Bangladesh NNP O
; , O
and CC O
238 CD O
cases NNS O
( , O
146 CD O
survey NN O
and CC O
92 CD O
case NN O
detection NN O
) -RRB- O
and CC O
180 CD O
controls NNS O
in IN O
the DT O
Philippines NNPS O
. . O

Data NNPS O
Collection NNP O

All DT O
case NN O
and CC O
control NN O
participants NNS B-Species
were VBD O
interviewed VBN O
in IN O
their PRP$ O
homes NNS O
by IN O
trained VBN O
interviewers NNS O
in IN O
the DT O
local JJ O
language NN O
. . O

Each DT O
interview NN O
lasted VBD O
approximately RB O
1 CD O
h NN O
. . O

Measures NNS O
of IN O
poverty NN O
. . O

Poverty NN O
was VBD O
measured VBN O
through IN O
( : O
a DT O
) , O
monthly JJ O
per IN O
capita FW O
expenditure NN O
( , O
PCE NNP O
) -RRB- O
to TO O
indicate VB O
consumption NN O
, , O
( , O
b LS O
) NFP O
asset NN O
ownership NN O
, , O
and CC O
( -LRB- O
c NN O
) , O
self NN O
- HYPH O
rated VBN O
wealth NN O
. . O

The DT O
economic JJ O
part NN O
of IN O
the DT O
questionnaires NNS O
was VBD O
adapted VBN O
through IN O
interviews NNS O
, , O
focus NN O
group NN O
discussions NNS O
, , O
and CC O
pilot NN O
testing NN O
in IN O
each DT O
country NN O
to TO O
ensure VB O
local JJ O
relevance NN O
. . O

The DT O
person NN B-Species
primarily RB O
responsible JJ O
for IN O
household NN O
finances NNS O
( , O
which WDT O
may MD O
have VB O
been VBN O
the DT O
case NN O
/ SYM O
control NN O
or CC O
another DT O
household NN O
member NN O
) , O
was VBD O
interviewed VBN O
to TO O
assess VB O
PCE NNP O
and CC O
assets NNS O
. . O

PCE NNP O
was VBD O
measured VBN O
using VBG O
methods NNS O
based VBN O
on IN O
the DT O
World NNP O
Bank NNP O
' POS O
s POS O
Living NNP O
Standards NNPS O
Measurement NNP O
Study NNP O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Items NNS O
were VBD O
included VBN O
on IN O
food NN O
( : O
42 CD O
- HYPH O
52 CD O
items NNS O
per IN O
country NN O
) -RRB- O
, , O
education NN O
( , O
three CD O
items NNS O
) -RRB- O
, , O
health NN O
( , O
five CD O
items NNS O
) -RRB- O
, , O
household NN O
expenses NNS O
( , O
nine CD O
items NNS O
) -RRB- O
, , O
and CC O
personal JJ O
expenses NNS O
( : O
21 CD O
or CC O
22 CD O
items NNS O
) -RRB- O
. . O

In IN O
total NN O
, , O
85 CD O
items NNS O
were VBD O
included VBN O
in IN O
the DT O
questionnaire NN O
in IN O
Kenya NNP O
, , O
90 CD O
in IN O
the DT O
Philippines NNP O
, , O
and CC O
79 CD O
in IN O
Bangladesh NNP O
. . O

The DT O
informant NN O
was VBD O
asked VBN O
to TO O
recall VB O
the DT O
monetary JJ O
value NN O
of IN O
food NN O
that WDT O
was VBD O
purchased VBN O
, , O
consumed VBN O
from IN O
home NN O
production NN O
, , O
or CC O
received VBN O
as IN O
payment NN O
in IN O
kind NN O
or CC O
as IN O
gifts NNS O
. . O

Consumption NN O
was VBD O
assessed VBN O
over IN O
a DT O
1 CD O
- HYPH O
wk NN O
period NN O
for IN O
frequently RB O
consumed VBN O
items NNS O
, , O
and CC O
this DT O
was VBD O
scaled VBN O
up RP O
to TO O
estimate VB O
monthly JJ O
consumption NN O
. . O

The DT O
amount NN O
consumed VBN O
monthly RB O
was VBD O
assessed VBN O
for IN O
items NNS O
that WDT O
were VBD O
consumed VBN O
more RBR O
rarely RB O
. . O

Monthly JJ O
rent NN O
was VBD O
recorded VBN O
among IN O
households NNS O
who WP O
rented VBD O
, , O
and CC O
households NNS O
who WP O
owned VBD O
their PRP$ O
property NN O
were VBD O
asked VBN O
to TO O
estimate VB O
the DT O
amount NN O
that IN O
they PRP O
could MD O
charge VB O
in IN O
rent NN O
per IN O
month NN O
. . O

The DT O
consumption NN O
on IN O
all DT O
items NNS O
was VBD O
summed VBN O
to TO O
calculate VB O
total JJ O
monthly JJ O
household NN O
consumption NN O
, , O
and CC O
this DT O
was VBD O
converted VBN O
to IN O
United NNP O
States NNP O
dollars NNS O
( : O
US NNP O
$ $ O
) -RRB- O
at IN O
the DT O
2005 CD O
exchange NN O
rate NN O
( : O
$ $ O
1 CD O
= SYM O
76 CD O
Kenya NNP O
shillings NNS O
, , O
64 CD O
Bangladesh JJ O
taka NN O
, , O
55 CD O
Philippine JJ O
pesos NNS O
) -RRB- O
. . O

Total JJ O
monthly JJ O
household NN O
consumption NN O
was VBD O
divided VBN O
by IN O
the DT O
number NN O
of IN O
household NN O
members NNS O
to TO O
calculate VB O
monthly JJ O
PCE NNP O
for IN O
the DT O
household NN O
. . O

The DT O
household NN O
informant NN O
was VBD O
also RB O
asked VBN O
about IN O
the DT O
number NN O
and CC O
type NN O
of IN O
context NN O
- HYPH O
specific JJ O
assets NNS O
owned VBN O
by IN O
the DT O
household NN O
, , O
including VBG O
different JJ O
types NNS O
of IN O
furniture NN O
, , O
electrical JJ O
equipment NN O
, , O
cattle NNS B-Species
, , O
and CC O
vehicles NNS O
. . O

Information NN O
was VBD O
collected VBN O
on IN O
household NN O
characteristics NNS O
, , O
including VBG O
the DT O
building NN O
material NN O
of IN O
the DT O
floor NN O
, , O
roof NN O
, , O
and CC O
walls NNS O
; , O
type NN O
of IN O
toilet NN O
; : O
and CC O
the DT O
number NN O
of IN O
rooms NNS O
. . O

Self NN O
- HYPH O
rated VBN O
wealth NN O
was VBD O
assessed VBN O
by IN O
asking VBG O
the DT O
household NN O
informant NN O
to TO O
rank VB O
the DT O
household NN O
' POS O
s POS O
wealth NN O
relative JJ O
to IN O
others NNS O
in IN O
the DT O
community NN O
on IN O
a DT O
scale NN O
from IN O
1 CD O
( SYM O
poorest JJS O
) -RRB- O
to IN O
10 CD O
( HYPH O
richest JJS O
) -RRB- O
. . O

Covariates NNS O
. . O

Case NN O
and CC O
control NN O
individuals NNS O
were VBD O
interviewed VBN O
about IN O
standard JJ O
sociodemographic JJ O
indicators NNS O
, , O
including VBG O
household NN O
composition NN O
, , O
education NN O
, , O
and CC O
employment NN O
. . O

Information NN O
was VBD O
collected VBN O
on IN O
vision NN O
- HYPH O
related VBN O
quality NN O
of IN O
life NN O
using VBG O
the DT O
World NNP O
Health NNP O
Organization NNP O
Prevention NNP O
of IN O
Blindness NNP O
and CC O
Deafness NNP O
20 CD O
- HYPH O
item NN O
Visual NNP O
Functioning NNP O
Questionnaire NNP O
[ -LRB- O
16 CD O
, , O
17 CD O
] -RRB- O
, , O
and CC O
health NN O
- HYPH O
related VBN O
quality NN O
of IN O
life NN O
was VBD O
assessed VBN O
using VBG O
items NNS O
from IN O
the DT O
European NNP O
Quality NNP O
of IN O
Life NNP O
Questionnaire NNP O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Detailed JJ O
time NN O
- HYPH O
use NN O
data NNS O
were VBD O
collected VBN O
using VBG O
methods NNS O
based VBN O
on IN O
the DT O
World NNP O
Bank NNP O
' POS O
s POS O
Living NNP O
Standards NNPS O
Measurement NNP O
Study NNP O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Training NN O
and CC O
Fieldwork NNP O

Interviewers NNS O
were VBD O
trained VBN O
for IN O
1 CD O
wk NN O
, , O
including VBG O
2 CD O
d NN O
of IN O
pilot NN O
testing NN O
. . O

Attempts NNS O
were VBD O
made VBN O
to TO O
minimise VB O
measurement NN O
bias NN O
by IN O
emphasising VBG O
the DT O
need NN O
for IN O
consistency NN O
in IN O
data NNS O
collection NN O
among IN O
cases NNS O
and CC O
controls NNS O
. . O

The DT O
questionnaires NNS O
were VBD O
translated VBN O
into IN O
the DT O
local JJ O
languages NNS O
( , O
three CD O
in IN O
Kenya NNP O
, , O
three CD O
in IN O
the DT O
Philippines NNPS O
, , O
and CC O
one CD O
in IN O
Bangladesh NNP O
) , O
and CC O
back RB O
- HYPH O
translated VBN O
by IN O
independent JJ O
translators NNS O
( , O
one CD O
for IN O
each DT O
language NN O
) , O
who WP O
were VBD O
also RB O
asked VBN O
to TO O
comment VB O
on IN O
appropriateness NN O
of IN O
language NN O
used VBN O
for IN O
the DT O
target NN O
population NN O
. . O

A DT O
review NN O
was VBD O
held VBN O
to TO O
discuss VB O
differences NNS O
in IN O
translation NN O
and CC O
modify VB O
accordingly RB O
. . O

The DT O
questionnaire NN O
was VBD O
piloted VBN O
in IN O
each DT O
setting NN O
and CC O
small JJ O
modifications NNS O
to IN O
wording NN O
of IN O
some DT O
items NNS O
were VBD O
made VBN O
, , O
where WRB O
appropriate JJ O
, , O
to TO O
ensure VB O
local JJ O
understanding NN O
. . O

Teams NNS O
were VBD O
accompanied VBN O
by IN O
a DT O
field NN O
supervisor NN O
at IN O
least JJS O
1 CD O
d NN O
per IN O
wk NN O
to TO O
ensure VB O
that IN O
high JJ O
quality NN O
was VBD O
maintained VBN O
and CC O
interviews NNS O
were VBD O
observed VBN O
randomly RB O
throughout IN O
the DT O
study NN O
. . O

Statistical NNP O
Analysis NNP O

Microsoft NNP O
Access NNP O
was VBD O
used VBN O
for IN O
data NN O
entry NN O
, , O
and CC O
all DT O
data NNS O
were VBD O
double RB O
entered VBN O
and CC O
validated VBN O
. . O

Analyses NNS O
were VBD O
undertaken VBN O
in IN O
SAS NNP O
version NN O
8 CD O
. . O
2 CD O
. . O

The DT O
mean NN O
and CC O
range NN O
of IN O
each DT O
expenditure NN O
item NN O
was VBD O
calculated VBN O
to TO O
assess VB O
whether IN O
answers NNS O
were VBD O
plausible JJ O
, , O
and CC O
to TO O
identify VB O
and CC O
exclude VB O
gross JJ O
outliers NNS O
( , O
none NN O
identified VBN O
) -RRB- O
. . O

Rental JJ O
equivalents NNS O
were VBD O
imputed VBN O
based VBN O
on IN O
household NN O
characteristics NNS O
and CC O
non JJ O
- HYPH O
rent NN O
expenditure NN O
for IN O
households NNS O
where WRB O
these DT O
estimates NNS O
were VBD O
missing VBG O
or CC O
unreasonably RB O
low JJ O
( : O
< $ O
$ $ O
1 CD O
per IN O
mo FW O
) -RRB- O
( , O
four CD O
in IN O
Kenya NNP O
, , O
three CD O
in IN O
Bangladesh NNP O
, , O
18 CD O
in IN O
the DT O
Philippines NNPS O
) -RRB- O
. . O

Total JJ O
monthly JJ O
household NN O
consumption NN O
was VBD O
divided VBN O
by IN O
the DT O
number NN O
of IN O
household NN O
members NNS O
to TO O
calculate VB O
per IN O
capita FW O
household NN O
expenditure NN O
. . O

Per IN O
capita FW O
household NN O
expenditure NN O
was VBD O
divided VBN O
into IN O
quartiles NNS O
, , O
separately RB O
for IN O
each DT O
country NN O
, , O
based VBN O
on IN O
the DT O
distribution NN O
of IN O
the DT O
data NNS O
for IN O
the DT O
case NN O
and CC O
control NN O
participants NNS B-Species
combined VBN O
. . O

Households NNS O
with IN O
incomplete JJ O
expenditure NN O
data NNS O
were VBD O
excluded VBN O
from IN O
analyses NNS O
( , O
five CD O
cases NNS O
and CC O
four CD O
controls NNS O
in IN O
Kenya NNP O
; : O
one CD O
case NN O
and CC O
one CD O
control NN O
in IN O
Bangladesh NNP O
) -RRB- O
. . O

A DT O
relative JJ O
index NN O
of IN O
household NN O
assets NNS O
was VBD O
derived VBN O
using VBG O
principal JJ O
components NNS O
analysis NN O
( , O
PCA NNP O
) -RRB- O
to TO O
determine VB O
weights NNS O
for IN O
a DT O
list NN O
of IN O
assets NNS O
and CC O
wealth NN O
indicators NNS O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Variables NNS O
entered VBD O
into IN O
the DT O
PCA NNP O
included VBD O
building NN O
materials NNS O
of IN O
the DT O
house NN O
, , O
ownership NN O
of IN O
ten CD O
household NN O
assets NNS O
, , O
animal NN O
ownership NN O
, , O
and CC O
education NN O
of IN O
the DT O
head NN O
of IN O
the DT O
household NN O
. . O

The DT O
derived VBN O
index NN O
was VBD O
divided VBN O
into IN O
quartiles NNS O
from IN O
poorest JJS O
( , O
lowest JJS O
socioeconomic JJ O
status NN O
[ -LRB- O
SES NNP O
] -RRB- O
index NN O
) -RRB- O
to IN O
least JJS O
poor JJ O
( HYPH O
highest JJS O
SES NNP O
index NN O
) -RRB- O
. . O

PCA NNP O
analyses NNS O
were VBD O
undertaken VBN O
separately RB O
for IN O
each DT O
country NN O
. . O

The DT O
means NNS O
of IN O
the DT O
poverty NN O
variables NNS O
were VBD O
first RB O
compared VBN O
for IN O
cases NNS O
recruited VBN O
through IN O
the DT O
two CD O
different JJ O
methods NNS O
, , O
and CC O
then RB O
from IN O
cases NNS O
and CC O
controls NNS O
using VBG O
t NN O
- HYPH O
tests NNS O
for IN O
continuous JJ O
variables NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
PCE NNP O
and CC O
assets NNS O
) -RRB- O
. . O

For IN O
categorical JJ O
variables NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
household NN O
rank NN O
) -RRB- O
we PRP O
used VBD O
the DT O
Mann NNP O
- HYPH O
Whitney NNP O
test NN O
and CC O
presented VBD O
medians NNS O
and CC O
interquartile JJ O
ranges NNS O
. . O

PCE NNP O
was VBD O
highly RB O
skewed JJ O
and CC O
therefore RB O
was VBD O
log NN O
transformed VBN O
for IN O
the DT O
t NN O
- HYPH O
tests NNS O
. . O

The DT O
two CD O
- HYPH O
way NN O
correlations NNS O
were VBD O
calculated VBN O
between IN O
PCE NNP O
, , O
assets NNS O
, , O
and CC O
household NN O
rank NN O
, , O
in IN O
turn NN O
. . O

Logistic JJ O
regression NN O
analyses NNS O
were VBD O
undertaken VBN O
separately RB O
for IN O
each DT O
country NN O
, , O
assessing VBG O
the DT O
association NN O
between IN O
case NN O
/ SYM O
control NN O
status NN O
and CC O
sociodemographic JJ O
and CC O
poverty NN O
variables NNS O
. . O

Conditional JJ O
logistic JJ O
regression NN O
was VBD O
not RB O
undertaken VBN O
, , O
since IN O
the DT O
matching NN O
was VBD O
incomplete JJ O
, , O
so IN O
all DT O
analyses NNS O
were VBD O
adjusted VBN O
for IN O
the DT O
matching NN O
variables NNS O
( , O
age NN O
, , O
sex NN O
, , O
and CC O
rural JJ O
/ SYM O
urban JJ O
location NN O
) -RRB- O
. . O

Likelihood NN O
ratio NN O
tests NNS O
were VBD O
undertaken VBN O
to TO O
assess VB O
the DT O
significance NN O
of IN O
adding VBG O
covariates NNS O
with IN O
more JJR O
than IN O
two CD O
levels NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
age NN O
groups NNS O
, , O
self NN O
- HYPH O
rated VBN O
health NN O
groups NNS O
) -RRB- O
to IN O
the DT O
model NN O
. . O

Tests NNS O
for IN O
trend NN O
were VBD O
undertaken VBN O
across IN O
quartiles NNS O
of IN O
the DT O
poverty NN O
variables NNS O
and CC O
assessed VBN O
using VBG O
the DT O
p NN O
- HYPH O
value NN O
for IN O
trend NN O
. . O

Analyses NNS O
were VBD O
also RB O
conducted VBN O
adjusting VBG O
for IN O
the DT O
logistic JJ O
regression NN O
analyses NNS O
for IN O
poverty NN O
by IN O
social JJ O
support NN O
indicators NNS O
( , O
marital JJ O
status NN O
and CC O
household NN O
size NN O
) -RRB- O
and CC O
self NN O
- HYPH O
rated VBN O
health NN O
, , O
since IN O
these DT O
variables NNS O
may MD O
confound VB O
the DT O
association NN O
between IN O
cataract NN O
visual JJ O
impairment NN O
and CC O
poverty NN O
. . O

Analyses NNS O
from IN O
the DT O
Philippines NNP O
were VBD O
also RB O
adjusted VBN O
for IN O
study NN O
site NN O
, , O
since IN O
data NNS O
were VBD O
obtained VBN O
from IN O
two CD O
settings NNS O
( , O
Negros NNP O
and CC O
Antique NNP O
) -RRB- O
. . O

An DT O
attempt NN O
was VBD O
made VBN O
to TO O
disentangle VB O
the DT O
relationship NN O
between IN O
poverty NN O
and CC O
cataract NN O
by IN O
stratifying VBG O
the DT O
analyses NNS O
by IN O
age NN O
, , O
sex NN O
, , O
and CC O
level NN O
of IN O
visual JJ O
impairment NN O
among IN O
the DT O
cases NNS O
. . O

Ethical JJ O
Approval NN O

Informed VBN O
signed VBN O
or CC O
thumb NN O
- HYPH O
printed VBN O
consent NN O
was VBD O
obtained VBN O
from IN O
all DT O
cases NNS O
and CC O
controls NNS O
. . O

In IN O
Kenya NNP O
and CC O
Bangladesh NNP O
all DT O
cases NNS O
were VBD O
offered VBN O
free JJ O
cataract NN O
surgery NN O
at IN O
the DT O
local JJ O
hospital NN O
, , O
with IN O
free JJ O
transport NN O
. . O

In IN O
the DT O
Philippines NNPS O
, , O
patients NNS B-Species
were VBD O
referred VBN O
for IN O
surgery NN O
, , O
which WDT O
was VBD O
subsidised VBN O
for IN O
patients NNS B-Species
who WP O
could MD O
not RB O
afford VB O
the DT O
fee NN O
. . O

Ethical JJ O
approval NN O
for IN O
this DT O
study NN O
was VBD O
obtained VBN O
from IN O
the DT O
ethics NNS O
committees NNS O
of IN O
the DT O
London NNP O
School NNP O
of IN O
Hygiene NNP O
& CC O
Tropical NNP O
Medicine NNP O
, , O
the DT O
Kenya NNP O
Medical NNP O
Research NNP O
Institute NNP O
, , O
the DT O
Bangladesh NNP O
Medical NNP O
Research NNP O
Council NNP O
, , O
and CC O
the DT O
University NNP O
of IN O
St NNP O
. . O

La NNP O
Salle NNP O
, , O
Bacolod NNP O
, , O
Philippines NNP O
. . O

This DT O
study NN O
complied VBD O
with IN O
the DT O
guidelines NNS O
of IN O
the DT O
Declaration NNP O
of IN O
Helsinki NNP O
. . O

Results NNS O

Sociodemographic JJ O
Characteristics NNS O
of IN O
Cases NNS O
and CC O
Controls NNS O

Case NN O
and CC O
control NN O
participants NNS B-Species
were VBD O
matched VBN O
reasonably RB O
closely RB O
by IN O
sex NN O
and CC O
location NN O
. . O

However RB O
, , O
within IN O
the DT O
age NN O
category NN O
> : O
= SYM O
70 CD O
y NN O
, , O
cases NNS O
tended VBD O
to TO O
be VB O
older JJR O
than IN O
the DT O
controls NNS O
, , O
so IN O
that IN O
cases NNS O
were VBD O
over RB O
- HYPH O
represented VBN O
in IN O
the DT O
oldest JJS O
age NN O
groups NNS O
( : O
75 CD O
- SYM O
79 CD O
and CC O
> SYM O
= SYM O
80 CD O
y NN O
) , O
compared VBN O
to IN O
controls NNS O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

Cases NNS O
were VBD O
less RBR O
likely JJ O
to TO O
be VB O
married JJ O
than IN O
controls NNS O
, , O
in IN O
Kenya NNP O
( , O
OR CC O
0 CD O
. . O
6 CD O
, , O
95 CD O
% NN O
CI NN O
0 CD O
. . O
3 CD O
- SYM O
1 CD O
. . O
1 CD O
) -RRB- O
, , O
Bangladesh NNP O
( : O
0 CD O
. . O
6 CD O
, , O
0 CD O
. . O
4 CD O
- SYM O
1 CD O
. . O
0 CD O
) -RRB- O
, , O
and CC O
the DT O
Philippines NNP O
( , O
0 CD O
. . O
7 CD O
, , O
0 CD O
. . O
4 CD O
- SYM O
1 CD O
. . O
0 CD O
) -RRB- O
, , O
although IN O
this DT O
only RB O
reached VBD O
statistical JJ O
significance NN O
in IN O
Bangladesh NNP O
( : O
p NN O
= SYM O
0 CD O
. . O
3 CD O
) -RRB- O
. . O

There EX O
was VBD O
a DT O
strong JJ O
protective JJ O
effect NN O
of IN O
literacy NN O
and CC O
education NN O
on IN O
cataract NN O
in IN O
Bangladesh NNP O
and CC O
Kenya NNP O
that WDT O
was VBD O
not RB O
evident JJ O
in IN O
the DT O
Philippines NNPS O
. . O

Cases NNS O
were VBD O
substantially RB O
less RBR O
likely JJ O
to TO O
have VB O
a DT O
job NN O
other JJ O
than IN O
working VBG O
in IN O
the DT O
field NN O
compared VBN O
to IN O
controls NNS O
in IN O
all DT O
three CD O
countries NNS O
. . O

Cases NNS O
reported VBD O
significantly RB O
poorer JJR O
self NN O
- HYPH O
rated VBN O
health NN O
than IN O
controls NNS O
- : O
- : O
this DT O
pattern NN O
was VBD O
particularly RB O
evident JJ O
in IN O
the DT O
Philippines NNP O
( , O
OR CC O
for IN O
lowest JJS O
versus IN O
highest JJS O
quartile NN O
of IN O
self NN O
- HYPH O
rated VBN O
health NN O
= SYM O
5 CD O
. . O
7 CD O
, , O
95 CD O
% NN O
CI NN O
3 CD O
. . O
0 CD O
- SYM O
10 CD O
. . O
7 CD O
) -RRB- O
but CC O
also RB O
apparent JJ O
in IN O
Kenya NNP O
( : O
2 CD O
. . O
6 CD O
, , O
1 CD O
. . O
1 CD O
- SYM O
6 CD O
. . O
2 CD O
) -RRB- O
and CC O
Bangladesh NNP O
( : O
3 CD O
. . O
3 CD O
, , O
2 CD O
. . O
1 CD O
- SYM O
5 CD O
. . O
3 CD O
) -RRB- O
. . O

Summary JJ O
Wealth NN O
Measures NNS O

All DT O
three CD O
settings NNS O
were VBD O
poor JJ O
. . O

The DT O
mean JJ O
PCE NNP O
was VBD O
less JJR O
than IN O
US NNP O
$ $ O
1 CD O
per IN O
person NN B-Species
per IN O
day NN O
in IN O
all DT O
three CD O
settings NNS O
: : O
US NNP O
$ $ O
26 CD O
. . O
4 CD O
( SYM O
standard JJ O
deviation NN O
[ -LRB- O
SD NN O
] -RRB- O
= SYM O
US NNP O
$ $ O
34 CD O
. . O
9 CD O
) -RRB- O
in IN O
Kenya NNP O
, , O
US NNP O
$ $ O
21 CD O
. . O
7 CD O
( SYM O
US NNP O
$ $ O
48 CD O
. . O
0 CD O
) -RRB- O
in IN O
Bangladesh NNP O
and CC O
US NNP O
$ $ O
26 CD O
. . O
1 CD O
( SYM O
US NNP O
$ $ O
23 CD O
. . O
5 CD O
) -RRB- O
in IN O
the DT O
Philippines NNPS O
. . O

The DT O
biggest JJS O
expense NN O
was VBD O
food NN O
in IN O
all DT O
three CD O
settings NNS O
, , O
making VBG O
up RP O
55 CD O
% NN O
of IN O
PCE NNP O
in IN O
Kenya NNP O
, , O
47 CD O
% NN O
in IN O
Bangladesh NNP O
, , O
and CC O
64 CD O
% NN O
in IN O
the DT O
Philippines NNPS O
, , O
followed VBN O
by IN O
household NN O
expenses NNS O
including VBG O
rent NN O
( : O
21 CD O
% NN O
in IN O
Kenya NNP O
, , O
28 CD O
% NN O
Bangladesh NNP O
, , O
and CC O
22 CD O
% NN O
Philippines NNPS O
) -RRB- O
( , O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
majority NN O
of IN O
food NN O
consumption NN O
was VBD O
from IN O
direct JJ O
purchase NN O
( : O
70 CD O
% NN O
in IN O
Kenya NNP O
, , O
75 CD O
% NN O
in IN O
Bangladesh NNP O
, , O
and CC O
77 CD O
% NN O
in IN O
the DT O
Philippines NNP O
) -RRB- O
or CC O
home NN O
- HYPH O
grown VBN O
production NN O
( : O
24 CD O
% NN O
in IN O
Kenya NNP O
, , O
22 CD O
% NN O
in IN O
Bangladesh NNP O
, , O
and CC O
17 CD O
% NN O
in IN O
the DT O
Philippines NNP O
) -RRB- O
, , O
and CC O
little JJ O
was VBD O
from IN O
gifts NNS O
or CC O
payments NNS O
. . O

An DT O
asset NN O
score NN O
was VBD O
created VBN O
through IN O
PCA NNP O
in IN O
the DT O
three CD O
settings NNS O
. . O

The DT O
first JJ O
principal JJ O
component NN O
explained VBD O
22 CD O
% NN O
of IN O
the DT O
variability NN O
in IN O
asset NN O
variables NNS O
in IN O
Kenya NNP O
, , O
25 CD O
% NN O
in IN O
Bangladesh NNP O
, , O
and CC O
24 CD O
% NN O
in IN O
the DT O
Philippines NNPS O
. . O

Self NN O
- HYPH O
perceived VBN O
wealth NN O
of IN O
the DT O
household NN O
clustered VBN O
around IN O
the DT O
average NN O
with IN O
a DT O
large JJ O
proportion NN O
of IN O
households NNS O
in IN O
Kenya NNP O
( : O
48 CD O
% NN O
) -RRB- O
, , O
Bangladesh NNP O
( , O
43 CD O
% NN O
) -RRB- O
, , O
and CC O
the DT O
Philippines NNP O
( : O
64 CD O
% NN O
) -RRB- O
; , O
households NNS O
stating VBG O
that IN O
they PRP O
were VBD O
ranked VBN O
between IN O
4 CD O
and CC O
6 CD O
, , O
on IN O
a DT O
scale NN O
from IN O
1 CD O
to IN O
10 CD O
, , O
in IN O
terms NNS O
of IN O
wealth NN O
in IN O
their PRP$ O
community NN O
. . O

The DT O
three CD O
measures NNS O
of IN O
poverty NN O
were VBD O
highly RB O
correlated JJ O
, , O
each DT O
showing VBG O
significant JJ O
correlation NN O
( : O
p NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
with IN O
the DT O
other JJ O
measure NN O
. . O

Economic JJ O
and CC O
Household NNP O
Characteristics NNPS O
of IN O
Cases NNS O
and CC O
Controls NNS O

There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
PCE NNP O
, , O
assets NNS O
, , O
or CC O
household NN O
rank NN O
between IN O
cases NNS O
recruited VBN O
through IN O
the DT O
population NN O
- HYPH O
based VBN O
survey NN O
and CC O
those DT O
recruited VBN O
through IN O
case NN O
detection NN O
, , O
with IN O
the DT O
exception NN O
that IN O
the DT O
case NN O
- HYPH O
detection NN O
cases NNS O
had VBD O
lower JJR O
household NN O
rank NN O
in IN O
Kenya NNP O
( : O
mean NN O
= SYM O
3 CD O
. . O
7 CD O
versus IN O
3 CD O
. . O
1 CD O
, , O
p NN O
= SYM O
0 CD O
. . O
2 CD O
) -RRB- O
. . O

Consequently RB O
, , O
cases NNS O
recruited VBN O
through IN O
the DT O
two CD O
methods NNS O
were VBD O
combined VBN O
in IN O
the DT O
subsequent JJ O
analyses NNS O
. . O

Cases NNS O
were VBD O
poorer JJR O
than IN O
controls NNS O
, , O
in IN O
all DT O
three CD O
settings NNS O
according VBG O
to IN O
all DT O
three CD O
poverty NN O
measurements NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

The DT O
mean JJ O
PCE NNP O
was VBD O
20 CD O
% NN O
- SYM O
28 CD O
% NN O
lower JJR O
for IN O
members NNS O
of IN O
households NNS O
with IN O
a DT O
case NN O
than IN O
for IN O
control NN O
households NNS O
, , O
and CC O
this DT O
difference NN O
was VBD O
highly RB O
significant JJ O
in IN O
Bangladesh NNP O
and CC O
the DT O
Philippines NNPS O
; : O
for IN O
Kenya NNP O
it PRP O
was VBD O
lower JJR O
but CC O
did VBD O
not RB O
reach VB O
significance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
7 CD O
) -RRB- O
. . O

The DT O
PCA NNP O
score NN O
for IN O
assets NNS O
was VBD O
significantly RB O
lower JJR O
among IN O
cases NNS O
than IN O
controls NNS O
in IN O
Kenya NNP O
and CC O
Bangladesh NNP O
, , O
and CC O
it PRP O
was VBD O
lower JJR O
in IN O
the DT O
Philippines NNP O
although IN O
it PRP O
did VBD O
not RB O
reach VB O
significance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
6 CD O
) -RRB- O
. . O

Self NN O
- HYPH O
perceived VBN O
wealth NN O
was VBD O
significantly RB O
lower JJR O
for IN O
households NNS O
with IN O
a DT O
case NN O
compared VBN O
to IN O
control NN O
households NNS O
in IN O
Kenya NNP O
( : O
3 CD O
. . O
4 CD O
versus IN O
4 CD O
. . O
5 CD O
) -RRB- O
and CC O
Bangladesh NNP O
( : O
3 CD O
. . O
9 CD O
versus IN O
4 CD O
. . O
6 CD O
) -RRB- O
, , O
though IN O
not RB O
in IN O
the DT O
Philippines NNP O
( , O
4 CD O
. . O
1 CD O
versus IN O
4 CD O
. . O
3 CD O
) -RRB- O
. . O

There EX O
was VBD O
no DT O
difference NN O
in IN O
the DT O
size NN O
of IN O
the DT O
households NNS O
of IN O
cases NNS O
and CC O
controls NNS O
in IN O
any DT O
of IN O
the DT O
three CD O
settings NNS O
. . O

The DT O
ratio NN O
of IN O
dependents NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
household NN O
member NN O
aged VBN O
< $ O
15 CD O
or CC O
> SYM O
= SYM O
50 CD O
y NN O
) -RRB- O
to IN O
independents NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
household NN O
member NN O
aged VBN O
15 CD O
- SYM O
50 CD O
y NN O
) -RRB- O
was VBD O
similar JJ O
between IN O
cases NNS O
and CC O
controls NNS O
in IN O
Bangladesh NNP O
( : O
1 CD O
. . O
4 CD O
versus IN O
1 CD O
. . O
4 CD O
) -RRB- O
, , O
but CC O
the DT O
dependency NN O
ratio NN O
was VBD O
higher JJR O
for IN O
controls NNS O
than IN O
cases NNS O
in IN O
Kenya NNP O
( : O
2 CD O
. . O
1 CD O
versus IN O
1 CD O
. . O
6 CD O
) -RRB- O
and CC O
the DT O
Philippines NNP O
( : O
1 CD O
. . O
7 CD O
versus IN O
1 CD O
. . O
3 CD O
) -RRB- O
, , O
due IN O
to IN O
the DT O
smaller JJR O
number NN O
of IN O
people NNS B-Species
of IN O
working VBG O
age NN O
. . O

Patterns NNS O
of IN O
Expenditure NN O
in IN O
Cases NNS O
and CC O
Controls NNS O

Figure NN O
1 CD O
shows VBZ O
the DT O
total JJ O
PCE NNP O
and CC O
the DT O
allocation NN O
of IN O
expenditure NN O
within IN O
quartiles NNS O
of IN O
PCE NNP O
for IN O
cases NNS O
and CC O
controls NNS O
. . O

Monthly JJ O
PCE NNP O
was VBD O
similar JJ O
for IN O
cases NNS O
and CC O
controls NNS O
within IN O
each DT O
of IN O
the DT O
quartiles NNS O
of IN O
expenditure NN O
. . O

There EX O
was VBD O
a DT O
gradual JJ O
increase NN O
in IN O
PCE NNP O
between IN O
the DT O
first JJ O
three CD O
quartiles NNS O
, , O
and CC O
then RB O
a DT O
rapid JJ O
increase NN O
between IN O
the DT O
third JJ O
and CC O
the DT O
richest JJS O
quartile NN O
. . O

Within IN O
the DT O
first JJ O
three CD O
quartiles NNS O
of IN O
PCE NNP O
the DT O
majority NN O
of IN O
expenditure NN O
was VBD O
on IN O
food NN O
. . O

Substantial JJ O
expenditure NN O
on IN O
non JJ O
- HYPH O
food NN O
items NNS O
was VBD O
observed VBN O
only RB O
in IN O
the DT O
highest JJS O
quartile NN O
of IN O
expenditure NN O
, , O
where WRB O
about IN O
half NN O
of IN O
expenditure NN O
was VBD O
on IN O
non JJ O
- HYPH O
food NN O
items NNS O
. . O

Similar JJ O
patterns NNS O
of IN O
PCE NNP O
were VBD O
observed VBN O
for IN O
cases NNS O
and CC O
controls NNS O
in IN O
Kenya NNP O
, , O
Bangladesh NNP O
, , O
and CC O
the DT O
Philippines NNP O
within IN O
each DT O
quartile NN O
of IN O
expenditure NN O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
cataract JJ O
visual JJ O
impairment NN O
was VBD O
related VBN O
to IN O
reduced VBN O
PCE NNP O
, , O
but CC O
not RB O
allocation NN O
of IN O
expenditure NN O
. . O

Multivariate NN O
Analyses NNS O
of IN O
Poverty NN O
and CC O
Cataract NN O
Visual JJ O
Impairment NN O

Multivariate JJ O
analyses NNS O
showed VBD O
that IN O
case NN O
participants NNS B-Species
were VBD O
consistently RB O
poorer JJR O
than IN O
controls NNS O
in IN O
Kenya NNP O
, , O
Bangladesh NNP O
, , O
and CC O
the DT O
Philippines NNP O
, , O
using VBG O
three CD O
different JJ O
measures NNS O
of IN O
poverty NN O
( , O
Table NNP O
3 CD O
) -RRB- O
. . O

Cases NNS O
were VBD O
more RBR O
likely JJ O
than IN O
controls NNS O
to TO O
be VB O
in IN O
the DT O
lowest JJS O
quartile NN O
of IN O
PCE NNP O
rather RB O
than IN O
the DT O
highest JJS O
quartile NN O
in IN O
Kenya NNP O
( : O
OR CC O
2 CD O
. . O
3 CD O
, , O
95 CD O
% NN O
CI NN O
0 CD O
. . O
9 CD O
- SYM O
5 CD O
. . O
5 CD O
) -RRB- O
, , O
Bangladesh NNP O
( : O
1 CD O
. . O
9 CD O
, , O
1 CD O
. . O
1 CD O
- SYM O
3 CD O
. . O
2 CD O
) -RRB- O
and CC O
the DT O
Philippines NNP O
( : O
3 CD O
. . O
1 CD O
, , O
1 CD O
. . O
7 CD O
- SYM O
5 CD O
. . O
7 CD O
) -RRB- O
. . O

In IN O
all DT O
three CD O
settings NNS O
these DT O
associations NNS O
showed VBD O
significant JJ O
dose NN O
- HYPH O
response NN O
as IN O
assessed VBN O
by IN O
the DT O
p NN O
- HYPH O
value NN O
for IN O
trend NN O
across IN O
the DT O
quartiles NNS O
, , O
with IN O
decreasing VBG O
PCE NNP O
related VBN O
to IN O
case NN O
status NN O
and CC O
these DT O
relationships NNS O
persisted VBD O
after IN O
adjustment NN O
for IN O
self NN O
- HYPH O
rated VBN O
health NN O
and CC O
social JJ O
support NN O
indicators NNS O
. . O

A DT O
similar JJ O
pattern NN O
was VBD O
observed VBN O
for IN O
the DT O
relationship NN O
between IN O
case NN O
- HYPH O
control NN O
status NN O
and CC O
asset NN O
ownership NN O
. . O

Cases NNS O
were VBD O
significantly RB O
more RBR O
likely JJ O
to TO O
be VB O
in IN O
the DT O
lowest JJS O
quartile NN O
of IN O
asset NN O
ownership NN O
rather RB O
than IN O
the DT O
highest JJS O
quartile NN O
compared VBN O
to IN O
controls NNS O
in IN O
Kenya NNP O
( : O
3 CD O
. . O
7 CD O
, , O
1 CD O
. . O
4 CD O
- SYM O
9 CD O
. . O
6 CD O
) -RRB- O
, , O
Bangladesh NNP O
( : O
2 CD O
. . O
6 CD O
, , O
1 CD O
. . O
5 CD O
- SYM O
4 CD O
. . O
4 CD O
) -RRB- O
, , O
and CC O
the DT O
Philippines NNP O
( , O
2 CD O
. . O
1 CD O
, , O
1 CD O
. . O
1 CD O
- SYM O
3 CD O
. . O
8 CD O
) -RRB- O
. . O

Cases NNS O
were VBD O
also RB O
significantly RB O
more RBR O
likely JJ O
to TO O
be VB O
in IN O
the DT O
lowest JJS O
quartile NN O
of IN O
household NN O
rank NN O
rather RB O
than IN O
the DT O
highest JJS O
, , O
compared VBN O
to IN O
controls NNS O
in IN O
Kenya NNP O
( : O
3 CD O
. . O
5 CD O
, , O
1 CD O
. . O
5 CD O
- SYM O
8 CD O
. . O
0 CD O
) -RRB- O
, , O
Bangladesh NNP O
( : O
2 CD O
. . O
7 CD O
, , O
1 CD O
. . O
6 CD O
- SYM O
4 CD O
. . O
7 CD O
) -RRB- O
and CC O
the DT O
Philippines NNP O
( : O
2 CD O
. . O
3 CD O
, , O
1 CD O
. . O
1 CD O
- SYM O
4 CD O
. . O
8 CD O
) -RRB- O
. . O

The DT O
associations NNS O
with IN O
assets NNS O
and CC O
household NN O
rank NN O
also RB O
showed VBD O
a DT O
significant JJ O
dose NN O
- HYPH O
response NN O
relationship NN O
, , O
and CC O
the DT O
associations NNS O
were VBD O
largely RB O
unchanged JJ O
after IN O
adjustment NN O
for IN O
self NN O
- HYPH O
rated VBN O
health NN O
and CC O
social JJ O
support NN O
indicators NNS O
. . O

In IN O
Kenya NNP O
and CC O
Bangladesh NNP O
the DT O
relationship NN O
between IN O
PCE NNP O
and CC O
case NN O
status NN O
was VBD O
somewhat RB O
weaker JJR O
than IN O
for IN O
the DT O
other JJ O
measures NNS O
of IN O
poverty NN O
, , O
while IN O
the DT O
reverse NN O
was VBD O
true JJ O
in IN O
the DT O
Philippines NNPS O
. . O

Stratifying VBG O
the DT O
association NN O
between IN O
PCE NN O
and CC O
cataract NN O
visual JJ O
impairment NN O
by IN O
level NN O
of IN O
visual JJ O
impairment NN O
showed VBD O
an DT O
inconsistent JJ O
pattern NN O
( -LRB- O
Table NNP O
4 CD O
) -RRB- O
. . O

In IN O
Kenya NNP O
, , O
the DT O
association NN O
with IN O
low JJ O
PCE NNP O
was VBD O
somewhat RB O
stronger JJR O
comparing VBG O
cataract NN O
blind JJ O
cases NNS O
to IN O
controls NNS O
( -LRB- O
OR CC O
3 CD O
. . O
1 CD O
, , O
95 CD O
% NN O
CI NN O
0 CD O
. . O
9 CD O
- SYM O
10 CD O
. . O
8 CD O
) -RRB- O
than IN O
comparing VBG O
moderate JJ O
visually RB O
impaired VBN O
cases NNS O
to IN O
controls NNS O
( : O
1 CD O
. . O
8 CD O
, , O
0 CD O
. . O
6 CD O
- SYM O
5 CD O
. . O
4 CD O
) -RRB- O
, , O
while IN O
this DT O
pattern NN O
was VBD O
reversed VBN O
in IN O
Bangladesh NNP O
( , O
blind JJ O
cases NNS O
versus IN O
controls NNS O
: : O
1 CD O
. . O
8 CD O
, , O
1 CD O
. . O
0 CD O
- SYM O
3 CD O
. . O
4 CD O
; : O
moderately RB O
visually RB O
impaired VBN O
cases NNS O
versus IN O
controls NNS O
: : O
3 CD O
. . O
1 CD O
, , O
1 CD O
. . O
3 CD O
- SYM O
7 CD O
. . O
2 CD O
) -RRB- O
. . O

In IN O
the DT O
Philippines NNP O
the DT O
association NN O
with IN O
low JJ O
PCE NNP O
was VBD O
strongest JJS O
comparing VBG O
severely RB O
visually RB O
impaired VBN O
cases NNS O
to IN O
controls NNS O
( : O
5 CD O
. . O
9 CD O
, , O
2 CD O
. . O
0 CD O
- SYM O
17 CD O
. . O
6 CD O
) -RRB- O
. . O

The DT O
association NN O
between IN O
cataract NN O
visual JJ O
impairment NN O
and CC O
PCE NNP O
was VBD O
stronger JJR O
among IN O
men NNS B-Species
than IN O
women NNS B-Species
in IN O
Bangladesh NNP O
and CC O
the DT O
Philippines NNPS O
, , O
while IN O
the DT O
reverse NN O
was VBD O
true JJ O
in IN O
Kenya NNP O
( : O
Table NNP O
5 CD O
) -RRB- O
. . O

In IN O
Kenya NNP O
and CC O
the DT O
Philippines NNP O
the DT O
strongest JJS O
association NN O
between IN O
cataract NN O
and CC O
PCE NNP O
was VBD O
among IN O
people NNS B-Species
aged VBN O
70 CD O
- SYM O
79 CD O
y NN O
, , O
while IN O
in IN O
Bangladesh NNP O
the DT O
strongest JJS O
effect NN O
was VBD O
in IN O
people NNS B-Species
aged VBN O
over IN O
80 CD O
y NN O
. . O

Stratifying VBG O
the DT O
association NN O
between IN O
assets NNS O
and CC O
household NN O
rank NN O
with IN O
cataract NN O
by IN O
level NN O
of IN O
visual JJ O
impairment NN O
, , O
sex NN O
, , O
or CC O
age NN O
broadly RB O
repeated VBD O
these DT O
findings NNS O
, , O
and CC O
generally RB O
supported VBD O
the DT O
lack NN O
of IN O
consistent JJ O
pattern NN O
( , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

Discussion NN O

This DT O
large JJ O
, , O
multicentre JJ O
population NN O
- HYPH O
based VBN O
case NN O
- HYPH O
control NN O
study NN O
provides VBZ O
evidence NN O
that IN O
people NNS B-Species
with IN O
visual JJ O
impairment NN O
from IN O
cataract NN O
are VBP O
poorer JJR O
than IN O
control NN O
participants NNS B-Species
with IN O
normal JJ O
vision NN O
matched VBN O
for IN O
age NN O
and CC O
sex NN O
. . O

This DT O
pattern NN O
was VBD O
evident JJ O
whether IN O
poverty NN O
was VBD O
measured VBN O
in IN O
terms NNS O
of IN O
PCE NNP O
, , O
assets NNS O
, , O
or CC O
self NN O
- HYPH O
rated VBN O
wealth NN O
. . O

Marital JJ O
status NN O
seemed VBD O
to TO O
be VB O
protective JJ O
for IN O
cataract NN O
visual JJ O
impairment NN O
, , O
possibly RB O
indicating VBG O
the DT O
role NN O
of IN O
social JJ O
support NN O
in IN O
health NN O
- HYPH O
seeking NN O
behaviour NN O
. . O

Reduced VBN O
self NN O
- HYPH O
rated VBN O
health NN O
was VBD O
also RB O
strongly RB O
related VBN O
to IN O
cataract NN O
visual JJ O
impairment NN O
. . O

This DT O
demonstrates VBZ O
the DT O
impact NN O
of IN O
poor JJ O
vision NN O
on IN O
overall JJ O
assessments NNS O
of IN O
health NN O
and CC O
supports VBZ O
our PRP$ O
previous JJ O
finding NN O
of IN O
a DT O
relationship NN O
between IN O
cataract NN O
and CC O
quality NN O
of IN O
life NN O
[ -LRB- O
17 CD O
] -RRB- O
. . O

Adjustment NN O
for IN O
marital JJ O
status NN O
and CC O
self NN O
- HYPH O
rated VBN O
health NN O
did VBD O
not RB O
entirely RB O
explain VB O
the DT O
association NN O
between IN O
poverty NN O
and CC O
cataract NN O
visual JJ O
impairment NN O
, , O
suggesting VBG O
that IN O
it PRP O
operated VBD O
through IN O
other JJ O
pathways NNS O
. . O

Visual JJ O
impairment NN O
could MD O
cause VB O
poverty NN O
through IN O
reduced VBN O
employment NN O
opportunities NNS O
. . O

We PRP O
might MD O
therefore RB O
expect VB O
to TO O
see VB O
a DT O
stronger JJR O
relationship NN O
between IN O
cataract NN O
and CC O
poverty NN O
among IN O
the DT O
blind JJ O
case NN O
participants NNS B-Species
who WP O
may MD O
have VB O
fewer JJR O
employment NN O
opportunities NNS O
than IN O
among IN O
those DT O
less RBR O
impaired VBN O
( : O
i PRP O
. . O
e -RRB- O
. . O
, , O
moderate JJ O
visual JJ O
impairment NN O
) -RRB- O
. . O

Poverty NN O
may MD O
also RB O
cause VB O
visual JJ O
impairment NN O
through IN O
restricted JJ O
access NN O
to IN O
cataract NN O
surgery NN O
. . O

In IN O
this DT O
case NN O
we PRP O
would MD O
expect VB O
to TO O
see VB O
a DT O
stronger JJR O
relationship NN O
between IN O
poverty NN O
and CC O
less RBR O
severely RB O
affected VBN O
cases NNS O
( : O
i LS O
. . O
e LS O
. . O
, , O
moderate JJ O
visual JJ O
impairment NN O
) -RRB- O
, , O
as IN O
poor JJ O
families NNS O
may MD O
allocate VB O
money NN O
for IN O
surgery NN O
on IN O
members NNS O
who WP O
are VBP O
blind JJ O
from IN O
cataract NN O
, , O
so IN O
that IN O
poverty NN O
mainly RB O
restricts VBZ O
access NN O
to IN O
surgery NN O
among IN O
people NNS B-Species
who WP O
are VBP O
moderately RB O
visually RB O
impaired JJ O
. . O

The DT O
relationships NNS O
that WDT O
we PRP O
observed VBD O
between IN O
level NN O
of IN O
visual JJ O
impairment NN O
and CC O
cataract NN O
were VBD O
inconsistent JJ O
across IN O
the DT O
three CD O
settings NNS O
. . O

Perhaps RB O
this DT O
shows VBZ O
that IN O
both DT O
pathways NNS O
were VBD O
operating VBG O
or CC O
that IN O
the DT O
dynamics NNS O
of IN O
the DT O
relationship NN O
between IN O
poverty NN O
and CC O
blindness NN O
vary VBP O
in IN O
different JJ O
settings NNS O
. . O

Levels NNS O
of IN O
literacy NN O
and CC O
education NN O
were VBD O
lower JJR O
among IN O
cases NNS O
than IN O
controls NNS O
. . O

These DT O
long JJ O
- HYPH O
term NN O
indicators NNS O
of IN O
disadvantage NN O
are VBP O
unlikely JJ O
to TO O
have VB O
changed VBN O
after IN O
the DT O
onset NN O
of IN O
cataract NN O
. . O

This DT O
observation NN O
provides VBZ O
some DT O
evidence NN O
that IN O
poverty NN O
preceded VBD O
blindness NN O
in IN O
our PRP$ O
study NN O
participants NNS B-Species
. . O

It PRP O
is VBZ O
frequently RB O
asserted VBN O
that IN O
blindness NN O
is VBZ O
both CC O
a DT O
cause NN O
and CC O
consequence NN O
of IN O
poverty NN O
, , O
but CC O
there EX O
are VBP O
few JJ O
empirical JJ O
data NNS O
to TO O
support VB O
this DT O
claim NN O
. . O

Globally RB O
, , O
the DT O
prevalence NN O
of IN O
blindness NN O
is VBZ O
five CD O
- HYPH O
fold NN O
higher JJR O
in IN O
poor JJ O
than IN O
rich JJ O
countries NNS O
[ -LRB- O
2 CD O
] -RRB- O
, , O
and CC O
data NNS O
from IN O
Pakistan NNP O
and CC O
India NNP O
suggest VBP O
that IN O
within IN O
countries NNS O
the DT O
poor JJ O
are VBP O
more RBR O
likely JJ O
to TO O
be VB O
blind JJ O
[ -LRB- O
3 CD O
, , O
4 CD O
] -RRB- O
. . O

Some DT O
blinding VBG O
conditions NNS O
are VBP O
a DT O
direct JJ O
consequence NN O
of IN O
poverty NN O
, , O
notably RB O
trachoma NN O
, , O
which WDT O
thrives VBZ O
in IN O
poor JJ O
areas NNS O
lacking VBG O
water NN O
and CC O
sanitation NN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Other JJ O
blinding VBG O
diseases NNS O
clearly RB O
contribute VBP O
to IN O
poverty NN O
, , O
such JJ O
as IN O
onchocerciasis NN O
, , O
which WDT O
results VBZ O
in IN O
the DT O
abandonment NN O
of IN O
the DT O
fertile JJ O
areas NNS O
near IN O
to IN O
the DT O
rivers NNS O
where WRB O
the DT O
disease NN O
vector NN O
thrives VBZ O
[ -LRB- O
9 CD O
] -RRB- O
. . O

A DT O
larger JJR O
literature NN O
shows VBZ O
that IN O
poor JJ O
people NNS B-Species
are VBP O
more RBR O
likely JJ O
to TO O
be VB O
ill JJ O
or CC O
disabled JJ O
than IN O
their PRP$ O
richer JJR O
compatriots NNS O
, , O
ranging VBG O
from IN O
general JJ O
disability NN O
in IN O
India NNP O
, , O
Bulgaria NNP O
, , O
and CC O
Ghana NNP O
[ -LRB- O
21 CD O
] -RRB- O
; , O
common JJ O
mental JJ O
disorders NNS O
in IN O
Brazil NNP O
, , O
Chile NNP O
, , O
India NNP O
, , O
and CC O
Zimbabwe NNP O
[ -LRB- O
22 CD O
] -RRB- O
; , O
deafness NN O
in IN O
Brazil NNP O
[ -LRB- O
23 CD O
] -RRB- O
; , O
and CC O
tuberculosis NN O
in IN O
China NNP O
[ -LRB- O
24 CD O
] -RRB- O
. . O

There EX O
are VBP O
also RB O
some DT O
exceptions NNS O
such JJ O
as IN O
a DT O
case NN O
- HYPH O
control NN O
study NN O
in IN O
Rwanda NNP O
which WDT O
failed VBD O
to TO O
show VB O
an DT O
association NN O
between IN O
PCE NNP O
and CC O
musculoskeletal JJ O
impairment NN O
, , O
perhaps RB O
because IN O
the DT O
population NN O
was VBD O
almost RB O
universally RB O
poor JJ O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Poverty NN O
may MD O
increase VB O
the DT O
incidence NN O
of IN O
disease NN O
, , O
particularly RB O
preventable JJ O
diseases NNS O
such JJ O
as IN O
tuberculosis NN O
. . O

Poverty NN O
may MD O
also RB O
restrict VB O
access NN O
to IN O
appropriate JJ O
health NN O
care NN O
and CC O
so RB O
prolong VB O
the DT O
duration NN O
of IN O
disease NN O
. . O

A DT O
study NN O
in IN O
rural JJ O
Tanzania NNP O
showed VBD O
that IN O
care NN O
- HYPH O
seeking NN O
behaviour NN O
for IN O
childhood NN O
illness NN O
is VBZ O
worse JJR O
among IN O
poorer JJR O
families NNS O
than IN O
among IN O
the DT O
relatively RB O
rich JJ O
families NNS O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Another DT O
Tanzanian JJ O
study NN O
found VBD O
that IN O
people NNS B-Species
with IN O
higher JJR O
levels NNS O
of IN O
asset NN O
ownership NN O
were VBD O
more RBR O
likely JJ O
to TO O
obtain VB O
antimalarials NNS O
even RB O
though IN O
they PRP O
were VBD O
less RBR O
likely JJ O
to TO O
be VB O
parasitaemic JJ O
[ -LRB- O
27 CD O
] -RRB- O
. . O

With IN O
respect NN O
to IN O
cataract NN O
, , O
there EX O
is VBZ O
little JJ O
evidence NN O
that IN O
prevention NN O
is VBZ O
possible JJ O
, , O
and CC O
so CC O
the DT O
main JJ O
pathway NN O
from IN O
poverty NN O
to IN O
blindness NN O
is VBZ O
likely JJ O
to TO O
be VB O
through IN O
reduced VBN O
access NN O
to IN O
cataract NN O
surgical JJ O
services NNS O
. . O

High JJ O
health NN O
care NN O
costs NNS O
may MD O
also RB O
exacerbate VB O
poverty NN O
. . O

A DT O
study NN O
in IN O
rural JJ O
China NNP O
showed VBD O
that IN O
ill JJ O
health NN O
increases VBZ O
medical JJ O
expenditure NN O
significantly RB O
, , O
which WDT O
detracts VBZ O
from IN O
expenditure NN O
on IN O
food NN O
, , O
education NN O
, , O
investment NN O
in IN O
farming NN O
, , O
and CC O
participation NN O
in IN O
social JJ O
activities NNS O
[ -LRB- O
28 CD O
] -RRB- O
. . O

Inability NN O
to TO O
afford VB O
cataract NN O
surgery NN O
is VBZ O
cited VBN O
as IN O
the DT O
major JJ O
barrier NN O
to IN O
the DT O
uptake NN O
of IN O
surgery NN O
in IN O
the DT O
surveys NNS O
conducted VBN O
in IN O
Kenya NNP O
, , O
the DT O
Philippines NNP O
, , O
and CC O
Bangladesh NNP O
[ -LRB- O
6 CD O
- SYM O
8 CD O
] -RRB- O
. . O

This DT O
indicates VBZ O
that IN O
the DT O
cost NN O
of IN O
surgery NN O
is VBZ O
perceived VBN O
as IN O
substantial JJ O
by IN O
many JJ O
households NNS O
, , O
notwithstanding IN O
the DT O
problems NNS O
of IN O
assessing VBG O
the DT O
complex JJ O
issue NN O
of IN O
barriers NNS O
in IN O
the DT O
absence NN O
of IN O
in IN O
- HYPH O
depth NN O
qualitative JJ O
interviews NNS O
. . O

Consequently RB O
, , O
there EX O
are VBP O
lower JJR O
rates NNS O
of IN O
cataract NN O
surgery NN O
among IN O
the DT O
poor JJ O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Poverty NN O
may MD O
also RB O
limit VB O
the DT O
employment NN O
opportunities NNS O
of IN O
the DT O
person NN B-Species
with IN O
disability NN O
or CC O
their PRP$ O
household NN O
members NNS O
. . O

This DT O
pattern NN O
has VBZ O
been VBN O
demonstrated VBN O
for IN O
people NNS B-Species
with IN O
HIV NNP B-Species
in IN O
South NNP O
Africa NNP O
[ -LRB- O
29 CD O
] -RRB- O
, , O
tuberculosis NN O
in IN O
China NNP O
[ -LRB- O
24 CD O
] -RRB- O
, , O
or CC O
disability NN O
in IN O
Sri NNP O
Lanka NNP O
[ -LRB- O
22 CD O
] -RRB- O
. . O

An DT O
impact NN O
of IN O
blindness NN O
on IN O
reduced VBN O
employment NN O
or CC O
income NN O
has VBZ O
been VBN O
observed VBN O
in IN O
Guinea NNP O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
India NNP O
[ -LRB- O
4 CD O
] -RRB- O
. . O

A DT O
belief NN O
that IN O
blindness NN O
reduces VBZ O
the DT O
employment NN O
opportunities NNS O
of IN O
household NN O
members NNS O
is VBZ O
widespread JJ O
, , O
but CC O
so RB O
far RB O
there EX O
is VBZ O
limited JJ O
supportive JJ O
evidence NN O
. . O

There EX O
is VBZ O
a DT O
further JJ O
complication NN O
to IN O
investigations NNS O
of IN O
the DT O
relationship NN O
between IN O
cataract NN O
and CC O
poverty NN O
, , O
as IN O
the DT O
individuals NNS O
with IN O
cataract NN O
are VBP O
likely JJ O
to TO O
be VB O
elderly JJ O
and CC O
facing VBG O
multiple JJ O
disabilities NNS O
. . O

Our PRP$ O
study NN O
took VBD O
account NN O
of IN O
the DT O
potential JJ O
impact NN O
of IN O
multiple JJ O
disabilities NNS O
, , O
as IN O
we PRP O
adjusted VBD O
for IN O
self NN O
- HYPH O
rated VBN O
health NN O
, , O
which WDT O
is VBZ O
closely RB O
related JJ O
to IN O
overall JJ O
health NN O
, , O
and CC O
this DT O
adjustment NN O
had VBD O
no DT O
overall JJ O
impact NN O
on IN O
our PRP$ O
results NNS O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Study NN O
Strengths NNS O

This DT O
was VBD O
a DT O
large JJ O
population NN O
- HYPH O
based VBN O
case NN O
- HYPH O
control NN O
study NN O
, , O
conducted VBN O
in IN O
three CD O
countries NNS O
, , O
allowing VBG O
international JJ O
comparisons NNS O
. . O

This DT O
was VBD O
the DT O
first JJ O
study NN O
, , O
to IN O
our PRP$ O
knowledge NN O
, , O
to TO O
relate VB O
PCE NN O
to IN O
visual JJ O
impairment NN O
. . O

We PRP O
also RB O
measured VBD O
assets NNS O
, , O
which WDT O
reflects VBZ O
long JJ O
- HYPH O
term NN O
access NN O
to IN O
resources NNS O
, , O
and CC O
self NN O
- HYPH O
rated VBN O
wealth NN O
. . O

We PRP O
used VBD O
expenditure NN O
as IN O
a DT O
proxy NN O
for IN O
income NN O
, , O
which WDT O
has VBZ O
aided VBN O
both CC O
academic JJ O
and CC O
nonacademic JJ O
investigations NNS O
. . O

As IN O
one CD O
example NN O
, , O
the DT O
notorious JJ O
Chicago NNP O
gangster NN O
Al NNP O
Capone NNP O
managed VBD O
to TO O
escape VB O
prosecution NN O
for IN O
smuggling NN O
, , O
gambling NN O
, , O
bootlegging NN O
, , O
and CC O
murder NN O
for IN O
years NNS O
, , O
but CC O
was VBD O
eventually RB O
convicted VBN O
of IN O
tax NN O
evasion NN O
, , O
because IN O
the DT O
jury NN O
was VBD O
convinced JJ O
that IN O
his PRP$ O
exorbitant JJ O
expenses NNS O
on IN O
clothes NNS O
, , O
furnishing NN O
, , O
foods NNS O
, , O
and CC O
gifts NNS O
were VBD O
inconsistent JJ O
with IN O
his PRP$ O
claim NN O
that IN O
he PRP O
had VBD O
no DT O
income NN O
. . O

Expenditure NN O
often RB O
provides VBZ O
a DT O
better JJR O
measure NN O
of IN O
poverty NN O
than IN O
income NN O
for IN O
a DT O
number NN O
of IN O
reasons NNS O
. . O

Income NN O
may MD O
be VB O
variable JJ O
by IN O
season NN O
, , O
whereas IN O
households NNS O
attempt VBP O
to TO O
smooth VB O
expenditure NN O
over IN O
the DT O
year NN O
. . O

People NNS B-Species
are VBP O
more RBR O
comfortable JJ O
sharing VBG O
information NN O
about IN O
expenditure NN O
than IN O
income NN O
, , O
and CC O
it PRP O
may MD O
be VB O
a DT O
more RBR O
meaningful JJ O
measure NN O
than IN O
income NN O
in IN O
an DT O
agrarian JJ O
society NN O
as IN O
it PRP O
reflects VBZ O
what WP O
the DT O
household NN O
is VBZ O
able JJ O
to TO O
command VB O
based VBN O
on IN O
its PRP$ O
current JJ O
income NN O
, , O
borrowing NN O
ability NN O
, , O
or CC O
household NN O
savings NNS O
[ -LRB- O
31 CD O
] -RRB- O
. . O

PCE NNP O
also RB O
has VBZ O
advantages NNS O
over IN O
assets NNS O
, , O
as IN O
it PRP O
may MD O
be VB O
more RBR O
responsive JJ O
to IN O
change NN O
, , O
which WDT O
will MD O
be VB O
important JJ O
for IN O
the DT O
follow NN O
- HYPH O
up NN O
analyses NNS O
of IN O
the DT O
study NN O
participants NNS B-Species
after IN O
they PRP O
have VBP O
undergone VBN O
cataract NN O
surgery NN O
. . O

Study NN O
Limitations NNS O

There EX O
are VBP O
a DT O
number NN O
of IN O
limitations NNS O
relating VBG O
to IN O
the DT O
measurement NN O
of IN O
poverty NN O
in IN O
this DT O
study NN O
. . O

Our PRP$ O
analyses NNS O
focus VBP O
on IN O
monetary JJ O
indicators NNS O
of IN O
poverty NN O
, , O
while IN O
we PRP O
acknowledge VBP O
that IN O
health NN O
, , O
education NN O
, , O
and CC O
housing NN O
are VBP O
also RB O
important JJ O
. . O

We PRP O
concede VBP O
that IN O
it PRP O
is VBZ O
difficult JJ O
to TO O
measure VB O
expenditure NN O
accurately RB O
[ -LRB- O
32 CD O
, , O
33 CD O
] -RRB- O
, , O
but CC O
this DT O
also RB O
true JJ O
for IN O
the DT O
measurement NN O
of IN O
diet NN O
and CC O
other JJ O
variables NNS O
, , O
which WDT O
is VBZ O
standard JJ O
practise NN O
in IN O
many JJ O
epidemiological JJ O
studies NNS O
. . O

Furthermore RB O
, , O
a DT O
large JJ O
number NN O
of IN O
items NNS O
were VBD O
included VBN O
in IN O
our PRP$ O
measure NN O
of IN O
expenditure NN O
so IN O
that IN O
the DT O
measure NN O
was VBD O
comprehensive JJ O
[ -LRB- O
33 CD O
] -RRB- O
. . O

Expenditure NN O
data NNS O
were VBD O
not RB O
validated VBN O
through IN O
diaries NNS O
or CC O
other JJ O
means NNS O
, , O
although IN O
assets NNS O
and CC O
self NN O
- HYPH O
rated VBN O
wealth NN O
correlated VBN O
highly RB O
with IN O
PCE NNP O
. . O

Other JJ O
recent JJ O
estimates NNS O
of IN O
expenditure NN O
are VBP O
not RB O
available JJ O
from IN O
surveys NNS O
conducted VBN O
in IN O
these DT O
countries NNS O
to TO O
allow VB O
comparison NN O
. . O

The DT O
per IN O
capita FW O
estimates NNS O
of IN O
monthly JJ O
gross JJ O
national JJ O
income NN O
from IN O
the DT O
World NNP O
Development NNP O
Indicators NNP O
database NN O
show VBP O
somewhat RB O
higher JJR O
estimates NNS O
in IN O
Kenya NNP O
( : O
US NNP O
$ $ O
48 CD O
) -RRB- O
and CC O
Bangladesh NNP O
( : O
US NNP O
$ $ O
40 CD O
) -RRB- O
than IN O
our PRP$ O
PCE NNP O
derived VBN O
estimates NNS O
, , O
and CC O
far RB O
higher JJR O
estimates NNS O
for IN O
the DT O
Philippines NNP O
( -LRB- O
US NNP O
$ $ O
108 CD O
) -RRB- O
. . O

This DT O
discrepancy NN O
may MD O
be VB O
reasonable JJ O
, , O
as IN O
the DT O
World NNP O
Development NNP O
Indicators NNPS O
reflect VBP O
national JJ O
averages NNS O
, , O
while IN O
we PRP O
sampled VBD O
the DT O
households NNS O
with IN O
elderly JJ O
people NNS B-Species
in IN O
poor JJ O
regions NNS O
of IN O
the DT O
country NN O
, , O
many DT O
of IN O
whom WP O
were VBD O
visually RB O
impaired VBN O
from IN O
cataract NN O
. . O

PCE NNP O
was VBD O
calculated VBN O
simply RB O
by IN O
dividing VBG O
the DT O
total JJ O
household NN O
expenditure NN O
by IN O
the DT O
number NN O
of IN O
household NN O
members NNS O
, , O
without IN O
inclusion NN O
of IN O
economies NNS O
of IN O
scale NN O
or CC O
equivalence NN O
scales NNS O
. . O

There EX O
is VBZ O
no DT O
widely RB O
accepted VBN O
alternative NN O
to IN O
the DT O
simple JJ O
equal JJ O
- HYPH O
sharing VBG O
convention NN O
, , O
and CC O
the DT O
majority NN O
of IN O
expenditure NN O
was VBD O
on IN O
food NN O
which WDT O
does VBZ O
not RB O
allow VB O
for IN O
economies NNS O
of IN O
scale NN O
. . O

Furthermore RB O
, , O
there EX O
were VBD O
slightly RB O
fewer JJR O
people NNS B-Species
of IN O
working VBG O
age NN O
in IN O
the DT O
control NN O
households NNS O
in IN O
Kenya NNP O
and CC O
the DT O
Philippines NNP O
, , O
so IN O
adjustment NN O
for IN O
equivalence NN O
scores NNS O
would MD O
be VB O
unlikely JJ O
to TO O
explain VB O
the DT O
higher JJR O
poverty NN O
among IN O
cases NNS O
. . O

The DT O
case NN O
and CC O
control NN O
households NNS O
were VBD O
of IN O
similar JJ O
sizes NNS O
in IN O
the DT O
three CD O
settings NNS O
, , O
so IN O
economies NNS O
of IN O
scales NNS O
are VBP O
unlikely JJ O
to TO O
have VB O
explained VBN O
the DT O
differences NNS O
. . O

There EX O
were VBD O
a DT O
number NN O
of IN O
limitations NNS O
relating VBG O
to IN O
study NN O
design NN O
. . O

Unfortunately RB O
, , O
we PRP O
did VBD O
not RB O
record VB O
the DT O
exact JJ O
numbers NNS O
of IN O
cases NNS O
and CC O
controls NNS O
who WP O
refused VBD O
to TO O
participate VB O
or CC O
were VBD O
unable JJ O
to TO O
communicate VB O
( , O
believed VBN O
to TO O
be VB O
fewer JJR O
than IN O
five CD O
in IN O
each DT O
country NN O
) -RRB- O
, , O
so CC O
the DT O
response NN O
rate NN O
is VBZ O
unknown JJ O
, , O
but CC O
was VBD O
believed VBN O
to TO O
be VB O
high JJ O
. . O

A DT O
variety NN O
of IN O
methods NNS O
were VBD O
used VBN O
for IN O
case NN O
recruitment NN O
, , O
as IN O
we PRP O
were VBD O
not RB O
able JJ O
to TO O
obtain VB O
enough JJ O
cases NNS O
through IN O
the DT O
survey NN O
alone RB O
. . O

However RB O
, , O
cases NNS O
recruited VBN O
through IN O
the DT O
population NN O
- HYPH O
based VBN O
survey NN O
and CC O
through IN O
case NN O
detection NN O
had VBD O
similar JJ O
poverty NN O
characteristics NNS O
. . O

Conclusions NNS O

Our PRP$ O
data NNS O
show VBP O
that IN O
people NNS B-Species
with IN O
visual JJ O
impairment NN O
due JJ O
to IN O
cataract NN O
were VBD O
poorer JJR O
than IN O
controls NNS O
in IN O
three CD O
low JJ O
income NN O
countries NNS O
, , O
Bangladesh NNP O
, , O
Kenya NNP O
, , O
and CC O
the DT O
Philippines NNP O
. . O

The DT O
Millennium NNP O
Development NNP O
Goals NNPS O
are VBP O
committed JJ O
to IN O
the DT O
eradication NN O
of IN O
extreme JJ O
poverty NN O
and CC O
provision NN O
of IN O
health NN O
care NN O
to IN O
poor JJ O
people NNS B-Species
. . O

This DT O
study NN O
confirms VBZ O
an DT O
association NN O
between IN O
poverty NN O
and CC O
blindness NN O
and CC O
highlights VBZ O
the DT O
need NN O
for IN O
increased VBN O
provision NN O
of IN O
cataract NN O
surgery NN O
to IN O
poor JJ O
people NNS B-Species
, , O
particularly RB O
since IN O
cataract NN O
surgery NN O
is VBZ O
a DT O
highly RB O
cost NN O
- HYPH O
effective JJ O
intervention NN O
in IN O
these DT O
settings NNS O
[ -LRB- O
34 CD O
] -RRB- O
. . O

Human JJ B-Species
genetic JJ O
selection NN O
on IN O
the DT O
MTHFR NNP O
677C NNP O
> : O
T NN O
polymorphism NN O

Abstract JJ O

Background NN O

The DT O
prevalence NN O
of IN O
genotypes NNS O
of IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
for IN O
the DT O
MTHFR NNP O
gene NN O
varies VBZ O
among IN O
humans NNS B-Species
. . O

In IN O
previous JJ O
studies NNS O
, , O
we PRP O
found VBD O
changes NNS O
in IN O
the DT O
genotypic JJ O
frequencies NNS O
of IN O
this DT O
polymorphism NN O
in IN O
populations NNS O
of IN O
different JJ O
ages NNS O
, , O
suggesting VBG O
that IN O
this DT O
could MD O
be VB O
caused VBN O
by IN O
an DT O
increase NN O
in IN O
the DT O
intake NN O
of IN O
folate NN O
and CC O
multivitamins NNS O
by IN O
women NNS B-Species
during IN O
the DT O
periconceptional JJ O
period NN O
. . O

The DT O
aim NN O
was VBD O
to TO O
analyze VB O
changes NNS O
in IN O
the DT O
allelic JJ O
frequencies NNS O
of IN O
this DT O
polymorphism NN O
in IN O
a DT O
Spanish JJ O
population NN O
, , O
including VBG O
samples NNS O
from IN O
spontaneous JJ O
abortions NNS O
( -LRB- O
SA NNP O
) -RRB- O
. . O

Methods NNS O

A DT O
total NN O
of IN O
1305 CD O
subjects NNS O
born VBN O
in IN O
the DT O
20th JJ O
century NN O
were VBD O
genotyped VBN O
for IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
using VBG O
allele NN O
specific JJ O
real JJ O
- HYPH O
time NN O
PCR NN O
with IN O
Taqman NNP O
( , O
R NNP O
) -RRB- O
probes NNS O
. . O

A DT O
section NN O
of IN O
our PRP$ O
population NN O
( , O
n CD O
= SYM O
276 CD O
) -RRB- O
born VBN O
in IN O
1980 CD O
- SYM O
1989 CD O
was VBD O
compared VBN O
with IN O
fetal JJ O
samples NNS O
( , O
n CD O
= SYM O
344 CD O
) -RRB- O
from IN O
SA NNP O
of IN O
unknown JJ O
etiology NN O
from IN O
the DT O
same JJ O
period NN O
. . O

Results NNS O

An DT O
increase NN O
in IN O
the DT O
frequency NN O
of IN O
the DT O
T NN O
allele NN O
( , O
0 CD O
. . O
38 CD O
vs IN O
0 CD O
. . O
47 CD O
; : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
and CC O
of IN O
the DT O
TT NNP O
genotype NN O
( , O
0 CD O
. . O
14 CD O
vs IN O
0 CD O
. . O
24 CD O
; : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
in IN O
subjects NNS O
born VBN O
in IN O
the DT O
last JJ O
quarter NN O
of IN O
the DT O
century NN O
was VBD O
observed VBN O
. . O

In IN O
the DT O
1980 CD O
- SYM O
1989 CD O
period NN O
, , O
the DT O
results NNS O
show VBP O
that IN O
the DT O
frequency NN O
of IN O
the DT O
wild JJ O
type NN O
genotype NN O
( -LRB- O
CC NN O
) -RRB- O
is VBZ O
about RB O
tenfold RB O
lower JJR O
in IN O
the DT O
SA NNP O
samples NNS O
than IN O
in IN O
the DT O
controls NNS O
( : O
0 CD O
. . O
3 CD O
vs IN O
0 CD O
. . O
33 CD O
; : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
and CC O
that IN O
the DT O
frequency NN O
of IN O
the DT O
TT NN O
genotype NN O
increases VBZ O
in IN O
the DT O
controls NNS O
( : O
0 CD O
. . O
19 CD O
to TO O
0 CD O
. . O
27 CD O
) -RRB- O
and CC O
in IN O
the DT O
SA NN O
samples NNS O
( : O
0 CD O
. . O
20 CD O
to TO O
0 CD O
. . O
33 CD O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) NFP O
) NFP O
; : O
r NN O
= SYM O
0 CD O
. . O
98 CD O
. . O

Conclusion NN O

Selection NN O
in IN O
favor NN O
of IN O
the DT O
T NNP O
allele NN O
has VBZ O
been VBN O
detected VBN O
. . O

This DT O
selection NN O
could MD O
be VB O
due IN O
to IN O
the DT O
increased VBN O
fetal JJ O
viability NN O
in IN O
early JJ O
stages NNS O
of IN O
embryonic JJ O
development NN O
, , O
as IN O
is VBZ O
deduced VBN O
by IN O
the DT O
increase NN O
of IN O
mutants NNS O
in IN O
both CC O
living JJ O
and CC O
SA NNP O
populations NNS O
. . O

Background NN O

The DT O
methylenetetrahydrof NN O
reductase NN O
enzyme NN O
( -LRB- O
MTHFR NNP O
) -RRB- O
catalyzes VBZ O
a DT O
reaction NN O
that WDT O
produces VBZ O
5 CD O
- HYPH O
methyltetrahydrofola NN O
( HYPH O
5 CD O
- HYPH O
methylTHF NN O
) -RRB- O
, , O
the DT O
methyl NN O
donor NN O
for IN O
homocysteine NN O
in IN O
the DT O
synthesis NN O
of IN O
methionine NN O
. . O

The DT O
677C CD O
> SYM O
T NN O
mutation NN O
of IN O
the DT O
MTHFR NNP O
gene NN O
has VBZ O
been VBN O
associated VBN O
with IN O
a DT O
thermolabile NN O
enzyme NN O
with IN O
decreased VBN O
activity NN O
that WDT O
may MD O
cause VB O
an DT O
increase NN O
in IN O
plasma NN O
homocysteine NN O
concentrations NNS O
[ -LRB- O
1 CD O
] -RRB- O
when WRB O
folate NN O
status NN O
is VBZ O
poor JJ O
. . O

This DT O
polymorphism NN O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
widely RB O
studied VBN O
clinically RB O
relevant JJ O
polymorphisms NNS O
in IN O
humans NNS B-Species
, , O
as IN O
it PRP O
is VBZ O
related VBN O
to IN O
cardiovascular JJ O
disease NN O
[ -LRB- O
2 CD O
] -RRB- O
and CC O
neural JJ O
tube NN O
defects NNS O
( -LRB- O
NTD NNP O
; : O
601634 CD O
) -RRB- O
[ -LRB- O
3 CD O
] -RRB- O
. . O

A DT O
large JJ O
number NN O
of IN O
studies NNS O
have VBP O
provided VBN O
a DT O
broad JJ O
overview NN O
of IN O
the DT O
prevalence NN O
of IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
in IN O
different JJ O
human JJ B-Species
populations NNS O
, , O
showing VBG O
that IN O
the DT O
distribution NN O
of IN O
frequencies NNS O
is VBZ O
diverse JJ O
[ -LRB- O
4 CD O
] -RRB- O
. . O

These DT O
differences NNS O
have VBP O
been VBN O
also RB O
observed VBN O
between IN O
groups NNS O
of IN O
different JJ O
ages NNS O
in IN O
the DT O
same JJ O
Spanish JJ O
population NN O
( , O
older JJR O
and CC O
younger JJR O
than IN O
24 CD O
years NNS O
) -RRB- O
[ -LRB- O
5 CD O
] -RRB- O
and CC O
in IN O
a DT O
Swiss JJ O
population NN O
( , O
older JJR O
and CC O
younger JJR O
than IN O
60 CD O
years NNS O
) -RRB- O
[ -LRB- O
6 CD O
] -RRB- O
, , O
as RB O
well RB O
as IN O
in IN O
a DT O
Japanese JJ O
population NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

In IN O
some DT O
populations NNS O
, , O
such PDT O
the DT O
Toscanians NNPS O
in IN O
Italy NNP O
[ -LRB- O
8 CD O
] -RRB- O
and CC O
Mexicans NNPS O
[ -LRB- O
9 CD O
] -RRB- O
, , O
the DT O
homozygous NN O
mutated VBN O
genotype NN O
( , O
TT NNP O
) -RRB- O
has VBZ O
reached VBN O
frequencies NNS O
greater JJR O
than IN O
30 CD O
% NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
in IN O
Africans NNPS O
the DT O
frequency NN O
of IN O
the DT O
TT NNP O
genotype NN O
is VBZ O
very RB O
low JJ O
( : O
less JJR O
than IN O
1 CD O
% NN O
) -RRB- O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
, , O
but CC O
, , O
in IN O
African NNP O
- HYPH O
Americans NNPS O
, , O
it PRP O
has VBZ O
already RB O
reached VBN O
2 CD O
% NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Studies NNS O
based VBN O
on IN O
the DT O
distribution NN O
of IN O
genotypic JJ O
and CC O
allelic JJ O
frequencies NNS O
of IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
and CC O
the DT O
1298A CD O
> SYM O
C NN O
polymorphism NN O
in IN O
the DT O
MTHFR NNP O
gene NN O
in IN O
Israeli JJ O
, , O
Japanese JJ O
and CC O
Ghanaian JJ O
Africans NNPS O
populations NNS O
[ -LRB- O
13 CD O
] -RRB- O
concluded VBD O
that IN O
the DT O
677T CD O
mutation NN O
in IN O
the DT O
MTHFR NNP O
gene NN O
emerged VBD O
as IN O
a DT O
founder JJ O
haplotype NN O
with IN O
some DT O
selective JJ O
advantage NN O
. . O

Recently RB O
, , O
preliminary JJ O
evidence NN O
of IN O
genetic JJ O
selection NN O
of IN O
this DT O
polymorphism NN O
related VBN O
to IN O
folate NN O
intake NN O
has VBZ O
been VBN O
reported VBN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

The DT O
aim NN O
of IN O
the DT O
present JJ O
study NN O
is VBZ O
to TO O
analyze VB O
the DT O
changes NNS O
in IN O
frequencies NNS O
of IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
during IN O
the DT O
20th JJ O
century NN O
and CC O
particularly RB O
the DT O
evolution NN O
of IN O
the DT O
frequencies NNS O
during IN O
the DT O
decade NN O
of IN O
1980 CD O
- SYM O
1989 CD O
, , O
by IN O
comparing VBG O
the DT O
genotype NN O
frequencies NNS O
between IN O
living VBG O
subjects NNS O
born VBN O
in IN O
this DT O
period NN O
versus IN O
samples NNS O
of IN O
spontaneous JJ O
abortions NNS O
( -LRB- O
SA NN O
) -RRB- O
that WDT O
occurred VBD O
during IN O
in IN O
the DT O
same JJ O
time NN O
period NN O
. . O

Methods NNS O

Subjects NNS O

This DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
Ethics NNP O
Committee NNP O
at IN O
the DT O
University NNP O
Hospital NNP O
"""" `` O
Virgen NNP O
de NNP O
la NNP O
Victoria NNP O
"""" '' O
( , O
M NNP O
a DT O
laga NN O
) -RRB- O
. . O

One CD O
of IN O
the DT O
study NN O
groups NNS O
consisted VBD O
of IN O
344 CD O
fetal JJ O
tissue NN O
samples NNS O
from IN O
SA NNP O
, , O
obtained VBN O
from IN O
the DT O
Department NNP O
of IN O
Pathology NNP O
of IN O
the DT O
University NNP O
Hospital NNP O
Carlos NNP O
Haya NNP O
( HYPH O
M NNP O
a DT O
laga NN O
) -RRB- O
. . O

These DT O
samples NNS O
were VBD O
selected VBN O
after IN O
checking VBG O
the DT O
clinical JJ O
history NN O
and CC O
by IN O
the DT O
inclusion NN O
criteria NNS O
of IN O
containing VBG O
histologically RB O
confirmed VBN O
fetal JJ O
tissue NN O
collected VBN O
in IN O
the DT O
1980s CD O
from IN O
SA NNP O
at IN O
less JJR O
than IN O
3 CD O
months NNS O
( : O
11 CD O
+ CD O
/ SYM O
- HYPH O
1 CD O
. . O
70 CD O
week NN O
) -RRB- O
and CC O
of IN O
unknown JJ O
etiology NN O
. . O

These DT O
fetal JJ O
samples NNS O
were VBD O
compared VBN O
with IN O
a DT O
control NN O
population NN O
of IN O
276 CD O
subjects NNS O
born VBN O
in IN O
the DT O
1980s NNS O
with IN O
an DT O
average JJ O
age NN O
of IN O
22 CD O
+ CD O
/ SYM O
- SYM O
4 CD O
. . O
58 CD O
. . O

Another DT O
population NN O
of IN O
subjects NNS O
born VBN O
in IN O
the DT O
south NN O
of IN O
Spain NNP O
in IN O
the DT O
20th JJ O
century NN O
were VBD O
genotyped VBN O
( , O
1305 CD O
subjects NNS O
, , O
697 CD O
women NNS B-Species
and CC O
608 CD O
men NNS B-Species
) , O
and CC O
divided VBN O
into IN O
four CD O
groups NNS O
according VBG O
to IN O
birth NN O
date NN O
: : O
1900 CD O
to IN O
1925 CD O
( , O
n CD O
= SYM O
206 CD O
) -RRB- O
; : O
1926 CD O
to IN O
1950 CD O
( , O
n CD O
= SYM O
320 CD O
) -RRB- O
, , O
1951 CD O
to IN O
1975 CD O
( , O
n CD O
= SYM O
408 CD O
) -RRB- O
, , O
1976 CD O
to IN O
2000 CD O
( SYM O
n CD O
= SYM O
371 CD O
) -RRB- O
. . O

Individuals NNS O
were VBD O
selected VBN O
randomly RB O
from IN O
different JJ O
areas NNS O
of IN O
the DT O
province NN O
of IN O
Malaga NNP O
, , O
in IN O
southern JJ O
Spain NNP O
, , O
and CC O
from IN O
different JJ O
social JJ O
statuses NNS O
to TO O
avoid VB O
a DT O
selection NN O
bias NN O
. . O

All PDT O
the DT O
selected VBN O
individuals NNS O
were VBD O
Caucasian JJ O
and CC O
residents NNS O
of IN O
the DT O
study NN O
area NN O
. . O

The DT O
parents NNS O
of IN O
all DT O
subjects NNS O
included VBN O
in IN O
the DT O
study NN O
were VBD O
also RB O
Caucasian JJ O
and CC O
born VBN O
in IN O
Spain NNP O
. . O

The DT O
possibility NN O
of IN O
a DT O
founder JJ O
effect NN O
or CC O
genetic JJ O
drift NN O
was VBD O
investigated VBN O
and CC O
rejected VBN O
. . O

All PDT O
the DT O
selected VBN O
individuals NNS O
were VBD O
also RB O
genotyped VBN O
for IN O
an DT O
insertion NN O
/ SYM O
deletion NN O
polymorphism NN O
in IN O
the DT O
angiotensin NN O
converting VBG O
enzyme NN O
( -LRB- O
ACE NN O
) -RRB- O
gene NN O
and CC O
/ SYM O
or CC O
the DT O
2756A CD O
> SYM O
G NN O
polymorphism NN O
in IN O
the DT O
methionine NN O
synthase NN O
gene NN O
( , O
MTR NNP O
) -RRB- O
, , O
in IN O
order NN O
to TO O
determine VB O
whether IN O
or CC O
not RB O
our PRP$ O
adult NN O
and CC O
young JJ O
populations NNS O
were VBD O
genetically RB O
homogeneous JJ O
. . O

No DT O
significant JJ O
differences NNS O
were VBD O
observed VBN O
in IN O
allelic JJ O
or CC O
genotypic JJ O
frequencies NNS O
for IN O
these DT O
genes NNS O
between IN O
the DT O
different JJ O
groups NNS O
. . O

The DT O
population NN O
studied VBD O
was VBD O
randomly RB O
selected VBN O
according VBG O
to IN O
age NN O
. . O

Subjects NNS O
0 CD O
- SYM O
12 CD O
years NNS O
old JJ O
were VBD O
selected VBN O
from IN O
dried VBN O
blood NN O
spots NNS O
from IN O
neonatal JJ O
screening NN O
papers NNS O
; : O
subjects NNS O
10 CD O
- SYM O
24 CD O
years NNS O
old JJ O
were VBD O
recruited VBN O
from IN O
students NNS O
in IN O
primary JJ O
and CC O
secondary JJ O
schools NNS O
and CC O
in IN O
university NN O
; , O
subjects NNS O
25 CD O
- SYM O
50 CD O
years NNS O
old JJ O
and CC O
> SYM O
51 CD O
years NNS O
old JJ O
were VBD O
recruited VBN O
using VBG O
their PRP$ O
Andalusia NNP O
Health NNP O
Service NNP O
identity NN O
cards NNS O
. . O

After IN O
approval NN O
by IN O
the DT O
University NNP O
Hospital NNP O
Ethical NNP O
Committee NNP O
, , O
all PDT O
the DT O
subjects NNS O
were VBD O
contacted VBN O
, , O
and CC O
, , O
from IN O
those DT O
whose WP$ O
written VBN O
consent NN O
was VBD O
obtained VBN O
, , O
10 CD O
ml NNS O
of IN O
blood NN O
was VBD O
taken VBN O
. . O

The DT O
investigation NN O
in IN O
this DT O
study NN O
conforms VBZ O
to IN O
the DT O
principles NNS O
outlined VBN O
in IN O
the DT O
Declaration NNP O
of IN O
Helsinki NNP O
. . O

Genetic JJ O
analysis NN O

The DT O
fetal JJ O
samples NNS O
were VBD O
extracted VBN O
from IN O
the DT O
archived VBN O
formalin NN O
- HYPH O
fixed VBN O
, , O
paraffin NN O
- HYPH O
embedded VBN O
tissue NN O
sections NNS O
. . O

Genomic JJ O
DNA NNP O
was VBD O
extracted VBN O
from IN O
fetal JJ O
tissue NN O
using VBG O
the DT O
method NN O
described VBN O
by IN O
Coombs NNP O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) : O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Genomic JJ O
DNA NN O
of IN O
the DT O
second JJ O
and CC O
third JJ O
groups NNS O
was VBD O
extracted VBN O
from IN O
peripheral JJ O
leukocytes NNS O
using VBG O
the DT O
AquaPure NNP O
Genomic NNP O
DNA NNP O
Blood NNP O
Kit NNP O
( -LRB- O
Bio NNP O
- HYPH O
Rad NNP O
) -RRB- O
. . O

Genotyping NN O
was VBD O
performed VBN O
using VBG O
Real NNP O
Time NNP O
PCR NNP O
with IN O
allele NN O
specific JJ O
Taqman NNP O
( , O
R NNP O
) -RRB- O
probes NNS O
and CC O
primers NNS O
described VBN O
by IN O
Ulvik NNP O
et FW O
al NNP O
. . O

( -LRB- O
2001 CD O
) -RRB- O
[ -LRB- O
16 CD O
] -RRB- O
and CC O
the DT O
following VBG O
optimized VBN O
protocol NN O
for IN O
45 CD O
cycles NNS O
: : O
10 CD O
s NNS O
- SYM O
94 CD O
degrees NNS O
C NN O
, , O
40 CD O
s NNS O
- SYM O
54 CD O
degrees NNS O
C NN O
, , O
15 CD O
s NNS O
- SYM O
72 CD O
degrees NNS O
C NN O
. . O

The DT O
PCR NNP O
mix NN O
( , O
25 CD O
mu NN O
l IN O
total JJ O
volume NN O
) , O
consisted VBD O
of IN O
5 CD O
mu NNS O
l NN O
of IN O
genomic JJ O
DNA NN O
, , O
0 CD O
. . O
5 CD O
mu NN O
l NN O
of IN O
sense NN O
primer NN O
, , O
0 CD O
. . O
62 CD O
mu NNS O
l NN O
of IN O
anti JJ O
- HYPH O
sense NN O
primer NN O
, , O
0 CD O
. . O
85 CD O
mu NNS O
l -LRB- O
Taqman NNP O
( -LRB- O
R NN O
) -RRB- O
probe NN O
FAM NNP O
, , O
0 CD O
. . O
43 CD O
mu NNS O
l -LRB- O
Taqman NNP O
( -LRB- O
R NN O
) -RRB- O
probe NN O
TET NNP O
, , O
20 CD O
mu NNS O
l -LRB- O
PCR NNP O
- HYPH O
buffer NN O
iQ NNP O
- HYPH O
SupermixTM NNP O
( -LRB- O
Bio NNP O
- HYPH O
Rad NNP O
) -RRB- O
( , O
containing VBG O
100 CD O
mM NN O
KCl NNP O
, , O
40 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
, , O
( , O
pH NN O
8 CD O
. . O
4 CD O
) SYM O
1 CD O
. . O
6 CD O
mM NN O
dNTP NN O
( , O
dATP NNP O
, , O
dCTP NNP O
, , O
dGTP NNP O
and CC O
dTTP NNP O
) -RRB- O
, , O
iTaq NNP O
( -LRB- O
R NNP O
) -RRB- O
polymerase NN O
( , O
50 CD O
units NNS O
/ SYM O
mL NNP O
) -RRB- O
and CC O
6 CD O
mM NN O
MgCl2 NN O
) -RRB- O
and CC O
17 CD O
. . O
75 CD O
mu NN O
l NN O
H2O NN O
. . O

Statistical JJ O
and CC O
mathematical JJ O
analysis NN O

All DT O
samples NNS O
were VBD O
genotyped VBN O
, , O
and CC O
the DT O
allelic JJ O
and CC O
genotypic JJ O
frequencies NNS O
were VBD O
compared VBN O
. . O

Differences NNS O
were VBD O
analyzed VBN O
statistically RB O
using VBG O
the DT O
chi JJ O
- HYPH O
square NN O
test NN O
or CC O
Fisher NNP O
' POS O
s NN O
exact JJ O
test NN O
. . O

Correlations NNS O
are VBP O
expressed VBN O
using VBG O
Pearson NNP O
' POS O
s NNS O
coefficient JJ O
( , O
r CC O
) -RRB- O
. . O

Compliance NN O
of IN O
genotype NN O
distributions NNS O
with IN O
Hardy NNP O
- HYPH O
Weinberg NNP O
( : O
HW NNP O
) -RRB- O
equilibrium NN O
was VBD O
evaluated VBN O
by IN O
chi NN O
- HYPH O
square NN O
analysis NN O
. . O

For IN O
all DT O
tests NNS O
, , O
a DT O
p NN O
- HYPH O
value NN O
< NN O
0 CD O
. . O
5 CD O
was VBD O
considered VBN O
to TO O
be VB O
statistically RB O
significant JJ O
. . O

Values NNS O
are VBP O
expressed VBN O
as IN O
the DT O
mean JJ O
+ SYM O
/ SYM O
- HYPH O
SD NN O
. . O

The DT O
genetic JJ O
selection NN O
model NN O
was VBD O
calculated VBN O
for IN O
the DT O
evolution NN O
of IN O
the DT O
677C CD O
> SYM O
T NNP O
genotypes NNS O
. . O

The DT O
genetic JJ O
selection NN O
could MD O
be VB O
classified VBN O
as IN O
codominant JJ O
or CC O
incompletely RB O
dominant JJ O
and CC O
directional JJ O
with IN O
the DT O
heterozygous JJ O
genotype NN O
having VBG O
an DT O
intermediate JJ O
fitness NN O
. . O

For IN O
this DT O
kind NN O
of IN O
selection NN O
, , O
the DT O
most RBS O
appropriate JJ O
mathematical JJ O
model NN O
is VBZ O
dq NN O
= : O
[ -LRB- O
spq NN O
( , O
2hp CD O
+ SYM O
q NN O
- HYPH O
h NN O
) -RRB- O
] -RRB- O
/ : O
[ -LRB- O
p2 NN O
+ CC O
2pq NNS O
( SYM O
1 CD O
- HYPH O
hs CD O
) NFP O
+ SYM O
q2 CD O
x SYM O
( SYM O
1 CD O
- HYPH O
s NN O
) -RRB- O
] -RRB- O
, , O
where WRB O
dq NN O
is VBZ O
the DT O
change NN O
of IN O
frequency NN O
of IN O
the DT O
allele NN O
with IN O
lower JJR O
fitness NN O
, , O
s FW O
is VBZ O
the DT O
fraction NN O
of IN O
that DT O
genotype NN O
lost VBN O
to IN O
selection NN O
, , O
h PRP O
is VBZ O
the DT O
degree NN O
of IN O
dominance NN O
( , O
between IN O
0 CD O
, , O
for IN O
no DT O
dominance NN O
and CC O
1 CD O
, , O
for IN O
complete JJ O
dominance NN O
) -RRB- O
, , O
and CC O
p NN O
is VBZ O
the DT O
frequency NN O
of IN O
the DT O
allele NN O
with IN O
higher JJR O
fitness NN O
. . O

Results NNS O

We PRP O
analyzed VBD O
the DT O
genotype NN O
frequencies NNS O
of IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
in IN O
a DT O
population NN O
born VBN O
during IN O
the DT O
20th JJ O
century NN O
. . O

A DT O
total NN O
of IN O
1305 CD O
subjects NNS O
were VBD O
divided VBN O
into IN O
four CD O
groups NNS O
of IN O
25 CD O
years NNS O
according VBG O
to IN O
birth NN O
date NN O
. . O

The DT O
genotype NN O
frequencies NNS O
were VBD O
compared VBN O
between IN O
the DT O
four CD O
quarters NNS O
of IN O
the DT O
century NN O
and CC O
showed VBD O
very RB O
significant JJ O
changes NNS O
( , O
p NN O
< $ O
0 CD O
. . O
1 CD O
) -RRB- O
in IN O
the DT O
group NN O
born VBN O
in IN O
the DT O
last JJ O
quarter NN O
of IN O
the DT O
20th JJ O
century NN O
( , O
1976 CD O
- SYM O
2000 CD O
) -RRB- O
, , O
when WRB O
compared VBN O
to IN O
any DT O
of IN O
the DT O
other JJ O
groups NNS O
. . O

The DT O
changes NNS O
show VBP O
a DT O
decrease NN O
of IN O
the DT O
CC NNP O
genotype NN O
and CC O
an DT O
increase NN O
of IN O
the DT O
TT NNP O
genotype NN O
in IN O
the DT O
last JJ O
25 CD O
years NNS O
of IN O
the DT O
20th JJ O
century NN O
. . O

( : O
Table NN O
1 CD O
) -RRB- O

Considering VBG O
that IN O
each DT O
25 CD O
year NN O
period NN O
corresponds VBZ O
to IN O
a DT O
generation NN O
, , O
allelic JJ O
frequencies NNS O
did VBD O
not RB O
change VB O
during IN O
the DT O
first JJ O
75 CD O
years NNS O
of IN O
the DT O
century NN O
( , O
HW NN O
equilibrium NN O
) -RRB- O
. . O

However RB O
, , O
we PRP O
found VBD O
that IN O
allelic JJ O
and CC O
genotypic JJ O
frequencies NNS O
for IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
in IN O
the DT O
last JJ O
quarter NN O
of IN O
the DT O
century NN O
are VBP O
significantly RB O
different JJ O
compared VBN O
to IN O
the DT O
previous JJ O
generation NN O
( , O
1951 CD O
- SYM O
1975 CD O
) -RRB- O
. . O

The DT O
genotype NN O
frequencies NNS O
in IN O
the DT O
last JJ O
quarter NN O
of IN O
the DT O
century NN O
are VBP O
not RB O
the DT O
expected VBN O
by IN O
a DT O
HW NNP O
calculation NN O
using VBG O
the DT O
allelic JJ O
frequencies NNS O
of IN O
the DT O
previous JJ O
generation NN O
. . O

This DT O
could MD O
be VB O
described VBN O
as IN O
a DT O
consequence NN O
of IN O
genetic JJ O
selection NN O
found VBN O
in IN O
this DT O
population NN O
, , O
in IN O
the DT O
absence NN O
of IN O
other JJ O
causes NNS O
. . O

Applying VBG O
the DT O
mathematical JJ O
model NN O
described VBN O
above RB O
to IN O
our PRP$ O
population NN O
, , O
the DT O
calculated VBN O
fitness NN O
( , O
s FW O
) -RRB- O
is VBZ O
0 CD O
. . O
5 CD O
, , O
and CC O
it PRP O
can MD O
be VB O
predicted VBN O
that IN O
both DT O
alleles NNS O
will MD O
be VB O
approximately RB O
at IN O
a DT O
frequency NN O
of IN O
50 CD O
% NN O
in IN O
the DT O
next JJ O
generation NN O
and CC O
allele NN O
T NNP O
will MD O
be VB O
at IN O
90 CD O
% NN O
after IN O
seven CD O
generations NNS O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
. . O

Another DT O
possibility NN O
is VBZ O
that IN O
a DT O
scenario NN O
could MD O
be VB O
predicted VBN O
in IN O
which WDT O
both DT O
alleles NNS O
will MD O
have VB O
frequencies NNS O
of IN O
about RB O
50 CD O
% NN O
in IN O
the DT O
next JJ O
generation NN O
and CC O
that IN O
they PRP O
will MD O
maintain VB O
this DT O
stability NN O
while IN O
conditions NNS O
remain VBP O
unchanged JJ O
. . O

( -LRB- O
Figure NN O
1B NN O
) -RRB- O

The DT O
comparison NN O
of IN O
the DT O
genotype NN O
frequencies NNS O
between IN O
a DT O
group NN O
of IN O
fetal JJ O
samples NNS O
from IN O
SA NNP O
that WDT O
occurred VBD O
during IN O
the DT O
1980 CD O
- SYM O
1989 CD O
decade NN O
and CC O
living NN O
subjects NNS O
born VBN O
in IN O
the DT O
same JJ O
decade NN O
showed VBD O
significant JJ O
differences NNS O
in IN O
genotype NN O
frequencies NNS O
( , O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

CC NNP O
genotypes NNS O
were VBD O
almost RB O
absent JJ O
in IN O
abortion NN O
samples NNS O
compared VBN O
to IN O
living VBG O
subjects NNS O
( : O
0 CD O
. . O
3 CD O
vs IN O
0 CD O
. . O
33 CD O
) -RRB- O
, , O
while IN O
CT NNP O
and CC O
TT NNP O
genotypes NNS O
were VBD O
overrepresented VBN O
in IN O
the DT O
same JJ O
group NN O
. . O

When WRB O
3 CD O
- HYPH O
year NN O
periods NNS O
are VBP O
studied VBN O
in IN O
the DT O
decade NN O
, , O
we PRP O
detected VBD O
a DT O
significant JJ O
increase NN O
of IN O
the DT O
mutated VBN O
subjects NNS O
during IN O
the DT O
decade NN O
( , O
CT NNP O
p NN O
< SYM O
0 CD O
. . O
5 CD O
; : O
TT NN O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Allele NNP O
frequencies NNS O
showed VBD O
the DT O
same JJ O
pattern NN O
( , O
p NN O
< SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Controls NNS O
showed VBD O
the DT O
same JJ O
tendency NN O
but CC O
without IN O
statistical JJ O
significance NN O
. . O

( : O
Table NN O
2 CD O
) -RRB- O

The DT O
evolution NN O
of IN O
genotype NN O
frequencies NNS O
during IN O
the DT O
1980 CD O
- SYM O
1989 CD O
decade NN O
of IN O
the DT O
TT NNP O
genotypes NNS O
correlates VBZ O
well RB O
in IN O
both DT O
living NN O
populations NNS O
as RB O
well RB O
as IN O
fetal JJ O
samples NNS O
r SYM O
= SYM O
0 CD O
. . O
98 CD O
( , O
p NN O
= SYM O
0 CD O
. . O
11 CD O
) -RRB- O
. . O

Discussion NN O

Different JJ O
reports NNS O
show VBP O
that IN O
the DT O
prevalence NN O
of IN O
the DT O
677C CD O
> SYM O
T NNP O
polymorphism NN O
of IN O
the DT O
MTHFR NNP O
gene NN O
differs VBZ O
dramatically RB O
among IN O
human JJ B-Species
populations NNS O
. . O

Evidence NN O
of IN O
this DT O
dynamism NN O
can MD O
be VB O
observed VBN O
in IN O
many JJ O
reports NNS O
: : O
frequency NN O
variations NNS O
between IN O
populations NNS O
that WDT O
are VBP O
geographically RB O
very RB O
close JJ O
, , O
even RB O
in IN O
the DT O
same JJ O
country NN O
[ -LRB- O
8 CD O
] -RRB- O
; , O
changes NNS O
found VBN O
in IN O
the DT O
same JJ O
race NN O
or CC O
ethnic JJ O
group NN O
such JJ O
as IN O
Africans NNPS O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
and CC O
African NNP O
- HYPH O
Americans NNPS O
[ -LRB- O
12 CD O
] -RRB- O
; , O
the DT O
high JJ O
prevalence NN O
of IN O
the DT O
677C CD O
> SYM O
T NN O
poymorphism NN O
in IN O
populations NNS O
with IN O
special JJ O
nutritional JJ O
features NNS O
such JJ O
as IN O
Mexicans NNPS O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
Japanese NNP O
[ -LRB- O
13 CD O
] -RRB- O
; , O
and CC O
changes NNS O
in IN O
frequencies NNS O
between IN O
generations NNS O
of IN O
the DT O
same JJ O
population NN O
, , O
as IN O
has VBZ O
been VBN O
observed VBN O
in IN O
Spain NNP O
[ -LRB- O
5 CD O
] -RRB- O
, , O
Switzerland NNP O
[ -LRB- O
6 CD O
] -RRB- O
and CC O
Japan NNP O
[ -LRB- O
7 CD O
] -RRB- O
. . O

There EX O
are VBP O
numerous JJ O
interpretations NNS O
of IN O
this DT O
great JJ O
diversity NN O
, , O
and CC O
most JJS O
tend VBP O
to TO O
be VB O
related VBN O
to IN O
adaptation NN O
to IN O
external JJ O
conditions NNS O
such JJ O
as IN O
climate NN O
or CC O
nutritional JJ O
status NN O
. . O

Dependence NN O
of IN O
folate NN O
degradation NN O
on IN O
skin NN O
pigmentation NN O
[ -LRB- O
17 CD O
] -RRB- O
, , O
nutritional JJ O
habits NNS O
or CC O
human JJ B-Species
intervention NN O
periconceptional JJ O
periods NNS O
could MD O
explain VB O
this DT O
genetic JJ O
variation NN O
. . O

Definitely RB O
, , O
external JJ O
factors NNS O
in IN O
combination NN O
with IN O
different JJ O
levels NNS O
of IN O
MTHFR NNP O
enzyme NN O
activity NN O
, , O
conditioned VBN O
by IN O
polymorphisms NNS O
, , O
could MD O
influence VB O
the DT O
fetal JJ O
viability NN O
of IN O
certain JJ O
genotypes NNS O
. . O

In IN O
1998 CD O
, , O
we PRP O
suggested VBD O
the DT O
possibility NN O
of IN O
genetic JJ O
selection NN O
in IN O
Spain NNP O
in IN O
favor NN O
of IN O
the DT O
mutants NNS O
of IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
in IN O
the DT O
MTHFR NNP O
gene NN O
based VBN O
on IN O
the DT O
fact NN O
that IN O
treatment NN O
with IN O
vitamins NNS O
and CC O
folates NNS O
during IN O
pregnancy NN O
increased VBD O
the DT O
viability NN O
of IN O
fetuses NNS O
with IN O
the DT O
TT NNP O
homozygous NN O
genotype NN O
. . O

This DT O
hypothesis NN O
was VBD O
based VBN O
on IN O
the DT O
increase NN O
in IN O
the DT O
number NN O
of IN O
mutated VBN O
individuals NNS O
found VBN O
in IN O
our PRP$ O
population NN O
since IN O
the DT O
mid JJ O
- HYPH O
1970s NNS O
[ -LRB- O
5 CD O
] -RRB- O
and CC O
the DT O
coincident JJ O
increased VBN O
intake NN O
of IN O
vitamins NNS O
and CC O
folate NN O
by IN O
pregnant JJ O
women NNS B-Species
in IN O
Spain NNP O
[ -LRB- O
18 CD O
, , O
19 CD O
] -RRB- O
. . O

In IN O
2002 CD O
, , O
a DT O
new JJ O
study NN O
found VBD O
changes NNS O
in IN O
genotype NN O
frequencies NNS O
for IN O
the DT O
677C CD O
> SYM O
T NNP O
and CC O
1298A CD O
> SYM O
C NN O
polymorphisms NNS O
in IN O
different JJ O
age NN O
groups NNS O
. . O

Total JJ O
homocysteine NN O
( -LRB- O
tHcy NNP O
) -RRB- O
levels NNS O
in IN O
plasma NN O
were VBD O
also RB O
analyzed VBN O
according VBG O
to IN O
the DT O
different JJ O
genotype NN O
interactions NNS O
[ -LRB- O
20 CD O
] -RRB- O
. . O

That DT O
study NN O
hypothesized VBD O
about IN O
fetal JJ O
viability NN O
and CC O
about IN O
a DT O
genetic JJ O
selection NN O
model NN O
on IN O
the DT O
basis NN O
of IN O
non JJ O
- HYPH O
linkage NN O
disequilibrium NN O
between IN O
both DT O
polymorphisms NNS O
. . O

Recently RB O
, , O
a DT O
study NN O
with IN O
fetal JJ O
and CC O
control NN O
populations NNS O
showed VBD O
the DT O
strong JJ O
influence NN O
of IN O
these DT O
polymorphisms NNS O
, , O
though IN O
mainly RB O
of IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
, , O
on IN O
spontaneous JJ O
early JJ O
abortion NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
significant JJ O
changes NNS O
in IN O
allelic JJ O
and CC O
genotypic JJ O
frequencies NNS O
are VBP O
detected VBN O
, , O
as IN O
is VBZ O
Hardy NNP O
- HYPH O
Weinberg NNP O
disequilibrium NN O
, , O
at IN O
the DT O
677C CD O
> SYM O
T NN O
polymorphism NN O
. . O

We PRP O
hypothesize VBP O
that IN O
there EX O
is VBZ O
a DT O
dynamic JJ O
process NN O
of IN O
genetic JJ O
selection NN O
that WDT O
favors VBZ O
the DT O
T NNP O
allele NN O
. . O

This DT O
process NN O
of IN O
selection NN O
started VBD O
during IN O
the DT O
last JJ O
quarter NN O
of IN O
the DT O
20th JJ O
century NN O
, , O
during IN O
which WDT O
the DT O
frequency NN O
for IN O
mutant JJ O
homozygous NN O
( , O
TT NNP O
) -RRB- O
rose VBD O
significantly RB O
from IN O
14 CD O
% NN O
to IN O
24 CD O
% NN O
. . O

We PRP O
propose VBP O
that IN O
this DT O
increase NN O
in IN O
mutants NNS O
is VBZ O
due IN O
to IN O
the DT O
inclusion NN O
of IN O
an DT O
external JJ O
factor NN O
that WDT O
enhances VBZ O
mutant JJ O
fetal JJ O
viability NN O
. . O

If IN O
we PRP O
apply VBP O
the DT O
mathematical JJ O
model NN O
for IN O
dynamic JJ O
selection NN O
developed VBN O
for IN O
diploid JJ O
organisms NNS O
with IN O
sexual JJ O
reproduction NN O
, , O
the DT O
T NNP O
allele NN O
could MD O
reach VB O
to IN O
90 CD O
% NN O
in IN O
seven CD O
generations NNS O
in IN O
our PRP$ O
population NN O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
. . O

However RB O
, , O
this DT O
model NN O
assumes VBZ O
selection NN O
in IN O
a DT O
constant JJ O
environment NN O
that WDT O
applies VBZ O
to IN O
all DT O
individuals NNS O
in IN O
the DT O
population NN O
studied VBN O
. . O

In IN O
our PRP$ O
case NN O
, , O
we PRP O
suggest VBP O
that IN O
the DT O
external JJ O
factor NN O
is VBZ O
related JJ O
to IN O
an DT O
increase NN O
in IN O
folate NN O
and CC O
vitamin NN O
intake NN O
in IN O
women NNS B-Species
in IN O
periconceptional JJ O
period NN O
and CC O
does VBZ O
not RB O
affect VB O
to IN O
all DT O
individuals NNS O
[ -LRB- O
18 CD O
, , O
19 CD O
] -RRB- O
. . O

We PRP O
assume VBP O
that IN O
prediction NN O
of IN O
a DT O
classic JJ O
selection NN O
model NN O
in IN O
this DT O
case NN O
is VBZ O
only RB O
theoretical JJ O
. . O

On IN O
the DT O
basis NN O
of IN O
a DT O
competition NN O
between IN O
alleles NNS O
in IN O
which WDT O
an DT O
environmental JJ O
factor NN O
favors VBZ O
one CD O
allele NN O
versus IN O
the DT O
other JJ O
, , O
the DT O
final JJ O
result NN O
would MD O
be VB O
that IN O
predicted VBN O
by IN O
the DT O
previous JJ O
mathematical JJ O
model NN O
. . O

However RB O
in IN O
this DT O
case NN O
, , O
the DT O
environment NN O
is VBZ O
not RB O
selecting VBG O
against IN O
the DT O
wild JJ O
type NN O
allele NN O
but CC O
rather RB O
allowing VBG O
the DT O
survival NN O
of IN O
more RBR O
mutated JJ O
alleles NNS O
. . O

Therefore RB O
, , O
the DT O
expected VBN O
result NN O
would MD O
be VB O
not RB O
a DT O
systematic JJ O
increase NN O
of IN O
the DT O
mutated VBN O
allele NN O
but CC O
the DT O
creation NN O
of IN O
an DT O
allelic JJ O
balance NN O
dependent JJ O
on IN O
vitamin NN O
and CC O
folate NN O
abundance NN O
conditions NNS O
. . O

In IN O
this DT O
case NN O
, , O
the DT O
mutation NN O
would MD O
have VB O
a DT O
lower JJR O
influence NN O
on IN O
fetal JJ O
viability NN O
( -LRB- O
Figure NN O
1B NN O
) -RRB- O
. . O

The DT O
results NNS O
showed VBD O
an DT O
increase NN O
in IN O
mutated VBN O
genotypes NNS O
( , O
CT NNP O
and CC O
TT NNP O
) -RRB- O
and CC O
a DT O
strong JJ O
protection NN O
against IN O
abortion NN O
by IN O
the DT O
wild JJ O
type NN O
genotype NN O
( -LRB- O
CC NN O
) -RRB- O
, , O
which WDT O
is VBZ O
practically RB O
non RB O
- HYPH O
existent JJ O
in IN O
the DT O
SA NNP O
group NN O
. . O

The DT O
frequency NN O
of IN O
the DT O
CC NNP O
genotype NN O
shows VBZ O
no DT O
change NN O
over IN O
the DT O
decade NN O
studied VBN O
( SYM O
1980 CD O
- SYM O
1989 CD O
) -RRB- O
, , O
which WDT O
indicates VBZ O
that IN O
folate NN O
does VBZ O
not RB O
exert VB O
a DT O
visible JJ O
effect NN O
on IN O
this DT O
genotype NN O
. . O

However RB O
, , O
the DT O
frequency NN O
of IN O
the DT O
mutated VBN O
allele NN O
increases VBZ O
during IN O
this DT O
decade NN O
, , O
especially RB O
in IN O
fetuses NNS O
from IN O
abortions NNS O
, , O
and CC O
this DT O
increase NN O
correlated VBD O
with IN O
the DT O
increase NN O
of IN O
the DT O
T NN O
allele NN O
in IN O
the DT O
control NN O
population NN O
. . O

This DT O
finding NN O
suggests VBZ O
that IN O
the DT O
effect NN O
of IN O
folate NN O
is VBZ O
crucial JJ O
to IN O
viability NN O
during IN O
the DT O
early JJ O
stages NNS O
of IN O
embryonic JJ O
development NN O
, , O
but CC O
, , O
even RB O
with IN O
folate NN O
, , O
not RB O
all DT O
embryos NNS O
will MD O
survive VB O
until IN O
birth NN O
. . O

In IN O
this DT O
population NN O
, , O
the DT O
mutant JJ O
allele NN O
with IN O
lower JJR O
enzymatic JJ O
activity NN O
has VBZ O
higher JJR O
fitness NN O
than IN O
the DT O
wild JJ O
type NN O
. . O

In IN O
the DT O
folate JJ O
cycle NN O
, , O
it PRP O
can MD O
be VB O
observed VBN O
that IN O
5 CD O
, , O
10 CD O
- HYPH O
methyleneTHF NN O
availability NN O
may MD O
be VB O
important JJ O
. . O

5 CD O
, , O
10 CD O
- HYPH O
methyleneTHF NN O
is VBZ O
the DT O
substrate NN O
for IN O
several JJ O
reactions NNS O
in IN O
the DT O
cycle NN O
, , O
but CC O
two CD O
of IN O
them PRP O
( , O
5 CD O
- HYPH O
methylTHF NN O
and CC O
thymidilate NN O
synthesis NN O
) -RRB- O
might MD O
be VB O
essential JJ O
for IN O
embryo NN O
development NN O
in IN O
folate NN O
deficiency NN O
conditions NNS O
. . O

In IN O
both DT O
cases NNS O
, , O
complete JJ O
or CC O
limited JJ O
MTHFR NNP O
activity NN O
will MD O
produce VB O
higher JJR O
or CC O
lower JJR O
5 CD O
, , O
10 CD O
- HYPH O
methyleneTHF NN O
availability NN O
, , O
which WDT O
might MD O
be VB O
an DT O
essential JJ O
factor NN O
for IN O
embryo NN O
development NN O
, , O
such JJ O
that IN O
a DT O
greater JJR O
folate NN O
levels NNS O
can MD O
compensate VB O
the DT O
lower JJR O
enzymatic JJ O
activity NN O
of IN O
the DT O
mutant NN O
. . O

The DT O
implications NNS O
of IN O
this DT O
polymorphism NN O
in IN O
nucleotide NN O
synthesis NN O
have VBP O
not RB O
yet RB O
been VBN O
determined VBN O
, , O
but CC O
certain JJ O
data NNS O
, , O
such JJ O
as IN O
high JJ O
levels NNS O
of IN O
uric NN O
acid NN O
found VBN O
in IN O
mutated VBN O
subjects NNS O
[ -LRB- O
22 CD O
, , O
23 CD O
] -RRB- O
, , O
suggest VBP O
that IN O
there EX O
are VBP O
different JJ O
turnover NN O
rates NNS O
associated VBN O
with IN O
different JJ O
polymorphisms NNS O
. . O

Conclusion NN O

We PRP O
suggest VBP O
that IN O
there EX O
is VBZ O
genetic JJ O
selection NN O
in IN O
our PRP$ O
population NN O
for IN O
the DT O
T NN O
allele NN O
of IN O
the DT O
MTHFR NNP O
- HYPH O
677C CD O
> SYM O
T NN O
polymorphism NN O
, , O
whose WP$ O
origin NN O
could MD O
be VB O
an DT O
increase NN O
in IN O
fetal JJ O
viability NN O
during IN O
the DT O
early JJ O
stages NNS O
of IN O
embryonic JJ O
development NN O
because IN O
of IN O
an DT O
increase NN O
in IN O
folate NN O
and CC O
vitamin NN O
intake NN O
by IN O
women NNS B-Species
in IN O
the DT O
periconceptional JJ O
period NN O
that WDT O
began VBD O
to TO O
be VB O
established VBN O
in IN O
Spain NNP O
in IN O
the DT O
last JJ O
quarter NN O
of IN O
the DT O
20th JJ O
century NN O
[ -LRB- O
18 CD O
, , O
19 CD O
] -RRB- O
. . O

Higher JJR O
frequencies NNS O
for IN O
the DT O
T NN O
allele NN O
and CC O
TT NNP O
genotype NN O
in IN O
our PRP$ O
population NN O
are VBP O
observed VBN O
in IN O
the DT O
living JJ O
and CC O
SA NNP O
populations NNS O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

AMO NNP O
performed VBD O
the DT O
statistical JJ O
analysis NN O
, , O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
and CC O
revised VBD O
it PRP O
for IN O
publication NN O
. . O

GC NNP O
is VBZ O
the DT O
corresponding VBG O
author NN O
, , O
participated VBD O
in IN O
the DT O
acquisition NN O
of IN O
samples NNS O
and CC O
carried VBN O
out RP O
the DT O
genotyping NN O
. . O

ARP NNP O
carried VBD O
out RP O
the DT O
bibliographic JJ O
search NN O
and CC O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
. . O

AJJ NNP O
participated VBD O
in IN O
the DT O
selection NN O
and CC O
the DT O
processing NN O
of IN O
samples NNS O
. . O

MJG NNP O
coordinated VBD O
the DT O
laboratory NN O
work NN O
and CC O
selected VBD O
the DT O
genotyping NN O
method NN O
. . O

AR NNP O
selected VBD O
the DT O
control NN O
subjects NNS O
and CC O
designed VBD O
the DT O
consent NN O
form NN O
. . O

MR NNP O
helped VBD O
in IN O
the DT O
interpretation NN O
of IN O
data NNS O
and CC O
tables NNS O
performance NN O
. . O

ARE VBP O
conceived VBN O
the DT O
study NN O
and CC O
is VBZ O
the DT O
guarantor NN O
of IN O
this DT O
work NN O
and CC O
the DT O
general JJ O
coordinator NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

Protein NN O
subfamily NN O
assignment NN O
using VBG O
the DT O
Conserved NNP O
Domain NNP O
Database NNP O

Abstract JJ O

Background NN O

Domains NNS O
, , O
evolutionarily RB O
conserved VBN O
units NNS O
of IN O
proteins NNS O
, , O
are VBP O
widely RB O
used VBN O
to TO O
classify VB O
protein NN O
sequences NNS O
and CC O
infer VB O
protein NN O
function NN O
. . O

Often RB O
, , O
two CD O
or CC O
more JJR O
overlapping JJ O
domain NN O
models NNS O
match VBP O
a DT O
region NN O
of IN O
a DT O
protein NN O
sequence NN O
. . O

Therefore RB O
, , O
procedures NNS O
are VBP O
required VBN O
to TO O
choose VB O
appropriate JJ O
domain NN O
annotations NNS O
for IN O
the DT O
protein NN O
. . O

Here RB O
, , O
we PRP O
propose VBP O
a DT O
method NN O
for IN O
assigning VBG O
NCBI NNP O
- HYPH O
curated VBN O
domains NNS O
from IN O
the DT O
Curated NNP O
Domain NNP O
Database NNP O
( -LRB- O
CDD NNP O
) -RRB- O
that WDT O
takes VBZ O
into IN O
account NN O
the DT O
organization NN O
of IN O
the DT O
domains NNS O
into IN O
hierarchies NNS O
of IN O
homologous JJ O
domain NN O
models NNS O
. . O

Findings NNS O

Our PRP$ O
analysis NN O
of IN O
alignment NN O
scores NNS O
from IN O
NCBI NNP O
- HYPH O
curated VBN O
domain NN O
assignments NNS O
suggests VBZ O
that IN O
identifying VBG O
the DT O
correct JJ O
model NN O
among IN O
closely RB O
related VBN O
models NNS O
is VBZ O
more RBR O
difficult JJ O
than IN O
choosing VBG O
between IN O
non AFX O
- HYPH O
overlapping VBG O
domain NN O
models NNS O
. . O

We PRP O
find VBP O
that IN O
simple JJ O
heuristics NNS O
based VBN O
on IN O
sorting NN O
scores NNS O
and CC O
domain NN O
- HYPH O
specific JJ O
thresholds NNS O
are VBP O
effective JJ O
at IN O
reducing VBG O
classification NN O
error NN O
. . O

In IN O
fact NN O
, , O
in IN O
our PRP$ O
test NN O
set NN O
, , O
the DT O
heuristics NNS O
result VBP O
in IN O
almost RB O
90 CD O
% NN O
of IN O
current JJ O
misclassifications NNS O
due IN O
to IN O
missing VBG O
domain NN O
subfamilies NNS O
being VBG O
replaced VBN O
by IN O
more JJR O
generic JJ O
domain NN O
assignments NNS O
, , O
thereby RB O
eliminating VBG O
a DT O
significant JJ O
amount NN O
of IN O
error NN O
within IN O
the DT O
database NN O
. . O

Conclusion NN O

Our PRP$ O
proposed VBN O
domain NN O
subfamily NN O
assignment NN O
rule NN O
has VBZ O
been VBN O
incorporated VBN O
into IN O
the DT O
CD NNP O
- HYPH O
Search NN O
software NN O
for IN O
assigning VBG O
CDD NN O
domains NNS O
to IN O
query NN O
protein NN O
sequences NNS O
and CC O
has VBZ O
significantly RB O
improved VBN O
pre NN O
- HYPH O
calculated VBN O
domain NN O
annotations NNS O
on IN O
protein NN O
sequences NNS O
in IN O
NCBI NNP O
' POS O
s NNP O
Entrez NNP O
resource NN O
. . O

Background NN O

A DT O
major JJ O
goal NN O
in IN O
the DT O
post JJ O
- HYPH O
genomic JJ O
world NN O
is VBZ O
to TO O
infer VB O
protein NN O
function NN O
from IN O
sequence NN O
information NN O
. . O

One CD O
popular JJ O
approach NN O
is VBZ O
to TO O
classify VB O
protein NN O
families NNS O
or CC O
domains NNS O
by IN O
grouping VBG O
homologous JJ O
sequences NNS O
and CC O
annotating VBG O
the DT O
groups NNS O
with IN O
properties NNS O
such JJ O
as IN O
general JJ O
function NN O
, , O
intracellular JJ O
location NN O
, , O
three CD O
- HYPH O
dimensional JJ O
structure NN O
, , O
conserved VBN O
sequence NN O
patterns NNS O
or CC O
motifs NNS O
, , O
evolutionary JJ O
origin NN O
, , O
and CC O
binding NN O
and CC O
active JJ O
sites NNS O
. . O

Novel JJ O
proteins NNS O
can MD O
be VB O
characterized VBN O
quickly RB O
by IN O
assigning VBG O
a DT O
group NN O
via IN O
profile NN O
search NN O
methods NNS O
. . O

However RB O
, , O
more JJR O
than IN O
one CD O
family NN O
or CC O
subfamily NN O
may MD O
exhibit VB O
similarity NN O
to IN O
overlapping JJ O
sequence NN O
intervals NNS O
and CC O
to IN O
a DT O
degree NN O
that WDT O
seems VBZ O
convincing JJ O
( : O
Figure NN O
1 CD O
) -RRB- O
. . O

Assigning VBG O
the DT O
protein NN O
to IN O
the DT O
correct JJ O
group NN O
not RB O
only RB O
yields VBZ O
the DT O
correct JJ O
annotations NNS O
, , O
but CC O
may MD O
also RB O
help VB O
to TO O
avoid VB O
propagating VBG O
annotation NN O
errors NNS O
and CC O
alleviate VB O
current JJ O
issues NNS O
with IN O
mislabelling NN O
in IN O
protein NN O
sequence NN O
databases NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

Here RB O
, , O
we PRP O
examine VBP O
the DT O
problem NN O
of IN O
making VBG O
correct JJ O
domain NN O
assignments NNS O
from IN O
the DT O
Conserved NNP O
Domain NNP O
Database NNP O
[ -LRB- O
3 CD O
, , O
4 CD O
] -RRB- O
. . O

Domains NNS O
are VBP O
evolutionarily RB O
conserved JJ O
units NNS O
in IN O
proteins NNS O
and CC O
frequently RB O
correspond VBP O
to IN O
recurrent JJ O
structural JJ O
and CC O
functional JJ O
units NNS O
. . O

The DT O
particular JJ O
function NN O
of IN O
a DT O
protein NN O
depends VBZ O
on IN O
its PRP$ O
combination NN O
of IN O
domains NNS O
; : O
two CD O
- HYPH O
thirds NNS O
of IN O
prokaryotic JJ O
proteins NNS O
and CC O
80 CD O
% NN O
of IN O
eukaryotic JJ O
proteins NNS O
have VBP O
more JJR O
than IN O
one CD O
domain NN O
. . O

To TO O
create VB O
new JJ O
protein NN O
functions NNS O
, , O
novel JJ O
domain NN O
architectures NNS O
arise VBP O
through IN O
domain NN O
rearrangement NN O
and CC O
recombination NN O
, , O
frequently RB O
through IN O
gene NN O
duplication NN O
and CC O
fission NN O
or CC O
fusion NN O
events NNS O
[ -LRB- O
5 CD O
, , O
6 CD O
] -RRB- O
. . O

A DT O
domain NN O
may MD O
be VB O
represented VBN O
as IN O
a DT O
multiple JJ O
sequence NN O
alignment NN O
( , O
MSA NNP O
) -RRB- O
of IN O
homologous JJ O
sequence NN O
fragments NNS O
. . O

To TO O
identify VB O
the DT O
domains NNS O
in IN O
a DT O
query NN O
protein NN O
sequence NN O
, , O
the DT O
MSAs NNPS O
are VBP O
converted VBN O
into IN O
scoring NN O
models NNS O
such JJ O
as IN O
hidden VBN O
Markov NNP O
model NN O
or CC O
position NN O
- HYPH O
specific JJ O
scoring NN O
matrix NN O
for IN O
use NN O
with IN O
database NN O
search NN O
algorithms NNS O
such JJ O
HMMER NNP O
[ -LRB- O
7 CD O
] -RRB- O
and CC O
RPS NNP O
- HYPH O
BLAST NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

To TO O
refine VB O
protein NN O
annotation NN O
, , O
domains NNS O
models NNS O
may MD O
be VB O
subdivided VBN O
to TO O
represent VB O
more RBR O
specific JJ O
functions NNS O
or CC O
conserved VBN O
features NNS O
. . O

CDD NN O
curators NNS O
apply VBP O
phylogenetic JJ O
and CC O
structural JJ O
analysis NN O
to TO O
construct VB O
hierarchies NNS O
of IN O
homologous JJ O
domain NN O
models NNS O
, , O
related VBN O
by IN O
common JJ O
descent NN O
, , O
to TO O
reflect VB O
aspects NNS O
of IN O
their PRP$ O
evolutionary JJ O
histories NNS O
[ -LRB- O
3 CD O
, , O
4 CD O
] -RRB- O
. . O

Curation NN O
follows VBZ O
an DT O
iterative JJ O
procedure NN O
to TO O
split VB O
domain NN O
models NNS O
into IN O
subfamilies NNS O
that WDT O
redistributes VBZ O
sequences NNS O
into IN O
more RBR O
narrowly RB O
defined VBN O
models NNS O
. . O

In IN O
the DT O
hierarchy NN O
tree NN O
structure NN O
, , O
the DT O
leaf NN O
domains NNS O
represent VBP O
highly RB O
conserved JJ O
and CC O
often RB O
orthologous JJ O
protein NN O
subgroups NNS O
. . O

Their PRP$ O
precursor NN O
( , O
internal JJ O
) , O
domains NNS O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
reflect VBP O
ancient JJ O
gene NN O
duplication NN O
events NNS O
, , O
as IN O
CDD NNP O
aims VBZ O
to TO O
categorize VB O
ancient JJ O
conserved VBN O
domain NN O
families NNS O
. . O

It PRP O
may MD O
seem VB O
natural JJ O
that IN O
once IN O
the DT O
profiles NNS O
have VBP O
been VBN O
defined VBN O
, , O
the DT O
most RBS O
significant JJ O
match NN O
to IN O
a DT O
query NN O
sequence NN O
is VBZ O
the DT O
correct JJ O
one CD O
. . O

Indeed RB O
, , O
domains NNS O
from IN O
Pfam NNP O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
and CC O
SMART NNP O
[ -LRB- O
11 CD O
] -RRB- O
are VBP O
assigned VBN O
following VBG O
the DT O
lowest JJS O
alignment NN O
E NN O
- HYPH O
value NN O
that WDT O
exceeds VBZ O
a DT O
family NN O
- HYPH O
specific JJ O
cutoff NN O
[ -LRB- O
12 CD O
, , O
13 CD O
] -RRB- O
. . O

This DT O
straightforward JJ O
approach NN O
works VBZ O
well RB O
when WRB O
the DT O
candidate NN O
domains NNS O
are VBP O
disjoint JJ O
. . O

Domain NN O
subfamilies NNS O
may MD O
be VB O
obtained VBN O
through IN O
automated JJ O
methods NNS O
such JJ O
as IN O
the DT O
SCI NNP O
- HYPH O
PHY NNP O
algorithm NN O
for IN O
identifying VBG O
functional JJ O
subtypes NNS O
of IN O
known VBN O
domain NN O
families NNS O
[ -LRB- O
14 CD O
, , O
15 CD O
] -RRB- O
or CC O
by IN O
mirroring VBG O
other JJ O
hierarchical JJ O
domain NN O
classifications NNS O
such JJ O
as IN O
SCOP NNP O
[ -LRB- O
16 CD O
] -RRB- O
and CC O
CATH NNP O
[ -LRB- O
17 CD O
] -RRB- O
. . O

However RB O
, , O
subfamily NN O
assignment NN O
methods NNS O
generally RB O
attempt VBP O
to TO O
classify VB O
a DT O
member NN O
of IN O
a DT O
family NN O
at IN O
the DT O
subfamily NN O
level NN O
given VBN O
that IN O
the DT O
family NN O
is VBZ O
known VBN O
, , O
as IN O
in IN O
a DT O
statistical JJ O
pairwise NN O
/ SYM O
profile NN O
method NN O
proposed VBN O
for IN O
SUPERFAMILY NNP O
[ -LRB- O
18 CD O
- SYM O
20 CD O
] -RRB- O
. . O

The DT O
systematic JJ O
arrangement NN O
of IN O
CDD NNP O
domains NNS O
requires VBZ O
identifying VBG O
the DT O
most RBS O
suitable JJ O
level NN O
of IN O
resolution NN O
among IN O
domain NN O
models NNS O
that WDT O
offer VBP O
more RBR O
or CC O
less RBR O
fine RB O
- HYPH O
grained JJ O
descriptions NNS O
of IN O
a DT O
protein NN O
. . O

We PRP O
take VBP O
the DT O
viewpoint NN O
that IN O
if IN O
a DT O
protein NN O
cannot MD O
be VB O
associated VBN O
unambiguously RB O
with IN O
a DT O
specific JJ O
subgroup NN O
or CC O
may MD O
be VB O
a DT O
member NN O
of IN O
a DT O
subgroup NN O
that WDT O
has VBZ O
not RB O
been VBN O
defined VBN O
, , O
the DT O
protein NN O
can MD O
be VB O
assigned VBN O
a DT O
more RBR O
generic JJ O
domain NN O
model NN O
or CC O
the DT O
superfamily NN O
in IN O
general NN O
. . O

Consequently RB O
the DT O
ideal JJ O
domain NN O
assignment NN O
to IN O
a DT O
query NN O
sequence NN O
will MD O
be VB O
the DT O
most RBS O
specific JJ O
domain NN O
, , O
within IN O
a DT O
candidate NN O
hierarchy NN O
, , O
with IN O
a DT O
strong JJ O
match NN O
to IN O
the DT O
sequence NN O
. . O

Here RB O
, , O
we PRP O
analyze VBP O
a DT O
set NN O
of IN O
correct JJ O
domain NN O
assignments NNS O
from IN O
CDD NNP O
to TO O
establish VB O
an DT O
improved JJ O
method NN O
for IN O
assigning VBG O
domains NNS O
to IN O
query NN O
sequences NNS O
. . O

The DT O
effectiveness NN O
of IN O
a DT O
traditional JJ O
alignment NN O
score NN O
and CC O
domain NN O
- HYPH O
specific JJ O
threshold NN O
is VBZ O
of IN O
particular JJ O
interest NN O
, , O
as IN O
this DT O
method NN O
is VBZ O
efficient JJ O
and CC O
makes VBZ O
use NN O
of IN O
alignment NN O
information NN O
that WDT O
is VBZ O
already RB O
computed VBN O
for IN O
CDD NNP O
. . O

Constructing VBG O
a DT O
benchmark JJ O
set NN O
of IN O
correct JJ O
domain NN O
assignments NNS O

To IN O
benchmark JJ O
domain NN O
assignment NN O
heuristics NNS O
, , O
a DT O
reference NN O
set NN O
of IN O
domain NN O
assignments NNS O
is VBZ O
constructed VBN O
from IN O
the DT O
NCBI NNP O
- HYPH O
curated VBN O
portion NN O
of IN O
CDD NNP O
v NN O
. . O

2 LS O
. . O
12 CD O
. . O

This DT O
set NN O
contains VBZ O
every DT O
sequence NN O
fragment NN O
present JJ O
among IN O
the DT O
MSAs NNPS O
and CC O
its PRP$ O
domain NN O
assignment NN O
. . O

The DT O
NCBI NNP O
- HYPH O
curated VBN O
domains NNS O
have VBP O
undergone VBN O
rigorous JJ O
testing NN O
to TO O
optimize VB O
the DT O
MSAs NNS O
and CC O
distributions NNS O
of IN O
representative JJ O
sequence NN O
fragments NNS O
. . O

The DT O
correct JJ O
or CC O
most RBS O
specific JJ O
domain NN O
for IN O
each DT O
sequence NN O
in IN O
a DT O
hierarchy NN O
is VBZ O
defined VBN O
as IN O
the DT O
domain NN O
having VBG O
no DT O
descendant NN O
that WDT O
contains VBZ O
an DT O
overlapping JJ O
sequence NN O
interval NN O
. . O

Two CD O
sequence NN O
intervals NNS O
from IN O
one CD O
protein NN O
are VBP O
said VBN O
to TO O
overlap VB O
if IN O
one CD O
sequence NN O
interval NN O
contains VBZ O
at RB O
least RBS O
30 CD O
% NN O
of IN O
the DT O
positions NNS O
of IN O
the DT O
other JJ O
. . O

While IN O
each DT O
sequence NN O
has VBZ O
been VBN O
placed VBN O
in IN O
the DT O
most RBS O
specific JJ O
domain NN O
model NN O
that WDT O
characterizes VBZ O
it PRP O
, , O
this DT O
step NN O
is VBZ O
required VBN O
as IN O
parent NN O
and CC O
child NN O
domains NNS O
share VBP O
overlapping JJ O
sequences NNS O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

Sequences NNS O
with IN O
overlapping JJ O
regions NNS O
from IN O
more JJR O
than IN O
one CD O
hierarchy NN O
are VBP O
counted VBN O
once RB O
for IN O
each DT O
hierarchy NN O
. . O

Non NNP O
- HYPH O
overlapping VBG O
regions NNS O
of IN O
a DT O
protein NN O
are VBP O
treated VBN O
independently RB O
. . O

Alignments NNS O
between IN O
all DT O
NCBI NNP O
- HYPH O
curated VBN O
domains NNS O
and CC O
proteins NNS O
present JJ O
in IN O
the DT O
public JJ O
Entrez NNP O
protein NN O
set VBN O
at IN O
time NN O
of IN O
analysis NN O
( , O
September NNP O
2007 CD O
) -RRB- O
[ -LRB- O
21 CD O
] -RRB- O
have VBP O
been VBN O
pre NN O
- HYPH O
computed VBN O
using VBG O
RPS NNP O
- HYPH O
BLAST NN O
. . O

In IN O
this DT O
analysis NN O
, , O
the DT O
alignment NN O
score NN O
refers VBZ O
to IN O
the DT O
bitscore NN O
, , O
a DT O
normalized JJ O
version NN O
of IN O
the DT O
raw JJ O
alignment NN O
score NN O
between IN O
the DT O
query NN O
sequence NN O
and CC O
the DT O
PSSM NNP O
, , O
which WDT O
allows VBZ O
alignments NNS O
from IN O
different JJ O
searches NNS O
to TO O
be VB O
compared VBN O
. . O

The DT O
bitscore NN O
corresponds VBZ O
roughly RB O
to IN O
the DT O
alignment NN O
E NN O
- HYPH O
value NN O
and CC O
is VBZ O
used VBN O
instead RB O
to TO O
avoid VB O
real JJ O
value NN O
rounding VBG O
issues NNS O
. . O

A DT O
significant JJ O
PSSM NNP O
- HYPH O
sequence NN O
alignment NN O
is VBZ O
called VBN O
a DT O
hit NN O
, , O
for IN O
brevity NN O
. . O

We PRP O
call VBP O
a DT O
match NN O
between IN O
a DT O
sequence NN O
region NN O
and CC O
its PRP$ O
correct JJ O
domain NN O
a DT O
self NN O
hit NN O
to TO O
distinguish VB O
it PRP O
from IN O
other JJ O
hits NNS O
to IN O
overlapping JJ O
sequence NN O
regions NNS O
. . O

Other JJ O
hits NNS O
to IN O
the DT O
sequences NNS O
in IN O
the DT O
reference NN O
dataset NN O
serve VBP O
as IN O
examples NNS O
of IN O
incorrect JJ O
domain NN O
assignments NNS O
. . O

CDD NN O
v NN O
2 CD O
. . O
12 CD O
contains VBZ O
3078 CD O
NCBI NNP O
- HYPH O
curated VBN O
domains NNS O
in IN O
495 CD O
hierarchies NNS O
, , O
including VBG O
298 CD O
single JJ O
- HYPH O
domain NN O
"""" `` O
hierarchies NNS O
"""" '' O
and CC O
197 CD O
trees NNS O
with IN O
2357 CD O
leaf NN O
and CC O
423 CD O
internal JJ O
domains NNS O
. . O

Many JJ O
sequence NN O
fragments NNS O
used VBN O
to TO O
construct VB O
the DT O
NCBI NNP O
- HYPH O
curated VBN O
domain NN O
profiles NNS O
come VBP O
from IN O
proteins NNS O
that WDT O
have VBP O
been VBN O
replaced VBN O
with IN O
newer JJR O
versions NNS O
or CC O
declared VBN O
obsolete JJ O
. . O

Among IN O
the DT O
109186 CD O
representative JJ O
sequences NNS O
in IN O
NCBI NNP O
- HYPH O
curated VBN O
domain NN O
hierarchies NNS O
, , O
over IN O
21 CD O
% NN O
have VBP O
no DT O
hits NNS O
and CC O
more JJR O
than IN O
90 CD O
% NN O
of IN O
those DT O
sequences NNS O
are VBP O
no RB O
longer RBR O
present JJ O
in IN O
Entrez NNP O
. . O

This DT O
analysis NN O
excludes VBZ O
the DT O
149 CD O
curated VBN O
domains NNS O
without IN O
corresponding VBG O
live JJ O
data NNS O
in IN O
Entrez NNP O
, , O
leaving VBG O
2929 CD O
domains NNS O
. . O

Performance NN O
of IN O
a DT O
simple JJ O
high JJ O
- HYPH O
score NN O
assignment NN O
method NN O

We PRP O
begin VBP O
by IN O
assessing VBG O
the DT O
performance NN O
of IN O
the DT O
previous JJ O
method NN O
for IN O
assigning VBG O
NCBI NNP O
- HYPH O
curated VBN O
domains NNS O
from IN O
CDD NNP O
. . O

The DT O
NCBI NNP O
CD NNP O
- HYPH O
Search NN O
tool NN O
[ -LRB- O
22 CD O
] -RRB- O
has VBZ O
historically RB O
relied VBN O
on IN O
alignment NN O
E NN O
- HYPH O
value NN O
and CC O
properties NNS O
such JJ O
as IN O
the DT O
source NN O
domain NN O
database NN O
to TO O
highlight VB O
one CD O
or CC O
a DT O
few JJ O
most RBS O
likely JJ O
domain NN O
assignments NNS O
, , O
without IN O
claiming VBG O
to TO O
pinpoint VB O
the DT O
correct JJ O
domain NN O
assignment NN O
. . O

Analysis NN O
of IN O
all DT O
hits NNS O
to IN O
the DT O
sequences NNS O
in IN O
the DT O
benchmark JJ O
set NN O
reveals VBZ O
that IN O
assigning VBG O
domains NNS O
by IN O
high JJ O
alignment NN O
score NN O
alone RB O
achieves VBZ O
96 CD O
% NN O
accuracy NN O
over IN O
all DT O
sequences NNS O
and CC O
100 CD O
% NN O
accuracy NN O
over IN O
the DT O
representative JJ O
sequences NNS O
for IN O
91 CD O
. . O
5 CD O
% NN O
of IN O
domain NN O
models NNS O
. . O

Further RB O
, , O
categorizing VBG O
non JJ O
- HYPH O
self NN O
hits NNS O
by IN O
their PRP$ O
hierarchical JJ O
relationships NNS O
to IN O
the DT O
correct JJ O
domain NN O
reveals VBZ O
that IN O
assigning VBG O
to IN O
a DT O
subclass NN O
of IN O
the DT O
correct JJ O
domain NN O
is VBZ O
the DT O
most RBS O
common JJ O
type NN O
of IN O
error NN O
when WRB O
a DT O
sequence NN O
matches VBZ O
the DT O
correct JJ O
domain NN O
and CC O
other JJ O
domains NNS O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
. . O

For IN O
simplicity NN O
, , O
all DT O
non AFX O
- HYPH O
self NN O
hits NNS O
are VBP O
labelled VBN O
as IN O
incorrect JJ O
hits NNS O
in IN O
the DT O
tables NNS O
although IN O
some DT O
child NN O
/ SYM O
descendant JJ O
and CC O
parent NN O
/ SYM O
ancestor NN O
assignments NNS O
may MD O
not RB O
be VB O
regarded VBN O
as IN O
actual JJ O
classification NN O
errors NNS O
. . O

Child NN O
/ SYM O
descendant JJ O
domains NNS O
score VBP O
higher JJR O
than IN O
the DT O
self NN O
hit NN O
for IN O
21 CD O
. . O
8 CD O
% NN O
of IN O
sequences NNS O
with IN O
both DT O
types NNS O
of IN O
hits NNS O
. . O

These DT O
higher JJR O
scores NNS O
may MD O
reflect VB O
computational JJ O
bias NN O
from IN O
longer JJR O
profiles NNS O
, , O
overly RB O
cautious JJ O
assignment NN O
of IN O
a DT O
sequence NN O
to IN O
a DT O
more RBR O
generic JJ O
domain NN O
, , O
or CC O
missing VBG O
subfamilies NNS O
. . O

In IN O
contrast NN O
, , O
higher JJR O
scores NNS O
from IN O
parent NN O
/ SYM O
ancestor NN O
domains NNS O
or CC O
domains NNS O
from IN O
other JJ O
branches NNS O
of IN O
a DT O
hierarchy NN O
are VBP O
rarely RB O
observed VBN O
. . O

For IN O
additional JJ O
data NNS O
and CC O
discussion NN O
of IN O
all DT O
analyses NNS O
described VBN O
in IN O
this DT O
document NN O
, , O
see VB O
[ -LRB- O
Additional JJ O
file NN O
1 CD O
] -RRB- O
. . O

We PRP O
define VBP O
a DT O
score NN O
threshold NN O
for IN O
each DT O
domain NN O
to TO O
be VB O
the DT O
lowest JJS O
self NN O
- HYPH O
hit VBN O
score NN O
to IN O
that DT O
domain NN O
among IN O
all DT O
of IN O
its PRP$ O
sequences NNS O
in IN O
the DT O
benchmark JJ O
set NN O
. . O

This DT O
additional JJ O
heuristic JJ O
, , O
in IN O
particular JJ O
, , O
reduces VBZ O
incorrect JJ O
assignments NNS O
to IN O
subclasses NNS O
as IN O
only RB O
9 CD O
. . O
1 CD O
% NN O
of IN O
hits NNS O
to IN O
subclasses NNS O
score VBP O
above IN O
the DT O
thresholds NNS O
for IN O
those DT O
subclasses NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

The DT O
threshold NN O
definition NN O
works VBZ O
around IN O
the DT O
issue NN O
of IN O
small JJ O
data NN O
size NN O
- : O
over IN O
60 CD O
% NN O
of IN O
domains NNS O
have VBP O
20 CD O
or CC O
fewer JJR O
self NN O
hits NNS O
- , O
and CC O
addresses VBZ O
variances NNS O
in IN O
scores NNS O
between IN O
domains NNS O
due IN O
to IN O
properties NNS O
such JJ O
as IN O
length NN O
and CC O
residue NN O
composition NN O
, , O
or CC O
practical JJ O
issues NNS O
such JJ O
as IN O
incomplete JJ O
local JJ O
alignments NNS O
, , O
which WDT O
are VBP O
not RB O
considered VBN O
by IN O
simple JJ O
high JJ O
- HYPH O
score NN O
heuristics NNS O
. . O

The DT O
definition NN O
is VBZ O
more RBR O
restrictive JJ O
than IN O
its PRP$ O
Pfam NNP O
counterpart NN O
, , O
the DT O
minimum JJ O
alignment NN O
score NN O
among IN O
all DT O
sequences NNS O
in IN O
the DT O
automated JJ O
"""" `` O
full JJ O
alignment NN O
"""" '' O
, , O
as IN O
NCBI NNP O
- HYPH O
curated VBN O
hierarchies NNS O
in IN O
CDD NNP O
tend VBP O
to TO O
present VB O
a DT O
finer RBR O
- HYPH O
grained VBN O
classification NN O
of IN O
a DT O
protein NN O
domain NN O
family NN O
. . O

Proposed VBN O
rule NN O
for IN O
specific JJ O
domain NN O
assignment NN O

We PRP O
propose VBP O
to TO O
label VB O
a DT O
single JJ O
domain NN O
as IN O
correct JJ O
or CC O
specific JJ O
for IN O
a DT O
protein NN O
sequence NN O
region NN O
if IN O
its PRP$ O
alignment NN O
score NN O
is VBZ O
highest JJS O
among IN O
all DT O
domains NNS O
that WDT O
align VBP O
to IN O
overlapping JJ O
regions NNS O
of IN O
the DT O
protein NN O
sequence NN O
and CC O
the DT O
score NN O
exceeds VBZ O
a DT O
pre RB O
- HYPH O
calculated VBN O
threshold NN O
for IN O
the DT O
domain NN O
, , O
defined VBN O
as IN O
the DT O
minimum JJ O
alignment NN O
score NN O
among IN O
confirmed VBN O
members NNS O
of IN O
the DT O
domain NN O
. . O

Sequence NN O
intervals NNS O
that WDT O
are VBP O
difficult JJ O
to TO O
group VB O
with IN O
a DT O
specific JJ O
subclass NN O
with IN O
high JJ O
confidence NN O
following VBG O
this DT O
rule NN O
may MD O
receive VB O
only RB O
generic JJ O
domain NN O
assignments NNS O
. . O

Assuming VBG O
that IN O
the DT O
set NN O
of IN O
overlapping JJ O
domains NNS O
represents VBZ O
an DT O
ancient JJ O
domain NN O
superfamily NN O
, , O
such PDT O
a DT O
generic JJ O
assignment NN O
would MD O
be VB O
characterized VBN O
as IN O
membership NN O
with IN O
the DT O
respective JJ O
superfamily NN O
. . O

Reducing VBG O
misclassifications NNS O
and CC O
errors NNS O
due IN O
to IN O
missing VBG O
subfamilies NNS O

A DT O
more RBR O
concrete JJ O
picture NN O
of IN O
the DT O
effect NN O
of IN O
the DT O
proposed VBN O
rule NN O
may MD O
be VB O
gleaned VBN O
by IN O
quantifying VBG O
misclassifications NNS O
, , O
defined VBN O
to TO O
be VB O
either CC O
descendants NNS O
of IN O
the DT O
correct JJ O
domain NN O
or CC O
domains NNS O
that WDT O
lie VBP O
in IN O
other JJ O
branches NNS O
of IN O
the DT O
correct JJ O
hierarchy NN O
. . O

Averaged VBN O
over IN O
domains NNS O
in IN O
multi JJ O
- HYPH O
domain NN O
hierarchies NNS O
and CC O
counting VBG O
only RB O
sequences NNS O
with IN O
self NN O
hits NNS O
, , O
the DT O
misclassification NN O
rate NN O
using VBG O
high JJ O
scores NNS O
only RB O
is VBZ O
2 CD O
. . O
6 CD O
% NN O
. . O

Incorporating VBG O
score NN O
thresholds NNS O
to TO O
eliminate VB O
low JJ O
- HYPH O
scoring VBG O
best JJS O
hits NNS O
reduces VBZ O
the DT O
misclassification NN O
rate NN O
to IN O
0 CD O
. . O
85 CD O
% NN O
. . O

Misclassifications NNS O
may MD O
also RB O
be VB O
used VBN O
to TO O
estimate VB O
error NN O
due IN O
to IN O
missing VBG O
subfamilies NNS O
. . O

Not RB O
all DT O
subclasses NNS O
in IN O
a DT O
domain NN O
hierarchy NN O
may MD O
have VB O
been VBN O
identified VBN O
as IN O
the DT O
available JJ O
sequence NN O
databases NNS O
only RB O
provide VBP O
a DT O
terse JJ O
snapshot NN O
of IN O
protein NN O
domain NN O
diversity NN O
. . O

We PRP O
simulate VBP O
a DT O
cross JJ O
- HYPH O
validation NN O
experiment NN O
to TO O
ask VB O
, , O
if IN O
an DT O
existing VBG O
domain NN O
model NN O
were VBD O
missing VBG O
from IN O
a DT O
hierarchy NN O
, , O
what WDT O
fraction NN O
of IN O
its PRP$ O
sequence NN O
intervals NNS O
have VBP O
best JJS O
hits NNS O
to IN O
other JJ O
models NNS O
in IN O
the DT O
hierarchy NN O
that WDT O
are VBP O
not RB O
ancestors NNS O
of IN O
the DT O
correct JJ O
model NN O
? . O

Averaged VBN O
over IN O
leaf NN O
domains NNS O
, , O
50 CD O
. . O
9 CD O
% NN O
of IN O
domain NN O
assignments NNS O
made VBN O
from IN O
high JJ O
alignment NN O
score NN O
alone RB O
are VBP O
misclassifications NNS O
, , O
compared VBN O
to IN O
6 CD O
. . O
0 CD O
% NN O
of IN O
domain NN O
assignments NNS O
after IN O
thresholds NNS O
are VBP O
used VBN O
to TO O
screen VB O
hits NNS O
. . O

Function NN O
and CC O
classification NN O
through IN O
specific JJ O
domain NN O
assignments NNS O
: : O
Glycyl JJ O
radical JJ O
enzymes NNS O

To TO O
illustrate VB O
the DT O
effect NN O
of IN O
our PRP$ O
proposed VBN O
method NN O
, , O
we PRP O
examine VBP O
domain NN O
assignments NNS O
from IN O
the DT O
glycyl JJ O
radical JJ O
enzymes NNS O
( , O
RNR NNP O
_ HYPH O
PFL NNP O
hierarchy NN O
) -RRB- O
. . O

Its PRP$ O
subgroups NNS O
have VBP O
distinct JJ O
and CC O
important JJ O
functions NNS O
, , O
including VBG O
ribonucleotide NN O
reductases NNS O
( , O
RNRs NNP O
) -RRB- O
, , O
which WDT O
synthesize VBP O
deoxyribonucleotides NNS O
, , O
and CC O
pyruvate NN O
- HYPH O
formate NN O
lysases NNS O
( , O
PFLs NNP O
) -RRB- O
, , O
a DT O
family NN O
of IN O
catabolic JJ O
enzymes NNS O
. . O

The DT O
proposed VBN O
method NN O
places VBZ O
the DT O
sequence NN O
[ -LRB- O
Entrez NNP O
: : O
CAA42118 NNP O
] -RRB- O
into IN O
RNR NNP O
class NN O
1 CD O
and CC O
places NNS O
[ -LRB- O
Entrez NNP O
: : O
AAZ61477 NNP O
] -RRB- O
into IN O
RNR NNP O
class NN O
- HYPH O
1 CD O
- HYPH O
like JJ O
domain NN O
. . O

The DT O
functions NNS O
of IN O
these DT O
proteins NNS O
are VBP O
inferred VBN O
by IN O
their PRP$ O
subclass NN O
. . O

Other JJ O
proteins NNS O
receive VBP O
generic JJ O
assignments NNS O
to IN O
this DT O
family NN O
. . O

For IN O
example NN O
, , O
PFL2 NNP O
( , O
cd01677 CD O
) -RRB- O
is VBZ O
the DT O
best JJS O
match NN O
to IN O
[ -LRB- O
Entrez NNP O
: : O
ABX41552 NNP O
] -RRB- O
and CC O
[ -LRB- O
Entrez NNP O
: : O
EDQ26237 NNP O
] -RRB- O
with IN O
alignment NN O
scores NNS O
that WDT O
fall VBP O
short JJ O
of IN O
the DT O
PFL2 NNP O
threshold NN O
. . O

The DT O
first JJ O
alignment NN O
includes VBZ O
a DT O
long JJ O
insertion NN O
( , O
gap NN O
) -RRB- O
, , O
and CC O
the DT O
latter JJ O
exhibits VBZ O
weak JJ O
sequence NN O
similarity NN O
; , O
in IN O
both DT O
of IN O
these DT O
scenarios NNS O
the DT O
transfer NN O
of IN O
functional JJ O
annotation NN O
may MD O
not RB O
be VB O
straightforward JJ O
. . O

Domain NN O
assignments NNS O
also RB O
help VBP O
to TO O
make VB O
biological JJ O
insights NNS O
. . O

RNRs NNS O
fall VBP O
into IN O
classes NNS O
that WDT O
use VBP O
different JJ O
mechanisms NNS O
and CC O
/ SYM O
or CC O
cofactors NNS O
. . O

Class NN O
1 CD O
is VBZ O
oxygen NN O
dependent JJ O
and CC O
class NN O
3 CD O
is VBZ O
used VBN O
by IN O
strictly RB O
or CC O
facultative JJ O
anaerobic JJ O
organisms NNS O
. . O

RNR NN O
_ : O
1 CD O
_ : O
like UH O
has VBZ O
a DT O
similar JJ O
active JJ O
site NN O
to IN O
class NN O
1 CD O
and CC O
at IN O
the DT O
time NN O
of IN O
curation NN O
, , O
no DT O
specific JJ O
literature NN O
was VBD O
available JJ O
about IN O
this DT O
subclass NN O
. . O

We PRP O
observed VBD O
that IN O
the DT O
strictly RB O
anaerobic JJ O
organism NN O
Chlorobium NN B-Species
limicola NN I-Species
DSM NNP O
24 CD O
has VBZ O
RNR NN O
_ : O
3 CD O
proteins NNS O
( , O
e LS O
. . O
g LS O
. . O
[ -LRB- O
Entrez NN O
: : O
ZP NN O
_ : O
512827 CD O
] -RRB- O
) -RRB- O
as RB O
well RB O
as IN O
an DT O
enzyme NN O
( , O
[ -LRB- O
Entrez NNP O
: : O
ZP NN O
_ : O
512727 CD O
] -RRB- O
) -RRB- O
that WDT O
matches VBZ O
RNR NN O
_ : O
1 CD O
_ SYM O
like JJ O
, , O
suggesting VBG O
that IN O
RNR NNP O
_ : O
1 CD O
_ SYM O
like JJ O
, , O
a DT O
subfamily NN O
lacking VBG O
experimental JJ O
characterization NN O
, , O
may MD O
contain VB O
non JJ O
- HYPH O
oxygen NN O
dependent JJ O
versions NNS O
of IN O
RNR NN O
_ : O
1 CD O
. . O

Discussion NN O

While IN O
many JJ O
sequences NNS O
can MD O
be VB O
classified VBN O
by IN O
sequence NN O
similarity NN O
, , O
profiles NNS O
of IN O
protein NN O
domain NN O
families NNS O
make VBP O
it PRP O
possible JJ O
to TO O
quickly RB O
classify VB O
more RBR O
distant JJ O
homologs NNS O
[ -LRB- O
23 CD O
] -RRB- O
and CC O
can MD O
better RBR O
handle VB O
multi JJ O
- HYPH O
domain NN O
proteins NNS O
. . O

An DT O
important JJ O
step NN O
in IN O
transferring VBG O
annotations NNS O
from IN O
known VBN O
protein NN O
families NNS O
is VBZ O
identifying VBG O
the DT O
subclass NN O
that WDT O
provides VBZ O
the DT O
best JJS O
characterization NN O
for IN O
the DT O
protein NN O
. . O

Here RB O
, , O
we PRP O
conducted VBD O
the DT O
first JJ O
focused JJ O
analysis NN O
of IN O
domain NN O
assignments NNS O
from IN O
CDD NNP O
in IN O
order NN O
to TO O
assess VB O
existing VBG O
methods NNS O
for IN O
domain NN O
and CC O
domain NN O
subfamily NN O
assignment NN O
and CC O
identify VB O
ways NNS O
to TO O
improve VB O
the DT O
quality NN O
of IN O
assignments NNS O
. . O

We PRP O
find VBP O
that IN O
best RB O
- HYPH O
scoring VBG O
hits NNS O
are VBP O
sometimes RB O
too RB O
specific JJ O
, , O
causing VBG O
a DT O
sequence NN O
to TO O
be VB O
mislabelled VBN O
by IN O
a DT O
subfamily NN O
of IN O
the DT O
correct JJ O
domain NN O
. . O

We PRP O
propose VBP O
a DT O
subclass NN O
assignment NN O
procedure NN O
that WDT O
enables VBZ O
concrete JJ O
assignments NNS O
, , O
computed VBN O
quickly RB O
using VBG O
existing JJ O
data NNS O
, , O
and CC O
demonstrate VB O
that IN O
this DT O
procedure NN O
largely RB O
avoids VBZ O
over IN O
- HYPH O
predictions NNS O
or CC O
false JJ O
positive JJ O
assignments NNS O
and CC O
is VBZ O
robust JJ O
enough RB O
to TO O
deal VB O
with IN O
situations NNS O
such JJ O
as IN O
incomplete JJ O
hierarchies NNS O
in IN O
which WDT O
not RB O
all DT O
subfamilies NNS O
have VBP O
been VBN O
identified VBN O
. . O

We PRP O
elected VBD O
to TO O
not RB O
employ VB O
standard JJ O
jack NN O
- HYPH O
knife NN O
or CC O
cross VB O
- HYPH O
validation NN O
testing NN O
for IN O
a DT O
sequence NN O
against IN O
its PRP$ O
correct JJ O
domain NN O
, , O
as IN O
the DT O
task NN O
is VBZ O
to TO O
classify VB O
sequence NN O
fragments NNS O
that WDT O
are VBP O
very RB O
similar JJ O
to IN O
a DT O
subfamily NN O
, , O
where WRB O
the DT O
subfamily NN O
model NN O
is VBZ O
also RB O
constructed VBN O
from IN O
very RB O
similar JJ O
sequences NNS O
. . O

Although IN O
the DT O
sequence NN O
and CC O
domain NN O
databases NNS O
evolve VBP O
rapidly RB O
, , O
we PRP O
expect VBP O
our PRP$ O
findings NNS O
to TO O
provide VB O
an DT O
accurate JJ O
snapshot NN O
for IN O
some DT O
time NN O
. . O

A DT O
version NN O
of IN O
our PRP$ O
proposed VBN O
method NN O
has VBZ O
been VBN O
incorporated VBN O
into IN O
the DT O
current JJ O
version NN O
of IN O
the DT O
CD NNP O
- HYPH O
Search NN O
program NN O
and CC O
the DT O
pre NN O
- HYPH O
calculated VBN O
annotation NN O
of IN O
proteins NNS O
with IN O
domains NNS O
in IN O
NCBI NNP O
' POS O
s NNP O
Entrez NNP O
system NN O
. . O

Domain NN O
assignments NNS O
to IN O
specific JJ O
orthologous JJ O
subfamilies NNS O
or CC O
ancient JJ O
subfamilies NNS O
are VBP O
distinguished VBN O
from IN O
non AFX O
- HYPH O
specific JJ O
assignments NNS O
to IN O
a DT O
domain NN O
superfamily NN O
. . O

High JJ O
- HYPH O
confidence NN O
annotation NN O
of IN O
functional JJ O
sites NNS O
is VBZ O
also RB O
provided VBN O
following VBG O
these DT O
results NNS O
. . O

We PRP O
hope VBP O
the DT O
improved JJ O
ability NN O
to TO O
quickly RB O
and CC O
accurately RB O
classify VB O
proteins NNS O
will MD O
be VB O
a DT O
valuable JJ O
step NN O
toward IN O
simplifying VBG O
protein NN O
sequence NN O
analysis NN O
and CC O
the DT O
computational JJ O
annotation NN O
of IN O
genomes NNS O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

JF NNP O
carried VBD O
out RP O
the DT O
experiments NNS O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

AMB NNP O
conceived VBD O
the DT O
study NN O
, , O
participated VBD O
in IN O
its PRP$ O
design NN O
, , O
and CC O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
. . O

Supplementary JJ O
Material NN O

Identification NN O
of IN O
recruitment NN O
and CC O
retention NN O
strategies NNS O
for IN O
rehabilitation NN O
professionals NNS O
in IN O
Ontario NNP O
, , O
Canada NNP O
: : O
results NNS O
from IN O
expert NN O
panels NNS O

Abstract JJ O

Background NN O

Demand NN O
for IN O
rehabilitation NN O
services NNS O
is VBZ O
expected VBN O
to TO O
increase VB O
due IN O
to IN O
factors NNS O
such JJ O
as IN O
an DT O
aging VBG O
population NN O
, , O
workforce NN O
pressures NNS O
, , O
rise NN O
in IN O
chronic JJ O
and CC O
complex JJ O
multi NN O
- HYPH O
system NN O
disorders NNS O
, , O
advances NNS O
in IN O
technology NN O
, , O
and CC O
changes NNS O
in IN O
interprofessional JJ O
health NN O
service NN O
delivery NN O
models NNS O
. . O

However RB O
, , O
health NN O
human JJ B-Species
resource NN O
( -LRB- O
HHR NN O
) -RRB- O
strategies NNS O
for IN O
Canadian JJ O
rehabilitation NN O
professionals NNS O
are VBP O
lagging VBG O
behind IN O
other JJ O
professional JJ O
groups NNS O
such JJ O
as IN O
physicians NNS O
and CC O
nurses NNS O
. . O

The DT O
objectives NNS O
of IN O
this DT O
study NN O
were VBD O
: : O
1 LS O
) -RRB- O
to TO O
identify VB O
recruitment NN O
and CC O
retention NN O
strategies NNS O
of IN O
rehabilitation NN O
professionals NNS O
including VBG O
occupational JJ O
therapists NNS O
, , O
physical JJ O
therapists NNS O
and CC O
speech NN O
language NN O
pathologists NNS O
from IN O
the DT O
literature NN O
; : O
and CC O
2 CD O
) -RRB- O
to TO O
investigate VB O
both CC O
the DT O
importance NN O
and CC O
feasibility NN O
of IN O
the DT O
identified VBN O
strategies NNS O
using VBG O
expert NN O
panels NNS O
amongst IN O
HHR NNP O
and CC O
education NN O
experts NNS O
. . O

Methods NNS O

A DT O
review NN O
of IN O
the DT O
literature NN O
was VBD O
conducted VBN O
to TO O
identify VB O
recruitment NN O
and CC O
retention NN O
strategies NNS O
for IN O
rehabilitation NN O
professionals NNS O
. . O

Two CD O
expert NN O
panels NNS O
, , O
one CD O
on IN O
Recruitment NNP O
and CC O
Retention NNP O
and CC O
the DT O
other JJ O
on IN O
Education NNP O
were VBD O
convened VBN O
to TO O
determine VB O
the DT O
importance NN O
and CC O
feasibility NN O
of IN O
the DT O
identified VBN O
strategies NNS O
. . O

A DT O
modified VBN O
- HYPH O
delphi NN O
process NN O
was VBD O
used VBN O
to TO O
gain VB O
consensus NN O
and CC O
to TO O
rate VB O
the DT O
identified VBN O
strategies NNS O
along IN O
these DT O
two CD O
dimensions NNS O
. . O

Results NNS O

A DT O
total NN O
of IN O
34 CD O
strategies NNS O
were VBD O
identified VBN O
by IN O
the DT O
Recruitment NNP O
and CC O
Retention NNP O
and CC O
Education NNP O
expert NN O
panels NNS O
as IN O
being VBG O
important JJ O
and CC O
feasible JJ O
for IN O
the DT O
development NN O
of IN O
a DT O
HHR NNP O
plan NN O
for IN O
recruitment NN O
and CC O
retention NN O
of IN O
rehabilitation NN O
professionals NNS O
. . O

Seven CD O
were VBD O
categorized VBN O
under IN O
the DT O
Quality NNP O
of IN O
Worklife NNP O
and CC O
Work NNP O
Environment NNP O
theme NN O
, , O
another DT O
seven CD O
in IN O
Financial NNP O
Incentives NNPS O
and CC O
Marketing NNP O
, , O
two CD O
in IN O
Workload NNP O
and CC O
Skill NNP O
Mix NNP O
, , O
thirteen CD O
in IN O
Professional NNP O
Development NNP O
and CC O
five CD O
in IN O
Education NNP O
and CC O
Training NNP O
. . O

Conclusion NN O

Based VBN O
on IN O
the DT O
results NNS O
from IN O
the DT O
expert NN O
panels NNS O
, , O
the DT O
three CD O
major JJ O
areas NNS O
of IN O
focus NN O
for IN O
HHR NNP O
planning NN O
in IN O
the DT O
rehabilitation NN O
sector NN O
should MD O
include VB O
strategies NNS O
addressing VBG O
Quality NNP O
of IN O
Worklife NNP O
and CC O
Work NNP O
Environment NNP O
, , O
Financial NNP O
Incentives NNPS O
and CC O
Marketing NNP O
and CC O
Professional NNP O
Development NNP O
. . O

Background NN O

Demand NN O
for IN O
rehabilitation NN O
services NNS O
is VBZ O
expected VBN O
to TO O
increase VB O
within IN O
the DT O
next JJ O
decade NN O
primarily RB O
due IN O
to IN O
factors NNS O
such JJ O
as IN O
an DT O
aging VBG O
population NN O
, , O
workforce NN O
pressures NNS O
, , O
rise NN O
in IN O
chronic JJ O
and CC O
complex JJ O
multi NN O
- HYPH O
system NN O
disorders NNS O
, , O
advances NNS O
in IN O
technology NN O
, , O
and CC O
changes NNS O
in IN O
health NN O
service NN O
delivery NN O
models NNS O
[ -LRB- O
1 CD O
- SYM O
4 CD O
] -RRB- O
. . O

In IN O
Canada NNP O
, , O
rehabilitation NN O
personnel NNS O
constitute VBP O
the DT O
third RB O
largest JJS O
health NN O
professional JJ O
group NN O
after IN O
nurses NNS O
and CC O
physicians NNS O
. . O

Despite IN O
the DT O
size NN O
of IN O
this DT O
workforce NN O
, , O
studies NNS O
have VBP O
consistently RB O
reported VBN O
ongoing JJ O
shortages NNS O
of IN O
physiotherapists NNS O
( , O
PTs NNS O
) -RRB- O
, , O
occupational JJ O
therapists NNS O
( , O
OTs NNS O
) -RRB- O
and CC O
speech NN O
- HYPH O
language NN O
pathologists NNS O
( , O
SLPs NNPS O
) -RRB- O
across IN O
all DT O
jurisdictions NNS O
[ -LRB- O
5 CD O
- SYM O
7 CD O
] -RRB- O
. . O

Similarly RB O
, , O
recruitment NN O
and CC O
retention NN O
of IN O
rehabilitation NN O
professionals NNS O
has VBZ O
been VBN O
considered VBN O
a DT O
challenge NN O
internationally RB O
, , O
nationally RB O
and CC O
provincially RB O
. . O

At IN O
the DT O
international JJ O
level NN O
, , O
the DT O
literature NN O
reports VBZ O
recruitment NN O
and CC O
retention NN O
difficulties NNS O
of IN O
rehabilitation NN O
therapists NNS O
in IN O
countries NNS O
such JJ O
as IN O
Australia NNP O
, , O
New NNP O
Zealand NNP O
, , O
United NNP O
Kingdom NNP O
and CC O
the DT O
United NNP O
States NNP O
[ -LRB- O
8 CD O
- SYM O
13 CD O
] -RRB- O
. . O

Provinces NNS O
across IN O
Canada NNP O
face VBP O
similar JJ O
issues NNS O
; : O
with IN O
Ontario NNP O
projected VBN O
to TO O
face VB O
the DT O
most JJS O
difficulty NN O
due IN O
to IN O
its PRP$ O
population NN O
growth NN O
rate NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Based VBN O
on IN O
the DT O
Canadian NNP O
Institute NNP O
for IN O
Health NNP O
Information NNP O
' POS O
s POS O
Health NNP O
Personnel NNP O
Trends NNPS O
in IN O
Canada NNP O
from IN O
1993 CD O
to IN O
2002 CD O
report NN O
, , O
numerous JJ O
factors NNS O
have VBP O
been VBN O
suggested VBN O
to TO O
influence VB O
demand NN O
for IN O
physiotherapy NN O
and CC O
occupational JJ O
therapy NN O
services NNS O
. . O

Factors NNS O
that WDT O
may MD O
influence VB O
increase VB O
demand NN O
for IN O
physiotherapy NN O
include VBP O
: : O
shift NN O
in IN O
health NN O
service NN O
delivery NN O
models NNS O
from IN O
hospital NN O
to IN O
community NN O
care NN O
; : O
earlier JJR O
patient NN B-Species
discharge NN O
; , O
increased VBN O
expectations NNS O
from IN O
aging VBG O
Canadians NNPS O
concerning VBG O
more RBR O
active JJ O
lifestyles NNS O
; , O
growing VBG O
private JJ O
practice NN O
sector NN O
and CC O
continued VBN O
shortages NNS O
for IN O
PTs NNS O
in IN O
both CC O
private JJ O
and CC O
public JJ O
sectors NNS O
in IN O
rural JJ O
, , O
remote JJ O
and CC O
urban JJ O
settings NNS O
across IN O
Canada NNP O
[ -LRB- O
2 CD O
] -RRB- O
. . O

In IN O
1993 CD O
, , O
an DT O
Ontario NNP O
study NN O
stated VBD O
that IN O
in IN O
order NN O
to TO O
meet VB O
demands NNS O
of IN O
changing VBG O
health NN O
care NN O
policy NN O
, , O
medical JJ O
technology NN O
and CC O
demographic JJ O
changes NNS O
in IN O
the DT O
population NN O
, , O
the DT O
PT NNP O
profession NN O
required VBD O
an DT O
annual JJ O
growth NN O
rate NN O
of IN O
4 CD O
. . O
4 CD O
% NN O
until IN O
the DT O
year NN O
2000 CD O
[ -LRB- O
5 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
national JJ O
health NN O
personnel NNS O
databases NNS O
revealed VBD O
that IN O
the DT O
actual JJ O
average JJ O
annual JJ O
growth NN O
rate NN O
of IN O
active JJ O
PTs NNS O
in IN O
Canada NNP O
from IN O
1995 CD O
to IN O
2004 CD O
was VBD O
only RB O
2 CD O
. . O
5 CD O
% NN O
, , O
approximately RB O
half NN O
of IN O
the DT O
projected VBN O
requirement NN O
suggested VBN O
to TO O
meet VB O
demand NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Similarly RB O
, , O
in IN O
Ontario NNP O
in IN O
the DT O
early JJ O
1990s CD O
an DT O
increase NN O
in IN O
demand NN O
for IN O
OTs NNP O
was VBD O
projected VBN O
because IN O
of IN O
the DT O
reported VBN O
shortage NN O
in IN O
OTs NNP O
and CC O
high JJ O
attrition NN O
rate NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

The DT O
shortage NN O
of IN O
OTs NNS O
was VBD O
explained VBN O
by IN O
another DT O
Ontario NNP O
study NN O
to TO O
be VB O
the DT O
result NN O
of IN O
the DT O
changing VBG O
philosophies NNS O
of IN O
care NN O
and CC O
management NN O
for IN O
the DT O
disabled JJ O
, , O
and CC O
a DT O
clearer JJR O
understanding NN O
of IN O
the DT O
role NN O
of IN O
OT NNP O
in IN O
the DT O
physical JJ O
and CC O
mental JJ O
well NN O
- HYPH O
being NN O
of IN O
the DT O
disabled JJ O
[ -LRB- O
17 CD O
] -RRB- O
. . O

In IN O
terms NNS O
of IN O
actual JJ O
shortages NNS O
, , O
some DT O
authors NNS O
have VBP O
reported VBN O
ongoing JJ O
vacancies NNS O
and CC O
recruitment NN O
difficulties NNS O
for IN O
OTs NNS O
[ -LRB- O
11 CD O
, , O
18 CD O
] -RRB- O
while IN O
others NNS O
have VBP O
reported VBN O
an DT O
increase NN O
in IN O
demand NN O
for IN O
both DT O
PTs NNS O
[ -LRB- O
19 CD O
] -RRB- O
and CC O
OTs NNS O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Speech NN O
language NN O
pathology NN O
is VBZ O
facing VBG O
similar JJ O
service NN O
demands NNS O
. . O

A DT O
report NN O
released VBN O
in IN O
March NNP O
2003 CD O
by IN O
the DT O
College NNP O
of IN O
Audiologists NNP O
and CC O
Speech NNP O
- HYPH O
Language NNP O
Pathologists NNPS O
of IN O
Ontario NNP O
( , O
CASLPO NNP O
) -RRB- O
concluded VBD O
that IN O
based VBN O
on IN O
prevalence NN O
rates NNS O
for IN O
Ontario NNP O
residents NNS O
with IN O
speech NN O
, , O
language NN O
and CC O
related JJ O
disorders NNS O
, , O
the DT O
demand NN O
for IN O
service NN O
would MD O
increase VB O
by IN O
13 CD O
% NN O
while IN O
the DT O
number NN O
of IN O
SLPs NNPS O
would MD O
decrease VB O
by IN O
4 CD O
% NN O
resulting VBG O
in IN O
an DT O
overall JJ O
reduction NN O
in IN O
service NN O
of IN O
15 CD O
% NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

The DT O
American NNP O
Speech NNP O
- HYPH O
Language NNP O
- HYPH O
Hearing NNP O
Association NNP O
( , O
ASHA NNP O
) -RRB- O
has VBZ O
been VBN O
tracking VBG O
SLP NNP O
vacancies NNS O
. . O

In IN O
their PRP$ O
2005 CD O
ASHA NNP O
Speech NNP O
- HYPH O
Language NNP O
Pathology NNP O
Health NNP O
Care NNP O
survey NN O
, , O
48 CD O
% NN O
of IN O
respondents NNS O
indicated VBD O
that IN O
they PRP O
had VBD O
funded VBN O
unfilled JJ O
positions NNS O
for IN O
SLPS NNP O
in IN O
their PRP$ O
agency NN O
[ -LRB- O
22 CD O
] -RRB- O
. . O

The DT O
same JJ O
survey NN O
also RB O
reported VBD O
that IN O
65 CD O
% NN O
of IN O
respondents NNS O
in IN O
home NN O
care NN O
indicated VBD O
that IN O
job NN O
openings NNS O
were VBD O
more RBR O
numerous JJ O
than IN O
job NN O
seekers NNS O
in IN O
their PRP$ O
geographic JJ O
area NN O
. . O

While IN O
labour NN O
market NN O
demand NN O
and CC O
supply NN O
are VBP O
influential JJ O
factors NNS O
on IN O
recruitment NN O
and CC O
retention NN O
decisions NNS O
, , O
the DT O
development NN O
of IN O
strategies NNS O
requires VBZ O
an DT O
understanding NN O
of IN O
conceptual JJ O
frameworks NNS O
or CC O
theories NNS O
to TO O
categorise VB O
and CC O
explain VB O
how WRB O
other JJ O
underlying VBG O
factors NNS O
impact VBP O
health NN O
worker NN O
' POS O
s POS O
mobility NN O
. . O

For IN O
example NN O
, , O
Lehmann NNP O
et FW O
al NNP O
. . O
' '' O
s POS O
model NN O
described VBN O
that IN O
health NN O
worker NN O
' POS O
s POS O
decisions NNS O
to TO O
accept VB O
and CC O
stay VB O
in IN O
remote JJ O
areas NNS O
in IN O
the DT O
public JJ O
sector NN O
depends VBZ O
on IN O
two CD O
interrelated JJ O
aspects NNS O
: : O
the DT O
impact NN O
of IN O
the DT O
different JJ O
environments NNS O
( , O
i LS O
. . O
e LS O
. . O
individual JJ O
, , O
local JJ O
, , O
work NN O
, , O
national JJ O
and CC O
international JJ O
) -RRB- O
and CC O
the DT O
location NN O
of IN O
decision NN O
- HYPH O
makers NNS O
( : O
i LS O
. . O
e -RRB- O
. , O
local JJ O
government NN O
, , O
Ministry NNP O
of IN O
Health NNP O
, , O
HR NNP O
directorate NN O
, , O
public JJ O
service NN O
and CC O
other JJ O
ministries NNS O
) -RRB- O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Behavioural JJ O
and CC O
social JJ O
science NN O
theories NNS O
, , O
such JJ O
as IN O
those DT O
explained VBN O
by IN O
Tett NNP O
and CC O
Meyer NNP O
, , O
found VBD O
that IN O
job NN O
satisfaction NN O
and CC O
organizational JJ O
commitment NN O
each DT O
contribute VBP O
independently RB O
to IN O
the DT O
prediction NN O
of IN O
the DT O
intention NN O
to TO O
resign VB O
( : O
turnover NN O
) -RRB- O
, , O
however RB O
job NN O
satisfaction NN O
was VBD O
a DT O
stronger JJR O
predictor NN O
than IN O
organizational JJ O
commitment NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Based VBN O
on IN O
this DT O
notion NN O
, , O
considerable JJ O
research NN O
has VBZ O
been VBN O
devoted VBN O
to IN O
identifying VBG O
factors NNS O
that WDT O
affect VBP O
job NN O
satisfaction NN O
among IN O
rehabilitation NN O
professionals NNS O
. . O

While IN O
there EX O
is VBZ O
no DT O
single JJ O
, , O
agreed VBN O
upon RP O
model NN O
of IN O
job NN O
satisfaction NN O
, , O
a DT O
variety NN O
of IN O
theoretical JJ O
models NNS O
have VBP O
been VBN O
studied VBN O
to TO O
explain VB O
concepts NNS O
and CC O
relationships NNS O
associated VBN O
with IN O
overall JJ O
job NN O
satisfaction NN O
. . O

The DT O
two CD O
most RBS O
commonly RB O
used VBN O
theories NNS O
of IN O
job NN O
satisfaction NN O
for IN O
rehabilitation NN O
professionals NNS O
are VBP O
the DT O
Herzberg NNP O
' '' O
s POS O
Motivation NNP O
- HYPH O
Hygiene NNP O
Theory NNP O
[ -LRB- O
25 CD O
] -RRB- O
and CC O
Mottaz NNP O
' POS O
s POS O
concepts NNS O
of IN O
work NN O
values NNS O
and CC O
work NN O
rewards NNS O
[ -LRB- O
26 CD O
] -RRB- O
. . O

A DT O
number NN O
of IN O
rehabilitation NN O
studies NNS O
have VBP O
used VBN O
the DT O
Herzberg NNP O
' POS O
s NNP O
Motivation NNP O
- HYPH O
Hygiene NNP O
Theory NNP O
, , O
also RB O
known VBN O
as IN O
the DT O
two CD O
- HYPH O
factor NN O
theory NN O
of IN O
motivation NN O
to TO O
explain VB O
associations NNS O
between IN O
motivation NN O
, , O
job NN O
satisfaction NN O
and CC O
retention NN O
factors NNS O
among IN O
OTs NNS O
, , O
PTs NNS O
and CC O
SLPs NNS O
[ -LRB- O
27 CD O
- SYM O
31 CD O
] -RRB- O
. . O

Frederick NNP O
Herzberg NNP O
et FW O
al NNP O
. . O
explained VBD O
that IN O
there EX O
were VBD O
two CD O
independent JJ O
incidents NNS O
occurring VBG O
at IN O
peoples NNS B-Species
' POS O
jobs NNS O
: : O
one CD O
that WDT O
made VBD O
them PRP O
feel VB O
good JJ O
or CC O
satisfied JJ O
, , O
and CC O
another DT O
that WDT O
made VBD O
them PRP O
feel VB O
bad JJ O
or CC O
dissatisfied JJ O
at IN O
work NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Intrinsic JJ O
factors NNS O
that WDT O
motivate VBP O
people NNS B-Species
such JJ O
as IN O
achievement NN O
, , O
recognition NN O
, , O
work NN O
itself PRP O
, , O
responsibility NN O
, , O
advancement NN O
and CC O
personal JJ O
growth NN O
were VBD O
called VBN O
the DT O
"""" `` O
motivators NNS O
"""" '' O
which WDT O
lead VBP O
to IN O
feelings NNS O
of IN O
satisfaction NN O
. . O

Extrinsic JJ O
factors NNS O
such JJ O
as IN O
work NN O
conditions NNS O
, , O
company NN O
policies NNS O
, , O
supervision NN O
, , O
interpersonal JJ O
work NN O
relations NNS O
, , O
salary NN O
and CC O
job NN O
security NN O
, , O
known VBN O
as IN O
"""" `` O
hygiene NN O
"""" '' O
factors NNS O
, , O
were VBD O
claimed VBN O
to TO O
prevent VB O
dissatisfaction NN O
. . O

"""" `` O
Motivators NNS O
"""" '' O
directly RB O
affect VBP O
a DT O
person NN B-Species
' POS O
s POS O
motivational JJ O
drive NN O
to TO O
do VB O
a DT O
good JJ O
job NN O
, , O
therefore RB O
they PRP O
are VBP O
believed VBN O
to TO O
be VB O
more RBR O
important JJ O
than IN O
hygiene NN O
factors NNS O
. . O

Mottaz NNP O
on IN O
the DT O
other JJ O
hand NN O
, , O
accounted VBD O
for IN O
individual JJ O
differences NNS O
in IN O
job NN O
satisfaction NN O
among IN O
workers NNS O
and CC O
based VBD O
his PRP$ O
study NN O
on IN O
two CD O
dimensions NNS O
: : O
"""" `` O
work NN O
rewards NNS O
"""" '' O
and CC O
"""" `` O
work NN O
values NNS O
"""" '' O
[ -LRB- O
26 CD O
] -RRB- O
. . O

"""" `` O
Work NN O
rewards NNS O
"""" '' O
are VBP O
perceived VBN O
characteristics NNS O
of IN O
the DT O
job NN O
and CC O
have VBP O
three CD O
conceptual JJ O
clusters NNS O
which WDT O
include VBP O
task NN O
, , O
social JJ O
and CC O
organizational JJ O
rewards NNS O
[ -LRB- O
26 CD O
] -RRB- O
. . O

Mottaz NNP O
describes VBZ O
"""" `` O
task NN O
rewards NNS O
"""" '' O
( , O
intrinsic JJ O
) -RRB- O
as IN O
having VBG O
five CD O
independent JJ O
characteristics NNS O
including VBG O
: : O
skill NN O
variety NN O
, , O
task NN O
identity NN O
, , O
task NN O
significance NN O
, , O
autonomy NN O
and CC O
feedback NN O
. . O

Examples NNS O
include VBP O
interesting JJ O
and CC O
challenging JJ O
work NN O
, , O
self NN O
- HYPH O
direction NN O
and CC O
responsibility NN O
, , O
creativity NN O
, , O
opportunities NNS O
to TO O
use VB O
one PRP O
' '' O
s POS O
skills NNS O
and CC O
feedback NN O
. . O

In IN O
the DT O
same JJ O
study NN O
, , O
Mottaz NNP O
stated VBD O
that IN O
"""" `` O
social JJ O
rewards NNS O
"""" '' O
( -LRB- O
extrinsic JJ O
) -RRB- O
are VBP O
derived VBN O
from IN O
the DT O
interpersonal JJ O
relationships NNS O
established VBN O
with IN O
others NNS O
at IN O
work NN O
. . O

Having VBG O
supportive JJ O
colleagues NNS O
and CC O
supervisors NNS O
is VBZ O
an DT O
example NN O
of IN O
this DT O
dimension NN O
. . O

Lastly RB O
, , O
"""" `` O
organizational JJ O
rewards NNS O
"""" '' O
( , O
extrinsic JJ O
) -RRB- O
are VBP O
tangible JJ O
rewards NNS O
that WDT O
are VBP O
provided VBN O
by IN O
the DT O
employer NN O
/ SYM O
organization NN O
to TO O
facilitate VB O
performance NN O
. . O

Such JJ O
factors NNS O
include VBP O
working VBG O
conditions NNS O
, , O
pay NN O
and CC O
fringe NN O
benefits NNS O
, , O
career NN O
advancement NN O
and CC O
security NN O
. . O

The DT O
second JJ O
dimension NN O
of IN O
job NN O
satisfaction NN O
is VBZ O
based VBN O
on IN O
"""" `` O
work NN O
values NNS O
"""" '' O
, , O
which WDT O
is VBZ O
the DT O
importance NN O
that WDT O
individuals NNS O
place VBP O
on IN O
their PRP$ O
work NN O
rewards NNS O
[ -LRB- O
26 CD O
] -RRB- O
. . O

For IN O
example NN O
, , O
some DT O
rehabilitation NN O
therapists NNS O
may MD O
value VB O
extrinsic JJ O
rewards NNS O
such JJ O
as IN O
pay NN O
and CC O
benefits NNS O
as IN O
more RBR O
important JJ O
than IN O
intrinsic JJ O
factors NNS O
like IN O
clinical JJ O
autonomy NN O
and CC O
challenging JJ O
work NN O
. . O

Although IN O
the DT O
Herzberg NNP O
and CC O
Mottaz NNP O
conceptual JJ O
frameworks NNS O
are VBP O
organized JJ O
differently RB O
, , O
their PRP$ O
job NN O
satisfaction NN O
variables NNS O
are VBP O
very RB O
similar JJ O
( , O
i LS O
. . O
e LS O
. . O
work NN O
conditions NNS O
, , O
pay NN O
, , O
interpersonal JJ O
relationships NNS O
, , O
etc FW O
. . O
) -RRB- O
and CC O
they PRP O
both DT O
classify VBP O
these DT O
factors NNS O
as IN O
having VBG O
intrinsic JJ O
or CC O
extrinsic JJ O
elements NNS O
. . O

Despite IN O
the DT O
growing VBG O
body NN O
of IN O
literature NN O
on IN O
recruitment NN O
and CC O
retention NN O
factors NNS O
in IN O
various JJ O
industries NNS O
, , O
there EX O
is VBZ O
a DT O
minimal JJ O
amount NN O
of IN O
research NN O
studying VBG O
these DT O
factors NNS O
specifically RB O
among IN O
rehabilitation NN O
professionals NNS O
. . O

One CD O
published VBN O
study NN O
however RB O
, , O
did VBD O
look VB O
at IN O
extrinsic JJ O
and CC O
intrinsic JJ O
job NN O
satisfaction NN O
factors NNS O
on IN O
recruitment NN O
and CC O
retention NN O
of IN O
rehabilitation NN O
professionals NNS O
( , O
OTs NNS O
, , O
PTs NNS O
and CC O
SLPs NNS O
) -RRB- O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Results NNS O
from IN O
this DT O
study NN O
showed VBD O
that IN O
intrinsic JJ O
factors NNS O
such JJ O
as IN O
professional JJ O
growth NN O
and CC O
having VBG O
a DT O
work NN O
environment NN O
in IN O
line NN O
with IN O
personal JJ O
values NNS O
are VBP O
more RBR O
significant JJ O
in IN O
predicting VBG O
career NN O
satisfaction NN O
than IN O
extrinsic JJ O
factors NNS O
such JJ O
as IN O
pay NN O
and CC O
continuing VBG O
education NN O
. . O

These DT O
same JJ O
intrinsic JJ O
factors NNS O
are VBP O
also RB O
significant JJ O
in IN O
predicting VBG O
retention NN O
in IN O
rehabilitation NN O
professionals NNS O
. . O

Another DT O
study NN O
looking VBG O
at IN O
recruitment NN O
and CC O
retention NN O
of IN O
allied JJ O
health NN O
professionals NNS O
in IN O
the DT O
rural JJ O
areas NNS O
in IN O
New NNP O
South NNP O
Wales NNP O
identified VBD O
that IN O
the DT O
main JJ O
reasons NNS O
why WRB O
people NNS B-Species
liked VBD O
working VBG O
in IN O
rural JJ O
areas NNS O
were VBD O
because IN O
of IN O
the DT O
attractive JJ O
environment NN O
and CC O
helpful JJ O
team NN O
members NNS O
[ -LRB- O
33 CD O
] -RRB- O
. . O

However RB O
82 CD O
% NN O
of IN O
employees NNS O
reported VBD O
that IN O
having VBG O
their PRP$ O
partner NN O
move VB O
away RB O
was VBD O
the DT O
number NN O
one CD O
reason NN O
for IN O
leaving VBG O
a DT O
rural JJ O
job NN O
. . O

A DT O
similar JJ O
study NN O
was VBD O
conducted VBN O
among IN O
OTs NNS O
and CC O
PTs NNS O
in IN O
Northwestern NNP O
Ontario NNP O
[ -LRB- O
34 CD O
] -RRB- O
. . O

Findings NNS O
from IN O
this DT O
study NN O
indicated VBD O
that IN O
factors NNS O
contributing VBG O
to IN O
initial JJ O
decision NN O
on IN O
location NN O
of IN O
practice NN O
include VBP O
availability NN O
of IN O
leisure NN O
/ SYM O
recreation NN O
activities NNS O
, , O
proximity NN O
of IN O
family NN O
origin NN O
and CC O
influences NNS O
of IN O
spouse NN O
/ SYM O
partners NNS O
. . O

Study NN O
results NNS O
also RB O
showed VBD O
that IN O
the DT O
main JJ O
reasons NNS O
therapists NNS O
left VBD O
their PRP$ O
job NN O
were VBD O
to TO O
be VB O
closer JJR O
to IN O
their PRP$ O
family NN O
, , O
lack NN O
of IN O
job NN O
opportunity NN O
and CC O
spousal JJ O
influence NN O
. . O

Solely RB O
understanding VBG O
factors NNS O
that WDT O
influence VBP O
recruitment NN O
and CC O
retention NN O
decisions NNS O
is VBZ O
not RB O
sufficient JJ O
in IN O
the DT O
development NN O
of IN O
a DT O
HHR NNP O
plan NN O
for IN O
rehabilitation NN O
professionals NNS O
. . O

In IN O
order NN O
for IN O
the DT O
plan NN O
to TO O
be VB O
effective JJ O
and CC O
sustainable JJ O
in IN O
addressing VBG O
these DT O
factors NNS O
, , O
the DT O
most RBS O
important JJ O
and CC O
feasible JJ O
workforce NN O
strategies NNS O
needs VBZ O
to TO O
be VB O
identified VBN O
. . O

There EX O
have VBP O
been VBN O
a DT O
number NN O
of IN O
reports NNS O
on IN O
health NN O
human JJ B-Species
resources NNS O
( -LRB- O
HHR NNP O
) -RRB- O
planning NN O
, , O
recruitment NN O
and CC O
retention NN O
strategies NNS O
for IN O
physicians NNS O
[ -LRB- O
35 CD O
, , O
36 CD O
] -RRB- O
and CC O
nurses NNS O
[ -LRB- O
37 CD O
] -RRB- O
, , O
however RB O
information NN O
regarding VBG O
rehabilitation NN O
professionals NNS O
is VBZ O
lacking VBG O
. . O

Canadian JJ O
reports NNS O
indicate VBP O
that IN O
the DT O
main JJ O
reason NN O
for IN O
significant JJ O
gaps NNS O
in IN O
this DT O
field NN O
is VBZ O
the DT O
absence NN O
of IN O
current JJ O
and CC O
reliable JJ O
data NNS O
available JJ O
on IN O
supply NN O
, , O
demand NN O
and CC O
labour NN O
force NN O
participation NN O
trends NNS O
for IN O
rehabilitation NN O
therapists NNS O
[ -LRB- O
38 CD O
- SYM O
40 CD O
] -RRB- O
. . O

There EX O
is VBZ O
some DT O
research NN O
that WDT O
has VBZ O
investigated VBN O
theoretical JJ O
models NNS O
of IN O
job NN O
satisfaction NN O
on IN O
recruitment NN O
and CC O
retention NN O
[ -LRB- O
28 CD O
, , O
32 CD O
] -RRB- O
; , O
however RB O
few JJ O
studies NNS O
have VBP O
looked VBN O
at IN O
how WRB O
these DT O
models NNS O
have VBP O
been VBN O
implemented VBN O
. . O

Other JJ O
studies NNS O
have VBP O
examined VBN O
the DT O
relationship NN O
of IN O
gender NN O
, , O
workplace NN O
setting NN O
( , O
i LS O
. . O
e LS O
. . O
hospital NN O
, , O
ambulatory NN O
, , O
rehabilitation NN O
, , O
acute JJ O
and CC O
long JJ O
- HYPH O
term NN O
care NN O
) -RRB- O
and CC O
geographical JJ O
location NN O
( : O
i LS O
. . O
e NFP O
. . O
rural JJ O
or CC O
urban JJ O
) -RRB- O
on IN O
job NN O
satisfaction NN O
and CC O
retention NN O
among IN O
rehabilitation NN O
professionals NNS O
[ -LRB- O
41 CD O
- SYM O
43 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
no DT O
empirical JJ O
studies NNS O
have VBP O
examined VBN O
conceptual JJ O
frameworks NNS O
for IN O
organizing VBG O
recruitment NN O
and CC O
retention NN O
strategies NNS O
for IN O
rehabilitation NN O
therapists NNS O
. . O

To TO O
address VB O
this DT O
gap NN O
, , O
this DT O
research NN O
identified VBD O
recruitment NN O
and CC O
retention NN O
strategies NNS O
from IN O
the DT O
literature NN O
for IN O
rehabilitation NN O
professionals NNS O
and CC O
determined VBD O
their PRP$ O
importance NN O
and CC O
feasibility NN O
using VBG O
expert NN O
panels NNS O
. . O

Methods NNS O

Phase NN O
1 CD O
: : O
Literature NNP O
Review NNP O

Identification NN O
of IN O
recruitment NN O
and CC O
retention NN O
strategies NNS O

A DT O
review NN O
of IN O
the DT O
literature NN O
was VBD O
conducted VBN O
to TO O
identify VB O
recruitment NN O
and CC O
retention NN O
strategies NNS O
for IN O
rehabilitation NN O
therapists NNS O
. . O

In IN O
this DT O
study NN O
, , O
rehabilitation NN O
professionals NNS O
were VBD O
defined VBN O
as IN O
physical JJ O
therapists NNS O
( , O
PTs NNS O
) -RRB- O
, , O
occupational JJ O
therapists NNS O
( , O
OTs NNS O
) -RRB- O
and CC O
speech NN O
- HYPH O
language NN O
pathologists NNS O
( , O
SLPs NNPS O
) -RRB- O
. . O

Both CC O
published VBN O
and CC O
non JJ O
- HYPH O
empirical JJ O
literature NN O
was VBD O
accessed VBN O
in IN O
this DT O
review NN O
. . O

Keywords NNS O
used VBD O
to TO O
search VB O
for IN O
relevant JJ O
published JJ O
studies NNS O
in IN O
the DT O
Consolidated NNP O
International NNP O
Nursing NNP O
and CC O
Allied NNP O
Health NNP O
Sciences NNPS O
Library NNP O
( -LRB- O
CINAHL NNP O
) -RRB- O
( : O
1982 CD O
to IN O
2005 CD O
) , O
and CC O
Medline NNP O
( : O
1996 CD O
to IN O
2005 CD O
) -RRB- O
included VBD O
: : O
"""" `` O
health NN O
human JJ B-Species
resources NNS O
or CC O
health NN O
manpower NN O
"""" '' O
, , O
"""" `` O
rehabilitation NN O
or CC O
rehabilitation NN O
professionals NNS O
or CC O
vocational JJ O
"""" '' O
, , O
"""" `` O
allied VBN O
health NN O
professionals NNS O
or CC O
personnel NNS O
"""" '' O
, , O
"""" '' O
recruitment NN O
strategies NNS O
"""" '' O
, , O
"""" '' O
retention NN O
strategies NNS O
"""" '' O
, , O
"""" `` O
physical JJ O
therapist NN O
or CC O
physiotherapist NN O
"""" '' O
, , O
"""" `` O
occupational JJ O
therapy NN O
or CC O
occupational JJ O
therapist NN O
"""" '' O
, , O
"""" '' O
speech NN O
- HYPH O
language NN O
pathologist NN O
or CC O
speech NN O
- HYPH O
language NN O
pathology NN O
"""" '' O
. . O

Non NNP O
- HYPH O
empirical JJ O
literature NN O
searches NNS O
were VBD O
made VBN O
on IN O
international JJ O
and CC O
national JJ O
on IN O
- HYPH O
line NN O
catalogues NNS O
and CC O
publications NNS O
from IN O
health NN O
organizations NNS O
, , O
professional JJ O
associations NNS O
, , O
and CC O
hospital NN O
and CC O
home NN O
care NN O
organizations NNS O
. . O

International JJ O
reports NNS O
were VBD O
limited VBN O
to IN O
developed VBN O
countries NNS O
since IN O
the DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
identify VB O
strategies NNS O
appropriate JJ O
to IN O
the DT O
Ontario NNP O
setting NN O
. . O

Organization NN O
and CC O
consolidation NN O
of IN O
strategies NNS O

There EX O
was VBD O
a DT O
paucity NN O
of IN O
peer NN O
- HYPH O
reviewed VBN O
studies NNS O
obtained VBN O
exploring VBG O
rehabilitation NN O
HHR NNP O
strategies NNS O
, , O
therefore RB O
the DT O
majority NN O
of IN O
strategies NNS O
were VBD O
selected VBN O
from IN O
grey JJ O
literature NN O
reports NNS O
from IN O
international JJ O
, , O
national JJ O
and CC O
provincial JJ O
health NN O
organizations NNS O
. . O

From IN O
the DT O
literature NN O
review NN O
, , O
107 CD O
potential JJ O
strategies NNS O
were VBD O
identified VBN O
according VBG O
to IN O
their PRP$ O
relevance NN O
to IN O
HHR NNP O
issues NNS O
for IN O
rehabilitation NN O
in IN O
Ontario NNP O
. . O

These DT O
strategies NNS O
were VBD O
then RB O
categorized VBN O
into IN O
two CD O
broad JJ O
groups NNS O
: : O
A NNP O
) , O
Recruitment NNP O
and CC O
Retention NNP O
( : O
n -LRB- O
= SYM O
73 CD O
) -RRB- O
, , O
and CC O
B NNP O
) -RRB- O
Education NNP O
( : O
n CD O
= SYM O
34 CD O
) -RRB- O
. . O

The DT O
majority NN O
of IN O
strategies NNS O
were VBD O
not RB O
specific JJ O
to IN O
rehabilitation NN O
professionals NNS O
and CC O
they PRP O
were VBD O
reviewed VBN O
by IN O
a DT O
group NN O
of IN O
three CD O
individuals NNS O
collectively RB O
( , O
rehabilitation NN O
researcher NN O
, , O
manager NN O
, , O
and CC O
clinician NN O
) , O
for IN O
duplication NN O
, , O
clarity NN O
, , O
action NN O
focused VBN O
properties NNS O
and CC O
appropriateness NN O
to IN O
the DT O
Canadian JJ O
or CC O
Ontario NNP O
setting NN O
. . O

When WRB O
necessary JJ O
, , O
a DT O
small JJ O
number NN O
of IN O
strategies NNS O
were VBD O
re RB O
- HYPH O
worded VBN O
to TO O
be VB O
relevant JJ O
to IN O
a DT O
rehabilitation NN O
context NN O
. . O

This DT O
analysis NN O
resulted VBD O
in IN O
the DT O
selection NN O
of IN O
40 CD O
Recruitment NNP O
and CC O
Retention NNP O
and CC O
24 CD O
Education NNP O
strategies NNS O
. . O

Only RB O
14 CD O
recruitment NN O
and CC O
retention NN O
and CC O
six CD O
education NN O
strategies NNS O
were VBD O
obtained VBN O
from IN O
peer NN O
- HYPH O
reviewed VBN O
articles NNS O
. . O

Since IN O
the DT O
majority NN O
of IN O
strategies NNS O
were VBD O
identified VBN O
from IN O
the DT O
grey JJ O
literature NN O
, , O
it PRP O
was VBD O
not RB O
surprising JJ O
that IN O
there EX O
was VBD O
no DT O
apriori NN O
peer NN O
- HYPH O
reviewed VBN O
conceptual JJ O
framework NN O
that WDT O
reflected VBD O
the DT O
breadth NN O
of IN O
the DT O
strategies NNS O
obtained VBN O
from IN O
the DT O
literature NN O
review NN O
. . O

As IN O
a DT O
result NN O
, , O
the DT O
themes NNS O
used VBN O
by IN O
the DT O
Health NNP O
and CC O
Community NNP O
Services NNPS O
Human NNP B-Species
Resources NNPS O
Sector NNP O
Study NNP O
in IN O
Newfoundland NNP O
and CC O
Labrador NNP O
[ -LRB- O
44 CD O
] -RRB- O
formed VBD O
the DT O
basis NN O
for IN O
the DT O
organizational JJ O
framework NN O
for IN O
this DT O
study NN O
since IN O
they PRP O
aligned VBD O
with IN O
the DT O
identified VBN O
strategies NNS O
. . O

Each DT O
group NN O
was VBD O
further RB O
categorized VBN O
into IN O
the DT O
five CD O
themes NNS O
( , O
three CD O
for IN O
Recruitment NNP O
and CC O
Retention NNP O
and CC O
two CD O
for IN O
Education NNP O
) -RRB- O
. . O

The DT O
three CD O
Recruitment NNP O
and CC O
Retention NNP O
strategy NN O
themes NNS O
were VBD O
: : O
( : O
1 CD O
) SYM O
Quality NNP O
of IN O
Worklife NNP O
and CC O
Work NNP O
Environment NNP O
[ -LRB- O
n CD O
= SYM O
19 CD O
] -RRB- O
; : O
( : O
2 CD O
) SYM O
Workload NNP O
and CC O
Skill NN O
Mix NN O
[ -LRB- O
n NN O
= SYM O
6 CD O
] -RRB- O
; : O
and CC O
( : O
3 LS O
) -RRB- O
Financial JJ O
Incentives NNS O
and CC O
Marketing NNP O
[ -LRB- O
n NNS O
= SYM O
15 CD O
] -RRB- O
. . O

The DT O
two CD O
Education NN O
strategy NN O
themes NNS O
were VBD O
: : O
( : O
1 LS O
) -RRB- O
Education NNP O
and CC O
Training NNP O
[ -LRB- O
n NNP O
= SYM O
11 CD O
] -RRB- O
and CC O
( : O
2 CD O
) SYM O
Professional NNP O
Development NNP O
( : O
n CD O
= SYM O
13 CD O
) -RRB- O
. . O

Phase NN O
2 CD O
: : O
Expert NNP O
Panel NNP O

Participant NN B-Species
Selection NN O

Once IN O
this DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
Research NNP O
Ethics NNP O
Board NNP O
at IN O
the DT O
University NNP O
of IN O
Toronto NNP O
, , O
key JJ O
informants NNS O
who WP O
participated VBD O
in IN O
a DT O
previous JJ O
study NN O
regarding VBG O
rehabilitation NN O
supply NN O
and CC O
demand NN O
at IN O
the DT O
University NNP O
of IN O
Toronto NNP O
[ -LRB- O
21 CD O
] -RRB- O
were VBD O
asked VBN O
to TO O
nominate VB O
potential JJ O
participants NNS B-Species
for IN O
the DT O
panels NNS O
. . O

The DT O
selection NN O
criteria NNS O
considered VBN O
were VBD O
acknowledged VBN O
leadership NN O
in IN O
the DT O
panel NN O
member NN O
' POS O
s POS O
specialty NN O
, , O
expertise NN O
in IN O
recruitment NN O
and CC O
retention NN O
or CC O
education NN O
and CC O
training NN O
of IN O
rehabilitation NN O
professionals NNS O
. . O

Absence NN O
of IN O
conflicts NNS O
of IN O
interest NN O
, , O
geographic JJ O
diversity NN O
, , O
and CC O
diversity NN O
of IN O
practice NN O
setting NN O
were VBD O
also RB O
considered VBN O
. . O

After IN O
purposefully RB O
selecting VBG O
the DT O
initial JJ O
list NN O
of IN O
candidates NNS O
from IN O
among IN O
the DT O
nominations NNS O
, , O
each DT O
nominee NN O
was VBD O
contacted VBN O
to TO O
establish VB O
their PRP$ O
interest NN O
and CC O
availability NN O
. . O

Those DT O
who WP O
expressed VBD O
an DT O
interest NN O
in IN O
participating VBG O
were VBD O
asked VBN O
to TO O
send VB O
their PRP$ O
curriculum NN O
vitae NN O
to TO O
help VB O
the DT O
research NN O
team NN O
evaluate VB O
their PRP$ O
contributions NNS O
to IN O
their PRP$ O
field NN O
of IN O
expertise NN O
. . O

Once IN O
candidate NN O
panelists NNS O
were VBD O
selected VBN O
, , O
each DT O
received VBD O
a DT O
letter NN O
explaining VBG O
the DT O
expert JJ O
panel NN O
process NN O
and CC O
consent NN O
form NN O
. . O

Two CD O
separate JJ O
panels NNS O
were VBD O
constructed VBN O
: : O
one CD O
for IN O
Recruitment NNP O
and CC O
Retention NNP O
( : O
n -LRB- O
= SYM O
8 CD O
) -RRB- O
and CC O
the DT O
other JJ O
for IN O
Education NNP O
( : O
n CD O
= SYM O
9 CD O
) -RRB- O
( : O
Table NN O
1 CD O
) -RRB- O
. . O

The DT O
size NN O
of IN O
the DT O
panel NN O
was VBD O
large JJ O
enough RB O
to TO O
permit VB O
diversity NN O
of IN O
representation NN O
while IN O
still RB O
being VBG O
small JJ O
enough RB O
to TO O
allow VB O
all DT O
participants NNS B-Species
to TO O
be VB O
involved VBN O
in IN O
the DT O
group NN O
discussion NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

Expert NN O
Panel NN O
Process NN O
: : O
Round NNP O
1 CD O
Survey NN O

A DT O
modified VBN O
- HYPH O
delphi NN O
technique NN O
was VBD O
then RB O
used VBN O
for IN O
the DT O
expert JJ O
panel NN O
process NN O
, , O
[ -LRB- O
46 CD O
, , O
47 CD O
] -RRB- O
based VBN O
on IN O
the DT O
RAND NNP O
/ SYM O
UCLA NNP O
appropriateness NN O
method NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

In IN O
round NN O
1 CD O
, , O
members NNS O
of IN O
the DT O
Recruitment NNP O
and CC O
Retention NNP O
panel NN O
were VBD O
sent VBN O
an DT O
electronic JJ O
survey NN O
containing VBG O
the DT O
40 CD O
strategies NNS O
identified VBN O
from IN O
the DT O
literature NN O
review NN O
and CC O
the DT O
Education NNP O
panelists NNS O
were VBD O
also RB O
sent VBN O
an DT O
electronic JJ O
survey NN O
with IN O
24 CD O
strategies NNS O
. . O

For IN O
Round NNP O
1 CD O
, , O
each DT O
panel NN O
was VBD O
asked VBN O
to TO O
rate VB O
the DT O
strategies NNS O
using VBG O
a DT O
nine CD O
- HYPH O
point NN O
Likert NNP O
- HYPH O
type NN O
rating NN O
scale NN O
that WDT O
ranged VBD O
from IN O
"""" `` O
none NN O
"""" '' O
( , O
1 CD O
) , O
to IN O
"""" `` O
maximum NN O
"""" '' O
( SYM O
9 CD O
) -RRB- O
, , O
on IN O
two CD O
key JJ O
dimensions NNS O
: : O
Feasibility NN O
and CC O
Importance NN O
. . O

Feasibility NN O
was VBD O
defined VBN O
as IN O
the DT O
practicality NN O
and CC O
cost NN O
implications NNS O
of IN O
the DT O
strategy NN O
and CC O
was VBD O
rated VBN O
from IN O
the DT O
respondents NNS O
' POS O
perspective NN O
. . O

Importance NN O
was VBD O
defined VBN O
as IN O
how WRB O
valuable JJ O
, , O
appropriate JJ O
and CC O
useful JJ O
the DT O
strategy NN O
could MD O
be VB O
for IN O
rehabilitation NN O
HHR NNP O
planning NN O
in IN O
Ontario NNP O
. . O

At IN O
the DT O
end NN O
of IN O
the DT O
survey NN O
, , O
panelists NNS O
were VBD O
given VBN O
the DT O
opportunity NN O
to TO O
suggest VB O
additional JJ O
strategies NNS O
that WDT O
they PRP O
felt VBD O
were VBD O
appropriate JJ O
to TO O
consider VB O
. . O

Once RB O
completed VBN O
, , O
panelists NNS O
were VBD O
asked VBN O
to TO O
return VB O
the DT O
survey NN O
to IN O
the DT O
study NN O
office NN O
by IN O
email NN O
or CC O
fax NN O
prior RB O
to IN O
the DT O
expert JJ O
panel NN O
meeting NN O
in IN O
Round NNP O
2 CD O
. . O

Data NNS O
from IN O
each DT O
questionnaire NN O
were VBD O
entered VBN O
into IN O
a DT O
spreadsheet NN O
and CC O
tabulated VBN O
. . O

Descriptive JJ O
statistics NNS O
were VBD O
calculated VBN O
for IN O
each DT O
strategy NN O
using VBG O
frequency NN O
distributions NNS O
and CC O
proportional JJ O
percentages NNS O
of IN O
respondents NNS O
. . O

Importance NN O
and CC O
feasibility NN O
rankings NNS O
were VBD O
based VBN O
on IN O
the DT O
percentage NN O
of IN O
expert NN O
panelists NNS O
' POS O
low JJ O
, , O
medium JJ O
and CC O
high JJ O
ratings NNS O
. . O

Expert NN O
Panel NNP O
Process NNP O
Round NNP O
2 CD O
: : O
Expert NNP O
Panel NNP O
one CD O
- HYPH O
day NN O
meeting NN O

After IN O
the DT O
independent JJ O
completion NN O
of IN O
the DT O
survey NN O
, , O
each DT O
panel NN O
was VBD O
convened VBN O
separately RB O
for IN O
a DT O
one CD O
- HYPH O
day NN O
meeting NN O
for IN O
final JJ O
discussions NNS O
, , O
debates NNS O
and CC O
consensus NN O
voting NN O
to TO O
decide VB O
on IN O
strategies NNS O
[ -LRB- O
48 CD O
] -RRB- O
. . O

A DT O
strategy NN O
that WDT O
had VBD O
been VBN O
scored VBN O
7 CD O
, , O
8 CD O
or CC O
9 CD O
for IN O
both DT O
feasibility NN O
and CC O
importance NN O
by IN O
two CD O
- HYPH O
thirds NNS O
of IN O
the DT O
panel NN O
was VBD O
considered VBN O
a DT O
high JJ O
rating NN O
. . O

Strategies NNS O
that WDT O
had VBD O
a DT O
combination NN O
of IN O
medium NN O
and CC O
high JJ O
scores NNS O
between IN O
4 CD O
and CC O
9 CD O
in IN O
either DT O
of IN O
the DT O
two CD O
dimensions NNS O
were VBD O
considered VBN O
medium JJ O
rated VBN O
strategies NNS O
, , O
while IN O
low JJ O
rated VBN O
strategies NNS O
had VBD O
scores NNS O
between IN O
1 CD O
and CC O
3 CD O
for IN O
both DT O
dimensions NNS O
. . O

On IN O
the DT O
day NN O
of IN O
the DT O
meeting NN O
, , O
the DT O
panelists NNS O
were VBD O
given VBN O
a DT O
copy NN O
of IN O
the DT O
aggregated VBN O
survey NN O
results NNS O
indicating VBG O
the DT O
ratings NNS O
of IN O
all DT O
of IN O
the DT O
strategies NNS O
. . O

High JJ O
and CC O
low JJ O
rated VBN O
strategies NNS O
were VBD O
not RB O
discussed VBN O
as IN O
there EX O
was VBD O
already RB O
consensus NN O
, , O
whereas IN O
all DT O
medium JJ O
rated VBN O
strategies NNS O
were VBD O
subject JJ O
to IN O
discussion NN O
. . O

Using VBG O
a DT O
nominal JJ O
group NN O
process NN O
[ -LRB- O
47 CD O
] -RRB- O
, , O
each DT O
strategy NN O
was VBD O
discussed VBN O
in IN O
turn NN O
, , O
and CC O
panelists NNS O
were VBD O
given VBN O
an DT O
opportunity NN O
to TO O
raise VB O
any DT O
issues NNS O
or CC O
concerns NNS O
regarding VBG O
the DT O
clarity NN O
and CC O
wording NN O
of IN O
each DT O
strategy NN O
. . O

Each DT O
of IN O
the DT O
strategies NNS O
discussed VBN O
were VBD O
then RB O
individually RB O
rated VBN O
a DT O
second JJ O
time NN O
by IN O
each DT O
panelist NN O
in IN O
an DT O
attempt NN O
to TO O
reach VB O
further JJ O
consensus NN O
. . O

Results NNS O

Selection NN O
of IN O
strategies NNS O
for IN O
Round NN O
1 CD O
: : O
Modified VBN O
Delphi NNP O
process NN O

Following VBG O
Round NNP O
1 CD O
rating NN O
of IN O
the DT O
40 CD O
identified VBN O
strategies NNS O
, , O
the DT O
Recruitment NNP O
and CC O
Retention NNP O
panel NN O
reached VBD O
consensus NN O
on IN O
12 CD O
strategies NNS O
. . O

However RB O
, , O
14 CD O
had VBD O
a DT O
combination NN O
of IN O
high JJ O
/ SYM O
medium NN O
importance NN O
and CC O
feasibility NN O
ratings NNS O
and CC O
14 CD O
had VBD O
medium JJ O
ratings NNS O
on IN O
both DT O
dimensions NNS O
, , O
therefore RB O
it PRP O
required VBD O
further JJ O
discussion NN O
. . O

An DT O
additional JJ O
strategy NN O
regarding VBG O
family NN O
relocation NN O
programs NNS O
was VBD O
added VBN O
by IN O
this DT O
panel NN O
. . O

The DT O
Education NNP O
Panel NNP O
ranked VBD O
16 CD O
of IN O
24 CD O
strategies NNS O
with IN O
high JJ O
importance NN O
and CC O
feasibility NN O
after IN O
Round NNP O
1 CD O
. . O

Since IN O
there EX O
were VBD O
only RB O
eight CD O
strategies NNS O
with IN O
medium JJ O
ratings NNS O
, , O
this DT O
expert NN O
panel NN O
decided VBD O
to TO O
review VB O
all PDT O
the DT O
strategies NNS O
at IN O
the DT O
face NN O
- HYPH O
to IN O
- HYPH O
face NN O
meeting NN O
to TO O
discuss VB O
the DT O
rationale NN O
that WDT O
would MD O
explain VB O
why WRB O
some DT O
of IN O
the DT O
highly RB O
rated VBN O
strategies NNS O
were VBD O
not RB O
already RB O
implemented VBN O
and CC O
to TO O
come VB O
to IN O
a DT O
consensus NN O
on IN O
the DT O
other JJ O
eight CD O
medium JJ O
rated VBN O
strategies NNS O
. . O

They PRP O
also RB O
added VBD O
an DT O
additional JJ O
strategy NN O
for IN O
career NN O
paths NNS O
. . O

Selection NN O
of IN O
strategies NNS O
for IN O
Round NN O
2 CD O
: : O
Face NN O
- HYPH O
to IN O
- HYPH O
face NN O
meeting NN O

A DT O
total NN O
of IN O
34 CD O
strategies NNS O
were VBD O
identified VBN O
by IN O
both CC O
the DT O
Recruitment NNP O
and CC O
Retention NNP O
and CC O
Education NNP O
expert NN O
panels NNS O
as IN O
being VBG O
important JJ O
and CC O
feasible JJ O
for IN O
the DT O
development NN O
of IN O
a DT O
HHR NNP O
plan NN O
for IN O
recruitment NN O
and CC O
retention NN O
of IN O
rehabilitation NN O
professionals NNS O
. . O

Under IN O
the DT O
Recruitment NNP O
and CC O
Retention NNP O
theme NN O
, , O
seven CD O
were VBD O
categorized VBN O
as IN O
Quality NNP O
of IN O
Worklife NNP O
and CC O
Work NNP O
Environment NNP O
; : O
two CD O
were VBD O
Workload NNP O
and CC O
Skill NNP O
Mix NNP O
, , O
and CC O
another DT O
seven CD O
were VBD O
Financial NNP O
Incentives NNPS O
and CC O
Marketing NNP O
. . O

As IN O
for IN O
the DT O
Education NNP O
panel NN O
, , O
five CD O
were VBD O
categorized VBN O
as IN O
Education NNP O
and CC O
Training NNP O
strategies NNS O
while IN O
the DT O
other JJ O
thirteen CD O
were VBD O
related VBN O
to IN O
Professional NNP O
Development NNP O
. . O

As IN O
indicated VBN O
in IN O
Table NNP O
2 CD O
, , O
at IN O
the DT O
end NN O
of IN O
the DT O
second JJ O
round NN O
of IN O
voting NN O
, , O
the DT O
Recruitment NNP O
and CC O
Retention NNP O
panel NN O
had VBD O
a DT O
total NN O
of IN O
16 CD O
highly RB O
important JJ O
and CC O
feasible JJ O
strategies NNS O
, , O
8 CD O
high JJ O
/ SYM O
medium NN O
importance NN O
and CC O
feasibility NN O
, , O
8 CD O
medium JJ O
and CC O
9 CD O
low JJ O
ratings NNS O
for IN O
both DT O
dimensions NNS O
. . O

The DT O
Education NNP O
panel NN O
on IN O
the DT O
other JJ O
hand NN O
had VBD O
a DT O
total NN O
of IN O
18 CD O
high JJ O
, , O
1 CD O
high JJ O
/ SYM O
medium JJ O
, , O
3 CD O
medium JJ O
and CC O
3 CD O
low JJ O
rating NN O
strategies NNS O
. . O

Recruitment NN O
and CC O
Retention NN O
Strategy NN O
Rankings NNS O

Table NNP O
3 CD O
provides VBZ O
a DT O
detailed JJ O
description NN O
and CC O
ranking NN O
of IN O
each DT O
of IN O
the DT O
recruitment NN O
and CC O
retention NN O
strategies NNS O
that WDT O
were VBD O
rated VBN O
highly RB O
important JJ O
and CC O
feasible JJ O
. . O

The DT O
importance NN O
and CC O
feasibility NN O
rankings NNS O
were VBD O
based VBN O
on IN O
the DT O
largest JJS O
proportion NN O
of IN O
panel NN O
members NNS O
rating VBG O
a DT O
strategy NN O
a DT O
7 CD O
, , O
8 CD O
or CC O
9 CD O
. . O

The DT O
overall JJ O
combined VBN O
ranking NN O
was VBD O
based VBN O
on IN O
the DT O
average NN O
of IN O
the DT O
proportion NN O
of IN O
these DT O
two CD O
dimensions NNS O
. . O

Among IN O
these DT O
selected VBN O
strategies NNS O
, , O
the DT O
majority NN O
were VBD O
classified VBN O
under IN O
Quality NNP O
of IN O
Worklife NNP O
and CC O
Work NNP O
Environment NNP O
( : O
44 CD O
% NN O
) -RRB- O
and CC O
Financial NNP O
Incentives NNPS O
and CC O
Marketing NNP O
( : O
44 CD O
% NN O
) -RRB- O
, , O
followed VBN O
by IN O
Workload NNP O
and CC O
Skill NNP O
Mix NNP O
( : O
12 CD O
% NN O
) -RRB- O
. . O

It PRP O
should MD O
be VB O
noted VBN O
that IN O
some DT O
strategies NNS O
had VBD O
equal JJ O
rankings NNS O
; : O
therefore RB O
the DT O
total JJ O
number NN O
of IN O
rankings NNS O
did VBD O
not RB O
equal VB O
the DT O
total JJ O
number NN O
of IN O
strategies NNS O
. . O

Recruitment NN O
and CC O
retention NN O
strategies NNS O
that WDT O
had VBD O
a DT O
combination NN O
of IN O
high JJ O
and CC O
medium JJ O
ratings NNS O
in IN O
either DT O
of IN O
the DT O
two CD O
dimensions NNS O
included VBN O
: : O
sense NN O
of IN O
empowerment NN O
in IN O
promoting VBG O
healthy JJ O
work NN O
environments NNS O
; , O
team NN O
- HYPH O
building VBG O
exercises NNS O
; , O
developing VBG O
participatory JJ O
decision NN O
- HYPH O
making VBG O
systems NNS O
; , O
improving VBG O
rural JJ O
working VBG O
conditions NNS O
; , O
recognizing VBG O
work NN O
- HYPH O
life NN O
balance NN O
; , O
creating VBG O
an DT O
environment NN O
where WRB O
staff NN O
are VBP O
valued VBN O
; , O
optimizing VBG O
scope NN O
of IN O
practice NN O
and CC O
work NN O
- HYPH O
management NN O
autonomy NN O
. . O

Strategies NNS O
that WDT O
had VBD O
medium JJ O
importance NN O
and CC O
feasibility NN O
ratings NNS O
included VBD O
: : O
resolving VBG O
concerns NNS O
about IN O
liability NN O
and CC O
accountability NN O
in IN O
collaborative JJ O
practice NN O
; , O
recruiting VBG O
international JJ O
trained VBN O
therapists NNS O
; : O
opportunity NN O
to TO O
work VB O
in IN O
different JJ O
settings NNS O
; : O
interprofessional JJ O
payment NN O
schemes NNS O
; : O
family NN O
leave NN O
; : O
staff NN O
recognition NN O
and CC O
creating VBG O
a DT O
position NN O
for IN O
a DT O
provincial JJ O
health NN O
professional JJ O
recruiter NN O
. . O

Low JJ O
importance NN O
and CC O
feasibility NN O
strategies NNS O
included VBD O
: : O
word NN O
of IN O
mouth NN O
references NNS O
; : O
bursaries NNS O
and CC O
retention NN O
bonuses NNS O
; : O
exchange NN O
employment NN O
opportunities NNS O
; : O
health NN O
promotion NN O
; : O
retention NN O
workshop NN O
; : O
80 CD O
- HYPH O
20 CD O
staffing NN O
model NN O
( : O
80 CD O
% NN O
clinical JJ O
and CC O
20 CD O
% NN O
learning VBG O
new JJ O
skills NNS O
or CC O
training VBG O
others NNS O
) -RRB- O
; , O
using VBG O
recruitment NN O
agencies NNS O
and CC O
providing VBG O
recruitment NN O
bonuses NNS O
( -LRB- O
Table NNP O
4 CD O
) -RRB- O
. . O

Education NN O
Strategy NN O
Rankings NNS O

Education NN O
strategies NNS O
that WDT O
were VBD O
rated VBN O
highly RB O
important JJ O
and CC O
feasible JJ O
are VBP O
described VBN O
in IN O
Table NNP O
5 CD O
. . O

The DT O
majority NN O
of IN O
strategies NNS O
in IN O
this DT O
group NN O
tend VBP O
to TO O
be VB O
in IN O
the DT O
area NN O
of IN O
Professional NNP O
Development NNP O
( : O
72 CD O
% NN O
) -RRB- O
, , O
more RBR O
so RB O
than IN O
Education NNP O
and CC O
Training NNP O
( : O
28 CD O
% NN O
) -RRB- O
. . O

The DT O
medium JJ O
rated VBN O
education NN O
strategies NNS O
included VBD O
: : O
expand VB O
interprofessional JJ O
education NN O
; , O
provide VB O
incentives NNS O
for IN O
students NNS O
interested JJ O
in IN O
rural JJ O
practice NN O
; , O
summer NN O
mentorship NN O
programs NNS O
for IN O
high JJ O
school NN O
students NNS O
; : O
and CC O
aboriginal JJ O
student NN O
support NN O
program NN O
. . O

The DT O
strategies NNS O
that WDT O
were VBD O
considered VBN O
neither CC O
feasible JJ O
nor CC O
important JJ O
included VBD O
: : O
using VBG O
return NN O
of IN O
service NN O
contracts NNS O
after IN O
professional JJ O
development NN O
; , O
create VB O
a DT O
tiered JJ O
pathway NN O
approach NN O
through IN O
modular JJ O
education NN O
and CC O
laddered JJ O
credentialing NN O
and CC O
in IN O
accreditation NN O
standards NNS O
allow VBP O
greater JJR O
use NN O
of IN O
rural JJ O
practice NN O
sites NNS O
( -LRB- O
Table NNP O
6 CD O
) -RRB- O
. . O

Since IN O
the DT O
purpose NN O
of IN O
the DT O
panel NN O
was VBD O
to TO O
identify VB O
recruitment NN O
and CC O
retention NN O
and CC O
education NN O
strategies NNS O
that WDT O
could MD O
inform VB O
the DT O
development NN O
of IN O
a DT O
HHR NNP O
plan NN O
for IN O
rehabilitation NN O
professionals NNS O
, , O
there EX O
was VBD O
also RB O
discussion NN O
about IN O
contextual JJ O
factors NNS O
that WDT O
would MD O
influence VB O
a DT O
plan NN O
. . O

Panelists NNS O
commented VBD O
that IN O
key JJ O
factors NNS O
to TO O
consider VB O
prior RB O
to IN O
implementation NN O
of IN O
these DT O
strategies NNS O
should MD O
include VB O
workplace JJ O
setting NN O
, , O
geographical JJ O
location NN O
( , O
i LS O
. . O
e -RRB- O
. . O
urban JJ O
and CC O
rural JJ O
) -RRB- O
and CC O
gender NN O
issues NNS O
. . O

Discussion NN O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
identify VB O
recruitment NN O
and CC O
retention NN O
strategies NNS O
to TO O
inform VB O
the DT O
development NN O
of IN O
HHR NNP O
planning NN O
for IN O
rehabilitation NN O
professionals NNS O
in IN O
Ontario NNP O
. . O

This DT O
study NN O
highlights VBZ O
that IN O
Quality NNP O
of IN O
Worklife NNP O
and CC O
Work NNP O
Environment NNP O
, , O
Financial NNP O
Incentives NNPS O
and CC O
Marketing NNP O
and CC O
Professional NNP O
Development NNP O
are VBP O
the DT O
three CD O
major JJ O
areas NNS O
of IN O
focus NN O
when WRB O
developing VBG O
a DT O
competitive JJ O
HR NN O
plan NN O
in IN O
the DT O
rehabilitation NN O
sector NN O
. . O

Quality NN O
of IN O
Worklife NNP O
and CC O
Work NNP O
Environment NNP O

Quality NN O
of IN O
Worklife NNP O
and CC O
Work NNP O
Environment NNP O
strategies NNS O
ranked VBD O
among IN O
the DT O
top JJ O
category NN O
for IN O
recruitment NN O
and CC O
retention NN O
of IN O
rehabilitation NN O
therapists NNS O
. . O

This DT O
has VBZ O
also RB O
been VBN O
found VBN O
among IN O
nurses NNS O
[ -LRB- O
44 CD O
] -RRB- O
where WRB O
it PRP O
was VBD O
reported VBN O
that IN O
addressing VBG O
such JJ O
factors NNS O
can MD O
affect VB O
the DT O
overall JJ O
success NN O
of IN O
the DT O
program NN O
[ -LRB- O
49 CD O
] -RRB- O
. . O

Specifically RB O
, , O
our PRP$ O
findings NNS O
showed VBD O
that IN O
the DT O
top JJ O
ranked VBN O
strategy NN O
for IN O
both CC O
importance NN O
and CC O
feasibility NN O
was VBD O
improving VBG O
and CC O
maintaining VBG O
the DT O
safety NN O
of IN O
rehabilitation NN O
professionals NNS O
in IN O
the DT O
workplace NN O
. . O

Specific JJ O
strategies NNS O
that WDT O
could MD O
reduce VB O
aggression NN O
, , O
abuse NN O
and CC O
violence NN O
in IN O
the DT O
workplace NN O
include VBP O
: : O
zero CD O
tolerance NN O
policies NNS O
, , O
access NN O
to IN O
employee NN O
support NN O
programs NNS O
and CC O
providing VBG O
assistance NN O
to IN O
rehabilitation NN O
professionals NNS O
who WP O
work VBP O
alone RB O
( : O
i PRP O
. . O
e LS O
. . O
home NN O
care NN O
and CC O
rural JJ O
and CC O
remote JJ O
areas NNS O
) -RRB- O
. . O

Since IN O
there EX O
is VBZ O
less JJR O
control NN O
over IN O
the DT O
environment NN O
in IN O
the DT O
home NN O
care NN O
setting NN O
, , O
safety NN O
may MD O
become VB O
a DT O
greater JJR O
concern NN O
in IN O
one CD O
practice NN O
setting NN O
over IN O
another DT O
. . O

This DT O
might MD O
suggest VB O
that IN O
because IN O
there EX O
is VBZ O
less JJR O
control NN O
in IN O
environments NNS O
such JJ O
as IN O
home NN O
care NN O
, , O
remote JJ O
areas NNS O
, , O
and CC O
psychiatric JJ O
settings NNS O
, , O
maintaining VBG O
safety NN O
will MD O
be VB O
more RBR O
difficult JJ O
and CC O
that IN O
solutions NNS O
will MD O
need VB O
to TO O
be VB O
tailored VBN O
to IN O
these DT O
settings NNS O
in IN O
order NN O
to TO O
ensure VB O
retention NN O
of IN O
providers NNS O
. . O

Although IN O
no DT O
studies NNS O
have VBP O
looked VBN O
at IN O
implementing VBG O
personal JJ O
safety NN O
strategies NNS O
for IN O
home NN O
care NN O
therapists NNS O
, , O
written VBN O
policies NNS O
and CC O
procedures NNS O
for IN O
home NN O
care NN O
nurses NNS O
during IN O
inclement JJ O
weather NN O
and CC O
for IN O
dealing VBG O
with IN O
abusive JJ O
or CC O
dangerous JJ O
patients NNS B-Species
, , O
families NNS O
and CC O
neighbourhoods NNS O
have VBP O
been VBN O
reported VBN O
[ -LRB- O
50 CD O
] -RRB- O
. . O

In IN O
addition NN O
to IN O
the DT O
above JJ O
, , O
ensuring VBG O
open JJ O
and CC O
timely JJ O
communication NN O
between IN O
employer NN O
and CC O
worker NN O
was VBD O
also RB O
ranked VBN O
highly RB O
among IN O
the DT O
recruitment NN O
and CC O
retention NN O
strategies NNS O
. . O

Examples NNS O
of IN O
strategies NNS O
include VBP O
: : O
open JJ O
door NN O
policies NNS O
, , O
employee NN O
advisory NN O
committees NNS O
and CC O
regular JJ O
staff NN O
meetings NNS O
and CC O
evaluations NNS O
. . O

Although IN O
these DT O
strategies NNS O
were VBD O
reported VBN O
to TO O
be VB O
used VBN O
among IN O
organizations NNS O
providing VBG O
services NNS O
to IN O
persons NNS B-Species
with IN O
developmental JJ O
disabilities NNS O
in IN O
Alberta NNP O
, , O
there EX O
was VBD O
no DT O
description NN O
of IN O
the DT O
organizations NNS O
, , O
sample NN O
size NN O
or CC O
methodology NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

Similar JJ O
findings NNS O
were VBD O
found VBN O
in IN O
a DT O
qualitative JJ O
study NN O
among IN O
16 CD O
nurses NNS O
working VBG O
from IN O
diverse JJ O
practice NN O
settings NNS O
( , O
acute JJ O
, , O
long JJ O
- HYPH O
term NN O
care NN O
, , O
rehabilitation NN O
and CC O
community NN O
; , O
from IN O
both CC O
urban JJ O
and CC O
rural JJ O
areas NNS O
) -RRB- O
in IN O
a DT O
health NN O
region NN O
in IN O
western JJ O
Canada NNP O
. . O

From IN O
the DT O
semi NN O
- HYPH O
structured VBN O
interviews NNS O
, , O
study NN O
participants NNS B-Species
expressed VBD O
a DT O
desire NN O
for IN O
improved JJ O
consultation NN O
and CC O
communication NN O
with IN O
nurses NNS O
regarding VBG O
changes NNS O
to IN O
the DT O
health NN O
care NN O
system NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

Financial NNP O
Incentives NNPS O
and CC O
Marketing NNP O

Another DT O
area NN O
that WDT O
was VBD O
ranked VBN O
highly RB O
was VBD O
marketing VBG O
strategies NNS O
to TO O
increase VB O
high JJ O
school NN O
student NN O
and CC O
public JJ O
awareness NN O
of IN O
rehabilitation NN O
careers NNS O
. . O

These DT O
specific JJ O
strategies NNS O
were VBD O
also RB O
recommended VBN O
by IN O
the DT O
Ontario NNP O
Hospital NNP O
Association NNP O
( : O
OHA NNP O
) -RRB- O
in IN O
order NN O
to TO O
establish VB O
a DT O
competitive JJ O
position NN O
for IN O
Ontario NNP O
hospitals NNS O
in IN O
respect NN O
of IN O
recruitment NN O
and CC O
retention NN O
of IN O
health NN O
care NN O
professionals NNS O
[ -LRB- O
53 CD O
] -RRB- O
. . O

Similar JJ O
strategies NNS O
have VBP O
been VBN O
developed VBN O
by IN O
the DT O
American NNP O
Physical NNP O
Therapy NNP O
Association NNP O
( : O
APTA NNP O
) -RRB- O
in IN O
response NN O
to IN O
the DT O
declining VBG O
number NN O
of IN O
students NNS O
applying VBG O
to IN O
Physical NNP O
Therapy NNP O
Education NNP O
Programs NNP O
[ -LRB- O
54 CD O
] -RRB- O
. . O

To TO O
address VB O
this DT O
trend NN O
, , O
APTA NNP O
developed VBD O
a DT O
campaign NN O
to TO O
promote VB O
Physical NNP O
Therapy NNP O
as IN O
the DT O
profession NN O
of IN O
choice NN O
to IN O
high JJ O
school NN O
and CC O
college NN O
students NNS O
across IN O
the DT O
United NNP O
States NNP O
. . O

The DT O
potential JJ O
components NNS O
of IN O
their PRP$ O
plan NN O
included VBD O
: : O
developing VBG O
a DT O
"""" `` O
Recruiting NNP O
Kit NNP O
"""" '' O
for IN O
educators NNS O
, , O
students NNS O
and CC O
various JJ O
APTA NNP O
members NNS O
to TO O
be VB O
used VBN O
in IN O
the DT O
high JJ O
school NN O
and CC O
college NN O
settings NNS O
to TO O
introduce VB O
Physical NNP O
Therapy NNP O
as IN O
a DT O
career NN O
; , O
establishing VBG O
public JJ O
relations NNS O
initiatives NNS O
that WDT O
demonstrate VBP O
the DT O
role NN O
of IN O
Physical NNP O
Therapy NNP O
in IN O
the DT O
public JJ O
arena NN O
targeting VBG O
minority NN O
groups NNS O
that WDT O
are VBP O
underrepresented VBN O
in IN O
the DT O
profession NN O
; , O
and CC O
creating VBG O
alliances NNS O
with IN O
professional JJ O
associations NNS O
of IN O
high JJ O
school NN O
guidance NN O
counsellors NNS O
and CC O
educators NNS O
. . O

Based VBN O
on IN O
our PRP$ O
finding NN O
, , O
the DT O
APTA NNP O
model NN O
may MD O
have VB O
applicability NN O
in IN O
Ontario NNP O
. . O

Workload NN O
and CC O
Skill NNP O
Mix NNP O

Of IN O
the DT O
six CD O
Workload NNP O
and CC O
Skill NNP O
Mix NNP O
strategies NNS O
only RB O
two CD O
were VBD O
highly RB O
rated VBN O
: : O
implementing VBG O
a DT O
caseload NN O
management NN O
database NN O
and CC O
using VBG O
support NN O
personnel NN O
. . O

Caseload NN O
management NN O
has VBZ O
been VBN O
identified VBN O
in IN O
the DT O
literature NN O
as IN O
an DT O
issue NN O
affecting VBG O
all DT O
three CD O
rehabilitation NN O
professions NNS O
. . O

For IN O
example NN O
, , O
in IN O
physiotherapy NN O
, , O
Christie NNP O
' POS O
s NN O
study NN O
[ -LRB- O
55 CD O
] -RRB- O
found VBD O
that IN O
caseload NN O
expectations NNS O
tended VBD O
to TO O
be VB O
significantly RB O
higher JJR O
than IN O
the DT O
reality NN O
and CC O
that DT O
caseload NN O
varies VBZ O
across IN O
different JJ O
programs NNS O
. . O

Similarly RB O
, , O
the DT O
Canadian NNP O
Association NNP O
of IN O
Speech NNP O
- HYPH O
Language NNP O
Pathologists NNPS O
and CC O
Audiologists NNPS O
( -LRB- O
CASPLA NNP O
) -RRB- O
survey NN O
indicated VBD O
that IN O
factors NNS O
affecting VBG O
the DT O
workload NN O
of IN O
SLPs NNS O
include VBP O
delivery NN O
models NNS O
, , O
client NN O
disorder NN O
, , O
severity NN O
and CC O
work NN O
setting NN O
[ -LRB- O
56 CD O
] -RRB- O
. . O

A DT O
literature NN O
review NN O
and CC O
environmental JJ O
scan NN O
undertaken VBN O
by IN O
the DT O
Canadian NNP O
Association NNP O
of IN O
Occupational NNP O
Therapists NNPS O
( -LRB- O
CAOT NNP O
) -RRB- O
proposed VBD O
that IN O
guiding VBG O
principles NNS O
for IN O
caseload NN O
management NN O
should MD O
include VB O
: : O
evidence NN O
- HYPH O
based VBN O
occupational JJ O
therapy NN O
, , O
cost NN O
- HYPH O
effectiveness NN O
, , O
accountability NN O
, , O
professional JJ O
leadership NN O
and CC O
expert NN O
judgment NN O
, , O
comprehensiveness NN O
and CC O
flexibility NN O
[ -LRB- O
57 CD O
] -RRB- O
. . O

Therefore RB O
, , O
upon IN O
implementation NN O
of IN O
a DT O
caseload NN O
management NN O
database NN O
for IN O
rehabilitation NN O
, , O
key JJ O
factors NNS O
to TO O
consider VB O
include VB O
workplace JJ O
setting NN O
and CC O
client NN O
service NN O
delivery NN O
models NNS O
. . O

The DT O
other JJ O
highly RB O
rated VBN O
Workload NNP O
and CC O
Skill NNP O
Mix NNP O
strategy NN O
was VBD O
the DT O
use NN O
of IN O
support NN O
personnel NNS O
( : O
i LS O
. . O
e LS O
. . O
physiotherapy NN O
assistants NNS O
or CC O
exercise NN O
therapists NNS O
) -RRB- O
to TO O
increase VB O
efficiency NN O
of IN O
utilization NN O
of IN O
scarcer JJR O
and CC O
higher JJR O
order NN O
rehabilitation NN O
competencies NNS O
. . O

Considerations NNS O
for IN O
implementing VBG O
this DT O
strategy NN O
include VBP O
addressing VBG O
key JJ O
issues NNS O
such JJ O
supply NN O
, , O
standards NNS O
of IN O
education NN O
, , O
standards NNS O
of IN O
practice NN O
and CC O
accreditation NN O
. . O

These DT O
are VBP O
highlighted VBN O
in IN O
an DT O
article NN O
by IN O
Salvatori NNP O
[ -LRB- O
58 CD O
] -RRB- O
who WP O
reported VBD O
that IN O
the DT O
actual JJ O
number NN O
of IN O
OT NNP O
personnel NNS O
delivering VBG O
OT NNP O
services NNS O
in IN O
Canada NNP O
remains VBZ O
unknown JJ O
and CC O
that IN O
there EX O
are VBP O
no DT O
national JJ O
standards NNS O
of IN O
education NN O
nor CC O
accreditation NN O
process NN O
for IN O
OT NNP O
assistants NNS O
. . O

CAOT NNP O
believes VBZ O
that IN O
in IN O
order NN O
to TO O
utilize VB O
support NN O
personnel NNS O
appropriately RB O
, , O
studies NNS O
on IN O
human JJ B-Species
resource NN O
needs NNS O
for IN O
occupational JJ O
therapy NN O
and CC O
support NN O
personnel NNS O
are VBP O
first RB O
needed VBN O
with IN O
input NN O
from IN O
OTs NNP O
, , O
stakeholders NNS O
, , O
funders NNS O
, , O
decision NN O
makers NNS O
and CC O
health NN O
policy NN O
planners NNS O
[ -LRB- O
59 CD O
] -RRB- O
. . O

Since IN O
there EX O
is VBZ O
a DT O
lack NN O
of IN O
competency NN O
profiles NNS O
related VBN O
to IN O
the DT O
role NN O
, , O
responsibilities NNS O
, , O
and CC O
supervision NN O
of IN O
assistants NNS O
, , O
particularly RB O
with IN O
regards NNS O
to IN O
delivering VBG O
services NNS O
in IN O
unsupervised JJ O
community NN O
- HYPH O
based VBN O
settings NNS O
, , O
the DT O
type NN O
of IN O
workplace NN O
setting NN O
where WRB O
this DT O
strategy NN O
may MD O
be VB O
implemented VBN O
should MD O
be VB O
considered VBN O
[ -LRB- O
58 CD O
] -RRB- O
. . O

Education NNP O
and CC O
Training NNP O

Given VBN O
that IN O
60 CD O
% NN O
of IN O
highly RB O
rated VBN O
Education NNP O
and CC O
Training NNP O
strategies NNS O
targeted VBN O
rural JJ O
and CC O
remote JJ O
practices NNS O
underscores VBZ O
the DT O
importance NN O
of IN O
specific JJ O
strategies NNS O
for IN O
rural JJ O
and CC O
remote JJ O
areas NNS O
in IN O
the DT O
development NN O
of IN O
a DT O
HHR NNP O
plan NN O
. . O

The DT O
need NN O
to TO O
build VB O
on IN O
existing VBG O
mechanisms NNS O
to TO O
expand VB O
the DT O
availability NN O
of IN O
rural JJ O
and CC O
remote JJ O
clinical JJ O
placements NNS O
by IN O
providing VBG O
financial JJ O
and CC O
accommodation NN O
support NN O
was VBD O
ranked VBN O
among IN O
the DT O
top JJ O
two CD O
most RBS O
important JJ O
and CC O
feasible JJ O
education NN O
strategies NNS O
for IN O
rehabilitation NN O
professionals NNS O
. . O

Not RB O
only RB O
has VBZ O
this DT O
strategy NN O
been VBN O
used VBN O
as IN O
a DT O
recruitment NN O
tool NN O
for IN O
rehabilitation NN O
students NNS O
, , O
it PRP O
has VBZ O
also RB O
been VBN O
reported VBN O
by IN O
Solomon NNP O
et FW O
al NNP O
. . O

[ -LRB- O
34 CD O
] -RRB- O
to TO O
be VB O
effective JJ O
in IN O
retaining VBG O
OTs NNS O
and CC O
PTs NNS O
in IN O
underserviced JJ O
Northwestern NNP O
Ontario NNP O
communities NNS O
. . O

Respondents NNS O
from IN O
Solomon NNP O
et FW O
al NNP O
. . O
' '' O
s POS O
study NN O
reported VBD O
that IN O
the DT O
top JJ O
three CD O
benefits NNS O
of IN O
supervising VBG O
students NNS O
were VBD O
that IN O
it PRP O
stimulates VBZ O
thinking NN O
, , O
it PRP O
provides VBZ O
opportunity NN O
to TO O
contribute VB O
to IN O
the DT O
profession NN O
and CC O
that IN O
it PRP O
provides VBZ O
access NN O
to IN O
current JJ O
information NN O
. . O

The DT O
reported JJ O
disadvantages NNS O
however RB O
was VBD O
that IN O
it PRP O
was VBD O
time NN O
- HYPH O
consuming VBG O
and CC O
students NNS O
contributed VBD O
stress NN O
to IN O
the DT O
working NN O
environment NN O
. . O

Similarly RB O
, , O
a DT O
two CD O
- HYPH O
part NN O
study NN O
found VBD O
substantial JJ O
gaps NNS O
between IN O
financial JJ O
incentives NNS O
students NNS O
deem VBP O
important JJ O
in IN O
the DT O
creation NN O
of IN O
an DT O
appealing JJ O
clinical JJ O
placement NN O
opportunity NN O
and CC O
the DT O
actual JJ O
provisions NNS O
offered VBN O
to IN O
them PRP O
by IN O
Southeastern NNP O
Ontario NNP O
communities NNS O
[ -LRB- O
60 CD O
, , O
61 CD O
] -RRB- O
. . O

Although IN O
OT NNP O
and CC O
PT NNP O
students NNS O
reported VBD O
that IN O
they PRP O
were VBD O
more RBR O
willing JJ O
to TO O
complete VB O
a DT O
clinical JJ O
placement NN O
in IN O
an DT O
underserviced JJ O
community NN O
if IN O
provided VBN O
travel NN O
stipends NNS O
, , O
rent VB O
- HYPH O
free JJ O
housing NN O
and CC O
interprofessional JJ O
education NN O
opportunities NNS O
, , O
the DT O
majority NN O
of IN O
these DT O
incentives NNS O
were VBD O
only RB O
available JJ O
to IN O
medical JJ O
students NNS O
. . O

In IN O
addition NN O
to IN O
training VBG O
students NNS O
for IN O
rural JJ O
and CC O
remote JJ O
practice NN O
, , O
a DT O
longitudinal JJ O
study NN O
reported VBD O
that IN O
perceived VBN O
opportunity NN O
for IN O
career NN O
development NN O
was VBD O
the DT O
most RBS O
significant JJ O
factor NN O
related VBN O
to IN O
job NN O
turnover NN O
and CC O
regional JJ O
attrition NN O
among IN O
physiotherapists NNS O
working VBG O
in IN O
Northern NNP O
Ontario NNP O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Therefore RB O
developing VBG O
workforce NN O
strategies NNS O
for IN O
rehabilitation NN O
therapists NNS O
working VBG O
in IN O
these DT O
areas NNS O
should MD O
be VB O
among IN O
one CD O
of IN O
the DT O
priority NN O
areas NNS O
in IN O
HHR NNP O
planning NN O
. . O

Professional NNP O
Development NNP O

Our PRP$ O
findings NNS O
indicate VBP O
that IN O
the DT O
theme NN O
with IN O
the DT O
largest JJS O
number NN O
of IN O
strategies NNS O
that WDT O
were VBD O
considered VBN O
important JJ O
and CC O
feasible JJ O
to TO O
implement VB O
as IN O
part NN O
of IN O
HHR NNP O
planning NN O
was VBD O
professional JJ O
development NN O
. . O

Many JJ O
were VBD O
specific JJ O
to IN O
rural JJ O
and CC O
remote JJ O
areas NNS O
. . O

Although IN O
the DT O
importance NN O
of IN O
continuous JJ O
professional JJ O
development NN O
( , O
CPD NNP O
) -RRB- O
in IN O
recruitment NN O
and CC O
retention NN O
is VBZ O
well RB O
recognized VBN O
, , O
a DT O
Canadian JJ O
study NN O
reported VBD O
several JJ O
barriers NNS O
to IN O
its PRP$ O
implementation NN O
[ -LRB- O
62 CD O
] -RRB- O
. . O

In IN O
the DT O
case NN O
of IN O
OTs NNP O
employed VBN O
in IN O
public JJ O
settings NNS O
in IN O
Nova NNP O
Scotia NNP O
, , O
Townsend NNP O
et FW O
al NNP O
. . O

( SYM O
2006 CD O
) -RRB- O
found VBD O
that IN O
the DT O
most RBS O
powerful JJ O
deterrent NN O
for IN O
CPD NNP O
was VBD O
the DT O
lack NN O
of IN O
support NN O
from IN O
workplace JJ O
policies NNS O
. . O

Based VBN O
on IN O
their PRP$ O
study NN O
results NNS O
, , O
the DT O
use NN O
of IN O
CPD NNP O
as IN O
a DT O
recruitment NN O
and CC O
retention NN O
strategy NN O
was VBD O
highly RB O
influenced VBN O
by IN O
gender NN O
issues NNS O
, , O
work NN O
- HYPH O
life NN O
balance NN O
, , O
career NN O
advancement NN O
, , O
working VBG O
conditions NNS O
, , O
geographical JJ O
location NN O
, , O
professional JJ O
versus IN O
employer NN O
responsibility NN O
, , O
and CC O
employee NN O
benefits NNS O
. . O

Although IN O
occupational JJ O
therapy NN O
is VBZ O
a DT O
female NN O
- HYPH O
dominated VBN O
profession NN O
, , O
workplace NN O
policies NNS O
did VBD O
not RB O
address VB O
issues NNS O
of IN O
gender NN O
. . O

For IN O
example NN O
, , O
therapists NNS O
in IN O
this DT O
study NN O
indicated VBD O
that IN O
CPD NNP O
competes VBZ O
with IN O
family NN O
commitments NNS O
, , O
therefore RB O
these DT O
activities NNS O
are VBP O
"""" `` O
done VBN O
largely RB O
during IN O
personal JJ O
time NN O
, , O
mainly RB O
at IN O
their PRP$ O
own JJ O
cost NN O
, , O
and CC O
on IN O
top NN O
of IN O
childcare NN O
, , O
eldercare NN O
, , O
homemaking NN O
and CC O
other JJ O
family NN O
responsibilities NNS O
"""" '' O
[ -LRB- O
62 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
heavy JJ O
workloads NNS O
, , O
lack NN O
of IN O
salary NN O
and CC O
career NN O
incentives NNS O
, , O
and CC O
lack NN O
of IN O
policy NN O
and CC O
funding NN O
support NN O
are VBP O
all RB O
barriers NNS O
to IN O
CPD NNP O
. . O

These DT O
issues NNS O
become VBP O
more RBR O
pronounced JJ O
in IN O
rural JJ O
and CC O
remote JJ O
settings NNS O
because IN O
smaller JJR O
communities NNS O
often RB O
only RB O
have VBP O
one CD O
therapist NN O
; : O
hence RB O
the DT O
systemic JJ O
pressure NN O
of IN O
workload NN O
demands NNS O
makes VBZ O
it PRP O
difficult JJ O
for IN O
the DT O
therapist NN O
to TO O
leave VB O
patient JJ B-Species
care NN O
. . O

OTs NNS O
from IN O
this DT O
study NN O
also RB O
questioned VBD O
who WP O
was VBD O
responsible JJ O
for IN O
CPD NNP O
. . O

Some DT O
felt VBD O
that IN O
it PRP O
was VBD O
the DT O
professional JJ O
' '' O
s POS O
responsibility NN O
while IN O
others NNS O
felt VBD O
that IN O
it PRP O
was VBD O
the DT O
responsibility NN O
of IN O
the DT O
employer NN O
to TO O
provide VB O
CPD NN O
opportunities NNS O
. . O

The DT O
primary JJ O
limitation NN O
employers NNS O
faced VBD O
was VBD O
the DT O
lack NN O
of IN O
financial JJ O
resources NNS O
, , O
however RB O
giving VBG O
employees NNS O
time NN O
off RP O
without IN O
pay NN O
was VBD O
an DT O
alternative JJ O
strategy NN O
utilized VBN O
instead RB O
of IN O
funding VBG O
professional JJ O
development NN O
activities NNS O
. . O

Although IN O
there EX O
are VBP O
professional JJ O
and CC O
provincial JJ O
variations NNS O
in IN O
funding NN O
for IN O
CPD NNP O
across IN O
Canada NNP O
, , O
these DT O
results NNS O
are VBP O
informative JJ O
in IN O
that IN O
it PRP O
highlights VBZ O
the DT O
need NN O
for IN O
employers NNS O
to TO O
consider VB O
how WRB O
workplace JJ O
policies NNS O
can MD O
affect VB O
recruitment NN O
and CC O
retention NN O
strategies NNS O
. . O

Limitations NNS O
of IN O
this DT O
study NN O
should MD O
be VB O
noted VBN O
. . O

First RB O
, , O
the DT O
majority NN O
of IN O
the DT O
strategies NNS O
were VBD O
obtained VBN O
from IN O
the DT O
grey JJ O
literature NN O
that WDT O
is VBZ O
not RB O
subject JJ O
to IN O
the DT O
same JJ O
scrutiny NN O
as IN O
the DT O
peer NN O
- HYPH O
reviewed VBN O
literature NN O
. . O

Second RB O
, , O
almost RB O
none NN O
of IN O
the DT O
strategies NNS O
were VBD O
specifically RB O
developed VBN O
for IN O
rehabilitation NN O
professionals NNS O
and CC O
in IN O
many JJ O
cases NNS O
had VBD O
to TO O
be VB O
re RB O
- HYPH O
worded VBN O
to TO O
fit VB O
the DT O
rehabilitation NN O
context NN O
. . O

There EX O
is VBZ O
a DT O
lack NN O
of IN O
research NN O
on IN O
rehabilitation NN O
clinicians NNS O
' POS O
perspectives NNS O
on IN O
recruitment NN O
and CC O
retention NN O
strategies NNS O
; , O
therefore RB O
future JJ O
research NN O
should MD O
focus VB O
on IN O
investigating VBG O
this DT O
area NN O
. . O

Third RB O
, , O
during IN O
the DT O
face NN O
- HYPH O
to IN O
- HYPH O
face NN O
meeting NN O
, , O
bias NN O
could MD O
have VB O
resulted VBN O
from IN O
panelists NNS O
whose WP$ O
opinion NN O
may MD O
have VB O
influenced VBN O
others NNS O
significantly RB O
, , O
especially RB O
if IN O
members NNS O
came VBD O
from IN O
similar JJ O
workplace JJ O
settings NNS O
. . O

The DT O
facilitator NN O
of IN O
the DT O
expert NN O
panels NNS O
however RB O
, , O
followed VBD O
a DT O
strict JJ O
process NN O
for IN O
managing VBG O
the DT O
discussion NN O
and CC O
ensured VBD O
that IN O
all DT O
panelists NNS O
were VBD O
given VBN O
the DT O
opportunity NN O
to TO O
express VB O
their PRP$ O
opinions NNS O
. . O

Finally RB O
, , O
although IN O
some DT O
strategies NNS O
such JJ O
as IN O
competitive JJ O
wage NN O
packages NNS O
, , O
training NN O
/ SYM O
growth NN O
opportunities NNS O
and CC O
professional JJ O
development NN O
are VBP O
viewed VBN O
as IN O
both CC O
a DT O
recruitment NN O
and CC O
retention NN O
incentive NN O
, , O
other JJ O
strategies NNS O
do VBP O
not RB O
overlap VB O
and CC O
are VBP O
appropriate JJ O
for IN O
only RB O
one CD O
of IN O
the DT O
two CD O
tasks NNS O
. . O

For IN O
example NN O
, , O
increasing VBG O
public JJ O
awareness NN O
of IN O
rehabilitation NN O
careers NNS O
, , O
providing VBG O
rural JJ O
and CC O
remote JJ O
orientation NN O
packages NNS O
and CC O
family NN O
relocation NN O
programs NNS O
are VBP O
only RB O
appropriate JJ O
for IN O
attracting VBG O
a DT O
worker NN O
while IN O
ensuring VBG O
open JJ O
and CC O
timely JJ O
communication NN O
may MD O
be VB O
seen VBN O
as IN O
a DT O
strategy NN O
only RB O
for IN O
retention NN O
. . O

Future JJ O
research NN O
should MD O
therefore RB O
consider VB O
studying VBG O
recruitment NN O
and CC O
retention NN O
strategies NNS O
separately RB O
so IN O
that IN O
a DT O
distinction NN O
between IN O
the DT O
two CD O
can MD O
be VB O
made VBN O
. . O

Conclusion NN O

This DT O
study NN O
identified VBD O
34 CD O
strategies NNS O
that WDT O
should MD O
be VB O
considered VBN O
as IN O
important JJ O
and CC O
feasible JJ O
for IN O
implementation NN O
as IN O
part NN O
of IN O
HHR NNP O
planning NN O
for IN O
rehabilitation NN O
professionals NNS O
. . O

Although IN O
the DT O
highest JJS O
ranked VBN O
strategies NNS O
focused VBD O
on IN O
areas NNS O
of IN O
Quality NNP O
of IN O
Worklife NNP O
and CC O
Work NNP O
Environment NNP O
, , O
Financial NNP O
Incentives NNPS O
and CC O
Marketing NNP O
and CC O
Professional NNP O
Development NNP O
, , O
key JJ O
factors NNS O
that WDT O
need VBP O
to TO O
be VB O
considered VBN O
in IN O
the DT O
context NN O
of IN O
implementation NN O
include VBP O
: : O
workplace NN O
setting NN O
, , O
geographical JJ O
location NN O
and CC O
gender NN O
issues NNS O
. . O

While IN O
this DT O
is VBZ O
the DT O
first JJ O
study NN O
to IN O
our PRP$ O
knowledge NN O
that WDT O
provides VBZ O
a DT O
comprehensive JJ O
list NN O
of IN O
recruitment NN O
and CC O
retention NN O
strategies NNS O
relevant JJ O
to IN O
rehabilitation NN O
professionals NNS O
, , O
more JJR O
information NN O
is VBZ O
needed VBN O
for IN O
the DT O
development NN O
of IN O
a DT O
HHR NNP O
plan NN O
. . O

Information NN O
on IN O
trends NNS O
in IN O
labour JJ O
force NN O
participation NN O
as RB O
well RB O
as IN O
knowledge NN O
regarding VBG O
the DT O
use NN O
and CC O
effectiveness NN O
of IN O
recruitment NN O
and CC O
retention NN O
strategies NNS O
for IN O
rehabilitation NN O
professionals NNS O
is VBZ O
needed VBN O
. . O

More RBR O
importantly RB O
, , O
the DT O
success NN O
of IN O
implementing VBG O
and CC O
sustaining VBG O
such JJ O
strategies NNS O
requires VBZ O
future JJ O
research NN O
to TO O
validate VB O
these DT O
strategies NNS O
from IN O
the DT O
perspective NN O
of IN O
rehabilitation NN O
clinicians NNS O
and CC O
human JJ B-Species
resource NN O
decisions NNS O
makers NNS O
( : O
i LS O
. . O
e LS O
. . O
local JJ O
government NN O
, , O
stakeholders NNS O
, , O
etc FW O
. . O
) -RRB- O
so IN O
that IN O
specific JJ O
barriers NNS O
and CC O
challenges NNS O
can MD O
be VB O
identified VBN O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

DT NNP O
participated VBD O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
, , O
conducted VBD O
the DT O
literature NN O
review NN O
, , O
analyzed VBD O
and CC O
interpreted VBD O
the DT O
results NNS O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

LMH NNP O
, , O
AD NNP O
, , O
DB NNP O
and CC O
KB NNP O
were VBD O
involved VBN O
in IN O
providing VBG O
feedback NN O
and CC O
editing VBG O
the DT O
content NN O
of IN O
the DT O
manuscript NN O
. . O

MDL NNP O
recommended VBD O
participants NNS B-Species
for IN O
the DT O
expert NN O
panel NN O
and CC O
was VBD O
involved VBN O
in IN O
providing VBG O
feedback NN O
and CC O
editing VBG O
the DT O
content NN O
of IN O
the DT O
manuscript NN O
. . O

SJ NNP O
participated VBD O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
, , O
recommended VBD O
participants NNS B-Species
for IN O
the DT O
expert NN O
panel NN O
, , O
organized JJ O
and CC O
consolidated VBN O
strategies NNS O
, , O
interpreted VBD O
the DT O
data NNS O
and CC O
edited VBD O
the DT O
content NN O
of IN O
the DT O
manuscript NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

A DT O
life NN O
threatening JJ O
uterine NN O
inversion NN O
and CC O
massive JJ O
post JJ O
partum NN O
hemorrhage NN O
caused VBN O
by IN O
placenta NN O
accrete NN O
during IN O
Caesarean JJ O
section NN O
in IN O
a DT O
primigravida NN O
: : O
a DT O
case NN O
report NN O

Abstract JJ O

Background NN O

A DT O
32 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
Caucasian JJ O
primigravida NN O
was VBD O
admitted VBN O
for IN O
elective JJ O
Caesarean NNP O
Section NNP O
at IN O
36 CD O
weeks NNS O
and CC O
6 CD O
days NNS O
with IN O
the DT O
diagnosis NN O
of IN O
preeclampsia NN O
. . O

Case NN O
presentation NN O

Traction NN O
of IN O
the DT O
umbilical JJ O
cord NN O
after IN O
delivery NN O
of IN O
a DT O
healthy JJ O
baby NN O
resulted VBD O
in IN O
uterine JJ O
inversion NN O
. . O

The DT O
placenta NN O
was VBD O
found VBN O
to TO O
be VB O
densely RB O
adherent JJ O
to IN O
the DT O
posterior JJ O
uterine NN O
wall NN O
. . O

Piecemeal JJ O
excision NN O
of IN O
the DT O
placenta NN O
as RB O
close JJ O
as IN O
possible JJ O
to IN O
the DT O
uterine NN O
lining NN O
was VBD O
then RB O
performed VBN O
. . O

Conclusion NN O

In IN O
this DT O
way NN O
we PRP O
were VBD O
able JJ O
to TO O
control VB O
a DT O
massive JJ O
post JJ O
partum NN O
hemorrhage NN O
and CC O
preserve VB O
the DT O
fertility NN O
of IN O
the DT O
patient NN B-Species
. . O

Background NN O

Placenta NN O
accreta NN O
is VBZ O
defined VBN O
as IN O
abnormal JJ O
adherence NN O
, , O
either CC O
in IN O
whole NN O
or CC O
in IN O
part NN O
of IN O
the DT O
afterbirth NN O
to IN O
the DT O
underlying VBG O
uterine NN O
wall NN O
. . O

Placenta NN O
accreta NN O
and CC O
other JJ O
pathological JJ O
placentations NNS O
( , O
such JJ O
as IN O
increta NN O
, , O
percreta NN O
) , O
are VBP O
rare JJ O
complications NNS O
of IN O
pregnancy NN O
with IN O
potential JJ O
life NN O
threatening NN O
and CC O
fertility NN O
threatening NN O
consequences NNS O
. . O

The DT O
incidence NN O
of IN O
placenta NN O
accreta NN O
has VBZ O
increased VBN O
ten CD O
times NNS O
over IN O
the DT O
last JJ O
fifteen CD O
years NNS O
, , O
which WDT O
reflects VBZ O
the DT O
increase NN O
in IN O
the DT O
rate NN O
of IN O
Caesarean JJ O
Sections NNS O
( -LRB- O
CS NNP O
) -RRB- O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Placenta NNP O
accreta NNP O
has VBZ O
become VBN O
the DT O
most RBS O
important JJ O
cause NN O
of IN O
peripartum NN O
hysterectomy NN O
. . O

A DT O
life NN O
threatening VBG O
acute JJ O
uterine NN O
inversion NN O
and CC O
massive JJ O
PPH NNP O
can MD O
be VB O
caused VBN O
by IN O
placenta NN O
accreta NN O
during IN O
CS NN O
but CC O
seldom RB O
in IN O
a DT O
primigravida NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

Case NN O
presentation NN O

A DT O
32 CD O
year NN O
old JJ O
, , O
primigravida NN O
, , O
was VBD O
admitted VBN O
in IN O
a DT O
District NNP O
General NNP O
Hospital NNP O
for IN O
elective JJ O
Caesarean JJ O
section NN O
at IN O
36 CD O
weeks NNS O
and CC O
6 CD O
days NNS O
with IN O
the DT O
diagnosis NN O
of IN O
preeclampsia NN O
. . O

She PRP O
had VBD O
two CD O
antenatal JJ O
ultrasound NN O
examinations NNS O
showing VBG O
a DT O
healthy JJ O
fetus NN O
and CC O
posterior NN O
fundal JJ O
placenta NN O
. . O

The DT O
patient NN B-Species
had VBD O
lower JJR O
segment NN O
CS NNS O
of IN O
a DT O
healthy JJ O
male JJ O
infant NN B-Species
under IN O
spinal JJ O
anesthesia NN O
. . O

The DT O
placenta NN O
was VBD O
found VBN O
to TO O
be VB O
densely RB O
adherent JJ O
to IN O
the DT O
posterior JJ O
uterine NN O
wall NN O
. . O

Traction NN O
of IN O
the DT O
umbilical JJ O
cord NN O
was VBD O
applied VBN O
and CC O
subsequently RB O
resulted VBN O
in IN O
uterine JJ O
inversion NN O
. . O

The DT O
placenta NN O
was VBD O
removed VBN O
by IN O
' `` O
piecemeal NN O
' '' O
excising VBG O
as RB O
close RB O
as IN O
possible JJ O
to IN O
the DT O
uterine JJ O
lining NN O
. . O

About RB O
80 CD O
% NN O
of IN O
the DT O
placental JJ O
tissue NN O
was VBD O
removed VBN O
until IN O
the DT O
uterine NN O
inversion NN O
was VBD O
corrected VBN O
. . O

The DT O
uterus NN O
was VBD O
closed JJ O
in IN O
two CD O
layers NNS O
. . O

Two CD O
intra JJ O
- HYPH O
abdominal JJ O
drains NNS O
were VBD O
sited VBN O
. . O

The DT O
estimated VBN O
blood NN O
loss NN O
was VBD O
2 CD O
. . O
5 CD O
litres NNS O
and CC O
five CD O
units NNS O
of IN O
blood NN O
were VBD O
transfused VBN O
together RB O
with IN O
2 CD O
units NNS O
of IN O
FFP NNP O
during IN O
intra JJ O
- HYPH O
operative NN O
and CC O
post NN O
- HYPH O
operative NN O
period NN O
. . O

In IN O
addition NN O
, , O
the DT O
patient NN B-Species
was VBD O
treated VBN O
with IN O
intravenous JJ O
oxytocin NN O
infusion NN O
, , O
pr NN O
misoprostol NN O
and CC O
antibiotics NNS O
. . O

On IN O
the DT O
second JJ O
post JJ O
partum NN O
day NN O
, , O
vaginal JJ O
Doppler NNP O
ultrasound NN O
scan NN O
showed VBD O
significant JJ O
amount NN O
of IN O
placental JJ O
tissues NNS O
with IN O
increased VBN O
vascularity NN O
measuring VBG O
2 CD O
. . O
7 CD O
x SYM O
6 CD O
. . O
6 CD O
x SYM O
6 CD O
. . O
8 CD O
cms NNS O
within IN O
the DT O
endometrial JJ O
cavity NN O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

The DT O
patient NN B-Species
was VBD O
discharged VBN O
on IN O
the DT O
fifth JJ O
post NN O
- HYPH O
operative NN O
day NN O
with IN O
a DT O
conservative JJ O
management NN O
. . O

A DT O
follow NN O
up RP O
Ultrasound NN O
scan NN O
after IN O
two CD O
weeks NNS O
showed VBD O
reduction NN O
of IN O
placental JJ O
mass NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
there EX O
was VBD O
significant JJ O
decrease NN O
in IN O
serum JJ O
beta NN O
HCG NNP O
levels NNS O
from IN O
2300 CD O
u NN O
/ SYM O
L NN O
on IN O
day NN O
1 CD O
to IN O
13 CD O
u NN O
/ SYM O
L NN O
at IN O
four CD O
weeks NNS O
post NN O
operatively RB O
. . O

The DT O
patient NN B-Species
remained VBD O
with IN O
minimal JJ O
vaginal JJ O
bleeding NN O
without IN O
abdominal JJ O
pain NN O
. . O

She PRP O
had VBD O
two CD O
normal JJ O
periods NNS O
after IN O
stopping VBG O
breastfeeding VBG O
and CC O
was VBD O
feeling VBG O
well RB O
. . O

She PRP O
was VBD O
discharged VBN O
from IN O
the DT O
early JJ O
pregnancy NN O
unit NN O
. . O

Discussion NN O

A DT O
life NN O
- HYPH O
threatening VBG O
uterine NN O
inversion NN O
can MD O
be VB O
rarely RB O
caused VBN O
by IN O
placenta NN O
accreta NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Placenta NNP O
accreta NNP O
classically RB O
presents VBZ O
with IN O
retained JJ O
placenta NN O
and CC O
hemorrhage NN O
. . O

The DT O
association NN O
between IN O
uterine NN O
inversion NN O
and CC O
placenta NN O
accreta NN O
is VBZ O
unclear JJ O
, , O
however RB O
, , O
strong JJ O
traction NN O
on IN O
the DT O
umbilical JJ O
cord NN O
with IN O
fundal JJ O
placenta NN O
, , O
excessive JJ O
fundal JJ O
pressure NN O
, , O
relaxed JJ O
uterus NN O
, , O
short JJ O
umbilical JJ O
cord NN O
, , O
uterine NN O
anomalies NNS O
and CC O
antepartum NN O
use NN O
of IN O
magnesium NN O
sulphate NN O
are VBP O
known VBN O
associated VBN O
factors NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Uterine NN O
inversion NN O
and CC O
retain VB O
placenta NN O
accreta NN O
can MD O
both DT O
be VB O
fatal JJ O
complications NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

In IN O
the DT O
case NN O
described VBD O
the DT O
placenta NN O
accreta NN O
was VBD O
complicated VBN O
by IN O
uterine JJ O
inversion NN O
and CC O
subsequent JJ O
massive JJ O
post NN O
partum NN O
hemorrhage NN O
, , O
significantly RB O
increasing VBG O
the DT O
risk NN O
of IN O
maternal JJ O
mortality NN O
. . O

Massive JJ O
post NN O
partum NN O
hemorrhage NN O
is VBZ O
a DT O
major JJ O
cause NN O
of IN O
maternal JJ O
mortality NN O
in IN O
the DT O
United NNP O
Kingdom NNP O
( : O
why WRB O
women NNS B-Species
die VBP O
latest JJS O
report NN O
) -RRB- O
[ -LRB- O
4 CD O
] -RRB- O
. . O

In IN O
this DT O
case NN O
, , O
the DT O
placenta NN O
was VBD O
clamped VBN O
as RB O
close RB O
to IN O
the DT O
uterine JJ O
cavity NN O
as IN O
possible JJ O
and CC O
cut VBN O
. . O

The DT O
base NN O
of IN O
the DT O
placenta NN O
was VBD O
overrun VBN O
with IN O
haemostatic JJ O
sutures NNS O
and CC O
this DT O
was VBD O
repeated VBN O
until IN O
as RB O
much JJ O
of IN O
the DT O
placenta NN O
as IN O
possible JJ O
was VBD O
removed VBN O
( : O
Figure NN O
4 CD O
) -RRB- O
. . O

Placental JJ O
removal NN O
enabled VBD O
correction NN O
of IN O
uterine JJ O
inversion NN O
. . O

Despite IN O
the DT O
many JJ O
conditions NNS O
associated VBN O
with IN O
uterine JJ O
inversion NN O
risk NN O
assessment NN O
is VBZ O
often RB O
lacking VBG O
making VBG O
the DT O
condition NN O
usually RB O
unexpected JJ O
at IN O
the DT O
time NN O
of IN O
presentation NN O
. . O

The DT O
association NN O
between IN O
abnormal JJ O
placentation NN O
such JJ O
as IN O
placenta NN O
accreta NN O
and CC O
uterine NN O
inversion NN O
is VBZ O
well RB O
supported VBN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Therefore RB O
, , O
we PRP O
advocate VBP O
antenatal JJ O
evaluation NN O
and CC O
risk NN O
assessment NN O
for IN O
placenta NN O
accreta NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Prenatal NNP O
Ultrasound NNP O
reported VBD O
sensitivity NN O
of IN O
94 CD O
% NN O
and CC O
specificity NN O
of IN O
79 CD O
% NN O
for IN O
placenta NN O
accreta NN O
, , O
but CC O
offer VB O
no DT O
more JJR O
than IN O
provisional JJ O
diagnostic JJ O
probability NN O
statement NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Moreover RB O
, , O
because IN O
45 CD O
% NN O
of IN O
placenta NN O
accreta NN O
cases NNS O
were VBD O
not RB O
detected VBN O
by IN O
ultrasound NN O
, , O
it PRP O
is VBZ O
important JJ O
to TO O
consider VB O
avoiding VBG O
manual JJ O
removal NN O
of IN O
placenta NN O
if IN O
there EX O
were VBD O
intraoperative JJ O
signs NNS O
of IN O
accreta NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

If IN O
clinically RB O
or CC O
sonographically RB O
the DT O
patient NN B-Species
is VBZ O
suspected VBN O
antenatally RB O
to TO O
be VB O
at IN O
risk NN O
of IN O
placenta NN O
accreta NN O
, , O
appropriate JJ O
management NN O
options NNS O
should MD O
be VB O
considered VBN O
, , O
such JJ O
as IN O
attempted VBN O
conservative JJ O
management NN O
or CC O
hysterectomy NN O
and CC O
counseling NN O
provided VBN O
about IN O
potential JJ O
sequelae NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

The DT O
traditional JJ O
management NN O
is VBZ O
abdominal JJ O
hysterectomy NN O
, , O
but CC O
this DT O
operation NN O
terminates VBZ O
fertility NN O
and CC O
may MD O
have VB O
devastating JJ O
psychological JJ O
effects NNS O
. . O

However RB O
, , O
in IN O
correct JJ O
circumstances NNS O
, , O
a DT O
conservative JJ O
approach NN O
may MD O
be VB O
suitable JJ O
. . O

Conservative JJ O
management NN O
of IN O
abnormally RB O
invasive JJ O
placentation NN O
can MD O
be VB O
effective JJ O
and CC O
fertility NN O
can MD O
be VB O
preserved VBN O
. . O

It PRP O
should MD O
be VB O
only RB O
considered VBN O
in IN O
highly RB O
selected VBN O
cases NNS O
when WRB O
blood NN O
loss NN O
is VBZ O
minimal JJ O
and CC O
there EX O
is VBZ O
wish NN O
for IN O
fertility NN O
preservation NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

For IN O
women NNS B-Species
who WP O
want VBP O
to TO O
preserve VB O
their PRP$ O
fertility NN O
the DT O
placenta NN O
should MD O
be VB O
left VBN O
intact JJ O
if IN O
possible JJ O
after IN O
caesarean JJ O
delivery NN O
as IN O
this DT O
approach NN O
lowers VBZ O
the DT O
risk NN O
of IN O
subsequent JJ O
hysterectomy NN O
from IN O
85 CD O
% NN O
to IN O
15 CD O
% NN O
. . O

For IN O
women NNS B-Species
who WP O
have VBP O
completed VBN O
their PRP$ O
family NN O
, , O
hysterectomy NN O
with IN O
placenta NN O
left VBN O
in IN O
situ NN O
is VBZ O
preferable JJ O
to TO O
lower VB O
the DT O
maternal JJ O
morbidity NN O
rates NNS O
[ -LRB- O
6 CD O
] -RRB- O
. . O

This DT O
case NN O
report NN O
involved VBD O
conservative JJ O
management NN O
. . O

Peripartum NN O
hysterectomy NN O
was VBD O
avoided VBN O
and CC O
the DT O
aim NN O
was VBD O
to TO O
preserve VB O
fertility NN O
. . O

Prophylactic JJ O
antibiotics NNS O
, , O
post NN O
partum NN O
oxytocics NNS O
and CC O
the DT O
use NN O
of IN O
misoprostol NN O
post NN O
operatively RB O
helped VBD O
to TO O
prevent VB O
further JJ O
post NN O
partum NN O
hemorrhage NN O
. . O

When WRB O
a DT O
patient NN B-Species
isinitially RB O
opted VBD O
for IN O
conservative JJ O
management NN O
, , O
the DT O
possibility NN O
of IN O
recurrence NN O
should MD O
be VB O
discussed VBN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
placentation NN O
should MD O
be VB O
carefully RB O
monitored VBN O
for IN O
recurrence NN O
in IN O
any DT O
subsequent JJ O
pregnancy NN O
, , O
particularly RB O
if IN O
the DT O
placenta NN O
is VBZ O
located VBN O
at IN O
the DT O
same JJ O
site NN O
as IN O
the DT O
previous JJ O
placenta NN O
accreta NN O
. . O

Conservative JJ O
treatment NN O
for IN O
placenta NN O
accreta NN O
may MD O
be VB O
an DT O
alternative JJ O
procedure NN O
in IN O
some DT O
selected VBN O
cases NNS O
. . O

Conclusion NN O

We PRP O
suggest VBP O
an DT O
alternative JJ O
approach NN O
for IN O
managing VBG O
uterine NN O
inversion NN O
caused VBN O
by IN O
placenta NN O
accreta NN O
that WDT O
involved VBD O
conservative JJ O
management NN O
. . O

This DT O
way NN O
hysterectomy NN O
was VBD O
avoided VBN O
and CC O
fertility NN O
was VBD O
preserved VBN O
. . O

Abbreviations NNS O

CS NN O
: : O
Caesarean JJ O
Section NN O
; : O
FFP NNP O
: : O
Fresh NNP O
Frozen NNP O
Plasma NNP O

Consent NN O

Written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
the DT O
patient NN B-Species
for IN O
publication NN O
of IN O
this DT O
case NN O
report NN O
and CC O
accompanying VBG O
images NNS O
. . O

A DT O
copy NN O
of IN O
the DT O
written JJ O
consent NN O
is VBZ O
available JJ O
for IN O
review NN O
by IN O
the DT O
Editor NNP O
- HYPH O
in IN O
Chief NNP O
of IN O
this DT O
journal NN O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

All DT O
authors NNS O
have VBP O
made VBN O
substantial JJ O
contribution NN O
to IN O
concept NN O
this DT O
case NN O
report NN O
. . O

Neurogenin2 NN O
Directs VBZ O
Granule NN O
Neuroblast NN O
Production NN O
and CC O
Amplification NN O
while IN O
NeuroD1 NN O
Specifies VBZ O
Neuronal JJ O
Fate NN O
during IN O
Hippocampal JJ O
Neurogenesis NN O

Abstract JJ O

The DT O
specification NN O
and CC O
differentiation NN O
of IN O
dentate NN O
gyrus NN O
granule NN O
neurons NNS O
in IN O
the DT O
hippocampus NN O
require VBP O
temporally RB O
and CC O
spatially RB O
coordinated VBN O
actions NNS O
of IN O
both CC O
intrinsic JJ O
and CC O
extrinsic JJ O
molecules NNS O
. . O

The DT O
basic JJ O
helix NN O
- HYPH O
loop NN O
- HYPH O
helix NN O
transcription NN O
factor NN O
Neurogenin2 NNP O
( , O
Ngn2 NNP O
) -RRB- O
and CC O
NeuroD1 NNP O
are VBP O
key JJ O
regulators NNS O
in IN O
these DT O
processes NNS O
. . O

Based VBN O
on IN O
existing JJ O
classification NN O
, , O
we PRP O
analyzed VBD O
the DT O
molecular JJ O
events NNS O
occurring VBG O
during IN O
hippocampal JJ O
neurogenesis NN O
, , O
primarily RB O
focusing VBG O
on IN O
juvenile JJ O
animals NNS O
. . O

We PRP O
found VBD O
that IN O
Ngn2 NNP O
is VBZ O
transiently RB O
expressed VBN O
by IN O
late JJ O
type NN O
- HYPH O
2a CD O
amplifying VBG O
progenitors NNS O
. . O

The DT O
Ngn2 NNP O
progenies NNS O
mature VBP O
into IN O
hippocampal JJ O
granule NN O
neurons NNS O
. . O

Interestingly RB O
, , O
the DT O
loss NN O
of IN O
Ngn2 NNP O
at IN O
early JJ O
stages NNS O
of IN O
development NN O
leads VBZ O
to IN O
a DT O
robust JJ O
reduction NN O
in IN O
neurogenesis NN O
, , O
but CC O
does VBZ O
not RB O
disturb VB O
granule NN O
neuron NN O
maturation NN O
per FW O
se FW O
. . O

We PRP O
found VBD O
that IN O
the DT O
role NN O
of IN O
Ngn2 NNP O
is VBZ O
to TO O
maintain VB O
progenitors NNS O
in IN O
an DT O
undifferentiated JJ O
state NN O
, , O
allowing VBG O
them PRP O
to TO O
amplify VB O
prior RB O
to IN O
their PRP$ O
maturation NN O
into IN O
granule NN O
neurons NNS O
upon IN O
NeuroD1 NNP O
induction NN O
. . O

When WRB O
we PRP O
overexpressed VBD O
Ngn2 NNP O
and CC O
NeuroD1 NNP O
in IN O
vivo NN O
, , O
we PRP O
found VBD O
NeuroD1 NNP O
to TO O
exhibit VB O
a DT O
more RBR O
pronounced JJ O
neuron NN O
- HYPH O
inductive JJ O
effect NN O
, , O
leading VBG O
to IN O
granule NN O
neuron NN O
commitment NN O
, , O
than IN O
that DT O
displayed VBN O
by IN O
Ngn2 NNP O
. . O

Finally RB O
, , O
we PRP O
observed VBD O
that IN O
all DT O
markers NNS O
expressed VBN O
during IN O
the DT O
transcriptional JJ O
control NN O
of IN O
hippocampal JJ O
neurogenesis NN O
in IN O
rodents NNS O
are VBP O
also RB O
present JJ O
in IN O
the DT O
human JJ B-Species
hippocampus NN O
. . O

Taken VBN O
together RB O
, , O
we PRP O
demonstrate VBP O
a DT O
critical JJ O
role NN O
of IN O
for IN O
Ngn2 NNP O
and CC O
NeuroD1 NNP O
in IN O
controlling VBG O
neuronal JJ O
commitment NN O
and CC O
hippocampal JJ O
granule NN O
neuroblast NN O
formation NN O
, , O
both CC O
during IN O
embryonic JJ O
development NN O
and CC O
in IN O
post NN O
- HYPH O
natal JJ O
hippocampal JJ O
granule NN O
neurogenesis NN O
. . O

Introduction NN O

Neurons NNS O
are VBP O
born VBN O
not RB O
only RB O
during IN O
development NN O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
but CC O
neurogenesis NN O
also RB O
continues VBZ O
into IN O
adulthood NN O
. . O

In IN O
both CC O
rodent JJ B-Species
and CC O
human JJ B-Species
adult NN O
brain NN O
, , O
neurogenesis NN O
is VBZ O
active JJ O
in IN O
two CD O
distinct JJ O
zones NNS O
of IN O
the DT O
forebrain NN O
: : O
the DT O
subventricular JJ O
zone NN O
( , O
SVZ NN O
) -RRB- O
of IN O
the DT O
lateral JJ O
ventricle NN O
and CC O
the DT O
subgranular JJ O
zone NN O
( -LRB- O
SGZ NNP O
) -RRB- O
of IN O
the DT O
hippocampal JJ O
dentate NN O
gyrus NN O
( , O
DG NNP O
) -RRB- O
[ -LRB- O
1 CD O
] -RRB- O
- : O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
molecular JJ O
mechanism NN O
underlying VBG O
neurogenesis NN O
in IN O
the DT O
DG NNP O
is VBZ O
not RB O
fully RB O
understood VBN O
. . O

Clearly RB O
, , O
a DT O
cascade NN O
of IN O
transcriptional JJ O
events NNS O
controls VBZ O
the DT O
specification NN O
of IN O
neuronal JJ O
identity NN O
in IN O
the DT O
DG NNP O
[ -LRB- O
3 CD O
] -RRB- O
, , O
[ -LRB- O
6 CD O
] -RRB- O
- : O
[ -LRB- O
8 CD O
] -RRB- O
, , O
but CC O
details NNS O
of IN O
the DT O
expression NN O
pattern NN O
and CC O
function NN O
of IN O
each DT O
transcription NN O
factor NN O
remain VBP O
elusive JJ O
. . O

The DT O
paired JJ O
- HYPH O
box NN O
homeodomain NN O
transcription NN O
factor NN O
Pax6 NNP O
and CC O
the DT O
bHLH NN O
transcription NN O
factors NNS O
Ngn2 NNP O
and CC O
NeuroD1 NNP O
are VBP O
important JJ O
when WRB O
cells NNS O
acquire VBP O
a DT O
pan NN O
- HYPH O
neuronal JJ O
character NN O
and CC O
a DT O
specific JJ O
neuronal JJ O
subtype NN O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
10 CD O
] -RRB- O
. . O

In IN O
the DT O
developing VBG O
neocortex NN O
, , O
Pax6 NNP O
is VBZ O
expressed VBN O
in IN O
dividing VBG O
radial JJ O
glial NN O
cells NNS O
at IN O
the DT O
ventricular JJ O
surface NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

In IN O
the DT O
adult NN O
hippocampus NN O
, , O
Pax6 NNP O
is VBZ O
expressed VBN O
in IN O
astrocytes NNS O
in IN O
the DT O
SGZ NNP O
and CC O
are VBP O
considered VBN O
to TO O
be VB O
the DT O
true JJ O
stem NN O
cells NNS O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Loss NN O
- HYPH O
and CC O
gain NN O
- HYPH O
of IN O
- HYPH O
function NN O
studies NNS O
indicate VBP O
that IN O
Pax6 NNP O
is VBZ O
involved VBN O
in IN O
regulating VBG O
the DT O
proliferation NN O
of IN O
neocortical JJ O
and CC O
hippocampal JJ O
progenitors NNS O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
12 CD O
] -RRB- O
- : O
[ -LRB- O
16 CD O
] -RRB- O
. . O

During IN O
neocorticogenesis NN O
, , O
high JJ O
concentrations NNS O
of IN O
Pax6 NNP O
induce VBP O
the DT O
expression NN O
of IN O
the DT O
bHLH NN O
transcription NN O
factor NN O
Neurogenin2 NNP O
( -LRB- O
Ngn2 NNP O
) -RRB- O
[ -LRB- O
17 CD O
] -RRB- O
. . O

In IN O
turn NN O
, , O
Ngn2 NNP O
causes VBZ O
cell NN O
cycle NN O
exit NN O
[ -LRB- O
18 CD O
] -RRB- O
, , O
an DT O
event NN O
that WDT O
takes VBZ O
place NN O
when WRB O
NeuroD1 NNP O
starts VBZ O
to TO O
be VB O
expressed VBN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

In IN O
the DT O
developing VBG O
hippocampus NN O
, , O
the DT O
absence NN O
of IN O
Ngn2 NNP O
leads VBZ O
to IN O
a DT O
reduced VBN O
number NN O
of IN O
granule NN O
neurons NNS O
[ -LRB- O
20 CD O
] -RRB- O
. . O

NeuroD1 NNP O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
is VBZ O
essential JJ O
for IN O
the DT O
differentiation NN O
and CC O
survival NN O
of IN O
hippocampal JJ O
granule NN O
neurons NNS O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
in IN O
the DT O
absence NN O
of IN O
Ngn2 NNP O
, , O
NeuroD1 NNP O
can MD O
still RB O
be VB O
activated VBN O
and CC O
neuronal JJ O
differentiation NN O
can MD O
still RB O
take VB O
place NN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

This DT O
has VBZ O
led VBN O
to IN O
the DT O
idea NN O
that IN O
the DT O
primary JJ O
role NN O
of IN O
Ngn2 NNP O
is VBZ O
not RB O
to TO O
direct VB O
neuronal JJ O
differentiation NN O
. . O

Only RB O
a DT O
small JJ O
number NN O
of IN O
studies NNS O
have VBP O
addressed VBN O
the DT O
role NN O
of IN O
Ngn2 NNP O
and CC O
NeuroD1 NNP O
in IN O
hippocampal JJ O
neurogenesis NN O
[ -LRB- O
10 CD O
] -RRB- O
, , O
[ -LRB- O
20 CD O
] -RRB- O
, , O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Therefore RB O
, , O
we PRP O
now RB O
re VBP O
- HYPH O
examine VBP O
their PRP$ O
roles NNS O
in IN O
hippocampal JJ O
neurogenesis NN O
in IN O
detail NN O
, , O
using VBG O
gain NN O
- HYPH O
and CC O
loss NN O
- HYPH O
of IN O
- HYPH O
function NN O
experiments NNS O
. . O

We PRP O
first RB O
establish VBP O
a DT O
hierarchy NN O
of IN O
transcriptional JJ O
events NNS O
that WDT O
occur VBP O
during IN O
neurogenesis NN O
in IN O
the DT O
DG NNP O
and CC O
then RB O
define VBP O
the DT O
place NN O
that WDT O
Ngn2 NNP O
, , O
NeuroD1 NNP O
and CC O
other JJ O
transcription NN O
factors NNS O
have VBP O
in IN O
this DT O
cascade NN O
. . O

We PRP O
find VBP O
that IN O
a DT O
lack NN O
of IN O
Ngn2 NNP O
expression NN O
result VBP O
in IN O
a DT O
markedly RB O
smaller JJR O
hippocampus NN O
and CC O
an DT O
almost RB O
complete JJ O
absence NN O
of IN O
the DT O
DG NNP O
. . O

We PRP O
show VBP O
that IN O
Ngn2 NNP O
is VBZ O
required VBN O
for IN O
granule NN O
neuroblasts NNS O
production NN O
/ SYM O
amplification NN O
. . O

Gain NN O
- HYPH O
of IN O
- HYPH O
function NN O
of IN O
NeuroD1 NNP O
during IN O
development NN O
of IN O
the DT O
DG NNP O
results VBZ O
in IN O
an DT O
efficient JJ O
generation NN O
of IN O
granule NN O
neuroblasts NNS O
, , O
an DT O
effect NN O
that WDT O
we PRP O
do VBP O
not RB O
observe VB O
when WRB O
we PRP O
overexpress VBP O
Ngn2 NNP O
. . O

Finally RB O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
same JJ O
transcription NN O
factors NNS O
and CC O
cellular JJ O
markers NNS O
seen VBN O
in IN O
mouse NN B-Species
and CC O
rat NN B-Species
tissue NN O
are VBP O
also RB O
present JJ O
in IN O
the DT O
human JJ B-Species
hippocampus NN O
. . O

Results NNS O

Expression NN O
of IN O
transcription NN O
factors NNS O
and CC O
cellular JJ O
markers NNS O
define VBP O
different JJ O
phases NNS O
of IN O
postnatal JJ O
hippocampal JJ O
granule NN O
neuron NN O
maturation NN O

We PRP O
first RB O
analyzed VBD O
in IN O
detail NN O
the DT O
chronology NN O
of IN O
expression NN O
of IN O
different JJ O
transcription NN O
factors NNS O
and CC O
cell NN O
- HYPH O
specific JJ O
markers NNS O
during IN O
DG NNP O
granule NN O
neuron NN O
formation NN O
and CC O
correlated VBD O
our PRP$ O
findings NNS O
to IN O
the DT O
previously RB O
established VBN O
classification NN O
of IN O
adult NN O
hippocampal JJ O
neurogenesis NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

The DT O
current JJ O
classification NN O
describes VBZ O
hippocampal JJ O
stem NN O
cells NNS O
and CC O
progenies NNS O
into IN O
three CD O
categories NNS O
( , O
type NN O
- HYPH O
1 CD O
, , O
- HYPH O
2 CD O
and CC O
- HYPH O
3 CD O
cells NNS O
) -RRB- O
depending VBG O
on IN O
the DT O
markers NNS O
they PRP O
express VBP O
as IN O
they PRP O
mature VBP O
. . O

In IN O
the DT O
adult NN O
mouse NN B-Species
DG NNP O
, , O
only RB O
a DT O
very RB O
small JJ O
proportion NN O
of IN O
cells NNS O
undergo VBP O
mitosis NN O
at IN O
any DT O
one CD O
given VBN O
time NN O
[ -LRB- O
22 CD O
] -RRB- O
. . O

Consequently RB O
, , O
in IN O
adult NN O
animals NNS O
it PRP O
is VBZ O
difficult JJ O
to TO O
analyze VB O
which WDT O
transcription NN O
factors NNS O
are VBP O
involved VBN O
in IN O
the DT O
transition NN O
phase NN O
from IN O
one CD O
cell NN O
category NN O
to IN O
the DT O
next JJ O
. . O

Therefore RB O
, , O
we PRP O
studied VBD O
2 CD O
week NN O
- HYPH O
old JJ O
rodents NNS O
which WDT O
have VBP O
higher JJR O
numbers NNS O
of IN O
maturing VBG O
granule NN O
neurons NNS O
in IN O
the DT O
DG NNP O
. . O

We PRP O
performed VBD O
triple JJ O
immunohistochemistry NN O
for IN O
all DT O
markers NNS O
of IN O
interest NN O
and CC O
compared VBD O
results NNS O
from IN O
2 CD O
week NN O
- HYPH O
and CC O
2 CD O
month NN O
- HYPH O
old JJ O
mice NNS B-Species
( -LRB- O
Figure NN O
1 CD O
and CC O
figure NN O
S1 NNP O
) -RRB- O
. . O

We PRP O
first RB O
confirmed VBD O
that IN O
stem NN O
cells NNS O
in IN O
the DT O
SGZ NNP O
exhibit NN O
characteristics NNS O
of IN O
radial JJ O
glia NN O
[ -LRB- O
3 CD O
] -RRB- O
, , O
[ -LRB- O
11 CD O
] -RRB- O
, , O
[ -LRB- O
16 CD O
] -RRB- O
. . O

They PRP O
extend VBP O
radial JJ O
processes NNS O
from IN O
the DT O
SGZ NNP O
to IN O
the DT O
apex NN O
of IN O
the DT O
subgranular JJ O
layer NN O
( , O
SGL NNP O
) -RRB- O
and CC O
the DT O
basal JJ O
molecular JJ O
layer NN O
. . O

Moreover RB O
, , O
they PRP O
express VBP O
the DT O
intermediate JJ O
filament NN O
protein NN O
nestin NN O
, , O
glial NN O
fibrillary NN O
acidic JJ O
protein NN O
( , O
GFAP NNP O
) -RRB- O
and CC O
glial NN O
glutamate NN O
transporter NN O
( -LRB- O
GLAST NNP O
) -RRB- O
[ -LRB- O
16 CD O
] -RRB- O
( -LRB- O
Figure NN O
1A NN O
and CC O
B NN O
and CC O
figure NN O
S1A NN O
and CC O
S1B NN O
) -RRB- O
. . O

The DT O
GFAP NNP O
- : O
and CC O
GLAST NNP O
+ CC O
cells NNS O
are VBP O
defined VBN O
as IN O
type NN O
- HYPH O
1 CD O
cells NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

They PRP O
also RB O
express VBP O
the DT O
paired VBN O
- HYPH O
homeodomain NN O
transcription NN O
factor NN O
Pax6 NNP O
( -LRB- O
Figure NNP O
1B NNP O
) -RRB- O
. . O

These DT O
radial JJ O
glia NN O
- HYPH O
like JJ O
stem NN O
cells NNS O
divide VBP O
relatively RB O
infrequently RB O
, , O
and CC O
are VBP O
believed VBN O
to TO O
undergo VB O
symmetric JJ O
division NN O
( , O
giving VBG O
rise NN O
to IN O
two CD O
identical JJ O
stem NN O
cells NNS O
) -RRB- O
under IN O
some DT O
conditions NNS O
. . O

They PRP O
can MD O
also RB O
divide VB O
asymmetrically RB O
and CC O
give VB O
rise NN O
to IN O
a DT O
new JJ O
stem NN O
cell NN O
and CC O
one CD O
neuronal JJ O
progenitor NN O
, , O
which WDT O
usually RB O
is VBZ O
defined VBN O
as IN O
a DT O
type NN O
- HYPH O
2 CD O
cell NN O
( -LRB- O
Figure NNP O
2B NNP O
) -RRB- O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Type NN O
- HYPH O
2 CD O
cells NNS O
are VBP O
divided VBN O
into IN O
two CD O
different JJ O
populations NNS O
: : O
type NN O
- HYPH O
2a CD O
expressing VBG O
nestin NN O
and CC O
type NN O
- HYPH O
2b NN O
co NN O
- HYPH O
expressing VBG O
nestin NN O
and CC O
doublecortin NN O
( : O
Dcx NN O
) -RRB- O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Based VBN O
on IN O
a DT O
previous JJ O
report NN O
[ -LRB- O
24 CD O
] -RRB- O
, , O
we PRP O
examined VBD O
the DT O
expression NN O
pattern NN O
of IN O
the DT O
T NNP O
- HYPH O
domain NN O
transcription NN O
factors NNS O
Tbr1 NNP O
and CC O
Tbr2 NNP O
. . O

We PRP O
found VBD O
that IN O
Tbr2 NNP O
is VBZ O
expressed VBN O
in IN O
type NN O
- HYPH O
2a NN O
cells NNS O
, , O
in IN O
agreement NN O
with IN O
a DT O
recent JJ O
report NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

In IN O
the DT O
SGZ NNP O
of IN O
2 CD O
week NN O
- HYPH O
old JJ O
mice NNS B-Species
, , O
we PRP O
found VBD O
an DT O
average NN O
of IN O
50 CD O
- SYM O
70 CD O
Tbr2 NNP O
+ CC O
cells NNS O
per IN O
30 CD O
micro JJ O
m NN O
- HYPH O
thick JJ O
section NN O
throughout IN O
the DT O
rostro NN O
- HYPH O
caudal JJ O
axis NN O
of IN O
the DT O
dorsal JJ O
hippocampus NN O
. . O

This DT O
number NN O
was VBD O
reduced VBN O
by IN O
35 CD O
% NN O
in IN O
2 CD O
month NN O
- HYPH O
old JJ O
mice NNS B-Species
( -LRB- O
Figure NNP O
1C NNP O
with IN O
figure NN O
S1C NNP O
and CC O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

As IN O
opposed VBN O
to IN O
Tbr1 NNP O
( -LRB- O
Figure NNP O
1D NN O
and CC O
figure NN O
S1D NN O
) -RRB- O
, , O
Tbr2 NNP O
+ CC O
cells NNS O
did VBD O
not RB O
co VB O
- HYPH O
express JJ O
Dcx NNP O
or CC O
PSA NNP O
- HYPH O
NCAM NNP O
( -LRB- O
Figure NN O
1C NN O
and CC O
figure NN O
S1C NNP O
) -RRB- O
. . O

We PRP O
observed VBD O
that IN O
Tbr1 NNP O
- HYPH O
immuoreactivity NN O
gradually RB O
decreased VBD O
as IN O
neurons NNS O
matured VBD O
and CC O
started VBD O
to TO O
express VB O
NeuN NNP O
( -LRB- O
Figure NNP O
1H NN O
and CC O
figure NN O
S1H NNP O
) -RRB- O
. . O

Thus RB O
, , O
Tbr2 NNP O
labels VBZ O
type NN O
- HYPH O
2 CD O
cells NNS O
, , O
while IN O
Tbr1 NNP O
is VBZ O
expressed VBN O
by IN O
immature JJ O
granule NN O
neurons NNS O
. . O

We PRP O
then RB O
examined VBD O
the DT O
molecular JJ O
phenotype NN O
of IN O
type NN O
- HYPH O
3 CD O
cells NNS O
, , O
a DT O
cell NN O
type NN O
that WDT O
transiently RB O
expresses VBZ O
Calretinin NNP O
[ -LRB- O
26 CD O
] -RRB- O
. . O

We PRP O
hypothesized VBD O
that IN O
hippocampal JJ O
type NN O
- HYPH O
3 CD O
cells NNS O
might MD O
also RB O
express VB O
the DT O
bHLH NN O
transcription NN O
factor NN O
NeuroD1 NNP O
, , O
known VBN O
to TO O
partially RB O
overlap VB O
with IN O
Tbr2 NNP O
and CC O
Tbr1 NNP O
in IN O
different JJ O
brain NN O
regions NNS O
[ -LRB- O
24 CD O
] -RRB- O
. . O

We PRP O
found VBD O
that IN O
NeuroD1 NNP O
expression NN O
in IN O
the DT O
hippocampus NN O
starts VBZ O
in IN O
Tbr2 NNP O
+ CC O
cells NNS O
and CC O
extends VBZ O
to IN O
post NN O
- HYPH O
mitotic JJ O
Tbr1 NNP O
+ CC O
cells NNS O
, , O
which WDT O
also RB O
express VBP O
the DT O
hippocampal JJ O
granule NN O
identity NN O
transcription NN O
factor NN O
Prox1 NNP O
( -LRB- O
Figure NNP O
1G NNP O
and CC O
1I NN O
and CC O
figure NN O
S1G NNP O
and CC O
S1I NNP O
) -RRB- O
. . O

While IN O
Tbr1 NNP O
expression NN O
ceases VBZ O
during IN O
granule NN O
maturation NN O
, , O
that DT O
of IN O
NeuroD1 NNP O
is VBZ O
weakly RB O
maintained VBN O
when WRB O
NeuN NNP O
expression NN O
starts VBZ O
( -LRB- O
Figure NNP O
1G NNP O
and CC O
1H NN O
and CC O
figure NN O
S1G NNP O
and CC O
S1H NNP O
) -RRB- O
. . O

We PRP O
found VBD O
that IN O
calretinin NN O
expression NN O
decreased VBD O
during IN O
granule NN O
neuron NN O
maturation NN O
, , O
before IN O
NeuroD1 NNP O
was VBD O
reduced VBN O
( -LRB- O
Figure NNP O
1F NNP O
) -RRB- O
. . O

Thus RB O
NeuroD1 NNP O
is VBZ O
expressed VBN O
in IN O
type NN O
- HYPH O
2b NN O
and CC O
type NN O
- HYPH O
3 CD O
cells NNS O
, , O
as RB O
well RB O
as IN O
immature JJ O
granule NN O
neurons NNS O
. . O

Finally RB O
, , O
we PRP O
found VBD O
that IN O
NeuroD2 NNP O
starts VBZ O
to TO O
be VB O
expressed VBN O
just RB O
after IN O
NeuroD1 NNP O
and CC O
, , O
unlike IN O
NeuroD1 NNP O
, , O
continues VBZ O
to TO O
be VB O
highly RB O
expressed VBN O
in IN O
mature JJ O
neurons NNS O
( -LRB- O
Figure NNP O
1J NN O
and CC O
data NNS O
not RB O
shown VBN O
) : O
. . O

Mash1 NNP O
and CC O
Ngn2 NNP O
define VBP O
the DT O
early JJ O
versus IN O
late JJ O
type NN O
- HYPH O
2a NN O
stage NN O
in IN O
2 CD O
weeks NNS O
old JJ O
mice NNS B-Species

Having VBG O
established VBN O
the DT O
hierarchy NN O
of IN O
transcription NN O
factors NNS O
and CC O
cellular JJ O
markers NNS O
appearing VBG O
during IN O
hippocampal JJ O
neurogenesis NN O
, , O
we PRP O
set VBD O
out RP O
to TO O
clarify VB O
the DT O
position NN O
of IN O
the DT O
two CD O
bHLH NN O
transcription NN O
factors NNS O
Ngn2 NNP O
and CC O
Mash1 NNP O
, , O
in IN O
this DT O
process NN O
. . O

We PRP O
found VBD O
that IN O
more JJR O
than IN O
90 CD O
% NN O
of IN O
Ngn2 NNP O
- HYPH O
immunoreactive JJ O
cells NNS O
are VBP O
Pax6 NNP O
positive JJ O
( : O
Figure NNP O
2A NNP O
) -RRB- O
, , O
and CC O
almost RB O
all DT O
co NN O
- HYPH O
express NN O
Tbr2 NNP O
( -LRB- O
Figure NNP O
2B NNP O
) -RRB- O
. . O

Thus RB O
, , O
Ngn2 NNP O
appears VBZ O
to TO O
be VB O
expressed VBN O
by IN O
type NN O
- HYPH O
2a NNP O
cells NNS O
. . O

As IN O
our PRP$ O
antibodies NNS O
against IN O
Ngn2 NNP O
and CC O
NeuroD1 NNP O
were VBD O
made VBN O
in IN O
the DT O
same JJ O
species NN O
, , O
we PRP O
could MD O
not RB O
determine VB O
if IN O
there EX O
was VBD O
an DT O
overlap NN O
between IN O
these DT O
two CD O
proteins NNS O
. . O

However RB O
, , O
by IN O
comparing VBG O
their PRP$ O
overlapping VBG O
expression NN O
pattern NN O
with IN O
that DT O
of IN O
Tbr2 NNP O
, , O
we PRP O
propose VBP O
that IN O
some DT O
Ngn2 NNP O
+ CC O
cells NNS O
co NN O
- HYPH O
express VBP O
NeuroD1 NNP O
, , O
and CC O
that IN O
they PRP O
appear VBP O
at IN O
the DT O
onset NN O
of IN O
NeuroD1 NNP O
expression NN O
and CC O
downregulation NN O
of IN O
Ngn2 NNP O
. . O

We PRP O
base VBP O
this DT O
assumption NN O
on IN O
the DT O
facts NNS O
that IN O
more JJR O
than IN O
50 CD O
% NN O
of IN O
the DT O
Tbr2 NNP O
+ CC O
cells NNS O
are VBP O
Ngn2 NNP O
+ CC O
and CC O
more JJR O
than IN O
50 CD O
% NN O
of IN O
Tbr2 NNP O
+ CC O
cells NNS O
also RB O
express VBP O
NeuroD1 NNP O
. . O

The DT O
expression NN O
of IN O
Ngn2 NNP O
in IN O
adult NN O
hippocampus NN O
was VBD O
hard JJ O
to TO O
detect VB O
using VBG O
immunohistochemistry NN O
due IN O
to IN O
the DT O
low JJ O
expression NN O
of IN O
the DT O
protein NN O
( , O
data NNS O
not RB O
shown VBN O
) : O
. . O

However RB O
, , O
it PRP O
is VBZ O
present JJ O
, , O
as IN O
previously RB O
described VBN O
using VBG O
reporter NN O
mice NNS B-Species
and CC O
as IN O
revealed VBN O
by IN O
in IN O
situ NN O
hybridization NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

We PRP O
next RB O
examined VBD O
the DT O
expression NN O
of IN O
Mash1 NNP O
and CC O
compared VBD O
it PRP O
with IN O
that DT O
of IN O
Ngn2 NNP O
, , O
Pax6 NNP O
and CC O
Tbr2 NNP O
. . O

We PRP O
found VBD O
some DT O
Mash1 NNP O
+ CC O
cells NNS O
( : O
10 CD O
- SYM O
20 CD O
cells NNS O
per IN O
section NN O
) -RRB- O
in IN O
the DT O
dorsal JJ O
hippocampus NN O
. . O

Almost RB O
all DT O
of IN O
them PRP O
co VBP O
- HYPH O
expressed VBN O
Pax6 NNP O
( -LRB- O
Figure NNP O
2C NNP O
) -RRB- O
. . O

Only RB O
few JJ O
cells NNS O
co NN O
- HYPH O
expressed VBN O
Tbr2 NNP O
( -LRB- O
Figure NNP O
2D NNP O
) -RRB- O
or CC O
Ngn2 NNP O
( -LRB- O
Figure NNP O
2E CD O
) -RRB- O
, , O
suggesting VBG O
that IN O
Mash1 NNP O
is VBZ O
downregulated VBN O
when WRB O
these DT O
two CD O
proteins NNS O
are VBP O
expressed VBN O
. . O

None NN O
of IN O
the DT O
Mash1 NNP O
- HYPH O
expressing VBG O
cells NNS O
were VBD O
positive JJ O
for IN O
NeuroD1 NNP O
( -LRB- O
Figure NNP O
2F NNP O
) -RRB- O
. . O

Mash1 NNP O
+ CC O
cells NNS O
were VBD O
still RB O
undergoing VBG O
mitosis NN O
( -LRB- O
Figure NNP O
2C NNP O
) -RRB- O
and CC O
consequently RB O
over IN O
90 CD O
% NN O
of IN O
them PRP O
co NN O
- HYPH O
labeled VBN O
with IN O
the DT O
cell NN O
- HYPH O
cycle NN O
marker NN O
Ki67 NNP O
( -LRB- O
Figure NNP O
S1J NNP O
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
we PRP O
show VBP O
that IN O
Mash1 NNP O
and CC O
Ngn2 NNP O
are VBP O
expressed VBN O
in IN O
early JJ O
and CC O
late JJ O
stages NNS O
of IN O
maturation NN O
of IN O
type2a NN O
progenitors NNS O
, , O
respectively RB O
, , O
and CC O
that IN O
both DT O
transcription NN O
factors NNS O
are VBP O
co NN O
- HYPH O
expressed VBN O
briefly RB O
when WRB O
cells NNS O
transit VBP O
from IN O
early JJ O
to IN O
late JJ O
phase NN O
type2a NN O
cells NNS O
. . O

Ngn2 NNP O
progenies NNS O
become VBP O
hippocampal JJ O
granule NN O
neurons NNS O

Previous JJ O
work NN O
has VBZ O
shown VBN O
that IN O
in IN O
Mash1 NNP O
null JJ O
mutant JJ O
mice NN B-Species
hippocampal JJ O
neurogenesis NN O
is VBZ O
not RB O
reduced VBN O
and CC O
the DT O
hippocampus NN O
is VBZ O
not RB O
malformed VBN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Therefore RB O
we PRP O
focused VBD O
our PRP$ O
initial JJ O
analysis NN O
on IN O
the DT O
role NN O
of IN O
Ngn2 NNP O
in IN O
hippocampal JJ O
neurogenesis NN O
. . O

We PRP O
characterized VBD O
the DT O
fate NN O
of IN O
Ngn2 NNP O
- HYPH O
expressing VBG O
cells NNS O
using VBG O
Ngn2 NNP O
Knock NNP O
- HYPH O
in IN O
green JJ O
fluorescent NN O
protein NN O
( -LRB- O
GFP NNP O
) -RRB- O
mice NNS B-Species
( , O
Ngn2 NNP O
+ SYM O
/ SYM O
GFP NNP O
) -RRB- O
[ -LRB- O
27 CD O
] -RRB- O
. . O

In IN O
the DT O
SGZ NNP O
of IN O
2 CD O
week NN O
- HYPH O
old JJ O
hippocampi NN O
, , O
we PRP O
found VBD O
bright JJ O
GFP NNP O
- HYPH O
expressing VBG O
cells NNS O
that WDT O
were VBD O
positive JJ O
for IN O
Tbr2 NNP O
( -LRB- O
Figure NNP O
2H CD O
) -RRB- O
, , O
the DT O
immature JJ O
neuronal JJ O
marker NN O
PSA NNP O
- HYPH O
NCAM NNP O
( -LRB- O
Figure NNP O
2I CD O
) -RRB- O
and CC O
NeuroD1 NNP O
( -LRB- O
Figure NNP O
2J NNP O
) -RRB- O
. . O

Furthermore RB O
, , O
Prox1 NNP O
+ CC O
, , O
NeuroD2 NNP O
+ CC O
and CC O
calretinin NN O
+ CC O
cells NNS O
were VBD O
also RB O
weakly RB O
positive JJ O
for IN O
GFP NNP O
. . O

We PRP O
made VBD O
similar JJ O
observations NNS O
in IN O
2 CD O
month NN O
- HYPH O
old JJ O
mice NNS B-Species
( , O
data NNS O
not RB O
shown VBN O
) , O
confirming VBG O
earlier JJR O
published VBN O
results NNS O
[ -LRB- O
21 CD O
] -RRB- O
) -RRB- O
. . O

We PRP O
did VBD O
not RB O
observe VB O
Mash1 NNP O
+ SYM O
/ SYM O
GFP NNP O
+ SYM O
and CC O
NeuN NNP O
+ SYM O
/ SYM O
GFP NNP O
+ SYM O
cells NNS O
( -LRB- O
Figure NNP O
2G NNP O
) -RRB- O
. . O

These DT O
data NNS O
from IN O
Ngn2 NNP O
+ CC O
/ SYM O
GFP NNP O
mice NNS B-Species
are VBP O
entirely RB O
consistent JJ O
with IN O
our PRP$ O
earlier JJR O
observations NNS O
using VBG O
immunocytochemistry NN O
to TO O
label VB O
Ngn2 NNP O
- HYPH O
expressing VBG O
cells NNS O
and CC O
with IN O
GFP NNP O
undergoing VBG O
slow JJ O
degradation NN O
after IN O
the DT O
expression NN O
of IN O
Ngn2 NNP O
has VBZ O
ceased VBN O
. . O

Importantly RB O
, , O
none NN O
of IN O
the DT O
GFP NNP O
- HYPH O
expressing VBG O
cells NNS O
, , O
including VBG O
those DT O
only RB O
weakly RB O
fluorescent JJ O
, , O
residing VBG O
in IN O
the DT O
SGL NNP O
expressed VBD O
the DT O
astrocytic JJ O
marker NN O
GFAP NNP O
or CC O
the DT O
oligodendrocytic JJ O
markers NNS O
CNPase NNP O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
the DT O
data NNS O
show VBP O
that IN O
Ngn2 NNP O
progenies NNS O
become VBP O
neurons NNS O
and CC O
never RB O
generate VBP O
astrocytes NNS O
or CC O
oligodendrocytes NNS O
. . O

Marked JJ O
reduction NN O
of IN O
hippocampal JJ O
granule NN O
neurons NNS O
in IN O
absence NN O
of IN O
Ngn2 NNP O

To TO O
determine VB O
the DT O
role NN O
of IN O
Ngn2 NNP O
during IN O
the DT O
initiation NN O
of IN O
hippocampal JJ O
granule NN O
neurogenesis NN O
, , O
we PRP O
analyzed VBD O
the DT O
hippocampus NN O
of IN O
mice NNS B-Species
lacking VBG O
Ngn2 NNP O
( , O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
) -RRB- O
. . O

In IN O
contrast NN O
to IN O
the DT O
mice NN B-Species
use NN O
by IN O
Galichet NNP O
and CC O
coworkers NNS O
, , O
our PRP$ O
mice NNS B-Species
have VBP O
a DT O
lifespan NN O
of IN O
only RB O
2 CD O
weeks NNS O
after IN O
birth NN O
. . O

Therefore RB O
, , O
we PRP O
analyzed VBD O
2 CD O
week NN O
- HYPH O
old JJ O
and CC O
younger JJR O
mice NNS B-Species
. . O

Consistent JJ O
with IN O
previous JJ O
observations NNS O
[ -LRB- O
20 CD O
] -RRB- O
, , O
the DT O
hippocampus NN O
in IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
mutants NNS O
is VBZ O
clearly RB O
malformed VBN O
( : O
Figure NNP O
3A NNP O
) -RRB- O
. . O

In IN O
two CD O
week NN O
- HYPH O
old JJ O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
mice NNS B-Species
, , O
the DT O
ventral JJ O
blade NN O
of IN O
the DT O
DG NNP O
is VBZ O
completely RB O
absent JJ O
. . O

Already RB O
on IN O
postnatal JJ O
day NN O
1 CD O
- SYM O
2 CD O
, , O
the DT O
ventral JJ O
blade NN O
of IN O
the DT O
DG NNP O
is VBZ O
malformed VBN O
along IN O
its PRP$ O
whole JJ O
rostro NN O
- HYPH O
caudal JJ O
axis NN O
( -LRB- O
Figure NNP O
3B NNP O
) -RRB- O
. . O

As IN O
neither DT O
migration NN O
defects NNS O
nor CC O
cell NN O
death NN O
cause VBP O
the DT O
reduced VBN O
number NN O
of IN O
hippocampal JJ O
neurons NNS O
in IN O
Ngn2 NNP O
null JJ O
mice NNS B-Species
[ -LRB- O
20 CD O
] -RRB- O
, , O
we PRP O
asked VBD O
if IN O
Ngn2 NNP O
is VBZ O
necessary JJ O
for IN O
production NN O
of IN O
hippocampal JJ O
granule NN O
neuroblasts NNS O
. . O

We PRP O
first RB O
injected VBD O
2 CD O
day NN O
- HYPH O
old JJ O
mouse NN B-Species
pups NNS O
with IN O
BrdU NNP O
2 CD O
hours NNS O
prior RB O
to IN O
sacrifice NN O
, , O
allowing VBG O
us PRP O
to TO O
evaluate VB O
cell NN O
proliferation NN O
and CC O
ongoing JJ O
neurogenesis NN O
. . O

We PRP O
also RB O
injected VBD O
BrdU NNP O
into IN O
female JJ O
mice NNS B-Species
on IN O
their PRP$ O
final JJ O
day NN O
of IN O
pregnancy NN O
and CC O
examined VBD O
the DT O
brains NNS O
of IN O
their PRP$ O
pups NNS O
48 CD O
hours NNS O
later RB O
( , O
corresponding VBG O
to IN O
P1 NN O
- HYPH O
P2 NN O
old JJ O
pups NNS O
) -RRB- O
. . O

This DT O
allowed VBD O
us PRP O
to TO O
assess VB O
the DT O
number NN O
of IN O
neurons NNS O
derived VBN O
from IN O
the DT O
last JJ O
day NN O
of IN O
intrauterine JJ O
development NN O
. . O

Regardless RB O
of IN O
whether IN O
the DT O
mice NN B-Species
were VBD O
WT NNP O
or CC O
hetero NN O
/ SYM O
homozygous JJ O
mutant JJ O
pups NNS O
, , O
we PRP O
found VBD O
cells NNS O
that WDT O
had VBD O
incorporated VBN O
BrdU NNP O
in IN O
the DT O
hippocampal JJ O
subventricular JJ O
zone NN O
( , O
hSVZ NNP O
) -RRB- O
, , O
fimbria NN O
and CC O
the DT O
DG NNP O
( -LRB- O
Figure NNP O
4A NNP O
and CC O
B NNP O
; : O
[ -LRB- O
28 CD O
] -RRB- O
) -RRB- O
, , O
suggesting VBG O
that IN O
progenitors NNS O
originating VBG O
in IN O
the DT O
hSVZ NNP O
divide NN O
while IN O
migrating VBG O
towards IN O
the DT O
DG NNP O
. . O

Most JJS O
of IN O
them PRP O
were VBD O
organized VBN O
in IN O
chains NNS O
typical JJ O
of IN O
migrating VBG O
cells NNS O
( -LRB- O
Figure NN O
4A NN O
and CC O
B NN O
and CC O
figure NN O
S2 NNP O
) -RRB- O
. . O

In IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
mutant NN O
mice NNS B-Species
injected VBN O
with IN O
BrdU NNP O
2 CD O
hours NNS O
prior RB O
to IN O
sacrifice NN O
, , O
we PRP O
observed VBD O
a DT O
decrease NN O
in IN O
the DT O
number NN O
of IN O
BrdU NNP O
+ CC O
cells NNS O
compared VBN O
to IN O
heterozygous JJ O
littermates NNS O
. . O

Thus RB O
, , O
the DT O
numbers NNS O
of IN O
newborn JJ O
cells NNS O
were VBD O
reduced VBN O
in IN O
the DT O
hSVZ NNP O
/ SYM O
fimbria NN O
( : O
133 CD O
. . O
3 CD O
+ SYM O
/ SYM O
- HYPH O
7 CD O
. . O
5 CD O
for IN O
Ngn2 CD O
+ SYM O
/ SYM O
GFP NN O
vs IN O
69 CD O
. . O
7 CD O
+ SYM O
/ SYM O
- HYPH O
5 CD O
. . O
0 CD O
for IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
) -RRB- O
and CC O
DG NNP O
( : O
132 CD O
. . O
0 CD O
+ NFP O
/ SYM O
- HYPH O
9 CD O
. . O
1 CD O
for IN O
Ngn2 CD O
+ SYM O
/ SYM O
GFP NN O
vs IN O
42 CD O
. . O
6 CD O
+ SYM O
/ SYM O
- HYPH O
2 CD O
. . O
2 CD O
for IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
) -RRB- O
( -LRB- O
Figure NN O
4C NN O
and CC O
D NN O
) -RRB- O
. . O

We PRP O
also RB O
examined VBD O
the DT O
number NN O
of IN O
newborn JJ O
cells NNS O
differentiating VBG O
into IN O
neurons NNS O
, , O
and CC O
identified VBD O
them PRP O
by IN O
the DT O
co NN O
- HYPH O
expression NN O
of IN O
BrdU NNP O
and CC O
NeuroD1 NNP O
. . O

As IN O
expected VBN O
, , O
they PRP O
were VBD O
relatively RB O
few JJ O
in IN O
numbers NNS O
because IN O
the DT O
short JJ O
delay NN O
( : O
2 CD O
hours NNS O
) -RRB- O
between IN O
BrdU NNP O
administration NN O
and CC O
sacrifice NN O
in IN O
this DT O
first JJ O
experimental JJ O
paradigm NN O
. . O

In IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
null JJ O
mutants NNS O
, , O
we PRP O
found VBD O
the DT O
number NN O
of IN O
cells NNS O
differentiating VBG O
into IN O
neurons NNS O
to TO O
be VB O
reduced VBN O
by IN O
60 CD O
% NN O
and CC O
71 CD O
% NN O
in IN O
the DT O
hSVZ NNP O
/ SYM O
fimbria NN O
( , O
8 CD O
. . O
6 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
. . O
4 CD O
for IN O
Ngn2 CD O
+ SYM O
/ SYM O
GFP NN O
vs IN O
3 CD O
. . O
4 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
5 CD O
for IN O
Ngn2GFP NNP O
/ SYM O
GFP NN O
) -RRB- O
and CC O
DG NN O
( : O
9 CD O
. . O
7 CD O
+ NFP O
/ SYM O
- HYPH O
1 CD O
. . O
1 CD O
for IN O
Ngn2 NN O
+ NFP O
/ SYM O
GFP NN O
vs IN O
2 CD O
. . O
8 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
6 CD O
for IN O
Ngn2GFP NNP O
/ SYM O
GFP NN O
) -RRB- O
, , O
respectively RB O
, , O
( : O
Figure NN O
4E CD O
and CC O
F NN O
) -RRB- O
. . O

As IN O
a DT O
result NN O
, , O
the DT O
number NN O
of IN O
NeuroD1 NNP O
+ CC O
cells NNS O
in IN O
the DT O
DG NNP O
was VBD O
reduced VBN O
by IN O
80 CD O
% NN O
( , O
580 CD O
. . O
3 CD O
+ SYM O
/ SYM O
- HYPH O
27 CD O
. . O
7 CD O
for IN O
Ngn2 CD O
+ SYM O
/ SYM O
GFP NN O
vs IN O
116 CD O
. . O
2 CD O
+ SYM O
/ SYM O
- HYPH O
7 CD O
. . O
3 CD O
for IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
; : O
Figure NNP O
4G NNP O
) -RRB- O
. . O

We PRP O
obtained VBD O
similar JJ O
results NNS O
in IN O
the DT O
second JJ O
paradigm NN O
, , O
i PRP O
. . O
e LS O
. . O
in IN O
mice NNS B-Species
that WDT O
we PRP O
sacrificed VBD O
48 CD O
hours NNS O
after IN O
BrdU NNP O
administration NN O
and CC O
in IN O
which WDT O
a DT O
larger JJR O
number NN O
of IN O
the DT O
newborn JJ O
cells NNS O
had VBD O
time NN O
to TO O
mature VB O
into IN O
neurons NNS O
. . O

In IN O
this DT O
case NN O
, , O
the DT O
number NN O
of IN O
BrdU NNP O
+ CC O
/ SYM O
NeuroD1 NNP O
+ CC O
cells NNS O
in IN O
the DT O
DG NNP O
was VBD O
reduced VBN O
by IN O
73 CD O
% NN O
of IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
mutant JJ O
animals NNS O
( : O
91 CD O
. . O
5 CD O
+ SYM O
/ SYM O
- HYPH O
24 CD O
. . O
1 CD O
for IN O
Ngn2 CD O
+ SYM O
/ SYM O
GFP NN O
vs IN O
26 CD O
. . O
4 CD O
+ SYM O
/ SYM O
- HYPH O
3 CD O
. . O
3 CD O
for IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
) -RRB- O
( -LRB- O
Figure NN O
4J NN O
) -RRB- O
. . O

We PRP O
found VBD O
no DT O
differences NNS O
in IN O
the DT O
proportion NN O
of IN O
BrdU NNP O
+ CC O
cells NNS O
that WDT O
expressed VBD O
NeuroD1 NNP O
in IN O
Ngn2 NNP O
+ SYM O
/ SYM O
GFP NNP O
and CC O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
mice NNS B-Species
( : O
14 CD O
. . O
2 CD O
+ NFP O
/ SYM O
- HYPH O
1 CD O
. . O
0 CD O
% NN O
and CC O
17 CD O
. . O
4 CD O
+ NN O
/ SYM O
- SYM O
1 CD O
. . O
8 CD O
% NN O
respectively RB O
; : O
Figure NN O
4K CD O
) -RRB- O
. . O

This DT O
shows VBZ O
that IN O
the DT O
few JJ O
cells NNS O
that WDT O
manage VBP O
to TO O
proliferate VB O
in IN O
the DT O
Ngn2 NNP O
null NN O
mice NN B-Species
have VBP O
the DT O
same JJ O
ability NN O
to TO O
differentiate VB O
into IN O
neurons NNS O
as IN O
those DT O
in IN O
mice NNS B-Species
with IN O
one CD O
Ngn2 NNP O
allele NN O
. . O

Interestingly RB O
, , O
the DT O
absence NN O
of IN O
Ngn2 NNP O
did VBD O
not RB O
alter VB O
the DT O
identity NN O
of IN O
neurons NNS O
in IN O
the DT O
DG NNP O
granule NN O
layer NN O
in IN O
2 CD O
week NN O
- HYPH O
old JJ O
Ngn2 NNP O
null JJ O
mice NN B-Species
. . O

The DT O
maturing VBG O
granule NN O
progenitors NNS O
sequentially RB O
expressed VBD O
Pax6 NNP O
, , O
Tbr2 NNP O
( , O
Figure NNP O
S3A NNP O
and CC O
S3B NNP O
) -RRB- O
, , O
NeuroD1 NNP O
and CC O
Calretinin NNP O
( -LRB- O
Figure NNP O
4L NNP O
) -RRB- O
, , O
PSA NNP O
- HYPH O
NCAM NNP O
( -LRB- O
Figure NNP O
4N NNP O
) -RRB- O
, , O
Tbr1 NNP O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
and CC O
Prox1 NNP O
( -LRB- O
Figure NNP O
4M NNP O
) -RRB- O
. . O

We PRP O
confirmed VBD O
that IN O
the DT O
same JJ O
transcriptional JJ O
cascade NN O
is VBZ O
active JJ O
in IN O
the DT O
20 CD O
% NN O
( , O
compared VBN O
to IN O
mice NNS B-Species
with IN O
one CD O
Ngn2 CD O
allele NN O
) , O
residual JJ O
granule NN O
neurons NNS O
that WDT O
are VBP O
formed VBN O
two CD O
day NN O
- HYPH O
old JJ O
in IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
mice NN B-Species
( -LRB- O
Figure NNP O
S3D NNP O
- HYPH O
G NNP O
and CC O
data NNS O
not RB O
shown VBN O
) : O
. . O

We PRP O
next RB O
investigated VBD O
if IN O
the DT O
cells NNS O
that WDT O
failed VBD O
to TO O
develop VB O
into IN O
neurons NNS O
in IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
mutant JJ O
mice NNS B-Species
, , O
became VBD O
glial JJ O
cells NNS O
. . O

We PRP O
found VBD O
that IN O
cells NNS O
expressing VBG O
GFP NNP O
never RB O
co VBP O
- HYPH O
labeled VBN O
with IN O
the DT O
astrocyte NN O
marker NN O
GFAP NNP O
( -LRB- O
Figure NNP O
4N NNP O
) -RRB- O
or CC O
the DT O
oligodendrocyte NN O
marker NN O
CNPase NNP O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

Altogether RB O
, , O
our PRP$ O
results NNS O
show VBP O
that IN O
Ngn2 NNP O
plays VBZ O
an DT O
important JJ O
role NN O
during IN O
the DT O
production NN O
/ SYM O
amplification NN O
of IN O
hippocampal JJ O
granule NN O
neuroblasts NNS O
, , O
but CC O
not RB O
the DT O
acquisition NN O
of IN O
the DT O
granule NN O
neuron NN O
identity NN O
( -LRB- O
Figure NNP O
S7 NNP O
) -RRB- O
. . O

Ngn2 NNP O
controls VBZ O
the DT O
amplification NN O
of IN O
granule NN O
neuron NN O
progenitors NNS O

We PRP O
next RB O
monitored VBD O
the DT O
mitogenic JJ O
activity NN O
of IN O
Ngn2 NNP O
+ CC O
cells NNS O
in IN O
the DT O
DG NNP O
of IN O
2 CD O
week NN O
- HYPH O
old JJ O
WT NNP O
mice NN B-Species
. . O

We PRP O
observed VBD O
that IN O
over IN O
50 CD O
% NN O
of IN O
Ngn2 NNP O
+ CC O
cells NNS O
in IN O
the DT O
DG NNP O
of IN O
WT NNP O
mice NN B-Species
co NN O
- HYPH O
expressed VBN O
the DT O
mitosis NN O
marker NN O
Ki67 NNP O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

Inspired VBN O
by IN O
this DT O
finding NN O
, , O
we PRP O
injected VBD O
BrdU NNP O
into IN O
2 CD O
week NN O
- HYPH O
old JJ O
WT NNP O
and CC O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
mice NNS B-Species
and CC O
compared VBD O
cell NN O
proliferation NN O
in IN O
the DT O
DG NNP O
. . O

We PRP O
observed VBD O
92 CD O
% NN O
reduction NN O
in IN O
number NN O
of IN O
proliferating VBG O
cells NNS O
in IN O
the DT O
SGZ NNP O
of IN O
Ngn2 NNP O
null JJ O
mutant JJ O
mice NNS B-Species
( : O
6 CD O
. . O
7 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
5 CD O
) , O
compared VBN O
to IN O
WT NNP O
( : O
83 CD O
. . O
6 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
. . O
2 CD O
) -RRB- O
and CC O
heterozygotic NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
littermates NNS O
( -LRB- O
Figure NN O
5B NN O
- HYPH O
C NN O
) -RRB- O
. . O

This DT O
data NNS O
confirm VBP O
the DT O
importance NN O
of IN O
Ngn2 NNP O
during IN O
the DT O
amplification NN O
of IN O
granule NN O
progenitor NN O
. . O
s NFP O
. . O

To TO O
further RB O
explore VB O
whether IN O
Ngn2 NNP O
+ CC O
cells NNS O
become VBP O
post NN O
- HYPH O
mitotic JJ O
or CC O
still RB O
proliferate VBP O
after IN O
Ngn2 NNP O
is VBZ O
downregulated VBN O
, , O
we PRP O
performed VBD O
immunohistochemistry NN O
on IN O
sections NNS O
through IN O
the DT O
DG NNP O
of IN O
Ngn2 NNP O
+ SYM O
/ SYM O
GFP NNP O
mice NNS B-Species
. . O

We PRP O
stained VBD O
them PRP O
with IN O
the DT O
mitosis NN O
marker NN O
Phospho NNP O
- HYPH O
histone NN O
3 CD O
( , O
PH3 NN O
) -RRB- O
and CC O
NeuroD1 NNP O
, , O
which WDT O
is VBZ O
downstream JJ O
of IN O
Ngn2 NNP O
in IN O
the DT O
transcriptional JJ O
cascade NN O
controlling VBG O
neurogenesis NN O
. . O

Thus RB O
, , O
in IN O
the DT O
same JJ O
sections NNS O
we PRP O
could MD O
identify VB O
whether IN O
cells NNS O
that WDT O
had VBD O
initiated VBN O
Ngn2 NNP O
expression NN O
( , O
GFP NNP O
labeled VBN O
) -RRB- O
, , O
continued VBN O
to TO O
divide VB O
( , O
PH3 NN O
+ CC O
) -RRB- O
or CC O
committed VBN O
to IN O
neuronal JJ O
differentiation NN O
( : O
NeuroD1 NN O
+ CC O
) -RRB- O
. . O

We PRP O
observed VBD O
some DT O
GFP NNP O
+ SYM O
cells NNS O
that WDT O
co VBP O
- HYPH O
expressed VBN O
PH3 NN O
. . O

They PRP O
all DT O
exhibited VBD O
morphological JJ O
characteristics NNS O
of IN O
one CD O
of IN O
the DT O
five CD O
mitotic JJ O
phases NNS O
: : O
prophase NN O
, , O
metaphase NN O
, , O
anaphase NN O
, , O
telophase NN O
and CC O
cytokinesis NN O
( , O
Figure NN O
5D NN O
and CC O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

Unexpectedly RB O
, , O
cells NNS O
that WDT O
colabeled VBD O
for IN O
GFP NNP O
, , O
PH3 NNP O
and CC O
NeuroD1 NNP O
( -LRB- O
Figure NNP O
5E CD O
and CC O
figure NN O
S4A NN O
and CC O
S4B NN O
) -RRB- O
were VBD O
rare JJ O
. . O

This DT O
indicates VBZ O
that IN O
Ngn2 NNP O
+ CC O
cells NNS O
undergo VBP O
division NN O
/ SYM O
amplification NN O
and CC O
that IN O
they PRP O
mature VBP O
into IN O
post NN O
- HYPH O
mitotic JJ O
neurons NNS O
upon IN O
NeuroD1 NNP O
expression NN O
. . O

In IN O
mice NNS B-Species
lacking VBG O
Ngn2 NNP O
, , O
we PRP O
found VBD O
the DT O
cells NNS O
expressing VBG O
GFP NN O
localized VBN O
to IN O
the DT O
malformed JJ O
ventral JJ O
blade NN O
of IN O
the DT O
DG NNP O
( -LRB- O
Figure NNP O
5F NNP O
and CC O
G NNP O
) -RRB- O
. . O

All DT O
of IN O
these DT O
cells NNS O
were VBD O
Ki67 NN O
+ CC O
and CC O
they PRP O
only RB O
very RB O
rarely RB O
expressed VBD O
PH3 NNP O
( -LRB- O
Figure NNP O
5F NN O
and CC O
G NNP O
, , O
and CC O
figure NN O
S4C NNP O
) -RRB- O
in IN O
the DT O
absence NN O
of IN O
Ngn2 NNP O
most JJS O
of IN O
the DT O
cells NNS O
are VBP O
arrested VBN O
in IN O
the DT O
cell NN O
cycle NN O
prior RB O
to IN O
entering VBG O
the DT O
M NNP O
phase NN O
and CC O
their PRP$ O
mitosis NN O
is VBZ O
impaired JJ O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
Ngn2 NNP O
is VBZ O
conserved VBN O
from IN O
development NN O
of IN O
the DT O
DG NNP O
to IN O
postnatal JJ O
hippocampal JJ O
neurogenesis NN O
. . O

Our PRP$ O
findings NNS O
suggest VBP O
that IN O
Ngn2 NNP O
regulates VBZ O
amplification NN O
and CC O
cell NN O
cycle NN O
exit NN O
of IN O
DG NNP O
granule NN O
progenitors NNS O
. . O

To TO O
examine VB O
this DT O
hypothesis NN O
, , O
we PRP O
compared VBD O
the DT O
effects NNS O
of IN O
Ngn2 NNP O
and CC O
NeuroD1 NN O
on IN O
mitotic JJ O
activity NN O
in IN O
embryonic JJ O
cortico NN O
- HYPH O
hippocampal NN O
neurosphere NN O
- HYPH O
derived VBN O
progenitors NNS O
, , O
5 CD O
days NNS O
upon IN O
transduction NN O
, , O
in IN O
vitro NN O
. . O

In IN O
cultures NNS O
transduced VBN O
with IN O
Ngn2 NNP O
retrovirus NN O
, , O
we PRP O
found VBD O
that IN O
27 CD O
. . O
2 CD O
% NN O
( , O
+ SYM O
/ SYM O
- HYPH O
4 CD O
. . O
1 CD O
% NN O
) -RRB- O
of IN O
the DT O
PH3 NN O
+ CC O
cells NNS O
had VBD O
been VBN O
transduced VBN O
( -LRB- O
Figure NN O
I1 CD O
- HYPH O
J NN O
) -RRB- O
. . O

These DT O
cells NNS O
were VBD O
immunopositive JJ O
for IN O
MAP2 NNP O
( -LRB- O
Figure NNP O
5I1 CD O
and CC O
I2 NNP O
) -RRB- O
and CC O
therefore RB O
represented VBD O
dividing VBG O
neuroblasts NNS O
. . O

By IN O
contrast NN O
, , O
in IN O
NeuroD1 NNP O
transduced VBN O
cultures NNS O
, , O
only RB O
7 CD O
. . O
3 CD O
% NN O
of IN O
PH3 NN O
+ CC O
cells NNS O
were VBD O
GFP NNP O
+ SYM O
( -LRB- O
Figure NNP O
5H1 CD O
, , O
H2 CD O
and CC O
J NNP O
) -RRB- O
. . O

All DT O
of IN O
the DT O
NeuroD1 NNP O
- HYPH O
transduced VBN O
cells NNS O
became VBD O
MAP2 NNP O
+ NN O
( -LRB- O
Figure NN O
5H CD O
) -RRB- O
. . O

To TO O
confirm VB O
this DT O
data NNS O
we PRP O
pulse VBP O
- HYPH O
labeled VBN O
transduced VBN O
cultures NNS O
with IN O
chlorodeoxyuridine NN O
( , O
CldU NNP O
) -RRB- O
for IN O
48 CD O
hours NNS O
, , O
five CD O
days NNS O
after IN O
differentiation NN O
. . O

In IN O
contrast NN O
to IN O
NeuroD1 NNP O
- HYPH O
transduced VBN O
cultures NNS O
, , O
we PRP O
observed VBD O
dividing VBG O
cells NNS O
transduced VBN O
with IN O
Ngn2 NNP O
retrovirus NN O
that WDT O
were VBD O
positive JJ O
for IN O
PH3 NNP O
and CC O
that WDT O
had VBD O
incorporated VBN O
CldU NNP O
( -LRB- O
Figure NNP O
5K NNP O
- HYPH O
L2 NNP O
) -RRB- O
. . O

As IN O
the DT O
number NN O
of IN O
cells NNS O
PH3 NN O
+ CC O
/ SYM O
CldU NNP O
+ CC O
/ SYM O
GFP NNP O
+ CC O
we PRP O
observed VBD O
was VBD O
low JJ O
, , O
we PRP O
did VBD O
not RB O
quantify VB O
this DT O
finding NN O
. . O

Collectively RB O
, , O
we PRP O
have VBP O
shown VBN O
that IN O
Ngn2 NNP O
is VBZ O
required VBN O
for IN O
granule NN O
neuroblast NN O
production NN O
and CC O
amplification NN O
and CC O
that IN O
in IN O
the DT O
absence NN O
of IN O
Ngn2 NNP O
the DT O
progenitors NNS O
arrest VBP O
in IN O
the DT O
cell NN O
cycle NN O
. . O

NeuroD1 NNP O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
induces VBZ O
cell NN O
cycle NN O
exit NN O
and CC O
promotes VBZ O
rapid JJ O
neuronal JJ O
maturation NN O
. . O

NeuroD1 NNP O
directs VBZ O
neuronal JJ O
differentiation NN O
and CC O
maturation NN O

Based VBN O
on IN O
our PRP$ O
previous JJ O
observations NNS O
we PRP O
proposed VBD O
that IN O
Ngn2 NNP O
primarily RB O
controls VBZ O
amplification NN O
of IN O
granule NN O
neuroblasts NNS O
and CC O
NeuroD1 NNP O
directs VBZ O
neuronal JJ O
differentiation NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
we PRP O
overexpressed VBD O
Ngn2 NNP O
or CC O
NeuroD1 NNP O
in IN O
E14 CD O
. . O
5 CD O
cortico JJ O
- HYPH O
hippocampal JJ O
neurospheres NNS O
and CC O
compared VBD O
their PRP$ O
effects NNS O
after IN O
5 CD O
days NNS O
of IN O
differentiation NN O
of IN O
the DT O
progenitors NNS O
. . O

All DT O
cortico JJ O
- HYPH O
hippocampal JJ O
progenitors NNS O
expressed VBD O
Pax6 NNP O
prior RB O
to IN O
differentiation NN O
( -LRB- O
Figure NNP O
S5 NNP O
) -RRB- O
. . O

After IN O
5 CD O
days NNS O
, , O
both DT O
factors NNS O
suppressed VBD O
Pax6 NNP O
and CC O
Sox2 NNP O
( -LRB- O
Figure NNP O
S5 NNP O
, , O
figure NN O
6C NNP O
) -RRB- O
and CC O
induced VBN O
expression NN O
of IN O
Tbr1 NNP O
, , O
Map2 NNP O
, , O
NeuroD1 NNP O
and CC O
PSA NNP O
- HYPH O
NCAM NNP O
( -LRB- O
Figure NN O
6D NN O
and CC O
E NN O
) -RRB- O
. . O

Interestingly RB O
, , O
all DT O
Ngn2 NNP O
- HYPH O
overexpressing VBG O
cells NNS O
co NN O
- HYPH O
expressed VBN O
NeuroD1 NNP O
. . O

Based VBN O
on IN O
these DT O
findings NNS O
, , O
we PRP O
next RB O
explored VBD O
whether IN O
Ngn2 NNP O
overexpression NN O
induces VBZ O
NeuroD1 NNP O
expression NN O
, , O
and CC O
if IN O
NeuroD1 NNP O
in IN O
turn NN O
directs VBZ O
neuronal JJ O
differentiation NN O
. . O

We PRP O
compared VBD O
the DT O
effects NNS O
of IN O
both DT O
transcription NN O
factors NNS O
in IN O
progenitors NNS O
that WDT O
either CC O
do VBP O
or CC O
do VBP O
not RB O
normally RB O
express VB O
them PRP O
. . O

Thus RB O
, , O
we PRP O
expressed VBD O
Ngn2 NNP O
in IN O
E14 NNP O
. , O
5 CD O
neural JJ O
progenitors NNS O
isolated VBN O
from IN O
three CD O
different JJ O
brain NN O
regions NNS O
: : O
cortex NN O
/ SYM O
hippocampus NN O
, , O
lateral JJ O
ganglionic JJ O
eminence NN O
( , O
LGE NNP O
) -RRB- O
and CC O
ventral JJ O
mesencephalon NN O
( -LRB- O
VM NN O
) -RRB- O
. . O

Ngn2 NNP O
expression NN O
in IN O
the DT O
developing VBG O
forebrain NN O
is VBZ O
normally RB O
limited VBN O
to IN O
the DT O
neocortex NN O
, , O
and CC O
it PRP O
does VBZ O
not RB O
appear VB O
in IN O
LGE NNP O
tissue NN O
[ -LRB- O
29 CD O
] -RRB- O
. . O

In IN O
the DT O
developing VBG O
VM NN O
, , O
both CC O
Ngn2 NNP O
and CC O
NeuroD1 NNP O
are VBP O
expressed VBN O
, , O
but CC O
not RB O
when WRB O
neural JJ O
progenitors NNS O
from IN O
this DT O
region NN O
are VBP O
cultured VBN O
in IN O
vitro FW O
[ -LRB- O
30 CD O
] -RRB- O
, , O
[ -LRB- O
31 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
experiments NNS O
, , O
cortico JJ O
- HYPH O
hippocampal JJ O
progenitors NNS O
could MD O
differentiate VB O
into IN O
neurons NNS O
, , O
although IN O
they PRP O
did VBD O
not RB O
normally RB O
express VB O
NeuroD1 NNP O
( -LRB- O
Figure NNP O
6E CD O
) -RRB- O
. . O

When WRB O
we PRP O
overexpressed VBD O
Ngn2 NNP O
in IN O
VM NNP O
and CC O
LGE NNP O
progenitors NNS O
, , O
the DT O
cells NNS O
started VBD O
to TO O
express VB O
both CC O
NeuroD1 NNP O
and CC O
PSA NNP O
- HYPH O
NCAM NNP O
( -LRB- O
Figure NNP O
6F NNP O
and CC O
G NNP O
) -RRB- O
. . O

We PRP O
then RB O
overexpressed VBD O
NeuroD1 NNP O
in IN O
the DT O
same JJ O
types NNS O
of IN O
cultured JJ O
progenitors NNS O
and CC O
found VBD O
that IN O
the DT O
cells NNS O
became VBD O
immunoreactive JJ O
for IN O
PSA NNP O
- HYPH O
NCAM NNP O
( -LRB- O
Figure NN O
6G NN O
and CC O
data NNS O
not RB O
shown VBN O
) : O
. . O

Thus RB O
, , O
NeuroD1 NNP O
is VBZ O
sufficient JJ O
to TO O
direct VB O
neuronal JJ O
differentiation NN O
in IN O
cortico NN O
- HYPH O
hippocampal NN O
- HYPH O
, , O
LGE NNP O
- HYPH O
and CC O
VM NNP O
- HYPH O
derived VBN O
progenitors NNS O
. . O

Our PRP$ O
results NNS O
from IN O
in FW O
vitro FW O
cultures NNS O
and CC O
the DT O
analysis NN O
of IN O
the DT O
DG NNP O
of IN O
Ngn2 NNP O
mutant JJ O
animals NNS O
collectively RB O
show VBP O
the DT O
neuron NN O
- HYPH O
inducing VBG O
effect NN O
of IN O
NeuroD1 NNP O
in IN O
hippocampal JJ O
granule NN O
cell NN O
progenitors NNS O
[ -LRB- O
32 CD O
] -RRB- O
. . O

NeuroD1 NNP O
directs VBZ O
exclusive JJ O
neuronal JJ O
differentiation NN O
of IN O
hippocampal JJ O
granule NN O
neuron NN O
progenitors NNS O

As IN O
the DT O
next JJ O
step NN O
, , O
we PRP O
tested VBD O
the DT O
effects NNS O
of IN O
NeuroD1 NNP O
in IN O
vivo NN O
and CC O
compared VBD O
them PRP O
with IN O
those DT O
of IN O
Ngn2 NNP O
. . O

We PRP O
injected VBD O
retroviruses NNS O
carrying VBG O
the DT O
gene NN O
for IN O
either CC O
Ngn2 NNP O
[ -LRB- O
33 CD O
] -RRB- O
or CC O
NeuroD1 NNP O
, , O
and CC O
the DT O
reporter NN O
gene NN O
eGFP NN O
into IN O
the DT O
ventricles NNS O
E15 CD O
. . O
5 CD O
rat NN B-Species
embryos NNS O
, , O
in IN O
utero NN O
( -LRB- O
Figure NNP O
7A NNP O
) -RRB- O
. . O

Three CD O
weeks NNS O
later RB O
, , O
when WRB O
the DT O
rats NNS B-Species
were VBD O
about RB O
two CD O
weeks NNS O
old JJ O
, , O
we PRP O
examined VBD O
their PRP$ O
hippocampi NN O
and CC O
analyzed VBD O
the DT O
eGFP NNP O
+ CC O
cells NNS O
. . O

The DT O
rats NNS B-Species
injected VBN O
with IN O
control NN O
vector NN O
exhibited VBD O
eGFP NNP O
+ CC O
cells NNS O
within IN O
the DT O
hippocampus NN O
that WDT O
were VBD O
either CC O
star NN O
- HYPH O
shaped JJ O
, , O
progenitor NN O
/ SYM O
glial NN O
- HYPH O
like JJ O
cells NNS O
( : O
14 CD O
. . O
8 CD O
+ SYM O
/ SYM O
- HYPH O
3 CD O
. . O
4 CD O
% NN O
) -RRB- O
or CC O
neuron NN O
- HYPH O
like JJ O
cells NNS O
with IN O
long JJ O
neurites NNS O
( : O
85 CD O
. . O
3 CD O
+ SYM O
/ SYM O
- HYPH O
3 CD O
. . O
4 CD O
% NN O
) -RRB- O
( -LRB- O
Figure NN O
7B NN O
) -RRB- O
. . O

In IN O
rats NNS B-Species
that WDT O
we PRP O
had VBD O
injected VBN O
with IN O
the DT O
vector NN O
encoding VBG O
Ngn2 NNP O
, , O
the DT O
eGFP NNP O
- HYPH O
labeled VBN O
, , O
the DT O
transduced VBN O
hippocampal JJ O
cells NNS O
were VBD O
composed VBN O
of IN O
31 CD O
. . O
9 CD O
% NN O
( , O
+ SYM O
/ SYM O
- HYPH O
5 CD O
. . O
7 CD O
% NN O
) -RRB- O
progenitor NN O
/ SYM O
glia NN O
- HYPH O
like JJ O
cells NNS O
and CC O
69 CD O
. . O
4 CD O
% NN O
( , O
+ SYM O
/ SYM O
- HYPH O
6 CD O
. . O
1 CD O
% NN O
) -RRB- O
neuron NN O
- HYPH O
like JJ O
cells NNS O
( -LRB- O
Figure NN O
7B NN O
) -RRB- O
. . O

The DT O
glia NN O
- HYPH O
like JJ O
subpopulation NN O
was VBD O
immunopositive JJ O
for IN O
the DT O
astrocytic JJ O
marker NN O
GFAP NNP O
( -LRB- O
Figure NNP O
7C NNP O
- HYPH O
D NNP O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
virtually RB O
all DT O
of IN O
the DT O
transduced VBN O
cells NNS O
in IN O
rats NNS B-Species
injected VBN O
with IN O
the DT O
NeuroD1 NNP O
vector NN O
became VBD O
neuron NN O
- HYPH O
like JJ O
cells NNS O
( : O
99 CD O
. . O
9 CD O
% NN O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
1 CD O
; : O
Figure NN O
7B NN O
) -RRB- O
. . O

None NN O
of IN O
these DT O
cells NNS O
stained VBN O
for IN O
GFAP NNP O
( -LRB- O
Figure NNP O
7E CD O
and CC O
F NN O
) -RRB- O
. . O

They PRP O
were VBD O
positioned VBN O
in IN O
the DT O
external JJ O
layers NNS O
of IN O
both CC O
the DT O
ventral JJ O
and CC O
dorsal JJ O
blades NNS O
of IN O
the DT O
DG NNP O
( -LRB- O
Figure NNP O
7B3 CD O
, , O
E NN O
and CC O
I NNP O
and CC O
figure NN O
S6A NNP O
) -RRB- O
. . O

When WRB O
we PRP O
examined VBD O
neuronal JJ O
maturation NN O
of IN O
Ngn2 NNP O
- HYPH O
and CC O
NeuroD1 NNP O
- HYPH O
transduced VBN O
cells NNS O
, , O
we PRP O
observed VBD O
that IN O
only RB O
a DT O
few JJ O
of IN O
those DT O
transduced VBN O
with IN O
the DT O
NeuroD1 NNP O
vector NN O
expressed VBD O
the DT O
early JJ O
mature JJ O
neuronal JJ O
marker NN O
Tbr1 NNP O
( : O
3 CD O
. . O
1 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
. . O
4 CD O
% NN O
; : O
Figure NN O
7I CD O
and CC O
J NNP O
) -RRB- O
. . O

They PRP O
were VBD O
located VBN O
within IN O
the DT O
basal JJ O
layers NNS O
, , O
near IN O
the DT O
SGL NNP O
, , O
of IN O
the DT O
ventral JJ O
and CC O
dorsal JJ O
blades NNS O
of IN O
the DT O
DG NNP O
. . O

In IN O
contrast NN O
, , O
a DT O
greater JJR O
proportion NN O
of IN O
the DT O
cells NNS O
transduced VBN O
with IN O
Ngn2 NNP O
still RB O
expressed VBD O
Tbr1 NNP O
( : O
19 CD O
. . O
6 CD O
% NN O
+ SYM O
/ SYM O
- HYPH O
3 CD O
. . O
3 CD O
% NN O
; : O
Figure NNP O
7H CD O
and CC O
J NNP O
) -RRB- O
, , O
indicating VBG O
that IN O
they PRP O
were VBD O
less RBR O
mature JJ O
than IN O
the DT O
vast JJ O
majority NN O
of IN O
the DT O
NeuroD1 NNP O
- HYPH O
transduced VBN O
cells NNS O
. . O

Immunohistochemistry NN O
for IN O
NeuN NNP O
confirmed VBD O
these DT O
data NNS O
( -LRB- O
Figure NN O
7M NN O
and CC O
O NN O
, , O
and CC O
figure NN O
S6A NNP O
) -RRB- O
. . O

Indeed RB O
, , O
when WRB O
we PRP O
overexpressed VBD O
Ngn2 NNP O
the DT O
proportion NN O
of IN O
hippocampal JJ O
progenitors NNS O
that WDT O
became VBD O
NeuN NNP O
+ SYM O
was VBD O
no RB O
greater JJR O
than IN O
in IN O
rats NNS B-Species
transduced VBN O
with IN O
the DT O
control NN O
virus NN O
( -LRB- O
Figure NNP O
7F NNP O
) -RRB- O
. . O

As IN O
a DT O
whole NN O
, , O
our PRP$ O
in IN O
utero JJ O
injection NN O
experiments NNS O
confirm VBP O
that IN O
NeuroD1 NNP O
has VBZ O
a DT O
stronger JJR O
neuron NN O
- HYPH O
inducing VBG O
effect NN O
than IN O
Ngn2 NNP O
when WRB O
overexpressed VBN O
in IN O
hippocampal JJ O
progenitors NNS O
. . O

Involvement NN O
of IN O
Mash1 NNP O
, , O
Ngn2 NNP O
, , O
Tbr NNP O
and CC O
NeuroD NNP O
proteins NNS O
during IN O
human JJ B-Species
hippocampal JJ O
neurogenesis NN O

Finally RB O
, , O
we PRP O
examined VBD O
whether IN O
the DT O
transcription NN O
factors NNS O
and CC O
cellular JJ O
markers NNS O
that WDT O
are VBP O
expressed VBN O
in IN O
rodents NNS O
are VBP O
also RB O
expressed VBN O
in IN O
human JJ B-Species
hippocampus NN O
. . O

We PRP O
performed VBD O
immunohistochemistry NN O
on IN O
aged VBN O
human JJ B-Species
hippocampal JJ O
DG NNP O
and CC O
found VBD O
GFAP NNP O
- : O
, , O
Sox2 NNP O
- HYPH O
, , O
Pax6 NNP O
- HYPH O
, , O
Nestin NNP O
- : O
, , O
Prox1 NNP O
- HYPH O
and CC O
NeuN NNP O
- HYPH O
immunopositive JJ O
cells NNS O
. . O

This DT O
indicates VBZ O
that IN O
radial JJ O
glia NN O
- HYPH O
like JJ O
stem NN O
cells NNS O
, , O
neural JJ O
progenitors NNS O
and CC O
mature JJ O
granule NN O
neurons NNS O
are VBP O
present JJ O
in IN O
the DT O
aged VBN O
human JJ B-Species
hippocampus NN O
( -LRB- O
Figure NNP O
8A NNP O
- HYPH O
E NN O
) -RRB- O
. . O

While IN O
Prox1 NNP O
is VBZ O
found VBN O
mainly RB O
in IN O
granule NN O
neurons NNS O
, , O
Sox2 NNP O
and CC O
Pax6 NNP O
are VBP O
exclusively RB O
localized VBN O
to IN O
cells NNS O
in IN O
the DT O
SGZ NNP O
( -LRB- O
Figure NNP O
8D NN O
and CC O
E NN O
) -RRB- O
. . O

As IN O
for IN O
aged VBN O
rodents NNS O
, , O
we PRP O
did VBD O
not RB O
observe VB O
the DT O
presence NN O
of IN O
Mash1 NNP O
, , O
Ngn2 NNP O
, , O
Tbr2 NNP O
, , O
Tbr1 NNP O
and CC O
NeuroD1 NNP O
proteins NNS O
in IN O
aged JJ O
human JJ B-Species
hippocampus NN O
, , O
using VBG O
immunohistochemistry NN O
. . O

However RB O
, , O
we PRP O
could MD O
identify VB O
the DT O
presence NN O
of IN O
the DT O
transcripts NNS O
, , O
using VBG O
RT NNP O
- HYPH O
PCR NNP O
( -LRB- O
Figure NNP O
8F NNP O
) -RRB- O
. . O

In IN O
addition NN O
, , O
we PRP O
detected VBD O
mRNA NNP O
for IN O
Prox1 NNP O
, , O
Calbindin1 NNP O
and CC O
Calbindin2 NNP O
/ SYM O
Calretinin NNP O
( -LRB- O
Figure NNP O
8F NNP O
) -RRB- O
. . O

Interestingly RB O
, , O
we PRP O
also RB O
observed VBD O
Sonic NNP O
Hedgehog NNP O
and CC O
Wnt NNP O
- HYPH O
3A NNP O
transcripts NNS O
, , O
indicating VBG O
that IN O
they PRP O
are VBP O
present JJ O
in IN O
the DT O
human JJ B-Species
DG NNP O
and CC O
supporting VBG O
previous JJ O
claims NNS O
that IN O
they PRP O
are VBP O
important JJ O
for IN O
the DT O
regulation NN O
of IN O
adult NN O
hippocampal JJ O
neurogenesis NN O
( -LRB- O
Figure NNP O
8F NNP O
; : O
[ -LRB- O
34 CD O
] -RRB- O
, , O
[ -LRB- O
35 CD O
] -RRB- O
) -RRB- O
. . O

Finally RB O
, , O
we PRP O
also RB O
found VBD O
mRNA NNP O
for IN O
GLAST NNP O
, , O
Pax6 NNP O
and CC O
GFAP NNP O
which WDT O
suggests VBZ O
that IN O
radial JJ O
glia NN O
- HYPH O
like JJ O
stem NN O
cells NNS O
are VBP O
present JJ O
in IN O
the DT O
adult NN O
human JJ B-Species
hippocampus NN O
, , O
and CC O
may MD O
play VB O
a DT O
role NN O
in IN O
adult NN O
human JJ B-Species
hippocampal JJ O
neurogenesis NN O
( -LRB- O
Figure NNP O
8F NNP O
; : O
[ -LRB- O
8 CD O
] -RRB- O
) -RRB- O
. . O

Overall RB O
, , O
our PRP$ O
data NNS O
show VBP O
that IN O
different JJ O
proteins NNS O
known VBN O
to TO O
play VB O
key JJ O
roles NNS O
in IN O
rodent JJ B-Species
hippocampal JJ O
granule NN O
neurogenesis NN O
are VBP O
present JJ O
in IN O
the DT O
adult NN O
human JJ B-Species
hippocampus NN O
. . O

Discussion NN O

In IN O
this DT O
study NN O
we PRP O
determine VBP O
the DT O
functions NNS O
of IN O
Ngn2 NNP O
and CC O
NeuroD1 NNP O
during IN O
hippocampal JJ O
neurogenesis NN O
. . O

First RB O
, , O
we PRP O
map VBP O
the DT O
hierarchy NN O
of IN O
molecular JJ O
markers NNS O
of IN O
neurogenesis NN O
in IN O
the DT O
DG NNP O
. . O

Second RB O
, , O
we PRP O
describe VBP O
that IN O
Ngn2 NNP O
is VBZ O
necessary JJ O
for IN O
granule NN O
progenitor NN O
production NN O
/ SYM O
amplification NN O
. . O

Third RB O
, , O
we PRP O
demonstrate VBP O
that IN O
NeuroD1 NNP O
directs VBZ O
neuronal JJ O
differentiation NN O
of IN O
granule NN O
progenitors NNS O
. . O

Finally RB O
, , O
we PRP O
show VBP O
that IN O
different JJ O
cellular JJ O
markers NNS O
expressed VBN O
during IN O
hippocampal JJ O
neurogenesis NN O
in IN O
rodents NNS O
are VBP O
present JJ O
in IN O
human NN B-Species
. . O

Sequential JJ O
expression NN O
of IN O
different JJ O
transcription NN O
factors NNS O
and CC O
cellular JJ O
markers NNS O
during IN O
hippocampal JJ O
neurogenesis NN O

We PRP O
clarified VBD O
the DT O
pattern NN O
of IN O
expression NN O
of IN O
various JJ O
markers NNS O
expressed VBN O
during IN O
postnatal JJ O
and CC O
adult NN O
hippocampal JJ O
granule NN O
neurogenesis NN O
in IN O
detail NN O
. . O

We PRP O
found VBD O
that IN O
the DT O
transcription NN O
factor NN O
Pax6 NN O
is VBZ O
initially RB O
expressed VBN O
by IN O
both DT O
radial JJ O
glia NN O
stem NN O
cells NNS O
( , O
type NN O
- HYPH O
1 CD O
) -RRB- O
and CC O
early JJ O
amplifying VBG O
progenitors NNS O
( , O
type NN O
- HYPH O
2a CD O
) -RRB- O
. . O

The DT O
next JJ O
transcription NN O
factor NN O
to TO O
appear VB O
in IN O
chronology NN O
is VBZ O
Mash1 NNP O
. . O

Mash1 NNP O
expression NN O
characterizes VBZ O
the DT O
early JJ O
stage NN O
of IN O
hippocampal JJ O
progenitor NN O
amplification NN O
( , O
early JJ O
type NN O
- HYPH O
2a NN O
) -RRB- O
. . O

The DT O
role NN O
of IN O
Mash1 NNP O
during IN O
hippocampal JJ O
granule NN O
neurogenesis NN O
is VBZ O
still RB O
unclear JJ O
. . O

Mash1 NNP O
null JJ O
mutant JJ O
mice NNS B-Species
do VBP O
not RB O
display VB O
any DT O
clear JJ O
malformation NN O
of IN O
the DT O
DG NNP O
[ -LRB- O
20 CD O
] -RRB- O
. . O

However RB O
, , O
overexpression NN O
of IN O
Mash1 NNP O
alone RB O
in IN O
the DT O
DG NNP O
leads VBZ O
to IN O
the DT O
generation NN O
of IN O
oligodendrocytes NNS O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Based VBN O
on IN O
these DT O
observations NNS O
, , O
we PRP O
hypothesize VBP O
that IN O
Mash1 NNP O
- HYPH O
expressing VBG O
cells NNS O
are VBP O
not RB O
yet RB O
committed VBN O
towards IN O
a DT O
granule NN O
cell NN O
fate NN O
. . O

They PRP O
may MD O
still RB O
have VB O
the DT O
potential NN O
to TO O
generate VB O
both DT O
neurons NNS O
and CC O
oligodendrocytes NNS O
, , O
as IN O
is VBZ O
the DT O
case NN O
in IN O
the DT O
SVZ NNP O
[ -LRB- O
37 CD O
] -RRB- O
. . O

In IN O
agreement NN O
with IN O
different JJ O
developing VBG O
brain NN O
regions NNS O
, , O
we PRP O
found VBD O
that IN O
Ngn2 NNP O
starts VBZ O
to TO O
be VB O
expressed VBN O
in IN O
Mash1 NNP O
- HYPH O
positive JJ O
transiently RB O
amplifying VBG O
progenitors NNS O
, , O
i PRP O
. . O
e LS O
. . O
"""" `` O
late JJ O
type NN O
- HYPH O
2a NN O
cells NNS O
"""" '' O
according VBG O
to IN O
the DT O
classification NN O
we PRP O
propose VBP O
. . O

We PRP O
observed VBD O
that IN O
Pax6 NNP O
expression NN O
persisted VBD O
longer RBR O
than IN O
that DT O
of IN O
Mash1 NNP O
, , O
in IN O
Ngn2 NNP O
- HYPH O
expressing VBG O
cells NNS O
( , O
late JJ O
type NN O
- HYPH O
2a NN O
cells NNS O
) -RRB- O
, , O
in IN O
juvenile NN O
but CC O
not RB O
adult NN O
DG NNP O
( , O
Fig NNP O
. . O
1 CD O
and CC O
figure NN O
S1 NNP O
) -RRB- O
. . O

Later RB O
on RB O
, , O
Ngn2 NNP O
is VBZ O
downregulated VBN O
, , O
whilst IN O
Tbr2 NNP O
expression NN O
persists VBZ O
( , O
type NN O
- HYPH O
2b NN O
cells NNS O
) -RRB- O
. . O

The DT O
transition NN O
from IN O
amplifying VBG O
progenitor NN O
to IN O
neuroblast NN O
is VBZ O
defined VBN O
by IN O
the DT O
expression NN O
of IN O
NeuroD1 NNP O
. . O

Thus RB O
, , O
Ngn2 NNP O
is VBZ O
expressed VBN O
at IN O
the DT O
beginning NN O
of IN O
the DT O
transiently RB O
amplifying VBG O
progenitor NN O
phase NN O
while IN O
NeuroD1 NNP O
marks VBZ O
the DT O
end NN O
of IN O
that DT O
period NN O
. . O

This DT O
applies VBZ O
both CC O
to IN O
the DT O
juvenile JJ O
and CC O
adult NN O
rat NN B-Species
brain NN O
[ -LRB- O
21 CD O
] -RRB- O
, , O
[ -LRB- O
25 CD O
] -RRB- O
. . O

After IN O
NeuroD1 NNP O
is VBZ O
turned VBN O
on IN O
the DT O
progenitors NNS O
leave VB O
the DT O
cell NN O
cycle NN O
, , O
gradually RB O
mature VB O
, , O
express VB O
PSA NNP O
- HYPH O
NCAM NNP O
, , O
NeuroD2 NNP O
, , O
Calretinin NNP O
, , O
Prox1 NNP O
, , O
Tbr1 NNP O
and CC O
, , O
finally RB O
, , O
NeuN NNP O
. . O

NeuroD1 NNP O
expression NN O
persists VBZ O
at IN O
low JJ O
levels NNS O
in IN O
mature JJ O
neurons NNS O
( -LRB- O
Figure NN O
9 CD O
; : O
[ -LRB- O
10 CD O
] -RRB- O
) -RRB- O
. . O

We PRP O
found VBD O
the DT O
sequential JJ O
expression NN O
of IN O
these DT O
markers NNS O
conserved VBN O
in IN O
juvenile NN O
( , O
P2 NN O
and CC O
2 CD O
weeks NNS O
) -RRB- O
and CC O
adult NN O
rodent NN B-Species
brains NNS O
. . O

Importantly RB O
, , O
we PRP O
observed VBD O
that IN O
the DT O
same JJ O
transcription NN O
factors NNS O
and CC O
neuronal JJ O
markers NNS O
are VBP O
also RB O
present JJ O
in IN O
the DT O
adult NN O
human JJ B-Species
hippocampus NN O
and CC O
arranged VBN O
spatially RB O
in IN O
a DT O
manner NN O
reminiscent JJ O
with IN O
what WP O
we PRP O
saw VBD O
in IN O
rodents NNS O
. . O

It PRP O
is VBZ O
possible JJ O
, , O
however RB O
, , O
that IN O
some DT O
of IN O
these DT O
markers NNS O
are VBP O
expressed VBN O
for IN O
longer JJR O
or CC O
shorter JJR O
periods NNS O
at IN O
postnatal JJ O
and CC O
adult NN O
stages NNS O
of IN O
hippocampal JJ O
progenitor NN O
maturation NN O
. . O

Moreover RB O
, , O
one PRP O
can MD O
ask VB O
to TO O
which WDT O
extent NN O
the DT O
number NN O
of IN O
divisions NNS O
occurring VBG O
during IN O
neuroblasts NNS O
maturation NN O
is VBZ O
conserved VBN O
at IN O
postnatal JJ O
and CC O
adult NN O
stages NNS O
of IN O
neurogenesis NN O
. . O

A DT O
new JJ O
function NN O
for IN O
Ngn2 NNP O
in IN O
maintenance NN O
of IN O
a DT O
progenitor NN O
state NN O
for IN O
granule NN O
neuron NN O
production NN O
/ SYM O
amplification NN O
during IN O
embryonic JJ O
and CC O
postnatal JJ O
hippocampal JJ O
neurogenesis NN O

In IN O
agreement NN O
with IN O
earlier JJR O
work NN O
, , O
we PRP O
confirm VBP O
that IN O
Ngn2 NNP O
is VBZ O
indispensable JJ O
for IN O
hippocampal JJ O
development NN O
and CC O
plays VBZ O
a DT O
vital JJ O
role NN O
in IN O
postnatal JJ O
hippocampal JJ O
granule NN O
neurogenesis NN O
. . O

Ngn2 NNP O
null JJ O
mutant JJ O
animals NNS O
display VBP O
a DT O
reduced VBN O
size NN O
of IN O
the DT O
cornu NN O
ammonis NN O
and CC O
a DT O
malformed VBN O
DG NNP O
( -LRB- O
Figure NNP O
3 CD O
and CC O
4 CD O
; : O
[ -LRB- O
20 CD O
] -RRB- O
) -RRB- O
. . O

We PRP O
show VBP O
that IN O
the DT O
number NN O
of IN O
newborn JJ O
neurons NNS O
( , O
incorporated VBN O
BrdU NNP O
) -RRB- O
is VBZ O
decreased VBN O
in IN O
absence NN O
of IN O
Ngn2 NNP O
, , O
but CC O
hippocampal JJ O
granule NN O
neuron NN O
subtype NN O
specification NN O
is VBZ O
not RB O
affected VBN O
, , O
post NN O
- HYPH O
nataly NN O
. . O

Likewise RB O
, , O
neurons NNS O
from IN O
other JJ O
brain NN O
regions NNS O
, , O
e UH O
. . O
g LS O
. . O
ventral JJ O
midbrain NN O
dopamine NN O
neurons NNS O
, , O
can MD O
be VB O
generated VBN O
in IN O
the DT O
absence NN O
of IN O
Ngn2 NNP O
[ -LRB- O
30 CD O
] -RRB- O
, , O
[ -LRB- O
31 CD O
] -RRB- O
. . O

The DT O
reduced VBN O
numbers NNS O
of IN O
mature JJ O
neurons NNS O
in IN O
the DT O
hippocampus NN O
and CC O
ventral JJ O
midbrain NN O
of IN O
Ngn2 NNP O
null JJ O
mutant JJ O
animals NNS O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
due IN O
to IN O
cell NN O
death NN O
or CC O
migration NN O
defects NNS O
[ -LRB- O
20 CD O
] -RRB- O
, , O
[ -LRB- O
31 CD O
] -RRB- O
. . O

Instead RB O
it PRP O
may MD O
be VB O
due IN O
to IN O
a DT O
defect NN O
in IN O
the DT O
generation NN O
and CC O
/ SYM O
or CC O
amplification NN O
of IN O
neuronal JJ O
progenitors NNS O
. . O

Indeed RB O
, , O
in IN O
the DT O
hippocampus NN O
of IN O
postnatal JJ O
animals NNS O
, , O
we PRP O
observed VBD O
that IN O
cells NNS O
lacking VBG O
Ngn2 NNP O
arrest NN O
in IN O
the DT O
cell NN O
cycle NN O
, , O
maintain VBP O
Pax6 NN O
expression NN O
and CC O
cease VBP O
to TO O
proliferate VB O
. . O

When WRB O
overexpressed VBN O
in IN O
neural JJ O
progenitors NNS O
in IN O
vitro FW O
, , O
Ngn2 NNP O
lead NN O
to IN O
up IN O
- HYPH O
regulation NN O
of IN O
NeuroD1 NNP O
and CC O
caused VBD O
neuronal JJ O
differentiation NN O
( -LRB- O
Figure NNP O
6 CD O
) -RRB- O
, , O
which WDT O
was VBD O
not RB O
always RB O
the DT O
case NN O
when WRB O
we PRP O
overexpressed VBD O
the DT O
same JJ O
factor NN O
in IN O
vivo NN O
( -LRB- O
Figure NNP O
7L NNP O
, , O
N CD O
and CC O
O NN O
) -RRB- O
. . O

We PRP O
also RB O
saw VBD O
that IN O
Ngn2 NNP O
does VBZ O
not RB O
always RB O
efficiently RB O
induce VB O
cell NN O
cycle NN O
exit NN O
. . O

Typically RB O
some DT O
mitotically RB O
active JJ O
eGFP NNP O
+ CC O
cells NNS O
were VBD O
present JJ O
in IN O
the DT O
DG NNP O
of IN O
rats NNS B-Species
injected VBN O
with IN O
the DT O
Ngn2 NNP O
retrovirus NN O
( -LRB- O
Figure NNP O
7P NNP O
) -RRB- O
, , O
and CC O
we PRP O
observed VBD O
that IN O
cultured VBN O
Ngn2 NNP O
- HYPH O
transduced VBN O
cells NNS O
are VBP O
still RB O
capable JJ O
of IN O
dividing VBG O
. . O

Thus RB O
, , O
Ngn2 NNP O
does VBZ O
not RB O
always RB O
promote VB O
cell NN O
cycle NN O
exit NN O
and CC O
neuronal JJ O
commitment NN O
, , O
but CC O
depending VBG O
on IN O
the DT O
state NN O
of IN O
the DT O
cells NNS O
, , O
Ngn2 NNP O
may MD O
instead RB O
promote VB O
alternate JJ O
cellular JJ O
fates NNS O
[ -LRB- O
38 CD O
] -RRB- O
- : O
[ -LRB- O
40 CD O
] -RRB- O
. . O

Indeed RB O
, , O
an DT O
earlier JJR O
study NN O
has VBZ O
shown VBN O
that IN O
Ngn2 NNP O
- HYPH O
overexpressing VBG O
progenitors NNS O
generate VBP O
oligodendrocytes NNS O
when WRB O
grafted VBN O
to IN O
the DT O
adult NN O
spinal JJ O
cord NN O
[ -LRB- O
40 CD O
] -RRB- O
. . O

We PRP O
have VBP O
also RB O
seen VBN O
that IN O
Ngn2 NNP O
- HYPH O
overexpressing VBG O
neural JJ O
progenitors NNS O
from IN O
the DT O
embryonic JJ O
midbrain NN O
form NN O
astrocytes NNS O
when WRB O
grafted VBN O
to IN O
the DT O
striatum NN O
( , O
unpublished JJ O
observations NNS O
) -RRB- O
. . O

Probably RB O
, , O
Ngn2 NNP O
cannot MD O
influence VB O
already RB O
committed VBN O
cells NNS O
, , O
but CC O
rather RB O
would MD O
control VB O
neuroblasts NNS O
production NN O
. . O

One PRP O
could MD O
speculate VB O
that IN O
Ngn2 NNP O
oscillates NNS O
during IN O
granule NN O
neuron NN O
formation NN O
, , O
as IN O
recently RB O
demonstrated VBN O
during IN O
neocorticogenesis NN O
[ -LRB- O
41 CD O
] -RRB- O
, , O
[ -LRB- O
42 CD O
] -RRB- O
. . O

NeuroD1 NNP O
, , O
but CC O
not RB O
Ngn2 NNP O
, , O
is VBZ O
obligatory JJ O
for IN O
granule NN O
neuron NN O
progenitor NN O
differentiation NN O

Hippocampal JJ O
granule NN O
progenitors NNS O
can MD O
mature VB O
and CC O
express VB O
Tbr1 NNP O
and CC O
Prox1 NNP O
, , O
both CC O
during IN O
the DT O
development NN O
and CC O
postnatally RB O
, , O
even RB O
in IN O
the DT O
absence NN O
of IN O
Ngn2 NNP O
. . O

Because IN O
neuronal JJ O
differentiation NN O
still RB O
occurs VBZ O
in IN O
Ngn2 NNP O
null JJ O
mice NNS B-Species
, , O
it PRP O
is VBZ O
clear JJ O
that IN O
compensatory JJ O
, , O
Ngn2 NNP O
- HYPH O
independent JJ O
mechanisms NNS O
induce VBP O
NeuroD1 NNP O
expression NN O
. . O

One CD O
candidate NN O
is VBZ O
Ngn1 NNP O
, , O
which WDT O
is VBZ O
expressed VBN O
during IN O
neocorticogenesis NN O
, , O
the DT O
specification NN O
of IN O
olfactory JJ O
sensory NN O
neurons NNS O
and CC O
during IN O
embryonic JJ O
rat NN B-Species
hippocampal NN O
development NN O
[ -LRB- O
43 CD O
] -RRB- O
- : O
[ -LRB- O
47 CD O
] -RRB- O
. . O

Both CC O
Ngn1 NNP O
and CC O
Ngn2 NNP O
regulate VBP O
NeuroD1 NNP O
[ -LRB- O
19 CD O
] -RRB- O
, , O
[ -LRB- O
48 CD O
] -RRB- O
. . O

The DT O
introduction NN O
of IN O
two CD O
mutant JJ O
forms NNS O
of IN O
Ngn1 NNP O
, , O
a DT O
deletion NN O
of IN O
the DT O
basic JJ O
region NN O
of IN O
Ngn1 NNP O
and CC O
a DT O
substitution NN O
of IN O
two CD O
amino NN O
acids NNS O
in IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
basic JJ O
region NN O
, , O
prevents VBZ O
NeuroD1 NNP O
expression NN O
and CC O
neuronal JJ O
differentiation NN O
[ -LRB- O
48 CD O
] -RRB- O
. . O

The DT O
double JJ O
null JJ O
Ngn1 NNP O
/ SYM O
Ngn2 NNP O
mutant NN O
displays VBZ O
a DT O
more RBR O
severe JJ O
phenotype NN O
than IN O
single JJ O
gene NN O
( , O
Ngn1 NNP O
or CC O
Ngn2 NNP O
) -RRB- O
mutant JJ O
mice NNS B-Species
. . O

For IN O
example NN O
, , O
the DT O
total JJ O
brain NN O
size NN O
of IN O
the DT O
double JJ O
mutants NNS O
is VBZ O
much RB O
smaller JJR O
[ -LRB- O
10 CD O
] -RRB- O
, , O
[ -LRB- O
32 CD O
] -RRB- O
. . O

If IN O
the DT O
role NN O
of IN O
Ngn1 NNP O
during IN O
hippocampal JJ O
neurogenesis NN O
is VBZ O
to TO O
activate VB O
NeuroD1 NNP O
and CC O
that DT O
of IN O
Ngn2 NNP O
is VBZ O
to TO O
control VB O
granule NN O
neuroblasts NNS O
production NN O
/ SYM O
amplification NN O
, , O
the DT O
DG NN O
of IN O
double JJ O
Ngn1 NNP O
/ SYM O
Ngn2 CD O
knockout NN O
mice NN B-Species
should MD O
resemble VB O
that DT O
of IN O
NeuroD1 NNP O
null JJ O
mutant JJ O
mice NNS B-Species
. . O

We PRP O
demonstrated VBD O
that IN O
NeuroD1 NNP O
directs VBZ O
neuronal JJ O
differentiation NN O
both CC O
in IN O
vitro FW O
and CC O
in IN O
vivo NN O
. . O

In IN O
progenitors NNS O
isolated VBN O
from IN O
different JJ O
embryonic JJ O
brain NN O
regions NNS O
and CC O
cultured VBN O
in IN O
vitro NN O
, , O
we PRP O
found VBD O
that IN O
overexpression NN O
of IN O
NeuroD1 NNP O
induced VBD O
neuronal JJ O
differentiation NN O
. . O

The DT O
neurons NNS O
generated VBD O
expressed VBN O
PSA NNP O
- HYPH O
NCAM NNP O
, , O
Dcx NNP O
and CC O
MAP2 NNP O
. . O

After IN O
in IN O
utero NN O
retroviral JJ O
vector NN O
- HYPH O
mediated VBN O
gene NN O
delivery NN O
, , O
virtually RB O
all DT O
cells NNS O
transduced VBN O
with IN O
NeuroD1 NNP O
became VBD O
neurons NNS O
. . O

In IN O
contrast NN O
, , O
progenitors NNS O
transduced VBN O
with IN O
Ngn2 NNP O
or CC O
control NN O
retroviruses NNS O
adopted VBD O
a DT O
neuron NN O
- HYPH O
like JJ O
morphology NN O
in IN O
only RB O
70 CD O
- SYM O
85 CD O
% NN O
of IN O
cases NNS O
. . O

Under IN O
in FW O
vitro FW O
cell NN O
culture NN O
conditions NNS O
, , O
when WRB O
we PRP O
overexpressed VBD O
Ngn2 NNP O
in IN O
progenitors NNS O
derived VBN O
from IN O
the DT O
LGE NNP O
we PRP O
observed VBD O
robust JJ O
expression NN O
of IN O
NeuroD1 NNP O
and CC O
neuronal JJ O
differentiation NN O
. . O

These DT O
in FW O
vitro FW O
results NNS O
differ VBP O
from IN O
those DT O
we PRP O
obtained VBD O
when WRB O
we PRP O
transduced VBD O
the DT O
embryonic JJ O
brain NN O
with IN O
a DT O
viral JJ O
vector NN O
expressing VBG O
Ngn2 NNP O
. . O

In IN O
this DT O
latter JJ O
case NN O
, , O
Ngn2 NNP O
did VBD O
not RB O
induce VB O
neurons NNS O
and CC O
the DT O
transduced VBN O
cells NNS O
did VBD O
not RB O
express VB O
NeuroD1 NNP O
. . O

Therefore RB O
, , O
Ngn2 NNP O
appears VBZ O
to TO O
direct VB O
non JJ O
- HYPH O
neuronal JJ O
cell NN O
type NN O
specification NN O
in IN O
vivo NN O
[ -LRB- O
38 CD O
] -RRB- O
- : O
[ -LRB- O
40 CD O
] -RRB- O
. . O

Taken VBN O
together RB O
, , O
we PRP O
have VBP O
confirmed VBN O
that IN O
NeuroD1 NNP O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
neuronal JJ O
differentiation NN O
in IN O
the DT O
hippocampus NN O
, , O
both CC O
during IN O
development NN O
and CC O
in IN O
the DT O
adult NN O
brain NN O
. . O

Concluding VBG O
remark NN O

We PRP O
present VBP O
a DT O
detailed JJ O
classification NN O
of IN O
different JJ O
stages NNS O
in IN O
hippocampal JJ O
neurogenesis NN O
. . O

Our PRP$ O
detailed JJ O
molecular JJ O
mapping NN O
of IN O
hippocampal JJ O
neurogenesis NN O
allows VBZ O
for IN O
a DT O
more RBR O
accurate JJ O
analysis NN O
of IN O
how WRB O
new JJ O
factors NNS O
stimulate VBP O
neurogenesis NN O
at IN O
different JJ O
steps NNS O
in IN O
the DT O
development NN O
of IN O
granule NN O
neurons NNS O
. . O

Thereby RB O
we PRP O
hope VBP O
to TO O
facilitate VB O
the DT O
development NN O
of IN O
new JJ O
agents NNS O
, , O
which WDT O
stimulate VBP O
endogenous JJ O
progenitors NNS O
in IN O
the DT O
treatment NN O
of IN O
diseases NNS O
. . O

Materials NNS O
and CC O
Methods NNS O

Animal NN O
tissue NN O
preparation NN O

The DT O
creation NN O
of IN O
the DT O
Ngn2 NNP O
transgenic JJ O
mice NN B-Species
was VBD O
reported VBN O
elsewhere RB O
( : O
ref NN O
guillemot NN O
) -RRB- O
. . O

Heterozygote NN O
male NN O
and CC O
female JJ O
mice NNS B-Species
were VBD O
crossed VBN O
to TO O
obtain VB O
WT NNP O
, , O
heterozygote NN O
( , O
Ngn2 NNP O
+ SYM O
/ SYM O
GFP NNP O
) -RRB- O
and CC O
null JJ O
mutant JJ O
( -LRB- O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
) -RRB- O
animals NNS O
. . O

Tails NNS O
of IN O
the DT O
Ngn2 NNP O
offspring NN O
were VBD O
used VBN O
to TO O
obtain VB O
DNA NN O
for IN O
determination NN O
of IN O
the DT O
genotype NN O
using VBG O
a DT O
polymerase NN O
chain NN O
reaction NN O
( -LRB- O
PCR NN O
) -RRB- O
assay NN O
as IN O
previously RB O
reported VBN O
[ -LRB- O
31 CD O
] -RRB- O
. . O

As IN O
null JJ O
mutant JJ O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
do VBP O
not RB O
survive VB O
longer RBR O
than IN O
2 CD O
. . O
5 CD O
- SYM O
3 CD O
weeks NNS O
after IN O
birth NN O
, , O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
and CC O
their PRP$ O
littermates NNS O
were VBD O
sacrificed VBN O
at IN O
the DT O
postnatal JJ O
ages NNS O
of IN O
two CD O
days NNS O
( : O
P2 NN O
) -RRB- O
or CC O
two CD O
weeks NNS O
for IN O
this DT O
study NN O
. . O

Neurogenesis NNP O
was VBD O
assessed VBN O
in IN O
two CD O
weeks NNS O
or CC O
two CD O
months NNS O
old JJ O
WT NNP O
mice NNS B-Species
. . O

Sprague NNP O
Dawley NNP O
pregnant JJ O
rats NNS B-Species
were VBD O
ordered VBN O
from IN O
B NNP O
& CC O
K NNP O
Universal NNP O
Ltd NNP O
, , O
Sollentuna NNP O
, , O
Sweden NNP O
( , O
hppt NN O
: : O
/ SYM O
/ SYM O
www NN O
. . O
bku NNP O
. . O
com NN O
) -RRB- O
. . O

All DT O
animals NNS O
were VBD O
housed VBN O
in IN O
groups NNS O
with IN O
ad NN O
libitum NN O
access NN O
to IN O
food NN O
and CC O
water NN O
at IN O
a DT O
12 CD O
- HYPH O
h NN O
light JJ O
/ SYM O
dark JJ O
cycle NN O
. . O

All DT O
experimental JJ O
procedures NNS O
conducted VBN O
in IN O
this DT O
study NN O
had VBD O
been VBN O
approved VBN O
by IN O
the DT O
Ethical NNP O
Committee NNP O
at IN O
Lund NNP O
University NNP O
. . O

For IN O
immunohistochemical JJ O
analysis NN O
, , O
mice NNS B-Species
( , O
from IN O
two CD O
weeks NNS O
old JJ O
and CC O
adult NN O
stage NN O
) , O
and CC O
juvenile JJ O
rats NNS B-Species
were VBD O
sacrificed VBN O
by IN O
transcardial JJ O
perfusion NN O
with IN O
saline NN O
for IN O
5 CD O
- SYM O
10 CD O
minutes NNS O
, , O
followed VBN O
by IN O
4 CD O
% NN O
paraformaldehyde NN O
( -LRB- O
PFA NNP O
) -RRB- O
for IN O
10 CD O
minutes NNS O
. . O

Brains NNS O
were VBD O
kept VBN O
in IN O
PFA NNP O
overnight RB O
at IN O
4 CD O
degrees NNS O
C NN O
and CC O
subsequently RB O
cryopreserved VBN O
in IN O
a DT O
20 CD O
- SYM O
30 CD O
% NN O
sucrose NN O
/ SYM O
0 CD O
. . O
1 CD O
M NN O
phosphate NN O
buffer NN O
solution NN O
until IN O
sectioning VBG O
on IN O
a DT O
microtome NN O
apparatus NN O
( , O
30 CD O
micro JJ O
m NN O
thickness NN O
sections NNS O
, , O
Microm NNP O
Zeiss NNP O
) -RRB- O
. . O

Seven CD O
series NN O
of IN O
coronal JJ O
sections NNS O
were VBD O
cut VBN O
throughout IN O
the DT O
brain NN O
. . O

Free JJ O
- HYPH O
floating VBG O
sections NNS O
were VBD O
preserved VBN O
in IN O
antifreeze NN O
solution NN O
until IN O
immunohistochemistry NN O
was VBD O
performed VBN O
. . O

Heads NNS O
of IN O
postanatal JJ O
two CD O
days NNS O
old JJ O
mice NNS B-Species
were VBD O
decapitated VBN O
and CC O
soaked VBN O
in IN O
PFA NNP O
4 CD O
% NN O
for IN O
24 CD O
hours NNS O
, , O
at IN O
4 CD O
degrees NNS O
C NN O
and CC O
transferred VBN O
into IN O
sucrose NN O
solution NN O
until IN O
sectioning VBG O
on IN O
cryostat NN O
apparatus NN O
( : O
16 CD O
micro NN O
m NN O
thickness NN O
; : O
Leica NNP O
CM3000 NNP O
) -RRB- O
. . O

Sections NNS O
were VBD O
mounted VBN O
on IN O
Superfrost NNP O
glass NN O
slides NNS O
and CC O
stored VBN O
at IN O
- SYM O
80 CD O
degrees NNS O
C NN O
until IN O
immunohistochemistry NN O
was VBD O
performed VBN O
. . O

Cloning NN O
, , O
subcloning NN O
, , O
virus NN O
production NN O
and CC O
titer NN O
measurement NN O

The DT O
Moloney NNP O
leukemia NN O
- HYPH O
derived VBN O
retroviral JJ O
vectors NNS O
used VBN O
in IN O
this DT O
study NN O
, , O
pCMMP NNP O
- HYPH O
IRES2eGFP NNP O
- HYPH O
WPRE NNP O
and CC O
pCMMP NNP O
- HYPH O
Ngn2 NNP O
- HYPH O
IRES2eGFP NNP O
- HYPH O
WPRE NNP O
were VBD O
previously RB O
described VBN O
[ -LRB- O
40 CD O
] -RRB- O
, , O
[ -LRB- O
49 CD O
] -RRB- O
. . O

To TO O
generate VB O
the DT O
construct NN O
pCMMP NNP O
- HYPH O
NeuroD1 NNP O
- HYPH O
IRES2eGFP NNP O
- HYPH O
WPRE NNP O
, , O
mouse NNP B-Species
NeuroD1 NNP O
cDNA NNP O
was VBD O
amplified VBN O
from IN O
a DT O
pCS2 NN O
+ CC O
mtNeuroD1 NN O
plasmid NN O
( , O
kindly RB O
provided VBN O
by IN O
Professor NNP O
Jackie NNP O
Lee NNP O
, , O
Denver NNP O
university NN O
, , O
Boulder NNP O
, , O
USA NNP O
) , O
by IN O
PCR NNP O
to TO O
introduce VB O
the DT O
restriction NN O
sites NNS O
PmeI NNP O
in IN O
5 CD O
' '' O
and CC O
XhoI NNP O
in IN O
3 CD O
' '' O
. . O

Amplification NN O
of IN O
cDNA NNP O
was VBD O
performed VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
49 CD O
] -RRB- O
. . O

The DT O
construction NN O
was VBD O
verified VBN O
by IN O
enzymatic JJ O
restriction NN O
and CC O
by IN O
DNA NNP O
sequencing NN O
using VBG O
BigDye NNP O
3 CD O
. . O
1 CD O
( SYM O
ABI NNP O
) -RRB- O
. . O

All DT O
infectious JJ O
particles NNS O
were VBD O
produced VBN O
using VBG O
the DT O
producer NN O
cell NN O
line NN O
293VSV NN O
- HYPH O
G NNP O
and CC O
as IN O
previously RB O
described VBN O
[ -LRB- O
49 CD O
] -RRB- O
. . O

The DT O
titer NN O
of IN O
each DT O
retrovirus NN O
was VBD O
measured VBN O
by IN O
flow NN O
- HYPH O
cytometry NN O
based VBN O
on IN O
eGFP NNP O
expression NN O
, , O
four CD O
days NNS O
following VBG O
infection NN O
of IN O
HT1080 NNP O
cells NNS O
and CC O
ranged VBN O
from IN O
0 CD O
. . O
5 CD O
x SYM O
109 CD O
- SYM O
2 CD O
. . O
1 CD O
x SYM O
109 CD O
TU NN O
/ SYM O
ml CD O
( , O
All DT O
details NNS O
on IN O
how WRB O
to TO O
produce VB O
infectious JJ O
particles NNS O
can MD O
be VB O
provided VBN O
upon IN O
request NN O
) -RRB- O
. . O

Neurosphere NN O
generation NN O
, , O
transduction NN O
and CC O
differentiation NN O

Pregnant JJ O
female JJ O
Sprague NNP B-Species
- HYPH I-Species
Dawley NNP I-Species
rats NNS I-Species
( , O
B NNP O
& CC O
K NNP O
Universal NNP O
, , O
Sollentuna NNP O
, , O
Sweden NNP O
) , O
were VBD O
terminally RB O
anesthetized VBN O
by IN O
an DT O
overdose NN O
of IN O
sodium NN O
pentobarbital NN O
( : O
i ADD O
. . O
p NN O
. . O
, , O
60 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
. . O

Embryos NNS O
at IN O
stage NN O
embryonic JJ O
day NN O
E14 CD O
. . O
5 CD O
( HYPH O
Plug NNP O
day NN O
as IN O
day NN O
0 CD O
) -RRB- O
were VBD O
collected VBN O
and CC O
cortical JJ O
- HYPH O
hippocampal JJ O
neurospheres NNS O
were VBD O
generated VBN O
following VBG O
dissection NN O
of IN O
the DT O
dorso NN O
- HYPH O
posterior JJ O
part NN O
of IN O
the DT O
cortical JJ O
tissue NN O
, , O
and CC O
generated VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
49 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
second JJ O
passage NN O
( , O
P2 NN O
) -RRB- O
neurospheres NNS O
were VBD O
used VBN O
to TO O
study VB O
the DT O
effect NN O
of IN O
the DT O
overexpression NN O
of IN O
Ngn2 NNP O
and CC O
NeuroD1 NNP O
on IN O
neuronal JJ O
differentiation NN O
. . O

Each DT O
well NN O
, , O
containing VBG O
an DT O
equal JJ O
starting VBG O
population NN O
of IN O
200 CD O
, , O
0 CD O
cells NNS O
/ SYM O
ml NNS O
, , O
corresponding VBG O
to IN O
15 CD O
- SYM O
25 CD O
neurospheres NNS O
, , O
was VBD O
transduced VBN O
independently RB O
with IN O
each DT O
retrovirus NN O
at IN O
a DT O
multiplicity NN O
of IN O
infection NN O
( -LRB- O
MOI NNP O
) -RRB- O
of IN O
1 CD O
, , O
in IN O
proliferation NN O
medium NN O
supplemented VBN O
by IN O
protamine NN O
- HYPH O
sulfate NN O
( : O
4 CD O
mg NN O
/ SYM O
ml NN O
, , O
Sigma NNP O
) -RRB- O
. . O

To TO O
induce VB O
differentiation NN O
, , O
the DT O
medium NN O
was VBD O
replaced VBN O
with IN O
normal JJ O
basic JJ O
differentiation NN O
medium NN O
two CD O
days NNS O
post NN O
- HYPH O
transduction NN O
and CC O
subsequently RB O
changed VBN O
every DT O
other JJ O
day NN O
until IN O
fixation NN O
. . O

Immunocytochemistry NN O
, , O
immunohistochemistry NN O
and CC O
microscopy NN O

The DT O
antibodies NNS O
used VBN O
in IN O
this DT O
study NN O
are VBP O
: : O
rabbit NN B-Species
anti AFX O
- HYPH O
GFAP NN O
( : O
1 CD O
: : O
1000 CD O
; : O
DAKO NNP O
) -RRB- O
, , O
mouse NN B-Species
anti JJ O
- HYPH O
Nestin NNP O
( , O
1 CD O
: : O
100 CD O
; : O
BD NNP O
PharMingen NNP O
) -RRB- O
, , O
guinea NN B-Species
pig NN I-Species
anti AFX O
- HYPH O
Glast NNP O
( : O
1 CD O
: : O
500 CD O
; : O
Chemicon NNP O
) -RRB- O
, , O
rabbit NN B-Species
anti JJ O
- HYPH O
Prox1 NN O
( : O
1 CD O
: : O
1000 CD O
; : O
Covance NNP O
) -RRB- O
, , O
goat NN B-Species
anti AFX O
- HYPH O
Ngn2 NNP O
( , O
1 CD O
: : O
20 CD O
; : O
Santa NNP O
Cruz NNP O
) -RRB- O
, , O
goat NN B-Species
anti AFX O
- HYPH O
NeuroD1 NN O
( : O
1 CD O
: : O
200 CD O
; : O
Santa NNP O
Cruz NNP O
) -RRB- O
, , O
rabbit NN B-Species
anti AFX O
- HYPH O
Pax6 NN O
( : O
1 CD O
: : O
150 CD O
; : O
Covance NNP O
) -RRB- O
, , O
rabbit NN B-Species
anti AFX O
- HYPH O
Trb2 NN O
( : O
1 CD O
: : O
500 CD O
; : O
Chemicon NNP O
) -RRB- O
, , O
rabbit NN B-Species
anti AFX O
- HYPH O
Trb1 NN O
: : O
( : O
1 CD O
: : O
1000 CD O
; : O
Chemicon NNP O
) -RRB- O
, , O
goat NN B-Species
anti AFX O
- HYPH O
Dcx NN O
: : O
( : O
1 CD O
: : O
500 CD O
; : O
Santa NNP O
Cruz NNP O
) -RRB- O
, , O
mouse NN B-Species
anti JJ O
- HYPH O
PSA NNP O
- HYPH O
NCAM NN O
: : O
( : O
1 CD O
: : O
500 CD O
; : O
Chemicon NNP O
) -RRB- O
, , O
mouse NN B-Species
anti NN O
- HYPH O
NeuN NNP O
( , O
1 CD O
: : O
300 CD O
; : O
Chemicon NNP O
) -RRB- O
, , O
rabbit NN B-Species
anti AFX O
- HYPH O
Calretinin NN O
( : O
1 CD O
: : O
500 CD O
; : O
Swant NNP O
) -RRB- O
; : O
mouse NNP B-Species
anti CC O
- HYPH O
Sox2 NN O
( : O
1 CD O
: SYM O
100 CD O
; : O
R NNP O
& CC O
D NNP O
systems NNS O
) -RRB- O
, , O
mouse NN B-Species
anti JJ O
- HYPH O
Mash1 NNP O
( SYM O
1 CD O
: : O
100 CD O
; : O
BD NNP O
PharMingen NNP O
) -RRB- O
, , O
rabbit NN B-Species
anti AFX O
- HYPH O
NeuroD2 NN O
( : O
1 CD O
: : O
300 CD O
; : O
ABCAM NNP O
) -RRB- O
, , O
mouse NN B-Species
anti AFX O
- HYPH O
MAP2 NN O
( : O
1 CD O
: : O
500 CD O
; : O
Sigma NNP O
) -RRB- O
, , O
rabbit NN B-Species
anti CD O
- HYPH O
Ki67 NN O
( , O
1 CD O
: : O
150 CD O
; : O
NovaCastra NNP O
) -RRB- O
and CC O
rabbit NN B-Species
anti AFX O
- HYPH O
phospho NN O
- HYPH O
Histone NN O
H3 CD O
. . O

The DT O
secondary JJ O
antibodies NNS O
( -LRB- O
1 CD O
: : O
200 CD O
) -RRB- O
Cy2 NNP O
, , O
FITC NNP O
, , O
Cy3 NNP O
and CC O
Cy5 NNP O
were VBD O
from IN O
Jackson NNP O
IR NNP O
laboratories NNS O
, , O
Alexa NNP O
- HYPH O
fluor NNP O
488 CD O
, , O
568 CD O
, , O
595 CD O
and CC O
647 CD O
from IN O
Invitrogen NNP O
- HYPH O
Molecular NNP O
Probes NNPS O
. . O

DAPI NNP O
( : O
1 CD O
: SYM O
1000 CD O
) -RRB- O
was VBD O
purchased VBN O
from IN O
Sigma NNP O
. . O

For IN O
immunocytochemistry NN O
, , O
cultures NNS O
were VBD O
fixed VBN O
in IN O
4 CD O
% NN O
paraformaldehyde NN O
at IN O
day NN O
five CD O
, , O
rinsed VBN O
with IN O
PBS NNP O
three CD O
times NNS O
prior RB O
to IN O
pre JJ O
- HYPH O
incubation NN O
with IN O
a DT O
blocking NN O
solution NN O
( : O
10 CD O
% NN O
donkey NN B-Species
serum NN O
, , O
0 CD O
. . O
25 CD O
% NN O
TritonX100 NN O
in IN O
PBS NN O
) -RRB- O
for IN O
1 CD O
hour NN O
. . O

The DT O
remainder NN O
of IN O
the DT O
procedure NN O
was VBD O
performed VBN O
as IN O
previously RB O
described VBN O
[ -LRB- O
49 CD O
] -RRB- O
. . O

Specimen NN O
analyses NNS O
were VBD O
performed VBN O
using VBG O
a DT O
Leica NNP O
confocal JJ O
microscope NN O
( , O
Leica NNP O
software NN O
, , O
equipped VBN O
with IN O
a DT O
GreNe NNP O
and CC O
a DT O
HeNe NNP O
laser NN O
, , O
using VBG O
the DT O
following VBG O
lines NNS O
of IN O
excitation NN O
: : O
488 CD O
nm NN O
, , O
594 CD O
nm CD O
and CC O
647 CD O
nm NN O
) -RRB- O
. . O

Samples NNS O
were VBD O
analyzed VBN O
using VBG O
20 CD O
x NN O
, , O
40 CD O
x SYM O
and CC O
63 CD O
x NN O
objectives NNS O
, , O
sometimes RB O
zoomed VBN O
. . O

Figures NNS O
were VBD O
composed VBN O
in IN O
CANVAS NNP O
- HYPH O
X NN O
software NN O
. . O

Bromo NNP O
- HYPH O
deoxyuridine NNP O
( , O
BrdU NNP O
) -RRB- O
and CC O
Cloro NNP O
- HYPH O
deoxyuridine NNP O
( -LRB- O
CldU NNP O
) -RRB- O
pulse NN O
labeling NN O
and CC O
immunohisto NN O
- HYPH O
and CC O
immunocyto NN O
- HYPH O
chemistry NN O

To TO O
assess VB O
cell NN O
proliferation NN O
and CC O
ongoing JJ O
neurogenesis NN O
in IN O
vivo NN O
, , O
animals NNS O
were VBD O
injected VBN O
with IN O
BrdU NNP O
( , O
100 CD O
mg NNS O
/ SYM O
kg NNS O
, , O
Sigma NNP O
) -RRB- O
, , O
two CD O
hours NNS O
prior RB O
to IN O
sacrifice NN O
( , O
for IN O
both DT O
P2 NN O
and CC O
two CD O
weeks NNS O
old JJ O
Ngn2 CD O
mice NNS B-Species
) -RRB- O
. . O

To TO O
assess VB O
neurogenesis NN O
, , O
BrdU NNP O
( , O
100 CD O
mg NNS O
/ SYM O
kg NN O
) -RRB- O
was VBD O
injected VBN O
48 CD O
hours NNS O
prior RB O
to IN O
sacrifice NN O
( , O
for IN O
P2 NN O
animals NNS O
, , O
BrdU NNP O
was VBD O
injected VBN O
in IN O
pregnant JJ O
dams NNS O
half NN O
day NN O
prior RB O
to TO O
give VB O
birth NN O
) -RRB- O
. . O

Immunohistochemistry NN O
was VBD O
carried VBN O
on IN O
as IN O
described VBN O
above IN O
using VBG O
a DT O
rat JJ B-Species
anti AFX O
- HYPH O
CldU NN O
/ SYM O
BrdU NNP O
primary JJ O
antibody NN O
( , O
1 CD O
: : O
200 CD O
, , O
monoclonal JJ O
, , O
Immunologicalsdirect NNP O
, , O
Oxfordshire NNP O
, , O
UK NNP O
) -RRB- O
, , O
with IN O
an DT O
additional JJ O
denaturation NN O
in IN O
1 CD O
M NN O
HCl NNP O
for IN O
30 CD O
minutes NNS O
prior RB O
to IN O
pre JJ O
- HYPH O
incubation NN O
with IN O
serum NN O
. . O

To TO O
assess VB O
the DT O
neuronal JJ O
- HYPH O
inducing VBG O
activity NN O
of IN O
Ngn2 NNP O
and CC O
NeuroD1 NNP O
, , O
transduced VBN O
cultures NNS O
were VBD O
incubated VBN O
with IN O
CldU NNP O
( , O
20 CD O
micro NN O
M NNP O
, , O
Sigma NNP O
) -RRB- O
for IN O
2 CD O
days NNS O
, , O
after IN O
a DT O
period NN O
of IN O
differentiation NN O
of IN O
five CD O
days NNS O
. . O

For IN O
immunocytochemistry NN O
, , O
cultures NNS O
were VBD O
fixed VBN O
with IN O
4 CD O
% NN O
paraformaldehyde NN O
at IN O
day NN O
7 CD O
, , O
rinsed VBN O
with IN O
PBS NNP O
three CD O
times NNS O
, , O
treated VBN O
with IN O
1 CD O
M NNP O
HCl NNP O
at IN O
65 CD O
degrees NNS O
C NN O
for IN O
5 CD O
- SYM O
10 CD O
min NN O
, , O
pre NN O
- HYPH O
incubated VBN O
and CC O
then RB O
incubated VBN O
with IN O
a DT O
rat NN B-Species
anti AFX O
- HYPH O
CldU NN O
/ SYM O
BrdU NNP O
antibody NN O
and CC O
other JJ O
primary JJ O
antibodies NNS O
. . O

The DT O
remainder NN O
of IN O
the DT O
procedure NN O
was VBD O
performed VBN O
according VBG O
to IN O
the DT O
protocol NN O
for IN O
immunohistochemistry NN O
already RB O
mentioned VBN O
. . O

In IN O
utero NN O
surgery NN O

Timed JJ O
pregnant JJ O
female JJ O
Sprague NNP B-Species
Dawley NNP I-Species
rats VBZ I-Species
with IN O
embryos NNS O
at IN O
gestational JJ O
age NN O
E15 CD O
. . O
5 CD O
were VBD O
anesthetized VBN O
with IN O
halothane NN O
. . O

The DT O
mother NN O
was VBD O
placed VBN O
in IN O
the DT O
lower JJR O
level NN O
of IN O
a DT O
two CD O
- HYPH O
level NN O
wooden JJ O
stage NN O
. . O

The DT O
abdomen NN O
was VBD O
shaved VBN O
with IN O
an DT O
electric JJ O
razor NN O
and CC O
then RB O
cleaned VBN O
with IN O
70 CD O
% NN O
alcohol NN O
. . O

A DT O
2 CD O
- SYM O
3 CD O
cm NN O
midline NN O
laparotomy NN O
was VBD O
performed VBN O
. . O

Each DT O
uterine NN O
horn NN O
was VBD O
carefully RB O
taken VBN O
out RP O
individually RB O
and CC O
the DT O
number NN O
of IN O
embryos NNS O
recorded VBN O
. . O

One CD O
horn NN O
was VBD O
then RB O
placed VBN O
back RB O
inside IN O
the DT O
mother NN O
, , O
whilst IN O
the DT O
other JJ O
horn NN O
was VBD O
prepared VBN O
for IN O
injection NN O
. . O

The DT O
embryos NNS O
were VBD O
kept VBN O
moist JJ O
with IN O
constant JJ O
application NN O
of IN O
warm JJ O
saline NN O
to TO O
prevent VB O
dehydration NN O
. . O

Approximately RB O
2 CD O
micro NN O
l NN O
of IN O
viral JJ O
suspension NN O
( : O
1 CD O
x SYM O
10 CD O
^ SYM O
9TU NN O
/ SYM O
ml NN O
) -RRB- O
was VBD O
injected VBN O
into IN O
the DT O
lateral JJ O
ventricle NN O
of IN O
each DT O
embryo NN O
, , O
except IN O
for IN O
the DT O
embryo NN O
closest JJS O
to IN O
the DT O
vagina NN O
. . O

After IN O
the DT O
injections NNS O
, , O
the DT O
uterine JJ O
horns NNS O
were VBD O
placed VBN O
back RB O
into IN O
the DT O
abdomen NN O
. . O

The DT O
abdominal JJ O
wall NN O
and CC O
the DT O
overlying JJ O
skin NN O
were VBD O
then RB O
sutured VBN O
. . O

Care NN O
was VBD O
taken VBN O
not RB O
to TO O
damage VB O
abdominal JJ O
muscles NNS O
so IN O
that IN O
normal JJ O
delivery NN O
of IN O
the DT O
pups NNS O
was VBD O
possible JJ O
at IN O
term NN O
. . O

The DT O
entire JJ O
surgery NN O
generally RB O
took VBD O
about RB O
45 CD O
minutes NNS O
to IN O
one CD O
hour NN O
. . O

Each DT O
mother NN O
was VBD O
allowed VBN O
to TO O
recover VB O
in IN O
her PRP$ O
cage NN O
before IN O
being VBG O
returned VBN O
to IN O
the DT O
animal NN O
stable JJ O
. . O

Shredded VBN O
paper NN O
was VBD O
added VBN O
to IN O
each DT O
cage NN O
to TO O
encourage VB O
nesting NN O
and CC O
special JJ O
care NN O
was VBD O
taken VBN O
not RB O
to TO O
stress VB O
the DT O
mothers NNS O
. . O

Following VBG O
normal JJ O
delivery NN O
, , O
the DT O
pups NNS O
were VBD O
allowed VBN O
to TO O
develop VB O
to IN O
adulthood NN O
up IN O
to TO O
two CD O
weeks NNS O
. . O

Quantification NN O

For IN O
the DT O
in IN O
vivo NN O
experiment NN O
, , O
manual JJ O
cell NN O
counting NN O
was VBD O
performed VBN O
on IN O
18 CD O
and CC O
30 CD O
micro JJ O
m NN O
thick JJ O
brain NN O
sections NNS O
for IN O
two CD O
days NNS O
and CC O
two CD O
weeks NNS O
old JJ O
animals NNS O
, , O
respectively RB O
. . O

The DT O
brain NN O
of IN O
P2 NN O
animals NNS O
was VBD O
cut VBN O
into IN O
10 CD O
series NN O
of IN O
coronal JJ O
sections NNS O
; : O
the DT O
brain NN O
of IN O
two CD O
- HYPH O
weeks NNS O
old JJ O
animals NNS O
was VBD O
cut VBN O
into IN O
7 CD O
- SYM O
8 CD O
series NN O
of IN O
coronal JJ O
sections NNS O
. . O

For IN O
each DT O
staining NN O
, , O
one CD O
- HYPH O
two CD O
series NN O
from IN O
three CD O
to IN O
five CD O
different JJ O
individuals NNS O
were VBD O
analyzed VBN O
per IN O
genotype NN O
using VBG O
a DT O
confocal JJ O
microscope NN O
with IN O
1 CD O
, , O
2 CD O
or CC O
3 CD O
lines NNS O
of IN O
excitation NN O
, , O
in IN O
sequential JJ O
scanning NN O
in IN O
order NN O
to TO O
avoid VB O
false JJ O
positives NNS O
. . O

When WRB O
two CD O
series NN O
were VBD O
analyzed VBN O
, , O
only RB O
one CD O
series NN O
was VBD O
counted VBN O
. . O

The DT O
mean JJ O
number NN O
of IN O
cells NNS O
per IN O
hippocampus NN O
expressing VBG O
the DT O
markers NNS O
of IN O
interest NN O
, , O
was VBD O
calculated VBN O
for IN O
each DT O
brain NN O
, , O
based VBN O
on IN O
the DT O
analysis NN O
of IN O
6 CD O
- SYM O
8 CD O
consecutive JJ O
dorsal JJ O
hippocampal JJ O
sections NNS O
. . O

The DT O
final JJ O
mean JJ O
number NN O
of IN O
cells NNS O
per IN O
section NN O
was VBD O
calculated VBN O
by IN O
adding VBG O
the DT O
mean JJ O
number NN O
from IN O
each DT O
individual NN O
. . O

We PRP O
expressed VBD O
the DT O
data NNS O
as IN O
the DT O
mean JJ O
number NN O
of IN O
positive JJ O
cells NNS O
+ SYM O
/ SYM O
- HYPH O
standard JJ O
error NN O
of IN O
the DT O
mean NN O
( , O
SEM NNP O
) -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
more JJR O
than IN O
25 CD O
Ngn2 CD O
null NN O
, , O
> SYM O
45 CD O
Ngn2 CD O
heterozygotes NNS O
, , O
and CC O
> SYM O
60 CD O
WT NNP O
individuals NNS O
( , O
including VBG O
rats NNS B-Species
injected VBN O
with IN O
retroviruses NNS O
) -RRB- O
were VBD O
analyzed VBN O
, , O
in IN O
total NN O
. . O

Statistical JJ O
comparison NN O
was VBD O
performed VBN O
using VBG O
one CD O
- HYPH O
factor NN O
analysis NN O
of IN O
variance NN O
( -LRB- O
ANOVA NNP O
) , O
with IN O
transcription NN O
factor NN O
, , O
cellular JJ O
marker NN O
, , O
genotype NN O
or CC O
time NN O
as IN O
variables NNS O
, , O
followed VBN O
by IN O
post NN O
- HYPH O
hoc NN O
analysis NN O
when WRB O
significant JJ O
differences NNS O
were VBD O
observed VBN O
, , O
using VBG O
Statview NNP O
5 CD O
. . O
0 CD O
software NN O
( : O
SAS NNP O
institute NN O
Inc NNP O
. . O
) -RRB- O
. . O

For IN O
cell NN O
culture NN O
experiments NNS O
, , O
three CD O
independent JJ O
experiments NNS O
were VBD O
performed VBN O
, , O
each DT O
in IN O
duplicate NN O
. . O

The DT O
counting NN O
was VBD O
based VBN O
on IN O
seven CD O
randomly RB O
chosen VBN O
different JJ O
fields NNS O
of IN O
view NN O
. . O

For IN O
each DT O
diagram NN O
, , O
the DT O
level NN O
of IN O
significance NN O
( : O
p NN O
- HYPH O
value NN O
) -RRB- O
is VBZ O
represented VBN O
as IN O
follows VBZ O
: : O
P NN O
< SYM O
0 CD O
. . O
5 CD O
= NFP O
* NFP O
; : O
P NN O
< SYM O
0 CD O
. . O
1 CD O
= NFP O
* NFP O
* NFP O
; : O
P NN O
< SYM O
0 CD O
. . O
1 CD O
= NFP O
* NFP O
* NFP O
* NFP O
. . O

All DT O
data NNS O
are VBP O
expressed VBN O
as IN O
+ SYM O
/ SYM O
- HYPH O
standard JJ O
error NN O
of IN O
the DT O
mean NN O
( -LRB- O
SEM NNP O
) -RRB- O
. . O

Human JJ B-Species
sample NN O
and CC O
RT NNP O
- HYPH O
PCR NNP O

The DT O
brain NN O
from IN O
a DT O
64 CD O
year NN O
- HYPH O
old JJ O
male NN O
was VBD O
provided VBN O
by IN O
the DT O
Harvard NNP O
Brain NNP O
Tissue NNP O
Resource NNP O
Center NNP O
. . O

The DT O
individual NN O
whose WP$ O
brain NN O
tissue NN O
was VBD O
being VBG O
analyzed VBN O
gave VBD O
written VBN O
consent NN O
for IN O
storage NN O
and CC O
use NN O
of IN O
his PRP$ O
tissue NN O
for IN O
research NN O
. . O

Five CD O
millimeters NNS O
thick JJ O
fresh JJ O
human JJ B-Species
hippocampal JJ O
tissue NN O
sample NN O
was VBD O
snap NN O
frozen JJ O
. . O

The DT O
frozen VBN O
tissue NN O
block NN O
was VBD O
cut VBN O
into IN O
20 CD O
series NN O
of IN O
coronal JJ O
sections NNS O
, , O
using VBG O
a DT O
cryostat NN O
. . O

Every DT O
10 CD O
sections NNS O
, , O
one CD O
section NN O
was VBD O
placed VBN O
in IN O
an DT O
Eppendorf NNP O
tube NN O
, , O
on IN O
dry JJ O
ice NN O
. . O

Pooled VBN O
sections NNS O
were VBD O
used VBN O
for IN O
RT NNP O
- HYPH O
PCR NNP O
. . O

Total JJ O
RNA NNP O
was VBD O
prepared VBN O
using VBG O
Trizol NNP O
and CC O
RNAeasy NNP O
, , O
supplemented VBN O
with IN O
RNAGuard NNP O
as IN O
previously RB O
described VBN O
[ -LRB- O
49 CD O
] -RRB- O
. . O

The DT O
RNA NNP O
was VBD O
digested VBN O
with IN O
shrimp NN O
DNAse NNP O
before IN O
cDNA NNP O
synthesis NN O
, , O
which WDT O
was VBD O
performed VBN O
using VBG O
a DT O
mix NN O
of IN O
oligo NN O
- HYPH O
dT NN O
and CC O
random JJ O
hexamer NN O
primers NNS O
and CC O
SuperscriptII NNP O
reverse JJ O
transcriptase NN O
. . O

Advantage2 NNP O
polymerase NN O
mix NN O
( , O
Clontech NNP O
/ SYM O
BRL NNP O
) -RRB- O
was VBD O
used VBN O
for IN O
PCR NNP O
, , O
with IN O
the DT O
following VBG O
cycling NN O
conditions NNS O
: : O
10 CD O
cycles NNS O
of IN O
94 CD O
degrees NNS O
C NN O
for IN O
30 CD O
seconds NNS O
, , O
68 CD O
degrees NNS O
C NN O
for IN O
2 CD O
minutes NNS O
, , O
30 CD O
cycles NNS O
of IN O
94 CD O
degrees NNS O
C NN O
for IN O
30 CD O
seconds NNS O
, , O
60 CD O
degrees NNS O
C NN O
for IN O
1 CD O
minute NN O
, , O
68 CD O
degrees NNS O
C NN O
for IN O
1 CD O
minute NN O
and CC O
30 CD O
seconds NNS O
, , O
one CD O
cycle NN O
of IN O
68 CD O
degrees NNS O
C NN O
for IN O
2 CD O
minutes NNS O
, , O
soak NN O
at IN O
16 CD O
degrees NNS O
C NN O
. . O

Primers NNS O
marked VBD O
* NFP O
were VBD O
designed VBN O
by IN O
PrimerBank NNP O
. . O

hRPS18 NNP O
( -LRB- O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
GCCTTTGCCATCACTGCCAT NNP O
and CC O
hRPS18 NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
GCCAGTGGTCTTGGTGTGCT NNP O
, , O
hPAX6 NNP O
( -LRB- O
sense NN O
) -RRB- O
5 CD O
' '' O
- HYPH O
GCCCTGGAGAAAGAGTTTGA NNP O
hPAX6 NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
GGGGAAATGAGTCCTGTTGA NNP O
, , O
hTBR1 NNP O
( -LRB- O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
GCGGACACCAATGTGCAAGG NNP O
and CC O
hTBR1 NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
CGAGGGGGTCAGGCGGTCCA NNP O
, , O
hTBR2 NNP O
( -LRB- O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
GACCTGTGGCAAAGCCGACA NNP O
and CC O
hTBR2 NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
GGGGGTGTCTCTATCCAAGA NNP O
, , O
hPDHX NNP O
( -LRB- O
= SYM O
PROX1 NNP O
) -RRB- O
( -LRB- O
sense NN O
) , O
5 CD O
' '' O
- : O
GGGACACTACGGTTCCGTTT NNP O
and CC O
hPDHX NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
CTCTCCATCCCAGCTTACAT NNP O
, , O
hNGN2 NNP O
( -LRB- O
sense NN O
) -RRB- O
* NFP O
5 CD O
' '' O
- : O
CATCAAGAAGACCCGTAGAC NN O
and CC O
hNGN2 NN O
( -LRB- O
antisense NN O
) -RRB- O
* NFP O
5 CD O
' '' O
- : O
CAACACTGCCTCGGAGAAG NNP O
, , O
hMASH1 NNP O
( -LRB- O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
CCTGGATCCGCATGGAAAGC NNP O
and CC O
hMASH1 NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
CCTGGATCCCCCCTCAGAAC NNP O
, , O
hNEUROD1 NNP O
( , O
sense NN O
) -RRB- O
5 CD O
' '' O
- HYPH O
GCTCAGGACCTACTAACAAC NNP O
and CC O
hNEUROD1 NNP O
( -LRB- O
antisense NNP O
) -RRB- O
5 CD O
' '' O
- : O
CAAAGCGTCTGAACGAAGGA NNP O
, , O
hGLAST NNP O
( , O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
CATCAGGGAAGATGGGAATG NNP O
and CC O
hGLAST NNP O
( -LRB- O
antisense NNP O
) -RRB- O
5 CD O
' '' O
- HYPH O
CCACGGGGGCATACCACATT NNP O
, , O
hNEST NNP O
( , O
sense NN O
) -RRB- O
5 CD O
' '' O
- HYPH O
CAGGAGCGGCTGCGGGCTAC NNP O
and CC O
hNEST NNP O
( -LRB- O
antisense NNP O
) -RRB- O
5 CD O
' '' O
- : O
CAGGGCTGAGGGGTGGTGCC NNP O
, , O
hGFAP NNP O
( , O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
CCACGAGGAGGAGGTTCGGG NNP O
and CC O
hGFAP NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
- HYPH O
GGAATGGTGATCCGGTTCTC NNP O
, , O
hCALB2 NNP O
( -LRB- O
= SYM O
Calretinin NNP O
) -RRB- O
( , O
sense NN O
) -RRB- O
5 CD O
' '' O
- HYPH O
GGCTCTGGCATGATGTCAAA NNP O
and CC O
hCALB2 NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
GGGCATCCAGCTCATGCTCG NNP O
, , O
hCALB1 NNP O
( -LRB- O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
GCGAAAGAAGGCTGGATTGG NNP O
and CC O
hCALB1 NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
CCCTCCATCCGACAAAGCCA NNP O
, , O
hSOX2 NNP O
( -LRB- O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
GGAGAACCCCAAGATGCACA NNP O
and CC O
hSOX2 NNP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
GAGGAAGAGGTAACCACAGG NNP O
, , O
hWNT3A NNP O
( -LRB- O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
CCGAGGGCATCAAGATTGGC NN O
and CC O
hWNT3A NN O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
TCGGGTTGCGACCACCAGCA NNP O
, , O
hSHH NNP O
* NFP O
( : O
sense NN O
) -RRB- O
5 CD O
' '' O
- : O
ACTCCGAGCGATTTAAGGAA NN O
and CC O
hSHH NN O
* NFP O
( -LRB- O
antisense NN O
) -RRB- O
5 CD O
' '' O
- : O
CAGACGTGGTGATGTCCACT NN O
. . O

Supporting VBG O
Information NN O

A DT O
novel JJ O
DNA NN O
- HYPH O
binding VBG O
protein NN O
modulating VBG O
methicillin NN O
resistance NN O
in IN O
Staphylococcus NNP B-Species
aureus NN I-Species

Abstract JJ O

Background NN O

Methicillin NN O
resistance NN O
in IN O
Staphylococcus NNP B-Species
aureus NN I-Species
is VBZ O
conferred VBN O
by IN O
the DT O
mecA NN O
- HYPH O
encoded VBN O
penicillin NN O
- HYPH O
binding VBG O
protein NN O
PBP2a NNP O
. . O

Additional JJ O
genomic JJ O
factors NNS O
are VBP O
also RB O
known VBN O
to TO O
influence VB O
resistance NN O
levels NNS O
in IN O
strain NN O
specific JJ O
ways NNS O
, , O
although IN O
little JJ O
is VBZ O
known VBN O
about IN O
their PRP$ O
contribution NN O
to IN O
resistance NN O
phenotypes NNS O
in IN O
clinical JJ O
isolates NNS O
. . O

Here RB O
we PRP O
searched VBD O
for IN O
novel JJ O
proteins NNS O
binding VBG O
to IN O
the DT O
mec NN O
operator NN O
, , O
in IN O
an DT O
attempt NN O
to TO O
identify VB O
new JJ O
factor NN O
( , O
s NNS O
) , O
controlling VBG O
methicillin NN O
resistance NN O
phenotypes NNS O
. . O

Results NNS O

Analysis NN O
of IN O
proteins NNS O
binding VBG O
to IN O
a DT O
DNA NNP O
fragment NN O
containing VBG O
the DT O
mec NN O
operator NN O
region NN O
identified VBD O
a DT O
novel JJ O
, , O
putative JJ O
helix NN O
- HYPH O
turn NN O
- HYPH O
helix NN O
DNA NN O
- HYPH O
binding VBG O
protein NN O
, , O
SA1665 NN O
. . O

Nonpolar JJ O
deletion NN O
of IN O
SA1665 NN O
, , O
in IN O
heterogeneously RB O
methicillin JJ O
resistant JJ O
S NNP B-Species
. . I-Species
aureus NN I-Species
( , O
MRSA NNP B-Species
) -RRB- O
of IN O
different JJ O
genetic JJ O
backgrounds NNS O
, , O
increased VBD O
methicillin NN O
resistance NN O
levels NNS O
in IN O
a DT O
strain NN O
dependent JJ O
manner NN O
. . O

This DT O
phenotype NN O
could MD O
be VB O
fully RB O
complemented VBN O
by IN O
reintroducing VBG O
SA1665 NN O
in IN O
trans NNS O
. . O

Northern JJ O
and CC O
Western JJ O
blot NN O
analyses NNS O
, , O
however RB O
, , O
revealed VBD O
that IN O
SA1665 NNP O
had VBD O
no DT O
visible JJ O
influence NN O
on IN O
mecA NN O
transcription NN O
or CC O
amounts NNS O
of IN O
PBP2a NNP O
produced VBN O
. . O

Conclusion NN O

SA1665 NN O
is VBZ O
a DT O
new JJ O
chromosomal JJ O
factor NN O
which WDT O
influences VBZ O
methicillin NN O
resistance NN O
in IN O
MRSA NNP B-Species
. . O

Although IN O
SA1665 NNP O
bound VBD O
to IN O
the DT O
mecA NN O
promoter NN O
region NN O
, , O
it PRP O
had VBD O
no DT O
apparent JJ O
influence NN O
on IN O
mecA NN O
transcription NN O
or CC O
translation NN O
, , O
suggesting VBG O
that IN O
this DT O
predicted VBN O
DNA NN O
- HYPH O
binding VBG O
protein NN O
modulates VBZ O
resistance NN O
indirectly RB O
, , O
most RBS O
likely RB O
through IN O
the DT O
control NN O
of IN O
other JJ O
genomic JJ O
factors NNS O
which WDT O
contribute VBP O
to IN O
resistance NN O
. . O

Background NN O

Methicillin NN O
resistant JJ O
S NNP B-Species
. . I-Species
aureus NN I-Species
( -LRB- O
MRSA NNP B-Species
) -RRB- O
are VBP O
an DT O
ever RB O
increasing VBG O
threat NN O
, , O
both CC O
in IN O
clinical JJ O
settings NNS O
and CC O
more RBR O
recently RB O
as IN O
an DT O
emerging VBG O
community NN O
acquired VBN O
pathogen NN O
. . O

Their PRP$ O
invasiveness NN O
and CC O
pathogenesis NN O
relies VBZ O
on IN O
a DT O
variable JJ O
arsenal NN O
of IN O
virulence NN O
factors NNS O
, , O
paired VBN O
with IN O
resistance NN O
to IN O
virtually RB O
all DT O
beta NN O
- HYPH O
lactams NNS O
and CC O
their PRP$ O
derivatives NNS O
. . O

Their PRP$ O
ability NN O
to TO O
rapidly RB O
generate VB O
resistance NN O
to IN O
other JJ O
unrelated JJ O
classes NNS O
of IN O
antibiotics NNS O
, , O
or CC O
to TO O
take VB O
up RP O
additional JJ O
resistance NN O
determinants NNS O
, , O
severely RB O
hampers VBZ O
therapy NN O
and CC O
eradication NN O
. . O

In IN O
S NNP B-Species
. . I-Species
aureus NN I-Species
, , O
methicillin NN O
resistance NN O
is VBZ O
conferred VBN O
by IN O
an DT O
acquired VBN O
, , O
beta JJ O
- HYPH O
lactam NN O
- HYPH O
insensitive JJ O
penicillin NN O
- HYPH O
binding VBG O
protein NN O
( -LRB- O
PBP NNP O
) -RRB- O
, , O
PBP2a NNP O
[ -LRB- O
1 CD O
- HYPH O
4 CD O
] -RRB- O
. . O

PBP2a NNP O
is VBZ O
encoded VBN O
by IN O
mecA NN O
, , O
which WDT O
is VBZ O
divergently RB O
transcribed VBN O
from IN O
its PRP$ O
cognate NN O
regulators NNS O
, , O
mecR1 NN O
( , O
sensor NN O
/ SYM O
signal NN O
transducer NN O
) -RRB- O
and CC O
mecI NN O
( , O
repressor NN O
) -RRB- O
. . O

If IN O
mecR1 NNP O
- HYPH O
mecI NN O
are VBP O
absent JJ O
or CC O
truncated VBN O
, , O
transcriptional JJ O
control NN O
of IN O
mecA NN O
is VBZ O
taken VBN O
over RP O
by IN O
the DT O
structurally RB O
similar JJ O
blaZ NN O
( -LRB- O
penicillinase NN O
) -RRB- O
regulatory JJ O
elements NNS O
blaR1 FW O
/ SYM O
blaI FW O
, , O
if IN O
present JJ O
. . O

In IN O
the DT O
absence NN O
of IN O
both CC O
regulatory JJ O
loci NN O
, , O
mecA NN O
is VBZ O
constitutively RB O
transcribed VBN O
[ -LRB- O
5 CD O
, , O
6 CD O
] -RRB- O
. . O

In IN O
the DT O
presence NN O
of IN O
beta NN O
- HYPH O
lactams NN O
, , O
the DT O
transmembrane NN O
sensor NN O
/ SYM O
signal NN O
transducers NNS O
BlaR1 NNP O
/ SYM O
MecR1 NNP O
, , O
undergo VBP O
a DT O
conformational JJ O
change NN O
, , O
followed VBN O
by IN O
autoproteolytic JJ O
cleavage NN O
of IN O
the DT O
n JJ O
- HYPH O
terminal JJ O
cytoplasmic JJ O
domain NN O
, , O
leading VBG O
to IN O
the DT O
activation NN O
of IN O
the DT O
cytoplasmic JJ O
peptidase NN O
and CC O
subsequent JJ O
dissociation NN O
of IN O
the DT O
repressor NN O
due IN O
to IN O
proteolytic JJ O
degradation NN O
[ -LRB- O
7 CD O
- SYM O
9 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
signal NN O
transduction NN O
cascade NN O
of IN O
this DT O
regulatory JJ O
system NN O
has VBZ O
still RB O
not RB O
been VBN O
completely RB O
elucidated VBN O
. . O

Oxacillin NN O
resistance NN O
levels NNS O
conferred VBN O
by IN O
mecA NN O
are VBP O
strain NN O
specific JJ O
and CC O
can MD O
vary VB O
greatly RB O
, , O
with IN O
oxacillin NN O
minimal JJ O
inhibitory JJ O
concentrations NNS O
( -LRB- O
MICs NNP O
) -RRB- O
of IN O
different JJ O
strains NNS O
ranging VBG O
from IN O
phenotypically RB O
susceptible JJ O
levels NNS O
, , O
as RB O
low JJ O
as IN O
1 CD O
mu NN O
g NN O
/ SYM O
ml NN O
up IN O
to IN O
extremely RB O
high JJ O
values NNS O
of IN O
> SYM O
500 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
. . O

Methicillin NN O
resistance NN O
is VBZ O
also RB O
generally RB O
expressed VBN O
heterogeneously RB O
. . O

Heterogeneously RB O
resistant JJ O
MRSA NNP B-Species
, , O
when WRB O
exposed VBN O
to IN O
beta NN O
- HYPH O
lactam NN O
antibiotics NNS O
, , O
segregate VBP O
highly RB O
resistant JJ O
subpopulations NNS O
, , O
which WDT O
are VBP O
much RB O
more RBR O
resistant JJ O
than IN O
the DT O
majority NN O
of IN O
the DT O
cells NNS O
[ -LRB- O
10 CD O
] -RRB- O
. . O

The DT O
frequency NN O
of IN O
highly RB O
resistant JJ O
subclones NNS O
generated VBN O
is VBZ O
often RB O
well RB O
above IN O
the DT O
spontaneous JJ O
mutation NN O
frequency NN O
, , O
and CC O
once RB O
selected VBN O
high JJ O
level NN O
resistance NN O
often RB O
remains VBZ O
stable JJ O
, , O
even RB O
in IN O
the DT O
absence NN O
of IN O
selective JJ O
pressure NN O
. . O

There EX O
is VBZ O
currently RB O
no DT O
satisfactory JJ O
genetic JJ O
model NN O
which WDT O
explains VBZ O
how WRB O
these DT O
higher JJR O
resistance NN O
levels NNS O
are VBP O
triggered VBN O
or CC O
selected VBN O
and CC O
exactly RB O
what WDT O
factors NNS O
are VBP O
functionally RB O
responsible JJ O
for IN O
the DT O
increased VBN O
resistance NN O
in IN O
clinical JJ O
isolates NNS O
. . O

Methicillin NN O
resistance NN O
levels NNS O
are VBP O
known VBN O
to TO O
not RB O
directly RB O
correlate VB O
with IN O
mecA NN O
transcription NN O
or CC O
levels NNS O
of IN O
PBP2a NNP O
produced VBN O
[ -LRB- O
11 CD O
, , O
12 CD O
] -RRB- O
. . O

However RB O
, , O
resistance NN O
levels NNS O
can MD O
be VB O
manipulated VBN O
by IN O
environmental JJ O
conditions NNS O
, , O
such JJ O
as IN O
temperature NN O
, , O
pH NN O
, , O
osmolarity NN O
, , O
and CC O
medium JJ O
composition NN O
[ -LRB- O
13 CD O
, , O
14 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
experimentally RB O
, , O
that IN O
in IN O
addition NN O
to IN O
mecA NN O
, , O
methicillin NN O
resistance NN O
depends VBZ O
on IN O
the DT O
correct JJ O
interplay NN O
of IN O
a DT O
multitude NN O
of IN O
genomic JJ O
factors NNS O
, , O
termed VBN O
fem NN O
/ SYM O
aux JJ O
factors NNS O
, , O
including VBG O
genes NNS O
involved VBN O
in IN O
peptidoglycan JJ O
precursor NN O
formation NN O
, , O
composition NN O
and CC O
turnover NN O
; , O
teichoic NN O
acid NN O
synthesis NN O
; : O
and CC O
genes NNS O
of IN O
unknown JJ O
or CC O
poorly RB O
characterised VBN O
functions NNS O
[ -LRB- O
15 CD O
- HYPH O
18 CD O
] -RRB- O
. . O

In IN O
addition NN O
to IN O
structural JJ O
genes NNS O
, , O
many JJ O
regulatory JJ O
loci NN O
have VBP O
also RB O
been VBN O
shown VBN O
to TO O
influence VB O
resistance NN O
levels NNS O
, , O
including VBG O
global JJ O
regulators NNS O
of IN O
virulence NN O
factor NN O
production NN O
such JJ O
as IN O
the DT O
quorum NN O
sensing VBG O
agr NN O
system NN O
, , O
the DT O
staphylococcal JJ O
accessory NN O
regulator NN O
SarA NNP O
and CC O
the DT O
alternate JJ O
sigma NN O
factor NN O
sigma NN O
B NNP O
[ -LRB- O
19 CD O
, , O
20 CD O
] -RRB- O
; : O
regulators NNS O
of IN O
metabolism NN O
, , O
such JJ O
as IN O
the DT O
catabolite NN O
control NN O
protein NN O
A NN O
( -LRB- O
CcpA NNP O
) -RRB- O
[ -LRB- O
21 CD O
] -RRB- O
; , O
and CC O
the DT O
VraSR NNP O
two CD O
- HYPH O
component NN O
sensor NN O
transducer NN O
, , O
which WDT O
induces VBZ O
the DT O
cell NN O
wall NN O
stress NN O
stimulon NN O
in IN O
response NN O
to IN O
cell NN O
wall NN O
active JJ O
antibiotic JJ O
challenge NN O
[ -LRB- O
22 CD O
] -RRB- O
. . O

The DT O
vast JJ O
MIC NNP O
differences NNS O
between IN O
MRSA NNP B-Species
strains NNS O
, , O
the DT O
population NN O
heterogeneity NN O
within IN O
single JJ O
strains NNS O
and CC O
the DT O
dependence NN O
of IN O
resistance NN O
levels NNS O
on IN O
external JJ O
factors NNS O
are VBP O
reflected VBN O
in IN O
these DT O
many JJ O
structural JJ O
genes NNS O
and CC O
global JJ O
regulators NNS O
, , O
which WDT O
can MD O
influence VB O
resistance NN O
levels NNS O
. . O

While IN O
typically RB O
considered VBN O
nosocomial JJ O
pathogens NNS O
, , O
new JJ O
faster RBR O
growing NN O
and CC O
apparently RB O
more RBR O
virulent JJ O
MRSA NNP B-Species
have VBP O
begun VBN O
spreading VBG O
in IN O
the DT O
community NN O
. . O

Interestingly RB O
, , O
these DT O
emerging VBG O
strains NNS O
often RB O
express VBP O
very RB O
low JJ O
methicillin NN O
resistance NN O
, , O
e UH O
. . O
g LS O
. . O
the DT O
MRSA NNP B-Species
clone NN O
spreading VBG O
amongst IN O
intravenous JJ O
drug NN O
users NNS O
in IN O
the DT O
Zurich NNP O
area NN O
, , O
which WDT O
has VBZ O
an DT O
in FW O
vitro FW O
doubling NN O
time NN O
of IN O
25 CD O
min NN O
, , O
but CC O
oxacillin NN O
MICs NNS O
of IN O
only RB O
0 CD O
. . O
5 CD O
to TO O
4 CD O
mu NN O
g NN O
/ SYM O
ml NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

This DT O
particular JJ O
clone NN O
' '' O
s POS O
low JJ O
- HYPH O
level NN O
resistance NN O
is VBZ O
partially RB O
due JJ O
to IN O
a DT O
promoter NN O
mutation NN O
, , O
leading VBG O
to IN O
tight JJ O
repression NN O
of IN O
mecA NN O
, , O
but CC O
resistance NN O
levels NNS O
appear VBP O
to TO O
be VB O
mainly RB O
restricted VBN O
by IN O
unknown JJ O
factors NNS O
within IN O
its PRP$ O
genomic JJ O
background NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

To TO O
identify VB O
potential JJ O
factors NNS O
involved VBN O
in IN O
mecA NN O
regulation NN O
or CC O
methicillin NN O
resistance NN O
levels NNS O
in IN O
such PDT O
an DT O
extremely RB O
low JJ O
level NN O
resistant JJ O
MRSA NNP B-Species
, , O
we PRP O
performed VBD O
DNA NN O
- HYPH O
binding VBG O
protein NN O
purification NN O
assays NNS O
, , O
using VBG O
the DT O
mecA NN O
operator NN O
region NN O
as IN O
bait NN O
. . O

A DT O
novel JJ O
, , O
uncharacterized JJ O
protein NN O
, , O
SA1665 NNP O
, , O
was VBD O
found VBN O
to TO O
bind VB O
to IN O
this DT O
DNA NN O
fragment NN O
, , O
and CC O
shown VBN O
to TO O
increase VB O
methicillin NN O
resistance NN O
levels NNS O
when WRB O
deleted VBN O
. . O

Results NNS O

Identification NN O
of IN O
SA1665 NN O

MRSA NNP B-Species
strain NN O
CHE482 NNP O
is VBZ O
the DT O
type NN O
strain NN O
for IN O
the DT O
so RB O
- HYPH O
called VBN O
"""" `` O
drug NN O
clone NN O
"""" '' O
spreading VBG O
amongst IN O
intravenous JJ O
drug NN O
users NNS O
in IN O
the DT O
Zurich NNP O
area NN O
[ -LRB- O
12 CD O
, , O
23 CD O
] -RRB- O
. . O

This DT O
strain NN O
carries VBZ O
mecA NN O
and CC O
expresses VBZ O
PBP2a NNP O
, , O
but CC O
appears VBZ O
phenotypically RB O
methicillin JJ O
susceptible JJ O
by IN O
conventional JJ O
phenotypic JJ O
tests NNS O
. . O

However RB O
, , O
like IN O
most JJS O
other JJ O
low JJ O
- HYPH O
level NN O
resistant JJ O
MRSA NNP B-Species
, , O
it PRP O
can MD O
segregate VB O
a DT O
small JJ O
proportion NN O
of IN O
higher JJR O
resistant JJ O
subclones NNS O
in IN O
the DT O
presence NN O
of IN O
beta NN O
- HYPH O
lactams NNS O
. . O

We PRP O
hypothesized VBD O
that IN O
regulation NN O
of IN O
methicillin NN O
resistance NN O
in IN O
such JJ O
low JJ O
- HYPH O
level NN O
resistant JJ O
clonal JJ O
lineages NNS O
may MD O
differ VB O
qualitatively RB O
from IN O
classical JJ O
heterogeneously RB O
- HYPH O
or CC O
highly RB O
- HYPH O
resistant JJ O
MRSA NNP B-Species
. . O

A DT O
DNA NN O
- HYPH O
binding VBG O
protein NN O
purification NN O
assay NN O
was VBD O
performed VBN O
to TO O
identify VB O
new JJ O
potential JJ O
factors NNS O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
mecA NNP O
/ SYM O
PBP2a NNP O
. . O

The DT O
mecA NNP O
/ SYM O
mecR1 NN O
intergenic JJ O
DNA NN O
region NN O
, , O
including VBG O
the DT O
5 CD O
' '' O
9 CD O
bp NN O
of IN O
mecR1 NN O
and CC O
the DT O
first JJ O
52 CD O
bp NN O
of IN O
mecA NN O
, , O
was VBD O
used VBN O
as IN O
bait NN O
against IN O
crude JJ O
protein NN O
extract NN O
from IN O
strain NN O
CHE482 NN O
. . O

Proteins NNS O
binding VBG O
to IN O
this DT O
DNA NNP O
fragment NN O
were VBD O
analysed VBN O
by IN O
SDS NNP O
- HYPH O
PAGE NNP O
. . O

Even RB O
though IN O
CHE482 NNP O
contained VBD O
BlaI NNP O
, , O
which WDT O
is VBZ O
known VBN O
to TO O
bind VB O
to IN O
the DT O
mec NN O
operator NN O
, , O
this DT O
band NN O
could MD O
not RB O
be VB O
identified VBN O
on IN O
gels NNS O
due IN O
to IN O
co NN O
- HYPH O
migrating VBG O
, , O
non CC O
- HYPH O
specific JJ O
bands NNS O
the DT O
same JJ O
size NN O
as IN O
BlaI NNP O
( , O
14 CD O
. . O
9 CD O
KDa NN O
) -RRB- O
that WDT O
bound VBD O
to IN O
both CC O
the DT O
DNA NN O
- HYPH O
coated VBN O
and CC O
uncoated JJ O
control NN O
beads NNS O
. . O

The DT O
most RBS O
prominent JJ O
protein NN O
band NN O
of IN O
~ $ O
16 CD O
- SYM O
20 CD O
kDa NN O
, , O
isolated VBN O
from IN O
DNA NN O
- , O
labelled VBN O
but CC O
not RB O
from IN O
control NN O
beads NNS O
, , O
was VBD O
identified VBN O
as IN O
the DT O
hypothetical JJ O
protein NN O
SA1665 NN O
( -LRB- O
N315 CD O
genome NN O
annotation NN O
[ -LRB- O
BA000018 NN O
] -RRB- O
) -RRB- O
( -LRB- O
Figure NN O
1A CD O
) -RRB- O
. . O

SA1665 NN O
encodes VBZ O
a DT O
predicted VBN O
17 CD O
- HYPH O
kDa NN O
protein NN O
with IN O
an DT O
n AFX O
- HYPH O
terminal JJ O
helix NN O
- HYPH O
turn NN O
- HYPH O
helix NN O
( -LRB- O
HTH NN O
) -RRB- O
motif NN O
characteristic JJ O
of IN O
DNA NN O
- HYPH O
binding VBG O
transcriptional JJ O
regulators NNS O
. . O

The DT O
amino JJ O
acid NN O
sequence NN O
of IN O
SA1665 NN O
showed VBD O
100 CD O
% NN O
identity NN O
amongst IN O
S NN B-Species
. . I-Species
aureus NN I-Species
database NN O
sequences NNS O
and CC O
97 CD O
- SYM O
98 CD O
% NN O
identity NN O
amongst IN O
other JJ O
staphylococci NN O
, , O
including VBG O
S NN B-Species
. . I-Species
haemolyticus NN I-Species
, , O
S NN B-Species
. . I-Species
epidermidis NN I-Species
and CC O
S NN B-Species
. . I-Species
saprophyticus NN I-Species
, , O
indicating VBG O
that IN O
SA1665 NN O
is VBZ O
highly RB O
conserved JJ O
. . O

Conversely RB O
, , O
there EX O
were VBD O
no DT O
orfs NNS O
highly RB O
similar JJ O
to IN O
SA1665 NNP O
found VBN O
in IN O
other JJ O
bacterial JJ O
species NNS O
, , O
with IN O
the DT O
most RBS O
similar JJ O
sequences NNS O
found VBN O
in IN O
Bacillus NNP B-Species
licheniformis NN I-Species
DSM13 NN O
and CC O
Desulfitobacterium NN B-Species
hafniense NN I-Species
Y51 CD I-Species
, , O
which WDT O
shared VBD O
only RB O
64 CD O
% NN O
and CC O
59 CD O
% NN O
similarity NN O
, , O
respectively RB O
. . O

Electro NN O
mobility NN O
shift NN O
assays NNS O
( -LRB- O
EMSA NNP O
) -RRB- O

EMSA NNP O
was VBD O
used VBN O
to TO O
confirm VB O
binding NN O
of IN O
SA1665 NNP O
to IN O
the DT O
mec NN O
operator NN O
region NN O
. . O

Crude JJ O
protein NN O
extracts NNS O
of IN O
E NNP B-Species
. . I-Species
coli NN I-Species
strain NN I-Species
BL21 NNP I-Species
, , O
carrying VBG O
the DT O
empty JJ O
plasmid NN O
( -LRB- O
pET28nHis6 NN O
) -RRB- O
or CC O
pME20 NN O
( -LRB- O
pET28nHis6 NN O
- HYPH O
SA1665 NN O
) -RRB- O
which WDT O
expressed VBD O
nHis6 NN O
- HYPH O
SA1665 NN O
upon IN O
induction NN O
with IN O
IPTG NNP O
, , O
were VBD O
incubated VBN O
with IN O
the DT O
161 CD O
- HYPH O
bp NN O
biotinylated JJ O
- HYPH O
DNA NN O
fragment NN O
previously RB O
used VBN O
as IN O
bait NN O
in IN O
the DT O
DNA NN O
- HYPH O
binding VBG O
protein NN O
assay NN O
. . O

A DT O
band NN O
shift NN O
was VBD O
observed VBN O
with IN O
extracts NNS O
from IN O
the DT O
strain NN O
expressing VBG O
recombinant JJ O
nHis6 NN O
- HYPH O
SA1665 NNP O
but CC O
not RB O
from IN O
the DT O
control NN O
strain NN O
carrying VBG O
the DT O
empty JJ O
plasmid NN O
. . O

Several JJ O
bands NNS O
resulted VBD O
from IN O
the DT O
shift NN O
, , O
which WDT O
is VBZ O
most RBS O
likely JJ O
due IN O
to IN O
protein NN O
oligomerisation NN O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

The DT O
specificity NN O
of IN O
the DT O
gel NN O
shift NN O
was VBD O
also RB O
demonstrated VBN O
by IN O
the DT O
addition NN O
of IN O
increasing VBG O
concentrations NNS O
of IN O
purified JJ O
nHis6 NNP O
- HYPH O
SA1665 NNP O
protein NN O
to IN O
the DT O
biotinylated JJ O
- HYPH O
DNA NN O
fragment NN O
( -LRB- O
Figure NNP O
2B NN O
) -RRB- O
. . O

Band NNP O
- HYPH O
shift NN O
of IN O
the DT O
biotinylated JJ O
DNA NNP O
was VBD O
inhibited VBN O
in IN O
the DT O
presence NN O
of IN O
specific JJ O
competitor NN O
DNA NN O
but CC O
not RB O
by IN O
the DT O
presence NN O
of IN O
the DT O
non AFX O
- HYPH O
specific JJ O
competitor NN O
DNA NN O
, , O
confirming VBG O
that IN O
nHis6 NNP O
- HYPH O
SA1665 NNP O
had VBD O
a DT O
specific JJ O
binding VBG O
affinity NN O
for IN O
the DT O
161 CD O
- HYPH O
bp NN O
DNA NN O
fragment NN O
. . O

Effect NN O
of IN O
SA1665 NN O
deletion NN O
on IN O
beta JJ O
- HYPH O
lactam NN O
resistance NN O

To TO O
analyse VB O
the DT O
effect NN O
of IN O
SA1665 NN O
inactivation NN O
on IN O
methicillin NN O
resistance NN O
, , O
nonpolar JJ O
markerless JJ O
deletions NNS O
of IN O
SA1665 NN O
( -LRB- O
Figure NNP O
1B NNP O
) -RRB- O
were VBD O
constructed VBN O
in IN O
a DT O
selection NN O
of IN O
clinical JJ O
MRSA NNP B-Species
isolates NNS O
, , O
which WDT O
varied VBD O
in IN O
their PRP$ O
genetic JJ O
background NN O
, , O
SCCmec NNP O
type NN O
, , O
and CC O
mecA NN O
regulation NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Strain NN O
CHE482 NNP O
, , O
belongs VBZ O
to IN O
clonal JJ O
complex JJ O
CC45 NN O
and CC O
sequence NN O
type NN O
ST45 NN O
, , O
and CC O
contains VBZ O
a DT O
novel JJ O
SCCmec NNP O
( -LRB- O
SCCmecN1 NNP O
[ -LRB- O
23 CD O
] -RRB- O
) -RRB- O
; , O
while IN O
strains NNS O
ZH37 NNP O
( -LRB- O
CC45 NN O
/ SYM O
ST45 CD O
) -RRB- O
and CC O
ZH73 NN O
( -LRB- O
CC22 NN O
/ SYM O
ST22 CD O
) -RRB- O
contain VBP O
type NN O
IV NN O
SCCmecs NNS O
. . O

All DT O
three CD O
of IN O
these DT O
strains NNS O
have VBP O
truncated VBN O
mecI NN O
/ SYM O
mecR1 NN O
regulatory JJ O
loci NN O
but CC O
intact JJ O
BlaI NNP O
/ SYM O
BlaR1 NNP O
loci NN O
controlling VBG O
mecA NN O
expression NN O
. . O

Strain NN O
ZH44 NNP O
( -LRB- O
CCT8 NN O
/ SYM O
ST8 CD O
) -RRB- O
contained VBD O
a DT O
type NN O
A NN O
mec NN O
complex NN O
( , O
mecI NN O
- HYPH O
mecR1 NN O
- HYPH O
mecA NN O
) -RRB- O
within IN O
a DT O
type NN O
II NNP O
SCCmec NNP O
, , O
and CC O
had VBD O
no DT O
beta JJ O
- HYPH O
lactamase NN O
locus NN O
; : O
so CC O
mecA NN O
was VBD O
only RB O
under IN O
the DT O
control NN O
of IN O
its PRP$ O
cognate JJ O
regulators NNS O
MecI NNP O
/ SYM O
MecR1 NNP O
. . O

Deletion NN O
of IN O
SA1665 NN O
increased VBD O
oxacillin NN O
resistance NN O
in IN O
all DT O
mutants NNS O
compared VBN O
to IN O
their PRP$ O
corresponding VBG O
parent NN O
strains NNS O
, , O
as IN O
demonstrated VBN O
on IN O
oxacillin NN O
gradient NN O
plates NNS O
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
; , O
with IN O
mutants NNS O
Delta NNP O
CHE482 NNP O
and CC O
Delta NNP O
ZH37 NNP O
approximately RB O
doubling VBG O
in IN O
resistance NN O
and CC O
Delta NNP O
ZH44 NNP O
and CC O
Delta NNP O
ZH73 NNP O
expressing VBG O
considerably RB O
higher JJR O
resistance NN O
. . O

Population NN O
analysis NN O
resistance NN O
profiles NNS O
of IN O
the DT O
mutants NNS O
showed VBD O
a DT O
distinct JJ O
shift NN O
at IN O
the DT O
top NN O
of IN O
the DT O
curve NN O
, , O
indicating VBG O
that IN O
the DT O
higher JJR O
resistance NN O
was VBD O
due JJ O
to IN O
increased VBN O
basal JJ O
oxacillin NN O
resistance NN O
levels NNS O
( -LRB- O
Figure NNP O
3B NNP O
) -RRB- O
. . O

Strains NNP O
CHE482 NNP O
/ SYM O
Delta NNP O
CHE482 NNP O
and CC O
ZH37 NNP O
/ SYM O
Delta NNP O
ZH37 NNP O
had VBD O
very RB O
similar JJ O
resistance NN O
profiles NNS O
, , O
despite IN O
having VBG O
different JJ O
SCCmec NNP O
elements NNS O
, , O
suggesting VBG O
that IN O
it PRP O
was VBD O
their PRP$ O
common JJ O
clonal JJ O
background NN O
( , O
CC45 NNP O
) -RRB- O
that WDT O
determined VBD O
their PRP$ O
resistance NN O
levels NNS O
and CC O
the DT O
extent NN O
of IN O
resistance NN O
increase NN O
upon IN O
SA1665 NNP O
deletion NN O
. . O

Growth NN O
curve NN O
analyses NNS O
showed VBD O
that IN O
deletion NN O
of IN O
SA1665 NNP O
slightly RB O
reduced VBD O
the DT O
growth NN O
rate NN O
of IN O
all DT O
strains NNS O
tested VBN O
( -LRB- O
Figure NNP O
3C NNP O
) -RRB- O
. . O

Wild JJ O
type NN O
growth NN O
rates NNS O
were VBD O
restored VBN O
upon IN O
complementation NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Resistance NN O
complementation NN O

Plasmids NNP O
pME26 NNP O
and CC O
pME27 CD O
were VBD O
constructed VBN O
for IN O
complementation NN O
of IN O
the DT O
deletion NN O
mutants NNS O
. . O

Both DT O
plasmids NNS O
contained VBD O
the DT O
SA1665 NNP O
orf NN O
along IN O
with IN O
its PRP$ O
own JJ O
promoter NN O
and CC O
transcriptional JJ O
terminator NN O
. . O

Strains NNS O
Delta NNP O
CHE482 NNP O
, , O
Delta NNP O
ZH37 NNP O
, , O
and CC O
Delta NNP O
ZH73 NNP O
were VBD O
complemented VBN O
with IN O
pME26 NN O
, , O
and CC O
intrinsically RB O
kanamycin NN O
resistant JJ O
strain NN O
Delta NNP O
ZH44 NNP O
was VBD O
complemented VBN O
with IN O
pME27 NN O
. . O

Wild JJ O
type NN O
- HYPH O
like JJ O
resistance NN O
levels NNS O
were VBD O
restored VBN O
in IN O
all DT O
mutants NNS O
by IN O
introduction NN O
of IN O
the DT O
complementing VBG O
plasmids NNS O
, , O
as IN O
shown VBN O
by IN O
gradient NN O
plates NNS O
( -LRB- O
Figure NNP O
3A NNP O
) -RRB- O
. . O

Transcriptional JJ O
analyses NNS O

Primer NN O
extension NN O
, , O
using VBG O
the DT O
5 CD O
' '' O
- HYPH O
biotinylated JJ O
primer NN O
me97 CD O
, , O
identified VBD O
two CD O
potential JJ O
SA1665 CD O
transcriptional JJ O
start NN O
sites NNS O
( , O
TSS NNP O
) -RRB- O
, , O
76 CD O
- HYPH O
nt CD O
and CC O
139 CD O
- : O
nt IN O
upstream NN O
of IN O
the DT O
SA1665 NNP O
ATG NNP O
start NN O
codon NN O
( -LRB- O
Figure NNP O
4A NNP O
) -RRB- O
. . O

Predicted VBN O
sigma NN O
A DT O
promoter NN O
consensus NN O
- HYPH O
10 CD O
/ SYM O
- HYPH O
35 CD O
box NN O
sequences NNS O
were VBD O
located VBN O
upstream RB O
of IN O
both DT O
TSS NNP O
( -LRB- O
Figure NNP O
4B NNP O
) -RRB- O
. . O

Identical JJ O
TSS NNP O
were VBD O
also RB O
identified VBN O
using VBG O
the DT O
downstream JJ O
primer NN O
me98 CD O
( , O
data NNS O
not RB O
shown VBN O
) : O
. . O

Northern JJ O
blot NN O
analysis NN O
was VBD O
used VBN O
to TO O
investigate VB O
SA1665 NN O
expression NN O
and CC O
the DT O
influence NN O
of IN O
SA1665 NN O
deletion NN O
on IN O
mecA NN O
and CC O
mecR1 NN O
transcription NN O
. . O

RNA NNP O
samples NNS O
taken VBN O
from IN O
different JJ O
time NN O
points NNS O
over IN O
the DT O
growth NN O
curve NN O
of IN O
CHE482 NNP O
showed VBD O
that IN O
SA1665 NN O
was VBD O
expressed VBN O
strongly RB O
in IN O
early JJ O
exponential JJ O
phase NN O
at IN O
OD600 NN O
nm ADD O
0 CD O
. . O
25 CD O
and CC O
0 CD O
. . O
5 CD O
, , O
then RB O
transcript NN O
levels NNS O
decreased VBD O
and CC O
were VBD O
almost RB O
undetectable JJ O
in IN O
early JJ O
stationary JJ O
phase NN O
at IN O
OD600 NN O
nm ADD O
4 CD O
. . O
0 CD O
( -LRB- O
Figure NN O
5A NN O
) -RRB- O
. . O

In IN O
addition NN O
to IN O
the DT O
main JJ O
transcript NN O
of IN O
~ $ O
0 CD O
. . O
46 CD O
kb NN O
, , O
a DT O
weaker JJR O
, , O
larger JJR O
transcript NN O
of IN O
~ $ O
0 CD O
. . O
6 CD O
kb NN O
was VBD O
also RB O
visible JJ O
, , O
especially RB O
at IN O
later JJ O
growth NN O
stages NNS O
. . O

Figure NN O
5B NN O
shows VBZ O
the DT O
transcriptional JJ O
behaviour NN O
of IN O
SA1665 NNP O
when WRB O
CHE482 NNP O
cells NNS O
were VBD O
challenged VBN O
with IN O
sub NN O
- HYPH O
inhibitory NN O
( , O
4 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
and CC O
inhibitory JJ O
( , O
120 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
concentrations NNS O
of IN O
cefoxitin NN O
. . O

These DT O
results NNS O
showed VBD O
that IN O
low JJ O
levels NNS O
of IN O
cefoxitin NN O
, , O
such JJ O
as IN O
those DT O
used VBN O
to TO O
induce VB O
mecA NN O
/ SYM O
mecR1 NN O
transcription NN O
, , O
appeared VBD O
to TO O
slightly RB O
decrease VB O
SA1665 NN O
transcription NN O
after IN O
30 CD O
min NN O
exposure NN O
, , O
while IN O
larger JJR O
, , O
inhibitory JJ O
concentrations NNS O
caused VBD O
even RB O
more RBR O
significant JJ O
alterations NNS O
in IN O
the DT O
SA1665 NNP O
transcriptional JJ O
profile NN O
, , O
making VBG O
it PRP O
similar JJ O
to IN O
that DT O
normally RB O
seen VBN O
in IN O
stationary JJ O
phase NN O
growth NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
transcription NN O
of IN O
SA1665 NN O
may MD O
respond VB O
in IN O
some DT O
way NN O
to IN O
cell NN O
wall NN O
stress NN O
, , O
rather RB O
than IN O
in IN O
direct JJ O
response NN O
to IN O
the DT O
presence NN O
of IN O
beta NN O
- HYPH O
lactams NNS O
. . O

This DT O
observation NN O
is VBZ O
based VBN O
on IN O
relatively RB O
subtle JJ O
changes NNS O
in IN O
SA1665 NN O
transcription NN O
, , O
especially RB O
at IN O
low JJ O
concentrations NNS O
of IN O
cefoxitin NN O
such JJ O
as IN O
those DT O
required VBN O
for IN O
mecA NN O
/ SYM O
mecR1 NN O
induction NN O
. . O

Since IN O
deletion NN O
of IN O
SA1665 NN O
has VBZ O
been VBN O
shown VBN O
to TO O
increase VB O
beta JJ O
- HYPH O
lactam NN O
resistance NN O
, , O
reduced VBN O
SA1665 NN O
transcription NN O
in IN O
the DT O
presence NN O
of IN O
beta NN O
- HYPH O
lactams NNS O
may MD O
also RB O
provide VB O
some DT O
protection NN O
against IN O
beta NN O
- HYPH O
lactam NN O
exposure NN O
. . O

Northerns NNP O
also RB O
showed VBD O
that IN O
, , O
as IN O
expected VBN O
, , O
the DT O
SA1665 NNP O
transcripts NNS O
were VBD O
absent JJ O
from IN O
the DT O
deletion NN O
mutant NN O
( , O
Figure NNP O
5C NNP O
) -RRB- O
, , O
and CC O
additional JJ O
experiments NNS O
demonstrated VBD O
that IN O
wild JJ O
type NN O
SA1665 NN O
transcription NN O
patterns NNS O
were VBD O
restored VBN O
by IN O
complementation NN O
of IN O
Delta NNP O
CHE482 NNP O
with IN O
pME26 NN O
( : O
data NNS O
not RB O
shown VBN O
) : O
. . O

The DT O
effects NNS O
of IN O
SA1665 NN O
deletion NN O
on IN O
directly RB O
up RB O
- HYPH O
and CC O
down RB O
- HYPH O
stream NN O
genes NNS O
were VBD O
also RB O
investigated VBN O
. . O

Northern JJ O
blots NNS O
of IN O
the DT O
neighbouring NN O
genes NNS O
SA1664 NN O
, , O
SA1666 NNP O
and CC O
SA1667 NNP O
, , O
showed VBD O
that IN O
expression NN O
of IN O
all DT O
three CD O
genes NNS O
was VBD O
very RB O
weak JJ O
compared VBN O
to IN O
that DT O
of IN O
SA1665 NN O
. . O

A DT O
weak JJ O
transcript NN O
of IN O
about RB O
3 CD O
kb NN O
was VBD O
present JJ O
in IN O
hybridizations NNS O
probed VBN O
with IN O
orfs NNS O
SA1665 CD O
- HYPH O
SA1667 NN O
. . O

This DT O
band NN O
decreased VBD O
in IN O
size NN O
in IN O
the DT O
SA1665 NNP O
mutant NN O
when WRB O
probed VBN O
with IN O
SA1666 NN O
and CC O
SA1667 NN O
. . O

One CD O
of IN O
the DT O
transcripts NNS O
hybridising VBG O
to IN O
the DT O
SA1664 NNP O
probe NN O
also RB O
decreased VBD O
in IN O
size NN O
by IN O
~ $ O
0 CD O
. . O
5 CD O
kb NN O
in IN O
the DT O
SA1665 NNP O
mutant NN O
, , O
suggesting VBG O
that IN O
SA1665 NNP O
was VBD O
present JJ O
on IN O
several JJ O
transcripts NNS O
of IN O
different JJ O
lengths NNS O
, , O
including VBG O
a DT O
high JJ O
abundance NN O
monocistronic JJ O
transcript NN O
and CC O
low JJ O
abundance NN O
polycistronic JJ O
transcripts NNS O
( -LRB- O
Figure NNP O
5C NNP O
) -RRB- O
. . O

Transcript NN O
abundance NN O
of IN O
both CC O
the DT O
upstream JJ O
SA1666 NNP O
- HYPH O
SA1667 NNP O
operon NN O
and CC O
the DT O
downstream JJ O
SA1664 NN O
- HYPH O
specific JJ O
transcript NN O
all DT O
appeared VBD O
to TO O
increase VB O
slightly RB O
in IN O
Delta NNP O
CHE482 NNP O
. . O

The DT O
significance NN O
of IN O
these DT O
subtle JJ O
increases NNS O
in IN O
transcription NN O
are VBP O
unknown JJ O
, , O
however RB O
, , O
polar JJ O
effects NNS O
from IN O
SA1665 NN O
deletion NN O
seem VBP O
unlikely JJ O
, , O
based VBN O
on IN O
the DT O
facts NNS O
that IN O
all DT O
genes NNS O
were VBD O
still RB O
transcribed VBN O
, , O
their PRP$ O
transcription NN O
levels NNS O
all DT O
remained VBD O
extremely RB O
low JJ O
and CC O
the DT O
transcriptional JJ O
terminator NN O
of IN O
SA1665 NNP O
remained VBD O
intact JJ O
in IN O
the DT O
deletion NN O
mutant NN O
( -LRB- O
Figure NN O
1B NN O
) -RRB- O
. . O

Expression NN O
of IN O
mecR1 NN O
and CC O
mecA NN O
were VBD O
analysed VBN O
from IN O
RNA NNP O
of IN O
uninduced JJ O
and CC O
induced VBN O
cultures NNS O
of IN O
CHE482 NNP O
and CC O
Delta NNP O
CHE482 NNP O
. . O

Cells NNS O
were VBD O
induced VBN O
at IN O
OD600 NN O
nm ADD O
0 CD O
. . O
25 CD O
( SYM O
Figure NNP O
5D CD O
) -RRB- O
and CC O
1 CD O
. . O
0 CD O
( , O
data NNS O
not RB O
shown VBN O
) , O
with IN O
sub NN O
- HYPH O
inhibitory JJ O
concentrations NNS O
of IN O
cefoxitin NN O
, , O
to TO O
relieve VB O
BlaI NNP O
- HYPH O
repression NN O
of IN O
mecA NN O
. . O

mecR1 NNP O
, , O
although IN O
truncated VBN O
in IN O
CHE482 NNP O
, , O
was VBD O
still RB O
transcribed VBN O
and CC O
had VBD O
the DT O
same JJ O
expression NN O
pattern NN O
as IN O
mecA NN O
, , O
as IN O
both DT O
became VBD O
derepressed JJ O
over IN O
time NN O
and CC O
had VBD O
the DT O
highest JJS O
transcript NN O
levels NNS O
after IN O
30 CD O
min NN O
of IN O
induction NN O
. . O

In IN O
the DT O
mutant JJ O
Delta NNP O
CHE482 NNP O
, , O
transcripts NNS O
of IN O
both DT O
mecA NN O
and CC O
mecR1 NN O
' '' O
were VBD O
unaffected JJ O
by IN O
SA1665 NNP O
deletion NN O
, , O
indicating VBG O
that IN O
SA1665 NNP O
had VBD O
no DT O
influence NN O
on IN O
their PRP$ O
expression NN O
at IN O
either CC O
OD NN O
0 CD O
. . O
25 CD O
( SYM O
Figure NNP O
5D CD O
) , O
or CC O
OD NN O
1 CD O
. . O
0 CD O
( HYPH O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

SA1665 NN O
deletion NN O
also RB O
had VBD O
no DT O
effect NN O
on IN O
mecA NN O
transcription NN O
or CC O
induction NN O
in IN O
strains NNS O
ZH37 NN O
, , O
ZH44 NN O
and CC O
ZH73 NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Western JJ O
blot NN O
analysis NN O

Mutants NNS O
of IN O
CHE482 NN O
and CC O
of IN O
ZH44 NN O
and CC O
ZH73 NN O
, , O
which WDT O
had VBD O
the DT O
largest JJS O
differences NNS O
in IN O
oxacillin NN O
resistance NN O
levels NNS O
, , O
were VBD O
analysed VBN O
by IN O
Western JJ O
blot NN O
analysis NN O
to TO O
determine VB O
if IN O
SA1665 NNP O
affected VBD O
production NN O
of IN O
PBP2a NNP O
from IN O
mecA NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
5E CD O
, , O
all DT O
pairs NNS O
of IN O
wild JJ O
type NN O
and CC O
mutant JJ O
strains NNS O
had VBD O
similar JJ O
amounts NNS O
of IN O
PBP2a NNP O
present JJ O
both CC O
before IN O
and CC O
after IN O
induction NN O
with IN O
cefoxitin NN O
, , O
indicating VBG O
that IN O
SA1665 NNP O
deletion NN O
did VBD O
not RB O
alter VB O
amounts NNS O
of IN O
PBP2a NNP O
produced VBN O
. . O

Therefore RB O
it PRP O
seems VBZ O
that IN O
SA1665 NN O
exerts VBZ O
no DT O
direct JJ O
control NN O
over IN O
mecA NN O
or CC O
PBP2a NNP O
expression NN O
. . O

Discussion NN O

Methicillin NN O
resistance NN O
in IN O
MRSA NNP B-Species
is VBZ O
primarily RB O
dependent JJ O
on IN O
the DT O
presence NN O
of IN O
the DT O
mecA NN O
gene NN O
, , O
however RB O
, , O
resistance NN O
levels NNS O
are VBP O
generally RB O
governed VBN O
by IN O
strain NN O
- HYPH O
specific JJ O
factors NNS O
including VBG O
mecA NN O
regulatory JJ O
elements NNS O
and CC O
other JJ O
chromosomal JJ O
fem NN O
/ SYM O
aux JJ O
factors NNS O
which WDT O
either CC O
enhance VBP O
or CC O
repress VBP O
the DT O
expression NN O
of IN O
resistance NN O
. . O

For IN O
instance NN O
, , O
the DT O
very RB O
low JJ O
- HYPH O
level NN O
methicillin NN O
resistance NN O
of IN O
the DT O
Zurich NNP O
drug NN O
clone NN O
CHE482 NNP O
, , O
was VBD O
shown VBN O
to TO O
be VB O
controlled VBN O
by IN O
its PRP$ O
genetic JJ O
background NN O
[ -LRB- O
12 CD O
] -RRB- O
suggesting VBG O
that IN O
it PRP O
either CC O
contained VBD O
or CC O
lacked VBD O
certain JJ O
fem NN O
/ SYM O
aux JJ O
factors NNS O
involved VBN O
in IN O
controlling VBG O
resistance NN O
expression NN O
. . O

Many JJ O
of IN O
the DT O
currently RB O
known VBN O
fem NN O
/ SYM O
aux JJ O
factors NNS O
are VBP O
directly RB O
or CC O
indirectly RB O
involved VBN O
in IN O
cell NN O
wall NN O
synthesis NN O
and CC O
turnover NN O
, , O
or CC O
envelope NN O
biogenesis NN O
, , O
however RB O
there EX O
still RB O
remain VBP O
factors NNS O
of IN O
unknown JJ O
function NN O
. . O

Most JJS O
of IN O
the DT O
currently RB O
known VBN O
fem NN O
/ SYM O
aux JJ O
factors NNS O
reduce VBP O
methicillin NN O
resistance NN O
levels NNS O
when WRB O
inactivated VBN O
. . O

A DT O
few JJ O
genes NNS O
, , O
such JJ O
as IN O
lytH NN O
, , O
dlt NN O
, , O
norG NN O
, , O
sarV NN O
and CC O
cidA NN O
increase VBP O
resistance NN O
levels NNS O
upon IN O
inactivation NN O
or CC O
mutation NN O
. . O

All DT O
of IN O
these DT O
genes NNS O
, , O
except IN O
norG NN O
, , O
which WDT O
is VBZ O
an DT O
efflux NN O
pump NN O
regulator NN O
, , O
play VBP O
a DT O
role NN O
in IN O
either CC O
autolysis NN O
or CC O
are VBP O
important JJ O
for IN O
cell NN O
physiology NN O
and CC O
growth NN O
[ -LRB- O
25 CD O
- SYM O
30 CD O
] -RRB- O
. . O

Other JJ O
genes NNS O
increase VBP O
beta NN O
- HYPH O
lactam NN O
resistance NN O
upon IN O
overexpression NN O
, , O
such JJ O
as IN O
hmrA NN O
coding NN O
for IN O
a DT O
putative JJ O
amidohydrolase NN O
, , O
hmrB NN O
coding NN O
for IN O
a DT O
putative JJ O
acyl NN O
carrier NN O
protein NN O
[ -LRB- O
31 CD O
] -RRB- O
, , O
or CC O
the DT O
NorG NNP O
- HYPH O
controlled VBN O
abcA NN O
multidrug NN O
efflux NN O
pump NN O
[ -LRB- O
28 CD O
] -RRB- O
. . O

SA1665 NNP O
, , O
a DT O
predicted VBN O
DNA NN O
- HYPH O
binding VBG O
transcriptional JJ O
regulator NN O
, , O
was VBD O
found VBN O
to TO O
bind VB O
to IN O
a DT O
DNA NN O
fragment NN O
containing VBG O
the DT O
mecA NN O
promoter NN O
region NN O
. . O

However RB O
, , O
although IN O
this DT O
protein NN O
shifted VBD O
the DT O
mecA NN O
operator NN O
/ SYM O
5 CD O
' '' O
coding VBG O
sequence NN O
, , O
it PRP O
did VBD O
not RB O
appear VB O
to TO O
directly RB O
control VB O
mecA NN O
or CC O
mecR1 NN O
transcription NN O
or CC O
PBP2a NN O
production NN O
. . O

Therefore RB O
its PRP$ O
binding NN O
to IN O
the DT O
mecA NN O
region NN O
may MD O
have VB O
no DT O
specific JJ O
regulatory JJ O
function NN O
. . O

Such JJ O
interactions NNS O
have VBP O
been VBN O
noted VBN O
before RB O
, , O
such JJ O
as IN O
the DT O
HTH NNP O
protein NN O
NorG NNP O
, , O
which WDT O
was VBD O
shown VBN O
to TO O
bind VB O
specifically RB O
to IN O
norA NN O
, , O
norB NN O
and CC O
norC NN O
promoters NNS O
, , O
but CC O
only RB O
transcription NN O
of IN O
norB NN O
was VBD O
increased VBN O
when WRB O
NorG NNP O
was VBD O
overexpressed VBN O
[ -LRB- O
28 CD O
] -RRB- O
. . O

We PRP O
have VBP O
to TO O
postulate VB O
therefore RB O
that IN O
SA1665 NNP O
may MD O
modulate VB O
beta NN O
- HYPH O
lactam NN O
resistance NN O
in IN O
a DT O
mecA NN O
- HYPH O
independent JJ O
manner NN O
, , O
by IN O
controlling VBG O
cellular JJ O
functions NNS O
affecting VBG O
resistance NN O
levels NNS O
. . O

Experiments NNS O
to TO O
determine VB O
the DT O
SA1665 NNP O
regulon NN O
are VBP O
ongoing VBG O
. . O

The DT O
impact NN O
of IN O
deleting VBG O
SA1665 NN O
in IN O
MRSA NNP B-Species
was VBD O
extremely RB O
strain JJ O
specific JJ O
, , O
underlining VBG O
the DT O
importance NN O
of IN O
the DT O
genetic JJ O
background NN O
in IN O
governing VBG O
the DT O
final JJ O
methicillin NN O
resistance NN O
levels NNS O
of IN O
MRSA NNP B-Species
, , O
and CC O
demonstrating VBG O
the DT O
large JJ O
genomic JJ O
variability NN O
between IN O
different JJ O
strain NN O
lineages NNS O
. . O

Conclusion NN O

SA1665 NN O
is VBZ O
a DT O
previously RB O
uncharacterised JJ O
DNA NN O
- HYPH O
binding VBG O
protein NN O
that WDT O
has VBZ O
a DT O
negative JJ O
effect NN O
on IN O
beta NN O
- HYPH O
lactam NN O
resistance NN O
in IN O
MRSA NNP B-Species
. . O

The DT O
SA1665 NNP O
protein NN O
was VBD O
identified VBN O
in IN O
a DT O
DNA NN O
- HYPH O
binding VBG O
protein NN O
purification NN O
assay NN O
, , O
in IN O
which WDT O
it PRP O
bound VBD O
to IN O
a DT O
DNA NN O
fragment NN O
covering VBG O
the DT O
mec NN O
operator NN O
region NN O
. . O

However RB O
, , O
while IN O
nonpolar JJ O
deletion NN O
of IN O
SA1665 NN O
was VBD O
shown VBN O
to TO O
increase VB O
oxacillin NN O
resistance NN O
levels NNS O
in IN O
several JJ O
heterogeneously RB O
resistant JJ O
MRSA NNP B-Species
, , O
its PRP$ O
deletion NN O
had VBD O
no DT O
effect NN O
on IN O
mecA NN O
transcription NN O
or CC O
PBP2a NN O
production NN O
. . O

Therefore RB O
the DT O
negative JJ O
impact NN O
of IN O
SA1665 NN O
on IN O
methicillin NN O
resistance NN O
is VBZ O
most RBS O
likely JJ O
to TO O
be VB O
through IN O
the DT O
regulation NN O
of IN O
other JJ O
chromosomal JJ O
factors NNS O
or CC O
cellular JJ O
functions NNS O
required VBN O
for IN O
methicllin NN O
resistance NN O
. . O

Methods NNS O

Strains NNS O
and CC O
growth NN O
conditions NNS O

Strains NNS O
and CC O
plasmids NNS O
used VBN O
in IN O
this DT O
study NN O
are VBP O
listed VBN O
in IN O
Table NNP O
1 CD O
. . O

Clinical JJ O
isolates NNS O
are VBP O
from IN O
the DT O
IMM NNP O
collection NN O
in IN O
Zurich NNP O
, , O
Switzerland NNP O
. . O

Strains NNS O
were VBD O
grown VBN O
at IN O
37 CD O
degrees NNS O
C NN O
in IN O
Luria NNP O
Bertani NNP O
( SYM O
LB NNP O
) SYM O
broth NN O
, , O
shaking VBG O
at IN O
180 CD O
rpm NN O
, , O
or CC O
on IN O
LB NNP O
agar RB O
. . O

Media NN O
were VBD O
supplemented VBN O
with IN O
the DT O
following VBG O
antibiotics NNS O
when WRB O
appropriate JJ O
: : O
25 CD O
or CC O
50 CD O
mu NNS O
g NNP O
/ SYM O
ml NNP O
kanamycin NN O
, , O
10 CD O
mu NN O
g NN O
/ SYM O
ml NN O
chloramphenicol NN O
, , O
5 CD O
or CC O
10 CD O
mu NN O
g NN O
/ SYM O
ml NN O
tetracycline NN O
, , O
100 CD O
mu NN O
g NN O
/ SYM O
ml NN O
ampicillin NN O
. . O

Concentrations NNS O
of IN O
cefoxitin NN O
used VBN O
for IN O
transcriptional JJ O
induction NN O
were VBD O
either CC O
sub NN O
- HYPH O
inhibitory NN O
( : O
4 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
or CC O
inhibitory JJ O
( , O
120 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
. . O

Susceptibility NN O
testing NN O

Oxacillin NNP O
resistance NN O
levels NNS O
were VBD O
compared VBN O
by IN O
swabbing VBG O
0 CD O
. . O
5 CD O
McFarland NNP O
cell NN O
suspensions NNS O
across IN O
agar JJ O
plates NNS O
containing VBG O
appropriate JJ O
concentration NN O
gradients NNS O
of IN O
oxacillin NN O
. . O

For IN O
population NN O
analysis NN O
profiles NNS O
, , O
appropriate JJ O
dilutions NNS O
of IN O
an DT O
overnight JJ O
culture NN O
, , O
ranging VBG O
from IN O
100 CD O
to IN O
108 CD O
, , O
were VBD O
plated VBN O
on IN O
increasing VBG O
concentrations NNS O
of IN O
oxacillin NN O
. . O

Plates NNS O
were VBD O
incubated VBN O
at IN O
35 CD O
degrees NNS O
C NN O
and CC O
colony NN O
forming VBG O
units NNS O
per IN O
ml NN O
( , O
cfu NN O
/ SYM O
ml NNP O
) -RRB- O
were VBD O
determined VBN O
after IN O
48 CD O
h NN O
. . O

Binding VBG O
- HYPH O
protein NN O
purification NN O

Crude JJ O
protein NN O
extracts NNS O
were VBD O
isolated VBN O
from IN O
CHE482 NNP O
, , O
grown VBN O
under IN O
normal JJ O
culture NN O
conditions NNS O
until IN O
OD600 NNP O
nm NNP O
1 CD O
. . O
5 CD O
. . O

Cells NNS O
were VBD O
harvested VBN O
, , O
resuspended VBN O
in IN O
PBS NNP O
( , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
and CC O
mechanically RB O
lysed VBN O
using VBG O
Lysing NNP O
Matrix NNP O
B NNP O
( -LRB- O
BIO NNP O
101 CD O
Systems NNPS O
) -RRB- O
tubes NNS O
and CC O
a DT O
FastPrep NNP O
FP120 NNP O
( , O
BIO NNP O
101 CD O
Systems NNPS O
) -RRB- O
. . O

Suspensions NNS O
were VBD O
clarified VBN O
by IN O
centrifugation NN O
and CC O
supernatants NNS O
, , O
containing VBG O
soluble JJ O
cytoplasmic JJ O
proteins NNS O
, , O
were VBD O
transferred VBN O
to IN O
Amicon NNP O
Ultra NNP O
centrifugal JJ O
filter NN O
devices NNS O
( -LRB- O
Millipore NNP O
) -RRB- O
with IN O
a DT O
pore NN O
cut VBN O
- HYPH O
off RP O
size NN O
of IN O
10 CD O
kDa NN O
. . O

Proteins NNS O
were VBD O
then RB O
washed VBN O
and CC O
concentrated VBN O
in IN O
1 CD O
x SYM O
binding VBG O
buffer NN O
( , O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
, , O
pH NN O
7 CD O
. . O
5 CD O
, , O
1 CD O
mM NN O
EDTA NNP O
, , O
and CC O
1 CD O
mM NN O
DTT NN O
, , O
0 CD O
. . O
5 CD O
M NN O
NaCl NN O
) -RRB- O
. . O

Protein NN O
concentrations NNS O
were VBD O
measured VBN O
by IN O
Bradford NNP O
assay NN O
( : O
BioRad NNP O
Laboratories NNP O
GmbH NNP O
) -RRB- O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Primer NN O
pair NN O
me36F NNP O
/ SYM O
me36Rbiot NNP O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
were VBD O
used VBN O
to TO O
amplify VB O
a DT O
biotinylated JJ O
mecA NN O
promoter NN O
/ SYM O
operator NN O
fragment NN O
, , O
which WDT O
was VBD O
bound VBN O
to IN O
streptavidin NN O
coated VBN O
magnetic JJ O
beads NNS O
( , O
Dynabeads NNP O
M NNP O
- HYPH O
280 CD O
Streptavidin NNP O
, , O
DYNAL NNP O
BIOTECH NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

Binding VBG O
reactions NNS O
, , O
containing VBG O
DNA NN O
- HYPH O
coated VBN O
beads NNS O
mixed VBN O
with IN O
100 CD O
mu NN O
g NN O
of IN O
crude JJ O
protein NN O
extract NN O
in IN O
1 CD O
x NN O
protein NN O
binding NN O
buffer NN O
( : O
20 CD O
mM NN O
Hepes NNS O
, , O
pH NN O
7 CD O
. . O
6 CD O
, , O
1 CD O
mM NN O
EDTA NNP O
, , O
10 CD O
mM NN O
( -LRB- O
NH4 NN O
) -RRB- O
2SO4 CD O
, , O
1 CD O
mM NN O
DTT NN O
, , O
0 CD O
. . O
2 CD O
% NN O
Tween NNP O
20 CD O
( SYM O
w CD O
/ SYM O
v NN O
) -RRB- O
, , O
30 CD O
mM NN O
KCl NN O
) -RRB- O
, , O
0 CD O
. . O
2 CD O
mu NN O
g NN O
/ SYM O
mu NN O
l -LRB- O
poly NN O
d NN O
( , O
I NN O
- HYPH O
C NN O
) -RRB- O
and CC O
2 CD O
ng CD O
/ SYM O
mu NN O
l CC O
poly JJ O
L NN O
- HYPH O
lysine NN O
, , O
were VBD O
incubated VBN O
at IN O
room NN O
temperature NN O
for IN O
30 CD O
min NN O
with IN O
constant JJ O
rotation NN O
. . O

Beads NNS O
were VBD O
then RB O
washed VBN O
and CC O
binding VBG O
- HYPH O
proteins NNS O
eluted VBN O
in IN O
elution NN O
buffer NN O
( , O
1 CD O
x NN O
protein NN O
binding VBG O
buffer NN O
containing VBG O
2 CD O
M NNP O
KCl NNP O
) -RRB- O
. . O

Eluted VBN O
proteins NNS O
were VBD O
dialysed VBN O
against IN O
water NN O
, , O
concentrated VBN O
by IN O
evaporation NN O
, , O
and CC O
run VBP O
on IN O
15 CD O
% NN O
SDS NNP O
polyacrylamide NN O
gels NNS O
. . O

Gels NNS O
were VBD O
silver NN O
stained VBN O
using VBG O
the DT O
Protein NNP O
Silver NNP O
Staining NNP O
kit NN O
( : O
Amersham NNP O
Biosciences NNPS O
AB NNP O
) -RRB- O
without IN O
the DT O
addition NN O
of IN O
glutaraldehyde NN O
. . O

Protein NN O
bands NNS O
were VBD O
excised VBN O
from IN O
gels NNS O
and CC O
analysed VBN O
by IN O
mass NN O
spectrometry NN O
( , O
LC NNP O
/ SYM O
ESI NNP O
/ SYM O
MS NNP O
/ SYM O
MS NNP O
) -RRB- O
at IN O
the DT O
Functional NNP O
Genomics NNP O
Centre NNP O
, , O
Zurich NNP O
. . O

The DT O
SA1665 NNP O
protein NN O
sequence NN O
[ -LRB- O
BAB42933 NN O
] -RRB- O
was VBD O
analysed VBN O
by IN O
Blast NNP O
search NN O
and CC O
motif NN O
scan NN O
. . O

Expression NN O
of IN O
recombinant JJ O
SA1665 NN O
protein NN O

SA1665 NN O
was VBD O
amplified VBN O
using VBG O
primer NN O
pair NN O
me65BamHI NNP O
/ SYM O
me65XhoI NNP O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
and CC O
cloned VBN O
in IN O
- HYPH O
frame NN O
into IN O
pET28nHis6 NN O
( , O
unpublished JJ O
, , O
D NNP O
. . O
Frey NNP O
) -RRB- O
. . O

The DT O
resulting VBG O
plasmid NN O
, , O
pME20 NN O
, , O
was VBD O
transformed VBN O
into IN O
E NN B-Species
. . I-Species
coli NN I-Species
BL21 CD I-Species
for IN O
expression NN O
of IN O
recombinant JJ O
nHis6 NNP O
- HYPH O
SA1665 NN O
protein NN O
. . O

To TO O
maximise VB O
the DT O
abundance NN O
of IN O
soluble JJ O
protein NN O
produced VBN O
, , O
cultures NNS O
were VBD O
grown VBN O
in IN O
osmotic JJ O
shock NN O
medium NN O
at IN O
37 CD O
degrees NNS O
C NN O
( , O
1 CD O
g NN O
/ SYM O
l NN O
NaCl NNP O
, , O
16 CD O
g NNS O
/ SYM O
l NN O
tryptone NN O
, , O
10 CD O
g NNS O
/ SYM O
l NN O
yeast NN B-Species
, , O
1 CD O
M NN O
sorbitol NN O
, , O
10 CD O
mM NN O
betaine NN O
, , O
modified VBN O
from IN O
[ $ O
33 CD O
] -RRB- O
) -RRB- O
to IN O
an DT O
OD600 NN O
nm NN O
of IN O
0 CD O
. . O
5 CD O
, , O
cooled VBN O
briefly RB O
on IN O
ice NN O
, , O
then RB O
induced VBN O
by IN O
adding VBG O
100 CD O
mu NNS O
M NNP O
IPTG NNP O
and CC O
growing VBG O
overnight RB O
at IN O
22 CD O
degrees NNS O
C NN O
. . O

Crude JJ O
soluble JJ O
proteins NNS O
were VBD O
extracted VBN O
using VBG O
CelLyticB NNP O
2 CD O
x SYM O
cell NN O
lysis NN O
reagent NN O
( -LRB- O
SIGMA NNP O
) -RRB- O
. . O

HIS PRP$ O
- HYPH O
Select NNP O
Cobalt NNP O
Affinity NNP O
Gel NNP O
( : O
SIGMA NNP O
) -RRB- O
was VBD O
used VBN O
to TO O
purify VB O
recombinant JJ O
nHis6 NNP O
- HYPH O
SA1665 NNP O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

Electro NN O
mobility NN O
shift NN O
assay NN O

For IN O
gel NN O
shift NN O
assays NNS O
, , O
6 CD O
ng NN O
aliquots NNS O
of IN O
the DT O
biotinylated JJ O
- HYPH O
DNA NN O
fragment NN O
used VBN O
for IN O
binding NN O
- HYPH O
protein NN O
purification NN O
were VBD O
incubated VBN O
with IN O
0 CD O
- SYM O
250 CD O
ng NN O
of IN O
purified JJ O
nHis6 NNP O
- HYPH O
SA1665 NN O
protein NN O
in IN O
1 CD O
x SYM O
binding VBG O
buffer NN O
( SYM O
20 CD O
mM NN O
Hepes NN O
pH NN O
7 CD O
. . O
6 CD O
, , O
1 CD O
mM NN O
EDTA NNP O
, , O
10 CD O
mM NN O
( -LRB- O
NH4 NN O
) -RRB- O
2SO4 CD O
, , O
1 CD O
mM NN O
DTT NN O
, , O
0 CD O
. . O
2 CD O
% NN O
Tween NNP O
20 CD O
( SYM O
w CD O
/ SYM O
v NN O
) -RRB- O
, , O
30 CD O
mM NN O
KCl NN O
) -RRB- O
containing VBG O
0 CD O
. . O
5 CD O
mu NN O
g NN O
/ SYM O
mu NN O
l NN O
poly NN O
d NN O
( , O
I NN O
- HYPH O
C NN O
) -RRB- O
( , O
Roche NNP O
) -RRB- O
and CC O
5 CD O
ng CD O
/ SYM O
mu NN O
l NN O
poly NN O
L NN O
- HYPH O
lysine NN O
( : O
Roche NNP O
) -RRB- O
. . O

For IN O
control NN O
binding NN O
reactions NNS O
, , O
130 CD O
x SYM O
unlabelled JJ O
mec NN O
operator NN O
DNA NNP O
( , O
amplified VBN O
using VBG O
primers NNS O
me36F NNP O
/ SYM O
me36R NNP O
, , O
Table NNP O
2 CD O
) -RRB- O
was VBD O
used VBN O
as IN O
a DT O
specific JJ O
binding VBG O
competitor NN O
and CC O
6 CD O
ng NN O
of IN O
herring NN O
sperm NN O
DNA NNP O
was VBD O
used VBN O
as IN O
unspecific JJ O
competitor NN O
DNA NNP O
. . O

Binding NN O
was VBD O
carried VBN O
out RP O
at IN O
22 CD O
degrees NNS O
C NN O
for IN O
30 CD O
min NN O
. . O

Samples NNS O
were VBD O
run VBN O
on IN O
6 CD O
% NN O
native JJ O
polyacrylamide NN O
gels NNS O
, , O
contact NN O
blotted VBN O
onto IN O
positively RB O
charged VBN O
nylon NN O
membrane NN O
and CC O
detected VBN O
with IN O
the DT O
Biotin NNP O
Chromogenic NNP O
Detection NNP O
Kit NNP O
( -LRB- O
Fermentas NNP O
) -RRB- O
. . O

Primer NNP O
extension NN O

RNA NNP O
was VBD O
extracted VBN O
from IN O
CHE482 NNP O
cultures NNS O
that WDT O
were VBD O
grown VBN O
to IN O
OD600 CD O
nm NN O
0 CD O
. . O
5 CD O
, , O
as IN O
previously RB O
described VBN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Primer NN O
extension NN O
reactions NNS O
were VBD O
performed VBN O
using VBG O
20 CD O
mu NN O
g NN O
of IN O
total JJ O
RNA NN O
and CC O
3 CD O
pmol NN O
of IN O
the DT O
5 CD O
' '' O
- HYPH O
biotin NN O
- HYPH O
labelled VBN O
primers NNS O
me97 CD O
and CC O
me98 CD O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
using VBG O
Superscript NN O
II NNP O
reverse JJ O
transcriptase NN O
( , O
Invitrogen NNP O
) -RRB- O
, , O
according VBG O
to IN O
the DT O
manufacturers NNS O
instructions NNS O
. . O

Sequencing VBG O
reactions NNS O
were VBD O
performed VBN O
using VBG O
the DT O
Thermo NNP O
Sequenase NNP O
cycle NN O
sequencing NN O
kit NN O
( , O
U NNP O
. . O
S NNP O
. . O
Biochemicals NNP O
) -RRB- O
. . O

The DT O
Biotin NNP O
Chromogenic NNP O
Detection NNP O
Kit NNP O
( -LRB- O
Fermentas NNP O
) -RRB- O
was VBD O
used VBN O
for IN O
biotin NN O
detection NN O
. . O

Markerless JJ O
deletion NN O
of IN O
SA1665 NN O

In IN O
frame NN O
markerless JJ O
deletions NNS O
of IN O
SA1665 NN O
, , O
from IN O
the DT O
chromosomes NNS O
of IN O
CHE482 NNP O
, , O
ZH37 NNP O
, , O
ZH44 NNP O
, , O
and CC O
ZH73 CD O
, , O
were VBD O
constructed VBN O
using VBG O
the DT O
pKOR1 NN O
allelic JJ O
replacement NN O
system NN O
, , O
as IN O
described VBN O
by IN O
Bae NNP O
et FW O
al NNP O
. . O

[ -LRB- O
34 CD O
] -RRB- O
. . O

Primer NN O
pairs NNS O
used VBN O
to TO O
amplify VB O
the DT O
DNA NN O
fragments NNS O
flanking VBG O
SA1665 NN O
, , O
for IN O
recombination NN O
into IN O
pKOR1 NN O
were VBD O
: : O
me62attB1 NNP O
/ SYM O
me51BamHI NNP O
and CC O
me62BamHI NNP O
/ SYM O
me62attB2 NN O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

All DT O
deletion NN O
mutants NNS O
were VBD O
confirmed VBN O
by IN O
nucleotide NN O
sequencing NN O
over IN O
the DT O
deleted VBN O
region NN O
, , O
as RB O
well RB O
as IN O
by IN O
Southern JJ O
blot NN O
analysis NN O
[ -LRB- O
35 CD O
] -RRB- O
and CC O
pulsed VBN O
field NN O
gel NN O
electrophoresis NN O
( -LRB- O
PFGE NNP O
) -RRB- O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Cloning NN O
of IN O
SA1665 NN O
for IN O
complementation NN O

A DT O
1533 CD O
- HYPH O
bp NN O
DNA NN O
fragment NN O
, , O
containing VBG O
SA1665 NN O
together RB O
with IN O
690 CD O
- HYPH O
bp NN O
of IN O
upstream NN O
and CC O
379 CD O
- HYPH O
bp NN O
of IN O
downstream JJ O
DNA NN O
, , O
was VBD O
amplified VBN O
from IN O
strain NN O
CHE482 NN O
using VBG O
primers NNS O
me94BamHI NNP O
/ SYM O
me94Asp718 CD O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
and CC O
cloned VBN O
into IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
/ : O
S NNP B-Species
. . I-Species
aureus NN I-Species
shuttle NN O
vectors NNS O
pAW17 NN O
and CC O
pBUS1 NNP O
[ -LRB- O
37 CD O
] -RRB- O
, , O
creating VBG O
the DT O
complementing VBG O
plasmids NNS O
pME26 NN O
and CC O
pME27 NN O
, , O
respectively RB O
. . O

Plasmids NNS O
were VBD O
electroporated VBN O
into IN O
RN4220 NNP O
[ -LRB- O
38 CD O
] -RRB- O
and CC O
then RB O
transduced VBN O
into IN O
different JJ O
strains NNS O
using VBG O
phage NN O
80 CD O
alpha NN O
. . O

Northern JJ O
blot NN O
analysis NN O

Strains NNS O
were VBD O
grown VBN O
overnight RB O
in IN O
LB NNP O
( : O
Difco NNP O
) -RRB- O
, , O
diluted VBN O
1 CD O
: SYM O
200 CD O
and CC O
grown VBN O
for IN O
another DT O
3 CD O
h NN O
. . O

This DT O
preculture NN O
was VBD O
used VBN O
to TO O
inoculate VB O
150 CD O
ml NNS O
( SYM O
1 CD O
: SYM O
1000 CD O
) -RRB- O
of IN O
fresh JJ O
prewarmed VBN O
LB NNP O
. . O

Cells NNS O
were VBD O
then RB O
grown VBN O
to IN O
OD600 NN O
nm ADD O
0 CD O
. . O
25 CD O
or CC O
1 CD O
. . O
0 CD O
and CC O
either CC O
left VBN O
uninduced JJ O
or CC O
induced VBN O
with IN O
cefoxitin NN O
4 CD O
or CC O
120 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
. . O

Cultures NNS O
were VBD O
sampled VBN O
from IN O
both CC O
uninduced JJ O
and CC O
induced VBN O
cells NNS O
at IN O
time NN O
point NN O
0 CD O
' '' O
before IN O
induction NN O
and CC O
at IN O
10 CD O
' '' O
and CC O
30 CD O
' '' O
( : O
min NN O
) -RRB- O
after IN O
induction NN O
. . O

To TO O
monitor VB O
SA1665 NN O
expression NN O
over IN O
growth NN O
, , O
separate JJ O
cultures NNS O
were VBD O
also RB O
sampled VBN O
at IN O
different JJ O
growth NN O
stages NNS O
corresponding VBG O
to IN O
OD600 NNP O
nm NNP O
0 CD O
. . O
25 CD O
, , O
0 CD O
. . O
5 CD O
, , O
1 CD O
, , O
2 CD O
, , O
and CC O
4 CD O
. . O

Total JJ O
RNA NNP O
was VBD O
extracted VBN O
as IN O
described VBN O
by IN O
Cheung NNP O
et FW O
al NNP O
. . O

[ -LRB- O
39 CD O
] -RRB- O
. . O

RNA NNP O
samples NNS O
( , O
10 CD O
mu NNS O
g NN O
) -RRB- O
were VBD O
separated VBN O
in IN O
a DT O
1 CD O
. . O
5 CD O
% NN O
agarose JJ O
- HYPH O
20 CD O
mM NN O
guanidine NN O
thiocyanate NN O
gel NN O
in IN O
1 CD O
x SYM O
TBE NNP O
running VBG O
buffer NN O
[ -LRB- O
40 CD O
] -RRB- O
, , O
then RB O
transferred VBN O
and CC O
detected VBN O
as IN O
described VBN O
previously RB O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Digoxigenin NNP O
( , O
DIG NNP O
) -RRB- O
labelled VBN O
- HYPH O
probes NNS O
were VBD O
amplified VBN O
using VBG O
the DT O
PCR NNP O
DIG NNP O
Probe NNP O
synthesis NN O
kit NN O
( : O
Roche NNP O
) -RRB- O
. . O

Table NN O
2 CD O
contains VBZ O
the DT O
list NN O
of IN O
primer JJ O
pairs NNS O
used VBN O
for IN O
the DT O
amplification NN O
of IN O
SA1664 NNP O
, , O
SA1665 NNP O
, , O
SA1666 NNP O
, , O
SA1667 NN O
, , O
mecR1 NN O
and CC O
mecA NN O
[ -LRB- O
42 CD O
] -RRB- O
probes NNS O
. . O

All DT O
Northern NNP O
' '' O
s NNS O
were VBD O
repeated VBN O
at IN O
least JJS O
two CD O
times NNS O
, , O
using VBG O
independently RB O
isolated VBN O
RNA NNP O
samples NNS O
. . O

Western JJ O
blot NN O
analysis NN O

Cells NNS O
were VBD O
cultured VBN O
, , O
as IN O
described VBN O
for IN O
Northern JJ O
blot NN O
analysis NN O
, , O
to IN O
OD600 NN O
nm ADD O
1 CD O
. . O
0 CD O
, , O
then RB O
induced VBN O
with IN O
cefoxitin NN O
4 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
. . O

Samples NNS O
were VBD O
collected VBN O
at IN O
time NN O
0 CD O
( , O
before IN O
induction NN O
) -RRB- O
, , O
10 CD O
and CC O
30 CD O
min NN O
( , O
after IN O
induction NN O
) -RRB- O
. . O

Cells NNS O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
, , O
resuspended VBN O
in IN O
PBS NNP O
pH NN O
7 CD O
. . O
4 CD O
containing VBG O
DNase NNP O
, , O
lysostaphin NN O
and CC O
lysozyme NN O
( : O
150 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
of IN O
each DT O
) -RRB- O
and CC O
incubated VBN O
for IN O
1 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Suspensions NNS O
were VBD O
then RB O
sonicated VBN O
and CC O
protein NN O
aliquots NNS O
( , O
15 CD O
mu NNS O
g NN O
) -RRB- O
were VBD O
separated VBN O
on IN O
7 CD O
. . O
5 CD O
% NN O
SDS NN O
- HYPH O
polyacrylamide NN O
gels NNS O
, , O
blotted VBN O
onto IN O
nitrocellulose NN O
membranes NNS O
( , O
Hybond NNP O
) -RRB- O
and CC O
stained VBN O
with IN O
Ponceau NNP O
to TO O
confirm VB O
equal JJ O
protein NN O
loading NN O
. . O

PBP2a NNP O
detection NN O
was VBD O
performed VBN O
using VBG O
monoclonal JJ O
PBP2a NNP O
antibody NN O
( , O
1 CD O
: SYM O
20000 CD O
) -RRB- O
from IN O
the DT O
MRSA NN B-Species
- HYPH O
screen NN O
kit NN O
( , O
Denka NNP O
Seiken NNP O
) -RRB- O
. . O

Authors NNS O
' POS O
contributions NNS O

ME NNP O
carried VBD O
out RP O
molecular JJ O
genetic JJ O
and CC O
microbiological JJ O
studies NNS O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

BB NNP O
participated VBD O
in IN O
the DT O
design NN O
of IN O
the DT O
study NN O
and CC O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
. . O

NM NNP O
participated VBD O
in IN O
the DT O
design NN O
and CC O
coordination NN O
of IN O
the DT O
study NN O
, , O
carried VBD O
out RP O
molecular JJ O
biological JJ O
studies NNS O
and CC O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Organization NN O
and CC O
structure NN O
of IN O
the DT O
mouse NN B-Species
interleukin NN O
- HYPH O
2 CD O
gene NN O
. . O

Abstract JJ O

We PRP O
have VBP O
cloned VBN O
a DT O
chromosomal JJ O
DNA NN O
segment NN O
which WDT O
covers VBZ O
the DT O
entire JJ O
sequence NN O
for IN O
the DT O
murine NN B-Species
interleukin NN O
- HYPH O
2 CD O
gene NN O
and CC O
analysed VBD O
the DT O
structure NN O
of IN O
the DT O
gene NN O
. . O

The DT O
coding VBG O
regions NNS O
are VBP O
separated VBN O
into IN O
four CD O
blocks NNS O
by IN O
three CD O
introns NNS O
each DT O
of IN O
which WDT O
is VBZ O
located VBN O
similarly RB O
to IN O
the DT O
corresponding VBG O
human JJ B-Species
gene NN O
. . O

The DT O
exon NN O
sequences NNS O
can MD O
be VB O
aligned VBN O
perfectly RB O
with IN O
the DT O
previously RB O
cloned VBN O
cDNA NNP O
sequence NN O
. . O

Of IN O
particular JJ O
interests NNS O
is VBZ O
the DT O
presence NN O
of IN O
sequences NNS O
within IN O
the DT O
5 CD O
' '' O
- HYPH O
flanking VBG O
region NN O
which WDT O
are VBP O
highly RB O
conserved VBN O
between IN O
mouse NN B-Species
and CC O
man NN B-Species
. . O

The DT O
conserved JJ O
region NN O
which WDT O
spans VBZ O
more JJR O
than IN O
400 CD O
base NN O
pairs NNS O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
IL NN O
- HYPH O
2 CD O
gene NN O
expression NN O
. . O
Images NNS O

Volume NN O
12 CD O
Number NNP O
24 CD O
1984 CD O
Nucleic NNP O
Acids NNP O
Research NNP O

Organization NN O
and CC O
structure NN O
of IN O
the DT O
mouse NN B-Species
interleukin NN O
- HYPH O
2 CD O
gene NN O

Akira NNP O
Fuse NNP O
* NFP O
, , O
Takashi NNP O
Fujita NNP O
, , O
Hidetaro NNP O
Yasumitsu NNP O
, , O
Nobukazu NNP O
Kashima NNP O
+ CC O
, , O
Katsushige NNP O
Hasegawa NNP O
and CC O
Tadatsugu NNP O
Taniguchi NNP O
? . O

Department NNP O
of IN O
Biochemistry NNP O
, , O
Cancer NNP O
Institute NNP O
, , O
Japanese NNP O
Foundation NNP O
for IN O
Cancer NNP O
Research NNP O
, , O
Toshimaku NNP O
, , O
Tokyo NNP O
170 CD O
and CC O
Institute NNP O
for IN O
Molecular NNP O
and CC O
Cellular NNP O
Biology NNP O
, , O
Osaka NNP O
University NNP O
, , O
Suita NNP O
- HYPH O
shi NNP O
, , O
Osaka NNP O
565 CD O
, , O
Japan NNP O

Received VBN O
10 CD O
October NNP O
1984 CD O
; : O
Revised VBN O
and CC O
Accepted VBN O
20 CD O
November NNP O
1984 CD O

ABSTRACT NNP O

We PRP O
have VBP O
cloned VBN O
a DT O
chromosomal JJ O
DNA NN O
segment NN O
which WDT O
covers VBZ O
the DT O
entire JJ O
sequence NN O
for IN O
the DT O
murine NN B-Species
interleukin NN O
- HYPH O
2 CD O
gene NN O
and CC O
analysed VBD O
the DT O
structure NN O
of IN O
the DT O
gene NN O
. . O

The DT O
coding VBG O
regions NNS O
are VBP O
separated VBN O
into IN O
four CD O
blocks NNS O
by IN O
three CD O
introns NNS O
each DT O
of IN O
which WDT O
is VBZ O
located VBN O
similarly RB O
to IN O
the DT O
corresponding VBG O
human JJ B-Species
gene NN O
. . O

The DT O
exon NN O
sequences NNS O
can MD O
be VB O
aligned VBN O
perfectly RB O
with IN O
the DT O
previously RB O
cloned VBN O
cDNA NNP O
sequence NN O
. . O

Of IN O
particular JJ O
interests NNS O
is VBZ O
the DT O
presence NN O
of IN O
sequences NNS O
within IN O
the DT O
5 CD O
' '' O
flanking NN O
region NN O
which WDT O
are VBP O
highly RB O
conserved VBN O
between IN O
mouse NN B-Species
and CC O
man NN B-Species
. . O

The DT O
conserved JJ O
region NN O
which WDT O
spans VBZ O
more JJR O
than IN O
400 CD O
base NN O
pairs NNS O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
IL NN O
- HYPH O
2 CD O
gene NN O
expression NN O
. . O

INTRODUCTION NN O

Interleukin NNP O
- HYPH O
2 CD O
( , O
IL NN O
- HYPH O
2 CD O
) -RRB- O
is VBZ O
a DT O
lymphokine NN O
produced VBN O
by IN O
T NN O
cells NNS O
upon IN O
antigenic JJ O
or CC O
mitogenic JJ O
stimulation NN O
and CC O
is VBZ O
required VBN O
for IN O
the DT O
proliferation NN O
of IN O
T NN O
cells NNS O
( SYM O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Several JJ O
other JJ O
biological JJ O
activities NNS O
of IN O
IL NN O
- HYPH O
2 CD O
which WDT O
appear VBP O
to TO O
be VB O
crucial JJ O
in IN O
the DT O
immune JJ O
regulation NN O
have VBP O
also RB O
been VBN O
reported VBN O
( : O
3 CD O
, , O
4 CD O
. . O
5 CD O
. . O
6 CD O
. . O
7 CD O
. . O
) -RRB- O
. . O

We PRP O
previously RB O
reported VBD O
isolation NN O
and CC O
sequence NN O
analysis NN O
of IN O
the DT O
cDNA NN O
for IN O
human JJ B-Species
IL NN O
- HYPH O
2 CD O
( SYM O
8 CD O
) -RRB- O
, , O
as RB O
well RB O
as IN O
the DT O
chromosomal JJ O
gene NN O
( : O
9 CD O
) -RRB- O
. . O

More RBR O
recently RB O
, , O
we PRP O
have VBP O
isolated VBN O
a DT O
cDNA NNP O
which WDT O
encodes VBZ O
murine NN B-Species
IL NNP O
- HYPH O
2 CD O
( , O
Kashima NNP O
et NN O
al NNP O
. . O
, , O
submitted VBN O
for IN O
publication NN O
) -RRB- O
. . O

The DT O
cDNA NNP O
contains VBZ O
a DT O
unique JJ O
tandem NN O
repeat NN O
of IN O
CAG NNP O
sequence NN O
which WDT O
would MD O
encode VB O
12 CD O
consecutive JJ O
glutamine NN O
residues NNS O
in IN O
the DT O
active JJ O
IL NN O
- HYPH O
2 CD O
molecule NN O
. . O

In IN O
order NN O
to TO O
study VB O
the DT O
structure NN O
of IN O
the DT O
murine NN B-Species
IL NN O
- HYPH O
2 CD O
chromosomal JJ O
gene NN O
and CC O
its PRP$ O
controlling VBG O
region NN O
, , O
we PRP O
isolated VBD O
and CC O
analysed VBD O
a DT O
A NN O
phage NN O
clone NN O
containing VBG O
the DT O
gene NN O
and CC O
its PRP$ O
flanking NN O
sequences NNS O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Southern JJ O
blotting NN O
of IN O
total JJ O
mouse NNP B-Species
DNA NNP O

Mouse NNP B-Species
chromosomal JJ O
DNA NNP O
was VBD O
extracted VBN O
from IN O
liver NN O
of IN O
BALB NNP O
/ SYM O
c6 NN O

? . O
I PRP O
R NNP O
L NNP O
Press NNP O
Limited NNP O
, , O
Oxford NNP O
, , O
England NNP O
. . O

Nucleic NNP O
Acids NNP O
Research NNP O

Volume NN O
12 CD O
Number NNP O
24 CD O
1984 CD O

9323 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

mouse NNP B-Species
as IN O
described VBN O
before RB O
( , O
10 CD O
) -RRB- O
. . O

High JJ O
molecular JJ O
genomic JJ O
DNA NNP O
was VBD O
digested VBN O
with IN O
various JJ O
restriction NN O
enzymes NNS O
and CC O
electrophoresed VBN O
on IN O
0 CD O
. . O
8 CD O
% NN O
agarose JJ O
gel NN O
. . O

Blotting VBG O
analysis NN O
of IN O
DNA NNP O
was VBD O
carried VBN O
out RP O
by IN O
the DT O
method NN O
of IN O
Southern NNP O
( , O
11 CD O
) -RRB- O
. . O

Hybridization NN O
was VBD O
carried VBN O
out RP O
as IN O
described VBN O
previously RB O
and CC O
filters NNS O
were VBD O
washed VBN O
either CC O
in IN O
3 CD O
x SYM O
SSC NNP O
at IN O
650C CD O
( SYM O
lower RBR O
stringent JJ O
condition NN O
) , O
or CC O
in IN O
0 CD O
. . O
1 CD O
x SYM O
SSC NNP O
at IN O
650C CD O
( : O
higher JJR O
stringent JJ O
condition NN O
) -RRB- O
. . O

Screening NN O
of IN O
genomic JJ O
DNA NNP O
library NN O

A DT O
bacteriophage NN O
XCharon NNP O
4A NNP O
/ SYM O
mouse NN B-Species
genomic JJ O
DNA NNP O
library NN O
prepared VBN O
with IN O
partial JJ O
EcoRI NNP O
digests NNS O
of IN O
mouse NNP B-Species
DNA NNP O
from IN O
MPC NNP O
11 CD O
plasmacytoma NN O
cells NNS O
was VBD O
kindly RB O
provided VBN O
by IN O
Dr NNP O
. . O
T NNP O
. . O

Honjo NNP O
. . O

Mouse NNP B-Species
IL NNP O
- HYPH O
2 CD O
- HYPH O
specific JJ O
clones NNS O
were VBD O
screened VBN O
by IN O
the DT O
method NN O
of IN O
Benton NNP O
and CC O
Davis NNP O
( HYPH O
12 CD O
) -RRB- O
, , O
using VBG O
700 CD O
bp NN O
PstI NNP O
- HYPH O
AccI NNP O
fragment NN O
of IN O
a DT O
cDNA NNP O
clone NN O
, , O
pMIL2 NN O
- HYPH O
45 CD O
as IN O
the DT O
probe NN O
( , O
Kashima NNP O
et NN O
al NNP O
. . O
, , O
submitted VBN O
for IN O
publication NN O
) -RRB- O
. . O

Hybridization NN O
was VBD O
performed VBN O
as IN O
described VBN O
previously RB O
( : O
13 CD O
) -RRB- O
. . O

Positive JJ O
clones NNS O
were VBD O
rescreened VBN O
at IN O
least JJS O
twice RB O
. . O

Subcloninq NN O
and CC O
sequencing NN O
of IN O
the DT O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O

Two CD O
EcoRI NNP O
fragments NNS O
of IN O
3 CD O
. . O
3 CD O
Kbp NN O
and CC O
2 CD O
. . O
8 CD O
Kbp NN O
from IN O
the DT O
positive JJ O
recombinant JJ O
X NN O
phage NN O
were VBD O
subcloned VBN O
into IN O
EcoRI NNP O
site NN O
of IN O
plasmid NN O
pBR322 CD O
. . O

DNA NN O
segments NNS O
derived VBN O
from IN O
subcloned VBN O
3 CD O
. . O
3 CD O
Kbp NNP O
and CC O
2 CD O
. . O
8 CD O
Kbp NN O
fragments NNS O
were VBD O
labelled VBN O
at IN O
either CC O
3 CD O
' '' O
end NN O
or CC O
5 CD O
' '' O
end NN O
, , O
and CC O
subjected VBN O
to IN O
sequence NN O
analysis NN O
by IN O
the DT O
chemical NN O
degradation NN O
method NN O
( : O
14 CD O
) -RRB- O
. . O

The DT O
0 CD O
. . O
8 CD O
Kbp NNP O
EcoRI NNP O
fragment NN O
from IN O
the DT O
same JJ O
X NN O
phage NN O
clone NN O
was VBD O
directly RB O
subjected VBN O
to IN O
sequence NN O
analysis NN O
by IN O
the DT O
dideoxy NN O
chain NN O
termination NN O
method NN O
( SYM O
15 CD O
) -RRB- O
. . O

RESULTS NNS O

Total JJ O
DNA NN O
blotting NN O
analysis NN O

In IN O
order NN O
to TO O
study VB O
structural JJ O
organization NN O
of IN O
the DT O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
, , O
we PRP O
first RB O
subjected VBD O
total JJ O
mouse NN B-Species
DNA NN O
to IN O
the DT O
blotting NN O
analysis NN O
by IN O
using VBG O
various JJ O
probes NNS O
specific JJ O
for IN O
IL NN O
- HYPH O
2 CD O
gene NN O
. . O

When WRB O
mouse NN B-Species
DNA NNP O
was VBD O
digested VBN O
with IN O
various JJ O
restriction NN O
endonucleases NNS O
and CC O
then RB O
probed VBN O
with IN O
a DT O
7 CD O
kb NN O
human JJ B-Species
chromosomal JJ O
DNA NN O
segment NN O
which WDT O
contains VBZ O
the DT O
human JJ B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
and CC O
its PRP$ O
flanking NN O
region NN O
( , O
Fig NNP O
. . O
1 CD O
lane NN O
1 CD O
- HYPH O
8 CD O
, , O
ref NN O
. . O
9 CD O
. . O
) -RRB- O
, , O
single JJ O
positive JJ O
band NN O
appeared VBD O
at IN O
lower JJR O
but CC O
not RB O
at IN O
higher JJR O
stringent JJ O
condition NN O
for IN O
washing VBG O
the DT O
filters NNS O
( , O
see VB O
Figure NNP O
legend NN O
) -RRB- O
. . O

Additional JJ O
bands NNS O
corresponding VBG O
to IN O
those DT O
observed VBN O
by IN O
using VBG O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
cDNA NN O
probes NNS O
( , O
lane NN O
13 CD O
- HYPH O
17 CD O
) -RRB- O
also RB O
appeared VBD O
by IN O
longer JJR O

9324 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

M NN O
1 CD O
2 CD O
3 CD O
4 CD O
M NN O
5 CD O
6 CD O
7 CD O
8 CD O
M NN O
9 CD O
101112 CD O
M NN O
13 CD O
141516 CD O
17 CD O

a DT O
~ : O
~ SYM O
3 CD O
. . O
. . O

I PRP O
pMIL2 NNP O
- HYPH O
45 CD O
SacI NNP O
Acc NNP O
I NN O

CZI NNP O
~ : O
~ $ O
1 CD O
1t CD O
L2 NN O
- HYPH O
20 CD O

Acc NNP O
I NN O

1 CD O
0 CD O
tp NN O
lX NN O
i NN O

Fig NN O
. . O

1 LS O
. . O

Blot NN O
hybridization NN O
analysis NN O
of IN O
mouse NN B-Species
chromosomal JJ O
DNA NN O
. . O

High JJ O
molecular JJ O
DNA NN O
prepared VBN O
from IN O
Liver NNP O
BALB NNP O
/ SYM O
C6 NNP O
mouse NN B-Species
was VBD O
digested VBN O
with IN O
various JJ O
restriction NN O
endonucleases NNS O
( , O
BamHI NNP O
for IN O
lanes NNS O
1 CD O
, , O
5 CD O
, , O
9 CD O
, , O
13 CD O
; , O
EcoRI NNP O
for IN O
lanes NNS O
2 CD O
, , O
6 CD O
, , O
10 CD O
, , O
14 CD O
, , O
17 CD O
; : O
HindIII NNP O
for IN O
lanes NNS O
3 CD O
, , O
7 CD O
, , O
11 CD O
, , O
15 CD O
; : O
XbaI NNP O
for IN O
lanes NNS O
4 CD O
, , O
8 CD O
, , O
12 CD O
, , O
16 CD O
) -RRB- O
. . O

The DT O
resulting VBG O
digests NNS O
were VBD O
fractionated VBN O
on IN O
0 CD O
. . O
8 CD O
% NN O
agarose JJ O
gel NN O
and CC O
transferred VBN O
to IN O
a DT O
nitrocellulose NN O
filter NN O
. . O

Filters NNS O
were VBD O
hybridized VBN O
by IN O
the DT O
published VBN O
procedure NN O
( SYM O
13 CD O
) , O
either CC O
with IN O
the DT O
nick NN O
- HYPH O
translated VBN O
chromosomal JJ O
DNA NN O
containing VBG O
human JJ B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
and CC O
its PRP$ O
flanking NN O
region NN O
( , O
total JJ O
length NN O
, , O
7 CD O
. . O
0 CD O
kb NN O
, , O
ref NN O
. . O
9 CD O
) -RRB- O
( , O
lane NN O
1 CD O
- HYPH O
8 CD O
) -RRB- O
or CC O
with IN O
the DT O
nick NN O
- HYPH O
translated VBN O
cDNA NN O
for IN O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
( HYPH O
see VB O
figure NN O
) -RRB- O
. . O

Filters NNS O
were VBD O
then RB O
washed VBN O
either CC O
in IN O
3 CD O
x SYM O
SSC NNP O
at IN O
65 CD O
% NN O
( , O
lower RBR O
stringent JJ O
condition NN O
) -RRB- O
( , O
lane NN O
1 CD O
- SYM O
4 CD O
, , O
9 CD O
- SYM O
12 CD O
) SYM O
or CC O
0 CD O
. . O
1 CD O
x SYM O
SSC NNP O
at IN O
65 CD O
OC NN O
( , O
higher JJR O
stringent JJ O
condition NN O
) -RRB- O
( , O
lane NN O
5 CD O
- HYPH O
8 CD O
, , O
13 CD O
- HYPH O
17 CD O
) -RRB- O
. . O

Lane NNP O
M NNP O
each DT O
contains VBZ O
7 CD O
size NN O
markers NNS O
with IN O
their PRP$ O
size NN O
being VBG O
23 CD O
. . O
7 CD O
kb NN O
, , O
9 CD O
. . O
5 CD O
kb NN O
, , O
6 CD O
. . O
7 CD O
kb NN O
, , O
4 CD O
. . O
3 CD O
kb NN O
, , O
2 CD O
. . O
3 CD O
kb NN O
, , O
2 CD O
. . O
0 CD O
kb NN O
and CC O
0 CD O
. . O
6 CD O
kb NN O
, , O
respectively RB O
. . O

Brief JJ O
restriction NN O
endonuclease NN O
cleavage NN O
map NN O
for IN O
the DT O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
cDNAs NNS O
is VBZ O
presented VBN O
in IN O
the DT O
lower JJR O
part NN O
of IN O
the DT O
figure NN O
. . O

exposure NN O
of IN O
the DT O
film NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

Those DT O
results NNS O
suggest VBP O
the DT O
presence NN O
of IN O
highly RB O
conserved VBN O
sequences NNS O
between IN O
human JJ B-Species
and CC O
mouse NN B-Species
DNA NN O
either CC O
in IN O
the DT O
flanking VBG O
regions NNS O
or CC O
in IN O
the DT O
introns NNS O
of IN O
the DT O
IL NN O
- HYPH O
2 CD O
gene NN O
, , O
since IN O
the DT O
coding VBG O
regions NNS O
apparently RB O
show VBP O
lower JJR O
degree NN O
of IN O
sequence NN O
homology NN O
as IN O
evidenced VBN O
in IN O
this DT O
series NN O
of IN O
blotting VBG O
analysis NN O
( , O
see VB O
below RB O
) -RRB- O
. . O

When WRB O
the DT O
PstI NNP O
insert NN O
of IN O
a DT O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
cDNA NN O
clone NN O
, , O
pMIL2 NN O
- HYPH O
20 CD O
, , O
was VBD O
used VBN O
as IN O
the DT O
probe NN O
, , O
a DT O
simple JJ O
pattern NN O
was VBD O

9325 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

obtained VBN O
at IN O
higher JJR O
stringent JJ O
condition NN O
( HYPH O
lane NN O
13 CD O
- HYPH O
17 CD O
) -RRB- O
. . O

While IN O
the DT O
EcoRI NNP O
- HYPH O
digested VBN O
DNA NNP O
gave VBD O
rise NN O
to IN O
two CD O
positive JJ O
bands NNS O
( : O
2 CD O
. . O
8 CD O
kb NN O
and CC O
0 CD O
. . O
8 CD O
kb NN O
) -RRB- O
( : O
Fig NNP O
. . O
1 CD O
, , O
lane NN O
14 CD O
) -RRB- O
by IN O
this DT O
analysis NN O
, , O
one CD O
additional JJ O
band NN O
of IN O
3 CD O
. . O
3 CD O
kb NN O
also RB O
appeared VBD O
when WRB O
the DT O
same JJ O
DNA NNP O
was VBD O
probed VBN O
with IN O
a DT O
longer JJR O
cDNA NN O
insert NN O
from IN O
another DT O
clone NN O
, , O
pMIL2 NNP O
- HYPH O
45 CD O
( HYPH O
Fig NNP O
. . O
1 CD O
, , O
lane NN O
17 CD O
) -RRB- O
. . O

The DT O
3 CD O
. . O
3 CD O
kb NN O
band NN O
was VBD O
similar JJ O
in IN O
its PRP$ O
size NN O
with IN O
the DT O
positive JJ O
band NN O
which WDT O
became VBD O
detectable JJ O
by IN O
probing VBG O
the DT O
same JJ O
DNA NN O
with IN O
the DT O
7 CD O
. . O
0 CD O
kb NN O
human JJ B-Species
DNA NN O
probe NN O
( , O
Fig NNP O
. . O
1 CD O
, , O
lane NN O
2 CD O
) -RRB- O
. . O

Since IN O
this DT O
band NN O
appeared VBD O
with IN O
the DT O
cDNA NNP O
probe NN O
extending VBG O
further RB O
upstream RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
the DT O
5 CD O
' '' O
region NN O
of IN O
the DT O
gene NN O
is VBZ O
located VBN O
within IN O
this DT O
DNA NNP O
segment NN O
( , O
see VB O
below RB O
) -RRB- O
. . O

Indeed RB O
, , O
this DT O
3 CD O
. . O
3 CD O
kb NN O
band NN O
did VBD O
not RB O
appear VB O
even RB O
after IN O
longer JJR O
exposure NN O
of IN O
lane NN O
14 CD O
( , O
result NN O
not RB O
shown VBN O
) : O
. . O

BamHI NNP O
digest VBD O
of IN O
the DT O
mouse NN B-Species
DNA NNP O
( , O
Fig NNP O
. . O
1 CD O
, , O
lane NN O
1 CD O
, , O
13 CD O
) -RRB- O
constantly RB O
gave VBD O
a DT O
very RB O
faint JJ O
signal NN O
which WDT O
would MD O
correspond VB O
to IN O
a DT O
DNA NN O
larger JJR O
than IN O
15 CD O
kb NNS O
. . O

Taken VBN O
together RB O
, , O
the DT O
results NNS O
suggested VBD O
the DT O
presence NN O
of IN O
a DT O
single JJ O
copy NN O
gene NN O
for IN O
murine NN B-Species
IL NN O
- HYPH O
2 CD O
. . O

On IN O
the DT O
other JJ O
hand NN O
appearance NN O
of IN O
the DT O
multiple JJ O
positive JJ O
bands NNS O
at IN O
lower JJR O
stringent JJ O
washing NN O
condition NN O
( , O
lane NN O
9 CD O
- HYPH O
12 CD O
) -RRB- O
indicates VBZ O
the DT O
presence NN O
of IN O
IL NN O
- HYPH O
2 CD O
related VBN O
sequences NNS O
within IN O
the DT O
mouse NN B-Species
genome NN O
. . O

Screening NN O
of IN O
recombinant JJ O
phaqe NN O
libraries NNS O

We PRP O
next RB O
screened VBD O
a DT O
gene NN O
library NN O
from IN O
partial JJ O
EcoRIdigested NNP O
DNA NNP O
from IN O
MPC NNP O
11 CD O
cells NNS O
and CC O
by IN O
using VBG O
0 CD O
. . O
8 CD O
Kbp NNP O
SacI NNP O
- HYPH O
AccI NNP O
cDNA NNP O
fragment NN O
as IN O
the DT O
probe NN O
and CC O
isolated VBN O
14 CD O
positive JJ O
clones NNS O
containing VBG O
sequences NNS O
specific JJ O
to IN O
the DT O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
. . O

Three CD O
of IN O
the DT O
clones NNS O
analysed VBN O
all DT O
contained VBD O
three CD O
EcoRI NNP O
fragments NNS O
whose WP$ O
size NN O
is VBZ O
in IN O
agreement NN O
with IN O
the DT O
result NN O
of IN O
blotting VBG O
analysis NN O
of IN O
the DT O
chromosomal JJ O
DNA NN O
as IN O
shown VBN O
in IN O
Fig NNP O
. . O

1 CD O
( HYPH O
lane NN O
17 CD O
) -RRB- O
. . O

One CD O
of IN O
these DT O
is VBZ O
designated VBN O
MIL NNP O
- HYPH O
2G70 CD O
. . O

Nucleotide NN O
sequence NN O
analysis NN O

Two CD O
DNA NN O
fragments NNS O
of IN O
3 CD O
. . O
3 CD O
Kbp NN O
and CC O
2 CD O
. . O
8 CD O
Kbp NN O
were VBD O
excised VBN O
from IN O
the DT O
phage NN O
clone NN O
MIL NN O
- HYPH O
2G70 CD O
by IN O
EcoRI NNP O
digestion NN O
and CC O
they PRP O
were VBD O
subcloned VBN O
into IN O
pBR322 CD O
. . O

DNA NN O
sequences NNS O
were VBD O
determined VBN O
for IN O
selected VBN O
regions NNS O
of IN O
both DT O
inserts NNS O
and CC O
compared VBN O
to IN O
the DT O
known VBN O
cDNA NNP O
sequences NNS O
( , O
Kashima NNP O
et NN O
al NNP O
. . O
, , O
submitted VBN O
for IN O
publication NN O
) -RRB- O
. . O

The DT O
strategy NN O
used VBN O
for IN O
sequence NN O
analysis NN O
of IN O
the DT O
genomic JJ O
DNA NNP O
is VBZ O
presented VBN O
in IN O
Fig NNP O
. . O

2 LS O
. . O

Comparison NN O
of IN O
the DT O
mouse NN B-Species
genomic JJ O
IL NN O
- HYPH O
2 CD O
sequence NN O
with IN O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
cDNA NN O
sequence NN O
revealed VBD O
that IN O
, , O
like IN O
the DT O
human JJ B-Species
gene NN O
, , O
the DT O
gene NN O
is VBZ O
divided VBN O
into IN O
four CD O
exons NNS O
. . O

A DT O
putative JJ O

9326 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

E NN O
E NN O
E NN O
E NN O
E NN O

500bp CD O
s NN O
7S NNS O
P NN O
HBH NN O
H NN O
\ NFP O
A NN O

200 CD O
bp NN O
* NFP O
, , O
- : O
4 CD O

I PRP O
4 CD O
- SYM O
4 CD O
- HYPH O
- HYPH O
- : O
- : O
* NFP O
* NFP O
- : O
- : O
- : O
4 CD O

Fig NN O
. . O

2 LS O
. . O

Restriction NN O
map NN O
and CC O
sequencing NN O
strategy NN O
of IN O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
. . O

Horizontal JJ O
lines NNS O
indicate VBP O
the DT O
length NN O
of IN O
mouse NN B-Species
DNA NN O
inserted VBN O
into IN O
the DT O
X NN O
phage NN O
Charon NNP O
4A NNP O
or CC O
plasmid JJ O
subclones NNS O
. . O

Filled VBN O
blocks NNS O
, , O
dashed VBN O
blocks NNS O
and CC O
open JJ O
blocks NNS O
indicate VBP O
protein NN O
coding VBG O
regions NNS O
, , O
untranslated JJ O
regions NNS O
and CC O
introns NNS O
, , O
respectively RB O
. . O

Horizontal JJ O
arrows NNS O
indicate VBP O
the DT O
direction NN O
and CC O
extent NN O
of IN O
sequence NN O
determination NN O
without IN O
ambiguity NN O
. . O

Dashed VBN O
arrows NNS O
: : O
determination NN O
was VBD O
done VBN O
by IN O
the DT O
chain NN O
termination NN O
method NN O
( , O
15 CD O
) -RRB- O
after IN O
subcloning VBG O
the DT O
0 CD O
. . O
8 CD O
kb NN O
fragment NN O
into IN O
M13 NNP O
. . O

Rest NN O
of IN O
the DT O
sequence NN O
determination NN O
was VBD O
carried VBN O
out RP O
by IN O
the DT O
method NN O
of IN O
Maxam NNP O
and CC O
Gilbert NNP O
( HYPH O
14 CD O
) -RRB- O
. . O

A DT O
AccI NNP O
site NN O
, , O
B NNP O
; : O
BamHI NNP O
site NN O
, , O
E NNP O
; : O
EcoRI NNP O
site NN O
, , O
H NNP O
; : O
HindIII NNP O
site NN O
, , O
P NN O
; : O
PstI NNP O
site NN O
, , O
S NNP O
; : O
SacI NNP O
site NN O
. . O

capping VBG O
site NN O
or CC O
the DT O
transcription NN O
initiation NN O
site NN O
was VBD O
located VBN O
32 CD O
bp NN O
downstream RB O
from IN O
a DT O
TATAAA NNP O
consensus NN O
promotor NN O
sequence NN O
( , O
Fig NNP O
. . O

3 LS O
) -RRB- O
. , O
The DT O
first JJ O
ATG NNP O
triplet NN O
was VBD O
located VBN O
79 CD O
bp NN O
downstream RB O
from IN O
the DT O
TATA NNP O
box NN O
. . O

As IN O
seen VBN O
also RB O
in IN O
the DT O
murine NN B-Species
IL NNP O
- HYPH O
2 CD O
cDNA NN O
, , O
there EX O
is VBZ O
an DT O
unusual JJ O
repeat NN O
of IN O
CAG NNP O
triplet NN O
coding VBG O
for IN O
12 CD O
glutamine NN O
residues NNS O
in IN O
a DT O
row NN O
in IN O
the DT O
first JJ O
exon NN O
. . O

The DT O
second JJ O
exon NN O
( : O
60 CD O
bp NN O
) -RRB- O
is VBZ O
separated VBN O
from IN O
the DT O
first JJ O
exon NN O
by IN O
a DT O
short JJ O
intron NN O
consisting VBG O
of IN O
97 CD O
bp NN O
. . O

The DT O
second JJ O
, , O
the DT O
third JJ O
and CC O
the DT O
fourth JJ O
exons NNS O
are VBP O
interrupted VBN O
by IN O
longer JJR O
introns NNS O
whose WP$ O
size NN O
is VBZ O
about RB O
2 CD O
. . O
3 CD O
Kbp NN O
and CC O
1 CD O
. . O
6 CD O
Kbp NN O
, , O
respectively RB O
. . O

As RB O
far RB O
as IN O
the DT O
available JJ O
sequence NN O
data NNS O
are VBP O
concerned VBN O
, , O
it PRP O
seems VBZ O
that IN O
, , O
despite IN O
their PRP$ O
identical JJ O
location NN O
, , O
intron NN O
sequences NNS O
are VBP O
distinctly RB O
dissimilar JJ O
except IN O
for IN O
the DT O
junction NN O
regions NNS O
between IN O
the DT O
human JJ B-Species
and CC O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
genes NNS O
. . O

There EX O
are VBP O
two CD O
potential JJ O
poly JJ O
( , O
A NN O
) -RRB- O
addition NN O
signals NNS O
within IN O
the DT O
mouse NN B-Species
gene NN O
( -LRB- O
nucleotide NN O
positions NNS O
793 CD O
- SYM O
798 CD O
and CC O
924 CD O
- SYM O
929 CD O
in IN O
Fig NNP O
. . O
3 CD O
) -RRB- O
and CC O
, , O
based VBN O
on IN O
our PRP$ O
sequence NN O
data NNS O
for IN O
various JJ O
cDNA NN O
clones NNS O
, , O
both DT O
signals NNS O
seem VBP O
to TO O
function VB O
and CC O
give VB O
rise NN O
to IN O
heterogeneous JJ O
termini NN O
of IN O
the DT O
mRNA NNP O
in IN O
the DT O
LBRM NNP O
- HYPH O
33 CD O
cells NNS O
( SYM O
16 CD O
) -RRB- O
. . O

We PRP O
have VBP O
also RB O
determined VBN O
the DT O
sequence NN O
of IN O
about RB O
500 CD O
bp NN O
of IN O
5 CD O
' '' O
- HYPH O
flanking VBG O
region NN O
of IN O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
, , O
since IN O
( , O
i PRP O
) -RRB- O
promoter NN O
/ SYM O
regulatory JJ O
sequences NNS O
are VBP O
located VBN O
in IN O
this DT O
region NN O
in IN O
many JJ O
other JJ O
genes NNS O
of IN O
eukaryotes NNS O
and CC O
( , O
ii FW O
) , O
this DT O
region NN O
appeared VBD O
to TO O
contain VB O
sequences NNS O
which WDT O
show VBP O
strongest JJS O
cross JJ O
- HYPH O
hybridization NN O
between IN O
human JJ B-Species
and CC O
mouse NN B-Species
DNA NN O
around IN O
the DT O
IL NN O
- HYPH O
2 CD O
gene NN O
( : O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

Comparison NN O
of IN O
the DT O
nucleotide NN O
sequences NNS O
for IN O
the DT O
5 CD O
' `` O
flanking NN O
region NN O

9327 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

- : O
4 CD O
. . O
0 NFP O

TAGGAGGTAAACCATCTCGA NNP O
- : O
400 CD O
- HYPH O
350 CD O

GATTTATTCTTTTCATCTAT NNP O

- : O
300 CD O
- HYPH O
250 CD O

CATGAGTTACTTTTGTGTCT NNP O

- : O
200 CD O
- SYM O
150 CD O

TGGGCTAACCCGACCAAGAG NNP O

- : O
100 CD O
- SYM O
50 CD O

AAACAAAGGTAATACTTTCT NNP O
CAGCATTAACAGTATAAATT NNP O
TCACCCTTGCTAATCACTCC NNP O

50 CD O
100 CD O

ATG NN O
TAC NN O
AGC NN O
ATG NN O
CAG NN O
CTC NN O
GCA NN O
TCC NN O
TGT NN O
GTC NNP O
ACA NNP O
TTG NNP O
ACA NNP O
CTT NNP O
GTG NNP O
CTC NNP O
CTT NNP O
GTC NNP O
AAC NN O
AGC NN O
GCA NN O
CCC NN O
ACT NN O
Met NN O
Tyr NN O
Ser NN O
Met NN O
Gln NNP O
Leu NNP O
Ala NN O
Ser NN O
Cys NN O
Val NN O
Thr NN O
Leu NNP O
Thr NNP O
Leu NNP O
Val NNP O
Leu NNP O
Leu NNP O
Val NNP O
Asn NNP O
Ser NNP O
Ala NNP O
Pro NNP O
Thr NNP O

150 CD O

TCA NN O
AGC NN O
TCC NN O
ACT NN O
TCA NN O
AGC NN O
TCT NN O
ACA NN O
GCG NNP O
GAA NNP O
GCA NNP O
CAG NNP O
CAG NNP O
CAG NNP O
CAG NNP O
CAG NNP O
CAG NNP O
CAG NNP O
CAG NNP O
CAG NNP O
CAG NNP O
CAG NNP O
CAG NNP O
Ser NNP O
Ser NNP O
Ser NNP O
Thr NNP O
Ser NNP O
Ser NNP O
Ser NNP O
Thr NNP O
Ala NNP O
Glu NNP O
Ala NNP O
Gln NNP O
Gln NNP O
Gln NNP O
Gln NNP O
Gln NNP O
Gln NNP O
Gln NNP O
Gln NNP O
Gln NNP O
Gln NNP O
Gln NNP O
Gln NNP O

200 CD O

CAC NNP O
CTG NNP O
GAG NNP O
CAG NNP O
CTG NNP O
TTG NNP O
ATG NNP O
GAC NNP O
CTA NNP O
CAG NNP O
GAG NNP O
CTC NNP O
CTG NN O
AGC NN O
AGG NN O
ATG NNP O
GAG NNP O
GTAAGTGCACAGCCATCCCA NNP O
His PRP$ O
Leu NNP O
Glu NNP O
Gln NNP O
Leu NNP O
Leu NNP O
Met NNP O
Asp NNP O
Leu NNP O
Gln NNP O
Glu NNP O
Leu NNP O
Leu NNP O
Ser NNP O
Arg NNP O
Met NNP O
Glu NNP O

TATAGGCAATACCTTTAGCT NNP O
AAT NNP O
TAC NNP O
AGG NNP O
AAC NNP O

lAsn NNP O
Tyr NNP O
Arg NNP O
Asn NNP O
250 CD O

CTG NN O
AAA NN O
CTC NN O
CCC NN O
AGG NN O
ATG NN O
CTC NN O
ACC NN O
TTC NN O
AAA NN O
TTT NNP O
TAC NNP O
TTG NNP O
CCC NNP O
AAG NNP O
CAG NNP O
GTGAGTGAGTTTCTGTTTAA NNP O
Leu NNP O
Lys NNP O
Leu NNP O
Pro NNP O
Arg NNP O
Met NNP O
Leu NNP O
Thr NNP O
Phe NNP O
Lys NNP O
Phe NNP O
Tyr NNP O
Leu NNP O
Pro NNP O
Lys NNP O
Gln NNP O

TCTAATG NFP O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- HYPH O
- : O
- HYPH O
- : O
- HYPH O
- HYPH O
- NFP O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- : O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- : O
- : O
- : O
- : O
- HYPH O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
_ NFP O
_ : O

? . O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
_ NFP O
- NFP O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- NFP O
- NFP O
- NFP O
- NFP O
2000 NFP O
bp NFP O
- HYPH O
- : O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- : O
- : O
- : O
- : O
? . O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- HYPH O
- : O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- : O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
AATGTGAACCTTGTAGTTTC NN O
TATGCATTGGTAGAGAAACA NNP O
TGGTTGTGAGCTCTTGCTCT NNP O
CCTTCTCTTGATTAGAGAGA NNP O

300 CD O
350 CD O

GCC NNP O
ACA NNP O
GAA NNP O
TTG NNP O
AAA NNP O
GAT NNP O
CTT NNP O
CAG NNP O
TGC NNP O
CTA NNP O
GAA NNP O
GAT NNP O
GAA NNP O
CTT NNP O
GGA NNP O
CCT NNP O
CTG NNP O
CGG NNP O
CAT NNP O
GTT NNP O
CTG NNP O
GAT NNP O
TTG NNP O
Ala NNP O
Thr NNP O
Glu NNP O
Leu NNP O
Lys NNP O
Asp NN O
Leu NNP O
Gln NNP O
Cys NNP O
Leu NNP O
Glu NNP O
Asp NNP O
Glu NNP O
Leu NNP O
Gly NNP O
Pro NNP O
Leu NNP O
Arg NNP O
His PRP$ O
Val NNP O
Leu NNP O
Asp NNP O
Leu NNP O

490 CD O

ACT NN O
CAA NN O
AGC NN O
AAA NN O
AGC NN O
TTT NNP O
CAA NNP O
TTG NNP O
GAA NNP O
GAT NNP O
GCT NNP O
GAG NNP O
AAT NNP O
TTC NNP O
ATC NN O
AGC NN O
AAT NN O
ATC NN O
AGA NN O
GTA NN O
ACT NN O
GTT NNP O
GTA NNP O
Thr NN O
Gln NNP O
Ser NNP O
Lys NNP O
Ser NNP O
Phe NNP O
Gln NNP O
Leu NNP O
Glu NNP O
Asp NNP O
Ala NNP O
Glu NNP O
Asn NNP O
Phe NNP O
Ile NNP O
Ser NNP O
Asn NNP O
Ile NNP O
Arg NNP O
Val NNP O
Thr NNP O
Val NNP O
Val NNP O
AAA NNP O
CTA NNP O
AAG NNP O
GTAAGGTGTTGCTTTATTTG NNP O
Lys VBZ O
Leu NNP O
Lys NNP O

CTTTGATGGGTTCTGTGCAT NFP O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- NFP O
- NFP O
- NFP O
- NFP O
- HYPH O
- HYPH O
- HYPH O
1000 CD O
bp HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- NFP O
- NFP O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- HYPH O
- : O
- : O
- : O
- HYPH O
GAATTCTACAGAAGTGTTCA NN O
TATTTTTTATGCTTTACCAT NN O

CAGTGTTAAAATAAATGCCT NNP O

450 CD O
500 CD O

GGC NNP O
TCT NNP O
GAC NNP O
AAC NNP O
ACA NNP O
TTT NNP O
GAG NNP O
TGC NNP O
CAA NNP O
TTC NNP O
GAT NNP O
GAT NNP O
GAG NNP O
TCA NN O
GCA NN O
ACT NN O
GTG NNP O
GTG NNP O
GAC NNP O
TTT NNP O
CTG NNP O
AGG NNP O
AGA NNP O
Gly NNP O
Ser NNP O
Asp NN O
Asn NN O
Thr NN O
Phe NN O
Glu NNP O
Cys NNP O
Gln NNP O
Phe NN O
Asp NN O
Asp NN O
GlU NNP O
Ser NNP O
Ala NNP O
Thr NNP O
Val NNP O
Val NNP O
Asp NNP O
Phe NNP O
Leu NNP O
Arg NNP O
Arg NNP O

550 CD O

TGG NN O
ATA NN O
GCC NN O
TTC NN O
TGT NN O
CAA NN O
AGC NN O
ATC NN O
ATC NN O
TCA NN O
ACA NN O
AGC NN O
CCT NN O
CAA NN O
TAACTATGTACCTCCTGCTT NN O
Trp NN O
Ile NNP O
Ala NNP O
Phe NNP O
Cys NN O
Gln NNP O
Ser NNP O
Ile NNP O
Ile NNP O
Ser NN O
Thr NN O
Ser NN O
Pro NNP O
Gln NNP O

600 CD O
650 CD O

TCTCTATTTAT4TAAATATT NNP O

700 CD O
750 CD O

GATCTTTAAAGATTCTTTTT NNP O
+ CC O
ATTATATTGAATTGTTAAAT NNP O

< NFP O
4 CD O
> SYM O
800 CD O
850 CD O

ATCATGTGTAGGTAGACTcA NNP O
TAAAAGTAmAGATGATTCAA NNP O

900 CD O
0 CD O
"""" '' O

TAAGCGCTAAAATAACTTCT NNP O
AAA NNP O
GATGGCTTGTGGGAAAAGAT NNP O

Fig NN O
. . O

3 LS O
. . O

Nucleotide NN O
sequence NN O
of IN O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
. . O

Four CD O
exons NNS O
are VBP O
framed VBN O
. . O

Numbers NNS O
refer VBP O
to IN O
nucleotide NN O
positions NNS O
of IN O
exons NNS O
from IN O
the DT O
presumed VBN O
cap NN O
site NN O
. . O

Dots NNS O
and CC O
open JJ O
circles NNS O
indicate VBP O
TATA NNP O
box NN O
and CC O
poly JJ O
A NN O
additional JJ O
signals NNS O
, , O
respectively RB O
. . O

9328 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

- HYPH O
4 CD O
5 CD O
0 CD O
- HYPH O
400 CD O

TAGGAGGT NNP O
AAACCA NNP O
T NNP O
CTCGAAAC NNP O
GGAAACCAATATCCTTCCTG NNP O

. . O
0 NFP O
* NFP O
. . O
0 NFP O
. . O
- : O
* NFP O
. . O

* NFP O
. . O
. . O
* NFP O
- : O
- : O
. . O

- : O
- : O
. . O
* NFP O
- : O
@ : O
. . O
. . O
. . O
. . O
. . O
. . O
. . O
. . O
. . O
. . O
. . O
. . O
. . O
. . O

- : O
- : O
- : O
* NFP O
- : O
* NFP O
* NFP O

TAAAAAGGTAAAACCAGTTC NNP O
GAAACAGGAAACCAATACAC NNP O
CATTTATTCTTTTCATCTGT NNP O

- : O
350 CD O
- SYM O
300 CD O

TCTTGCGCCCGTCCACCACA NNP O
T NNP O
ACAGGTTCAGGATGGTTTTG NNP O
TCTTGCTCTTGTTCACCACA NNP O
TGCTATTCACATGTTCAGTG NNP O
TGAGTTACTTTTGTATCCC NNP O

- : O
250 CD O

CA NN O
CCCC NNP O
AAAG NNP O
AGGAAAATTTGTTTCATACG NNP O
CCACCTAAGAGTGGGCTAAC NNP O

* NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
. . O
. . O
. . O
. . O
. . O

* NFP O
. . O
- : O
- : O
* NFP O
. . O
. . O
- : O
* NFP O
. . O
- : O
- : O
. . O
* NFP O
* NFP O
. . O

* NFP O
- : O
. . O

- : O
- : O
. . O

* NFP O
- : O
* NFP O
- : O
- : O
- : O
* NFP O
- : O
0 NFP O
@ CC O
* NFP O
- HYPH O
- : O
0 NFP O
. . O
. . O

. . O

CACCCCCTTAAAGAAAGGAG NNP O

- : O
200 CD O
- SYM O
150 CD O

CCAAGAGGGATTTCACCTAA NNP O
GGGGTTTAAACAAATTCCAG NNP O
CAAAGAGGGATTTCACCTAC NNP O
AAATTCCAAAGAGTCATCAG NNP O

- : O
100 CD O
- SYM O
50 CD O

TACTTTCTGCCACACAGGTA NNP O
TGTTTTTT NNP O
CAGACAGGTAAAGTC NNP O
TTTGAAAATATGTGTAATAT NNP O
ATAAGCCTCCCATGCTGAAG NNP O
Mouse NNP B-Species
rTATGCATCTCTTGTTCAAG NNP O
Human NNP B-Species

Fig NN O
. . O

4 LS O
. . O

Comparison NN O
of IN O
5 CD O
' '' O
- HYPH O
flanking VBG O
regions NNS O
of IN O
mouse NN B-Species
and CC O
human JJ B-Species
IL NN O
- HYPH O
2 CD O
genes NNS O
. . O

In IN O
aligning VBG O
the DT O
sequences NNS O
for IN O
both DT O
genes NNS O
, , O
gaps NNS O
were VBD O
introduced VBN O
to TO O
maximize VB O
homology NN O
. . O

Dots NNS O
indicate VBP O
identical JJ O
nucleotide JJ O
sequences NNS O
. . O

Number NN O
1 CD O
indicates VBZ O
putative JJ O
transcription NN O
initiation NN O
site NN O
. . O

Inverted VBN O
repeats NNS O
are VBP O
indicated VBN O
by IN O
bars NNS O
and CC O
dashed VBN O
lines NNS O
. . O

TATA NNP O
box NN O
is VBZ O
framed VBN O
. . O

of IN O
both DT O
genes NNS O
is VBZ O
illustrated VBN O
in IN O
Fig NNP O
. . O

4 LS O
. . O

The DT O
nucleotide NN O
sequence NN O
homology NN O
from IN O
the DT O
TATA NNP O
box NN O
to IN O
- HYPH O
470 CD O
is VBZ O
85 CD O
% NN O
. . O

The DT O
highest JJS O
region NN O
of IN O
homology NN O
was VBD O
observed VBN O
between IN O
the DT O
TATA NNP O
box NN O
and CC O
position NN O
- HYPH O
97 CD O
( , O
60 CD O
bp NN O
matches NNS O
out IN O
of IN O
64 CD O
bp NN O
) -RRB- O
of IN O
both DT O
genes NNS O
. . O

DISCUSSION NN O

We PRP O
have VBP O
isolated VBN O
recombinant JJ O
clones NNS O
for IN O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
from IN O
a DT O
phage NN O
Charon NNP O
4A NNP O
/ SYM O
mouse NN B-Species
genomic JJ O
DNA NNP O
library NN O
and CC O
determined VBD O
the DT O
entire JJ O
sequence NN O
of IN O
the DT O
gene NN O
except IN O
for IN O
the DT O
sequence NN O
of IN O
the DT O
internal JJ O
portion NN O
of IN O
the DT O
second JJ O
and CC O
third JJ O
introns NNS O
. . O

The DT O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
cDNA NN O
sequence NN O
was VBD O
aligned VBN O
with IN O
the DT O
genomic JJ O
sequence NN O
and CC O
both DT O
sequences NNS O
matched VBN O
completely RB O
each DT O
other JJ O
. . O

The DT O
unusual JJ O
CAG NNP O
repeats NNS O
encoding VBG O
12 CD O
glutamines NNS O
which WDT O
was VBD O
found VBN O
previously RB O
in IN O
the DT O
cloned VBN O
cDNA NN O
was VBD O
shown VBN O
to TO O
be VB O
present JJ O
also RB O
in IN O
the DT O
chromosomal JJ O
gene NN O
. . O

This DT O
finding NN O
further RB O
excludes VBZ O
the DT O
possibility NN O
that IN O
the DT O
unique JJ O
repeat NN O
is VBZ O
generated VBN O
by IN O
artifacts NNS O
during IN O
the DT O
cDNA NNP O
cloning NN O
process NN O
. . O

Although IN O
we PRP O
can MD O
not RB O
rule VB O
out RP O
the DT O
possibility NN O
for IN O
the DT O
deletion NN O
of IN O
this DT O
sequence NN O
in IN O
the DT O
human JJ B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
, , O
it PRP O
is VBZ O
more RBR O
likely JJ O
that IN O
the DT O
CAG NNP O
repeat NN O
has VBZ O
been VBN O
generated VBN O
in IN O
the DT O
mouse NN B-Species
genome NN O
rather RB O
recently RB O
. . O

The DT O
repeat NN O
could MD O
have VB O
been VBN O
generated VBN O
either CC O
by IN O
a DT O
direct JJ O
insertion NN O
of IN O
the DT O
sequence NN O
or CC O
by IN O
the DT O
duplication NN O
after IN O
insertion NN O
of IN O
a DT O
unit NN O
sequence NN O
. . O

9329 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Organization NN O
of IN O
the DT O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
resembles VBZ O
to IN O
that DT O
of IN O
the DT O
human JJ B-Species
gene NN O
( : O
Fig NNP O
. . O
2 CD O
. . O
, , O
ref NN O
. . O
9 CD O
) -RRB- O
. . O

There EX O
seems VBZ O
to TO O
be VB O
little JJ O
sequence NN O
homology NN O
between IN O
corresponding VBG O
introns NNS O
of IN O
mouse NN B-Species
and CC O
human JJ B-Species
IL NN O
- HYPH O
2 CD O
genes NNS O
, , O
except IN O
for IN O
the DT O
intron NN O
- HYPH O
exon NN O
junctions NNS O
part NN O
of IN O
which WDT O
is VBZ O
thought VBN O
to TO O
be VB O
necessary JJ O
for IN O
the DT O
RNA NNP O
splicing NN O
( , O
17 CD O
, , O
18 CD O
) -RRB- O
. . O

Dissimilarity NN O
of IN O
the DT O
intron NN O
sequences NNS O
among IN O
the DT O
genes NNS O
which WDT O
are VBP O
derived VBN O
from IN O
a DT O
common JJ O
ancestor NN O
has VBZ O
been VBN O
reported VBN O
in IN O
other JJ O
genes NNS O
( , O
19 CD O
, , O
20 CD O
) -RRB- O
. . O

In IN O
spite NN O
of IN O
the DT O
divergence NN O
in IN O
sequence NN O
of IN O
introns NNS O
, , O
the DT O
size NN O
and CC O
position NN O
of IN O
the DT O
introns NNS O
are VBP O
very RB O
similar JJ O
between IN O
the DT O
murine NN B-Species
and CC O
human JJ B-Species
IL NN O
- HYPH O
2 CD O
genes NNS O
. . O

Of IN O
particular JJ O
interests NNS O
is VBZ O
the DT O
presence NN O
of IN O
highly RB O
conserved VBN O
sequences NNS O
in IN O
the DT O
5 CD O
' '' O
- HYPH O
flanking VBG O
region NN O
of IN O
the DT O
human JJ B-Species
and CC O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
( : O
Fig NNP O
. . O
4 CD O
) -RRB- O
. . O

Whereas IN O
the DT O
coding VBG O
region NN O
shows VBZ O
nucleotide NN O
sequence NN O
homology NN O
of IN O
72 CD O
% NN O
between IN O
the DT O
two CD O
genes NNS O
, , O
the DT O
5 CD O
' '' O
upstream JJ O
region NN O
spanning VBG O
about IN O
500 CD O
bp NN O
( , O
Fig NNP O
. . O
4 CD O
) -RRB- O
shows VBZ O
85 CD O
% NN O
homology NN O
which WDT O
was VBD O
readily RB O
detectable JJ O
by IN O
the DT O
blotting NN O
analysis NN O
( , O
Fig NNP O
. . O
1 CD O
, , O
lane NN O
1 CD O
- HYPH O
4 CD O
) -RRB- O
. . O

Since IN O
we PRP O
have VBP O
not RB O
yet RB O
determined VBN O
the DT O
nucleotide NN O
sequence NN O
further RB O
upstream RB O
of IN O
the DT O
mouse NN B-Species
gene NN O
, , O
we PRP O
do VBP O
not RB O
know VB O
whether IN O
or CC O
not RB O
this DT O
similarity NN O
extends VBZ O
further RBR O
. . O

It PRP O
is VBZ O
likely JJ O
that IN O
such JJ O
sequences NNS O
are VBP O
involved VBN O
in IN O
the DT O
controlled VBN O
expression NN O
of IN O
the DT O
IL NN O
- HYPH O
2 CD O
genes NNS O
in IN O
activated VBN O
T NNP O
- HYPH O
lymphocytes NNS O
. . O

Work NN O
is VBZ O
in IN O
progress NN O
to TO O
identify VB O
such JJ O
DNA NN O
sequences NNS O
by IN O
introducing VBG O
the DT O
cloned VBN O
genes NNS O
into IN O
various JJ O
lymphocytic JJ O
cell NN O
lines NNS O
. . O

Our PRP$ O
preliminary JJ O
results NNS O
indicate VBP O
that IN O
the DT O
5 CD O
' '' O
- HYPH O
flanking VBG O
sequence NN O
of IN O
the DT O
human JJ B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
mediates VBZ O
mitogen NN O
induced VBN O
expression NN O
of IN O
the DT O
gene NN O
in IN O
T NNP O
- HYPH O
lymphocytic JJ O
cells NNS O
( , O
Fujita NNP O
& CC O
Taniguchi NNP O
, , O
unpublished JJ O
observation NN O
) -RRB- O
. . O

ACKNOWLEDGEMENTS NNS O

We PRP O
thank VBP O
Dr NNP O
. . O
T NNP O
. . O

Honjo NNP O
for IN O
mouse NN B-Species
gene NN O
library NN O
. . O

We PRP O
are VBP O
also RB O
indepted JJ O
to IN O
Ms NNP O
. . O
M NNP O
. . O

Nagatsuka NNP O
for IN O
typing VBG O
the DT O
manuscript NN O
. . O

This DT O
work NN O
was VBD O
supported VBN O
in IN O
part NN O
by IN O
Grant NNP O
- HYPH O
in IN O
- HYPH O
Aid NNP O
for IN O
Special NNP O
Project NNP O
Research NNP O
, , O
Cancer NNP O
- HYPH O
Bioscience NNP O
from IN O
the DT O
Ministry NNP O
of IN O
Education NNP O
, , O
Science NNP O
and CC O
Culture NNP O
, , O
Japan NNP O
. . O

? , O
To TO O
whom WP O
correspondence NN O
should MD O
be VB O
addressed VBN O

* NFP O
Present JJ O
address NN O
: : O
Department NNP O
of IN O
Microbiology NNP O
, , O
School NNP O
of IN O
Medicine NNP O
, , O
Chiba NNP O
University NNP O
, , O
Chiba NNP O
280 CD O
, , O
Japan NNP O

+ NFP O
Present JJ O
address NN O
: : O
Central NNP O
Research NNP O
Laboratory NNP O
, , O
Ajinomoto NNP O
Co NNP O
. . O
Inc NNP O
. . O
, , O
Totsuka NNP O
- HYPH O
ku NNP O
, , O
Yokohama NNP O
244 CD O
, , O
Japan NNP O

9330 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

REFERENCES NNS O

1 LS O
. . O

Morgan NNP O
, , O
D NNP O
. . O

A UH O
. . O
, , O
Ruscetti NNP O
, , O
F NNP O
. . O

W UH O
. . O
and CC O
Gallo NNP O
, , O
R NN O
. . O

( -LRB- O
1976 CD O
) -RRB- O
Science NN O
, , O

193 CD O
, , O
1007 CD O
- SYM O
1008 CD O
. . O

2 LS O
. . O

Gil NNP O
lis NNP O
, , O
S NNP O
. . O

Ferm NNP O
, , O
M NNP O
. . O

M UH O
. . O
, , O
Ou NNP O
, , O
W NNP O
. . O
and CC O
Smith NNP O
, , O
K NNP O
. . O

( : O
1 CD O
978 CD O
) SYM O
J NN O
. . O

Immunol NNP O
. . O
, , O
120 CD O
, , O
2023 CD O
- HYPH O
2027 CD O
. . O

3 LS O
. . O

Chen NNP O
, , O
B NNP O
. . O

M UH O
. . O
and CC O
Di NNP O
Sabato NNP O
, , O
G NNP O
. . O

( -LRB- O
1976 CD O
) SYM O
Cell NNP O
. . O

Immunol NNP O
. . O
, , O
22 CD O
, , O
211 CD O

224 CD O
. . O

4 LS O
. . O

Henney NNP O
, , O
C NNP O
. . O

S NNP O
. . O
, , O
Kuribayashi NNP O
, , O
K NNP O
. . O
, , O
Kern NNP O
, , O
D NNP O
. . O

E UH O
. . O
and CC O
Gillis NNP O
, , O
S NNP O
. . O

( : O
1981 CD O
) SYM O
Nature NNP O
, , O
291 CD O
, , O
335 CD O
- HYPH O
338 CD O
. . O

5 LS O
. . O

Wagner NNP O
, , O
H NNP O
. . O
, , O
Hardt NNP O
, , O
C NNP O
. . O
, , O
Heeg NNP O
, , O
K NNP O
. . O
, , O
Rollinghoff NNP O
, , O
M NNP O
. . O
and CC O

Pfizenmaier NNP O
, , O
K NNP O
. . O

( : O
1980 CD O
) SYM O
Nature NNP O
, , O
284 CD O
, , O
278 CD O
- HYPH O
280 CD O
. . O

6 LS O
. . O

Farrar NNP O
, , O
J NNP O
. . O

J NNP O
. . O
, , O
Benjamin NNP O
, , O
W NNP O
. . O

R NNP O
. . O
, , O
Hilfikr NNP O
M NNP O
. . O

L NNP O
. . O
, , O
Howard NNP O
, , O
M NNP O
. . O
, , O

Farrar NNP O
, , O
W NNP O
. . O

L NNP O
. . O
and CC O
Fuller NNP O
- HYPH O
Farrar NNP O
, , O
J NNP O
. . O

( -LRB- O
1982 CD O
) SYM O
Immunol NNP O
. . O

Rev NNP O
. . O

63 CD O
, , O
129 CD O
- SYM O
166 CD O
. . O

7 LS O
. . O

Pearlstein NNP O
, , O
K NNP O
. . O
, , O
Palladino NNP O
, , O
M NNP O
. . O

A DT O
. . O
, , O
Welte NNP O
, , O
K NNP O
. . O
and CC O
Vilcek NNP O
, , O
J NNP O
. . O

( -LRB- O
1983 CD O
) SYM O
Cell NNP O
. . O

Immunol NNP O
. . O
, , O
80 CD O
, , O
1 CD O
- SYM O
9 CD O
. . O

8 LS O
. . O

Taniguchi NNP O
, , O
T NNP O
. . O
, , O
Matsui NNP O
, , O
H NNP O
. . O
, , O
Fujita NNP O
, , O
T NNP O
. . O
, , O
Takaoka NNP O
, , O
C NNP O
. . O
, , O
Kashima NNP O
, , O

N NNP O
. . O
, , O
Yoshimoto NNP O
, , O
R NNP O
. . O
and CC O
Hamuro NNP O
, , O
J NNP O
. . O

( -LRB- O
1983 CD O
) SYM O
Nature NNP O
302 CD O
, , O
305 CD O
- HYPH O
310 CD O
. . O

9 LS O
. . O

Fujita NNP O
, , O
T NNP O
. . O
, , O
Takaoka NNP O
, , O
C NNP O
. . O
, , O
Matsui NNP O
, , O
H NNP O
. . O
and CC O
Taniguchi NNP O
T NNP O
. . O

( -LRB- O
1983 CD O
) NFP O

Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
80 CD O
, , O
7437 CD O
- HYPH O
7411 CD O
. . O

10 CD O
. . O

Ohno NNP O
, , O
S UH O
. . O
and CC O
Taniguchi NNP O
, , O
T NNP O
. . O

( : O
1982 CD O
) SYM O
Nucleic JJ O
Acids NNS O
Res NNP O
. . O

10 CD O
, , O
967 CD O

977 CD O
. . O

11 CD O
. . O

Southern JJ O
, , O
E UH O
. . O

M UH O
. . O

( : O
1975 CD O
) SYM O
J NN O
. . O

Mol NNP O
. . O

Biol NNP O
. . O

98 CD O
, , O
503 CD O
- HYPH O
517 CD O
. . O

12 CD O
. . O

Benton NNP O
, , O
W NNP O
. . O

D UH O
. . O
and CC O
Davis NNP O
, , O
R NN O
. . O

W UH O
. . O

( : O
1977 CD O
) -RRB- O
Science NN O
196 CD O
, , O
180 CD O
- SYM O
182 CD O
. . O

13 CD O
. . O

Ohno NNP O
, , O
S UH O
. . O
and CC O
Taniguchi NNP O
, , O
T NNP O
. . O

( -LRB- O
1981 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O

78 CD O
, , O
5305 CD O
- HYPH O
5309 CD O
. . O

14 CD O
. . O

Maxam NNP O
, , O
A NNP O
. . O

M UH O
. . O
and CC O
Gilbert NNP O
, , O
W NNP O
. . O

( : O
1980 CD O
) SYM O
Meth NNP O
. . O

Enzymol NNP O
. . O

65 CD O
, , O
560 CD O

580 CD O
. . O

15 CD O
. . O

Sanger NNP O
, , O
F NNP O
. . O
, , O
Nicklen NNP O
, , O
S NNP O
. . O
and CC O
Coulson NNP O
, , O
A NNP O
. . O

R NN O
. . O

( -LRB- O
1977 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
, , O
74 CD O
, , O
5463 CD O
- HYPH O
5467 CD O
. . O

16 CD O
. . O

Gillis NNP O
, , O
S NNP O
. . O
, , O
Scheid NNP O
, , O
M NNP O
. . O
and CC O
Watson NNP O
, , O
J NNP O
. . O

D NNP O
. . O
( : O
1980 CD O
) : O
J NN O
. . O

Immunol NNP O
. . O

, , O
125 CD O
, , O
2570 CD O
- HYPH O
2580 CD O
. . O

17 CD O
. . O

Breathnach NNP O
, , O
R NNP O
. . O
, , O
Benoist NNP O
, , O
C NNP O
. . O
, , O
O UH O
' '' O
Hare NNP O
, , O
K NNP O
. . O
, , O
Gannon NNP O
, , O
F NNP O
. . O
and CC O

Chambon NNP O
, , O
P NN O
. . O
( : O
1978 CD O
) -RRB- O
Proc NN O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
, , O
75 CD O
, , O
4853 CD O
- HYPH O
4857 CD O
. . O

18 CD O
. . O

Lerner NNP O
, , O
M NNP O
. . O

R NNP O
. . O
, , O
Boyle NNP O
, , O
J NNP O
. . O

A DT O
. . O
, , O
Mount NNP O
, , O
S NNP O
. . O

M UH O
. . O
, , O
Wolin NNP O
, , O
S NNP O
. . O

L NNP O
. . O
and CC O

Steitz NNP O
, , O
J NNP O
. . O

A DT O
. . O

( : O
1980 CD O
) SYM O
Nature NNP O
, , O
283 CD O
, , O
220 CD O
- HYPH O
224 CD O
. . O

19 CD O
. . O

Van NNP O
Ooyen NNP O
, , O
A NNP O
. . O
, , O
Van NNP O
den NNP O
Berg NNP O
, , O
J NNP O
. . O
, , O
Mantei NNP O
, , O
N NNP O
. . O
and CC O
Weissmann NNP O
, , O

C NN O
. . O
( : O
1979 CD O
) SYM O
Science NNP O
, , O
206 CD O
, , O
337 CD O
- HYPH O
344 CD O
. . O

20 CD O
. . O

Searle NNP O
, , O
P NN O
. . O

F NNP O
. . O
, , O
Davison NNP O
, , O
B NNP O
. . O

L NNP O
. . O
, , O
Stuart NNP O
, , O
G NNP O
. . O

W UH O
. . O
, , O
Wilkie NNP O
, , O
T NNP O
. . O

M UH O
. . O
, , O

Norstedt NNP O
, , O
G NNP O
. . O
and CC O
Palmiter NNP O
, , O
R NN O
. . O

D NNP O
. . O

( -LRB- O
1984 CD O
) SYM O
Mol NNP O
. . O

Cell NN O
. . O

Biol NNP O
. . O

4 CD O
, , O
1221 CD O
- SYM O
1230 CD O
. . O

9331 CD O

Preparation NN O
of IN O
oligodeoxyribonucleo NN O
methylphosphonates NNS O
on IN O
a DT O
polystyrene NN O
support NN O
. . O

Abstract JJ O

An DT O
efficient JJ O
procedure NN O
is VBZ O
described VBN O
for IN O
synthesizing VBG O
deoxyribonucleoside NN O
methylphosphonates NNS O
on IN O
polystyrene NN O
polymer NN O
supports NNS O
which WDT O
involves VBZ O
condensing VBG O
5 CD O
' '' O
- HYPH O
dimethoxytrityldeoxy NN O
3 CD O
' '' O
- HYPH O
methylphosphonates NNS O
. . O

The DT O
oligomers NNS O
are VBP O
removed VBN O
from IN O
the DT O
support NN O
and CC O
the DT O
base NN O
protecting VBG O
groups NNS O
hydrolyzed VBN O
by IN O
treatment NN O
with IN O
ethylenediamine NN O
in IN O
ethanol NN O
, , O
which WDT O
avoids VBZ O
hydrolysis NN O
of IN O
the DT O
methylphosphonate NN O
linkages NNS O
. . O

Two CD O
types NNS O
of IN O
oligomers NNS O
were VBD O
synthesized VBN O
: : O
those DT O
containing VBG O
only RB O
methylphosphonate NN O
linkages NNS O
, , O
d NN O
- HYPH O
Np NNP O
( , O
Np NNP O
) -RRB- O
nN CD O
, , O
and CC O
those DT O
which WDT O
terminate VBP O
with IN O
a DT O
5 CD O
' NN O
nucleotide NN O
residue NN O
, , O
dNp NN O
( , O
Np NNP O
) -RRB- O
nN CD O
. . O

The DT O
latter JJ O
oligomers NNS O
can MD O
be VB O
phosphorylated VBN O
by IN O
polynucleotide NN O
kinase NN O
, , O
and CC O
are VBP O
separated VBN O
by IN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
according VBG O
to IN O
their PRP$ O
chain NN O
length NN O
. . O

Piperdine NNP O
randomly RB O
cleaves VBZ O
the DT O
oligomer NN O
methylphosphonate NN O
linkages NNS O
and CC O
generates VBZ O
a DT O
series NN O
of IN O
shorter JJR O
oligomers NNS O
whose WP$ O
number NN O
corresponds VBZ O
to IN O
the DT O
length NN O
of IN O
the DT O
original JJ O
oligomer NN O
. . O

Apurinic JJ O
sites NNS O
introduced VBN O
by IN O
acid NN O
treatment NN O
spontaneously RB O
hydrolyze VBP O
to TO O
give VB O
oligomers NNS O
which WDT O
terminate VBP O
with IN O
free JJ O
3 CD O
' '' O
and CC O
5 CD O
' '' O
OH NN O
groups NNS O
. . O

These DT O
reactions NNS O
may MD O
be VB O
used VBN O
to TO O
characterize VB O
the DT O
oligomers NNS O
. . O
Images NNS O

Vlue1Nubr1193NcecAis NNS O

Preparation NN O
of IN O
oligodeoxyribonucleo NN O
methylphosphonates NNS O
on IN O
a DT O
polystyrene NN O
support NN O
P NN O
. . O
S NNP O
. . O
Miller NNP O
, , O
C NNP O
. . O
H NN O
. . O
Agris NNP O
, , O
A NN O
. . O
Murakami NNP O
, , O
P NN O
. . O
M NN O
. . O
Reddy NNP O
, , O
S NNP O
. . O
A DT O
. . O
Spitz NN O
and CC O
P NN O
. . O
O UH O
. . O
P NN O
. . O
Ts NNS O
' '' O
o IN O

Division NNP O
of IN O
Biophysics NNP O
, , O
Johns NNP O
Hopkins NNP O
University NNP O
, , O
School NNP O
of IN O
Hygiene NNP O
and CC O
Public NNP O
Health NNP O
, , O
Baltimore NNP O
, , O
MD NNP O
21205 CD O
, , O
USA NNP O

Received VBN O
26 CD O
July NNP O
1983 CD O
; : O
Accepted VBN O
5 CD O
September NNP O
1983 CD O

ABSTRACT NNP O

An DT O
efficient JJ O
procedure NN O
is VBZ O
described VBN O
for IN O
synthesizing VBG O
deoxyribonucleoside NN O
methylphosphonates NNS O
on IN O
polystyrene NN O
polyner NN O
supports NNS O
which WDT O
involves VBZ O
condensing VBG O
5 CD O
' '' O
- HYPH O
dimethoxytrityldeoxy NN O
3 CD O
' '' O
- HYPH O
methylphosphonates NNS O
. . O

The DT O
oligomers NNS O
are VBP O
removed VBN O
from IN O
the DT O
support NN O
and CC O
the DT O
base NN O
protecting VBG O
groups NNS O
hydrolyzed VBN O
by IN O

treatment NN O
with IN O
ethylenediamine NN O
in IN O
ethanol NN O
, , O
which WDT O
avoids VBZ O
hydrolysis NN O
of IN O
the DT O

methylphosphonate NN O
linkages NNS O
. . O

Two CD O
types NNS O
of IN O
oligomers NNS O
were VBD O
synthesized VBN O
: : O
those DT O
containing VBG O
only RB O
methylphosphonate NN O
linkages NNS O
, , O
d NN O
- HYPH O
Np NN O
( -LRB- O
Np NNP O
) -RRB- O
N CD O
, , O
and CC O
those DT O
which WDT O

terminate VB O
with IN O
a DT O
5 CD O
' '' O
nucleotide NN O
residue NN O
, , O
dNp NN O
( -LRB- O
Np NN O
) : O
N NN O
. . O
- HYPH O
J NN O
he PRP O
latter JJ O
oligomers NNS O
can MD O
be VB O
phosphorylated VBN O
by IN O
polynucleotide NN O
kinase NN O
, , O
and CC O
are VBP O
separated VBN O
by IN O

polyacrylamide NN O
gel NN O
electrophoresis NN O
according VBG O
to IN O
their PRP$ O
chain NN O
length NN O
. . O

Piperdine NNP O
randomly RB O
cleaves VBZ O
the DT O
oligomer NN O
methylphosphonate NN O
linkages NNS O
and CC O
generates VBZ O
a DT O

series NN O
of IN O
shorter JJR O
oligomers NNS O
whose WP$ O
number NN O
corresponds VBZ O
to IN O
the DT O
length NN O
of IN O
the DT O

original JJ O
oligomer NN O
. . O

Apurinic JJ O
sites NNS O
introduced VBN O
by IN O
acid NN O
treatment NN O
spontaneously RB O
hydrolyze VBP O
to TO O
give VB O
oligomers NNS O
which WDT O
terminate VBP O
with IN O
free JJ O
3 CD O
' '' O
and CC O
5 CD O
' '' O
OH NN O
groups NNS O
. . O

These DT O
reactions NNS O
may MD O
be VB O
used VBN O
to TO O
characterize VB O
the DT O
oligomers NNS O
. . O

INTRODUCTION NN O

Oligonucleoside NN O
methylphosphonates NNS O
have VBP O
been VBN O
used VBN O
to IN O
st RB O
- HYPH O
udy VB O
the DT O
function NN O
of IN O
specific JJ O
RNA NNP O
sequences NNS O
in IN O
biochemical JJ O
and CC O
intact JJ O
cellular JJ O
systems NNS O
( SYM O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Since IN O
these DT O
nonionic JJ O
nucleic JJ O
acid NN O
analogs NNS O
can MD O
be VB O
taken VBN O
up RP O
intact JJ O
by IN O
mammalian JJ O
cells NNS O
and CC O
certain JJ O
bacterial JJ O
cells NNS O
in IN O
culture NN O
, , O
these DT O
compounds NNS O
promise VBP O
to TO O
be VB O
useful JJ O
reagents NNS O
for IN O
exploring VBG O
and CC O
regulating VBG O
the DT O
function NN O
of IN O
nucleic JJ O
acids NNS O
within IN O
living VBG O
cells NNS O
. . O

In IN O
order NN O
to TO O
carry VB O
out RP O
more RBR O
extensive JJ O
biochemical JJ O
and CC O
biological JJ O
studies NNS O
, , O
an DT O
efficient JJ O
method NN O
for IN O
synthesis NN O
of IN O
oligonucleoside NN O
methylphosphonates NNS O
of IN O
defined VBN O
sequence NN O
is VBZ O
needed VBN O
. . O

Previously RB O
we PRP O
described VBD O
the DT O
synthesis NN O
of IN O

methylphosphonate NN O
analogs NNS O
on IN O
a DT O
silica NN O
gel NN O
support NN O
( , O
3 CD O
) -RRB- O
. . O

Protected VBN O
nucleoside NN O
3 CD O
' '' O
- HYPH O
methylphosphonic JJ O
chlorides NNS O
or CC O
tetrazolides NNS O
were VBD O
used VBN O
as IN O
synthetic JJ O

intermediates NNS O
. . O

While IN O
oligothymidine NN O
methylphosphonates NNS O
could MD O
be VB O
efficiently RB O
synthesized VBN O
by IN O
this DT O
procedure NN O
, , O
low JJ O
yields NNS O
were VBD O
encountered VBN O
when WRB O
other JJ O

nucleosides NNS O
, , O
particularly RB O
d RB O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
ibuG NN O
were VBD O
used VBN O
. . O

Recently RB O
Sinha NNP O
et FW O
al FW O
. . O

? . O
) : O
I NNP O
RL NNP O
Press NNP O
Limited NNP O
, , O
Oxford NNP O
, , O
England NNP O
. . O

Nucleic NNP O
Acids NNP O
Research NNP O

Volume NN O
1 CD O
1 CD O
Number NNP O
18 CD O
1983 CD O

6225 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

described VBD O
the DT O
preparation NN O
of IN O
oligonucleoside NN O
methylphosphophonate NN O
on IN O
a DT O
glass NN O
support NN O
using VBG O
nucleoside NN O
3 CD O
' '' O
- HYPH O
methylphosphine NN O
chlorides NNS O
as IN O
reactive JJ O
intermediates NNS O
( , O
4 CD O
) -RRB- O
. . O

In IN O
this DT O
paper NN O
we PRP O
describe VBP O
a DT O
set NN O
of IN O
useful JJ O
methods NNS O
for IN O
the DT O
synthesis NN O
and CC O
analysis NN O
of IN O
these DT O
analogs NNS O
. . O

The DT O
synthesis NN O
involves VBZ O
condensation NN O
of IN O
protected VBN O
nucleoside NN O
3 CD O
' '' O
- HYPH O
methylphosphonate NN O
triethylammonium NN O
salts NNS O
with IN O
nucleosides NNS O
or CC O

oligomers NNS O
linked VBN O
to IN O
a DT O
polystyrene JJ O
support NN O
. . O

This DT O
method NN O
has VBZ O
proven VBN O
to TO O
be VB O
easy JJ O
to TO O
use VB O
and CC O
allows VBZ O
relatively RB O
rapid JJ O
synthesis NN O
of IN O
oligomers NNS O
of IN O
defined VBN O
sequence NN O
up IN O
to TO O
nine CD O
nucleosides NNS O
in IN O
length NN O
. . O

We PRP O
have VBP O
also RB O
developed VBN O
conditions NNS O
for IN O
the DT O

efficient JJ O
removal NN O
of IN O
base NN O
protecting VBG O
groups NNS O
and CC O
subsequent JJ O
purification NN O
of IN O
the DT O
oligomers NNS O
. . O

A DT O
novel JJ O
hydrolysis NN O
reaction NN O
which WDT O
can MD O
be VB O
used VBN O
as IN O
a DT O
basis NN O
for IN O

characterizing VBG O
and CC O
sequencing VBG O
these DT O
oligonucleotide NN O
analogs NNS O
occurs VBZ O
at IN O
apurinic JJ O
sites NNS O
created VBN O
by IN O
acid NN O
treatment NN O
of IN O
the DT O
oligomers NNS O
. . O

EXPERIMENTAL JJ O

Materials NNS O
and CC O
Methods NNS O

Protected VBN O
nucleosides NNS O
, , O
d NN O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
N CD O
, , O
were VBD O
purchased VBN O
from IN O
P NNP O
. . O
L NNP O
. . O

Biochemicals NNS O
and CC O
were VBD O
used VBN O
without IN O
further JJ O
purification NN O
. . O

Protected VBN O
nucleoside NN O
3 CD O
' '' O
- HYPH O
methylphosphonate NN O
triethylammoni NN O
um UH O
salts NNS O
, , O
d FW O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
Np NN O
* NFP O
Et3NH NNP O
, , O
were VBD O

prepared VBN O
as IN O
previously RB O
described VBN O
( : O
3 CD O
) -RRB- O
. . O

5 LS O
- HYPH O
Dimethoxytrityl NN O
protected VBN O
nucleosides NNS O
esterified VBN O
to IN O
1 CD O
% NN O
or CC O
2 CD O
% NN O
crosslinked VBN O
polystyrene NN O
were VBD O
purchased VBN O
from IN O
Chem NNP O
Genes NNPS O
Inc NNP O
. . O

The DT O
nucleoside NN O
loading NN O
level NN O
was VBD O
40 CD O
to IN O
120 CD O
pmol NN O
of IN O

nucleoside NN O
/ SYM O
g NN O
of IN O
support NN O
. . O

Mesitylenesulfonyl NNP O
- HYPH O
3 CD O
- HYPH O
nitrotriazole NN O
( : O
MSNT NNP O
) -RRB- O
was VBD O
purchased VBN O
from IN O
Vega NNP O
Biochemicals NNPS O
. . O

Anhydrous JJ O
pyridine NN O
was VBD O
prepared VBN O
by IN O

refluxing VBG O
previously RB O
purified VBN O
pyridine NN O
( , O
5 CD O
) -RRB- O
over IN O
calcium NN O
hydride NN O
chips NNS O
for IN O
several JJ O
hours NNS O
followed VBN O
by IN O
distillation NN O
onto IN O
calcium NN O
hydride NN O
chips NNS O
in IN O
5 CD O
ml NNS O
V NN O
- HYPH O
vials NNS O
fitted VBN O
with IN O
Teflon NNP O
- HYPH O
lined VBN O
septum NN O
caps NNS O
( : O
Wheaton NNP O
Scientific NNP O
) -RRB- O
. . O

Lyophilized JJ O
spleen NN O
phosphodiesterase NN O
was VBD O
obtained VBN O
from IN O
P NNP O
. . O
L NN O
. . O

Biochemicals NNS O
. . O

T NNP O
- HYPH O
4 CD O
polynucleotide NN O
kinase NN O
and CC O
[ -LRB- O
y IN O
- HYPH O
32P CD O
] -RRB- O
- HYPH O
ATP NN O
were VBD O
obtained VBN O
from IN O
New NNP O
England NNP O
Nuclear NNP O
. . O

Reversed VBN O
phase NN O
high JJ O
performance NN O
liquid NN O
chromatography NN O
( -LRB- O
HPLC NNP O
) -RRB- O
was VBD O
carried VBN O
out RP O
on IN O
Whatman NNP O
Inc NNP O
. . O

C NNP O
- HYPH O
18 CD O
( , O
ODS NNP O
- HYPH O
3 CD O
) SYM O
columns NNS O
( : O
0 CD O
. . O
4 CD O
x SYM O
25 CD O
cm NN O
) -RRB- O
. . O

Analytical JJ O
columns NNS O
were VBD O

eluted VBN O
with IN O
50 CD O
ml NNS O
linear JJ O
gradients NNS O
of IN O
acetonitrile NN O
in IN O
water NN O
or CC O
acetonitrile NN O
in IN O
0 CD O
. . O
1 CD O
M NN O
ammonium NN O
acetate NN O
( , O
pH NN O
5 CD O
. . O
8 CD O
) -RRB- O
at IN O
a DT O
flow NN O
rate NN O
of IN O
2 CD O
. . O
5 CD O
ml NNS O
/ SYM O
min NN O
. . O

The DT O
eluate NN O
was VBD O

monitored VBN O
at IN O
254 CD O
nm NN O
. . O

The DT O
following VBG O
molar JJ O
extinction NN O
coefficients NNS O
were VBD O
used VBN O
at IN O
254 CD O
nm NN O
: : O
d NNP O
- HYPH O
T NNP O
7 CD O
, , O
250 CD O
, , O
dA NN O
13 CD O
, , O
270 CD O
, , O
dC NNP O
6 CD O
, , O
260 CD O
, , O
dG NNP O
13 CD O
, , O
700 CD O
. . O

Unless IN O
otherwise RB O
noted VBD O
, , O
all DT O
reactions NNS O
and CC O
operations NNS O
were VBD O
carried VBN O
out RP O
at IN O
room NN O
temperature NN O
. . O

General NNP O
Procedure NNP O
for IN O
Preparing VBG O
Oligonucleoside NNP O
Methylphosphonates NNPS O
. . O

The DT O

following VBG O
procedure NN O
represents VBZ O
the DT O
current JJ O
method NN O
used VBN O
in IN O
our PRP$ O
laboratory NN O
to IN O

6226 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

synthesize NN O
methylphosphonate NN O
oligomers NNS O
. . O

Table NNP O
I PRP O
lists VBZ O
some DT O
of IN O
the DT O
oligomers NNS O
which WDT O
have VBP O
been VBN O
synthesized VBN O
on IN O
polystyrene NN O
supports NNS O
. . O

Oligomers NNP O
7 CD O
, , O
8 CD O
, , O
and CC O
10 CD O
were VBD O
synthesized VBN O
as IN O
described VBN O
below RB O
. . O

The DT O
other JJ O
oligomers NNS O
were VBD O
synthesized VBN O
in IN O
essentially RB O
the DT O
same JJ O
manner NN O
except IN O
the DT O
condensation NN O
reactions NNS O
were VBD O
run VBN O
in IN O
1 CD O
ml NN O
V NN O
- HYPH O
vials NNS O
or CC O
in IN O
glass NN O
reaction NN O
columns NNS O
purchased VBN O
from IN O
Bachem NNP O
Inc NNP O
. . O

When WRB O
the DT O

reactions NNS O
were VBD O
run VBN O
in IN O
V NN O
- HYPH O
vials NNS O
, , O
the DT O
support NN O
was VBD O
dried VBN O
by IN O
several JJ O
evaporations NNS O

with IN O
anhydrous JJ O
pyridine NN O
in IN O
the DT O
V NN O
- HYPH O
vial NN O
( , O
3 CD O
) -RRB- O
. . O

When WRB O
the DT O
reactions NNS O
were VBD O
run VBN O
in IN O
the DT O
glass NN O
reaction NN O
column NN O
, , O
the DT O
support NN O
was VBD O
dried VBN O
by IN O
a DT O
single JJ O
evaporation NN O
with IN O
anhydrous JJ O
pyridine NN O
overnight RB O
at IN O
room NN O
temperature NN O
. . O

Synthesis NN O
of IN O
Protected VBN O
Oligonucleoside NNP O
Methylphosphonates NNP O
. . O

The DT O
synthetic NN O

reactions NNS O
are VBP O
most RBS O
conveniently RB O
carried VBN O
out RP O
in IN O
a DT O
polypropylene JJ O
col NN O
umn NN O
( -LRB- O
Bio NNP O
Rad NNP O
Econo NNP O
column NN O
) , O
fitted VBN O
with IN O
a DT O
Teflon NNP O
3 CD O
- HYPH O
way NN O
valve NN O
( , O
Bio NNP O
Rad NNP O
) , O
and CC O
a DT O
rubber NN O
septum NN O
cap NN O
( : O
Wheaton NNP O
Scientific NNP O
) -RRB- O
. . O

During IN O
washing NN O
operations NNS O
, , O
the DT O
septum NN O
cap NN O
is VBZ O
removed VBN O
and CC O
the DT O
3 CD O
- HYPH O
way NN O
valve NN O
is VBZ O
connected VBN O
to IN O
a DT O
filter NN O
flask NN O
via IN O
a DT O
Luerer NNP O

adaptor NN O
and CC O
tubing NN O
set NN O
( : O
Bio NNP O
Rad NNP O
) -RRB- O
. . O

Generally RB O
vacuum NN O
is VBZ O
not RB O
required VBN O
to TO O
wash VB O

the DT O
support NN O
. . O

During IN O
the DT O
drying NN O
step NN O
, , O
one CD O
port NN O
of IN O
the DT O
3 CD O
- HYPH O
way NN O
valve NN O
is VBZ O
connected VBN O
to IN O
a DT O
cold JJ O
trap NN O
and CC O
vacuum NN O
pump NN O
via IN O
the DT O
barrel NN O
of IN O
a DT O
1 CD O
ml NN O
plastic NN O
syringe NN O
. . O

The DT O
other JJ O
port NN O
is VBZ O
connected VBN O
to IN O
a DT O
Drierite NNP O
column NN O
filled VBN O
with IN O
dry JJ O
argon NN O
. . O

A DT O
reaction NN O
cycle NN O
consists VBZ O
of IN O
the DT O
following VBG O
10 CD O
steps NNS O
: : O
1 CD O
) : O
The DT O
support NN O
( : O
60 CD O
mg NN O
, , O
1 CD O
% NN O
crosslinked VBN O
) -RRB- O
in IN O
the DT O
column NN O
is VBZ O
washed VBN O
with IN O
three CD O
2 CD O
ml NNS O
portions NNS O
of IN O

methylene NN O
chloride NN O
/ SYM O
isopropanol NN O
( , O
85 CD O
: : O
15 CD O
, , O
v NN O
/ , O
v NN O
) -RRB- O
. . O

2 LS O
) -RRB- O
The DT O
support NN O
is VBZ O
treated VBN O
with IN O
2 CD O
ml NNS O
of IN O
1 CD O
M NN O
zinc NN O
bromide NN O
in IN O
methylene NN O
chloride NN O
/ SYM O
isopropanol NN O
solution NN O
. . O

Two CD O
fiveminute JJ O
treatments NNS O
are VBP O
used VBN O
when WRB O
the DT O
support NN O
- HYPH O
bound VBN O
nucleoside NN O
is VBZ O

d LS O
- : O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
bzA FW O
or CC O
d NNP O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
ibuG NNP O
, , O
while IN O
four CD O
treatments NNS O
are VBP O
used VBN O
when WRB O
the DT O
nucleoside NN O
is VBZ O
d NN O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
T NN O
or CC O
d NNP O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
bzC NN O
. . O

After IN O
each DT O
treatment NN O
the DT O

orange NN O
solution NN O
is VBZ O
collected VBN O
in IN O
a DT O
clean JJ O
flask NN O
. . O

3 LS O
) -RRB- O
The DT O
support NN O
is VBZ O
washed VBN O
with IN O
two CD O
2 CD O
ml NNS O
portions NNS O
of IN O
methylene NN O
chloride NN O
/ SYM O
isopropanol NN O
and CC O
the DT O
washings NNS O
are VBP O

collected VBN O
in IN O
same JJ O
flask NN O
used VBN O
in IN O
step NN O
2 CD O
) -RRB- O
. . O

The DT O
solution NN O
is VBZ O
diluted VBN O
to IN O
50 CD O
ml NNS O
and CC O
a DT O
0 CD O
. . O
20 CD O
ml NN O
aliquot NN O
is VBZ O
dissolved VBN O
in IN O
0 CD O
. . O
80 CD O
ml NN O
of IN O
perchloric JJ O
acid NN O
/ SYM O
ethanol NN O
( , O
3 CD O
: SYM O
2 CD O
, , O

v NN O
/ : O
v NN O
) -RRB- O
. . O

The DT O
absorbance NN O
is VBZ O
determined VBN O
at IN O
500 CD O
nm NN O
and CC O
the DT O
amount NN O
of IN O
trityl NN O
cation NN O
is VBZ O
determined VBN O
using VBG O
a DT O
molar JJ O
extinction NN O
coefficient NN O
of IN O
89 CD O
, , O
0 CD O
. . O

4 LS O
) -RRB- O
The DT O
column NN O
is VBZ O
attached VBN O
to IN O
a DT O
waste NN O
flask NN O
and CC O
the DT O
support NN O
is VBZ O
washed VBN O
with IN O
three CD O
2 CD O
ml NNS O

portions NNS O
of IN O
0 CD O
. . O
5 CD O
M NN O
triethylammonium NN O
acetate NN O
in IN O
dimethylformamide NN O
; : O
three CD O
2 CD O
ml NNS O

portions NNS O
of IN O
anhydrous JJ O
pyridine NN O
and CC O
three CD O
2 CD O
ml NNS O
portions NNS O
of IN O
diethyl NN O
ether NN O
. . O

5 LS O
) -RRB- O
The DT O
column NN O
is VBZ O
fitted VBN O
with IN O
the DT O
septum NN O
cap NN O
and CC O
set VBN O
up RP O
in IN O
the DT O
drying NN O
mode NN O
under IN O

house NN O
vacuum NN O
for IN O
at RB O
least RBS O
5 CD O
min NN O
. . O

6 LS O
) -RRB- O
The DT O
support NN O
is VBZ O
dried VBN O
by IN O
adding VBG O
300 CD O
jl NN O
of IN O
anhydrous JJ O
pyridine NN O
via IN O
a DT O
gas NN O
tight NN O
syringe NN O
( -LRB- O
Hamilton NNP O
) -RRB- O
. . O

After IN O
the DT O
support NN O
has VBZ O
swollen VBN O
, , O
the DT O
vacuum NN O
( , O
oil NN O
pump NN O
) -RRB- O
is VBZ O
applied VBN O
and CC O
the DT O
support NN O
is VBZ O
warmed VBN O
with IN O
a DT O

6227 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

stream NN O
of IN O
air NN O
from IN O
a DT O
hair NN O
dryer NN O
. . O

Evaporation NN O
is VBZ O
continued VBN O
for IN O
10 CD O
min NN O
. . O

Dry JJ O
argon NN O
is VBZ O
then RB O
admitted VBN O
and CC O
the DT O
drying NN O
operation NN O
is VBZ O
repeated VBN O
two CD O
more JJR O
times NNS O
. . O

7 LS O
) -RRB- O
The DT O
coupling NN O
mixture NN O
is VBZ O
prepared VBN O
by IN O
dissolving VBG O
0 CD O
. . O
20 CD O
mmol NN O
of IN O
MSNT NN O
in IN O
320 CD O
pl NN O
of IN O
anhydrous JJ O
pyridine NN O
. . O

The DT O
solution NN O
is VBZ O
then RB O
transferred VBN O
to IN O
the DT O
vial NN O

containing VBG O
0 CD O
. . O
6 CD O
mmol NN O
of IN O
d NNP O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
Np NNP O
- HYPH O
Et3NH NN O
. . O

The DT O
nucleotide NN O
is VBZ O
dissolved VBN O
by IN O
vortexing NN O
and CC O
the DT O
coupling NN O
solution NN O
is VBZ O
then RB O
added VBN O
dropwise RB O
to IN O
the DT O
support NN O
. . O

It PRP O
is VBZ O
important JJ O
to TO O
add VB O
the DT O
solution NN O
slowly RB O
and CC O
to TO O
allow VB O
the DT O
support NN O
to TO O
swell VB O
. . O

Trapped VBN O
gas NN O
bubbles NNS O
may MD O
be VB O
removed VBN O
by IN O
gently RB O
tapping VBG O
the DT O
column NN O
. . O

This DT O
entire JJ O
operation NN O
is VBZ O
carried VBN O
out RP O
using VBG O
one CD O
predried JJ O
syringe NN O
. . O

The DT O
syringe NN O
is VBZ O
left VBN O
in IN O

the DT O
V NN O
- HYPH O
vial NN O
while IN O
the DT O
reagents NNS O
are VBP O
being VBG O
dissolved VBN O
. . O

8 CD O
) NFP O
The DT O
reaction NN O
mixture NN O
is VBZ O
kept VBN O
at IN O
room NN O
temperature NN O
for IN O
two CD O
hrs NNS O
. . O

9 LS O
) -RRB- O
The DT O
column NN O
is VBZ O
set VBN O
up RP O
in IN O
the DT O

washing NN O
mode NN O
and CC O
the DT O
support NN O
is VBZ O
washed VBN O
with IN O
three CD O
2 CD O
ml NNS O
portions NNS O
of IN O
anhydrous JJ O
pyridine NN O
. . O

The DT O
solution NN O
, , O
which WDT O
contains VBZ O
unreacted JJ O
nucleoside NN O

3 CD O
' '' O
- HYPH O
methylphosphonate NN O
and CC O
MSNT NNP O
, , O
is VBZ O
collected VBN O
in IN O
a DT O
separate JJ O
flask NN O
. . O

A DT O
50 CD O
% NN O

aqueous JJ O
pyridine NN O
solution NN O
( : O
1 CD O
ml NNS O
) -RRB- O
is VBZ O
added VBN O
and CC O
the DT O
solution NN O
is VBZ O
kept VBN O
at IN O
40C CD O
for IN O

later JJ O
purification NN O
and CC O
recovery NN O
of IN O
d NN O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) NFP O
2Tr NN O
] -RRB- O
Np NNP O
. . O

10 CD O
) : O
The DT O
support NN O
is VBZ O
treated VBN O
with IN O
a DT O
solution NN O
containing VBG O
2 CD O
ml NNS O
of IN O
anhydrous JJ O
pyridine NN O
, , O
1 CD O
ml NNS O
of IN O
acetic NN O

anhydride NN O
and CC O
20 CD O
mg NN O
of IN O
dimethylaminopyridin NN O
for IN O
30 CD O
min NN O
. . O

( : O
This DT O
step NN O
was VBD O
not RB O
included VBN O
for IN O
the DT O
synthesis NN O
of IN O
oligomer NN O
10 CD O
) -RRB- O
. . O

11 CD O
) : O
Return VB O
to IN O
step NN O
1 CD O
, , O
for IN O
the DT O
next JJ O
cycle NN O
. . O

Removal NN O
of IN O
Base NNP O
Protecting NNP O
Groups NNPS O
. . O

The DT O
following VBG O
general JJ O
procedure NN O
was VBD O
found VBN O
to TO O
be VB O
the DT O
most RBS O
effective JJ O
method NN O
for IN O
cleaving VBG O
the DT O
oligonucleotide NN O
from IN O
the DT O
1 CD O
% NN O
crosslinked JJ O
support NN O
and CC O
for IN O
removing VBG O
the DT O
base NN O
protecting VBG O
groups NNS O
with IN O
minimal JJ O
hydrolysis NN O
of IN O
the DT O
phosphonate NN O
backbone NN O
. . O

The DT O
following VBG O
steps NNS O
were VBD O
used VBN O
for IN O

deprotecting VBG O
oligomers NNS O
7 CD O
, , O
8 CD O
and CC O
10 CD O
. . O

Oligomer NNP O
9 CD O
was VBD O
deprotected VBN O
in IN O
a DT O
similar JJ O

fashion NN O
except IN O
step NN O
4 CD O
) -RRB- O
was VBD O
carried VBN O
out RP O
at IN O
650C CD O
for IN O
3 CD O
hrs NNS O
. . O

For IN O
oligomers NNS O
1 CD O
- SYM O
6 CD O
, , O
step NN O
3 CD O
) -RRB- O
was VBD O
not RB O
included VBN O
and CC O
step NN O
4 CD O
) -RRB- O
was VBD O
carried VBN O
out RP O
at IN O
650 CD O
for IN O
3 CD O
hrs NNS O
. . O

1 LS O
) -RRB- O
After IN O
the DT O
final JJ O
condensation NN O
step NN O
the DT O
support NN O
( , O
60 CD O
mg NN O
) -RRB- O
is VBZ O
washed VBN O
with IN O
three CD O
2 CD O
ml NN O
portions NNS O
of IN O
anhydrous JJ O
pyridine NN O
; : O
three CD O
2 CD O
ml NNS O
portions NNS O
of IN O
methylene NN O

chloride NN O
/ SYM O
isopropanol NN O
and CC O
three CD O
2 CD O
ml NNS O
portions NNS O
of IN O
diethyl NN O
ether NN O
. . O

The DT O
support NN O
is VBZ O
then RB O
dried VBN O
under IN O
house NN O
vacuum NN O
. . O

2 LS O
) -RRB- O
The DT O
support NN O
is VBZ O
swollen VBN O
by IN O
addition NN O
of IN O
2 CD O
ml NNS O
of IN O
pyridine NN O
and CC O
the DT O
excess NN O
is VBZ O
removed VBN O
under IN O
house NN O
vacuum NN O
. . O

3 LS O
) -RRB- O
The DT O
support NN O
is VBZ O
treated VBN O
with IN O
3 CD O
ml NNS O
of IN O
0 CD O
. . O
17 CD O
M NN O
tetra NN O
- HYPH O
n NN O
- HYPH O
butylammonium NN O
fluoride NN O
in IN O

tetrahydrofuran NN O
/ SYM O
pyridine NN O
/ SYM O
water NN O
( , O
8 CD O
: : O
1 CD O
: : O
1 CD O
, , O
v NN O
/ , O
v NN O
) -RRB- O
for IN O
40 CD O
hrs NNS O
at IN O
room NN O
temperature NN O
. . O

No DT O
shaking NN O
is VBZ O
required VBN O
. . O

The DT O
support NN O
is VBZ O
then RB O
washed VBN O
with IN O
three CD O
2 CD O
ml NN O
portions NNS O
of IN O
50 CD O
% NN O
pyridine NN O
/ SYM O
water NN O
; , O
three CD O
2 CD O
ml NNS O
portions NNS O
of IN O
pyridine NN O
; : O
and CC O
three CD O
2 CD O
ml NNS O

portions NNS O
of IN O
methylene NN O
chloride NN O
/ SYM O
isopropanol NN O
. . O

4 LS O
) -RRB- O
The DT O
support NN O
is VBZ O
treated VBN O
with IN O
3 CD O
ml NN O
of IN O
ethylenediamine NN O
/ SYM O
ethanol NN O
( , O
1 CD O
: SYM O
1 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
for IN O
7 CD O
hrs NNS O
at IN O
room NN O
temperature NN O

6228 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

without IN O
shaking VBG O
. . O

The DT O
solution NN O
is VBZ O
collected VBN O
and CC O
the DT O
support NN O
is VBZ O
washed VBN O
with IN O

four CD O
2 CD O
ml CD O
portions NNS O
of IN O
pyridine NN O
/ SYM O
ethanol NN O
( , O
1 CD O
: : O
1 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
and CC O
four CD O
2 CD O
ml NNS O
portions NNS O
of IN O
N NN O
, , O
N NN O
- HYPH O
dimethylformamide NN O
. . O

The DT O
combined VBN O
eluate NN O
and CC O
washings NNS O
are VBP O
evaporated VBN O
at IN O
250C CD O
and CC O
the DT O
oily JJ O
residue NN O
is VBZ O
co NN O
- HYPH O
evaporated VBN O
several JJ O
time NN O
with IN O
50 CD O
% NN O
aqueous JJ O
ethanol NN O
. . O

Purification NN O
of IN O
Oligonucleoside NNP O
Methylphosphonates NNPS O
. . O

For IN O
oligomers NNS O
which WDT O

contain VB O
only RB O
methylphosphonate NN O
linkages NNS O
( : O
1 CD O
- SYM O
6 CD O
) -RRB- O
, , O
the DT O
residue NN O
from IN O
step NN O
4 CD O
) -RRB- O
of IN O
the DT O
previous JJ O
section NN O
is VBZ O
dissolved VBN O
in IN O
a DT O
small JJ O
volume NN O
of IN O
50 CD O
% NN O
aqueous JJ O
ethanol NN O
. . O

The DT O
solution NN O
is VBZ O
chromatographed VBN O
on IN O
a DT O
C NNP O
- HYPH O
18 CD O
reversed VBN O
phase NN O
column NN O
( : O
0 CD O
. . O
46 CD O
cm NN O
x SYM O
25 CD O
cm NNS O

for IN O
100 CD O
A254 CD O
units NNS O
or CC O
less JJR O
; : O
0 CD O
. . O
9 CD O
cm NN O
x SYM O
50 CD O
cm NNS O
for IN O
more JJR O
than IN O
100 CD O
A254 CD O
units NNS O
) , O
using VBG O
a DT O
linear JJ O
gradient NN O
of IN O
0 CD O
% NN O
to TO O
25 CD O
% NN O
( SYM O
8 CD O
- HYPH O
mer NN O
or CC O
less JJR O
) , O
or CC O
0 CD O
% NN O
to TO O
35 CD O
% NN O
( SYM O
9 CD O
mer NN O
) . O

acetonitrile NN O
in IN O
water NN O
to TO O
remove VB O
non JJ O
- HYPH O
tritylated JJ O
oligomers NNS O
. . O

The DT O
desired VBN O

tritylated VBN O
oligomer NN O
is VBZ O
eluted VBN O
with IN O
50 CD O
% NN O
acetonitrile NN O
in IN O
water NN O
. . O

The DT O
solvents NNS O
are VBP O
evaporated VBN O
and CC O
the DT O
residue NN O
is VBZ O
treated VBN O
with IN O
1 CD O
ml CD O
of IN O
80 CD O
% NN O
acetic JJ O
acid NN O
in IN O
water NN O
for IN O
1 CD O
hr NN O
at IN O
room NN O
temperature NN O
. . O

The DT O
solvents NNS O
are VBP O
evaporated VBN O
and CC O
the DT O

residue NN O
is VBZ O
repeatedly RB O
evaporated VBN O
with IN O
ethanol NN O
to TO O
ensure VB O
complete JJ O
removal NN O
of IN O

acetic JJ O
acid NN O
. . O

The DT O
oligomer NN O
is VBZ O
then RB O
purified VBN O
by IN O
C NNP O
- HYPH O
18 CD O
reversed VBN O
phase NN O
HPLC NNP O
using VBG O
a DT O
0 CD O
% NN O
to TO O
25 CD O
% NN O
or CC O
30 CD O
% NN O
acetonitrile NN O
in IN O
water NN O
gradient NN O
. . O

For IN O
oligomers NNS O
which WDT O
terminate VBP O
with IN O
a DT O
5 CD O
' '' O
- HYPH O
nucleoside NN O
phosphodiester NN O
linkage NN O
( : O
7 CD O
- SYM O
10 CD O
) , O
the DT O
residue NN O
from IN O
step NN O
4 CD O
) -RRB- O
described VBN O
in IN O
the DT O
preceeding VBG O
section NN O
is VBZ O
treated VBN O
with IN O
80 CD O
% NN O
acetic JJ O
acid NN O
in IN O
water NN O
for IN O
15 CD O
min NN O
at IN O
room NN O
temperature NN O
. . O

After IN O
removal NN O
of IN O
the DT O
acetic JJ O
acid NN O
by IN O
evaporation NN O
, , O
the DT O
residue NN O
is VBZ O
dissolved VBN O
in IN O
20 CD O
ml NNS O
of IN O
50 CD O
% NN O
aqueous JJ O
ethanol NN O
and CC O
the DT O
solution NN O
is VBZ O
passed VBN O
through IN O
a DT O
DEAE NNP O
cellulose NN O
column NN O
( , O
2 CD O
. . O
5 CD O
x SYM O
8 CD O
cm NN O
, , O
bicarbonate NN O
form NN O
) -RRB- O
which WDT O
has VBZ O
been VBN O
previously RB O
washed VBN O
with IN O
50 CD O
% NN O
aqueous JJ O
ethanol NN O
. . O

The DT O
column NN O
is VBZ O
monitored VBN O
at IN O
254 CD O
nm NN O
and CC O
washed VBN O
with IN O
50 CD O
% NN O

aqueous JJ O
ethanol NN O
until IN O
the DT O
pen NN O
returns VBZ O
to IN O
the DT O
baseline NN O
. . O

The DT O
desired VBN O
oligomer NN O
is VBZ O
then RB O
eluted VBN O
with IN O
0 CD O
. . O
15 CD O
M NN O
triethylammonium NN O
bicarbonate NN O
in IN O
50 CD O
% NN O
aqueous JJ O

ethanol NN O
. . O

The DT O
buffer NN O
is VBZ O
removed VBN O
by IN O
evaporation NN O
and CC O
co NN O
- HYPH O
evaporated VBN O
with IN O
50 CD O
% NN O

aqueous JJ O
ethanol NN O
. . O

The DT O
oligomer NN O
is VBZ O
then RB O
further RB O
purified VBN O
by IN O
C NNP O
- HYPH O
18 CD O
reversed VBN O
phase NN O
HPLC NNP O
using VBG O
a DT O
0 CD O
% NN O
to TO O
30 CD O
% NN O
acetonitrile NN O
in IN O
0 CD O
. . O
10 CD O
M NN O
ammonium NN O
acetate NN O
( , O
pH NN O
5 CD O
. . O
8 CD O
) NFP O

gradient NN O
. . O

The DT O
oligomer NN O
is VBZ O
freed VBN O
of IN O
ammonium NN O
acetate NN O
by IN O
desalting VBG O
on IN O
a DT O
Bio NNP O
- HYPH O
Gel NNP O
P NN O
- HYPH O
2 CD O
column NN O
( : O
1 CD O
. . O
5 CD O
x SYM O
20 CD O
cm NN O
) -RRB- O
. . O

Removal NN O
of IN O
the DT O
5 CD O
' '' O
- HYPH O
Terminal NNP O
Nucleotide NNP O
Unit NNP O
. . O

Oligomers NNS O
which WDT O
terminate VBP O
with IN O
a DT O
5 CD O
' '' O
- HYPH O
nucleotide NN O
phosphodiester NN O
may MD O
be VB O
converted VBN O
to IN O
the DT O
oligonucleoside NN O

methylphosphonate NN O
by IN O
the DT O
following VBG O
procedure NN O
. . O

The DT O
oligomer NN O
( , O
3 CD O
A254 CD O
units NNS O
) -RRB- O
is VBZ O
dissolved VBN O
in IN O
40 CD O
pl NNS O
of IN O
water NN O
and CC O
treated VBN O
at IN O
370C CD O
for IN O
2 CD O
hrs NNS O
with IN O
10 CD O
PI NN O
( , O
1 CD O
- SYM O
2 CD O

units NNS O
) , O
of IN O
spleen NN O
phosphodiesterase NN O
dissolved VBN O
in IN O
water NN O
. . O

The DT O
completeness NN O
of IN O
the DT O
reaction NN O
is VBZ O
determined VBN O
by IN O
reversed VBN O
phase NN O
HPLC NNP O
. . O

The DT O
solution NN O
is VBZ O
then RB O

6229 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

diluted VBN O
with IN O
50 CD O
ul CD O
of IN O
water NN O
and CC O
passed VBN O
through IN O
a DT O
DEAE NNP O
cellulose NN O
column NN O
( : O
0 CD O
. . O
5 CD O
x SYM O
1 CD O
cm NN O
) -RRB- O
. . O

The DT O
column NN O
is VBZ O
washed VBN O
with IN O
500 CD O
Pl NNS O
of IN O
water NN O
and CC O
the DT O
oligomer NN O
is VBZ O
recovered VBN O
by IN O
lyophilization NN O
. . O

Recovery NN O
of IN O
Protected VBN O
Nucleoside NNP O
3 CD O
' '' O
- : O
Methylphosphonates NNS O
. . O

The DT O
aqueous JJ O
pyridine NN O
solution NN O
from IN O
step NN O
9 CD O
) -RRB- O
described VBN O
in IN O
General NNP O
Procedure NNP O
for IN O
Preparing VBG O

Oligonucleoside NNP O
Methylphosphonates NNP O
, , O
is VBZ O
evaporated VBN O
after IN O
addition NN O
of IN O
0 CD O
. . O
1 CD O
ml NNS O
of IN O
triethylamine NN O
. . O

The DT O
residue NN O
is VBZ O
dissolved VBN O
in IN O
50 CD O
ml NNS O
of IN O
chloroform NN O
and CC O
the DT O

solution NN O
is VBZ O
extracted VBN O
twice RB O
with IN O
50 CD O
ml NNS O
of IN O
1 CD O
M NN O
ammonium NN O
bicarbonate NN O
. . O

The DT O

chloroform NN O
layer NN O
is VBZ O
dried VBN O
over IN O
anhydrous JJ O
sodium NN O
sulfate NN O
. . O

Several JJ O
drops NNS O
of IN O
triethylamine NN O
are VBP O
added VBN O
to TO O
clarify VB O
the DT O
solution NN O
. . O

After IN O
filtration NN O
the DT O

solvents NNS O
are VBP O
evaporated VBN O
and CC O
the DT O
residue NN O
is VBZ O
evaporated VBN O
with IN O
three CD O
2 CD O
ml NNS O
portions NNS O
of IN O
anhydrous JJ O
pyridine NN O
on IN O
an DT O
oil NN O
pump NN O
. . O

The DT O
foamy JJ O
residue NN O
is VBZ O
dissolved VBN O
in IN O
2 CD O
ml NNS O
of IN O
dry JJ O
methylene NN O
chloride NN O
and CC O
the DT O
solution NN O
is VBZ O
added VBN O
dropwise JJ O
to IN O
a DT O
stirred JJ O
solution NN O
of IN O
1 CD O
% NN O
triethylamine NN O
in IN O
hexane NN O
. . O

The DT O
resulting VBG O
precipitate NN O
is VBZ O

collected VBN O
via IN O
filtration NN O
on IN O
a DT O
sintered JJ O
glass NN O
filter NN O
, , O
washed VBN O
with IN O
hexane NN O
and CC O
dried VBN O
in IN O
a DT O
vacuum NN O
desiccator NN O
. . O

Removal NN O
of IN O
Base NNP O
Protecting NNP O
Groups NNP O
with IN O
Ethylenediamine NN O
. . O

Several JJ O
mg NN O
of IN O

d LS O
- : O
I PRP O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
bzA FW O
, , O
d NNP O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
bzC NNP O
and CC O
d NNP O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
ibu NNP O
G NNP O
were VBD O
each DT O
dissolved VBN O
in IN O
250 CD O
pl NN O
of IN O
ethylenediamine NN O
/ SYM O
ethanol NN O
( : O
1 CD O
: SYM O
1 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
. . O

The DT O
solutions NNS O
were VBD O
incubated VBN O
at IN O
room NN O
temperature NN O
. . O

At IN O
various JJ O
times NNS O
aliquots NNS O
were VBD O
chromatographed VBN O
on IN O
silica NN O
gel NN O
TLC NNP O
plates NNS O
which WDT O
were VBD O
eluted VBN O
with IN O
10 CD O
% NN O
methanol NN O
in IN O
chloroform NN O
. . O

The DT O
spots NNS O
corresponding VBG O
to IN O
the DT O
starting VBG O
material NN O
and CC O
the DT O
product NN O
were VBD O
cut VBN O
out RP O
and CC O

treated VBN O
with IN O
1 CD O
. . O
5 CD O
ml NN O
of IN O
perchloric JJ O
acid NN O
/ SYM O
ethanol NN O
( : O
3 CD O
: SYM O
2 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
for IN O
30 CD O
min NN O
. . O

The DT O

absorbance NN O
of IN O
each DT O
solution NN O
was VBD O
measured VBN O
at IN O
500 CD O
nm NN O
and CC O
the DT O
percent NN O
reaction NN O
was VBD O
determined VBN O
. . O

The DT O
half JJ O
- HYPH O
lives NNS O
of IN O
the DT O
reactions NNS O
are VBP O
given VBN O
in IN O
Table NNP O
II NNP O
. . O

Removal NN O
of IN O
Protected VBN O
- HYPH O
Nucleosides NNS O
from IN O
Polystyrene NNP O
Support NNP O
. . O

Five CD O
mg NN O
of IN O
d NN O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
T NN O
( , O
ED NN O
( : O
1 CD O
% NN O
crosslinked VBN O
) -RRB- O
, , O
d FW O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
bzA NN O
O NN O
? . O
( : O
1 CD O
% NN O
crosslinked VBN O
) -RRB- O
, , O

d LS O
- : O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
bzC NN O
( : O
? . O
) -RRB- O
( : O
1 CD O
% NN O
and CC O
2 CD O
% NN O
crosslinked VBN O
) -RRB- O
and CC O
d LS O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NN O
) -RRB- O
2Tr NN O
] -RRB- O
ibuGcD NN O
( : O
1 CD O
% NN O
and CC O
2 CD O
% NN O
crosslinked VBN O
) -RRB- O
were VBD O
each DT O
treated VBN O
with IN O
500 CD O
ul NNS O
of IN O
ethylenediamine NN O
/ SYM O
ethanol NN O
( , O
1 CD O
: : O
1 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
solution NN O
at IN O
room NN O
temperature NN O
. . O

At IN O
various JJ O
times NNS O
, , O
10 CD O
pl CD O
aliquots NNS O
were VBD O

removed VBN O
, , O
the DT O
solvent NN O
was VBD O
evaporated VBN O
and CC O
the DT O
residue NN O
was VBD O
dissolved VBN O
in IN O
1 CD O
ml NNS O
of IN O
perchloric JJ O
acid NN O
/ SYM O
ethanol NN O
solution NN O
( : O
3 CD O
: SYM O
2 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
. . O

The DT O
amount NN O
of IN O
dimethoxytrityl NN O
cation NN O
and CC O
hence RB O
the DT O
amount NN O
of IN O
nucleoside NN O
cleaved VBN O
from IN O
the DT O
support NN O
was VBD O

determined VBN O
by IN O
measuring VBG O
the DT O
absorbance NN O
at IN O
500 CD O
nm NN O
. . O

The DT O
half JJ O
lives NNS O
of IN O
the DT O
cleavage NN O
reactions NNS O
are VBP O
given VBN O
in IN O
Table NNP O
II NNP O
. . O

Hydrolysis NN O
of IN O
the DT O
Methylphosphonate NN O
Linkage NN O
by IN O
Ethylenediamine NNP O
. . O

Oligonucleoside NN O
methylphosphonates NNS O
( , O
1 CD O
. , O
25 CD O
A254 CD O
units NNS O
each DT O
) -RRB- O
were VBD O
treated VBN O
with IN O
50 CD O
il NN O
of IN O
ethylenediamine NN O
/ SYM O
ethanol NN O
( : O
1 CD O
: SYM O
1 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
at IN O
room NN O
temperature NN O
. . O

Aliquots NNP O

6230 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

( : O
10 CD O
pl NN O
) -RRB- O
were VBD O
withdrawn VBN O
at IN O
various JJ O
times NNS O
and CC O
the DT O
solvents NNS O
were VBD O
evaporated VBN O
. . O

The DT O
residue NN O
was VBD O
dissolved VBN O
in IN O
20 CD O
PI NN O
of IN O
50 CD O
% NN O
aqueous JJ O
ethanol NN O
and CC O
the DT O
solution NN O

examined VBN O
by IN O
C NNP O
- HYPH O
18 CD O
reversed VBD O
phase NN O
HPLC NNP O
using VBG O
a DT O
0 CD O
% NN O
to TO O
25 CD O
% NN O
acetonitrile NN O
in IN O
water NN O
gradient NN O
. . O

The DT O
mole NN O
percent NN O
of IN O
starting VBG O
oligomer NN O
remaining VBG O
after IN O
100 CD O
hrs NNS O
of IN O
treatment NN O
is VBZ O
given VBN O
in IN O
Table NNP O
III NNP O
. . O

Hydrolysis NN O
of IN O
Oligonucleoside NNP O
Methylphosphonates NNP O
in IN O
Acid NNP O
. . O

Six CD O
A254 CD O
units NNS O
of IN O
oligomer NN O
were VBD O
dissolved VBN O
in IN O
100 CD O
pl CD O
of IN O
0 CD O
. . O
1 CD O
M NN O
hydrochloric JJ O
acid NN O
solution NN O
. . O

The DT O

solution NN O
was VBD O
heated VBN O
at IN O
either CC O
450 CD O
or CC O
650C CD O
. . O

Aliquots NNP O
( : O
10 CD O
Pil NNP O
) -RRB- O
were VBD O
withdrawn VBN O
at IN O
various JJ O
times NNS O
and CC O
added VBD O
to IN O
10 CD O
pl CD O
of IN O
0 CD O
. . O
15 CD O
M NN O
ammonium NN O
hydroxide NN O
at IN O
0 CD O
? . O
C NN O
. . O

The DT O
samples NNS O
were VBD O
then RB O
injected VBN O
directly RB O
onto IN O
a DT O
C NNP O
- HYPH O
18 CD O
reversed VBN O
phase NN O
column NN O
which WDT O

was VBD O
eluted VBN O
with IN O
50 CD O
ml NNS O
of IN O
a DT O
linear JJ O
gradient NN O
of IN O
0 CD O
% NN O
to TO O
25 CD O
% NN O
acetonitrile NN O
in IN O
water NN O

at IN O
a DT O
flow NN O
rate NN O
of IN O
2 CD O
. . O
5 CD O
ml NNS O
/ SYM O
min NN O
. . O

The DT O
products NNS O
of IN O
the DT O
reaction NN O
were VBD O
determined VBN O
by IN O
comparison NN O
with IN O
authentic JJ O
samples NNS O
. . O

Labeling VBG O
5 CD O
' '' O
- HYPH O
End NN O
of IN O
Oligonucleoside NNP O
Methylphosphonates NNP O
with IN O
T4 NNP O
- HYPH O
Polynucleotide NNP O
Kinase NNP O
. . O

Oligonucleoside NN O
methylphosphonates NNS O
( , O
2 CD O
nmol NN O
) -RRB- O
were VBD O
dissolved VBN O
in IN O
a DT O
buffer NN O
solution NN O
containing VBG O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HC1 NNP O
( -LRB- O
pH NN O
9 CD O
. . O
0 CD O
) -RRB- O
, , O
10 CD O
mM NN O
MgCl2 NNP O
, , O
5 CD O
mM NN O
dithiothreitol NN O
, , O
20 CD O
pM NN O
spermidine NN O
, , O
and CC O
[ -LRB- O
y CD O
- HYPH O
32P CD O
] -RRB- O
ATP NN O
( SYM O
8 CD O
ljCi NNP O
, , O
4Ci NN O
/ SYM O
mmol NN O
) -RRB- O
. . O

T4 NNP O
- HYPH O
polynucleotide NN O
kinase NN O
( -LRB- O
4 CD O
units NNS O
) -RRB- O
was VBD O
added VBN O
to IN O
the DT O
solution NN O
, , O
which WDT O
was VBD O
made VBN O
up RP O
to IN O
50 CD O
ul CD O
by IN O
adding VBG O
water NN O
. . O

The DT O
solutions NNS O
were VBD O
incubated VBN O
at IN O
370C CD O
for IN O
2 CD O
hrs NNS O
. . O

The DT O
reaction NN O
was VBD O
checked VBN O
by IN O
PEI NNP O
- HYPH O
cellulose NNP O
TLC NNP O
. . O

The DT O
PEI NNP O
- HYPH O
cellulose NN O
plate NN O

( : O
12x2Ocm NNP O
, , O
Merck NNP O
) -RRB- O
was VBD O
preactivated VBN O
by IN O
elution NN O
with IN O
1 CD O
. . O
2 CD O
M NN O
pyridinium NN O
formate NN O
( , O
pH NN O
3 CD O
. . O
5 CD O
) -RRB- O
. . O

Small JJ O
aliquots NNS O
( : O
0 CD O
. . O
1 CD O
pl NN O
) -RRB- O
of IN O
PNK NNP O
reaction NN O
solutions NNS O
were VBD O
applied VBN O
and CC O

developed VBN O
with IN O
1 CD O
. . O
5 CD O
M NN O
pyridinium NN O
formate NN O
( , O
pH NN O
3 CD O
. . O
5 CD O
) -RRB- O
. . O

The DT O
TLC NNP O
plate NN O
was VBD O
dried VBN O
and CC O
autoradiographed VBN O
using VBG O
an DT O
intensifying VBG O
screen NN O
at IN O
room NN O
temperature NN O
. . O

Gel NNP O
Electrophoresis NNP O
of IN O
5 CD O
' '' O
- HYPH O
Labeled VBN O
Oligonucleoside NNP O
Methylphosphonates NNPS O
. . O

Polyacrylamide NN O
gels NNS O
were VBD O
prepared VBN O
by IN O
polymerizing VBG O
a DT O
solution NN O
containing VBG O
18 CD O
% NN O
( , O
w NN O
/ SYM O
v NN O
) SYM O
acrylamide NN O
, , O
0 CD O
. . O
8 CD O
% NN O
( HYPH O
w NN O
/ SYM O
v NN O
) -RRB- O
N NN O
, , O
N NN O
' '' O
- HYPH O
methylenebisacrylami NN O
. . O

7M NN O
urea NN O
, , O
89 CD O
mM NN O
Tris NN O
- HYPH O
borate NN O
( , O
pH NN O
8 CD O
. . O
2 CD O
) -RRB- O
, , O
2 CD O
mM NN O
EDTA NNP O
, , O
0 CD O
. . O
7 CD O
% NN O
( , O
w NN O
/ SYM O
v NN O
) -RRB- O
ammonium NN O
persulfate NN O
, , O
in IN O
the DT O

presence NN O
of IN O
N NNP O
, , O
N NNP O
, , O
N NNP O
' '' O
, , O
N NNP O
' '' O
- HYPH O
tetramethylethylened NN O
( , O
20 CD O
Pil NNP O
/ SYM O
20 CD O
ml NN O
solution NN O
) -RRB- O
. . O

The DT O

solution NN O
was VBD O
poured VBN O
into IN O
a DT O
0 CD O
. . O
75 CD O
x SYM O
140 CD O
x SYM O
150 CD O
mm NN O
mold NN O
and CC O
allowed VBN O
to TO O
polymerize VB O
for IN O
2 CD O
hrs NNS O
at IN O
room NN O
temperature NN O
. . O

5 CD O
' '' O
- HYPH O
Labeled VBN O
oligonucleoside NN O
methylphosphonates NNS O
were VBD O
dissolved VBN O
in IN O
10 CD O
% NN O
aqueous JJ O
glycerol NN O
solution NN O
containing VBG O
0 CD O
. . O
4 CD O
% NN O
bromophenol NN O
blue JJ O
and CC O
applied VBN O
to IN O
the DT O
gel NN O
. . O

The DT O
electrophoresis NN O
was VBD O
run VBN O
using VBG O
89 CD O
mM NN O

Tris NNP O
- HYPH O
Borate NNP O
buffer NN O
containing VBG O
10 CD O
mM NN O
EDTA NNP O
. . O

After IN O
electrophoresis NN O
the DT O
gel NN O
was VBD O
dried VBN O
using VBG O
a DT O
gel NN O
- HYPH O
dryer NN O
and CC O
autoradiographed VBN O
using VBG O
intensifying VBG O
screens NNS O
at IN O
room NN O
temperature NN O
. . O

Pa NNP O
rti NNP O
al NNP O
Cl NN O
eavage NN O
of IN O
1 CD O
i NN O
gonucl FW O
eosi FW O
de FW O
Methyl FW O
phosphonates FW O
wi FW O
th FW O
Hydrochl FW O
ori FW O
c NN O
Aci NNP O
d NN O
or CC O
Piperidine NN O
. . O

Aliquots NNP O
( : O
1 CD O
, , O
jl NN O
) , O
from IN O
the DT O
polynucleotide NN O
kinase NN O
reaction NN O

6231 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

mixture NN O
were VBD O
incubated VBN O
with IN O
1 CD O
il NN O
of IN O
1 CD O
M NN O
hydrochloric JJ O
acid NN O
at IN O
37 CD O
? . O
C NN O
for IN O
30 CD O
min NN O
. . O

After IN O
incubation NN O
the DT O
solution NN O
was VBD O
neutralized VBN O
with IN O
1 CD O
Pl NNS O
of IN O
1 CD O
M NN O
ammonium NN O

hydroxide NN O
and CC O
then RB O
allowed VBN O
to TO O
stand VB O
at IN O
room NN O
temperature NN O
for IN O
10 CD O
min NN O
before IN O
cooling VBG O
to IN O
0 CD O
. . O

Alternatively RB O
, , O
aliquots NNS O
( , O
1 CD O
pl NN O
) -RRB- O
from IN O
the DT O
phosphorylation NN O

reaction NN O
were VBD O
incubated VBN O
with IN O
1 CD O
ul CD O
of IN O
1 CD O
M NN O
aqueous JJ O
piperidine NN O
at IN O
370C CD O
for IN O
10 CD O
min NN O
after IN O
which WDT O
the DT O
solution NN O
was VBD O
cooled VBN O
to IN O
0 CD O
? , O
and CC O
evaporated VBN O
. . O

The DT O
treated VBN O

samples NNS O
were VBD O
then RB O
subjected VBN O
to IN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
as IN O
described VBN O
above RB O
without IN O
further JJ O
purification NN O
. . O

RESULTS NNS O
AND CC O
DISCUSSION NN O

Synthesis NN O
of IN O
Protected VBN O
Oligonucleoside NNP O
Methylphosphonates NNP O
. . O

Table NN O
I PRP O
shows VBZ O
some DT O
of IN O
the DT O
protected VBN O
oligonucleoside JJ O
methylphosphonates NNS O
which WDT O
have VBP O
been VBN O

synthesized VBN O
on IN O
aminomethyl NN O
succinyl NN O
- HYPH O
derivatized VBN O
polystyrene NN O
supports VBZ O
. . O

The DT O
basic JJ O
synthetic JJ O
steps NNS O
which WDT O
are VBP O
shown VBN O
in IN O
Figure NN O
1 CD O
are VBP O
described VBN O
in IN O
detail NN O
in IN O
the DT O
Experimental NNP O
section NN O
. . O

These DT O
steps NNS O
are VBP O
: : O
( : O
1 LS O
) -RRB- O
removal NN O
of IN O
the DT O

dimethoxytrityl NN O
group NN O
with IN O
1 CD O
M NN O
zinc NN O
bromide NN O
solution NN O
; : O
( : O
2 CD O
) -RRB- O
drying VBG O
the DT O
support NN O

via IN O
co NN O
- HYPH O
evaporation NN O
with IN O
anhydrous JJ O
pyridine NN O
; : O
( : O
3 CD O
) NFP O
reaction NN O
of IN O
the DT O
support NN O
- HYPH O
bound VBN O

nucleoside NN O
or CC O
oligonucleotide NN O
with IN O
a DT O
coupling NN O
mixture NN O
containing VBG O
0 CD O
. . O
15 CD O
to TO O
0 CD O
. . O
2 CD O
M NN O
d NN O
- HYPH O
[ -LRB- O
( : O
MeO NN O
) : O
2Tr NN O
) : O
- : O
NpjEt3NH NN O
and CC O
0 CD O
. . O
3 CD O
to TO O
0 CD O
. . O
6 CD O
M NN O
mesitylenesulfonyl NN O
- HYPH O
3 CD O
- HYPH O
nitrotriazole NN O
in IN O
anhydrous JJ O
pyridine NN O
and CC O
( , O
4 CD O
) NFP O
acetylation NN O
of IN O
unreacted JJ O
5 CD O
' '' O
- HYPH O
OH NN O
groups NNS O
with IN O
acetic JJ O

anhydride NN O
. . O

The DT O
reactions NNS O
and CC O
washing NN O
steps NNS O
were VBD O
most RBS O
conveniently RB O
carried VBN O
out RP O
in IN O
a DT O
polypropylene NN O
Econo NNP O
Column NNP O
fitted VBN O
with IN O
a DT O
septum NN O
cap NN O
and CC O
a DT O
3 CD O
- HYPH O
way NN O
Teflon NNP O

DMTrO NNP O
, , O
O NN O
Figure NN O
1 CD O
: : O
Preparation NN O
of IN O
Protected VBN O

Oligonucleoside NN O
Methylphosphonates NNS O
on IN O
a DT O
1 CD O
T NN O
o NN O
w NN O
Polystyrene NN O
Support NN O

0 NFP O

H NN O
BFvON NNP O
DlDTrOjO4B NNP O

U NN O
) NFP O
I NNP O
CH3 NNP O
- HYPH O
gd NNP O
- HYPH O
OEt NNP O
3NH NNP O

0 NFP O

6232 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

stopcock NN O
. . O

Thus RB O
no DT O
transfers NNS O
of IN O
the DT O
support NN O
are VBP O
required VBN O
using VBG O
this DT O
apparatus NN O
. . O

The DT O
synthetic JJ O
procedure NN O
is VBZ O
analogous JJ O
to IN O
the DT O
phosphotriester NN O
approach NN O
used VBN O
to IN O
prepared VBN O
protected VBN O
oligonucleotide NN O
phosphotriesters NNS O
on IN O
polystyrene NN O
supports NNS O
( : O
6 CD O
) -RRB- O
. . O

However RB O
, , O
we PRP O
found VBD O
the DT O
methylphosrhonate NN O
coupling VBG O
reaction NN O
to TO O
be VB O

extremely RB O
sensitive JJ O
to IN O
moisture NN O
. . O

Drying VBG O
procedures NNS O
such JJ O
as IN O
washing NN O
with IN O

anhydrous JJ O
solvent NN O
or CC O
blowing VBG O
dry JJ O
nitrogen NN O
gas NN O
through IN O
the DT O
support NN O
which WDT O
are VBP O
satisfactory JJ O
for IN O
phosphotriester NN O
synthesis NN O
resulted VBD O
in IN O
low JJ O
yields NNS O
of IN O
the DT O
methylphosphonates NNS O
. . O

The DT O
best JJS O
yields NNS O
were VBD O
obtained VBN O
when WRB O
the DT O
support NN O
was VBD O

co NN O
- HYPH O
evaporated VBN O
with IN O
anhydrous JJ O
pyridine NN O
by IN O
directly RB O
attaching VBG O
the DT O
reaction NN O

column NN O
to IN O
a DT O
vacuum NN O
pump NN O
and CC O
dry JJ O
- HYPH O
ice NN O
trap NN O
. . O

Three CD O
10 CD O
min NN O
co NN O
- HYPH O
evaporations NNS O
were VBD O
sufficient JJ O
to TO O
render VB O
the DT O
support NN O
anhydrous JJ O
. . O

The DT O
protected VBN O
nucleoside NN O
3 CD O
' '' O
- HYPH O
methylphosphonate NN O
triethylammonium NN O
salts NNS O
used VBN O
in IN O
the DT O
coupling NN O
reactions NNS O
were VBD O
prepared VBN O
from IN O
their PRP$ O
cyanoethyl NN O
ester NN O

derivatives NNS O
( : O
3 CD O
) -RRB- O
. . O

These DT O
monomers NNS O
were VBD O
recovered VBN O
after IN O
each DT O
coupling NN O
step NN O
and CC O

were VBD O
freed VBN O
of IN O
unreacted JJ O
MSNT NNP O
by IN O
a DT O
simple JJ O
extraction NN O
step NN O
. . O

After IN O
precipitation NN O
and CC O
drying NN O
, , O
the DT O
monomers NNS O
could MD O
be VB O
reused VBN O
for IN O
other JJ O
syntheses NNS O
. . O

The DT O
ability NN O
to TO O
recover VB O
the DT O
unreacted JJ O
monomers NNS O
is VBZ O
particularly RB O
important JJ O
for IN O
large JJ O
scale NN O

synthesis NN O
since IN O
large JJ O
excesses NNS O
of IN O
these DT O
materials NNS O
are VBP O
employed VBN O
in IN O
the DT O
coupling NN O
step NN O
. . O

This DT O
recovery NN O
step NN O
represents VBZ O
a DT O
potential JJ O
advantage NN O
over IN O
the DT O
phosphine NN O
synthetic JJ O
method NN O
( , O
4 CD O
) -RRB- O
, , O
since IN O
it PRP O
is VBZ O
not RB O
clear JJ O
that IN O
nucleoside NN O
3 CD O
' '' O
- HYPH O
methylphosphine NN O
chlorides NNS O
can MD O
be VB O
recovered VBN O
after IN O
reaction NN O
. . O

Two CD O
types NNS O
of IN O
methylphosphonate NN O
oligomers NNS O
were VBD O
prepared VBN O
; : O
those DT O
which WDT O
contain VBP O
only RB O
methylphosphonate NN O
linkages NNS O
, , O
oligomers NNS O
1 CD O
- HYPH O
6 CD O
, , O
and CC O
those DT O
which WDT O
terminate VBP O
with IN O
a DT O
5 CD O
' NN O
- HYPH O
nucleoside NN O
3 CD O
' '' O
- HYPH O
p NN O
- HYPH O
chlorophenyl NN O
phosphotriester NN O
moiety NN O
, , O

oligomers NNS O
7 CD O
- SYM O
10 CD O
. . O

Oligomers NNS O
were VBD O
synthesized VBN O
on IN O
both DT O
1 CD O
% NN O
and CC O
2 CD O
% NN O
crosslinked VBN O

supports NNS O
. . O

As IN O
shown VBN O
in IN O
Table NNP O
I NNP O
, , O
the DT O
average JJ O
yield NN O
per IN O
coupling NN O
step NN O
which WDT O
was VBD O
determined VBN O
by IN O
trityl NN O
group NN O
analysis NN O
was VBD O
approximately RB O
82 CD O
% NN O
, , O
for IN O
both DT O
types NNS O
of IN O

support NN O
. . O

This DT O
yield NN O
is VBZ O
adequate JJ O
to TO O
allow VB O
preparation NN O
of IN O
protected VBN O
octamers NNS O
or CC O
nonamers NNS O
in IN O
25 CD O
% NN O
and CC O
20 CD O
% NN O
overall JJ O
yield NN O
, , O
respectively RB O
. . O

Deprotection NN O
. . O

Our PRP$ O
previous JJ O
studies NNS O
( , O
1 CD O
) -RRB- O
and CC O
those DT O
of IN O
Sinha NNP O
et FW O
al JJ O
. . O

( : O
4 CD O
) SYM O
show NN O

that IN O
methylphosphonate NN O
linkages NNS O
are VBP O
cleaved VBN O
by IN O
base NN O
. . O

We PRP O
found VBD O
this DT O
hydrolysis NN O
reaction NN O
to TO O
depend VB O
to IN O
some DT O
extent NN O
upon IN O
the DT O
nucleoside JJ O
sequence NN O
of IN O
the DT O

oligomer NNP O
. . O

Hydrolysis NN O
of IN O
methylphosphonate NN O
linkages NNS O
by IN O
concentrated VBN O
ammonium NN O
hydroxide NN O
in IN O
pyridine NN O
( , O
1 CD O
: SYM O
1 CD O
v NN O
/ SYM O
v NN O
) -RRB- O
, , O
the DT O
reagent NN O
commonly RB O
used VBN O
to TO O
remove VB O

oligonucleotide NN O
base NN O
protecting VBG O
groups NNS O
, , O
can MD O
be VB O
largely RB O
suppressed VBN O
if IN O
the DT O

reactions NNS O
are VBP O
run VBN O
at IN O
0 CD O
? . O
C NN O
( , O
1 CD O
) -RRB- O
. . O

However RB O
, , O
these DT O
conditions NNS O
are VBP O
unsatisfactory JJ O
for IN O
removal NN O
of IN O
oligonucleoside JJ O
methylphosphonates NNS O
from IN O
the DT O
polystyrene NN O

6233 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Table NN O
I CD O
. . O
Syntheses NNS O
of IN O
Protected VBN O
Oligonucleoside NN O
Methylphosphonates NNS O
on IN O

Polystyrene NN O
Supports VBZ O

Support NN O
Average JJ O
cross JJ O
- HYPH O
yield NN O
Protected VBN O
oligomer NN O
( : O
a DT O
) -RRB- O
linking NN O
per IN O

( : O
% NN O
) -RRB- O
coupling NN O

step NN O
( : O
% NN O
) -RRB- O

1 LS O
d NN O
- HYPH O
[ -LRB- O
( : O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
bzCpbzCpbzApT NN O
- HYPH O
O NN O
1 CD O
81 CD O
2 CD O
d CD O
- HYPH O
[ NN O
( : O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
ibuGpbzCpbzCpbzApT NNP O
- HYPH O
1 CD O
82 CD O
3 CD O
d CD O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
bzCpbzApi NN O
buGpi NN O
buGpTpbzApbzA NN O
- HYPH O
G1i NNP O
2 CD O
83 CD O
4 CD O
d NN O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr CD O
] -RRB- O
bzCLpTpT NN O
bzApbzCpbzCpTpibuG NN O
- : O
? . O

2 CD O
85 CD O
5 CD O
d SYM O
- HYPH O
[ -LRB- O
( : O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
TpbzCpbzCpTpbzCpbzCp NN O
- : O
( : O
? . O

2 CD O
86 CD O
6 CD O
d CD O
- HYPH O
[ -LRB- O
( : O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
TpTpTpbzApbzCpbzCpTp NN O
- : O
? . O

1 CD O
83 CD O
7 CD O
d CD O
- HYPH O
[ -LRB- O
( : O
MeO NNP O
) NFP O
2Tr NN O
] -RRB- O
bzApbzApbzA NN O
- : O
? . O

1 CD O
83 CD O
8 CD O
d CD O
- HYPH O
[ -LRB- O
( : O
MeO NNP O
) NFP O
2Tr NN O
] -RRB- O
bzA4bzCpbzCpbzApT NN O
- : O
? . O

1 CD O
81 CD O
9 CD O
d NN O
- HYPH O
[ -LRB- O
( : O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
bzApibuGpbzCpbzApbzA NN O
- : O
( : O
2 CD O
74 CD O
10 CD O
d CD O
- HYPH O
[ -LRB- O
( : O
MeO NNP O
) NFP O
2Tr NN O
] -RRB- O
bzApbzApbzApbzApibuG NN O
- HYPH O
( : O
Q NN O
1 CD O
86 CD O

( : O
a DT O
) NFP O
p NN O
= SYM O
methylphosphonate NN O
linkage NN O

T NN O
= : O
p NN O
- HYPH O
chlorophenyl NN O
phosphotriester NN O
linkage NN O
( , O
Q NN O
= SYM O
polystyrene NN O
support NN O

( : O
b LS O
) NFP O
Determined VBN O
by IN O
analysis NN O
of IN O
the DT O
dimethoxytrityl NN O
group NN O
after IN O
each DT O

coupling VBG O
step NN O
. . O

support NN O
. . O

We PRP O
therefore RB O
examined VBD O
other JJ O
deprotection NN O
procedures NNS O
. . O

Recently RB O
Barnett NNP O
and CC O
Letsinger NNP O
described VBD O
removal NN O
of IN O
base NN O
protecting VBG O
groups NNS O
from IN O
oligonucleotide NN O
B NN O
, , O
B NN O
, , O
0 CD O
- HYPH O
trichloroethylphosph NN O
using VBG O
a DT O

mixture NN O
of IN O
ethylenediamine NN O
in IN O
phenol NN O
( HYPH O
7 CD O
) -RRB- O
. . O

We PRP O
have VBP O
found VBN O
ethylenediamine NN O
in IN O
ethanol NN O
( , O
1 CD O
: : O
1 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
rapidly RB O
and CC O
cleanly RB O
removes VBZ O
benzoyl NN O
and CC O
isobutyryl NN O
protecting VBG O
groups NNS O
from IN O
dA NN O
, , O
dC NN O
and CC O
dG NNP O
nucleosides NNS O
. . O

This DT O
reagent NN O
is VBZ O

particularly RB O
attractive JJ O
since IN O
it PRP O
can MD O
be VB O
easily RB O
removed VBN O
by IN O
evaporation NN O
. . O

In IN O
our PRP$ O
initial JJ O
investigations NNS O
, , O
ol JJ O
igonucleoside NN O
methylphosphonates NNS O
were VBD O

cleaved VBN O
from IN O
the DT O
support NN O
and CC O
base NN O
protecting VBG O
groups NNS O
were VBD O
removed VBN O
by IN O
treatment NN O
with IN O
ethylenediamine NN O
/ SYM O
ethanol NN O
( : O
1 CD O
: SYM O
1 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
at IN O
65 CD O
? . O
C NN O
for IN O
3 CD O
hrs NNS O
. . O

Although IN O

preliminary JJ O
results NNS O
indicated VBD O
the DT O
methylphosphonate NN O
linkages NNS O
of IN O
several JJ O
dimers NNS O
were VBD O
stable JJ O
to IN O
these DT O
conditions NNS O
, , O
we PRP O
later RB O
found VBD O
that IN O
the DT O
linkages NNS O
of IN O
onger NN O

6234 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Table NNP O
II NNP O
. . O

Hydrolysis NN O
of IN O
Protected VBN O
Nucleosides NNS O
by IN O
Ethylenediamine NN O
at IN O
220C CD O

Protected VBN O
Time NN O
required VBD O
to IN O
Time NN O
required VBD O
to IN O
nucleoside NN O
remove VB O
50 CD O
% NN O
of IN O
the DT O
cleave NN O
50 CD O
% NN O
of IN O
the DT O

base NN O
protecting VBG O
nucleoside NN O
from IN O
the DT O
groups NNS O
( -LRB- O
min NN O
) -RRB- O
1 CD O
% NN O
crosslinked VBN O

support NN O
( : O
min NN O
) -RRB- O

d LS O
- : O
[ -LRB- O
( -LRB- O
MeO NNP O
) NFP O
2Tr NN O
) NFP O
bzA NN O
10 CD O
105 CD O
d CD O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NN O
) NFP O
2Tr NN O
bzC NN O
20 CD O
105 CD O
d CD O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NN O
) NFP O
2Tr NN O
] -RRB- O
i CD O
buG NN O
40 CD O
54 CD O
d CD O
- HYPH O
[ -LRB- O
( : O
MeO NN O
) NFP O
2Tr NN O
] -RRB- O
T NN O
_ : O
105 CD O

oligomers NNS O
were VBD O
hydrolyzed VBN O
to IN O
various JJ O
extents NNS O
by IN O
this DT O
procedure NN O
. . O

This DT O
of IN O

course NN O
resulted VBD O
in IN O
loss NN O
of IN O
product NN O
as IN O
was VBD O
evidenced VBN O
by IN O
the DT O
presence NN O
of IN O
shorter JJR O
oligomers NNS O
in IN O
amounts NNS O
greater JJR O
than IN O
expected VBN O
based VBN O
upon IN O
the DT O
coupling NN O
yields NNS O
. . O

To TO O
circumvent VB O
this DT O
problem NN O
we PRP O
examined VBD O
the DT O
deprotection NN O
reactions NNS O
at IN O
lower JJR O
temperatures NNS O
and CC O
found VBD O
they PRP O
could MD O
be VB O
run VBN O
effectively RB O
at IN O
room NN O

temperature NN O
. . O

Table NNP O
II NNP O
shows VBZ O
the DT O
half JJ O
- HYPH O
lives NNS O
for IN O
removing VBG O
the DT O
base NN O
protecting VBG O
groups NNS O
from IN O
nucleosides NNS O
at IN O
room NN O
temperature NN O
. . O

While IN O
the DT O
isobutryl NN O
protecting VBG O
group NN O
is VBZ O
removed VBN O
at IN O
the DT O
slowest JJS O
rate NN O
, , O
all PDT O
the DT O
groups NNS O
are VBP O
completely RB O
removed VBN O
within IN O
240 CD O
min NN O
. . O

The DT O
sole JJ O
product NN O
of IN O
each DT O
reaction NN O
is VBZ O
the DT O
5 CD O
' '' O
- HYPH O
O NN O
- HYPH O
dimethoxytritylnucle NN O
as IN O
shown VBN O
by IN O
TLC NNP O
. . O

Table NNP O
II NNP O
also RB O
shows VBZ O
the DT O
half JJ O
- HYPH O
lives NNS O
for IN O
cleavage NN O
of IN O
protected VBN O
nucleosides NNS O
from IN O
the DT O
1 CD O
% NN O
crosslinked JJ O
support NN O
. . O

The DT O
deoxyguanosine JJ O
nucleoside NN O
is VBZ O
cleaved VBN O

most RBS O
rapidly RB O
while IN O
the DT O
other JJ O
three CD O
nucleosides NNS O
have VBP O
essentially RB O
the DT O
same JJ O
rates NNS O
of IN O
hydrolysis NN O
. . O

All PDT O
the DT O
nucleosides NNS O
are VBP O
completely RB O
removed VBN O
from IN O
the DT O
support NN O
within IN O
7 CD O
hrs NNS O
. . O

In IN O
contrast NN O
, , O
very RB O
different JJ O
rates NNS O
were VBD O
observed VBN O
for IN O
the DT O
2 CD O
% NN O

crosslinked JJ O
supports NNS O
. . O

In IN O
these DT O
cases NNS O
, , O
very RB O
little JJ O
cleavage NN O
occurred VBD O
during IN O
the DT O
first JJ O
4 CD O
hrs NNS O
of IN O
incubation NN O
after IN O
which WDT O
increasing VBG O
amounts NNS O
of IN O
nucleoside NN O
were VBD O
released VBN O
over IN O
a DT O
24 CD O
hr NN O
period NN O
. . O

This DT O
effect NN O
may MD O
be VB O
due IN O
to IN O
the DT O
slower JJR O
swelling VBG O
rate NN O
of IN O
the DT O
2 CD O
% NN O
crosslinked JJ O
support NN O
versus IN O
the DT O
1 CD O
% NN O
support NN O
. . O

The DT O

results NNS O
of IN O
these DT O
experiments NNS O
suggest VBP O
that IN O
, , O
although IN O
condensation NN O
reactions NNS O

occur VB O
with IN O
equal JJ O
efficiencies NNS O
on IN O
both CC O
the DT O
1 CD O
% NN O
and CC O
2 CD O
% NN O
crosslinked JJ O
supports NNS O
, , O
the DT O
1 CD O
% NN O
support NN O
is VBZ O
preferred VBN O
for IN O
syntheses NNS O
since IN O
the DT O
oligomers NNS O
can MD O
be VB O
removed VBN O
more RBR O
readily RB O
under IN O
mild JJ O
conditions NNS O
. . O

The DT O
stability NN O
of IN O
the DT O
methylphosphonate NN O
linkage NN O
in IN O
a DT O
number NN O
of IN O
oligomers NNS O

of IN O
varying VBG O
chain NN O
length NN O
and CC O
base NN O
composition NN O
was VBD O
examined VBN O
following VBG O
prolonged VBN O
exposure NN O
to IN O
ethylenediamine NN O
/ SYM O
ethanol NN O
at IN O
room NN O
temperature NN O
. . O

As IN O
shown VBN O
in IN O
Table NNP O
III NNP O
, , O
some DT O
of IN O
these DT O
oligomers NNS O
, , O
most RBS O
notably RB O
the DT O
dimer NN O
and CC O
d NN O
- HYPH O
GpGpT NNP O
, , O
were VBD O

6235 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Table NNP O
III NNP O
. . O

Hydrolysis NN O
of IN O
Oligonucleoside NNP O
Methylphosphonates NNPS O
by IN O

Ethylenediamine NN O
at IN O
22 CD O
? . O
C NN O

| NFP O
Oligomer NNP O
Mole NNP O
percent NN O
of IN O
oligomer NN O
remaining VBG O
after IN O
treatment NN O
for IN O

24 CD O
hrs VBZ O
48 CD O
hrs NNS O
96 CD O
hrs NNS O

d LS O
- : O
T NN O
A NN O
100 CD O
100 CD O
100 CD O
d CD O
- HYPH O
A5r CD O
100 CD O
100 CD O
100 CD O
d CD O
- HYPH O
TpT NN O
100 CD O
100 CD O
100 CD O
d CD O
- HYPH O
l NN O
pT NN O
95 CD O
97 CD O
91 CD O
d CD O
- HYPH O
qgG NN O
{ CD O
T NN O
100 CD O
100 CD O
100 CD O
d CD O
- HYPH O
ApApA NN O
93 CD O
87 CD O
75 CD O
d CD O
- HYPH O
C NN O
pC NN O
ApT NN O
92 CD O
83 CD O
67 CD O

completely RB O
stable JJ O
over IN O
a DT O
96 CD O
hr NN O
period NN O
. . O

The DT O
maximum JJ O
rate NN O
of IN O
hydrolysis NN O
for IN O
a DT O
methylphosphonate NN O
linkage NN O
in IN O
those DT O
oligomers NNS O
which WDT O
were VBD O
hydrolyzed VBN O
is VBZ O

estimated VBN O
to TO O
be VB O
0 CD O
. . O
13 CD O
mole NN O
% NN O
/ SYM O
hr NN O
. . O

The DT O
results NNS O
of IN O
these DT O
studies NNS O
show VBP O
that IN O
the DT O
oligonucleoside JJ O
methylphosphonates NNS O
could MD O
be VB O
cleaved VBN O
from IN O
the DT O
1 CD O
% NN O
crosslinked JJ O
support NN O
and CC O
completely RB O
freed VBN O
of IN O
base NN O
protecting VBG O
groups NNS O
with IN O
little JJ O
or CC O
no DT O
hydrolysis NN O
of IN O
the DT O
methylphosphonate NN O
linkage NN O
by IN O
treatment NN O
with IN O

ethylenediamine NN O
/ SYM O
ethanol NN O
( : O
1 CD O
: : O
1 CD O
, , O
v NN O
/ , O
v NN O
) -RRB- O
at IN O
room NN O
temperature NN O
for IN O
7 CD O
hrs NNS O
. . O

These DT O
conditions NNS O
were VBD O
subsequently RB O
adopted VBN O
for IN O
the DT O
deprotection NN O
step NN O
. . O

Purification NN O
of IN O
Oligonucleoside NNP O
Methylphosphonates NNPS O
. . O

Two CD O
methods NNS O
were VBD O
employed VBN O
to TO O
purify VB O
oligomers NNS O
following VBG O
cleavage NN O
from IN O
the DT O
support NN O
. . O

For IN O
oligomers NNS O
which WDT O
contain VBP O
only RB O
methylphosphonate NN O
linkages NNS O
, , O
the DT O
tritylated JJ O
oligomer NN O
was VBD O
isolated VBN O

by IN O
preparative JJ O
reversed JJ O
phase NN O
HPLC NNP O
. . O

This DT O
separation NN O
is VBZ O
based VBN O
upon IN O
the DT O
greater JJR O
affinity NN O
of IN O
the DT O
tritylated JJ O
oligomer NN O
for IN O
the DT O
hydrophobic JJ O
C NN O
- HYPH O
18 CD O
matrix NN O
of IN O
the DT O

column NN O
. . O

Shorter JJR O
, , O
non AFX O
- HYPH O
tritylated JJ O
oligomers NNS O
were VBD O
first RB O
eluted VBN O
with IN O
a DT O
0 CD O
% NN O
to TO O
25 CD O
% NN O
or CC O
0 CD O
% NN O
to TO O
30 CD O
% NN O
acetonitrile NN O
in IN O
water NN O
gradient NN O
. . O

The DT O
tritylated JJ O
product NN O
was VBD O
then RB O
eluted VBN O
with IN O
a DT O
step NN O
gradient NN O
of IN O
50 CD O
% NN O
acetonitrile NN O
in IN O
water NN O
. . O

The DT O
dimethoxytrityl NN O
group NN O
was VBD O
removed VBN O
from IN O
the DT O
material NN O
in IN O
the DT O
50 CD O
% NN O

acetonitrile NN O
fraction NN O
by IN O
treatment NN O
with IN O
80 CD O
% NN O
acetic JJ O
acid NN O
at IN O
room NN O
temperature NN O
. . O

Because IN O
these DT O
oligomers NNS O
were VBD O
originally RB O
cleaved VBN O
from IN O
the DT O
support NN O
by IN O

ethylenediamine NN O
/ SYM O
ethanol NN O
( : O
1 CD O
: : O
1 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
at IN O
65 CD O
? , O
C NN O
, , O
we PRP O
usually RB O
found VBD O
that IN O
the DT O

tritylated VBN O
oligomer NN O
fraction NN O
contained VBD O
shorter JJR O
oligomers NNS O
in IN O
addition NN O
to IN O
the DT O
desired VBN O
product NN O
. . O

These DT O
were VBD O
easily RB O
separated VBN O
by IN O
preparative JJ O
reversed VBN O
phase NN O
HPLC NNP O
. . O

While IN O
this DT O
purification NN O
procedure NN O
is VBZ O
qualitatively RB O
satisfactory JJ O
, , O

recoveries NNS O
from IN O
the DT O
reversed JJ O
phase NN O
columns NNS O
varied VBD O
from IN O
50 CD O
% NN O
to IN O
90 CD O
% NN O
. . O

These DT O

losses NNS O
which WDT O
appeared VBD O
to TO O
be VB O
due IN O
to IN O
irreverisble JJ O
absorption NN O
of IN O
the DT O
oligomers NNS O
to IN O
the DT O
column NN O
varied VBD O
depending VBG O
on IN O
the DT O
base JJ O
composition NN O
of IN O
the DT O
oligomers NNS O
. . O

6236 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Figure NN O
2 CD O
: : O
Purification NN O
of IN O

d LS O
- : O
ApApApApGpCpApApG NNP O
. . O

( : O
a DT O
) NFP O
Ol NNP O
igomers NNS O
obtained VBD O
after IN O
treatment NN O
of IN O
support NN O
wi NN O
th IN O
ethylenediamine NN O
/ SYM O
ethanol NN O
( , O
1 CD O
: SYM O
1 CD O
, , O

v NN O
/ : O
v NN O
) -RRB- O
. . O

( : O
b LS O
) NFP O
Ol NNP O
igomers NNS O
obtained VBD O
after IN O
treatment NN O
of IN O
the DT O
mixture NN O
in IN O
( : O
a DT O
) NFP O
with IN O
80 CD O
% NN O
acetic JJ O
acid NN O
. . O

( : O
c NN O
) -RRB- O
Oligomers NNPS O
eluted VBD O
from IN O
DEAE NNP O
cellulose NN O
column NN O
with IN O

0 NFP O
. . O
15 CD O
M NN O
triethylammonium NN O
bicarbonate NN O
. . O

( : O
d LS O
) -RRB- O
Nonamer NNP O
obtained VBD O
after IN O
preparative JJ O
reversed JJ O
phase NN O
HPLC NNP O
. . O

Peaks NNS O
marked VBD O

with IN O
the DT O
symbol NN O
( , O
X NNP O
) -RRB- O
are VBP O
derived VBN O
from IN O
impurities NNS O
in IN O
the DT O
solvents NNS O
used VBN O
to TO O
elute VB O
the DT O
oligomer NN O
from IN O
the DT O
polystyrene NN O
support NN O
. . O

d LS O
"""" `` O
AAAGCAAGc NNP O

O NN O
I NN O
t10 CD O
15 CD O
20 CD O
25 CD O

Time NN O
( : O
min NN O
) -RRB- O

For IN O
the DT O
oligomers NNS O
which WDT O
terminate VBP O
with IN O
a DT O
5 CD O
' '' O
- HYPH O
nucleoside NN O
phosphotriester NN O
group NN O
, , O
the DT O
support NN O
was VBD O
first RB O
treated VBN O
for IN O
40 CD O
hrs NNS O
with IN O
tetra NN O
- HYPH O
n CC O
- HYPH O
butylammonium NN O

fluoride NN O
( , O
8 CD O
) -RRB- O
to TO O
remove VB O
the DT O
p NN O
- HYPH O
chlorophenyl NN O
protecting NN O
group NN O
. . O

These DT O
oligomers NNS O

6237 CD O

b LS O

Nucleic NNP O
Acids NNP O
Research NNP O

were VBD O
then RB O
cleaved VBN O
from IN O
the DT O
support NN O
and CC O
the DT O
base NN O
protecting VBG O
groups NNS O
were VBD O
removed VBN O
by IN O
treatment NN O
with IN O
ethylenediamine NN O
/ SYM O
ethanol NN O
( : O
1 CD O
: SYM O
1 CD O
, , O
v NN O
/ SYM O
v NN O
) -RRB- O
for IN O
7 CD O
hrs NNS O
at IN O
room NN O
temperature NN O
. . O

For IN O
example NN O
, , O
the DT O
reversed JJ O
phase NN O
HPLC NNP O
profile NN O
for IN O
products NNS O

obtained VBN O
after IN O
cleavage NN O
of IN O
the DT O
nonamer NN O
, , O
d NNP O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
ApAjApApGpCpApApG NNP O
, , O
is VBZ O
shown VBN O
in IN O
Figure NNP O
2a CD O
. . O

The DT O
peaks NNS O
marked VBN O
with IN O
( : O
X NNP O
) -RRB- O
are VBP O
from IN O
impurities NNS O
in IN O
the DT O

solvents NNS O
used VBN O
to TO O
elute VB O
the DT O
oligomer NN O
from IN O
the DT O
support NN O
. . O

The DT O
tritylated JJ O
nonamer NN O
appears VBZ O
at IN O
22 CD O
min NN O
in IN O
the DT O
chromatogram NN O
and CC O
is VBZ O
eluted VBN O
with IN O
50 CD O
% NN O
aqueous JJ O

acetonitrile FW O
. . O

After IN O
removal NN O
of IN O
the DT O
dimethoxytrityl NN O
group NN O
, , O
the DT O
nonamer JJ O
elutes NNS O
at IN O
15 CD O
. . O
2 CD O
min NN O
( -LRB- O
Figure NN O
2b CD O
) -RRB- O
. . O

The DT O
peaks NNS O
which WDT O
appear VBP O
between IN O
19 CD O
and CC O
25 CD O
min NNS O
are VBP O
shorter JJR O
oligomers NNS O
which WDT O
contain VBP O
a DT O
5 CD O
' '' O
- HYPH O
mesitylenesulfonate NN O
group NN O
. . O

At IN O
this DT O
stage NN O
, , O
the DT O
nonamer NN O
was VBD O
partially RB O
purified VBN O
by IN O
ion NN O
exchange NN O

chromatography NN O
on IN O
a DT O
DEAE NNP O
cellulose NN O
column NN O
. . O

This DT O
step NN O
, , O
which WDT O
resulted VBD O
in IN O
84 CD O
% NN O
recovery NN O
of IN O
material NN O
loaded VBN O
onto IN O
the DT O
column NN O
, , O
removed VBD O
most JJS O
of IN O
the DT O
shorter JJR O

oligomers NNS O
as IN O
shown VBN O
in IN O
Figure NN O
2c CD O
. . O

After IN O
removal NN O
of IN O
the DT O
buffer NN O
, , O
the DT O
nonamer NN O
was VBD O
purified VBN O
by IN O
preparative JJ O
reversed VBN O
phase NN O
HPLC NNP O
using VBG O
a DT O
0 CD O
% NN O
to TO O
30 CD O
% NN O
acetonitrile NN O
in IN O
0 CD O
. . O
1 CD O
M NN O
ammonium NN O
acetate NN O
gradient NN O
. . O

The DT O
recovery NN O
of IN O
material NN O
from IN O
the DT O
column NN O

( : O
84 CD O
% NN O
) -RRB- O
appears VBZ O
to TO O
be VB O
higher JJR O
when WRB O
ammonium NN O
acetate NN O
is VBZ O
used VBN O
. . O

The DT O
pure JJ O
nonamer NN O

( -LRB- O
Figure NN O
2d CD O
) -RRB- O
was VBD O
obtained VBN O
in IN O
10 CD O
% NN O
overall JJ O
yield NN O
based VBN O
on IN O
the DT O
amount NN O
of IN O
d NN O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2 CD O
Tr NN O
] -RRB- O
ibuG NNP O
originally RB O
bound VBN O
to IN O
the DT O
polystyrene JJ O
support NN O
. . O

The DT O
oligomer NN O
was VBD O
desalted VBN O
on IN O
a DT O
Bio NNP O
- HYPH O
Gel NNP O
P NNP O
- HYPH O
2 CD O
gel NN O
filtration NN O
column NN O
. . O

Similar JJ O
results NNS O
were VBD O

obtained VBN O
for IN O
the DT O
other JJ O
oligomers NNS O
purified VBN O
by IN O
this DT O
method NN O
. . O

Thus RB O
, , O
for IN O
example NN O
dApApA NNP O
and CC O
d NN O
- HYPH O
ApCpCpApT NN O
were VBD O
obtained VBN O
in IN O
44 CD O
% NN O
and CC O
22 CD O
% NN O
isolated VBN O
yields NNS O
respectively RB O
based VBN O
upon IN O
the DT O
amount NN O
of IN O
d NN O
- HYPH O
[ -LRB- O
( -LRB- O
MeO NNP O
) -RRB- O
2Tr NN O
] -RRB- O
N NN O
. . O

The DT O
5 CD O
' '' O
- HYPH O
terminal JJ O
nucleotide NN O
may MD O
be VB O
removed VBN O
enzynatically RB O
to TO O
give VB O
an DT O

oligomer NNP O
which WDT O
contains VBZ O
only RB O
methylphosphonate NN O
linkages NNS O
. . O

Thus RB O
treatment NN O
of IN O

the DT O
nonamer NNP O
, , O
d NN O
- HYPH O
ApApApApGpCpApApG NNP O
, , O
with IN O
spleen NN O
phosphodiesterase NN O
gave VBD O
d NN O
- HYPH O
Ap NN O
and CC O

the DT O
octamer NN O
d NN O
- HYPH O
ApApApGpCpApApG NN O
whose WP$ O
retention NN O
time NN O
is VBZ O
16 CD O
. . O
4 CD O
min NN O
on IN O
the DT O
reversed JJ O
phase NN O
column NN O
. . O

The DT O
noncharged JJ O
octamer NN O
was VBD O
freed VBN O
of IN O
d VBN O
- HYPH O
Ap NNP O
and CC O
enzyne NN O
by IN O
simply RB O
passing VBG O
it PRP O
through IN O
a DT O
small JJ O
DEAE NNP O
cellulose NN O
column NN O
. . O

Characterization NN O
. . O

Methylphosphonate NN O
linkages NNS O
are VBP O
cleaved VBN O
by IN O
base NN O
. . O

We PRP O
have VBP O
found VBN O
piperdine NN O
is VBZ O
particularly RB O
effective JJ O
. . O

The DT O
cleavage NN O
occurs VBZ O
in IN O
a DT O
random JJ O
manner NN O
giving VBG O
nucleosides NNS O
, , O
nucleoside NN O
3 CD O
' '' O
- HYPH O
or CC O
5 CD O
' '' O
- HYPH O
methylphosphonates NNS O
and CC O

nucleoside NN O
3 CD O
' '' O
, , O
5 CD O
' '' O
- HYPH O
bis NN O
- HYPH O
methylphosphonates NNS O
. . O

This DT O
hydrolysis NN O
reaction NN O
may MD O
be VB O
used VBN O
to TO O
characterize VB O
dimers NNS O
, , O
since IN O
the DT O
identity NN O
and CC O
ratio NN O
of IN O
the DT O
products NNS O
formed VBN O
are VBP O
easily RB O
determined VBN O
by IN O
reversed VBN O
phase NN O
HPLC NNP O
. . O

However RB O
, , O
the DT O
method NN O
becomes VBZ O
less RBR O
satisfactory JJ O
for IN O
longer JJR O
oligomers NNS O
. . O

Purine NN O
- HYPH O
containing VBG O
oligonucleoside NN O
methylphosphonates NNS O
may MD O
be VB O
depurinated VBN O
by IN O
treatment NN O
with IN O
hydrochloric JJ O
acid NN O
at IN O
650 CD O
. . O

The DT O
methylphosphonate NN O
linkage NN O
is VBZ O

6238 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

9 CD O
0 CD O
OH NN O
cH3P NN O
: : O
O NN O
cH NN O
CH3P NN O

9 CD O
9 CD O

CH NN O
- HYPH O
P NN O
: : O
O NN O
C NN O
cH NN O
: : O
0pO NN O

O NN O
~ NFP O
~ NFP O
~ NFP O
j4 CD O
HO NN O
OP NN O
3 CD O
0 CD O
H NN O
0 CD O
0OH0 CD O

9 CD O
S NN O
S NN O

Figure NN O
3 CD O
: : O
Hydrolysis NN O
of IN O
the DT O
internucleoside JJ O
methylphsophonate NN O
linkages NNS O
at IN O
an DT O

apurinic JJ O
site NN O
produced VBN O
by IN O
treatment NN O
of IN O
the DT O
oligomer NN O
with IN O
hydrochloric JJ O
acid NN O
at IN O
pH NN O
2 CD O
. . O

resistant JJ O
to IN O
hydrolysis NN O
by IN O
these DT O
conditions NNS O
as IN O
shown VBN O
by IN O
the DT O
stability NN O
of IN O
d NNP O
- HYPH O
TpT NNP O
and CC O
d NNP O
- HYPH O
TpTpT NNP O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
dimers NNS O
or CC O
trimers NNS O
containing VBG O
purine NN O
bases NNS O

such JJ O
as IN O
d NNP O
- HYPH O
ApA NNP O
, , O
dApT NNP O
, , O
dTpA NNP O
or CC O
d NNP O
- HYPH O
ApApA NNP O
have VBP O
half JJ O
- HYPH O
lives NNS O
between IN O
92 CD O
and CC O
144 CD O
min NN O
in IN O
0 CD O
. . O
1 CD O
M NN O
hydrochloric JJ O
acid NN O
. . O

Following VBG O
neutralization NN O
with IN O
ammonium NN O
hydroxide NN O
, , O
the DT O
products NNS O
of IN O
these DT O
reactions NNS O
were VBD O
characterized VBN O
by IN O
reversed VBN O
phase NN O
HPLC NNP O
. . O

d LS O
- : O
ApA NNP O
gave VBD O
adenine NN O
, , O
while IN O
both CC O
d NNP O
- HYPH O
ApT NNP O
and CC O
d NNP O
- HYPH O
TpA NNP O
gave VBD O
adenine NN O
and CC O
thymidine NN O
as IN O
the DT O
sole JJ O
products NNS O
of IN O
the DT O
reaction NN O
. . O

Adenine NNP O
and CC O
d NNP O
- HYPH O
ApA NNP O
were VBD O
the DT O
only JJ O
products NNS O

observed VBN O
when WRB O
d NNP O
- HYPH O
ApApA NNP O
was VBD O
partially RB O
hydrolyzed VBN O
. . O

When WRB O
d NNP O
- HYPH O
CpCpApT NNP O
was VBD O
completely RB O
hydrolyzed VBN O
in IN O
acid NN O
three CD O
products NNS O
, , O
d NN O
- HYPH O
CpC NNP O
, , O
adenine NN O
and CC O
thynidine NN O
, , O
were VBD O
observed VBN O
in IN O
a DT O
molar JJ O
ratio NN O
of IN O
1 CD O
: SYM O
1 CD O
: SYM O
1 CD O
. . O

In IN O
contrast NN O
to IN O
the DT O
base NN O
hydrolysis NN O
of IN O
the DT O
methylphosphonate NN O
group NN O
, , O
apurinic JJ O
sites NNS O
produced VBN O
by IN O
acid NN O
treatment NN O
are VBP O
further RB O
hydrolyzed VBN O
to IN O

nucleosides NNS O
or CC O
oligomers NNS O
with IN O
free JJ O
5 CD O
' '' O
- HYPH O
and CC O
3 CD O
' '' O
- HYPH O
OH NNP O
groups NNS O
. . O

The DT O
absence NN O
of IN O

terminal JJ O
phosphonate NN O
residues NNS O
suggests VBZ O
hydrolysis NN O
occurs VBZ O
as IN O
shown VBN O
in IN O
Figure NN O
3 CD O
. . O

The DT O
OH NNP O
group NN O
on IN O
the DT O
4 CD O
' '' O
- HYPH O
carbon NN O
generated VBN O
by IN O
opening VBG O
the DT O
ribose NN O
at IN O
the DT O
apurinic JJ O
site NN O
may MD O
participate VB O
in IN O
an DT O
intramolecular JJ O
attack NN O
on IN O
the DT O
adjacent JJ O
phosphonate NN O
linkages NNS O
which WDT O
results VBZ O
in IN O
removal NN O
of IN O
the DT O
phosphonate NN O
residues NNS O
from IN O
the DT O
neighboring JJ O
nucleoside NN O
hydroxyls NNS O
. . O

Previous JJ O
studies NNS O
by IN O
Agarwal NNP O
and CC O
Riftina NNP O
indicated VBD O
dithymidine NN O
methyl NN O
- HYPH O
or CC O
phenylphosphonates NNS O
can MD O
be VB O
phosphorylated VBN O
by IN O
polynucleotide NN O
kinase NN O
( : O
9 CD O
) -RRB- O
. . O

Sinha NNP O
et FW O
al NNP O
. . O
reported VBD O
that IN O
dimers NNS O
but CC O
not RB O
trimers NNS O
or CC O
tetramers NNS O
served VBD O
as IN O

substrates NNS O
for IN O
this DT O
enzyme NN O
( : O
4 CD O
) -RRB- O
. . O

We PRP O
were VBD O
unable JJ O
to TO O
phosphorylate VB O
tetramers NNS O
or CC O
longer JJR O
oligomers NNS O
which WDT O
contain VBP O
only RB O
methylphosphonate NN O
linkages NNS O
. . O

However RB O
, , O
those DT O
oligomers NNS O
which WDT O
terminate VBP O
with IN O
a DT O
5 CD O
' '' O
- HYPH O
dAp NN O
- HYPH O
residue NN O
are VBP O
readily RB O

6239 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

a LS O

ATP NNP O
1 CD O

1 CD O
2 CD O
3 CD O
4 CD O

b LS O

6 CD O
mer NN O
Mik NNP O

6 CD O
mer NN O
go VB O

3mer UH O
a DT O
a NN O
a DT O
X NN O
2mer NN O
do VBP O
ATP NN O
411 CD O

12 CD O
w NN O
34 CD O

1 CD O
2 CD O
3 CD O
4 CD O
5 CD O
6 CD O

Figure NN O
4 CD O
: : O
( : O
a LS O
) NFP O
PEI NNP O
- HYPH O
cellulose NN O
TLC NNP O
of IN O
T4 NN O
polynucleotide NN O
kinase NN O
reactions NNS O
. . O

1 CD O
) : O
[ -LRB- O
y CD O
- HYPH O
32p CD O
] -RRB- O
ATP NN O
; : O
2 CD O
) SYM O
d CD O
- HYPH O
ApApA NN O
reaction NN O
mixture NN O
; : O
3 CD O
) : O
d NN O
- HYPH O
ApGpCpApApG NN O

reaction NN O
mixture NN O
; : O
4 CD O
) SYM O
d NN O
- HYPH O
ApApApApG NN O
_ HYPH O
pCpApAeG NN O
reaction NN O
mixture NN O
. . O

The DT O
chromatogram NN O
was VBD O
eluted VBN O
wi XX O
th1 CD O
. . O
5 CD O
M NN O
pyridinium NN O
formate NN O
, , O
pH NN O
3 CD O
. . O
5 CD O
. . O

( : O
b LS O
) NFP O
Polyacrylamide NNP O
gel NN O
electrophoresis NN O
of IN O
phosphoryljted NN O

olihonucleoside NN O
methylghosphonates NNS O
. . O

1 CD O
) : O
markers NNS O
: : O
d LS O
- : O
pTpT NN O
( : O
2 CD O
mer NN O
) -RRB- O
; : O
d NNP O
- : O
, , O
3pApApA NN O
( : O
3 CD O
mer NN O
) -RRB- O
; : O
d NNP O
- HYPH O
2pApGpCpApApG NN O
( : O
6 CD O
mer NN O
) -RRB- O
; : O

d LS O
- : O
32pApApApApGpCpApApG NN O
( : O
9 CD O
mer NN O
. . O

Lanes NNP O
2 CD O
- HYPH O
4 CD O
: : O
products NNS O
obtained VBN O

after IN O
partTaT NN O
fy NN O
? , O
rlysis NN O
of IN O
dl2pApApA NN O
( : O
2 CD O
) -RRB- O
; : O
d NN O
- HYPH O
2pApGpCpApApG NN O
( : O
3 CD O
) -RRB- O
and CC O
d NN O
- HYPH O
32pApARApApGpCpAZARG NN O
; : O
( : O
4 CD O
) NFP O
with IN O
0 CD O
. . O
5 CD O
M NN O
piperidine NN O
at IN O
377C CD O
for IN O
10 CD O
min NN O
Lanel NNP O
t NN O
: : O
products NNS O
obtained VBN O
Wfter NN O
partial JJ O
hydrolysis NN O
of IN O
d NN O
- HYPH O
3Kp NNP O
- HYPH O
ApGRCpApApG NN O
( : O
5 CD O
) -RRB- O
and CC O
d VBN O
- HYPH O
32p CD O
- HYPH O
ApApAppGpjCppAjG NN O
( : O
6 CD O
) -RRB- O
with IN O
0 CD O
. . O
5 CD O
M NN O
HC1 NN O
at IN O
371C CD O
fCor30 CD O
min NN O
. . O

Electrophoresis NN O
was VBD O
carried VBN O
out RP O
at IN O

constant JJ O
voltage NN O
( , O
800 CD O
v NN O
) -RRB- O
until IN O
the DT O
bromphenol NN O
blue JJ O
marker NN O
dye NN O
had VBD O
migrated VBN O
halfway RB O
down IN O
the DT O
gel NN O
. . O

phosphorylated VBN O
by IN O
polynucleotide NN O
kinase NN O
. . O

The DT O
phosphorylation NN O
reaction NN O
is VBZ O
easily RB O
followed VBN O
by IN O
PEI NNP O
- HYPH O
cellulose NNP O
TLC NNP O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4a CD O
, , O
the DT O
phosphorylated VBN O
oligomers NNS O
have VBP O
a DT O
higher JJR O
Rf NNP O
values NNS O
than IN O
does VBZ O
d VBN O
- HYPH O
ATP NNP O
. . O

The DT O
phosphorylated VBN O
methylphosphonate NN O
oligomers NNS O
can MD O
be VB O
separated VBN O
according VBG O
to IN O
their PRP$ O
chain NN O
lengths NNS O
by IN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
on IN O
an DT O
18 CD O
% NN O
gel NN O

containing VBG O
7 CD O
M NN O
urea NN O
as IN O
shown VBN O
in IN O
Figure NN O
4 CD O
( SYM O
b CD O
) -RRB- O
. . O

Lane NNP O
1 CD O
shows VBZ O
the DT O
separation NN O
of IN O
a DT O
trimer NN O
, , O
hexamer NN O
and CC O
nonamer NN O
. . O

The DT O
band NN O
which WDT O
appears VBZ O
directly RB O
below IN O
the DT O

nonamer NN O
may MD O
arise VB O
from IN O
traces NNS O
of IN O
contaminating VBG O
octamer NN O
which WDT O
were VBD O
not RB O
removed VBN O
during IN O
the DT O
purification NN O
of IN O
d NN O
- HYPH O
ApApApApGpCpApApG NN O
. . O

6240 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

When WRB O
the DT O
oligomers NNS O
were VBD O
partially RB O
hydrolyzed VBN O
with IN O
piperidine NN O
, , O
a DT O
series NN O
of IN O
new JJ O
bands NNS O
appears VBZ O
corresponding VBG O
to IN O
shorter JJR O
oligomers NNS O
produced VBN O
via IN O
hydrolysis NN O
of IN O
the DT O
methylphosphonate NN O
linkages NNS O
( , O
Lanes NNP O
2 CD O
- HYPH O
4 CD O
) -RRB- O
. . O

Because IN O
of IN O
the DT O
random JJ O
nature NN O
of IN O
this DT O
cleavage NN O
reaction NN O
, , O
the DT O
oligomers NNS O
should MD O
terminate VB O
with IN O
either CC O
a DT O
3 CD O
' '' O
- HYPH O
OH NN O
or CC O
a DT O
3 CD O
' '' O
- HYPH O
methylphosphonate NN O
group NN O
. . O

In IN O
the DT O
case NN O
of IN O
the DT O
trimer NN O
, , O
32pApApA NNP O
, , O

hydrolysis NN O
gives VBZ O
two CD O
bands NNS O
which WDT O
correspond VBP O
to IN O
d CD O
- HYPH O
32pApA NN O
and CC O
d NN O
- HYPH O
32pApAp NNP O
( HYPH O
Lane NNP O
2 CD O
) -RRB- O
. . O

The DT O
same JJ O
products NNS O
are VBP O
observed VBN O
for IN O
hydrolysis NN O
of IN O
the DT O
nonamer NN O
, , O

d LS O
- : O
32pApApApApGpCpApApG NNP O
( : O
Lane NNP O
4 CD O
) -RRB- O
. . O

A DT O
similar JJ O
situation NN O
is VBZ O
observed VBN O
for IN O

d32pApGpCpApApG NN O
although IN O
the DT O
dimers NNS O
d NN O
- HYPH O
32pApG NN O
and CC O
d NN O
- HYPH O
32pApGp NN O
have VBP O
somewhat RB O

different JJ O
mobilities NNS O
( -LRB- O
Lane NNP O
3 CD O
) -RRB- O
. . O

These DT O
dimers NNS O
cannot MD O
be VB O
separated VBN O
when WRB O
the DT O
gel NN O
is VBZ O
run VBN O
in IN O
the DT O
absence NN O
of IN O
urea NN O
. . O

It PRP O
is VBZ O
possible JJ O
to TO O
determine VB O
the DT O
chain NN O
lengths NNS O
of IN O
the DT O
original JJ O
oligomers NNS O

by IN O
counting VBG O
the DT O
number NN O
of IN O
oligomers NNS O
produced VBN O
by IN O
partial JJ O
piperidine NN O
hydrolysis NN O
. . O

For IN O
example NN O
, , O
starting VBG O
with IN O
the DT O
trimer NN O
band NN O
, , O
one PRP O
can MD O
observe VB O
3 CD O
bands NNS O

corresponding VBG O
to IN O
tetramer NN O
, , O
pentamer NN O
and CC O
hexamer NN O
for IN O
the DT O
hydrolysis NN O
products NNS O
of IN O
d NNP O
- HYPH O
32pApGpCpApApG NNP O
( -LRB- O
Lane NNP O
3 CD O
) -RRB- O
and CC O
6 CD O
bands NNS O
corresponding VBG O
to IN O
tetramer NN O
, , O
pentamer NN O
, , O
hexamer NN O
, , O
heptamer NN O
, , O
octamer NN O
and CC O
nonamer NN O
for IN O
the DT O
hydrolysis NN O
products NNS O
of IN O

32pApApApApGpCpApApG NNP O
( -LRB- O
Lane NNP O
4 CD O
) -RRB- O
. . O

The DT O
positions NNS O
of IN O
the DT O
oligomers NNS O
of IN O
the DT O
same JJ O

chain NN O
length NN O
appear VBP O
to TO O
be VB O
very RB O
similar JJ O
which WDT O
suggests VBZ O
that IN O
the DT O
mobilities NNS O
are VBP O
not RB O
greatly RB O
affected VBN O
by IN O
base NN O
composition NN O
on IN O
the DT O
urea NN O
- HYPH O
containing VBG O
gel NN O
. . O

This DT O

procedure NN O
thus RB O
provides VBZ O
a DT O
rapid JJ O
and CC O
convenient JJ O
method NN O
for IN O
characterizing VBG O
the DT O
methyl NN O
phosphonate NN O
ol NN O
i HYPH O
gomers NNS O
. . O

Treatment NN O
of IN O
the DT O
phosphorylated VBN O
oligomers NNS O
with IN O
acid NN O
produces VBZ O
shorter JJR O

oligomers NNS O
which WDT O
result VBP O
from IN O
chain NN O
cleavage NN O
at IN O
apurinic JJ O
sites NNS O
. . O

In IN O
this DT O
case NN O
the DT O
oligomers NNS O
terminate VBP O
with IN O
a DT O
3 CD O
' '' O
- HYPH O
OH NN O
group NN O
. . O

Treatment NN O
of IN O
32pApGpCpApALpG NNP O

produces VBZ O
an DT O
intense JJ O
band NN O
corresponding VBG O
to IN O
the DT O
pentamer NN O
, , O
d NNP O
- HYPH O
32pApGjCpAjA NNP O
( , O
Lane NNP O
5 CD O
) -RRB- O
while IN O
treatment NN O
of IN O
32pApApApApGpCpApApG NNP O
produces VBZ O
an DT O
intense JJ O
band NN O
corresponding VBG O
to IN O
the DT O
octamer NN O
d NN O
- HYPH O
32pApApAPApGpCpApA NN O
and CC O
fainter JJR O
bands NNS O

corresponding VBG O
to IN O
the DT O
heptamer NN O
, , O
hexamer NN O
, , O
tetramer NN O
and CC O
trimer NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
under IN O
the DT O
conditions NNS O
of IN O
the DT O
experiment NN O
, , O
hydrolysis NN O
occurs VBZ O
preferentially RB O
at IN O
the DT O
3 CD O
' '' O
- HYPH O
terminal JJ O
G NN O
residue NN O
of IN O
both DT O
oligomers NNS O
. . O

It PRP O
should MD O
be VB O
possible JJ O
to TO O
extend VB O
this DT O
methodology NN O
to IN O
other JJ O
base NN O
specific JJ O

depurination NN O
or CC O
depyrimidination NN O
reactions NNS O
similar JJ O
to IN O
those DT O
employed VBN O
in IN O
the DT O
Maxam NNP O
- HYPH O
Gilbert NNP O
sequencing NN O
method NN O
( : O
10 CD O
) -RRB- O
. . O

Experiments NNS O
directed VBN O
toward IN O
this DT O
goal NN O
are VBP O
currently RB O
in IN O
progress NN O
and CC O
will MD O
be VB O
reported VBN O
in IN O
a DT O
future JJ O
communication NN O
. . O

ACKNOWLEDGEMENT NN O
: : O
This DT O
work NN O
was VBD O
supported VBN O
in IN O
part NN O
by IN O
the DT O
following VBG O
grants NNS O
from IN O
the DT O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
: : O
GM NNP O
16066 CD O
( , O
P NNP O
. . O
O NNP O
. . O
P NN O
. . O
T NNP O
. . O
) -RRB- O
and CC O
GM NNP O
31927 CD O

6241 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

( : O
P NN O
. . O
S NNP O
. . O
M NNP O
. . O
) -RRB- O
, , O
and CC O
from IN O
a DT O
grant NN O
from IN O
Association NNP O
for IN O
International NNP O
Cancer NNP O
Research NNP O
. . O

REFERENCES NNS O
: : O

1 LS O
. . O

MTTITr NNP O
, , O
P NNP O
. . O
S NNP O
. . O
, , O
McParland NNP O
, , O
K NNP O
. . O
B NNP O
. . O
, , O
Jayaraman NNP O
, , O
K UH O
. . O
and CC O
Ts NNS O
' '' O
o UH O
, , O
P NN O
. . O
O UH O
. . O
P NN O
. . O

( -LRB- O
1981 CD O
) NFP O

Biochemistry NNP O
20 CD O
, , O
1874 CD O
- SYM O
1880 CD O
. . O

2 LS O
. . O

Jayaraman NNP O
, , O
K NNP O
. . O
, , O
McParland NNP O
, , O
K NNP O
. . O
B NNP O
. . O
, , O
Miller NNP O
, , O
P NN O
. . O
S NNP O
. . O
and CC O
Ts NNS O
' '' O
o UH O
, , O
P NN O
. . O
O UH O
. . O
P NN O
. . O

( -LRB- O
1981 CD O
) NFP O

Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

78 CD O
, , O
1537 CD O
- SYM O
1541 CD O
. . O

3 LS O
. . O

Miller NNP O
, , O
P NNP O
. . O
S NNP O
. . O
, , O
Agris NNP O
, , O
C NNP O
. . O
H NNP O
. . O
, , O
Blandin NNP O
, , O
M NNP O
. . O
, , O
Murakami NNP O
, , O
A NNP O
. . O
, , O
Reddy NNP O
, , O
P NN O
. . O
M NNP O
. . O
, , O

Spitz NNP O
, , O
S NNP O
. . O
A DT O
. . O
and CC O
Ts NNS O
' '' O
o NFP O
, , O
P NN O
. . O
O UH O
. . O
P NN O
. . O

( -LRB- O
1983 CD O
) SYM O
Nucleic NNP O
Acids NNP O
Res NNP O
. . O
, , O
submitted VBN O
for IN O
publ NN O
ication NN O
. . O

4 LS O
. . O

Sinha NNP O
, , O
N NNP O
. . O
D NN O
. . O

Grossbruchaus NNP O
, , O
V NNP O
. . O
and CC O
Koester NNP O
, , O
H NN O
. . O

( : O
1983 CD O
) -RRB- O
Tetrahedron NNP O
Letters NNPS O

24 CD O
, , O
877 CD O
- SYM O
880 CD O
. . O

5 LS O
. . O

Miller NNP O
, , O
P UH O
. . O
S UH O
. . O
, , O
Cheng NNP O
, , O
D NNP O
. . O
M NNP O
. . O
, , O
Dreon NNP O
, , O
N NNP O
. . O
, , O
Jayaraman NNP O
, , O
K NNP O
. . O
, , O
Kan NNP O
, , O
L NNP O
. . O
- : O
S NNP O
. . O
, , O

Leutzinger NNP O
, , O
E UH O
. . O
E NN O
. . O
, , O
Pulford NNP O
, , O
S NNP O
. . O
M NN O
. . O
and CC O
Ts NNS O
' '' O
o UH O
, , O
P NN O
. . O
O UH O
. . O
P NN O
. . O

( : O
1980 CD O
) SYM O
Biochemistry NNP O
19 CD O
, , O
4688 CD O
- HYPH O
4698 CD O
. . O

6 LS O
. . O

Ito NNP O
, , O
H NNP O
. . O
, , O
Ike NNP O
, , O
Y NNP O
. . O
, , O
Ikuta NNP O
, , O
S NNP O
. . O
and CC O
Itakura NNP O
, , O
K NNP O
. . O
, , O
( , O
1982 CD O
) SYM O
Nucleic JJ O
Acids NN O
Res NNS O

10 CD O
, , O
1755 CD O
- SYM O
1769 CD O
. . O

7 LS O
. . O

Barnett NNP O
, , O
R NNP O
. . O
W UH O
. . O
and CC O
Letsinger NNP O
, , O
R NNP O
. . O
L NN O
. . O

( : O
1981 CD O
) SYM O
Tetrahedron NNP O
Letters NNP O
22 CD O
, , O

991 CD O
- SYM O
994 CD O
. . O

6242 CD O

Further JJ O
studies NNS O
on IN O
partially RB O
purified VBN O
calf NN B-Species
thymus NN O
DNA NN O
polymerase NN O
a DT O
. . O

Abstract JJ O

Attempts NNS O
to TO O
prevent VB O
the DT O
urea NN O
conversion NN O
of IN O
a DT O
200 CD O
- SYM O
230 CD O
, , O
0 CD O
molecular JJ O
weight NN O
DNA NN O
polymerase NN O
alpha NN O
to IN O
a DT O
150 CD O
- SYM O
170 CD O
, , O
0 CD O
molecular JJ O
weight NN O
form NN O
by IN O
the DT O
inclusion NN O
of IN O
protease NN O
inhibitors NNS O
have VBP O
not RB O
been VBN O
successful JJ O
. . O

No DT O
other JJ O
method NN O
has VBZ O
been VBN O
found VBN O
capable JJ O
of IN O
dissociating VBG O
a DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
fragment NN O
or CC O
subunit NN O
from IN O
the DT O
DNA NNP O
polymerase NN O
subunit NN O
. . O

Addition NN O
of IN O
this DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
subunit NN O
to IN O
the DT O
polymerase NN O
subunit NN O
does VBZ O
not RB O
aid VB O
the DT O
binding NN O
of IN O
the DT O
enzyme NN O
to IN O
DNA NN O
, , O
but CC O
does VBZ O
have VB O
an DT O
effect NN O
on IN O
the DT O
utilisation NN O
of IN O
synthetic JJ O
template NN O
- HYPH O
initiator NN O
complexes NNS O
by IN O
the DT O
polymerase NN O
subunit NN O
. . O

Volume NN O
6 CD O
Number NN O
10 CD O
1979 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Further JJ O
studies NNS O
on IN O
partially RB O
purified VBN O
calf NN B-Species
thymus NN O
DNA NNP O
polymerase NN O
a DT O
Keith NNP O
McKune NNP O
and CC O
Andrew NNP O
M NNP O
. . O
Holmes NNP O
* NFP O

Biochemistry NNP O
Department NNP O
, , O
Strathclyde NNP O
University NNP O
, , O
The DT O
Todd NNP O
Centre NNP O
, , O
31 CD O
Taylor NNP O
Street NNP O
, , O
Glasgow NNP O
, , O
G4 NNP O
ONR NNP O
, , O
UK NNP O

Received VBN O
I PRP O
June NNP O
1979 CD O
ABSTRACT NN O

Attempts NNS O
to TO O
prevent VB O
the DT O
urea NN O
conversion NN O
of IN O
a DT O
200 CD O
- SYM O
230 CD O
, , O
0 CD O
molecular JJ O
weight NN O
DNA NN O
polymerase NN O
a DT O
to IN O
a DT O
150 CD O
- SYM O
170 CD O
, , O
0 CD O
molecular JJ O
weight NN O
form NN O
by IN O
the DT O

inclusion NN O
of IN O
protease NN O
inhibitors NNS O
have VBP O
not RB O
been VBN O
successful JJ O
. . O

No DT O
other JJ O
method NN O
has VBZ O
been VBN O
found VBN O
capable JJ O
of IN O
dissociating VBG O
a DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
fragment NN O
or CC O
subunit NN O
from IN O
the DT O
DNA NNP O
polymerase NN O
subunit NN O
. . O

Addition NN O
of IN O
this DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
subunit NN O
to IN O
the DT O
polymerase NN O
subunit NN O
does VBZ O
not RB O
aid VB O
the DT O
binding NN O
of IN O
the DT O
enzyme NN O
to IN O
DNA NN O
, , O
but CC O
does VBZ O
have VB O
an DT O
effect NN O
on IN O
the DT O
utilisation NN O
of IN O
synthetic JJ O
template NN O
- HYPH O
initiator NN O
complexes NNS O
by IN O
the DT O
polymerase NN O
subunit NN O
. . O

INTRODUCTION NN O

In IN O
mammals NNS O
DNA NN O
polymerase NN O
a DT O
is VBZ O
thought VBN O
to TO O
be VB O
the DT O
replicative JJ O

enzyme NN O
, , O
but CC O
due IN O
to IN O
low JJ O
levels NNS O
of IN O
activity NN O
, , O
even RB O
in IN O
tissues NNS O
actively RB O
making VBG O
DNA NN O
, , O
and CC O
to TO O
enzyme VB O
heterogeneity NN O
it PRP O
has VBZ O
been VBN O
found VBN O
difficult JJ O
to TO O
purify VB O

However RB O
, , O
small JJ O
samples NNS O
of IN O
DNA NNP O
polymerase NN O
a DT O
have VBP O
been VBN O
highly RB O
purified VBN O

2 CD O
, , O
3 CD O
, , O
4 CD O
, , O
5 CD O
from IN O
several JJ O
sources NNS O
and CC O
partially RB O
characterised VBN O

Heterogeneity NN O
has VBZ O
been VBN O
observed VBN O
in IN O
DNA NNP O
polymerase NN O
a DT O
from IN O
a DT O
var NN O

6 CD O
7 CD O

iety NN O
of IN O
sources NNS O
, , O
including VBG O
rat NN B-Species
liver NN O
and CC O
spleen NN O
, , O
Hela NNP O
cells NNS O
, , O
baby NN O
hamster NN O

8 CD O
9 CD O
, , O
10 CD O
11 CD O

kidney NN O
cells NNS O
, , O
mouse NN B-Species
myeloma NN O
, , O
Drosophila NNP B-Species
embryos NNS O
and CC O
calf NN B-Species
thymus NN O

1 CD O
, , O
6 CD O
, , O
12 CD O
, , O
13 CD O
. . O

We PRP O
have VBP O
previously RB O
observed VBN O
several JJ O
species NNS O
of IN O
calf NN B-Species
thymus NN O

DNA NN O
polymerase NN O
a DT O
differing NN O
in IN O
size NN O
and CC O
charge NN O
. . O

In IN O
order NN O
of IN O
elution NN O
from IN O
DEAE NNP O
cellulose NN O
they PRP O
are VBP O
enzyme NN O
A1 NNP O
( SYM O
200 CD O
- SYM O
230 CD O
, , O
0 CD O
molecular JJ O
weight NN O
) -RRB- O
, , O
A2 NNP O
( : O
200 CD O
- SYM O
230 CD O
, , O
0 CD O
) -RRB- O
, , O
B NNP O
( , O
100 CD O
- SYM O
110 CD O
, , O
0 CD O
) -RRB- O
and CC O
C NNP O
( , O
150 CD O
- SYM O
170 CD O
, , O
0 CD O
) -RRB- O
. . O

A DT O
poly NN O
( , O
dA FW O
) -RRB- O
. . O
oligo NN O

( -LRB- O
dT NNP O
) SYM O
10 CD O
preferring VBG O
enzyme NN O
, , O
enzyrrme NN O
D NNP O
( , O
140 CD O
- SYM O
150 CD O
, , O
0 CD O
molecular JJ O
weight NN O
) -RRB- O
elutes VBZ O
just RB O
after IN O
enzyme NN O
B NN O
. . O

The DT O
A NNP O
enzymes NNS O
seem VBP O
identical JJ O
in IN O
all DT O
properties NNS O
except IN O
their PRP$ O
charge NN O
. . O

5 LS O
. . O
0 CD O
- SYM O
5 CD O
. . O

5S NNP O
enzymes NNS O
, , O
analagous JJ O
to IN O
B NNP O
, , O
have VBP O
been VBN O
observed VBN O
to IN O

C NN O
Information NN O
Retrieval NN O
Limited NN O
1 CD O
Falconberg NNP O
Court NNP O
London NNP O
Wl NNP O
V NNP O
5FG NNP O
England NNP O

3341 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

arise VB O
as IN O
the DT O
result NN O
of IN O
proteolytic JJ O
action NN O
' '' O
, , O
similarly RB O
the DT O
B NN O
enzyme NN O
above IN O
14 CD O

, , O
but CC O
the DT O
relationship NN O
of IN O
the DT O
other JJ O
observed VBN O
species NN O
is VBZ O
not RB O
clear JJ O
, , O
nor CC O
is VBZ O

the DT O
problem NN O
of IN O
which WDT O
, , O
if IN O
any DT O
, , O
of IN O
these DT O
species NNS O
is VBZ O
the DT O
replicative JJ O
enzyme NN O
, , O

although IN O
circumstantial JJ O
evidence NN O
has VBZ O
implicated VBN O
a DT O
DNA NNP O
polymerase NN O
a DT O
to TO O
be VB O

15 CD O
the DT O
replicative JJ O
enzyme NN O
in IN O
adenovirus NN B-Species
infected VBN O
KB NNP O
cells NNS O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
several JJ O
of IN O
these DT O
enzymes NNS O
are VBP O
inter JJ O

16 CD O

convertible JJ O
. . O

In IN O
particular JJ O
, , O
mild JJ O
urea NN O
treatment NN O
can MD O
convert VB O
both DT O
A NN O

enzymes NNS O
to IN O
C NN O
enzyme NN O
, , O
with IN O
the DT O
loss NN O
of IN O
a DT O
subunit NN O
or CC O
fragment NN O
of IN O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
. . O

The DT O
C NNP O
enzyme NN O
retains VBZ O
DNA NN O
polymerase NN O
activity NN O
, , O
but CC O

does VBZ O
show VB O
differences NNS O
compared VBN O
to IN O
A DT O
enzyme NN O
in IN O
heat NN O
sensitivity NN O
and CC O
sensitivity NN O
to IN O
N NN O
- HYPH O
ethylmaleimide NN O
. . O

Highly RB O
purified VBN O
samples NNS O
of IN O
A NN O
and CC O
C NN O
enzymes NNS O
when WRB O
subjected VBN O
to IN O
sodium NN O
dodecyl NN O
sulphate NN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
have VBP O
shown VBN O
a DT O
corre NN O

lation NN O
of IN O
DNA NNP O
polymerase NN O
activity NN O
with IN O
a DT O
polypeptide JJ O
band NN O
155 CD O
, , O
0 CD O
molecular JJ O
weight NN O
. . O

Contaminating VBG O
material NN O
of IN O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
appeared VBD O

to TO O
obscure VB O
the DT O
putative JJ O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
subunit NN O
in IN O
gels NNS O
of IN O
A DT O
enzyme NN O
. . O

The DT O
conclusions NNS O
drawn VBN O
were VBD O
that IN O
DNA NNP O
polymerase NN O
a DT O
is VBZ O
a DT O
155 CD O
, , O
0 CD O
molecular JJ O
weight NN O

polypeptide NN O
( -LRB- O
C NN O
enzyrrme NN O
) -RRB- O
which WDT O
can MD O
and CC O
does VBZ O
associated VBN O
with IN O
material NN O
of IN O
50 CD O

70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
to TO O
give VB O
A NN O
enzyme NN O
, , O
and CC O
that DT O
enzyme NN O
B NN O
is VBZ O
a DT O
proteol NN O

14 CD O

ytic NNP O
degradation NN O
product NN O
. . O

The DT O
relationship NN O
of IN O
enzyme NN O
D NN O
to IN O
the DT O
others NNS O
is VBZ O

not RB O
clear JJ O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
during IN O
the DT O
enzyme NN O
isolation NN O
procedure NN O
proteolytic JJ O
action NN O
may MD O
have VB O
taken VBN O
place NN O
on IN O
a DT O
200 CD O
- SYM O
230 CD O
, , O
0 CD O
molecular JJ O
weight NN O
enzyme NN O
releasing VBG O
155 CD O
, , O
0 CD O
and CC O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
fragments NNS O
which WDT O
remain VBP O
in IN O
association NN O

until IN O
urea NN O
treatment NN O
separates VBZ O
them PRP O
. . O

It PRP O
is VBZ O
also RB O
possible JJ O
that IN O
urea NN O
treatment NN O
itself PRP O
renders VBZ O
the DT O
enzyme NN O
susceptible JJ O
to IN O
contaminating VBG O
proteases NNS O
. . O

Further JJ O
experiments NNS O
to TO O
ascertain VB O
whether IN O
or CC O
not RB O
this DT O
is VBZ O
the DT O
case NN O
and CC O
, , O
if IN O
so RB O
, , O
to TO O
prevent VB O
it PRP O
, , O
have VBP O
been VBN O
carried VBN O
out RP O
. . O

A DT O
enzyme NN O
can MD O
be VB O
reconstituted VBN O
from IN O
C NNP O
enzyme NN O
formed VBN O
by IN O
the DT O
action NN O

of IN O
urea NN O
on IN O
A DT O
enzyme NN O
by IN O
concentrating VBG O
it PRP O
with IN O
the DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
material NN O
. . O

The DT O
A NNP O
enzyrme NN O
obtained VBN O
in IN O
this DT O
manner NN O
is VBZ O
highly RB O
purified JJ O
, , O
as IN O
is VBZ O

the DT O
C NNP O
enzyme NN O
formed VBN O
by IN O
the DT O
urea NN O
treatment NN O
, , O
and CC O
has VBZ O
been VBN O
used VBN O
in IN O
attempts NNS O
to TO O
show VB O
differences NNS O
in IN O
synthetic JJ O
template NN O
- HYPH O
initiator NN O
complex NN O
utilisation NN O

3342 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

b LS O
y UH O
the DT O
se `` O
two CD O
enzyme NN O
s NNS O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Calf NN B-Species
thymus NNS O
was VBD O
obtained VBN O
from IN O
10 CD O
- SYM O
16 CD O
week NN O
old JJ O
calves NNS B-Species
and CC O
frozen VBN O
at IN O

- : O
20 CD O
? . O
C NN O
until IN O
required VBD O
. . O

Chromatographic JJ O
media NN O
and CC O
chemicals NNS O
were VBD O
obtained VBN O

6 CD O

from IN O
sources NNS O
previously RB O
referred VBN O
to IN O
. . O

Radioactive JJ O
deoxynucleoside NN O
tri NN O

phosphates NNS O
were VBD O
obtained VBN O
from IN O
the DT O
Radiochemical NNP O
Centre NNP O
, , O
Amersham NNP O
, , O
Bucks NNP O
. . O

Synthetic JJ O
oligo NN O
and CC O
polynucleotides NNS O
were VBD O
obtained VBN O
from IN O
P NNP O
. . O

L NN O
. . O

Biochemicals NNS O

Inc NNP O
. . O
, , O
except IN O
for IN O
poly JJ O
( , O
dC NNP O
) -RRB- O
which WDT O
was VBD O
a DT O
gift NN O
from IN O
Dr NNP O
. . O
I PRP O
. . O
R NN O
. . O

Johnston NNP O
and CC O
pre NN O

17 CD O

pared VBN O
from IN O
oligo NN O
d NN O
( , O
C NNP O
) -RRB- O
5 CD O
as IN O
described VBN O
. . O

N NNP O
- HYPH O
a NNP O
- HYPH O
p NN O
Tosyl NNP O
- HYPH O
L NN O
- HYPH O
lysine NN O
chloromethy NN O

lketone NNP O
HCl NNP O
and CC O
phenylmethylsulphony NN O
were VBD O
obtained VBN O
from IN O
Sigma NNP O
and CC O
Trasylol NNP O
from IN O
Bayer NNP O
. . O

Except IN O
where WRB O
indicated VBD O
all DT O
buffers NNS O
contained VBD O
20 CD O
% NN O
w NN O
/ SYM O
v NN O
glycerol NN O
and CC O

1 CD O
mM NN O
dithiothreitol NN O
. . O

Standard JJ O
linear JJ O
phosphate NN O
gradients NNS O
were VBD O
run VBN O
between IN O
0 CD O
. . O
3 CD O
M NN O
and CC O
0 CD O
. . O
25 CD O
M NN O
potassium NN O
phosphate NN O
, , O
pH NN O
7 CD O
. . O
8 CD O
. . O

Gradient JJ O
salt NN O
concentr NN O

2 LS O

ations NNS O
were VBD O
measured VBN O
using VBG O
a DT O
conductivity NN O
meter NN O
as IN O
described VBN O
. . O

Urea NNP O
was VBD O

prepared VBN O
as IN O
a DT O
4 CD O
. . O

8 CD O
M NN O
solution NN O
in IN O
20 CD O
% NN O
w NN O
/ SYM O
v NN O
glycerol NN O
, , O
stirred VBN O
with IN O
Amberlite NNP O

MB3 NNP O
and CC O
filtered VBD O
. . O

Dithiothreitol NNP O
was VBD O
added VBN O
to IN O
a DT O
final JJ O
concentration NN O
of IN O
1 CD O
mM NN O
before IN O
use NN O
. . O

6 CD O
DNA NNP O
polymerase NN O
was VBD O
assayed VBN O
using VBG O
activated VBN O
DNA NNP O
as IN O
described VBN O

except IN O
that IN O
the DT O
buffer NN O
was VBD O
50 CD O
mM NN O
tris NNS O
HC1 NNP O
, , O
pH NN O
7 CD O
. . O
8 CD O
. . O

One CD O
unit NN O
of IN O
DNA NN O
polymerase NN O
activity NN O
incorporates VBZ O
ln NN O
mol NN O
[ -LRB- O
H NN O
] -RRB- O
dTMP NN O
into IN O
an DT O
acid NN O
insoluble JJ O
form NN O
in IN O
one CD O
hour NN O
at IN O
370C CD O
. . O

Assays NNS O
using VBG O
synthetic JJ O
template NN O
- HYPH O
initiator NN O
complexes NNS O
were VBD O
carried VBN O
out RP O
at IN O
30 CD O
? . O
C NN O
in IN O
0 CD O
. . O

12 CD O
ml NNS O
. . O

The DT O
template NN O
- HYPH O
initiator NN O
complexes NNS O

6 CD O

were VBD O
prepared JJ O
and CC O
assays NNS O
processed VBN O
as IN O
described VBN O
. . O

All DT O
assays NNS O
contained VBN O

1 CD O
mM NN O
dithiothreitol NN O
, , O
62 CD O
. . O

5 CD O
p NN O
. . O
g NN O
bovine JJ B-Species
serum NN O
albumin NN O
, , O
1 CD O
, , O
ug JJ O
template NN O
- HYPH O
initiator NN O
complex NN O
, , O
enzyme NN O
protein NN O
and CC O
the DT O
relevant JJ O
[ -LRB- O
H NN O
] -RRB- O
deoxynucleoside NN O
triphosphate NN O
at IN O
0 CD O
. . O
1 CD O
mM NN O
and CC O
12 CD O
- SYM O
15 CD O
cpm NN O
/ SYM O
pmol NN O
. . O

These DT O
assays NNS O
were VBD O
carried VBN O
out RP O
at IN O
either CC O
pH NN O
6 CD O
. . O
4 CD O
in IN O
20 CD O
mM NN O
sodium NN O
- HYPH O
potassium NN O
phosphate NN O
, , O
or CC O
at IN O
pH NN O
7 CD O
. . O
8 CD O
in IN O
50 CD O
mM NN O
tris NNS O
HCl NNP O
and CC O
contained VBD O
either CC O
10 CD O
mM NN O
MgCl2 NN O
or CC O
1 CD O
mM NN O
MnCl2 NNP O
as IN O
indicated VBN O
. . O

Preliminary JJ O
purification NN O
of IN O
DNA NN O
polymerase NN O
a NN O
to IN O
Fraction NN O
IV NN O
was VBD O
as IN O

6 CD O

described VBN O
, , O
the DT O
purification NN O
steps NNS O
being VBG O
phosphocellulose NN O
chromatography NN O
, . O

ammonium NN O
sulphate NN O
precipitation NN O
and CC O
gel NN O
filtration NN O
on IN O
Sepharose NNP O
6B NNP O
. . O

3343 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Enzyme NN O
obtained VBN O
from IN O
the DT O
DEAE NNP O
cellulose NN O
step NN O
is VBZ O
referred VBN O
to IN O
as IN O
Fraction NNP O

V NN O
enzyme NN O
. . O

Samples NNS O
were VBD O
prepared VBN O
for IN O
sodium NN O
dodecyl NN O
sulphate NN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
and CC O
scanned VBN O
as IN O
previously RB O
described2 VBN O

RESULTS NNS O
AND CC O
DISCUSSION NN O

( : O
a DT O
) -RRB- O
Interconversion NNP O
Studies NNPS O

A DT O
enzyme NN O
was VBD O
routinely RB O
converted VBN O
to IN O
C NN O
enzyme NN O
by IN O
incubating VBG O
200500 CD O
units NNS O
/ SYM O
ml NNS O
of IN O
Fraction NN O
V NN O
A NN O
enzyme NN O
in IN O
2 CD O
. . O
4 CD O
M NN O
urea NN O
in IN O
0 CD O
. . O

2 CD O
M NN O
potassium NN O

phosphate NN O
, , O
pH NN O
7 CD O
. . O
8 CD O
, , O
for IN O
60 CD O
minutes NNS O
at IN O
0 CD O
? . O
C NN O
. . O

The DT O
mixture NN O
was VBD O
then RB O
loaded VBN O
on IN O
to IN O
a DT O
DEAE NNP O
cellulose NN O
, , O
washed VBN O
with IN O
0 CD O
. . O

3 CD O
M NN O
potassium NN O
phosphate NN O
pH NN O
7 CD O
. . O

8 CD O
, , O
and CC O
enzyrme NN O
eluted VBD O
either CC O
with IN O
the DT O
standard JJ O
phosphate NN O
gradient NN O
or CC O
batchwise JJ O
. . O

Under IN O
these DT O
conditions NNS O
usually RB O
about RB O
50 CD O
- SYM O
60 CD O
% NN O
of IN O
recovered VBN O
activity NN O
was VBD O

enzyme NN O
C NN O
( -LRB- O
Fig NNP O
1 CD O
a NN O
) -RRB- O
. . O

Overall JJ O
recovery NN O
was VBD O
70 CD O
- SYM O
80 CD O
% NN O
. . O

A DT O
enzyme NN O
was VBD O
recon VBN O

14 CD O

stituted VBN O
essentially RB O
as IN O
described VBN O
. . O

The DT O
flow NN O
through IN O
material NN O
from IN O
the DT O

DEAE NNP O
cellulose NN O
column NN O
after IN O
the DT O
urea NN O
treatment NN O
was VBD O
loaded VBN O
on IN O
to IN O
a DT O
1 CD O
x SYM O
0 CD O
. . O

8 CD O
cm NN O
phosphocellulose NN O
column NN O
, , O
washed VBN O
with IN O
0 CD O
. . O
3 CD O
M NN O
potassium NN O
phosphate NN O
, , O
pH NN O
7 CD O
. . O
8 CD O
, , O
and CC O
the DT O
protein NN O
eluted VBN O
with IN O
0 CD O
. . O
25 CD O
M NN O
potassium NN O
phosphate NN O
, , O
pH NN O
7 CD O
. . O

8 LS O
. . O

This DT O
material NN O
, , O
the DT O
putative JJ O
subunit NN O
, , O
was VBD O
vacuum NN O
dialysed VBN O
with IN O
the DT O
C NNP O
enzyme NN O
produced VBN O
by IN O
the DT O
urea NN O
treatment NN O
, , O
rechromatographed VBN O
on IN O
DEAE NNP O
cellulose NN O
and CC O
enzyme NN O
eluted VBN O
batchwise NN O
( -LRB- O
Fig NN O
1 CD O
b NN O
) -RRB- O
. . O

Recovery NN O
from IN O
this DT O
procedure NN O
was VBD O

usually RB O
50 CD O
- SYM O
70 CD O
% NN O
A NN O
enzyme NN O
. . O

Overall JJ O
recovery NN O
was VBD O
30 CD O
- SYM O
40 CD O
% NN O
of IN O
the DT O
C NNP O
enzyme NN O
dialysed VBN O
. . O

If IN O
the DT O
material NN O
eluted VBN O
from IN O
the DT O
phosphocellulose NN O
by IN O
the DT O
0 CD O
. . O

25 CD O
M NN O
potassium NN O
phosphate NN O
was VBD O
heated VBN O
to IN O
90 CD O
? . O
C NN O
for IN O
5 CD O
minutes NNS O
prior RB O
to IN O
vacuum NN O

dialysis NN O
with IN O
the DT O
C NN O
enzyme NN O
the DT O
recovery NN O
from IN O
the DT O
DEAE NNP O
cellulose NN O
column NN O

was VBD O
significantly RB O
higher JJR O
( : O
60 CD O
- SYM O
70 CD O
% NN O
of IN O
the DT O
original JJ O
C NNP O
enzyme NN O
activity NN O
) -RRB- O
, , O
but CC O
all DT O
recoverable JJ O
DNA NN O
polymerase NN O
activity NN O
was VBD O
C NN O
enzyme NN O
. . O

This DT O
, , O
together RB O
with IN O
the DT O
fact NN O
that IN O
the DT O
60 CD O
minute NN O
treatment NN O
with IN O
urea NN O
has VBZ O
, , O
on IN O
occasions NNS O
, , O
given VBN O

rise VB O
to IN O
a DT O
50 CD O
% NN O
increase NN O
in IN O
DNA NN O
polymerase NN O
activity NN O
prior RB O
to IN O
loading VBG O
on IN O
to IN O
the DT O
DEAE NNP O
cellulose NN O
column NN O
, , O
would MD O
indicate VB O
that IN O
A DT O
enzyme NN O
is VBZ O
less RBR O
active JJ O
on IN O

activated VBN O
DNA NNP O
than IN O
is VBZ O
C NN O
enzyme NN O
. . O

If IN O
the DT O
DEAE NNP O
cellulose NN O
flow NN O
through IN O
material NN O
came VBD O
from IN O
urea NN O
treatment NN O
of IN O
A2 NN O
enzyme NN O
then RB O
A2 NNP O
was VBD O
produced VBN O
on IN O
reconstitution NN O
; : O
if IN O
from IN O
A1 NNP O
then RB O
A1 NNP O
was VBD O
produced VBN O
. . O

Although IN O
the DT O
mild JJ O
urea NN O
treatment NN O
of IN O
A NNP O
has VBZ O
been VBN O
used VBN O
to TO O
prepare VB O
C NN O
of IN O

3344 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

b LS O

120 CD O
180 CD O
C NN O

I PRP O
I PRP O
^ NFP O

Figure NN O
la FW O
DEAE NN O
cellulose NN O
chromatography NN O
after IN O
2 CD O
. . O
4 CD O
M NN O
urea NN O
treatment NN O
. . O

4 CD O
, , O
5000 CD O
units NNS O
, , O
4 CD O
. . O
4 CD O
mg NN O
of IN O
Fraction NNP O
II NNP O
A2 NNP O
enzyme NN O
were VBD O
incubated VBN O
with IN O
urea NN O
at IN O
a DT O
final JJ O
concentration NN O
of IN O
2 CD O
. . O
4 CD O
M NN O
for IN O
60 CD O
minutes NNS O
at IN O
0 CD O
? . O
C NN O
, , O
loaded VBN O
on IN O
to IN O
a DT O
5 CD O
x SYM O
1 CD O
. . O
4 CD O
cm NN O
DEAE NN O
cellulose NN O
column NN O
, , O
the DT O
column NN O
was VBD O
washed VBN O
with IN O
0 CD O
. . O

3 CD O
M NN O
potassium NN O
phosphate NN O
, , O
pH NN O
7 CD O
. . O
8 CD O
and CC O
a DT O
200 CD O
ml NN O
standard JJ O
phosphate NN O
gradient NN O
applied VBN O
. . O

2 LS O
. . O
3 CD O
ml NNS O
fractions NNS O
were VBD O
collected VBN O
and CC O
10 CD O
Rl NNP O
assayed VBD O
for IN O
5 CD O
minutes NNS O
. . O

( NFP O
o NFP O
- HYPH O
o XX O
) NFP O
no UH O

phenylmethylsulphony NN O
( : O
* NFP O
- : O
* NFP O
) NFP O
3 CD O
mM NN O
phenylmethylsulphony NN O
( : O
- HYPH O
) -RRB- O
phosphate NN O
gradient NN O
. . O

Figure NN O
lb IN O
The DT O
reconstitution NN O
of IN O
A2 NN O
enzyme NN O
. . O

3000 CD O
units NNS O
for IN O
C NN O
enzyme NN O

derived VBN O
by IN O
urea NN O
treatment NN O
of IN O
A2 NNP O
were VBD O
vacuum NN O
dialysed VBN O
with IN O
the DT O
DEAE NN O
cellulose NN O
flow NN O
through IN O
material NN O
after IN O
phosphocellulose NN O
chromatography NN O
and CC O

chromatographed VBN O
on IN O
a DT O
2 CD O
x SYM O
1 CD O
. . O

2 CD O
cm NN O
DEAE NN O
cellulose NN O
column NN O
. . O

After IN O
washing VBG O
with IN O
0 CD O
. . O
3 CD O
M NN O
potassium NN O
phosphate NN O
, , O
pH NN O
7 CD O
. . O
7 CD O
, , O
the DT O
enzymes NNS O
were VBD O
eluted VBN O
batchwise JJ O
with IN O
the DT O
above JJ O
concentrations NNS O
of IN O
potassium NN O
phosphate NN O
, , O
pH NN O
7 CD O
. . O
8 CD O
. . O

1 CD O
ml NNS O
fractions NNS O
were VBD O
collected VBN O
and CC O
10 CD O
. . O
l WP$ O
assayed VBN O
for IN O
10 CD O
minutes NNS O
. . O

3345 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

high JJ O
specific JJ O
activity NN O
it PRP O
is VBZ O
possible JJ O
that IN O
conversion NN O
of IN O
the DT O
200 CD O
- SYM O
230 CD O
, , O
0 CD O
molecular JJ O
weight NN O
enzymes NNS O
to IN O
a DT O
155 CD O
- SYM O
170 CD O
, , O
0 CD O
species NNS O
maybe RB O
due JJ O
to IN O
unfolding NN O
of IN O
the DT O
molecule NN O
to TO O
allow VB O
limited JJ O
attack NN O
by IN O
contaminating VBG O
proteases NNS O
. . O

Accord VB O

ingly JJ O
the DT O
urea NN O
conversion NN O
of IN O
A NN O
to IN O
C NN O
was VBD O
investigated VBN O
in IN O
the DT O
presence NN O
of IN O
certain JJ O
protease NN O
inhibitors NNS O
. . O

The DT O
presence NN O
of IN O
the DT O
serine NN O
protease NN O
inhibitor NN O

phenylmethylsulphony NN O
- HYPH O
fluoride NN O
in IN O
the DT O
incubation NN O
and CC O
chromatography NN O
buffers NNS O
did VBD O
not RB O
affect VB O
the DT O
conversion NN O
of IN O
A2to NNP O
C NNP O
( -LRB- O
Fig NNP O
1 CD O
a NN O
) -RRB- O
. . O

Likewise JJ O
trasylol NN O
and CC O
Na NNP O
- HYPH O
p NNP O
Tosyl NNP O
- HYPH O
L NN O
- HYPH O
lysine NN O
chloromethylketone NN O
HC1 NN O
had VBD O
no DT O
effect NN O
. . O

However RB O
, , O
protease NN O
action NN O
could MD O
have VB O
occurred VBN O
earlier RBR O
in IN O
the DT O
purification NN O
procedure NN O
and CC O
the DT O
urea NN O
could MD O
be VB O
separating VBG O
two CD O
fragments NNS O
. . O

Usually RB O
the DT O
DEAE NNP O
cellulose NN O
profile NN O
shows VBZ O
that IN O
the DT O
majority NN O
of IN O
the DT O
enzyme NN O
activity NN O
is VBZ O
present JJ O
as IN O
A NN O

enzyme NN O
( -LRB- O
Fig NNP O
2 CD O
) -RRB- O
. . O

In IN O
this DT O
instance NN O
A1 NNP O
and CC O
A2 NNP O
have VBP O
not RB O
been VBN O
separated VBN O
. . O

When WRB O
the DT O
temperature NN O
of IN O
the DT O
material NN O
in IN O
the DT O
original JJ O
blending NN O
procedure NN O
was VBD O
kept VBN O
below IN O
0 CD O
? , O
C NN O
or CC O
phenylmethylsulphony NN O
, , O
N NNP O
- HYPH O
a NN O
- HYPH O
p NN O
Tosyl NNP O
- HYPH O
L NN O
- HYPH O
lysine NN O
chloromethylketone NN O
HCl NN O
or CC O
trasylol NN O
was VBD O
included VBN O
in IN O
the DT O
isolation NN O
buffers NNS O
the DT O
DEAE NNP O
cellulose NN O
profile NN O
was VBD O
similar JJ O
. . O

The DT O
A NNP O
enzymes NNS O
were VBD O
still RB O
capable JJ O
of IN O
conversion NN O
by IN O
mild JJ O
urea NN O
treatment NN O
to IN O
C NN O
enzyme NN O
, , O
indicating VBG O
that IN O
if IN O
protease NN O
activity NN O
is VBZ O
involved VBN O
then RB O
it PRP O
is VBZ O
not RB O
susceptible JJ O
to IN O
these DT O
inhibitors NNS O
. . O

When WRB O
the DT O
calf NN B-Species

20FI NN O
: : O
Now RB O
~ NFP O
~ NFP O
~ NFP O
20 CD O
20Fr CD O
Na NN O
6 CD O

Figure NN O
2 CD O
DEAE NN O
cellulose NN O
elution NN O
profile NN O
of IN O
calf NN B-Species
thymus NN O
DNA NN O
polymerase NN O
a DT O
. . O

47 CD O
, , O
0 CD O
units NNS O
, , O
97 CD O
mg NN O
of IN O
Fraction NNP O
IV NNP O
enzyme NN O
prepared VBN O
from IN O
415 CD O
g NN O
of IN O
calf NN B-Species

thymus NNS O
were VBD O
loaded VBN O
on IN O
to IN O
a DT O
10 CD O
x SYM O
1 CD O
. . O
8 CD O
cm NN O
DEAE NN O
cellulose NN O
column NN O
, , O
after IN O
washing VBG O
with IN O
0 CD O
. . O

3 CD O
M NN O
potassium NN O
phosphate NN O
, , O
pH NN O
7 CD O
. . O

8 CD O
a DT O
400 CD O
ml NN O
standard JJ O
phosphate NN O
gradient NN O
was VBD O
applied VBN O
. . O

5 CD O
ml NNS O
fractions NNS O
were VBD O
collected VBN O
and CC O
10 CD O
, , O
ul CD O
assayed VBD O
for IN O
5 CD O
minutes NNS O
. . O

3346 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

thymus NN O
was VBD O
allowed VBN O
to TO O
warm VB O
up RP O
during IN O
the DT O
blending NN O
procedure NN O
, , O
or CC O
the DT O
supernatant NN O
prior RB O
to IN O
phosphocellulose NN O
chromatography NN O
was VBD O
heated VBN O
to IN O
37 CD O
? , O
C NN O
for IN O
30 CD O
minutes NNS O
, , O
there EX O
was VBD O
a DT O
marked JJ O
decrease NN O
in IN O
the DT O
amount NN O
of IN O
A NN O
enzyme NN O
with IN O
a DT O
concomitant JJ O
increase NN O
in IN O
the DT O
amount NN O
of IN O
B NN O
and CC O
C NN O
( HYPH O
unpublished JJ O
observation NN O
) -RRB- O
. . O

The DT O
presence NN O
of IN O
phenylmethylsulphony NN O
, , O
N NNP O
- HYPH O
a NN O
- HYPH O
p NN O
T NN O
osyl NN O
- HYPH O
L NN O
- HYPH O
lysine NN O

chloromethylketone NN O
HCl NNP O
or CC O
trasylol NN O
under IN O
these DT O
conditions NNS O
only RB O
had VBD O
a DT O
marginal JJ O
effect NN O
on IN O
the DT O
appearance NN O
of IN O
C NN O
enzyme NN O
, , O
but CC O
did VBD O
reduce VB O
the DT O
amount NN O
of IN O
B NN O

enzyme NN O
. . O

Heating VBG O
the DT O
enzyme NN O
to IN O
37 CD O
? , O
C NN O
after IN O
the DT O
phosphocellulose NN O
step NN O
had VBD O
no DT O
effect NN O
on IN O
the DT O
DEAE JJ O
cellulose NN O
elution NN O
profile NN O
. . O

Attempts NNS O
to TO O
convert VB O
A DT O
enzyme NN O
to IN O
C NN O
using VBG O
trypsin NN O
have VBP O
not RB O
been VBN O
successful JJ O
. . O

A DT O
enzyme NN O
activity NN O
is VBZ O
lost VBN O
without IN O
the DT O
appearance NN O
of IN O
any DT O
other JJ O
species NNS O
( , O
unpublished JJ O
observation NN O
) -RRB- O
, , O
although IN O

14 CD O
the DT O
action NN O
of IN O
trypsin NN O
on IN O
C NN O
enzyme NN O
can MD O
give VB O
rise NN O
to IN O
small JJ O
amounts NNS O
of IN O
B NN O

Although IN O
the DT O
conversion NN O
of IN O
A NN O
enzyme NN O
to IN O
C NN O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
the DT O
result NN O
of IN O
serine NN O
protease NN O
action NN O
, , O
proteases NNS O
other JJ O
than IN O
serine NN O
proteases NNS O

18 CD O

could MD O
have VB O
been VBN O
responsible JJ O
. . O

Also RB O
, , O
the DT O
fact NN O
that IN O
A DT O
enzyme NN O
can MD O
be VB O
recon VBN O

stituted VBN O
from IN O
C NN O
plus CC O
the DT O
flow NN O
through IN O
material NN O
from IN O
the DT O
DEAE NNP O
cellulose NN O
after IN O
urea NN O
treatment NN O
does VBZ O
not RB O
necessarily RB O
mean VB O
we PRP O
are VBP O
dealing VBG O
with IN O
two CD O
subunits NNS O
as IN O
fragments NNS O
produced VBN O
by IN O
proteases NNS O
mray NN O
be VB O
reassembled VBN O
to TO O
give VB O
active JJ O

enzyme NN O
9 CD O
. . O

However RB O
, , O
the DT O
fact NN O
that IN O
a DT O
200 CD O
- SYM O
230 CD O
, , O
0 CD O
molecular JJ O
weight NN O
polypeptide NN O
band NN O
has VBZ O
never RB O
been VBN O
observed VBN O
in IN O
sodium NN O
dodecylsulphate NN O
polyacrylamride NN O
gels NNS O
of IN O
highly RB O
purified VBN O
A NN O
enzyme NN O
, , O
or CC O
even RB O
cruder NN O
fractions NNS O
of IN O
A NN O

enzyrre NNP O
( , O
unpublished JJ O
observation NN O
) -RRB- O
, , O
may MD O
be VB O
significant JJ O
. . O

One PRP O
might MD O
expect VB O

some DT O
of IN O
the DT O
enzyme NN O
not RB O
to TO O
have VB O
been VBN O
attacked VBN O
by IN O
whatever WDT O
is VBZ O
responsible JJ O
for IN O
cleaving VBG O
the DT O
molecule NN O
, , O
if IN O
, , O
indeed RB O
, , O
this DT O
does VBZ O
happen VB O
. . O

It PRP O
would MD O
appear VB O
, , O
therefore RB O
, , O
that IN O
the DT O
A NNP O
enzyme NN O
consists VBZ O
of IN O
subunits NNS O
of IN O
155 CD O
, , O
0 CD O
and CC O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
with IN O
the DT O
small JJ O
subunit NN O
having VBG O
a DT O
slightly RB O
different JJ O
charge NN O
in IN O
the DT O

case NN O
of IN O
A NN O
and CC O
A2 NN O
. . O

It PRP O
has VBZ O
also RB O
been VBN O
concluded VBN O
that IN O
the DT O
heterogeneity NN O
in IN O
the DT O

1 CD O
~ SYM O
~ : O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ SYM O
3 CD O
mouse NN B-Species
myeloma NN O
DNA NN O
polymerase NN O
a DT O
fraction NN O
is VBZ O
not RB O
due JJ O
to IN O
proteolysis NN O
. . O

However RB O
, , O
the DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
subunit NN O
has VBZ O
not RB O
yet RB O
been VBN O
identified VBN O
. . O

Sodiurrm NN O
dodecylsulphate NN O
polyacrylamide NN O
gels NNS O
of IN O
reconstituted VBN O
A NN O
enzyme NN O
have VBP O
shown VBN O
polypeptide NN O
bands NNS O
at IN O
150 CD O
- SYM O
160 CD O
, , O
0 CD O
and CC O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
molecular JJ O
weight NN O

( : O
Fig NNP O
. . O
3 CD O
) -RRB- O
, , O
but CC O
the DT O
ratio NN O
of IN O
staining VBG O
intensity NN O
of IN O
the DT O
bands NNS O
does VBZ O
not RB O
correspond VB O
to IN O
a DT O
1 CD O
: SYM O
1 CD O
relationship NN O
. . O

The DT O
ratio NN O
of IN O
the DT O
two CD O
bands NNS O
is VBZ O
variable JJ O
but CC O
is VBZ O
usually RB O
between IN O
1 CD O
: SYM O
2 CD O
and CC O
1 CD O
: SYM O
3 CD O
, , O
indicating VBG O
, , O
perhaps RB O
, , O
that IN O
more JJR O
than IN O
one CD O
subunit NN O
of IN O
50 CD O

3347 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

TOP NNP O
123 CD O
4 CD O
5 CD O
6 CD O

Figure NN O
3 CD O
Scan NN O
of IN O
a DT O
5 CD O
% NN O
sodium NN O
dodecyl NN O
sulphate NN O
polyacrylamide NN O
gel NN O
of IN O

reconstituted VBN O
A2 NN O
enzyme NN O
. . O

1500 CD O
units NNS O
of IN O
reconstituted VBN O
A2 NN O
enzyme NN O
were VBD O
subjected VBN O
to IN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
under IN O
non JJ O
- HYPH O
denaturing VBG O
conditions NNS O
. . O

The DT O
gels NNS O
were VBD O
sliced VBN O
, , O
enzyme NN O
extracted VBN O
and CC O
assayed VBN O
and CC O
the DT O
peak NN O

fraction NN O
of IN O
DNA NNP O
polymerase NN O
activity NN O
from IN O
three CD O
gels NNS O
were VBD O
pooled VBN O
, , O
subjected VBN O
to IN O
sodium NN O
dodecyl NN O
sulphate NN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
on IN O
a DT O
single JJ O

gel NN O
, , O
stained VBN O
and CC O
scanned VBN O
at IN O
2 CD O
volt NN O
sensitivity NN O
as IN O
described2 VBN O
. . O

The DT O
molecular JJ O
weight NN O
standards NNS O
were VBD O
: : O
( : O
1 CD O
) SYM O
bovine JJ B-Species
serum NN O
albumin NN O
dimer NN O
( , O
134 CD O
, , O
0 CD O
) -RRB- O
, , O
( , O
2 CD O
) -RRB- O
, , O
3 CD O
galactosidase NN O
( SYM O
130 CD O
, , O
0 CD O
) -RRB- O
, , O
( , O
3 CD O
) SYM O
phosphorylase NN O
a DT O
( SYM O
94 CD O
, , O
0 CD O
) -RRB- O
, , O
( SYM O
4 CD O
) SYM O
bovine JJ B-Species
serum NN O

albumin NNP O
( : O
68 CD O
, , O
0 CD O
) -RRB- O
, , O
( , O
5 CD O
) SYM O
pyruvate NN O
kinase NN O
( : O
57 CD O
, , O
0 CD O
) -RRB- O
and CC O
( , O
6 CD O
) SYM O
lactate NN O
dehydrogenase NN O
( , O
35 CD O
, , O
0 CD O
) -RRB- O
. . O

70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
can MD O
associate VB O
with IN O
the DT O
155 CD O
, , O
0 CD O
subunit NN O
. . O

The DT O
proportion NN O
of IN O
the DT O
lower JJR O
molecular JJ O
weight NN O
polypeptide NN O
band NN O
is VBZ O
higher JJR O
in IN O
the DT O
reconstituted VBN O
A NN O
enzyrrme NN O
than IN O
in IN O
the DT O
C NNP O
enzyme NN O
preparation NN O
from IN O
which WDT O
it PRP O
was VBD O
formed VBN O
, , O
but CC O
even RB O
the DT O
C NNP O
enzyme NN O
contained VBD O
some DT O
material NN O
in IN O
the DT O
region NN O
. . O

Breakdown NN O
of IN O
material NN O
from IN O
155 CD O
, , O
0 CD O
to IN O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
may MD O
be VB O
partly RB O
responsible JJ O
for IN O
the DT O
contamination NN O
, , O
but CC O
the DT O
presence NN O
of IN O
phenylmethylsulphony NN O
in IN O
samples NNS O
in IN O
preparation NN O
for IN O
sodium NN O
dodecylsulphate NN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
has VBZ O
not RB O
been VBN O
successful JJ O
in IN O
preventing VBG O
it PRP O
. . O

The DT O
human JJ B-Species
KB NNP O
cell NN O

DNA NN O
polymerase NN O
a DT O
, , O
equivalent JJ O
to IN O
the DT O
C NNP O
enzyme NN O
, , O
has VBZ O
been VBN O
reported VBN O
to TO O
consist VB O

4 LS O

of IN O
subunits NNS O
of IN O
76 CD O
, , O
0 CD O
and CC O
66 CD O
, , O
0 CD O
molecular JJ O
weight NN O
, , O
but CC O
at IN O
no DT O
time NN O
have VBP O
we PRP O

observed VBN O
polypeptide NN O
bands NNS O
at IN O
76 CD O
, , O
0 CD O
and CC O
66 CD O
, , O
0 CD O
rising VBG O
and CC O
falling VBG O
with IN O

enzyme NN O
activity NN O
in IN O
any DT O
gels NNS O
of IN O
calf NN B-Species
thyrrmus NN O
enzymes NNS O
A1 NN O
, , O
A NN O
and CC O
C NN O
( , O
and CC O

2 CD O
unpublished JJ O
observations NNS O
) -RRB- O
. . O

( : O
b LS O
) -RRB- O
Template NN O
Studies NNS O

Use NN O
has VBZ O
been VBN O
made VBN O
of IN O
the DT O
urea NN O
conversion NN O
of IN O
A NN O
to IN O
C NN O
and CC O
of IN O
the DT O
reconstitution NN O
of IN O
A DT O
enzyme NN O
to TO O
obtain VB O
samples NNS O
of IN O
highly RB O
purified VBN O
DNA NNP O
polymerase NN O
, . O

specific JJ O
activity NN O
in IN O
excess NN O
of IN O
50 CD O
, , O
0 CD O
units NNS O
/ SYM O
mg NN O
, , O
in IN O
order NN O
to TO O
study VB O
the DT O
effect NN O
of IN O
this DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
subunit NN O
on IN O
the DT O
DNA NN O
polymerase NN O
subunit NN O
. . O

Previous JJ O
results NNS O
have VBP O
indicated VBN O
that IN O
A DT O
enzyrrme NN O
is VBZ O
stabler JJR O
to IN O
heat NN O
and CC O
less JJR O

3348 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

14 CD O
, , O
21 CD O

susceptible JJ O
to IN O
N NN O
- HYPH O
ethylmaleimide NN O
than IN O
C NN O
enzyme NN O
. . O

It PRP O
has VBZ O
been VBN O
reported VBN O

that IN O
highly RB O
purified VBN O
DNA NNP O
polymerase NN O
a DT O
can MD O
be VB O
associated VBN O
with IN O
a DT O
protein NN O
capable JJ O
of IN O
binding VBG O
to IN O
DNA NN O
containing VBG O
no DT O
3 CD O
' '' O
OH NN O
ends NNS O
and CC O
capable JJ O
of IN O
being VBG O
released VBN O
during IN O
the DT O
DNA NNP O
polymerase NN O
assay NN O
. . O

Attempts NNS O
to TO O
dissociate VB O
the DT O
50 CD O

70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
subunit NN O
from IN O
the DT O
polymerase NN O
subunit NN O
by IN O
incubating VBG O
A2 NNP O
with IN O
DNA NN O
polymerase NN O
reaction NN O
mixes NNS O
containing VBG O
activated VBN O
DNA NN O
, , O
poly NN O

( : O
dA NN O
- HYPH O
T NNP O
) -RRB- O
and CC O
poly NN O
( , O
dT NN O
) -RRB- O
. , O
oligo NN O
( , O
A NN O
) -RRB- O
10 CD O
followed VBN O
by IN O
ultracentrifugation NN O
in IN O
high JJ O
salt NN O
have VBP O
been VBN O
unsuccessful JJ O
. . O

Similarly RB O
A NN O
absorbed VBN O
and CC O
eluted VBN O
from IN O
either CC O
native JJ O
or CC O
denatured VBN O
DNA NNP O
cellulose NN O
remained VBD O
A DT O
enzyme NN O
. . O

Both CC O
A NN O
and CC O
C NN O
enzymes NNS O

were VBD O
eluted VBN O
from IN O
the DT O
DNA NNP O
celluloses NNS O
by IN O
less JJR O
than IN O
0 CD O
. . O

1 CD O
M NN O
NaCl NNP O
so RB O
it PRP O
does VBZ O
not RB O
appear VB O
that IN O
the DT O
subunit NN O
enhances VBZ O
the DT O
binding NN O
of IN O
the DT O
DNA NNP O
polymerase NN O
subunit NN O
to IN O
DNA NNP O
. . O

However RB O
, , O
there EX O
are VBP O
differences NNS O
in IN O
the DT O
response NN O
of IN O
A NN O
and CC O
C NN O

enzymes NNS O
to IN O
synthetic JJ O
template NN O
- HYPH O
initiator NN O
complexes NNS O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
. . O

Even RB O
if IN O
one PRP O
takes VBZ O
into IN O
account NN O
the DT O
fact NN O
that IN O
A DT O
enzyme NN O
is VBZ O
less RBR O
active JJ O
on IN O
activated JJ O
DNA NNP O

than IN O
C NNP O
enzyme NN O
( , O
the DT O
addition NN O
of IN O
the DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
subunit NN O
to IN O
the DT O
polymerase NN O
subunit NN O
appears VBZ O
to TO O
result VB O
in IN O
a DT O
decrease NN O
of IN O
about RB O
30 CD O
% NN O
of IN O
polymerase NN O
activity NN O
on IN O
activated VBN O
DNA NNP O
) , O
the DT O
A NN O
enzyme NN O
is VBZ O
still RB O
more RBR O
active JJ O
on IN O
these DT O
templates NNS O
. . O

Although IN O
there EX O
is VBZ O
a DT O
variation NN O
in IN O
activity NN O
on IN O
these DT O
template NN O
- HYPH O
initiator NN O
comp NN O

lexes NNS O
each DT O
time NN O
assays NNS O
are VBP O
carried VBN O
out RP O
on IN O
them PRP O
depending VBG O
on IN O
the DT O
method NN O
of IN O
preparing VBG O
the DT O
complexes NNS O
and CC O
the DT O
base NN O
ratio NN O
of IN O
template NN O
to IN O
initiator NN O
, , O
A DT O
enzyme NN O
always RB O
seems VBZ O
to TO O
be VB O
significantly RB O
more RBR O
active JJ O
than IN O
C NN O
. . O

The DT O
A2 NNP O

enzyme NN O
at IN O
pH NN O
7 CD O
. . O
8 CD O
, , O
with IN O
extra JJ O
subunit NN O
( , O
s NNS O
) -RRB- O
is VBZ O
clearly RB O
more RBR O
effective JJ O
on IN O
the DT O

oligoribonucleotide NN O
initiator NN O
, , O
oligo NN O
( , O
A NN O
) -RRB- O
10 CD O
than IN O
is VBZ O
enzyme NN O
C NN O
. . O

In IN O
view NN O
of IN O
the DT O
proposed VBN O
RNA NNP O
initiation NN O
of IN O
Okazaki NNP O
pieces NNS O
this DT O
may MD O
indicate VB O
a DT O
role NN O
of IN O
this DT O
subunit NN O
in IN O
Okazaki NNP O
piece NN O
synthesis NN O
, , O
in IN O
that IN O
it PRP O
may MD O
aid VB O
the DT O
DNA NNP O
polymerase NN O
to TO O
' `` O
take VB O
over RP O
' '' O
from IN O
the DT O
RNA NNP O
polymerase NN O
. . O

Using VBG O
poly NN O
( , O
dA FW O
) -RRB- O
. . O
oligo NN O
( , O
dT NN O
) SYM O
10 CD O

( : O
A NN O
: : O
T NN O
= SYM O
20 CD O
: : O
1 CD O
) -RRB- O
and CC O
following VBG O
the DT O
incorporation NN O
of IN O
[ -LRB- O
H NN O
] -RRB- O
dTMP NN O
as IN O
a DT O
function NN O
of IN O
time NN O
a DT O
short JJ O
lag NN O
was VBD O
observed VBN O
for IN O
C NN O
enzyme NN O
, , O
but CC O
not RB O
for IN O
A2 NNP O
( : O
Fig NNP O
. . O
4 CD O
) -RRB- O
. . O

Similar JJ O
re NN O
sult NN O
s NNS O
we PRP O
re VBP O
obtained VBN O
when WRB O
poly JJ O
( , O
dC NN O
) -RRB- O
. , O
oligo NN O
( : O
dG NN O
) SYM O
1 CD O
0 CD O
( SYM O
C NN O
: : O
G NN O
= SYM O
5 CD O
: : O
1 CD O
) -RRB- O
wa NN O
s . O

used VBN O
as IN O
temrrplate NN O
- HYPH O
initiator NN O
, , O
but CC O
not RB O
when WRB O
poly JJ O
( , O
dT NN O
) -RRB- O
. . O
oligo NN O
( : O
A NN O
) SYM O
10 CD O
( SYM O
T NN O
: : O
A NN O
= SYM O
1 CD O
: : O
1 CD O
) -RRB- O
was VBD O
used VBN O
. . O

Neither DT O
enzyme NN O
showed VBD O
a DT O
lag NN O
on IN O
this DT O
template NN O
- HYPH O
initiator NN O
complex NN O
or CC O
on IN O
activated VBN O
DNA NNP O
. . O

Incorporation NN O
versus IN O
enzyme NN O
concentration NN O
also RB O
showed VBD O
this DT O
lag NN O
for IN O
C NN O
enzyme NN O
on IN O
poly JJ O
( , O
dA FW O
) -RRB- O
. . O
oligo NN O
( , O
dT NNP O
) SYM O
10 CD O
. . O

It PRP O
is VBZ O
not RB O
certain JJ O
what WP O
causes VBZ O

3349 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

TABLE NN O
1 CD O
Template NN O
utilisation NN O
by IN O
reconstituted VBN O
A NN O
and CC O
C NN O
derived VBN O
from IN O
A NN O
. . O

3H NN O
] -RRB- O
dNTP NN O
Divalent NN O
cation NN O
A2 NN O
at IN O
pH NN O
C NN O
at IN O
pH NN O

Template NN O
_ : O
6 CD O
. . O
4 CD O
7 CD O
. . O
8 CD O
6 CD O
. . O
4 CD O
7 CD O
. . O
8 CD O
Activated JJ O
DNA NN O
dTTP NN O
Mg NN O
+ NFP O
+ SYM O
100 CD O
100 CD O
Activated VBN O
DNA NN O
dATP NN O
Mg NN O
+ CC O
+ SYM O
91 CD O
85 CD O
Activated JJ O
DNA NN O
dGTP NN O
Mg NN O
+ SYM O
+ SYM O
85 CD O
82 CD O
poly NN O
( : O
dA NN O
) -RRB- O
. . O
oligo NN O
( : O
dT NN O
) SYM O
10 CD O
dTTP NN O
Mg NNP O
66 CD O
. . O
0 CD O
4 CD O
. . O
0 CD O
20 CD O
91 CD O

( : O
A NN O
: : O
T NN O
= SYM O
20 CD O
: : O
1 CD O
) NFP O

poly NN O
( : O
dA NN O
) -RRB- O
. . O

oligo NNP O
( , O
dT NN O
) , O
dTTP NNP O
Mu NNP O
19 CD O
. . O
0 CD O
4 CD O
. . O

5 CD O
6 CD O
. . O

5 CD O
2 CD O
. . O
5 CD O

poly JJ O
( : O
dA FW O
. . O

oig NN O
~ SYM O
10 CD O
( : O
A NN O
: : O
T NN O
= SYM O
20 CD O
: : O
1 CD O
) NFP O

poly NN O
( , O
dT NN O
) -RRB- O
. . O

oligo NNP O
( : O
dA NN O
) SYM O
10 CD O
dATP NN O
Mg NNP O
2 CD O
. . O
5 CD O
< SYM O
1 CD O
( SYM O
1 CD O
( SYM O
1 CD O

( : O
T NN O
: : O
A NN O
= SYM O
5 CD O
: : O
1 CD O
) NFP O

poly NN O
( , O
dT NN O
) -RRB- O
. . O
oligo NN O
( : O
dA NN O
) SYM O
1 CD O
dATP NN O
Mn NN O
+ NFP O
+ SYM O
15 CD O
. . O
5 CD O
23 CD O
. . O
0 CD O
9 CD O
. . O

0 NFP O
3 CD O
. . O

0 NFP O

poly NN O
( , O
dT NN O
) -RRB- O
. . O

oligo NNP O
( , O
A NN O
) SYM O
10 CD O
dATP NN O
Mg NNP O
15 CD O
. . O
0 CD O
230 CD O
. . O
0 CD O
10 CD O
. . O
0 CD O
77 CD O
. . O

5 CD O

( : O
T NN O
: : O
A NN O
= SYM O
1 CD O
: : O
1 CD O
) NFP O

poly JJ O
( , O
dT NN O
) -RRB- O
* NFP O
oligo NN O
( , O
A NN O
) SYM O
10 CD O
dATP NN O
Mn NNP O
41 CD O
. . O
5 CD O
75 CD O
. . O

5 CD O
19 CD O
. . O
5 CD O
21 CD O
. . O
5 CD O

( : O
T NN O
: : O
A NN O
= SYM O
1 CD O
: : O
1 CD O
) NFP O

poly NN O
( , O
dC NN O
) -RRB- O
. . O

oligo NN O
( : O
dG NN O
) : O
dGTP NN O
Mg NN O
+ CC O
+ SYM O
6 CD O
. . O

0 CD O
15 CD O
. . O
5 CD O
4 CD O
. . O

5 CD O
7 CD O
. . O

5 CD O

( : O
C NN O
: : O
G NN O
= SYM O
5 CD O
: : O
1 CD O
) SYM O
10 CD O

poly NN O
( , O
dC NN O
) -RRB- O
. . O

oligo NNP O
( : O
dG NN O
) SYM O
10 CD O
dGTP NN O
Mn NN O
+ SYM O
6 CD O
. . O

0 CD O
29 CD O
. . O
5 CD O
5 CD O
. . O

0 NFP O
6 CD O
. . O

5 CD O

( : O
C NN O
: : O
G NN O
= SYM O
5 CD O
: : O
1 CD O
) -RRB- O
. . O

. . O

Values NNS O
given VBN O
are VBP O
relative JJ O
to IN O
incorporation NN O
of IN O
[ -LRB- O
H NN O
] -RRB- O
dTMP NNP O
at IN O
pH NN O
7 CD O
. . O

8 CD O
on IN O
activated VBN O
DNA NNP O
. . O

For IN O
A2 NNP O
this DT O
was VBD O
176 CD O
. . O
5 CD O
pmol NN O
, , O
for IN O
C NN O
232 CD O
pmol NN O
. . O

dATP NNP O
, , O
dCTP NNP O
, , O
dGTP NNP O
and CC O
dTTP NNP O
were VBD O
included VBN O
for IN O
assays NNS O
using VBG O
activated VBN O
DNA NN O
, , O
only RB O
the DT O
deoxynucleoside NN O
triphosphate NN O
stated VBD O
was VBD O
used VBN O
in IN O
the DT O
synthetic JJ O
template NN O

initiator NN O
complex JJ O
assays NNS O
. . O

Assays NNS O
were VBD O
for IN O
10 CD O
minutes NNS O
. . O

The DT O
buffers NNS O
and CC O
concentrations NNS O
of IN O
the DT O
divalent JJ O
cations NNS O
were VBD O
as IN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

this DT O
lag NN O
, , O
but CC O
the DT O
annealing NN O
of IN O
template NN O
to IN O
initiator NN O
is VBZ O
only RB O
transient JJ O
' '' O
and CC O
the DT O
DNA NN O
polymerase NN O
subunit NN O
may MD O
have VB O
difficulty NN O
in IN O
stabilising VBG O
the DT O
complex NN O
and CC O
the DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
molecular JJ O
weight NN O
subunit NN O
may MD O
be VB O
able JJ O
to TO O
help VB O
the DT O
poly NN O

merase UH O
subunit NN O
to TO O
overcome VB O
this DT O
. . O

Addition NN O
of IN O
the DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
subunit NN O
to IN O
the DT O
polymerase NN O
subunit NN O
prior RB O
to IN O
assaying VBG O
with IN O
these DT O
templates NNS O
had VBD O
no DT O
effect NN O
on IN O
activity NN O
and CC O
it PRP O
may MD O
be VB O
that IN O
a DT O
preincubation NN O
period NN O
is VBZ O
required VBN O
before IN O
the DT O
two CD O
3350 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Figure NN O
4 CD O
Activity NN O
of IN O
A2 NN O
and CC O
C NN O
enzymes NNS O
on IN O
poly NN O
( , O
dA FW O
) -RRB- O
. . O
oligo NN O
( , O
dT NN O
) : O
jO NN O
( : O
A NN O
: : O
T NNP O
= . O

20 CD O
: : O
1 CD O
) -RRB- O
as IN O
a DT O
function NN O
of IN O
time NN O
. . O

50 CD O
, , O
ul IN O
samples NNS O
were VBD O
withdrawn VBN O
at IN O
various JJ O
times NNS O
from IN O
a DT O
0 CD O
. . O

6 CD O
inl DT O
incubation NN O
mix NN O
at IN O
30 CD O
? . O
C NN O
and CC O
added VBD O
to IN O
0 CD O
. . O

5 CD O
ml CD O
0 CD O
. . O

1 CD O
M NN O
sodium NN O

pyrophosphate NN O
containing VBG O
100 CD O
, , O
ug NN O
/ SYM O
ml NNP O
native JJ O
calf NN B-Species
thymus NN O
DNA NN O
and CC O
processed VBN O
for IN O
counting VBG O
in IN O
the DT O
usual JJ O
manner6 NN O
. . O

The DT O
mix NN O
contained VBD O
1 CD O
mM NN O
dithiothreitol NN O
, , O
50 CD O
mM NN O
tris NNS O
HC1 NN O
, , O
pH NN O
7 CD O
. . O
8 CD O
10 CD O
mM NN O
MgC12 CD O
, , O
0 CD O
. . O

1 CD O
mM NN O
[ -LRB- O
3H CD O
] -RRB- O
dTTP NNP O
( : O
15 CD O
cpm NN O
/ SYM O
pmol NN O
) -RRB- O
, , O
312 CD O
. . O
5 CD O
, , O
ug IN O
bovine NN B-Species
serum NN O
albumin NN O
, , O
5 CD O
Fg NNP O
poly NN O
( HYPH O
dA NN O
) -RRB- O
. , O
oligo NN O
( , O
dT NN O
) -RRB- O
( , O
A NN O
: : O
T NN O
= SYM O
20 CD O
: : O
1 CD O
) -RRB- O
and CC O
enzyme NN O
protein NN O
( : O
* NFP O
- : O
* NFP O
) NFP O
3 CD O
. . O
3 CD O
units NNS O
reconstituted VBN O
A2 NN O
, , O
( : O
o CD O
- HYPH O
o CD O
) SYM O
16 CD O
. . O

0 NFP O
units NNS O
urea NN O
derived VBN O
C NN O
enzyme NN O
. . O

subunits NNS O
become VBP O
fully RB O
associated VBN O
. . O

After IN O
the DT O
lag NN O
phase NN O
is VBZ O
over IN O
the DT O
C NNP O
enzyme NN O
is VBZ O
still RB O
less RBR O
active JJ O
on IN O
these DT O
template NN O
- HYPH O
initiators NNS O
than IN O
A DT O
enzyme NN O
. . O

That DT O
is VBZ O
the DT O
A NNP O
enzyme NN O
seems VBZ O
capable JJ O
of IN O
elongating VBG O
the DT O
initiator NN O
faster RBR O
than IN O
the DT O
C NNP O
enzyme NN O
. . O

Experiments NNS O
to TO O
determine VB O
whether IN O
the DT O
differences NNS O
in IN O
rates NNS O
of IN O
elongation NN O
of IN O
these DT O
template NN O
- HYPH O
initiator NN O
complexes NNS O
are VBP O
differences NNS O
in IN O
processivity NN O
of IN O
the DT O

enzymes NNS O
under IN O
the DT O
different JJ O
pH NN O
and CC O
divalent JJ O
cation NN O
conditions NNS O
are VBP O
under IN O
way NN O
. . O

ACKNOWLEDGEMENTS NNS O

We PRP O
thank VBP O
the DT O
Medical NNP O
Research NNP O
Council NNP O
for IN O
a DT O
research NN O
grant NN O
. . O

Communications NNS O
concerning VBG O
the DT O
paper NN O
should MD O
be VB O
sent VBN O
to IN O
: : O

Dr NNP O
. . O
A DT O
. . O

M UH O
. . O

Holmes NNP O
, , O
Department NNP O
of IN O
Biochemistry NNP O
, , O
University NNP O
of IN O
Strathclyde NNP O
, , O
The DT O
Todd NNP O
Centre NNP O
, , O
31 CD O
Taylor NNP O
Street NNP O
, , O
Glasgow NNP O
G4 NNP O
ONR NNP O
, , O
U NNP O
. . O
K NNP O
. . O

3351 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

REFERENCES NNS O

( : O
1 CD O
) SYM O
Bollum NNP O
, , O
F NNP O
. . O
J NNP O
. . O

( -LRB- O
1975 CD O
) -RRB- O
. . O

Prog NNP O
. . O

Nucleic JJ O
Acid NNP O
Res NNP O
. . O

Mol NNP O
. . O

Biol NNP O
. . O

15 CD O
, , O

109 CD O
- SYM O
144 CD O
. . O

( : O
2 CD O
) SYM O
Holmes NNP O
, , O
A NNP O
. . O
M UH O
. . O
, , O
Hesslewood NNP O
, , O
I PRP O
. . O
P NN O
. . O
and CC O
Johnston NNP O
, , O
I PRP O
. . O
R NN O
. . O

( -LRB- O
1976 CD O
) -RRB- O
. . O

Eur UH O
. . O

J NNP O
. . O

Biochem NNP O
. . O

62 CD O
, , O
229 CD O
- SYM O
235 CD O
. . O

( : O
3 CD O
) SYM O
Matsukage NNP O
, , O
A NNP O
. . O
, , O
Sivarajan NNP O
, , O
M NNP O
. . O
and CC O
Wilson NNP O
, , O
S NNP O
. . O
H NN O
. . O

( -LRB- O
1976 CD O
) -RRB- O
. . O

Biochem NNP O

istry NNP O
15 CD O
, , O
5305 CD O
- HYPH O
5314 CD O
. . O

( : O
4 CD O
) SYM O
Fisher NNP O
, , O
P NN O
. . O
A NN O
. . O
and CC O
Korn NNP O
, , O
D NNP O
. . O

( -LRB- O
1977 CD O
) -RRB- O
. . O

J NNP O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

252 CD O
, , O
6528 CD O

6535 CD O
. . O

( : O
5 CD O
) SYM O
Fichot NNP O
, , O
O NNP O
. . O
, , O
Pascal NNP O
, , O
M NNP O
. . O
, , O
Mechali NNP O
, , O
M NNP O
. . O
and CC O
De NNP O
Recondo NNP O
, , O
A NNP O
, , O
- HYPH O
M NN O
. . O

( -LRB- O
1979 CD O
) -RRB- O
. . O

Biochim NNP O
. . O

Biophys NNP O
. . O

Acta NNP O
, , O
561 CD O
, , O
28 CD O
- HYPH O
41 CD O
. . O

( : O
6 CD O
) SYM O
Holmes NNP O
, , O
A NNP O
. . O
M NNP O
. . O
, , O
Hesslewood NNP O
, , O
I PRP O
. . O
R NN O
. . O
and CC O
Johnston NNP O
, , O
I PRP O
. . O
R NN O
. . O

( -LRB- O
1974 CD O
) -RRB- O
. . O

Eur UH O
. . O

J NNP O
. . O

Biochemn NNP O
. . O

43 CD O
, , O
487 CD O
- HYPH O
499 CD O
. . O

( : O
7 CD O
) SYM O
Noy NNP O
, , O
G NNP O
. . O
P NN O
. . O
and CC O
Weissbach NNP O
, , O
A NNP O
. . O

( -LRB- O
1977 CD O
) -RRB- O
. . O

Biochim NNP O
. . O

Biophys NNP O
. . O

Acta NNP O
, , O

447 CD O
, , O
70 CD O
- HYPH O
83 CD O
. . O

( : O
8 CD O
) SYM O
Craig NNP O
, , O
R NNP O
. . O
K UH O
. . O
and CC O
Keir NNP O
, , O
H NN O
. . O

M UH O
. . O

( -LRB- O
1975 CD O
) -RRB- O
. . O

Biochem NNP O
. . O

J NNP O
. . O

145 CD O
, , O
225 CD O
- HYPH O
232 CD O
. . O

( : O
9 CD O
) SYM O
Matsukage NNP O
, , O
A NNP O
. . O
, , O
Bohn NNP O
, , O
E NNP O
. . O
W NNP O
. . O
and CC O
Wilson NNP O
, , O
S NNP O
. . O
H NN O
. . O

( -LRB- O
1974 CD O
) -RRB- O
. . O

Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

71 CD O
, , O
578 CD O
- HYPH O
582 CD O
. . O

110 CD O
) : O
Hachmann NNP O
, , O
H NNP O
. . O
J NNP O
. . O
and CC O
Lezius NNP O
, , O
A NN O
. . O
G NN O
. . O

( -LRB- O
1975 CD O
) -RRB- O
. . O

Eur UH O
. . O

J NNP O
. . O

Biochem NNP O
. . O

50 CD O
, , O

357 CD O
- HYPH O
366 CD O
. . O

( NFP O
11 CD O
) SYM O
Brakel NNP O
, , O
C NNP O
. . O
L NNP O
. . O
and CC O
Blumenthal NNP O
, , O
A NN O
. . O
B NN O
. . O

( -LRB- O
1977 CD O
) -RRB- O
. . O

Biochemistry NN O
, , O
16 CD O
, , O

3137 CD O
- HYPH O
3143 CD O
. . O

( : O
12 CD O
) SYM O
Momparler NNP O
, , O
R NNP O
. . O
L NNP O
. . O
, , O
Rossi NNP O
, , O
M NNP O
. . O
and CC O
Labitan NNP O
, , O
A NNP O
. . O

( -LRB- O
1973 CD O
) -RRB- O
. . O

J NNP O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

248 CD O
, , O
285 CD O
- HYPH O
293 CD O
. . O

( NFP O
13 CD O
) SYM O
Yoshida NNP O
, , O
S NNP O
. . O
, , O
Konda NNP O
, , O
T NNP O
. . O
and CC O
Ando NNP O
, , O
T NNP O
. . O

( -LRB- O
1974 CD O
) -RRB- O
. . O

Biochim NNP O
. . O

Biophys NNP O
. . O

Acta NNP O
, , O
353 CD O
, , O
463 CD O
- HYPH O
474 CD O
. . O

( : O
14 CD O
) SYM O
Holmes NNP O
, , O
A NNP O
. . O
M NNP O
. . O
, , O
Hesslewood NNP O
, , O
I NNP O
. . O
P NN O
. . O
, , O
Wickremasinghe NNP O
, , O
R NN O
. . O
G NNP O
. . O
and CC O

Johnston NNP O
, , O
I PRP O
. . O
R NN O
. . O

( -LRB- O
1977 CD O
) -RRB- O
. . O

Biochem NNP O
. . O

Soc NN O
. . O

Symp NN O
. . O

42 CD O
, , O
17 CD O
- SYM O
36 CD O
. . O

( : O
15 CD O
) SYM O
De NNP O
Jong NNP O
, , O
A NNP O
. . O
, , O
Van NNP O
der NNP O
Vliet NNP O
, , O
P NNP O
. . O
and CC O
Jansz NNP O
, , O
H NN O
. . O
S NN O
. . O

( -LRB- O
1977 CD O
) -RRB- O
. . O

Biochim NNP O
. . O

Biophys NNP O
. . O

Acta NNP O
, , O
476 CD O
, , O
156 CD O
- HYPH O
165 CD O
. . O

( : O
16 CD O
) SYM O
Holmes NNP O
, , O
A NNP O
. . O
M UH O
. . O
, , O
Hesslewood NNP O
, , O
I PRP O
. . O
P NN O
. . O
and CC O
Johnston NNP O
, , O
I PRP O
. . O
R NN O
. . O

( -LRB- O
1975 CD O
) -RRB- O
. . O

Nature NNP O
( : O
London NNP O
) , O
255 CD O
, , O
420 CD O
- HYPH O
422 CD O
. . O

( : O
17 CD O
) SYM O
Bollum NNP O
, , O
F NNP O
. . O

J NNP O
. . O

( : O
1966 CD O
) -RRB- O
. . O

Procedures NNS O
in IN O
Nucleic NNP O
Acid NNP O
Research NNP O

( : O
Cantoni NNP O
, , O
G NNP O
. . O
L NNP O
. . O
and CC O
Davis NNP O
, , O
D NNP O
. . O
R NN O
. . O
eds NNS O
) -RRB- O
. . O

pp NN O
577 CD O
- HYPH O
583 CD O
, , O
Harper NNP O
and CC O
Row NNP O
, , O
New NNP O
York NNP O
. . O

( : O
18 CD O
) SYM O
Barrett NNP O
, , O
A NN O
. . O
J NN O
. . O

( -LRB- O
1975 CD O
) -RRB- O
. . O

Proteases NNS O
and CC O
Biological NNP O
Control NNP O
pp NN O
467 CD O
- HYPH O
482 CD O
, , O

Cold NNP O
Spring NNP O
Harbor NNP O
Laboratory NNP O
, , O
Cold NNP O
Spring NNP O
Harbor NNP O
. . O

( : O
19 CD O
) SYM O
Richards NNP O
, , O
F NNP O
. . O

M UH O
. . O
and CC O
Vithayathil NNP O
, , O
P NN O
. . O
J NNP O
. . O

( : O
1960 CD O
) -RRB- O
. . O

Brookhaven NNP O
Symp NNP O
. . O

Biol NNP O
. . O

13 CD O
, , O
115 CD O
- SYM O
134 CD O
. . O

( : O
20 CD O
) SYM O
Lowe NNP O
, , O
P NNP O
. . O
A NNP O
. . O
, , O
and CC O
Malcolm NNP O
, , O
A NNP O
. . O
B NN O
. . O
D NN O
. . O

( -LRB- O
1976 CD O
) -RRB- O
. . O

Eur UH O
. . O

J NNP O
. . O

Biochem NNP O
. . O

64 CD O
, , O

177 CD O
- SYM O
188 CD O
. . O

( : O
21 CD O
) SYM O
Hesslewood NNP O
, , O
I NNP O
. . O
P UH O
. . O
, , O
Holmes NNP O
, , O
A NNP O
. . O
M UH O
. . O
, , O
Wakeling NNP O
, , O
W NNP O
. . O
F NNP O
. . O
and CC O
Johnston NNP O
, , O

I PRP O
. . O
R NN O
. . O

( -LRB- O
1978 CD O
) -RRB- O
. . O

Eur UH O
. . O

J NNP O
. . O

Biochenr NNP O
. . O
. . O

84 CD O
, , O
123 CD O
- SYM O
131 CD O
. . O

( : O
22 CD O
) SYM O
Mechali NNP O
, , O
M NNP O
. . O
and CC O
De NNP O
Recondo NNP O
, , O
A NNP O
. . O

- HYPH O
M NN O
. . O

( -LRB- O
1978 CD O
) -RRB- O
. . O

Biochim NNP O
. . O

Biophys NNP O
. . O

Res NNS O
. . O

Comm NNP O
, , O
82 CD O
, , O
255 CD O
- SYM O
264 CD O
. . O

( : O
23 CD O
) SYM O
Chang NNP O
, , O
L NNP O
. . O
M NNP O
. . O
S NNP O
. . O
, , O
Cassani NNP O
, , O
G NNP O
. . O
R NN O
. . O
and CC O
Bollum NNP O
, , O
F NNP O
. . O
J NNP O
. . O

( -LRB- O
1972 CD O
) -RRB- O
. . O

J NNP O
. . O

Biol NNP O
. . O

Che NNP O
. . O

247 CD O
, , O
7718 CD O
- HYPH O
7723 CD O
. . O

( : O
24 CD O
) SYM O
Wickremasinghe NNP O
, , O
R NN O
. . O
G NNP O
. . O
and CC O
Johnston NNP O
, , O
I PRP O
. . O
R NN O
. . O

( -LRB- O
1974 CD O
) -RRB- O
. . O

Biochim NNP O
. . O

Biophys NNP O
. . O

Acta NNP O
, , O
361 CD O
, , O
37 CD O
- HYPH O
52 CD O
. . O

3352 CD O

Primitive NNP O
Neuroectodermal NNP O
Tumor NNP O
( : O
PNET NNP O
) -RRB- O
of IN O
the DT O
kidney NN O
: : O
a DT O
case NN O
report NN O

Abstract JJ O

Background NN O

A DT O
case NN O
of IN O
Primitive NNP O
Neuroectodermal NNP O
Tumor NNP O
( -LRB- O
PNET NNP O
) -RRB- O
of IN O
the DT O
kidney NN O
in IN O
a DT O
27 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
woman NN B-Species
is VBZ O
presented VBN O
. . O

Few JJ O
cases NNS O
are VBP O
reported VBN O
in IN O
the DT O
literature NN O
with IN O
a DT O
variable JJ O
, , O
nonspecific JJ O
presentation NN O
and CC O
an DT O
aggressive JJ O
behaviour NN O
. . O

In IN O
our PRP$ O
case NN O
, , O
a DT O
radical JJ O
nephrectomy NN O
with IN O
lymphadenectomy NN O
was VBD O
performed VBN O
and CC O
there EX O
was VBD O
no DT O
residual JJ O
or CC O
recurrent JJ O
tumour NN O
at IN O
24 CD O
- HYPH O
month NN O
follow NN O
- HYPH O
up NN O
. . O

Methods NNS O

The DT O
surgical JJ O
specimens NNS O
were VBD O
formalin NN O
- HYPH O
fixed VBN O
and CC O
paraffin NN O
embedded VBN O
. . O

The DT O
sections NNS O
were VBD O
stained VBN O
with IN O
routinary JJ O
H NNP O
& CC O
E NNP O
. . O

Immunohistochemistry NN O
was VBD O
performed VBN O
. . O

Results NNS O

The DT O
immunohistochemical JJ O
evaluation NN O
revealed VBD O
a DT O
diffuse JJ O
CD99 NN O
positivity NN O
in IN O
the DT O
cytoplasm NN O
of IN O
the DT O
neoplastic JJ O
cells NNS O
. . O

Pankeratin NNP O
, , O
cytokeratin NN O
AE1 NNP O
/ , O
AE3 NN O
, , O
vimentin NN O
, , O
desmin NN O
, , O
S100 NN O
, , O
cromogranin NN O
were VBD O
negative JJ O
. . O

The DT O
clinical JJ O
presentation NN O
and CC O
the DT O
macroscopic JJ O
aspect NN O
, , O
together RB O
with IN O
the DT O
histological JJ O
pattern NN O
, , O
the DT O
cytological JJ O
characteristic NN O
and CC O
the DT O
cellular JJ O
immunophenotype NN O
addressed VBD O
the DT O
diagnosis NN O
towards IN O
primary JJ O
PNET NNP O
of IN O
kidney NN O
. . O

Conclusions NNS O

Since IN O
sometimes RB O
it PRP O
is VBZ O
difficult JJ O
to TO O
discriminate VB O
between IN O
PNET NNP O
and CC O
Ewing NNP O
' POS O
s POS O
tumour NN O
, , O
we PRP O
reviewed VBD O
the DT O
difficulties NNS O
in IN O
differential JJ O
diagnosis NN O
. . O

These DT O
tumors NNS O
have VBP O
a DT O
common JJ O
precursor NN O
but CC O
the DT O
stage NN O
of IN O
differentiation NN O
in IN O
which WDT O
it PRP O
is VBZ O
blocked VBN O
is VBZ O
probably RB O
different JJ O
. . O

This DT O
could MD O
also RB O
explain VB O
their PRP$ O
different JJ O
biological JJ O
behaviour NN O
and CC O
prognosis NN O
. . O

Background NN O

The DT O
peripheral JJ O
Primitive NNP O
Neuroectodermal NNP O
Tumor NNP O
( -LRB- O
PNET NNP O
) -RRB- O
, , O
firstly RB O
recognized VBN O
by IN O
Arthur NNP O
Purdy NNP O
Stout NNP O
in IN O
1918 CD O
, , O
is VBZ O
a DT O
member NN O
of IN O
the DT O
family NN O
of IN O
"""" `` O
small JJ O
round JJ O
- HYPH O
cell NN O
tumors NNS O
"""" '' O
. . O

Primitive JJ O
renal JJ O
localization NN O
is VBZ O
very RB O
rare JJ O
. . O

There EX O
are VBP O
almost RB O
50 CD O
cases NNS O
reported VBN O
in IN O
the DT O
literature NN O
, , O
although IN O
it PRP O
is VBZ O
difficult JJ O
to TO O
estimate VB O
the DT O
exact JJ O
number NN O
since IN O
often RB O
it PRP O
has VBZ O
not RB O
been VBN O
differentiated VBN O
from IN O
Ewing NNP O
' POS O
s POS O
Sarcoma NNP O
[ -LRB- O
1 CD O
- HYPH O
13 CD O
] -RRB- O
. . O

Renal NNP O
PNET NNP O
is VBZ O
more RBR O
aggressive JJ O
than IN O
in IN O
the DT O
other JJ O
sites NNS O
. . O

It PRP O
frequently RB O
arises VBZ O
during IN O
childhood NN O
or CC O
adolescence NN O
, , O
having VBG O
an DT O
aggressive JJ O
clinical JJ O
course NN O
towards IN O
metastatic JJ O
disease NN O
and CC O
death NN O
. . O

It PRP O
often RB O
recurs VBZ O
locally RB O
and CC O
metastasises VBZ O
early RB O
to IN O
regional JJ O
lymph JJ O
nodes NNS O
, , O
lungs NNS O
, , O
liver NN O
, , O
bone NN O
and CC O
bone NN O
marrow NN O
, , O
resulting VBG O
in IN O
a DT O
poor JJ O
prognosis NN O
. . O

The DT O
5 CD O
- HYPH O
year NN O
disease NN O
- HYPH O
free JJ O
survival NN O
rate NN O
, , O
for IN O
patients NNS B-Species
presenting VBG O
well RB O
confined VBN O
extra JJ O
- HYPH O
skeletal JJ O
PNET NNP O
, , O
is VBZ O
around RB O
45 CD O
- SYM O
55 CD O
% NN O
and CC O
cases NNS O
with IN O
advanced JJ O
disease NN O
at IN O
presentation NN O
have VBP O
a DT O
median JJ O
relapse NN O
- HYPH O
free JJ O
survival NN O
of IN O
only RB O
2 CD O
years NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Case NN O
presentation NN O

A DT O
27 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
woman NN B-Species
was VBD O
referred VBN O
because IN O
of IN O
a DT O
mild JJ O
left JJ O
flank NN O
pain NN O
and CC O
haematuria NN O
. . O

Ultrasonography NN O
identified VBD O
a DT O
left JJ O
renal JJ O
mass NN O
homogeneously RB O
hyperechogenic JJ O
in IN O
comparison NN O
with IN O
renal JJ O
parenchyma NN O
. . O

CT NNP O
scan NN O
showed VBD O
a DT O
11 CD O
mm CD O
x SYM O
8 CD O
mm NN O
x NN O
6 CD O
mm NN O
tumor NN O
replacing VBG O
the DT O
upper JJ O
half NN O
of IN O
the DT O
left JJ O
kidney NN O
with IN O
extension NN O
into IN O
the DT O
renal JJ O
vein NN O
. . O

Chest NN O
x NN O
- HYPH O
ray NN O
was VBD O
negative JJ O
. . O

Pathological JJ O
stage NN O
after IN O
radical JJ O
nephrectomy NN O
was VBD O
T3aN0Mx NNP O
. . O

The DT O
surgical JJ O
specimens NNS O
were VBD O
formalin NN O
- HYPH O
fixed VBN O
and CC O
paraffin NN O
embedded VBN O
. . O

The DT O
sections NNS O
were VBD O
stained VBN O
with IN O
routinary JJ O
H NNP O
& CC O
E NNP O
. . O

Immunohistochemistry NN O
was VBD O
performed VBN O
using VBG O
avidin NN O
biotin NN O
complex JJ O
technique NN O
and CC O
diaminobenzidine NN O
as IN O
chromogen NN O
. . O

The DT O
antibodies NNS O
used VBN O
included VBD O
CD99 NNP O
( , O
Dako NNP O
, , O
M3601 NNP O
) -RRB- O
, , O
pankeratin NN O
( , O
Dako NNP O
, , O
M0821 NNP O
) -RRB- O
, , O
cytokeratin NN O
AE1 NNP O
/ SYM O
AE3 NNP O
( , O
Dako NNP O
, , O
M3515 NNP O
) -RRB- O
, , O
vimentin NN O
( , O
Dako NNP O
, , O
M7010 NNP O
) -RRB- O
, , O
desmin NN O
( , O
Dako NNP O
, , O
M0760 NNP O
) -RRB- O
, , O
S100 NNP O
( , O
Dako NNP O
, , O
Z0311 NNP O
) -RRB- O
, , O
and CC O
chromogranin NN O
A NN O
( , O
Dako NNP O
, , O
M0869 NNP O
) -RRB- O
, , O
at IN O
suggested VBN O
dilution NN O
. . O

We PRP O
performed VBD O
also RB O
appropriate JJ O
routinely RB O
positive JJ O
and CC O
negative JJ O
controls NNS O
. . O

The DT O
tumor NN O
was VBD O
multilobular JJ O
, , O
grey JJ O
, , O
glistening JJ O
, , O
focally RB O
hemorrhagic JJ O
, , O
surrounded VBN O
by IN O
a DT O
capsule NN O
and CC O
with IN O
a DT O
sharp JJ O
demarcation NN O
from IN O
the DT O
uninvolved JJ O
kidney NN O
. . O

Histologically RB O
, , O
the DT O
tumor NN O
consisted VBD O
of IN O
small JJ O
round JJ O
cells NNS O
with IN O
round NN O
nuclei NNS O
and CC O
scant JJ O
cytoplasm NN O
. . O

It PRP O
presented VBD O
different JJ O
patterns NNS O
, , O
with IN O
cohesive JJ O
lobules NNS O
or CC O
rosettes NNS O
and CC O
perivascular JJ O
pseudo NN O
- HYPH O
rosettes NNS O
or CC O
, , O
in IN O
some DT O
areas NNS O
, , O
spindle JJ O
cellular JJ O
elements NNS O
( , O
fig NN O
. . O
1 CD O
) -RRB- O
. . O

The DT O
immunohistochemical JJ O
evaluation NN O
revealed VBD O
a DT O
diffuse JJ O
CD99 NN O
positivity NN O
in IN O
the DT O
cytoplasm NN O
of IN O
the DT O
neoplastic JJ O
cells NNS O
( -LRB- O
fig NN O
. . O
2 CD O
) -RRB- O
; , O
tumoral JJ O
cells NNS O
were VBD O
also RB O
visible JJ O
in IN O
the DT O
vascular JJ O
lumens NNS O
( , O
fig NN O
. . O
3 CD O
) -RRB- O
. . O

By IN O
contrast NN O
, , O
pankeratin NN O
, , O
cytokeratin NN O
AE1 NNP O
/ , O
AE3 NN O
, , O
vimentin NN O
, , O
desmin NN O
, , O
S100 NNP O
, , O
cromogranin NN O
were VBD O
negative JJ O
. . O

The DT O
clinical JJ O
presentation NN O
and CC O
the DT O
macroscopic JJ O
aspect NN O
, , O
together RB O
with IN O
the DT O
histological JJ O
pattern NN O
, , O
the DT O
cytological JJ O
characteristic NN O
and CC O
the DT O
cellular JJ O
immunophenotype NN O
addressed VBD O
the DT O
diagnosis NN O
towards IN O
primary JJ O
PNET NNP O
of IN O
kidney NN O
. . O

A DT O
bone NN O
scan NN O
did VBD O
not RB O
reveal VB O
positive JJ O
areas NNS O
. . O

Eight CD O
cycles NNS O
of IN O
chemotherapy NN O
with IN O
Vincristine NNP O
, , O
Ifosfamide NNP O
and CC O
Adriamycin NNP O
, , O
four CD O
cycles NNS O
of IN O
Ifosfamide NNP O
and CC O
VP16 NN O
and CC O
eight CD O
sittings NNS O
of IN O
local JJ O
radiotherapy NN O
were VBD O
sequentially RB O
performed VBN O
. . O

Follow VB O
- HYPH O
up NN O
examinations NNS O
with IN O
CT NN O
and CC O
bone NN O
scan NN O
failed VBD O
to TO O
show VB O
residual JJ O
or CC O
recurrent JJ O
tumor NN O
after IN O
24 CD O
months NNS O
. . O

Conclusions NNS O

Primitive JJ O
Neuroectodermal NNP O
Tumor NNP O
of IN O
the DT O
kidney NN O
is VBZ O
a DT O
rare JJ O
entity NN O
. . O

The DT O
few JJ O
cases NNS O
reported VBN O
revealed VBD O
a DT O
variable JJ O
presentation NN O
and CC O
an DT O
aggressive JJ O
behaviour NN O
. . O

The DT O
distinction NN O
from IN O
other JJ O
primary JJ O
malignancies NNS O
of IN O
the DT O
kidneys NNS O
is VBZ O
crucial JJ O
for IN O
prognosis NN O
. . O

The DT O
differential JJ O
diagnosis NN O
includes VBZ O
extra JJ O
- HYPH O
osseous JJ O
Ewing NNP O
' POS O
s NN O
sarcoma NN O
, , O
rhabdomyosarcoma NN O
, , O
Wilm NNP O
' POS O
s NN O
tumor NN O
, , O
carcinoid NN O
, , O
neuroblastoma NN O
, , O
clear JJ O
cell NN O
sarcoma NN O
of IN O
the DT O
kidney NN O
, , O
lymphoma NN O
, , O
the DT O
small JJ O
cell NN O
variant NN O
of IN O
osteosarcoma NN O
, , O
desmoplastic JJ O
small JJ O
round NN O
cell NN O
tumor NN O
and CC O
nephroblastoma NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
Homer NNP O
- HYPH O
Wright NNP O
type NN O
rosettes NNS O
, , O
commonly RB O
scarce JJ O
of IN O
number NN O
or CC O
less RBR O
defined VBN O
in IN O
extra JJ O
skeletal JJ O
Ewing NNP O
' POS O
s NN O
sarcoma NN O
( , O
ES NN O
) -RRB- O
, , O
are VBP O
a DT O
typical JJ O
histological JJ O
feature NN O
for IN O
PNET NNP O
and CC O
can MD O
address VB O
the DT O
diagnosis NN O
although IN O
they PRP O
can MD O
be VB O
found VBN O
also RB O
in IN O
neuroblastoma NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

To TO O
better RBR O
address VB O
the DT O
diagnosis NN O
, , O
an DT O
immunohistochemical JJ O
analysis NN O
is VBZ O
necessary JJ O
. . O

In IN O
our PRP$ O
case NN O
the DT O
presence NN O
of IN O
MIC NNP O
- HYPH O
2 CD O
gene NN O
products NNS O
, , O
known VBN O
also RB O
as IN O
CD99 NNP O
, , O
120000000 CD O
, , O
E2 NNP O
, , O
13 CD O
and CC O
HBA71 NNP O
, , O
suggested VBD O
a DT O
PNET NNP O
diagnosis NN O
. . O

Primitive JJ O
neuroectodermal NN O
tumors NNS O
only RB O
immunorreactive JJ O
to IN O
CD99 NNP O
, , O
even RB O
if IN O
uncommon JJ O
, , O
are VBP O
reported VBN O
in IN O
the DT O
literature NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

The DT O
reactivity NN O
to IN O
vimentin NN O
, , O
NSE NNP O
and CC O
S NNP O
- HYPH O
100 CD O
may MD O
facilitate VB O
the DT O
diagnosis NN O
but CC O
is VBZ O
not RB O
patognomonic JJ O
, , O
while IN O
CD NN O
99 CD O
positivity NN O
is VBZ O
nowadays RB O
a DT O
clue NN O
for IN O
the DT O
diagnosis NN O
. . O

Moreover RB O
cytogenetic JJ O
studies NNS O
( , O
not RB O
performed VBN O
in IN O
our PRP$ O
case NN O
) -RRB- O
demonstrated VBD O
that IN O
PNET NNP O
and CC O
Ewing NNP O
' POS O
s NNS O
sarcoma NN O
can MD O
both DT O
be VB O
associated VBN O
to IN O
a DT O
translocation NN O
of IN O
the DT O
long JJ O
arms NNS O
of IN O
chromosome NN O
11 CD O
and CC O
22 CD O
, , O
t CD O
( SYM O
11 CD O
; : O
22 CD O
) CD O
( HYPH O
q22 CD O
; : O
q12 CD O
) -RRB- O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Despite IN O
their PRP$ O
genetic JJ O
and CC O
antigenic JJ O
similarity NN O
, , O
many JJ O
authors NNS O
currently RB O
recognize VBP O
PNET NNP O
and CC O
extra JJ O
- HYPH O
skeletal JJ O
Ewing NNP O
' POS O
s JJ O
sarcoma NN O
of IN O
the DT O
kidney NN O
as IN O
separate JJ O
entities NNS O
. . O

It PRP O
is VBZ O
also RB O
important JJ O
to TO O
keep VB O
separate JJ O
renal JJ O
PNET NN O
and CC O
malignant JJ O
rhabdomyosarcoma NN O
tumor NN O
( -LRB- O
MRT NNP O
) -RRB- O
. . O

Weeks NNS O
et FW O
al NNP O
reported VBD O
8 CD O
cases NNS O
suggestive JJ O
for IN O
PNET NNP O
but CC O
mimicking VBG O
MRT NNP O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Although IN O
renal JJ O
PNET NNP O
and CC O
MRT NNP O
show VBP O
similar JJ O
clinico JJ O
- HYPH O
pathological JJ O
features NNS O
, , O
the DT O
latter JJ O
usually RB O
occurs VBZ O
in IN O
very RB O
young JJ O
children NNS O
, , O
having VBG O
a DT O
more RBR O
aggressive JJ O
prognosis NN O
. . O

Rodriguez NNP O
et FW O
al NNP O
postulated VBD O
that IN O
these DT O
two CD O
renal JJ O
neoplasms NNS O
share VBP O
a DT O
common JJ O
undifferentiated JJ O
precursor NN O
to TO O
explain VB O
their PRP$ O
similarity NN O
and CC O
we PRP O
agree VBP O
with IN O
these DT O
Authors NNPS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Indeed RB O
, , O
the DT O
hypothesis NN O
that IN O
tumors NNS O
arise VBP O
from IN O
stem NN O
cells NNS O
( -LRB- O
SCs NNP O
) -RRB- O
as IN O
a DT O
consequence NN O
of IN O
a DT O
maturative JJ O
arrest NN O
is VBZ O
now RB O
growing VBG O
[ -LRB- O
15 CD O
] -RRB- O
. . O

SCs NNS O
are VBP O
present JJ O
in IN O
almost RB O
all DT O
tissues NNS O
and CC O
may MD O
originate VB O
different JJ O
cellular JJ O
lineages NNS O
by IN O
the DT O
multi JJ O
- HYPH O
step NN O
process NN O
named VBN O
"""" `` O
differentiation NN O
"""" '' O
. . O

The DT O
role NN O
of IN O
SCs NNP O
in IN O
tumorigenesis NN O
was VBD O
clearly RB O
demonstrated VBN O
in IN O
a DT O
number NN O
of IN O
carcinogenic JJ O
models NNS O
showing VBG O
that IN O
solid JJ O
and CC O
haematopoietic JJ O
cancers NNS O
could MD O
arise VB O
from IN O
tissue NN O
- HYPH O
specific JJ O
SCs NNS O
[ -LRB- O
16 CD O
- HYPH O
19 CD O
] -RRB- O
. . O

In IN O
agreement NN O
with IN O
Sell NNP O
and CC O
Pierce NNP O
, , O
we PRP O
retain VBP O
that IN O
the DT O
degree NN O
of IN O
malignancy NN O
of IN O
a DT O
carcinoma NN O
depends VBZ O
by IN O
the DT O
stage NN O
in IN O
which WDT O
SCs NNS O
differentiation NN O
stopped VBD O
during IN O
carcinogenesis NN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

In IN O
particular JJ O
, , O
since IN O
PNET NNP O
, , O
Ewing NNP O
' POS O
s NN O
tumour NN O
and CC O
MRT NNP O
have VBP O
a DT O
similar JJ O
morphology NN O
, , O
our PRP$ O
hypothesis NN O
is VBZ O
that IN O
the DT O
mesenchimal JJ O
stem NN O
precursor NN O
of IN O
these DT O
tumors NNS O
is VBZ O
the DT O
same JJ O
, , O
but CC O
the DT O
stage NN O
of IN O
differentiation NN O
in IN O
which WDT O
it PRP O
is VBZ O
blocked VBN O
is VBZ O
different JJ O
. . O

This DT O
could MD O
explain VB O
why WRB O
sometimes RB O
it PRP O
is VBZ O
difficult JJ O
to TO O
discriminate VB O
between IN O
these DT O
tumors NNS O
, , O
notwithstanding IN O
they PRP O
present VBP O
a DT O
different JJ O
biological JJ O
behaviour NN O
. . O

Competing VBG O
interests NNS O

None NN O
declared VBD O
. . O

Authors NNS O
' POS O
contribution NN O

All DT O
authors NNS O
contributed VBD O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

The DT O
c1 CD O
genes NNS O
of IN O
P1 NNP O
and CC O
P7 NNP O
. . O

Abstract JJ O

The DT O
c1 CD O
genes NNS O
of IN O
the DT O
heteroimmune JJ O
phages NNS O
P1 NN O
and CC O
P7 NNP O
were VBD O
sequenced VBN O
and CC O
their PRP$ O
products NNS O
were VBD O
compared VBN O
. . O

P7c1 NN O
expression NN O
was VBD O
correlated VBN O
with IN O
the DT O
translation NN O
in IN O
vitro NN O
of IN O
a DT O
protein NN O
whose WP$ O
predicted VBN O
molecular JJ O
weight NN O
( , O
33 CD O
, , O
0 CD O
daltons NNS O
) -RRB- O
is VBZ O
indistinguishable JJ O
from IN O
that DT O
of IN O
the DT O
P1c1 NNP O
repressor NN O
. . O

The DT O
c1 CD O
regions NNS O
from IN O
both CC O
P1 NNP O
and CC O
P7 NNP O
were VBD O
found VBN O
to TO O
contain VB O
open JJ O
reading NN O
frames NNS O
capable JJ O
of IN O
coding VBG O
for IN O
a DT O
283 CD O
- HYPH O
amino NN O
acid NN O
protein NN O
whose WP$ O
predicted VBN O
secondary JJ O
structure NN O
lacks VBZ O
the DT O
helix NN O
- HYPH O
turn NN O
- HYPH O
helix NN O
motif NN O
commonly RB O
associated VBN O
with IN O
repressor NN O
proteins NNS O
. . O

Two CD O
P1c1 NN O
amber NN O
mutations NNS O
were VBD O
localized VBN O
to IN O
the DT O
283 CD O
- HYPH O
amino NN O
acid NN O
open JJ O
reading NN O
frame NN O
. . O

The DT O
P1c1 NNP O
and CC O
P7c1 NNP O
sequences NNS O
were VBD O
found VBN O
to TO O
differ VB O
at IN O
only RB O
18 CD O
positions NNS O
, , O
all DT O
but IN O
two CD O
of IN O
which WDT O
alter VBP O
the DT O
third JJ O
position NN O
of IN O
the DT O
affected JJ O
codon NN O
and CC O
do VBP O
not RB O
alter VB O
the DT O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
protein NN O
. . O

Plasmids NNS O
expressing VBG O
the DT O
c1 NN O
gene NN O
from IN O
either DT O
phage NN O
cause VBP O
the DT O
repression NN O
of IN O
transcription NN O
from IN O
a DT O
cloned JJ O
promoter NN O
situated VBN O
upstream RB O
of IN O
P1c1 NNP O
. . O
Images NNS O

Volme NNP O
7 CD O
Nmbe NNP O
19198 CD O
Nulei NNP O
Acds NNP O
eserc NNP O

The DT O
cl NN O
genes NNS O
of IN O
P1 NN O
and CC O
P7 NNP O

Francis NNP O
A NNP O
. . O
Osborne NNP O
, , O
Sonja NNP O
R NNP O
. . O
Stovall NNP O
and CC O
Barbara NNP O
R NNP O
. . O
Baumstark NNP O
* NFP O

Department NNP O
of IN O
Biology NNP O
, , O
Georgia NNP O
State NNP O
University NNP O
, , O
Atlanta NNP O
, , O
GA NNP O
30303 CD O
, , O
USA NNP O

Received VBN O
July NNP O
11 CD O
, , O
1989 CD O
; : O
Revised VBN O
and CC O
Accepted VBN O
August NNP O
29 CD O
, , O
1989 CD O
EMBL NNP O
accession NN O
nos FW O
X16005 CD O
, , O
X16006 CD O

ABSTRACT NNP O

The DT O
cl NN O
genes NNS O
of IN O
the DT O
heteroimmune NN O
phages NNS O
P1 NN O
and CC O
P7 NNP O
were VBD O
sequenced VBN O
and CC O
their PRP$ O
products NNS O
were VBD O
compared VBN O
. . O

P7cl NNP O
expression NN O
was VBD O
correlated VBN O
with IN O
the DT O
translation NN O
in IN O
vitro NN O
of IN O
a DT O
protein NN O
whose WP$ O
predicted VBN O
molecular JJ O
weight NN O
( , O
33 CD O
, , O
0 CD O
daltons NNS O
) -RRB- O
is VBZ O
indistinguishable JJ O
from IN O
that DT O
of IN O
the DT O
Plcl NNP O
repressor NN O
. . O

The DT O
cl NN O
regions NNS O
from IN O
both CC O
P1 NNP O
and CC O
P7 NNP O
were VBD O
found VBN O
to TO O
contain VB O
open JJ O
reading NN O
frames NNS O
capable JJ O
of IN O
coding VBG O
for IN O
a DT O
283 CD O
- HYPH O
amino NN O
acid NN O
protein NN O
whose WP$ O
predicted VBN O
secondary JJ O
structure NN O
lacks VBZ O
the DT O
helix NN O
- HYPH O
tum NN O
- HYPH O
helix NN O
motif NN O
commonly RB O
associated VBN O
with IN O
repressor NN O
proteins NNS O
. . O

Two CD O
Plcl NNP O
amber NN O
mutations NNS O
were VBD O
localized VBN O
to IN O
the DT O
283 CD O
- HYPH O
amino NN O
acid NN O
open JJ O
reading NN O
frame NN O
. . O

The DT O
Plcl NNP O
and CC O
P7cl NNP O
sequences NNS O
were VBD O
found VBN O
to TO O
differ VB O
at IN O
only RB O
18 CD O
positions NNS O
, , O
all DT O
but IN O
two CD O
of IN O
which WDT O
alter VBP O
the DT O
third JJ O
position NN O
of IN O
the DT O
affected JJ O
codon NN O
and CC O
do VBP O
not RB O
alter VB O
the DT O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
protein NN O
. . O

Plasmids NNS O
expressing VBG O
the DT O
cI NN O
gene NN O
from IN O
either DT O
phage NN O
cause VBP O
the DT O
repression NN O
of IN O
transcription NN O
from IN O
a DT O
cloned JJ O
promoter NN O
situated VBN O
upstream RB O
of IN O
Plcl NNP O
. . O

INTRODUCTION NN O

The DT O
cl NN O
genes NNS O
of IN O
the DT O
plasmid NN O
prophages NNS O
P1 NN O
and CC O
P7 NN O
code NN O
for IN O
repressor NN O
proteins NNS O
that WDT O
are VBP O
required VBN O
for IN O
the DT O
establishment NN O
and CC O
maintenance NN O
of IN O
lysogeny NN O
( , O
reviewed VBN O
in IN O
1 CD O
) -RRB- O
. . O

A DT O
protein NN O
corresponding VBG O
to IN O
the DT O
Plcl NNP O
repressor NN O
has VBZ O
been VBN O
isolated VBN O
and CC O
shown VBN O
to TO O
be VB O
a DT O
sequence NN O
- HYPH O
specific JJ O
DNA NN O
binding NN O
protein NN O
that WDT O
recognizes VBZ O
several JJ O
widely RB O
dispersed VBN O
sites NNS O
on IN O
the DT O
phage NN O
DNA NN O
( , O
2 CD O
- HYPH O
7 CD O
) -RRB- O
. . O

The DT O
consensus NN O
DNA NN O
sequence NN O
recognized VBN O
by IN O
the DT O
Plcl NNP O
repressor NN O
( , O
ATTTATTAGAGCA NNP O
[ -LRB- O
A NN O
/ SYM O
T NNP O
] -RRB- O
T NNP O
) -RRB- O
contains VBZ O
no DT O
discernable JJ O
bilateral JJ O
symmetry NN O
, , O
a DT O
feature NN O
that WDT O
is VBZ O
highly RB O
unusual JJ O
among IN O
prokaryotic JJ O
operator NN O
sites NNS O
. . O

P1 NN O
and CC O
P7 NN O
are VBP O
heteroimmune JJ O
; : O
that RB O
is RB O
, , O
each DT O
phage NN O
is VBZ O
able JJ O
to TO O
establish VB O
a DT O
lytic JJ O
infection NN O
on IN O
a DT O
lysogen NN O
of IN O
the DT O
other JJ O
phage NN O
. . O

In IN O
this DT O
sense NN O
, , O
their PRP$ O
relationship NN O
is VBZ O
analogous JJ O
to IN O
that DT O
of IN O
phage NN O
X NNP O
and CC O
434 CD O
, , O
which WDT O
differ VBP O
in IN O
the DT O
DNA NN O
specificity NN O
of IN O
their PRP$ O
cI NN O
repressor NN O
proteins NNS O
( , O
8 CD O
) -RRB- O
. . O

However RB O
, , O
genetic JJ O
studies NNS O
indicate VBP O
that IN O
Plcl NNP O
and CC O
P7cl NNP O
can MD O
be VB O
crossed VBN O
into IN O
the DT O
heterologous JJ O
phage NN O
without IN O
affecting VBG O
the DT O
immunity NN O
specificity NN O
of IN O
the DT O
recipient NN O
( : O
9 CD O
) -RRB- O
. . O

The DT O
basis NN O
for IN O
P1 NNP O
/ SYM O
P7 NN O
heteroimmunity NN O
has VBZ O
been VBN O
localized VBN O
to IN O
a DT O
second JJ O
regulatory JJ O
gene NN O
, , O
c4 NN O
, , O
that WDT O
is VBZ O
unlinked JJ O
to IN O
cl NN O
. . O

The DT O
c4 NN O
gene NN O
products NNS O
prevent VBP O
the DT O
expression NN O
of IN O
antireb NN O
, , O
a DT O
closely RB O
linked VBN O
gene NN O
that WDT O
interferes VBZ O
with IN O
cl NN O
- HYPH O
mediated VBN O
repression NN O
( , O
10 CD O
, , O
11 CD O
) -RRB- O
. . O

According VBG O
to IN O
current JJ O
models NNS O
, , O
P1 NNP O
/ SYM O
P7 NN O
heteroimmunity NN O
results VBZ O
from IN O
the DT O
inability NN O
of IN O
the DT O
c4 NN O
repressor NN O
of IN O
one CD O
phage NN O
to TO O
prevent VB O
antireb JJ O
expression NN O
from IN O
the DT O
heteroimmune NN O
phage NN O
genome NN O
( , O
10 CD O
, , O
11 CD O
) -RRB- O
. . O

Because IN O
the DT O
cl NN O
genes NNS O
of IN O
P1 NN O
and CC O
P7 NN O
are VBP O
genetically RB O
interchangeable JJ O
, , O
it PRP O
is VBZ O
anticipated VBN O
that IN O
the DT O
two CD O
gene NN O
products NNS O
carry VBP O
out RP O
similar JJ O
or CC O
identical JJ O
regulatory JJ O
functions NNS O
. . O

The DT O
studies NNS O
presented VBN O
in IN O
this DT O
paper NN O
were VBD O
undertaken VBN O
to TO O
investigate VB O
the DT O
biochemical JJ O
basis NN O
for IN O
the DT O
apparent JJ O
genetic JJ O
identity NN O
of IN O
the DT O
two CD O
cl NN O
genes NNS O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
present VBP O
the DT O
DNA NN O
sequence NN O
of IN O
the DT O
cl NN O
genes NNS O
of IN O
P1 NN O
and CC O
P7 NN O
and CC O
the DT O
predicted VBN O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
cl NN O
repressor NN O
proteins NNS O
. . O

We PRP O
report VBP O
that IN O
Plcl NNP O
and CC O
P7cl NNP O
code NN O
for IN O
proteins NNS O
of IN O
identical JJ O
size NN O
( , O
283 CD O
amino NN O
acids NNS O
) -RRB- O
and CC O

Nucleic NNP O
Acids NNP O
Research NNP O

Volume NN O
17 CD O
Number NN O
19 CD O
1989 CD O

767 CD O
1 CD O

( : O
r NN O
IRL NNP O
Press NNP O

Nucleic NNP O
Acids NNP O
Research NNP O

nearly RB O
identical JJ O
sequence NN O
. . O

We PRP O
report VBP O
further RB O
that IN O
both DT O
repressors NNS O
prevent VBP O
the DT O
expression NN O
of IN O
a DT O
promoter NN O
located VBN O
immediately RB O
upstream RB O
of IN O
the DT O
Plc NNP O
1 CD O
open JJ O
reading NN O
frame NN O
, , O
an DT O
observation NN O
that WDT O
confirms VBZ O
their PRP$ O
functional JJ O
similarity NN O
and CC O
suggests VBZ O
an DT O
autoregulatory JJ O
role NN O
for IN O
the DT O
two CD O
proteins NNS O
. . O

Analysis NN O
of IN O
the DT O
secondary JJ O
structure NN O
predicted VBN O
by IN O
the DT O
open JJ O
reading NN O
frames NNS O
does VBZ O
not RB O
reveal VB O
the DT O
characteristic JJ O
helix NN O
- HYPH O
turn NN O
- HYPH O
helix NN O
( HYPH O
12 CD O
) , O
or CC O
other JJ O
motifs NNS O
commonly RB O
associated VBN O
with IN O
DNA NN O
binding NN O
proteins NNS O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O
Bacterial JJ O
and CC O
phage NN O
strains NNS O
. . O

E NN B-Species
. . I-Species
coli NNP I-Species
K336 CD O
is VBZ O
a DT O
SuO NNP O
derivative NN O
of IN O
K140 CD O
( SYM O
13 CD O
) -RRB- O
. . O

E NN B-Species
. . I-Species
coli NNP I-Species
CB454 NNP O
is VBZ O
a DT O
recA NN O
- HYPH O
, , O
lacZderivative NN O
of IN O
K NNP O
- HYPH O
12 CD O
( SYM O
14 CD O
) -RRB- O
. . O

P1 NN O
+ CC O
is VBZ O
described VBN O
by IN O
Scott NNP O
( HYPH O
13 CD O
) -RRB- O
. . O

P7 NN O
+ CC O
is VBZ O
the DT O
strain NN O
of IN O
Smith NNP O
( SYM O
15 CD O
) -RRB- O
, , O
as IN O
described VBN O
by IN O
Scott NNP O
( SYM O
16 CD O
) -RRB- O
. . O

P7cl NNP O
. . O

1 CD O
contains VBZ O
a DT O
missense JJ O
mutation NN O
in IN O
the DT O
cl NN O
gene NN O
( SYM O
17 CD O
) -RRB- O
. . O

The DT O
P7 NNP O
phage NN O
strains NNS O
and CC O
the DT O
cl JJ O
amber NN O
mutant JJ O
phage NN O
strains VBZ O
PIci NNP O
. . O
245Cm CD O
, , O
Plc1 NNP O
. . O

169 CD O
and CC O
P NNP O
Ic NNP O
. . O
55 CD O
( SYM O
11 CD O
) -RRB- O
were VBD O
generously RB O
provided VBN O
by IN O
June NNP O
Scott NNP O
. . O

Enzymes NNS O
and CC O
reagents NNS O
. . O

Restriction NN O
enzymes NNS O
, , O
T4 NN O
DNA NN O
ligase NN O
and CC O
polymerase NN O
, , O
and CC O
the DT O
Klenow NNP O
fragment NN O
of IN O
E NNP B-Species
. . I-Species
coli NN I-Species
DNA NNP O
polymerase NN O
were VBD O
purchased VBN O
from IN O
Boehringer NNP O
Biochemicals NNP O
or CC O
New NNP O
England NNP O
Biolabs NNPS O
and CC O
reactions NNS O
were VBD O
carried VBN O
out RP O
according VBG O
to IN O
the DT O
manufacturers NNS O
' POS O
instructions NNS O
. . O

DNA NN O
sequencing NN O
kits NNS O
and CC O
in FW O
vitro FW O
transcription NN O
- HYPH O
translation NN O
kits NNS O
were VBD O
purchased VBN O
from IN O
Bethesda NNP O
Research NNP O
Laboratories NNPS O
and CC O
Amersham NNP O
Corporation NNP O
, , O
respectively RB O
. . O

Synthetic JJ O
oligonucleotides NNS O
to TO O
be VB O
used VBN O
as IN O
sequencing NN O
primers NNS O
were VBD O
prepared VBN O
on IN O
an DT O
Applied NNP O
Biosystems NNP O
DNA NNP O
synthesizer NN O
. . O

Plasmid NN O
construction NN O
. . O

pBRB7 NNP O
. . O
2 LS O
. . O

pBRB7 NNP O
. . O
2 CD O
( SYM O
2 CD O
) -RRB- O
contains VBZ O
a DT O
3 CD O
. SYM O
2 CD O
kb NN O
EcoRI NNP O
/ SYM O
PvuII NNP O
fragment NN O
from IN O
the DT O
cl NN O
region NN O
of IN O
P1 NNP O
( -LRB- O
Figure NNP O
1 CD O
) -RRB- O
inserted VBN O
into IN O
the DT O
2 CD O
. . O
3 CD O
kb NN O
EcoRIlPvuII NNP O
fragment NN O
of IN O
pBR322 NN O
that WDT O
contains VBZ O
the DT O
origin NN O
of IN O
replication NN O
and CC O
the DT O
f3 NN O
- HYPH O
lactamase NN O
gene NN O
. . O

pFA02 NN O
. . O

P7 NN O
plasmid NN O
DNA NNP O
was VBD O
digested VBN O
with IN O
PvuII NNP O
, , O
ligated VBN O
to IN O
similarly RB O
digested VBN O
pBR322 NN O
, , O
and CC O
transformed VBN O
into IN O
E NN B-Species
. . I-Species
coli NNP I-Species
K336 CD O
. . O

Ampicillin NNP O
- HYPH O
resistant JJ O
colonies NNS O
were VBD O
screened VBN O
for IN O
cl JJ O
activity NN O
by IN O
cross JJ O
- HYPH O
streak NN O
complementation NN O
analysis NN O
against IN O
P7cl NNP O
. . O
1 CD O
( SYM O
18 CD O
) -RRB- O
. . O

pFAO2 NN O
contains VBZ O
a DT O
3 CD O
. . O
5 CD O
kb NN O
insert NN O
of IN O
P7 NNP O
DNA NNP O
. . O

The DT O
fragment NN O
was VBD O
localized VBN O
to IN O
the DT O
cl JJ O
region NN O
of IN O
the DT O
P7 NN O
genome NN O
by IN O
Southern JJ O
hybridization NN O
against IN O
P1 NNP O
and CC O
P7 NNP O
DNA NNP O
that WDT O
had VBD O
been VBN O
digested VBN O
with IN O
BamHI NNP O
and CC O
BglII NNP O
( , O
data NNS O
not RB O
shown VBN O
) : O
. . O

pBRBJ69 NN O
. . O

1 CD O
and CC O
pBRB55 CD O
. . O

1 LS O
. . O

The DT O
PI NNP O
cI NNP O
open JJ O
reading NN O
frame NN O
was VBD O
previously RB O
localized VBN O
to IN O
a DT O
2 CD O
. . O
6 CD O
kb NN O
EcoRlIBamHI NNP O
fragment NN O
derived VBN O
from IN O
PlEcoRI NNP O
- HYPH O
7 CD O
( SYM O
2 CD O
) -RRB- O
. . O

This DT O
fragment NN O
also RB O
contains VBZ O
the DT O
wildtype JJ O
allele NN O
for IN O
the DT O
conditional JJ O
lethal JJ O
mutation NN O
am43 CD O
( SYM O
19 CD O
, , O
20 CD O
) -RRB- O
. . O

To TO O
clone VB O
the DT O
cl JJ O
reading NN O
frame NN O
from IN O
the DT O
amber NN O
mutant JJ O
phage NN O
Plc1 NNP O
. . O
169 CD O
and CC O
P NNP O
Ic NNP O
. . O
55 CD O
, , O
we PRP O
digested VBD O
phage NN O
DNA NNP O
with IN O
EcoRI NNP O
and CC O
BamHI NNP O
, , O
ligated VBD O
the DT O
digestion NN O
products NNS O
into IN O
similarly RB O
digested VBN O
pBR322 NN O
, , O
and CC O
transformed VBD O
the DT O
ligation NN O
mixture NN O
into IN O
E NN B-Species
. . I-Species
coli NN I-Species
K336 CD O
. . O

Ampicillin NNP O
- HYPH O
resistant JJ O
, , O
tetracyclinesensitiv JJ O
colonies NNS O
were VBD O
screened VBN O
by IN O
cross JJ O
- HYPH O
streak NN O
complementation NN O
analysis NN O
for IN O
their PRP$ O
ability NN O
to TO O
support VB O
the DT O
growth NN O
of IN O
Plam43 NNP O
. . O

Plasmid NN O
DNA NN O
isolated VBN O
from IN O
complementation NN O
- HYPH O
positive JJ O
cells NNS O
was VBD O
shown VBN O
by IN O
agarose NN O
gel NN O
electrophoresis NN O
to TO O
carry VB O
plasmids NNS O
containing VBG O
the DT O
2 CD O
. . O
6 CD O
kb NN O
EcoRIlBamHI NNP O
fragment NN O
from IN O
the DT O
cl JJ O
region NN O
. . O

The DT O
cl NN O
mutant JJ O
open JJ O
reading NN O
frames NNS O
were VBD O
placed VBN O
under IN O
the DT O
control NN O
of IN O
normal JJ O
regulatory JJ O
signals NNS O
present JJ O
in IN O
the DT O
cI NNP O
region NN O
by IN O
digesting VBG O
the DT O
cl NN O
. . O
55 CD O
and CC O
cl NN O
. . O

169 CD O
- HYPH O
containing VBG O
plasmids NNS O
with IN O
BamHI NNP O
and CC O
PvuII NNP O
and CC O
inserting VBG O
a DT O
601 CD O
bp NN O
BamHI NNP O
/ SYM O
PvuH NNP O
fragment NN O
containing VBG O
the DT O
cl NN O
promoter NN O
region NN O
( , O
2 CD O
) -RRB- O
. . O

The DT O
resulting VBG O
plasmids NNS O
, , O
pBRB55 NN O
. . O
1 CD O
and CC O
pBRB169 CD O
. . O
1 CD O
, , O
respectively RB O
, , O
contain VBP O
the DT O
3 CD O
. . O
2 CD O
kb NN O
EcoRllPvuIl NN O
fragment NN O
analogous JJ O
to IN O
that DT O
present JJ O
in IN O
pBRB7 NN O
. . O
2 CD O
( : O
Figure NN O
1 CD O
) -RRB- O
. . O

pBCB2 NNP O
. . O

13 CD O
- SYM O
2 CD O
. . O
18 CD O
. . O

To TO O
identify VB O
cl NN O
- HYPH O
repressible JJ O
promoters NNS O
, , O
we PRP O
introduced VBD O
selected VBN O
fragments NNS O

7672 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

4 CD O
f SYM O
- : O
- : O
+ NFP O

I PRP O
4 CD O
P1 NN O
4 CD O
- HYPH O
4 CD O
- SYM O
4 CD O

ECAR NN O
H NN O
C NN O
B NN O
R NN O
P NN O

4 CD O
4 CD O
. . O
4 CD O
, , O
~ SYM O
4 CD O
, , O
1 CD O
1 CD O
4 CD O
. . O

I PRP O
4 CD O
, , O
I PRP O
11 CD O

t LS O
t NN O
t NN O
t NN O
t NN O
E NN O
G NN O
R NN O
N NN O
E NN O
B NN O
R NN O
P NN O

4 CD O
4 CD O
- SYM O

4 LS O

1 CD O
' '' O
' '' O
110z CD O
I NN O
I PRP O
I PRP O
I PRP O
I PRP O
I PRP O
1 CD O

3 CD O
. . O
2 CD O
1 CD O
. . O
5 CD O
1 CD O
. . O
0 CD O
0 CD O
. . O
5 CD O
0 CD O

P7 NN O

pBRB7 NNP O
. . O
2 NFP O

- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- : O
- HYPH O
cl1 NNP O
- HYPH O
- : O
- : O
- : O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O
- NFP O

r NFP O
~ NFP O
/ NFP O
> NFP O
' '' O
pFAO2 NN O

* NFP O
- : O
lacZ NN O
pBCB2 ADD O
. . O
13 CD O

< NFP O
- : O
lacZ NN O
Z NN O
pBCB2 NN O
. . O
16 CD O
< SYM O
- HYPH O
lacZX NN O
pBCB2 NN O
. . O
18 CD O

Fig NN O
. . O

1 LS O
. . O

The DT O
cl JJ O
regions NNS O
of IN O
P1 NNP O
and CC O
P7 NNP O
. . O

A DT O
restriction NN O
map NN O
is VBZ O
indicated VBN O
by IN O
the DT O
solid JJ O
line NN O
in IN O
the DT O
upper JJ O
part NN O
of IN O
the DT O
figure NN O
. . O

Sites NNS O
for IN O
EcoRI NNP O
( -LRB- O
E NNP O
) -RRB- O
, , O
Pvul NNP O
( , O
P NNP O
) -RRB- O
, , O
NnrI NNP O
( -LRB- O
N NNP O
) -RRB- O
, , O
Bgll NNP O
( , O
G NNP O
) -RRB- O
, , O
BamHI NNP O
( , O
B NNP O
) -RRB- O
, , O
and CC O
EcoRV NNP O
( , O
R NNP O
) -RRB- O
are VBP O
shown VBN O
. . O

The DT O
sequencing NN O
strategy NN O
is VBZ O
indicated VBN O
by IN O
the DT O
horizontal JJ O
arrows NNS O
. . O

Letters NNS O
and CC O
arrows NNS O
above IN O
and CC O
below IN O
the DT O
map NN O
refer VBP O
to IN O
sites NNS O
and CC O
sequence NN O
analysis NN O
for IN O
P1 NNP O
and CC O
P7 NNP O
, , O
respectively RB O
. . O

The DT O
size NN O
of IN O
this DT O
region NN O
( , O
in IN O
kilobase NN O
pairs NNS O
) -RRB- O
is VBZ O
indicated VBN O
below IN O
the DT O
map NN O
. . O

The DT O
DNA NN O
fragments NNS O
present JJ O
in IN O
selected VBN O
plasmids NNS O
are VBP O
illustrated VBN O
by IN O
boxes NNS O
at IN O
the DT O
bottom NN O
of IN O
the DT O
figure NN O
. . O

The DT O
dashed VBN O
line NN O
reveals VBZ O
the DT O
approximate JJ O
position NN O
of IN O
the DT O
cl NN O
gene NN O
( -LRB- O
2 CD O
) -RRB- O
. . O

The DT O
sites NNS O
of IN O
the DT O
- HYPH O
yb NN O
mutations NNS O
introduced VBN O
into IN O
pFA02 NN O
are VBP O
indicated VBN O
by IN O
asterisks NNS O
. . O

pFA02 NN O
. . O
16 CD O
and CC O
pFA02 CD O
. . O
26 CD O
contain VB O
insertions NNS O
located VBN O
0 CD O
. . O
9 CD O
kb NN O
and CC O
1 CD O
. . O
4 CD O
kb NN O
, , O
respectively RB O
, , O
from IN O
the DT O
PvuIl NNP O
site NN O
at IN O
the DT O
left JJ O
side NN O
of IN O
the DT O
map NN O
. . O

The DT O
direction NN O
of IN O
the DT O
lacZ NN O
open JJ O
reading NN O
frame NN O
in IN O
pBCB2 NN O
. . O
13 CD O
- HYPH O
18 CD O
is VBZ O
indicated VBN O
by IN O
the DT O
adjacent JJ O
arrow NN O
. . O

from IN O
the DT O
cI NNP O
region NN O
of IN O
P1 NNP O
into IN O
pCB192 CD O
, , O
a DT O
promoter NN O
- HYPH O
probe NN O
vector NN O
containing VBG O
promoterless JJ O
copies NNS O
of IN O
lacZ NN O
and CC O
galK NN O
extending VBG O
in IN O
opposite JJ O
directions NNS O
from IN O
a DT O
multiple JJ O
cloning NN O
site NN O
( SYM O
21 CD O
) -RRB- O
. . O

The DT O
source NN O
of IN O
P1 NNP O
DNA NNP O
for IN O
these DT O
constructions NNS O
was VBD O
pZHA3 NNP O
, , O
a DT O
derivative NN O
of IN O
pBRB7 NNP O
. , O
2 CD O
that WDT O
contains VBZ O
a DT O
HindIlI NNP O
linker NN O
at IN O
the DT O
single JJ O
EcoRV NNP O
site NN O
located VBN O
about RB O
200 CD O
bps NNS O
upstream RB O
of IN O
the DT O
cl JJ O
open JJ O
reading NN O
frame NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

pBCB2 NNP O
. . O
13 CD O
contains VBZ O
a DT O
460 CD O
bp NN O
fragment NN O
of IN O
P1 NNP O
DNA NNP O
extending VBG O
from IN O
the DT O
EcoRV NNP O
site NN O
to IN O
a DT O
Bgll NNP O
site NN O
within IN O
the DT O
cI NNP O
open JJ O
reading NN O
frame NN O
. . O

pBCB2 NNP O
. . O

16 CD O
contains VBZ O
a DT O
130 CD O
bp NN O
fragment NN O
extending VBG O
from IN O
the DT O
EcoRV NNP O
site NN O
to IN O
a DT O
BamHI NNP O
site NN O
located VBN O
about RB O
100 CD O
bps NNS O
upstream RB O
of IN O
the DT O
cl JJ O
open JJ O
reading NN O
frame NN O
, , O
while IN O
pBCB2 NNP O
. . O
18 CD O
contains VBZ O
the DT O
region NN O
extending VBG O
from IN O
this DT O
BamHI NNP O
site NN O
to IN O
the DT O
Bglll NNP O
site NN O
within IN O
the DT O
open JJ O
reading NN O
frame NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
orientation NN O
of IN O
the DT O
P1 NNP O
DNA NNP O
fragments NNS O
within IN O
these DT O
plasmids NNS O
was VBD O
confirmed VBN O
by IN O
restriction NN O
mapping NN O
and CC O
DNA NN O
sequencing NN O
. . O

To TO O
test VB O
for IN O
the DT O
regulation NN O
of IN O
promoter NN O
expression NN O
by IN O
cl NN O
, , O
we PRP O
transformed VBD O
pBCB2 NNP O
. . O
13 CD O
and CC O
its PRP$ O
derivatives NNS O
into IN O
CB454 NNP O
( -LRB- O
pBRB7 NNP O
. . O
152 CD O
) -RRB- O
and CC O
CB454 CD O
( : O
pFAO2 NNP O
. . O
152 CD O
) -RRB- O
, , O
two CD O
strains NNS O
that WDT O
express VBP O
P7cl NNP O
and CC O
Pll NNP O
, , O
respectively RB O
, , O
from IN O
the DT O
pCB192 NNP O
- HYPH O
compatible JJ O
kanamycin NN O
- HYPH O
resistant JJ O
vector NN O
pDPT152 CD O
( SYM O
22 CD O
) -RRB- O
. . O

Cells NNS O
harboring VBG O
both DT O
plasmids NNS O
were VBD O
selected VBN O
by IN O
their PRP$ O
resistance NN O
to IN O
both CC O
ampicillin NN O
and CC O
kanamycin NN O
. . O

lacZ NN O
expression NN O
was VBD O
measured VBN O
by IN O
the DT O
procedure NN O
of IN O
Miller NNP O
( : O
23 CD O
) -RRB- O
. . O

pBRB7 NNP O
. . O
152 CD O
was VBD O
generated VBN O
by IN O
introducing VBG O
PlEcoRI NNP O
- HYPH O
7 CD O
into IN O
pDPT152 CD O
. . O

pBRB7 NNP O
. . O
152 CD O
has VBZ O
sustained VBN O
a DT O
spontaneous JJ O
deletion NN O
within IN O
the DT O
EcoRI NNP O
- HYPH O
7 CD O
fragment NN O
that WDT O
results VBZ O
in IN O
the DT O
loss NN O
of IN O
2 CD O
. , O
5 CD O
kb NN O
of IN O
P1 NN O
DNA NN O
from IN O
the DT O
far JJ O
left JJ O
side NN O
of IN O
the DT O
P1 NN O
genetic JJ O
map NN O
, , O
but CC O
retains VBZ O
the DT O
3 CD O
. . O
2 CD O
kb NN O
PvuHlEcoRI NNP O
fragment NN O
required VBN O
for IN O
cl NN O
expression NN O
that WDT O
is VBZ O
present JJ O
in IN O
pBRB7 NN O
. . O
2 CD O
( SYM O
Figure NN O
1 CD O
) -RRB- O
. . O

7673 CD O

z LS O

I PRP O
011Z CD O
I PRP O

e UH O
. . O
, , O

Nucleic NNP O
Acids NNP O
Research NNP O

Table NN O
1 CD O
. . O

Complementation NN O
of IN O
PIci NNP O
. . O
245 CD O
by IN O
plasmids NNS O
that WDT O
contain VBP O
cI NN O
genes NNS O
. . O

Phenotype NN O
Efficiency NN O
Relative NN O

of IN O
of IN O
Efficiency NN O
of IN O
Plasmid NN O
cI NN O
gene NN O
Lysogeny NN O
Lysogeny NN O
pBR322 CD O
1 CD O
. . O
5x CD O
10 CD O
- SYM O
6 CD O
6 CD O
. . O
0x CD O
10 CD O
- SYM O
6 CD O
pBRB7 CD O
. . O
2 CD O
Plcl NN O
+ SYM O
2 CD O
. . O
5 CD O
x SYM O
10 CD O
- SYM O
' : O
1 CD O
. . O
0 NFP O

pBRB55 CD O
. . O
1 CD O
Plcl NN O
- HYPH O
am NN O
1 CD O
. . O
4 CD O
x SYM O
10 CD O
- SYM O
6 CD O
5 CD O
. . O
6 CD O
x SYM O
10 CD O
- HYPH O
6 CD O
pBRB169 CD O
. . O
1 CD O
PlCl NN O
- HYPH O
am NN O
2 CD O
. . O
1 CD O
x SYM O
10 CD O
- HYPH O
6 CD O
8 CD O
. . O
4 CD O
x SYM O
10 CD O
- HYPH O
6 CD O
pFAO2 NN O
P7cl NN O
+ SYM O
8 CD O
. . O
7 CD O
x SYM O
10 CD O
- SYM O
2 CD O
0 CD O
. . O
35 CD O

pFAO2 NN O
. . O
16 CD O
P7c NN O
I CD O
- HYPH O
, , O
4 CD O
. . O
7 CD O
x SYM O
10 CD O
- SYM O
6 CD O
1 CD O
. . O
9 CD O
X SYM O
10 CD O
- SYM O
5 CD O
pFAO2 NN O
. . O
26 CD O
P7cI CD O
- HYPH O
1 CD O
3 CD O
. . O
1 CD O
x SYM O
10 CD O
- SYM O
6 CD O
1 CD O
. . O
2 CD O
x SYM O
10 CD O
- SYM O
5 CD O

Complementation NN O
for IN O
lysogeny NN O
was VBD O
carried VBN O
out RP O
as IN O
described VBN O
by IN O
Devlin NNP O
et FW O
al NNP O
. . O

( SYM O
26 CD O
) -RRB- O
. . O

The DT O
plasmids NNS O
were VBD O
carried VBN O
by IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
K336 CD O
. . O

Cells NNS O
were VBD O
grown VBN O
to IN O
mid JJ O
- HYPH O
log NN O
phase NN O
at IN O
370 CD O
in IN O
LB NN O
containing VBG O
50 CD O
tig NN O
/ SYM O
m1 NN O
sodium NN O
ampicillin NN O
and CC O
infected VBN O
with IN O
Plcl NNP O
. . O
245 CD O
at IN O
a DT O
multiplicity NN O
of IN O
infection NN O
of IN O
5 CD O
in IN O
the DT O
presence NN O
of IN O
50 CD O
mM NN O
CaC12 NN O
. . O

After IN O
10 CD O
minutes NNS O
, , O
non RB O
- HYPH O
absorbed VBN O
phage NN O
were VBD O
removed VBN O
by IN O
centrifugation NN O
and CC O
the DT O
infection NN O
was VBD O
allowed VBN O
to TO O
proceed VB O
for IN O
2 CD O
hours NNS O
at IN O
370 CD O
. . O

The DT O
infected JJ O
cells NNS O
were VBD O
plated VBN O
on IN O
LB NNP O
plates NNS O
containing VBG O
50 CD O
pLg NN O
/ SYM O
ml NN O
sodium NN O
ampicillin NN O
, , O
50 CD O
pLg NN O
/ SYM O
ml NN O
chloramphenicol NN O
, , O
and CC O
40 CD O
mM NN O
sodium NN O
citrate NN O
. . O

The DT O
efficiency NN O
of IN O
lysogeny NN O
is VBZ O
defined VBN O
as IN O
the DT O
number NN O
of IN O
ApRCmR NNP O
cells NNS O
at IN O
the DT O
end NN O
of IN O
infection NN O
divided VBN O
by IN O
the DT O
number NN O
of IN O
ApR NNP O
cells NNS O
present JJ O
at IN O
the DT O
start NN O
of IN O
the DT O
infection NN O
. . O

To TO O
construct VB O
pFA02 NN O
. . O
152 CD O
, , O
we PRP O
introduced VBD O
a DT O
2 CD O
. . O
8 CD O
kb NN O
EcoRV NNP O
fragment NN O
of IN O
P7 NN O
DNA NNP O
containing VBG O
the DT O
cl NN O
gene NN O
( -LRB- O
Figure NNP O
1 CD O
) -RRB- O
into IN O
the DT O
single JJ O
EcoRI NNP O
site NN O
of IN O
pDPT152 NN O
after IN O
it PRP O
had VBD O
been VBN O
rendered VBN O
blunt JJ O
- HYPH O
ended VBN O
by IN O
extension NN O
with IN O
T4 NNP O
DNA NNP O
polymerase NN O
. . O

cl NN O
expression NN O
by IN O
cells NNS O
harboring VBG O
either CC O
pBRB7 NNP O
. . O
152 CD O
or CC O
pFA02 NN O
. . O
152 CD O
was VBD O
confirmed VBN O
by IN O
measuring VBG O
their PRP$ O
ability NN O
to TO O
form VB O
chloramphenicol NN O
- HYPH O
resistant JJ O
lysogens NNS O
when WRB O
infected VBN O
with IN O
Plcl NNP O
. . O
245Cm CD O
. . O

, , O
yb `` O
insertional JJ O
mutagenesis NN O
. . O

Insertional JJ O
mutagenesis NN O
of IN O
P7cl NNP O
was VBD O
carried VBN O
out RP O
using VBG O
the DT O
' `` O
yb JJ O
transposon NN O
of IN O
F NNP O
( SYM O
24 CD O
) -RRB- O
as IN O
described VBN O
by IN O
Devlin NNP O
et FW O
al NNP O
. . O

( SYM O
25 CD O
) -RRB- O
. . O

E NN B-Species
. . I-Species
coli NNP I-Species
W1485 CD O
( , O
pFA02 CD O
) -RRB- O
was VBD O
mated VBN O
with IN O
the DT O
F NNP O
- HYPH O
strain NN O
MX648 NN O
and CC O
subsequently RB O
plated VBN O
on IN O
ampicillin NN O
( , O
to TO O
select VB O
for IN O
the DT O
plasmid NN O
) , O
and CC O
streptomycin NN O
sulfate NN O
( , O
to TO O
select VB O
for IN O
the DT O
recipient JJ O
strain NN O
) -RRB- O
. . O

Transconjugants NNS O
which WDT O
could MD O
support VB O
only RB O
lytic JJ O
growth NN O
upon IN O
infection NN O
by IN O
P7cl NNP O
. . O
1 CD O
( , O
as IN O
scored VBN O
by IN O
cross JJ O
- HYPH O
streak NN O
analysis NN O
; : O
18 CD O
) -RRB- O
were VBD O
assumed VBN O
to TO O
have VB O
lost VBN O
cl NN O
- HYPH O
complementing VBG O
activity NN O
and CC O
were VBD O
characterized VBN O
further RB O
. . O

The DT O
positions NNS O
of IN O
two CD O
cl NN O
- HYPH O
insertional JJ O
mutations NNS O
, , O
carried VBN O
by IN O
pFA02 NN O
. . O
16 CD O
and CC O
pFA02 CD O
. . O
26 CD O
, , O
were VBD O
identified VBN O
by IN O
restriction NN O
mapping NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

DNA NN O
sequencing NN O
. . O

DNA NN O
sequence NN O
analysis NN O
was VBD O
carried VBN O
out RP O
using VBG O
the DT O
M13 NNP O
- HYPH O
dideoxy NN O
technique NN O
of IN O
Sanger NNP O
et FW O
al NNP O
. . O

( SYM O
26 CD O
) -RRB- O
. . O

Selected VBN O
DNA NN O
fragments NNS O
containing VBG O
the DT O
cl JJ O
wildtype NN O
or CC O
mutant JJ O
genes NNS O
were VBD O
introduced VBN O
into IN O
M13 NNP O
mp8 NNP O
or CC O
mp9 CD O
. . O

18 CD O
- HYPH O
nucleotide NN O
oligomers NNS O
complementary JJ O
to IN O
defined VBN O
sequences NNS O
within IN O
the DT O
cl NN O
gene NN O
were VBD O
extended VBN O
using VBG O
the DT O
Klenow NNP O
fragment NN O
of IN O
DNA NNP O
polymerase NN O
in IN O
the DT O
presence NN O
of IN O
dideoxynucleotide NN O
triphosphates NNS O
and CC O
analyzed VBN O
by IN O
polyacrylamide NN O
- HYPH O
urea NN O
gel NN O
electrophoresis NN O
. . O

The DT O
sequencing NN O
strategy NN O
is VBZ O
shown VBN O
in IN O
Figure NNP O
1 CD O
. . O

RESULTS NNS O

Localization NN O
of IN O
the DT O
P7cJ NNP O
gene NN O
. . O

Initial JJ O
localization NN O
of IN O
the DT O
P7cl NNP O
gene NN O
was VBD O
undertaken VBN O
by IN O
subjecting VBG O
pFA02 NN O
to IN O
' `` O
yb NN O
mutagenesis NN O
and CC O
determining VBG O
the DT O
map NN O
position NN O
of IN O
inserts NNS O
which WDT O
destroy VBP O
the DT O
ability NN O
of IN O
the DT O
plasmids NNS O
to TO O
complement VB O
a DT O
P7cl NNP O
- HYPH O
mutation NN O
( , O
as IN O
determined VBN O
by IN O
cross JJ O
- HYPH O
streak NN O
analysis NN O
) -RRB- O
. . O

pFA02 NN O
and CC O
the DT O
- HYPH O
yb NN O
insertion NN O
mutants NNS O
were VBD O
tested VBN O
further RBR O
by IN O
comparing VBG O
their PRP$ O
ability NN O
to TO O
complement VB O
a DT O
PIcI NNP O
amber NN O
mutation NN O
with IN O
the DT O
complementation NN O
activity NN O
of IN O
plasmids NNS O
containing VBG O
cl NN O
genes NNS O
isolated VBN O

7674 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

B NN O
C NN O
D NN O
E NN O
F NN O
G NN O

* NFP O
. . O
4 NFP O

68 CD O

43 CD O

29 CD O
- : O
_ NFP O
- : O
= : O
I PRP O
= NFP O
Am VBP O
~ NFP O
W NN O
_ : O

18 CD O

14 CD O
p NN O

Fig NN O
. . O

2 LS O
. . O

In IN O
vitro FW O
transcription NN O
- HYPH O
translation NN O
of IN O
plasmids NNS O
carrying VBG O
the DT O
cl JJ O
region NN O
of IN O
P1 NNP O
and CC O
P7 NNP O
. . O

Proteins NNS O
encoded VBN O
by IN O
selected VBN O
plasmids NNS O
were VBD O
labeled VBN O
with IN O
35S NNP O
methionine NN O
according VBG O
to IN O
the DT O
procedure NN O
of IN O
DeVries NNP O
and CC O
Zubay NNP O
( HYPH O
27 CD O
) -RRB- O
, , O
using VBG O
a DT O
commercial JJ O
in FW O
vitro FW O
transcription NN O
/ SYM O
tramnslation NN O
kit NN O
from IN O
Amersham NNP O
Corporation NNP O
. . O

The DT O
reaction NN O
mixtures NNS O
were VBD O
subjected VBN O
to IN O
electrophoresis NN O
on IN O
a DT O
12 CD O
. . O
5 CD O
% NN O
SDS NN O
- HYPH O
polyacrylamide NN O
gel NN O
and CC O
the DT O
labeled VBN O
proteins NNS O
were VBD O
visualized VBN O
by IN O
autoradiography NN O
. . O

The DT O
migration NN O
of IN O
14C CD O
- HYPH O
labeled VBN O
protein NN O
molecular JJ O
weight NN O
standards NNS O
( , O
Bethesda NNP O
Research NNP O
Laboratories NNPS O
) -RRB- O
is VBZ O
indicated VBN O
at IN O
the DT O
left JJ O
side NN O
of IN O
the DT O
figure NN O
. . O

Plasmids NNS O
present JJ O
in IN O
each DT O
lane NN O
are VBP O
: : O
A DT O
. . O

pBRB55 CD O
. . O
1 CD O
; : O
B NN O
. . O

pBRB169 CD O
. . O
1 CD O
; : O
C NN O
. . O

pBRB7 NNP O
. . O
2 CD O
; : O
D NN O
. . O

pFAO2 NN O
; : O
E NN O
. . O

pFAO2 NN O
. . O
16 CD O
; : O
F NNP O
. . O

pFAO2 NN O
. . O
26 CD O
; : O
G NNP O
. . O

pBR322 CD O
. . O

from IN O
P1 NN O
wildtype NN O
and CC O
amber NN O
mutants NNS O
. . O

Lysogeny NNP O
by IN O
cells NNS O
infected VBN O
with IN O
Plcl NNP O
. . O
245Cm CD O
was VBD O
scored VBN O
as IN O
the DT O
growth NN O
of IN O
infected JJ O
cells NNS O
on IN O
ampicillin NN O
( , O
to TO O
select VB O
for IN O
the DT O
resident JJ O
plasmid NN O
) , O
and CC O
chloramphenicol NN O
( , O
to TO O
select VB O
for IN O
the DT O
phage NN O
genome NN O
) -RRB- O
. . O

The DT O
values NNS O
observed VBN O
for IN O
the DT O
two CD O
plasmids NNS O
containing VBG O
Plcl NNP O
and CC O
P7cl NNP O
( , O
pBRB7 NNP O
. . O
2 CD O
and CC O
pFA02 NN O
, , O
respectively RB O
) -RRB- O
are VBP O
very RB O
similar JJ O
and CC O
significantly RB O
higher JJR O
than IN O
those DT O
obtained VBN O
for IN O
pBR322 CD O
or CC O
for IN O
any DT O
of IN O
the DT O
plasmids NNS O
carrying VBG O

Table NN O
2 CD O
. . O

Assay NN O
for IN O
lacZ NN O
expression NN O
from IN O
plasmids NNS O
containing VBG O
P1 NNP O
DNA NNP O
fragments NNS O
. . O

, , O
3 CD O
- HYPH O
galactosidase NN O
activity NN O
( : O
units NNS O
) -RRB- O

minus CC O
cI NN O
plus CC O
Pici NNP O
plus CC O
P7cl NNP O
relative JJ O
activity NN O

( -LRB- O
pDPT152 NN O
) -RRB- O
( : O
pBB7 NN O
. . O
152 CD O
) -RRB- O
( : O
pFA02 NN O
. . O
152 CD O
) NFP O
+ SYM O
PICJ NN O
+ SYM O
P7cJ NN O

pCB192 NN O
0 CD O
. . O
58 CD O
0 CD O
. . O
55 CD O
0 CD O
. . O
54 CD O
0 CD O
. . O
95 CD O
0 CD O
. . O
93 CD O
pBCB2 CD O
. . O
13 CD O
154 CD O
15 CD O
. . O
2 CD O
13 CD O
. . O
6 CD O
0 CD O
. . O
10 CD O
0 CD O
. . O
9 CD O
pBCB2 CD O
. . O
16 CD O
1 CD O
. . O
1 CD O
1 CD O
. . O
2 CD O
1 CD O
. . O
1 CD O
1 CD O
. . O
1 CD O
1 CD O
. . O
0 CD O
pBCB2 CD O
. . O
18 CD O
4 CD O
. . O
0 CD O
3 CD O
. . O
4 CD O
3 CD O
. . O
9 CD O
0 CD O
. . O
9 CD O
1 CD O
. . O
0 NFP O

Cells NNS O
containing VBG O
derivatives NNS O
of IN O
the DT O
ApR NNP O
promoter NN O
- HYPH O
probe NN O
plasmid NN O
pCB192 NN O
and CC O
the DT O
compatible JJ O
KnR NNP O
plasmid NN O
pDPT152 CD O
were VBD O
grown VBN O
in IN O
LB NNP O
at IN O
37 CD O
? . O
. . O

When WRB O
they PRP O
reached VBD O
mid JJ O
- HYPH O
log NN O
phase NN O
, , O
the DT O
cells NNS O
were VBD O
chilled VBN O
, , O
lysed VBN O
, , O
and CC O
assayed VBN O
for IN O
( , O
3 CD O
- HYPH O
galactosidase NN O
activity NN O
according VBG O
to IN O
the DT O
procedure NN O
of IN O
Miller NNP O
( SYM O
23 CD O
) -RRB- O
. . O

Plasmids NNS O
derived VBN O
from IN O
pCB192 NN O
are VBP O
indicated VBN O
at IN O
the DT O
left JJ O
side NN O
of IN O
the DT O
Table NNP O
. . O

Plasmids NNS O
derived VBD O
from IN O
pDPT152 NN O
are VBP O
indicated VBN O
in IN O
parentheses NNS O
across IN O
the DT O
top NN O
of IN O
the DT O
Table NNP O
. . O

The DT O
values NNS O
reported VBN O
are VBP O
the DT O
average NN O
of IN O
two CD O
independent JJ O
experiments NNS O
. . O

Relative JJ O
activity NN O
is VBZ O
defined VBN O
as IN O
the DT O
f3 NN O
- HYPH O
galactosidase NN O
activity NN O
measured VBN O
in IN O
cells NNS O
harboring VBG O
plasmids NNS O
expressing VBG O
cl NN O
divided VBN O
by IN O
the DT O
activity NN O
measured VBN O
in IN O
cells NNS O
carrying VBG O
only RB O
pDPT152 CD O
. . O

7675 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

GATATCCAATCAGGAGTACC NNP O
GCATCACCCAAGACGACCTG NNP O
GATGATCTCACTGACACAAT NNP O
CGAATATCTCATGGCCACTA NNP O
ACCAGCCAGACTCACAATAA NNP O
105 CD O
v : O
- : O
- : O

TtgAca NNP O
TATAATG NNP O

CTAATAAATCTATTATTTTC NNP O
GTTGGATCCTTCTATAATGG NNP O
TGGCCAACAACTCCCAGTGT NNP O
AATCCGCTGTGAGTTGTTGG NNP O
CCATGTCAATTCTGGAGGAG NNP O
210 CD O

b LS O
- : O
- : O
- : O
- : O
- : O
I PRP O
I PRP O
GGAGGtG NNP O

ATG NN O
ATA NNP O
AAT NNP O
TAT NNP O
GTC NNP O
TAC NNP O
GGC NNP O
GAA NNP O
CAA NNP O
CTG NNP O
TAC NNP O
CAG NNP O
GAG NNP O
TTC NNP O
GTC NNP O
AGC NNP O
TTC NNP O
AGG NNP O
GAT NNP O
CTC NNP O
TTT NNP O
CTA NNP O
AAA NNP O
AAA NNP O
GCT NNP O
GTT NNP O
GCA NNP O
CGC NNP O
GCC NNP O
CAA NNP O
300 CD O
MET NN O
lIe NN O
Asn NN O
Tyr NN O
Vat NNP O
Tyr NNP O
Gly NNP O
Glu NNP O
Gin NNP O
Leu NNP O
Tyr NNP O
Gin NNP O
Gtu NNP O
Phe NNP O
Vat NNP O
Ser NNP O
Phe NN O
Arg NN O
Asp NN O
Leu NNP O
Phe NNP O
Leu NNP O
Lys NNP O
Lys NNP O
Ala NNP O
Val NNP O
Ala NNP O
Arg NNP O
Ala NNP O
Gtn NNP O

tag NN O
( : O
cl NN O
. . O
55 CD O
) NFP O

CAC NNP O
GTT NNP O
GAT NNP O
GCC NNP O
GCC NN O
AGC NN O
GAC NN O
GGT NN O
CGT NN O
CCT NN O
GTT NN O
CGC NN O
CCG NN O
GTT NNP O
GTC NNP O
GTT NNP O
CTG NN O
CCG NN O
TTC NN O
AM NN O
GM NN O
ACG NN O
GAC NNP O
AGC NNP O
ATT NNP O
CAG NNP O
GCT NNP O
GMA NNP O
ATT NNP O
GAT NNP O
390 CD O
His PRP$ O
Val NN O
Asp NN O
Ala NN O
Ala NN O
Ser NN O
Asp NN O
Gly JJ O
Arg NN O
Pro NN O
Vat NN O
Arg NN O
Pro NN O
Vat NN O
Vat NNP O
Vat NNP O
Leu NNP O
Pro NNP O
Phe NNP O
Lys NNP O
Glu NNP O
Thr NN O
Asp NN O
Ser NN O
lIe NN O
Gin NNP O
Ala NNP O
Glu NNP O
lie NN O
Asp NN O

T NN O
A NN O
C NN O
A NN O
G NN O

AAA NN O
TGG NN O
ACA NN O
TTA NNP O
ATG NNP O
GCG NNP O
CGG NNP O
GAA NNP O
CTG NNP O
GAG NNP O
CAG NNP O
TAC NNP O
CCA NNP O
GAT NNP O
CTC NNP O
MT NNP O
ATC NNP O
CCA NNP O
MG NNP O
ACT NN O
ATT NNP O
TTA NNP O
TAT NNP O
CCT NNP O
GTA NNP O
CCT NNP O
AAC NNP O
ATC NNP O
CTT NNP O
CGC NNP O
480 CD O

9 CD O

Lys NN O
Trp NN O
Thr NN O
Leu NNP O
MET NNP O
Ala NNP O
Arg NNP O
Glu NNP O
Leu NNP O
Gtu NNP O
Gin NNP O
Tyr NNP O
Pro NNP O
Asp NN O
Leu NNP O
Asn NNP O
lIe FW O
Pro FW O
Lys NN O
Thr NN O
lie NNP O
Leu NNP O
Tyr NNP O
Pro NNP O
Vat NNP O
Pro NNP O
Asn NNP O
lIe NNP O
Leu NNP O
Arg NNP O

A DT O
T NN O
C NN O

GGT NN O
GTG NN O
CGT NN O
AAG NN O
GTT NN O
ACG NN O
ACT NN O
TAT NN O
CAG NN O
ACA NN O
GAA NNP O
GCA NNP O
GTG NNP O
MC NNP O
AGC NN O
GTC NN O
AAT NN O
ATG NN O
ACC NN O
GCT NN O
GGC NN O
CGC NN O
ATT NN O
ATT NNP O
CAT NNP O
CTG NNP O
ATT NNP O
GAT NNP O
AAG NNP O
GAC NNP O
570 CD O
Gly JJ O
Vat NN O
Arg NN O
Lys NN O
Vat NN O
Thr NN O
Thr NN O
Tyr NN O
Gin NN O
Thr NN O
Glu NN O
Ala NN O
Vat NN O
Asn NN O
Ser NN O
Vat NN O
Asn NN O
MET NN O
Thr DT O
Ala NNP O
Gly NNP O
Arg NN O
lIe NN O
lIe NN O
His PRP$ O
Leu NNP O
lIe NNP O
Asp NNP O
Lys VBZ O
Asp NN O

G NN O

ATT NN O
CGC NNP O
ATC NNP O
CAA NNP O
AM NN O
AGC NN O
GCG NN O
GGG NN O
ATC NNP O
MT NNP O
GAG NNP O
CAC NN O
AGT NN O
GCG NNP O
AAA NNP O
TAC NNP O
ATA NNP O
GAG NNP O
MC NNP O
CTG NNP O
GAA NNP O
GCA NNP O
ACA NNP O
AM NNP O
GAG NNP O
CTA NNP O
ATG NNP O
AAG NNP O
CAG NNP O
TAC NNP O
660 CD O
lle NN O
Arg NNP O
lIe NNP O
Gin NNP O
Lys NNP O
Ser NNP O
Ala NNP O
Gly NNP O
lIe NN O
Asn NN O
Gtu NNP O
His NNP O
Ser NNP O
Ala NNP O
Lys NNP O
Tyr NNP O
lIe NNP O
Gtu NNP O
Asn NNP O
Leu NNP O
Gtu NNP O
Ala NNP O
Thr NNP O
Lys NNP O
Gtu NNP O
Leu NNP O
MET NNP O
Lys NNP O
Gin NNP O
Tyr NNP O

T NN O
T NN O

CCG NNP O
GAG NNP O
GAT NNP O
GAA NNP O
AAA NNP O
TTC NNP O
CGT NN O
ATG NN O
CGC NN O
GTA NN O
CAC NN O
GGC NN O
TTT NN O
AGC NN O
GAA NN O
ACA NN O
ATG NNP O
CTG NNP O
CGC NNP O
GTC NNP O
CAT NN O
TAC NN O
ATT NN O
TCC NN O
AGT NN O
AGC NN O
CCT NN O
AAC NN O
TAC NN O
AAT NN O
750 CD O
Pro NN O
Glu NN O
Asp NN O
Glu NN O
Lys NN O
Phe NN O
Arg NN O
MET NN O
Arg NN O
Vat NN O
His PRP$ O
Gly JJ O
Phe NN O
Ser NN O
Gtu NNP O
Thr NNP O
MET NNP O
Leu NNP O
Arg NNP O
Vat NNP O
His PRP$ O
Tyr NN O
lie NN O
Ser NNP O
Ser NNP O
Ser NNP O
Pro NNP O
Asn NNP O
Tyr NNP O
Asn NNP O

Phe UH O

T NN O
C NN O
G NN O
T NN O
T NN O

I PRP O
~ NFP O
~ NFP O
~ NFP O
I PRP O
I PRP O
II VBP O

GAT NNP O
GGC NNP O
MA NNP O
TCA NNP O
GTT NN O
AGT NN O
TAC NNP O
CAT NNP O
GTG NNP O
CTG NNP O
CTA NNP O
TGT NNP O
GGC NNP O
GTG NNP O
TTT NNP O
ATC NNP O
TGC NNP O
GAT NNP O
GM NNP O
ACT NNP O
CTC NNP O
CGA NNP O
GAT NNP O
GGA NNP O
ATC NNP O
ATC NNP O
ATC NNP O
AAC NNP O
GGT NNP O
GAA NNP O
840 CD O

e LS O
. . O
. . O

Asp NN O
Gly NNP O
Lys NNP O
Ser NN O
Vat NN O
Ser NN O
Tyr NN O
His PRP$ O
Vat NN O
Leu NNP O
Leu NNP O
Cys NNP O
Gly NNP O
Vat NNP O
Phe NN O
lie NN O
Cys NN O
Asp NN O
Glu NN O
Thr NN O
Leu NNP O
Arg NN O
Asp NN O
Gly NNP O
lIe FW O
lie FW O
lIe FW O
Asn NNP O
Gly NNP O
Gtu NNP O

Pro NNP O

C NN O
tag NN O
( , O
cl NN O
. . O
169 CD O
) -RRB- O

TTT NNP O
GAG NNP O
AM NNP O
GCA NNP O
AAA NNP O
TTT NNP O
AGC NNP O
CTT NNP O
TAT NNP O
GAC NNP O
TCT NNP O
ATA NNP O
GM NNP O
CCG NNP O
ATC NNP O
ATC NNP O
TGC NNP O
GAC NNP O
CGC NNP O
TGG NNP O
CCG NNP O
CAG NNP O
GCA NNP O
AM NNP O
ATA NNP O
TAT NNP O
CGC NNP O
CTG NNP O
GCA NNP O
GAT NNP O
930 CD O
Phe NNP O
Gtu NNP O
Lys NNP O
Ala NNP O
Lys NNP O
Phe NNP O
Ser NNP O
Leu NNP O
Tyr NNP O
Asp NNP O
Ser NNP O
lIe NNP O
Glu NNP O
Pro FW O
lie FW O
lie FW O
Cys NNP O
Asp NNP O
Arg NNP O
Trp NNP O
Pro NNP O
Gin NNP O
Ala NNP O
Lys NNP O
lIe NNP O
Tyr NNP O
Arg NNP O
Leu NNP O
Ala NNP O
Asp NNP O

T NN O

ATT NNP O
GM NNP O
MT NNP O
GTA NNP O
AM NNP O
AM NNP O
CM NNP O
ATT NNP O
GCC NNP O
ATC NNP O
ACT NN O
CGC NNP O
GM NNP O
GAG NNP O
AAA NNP O
G NNP O
GTC NNP O
AM NNP O
TCA NNP O
GCC NNP O
GCA NNP O
TCA NNP O
GTT NNP O
ACG NNP O
CGC NNP O
AGC NNP O
CGC NNP O
AAA NNP O
ACT NNP O
AAG NNP O
1020 CD O

n LS O
- : O
- : O
- : O
- : O
- : O

lie VB O
Glu NNP O
Asn NNP O
Vat NNP O
Lys NNP O
Lys NNP O
Gin NNP O
lIe NNP O
Ala NNP O
lie NN O
Thr NN O
Arg NN O
Glu NNP O
Glu NNP O
Lys NN O
Lys VBZ O
Vat NN O
Lys VBZ O
Ser NNP O
Ala NNP O
Ala NNP O
Ser NN O
Vat NN O
Thr NN O
Arg NN O
Ser NN O
Arg NN O
Lys NN O
Thr NNP O
Lys NNP O

AAG NNP O
GGG NNP O
CAG NNP O
CCA NNP O
GTA NNP O
AAC NNP O
GAC NNP O
MC NNP O
CCC NNP O
GAA NNP O
AGC NN O
GCG NN O
CM NN O
TAG NN O
Lys NNP O
Gly NNP O
Gin NNP O
Pro NNP O
Val NNP O
Asn NNP O
Asp NN O
Asn NN O
Pro NN O
Glu NNP O
Ser NNP O
Ala NNP O
Gin NNP O
ter NN O

Fig NN O
. . O

3 LS O
. . O

DNA NN O
sequence NN O
of IN O
PIcI NNP O
and CC O
P7cl NNP O
. . O

The DT O
DNA NNP O
sequence NN O
of IN O
PIcI NNP O
is VBZ O
indicated VBN O
. . O

Positions NNS O
where WRB O
the DT O
sequence NN O
of IN O
P7cl NNP O
differs VBZ O
from IN O
that DT O
of IN O
Plcl NNP O
are VBP O
indicated VBN O
above IN O
the DT O
P1 NN O
sequence NN O
. . O

The DT O
amino JJ O
acid NN O
sequence NN O
predicted VBN O
by IN O
the DT O
open JJ O
reading NN O
frame NN O
is VBZ O
given VBN O
below IN O
the DT O
sequence NN O
. . O

The DT O
two CD O
amino JJ O
acid NN O
substitutions NNS O
present VBP O
in IN O
P7cl NNP O
are VBP O
shown VBN O
below IN O
the DT O
open JJ O
reading NN O
frame NN O
. . O

The DT O
locations NNS O
of IN O
the DT O
amber NN O
mutant JJ O
codons NNS O
in IN O
cl NN O
. . O
55 CD O
and CC O
ci NN O
. . O

169 CD O
are VBP O
indicated VBN O
by IN O
small JJ O
letters NNS O
above IN O
the DT O
sequence NN O
. . O

Sites NNS O
for IN O
selected VBN O
restriction NN O
enzymes NNS O
( -LRB- O
EcoRV NNP O
[ -LRB- O
v NN O
] -RRB- O
; : O
BamHI NNP O
[ -LRB- O
b NN O
] -RRB- O
; : O
Bgll NNP O
[ -LRB- O
g NNP O
] -RRB- O
; : O
EcoRP NNP O
[ -LRB- O
e NNP O
] -RRB- O
; , O
and CC O
NruI NNP O
[ -LRB- O
n NNP O
] -RRB- O
) -RRB- O
are VBP O
illustrated VBN O
by IN O
dashed VBN O
lines NNS O
beneath IN O
the DT O
sequence NN O
. . O

The DT O
cl NN O
repressor NN O
binding VBG O
site NN O
is VBZ O
underlined VBN O
. . O

Inverted VBN O
arrows NNS O
beneath IN O
the DT O
sequence NN O
illustrate VBP O
the DT O
inverted JJ O
repeat NN O
sequence NN O
upstream RB O
of IN O
the DT O
open JJ O
reading NN O
frame NN O
. . O

Predicted VBN O
promoter NN O
ribosome NN O
binding NN O
sites NNS O
are VBP O
indicated VBN O
by IN O
the DT O
presence NN O
of IN O
the DT O
consensus NN O
sequences NNS O
above IN O
and CC O
below IN O
the DT O
line NN O
, , O
respectively RB O
. . O

The DT O
DNA NNP O
sequences NNS O
of IN O
Plcl NNP O
from IN O
bp NN O
1 CD O
- SYM O
134 CD O
and CC O
bp NN O
1 CD O
- HYPH O
434 CD O
were VBD O
reported VBN O
previously RB O
( , O
2 CD O
, , O
5 CD O
) -RRB- O
. . O

mutant JJ O
cl NN O
genes NNS O
from IN O
either CC O
P1 NNP O
or CC O
P7 NN O
( , O
Table NN O
1 CD O
) -RRB- O
. . O

The DT O
efficiency NN O
with IN O
which WDT O
a DT O
cloned VBN O
P7cl NNP O
gene NN O
complements VBZ O
a DT O
PlcI NNP O
mutation NN O
confirms VBZ O
previous JJ O
genetic JJ O
studies NNS O
indicating VBG O
that IN O
these DT O
two CD O
genes NNS O
are VBP O
functionally RB O
interchangeable JJ O
( : O
9 CD O
) -RRB- O
. . O

The DT O
location NN O
of IN O
the DT O
' `` O
y6 CD O
mutations NNS O
that WDT O
destroy VBP O
cl NN O
- HYPH O
complementing VBG O
activity NN O
suggests VBZ O
that IN O
the DT O
P7cl NNP O
open JJ O
reading NN O
frame NN O
occupies VBZ O
a DT O
map NN O
position NN O
similar JJ O
to IN O
that DT O
of IN O
the DT O
P1 NN O
open JJ O
reading NN O
frame NN O
( -LRB- O
Figure NNP O
1 CD O
) -RRB- O
. . O

7676 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Proteins NNS O
produced VBN O
by IN O
fragments NNS O
containing VBG O
Plcl NNP O
. . O

As IN O
an DT O
initial JJ O
step NN O
in IN O
the DT O
comparison NN O
of IN O
the DT O
P1 NNP O
and CC O
P7 NNP O
repressors NNS O
, , O
we PRP O
analyzed VBD O
the DT O
gene NN O
products NNS O
expressed VBN O
from IN O
the DT O
cloned VBN O
cl NN O
regions NNS O
. . O

In IN O
an DT O
in FW O
vitro FW O
transcription NN O
- HYPH O
translation NN O
reaction NN O
, , O
plasmids NNS O
coding VBG O
for IN O
the DT O
wildtpe NN O
alleles NNS O
of IN O
either CC O
PIcI NNP O
or CC O
P7cl NNP O
direct VBP O
the DT O
production NN O
of IN O
a DT O
protein NN O
with IN O
an DT O
estimated VBN O
molecular JJ O
weight NN O
of IN O
33 CD O
, , O
0 CD O
daltons NNS O
( , O
Figure NNP O
2 CD O
, , O
Lanes NNP O
C NNP O
and CC O
D NNP O
) -RRB- O
, , O
a DT O
size NN O
that WDT O
agrees VBZ O
closely RB O
with IN O
the DT O
predicted VBN O
molecular JJ O
weight NN O
of IN O
the DT O
PIcI NNP O
repressor NN O
reported VBN O
previously RB O
( , O
3 CD O
, , O
28 CD O
) -RRB- O
. . O

The DT O
loss NN O
of IN O
the DT O
33 CD O
, , O
0 CD O
dalton NN O
protein NN O
in IN O
the DT O
cl NN O
- HYPH O
' '' O
ya NN O
- HYPH O
induced VBN O
P7 NNP O
mutant JJ O
plasmids NNS O
( -LRB- O
Figure NNP O
2 CD O
, , O
Lanes NNP O
E NNP O
and CC O
F NNP O
) -RRB- O
is VBZ O
consistent JJ O
with IN O
its PRP$ O
designation NN O
as IN O
the DT O
P7cl NNP O
repressor NN O
. . O

As IN O
expected VBN O
, , O
the DT O
33 CD O
, , O
0 CD O
dalton NN O
protein NN O
is VBZ O
not RB O
observed VBN O
when WRB O
reaction NN O
mixtures NNS O
contain VBP O
DNA NN O
from IN O
Plcl NNP O
amber NN O
mutants NNS O
( -LRB- O
Figure NNP O
2 CD O
, , O
Lanes NNP O
A NN O
and CC O
B NNP O
) -RRB- O
. . O

DNA NN O
sequence NN O
analysis NN O
of IN O
the DT O
cl NN O
genes NNS O
. . O

To TO O
make VB O
a DT O
direct JJ O
comparison NN O
between IN O
the DT O
Plcl NNP O
and CC O
P7cl NNP O
DNA NNP O
sequences NNS O
and CC O
to TO O
predict VB O
the DT O
amino JJ O
acid NN O
sequences NNS O
of IN O
the DT O
repressor NN O
proteins NNS O
, , O
we PRP O
carried VBD O
out RP O
M NN O
13 CD O
- HYPH O
dideoxy NN O
sequence NN O
analysis NN O
of IN O
cloned VBN O
fragments NNS O
carrying VBG O
the DT O
cl NNP O
genes NNS O
. . O

The DT O
sequences NNS O
of IN O
about RB O
1 CD O
kb NN O
of IN O
P1 NN O
and CC O
P7 NNP O
DNA NNP O
were VBD O
determined VBN O
starting VBG O
from IN O
a DT O
common JJ O
EcoRV NNP O
site NN O
predicted VBN O
to TO O
lie VB O
approximately RB O
200 CD O
bps NNS O
upstream RB O
of IN O
the DT O
cl NN O
genes NNS O
. . O

The DT O
P1 NNP O
and CC O
P7 NN O
sequences NNS O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
both DT O
contain VBP O
an DT O
ATG NNP O
initiation NN O
codon NN O
preceded VBN O
by IN O
a DT O
putative JJ O
ribosome NN O
binding NN O
sequence NN O
( : O
29 CD O
) -RRB- O
situated VBN O
211 CD O
bps NNS O
downstream RB O
of IN O
the DT O
EcoRV NNP O
site NN O
. . O

In IN O
each DT O
case NN O
, , O
the DT O
initiation NN O
codon NN O
is VBZ O
followed VBN O
by IN O
an DT O
open JJ O
reading NN O
reading NN O
frame NN O
extending VBG O
for IN O
283 CD O
codons NNS O
. . O

The DT O
P1 NNP O
and CC O
P7 NN O
open JJ O
reading NN O
frames NNS O
code VBP O
for IN O
proteins NNS O
with IN O
predicted VBN O
molecular JJ O
weights NNS O
( , O
32 CD O
, , O
515 CD O
and CC O
32 CD O
, , O
499 CD O
daltons NNS O
, , O
respectively RB O
) -RRB- O
that WDT O
agree VBP O
closely RB O
with IN O
the DT O
values NNS O
of IN O
the DT O
proteins NNS O
expressed VBN O
from IN O
the DT O
cloned VBN O
DNA NNP O
fragments NNS O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
and CC O
with IN O
results NNS O
predicted VBN O
independently RB O
for IN O
the DT O
purified JJ O
PIcI NNP O
repressor NN O
( , O
3 CD O
- SYM O
4 CD O
) -RRB- O
. . O

The DT O
localization NN O
of IN O
two CD O
PIcI NNP O
amber NN O
mutations NNS O
to IN O
the DT O
P1 NN O
open JJ O
reading NN O
frame NN O
confirms VBZ O
its PRP$ O
identification NN O
as IN O
the DT O
cI NNP O
coding VBG O
sequence NN O
. . O

cI NN O
. . O

169 CD O
contains VBZ O
an DT O
amber NN O
mutation NN O
that WDT O
would MD O
result VB O
in IN O
a DT O
protein NN O
fragment NN O
of IN O
26 CD O
, , O
680 CD O
daltons NNS O
, , O
a DT O
value NN O
that WDT O
agrees VBZ O
well RB O
with IN O
the DT O
size NN O
of IN O
a DT O
protein NN O
fragment NN O
observed VBN O
under IN O
the DT O
in FW O
vitro FW O
transcription NN O
/ SYM O
translation NN O
reaction NN O
conditions NNS O
( -LRB- O
Figure NNP O
2 CD O
, , O
Lane NNP O
B NNP O
) -RRB- O
. . O

The DT O
cl NN O
. . O
55 CD O
amber NN O
mutation NN O
lies VBZ O
close RB O
to IN O
the DT O
N NNP O
- HYPH O
terminal JJ O
region NN O
of IN O
the DT O
protein NN O
, , O
resulting VBG O
in IN O
the DT O
production NN O
of IN O
a DT O
fragment NN O
of IN O
55 CD O
amino NN O
acids NNS O
that WDT O
is VBZ O
apparently RB O
too RB O
small JJ O
to TO O
resolve VB O
under IN O
the DT O
electrophoretic JJ O
conditions NNS O
used VBN O
for IN O
separation NN O
of IN O
the DT O
proteins NNS O
. . O

Over IN O
60 CD O
% NN O
of IN O
the DT O
amino JJ O
acid NN O
sequence NN O
predicted VBN O
for IN O
the DT O
PIcI NNP O
open JJ O
reading NN O
frame NN O
has VBZ O
been VBN O
verified VBN O
by IN O
amino NN O
acid NN O
sequence NN O
analysis NN O
of IN O
peptide NN O
fragments NNS O
isolated VBN O
from IN O
the DT O
purified JJ O
repressor NN O
protein NN O
( , O
see VB O
accompanying VBG O
paper NN O
, , O
reference NN O
3 CD O
) -RRB- O
. . O

The DT O
DNA NNP O
sequences NNS O
of IN O
P1 NN O
and CC O
P7 NN O
are VBP O
identical JJ O
for IN O
a DT O
399 CD O
- HYPH O
bp NN O
region NN O
that WDT O
extends VBZ O
from IN O
the DT O
EcoRV NNP O
site NN O
at IN O
the DT O
5 CD O
' '' O
side NN O
of IN O
the DT O
cl NN O
gene NN O
to IN O
a DT O
point NN O
188 CD O
bps NNS O
within IN O
the DT O
open JJ O
reading NN O
frame NN O
. . O

The DT O
sequences NNS O
within IN O
the DT O
Plcl NNP O
and CC O
the DT O
P7cl NNP O
open JJ O
reading NN O
frames NNS O
differ VBP O
at IN O
only RB O
18 CD O
positions NNS O
, , O
all DT O
but IN O
two CD O
of IN O
which WDT O
occur VBP O
in IN O
the DT O
wobble JJ O
position NN O
of IN O
the DT O
predicted VBN O
codon NN O
. . O

From IN O
these DT O
results NNS O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
functional JJ O
identity NN O
of IN O
the DT O
P1 NNP O
and CC O
P7 NN O
cl NN O
genes NNS O
is VBZ O
a DT O
consequence NN O
of IN O
their PRP$ O
nearly RB O
identical JJ O
amino NN O
acid NN O
sequence NN O
. . O

Analysis NN O
of IN O
promoters NNS O
upstream RB O
of IN O
the DT O
cl `` O
open JJ O
reading NN O
frame NN O
. . O

Expression NN O
of IN O
Plcl NNP O
was VBD O
shown VBN O
previously RB O
to TO O
require VB O
sequences NNS O
on IN O
the DT O
distal JJ O
side NN O
of IN O
a DT O
BamHI NNP O
site NN O
( , O
2 CD O
, , O
5 CD O
) , O
located VBN O
about RB O
100 CD O
bps NNS O
upstream RB O
of IN O
the DT O
open JJ O
reading NN O
frame NN O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
. . O

A DT O
binding VBG O
site NN O
for IN O
the DT O
cl NN O
repressor NN O
has VBZ O
also RB O
been VBN O
shown VBN O
to TO O
exist VB O
close RB O
to IN O
this DT O
BamHI NNP O
site NN O
( , O
2 CD O
, , O
5 CD O
, , O
6 CD O
) -RRB- O
. . O

To TO O
determine VB O
whether IN O
this DT O
region NN O
contains VBZ O
a DT O
promoter NN O
that WDT O
is VBZ O
detectable JJ O
in IN O
vivo NN O
and CC O
, , O
further RB O
, , O
to TO O
determine VB O
whether IN O
this DT O
promoter NN O
can MD O
be VB O
regulated VBN O
by IN O
cl NN O
repressor NN O
proteins NNS O
from IN O
either CC O
P1 NNP O
or CC O
P7 NNP O
, , O
we PRP O
introduced VBD O
several JJ O
DNA NNP O
fragments NNS O
from IN O
this DT O
region NN O
into IN O
the DT O
promoter NN O
probe NN O
vector NN O
pCB192 NN O
, , O
screened VBN O
for IN O
promoter NN O
activity NN O
( , O
as IN O
monitored VBN O
by IN O
lacZ NN O
expression NN O
) , O
and CC O
checked VBN O
for IN O
repression NN O
of IN O
this DT O
activity NN O
in IN O
the DT O
presence NN O
of IN O
a DT O
compatible JJ O

7677 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

plasmid NN O
expressing VBG O
Plcl NNP O
or CC O
P7cl NNP O
. . O

Cells NNS O
harboring VBG O
pBCB2 NNP O
. . O
13 CD O
( , O
a DT O
plasmid NN O
which WDT O
carries VBZ O
a DT O
460 CD O
bp NN O
fragment NN O
of IN O
P1 NN O
DNA NNP O
that WDT O
extends VBZ O
across IN O
the DT O
BamHI NNP O
site NN O
upstream RB O
of IN O
cl NN O
into IN O
the DT O
open JJ O
reading NN O
frame NN O
) -RRB- O
are VBP O
dark JJ O
blue JJ O
in IN O
the DT O
presence NN O
of IN O
Xgal NNP O
and CC O
produce VB O
significant JJ O
levels NNS O
of IN O
3 CD O
- HYPH O
galactosidase NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
pBCB2 NNP O
. . O
16 CD O
and CC O
pBCB2 NNP O
. . O
18 CD O
( : O
which WDT O
each DT O
contain VBP O
DNA NN O
from IN O
only RB O
one CD O
side NN O
of IN O
the DT O
BamHI NNP O
site NN O
located VBN O
in IN O
pBCB2 NNP O
. . O
13 CD O
) -RRB- O
do VBP O
not RB O
confer VB O
a DT O
blue JJ O
color NN O
on IN O
their PRP$ O
host NN O
cell NN O
in IN O
the DT O
presence NN O
of IN O
X NNP O
- HYPH O
Gal NNP O
and CC O
express VB O
negligible JJ O
amounts NNS O
of IN O
3 CD O
- HYPH O
galactosidase NN O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

These DT O
observations NNS O
suggest VBP O
that IN O
expression NN O
from IN O
the DT O
promoter NN O
identified VBN O
here RB O
requires VBZ O
sequences NNS O
that WDT O
span VBP O
the DT O
BamHI NNP O
site NN O
upstream RB O
of IN O
cl NN O
. . O

Expression NN O
of IN O
cl NN O
from IN O
a DT O
compatible JJ O
plasmid NN O
in IN O
the DT O
presence NN O
of IN O
pBCB2 NN O
. . O

13 CD O
results VBZ O
in IN O
a DT O
90 CD O
% NN O
reduction NN O
in IN O
promoter NN O
strength NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

This DT O
reduction NN O
is VBZ O
seen VBN O
in IN O
the DT O
presence NN O
of IN O
either CC O
Plcl NNP O
or CC O
P7cl NNP O
, , O
indicating VBG O
that IN O
the DT O
two CD O
repressor NN O
proteins NNS O
are VBP O
both DT O
capable JJ O
of IN O
repressing VBG O
expression NN O
from IN O
this DT O
promoter NN O
. . O

DISCUSSION NN O
. . O

The DT O
DNA NNP O
sequences NNS O
of IN O
Plcl NNP O
and CC O
P7cl NNP O
differ VBP O
at IN O
only RB O
18 CD O
sites NNS O
, , O
all DT O
but IN O
two CD O
of IN O
which WDT O
occur VBP O
at IN O
the DT O
third JJ O
position NN O
of IN O
the DT O
affected VBN O
codon NN O
. . O

This DT O
observation NN O
provides VBZ O
biochemical JJ O
confirmation NN O
of IN O
the DT O
functional JJ O
identity NN O
predicted VBN O
on IN O
the DT O
basis NN O
of IN O
previous JJ O
genetic JJ O
analysis NN O
( , O
9 CD O
) -RRB- O
. . O

A DT O
number NN O
of IN O
DNA NN O
binding NN O
proteins NNS O
exhibit VBP O
a DT O
common JJ O
structural JJ O
motif NN O
in IN O
which WDT O
two CD O
helices NNS O
are VBP O
separated VBN O
by IN O
a DT O
glycine NN O
residue NN O
( SYM O
12 CD O
) -RRB- O
. . O

This DT O
motif NN O
is VBZ O
not RB O
observed VBN O
in IN O
the DT O
predicted VBN O
secondary JJ O
structures NNS O
( , O
30 CD O
) -RRB- O
of IN O
the DT O
Plcl NNP O
and CC O
P7cl NNP O
amino NN O
acid NN O
sequences NNS O
. . O

A DT O
sequence NN O
with IN O
some DT O
similarity NN O
to IN O
the DT O
XCro NNP O
helix NN O
- HYPH O
turn NN O
- HYPH O
helix NN O
region NN O
was VBD O
previously RB O
reported VBN O
near IN O
the DT O
Nterminus NNP O
of IN O
the DT O
PIcI NNP O
protein NN O
( , O
5 CD O
) -RRB- O
; , O
however RB O
, , O
it PRP O
was VBD O
noted VBN O
that IN O
the DT O
potential NN O
for IN O
helix NN O
formation NN O
is VBZ O
disrupted VBN O
by IN O
the DT O
presence NN O
of IN O
several JJ O
prolines NNS O
within IN O
the DT O
region NN O
. . O

The DT O
secondary JJ O
structure NN O
predicted VBN O
for IN O
the DT O
Plcl NNP O
and CC O
P7cl NNP O
repressor NN O
proteins NNS O
( , O
30 CD O
) -RRB- O
does VBZ O
not RB O
reveal VB O
other JJ O
structural JJ O
characteristics NNS O
( , O
e LS O
. . O
g LS O
. . O
, , O
Zn NNP O
fingers NNS O
( , O
31 CD O
) -RRB- O
, , O
leucine NN O
zippers NNS O
( , O
32 CD O
) -RRB- O
, , O
or CC O
helix NN O
- HYPH O
loop NN O
- HYPH O
helix NN O
motifs NNS O
( , O
33 CD O
) -RRB- O
) -RRB- O
that WDT O
have VBP O
been VBN O
associated VBN O
with IN O
DNA NN O
binding NN O
activity NN O
in IN O
other JJ O
systems NNS O
. . O

A DT O
search NN O
of IN O
the DT O
GenBank NNP O
and CC O
EMBL NNP O
databases NNS O
does VBZ O
not RB O
reveal VB O
any DT O
other JJ O
known VBN O
regulatory JJ O
proteins NNS O
with IN O
significant JJ O
amino NN O
acid NN O
similarity NN O
to IN O
the DT O
Plcl NNP O
or CC O
the DT O
P7cl NNP O
repressor NN O
sequences NNS O
. . O

Since IN O
the DT O
Plcl NNP O
repressor NN O
differs VBZ O
from IN O
most JJS O
other JJ O
repressors NNS O
in IN O
DNA NN O
binding VBG O
specificity NN O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
in IN O
its PRP$ O
recognition NN O
of IN O
an DT O
asymmetric JJ O
operator NN O
sequence NN O
) -RRB- O
, , O
it PRP O
is VBZ O
not RB O
unexpected JJ O
to TO O
find VB O
that IN O
the DT O
protein NN O
does VBZ O
not RB O
exhibit VB O
common JJ O
structural JJ O
motifs NNS O
at IN O
the DT O
amino JJ O
acid NN O
level NN O
. . O

The DT O
cl NN O
- HYPH O
repressible JJ O
promoter NN O
described VBN O
in IN O
this DT O
report NN O
is VBZ O
located VBN O
in IN O
a DT O
region NN O
just RB O
upstream RB O
of IN O
the DT O
cl JJ O
open JJ O
reading NN O
frame NN O
and CC O
is VBZ O
oriented VBN O
in IN O
the DT O
direction NN O
of IN O
cl NN O
. . O

Because IN O
the DT O
promoter NN O
is VBZ O
present JJ O
on IN O
a DT O
multicopy JJ O
plasmid NN O
, , O
it PRP O
is VBZ O
not RB O
possible JJ O
to TO O
make VB O
a DT O
direct JJ O
calculation NN O
of IN O
promoter NN O
strength NN O
; : O
however RB O
, , O
the DT O
values NNS O
observed VBN O
are VBP O
about RB O
five CD O
- HYPH O
fold NN O
lower JJR O
than IN O
the DT O
levels NNS O
produced VBN O
by IN O
a DT O
derivative NN O
of IN O
pCB192 NN O
that WDT O
contains VBZ O
the DT O
plac NN O
promoter NN O
from IN O
pUC19 NNP O
( SYM O
34 CD O
) -RRB- O
. . O

Because IN O
sequences NNS O
on IN O
both DT O
sides NNS O
of IN O
the DT O
BamHI NNP O
site NN O
located VBN O
upstream RB O
of IN O
cl NN O
are VBP O
required VBN O
for IN O
promoter NN O
activity NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
, , O
we PRP O
suggest VBP O
that IN O
the DT O
promoter NN O
spans VBZ O
this DT O
site NN O
. . O

Less JJR O
than IN O
10 CD O
bps NNS O
downstream RB O
of IN O
this DT O
BamHI NNP O
site NN O
is VBZ O
a DT O
heptanucleotide NN O
sequence NN O
( , O
TATAATG NNP O
) -RRB- O
that WDT O
is VBZ O
identical JJ O
to IN O
the DT O
- HYPH O
10 CD O
consensus NN O
sequence NN O
for IN O
RNA NNP O
polymerase NN O
( SYM O
35 CD O
) -RRB- O
. . O

If IN O
this DT O
sequence NN O
does VBZ O
indeed RB O
correspond VB O
to IN O
the DT O
- HYPH O
10 CD O
region NN O
of IN O
the DT O
promoter NN O
, , O
the DT O
- HYPH O
35 CD O
region NN O
would MD O
be VB O
predicted VBN O
to TO O
lie VB O
on IN O
the DT O
other JJ O
side NN O
of IN O
the DT O
BamHI NNP O
site NN O
in IN O
a DT O
region NN O
that WDT O
overlaps VBZ O
a DT O
known VBN O
cI NN O
repressor NN O
binding NN O
site NN O
( , O
2 CD O
- HYPH O
5 CD O
) -RRB- O
. . O

Analysis NN O
of IN O
this DT O
region NN O
does VBZ O
not RB O
reveal VB O
any DT O
sequences NNS O
with IN O
significant JJ O
similarity NN O
to IN O
the DT O
- SYM O
35 CD O
consensus NN O
sequence NN O
. . O

The DT O
best JJS O
fit NN O
is VBZ O
the DT O
sequence NN O
TCTATT NNP O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
, , O
which WDT O
matches VBZ O
only RB O
two CD O
positions NNS O
of IN O
the DT O
- HYPH O
35 CD O
consensus NN O
( : O
TTGACA NNP O
) -RRB- O
. . O

The DT O
lack NN O
of IN O
a DT O
strong JJ O
- HYPH O
35 CD O
region NN O
is VBZ O
often RB O
observed VBN O
with IN O
genes NNS O
that WDT O
require VBP O
an DT O
activator NN O
. . O

Although IN O
a DT O
pentanucleotide NN O
sequence NN O
corresponding VBG O
to IN O
the DT O
conserved VBN O
portion NN O
of IN O
the DT O
CRP NNP O
protein NN O
consensus NN O
binding NN O
site NN O
( SYM O
36 CD O
) -RRB- O

7678 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

is VBZ O
located VBN O
just RB O
upstream RB O
of IN O
the DT O
predicted VBN O
- HYPH O
35 CD O
region NN O
( : O
at IN O
position NN O
91 CD O
; : O
Figure NNP O
3 CD O
) -RRB- O
, , O
a DT O
role NN O
for IN O
CRP NNP O
- HYPH O
mediated VBN O
activation NN O
in IN O
cl NN O
expression NN O
has VBZ O
not RB O
previously RB O
been VBN O
described VBN O
. . O

The DT O
orientation NN O
of IN O
the DT O
promoter NN O
and CC O
its PRP$ O
cl NN O
- HYPH O
repressible JJ O
character NN O
raise VBP O
the DT O
possibility NN O
that IN O
cl NN O
expression NN O
is VBZ O
autoregulatory JJ O
. . O

If IN O
this DT O
is VBZ O
so RB O
, , O
one CD O
potential JJ O
activator NN O
would MD O
be VB O
the DT O
cl JJ O
repressor NN O
itself PRP O
. . O

Expression NN O
cannot MD O
be VB O
absolutely RB O
dependent JJ O
on IN O
cl NN O
- HYPH O
mediated VBN O
activation NN O
, , O
however RB O
, , O
because IN O
the DT O
cloned JJ O
promoter NN O
exhibits VBZ O
significant JJ O
activity NN O
in IN O
the DT O
absence NN O
of IN O
the DT O
cl NN O
gene NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

Under IN O
the DT O
conditions NNS O
reported VBN O
here RB O
, , O
the DT O
presence NN O
of IN O
the DT O
cl NN O
gene NN O
results VBZ O
in IN O
a DT O
decrease NN O
rather RB O
than IN O
an DT O
increase NN O
in IN O
lacZ NN O
expression NN O
; : O
however RB O
, , O
these DT O
observations NNS O
do VBP O
not RB O
rule VB O
out RP O
a DT O
potential JJ O
activator NN O
role NN O
for IN O
the DT O
cl NN O
protein NN O
, , O
since IN O
the DT O
ratios NNS O
of IN O
repressor NN O
and CC O
operator NN O
provided VBN O
by IN O
the DT O
multicopy NN O
plasmids NNS O
may MD O
not RB O
be VB O
optimal JJ O
for IN O
activation NN O
. . O

Physiologically RB O
, , O
the DT O
role NN O
of IN O
additional JJ O
repressor JJ O
binding NN O
sites NNS O
in IN O
regulating VBG O
cl NN O
expression NN O
also RB O
cannot MD O
be VB O
discounted VBN O
. . O

Three CD O
potential JJ O
operator NN O
sites NNS O
have VBP O
been VBN O
identified VBN O
several JJ O
hundred CD O
bps NNS O
upstream RB O
of IN O
the DT O
cI NN O
open JJ O
reading NN O
frame NN O
( , O
2 CD O
- SYM O
5 CD O
) -RRB- O
; : O
one CD O
or CC O
more JJR O
of IN O
these DT O
could MD O
be VB O
involved VBN O
( : O
possibly RB O
through IN O
a DT O
DNA NN O
looping VBG O
mechanism NN O
; : O
37 CD O
) , O
in IN O
the DT O
activation NN O
or CC O
repression NN O
of IN O
cl NN O
expression NN O
during IN O
phage NN O
growth NN O
. . O

A DT O
cl NN O
- HYPH O
repressible JJ O
promoter NN O
oriented VBN O
in IN O
the DT O
direction NN O
of IN O
cl NN O
was VBD O
previously RB O
reported VBN O
( SYM O
38 CD O
) -RRB- O
to TO O
be VB O
located VBN O
entirely RB O
within IN O
PlBamHI NNP O
- HYPH O
9 CD O
, , O
a DT O
fragment NN O
located VBN O
upstream NN O
of IN O
cl NN O
which WDT O
is VBZ O
bracketed VBN O
by IN O
the DT O
BamHI NNP O
site NN O
within IN O
pBCB2 NNP O
. . O

13 CD O
. . O

Because IN O
sequences NNS O
on IN O
both DT O
sides NNS O
of IN O
this DT O
BamHI NNP O
site NN O
are VBP O
required VBN O
for IN O
the DT O
activity NN O
of IN O
the DT O
promoter NN O
in IN O
pBCB2 NNP O
. . O
13 CD O
, , O
we PRP O
suggest VBP O
that IN O
the DT O
previously RB O
identified VBN O
promoter NN O
is VBZ O
distinct JJ O
from IN O
the DT O
one NN O
reported VBN O
here RB O
. . O

The DT O
promoter NN O
from IN O
BamHI NNP O
- HYPH O
9 CD O
could MD O
correspond VB O
to IN O
a DT O
consensus NN O
promoter NN O
sequence NN O
that WDT O
is VBZ O
situated VBN O
about RB O
500 CD O
bps NNS O
upstream RB O
of IN O
cl NN O
and CC O
overlaps VBZ O
a DT O
cl NN O
repressor NN O
binding VBG O
site NN O
( : O
2 CD O
) -RRB- O
. . O

If IN O
so RB O
, , O
cl `` O
expression NN O
is VBZ O
likely JJ O
to TO O
be VB O
controlled VBN O
by IN O
more JJR O
than IN O
one CD O
promoter NN O
. . O

Located VBN O
between IN O
this DT O
promoter NN O
sequence NN O
and CC O
the DT O
promoter NN O
encoded VBN O
on IN O
pBCB2 NN O
. . O

13 CD O
is VBZ O
an DT O
open JJ O
reading NN O
frame NN O
whose WP$ O
product NN O
( , O
termed VBN O
coi NN O
, , O
or CC O
c NN O
- HYPH O
one CD O
inactivator NN O
) -RRB- O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
establishment NN O
of IN O
lytic JJ O
growth NN O
( , O
1 CD O
, , O
39 CD O
; : O
B NN O
. . O
R NN O
. . O
Baumstark NNP O
, , O
unpublished JJ O
results NNS O
) -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
( : O
2 CD O
) -RRB- O
that IN O
the DT O
decision NN O
to TO O
enter VB O
lytic NN O
or CC O
lysogenic JJ O
growth NN O
is VBZ O
influenced VBN O
by IN O
the DT O
level NN O
of IN O
transcription NN O
initiated VBN O
from IN O
the DT O
distal NN O
promoter NN O
( , O
which WDT O
would MD O
transcribe VB O
coi NN O
prior RB O
to IN O
the DT O
transcription NN O
of IN O
cl NN O
) -RRB- O
relative JJ O
to IN O
that DT O
of IN O
the DT O
promoter NN O
located VBN O
immediately RB O
upstream RB O
of IN O
the DT O
cl NN O
gene NN O
( , O
which WDT O
would MD O
transcribe VB O
only RB O
ci NN O
) -RRB- O
. . O

A DT O
32 CD O
- HYPH O
nucleotide NN O
hyphenated VBN O
inverted VBN O
repeat NN O
sequence NN O
is VBZ O
located VBN O
just RB O
upstream RB O
of IN O
the DT O
cl JJ O
open JJ O
reading NN O
frame NN O
( , O
positions NNS O
146 CD O
- HYPH O
188 CD O
; : O
Figure NN O
3 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
not RB O
currently RB O
known VBN O
whether IN O
this DT O
sequence NN O
has VBZ O
any DT O
regulatory JJ O
effect NN O
on IN O
cl NN O
expression NN O
. . O

Conceivably RB O
, , O
the DT O
sequence NN O
could MD O
serve VB O
as IN O
a DT O
recognition NN O
site NN O
for IN O
an DT O
as IN O
- HYPH O
yet CC O
- HYPH O
unidentified JJ O
regulatory JJ O
protein NN O
. . O

Alternatively RB O
, , O
it PRP O
may MD O
affect VB O
the DT O
secondary JJ O
structure NN O
of IN O
the DT O
messenger NN O
RNA NNP O
. . O

A DT O
transcript NN O
extending VBG O
from IN O
a DT O
promoter NN O
located VBN O
upstream NN O
of IN O
the DT O
putative JJ O
coi NN O
open JJ O
reading NN O
frame NN O
would MD O
be VB O
capable JJ O
of IN O
forming VBG O
a DT O
stable JJ O
stem NN O
- HYPH O
loop NN O
structure NN O
containing VBG O
16 CD O
bps NNS O
with IN O
a DT O
single JJ O
bp NN O
mismatch NN O
( , O
AG NNP O
= : O
- HYPH O
33 CD O
. . O
6 CD O
Kcal NNP O
) -RRB- O
of IN O
this DT O
inverted JJ O
repeat NN O
sequence NN O
. . O

Such JJ O
a DT O
structure NN O
could MD O
potentially RB O
serve VB O
as IN O
a DT O
recognition NN O
site NN O
for IN O
a DT O
regulatory JJ O
factor NN O
or CC O
, , O
alternatively RB O
, , O
could MD O
mask VB O
such PDT O
a DT O
site NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
transcription NN O
originating VBG O
from IN O
the DT O
promoter NN O
spanning VBG O
the DT O
BamHI NNP O
site NN O
just RB O
upstream RB O
of IN O
cl NN O
would MD O
start VB O
at IN O
a DT O
site NN O
within IN O
the DT O
inverted JJ O
repeat NN O
sequence NN O
, , O
forming VBG O
a DT O
comparatively RB O
less RBR O
stable JJ O
stem NN O
- HYPH O
loop NN O
structure NN O
of IN O
about RB O
8 CD O
bps NNS O
. . O

The DT O
role NN O
of IN O
the DT O
inverted VBN O
repeat NN O
region NN O
in IN O
the DT O
regulation NN O
of IN O
cl NN O
expression NN O
is VBZ O
currently RB O
under IN O
investigation NN O
. . O

ACKNOWLEDGEMENTS NNS O

We PRP O
thank VBP O
Heinz NNP O
Schuster NNP O
for IN O
his PRP$ O
review NN O
of IN O
the DT O
manuscript NN O
. . O

This DT O
work NN O
was VBD O
supported VBN O
by IN O
National NNP O
Science NNP O
Foundation NNP O
grant NN O
DMB NNP O
- HYPH O
8704146 CD O
. . O

7679 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Abbreviations NNS O
: : O
bp NN O
, , O
basepairs NNS O
; : O
kb NN O
, , O
kilobase NN O
pairs NNS O
; : O
X NNP O
- HYPH O
Gal NNP O
, , O
5 CD O
- HYPH O
Bromo NNP O
- HYPH O
4 CD O
- HYPH O
Chloro NNP O
- HYPH O
3 CD O
- HYPH O
indolylbeta NN O
- HYPH O
D NN O
- HYPH O
galactopyranoside NN O
. . O

* NFP O
To TO O
whom WP O
correspondence NN O
should MD O
be VB O
addressed VBN O

REFERENCES NNS O

1 LS O
. . O

Yarmolinsky NNP O
, , O
M NNP O
. . O
B NNP O
. . O
, , O
and CC O
Steinberg NNP O
, , O
N NNP O
. . O

( -LRB- O
1988 CD O
) -RRB- O
. . O

In IN O
Calendar NNP O
, , O
R NNP O
. . O
, , O
( , O
ed NNP O
. . O
) -RRB- O
, , O
The DT O
Bacteriophages NNPS O
, , O
Plenum NNP O
Publishing NNP O

Corp NNP O
. . O
, , O
NY NNP O
, , O
Vol NNP O
. . O

1 CD O
, , O
pp UH O
. . O

291 CD O
- HYPH O
438 CD O
. . O

2 LS O
. . O

Baumstark NNP O
, , O
B NNP O
. . O
R NNP O
. . O
, , O
Stovall NNP O
, , O
S NNP O
. . O
R NNP O
. . O
, , O
and CC O
Ashkar NNP O
, , O
S NNP O
. . O

( -LRB- O
1987 CD O
) -RRB- O
. . O

Virology NNP O
156 CD O
, , O
404 CD O
- HYPH O
413 CD O
. . O

3 LS O
. . O

Dreiseikelmann NNP O
, , O
B NNP O
. . O
, , O
Velleman NNP O
, , O
M NNP O
. . O
, , O
and CC O
Schuster NNP O
, , O
H NNP O
. . O

( -LRB- O
1988 CD O
) -RRB- O
. . O

J NNP O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

263 CD O
, , O
1391 CD O
- HYPH O
1397 CD O
. . O

4 LS O
. . O

Heinrich NNP O
, , O
J NNP O
. . O
, , O
Riedel NNP O
, , O
H NNP O
. . O
- : O
D NNP O
. . O
, , O
Baumstark NNP O
, , O
B NNP O
. . O
R NNP O
. . O
, , O
Kimura NNP O
, , O
M NNP O
. . O
, , O
and CC O
Schuster NNP O
, , O
H NNP O
. . O

( -LRB- O
1989 CD O
) -RRB- O
. . O

Nucleic JJ O
Acids NN O
Res NNS O
, , O

this DT O
volume NN O
. . O

5 LS O
. . O

Eliason NNP O
, , O
J NNP O
. . O
L NNP O
. . O
, , O
and CC O
Stemnberg NNP O
, , O
N NNP O
. . O

( -LRB- O
1987 CD O
) -RRB- O
. . O

J NNP O
. . O

Mol NNP O
. . O

Biol NNP O
. . O

198 CD O
, , O
281 CD O
- HYPH O
293 CD O
. . O

6 LS O
. . O

Velleman NNP O
, , O
M NNP O
. . O
, , O
Dreiseikelmann NNP O
, , O
B NNP O
. . O
, , O
and CC O
Schuster NNP O
, , O
H NNP O
. . O

( -LRB- O
1987 CD O
) -RRB- O
. . O

Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
84 CD O
, , O
5570 CD O
- HYPH O
5574 CD O
. . O

7 LS O
. . O

Citron NNP O
, , O
M NNP O
. . O
, , O
Velleman NNP O
, , O
M NNP O
. . O
, , O
and CC O
Schuster NNP O
, , O
H NNP O
. . O

( -LRB- O
1988 CD O
) -RRB- O
. . O

J NNP O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

264 CD O
, , O
3611 CD O
- HYPH O
3617 CD O
. . O

8 LS O
. . O

Chadwick NNP O
, , O
P NNP O
. . O
, , O
Pirotta NNP O
, , O
V NNP O
. . O
, , O
Steinberg NNP O
, , O
R NNP O
. . O
, , O
Hopkins NNP O
, , O
N NNP O
. . O
, , O
and CC O
Ptashne NNP O
, , O
M NNP O
. . O

( : O
1970 CD O
) -RRB- O
. . O

Cold NNP O
Spring NNP O
Harbor NNP O
Symp NNP O
. . O

Quant NN O
. . O

Biol NNP O
. . O

35 CD O
, , O
283 CD O
- SYM O
294 CD O
. . O

9 LS O
. . O

Chesney NNP O
, , O
R NNP O
. . O
H NNP O
. . O
, , O
and CC O
Scott NNP O
, , O
J NNP O
. . O
R NN O
. . O

( -LRB- O
1975 CD O
) -RRB- O
. . O

Virology NNP O
67 CD O
, , O
375 CD O
- HYPH O
384 CD O
. . O

10 CD O
. . O

Wandersman NNP O
, , O
C NNP O
. . O
, , O
and CC O
Yarmolinsky NNP O
, , O
M NNP O
. . O

( -LRB- O
1977 CD O
) -RRB- O
. . O

Virology NNP O
78 CD O
, , O
267 CD O
- HYPH O
276 CD O
. . O

11 CD O
. . O

Scott NNP O
, , O
J NNP O
. . O
R NNP O
. . O
, , O
West NNP O
, , O
B NNP O
. . O
W NNP O
. . O
, , O
and CC O
Laping NNP O
, , O
J NNP O
. . O
L NN O
. . O

( -LRB- O
1978 CD O
) -RRB- O
. . O

Virology NNP O
85 CD O
, , O
587 CD O
- HYPH O
600 CD O
. . O

12 CD O
. . O

Pabo NNP O
, , O
C NNP O
. . O
O NNP O
. . O
, , O
and CC O
Sauer NNP O
, , O
R NNP O
. . O

A DT O
. . O

( -LRB- O
1984 CD O
) -RRB- O
. . O

Ann NNP O
. . O

Rev NNP O
. . O

Biochem NNP O
. . O

53 CD O
, , O
293 CD O
- HYPH O
321 CD O
. . O

13 CD O
. . O

Scott NNP O
, , O
J NNP O
. . O
R NN O
. . O

( -LRB- O
1974 CD O
) -RRB- O
. . O

Virology NNP O
62 CD O
, , O
344 CD O
- HYPH O
349 CD O
. . O

14 CD O
. . O

Schneider NNP O
, , O
K NNP O
. . O
, , O
and CC O
Beck NNP O
, , O
C NNP O
. . O
F NNP O
. . O

( -LRB- O
1987 CD O
) -RRB- O
. . O

Methods NNS O
in IN O
Enzymol NNP O
. . O

153 CD O
, , O
452 CD O
- HYPH O
461 CD O
. . O

15 CD O
. . O

Smith NNP O
, , O
H UH O
. . O
W UH O
. . O

( -LRB- O
1972 CD O
) -RRB- O
. . O

Nature NN O
New NNP O
Biol NNP O
. . O

238 CD O
, , O
205 CD O
- HYPH O
206 CD O
. . O

16 CD O
. . O

Scott NNP O
, , O
J NNP O
. . O
R NN O
. . O

( -LRB- O
1975 CD O
) -RRB- O
. . O

Virology NNP O
65 CD O
, , O
173 CD O
- HYPH O
178 CD O
. . O

17 CD O
. . O

Scott NNP O
, , O
J NNP O
. . O
R NNP O
. . O
, , O
Kropf NNP O
, , O
M NNP O
. . O
M NNP O
. . O
, , O
and CC O
Mendelson NNP O
, , O
L NNP O
. . O

( -LRB- O
1977 CD O
) -RRB- O
. . O

Virology NNP O
76 CD O
, , O
39 CD O
- HYPH O
46 CD O
. . O

18 CD O
. . O

Scott NNP O
, , O
J NNP O
. . O
R NN O
. . O

( -LRB- O
1968 CD O
) -RRB- O
. . O

Virology NNP O
36 CD O
, , O
564 CD O
- HYPH O
574 CD O
. . O

19 CD O
. . O

Walker NNP O
, , O
D NNP O
. . O
H NNP O
. . O
, , O
Jr NNP O
. . O
, , O
and CC O
Walker NNP O
, , O
J NNP O
. . O
T NNP O
. . O

( -LRB- O
1976 CD O
) -RRB- O
. . O

J NNP O
. . O

Virol NNP O
. . O

20 CD O
, , O
177 CD O
- SYM O
187 CD O
. . O

20 CD O
. . O

Stemnberg NNP O
, , O
N NNP O
. . O

( -LRB- O
1979 CD O
) -RRB- O
. . O

Virology NNP O
96 CD O
, , O
129 CD O
- HYPH O
142 CD O
. . O

21 CD O
. . O

Schneider NNP O
, , O
K NNP O
. . O
, , O
and CC O
Beck NNP O
, , O
C NNP O
. . O
F NNP O
. . O

( -LRB- O
1986 CD O
) -RRB- O
. . O

Gene NNP O
42 CD O
, , O
37 CD O
- SYM O
48 CD O
. . O

22 CD O
. . O

Taylor NNP O
, , O
D NNP O
. . O
P NN O
. . O
, , O
and CC O
Cohen NNP O
, , O
S NNP O
. . O
N NNP O
. . O

( -LRB- O
1979 CD O
) -RRB- O
. . O

J NNP O
. . O

Bacteriol NN O
. . O

137 CD O
, , O
92 CD O
- HYPH O
104 CD O
. . O

23 CD O
. . O

Miller NNP O
, , O
J NNP O
. . O
H NN O
. . O

( -LRB- O
1972 CD O
) -RRB- O
. . O

In IN O
Experiments NNS O
in IN O
Molecular NNP O
Genetics NNP O
, , O
Cold NNP O
Spring NNP O
Harbor NNP O
Laboratory NNP O
, , O
Cold NNP O
Spring NNP O

Harbor NNP O
, , O
N NNP O
. . O
Y UH O
. . O

352 CD O
- SYM O
355 CD O
. . O

24 CD O
. . O

Guyer NNP O
, , O
R NNP O
. . O
S NN O
. . O

( -LRB- O
1978 CD O
) -RRB- O
. . O

J NNP O
. . O

Mol NNP O
. . O

Biol NNP O
. . O

126 CD O
, , O
347 CD O
- HYPH O
365 CD O
. . O

25 CD O
. . O

Devlin NNP O
, , O
B NNP O
. . O
H NNP O
. . O
, , O
Baumstark NNP O
, , O
B NNP O
. . O
R NNP O
. . O
, , O
and CC O
Scott NNP O
, , O
J NNP O
. . O
R NN O
. . O

( -LRB- O
1982 CD O
) -RRB- O
. . O

Virology NNP O
120 CD O
, , O
360 CD O
- HYPH O
375 CD O
. . O

26 CD O
. . O

Sanger NNP O
, , O
F NNP O
. . O
, , O
Nicklen NNP O
, , O
S NNP O
. . O
, , O
and CC O
Coulson NNP O
, , O
A NNP O
. . O
R NN O
. . O

( -LRB- O
1977 CD O
) -RRB- O
. . O

Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
74 CD O
, , O
5463 CD O
- HYPH O
5467 CD O
. . O

27 CD O
. . O

DeVries NNP O
, , O
J NNP O
. . O
K NNP O
. . O
, , O
and CC O
Zubay NNP O
, , O
G NNP O
. . O

( -LRB- O
1967 CD O
) -RRB- O
. . O

Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
57 CD O
, , O
1010 CD O
- SYM O
1012 CD O
. . O

28 CD O
. . O

Heilmann NNP O
, , O
H NNP O
. . O
, , O
Reeve NNP O
, , O
J NNP O
. . O
R NNP O
. . O
, , O
and CC O
Puhler NNP O
, , O
A NNP O
. . O

( -LRB- O
1980 CD O
) -RRB- O
. . O

Mol NNP O
. . O

Gen UH O
. . O

Genet NNP O
. . O

178 CD O
, , O
149 CD O
- SYM O
154 CD O
. . O

29 CD O
. . O

Shine NNP O
, , O
J NNP O
. . O
, , O
and CC O
Dalgarno NNP O
, , O
L NNP O
. . O

( -LRB- O
1974 CD O
) -RRB- O
. . O

Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

USA NNP O
71 CD O
, , O
1342 CD O
- HYPH O
1346 CD O
. . O

30 CD O
. . O

Chou NNP O
, , O
P NNP O
. . O
Y UH O
. . O
, , O
and CC O
Fasman NNP O
, , O
G NNP O
. . O
D NN O
. . O

( -LRB- O
1978 CD O
) -RRB- O
. . O

Adv UH O
. . O

Enzymol NNP O
. . O

47 CD O
, , O
45 CD O
- SYM O
148 CD O
. . O

31 CD O
. . O

Berg NNP O
, , O
J NNP O
. . O
M NNP O
. . O

( -LRB- O
1986 CD O
) -RRB- O
. . O

Nature NNP O
319 CD O
, , O
264 CD O
- HYPH O
265 CD O
. . O

32 CD O
. . O

Landschultz NNP O
, , O
W NNP O
. . O
H NNP O
. . O
, , O
Johnson NNP O
, , O
P NNP O
. . O
F NNP O
. . O
, , O
and CC O
McKnight NNP O
, , O
S NNP O
. . O
L NNP O
. . O

( -LRB- O
1988 CD O
) -RRB- O
. . O

Science NN O
240 CD O
, , O
1759 CD O
- SYM O
1764 CD O
. . O

33 CD O
. . O

Murre NNP O
, , O
C NNP O
. . O
, , O
McCaw NNP O
, , O
P NNP O
. . O
, , O
and CC O
Baltimore NNP O
, , O
D NNP O
. . O

Cell NNP O
56 CD O
, , O
777 CD O
- HYPH O
783 CD O
. . O

34 CD O
. . O

Anderson NNP O
, , O
B NNP O
. . O
E NNP O
. . O
, , O
Baumstark NNP O
, , O
B NNP O
. . O
R NNP O
. . O
, , O
and CC O
Bellini NNP O
, , O
W NNP O
. . O
J NNP O
. . O

( -LRB- O
1988 CD O
) -RRB- O
. . O

J NNP O
. . O

Bacteriol NN O
. . O

170 CD O
, , O
4493 CD O
- HYPH O
4500 CD O
. . O

35 CD O
. . O

Rosenberg NNP O
, , O
M NNP O
. . O
, , O
and CC O
Court NNP O
, , O
D NNP O
. . O

( -LRB- O
1979 CD O
) -RRB- O
. . O

Annu NNP O
. . O

Rev NNP O
. . O

Genet NNP O
. . O

13 CD O
, , O
319 CD O
- SYM O
353 CD O
. . O

36 CD O
. . O

Ebright NNP O
, , O
R NNP O
. . O
H NNP O
. . O
, , O
Cossart NNP O
, , O
P NNP O
. . O
, , O
Gicquel NNP O
- HYPH O
Sanzey NNP O
, , O
B NNP O
. . O
, , O
and CC O
Beckwith NNP O
, , O
J NNP O
. . O

( -LRB- O
1984 CD O
) -RRB- O
. . O

Nature NNP O
311 CD O
, , O
232 CD O
- HYPH O
235 CD O
. . O

37 CD O
. . O

Ptashne NNP O
, , O
M NNP O
. . O

( -LRB- O
1986 CD O
) -RRB- O
. . O

Nature NNP O
322 CD O
, , O
697 CD O
- HYPH O
701 CD O
. . O

38 CD O
. . O

Stemnberg NNP O
, , O
N NNP O
. . O
, , O
and CC O
Hoess NNP O
, , O
R NNP O
. . O

( -LRB- O
1983 CD O
) -RRB- O
. . O

Annu NNP O
. . O

Rev NNP O
. . O

Genet NNP O
. . O

17 CD O
, , O
123 CD O
- SYM O
154 CD O
. . O

39 CD O
. . O

Scott NNP O
, , O
J NNP O
. . O
R NN O
. . O

( -LRB- O
1980 CD O
) -RRB- O
. . O

Curr UH O
. . O

Top NN O
. . O

Microbiol NNP O
. . O

Immunol NNP O
. . O

90 CD O
, , O
49 CD O
- SYM O
65 CD O
. . O

7680 CD O

This DT O
article NN O
, , O
submitted VBN O
on IN O
disc NN O
, , O
has VBZ O
been VBN O
automatically RB O

converted VBN O
into IN O
this DT O
typeset NN O
format NN O
by IN O
the DT O
publisher NN O
. . O

Down RB O
- HYPH O
regulation NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF NNP O
- HYPH O
II NNP O
receptor NN O
increases VBZ O
cell NN O
proliferation NN O
and CC O
reduces VBZ O
apoptosis NN O
in IN O
neonatal JJ O
rat NN B-Species
cardiac JJ O
myocytes NNS O

Abstract JJ O

Background NN O

The DT O
mannose NN O
6 CD O
- HYPH O
phosphate NN O
/ SYM O
insulin NN O
- HYPH O
like JJ O
growth NN O
factor NN O
- HYPH O
II NN O
receptor NN O
( , O
M6P NNP O
/ SYM O
IGF2R NNP O
) -RRB- O
is VBZ O
a DT O
multi JJ O
- HYPH O
functional JJ O
protein NN O
that WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
regulation NN O
of IN O
cell NN O
growth NN O
and CC O
apoptosis NN O
. . O

Cardiac JJ O
myocytes NNS O
express VBP O
relatively RB O
high JJ O
levels NNS O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
, , O
and CC O
cardiomyocyte NN O
apoptosis NN O
has VBZ O
been VBN O
identified VBN O
in IN O
a DT O
variety NN O
of IN O
cardiovascular JJ O
disorders NNS O
, , O
such JJ O
as IN O
myocardial JJ O
infarction NN O
and CC O
heart NN O
failure NN O
. . O

However RB O
, , O
involvement NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
the DT O
pathogenesis NN O
of IN O
these DT O
conditions NNS O
has VBZ O
not RB O
been VBN O
determined VBN O
. . O

Thus RB O
, , O
the DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
the DT O
role NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
regulation NN O
of IN O
cardiac JJ O
myocyte NN O
growth NN O
and CC O
apoptosis NN O
. . O

Results NNS O

We PRP O
down RB O
- HYPH O
regulated VBD O
the DT O
expression NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
neonatal JJ O
rat NN B-Species
cardiac JJ O
myocytes NNS O
and CC O
examined VBD O
the DT O
effect NN O
on IN O
cell NN O
proliferation NN O
and CC O
apoptosis NN O
. . O

Infection NN O
of IN O
neonatal JJ O
cardiomyocytes NNS O
with IN O
an DT O
adenovirus NN O
expressing VBG O
a DT O
ribozyme NN O
targeted VBN O
against IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
significantly RB O
reduced VBD O
the DT O
level NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
mRNA NNP O
, , O
as IN O
determined VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
and CC O
Ribonuclease NNP O
Protection NNP O
Assay NNP O
( -LRB- O
RPA NNP O
) -RRB- O
. . O

M6P NN O
- HYPH O
containing VBG O
protein NN O
binding NN O
and CC O
endocytosis NN O
as RB O
well RB O
as IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
- HYPH O
mediated VBN O
internalization NN O
of IN O
125I CD O
- HYPH O
IGF NNP O
- HYPH O
II NNP O
were VBD O
lower JJR O
in IN O
the DT O
ribozyme NN O
- HYPH O
treated VBN O
cells NNS O
than IN O
the DT O
control NN O
myocytes NNS O
, , O
indicating VBG O
that IN O
the DT O
number NN O
of IN O
functional JJ O
M6P NNP O
/ SYM O
IGF2R NN O
in IN O
the DT O
ribozyme NN O
treated VBN O
cells NNS O
was VBD O
reduced VBN O
. . O

Accordingly RB O
, , O
a DT O
marked JJ O
increase NN O
in IN O
cell NN O
proliferation NN O
and CC O
a DT O
reduced VBN O
cell NN O
susceptibility NN O
to IN O
hypoxia NN O
- HYPH O
and CC O
TNF NNP O
- HYPH O
induced VBN O
apoptosis NN O
were VBD O
observed VBN O
in IN O
the DT O
ribozyme NN O
- HYPH O
treated VBN O
cells NNS O
. . O

Conclusions NNS O

These DT O
findings NNS O
suggest VBP O
that IN O
M6P NNP O
/ SYM O
IGF2R NNP O
may MD O
play VB O
a DT O
role NN O
in IN O
regulation NN O
of IN O
cardiac JJ O
myocyte NN O
growth NN O
and CC O
apoptosis NN O
. . O

Down RB O
regulation NN O
of IN O
this DT O
gene NN O
in IN O
cardiac JJ O
tissues NNS O
might MD O
be VB O
a DT O
new JJ O
approach NN O
to IN O
prevention NN O
of IN O
cell NN O
death NN O
or CC O
promotion NN O
of IN O
mitogenesis NN O
for IN O
certain JJ O
heart NN O
diseases NNS O
. . O

Background NN O

The DT O
mannose NN O
6 CD O
- HYPH O
phosphate NN O
/ SYM O
insulin NN O
- HYPH O
like JJ O
growth NN O
factor NN O
- HYPH O
II NN O
receptor NN O
( , O
M6P NNP O
/ SYM O
IGF2R NNP O
) -RRB- O
is VBZ O
a DT O
unique JJ O
protein NN O
that WDT O
interacts VBZ O
with IN O
multiple JJ O
ligands NNS O
, , O
some DT O
of IN O
which WDT O
are VBP O
important JJ O
growth NN O
regulatory JJ O
factors NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

The DT O
M6P NNP O
/ SYM O
IGF2R NNP O
participates VBZ O
in IN O
internalization NN O
and CC O
lysosomal JJ O
degradation NN O
of IN O
IGF NNP O
- HYPH O
II NNP O
, , O
a DT O
mitogen NN O
normally RB O
acting VBG O
through IN O
the DT O
IGF NNP O
- HYPH O
I NNP O
receptor NN O
to TO O
stimulate VB O
cell NN O
proliferation NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

The DT O
M6P NNP O
/ SYM O
IGF2 NNP O
receptor NN O
is VBZ O
required VBN O
for IN O
the DT O
activation NN O
of IN O
TGF NNP O
- HYPH O
beta NN O
[ -LRB- O
3 CD O
] -RRB- O
, , O
a DT O
potent JJ O
growth NN O
inhibitor NN O
for IN O
many JJ O
cell NN O
types NNS O
. . O

This DT O
receptor NN O
is VBZ O
also RB O
involved VBN O
in IN O
the DT O
binding NN O
, , O
transport NN O
and CC O
activation NN O
of IN O
newly RB O
- HYPH O
synthesized VBN O
lysosomal JJ O
enzymes NNS O
, , O
such JJ O
as IN O
cathepsins NNS O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
, , O
which WDT O
have VBP O
been VBN O
recently RB O
implicated VBN O
in IN O
the DT O
induction NN O
of IN O
apoptosis NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

On IN O
the DT O
basis NN O
of IN O
these DT O
functions NNS O
, , O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
has VBZ O
been VBN O
proposed VBN O
to TO O
play VB O
a DT O
significant JJ O
role NN O
in IN O
regulation NN O
of IN O
cell NN O
growth NN O
and CC O
apoptosis NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Apoptosis NN O
, , O
or CC O
programmed VBN O
cell NN O
death NN O
, , O
is VBZ O
a DT O
tightly RB O
regulated VBN O
process NN O
used VBN O
to TO O
remove VB O
excess JJ O
, , O
hazardous JJ O
or CC O
damaged VBN O
somatic JJ O
cells NNS O
, , O
and CC O
is VBZ O
crucial JJ O
for IN O
the DT O
development NN O
, , O
maintenance NN O
and CC O
survival NN O
of IN O
an DT O
organism NN O
. . O

However RB O
, , O
alterations NNS O
in IN O
the DT O
control NN O
of IN O
apoptosis NN O
have VBP O
also RB O
been VBN O
shown VBN O
to TO O
contribute VB O
to IN O
human JJ B-Species
diseases NNS O
. . O

In IN O
fact NN O
, , O
morphological JJ O
and CC O
biochemical JJ O
markers NNS O
of IN O
apoptosis NN O
have VBP O
been VBN O
identified VBN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
cardiovascular JJ O
disorders NNS O
, , O
including VBG O
myocardial JJ O
infarction NN O
and CC O
heart NN O
failure NN O
. . O

This DT O
suggests VBZ O
that IN O
activation NN O
of IN O
apoptotic JJ O
pathways NNS O
contributes VBZ O
to IN O
cardiomyocyte NN O
loss NN O
and CC O
subsequent JJ O
cardiac JJ O
dysfunction NN O
in IN O
these DT O
conditions NNS O
. . O

A DT O
number NN O
of IN O
factors NNS O
involved VBN O
in IN O
cardiomyocyte NN O
apoptosis NN O
are VBP O
currently RB O
known VBN O
and CC O
include VBP O
insulin NN O
- HYPH O
like JJ O
growth NN O
factor NN O
- HYPH O
I NN O
( , O
IGF NNP O
- HYPH O
I NNP O
) -RRB- O
, , O
stress NN O
- HYPH O
activated VBN O
protein NN O
kinases NNS O
( , O
SAPKs NNP O
) -RRB- O
and CC O
the DT O
anti AFX O
- HYPH O
apoptotic JJ O
Bcl NNP O
- HYPH O
2 CD O
family NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

There EX O
are VBP O
indications NNS O
that IN O
other JJ O
factors NNS O
may MD O
be VB O
involved VBN O
in IN O
induction NN O
and CC O
regulation NN O
of IN O
cardiac JJ O
apoptosis NN O
. . O

However RB O
, , O
these DT O
potential JJ O
factors NNS O
and CC O
their PRP$ O
corresponding VBG O
mechanisms NNS O
have VBP O
not RB O
been VBN O
identified VBN O
. . O

Several JJ O
lines NNS O
of IN O
evidence NN O
point VBP O
to IN O
the DT O
potential JJ O
involvement NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
cardiac JJ O
myocyte NN O
proliferation NN O
and CC O
apoptosis NN O
. . O

Cardiac JJ O
myocytes NNS O
express VBP O
relatively RB O
high JJ O
levels NNS O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
and CC O
transgenic JJ O
mice NNS B-Species
containing VBG O
a DT O
homologous JJ O
deletion NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
gene NN O
manifest NN O
ventricular JJ O
hyperplasia NN O
due IN O
to IN O
an DT O
increase NN O
in IN O
cell NN O
number NN O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
normally RB O
acts VBZ O
to TO O
suppress VB O
cardiac JJ O
myocyte NN O
cell NN O
growth NN O
. . O

It PRP O
has VBZ O
also RB O
been VBN O
shown VBN O
that IN O
TGF NNP O
- HYPH O
beta NN O
, , O
a DT O
potent JJ O
growth NN O
suppressor NN O
whose WP$ O
activation NN O
requires VBZ O
the DT O
binding NN O
of IN O
latent JJ O
TGF NNP O
- HYPH O
beta NN O
to IN O
M6P NNP O
/ SYM O
IGF2R NNP O
[ -LRB- O
3 CD O
] -RRB- O
, , O
is VBZ O
commonly RB O
upregulated VBN O
in IN O
chronic JJ O
heart NN O
failure NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Additional JJ O
evidence NN O
for IN O
the DT O
involvement NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
regulation NN O
of IN O
apoptosis NN O
comes VBZ O
from IN O
studies NNS O
of IN O
tumorigenesis NN O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
M6P NNP O
/ SYM O
IGF2R NNP O
expression NN O
is VBZ O
significantly RB O
reduced VBN O
in IN O
a DT O
variety NN O
of IN O
tumors NNS O
and CC O
loss NN O
of IN O
heterozygocity NN O
( -LRB- O
LOH NNP O
) -RRB- O
at IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
gene NN O
locus NN O
6q26 CD O
have VBP O
been VBN O
found VBN O
in IN O
breast NN O
, , O
liver NN O
cancers NNS O
and CC O
squamous JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
lung NN O
[ -LRB- O
12 CD O
- HYPH O
15 CD O
] -RRB- O
. . O

Although IN O
several JJ O
studies NNS O
have VBP O
examined VBN O
the DT O
effect NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
over IN O
- HYPH O
expression NN O
on IN O
cell NN O
growth NN O
[ -LRB- O
7 CD O
] -RRB- O
, , O
it PRP O
is VBZ O
not RB O
known VBN O
whether IN O
down RB O
- HYPH O
regulation NN O
of IN O
this DT O
receptor NN O
protein NN O
leads VBZ O
to IN O
cellular JJ O
protection NN O
against IN O
apoptosis NN O
. . O

Ribozymes NNP O
are VBP O
catalytic JJ O
RNA NNP O
molecules NNS O
that WDT O
cleave VBP O
a DT O
complementary JJ O
mRNA NN O
sequence NN O
[ -LRB- O
16 CD O
] -RRB- O
, , O
thereby RB O
inactivating VBG O
specific JJ O
mRNAs NNS O
and CC O
suppressing VBG O
gene NN O
expression NN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
[ -LRB- O
17 CD O
, , O
18 CD O
] -RRB- O
. . O

Ribozymes NNP O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
highly RB O
specific JJ O
, , O
efficient JJ O
and CC O
stable JJ O
. . O

They PRP O
can MD O
be VB O
packaged VBN O
into IN O
viral JJ O
vectors NNS O
to TO O
enhance VB O
transfer NN O
into IN O
cells NNS O
and CC O
to TO O
achieve VB O
longer JJR O
expression NN O
compared VBN O
with IN O
naked JJ O
oligonucleotides NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
employed VBD O
ribozyme NN O
technology NN O
to TO O
study VB O
the DT O
role NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
regulation NN O
of IN O
cardiac JJ O
myocyte NN O
cell NN O
growth NN O
. . O

A DT O
hammerhead NN O
ribozyme NN O
against IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
mRNA NNP O
was VBD O
constructed VBN O
and CC O
packaged VBN O
in IN O
an DT O
adenoviral JJ O
vector NN O
. . O

We PRP O
then RB O
examined VBD O
the DT O
effect NN O
of IN O
ribozyme NN O
- HYPH O
mediated VBN O
down IN O
- HYPH O
regulation NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
expression NN O
on IN O
cell NN O
growth NN O
and CC O
hypoxia NN O
- HYPH O
and CC O
TNF NNP O
- HYPH O
induced VBN O
apoptosis NN O
. . O

Results NNS O

Cleavage NN O
reaction NN O
of IN O
the DT O
ribozyme NN O
in IN O
vitro FW O

The DT O
M6P NNP O
/ SYM O
IGF2R NNP O
ribozyme NN O
we PRP O
constructed VBD O
has VBZ O
13 CD O
- HYPH O
bp NN O
binding VBG O
arms NNS O
complementary JJ O
to IN O
the DT O
target NN O
site NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
mRNA NNP O
, , O
and CC O
a DT O
catalytic JJ O
core NN O
( , O
Fig NNP O
. . O
1A NN O
) -RRB- O
. . O

To TO O
evaluate VB O
the DT O
bioactivity NN O
of IN O
the DT O
ribozyme NN O
and CC O
the DT O
accessibility NN O
of IN O
the DT O
target NN O
site NN O
, , O
a DT O
cleavage NN O
reaction NN O
was VBD O
performed VBN O
in IN O
vitro NN O
. . O

The DT O
substrates NNS O
, , O
[ -LRB- O
alpha NN O
- HYPH O
32P CD O
] -RRB- O
labeled VBN O
RNA NNP O
transcripts NNS O
containing VBG O
45 CD O
bp NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
mRNA NNP O
or CC O
an DT O
unmatched JJ O
sequence NN O
, , O
were VBD O
incubated VBN O
with IN O
the DT O
ribozyme NN O
as IN O
described VBN O
( , O
see VB O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
. . O

The DT O
ribozyme NN O
cleaved VBD O
only RB O
the DT O
specific JJ O
M6P NNP O
/ SYM O
IGF2R NNP O
mRNA NNP O
into IN O
the DT O
expected JJ O
products NNS O
. . O

In IN O
the DT O
assay NN O
of IN O
time NN O
course NN O
, , O
the DT O
hammerhead NN O
ribozyme NN O
was VBD O
able JJ O
to TO O
cleave VB O
24 CD O
. . O
2 CD O
% NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
target NN O
within IN O
10 CD O
minutes NNS O
of IN O
incubation NN O
, , O
50 CD O
. . O
3 CD O
% NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
target NN O
within IN O
40 CD O
minutes NNS O
of IN O
incubation NN O
, , O
and CC O
by IN O
640 CD O
minutes NNS O
, , O
80 CD O
. . O
8 CD O
% NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
target NN O
was VBD O
converted VBN O
to IN O
the DT O
expected JJ O
products NNS O
( , O
Fig NNP O
. . O
1B NN O
) -RRB- O
. . O

This DT O
ribozyme NN O
did VBD O
not RB O
digest VB O
the DT O
unmatched JJ O
sequence NN O
( : O
Fig NNP O
. . O
1B NN O
) -RRB- O
. . O

These DT O
results NNS O
indicate VBP O
a DT O
high JJ O
efficiency NN O
and CC O
specificity NN O
of IN O
the DT O
ribozyme NN O
in IN O
vitro FW O
. . O

Ribozymes NNS O
down RB O
- HYPH O
regulate VBP O
M6P NNP O
/ SYM O
IGF2R NNP O
expression NN O
in IN O
cardiac JJ O
myocytes NNS O

To TO O
examine VB O
the DT O
ability NN O
of IN O
the DT O
ribozyme NN O
to TO O
reduce VB O
levels NNS O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
mRNA NNP O
in IN O
cultured JJ O
cardiac JJ O
myocytes NNS O
, , O
total JJ O
RNA NNP O
was VBD O
extracted VBN O
from IN O
cells NNS O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
or CC O
Ad NNP O
- HYPH O
GFP NNP O
, , O
and CC O
subjected VBN O
to IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
M6P NNP O
/ SYM O
IGF2R NNP O
- HYPH O
specific JJ O
primers NNS O
. . O

Primers NNS O
specific JJ O
for IN O
beta NN O
- HYPH O
actin NN O
were VBD O
added VBN O
to IN O
a DT O
parallel JJ O
reaction NN O
to TO O
serve VB O
as IN O
an DT O
internal JJ O
standard NN O
. . O

Cells NNS O
were VBD O
used VBN O
4 CD O
days NNS O
after IN O
infection NN O
, , O
with IN O
average JJ O
infection NN O
efficiency NN O
of IN O
70 CD O
- SYM O
80 CD O
% NN O
( , O
for IN O
which WDT O
a DT O
viral JJ O
dose NN O
used VBD O
had VBD O
minimal JJ O
cytotoxicity NN O
) -RRB- O
. . O

The DT O
RT NNP O
- HYPH O
PCR NNP O
product NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
was VBD O
856 CD O
bp NN O
, , O
and CC O
the DT O
beta NN O
- HYPH O
actin NN O
product NN O
was VBD O
285 CD O
bp NN O
. . O

As IN O
shown VBN O
in IN O
Fig NNP O
. . O

2A NN O
, , O
the DT O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
- HYPH O
infected VBN O
cells NNS O
exhibited VBD O
a DT O
significantly RB O
lower JJR O
level NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
mRNA NNP O
than IN O
Ad NN O
- HYPH O
GFP NNP O
- HYPH O
infected VBN O
cells NNS O
, , O
with IN O
a DT O
reduction NN O
of IN O
about RB O
50 CD O
% NN O
. . O

This DT O
result NN O
was VBD O
confirmed VBN O
by IN O
ribonuclease NN O
protection NN O
assay NN O
( -LRB- O
RPA NNP O
) -RRB- O
, , O
in IN O
which WDT O
GAPDH NNP O
was VBD O
used VBN O
as IN O
a DT O
control NN O
( , O
Fig NNP O
. . O
2C NN O
& CC O
2D NN O
) -RRB- O
. . O

There EX O
was VBD O
no DT O
significant JJ O
difference NN O
in IN O
the DT O
level NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
mRNA NNP O
between IN O
Ad NN O
- HYPH O
GFP NNP O
- HYPH O
infected VBN O
cells NNS O
and CC O
uninfected JJ O
cells NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
indicating VBG O
that IN O
infection NN O
with IN O
the DT O
adenovirus NN O
itself PRP O
did VBD O
not RB O
alter VB O
the DT O
endogenous JJ O
M6P NNP O
/ SYM O
IGF2R NNP O
mRNA NNP O
level NN O
. . O

The DT O
results NNS O
demonstrated VBD O
that IN O
the DT O
ribozyme NN O
was VBD O
highly RB O
effective JJ O
in IN O
suppressing VBG O
M6P NNP O
/ SYM O
IGF2R NNP O
expression NN O
in IN O
cultured JJ O
cardiac JJ O
myocytes NNS O
. . O

Effect NN O
of IN O
ribozyme NN O
expression NN O
on IN O
the DT O
functional JJ O
activity NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O

To TO O
determine VB O
the DT O
effect NN O
of IN O
the DT O
ribozyme NN O
on IN O
the DT O
functional JJ O
activity NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
, , O
binding NN O
and CC O
internalization NN O
of IN O
exogenous JJ O
125I CD O
- HYPH O
IGF NNP O
- HYPH O
II NNP O
was VBD O
measured VBN O
in IN O
cells NNS O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
. . O

As IN O
shown VBN O
in IN O
Fig NNP O
. . O

3A NN O
, , O
cells NNS O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
showed VBD O
a DT O
54 CD O
% NN O
reduction NN O
in IN O
125I CD O
- HYPH O
IGF NNP O
- HYPH O
II NN O
internalization NN O
when WRB O
compared VBN O
with IN O
the DT O
control NN O
cells NNS O
( , O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
) -RRB- O
. . O

We PRP O
also RB O
examined VBD O
the DT O
effect NN O
of IN O
the DT O
ribozyme NN O
on IN O
the DT O
M6P NNP O
- HYPH O
binding VBG O
activity NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
using VBG O
the DT O
M6P NNP O
- HYPH O
bearing VBG O
lysosomal JJ O
enzyme NN O
, , O
beta NN O
- HYPH O
glucuronidase NN O
, , O
as IN O
a DT O
probe NN O
. . O

The DT O
results NNS O
showed VBD O
that IN O
the DT O
maximal JJ O
M6P NN O
- HYPH O
binding VBG O
capacity NN O
of IN O
cells NNS O
treated VBN O
with IN O
the DT O
ribozyme NN O
was VBD O
about RB O
50 CD O
% NN O
less JJR O
than IN O
that DT O
of IN O
controls NNS O
( : O
Fig NNP O
. . O
3B NN O
) -RRB- O
. . O

Furthermore RB O
, , O
we PRP O
assessed VBD O
the DT O
ability NN O
of IN O
cells NNS O
to TO O
internalize VB O
exogenous JJ O
beta NN O
- HYPH O
glucuronidase NN O
after IN O
treatment NN O
with IN O
ribozyme NN O
. . O

Similarly RB O
, , O
the DT O
M6P NNP O
- HYPH O
inhibitable JJ O
endocytosis NN O
of IN O
beta NN O
- HYPH O
glucuronidase NN O
by IN O
ribozyme NN O
- HYPH O
treated VBN O
cells NNS O
was VBD O
about RB O
52 CD O
% NN O
less JJR O
than IN O
that DT O
of IN O
control NN O
cells NNS O
( , O
Fig NNP O
. . O
3C NNP O
) -RRB- O
. . O

These DT O
results NNS O
confirm VBP O
that IN O
the DT O
number NN O
of IN O
functional JJ O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
ribozyme NN O
- HYPH O
treated VBN O
cells NNS O
was VBD O
reduced VBN O
. . O

Adenoviral JJ O
delivery NN O
of IN O
ribozymes NNS O
increases VBZ O
the DT O
proliferation NN O
of IN O
cardiac JJ O
myocytes NNS O

We PRP O
examined VBD O
the DT O
effects NNS O
of IN O
the DT O
ribozyme NN O
on IN O
the DT O
growth NN O
of IN O
cultured VBN O
neonatal JJ O
rat NN B-Species
cardiac JJ O
myocytes NNS O
. . O

Morphological JJ O
evaluation NN O
showed VBD O
a DT O
remarkable JJ O
difference NN O
in IN O
growth NN O
pattern NN O
between IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
- HYPH O
infected VBN O
cells NNS O
and CC O
the DT O
control NN O
cells NNS O
: : O
the DT O
ribozyme NN O
- HYPH O
expressing VBG O
cells NNS O
formed VBD O
larger JJR O
and CC O
more RBR O
spread JJ O
colonies NNS O
( -LRB- O
Fig NNP O
. . O
4 CD O
) -RRB- O
. . O

Assessment NN O
of IN O
cell NN O
proliferative JJ O
activity NN O
by IN O
the DT O
MTT NNP O
assay NN O
and CC O
counts NNS O
of IN O
viable JJ O
cells NNS O
showed VBD O
that IN O
the DT O
number NN O
of IN O
cardiac JJ O
myocytes NNS O
in IN O
ribozyme NN O
- HYPH O
expressing VBG O
cultures NNS O
was VBD O
significantly RB O
higher JJR O
than IN O
in IN O
control NN O
cultures NNS O
( , O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
treatment NN O
with IN O
M6P NNP O
/ SYM O
IGF2R NNP O
- HYPH O
ribozyme NN O
can MD O
promote VB O
cardiac JJ O
myocyte NN O
proliferation NN O
. . O

Effect NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NN O
- HYPH O
ribozyme NN O
expression NN O
on IN O
apoptosis NN O
of IN O
cardiac JJ O
myocytes NNS O

We PRP O
examined VBD O
the DT O
effects NNS O
of IN O
ribozyme NN O
expression NN O
on IN O
TNF NNP O
- HYPH O
alpha NN O
and CC O
hypoxia NN O
- HYPH O
induced VBN O
apoptosis NN O
of IN O
cultured VBN O
cardiac JJ O
myocytes NNS O
. . O

After IN O
a DT O
24 CD O
hr NN O
challenge NN O
with IN O
hypoxia NN O
, , O
the DT O
number NN O
of IN O
apoptotic JJ O
cells NNS O
in IN O
M6P NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
expressing VBG O
cultures NNS O
was VBD O
38 CD O
% NN O
lower JJR O
than IN O
in IN O
control NN O
cultures NNS O
as IN O
determined VBN O
by IN O
Hoechst NNP O
staining NN O
( , O
which WDT O
highlights VBZ O
the DT O
nuclei NNS O
of IN O
apoptotic JJ O
cells NNS O
) -RRB- O
and CC O
ELISA NNP O
( -LRB- O
Fig NNP O
. . O
6A NNP O
, , O
7A CD O
) -RRB- O
. . O

MTT NNP O
analysis NN O
showed VBD O
that IN O
the DT O
number NN O
of IN O
viable JJ O
cells NNS O
in IN O
ribozyme NN O
- HYPH O
treated VBN O
cultures NNS O
was VBD O
40 CD O
% NN O
higher JJR O
than IN O
in IN O
control NN O
cultures NNS O
( , O
Fig NNP O
. . O
7A CD O
) -RRB- O
. . O

After IN O
treatment NN O
with IN O
TNF NNP O
- HYPH O
alpha NNP O
, , O
as IN O
shown VBN O
in IN O
Fig NNP O
. . O

6B NN O
, , O
a DT O
large JJ O
number NN O
of IN O
control NN O
cells NNS O
underwent VBD O
apoptosis NN O
, , O
as IN O
indicated VBN O
by IN O
morphological JJ O
changes NNS O
( , O
small JJ O
round NN O
shape NN O
) -RRB- O
and CC O
bright JJ O
blue JJ O
nuclear JJ O
staining NN O
. . O

There EX O
were VBD O
significantly RB O
more JJR O
apoptotic JJ O
cells NNS O
in IN O
control NN O
cultures NNS O
than IN O
in IN O
cultures NNS O
expressing VBG O
the DT O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
. . O

The DT O
number NN O
of IN O
apoptotic JJ O
cells NNS O
, , O
as IN O
measured VBN O
by IN O
the DT O
cell NN O
death NN O
ELISA NNP O
assay NN O
, , O
in IN O
cultures NNS O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
was VBD O
significantly RB O
( : O
about RB O
40 CD O
% NN O
) -RRB- O
lower JJR O
than IN O
in IN O
cultures NNS O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
( : O
Fig NNP O
. . O
7B NN O
) -RRB- O
. . O

Accordingly RB O
, , O
the DT O
number NN O
of IN O
viable JJ O
cells NNS O
, , O
as IN O
measured VBN O
by IN O
MTT NNP O
analysis NN O
, , O
in IN O
cultures NNS O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
was VBD O
significantly RB O
( : O
about RB O
45 CD O
% NN O
) -RRB- O
higher JJR O
than IN O
in IN O
cultures NNS O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
( : O
Fig NNP O
. . O
7B NN O
) -RRB- O
. . O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
hypothesis NN O
that IN O
decreasing VBG O
M6P NNP O
/ SYM O
IGF2R NNP O
expression NN O
by IN O
ribozyme NN O
treatment NN O
can MD O
reduce VB O
cell NN O
apoptosis NN O
. . O

Discussion NN O

Some DT O
62 CD O
, , O
0 CD O
, , O
0 CD O
Americans NNPS O
have VBP O
one CD O
or CC O
more JJR O
types NNS O
of IN O
cardiovascular JJ O
disease NN O
( : O
CVD NN O
) -RRB- O
and CC O
CVD NN O
is VBZ O
the DT O
leading VBG O
cause NN O
( : O
40 CD O
. . O
1 CD O
% NN O
) -RRB- O
of IN O
death NN O
in IN O
the DT O
United NNP O
States NNP O
. . O

Myocardial JJ O
infarction NN O
and CC O
heart NN O
failure NN O
, , O
conditions NNS O
accompanied VBN O
by IN O
cardiac JJ O
myocyte NN O
apoptosis NN O
, , O
represent VBP O
23 CD O
% NN O
of IN O
all DT O
CVDs NNS O
and CC O
are VBP O
a DT O
growing VBG O
clinical JJ O
challenge NN O
in IN O
need NN O
of IN O
novel JJ O
therapeutic JJ O
strategies NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
as IN O
a DT O
potential JJ O
new JJ O
therapeutic JJ O
target NN O
for IN O
reduction NN O
of IN O
cardiac JJ O
apoptosis NN O
and CC O
cardiac JJ O
injury NN O
in IN O
these DT O
conditions NNS O
. . O

Using VBG O
ribozyme NN O
technology NN O
we PRP O
down RB O
- HYPH O
regulated VBD O
the DT O
expression NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
neonatal JJ O
cardiac JJ O
myocytes NNS O
. . O

We PRP O
then RB O
examined VBD O
cell NN O
proliferation NN O
and CC O
apoptosis NN O
under IN O
normal JJ O
conditions NNS O
and CC O
post NN O
challenge NN O
with IN O
either CC O
hypoxia NN O
, , O
a DT O
model NN O
of IN O
ischemia NN O
- HYPH O
reperfusion NN O
, , O
or CC O
TNF NNP O
- HYPH O
alpha NN O
, , O
a DT O
cytokine NN O
implicated VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
chronic JJ O
heart NN O
failure NN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
an DT O
association NN O
of IN O
a DT O
decrease NN O
in IN O
the DT O
expression NN O
and CC O
function NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
with IN O
increased VBN O
cell NN O
proliferation NN O
and CC O
decreased VBN O
cell NN O
susceptibility NN O
to IN O
hypoxia NN O
- HYPH O
and CC O
TNF NNP O
- HYPH O
induced VBN O
apoptosis NN O
. . O

Expression NN O
of IN O
the DT O
ribozyme NN O
targeted VBN O
against IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
cardiomyocytes NNS O
resulted VBD O
in IN O
down IN O
- HYPH O
regulation NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
expression NN O
, , O
as IN O
measured VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
and CC O
RPA NNP O
, , O
and CC O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
function NN O
, , O
as IN O
indicated VBN O
by IN O
a DT O
decrease NN O
in IN O
internalization NN O
of IN O
125I CD O
- HYPH O
IGF NNP O
- HYPH O
II NN O
, , O
and CC O
beta NN O
- HYPH O
glucuronidase NN O
binding NN O
and CC O
endocytosis NN O
. . O

MTT NNP O
analysis NN O
and CC O
viable JJ O
cell NN O
counts NNS O
showed VBD O
that IN O
ribozyme NN O
- HYPH O
mediated VBN O
down IN O
- HYPH O
regulation NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
resulted VBD O
in IN O
a DT O
marked JJ O
increase NN O
in IN O
cell NN O
proliferation NN O
of IN O
cardiomyocytes NNS O
, , O
which WDT O
normally RB O
express VBP O
high JJ O
levels NNS O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
[ -LRB- O
20 CD O
] -RRB- O
and CC O
have VBP O
limited JJ O
proliferative JJ O
capabilities NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
findings NNS O
of IN O
previous JJ O
knockout NN O
studies NNS O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
. . O

Since IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
has VBZ O
multiple JJ O
actions NNS O
on IN O
cell NN O
growth NN O
, , O
its PRP$ O
proliferative JJ O
effect NN O
on IN O
the DT O
heart NN O
cells NNS O
observed VBN O
in IN O
this DT O
study NN O
might MD O
involve VB O
multiple JJ O
mechanisms NNS O
. . O

However RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
unchecked JJ O
IGF NNP O
- HYPH O
II NNP O
stimulation NN O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
the DT O
effect NN O
. . O

Because IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
is VBZ O
believed VBN O
to TO O
sequester VB O
and CC O
degrade VB O
IGF NNP O
- HYPH O
II NN O
[ -LRB- O
2 CD O
] -RRB- O
, , O
a DT O
decrease NN O
in IN O
M6P NN O
/ SYM O
IGF2R NN O
expression NN O
and CC O
function NN O
could MD O
result VB O
in IN O
decreased VBN O
degradation NN O
and CC O
hence RB O
increased VBN O
bioavailability NN O
of IN O
IGF NNP O
- HYPH O
II NNP O
to IN O
the DT O
IGF NNP O
- HYPH O
I NNP O
receptor NN O
, , O
which WDT O
mediates VBZ O
the DT O
growth NN O
- HYPH O
promoting VBG O
effect NN O
of IN O
IGF NNP O
- HYPH O
II NNP O
. . O

Supporting VBG O
evidence NN O
for IN O
the DT O
involvement NN O
of IN O
IGF NNP O
- HYPH O
II NNP O
in IN O
the DT O
proliferative JJ O
effect NN O
resulting VBG O
from IN O
loss NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
function NN O
comes VBZ O
from IN O
studies NNS O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
knock VB O
- HYPH O
out RP O
mice NNS B-Species
. . O

M6P NNP O
/ SYM O
IGF2R NNP O
- HYPH O
null JJ O
mice NN B-Species
display VBP O
global JJ O
hyperplasia NN O
that WDT O
coincides VBZ O
with IN O
elevated JJ O
levels NNS O
of IN O
IGF NNP O
- HYPH O
II NNP O
. . O

Most RBS O
importantly RB O
, , O
however RB O
, , O
the DT O
lethal JJ O
nature NN O
of IN O
an DT O
M6P NNP O
/ SYM O
IGF2R NNP O
- HYPH O
null JJ O
phenotype NN O
is VBZ O
reversed VBN O
in IN O
an DT O
IGF NNP O
- HYPH O
II NNP O
- HYPH O
null JJ O
background NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Our PRP$ O
results NNS O
showing VBG O
that IN O
ribozyme NN O
- HYPH O
mediated VBN O
down IN O
- HYPH O
regulation NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
lead VBP O
to IN O
a DT O
decrease NN O
in IN O
IGF NNP O
- HYPH O
II NNP O
internalization NN O
support VBP O
the DT O
above JJ O
possibility NN O
. . O

However RB O
, , O
further JJ O
investigation NN O
to TO O
confirm VB O
this DT O
mechanism NN O
is VBZ O
warranted VBN O
. . O

More RBR O
importantly RB O
, , O
our PRP$ O
results NNS O
also RB O
showed VBD O
that IN O
M6P NNP O
/ SYM O
IGF2R NNP O
down RB O
- HYPH O
regulation NN O
resulted VBD O
in IN O
decreased VBN O
sensitivity NN O
of IN O
cardiomyocytes NNS O
to IN O
hypoxia NN O
- HYPH O
and CC O
TNF NNP O
- HYPH O
induced VBN O
apoptosis NN O
. . O

There EX O
is VBZ O
evidence NN O
that IN O
lysosomal JJ O
enzymes NNS O
, , O
such JJ O
as IN O
cathepsins NNS O
B NN O
and CC O
D NN O
contribute VBP O
to IN O
hypoxia NN O
- HYPH O
and CC O
TNF NNP O
- HYPH O
induced VBN O
apoptosis NN O
in IN O
vitro FW O
[ -LRB- O
22 CD O
- HYPH O
25 CD O
] -RRB- O
and CC O
in IN O
vivo FW O
[ -LRB- O
26 CD O
, , O
27 CD O
] -RRB- O
. . O

The DT O
M6P NNP O
/ SYM O
IGF2R NNP O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
binding NN O
, , O
transport NN O
and CC O
activation NN O
of IN O
lysosomal JJ O
enzymes NNS O
, , O
including VBG O
cathepsins NNS O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
down IN O
- HYPH O
regulation NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
results VBZ O
in IN O
improper JJ O
trafficking NN O
and CC O
activation NN O
of IN O
cathepsins NNS O
. . O

This DT O
, , O
in IN O
turn NN O
would MD O
eliminate VB O
the DT O
apoptotic JJ O
cascades NNS O
triggered VBN O
by IN O
these DT O
enzymes NNS O
under IN O
hypoxia NN O
and CC O
TNF NN O
stimulation NN O
and CC O
result VBP O
in IN O
decreased VBN O
sensitivity NN O
of IN O
cardiomyocytes NNS O
to IN O
apoptosis NN O
. . O

It PRP O
has VBZ O
also RB O
been VBN O
shown VBN O
that IN O
TNF NNP O
stimulation NN O
involves VBZ O
the DT O
activation NN O
of IN O
TGF NNP O
- HYPH O
beta NN O
[ -LRB- O
28 CD O
- SYM O
30 CD O
] -RRB- O
, , O
a DT O
ligand NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
that WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
progression NN O
of IN O
chronic JJ O
heart NN O
failure NN O
[ -LRB- O
11 CD O
, , O
31 CD O
] -RRB- O
. . O

Therefore RB O
, , O
down RB O
- HYPH O
regulation NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
expression NN O
could MD O
also RB O
lead VB O
to IN O
a DT O
decreased VBN O
bioavailability NN O
of IN O
activated VBN O
TGF NNP O
- HYPH O
beta NN O
, , O
thereby RB O
decreasing VBG O
the DT O
sensitivity NN O
of IN O
cardiomyocytes NNS O
to IN O
the DT O
TNF NNP O
/ SYM O
TGF NNP O
- HYPH O
beta NN O
apoptotic JJ O
pathway NN O
. . O

The DT O
detailed JJ O
mechanism NN O
of IN O
the DT O
observed JJ O
effects NNS O
is VBZ O
unknown JJ O
and CC O
requires VBZ O
further JJ O
investigation NN O
. . O

Conclusions NNS O

The DT O
present JJ O
study NN O
demonstrates VBZ O
that IN O
ribozyme NN O
- HYPH O
mediated VBN O
down IN O
- HYPH O
regulation NN O
of IN O
expression NN O
and CC O
functional JJ O
activity NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
results VBZ O
in IN O
a DT O
decrease NN O
in IN O
the DT O
susceptibility NN O
of IN O
cardiac JJ O
myocytes NNS O
to IN O
apoptotic JJ O
stimuli NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
this DT O
receptor NN O
might MD O
be VB O
involved VBN O
in IN O
cardiac JJ O
cell NN O
growth NN O
and CC O
apoptosis NN O
. . O

The DT O
ability NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
ribozyme NN O
to TO O
reduce VB O
M6P NN O
/ SYM O
IGF2R NN O
expression NN O
and CC O
function NN O
in IN O
transfected VBN O
cells NNS O
verifies VBZ O
the DT O
utility NN O
of IN O
the DT O
ribozyme NN O
in IN O
studying VBG O
the DT O
role NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
in IN O
cardiomyocyte NN O
growth NN O
and CC O
apoptosis NN O
. . O

In IN O
addition NN O
to IN O
its PRP$ O
utility NN O
as IN O
a DT O
research NN O
tool NN O
, , O
the DT O
ribozyme NN O
, , O
with IN O
further JJ O
exploration NN O
and CC O
development NN O
, , O
might MD O
have VB O
potential JJ O
application NN O
as IN O
a DT O
therapeutic JJ O
agent NN O
to TO O
prevent VB O
cell NN O
death NN O
or CC O
promote VB O
mitogenesis NN O
for IN O
certain JJ O
clinical JJ O
conditions NNS O
, , O
such JJ O
as IN O
, , O
myocardial JJ O
infarction NN O
and CC O
chronic JJ O
heart NN O
failure NN O
. . O

Methods NNS O

Construction NN O
of IN O
recombinant JJ O
M6P NNP O
/ SYM O
IGF2R NNP O
- HYPH O
RZ NN O
adenoviral JJ O
vector NN O

The DT O
nucleotide NN O
numbers NNS O
of IN O
the DT O
rat NN B-Species
M6P NNP O
/ SYM O
IGF2R NNP O
sequence NN O
targeted VBN O
by IN O
the DT O
hammerhead NN O
ribozyme NN O
is VBZ O
1147 CD O
- HYPH O
1160 CD O
after IN O
coding VBG O
site NN O
( , O
exon NN O
9 CD O
) -RRB- O
. . O

The DT O
structure NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
hammerhead NN O
ribozyme NN O
is VBZ O
shown VBN O
in IN O
Fig NNP O
. . O

1 LS O
. . O

A DT O
49 CD O
bp NN O
M6P NN O
/ SYM O
IGF2R NN O
ribozyme NN O
oligonucleotide NN O
, , O
5 CD O
' '' O
- HYPH O
GAATTCCCC NN O
ACACTG NN O
ATGAGCCGCTTCGGCGGCGA NNP O
GCGT NNP O
- HYPH O
3 CD O
' '' O
and CC O
the DT O
corresponding VBG O
reverse JJ O
complementary JJ O
strand NN O
were VBD O
synthesized VBN O
. . O

The DT O
fragments NNS O
were VBD O
subcloned VBN O
to TO O
produce VB O
a DT O
plasmid NN O
containing VBG O
a DT O
ribozyme NN O
against IN O
M6P NNP O
/ SYM O
IGF2R NNP O
. . O

For IN O
construction NN O
of IN O
the DT O
recombinant JJ O
adenovirus NN O
containing VBG O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
- HYPH O
ribozyme NNP O
( , O
pAd NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
) -RRB- O
, , O
the DT O
segments NNS O
containing VBG O
the DT O
ribozymes NNS O
were VBD O
amplified VBN O
by IN O
PCR NNP O
and CC O
cloned VBN O
into IN O
a DT O
pAdTrack NN O
- HYPH O
CMV NN O
vector NN O
and CC O
then RB O
recombined VBN O
homologously RB O
with IN O
an DT O
adenoviral JJ O
backbone NN O
pAdEasy NN O
1 CD O
vector NN O
to TO O
generate VB O
( , O
pAd NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
) -RRB- O
, , O
following VBG O
the DT O
protocol NN O
described VBN O
by IN O
He PRP O
et FW O
al NNP O
. . O

[ -LRB- O
32 CD O
] -RRB- O
. . O

The DT O
pAd NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
carries VBZ O
both CC O
the DT O
IGF2R NNP O
- HYPH O
Rz NNP O
and CC O
GFP NNP O
( -LRB- O
as IN O
reporter NN O
) -RRB- O
genes NNS O
, , O
each DT O
under IN O
the DT O
control NN O
of IN O
separate JJ O
cytomegalovirus NN O
( -LRB- O
CMV NNP O
) -RRB- O
promoters NNS O
. . O

Another DT O
viral JJ O
vector NN O
, , O
pAd NN O
- HYPH O
GFP NNP O
, , O
which WDT O
carries VBZ O
the DT O
GFP NNP O
gene NN O
only RB O
under IN O
the DT O
control NN O
of IN O
the DT O
CMV NNP O
promoter NN O
, , O
was VBD O
generated VBN O
and CC O
used VBN O
as IN O
a DT O
control NN O
vector NN O
. . O

The DT O
adenoviral JJ O
vector NN O
DNA NN O
were VBD O
linerized VBN O
with IN O
Pac NNP O
I NNP O
and CC O
transfected VBN O
into IN O
the DT O
replication NN O
- HYPH O
permissive JJ O
293 CD O
cells NNS O
( , O
E1A NNP O
transcomplementing VBG O
cell NN O
line NN O
) , O
by IN O
using VBG O
Lipofectamine NNP O
( -LRB- O
Life NNP O
Technologies NNP O
) -RRB- O
to TO O
produce VB O
E1 NN O
- HYPH O
deleted VBN O
, , O
replication NN O
- HYPH O
defective JJ O
recombinant JJ O
adenovirus NN O
as IN O
described VBN O
previously RB O
[ -LRB- O
33 CD O
] -RRB- O
. . O

Large JJ O
- HYPH O
scale NN O
amplification NN O
of IN O
recombinant JJ O
adenovirus NN O
in IN O
293 CD O
cells NNS O
was VBD O
followed VBN O
by IN O
purification NN O
using VBG O
a DT O
discontinuous JJ O
CsCl NNP O
gradient NN O
. . O

The DT O
constructs NNS O
were VBD O
confirmed VBN O
by IN O
enzymatic JJ O
digestion NN O
and CC O
DNA NN O
sequencing NN O
. . O

Transcription NN O
and CC O
cleavage NN O
reaction NN O
of IN O
ribozyme NN O
in IN O
vitro FW O

Plasmids NNS O
containing VBG O
the DT O
ribozyme NN O
or CC O
the DT O
substrate NN O
( , O
either CC O
45 CD O
bp NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NN O
mRNA NN O
or CC O
an DT O
unmatched JJ O
sequence NN O
5 CD O
' '' O
- HYPH O
GTGCTGTCTGTATG NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
were VBD O
linearized VBN O
with IN O
MluI NNP O
, , O
respectively RB O
. . O

All DT O
transcripts NNS O
were VBD O
generated VBN O
with IN O
T7 NNP O
RNA NNP O
polymerase NN O
( -LRB- O
Promega NNP O
) -RRB- O
. . O

Substrate NN O
transcripts NNS O
were VBD O
labeled VBN O
by IN O
incorporation NN O
of IN O
[ -LRB- O
alpha NN O
- HYPH O
32P CD O
] -RRB- O
UTP NNP O
( , O
NEN NNP O
Life NNP O
Science NNP O
Products NNPS O
, , O
Inc NNP O
. . O
) -RRB- O
. . O

Specific JJ O
activity NN O
of IN O
the DT O
[ -LRB- O
alpha NN O
- HYPH O
32P CD O
] -RRB- O
UTP NNP O
( SYM O
10 CD O
mu NN O
Ci NN O
/ SYM O
mu NN O
l '' O
) -RRB- O
and CC O
the DT O
base JJ O
composition NN O
of IN O
each DT O
substrate NN O
molecule NN O
were VBD O
used VBN O
to TO O
calculate VB O
the DT O
substrate NN O
concentration NN O
. . O

Ribozyme NNP O
transcripts NNS O
were VBD O
quantified VBN O
spectrophotometrical JJ O
. . O

( : O
The DT O
half JJ O
- HYPH O
life NN O
of IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
target NN O
is VBZ O
about RB O
280 CD O
minutes NNS O
) -RRB- O
. . O

Cleavage NN O
reaction NN O
mixture NN O
contained VBD O
substrate NN O
RNA NNP O
( , O
40 CD O
nM NN O
) -RRB- O
, , O
increasing VBG O
amounts NNS O
of IN O
ribozyme NN O
( , O
60 CD O
nM NN O
) -RRB- O
, , O
20 CD O
mM NN O
MgCl2 NN O
and CC O
20 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
, , O
pH8 NN O
. . O
0 CD O
, , O
in IN O
a DT O
final JJ O
volume NN O
of IN O
10 CD O
mu NNS O
l -RRB- O
. . O

The DT O
mixture NN O
was VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
a DT O
time NN O
- HYPH O
course NN O
of IN O
cleavage NN O
reaction NN O
from IN O
0 CD O
, , O
5 CD O
, , O
10 CD O
, , O
20 CD O
, , O
40 CD O
, , O
80 CD O
, , O
160 CD O
, , O
320 CD O
, , O
to IN O
640 CD O
minutes NNS O
and CC O
the DT O
cleavage NN O
reaction NN O
was VBD O
stopped VBN O
by IN O
addition NN O
of IN O
loading NN O
buffer NN O
( , O
80 CD O
% NN O
formamide NN O
, , O
10 CD O
mM NN O
Na2EDTA NN O
, , O
pH NN O
8 CD O
. . O
0 CD O
, , O
and CC O
1 CD O
mg NN O
/ SYM O
ml NN O
each DT O
bromophenol NN O
blue JJ O
and CC O
xylene NN O
cyanol NN O
) -RRB- O
. . O

Cleavage NN O
products NNS O
were VBD O
analyzed VBN O
on IN O
a DT O
15 CD O
% NN O
polyacrylamide NN O
and CC O
8M NN O
urea NN O
gel NN O
. . O

Product NN O
and CC O
substrate NN O
fragments NNS O
were VBD O
quantitated VBN O
by IN O
using VBG O
NIH NNP O
Imager NNP O
. . O

Cell NN O
cultures NNS O
and CC O
infection NN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
Rz NNP O
- HYPH O
IGF2R NNP O
and CC O
Ad NNP O
- HYPH O
GFP NNP O

Cardiac JJ O
myocytes NNS O
were VBD O
isolated VBN O
from IN O
1 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
newborn JJ O
rats NNS B-Species
using VBG O
the DT O
Neonatal NNP O
Cardiomyocyte NNP O
Isolation NNP O
System NNP O
( : O
Worthington NNP O
) -RRB- O
. . O

The DT O
isolated VBN O
cells NNS O
were VBD O
plated VBN O
in IN O
6 CD O
- HYPH O
well NN O
plates NNS O
and CC O
cultured VBN O
in IN O
F NNP O
- HYPH O
10 CD O
medium NN O
containing VBG O
5 CD O
% NN O
( , O
vol NN O
/ SYM O
vol NN O
) SYM O
FBS NN O
and CC O
10 CD O
% NN O
( , O
vol NN O
/ SYM O
vol NN O
) -RRB- O
horse NN B-Species
serum NN O
at IN O
37 CD O
degrees NNS O
C NN O
in IN O
a DT O
tissue NN O
culture NN O
incubator NN O
with IN O
5 CD O
% NN O
CO2 NN O
and CC O
98 CD O
% NN O
relative JJ O
humidity NN O
. . O

Cells NNS O
were VBD O
used VBN O
for IN O
experiments NNS O
after IN O
2 CD O
- SYM O
3 CD O
days NNS O
of IN O
culture NN O
. . O

Viral JJ O
infections NNS O
were VBD O
carried VBN O
out RP O
by IN O
adding VBG O
viral JJ O
particles NNS O
at IN O
various JJ O
concentrations NNS O
( , O
usually RB O
, , O
2 CD O
x SYM O
108 CD O
virus NN O
particles NNS O
/ SYM O
ml NN O
) -RRB- O
to IN O
culture NN O
medium NN O
containing VBG O
2 CD O
% NN O
( , O
vol NN O
/ SYM O
vol NN O
) -RRB- O
FBS NNP O
. . O

Initially RB O
, , O
optimal JJ O
viral JJ O
concentration NN O
was VBD O
determined VBN O
by IN O
using VBG O
Ad NNP O
- HYPH O
GFP NNP O
to TO O
achieve VB O
an DT O
optimal JJ O
balance NN O
of IN O
high JJ O
gene NN O
expression NN O
and CC O
low JJ O
viral JJ O
titer NN O
to TO O
minimize VB O
cytotoxicity NN O
. . O

After IN O
24 CD O
hours NNS O
of IN O
incubation NN O
, , O
the DT O
infection NN O
medium NN O
was VBD O
replaced VBN O
with IN O
normal JJ O
( , O
15 CD O
% NN O
vol NN O
/ SYM O
vol NN O
serum NN O
) , O
culture NN O
medium NN O
. . O

For IN O
treatment NN O
with IN O
IGF NNP O
- HYPH O
II NNP O
, , O
cells NNS O
were VBD O
incubated VBN O
with IN O
50 CD O
ng CD O
/ SYM O
ml NNP O
IGF NNP O
- HYPH O
II NNP O
after IN O
24 CD O
hours NNS O
infection NN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
or CC O
Ad NNP O
- HYPH O
GFP NNP O
. . O

Four CD O
days NNS O
after IN O
infection NN O
, , O
cells NNS O
were VBD O
used VBN O
for IN O
analysis NN O
of IN O
gene NN O
expression NN O
of IN O
M6P NNP O
/ SYM O
IGF2R NNP O
and CC O
its PRP$ O
effect NN O
on IN O
cell NN O
growth NN O
and CC O
apoptosis NN O
. . O

Analysis NN O
of IN O
gene NN O
expression NN O
in IN O
cardiac JJ O
myocytes NNS O

The DT O
M6P NNP O
/ SYM O
IGF2R NNP O
transcripts NNS O
were VBD O
determined VBN O
by IN O
both CC O
RT NNP O
- HYPH O
PCR NNP O
and CC O
Ribonuclease NNP O
Protection NNP O
Assay NNP O
( : O
RPA NNP O
) -RRB- O
. . O

RT NNP O
- HYPH O
PCR NNP O
was VBD O
performed VBN O
using VBG O
the DT O
GeneAmp NNP O
EZ NNP O
rTth NNP O
RNA NNP O
PCR NNP O
kit NN O
( : O
Roche NNP O
) -RRB- O
. . O

Total JJ O
RNA NNP O
was VBD O
extracted VBN O
from IN O
cultured VBN O
cells NNS O
using VBG O
an DT O
RNA NNP O
isolation NN O
kit NN O
( , O
Qiagen NNP O
, , O
) -RRB- O
, , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

M6P NNP O
/ SYM O
IGF2R NNP O
transcripts NNS O
were VBD O
amplified VBN O
using VBG O
the DT O
primers NNS O
( -LRB- O
5 CD O
' '' O
- HYPH O
GACAGGCTCGTTCTGACTTA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
( : O
5 CD O
' '' O
- HYPH O
CTTCCACTCTTATCCACAGC NN O
- HYPH O
3 CD O
' '' O
) -RRB- O
specific JJ O
to IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
. . O

Each DT O
RT NNP O
- HYPH O
PCR NNP O
assay NN O
was VBD O
performed VBN O
in IN O
triplicate NN O
and CC O
product NN O
levels NNS O
varied VBN O
by IN O
less JJR O
than IN O
3 CD O
. . O
2 CD O
% NN O
for IN O
each DT O
RNA NNP O
sample NN O
. . O

Primers NNS O
specific JJ O
for IN O
beta NN O
- HYPH O
actin NN O
cDNA NNP O
were VBD O
added VBN O
to IN O
a DT O
parallel JJ O
reaction NN O
to TO O
standardize VB O
for IN O
variations NNS O
in IN O
PCR NN O
between IN O
samples NNS O
. . O

PCR NN O
products NNS O
were VBD O
resolved VBN O
on IN O
a DT O
1 CD O
. . O
0 CD O
% NN O
agarose NN O
gel NN O
, , O
visualized VBN O
under IN O
UV NNP O
light NN O
and CC O
quantitated VBN O
using VBG O
NIH NNP O
Imager NNP O
. . O

RPA NNP O
was VBD O
performed VBN O
using VBG O
the DT O
RPA NNP O
III NNP O
kit NN O
( : O
Ambion NNP O
, , O
Austin NNP O
, , O
TX NNP O
) -RRB- O
. . O

Briefly RB O
, , O
total JJ O
RNA NNP O
was VBD O
extracted VBN O
from IN O
cultured JJ O
cells NNS O
using VBG O
a DT O
total JJ O
RNA NNP O
isolation NN O
reagent NN O
( , O
TRIzol NNP O
, , O
Gibco NNP O
BRL NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

The DT O
plasmid NN O
containing VBG O
the DT O
rat NN B-Species
M6P NNP O
/ SYM O
IGF2R NNP O
gene NN O
was VBD O
linearized VBN O
and CC O
used VBN O
as IN O
a DT O
transcription NN O
template NN O
. . O

Antisense JJ O
RNA NNP O
probes NNS O
were VBD O
transcribed VBN O
in IN O
vitro FW O
using VBG O
[ -LRB- O
33P NN O
] -RRB- O
- HYPH O
UTP NNP O
, , O
T7 NN O
polymerase NN O
( , O
Riboprobea NNP O
System NNP O
T7 NN O
kit NN O
, , O
Promega NNP O
) -RRB- O
, , O
hybridized VBN O
with IN O
the DT O
total JJ O
RNA NNP O
extracted VBN O
from IN O
the DT O
rat NN B-Species
cardiomyocytes NNS O
, , O
and CC O
digested VBN O
with IN O
ribonuclease NN O
to TO O
remove VB O
non NN O
- HYPH O
hybridized JJ O
RNA NN O
and CC O
probe NN O
. . O

The DT O
protected VBN O
RNA NNP O
. . O
RNA NNP O
was VBD O
resolved VBN O
on IN O
a DT O
denaturing JJ O
5 CD O
% NN O
sequence NN O
gel NN O
and CC O
subjected VBN O
to IN O
autoradiography NN O
. . O

A DT O
probe NN O
targeting VBG O
the DT O
GAPDH NNP O
gene NN O
was VBD O
used VBN O
as IN O
an DT O
internal JJ O
control NN O
. . O

Measurement NN O
of IN O
125I CD O
- HYPH O
IGF NNP O
- HYPH O
II NNP O
internalization NN O

Cells NNS O
were VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
2 CD O
hrs NNS O
in IN O
serum NN O
- HYPH O
free JJ O
F NNP O
- HYPH O
10 CD O
culture NN O
medium NN O
containing VBG O
125I NNP O
- HYPH O
labeled VBN O
IGF NNP O
- HYPH O
II NNP O
( : O
0 CD O
. . O
5 CD O
ng NN O
/ SYM O
ml NN O
) -RRB- O
with IN O
or CC O
without IN O
excess JJ O
unlabeled JJ O
IGF NNP O
- HYPH O
II NN O
( : O
2 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
. . O

Following VBG O
the DT O
incubation NN O
, , O
the DT O
cells NNS O
were VBD O
washed VBN O
three CD O
times NNS O
with IN O
ice NN O
- HYPH O
cold JJ O
PBS NNP O
, , O
and CC O
cell NN O
- HYPH O
associated VBN O
radioactivity NN O
was VBD O
determined VBN O
by IN O
a DT O
gamma NN O
counter NN O
. . O

Specific JJ O
internalized JJ O
125I CD O
- HYPH O
IGF NNP O
- HYPH O
II NNP O
was VBD O
calculated VBN O
by IN O
subtracting VBG O
the DT O
count NN O
of IN O
samples NNS O
with IN O
excessive JJ O
unlabeled JJ O
IGF NNP O
- HYPH O
II NNP O
from IN O
that DT O
without IN O
unlabeled JJ O
IGF NNP O
- HYPH O
II NNP O
, , O
and CC O
normalized VBN O
to IN O
protein NN O
contents NNS O
. . O

Beta JJ O
- HYPH O
glucuronidase NN O
binding VBG O
assay NN O

Binding VBG O
of IN O
beta NN O
- HYPH O
glucuronidase NN O
was VBD O
assayed VBN O
as IN O
described VBN O
previously RB O
[ -LRB- O
34 CD O
, , O
35 CD O
] -RRB- O
. . O

Briefly RB O
, , O
cells NNS O
were VBD O
permeabilized VBN O
with IN O
0 CD O
. . O
25 CD O
% NN O
saponin NN O
in IN O
50 CD O
mM NN O
Hepes NNS O
( : O
pH NN O
7 CD O
. . O
0 CD O
) -RRB- O
, , O
150 CD O
mM NN O
NaCl NN O
, , O
5 CD O
mM NN O
beta NN O
- HYPH O
glycerophosphate NN O
, , O
0 CD O
. . O
5 CD O
% NN O
human JJ B-Species
serum NN O
albumin NN O
, , O
and CC O
10 CD O
mM NN O
mannose NN O
- HYPH O
6 CD O
- HYPH O
phosphate NN O
( , O
M6P NN O
) -RRB- O
for IN O
30 CD O
minutes NNS O
on IN O
ice NN O
. . O

The DT O
cells NNS O
were VBD O
washed VBN O
three CD O
times NNS O
with IN O
ice NN O
- HYPH O
cold JJ O
PBS NNS O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
saponin NN O
. . O

They PRP O
were VBD O
incubated VBN O
with IN O
20 CD O
, , O
0 CD O
units NNS O
/ SYM O
ml NNS O
beta NN O
- HYPH O
glucuronidase NN O
from IN O
bovine JJ B-Species
liver NN O
( -LRB- O
Sigma NNP O
) -RRB- O
in IN O
50 CD O
mM NN O
Hepes NNP O
( , O
pH NN O
7 CD O
. . O
5 CD O
) -RRB- O
containing VBG O
150 CD O
mM NN O
NaCl NN O
, , O
5 CD O
mM NN O
beta NN O
- HYPH O
glycerophosphate NN O
, , O
0 CD O
. . O
5 CD O
% NN O
human JJ B-Species
serum NN O
albumin NN O
, , O
0 CD O
. . O
5 CD O
% NN O
saponin NN O
with IN O
or CC O
without IN O
10 CD O
mM NN O
M6P NN O
overnight RB O
on IN O
ice NN O
. . O

Cells NNS O
were VBD O
washed VBN O
five CD O
times NNS O
with IN O
ice NN O
- HYPH O
cold JJ O
PBS NN O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
saponin NN O
and CC O
sonicated VBN O
in IN O
100 CD O
mM NN O
sodium NN O
acetate NN O
( , O
pH NN O
4 CD O
. . O
6 CD O
) -RRB- O
. . O

The DT O
protein NN O
concentration NN O
of IN O
solubilized VBN O
cell NN O
extract NN O
was VBD O
measured VBN O
and CC O
enzyme NN O
activity NN O
was VBD O
assayed VBN O
as IN O
follows VBZ O
: : O
for IN O
each DT O
reaction NN O
50 CD O
ul NN O
cell NN O
extract NN O
were VBD O
added VBN O
to IN O
500 CD O
ul NNS O
of IN O
100 CD O
mM NN O
sodium NN O
acetate NN O
( HYPH O
pH NN O
4 CD O
. . O
0 CD O
) -RRB- O
containing VBG O
1 CD O
mM NN O
paranitrophenyl NN O
( , O
PNP NN O
) -RRB- O
- HYPH O
beta NN O
- HYPH O
glucuronide NN O
( : O
Sigma NNP O
) -RRB- O
as IN O
substrate NN O
. . O

After IN O
an DT O
incubation NN O
period NN O
of IN O
3 CD O
hours NNS O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
500 CD O
ul NN O
1 CD O
M NN O
Na2CO3 NNP O
were VBD O
added VBN O
to IN O
each DT O
reaction NN O
and CC O
the DT O
absorbance NN O
was VBD O
measured VBN O
at IN O
400 CD O
nm NN O
. . O

Experimental JJ O
values NNS O
were VBD O
compared VBN O
to IN O
a DT O
standard JJ O
curve NN O
that WDT O
was VBD O
constructed VBN O
using VBG O
1 CD O
- SYM O
100 CD O
nM NN O
solutions NNS O
of IN O
PNP NNP O
( -LRB- O
Sigma NNP O
) -RRB- O
in IN O
500 CD O
ul NN O
100 CD O
mM NN O
sodium NN O
acetate NN O
and CC O
500 CD O
u1 NN O
1 CD O
M NN O
Na2CO3 NN O
. . O

Specific JJ O
activity NN O
was VBD O
calculated VBN O
as IN O
nM NNP O
of IN O
PNP NNP O
produced VBN O
/ SYM O
hour NN O
/ SYM O
mg NN O
of IN O
protein NN O
. . O

Beta JJ O
- HYPH O
glucuronidase JJ O
endocytosis NN O
assay NN O

Beta JJ O
- HYPH O
glucuronidase NNP O
endocytosis NN O
assay NN O
was VBD O
carried VBN O
out RP O
as IN O
described VBN O
previously RB O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Briefly RB O
, , O
confluent JJ O
cell NN O
cultures NNS O
were VBD O
washed VBN O
twice RB O
with IN O
pre NN O
- HYPH O
warmed VBN O
serum NN O
- HYPH O
free JJ O
DMEM NNP O
followed VBN O
by IN O
incubation NN O
with IN O
DMEM NNP O
containing VBG O
5 CD O
mg NN O
/ SYM O
ml NN O
human JJ B-Species
serum NN O
albumin NN O
and CC O
10 CD O
mM NN O
M6P NN O
for IN O
20 CD O
minutes NNS O
. . O

Following VBG O
incubation NN O
cells NNS O
were VBD O
washed VBN O
3 CD O
times NNS O
with IN O
pre NN O
- HYPH O
warmed VBN O
DMEM NNP O
. . O

Cells NNS O
were VBD O
then RB O
incubated VBN O
in IN O
DMEM NNP O
containing VBG O
5 CD O
mg NN O
/ SYM O
ml NN O
human JJ B-Species
serum NN O
albumin NN O
alone RB O
or CC O
4000 CD O
units NNS O
beta NN O
- HYPH O
glucuronidase NN O
with IN O
or CC O
without IN O
10 CD O
mM NN O
M6P NN O
for IN O
2 CD O
hours NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Following VBG O
the DT O
incubation NN O
, , O
the DT O
cells NNS O
were VBD O
washed VBN O
5 CD O
times NNS O
with IN O
ice NN O
- HYPH O
cold JJ O
PBS NNP O
and CC O
subjected VBN O
to IN O
enzyme NN O
activity NN O
assay NN O
as IN O
described VBN O
above RB O
. . O

Cell NN O
proliferation NN O
assay NN O
( -LRB- O
MTT NNP O
assay NN O
and CC O
cell NN O
counts NNS O
) -RRB- O

Cardiac JJ O
myocytes NNS O
were VBD O
grown VBN O
in IN O
culture NN O
plates NNS O
( , O
tissue NN O
culture NN O
grade NN O
, , O
12 CD O
wells NNS O
, , O
flat JJ O
bottom NN O
) , O
in IN O
a DT O
final JJ O
volume NN O
of IN O
1 CD O
ml NN O
serum NN O
- HYPH O
containing VBG O
culture NN O
medium NN O
per IN O
well NN O
, , O
in IN O
a DT O
humidified JJ O
atmosphere NN O
( , O
37 CD O
degrees NNS O
C NN O
and CC O
5 CD O
% NN O
C02 CD O
) -RRB- O
for IN O
3 CD O
days NNS O
. . O

After IN O
infection NN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
or CC O
Ad NN O
- HYPH O
GFP NNP O
, , O
cells NNS O
were VBD O
incubated VBN O
with IN O
or CC O
without IN O
50 CD O
ng CD O
/ SYM O
ml NNP O
IGF NNP O
- HYPH O
II NNP O
for IN O
4 CD O
days NNS O
. . O

Following VBG O
supplementation NN O
with IN O
IGF NNP O
- HYPH O
II NNP O
, , O
100 CD O
mu NNS O
l SYM O
MTT NNP O
labeling NN O
reagent NN O
( , O
Roche NNP O
) -RRB- O
were VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
cells NNS O
were VBD O
incubated VBN O
for IN O
4 CD O
hours NNS O
, , O
followed VBN O
by IN O
addition NN O
of IN O
1 CD O
ml NN O
solubilization NN O
solution NN O
into IN O
each DT O
well NN O
. . O

The DT O
plate NN O
was VBD O
placed VBN O
in IN O
an DT O
incubator NN O
at IN O
37 CD O
degrees NNS O
C NNP O
overnight RB O
. . O

Spectrophotometrical JJ O
absorbency NN O
of IN O
the DT O
samples NNS O
was VBD O
measured VBN O
using VBG O
an DT O
UV NN O
- HYPH O
visible JJ O
Recording NNP O
Spectrophotometer NNP O
with IN O
wavelength NN O
of IN O
550 CD O
- SYM O
690 CD O
nm NN O
. . O

In IN O
addition NN O
, , O
the DT O
total JJ O
number NN O
of IN O
viable JJ O
cells NNS O
in IN O
each DT O
treatment NN O
was VBD O
counted VBN O
by IN O
trypan NN O
blue JJ O
exclusion NN O
method NN O
using VBG O
a DT O
hemocytometer NN O
. . O

Induction NN O
and CC O
analysis NN O
of IN O
cell NN O
apoptosis NN O

Cells NNS O
were VBD O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
or CC O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
. . O

Seventy CD O
- HYPH O
two CD O
hours NNS O
post NN O
infection NN O
, , O
cells NNS O
were VBD O
treated VBN O
with IN O
TNF NNP O
( , O
0 CD O
. . O
1 CD O
ng NN O
/ SYM O
ml NN O
) -RRB- O
for IN O
24 CD O
hrs NNS O
or CC O
subjected VBN O
to IN O
hypoxia NN O
. . O

For IN O
induction NN O
of IN O
apoptosis NN O
by IN O
hypoxia NN O
, , O
cell NN O
culture NN O
medium NN O
was VBD O
changed VBN O
to IN O
serum NN O
- HYPH O
free JJ O
F NNP O
- HYPH O
10 CD O
saturated VBN O
with IN O
95 CD O
% NN O
N2 CD O
/ SYM O
5 CD O
% NN O
CO2 NN O
and CC O
cells NNS O
were VBD O
placed VBN O
in IN O
a DT O
37 CD O
degrees NNS O
C NN O
airtight JJ O
box NN O
saturated VBN O
with IN O
95 CD O
% NN O
N2 CD O
/ SYM O
5 CD O
% NN O
CO2 NN O
for IN O
24 CD O
hrs NNS O
. . O

For IN O
normoxic JJ O
controls NNS O
, , O
culture NN O
medium NN O
was VBD O
changed VBN O
to IN O
F NNP O
- HYPH O
10 CD O
/ SYM O
5 CD O
% NN O
F NN O
BS NNS O
/ SYM O
10 CD O
% NN O
HS NN O
and CC O
cells NNS O
were VBD O
placed VBN O
in IN O
a DT O
37 CD O
degrees NNS O
C NN O
/ SYM O
5 CD O
% NN O
CO2 NNP O
incubator NN O
for IN O
24 CD O
hrs NNS O
before IN O
analysis NN O
. . O

Apoptotic JJ O
cells NNS O
were VBD O
identified VBN O
by IN O
Hoechst NNP O
staining VBG O
using VBG O
the DT O
Vybrant NNP O
( -LRB- O
TM NN O
) , O
Apoptosis NN O
Kit NN O
# NN O
5 CD O
( , O
Molecular NNP O
Probes NNPS O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

In IN O
addition NN O
, , O
after IN O
infection NN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
or CC O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NN O
and CC O
challenge NN O
with IN O
either CC O
TNF NNP O
or CC O
hypoxia NN O
, , O
cell NN O
viability NN O
was VBD O
assessed VBN O
using VBG O
the DT O
MTT NNP O
assay NN O
Kit NNP O
( , O
Roche NNP O
Molecular NNP O
Biochemicals NNP O
) -RRB- O
and CC O
cell NN O
apoptosis NN O
was VBD O
determined VBN O
using VBG O
the DT O
Cell NNP O
Death NNP O
Detection NNP O
ELISA NNP O
Kit NNP O
assay NN O
( : O
Roche NNP O
Molecular NNP O
Biochemicals NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

Statistical JJ O
analysis NN O

Students NNS O
' POS O
t NN O
- HYPH O
test NN O
was VBD O
used VBN O
to TO O
evaluate VB O
the DT O
difference NN O
between IN O
two CD O
values NNS O
. . O

Each DT O
experiment NN O
was VBD O
repeated VBN O
at IN O
least JJS O
three CD O
times NNS O
. . O

Statistical JJ O
significance NN O
was VBD O
accepted VBN O
at IN O
the DT O
level NN O
of IN O
p NN O
< SYM O
0 CD O
. . O
5 CD O
. . O

List NN O
of IN O
abbreviations NNS O
used VBN O

Ad NN O
- HYPH O
GFP NNP O
, , O
adenovirus NN O
carrying VBG O
GFP NNP O
gene NN O
; : O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
, , O
adenovirus NN O
carrying VBG O
both CC O
the DT O
ribozyme NN O
against IN O
M6P NNP O
/ SYM O
IGF2R NNP O
and CC O
the DT O
GFP NNP O
gene NN O
; : O
GFP NNP O
, , O
green JJ O
fluorescent NN O
protein NN O
; , O
IGF NNP O
- HYPH O
II NNP O
, , O
insulin NN O
- HYPH O
like JJ O
growth NN O
factor NN O
II NN O
; : O
M6P NNP O
/ SYM O
IGF2R NNP O
, , O
mannose NN O
6 CD O
- HYPH O
phosphate NN O
/ SYM O
insulin NN O
- HYPH O
like JJ O
growth NN O
factor NN O
II NN O
receptor NN O
; : O
Rz NN O
, , O
ribozyme NN O
. . O

Authors NNS O
' POS O
contributions NNS O

ZC NNP O
carried VBD O
out RP O
construction NN O
of IN O
the DT O
ribozyme NN O
, , O
production NN O
of IN O
the DT O
viruses NNS O
, , O
cellular JJ O
experiments NNS O
, , O
biochemical JJ O
assays NNS O
and CC O
data NN O
analysis NN O
. . O

YG NNP O
carried VBD O
out RP O
the DT O
RPA NNP O
assay NN O
and CC O
participated VBD O
in IN O
the DT O
molecular JJ O
biological JJ O
studies NNS O
. . O

JXK NNP O
conceived VBD O
of IN O
the DT O
study NN O
, , O
participated VBD O
in IN O
its PRP$ O
design NN O
and CC O
coordination NN O
, , O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

SledgeHMMER NNP O
: : O
a DT O
web NN O
server NN O
for IN O
batch NN O
searching VBG O
the DT O
Pfam NNP O
database NN O

Abstract JJ O

The DT O
SledgeHMMER NNP O
web NN O
server NN O
is VBZ O
intended VBN O
for IN O
genome NN O
- HYPH O
scale NN O
searching NN O
of IN O
the DT O
Pfam NNP O
database NN O
without IN O
having VBG O
to TO O
install VB O
this DT O
database NN O
and CC O
the DT O
HMMER NNP O
software NN O
locally RB O
. . O

The DT O
server NN O
implements VBZ O
a DT O
parallelized JJ O
version NN O
of IN O
hmmpfam NN O
, , O
the DT O
program NN O
used VBN O
for IN O
searching VBG O
the DT O
Pfam NNP O
HMM NNP O
database NN O
. . O

Pfam NNP O
search NN O
results NNS O
have VBP O
been VBN O
calculated VBN O
for IN O
the DT O
entire JJ O
Swiss NNP O
- HYPH O
Prot NNP O
and CC O
TrEmbl NNP O
database NN O
sequences NNS O
( : O
~ $ O
1 CD O
. . O
2 CD O
million CD O
) -RRB- O
on IN O
256 CD O
processors NNS O
of IN O
IA64 NN O
- HYPH O
based VBN O
teragrid NN O
machines NNS O
. . O

The DT O
Pfam NNP O
database NN O
can MD O
be VB O
searched VBN O
in IN O
local JJ O
, , O
glocal JJ O
or CC O
merged VBN O
mode NN O
, , O
using VBG O
either CC O
gathering NN O
or CC O
E NN O
- HYPH O
value NN O
thresholds NNS O
. . O

Query NN O
sequences NNS O
are VBP O
first RB O
matched VBN O
against IN O
the DT O
pre NN O
- HYPH O
calculated VBN O
entries NNS O
to TO O
retrieve VB O
results NNS O
, , O
and CC O
those DT O
without IN O
matches NNS O
are VBP O
processed VBN O
through IN O
a DT O
new JJ O
search NN O
process NN O
. . O

Results NNS O
are VBP O
emailed VBN O
in IN O
a DT O
space NN O
- HYPH O
delimited VBN O
tabular JJ O
format NN O
upon IN O
completion NN O
of IN O
the DT O
search NN O
. . O

While IN O
most JJS O
other JJ O
Pfam NNP O
- HYPH O
searching VBG O
web NN O
servers NNS O
set VBP O
a DT O
limit NN O
of IN O
one CD O
sequence NN O
per IN O
query NN O
, , O
this DT O
server NN O
processes VBZ O
batch NN O
sequences NNS O
with IN O
no DT O
limit NN O
on IN O
the DT O
number NN O
of IN O
input NN O
sequences NNS O
. . O

The DT O
web NN O
server NN O
and CC O
downloadable JJ O
data NNS O
are VBP O
accessible JJ O
from IN O
http NN O
: : O
/ NFP O
/ SYM O
SledgeHmmer NNP O
. . O
sdsc NNP O
. . O
edu NNP O
. . O

INTRODUCTION NN O

Searching VBG O
for IN O
conserved VBN O
domains NNS O
has VBZ O
become VBN O
an DT O
integral JJ O
part NN O
of IN O
several JJ O
bioinformatics NNS O
data NN O
analysis NN O
pipelines NNS O
. . O

The DT O
Pfam NNP O
protein NN O
families NNS O
database NN O
[ -LRB- O
( : O
1 CD O
) -RRB- O
; : O
http NN O
: : O
/ : O
/ SYM O
pfam NN O
. . O
wustl NNP O
. . O
edu NNP O
] -RRB- O
contains VBZ O
the DT O
single JJ O
largest JJS O
public JJ O
collection NN O
of IN O
conserved VBN O
functional JJ O
domains NNS O
and CC O
hence RB O
is VBZ O
integrated VBN O
into IN O
many JJ O
bioinformatics NNS O
resources NNS O
. . O

The DT O
current JJ O
version NN O
( , O
release NN O
12 CD O
) -RRB- O
of IN O
the DT O
Pfam NNP O
- HYPH O
A NNP O
database NN O
contains VBZ O
7316 CD O
HMM NNP O
domains NNS O
, , O
making VBG O
it PRP O
an DT O
indispensable JJ O
resource NN O
for IN O
protein NN O
functional JJ O
annotation NN O
( , O
2 CD O
) -RRB- O
. . O

However RB O
, , O
the DT O
size NN O
of IN O
the DT O
Pfam NNP O
database NN O
is VBZ O
quite RB O
large JJ O
( : O
~ $ O
600 CD O
MB NN O
) -RRB- O
and CC O
genome NN O
- HYPH O
scale NN O
searching NN O
of IN O
protein NN O
sequences NNS O
against IN O
this DT O
database NN O
is VBZ O
a DT O
highly RB O
compute NN O
- HYPH O
intensive JJ O
task NN O
. . O

Hence RB O
, , O
with IN O
the DT O
exception NN O
of IN O
the DT O
Sanger NNP O
Center NNP O
web NN O
server NN O
( : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
sanger NN O
. . O
ac ADD O
. . O
uk IN O
/ SYM O
Software NNP O
/ SYM O
Pfam NNP O
) -RRB- O
, , O
all DT O
other JJ O
Pfam NNP O
- HYPH O
searching VBG O
servers NNS O
permit VBP O
submission NN O
of IN O
only RB O
one CD O
protein NN O
sequence NN O
at IN O
a DT O
time NN O
( : O
http NN O
: : O
/ : O
/ SYM O
pfam NN O
. . O
wustl NNP O
. . O
edu NNP O
, , O
http NN O
: : O
/ : O
/ SYM O
pfam NN O
. . O
jouy NNP O
. . O
inra NNP O
. . O
fr FW O
, , O
http NN O
: : O
/ : O
/ SYM O
pfam NN O
. . O
cgb ADD O
. . O
ki NN O
. . O
se FW O
) -RRB- O
. . O

Currently RB O
, , O
the DT O
Sanger NNP O
Center NNP O
web NN O
server NN O
limits VBZ O
batch NN O
submission NN O
to IN O
1000 CD O
sequences NNS O
at IN O
a DT O
time NN O
. . O

Other RB O
than IN O
this DT O
, , O
for IN O
batch NN O
searching NN O
, , O
users NNS O
are VBP O
required VBN O
to TO O
install VB O
the DT O
Pfam NNP O
database NN O
and CC O
the DT O
HMMER NNP O
software NN O
[ -LRB- O
( SYM O
3 CD O
) -RRB- O
; : O
http NN O
: : O
/ : O
/ SYM O
hmmer NNP O
. . O
wustl NNP O
. . O
edu NNP O
) -RRB- O
locally RB O
. . O

Given VBN O
the DT O
size NN O
and CC O
dynamic JJ O
nature NN O
of IN O
this DT O
database NN O
( , O
14 CD O
updates NNS O
in IN O
the DT O
last JJ O
two CD O
years NNS O
) -RRB- O
, , O
it PRP O
is VBZ O
not RB O
convenient JJ O
to TO O
maintain VB O
the DT O
latest JJS O
versions NNS O
of IN O
these DT O
tools NNS O
locally RB O
. . O

Moreover RB O
, , O
the DT O
hmmpfam NN O
program NN O
used VBN O
for IN O
searching VBG O
the DT O
Pfam NNP O
database NN O
is VBZ O
very RB O
slow JJ O
and CC O
memory NN O
intensive JJ O
( , O
on IN O
Solaris NNP O
machines NNS O
, , O
the DT O
processing NN O
speed NN O
is VBZ O
about RB O
10 CD O
sequences NNS O
per IN O
1 CD O
h NN O
of IN O
CPU NN O
time NN O
) -RRB- O
, , O
making VBG O
this DT O
process NN O
a DT O
bottleneck NN O
in IN O
several JJ O
data NNS O
analysis NN O
pipelines NNS O
. . O

Web NN O
servers NNS O
that WDT O
enable VBP O
batch NN O
searching NN O
of IN O
the DT O
Pfam NNP O
database NN O
are VBP O
extremely RB O
beneficial JJ O
to IN O
the DT O
user NN O
community NN O
, , O
especially RB O
to IN O
those DT O
without IN O
local JJ O
access NN O
to IN O
high JJ O
- HYPH O
end NN O
computational JJ O
power NN O
, , O
memory NN O
and CC O
disk NN O
space NN O
. . O

To IN O
this DT O
end NN O
we PRP O
have VBP O
developed VBN O
a DT O
parallelized JJ O
version NN O
, , O
as RB O
well RB O
as IN O
an DT O
optimized VBN O
single JJ O
- HYPH O
processor NN O
version NN O
, , O
of IN O
hmmpfam NN O
from IN O
release NN O
2 CD O
. . O
3 CD O
. . O
2 CD O
of IN O
the DT O
HMMER NNP O
software NN O
, , O
as IN O
described VBN O
in IN O
the DT O
next JJ O
section NN O
. . O

Using VBG O
these DT O
programs NNS O
, , O
we PRP O
present VBP O
the DT O
SledgeHMMER NNP O
web NN O
server NN O
( , O
http NN O
: : O
/ : O
/ SYM O
SledgeHmmer NNP O
. . O
sdsc NNP O
. . O
edu NNP O
) -RRB- O
, , O
which WDT O
is VBZ O
capable JJ O
of IN O
batch NN O
searching VBG O
a DT O
large JJ O
number NN O
of IN O
protein NN O
sequences NNS O
concurrently RB O
. . O

DESIGN NN O
AND CC O
IMPLEMENTATION NN O

The DT O
current JJ O
web NN O
service NN O
is VBZ O
mainly RB O
intended VBN O
for IN O
genome NN O
- HYPH O
scale NN O
searching NN O
of IN O
the DT O
Pfam NNP O
- HYPH O
A NNP O
database NN O
. . O

Searches NNS O
are VBP O
possible JJ O
for IN O
different JJ O
Pfam NNP O
- HYPH O
searching VBG O
modes NNS O
such JJ O
as IN O
local JJ O
, , O
glocal JJ O
and CC O
merged VBN O
, , O
using VBG O
either CC O
gathering NN O
or CC O
E NN O
- HYPH O
value NN O
thresholds NNS O
. . O

To TO O
expedite VB O
the DT O
response NN O
time NN O
, , O
we PRP O
developed VBD O
a DT O
database NN O
containing VBG O
pre NN O
- HYPH O
calculated VBN O
Pfam NNP O
search NN O
results NNS O
. . O

Query NN O
sequences NNS O
are VBP O
matched VBN O
against IN O
the DT O
pre NN O
- HYPH O
calculated VBN O
entries NNS O
using VBG O
hexadecimal JJ O
hashing NN O
methods NNS O
from IN O
the DT O
MD5 NNP O
Perl NNP O
module NN O
, , O
and CC O
those DT O
without IN O
matches NNS O
are VBP O
separated VBN O
out RB O
. . O

Results NNS O
for IN O
matching NN O
sequences NNS O
are VBP O
retrieved VBN O
from IN O
the DT O
pre NN O
- HYPH O
calculated VBN O
database NN O
while IN O
, , O
for IN O
other JJ O
sequences NNS O
, , O
a DT O
new JJ O
search NN O
process NN O
is VBZ O
initiated VBN O
using VBG O
our PRP$ O
improved JJ O
hmmpfam NN O
program NN O
. . O

Results NNS O
are VBP O
emailed VBN O
in IN O
a DT O
space NN O
- HYPH O
delimited VBN O
tabular JJ O
format NN O
upon IN O
completion NN O
of IN O
the DT O
search NN O
. . O

Parallelizing VBG O
the DT O
hmmpfam NN O
algorithm NN O

Computing NN O
batch NN O
searches NNS O
against IN O
the DT O
Pfam NNP O
database NN O
is VBZ O
a DT O
two CD O
- HYPH O
dimensional JJ O
( HYPH O
2D NN O
) -RRB- O
problem NN O
, , O
i PRP O
. . O
e LS O
. . O
searching VBG O
N NN O
query NN O
sequences NNS O
against IN O
M NNP O
Pfam NNP O
HMMs NNPS O
. . O

Thus RB O
, , O
this DT O
problem NN O
can MD O
be VB O
parallelized VBN O
across IN O
any DT O
dimension NN O
or CC O
across IN O
both DT O
dimensions NNS O
. . O

A DT O
minor JJ O
disadvantage NN O
of IN O
parallelizing VBG O
across IN O
the DT O
M NNP O
dimension NN O
is VBZ O
that IN O
a DT O
global JJ O
gather NN O
needs VBZ O
to TO O
be VB O
performed VBN O
at IN O
the DT O
end NN O
of IN O
the DT O
computation NN O
to TO O
identify VB O
the DT O
best RBS O
matched VBN O
HMM NNP O
models NNS O
. . O

Along IN O
the DT O
N NNP O
dimension NN O
the DT O
computation NN O
is VBZ O
completely RB O
independent JJ O
, , O
however RB O
; , O
due IN O
to IN O
the DT O
variation NN O
in IN O
the DT O
query NN O
sequence NN O
lengths NNS O
, , O
the DT O
traditional JJ O
message NN O
passing NN O
interface NN O
( , O
MPI NNP O
) -RRB- O
technique NN O
of IN O
splitting VBG O
the DT O
file NN O
into IN O
equal JJ O
numbers NNS O
of IN O
sequences NNS O
may MD O
result VB O
in IN O
load NN O
imbalance NN O
. . O

Hence RB O
, , O
the DT O
best JJS O
way NN O
to TO O
parallelize VB O
code NN O
along IN O
the DT O
N NNP O
dimension NN O
is VBZ O
to TO O
stripmine VB O
the DT O
query NN O
sequences NNS O
as IN O
the DT O
processors NNS O
finish VBP O
working VBG O
on IN O
their PRP$ O
previous JJ O
ones NNS O
. . O

This DT O
can MD O
be VB O
achieved VBN O
using VBG O
an DT O
MPI NNP O
technique NN O
in IN O
which WDT O
one CD O
processor NN O
reads VBZ O
the DT O
query NN O
sequence NN O
file NN O
and CC O
sends VBZ O
the DT O
sequences NNS O
to IN O
all DT O
others NNS O
. . O

Here RB O
, , O
we PRP O
have VBP O
parallelized VBN O
the DT O
HMMER NNP O
code NN O
along IN O
the DT O
N NNP O
dimension NN O
( , O
query NN O
sequences NNS O
) , O
using VBG O
a DT O
Unix NNP O
- HYPH O
based VBN O
file NN O
- HYPH O
locking VBG O
technique NN O
. . O

This DT O
implementation NN O
requires VBZ O
all PDT O
the DT O
processors NNS O
, , O
nodes NNS O
and CC O
computers NNS O
working VBG O
on IN O
a DT O
single JJ O
problem NN O
to TO O
have VB O
access NN O
to IN O
a DT O
file NN O
system NN O
that WDT O
honors VBZ O
Unix NNP O
file NN O
locking NN O
. . O

So RB O
far RB O
, , O
we PRP O
have VBP O
tested VBN O
the DT O
implementation NN O
on IN O
AIX NNP O
, , O
Linux NNP O
, , O
NFS NNP O
and CC O
GPFS NNP O
file NN O
systems NNS O
and CC O
found VBD O
our PRP$ O
program NN O
to TO O
work VB O
correctly RB O
. . O

The DT O
advantages NNS O
of IN O
parallelizing VBG O
with IN O
file NN O
locking NN O
are VBP O
that IN O
( : O
i PRP O
) -RRB- O
new JJ O
processes NNS O
can MD O
join VB O
or CC O
leave VB O
the DT O
process NN O
pool NN O
in IN O
the DT O
middle NN O
of IN O
computing NN O
; : O
( : O
ii IN O
) SYM O
almost RB O
perfect JJ O
load NN O
balancing NN O
can MD O
be VB O
achieved VBN O
; : O
( , O
iii FW O
) -RRB- O
processors NNS O
with IN O
different JJ O
clock NN O
speeds NNS O
running VBG O
different JJ O
operating NN O
systems NNS O
can MD O
be VB O
part NN O
of IN O
the DT O
same JJ O
pool NN O
; : O
and CC O
( -LRB- O
iv NN O
) -RRB- O
systems NNS O
do VBP O
not RB O
need VB O
to TO O
have VB O
MPI NN O
or CC O
parallel JJ O
virtual JJ O
machine NN O
( -LRB- O
PVM NN O
) -RRB- O
installed VBN O
. . O

Since IN O
the DT O
parallelized JJ O
subroutines NNS O
are VBP O
written VBN O
in IN O
a DT O
separate JJ O
file NN O
as IN O
function NN O
calls VBZ O
, , O
very RB O
little JJ O
change NN O
is VBZ O
needed VBN O
to IN O
the DT O
original JJ O
HMMER NNP O
code NN O
. . O

These DT O
parallel JJ O
routines NNS O
are VBP O
generic JJ O
and CC O
, , O
hence RB O
, , O
can MD O
be VB O
used VBN O
to TO O
parallelize VB O
other JJ O
programs NNS O
with IN O
similar JJ O
computational JJ O
requirements NNS O
, , O
such JJ O
as IN O
the DT O
BLAST NNP O
suite NN O
of IN O
programs NNS O
. . O

A DT O
brief JJ O
description NN O
of IN O
the DT O
parallel JJ O
function NN O
calls VBZ O
is VBZ O
provided VBN O
below RB O
. . O

All PDT O
the DT O
processes NNS O
joining VBG O
the DT O
work NN O
pool NN O
will MD O
call VB O

The DT O
first JJ O
process NN O
that WDT O
calls VBZ O
this DT O
subroutine NN O
will MD O
create VB O
the DT O
lockFile NN O
and CC O
write VB O
the DT O
starting NN O
index NN O
. . O

This DT O
is VBZ O
the DT O
index NN O
from IN O
which WDT O
sequence NN O
stripmining NN O
happens VBZ O
. . O

The DT O
rest NN O
of IN O
the DT O
processes NNS O
open VBP O
the DT O
file NN O
stream NN O
to IN O
the DT O
lockFile NN O
. . O

Then RB O
, , O
inside IN O
the DT O
main JJ O
work NN O
loop NN O
, , O
every DT O
process NN O
calls VBZ O

resulting VBG O
in IN O
every DT O
process NN O
getting VBG O
a DT O
unique JJ O
next JJ O
available JJ O
job NN O
( : O
index NN O
) -RRB- O
. . O

Each DT O
process NN O
computes VBZ O
the DT O
homology NN O
search NN O
for IN O
the DT O
sequence NN O
index NN O
matching VBG O
the DT O
unique JJ O
index NN O
obtained VBN O
. . O

These DT O
steps NNS O
are VBP O
iterated VBN O
until IN O
no DT O
more JJR O
sequences NNS O
are VBP O
left VBN O
in IN O
the DT O
query NN O
sequence NN O
file NN O
. . O

Outside IN O
the DT O
work NN O
loop NN O
at IN O
the DT O
end NN O
, , O
all PDT O
the DT O
processes NNS O
call VBP O

which WDT O
will MD O
close VB O
the DT O
lockFile NN O
. . O

The DT O
user NN O
has VBZ O
to TO O
ensure VB O
a DT O
unique JJ O
lockFile NN O
for IN O
each DT O
new JJ O
query NN O
sequence NN O
file NN O
. . O

If IN O
for IN O
some DT O
reason NN O
the DT O
work NN O
pool NN O
is VBZ O
stopped VBN O
in IN O
the DT O
middle NN O
of IN O
a DT O
query NN O
sequence NN O
file NN O
, , O
it PRP O
can MD O
continue VB O
from IN O
the DT O
same JJ O
point NN O
by IN O
using VBG O
the DT O
same JJ O
lockFile NN O
. . O

In IN O
this DT O
version NN O
of IN O
the DT O
hmmpfam NN O
program NN O
, , O
all DT O
processes NNS O
write VBP O
search NN O
results NNS O
to IN O
a DT O
single JJ O
output NN O
file NN O
. . O

To TO O
minimize VB O
synchronization NN O
overheads NNS O
, , O
each DT O
process NN O
writes VBZ O
the DT O
output NN O
into IN O
a DT O
temporary JJ O
buffer NN O
and CC O
writes VBZ O
once RB O
per IN O
sequence NN O
into IN O
the DT O
output NN O
file NN O
. . O

For IN O
the DT O
sake NN O
of IN O
convenience NN O
, , O
additional JJ O
synchronization NN O
routines NNS O
are VBP O
provided VBN O
for IN O
locking VBG O
and CC O
unlocking VBG O
. . O

This DT O
parallel JJ O
algorithm NN O
has VBZ O
been VBN O
tested VBN O
on IN O
several JJ O
platforms NNS O
and CC O
file NN O
systems NNS O
including VBG O
Intel NNP O
IA32 NNP O
, , O
IA64 NNP O
Linux NNP O
platforms NNS O
, , O
power3 NN O
and CC O
power4 NN O
- HYPH O
based VBN O
AIX NN O
platforms NNS O
and CC O
Sparc4 NNP O
- HYPH O
based VBN O
Solaris NNP O
platforms NNS O
. . O

The DT O
code NN O
was VBD O
run VBN O
on IN O
800 CD O
processors NNS O
of IN O
power4 NN O
- HYPH O
based VBN O
datastar NN O
machines NNS O
and CC O
256 CD O
processors NNS O
of IN O
IA64 NN O
- HYPH O
based VBN O
teragrid NN O
machines NNS O
located VBN O
at IN O
the DT O
San NNP O
Diego NNP O
Supercomputer NNP O
Center NNP O
( : O
SDSC NNP O
) -RRB- O
to TO O
test VB O
scalability NN O
issues NNS O
. . O

Single JJ O
- HYPH O
processor NN O
optimization NN O
of IN O
hmmpfam NN O

Initially RB O
, , O
we PRP O
utilized VBD O
version NN O
2 CD O
. . O
2g CD O
of IN O
HMMER NNP O
. . O

Performance NN O
analysis NN O
revealed VBD O
that IN O
the DT O
main JJ O
computational JJ O
kernel NN O
was VBD O
accessing VBG O
the DT O
2D JJ O
arrays NNS O
with IN O
a DT O
wrong JJ O
stride NN O
. . O

Correcting VBG O
this DT O
resulted VBD O
in IN O
doubling NN O
of IN O
the DT O
performance NN O
; : O
however RB O
, , O
the DT O
HMMER NNP O
developer NN O
has VBZ O
rectified VBN O
this DT O
issue NN O
in IN O
release NN O
2 CD O
. . O
3 CD O
. . O
2 CD O
. . O

In IN O
addition NN O
, , O
HMMER NNP O
reads VBZ O
the DT O
database NN O
file NN O
from IN O
disk NN O
for IN O
every DT O
sequence NN O
it PRP O
searches VBZ O
. . O

This DT O
is VBZ O
extremely RB O
inefficient JJ O
for IN O
batch NN O
searches NNS O
. . O

We PRP O
have VBP O
corrected VBN O
this DT O
by IN O
reading VBG O
the DT O
whole JJ O
database NN O
into IN O
memory NN O
once RB O
and CC O
conducting VBG O
searches NNS O
from IN O
memory NN O
. . O

Performance NN O
testing NN O

We PRP O
compared VBD O
our PRP$ O
improved JJ O
IA64 NNP O
single JJ O
- HYPH O
processor NN O
hmmpfam NN O
with IN O
the DT O
equivalent JJ O
program NN O
from IN O
the DT O
original JJ O
HMMER NNP O
2 CD O
. . O
3 CD O
. . O
2 CD O
release NN O
on IN O
an DT O
Itanium NNP O
II NNP O
IA64 NNP O
processor NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

As IN O
expected VBN O
, , O
the DT O
per IN O
sequence NN O
CPU NN O
time NN O
for IN O
our PRP$ O
program NN O
is VBZ O
reduced VBN O
up IN O
to IN O
10 CD O
- HYPH O
fold NN O
in IN O
batch NN O
searches NNS O
, , O
while IN O
in IN O
the DT O
case NN O
of IN O
the DT O
original JJ O
2 CD O
. . O
3 CD O
. . O
2 CD O
release NN O
, , O
it PRP O
is VBZ O
linear JJ O
to IN O
the DT O
number NN O
of IN O
sequences NNS O
. . O

Performance NN O
difference NN O
in IN O
single JJ O
- HYPH O
sequence NN O
processing NN O
could MD O
be VB O
attributed VBN O
to IN O
compilation NN O
differences NNS O
. . O

Performance NN O
differences NNS O
resulting VBG O
in IN O
the DT O
slope NN O
difference NN O
of IN O
the DT O
two CD O
plots NNS O
may MD O
be VB O
due IN O
to IN O
the DT O
elimination NN O
of IN O
the DT O
need NN O
to TO O
reload VB O
the DT O
Pfam NNP O
database NN O
from IN O
disk NN O
for IN O
every DT O
sequence NN O
in IN O
our PRP$ O
case NN O
. . O

Processing NN O
data NNS O
from IN O
disk NN O
can MD O
be VB O
an DT O
order NN O
of IN O
magnitude NN O
slower JJR O
than IN O
processing NN O
in IN O
memory NN O
. . O

Scaling VBG O
tests NNS O
were VBD O
conducted VBN O
on IN O
a DT O
128 CD O
- HYPH O
node NN O
Itanium NNP O
II NNP O
IA64 NNP O
cluster NN O
. . O

We PRP O
used VBD O
a DT O
fixed JJ O
set NN O
of IN O
500 CD O
sequences NNS O
as IN O
the DT O
test NN O
set NN O
and CC O
ran VBD O
on IN O
1 CD O
- HYPH O
32 CD O
processors NNS O
. . O

As IN O
expected VBN O
, , O
the DT O
time NN O
required VBN O
to TO O
process VB O
a DT O
given VBN O
set NN O
of IN O
sequences NNS O
reduces VBZ O
linearly RB O
with IN O
the DT O
number NN O
of IN O
processors NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

This DT O
also RB O
indicates VBZ O
that IN O
the DT O
parallelization NN O
overheads NNS O
using VBG O
our PRP$ O
method NN O
are VBP O
minimal JJ O
. . O

However RB O
, , O
as IN O
the DT O
ratio NN O
of IN O
the DT O
number NN O
of IN O
sequences NNS O
to IN O
the DT O
number NN O
of IN O
processors NNS O
reduces VBZ O
to IN O
one CD O
, , O
load NN O
imbalances NNS O
due IN O
to IN O
the DT O
processing NN O
time NN O
differences NNS O
between IN O
different JJ O
sequences NNS O
start VBP O
to TO O
dominate VB O
, , O
reducing VBG O
parallel JJ O
efficiency NN O
. . O

Pre NN O
- HYPH O
calculated VBN O
results NNS O

We PRP O
have VBP O
generated VBN O
pre NN O
- HYPH O
calculated VBN O
Pfam NNP O
search NN O
results NNS O
for IN O
the DT O
entire JJ O
Swiss NNP O
- HYPH O
Prot NNP O
and CC O
TrEmbl NNP O
protein NN O
sequences NNS O
( : O
~ $ O
1 CD O
. . O
2 CD O
million CD O
) -RRB- O
, , O
using VBG O
our PRP$ O
parallelized VBN O
' `` O
hmmpfam NN O
' '' O
on IN O
256 CD O
processors NNS O
of IN O
IA64 NN O
- HYPH O
based VBN O
teragrid NN O
machines NNS O
located VBN O
at IN O
the DT O
SDSC NNP O
. . O

Pfam NN O
searches NNS O
have VBP O
been VBN O
performed VBN O
separately RB O
, , O
using VBG O
either CC O
gathering NN O
thresholds NNS O
or CC O
E NN O
- HYPH O
value NN O
cutoffs NNS O
against IN O
glocal JJ O
( -LRB- O
Pfam NNP O
_ HYPH O
ls NNP O
) -RRB- O
or CC O
local JJ O
( , O
Pfam NNP O
_ HYPH O
fs NNP O
) -RRB- O
alignment NN O
models NNS O
. . O

Glocal JJ O
and CC O
local JJ O
search NN O
results NNS O
were VBD O
parsed VBN O
and CC O
merged VBN O
by IN O
removing VBG O
all DT O
local JJ O
search NN O
hits NNS O
that WDT O
are VBP O
completely RB O
overlapped VBN O
by IN O
glocal JJ O
search NN O
hits NNS O
. . O

Input NN O
and CC O
output NN O
formats NNS O

The DT O
program NN O
takes VBZ O
only RB O
FASTA NNP O
- HYPH O
formatted VBN O
sequences NNS O
as IN O
input NN O
and CC O
searches NNS O
can MD O
be VB O
done VBN O
in IN O
any DT O
search NN O
mode NN O
, , O
i PRP O
. . O
e UH O
. . O
local JJ O
, , O
glocal JJ O
or CC O
merged VBN O
. . O

The DT O
maximum JJ O
E NN O
- HYPH O
value NN O
allowed VBN O
for IN O
searches NNS O
is VBZ O
10 CD O
. . O

SledgeHMMER NNP O
results NNS O
are VBP O
emailed VBN O
to IN O
the DT O
user NN O
in IN O
a DT O
space NN O
- HYPH O
delimited VBN O
, , O
one CD O
hit NN O
per IN O
line NN O
tabular JJ O
format NN O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

The DT O
response NN O
time NN O
for IN O
receiving VBG O
results NNS O
depends VBZ O
on IN O
the DT O
number NN O
of IN O
query NN O
sequences NNS O
and CC O
the DT O
fraction NN O
of IN O
these DT O
existing VBG O
in IN O
the DT O
pre NN O
- HYPH O
calculated VBN O
entries NNS O
. . O

DISCUSSION NN O

The DT O
SledgeHMMER NNP O
server NN O
provides VBZ O
a DT O
unique JJ O
service NN O
to IN O
the DT O
scientific JJ O
community NN O
wishing VBG O
to TO O
batch VB O
search NN O
the DT O
Pfam NNP O
database NN O
on IN O
the DT O
web NN O
. . O

To IN O
the DT O
best JJS O
of IN O
our PRP$ O
knowledge NN O
, , O
this DT O
is VBZ O
the DT O
only JJ O
such JJ O
server NN O
that WDT O
has VBZ O
no DT O
limit NN O
on IN O
the DT O
number NN O
of IN O
input NN O
sequences NNS O
. . O

The DT O
current JJ O
pre NN O
- HYPH O
calculated VBN O
database NN O
covers VBZ O
~ $ O
70 CD O
% NN O
of IN O
the DT O
available JJ O
non NN O
- HYPH O
redundant JJ O
protein NN O
sequence NN O
space NN O
, , O
and CC O
we PRP O
plan VBP O
to TO O
add VB O
additional JJ O
new JJ O
sequences NNS O
from IN O
other JJ O
resources NNS O
such JJ O
as IN O
the DT O
NR NNP O
database NN O
from IN O
GenBank NNP O
and CC O
SEQRES NNP O
from IN O
the DT O
PDB NNP O
( -LRB- O
Protein NNP O
Data NNP O
Bank NNP O
) -RRB- O
in IN O
the DT O
future NN O
. . O

Our PRP$ O
pre NN O
- HYPH O
calculated VBN O
database NN O
is VBZ O
updated VBN O
for IN O
every DT O
new JJ O
release NN O
of IN O
the DT O
Pfam NNP O
database NN O
or CC O
SPTr NNP O
databases NNS O
( , O
Swiss NNP O
- HYPH O
Prot NNP O
+ CC O
TrEMBL NNP O
) -RRB- O
in IN O
order NN O
to TO O
provide VB O
access NN O
to IN O
the DT O
most RBS O
current JJ O
data NNS O
. . O

Single JJ O
- HYPH O
processor NN O
optimized VBN O
hmmpfam NN O
binaries NNS O
and CC O
the DT O
source NN O
code NN O
can MD O
be VB O
downloaded VBN O
from IN O
the DT O
current JJ O
web NN O
server NN O
. . O

In IN O
the DT O
future NN O
, , O
we PRP O
intend VBP O
to TO O
make VB O
such JJ O
binaries NNS O
available JJ O
for IN O
many JJ O
additional JJ O
operating NN O
systems NNS O
and CC O
propagate VB O
these DT O
modifications NNS O
to IN O
other JJ O
HMMER NNP O
programs NNS O
as RB O
well RB O
. . O

Medicinal JJ O
herb NN O
use NN O
among IN O
asthmatic JJ O
patients NNS B-Species
attending VBG O
a DT O
specialty NN O
care NN O
facility NN O
in IN O
Trinidad NNP O

Abstract JJ O

Background NN O

There EX O
is VBZ O
an DT O
increasing VBG O
prevalence NN O
of IN O
asthma NN O
in IN O
the DT O
Caribbean NNP O
and CC O
patients NNS B-Species
remain VBP O
non RB O
- HYPH O
compliant JJ O
to IN O
therapy NN O
despite IN O
the DT O
development NN O
of IN O
guidelines NNS O
for IN O
management NN O
and CC O
prevention NN O
. . O

Some DT O
patients NNS B-Species
may MD O
self NN O
- HYPH O
medicate VB O
with IN O
medicinal JJ O
herbs NNS O
for IN O
symptomatic JJ O
relief NN O
, , O
as IN O
there EX O
is VBZ O
a DT O
long JJ O
tradition NN O
of IN O
use NN O
for IN O
a DT O
variety NN O
of IN O
ailments NNS O
. . O

The DT O
study NN O
assessed VBD O
the DT O
prevalence NN O
of IN O
use NN O
and CC O
the DT O
factors NNS O
affecting VBG O
the DT O
decision NN O
to TO O
use VB O
herbs NNS O
in IN O
asthmatic JJ O
patients NNS B-Species
attending VBG O
a DT O
public JJ O
specialty NN O
care NN O
clinic NN O
in IN O
Trinidad NNP O
. . O

Methods NNS O

A DT O
descriptive JJ O
, , O
cross JJ O
- HYPH O
sectional JJ O
study NN O
was VBD O
conducted VBN O
at IN O
the DT O
Chest NNP O
Clinic NNP O
in IN O
Trinidad NNP O
using VBG O
a DT O
de FW O
novo FW O
, , O
pilot NN O
- HYPH O
tested VBN O
, , O
researcher NN O
- HYPH O
administered VBN O
questionnaire NN O
between IN O
June NNP O
and CC O
July NNP O
2003 CD O
. . O

Results NNS O

Fifty CD O
- HYPH O
eight CD O
out IN O
of IN O
191 CD O
patients NNS B-Species
( : O
30 CD O
. . O
4 CD O
% NN O
) -RRB- O
reported VBD O
using VBG O
herbal JJ O
remedies NNS O
for IN O
symptomatic JJ O
relief NN O
. . O

Gender NN O
, , O
age NN O
, , O
ethnicity NN O
, , O
and CC O
asthma NN O
severity NN O
did VBD O
not RB O
influence VB O
the DT O
decision NN O
to TO O
use VB O
herbs NNS O
; : O
however RB O
, , O
62 CD O
. . O
5 CD O
% NN O
of IN O
patients NNS B-Species
with IN O
tertiary JJ O
level NN O
schooling NN O
used VBD O
herbs NNS O
, , O
p NN O
= SYM O
0 CD O
. . O
25 CD O
. . O

Thirty CD O
- HYPH O
four CD O
of IN O
these DT O
58 CD O
patients NNS B-Species
( SYM O
58 CD O
. . O
6 CD O
% NN O
) -RRB- O
obtained VBD O
herbs NNS O
from IN O
their PRP$ O
backyards NNS O
or CC O
the DT O
supermarket NN O
; : O
only RB O
14 CD O
patients NNS B-Species
( : O
24 CD O
. . O
1 CD O
% NN O
) -RRB- O
obtained VBD O
herbs NNS O
from IN O
an DT O
herbalist NN O
, , O
herbal JJ O
shop NN O
or CC O
pharmacy NN O
. . O

Relatives NNS O
and CC O
friends NNS O
were VBD O
the DT O
sole JJ O
source NN O
of IN O
information NN O
for IN O
most JJS O
patients NNS B-Species
( , O
70 CD O
. . O
7 CD O
% NN O
) -RRB- O
, , O
and CC O
only RB O
10 CD O
. . O
3 CD O
% NN O
consulted VBD O
an DT O
herbalist NN O
. . O

Ginger NN B-Species
, , O
garlic NN B-Species
, , O
aloes NNS O
, , O
shandileer NN B-Species
, , O
wild JJ O
onion NN B-Species
, , O
pepper NN O
and CC O
black JJ B-Species
sage NN I-Species
were VBD O
the DT O
most RBS O
commonly RB O
used VBN O
herbs NNS O
. . O

Conclusions NNS O

Among IN O
patients NNS B-Species
attending VBG O
the DT O
Chest NNP O
Clinic NNP O
in IN O
Trinidad NNP O
the DT O
use NN O
of IN O
herbal JJ O
remedies NNS O
in IN O
asthma NN O
is VBZ O
relatively RB O
common JJ O
on IN O
the DT O
advice NN O
of IN O
relatives NNS O
and CC O
friends NNS O
. . O

It PRP O
is VBZ O
therefore RB O
becoming VBG O
imperative JJ O
for IN O
healthcare NN O
providers NNS O
to TO O
become VB O
more RBR O
knowledgeable JJ O
on IN O
this DT O
modality NN O
and CC O
to TO O
keep VB O
abreast RB O
with IN O
the DT O
latest JJS O
developments NNS O
. . O

Background NN O

Recent JJ O
reports NNS O
from IN O
the DT O
Caribbean NNP O
suggest VBP O
that IN O
the DT O
incidence NN O
of IN O
asthma NN O
is VBZ O
following VBG O
the DT O
global JJ O
trend NN O
of IN O
increasing VBG O
prevalence NN O
. . O

In IN O
Jamaica NNP O
, , O
a DT O
prevalence NN O
of IN O
20 CD O
. . O
8 CD O
% NN O
for IN O
exercise NN O
- HYPH O
induced VBN O
asthma NN O
was VBD O
estimated VBN O
in IN O
a DT O
cross JJ O
- HYPH O
sectional JJ O
study NN O
in IN O
schoolchildren NNS B-Species
[ -LRB- O
1 CD O
] -RRB- O
. . O

About RB O
one CD O
in IN O
ten CD O
patients NNS B-Species
attending VBG O
an DT O
Accident NNP O
and CC O
Emergency NNP O
Department NNP O
in IN O
Trinidad NNP O
were VBD O
treated VBN O
for IN O
acute JJ O
severe JJ O
asthma NN O
[ -LRB- O
2 CD O
] -RRB- O
and CC O
over IN O
15 CD O
, , O
0 CD O
patients NNS B-Species
attended VBD O
four CD O
A NNP O
& CC O
E NNP O
departments NNS O
throughout IN O
the DT O
island NN O
over IN O
a DT O
12 CD O
- HYPH O
month NN O
period NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Inhaled VBN O
corticosteroids NNS O
as IN O
prophylaxis NN O
and CC O
' `` O
as IN O
required VBN O
' '' O
bronchodilator NN O
for IN O
symptomatic JJ O
relief NN O
are VBP O
established VBN O
modalities NNS O
for IN O
asthma NN O
management NN O
and CC O
prevention NN O
and CC O
the DT O
Commonwealth NNP O
Caribbean NNP O
Medical NNP O
Research NNP O
Council NNP O
/ SYM O
Global NNP O
Initiative NNP O
for IN O
Asthma NNP O
guidelines NNS O
were VBD O
adopted VBN O
in IN O
the DT O
Caribbean NNP O
in IN O
1997 CD O
[ -LRB- O
4 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
noted VBN O
that IN O
inefficient JJ O
management NN O
predisposes VBZ O
patients NNS B-Species
to IN O
frequent JJ O
hospitalization NN O
and CC O
reduced VBN O
quality NN O
of IN O
life NN O
. . O

In IN O
Trinidad NNP O
, , O
non JJ O
- HYPH O
compliance NN O
and CC O
inadequate JJ O
inhaler NN O
technique NN O
negatively RB O
impact VBP O
on IN O
effective JJ O
disease NN O
management NN O
[ -LRB- O
5 CD O
, , O
6 CD O
] -RRB- O
. . O

The DT O
frequent JJ O
unavailability NN O
of IN O
medication NN O
at IN O
public JJ O
health NN O
facilities NNS O
and CC O
the DT O
prohibitive JJ O
cost NN O
at IN O
private JJ O
pharmacies NNS O
are VBP O
significantly RB O
associated VBN O
with IN O
non JJ O
- HYPH O
compliance NN O
and CC O
consequently RB O
poor JJ O
disease NN O
control NN O
. . O

In IN O
these DT O
studies NNS O
, , O
some DT O
patients NNS B-Species
indicated VBD O
their PRP$ O
use NN O
of IN O
herbal JJ O
remedies NNS O
as IN O
an DT O
alternative NN O
to IN O
conventional JJ O
medicines NNS O
. . O

Over IN O
the DT O
last JJ O
few JJ O
decades NNS O
, , O
a DT O
global JJ O
resurgence NN O
in IN O
the DT O
use NN O
of IN O
herbal JJ O
remedies NNS O
has VBZ O
fuelled VBN O
the DT O
growing VBG O
multi JJ O
- HYPH O
billion CD O
dollar NN O
international JJ O
trade NN O
of IN O
botanical JJ O
products NNS O
. . O

Many JJ O
patients NNS B-Species
, , O
dissatisfied JJ O
with IN O
conventional JJ O
medicines NNS O
because IN O
they PRP O
expect VBP O
permanent JJ O
cures NNS O
, , O
believe VBP O
that IN O
herbal JJ O
remedies NNS O
are VBP O
' `` O
natural JJ O
' '' O
and CC O
sometimes RB O
self NN O
- HYPH O
medicate NN O
without IN O
informing VBG O
their PRP$ O
attending VBG O
physician NN O
. . O

Although IN O
there EX O
is VBZ O
a DT O
long JJ O
history NN O
of IN O
traditional JJ O
use NN O
of IN O
medicinal JJ O
herbs NNS O
throughout IN O
the DT O
Caribbean NNP O
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
few JJ O
studies NNS O
were VBD O
done VBN O
to TO O
assess VB O
the DT O
prevalence NN O
of IN O
use NN O
. . O

Surveys NNS O
in IN O
Jamaica NNP O
reported VBD O
an DT O
almost RB O
100 CD O
% NN O
use NN O
of IN O
herbal JJ O
teas NNS O
and CC O
remedies NNS O
by IN O
respondents NNS O
throughout IN O
the DT O
island NN O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
71 CD O
% NN O
in IN O
paediatrics NNS O
inpatients NNS O
at IN O
the DT O
University NNP O
Hospital NNP O
[ -LRB- O
10 CD O
] -RRB- O
. . O

These DT O
studies NNS O
, , O
however RB O
, , O
assessed VBD O
only RB O
the DT O
lifetime JJ O
use NN O
of IN O
medicinal JJ O
herbs NNS O
and CC O
did VBD O
not RB O
identify VB O
their PRP$ O
use NN O
for IN O
any DT O
particular JJ O
disease NN O
. . O

In IN O
Trinidad NNP O
and CC O
Tobago NNP O
, , O
the DT O
use NN O
of IN O
' `` O
bush NN O
medicine NN O
' '' O
in IN O
diabetic JJ O
patients NNS B-Species
attending VBG O
primary JJ O
healthcare NN O
facilities NNS O
throughout IN O
the DT O
island NN O
was VBD O
assessed VBN O
and CC O
although IN O
42 CD O
% NN O
reportedly RB O
used VBD O
herbs NNS O
, , O
only RB O
24 CD O
% NN O
used VBD O
this DT O
healthcare NN O
modality NN O
for IN O
self NN O
- HYPH O
management NN O
of IN O
diabetes NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Another DT O
survey NN O
conducted VBN O
at IN O
an DT O
outpatient JJ O
surgical JJ O
facility NN O
in IN O
Trinidad NNP O
indicated VBD O
a DT O
lifetime NN O
prevalence NN O
of IN O
86 CD O
% NN O
among IN O
patients NNS B-Species
[ -LRB- O
12 CD O
] -RRB- O
for IN O
any DT O
healthcare NN O
issue NN O
. . O

This DT O
study NN O
was VBD O
undertaken VBN O
to TO O
assess VB O
the DT O
extent NN O
of IN O
use NN O
of IN O
herbal JJ O
remedies NNS O
by IN O
asthmatic JJ O
patients NNS B-Species
attending VBG O
a DT O
specialty NN O
chest NN O
clinic NN O
in IN O
Trinidad NNP O
for IN O
symptomatic JJ O
relief NN O
and CC O
to TO O
determine VB O
the DT O
factors NNS O
influencing VBG O
the DT O
patient NN B-Species
' POS O
s POS O
decision NN O
to TO O
use VB O
herbs NNS O
. . O

Methods NNS O

The DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
Ethics NNP O
Committee NNP O
of IN O
the DT O
Faculty NNP O
of IN O
Medical NNP O
Sciences NNPS O
, , O
University NNP O
of IN O
the DT O
West NNP O
Indies NNPS O
, , O
St NNP O
. . O

Augustine JJ O
campus NN O
and CC O
permission NN O
to TO O
interview VB O
patients NNS B-Species
was VBD O
granted VBN O
by IN O
the DT O
Director NNP O
of IN O
the DT O
Chest NNP O
Clinic NNP O
of IN O
the DT O
Ministry NNP O
of IN O
Health NNP O
, , O
Trinidad NNP O
and CC O
Tobago NNP O
. . O

The DT O
study NN O
was VBD O
conducted VBN O
over IN O
the DT O
two CD O
- HYPH O
month NN O
period NN O
June NNP O
to IN O
July NNP O
2003 CD O
. . O

Sample NN O
and CC O
setting NN O

The DT O
Chest NNP O
Clinic NNP O
was VBD O
chosen VBN O
as IN O
the DT O
source NN O
of IN O
subjects NNS O
as IN O
this DT O
is VBZ O
the DT O
only JJ O
national JJ O
tertiary JJ O
level NN O
health NN O
facility NN O
specializing VBG O
in IN O
the DT O
management NN O
of IN O
respiratory JJ O
diseases NNS O
. . O

Patients NNS B-Species
entering VBG O
the DT O
study NN O
were VBD O
physician NN O
- HYPH O
diagnosed VBN O
asthmatics NNS O
based VBN O
on IN O
self NN O
- HYPH O
reporting VBG O
symptoms NNS O
of IN O
wheezing NN O
, , O
chest NN O
tightness NN O
and CC O
nocturnal JJ O
coughing NN O
in IN O
the DT O
previous JJ O
year NN O
. . O

Patients NNS B-Species
were VBD O
recruited VBN O
by IN O
consecutive JJ O
sampling NN O
and CC O
the DT O
nature NN O
and CC O
purpose NN O
of IN O
the DT O
study NN O
were VBD O
explained VBN O
on IN O
an DT O
individual JJ O
basis NN O
. . O

Those DT O
confirming VBG O
their PRP$ O
willingness NN O
to TO O
participate VB O
signed VBD O
their PRP$ O
informed JJ O
consent NN O
and CC O
were VBD O
interviewed VBN O
using VBG O
a DT O
de FW O
novo FW O
, , O
pilot NN O
- HYPH O
tested VBN O
, , O
researcher NN O
- HYPH O
administered VBN O
questionnaire NN O
. . O

Interview NN O
instrument NN O

The DT O
questionnaire NN O
assessed VBD O
demographic JJ O
data NNS O
such JJ O
as IN O
age NN O
, , O
gender NN O
, , O
ethnicity NN O
, , O
residential JJ O
district NN O
, , O
education NN O
, , O
employment NN O
and CC O
socioeconomic JJ O
status NN O
. . O

Subjects NNS O
reported VBD O
their PRP$ O
disease NN O
severity NN O
as IN O
intermittent JJ O
, , O
moderate JJ O
or CC O
severe JJ O
as IN O
determined VBN O
by IN O
the DT O
Global NNP O
Initiative NNP O
for IN O
Asthma NNP O
( -LRB- O
GINA NNP O
) -RRB- O
guidelines NNS O
with IN O
respect NN O
to IN O
symptom NN O
frequency NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Patients NNS B-Species
also RB O
reported VBD O
their PRP$ O
use NN O
of IN O
herbal JJ O
remedies NNS O
, , O
identified VBD O
the DT O
herbs NNS O
used VBN O
, , O
the DT O
frequency NN O
of IN O
use NN O
, , O
source NN O
of IN O
herbal JJ O
medicines NNS O
and CC O
the DT O
reasons NNS O
for IN O
the DT O
use NN O
of IN O
herbs NNS O
. . O

Statistical JJ O
analysis NN O

The DT O
sample NN O
size NN O
was VBD O
calculated VBN O
as IN O
185 CD O
patients NNS B-Species
assuming VBG O
a DT O
prevalence NN O
of IN O
86 CD O
% NN O
[ -LRB- O
13 CD O
] -RRB- O
with IN O
a DT O
confidence NN O
level NN O
of IN O
95 CD O
% NN O
. . O

Since IN O
all DT O
variables NNS O
were VBD O
categorical JJ O
, , O
chi NN O
2 CD O
tests NNS O
were VBD O
performed VBN O
to TO O
determine VB O
whether IN O
there EX O
were VBD O
statistically RB O
significant JJ O
associations NNS O
between IN O
the DT O
use NN O
of IN O
herbs NNS O
and CC O
these DT O
variables NNS O
. . O

The DT O
p NN O
value NN O
was VBD O
set VBN O
at IN O
< $ O
0 CD O
. . O
5 CD O
for IN O
statistical JJ O
significance NN O
. . O

The DT O
data NNS O
was VBD O
analyzed VBN O
using VBG O
SPSS NNP O
for IN O
Windows NNP O
( : O
Version NNP O
9 CD O
. . O
0 CD O
, , O
Chicago NNP O
, , O
IL NNP O
) -RRB- O
. . O

Results NNS O

Demography NN O

During IN O
the DT O
study NN O
period NN O
one CD O
hundred CD O
and CC O
ninety CD O
one CD O
patients NNS B-Species
consented VBD O
to TO O
participate VB O
. . O

The DT O
demographic JJ O
details NNS O
of IN O
the DT O
sample NN O
are VBP O
given VBN O
in IN O
Table NNP O
1 CD O
. . O

Patients NNS B-Species
between IN O
35 CD O
and CC O
64 CD O
years NNS O
of IN O
age NN O
formed VBD O
the DT O
largest JJS O
portion NN O
of IN O
the DT O
sample NN O
( : O
62 CD O
. . O
3 CD O
% NN O
) -RRB- O
. . O

There EX O
was VBD O
a DT O
significant JJ O
gender NN O
difference NN O
with IN O
females NNS O
outnumbering VBG O
males NNS O
by IN O
a DT O
2 CD O
: SYM O
1 CD O
ratio NN O
, , O
p NN O
< NN O
0 CD O
. . O
1 CD O
. . O

Most JJS O
patients NNS B-Species
were VBD O
of IN O
Asian JJ O
Indian JJ O
origin NN O
( : O
58 CD O
. . O
1 CD O
% NN O
) -RRB- O
and CC O
resided VBN O
in IN O
suburban JJ O
areas NNS O
( : O
60 CD O
. . O
2 CD O
% NN O
) -RRB- O
. . O

There EX O
was VBD O
a DT O
high JJ O
level NN O
of IN O
unemployment NN O
( : O
30 CD O
. . O
4 CD O
% NN O
) -RRB- O
; , O
this DT O
could MD O
be VB O
correlated VBN O
to IN O
primary JJ O
schooling NN O
( , O
seven CD O
or CC O
less JJR O
years NNS O
of IN O
formal JJ O
education NN O
) -RRB- O
being VBG O
the DT O
highest JJS O
educational JJ O
level NN O
attained VBN O
in IN O
52 CD O
. . O
9 CD O
% NN O
and CC O
no DT O
formal JJ O
schooling NN O
in IN O
5 CD O
. . O
2 CD O
% NN O
of IN O
the DT O
sample NN O
population NN O
. . O

Income NN O
was VBD O
low JJ O
, , O
with IN O
42 CD O
. . O
9 CD O
% NN O
of IN O
the DT O
sample NN O
population NN O
earning VBG O
below IN O
US NNP O
$ $ O
4 CD O
, , O
0 CD O
per IN O
year NN O
. . O

Antiasthmatic JJ O
drug NN O
use NN O

The DT O
GINA NNP O
guidelines NNS O
were VBD O
recently RB O
adopted VBN O
in IN O
the DT O
Caribbean NNP O
and CC O
asthmatic JJ O
patients NNS B-Species
are VBP O
currently RB O
treated VBN O
according VBG O
to IN O
their PRP$ O
symptom NN O
severity NN O
. . O

In IN O
our PRP$ O
sample NN O
population NN O
, , O
particularly RB O
in IN O
patients NNS B-Species
with IN O
moderate JJ O
and CC O
severe JJ O
symptoms NNS O
, , O
corticosteroids NNS O
( , O
controllers NNS O
) , O
and CC O
beta NN O
2 CD O
- HYPH O
agonists NNS O
( , O
relievers NNS O
) , O
were VBD O
prescribed VBN O
at IN O
very RB O
high JJ O
rates NNS O
, , O
Table NNP O
2 CD O
. . O

Almost RB O
90 CD O
% NN O
of IN O
all DT O
patients NNS B-Species
with IN O
moderate JJ O
symptoms NNS O
were VBD O
prescribed VBN O
drugs NNS O
in IN O
these DT O
classes NNS O
. . O

Almost RB O
all DT O
patients NNS B-Species
with IN O
severe JJ O
symptoms NNS O
were VBD O
prescribed VBN O
beta NN O
2 CD O
- HYPH O
agonists NNS O
. . O

This DT O
high JJ O
level NN O
of IN O
prescription NN O
and CC O
use NN O
of IN O
beta NN O
2 CD O
- HYPH O
agonists NNS O
suggest VBP O
a DT O
lack NN O
of IN O
symptomatic JJ O
control NN O
in IN O
our PRP$ O
sample NN O
population NN O
. . O

Theophylline NN O
and CC O
anticholinergics NNS O
were VBD O
prescribed VBN O
in IN O
both DT O
categories NNS O
of IN O
patients NNS B-Species
, , O
but CC O
to IN O
a DT O
lesser JJR O
extent NN O
. . O

Factors NNS O
influencing VBG O
the DT O
use NN O
of IN O
herbal JJ O
remedies NNS O

Gender NN O
, , O
age NN O
, , O
ethnicity NN O
, , O
residential JJ O
district NN O
, , O
employment NN O
status NN O
, , O
income NN O
and CC O
asthma NN O
severity NN O
had VBD O
no DT O
statistically RB O
significant JJ O
effect NN O
on IN O
the DT O
use NN O
of IN O
herbal JJ O
remedies NNS O
within IN O
the DT O
sample NN O
population NN O
, , O
Table NNP O
3 CD O
. . O

However RB O
, , O
almost RB O
two CD O
- HYPH O
thirds NNS O
( SYM O
62 CD O
. . O
5 CD O
% NN O
) , O
of IN O
patients NNS B-Species
with IN O
tertiary JJ O
education NN O
used VBD O
herbal JJ O
remedies NNS O
for IN O
asthma NN O
, , O
p NN O
= SYM O
0 CD O
. . O
25 CD O
. . O

Characteristics NNS O
of IN O
patients NNS B-Species
using VBG O
herbal JJ O
remedies NNS O

Most JJS O
patients NNS B-Species
( : O
70 CD O
. . O
7 CD O
% NN O
) -RRB- O
using VBG O
herbs NNS O
were VBD O
advised VBN O
by IN O
a DT O
relative NN O
or CC O
friend NN O
and CC O
only RB O
10 CD O
. . O
3 CD O
% NN O
sought VBD O
the DT O
advice NN O
of IN O
an DT O
herbalist NN O
, , O
Table NNP O
4 CD O
. . O

A DT O
cultural JJ O
/ SYM O
traditional JJ O
basis NN O
was VBD O
the DT O
reason NN O
for IN O
herbal JJ O
remedy NN O
usage NN O
in IN O
twenty CD O
- HYPH O
one CD O
( SYM O
36 CD O
. . O
2 CD O
% NN O
) SYM O
patients NNS B-Species
and CC O
another DT O
twelve CD O
( SYM O
20 CD O
. . O
7 CD O
% NN O
) , O
patients NNS B-Species
used VBD O
herbs NNS O
because IN O
they PRP O
felt VBD O
that IN O
were VBD O
either CC O
' `` O
natural JJ O
' '' O
or CC O
' `` O
healthy JJ O
' '' O
. . O

Twelve CD O
( SYM O
20 CD O
. . O
7 CD O
% NN O
) SYM O
patients NNS B-Species
used VBD O
herbs NNS O
because IN O
they PRP O
believed VBD O
that IN O
their PRP$ O
physician NN O
- HYPH O
prescribed VBN O
allopathic JJ O
medicines NNS O
were VBD O
not RB O
working VBG O
. . O

Most JJS O
patients NNS B-Species
( , O
58 CD O
. . O
6 CD O
% NN O
) -RRB- O
obtained VBD O
their PRP$ O
herbs NNS O
or CC O
medicinal JJ O
plants NNS O
from IN O
either CC O
their PRP$ O
backyards NNS O
or CC O
the DT O
supermarket NN O
. . O

Only RB O
fourteen CD O
( SYM O
24 CD O
. . O
1 CD O
% NN O
) -RRB- O
obtained VBD O
their PRP$ O
herbal JJ O
supplies NNS O
from IN O
an DT O
herbalist NN O
, , O
herbal JJ O
shop NN O
or CC O
pharmacy NN O
. . O

Seventeen CD O
( SYM O
29 CD O
. . O
3 CD O
% NN O
) -RRB- O
of IN O
these DT O
patients NNS B-Species
reported VBD O
using VBG O
herbs NNS O
within IN O
the DT O
last JJ O
week NN O
and CC O
most JJS O
these DT O
patients NNS B-Species
( SYM O
60 CD O
. . O
3 CD O
% NN O
) -RRB- O
used VBD O
herbs NNS O
within IN O
the DT O
last JJ O
six CD O
months NNS O
. . O

Many JJ O
of IN O
these DT O
patients NNS B-Species
were VBD O
using VBG O
both CC O
physician NN O
- HYPH O
prescribed VBN O
antiasthmatic JJ O
drugs NNS O
and CC O
herbal JJ O
remedies NNS O
, , O
Table NNP O
5 CD O
. . O

No DT O
patient NN B-Species
with IN O
either CC O
moderate JJ O
or CC O
severe JJ O
symptoms NNS O
indicated VBD O
that IN O
herbal JJ O
remedies NNS O
alone RB O
were VBD O
sufficient JJ O
to TO O
relieve VB O
symptomatic JJ O
episodes NNS O
. . O

It PRP O
is VBZ O
interesting JJ O
to TO O
note VB O
that IN O
most JJS O
patients NNS B-Species
with IN O
moderate JJ O
symptoms NNS O
( : O
57 CD O
. . O
1 CD O
% NN O
) -RRB- O
believed VBD O
that IN O
concurrent JJ O
use NN O
of IN O
conventional JJ O
medications NNS O
and CC O
herbs NNS O
gave VBD O
better JJR O
symptomatic JJ O
relieve NN O
. . O

One CD O
the DT O
other JJ O
hand NN O
, , O
most JJS O
patients NNS B-Species
with IN O
severe JJ O
symptoms NNS O
( : O
53 CD O
. . O
8 CD O
% NN O
) -RRB- O
believed VBD O
that IN O
physician NN O
- HYPH O
prescribed VBN O
medications NNS O
worked VBD O
better RBR O
than IN O
herbal JJ O
remedies NNS O
, , O
while IN O
23 CD O
. . O
1 CD O
% NN O
believed VBD O
that IN O
neither CC O
relieved VBD O
their PRP$ O
symptoms NNS O
. . O

Herbs NNS O
used VBN O
in IN O
asthma NN O

Most JJS O
patients NNS B-Species
in IN O
the DT O
sample NN O
used VBD O
more JJR O
than IN O
one CD O
medicinal JJ O
herb NN O
simultaneously RB O
, , O
which WDT O
were VBD O
usually RB O
prepared VBN O
and CC O
administered VBN O
as IN O
mixtures NNS O
in IN O
teas NNS O
. . O

Almost RB O
one CD O
in IN O
four CD O
patients NNS B-Species
using VBG O
medicinal JJ O
herbs NNS O
( : O
22 CD O
. . O
5 CD O
% NN O
) -RRB- O
used VBD O
either CC O
garlic NN B-Species
( , O
Allium NN B-Species
sativum NN I-Species
) , O
or CC O
ginger NN B-Species
( , O
Zingiber NNP B-Species
officinale NN I-Species
) -RRB- O
for IN O
symptomatic JJ O
relief NN O
of IN O
asthma NN O
, , O
Table NNP O
6 CD O
. . O

Aloes NNP O
( : O
Aloe NNP B-Species
vera FW I-Species
) , O
shandileer NN B-Species
( , O
Leonotis NNP B-Species
nepetifolia NN I-Species
) -RRB- O
, , O
wild JJ O
onion NN B-Species
( , O
Hymenocallis NNP B-Species
tubiflora NN I-Species
) -RRB- O
, , O
pepper NN O
( , O
Capsicum NN O
spp NN O
. . O
) -RRB- O
tulsi NN B-Species
( , O
Ocimum NN B-Species
gratissimum NN I-Species
) -RRB- O
, , O
black JJ B-Species
sage NN I-Species
( , O
Cordia NNP B-Species
curassavica NN I-Species
) -RRB- O
, , O
shadon NN B-Species
beni NN I-Species
( , O
Eryngium NNP B-Species
foetidium NN I-Species
) -RRB- O
, , O
lemongrass NN B-Species
( , O
Cymbopogon NNP B-Species
citratus NN I-Species
) , O
and CC O
nutmeg NN B-Species
( , O
Myristica NNP B-Species
fragrans NNS I-Species
) -RRB- O
were VBD O
the DT O
more RBR O
popular JJ O
traditional JJ O
indigenous JJ O
West JJ O
Indian JJ O
medicinal JJ O
plants NNS O
used VBN O
. . O

Two CD O
patients NNS B-Species
reported VBD O
using VBG O
marijuana NN O
( , O
leaves NNS O
and CC O
roots NNS O
) -RRB- O
. . O

Herbs NNS O
of IN O
European JJ O
and CC O
North JJ O
American JJ O
origin NN O
, , O
identified VBN O
as IN O
Echinacea NNP O
( , O
Echinacea NNP B-Species
purpurea NN I-Species
) -RRB- O
, , O
Golden NNP B-Species
Seal NNP I-Species
( , O
Hydrastis NNP B-Species
canadensis NNP I-Species
) , O
and CC O
Chamomile NNP B-Species
( , O
Matricaria NNP B-Species
chamomilla NN I-Species
) -RRB- O
were VBD O
less RBR O
frequently RB O
used VBN O
. . O

Five CD O
patients NNS B-Species
reported VBD O
using VBG O
trade NN O
name NN O
imported VBN O
tablets NNS O
for IN O
asthma NN O
. . O

Effect NN O
of IN O
income NN O
and CC O
education NN O
on IN O
the DT O
use NN O
of IN O
herbs NNS O

Patients NNS B-Species
using VBG O
easily RB O
accessible JJ O
herbs NNS O
such JJ O
as IN O
ginger NN B-Species
( , O
Zingiber NNP B-Species
officinale NN I-Species
) , O
and CC O
aloes NNS O
( , O
Aloe NNP B-Species
vera FW I-Species
) -RRB- O
, , O
and CC O
traditional JJ O
indigenous JJ O
medicinal JJ O
herbs NNS O
such JJ O
as IN O
shandileer NN B-Species
( , O
Leonotis NNP B-Species
nepetifolia NN I-Species
) -RRB- O
and CC O
tulsi NN B-Species
( , O
Ocimum NN B-Species
gratissimum NN I-Species
) -RRB- O
were VBD O
more RBR O
likely JJ O
to TO O
be VB O
earning VBG O
less JJR O
than IN O
US NNP O
$ $ O
12 CD O
, , O
0 CD O
, , O
Table NNP O
7 CD O
. . O

Herbs NNS O
of IN O
European JJ O
or CC O
North JJ O
American JJ O
origin NN O
( , O
Echinacea NNP B-Species
purpurea NN I-Species
and CC O
Matricaria NNP B-Species
chamomilla NN I-Species
) -RRB- O
were VBD O
more RBR O
likely JJ O
to TO O
be VB O
used VBN O
by IN O
patients NNS B-Species
earning VBG O
in IN O
excess NN O
of IN O
US NNP O
$ $ O
12 CD O
, , O
0 CD O
per IN O
annum FW O
. . O

Income NN O
did VBD O
not RB O
affect VB O
the DT O
use NN O
of IN O
either CC O
garlic NN B-Species
or CC O
cocoa NN O
onion NN B-Species
. . O

Aloes NNP O
( : O
Aloe NNP B-Species
vera NNP I-Species
) -RRB- O
, , O
tulsi NN B-Species
( , O
Ocimum NN B-Species
gratissimum NN I-Species
) , O
and CC O
golden JJ O
seal NN O
were VBD O
preferred VBN O
in IN O
patients NNS B-Species
with IN O
at IN O
least JJS O
twelve CD O
years NNS O
of IN O
formal JJ O
education NN O
, , O
Table NNP O
7 CD O
. . O

Garlic NNP B-Species
and CC O
Echinacea NNP B-Species
were VBD O
the DT O
preferred VBN O
herbal JJ O
medicines NNS O
in IN O
patients NNS B-Species
with IN O
more JJR O
than IN O
twelve CD O
years NNS O
formal JJ O
education NN O
. . O

Educational JJ O
level NN O
did VBD O
not RB O
affect VB O
the DT O
patients NNS B-Species
' POS O
decision NN O
to TO O
use VB O
shandileer NN B-Species
( -LRB- O
Leonotis NNP B-Species
nepetifolia NN I-Species
) -RRB- O
, , O
wild JJ O
onion NN B-Species
( , O
Hymenocallis NNP B-Species
tubiflora NN I-Species
) , O
or CC O
ginger NN B-Species
( HYPH O
Zingibe NNP B-Species
officinale NN I-Species
) -RRB- O
. . O

Discussion NN O

This DT O
is VBZ O
the DT O
first JJ O
study NN O
of IN O
its PRP$ O
kind NN O
in IN O
the DT O
Caribbean NNP O
to TO O
assess VB O
the DT O
use NN O
of IN O
medicinal JJ O
herbs NNS O
by IN O
asthmatic JJ O
patients NNS B-Species
attending VBG O
a DT O
specialty NN O
care NN O
clinic NN O
. . O

The DT O
findings NNS O
of IN O
this DT O
study NN O
are VBP O
instructive JJ O
as IN O
the DT O
use NN O
of IN O
medicinal JJ O
herbs NNS O
for IN O
self NN O
- HYPH O
medication NN O
in IN O
disease NN O
management NN O
has VBZ O
far RB O
reaching VBG O
implications NNS O
on IN O
the DT O
quality NN O
of IN O
healthcare NN O
delivery NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

We PRP O
report VBP O
a DT O
prevalence NN O
of IN O
30 CD O
. . O
4 CD O
% NN O
in IN O
our PRP$ O
patient JJ B-Species
sample NN O
, , O
which WDT O
is VBZ O
significantly RB O
higher JJR O
than IN O
that DT O
in IN O
the DT O
UK NNP O
, , O
Denmark NNP O
, , O
Singapore NNP O
and CC O
in IN O
the DT O
US NNP O
[ -LRB- O
15 CD O
- SYM O
18 CD O
] -RRB- O
. . O

Most JJS O
patients NNS B-Species
using VBG O
medicinal JJ O
herbs NNS O
relied VBD O
on IN O
the DT O
advice NN O
of IN O
relatives NNS O
and CC O
friends NNS O
as IN O
their PRP$ O
sole JJ O
source NN O
of IN O
information NN O
, , O
as IN O
were VBD O
caregivers NNS O
of IN O
children NNS O
in IN O
a DT O
US NNP O
study NN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

We PRP O
suggest VBP O
that IN O
this DT O
information NN O
on IN O
the DT O
use NN O
of IN O
medicinal JJ O
plants NNS O
could MD O
have VB O
come VBN O
from IN O
traditional JJ O
/ SYM O
cultural JJ O
knowledge NN O
, , O
anecdotal JJ O
evidence NN O
or CC O
from IN O
the DT O
greater JJR O
public JJ O
awareness NN O
through IN O
information NN O
networks NNS O
such JJ O
as IN O
the DT O
internet NN O
on IN O
the DT O
potential JJ O
medicinal JJ O
benefits NNS O
of IN O
herbs NNS O
. . O

Asthma NN O
is VBZ O
an DT O
emerging VBG O
chronic JJ O
disease NN O
in IN O
the DT O
Caribbean NNP O
and CC O
we PRP O
suggest VBP O
that IN O
the DT O
traditional JJ O
knowledge NN O
in IN O
this DT O
area NN O
may MD O
be VB O
relatively RB O
' `` O
new JJ O
' '' O
and CC O
exist VBP O
in IN O
relation NN O
to IN O
other JJ O
diseases NNS O
affecting VBG O
the DT O
respiratory JJ O
tract NN O
, , O
such JJ O
as IN O
cough NN O
, , O
the DT O
common JJ O
cold NN O
and CC O
the DT O
flu NN O
. . O

This DT O
may MD O
be VB O
one CD O
of IN O
the DT O
reasons NNS O
for IN O
the DT O
low JJ O
prevalence NN O
of IN O
use NN O
of IN O
herbs NNS O
in IN O
elderly JJ O
asthmatic JJ O
patients NNS B-Species
, , O
as IN O
a DT O
strong JJ O
traditional JJ O
knowledge NN O
may MD O
not RB O
have VB O
existed VBN O
. . O

We PRP O
expected VBD O
a DT O
higher JJR O
prevalence NN O
of IN O
herbal JJ O
use NN O
in IN O
individuals NNS O
living VBG O
in IN O
rural JJ O
areas NNS O
as IN O
these DT O
districts NNS O
are VBP O
depots NNS O
for IN O
traditional JJ O
knowledge NN O
as IN O
was VBD O
reported VBN O
in IN O
Jamaica NNP O
where WRB O
rural JJ O
respondents NNS O
used VBD O
a DT O
larger JJR O
variety NN O
of IN O
herbs NNS O
than IN O
those DT O
living VBG O
in IN O
urban JJ O
areas NNS O
[ -LRB- O
10 CD O
] -RRB- O
. . O

As IN O
suggested VBN O
earlier RBR O
, , O
we PRP O
suspect VBP O
that IN O
due IN O
to IN O
the DT O
recent JJ O
emergence NN O
of IN O
asthma NN O
as IN O
a DT O
chronic JJ O
disease NN O
in IN O
the DT O
Caribbean NNP O
it PRP O
is VBZ O
reasonable JJ O
to TO O
expect VB O
that IN O
traditional JJ O
knowledge NN O
in IN O
the DT O
management NN O
of IN O
this DT O
disease NN O
is VBZ O
not RB O
strong JJ O
and CC O
our PRP$ O
results NNS O
are VBP O
indicative JJ O
of IN O
this DT O
. . O

We PRP O
suspected VBD O
that IN O
employment NN O
status NN O
could MD O
have VB O
predicted VBN O
the DT O
use NN O
of IN O
herbs NNS O
, , O
however RB O
, , O
this DT O
was VBD O
not RB O
the DT O
case NN O
in IN O
our PRP$ O
study NN O
sample NN O
. . O

Unemployed JJ O
patients NNS B-Species
did VBD O
not RB O
improvise VB O
more RBR O
in IN O
their PRP$ O
use NN O
of IN O
herbal JJ O
remedies NNS O
than IN O
those DT O
in IN O
other JJ O
income NN O
groups NNS O
, , O
even RB O
though IN O
most JJS O
of IN O
the DT O
herbs NNS O
used VBN O
were VBD O
relatively RB O
common JJ O
, , O
readily RB O
available JJ O
and CC O
cheap JJ O
. . O

The DT O
low JJ O
socioeconomic JJ O
status NN O
of IN O
the DT O
majority NN O
of IN O
the DT O
sample NN O
may MD O
have VB O
prohibited VBN O
both DT O
consultation NN O
with IN O
qualified JJ O
herbalists NNS O
and CC O
the DT O
purchase NN O
of IN O
imported VBN O
, , O
processed VBN O
herbs NNS O
that WDT O
would MD O
have VB O
incurred VBN O
additional JJ O
out IN O
- HYPH O
of IN O
- HYPH O
pocket NN O
expense NN O
to IN O
the DT O
patient NN B-Species
. . O

What WP O
we PRP O
noted VBD O
was VBD O
that IN O
there EX O
was VBD O
no DT O
difference NN O
in IN O
the DT O
use NN O
of IN O
herbs NNS O
across IN O
the DT O
income NN O
ranges NNS O
and CC O
that IN O
in IN O
fact NN O
, , O
patients NNS B-Species
earning VBG O
relatively RB O
modest JJ O
annual JJ O
incomes NNS O
between IN O
$ $ O
US12 CD O
, , O
0 CD O
and CC O
$ $ O
US19 CD O
, , O
999 CD O
were VBD O
most RBS O
likely JJ O
to TO O
use VB O
herbs NNS O
, , O
although IN O
this DT O
did VBD O
not RB O
reach VB O
statistical JJ O
significance NN O
. . O

Attaining VBG O
a DT O
higher JJR O
education NN O
positively RB O
influence VBP O
the DT O
decision NN O
to TO O
use VB O
herbs NNS O
. . O

We PRP O
suggest VBP O
that IN O
in IN O
the DT O
absence NN O
of IN O
traditional JJ O
knowledge NN O
regarding VBG O
the DT O
medicinal JJ O
use NN O
of IN O
herbs NNS O
for IN O
asthma NN O
, , O
a DT O
higher JJR O
educational JJ O
level NN O
may MD O
predispose VB O
an DT O
individual NN O
to IN O
greater JJR O
access NN O
to IN O
general JJ O
knowledge NN O
, , O
especially RB O
with IN O
greater JJR O
exposure NN O
to IN O
the DT O
internet NN O
and CC O
other JJ O
sources NNS O
of IN O
information NN O
, , O
and CC O
this DT O
could MD O
be VB O
a DT O
factor NN O
in IN O
positively RB O
influencing VBG O
the DT O
individual NN O
' POS O
s POS O
decision NN O
to TO O
use VB O
medicinal JJ O
herbs NNS O
. . O

The DT O
availability NN O
of IN O
scientific JJ O
evidence NN O
- HYPH O
based VBN O
information NN O
on IN O
the DT O
efficacy NN O
of IN O
herbs NNS O
for IN O
diverse JJ O
healthcare NN O
problems NNS O
may MD O
be VB O
particularly RB O
significant JJ O
in IN O
patients NNS B-Species
with IN O
the DT O
resources NNS O
to TO O
avail VB O
themselves PRP O
to IN O
such JJ O
information NN O
, , O
particularly RB O
those DT O
with IN O
higher JJR O
educational JJ O
and CC O
income NN O
levels NNS O
. . O

This DT O
is VBZ O
particularly RB O
true JJ O
for IN O
garlic NN B-Species
and CC O
Echinacea NNP B-Species
, , O
which WDT O
have VBP O
been VBN O
extensively RB O
researched VBN O
and CC O
furthermore JJ O
patients NNS B-Species
with IN O
higher JJR O
educational JJ O
and CC O
income NN O
levels NNS O
would MD O
be VB O
more RBR O
likely JJ O
be VB O
at IN O
an DT O
advantage NN O
to TO O
access VB O
information NN O
via IN O
literature NN O
or CC O
on IN O
the DT O
world NN O
wide JJ O
web NN O
regarding VBG O
the DT O
use NN O
of IN O
these DT O
medicinal JJ O
plants NNS O
. . O

Patients NNS B-Species
using VBG O
imported VBN O
, , O
processed VBN O
, , O
and CC O
obviously RB O
more RBR O
expensive JJ O
herbal JJ O
medications NNS O
were VBD O
on IN O
the DT O
higher JJR O
end NN O
of IN O
the DT O
socioeconomic JJ O
scale NN O
and CC O
were VBD O
more RBR O
likely JJ O
to TO O
afford VB O
these DT O
medications NNS O
. . O

It PRP O
was VBD O
also RB O
observed VBN O
that IN O
garlic NN B-Species
and CC O
Echinacea NNP B-Species
were VBD O
the DT O
herbs NNS O
of IN O
choice NN O
in IN O
patients NNS B-Species
with IN O
higher JJR O
educational JJ O
levels NNS O
. . O

These DT O
herbs NNS O
have VBP O
a DT O
long JJ O
tradition NN O
of IN O
use NN O
and CC O
are VBP O
widely RB O
researched VBN O
in IN O
Europe NNP O
and CC O
North NNP O
America NNP O
. . O

The DT O
traditional JJ O
use NN O
and CC O
strong JJ O
scientific JJ O
evidence NN O
to TO O
support VB O
their PRP$ O
therapeutic JJ O
efficacy NN O
could MD O
be VB O
important JJ O
factors NNS O
influencing VBG O
the DT O
patient NN B-Species
' POS O
s POS O
decision NN O
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
elsewhere RB O
that IN O
patients NNS B-Species
with IN O
higher JJR O
educational JJ O
levels NNS O
also RB O
tend VBP O
be VB O
more RBR O
involved JJ O
in IN O
the DT O
management NN O
of IN O
their PRP$ O
health NN O
; : O
they PRP O
tend VBP O
to TO O
self NN O
- HYPH O
medicate VBP O
or CC O
even RB O
suggest VBP O
to IN O
their PRP$ O
physicians NNS O
the DT O
course NN O
of IN O
therapy NN O
. . O

Although IN O
one CD O
in IN O
five CD O
patients NNS B-Species
using VBG O
medicinal JJ O
herbs NNS O
stated VBD O
that IN O
"""" `` O
conventional JJ O
medicines NNS O
were VBD O
not RB O
working VBG O
"""" '' O
as IN O
the DT O
reason NN O
for IN O
using VBG O
this DT O
alternative JJ O
healthcare NN O
modality NN O
, , O
we PRP O
noted VBD O
that IN O
asthma NN O
severity NN O
does VBZ O
not RB O
affect VB O
the DT O
decision NN O
to TO O
use VB O
herbs NNS O
. . O

In IN O
previous JJ O
studies NNS O
, , O
poor JJ O
management NN O
was VBD O
associated VBN O
with IN O
non JJ O
- HYPH O
compliance NN O
with IN O
prescribed VBN O
pharmacotherapy NN O
and CC O
poor JJ O
inhaler NN O
technique NN O
[ -LRB- O
5 CD O
, , O
6 CD O
] -RRB- O
. . O

The DT O
backyard NN O
and CC O
home NN O
garden NN O
were VBD O
major JJ O
sources NNS O
of IN O
readily RB O
available JJ O
herbs NNS O
such JJ O
as IN O
aloes NNS O
, , O
shadon NN B-Species
beni NN I-Species
and CC O
lemongrass NN B-Species
. . O

Wild JJ O
growing VBG O
' `` O
weeds NNS O
' '' O
such JJ O
as IN O
shandileer NN B-Species
, , O
tulsi NN B-Species
, , O
cocoa NN O
onion NN B-Species
and CC O
black JJ B-Species
sage NN I-Species
were VBD O
also RB O
identified VBN O
. . O

The DT O
supermarket NN O
was VBD O
a DT O
major JJ O
source NN O
of IN O
inexpensive JJ O
common JJ O
medicinal JJ O
herbs NNS O
such JJ O
as IN O
garlic NN B-Species
, , O
ginger NN B-Species
and CC O
nutmeg NN B-Species
. . O

The DT O
identification NN O
of IN O
these DT O
medicinal JJ O
herbs NNS O
provides VBZ O
an DT O
opportunity NN O
to TO O
investigate VB O
West JJ O
Indian JJ O
plants NNS O
used VBN O
to TO O
treat VB O
asthma NN O
to TO O
determine VB O
whether IN O
they PRP O
possess VBP O
pharmacological JJ O
properties NNS O
. . O

Scientific JJ O
investigations NNS O
have VBP O
shown VBN O
that IN O
some DT O
of IN O
these DT O
herbs NNS O
possess VBP O
pharmacological JJ O
and CC O
anti JJ O
- HYPH O
inflammatory JJ O
properties NNS O
, , O
and CC O
these DT O
may MD O
be VB O
useful JJ O
in IN O
suppressing VBG O
the DT O
characteristic JJ O
exaggerated VBN O
immune JJ O
response NN O
in IN O
asthma NN O
[ -LRB- O
20 CD O
- SYM O
24 CD O
] -RRB- O
. . O

Pepper NN O
and CC O
bayleaf NN B-Species
have VBP O
also RB O
been VBN O
shown VBN O
to TO O
exhibit VB O
anti JJ O
- HYPH O
inflammatory JJ O
properties NNS O
[ -LRB- O
[ -LRB- O
25 CD O
, , O
26 CD O
] -RRB- O
27 CD O
] -RRB- O
. . O

There EX O
is VBZ O
an DT O
imperative NN O
to TO O
commence VB O
scientific JJ O
investigations NNS O
on IN O
traditional JJ O
West JJ O
Indian JJ O
medicinal JJ O
plants NNS O
to TO O
determine VB O
their PRP$ O
therapeutic JJ O
efficacy NN O
and CC O
safety NN O
. . O

The DT O
survey NN O
instrument NN O
specifically RB O
asked VBD O
questions NNS O
on IN O
the DT O
use NN O
of IN O
medicinal JJ O
herbs NNS O
in IN O
asthma NN O
and CC O
did VBD O
not RB O
inquire VB O
about IN O
the DT O
use NN O
of IN O
herbs NNS O
as IN O
customary JJ O
teas NNS O
or CC O
tonics NNS O
. . O

We PRP O
therefore RB O
did VBD O
not RB O
determine VB O
lifetime NN O
prevalence NN O
for IN O
the DT O
use NN O
of IN O
herbs NNS O
in IN O
our PRP$ O
patient JJ B-Species
sample NN O
, , O
but CC O
we PRP O
suppose VBP O
that IN O
had VBD O
this DT O
been VBN O
included VBN O
that IN O
there EX O
might MD O
have VB O
been VBN O
a DT O
prevalence NN O
similar JJ O
to IN O
those DT O
reported VBN O
in IN O
the DT O
Jamaica NNP O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
and CC O
Trinidad NNP O
[ -LRB- O
13 CD O
] -RRB- O
surveys NNS O
. . O

The DT O
survey NN O
was VBD O
also RB O
limited VBN O
in IN O
that IN O
by IN O
electing VBG O
to TO O
conduct VB O
the DT O
study NN O
at IN O
a DT O
public JJ O
health NN O
facility NN O
we PRP O
obviously RB O
had VBD O
a DT O
bias NN O
towards IN O
patients NNS B-Species
at IN O
the DT O
lower JJR O
rung NN O
of IN O
the DT O
socioeconomic JJ O
ladder NN O
, , O
with IN O
lower JJR O
income NN O
and CC O
educational JJ O
status NN O
. . O

As IN O
a DT O
consequence NN O
, , O
the DT O
results NNS O
reflected VBD O
patients NNS B-Species
from IN O
this DT O
demographic JJ O
background NN O
. . O

We PRP O
may MD O
have VB O
expected VBN O
a DT O
different JJ O
outcome NN O
in IN O
asthmatic JJ O
patients NNS B-Species
attending VBG O
private JJ O
institutions NNS O
, , O
where WRB O
their PRP$ O
characteristics NNS O
would MD O
have VB O
been VBN O
slightly RB O
different JJ O
, , O
as IN O
we PRP O
noted VBD O
that IN O
even RB O
in IN O
our PRP$ O
sample NN O
the DT O
small JJ O
number NN O
of IN O
persons NNS O
with IN O
higher JJR O
income NN O
and CC O
educational JJ O
status NN O
tended VBD O
to TO O
use VB O
more JJR O
medicinal JJ O
herbs NNS O
for IN O
symptomatic JJ O
relief NN O
. . O

We PRP O
did VBD O
not RB O
assess VB O
whether IN O
patients NNS B-Species
informed VBD O
their PRP$ O
attending VBG O
physician NN O
at IN O
the DT O
clinic NN O
about IN O
their PRP$ O
use NN O
of IN O
herbs NNS O
or CC O
determined VBD O
whether IN O
the DT O
knowledge NN O
or CC O
attitudes NNS O
of IN O
these DT O
physicians NNS O
regarding VBG O
the DT O
use NN O
of IN O
herbs NNS O
influenced VBD O
the DT O
patients NNS B-Species
' POS O
decision NN O
to TO O
use VB O
herbs NNS O
. . O

The DT O
study NN O
was VBD O
also RB O
limited VBN O
in IN O
that IN O
we PRP O
did VBD O
not RB O
ascertain VB O
the DT O
out IN O
- HYPH O
of IN O
- HYPH O
pocket NN O
expense NN O
for IN O
herbal JJ O
remedies NNS O
by IN O
patients NNS B-Species
, , O
although IN O
most JJS O
stated VBD O
that IN O
herbal JJ O
medicines NNS O
( , O
which WDT O
we PRP O
supposed VBD O
were VBD O
processed VBN O
, , O
imported VBN O
products NNS O
) , O
were VBD O
more RBR O
expensive JJ O
than IN O
conventional JJ O
medicines NNS O
. . O

We PRP O
assumed VBD O
that IN O
an DT O
additional JJ O
expense NN O
would MD O
have VB O
only RB O
been VBN O
incurred VBN O
by IN O
those DT O
patients NNS B-Species
purchasing VBG O
processed VBN O
, , O
imported VBN O
herbs NNS O
obtained VBN O
from IN O
a DT O
herbalist NN O
, , O
herbal JJ O
shop NN O
or CC O
pharmacy NN O
( : O
24 CD O
. . O
1 CD O
% NN O
) -RRB- O
and CC O
who WP O
actually RB O
consulted VBD O
a DT O
herbalist NN O
( : O
10 CD O
. . O
3 CD O
% NN O
) -RRB- O
. . O

We PRP O
also RB O
reasoned VBD O
that IN O
since IN O
all PDT O
the DT O
other JJ O
herbs NNS O
used VBN O
were VBD O
inexpensive JJ O
and CC O
available JJ O
from IN O
either CC O
the DT O
backyard NN O
garden NN O
or CC O
supermarket NN O
( , O
58 CD O
. . O
6 CD O
% NN O
) : O
that IN O
the DT O
cost NN O
to IN O
patients NNS B-Species
selecting VBG O
these DT O
remedies NNS O
was VBD O
minimal JJ O
. . O

Conclusions NNS O

The DT O
findings NNS O
of IN O
this DT O
study NN O
are VBP O
important JJ O
in IN O
that IN O
local JJ O
medicinal JJ O
plants NNS O
in IN O
Trinidad NNP O
have VBP O
been VBN O
identified VBN O
in IN O
the DT O
self NN O
- HYPH O
management NN O
of IN O
asthma NN O
in IN O
a DT O
significant JJ O
number NN O
of IN O
patients NNS B-Species
attending VBG O
the DT O
specialty NN O
clinic NN O
. . O

These DT O
identified VBN O
herbs NNS O
can MD O
now RB O
be VB O
targeted VBN O
for IN O
scientific JJ O
investigation NN O
to TO O
determine VB O
whether IN O
their PRP$ O
pharmacological JJ O
efficacy NN O
will MD O
assist VB O
in IN O
the DT O
development NN O
of IN O
viable JJ O
healthcare NN O
alternatives NNS O
in IN O
a DT O
developing VBG O
country NN O
. . O

These DT O
findings NNS O
are VBP O
also RB O
important JJ O
for IN O
policymakers NNS O
in IN O
the DT O
health NN O
sector NN O
who WP O
are VBP O
given VBN O
the DT O
mandate NN O
to TO O
regulate VB O
issues NNS O
pertaining VBG O
to IN O
the DT O
public NN O
' POS O
s POS O
health NN O
. . O

We PRP O
are VBP O
also RB O
becoming VBG O
more RBR O
aware JJ O
of IN O
the DT O
potential NN O
for IN O
critical JJ O
interplay NN O
between IN O
herbs NNS O
and CC O
drugs NNS O
when WRB O
taken VBN O
concomitantly RB O
to TO O
produce VB O
life NN O
- HYPH O
threatening VBG O
interactions NNS O
. . O

Since IN O
herbs NNS O
are VBP O
here RB O
to TO O
stay VB O
and CC O
patients NNS B-Species
will MD O
continue VB O
to TO O
self NN O
- HYPH O
medicate VB O
with IN O
increasing VBG O
frequency NN O
, , O
it PRP O
is VBZ O
imperative JJ O
that IN O
healthcare NN O
providers NNS O
become VBP O
more RBR O
knowledgeable JJ O
on IN O
this DT O
modality NN O
and CC O
keep VB O
abreast RB O
with IN O
the DT O
latest JJS O
developments NNS O
in IN O
herbal JJ O
therapy NN O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

YNC NNP O
was VBD O
the DT O
P NN O
. . O
I PRP O
. . O
in IN O
this DT O
study NN O
. . O

He PRP O
was VBD O
responsible JJ O
for IN O
the DT O
study NN O
concept NN O
, , O
development NN O
of IN O
methodology NN O
, , O
coordinating VBG O
the DT O
research NN O
activities NNS O
, , O
analyzing VBG O
the DT O
data NNS O
, , O
and CC O
writing VBG O
the DT O
manuscript NN O
. . O

AFW NNP O
was VBD O
responsible JJ O
for IN O
data NN O
input NN O
and CC O
analysis NN O
. . O

DA NN O
was VBD O
involved VBN O
in IN O
methodological JJ O
development NN O
, , O
data NN O
collection NN O
, , O
data NN O
input NN O
and CC O
analysis NN O
and CC O
presentation NN O
at IN O
regional JJ O
conference NN O
. . O

RC NNP O
was VBD O
involved VBN O
in IN O
methodological JJ O
development NN O
, , O
data NN O
collection NN O
, , O
data NN O
input NN O
and CC O
analysis NN O
. . O

NW NNP O
was VBD O
involved VBN O
in IN O
methodological JJ O
development NN O
, , O
data NN O
collection NN O
and CC O
input NN O
. . O

RM NNP O
was VBD O
involved VBN O
in IN O
methodological JJ O
development NN O
, , O
data NN O
collection NN O
and CC O
input NN O
. . O

OS NNP O
was VBD O
involved VBN O
in IN O
methodological JJ O
development NN O
, , O
data NN O
collection NN O
and CC O
input NN O
. . O

DW NNP O
was VBD O
involved VBN O
in IN O
methodological JJ O
development NN O
, , O
data NN O
collection NN O
and CC O
input NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

Gene NN O
expression NN O
studies NNS O
in IN O
isolated VBN O
mitochondria NN O
: : O
Solanum NN B-Species
tuberosum NN I-Species
rps10 NN O
is VBZ O
recognized VBN O
by IN O
cognate JJ O
potato NN B-Species
but CC O
not RB O
by IN O
the DT O
transcription NN O
, , O
splicing NN O
and CC O
editing VBG O
machinery NN O
of IN O
wheat NN B-Species
mitochondria NN O

Abstract JJ O

The DT O
complex JJ O
gene NN O
expression NN O
mechanisms NNS O
that WDT O
occur VBP O
in IN O
plant NN O
mitochondria NN O
, , O
such JJ O
as IN O
RNA NN O
editing NN O
and CC O
splicing NN O
, , O
are VBP O
not RB O
yet RB O
well RB O
understood VBN O
. . O

RNA NNP O
editing NN O
in IN O
higher JJR O
plant NN O
mitochondria NN O
is VBZ O
a DT O
highly RB O
specific JJ O
process NN O
which WDT O
modifies VBZ O
mRNA NNP O
sequences NNS O
by IN O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
conversions NNS O
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
in IN O
some DT O
cases NNS O
this DT O
process NN O
is VBZ O
required VBN O
for IN O
splicing NN O
. . O

Here RB O
, , O
we PRP O
use VBP O
an DT O
experimental JJ O
model NN O
based VBN O
on IN O
the DT O
introduction NN O
of IN O
DNA NNP O
into IN O
isolated VBN O
mitochondria NN O
by IN O
electroporation NN O
to TO O
study VB O
organellar JJ O
gene NN O
expression NN O
events NNS O
. . O

Our PRP$ O
aim NN O
was VBD O
to TO O
compare VB O
processing NN O
and CC O
editing NN O
of IN O
potato NN B-Species
small JJ O
ribosomal NN O
protein NN O
10 CD O
gene NN O
( -LRB- O
rps10 NN O
) -RRB- O
transcripts NNS O
in IN O
heterologous JJ O
( , O
wheat NN B-Species
mitochondria NN O
) NFP O
and CC O
homologous JJ O
( , O
potato NN B-Species
mitochondria NN O
) -RRB- O
contexts NNS O
. . O

rps10 NN O
is VBZ O
a DT O
suitable JJ O
model NN O
because IN O
it PRP O
contains VBZ O
a DT O
group NN O
II NN O
intron NN O
, , O
is VBZ O
absent JJ O
in IN O
wheat NN B-Species
mitochondria NN O
but CC O
is VBZ O
actively RB O
expressed VBN O
in IN O
potato NN B-Species
mitochondria NN O
, , O
where WRB O
transcripts NNS O
are VBP O
spliced VBN O
and CC O
undergo VBP O
five CD O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
editing NN O
events NNS O
. . O

For IN O
this DT O
purpose NN O
, , O
conditions NNS O
for IN O
electroporating VBG O
isolated VBN O
potato NN B-Species
mitochondria NN O
were VBD O
established VBN O
. . O

rps10 NN O
was VBD O
placed VBN O
under IN O
the DT O
control NN O
of IN O
either CC O
potato NN B-Species
or CC O
wheat NN B-Species
cox2 NN O
promoters NNS O
. . O

We PRP O
found VBD O
that IN O
rps10 NN O
was VBD O
only RB O
transcribed VBN O
under IN O
the DT O
control NN O
of IN O
a DT O
cognate JJ O
promoter NN O
. . O

In IN O
wheat NN B-Species
mitochondria NN O
, , O
rps10 NN O
transcripts NNS O
were VBD O
neither CC O
spliced VBN O
nor CC O
edited VBN O
while IN O
they PRP O
are VBP O
correctly RB O
processed VBN O
in IN O
potato NN B-Species
mitochondria NN O
. . O

Interestingly RB O
, , O
a DT O
wheat NN B-Species
editing NN O
site NN O
grafted VBD O
into IN O
rps10 NN O
was VBD O
not RB O
recognized VBN O
by IN O
wheat NN B-Species
mitochondria NNS O
but CC O
was VBD O
correctly RB O
edited VBN O
in IN O
potato NN B-Species
mitochondria NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
editing NN O
might MD O
occur VB O
only RB O
when WRB O
the DT O
transcripts NNS O
are VBP O
engaged VBN O
in IN O
processing NN O
and CC O
that IN O
they PRP O
would MD O
not RB O
be VB O
available JJ O
to IN O
editing VBG O
factors NNS O
outside RB O
of IN O
a DT O
putative JJ O
RNA NNP O
maturation NN O
machinery NN O
complex NN O
. . O

INTRODUCTION NN O

Gene NN O
expression NN O
in IN O
plant NN O
mitochondria NN O
is VBZ O
a DT O
complex JJ O
process NN O
involving VBG O
multiple JJ O
steps NNS O
such JJ O
as IN O
transcription NN O
, , O
cis NN O
- HYPH O
and CC O
trans NN O
- HYPH O
splicing NN O
, , O
RNA NNP O
trimming NN O
and CC O
RNA NN O
editing NN O
on IN O
the DT O
way NN O
to IN O
translation NN O
( , O
1 CD O
) -RRB- O
. . O

RNA NNP O
editing NN O
has VBZ O
been VBN O
found VBN O
in IN O
a DT O
variety NN O
of IN O
organisms NNS O
and CC O
occurs VBZ O
through IN O
different JJ O
mechanisms NNS O
such JJ O
as IN O
insertion NN O
or CC O
deletion NN O
of IN O
nucleotides NNS O
, , O
or CC O
base NN O
conversions NNS O
[ -LRB- O
for IN O
details NNS O
see VB O
reference NN O
( -LRB- O
2 CD O
) -RRB- O
] -RRB- O
. . O

In IN O
higher JJR O
plant NN O
organelles NNS O
, , O
RNA NNP O
editing NN O
is VBZ O
an DT O
important JJ O
post NN O
- HYPH O
transcriptional JJ O
event NN O
characterized VBN O
by IN O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
changes VBZ O
via IN O
a DT O
deamination NN O
mechanism NN O
( , O
3 CD O
- HYPH O
5 CD O
) -RRB- O
. . O

In IN O
Arabidopsis NN B-Species
thaliana NN I-Species
456 CD O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
editing NN O
events NNS O
have VBP O
been VBN O
described VBN O
( , O
6 CD O
) -RRB- O
. . O

RNA NNP O
editing NN O
occurs VBZ O
mostly RB O
in IN O
the DT O
coding VBG O
regions NNS O
which WDT O
alter VBP O
the DT O
identity NN O
of IN O
the DT O
encoded VBN O
amino NN O
acid NN O
, , O
but CC O
some DT O
editing NN O
events NNS O
occur VBP O
in IN O
highly RB O
structured JJ O
regions NNS O
of IN O
introns NNS O
( SYM O
7 CD O
, , O
8 CD O
) -RRB- O
. . O

Like IN O
other JJ O
maturation NN O
processes NNS O
, , O
RNA NNP O
editing NN O
is VBZ O
an DT O
essential JJ O
post NN O
- HYPH O
transcriptional JJ O
event NN O
in IN O
plant NN O
mitochondrial JJ O
gene NN O
expression NN O
( , O
9 CD O
- HYPH O
11 CD O
) -RRB- O
required VBN O
for IN O
the DT O
synthesis NN O
of IN O
functional JJ O
proteins NNS O
( , O
12 CD O
, , O
13 CD O
) -RRB- O
. . O

The DT O
introduction NN O
of IN O
foreign JJ O
DNA NNP O
into IN O
isolated VBN O
mitochondria NN O
is VBZ O
a DT O
novel JJ O
experimental JJ O
model NN O
which WDT O
has VBZ O
provided VBN O
important JJ O
information NN O
on IN O
RNA NNP O
editing NN O
and CC O
RNA NN O
splicing NN O
enabling VBG O
the DT O
use NN O
of IN O
a DT O
site NN O
- HYPH O
directed VBN O
mutagenesis NN O
approach NN O
( , O
14 CD O
, , O
15 CD O
) -RRB- O
. . O

Using VBG O
a DT O
cognate JJ O
cox2 NN O
chimeric NN O
gene NN O
construct NN O
, , O
the DT O
cis NN O
- HYPH O
recognition NN O
elements NNS O
required VBN O
for IN O
plant NN O
mitochondria NN O
RNA NNP O
editing NN O
have VBP O
been VBN O
determined VBN O
( SYM O
16 CD O
, , O
17 CD O
) -RRB- O
. . O

Using VBG O
the DT O
same JJ O
approach NN O
, , O
Staudinger NNP O
and CC O
Kempken NNP O
( : O
18 CD O
) -RRB- O
have VBP O
reported VBN O
that IN O
transcripts NNS O
from IN O
A NN B-Species
. . I-Species
thaliana NN I-Species
cox2 NN O
, , O
but CC O
not RB O
Sorghum NN B-Species
bicolor NN I-Species
atp6 NN O
, , O
are VBP O
edited VBN O
when WRB O
the DT O
genes NNS O
are VBP O
introduced VBN O
into IN O
maize NN B-Species
mitochondria NN O
. . O

Interestingly RB O
, , O
higher JJR O
plant NN O
mitochondrial JJ O
genomes NNS O
differ VBP O
in IN O
their PRP$ O
gene NN O
contents NNS O
due IN O
to IN O
an DT O
evolutionary JJ O
information NN O
transfer NN O
from IN O
the DT O
organelle NN O
to IN O
the DT O
nucleus NN O
( SYM O
19 CD O
) -RRB- O
. . O

Of IN O
particular JJ O
interest NN O
is VBZ O
the DT O
situation NN O
of IN O
the DT O
small JJ O
ribosomal JJ O
protein NN O
10 CD O
gene NN O
( HYPH O
rps10 NN O
) -RRB- O
, , O
a DT O
group NN O
II NNP O
intron NN O
- HYPH O
bearing VBG O
gene NN O
which WDT O
is VBZ O
encoded VBN O
in IN O
Solanum NNP B-Species
tuberosum NN I-Species
mitochondrial NN O
DNA NN O
but CC O
is VBZ O
absent JJ O
from IN O
the DT O
wheat NN B-Species
mitochondrial JJ O
genome NN O
( , O
20 CD O
) -RRB- O
. . O

Higher JJR O
plant NN O
mitochondria NN O
contain VBP O
group NN O
II NN O
introns NNS O
either CC O
in IN O
cis NN O
- HYPH O
or CC O
trans NN O
- HYPH O
configuration NN O
( : O
1 CD O
) -RRB- O
which WDT O
can MD O
be VB O
folded VBN O
in IN O
a DT O
characteristic JJ O
secondary JJ O
structure NN O
( SYM O
21 CD O
) -RRB- O
. . O

Intron NN O
removal NN O
in IN O
plant NN O
mitochondrial JJ O
mRNAs NNS O
is VBZ O
not RB O
well RB O
documented VBN O
because IN O
such JJ O
introns NNS O
are VBP O
unable JJ O
to TO O
self NN O
- HYPH O
splice NN O
. . O

Previously RB O
, , O
we PRP O
described VBD O
that IN O
electroporated VBN O
cox2 NN O
constructs NNS O
were VBD O
a DT O
good JJ O
model NN O
for IN O
the DT O
study NN O
of IN O
the DT O
splicing NN O
process NN O
. . O

Using VBG O
this DT O
model NN O
, , O
we PRP O
found VBD O
that IN O
editing NN O
and CC O
splicing NN O
of IN O
cox2 NN O
transcripts NNS O
were VBD O
not RB O
linked VBN O
in IN O
wheat NN B-Species
mitochondria NN O
( SYM O
15 CD O
) -RRB- O
. . O

To TO O
challenge VB O
the DT O
ability NN O
of IN O
mitochondrial JJ O
gene NN O
expression NN O
machinery NN O
to TO O
recognize VB O
genetic JJ O
information NN O
which WDT O
has VBZ O
been VBN O
lost VBN O
during IN O
evolution NN O
, , O
we PRP O
decided VBD O
to TO O
introduce VB O
the DT O
S NN B-Species
. . I-Species
tuberosum NN I-Species
non JJ O
- HYPH O
cognate NN O
rps10 NN O
gene NN O
into IN O
wheat NN B-Species
mitochondria NN O
. . O

Five CD O
C NN O
residues NNS O
are VBP O
changed VBN O
to IN O
U NNP O
in IN O
potato NN B-Species
mitochondria NN O
rps10 NN O
transcripts NNS O
by IN O
editing NN O
. . O

Two CD O
of IN O
them PRP O
have VBP O
been VBN O
postulated VBN O
as IN O
being VBG O
necessary JJ O
for IN O
acquisition NN O
of IN O
a DT O
proper JJ O
secondary JJ O
and CC O
/ SYM O
or CC O
tertiary JJ O
structure NN O
for IN O
splicing NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
it PRP O
was VBD O
necessary JJ O
to TO O
set VB O
up RP O
the DT O
conditions NNS O
for IN O
electroporation NN O
of IN O
foreign JJ O
DNA NN O
into IN O
S NN B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
a DT O
potato NN B-Species
rps10 NN O
construct NN O
is VBZ O
transcribed VBN O
when WRB O
introduced VBN O
into IN O
wheat NN B-Species
mitochondria NN O
, , O
but CC O
transcripts NNS O
are VBP O
not RB O
recognized VBN O
by IN O
the DT O
post NN O
- HYPH O
transcriptional JJ O
processing NN O
machinery NN O
. . O

In IN O
contrast NN O
, , O
a DT O
rps10 NN O
construct NN O
is VBZ O
correctly RB O
expressed VBN O
and CC O
processed VBN O
in IN O
cognate JJ O
potato NN B-Species
mitochondria NN O
. . O

Moreover RB O
, , O
we PRP O
present VBP O
evidence NN O
that IN O
transcript NN O
editing NN O
might MD O
be VB O
linked VBN O
to IN O
overall JJ O
RNA NNP O
processing NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
on IN O
DNA NN O
electroporation NN O
into IN O
potato NN B-Species
mitochondria NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Plasmids NNS O

All DT O
plasmids NNS O
used VBN O
in IN O
this DT O
study NN O
are VBP O
based VBN O
on IN O
the DT O
previously RB O
described VBN O
pCOXII NNP O
vector NN O
( HYPH O
14 CD O
) -RRB- O
. . O

An DT O
NsiI NNP O
restriction NN O
site NN O
was VBD O
introduced VBN O
at IN O
the DT O
initiation NN O
codon NN O
of IN O
the DT O
wheat NN B-Species
cox2 NN O
open JJ O
reading NN O
frame NN O
( , O
ORF NNP O
) -RRB- O
. . O

Then RB O
, , O
NsiI NNP O
was VBD O
used VBN O
in IN O
combination NN O
with IN O
a DT O
SpeI NNP O
restriction NN O
site NN O
present JJ O
in IN O
the DT O
original JJ O
vector NN O
after IN O
the DT O
stop NN O
codon NN O
, , O
to TO O
produce VB O
the DT O
chimeric JJ O
vectors NNS O
. . O

S NN B-Species
. . I-Species
tuberosum NN I-Species
cox2 NN O
gene NN O
, , O
including VBG O
a DT O
727 CD O
bp NN O
non JJ O
- HYPH O
coding VBG O
upstream JJ O
region NN O
, , O
was VBD O
isolated VBN O
by IN O
PCR NNP O
from IN O
total JJ O
DNA NNP O
using VBG O
the DT O
primer NN O
A NN O
designed VBN O
from IN O
partial JJ O
sequences NNS O
reported VBN O
by IN O
L NNP O
o FW O
essl FW O
et FW O
al NNP O
. . O

( : O
22 CD O
) -RRB- O
, , O
accession NN O
no UH O
. . O

AF096321 NN O
, , O
containing VBG O
the DT O
KpnI NNP O
restriction NN O
sequence NN O
, , O
and CC O
primer NN O
B NN O
derived VBN O
from IN O
Triticum NNP B-Species
timopheevi NNP I-Species
cox2 NN O
( : O
AF336134 CD O
) -RRB- O
. . O

A DT O
fragment NN O
of IN O
2888 CD O
bp NN O
was VBD O
obtained VBN O
and CC O
cloned VBN O
on IN O
pGEM NNP O
- HYPH O
T NNP O
vector NN O
. . O

The DT O
complete JJ O
sequence NN O
of IN O
the DT O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
cox2 NN O
was VBD O
determined VBN O
( : O
accession NN O
no UH O
. . O
DQ18064 NN O
) -RRB- O
. . O

To TO O
generate VB O
the DT O
plasmid NN O
pCOXIISt NN O
containing VBG O
the DT O
S NN B-Species
. . I-Species
tuberosum NN I-Species
cox2 NN O
gene NN O
, , O
a DT O
KpnI NNP O
/ SYM O
SpeI NNP O
fragment NN O
containing VBG O
the DT O
727 CD O
bp NN O
upstream JJ O
region NN O
and CC O
the DT O
complete JJ O
coding VBG O
region NN O
was VBD O
used VBN O
to TO O
replace VB O
the DT O
wheat NN B-Species
gene NN O
from IN O
pCOXII NNP O
. . O

As IN O
for IN O
pCOXII NNP O
, , O
a DT O
NsiI NNP O
site NN O
was VBD O
inserted VBN O
at IN O
the DT O
ATG NNP O
start NN O
codon NN O
and CC O
a DT O
23 CD O
bp NN O
fragment NN O
was VBD O
inserted VBN O
at IN O
position NN O
- HYPH O
20 CD O
. . O

This DT O
23 CD O
bp NN O
insertion NN O
provides VBZ O
a DT O
specific JJ O
sequence NN O
allowing VBG O
isolation NN O
of IN O
potato NN B-Species
cox2 NN O
transcripts NNS O
originating VBG O
from IN O
the DT O
introduced VBN O
DNA NNP O
by IN O
RT NNP O
- HYPH O
PCR NNP O
. . O

The DT O
chimeric JJ O
wheat NN B-Species
/ SYM O
potato NN B-Species
cox2 NN O
gene NN O
was VBD O
constructed VBN O
by IN O
replacing VBG O
727 CD O
bp NN O
KpnI NNP O
/ SYM O
NsiI NNP O
promoter NN O
sequence NN O
from IN O
pCOXIISt NN O
with IN O
the DT O
880 CD O
bp NN O
wheat NN B-Species
upstream JJ O
region NN O
from IN O
pCOXII NNP O
. . O

The DT O
vectors NNS O
pRPS10W NNP O
and CC O
the DT O
pRPS10St NN O
derivative JJ O
, , O
containing VBG O
wheat NN B-Species
and CC O
potato NN B-Species
cox2 NN O
promoters NNS O
, , O
respectively RB O
, , O
were VBD O
constructed VBN O
by IN O
inserting VBG O
the DT O
1178 CD O
bp NN O
rps10 NN O
sequence NN O
containing VBG O
two CD O
exons NNS O
separated VBN O
by IN O
a DT O
777 CD O
bp NN O
intronic JJ O
sequence NN O
[ -LRB- O
( SYM O
23 CD O
) -RRB- O
, , O
accession NN O
no UH O
. . O
X74826 CD O
] -RRB- O
. . O

The DT O
coding VBG O
region NN O
was VBD O
isolated VBN O
from IN O
total JJ O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
DNA NNP O
by IN O
PCR NNP O
using VBG O
primers NNS O
D1 NNP O
and CC O
D2 NNP O
containing VBG O
the DT O
restriction NN O
sites NNS O
NsiI NNP O
and CC O
SpeI NNP O
, , O
respectively RB O
. . O

The DT O
fragment NN O
NsiI NNP O
/ SYM O
SpeI NNP O
was VBD O
purified VBN O
and CC O
cloned VBN O
into IN O
pCOXII NNP O
and CC O
pCOXIISt NN O
, , O
replacing VBG O
the DT O
respective JJ O
cox2 NN O
coding VBG O
regions NNS O
. . O

Since IN O
all DT O
vectors NNS O
used VBN O
here RB O
were VBD O
based VBN O
on IN O
pCOXII NNP O
, , O
they PRP O
contain VBP O
the DT O
downstream JJ O
region NN O
from IN O
the DT O
wheat NN B-Species
cob NN O
gene NN O
( , O
Ir NN O
- HYPH O
cob NN O
) -RRB- O
( , O
accession NN O
no UH O
. . O
AF337547 CD O
) -RRB- O
( SYM O
14 CD O
) -RRB- O
. . O

This DT O
sequence NN O
, , O
combined VBN O
with IN O
the DT O
23 CD O
bp NN O
upstream NN O
insert NN O
sequence NN O
served VBD O
to TO O
distinguish VB O
, , O
using VBG O
primers NNS O
1a CD O
and CC O
1b NN O
, , O
foreign JJ O
from IN O
endogenous JJ O
transcripts NNS O
. . O

All DT O
mutants NNS O
were VBD O
obtained VBN O
using VBG O
QuickChange NNP O
( -LRB- O
R NNP O
) -RRB- O
Site NN O
- HYPH O
Directed NNP O
Mutagenesis NNP O
kit NN O
( : O
Stratagene NNP O
) -RRB- O
. . O

PCR NN O
product NN O
purifications NNS O
were VBD O
carried VBN O
out RP O
with IN O
the DT O
Wizard NNP O
( -LRB- O
R NNP O
) -RRB- O
Clean NNP O
- HYPH O
Up NNP O
System NNP O
( -LRB- O
Promega NNP O
) -RRB- O
. . O

PCR NN O
primers NNS O
used VBD O

Oligonucleotides NNS O
sequences NNS O
are VBP O
in IN O
5 CD O
' '' O
to TO O
3 CD O
' '' O
orientation NN O
. . O

( : O
1a CD O
) NFP O
, , O
GCGGTGCAGTCATACAGATC NNP O
; : O
( : O
1b ADD O
) NFP O
, , O
TATCCAGATTTGGTACCAAA NNP O
; : O
( : O
2a CD O
) NFP O
, , O
GCAGTCATACAGATCTGCCA NNP O
; : O
( : O
2b LS O
) -RRB- O
, , O
AGATTTGGTACCAAACCCGG NNP O
; : O
( : O
A NNP O
) -RRB- O
, , O
TATAGGTACCTCTCAGGTGT NNP O
; : O
( -LRB- O
B NNP O
) -RRB- O
, , O
TATAACTAGTTTAAGCTTCC NNP O
; : O
( : O
D1 NNP O
) -RRB- O
, , O
TATAATGCATAGACAAAGGA NNP O
; : O
( : O
D2 NNP O
) -RRB- O
, , O
TATAACTAGTTCAGGAAAGG NNP O
. . O

Restriction NN O
sites NNS O
are VBP O
underlined VBN O
. . O

Mutagenesis NN O
primers NNS O
( , O
only RB O
sense NN O
primers NNS O
in IN O
5 CD O
' '' O
- HYPH O
3 CD O
' '' O
orientation NN O
are VBP O
indicated VBN O
) . O

Single NNP O
C2 NNP O
, , O
C3 NNP O
and CC O
C2 NNP O
+ CC O
C3 NN O
double JJ O
mutant NN O
plasmids NNS O
were VBD O
constructed VBN O
with IN O
primers NNS O
( -LRB- O
C2 NNP O
) -RRB- O
AAGAAGTTCTTTTGGTTAAA NN O
and CC O
( , O
C3 NN O
) -RRB- O
CGCCGTGCGACTTGGAGGAC NN O
. . O

NsiI NNP O
- HYPH O
pCOXII NNP O
: : O
GGAAATCCAATGCATCTTCG NNP O
and CC O
NsiI NNP O
- HYPH O
pCOXIISt NNP O
: : O
CCAAACCAAATGCATGTTCT NNP O
. . O

Construct VB O
pCOXIISt NN O
containing VBG O
a DT O
23 CD O
nt NN O
insertion NN O
in IN O
the DT O
promoter NN O
region NN O
, , O
was VBD O
carried VBN O
out RP O
into IN O
two CD O
consecutive JJ O
insertions NNS O
using VBG O
primers NNS O
: : O
TGGGGGGAGCAGAGCAGTGC NNP O
and CC O
GCAGTGCGGTGCAGTCATAC NNP O
. . O

For IN O
constructs NNS O
MA NNP O
and CC O
MAB NNP O
containing VBG O
the DT O
wheat NN B-Species
cox2 NN O
C259 CD O
editing NN O
site NN O
, , O
two CD O
consecutive JJ O
insertions NNS O
were VBD O
carried VBN O
out RP O
using VBG O
primers NNS O
: : O
GGAAGATTGGATTACTATCG NNP O
and CC O
TACTATCGAAATTATTCGGA NNP O
. . O

For IN O
ME6 NNP O
and CC O
ME6b NNP O
constructs NNS O
, , O
primers NNS O
CCGCGAGGAATCAACTACTA NNP O
and CC O
CAACTACTATCGAAATTATT NNP O
were VBD O
used VBN O
. . O

Inserted VBN O
nucleotides NNS O
are VBP O
underlined VBN O
and CC O
the DT O
modified VBN O
residues NNS O
are VBP O
indicated VBN O
in IN O
bold JJ O
. . O

Mitochondria NN O
purification NN O

S UH B-Species
. . I-Species
tuberosum NN I-Species
cv NN O
. . O

Rosevalt NNP O
tubers NNS O
and CC O
T NN B-Species
. . I-Species
aestivum NN I-Species
var NN I-Species
Fortal NNP I-Species
seeds NNS O
were VBD O
used VBN O
. . O

Potato NN B-Species
mitochondria NNS O
were VBD O
prepared VBN O
from IN O
2 CD O
kg NNS O
of IN O
tubers NNS O
in IN O
batches NNS O
of IN O
200 CD O
g NNS O
with IN O
200 CD O
ml NNS O
of IN O
a DT O
homogenization NN O
buffer NN O
containing VBG O
0 CD O
. . O
4 CD O
M NN O
mannitol NN O
, , O
25 CD O
mM NN O
MOPS NNS O
( , O
pH NN O
7 CD O
. . O
8 CD O
) -RRB- O
, , O
1 CD O
mM NN O
EGTA NN O
, , O
8 CD O
mM NN O
cysteine NN O
and CC O
1 CD O
mg NN O
/ SYM O
ml NN O
fatty JJ O
acid NN O
- HYPH O
free JJ O
BSA NNP O
. . O

Homogenization NN O
was VBD O
carried VBN O
out RP O
for IN O
15 CD O
s NNS O
in IN O
a DT O
Waring NNP O
blendor NN O
at IN O
full JJ O
speed NN O
. . O

Homogenate NNP O
was VBD O
centrifuged VBN O
in IN O
a DT O
Sorvall NNP O
GSA NNP O
rotor NN O
at IN O
1500 CD O
g NN O
for IN O
10 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

Supernatant NNP O
was VBD O
centrifuged VBN O
in IN O
a DT O
GSA NNP O
rotor NN O
at IN O
12 CD O
0 CD O
g CD O
for IN O
15 CD O
min NN O
. . O

The DT O
mitochondrial JJ O
pellet NN O
was VBD O
resuspended VBN O
in IN O
50 CD O
ml NNS O
of IN O
homogenization NN O
buffer NN O
and CC O
centrifuged VBN O
at IN O
1500 CD O
g NN O
. . O

The DT O
supernatant NN O
was VBD O
centrifuged VBN O
in IN O
a DT O
Sorvall NNP O
SS NNP O
- HYPH O
34 CD O
rotor NN O
at IN O
15 CD O
0 CD O
g CD O
for IN O
10 CD O
min NN O
, , O
the DT O
pellet NN O
was VBD O
resuspended VBN O
in IN O
12 CD O
ml NNS O
of IN O
homogenization NN O
buffer NN O
and CC O
mitochondria NN O
were VBD O
purified VBN O
by IN O
centrifugation NN O
on IN O
a DT O
sucrose JJ O
gradient NN O
essentially RB O
as IN O
described VBN O
for IN O
wheat NN B-Species
embryo NN O
mitochondria NN O
( SYM O
14 CD O
) -RRB- O
. . O

Electroporation NN O

Electrotransfer NN O
experiments NNS O
were VBD O
carried VBN O
out RP O
with IN O
1 CD O
mg NN O
of IN O
purified JJ O
wheat NN B-Species
embryo NN O
or CC O
potato NN B-Species
tuber NN O
mitochondria NN O
in IN O
50 CD O
micro NN O
l NN O
of IN O
0 CD O
. . O
33 CD O
M NN O
sucrose NN O
and CC O
1 CD O
micro JJ O
g NN O
of IN O
recombinant JJ O
plasmid NN O
as IN O
described VBN O
( SYM O
14 CD O
) -RRB- O
. . O

The DT O
electroporated JJ O
mitochondria NN O
were VBD O
incubated VBN O
for IN O
18 CD O
h NNS O
at IN O
25 CD O
degrees NNS O
C NN O
, , O
then RB O
recovered VBN O
by IN O
centrifugation NN O
in IN O
a DT O
Sigma NNP O
N NNP O
degrees NNS O
12024 CD O
rotor NN O
( HYPH O
Sigma NNP O
1K15 CD O
refrigerated VBN O
centrifuge NN O
) -RRB- O
at IN O
15 CD O
0 CD O
g CD O
for IN O
15 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

In IN O
the DT O
case NN O
of IN O
potato NN B-Species
mitochondria NN O
the DT O
incubation NN O
mixture NN O
was VBD O
supplemented VBN O
with IN O
1 CD O
mg CD O
/ SYM O
ml NN O
of IN O
fatty JJ O
acid NN O
- HYPH O
free JJ O
BSA NNP O
. . O

RNA NNP O
was VBD O
purified VBN O
with IN O
200 CD O
micro JJ O
l NN O
of IN O
TRIzol NNP O
( -LRB- O
TM NNP O
) -RRB- O
reagent NN O
( , O
Gibco NNP O
- HYPH O
BRL NNP O
) -RRB- O
according VBG O
to IN O
the DT O
supplier NN O
' POS O
s NN O
protocol NN O
. . O

DNAse NNP O
I NN O
protection NN O
assay NN O
and CC O
DNA NN O
purification NN O

After IN O
electroporation NN O
and CC O
centrifugation NN O
, , O
the DT O
mitochondrial JJ O
pellet NN O
was VBD O
resuspended VBN O
in IN O
100 CD O
micro NN O
l NN O
of IN O
buffer NN O
[ -LRB- O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
5 CD O
) -RRB- O
, , O
2 CD O
mM NN O
magnesium NN O
acetate NN O
and CC O
0 CD O
. . O
33 CD O
M NN O
sucrose NN O
] -RRB- O
containing VBG O
60 CD O
U NN O
of IN O
DNase NNP O
I NNP O
( , O
Gibco NNP O
- HYPH O
BRL NNP O
) -RRB- O
and CC O
incubated VBN O
for IN O
1 CD O
h NNS O
at IN O
room NN O
temperature NN O
. . O

The DT O
DNase NNP O
reaction NN O
was VBD O
stopped VBN O
by IN O
adding VBG O
4 CD O
micro NN O
l NN O
of IN O
0 CD O
. . O
5 CD O
M NN O
EDTA NN O
and CC O
then RB O
heating NN O
for IN O
10 CD O
min NN O
at IN O
65 CD O
degrees NNS O
C NN O
. . O

Mitochondria NNS O
were VBD O
incubated VBN O
with IN O
100 CD O
micro NN O
g NN O
of IN O
Proteinase NNP O
K NNP O
( SYM O
Merck NNP O
) -RRB- O
for IN O
4 CD O
h NN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

One CD O
microliter NN O
of IN O
20 CD O
% NN O
SDS NNP O
was VBD O
added VBN O
to TO O
achieve VB O
mitochondrial JJ O
lysis NN O
and CC O
the DT O
DNA NN O
was VBD O
extracted VBN O
with IN O
phenol NN O
/ SYM O
chloroform NN O
, , O
precipitated VBN O
with IN O
0 CD O
. . O
1 CD O
vol NN O
of IN O
3 CD O
M NN O
Sodium NNP O
Acetate NNP O
( , O
pH NN O
5 CD O
. . O
2 CD O
) -RRB- O
, , O
3 CD O
vol NN O
of IN O
100 CD O
% NN O
ethanol NN O
and CC O
100 CD O
ng NN O
of IN O
carrier NN O
yeast NN B-Species
tRNA NN O
and CC O
left VBN O
overnight RB O
at IN O
- HYPH O
20 CD O
degrees NNS O
C NN O
. . O

After IN O
centrifugation NN O
, , O
the DT O
DNA NNP O
pellet NN O
was VBD O
resuspended VBN O
in IN O
TE NNP O
buffer NN O
[ -LRB- O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( -LRB- O
pH NN O
8 CD O
) -RRB- O
and CC O
1 CD O
mM NN O
EDTA NNP O
] -RRB- O
. . O

RT NNP O
- HYPH O
PCR NNP O

RNA NNP O
( : O
1 CD O
micro NN O
g NN O
) -RRB- O
was VBD O
treated VBN O
with IN O
2 CD O
U NN O
of IN O
Amplification NN O
grade NN O
DNase NNP O
I NNP O
( , O
Promega NNP O
) -RRB- O
. . O

cDNA NNP O
synthesis NN O
was VBD O
performed VBN O
with IN O
200 CD O
U NNP O
of IN O
Superscript NNP O
II NNP O
RT NNP O
using VBG O
100 CD O
ng NNS O
of IN O
random JJ O
hexamers NNS O
. . O

The DT O
PCR NNP O
were VBD O
performed VBN O
with IN O
primers NNS O
1a CD O
and CC O
1b NN O
using VBG O
Advantage NNP O
( -LRB- O
R NNP O
) -RRB- O
2 CD O
Polymerase NNP O
Mix NNP O
( -LRB- O
Clontech NNP O
) -RRB- O
as IN O
follows VBZ O
: : O
95 CD O
degrees NNS O
C NN O
, , O
1 CD O
min NN O
; : O
5 CD O
cycles NNS O
at IN O
95 CD O
degrees NNS O
C NN O
for IN O
30 CD O
s NNS O
and CC O
68 CD O
degrees NNS O
C NN O
for IN O
1 CD O
min NN O
; : O
30 CD O
cycles NNS O
at IN O
95 CD O
degrees NNS O
C NN O
for IN O
30 CD O
s NNS O
, , O
58 CD O
degrees NNS O
C NN O
for IN O
30 CD O
s NNS O
and CC O
68 CD O
degrees NNS O
C NN O
for IN O
30 CD O
s NNS O
, , O
and CC O
finally RB O
68 CD O
degrees NNS O
C NN O
for IN O
1 CD O
min NN O
. . O

Primers NNS O
2a CD O
and CC O
2b NN O
were VBD O
used VBN O
for IN O
nested VBN O
PCR NN O
from IN O
1 CD O
micro NN O
l NN O
of IN O
the DT O
first JJ O
PCR NNP O
. . O

No DT O
RT NNP O
- HYPH O
PCR NN O
amplification NN O
products NNS O
were VBD O
obtained VBN O
with IN O
RNA NNP O
from IN O
non RB O
- HYPH O
electroporated VBN O
mitochondria NN O
. . O

DNA NN O
sequencing NN O

Sequence NN O
analyses NNS O
were VBD O
performed VBN O
directly RB O
on IN O
the DT O
RT NNP O
- HYPH O
PCR NNP O
product NN O
using VBG O
an DT O
automatic JJ O
DNA NN O
sequencing VBG O
equipment NN O
with IN O
the DT O
BigDye NNP O
( -LRB- O
R NNP O
) -RRB- O
Terminator NNP O
Cycle NNP O
Sequencing NNP O
Kit NNP O
( , O
Applied NNP O
Biosystem NNP O
) -RRB- O
. . O

RESULTS NNS O

S NN B-Species
. . I-Species
tuberosum NN I-Species
rps10 NN O
transcripts NNS O
are VBP O
not RB O
processed VBN O
in IN O
wheat NN B-Species
mitochondria NN O

The DT O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
rps10 NN O
construct NN O
under IN O
control NN O
of IN O
a DT O
wheat NN B-Species
cox2 NN O
promoter NN O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
was VBD O
incorporated VBN O
into IN O
purified JJ O
wheat NN B-Species
mitochondria NN O
by IN O
electroporation NN O
as IN O
indicated VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

After IN O
electroporation NN O
and CC O
incubation NN O
in IN O
expression NN O
medium NN O
, , O
mitochondrial JJ O
RNA NNP O
was VBD O
extracted VBN O
and CC O
analysed VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
. . O

The DT O
primers NNS O
used VBD O
allowed VBN O
detection NN O
of IN O
the DT O
transcripts NNS O
generated VBN O
by IN O
the DT O
constructs NNS O
introduced VBN O
and CC O
excluded VBN O
any DT O
product NN O
from IN O
endogenous JJ O
cox2 NN O
( , O
or CC O
rps10 NN O
in IN O
the DT O
potato NN B-Species
system NN O
) -RRB- O
. . O

Two CD O
bands NNS O
of IN O
1204 CD O
and CC O
427 CD O
bp NN O
were VBD O
expected VBN O
from IN O
precursor NN O
and CC O
mature JJ O
rps10 NN O
mRNAs NNS O
, , O
respectively RB O
. . O

Only JJ O
precursor NN O
rps10 NN O
molecules NNS O
were VBD O
detected VBN O
( -LRB- O
Figure NNP O
1B NNP O
) -RRB- O
. . O

As IN O
a DT O
control NN O
, , O
a DT O
cognate JJ O
cox2 NN O
construct NN O
( , O
16 CD O
) -RRB- O
was VBD O
used VBN O
. . O

In IN O
this DT O
case NN O
, , O
the DT O
2048 CD O
and CC O
827 CD O
bp NN O
RT NNP O
- HYPH O
PCR NN O
bands NNS O
representing VBG O
the DT O
precursor NN O
and CC O
spliced VBN O
cox2 NN O
products NNS O
, , O
respectively RB O
were VBD O
observed VBN O
( : O
Figure NNP O
1B NNP O
) -RRB- O
. . O

In IN O
all DT O
cases NNS O
, , O
the DT O
PCR NNP O
bands NNS O
actually RB O
represent VBP O
transcription NN O
products NNS O
since IN O
when WRB O
PCR NNP O
was VBD O
performed VBN O
without IN O
the DT O
RT NNP O
step NN O
we PRP O
observed VBD O
no DT O
amplification NN O
products NNS O
. . O

Previously RB O
, , O
five CD O
C NNP O
residues NNS O
, , O
two CD O
in IN O
exon NN O
1 CD O
, , O
one CD O
in IN O
the DT O
intron NN O
and CC O
two CD O
in IN O
exon NN O
2 CD O
have VBP O
been VBN O
reported VBN O
to TO O
be VB O
changed VBN O
to IN O
U NNP O
by IN O
editing VBG O
in IN O
potato NN B-Species
mitochondria NN O
( SYM O
23 CD O
) -RRB- O
. . O

To TO O
determine VB O
if IN O
the DT O
non AFX O
- HYPH O
cognate NN O
transcript NN O
could MD O
be VB O
recognized VBN O
by IN O
the DT O
wheat NN B-Species
RNA NNP O
editing NN O
machinery NN O
, , O
the DT O
1204 CD O
bp NN O
RT NNP O
- HYPH O
PCR NNP O
product NN O
was VBD O
sequenced VBN O
. . O

While IN O
wheat NN B-Species
cox2 NN O
editing NN O
sites NNS O
were VBD O
correctly RB O
edited VBN O
in IN O
control NN O
as IN O
expected VBN O
( : O
Figure NNP O
1C NNP O
, , O
only RB O
site NN O
C77 NNP O
is VBZ O
shown VBN O
) -RRB- O
, , O
all DT O
five CD O
editable JJ O
residues NNS O
in IN O
potato NN B-Species
rps10 NN O
transcript NN O
remain VBP O
unchanged JJ O
. . O

cox2 NN O
C77 CD O
editing NN O
sites NNS O
are VBP O
identical JJ O
in IN O
potato NN B-Species
and CC O
wheat NN B-Species
. . O

Failure NN O
of IN O
rps10 NN O
transcript NN O
splicing NN O
in IN O
wheat NN B-Species
mitochondria NN O
is VBZ O
not RB O
linked VBN O
to IN O
the DT O
absence NN O
of IN O
editing NN O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
residues NNS O
C2 NNP O
and CC O
C3 NNP O
participate VBP O
in IN O
the DT O
secondary JJ O
structure NN O
of IN O
the DT O
intron NN O
necessary JJ O
for IN O
splicing NN O
( SYM O
23 CD O
) -RRB- O
. . O

A DT O
possible JJ O
explanation NN O
to IN O
the DT O
failure NN O
observed VBN O
in IN O
precursor NN O
rps10 NN O
splicing NN O
could MD O
be VB O
that IN O
the DT O
absence NN O
of IN O
edition NN O
of IN O
C2 NNP O
and CC O
C3 NNP O
prevent VB O
the DT O
intron NN O
from IN O
organizing VBG O
itself PRP O
in IN O
a DT O
catalytically RB O
competent JJ O
conformation NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
single JJ O
C2 NN O
and CC O
C3 NNP O
mutants NNS O
and CC O
a DT O
C2 NNP O
+ SYM O
C3 NN O
double JJ O
mutant NN O
were VBD O
constructed VBN O
by IN O
changing VBG O
the DT O
C NNP O
residues NNS O
to IN O
T NN O
. . O

Neither CC O
single JJ O
nor CC O
double JJ O
mutants NNS O
were VBD O
able JJ O
to TO O
undergo VB O
splicing NN O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Electroporation NN O
of IN O
S NN B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O

Since IN O
two CD O
important JJ O
post NN O
- HYPH O
transcriptional JJ O
processes NNS O
, , O
RNA NNP O
editing NN O
and CC O
splicing NN O
, , O
were VBD O
inoperative JJ O
when WRB O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
rps10 NN O
was VBD O
expressed VBN O
in IN O
wheat NN B-Species
mitochondria NN O
, , O
we PRP O
decided VBD O
to TO O
verify VB O
whether IN O
the DT O
negative JJ O
results NNS O
were VBD O
inherent JJ O
to IN O
the DT O
rps10 NN O
chimeric JJ O
constructs NNS O
or CC O
due IN O
to IN O
the DT O
lack NN O
of IN O
trans NN O
- HYPH O
recognition NN O
elements NNS O
in IN O
wheat NN B-Species
mitochondria NN O
. . O

For IN O
this DT O
purpose NN O
, , O
it PRP O
was VBD O
necessary JJ O
to TO O
set VB O
up RP O
an DT O
electroporation NN O
protocol NN O
adapted VBN O
to IN O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O
. . O

Purified JJ O
organelles NNS O
were VBD O
prepared VBN O
from IN O
potato NN B-Species
tubers NNS O
as IN O
indicated VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

Electric JJ O
pulses NNS O
in IN O
the DT O
range NN O
between IN O
8 CD O
and CC O
20 CD O
kV NNS O
were VBD O
performed VBN O
. . O

Internalization NN O
of IN O
exogenous JJ O
DNA NNP O
was VBD O
measured VBN O
by IN O
DNAse NNP O
protection NN O
assays NNS O
( SYM O
14 CD O
) -RRB- O
. . O

Potato NN B-Species
mitochondria NN O
show VBP O
a DT O
broad JJ O
range NN O
response NN O
with IN O
a DT O
maximum NN O
around IN O
13 CD O
kV NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

This DT O
voltage NN O
setting NN O
was VBD O
therefore RB O
used VBN O
for IN O
further JJ O
experiments NNS O
. . O

S NN B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O
does VBZ O
not RB O
recognize VB O
the DT O
wheat NN B-Species
cox2 NN O
promoter NN O

To TO O
ascertain VB O
the DT O
ability NN O
of IN O
electroporated VBN O
mitochondria NN O
to TO O
perform VB O
expression NN O
of IN O
the DT O
exogenous JJ O
gene NN O
construct NN O
, , O
we PRP O
used VBD O
a DT O
plasmid NN O
containing VBG O
the DT O
potato NN B-Species
cox2 NN O
gene NN O
controlled VBN O
either CC O
by IN O
T NN B-Species
. . I-Species
aestivum NN I-Species
or CC O
S NN B-Species
. . I-Species
tuberosum NN I-Species
promoters NNS O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4 CD O
, , O
the DT O
construct NN O
containing VBG O
the DT O
wheat NN B-Species
or CC O
potato NN B-Species
promoters NNS O
was VBD O
transcribed VBN O
only RB O
in IN O
cognate JJ O
mitochondria NN O
. . O

In IN O
potato NN B-Species
, , O
the DT O
mature JJ O
product NN O
is VBZ O
barely RB O
detectable JJ O
. . O

In IN O
contrast NN O
to IN O
wheat NN B-Species
mitochondria NN O
, , O
the DT O
821 CD O
nt NN O
mature JJ O
transcript NN O
was VBD O
only RB O
detected VBN O
when WRB O
the DT O
electroporated VBN O
potato NN B-Species
mitochondria NN O
were VBD O
incubated VBN O
in IN O
the DT O
presence NN O
of IN O
fatty JJ O
acid NN O
- HYPH O
free JJ O
BSA NNP O
. . O

A DT O
cognate NN O
rps10 NN O
construct NN O
is VBZ O
correctly RB O
expressed VBN O
, , O
edited VBN O
and CC O
processed VBN O
in IN O
potato NN B-Species
mitochondria NN O

The DT O
construct NN O
expressing VBG O
potato NN B-Species
rps10 NN O
under IN O
the DT O
control NN O
of IN O
potato NN B-Species
cox2 NN O
promoter NN O
was VBD O
introduced VBN O
into IN O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
isolated VBN O
mitochondria NN O
. . O

After IN O
incubation NN O
, , O
the DT O
precursor NN O
and CC O
mature JJ O
transcripts NNS O
were VBD O
amplified VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
and CC O
sequenced VBN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
5B NNP O
, , O
the DT O
four CD O
editing NN O
sites NNS O
C1 NNP O
, , O
C2 NNP O
, , O
C4 NNP O
and CC O
C5 NNP O
, , O
described VBN O
previously RB O
in IN O
endogenous JJ O
transcripts NNS O
, , O
were VBD O
found VBN O
edited VBN O
in IN O
mature JJ O
mRNA NN O
. . O

The DT O
presence NN O
of IN O
spliced VBN O
molecules NNS O
containing VBG O
unedited JJ O
residues NNS O
( -LRB- O
Figure NNP O
5B NNP O
) -RRB- O
indicates VBZ O
that IN O
rps10 NN O
transcripts NNS O
could MD O
be VB O
spliced VBN O
before IN O
editing NN O
. . O

To TO O
confirm VB O
this DT O
observation NN O
, , O
the DT O
PCR NNP O
product NN O
was VBD O
cloned VBN O
and CC O
sequenced VBN O
. . O

One CD O
half NN O
of IN O
the DT O
individual JJ O
clones NNS O
were VBD O
found VBN O
edited VBN O
at IN O
sites NNS O
C1 NNP O
and CC O
C2 NNP O
; : O
65 CD O
% NN O
were VBD O
edited VBN O
at IN O
site NN O
C4 NN O
and CC O
25 CD O
% NN O
were VBD O
edited VBN O
at IN O
site NN O
C5 NNP O
. . O

A DT O
cognate JJ O
editing NN O
site NN O
in IN O
a DT O
non JJ O
- HYPH O
native JJ O
context NN O
is VBZ O
not RB O
recognized VBN O
by IN O
wheat NN B-Species
mitochondria NNS O
but CC O
is VBZ O
recognized VBN O
in IN O
heterologous JJ O
mitochondria NN O

To TO O
test VB O
whether IN O
wheat NN B-Species
mitochondria NN O
are VBP O
able JJ O
to TO O
edit VB O
a DT O
cognate JJ O
site NN O
when WRB O
placed VBN O
in IN O
the DT O
context NN O
of IN O
a DT O
potato NN B-Species
transcript NN O
, , O
we PRP O
introduced VBD O
the DT O
C259 CD O
- HYPH O
16 CD O
/ SYM O
+ SYM O
6 CD O
region NN O
from IN O
wheat NN B-Species
cox2 NN O
into IN O
potato NN B-Species
rps10 NN O
exon NN O
1 CD O
or CC O
intron NN O
( -LRB- O
Figure NNP O
6A NNP O
, , O
construct VB O
MA NNP O
and CC O
ME6 NNP O
, , O
respectively RB O
) -RRB- O
. . O

As IN O
reported VBN O
previously RB O
, , O
the DT O
23 CD O
nt NN O
region NN O
forming VBG O
the DT O
C259 CD O
editing NN O
site NN O
from IN O
wheat NN B-Species
cox2 NN O
was VBD O
efficiently RB O
edited VBN O
when WRB O
grafted VBN O
into IN O
a DT O
different JJ O
context NN O
in IN O
a DT O
wheat NN B-Species
transcript NN O
( SYM O
17 CD O
) -RRB- O
. . O

Wild JJ O
- HYPH O
type NN O
rps10 NN O
( : O
pRPS10W NNP O
) -RRB- O
and CC O
the DT O
MA NNP O
and CC O
ME6 NNP O
mutants NNS O
were VBD O
expressed VBN O
in IN O
wheat NN B-Species
mitochondria NN O
but CC O
no DT O
splicing NN O
was VBD O
observed VBN O
( -LRB- O
Figure NNP O
6B NNP O
) -RRB- O
. . O

Unexpectedly RB O
, , O
wheat NN B-Species
mitochondria NNS O
appear VBP O
to TO O
be VB O
unable JJ O
to TO O
edit VB O
the DT O
cognate JJ O
C259 CD O
site NN O
when WRB O
the DT O
- HYPH O
16 CD O
/ SYM O
+ NN O
6 CD O
region NN O
is VBZ O
located VBN O
on IN O
a DT O
potato NN B-Species
rps10 NN O
precursor NN O
. . O

The DT O
control NN O
CM NNP O
construct NN O
, , O
containing VBG O
the DT O
C259 NNP O
site NN O
grafted VBN O
in IN O
a DT O
different JJ O
context NN O
but CC O
in IN O
its PRP$ O
own JJ O
cox2 NN O
gene NN O
, , O
was VBD O
expressed VBN O
, , O
spliced VBN O
and CC O
edited VBN O
as IN O
expected VBN O
[ -LRB- O
( , O
17 CD O
) -RRB- O
, , O
Figure NNP O
6B NNP O
and CC O
D NNP O
] -RRB- O
. . O

To TO O
compare VB O
the DT O
editing NN O
status NN O
of IN O
RNAs NNS O
at IN O
the DT O
same JJ O
stage NN O
of IN O
processing NN O
, , O
the DT O
editing NN O
status NN O
of IN O
the DT O
inserted VBN O
C259 CD O
site NN O
in IN O
precursor NN O
cox2 NN O
transcripts NNS O
is VBZ O
shown VBN O
( -LRB- O
Figure NN O
6D NN O
) -RRB- O
. . O

The DT O
analogous JJ O
MAb NNP O
and CC O
ME6b NNP O
constructs NNS O
, , O
containing VBG O
the DT O
S NNP B-Species
. , I-Species
tuberosum NN I-Species
cox2 NN O
promoter NN O
and CC O
the DT O
C259 NNP O
region NN O
inserted VBN O
into IN O
rps10 CD O
exon NN O
1 CD O
and CC O
intron NN O
were VBD O
used VBN O
to TO O
electroporate VB O
potato NN B-Species
mitochondria NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
6C NNP O
, , O
MAb NNP O
and CC O
ME6b NNP O
were VBD O
expressed VBN O
and CC O
spliced VBN O
at IN O
the DT O
same JJ O
level NN O
as IN O
the DT O
control NN O
in IN O
the DT O
homologous JJ O
context NN O
, , O
indicating VBG O
that IN O
insertion NN O
does VBZ O
not RB O
affect VB O
the DT O
splicing NN O
process NN O
. . O

Interestingly RB O
, , O
while IN O
C259 NNP O
insertion NN O
was VBD O
not RB O
recognized VBN O
in IN O
wheat NN B-Species
mitochondria NN O
( -LRB- O
Figure NNP O
6D NNP O
) -RRB- O
, , O
the DT O
potato NN B-Species
RNA NNP O
editing NN O
machinery NN O
edited VBD O
the DT O
inserted VBN O
C259 CD O
region NN O
( -LRB- O
Figure NNP O
6E CD O
) -RRB- O
. . O

The DT O
C259 NNP O
region NN O
inserted VBN O
in IN O
the DT O
rps10 NN O
intron NN O
( , O
construct NN O
ME6b NNP O
) -RRB- O
was VBD O
also RB O
edited VBN O
, , O
although IN O
at IN O
a DT O
very RB O
low JJ O
level NN O
, , O
showing VBG O
that IN O
editing NN O
may MD O
precede VB O
intron NN O
removal NN O
( , O
not RB O
shown VBN O
) NFP O
. . O

DISCUSSION NN O

Plant NN O
mitochondria NN O
undergo VBP O
complex JJ O
expression NN O
mechanisms NNS O
which WDT O
are VBP O
poorly RB O
understood VBN O
. . O

Most JJS O
studies NNS O
are VBP O
based VBN O
on IN O
analysis NN O
of IN O
in IN O
vivo NN O
mature NN O
or CC O
intermediate JJ O
gene NN O
products NNS O
giving VBG O
clues NNS O
on IN O
possible JJ O
mechanisms NNS O
and CC O
suggesting VBG O
pathways NNS O
operating VBG O
in IN O
gene NN O
expression NN O
. . O

Direct JJ O
tests NNS O
using VBG O
in FW O
vitro FW O
approaches NNS O
have VBP O
been VBN O
fruitful JJ O
( , O
4 CD O
, , O
5 CD O
, , O
24 CD O
) -RRB- O
, , O
but CC O
are VBP O
hampered VBN O
by IN O
the DT O
difficulty NN O
of IN O
obtaining VBG O
active JJ O
mitochondrial JJ O
extracts NNS O
. . O

Previously RB O
, , O
we PRP O
devised VBD O
an DT O
experimental JJ O
model NN O
based VBN O
on IN O
electroporation NN O
of IN O
isolated VBN O
mitochondria NN O
that WDT O
allows VBZ O
us PRP O
to TO O
test VB O
gene NN O
expression NN O
of IN O
wild JJ O
- HYPH O
type NN O
and CC O
mutant JJ O
genes NNS O
. . O

This DT O
approach NN O
has VBZ O
been VBN O
very RB O
useful JJ O
in IN O
elucidating VBG O
the DT O
process NN O
of IN O
RNA NNP O
maturation NN O
in IN O
plant NN O
mitochondria NN O
, , O
in IN O
particular JJ O
splicing NN O
and CC O
editing NN O
( , O
14 CD O
, , O
15 CD O
) -RRB- O
. . O

The DT O
aim NN O
of IN O
this DT O
work NN O
was VBD O
to TO O
analyse VB O
different JJ O
gene NN O
expression NN O
events NNS O
when WRB O
a DT O
foreign JJ O
gene NN O
was VBD O
expressed VBN O
in IN O
a DT O
heterologous JJ O
context NN O
. . O

rps10 NN O
was VBD O
chosen VBN O
precisely RB O
because IN O
this DT O
genetic JJ O
information NN O
is VBZ O
lacking VBG O
in IN O
wheat NN B-Species
mitochondria NN O
but CC O
is VBZ O
active JJ O
in IN O
potato NN B-Species
mitochondria NN O
( , O
20 CD O
, , O
23 CD O
, , O
25 CD O
) -RRB- O
. . O

Moreover RB O
, , O
rps10 CD O
transcripts NNS O
undergo VBP O
five CD O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
editing NN O
events NNS O
in IN O
potato NN B-Species
mitochondria NN O
and CC O
rps10 NN O
contains VBZ O
an DT O
intron NN O
, , O
thus RB O
facilitating VBG O
the DT O
analysis NN O
of IN O
post NN O
- HYPH O
transcriptional JJ O
processing NN O
. . O

To TO O
best RBS O
evaluate VB O
the DT O
expression NN O
of IN O
rps10 NN O
in IN O
the DT O
non JJ O
- HYPH O
cognate NN O
mitochondria NN O
, , O
it PRP O
was VBD O
necessary JJ O
to TO O
set VB O
up RP O
electroporation NN O
conditions NNS O
for IN O
introducing VBG O
foreign JJ O
DNA NN O
into IN O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
mitochondria NN O
. . O

Potato NN B-Species
tuber NN O
mitochondria NN O
were VBD O
able JJ O
to TO O
incorporate VB O
DNA NN O
essentially RB O
under IN O
the DT O
same JJ O
conditions NNS O
described VBN O
for IN O
wheat NN B-Species
embryo NN O
organelles NNS O
( SYM O
14 CD O
) -RRB- O
, , O
except IN O
that IN O
the DT O
optimal JJ O
voltage NN O
range NN O
was VBD O
larger JJR O
. . O

A DT O
major JJ O
difference NN O
to IN O
wheat NN B-Species
was VBD O
that IN O
isolated VBN O
potato NN B-Species
mitochondria NN O
were VBD O
viable JJ O
for IN O
3 CD O
- SYM O
4 CD O
h NN O
as IN O
measured VBN O
by IN O
oxygen NN O
consumption NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Thus RB O
, , O
to TO O
observe VB O
transcript NN O
maturation NN O
after IN O
electroporation NN O
the DT O
incubation NN O
mixture NN O
needed VBD O
to TO O
be VB O
supplemented VBN O
with IN O
fatty JJ O
acid NN O
- HYPH O
free JJ O
BSA NNP O
( : O
see VB O
Figure NNP O
4 CD O
) -RRB- O
. . O

This DT O
behaviour NN O
probably RB O
reflects VBZ O
the DT O
uncoupling NN O
of IN O
oxidative JJ O
phosphorylation NN O
by IN O
fatty NN O
acids NNS O
during IN O
incubation NN O
of IN O
potato NN B-Species
mitochondria NN O
( SYM O
26 CD O
) -RRB- O
. . O

In IN O
fact NN O
, , O
previously RB O
we PRP O
found VBD O
that IN O
proper JJ O
gene NN O
expression NN O
in IN O
isolated VBN O
mitochondria NN O
requires VBZ O
a DT O
functional JJ O
organelle NN O
able JJ O
to TO O
generate VB O
ATP NN O
from IN O
ADP NNP O
and CC O
succinate VB O
( SYM O
14 CD O
) -RRB- O
. . O

An DT O
interesting JJ O
observation NN O
was VBD O
that IN O
neither CC O
the DT O
wheat NN B-Species
nor CC O
the DT O
potato NN B-Species
cox2 NN O
promoters NNS O
were VBD O
recognized VBN O
in IN O
a DT O
heterologous JJ O
context NN O
( -LRB- O
Figure NN O
4A NN O
and CC O
B NN O
) -RRB- O
. . O

This DT O
situation NN O
might MD O
by IN O
explained VBN O
by IN O
the DT O
fact NN O
that IN O
potato NN B-Species
and CC O
wheat NN B-Species
promoter NN O
sequences NNS O
have VBP O
no DT O
recognizable JJ O
homologous JJ O
motifs NNS O
. . O

Plant NN O
mitochondria NN O
promoters NNS O
are VBP O
characterized VBN O
by IN O
a DT O
conserved VBN O
core NN O
CRTA NNP O
sequence NN O
with IN O
differences NNS O
in IN O
the DT O
extent NN O
and CC O
the DT O
composition NN O
of IN O
sequences NNS O
around IN O
the DT O
consensus NN O
motif NN O
( SYM O
27 CD O
, , O
28 CD O
) -RRB- O
. . O

While IN O
the DT O
transcription NN O
initiation NN O
site NN O
in IN O
wheat NN B-Species
mitochondria NN O
is VBZ O
located VBN O
at IN O
position NN O
- HYPH O
170 CD O
( SYM O
29 CD O
) -RRB- O
, , O
the DT O
potato NN B-Species
promoter NN O
has VBZ O
not RB O
yet RB O
been VBN O
described VBN O
. . O

Transcription NN O
may MD O
be VB O
initiated VBN O
at IN O
numerous JJ O
sites NNS O
suggesting VBG O
a DT O
relaxed VBN O
promoter NN O
recognition NN O
by IN O
the DT O
transcription NN O
machinery NN O
( , O
28 CD O
) -RRB- O
. . O

However RB O
, , O
the DT O
lack NN O
of IN O
crossed JJ O
recognition NN O
of IN O
cox2 NN O
promoters NNS O
in IN O
wheat NN B-Species
and CC O
potato NN B-Species
is VBZ O
not RB O
a DT O
general JJ O
situation NN O
since IN O
the DT O
A NNP B-Species
. . I-Species
thaliana NN I-Species
cox2 NN O
gene NN O
is VBZ O
expressed VBN O
and CC O
spliced VBN O
when WRB O
introduced VBN O
into IN O
maize NN B-Species
mitochondria NN O
, , O
indicating VBG O
that IN O
the DT O
Arabidopsis NNP B-Species
gene NN O
shares VBZ O
some DT O
signals NNS O
with IN O
maize NN B-Species
cox2 NN O
promoter NN O
that WDT O
are VBP O
sufficient JJ O
for IN O
transcription NN O
( , O
18 CD O
) -RRB- O
. . O

The DT O
sites NNS O
required VBN O
for IN O
transcript NN O
initiation NN O
have VBP O
been VBN O
recently RB O
described VBN O
in IN O
A NNP B-Species
. . I-Species
thaliana NN I-Species
mitochondrial NN O
genes NNS O
( SYM O
28 CD O
) -RRB- O
. . O

Three CD O
regions NNS O
were VBD O
described VBN O
as IN O
important JJ O
for IN O
transcription NN O
initiation NN O
. . O

We PRP O
found VBD O
no DT O
such JJ O
homologous JJ O
sequences NNS O
in IN O
the DT O
potato NN B-Species
cox2 NN O
upstream JJ O
region NN O
indicating VBG O
that IN O
the DT O
two CD O
dicot NN O
promoters NNS O
do VBP O
not RB O
have VB O
the DT O
same JJ O
origin NN O
. . O

This DT O
in IN O
turn NN O
may MD O
reflect VB O
the DT O
natural JJ O
history NN O
of IN O
this DT O
particular JJ O
mitochondrial JJ O
gene NN O
evolving VBG O
in IN O
its PRP$ O
own JJ O
context NN O
. . O

It PRP O
should MD O
be VB O
mentioned VBN O
that IN O
the DT O
presence NN O
of IN O
a DT O
conserved VBN O
sequence NN O
is VBZ O
not RB O
sufficient JJ O
for IN O
expression NN O
since IN O
a DT O
region NN O
that WDT O
acts VBZ O
as IN O
promoter NN O
in IN O
Arabidopsis NNP B-Species
, , O
potato NN B-Species
and CC O
Oenothera NNP O
is VBZ O
inactive JJ O
in IN O
vivo NN O
in IN O
pea NN B-Species
( SYM O
30 CD O
) -RRB- O
. . O

Further JJ O
studies NNS O
will MD O
be VB O
required VBN O
to TO O
understand VB O
the DT O
transcriptional JJ O
events NNS O
in IN O
plant NN O
mitochondria NN O
. . O

Electroporation NN O
of IN O
foreign JJ O
DNA NNP O
into IN O
isolated VBN O
mitochondria NN O
provides VBZ O
an DT O
interesting JJ O
functional JJ O
model NN O
, , O
complementary JJ O
to IN O
in FW O
vitro FW O
transcription NN O
assay NN O
, , O
for IN O
answering VBG O
these DT O
questions NNS O
. . O

The DT O
potato NN B-Species
rps10 NN O
gene NN O
controlled VBN O
by IN O
a DT O
T NN B-Species
. . I-Species
aestivum NN I-Species
promoter NN O
( -LRB- O
Figure NNP O
1A NNP O
) -RRB- O
was VBD O
transcribed VBN O
as IN O
a DT O
1204 CD O
nt NN O
precursor NN O
in IN O
wheat NN B-Species
mitochondria NN O
, , O
but CC O
no DT O
traces NNS O
of IN O
mature JJ O
RNA NNP O
were VBD O
observed VBN O
. . O

Moreover RB O
, , O
the DT O
five CD O
C NN O
residues NNS O
reported VBN O
as IN O
RNA NNP O
editing NN O
targets NNS O
in IN O
vivo NN O
( : O
23 CD O
) -RRB- O
remain VBP O
unchanged JJ O
, , O
indicating VBG O
that IN O
rps10 NN O
transcript NN O
was VBD O
not RB O
recognized VBN O
by IN O
the DT O
wheat NN B-Species
splicing NN O
and CC O
editing NN O
machinery NN O
. . O

A DT O
control NN O
using VBG O
the DT O
cognate JJ O
cox2 NN O
construct NN O
demonstrates VBZ O
that IN O
electroporated VBN O
organelles NNS O
were VBD O
competent JJ O
for IN O
splicing NN O
and CC O
editing NN O
( -LRB- O
Figure NNP O
1B NNP O
and CC O
C NN O
) -RRB- O
. . O

Some DT O
editing NN O
events NNS O
occur VBP O
in IN O
highly RB O
structured JJ O
domains NNS O
of IN O
introns NNS O
. . O

Because IN O
in IN O
some DT O
cases NNS O
, , O
editing NN O
corrects VBZ O
A NNP O
- HYPH O
C NN O
mispairing VBG O
improving VBG O
conformation NN O
of IN O
the DT O
intron NN O
, , O
it PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
the DT O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
change NN O
might MD O
be VB O
necessary JJ O
for IN O
efficient JJ O
splicing NN O
( , O
8 CD O
, , O
9 CD O
, , O
23 CD O
, , O
31 CD O
) -RRB- O
. . O

Based VBN O
on IN O
the DT O
canonical JJ O
structure NN O
of IN O
group NN O
II NNP O
mitochondrial JJ O
introns NNS O
( , O
21 CD O
) -RRB- O
, , O
two CD O
editing NN O
sites NNS O
, , O
C2 NNP O
located VBN O
at IN O
the DT O
Intron NNP O
Binding NNP O
Site NNP O
2 CD O
( , O
IBS2 NNP O
) -RRB- O
and CC O
C3 NN O
located VBN O
in IN O
the DT O
intron NN O
, , O
nine CD O
residues NNS O
downstream RB O
from IN O
the DT O
end NN O
of IN O
exon NN O
1 CD O
in IN O
S NNP B-Species
. . I-Species
tuberosum NN I-Species
rps10 NN O
are VBP O
of IN O
particular JJ O
interest NN O
. . O

It PRP O
has VBZ O
been VBN O
predicted VBN O
that IN O
both CC O
edited VBN O
residues NNS O
participate VBP O
in IN O
base NN O
- HYPH O
pair NN O
interactions NNS O
in IN O
the DT O
putative JJ O
secondary JJ O
structure NN O
. . O

Of IN O
particular JJ O
interest NN O
is VBZ O
the DT O
site NN O
C3 NNP O
located VBN O
in IN O
intron NN O
domain NN O
I NNP O
( HYPH O
23 CD O
) -RRB- O
. . O

This DT O
position NN O
may MD O
be VB O
crucial JJ O
for IN O
splicing VBG O
as IN O
inferred VBN O
from IN O
mutants NNS O
of IN O
a DT O
yeast NN B-Species
mitochondrial JJ O
intron NN O
( SYM O
32 CD O
) -RRB- O
. . O

We PRP O
addressed VBD O
this DT O
question NN O
by IN O
introducing VBG O
rps10 CD O
mutant JJ O
genes NNS O
presenting VBG O
C2 NNP O
, , O
C3 NNP O
or CC O
both DT O
positions NNS O
in IN O
the DT O
edited VBN O
form NN O
into IN O
mitochondria NN O
. . O

As IN O
shown VBN O
in IN O
Figure NN O
2 CD O
, , O
transcription NN O
was VBD O
as RB O
efficient JJ O
as IN O
for IN O
the DT O
cognate JJ O
cox2 NN O
construct NN O
but CC O
neither CC O
wild JJ O
- HYPH O
type NN O
rps10 NN O
nor CC O
the DT O
C NNP O
- HYPH O
U NNP O
mutants NNS O
underwent VBD O
splicing NN O
. . O

These DT O
results NNS O
clearly RB O
demonstrate VBP O
that IN O
C2 NNP O
and CC O
C3 NNP O
editing NN O
is VBZ O
not RB O
sufficient JJ O
for IN O
splicing NN O
of IN O
rps10 NN O
precursor NN O
in IN O
wheat NN B-Species
mitochondria NN O
and CC O
lead VB O
us PRP O
to TO O
conclude VB O
that IN O
splicing VBG O
failure NN O
is VBZ O
probably RB O
linked VBN O
to IN O
the DT O
lack NN O
of IN O
trans NN O
- HYPH O
recognition NN O
elements NNS O
. . O

One CD O
may MD O
speculate VB O
that IN O
these DT O
trans NNS O
- HYPH O
acting VBG O
factors NNS O
, , O
for IN O
instance NN O
nuclear NN O
- HYPH O
encoded VBN O
maturases NNS O
, , O
were VBD O
lost VBN O
after IN O
rps10 NN O
was VBD O
transferred VBN O
to IN O
the DT O
nucleus NN O
in IN O
monocots NNS O
( , O
20 CD O
, , O
25 CD O
) -RRB- O
. . O

The DT O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
mutants NNS O
were VBD O
also RB O
tested VBN O
in IN O
potato NN B-Species
mitochondria NN O
; , O
no DT O
significant JJ O
differences NNS O
were VBD O
detected VBN O
in IN O
splicing VBG O
efficiency NN O
when WRB O
compared VBN O
to IN O
the DT O
unedited JJ O
construct NN O
( , O
D NNP O
. . O
Choury NNP O
, , O
unpublished JJ O
data NNS O
) -RRB- O
. . O

It PRP O
should MD O
be VB O
noted VBN O
that IN O
the DT O
lack NN O
of IN O
splicing NN O
in IN O
wheat NN B-Species
mitochondria NN O
is VBZ O
not RB O
a DT O
general JJ O
feature NN O
of IN O
potato NN B-Species
introns NNS O
, , O
since IN O
the DT O
potato NN B-Species
cox2 NN O
intron NN O
is VBZ O
removed VBN O
efficiently RB O
( : O
Figure NNP O
4B NNP O
) -RRB- O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
the DT O
hypothesis NN O
that IN O
potato NN B-Species
and CC O
wheat NN B-Species
mitochondria NN O
have VBP O
similar JJ O
trans NNS O
- HYPH O
acting VBG O
factors NNS O
for IN O
cox2 NN O
intron NN O
removal NN O
. . O

A DT O
possible JJ O
link NN O
between IN O
intron NN O
removal NN O
and CC O
editing NN O
has VBZ O
been VBN O
proposed VBN O
for IN O
splicing NN O
of IN O
nad1e NN O
and CC O
nad5III NN O
trans NNS O
- HYPH O
introns NNS O
where WRB O
domain NN O
six CD O
may MD O
require VB O
editing NN O
to TO O
be VB O
structured VBN O
in IN O
a DT O
catalytic JJ O
competent JJ O
secondary JJ O
conformation NN O
( : O
8 CD O
) -RRB- O
. . O

In IN O
rice NN B-Species
, , O
failure NN O
of IN O
RNA NNP O
maturation NN O
and CC O
editing NN O
has VBZ O
been VBN O
correlated VBN O
with IN O
cytoplasmic JJ O
male NN O
sterile JJ O
phenotype NN O
. . O

In IN O
this DT O
model NN O
, , O
the DT O
absence NN O
of IN O
the DT O
nuclear JJ O
gene NN O
Rf NNP O
- HYPH O
1 CD O
affects VBZ O
B NN O
- HYPH O
atp6 NNP O
RNA NNP O
cleavage NN O
and CC O
editing NN O
( SYM O
33 CD O
) -RRB- O
. . O

In IN O
organello NN O
studies NNS O
have VBP O
shown VBN O
that IN O
S NNP B-Species
. . I-Species
bicolor NN I-Species
atp6 NN O
- HYPH O
1 CD O
gene NN O
was VBD O
transcribed VBN O
but CC O
not RB O
edited VBN O
when WRB O
introduced VBN O
into IN O
maize NN B-Species
mitochondria NN O
( SYM O
18 CD O
) -RRB- O
. . O

However RB O
, , O
partially RB O
edited VBN O
molecules NNS O
were VBD O
detected VBN O
in IN O
sorghum NN B-Species
- HYPH O
maize NN B-Species
atp6 NN O
chimeric JJ O
transcripts NNS O
when WRB O
they PRP O
included VBD O
the DT O
maize NN B-Species
atp6 NN O
5 CD O
' '' O
- HYPH O
untranslated JJ O
sequence NN O
, , O
suggesting VBG O
that IN O
the DT O
5 CD O
' '' O
non AFX O
- HYPH O
coding VBG O
region NN O
provides VBZ O
a DT O
structural JJ O
motif NN O
or CC O
binding VBG O
site NN O
for IN O
a DT O
transcript NN O
- HYPH O
specific JJ O
editing NN O
factor NN O
( : O
34 CD O
) -RRB- O
. . O

Unfortunately RB O
, , O
no DT O
data NNS O
on IN O
atp6 NN O
processing NN O
was VBD O
reported VBN O
to TO O
determine VB O
whether IN O
this DT O
region NN O
is VBZ O
directly RB O
involved VBN O
in IN O
editing NN O
or CC O
some DT O
other JJ O
maturation NN O
event NN O
. . O

Since IN O
wheat NN B-Species
mitochondria NN O
do VBP O
not RB O
have VB O
rps10 NN O
encoded VBN O
in IN O
the DT O
mitochondrial JJ O
genome NN O
( , O
20 CD O
) -RRB- O
, , O
it PRP O
was VBD O
interesting JJ O
to TO O
test VB O
whether IN O
wheat NN B-Species
mitochondria NN O
were VBD O
able JJ O
to TO O
recognize VB O
editing NN O
sites NNS O
which WDT O
had VBD O
been VBN O
lost VBN O
during IN O
evolution NN O
. . O

In IN O
other JJ O
words NNS O
, , O
whether IN O
the DT O
mitochondrial JJ O
trans NN O
- HYPH O
recognition NN O
elements NNS O
are VBP O
specific JJ O
for IN O
each DT O
site NN O
or CC O
whether IN O
they PRP O
are VBP O
operating VBG O
on IN O
a DT O
subset NN O
of IN O
editing NN O
sites NNS O
. . O

This DT O
question NN O
is VBZ O
important JJ O
since IN O
to IN O
date NN O
the DT O
factors NNS O
responsible JJ O
for IN O
RNA NNP O
editing NN O
in IN O
plant NN O
mitochondria NN O
remain VBP O
unknown JJ O
. . O

Solving VBG O
this DT O
issue NN O
may MD O
provide VB O
clues NNS O
to TO O
uncover VB O
such JJ O
factors NNS O
. . O

As IN O
described VBN O
above RB O
, , O
the DT O
rps10 NN O
transcript NN O
was VBD O
not RB O
processed VBN O
in IN O
wheat NN B-Species
but CC O
it PRP O
was VBD O
correctly RB O
spliced VBN O
in IN O
cognate NN O
mitochondria NN O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

Indeed RB O
, , O
the DT O
mature JJ O
transcript NN O
had VBD O
identical JJ O
exon1 NN O
and CC O
exon2 NN O
junction NN O
as IN O
found VBN O
in IN O
endogenous JJ O
rps10 NN O
mRNA NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

More RBR O
importantly RB O
, , O
all DT O
editing NN O
sites NNS O
, , O
C1 NNP O
, , O
C2 NNP O
, , O
C4 NNP O
and CC O
C5 NNP O
were VBD O
significantly RB O
converted VBN O
to IN O
Us NNP O
( -LRB- O
Figure NNP O
5B NNP O
) -RRB- O
. . O

The DT O
fact NN O
that IN O
the DT O
four CD O
editing NN O
sites NNS O
were VBD O
found VBN O
either CC O
edited VBN O
or CC O
unedited VBN O
in IN O
spliced JJ O
rps10 NN O
mRNA NN O
is VBZ O
an DT O
indication NN O
that IN O
editing NN O
does VBZ O
not RB O
precede VB O
splicing NN O
as IN O
was VBD O
previously RB O
found VBN O
for IN O
cox2 NN O
in IN O
wheat NN B-Species
( SYM O
15 CD O
) -RRB- O
. . O

It PRP O
may MD O
be VB O
argued VBN O
that IN O
the DT O
absence NN O
of IN O
splicing NN O
precluded VBD O
editing NN O
. . O

This DT O
possibility NN O
can MD O
be VB O
discarded VBN O
since IN O
potato NN B-Species
rps10 NN O
precursor NN O
mRNA NNP O
was VBD O
found VBN O
to TO O
be VB O
edited VBN O
in IN O
vivo NN O
( SYM O
23 CD O
) -RRB- O
. . O

These DT O
data NNS O
clearly RB O
show VBP O
that IN O
splicing NN O
is VBZ O
not RB O
required VBN O
for IN O
rps10 NN O
editing NN O
, , O
similar JJ O
to IN O
previous JJ O
findings NNS O
for IN O
cox2 NN O
mRNA NN O
and CC O
also RB O
in IN O
cox2 NN O
mutant JJ O
derivatives NNS O
unable JJ O
to TO O
remove VB O
the DT O
intron NN O
( HYPH O
15 CD O
) -RRB- O
. . O

This DT O
led VBD O
us PRP O
to TO O
postulate VB O
that IN O
the DT O
inability NN O
of IN O
wheat NN B-Species
mitochondria NN O
to TO O
recognize VB O
rps10 NN O
editing NN O
sites NNS O
is VBZ O
likely JJ O
due IN O
to IN O
the DT O
fact NN O
that IN O
wheat NN B-Species
mitochondria NN O
have VBP O
lost VBN O
the DT O
editing NN O
trans NN O
- HYPH O
recognition NN O
elements NNS O
which WDT O
become VBP O
dispensable JJ O
after IN O
transfer NN O
of IN O
rps10 NN O
to IN O
the DT O
nucleus NN O
. . O

To TO O
test VB O
this DT O
possibility NN O
, , O
rps10 CD O
chimeric JJ O
plasmids NNS O
containing VBG O
editing NN O
site NN O
C259 NN O
from IN O
wheat NN B-Species
cox2 NN O
inserted VBN O
either CC O
in IN O
exon1 NN O
or CC O
the DT O
intron NN O
were VBD O
constructed VBN O
. . O

Site NN O
C259 CD O
is VBZ O
formed VBN O
by IN O
23 CD O
nt IN O
corresponding VBG O
to IN O
the DT O
- HYPH O
16 CD O
/ SYM O
+ SYM O
6 CD O
sequence NN O
embedding VBG O
the DT O
target NN O
C NN O
. . O

Previously RB O
we PRP O
found VBD O
that IN O
this DT O
small JJ O
region NN O
could MD O
be VB O
recognized VBN O
by IN O
the DT O
RNA NNP O
editing NN O
machinery NN O
when WRB O
placed VBN O
outside IN O
of IN O
its PRP$ O
natural JJ O
context NN O
( , O
16 CD O
, , O
17 CD O
) -RRB- O
. . O

The DT O
wheat NN B-Species
C259 CD O
editing NN O
site NN O
in IN O
the DT O
chimeric JJ O
construct NN O
was VBD O
correctly RB O
edited VBN O
by IN O
potato NN B-Species
mitochondria NNS O
. . O

This DT O
result NN O
is VBZ O
not RB O
unexpected JJ O
since IN O
the DT O
corresponding VBG O
region NN O
in IN O
endogenous JJ O
potato NN B-Species
cox2 NN O
mRNA NN O
, , O
which WDT O
presents VBZ O
two CD O
differences NNS O
at IN O
positions NNS O
- : O
3 CD O
( SYM O
C NN O
instead RB O
of IN O
A NN O
) -RRB- O
and CC O
- HYPH O
7 CD O
( HYPH O
G NN O
instead RB O
of IN O
A NN O
) -RRB- O
, , O
is VBZ O
edited VBN O
. . O

Furthermore RB O
, , O
these DT O
positions NNS O
were VBD O
not RB O
crucial JJ O
for IN O
editing NN O
of IN O
C259 NNP O
( SYM O
17 CD O
) -RRB- O
. . O

Surprisingly RB O
, , O
the DT O
C259 NNP O
editing NN O
site NN O
grafted VBD O
in IN O
rps10 NN O
was VBD O
not RB O
recognized VBN O
by IN O
the DT O
wheat NN B-Species
editing NN O
machinery NN O
. . O

We PRP O
cannot MD O
exclude VB O
the DT O
possibility NN O
that IN O
editing VBG O
efficiency NN O
in IN O
precursor NN O
molecules NNS O
is VBZ O
very RB O
low JJ O
and CC O
so RB O
is VBZ O
undetectable JJ O
when WRB O
sequencing VBG O
RT NNP O
- HYPH O
PCR NNP O
products NNS O
representing VBG O
a DT O
pool NN O
of IN O
transcripts NNS O
. . O

However RB O
, , O
analysis NN O
of IN O
the DT O
same JJ O
region NN O
in IN O
cox2 NN O
precursors NNS O
indicates VBZ O
that IN O
this DT O
was VBD O
not RB O
the DT O
case NN O
since IN O
significant JJ O
C NN O
- HYPH O
to IN O
- HYPH O
U NN O
conversion NN O
was VBD O
observed VBN O
( -LRB- O
Figure NNP O
6D NNP O
) -RRB- O
. . O

These DT O
observations NNS O
lead VBP O
us PRP O
to TO O
postulate VB O
that IN O
editing NN O
is VBZ O
occurring VBG O
only RB O
when WRB O
the DT O
transcript NN O
is VBZ O
engaged VBN O
in IN O
post NN O
- HYPH O
transcriptional JJ O
processing NN O
, , O
suggesting VBG O
that IN O
rps10 NN O
transcripts NNS O
are VBP O
not RB O
available JJ O
to IN O
editing NN O
factors NNS O
independently RB O
of IN O
the DT O
RNA NNP O
maturation NN O
machinery NN O
. . O

The DT O
fact NN O
that IN O
the DT O
wheat NN B-Species
editing NN O
site NN O
C259 CD O
inserted VBN O
in IN O
chimeric JJ O
rps10 NN O
transcripts NNS O
was VBD O
not RB O
recognized VBN O
by IN O
wheat NN B-Species
mitochondria NN O
is VBZ O
a DT O
strong JJ O
argument NN O
for IN O
this DT O
hypothesis NN O
. . O

One PRP O
might MD O
speculate VB O
that IN O
in IN O
plant NN O
mitochondria NN O
, , O
transcripts NNS O
have VBP O
to TO O
be VB O
engaged VBN O
in IN O
a DT O
kind NN O
of IN O
multiprotein NN O
processing NN O
complex NN O
. . O

A DT O
failure NN O
to TO O
be VB O
recognized VBN O
at IN O
some DT O
early JJ O
stage NN O
will MD O
lead VB O
to IN O
their PRP$ O
accumulation NN O
as IN O
unmodified JJ O
precursors NNS O
. . O

Rap1p NN O
and CC O
other JJ O
transcriptional JJ O
regulators NNS O
can MD O
function VB O
in IN O
defining VBG O
distinct JJ O
domains NNS O
of IN O
gene NN O
expression NN O

Abstract JJ O

Barrier NN O
elements NNS O
that WDT O
are VBP O
able JJ O
to TO O
block VB O
the DT O
propagation NN O
of IN O
transcriptional JJ O
silencing NN O
in IN O
yeast NN B-Species
are VBP O
functionally RB O
similar JJ O
to IN O
chromatin NN O
boundary NN O
/ SYM O
insulator NN O
elements NNS O
in IN O
metazoans NNS O
that WDT O
delimit VBP O
functional JJ O
chromosomal JJ O
domains NNS O
. . O

We PRP O
show VBP O
that IN O
the DT O
upstream JJ O
activating VBG O
sequences NNS O
of IN O
many JJ O
highly RB O
expressed VBN O
ribosome NN O
protein NN O
genes NNS O
and CC O
glycolytic JJ O
genes NNS O
exhibit VBP O
barrier NN O
activity NN O
. . O

Analyses NNS O
of IN O
these DT O
barriers NNS O
indicate VBP O
that IN O
binding VBG O
sites NNS O
for IN O
transcriptional JJ O
regulators NNS O
Rap1p NNP O
, , O
Abf1p NNP O
, , O
Reb1p NNP O
, , O
Adr1p NNP O
and CC O
Gcn4p NNP O
may MD O
participate VB O
in IN O
barrier NN O
function NN O
. . O

We PRP O
also RB O
present VBP O
evidence NN O
suggesting VBG O
that IN O
Rap1p NNP O
is VBZ O
directly RB O
involved VBN O
in IN O
barrier NN O
activity NN O
, , O
and CC O
its PRP$ O
barrier NN O
function NN O
correlates VBZ O
with IN O
local JJ O
changes NNS O
in IN O
chromatin NN O
structure NN O
. . O

We PRP O
further RB O
demonstrate VBP O
that IN O
tethering VBG O
the DT O
transcriptional JJ O
activation NN O
domain NN O
of IN O
Rap1p NNP O
to IN O
DNA NNP O
is VBZ O
sufficient JJ O
to TO O
recapitulate VB O
barrier NN O
activity NN O
. . O

Moreover RB O
, , O
targeting VBG O
the DT O
activation NN O
domain NN O
of IN O
Adr1p NNP O
or CC O
Gcn4p NNP O
also RB O
establishes VBZ O
a DT O
barrier NN O
to IN O
silencing NN O
. . O

These DT O
results NNS O
support VBP O
the DT O
notion NN O
that IN O
transcriptional JJ O
regulators NNS O
could MD O
also RB O
participate VB O
in IN O
delimiting VBG O
functional JJ O
domains NNS O
in IN O
the DT O
genome NN O
. . O

INTRODUCTION NN O

The DT O
eukaryotic JJ O
genome NN O
is VBZ O
organized VBN O
into IN O
discrete JJ O
functional JJ O
domains NNS O
in IN O
which WDT O
gene NN O
expression NN O
is VBZ O
either CC O
permitted VBN O
or CC O
repressed VBN O
. . O

Domains NNS O
permissive JJ O
for IN O
gene NN O
expression NN O
are VBP O
usually RB O
defined VBN O
as IN O
euchromatin NN O
or CC O
active JJ O
chromatin NN O
, , O
and CC O
domains NNS O
that WDT O
repress VBP O
gene NN O
expression NN O
heterochromatin NN O
or CC O
silent JJ O
chromatin NN O
. . O

The DT O
HML NNP O
and CC O
HMR NNP O
loci NN O
in IN O
Saccharomyces NNP B-Species
cerevisiae NN I-Species
are VBP O
silent JJ O
chromatin NN O
domains NNS O
( , O
1 CD O
) -RRB- O
. . O

Compared VBN O
to IN O
active JJ O
chromatin NN O
, , O
silent JJ O
chromatin NN O
is VBZ O
more RBR O
compact JJ O
and CC O
its PRP$ O
histone NN O
components NNS O
are VBP O
hypoacetylated VBN O
( SYM O
2 CD O
) -RRB- O
. . O

The DT O
SIR NNP O
complex NN O
consisting VBG O
of IN O
Sir2p NNP O
through IN O
Sir4p NNP O
is VBZ O
an DT O
integral JJ O
part NN O
of IN O
yeast NN B-Species
silent JJ O
chromatin NN O
. . O

Sir3p NNP O
and CC O
Sir4p NNP O
interact VBP O
with IN O
the DT O
N NN O
- HYPH O
terminal JJ O
tails NNS O
of IN O
histones NNS O
H3 NNP O
and CC O
H4 NNP O
providing VBG O
the DT O
structural JJ O
basis NN O
of IN O
silent JJ O
chromatin NN O
( : O
1 CD O
) -RRB- O
. . O

Sir2p NNP O
was VBD O
recently RB O
found VBN O
to TO O
be VB O
an DT O
NAD NNP O
- HYPH O
dependent JJ O
histone NN O
deacetylase NN O
and CC O
was VBD O
suggested VBN O
to TO O
be VB O
responsible JJ O
for IN O
histone NN O
hypoacetylation NN O
in IN O
silent JJ O
chromatin NN O
( HYPH O
3 CD O
) -RRB- O
. . O

Silent JJ O
chromatin NN O
is VBZ O
initiated VBN O
at IN O
small JJ O
cis NN O
- HYPH O
acting VBG O
DNA NN O
elements NNS O
known VBN O
as IN O
the DT O
E NN O
and CC O
I NNP O
silencers NNS O
flanking VBG O
each DT O
of IN O
the DT O
HM NNP O
loci NN O
( HYPH O
4 CD O
) -RRB- O
. . O

Increasing VBG O
evidence NN O
indicates VBZ O
that IN O
histone NN O
deacetylation NN O
is VBZ O
key JJ O
to IN O
the DT O
propagation NN O
of IN O
silent JJ O
chromatin NN O
( , O
4 CD O
) -RRB- O
. . O

In IN O
vertebrates NNS O
and CC O
fission NN O
yeast NN B-Species
, , O
spread NN O
of IN O
silent JJ O
chromatin NN O
involves VBZ O
a DT O
chain NN O
of IN O
events NNS O
of IN O
histone NN O
H3 NN O
deacetylation NN O
- HYPH O
- : O
> SYM O
H3 CD O
methylation NN O
- HYPH O
- HYPH O
> XX O
binding NN O
of IN O
methylated VBN O
H3 NN O
by IN O
HP1 NN O
( : O
heterochromatin NN O
protein NN O
1 CD O
) -RRB- O
or CC O
swi6 NN O
( HYPH O
4 CD O
) -RRB- O
. . O

In IN O
S NNP B-Species
. . I-Species
cerevisiae NN I-Species
, , O
there EX O
is VBZ O
evidence NN O
that IN O
Sir3p NNP O
( , O
hence RB O
the DT O
SIR NNP O
complex NN O
) -RRB- O
has VBZ O
much RB O
higher JJR O
affinity NN O
to IN O
unacetylated JJ O
histone NN O
H4 NN O
than IN O
acetylated VBN O
H4 NNP O
( SYM O
5 CD O
) -RRB- O
. . O

Based VBN O
on IN O
this DT O
and CC O
the DT O
fact NN O
that IN O
Sir2p NNP O
is VBZ O
a DT O
histone NN O
deacetylase NN O
, , O
a DT O
refined JJ O
model NN O
for IN O
the DT O
propagation NN O
of IN O
silent JJ O
chromatin NN O
can MD O
be VB O
proposed VBN O
. . O

In IN O
this DT O
model NN O
, , O
Sir2p NNP O
recruited VBD O
to IN O
the DT O
silencer NN O
deacetylates VBZ O
histones NNS O
in IN O
an DT O
adjacent JJ O
nucleosome NN O
enabling VBG O
it PRP O
to TO O
bind VB O
another DT O
SIR NNP O
complex NN O
with IN O
high JJ O
affinity NN O
. . O

The DT O
nucleosome NN O
- HYPH O
bound VBN O
SIR NNP O
complex NN O
in IN O
turn NN O
deacetylates VBZ O
the DT O
neighboring VBG O
nucleosome NN O
allowing VBG O
it PRP O
to TO O
recruit VB O
a DT O
new JJ O
SIR NNP O
complex NN O
. . O

In IN O
this DT O
manner NN O
, , O
the DT O
SIR NNP O
complex NN O
promotes VBZ O
its PRP$ O
own JJ O
propagation NN O
along IN O
an DT O
array NN O
of IN O
nucleosomes NNS O
( , O
4 CD O
) -RRB- O
. . O

The DT O
fact NN O
that IN O
transcriptionally RB O
silent JJ O
chromatin NN O
can MD O
encroach VB O
upon IN O
active JJ O
chromatin NN O
poses VBZ O
the DT O
question NN O
of IN O
how WRB O
interspersed JJ O
domains NNS O
of IN O
silent JJ O
and CC O
active JJ O
chromatin NN O
are VBP O
demarcated VBN O
. . O

Studies NNS O
of IN O
the DT O
Drosophila NNP O
and CC O
vertebrate JJ O
genomes NNS O
demonstrated VBD O
that IN O
some DT O
domains NNS O
are VBP O
delimited VBN O
by IN O
boundary NN O
or CC O
insulator NN O
elements NNS O
( , O
6 CD O
) -RRB- O
. . O

These DT O
elements NNS O
are VBP O
specialized JJ O
DNA NN O
sequences NNS O
that WDT O
act VBP O
as IN O
barriers NNS O
to IN O
enhancers NNS O
and CC O
/ SYM O
or CC O
silent JJ O
chromatin NN O
. . O

One CD O
of IN O
the DT O
best RBS O
characterized VBN O
insulators NNS O
is VBZ O
the DT O
chicken NN B-Species
HS4 NNP O
insulator NN O
at IN O
the DT O
beta NN O
- HYPH O
globin NN O
locus NN O
. . O

Histones NNS O
surrounding VBG O
this DT O
insulator NN O
are VBP O
hyperacetylated VBN O
indicating VBG O
the DT O
presence NN O
of IN O
histone NN O
acetyltransferase NN O
( , O
HAT NN O
) -RRB- O
activity NN O
at IN O
the DT O
insulator NN O
( , O
6 CD O
) -RRB- O
. . O

Recently RB O
, , O
sequences NNS O
that WDT O
could MD O
block VB O
the DT O
spread NN O
of IN O
silent JJ O
chromatin NN O
have VBP O
been VBN O
discovered VBN O
in IN O
S NNP B-Species
. . I-Species
cerevisiae NN I-Species
( , O
7 CD O
, , O
8 CD O
) -RRB- O
. . O

These DT O
sequences NNS O
( , O
referred VBN O
to IN O
as IN O
silent JJ O
chromatin NN O
barriers NNS O
) , O
include VBP O
sub JJ O
- HYPH O
telomeric JJ O
anti JJ O
- HYPH O
silencing VBG O
regions NNS O
( , O
STARs NNPS O
) -RRB- O
, , O
the DT O
right JJ O
boundary NN O
of IN O
HMR NNP O
, , O
and CC O
the DT O
upstream JJ O
activating VBG O
sequence NN O
( , O
UAS NNP O
) -RRB- O
of IN O
the DT O
highly RB O
expressed VBN O
TEF2 NNP O
gene NN O
( : O
9 CD O
- SYM O
11 CD O
) -RRB- O
. . O

The DT O
mechanisms NNS O
underlying VBG O
barrier NN O
functions NNS O
in IN O
yeast NN B-Species
are VBP O
not RB O
known VBN O
. . O

TEF2 NNP O
- HYPH O
UAS NNP O
contains VBZ O
three CD O
tandem NN O
repressor NN O
activator NN O
protein NN O
1 CD O
( SYM O
Rap1p NNP O
) -RRB- O
- HYPH O
binding VBG O
sites NNS O
that WDT O
are VBP O
necessary JJ O
and CC O
sufficient JJ O
for IN O
its PRP$ O
barrier NN O
function NN O
( , O
11 CD O
) -RRB- O
. . O

Rap1p NN O
is VBZ O
an DT O
abundant JJ O
sequence NN O
- HYPH O
specific JJ O
DNA NN O
- HYPH O
binding VBG O
protein NN O
( : O
12 CD O
) -RRB- O
. . O

Variants NNS O
of IN O
the DT O
13 CD O
bp NN O
consensus NN O
sequence NN O
for IN O
Rap1p NNP O
binding NN O
( -LRB- O
ACACC NNP O
CRYACAYM NNP O
) -RRB- O
( , O
13 CD O
) -RRB- O
lie VBP O
not RB O
only RB O
in IN O
the DT O
UASs NNS O
of IN O
numerous JJ O
genes NNS O
but CC O
also RB O
in IN O
the DT O
silencers NNS O
of IN O
the DT O
HM NNP O
loci NN O
and CC O
in IN O
telomeric JJ O
C1 NN O
- HYPH O
3A NN O
repeats NNS O
. . O

Accordingly RB O
, , O
Rap1p NNP O
functions VBZ O
as IN O
a DT O
global JJ O
regulator NN O
of IN O
transcriptional JJ O
activation NN O
and CC O
repression NN O
, , O
silencing NN O
, , O
as RB O
well RB O
as IN O
telomere NN O
length NN O
( SYM O
12 CD O
) -RRB- O
. . O

Rap1p NNP O
performs VBZ O
these DT O
diverse JJ O
functions NNS O
by IN O
interacting VBG O
with IN O
different JJ O
factors NNS O
in IN O
respective JJ O
contexts NNS O
. . O

As IN O
an DT O
activator NN O
, , O
Rap1p NNP O
binds VBZ O
to IN O
the DT O
promoters NNS O
of IN O
362 CD O
ORFs NNS O
( SYM O
13 CD O
) -RRB- O
and CC O
can MD O
function VB O
via IN O
at RB O
least RBS O
three CD O
mechanisms NNS O
. . O

First RB O
, , O
Rap1p NN O
binding NN O
can MD O
' `` O
open VB O
up RP O
' '' O
local JJ O
chromatin NN O
structure NN O
at IN O
a DT O
promoter NN O
to TO O
help VB O
another DT O
activator NN O
to TO O
bind VB O
( SYM O
14 CD O
) -RRB- O
. . O

Secondly RB O
, , O
Rap1p NNP O
bound VBN O
to IN O
DNA NNP O
can MD O
help VB O
Gcr1p NNP O
bind VB O
to IN O
an DT O
adjacent JJ O
site NN O
in IN O
the DT O
promoter NN O
through IN O
physical JJ O
interaction NN O
( : O
15 CD O
) -RRB- O
. . O

Thirdly RB O
, , O
Rap1p NNP O
is VBZ O
involved VBN O
in IN O
the DT O
recruitment NN O
of IN O
the DT O
NuA4 NNP O
HAT NNP O
complex NN O
and CC O
TFIID NNP O
to IN O
ribosome NN O
protein NN O
genes NNS O
( -LRB- O
RPGs NNS O
) -RRB- O
( : O
16 CD O
, , O
17 CD O
) -RRB- O
. . O

As IN O
a DT O
silencing VBG O
factor NN O
, , O
Rap1p NNP O
binds VBZ O
to IN O
silencers NNS O
or CC O
telomeric JJ O
repeats NNS O
and CC O
recruits VBZ O
Sir3p NNP O
/ SYM O
Sir4p NNP O
through IN O
direct JJ O
interactions NNS O
( , O
18 CD O
) -RRB- O
. . O

Rap1p NNP O
also RB O
interacts VBZ O
with IN O
telomere NN O
- HYPH O
specific JJ O
proteins NNS O
in IN O
executing VBG O
its PRP$ O
role NN O
in IN O
regulating VBG O
telomere NN O
length NN O
( SYM O
19 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
puzzling JJ O
that IN O
a DT O
protein NN O
that WDT O
helps VBZ O
establish VB O
silent JJ O
chromatin NN O
could MD O
also RB O
act VB O
as IN O
a DT O
barrier NN O
to IN O
its PRP$ O
propagation NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
found VBD O
that IN O
in IN O
addition NN O
to IN O
TEF2 NNP O
- HYPH O
UAS NNP O
, , O
UASs NNP O
of IN O
many JJ O
yeast NN B-Species
genes NNS O
exhibit VBP O
barrier NN O
activity NN O
. . O

Analyses NNS O
of IN O
these DT O
UASs NNS O
indicate VBP O
that IN O
binding VBG O
sites NNS O
for IN O
transcriptional JJ O
regulators NNS O
Abf1p NNP O
, , O
Reb1p NNP O
, , O
Adr1p NNP O
, , O
Gcn4p NNP O
, , O
as RB O
well RB O
as IN O
Rap1p NNP O
, , O
may MD O
participate VB O
in IN O
barrier NN O
function NN O
. . O

These DT O
UASs NNS O
are VBP O
dispersed VBN O
across IN O
the DT O
genome NN O
and CC O
might MD O
play VB O
a DT O
role NN O
in IN O
defining VBG O
functional JJ O
chromosomal JJ O
domains NNS O
. . O

Moreover RB O
, , O
we PRP O
demonstrated VBD O
that IN O
targeting VBG O
the DT O
activation NN O
domain NN O
of IN O
Rap1p NNP O
, , O
Adr1p NNP O
or CC O
Gcn4p NNP O
alone RB O
, , O
led VBD O
to IN O
barrier NN O
function NN O
. . O

Since IN O
the DT O
activation NN O
domain NN O
of IN O
an DT O
activator NN O
was VBD O
usually RB O
involved VBN O
in IN O
interacting VBG O
with IN O
co NN O
- HYPH O
activators NNS O
and CC O
/ SYM O
or CC O
components NNS O
of IN O
the DT O
transcriptional JJ O
machinery NN O
, , O
these DT O
data NNS O
indicated VBD O
that IN O
other JJ O
factors NNS O
might MD O
also RB O
be VB O
involved VBN O
in IN O
barrier NN O
function NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Plasmids NNS O
and CC O
strains NNS O

Plasmids NNP O
1 CD O
- HYPH O
53 CD O
were VBD O
used VBN O
to TO O
make VB O
strains NNS O
1 CD O
- SYM O
53 CD O
, , O
respectively RB O
( , O
see VB O
Figs NNP O
1 CD O
- HYPH O
6 CD O
) -RRB- O
. . O

Plasmid NN O
1 CD O
was VBD O
previously RB O
named VBN O
pMB22 NN O
- : O
a DT O
that WDT O
contained VBD O
a DT O
HindIII NNP O
- HYPH O
BamHI NNP O
fragment NN O
of IN O
chromosome NN O
III NNP O
( , O
coordinates VBZ O
14838 CD O
- HYPH O
16263 CD O
) -RRB- O
with IN O
a DT O
URA3 NNP O
gene NN O
inserted VBN O
at IN O
its PRP$ O
EcoRV NNP O
site NN O
( SYM O
20 CD O
) -RRB- O
. . O

Plasmid NN O
2 CD O
was VBD O
derived VBN O
from IN O
1 CD O
by IN O
inserting VBG O
TEF2 NNP O
- HYPH O
UAS NNP O
( : O
- HYPH O
511 CD O
to IN O
- HYPH O
407 CD O
bp NN O
relative JJ O
to IN O
the DT O
translation NN O
start NN O
codon NN O
) -RRB- O
at IN O
the DT O
SnaBI NNP O
site NN O
. . O

Plasmids NNP O
3 CD O
- SYM O
38 CD O
were VBD O
identical JJ O
to IN O
2 CD O
except IN O
that IN O
different JJ O
fragments NNS O
from IN O
various JJ O
promoters NNS O
( , O
see VB O
Figs NNP O
1 CD O
and CC O
2 CD O
) -RRB- O
were VBD O
inserted VBN O
at IN O
the DT O
SnaBI NNP O
site NN O
. . O

Plasmid NNP O
29 CD O
had VBD O
a DT O
sequence NN O
of IN O
chromosome NN O
III NNP O
( : O
295327 CD O
- HYPH O
295713 CD O
) -RRB- O
containing VBG O
the DT O
HMR NNP O
- HYPH O
tRNA NNP O
gene NN O
( SYM O
21 CD O
) -RRB- O
inserted VBN O
at IN O
the DT O
SnaBI NNP O
site NN O
of IN O
plasmid NN O
1 CD O
. . O

Plasmids NNS O
39 CD O
and CC O
40 CD O
were VBD O
previously RB O
named VBN O
pYXB26 NN O
and CC O
pYXB59 CD O
, , O
respectively RB O
( : O
11 CD O
) -RRB- O
. . O

Plasmid NN O
41 CD O
was VBD O
identical JJ O
to IN O
pYXB59 CD O
except IN O
bearing VBG O
mutations NNS O
illustrated VBN O
in IN O
Figure NNP O
3A NNP O
. . O

Plasmids NNP O
42 CD O
- SYM O
48 CD O
were VBD O
previously RB O
described VBN O
as IN O
pYXB29 NN O
, , O
48 CD O
, , O
28 CD O
, , O
27 CD O
, , O
59 CD O
, , O
31 CD O
and CC O
37 CD O
, , O
respectively RB O
( : O
11 CD O
) -RRB- O
. . O

Plasmid NN O
50 CD O
was VBD O
derived VBN O
from IN O
plasmid NN O
1 CD O
by IN O
inserting VBG O
two CD O
copies NNS O
of IN O
a DT O
sequence NN O
bearing VBG O
the DT O
consensus NN O
binding VBG O
sequence NN O
of IN O
LexA NNP O
( : O
bold JJ O
) -RRB- O
( , O
22 CD O
) -RRB- O
, , O
GGGGTACGTACTGTATGTAC NNP O
, , O
at IN O
the DT O
SnaBI NNP O
site NN O
. . O

Plasmid NN O
51 CD O
was VBD O
identical JJ O
to IN O
50 CD O
except IN O
having VBG O
only RB O
one CD O
copy NN O
of IN O
the DT O
LexA NNP O
- HYPH O
binding VBG O
sequence NN O
. . O

Plasmid NN O
52 CD O
was VBD O
derived VBN O
from IN O
pYXB26 NNP O
( SYM O
11 CD O
) -RRB- O
by IN O
inserting VBG O
a DT O
SpeI NNP O
- HYPH O
ADE2 NNP O
- HYPH O
AvrII NNP O
sequence NN O
at IN O
the DT O
SpeI NNP O
site NN O
. . O

Plasmid NN O
53 CD O
was VBD O
derived VBN O
from IN O
plasmid NN O
52 CD O
by IN O
inserting VBG O
TEF2 NNP O
- HYPH O
UAS NNP O
( : O
- HYPH O
511 CD O
to IN O
- HYPH O
407 CD O
bp NN O
relative JJ O
to IN O
the DT O
translation NN O
start NN O
codon NN O
) -RRB- O
at IN O
the DT O
SpeI NNP O
site NN O
. . O

Plasmid NNP O
L1 NNP O
( , O
see VB O
Fig NNP O
. . O
5A NNP O
) -RRB- O
was VBD O
made VBN O
by IN O
inserting VBG O
LEU2 NNP O
into IN O
pBTM116 CD O
( SYM O
23 CD O
) -RRB- O
carrying VBG O
the DT O
LexA NNP O
gene NN O
flanked VBN O
by IN O
the DT O
promoter NN O
and CC O
terminator NN O
of IN O
ADH1 NNP O
. . O

L2 NNP O
through IN O
L8 NNP O
were VBD O
derived VBN O
from IN O
L1 NNP O
by IN O
fusing VBG O
various JJ O
sequences NNS O
to IN O
LexA NNP O
( , O
see VB O
Fig NNP O
. . O
5A NN O
and CC O
B NN O
) -RRB- O
. . O

Plasmid NNP O
pRS425 NNP O
( -LRB- O
24 CD O
) -RRB- O
carried VBD O
the DT O
2 CD O
micro JJ O
m NN O
origin NN O
and CC O
LEU2 NNP O
. . O

Strain NN O
YXB76 CD O
was VBD O
MATa NNP O
ura3 CD O
- HYPH O
52 CD O
leu2 CD O
- HYPH O
3 CD O
, , O
112 CD O
ade2 CD O
- HYPH O
1 CD O
lys1 CD O
- HYPH O
1 CD O
his5 CD O
- HYPH O
2 CD O
can1 NN O
- HYPH O
100 CD O
, , O
E NNP O
- HYPH O
HML NNP O
alpha NN O
- HYPH O
Iinverted NNP O
( HYPH O
20 CD O
) -RRB- O
. . O

Y2047b NN O
was VBD O
MATa NNP O
HMRa NNP O
HML NNP O
alpha NN O
E NN O
Delta NNP O
79 CD O
- HYPH O
113 CD O
: : O
: : O
SUP4 CD O
- HYPH O
o -LRB- O
I NNP O
Delta NNP O
242 CD O
LEU2 NNP O
- HYPH O
GAL10 NNP O
- HYPH O
FLP1 CD O
ura3 CD O
- HYPH O
52 CD O
ade2 CD O
- HYPH O
1 CD O
lys1 CD O
- HYPH O
1 CD O
his5 CD O
- HYPH O
1 CD O
can1 NN O
- HYPH O
100 CD O
[ -LRB- O
cir0 NN O
] -RRB- O
( : O
25 CD O
) -RRB- O
. . O

Strain NN O
1 CD O
was VBD O
made VBN O
by IN O
transforming VBG O
YXB76 NNP O
to IN O
Ura NNP O
+ CC O
with IN O
HindIII NNP O
+ CC O
BamHI NNP O
digested VBN O
plasmid NN O
1 CD O
. . O

Strains NNS O
2 CD O
- SYM O
38 CD O
, , O
50 CD O
and CC O
51 CD O
were VBD O
similarly RB O
made VBN O
with IN O
corresponding JJ O
plasmids NNS O
, , O
respectively RB O
( : O
e LS O
. . O
g LS O
. . O
strain NN O
2 CD O
was VBD O
made VBN O
with IN O
plasmid NN O
2 CD O
) -RRB- O
. . O

Strains NNS O
39 CD O
, , O
40 CD O
and CC O
42 CD O
- SYM O
48 CD O
were VBD O
previously RB O
described VBN O
as IN O
YXB26 NNP O
, , O
48 CD O
, , O
29 CD O
, , O
48 CD O
, , O
28 CD O
, , O
27 CD O
, , O
59 CD O
, , O
31 CD O
and CC O
37 CD O
, , O
respectively RB O
( SYM O
11 CD O
) -RRB- O
. . O

Strains NNS O
41 CD O
, , O
52 CD O
and CC O
53 CD O
( , O
see VBP O
Figs NNP O
3C NNP O
and CC O
6 CD O
) -RRB- O
were VBD O
made VBN O
by IN O
transforming VBG O
Y2047b NN O
to IN O
canavanine NN O
- HYPH O
resistant JJ O
by IN O
BamHI NNP O
- HYPH O
digested VBN O
plasmids NNS O
41 CD O
, , O
52 CD O
and CC O
53 CD O
, , O
respectively RB O
. . O

Strains NNS O
40 CD O
' '' O
- HYPH O
48 CD O
' '' O
were VBD O
sir3 NN O
: : O
: : O
URA3 NNP O
derivatives NNS O
of IN O
strains NNS O
40 CD O
- SYM O
48 CD O
, , O
respectively RB O
. . O

The DT O
relevant JJ O
genotypes NNS O
of IN O
all PDT O
the DT O
strains NNS O
were VBD O
confirmed VBN O
by IN O
Southern JJ O
blotting NN O
. . O

Quantitative JJ O
mating NN O
assay NN O

Quantitative JJ O
mating NN O
was VBD O
performed VBN O
as IN O
described VBN O
( SYM O
11 CD O
) -RRB- O
. . O

Electrophoresis NN O
mobility NN O
shift NN O
assay NN O
( : O
EMSA NNP O
) -RRB- O

Rap1p NN O
was VBD O
expressed VBN O
in IN O
Escherichia NNP B-Species
coli NNP I-Species
BL21 NNP I-Species
( -LRB- I-Species
DE3 NNP I-Species
) -RRB- I-Species
from IN O
pL3S5 NN O
, , O
a DT O
pET NN O
vector NN O
carrying VBG O
the DT O
RAP1 NNP O
gene NN O
downstream NN O
of IN O
a DT O
T7 NNP O
promoter NN O
( SYM O
26 CD O
) -RRB- O
. . O

Crude JJ O
protein NN O
extracts NNS O
were VBD O
prepared VBN O
from IN O
40 CD O
ml CD O
cultures NNS O
harvested VBN O
after IN O
3 CD O
h NN O
of IN O
IPTG NNP O
induction NN O
and CC O
resuspended VBN O
in IN O
1 CD O
ml NNS O
of IN O
lysis NN O
buffer NN O
( : O
50 CD O
mM NN O
NaH2PO4 NN O
, , O
300 CD O
mM NN O
NaCl NN O
, , O
pH NN O
8 CD O
. . O
0 CD O
) -RRB- O
. . O

A DT O
control NN O
extract NN O
was VBD O
prepared VBN O
from IN O
a DT O
culture NN O
without IN O
IPTG NNP O
induction NN O
. . O

Western JJ O
blotting NN O
revealed VBD O
that IN O
Rap1p NNP O
protein NN O
was VBD O
present JJ O
in IN O
the DT O
induced VBN O
extract NN O
but CC O
not RB O
the DT O
uninduced JJ O
one CD O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

DNA NN O
fragments NNS O
of IN O
26 CD O
bp NN O
in IN O
length NN O
( , O
see VBP O
Fig NNP O
. . O
3A NNP O
) -RRB- O
were VBD O
end NN O
- HYPH O
labeled VBN O
with IN O
32P CD O
- HYPH O
phosphate NN O
. . O

Fifteen CD O
microliter NN O
binding NN O
reactions NNS O
were VBD O
prepared VBN O
, , O
each DT O
consisting VBG O
of IN O
20 CD O
0 CD O
c NN O
. . O
p NN O
. . O
m NN O
. . O
radiolabeled VBN O
DNA NN O
probe NN O
, , O
5 CD O
micro NN O
g NN O
of IN O
crude JJ O
protein NN O
extract NN O
, , O
non JJ O
- HYPH O
specific JJ O
competitor NN O
DNAs NNS O
( : O
0 CD O
. . O
3 CD O
micro NN O
g NN O
of IN O
yeast NN B-Species
tRNA NN O
, , O
0 CD O
. . O
3 CD O
micro NN O
g NN O
of IN O
salmon NN B-Species
sperm NN O
DNA NN O
and CC O
0 CD O
. . O
5 CD O
micro NN O
g NN O
of IN O
E NN B-Species
. . I-Species
coli NNP I-Species
DNA NNP O
) -RRB- O
, , O
10 CD O
micro NN O
g NN O
of IN O
BSA NNP O
, , O
10 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
8 CD O
. . O
0 CD O
) -RRB- O
, , O
10 CD O
mM NN O
MgCl2 NN O
and CC O
8 CD O
% NN O
glycerol NN O
. . O

The DT O
reactions NNS O
were VBD O
incubated VBN O
at IN O
25 CD O
degrees NNS O
C NN O
for IN O
20 CD O
min NN O
and CC O
loaded VBN O
onto IN O
non JJ O
- HYPH O
denaturing VBG O
polyacrylamide NN O
gels NNS O
( : O
4 CD O
- SYM O
5 CD O
% NN O
) -RRB- O
. . O

Gels NNS O
were VBD O
run VBN O
at IN O
40 CD O
mA NN O
for IN O
1 CD O
h NNS O
in IN O
0 CD O
. . O
5 CD O
x SYM O
TBE NN O
buffer NN O
. . O

Analysis NN O
of IN O
the DT O
supercoiling NN O
of IN O
DNA NNP O
circles NNS O

Cells NNS O
were VBD O
grown VBN O
in IN O
YPR NN O
( : O
yeast NN B-Species
extract NN O
+ CC O
bacto NN O
peptone NN O
+ SYM O
2 CD O
% NN O
raffinose NN O
) -RRB- O
to IN O
early JJ O
log NN O
phase NN O
. . O

Galactose NNP O
( : O
2 CD O
% NN O
) -RRB- O
was VBD O
then RB O
added VBN O
to IN O
the DT O
culture NN O
to TO O
induce VB O
the DT O
expression NN O
of IN O
FLP1 NNP O
. . O

After IN O
2 CD O
. . O
5 CD O
h NN O
of IN O
incubation NN O
, , O
nucleic JJ O
acid NN O
was VBD O
isolated VBN O
using VBG O
the DT O
glass NN O
bead NN O
method NN O
and CC O
fractionated VBN O
on IN O
agarose JJ O
gels NNS O
with IN O
30 CD O
micro JJ O
g NN O
/ SYM O
ml NN O
chloroquine NN O
. . O

DNA NN O
circles NNS O
were VBD O
detected VBN O
by IN O
Southern JJ O
blotting NN O
. . O

RESULTS NNS O

UASs NNP O
of IN O
many JJ O
highly RB O
expressed VBN O
genes NNS O
can MD O
function VB O
as IN O
barriers NNS O
to IN O
the DT O
spread NN O
of IN O
silencing NN O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
TEF2 NNP O
- HYPH O
UAS NNP O
was VBD O
able JJ O
to TO O
block VB O
the DT O
spread NN O
of IN O
silencing NN O
in IN O
a DT O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
( SYM O
11 CD O
) -RRB- O
. . O

Such PDT O
an DT O
assay NN O
tested VBD O
if IN O
a DT O
sequence NN O
had VBD O
the DT O
ability NN O
to TO O
prevent VB O
a DT O
silencer NN O
from IN O
silencing VBG O
a DT O
reporter NN O
gene NN O
when WRB O
it PRP O
was VBD O
positioned VBN O
between IN O
the DT O
silencer NN O
and CC O
the DT O
reporter NN O
. . O

In IN O
this DT O
report NN O
we PRP O
used VBD O
a DT O
new JJ O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
to TO O
identify VB O
more JJR O
barrier NN O
elements NNS O
. . O

This DT O
assay NN O
employed VBD O
the DT O
URA3 NNP O
gene NN O
and CC O
an DT O
inverted JJ O
HML NNP O
- HYPH O
I NNP O
that WDT O
could MD O
silence VB O
sequences NNS O
to IN O
the DT O
right NN O
of IN O
HML NNP O
( SYM O
20 CD O
) -RRB- O
( , O
Fig NNP O
. . O
1 CD O
, , O
strain NN O
1 CD O
) -RRB- O
. . O

URA3 NNP O
expression NN O
makes VBZ O
cells NNS O
sensitive JJ O
to IN O
5 CD O
- HYPH O
fluoroorotic NN O
acid NN O
( -LRB- O
FOA NNP O
) -RRB- O
thus RB O
URA3 NNP O
silencing NN O
could MD O
be VB O
measured VBN O
by IN O
cell NN O
growth NN O
on IN O
FOA NNP O
medium NN O
( : O
Fig NNP O
. . O
1 CD O
, , O
strain NN O
1 CD O
) -RRB- O
. . O

As IN O
expected VBN O
, , O
TEF2 NNP O
- HYPH O
UAS NNP O
and CC O
another DT O
known VBN O
barrier NN O
element NN O
, , O
HMR NNP O
- HYPH O
tRNA NNP O
gene NN O
( , O
21 CD O
) -RRB- O
exhibited VBD O
barrier NN O
activity NN O
in IN O
this DT O
assay NN O
as IN O
indicated VBN O
by IN O
the DT O
lack NN O
of IN O
silencing NN O
of IN O
URA3 NNP O
in IN O
strains NNS O
2 CD O
and CC O
29 CD O
( SYM O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

TEF2 NN O
encoding VBG O
translation NN O
elongation NN O
factor NN O
1 CD O
alpha NN O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
highly RB O
expressed VBN O
genes NNS O
in IN O
yeast NN B-Species
( SYM O
27 CD O
) -RRB- O
. . O

Other JJ O
highly RB O
expressed VBN O
genes NNS O
include VBP O
ribosome NN O
protein NN O
genes NNS O
( , O
RPGs NNS O
) -RRB- O
and CC O
genes NNS O
coding VBG O
for IN O
glycolytic JJ O
enzymes NNS O
( SYM O
27 CD O
) -RRB- O
. . O

The DT O
coordinated JJ O
regulation NN O
of IN O
most JJS O
of IN O
these DT O
genes NNS O
requires VBZ O
the DT O
so RB O
- HYPH O
called VBN O
general JJ O
regulatory JJ O
factors NNS O
Rap1p NNP O
, , O
Abf1p NNP O
and CC O
Reb1p NNP O
( SYM O
28 CD O
, , O
29 CD O
) -RRB- O
. . O

Using VBG O
the DT O
above JJ O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
, , O
we PRP O
tested VBD O
if IN O
the DT O
UASs NNS O
of IN O
other JJ O
highly RB O
expressed VBN O
genes NNS O
could MD O
also RB O
block VB O
URA3 NNP O
silencing NN O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

Seventeen JJ O
new JJ O
barrier NN O
elements NNS O
were VBD O
identified VBN O
from IN O
a DT O
total NN O
of IN O
26 CD O
UASs NNS O
tested VBN O
. . O

These DT O
17 CD O
elements NNS O
were VBD O
UASs NNS O
of IN O
eight CD O
RPGs NNS O
( , O
see VB O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
3 CD O
- SYM O
10 CD O
) -RRB- O
, , O
eight CD O
glycolytic JJ O
genes NNS O
( , O
strains NNS O
18 CD O
- SYM O
25 CD O
) -RRB- O
and CC O
the DT O
HIS3 NN O
gene NN O
( , O
strain NN O
26 CD O
) -RRB- O
. . O

All DT O
17 CD O
elements NNS O
except IN O
ADH2 NNP O
- HYPH O
UAS NNP O
and CC O
HIS3 NNP O
- HYPH O
UAS NNP O
exhibited VBD O
very RB O
strong JJ O
barrier NN O
activity NN O
as IN O
evidenced VBN O
by IN O
the DT O
absence NN O
of IN O
URA3 NNP O
- HYPH O
silencing NN O
in IN O
strains NNS O
3 CD O
- SYM O
10 CD O
and CC O
18 CD O
- SYM O
24 CD O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

Seven CD O
of IN O
the DT O
eight CD O
RPG NNP O
- HYPH O
UASs NNS O
that WDT O
had VBD O
barrier NN O
activity NN O
, , O
contained VBD O
a DT O
single JJ O
or CC O
a DT O
pair NN O
of IN O
tandem NN O
Rap1p NNP O
- HYPH O
binding VBG O
sites NNS O
( : O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
3 CD O
- SYM O
9 CD O
) -RRB- O
. . O

Three CD O
of IN O
them PRP O
also RB O
contained VBD O
an DT O
Abf1p NNP O
or CC O
Reb1p NNP O
site NN O
( : O
strains NNS O
6 CD O
, , O
8 CD O
and CC O
9 CD O
) -RRB- O
. . O

One CD O
barrier NN O
RPG NNP O
- HYPH O
UAS NNP O
( HYPH O
strain NN O
10 CD O
) -RRB- O
had VBD O
only RB O
a DT O
predicted VBN O
Abf1p NNP O
site NN O
. . O

Of IN O
the DT O
seven CD O
RPG NNP O
- HYPH O
UASs NNS O
that WDT O
had VBD O
no DT O
barrier NN O
activity NN O
( : O
Fig NNP O
. . O
1 CD O
, , O
11 CD O
- HYPH O
17 CD O
) -RRB- O
, , O
only RB O
two CD O
bore VBD O
no DT O
site NN O
for IN O
Rap1p NNP O
, , O
Abf1p NNP O
or CC O
Reb1p NNP O
( SYM O
11 CD O
and CC O
12 CD O
) -RRB- O
. . O

The DT O
remaining VBG O
five CD O
each DT O
contained VBD O
one CD O
to TO O
three CD O
Rap1p NNP O
sites NNS O
( : O
strains NNS O
13 CD O
- HYPH O
17 CD O
) -RRB- O
. . O

RPL15A NNP O
- HYPH O
UAS NNP O
( : O
17 CD O
) -RRB- O
also RB O
contained VBD O
an DT O
Abf1p NNP O
site NN O
. . O

For IN O
most JJS O
of IN O
the DT O
15 CD O
RPG NNP O
- HYPH O
UASs NNP O
tested VBN O
( : O
3 CD O
- HYPH O
17 CD O
) -RRB- O
, , O
the DT O
presence NN O
or CC O
absence NN O
of IN O
predicted VBN O
Rap1p NNP O
sites NNS O
correlated VBN O
with IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
Rap1p NN O
association NN O
in IN O
vivo NN O
as IN O
previously RB O
examined VBN O
by IN O
chromatin NN O
immunoprecipitation NN O
assays NNS O
( SYM O
13 CD O
) -RRB- O
. . O

Exceptions NNS O
were VBD O
the DT O
UASs NNP O
of IN O
RPS24B NNP O
, , O
RPS28A NNP O
and CC O
RPL15A NNP O
( SYM O
13 CD O
) -RRB- O
. . O

Of IN O
the DT O
eight CD O
UASs NNS O
of IN O
glycolytic JJ O
genes NNS O
tested VBN O
( : O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
18 CD O
- HYPH O
25 CD O
) -RRB- O
, , O
seven CD O
exhibited VBD O
strong JJ O
barrier NN O
activity NN O
( , O
18 CD O
- SYM O
24 CD O
) -RRB- O
and CC O
one CD O
had VBD O
weaker JJR O
but CC O
detectable JJ O
barrier NN O
activity NN O
( , O
strain NN O
25 CD O
) -RRB- O
. . O

Glycolytic NN O
genes NNS O
are VBP O
among IN O
the DT O
most RBS O
highly RB O
expressed VBN O
genes NNS O
and CC O
their PRP$ O
high JJ O
expression NN O
depends VBZ O
on IN O
the DT O
functions NNS O
of IN O
Rap1p NNP O
, , O
Abf1p NNP O
or CC O
Reb1p NNP O
as RB O
well RB O
as IN O
Gcr1p NNP O
( : O
29 CD O
, , O
30 CD O
) -RRB- O
. . O

The DT O
seven CD O
strong JJ O
glycolytic JJ O
barriers NNS O
all DT O
consist VBP O
of IN O
one CD O
or CC O
two CD O
Rap1p NNP O
sites NNS O
plus CC O
one CD O
or CC O
two CD O
Reb1p NN O
or CC O
Abf1p NNP O
sites NNS O
( : O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
18 CD O
- HYPH O
24 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
one CD O
or CC O
more JJR O
Gcr1p NNP O
- HYPH O
binding VBG O
sites NNS O
are VBP O
found VBN O
adjacent JJ O
to IN O
each DT O
Rap1p NNP O
site NN O
. . O

It PRP O
was VBD O
proposed VBN O
that IN O
the DT O
function NN O
of IN O
Rap1p NNP O
was VBD O
to TO O
facilitate VB O
the DT O
binding NN O
of IN O
Gcr1p NNP O
to IN O
the DT O
UAS NNP O
( SYM O
15 CD O
) -RRB- O
. . O

Abf1p NNP O
or CC O
Reb1p NNP O
was VBD O
shown VBN O
to TO O
play VB O
a DT O
role NN O
similar JJ O
to IN O
that DT O
of IN O
Rap1p NNP O
in IN O
activating VBG O
glycolytic JJ O
genes NNS O
( SYM O
31 CD O
- SYM O
33 CD O
) -RRB- O
. . O

Although IN O
the DT O
above JJ O
data NNS O
reinforced VBD O
the DT O
notion NN O
that IN O
certain JJ O
Rap1p NNP O
- HYPH O
binding VBG O
UASs NNP O
could MD O
serve VB O
as IN O
barriers NNS O
to IN O
silencing NN O
, , O
they PRP O
raised VBD O
new JJ O
questions NNS O
about IN O
the DT O
essential JJ O
components NNS O
of IN O
a DT O
barrier NN O
element NN O
. . O

For IN O
example NN O
, , O
some DT O
of IN O
the DT O
UASs NNS O
that WDT O
contained VBD O
only RB O
a DT O
single JJ O
Rap1p NNP O
site NN O
had VBD O
barrier NN O
activity NN O
( : O
e LS O
. . O
g LS O
. . O
RPL19B NN O
- HYPH O
UAS NNP O
, , O
strain NN O
3 CD O
) -RRB- O
whereas IN O
others NNS O
that WDT O
contained VBD O
two CD O
or CC O
three CD O
sites NNS O
had VBD O
no DT O
activity NN O
( : O
e LS O
. . O
g LS O
. . O
RPL39 NN O
, , O
strain NN O
16 CD O
) -RRB- O
. . O

One CD O
explanation NN O
was VBD O
that IN O
sequences NNS O
flanking VBG O
the DT O
Rap1p NNP O
site NN O
( , O
s FW O
) -RRB- O
in IN O
a DT O
particular JJ O
UAS NNP O
could MD O
positively RB O
or CC O
negatively RB O
influence VB O
barrier NN O
function NN O
. . O

Moreover RB O
, , O
the DT O
presence NN O
of IN O
Abf1p NNP O
or CC O
Reb1p NNP O
sites NNS O
in IN O
11 CD O
of IN O
the DT O
17 CD O
new JJ O
barriers NNS O
made VBD O
us PRP O
wonder VB O
if IN O
they PRP O
also RB O
participated VBD O
in IN O
barrier NN O
function NN O
. . O

We PRP O
began VBD O
to TO O
address VB O
these DT O
issues NNS O
by IN O
analyzing VBG O
three CD O
new JJ O
barrier NN O
elements NNS O
( , O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

RPS10A NNP O
- HYPH O
UAS NNP O
containing VBG O
an DT O
Abf1p NNP O
- HYPH O
binding VBG O
site NN O
and CC O
a DT O
pair NN O
of IN O
Rap1p NNP O
sites NNS O
was VBD O
divided VBN O
into IN O
three CD O
fragments NNS O
that WDT O
were VBD O
tested VBN O
in IN O
a DT O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
( -LRB- O
Fig NNP O
. . O
2 CD O
, , O
strains NNS O
30 CD O
- HYPH O
32 CD O
) -RRB- O
. . O

It PRP O
was VBD O
clear JJ O
that IN O
only RB O
the DT O
fragment NN O
containing VBG O
Rap1p NNP O
sites NNS O
functioned VBD O
as IN O
a DT O
barrier NN O
( , O
strain NN O
31 CD O
) -RRB- O
. . O

TPI1 NNP O
- HYPH O
UAS NNP O
bearing VBG O
a DT O
Reb1p NNP O
site NN O
and CC O
a DT O
Rap1p NNP O
site NN O
was VBD O
divided VBN O
into IN O
two CD O
parts NNS O
with IN O
one CD O
containing VBG O
the DT O
Rap1p NNP O
site NN O
( : O
Fig NNP O
. . O
2 CD O
, , O
strain NN O
34 CD O
) -RRB- O
and CC O
the DT O
other JJ O
Reb1p NN O
site NN O
( HYPH O
strain NN O
33 CD O
) -RRB- O
. . O

Neither DT O
of IN O
these DT O
fragments NNS O
alone RB O
retained VBD O
barrier NN O
activity NN O
indicating VBG O
that IN O
concerted JJ O
action NN O
of IN O
Reb1p NNP O
and CC O
Rap1p NNP O
was VBD O
required VBN O
for IN O
barrier NN O
activity NN O
. . O

Duplicating VBG O
the DT O
Reb1p NNP O
- HYPH O
bearing VBG O
part NN O
of IN O
TPI1 NNP O
- HYPH O
UAS NNP O
didn VBD O
' '' O
t RB O
restore VB O
barrier NN O
activity NN O
( , O
strain NN O
35 CD O
) -RRB- O
. . O

However RB O
, , O
triplicating VBG O
the DT O
Rap1p NNP O
- HYPH O
containing VBG O
part NN O
did VBD O
re RB O
- HYPH O
create VB O
barrier NN O
function NN O
( , O
strain NN O
36 CD O
) -RRB- O
. . O

RPS28A NNP O
- HYPH O
UAS NNP O
bore VBD O
, , O
in IN O
addition NN O
to IN O
a DT O
Rap1p NNP O
site NN O
, , O
an DT O
Abf1p NNP O
site NN O
and CC O
an DT O
adjacent JJ O
T NNP O
- HYPH O
rich JJ O
region NN O
that WDT O
are VBP O
required VBN O
for IN O
efficient JJ O
transcription NN O
of IN O
RPS28A NNP O
( SYM O
34 CD O
) -RRB- O
. . O

A DT O
sequence NN O
of IN O
RPS28A NNP O
- HYPH O
UAS NNP O
deleted VBN O
for IN O
a DT O
fragment NN O
bearing VBG O
the DT O
Rap1p NNP O
site NN O
lost VBD O
the DT O
barrier NN O
activity NN O
( : O
Fig NNP O
. . O
2 CD O
, , O
strain NN O
37 CD O
) -RRB- O
. . O

However RB O
, , O
duplicating VBG O
this DT O
sequence NN O
restored VBD O
barrier NN O
activity NN O
( , O
strain NN O
38 CD O
) -RRB- O
. . O

The DT O
above JJ O
results NNS O
indicated VBD O
again RB O
that IN O
Rap1p NNP O
sites NNS O
could MD O
form VB O
barriers NNS O
( , O
strains NNS O
31 CD O
and CC O
36 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
they PRP O
also RB O
suggested VBD O
that IN O
synergistic JJ O
actions NNS O
of IN O
Abf1p NNP O
sites NNS O
( -LRB- O
strain NN O
38 CD O
) -RRB- O
, , O
Reb1p NNP O
site NN O
+ CC O
Rap1p NNP O
site NN O
( -LRB- O
strain NN O
18 CD O
) -RRB- O
, , O
or CC O
Abf1p NN O
site NN O
+ CC O
Rap1p NN O
site NN O
( -LRB- O
strain NN O
16 CD O
) -RRB- O
could MD O
all DT O
lead VB O
to IN O
barrier NN O
function NN O
. . O

This DT O
was VBD O
not RB O
very RB O
surprising JJ O
since IN O
Rap1p NNP O
, , O
Abf1p NNP O
and CC O
Reb1p NNP O
could MD O
perform VB O
similar JJ O
and CC O
sometimes RB O
interchangeable JJ O
functions NNS O
in IN O
gene NN O
regulation NN O
( : O
16 CD O
, , O
35 CD O
, , O
36 CD O
) -RRB- O
. . O

Note VB O
, , O
however RB O
, , O
we PRP O
haven VBP O
' '' O
t VBZ O
ruled VBN O
out RP O
the DT O
possibility NN O
that IN O
other JJ O
factors NNS O
( , O
e LS O
. . O
g LS O
. . O
Gcr1p NN O
) -RRB- O
or CC O
structure NN O
features NNS O
of IN O
DNA NN O
( : O
e LS O
. . O
g LS O
. . O
T NNP O
- HYPH O
tracks NNS O
) -RRB- O
were VBD O
also RB O
involved VBN O
in IN O
barrier NN O
function NN O
. . O

It PRP O
was VBD O
interesting JJ O
that IN O
ADH2 NNP O
- HYPH O
UAS NNP O
and CC O
HIS3 NNP O
- HYPH O
UAS NNP O
bearing VBG O
no DT O
site NN O
for IN O
Rap1p NNP O
, , O
Abf1p NNP O
or CC O
Reb1p NNP O
exhibited VBD O
detectable JJ O
barrier NN O
activity NN O
( , O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
25 CD O
and CC O
26 CD O
) -RRB- O
. . O

However RB O
, , O
binding VBG O
sites NNS O
for IN O
other JJ O
transcriptional JJ O
activators NNS O
existed VBD O
in IN O
these DT O
UASs NNS O
. . O

The DT O
major JJ O
regulator NN O
that WDT O
binds VBZ O
to IN O
ADH2 NNP O
- HYPH O
UAS NNP O
is VBZ O
Adr1p NNP O
( : O
37 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
Gcn4p NNP O
binds VBZ O
to IN O
multiple JJ O
sites NNS O
in IN O
HIS3 NNP O
- HYPH O
UAS NNP O
and CC O
activates VBZ O
HIS3 NNP O
transcription NN O
( , O
38 CD O
) -RRB- O
. . O

The DT O
possible JJ O
involvement NN O
of IN O
Adr1p NNP O
or CC O
Gcn4p NNP O
in IN O
barrier NN O
function NN O
was VBD O
examined VBN O
below RB O
. . O

Note NN O
Adr1p NN O
function NN O
was VBD O
subject JJ O
to IN O
glucose NN O
repression NN O
( : O
37 CD O
) -RRB- O
, , O
which WDT O
might MD O
explain VB O
why WRB O
ADH2 NNP O
- HYPH O
UAS NNP O
only RB O
exhibited VBD O
limited JJ O
barrier NN O
activity NN O
since IN O
glucose NN O
was VBD O
used VBN O
in IN O
the DT O
media NNS O
used VBN O
in IN O
our PRP$ O
assay NN O
. . O

Effect NN O
of IN O
mutating VBG O
Rap1p NN O
- HYPH O
binding VBG O
sites NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
on IN O
barrier NN O
function NN O

Although IN O
we PRP O
had VBD O
shown VBN O
that IN O
the DT O
three CD O
Rap1p NNP O
- HYPH O
binding VBG O
sites NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
were VBD O
necessary JJ O
and CC O
sufficient JJ O
for IN O
its PRP$ O
barrier NN O
activity NN O
( : O
11 CD O
) -RRB- O
, , O
we PRP O
had VBD O
not RB O
shown VBN O
if IN O
binding NN O
of IN O
Rap1p NNP O
to IN O
these DT O
sites NNS O
was VBD O
required VBN O
. . O

To TO O
address VB O
this DT O
we PRP O
performed VBD O
mutational JJ O
analysis NN O
of IN O
TEF2 NNP O
- HYPH O
UAS NNP O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
3A NNP O
and CC O
B NN O
, , O
the DT O
three CD O
Rap1p NNP O
- HYPH O
binding VBG O
sites NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
( , O
designated VBN O
as IN O
R1 NNP O
, , O
R2 NNP O
and CC O
R3 CD O
) -RRB- O
were VBD O
all DT O
able JJ O
to TO O
bind VB O
Rap1p NNP O
in IN O
an DT O
EMSA NNP O
( -LRB- O
Fig NNP O
. . O
3B NN O
) -RRB- O
. . O

Single JJ O
or CC O
double JJ O
C NN O
- HYPH O
- HYPH O
> : O
A DT O
mutations NNS O
were VBD O
introduced VBN O
into IN O
R1 NNP O
, , O
R2 NNP O
and CC O
R3 NNP O
resulting VBG O
in IN O
m1 CD O
, , O
m2 CD O
and CC O
m3 CD O
, , O
respectively RB O
( : O
Fig NNP O
. . O
3A NN O
) -RRB- O
. . O

The DT O
m2 NN O
and CC O
m3 NNP O
sites NNS O
had VBD O
both DT O
lost VBN O
the DT O
ability NN O
to TO O
bind VB O
Rap1p NNP O
, , O
whereas IN O
m1 CD O
still RB O
bound VBD O
Rap1p NNP O
( , O
Fig NNP O
. . O
3B NN O
) -RRB- O
, , O
which WDT O
could MD O
be VB O
predicted VBN O
from IN O
the DT O
specific JJ O
mutations NNS O
in IN O
each DT O
site NN O
( -LRB- O
Fig NNP O
. . O
3A NN O
, , O
compare VB O
m1 CD O
, , O
m2 CD O
and CC O
m3 CD O
to IN O
the DT O
consensus NN O
sequence NN O
) -RRB- O
. . O

We PRP O
then RB O
tested VBD O
a DT O
mutated VBN O
TEF2 NNP O
- HYPH O
UAS NNP O
containing VBG O
m1 CD O
, , O
m2 CD O
and CC O
m3 CD O
in IN O
a DT O
silencer NN O
- HYPH O
blocking VBG O
assay NN O
using VBG O
the DT O
HML NNP O
- HYPH O
E NNP O
silencer NN O
and CC O
the DT O
HML NNP O
alpha NN O
genes NNS O
( -LRB- O
Fig NNP O
. . O
3C NNP O
) -RRB- O
. . O

In IN O
this DT O
assay NN O
, , O
the DT O
HML NNP O
- HYPH O
I NNP O
silencer NN O
was VBD O
deleted VBN O
but CC O
the DT O
HML NNP O
- HYPH O
E NN O
silencer NN O
was VBD O
sufficient JJ O
to TO O
silence VB O
the DT O
HML NNP O
alpha NN O
genes NNS O
( -LRB- O
Fig NNP O
. . O
3C NNP O
, , O
strain NN O
39 CD O
) -RRB- O
( SYM O
11 CD O
) -RRB- O
. . O

Silencing VBG O
in IN O
strain NN O
39 CD O
( HYPH O
a DT O
- HYPH O
type NN O
) , O
was VBD O
measured VBN O
by IN O
its PRP$ O
ability NN O
to TO O
mate VB O
with IN O
an DT O
alpha NN O
- HYPH O
type NN O
strain NN O
( , O
Fig NNP O
. . O
3C NN O
) -RRB- O
. . O

As IN O
predicted VBN O
, , O
the DT O
wild JJ O
- HYPH O
type NN O
TEF2 NNP O
- HYPH O
UAS NNP O
blocked VBD O
HML NNP O
alpha NN O
silencing NN O
( SYM O
11 CD O
) -RRB- O
( , O
Fig NNP O
. . O
3C NNP O
, , O
strain NN O
40 CD O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
mutated VBN O
TEF2 NNP O
- HYPH O
UAS NNP O
containing VBG O
m1 NNP O
, , O
m2 CD O
and CC O
m3 CD O
had VBD O
lost VBN O
barrier NN O
activity NN O
( , O
Fig NNP O
. . O
3C NNP O
, , O
compare VB O
the DT O
mating NN O
efficiencies NNS O
of IN O
strains NNS O
41 CD O
and CC O
40 CD O
) -RRB- O
. . O

Therefore RB O
, , O
mutations NNS O
that WDT O
prevented VBD O
Rap1p NNP O
from IN O
binding VBG O
two CD O
of IN O
the DT O
three CD O
sites NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
abolished VBD O
its PRP$ O
barrier NN O
activity NN O
, , O
indicating VBG O
that IN O
association NN O
of IN O
Rap1p NNP O
with IN O
TEF2 NNP O
- HYPH O
UAS NNP O
at IN O
more JJR O
than IN O
one CD O
site NN O
was VBD O
required VBN O
for IN O
barrier NN O
function NN O
. . O

The DT O
barrier NN O
TEF2 NNP O
- HYPH O
UAS NNP O
alters VBZ O
local JJ O
chromatin NN O
structure NN O

In IN O
eukaryotic JJ O
cells NNS O
, , O
the DT O
topology NN O
of IN O
local JJ O
DNA NNP O
reflects VBZ O
the DT O
chromatin NN O
structure NN O
in IN O
which WDT O
it PRP O
resides VBZ O
. . O

We PRP O
had VBD O
previously RB O
developed VBN O
a DT O
DNA NNP O
topology NN O
- HYPH O
based VBN O
assay NN O
to TO O
examine VB O
chromatin NN O
structure NN O
in IN O
vivo NN O
, , O
which WDT O
involved VBD O
excising VBG O
a DT O
chromosomal JJ O
region NN O
of IN O
interest NN O
from IN O
its PRP$ O
genomic JJ O
location NN O
as IN O
a DT O
circle NN O
using VBG O
site NN O
- HYPH O
specific JJ O
recombination NN O
( SYM O
39 CD O
) -RRB- O
. . O

Using VBG O
this DT O
strategy NN O
, , O
we PRP O
demonstrated VBD O
that IN O
DNA NN O
in IN O
silenced JJ O
chromatin NN O
was VBD O
more RBR O
negatively RB O
supercoiled VBN O
than IN O
that DT O
in IN O
active JJ O
chromatin NN O
( : O
39 CD O
) -RRB- O
. . O

In IN O
this DT O
report NN O
we PRP O
used VBD O
the DT O
topology NN O
assay NN O
to TO O
address VB O
if IN O
barrier NN O
elements NNS O
altered VBD O
local JJ O
chromatin NN O
structure NN O
as IN O
Drosophila NNP B-Species
or CC O
chicken NN B-Species
insulators NNS O
did VBD O
( : O
40 CD O
, , O
41 CD O
) -RRB- O
. . O

Various JJ O
sequences NNS O
( , O
designated VBN O
X NNP O
) , O
from IN O
UASs NNP O
of IN O
TEF2 NNP O
, , O
AgTEF NNP O
( , O
TEF NNP O
gene NN O
from IN O
Ashbya NNP B-Species
gossypii NN I-Species
) , O
and CC O
ADE2 NN O
were VBD O
inserted VBN O
between IN O
HML NNP O
- HYPH O
E NNP O
and CC O
HML NNP O
alpha NN O
at IN O
HML NNP O
Delta NNP O
I NNP O
( -LRB- O
HML NNP O
locus NN O
deleted VBN O
for IN O
the DT O
I NNP O
silencer NN O
) -RRB- O
flanked VBN O
by IN O
the DT O
FRT NNP O
sites NNS O
for IN O
the DT O
Flp1p NNP O
site NN O
- HYPH O
specific JJ O
recombinase NN O
( , O
Fig NNP O
. . O
4A NN O
and CC O
B NN O
) -RRB- O
. . O

The DT O
FLP1 NNP O
gene NN O
was VBD O
under IN O
the DT O
control NN O
of IN O
the DT O
inducible JJ O
GAL10 NNP O
promoter NN O
( SYM O
39 CD O
) -RRB- O
. . O

The DT O
mating NN O
efficiency NN O
of IN O
each DT O
strain NN O
measured VBD O
silencing NN O
of IN O
HML NNP O
alpha NN O
( , O
Fig NNP O
. . O
4C NNP O
) -RRB- O
. . O

In IN O
strains NNS O
40 CD O
, , O
42 CD O
, , O
44 CD O
and CC O
47 CD O
, , O
silencing NN O
was VBD O
restricted VBN O
to IN O
the DT O
left NN O
of IN O
the DT O
X NNP O
insertions NNS O
and CC O
HML NNP O
alpha NN O
was VBD O
derepressed VBN O
( : O
Fig NNP O
. . O
4C NNP O
) -RRB- O
. . O

Consistently RB O
, , O
the DT O
proportion NN O
of IN O
silent JJ O
chromatin NN O
in IN O
the DT O
region NN O
flanked VBN O
by IN O
the DT O
FRT NNP O
sites NNS O
in IN O
each DT O
of IN O
these DT O
strains NNS O
was VBD O
decreased VBN O
, , O
as IN O
indicated VBN O
by IN O
the DT O
reduced VBN O
negative JJ O
supercoiling NN O
of IN O
the DT O
excised VBN O
circle NN O
( SYM O
11 CD O
) -RRB- O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Note VB O
that IN O
the DT O
above JJ O
effect NN O
of IN O
a DT O
barrier NN O
on IN O
HML NNP O
chromatin NN O
reflected VBD O
both DT O
change NN O
in IN O
the DT O
scope NN O
of IN O
silencing NN O
caused VBN O
by IN O
the DT O
barrier NN O
activity NN O
and CC O
alteration NN O
( , O
if IN O
any DT O
) , O
in IN O
chromatin NN O
structure NN O
at IN O
the DT O
barrier NN O
independent JJ O
of IN O
the DT O
silencing VBG O
state NN O
of IN O
the DT O
locus NN O
. . O

To TO O
exclusively RB O
examine VB O
the DT O
latter JJ O
, , O
we PRP O
analyzed VBD O
the DT O
topology NN O
of IN O
HML NNP O
DNA NNP O
in IN O
a DT O
silencing VBG O
- HYPH O
deficient JJ O
background NN O
. . O

The DT O
SIR3 NNP O
gene NN O
in IN O
strains NNS O
described VBN O
in IN O
Figure NN O
4B NNP O
was VBD O
disrupted VBN O
rendering VBG O
them PRP O
defective JJ O
in IN O
silencing NN O
( , O
strains NNS O
40 CD O
' '' O
- HYPH O
48 CD O
' '' O
in IN O
Fig NNP O
. . O
4D CD O
) -RRB- O
. . O

Recombination NN O
mediated VBN O
by IN O
Flp1p NNP O
in IN O
these DT O
strains NNS O
led VBD O
to IN O
the DT O
excision NN O
of IN O
a DT O
group NN O
of IN O
chromosomal JJ O
circles NNS O
that WDT O
differed VBD O
only RB O
in IN O
the DT O
X NN O
insertion NN O
. . O

The DT O
supercoiling NN O
of IN O
these DT O
circles NNS O
was VBD O
analyzed VBN O
as IN O
a DT O
function NN O
of IN O
the DT O
length NN O
of IN O
the DT O
insertion NN O
( , O
Fig NNP O
. . O
4D NN O
) -RRB- O
. . O

If IN O
an DT O
insertion NN O
simply RB O
lengthened VBD O
a DT O
circle NN O
without IN O
causing VBG O
abnormal JJ O
changes NNS O
in IN O
nucleosomal JJ O
structure NN O
and CC O
/ SYM O
or CC O
density NN O
, , O
the DT O
topoisomers NNS O
of IN O
this DT O
circle NN O
would MD O
migrate VB O
slower RBR O
relative JJ O
to IN O
those DT O
of IN O
a DT O
similar JJ O
circle NN O
with IN O
a DT O
smaller JJR O
size NN O
. . O

Otherwise RB O
, , O
migration NN O
of IN O
the DT O
topoisomers NNS O
would MD O
deviate VB O
from IN O
that DT O
predicted VBN O
based VBN O
on IN O
the DT O
size NN O
of IN O
the DT O
circle NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
4D CD O
, , O
the DT O
circle NN O
from IN O
strain NN O
40 CD O
' '' O
bearing VBG O
a DT O
104 CD O
bp NN O
barrier NN O
element NN O
migrated VBD O
faster RBR O
rather RB O
than IN O
slower JJR O
than IN O
the DT O
circle NN O
from IN O
strain NN O
46 CD O
' '' O
bearing VBG O
a DT O
91 CD O
bp NN O
non JJ O
- HYPH O
barrier NN O
element NN O
. . O

Circles NNS O
bearing VBG O
other JJ O
barrier NN O
elements NNS O
also RB O
exhibited VBD O
unexpected JJ O
faster JJR O
migration NN O
( , O
compare VBP O
strains NNS O
44 CD O
' '' O
to IN O
45 CD O
' '' O
, , O
47 CD O
' '' O
to TO O
43 CD O
' '' O
, , O
42 CD O
' '' O
to TO O
48 CD O
' '' O
, , O
respectively RB O
) -RRB- O
. . O

Therefore RB O
, , O
these DT O
data NNS O
indicated VBD O
that IN O
barrier NN O
function NN O
correlated VBD O
with IN O
altered VBN O
topology NN O
of IN O
local JJ O
DNA NNP O
. . O

This DT O
was VBD O
further RB O
demonstrated VBN O
by IN O
that DT O
mutations NNS O
in IN O
TEF2 NNP O
- HYPH O
UAS NNP O
that WDT O
abolished VBD O
its PRP$ O
barrier NN O
activity NN O
also RB O
abolished VBD O
its PRP$ O
effect NN O
on IN O
DNA NNP O
topology NN O
( , O
Fig NNP O
. . O
4D CD O
, , O
compare VB O
41 CD O
' '' O
to IN O
40 CD O
' '' O
; : O
note VB O
that IN O
circles NNS O
from IN O
both DT O
strains NNS O
had VBD O
the DT O
same JJ O
size NN O
) -RRB- O
. . O

Since IN O
in IN O
our PRP$ O
gel NN O
assay NN O
more RBR O
negatively RB O
supercoiled VBN O
DNA NNP O
migrate VBP O
slower RBR O
, , O
we PRP O
concluded VBD O
that IN O
every DT O
fragment NN O
with IN O
barrier NN O
activity NN O
caused VBD O
a DT O
reduction NN O
in IN O
negative JJ O
supercoiling NN O
of IN O
approximately RB O
one CD O
to TO O
two CD O
turns NNS O
in IN O
HML NNP O
Delta NNP O
I NNP O
DNA NNP O
( : O
Fig NNP O
. . O
4D CD O
, , O
compare VB O
the DT O
centers NNS O
of IN O
distributions NNS O
of IN O
topoisomers NNS O
in IN O
pairs NNS O
of IN O
lanes NNS O
, , O
e FW O
. . O
g LS O
. . O
40 CD O
' '' O
and CC O
41 CD O
' '' O
) -RRB- O
. . O

The DT O
topology NN O
of IN O
eukaryotic JJ O
DNA NNP O
reflects VBZ O
mainly RB O
the DT O
wrapping NN O
of IN O
DNA NN O
into IN O
nucleosomes NNS O
( , O
approximately RB O
one CD O
negative JJ O
superhelical JJ O
turn NN O
is VBZ O
associated VBN O
with IN O
each DT O
nucleosome NN O
) -RRB- O
( , O
42 CD O
) -RRB- O
. . O

Therefore RB O
, , O
removal NN O
of IN O
one CD O
nucleosome NN O
would MD O
eliminate VB O
approximately RB O
one CD O
turn NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
histone NN O
acetylation NN O
can MD O
reduce VB O
negative JJ O
supercoiling NN O
associated VBN O
with IN O
a DT O
nucleosome NN O
by IN O
approximately RB O
0 CD O
. . O
2 CD O
turns NNS O
( SYM O
43 CD O
) -RRB- O
. . O

Therefore RB O
, , O
acetylating VBG O
five CD O
nucleosomes NNS O
would MD O
reduce VB O
negative JJ O
supercoiling NN O
by IN O
approximately RB O
one CD O
turn NN O
. . O

Consequently RB O
, , O
the DT O
linking VBG O
number NN O
change NN O
of IN O
one CD O
to IN O
two CD O
brought VBN O
about RP O
by IN O
TEF2 NNP O
- HYPH O
UAS NNP O
can MD O
be VB O
accounted VBN O
for IN O
by IN O
either CC O
the DT O
loss NN O
of IN O
one CD O
to TO O
two CD O
nucleosomes NNS O
or CC O
acetylation NN O
of IN O
five CD O
to TO O
10 CD O
nucleosomes NNS O
. . O

Further JJ O
experiments NNS O
are VBP O
under IN O
way NN O
to TO O
clarify VB O
the DT O
nature NN O
of IN O
change NN O
in IN O
chromatin NN O
induced VBN O
by IN O
a DT O
barrier NN O
. . O

Targeting VBG O
the DT O
transcription NN O
activation NN O
domain NN O
of IN O
Rap1p NNP O
recapitulates VBZ O
its PRP$ O
barrier NN O
activity NN O

The DT O
multifunctional JJ O
Rap1p NNP O
can MD O
be VB O
divided VBN O
into IN O
at RB O
least RBS O
four CD O
functional JJ O
domains NNS O
( -LRB- O
Fig NNP O
. . O
5A NNP O
) -RRB- O
( : O
12 CD O
) -RRB- O
. . O

We PRP O
were VBD O
interested JJ O
in IN O
defining VBG O
which WDT O
of IN O
these DT O
domains NNS O
might MD O
be VB O
involved VBN O
in IN O
the DT O
barrier NN O
activity NN O
of IN O
Rap1p NNP O
. . O

To IN O
this DT O
end NN O
, , O
we PRP O
fused VBD O
various JJ O
parts NNS O
of IN O
Rap1p NNP O
to IN O
the DT O
bacterial JJ O
LexA NNP O
protein NN O
and CC O
tested VBD O
if IN O
targeting VBG O
any DT O
of IN O
the DT O
fusion NN O
proteins NNS O
to IN O
LexA NNP O
- HYPH O
binding VBG O
sites NNS O
could MD O
re VB O
- HYPH O
create VB O
a DT O
barrier NN O
to IN O
silencing NN O
( , O
Fig NNP O
. . O
5A NN O
) -RRB- O
. . O

The DT O
LexA NNP O
- HYPH O
RAP1 NNP O
fusion NN O
genes NNS O
were VBD O
carried VBN O
on IN O
2 CD O
micro NN O
m NN O
based VBN O
plasmids NNS O
marked VBN O
by IN O
LEU2 NNP O
( -LRB- O
designated VBN O
L1 NNP O
- HYPH O
L6 NNP O
, , O
Fig NNP O
. . O
5A NNP O
) -RRB- O
. . O

When WRB O
introduced VBN O
into IN O
strain NN O
50 CD O
in IN O
which WDT O
two CD O
LexA NNP O
- HYPH O
binding VBG O
sites NNS O
had VBD O
been VBN O
inserted VBN O
between IN O
the DT O
inverted VBN O
HML NNP O
- HYPH O
I NNP O
and CC O
URA3 NNP O
, , O
LexA NNP O
alone RB O
had VBD O
no DT O
effect NN O
on IN O
URA3 NNP O
silencing NN O
( , O
Fig NNP O
. . O
5A NN O
, , O
plasmid NN O
L1 NNP O
) -RRB- O
. . O

Targeting VBG O
the DT O
DNA NN O
binding VBG O
domain NN O
, , O
DNA NN O
bending VBG O
domain NN O
, , O
silencing VBG O
domain NN O
, , O
or CC O
the DT O
activating VBG O
+ CC O
silencing NN O
domain NN O
of IN O
Rap1p NNP O
also RB O
did VBD O
not RB O
affect VB O
URA3 NNP O
silencing NN O
( : O
L2 NNP O
- HYPH O
L5 NNP O
) -RRB- O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
targeting VBG O
the DT O
activation NN O
domain NN O
alone RB O
recapitulated VBD O
the DT O
barrier NN O
activity NN O
of IN O
Rap1p NNP O
( : O
L6 NNP O
) -RRB- O
. . O

These DT O
results NNS O
indicated VBD O
that IN O
the DT O
activation NN O
domain NN O
of IN O
Rap1p NNP O
was VBD O
involved VBN O
in IN O
barrier NN O
activity NN O
. . O

The DT O
inability NN O
of IN O
the DT O
Rap1p NNP O
- HYPH O
silencing VBG O
domain NN O
to TO O
block VB O
URA3 NNP O
silencing NN O
in IN O
our PRP$ O
assay NN O
did VBD O
not RB O
necessarily RB O
mean VB O
that IN O
this DT O
domain NN O
had VBD O
no DT O
barrier NN O
function NN O
, , O
since IN O
such PDT O
a DT O
function NN O
might MD O
be VB O
suppressed VBN O
by IN O
much RB O
stronger JJR O
silencing NN O
activity NN O
associated VBN O
with IN O
the DT O
silencing NN O
domain NN O
. . O

Was VBD O
the DT O
lack NN O
of IN O
barrier NN O
function NN O
of IN O
fusion NN O
constructs VBZ O
L2 NNP O
- HYPH O
L5 NNP O
due IN O
to IN O
a DT O
lack NN O
of IN O
expression NN O
of IN O
these DT O
proteins NNS O
? . O

To TO O
address VB O
this DT O
possibility NN O
, , O
we PRP O
examined VBD O
the DT O
levels NNS O
of IN O
L1 NNP O
- HYPH O
L6 NNP O
proteins NNS O
as RB O
well RB O
as IN O
L7 NNP O
and CC O
L8 CD O
proteins NNS O
described VBN O
in IN O
Figure NNP O
5B NNP O
by IN O
western JJ O
blotting NN O
using VBG O
an DT O
antibody NN O
against IN O
LexA NNP O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
5C NNP O
, , O
L5 NNP O
was VBD O
expressed VBN O
at IN O
a DT O
level NN O
comparable JJ O
to IN O
L6 NNP O
, , O
and CC O
L4 NNP O
was VBD O
expressed VBN O
at IN O
a DT O
higher JJR O
level NN O
than IN O
L6 NNP O
. . O

Therefore RB O
, , O
the DT O
lack NN O
of IN O
barrier NN O
function NN O
of IN O
L4 NNP O
and CC O
L6 NNP O
was VBD O
not RB O
the DT O
result NN O
of IN O
their PRP$ O
lack NN O
of IN O
expression NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
level NN O
of IN O
L2 NNP O
or CC O
L3 NNP O
was VBD O
significantly RB O
lower JJR O
than IN O
that DT O
of IN O
L6 NNP O
, , O
hence RB O
the DT O
lack NN O
of IN O
barrier NN O
function NN O
of IN O
L2 NNP O
and CC O
L3 NNP O
might MD O
be VB O
due IN O
to IN O
their PRP$ O
insufficient JJ O
expression NN O
. . O

As IN O
an DT O
important JJ O
control NN O
for IN O
the DT O
above JJ O
targeting NN O
experiments NNS O
, , O
we PRP O
showed VBD O
that IN O
plasmids NNS O
L1 NNP O
- HYPH O
L6 NNP O
( -LRB- O
Fig NNP O
. . O
5A NN O
) -RRB- O
as RB O
well RB O
as IN O
L7 NNP O
and CC O
L8 NNP O
( -LRB- O
Fig NNP O
. . O
5B NN O
) -RRB- O
bearing VBG O
LexA NNP O
- HYPH O
fusion NN O
genes NNS O
had VBD O
no DT O
effect NN O
on IN O
URA3 NNP O
silencing NN O
in IN O
strain NN O
1 CD O
( SYM O
Fig NNP O
. . O
1 CD O
) -RRB- O
in IN O
which WDT O
there EX O
was VBD O
no DT O
binding VBG O
site NN O
for IN O
LexA NNP O
present JJ O
between IN O
HML NNP O
- HYPH O
I NNP O
and CC O
URA3 NNP O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Hence RB O
, , O
the DT O
effect NN O
of IN O
the DT O
fusion NN O
proteins NNS O
on IN O
URA3 NNP O
silencing NN O
was VBD O
the DT O
result NN O
of IN O
their PRP$ O
targeting NN O
to IN O
specific JJ O
loci NN O
, , O
not RB O
the DT O
consequence NN O
of IN O
non AFX O
- HYPH O
specific JJ O
, , O
indirect JJ O
functions NNS O
( , O
if IN O
any DT O
) -RRB- O
of IN O
these DT O
proteins NNS O
. . O

Targeted VBN O
activation NN O
domain NN O
of IN O
Adr1p NNP O
or CC O
Gcn4p NNP O
can MD O
also RB O
act VB O
as IN O
a DT O
barrier NN O
factor NN O

We PRP O
have VBP O
shown VBN O
above IN O
that DT O
ADH2 NNP O
- HYPH O
UAS NNP O
bearing VBG O
Adr1p NNP O
- HYPH O
binding VBG O
sites NNS O
and CC O
HIS3 NNP O
- HYPH O
UAS NNP O
bearing VBG O
Gcn4p NNP O
sites NNS O
both DT O
had VBD O
detectable JJ O
barrier NN O
activity NN O
( , O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
25 CD O
and CC O
26 CD O
) -RRB- O
. . O

Given VBN O
that IN O
tethering VBG O
the DT O
activation NN O
domain NN O
of IN O
Rap1p NNP O
is VBZ O
sufficient JJ O
for IN O
barrier NN O
function NN O
, , O
we PRP O
tested VBD O
if IN O
targeting VBG O
the DT O
activation NN O
domain NN O
of IN O
Adr1p NNP O
or CC O
Gcn4p NNP O
could MD O
also RB O
establish VB O
a DT O
barrier NN O
. . O

Adr1p NNP O
contains VBZ O
four CD O
separate JJ O
activation NN O
domains NNS O
( , O
TADI NNP O
- HYPH O
TADIV NNP O
) -RRB- O
that WDT O
can MD O
contact VB O
Ada2p NNP O
, , O
Gcn5p NNP O
and CC O
/ SYM O
or CC O
TFIIB NNP O
( SYM O
45 CD O
) -RRB- O
. . O

TAD NNP O
III NNP O
( : O
415 CD O
- HYPH O
467 CD O
) -RRB- O
interacts VBZ O
with IN O
only RB O
Gcn5p NNP O
but CC O
not RB O
Ada2p NNP O
or CC O
TFIIB NNP O
. . O

We PRP O
fused VBD O
this DT O
domain NN O
of IN O
Adr1p NNP O
and CC O
the DT O
activation NN O
domain NN O
of IN O
Gcn4p NNP O
( : O
102 CD O
- HYPH O
149 CD O
) -RRB- O
to IN O
LexA NNP O
, , O
respectively RB O
( , O
Fig NNP O
. . O
5B NN O
, , O
L7 NNP O
and CC O
L8 NNP O
) -RRB- O
. . O

Targeting VBG O
these DT O
fusion NN O
proteins NNS O
to IN O
two CD O
LexA NNP O
- HYPH O
binding VBG O
sites NNS O
between IN O
HML NNP O
- HYPH O
I NNP O
and CC O
URA3 NNP O
in IN O
strain NN O
50 CD O
dramatically RB O
reduced VBD O
URA3 NNP O
silencing NN O
( : O
Fig NNP O
. . O
5B NN O
, , O
compare VBP O
L7 NN O
and CC O
L8 CD O
to IN O
L1 NN O
) -RRB- O
. . O

Therefore RB O
, , O
like IN O
LexA NNP O
- HYPH O
Rap1p NNP O
( : O
627 CD O
- HYPH O
695 CD O
) -RRB- O
, , O
both CC O
LexA NNP O
- HYPH O
Adr1p NNP O
( : O
415 CD O
- HYPH O
467 CD O
) -RRB- O
and CC O
LexA NNP O
- HYPH O
Gcn4p NNP O
( : O
102 CD O
- HYPH O
149 CD O
) -RRB- O
also RB O
had VBD O
barrier NN O
activity NN O
. . O

Barrier NN O
function NN O
of IN O
these DT O
fusion NN O
proteins NNS O
was VBD O
significantly RB O
decreased VBN O
in IN O
strain NN O
51 CD O
in IN O
which WDT O
only RB O
one CD O
LexA NNP O
site NN O
was VBD O
inserted VBN O
between IN O
HML NNP O
- HYPH O
I NNP O
and CC O
URA3 NNP O
( , O
compare VBP O
strains NNS O
50 CD O
and CC O
51 CD O
carrying VBG O
plasmid NN O
L7 NNP O
) -RRB- O
, , O
indicating VBG O
that IN O
the DT O
potency NN O
of IN O
such JJ O
barriers NNS O
was VBD O
dependent JJ O
on IN O
the DT O
amount NN O
of IN O
tethered VBN O
fusion NN O
proteins NNS O
. . O

DISCUSSION NN O

We PRP O
have VBP O
shown VBN O
in IN O
this DT O
report NN O
that IN O
UASs NNP O
of IN O
many JJ O
highly RB O
expressed VBN O
genes NNS O
could MD O
function VB O
as IN O
barriers NNS O
to IN O
the DT O
spread NN O
of IN O
transcriptional JJ O
silencing NN O
. . O

These DT O
newly RB O
identified VBN O
barrier NN O
elements NNS O
together RB O
with IN O
previously RB O
described VBN O
barrier NN O
elements NNS O
( , O
STARs NNPS O
, , O
HMR NNP O
- HYPH O
tRNA NNP O
gene NN O
, , O
TEF2 NNP O
- HYPH O
UAS NNP O
and CC O
CHA1 NNP O
- HYPH O
UAS NNP O
) -RRB- O
( , O
9 CD O
- SYM O
11 CD O
, , O
21 CD O
) -RRB- O
are VBP O
scattered VBN O
across IN O
the DT O
yeast NN B-Species
genome NN O
and CC O
may MD O
play VB O
a DT O
role NN O
in IN O
dividing VBG O
the DT O
genome NN O
into IN O
functional JJ O
domains NNS O
. . O

Analyses NNS O
of IN O
the DT O
barrier NN O
UASs NNS O
suggest VBP O
that IN O
binding VBG O
sites NNS O
for IN O
transcriptional JJ O
regulators NNS O
Rap1p NNP O
, , O
Abf1p NNP O
, , O
Reb1p NNP O
, , O
Adr1p NNP O
and CC O
Gcn4p NNP O
can MD O
participate VB O
in IN O
barrier NN O
function NN O
. . O

Barrier NN O
activity NN O
often RB O
requires VBZ O
concerted JJ O
actions NNS O
of IN O
more JJR O
than IN O
one CD O
factor NN O
- HYPH O
binding VBG O
site NN O
. . O

Our PRP$ O
mutational JJ O
analysis NN O
of IN O
TEF2 NNP O
- HYPH O
UAS NNP O
suggests VBZ O
a DT O
direct JJ O
involvement NN O
of IN O
Rap1p NNP O
in IN O
its PRP$ O
barrier NN O
function NN O
. . O

It PRP O
is VBZ O
noteworthy JJ O
that IN O
not RB O
all DT O
UASs NNPS O
of IN O
highly RB O
expressed VBN O
genes NNS O
have VBP O
barrier NN O
activity NN O
. . O

Many JJ O
non JJ O
- HYPH O
barrier NN O
UASs NNPS O
also RB O
consist VBP O
of IN O
multiple JJ O
regulator NN O
binding VBG O
sites NNS O
, , O
therefore RB O
other JJ O
unknown JJ O
factors NNS O
might MD O
determine VB O
whether IN O
a DT O
UAS NNP O
could MD O
act VB O
as IN O
a DT O
barrier NN O
. . O

How WRB O
Rap1p NNP O
and CC O
the DT O
other JJ O
transcriptional JJ O
regulators NNS O
act VBP O
to TO O
block VB O
silencing NN O
is VBZ O
not RB O
clear JJ O
. . O

Since IN O
they PRP O
can MD O
all RB O
act VB O
as IN O
transcriptional JJ O
activators NNS O
, , O
one CD O
natural JJ O
explanation NN O
is VBZ O
that IN O
they PRP O
may MD O
overcome VB O
the DT O
silencing NN O
effect NN O
of IN O
a DT O
silencer NN O
and CC O
directly RB O
activate VB O
the DT O
reporter NN O
gene NN O
. . O

However RB O
, , O
it PRP O
has VBZ O
been VBN O
well RB O
documented VBN O
that IN O
Rap1p NNP O
and CC O
the DT O
other JJ O
transcriptional JJ O
regulators NNS O
usually RB O
act VBP O
at IN O
relatively RB O
short JJ O
distances NNS O
( : O
less JJR O
than IN O
~ $ O
600 CD O
bp NN O
upstream RB O
of IN O
the DT O
translation NN O
start NN O
codon NN O
) -RRB- O
( : O
28 CD O
, , O
29 CD O
, , O
46 CD O
) -RRB- O
, , O
but CC O
the DT O
binding VBG O
sites NNS O
for IN O
these DT O
regulators NNS O
were VBD O
> SYM O
800 CD O
bp NN O
from IN O
the DT O
translation NN O
start VBP O
codon NN O
in IN O
most JJS O
of IN O
the DT O
silencing NN O
- HYPH O
blocking VBG O
tests NNS O
in IN O
this DT O
report NN O
( : O
Figs NNP O
1 CD O
and CC O
2 CD O
) -RRB- O
. . O

In IN O
the DT O
test NN O
shown VBN O
in IN O
Figure NNP O
6 CD O
, , O
TEF2 NNP O
- HYPH O
UAS NNP O
blocked VBD O
ADE2 NNP O
silencing NN O
when WRB O
it PRP O
was VBD O
~ $ O
2 CD O
kb NN O
downstream RB O
from IN O
the DT O
translation NN O
start NN O
codon NN O
of IN O
the DT O
gene NN O
. . O

Moreover RB O
, , O
Fourel NNP O
et FW O
al NNP O
. . O

( : O
44 CD O
) , O
demonstrated VBD O
that IN O
the DT O
barrier NN O
function NN O
( , O
or CC O
anti JJ O
- HYPH O
silencing VBG O
function NN O
) -RRB- O
of IN O
an DT O
activator NN O
was VBD O
independent JJ O
of IN O
its PRP$ O
role NN O
in IN O
activating VBG O
transcription NN O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
unlikely JJ O
that IN O
the DT O
ability NN O
of IN O
a DT O
UAS NNP O
to TO O
prevent VB O
gene NN O
silencing NN O
is VBZ O
due JJ O
to IN O
its PRP$ O
direct JJ O
activation NN O
of IN O
the DT O
gene NN O
. . O

In IN O
light NN O
of IN O
this DT O
, , O
our PRP$ O
results NNS O
are VBP O
in IN O
agreement NN O
with IN O
the DT O
notion NN O
that IN O
transcriptional JJ O
regulators NNS O
can MD O
also RB O
participate VB O
in IN O
defining VBG O
the DT O
boundaries NNS O
of IN O
functional JJ O
chromosomal JJ O
domains NNS O
. . O

A DT O
few JJ O
models NNS O
have VBP O
been VBN O
proposed VBN O
for IN O
the DT O
barrier NN O
functions NNS O
of IN O
transcriptional JJ O
regulators NNS O
. . O

One CD O
model NN O
proposed VBD O
that IN O
binding NN O
of IN O
a DT O
regulator NN O
to IN O
a DT O
barrier NN O
led VBD O
to IN O
the DT O
formation NN O
of IN O
a DT O
nucleosome NN O
- HYPH O
free JJ O
region NN O
thereby RB O
disrupting VBG O
a DT O
continuous JJ O
nucleosome NN O
array NN O
( SYM O
11 CD O
) -RRB- O
. . O

Since IN O
the DT O
SIR NNP O
complexes NNS O
spread VBP O
by IN O
self NN O
- HYPH O
interaction NN O
and CC O
interacting VBG O
with IN O
adjacent JJ O
nucleosmes NNS O
in IN O
a DT O
stepwise JJ O
fashion NN O
( , O
4 CD O
) -RRB- O
, , O
a DT O
nucleosome NN O
- HYPH O
free JJ O
gap NN O
could MD O
present VB O
a DT O
barrier NN O
to IN O
the DT O
spreading VBG O
SIR NNP O
complex NN O
. . O

This DT O
' `` O
nucleosome JJ O
gap NN O
' '' O
hypothesis NN O
is VBZ O
consistent JJ O
with IN O
that DT O
certain JJ O
barrier NN O
factors NNS O
such JJ O
as IN O
Rap1p NNP O
and CC O
Reb1p NNP O
could MD O
indeed RB O
prevent VB O
nucleosome JJ O
formation NN O
around IN O
their PRP$ O
binding VBG O
sites NNS O
( : O
14 CD O
) -RRB- O
and CC O
the DT O
barrier NN O
function NN O
of IN O
TEF2 NNP O
- HYPH O
UAS NNP O
correlated VBN O
with IN O
its PRP$ O
ability NN O
to TO O
alter VB O
local JJ O
chromatin NN O
structure NN O
( : O
this DT O
report NN O
) -RRB- O
. . O

In IN O
fact NN O
, , O
many JJ O
insulator NN O
/ SYM O
boundary JJ O
elements NNS O
in IN O
higher JJR O
organisms NNS O
have VBP O
also RB O
been VBN O
shown VBN O
to TO O
alter VB O
local JJ O
chromatin NN O
structure NN O
. . O

For IN O
instance NN O
, , O
the DT O
chicken NN B-Species
beta NN O
- HYPH O
globin NN O
insulator NN O
was VBD O
linked VBN O
to IN O
changes NNS O
in IN O
nucleosome NN O
positioning NN O
, , O
and CC O
the DT O
Drosophila NN B-Species
scs NNS O
and CC O
scs NNS O
' POS O
boundary NN O
elements NNS O
are VBP O
associated VBN O
with IN O
unusual JJ O
chromatin NN O
structures NNS O
that WDT O
are VBP O
hypersensitive JJ O
to IN O
nucleases NNS O
( : O
40 CD O
, , O
41 CD O
) -RRB- O
. . O

However RB O
, , O
it PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
any DT O
chromatin NN O
change NN O
associated VBN O
with IN O
barrier NN O
function NN O
in IN O
yeast NN B-Species
or CC O
insulator NN O
function NN O
in IN O
higher JJR O
cells NNS O
is VBZ O
the DT O
cause NN O
or CC O
effect NN O
of IN O
the DT O
function NN O
. . O

Another DT O
model NN O
for IN O
barrier NN O
action NN O
proposed VBN O
by IN O
R NNP O
. . O

Kamakaka NNP O
and CC O
colleagues NNS O
( , O
21 CD O
) -RRB- O
proposed VBD O
that IN O
barrier NN O
factors NNS O
recruit VBP O
chromatin NN O
modifying NN O
and CC O
/ SYM O
or CC O
remodeling NN O
complexes NNS O
to TO O
counteract VB O
the DT O
more RBR O
compact JJ O
, , O
hypoacetylated JJ O
silent JJ O
chromatin NN O
. . O

In IN O
agreement NN O
with IN O
this DT O
hypothesis NN O
, , O
targeted VBN O
HATs NNP O
SAS2 NNP O
, , O
GCN5 NNP O
and CC O
ESA1 NNP O
all DT O
had VBD O
barrier NN O
activity NN O
( : O
21 CD O
; : O
Y NN O
. . O
- HYPH O
H NN O
. . O
Chiu NNP O
, , O
Q NNP O
. . O
Yu NNP O
and CC O
X NNP O
. . O
Bi NNP O
, , O
unpublished JJ O
results NNS O
) -RRB- O
. . O

Interestingly RB O
, , O
Rap1p NNP O
, , O
Adr1p NNP O
, , O
Gcn4p NNP O
and CC O
Abf1p NNP O
share VBP O
the DT O
ability NN O
to TO O
recruit VB O
HAT NNP O
complexes NNS O
NuA4 NNP O
and CC O
/ SYM O
or CC O
SAGA NNP O
to TO O
target VB O
genes NNS O
( : O
16 CD O
, , O
45 CD O
, , O
47 CD O
- HYPH O
49 CD O
) -RRB- O
. . O

Therefore RB O
, , O
these DT O
factors NNS O
that WDT O
are VBP O
capable JJ O
of IN O
binding NN O
to IN O
the DT O
newly RB O
identified VBN O
barriers NNS O
may MD O
function VB O
as IN O
barrier NN O
factors NNS O
by IN O
recruiting VBG O
HAT NNP O
complexes NNS O
. . O

In IN O
fact NN O
, , O
recruitment NN O
of IN O
HAT NNP O
activity NN O
has VBZ O
also RB O
been VBN O
suggested VBN O
to TO O
be VB O
the DT O
mechanism NN O
underlying VBG O
the DT O
function NN O
of IN O
the DT O
chicken NN B-Species
beta NN O
- HYPH O
globin NN O
insulator NN O
( , O
6 CD O
) -RRB- O
, , O
although IN O
it PRP O
was VBD O
not RB O
known VBN O
what WP O
HAT NNP O
might MD O
be VB O
involved VBN O
. . O

Our PRP$ O
demonstration NN O
that IN O
tethering VBG O
the DT O
activation NN O
domain NN O
of IN O
Rap1p NNP O
, , O
Adr1p NNP O
or CC O
Gcn4p NNP O
alone RB O
recapitulates VBZ O
barrier NN O
activity NN O
is VBZ O
consistent JJ O
with IN O
the DT O
above JJ O
HAT NNP O
model NN O
for IN O
barrier NN O
function NN O
, , O
since IN O
at IN O
least JJS O
the DT O
activation NN O
domain NN O
of IN O
Adr1p NNP O
has VBZ O
been VBN O
shown VBN O
to TO O
directly RB O
interact VB O
with IN O
HAT NNP O
complexes NNS O
( SYM O
45 CD O
) -RRB- O
. . O

However RB O
, , O
we PRP O
haven VBP O
' `` O
t VB O
ruled VBN O
out RP O
the DT O
possibility NN O
that IN O
the DT O
barrier NN O
function NN O
of IN O
the DT O
targeted VBN O
activation NN O
domain NN O
of IN O
Rap1p NNP O
, , O
Adr1p NNP O
or CC O
Gcn4p NNP O
is VBZ O
not RB O
related VBN O
to IN O
the DT O
barrier NN O
function NN O
of IN O
the DT O
native JJ O
protein NN O
. . O

Note VB O
that IN O
the DT O
' `` O
nucleosome JJ O
gap NN O
' '' O
model NN O
and CC O
the DT O
HAT NNP O
model NN O
are VBP O
not RB O
mutually RB O
exclusive JJ O
since IN O
the DT O
nucleosome JJ O
gap NN O
could MD O
result VB O
from IN O
destabilization NN O
of IN O
nucelosomes NNS O
caused VBN O
by IN O
HAT NNP O
function NN O
. . O

A DT O
recent JJ O
intriguing JJ O
study NN O
showed VBD O
that IN O
targeting VBG O
proteins NNS O
of IN O
the DT O
nuclear JJ O
pore NN O
complex NN O
( -LRB- O
NPC NNP O
) -RRB- O
could MD O
also RB O
establish VB O
a DT O
boundary NN O
for IN O
silent JJ O
chromatin NN O
, , O
and CC O
that IN O
tethering VBG O
to IN O
NPC NNP O
was VBD O
required VBN O
for IN O
boundary NN O
activity NN O
( : O
50 CD O
) -RRB- O
. . O

This DT O
led VBD O
to IN O
a DT O
revisit NN O
to IN O
the DT O
looping VBG O
model NN O
for IN O
the DT O
function NN O
of IN O
boundary NN O
/ SYM O
insulator NN O
elements NNS O
( SYM O
51 CD O
) -RRB- O
. . O

However RB O
, , O
an DT O
alternative JJ O
explanation NN O
was VBD O
that IN O
the DT O
NPC NNP O
compartment NN O
could MD O
simply RB O
be VB O
rich JJ O
in IN O
transcriptional JJ O
activating VBG O
factors NNS O
or CC O
poor JJ O
in IN O
silencing VBG O
factors NNS O
like IN O
the DT O
SIR NNP O
proteins NNS O
( SYM O
50 CD O
) -RRB- O
. . O

In IN O
summary NN O
, , O
results NNS O
from IN O
this DT O
and CC O
other JJ O
studies NNS O
indicate VBP O
that IN O
factors NNS O
previously RB O
identified VBN O
as IN O
positive JJ O
and CC O
/ SYM O
or CC O
negative JJ O
regulators NNS O
of IN O
gene NN O
activation NN O
could MD O
also RB O
function VB O
in IN O
demarcating VBG O
distinct JJ O
domains NNS O
of IN O
gene NN O
activity NN O
. . O

How WRB O
these DT O
factors NNS O
carry VBP O
out RP O
their PRP$ O
boundary JJ O
function NN O
is VBZ O
not RB O
resolved VBN O
but CC O
recruitment NN O
of IN O
other JJ O
factors NNS O
( : O
e LS O
. . O
g LS O
. . O
chromatin NN O
modifying VBG O
complexes NNS O
) -RRB- O
is VBZ O
likely JJ O
to TO O
be VB O
involved VBN O
. . O

NOTE NN O
ADDED VBN O
IN IN O
PROOF NN O

After IN O
this DT O
work NN O
was VBD O
completed VBN O
and CC O
submitted VBN O
for IN O
publication NN O
the DT O
first JJ O
time NN O
, , O
Fourel NNP O
et FW O
al NNP O
. . O

( HYPH O
52 CD O
) , O
reported VBD O
that IN O
targeted VBN O
activation NN O
domains NNS O
of IN O
Rap1p NNP O
and CC O
Abf1p NNP O
had VBD O
insulating VBG O
capacity NN O
. . O

Comparison NN O
of IN O
age NN O
- HYPH O
specific JJ O
cataract NN O
prevalence NN O
in IN O
two CD O
population NN O
- HYPH O
based VBN O
surveys NNS O
6 CD O
years NNS O
apart RB O

Abstract JJ O

Background NN O

In IN O
this DT O
study NN O
, , O
we PRP O
aimed VBD O
to TO O
compare VB O
age NN O
- HYPH O
specific JJ O
cortical JJ O
, , O
nuclear JJ O
and CC O
posterior JJ O
subcapsular NN O
( , O
PSC NNP O
) -RRB- O
cataract NN O
prevalence NN O
in IN O
two CD O
surveys NNS O
6 CD O
years NNS O
apart RB O
. . O

Methods NNS O

The DT O
Blue NNP O
Mountains NNPS O
Eye NNP O
Study NNP O
examined VBD O
3654 CD O
participants NNS B-Species
( , O
82 CD O
. . O
4 CD O
% NN O
of IN O
those DT O
eligible JJ O
) -RRB- O
in IN O
cross JJ O
- HYPH O
section NN O
I CD O
( , O
1992 CD O
- SYM O
4 CD O
) -RRB- O
and CC O
3509 CD O
participants NNS B-Species
( SYM O
75 CD O
. . O
1 CD O
% NN O
of IN O
survivors NNS O
and CC O
85 CD O
. . O
2 CD O
% NN O
of IN O
newly RB O
eligible JJ O
) -RRB- O
in IN O
cross JJ O
- HYPH O
section NN O
II CD O
( , O
1997 CD O
- SYM O
2000 CD O
, , O
66 CD O
. . O
5 CD O
% NN O
overlap NN O
with IN O
cross JJ O
- HYPH O
section NN O
I NN O
) -RRB- O
. . O

Cataract NN O
was VBD O
assessed VBN O
from IN O
lens NN O
photographs NNS O
following VBG O
the DT O
Wisconsin NNP O
Cataract NNP O
Grading NNP O
System NNP O
. . O

Cortical JJ O
cataract NN O
was VBD O
defined VBN O
if IN O
cortical JJ O
opacity NN O
comprised VBN O
> : O
= SYM O
5 CD O
% NN O
of IN O
lens NN O
area NN O
. . O

Nuclear JJ O
cataract NN O
was VBD O
defined VBN O
if IN O
nuclear JJ O
opacity NN O
> NFP O
= SYM O
Wisconsin NNP O
standard NN O
4 CD O
. . O

PSC NNP O
was VBD O
defined VBN O
if IN O
any DT O
present JJ O
. . O

Any DT O
cataract NN O
was VBD O
defined VBN O
to TO O
include VB O
persons NNS B-Species
who WP O
had VBD O
previous JJ O
cataract NN O
surgery NN O
. . O

Weighted JJ O
kappa NN O
for IN O
inter JJ O
- HYPH O
grader NN O
reliability NN O
was VBD O
0 CD O
. . O
82 CD O
, , O
0 CD O
. . O
55 CD O
and CC O
0 CD O
. . O
82 CD O
for IN O
cortical JJ O
, , O
nuclear JJ O
and CC O
PSC NNP O
cataract NN O
, , O
respectively RB O
. . O

We PRP O
assessed VBD O
age NN O
- HYPH O
specific JJ O
prevalence NN O
using VBG O
an DT O
interval NN O
of IN O
5 CD O
years NNS O
, , O
so IN O
that IN O
participants NNS B-Species
within IN O
each DT O
age NN O
group NN O
were VBD O
independent JJ O
between IN O
the DT O
two CD O
surveys NNS O
. . O

Results NNS O

Age NN O
and CC O
gender NN O
distributions NNS O
were VBD O
similar JJ O
between IN O
the DT O
two CD O
populations NNS O
. . O

The DT O
age NN O
- HYPH O
specific JJ O
prevalence NN O
of IN O
cortical JJ O
( : O
23 CD O
. . O
8 CD O
% NN O
in IN O
1st NN O
, , O
23 CD O
. . O
7 CD O
% NN O
in IN O
2nd CD O
) -RRB- O
and CC O
PSC NNP O
cataract NN O
( : O
6 CD O
. . O
3 CD O
% NN O
, , O
6 CD O
. . O
0 CD O
% NN O
) -RRB- O
was VBD O
similar JJ O
. . O

The DT O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
increased VBD O
slightly RB O
from IN O
18 CD O
. . O
7 CD O
% NN O
to IN O
23 CD O
. . O
9 CD O
% NN O
. . O

After IN O
age NN O
standardization NN O
, , O
the DT O
similar JJ O
prevalence NN O
of IN O
cortical JJ O
( : O
23 CD O
. . O
8 CD O
% NN O
, , O
23 CD O
. . O
5 CD O
% NN O
) -RRB- O
and CC O
PSC NNP O
cataract NN O
( , O
6 CD O
. . O
3 CD O
% NN O
, , O
5 CD O
. . O
9 CD O
% NN O
) -RRB- O
, , O
and CC O
the DT O
increased VBN O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
( : O
18 CD O
. . O
7 CD O
% NN O
, , O
24 CD O
. . O
2 CD O
% NN O
) -RRB- O
remained VBD O
. . O

Conclusion NN O

In IN O
two CD O
surveys NNS O
of IN O
two CD O
population NN O
- HYPH O
based VBN O
samples NNS O
with IN O
similar JJ O
age NN O
and CC O
gender NN O
distributions NNS O
, , O
we PRP O
found VBD O
a DT O
relatively RB O
stable JJ O
cortical JJ O
and CC O
PSC NNP O
cataract NN O
prevalence NN O
over IN O
a DT O
6 CD O
- HYPH O
year NN O
period NN O
. . O

The DT O
increased VBN O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
deserves VBZ O
further JJ O
study NN O
. . O

Background NN O

Age NN O
- HYPH O
related VBN O
cataract NN O
is VBZ O
the DT O
leading VBG O
cause NN O
of IN O
reversible JJ O
visual JJ O
impairment NN O
in IN O
older JJR O
persons NNS B-Species
[ -LRB- O
1 CD O
- SYM O
6 CD O
] -RRB- O
. . O

In IN O
Australia NNP O
, , O
it PRP O
is VBZ O
estimated VBN O
that IN O
by IN O
the DT O
year NN O
2021 CD O
, , O
the DT O
number NN O
of IN O
people NNS B-Species
affected VBN O
by IN O
cataract NN O
will MD O
increase VB O
by IN O
63 CD O
% NN O
, , O
due IN O
to IN O
population NN O
aging NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Surgical JJ O
intervention NN O
is VBZ O
an DT O
effective JJ O
treatment NN O
for IN O
cataract NN O
and CC O
normal JJ O
vision NN O
( : O
> SYM O
20 CD O
/ SYM O
40 CD O
) -RRB- O
can MD O
usually RB O
be VB O
restored VBN O
with IN O
intraocular JJ O
lens NN O
( -LRB- O
IOL NN O
) -RRB- O
implantation NN O
. . O

Cataract JJ O
surgery NN O
with IN O
IOL NN O
implantation NN O
is VBZ O
currently RB O
the DT O
most RBS O
commonly RB O
performed VBN O
, , O
and CC O
is VBZ O
, , O
arguably RB O
, , O
the DT O
most RBS O
cost RBS O
effective JJ O
surgical JJ O
procedure NN O
worldwide RB O
. . O

Performance NN O
of IN O
this DT O
surgical JJ O
procedure NN O
has VBZ O
been VBN O
continuously RB O
increasing VBG O
in IN O
the DT O
last JJ O
two CD O
decades NNS O
. . O

Data NNS O
from IN O
the DT O
Australian NNP O
Health NNP O
Insurance NNP O
Commission NNP O
has VBZ O
shown VBN O
a DT O
steady JJ O
increase NN O
in IN O
Medicare NNP O
claims NNS O
for IN O
cataract NN O
surgery NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

A DT O
2 CD O
. . O
6 CD O
- HYPH O
fold NN O
increase NN O
in IN O
the DT O
total JJ O
number NN O
of IN O
cataract NN O
procedures NNS O
from IN O
1985 CD O
to IN O
1994 CD O
has VBZ O
been VBN O
documented VBN O
in IN O
Australia NNP O
[ -LRB- O
9 CD O
] -RRB- O
. . O

The DT O
rate NN O
of IN O
cataract NN O
surgery NN O
per IN O
thousand CD O
persons NNS B-Species
aged VBN O
65 CD O
years NNS O
or CC O
older JJR O
has VBZ O
doubled VBN O
in IN O
the DT O
last JJ O
20 CD O
years NNS O
[ -LRB- O
8 CD O
, , O
9 CD O
] -RRB- O
. . O

In IN O
the DT O
Blue NNP O
Mountains NNPS O
Eye NNP O
Study NNP O
population NN O
, , O
we PRP O
observed VBD O
a DT O
one CD O
- HYPH O
third NN O
increase NN O
in IN O
cataract NN O
surgery NN O
prevalence NN O
over IN O
a DT O
mean JJ O
6 CD O
- HYPH O
year NN O
interval NN O
, , O
from IN O
6 CD O
% NN O
to IN O
nearly RB O
8 CD O
% NN O
in IN O
two CD O
cross JJ O
- HYPH O
sectional JJ O
population NN O
- HYPH O
based VBN O
samples NNS O
with IN O
a DT O
similar JJ O
age NN O
range NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Further JJ O
increases NNS O
in IN O
cataract NN O
surgery NN O
performance NN O
would MD O
be VB O
expected VBN O
as IN O
a DT O
result NN O
of IN O
improved VBN O
surgical JJ O
skills NNS O
and CC O
technique NN O
, , O
together RB O
with IN O
extending VBG O
cataract NN O
surgical JJ O
benefits NNS O
to IN O
a DT O
greater JJR O
number NN O
of IN O
older JJR O
people NNS B-Species
and CC O
an DT O
increased VBN O
number NN O
of IN O
persons NNS B-Species
with IN O
surgery NN O
performed VBN O
on IN O
both DT O
eyes NNS O
. . O

Both CC O
the DT O
prevalence NN O
and CC O
incidence NN O
of IN O
age NN O
- HYPH O
related VBN O
cataract NN O
link NN O
directly RB O
to IN O
the DT O
demand NN O
for IN O
, , O
and CC O
the DT O
outcome NN O
of IN O
, , O
cataract NN O
surgery NN O
and CC O
eye NN O
health NN O
care NN O
provision NN O
. . O

This DT O
report NN O
aimed VBD O
to TO O
assess VB O
temporal JJ O
changes NNS O
in IN O
the DT O
prevalence NN O
of IN O
cortical JJ O
and CC O
nuclear JJ O
cataract NN O
and CC O
posterior JJ O
subcapsular NN O
cataract NN O
( -LRB- O
PSC NNP O
) -RRB- O
in IN O
two CD O
cross JJ O
- HYPH O
sectional JJ O
population NN O
- HYPH O
based VBN O
surveys NNS O
6 CD O
years NNS O
apart RB O
. . O

Methods NNS O

The DT O
Blue NNP O
Mountains NNPS O
Eye NNP O
Study NNP O
( , O
BMES NNP O
) -RRB- O
is VBZ O
a DT O
population NN O
- HYPH O
based VBN O
cohort NN O
study NN O
of IN O
common JJ O
eye NN O
diseases NNS O
and CC O
other JJ O
health NN O
outcomes NNS O
. . O

The DT O
study NN O
involved VBD O
eligible JJ O
permanent JJ O
residents NNS O
aged JJ O
49 CD O
years NNS O
and CC O
older JJR O
, , O
living VBG O
in IN O
two CD O
postcode NN O
areas NNS O
in IN O
the DT O
Blue NNP O
Mountains NNPS O
, , O
west NN O
of IN O
Sydney NNP O
, , O
Australia NNP O
. . O

Participants NNS B-Species
were VBD O
identified VBN O
through IN O
a DT O
census NN O
and CC O
were VBD O
invited VBN O
to TO O
participate VB O
. . O

The DT O
study NN O
was VBD O
approved VBN O
at IN O
each DT O
stage NN O
of IN O
the DT O
data NNS O
collection NN O
by IN O
the DT O
Human NNP B-Species
Ethics NNP O
Committees NNPS O
of IN O
the DT O
University NNP O
of IN O
Sydney NNP O
and CC O
the DT O
Western NNP O
Sydney NNP O
Area NNP O
Health NNP O
Service NNP O
and CC O
adhered VBN O
to IN O
the DT O
recommendations NNS O
of IN O
the DT O
Declaration NNP O
of IN O
Helsinki NNP O
. . O

Written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
each DT O
participant NN B-Species
. . O

Details NNS O
of IN O
the DT O
methods NNS O
used VBN O
in IN O
this DT O
study NN O
have VBP O
been VBN O
described VBN O
previously RB O
[ -LRB- O
11 CD O
] -RRB- O
. . O

The DT O
baseline NN O
examinations NNS O
( , O
BMES NNP O
cross JJ O
- HYPH O
section NN O
I NNP O
) -RRB- O
were VBD O
conducted VBN O
during IN O
1992 CD O
- SYM O
1994 CD O
and CC O
included VBD O
3654 CD O
( SYM O
82 CD O
. . O
4 CD O
% NN O
) -RRB- O
of IN O
4433 CD O
eligible JJ O
residents NNS O
. . O

Follow VB O
- HYPH O
up NN O
examinations NNS O
( , O
BMES NNP O
IIA NNP O
) -RRB- O
were VBD O
conducted VBN O
during IN O
1997 CD O
- SYM O
1999 CD O
, , O
with IN O
2335 CD O
( SYM O
75 CD O
. . O
0 CD O
% NN O
of IN O
BMES NNP O
cross NN O
section NN O
I PRP O
survivors NNS O
) -RRB- O
participating VBG O
. . O

A DT O
repeat NN O
census NN O
of IN O
the DT O
same JJ O
area NN O
was VBD O
performed VBN O
in IN O
1999 CD O
and CC O
identified VBD O
1378 CD O
newly RB O
eligible JJ O
residents NNS O
who WP O
moved VBD O
into IN O
the DT O
area NN O
or CC O
the DT O
eligible JJ O
age NN O
group NN O
. . O

During IN O
1999 CD O
- SYM O
2000 CD O
, , O
1174 CD O
( : O
85 CD O
. . O
2 CD O
% NN O
) -RRB- O
of IN O
this DT O
group NN O
participated VBD O
in IN O
an DT O
extension NN O
study NN O
( , O
BMES NNP O
IIB NNP O
) -RRB- O
. . O

BMES NNP O
cross JJ O
- HYPH O
section NN O
II NNP O
thus RB O
includes VBZ O
BMES NNP O
IIA NNP O
( : O
66 CD O
. . O
5 CD O
% NN O
) -RRB- O
and CC O
BMES NNP O
IIB NNP O
( : O
33 CD O
. . O
5 CD O
% NN O
) -RRB- O
participants NNS B-Species
( : O
n CD O
= SYM O
3509 CD O
) -RRB- O
. . O

Similar JJ O
procedures NNS O
were VBD O
used VBN O
for IN O
all DT O
stages NNS O
of IN O
data NNS O
collection NN O
at IN O
both DT O
surveys NNS O
. . O

A DT O
questionnaire NN O
was VBD O
administered VBN O
including VBG O
demographic JJ O
, , O
family NN O
and CC O
medical JJ O
history NN O
. . O

A DT O
detailed JJ O
eye NN O
examination NN O
included VBD O
subjective JJ O
refraction NN O
, , O
slit NN O
- HYPH O
lamp NN O
( , O
Topcon NNP O
SL NNP O
- HYPH O
7e CD O
camera NN O
, , O
Topcon NNP O
Optical NNP O
Co NNP O
, , O
Tokyo NNP O
, , O
Japan NNP O
) , O
and CC O
retroillumination NN O
( , O
Neitz NNP O
CT NNP O
- HYPH O
R NN O
camera NN O
, , O
Neitz NNP O
Instrument NNP O
Co NNP O
, , O
Tokyo NNP O
, , O
Japan NNP O
) , O
photography NN O
of IN O
the DT O
lens NN O
. . O

Grading NN O
of IN O
lens NNS O
photographs NNS O
in IN O
the DT O
BMES NNP O
has VBZ O
been VBN O
previously RB O
described VBN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Briefly RB O
, , O
masked VBN O
grading NN O
was VBD O
performed VBN O
on IN O
the DT O
lens NN O
photographs NNS O
using VBG O
the DT O
Wisconsin NNP O
Cataract NNP O
Grading NNP O
System NNP O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Cortical JJ O
cataract NN O
and CC O
PSC NNP O
were VBD O
assessed VBN O
from IN O
the DT O
retroillumination NN O
photographs NNS O
by IN O
estimating VBG O
the DT O
percentage NN O
of IN O
the DT O
circular JJ O
grid NN O
involved VBN O
. . O

Cortical JJ O
cataract NN O
was VBD O
defined VBN O
when WRB O
cortical JJ O
opacity NN O
involved VBD O
at RB O
least RBS O
5 CD O
% NN O
of IN O
the DT O
total JJ O
lens NN O
area NN O
. . O

PSC NNP O
was VBD O
defined VBN O
when WRB O
opacity NN O
comprised VBD O
at RB O
least RBS O
1 CD O
% NN O
of IN O
the DT O
total JJ O
lens NN O
area NN O
. . O

Slit JJ O
- HYPH O
lamp NN O
photographs NNS O
were VBD O
used VBN O
to TO O
assess VB O
nuclear JJ O
cataract NN O
using VBG O
the DT O
Wisconsin NNP O
standard JJ O
set NN O
of IN O
four CD O
lens NNS O
photographs NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Nuclear JJ O
cataract NN O
was VBD O
defined VBN O
when WRB O
nuclear JJ O
opacity NN O
was VBD O
at IN O
least JJS O
as RB O
great JJ O
as IN O
the DT O
standard JJ O
4 CD O
photograph NN O
. . O

Any DT O
cataract NN O
was VBD O
defined VBN O
to TO O
include VB O
persons NNS B-Species
who WP O
had VBD O
previous JJ O
cataract JJ O
surgery NN O
as RB O
well RB O
as IN O
those DT O
with IN O
any DT O
of IN O
three CD O
cataract NN O
types NNS O
. . O

Inter NN O
- HYPH O
grader NN O
reliability NN O
was VBD O
high JJ O
, , O
with IN O
weighted JJ O
kappa NN O
0 CD O
. . O
82 CD O
for IN O
cortical JJ O
cataract NN O
, , O
0 CD O
. . O
55 CD O
( HYPH O
simple JJ O
kappa NN O
0 CD O
. . O
75 CD O
) -RRB- O
for IN O
nuclear JJ O
cataract NN O
and CC O
0 CD O
. . O
82 CD O
for IN O
PSC NNP O
grading NN O
. . O

The DT O
intra NN O
- HYPH O
grader NN O
reliability NN O
for IN O
nuclear JJ O
cataract NN O
was VBD O
assessed VBN O
with IN O
simple JJ O
kappa NN O
0 CD O
. . O
83 CD O
for IN O
the DT O
senior JJ O
grader NN O
who WP O
graded VBD O
nuclear JJ O
cataract NN O
at IN O
both DT O
surveys NNS O
. . O

All DT O
PSC NNP O
cases NNS O
were VBD O
confirmed VBN O
by IN O
an DT O
ophthalmologist NN O
( -LRB- O
PM NN O
) -RRB- O
. . O

In IN O
cross JJ O
- HYPH O
section NN O
I PRP O
, , O
219 CD O
persons NNS B-Species
( , O
6 CD O
. . O
0 CD O
% NN O
) -RRB- O
had VBD O
missing JJ O
or CC O
ungradable JJ O
Neitz NNP O
photographs NNS O
, , O
leaving VBG O
3435 CD O
with IN O
photographs NNS O
available JJ O
for IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
assessment NN O
, , O
while IN O
1153 CD O
( SYM O
31 CD O
. . O
6 CD O
% NN O
) -RRB- O
had VBD O
randomly RB O
missing VBG O
or CC O
ungradable JJ O
Topcon NNP O
photographs NNS O
due IN O
to IN O
a DT O
camera NN O
malfunction NN O
, , O
leaving VBG O
2501 CD O
with IN O
photographs NNS O
available JJ O
for IN O
nuclear JJ O
cataract NN O
assessment NN O
. . O

Comparison NN O
of IN O
characteristics NNS O
between IN O
participants NNS B-Species
with IN O
and CC O
without IN O
Neitz NNP O
or CC O
Topcon NNP O
photographs NNS O
in IN O
cross JJ O
- HYPH O
section NN O
I PRP O
showed VBD O
no DT O
statistically RB O
significant JJ O
differences NNS O
between IN O
the DT O
two CD O
groups NNS O
, , O
as IN O
reported VBN O
previously RB O
[ -LRB- O
12 CD O
] -RRB- O
. . O

In IN O
cross JJ O
- HYPH O
section NN O
II CD O
, , O
441 CD O
persons NNS B-Species
( , O
12 CD O
. . O
5 CD O
% NN O
) -RRB- O
had VBD O
missing JJ O
or CC O
ungradable JJ O
Neitz NNP O
photographs NNS O
, , O
leaving VBG O
3068 CD O
for IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
assessment NN O
, , O
and CC O
648 CD O
( SYM O
18 CD O
. . O
5 CD O
% NN O
) -RRB- O
had VBD O
missing VBG O
or CC O
ungradable JJ O
Topcon NNP O
photographs NNS O
, , O
leaving VBG O
2860 CD O
for IN O
nuclear JJ O
cataract NN O
assessment NN O
. . O

Data NN O
analysis NN O
was VBD O
performed VBN O
using VBG O
the DT O
Statistical NNP O
Analysis NNP O
System NNP O
( : O
SAS NNP O
, , O
SAS NNP O
Institute NNP O
, , O
Cary NNP O
, , O
NC NNP O
, , O
USA NNP O
) -RRB- O
. . O

Age NN O
- HYPH O
adjusted VBN O
prevalence NN O
was VBD O
calculated VBN O
using VBG O
direct JJ O
standardization NN O
of IN O
the DT O
cross JJ O
- HYPH O
section NN O
II NNP O
population NN O
to IN O
the DT O
cross JJ O
- HYPH O
section NN O
I PRP O
population NN O
. . O

We PRP O
assessed VBD O
age NN O
- HYPH O
specific JJ O
prevalence NN O
using VBG O
an DT O
interval NN O
of IN O
5 CD O
years NNS O
, , O
so IN O
that IN O
participants NNS B-Species
within IN O
each DT O
age NN O
group NN O
were VBD O
independent JJ O
between IN O
the DT O
two CD O
cross JJ O
- HYPH O
sectional JJ O
surveys NNS O
. . O

Results NNS O

Characteristics NNS O
of IN O
the DT O
two CD O
survey NN O
populations NNS O
have VBP O
been VBN O
previously RB O
compared VBN O
[ -LRB- O
14 CD O
] -RRB- O
and CC O
showed VBD O
that IN O
age NN O
and CC O
sex NN O
distributions NNS O
were VBD O
similar JJ O
. . O

Table NN O
1 CD O
compares VBZ O
participant NN B-Species
characteristics NNS O
between IN O
the DT O
two CD O
cross JJ O
- HYPH O
sections NNS O
. . O

Cross JJ O
- HYPH O
section NN O
II NN O
participants NNS B-Species
generally RB O
had VBD O
higher JJR O
rates NNS O
of IN O
diabetes NNS O
, , O
hypertension NN O
, , O
myopia NN O
and CC O
more JJR O
users NNS O
of IN O
inhaled VBN O
steroids NNS O
. . O

Cataract NN O
prevalence NN O
rates NNS O
in IN O
cross JJ O
- HYPH O
sections NNS O
I PRP O
and CC O
II NN O
are VBP O
shown VBN O
in IN O
Figure NN O
1 CD O
. . O

The DT O
overall JJ O
prevalence NN O
of IN O
cortical JJ O
cataract NN O
was VBD O
23 CD O
. . O
8 CD O
% NN O
and CC O
23 CD O
. . O
7 CD O
% NN O
in IN O
cross JJ O
- HYPH O
sections NNS O
I PRP O
and CC O
II CD O
, , O
respectively RB O
( , O
age NN O
- HYPH O
sex NN O
adjusted JJ O
P NN O
= SYM O
0 CD O
. . O
81 CD O
) -RRB- O
. . O

Corresponding VBG O
prevalence NN O
of IN O
PSC NNP O
was VBD O
6 CD O
. . O
3 CD O
% NN O
and CC O
6 CD O
. . O
0 CD O
% NN O
for IN O
the DT O
two CD O
cross JJ O
- HYPH O
sections NNS O
( , O
age NN O
- HYPH O
sex NN O
adjusted JJ O
P NN O
= SYM O
0 CD O
. . O
60 CD O
) -RRB- O
. . O

There EX O
was VBD O
an DT O
increased VBN O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
, , O
from IN O
18 CD O
. . O
7 CD O
% NN O
in IN O
cross JJ O
- HYPH O
section NN O
I CD O
to IN O
23 CD O
. . O
9 CD O
% NN O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
over IN O
the DT O
6 CD O
- HYPH O
year NN O
period NN O
( , O
age NN O
- HYPH O
sex NN O
adjusted JJ O
P NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Prevalence NN O
of IN O
any DT O
cataract NN O
( , O
including VBG O
persons NNS B-Species
who WP O
had VBD O
cataract NN O
surgery NN O
) -RRB- O
, , O
however RB O
, , O
was VBD O
relatively RB O
stable JJ O
( : O
46 CD O
. . O
9 CD O
% NN O
and CC O
46 CD O
. . O
8 CD O
% NN O
in IN O
cross JJ O
- HYPH O
sections NNS O
I PRP O
and CC O
II NN O
, , O
respectively RB O
) -RRB- O
. . O

After IN O
age NN O
- HYPH O
standardization NN O
, , O
these DT O
prevalence NN O
rates NNS O
remained VBD O
stable JJ O
for IN O
cortical JJ O
cataract NN O
( , O
23 CD O
. . O
8 CD O
% NN O
and CC O
23 CD O
. . O
5 CD O
% NN O
in IN O
the DT O
two CD O
surveys NNS O
) , O
and CC O
PSC NNP O
( : O
6 CD O
. . O
3 CD O
% NN O
and CC O
5 CD O
. . O
9 CD O
% NN O
) -RRB- O
. . O

The DT O
slightly RB O
increased VBN O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
( , O
from IN O
18 CD O
. . O
7 CD O
% NN O
to IN O
24 CD O
. . O
2 CD O
% NN O
) -RRB- O
was VBD O
not RB O
altered VBN O
. . O

Table NN O
2 CD O
shows VBZ O
the DT O
age NN O
- HYPH O
specific JJ O
prevalence NN O
rates NNS O
for IN O
cortical JJ O
cataract NN O
, , O
PSC NNP O
and CC O
nuclear JJ O
cataract NN O
in IN O
cross JJ O
- HYPH O
sections NNS O
I PRP O
and CC O
II NNP O
. . O

A DT O
similar JJ O
trend NN O
of IN O
increasing VBG O
cataract JJ O
prevalence NN O
with IN O
increasing VBG O
age NN O
was VBD O
evident JJ O
for IN O
all DT O
three CD O
types NNS O
of IN O
cataract NN O
in IN O
both DT O
surveys NNS O
. . O

Comparing VBG O
the DT O
age NN O
- HYPH O
specific JJ O
prevalence NN O
between IN O
the DT O
two CD O
surveys NNS O
, , O
a DT O
reduction NN O
in IN O
PSC NNP O
prevalence NN O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
was VBD O
observed VBN O
in IN O
the DT O
older JJR O
age NN O
groups NNS O
( : O
> : O
= SYM O
75 CD O
years NNS O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
increased VBN O
nuclear JJ O
cataract NN O
prevalence NN O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
was VBD O
observed VBN O
in IN O
the DT O
older JJR O
age NN O
groups NNS O
( : O
> : O
= SYM O
70 CD O
years NNS O
) -RRB- O
. . O

Age NN O
- HYPH O
specific JJ O
cortical JJ O
cataract NN O
prevalence NN O
was VBD O
relatively RB O
consistent JJ O
between IN O
the DT O
two CD O
surveys NNS O
, , O
except IN O
for IN O
a DT O
reduction NN O
in IN O
prevalence NN O
observed VBN O
in IN O
the DT O
80 CD O
- SYM O
84 CD O
age NN O
group NN O
and CC O
an DT O
increasing VBG O
prevalence NN O
in IN O
the DT O
older JJR O
age NN O
groups NNS O
( : O
> NFP O
= SYM O
85 CD O
years NNS O
) -RRB- O
. . O

Similar JJ O
gender NN O
differences NNS O
in IN O
cataract NN O
prevalence NN O
were VBD O
observed VBN O
in IN O
both DT O
surveys NNS O
( -LRB- O
Table NNP O
3 CD O
) -RRB- O
. . O

Higher JJR O
prevalence NN O
of IN O
cortical JJ O
and CC O
nuclear JJ O
cataract NN O
in IN O
women NNS B-Species
than IN O
men NNS B-Species
was VBD O
evident JJ O
but CC O
the DT O
difference NN O
was VBD O
only RB O
significant JJ O
for IN O
cortical JJ O
cataract NN O
( , O
age NN O
- HYPH O
adjusted VBN O
odds NNS O
ratio NN O
, , O
OR CC O
, , O
for IN O
women NNS B-Species
1 CD O
. . O
3 CD O
, , O
95 CD O
% NN O
confidence NN O
intervals NNS O
, , O
CI NN O
, , O
1 CD O
. . O
1 CD O
- SYM O
1 CD O
. . O
5 CD O
in IN O
cross JJ O
- HYPH O
section NN O
I NN O
and CC O
OR NN O
1 CD O
. . O
4 CD O
, , O
95 CD O
% NN O
CI NN O
1 CD O
. . O
1 CD O
- SYM O
1 CD O
. . O
6 CD O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
men NNS B-Species
had VBD O
slightly RB O
higher JJR O
PSC NNP O
prevalence NN O
than IN O
women NNS B-Species
in IN O
both DT O
cross JJ O
- HYPH O
sections NNS O
but CC O
the DT O
difference NN O
was VBD O
not RB O
significant JJ O
( : O
OR CC O
1 CD O
. . O
1 CD O
, , O
95 CD O
% NN O
CI NN O
0 CD O
. . O
8 CD O
- SYM O
1 CD O
. . O
4 CD O
for IN O
men NNS B-Species
in IN O
cross JJ O
- HYPH O
section NN O
I NN O
and CC O
OR NN O
1 CD O
. . O
2 CD O
, , O
95 CD O
% NN O
0 CD O
. . O
9 CD O
- SYM O
1 CD O
. . O
6 CD O
in IN O
cross JJ O
- HYPH O
section NN O
II NN O
) -RRB- O
. . O

Discussion NN O

Findings NNS O
from IN O
two CD O
surveys NNS O
of IN O
BMES NNP O
cross JJ O
- HYPH O
sectional JJ O
populations NNS O
with IN O
similar JJ O
age NN O
and CC O
gender NN O
distribution NN O
showed VBD O
that IN O
the DT O
prevalence NN O
of IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
remained VBD O
stable JJ O
, , O
while IN O
the DT O
prevalence NN O
of IN O
nuclear JJ O
cataract NN O
appeared VBD O
to TO O
have VB O
increased VBN O
. . O

Comparison NN O
of IN O
age NN O
- HYPH O
specific JJ O
prevalence NN O
, , O
with IN O
totally RB O
independent JJ O
samples NNS O
within IN O
each DT O
age NN O
group NN O
, , O
confirmed VBD O
the DT O
robustness NN O
of IN O
our PRP$ O
findings NNS O
from IN O
the DT O
two CD O
survey NN O
samples NNS O
. . O

Although IN O
lens NNS O
photographs NNS O
taken VBN O
from IN O
the DT O
two CD O
surveys NNS O
were VBD O
graded VBN O
for IN O
nuclear JJ O
cataract NN O
by IN O
the DT O
same JJ O
graders NNS O
, , O
who WP O
documented VBD O
a DT O
high JJ O
inter JJ O
- HYPH O
and CC O
intra NN O
- HYPH O
grader NN O
reliability NN O
, , O
we PRP O
cannot MD O
exclude VB O
the DT O
possibility NN O
that IN O
variations NNS O
in IN O
photography NN O
, , O
performed VBN O
by IN O
different JJ O
photographers NNS O
, , O
may MD O
have VB O
contributed VBN O
to IN O
the DT O
observed VBN O
difference NN O
in IN O
nuclear JJ O
cataract NN O
prevalence NN O
. . O

However RB O
, , O
the DT O
overall JJ O
prevalence NN O
of IN O
any DT O
cataract NN O
( , O
including VBG O
cataract NN O
surgery NN O
) , O
was VBD O
relatively RB O
stable JJ O
over IN O
the DT O
6 CD O
- HYPH O
year NN O
period NN O
. . O

Although IN O
different JJ O
population NN O
- HYPH O
based VBN O
studies NNS O
used VBD O
different JJ O
grading NN O
systems NNS O
to TO O
assess VB O
cataract NN O
[ -LRB- O
15 CD O
] -RRB- O
, , O
the DT O
overall JJ O
prevalence NN O
of IN O
the DT O
three CD O
cataract NN O
types NNS O
were VBD O
similar JJ O
across IN O
different JJ O
study NN O
populations NNS O
[ -LRB- O
12 CD O
, , O
16 CD O
- SYM O
23 CD O
] -RRB- O
. . O

Most JJS O
studies NNS O
have VBP O
suggested VBN O
that IN O
nuclear JJ O
cataract NN O
is VBZ O
the DT O
most RBS O
prevalent JJ O
type NN O
of IN O
cataract NN O
, , O
followed VBN O
by IN O
cortical JJ O
cataract NN O
[ -LRB- O
16 CD O
- SYM O
20 CD O
] -RRB- O
. . O

Ours PRP O
and CC O
other JJ O
studies NNS O
reported VBD O
that IN O
cortical JJ O
cataract NN O
was VBD O
the DT O
most RBS O
prevalent JJ O
type NN O
[ -LRB- O
12 CD O
, , O
21 CD O
- SYM O
23 CD O
] -RRB- O
. . O

Our PRP$ O
age NN O
- HYPH O
specific JJ O
prevalence NN O
data NNS O
show VBP O
a DT O
reduction NN O
of IN O
15 CD O
. . O
9 CD O
% NN O
in IN O
cortical JJ O
cataract NN O
prevalence NN O
for IN O
the DT O
80 CD O
- SYM O
84 CD O
year NN O
age NN O
group NN O
, , O
concordant JJ O
with IN O
an DT O
increase NN O
in IN O
cataract NN O
surgery NN O
prevalence NN O
by IN O
9 CD O
% NN O
in IN O
those DT O
aged VBN O
80 CD O
+ CD O
years NNS O
observed VBN O
in IN O
the DT O
same JJ O
study NN O
population NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Although IN O
cortical JJ O
cataract NN O
is VBZ O
thought VBN O
to TO O
be VB O
the DT O
least RBS O
likely JJ O
cataract NN O
type NN O
leading VBG O
to IN O
a DT O
cataract NN O
surgery NN O
, , O
this DT O
may MD O
not RB O
be VB O
the DT O
case NN O
in IN O
all DT O
older JJR O
persons NNS B-Species
. . O

A DT O
relatively RB O
stable JJ O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
prevalence NN O
over IN O
the DT O
6 CD O
- HYPH O
year NN O
period NN O
is VBZ O
expected VBN O
. . O

We PRP O
cannot MD O
offer VB O
a DT O
definitive JJ O
explanation NN O
for IN O
the DT O
increase NN O
in IN O
nuclear JJ O
cataract NN O
prevalence NN O
. . O

A DT O
possible JJ O
explanation NN O
could MD O
be VB O
that IN O
a DT O
moderate JJ O
level NN O
of IN O
nuclear JJ O
cataract NN O
causes VBZ O
less JJR O
visual JJ O
disturbance NN O
than IN O
the DT O
other JJ O
two CD O
types NNS O
of IN O
cataract NN O
, , O
thus RB O
for IN O
the DT O
oldest JJS O
age NN O
groups NNS O
, , O
persons NNS B-Species
with IN O
nuclear JJ O
cataract NN O
could MD O
have VB O
been VBN O
less RBR O
likely JJ O
to TO O
have VB O
surgery NN O
unless IN O
it PRP O
is VBZ O
very RB O
dense JJ O
or CC O
co NN O
- HYPH O
existing VBG O
with IN O
cortical JJ O
cataract NN O
or CC O
PSC NNP O
. . O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
functional JJ O
vision NN O
and CC O
reading NN O
performance NN O
were VBD O
high JJ O
in IN O
patients NNS B-Species
undergoing VBG O
cataract JJ O
surgery NN O
who WP O
had VBD O
nuclear JJ O
cataract NN O
only RB O
compared VBN O
to IN O
those DT O
with IN O
mixed JJ O
type NN O
of IN O
cataract NN O
( , O
nuclear JJ O
and CC O
cortical JJ O
) -RRB- O
or CC O
PSC NNP O
[ -LRB- O
24 CD O
, , O
25 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
the DT O
overall JJ O
prevalence NN O
of IN O
any DT O
cataract NN O
( , O
including VBG O
cataract NN O
surgery NN O
) , O
was VBD O
similar JJ O
in IN O
the DT O
two CD O
cross JJ O
- HYPH O
sections NNS O
, , O
which WDT O
appears VBZ O
to TO O
support VB O
our PRP$ O
speculation NN O
that IN O
in IN O
the DT O
oldest JJS O
age NN O
group NN O
, , O
nuclear JJ O
cataract NN O
may MD O
have VB O
been VBN O
less RBR O
likely JJ O
to TO O
be VB O
operated VBN O
than IN O
the DT O
other JJ O
two CD O
types NNS O
of IN O
cataract NN O
. . O

This DT O
could MD O
have VB O
resulted VBN O
in IN O
an DT O
increased VBN O
nuclear JJ O
cataract NN O
prevalence NN O
( , O
due IN O
to IN O
less RBR O
being VBG O
operated VBN O
) -RRB- O
, , O
compensated VBN O
by IN O
the DT O
decreased VBN O
prevalence NN O
of IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
( , O
due IN O
to IN O
these DT O
being VBG O
more RBR O
likely JJ O
to TO O
be VB O
operated VBN O
) -RRB- O
, , O
leading VBG O
to IN O
stable JJ O
overall JJ O
prevalence NN O
of IN O
any DT O
cataract NN O
. . O

Possible JJ O
selection NN O
bias NN O
arising VBG O
from IN O
selective JJ O
survival NN O
among IN O
persons NNS B-Species
without IN O
cataract NN O
could MD O
have VB O
led VBN O
to IN O
underestimation NN O
of IN O
cataract NN O
prevalence NN O
in IN O
both DT O
surveys NNS O
. . O

We PRP O
assume VBP O
that IN O
such PDT O
an DT O
underestimation NN O
occurred VBD O
equally RB O
in IN O
both DT O
surveys NNS O
, , O
and CC O
thus RB O
should MD O
not RB O
have VB O
influenced VBN O
our PRP$ O
assessment NN O
of IN O
temporal JJ O
changes NNS O
. . O

Measurement NN O
error NN O
could MD O
also RB O
have VB O
partially RB O
contributed VBN O
to IN O
the DT O
observed VBN O
difference NN O
in IN O
nuclear JJ O
cataract NN O
prevalence NN O
. . O

Assessment NN O
of IN O
nuclear JJ O
cataract NN O
from IN O
photographs NNS O
is VBZ O
a DT O
potentially RB O
subjective JJ O
process NN O
that WDT O
can MD O
be VB O
influenced VBN O
by IN O
variations NNS O
in IN O
photography NN O
( , O
light JJ O
exposure NN O
, , O
focus NN O
and CC O
the DT O
slit NN O
- HYPH O
lamp NN O
angle NN O
when WRB O
the DT O
photograph NN O
was VBD O
taken VBN O
) , O
and CC O
grading NN O
. . O

Although IN O
we PRP O
used VBD O
the DT O
same JJ O
Topcon NNP O
slit NN O
- HYPH O
lamp NN O
camera NN O
and CC O
the DT O
same JJ O
two CD O
graders NNS O
who WP O
graded VBD O
photos NNS O
from IN O
both DT O
surveys NNS O
, , O
we PRP O
are VBP O
still RB O
not RB O
able JJ O
to TO O
exclude VB O
the DT O
possibility NN O
of IN O
a DT O
partial JJ O
influence NN O
from IN O
photographic JJ O
variation NN O
on IN O
this DT O
result NN O
. . O

A DT O
similar JJ O
gender NN O
difference NN O
( , O
women NNS B-Species
having VBG O
a DT O
higher JJR O
rate NN O
than IN O
men NNS B-Species
) , O
in IN O
cortical JJ O
cataract NN O
prevalence NN O
was VBD O
observed VBN O
in IN O
both DT O
surveys NNS O
. . O

Our PRP$ O
findings NNS O
are VBP O
in IN O
keeping NN O
with IN O
observations NNS O
from IN O
the DT O
Beaver NNP O
Dam NNP O
Eye NNP O
Study NNP O
[ -LRB- O
18 CD O
] -RRB- O
, , O
the DT O
Barbados NNP O
Eye NNP O
Study NNP O
[ -LRB- O
22 CD O
] -RRB- O
and CC O
the DT O
Lens NNP O
Opacities NNP O
Case NNP O
- HYPH O
Control NNP O
Group NNP O
[ -LRB- O
26 CD O
] -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
the DT O
difference NN O
could MD O
be VB O
related VBN O
to IN O
hormonal JJ O
factors NNS O
[ -LRB- O
18 CD O
, , O
22 CD O
] -RRB- O
. . O

A DT O
previous JJ O
study NN O
on IN O
biochemical JJ O
factors NNS O
and CC O
cataract NN O
showed VBD O
that IN O
a DT O
lower JJR O
level NN O
of IN O
iron NN O
was VBD O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
cortical JJ O
cataract NN O
[ -LRB- O
27 CD O
] -RRB- O
. . O

No DT O
interaction NN O
between IN O
sex NN O
and CC O
biochemical JJ O
factors NNS O
were VBD O
detected VBN O
and CC O
no DT O
gender NN O
difference NN O
was VBD O
assessed VBN O
in IN O
this DT O
study NN O
[ -LRB- O
27 CD O
] -RRB- O
. . O

The DT O
gender NN O
difference NN O
seen VBN O
in IN O
cortical JJ O
cataract NN O
could MD O
be VB O
related VBN O
to IN O
relatively RB O
low JJ O
iron NN O
levels NNS O
and CC O
low JJ O
hemoglobin NN O
concentration NN O
usually RB O
seen VBN O
in IN O
women NNS B-Species
[ -LRB- O
28 CD O
] -RRB- O
. . O

Diabetes NN O
is VBZ O
a DT O
known JJ O
risk NN O
factor NN O
for IN O
cortical JJ O
cataract NN O
but CC O
in IN O
this DT O
particular JJ O
population NN O
diabetes NN O
is VBZ O
more RBR O
prevalent JJ O
in IN O
men NNS B-Species
than IN O
women NNS B-Species
in IN O
all DT O
age NN O
groups NNS O
[ -LRB- O
29 CD O
] -RRB- O
. . O

Differential JJ O
exposures NNS O
to IN O
cataract NN O
risk NN O
factors NNS O
or CC O
different JJ O
dietary JJ O
or CC O
lifestyle NN O
patterns NNS O
between IN O
men NNS B-Species
and CC O
women NNS B-Species
may MD O
also RB O
be VB O
related VBN O
to IN O
these DT O
observations NNS O
and CC O
warrant VB O
further JJ O
study NN O
. . O

Conclusion NN O

In IN O
summary NN O
, , O
in IN O
two CD O
population NN O
- HYPH O
based VBN O
surveys NNS O
6 CD O
years NNS O
apart RB O
, , O
we PRP O
have VBP O
documented VBN O
a DT O
relatively RB O
stable JJ O
prevalence NN O
of IN O
cortical JJ O
cataract NN O
and CC O
PSC NNP O
over IN O
the DT O
period NN O
. . O

The DT O
observed VBN O
overall JJ O
increased VBN O
nuclear JJ O
cataract NN O
prevalence NN O
by IN O
5 CD O
% NN O
over IN O
a DT O
6 CD O
- HYPH O
year NN O
period NN O
needs VBZ O
confirmation NN O
by IN O
future JJ O
studies NNS O
, , O
and CC O
reasons NNS O
for IN O
such PDT O
an DT O
increase NN O
deserve VBP O
further JJ O
study NN O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

AGT NNP O
graded VBD O
the DT O
photographs NNS O
, , O
performed VBD O
literature NN O
search NN O
and CC O
wrote VBD O
the DT O
first JJ O
draft NN O
of IN O
the DT O
manuscript NN O
. . O

JJW NNP O
graded VBD O
the DT O
photographs NNS O
, , O
critically RB O
reviewed VBD O
and CC O
modified VBD O
the DT O
manuscript NN O
. . O

ER NNP O
performed VBD O
the DT O
statistical JJ O
analysis NN O
and CC O
critically RB O
reviewed VBD O
the DT O
manuscript NN O
. . O

PM NN O
designed VBD O
and CC O
directed VBD O
the DT O
study NN O
, , O
adjudicated VBD O
cataract NN O
cases NNS O
and CC O
critically RB O
reviewed VBD O
and CC O
modified VBD O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

QGRS NNP O
Mapper NNP O
: : O
a DT O
web NN O
- HYPH O
based VBN O
server NN O
for IN O
predicting VBG O
G NN O
- HYPH O
quadruplexes NNS O
in IN O
nucleotide NN O
sequences NNS O

Abstract JJ O

The DT O
quadruplex NN O
structures NNS O
formed VBN O
by IN O
guanine NN O
- HYPH O
rich JJ O
nucleic JJ O
acid NN O
sequences NNS O
have VBP O
received VBN O
significant JJ O
attention NN O
recently RB O
because IN O
of IN O
growing VBG O
evidence NN O
for IN O
their PRP$ O
role NN O
in IN O
important JJ O
biological JJ O
processes NNS O
and CC O
as IN O
therapeutic JJ O
targets NNS O
. . O

G NNP O
- HYPH O
quadruplex NNP O
DNA NNP O
has VBZ O
been VBN O
suggested VBN O
to TO O
regulate VB O
DNA NN O
replication NN O
and CC O
may MD O
control VB O
cellular JJ O
proliferation NN O
. . O

Sequences NNS O
capable JJ O
of IN O
forming VBG O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
RNA NNP O
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
significant JJ O
roles NNS O
in IN O
regulation NN O
of IN O
polyadenylation NN O
and CC O
splicing VBG O
events NNS O
in IN O
mammalian JJ O
transcripts NNS O
. . O

Whether IN O
quadruplex NN O
structure NN O
directly RB O
plays VBZ O
a DT O
role NN O
in IN O
regulating VBG O
RNA NNP O
processing NN O
requires VBZ O
investigation NN O
. . O

Computational JJ O
approaches NNS O
to IN O
study NN O
G NN O
- HYPH O
quadruplexes NNS O
allow VBP O
detailed JJ O
analysis NN O
of IN O
mammalian JJ O
genomes NNS O
. . O

There EX O
are VBP O
no DT O
known VBN O
easily RB O
accessible JJ O
user NN O
- HYPH O
friendly JJ O
tools NNS O
that WDT O
can MD O
compute VB O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
nucleotide NN O
sequences NNS O
. . O

We PRP O
have VBP O
developed VBN O
a DT O
web NN O
- HYPH O
based VBN O
server NN O
, , O
QGRS NNP O
Mapper NNP O
, , O
that WDT O
predicts VBZ O
quadruplex NN O
forming VBG O
G NN O
- HYPH O
rich JJ O
sequences NNS O
( , O
QGRS NNP O
) -RRB- O
in IN O
nucleotide NN O
sequences NNS O
. . O

It PRP O
is VBZ O
a DT O
user NN O
- HYPH O
friendly JJ O
application NN O
that WDT O
provides VBZ O
many JJ O
options NNS O
for IN O
defining VBG O
and CC O
studying VBG O
G NNP O
- HYPH O
quadruplexes NNS O
. . O

It PRP O
performs VBZ O
analysis NN O
of IN O
the DT O
user NN O
provided VBN O
genomic JJ O
sequences NNS O
, , O
e UH O
. . O
g LS O
. . O
promoter NN O
and CC O
telomeric JJ O
regions NNS O
, , O
as RB O
well RB O
as IN O
RNA NNP O
sequences NNS O
. . O

It PRP O
is VBZ O
also RB O
useful JJ O
for IN O
predicting VBG O
G NNP O
- HYPH O
quadruplex NN O
structures NNS O
in IN O
oligonucleotides NNS O
. . O

The DT O
program NN O
provides VBZ O
options NNS O
to TO O
search VB O
and CC O
retrieve VB O
desired JJ O
gene NN O
/ SYM O
nucleotide NN O
sequence NN O
entries NNS O
from IN O
NCBI NNP O
databases NNS O
for IN O
mapping VBG O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
context NN O
of IN O
RNA NNP O
processing NN O
sites NNS O
. . O

This DT O
feature NN O
is VBZ O
very RB O
useful JJ O
for IN O
investigating VBG O
the DT O
functional JJ O
relevance NN O
of IN O
G NNP O
- HYPH O
quadruplex NN O
structure NN O
, , O
in IN O
particular JJ O
its PRP$ O
role NN O
in IN O
regulating VBG O
the DT O
gene NN O
expression NN O
by IN O
alternative JJ O
processing NN O
. . O

In IN O
addition NN O
to IN O
providing VBG O
data NNS O
on IN O
composition NN O
and CC O
locations NNS O
of IN O
QGRS NNP O
relative JJ O
to IN O
the DT O
processing NN O
sites NNS O
in IN O
the DT O
pre JJ O
- HYPH O
mRNA NN O
sequence NN O
, , O
QGRS NNP O
Mapper NNP O
features VBZ O
interactive JJ O
graphic JJ O
representation NN O
of IN O
the DT O
data NNS O
. . O

The DT O
user NN O
can MD O
also RB O
use VB O
the DT O
graphics NNS O
module NN O
to TO O
visualize VB O
QGRS NNP O
distribution NN O
patterns NNS O
among IN O
all PDT O
the DT O
alternative JJ O
RNA NNP O
products NNS O
of IN O
a DT O
gene NN O
simultaneously RB O
on IN O
a DT O
single JJ O
screen NN O
. . O

QGRS NNP O
Mapper NNP O
can MD O
be VB O
accessed VBN O
at IN O
. . O

INTRODUCTION NN O

The DT O
quadruplex NN O
structures NNS O
formed VBN O
by IN O
guanine NN O
- HYPH O
rich JJ O
nucleic JJ O
acid NN O
sequences NNS O
have VBP O
received VBN O
significant JJ O
attention NN O
recently RB O
because IN O
of IN O
increasing VBG O
evidence NN O
for IN O
their PRP$ O
role NN O
in IN O
important JJ O
biological JJ O
processes NNS O
and CC O
as IN O
therapeutic JJ O
targets NNS O
( : O
1 CD O
- SYM O
5 CD O
) -RRB- O
. . O

The DT O
G NNP O
- HYPH O
quadruplex NN O
structure NN O
, , O
also RB O
known VBN O
as IN O
a DT O
G NNP O
- HYPH O
quartet NN O
, , O
is VBZ O
formed VBN O
by IN O
repeated VBN O
folding NN O
of IN O
either CC O
the DT O
single JJ O
polynucleotide NN O
molecule NN O
or CC O
by IN O
association NN O
of IN O
two CD O
or CC O
four CD O
molecules NNS O
. . O

The DT O
structure NN O
consists VBZ O
of IN O
stacked VBN O
G NNP O
- HYPH O
tetrads NNS O
, , O
which WDT O
are VBP O
square JJ O
co NN O
- HYPH O
planar NN O
arrays NNS O
of IN O
four CD O
guanine NN O
bases NNS O
each DT O
( , O
6 CD O
) -RRB- O
. . O

G NN O
- HYPH O
quadruplex NN O
is VBZ O
stabilized VBN O
with IN O
cyclic JJ O
Hoogsteen NNP O
hydrogen NN O
bonding NN O
between IN O
the DT O
four CD O
guanines NNS O
within IN O
each DT O
tetrad NN O
. . O

The DT O
present JJ O
work NN O
focuses VBZ O
only RB O
on IN O
the DT O
unimolecular JJ O
quadruplexes NNS O
, , O
since IN O
it PRP O
is VBZ O
more RBR O
likely JJ O
to TO O
be VB O
encountered VBN O
in IN O
physiological JJ O
conditions NNS O
( , O
7 CD O
, , O
8 CD O
) -RRB- O
. . O

Guanine NNP O
- HYPH O
rich JJ O
sequences NNS O
capable JJ O
of IN O
forming VBG O
G NNP O
- HYPH O
quadruplexes NNS O
are VBP O
found VBN O
in IN O
telomeres NNS O
, , O
promoter NN O
regions NNS O
, , O
transcribed VBN O
and CC O
other JJ O
biologically RB O
important JJ O
regions NNS O
of IN O
the DT O
mammalian JJ O
genomes NNS O
. . O

G NNP O
- HYPH O
quadruplex NNP O
DNA NNP O
has VBZ O
been VBN O
suggested VBN O
to TO O
regulate VB O
DNA NN O
replication NN O
in IN O
retinoblastoma NN O
susceptibility NN O
gene NN O
( -LRB- O
Rb NN O
) -RRB- O
region NN O
( : O
9 CD O
) -RRB- O
. . O

This DT O
structure NN O
may MD O
control VB O
cellular JJ O
proliferation NN O
at IN O
telomeric JJ O
level NN O
and CC O
by IN O
transcriptional JJ O
regulation NN O
of IN O
oncogenes NNS O
like IN O
c NN O
- HYPH O
myc NNP O
( : O
2 CD O
, , O
10 CD O
, , O
11 CD O
) -RRB- O
and CC O
c NN O
- HYPH O
kit NN O
( SYM O
12 CD O
) -RRB- O
. . O

Formation NN O
of IN O
G NNP O
- HYPH O
quadruplex NN O
seems VBZ O
to TO O
be VB O
regulated VBN O
through IN O
interactions NNS O
with IN O
cellular JJ O
proteins NNS O
. . O

While IN O
some DT O
proteins NNS O
help VBP O
stabilize VB O
the DT O
structure NN O
( , O
13 CD O
) -RRB- O
, , O
others NNS O
are VBP O
known VBN O
to TO O
resolve VB O
it PRP O
( , O
1 CD O
, , O
4 CD O
, , O
14 CD O
, , O
15 CD O
) -RRB- O
. . O

Proteins NNS O
and CC O
chemicals NNS O
that WDT O
stabilize VBP O
the DT O
G NNP O
- HYPH O
quadruplex NN O
structure NN O
can MD O
inhibit VB O
telomerase NN O
action NN O
and CC O
, , O
therefore RB O
, , O
are VBP O
being VBG O
evaluated VBN O
as IN O
anticancer NN O
therapeutic JJ O
agents NNS O
( : O
16 CD O
- HYPH O
20 CD O
) -RRB- O
. . O

Chemical JJ O
compounds NNS O
that WDT O
inhibit VBP O
G NN O
- HYPH O
quadruplex NN O
helicase NN O
activity NN O
may MD O
also RB O
be VB O
capable JJ O
of IN O
regulating VBG O
cellular JJ O
proliferation NN O
( : O
4 CD O
) -RRB- O
. . O

G NN O
- HYPH O
quadruplexes NNS O
are VBP O
also RB O
being VBG O
eyed VBN O
as IN O
potential JJ O
antimicrobial JJ O
agents NNS O
due IN O
to IN O
their PRP$ O
ability NN O
to TO O
transport VB O
monovalent JJ O
anions NNS O
( SYM O
21 CD O
) -RRB- O
. . O

G NN O
- HYPH O
quadruplex NN O
motifs NNS O
in IN O
the DT O
RNA NNP O
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
significant JJ O
roles NNS O
in IN O
mRNA NNP O
turnover NN O
( : O
1 CD O
) -RRB- O
, , O
FMRP NNP O
binding NN O
( : O
22 CD O
) -RRB- O
, , O
translation NN O
initiation NN O
( SYM O
23 CD O
) -RRB- O
as RB O
well RB O
as IN O
repression NN O
( SYM O
24 CD O
) -RRB- O
. . O

We PRP O
have VBP O
shown VBN O
previously RB O
that IN O
a DT O
G NNP O
- HYPH O
rich JJ O
sequence NN O
( , O
GRS NNP O
) -RRB- O
can MD O
mediate VB O
3 CD O
' '' O
end NN O
processing NN O
of IN O
mammalian JJ O
pre NN O
- HYPH O
mRNAs NNS O
by IN O
interacting VBG O
with IN O
DSEF NNP O
- HYPH O
1 CD O
/ SYM O
hnRNPH NNP O
/ SYM O
H NN O
' '' O
protein NN O
( , O
25 CD O
- HYPH O
27 CD O
) -RRB- O
. . O

Members NNS O
of IN O
the DT O
hnRNP NNP O
H NNP O
protein NN O
family NN O
recognize VBP O
G NNP O
- HYPH O
rich JJ O
motifs NNS O
capable JJ O
of IN O
forming VBG O
G NNP O
- HYPH O
quadruplexes NNS O
and CC O
are VBP O
known VBN O
to TO O
regulate VB O
polyadenylation NN O
and CC O
splicing VBG O
events NNS O
in IN O
mammalian JJ O
transcripts NNS O
( : O
28 CD O
- HYPH O
30 CD O
) -RRB- O
. . O

Regulated VBN O
RNA NNP O
processing NN O
is VBZ O
an DT O
essential JJ O
component NN O
of IN O
differential JJ O
gene NN O
expression NN O
which WDT O
is VBZ O
central JJ O
to IN O
many JJ O
important JJ O
biologically RB O
processes NNS O
. . O

More JJR O
than IN O
half NN O
of IN O
human JJ B-Species
genes NNS O
are VBP O
known VBN O
to TO O
have VB O
alternative JJ O
polyadenylation NN O
( SYM O
31 CD O
) -RRB- O
. . O

Over IN O
two CD O
- HYPH O
thirds NNS O
of IN O
human JJ B-Species
genes NNS O
are VBP O
thought VBN O
to TO O
undergo VB O
alternative JJ O
splicing NN O
( SYM O
32 CD O
) -RRB- O
. . O

Sequences NNS O
capable JJ O
of IN O
forming VBG O
G NNP O
- HYPH O
quadruplexes NNS O
found VBN O
in IN O
the DT O
vicinity NN O
of IN O
polyadenylation NN O
and CC O
splice NN O
sites NNS O
act VBP O
as IN O
regulators NNS O
by IN O
interacting VBG O
with IN O
hnRNP NNP O
F NNP O
and CC O
H NNP O
proteins NNS O
( , O
25 CD O
- SYM O
27 CD O
, , O
30 CD O
, , O
33 CD O
) -RRB- O
. . O

Whether IN O
quadruplex NN O
structure NN O
directly RB O
plays VBZ O
a DT O
role NN O
in IN O
regulating VBG O
RNA NNP O
processing NN O
events NNS O
requires VBZ O
investigation NN O
. . O

Computational JJ O
approaches NNS O
to IN O
study NN O
G NN O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
mammalian JJ O
genomes NNS O
allow VBP O
large JJ O
- HYPH O
scale NN O
and CC O
detailed JJ O
analysis NN O
of IN O
mammalian JJ O
genes NNS O
. . O

Although IN O
, , O
G NNP O
- HYPH O
quadruplexes NNS O
have VBP O
been VBN O
surveyed VBN O
in IN O
the DT O
human JJ B-Species
genome NN O
with IN O
such JJ O
techniques NNS O
( , O
34 CD O
, , O
35 CD O
) -RRB- O
, , O
there EX O
are VBP O
no DT O
known VBN O
user NN O
- HYPH O
friendly JJ O
computational JJ O
tools NNS O
easily RB O
accessible JJ O
to IN O
the DT O
public NN O
. . O

We PRP O
had VBD O
previously RB O
built VBN O
a DT O
database NN O
of IN O
mapped VBN O
G NNP O
- HYPH O
quadruplex NN O
sequences NNS O
in IN O
selected VBN O
alternatively RB O
processed VBN O
human JJ B-Species
and CC O
mouse NN B-Species
genes NNS O
( SYM O
36 CD O
) -RRB- O
. . O

Our PRP$ O
preliminary JJ O
analysis NN O
of IN O
the DT O
database NN O
suggests VBZ O
prevalence NN O
of IN O
such JJ O
motifs NNS O
near IN O
alternative JJ O
splice NN O
and CC O
poly NN O
( HYPH O
A NN O
) -RRB- O
sites NNS O
. . O

We PRP O
have VBP O
now RB O
developed VBN O
a DT O
web NN O
- HYPH O
based VBN O
server NN O
, , O
QGRS NNP O
Mapper NNP O
, , O
that WDT O
generates VBZ O
detailed JJ O
information NN O
on IN O
composition NN O
and CC O
distribution NN O
of IN O
putative JJ O
quadruplex NN O
forming VBG O
G NN O
- HYPH O
rich JJ O
sequences NNS O
( , O
QGRS NNP O
) -RRB- O
in IN O
any DT O
NCBI NNP O
nucleotide NN O
sequence NN O
identified VBN O
or CC O
provided VBN O
by IN O
the DT O
user NN O
. . O

The DT O
program NN O
is VBZ O
also RB O
designed VBN O
to TO O
handle VB O
the DT O
analysis NN O
of IN O
mammalian JJ O
pre NN O
- HYPH O
mRNA NN O
sequences NNS O
, , O
including VBG O
those DT O
that WDT O
are VBP O
alternatively RB O
processed VBN O
( , O
alternatively RB O
spliced VBN O
or CC O
alternatively RB O
polyadenylated VBN O
) -RRB- O
. . O

Researchers NNS O
interested JJ O
in IN O
predicting VBG O
the DT O
ability NN O
of IN O
a DT O
nucleotide NN O
sequence NN O
to TO O
form VB O
G NN O
- HYPH O
quadruplex NN O
structure NN O
will MD O
find VB O
QGRS NNP O
Mapper NNP O
to TO O
be VB O
a DT O
user NN O
- HYPH O
friendly JJ O
application NN O
that WDT O
provides VBZ O
many JJ O
options NNS O
for IN O
analysis NN O
. . O

The DT O
user NN O
can MD O
define VB O
the DT O
minimum JJ O
number NN O
of IN O
tetrads NNS O
, , O
maximum NN O
length NN O
of IN O
the DT O
G NN O
- HYPH O
quadruplex NN O
motif NN O
, , O
and CC O
size NN O
as RB O
well RB O
as IN O
composition NN O
of IN O
the DT O
loops NNS O
. . O

The DT O
program NN O
can MD O
map VB O
unimolecular JJ O
QGRS NNS O
in IN O
the DT O
entire JJ O
nucleotide NN O
sequence NN O
provided VBN O
in IN O
the DT O
raw JJ O
or CC O
FASTA NNP O
format NN O
by IN O
the DT O
user NN O
. . O

This DT O
method NN O
can MD O
be VB O
used VBN O
for IN O
the DT O
analysis NN O
of IN O
genomic JJ O
sequences NNS O
, , O
e UH O
. . O
g LS O
. . O
promoter NN O
and CC O
telomeric JJ O
regions NNS O
, , O
as RB O
well RB O
as IN O
RNA NNP O
sequences NNS O
. . O

It PRP O
is VBZ O
also RB O
useful JJ O
for IN O
predicting VBG O
G NNP O
- HYPH O
quadruplex NN O
structures NNS O
in IN O
oligonucleotides NNS O
. . O

Alternatively RB O
, , O
the DT O
program NN O
provides VBZ O
options NNS O
to TO O
search VB O
the DT O
entire JJ O
NCBI NNP O
Gene NNP O
Entrez NNP O
, , O
RefSeq NNP O
and CC O
GenBank NNP O
databases NNS O
in IN O
order NN O
to TO O
retrieve VB O
the DT O
desired VBN O
gene NN O
/ SYM O
nucleotide NN O
sequence NN O
entries NNS O
for IN O
analysis NN O
of IN O
their PRP$ O
transcribed VBN O
regions NNS O
. . O

Furthermore RB O
, , O
QGRS NNP O
Mapper NNP O
is VBZ O
a DT O
unique JJ O
tool NN O
for IN O
mapping VBG O
G NN O
- HYPH O
quadruplex NNP O
forming VBG O
sequences NNS O
in IN O
the DT O
context NN O
of IN O
RNA NNP O
processing NN O
sites NNS O
. . O

This DT O
feature NN O
is VBZ O
very RB O
useful JJ O
for IN O
investigating VBG O
the DT O
functional JJ O
relevance NN O
of IN O
G NNP O
- HYPH O
quadruplex NN O
structure NN O
, , O
in IN O
particular JJ O
its PRP$ O
role NN O
in IN O
regulating VBG O
the DT O
gene NN O
expression NN O
by IN O
alternative JJ O
processing NN O
. . O

In IN O
addition NN O
to IN O
providing VBG O
data NNS O
on IN O
composition NN O
and CC O
locations NNS O
of IN O
QGRS NNP O
relative JJ O
to IN O
the DT O
processing NN O
sites NNS O
in IN O
the DT O
pre JJ O
- HYPH O
mRNA NN O
sequence NN O
, , O
QGRS NNP O
Mapper NNP O
offers VBZ O
interactive JJ O
graphic JJ O
representation NN O
of IN O
the DT O
data NNS O
. . O

The DT O
user NN O
can MD O
also RB O
use VB O
a DT O
graphics NNS O
module NN O
to TO O
visualize VB O
QGRS NNP O
distribution NN O
patterns NNS O
among IN O
all PDT O
the DT O
alternative JJ O
RNA NNP O
products NNS O
of IN O
a DT O
gene NN O
simultaneously RB O
on IN O
a DT O
single JJ O
screen NN O
. . O

METHODS NNS O

QGRS NNP O
definition NN O

The DT O
main JJ O
goal NN O
of IN O
the DT O
QGRS NNP O
Mapper NNP O
program NN O
is VBZ O
to TO O
predict VB O
the DT O
presence NN O
of IN O
QGRS NNP O
in IN O
nucleotide NN O
entries NNS O
. . O

These DT O
putative JJ O
G NNP O
- HYPH O
quadruplexes NNS O
are VBP O
identified VBN O
using VBG O
the DT O
following VBG O
motif NN O
. . O

GxNy1GxNy2GxNy3Gx NNP O

Here RB O
x NN O
= : O
number NN O
of IN O
guanine NN O
tetrads NNS O
in IN O
the DT O
G NN O
- HYPH O
quadruplex NN O
and CC O
y1 CD O
, , O
y2 CD O
, , O
y3 CD O
= , O
length NN O
of IN O
gaps NNS O
( : O
i LS O
. . O
e LS O
. . O
the DT O
length NN O
of IN O
the DT O
loops NNS O
connecting VBG O
the DT O
guanine NN O
tetrads NNS O
) -RRB- O
. . O

The DT O
motif NN O
consists VBZ O
of IN O
four CD O
equal JJ O
length NN O
sets NNS O
of IN O
guanines NNS O
( : O
which WDT O
we PRP O
call VBP O
G NNP O
- HYPH O
groups NNS O
) -RRB- O
, , O
separated VBN O
by IN O
arbitrary JJ O
nucleotide NN O
sequences NNS O
, , O
with IN O
the DT O
following VBG O
restrictions NNS O
. . O

The DT O
sequence NN O
must MD O
contain VB O
at IN O
least JJS O
two CD O
tetrads NNS O
( : O
i PRP O
. . O
e NN O
. . O
x SYM O
> NFP O
= SYM O
2 CD O
) -RRB- O
. . O

Although IN O
structures NNS O
with IN O
three CD O
or CC O
more JJR O
G NNP O
- HYPH O
tetrads NNS O
are VBP O
considered VBN O
to TO O
be VB O
more RBR O
stable JJ O
, , O
many JJ O
nucleotide NN O
sequences NNS O
are VBP O
known VBN O
to TO O
form VB O
quadruplexes NNS O
with IN O
two CD O
G NNP O
- HYPH O
tetrads NNS O
( SYM O
37 CD O
, , O
38 CD O
) -RRB- O
. . O

QGRS NNP O
Mapper NNP O
is VBZ O
meant VBN O
to TO O
be VB O
a DT O
flexible JJ O
and CC O
comprehensive JJ O
tool NN O
for IN O
investigating VBG O
G NNP O
- HYPH O
quadruplexes NNS O
; : O
hence RB O
it PRP O
considers VBZ O
sequences NNS O
with IN O
two CD O
tetrads NNS O
. , O
By IN O
default NN O
, , O
only RB O
QGRS NNP O
of IN O
maximum JJ O
length NN O
of IN O
30 CD O
bases NNS O
are VBP O
considered VBN O
. . O

However RB O
, , O
the DT O
program NN O
gives VBZ O
the DT O
user NN O
the DT O
option NN O
to TO O
search VB O
for IN O
sequences NNS O
up IN O
to TO O
45 CD O
bases NNS O
. . O

This DT O
restriction NN O
on IN O
the DT O
length NN O
of IN O
the DT O
sequences NNS O
being VBG O
considered VBN O
is VBZ O
in IN O
agreement NN O
with IN O
recent JJ O
literature NN O
( , O
34 CD O
, , O
35 CD O
) -RRB- O
. . O

The DT O
maximum JJ O
length NN O
of IN O
30 CD O
bases NNS O
restricts VBZ O
G NNP O
- HYPH O
groups NNS O
to IN O
a DT O
maximum JJ O
size NN O
of IN O
6 CD O
. , O
The DT O
gaps NNS O
or CC O
loops NNS O
between IN O
the DT O
G NNP O
- HYPH O
groups NNS O
may MD O
be VB O
arbitrary JJ O
in IN O
composition NN O
or CC O
length NN O
( , O
within IN O
the DT O
overall JJ O
restrictions NNS O
on IN O
the DT O
length NN O
of IN O
QGRS NNP O
) -RRB- O
. . O

The DT O
program NN O
gives VBZ O
the DT O
user NN O
the DT O
option NN O
to TO O
search VB O
for IN O
QGRS NNP O
having VBG O
loops NNS O
with IN O
a DT O
specified JJ O
length NN O
range NN O
( : O
e LS O
. . O
g LS O
. . O
the DT O
user NN O
can MD O
search VB O
for IN O
QGRS NNP O
with IN O
loops NNS O
of IN O
lengths NNS O
between IN O
1 CD O
and CC O
4 CD O
) -RRB- O
. . O

The DT O
user NN O
can MD O
also RB O
specify VB O
a DT O
string NN O
that IN O
one CD O
or CC O
more JJR O
loops NNS O
of IN O
each DT O
QGRS NNP O
must MD O
contain VB O
. . O

This DT O
string NN O
can MD O
be VB O
given VBN O
as IN O
a DT O
regular JJ O
expression NN O
. . O

For IN O
example NN O
, , O
entering VBG O
the DT O
regular JJ O
expression NN O
' '' O
T NNP O
{ SYM O
3 CD O
, , O
5 CD O
} , O
' '' O
will MD O
search VB O
for IN O
QGRS NNP O
having VBG O
one CD O
or CC O
more JJR O
loops NNS O
that WDT O
contain VBP O
three CD O
to IN O
five CD O
consecutive JJ O
T NN O
' '' O
s NNS O
. , O
Also RB O
, , O
at IN O
most JJS O
one CD O
of IN O
the DT O
gaps NNS O
is VBZ O
allowed VBN O
to TO O
be VB O
of IN O
zero CD O
length NN O

Table NN O
1 CD O
shows VBZ O
some DT O
examples NNS O
of IN O
valid JJ O
QGRS NNP O
. . O

The DT O
guanine NN O
groups NNS O
which WDT O
form VBP O
the DT O
tetrads NNS O
are VBP O
underlined VBN O
. . O

The DT O
first JJ O
sequence NN O
has VBZ O
four CD O
tetrads NNS O
and CC O
equal JJ O
length NN O
gaps NNS O
. . O

This DT O
would MD O
seem VB O
to TO O
provide VB O
a DT O
G NNP O
- HYPH O
quadruplex NN O
that WDT O
is VBZ O
the DT O
most RBS O
stable JJ O
of IN O
the DT O
three CD O
sequences NNS O
. . O

The DT O
second JJ O
sequence NN O
is VBZ O
notable JJ O
for IN O
the DT O
significant JJ O
differences NNS O
in IN O
the DT O
size NN O
of IN O
its PRP$ O
loops NNS O
. . O

The DT O
third JJ O
sequence NN O
has VBZ O
two CD O
tetrads NNS O
, , O
even RB O
though IN O
three CD O
of IN O
the DT O
G NNP O
- HYPH O
groups NNS O
could MD O
have VB O
included VBN O
another DT O
G NNP O
( , O
since IN O
all DT O
G NNP O
- HYPH O
groups NNS O
must MD O
be VB O
equal JJ O
in IN O
size NN O
) -RRB- O
. . O

G NNP O
- HYPH O
scores NNS O

We PRP O
have VBP O
devised VBN O
a DT O
scoring NN O
system NN O
that WDT O
evaluates VBZ O
a DT O
QGRS NNP O
for IN O
its PRP$ O
likelihood NN O
to TO O
form VB O
a DT O
stable JJ O
G NN O
- HYPH O
quadruplex NN O
. . O

Higher JJR O
scoring NN O
sequences NNS O
will MD O
make VB O
better JJR O
candidates NNS O
for IN O
G NNP O
- HYPH O
quadruplexes NNS O
. . O

The DT O
scoring NN O
method NN O
uses VBZ O
the DT O
following VBG O
principles NNS O
which WDT O
are VBP O
based VBN O
on IN O
previous JJ O
studies NNS O
( , O
34 CD O
, , O
35 CD O
, , O
39 CD O
- HYPH O
42 CD O
) -RRB- O
. . O

Shorter JJR O
loops NNS O
are VBP O
more RBR O
common JJ O
than IN O
longer JJR O
loops NNS O
. . O
G NN O
- HYPH O
quadruplexes NNS O
tend VBP O
to TO O
have VB O
loops NNS O
roughly RB O
equal JJ O
in IN O
size NN O
. , O
The DT O
greater JJR O
the DT O
number NN O
of IN O
guanine NN O
tetrads NNS O
, , O
the DT O
more RBR O
stable JJ O
the DT O
quadruplex NN O
. . O

The DT O
computed VBN O
G NNP O
- HYPH O
scores NNS O
are VBP O
dependent JJ O
on IN O
the DT O
user NN O
selected VBN O
maximum JJ O
QGRS NNP O
length NN O
. . O

The DT O
highest JJS O
possible JJ O
G NNP O
- HYPH O
score NN O
, , O
using VBG O
the DT O
default NN O
maximum JJ O
QGRS NNP O
length NN O
of IN O
30 CD O
, , O
is VBZ O
105 CD O
. . O

Here RB O
is VBZ O
a DT O
sequence NN O
attaining VBG O
that DT O
score NN O
: : O

GGGGGGTGGGGGGTGGGGGG NN O
. . O

Eliminating VBG O
QGRS NNP O
overlaps VBZ O

Two CD O
QGRS NNP O
are VBP O
said VBN O
to TO O
overlap VB O
if IN O
their PRP$ O
positions NNS O
in IN O
the DT O
nucleotide NN O
sequence NN O
overlap VBP O
. . O

QGRS NNP O
Mapper NNP O
will MD O
start VB O
with IN O
a DT O
nucleotide NN O
sequence NN O
, , O
find VB O
all DT O
QGRS NNS O
occurring VBG O
in IN O
the DT O
sequence NN O
and CC O
then RB O
produce VB O
a DT O
non AFX O
- HYPH O
overlapping VBG O
set NN O
of IN O
QGRS NNP O
. . O

Overlaps NNS O
are VBP O
eliminated VBN O
by IN O
selecting VBG O
the DT O
higher JJR O
scoring VBG O
QGRS NNP O
. . O

In IN O
the DT O
non RB O
- HYPH O
overlapping JJ O
view NN O
, , O
only RB O
this DT O
sequence NN O
will MD O
be VB O
displayed VBN O
, , O
although IN O
the DT O
user NN O
can MD O
request VB O
that IN O
all DT O
overlapping JJ O
sequences NNS O
be VB O
displayed VBN O
. . O

Please UH O
see VB O
supplementary JJ O
materials NNS O
at IN O
NAR NNP O
online RB O
for IN O
more JJR O
details NNS O
on IN O
the DT O
elimination NN O
of IN O
overlapping VBG O
QGRS NNP O
. . O

FEATURES NNS O

Design NN O
and CC O
implementation NN O

QGRS NNP O
Mapper NNP O
is VBZ O
a DT O
web NN O
- HYPH O
based VBN O
program NN O
, , O
written VBN O
in IN O
PHP NNP O
, , O
with IN O
Java NNP O
being VBG O
used VBN O
for IN O
some DT O
of IN O
its PRP$ O
graphics NNS O
. . O

The DT O
program NN O
takes VBZ O
a DT O
nucleotide NN O
sequence NN O
from IN O
NCBI NNP O
( : O
or CC O
as IN O
provided VBN O
by IN O
the DT O
user NN O
) -RRB- O
and CC O
analyzes VBZ O
it PRP O
for IN O
the DT O
presence NN O
of IN O
putative JJ O
G NN O
- HYPH O
quadruplexes NNS O
. . O

The DT O
structure NN O
of IN O
QGRS NNP O
Mapper NNP O
is VBZ O
summarized VBN O
in IN O
Table NNP O
2 CD O
. . O

Search NN O
and CC O
analysis NN O

QGRS NNP O
Mapper NNP O
allows VBZ O
the DT O
user NN O
to TO O
search VB O
for IN O
putative JJ O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
a DT O
variety NN O
of IN O
ways NNS O
. . O

It PRP O
is VBZ O
possible JJ O
to TO O
enter VB O
a DT O
nucleotide NN O
sequence NN O
in IN O
raw JJ O
or CC O
FASTA NNP O
format NN O
for IN O
analysis NN O
. . O

One PRP O
can MD O
search VB O
and CC O
analyze VB O
gene NN O
sequences NNS O
by IN O
Gene NNP O
ID NNP O
, , O
Gene NNP O
name NN O
or CC O
symbol NN O
, , O
accession NN O
number NN O
or CC O
GI NNP O
number NN O
for IN O
an DT O
NCBI NNP O
nucleotide NN O
sequence NN O
entry NN O
. . O

The DT O
user NN O
can MD O
opt VB O
to TO O
change VB O
the DT O
maximum JJ O
length NN O
of IN O
QGRS NNP O
that WDT O
will MD O
be VB O
searched VBN O
for IN O
( : O
the DT O
default NN O
maximum JJ O
length NN O
being VBG O
30 CD O
) -RRB- O
and CC O
change VB O
the DT O
minimum JJ O
sized JJ O
G NNP O
- HYPH O
group NN O
( : O
which WDT O
is VBZ O
two CD O
by IN O
default NN O
) -RRB- O
. . O

Also RB O
, , O
the DT O
user NN O
can MD O
specify VB O
that IN O
the DT O
loops NNS O
in IN O
the DT O
QGRS NNP O
fall VBP O
within IN O
a DT O
given VBN O
size NN O
range NN O
and CC O
that IN O
one CD O
or CC O
more JJR O
loops NNS O
of IN O
the DT O
QGRS NNP O
contain VBP O
a DT O
given VBN O
string NN O
( : O
for IN O
which WDT O
the DT O
user NN O
may MD O
enter VB O
a DT O
regular JJ O
expression NN O
) -RRB- O
. . O

The DT O
web NN O
page NN O
for IN O
QGRS NNP O
analysis NN O
can MD O
be VB O
seen VBN O
in IN O
Figure NNP O
1 CD O
. . O

After IN O
entering VBG O
a DT O
sequence NN O
in IN O
raw JJ O
or CC O
FASTA NNP O
format NN O
, , O
QGRS NNP O
Mapper NNP O
will MD O
search VB O
the DT O
sequence NN O
for IN O
occurrences NNS O
of IN O
QGRS NNP O
. . O

The DT O
user NN O
may MD O
enter VB O
any DT O
combination NN O
of IN O
the DT O
letters NNS O
A NNP O
, , O
C NNP O
, , O
T NNP O
, , O
G NNP O
, , O
U NNP O
, , O
N NNP O
. . O

The DT O
Gene NNP O
ID NN O
field NN O
allows VBZ O
the DT O
user NN O
to TO O
search VB O
the DT O
NCBI NNP O
Entrez NNP O
Gene NNP O
database NN O
. . O

QGRS NNP O
Mapper NNP O
will MD O
connect VB O
to IN O
NCBI NNP O
, , O
download VB O
and CC O
parse VB O
the DT O
gene NN O
entry NN O
, , O
and CC O
then RB O
analyze VB O
the DT O
transcribed VBN O
region NN O
of IN O
its PRP$ O
nucleotide NN O
sequence NN O
for IN O
the DT O
presence NN O
of IN O
QGRS NNP O
. . O

For IN O
example NN O
, , O
entering VBG O
the DT O
gene NN O
ID NN O
403437 CD O
results NNS O
in IN O
downloading VBG O
the DT O
Brca1 NNP O
gene NN O
sequence NN O
for IN O
Canis NNP B-Species
familiaris NNS I-Species
. . O

Using VBG O
the DT O
default JJ O
QGRS NNP O
search NN O
parameters NNS O
, , O
QGRS NNP O
Mapper NNP O
finds VBZ O
156 CD O
non AFX O
- HYPH O
overlapping VBG O
QGRS NNP O
and CC O
3394 CD O
overlapping VBG O
QGRS NNS O
in IN O
the DT O
transcribed VBN O
region NN O
of IN O
this DT O
gene NN O
. . O

The DT O
Gene NNP O
Name NNP O
or CC O
Gene NNP O
Symbol NNP O
field NN O
also RB O
allows VBZ O
the DT O
user NN O
to TO O
search VB O
the DT O
NCBI NNP O
databases NNS O
for IN O
all DT O
such JJ O
genes NNS O
. . O

Entering VBG O
the DT O
gene NN O
name NN O
Bcl2 NNP O
results VBZ O
in IN O
nine CD O
different JJ O
hits NNS O
which WDT O
are VBP O
displayed VBN O
in IN O
Table NNP O
3 CD O
. . O

All DT O
nine CD O
of IN O
these DT O
entries NNS O
can MD O
be VB O
analyzed VBN O
for IN O
the DT O
occurrence NN O
of IN O
QGRS NNP O
. . O

Clicking VBG O
on IN O
the DT O
Gene NNP O
ID NNP O
takes VBZ O
the DT O
user NN O
to IN O
the DT O
respective JJ O
Entrez NNP O
Gene NNP O
entry NN O
. . O

Clicking VBG O
on IN O
the DT O
last JJ O
column NN O
initiates VBZ O
analysis NN O
of IN O
the DT O
selection NN O
by IN O
QGRS NNP O
Mapper NNP O
. . O

Similarly RB O
, , O
the DT O
user NN O
can MD O
also RB O
enter VB O
an DT O
NCBI NNP O
accession NN O
number NN O
to TO O
search VB O
for IN O
gene NN O
sequences NNS O
. . O

For IN O
example NN O
, , O
searching VBG O
the DT O
accession NN O
number NN O
AF312033 NN O
results VBZ O
in IN O
12 CD O
hits NNS O
being VBG O
displayed VBN O
for IN O
this DT O
GenBank NNP O
nucleotide NN O
sequence NN O
entry NN O
. . O

The DT O
search NN O
phase NN O
of IN O
the DT O
program NN O
is VBZ O
followed VBN O
by IN O
an DT O
analysis NN O
of IN O
the DT O
QGRS NNP O
contained VBN O
in IN O
the DT O
query NN O
sequence NN O
. . O

In IN O
this DT O
phase NN O
of IN O
QGRS NNP O
Mapper NNP O
, , O
the DT O
sequence NN O
data NNS O
downloaded VBN O
previously RB O
is VBZ O
analyzed VBN O
to TO O
identify VB O
and CC O
map VB O
all DT O
QGRS NNP O
relative JJ O
to IN O
locations NNS O
such JJ O
as IN O
splice NN O
sites NNS O
in IN O
exons NNS O
/ SYM O
introns NNS O
, , O
and CC O
poly NN O
( , O
A NN O
) -RRB- O
site NN O
( , O
if IN O
these DT O
locations NNS O
are VBP O
known VBN O
) -RRB- O
. . O

Furthermore RB O
the DT O
QGRS NNP O
are VBP O
scored VBN O
by IN O
the DT O
method NN O
described VBN O
above RB O
. . O

The DT O
computed VBN O
G NNP O
- HYPH O
score NN O
is VBZ O
used VBN O
to TO O
eliminate VB O
overlapping JJ O
QGRS NNS O
. . O

At IN O
times NNS O
, , O
QGRS NNP O
Mapper NNP O
must MD O
analyze VB O
a DT O
considerable JJ O
amount NN O
of IN O
data NNS O
. . O

For IN O
example NN O
, , O
the DT O
mouse NN B-Species
version NN O
of IN O
the DT O
gene NN O
PTPRU NNP O
, , O
which WDT O
is VBZ O
69822 CD O
bases NNS O
long JJ O
, , O
contains VBZ O
94681 CD O
QGRS NNS O
of IN O
length NN O
up IN O
to TO O
45 CD O
bases NNS O
. . O

QGRS NNP O
Mapper NNP O
will MD O
find VB O
, , O
analyze VB O
and CC O
map VB O
all DT O
of IN O
these DT O
sequences NNS O
. . O

During IN O
this DT O
analysis NN O
a DT O
message NN O
is VBZ O
displayed VBN O
indicating VBG O
the DT O
estimated VBN O
time NN O
left VBN O
to IN O
completion NN O
. . O

QGRS NNP O
Mapper NNP O
output NN O

After IN O
the DT O
analysis NN O
of IN O
overlaps NNS O
is VBZ O
completed VBN O
, , O
QGRS NNP O
Mapper NNP O
displays VBZ O
a DT O
summary NN O
of IN O
its PRP$ O
findings NNS O
, , O
in IN O
the DT O
Gene NNP O
View NNP O
. . O

This DT O
summary NN O
includes VBZ O
basic JJ O
gene NN O
information NN O
such JJ O
as IN O
the DT O
gene NN O
ID NN O
, , O
gene NN O
symbol NN O
, , O
gene NN O
name NN O
, , O
a DT O
link NN O
to IN O
the DT O
NCBI NNP O
entry NN O
, , O
organism NN O
name NN O
, , O
chromosome NN O
number NN O
and CC O
number NN O
of IN O
products NNS O
and CC O
poly NN O
( , O
A NN O
) -RRB- O
signals NNS O
. . O

Information NN O
is VBZ O
also RB O
given VBN O
for IN O
each DT O
product NN O
, , O
such JJ O
as IN O
the DT O
number NN O
of IN O
exons NNS O
and CC O
introns NNS O
, , O
number NN O
of IN O
QGRS NNP O
( , O
non NN O
- HYPH O
overlapping JJ O
and CC O
overlapping JJ O
) -RRB- O
, , O
number NN O
of IN O
QGRS NNP O
found VBN O
near IN O
RNA NNP O
processing NN O
sites NNS O
, , O
and CC O
a DT O
visual JJ O
map NN O
of IN O
the DT O
product NN O
. . O

As IN O
an DT O
example NN O
, , O
the DT O
Gene NNP O
View NNP O
for IN O
the DT O
human JJ B-Species
GREB1 NN O
is VBZ O
displayed VBN O
in IN O
Figure NNP O
2 CD O
, , O
showing VBG O
the DT O
table NN O
of IN O
gene NN O
information NN O
and CC O
product NN O
information NN O
for IN O
the DT O
first JJ O
product NN O
( , O
the DT O
output NN O
for IN O
all DT O
products NNS O
may MD O
be VB O
seen VBN O
in IN O
the DT O
supplementary JJ O
material NN O
) -RRB- O
. . O

At IN O
this DT O
stage NN O
in IN O
the DT O
analysis NN O
the DT O
user NN O
can MD O
choose VB O
among IN O
three CD O
further JJ O
displays NNS O
: : O
' '' O
Data NNP O
View NNP O
' '' O
, , O
' '' O
Data NNP O
View NNP O
( , O
with IN O
overlaps NNS O
) , O
' '' O
and CC O
' `` O
Graphics NNS O
View NNP O
' '' O
. . O

This DT O
can MD O
be VB O
done VBN O
for IN O
the DT O
entire JJ O
gene NN O
or CC O
for IN O
any DT O
particular JJ O
product NN O
. . O

In IN O
the DT O
Data NNP O
View NNP O
, , O
a DT O
table NN O
is VBZ O
displayed VBN O
showing VBG O
information NN O
for IN O
each DT O
of IN O
the DT O
set NN O
of IN O
non AFX O
- HYPH O
overlapping VBG O
QGRS NNP O
. . O

This DT O
table NN O
displays VBZ O
the DT O
position NN O
of IN O
the DT O
QGRS NNP O
, , O
which WDT O
exon NN O
/ SYM O
intron NN O
it PRP O
appears VBZ O
in IN O
, , O
its PRP$ O
distance NN O
from IN O
3 CD O
' '' O
and CC O
5 CD O
' '' O
splice NN O
sites NNS O
, , O
the DT O
QGRS NNP O
sequence NN O
( , O
with IN O
each DT O
G NNP O
- HYPH O
group NN O
underlined VBN O
) -RRB- O
and CC O
the DT O
corresponding VBG O
G NNP O
- HYPH O
score NN O
. . O

Similar JJ O
display NN O
is VBZ O
also RB O
shown VBN O
for IN O
each DT O
QGRS NNP O
mapped VBN O
to IN O
poly JJ O
( , O
A NNP O
) -RRB- O
region NN O
in IN O
the DT O
product NN O
. . O

If IN O
the DT O
user NN O
requests VBZ O
the DT O
Data NNP O
View NNP O
for IN O
the DT O
entire JJ O
gene NN O
, , O
then RB O
the DT O
QGRS NNP O
information NN O
is VBZ O
shown VBN O
for IN O
each DT O
product NN O
. . O

The DT O
' '' O
Data NNP O
View NNP O
( , O
with IN O
overlaps NNS O
) -RRB- O
' '' O
gives VBZ O
the DT O
same JJ O
information NN O
but CC O
shows VBZ O
the DT O
locations NNS O
of IN O
all DT O
QGRS NNP O
. . O

Figure NN O
3 CD O
shows VBZ O
the DT O
Data NNP O
View NNP O
for IN O
product NN O
1 CD O
of IN O
the DT O
GREB1 NNP O
gene NN O
. . O

The DT O
user NN O
can MD O
also RB O
choose VB O
the DT O
Graphics NNP O
View NNP O
to TO O
give VB O
a DT O
visual JJ O
display NN O
of IN O
the DT O
location NN O
of IN O
QGRS NNP O
. . O

This DT O
allows VBZ O
the DT O
user NN O
to TO O
see VB O
the DT O
location NN O
of IN O
QGRS NNP O
relative JJ O
to IN O
exons NNS O
and CC O
introns NNS O
( , O
if IN O
that DT O
information NN O
is VBZ O
available JJ O
) -RRB- O
. . O

The DT O
Graphics NNP O
View NNP O
has VBZ O
the DT O
following VBG O
components NNS O
. . O

A DT O
graphic JJ O
display NN O
of IN O
the DT O
entire JJ O
gene NN O
( , O
showing VBG O
the DT O
location NN O
of IN O
the DT O
exons NNS O
) -RRB- O
. . O

This DT O
display NN O
includes VBZ O
a DT O
sliding VBG O
window NN O
that WDT O
can MD O
be VB O
used VBN O
to TO O
focus VB O
on IN O
any DT O
particular JJ O
segment NN O
of IN O
the DT O
gene NN O
. . O

This DT O
window NN O
may MD O
be VB O
dragged VBN O
to IN O
the DT O
left NN O
or CC O
right JJ O
to TO O
change VB O
position NN O
within IN O
the DT O
gene NN O
. , O
A DT O
magnified JJ O
view NN O
of IN O
the DT O
fragment NN O
of IN O
the DT O
gene NN O
within IN O
the DT O
sliding VBG O
window NN O
. , O
A DT O
graph NN O
showing VBG O
the DT O
location NN O
of IN O
QGRS NNP O
within IN O
the DT O
fragment NN O
, , O
with IN O
each DT O
QGRS NNP O
being VBG O
displayed VBN O
by IN O
a DT O
bar NN O
whose WP$ O
height NN O
represents VBZ O
its PRP$ O
G NN O
- HYPH O
score NN O
. . O
A DT O
vertical JJ O
slider NN O
that WDT O
allows VBZ O
the DT O
user NN O
to TO O
change VB O
the DT O
size NN O
of IN O
the DT O
window NN O
. . O

This DT O
allows VBZ O
the DT O
user NN O
to TO O
zoom VB O
in RP O
or CC O
out RB O
on IN O
any DT O
part NN O
of IN O
the DT O
gene NN O
. . O

The DT O
sliding VBG O
window NN O
on IN O
the DT O
gene NN O
expands VBZ O
or CC O
contracts VBZ O
as IN O
one CD O
zooms VBZ O
in IN O
or CC O
out RB O
. . O

It PRP O
is VBZ O
possible JJ O
to TO O
see VB O
the DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
product NN O
at IN O
maximum JJ O
zoom NN O
levels NNS O
. . O

The DT O
Graphics NNP O
View NNP O
for IN O
the DT O
entire JJ O
gene NN O
shows VBZ O
the DT O
G NN O
- HYPH O
score NN O
graph NN O
together RB O
with IN O
an DT O
exon NN O
/ SYM O
intron NN O
map NN O
for IN O
each DT O
product NN O
. . O

This DT O
allows VBZ O
the DT O
user NN O
to TO O
visually RB O
compare VB O
the DT O
location NN O
of IN O
QGRS NNP O
for IN O
each DT O
product NN O
relative JJ O
to IN O
that DT O
of IN O
splice NN O
sites NNS O
. . O

The DT O
Graphics NNP O
View NNP O
for IN O
the DT O
first JJ O
product NN O
of IN O
the DT O
GREB1 NNP O
gene NN O
is VBZ O
represented VBN O
in IN O
Figure NN O
4 CD O
. . O

The DT O
Graphics NNP O
View NNP O
for IN O
the DT O
entire JJ O
GREB1 NN O
gene NN O
may MD O
be VB O
seen VBN O
in IN O
the DT O
Supplementary NNP O
Data NNP O
. . O

CONCLUSIONS NNS O

QGRS NNP O
Mapper NNP O
is VBZ O
a DT O
user NN O
- HYPH O
friendly JJ O
web NN O
- HYPH O
based VBN O
server NN O
that WDT O
provides VBZ O
computational JJ O
tools NNS O
for IN O
prediction NN O
of IN O
Quadruplex NNP O
forming VBG O
G NN O
- HYPH O
rich JJ O
sequences NNS O
in IN O
the DT O
nucleotide NN O
sequences NNS O
identified VBN O
or CC O
provided VBN O
by IN O
the DT O
user NN O
. . O

The DT O
program NN O
offers VBZ O
many JJ O
options NNS O
, , O
including VBG O
user NN O
- HYPH O
defined VBN O
composition NN O
of IN O
the DT O
quadruplex NN O
. . O

It PRP O
can MD O
analyze VB O
DNA NN O
or CC O
RNA NN O
sequence NN O
provided VBN O
by IN O
the DT O
user NN O
in IN O
the DT O
raw JJ O
or CC O
FASTA NNP O
format NN O
. . O

The DT O
application NN O
also RB O
provides VBZ O
tools NNS O
for IN O
searching VBG O
and CC O
retrieving VBG O
gene NN O
/ SYM O
nucleotide NN O
entries NNS O
from IN O
a DT O
variety NN O
of IN O
NCBI NNP O
databases NNS O
. . O

There EX O
are VBP O
several JJ O
options NNS O
for IN O
data NN O
output NN O
format NN O
, , O
including VBG O
an DT O
interactive JJ O
graphic JJ O
module NN O
. . O

Researchers NNS O
interested JJ O
in IN O
evaluating VBG O
the DT O
ability NN O
of IN O
nucleotide JJ O
sequences NNS O
to TO O
form VB O
unimolecular JJ O
G NNP O
- HYPH O
quadruplexes NNS O
will MD O
find VB O
QGRS NNP O
Mapper NNP O
to TO O
be VB O
very RB O
useful JJ O
. . O

Owing VBG O
to IN O
the DT O
flexible JJ O
and CC O
comprehensive JJ O
nature NN O
of IN O
the DT O
design NN O
, , O
it PRP O
is VBZ O
expected VBN O
to TO O
serve VB O
a DT O
variety NN O
of IN O
scientists NNS O
. . O

The DT O
application NN O
will MD O
be VB O
especially RB O
attractive JJ O
to IN O
individuals NNS O
interested JJ O
in IN O
exploring VBG O
the DT O
role NN O
of IN O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
regulated VBN O
RNA NNP O
processing NN O
. . O

We PRP O
are VBP O
using VBG O
the DT O
server NN O
to TO O
perform VB O
a DT O
large JJ O
- HYPH O
scale NN O
analysis NN O
of IN O
alternatively RB O
processed VBN O
mammalian JJ O
transcripts NNS O
. . O

We PRP O
are VBP O
particularly RB O
interested JJ O
in IN O
studying VBG O
the DT O
composition NN O
and CC O
distribution NN O
patterns NNS O
of IN O
G NNP O
- HYPH O
quadruplexes NNS O
in IN O
the DT O
transcribed VBN O
regions NNS O
of IN O
mammalian JJ O
genes NNS O
. . O

SUPPLEMENTARY NNP O
DATA NNP O

Supplementary JJ O
Data NNS O
are VBP O
available JJ O
at IN O
NAR NNP O
online RB O
. . O

Drug NN O
information NN O
resources NNS O
used VBN O
by IN O
nurse NN O
practitioners NNS O
and CC O
collaborating VBG O
physicians NNS O
at IN O
the DT O
point NN O
of IN O
care NN O
in IN O
Nova NNP O
Scotia NNP O
, , O
Canada NNP O
: : O
a DT O
survey NN O
and CC O
review NN O
of IN O
the DT O
literature NN O

Abstract JJ O

Background NN O

Keeping VBG O
current JJ O
with IN O
drug NN O
therapy NN O
information NN O
is VBZ O
challenging JJ O
for IN O
health NN O
care NN O
practitioners NNS O
. . O

Technologies NNS O
are VBP O
often RB O
implemented VBN O
to TO O
facilitate VB O
access NN O
to IN O
current JJ O
and CC O
credible JJ O
drug NN O
information NN O
sources NNS O
. . O

In IN O
the DT O
Canadian JJ O
province NN O
of IN O
Nova NNP O
Scotia NNP O
, , O
legislation NN O
was VBD O
passed VBN O
in IN O
2002 CD O
to TO O
allow VB O
nurse NN O
practitioners NNS O
( , O
NPs NNPS O
) -RRB- O
to TO O
practice VB O
collaboratively RB O
with IN O
physician JJ O
partners NNS O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
the DT O
current JJ O
utilization NN O
patterns NNS O
of IN O
information NN O
technologies NNS O
by IN O
these DT O
groups NNS O
of IN O
practitioners NNS O
. . O

Methods NNS O

Nurse NN O
practitioners NNS O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
in IN O
Nova NNP O
Scotia NNP O
were VBD O
sent VBN O
a DT O
survey NN O
in IN O
February NNP O
2005 CD O
to TO O
determine VB O
the DT O
frequency NN O
of IN O
use NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
of IN O
personal JJ O
digital JJ O
assistant NN O
( : O
PDA NNP O
) -RRB- O
, , O
computer NN O
, , O
and CC O
print NN O
drug NN O
information NN O
resources NNS O
. . O

Two CD O
surveys NNS O
were VBD O
developed VBN O
( , O
one CD O
for IN O
PDA NNP O
users NNS O
and CC O
one CD O
for IN O
computer NN O
users NNS O
) -RRB- O
and CC O
revised VBN O
based VBN O
on IN O
a DT O
literature NN O
search NN O
, , O
stakeholder NN O
consultation NN O
, , O
and CC O
pilot NN O
- HYPH O
testing VBG O
results NNS O
. . O

A DT O
second JJ O
distribution NN O
to IN O
nonresponders NNS O
occurred VBD O
two CD O
weeks NNS O
following VBG O
the DT O
first JJ O
. . O

Data NNS O
were VBD O
entered VBN O
and CC O
analysed VBN O
with IN O
SPSS NNP O
. . O

Results NNS O

Twenty CD O
- HYPH O
seven CD O
( , O
14 CD O
NPs NNS O
and CC O
13 CD O
physicians NNS O
) -RRB- O
of IN O
36 CD O
( SYM O
75 CD O
% NN O
) -RRB- O
recipients NNS O
responded VBD O
. . O

22 CD O
% NN O
( SYM O
6 CD O
) SYM O
returned VBN O
personal JJ O
digital JJ O
assistant NN O
( : O
PDA NNP O
) -RRB- O
surveys NNS O
. . O

Respondents NNS O
reported VBD O
print NN O
, , O
health NN O
professionals NNS O
, , O
and CC O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
as IN O
the DT O
most RBS O
to IN O
least JJS O
preferred VBN O
means NNS O
to TO O
access VB O
drug NN O
information NN O
, , O
respectively RB O
. . O

37 CD O
% NN O
and CC O
35 CD O
% NN O
of IN O
respondents NNS O
reported VBN O
using VBG O
"""" `` O
both CC O
print NN O
and CC O
electronic JJ O
but CC O
print NN O
more JJR O
than IN O
electronic JJ O
"""" '' O
and CC O
"""" `` O
print NN O
only RB O
"""" '' O
, , O
respectively RB O
, , O
to TO O
search VB O
monograph NN O
- HYPH O
related VBN O
drug NN O
information NN O
queries NNS O
whereas IN O
4 CD O
% NN O
reported VBD O
using VBG O
"""" `` O
PDA NNP O
only RB O
"""" '' O
. . O

Analysis NN O
of IN O
respondent NN O
ratings NNS O
for IN O
all DT O
resources NNS O
in IN O
the DT O
categories NNS O
print NN O
, , O
health NN O
professionals NNS O
and CC O
other JJ O
, , O
and CC O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
, , O
indicated VBD O
that IN O
the DT O
Compendium NNP O
of IN O
Pharmaceuticals NNPS O
and CC O
Specialties NNPS O
and CC O
pharmacists NNS O
ranked VBD O
highly RB O
for IN O
frequency NN O
of IN O
use NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
by IN O
both DT O
groups NNS O
of IN O
practitioners NNS O
. . O

Respondents NNS O
' POS O
preferences NNS O
and CC O
resource NN O
ratings NNS O
were VBD O
consistent JJ O
with IN O
self NN O
- HYPH O
reported VBN O
methods NNS O
for IN O
conducting VBG O
drug NN O
information NN O
queries NNS O
. . O

Few JJ O
differences NNS O
existed VBD O
between IN O
NP NNP O
and CC O
physician NN O
rankings NNS O
of IN O
resources NNS O
. . O

Conclusion NN O

The DT O
use NN O
of IN O
computers NNS O
and CC O
PDAs NNS O
remains VBZ O
limited JJ O
, , O
which WDT O
is VBZ O
also RB O
consistent JJ O
with IN O
preferred JJ O
and CC O
frequent JJ O
use NN O
of IN O
print NN O
resources NNS O
. . O

Education NN O
for IN O
these DT O
practitioners NNS O
regarding VBG O
available JJ O
electronic JJ O
drug NN O
information NN O
resources NNS O
may MD O
facilitate VB O
future JJ O
computer NN O
and CC O
PDA NN O
use NN O
. . O

Further JJ O
research NN O
is VBZ O
needed VBN O
to TO O
determine VB O
methods NNS O
to TO O
increase VB O
computer NN O
and CC O
PDA NN O
use NN O
and CC O
whether IN O
these DT O
technologies NNS O
affect VBP O
prescribing NN O
and CC O
patient NN B-Species
outcomes NNS O
. . O

Background NN O

Challenges NNS O
with IN O
knowledge NN O
management NN O
for IN O
health NN O
care NN O
professionals NNS O

In IN O
1986 CD O
, , O
Haynes NNP O
et FW O
al NNP O
. , O
published VBD O
a DT O
series NN O
of IN O
6 CD O
articles NNS O
entitled VBN O
"""" `` O
how WRB O
to TO O
keep VB O
up RP O
with IN O
the DT O
medical JJ O
literature NN O
"""" '' O
in IN O
an DT O
effort NN O
to TO O
help VB O
clinicians NNS O
with IN O
information NN O
management NN O
, , O
but CC O
this DT O
challenge NN O
has VBZ O
not RB O
decreased VBN O
in IN O
last JJ O
two CD O
decades NNS O
[ -LRB- O
1 CD O
- SYM O
6 CD O
] -RRB- O
. . O

Alper NNP O
et FW O
al JJ O
. . O
suggest VBP O
that IN O
maintaining VBG O
currency NN O
with IN O
relevant JJ O
literature NN O
in IN O
primary JJ O
care NN O
would MD O
"""" `` O
require VB O
627 CD O
. . O
5 CD O
hours NNS O
per IN O
month NN O
, , O
or CC O
about RB O
29 CD O
hours NNS O
per IN O
weekday NN O
, , O
or CC O
3 CD O
. . O
6 CD O
full JJ O
- HYPH O
time NN O
equivalents NNS O
of IN O
physician NN O
effort NN O
"""" '' O
[ -LRB- O
7 CD O
] -RRB- O
. . O

The DT O
volume NN O
of IN O
information NN O
associated VBN O
with IN O
keeping VBG O
up RP O
to IN O
date NN O
is VBZ O
frequently RB O
cited VBN O
as IN O
a DT O
barrier NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
estimated VBN O
that IN O
annually RB O
there EX O
are VBP O
approximately RB O
10 CD O
, , O
0 CD O
new JJ O
randomized JJ O
trials NNS O
in IN O
MEDLINE NNP O
and CC O
over IN O
450 CD O
, , O
0 CD O
clinical JJ O
trials NNS O
identified VBN O
by IN O
the DT O
Cochrane NNP O
Collaboration NNP O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
. . O

Keeping VBG O
up RP O
to IN O
date NN O
has VBZ O
been VBN O
described VBN O
with IN O
several JJ O
analogies NNS O
including VBG O
clinicians NNS O
attempting VBG O
to TO O
drink VB O
water NN O
from IN O
a DT O
fire NN O
hose NN O
and CC O
swimming VBG O
in IN O
rivers NNS O
of IN O
clinical JJ O
research NN O
with IN O
unprecedented JJ O
depth NN O
, , O
velocity NN O
, , O
and CC O
turbulence NN O
[ -LRB- O
11 CD O
, , O
12 CD O
] -RRB- O
. . O

Difficulties NNS O
with IN O
dissemination NN O
of IN O
research NN O
evidence NN O
and CC O
keeping VBG O
up RP O
to IN O
date NN O
on IN O
pharmacotherapeutic JJ O
interventions NNS O
are VBP O
reported VBN O
despite IN O
the DT O
development NN O
of IN O
tools NNS O
such JJ O
as IN O
clinical JJ O
practice NN O
guidelines NNS O
and CC O
systematic JJ O
reviews NNS O
that WDT O
are VBP O
intended VBN O
to TO O
reduce VB O
the DT O
need NN O
for IN O
practitioners NNS O
to TO O
evaluate VB O
original JJ O
research NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

To TO O
complicate VB O
matters NNS O
further RB O
, , O
there EX O
are VBP O
often RB O
issues NNS O
of IN O
credibility NN O
, , O
timeliness NN O
, , O
and CC O
volume NN O
of IN O
clinical JJ O
practice NN O
guidelines NNS O
and CC O
reviews NNS O
. . O

Many JJ O
guidelines NNS O
are VBP O
criticized VBN O
for IN O
their PRP$ O
methodological JJ O
development NN O
. . O

Shaneyfelt NNP O
et FW O
al NNP O
. . O
reviewed VBD O
279 CD O
guidelines NNS O
for IN O
methodological JJ O
standards NNS O
from IN O
peer NN O
reviewed VBN O
medical JJ O
literature NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

These DT O
authors NNS O
found VBD O
that IN O
only RB O
51 CD O
% NN O
, , O
33 CD O
. . O
6 CD O
% NN O
, , O
and CC O
46 CD O
% NN O
adhered VBN O
to IN O
standards NNS O
on IN O
guideline NN O
development NN O
and CC O
format NN O
, , O
evidence NN O
identification NN O
and CC O
summary NN O
, , O
and CC O
formulation NN O
of IN O
recommendations NNS O
, , O
respectively RB O
[ -LRB- O
14 CD O
] -RRB- O
. . O

A DT O
Canadian JJ O
review NN O
on IN O
drug NN O
therapy NN O
guidelines NNS O
found VBD O
significant JJ O
variation NN O
in IN O
quality NN O
depending VBG O
on IN O
the DT O
developer NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Approximately RB O
25 CD O
% NN O
of IN O
guidelines NNS O
were VBD O
not RB O
recommended VBN O
for IN O
use NN O
in IN O
practice NN O
by IN O
the DT O
appraisers NNS O
' POS O
criteria NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

As IN O
an DT O
example NN O
of IN O
the DT O
volume NN O
of IN O
clinical JJ O
practice NN O
guidelines NNS O
available JJ O
, , O
eleven CD O
recent JJ O
guidelines NNS O
on IN O
community NN O
acquired VBN O
pneumonia NN O
exist VBP O
[ -LRB- O
15 CD O
] -RRB- O
. . O

To TO O
add VB O
to IN O
the DT O
complexities NNS O
involved VBN O
with IN O
keeping VBG O
current JJ O
with IN O
pharmacotherapeutic JJ O
management NN O
strategies NNS O
, , O
as IN O
of IN O
2000 CD O
, , O
there EX O
were VBD O
over IN O
22 CD O
, , O
0 CD O
drug NN O
products NNS O
approved VBN O
for IN O
sale NN O
in IN O
Canada NNP O
for IN O
human JJ B-Species
use NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

There EX O
is VBZ O
also RB O
considerable JJ O
debate NN O
regarding VBG O
what WP O
constitutes VBZ O
"""" `` O
evidence NN O
"""" '' O
in IN O
practice NN O
, , O
which WDT O
contributes VBZ O
to IN O
confusion NN O
for IN O
clinicians NNS O
[ -LRB- O
17 CD O
, , O
18 CD O
] -RRB- O
. . O

Sim NNP O
et FW O
al NNP O
. . O
succinctly RB O
describe VBP O
the DT O
gap NN O
between IN O
evidence NN O
and CC O
action NN O
as IN O
difficulties NNS O
with IN O
obtaining VBG O
, , O
systematically RB O
reviewing VBG O
, , O
applying VBG O
in IN O
context NN O
, , O
and CC O
measuring VBG O
the DT O
outcome NN O
following VBG O
application NN O
of IN O
evidence NN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Maintaining VBG O
competence NN O
- HYPH O
nurse NN O
practitioners NNS O
as IN O
a DT O
new JJ O
group NN O
of IN O
prescribers NNS O

Competencies NNS O
for IN O
nurse NN O
practitioners NNS O
( -LRB- O
NPs NNS O
) -RRB- O
on IN O
a DT O
local JJ O
and CC O
international JJ O
level NN O
include VBP O
critically RB O
appraising VBG O
and CC O
applying VBG O
literature NN O
and CC O
research NN O
findings NNS O
in IN O
practice NN O
[ -LRB- O
20 CD O
- SYM O
23 CD O
] -RRB- O
. . O

The DT O
Canadian NNP O
Nurses NNPS O
Association NNP O
( : O
CNA NNP O
) -RRB- O
has VBZ O
developed VBN O
the DT O
Canadian NNP O
Nurse NNP O
Practitioner NNP O
Core NNP O
Competency NNP O
Framework NNP O
that WDT O
describes VBZ O
the DT O
knowledge NN O
, , O
skills NNS O
, , O
judgment NN O
, , O
and CC O
attributes NNS O
required VBN O
for IN O
practice NN O
. . O

Evidence NN O
based VBN O
practice NN O
is VBZ O
integral JJ O
to IN O
pharmacotherapeutic JJ O
interventions NNS O
and CC O
prescribing NN O
competencies NNS O
[ -LRB- O
23 CD O
] -RRB- O
. . O

The DT O
National NNP O
Prescribing NNP O
Centre NNP O
, , O
an DT O
organization NN O
of IN O
the DT O
National NNP O
Health NNP O
Service NNP O
in IN O
the DT O
UK NNP O
, , O
describes VBZ O
several JJ O
competencies NNS O
around IN O
information NN O
needs NNS O
relevant JJ O
to IN O
prescribing NN O
and CC O
emphasis NN O
is VBZ O
placed VBN O
on IN O
using VBG O
relevant JJ O
and CC O
up IN O
to IN O
date NN O
information NN O
in IN O
various JJ O
formats NNS O
( , O
e LS O
. . O
g LS O
. . O
print NN O
, , O
electronic JJ O
, , O
verbal JJ O
) -RRB- O
. . O

Several JJ O
related JJ O
competencies NNS O
include VBP O
understanding VBG O
advantages NNS O
and CC O
disadvantages NNS O
of IN O
information NN O
sources NNS O
and CC O
the DT O
currency NN O
of IN O
resources NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Researchers NNS O
in IN O
the DT O
US NNP O
developed VBD O
NP NNP O
informatics NNS O
competencies NNS O
for IN O
integration NN O
into IN O
advanced JJ O
nursing NN O
practice NN O
curricula NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Competencies NNS O
related VBN O
to IN O
informatics NNS O
knowledge NN O
include VBP O
critical JJ O
analysis NN O
of IN O
data NNS O
and CC O
information NN O
for IN O
use NN O
in IN O
evidence NN O
based VBN O
practice NN O
, , O
evaluating VBG O
and CC O
applying VBG O
relevant JJ O
information NN O
, , O
synthesizing VBG O
best JJS O
evidence NN O
, , O
and CC O
using VBG O
optimal JJ O
search NN O
strategies NNS O
to TO O
locate VB O
clinically RB O
sound JJ O
and CC O
useful JJ O
studies NNS O
from IN O
information NN O
resources NNS O
[ -LRB- O
24 CD O
] -RRB- O
. . O

Achieving VBG O
and CC O
maintaining VBG O
competence NN O
in IN O
these DT O
domains NNS O
as RB O
well RB O
as IN O
a DT O
solid JJ O
foundation NN O
in IN O
pharmacology NN O
is VBZ O
necessary JJ O
to TO O
support VB O
NPs NNPS O
in IN O
their PRP$ O
relatively RB O
new JJ O
role NN O
as IN O
a DT O
prescriber NN O
[ -LRB- O
25 CD O
- SYM O
27 CD O
] -RRB- O
. . O

Knowledge NN O
management NN O
and CC O
information NN O
seeking VBG O
behaviours NNS O
among IN O
nurse NN O
practitioners NNS O
and CC O
physicians NNS O

Information NN O
seeking VBG O
behaviours NNS O
of IN O
physicians NNS O
are VBP O
better RBR O
documented VBN O
than IN O
NPs NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Information NN O
related VBN O
to IN O
diagnosis NN O
is VBZ O
important JJ O
to IN O
both DT O
groups NNS O
but CC O
drug NN O
therapy NN O
queries NNS O
may MD O
occur VB O
more RBR O
frequently RB O
with IN O
NPs NNS O
[ -LRB- O
28 CD O
- SYM O
33 CD O
] -RRB- O
. . O

Research NN O
on IN O
nurses NNS O
' POS O
behaviours NNS O
related VBN O
to IN O
information NN O
seeking VBG O
is VBZ O
available JJ O
from IN O
the DT O
hospital NN O
setting NN O
[ -LRB- O
33 CD O
- HYPH O
35 CD O
] -RRB- O
but CC O
the DT O
generalizability NN O
of IN O
these DT O
behaviours NNS O
to IN O
NPs NNPS O
with IN O
a DT O
prescribing VBG O
role NN O
is VBZ O
unclear JJ O
. . O

Differences NNS O
in IN O
nursing NN O
roles NNS O
, , O
responsibilities NNS O
, , O
and CC O
legislation NN O
, , O
including VBG O
prescriptive JJ O
authority NN O
, , O
exist VBP O
depending VBG O
on IN O
the DT O
country NN O
of IN O
practice NN O
. . O

Nurse NN O
practitioners NNS O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
in IN O
Nova NNP O
Scotia NNP O

Nova NNP O
Scotia NNP O
is VBZ O
a DT O
Canadian JJ O
province NN O
with IN O
a DT O
population NN O
of IN O
approximately RB O
942 CD O
, , O
0 CD O
[ SYM O
36 CD O
] -RRB- O
. . O

The DT O
province NN O
is VBZ O
divided VBN O
into IN O
six CD O
health NN O
zones NNS O
that WDT O
include VBP O
nine CD O
district NN O
health NN O
authorities NNS O
, , O
one CD O
of IN O
which WDT O
includes VBZ O
the DT O
provincial JJ O
capital NN O
and CC O
is VBZ O
considered VBN O
to TO O
be VB O
urban JJ O
[ -LRB- O
37 CD O
, , O
38 CD O
] -RRB- O
. . O

Health NN O
care NN O
service NN O
delivery NN O
is VBZ O
challenging JJ O
due IN O
to IN O
many JJ O
factors NNS O
including VBG O
the DT O
rural JJ O
nature NN O
of IN O
the DT O
province NN O
, , O
which WDT O
is VBZ O
estimated VBN O
to TO O
be VB O
60 CD O
% NN O
of IN O
population NN O
[ -LRB- O
37 CD O
, , O
39 CD O
] -RRB- O
. . O

Starting VBG O
in IN O
1998 CD O
, , O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
led VBD O
an DT O
initiative NN O
to TO O
explore VB O
different JJ O
methods NNS O
of IN O
delivering VBG O
, , O
managing VBG O
, , O
and CC O
funding VBG O
primary JJ O
care NN O
services NNS O
. . O

The DT O
Strengthening NNP O
Primary NNP O
Care NNP O
in IN O
Nova NNP O
Scotia NNP O
Communities NNPS O
Initiative NNP O
( -LRB- O
SPCI NNP O
) -RRB- O
was VBD O
established VBN O
with IN O
the DT O
selection NN O
of IN O
four CD O
primary JJ O
care NN O
demonstration NN O
sites NNS O
where WRB O
a DT O
primary JJ O
health NN O
care NN O
NP NNP O
was VBD O
hired VBN O
to TO O
practice VB O
collaboratively RB O
with IN O
one CD O
or CC O
more JJR O
family NN O
/ SYM O
general JJ O
physicians NNS O
and CC O
other JJ O
members NNS O
of IN O
an DT O
interdisciplinary JJ O
team NN O
. . O

Each DT O
demonstration NN O
site NN O
adopted VBD O
alternative JJ O
( , O
non JJ O
fee NN O
- HYPH O
for IN O
- HYPH O
service NN O
) -RRB- O
physician NN O
payment NN O
mechanisms NNS O
and CC O
used VBD O
electronic JJ O
patient NN B-Species
records NNS O
( -LRB- O
EPRs NNS O
) -RRB- O
to TO O
support VB O
service NN O
delivery NN O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Demonstration NN O
sites NNS O
participated VBD O
in IN O
project NN O
evaluation NN O
components NNS O
that WDT O
included VBD O
, , O
but CC O
were VBD O
not RB O
limited VBN O
to IN O
, , O
NP NNP O
roles NNS O
, , O
alternative JJ O
fee NN O
structures NNS O
, , O
consumer NN O
satisfaction NN O
, , O
and CC O
implementation NN O
and CC O
integration NN O
of IN O
EPRs NNS O
[ -LRB- O
41 CD O
, , O
42 CD O
] -RRB- O
. . O

Legislation NN O
to TO O
allow VB O
NPs NNPS O
to TO O
practice VB O
collaboratively RB O
with IN O
physicians NNS O
in IN O
Nova NNP O
Scotia NNP O
was VBD O
passed VBN O
in IN O
2002 CD O
, , O
part NN O
way NN O
through IN O
the DT O
SPCI NNP O
project NN O
[ -LRB- O
39 CD O
] -RRB- O
. . O

Prescriptive JJ O
authority NN O
granted VBN O
through IN O
legislation NN O
authorizes VBZ O
NPs NNPS O
to TO O
prescribe VB O
from IN O
a DT O
schedule NN O
of IN O
drugs NNS O
[ -LRB- O
43 CD O
, , O
44 CD O
] -RRB- O
. . O

At IN O
the DT O
time NN O
of IN O
conducting VBG O
this DT O
research NN O
project NN O
, , O
16 CD O
primary JJ O
health NN O
care NN O
NPs NNS O
were VBD O
in IN O
active JJ O
practice NN O
[ -LRB- O
43 CD O
] -RRB- O
. . O

The DT O
EPR NNP O
component NN O
of IN O
the DT O
SPCI NNP O
project NN O
evaluation NN O
provided VBD O
information NN O
on IN O
the DT O
use NN O
of IN O
technologies NNS O
in IN O
the DT O
community NN O
context NN O
. . O

Results NNS O
from IN O
the DT O
implementation NN O
process NN O
indicated VBD O
that IN O
considerable JJ O
attention NN O
is VBZ O
required VBN O
for IN O
technology NN O
literacy NN O
, , O
time NN O
for IN O
training NN O
, , O
and CC O
selection NN O
of IN O
software NN O
for IN O
EPRs NNS O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Although IN O
the DT O
majority NN O
of IN O
community NN O
- HYPH O
based VBN O
, , O
non JJ O
- HYPH O
institutional JJ O
clinical JJ O
practice NN O
settings NNS O
in IN O
Nova NNP O
Scotia NNP O
primarily RB O
operate VBP O
with IN O
paper NN O
- HYPH O
based VBN O
charting NN O
systems NNS O
, , O
there EX O
is VBZ O
a DT O
movement NN O
toward IN O
integrating VBG O
electronic JJ O
technologies NNS O
, , O
including VBG O
the DT O
EPR NNP O
, , O
in IN O
practice NN O
among IN O
health NN O
care NN O
providers NNS O
, , O
administrators NNS O
, , O
and CC O
the DT O
provincial JJ O
government NN O
. . O

In IN O
addition NN O
to IN O
recording VBG O
patient JJ B-Species
visit NN O
information NN O
, , O
a DT O
component NN O
of IN O
the DT O
EPR NNP O
package NN O
serves VBZ O
to TO O
provide VB O
drug NN O
information NN O
resources NNS O
. . O

Drug NN O
therapy NN O
information NN O
resources NNS O
for IN O
NPs NNS O
and CC O
nurse NN O
prescribers NNS O
have VBP O
frequently RB O
been VBN O
described VBN O
as IN O
essential JJ O
in IN O
supporting VBG O
practice NN O
[ -LRB- O
25 CD O
, , O
28 CD O
, , O
29 CD O
] -RRB- O
. . O

The DT O
role NN O
of IN O
NPs NNPS O
is VBZ O
relatively RB O
new JJ O
in IN O
Canada NNP O
[ -LRB- O
39 CD O
] -RRB- O
and CC O
there EX O
is VBZ O
limited JJ O
information NN O
available JJ O
to TO O
indicate VB O
the DT O
type NN O
of IN O
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
print NN O
, , O
electronic JJ O
, , O
EPR NN O
based VBN O
) -RRB- O
these DT O
prescribers NNS O
use VBP O
for IN O
drug NN O
and CC O
therapeutic JJ O
information NN O
queries NNS O
at IN O
the DT O
point NN O
of IN O
care NN O
. . O

It PRP O
is VBZ O
unknown JJ O
as IN O
to IN O
whether IN O
differences NNS O
exist VBP O
regarding VBG O
types NNS O
of IN O
resources NNS O
used VBN O
, , O
drug NN O
information NN O
needs NNS O
, , O
and CC O
utilization NN O
patterns NNS O
among IN O
NPs NNS O
and CC O
collaborating VBG O
physician NN O
partners NNS O
. . O

Some DT O
research NN O
has VBZ O
suggested VBN O
that IN O
the DT O
degree NN O
of IN O
multidisciplinary JJ O
team NN O
functioning NN O
relates VBZ O
to IN O
the DT O
adoption NN O
of IN O
technology NN O
or CC O
innovations NNS O
in IN O
practice NN O
but CC O
more JJR O
research NN O
is VBZ O
required VBN O
to TO O
determine VB O
the DT O
extent NN O
of IN O
these DT O
relationships NNS O
[ -LRB- O
45 CD O
, , O
46 CD O
] -RRB- O
. . O

The DT O
use NN O
of IN O
EPR NNP O
technology NN O
is VBZ O
increasing VBG O
in IN O
Nova NNP O
Scotia NNP O
but CC O
little JJ O
information NN O
is VBZ O
available JJ O
regarding VBG O
the DT O
readiness NN O
of IN O
practitioners NNS O
for IN O
use NN O
of IN O
specific JJ O
features NNS O
such JJ O
as IN O
drug NN O
information NN O
resources NNS O
. . O

Based VBN O
on IN O
the DT O
EPR NNP O
related VBN O
results NNS O
of IN O
the DT O
SPCI NNP O
evaluation NN O
, , O
use NN O
of IN O
these DT O
functions NNS O
could MD O
be VB O
challenging JJ O
without IN O
proper JJ O
facilitation NN O
. . O

The DT O
purpose NN O
of IN O
the DT O
survey NN O
for IN O
this DT O
research NN O
was VBD O
to TO O
describe VB O
drug NN O
information NN O
resources NNS O
used VBN O
by IN O
NPs NNPS O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
at IN O
the DT O
point NN O
of IN O
care NN O
. . O

The DT O
results NNS O
of IN O
the DT O
survey NN O
will MD O
be VB O
used VBN O
to TO O
guide VB O
further JJ O
technology NN O
implementation NN O
strategies NNS O
and CC O
stimulate VB O
further JJ O
discussion NN O
around IN O
drug NN O
information NN O
resource NN O
usage NN O
at IN O
the DT O
point NN O
of IN O
care NN O
. . O

Methods NNS O

Survey NN O
development NN O

Survey NN O
development NN O
involved VBD O
three CD O
stages NNS O
including VBG O
identification NN O
of IN O
important JJ O
content NN O
areas NNS O
, , O
development NN O
of IN O
draft NN O
questions NNS O
, , O
and CC O
survey NN O
refinement NN O
. . O

Identifying VBG O
important JJ O
content NN O
areas NNS O
for IN O
inclusion NN O
in IN O
the DT O
survey NN O
involved VBD O
conducting VBG O
a DT O
comprehensive JJ O
English NNP O
language NN O
literature NN O
search NN O
, , O
consultation NN O
with IN O
relevant JJ O
stakeholders NNS O
( , O
e LS O
. . O
g LS O
. . O
members NNS O
of IN O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
) -RRB- O
, , O
and CC O
input NN O
from IN O
subject NN O
matter NN O
experts NNS O
at IN O
Dalhousie NNP O
University NNP O
. . O

The DT O
literature NN O
review NN O
was VBD O
conducted VBN O
using VBG O
the DT O
following VBG O
bibliographic JJ O
databases NNS O
: : O
PubMed NNP O
, , O
Cumulative NNP O
Index NNP O
to IN O
Nursing NNP O
and CC O
Allied NNP O
Health NNP O
Literature NNP O
( , O
CINAHL NNP O
) -RRB- O
, , O
International NNP O
Pharmaceutical NNP O
Abstracts NNPS O
( : O
IPA NNP O
) -RRB- O
, , O
and CC O
Web NNP O
of IN O
Science NNP O
Citation NNP O
Databases NNPS O
. . O

Hand NN O
and CC O
electronic JJ O
searching NN O
of IN O
relevant JJ O
journals NNS O
was VBD O
also RB O
conducted VBN O
. . O

Broad JJ O
search NN O
terms NNS O
were VBD O
used VBN O
without IN O
limits NNS O
on IN O
publication NN O
date NN O
or CC O
place NN O
as IN O
nurse NN O
practitioner NN O
titles NNS O
, , O
roles NNS O
and CC O
scopes NNS O
of IN O
practice NN O
, , O
and CC O
terminology NN O
regarding VBG O
technology NN O
vary VBP O
nationally RB O
and CC O
internationally RB O
. . O

Some DT O
examples NNS O
of IN O
terms NNS O
used VBN O
included VBD O
nurse NN O
practitioner NN O
, , O
nurse NN O
prescriber NN O
, , O
nurse NN O
clinicians NNS O
, , O
district NN O
nurse NN O
, , O
health NN O
visitor NN O
, , O
drug NN O
information NN O
resources NNS O
, , O
drug NN O
information NN O
services NNS O
, , O
information NN O
needs NNS O
, , O
and CC O
information NN O
technology NN O
. . O

The DT O
draft NN O
survey NN O
was VBD O
reviewed VBN O
by IN O
the DT O
research NN O
team NN O
to TO O
reduce VB O
the DT O
number NN O
of IN O
items NNS O
and CC O
improve VB O
clarity NN O
. . O

The DT O
layout NN O
of IN O
the DT O
questionnaire NN O
was VBD O
carefully RB O
examined VBN O
to TO O
ensure VB O
that IN O
it PRP O
was VBD O
easy JJ O
to TO O
follow VB O
and CC O
complete VB O
. . O

Research NN O
results NNS O
from IN O
a DT O
previous JJ O
investigation NN O
of IN O
Nova NNP O
Scotian NNP O
physicians NNS O
' POS O
behaviours NNS O
regarding VBG O
drug NN O
information NN O
were VBD O
also RB O
used VBN O
to TO O
further RB O
revise VB O
the DT O
survey NN O
[ -LRB- O
47 CD O
] -RRB- O
. . O

This DT O
draft NN O
questionnaire NN O
was VBD O
pilot NN O
tested VBN O
by IN O
two CD O
out IN O
of IN O
province NN O
NPs NNS O
and CC O
one CD O
physician NN O
. . O

The DT O
results NNS O
of IN O
the DT O
pilot NN O
were VBD O
used VBN O
to TO O
make VB O
final JJ O
revisions NNS O
to IN O
the DT O
survey NN O
. . O

Based VBN O
on IN O
pilot NN O
- HYPH O
testing VBG O
feedback NN O
and CC O
investigator NN O
consensus NN O
, , O
the DT O
final JJ O
survey NN O
was VBD O
divided VBN O
into IN O
2 CD O
versions NNS O
, , O
one CD O
for IN O
personal JJ O
digital JJ O
assistant NN O
( : O
PDA NN O
) -RRB- O
users NNS O
and CC O
one CD O
for IN O
computer NN O
users NNS O
. . O

The DT O
10 CD O
page NN O
surveys NNS O
for IN O
PDA NNP O
and CC O
computer NN O
users NNS O
had VBD O
5 CD O
or CC O
6 CD O
sections NNS O
, , O
respectively RB O
, , O
and CC O
37 CD O
questions NNS O
, , O
many JJ O
with IN O
multiple JJ O
parts NNS O
. . O

The DT O
survey NN O
content NN O
included VBD O
demographics NNS O
, , O
computer NN O
or CC O
PDA NN O
use NN O
and CC O
experience NN O
, , O
drug NN O
and CC O
therapeutic JJ O
resource NN O
use NN O
and CC O
preferences NNS O
, , O
PDA NNP O
future JJ O
use NN O
, , O
perceived VBN O
barriers NNS O
and CC O
facilitators NNS O
to IN O
PDA NN O
use NN O
, , O
and CC O
technology NN O
training NN O
preferences NNS O
. . O

Section NN O
one CD O
contained VBD O
demographic JJ O
questions NNS O
such JJ O
as IN O
gender NN O
, , O
age NN O
, , O
job NN O
title NN O
, , O
volume NN O
of IN O
patients NNS B-Species
, , O
and CC O
EPR NN O
availability NN O
in IN O
the DT O
practice NN O
setting NN O
. . O

Section NN O
two CD O
was VBD O
designed VBN O
to TO O
determine VB O
PDA NN O
or CC O
computer NN O
use NN O
and CC O
experience NN O
in IN O
the DT O
practice NN O
setting NN O
with IN O
questions NNS O
regarding VBG O
length NN O
of IN O
use NN O
, , O
costs NNS O
, , O
and CC O
work NN O
versus IN O
home NN O
usage NN O
. . O

This DT O
section NN O
also RB O
addressed VBD O
usage NN O
and CC O
rating NN O
of IN O
different JJ O
drug NN O
information NN O
resources NNS O
. . O

Resource NN O
ratings NNS O
were VBD O
based VBN O
on IN O
the DT O
frequency NN O
of IN O
usage NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
. . O

Resources NNS O
were VBD O
grouped VBN O
as IN O
print NN O
( : O
i LS O
. . O
e ADD O
. . O
books NNS O
, , O
journals NNS O
, , O
and CC O
clinical JJ O
practice NN O
guidelines NNS O
) -RRB- O
, , O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
, , O
and CC O
health NN O
professionals NNS O
and CC O
other JJ O
. . O

Respondents NNS O
used VBD O
5 CD O
- HYPH O
point NN O
Likert NNP O
scales NNS O
( , O
strongly RB O
agree VB O
to TO O
strongly RB O
disagree VB O
) , O
for IN O
rating VBG O
opinions NNS O
related VBN O
to IN O
resources NNS O
. . O

A DT O
rating NN O
of IN O
6 CD O
( : O
not RB O
applicable JJ O
, , O
I PRP O
do VBP O
not RB O
use VB O
this DT O
resource NN O
) -RRB- O
was VBD O
also RB O
included VBN O
for IN O
respondents NNS O
who WP O
did VBD O
not RB O
use VB O
a DT O
particular JJ O
resource NN O
. . O

Frequency NN O
of IN O
searching VBG O
for IN O
specific JJ O
information NN O
was VBD O
rated VBN O
on IN O
a DT O
3 CD O
- HYPH O
point NN O
Likert NNP O
scale NN O
( : O
frequently RB O
to IN O
never RB O
) -RRB- O
. . O

The DT O
final JJ O
sections NNS O
of IN O
the DT O
survey NN O
included VBD O
categorical JJ O
, , O
open RB O
- HYPH O
ended JJ O
, , O
and CC O
Likert NNP O
scale NN O
questions NNS O
regarding VBG O
preferred JJ O
resources NNS O
, , O
technology NN O
barriers NNS O
, , O
PDA NNP O
future JJ O
use NN O
, , O
and CC O
technology NN O
training NN O
preferences NNS O
. . O

Copies NNS O
of IN O
the DT O
surveys NNS O
are VBP O
attached VBN O
as IN O
an DT O
appendix NN O
in IN O
PDF NNP O
format NN O
[ -LRB- O
see VBP O
additional JJ O
file NN O
1 CD O
and CC O
2 CD O
] -RRB- O
or CC O
can MD O
also RB O
be VB O
accessed VBN O
from IN O
the DT O
Initiative NNP O
for IN O
Medication NNP O
Management NNP O
, , O
Policy NNP O
Analysis NNP O
, , O
Research NNP O
& CC O
Training NNP O
( , O
IMPART NNP O
) -RRB- O
website NN O
[ -LRB- O
48 CD O
] -RRB- O
. . O

Ethics NNS O
approval NN O
for IN O
the DT O
survey NN O
was VBD O
granted VBN O
through IN O
Dalhousie NNP O
University NNP O
Research NNP O
Ethics NNP O
Board NNP O
on IN O
February NNP O
3 CD O
, , O
2005 CD O
. . O

Survey NN O
population NN O

Licensed VBN O
, , O
actively RB O
practicing VBG O
, , O
primary JJ O
health NN O
care NN O
NPs NNS O
( : O
n -LRB- O
= SYM O
16 CD O
) -RRB- O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
( : O
n CD O
= SYM O
21 CD O
) -RRB- O
were VBD O
eligible JJ O
to TO O
participate VB O
. . O

Survey NN O
procedures NNS O

The DT O
survey NN O
recruitment NN O
procedures NNS O
were VBD O
based VBN O
on IN O
the DT O
methods NNS O
of IN O
Dillman NNP O
[ -LRB- O
49 CD O
] -RRB- O
and CC O
Salant NNP O
and CC O
Dillman NNP O
[ -LRB- O
50 CD O
] -RRB- O
. . O

Survey NN O
packages NNS O
contained VBD O
a DT O
cover NN O
letter NN O
, , O
separate JJ O
surveys NNS O
for IN O
PDA NNP O
and CC O
computer NN O
users NNS O
, , O
and CC O
a DT O
return NN O
self NN O
- HYPH O
addressed VBN O
stamped VBN O
envelope NN O
. . O

The DT O
covering VBG O
letter NN O
instructed VBD O
respondents NNS O
to TO O
self VB O
- HYPH O
select VB O
the DT O
appropriate JJ O
survey NN O
( , O
either CC O
PDA NNP O
or CC O
computer NN O
) -RRB- O
based VBN O
on IN O
their PRP$ O
drug NN O
information NN O
seeking VBG O
behaviours NNS O
. . O

Participants NNS B-Species
who WP O
had VBD O
used VBN O
a DT O
PDA NNP O
at IN O
any DT O
time NN O
were VBD O
instructed VBN O
to TO O
complete VB O
the DT O
PDA NNP O
version NN O
of IN O
the DT O
survey NN O
. . O

Those DT O
who WP O
had VBD O
never RB O
used VBN O
a DT O
PDA NNP O
for IN O
drug NN O
information NN O
were VBD O
instructed VBN O
to TO O
complete VB O
the DT O
computer NN O
version NN O
of IN O
the DT O
survey NN O
. . O

Several JJ O
strategies NNS O
were VBD O
used VBN O
to TO O
optimize VB O
response NN O
rate NN O
and CC O
included VBD O
: : O
personalized JJ O
cover NN O
letters NNS O
, , O
coloured VBN O
paper NN O
for IN O
surveys NNS O
, , O
stamped VBN O
return NN O
envelopes NNS O
, , O
follow VB O
- HYPH O
up NN O
mailing NN O
, , O
and CC O
a DT O
priority NN O
post NN O
mailing NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

The DT O
covering VBG O
letter NN O
included VBD O
coloured JJ O
logos NNS O
of IN O
Dalhousie NNP O
University NNP O
and CC O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
representing VBG O
the DT O
investigator NN O
affiliations NNS O
and CC O
endorsement NN O
of IN O
the DT O
project NN O
. . O

A DT O
master NN O
mailing NN O
list NN O
with IN O
names NNS O
and CC O
addresses NNS O
of IN O
NPs NNPS O
and CC O
their PRP$ O
collaborating VBG O
physician NN O
partners NNS O
was VBD O
created VBN O
. . O

To TO O
maintain VB O
confidentiality NN O
of IN O
respondents NNS O
, , O
a DT O
number NN O
placed VBN O
on IN O
the DT O
bottom JJ O
right JJ O
corner NN O
of IN O
each DT O
survey NN O
corresponded VBD O
to IN O
a DT O
name NN O
on IN O
the DT O
confidential JJ O
master NN O
mailing NN O
sheet NN O
. . O

The DT O
postage NN O
paid VBN O
return NN O
envelopes NNS O
were VBD O
addressed VBN O
to IN O
the DT O
research NN O
coordinator NN O
at IN O
the DT O
School NNP O
of IN O
Nursing NNP O
, , O
Dalhousie NNP O
University NNP O
, , O
who WP O
matched VBD O
respondents NNS O
to IN O
the DT O
mailing NN O
list NN O
from IN O
the DT O
first JJ O
distribution NN O
. . O

The DT O
cross NN O
- HYPH O
referenced VBN O
mailing NN O
list NN O
was VBD O
not RB O
accessible JJ O
to IN O
those DT O
entering VBG O
or CC O
analysing VBG O
data NNS O
. . O

The DT O
research NN O
coordinator NN O
sent VBD O
the DT O
second JJ O
distribution NN O
to IN O
those DT O
who WP O
had VBD O
not RB O
initially RB O
responded VBN O
. . O

A DT O
fluorescent JJ O
coloured VBN O
page NN O
was VBD O
included VBN O
in IN O
the DT O
second JJ O
mailing NN O
to TO O
notify VB O
recipients NNS O
of IN O
the DT O
second JJ O
and CC O
final JJ O
mailing NN O
status NN O
. . O

The DT O
second JJ O
mailing NN O
followed VBD O
2 CD O
weeks NNS O
after IN O
the DT O
initial JJ O
mailing NN O
( , O
February NNP O
2005 CD O
) -RRB- O
. . O

The DT O
surveys NNS O
were VBD O
sent VBN O
via IN O
Xpresspost NNP O
( -LRB- O
TM NNP O
) -RRB- O
through IN O
Canada NNP O
Post NNP O
. . O

Data NN O
analyses NNS O

Quantitative JJ O

Data NNS O
were VBD O
entered VBN O
and CC O
analysed VBN O
in IN O
Statistical NNP O
Package NNP O
for IN O
Social NNP O
Sciences NNPS O
( : O
SPSS NNP O
) -RRB- O
( , O
version NN O
11 CD O
. . O
5 CD O
for IN O
Windows NNS O
) -RRB- O
. . O

Five CD O
surveys NNS O
were VBD O
randomly RB O
selected VBN O
as IN O
a DT O
check NN O
for IN O
accuracy NN O
of IN O
data NN O
entry NN O
. . O

Descriptive JJ O
statistics NNS O
were VBD O
used VBN O
to TO O
describe VB O
resource NN O
usage NN O
by IN O
practitioners NNS O
. . O

Chi NNP O
Square NNP O
( : O
Fisher NNP O
' '' O
s POS O
Exact NNP O
when WRB O
cell NN O
count VBP O
less JJR O
than IN O
5 CD O
) -RRB- O
analyses NNS O
were VBD O
used VBN O
to TO O
determine VB O
differences NNS O
in IN O
computer NN O
or CC O
PDA NN O
use NN O
based VBN O
on IN O
predetermined VBN O
variables NNS O
( : O
e LS O
. . O
g LS O
. . O
high JJ O
speed NN O
Internet NN O
connection NN O
, , O
number NN O
of IN O
patients NNS B-Species
per IN O
day NN O
) -RRB- O
. . O

Mann NNP O
Whitney NNP O
U NNP O
tests NNS O
were VBD O
used VBN O
to TO O
compare VB O
physician NN O
and CC O
NPs NNP O
Likert NNP O
scale NN O
ratings NNS O
( : O
1 CD O
= SYM O
strongly RB O
agree VB O
to IN O
5 CD O
= SYM O
strongly RB O
disagree VB O
) -RRB- O
of IN O
resource NN O
use NN O
. . O

Physician NN O
and CC O
NP NNP O
rankings NNS O
of IN O
all DT O
resources NNS O
( , O
print NN O
, , O
online JJ O
/ SYM O
electronic JJ O
, , O
and CC O
health NN O
professionals NNS O
and CC O
other JJ O
) -RRB- O
were VBD O
determined VBN O
from IN O
means NNS O
of IN O
Likert NNP O
scale NN O
ratings NNS O
( , O
1 CD O
= SYM O
strongly RB O
agree VB O
, , O
5 CD O
= SYM O
strongly RB O
disagree VB O
) , O
for IN O
each DT O
of IN O
the DT O
pre JJ O
- HYPH O
specified VBN O
characteristics NNS O
( : O
e LS O
. . O
g LS O
. . O
frequency NN O
of IN O
use NN O
, , O
accessibility NN O
, , O
etc FW O
. . O
) -RRB- O
and CC O
the DT O
frequency NN O
of IN O
use NN O
of IN O
the DT O
resources NNS O
. . O

The DT O
best JJS O
rankings NNS O
were VBD O
assigned VBN O
for IN O
the DT O
lowest JJS O
mean JJ O
scores NNS O
and CC O
the DT O
largest JJS O
number NN O
of IN O
the DT O
sample NN O
using VBG O
a DT O
resource NN O
. . O

These DT O
rankings NNS O
( , O
ranks NNS O
based VBN O
on IN O
mean JJ O
and CC O
ranks NNS O
based VBN O
on IN O
sample NN O
) -RRB- O
were VBD O
then RB O
entered VBN O
into IN O
a DT O
formula NN O
to TO O
calculate VB O
an DT O
overall JJ O
rank NN O
. . O

The DT O
formula NN O
includes VBZ O
: : O
rank NN O
= : O
[ -LRB- O
( , O
rank VB O
according VBG O
to IN O
% NN O
of IN O
sample NN O
using VBG O
the DT O
resource NN O
+ CC O
rank NN O
based VBN O
on IN O
mean JJ O
score NN O
) NFP O
/ SYM O
2 CD O
] -RRB- O
. . O

This DT O
formula NN O
was VBD O
used VBN O
to TO O
account VB O
for IN O
mean JJ O
scores NNS O
based VBN O
on IN O
small JJ O
samples NNS O
as IN O
these DT O
numbers NNS O
could MD O
potentially RB O
over RB O
or CC O
underestimate VB O
the DT O
value NN O
of IN O
a DT O
resource NN O
. . O

Ratings NNS O
of IN O
6 CD O
( : O
i PRP O
. . O
e UH O
. . O
not RB O
applicable JJ O
, , O
I PRP O
do VBP O
not RB O
use VB O
this DT O
resource NN O
) -RRB- O
were VBD O
excluded VBN O
from IN O
the DT O
analyses NNS O
. . O

Qualitative JJ O

Comments NNS O
were VBD O
entered VBN O
in IN O
a DT O
word NN O
- HYPH O
processing NN O
program NN O
and CC O
organized VBN O
by IN O
type NN O
of IN O
respondent NN O
( : O
PDA NNP O
versus IN O
computer NN O
) -RRB- O
and CC O
question NN O
number NN O
. . O

The DT O
coded VBN O
survey NN O
number NN O
and CC O
respondent NN O
type NN O
( -LRB- O
NP NNP O
or CC O
physician NN O
) -RRB- O
were VBD O
also RB O
included VBN O
next RB O
to IN O
comments NNS O
. . O

Investigators NNS O
determined VBD O
themes NNS O
and CC O
categorized VBN O
comments NNS O
based VBN O
on IN O
previous JJ O
experience NN O
, , O
knowledge NN O
, , O
and CC O
familiarity NN O
with IN O
the DT O
topic NN O
. . O

Results NNS O

Surveys NNS O
were VBD O
completed VBN O
and CC O
returned VBN O
by IN O
75 CD O
% NN O
of IN O
eligible JJ O
participants NNS B-Species
( : O
27 CD O
of IN O
36 CD O
) -RRB- O
. . O

One CD O
physician NN O
survey NN O
was VBD O
undeliverable JJ O
. . O

The DT O
response NN O
rates NNS O
from IN O
within IN O
the DT O
NP NNP O
and CC O
physician NN O
samples NNS O
were VBD O
88 CD O
% NN O
and CC O
65 CD O
% NN O
, , O
respectively RB O
. . O

Complete JJ O
demographic JJ O
information NN O
is VBZ O
available JJ O
in IN O
Table NNP O
1 CD O
. . O

Methods NNS O
for IN O
accessing VBG O
resources NNS O
and CC O
self NN O
- HYPH O
reported VBN O
resource NN O
use NN O

Resource NN O
use NN O
was VBD O
similar JJ O
amongst IN O
practitioners NNS O
. . O

Respondents NNS O
indicated VBD O
that IN O
print NN O
resources NNS O
( , O
mean VBP O
4 CD O
. . O
56 CD O
, , O
SD NN O
0 CD O
. . O
80 CD O
) -RRB- O
, , O
health NN O
professionals NNS O
( , O
mean JJ O
3 CD O
. . O
26 CD O
, , O
SD NN O
0 CD O
. . O
90 CD O
) -RRB- O
, , O
and CC O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
( , O
mean JJ O
2 CD O
. . O
70 CD O
, , O
SD NN O
1 CD O
. . O
20 CD O
) -RRB- O
were VBD O
the DT O
preferred JJ O
method NN O
( : O
1 CD O
= SYM O
least RBS O
preferred VBN O
to IN O
5 CD O
= SYM O
most RBS O
preferred VBN O
) -RRB- O
for IN O
accessing VBG O
drug NN O
information NN O
. . O

Thirty CD O
- HYPH O
seven CD O
percent NN O
of IN O
respondents NNS O
reported VBD O
that IN O
searching VBG O
for IN O
specific JJ O
questions NNS O
related VBN O
to IN O
drug NN O
information NN O
( : O
e LS O
. . O
g LS O
. . O
usual JJ O
dosage NN O
, , O
duration NN O
of IN O
therapy NN O
) , O
was VBD O
conducted VBN O
using VBG O
both CC O
print NN O
and CC O
electronic JJ O
resources NNS O
( , O
but CC O
print NN O
use NN O
greater JJR O
than IN O
electronic JJ O
) -RRB- O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

The DT O
preferred JJ O
means NN O
( : O
i LS O
. . O
e ADD O
. . O
print NN O
) -RRB- O
to TO O
access VB O
resources NNS O
was VBD O
consistent JJ O
with IN O
the DT O
most RBS O
common JJ O
means NN O
of IN O
conducting VBG O
searches NNS O
for IN O
specific JJ O
drug NN O
information NN O
queries NNS O
. . O

Respondents NNS O
' POS O
ratings NNS O
for IN O
pre JJ O
- HYPH O
specified VBN O
print NN O
, , O
online JJ O
/ SYM O
electronic JJ O
, , O
and CC O
professional JJ O
resources NNS O
and CC O
other JJ O
, , O
based VBN O
on IN O
means NNS O
from IN O
Likert NNP O
scales NNS O
and CC O
number NN O
of IN O
respondents NNS O
using VBG O
the DT O
resources NNS O
, , O
are VBP O
presented VBN O
in IN O
Tables NNP O
3 CD O
, , O
4 CD O
, , O
and CC O
5 CD O
. . O

Of IN O
all DT O
resources NNS O
within IN O
the DT O
print NN O
, , O
online JJ O
/ SYM O
electronic JJ O
, , O
and CC O
health NN O
professionals NNS O
or CC O
other JJ O
categories NNS O
, , O
NPs NNS O
and CC O
physicians NNS O
rated VBD O
the DT O
Compendium NNP O
of IN O
Pharmaceuticals NNPS O
and CC O
Specialties NNPS O
( -LRB- O
CPS NNP O
) -RRB- O
[ -LRB- O
52 CD O
] -RRB- O
and CC O
pharmacists NNS O
as IN O
the DT O
top JJ O
two CD O
most RBS O
frequently RB O
used VBN O
resources NNS O
for IN O
providing VBG O
drug NN O
and CC O
therapeutic JJ O
information NN O
. . O

Physicians NNS O
rated VBD O
other JJ O
physicians NNS O
as IN O
the DT O
third RB O
most RBS O
frequently RB O
used VBN O
resource NN O
. . O

The DT O
book NN O
Therapeutic NNP O
Choices NNPS O
[ -LRB- O
53 CD O
] -RRB- O
ranked VBD O
third RB O
for IN O
NPs NNPS O
. . O

Based VBN O
on IN O
written VBN O
feedback NN O
, , O
physicians NNS O
and CC O
NPs NNP O
consulted VBD O
pharmacists NNS O
and CC O
other JJ O
physicians NNS O
most RBS O
frequently RB O
. . O

The DT O
CPS NNP O
and CC O
pharmacists NNS O
were VBD O
also RB O
ranked VBN O
as IN O
the DT O
top JJ O
two CD O
resources NNS O
overall RB O
in IN O
terms NNS O
of IN O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
for IN O
physicians NNS O
. . O

Rankings NNS O
by IN O
NPs NNPS O
were VBD O
similar JJ O
for IN O
usefulness NN O
, , O
accessibility NN O
, , O
and CC O
credibility NN O
. . O

NPs NNP O
ranked VBD O
pharmacists NNS O
, , O
Therapeutic NNP O
Choices NNPS O
, , O
and CC O
academic JJ O
detailing NN O
first RB O
and CC O
the DT O
CPS NNP O
as IN O
second JJ O
for IN O
current JJ O
/ SYM O
timeliness NN O
. . O

Within IN O
the DT O
online JJ O
/ SYM O
electronic JJ O
category NN O
, , O
electronic JJ O
clinical JJ O
practice NN O
guidelines NNS O
( , O
eCPGs NNS O
) -RRB- O
were VBD O
rated VBN O
the DT O
highest JJS O
for IN O
all DT O
characteristics NNS O
( , O
e LS O
. . O
g LS O
. . O
usefulness NN O
, , O
credibility NN O
) -RRB- O
. . O

Although IN O
eCPGs NNS O
were VBD O
highly RB O
ranked VBN O
, , O
approximately RB O
30 CD O
% NN O
of IN O
the DT O
sample NN O
reported VBD O
not RB O
using VBG O
this DT O
resource NN O
. . O

Other JJ O
resources NNS O
in IN O
this DT O
category NN O
were VBD O
infrequently RB O
used VBN O
based VBN O
on IN O
respondents NNS O
' POS O
self NN O
- HYPH O
reports NNS O
. . O

Pharmaceutical JJ O
industry NN O
representatives NNS O
were VBD O
used VBN O
as IN O
a DT O
source NN O
of IN O
drug NN O
information NN O
by IN O
85 CD O
% NN O
and CC O
86 CD O
% NN O
of IN O
physicians NNS O
and CC O
NPs NNS O
, , O
respectively RB O
( : O
Table NNP O
5 CD O
) -RRB- O
. . O

This DT O
was VBD O
higher JJR O
than IN O
regional JJ O
drug NN O
information NN O
services NNS O
( , O
used VBN O
by IN O
23 CD O
% NN O
of IN O
physicians NNS O
and CC O
50 CD O
% NN O
of IN O
NPs NNPS O
) -RRB- O
. . O

After IN O
exclusion NN O
of IN O
traditional JJ O
health NN O
professionals NNS O
( : O
i PRP O
. . O
e LS O
. . O
physicians NNS O
, , O
nurses NNS O
, , O
pharmacists NNS O
, , O
allied JJ O
health NN O
) -RRB- O
in IN O
the DT O
health NN O
professionals NNS O
and CC O
other JJ O
category NN O
, , O
pharmaceutical NN O
industry NN O
representatives NNS O
received VBD O
rankings NNS O
for IN O
second JJ O
or CC O
third JJ O
for IN O
frequency NN O
of IN O
use NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
, , O
based VBN O
on IN O
means NN O
and CC O
number NN O
of IN O
respondents NNS O
using VBG O
this DT O
resource NN O
( : O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Differences NNS O
between IN O
nurse NN O
practitioners NNS O
and CC O
physicians NNS O

A DT O
series NN O
of IN O
Mann NNP O
Whitney NNP O
U NNP O
tests NNS O
were VBD O
used VBN O
to TO O
compare VB O
the DT O
responses NNS O
of IN O
NPs NNPS O
and CC O
physicians NNS O
on IN O
their PRP$ O
use NN O
of IN O
print NN O
, , O
online JJ O
/ SYM O
electronic JJ O
, , O
and CC O
health NN O
professional JJ O
resources NNS O
. . O

In IN O
total JJ O
95 CD O
statistical JJ O
tests NNS O
were VBD O
conducted VBN O
. . O

The DT O
large JJ O
number NN O
of IN O
tests NNS O
increases VBZ O
the DT O
likelihood NN O
of IN O
a DT O
type NN O
I NN O
error NN O
as IN O
five CD O
significant JJ O
differences NNS O
would MD O
be VB O
expected VBN O
by IN O
chance NN O
alone RB O
at IN O
an DT O
alpha NN O
threshold NN O
of IN O
0 CD O
. . O
5 CD O
. . O

It PRP O
is VBZ O
therefore RB O
important JJ O
to TO O
treat VB O
these DT O
results NNS O
with IN O
caution NN O
. . O

A DT O
limited JJ O
number NN O
of IN O
statistically RB O
significant JJ O
( , O
p NN O
< SYM O
0 CD O
. . O
5 CD O
) -RRB- O
differences NNS O
were VBD O
identified VBN O
between IN O
physicians NNS O
and CC O
NPs NNS O
and CC O
are VBP O
reported VBN O
in IN O
Table NNP O
6 CD O
. . O

Therapeutic JJ O
Choices NNS O
differed VBD O
significantly RB O
for IN O
frequency NN O
of IN O
use NN O
with IN O
more JJR O
NPs NNS O
making VBG O
use NN O
of IN O
this DT O
resource NN O
. . O

Allied JJ O
health NN O
professionals NNS O
significantly RB O
differed VBD O
between IN O
NPs NNS O
and CC O
physicians NNS O
for IN O
accessibility NN O
and CC O
current JJ O
/ SYM O
timeliness NN O
while IN O
NPs NNPS O
were VBD O
more RBR O
in IN O
agreement NN O
with IN O
these DT O
characteristics NNS O
of IN O
the DT O
resource NN O
. . O

Nurse NN O
colleague NN O
credibility NN O
and CC O
current JJ O
/ SYM O
timeliness NN O
was VBD O
rated VBN O
significantly RB O
higher JJR O
by IN O
NPs NNPS O
versus IN O
physicians NNS O
. . O

Factors NNS O
influencing VBG O
electronic JJ O
technology NN O
use NN O
at IN O
the DT O
point NN O
of IN O
care NN O

Factors NNS O
such JJ O
as IN O
gender NN O
, , O
age NN O
, , O
practitioner NN O
type NN O
( , O
NP NNP O
vs IN O
physician NN O
) -RRB- O
, , O
accessibility NN O
, , O
technical JJ O
support NN O
, , O
Internet NN O
connection NN O
speed NN O
, , O
patient NN B-Species
volume NN O
, , O
presence NN O
of IN O
an DT O
EPR NN O
, , O
and CC O
home NN O
computer NN O
use NN O
were VBD O
examined VBN O
to TO O
determine VB O
if IN O
they PRP O
were VBD O
associated VBN O
with IN O
the DT O
use NN O
of IN O
a DT O
work NN O
computer NN O
to TO O
search VB O
for IN O
drug NN O
information NN O
at IN O
the DT O
point NN O
of IN O
care NN O
. . O

No DT O
statistically RB O
significant JJ O
associations NNS O
were VBD O
found VBN O
( : O
Fisher NNP O
' POS O
s POS O
Exact NNP O
) -RRB- O
. . O

Additional JJ O
resources NNS O
from IN O
respondent NN O
comments NNS O

Respondents NNS O
indicated VBD O
other JJ O
resources NNS O
and CC O
programs NNS O
, , O
such JJ O
as IN O
clinical JJ O
calculators NNS O
, , O
that IN O
they PRP O
would MD O
like VB O
to TO O
access VB O
from IN O
their PRP$ O
computer NN O
or CC O
PDA NNP O
. . O

The DT O
top JJ O
three CD O
resources NNS O
that WDT O
were VBD O
desired VBN O
included VBD O
Canadian JJ O
clinical JJ O
practice NN O
guidelines NNS O
, , O
patient JJ B-Species
education NN O
information NN O
, , O
and CC O
ability NN O
to TO O
track VB O
clinical JJ O
activities NNS O
/ SYM O
statistics NNS O
. . O

Further JJ O
comments NNS O
from IN O
two CD O
NP NNP O
computer NN O
survey NN O
respondents NNS O
revealed VBD O
that IN O
a DT O
resource NN O
on IN O
drug NN O
interactions NNS O
and CC O
dosages NNS O
would MD O
be VB O
desired VBN O
. . O

One CD O
other JJ O
NP NNP O
also RB O
indicated VBD O
"""" `` O
up IN O
to IN O
date NN O
info NN O
[ -LRB- O
sic NN O
] -RRB- O
on IN O
drugs NNS O
to TO O
treat VB O
various JJ O
illnesses NNS O
ie IN O
doseage NN O
[ -LRB- O
sic NN O
] -RRB- O
, , O
length NN O
of IN O
use NN O
etc FW O
. . O
"""" '' O

Computer NN O
or CC O
personal JJ O
digital JJ O
assistant NN O
use NN O
in IN O
practice NN O

Approximately RB O
50 CD O
% NN O
of IN O
computer NN O
survey NN O
respondents NNS O
reported VBD O
using VBG O
their PRP$ O
work NN O
computers NNS O
for IN O
searching VBG O
drug NN O
or CC O
therapeutic JJ O
information NN O
related VBN O
to IN O
patient JJ B-Species
care NN O
. . O

Of IN O
those DT O
respondents NNS O
, , O
just RB O
over IN O
half DT O
( : O
54 CD O
% NN O
) -RRB- O
also RB O
reported VBD O
using VBG O
their PRP$ O
home NN O
computer NN O
for IN O
this DT O
purpose NN O
. . O

Sixty CD O
- HYPH O
seven CD O
and CC O
17 CD O
% NN O
of IN O
PDA NNP O
survey NN O
respondents NNS O
reported VBD O
using VBG O
their PRP$ O
PDA NNP O
for IN O
searching VBG O
drug NN O
or CC O
therapeutic JJ O
information NN O
related VBN O
to IN O
patient JJ B-Species
care NN O
at IN O
work NN O
and CC O
home NN O
, , O
respectively RB O
. . O

Searching VBG O
on IN O
a DT O
weekly JJ O
basis NN O
for IN O
specific JJ O
information NN O
related VBN O
to IN O
drugs NNS O

Of IN O
the DT O
24 CD O
specified VBN O
categories NNS O
of IN O
drug NN O
information NN O
included VBN O
in IN O
the DT O
survey NN O
, , O
the DT O
majority NN O
were VBD O
reported VBN O
as IN O
infrequently RB O
searched VBN O
and CC O
a DT O
smaller JJR O
percentage NN O
as IN O
never RB O
searched VBN O
by IN O
respondents NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

The DT O
top JJ O
three CD O
categories NNS O
rated VBD O
as IN O
frequently RB O
searched VBN O
were VBD O
side JJ O
effects NNS O
, , O
adult NN O
or CC O
usual JJ O
drug NN O
dosage NN O
, , O
and CC O
most RBS O
appropriate JJ O
drug NN O
for IN O
an DT O
indication NN O
. . O

( -LRB- O
Table NN O
7 CD O
) -RRB- O

Issues NNS O
related VBN O
to IN O
personal JJ O
digital JJ O
assistants NNS O

Respondents NNS O
reported VBD O
their PRP$ O
level NN O
of IN O
agreement NN O
with IN O
statements NNS O
related VBN O
to IN O
how WRB O
PDAs NNPS O
may MD O
influence VB O
their PRP$ O
practice NN O
. . O

The DT O
statements NNS O
included VBD O
aspects NNS O
of IN O
workload NN O
( , O
organization NN O
and CC O
paper NN O
work NN O
) -RRB- O
, , O
convenience NN O
, , O
and CC O
improving VBG O
quality NN O
of IN O
care NN O
and CC O
patient JJ B-Species
outcomes NNS O
. . O

( -LRB- O
Table NNP O
8 CD O
) -RRB- O
Respondents NNS O
agreed VBD O
that IN O
PDAs NNS O
are VBP O
a DT O
convenient JJ O
resource NN O
but CC O
indicated VBD O
that IN O
PDAs NNS O
would MD O
not RB O
decrease VB O
paperwork NN O
or CC O
improve VB O
patient JJ B-Species
health NN O
outcomes NNS O
. . O

Barriers NNS O
and CC O
facilitators NNS O
to IN O
personal JJ O
digital JJ O
assistants NNS O
: : O
themes NNS O
from IN O
written VBN O
comments NNS O

Peer NN O
support NN O
from IN O
colleagues NNS O
, , O
convenience NN O
, , O
standardized JJ O
usage NN O
, , O
and CC O
financial JJ O
and CC O
technical JJ O
support NN O
were VBD O
the DT O
main JJ O
perceived VBN O
facilitators NNS O
to IN O
PDA NNP O
use NN O
reported VBN O
by IN O
respondents NNS O
. . O

The DT O
main JJ O
perceived VBN O
barrier NN O
to IN O
PDA NNP O
use NN O
reported VBN O
by IN O
respondents NNS O
( : O
n CD O
= SYM O
10 CD O
) -RRB- O
included VBD O
cost NN O
. . O

Other JJ O
factors NNS O
such JJ O
as IN O
technology NN O
literacy NN O
, , O
time NN O
, , O
lack NN O
of IN O
peer NN O
support NN O
, , O
no DT O
high JJ O
speed NN O
internet NN O
for IN O
downloads NNS O
, , O
lack NN O
of IN O
needed VBN O
resources NNS O
, , O
keeping VBG O
up IN O
to IN O
date NN O
on IN O
resources NNS O
, , O
and CC O
searching NN O
speed NN O
were VBD O
also RB O
reported VBN O
. . O

Future JJ O
use NN O
of IN O
personal JJ O
digital JJ O
assistants NNS O

Fifty CD O
- HYPH O
two CD O
percent NN O
, , O
including VBG O
current JJ O
PDA NNP O
users NNS O
, , O
reported VBD O
that IN O
they PRP O
would MD O
use VB O
a DT O
PDA NNP O
in IN O
the DT O
future NN O
. . O

Twenty CD O
two CD O
percent NN O
were VBD O
uncertain JJ O
and CC O
19 CD O
% NN O
reported VBD O
that IN O
they PRP O
would MD O
not RB O
use VB O
a DT O
PDA NNP O
in IN O
the DT O
future NN O
. . O

Two CD O
people NNS B-Species
did VBD O
not RB O
respond VB O
. . O

Confidentiality NN O

Fifty CD O
two CD O
percent NN O
of IN O
respondents NNS O
indicated VBD O
that IN O
patient JJ B-Species
confidentiality NN O
with IN O
PDAs NNS O
was VBD O
no RB O
more RBR O
concerning JJ O
compared VBN O
to IN O
use NN O
of IN O
other JJ O
technologies NNS O
. . O

Forty CD O
- HYPH O
four CD O
percent NN O
did VBD O
not RB O
know VB O
if IN O
they PRP O
had VBD O
a DT O
policy NN O
on IN O
patient JJ B-Species
confidentiality NN O
with IN O
regard NN O
to IN O
technologies NNS O
. . O

Technology NN O
training NN O
and CC O
reimbursement NN O

Respondents NNS O
rated VBD O
( : O
1 CD O
= SYM O
least RBS O
preferred VBN O
to TO O
5 CD O
= SYM O
most RBS O
preferred VBN O
) -RRB- O
one CD O
on IN O
one CD O
instruction NN O
and CC O
group NN O
learning NN O
led VBN O
by IN O
an DT O
expert JJ O
facilitator NN O
as IN O
the DT O
most RBS O
preferred VBN O
( , O
mean JJ O
4 CD O
. . O
32 CD O
, , O
SD NN O
0 CD O
. . O
99 CD O
) -RRB- O
means NNS O
by IN O
which WDT O
to TO O
receive VB O
instruction NN O
on IN O
a DT O
new JJ O
technology NN O
. . O

Least JJS O
preferred JJ O
methods NNS O
included VBD O
online JJ O
discussions NNS O
/ SYM O
chatrooms NNS O
( , O
mean JJ O
1 CD O
. . O
52 CD O
, , O
SD NN O
1 CD O
. . O
4 CD O
) -RRB- O
, , O
internet NN O
videos NNS O
( , O
live JJ O
: : O
mean JJ O
1 CD O
. . O
70 CD O
, , O
SD NN O
1 CD O
. . O
10 CD O
, , O
or CC O
static JJ O
: : O
mean VB O
1 CD O
. . O
87 CD O
, , O
SD NN O
1 CD O
. . O
14 CD O
) -RRB- O
, , O
video NN O
cassettes NNS O
( , O
mean JJ O
2 CD O
. . O
30 CD O
, , O
SD NN O
1 CD O
. . O
55 CD O
) -RRB- O
, , O
trial NN O
and CC O
error NN O
learning NN O
( , O
mean JJ O
2 CD O
. . O
32 CD O
, , O
SD NN O
1 CD O
. . O
28 CD O
) -RRB- O
, , O
and CC O
written VBN O
manuals NNS O
( , O
mean JJ O
2 CD O
. . O
92 CD O
, , O
SD NN O
1 CD O
. . O
44 CD O
) -RRB- O
. . O

Paid VBN O
leave NN O
for IN O
attendance NN O
at IN O
technology NN O
training NN O
sessions NNS O
was VBD O
the DT O
preferred VBN O
means NN O
( , O
mean JJ O
1 CD O
. . O
77 CD O
, , O
SD NN O
0 CD O
. . O
86 CD O
; : O
1 CD O
= SYM O
strongly RB O
agree VB O
to IN O
5 CD O
= SYM O
strongly RB O
disagree VB O
) -RRB- O
of IN O
remuneration NN O
for IN O
respondents NNS O
. . O

Respondents NNS O
also RB O
indicated VBD O
that IN O
if IN O
financial JJ O
remuneration NN O
was VBD O
to TO O
occur VB O
, , O
it PRP O
should MD O
correspond VB O
to IN O
the DT O
amount NN O
of IN O
time NN O
for IN O
training NN O
that WDT O
is VBZ O
required VBN O
( , O
versus IN O
a DT O
flat JJ O
rate NN O
) -RRB- O
( , O
mean JJ O
1 CD O
. . O
96 CD O
, , O
SD NN O
1 CD O
. . O
8 CD O
) -RRB- O
. . O

Continuing VBG O
education NN O
credits NNS O
were VBD O
not RB O
viewed VBN O
as IN O
an DT O
incentive NN O
( , O
mean JJ O
2 CD O
. . O
69 CD O
, , O
SD NN O
1 CD O
. . O
44 CD O
) -RRB- O
. . O

Discussion NN O

Preferred JJ O
resources NNS O

In IN O
our PRP$ O
study NN O
, , O
printed VBN O
materials NNS O
( , O
e LS O
. . O
g LS O
. . O
compendia NN O
, , O
journals NNS O
, , O
textbook NN O
resources NNS O
) , O
and CC O
professionals NNS O
( , O
e LS O
. . O
g LS O
. . O
pharmacists NNS O
) -RRB- O
were VBD O
the DT O
most RBS O
preferred VBN O
and CC O
frequently RB O
used VBN O
means NNS O
to TO O
access VB O
information NN O
. . O

Physician NN O
reliance NN O
on IN O
text NN O
and CC O
compendia NN O
relative JJ O
to IN O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
has VBZ O
been VBN O
frequently RB O
reported VBN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

In IN O
a DT O
study NN O
examining VBG O
family NN O
doctors NNS O
' POS O
use NN O
of IN O
information NN O
sources NNS O
to TO O
answer VB O
clinical JJ O
questions NNS O
, , O
human JJ B-Species
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
doctor NN O
, , O
pharmacist NN O
) -RRB- O
, , O
non JJ O
- HYPH O
prescribing VBG O
print NN O
information NN O
( : O
e LS O
. . O
g LS O
. . O
textbooks NNS O
and CC O
journal NN O
articles NNS O
) -RRB- O
, , O
and CC O
prescribing VBG O
texts NNS O
were VBD O
used VBN O
36 CD O
% NN O
, , O
32 CD O
% NN O
, , O
and CC O
25 CD O
% NN O
of IN O
the DT O
time NN O
, , O
respectively RB O
[ -LRB- O
54 CD O
] -RRB- O
. . O

Books NNS O
from IN O
the DT O
workplace NN O
were VBD O
reported VBN O
by IN O
approximately RB O
79 CD O
% NN O
of IN O
UK NNP O
primary JJ O
care NN O
nurses NNS O
as IN O
a DT O
commonly RB O
used VBN O
source NN O
of IN O
knowledge NN O
and CC O
information NN O
used VBN O
to TO O
support VB O
practice NN O
[ -LRB- O
55 CD O
] -RRB- O
. . O

Fewer JJR O
than IN O
one CD O
- HYPH O
third NN O
( , O
31 CD O
% NN O
) -RRB- O
reported VBD O
using VBG O
electronic JJ O
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
Internet NNP O
, , O
electronic JJ O
journals NNS O
) -RRB- O
for IN O
this DT O
purpose NN O
[ -LRB- O
55 CD O
] -RRB- O
. . O

Results NNS O
of IN O
a DT O
postal JJ O
questionnaire NN O
to IN O
NPs NNPS O
demonstrated VBD O
that IN O
61 CD O
% NN O
and CC O
51 CD O
% NN O
of IN O
respondents NNS O
reported VBD O
using VBG O
drug NN O
reference NN O
manuals NNS O
and CC O
textbooks NNS O
, , O
respectively RB O
, , O
a DT O
few JJ O
times NNS O
a DT O
week NN O
or CC O
more JJR O
[ -LRB- O
29 CD O
] -RRB- O
. . O

These DT O
frequencies NNS O
were VBD O
second JJ O
and CC O
third RB O
only RB O
to IN O
consulting VBG O
with IN O
their PRP$ O
physician NN O
supervisor NN O
( : O
63 CD O
% NN O
) -RRB- O
. . O

Data NNS O
from IN O
structured VBN O
interviews NNS O
of IN O
a DT O
sample NN O
of IN O
22 CD O
community NN O
nurse NN O
prescribers NNS O
reported VBN O
by IN O
Hall NNP O
et FW O
al NNP O
. , O
revealed VBD O
that IN O
the DT O
majority NN O
relied VBD O
on IN O
print NN O
materials NNS O
to TO O
access VB O
information NN O
, , O
namely RB O
the DT O
British NNP O
National NNP O
Formulary NNP O
[ -LRB- O
32 CD O
] -RRB- O
. . O

A DT O
survey NN O
of IN O
a DT O
primary JJ O
care NN O
practice NN O
- HYPH O
based VBN O
research NN O
network NN O
in IN O
the DT O
US NNP O
that WDT O
included VBD O
physicians NNS O
, , O
physician NN O
assistants NNS O
, , O
and CC O
nurse NN O
practitioners NNS O
, , O
revealed VBD O
that IN O
interpersonal JJ O
and CC O
rapidly RB O
accessed VBN O
print NN O
resources NNS O
were VBD O
preferred VBN O
. . O

Sixty CD O
- HYPH O
one CD O
and CC O
58 CD O
% NN O
of IN O
respondents NNS O
reported VBD O
using VBG O
drug NN O
reference NN O
sources NNS O
such JJ O
as IN O
the DT O
Physician NNP O
' POS O
s NNP O
Desk NNP O
Reference NNP O
( -LRB- O
PDR NNP O
) -RRB- O
and CC O
medical JJ O
textbooks NNS O
, , O
respectively RB O
, , O
a DT O
few JJ O
times NNS O
a DT O
day NN O
or CC O
daily RB O
[ -LRB- O
56 CD O
] -RRB- O
. . O

The DT O
clinicians NNS O
in IN O
our PRP$ O
sample NN O
perceived VBD O
the DT O
Canadian JJ O
compendium NN O
, , O
the DT O
CPS NNP O
, , O
to TO O
be VB O
useful JJ O
, , O
accessible JJ O
, , O
credible JJ O
, , O
and CC O
current JJ O
/ SYM O
timely JJ O
. . O

The DT O
CPS NNP O
, , O
is VBZ O
described VBN O
as IN O
"""" `` O
the DT O
Canadian JJ O
drug NN O
reference NN O
for IN O
health NN O
professionals NNS O
"""" '' O
and CC O
is VBZ O
intended VBN O
to TO O
provide VB O
a DT O
central JJ O
source NN O
of IN O
drug NN O
information NN O
on IN O
drug NN O
products NNS O
available JJ O
in IN O
Canada NNP O
[ -LRB- O
52 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
available JJ O
in IN O
print NN O
( , O
English NNP O
and CC O
French NNP O
) -RRB- O
and CC O
became VBD O
available JJ O
online RB O
in IN O
June NNP O
2004 CD O
. . O

The DT O
CPS NNP O
includes VBZ O
drug NN O
monographs NNS O
for IN O
commonly RB O
used VBN O
products NNS O
approved VBN O
for IN O
use NN O
in IN O
Canada NNP O
, , O
but CC O
it PRP O
does VBZ O
not RB O
include VB O
all DT O
drugs NNS O
available JJ O
on IN O
the DT O
Canadian JJ O
market NN O
[ -LRB- O
57 CD O
] -RRB- O
. . O

The DT O
majority NN O
of IN O
these DT O
product NN O
monographs NNS O
are VBP O
based VBN O
on IN O
monographs NNS O
submitted VBN O
by IN O
pharmaceutical JJ O
manufacturers NNS O
and CC O
approved VBN O
by IN O
Health NNP O
Canada NNP O
. . O

Some DT O
of IN O
the DT O
monographs NNS O
are VBP O
written VBN O
by IN O
the DT O
Canadian NNP O
Pharmacists NNPS O
Association NNP O
and CC O
are VBP O
described VBN O
as IN O
being VBG O
evidence NN O
- HYPH O
based VBN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

The DT O
CPS NNP O
also RB O
includes VBZ O
more JJR O
than IN O
100 CD O
pages NNS O
of IN O
clinical JJ O
tools NNS O
[ -LRB- O
52 CD O
] -RRB- O
. . O

The DT O
CPS NNP O
has VBZ O
been VBN O
criticized VBN O
for IN O
including VBG O
pharmaceutical JJ O
company NN O
advertising NN O
and CC O
requiring VBG O
manufacturer NN O
payment NN O
for IN O
inclusion NN O
of IN O
product NN O
monographs NNS O
[ -LRB- O
58 CD O
] -RRB- O
. . O

The DT O
accuracy NN O
of IN O
particular JJ O
components NNS O
of IN O
CPS NNP O
monographs NNS O
has VBZ O
also RB O
been VBN O
investigated VBN O
. . O

A DT O
review NN O
of IN O
overdose NN O
management NN O
in IN O
119 CD O
monographs NNS O
from IN O
the DT O
2001 CD O
CPS NNP O
revealed VBD O
considerable JJ O
variability NN O
in IN O
the DT O
utility NN O
of IN O
information NN O
with IN O
50 CD O
% NN O
of IN O
the DT O
monographs NNS O
containing VBG O
misleading JJ O
or CC O
dangerous JJ O
advice NN O
[ -LRB- O
59 CD O
] -RRB- O
. . O

Since IN O
2004 CD O
, , O
the DT O
CPS NNP O
has VBZ O
included VBN O
an DT O
alert NN O
box NN O
in IN O
the DT O
overdose NN O
section NN O
of IN O
monographs NNS O
notifying VBG O
users NNS O
to TO O
contact VB O
Poison NNP O
Control NNP O
Centres NNPS O
for IN O
overdose NN O
management NN O
information NN O
. . O

Some DT O
authors NNS O
have VBP O
criticized VBN O
references NNS O
that WDT O
are VBP O
similar JJ O
to IN O
the DT O
CPS NNP O
as IN O
being VBG O
inadequate JJ O
with IN O
regard NN O
to IN O
inclusion NN O
of IN O
evidence NN O
based VBN O
information NN O
[ -LRB- O
60 CD O
] -RRB- O
. . O

The DT O
NPs NNPS O
in IN O
our PRP$ O
sample NN O
also RB O
rated VBD O
Therapeutic NNP O
Choices NNPS O
highly RB O
for IN O
all DT O
characteristics NNS O
. . O

This DT O
finding NN O
is VBZ O
most RBS O
likely JJ O
attributable JJ O
to IN O
the DT O
fact NN O
that IN O
it PRP O
is VBZ O
a DT O
recommended VBN O
resource NN O
for IN O
coursework NN O
associated VBN O
with IN O
the DT O
Dalhousie NNP O
NP NNP O
university NN O
program NN O
curriculum NN O
. . O

Therapeutic JJ O
Choices NNPS O
is VBZ O
a DT O
concise JJ O
therapeutics NNS O
reference NN O
text NN O
published VBN O
by IN O
the DT O
Canadian NNP O
Pharmacists NNPS O
Association NNP O
. . O

The DT O
text NN O
contains VBZ O
approximately RB O
120 CD O
extensively RB O
referenced VBN O
chapters NNS O
with IN O
a DT O
disease NN O
management NN O
approach NN O
including VBG O
easy JJ O
to TO O
use VB O
algorithms NNS O
and CC O
tables NNS O
. . O

An DT O
editorial JJ O
board NN O
is VBZ O
responsible JJ O
for IN O
extensively RB O
reviewing VBG O
the DT O
content NN O
to TO O
ensure VB O
unbiased JJ O
and CC O
objective JJ O
information NN O
is VBZ O
presented VBN O
[ -LRB- O
53 CD O
] -RRB- O
. . O

Health NN O
professionals NNS O

Reliance NN O
on IN O
other JJ O
health NN O
professionals NNS O
, , O
especially RB O
pharmacists NNS O
and CC O
physicians NNS O
, , O
as IN O
a DT O
resource NN O
for IN O
information NN O
was VBD O
evident JJ O
from IN O
our PRP$ O
study NN O
and CC O
concurs VBZ O
with IN O
the DT O
findings NNS O
of IN O
others NNS O
[ -LRB- O
28 CD O
, , O
32 CD O
, , O
55 CD O
, , O
61 CD O
] -RRB- O
. . O

Nurse NN O
practitioners NNS O
have VBP O
reported VBN O
that IN O
collaborative JJ O
relationships NNS O
with IN O
pharmacists NNS O
increase VBP O
NP NNP O
role NN O
satisfaction NN O
[ -LRB- O
61 CD O
] -RRB- O
. . O

NPs NNS O
frequently RB O
consult VBP O
with IN O
allied JJ O
health NN O
care NN O
professionals NNS O
in IN O
their PRP$ O
primary JJ O
health NN O
care NN O
provider NN O
role NN O
and CC O
this DT O
is VBZ O
supported VBN O
by IN O
written VBN O
feedback NN O
from IN O
our PRP$ O
sample NN O
regarding VBG O
frequently RB O
consulted VBN O
health NN O
professionals NNS O
. . O

Nursing NN O
colleagues NNS O
are VBP O
also RB O
likely JJ O
to TO O
be VB O
rated VBN O
highly RB O
by IN O
NPs NNPS O
due IN O
to IN O
their PRP$ O
affiliation NN O
with IN O
peers NNS O
from IN O
the DT O
same JJ O
profession NN O
. . O

Some DT O
investigators NNS O
have VBP O
shown VBN O
that IN O
non JJ O
- HYPH O
human JJ B-Species
references NNS O
( : O
e LS O
. . O
g LS O
. . O
textbook NN O
) -RRB- O
are VBP O
sought VBN O
for IN O
more JJR O
technical JJ O
aspects NNS O
of IN O
prescribing NN O
( : O
e LS O
. . O
g LS O
. . O
dose NN O
) -RRB- O
, , O
whereas IN O
guidance NN O
regarding VBG O
selection NN O
of IN O
agents NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
right JJ O
drug NN O
for IN O
an DT O
indication NN O
) -RRB- O
is VBZ O
sought VBN O
from IN O
human JJ B-Species
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
pharmacists NNS O
or CC O
physicians NNS O
) -RRB- O
[ -LRB- O
62 CD O
] -RRB- O
. . O

We PRP O
were VBD O
unable JJ O
to TO O
determine VB O
what WDT O
kinds NNS O
of IN O
resources NNS O
were VBD O
used VBN O
for IN O
specific JJ O
purposes NNS O
from IN O
our PRP$ O
study NN O
. . O

Online JJ O
and CC O
electronic JJ O
resources NNS O
, , O
computers NNS O
, , O
and CC O
personal JJ O
digital JJ O
assistants NNS O

From IN O
our PRP$ O
study NN O
, , O
computer NN O
survey NN O
respondents NNS O
ranked VBD O
online JJ O
/ SYM O
electronic JJ O
resources NNS O
third RB O
in IN O
preference NN O
following VBG O
print NN O
and CC O
health NN O
professionals NNS O
. . O

Various JJ O
barriers NNS O
and CC O
facilitators NNS O
to IN O
accessing VBG O
information NN O
online RB O
/ SYM O
electronically RB O
or CC O
via IN O
the DT O
Internet NN O
have VBP O
been VBN O
described VBN O
in IN O
the DT O
literature NN O
[ -LRB- O
55 CD O
, , O
63 CD O
- HYPH O
66 CD O
] -RRB- O
. . O

Variables NNS O
that WDT O
have VBP O
been VBN O
described VBN O
by IN O
others NNS O
as IN O
barriers NNS O
such JJ O
as IN O
accessibility NN O
, , O
high JJ O
speed NN O
internet NN O
access NN O
, , O
patient NN B-Species
volume NN O
, , O
age NN O
, , O
practitioner NN O
type NN O
, , O
and CC O
technology NN O
support NN O
did VBD O
not RB O
appear VB O
to TO O
influence VB O
computer NN O
searching NN O
for IN O
information NN O
on IN O
drugs NNS O
or CC O
therapeutics NNS O
related VBN O
to IN O
patient JJ B-Species
care NN O
in IN O
our PRP$ O
results NNS O
. . O

Some DT O
qualitative JJ O
feedback NN O
does VBZ O
however RB O
support VB O
this DT O
notion NN O
. . O

As IN O
an DT O
example NN O
, , O
in IN O
response NN O
to IN O
a DT O
request NN O
for IN O
a DT O
rationale NN O
for IN O
not RB O
using VBG O
computers NNS O
one CD O
physician NN O
commented VBD O
: : O
"""" `` O
Retro VB O
tech NN O
[ -LRB- O
sic NN O
] -RRB- O
/ SYM O
old JJ O
fashion NN O
. . O

I PRP O
still RB O
like VBP O
to TO O
use VB O
my PRP$ O
mind NN O
and CC O
have VBP O
always RB O
been VBN O
a DT O
fan NN O
of IN O
pen NN O
and CC O
paper NN O
"""" '' O
. . O

Barriers NNS O
that WDT O
were VBD O
identified VBN O
with IN O
our PRP$ O
sample NN O
regarding VBG O
the DT O
use NN O
of IN O
handheld JJ O
technologies NNS O
such JJ O
as IN O
PDAs NNS O
included VBD O
cost NN O
, , O
time NN O
, , O
and CC O
issues NNS O
related VBN O
to IN O
technology NN O
literacy NN O
. . O

Several JJ O
people NNS B-Species
questioned VBD O
the DT O
value NN O
of IN O
PDAs NNS O
. . O

One CD O
GP NNP O
stated VBD O
when WRB O
referring VBG O
to IN O
a DT O
PDA NNP O
: : O
"""" `` O
So RB O
far RB O
I PRP O
have VBP O
not RB O
discovered VBN O
a DT O
use NN O
for IN O
one CD O
"""" '' O
. . O

Other JJ O
respondents NNS O
reinforced VBD O
their PRP$ O
preferences NNS O
for IN O
other JJ O
resources NNS O
( : O
e LS O
. . O
g LS O
. . O
books NNS O
) -RRB- O
and CC O
resistance NN O
to IN O
technology NN O
. . O

When WRB O
responding VBG O
to IN O
barriers NNS O
for IN O
the DT O
use NN O
of IN O
PDAs NNS O
, , O
one CD O
NP NNP O
commented VBD O
, , O
"""" `` O
My PRP$ O
huge JJ O
dislike NN O
for IN O
machinery NN O
that WDT O
frequently RB O
requires VBZ O
updating NN O
and CC O
patience NN O
"""" '' O
. . O

A DT O
physician NN O
responded VBD O
, , O
"""" `` O
as IN O
stated VBN O
, , O
I PRP O
like VBP O
to TO O
use VB O
my PRP$ O
own JJ O
mind NN O
, , O
and CC O
can MD O
get VB O
all PDT O
the DT O
info NN O
I PRP O
need VBP O
from IN O
books NNS O
relatively RB O
quickly RB O
"""" '' O
. . O

Facilitators NNS O
to IN O
the DT O
use NN O
of IN O
PDAs NNS O
mainly RB O
included VBD O
convenience NN O
factors NNS O
such JJ O
as IN O
having VBG O
resources NNS O
all RB O
in IN O
one CD O
place NN O
, , O
faster JJR O
means NNS O
to TO O
get VB O
information NN O
, , O
and CC O
portability NN O
. . O

Our PRP$ O
sample NN O
was VBD O
not RB O
in IN O
agreement NN O
with IN O
some DT O
convenience NN O
factors NNS O
in IN O
that IN O
they PRP O
did VBD O
not RB O
feel VB O
that IN O
PDAs NNPS O
would MD O
decrease VB O
paperwork NN O
. . O

Practitioners NNS O
from IN O
our PRP$ O
sample NN O
felt VBD O
relatively RB O
neutral JJ O
about IN O
PDAs NNS O
improving VBG O
patient NN B-Species
' '' O
s POS O
health NN O
outcomes NNS O
with IN O
41 CD O
% NN O
responding VBG O
in IN O
this DT O
manner NN O
. . O

Results NNS O
from IN O
a DT O
sample NN O
of IN O
primary JJ O
care NN O
practitioners NNS O
in IN O
the DT O
US NNP O
revealed VBD O
that IN O
76 CD O
% NN O
agreed VBD O
that IN O
the DT O
use NN O
of IN O
handheld JJ O
devices NNS O
for IN O
electronic JJ O
prescribing NN O
would MD O
substantially RB O
reduce VB O
medical JJ O
errors NNS O
and CC O
improve VB O
the DT O
quality NN O
of IN O
health NN O
care NN O
[ -LRB- O
67 CD O
] -RRB- O
. . O

Our PRP$ O
study NN O
also RB O
suggests VBZ O
that IN O
resources NNS O
such JJ O
as IN O
the DT O
Cochrane NNP O
Library NNP O
and CC O
its PRP$ O
Database NNP O
of IN O
Systematic NNP O
Reviews NNPS O
were VBD O
not RB O
frequently RB O
used VBN O
. . O

This DT O
finding NN O
is VBZ O
similar JJ O
to IN O
that DT O
of IN O
other JJ O
investigators NNS O
[ -LRB- O
30 CD O
, , O
35 CD O
, , O
64 CD O
] -RRB- O
. . O

Despite IN O
the DT O
desire NN O
of IN O
some DT O
clinicians NNS O
to TO O
use VB O
these DT O
resources NNS O
, , O
lack NN O
of IN O
confidence NN O
and CC O
ability NN O
to TO O
use VB O
them PRP O
appropriately RB O
has VBZ O
been VBN O
found VBN O
[ -LRB- O
30 CD O
, , O
64 CD O
, , O
68 CD O
, , O
69 CD O
] -RRB- O
. . O

Our PRP$ O
study NN O
suggests VBZ O
that IN O
although IN O
this DT O
resource NN O
is VBZ O
perceived VBN O
as IN O
credible JJ O
, , O
current JJ O
/ SYM O
timely JJ O
, , O
and CC O
useful JJ O
, , O
it PRP O
is VBZ O
also RB O
perceived VBN O
to TO O
be VB O
somewhat RB O
inaccessible JJ O
. . O

The DT O
Cochrane NNP O
Library NNP O
is VBZ O
available JJ O
to IN O
the DT O
health NN O
professionals NNS O
( , O
e LS O
. . O
g LS O
. . O
nurses NNS O
, , O
physicians NNS O
, , O
pharmacists NNS O
, , O
occupational JJ O
therapists NNS O
, , O
physiotherapists NNS O
, , O
etc FW O
. . O
) -RRB- O
in IN O
our PRP$ O
sample NN O
through IN O
professional JJ O
bodies NNS O
via IN O
the DT O
Atlantic NNP O
Health NNP O
Knowledge NNP O
Partnership NNP O
[ -LRB- O
70 CD O
] -RRB- O
. . O

Technology NN O
training NN O
: : O
preferences NNS O
and CC O
incentives NNS O

With IN O
regard NN O
to IN O
receiving VBG O
training NN O
for IN O
a DT O
new JJ O
technology NN O
, , O
our PRP$ O
study NN O
demonstrates VBZ O
that IN O
in IN O
person NN B-Species
conferences NNS O
or CC O
one CD O
on IN O
one CD O
training NN O
sessions NNS O
are VBP O
the DT O
preferred JJ O
means NNS O
to TO O
receive VB O
continuing VBG O
education NN O
. . O

Person NN B-Species
to IN O
person NN B-Species
interaction NN O
has VBZ O
been VBN O
reported VBN O
as IN O
the DT O
preferred VBN O
and CC O
most RBS O
frequently RB O
used VBN O
means NNS O
to TO O
access VB O
continuing VBG O
education NN O
or CC O
training NN O
by IN O
other JJ O
investigators NNS O
[ -LRB- O
55 CD O
, , O
71 CD O
] -RRB- O
. . O

Our PRP$ O
study NN O
also RB O
indicates VBZ O
that IN O
this DT O
group NN O
of IN O
practitioners NNS O
may MD O
benefit VB O
from IN O
accessing VBG O
resources NNS O
[ -LRB- O
72 CD O
- SYM O
80 CD O
] -RRB- O
that WDT O
provide VBP O
guidance NN O
on IN O
useful JJ O
drug NN O
information NN O
resources NNS O
available JJ O
for IN O
devices NNS O
such JJ O
as IN O
PDAs NNS O
. . O

This DT O
is VBZ O
exemplified VBN O
by IN O
one CD O
respondent NN O
' POS O
s POS O
statement NN O
"""" `` O
knowledge NN O
regarding VBG O
good JJ O
software NN O
programs NNS O
"""" '' O
as IN O
a DT O
barrier NN O
to IN O
the DT O
use NN O
of IN O
PDAs NNS O
. . O

Pharmaceutical JJ O
industry NN O

The DT O
influence NN O
of IN O
the DT O
pharmaceutical JJ O
industry NN O
on IN O
physician NN O
prescribing NN O
and CC O
research NN O
outcomes NNS O
has VBZ O
been VBN O
documented VBN O
[ -LRB- O
81 CD O
, , O
82 CD O
] -RRB- O
. . O

Although IN O
NP NNP O
use NN O
of IN O
industry NN O
representatives NNS O
as IN O
a DT O
source NN O
of IN O
pharmacological JJ O
information NN O
has VBZ O
been VBN O
documented VBN O
, , O
the DT O
influence NN O
on IN O
prescribing NN O
is VBZ O
largely RB O
uninvestigated JJ O
[ -LRB- O
32 CD O
, , O
61 CD O
, , O
83 CD O
- HYPH O
85 CD O
] -RRB- O
. . O

The DT O
CNA NNP O
competency NN O
framework NN O
includes VBZ O
a DT O
statement NN O
regarding VBG O
prescribing NN O
and CC O
industry NN O
relations NNS O
[ -LRB- O
23 CD O
] -RRB- O
. . O

In IN O
our PRP$ O
study NN O
, , O
the DT O
physician NN O
and CC O
NP NNP O
rankings NNS O
of IN O
industry NN O
representatives NNS O
were VBD O
similar JJ O
. . O

Within IN O
the DT O
health NN O
professionals NNS O
and CC O
other JJ O
category NN O
, , O
pharmaceutical NN O
representatives NNS O
were VBD O
used VBN O
as IN O
a DT O
resource NN O
by IN O
more JJR O
of IN O
the DT O
sample NN O
than IN O
regional JJ O
drug NN O
information NN O
services NNS O
and CC O
comparably RB O
to IN O
academic JJ O
detailing NN O
services NNS O
. . O

Academic JJ O
detailing NN O
is VBZ O
a DT O
form NN O
of IN O
continuing VBG O
medical JJ O
education NN O
where WRB O
a DT O
trained VBN O
health NN O
professional NN O
visits VBZ O
prescribers NNS O
for IN O
a DT O
fifteen CD O
to TO O
twenty CD O
minute NN O
session NN O
to TO O
provide VB O
objective JJ O
information NN O
regarding VBG O
a DT O
therapeutic JJ O
topic NN O
based VBN O
on IN O
best RB O
available JJ O
evidence NN O
[ -LRB- O
86 CD O
, , O
87 CD O
] -RRB- O
. . O

Following VBG O
academic JJ O
detailing NN O
, , O
physician NN O
and CC O
NP NNP O
rankings NNS O
of IN O
pharmaceutical JJ O
industry NN O
representatives NNS O
were VBD O
second JJ O
or CC O
third JJ O
for IN O
frequency NN O
of IN O
use NN O
, , O
usefulness NN O
, , O
accessibility NN O
, , O
credibility NN O
, , O
and CC O
current JJ O
/ SYM O
timeliness NN O
. . O

Limitations NNS O

We PRP O
do VBP O
not RB O
have VB O
demographics NNS O
or CC O
information NN O
regarding VBG O
the DT O
reasons NNS O
why WRB O
survey NN O
recipients NNS O
did VBD O
not RB O
respond VB O
. . O

As IN O
per IN O
ethical JJ O
requirements NNS O
to TO O
maintain VB O
confidentiality NN O
of IN O
respondents NNS O
, , O
we PRP O
were VBD O
not RB O
able JJ O
to TO O
match VB O
respondents NNS O
from IN O
their PRP$ O
respective JJ O
place NN O
of IN O
practice NN O
and CC O
therefore RB O
cannot MD O
conclude VB O
whether IN O
the DT O
practitioners NNS O
within IN O
a DT O
practice NN O
setting NN O
influenced VBD O
the DT O
others NNS O
' POS O
responses NNS O
. . O

The DT O
sample NN O
size NN O
of IN O
the DT O
survey NN O
is VBZ O
small JJ O
although IN O
it PRP O
includes VBZ O
88 CD O
% NN O
response NN O
from IN O
community NN O
based VBN O
NPs NNPS O
in IN O
Nova NNP O
Scotia NNP O
. . O

The DT O
generalizability NN O
of IN O
the DT O
results NNS O
is VBZ O
limited JJ O
due IN O
to IN O
the DT O
variations NNS O
in IN O
NP NNP O
scopes NNS O
of IN O
practice NN O
nationally RB O
and CC O
internationally RB O
. . O

It PRP O
is VBZ O
unknown JJ O
whether IN O
the DT O
findings NNS O
are VBP O
generalizable JJ O
to IN O
nonresponding JJ O
physicians NNS O
within IN O
Nova NNP O
Scotia NNP O
collaborating VBG O
with IN O
NPs NNPS O
or CC O
to IN O
physicians NNS O
not RB O
in IN O
collaborative JJ O
practices NNS O
with IN O
NPs NNPS O
as IN O
they PRP O
were VBD O
not RB O
included VBN O
as IN O
a DT O
part NN O
of IN O
the DT O
sample NN O
. . O

Due IN O
to IN O
multiple JJ O
statistical JJ O
comparisons NNS O
( : O
Mann NNP O
Whitney NNP O
U NNP O
) -RRB- O
, , O
the DT O
results NNS O
comparing VBG O
NP NNP O
and CC O
physician NN O
ratings NNS O
of IN O
results NNS O
should MD O
be VB O
interpreted VBN O
with IN O
caution NN O
. . O

Conclusion NN O

Respondent NN O
ratings NNS O
of IN O
resources NNS O
and CC O
preferences NNS O
for IN O
resource NN O
use NN O
were VBD O
consistent JJ O
with IN O
self NN O
- HYPH O
reported VBN O
means NNS O
of IN O
conducting VBG O
searches NNS O
for IN O
specific JJ O
drug NN O
information NN O
queries NNS O
. . O

The DT O
use NN O
of IN O
computers NNS O
and CC O
PDAs NNS O
remains VBZ O
limited JJ O
and CC O
also RB O
matches VBZ O
preferences NNS O
and CC O
resource NN O
ratings NNS O
. . O

Education NN O
to IN O
this DT O
group NN O
of IN O
practitioners NNS O
regarding VBG O
available JJ O
drug NN O
information NN O
resources NNS O
may MD O
facilitate VB O
use NN O
of IN O
computer NN O
and CC O
PDA NNP O
resources NNS O
. . O

Further JJ O
research NN O
is VBZ O
needed VBN O
to TO O
determine VB O
methods NNS O
to TO O
increase VB O
the DT O
use NN O
of IN O
computers NNS O
and CC O
PDAs NNS O
and CC O
if IN O
use NN O
of IN O
these DT O
technologies NNS O
affects VBZ O
prescribing NN O
and CC O
patient NN B-Species
outcomes NNS O
. . O

Competing VBG O
interests NNS O

Ingrid NNP O
Sketris NNP O
holds VBZ O
a DT O
Chair NNP O
from IN O
Canadian NNP O
Institutes NNPS O
of IN O
Health NNP O
Research NNP O
( -LRB- O
CIHR NNP O
) -RRB- O
, , O
Canadian NNP O
Health NNP O
Services NNPS O
Research NNP O
Foundation NNP O
( , O
CHSRF NNP O
) , O
co NN O
- HYPH O
sponsored VBN O
by IN O
the DT O
Nova NNP O
Scotia NNP O
Health NNP O
Research NNP O
Foundation NNP O
( -LRB- O
NSHRF NNP O
) -RRB- O
. . O

Andrea NNP O
Murphy NNP O
received VBD O
salary NN O
support NN O
through IN O
this DT O
Chair NNP O
as IN O
a DT O
research NN O
fellow NN O
at IN O
the DT O
time NN O
of IN O
conducting VBG O
this DT O
research NN O
. . O

The DT O
survey NN O
was VBD O
performed VBN O
in IN O
fulfillment NN O
of IN O
the DT O
requirements NNS O
for IN O
the DT O
Drug NNP O
Use NNP O
Management NNP O
and CC O
Policy NNP O
Residency NNP O
that WDT O
Murphy NNP O
participated VBD O
in IN O
as IN O
a DT O
part NN O
of IN O
her PRP$ O
fellowship NN O
. . O

The DT O
residency NN O
was VBD O
conducted VBN O
with IN O
a DT O
decision NN O
making VBG O
partner NN O
from IN O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
. . O

The DT O
opinions NNS O
expressed VBN O
in IN O
this DT O
paper NN O
are VBP O
those DT O
of IN O
the DT O
authors NNS O
and CC O
do VBP O
not RB O
represent VB O
the DT O
opinions NNS O
of IN O
the DT O
Nova NNP O
Scotia NNP O
Department NNP O
of IN O
Health NNP O
, , O
CIHR NNP O
/ SYM O
CHSRF NNP O
or CC O
NSHRF NNP O
. . O

MF NNP O
, , O
MM NNP O
, , O
RMM NNP O
, , O
and CC O
DG NNP O
have VBP O
no DT O
competing VBG O
interests NNS O
to TO O
declare VB O
. . O

Authors NNS O
' POS O
contributions NNS O

AM NNP O
conceptualized VBD O
the DT O
design NN O
and CC O
composed VBD O
the DT O
survey NN O
instruments NNS O
, , O
carried VBD O
out RP O
the DT O
study NN O
, , O
entered VBD O
and CC O
analyzed VBD O
the DT O
data NNS O
, , O
drafted VBD O
the DT O
original JJ O
manuscript NN O
, , O
and CC O
modified VBD O
subsequent JJ O
drafts NNS O
based VBN O
on IN O
authors NNS O
' POS O
and CC O
reviewers NNS O
' POS O
feedback NN O
. . O

MF NNP O
, , O
RMM NNP O
, , O
IS NNP O
, , O
MM NNP O
, , O
and CC O
DG NNP O
reviewed VBD O
and CC O
suggested VBD O
revisions NNS O
to IN O
the DT O
survey NN O
tools NNS O
, , O
covering VBG O
letters NNS O
, , O
overall JJ O
study NN O
design NN O
, , O
and CC O
contributed VBD O
to IN O
feedback NN O
on IN O
the DT O
analysis NN O
and CC O
manuscript NN O
revisions NNS O
. . O

Pre NN O
- HYPH O
publication NN O
history NN O

The DT O
pre JJ O
- HYPH O
publication NN O
history NN O
for IN O
this DT O
paper NN O
can MD O
be VB O
accessed VBN O
here RB O
: : O

Supplementary JJ O
Material NN O

Expression NN O
of IN O
C NN O
- HYPH O
terminal NN O
deleted VBN O
p53 NN O
isoforms NNS O
in IN O
neuroblastoma NN O

Abstract JJ O

The DT O
tumor NN O
suppressor NN O
gene NN O
, , O
p53 NN O
, , O
is VBZ O
rarely RB O
mutated VBN O
in IN O
neuroblastomas NN O
( , O
NB NNP O
) -RRB- O
at IN O
the DT O
time NN O
of IN O
diagnosis NN O
, , O
but CC O
its PRP$ O
dysfunction NN O
could MD O
result VB O
from IN O
a DT O
nonfunctional JJ O
conformation NN O
or CC O
cytoplasmic JJ O
sequestration NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
p53 NN O
protein NN O
. . O

However RB O
, , O
p53 NN O
mutation NN O
, , O
when WRB O
it PRP O
occurs VBZ O
, , O
is VBZ O
found VBN O
in IN O
NB NNP O
tumors NNS O
with IN O
drug NN O
resistance NN O
acquired VBN O
over IN O
the DT O
course NN O
of IN O
chemotherapy NN O
. . O

As IN O
yet RB O
, , O
no DT O
study NN O
has VBZ O
been VBN O
devoted VBN O
to IN O
the DT O
function NN O
of IN O
the DT O
specific JJ O
p53 NN O
mutants NNS O
identified VBN O
in IN O
NB NNP O
cells NNS O
. . O

This DT O
study NN O
includes VBZ O
characterization NN O
and CC O
functional JJ O
analysis NN O
of IN O
p53 NN O
expressed VBN O
in IN O
eight CD O
cell NN O
lines NNS O
: : O
three CD O
wild JJ O
- HYPH O
type NN O
cell NN O
lines NNS O
and CC O
five CD O
cell NN O
lines NNS O
harboring VBG O
mutations NNS O
. . O

We PRP O
identified VBD O
two CD O
transcription NN O
- HYPH O
inactive JJ O
p53 NN O
variants NNS O
truncated VBN O
in IN O
the DT O
C NNP O
- HYPH O
terminus NN O
, , O
one CD O
of IN O
which WDT O
corresponded VBD O
to IN O
the DT O
p53 NN O
beta NN O
isoform NN O
recently RB O
identified VBN O
in IN O
normal JJ O
tissue NN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

[ -LRB- O
J NNP O
. . O
C NNP O
. . O
Bourdon NNP O
, , O
K NNP O
. . O
Fernandes NNP O
, , O
F NNP O
. . O
Murray NNP O
- HYPH O
Zmijewski NNP O
, , O
G NNP O
. . O
Liu NNP O
, , O
A NNP O
. . O
Diot NNP O
, , O
D NNP O
. . O
P NN O
. . O
Xirodimas NNP O
, , O
M NNP O
. . O
K NNP O
. . O
Saville NNP O
and CC O
D NNP O
. . O
P NN O
. . O
Lane NNP O
( , O
2005 CD O
) SYM O
Genes NNP O
Dev NNP O
. . O
, , O
19 CD O
, , O
2122 CD O
- HYPH O
2137 CD O
] -RRB- O
. . O

Our PRP$ O
results NNS O
show VBP O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
that IN O
the DT O
p53 NN O
beta NN O
isoform NN O
is VBZ O
the DT O
only JJ O
p53 NN O
species NNS O
to TO O
be VB O
endogenously RB O
expressed VBN O
in IN O
the DT O
human JJ B-Species
NB NNP O
cell NN O
line NN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
, , O
suggesting VBG O
that IN O
the DT O
C NNP O
- HYPH O
terminus NN O
truncated VBN O
p53 NN O
isoforms NNS O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
NB NNP O
tumor NN O
development NN O
. . O

INTRODUCTION NN O

The DT O
p53 NN O
tumor NN O
suppressor NN O
gene NN O
remains VBZ O
the DT O
most RBS O
frequently RB O
altered VBN O
gene NN O
in IN O
human JJ B-Species
tumors NNS O
. . O

Several JJ O
p53 NN O
mutation NN O
databases NNS O
have VBP O
been VBN O
reported VBN O
previously RB O
( , O
1 CD O
- HYPH O
3 CD O
) -RRB- O
, , O
and CC O
to IN O
date NN O
, , O
more JJR O
than IN O
1500 CD O
different JJ O
p53 NN O
mutants NNS O
have VBP O
been VBN O
described VBN O
( SYM O
4 CD O
) -RRB- O
. . O

Functional JJ O
inactivation NN O
of IN O
p53 NN O
is VBZ O
usually RB O
due JJ O
to IN O
gene NN O
mutation NN O
, , O
deletion NN O
or CC O
protein NN O
degradation NN O
. . O

In IN O
general JJ O
, , O
the DT O
majority NN O
of IN O
p53 NN O
mutations NNS O
in IN O
human JJ B-Species
neoplasia NN O
are VBP O
missense JJ O
mutations NNS O
affecting VBG O
the DT O
DNA NNP O
- HYPH O
binding VBG O
domain NN O
( -LRB- O
DBD NNP O
) -RRB- O
. . O

Unlike IN O
other JJ O
human JJ B-Species
cancers NNS O
, , O
p53 NN O
in IN O
neuroblastoma NN O
( , O
NB NNP O
) -RRB- O
is VBZ O
rarely RB O
mutated VBN O
in IN O
the DT O
primary JJ O
tumor NN O
at IN O
diagnosis NN O
but CC O
high JJ O
levels NNS O
of IN O
wild JJ O
- HYPH O
type NN O
p53 NN O
( -LRB- O
wt NN O
p53 NN O
) -RRB- O
protein NN O
expression NN O
have VBP O
been VBN O
found VBN O
in IN O
the DT O
cytoplasm NN O
of IN O
undifferentiated JJ O
tumors NNS O
( : O
5 CD O
, , O
6 CD O
) -RRB- O
. . O

More RBR O
recently RB O
, , O
in IN O
normal JJ O
unstressed JJ O
cells NNS O
, , O
wt CD O
p53 NN O
protein NN O
was VBD O
found VBN O
to TO O
be VB O
retained VBN O
in IN O
the DT O
cytoplasm NN O
as IN O
a DT O
latent NN O
form NN O
, , O
in IN O
huge JJ O
, , O
p53 NN O
- HYPH O
associated VBN O
protein NN O
complexes NNS O
known VBN O
as IN O
' `` O
Parc NNP O
' '' O
( : O
7 CD O
) -RRB- O
. . O

The DT O
steady JJ O
- HYPH O
state NN O
concentration NN O
of IN O
p53 NN O
in IN O
normal JJ O
unstressed JJ O
cells NNS O
is VBZ O
usually RB O
very RB O
low JJ O
because IN O
of IN O
the DT O
short JJ O
half JJ O
- HYPH O
life NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
( HYPH O
wt NN O
) -RRB- O
protein NN O
. . O

Overexpression NN O
of IN O
p53 NN O
in IN O
most JJS O
of IN O
the DT O
transformed VBN O
cells NNS O
containing VBG O
a DT O
missense NN O
mutation NN O
within IN O
the DT O
p53 NN O
gene NN O
appears VBZ O
to TO O
be VB O
due IN O
to IN O
the DT O
increased VBN O
stability NN O
of IN O
mutated VBN O
p53 NN O
( SYM O
8 CD O
) -RRB- O
. . O

In IN O
unstressed JJ O
NB NNP O
cells NNS O
, , O
high JJ O
wt NN O
p53 NN O
expression NN O
may MD O
reflect VB O
the DT O
embryonic JJ O
origin NN O
of IN O
NBs NNP O
, , O
in IN O
which WDT O
precursor NN O
cells NNS O
fail VBP O
to TO O
mature VB O
( , O
9 CD O
) -RRB- O
. . O

p53 NN O
mutations NNS O
are VBP O
unusual JJ O
in IN O
human JJ B-Species
NB NNP O
but CC O
, , O
when WRB O
they PRP O
do VBP O
occur VB O
, , O
are VBP O
found VBN O
in IN O
post NN O
- HYPH O
chemotherapy NN O
tumors NNS O
. . O

In IN O
this DT O
respect NN O
, , O
Tweddle NNP O
et FW O
al NNP O
. . O

( : O
10 CD O
) , O
described VBD O
how WRB O
two CD O
NB NNP O
cell NN O
lines NNS O
derived VBN O
from IN O
the DT O
same JJ O
patient NN B-Species
can MD O
elicit VB O
a DT O
different JJ O
p53 NN O
status NN O
: : O
wt PRP O
p53 CD O
for IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( HYPH O
1a CD O
) -RRB- O
established VBN O
before IN O
treatment NN O
, , O
and CC O
mutated VBN O
p53 NN O
for IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( HYPH O
2c CD O
) -RRB- O
established VBN O
after IN O
relapse NN O
of IN O
the DT O
patient NN B-Species
under IN O
treatment NN O
with IN O
cytotoxic JJ O
agents NNS O
such JJ O
as IN O
cyclophosphamide NN O
, , O
doxorubicin NN O
, , O
vincristine NN O
and CC O
radiotherapy NN O
. . O

In IN O
NB NNP O
cell NN O
lines NNS O
, , O
p53 NN O
mutation NN O
has VBZ O
been VBN O
found VBN O
in IN O
multidrug NN O
- HYPH O
resistant JJ O
cells NNS O
( SYM O
11 CD O
) -RRB- O
. . O

Various JJ O
types NNS O
of IN O
p53 NN O
mutation NN O
have VBP O
been VBN O
detected VBN O
in IN O
NB NNP O
cells NNS O
and CC O
can MD O
lead VB O
to IN O
inactivation NN O
either CC O
by IN O
shut VBN O
- HYPH O
down RP O
of IN O
protein NN O
expression NN O
or CC O
production NN O
of IN O
aberrant JJ O
p53 NN O
products NNS O
. . O

Indeed RB O
, , O
in IN O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
, , O
p53 NN O
nonsense NN O
mutation NN O
at IN O
cysteine NN O
182 CD O
in IN O
exon NN O
5 CD O
leads VBZ O
to IN O
the DT O
absence NN O
of IN O
protein NN O
( , O
9 CD O
) -RRB- O
, , O
whereas IN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( , O
2 CD O
) -RRB- O
cells NNS O
, , O
missense NN O
mutation NN O
at IN O
codon NN O
135 CD O
( , O
C135F NN O
) -RRB- O
leads VBZ O
to IN O
stable JJ O
overexpressed JJ O
protein NN O
( SYM O
11 CD O
) -RRB- O
. . O

By IN O
analyzing VBG O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
a DT O
cell NN O
line NN O
established VBN O
in IN O
our PRP$ O
laboratory NN O
from IN O
the DT O
bone NN O
marrow NN O
of IN O
a DT O
patient NN B-Species
with IN O
metastatic JJ O
NB NNP O
after IN O
unsuccessful JJ O
Adriamycin NNP O
- HYPH O
vincristine NN O
chemotherapy NN O
( SYM O
12 CD O
) -RRB- O
, , O
we PRP O
identified VBD O
another DT O
type NN O
of IN O
aberrant JJ O
protein NN O
that WDT O
arises VBZ O
from IN O
the DT O
duplication NN O
of IN O
exons NNS O
7 CD O
- SYM O
8 CD O
- SYM O
9 CD O
. . O

This DT O
duplication NN O
spans VBZ O
from IN O
amino NN O
acids NNS O
225 CD O
to IN O
331 CD O
, , O
which WDT O
represent VBP O
part NN O
of IN O
the DT O
DBD NN O
and CC O
part NN O
of IN O
the DT O
oligomerization NN O
domain NN O
( -LRB- O
13 CD O
) -RRB- O
. . O

However RB O
, , O
each DT O
p53 NN O
mutant NN O
has VBZ O
been VBN O
described VBN O
in IN O
the DT O
literature NN O
as IN O
a DT O
case NN O
report NN O
, , O
and CC O
so RB O
far RB O
, , O
no DT O
comparative JJ O
study NN O
has VBZ O
been VBN O
undertaken VBN O
to TO O
link VB O
their PRP$ O
biochemical JJ O
features NNS O
with IN O
functional JJ O
properties NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
report VBP O
two CD O
novel JJ O
p53 NN O
C NN O
- HYPH O
terminus NN O
mutants NNS O
identified VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
human JJ B-Species
NB NNP O
cell NN O
lines NNS O
. . O

The DT O
biological JJ O
properties NNS O
of IN O
these DT O
two CD O
new JJ O
variants NNS O
were VBD O
analyzed VBN O
in IN O
comparison NN O
with IN O
p53 NN O
isolated VBN O
from IN O
six CD O
other JJ O
human JJ B-Species
NB NNP O
lines NNS O
: : O
three CD O
[ -LRB- O
LAN NNP O
- HYPH O
1 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
and CC O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
] -RRB- O
expressing VBG O
mutant JJ O
p53 NN O
and CC O
three CD O
( , O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
LAN NNP O
- HYPH O
5 CD O
and CC O
IMR NN O
- HYPH O
32 CD O
) , O
expressing VBG O
the DT O
wt NN O
protein NN O
. . O

This DT O
characterization NN O
was VBD O
done VBN O
by IN O
using VBG O
a DT O
range NN O
of IN O
functional JJ O
assays NNS O
: : O
( : O
i PRP O
) -RRB- O
the DT O
ability NN O
of IN O
the DT O
protein NN O
to TO O
bind VB O
with IN O
p53 NN O
consensus NN O
sequence NN O
using VBG O
the DT O
functional JJ O
analysis NN O
of IN O
separated VBN O
allele NN O
in IN O
yeast NN B-Species
( , O
FASAY NNP O
) -RRB- O
; : O
( , O
ii FW O
) -RRB- O
the DT O
ability NN O
of IN O
the DT O
protein NN O
to TO O
transactivate VB O
the DT O
p53 NN O
- HYPH O
responsive JJ O
element NN O
( -LRB- O
RE NN O
) -RRB- O
identified VBN O
either CC O
in IN O
the DT O
promoter NN O
of IN O
p21 NN O
/ SYM O
WAF1 NNP O
or CC O
in IN O
the DT O
first JJ O
intron NN O
of IN O
BAX NNP O
, , O
using VBG O
luciferase NN O
reporter NN O
assay NN O
; : O
( , O
iii FW O
) -RRB- O
the DT O
induction NN O
of IN O
endogenous JJ O
p21 NN O
/ SYM O
WAF1 NN O
gene NN O
expression NN O
under IN O
stress NN O
conditions NNS O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Neuroblastoma NN O
cell NN O
lines NNS O
, , O
culture NN O
and CC O
drug NN O
treatments NNS O

The DT O
parental JJ O
human JJ B-Species
NB NNP O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS IN O
, , O
IMR NNP O
- HYPH O
32 CD O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) SYM O
cell NN O
lines NNS O
were VBD O
purchased VBN O
from IN O
the DT O
European NNP O
Collection NNP O
of IN O
Cell NNP O
Cultures NNP O
( : O
ECACC NNP O
, , O
Wiltshire NNP O
, , O
UK NNP O
) -RRB- O
. . O

The DT O
human JJ B-Species
IGR NNP O
- HYPH O
NB8 NNP O
cells NNS O
( , O
a DT O
gift NN O
of IN O
Prof NNP O
. . O
Gilles NNP O
Vassal NNP O
, , O
UPRES NNP O
EA NNP O
3535 CD O
, , O
Institut NNP O
Gustave NNP O
Roussy NNP O
, , O
Villejuif NNP O
) -RRB- O
were VBD O
derived VBN O
from IN O
a DT O
previously RB O
untreated JJ O
localized VBN O
NB NNP O
( SYM O
14 CD O
) -RRB- O
. . O

The DT O
LAN NNP O
- HYPH O
1 CD O
and CC O
LAN NNP O
- HYPH O
5 CD O
cell NN O
lines NNS O
were VBD O
provided VBN O
by IN O
Dr NNP O
Nicole NNP O
Gross NNP O
( : O
Pediatric NNP O
Oncology NNP O
Research NNP O
, , O
Lausanne NNP O
, , O
Switzerland NNP O
) -RRB- O
. . O

The DT O
human JJ B-Species
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cell NN O
line NN O
was VBD O
established VBN O
in IN O
our PRP$ O
laboratory NN O
from IN O
the DT O
bone NN O
marrow NN O
of IN O
a DT O
patient NN B-Species
with IN O
metastatic JJ O
NB NNP O
after IN O
unsuccessful JJ O
adriamycin NN O
- HYPH O
vincristin NN O
chemotherapy NN O
( : O
12 CD O
) -RRB- O
. . O

LAN NNP O
- HYPH O
1 CD O
, , O
LAN NNP O
- HYPH O
5 CD O
and CC O
IMR NNP O
- HYPH O
32 CD O
were VBD O
grown VBN O
in IN O
RPMI NNP O
medium NN O
supplemented VBN O
with IN O
2 CD O
mM NN O
l NN O
- HYPH O
glutamine NN O
and CC O
10 CD O
% NN O
fetal JJ O
calf NN O
serum NN O
and CC O
gentamicine NN O
10 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
. . O

Others NNS O
cell NN O
lines NNS O
were VBD O
cultured VBN O
in IN O
DMEM NNP O
. . O

For IN O
activation NN O
of IN O
endogenous JJ O
p53 NN O
, , O
cells NNS O
were VBD O
treated VBN O
with IN O
cis NN O
- HYPH O
platinum NN O
( -LRB- O
Sigma NNP O
) -RRB- O
( , O
10 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
for IN O
24 CD O
h NNS O
then RB O
lysed VBN O
for IN O
western JJ O
blot NN O
analysis NN O
. . O

Western JJ O
blot NN O
analysis NN O

This DT O
procedure NN O
was VBD O
carried VBN O
out RP O
as IN O
described VBN O
previously RB O
( : O
13 CD O
) -RRB- O
. . O

Protein NN O
lysates NNS O
( : O
50 CD O
mu NNS O
g NN O
) -RRB- O
were VBD O
submitted VBN O
to IN O
10 CD O
% NN O
SDS NN O
- HYPH O
PAGE NN O
, , O
and CC O
then RB O
transferred VBN O
onto IN O
nitrocellulose NN O
filters NNS O
. . O

After IN O
saturation NN O
, , O
the DT O
membranes NNS O
were VBD O
incubated VBN O
with IN O
primary JJ O
antibody NN O
diluted VBN O
in IN O
0 CD O
. . O
1 CD O
% NN O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
, , O
Tween NNP O
- HYPH O
20 CD O
and CC O
3 CD O
% NN O
skim NN O
milk NN O
. . O

The DT O
primary JJ O
antibodies NNS O
used VBN O
were VBD O
anti JJ O
- HYPH O
p53 NN O
monoclonal JJ O
antibody NN O
( , O
clone JJ O
DO NN O
- HYPH O
7 CD O
, , O
1 CD O
/ SYM O
1000 CD O
, , O
DAKO NNP O
) -RRB- O
, , O
anti JJ O
- HYPH O
p21 NN O
/ SYM O
WAF1 NNP O
monoclonal JJ O
antibody NN O
( , O
Ab NNP O
- HYPH O
1 CD O
, , O
1 CD O
/ SYM O
200 CD O
, , O
Oncogene NNP O
Research NNP O
) -RRB- O
and CC O
anti JJ O
- HYPH O
beta NN O
- HYPH O
actin NN O
monoclonal JJ O
antibody NN O
( , O
1 CD O
/ SYM O
1000 CD O
; : O
Chemicon NNP O
) -RRB- O
as IN O
internal JJ O
control NN O
. . O

Protein NN O
bands NNS O
were VBD O
detected VBN O
by IN O
ECL NNP O
system NN O
( : O
Amersham NNP O
) -RRB- O
. . O

PCR NN O
, , O
plasmids NNS O
cloning VBG O

Genomic JJ O
DNA NNP O
was VBD O
extracted VBN O
using VBG O
lysis NN O
buffer NN O
containing VBG O
20 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
, , O
pH NN O
7 CD O
. . O
5 CD O
; : O
0 CD O
. . O
4 CD O
M NN O
NaCl NN O
; : O
0 CD O
. . O
5 CD O
% NN O
SDS NN O
; : O
10 CD O
mM NN O
EDTA NNP O
, , O
treated VBN O
with IN O
proteinase NN O
K NNP O
( , O
200 CD O
mu NNS O
g NN O
/ SYM O
mu NN O
l NN O
) -RRB- O
, , O
purified VBN O
with IN O
phenol NN O
/ SYM O
chloroform NN O
, , O
precipitated VBN O
with IN O
ethanol NN O
and CC O
dissolved VBN O
in IN O
DNase NNP O
free JJ O
water NN O
. . O

Total JJ O
RNA NNP O
were VBD O
purified VBN O
using VBG O
RNAble NNP O
reagent NN O
( , O
Eurobio NNP O
) -RRB- O
, , O
precipitated VBN O
with IN O
isopropanol NN O
and CC O
dissolved VBN O
in IN O
RNase NNP O
free JJ O
water NN O
. . O

cDNA NNP O
was VBD O
obtained VBN O
by IN O
reverse JJ O
transcription NN O
of IN O
1 CD O
mu NNS O
g NN O
of IN O
total JJ O
RNA NNP O
using VBG O
Superscript NNP O
II NNP O
( -LRB- O
TM NNP O
) -RRB- O
RNase NNP O
H NNP O
- HYPH O
Reverse NNP O
transcriptase NN O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
Oligo NNP O
- HYPH O
d NNP O
( -LRB- O
T NNP O
) -RRB- O
16 CD O
in IN O
conditions NNS O
specified VBN O
by IN O
the DT O
manufacturer NN O
. . O

Amplification NN O
of IN O
full JJ O
- HYPH O
length NN O
p53 NN O
coding VBG O
region NN O
from IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
IGR NNP O
- HYPH O
NB8 NNP O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
cell NN O
lines NNS O
was VBD O
performed VBN O
using VBG O
forward JJ O
primer NN O
at IN O
position NN O
152 CD O
and CC O
reverse JJ O
primer NN O
at IN O
position NN O
1583 CD O
( SYM O
F1 CD O
and CC O
R7 CD O
, , O
respectively RB O
, , O
Table NNP O
1 CD O
; : O
GenBank NNP O
accession NN O
no UH O
. . O
K03199 CD O
) -RRB- O
. . O

p53 NN O
cDNA NN O
from IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
for IN O
cloning NN O
was VBD O
obtained VBN O
from IN O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
F1 NN O
and CC O
reverse JJ O
primer NN O
i9 CD O
+ SYM O
: : O
5 CD O
' '' O
- HYPH O
GCAAAGTCATAGAACCATTT NNP O
- HYPH O
3 CD O
' '' O
( -LRB- O
nucleotide NN O
position NN O
14989 CD O
, , O
GenBank NNP O
accession NN O
no NN O
. . O
X54156 CD O
) -RRB- O
primers NNS O
which WDT O
encompass VBP O
from IN O
exon NN O
1 CD O
to IN O
exon NN O
i9 CD O
+ SYM O
first RB O
identified VBN O
by IN O
Flaman NNP O
et FW O
al NNP O
. . O

( : O
15 CD O
) NFP O
included VBN O
. . O

The DT O
PCR NNP O
was VBD O
done VBN O
in IN O
the DT O
presence NN O
of IN O
pfu NN O
Hotstart NNP O
DNA NNP O
polymerase NN O
( , O
Stratagene NNP O
) -RRB- O
for IN O
30 CD O
cycles NNS O
of IN O
1 CD O
min NN O
at IN O
90 CD O
degrees NNS O
C NN O
, , O
1 CD O
min NN O
at IN O
65 CD O
degrees NNS O
C NN O
and CC O
2 CD O
min NN O
30 CD O
s NNS O
at IN O
72 CD O
degrees NNS O
C NN O
using VBG O
PTC NNP O
- HYPH O
100 CD O
thermocycler NN O
( , O
MJ NNP O
- HYPH O
Research NNP O
) -RRB- O
. . O

The DT O
p53 NN O
cDNA NN O
from IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
IGR NNP O
- HYPH O
NB8 NNP O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
were VBD O
then RB O
cloned VBN O
into IN O
pcDNA3 NN O
. . O
1 CD O
/ SYM O
V5 NNP O
- HYPH O
His PRP$ O
- HYPH O
Topo NN O
vector NN O
( , O
Invitrogen NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instruction NN O
. . O

The DT O
p53 NN O
sequence NN O
of IN O
each DT O
cell NN O
line NN O
was VBD O
investigated VBN O
by IN O
sequencing NN O
of IN O
plasmids NNS O
after IN O
cloning NN O
. . O

Sequencing NN O
was VBD O
performed VBN O
by IN O
Genome NNP O
Express NNP O
( : O
Meylan NNP O
, , O
France NNP O
) -RRB- O
. . O

The DT O
pDDm NNP O
- HYPH O
TO NNP O
harboring VBG O
p53 NN O
dominant JJ O
negative JJ O
form NN O
( -LRB- O
p53DD NN O
) -RRB- O
pGL3 NNP O
- HYPH O
E1bTATA NNP O
and CC O
the DT O
pE1B NN O
- HYPH O
hWAF1 NNP O
firefly NN O
luciferase NN O
reporter NN O
containing VBG O
the DT O
p53 NN O
- HYPH O
responsive JJ O
element NN O
of IN O
the DT O
p21 NN O
/ SYM O
WAF1 NNP O
promoter NN O
were VBD O
described VBN O
previously RB O
( : O
16 CD O
, , O
17 CD O
) , O
pE1B NN O
- HYPH O
BAXi NNP O
contains VBZ O
the DT O
p53RE NN O
identified VBN O
in IN O
the DT O
intron NN O
1 CD O
of IN O
the DT O
BAX NNP O
gene NN O
[ -LRB- O
( SYM O
18 CD O
) -RRB- O
and CC O
D NNP O
. . O
Munsch NNP O
, , O
personal JJ O
communication NN O
] -RRB- O
. . O

Oligonucleotides NNP O
TCGAGGGCAGGCCCGGGCTT NNP O
and CC O
CTAGCGACAAGCCCGGGCCT NNP O
were VBD O
annealed VBN O
and CC O
cloned VBN O
into IN O
pGL3 NNP O
- HYPH O
E1bTATA NNP O
digested VBN O
with IN O
NheI NNP O
and CC O
XhoI NNP O
to TO O
obtain VB O
pE1B NN O
- HYPH O
BAXi NNP O
. . O

The DT O
pcDNA3 NNP O
- HYPH O
Delta NNP O
Np73 NNP O
alpha NN O
expression NN O
plasmid NN O
was VBD O
a DT O
gift NN O
of IN O
Dr NNP O
Daniel NNP O
Caput NNP O
( : O
SANOFI NNP O
, , O
Lab NNP O
e FW O
ges FW O
, , O
France NNP O
) -RRB- O
. . O

Fluorescent JJ O
in IN O
situ NN O
hybridization NN O
( , O
FISH NNP O
) -RRB- O

Cytogenetic JJ O
preparations NNS O

Metaphase NN O
spreads VBZ O
from IN O
healthy JJ O
human JJ B-Species
male JJ O
lymphocytes NNS O
and CC O
tumor NN O
cell NN O
lines NNS O
were VBD O
prepared VBN O
as IN O
described VBN O
previously RB O
( : O
19 CD O
) -RRB- O
. . O

BAC NNP O
probe NN O
RP11 NNP O
- HYPH O
199F11 CD O
, , O
containing VBG O
a DT O
167 CD O
kb NN O
region NN O
spanning VBG O
TP53 NN O
gene NN O
, , O
was VBD O
labeled VBN O
by IN O
random JJ O
priming NN O
in IN O
the DT O
presence NN O
of IN O
Alexa NNP O
594 CD O
- HYPH O
dUTP NN O
( : O
Molecular NNP O
Probes NNPS O
) -RRB- O
. . O

A DT O
commercial JJ O
probe NN O
specific JJ O
for IN O
chromosome NN O
17 CD O
centromere NN O
, , O
and CC O
labeled VBN O
with IN O
spectrum NN O
green NN O
, , O
was VBD O
obtained VBN O
from IN O
Vysis NNP O
. . O

After IN O
over IN O
- HYPH O
night NN O
cohybridization NN O
of IN O
the DT O
probes NNS O
in IN O
the DT O
presence NN O
of IN O
Cot NNP O
- HYPH O
1 CD O
DNA NN O
, , O
the DT O
slides NNS O
were VBD O
washed VBN O
and CC O
DNA NNP O
counterstained VBN O
with IN O
DAPI NNP O
. . O

The DT O
preparations NNS O
were VBD O
observed VBN O
with IN O
an DT O
epifluorescence NN O
microscope NN O
and CC O
images NNS O
captured VBN O
with IN O
a DT O
Vysis NNP O
imaging NN O
station NN O
. . O

Between IN O
3 CD O
and CC O
14 CD O
metaphases NNS O
spreads VBZ O
and CC O
30 CD O
- SYM O
200 CD O
nuclei NNS O
were VBD O
examined VBN O
for IN O
each DT O
cell NN O
line NN O
. . O

Luciferase NNP O
reporter NN O
assays NNS O

LAN NNP O
- HYPH O
1 CD O
or CC O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
were VBD O
seeded VBN O
in IN O
duplicates NNS O
onto IN O
6 CD O
- HYPH O
well NN O
plates NNS O
at IN O
a DT O
density NN O
of IN O
2 CD O
x SYM O
104 CD O
cells NNS O
per IN O
cm2 CD O
and CC O
cotransfected VBN O
24 CD O
h NN O
later RB O
with IN O
0 CD O
. . O
5 CD O
mu NN O
g NN O
( : O
2 CD O
. . O
5 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
of IN O
pGL3 NN O
firefly JJ O
luciferase NN O
reporter NN O
gene NN O
plasmid NN O
under IN O
the DT O
control NN O
of IN O
either CC O
pE1B NN O
- HYPH O
hWAF1 NN O
or CC O
pE1B NN O
- HYPH O
BAX NN O
using VBG O
lipofectamine NN O
2000 CD O
and CC O
1 CD O
mu NN O
g NN O
of IN O
either CC O
a DT O
p53 NN O
expressing VBG O
plasmid NN O
or CC O
an DT O
empty JJ O
vector NN O
. . O

At IN O
24 CD O
h NN O
after IN O
transfection NN O
, , O
cells NNS O
were VBD O
lysed VBN O
with IN O
200 CD O
mu NNS O
l NN O
/ SYM O
well NN O
of IN O
passive JJ O
lysis NN O
buffer NN O
provided VBN O
with IN O
the DT O
' `` O
Luciferase NNP O
assay NN O
kit NN O
' '' O
( -LRB- O
Promega NNP O
) -RRB- O
. . O

Luciferase NNP O
activity NN O
was VBD O
measured VBN O
using VBG O
Microlumat NNP O
LB96P NNP O
luminometer NN O
( , O
EG NNP O
& CC O
G NNP O
Berthold NNP O
Instrument NNP O
) -RRB- O
. . O

Functional JJ O
assay NN O
in IN O
yeast NN B-Species

cDNA NNP O
was VBD O
obtained VBN O
by IN O
RT NNP O
of IN O
1 CD O
mu NNS O
g NN O
of IN O
total JJ O
RNA NNP O
using VBG O
Superscript NNP O
II NNP O
( -LRB- O
TM NNP O
) -RRB- O
RNase NNP O
H NNP O
- HYPH O
Reverse NN O
transcriptase NN O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
random JJ O
hexamers NNS O
to TO O
prime VB O
the DT O
synthesis NN O
in IN O
conditions NNS O
specified VBN O
by IN O
the DT O
manufacturer NN O
. . O

p53 NN O
cDNA NNP O
was VBD O
amplified VBN O
by IN O
PCR NNP O
and CC O
cotransformed VBN O
into IN O
yeast NN B-Species
, , O
IG397 NNP O
Ade2 NNP O
strain NN O
, , O
together RB O
with IN O
either CC O
pRDI NNP O
- HYPH O
22 CD O
vector NN O
for IN O
p53 CD O
- HYPH O
standard JJ O
assay NN O
or CC O
pFW35 NN O
and CC O
pFW34 NN O
plasmid NN O
for IN O
5 CD O
' '' O
or CC O
3 CD O
' '' O
split VBN O
assay NN O
, , O
respectively RB O
, , O
carrying VBG O
the DT O
ADE2 NNP O
open JJ O
reading NN O
frame NN O
under IN O
the DT O
control NN O
of IN O
a DT O
p53 NN O
- HYPH O
responsive JJ O
promoter NN O
( SYM O
20 CD O
) -RRB- O
. . O

In IN O
a DT O
selective JJ O
medium NN O
lacking VBG O
leucine NN O
, , O
wt PRP O
- HYPH O
p53 NN O
activates VBZ O
transcription NN O
of IN O
ADE2 NNP O
gene NN O
that WDT O
encodes VBZ O
enzyme NN O
- HYPH O
- HYPH O
phosphoribosylimidaz NN O
carboxylase NN O
- HYPH O
- HYPH O
implicated VBN O
in IN O
adenine JJ O
biosynthesis NN O
. . O

Therefore RB O
, , O
a DT O
colony NN O
of IN O
cells NNS O
that WDT O
expresses VBZ O
ADE2 NNP O
gene NN O
is VBZ O
white JJ O
whereas IN O
the DT O
one CD O
composed VBN O
of IN O
cells NNS O
where WRB O
ADE2 NN O
gene NN O
is VBZ O
not RB O
expressed VBN O
owing VBG O
p53 NN O
mutation NN O
is VBZ O
red JJ O
. . O

RESULTS NNS O

P53 NN O
status NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
cells NNS O

We PRP O
first RB O
compared VBD O
the DT O
migration NN O
profiles NNS O
of IN O
p53 NN O
expressed VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
with IN O
those DT O
expressed VBN O
in IN O
the DT O
other JJ O
six CD O
NB NNP O
cells NNS O
, , O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
LAN NNP O
- HYPH O
5 CD O
, , O
LAN NNP O
- HYPH O
1 CD O
, , O
IMR NNP O
- HYPH O
32 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
and CC O
IGR NN O
- HYPH O
N NN O
- HYPH O
91 CD O
. . O

Western JJ O
blots NNS O
from IN O
50 CD O
mu NNS O
g NN O
of IN O
total JJ O
protein NN O
extracts NNS O
were VBD O
revealed VBN O
with IN O
p53 NN O
monoclonal JJ O
antibody NN O
( -LRB- O
DO NN O
- HYPH O
7 CD O
) -RRB- O
. . O

A DT O
range NN O
of IN O
profiles NNS O
was VBD O
identified VBN O
as IN O
shown VBN O
in IN O
Figure NNP O
1A CD O
. . O

As IN O
expected VBN O
, , O
p53 NN O
extracted VBN O
from IN O
the DT O
three CD O
cell NN O
lines NNS O
, , O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
LAN NNP O
- HYPH O
5 CD O
and CC O
IMR NNP O
- HYPH O
32 CD O
, , O
expressing VBG O
wt NN O
protein NN O
( , O
13 CD O
, , O
21 CD O
) -RRB- O
migrated VBD O
at IN O
the DT O
wt JJ O
position NN O
. . O

Of IN O
particular JJ O
note NN O
in IN O
these DT O
three CD O
wt CD O
p53 NN O
cell NN O
lines NNS O
was VBD O
an DT O
additional JJ O
faint JJ O
band NN O
that WDT O
migrated VBD O
faster RBR O
than IN O
the DT O
full JJ O
- HYPH O
length NN O
protein NN O
. . O

The DT O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
were VBD O
found VBN O
to TO O
be VB O
p53 NN O
deficient JJ O
( : O
9 CD O
) -RRB- O
. . O

The DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) SYM O
cell NN O
line NN O
showed VBD O
an DT O
intense JJ O
band NN O
reflecting VBG O
p53 NN O
stability NN O
due IN O
to IN O
a DT O
missense JJ O
mutation NN O
at IN O
codon NN O
135 CD O
( SYM O
11 CD O
) -RRB- O
. . O

As IN O
expected VBN O
, , O
due IN O
to IN O
the DT O
previously RB O
identified VBN O
duplication NN O
of IN O
exons NNS O
7 CD O
- SYM O
8 CD O
- SYM O
9 CD O
( SYM O
13 CD O
) -RRB- O
, , O
p53 NN O
protein NN O
migration NN O
was VBD O
delayed VBN O
in IN O
the DT O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cells NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
p53 NN O
protein NN O
in IN O
the DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
line NN O
migrated VBD O
noticeably RB O
faster RBR O
than IN O
the DT O
wt NN O
protein NN O
, , O
indicating VBG O
that IN O
it PRP O
was VBD O
smaller JJR O
in IN O
size NN O
. . O

The DT O
p53 NN O
protein NN O
in IN O
the DT O
IGR NNP O
- HYPH O
NB8 NNP O
cell NN O
line NN O
was VBD O
even RB O
smaller JJR O
than IN O
that DT O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
. . O

To TO O
analyze VB O
the DT O
coding VBG O
region NN O
of IN O
each DT O
of IN O
the DT O
p53 NN O
variants NNS O
, , O
RT NNP O
- HYPH O
PCR NNP O
was VBD O
performed VBN O
using VBG O
p53 NN O
- HYPH O
specific JJ O
F1 NNP O
- HYPH O
R7 NN O
primers NNS O
( -LRB- O
Table NN O
1 CD O
and CC O
Figure NNP O
1B NNP O
) -RRB- O
. . O

The DT O
expected VBN O
1430 CD O
bp NN O
for IN O
full JJ O
- HYPH O
length NN O
p53 NN O
was VBD O
amplified VBN O
from IN O
wt NN O
p53 CD O
- HYPH O
expressing VBG O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
LAN NNP O
- HYPH O
5 CD O
and CC O
IMR NNP O
- HYPH O
32 CD O
cell NN O
lines NNS O
. . O

As IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
harbors VBZ O
a DT O
single JJ O
point NN O
mutation NN O
at IN O
codon NN O
135 CD O
( SYM O
C135F NNP O
) -RRB- O
, , O
the DT O
amplified VBN O
fragment NN O
analyzed VBN O
by IN O
electrophoresis NN O
migrated VBN O
as IN O
wt PRP O
p53 CD O
( -LRB- O
Figure NN O
1B NN O
) -RRB- O
. . O

The DT O
longer JJR O
RT NNP O
- HYPH O
PCR NNP O
fragment NN O
from IN O
the DT O
mutated VBN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cell NN O
line NN O
resulted VBD O
from IN O
the DT O
duplication NN O
of IN O
exons NNS O
7 CD O
- SYM O
8 CD O
- SYM O
9 CD O
, , O
as IN O
shown VBN O
in IN O
our PRP$ O
previous JJ O
data NN O
( : O
13 CD O
) -RRB- O
, , O
which WDT O
corresponds VBZ O
to IN O
extra JJ O
nucleic JJ O
material NN O
of IN O
321 CD O
nt NNS O
. . O

For IN O
the DT O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
, , O
no DT O
amplified JJ O
fragment NN O
was VBD O
observed VBN O
in IN O
accordance NN O
with IN O
published VBN O
data NNS O
, , O
which WDT O
demonstrates VBZ O
the DT O
extremely RB O
low JJ O
levels NNS O
of IN O
p53 NN O
mRNA NN O
and CC O
the DT O
undetectable JJ O
level NN O
of IN O
protein NN O
( : O
9 CD O
) -RRB- O
. . O

An DT O
amplified JJ O
fragment NN O
of IN O
the DT O
same JJ O
length NN O
as IN O
the DT O
wt NN O
protein NN O
was VBD O
observed VBN O
in IN O
the DT O
IGR NNP O
- HYPH O
NB8 NNP O
cell NN O
line NN O
( -LRB- O
Figure NNP O
1B NN O
) -RRB- O
. . O

Indeed RB O
, , O
complete JJ O
gene NN O
sequencing NN O
revealed VBD O
a DT O
point NN O
mutation NN O
E326STOP NN O
leading VBG O
to IN O
a DT O
truncated VBN O
protein NN O
at IN O
C NNP O
- HYPH O
terminus NN O
. . O

No DT O
fragment NN O
, , O
however RB O
, , O
was VBD O
amplified VBN O
from IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
with IN O
F1 NNP O
- HYPH O
R7 NNP O
primers NNS O
. . O

To TO O
further RB O
map VB O
the DT O
p53 NN O
mRNA NNP O
transcribed VBN O
in IN O
these DT O
cells NNS O
, , O
series NN O
of IN O
RT NNP O
- HYPH O
PCR NNP O
tests NNS O
were VBD O
performed VBN O
using VBG O
the DT O
forward JJ O
primer NN O
, , O
F2 NNP O
( HYPH O
exon NN O
8 CD O
position NN O
1008th NN O
according VBG O
to IN O
GenBank NNP O
accession NN O
no UH O
. , O
K03199 CD O
) -RRB- O
, , O
matched VBN O
with IN O
different JJ O
reverse JJ O
primers NNS O
, , O
R3 NNP O
( , O
at IN O
the DT O
junction NN O
of IN O
exon NN O
8 CD O
/ SYM O
9 CD O
, , O
nt CD O
position NN O
1124 CD O
) -RRB- O
, , O
R4 NNP O
, , O
R5 CD O
( , O
in IN O
exon NN O
9 CD O
at IN O
positions NNS O
1154 CD O
and CC O
1184 CD O
, , O
respectively RB O
) -RRB- O
, , O
and CC O
R6 CD O
( , O
in IN O
exon NN O
10 CD O
, , O
at IN O
position NN O
1230 CD O
) -RRB- O
. . O

The DT O
sequences NNS O
of IN O
these DT O
primers NNS O
are VBP O
given VBN O
in IN O
Table NNP O
1 CD O
and CC O
the DT O
results NNS O
are VBP O
presented VBN O
in IN O
Figure NNP O
2A NNP O
. . O

SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cDNA NNP O
gave VBD O
an DT O
amplified JJ O
fragment NN O
of IN O
the DT O
same JJ O
size NN O
as IN O
SH NNP O
- HYPH O
SY5Y NNP O
cDNA NNP O
with IN O
the DT O
three CD O
primer NN O
pairs NNS O
, , O
F2 NNP O
/ SYM O
R3 NNP O
, , O
F2 NNP O
/ SYM O
R4 NNP O
and CC O
F3 NNP O
/ SYM O
R5 NNP O
. . O

However RB O
, , O
in IN O
contrast NN O
to IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
no DT O
fragment NN O
was VBD O
obtained VBN O
with IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cDNA NNP O
using VBG O
the DT O
F2 NNP O
/ SYM O
R6 NNP O
primer NN O
pair NN O
, , O
which WDT O
suggests VBZ O
the DT O
absence NN O
of IN O
exon NN O
10 CD O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
mRNA NNP O
. . O

The DT O
p53 NN O
protein NN O
expressed VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
is VBZ O
the DT O
p53 NN O
beta JJ O
isoform NN O

An DT O
alternatively RB O
spliced VBN O
form NN O
of IN O
human JJ B-Species
p53 NN O
mRNA NN O
with IN O
an DT O
additional JJ O
133 CD O
bp NN O
exon NN O
derived VBN O
from IN O
intron NN O
9 CD O
has VBZ O
been VBN O
detected VBN O
in IN O
normal JJ O
human JJ B-Species
lymphocytes NNS O
( SYM O
15 CD O
) -RRB- O
. . O

This DT O
spliced VBN O
variant NN O
named VBN O
' `` O
i9 CD O
+ NN O
' '' O
encodes VBZ O
a DT O
truncated VBN O
protein NN O
of IN O
341 CD O
amino NN O
acids NNS O
including VBG O
10 CD O
new JJ O
amino NN O
acids NNS O
derived VBN O
from IN O
the DT O
novel JJ O
exon NN O
, , O
the DT O
p53 NN O
beta NN O
isoform NN O
according VBG O
to IN O
Bourdon NNP O
et FW O
al NNP O
. . O
nomenclature NN O
( SYM O
22 CD O
) -RRB- O
. . O

This DT O
led VBD O
us PRP O
to TO O
hypothesize VB O
that IN O
the DT O
shorter JJR O
protein NN O
expressed VBN O
by IN O
the DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
line NN O
could MD O
be VB O
the DT O
p53 NN O
beta NN O
isoform NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
RT NNP O
- HYPH O
PCRs NNS O
were VBD O
performed VBN O
using VBG O
primer NN O
sets NNS O
designed VBN O
to TO O
amplify VB O
the DT O
3 CD O
' '' O
region NN O
of IN O
p53 NN O
mRNA NN O
encoding VBG O
either CC O
the DT O
specific JJ O
C NN O
- HYPH O
terminal JJ O
part NN O
of IN O
the DT O
wt NN O
protein NN O
( , O
wt PRP$ O
C NN O
- HYPH O
ter NN O
) -RRB- O
or CC O
the DT O
specific JJ O
C NN O
- HYPH O
terminal JJ O
part NN O
of IN O
the DT O
beta NN O
isoform NN O
( , O
beta NN O
C NN O
- HYPH O
ter NN O
) -RRB- O
. . O

In IN O
parallel JJ O
amplification NN O
with IN O
a DT O
primer JJ O
pair NN O
amplifying VBG O
the DT O
DBD NNP O
was VBD O
used VBN O
as IN O
control NN O
. . O

The DT O
sequences NNS O
of IN O
these DT O
oligonucleotides NNS O
are VBP O
given VBN O
in IN O
Table NNP O
1 CD O
. . O

The DT O
results NNS O
presented VBN O
in IN O
Figure NNP O
2B NNP O
are VBP O
consistent JJ O
with IN O
the DT O
only JJ O
expression NN O
of IN O
the DT O
p53 NN O
beta NN O
isoform NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
as IN O
no DT O
band NN O
was VBD O
observed VBN O
in IN O
lane NN O
using VBG O
specific JJ O
C NN O
- HYPH O
ter NN O
primer NN O
located VBN O
in IN O
exon NN O
10 CD O
. . O

Interestingly RB O
, , O
RT NNP O
- HYPH O
PCR NNP O
using VBG O
SH NNP O
- HYPH O
SY5Y NNP O
( -LRB- O
SH NNP O
) -RRB- O
gave VBD O
an DT O
amplified JJ O
fragment NN O
not RB O
only RB O
with IN O
the DT O
primer JJ O
pair NN O
specific JJ O
to IN O
the DT O
C NNP O
- HYPH O
ter CD O
domain NN O
of IN O
wt NN O
p53 NN O
but CC O
also RB O
with IN O
the DT O
primer NN O
pair NN O
specific JJ O
to IN O
the DT O
p53 NN O
beta NN O
isoform NN O
. . O

This DT O
result NN O
, , O
combined VBN O
with IN O
the DT O
presence NN O
of IN O
an DT O
additional JJ O
faint JJ O
band NN O
migrating VBG O
faster RBR O
than IN O
wt NN O
p53 NN O
in IN O
denaturing VBG O
polyacrylamide NN O
gel NN O
( , O
Figure NNP O
1A NNP O
) -RRB- O
, , O
strongly RB O
suggests VBZ O
that IN O
both CC O
the DT O
p53 NN O
full JJ O
- HYPH O
length NN O
protein NN O
and CC O
the DT O
beta NN O
isoform NN O
were VBD O
expressed VBN O
in IN O
the DT O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
. . O

The DT O
full JJ O
- HYPH O
length NN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
p53 CD O
cDNA NN O
was VBD O
then RB O
amplified VBN O
with IN O
the DT O
forward JJ O
primer NN O
F1 NN O
and CC O
a DT O
reverse JJ O
primer NN O
located VBN O
within IN O
the DT O
novel NN O
exon NN O
i9 CD O
+ NN O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

This DT O
amplified JJ O
fragment NN O
was VBD O
cloned VBN O
in IN O
pcDNA3 NN O
/ SYM O
V5 NNP O
- HYPH O
His NNP O
- HYPH O
Topo NNP O
, , O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

Its PRP$ O
sequence NN O
analysis NN O
confirmed VBD O
that IN O
the DT O
truncated VBN O
p53 NN O
expressed VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
was VBD O
encoded VBN O
by IN O
the DT O
i9 CD O
+ SYM O
splice NN O
variant NN O
described VBN O
previously RB O
by IN O
Flaman NNP O
et FW O
al NNP O
. . O

( : O
15 CD O
) NFP O
that DT O
encodes VBZ O
the DT O
p53 NN O
beta NN O
isoform NN O
characterized VBN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

( SYM O
22 CD O
) -RRB- O
. . O

A DT O
series NN O
of IN O
genomic JJ O
amplifications NNS O
were VBD O
performed VBN O
to TO O
identify VB O
a DT O
possible JJ O
deletion NN O
within IN O
the DT O
intron NN O
9 CD O
that WDT O
could MD O
account VB O
for IN O
the DT O
absence NN O
of IN O
normal JJ O
size NN O
p53 NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
. . O

The DT O
primer NN O
sequences NNS O
are VBP O
given VBN O
in IN O
Table NNP O
1 CD O
. . O

Amplifications NNS O
were VBD O
performed VBN O
in IN O
parallel NN O
with IN O
total JJ O
DNA NNP O
extracted VBN O
from IN O
SH NNP O
- HYPH O
SY5Y NNP O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
. . O

Results NNS O
are VBP O
presented VBN O
in IN O
Figure NNP O
3 CD O
. . O

Normal JJ O
size NN O
fragments NNS O
that WDT O
encompass VBP O
the DT O
acceptor NN O
site NN O
of IN O
intron NN O
9 CD O
were VBD O
amplified VBN O
with IN O
SH NNP O
- HYPH O
SY5Y NNP O
as RB O
well RB O
as IN O
with IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
DNA NNP O
. . O

On IN O
the DT O
contrary JJ O
amplification NN O
fragments NNS O
that WDT O
encompass VBP O
the DT O
intron NN O
9 CD O
donor NN O
site NN O
were VBD O
obtained VBN O
only RB O
with IN O
SH NNP O
- HYPH O
SY5Y NNP O
but CC O
not RB O
with IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
DNA NNP O
. . O

These DT O
results NNS O
identify VBP O
a DT O
deletion NN O
of IN O
the DT O
intron NN O
9 CD O
/ SYM O
exon NN O
10 CD O
junction NN O
within IN O
the DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
p53 NN O
gene NN O
. . O

A DT O
yeast NN B-Species
functional JJ O
assay NN O
confirmed VBD O
the DT O
absence NN O
of IN O
p53 CD O
full JJ O
- HYPH O
length NN O
expression NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O

It PRP O
is VBZ O
possible JJ O
to TO O
detect VB O
p53 NN O
mutation NN O
using VBG O
a DT O
simple JJ O
yeast NN B-Species
colony NN O
color NN O
assay NN O
as IN O
described VBN O
by IN O
Flaman NNP O
et FW O
al NNP O
. . O

( SYM O
23 CD O
) -RRB- O
. . O

When WRB O
the DT O
strain NN O
is VBZ O
transformed VBN O
with IN O
a DT O
plasmid NN O
- HYPH O
encoding VBG O
wt NN O
p53 NN O
, , O
the DT O
cells NNS O
express VBP O
the DT O
ADE2 NNP O
gene NN O
and CC O
produce VBP O
white JJ O
colonies NNS O
( -LRB- O
Figure NNP O
4A NN O
, , O
a DT O
, , O
b2 NN O
and CC O
c1 NN O
, , O
and CC O
Figure NNP O
4B NN O
, , O
dish NN O
a NN O
) -RRB- O
. . O

Cells NNS O
containing VBG O
mutant JJ O
p53 NN O
fail VBP O
to TO O
express VB O
ADE2 NNP O
and CC O
form VB O
small JJ O
red JJ O
colonies NNS O
( -LRB- O
Figure NN O
4A NN O
, , O
b NN O
and CC O
b1 NN O
, , O
and CC O
Figure NNP O
4B NN O
, , O
dish NN O
c NN O
) -RRB- O
. . O

When WRB O
the DT O
p53 NN O
cDNA NN O
fragment NN O
is VBZ O
deleted VBN O
, , O
cells NNS O
are VBP O
unable JJ O
to TO O
form VB O
a DT O
colony NN O
( -LRB- O
Figure NNP O
4A NN O
, , O
c NN O
and CC O
c2 NN O
) -RRB- O
. . O

As IN O
shown VBN O
in IN O
Table NNP O
2 CD O
, , O
FASAY NNP O
was VBD O
performed VBN O
as IN O
a DT O
p53 NN O
- HYPH O
standard JJ O
test NN O
with IN O
full JJ O
- HYPH O
length NN O
cDNA NN O
or CC O
with IN O
the DT O
split JJ O
version NN O
at IN O
the DT O
5 CD O
' '' O
and CC O
3 CD O
' '' O
end NN O
( SYM O
15 CD O
) -RRB- O
. . O

The DT O
background NN O
of IN O
FASAY NNP O
experiments NNS O
is VBZ O
around RB O
10 CD O
% NN O
. . O

p53 CD O
wt NN O
expressing VBG O
SH NNP O
- HYPH O
SY5Y NNP O
and CC O
LAN NNP O
- HYPH O
5 CD O
, , O
2 CD O
wt NN O
cell NN O
lines NNS O
, , O
yielded VBD O
~ $ O
92 CD O
- SYM O
97 CD O
% NN O
of IN O
white JJ O
colonies NNS O
( : O
Table NNP O
2 CD O
) -RRB- O
. . O

One CD O
hundred CD O
percent NN O
of IN O
the DT O
colonies NNS O
carrying VBG O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) SYM O
p53 CD O
, , O
which WDT O
is VBZ O
homozygous JJ O
for IN O
the DT O
C135F NNP O
mutation NN O
, , O
turned VBD O
red JJ O
with IN O
the DT O
standard JJ O
or CC O
5 CD O
' '' O
split JJ O
assay NN O
, , O
whereas IN O
94 CD O
% NN O
of IN O
the DT O
colonies NNS O
turned VBD O
white JJ O
with IN O
the DT O
3 CD O
' '' O
split JJ O
assay NN O
since IN O
the DT O
missense NN O
mutation NN O
does VBZ O
not RB O
extend VB O
to IN O
the DT O
C NNP O
' '' O
- HYPH O
terminus NN O
of IN O
the DT O
gene NN O
( -LRB- O
Table NN O
2 CD O
and CC O
Figure NNP O
4B NN O
, , O
dish NN O
c NN O
) -RRB- O
. . O

No DT O
colonies NNS O
were VBD O
observed VBN O
with IN O
p53 NN O
- HYPH O
deficient JJ O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
, , O
( , O
see VB O
also RB O
Figure NNP O
4A NNP O
, , O
c NN O
and CC O
c2 NN O
) -RRB- O
. . O

With IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cells NNS O
, , O
the DT O
split NN O
5 CD O
' '' O
assay NN O
gave VBD O
96 CD O
% NN O
white JJ O
colonies NNS O
, , O
while IN O
the DT O
p53 NN O
- HYPH O
standard NN O
and CC O
split VBN O
3 CD O
' '' O
assay NN O
did VBD O
not RB O
produce VB O
any DT O
colonies NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

This DT O
means VBZ O
that IN O
the DT O
5 CD O
' '' O
terminus NN O
was VBD O
intact JJ O
whereas IN O
the DT O
3 CD O
' '' O
terminus NN O
had VBD O
been VBN O
deleted VBN O
, , O
as IN O
was VBD O
confirmed VBN O
by IN O
nucleotide NN O
sequence NN O
analysis NN O
. . O

The DT O
IGR NNP O
- HYPH O
NB8 NNP O
colonies NNS O
, , O
however RB O
, , O
were VBD O
red JJ O
both CC O
with IN O
the DT O
p53 NN O
- HYPH O
standard JJ O
assay NN O
and CC O
the DT O
split NN O
3 CD O
' '' O
assay NN O
. . O

In IN O
the DT O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cell NN O
line NN O
, , O
where WRB O
p53 NN O
harbors VBZ O
two CD O
contiguous JJ O
sets NNS O
of IN O
exons NNS O
7 CD O
- SYM O
9 CD O
, , O
spanning VBG O
the DT O
DBD NN O
and CC O
oligomerization NN O
domain NN O
, , O
it PRP O
is VBZ O
interesting JJ O
to TO O
note VB O
that IN O
the DT O
yeast NN B-Species
colonies NNS O
were VBD O
predominantly RB O
white JJ O
( , O
Figure NN O
4B NN O
, , O
dish NN O
b NN O
) , O
with IN O
the DT O
split JJ O
5 CD O
' '' O
and CC O
the DT O
split VBN O
3 CD O
' '' O
assay NN O
( : O
96 CD O
and CC O
87 CD O
% NN O
of IN O
white JJ O
colonies NNS O
, , O
respectively RB O
) , O
This DT O
suggests VBZ O
that IN O
the DT O
cells NNS O
express VBP O
a DT O
binding VBG O
ability NN O
that WDT O
is VBZ O
specific JJ O
to IN O
wild JJ O
- HYPH O
type NN O
p53 NN O
rather RB O
than IN O
mutated VBN O
p53 NN O
( -LRB- O
Table NN O
2 CD O
) -RRB- O
. . O

Transcription NN O
activity NN O
of IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
p53 CD O
variants NNS O
in IN O
mammalian JJ O
cells NNS O

To TO O
determine VB O
the DT O
transactivation NN O
ability NN O
of IN O
p53 NN O
variants NNS O
in IN O
mammalian JJ O
cells NNS O
, , O
we PRP O
used VBD O
a DT O
reporter NN O
gene NN O
strategy NN O
. . O

The DT O
p53RE NN O
located VBN O
within IN O
either CC O
the DT O
human JJ B-Species
p21 NN O
/ SYM O
WAF1 NNP O
promoter NN O
or CC O
the DT O
intron NN O
1 CD O
of IN O
the DT O
mouse NN B-Species
and CC O
human JJ B-Species
BAX NN O
gene NN O
[ -LRB- O
( SYM O
18 CD O
) -RRB- O
and CC O
D NN O
. . O

Munsch NNP O
, , O
personnal JJ O
communication NN O
) , O
were VBD O
cloned VBN O
in IN O
a DT O
luciferase NN O
reporter NN O
gene NN O
plasmid NN O
upstream NN O
of IN O
the DT O
E1B NNP O
minimal JJ O
promoter NN O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

The DT O
p53 NN O
- HYPH O
negative JJ O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
were VBD O
cotransfected VBN O
with IN O
the DT O
p53 NN O
vectors NNS O
expressing VBG O
the DT O
p53 NN O
cloned VBN O
from IN O
either CC O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
or CC O
IGR NNP O
- HYPH O
NB8 NNP O
and CC O
the DT O
luciferase NN O
reporter NN O
plasmids NNS O
. . O

Both DT O
p53RE NN O
were VBD O
strongly RB O
stimulated VBN O
in IN O
cells NNS O
cotransfected VBN O
with IN O
wt NN O
p53 NN O
cloned VBN O
from IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
as IN O
compared VBN O
to IN O
cells NNS O
cotransfected VBN O
with IN O
an DT O
empty JJ O
plasmid NN O
. . O

In IN O
contrast NN O
, , O
none NN O
of IN O
the DT O
p53 NN O
variants NNS O
was VBD O
able JJ O
to TO O
transactivate VB O
the DT O
expression NN O
of IN O
luciferase NN O
driven VBN O
by IN O
either CC O
p21 CD O
/ SYM O
WAF1 NNP O
or CC O
BAX NN O
p53RE NN O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

To TO O
test VB O
transactivation NN O
capability NN O
at IN O
the DT O
protein NN O
level NN O
, , O
each DT O
variant NN O
was VBD O
transfected VBN O
into IN O
p53 NN O
- HYPH O
negative JJ O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
and CC O
the DT O
stimulation NN O
of IN O
endogenous JJ O
p21 NN O
/ SYM O
Waf1 NNP O
gene NN O
expression NN O
was VBD O
analyzed VBN O
by IN O
western JJ O
blotting NN O
. . O

As IN O
shown VBN O
in IN O
Figure NN O
6 CD O
, , O
in IN O
contrast NN O
to IN O
wt PRP O
p53 CD O
, , O
none NN O
of IN O
the DT O
p53 NN O
variants NNS O
was VBD O
able JJ O
to TO O
induce VB O
p21 NN O
protein NN O
accumulation NN O
. . O

We PRP O
then RB O
tested VBD O
for IN O
a DT O
possible JJ O
dominant JJ O
negative JJ O
effect NN O
of IN O
these DT O
various JJ O
mutants NNS O
on IN O
wt JJ O
p53 NN O
- HYPH O
dependent JJ O
transcriptional JJ O
activity NN O
. . O

To IN O
this DT O
end NN O
, , O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
were VBD O
cotransfected VBN O
with IN O
constructs NNS O
encoding VBG O
the DT O
luciferase NN O
gene NN O
driven VBN O
by IN O
either CC O
the DT O
p21 NNP O
/ SYM O
Waf1 NNP O
or CC O
BAX NNP O
p53RE NNP O
and CC O
the DT O
constructs NNS O
expressing VBG O
the DT O
various JJ O
p53s NNS O
cloned VBN O
from IN O
IGR NNP O
- HYPH O
NB8 NNP O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
NB NNP O
cells NNS O
or CC O
p53DD NN O
, , O
a DT O
dominant JJ O
negative JJ O
mutant NN O
of IN O
wt NN O
p53 CD O
( SYM O
24 CD O
) -RRB- O
. . O

The DT O
stress NN O
induced VBN O
by IN O
transfection NN O
activated VBD O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
wt VBN O
p53 NN O
expressed VBN O
in IN O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
leading VBG O
to IN O
a DT O
p53 NN O
- HYPH O
dependent JJ O
expression NN O
of IN O
luciferase NN O
as IN O
illustrated VBN O
by IN O
the DT O
fact NN O
that IN O
coexpression NN O
of IN O
p53DD NN O
led VBD O
to IN O
a DT O
substantial JJ O
decrease NN O
in IN O
luciferase NN O
activity NN O
when WRB O
compared VBN O
to IN O
the DT O
luciferase JJ O
activity NN O
of IN O
cells NNS O
cotransfected VBN O
with IN O
an DT O
empty JJ O
plasmid NN O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Compared VBN O
to IN O
p53DD NN O
, , O
mutants NNS O
within IN O
the DT O
DBD NNP O
isolated VBN O
from IN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
or CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( : O
2 CD O
) -RRB- O
had VBD O
only RB O
a DT O
moderate JJ O
dominant JJ O
negative JJ O
effect NN O
on IN O
endogenous JJ O
wt NN O
p53 NN O
transcriptional JJ O
activity NN O
. . O

More RBR O
surprisingly RB O
, , O
the DT O
transfection NN O
of IN O
the DT O
C NNP O
- HYPH O
terminal NN O
truncated VBN O
variant JJ O
IGR NNP O
- HYPH O
NB8 NNP O
enhanced VBD O
both CC O
BAX NNP O
and CC O
p21 NN O
/ SYM O
WAF1 NNP O
p53RE NN O
activity NN O
. . O

The DT O
coexpression NN O
of IN O
p53 NN O
beta NN O
cloned VBN O
from IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
also RB O
enhanced VBN O
BAX NNP O
p53RE NN O
activity NN O
. . O

A DT O
similar JJ O
effect NN O
has VBZ O
been VBN O
reported VBN O
already RB O
for IN O
p53 NN O
beta NN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

( SYM O
22 CD O
) -RRB- O
. . O

When WRB O
combined VBN O
, , O
these DT O
results NNS O
show VBP O
that IN O
all PDT O
the DT O
p53 NN O
variants NNS O
isolated VBN O
from IN O
the DT O
NB NNP O
cells NNS O
had VBD O
lost VBN O
the DT O
ability NN O
to TO O
specifically RB O
transactivate VB O
the DT O
p53 NN O
target NN O
genes NNS O
. . O

Their PRP$ O
effect NN O
on IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
endogenous JJ O
wt NN O
p53 NN O
expressed VBN O
in IN O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
, , O
however RB O
, , O
largely RB O
depended VBD O
on IN O
the DT O
p53 NN O
domain NN O
affected VBN O
by IN O
the DT O
modification NN O
. . O

All PDT O
the DT O
identified VBN O
p53 NN O
variants NNS O
inhibited VBD O
the DT O
induction NN O
of IN O
endogenous JJ O
p21 NN O
/ SYM O
WAF1 NNP O
gene NN O
expression NN O
under IN O
stress NN O
conditions NNS O

We PRP O
further RB O
examined VBD O
whether IN O
the DT O
four CD O
p53 NN O
variants NNS O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
, , O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
, , O
had VBD O
loss NN O
their PRP$ O
ability NN O
to TO O
stimulate VB O
the DT O
endogenous JJ O
expression NN O
of IN O
the DT O
p21 NN O
/ SYM O
WAF1 NNP O
gene NN O
, , O
the DT O
archetypical JJ O
cell NN O
cycle NN O
inhibitor NN O
and CC O
the DT O
true JJ O
target NN O
of IN O
p53 NN O
. . O

To IN O
this DT O
end NN O
, , O
cellular JJ O
response NN O
to IN O
genotoxic JJ O
stress NN O
was VBD O
analyzed VBN O
by IN O
western JJ O
blot NN O
following VBG O
treatment NN O
of IN O
the DT O
various JJ O
cell NN O
lines NNS O
with IN O
cisplatin NN O
, , O
one CD O
of IN O
the DT O
most RBS O
potent JJ O
antitumor NN O
agents NNS O
used VBN O
in IN O
neuroblastoma NN O
. . O

Results NNS O
are VBP O
presented VBN O
in IN O
Figure NNP O
7 CD O
. . O

None NN O
of IN O
the DT O
mutant JJ O
cells NNS O
, , O
regardless RB O
of IN O
the DT O
type NN O
of IN O
mutation NN O
, , O
was VBD O
able JJ O
to TO O
induce VB O
p21 NN O
/ SYM O
WAF1 NN O
protein NN O
accumulation NN O
, , O
unlike IN O
the DT O
3 CD O
p53 CD O
wild JJ O
- HYPH O
type NN O
cells NNS O
( -LRB- O
SH NNP O
- HYPH O
SY5Y NNP O
, , O
IMR NNP O
- HYPH O
32 CD O
and CC O
LAN NN O
- HYPH O
5 CD O
) -RRB- O
. . O

Genomic JJ O
status NN O
of IN O
TP53 NN O
region NN O
in IN O
the DT O
various JJ O
cell NN O
lines NNS O

According VBG O
to IN O
Knudson NNP O
' POS O
s NNS O
' `` O
two CD O
hit NN O
' '' O
model NN O
of IN O
tumor NN O
suppressor NN O
gene NN O
functional JJ O
inactivation NN O
, , O
the DT O
mutation NN O
of IN O
one CD O
allele NN O
is VBZ O
supposed VBN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
deletion NN O
of IN O
the DT O
second JJ O
allele NN O
. . O

To TO O
assess VB O
this DT O
genetic JJ O
mechanism NN O
, , O
we PRP O
performed VBD O
FISH NNP O
experiments NNS O
to TO O
search VB O
for IN O
deletions NNS O
of IN O
one CD O
copy NN O
of IN O
the DT O
TP53 NNP O
region NN O
, , O
especially RB O
in IN O
cell NN O
lines NNS O
with IN O
a DT O
mutated VBN O
TP53 NN O
gene NN O
. . O

For IN O
this DT O
purpose NN O
, , O
metaphase NN O
preparations NNS O
of IN O
the DT O
studied VBN O
cell NN O
lines NNS O
were VBD O
cohybridized VBN O
with IN O
a DT O
p53 NN O
DNA NN O
probe NN O
labeled VBN O
in IN O
red JJ O
( HYPH O
BAC NNP O
clone NN O
RP11 NN O
- SYM O
199F11 CD O
) -RRB- O
as IN O
described VBN O
previously RB O
( : O
25 CD O
) -RRB- O
and CC O
a DT O
chromosome NN O
17 CD O
- HYPH O
specific JJ O
centromeric JJ O
probe NN O
labeled VBN O
in IN O
green NN O
. . O

The DT O
three CD O
cell NN O
lines NNS O
shown VBN O
previously RB O
to TO O
express VB O
a DT O
wt NN O
p53 NN O
protein NN O
( -LRB- O
LAN5 NNP O
, , O
IMR32 NNP O
and CC O
SH NNP O
- HYPH O
SY5Y NNP O
) -RRB- O
, , O
displayed VBN O
as IN O
expected VBN O
two CD O
signals NNS O
with IN O
each DT O
probe NN O
, , O
confirming VBG O
the DT O
presence NN O
of IN O
both DT O
TP53 NN O
alleles NNS O
in IN O
these DT O
cells NNS O
( -LRB- O
Figure NN O
8 CD O
and CC O
Table NN O
3 CD O
) -RRB- O
. . O

Conversely RB O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
lines NNS O
displayed VBD O
only RB O
one CD O
fluorescent JJ O
signal NN O
for IN O
each DT O
probe NN O
, , O
suggesting VBG O
a DT O
whole JJ O
chromosome NN O
17 CD O
lost VBN O
, , O
or CC O
at IN O
least JJS O
losses NNS O
of IN O
the DT O
17p CD O
arm NN O
and CC O
the DT O
centromeric JJ O
region NN O
. . O

The DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
cell NN O
line NN O
has VBZ O
been VBN O
described VBN O
as IN O
containing VBG O
only RB O
one CD O
chromosome NN O
17 CD O
and CC O
one CD O
TP53 NN O
signal NN O
( HYPH O
10 CD O
) -RRB- O
. . O

In IN O
our PRP$ O
analysis NN O
, , O
only RB O
10 CD O
% NN O
of IN O
the DT O
cells NNS O
displayed VBD O
this DT O
characteristic NN O
, , O
whilst IN O
most JJS O
of IN O
the DT O
cells NNS O
had VBD O
two CD O
copies NNS O
of IN O
both DT O
( -LRB- O
Figure NN O
8 CD O
and CC O
Table NN O
3 CD O
) -RRB- O
. . O

p53 NN O
sequencing NN O
, , O
however RB O
, , O
confirmed VBD O
the DT O
previously RB O
described VBN O
mutation NN O
, , O
and CC O
the DT O
absence NN O
of IN O
a DT O
normal JJ O
allele NN O
, , O
suggesting VBG O
that IN O
the DT O
cells NNS O
used VBN O
in IN O
our PRP$ O
study NN O
had VBD O
acquired VBN O
, , O
during IN O
culture NN O
, , O
an DT O
uniparental JJ O
disomy NN O
for IN O
the DT O
TP53 NNP O
- HYPH O
mutated VBN O
chromosome NN O
17 CD O
. . O

Finally RB O
, , O
the DT O
other JJ O
two CD O
cell NN O
lines NNS O
( , O
LAN NNP O
- HYPH O
1 CD O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
) -RRB- O
displayed VBD O
highly RB O
variable JJ O
genetic JJ O
heterogeneity NN O
from IN O
one CD O
cell NN O
to IN O
the DT O
next JJ O
( , O
Table NNP O
3 CD O
) -RRB- O
. . O

Surprisingly RB O
, , O
although IN O
p53 NN O
transcripts NNS O
are VBP O
extremely RB O
faintly RB O
expressed VBN O
in IN O
LAN NNP O
- HYPH O
1 CD O
cell NN O
line NN O
, , O
all DT O
cells NNS O
showed VBD O
several JJ O
FISH NNP O
signals NNS O
with IN O
the DT O
167 CD O
kb NN O
BAC NNP O
probe NN O
used VBN O
here RB O
. . O

To TO O
understand VB O
this DT O
apparent JJ O
contradiction NN O
, , O
an DT O
array JJ O
- HYPH O
CGH NNP O
experiment NN O
was VBD O
performed VBN O
on IN O
an DT O
oligo NN O
- HYPH O
array NN O
Agilent NNP O
, , O
which WDT O
indicated VBD O
a DT O
133 CD O
kb NN O
interstitial JJ O
deletion NN O
corresponding VBG O
to IN O
the DT O
p53 NN O
coding VBG O
region NN O
and CC O
the DT O
97 CD O
kb NN O
upstream JJ O
region NN O
. . O

Accordingly RB O
, , O
the DT O
fluorescent JJ O
spots NNS O
observed VBN O
in IN O
FISH NNP O
experiments NNS O
on IN O
LAN NNP O
- HYPH O
1 CD O
cells NNS O
should MD O
be VB O
related VBN O
to IN O
the DT O
hybridization NN O
of IN O
the DT O
57 CD O
kb NN O
region NN O
downstream RB O
of IN O
p53 NN O
gene NN O
present JJ O
in IN O
the DT O
BAC NNP O
probe NN O
. . O

IGRN NNP O
- HYPH O
B8 NNP O
cell NN O
line NN O
displayed VBD O
a DT O
number NN O
of IN O
signals NNS O
of IN O
both DT O
colors NNS O
ranging VBG O
from IN O
0 CD O
to IN O
4 CD O
, , O
with IN O
87 CD O
% NN O
of IN O
cells NNS O
displaying VBG O
a DT O
loss NN O
for IN O
one CD O
TP53 NN O
allele NN O
. . O

Despite IN O
this DT O
genomic JJ O
variability NN O
, , O
analysis NN O
of IN O
the DT O
p53 NN O
protein NN O
showed VBD O
a DT O
single JJ O
shortened VBN O
form NN O
in IN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
B8 NN O
cell NN O
line NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

Consequently RB O
, , O
and CC O
as IN O
suggested VBN O
for IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) SYM O
cell NN O
line NN O
, , O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
B8 NNP O
cell NN O
line NN O
should MD O
contain VB O
a DT O
variable JJ O
number NN O
of IN O
copies NNS O
of IN O
chromosome NN O
17 CD O
with IN O
mutated VBN O
p53 NN O
. . O

DISCUSSION NN O

The DT O
p53 NN O
gene NN O
, , O
the DT O
' `` O
genome NN O
guardian NN O
' '' O
, , O
is VBZ O
mutated VBN O
in IN O
over IN O
50 CD O
% NN O
of IN O
human JJ B-Species
cancers NNS O
, , O
with IN O
the DT O
most RBS O
common JJ O
mutations NNS O
being VBG O
missense JJ O
mutations NNS O
( : O
> SYM O
2 CD O
/ SYM O
3 CD O
of IN O
mutations NNS O
) -RRB- O
( , O
26 CD O
) -RRB- O
. . O

In IN O
human JJ B-Species
neuroblastoma NN O
tumors NNS O
, , O
p53 NN O
mutations NNS O
are VBP O
rarely RB O
present JJ O
at IN O
the DT O
time NN O
of IN O
diagnosis NN O
( , O
5 CD O
, , O
27 CD O
) -RRB- O
; , O
however RB O
, , O
oncogenic JJ O
p53 NN O
mutations NNS O
can MD O
be VB O
found VBN O
in IN O
advanced JJ O
neuroblastomas NNS O
that WDT O
often RB O
relapse VBP O
following VBG O
high JJ O
- HYPH O
dose NN O
chemotherapy NN O
( SYM O
10 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
in IN O
breast NN O
cancers NNS O
, , O
it PRP O
has VBZ O
been VBN O
reported VBN O
that IN O
p53 NN O
mutations NNS O
might MD O
improve VB O
response NN O
to IN O
high JJ O
- HYPH O
dose NN O
chemotherapy NN O
including VBG O
therapy NN O
with IN O
epirubicin NN O
and CC O
cyclophosphamide NN O
( SYM O
28 CD O
) -RRB- O
. . O

An DT O
investigation NN O
into IN O
the DT O
p53 NN O
genomic JJ O
status NN O
and CC O
functions NNS O
of IN O
eight CD O
human JJ B-Species
NB NNP O
lines NNS O
revealed VBD O
that IN O
all DT O
five CD O
of IN O
the DT O
mutated VBN O
cell NN O
lines NNS O
had VBD O
distinct JJ O
genetic JJ O
characteristics NNS O
as IN O
is VBZ O
schematically RB O
represented VBN O
in IN O
Figure NNP O
9 CD O
: : O
SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( HYPH O
2 CD O
) -RRB- O
with IN O
a DT O
single JJ O
missense NN O
mutation NN O
in IN O
the DT O
p53 NN O
gene NN O
, , O
encoding VBG O
a DT O
highly RB O
stable JJ O
full JJ O
- HYPH O
length NN O
protein NN O
. . O

SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 CD O
proteins NNS O
, , O
although IN O
they PRP O
have VBP O
intact JJ O
transactivation NN O
and CC O
DBDs NNS O
, , O
were VBD O
truncated VBN O
at IN O
the DT O
C NNP O
- HYPH O
terminus NN O
generating VBG O
341 CD O
and CC O
326 CD O
amino NN O
acids NNS O
respectively RB O
; : O
they PRP O
therefore RB O
lack VBP O
the DT O
tetramerization NN O
domain NN O
that WDT O
is VBZ O
essential JJ O
for IN O
an DT O
active JJ O
conformation NN O
. . O

Very RB O
recently RB O
, , O
Bourdon NNP O
et FW O
al NNP O
. . O

( : O
22 CD O
) , O
reported VBD O
the DT O
putative JJ O
occurrence NN O
of IN O
beta NN O
and CC O
gamma NN O
isoforms NNS O
from IN O
different JJ O
tissues NNS O
due IN O
to IN O
alternate JJ O
splicing NN O
that WDT O
indicates VBZ O
the DT O
similarity NN O
to IN O
those DT O
of IN O
p73 NN O
and CC O
p63 NN O
as IN O
identified VBN O
previously RB O
by IN O
Daniel NNP O
Caput NNP O
and CC O
co NN O
- HYPH O
workers NNS O
( SYM O
29 CD O
) -RRB- O
. . O

In IN O
the DT O
p53 NN O
isoforms NNS O
scheme NN O
proposed VBN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

( : O
22 CD O
) -RRB- O
, , O
the DT O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
line NN O
that WDT O
elicits VBZ O
p53i9 NN O
protein NN O
expression NN O
is VBZ O
consistent JJ O
with IN O
the DT O
p53 NN O
beta NN O
isoform NN O
. . O

Genomic JJ O
analysis NN O
reveals VBZ O
that IN O
the DT O
only JJ O
occurrence NN O
of IN O
the DT O
p53 NN O
beta NN O
isoform NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
results VBZ O
from IN O
a DT O
deletion NN O
spanning VBG O
the DT O
intron NN O
9 CD O
/ SYM O
exon NN O
10 CD O
junction NN O
. . O

Similar JJ O
to IN O
the DT O
p53 NN O
beta NN O
isoform NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
, , O
the DT O
p53 NN O
in IN O
IGR NNP O
- HYPH O
NB8 NNP O
that WDT O
lacks VBZ O
67 CD O
amino NN O
acids NNS O
at IN O
C NNP O
- HYPH O
terminus NN O
was VBD O
, , O
alone RB O
, , O
unable JJ O
to TO O
induce VB O
p21 NN O
/ SYM O
WAF1 NNP O
promoter NN O
activation NN O
except IN O
with IN O
endogenous JJ O
wt NN O
- HYPH O
p53 NN O
on IN O
SH NNP O
- HYPH O
SY5Y NNP O
cells NNS O
where WRB O
transfection NN O
with IN O
IGR NNP O
- HYPH O
NB8 NNP O
significantly RB O
augmented VBD O
the DT O
transcriptional JJ O
activation NN O
of IN O
the DT O
p21 NNP O
/ SYM O
Waf NNP O
- HYPH O
1 CD O
promoter NN O
( -LRB- O
Figure NNP O
5A NNP O
) -RRB- O
. . O

Studies NNS O
by IN O
other JJ O
authors NNS O
have VBP O
reported VBN O
the DT O
interaction NN O
between IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
domain NN O
and CC O
another DT O
region NN O
that WDT O
impedes VBZ O
the DT O
active JJ O
conformation NN O
of IN O
p53 NN O
, , O
suggesting VBG O
an DT O
allosteric JJ O
model NN O
for IN O
p53 NN O
activity NN O
regulation NN O
( SYM O
30 CD O
) -RRB- O
. . O

Such JJ O
events NNS O
have VBP O
been VBN O
demonstrated VBN O
for IN O
the DT O
342 CD O
- HYPH O
stop NN O
mutant NN O
, , O
generated VBN O
by IN O
mutagenesis NN O
, , O
which WDT O
can MD O
modulate VB O
transactivation NN O
, , O
growth NN O
and CC O
apoptosis NN O
( SYM O
31 CD O
) -RRB- O
. . O

Moreover RB O
, , O
Harms NNP O
and CC O
Chen NNP O
( : O
32 CD O
) -RRB- O
reported VBD O
that IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
basic JJ O
domain NN O
inhibits VBZ O
induction NN O
of IN O
the DT O
proapoptotic JJ O
target NN O
gene NN O
insulin NN O
- HYPH O
like JJ O
growth NN O
factor NN O
binding NN O
protein NN O
3 CD O
, , O
suggesting VBG O
that IN O
IGR NNP O
- HYPH O
NB8 NNP O
might MD O
induce VB O
this DT O
gene NN O
. . O

IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
had VBD O
an DT O
abnormally RB O
high JJ O
molecular JJ O
weight NN O
protein NN O
due IN O
to IN O
the DT O
duplication NN O
of IN O
wild JJ O
- HYPH O
type NN O
exons NNS O
7 CD O
- SYM O
8 CD O
- SYM O
9 CD O
, , O
thus RB O
affecting VBG O
the DT O
DBD NNP O
and CC O
OD NN O
; : O
and CC O
LAN NNP O
- HYPH O
1 CD O
, , O
with IN O
a DT O
mutation NN O
at IN O
codon NN O
182 CD O
( , O
Cys NNP O
- HYPH O
- HYPH O
> SYM O
stop VB O
) -RRB- O
concurred VBN O
with IN O
an DT O
earlier JJR O
report NN O
showing VBG O
extremely RB O
low JJ O
levels NNS O
of IN O
mRNA NN O
and CC O
undetectable JJ O
protein NN O
expression NN O
( SYM O
9 CD O
) -RRB- O
. . O

Notably RB O
, , O
all PDT O
the DT O
p53 NN O
variants NNS O
, , O
including VBG O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
( : O
beta JJ O
isoform NN O
) -RRB- O
and CC O
IGR NN O
- HYPH O
NB8 NNP O
( : O
C NN O
- HYPH O
terminal NN O
truncated VBN O
p53 NN O
) -RRB- O
, , O
elicited VBD O
a DT O
total JJ O
lack NN O
of IN O
p21 NN O
promoter NN O
activation NN O
. . O

In IN O
particular JJ O
, , O
the DT O
p53 NN O
beta NN O
isoform NN O
was VBD O
unable JJ O
to TO O
induce VB O
endogenous JJ O
p21 NN O
expression NN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
( -LRB- O
Figure NNP O
6 CD O
) -RRB- O
, , O
concurring VBG O
with IN O
data NNS O
obtained VBN O
from IN O
in FW O
vitro FW O
transfection NN O
experiments NNS O
in IN O
H1299 CD O
cells NNS O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

( SYM O
22 CD O
) -RRB- O
. . O

For IN O
the DT O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
cells NNS O
, , O
although IN O
p53 NN O
was VBD O
mutated VBN O
and CC O
unable JJ O
to TO O
transactivate VB O
the DT O
p21 NN O
/ SYM O
WAF1 NNP O
promoter NN O
, , O
the DT O
FASAY NNP O
global JJ O
test NN O
was VBD O
not RB O
conclusive JJ O
since IN O
~ $ O
80 CD O
% NN O
of IN O
colonies NNS O
were VBD O
white JJ O
and CC O
nearly RB O
20 CD O
% NN O
( , O
see VBP O
also RB O
Table NNP O
2 CD O
) -RRB- O
, , O
though IN O
not RB O
enough RB O
, , O
were VBD O
red JJ O
. . O

Moreover RB O
, , O
in IN O
this DT O
particular JJ O
line NN O
, , O
standard JJ O
sequencing NN O
on IN O
cDNA NN O
using VBG O
primers NNS O
located VBN O
within IN O
each DT O
exon NN O
as IN O
used VBN O
for IN O
routine JJ O
tumor NN O
analysis NN O
was VBD O
unable JJ O
to TO O
detect VB O
any DT O
anomalies NNS O
in IN O
p53 NN O
genetic JJ O
status NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

These DT O
results NNS O
enlighten VBP O
the DT O
limit NN O
of IN O
the DT O
conventional JJ O
tests NNS O
to TO O
detect VB O
a DT O
transcription NN O
inactivation NN O
of IN O
p53 NN O
brought VBN O
by IN O
duplication NN O
within IN O
the DT O
DBD NNP O
. . O

Analysis NN O
of IN O
p53 NN O
genomic JJ O
status NN O
was VBD O
explored VBN O
by IN O
FISH NNP O
experiments NNS O
, , O
in IN O
search NN O
for IN O
a DT O
potential JJ O
biallelic JJ O
inactivation NN O
of IN O
p53 NN O
, , O
with IN O
a DT O
mutation NN O
of IN O
one CD O
allele NN O
and CC O
a DT O
deletion NN O
of IN O
the DT O
second JJ O
one NN O
. . O

This DT O
situation NN O
was VBD O
indeed RB O
clearly RB O
observed VBN O
in IN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
and CC O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
cell NN O
lines NNS O
, , O
with IN O
an DT O
unambiguous JJ O
loss NN O
of IN O
one CD O
chromosome NN O
17p NN O
arm NN O
in IN O
all DT O
cells NNS O
of IN O
both DT O
. . O

SK NNP O
- HYPH O
N NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
, , O
LAN NNP O
- HYPH O
1 CD O
and CC O
IGR NNP O
- HYPH O
NB NNP O
- HYPH O
8 CD O
cell NN O
lines NNS O
showed VBD O
a DT O
more RBR O
complex JJ O
genomic JJ O
situation NN O
which WDT O
should MD O
be VB O
relevant JJ O
of IN O
variable JJ O
copy NN O
numbers NNS O
of IN O
chromosome NN O
17 CD O
bearing NN O
in IN O
most JJS O
cases NNS O
( , O
LAN NNP O
- HYPH O
1 CD O
) -RRB- O
or CC O
in IN O
all DT O
cases NNS O
[ -LRB- O
SKN NNP O
- HYPH O
BE NNP O
( -LRB- O
2 CD O
) -RRB- O
, , O
IGR NNP O
- HYPH O
NB8 NNP O
] -RRB- O
the DT O
mutated JJ O
characteristic JJ O
p53 NN O
allele NN O
. . O

Our PRP$ O
data NNS O
therefore RB O
clearly RB O
demonstrate VBP O
that IN O
each DT O
technique NN O
has VBZ O
a DT O
role NN O
and CC O
a DT O
combination NN O
of IN O
techniques NNS O
is VBZ O
required VBN O
in IN O
order NN O
to TO O
correctly RB O
define VB O
the DT O
p53 NN O
phenotype NN O
and CC O
genotype NN O
in IN O
tumor NN O
and CC O
particularly RB O
in IN O
NB NNP O
cells NNS O
. . O

Our PRP$ O
data NNS O
enlighten VBP O
a DT O
high JJ O
frequency NN O
of IN O
the DT O
C NN O
- HYPH O
terminal JJ O
abnormalities NNS O
( , O
3 CD O
/ SYM O
5 CD O
mutated VBN O
) -RRB- O
in IN O
NB NNP O
cell NN O
lines NNS O
. . O

For IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
, , O
a DT O
part NN O
of IN O
the DT O
oligomerization NN O
domain NN O
was VBD O
lost VBN O
and CC O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
gained VBD O
an DT O
extra JJ O
oligomerization NN O
domain NN O
. . O

According VBG O
to IN O
FASAY NNP O
assay NN O
the DT O
p53 NN O
expressed VBN O
in IN O
IGR NNP O
- HYPH O
N NNP O
- HYPH O
91 CD O
still RB O
specifically RB O
bind VBP O
DNA NN O
but CC O
not RB O
the DT O
p53 NN O
expressed VBN O
in IN O
SK NNP O
- HYPH O
N NNP O
- HYPH O
AS NNP O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
in IN O
agreement NN O
with IN O
previous JJ O
published VBN O
data NNS O
obtained VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
( SYM O
33 CD O
) -RRB- O
. . O

With IN O
regards NNS O
to IN O
biological JJ O
relevance NN O
, , O
different JJ O
mutants NNS O
within IN O
the DT O
DBD NNP O
vary VBP O
in IN O
their PRP$ O
oncogenicity NN O
. . O

They PRP O
are VBP O
classified VBN O
into IN O
two CD O
types NNS O
depending VBG O
of IN O
the DT O
location NN O
of IN O
the DT O
mutation NN O
, , O
mutations NNS O
of IN O
class NN O
I PRP O
occur VBP O
in IN O
the DT O
DNA NN O
contact NN O
areas NNS O
, , O
while IN O
class NN O
II NN O
mutations NNS O
occur VBP O
in IN O
areas NNS O
important JJ O
for IN O
the DT O
conformational JJ O
stability NN O
of IN O
p53 NN O
protein NN O
( SYM O
30 CD O
) -RRB- O
. . O

Although IN O
both DT O
class NN O
I PRP O
and CC O
class NN O
II NNP O
mutants NNS O
have VBP O
loss NN O
its PRP$ O
ability NN O
to TO O
specifically RB O
bind VB O
DNA NN O
, , O
class NN O
II NN O
mutations NNS O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
more RBR O
oncogenic JJ O
than IN O
class NN O
I PRP O
. . O

However RB O
, , O
to IN O
our PRP$ O
knowledge NN O
the DT O
oncogenicity NN O
of IN O
mutant NN O
affecting VBG O
the DT O
C NNP O
- HYPH O
terminal JJ O
domain NN O
have VBP O
not RB O
been VBN O
studied VBN O
. . O

The DT O
biological JJ O
role NN O
of IN O
the DT O
C NN O
- HYPH O
terminal JJ O
mutants NNS O
needs VBZ O
now RB O
to TO O
be VB O
thoroughly RB O
investigated VBN O
in IN O
NB NNP O
tumors NNS O
. . O

MUC1 NNP O
alters VBZ O
oncogenic JJ O
events NNS O
and CC O
transcription NN O
in IN O
human JJ B-Species
breast NN O
cancer NN O
cells NNS O

Abstract JJ O

Introduction NN O

MUC1 NNP O
is VBZ O
an DT O
oncoprotein NN O
whose WP$ O
overexpression NN O
correlates VBZ O
with IN O
aggressiveness NN O
of IN O
tumors NNS O
and CC O
poor JJ O
survival NN O
of IN O
cancer NN O
patients NNS B-Species
. . O

Many JJ O
of IN O
the DT O
oncogenic JJ O
effects NNS O
of IN O
MUC1 NNP O
are VBP O
believed VBN O
to TO O
occur VB O
through IN O
interaction NN O
of IN O
its PRP$ O
cytoplasmic JJ O
tail NN O
with IN O
signaling VBG O
molecules NNS O
. . O

As IN O
expected VBN O
for IN O
a DT O
protein NN O
with IN O
oncogenic JJ O
functions NNS O
, , O
MUC1 NNP O
is VBZ O
linked VBN O
to IN O
regulation NN O
of IN O
proliferation NN O
, , O
apoptosis NN O
, , O
invasion NN O
, , O
and CC O
transcription NN O
. . O

Methods NNS O

To TO O
clarify VB O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
cancer NN O
, , O
we PRP O
transfected VBD O
two CD O
breast NN O
cancer NN O
cell NN O
lines NNS O
( : O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
) -RRB- O
with IN O
small JJ O
interfering VBG O
( , O
si NN O
) , O
RNA NN O
directed VBN O
against IN O
MUC1 NNP O
and CC O
analyzed VBN O
transcriptional JJ O
responses NNS O
and CC O
oncogenic JJ O
events NNS O
( , O
proliferation NN O
, , O
apoptosis NN O
and CC O
invasion NN O
) -RRB- O
. . O

Results NNS O

Transcription NN O
of IN O
several JJ O
genes NNS O
was VBD O
altered VBN O
after IN O
transfection NN O
of IN O
MUC1 NNP O
siRNA NNP O
, , O
including VBG O
decreased VBN O
MAP2K1 NNP O
( , O
MEK1 NNP O
) -RRB- O
, , O
JUN NNP O
, , O
PDGFA NNP O
, , O
CDC25A NNP O
, , O
VEGF NNP O
and CC O
ITGAV NNP O
( , O
integrin NN O
alpha NN O
v NN O
) -RRB- O
, , O
and CC O
increased VBN O
TNF NNP O
, , O
RAF1 NNP O
, , O
and CC O
MMP2 NNP O
. . O

Additional JJ O
changes NNS O
were VBD O
seen VBN O
at IN O
the DT O
protein NN O
level NN O
, , O
such JJ O
as IN O
increased VBN O
expression NN O
of IN O
c NN O
- HYPH O
Myc NNP O
, , O
heightened VBN O
phosphorylation NN O
of IN O
AKT NNP O
, , O
and CC O
decreased VBN O
activation NN O
of IN O
MEK1 NNP O
/ SYM O
2 CD O
and CC O
ERK1 NNP O
/ SYM O
2 CD O
. . O

These DT O
were VBD O
correlated VBN O
with IN O
cellular JJ O
events NNS O
, , O
as IN O
MUC1 NNP O
siRNA NNP O
in IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
line NN O
decreased VBD O
proliferation NN O
and CC O
invasion NN O
, , O
and CC O
increased VBD O
stress NN O
- HYPH O
induced VBN O
apoptosis NN O
. . O

Intriguingly RB O
, , O
BT NNP O
- HYPH O
20 CD O
cells NNS O
displayed VBD O
similar JJ O
levels NNS O
of IN O
apoptosis NN O
regardless RB O
of IN O
siRNA NNP O
, , O
and CC O
actually RB O
increased VBN O
proliferation NN O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

Conclusion NN O

These DT O
results NNS O
further RBR O
the DT O
growing VBG O
knowledge NN O
of IN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
transcription NN O
, , O
and CC O
suggest VBP O
that IN O
the DT O
regulation NN O
of IN O
MUC1 NNP O
in IN O
breast NN O
cancer NN O
may MD O
be VB O
more RBR O
complex JJ O
than IN O
previously RB O
appreciated VBN O
. . O

The DT O
differences NNS O
between IN O
these DT O
two CD O
cell NN O
lines NNS O
emphasize VBP O
the DT O
importance NN O
of IN O
understanding VBG O
the DT O
context NN O
of IN O
cell NN O
- HYPH O
specific JJ O
signaling VBG O
events NNS O
when WRB O
analyzing VBG O
the DT O
oncogenic JJ O
functions NNS O
of IN O
MUC1 NNP O
, , O
and CC O
caution VBP O
against IN O
generalizing VBG O
the DT O
results NNS O
of IN O
individual JJ O
cell NN O
lines NNS O
without IN O
adequate JJ O
confirmation NN O
in IN O
intact JJ O
biological JJ O
systems NNS O
. . O

Introduction NN O

MUC1 NNP O
is VBZ O
the DT O
founding VBG O
member NN O
of IN O
the DT O
mucin NN O
family NN O
: : O
proteins NNS O
characterized VBN O
by IN O
heavy JJ O
O NN O
- HYPH O
glycosylation NN O
centering VBG O
around IN O
a DT O
variable JJ O
number NN O
of IN O
tandem NN O
repeats NNS O
that WDT O
are VBP O
rich JJ O
in IN O
serine NN O
and CC O
threonine NN O
residues NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

MUC1 NNP O
is VBZ O
a DT O
transmembrane JJ O
heterodimer NN O
with IN O
one CD O
subunit NN O
solely RB O
extracellular JJ O
( , O
MUC1 NNP O
- HYPH O
EX NNP O
) -RRB- O
, , O
and CC O
the DT O
other JJ O
subunit NN O
composed VBN O
of IN O
a DT O
short JJ O
extracellular JJ O
stem NN O
, , O
a DT O
single JJ O
transmembrane NN O
domain NN O
, , O
and CC O
the DT O
cytoplasmic JJ O
tail NN O
( , O
together RB O
called VBN O
the DT O
MUC1 NNP O
- HYPH O
CT NNP O
) -RRB- O
. . O

MUC1 NNP O
possesses VBZ O
both CC O
pro JJ O
- HYPH O
and CC O
anti JJ O
- HYPH O
adhesive JJ O
capacities NNS O
, , O
as IN O
the DT O
MUC1 NNP O
- HYPH O
EX NNP O
provides VBZ O
binding VBG O
sites NNS O
for IN O
a DT O
variety NN O
of IN O
adhesion NN O
proteins NNS O
, , O
while IN O
its PRP$ O
large JJ O
size NN O
and CC O
extended JJ O
structure NN O
prevents VBZ O
cell NN O
- HYPH O
cell NN O
contact NN O
[ -LRB- O
3 CD O
- HYPH O
5 CD O
] -RRB- O
. . O

Initially RB O
described VBN O
as IN O
a DT O
tumor NN O
antigen NN O
overexpressed VBN O
in IN O
> SYM O
90 CD O
% NN O
of IN O
breast NN O
cancers NNS O
, , O
MUC1 NNP O
is VBZ O
now RB O
known VBN O
to TO O
be VB O
an DT O
oncogene NN O
with IN O
roles NNS O
in IN O
both CC O
tumor NN O
formation NN O
and CC O
progression NN O
[ -LRB- O
1 CD O
, , O
6 CD O
] -RRB- O
. . O

Mouse NNP B-Species
studies NNS O
have VBP O
been VBN O
integral JJ O
to IN O
the DT O
current JJ O
understanding NN O
of IN O
MUC1 NNP O
in IN O
cancer NN O
. . O

Muc1 NNP O
knockout NN O
mice NNS B-Species
( -LRB- O
Muc1 NNP O
- HYPH O
/ : O
- : O
; : O
MUC1 NNP O
is VBZ O
human JJ B-Species
; : O
Muc1 NNP O
is VBZ O
mouse NN B-Species
) -RRB- O
show VBP O
a DT O
reduction NN O
in IN O
tumorigenic JJ O
phenotype NN O
when WRB O
crossed VBN O
onto IN O
mice NNS B-Species
overexpressing VBG O
the DT O
Wnt NNP O
- HYPH O
1 CD O
[ -LRB- O
7 CD O
] -RRB- O
or CC O
polyomavirus NN O
middle JJ O
T NN O
antigen NN O
[ -LRB- O
8 CD O
] -RRB- O
oncogenes NNS O
in IN O
the DT O
mammary NN O
gland NN O
. . O

In IN O
contrast NN O
, , O
MUC1 NNP O
overexpression NN O
in IN O
the DT O
mammary JJ O
gland NN O
drives VBZ O
tumor NN O
formation NN O
[ -LRB- O
9 CD O
] -RRB- O
, , O
indicating VBG O
that IN O
MUC1 NN O
is VBZ O
a DT O
true JJ O
oncogene NN O
. . O

Many JJ O
of IN O
the DT O
oncogenic JJ O
effects NNS O
of IN O
MUC1 NNP O
stem VBP O
from IN O
its PRP$ O
cytoplasmic JJ O
tail NN O
, , O
which WDT O
binds VBZ O
to IN O
several JJ O
proteins NNS O
implicated VBN O
in IN O
cancer NN O
, , O
including VBG O
c NN O
- HYPH O
Src NNP O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
and CC O
the DT O
epidermal JJ O
growth NN O
factor NN O
receptor NN O
( -LRB- O
EGFR NNP O
) -RRB- O
family NN O
[ -LRB- O
12 CD O
, , O
13 CD O
] -RRB- O
. . O

MUC1 NNP O
stimulates VBZ O
mitogen NN O
activated VBN O
protein NN O
kinase NN O
( -LRB- O
MAPK NNP O
) -RRB- O
signaling VBG O
through IN O
the DT O
extracellular JJ O
signal NN O
regulated VBN O
kinases NNS O
( -LRB- O
ERK1 NNP O
/ SYM O
2 CD O
) -RRB- O
[ -LRB- O
12 CD O
, , O
14 CD O
] -RRB- O
; , O
this DT O
can MD O
occur VB O
through IN O
MUC1 NNP O
association NN O
with IN O
Grb2 NNP O
and CC O
son NN O
of IN O
sevenless JJ O
to TO O
activate VB O
Ras NNP O
[ -LRB- O
15 CD O
] -RRB- O
. . O

ERK1 NNP O
/ SYM O
2 CD O
signaling NN O
is VBZ O
commonly RB O
stimulated VBN O
by IN O
the DT O
Ras NNP O
- HYPH O
Raf NNP O
- HYPH O
MEK NNP O
( , O
MAPK NNP O
and CC O
ERK NNP O
kinase NN O
) -RRB- O
cascade NN O
downstream NN O
of IN O
mitogens NNS O
such JJ O
as IN O
EGFR NNP O
[ -LRB- O
16 CD O
] -RRB- O
, , O
and CC O
regulates VBZ O
transcription NN O
via IN O
factors NNS O
like IN O
the DT O
activator NN O
protein NN O
- HYPH O
1 CD O
complex NN O
. . O

Loss NN O
of IN O
MUC1 NNP O
can MD O
reduce VB O
EGFR NNP O
expression NN O
[ -LRB- O
17 CD O
] -RRB- O
, , O
providing VBG O
another DT O
means NN O
of IN O
affecting VBG O
MAPK NNP O
signaling VBG O
. . O

Our PRP$ O
results NNS O
describe VBP O
a DT O
novel JJ O
mechanism NN O
by IN O
which WDT O
MUC1 NNP O
regulates VBZ O
the DT O
ERK1 NNP O
/ SYM O
2 CD O
pathway NN O
, , O
through IN O
modulating VBG O
transcription NN O
of IN O
the DT O
genes NNS O
encoding VBG O
MEK1 NNP O
, , O
Raf NNP O
- HYPH O
1 CD O
, , O
and CC O
c NN O
- HYPH O
Jun NNP O
. . O

MUC1 NNP O
expression NN O
correlates VBZ O
with IN O
increased VBN O
survival NN O
in IN O
response NN O
to IN O
cytotoxic JJ O
or CC O
oxidative JJ O
agents NNS O
[ -LRB- O
18 CD O
- SYM O
21 CD O
] -RRB- O
, , O
and CC O
can MD O
activate VB O
the DT O
phosphoinositol NN O
- HYPH O
3 CD O
kinase NN O
- HYPH O
AKT NN O
pathway NN O
as IN O
part NN O
of IN O
an DT O
anti AFX O
- HYPH O
apoptotic JJ O
response NN O
[ -LRB- O
18 CD O
] -RRB- O
. . O

MUC1 NNP O
has VBZ O
also RB O
recently RB O
been VBN O
linked VBN O
to IN O
transcription NN O
, , O
as IN O
the DT O
MUC1 NNP O
- HYPH O
CT NNP O
localizes VBZ O
to IN O
the DT O
nucleus NN O
[ -LRB- O
22 CD O
] -RRB- O
and CC O
affects VBZ O
transcription NN O
by IN O
beta NN O
- HYPH O
catenin NN O
[ -LRB- O
22 CD O
, , O
23 CD O
] -RRB- O
, , O
FOXO3a NNP O
[ -LRB- O
21 CD O
] -RRB- O
, , O
p53 NN O
[ -LRB- O
24 CD O
] -RRB- O
, , O
and CC O
estrogen NN O
receptor NN O
alpha NN O
[ -LRB- O
25 CD O
] -RRB- O
. . O

However RB O
, , O
there EX O
are VBP O
indications NNS O
that IN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
oncogenesis NN O
is VBZ O
regulated VBN O
by IN O
cell NN O
type NN O
and CC O
signaling NN O
context NN O
. . O

For IN O
example NN O
, , O
MUC1 NNP O
can MD O
stimulate VB O
Fas NNP O
- HYPH O
mediated VBN O
apoptosis NN O
[ -LRB- O
26 CD O
] -RRB- O
, , O
while IN O
Muc1 NNP O
is VBZ O
specifically RB O
down RB O
- HYPH O
regulated VBN O
in IN O
c NN O
- HYPH O
neu NN O
- HYPH O
induced VBN O
mammary JJ O
tumors NNS O
[ -LRB- O
27 CD O
] -RRB- O
. . O

This DT O
report NN O
emphasizes VBZ O
the DT O
complexity NN O
of IN O
MUC1 NNP O
signaling NN O
in IN O
breast NN O
cancer NN O
by IN O
contrasting VBG O
results NNS O
from IN O
two CD O
established VBN O
breast NN O
cancer NN O
cell NN O
lines NNS O
. . O

To TO O
understand VB O
MUC1 NN O
function NN O
in IN O
cells NNS O
with IN O
high JJ O
endogenous JJ O
expression NN O
, , O
that RB O
is RB O
, , O
cells NNS O
likely JJ O
to TO O
have VB O
evolved VBN O
with IN O
active JJ O
MUC1 NNP O
signaling NN O
, , O
we PRP O
used VBD O
small JJ O
interfering VBG O
RNA NNP O
( -LRB- O
siRNA NNP O
) -RRB- O
to TO O
knock VB O
down RP O
MUC1 NNP O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
cells NNS O
. . O

We PRP O
then RB O
analyzed VBD O
transcription NN O
of IN O
84 CD O
genes NNS O
involved VBN O
in IN O
cancer NN O
, , O
as RB O
well RB O
as IN O
the DT O
effects NNS O
upon IN O
cellular JJ O
events NNS O
linked VBN O
to IN O
oncogenesis NN O
, , O
such JJ O
as IN O
apoptosis NN O
and CC O
proliferation NN O
. . O

Though IN O
the DT O
cell NN O
lines NNS O
show VBP O
some DT O
similarity NN O
in IN O
transcriptional JJ O
alterations NNS O
after IN O
transfection NN O
with IN O
MUC1 NNP O
siRNA NNP O
, , O
their PRP$ O
phenotypes NNS O
are VBP O
quite RB O
dissimilar JJ O
: : O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
increases VBZ O
apoptosis NN O
and CC O
reduces VBZ O
proliferation NN O
and CC O
invasion NN O
, , O
while IN O
BT NNP O
- HYPH O
20 CD O
proliferates VBZ O
more RBR O
rapidly RB O
after IN O
loss NN O
of IN O
MUC1 NNP O
. . O

This DT O
last JJ O
may MD O
reflect VB O
the DT O
striking JJ O
amount NN O
of IN O
active JJ O
AKT NNP O
in IN O
BT NNP O
- HYPH O
20 CD O
; : O
AKT NNP O
activity NN O
is VBZ O
increased VBN O
in IN O
both DT O
cell NN O
lines NNS O
after IN O
MUC1 NNP O
siRNA NNP O
, , O
which WDT O
agrees VBZ O
with IN O
a DT O
previous JJ O
study NN O
of IN O
MUC1 NNP O
siRNA NNP O
[ -LRB- O
21 CD O
] -RRB- O
, , O
but CC O
disagrees VBZ O
with IN O
results NNS O
from IN O
3Y1 CD O
fibroblasts NNS O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Recent JJ O
studies NNS O
have VBP O
emphasized VBN O
the DT O
complex JJ O
and CC O
context NN O
- HYPH O
specific JJ O
regulation NN O
of IN O
even RB O
such JJ O
classic JJ O
oncogenes NNS O
as IN O
AKT NNP O
[ -LRB- O
28 CD O
] -RRB- O
. . O

The DT O
differences NNS O
between IN O
the DT O
two CD O
breast NN O
cancer NN O
cell NN O
lines NNS O
in IN O
this DT O
study NN O
suggest VBP O
that IN O
MUC1 NNP O
oncogenic JJ O
functions NNS O
are VBP O
also RB O
subject JJ O
to IN O
cell NN O
- HYPH O
specific JJ O
regulation NN O
, , O
and CC O
stress VB O
the DT O
need NN O
for IN O
understanding VBG O
the DT O
cellular JJ O
signaling NN O
context NN O
when WRB O
interpreting VBG O
results NNS O
. . O

Materials NNS O
and CC O
methods NNS O

Cell NN O
culture NN O
and CC O
siRNA NN O
transfection NN O

MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
cells NNS O
( , O
American NNP O
Type NNP O
Culture NNP O
Collection NNP O
) -RRB- O
were VBD O
cultured VBN O
in IN O
Dulbecco NNP O
' POS O
s NNP O
modified VBN O
Eagle NNP O
' POS O
s NN O
medium NN O
( , O
Invitrogen NNP O
, , O
Carlsbad NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
plus CC O
10 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
, , O
1 CD O
% NN O
Glutamax NNP O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
1 CD O
% NN O
penicillin NN O
/ SYM O
streptomycin NN O
. . O

Stable JJ O
cell NN O
lines NNS O
( : O
468 CD O
. . O
Neo NNP O
and CC O
468 CD O
. . O
MUC1 NNP O
Delta NNP O
8 CD O
) -RRB- O
were VBD O
selected VBN O
with IN O
0 CD O
. . O
5 CD O
mg CD O
/ SYM O
ml NN O
G418 CD O
. . O

For IN O
epidermal JJ O
growth NN O
factor NN O
( -LRB- O
EGF NNP O
) -RRB- O
stimulation NN O
, , O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
cells NNS O
were VBD O
serum NN O
- HYPH O
starved VBN O
overnight RB O
and CC O
treated VBN O
for IN O
10 CD O
minutes NNS O
at IN O
37 CD O
degrees NNS O
C NN O
with IN O
100 CD O
ng NNS O
/ SYM O
ml NN O
EGF NNP O
. . O

Transient JJ O
siRNA NNP O
transfection NN O
was VBD O
performed VBN O
with IN O
Lipofectamine2000 NNP O
( , O
Invitrogen NNP O
) -RRB- O
and CC O
100 CD O
nM NN O
siRNA NNP O
oligonucleotides NNS O
. . O

The DT O
commercially RB O
available JJ O
siRNA NNP O
constructs NNS O
( , O
all DT O
from IN O
Dharmacon NNP O
, , O
Lafayette NNP O
, , O
CO NNP O
, , O
USA NNP O
) -RRB- O
were VBD O
scrambled VBN O
( : O
siCONTROL NNP O
non NN O
- HYPH O
targeting VBG O
siRNA NN O
# NN O
1 CD O
) -RRB- O
, , O
or CC O
directed VBN O
against IN O
firefly JJ O
luciferase NN O
( , O
siCONTROL NNP O
non NNP O
- HYPH O
targeting VBG O
siRNA NN O
# NN O
2 CD O
) -RRB- O
or CC O
MUC1 NNP O
( -LRB- O
siGENOME NN O
smartpool NN O
) -RRB- O
. . O

The DT O
independent JJ O
oligonucleotides NNS O
designed VBN O
in IN O
our PRP$ O
laboratory NN O
target NN O
sequences NNS O
beginning VBG O
at IN O
MUC1 NNP O
codons NNS O
882 CD O
and CC O
956 CD O
, , O
and CC O
have VBP O
been VBN O
described VBN O
previously RB O
[ -LRB- O
29 CD O
] -RRB- O
. . O

The DT O
scrambled VBN O
siRNA NNP O
construct NN O
was VBD O
used VBN O
only RB O
in IN O
BT NNP O
- HYPH O
20 CD O
cells NNS O
as IN O
it PRP O
causes VBZ O
a DT O
non AFX O
- HYPH O
specific JJ O
knockdown NN O
of IN O
MUC1 NNP O
in IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
line NN O
. . O

Cloning NN O
of IN O
MUC1 NN O
WT NN O
vector NN O
and CC O
stable JJ O
transfection NN O

Two CD O
silent JJ O
mutations NNS O
( -LRB- O
G891A NNP O
and CC O
T894C NNP O
) -RRB- O
were VBD O
introduced VBN O
into IN O
the DT O
MUC1 NNP O
cDNA NNP O
( , O
called VBN O
MUC1 NNP O
Delta NNP O
8 CD O
) -RRB- O
to TO O
make VB O
it PRP O
resistant JJ O
to IN O
the DT O
882 CD O
siRNA NNP O
that WDT O
targets VBZ O
that DT O
region NN O
of IN O
the DT O
mRNA NNP O
. . O

The DT O
mutant JJ O
cDNA NN O
was VBD O
cloned VBN O
into IN O
the DT O
pLNCX NN O
. . O
1 CD O
vector NN O
with IN O
neomycin NN O
resistance NN O
( , O
gift NN O
of IN O
Joseph NNP O
Loftus NNP O
, , O
Mayo NNP O
Clinic NNP O
, , O
Arizona NNP O
, , O
USA NNP O
) -RRB- O
. . O

Stable JJ O
transfection NN O
was VBD O
performed VBN O
with IN O
Lipofectamine2000 NNP O
; : O
cells NNS O
were VBD O
selected VBN O
beginning VBG O
24 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
and CC O
maintained VBN O
as IN O
a DT O
polyclonal JJ O
population NN O
. . O

Western JJ O
blots NNS O
and CC O
antibodies NNS O

Cells NNS O
were VBD O
lysed VBN O
in IN O
buffer NN O
( , O
20 CD O
mM NN O
HEPES NN O
pH NN O
8 CD O
. . O
0 CD O
, , O
150 CD O
mM NN O
sodium NN O
chloride NN O
, , O
1 CD O
% NN O
Triton NNP O
X NNP O
- HYPH O
100 CD O
, , O
2 CD O
mM NN O
EDTA NNP O
) , O
with IN O
commercial JJ O
protease NN O
( , O
Complete JJ O
inhibitor NN O
cocktail NN O
, , O
Roche NNP O
, , O
Pleasanton NNP O
, , O
CA NNP O
, , O
USA NNP O
) , O
and CC O
phosphatase NN O
inhibitors NNS O
( , O
10 CD O
mM NN O
sodium NN O
fluoride NN O
, , O
2 CD O
mM NN O
sodium NN O
vanadate NN O
, , O
50 CD O
mu NN O
M NN O
ammonium NN O
molybdate NN O
) -RRB- O
. . O

Protein NN O
concentration NN O
was VBD O
determined VBN O
by IN O
BCA NNP O
( : O
Pierce NNP O
, , O
Rockford NNP O
, , O
IL NNP O
, , O
USA NNP O
) -RRB- O
; : O
50 CD O
mu NNS O
g NN O
of IN O
lysate NN O
were VBD O
loaded VBN O
on IN O
SDS NNP O
- HYPH O
PAGE NNP O
gels NNS O
for IN O
each DT O
experiment NN O
, , O
except IN O
for IN O
the DT O
pMEK1 CD O
/ SYM O
2 CD O
blot NN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
, , O
where WRB O
150 CD O
mu NNS O
g VBP O
were VBD O
used VBN O
. . O

Non JJ O
- HYPH O
commercial JJ O
antibodies NNS O
used VBN O
were VBD O
: : O
BC2 NNP O
, , O
a DT O
mouse NN B-Species
monoclonal JJ O
to IN O
the DT O
MUC1 NNP O
- HYPH O
EX NNP O
( , O
gift NN O
of IN O
Dr NNP O
McGuckin NNP O
, , O
Queensland NNP O
University NNP O
, , O
Queensland NNP O
, , O
Australia NNP O
) -RRB- O
, , O
and CC O
CT2 NNP O
, , O
an DT O
Armenian JJ B-Species
hamster NN I-Species
monoclonal JJ O
to IN O
the DT O
MUC1 NNP O
- HYPH O
CT NNP O
developed VBN O
in IN O
our PRP$ O
lab NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Antibodies NNS O
to IN O
pMEK1 NN O
/ SYM O
2 CD O
, , O
MEK1 NNP O
/ , O
2 CD O
, , O
ERK1 NNP O
/ , O
2 CD O
, , O
Myc NNP O
, , O
pAKT NNP O
, , O
AKT NNP O
, , O
beta NN O
- HYPH O
tubulin NN O
( , O
all DT O
Cell NNP O
Signaling NNP O
, , O
Danvers NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
, , O
beta NN O
- HYPH O
actin NN O
and CC O
dpERK1 NNP O
/ SYM O
2 CD O
( , O
both DT O
Sigma NNP O
, , O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
, , O
USA NNP O
) -RRB- O
were VBD O
used VBN O
according VBG O
to IN O
manufacturers NNS O
' POS O
recommendations NNS O
. . O

All DT O
antibodies NNS O
except IN O
beta NN O
- HYPH O
actin NN O
( : O
1 CD O
: SYM O
2 CD O
, , O
500 CD O
) -RRB- O
and CC O
dpERK1 CD O
/ SYM O
2 CD O
( SYM O
1 CD O
: SYM O
10 CD O
, , O
0 CD O
) -RRB- O
were VBD O
used VBN O
at IN O
1 CD O
: SYM O
1 CD O
, , O
0 CD O
dilution NN O
for IN O
western JJ O
blots NNS O
. . O

Flow NN O
cytometric JJ O
analysis NN O
of IN O
MUC1 NNP O
was VBD O
done VBN O
with IN O
HMPV NNP O
- HYPH O
FITC NNP O
, , O
which WDT O
recognizes VBZ O
the DT O
core NN O
peptide NN O
of IN O
the DT O
MUC1 NNP O
- HYPH O
EX NN O
tandem NN O
repeats NNS O
( , O
Pharmingen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

Bromodeoxyuridine NNP O
( -LRB- O
BrdU NNP O
) -RRB- O
staining NN O
was VBD O
performed VBN O
with IN O
a DT O
fluorescently RB O
conjugated VBN O
antibody NN O
to IN O
BrdU NNP O
( : O
BrdU NNP O
- HYPH O
PE NNP O
, , O
BD NNP O
Biosciences NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
as IN O
described VBN O
below RB O
. . O

Densitometry NNP O
was VBD O
performed VBN O
using VBG O
the DT O
public JJ O
domain NN O
ImageJ NNP O
program NN O
( , O
developed VBN O
at IN O
the DT O
NIH NNP O
and CC O
available JJ O
at IN O
[ $ O
30 CD O
] -RRB- O
. . O

Each DT O
band NN O
was VBD O
measured VBN O
in IN O
three CD O
places NNS O
; : O
the DT O
results NNS O
were VBD O
averaged VBN O
and CC O
normalized VBN O
to IN O
tubulin NN O
to TO O
control VB O
for IN O
loading NN O
. . O

Transwell NNP O
invasion NN O
assays NNS O

Cells NNS O
were VBD O
serum NN O
- HYPH O
starved VBN O
beginning VBG O
24 CD O
hours NNS O
post JJ O
- HYPH O
siRNA NNP O
transfection NN O
. . O

Cells NNS O
were VBD O
re RB O
- HYPH O
plated VBN O
in IN O
serum NN O
- HYPH O
free JJ O
medium NN O
48 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
at IN O
50 CD O
, , O
0 CD O
cells NNS O
per IN O
insert NN O
( , O
sized JJ O
for IN O
24 CD O
- HYPH O
well NN O
plates NNS O
) -RRB- O
, , O
with IN O
serum NN O
- HYPH O
containing VBG O
medium NN O
in IN O
the DT O
bottom NN O
of IN O
the DT O
growth NN O
well RB O
as IN O
an DT O
attractant NN O
. . O

Transwell NNP O
inserts VBZ O
( -LRB- O
BD NNP O
Biosciences NNP O
) -RRB- O
pre NN O
- HYPH O
coated VBN O
with IN O
laminin NN O
, , O
fibronectin NN O
, , O
collagen NN O
IV NN O
, , O
or CC O
control NN O
( , O
no DT O
matrix NN O
) -RRB- O
were VBD O
used VBN O
, , O
and CC O
cells NNS O
were VBD O
permitted VBN O
to TO O
invade VB O
for IN O
48 CD O
hours NNS O
. . O

At IN O
this DT O
point NN O
( , O
96 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
) -RRB- O
, , O
visual JJ O
inspection NN O
of IN O
the DT O
growth NN O
wells NNS O
confirmed VBD O
that IN O
negligible JJ O
numbers NNS O
of IN O
cells NNS O
went VBD O
through RB O
to IN O
the DT O
bottom NN O
of IN O
the DT O
plate NN O
. . O

Non NNP O
- HYPH O
invaded VBN O
cells NNS O
were VBD O
swabbed VBN O
from IN O
the DT O
tops NNS O
of IN O
half NN O
of IN O
the DT O
inserts NNS O
( , O
' `` O
samples NNS O
' '' O
, , O
containing VBG O
only RB O
invaded VBN O
cells NNS O
) -RRB- O
, , O
and CC O
retained VBN O
in IN O
the DT O
others NNS O
( , O
' `` O
controls NNS O
' '' O
, , O
all DT O
cells NNS O
) -RRB- O
. . O

Inserts NNS O
were VBD O
stained VBN O
for IN O
10 CD O
minutes NNS O
with IN O
crystal NN O
violet NN O
( , O
0 CD O
. . O
5 CD O
% NN O
in IN O
20 CD O
% NN O
methanol NN O
) -RRB- O
and CC O
washed VBN O
with IN O
water NN O
. . O

Membranes NNS O
were VBD O
cut VBN O
out RP O
and CC O
destained VBD O
for IN O
10 CD O
minutes NNS O
in IN O
10 CD O
% NN O
acetic JJ O
acid NN O
in IN O
a DT O
96 CD O
- HYPH O
well NN O
plate NN O
; : O
membranes NNS O
were VBD O
removed VBN O
and CC O
absorbance NN O
was VBD O
read VBN O
at IN O
570 CD O
nm NN O
. . O

Percent NN O
invasion NN O
is VBZ O
defined VBN O
as IN O
( , O
absorbance NN O
of IN O
samples NNS O
/ SYM O
absorbance NN O
of IN O
controls NNS O
) SYM O
x SYM O
100 CD O
. . O

[ -LRB- O
3H NN O
] -RRB- O
Thymidine NN O
incorporation NN O
assays NNS O

Cells NNS O
were VBD O
re RB O
- HYPH O
plated VBN O
in IN O
quadruplicate JJ O
24 CD O
hours NNS O
post NN O
- HYPH O
siRNA NN O
transfection NN O
at IN O
15 CD O
, , O
0 CD O
cells NNS O
/ SYM O
well NN O
( HYPH O
96 CD O
- HYPH O
well NN O
plate NN O
) -RRB- O
with IN O
[ -LRB- O
3H CD O
] -RRB- O
thymidine NN O
( , O
1 CD O
mu NN O
Ci NN O
/ SYM O
well NN O
) -RRB- O
, , O
then RB O
incubated VBN O
in IN O
normal JJ O
conditions NNS O
for IN O
24 CD O
hours NNS O
. . O

At IN O
this DT O
time NN O
( , O
48 CD O
hours NNS O
post NN O
- HYPH O
siRNA NNP O
transfection NN O
) , O
excess JJ O
radioactivity NN O
was VBD O
washed VBN O
off RP O
and CC O
the DT O
cells NNS O
were VBD O
harvested VBN O
and CC O
read VBN O
on IN O
a DT O
TopCount NNP O
plate NN O
reader NN O
. . O

Statistical JJ O
analysis NN O
was VBD O
performed VBN O
using VBG O
JMP NNP O
5 CD O
. . O
1 CD O
. . O
2 CD O
software NN O
( : O
SAS NNP O
Institute NNP O
, , O
Inc NNP O
. . O
, , O
Cary NNP O
, , O
NC NNP O
, , O
USA NNP O
) -RRB- O
; : O
the DT O
student NN O
' '' O
s POS O
t NN O
test NN O
was VBD O
used VBN O
to TO O
determine VB O
p NN O
values NNS O
and CC O
significance NN O
was VBD O
confirmed VBN O
with IN O
Wilcoxon NNP O
rank NN O
sum NN O
and CC O
Pearson NNP O
chi NN O
squared VBD O
analyses NNS O
. . O

BrdU NNP O
incorporation NN O

BrdU NNP O
( , O
50 CD O
mu NNS O
M NN O
) -RRB- O
was VBD O
given VBN O
to IN O
cells NNS O
48 CD O
hours NNS O
post JJ O
- HYPH O
siRNA NN O
transfection NN O
and CC O
permitted VBN O
to TO O
incorporate VB O
for IN O
1 CD O
. . O
5 CD O
hours NNS O
. . O

Cells NNS O
were VBD O
then RB O
washed VBN O
with IN O
PBS NNP O
, , O
trypsinized VBN O
, , O
and CC O
washed VBN O
again RB O
. . O

BrdU NNP O
staining NN O
was VBD O
performed VBN O
according VBG O
to IN O
an DT O
adaptation NN O
of IN O
the DT O
manufacturer NN O
' POS O
s POS O
protocol NN O
: : O
cells NNS O
were VBD O
re RB O
- HYPH O
suspended VBN O
in IN O
PBS NNP O
, , O
mixed JJ O
1 CD O
: SYM O
1 CD O
with IN O
- SYM O
20 CD O
degrees NNS O
C NN O
neat JJ O
ethanol NN O
, , O
and CC O
incubated VBN O
1 CD O
hour NN O
at IN O
- HYPH O
20 CD O
degrees NNS O
C NN O
to TO O
fix VB O
. . O

Fixed VBN O
cells NNS O
were VBD O
then RB O
washed VBN O
gently RB O
and CC O
denatured VBN O
in IN O
2 CD O
M NN O
HCl NNP O
for IN O
20 CD O
minutes NNS O
at IN O
room NN O
temperature NN O
. . O

Following VBG O
washing NN O
and CC O
2 CD O
minute NN O
' POS O
s NNS O
incubation NN O
with IN O
0 CD O
. . O
1 CD O
M NN O
Tris NN O
to TO O
neutralize VB O
the DT O
acid NN O
, , O
cells NNS O
were VBD O
re RB O
- HYPH O
suspended VBN O
in IN O
FACS NNP O
buffer NN O
( : O
0 CD O
. . O
5 CD O
% NN O
fetal JJ O
calf NN B-Species
serum NN O
in IN O
PBS NNP O
) -RRB- O
and CC O
stained VBN O
with IN O
Phycoerythrin NNP O
( -LRB- O
PE NN O
) -RRB- O
- HYPH O
conjugated VBN O
anti JJ O
- HYPH O
BrdU NN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
for IN O
flow NN O
cytometry NN O
analysis NN O
on IN O
a DT O
FACScan NNP O
instrument NN O
. . O

Apoptosis NN O
and CC O
trypan NN O
blue JJ O
staining NN O

Apoptosis NN O
was VBD O
measured VBN O
using VBG O
a DT O
kit NN O
( , O
BD NNP O
Biosciences NNPS O
) , O
containing VBG O
propidium NN O
iodide NN O
( , O
PI NN O
) -RRB- O
and CC O
FITC NNP O
- HYPH O
conjugated VBN O
annexin NN O
V NN O
. . O

Cells NNS O
were VBD O
stained VBN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
protocol NN O
and CC O
the DT O
level NN O
of IN O
apoptosis NN O
determined VBN O
by IN O
flow NN O
cytometry NN O
. . O

Quadrants NNS O
are VBP O
: : O
early JJ O
apoptosis NN O
( , O
annexin NN O
V NN O
+ CC O
/ SYM O
PI NN O
- HYPH O
, , O
lower RBR O
right JJ O
) , O
late JJ O
apoptosis NN O
( , O
annexin NN O
V NN O
+ CC O
/ SYM O
PI NN O
+ CC O
, , O
upper JJ O
right NN O
) NFP O
and CC O
non JJ O
- HYPH O
apoptotic JJ O
cell NN O
death NN O
( , O
annexin NN O
V NN O
- HYPH O
/ SYM O
PI NN O
+ CC O
, , O
upper JJ O
left NN O
) -RRB- O
. . O

Treatments NNS O
for IN O
the DT O
stress NN O
panel NN O
were VBD O
: : O
no DT O
treatment NN O
( HYPH O
control NN O
) -RRB- O
; , O
DMSO NNP O
as IN O
a DT O
control NN O
for IN O
celecoxib NN O
; : O
20 CD O
mM NN O
celecoxib NN O
, , O
brand NN O
name NN O
Celebrex NNP O
( -LRB- O
TM NNP O
) -RRB- O
( , O
dissolved VBN O
in IN O
DMSO NNP O
) -RRB- O
[ -LRB- O
31 CD O
] -RRB- O
; : O
0 CD O
. . O
2 CD O
mM NN O
H2O2 NNP O
[ -LRB- O
32 CD O
] -RRB- O
; : O
or CC O
1 CD O
mg NN O
/ SYM O
mL NN O
G418 CD O
( , O
Pfizer NNP O
, , O
New NNP O
York NNP O
, , O
NY NNP O
, , O
USA NNP O
) -RRB- O
. . O

Real JJ O
- HYPH O
time NN O
PCR NNP O
arrays VBZ O

Transcriptional JJ O
analysis NN O
using VBG O
Cancer NNP O
PathwayFinder NNP O
RT2 NNP O
profiler NN O
arrays NNS O
( , O
SuperArray NNP O
, , O
Frederick NNP O
, , O
MD NNP O
, , O
USA NNP O
) -RRB- O
was VBD O
performed VBN O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

Briefly RB O
, , O
total JJ O
RNA NNP O
was VBD O
isolated VBN O
using VBG O
an DT O
RNeasy NNP O
extraction NN O
kit NN O
( , O
Qiagen NNP O
, , O
Valencia NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
; : O
1 CD O
mu NN O
g NN O
of IN O
RNA NNP O
was VBD O
reverse RB O
transcribed VBN O
with IN O
the DT O
cDNA NNP O
synthesis NN O
kit NN O
( , O
SuperArray NNP O
) -RRB- O
and CC O
cDNA NNP O
was VBD O
subjected VBN O
to IN O
real JJ O
- HYPH O
time NN O
PCR NN O
using VBG O
SYBR NN O
green NN O
to TO O
detect VB O
product NN O
. . O

Arrays NNS O
were VBD O
performed VBN O
independently RB O
at IN O
least JJS O
twice RB O
for IN O
each DT O
cell NN O
line NN O
; : O
all DT O
PCR NNP O
products NNS O
were VBD O
checked VBN O
on IN O
agarose JJ O
gels NNS O
. . O

Values NNS O
were VBD O
obtained VBN O
for IN O
the DT O
threshold NN O
cycle NN O
( -LRB- O
Ct NNP O
) -RRB- O
for IN O
each DT O
gene NN O
and CC O
normalized VBN O
using VBG O
the DT O
average NN O
of IN O
four CD O
housekeeping NN O
genes NNS O
on IN O
the DT O
same JJ O
array NN O
( , O
HPRT1 NNP O
, , O
RPL13A NNP O
, , O
GAPD NNP O
, , O
ACTB NNP O
) -RRB- O
. . O

Ct NN O
values NNS O
for IN O
housekeeping NN O
genes NNS O
and CC O
a DT O
dilution NN O
series NN O
of IN O
ACTB NNP O
were VBD O
monitored VBN O
for IN O
consistency NN O
between IN O
arrays NNS O
. . O

Change NNP O
( -LRB- O
Delta NNP O
Ct NNP O
) -RRB- O
between IN O
MUC1 NNP O
siRNA NNP O
and CC O
control NN O
siRNA NNP O
was VBD O
found VBN O
by IN O
: : O

Delta NNP O
Ct NNP O
= : O
Ct NNP O
( , O
MUC1 NNP O
siRNA NNP O
) -RRB- O
- : O
Ct NNP O
( HYPH O
control NN O
siRNA NNP O
) -RRB- O

and CC O
fold VB O
change NN O
by IN O
: : O

Fold NN O
change NN O
= SYM O
2 CD O
( SYM O
- HYPH O
Delta NNP O
Ct NNP O
) . O

Values NNS O
are VBP O
given VBN O
as IN O
fold NN O
change NN O
; , O
only RB O
genes NNS O
showing VBG O
two CD O
- HYPH O
fold NN O
or CC O
greater JJR O
change NN O
were VBD O
considered VBN O
. . O

Both DT O
luciferase NN O
and CC O
scrambled VBN O
siRNA NNP O
controls NNS O
were VBD O
used VBN O
in IN O
BT NNP O
- HYPH O
20 CD O
; : O
only RB O
genes NNS O
showing VBG O
consistent JJ O
alteration NN O
with IN O
both DT O
controls NNS O
were VBD O
included VBN O
in IN O
the DT O
results NNS O
reported VBN O
here RB O
. . O

The DT O
scrambled VBN O
siRNA NNP O
could MD O
be VB O
not RB O
used VBN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
as IN O
these DT O
cells NNS O
decrease VBP O
MUC1 NNP O
expression NN O
in IN O
response NN O
to IN O
this DT O
construct NN O
. . O

Results NNS O

siRNA NNP O
transfection NN O
decreases VBZ O
MUC1 NNP O
expression NN O
in IN O
breast NN O
cancer NN O
cell NN O
lines NNS O

Two CD O
human JJ B-Species
breast NN O
cancer NN O
cell NN O
lines NNS O
, , O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
, , O
were VBD O
transiently RB O
transfected VBN O
with IN O
a DT O
pool NN O
of IN O
four CD O
siRNA NNP O
oligonucleotides NNS O
directed VBN O
against IN O
the DT O
MUC1 NNP O
mRNA NNP O
( SYM O
468 CD O
. , O
siMUC1 NN O
and CC O
BT NN O
. . O
siMUC1 NNP O
) -RRB- O
, , O
or CC O
a DT O
control NN O
oligonucleotide NN O
directed VBN O
against IN O
luciferase NN O
( , O
468 CD O
. . O
siLuc NN O
and CC O
BT NN O
. . O
siLuc NNP O
) -RRB- O
. . O

Both DT O
cell NN O
lines NNS O
express VBP O
high JJ O
levels NNS O
of IN O
MUC1 NNP O
, , O
making VBG O
them PRP O
promising JJ O
targets NNS O
for IN O
this DT O
analysis NN O
. . O

Western JJ O
blots NNS O
( -LRB- O
Figure NNP O
1a NNP O
) -RRB- O
show VBP O
successful JJ O
knockdown NN O
of IN O
both CC O
the DT O
extracellular JJ O
domain NN O
and CC O
cytoplasmic JJ O
tail NN O
fragments NNS O
of IN O
MUC1 NNP O
; : O
luciferase NN O
siRNA NNP O
does VBZ O
not RB O
substantially RB O
change VB O
the DT O
level NN O
of IN O
MUC1 NNP O
compared VBN O
to IN O
parental JJ O
cells NNS O
. . O

468 CD O
. . O
siMUC1 NNP O
show VBP O
a DT O
substantial JJ O
decrease NN O
in IN O
the DT O
amount NN O
of IN O
MUC1 NNP O
- HYPH O
CT NNP O
, , O
while IN O
BT NNP O
. . O
siMUC1 NNP O
show VBP O
slightly RB O
less JJR O
knockdown NN O
of IN O
MUC1 NNP O
- HYPH O
CT NNP O
. . O

Both CC O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
display VBP O
a DT O
less RBR O
dramatic JJ O
decrease NN O
of IN O
MUC1 NNP O
extracellular JJ O
domain NN O
compared VBN O
to IN O
MUC1 NNP O
- HYPH O
CT NNP O
( -LRB- O
Figure NNP O
1a CD O
) -RRB- O
; , O
this DT O
likely RB O
represents VBZ O
protein NN O
synthesized VBN O
prior RB O
to IN O
transfection NN O
, , O
and CC O
may MD O
reflect VB O
differences NNS O
in IN O
the DT O
turnover NN O
rates NNS O
of IN O
the DT O
two CD O
subunits NNS O
. . O

Analysis NN O
of IN O
the DT O
MUC1 NNP O
extracellular JJ O
domain NN O
by IN O
flow NN O
cytometry NN O
confirms VBZ O
that IN O
both DT O
cell NN O
lines NNS O
substantially RB O
decrease VBP O
MUC1 NNP O
expression NN O
after IN O
siRNA NNP O
( -LRB- O
Figure NNP O
1b NN O
) -RRB- O
. . O

By IN O
flow NN O
cytometry NN O
, , O
468 CD O
. , O
siMUC1 NN O
averaged VBD O
75 CD O
% NN O
knockdown NN O
of IN O
MUC1 NNP O
compared VBN O
to IN O
468 CD O
. . O
siLuc NNP O
; : O
and CC O
BT NNP O
. . O
siMUC1 NNP O
averaged VBD O
50 CD O
% NN O
knockdown NN O
relative JJ O
to IN O
BT NNP O
. . O
siLuc NNP O
. . O

These DT O
effects NNS O
could MD O
be VB O
titrated VBN O
with IN O
the DT O
concentration NN O
of IN O
siRNA NNP O
, , O
were VBD O
seen VBN O
as RB O
early RB O
as IN O
24 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
( , O
data NNS O
not RB O
shown VBN O
) , O
and CC O
lasted VBN O
to IN O
at IN O
least JJS O
96 CD O
h CD O
post NN O
- HYPH O
transfection NN O
( -LRB- O
Figure NNP O
1b NN O
) -RRB- O
. . O

All DT O
experiments NNS O
were VBD O
conducted VBN O
within IN O
48 CD O
to TO O
96 CD O
hours NNS O
after IN O
siRNA NNP O
transfection NN O
. . O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
using VBG O
two CD O
independent JJ O
oligonucleotides NNS O
designed VBN O
in IN O
our PRP$ O
lab NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
designated VBN O
' `` O
882 CD O
' '' O
and CC O
' `` O
956 CD O
' '' O
for IN O
the DT O
initial JJ O
codon NN O
recognized VBN O
by IN O
each DT O
. . O

Transcriptional JJ O
changes NNS O
are VBP O
seen VBN O
after IN O
MUC1 NNP O
siRNA NNP O

Recent JJ O
work NN O
indicates VBZ O
that IN O
MUC1 NNP O
may MD O
affect VB O
transcription NN O
both DT O
directly RB O
via IN O
interaction NN O
with IN O
transcription NN O
factors NNS O
and CC O
indirectly RB O
( , O
for IN O
example NN O
, , O
through IN O
modulating VBG O
signaling NN O
) -RRB- O
. . O

To TO O
study VB O
the DT O
effects NNS O
of IN O
MUC1 NNP O
knockdown NN O
in IN O
breast NN O
cancer NN O
cell NN O
lines NNS O
, , O
real JJ O
- HYPH O
time NN O
PCR NN O
arrays NNS O
were VBD O
used VBN O
to TO O
analyze VB O
transcription NN O
of IN O
84 CD O
genes NNS O
implicated VBN O
in IN O
cancer NN O
. . O

Only RB O
genes NNS O
with IN O
greater JJR O
than IN O
two CD O
- HYPH O
fold NN O
change NN O
were VBD O
considered VBN O
. . O

Three CD O
genes NNS O
( , O
MAP2K1 NNP O
, , O
VEGF NNP O
, , O
PDGFA NNP O
) -RRB- O
were VBD O
altered VBN O
two CD O
- HYPH O
fold NN O
or CC O
more JJR O
after IN O
MUC1 NNP O
siRNA NNP O
in IN O
both DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
cells NNS O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
; , O
two CD O
genes NNS O
( , O
ITGAV NNP O
, , O
MMP2 NNP O
) -RRB- O
changed VBN O
only RB O
in IN O
468 CD O
. , O
siMUC1 NNP O
; : O
and CC O
five CD O
genes NNS O
( , O
TIMP3 NNP O
, , O
RAF1 NNP O
, , O
JUN NNP O
, , O
TNF NNP O
, , O
CDC25A NNP O
) -RRB- O
only RB O
in IN O
BT NNP O
. . O
siMUC1 NNP O
. . O

This DT O
list NN O
represents VBZ O
all DT O
genes NNS O
affected VBN O
greater JJR O
than IN O
two CD O
- HYPH O
fold NN O
after IN O
MUC1 NNP O
siRNA NNP O
, , O
rather RB O
than IN O
a DT O
select JJ O
group NN O
. . O

Three CD O
genes NNS O
whose WP$ O
transcription NN O
was VBD O
changed VBN O
by IN O
less JJR O
than IN O
two CD O
- HYPH O
fold NN O
are VBP O
shown VBN O
, , O
two CD O
of IN O
which WDT O
( , O
PDGFB NNP O
and CC O
ITGB1 NNP O
) -RRB- O
are VBP O
listed VBN O
because IN O
they PRP O
relate VBP O
closely RB O
to IN O
genes NNS O
altered VBN O
by IN O
two CD O
- HYPH O
fold NN O
( , O
PDGFA NNP O
and CC O
ITGAV NNP O
) -RRB- O
. . O

The DT O
third JJ O
, , O
MYC NNP O
, , O
is VBZ O
included VBN O
because IN O
western JJ O
blots NNS O
confirmed VBD O
a DT O
substantial JJ O
change NN O
at IN O
the DT O
protein NN O
level NN O
( -LRB- O
Figure NNP O
3a CD O
) -RRB- O
that WDT O
may MD O
reflect VB O
both CC O
transcriptional JJ O
and CC O
post NN O
- HYPH O
transcriptional JJ O
regulation NN O
. . O

Interestingly RB O
, , O
transcription NN O
of IN O
MAP2K1 NNP O
was VBD O
decreased VBN O
in IN O
both DT O
cell NN O
lines NNS O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

This DT O
gene NN O
encodes VBZ O
MEK1 NNP O
, , O
one CD O
of IN O
the DT O
primary JJ O
regulators NNS O
of IN O
the DT O
ERK1 NNP O
/ SYM O
2 CD O
MAPK NNP O
pathway NN O
[ -LRB- O
33 CD O
] -RRB- O
, , O
a DT O
network NN O
that WDT O
has VBZ O
been VBN O
linked VBN O
several JJ O
times NNS O
to IN O
MUC1 NNP O
[ -LRB- O
12 CD O
, , O
34 CD O
- HYPH O
36 CD O
] -RRB- O
. . O

We PRP O
examined VBD O
MEK1 NNP O
and CC O
MEK2 NNP O
levels NNS O
by IN O
western JJ O
blot NN O
to TO O
confirm VB O
decreased VBN O
protein NN O
in IN O
MUC1 NNP O
siRNA NNP O
- HYPH O
treated VBN O
cells NNS O
( -LRB- O
Figure NNP O
3a NNP O
) -RRB- O
, , O
and CC O
found VBD O
that IN O
not RB O
only RB O
were VBD O
total JJ O
MEK1 NNP O
/ SYM O
2 CD O
levels NNS O
lower JJR O
in IN O
468 CD O
. , O
siMUC1 NN O
and CC O
BT NN O
. , O
siMUC1 NNP O
compared VBN O
to IN O
controls NNS O
( SYM O
0 CD O
. . O
48 CD O
and CC O
0 CD O
. SYM O
68 CD O
relative JJ O
to IN O
siLuc NNP O
, , O
respectively RB O
) -RRB- O
, , O
but CC O
so RB O
were VBD O
the DT O
basal JJ O
amounts NNS O
of IN O
active JJ O
( , O
phosphorylated VBN O
) SYM O
MEK1 CD O
/ SYM O
2 CD O
( SYM O
pMEK1 CD O
/ SYM O
2 CD O
; : O
0 CD O
. . O
12 CD O
and CC O
0 CD O
. . O
42 CD O
relative JJ O
to IN O
siLuc NNP O
, , O
respectively RB O
) -RRB- O
. . O

Both DT O
468 CD O
. , O
siMUC1 NNP O
and CC O
BT NNP O
. , O
siMUC1 NNP O
also RB O
showed VBD O
reduced VBN O
activation NN O
of IN O
ERK1 NNP O
/ SYM O
2 CD O
( SYM O
dpERK1 CD O
/ SYM O
2 CD O
; : O
0 CD O
. . O
21 CD O
and CC O
0 CD O
. . O
27 CD O
relative JJ O
to IN O
siLuc NNP O
, , O
respectively RB O
) -RRB- O
, , O
as IN O
would MD O
be VB O
expected VBN O
with IN O
diminished VBN O
signaling NN O
through IN O
MEK1 NNP O
/ SYM O
2 CD O
; : O
total JJ O
ERK1 NNP O
/ SYM O
2 CD O
levels NNS O
remain VBP O
unchanged JJ O
. . O

As IN O
both DT O
lines NNS O
have VBP O
high JJ O
levels NNS O
of IN O
EGFR NNP O
and CC O
thus RB O
activate VBP O
the DT O
MEK NNP O
- HYPH O
ERK NNP O
cascade NN O
intensely RB O
when WRB O
stimulated VBN O
with IN O
EGF NNP O
[ -LRB- O
37 CD O
] -RRB- O
, , O
siRNA NNP O
- HYPH O
transfected VBN O
cells NNS O
were VBD O
treated VBN O
with IN O
EGF NNP O
. . O

Notably RB O
, , O
MUC1 NNP O
siRNA NNP O
impairs VBZ O
this DT O
important JJ O
oncogenic JJ O
pathway NN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
cells NNS O
, , O
as IN O
468 CD O
. , O
siMUC1 NNP O
display VBP O
less JJR O
pMEK1 NN O
/ SYM O
2 CD O
in IN O
response NN O
to IN O
EGF NNP O
than IN O
do VBP O
468 CD O
. . O
siLuc NN O
( -LRB- O
Figure NN O
3b NN O
) -RRB- O
. . O

Interestingly RB O
, , O
EGF NNP O
treatment NN O
of IN O
BT NNP O
- HYPH O
20 CD O
cells NNS O
results VBZ O
in IN O
slightly RB O
higher JJR O
pMEK1 NN O
/ SYM O
2 CD O
levels NNS O
in IN O
BT NNP O
. , O
siMUC1 NNP O
compared VBN O
to IN O
BT NNP O
. . O
siLuc NNP O
. . O

Though IN O
this DT O
result NN O
seems VBZ O
paradoxical JJ O
in IN O
light NN O
of IN O
decreased VBN O
MAP2K1 NN O
transcription NN O
in IN O
BT NNP O
. , O
siMUC1 NNP O
, , O
it PRP O
likely RB O
results VBZ O
from IN O
differential JJ O
functions NNS O
of IN O
Raf NNP O
isoforms NNS O
in IN O
combination NN O
with IN O
the DT O
increased VBN O
RAF1 NN O
transcription NN O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
and CC O
protein NN O
level NN O
( -LRB- O
Figure NN O
3a CD O
) -RRB- O
in IN O
these DT O
cells NNS O
. . O

Specifically RB O
, , O
B NNP O
- HYPH O
Raf NNP O
is VBZ O
thought VBN O
to TO O
be VB O
the DT O
main JJ O
activator NN O
of IN O
MEK NNP O
under IN O
normal JJ O
conditions NNS O
; : O
Raf NNP O
- HYPH O
1 CD O
activates VBZ O
MEK NNP O
in IN O
response NN O
to IN O
stimulus NN O
[ -LRB- O
38 CD O
] -RRB- O
. . O

Thus RB O
, , O
it PRP O
appears VBZ O
that IN O
basal JJ O
pMEK1 NN O
/ SYM O
2 CD O
levels NNS O
are VBP O
not RB O
greatly RB O
affected VBN O
by IN O
Raf NNP O
- HYPH O
1 CD O
overexpression NN O
in IN O
BT NNP O
. . O
siMUC1 NNP O
cells NNS O
, , O
likely JJ O
because IN O
MEK NNP O
is VBZ O
regulated VBN O
primarily RB O
by IN O
B NNP O
- HYPH O
Raf NNP O
under IN O
normal JJ O
growth NN O
conditions NNS O
. . O

In IN O
contrast NN O
, , O
when WRB O
the DT O
cells NNS O
are VBP O
stimulated VBN O
( , O
EGF NNP O
) -RRB- O
, , O
increased VBN O
Raf NNP O
- HYPH O
1 CD O
levels NNS O
in IN O
BT NNP O
. . O
siMUC1 NNP O
leads VBZ O
to IN O
heightened VBN O
pMEK1 NN O
/ SYM O
2 CD O
( -LRB- O
Figure NN O
3b NN O
) -RRB- O
. . O

MUC1 NNP O
siRNA NNP O
increases VBZ O
apoptosis NN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
but CC O
not RB O
BT NN O
- HYPH O
20 CD O

We PRP O
next RB O
examined VBD O
whether IN O
MUC1 NNP O
knockdown NN O
and CC O
its PRP$ O
associated JJ O
transcriptional JJ O
alterations NNS O
would MD O
affect VB O
overall JJ O
cellular JJ O
events NNS O
. . O

As IN O
several JJ O
of IN O
the DT O
genes NNS O
shown VBN O
in IN O
Figure NN O
2 CD O
are VBP O
important JJ O
in IN O
regulating VBG O
proliferation NN O
and CC O
survival NN O
, , O
and CC O
because IN O
of IN O
the DT O
recently RB O
described VBN O
role NN O
of IN O
MUC1 NNP O
in IN O
modulating VBG O
apoptosis NN O
in IN O
response NN O
to IN O
cellular JJ O
stresses NNS O
[ -LRB- O
20 CD O
, , O
21 CD O
, , O
24 CD O
] -RRB- O
, , O
we PRP O
first RB O
analyzed VBD O
whether IN O
MUC1 NNP O
siRNA NNP O
would MD O
alter VB O
apoptosis NN O
in IN O
these DT O
lines NNS O
. . O

Although IN O
there EX O
was VBD O
no DT O
change NN O
in IN O
basal JJ O
apoptosis NN O
in IN O
either DT O
line NN O
( -LRB- O
Figure NNP O
4a NNP O
) -RRB- O
, , O
we PRP O
observed VBD O
that IN O
the DT O
cell NN O
lines NNS O
responded VBD O
differently RB O
when WRB O
trypsinized VBN O
for IN O
re NN O
- HYPH O
plating VBG O
24 CD O
hours NNS O
after IN O
transfection NN O
( -LRB- O
Figure NN O
4b NN O
) -RRB- O
. . O

Interestingly RB O
, , O
468 CD O
. , O
siMUC1 CD O
cells NNS O
show VBP O
greater JJR O
apoptosis NN O
after IN O
trypsinization NN O
than IN O
do VBP O
468 CD O
. . O
siLuc NNP O
( : O
49 CD O
. . O
8 CD O
% NN O
versus IN O
34 CD O
. . O
0 CD O
% NN O
, , O
respectively RB O
) -RRB- O
, , O
while IN O
BT NNP O
- HYPH O
20 CD O
cells NNS O
from IN O
both DT O
siRNA NNP O
treatments NNS O
display VBP O
similar JJ O
levels NNS O
of IN O
apoptosis NN O
( : O
around IN O
22 CD O
% NN O
) -RRB- O
. . O

To TO O
examine VB O
whether IN O
this DT O
phenomenon NN O
is VBZ O
specific JJ O
to IN O
trypsin NN O
treatment NN O
or CC O
part NN O
of IN O
a DT O
general JJ O
stress NN O
response NN O
involving VBG O
MUC1 NNP O
, , O
we PRP O
subjected VBD O
cells NNS O
to IN O
a DT O
panel NN O
of IN O
stresses NNS O
and CC O
measured VBN O
cell NN O
death NN O
. . O

In IN O
agreement NN O
with IN O
the DT O
patterns NNS O
seen VBN O
with IN O
trypsinization NN O
, , O
BT NNP O
. . O
siLuc NNP O
and CC O
BT NNP O
. , O
siMUC1 NNP O
respond VBP O
similarly RB O
to IN O
all DT O
treatments NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
, , O
while IN O
468 CD O
. , O
siMUC1 NN O
die VBP O
more RBR O
readily RB O
than IN O
468 CD O
. . O
siLuc NNP O
in IN O
response NN O
to IN O
trypsin NN O
, , O
G418 NNP O
, , O
hydrogen NN O
peroxide NN O
, , O
or CC O
celecoxib NN O
, , O
a DT O
chemotherapeutic NN O
that WDT O
targets VBZ O
the DT O
cyclooxygenase NN O
- HYPH O
2 CD O
( HYPH O
COX NN O
- HYPH O
2 CD O
) -RRB- O
pathway NN O
( -LRB- O
Figure NNP O
4c CD O
) -RRB- O
; : O
these DT O
data NNS O
were VBD O
confirmed VBN O
with IN O
two CD O
independent JJ O
siRNA NNP O
constructs NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Like IN O
the DT O
MAPK NNP O
pathway NN O
, , O
AKT NNP O
signaling NN O
has VBZ O
been VBN O
linked VBN O
to IN O
MUC1 NNP O
in IN O
cancer NN O
. . O

Although IN O
transcription NN O
of IN O
AKT NNP O
was VBD O
not RB O
altered VBN O
in IN O
MUC1 NNP O
siRNA NNP O
- HYPH O
treated VBN O
cells NNS O
, , O
the DT O
results NNS O
of IN O
our PRP$ O
apoptosis NN O
studies NNS O
prompted VBD O
us PRP O
to TO O
investigate VB O
levels NNS O
of IN O
AKT NNP O
further RB O
. . O

As IN O
expected VBN O
, , O
the DT O
total JJ O
AKT NNP O
protein NN O
level NN O
is VBZ O
not RB O
greatly RB O
changed VBN O
after IN O
MUC1 NNP O
siRNA NNP O
in IN O
either DT O
cell NN O
line NN O
, , O
though IN O
the DT O
active JJ O
form NN O
( : O
pAKT NN O
) -RRB- O
is VBZ O
increased VBN O
in IN O
both DT O
468 CD O
. , O
siMUC1 NNP O
and CC O
BT NNP O
. , O
siMUC1 NNP O
compared VBN O
to IN O
controls NNS O
( -LRB- O
Figure NNP O
3a CD O
) -RRB- O
. . O

This DT O
result NN O
disagrees VBZ O
with IN O
MUC1 NNP O
activation NN O
of IN O
the DT O
AKT NNP O
pathway NN O
in IN O
rat NN B-Species
3Y1 CD O
cells NNS O
[ -LRB- O
18 CD O
] -RRB- O
, , O
and CC O
may MD O
reflect VB O
regulation NN O
more RBR O
appropriate JJ O
to IN O
breast NN O
cancer NN O
cells NNS O
; , O
this DT O
is VBZ O
supported VBN O
by IN O
activation NN O
of IN O
AKT NNP O
in IN O
response NN O
to IN O
MUC1 NNP O
siRNA NNP O
in IN O
other JJ O
lines NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
there EX O
is VBZ O
a DT O
striking JJ O
difference NN O
in IN O
the DT O
relative JJ O
amounts NNS O
of IN O
AKT NN O
and CC O
pAKT NN O
in IN O
the DT O
two CD O
cell NN O
lines NNS O
( -LRB- O
Figure NNP O
4d NNP O
) -RRB- O
. . O

When WRB O
lysates NNS O
from IN O
both DT O
lines NNS O
are VBP O
exposed VBN O
to IN O
film NN O
for IN O
the DT O
same JJ O
length NN O
of IN O
time NN O
( , O
overexposure NN O
masks VBZ O
the DT O
differences NNS O
between IN O
BT NNP O
. . O
siLuc NNP O
and CC O
BT NNP O
. , O
siMUC1 NNP O
that WDT O
are VBP O
apparent JJ O
in IN O
Figure NNP O
3a CD O
) -RRB- O
, , O
it PRP O
is VBZ O
clear JJ O
that IN O
pAKT NN O
levels NNS O
are VBP O
much RB O
higher JJR O
in IN O
BT NNP O
- HYPH O
20 CD O
than IN O
in IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
, , O
despite IN O
lower JJR O
total JJ O
AKT NNP O
expression NN O
. . O

This DT O
difference NN O
in IN O
AKT NNP O
activation NN O
between IN O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
likely RB O
contributes VBZ O
to IN O
the DT O
disparity NN O
in IN O
their PRP$ O
sensitivity NN O
to IN O
the DT O
increased JJ O
apoptosis NN O
expected VBN O
with IN O
loss NN O
of IN O
MUC1 NNP O
. . O

MUC1 NNP O
siRNA NNP O
alters VBZ O
proliferation NN O
and CC O
invasion NN O

As IN O
MUC1 NNP O
is VBZ O
involved VBN O
in IN O
apoptosis NN O
, , O
we PRP O
next RB O
analyzed VBD O
its PRP$ O
effects NNS O
on IN O
proliferation NN O
. . O

BrdU NNP O
and CC O
[ -LRB- O
3H CD O
] -RRB- O
thymidine NN O
incorporation NN O
were VBD O
used VBN O
to TO O
analyze VB O
proliferation NN O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

468 CD O
. , O
siMUC1 NN O
cells NNS O
show VBP O
a DT O
significant JJ O
decrease NN O
in IN O
[ -LRB- O
3H CD O
] -RRB- O
thymidine NN O
incorporation NN O
compared VBN O
to IN O
468 CD O
. , O
siLuc NNP O
, , O
while IN O
intriguingly RB O
, , O
BT NNP O
. . O
siMUC1 NNP O
cells NNS O
show VBP O
a DT O
significant JJ O
increase NN O
in IN O
proliferation NN O
( -LRB- O
Figure NN O
5a CD O
) -RRB- O
. . O

Growth NN O
curves NNS O
mirror VBP O
these DT O
results NNS O
, , O
as IN O
do VBP O
experiments NNS O
with IN O
the DT O
two CD O
independent JJ O
MUC1 NNP O
siRNA NNP O
oligonucleotides NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Note VB O
that IN O
these DT O
assays NNS O
require VBP O
trypsinizing VBG O
cells NNS O
24 CD O
hours NNS O
post NN O
- HYPH O
transfection NN O
; : O
therefore RB O
, , O
the DT O
results NNS O
in IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
line NN O
could MD O
stem VB O
from IN O
the DT O
changes NNS O
in IN O
apoptosis NN O
described VBN O
in IN O
the DT O
previous JJ O
section NN O
, , O
rather RB O
than IN O
a DT O
true JJ O
effect NN O
on IN O
proliferation NN O
. . O

To TO O
control VB O
for IN O
this DT O
, , O
we PRP O
incubated VBD O
non AFX O
- HYPH O
trypsinized JJ O
, , O
siRNA NNP O
- HYPH O
transfected VBN O
cells NNS O
at IN O
similar JJ O
confluence NN O
with IN O
BrdU NNP O
to TO O
measure VB O
incorporation NN O
. . O

The DT O
' `` O
clumped JJ O
' '' O
profile NN O
of IN O
cells NNS O
( , O
contrast NN O
to IN O
Figure NNP O
4b CD O
) -RRB- O
is VBZ O
likely RB O
a DT O
result NN O
of IN O
the DT O
acid NN O
denaturation NN O
( , O
recommended VBN O
by IN O
the DT O
antibody NN O
manufacturer NN O
) -RRB- O
, , O
as IN O
it PRP O
occurs VBZ O
uniformly RB O
in IN O
these DT O
experiments NNS O
. . O

BrdU NNP O
incorporation NN O
( -LRB- O
Figure NNP O
5b NNP O
) -RRB- O
confirms VBZ O
that IN O
the DT O
[ -LRB- O
3H CD O
] -RRB- O
thymidine NN O
results NNS O
are VBP O
not RB O
solely RB O
due JJ O
to IN O
alterations NNS O
in IN O
apoptosis NN O
, , O
as IN O
468 CD O
. , O
siMUC1 NN O
cells NNS O
incorporate VBP O
less JJR O
BrdU NNP O
than IN O
468 CD O
. . O
siLuc NNP O
; : O
once RB O
again RB O
, , O
BT NNP O
. , O
siMUC1 NNP O
cells NNS O
show VBP O
increased JJ O
proliferation NN O
over IN O
BT NNP O
. . O
siLuc NNP O
. . O

Given VBN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
adhesion NN O
, , O
we PRP O
examined VBD O
whether IN O
MUC1 NNP O
siRNA NNP O
affects VBZ O
cellular JJ O
invasion NN O
. . O

In IN O
transwell NN O
assays NNS O
, , O
BT NNP O
- HYPH O
20 CD O
cells NNS O
invaded VBD O
poorly RB O
, , O
regardless RB O
of IN O
the DT O
siRNA NNP O
used VBN O
( : O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

However RB O
, , O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
cells NNS O
invade VBP O
more RBR O
readily RB O
, , O
and CC O
were VBD O
analyzed VBN O
on IN O
a DT O
panel NN O
of IN O
three CD O
different JJ O
extracellular JJ O
matrix NN O
proteins NNS O
. . O

Interestingly RB O
, , O
468 CD O
. , O
siMUC1 CD O
cells NNS O
display VBP O
somewhat RB O
decreased VBN O
invasion NN O
on IN O
collagen NN O
IV NN O
, , O
laminin NN O
, , O
and CC O
fibronectin NN O
matrices NNS O
, , O
and CC O
on IN O
a DT O
no DT O
- HYPH O
matrix NN O
control NN O
( -LRB- O
Figure NNP O
5c NNP O
) -RRB- O
, , O
which WDT O
is VBZ O
in IN O
agreement NN O
with IN O
the DT O
trend NN O
towards IN O
decreased VBN O
metastasis NN O
observed VBN O
in IN O
Muc1 NNP O
- HYPH O
/ SYM O
- HYPH O
x NNP O
MMTV NNP B-Species
- HYPH O
PyV NNP O
MT NNP O
mice NNS B-Species
[ -LRB- O
8 CD O
] -RRB- O
. . O

Transfection NN O
of IN O
MUC1 NNP O
rescues VBZ O
the DT O
468 CD O
. . O
siMUC1 NN O
phenotype NN O

To TO O
determine VB O
if IN O
the DT O
above JJ O
effects NNS O
are VBP O
specific JJ O
to IN O
MUC1 NNP O
, , O
we PRP O
created VBD O
stable JJ O
transfectants NNS O
of IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
line NN O
using VBG O
empty JJ O
vector NN O
( , O
468 CD O
. . O
Neo NNP O
) -RRB- O
or CC O
a DT O
full JJ O
- HYPH O
length NN O
MUC1 NNP O
construct NN O
( : O
468 CD O
. . O
MUC1 NNP O
Delta NNP O
8 CD O
) -RRB- O
that WDT O
is VBZ O
resistant JJ O
to IN O
one CD O
of IN O
the DT O
independent JJ O
MUC1 NN O
- HYPH O
directed VBN O
oligonucleotides NNS O
( : O
' `` O
882 CD O
' '' O
) -RRB- O
. . O

These DT O
cells NNS O
were VBD O
maintained VBN O
in IN O
G418 CD O
- HYPH O
containing VBG O
medium NN O
to TO O
retain VB O
transgene NN O
selection NN O
. . O

As IN O
expected VBN O
, , O
468 CD O
. , O
MUC1 NNP O
Delta NNP O
8 CD O
cells NNS O
show VBP O
higher JJR O
levels NNS O
of IN O
both DT O
the DT O
MUC1 NNP O
extracellular JJ O
domain NN O
and CC O
the DT O
MUC1 NNP O
- HYPH O
CT NNP O
than IN O
do VBP O
468 CD O
. . O
Neo NNP O
( -LRB- O
Figure NNP O
6a CD O
) -RRB- O
. . O

Note VB O
that IN O
468 CD O
. , O
Neo NNP O
have VBP O
MUC1 NNP O
expression NN O
comparable JJ O
to IN O
parental JJ O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
; : O
the DT O
exposures NNS O
in IN O
Figure NN O
6a CD O
are VBP O
lighter JJR O
than IN O
those DT O
in IN O
Figure NNP O
1a CD O
, , O
in IN O
order NN O
to TO O
clearly RB O
show VB O
the DT O
relative JJ O
levels NNS O
of IN O
MUC1 NN O
in IN O
the DT O
stable JJ O
transfectants NNS O
. . O

After IN O
MUC1 NNP O
siRNA NNP O
, , O
468 CD O
. , O
MUC1 NNP O
Delta NNP O
8 CD O
lose VBP O
some DT O
MUC1 NNP O
( , O
likely JJ O
endogenous JJ O
protein NN O
, , O
which WDT O
is VBZ O
not RB O
siRNA NN O
- HYPH O
resistant JJ O
) -RRB- O
but CC O
retain VB O
high JJ O
- HYPH O
level NN O
expression NN O
, , O
while IN O
468 CD O
. , O
Neo NN O
show VBP O
a DT O
decrease NN O
in IN O
MUC1 NNP O
levels NNS O
similar JJ O
to IN O
parental JJ O
468 CD O
. . O
siMUC1 NN O
cells NNS O
( -LRB- O
Figures NNS O
6a CD O
, , O
b NN O
) -RRB- O
. . O

The DT O
difference NN O
in IN O
the DT O
amount NN O
of IN O
MUC1 NNP O
knockdown NN O
between IN O
468 CD O
. . O
Neo NNP O
and CC O
468 CD O
. . O
MUC1 NNP O
Delta NNP O
8 CD O
is VBZ O
highlighted VBN O
by IN O
the DT O
purple JJ O
shading NN O
in IN O
Figure NN O
6b CD O
. . O

BrdU NNP O
incorporation NN O
( -LRB- O
Figure NNP O
6c NNP O
) -RRB- O
indicates VBZ O
that IN O
468 CD O
. , O
Neo NN O
show VBP O
decreased VBN O
nucleotide NN O
incorporation NN O
after IN O
MUC1 NNP O
siRNA NNP O
compared VBN O
to IN O
control NN O
( : O
3 CD O
. . O
3 CD O
% NN O
versus IN O
25 CD O
. . O
0 CD O
% NN O
, , O
respectively RB O
) -RRB- O
; , O
this DT O
is VBZ O
not RB O
seen VBN O
in IN O
468 CD O
. , O
MUC1 NNP O
Delta NNP O
8 CD O
cells NNS O
, , O
which WDT O
show VBP O
similar JJ O
levels NNS O
of IN O
BrdU NNP O
incorporation NN O
regardless RB O
of IN O
the DT O
siRNA NNP O
used VBN O
( SYM O
21 CD O
. . O
5 CD O
% NN O
for IN O
luciferase NN O
, , O
23 CD O
. . O
9 CD O
% NN O
for IN O
MUC1 NNP O
) -RRB- O
. . O

468 CD O
. , O
Neo NN O
cells NNS O
display VBP O
a DT O
more RBR O
dramatic JJ O
decrease NN O
in IN O
BrdU NNP O
incorporation NN O
after IN O
MUC1 NNP O
siRNA NNP O
than IN O
what WP O
is VBZ O
seen VBN O
in IN O
parental JJ O
468 CD O
. . O
siMUC1 NN O
cells NNS O
, , O
which WDT O
may MD O
reflect VB O
the DT O
additional JJ O
stress NN O
of IN O
being VBG O
maintained VBN O
in IN O
G418 NNP O
- HYPH O
containing VBG O
medium NN O
. . O

Similarly RB O
, , O
analysis NN O
of IN O
apoptosis NN O
in IN O
trypsinized VBN O
cells NNS O
indicates VBZ O
that IN O
the DT O
increased VBN O
apoptosis NN O
seen VBN O
in IN O
parental JJ O
468 CD O
. , O
siMUC1 NN O
cells NNS O
is VBZ O
also RB O
present JJ O
in IN O
the DT O
468 CD O
. , O
Neo NN O
line NN O
after IN O
MUC1 NNP O
siRNA NNP O
( -LRB- O
Figure NNP O
6d CD O
; : O
43 CD O
. . O
6 CD O
% NN O
in IN O
control NN O
versus IN O
59 CD O
. . O
6 CD O
% NN O
in IN O
MUC1 NNP O
siRNA NNP O
) -RRB- O
. . O

However RB O
, , O
in IN O
468 CD O
. , O
MUC1 NNP O
Delta NNP O
8 CD O
cells NNS O
, , O
the DT O
level NN O
of IN O
apoptosis NN O
after IN O
luciferase NN O
siRNA NNP O
( : O
34 CD O
. . O
1 CD O
% NN O
) -RRB- O
is VBZ O
lower JJR O
than IN O
that DT O
in IN O
468 CD O
. , O
Neo JJ O
cells NNS O
; : O
MUC1 NNP O
siRNA NNP O
increases VBZ O
the DT O
amount NN O
of IN O
apoptosis NN O
slightly RB O
( : O
42 CD O
. . O
8 CD O
% NN O
) -RRB- O
, , O
restoring VBG O
it PRP O
to IN O
a DT O
level NN O
similar JJ O
to IN O
that DT O
seen VBN O
in IN O
luciferase NN O
siRNA NNP O
- HYPH O
treated VBN O
468 CD O
. . O
Neo JJ O
cells NNS O
. . O

Together RB O
, , O
these DT O
studies NNS O
suggest VBP O
that IN O
the DT O
above RB O
- HYPH O
described VBN O
results NNS O
are VBP O
specific JJ O
to IN O
MUC1 NNP O
, , O
as IN O
stable JJ O
transfection NN O
of IN O
an DT O
siRNA NNP O
- HYPH O
resistant JJ O
MUC1 NNP O
rescues VBZ O
the DT O
phenotype NN O
seen VBN O
in IN O
468 CD O
. . O
siMUC1 NN O
cells NNS O
. . O

Discussion NN O

This DT O
report NN O
describes VBZ O
both CC O
the DT O
transcriptional JJ O
alterations NNS O
seen VBN O
after IN O
transfection NN O
with IN O
MUC1 NNP O
siRNA NNP O
in IN O
human JJ B-Species
breast NN O
cancer NN O
cells NNS O
and CC O
the DT O
effects NNS O
on IN O
events NNS O
such JJ O
as IN O
apoptosis NN O
and CC O
proliferation NN O
. . O

The DT O
two CD O
cell NN O
lines NNS O
used VBN O
( , O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
) -RRB- O
were VBD O
chosen VBN O
for IN O
high JJ O
expression NN O
of IN O
MUC1 NNP O
and CC O
a DT O
substantial JJ O
( : O
50 CD O
% NN O
to TO O
75 CD O
% NN O
) -RRB- O
, , O
consistent JJ O
decrease NN O
in IN O
MUC1 NNP O
expression NN O
after IN O
siRNA NNP O
. . O

Both DT O
lines NNS O
have VBP O
epithelial JJ O
morphology NN O
, , O
form NN O
tumors NNS O
slowly RB O
in IN O
nude JJ B-Species
mice NN I-Species
[ -LRB- O
37 CD O
] -RRB- O
, , O
have VBP O
mutant JJ O
p53 NN O
[ -LRB- O
39 CD O
, , O
40 CD O
] -RRB- O
, , O
express VBP O
EGFR NNP O
[ -LRB- O
37 CD O
] -RRB- O
, , O
and CC O
lack VBP O
estrogen NN O
receptor NN O
alpha NN O
[ -LRB- O
41 CD O
] -RRB- O
. . O

One CD O
striking VBG O
difference NN O
between IN O
these DT O
lines NNS O
, , O
however RB O
, , O
is VBZ O
their PRP$ O
response NN O
to IN O
MUC1 NNP O
siRNA NNP O
. . O

MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
cells NNS O
behave VBP O
as IN O
expected VBN O
for IN O
loss NN O
of IN O
an DT O
oncogene NN O
: : O
MUC1 NNP O
siRNA NNP O
correlates VBZ O
with IN O
increased VBN O
apoptosis NN O
in IN O
response NN O
to IN O
stress NN O
, , O
decreased VBN O
proliferation NN O
, , O
and CC O
reduced VBN O
invasion NN O
. . O

In IN O
contrast NN O
, , O
BT NNP O
. . O
siMUC1 CD O
cells NNS O
proliferate VBP O
more RBR O
rapidly RB O
than IN O
BT NNP O
. . O
siLuc NNP O
cells NNS O
with IN O
little JJ O
effect NN O
on IN O
apoptosis NN O
. . O

Much JJ O
of IN O
the DT O
phenotype NN O
of IN O
these DT O
cells NNS O
can MD O
be VB O
understood VBN O
in IN O
light NN O
of IN O
protein NN O
levels NNS O
and CC O
transcriptional JJ O
activity NN O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

As IN O
mentioned VBN O
, , O
both CC O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
display VBP O
increased VBN O
pAKT NNP O
after IN O
MUC1 NNP O
siRNA NNP O
, , O
but CC O
the DT O
ratio NN O
of IN O
active JJ O
to IN O
total JJ O
AKT NNP O
is VBZ O
considerably RB O
higher JJR O
in IN O
the DT O
BT NNP O
- HYPH O
20 CD O
line NN O
, , O
which WDT O
may MD O
help VB O
these DT O
cells NNS O
resist VB O
the DT O
increased JJ O
apoptosis NN O
expected VBN O
with IN O
loss NN O
of IN O
MUC1 NNP O
. . O

Myc NN O
levels NNS O
are VBP O
also RB O
higher JJR O
in IN O
both DT O
cell NN O
lines NNS O
after IN O
MUC1 NNP O
siRNA NNP O
, , O
although IN O
the DT O
ability NN O
of IN O
Myc NNP O
to TO O
promote VB O
proliferation NN O
and CC O
apoptosis NN O
in IN O
different JJ O
cellular JJ O
contexts NNS O
[ -LRB- O
42 CD O
] -RRB- O
complicates VBZ O
the DT O
interpretation NN O
of IN O
this DT O
finding NN O
. . O

Both DT O
cell NN O
lines NNS O
show VBP O
reduced VBN O
transcription NN O
of IN O
VEGF NNP O
, , O
PDGFA NNP O
, , O
PDGFB NNP O
, , O
and CC O
MAP2K1 NNP O
( -LRB- O
MEK1 NNP O
) -RRB- O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

The DT O
genes NNS O
encoding VBG O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( -LRB- O
VEGF NNP O
) -RRB- O
and CC O
the DT O
A NN O
and CC O
B NN O
chains NNS O
of IN O
platelet NN O
- HYPH O
derived VBN O
growth NN O
factor NN O
( , O
PDGF NNP O
- HYPH O
A NN O
and CC O
PDGF NNP O
- HYPH O
B NN O
) -RRB- O
are VBP O
interesting JJ O
as IN O
these DT O
proteins NNS O
have VBP O
been VBN O
heavily RB O
implicated VBN O
in IN O
angiogenesis NN O
, , O
suggesting VBG O
a DT O
novel JJ O
function NN O
for IN O
MUC1 NNP O
in IN O
regulating VBG O
this DT O
process NN O
. . O

Vascular JJ O
endothelial JJ O
growth NN O
factor NN O
expression NN O
in IN O
cancer NN O
is VBZ O
linked VBN O
to IN O
tumor NN O
growth NN O
and CC O
metastasis NN O
[ -LRB- O
43 CD O
, , O
44 CD O
] -RRB- O
; , O
platelet NN O
- HYPH O
derived VBN O
growth NN O
factor NN O
is VBZ O
also RB O
angiogenic JJ O
, , O
but CC O
has VBZ O
an DT O
additional JJ O
role NN O
in IN O
stimulating VBG O
desmoplasia NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

Reduced VBN O
transcription NN O
of IN O
these DT O
genes NNS O
after IN O
MUC1 NNP O
siRNA NNP O
suggests VBZ O
that IN O
MUC1 NNP O
may MD O
foster VB O
angiogenesis NN O
and CC O
stromal JJ O
proliferation NN O
, , O
although IN O
this DT O
must MD O
be VB O
confirmed VBN O
in IN O
a DT O
more RBR O
appropriate JJ O
model NN O
system NN O
. . O

Decreased VBN O
MAP2K1 NNP O
( -LRB- O
MEK1 NN O
) -RRB- O
transcription NN O
after IN O
MUC1 NNP O
siRNA NNP O
provides VBZ O
a DT O
novel JJ O
mechanism NN O
by IN O
which WDT O
MUC1 NNP O
can MD O
affect VB O
the DT O
ERK1 NNP O
/ SYM O
2 CD O
MAPK NNP O
pathway NN O
. . O

MUC1 NNP O
has VBZ O
often RB O
been VBN O
linked VBN O
to IN O
the DT O
Ras NNP O
- HYPH O
Raf NNP O
- HYPH O
MEK NNP O
- HYPH O
ERK NNP O
cascade NN O
[ -LRB- O
12 CD O
, , O
34 CD O
- HYPH O
36 CD O
, , O
46 CD O
] -RRB- O
, , O
and CC O
at RB O
least RBS O
two CD O
mechanisms NNS O
by IN O
which WDT O
MUC1 NNP O
can MD O
alter VB O
MAPK NNP O
signaling NN O
have VBP O
been VBN O
described VBN O
: : O
MUC1 NN O
interaction NN O
with IN O
and CC O
phosphorylation NN O
by IN O
the DT O
EGFR NNP O
family NN O
[ -LRB- O
12 CD O
, , O
13 CD O
] -RRB- O
, , O
and CC O
MUC1 NNP O
binding NN O
to IN O
the DT O
Grb2 NNP O
/ SYM O
Sos NNP O
complex NN O
that WDT O
activates VBZ O
Ras NNP O
[ -LRB- O
46 CD O
] -RRB- O
. . O

Reduction NN O
of IN O
MEK1 NNP O
levels NNS O
after IN O
MUC1 NNP O
siRNA NNP O
agrees VBZ O
with IN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
strengthening VBG O
MAPK NNP O
signaling NN O
, , O
and CC O
indicates VBZ O
that IN O
MUC1 NNP O
can MD O
regulate VB O
both CC O
the DT O
transcription NN O
and CC O
activity NN O
of IN O
members NNS O
of IN O
this DT O
pathway NN O
. . O

Two CD O
additional JJ O
MAPK NNP O
pathway NN O
members NNS O
are VBP O
altered VBN O
specifically RB O
in IN O
BT NNP O
. , O
siMUC1 NNP O
, , O
with IN O
no DT O
corresponding VBG O
change NN O
in IN O
468 CD O
. . O
siMUC1 NN O
cells NNS O
. . O

These DT O
genes NNS O
are VBP O
RAF1 NNP O
and CC O
JUN NNP O
which WDT O
are VBP O
increased VBN O
and CC O
decreased VBN O
, , O
respectively RB O
, , O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

Raf NNP O
- HYPH O
1 CD O
and CC O
c NN O
- HYPH O
Jun NNP O
both DT O
function NN O
outside IN O
of IN O
the DT O
ERK1 NNP O
/ SYM O
2 CD O
MAPK NNP O
pathway NN O
, , O
which WDT O
may MD O
explain VB O
the DT O
seeming VBG O
paradox NN O
of IN O
increased VBN O
RAF1 NN O
transcription NN O
with IN O
simultaneous JJ O
decreases NNS O
in IN O
MAP2K1 NNP O
and CC O
JUN NNP O
. . O

Specifically RB O
, , O
Raf NNP O
- HYPH O
1 CD O
can MD O
inhibit VB O
ASK1 NNP O
( , O
apoptosis NN O
signal NN O
- HYPH O
regulated VBN O
kinase NN O
1 CD O
) -RRB- O
upstream RB O
of IN O
p38 NN O
and CC O
JNK NNP O
( -LRB- O
Jun NNP O
N NNP O
- HYPH O
terminal JJ O
kinase NN O
) -RRB- O
[ -LRB- O
38 CD O
] -RRB- O
. . O

ASK1 NNP O
phosphorylates VBZ O
JNK NNP O
in IN O
response NN O
to IN O
stress NN O
, , O
resulting VBG O
in IN O
activation NN O
of IN O
c NN O
- HYPH O
Jun NN O
and CC O
stimulation NN O
of IN O
apoptosis NN O
[ -LRB- O
47 CD O
] -RRB- O
, , O
indicating VBG O
that IN O
the DT O
coordinate NN O
up IN O
- HYPH O
regulation NN O
of IN O
RAF1 NNP O
and CC O
down RB O
- HYPH O
regulation NN O
of IN O
JUN NNP O
may MD O
provide VB O
a DT O
potent JJ O
anti AFX O
- HYPH O
apoptotic JJ O
effect NN O
in IN O
BT NNP O
. . O
siMUC1 NNP O
. . O

Regulation NN O
of IN O
life NN O
and CC O
death NN O
is VBZ O
also RB O
a DT O
hallmark NN O
of IN O
the DT O
CDC25A NNP O
and CC O
TNF NNP O
gene NN O
products NNS O
. . O

CDC25A NNP O
is VBZ O
a DT O
phosphatase NN O
that WDT O
stimulates VBZ O
cell NN O
cycle NN O
progression NN O
[ -LRB- O
48 CD O
] -RRB- O
, , O
thus RB O
the DT O
effects NNS O
of IN O
its PRP$ O
decrease NN O
in IN O
BT NNP O
. . O
siMUC1 NNP O
are VBP O
unclear JJ O
in IN O
light NN O
of IN O
the DT O
increased VBN O
proliferation NN O
of IN O
these DT O
cells NNS O
. . O

However RB O
, , O
the DT O
CDC25 NNP O
proteins NNS O
( , O
A NNP O
, , O
B NNP O
, , O
and CC O
C NNP O
) -RRB- O
were VBD O
recently RB O
shown VBN O
to TO O
have VB O
greater JJR O
functional JJ O
overlap NN O
than IN O
was VBD O
previously RB O
thought VBN O
[ -LRB- O
49 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
the DT O
other JJ O
two CD O
isoforms NNS O
may MD O
compensate VB O
for IN O
reduced VBN O
CDC25A NNP O
levels NNS O
. . O

TNF NNP O
encodes VBZ O
tumor NN O
necrosis NN O
factor NN O
( -LRB- O
TNF NNP O
) -RRB- O
alpha NN O
, , O
known VBN O
for IN O
its PRP$ O
potent JJ O
, , O
cell NN O
type NN O
- HYPH O
specific JJ O
control NN O
of IN O
life NN O
and CC O
death NN O
. . O

In IN O
tumor NN O
cells NNS O
, , O
TNF NNP O
alpha NN O
expression NN O
can MD O
promote VB O
proliferation NN O
and CC O
inhibit VB O
apoptosis NN O
[ -LRB- O
50 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
increased VBN O
TNF NN O
transcription NN O
in IN O
BT NNP O
. , O
siMUC1 NNP O
could MD O
contribute VB O
to IN O
the DT O
increased VBN O
proliferation NN O
seen VBN O
in IN O
these DT O
cells NNS O
. . O

Interestingly RB O
, , O
the DT O
increase NN O
in IN O
TNF NNP O
is VBZ O
accompanied VBN O
by IN O
decreased VBN O
transcription NN O
of IN O
TIMP3 NNP O
, , O
encoding VBG O
tissue NN O
inhibitor NN O
of IN O
metalloproteinases NNS O
( -LRB- O
TIMP NNP O
) -RRB- O
3 CD O
. . O

The DT O
TIMP NNP O
family NN O
disrupts VBZ O
the DT O
function NN O
of IN O
matrix NN O
metalloproteinases NNS O
( -LRB- O
MMPs NNS O
) -RRB- O
, , O
generally RB O
resulting VBG O
in IN O
decreased VBN O
invasion NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

TIMP3 NNP O
is VBZ O
unique JJ O
in IN O
that IN O
it PRP O
can MD O
also RB O
inhibit VB O
TNF NNP O
alpha NN O
converting VBG O
enzyme NN O
( , O
TACE NNP O
) -RRB- O
, , O
which WDT O
activates VBZ O
TNF NNP O
alpha NN O
by IN O
cleaving VBG O
it PRP O
from IN O
the DT O
cell NN O
surface NN O
[ -LRB- O
50 CD O
] -RRB- O
. . O

Reduced VBN O
expression NN O
of IN O
TIMP3 NNP O
would MD O
, , O
therefore RB O
, , O
foster VB O
signaling VBG O
through IN O
TNF NNP O
alpha NN O
by IN O
releasing VBG O
inhibition NN O
of IN O
TNF NNP O
alpha NN O
converting NN O
enzyme NN O
. . O

In IN O
agreement NN O
with IN O
this DT O
, , O
TIMP3 NNP O
can MD O
promote VB O
apoptosis NN O
[ -LRB- O
52 CD O
] -RRB- O
; : O
thus RB O
, , O
its PRP$ O
down RB O
- HYPH O
regulation NN O
in IN O
BT NNP O
. , O
siMUC1 NNP O
provides VBZ O
another DT O
mechanism NN O
by IN O
which WDT O
these DT O
cells NNS O
are VBP O
able JJ O
to TO O
resist VB O
the DT O
increased VBN O
apoptosis NN O
expected VBN O
with IN O
loss NN O
of IN O
MUC1 NNP O
. . O

Another DT O
TIMP NNP O
target NN O
responds VBZ O
to IN O
MUC1 NNP O
siRNA NNP O
, , O
as IN O
468 CD O
. , O
siMUC1 CD O
cells NNS O
show VBP O
significantly RB O
increased VBN O
expression NN O
of IN O
MMP2 NNP O
( , O
encoding VBG O
MMP NNP O
- HYPH O
2 CD O
/ SYM O
gelatinase NN O
A NNP O
) -RRB- O
, , O
the DT O
product NN O
of IN O
which WDT O
degrades VBZ O
type NN O
IV NN O
collagen NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

In IN O
breast NN O
cancer NN O
, , O
the DT O
ratio NN O
of IN O
active JJ O
to IN O
latent JJ O
MMP NNP O
- HYPH O
2 CD O
increases VBZ O
with IN O
tumor NN O
progression NN O
; : O
MMP NNP O
- HYPH O
2 CD O
may MD O
facilitate VB O
both CC O
angiogenesis NN O
and CC O
metastasis NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

Its PRP$ O
increase NN O
after IN O
loss NN O
of IN O
MUC1 NNP O
is VBZ O
, , O
therefore RB O
, , O
unexpected JJ O
, , O
but CC O
at RB O
least RBS O
two CD O
factors NNS O
may MD O
clarify VB O
this DT O
result NN O
. . O

First RB O
, , O
though IN O
MMP NNP O
- HYPH O
2 CD O
levels NNS O
are VBP O
increased VBN O
in IN O
mouse NN B-Species
mammary NN O
tumors NNS O
, , O
its PRP$ O
expression NN O
is VBZ O
confined VBN O
to IN O
the DT O
stroma NN O
[ -LRB- O
53 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
increased VBN O
MMP2 NN O
transcription NN O
after IN O
loss NN O
of IN O
the DT O
epithelium NN O
- HYPH O
specific JJ O
MUC1 NNP O
might MD O
reflect VB O
a DT O
shift NN O
towards IN O
a DT O
more RBR O
mesenchymal JJ O
phenotype NN O
. . O

Second RB O
, , O
MMP NNP O
- HYPH O
2 CD O
levels NNS O
are VBP O
increased VBN O
by IN O
overexpression NN O
of IN O
erbB2 NN O
[ -LRB- O
52 CD O
] -RRB- O
; , O
previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
erbB2 NN O
and CC O
Muc1 NNP O
expression NN O
are VBP O
mutually RB O
exclusive JJ O
in IN O
mammary JJ O
tumors NNS O
[ -LRB- O
27 CD O
] -RRB- O
, , O
implying VBG O
that IN O
MMP2 NNP O
might MD O
be VB O
part NN O
of IN O
a DT O
transcriptional JJ O
profile NN O
linked VBN O
to IN O
low JJ O
MUC1 NNP O
levels NNS O
. . O

It PRP O
is VBZ O
intriguing JJ O
that IN O
, , O
despite IN O
increased JJ O
MMP2 NN O
transcription NN O
, , O
invasion NN O
is VBZ O
decreased VBN O
in IN O
468 CD O
. . O
siMUC1 CD O
cells NNS O
, , O
even RB O
on IN O
collagen NN O
IV NN O
. . O

This DT O
may MD O
reflect VB O
insufficient JJ O
activation NN O
of IN O
MMP NNP O
- HYPH O
2 CD O
, , O
as IN O
the DT O
precursor NN O
protein NN O
must MD O
be VB O
cleaved VBN O
for IN O
enzymatic JJ O
function NN O
[ -LRB- O
52 CD O
] -RRB- O
. . O

Alternatively RB O
, , O
the DT O
slowed JJ O
invasion NN O
of IN O
these DT O
cells NNS O
may MD O
relate VB O
to IN O
impaired JJ O
adhesion NN O
resulting VBG O
from IN O
decreased VBN O
transcription NN O
of IN O
ITGAV NNP O
and CC O
ITGB1 NNP O
( , O
alpha NN O
v NN O
and CC O
beta NN O
1 CD O
integrins NNS O
, , O
respectively RB O
) -RRB- O
. . O

Integrin NN O
signaling NN O
is VBZ O
tied VBN O
to IN O
life NN O
- HYPH O
or CC O
- HYPH O
death NN O
decisions NNS O
in IN O
epithelial JJ O
cells NNS O
, , O
and CC O
integrin JJ O
expression NN O
is VBZ O
vital JJ O
for IN O
processes NNS O
from IN O
wound NN O
healing NN O
to IN O
metastasis NN O
[ -LRB- O
54 CD O
] -RRB- O
. . O

Integrin NN O
alpha NN O
v IN O
beta NN O
3 CD O
is VBZ O
implicated VBN O
in IN O
facilitating VBG O
metastasis NN O
of IN O
breast NN O
cancer NN O
cells NNS O
to IN O
bone NN O
[ -LRB- O
55 CD O
] -RRB- O
; , O
decreased VBN O
transcription NN O
of IN O
ITGAV NN O
after IN O
MUC1 NNP O
siRNA NNP O
may MD O
, , O
therefore RB O
, , O
suggest VB O
that IN O
MUC1 NNP O
is VBZ O
involved VBN O
in IN O
this DT O
lethal JJ O
process NN O
as RB O
well RB O
. . O

The DT O
MUC1 NNP O
oncogene NN O
has VBZ O
been VBN O
linked VBN O
to IN O
apoptosis NN O
[ -LRB- O
18 CD O
, , O
20 CD O
, , O
26 CD O
] -RRB- O
, , O
proliferation NN O
[ -LRB- O
17 CD O
] -RRB- O
, , O
and CC O
transcription NN O
[ -LRB- O
21 CD O
, , O
23 CD O
- SYM O
25 CD O
] -RRB- O
in IN O
cancer NN O
. . O

However RB O
, , O
the DT O
two CD O
cell NN O
lines NNS O
chosen VBN O
for IN O
our PRP$ O
study NN O
display VBP O
very RB O
different JJ O
responses NNS O
to IN O
MUC1 NNP O
siRNA NNP O
, , O
indicating VBG O
that IN O
regulation NN O
of IN O
MUC1 NN O
in IN O
breast NN O
cancer NN O
is VBZ O
likely RB O
quite RB O
complex JJ O
and CC O
cautioning VBG O
against IN O
over IN O
- HYPH O
generalization NN O
of IN O
results NNS O
from IN O
individual JJ O
cell NN O
lines NNS O
. . O

Previous JJ O
reports NNS O
suggest VBP O
that IN O
, , O
though IN O
most JJS O
studies NNS O
outline VBP O
a DT O
clearly RB O
oncogenic JJ O
role NN O
for IN O
MUC1 NNP O
in IN O
breast NN O
cancer NN O
, , O
the DT O
exact JJ O
details NNS O
may MD O
vary VB O
depending VBG O
on IN O
factors NNS O
such JJ O
as IN O
cell NN O
type NN O
and CC O
signaling NN O
context NN O
. . O

For IN O
example NN O
, , O
MUC1 NNP O
stimulates VBZ O
Fas NNP O
- HYPH O
mediated VBN O
apoptosis NN O
in IN O
CHO NNP O
cells NNS O
[ -LRB- O
26 CD O
] -RRB- O
, , O
quite RB O
unlike IN O
the DT O
inhibition NN O
of IN O
apoptosis NN O
seen VBN O
in IN O
other JJ O
cell NN O
lines NNS O
. . O

Similarly RB O
, , O
though IN O
MUC1 NNP O
drives VBZ O
mammary JJ O
oncogenesis NN O
in IN O
its PRP$ O
own JJ O
right NN O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
facilitates VBZ O
tumorigenesis NN O
driven VBN O
by IN O
other JJ O
oncogenes NNS O
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
, , O
Muc1 NNP O
is VBZ O
selectively RB O
down RB O
- HYPH O
regulated VBN O
in IN O
c NN O
- HYPH O
neu NN O
- HYPH O
induced VBN O
mouse NN B-Species
mammary NN O
tumors NNS O
[ -LRB- O
27 CD O
] -RRB- O
, , O
indicating VBG O
that IN O
the DT O
context NN O
of IN O
oncogenic JJ O
signaling NN O
is VBZ O
vital JJ O
to IN O
understanding VBG O
the DT O
function NN O
of IN O
MUC1 NNP O
. . O

Thus RB O
, , O
it PRP O
is VBZ O
important JJ O
to TO O
consider VB O
the DT O
relative JJ O
levels NNS O
of IN O
knockdown NN O
of IN O
MUC1 NNP O
in IN O
the DT O
two CD O
cell NN O
lines NNS O
: : O
BT NNP O
- HYPH O
20 CD O
cells NNS O
reduce VBP O
MUC1 NN O
expression NN O
after IN O
siRNA NNP O
less RBR O
strongly RB O
than IN O
do VBP O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
( : O
50 CD O
% NN O
versus IN O
75 CD O
% NN O
knockdown NN O
, , O
respectively RB O
) -RRB- O
. . O

As IN O
MUC1 NNP O
serves VBZ O
as IN O
a DT O
scaffold NN O
[ -LRB- O
11 CD O
] -RRB- O
, , O
overexpression NN O
of IN O
MUC1 NNP O
relative JJ O
to IN O
its PRP$ O
associated JJ O
signaling NN O
proteins NNS O
might MD O
create VB O
a DT O
dilution NN O
effect NN O
, , O
sequestering VBG O
signal NN O
transducers NNS O
away RB O
from IN O
each DT O
other JJ O
; : O
this DT O
would MD O
be VB O
relieved VBN O
by IN O
MUC1 NNP O
siRNA NNP O
. . O

Thus RB O
, , O
enough JJ O
MUC1 NNP O
may MD O
be VB O
retained VBN O
in IN O
BT NNP O
. . O
siMUC1 NNP O
cells NNS O
for IN O
its PRP$ O
oncogenic JJ O
effects NNS O
, , O
while IN O
signaling VBG O
complex JJ O
formation NN O
would MD O
be VB O
enhanced VBN O
by IN O
lowering VBG O
the DT O
amount NN O
of IN O
MUC1 NNP O
relative JJ O
to IN O
other JJ O
signaling VBG O
proteins NNS O
. . O

Conclusion NN O

The DT O
contrast NN O
between IN O
the DT O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
lines NNS O
in IN O
response NN O
to IN O
MUC1 NNP O
siRNA NNP O
serves VBZ O
as IN O
a DT O
reminder NN O
that IN O
simplified JJ O
models NNS O
such JJ O
as IN O
cell NN O
lines NNS O
fail VBP O
to TO O
encompass VB O
the DT O
complexity NN O
of IN O
intact JJ O
biological JJ O
systems NNS O
. . O

This DT O
report NN O
describes VBZ O
transcriptional JJ O
alterations NNS O
seen VBN O
after IN O
MUC1 NNP O
knockdown NN O
: : O
decreased VBN O
transcription NN O
of IN O
MAP2K1 NNP O
, , O
VEGF NNP O
, , O
PDGFA NNP O
, , O
ITGAV NNP O
, , O
TIMP3 NNP O
, , O
CDC25A NNP O
, , O
and CC O
JUN NNP O
, , O
and CC O
increased VBN O
transcription NN O
of IN O
MMP2 NNP O
, , O
TNF NNP O
, , O
and CC O
RAF1 NN O
. . O

The DT O
alterations NNS O
in IN O
MAP2K1 NNP O
, , O
RAF1 NNP O
, , O
and CC O
JUN NNP O
represent VBP O
a DT O
novel JJ O
means NN O
by IN O
which WDT O
MUC1 NNP O
can MD O
affect VB O
ERK1 NNP O
/ SYM O
2 CD O
signaling NN O
: : O
transcriptional JJ O
regulation NN O
of IN O
MAPK NNP O
pathway NN O
members NNS O
. . O

Oncogenic JJ O
events NNS O
are VBP O
also RB O
altered VBN O
in IN O
both DT O
cell NN O
lines NNS O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

These DT O
results NNS O
strengthen VBP O
the DT O
growing VBG O
ties NNS O
linking VBG O
MUC1 NNP O
and CC O
transcriptional JJ O
regulation NN O
, , O
and CC O
suggest VBP O
that IN O
the DT O
role NN O
of IN O
MUC1 NNP O
in IN O
breast NN O
cancer NN O
may MD O
be VB O
more RBR O
complex JJ O
than IN O
a DT O
direct JJ O
correlation NN O
between IN O
MUC1 NN O
level NN O
and CC O
oncogenic JJ O
function NN O
. . O

Abbreviations NNS O

BrdU NNP O
= : O
bromodeoxyuridine NN O
; : O
EGF NNP O
= : O
epidermal JJ O
growth NN O
factor NN O
; : O
EGFR NNP O
= : O
epidermal JJ O
growth NN O
factor NN O
receptor NN O
; : O
ERK NNP O
= : O
extracellular JJ O
signal NN O
regulated VBN O
kinase NN O
; : O
MAPK NNP O
= , O
mitogen NN O
activated VBN O
protein NN O
kinase NN O
; , O
MEK NNP O
= , O
MAPK NNP O
and CC O
ERK NNP O
kinase NN O
; : O
MMP NNP O
= : O
matrix NN O
metalloproteinases NN O
; : O
MUC1 NNP O
- HYPH O
CT NNP O
= SYM O
MUC1 NN O
cytoplasmic JJ O
tail NN O
; : O
MUC1 NNP O
- HYPH O
EX NN O
= : O
MUC1 NN O
extracellular JJ O
subunit NN O
; : O
PBS NN O
= : O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
; : O
PI NN O
= , O
propidium NN O
iodide NN O
; : O
siRNA NNP O
= , O
small JJ O
interfering NN O
RNA NN O
; : O
TIMP NN O
= HYPH O
tissue NN O
inhibitor NN O
of IN O
metalloproteinases NNS O
; : O
TNF NN O
= : O
tumor NN O
necrosis NN O
factor NN O
. . O

Competing VBG O
interests NNS O

The DT O
authors NNS O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

CLH NNP O
performed VBD O
all DT O
studies NNS O
and CC O
composed VBD O
the DT O
manuscript NN O
. . O

SJG NNP O
participated VBD O
in IN O
the DT O
design NN O
and CC O
coordination NN O
of IN O
the DT O
studies NNS O
and CC O
contributed VBD O
strongly RB O
to IN O
the DT O
revision NN O
of IN O
the DT O
manuscript NN O
. . O

Both DT O
authors NNS O
have VBP O
read VBN O
and CC O
approved VBN O
the DT O
manuscript NN O
. . O

The DT O
recombination NN O
- HYPH O
associated VBN O
protein NN O
RdgC NNP O
adopts VBZ O
a DT O
novel JJ O
toroidal JJ O
architecture NN O
for IN O
DNA NNP O
binding NN O

Abstract JJ O

RecA NNP O
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
the DT O
nonmutagenic JJ O
repair NN O
of IN O
stalled VBN O
replication NN O
forks NNS O
in IN O
bacteria NNS O
. . O

RdgC NNP O
, , O
a DT O
recombination NN O
- HYPH O
associated VBN O
DNA NN O
- HYPH O
binding VBG O
protein NN O
, , O
is VBZ O
a DT O
potential JJ O
negative JJ O
regulator NN O
of IN O
RecA NNP O
function NN O
. . O

Here RB O
, , O
we PRP O
have VBP O
determined VBN O
the DT O
crystal NN O
structure NN O
of IN O
RdgC NNP O
from IN O
Pseudomonas NNP B-Species
aeruginosa NN I-Species
. . O

The DT O
J NNP O
- HYPH O
shaped JJ O
monomer NN O
has VBZ O
a DT O
unique JJ O
fold NN O
and CC O
can MD O
be VB O
divided VBN O
into IN O
three CD O
structural JJ O
domains NNS O
: : O
tip NN O
domain NN O
, , O
center NN O
domain NN O
and CC O
base NN O
domain NN O
. . O

Two CD O
such JJ O
monomers NNS O
dimerize VBP O
to TO O
form VB O
a DT O
ring NN O
- HYPH O
shaped JJ O
molecule NN O
of IN O
approximate JJ O
2 CD O
- HYPH O
fold NN O
symmetry NN O
. . O

Of IN O
the DT O
two CD O
inter JJ O
- HYPH O
subunit NN O
interfaces NNS O
within IN O
the DT O
dimer NN O
, , O
one CD O
interface NN O
( , O
' `` O
interface NN O
A NN O
' '' O
) -RRB- O
between IN O
tip NN O
/ SYM O
center NN O
domains NNS O
is VBZ O
more RBR O
nonpolar JJ O
than IN O
the DT O
other JJ O
( , O
' `` O
interface NN O
B NN O
' '' O
) -RRB- O
between IN O
base NN O
domains NNS O
. . O

The DT O
structure NN O
allows VBZ O
us PRP O
to TO O
propose VB O
that IN O
the DT O
RdgC NNP O
dimer NN O
binds VBZ O
dsDNA NNP O
through IN O
the DT O
central JJ O
hole NN O
of IN O
~ $ O
30 CD O
A NN O
diameter NN O
. . O

The DT O
proposed VBN O
model NN O
is VBZ O
supported VBN O
by IN O
our PRP$ O
DNA NN O
- HYPH O
binding VBG O
assays NNS O
coupled VBN O
with IN O
mutagenesis NN O
, , O
which WDT O
indicate VBP O
that IN O
the DT O
conserved VBN O
positively RB O
charged VBN O
residues NNS O
on IN O
the DT O
protein NN O
surface VBP O
around IN O
the DT O
central JJ O
hole NN O
play VBP O
important JJ O
roles NNS O
in IN O
DNA NN O
binding NN O
. . O

The DT O
novel NN O
ring NN O
- HYPH O
shaped JJ O
architecture NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
has VBZ O
significant JJ O
implications NNS O
for IN O
its PRP$ O
role NN O
in IN O
homologous JJ O
recombination NN O
. . O

INTRODUCTION NN O

Homologous JJ O
recombination NN O
systems NNS O
contribute VBP O
to IN O
the DT O
maintenance NN O
of IN O
genome NN O
integrity NN O
and CC O
are VBP O
essential JJ O
for IN O
the DT O
repair NN O
of IN O
stalled VBN O
replication NN O
forks NNS O
( : O
1 CD O
) -RRB- O
. . O

Genetic JJ O
studies NNS O
of IN O
the DT O
recombination NN O
- HYPH O
dependent JJ O
growth NN O
C NN O
( -LRB- O
rdgC NN O
) -RRB- O
gene NN O
in IN O
bacterial JJ O
systems NNS O
have VBP O
suggested VBN O
that IN O
it PRP O
is VBZ O
involved VBN O
in IN O
DNA NN O
replication NN O
and CC O
recombination NN O
( , O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

In IN O
Neisseria NNP B-Species
gonorrhoeae NN I-Species
( , O
the DT O
gonococcus NN O
) -RRB- O
, , O
RdgC NNP O
is VBZ O
required VBN O
for IN O
efficient JJ O
pilin NN O
antigenic JJ O
variation NN O
and CC O
plays VBZ O
some DT O
role NN O
in IN O
cell NN O
growth NN O
( , O
4 CD O
, , O
5 CD O
) -RRB- O
. . O

The DT O
Escherichia NNP B-Species
coli NN I-Species
rdgC NN O
gene NN O
encodes VBZ O
a DT O
DNA NN O
- HYPH O
binding VBG O
protein NN O
of IN O
34 CD O
kDa NN O
, , O
whose WP$ O
expression NN O
level NN O
was VBD O
at IN O
its PRP$ O
highest JJS O
during IN O
exponential JJ O
phase NN O
, , O
reaching VBG O
its PRP$ O
maximum NN O
at IN O
~ $ O
1000 CD O
dimers NNS O
per IN O
cell NN O
( SYM O
2 CD O
) -RRB- O
. . O

Its PRP$ O
level NN O
decreased VBD O
sharply RB O
to IN O
~ $ O
50 CD O
dimers NNS O
per IN O
cell NN O
in IN O
stationary JJ O
phase NN O
. . O

This DT O
profile NN O
suggests VBZ O
that IN O
RdgC NNP O
might MD O
function VB O
during IN O
the DT O
period NN O
of IN O
DNA NNP O
replication NN O
( : O
2 CD O
) -RRB- O
. . O

The DT O
RecA NNP O
proteins NNS O
and CC O
their PRP$ O
homologs NNS O
play VBP O
a DT O
key JJ O
role NN O
in IN O
recombinational JJ O
DNA NN O
repair NN O
in IN O
bacteria NNS O
and CC O
eukaryotes NNS O
. . O

Their PRP$ O
aberrant JJ O
reactions NNS O
could MD O
result VB O
in IN O
gross JJ O
chromosomal JJ O
rearrangements NNS O
that WDT O
lead VBP O
to IN O
human JJ B-Species
diseases NNS O
, , O
including VBG O
cancer NN O
. . O

Therefore RB O
, , O
their PRP$ O
functions NNS O
must MD O
be VB O
tightly RB O
regulated VBN O
, , O
and CC O
understanding VBG O
how WRB O
the DT O
RecA NNP O
family NN O
of IN O
recombinases NNS O
is VBZ O
regulated VBN O
is VBZ O
of IN O
utmost JJ O
importance NN O
( : O
1 CD O
) -RRB- O
. . O

The DT O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
protein NN O
is VBZ O
a DT O
potential JJ O
negative JJ O
regulator NN O
of IN O
the DT O
function NN O
of IN O
RecA NNP O
( : O
1 CD O
) -RRB- O
. . O

It PRP O
inhibits VBZ O
RecA NNP O
- HYPH O
promoted VBN O
DNA NN O
strand NN O
exchange NN O
, , O
RecA NNP O
- HYPH O
mediated VBN O
ATPase NNP O
activity NN O
and CC O
RecA NNP O
- HYPH O
dependent JJ O
LexA NNP O
cleavage NN O
( -LRB- O
1 CD O
) -RRB- O
. . O

Sedimentation NN O
equilibrium NN O
data NNS O
indicated VBD O
that IN O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
exists VBZ O
in IN O
solution NN O
as IN O
a DT O
mixture NN O
of IN O
oligomeric JJ O
states NNS O
in IN O
equilibrium NN O
, , O
most RBS O
likely JJ O
monomers NNS O
, , O
dimers NNS O
and CC O
tetramers NNS O
( , O
1 CD O
) -RRB- O
. . O

This DT O
concentration NN O
- HYPH O
dependent JJ O
change NN O
in IN O
the DT O
oligomeric JJ O
state NN O
appears VBZ O
to TO O
affect VB O
its PRP$ O
mode NN O
of IN O
binding NN O
to IN O
DNA NN O
and CC O
its PRP$ O
capacity NN O
to TO O
inhibit VB O
RecA NNP O
( -LRB- O
1 CD O
) -RRB- O
. . O

The DT O
primary JJ O
mechanism NN O
of IN O
RdgC NNP O
inhibition NN O
appears VBZ O
to TO O
involve VB O
a DT O
simple JJ O
competition NN O
for IN O
DNA NN O
- HYPH O
binding VBG O
sites NNS O
, , O
especially RB O
on IN O
double JJ O
- HYPH O
stranded VBN O
DNA NNP O
( -LRB- O
dsDNA NNP O
) -RRB- O
( -LRB- O
1 CD O
) -RRB- O
. . O

Deletion NN O
of IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
rdgC NN O
gene NN O
alone RB O
causes VBZ O
no DT O
obvious JJ O
phenotype NN O
but CC O
is VBZ O
highly RB O
deleterious JJ O
in IN O
strains NNS O
lacking VBG O
certain JJ O
enzymes NNS O
involved VBN O
in IN O
recombination NN O
and CC O
replication NN O
restart NN O
( , O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

RdgC NNP O
is VBZ O
essential JJ O
for IN O
the DT O
growth NN O
of IN O
an DT O
E NN B-Species
. . I-Species
coli NN I-Species
strain NN O
lacking VBG O
PriA NNP O
, , O
indicating VBG O
that IN O
it PRP O
might MD O
affect VB O
replication NN O
fork NN O
progression NN O
or CC O
fork NN O
rescue NN O
( , O
2 CD O
) -RRB- O
. . O

PriA NNP O
provides VBZ O
a DT O
means NN O
to TO O
load VB O
the DT O
DnaB NNP O
replicative JJ O
helicase NN O
at IN O
DNA NN O
replication NN O
fork NN O
and CC O
D NN O
loop NN O
structures NNS O
( , O
2 CD O
) -RRB- O
. . O

RdgC NNP O
is VBZ O
, , O
therefore RB O
, , O
a DT O
key JJ O
factor NN O
in IN O
the DT O
rescue NN O
of IN O
stalled VBN O
or CC O
broken VBN O
forks NNS O
and CC O
subsequent JJ O
replication NN O
restart NN O
. . O

dnaC NNP O
suppressors NNS O
of IN O
PriA NNP O
can MD O
overcome VB O
this DT O
inviability NN O
, , O
especially RB O
when WRB O
RecF NNP O
, , O
RecO NNP O
or CC O
RecR NNP O
is VBZ O
inactivated VBN O
, , O
which WDT O
indicates VBZ O
that IN O
RdgC NNP O
avoids VBZ O
or CC O
counters VBZ O
the DT O
toxic JJ O
effect NN O
of IN O
these DT O
proteins NNS O
by IN O
limiting VBG O
inappropriate JJ O
RecA NNP O
loading NN O
on IN O
SSB NNP O
- HYPH O
coated VBN O
ssDNA NNP O
( -LRB- O
2 CD O
) -RRB- O
. . O

The DT O
DNA NN O
- HYPH O
binding VBG O
ability NN O
of IN O
the DT O
RdgC NNP O
protein NN O
has VBZ O
been VBN O
demonstrated VBN O
clearly RB O
using VBG O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
( -LRB- O
2 CD O
) -RRB- O
. . O

Escherichia NNP B-Species
coli NN I-Species
RdgC NNP O
binds VBZ O
non NNP O
- HYPH O
specifically RB O
to IN O
dsDNA NNP O
and CC O
with IN O
higher JJR O
affinity NN O
than IN O
ssDNA NNP O
( : O
2 CD O
) -RRB- O
. . O

RdgC NN O
from IN O
N NNP B-Species
. , I-Species
meningitidis NNP I-Species
also RB O
binds VBZ O
DNA NN O
with IN O
little JJ O
specificity NN O
for IN O
sequence NN O
or CC O
structure NN O
, , O
like IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
protein NN O
( , O
4 CD O
) -RRB- O
. . O

RdgC NNP O
exhibits VBZ O
no DT O
preference NN O
for IN O
DNA NN O
replication NN O
or CC O
recombination NN O
intermediates NNS O
( , O
2 CD O
) -RRB- O
. . O

However RB O
, , O
no DT O
detectable JJ O
domains NNS O
or CC O
nuclease JJ O
activity NN O
could MD O
be VB O
identified VBN O
for IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
protein NN O
( , O
2 CD O
, , O
6 CD O
) -RRB- O
. . O

The DT O
complexes NNS O
of IN O
E NNP B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
with IN O
both CC O
linear JJ O
and CC O
supercoiled VBN O
circular JJ O
plasmid NN O
DNA NNP O
were VBD O
imaged VBN O
using VBG O
atomic JJ O
force NN O
microscopy NN O
( , O
7 CD O
) -RRB- O
. . O

RdgC NNP O
was VBD O
found VBN O
to TO O
have VB O
an DT O
increased VBN O
affinity NN O
to IN O
DNA NN O
ends NNS O
and CC O
to TO O
promote VB O
bending NN O
of IN O
DNA NNP O
( : O
7 CD O
) -RRB- O
. . O

RdgC NNP O
has VBZ O
the DT O
effect NN O
on IN O
DNA NNP O
superstructure NN O
; , O
the DT O
promotion NN O
of IN O
DNA NN O
condensation NN O
was VBD O
observed VBN O
at IN O
high JJ O
protein NN O
concentrations NNS O
( SYM O
7 CD O
) -RRB- O
. . O

Recombination NN O
is VBZ O
largely RB O
enhanced VBN O
by IN O
close JJ O
contacts NNS O
of IN O
distant JJ O
regions NNS O
along IN O
the DT O
DNA NN O
strands NNS O
through IN O
condensation NN O
( : O
7 CD O
) -RRB- O
. . O

Pseudomonas NNP B-Species
aeruginosa NN I-Species
is VBZ O
a DT O
ubiquitous JJ O
environmental JJ O
Gram NNP O
- HYPH O
negative JJ O
bacterium NN O
that WDT O
belongs VBZ O
to IN O
the DT O
gamma NN O
subdivision NN O
of IN O
the DT O
Proteobacteria NNP O
. . O

Orthologs NNS O
of IN O
the DT O
rdgC NN O
gene NN O
are VBP O
found VBN O
only RB O
in IN O
beta NN O
and CC O
gamma NN O
subdivisions NNS O
of IN O
the DT O
Proteobacteria NNP O
( -LRB- O
2 CD O
) -RRB- O
. . O

The DT O
amino JJ O
acid NN O
sequence NN O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
, , O
a DT O
306 CD O
- HYPH O
residue NN O
protein NN O
, , O
shows VBZ O
46 CD O
and CC O
36 CD O
% NN O
identities NNS O
against IN O
those DT O
of IN O
E NNP B-Species
. . I-Species
coli NN I-Species
and CC O
N NNP B-Species
. . I-Species
meningitidis NN I-Species
, , O
respectively RB O
. . O

Despite IN O
the DT O
importance NN O
of IN O
DNA NN O
- HYPH O
binding VBG O
ability NN O
of IN O
RdgC NNP O
in IN O
its PRP$ O
biological JJ O
roles NNS O
, , O
the DT O
structural JJ O
details NNS O
of IN O
RdgC NNP O
and CC O
the DT O
mechanism NN O
of IN O
its PRP$ O
action NN O
remain VBP O
unclear JJ O
. . O

Here RB O
, , O
we PRP O
report VBP O
the DT O
crystal NN O
structure NN O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
as IN O
determined VBN O
by IN O
the DT O
multiwavelength JJ O
anomalous JJ O
diffraction NN O
( -LRB- O
MAD NNP O
) -RRB- O
method NN O
of IN O
X NN O
- HYPH O
ray NN O
crystallography NN O
. . O

It PRP O
reveals VBZ O
that IN O
RdgC NNP O
dimer NN O
is VBZ O
ring NN O
- HYPH O
shaped JJ O
, , O
with IN O
a DT O
central JJ O
hole NN O
of IN O
~ $ O
30 CD O
A NN O
diameter NN O
. . O

The DT O
inside JJ O
surface NN O
around IN O
the DT O
central JJ O
hole NN O
is VBZ O
rich JJ O
in IN O
conserved JJ O
, , O
positively RB O
charged VBN O
residues NNS O
, , O
which WDT O
are VBP O
implicated VBN O
in IN O
DNA NN O
- HYPH O
binding NN O
by IN O
mutagenesis NN O
. . O

We PRP O
propose VBP O
that IN O
dsDNA NNP O
binds NNS O
to IN O
RdgC NNP O
through IN O
this DT O
central JJ O
hole NN O
. . O

Our PRP$ O
structure NN O
provides VBZ O
a DT O
solid JJ O
structural JJ O
framework NN O
for IN O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
role NN O
of IN O
RdgC NNP O
in IN O
homologous JJ O
recombination NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Protein NN O
expression NN O
and CC O
purification NN O

The DT O
rdgC NN O
gene NN O
( -LRB- O
PA3263 NN O
) -RRB- O
was VBD O
amplified VBN O
by IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
( , O
PCR NN O
) -RRB- O
using VBG O
the DT O
genomic JJ O
DNA NN O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
strain NN O
PAO1 NN O
as IN O
a DT O
template NN O
. . O

The DT O
oligonucleotide NN O
primers NNS O
designed VBN O
using VBG O
the DT O
published VBN O
genome NN O
sequence NN O
( , O
8 CD O
) -RRB- O
were VBD O
5 CD O
' '' O
- HYPH O
G NNP O
GAA NNP O
TTC NNP O
CAT NNP O
ATG NNP O
TGG NNP O
TTC NNP O
CGC NNP O
AAT NNP O
CTG NNP O
CTC NNP O
G NNP O
- HYPH O
3 CD O
' '' O
( : O
forward RB O
) -RRB- O
and CC O
5 CD O
' '' O
- HYPH O
CCG NN O
CCG NN O
CTC NNP O
GAG NNP O
GAC NNP O
GCC NNP O
CTG NNP O
GGG NNP O
GAT NNP O
TTC NNP O
TTC NNP O
- HYPH O
3 CD O
' '' O
( : O
reverse NN O
) -RRB- O
. . O

The DT O
bases NNS O
in IN O
bold JJ O
denote VBP O
the DT O
NdeI NNP O
and CC O
XhoI NNP O
cleavage NN O
sites NNS O
, , O
respectively RB O
. . O

The DT O
PCR NNP O
product NN O
was VBD O
digested VBN O
with IN O
NdeI NNP O
and CC O
XhoI NNP O
, , O
and CC O
was VBD O
then RB O
inserted VBN O
into IN O
the DT O
NdeI NNP O
/ SYM O
XhoI NNP O
- HYPH O
digested VBN O
expression NN O
vector NN O
pET NN O
- HYPH O
21a CD O
( , O
+ CC O
) -RRB- O
( : O
Novagen NNP O
) -RRB- O
. . O

This DT O
vector NN O
construction NN O
adds VBZ O
an DT O
eight CD O
- HYPH O
residue NN O
tag NN O
( , O
LEHHHHHH NNP O
) -RRB- O
to IN O
the DT O
carboxyl NN O
terminus NN O
of IN O
the DT O
gene NN O
product NN O
to TO O
facilitate VB O
protein NN O
purification NN O
. . O

The DT O
protein NN O
was VBD O
expressed VBN O
in IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
C41 NNP O
( -LRB- O
DE3 NNP O
) -RRB- O
cells NNS O
( SYM O
9 CD O
) -RRB- O
. . O

The DT O
cells NNS O
were VBD O
grown VBN O
at IN O
37 CD O
degrees NNS O
C NN O
up IN O
to IN O
OD600 CD O
of IN O
0 CD O
. . O
6 CD O
in IN O
Luria NNP O
- HYPH O
Bertani NNP O
medium NN O
that WDT O
contained VBD O
50 CD O
mu NNS O
g NN O
ml NN O
- HYPH O
1 CD O
ampicillin NN O
, , O
and CC O
the DT O
protein NN O
expression NN O
was VBD O
induced VBN O
by IN O
0 CD O
. . O
5 CD O
mM NN O
isopropyl NN O
- HYPH O
beta NN O
- HYPH O
d NN O
- HYPH O
thiogalactopyranosid NN O
( : O
IPTG NNP O
) -RRB- O
. . O

The DT O
cells NNS O
were VBD O
allowed VBN O
to TO O
grow VB O
at IN O
20 CD O
degrees NNS O
C NN O
for IN O
22 CD O
h NN O
after IN O
IPTG NNP O
induction NN O
and CC O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
at IN O
4200 CD O
g CD O
( SYM O
6000 CD O
rev NN O
min NN O
- HYPH O
1 CD O
; : O
Sorvall NNP O
GSA NNP O
rotor NN O
) -RRB- O
for IN O
10 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

The DT O
cell NN O
pellet NN O
was VBD O
resuspended VBN O
in IN O
an DT O
ice NN O
- HYPH O
cold JJ O
lysis NN O
buffer NN O
[ -LRB- O
20 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
9 CD O
) -RRB- O
, , O
500 CD O
mM NN O
sodium NN O
chloride NN O
, , O
5 CD O
mM NN O
imidazole NN O
] -RRB- O
and CC O
was VBD O
then RB O
homogenized VBN O
with IN O
an DT O
ultrasonic JJ O
processor NN O
. . O

The DT O
crude JJ O
cell NN O
extract NN O
was VBD O
centrifuged VBN O
at IN O
36 CD O
0 CD O
g CD O
( SYM O
18 CD O
0 CD O
rev NN O
min NN O
- HYPH O
1 CD O
; : O
Hanil NNP O
Supra NNP O
21 CD O
K NN O
rotor NN O
) -RRB- O
for IN O
60 CD O
min NN O
at IN O
4 CD O
degrees NNS O
C NN O
, , O
and CC O
the DT O
recombinant JJ O
protein NN O
in IN O
the DT O
supernatant JJ O
fraction NN O
was VBD O
purified VBN O
in IN O
three CD O
chromatographic JJ O
steps NNS O
. . O

The DT O
first JJ O
purification NN O
step NN O
utilized VBD O
the DT O
C NNP O
- HYPH O
terminal JJ O
hexahistidine NN O
- HYPH O
tag NN O
by IN O
Ni2 NNP O
+ SYM O
- HYPH O
chelated VBN O
HiTrap NNP O
chelating NN O
column NN O
( : O
GE NNP O
Healthcare NNP O
) -RRB- O
. . O

The DT O
eluent NN O
was VBD O
diluted VBN O
3 CD O
- HYPH O
fold NN O
with IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
at IN O
pH NN O
7 CD O
. . O
4 CD O
. . O

The DT O
diluted JJ O
solution NN O
was VBD O
applied VBN O
to IN O
a DT O
20 CD O
- HYPH O
ml NN O
heparin NN O
- HYPH O
Sepharose NNP O
column NN O
( : O
GE NNP O
Healthcare NNP O
) -RRB- O
, , O
which WDT O
was VBD O
previously RB O
equilibrated VBN O
with IN O
a DT O
buffer NN O
of IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
, , O
1 CD O
mM NN O
dithiothreitol NN O
and CC O
1 CD O
mM NN O
EDTA NNP O
. . O

The DT O
protein NN O
was VBD O
eluted VBN O
with IN O
a DT O
linear JJ O
gradient NN O
of IN O
0 CD O
- SYM O
2 CD O
. . O
0 CD O
M NN O
sodium NN O
chloride NN O
in IN O
the DT O
same JJ O
buffer NN O
. . O

The DT O
first JJ O
peak NN O
corresponded VBD O
to IN O
high JJ O
molecular JJ O
aggregates NNS O
of IN O
RdgC NNP O
and CC O
the DT O
second JJ O
peak NN O
to IN O
RdgC NNP O
dimers NNS O
, , O
which WDT O
was VBD O
also RB O
consistent JJ O
with IN O
our PRP$ O
dynamic JJ O
light JJ O
scattering NN O
measurements NNS O
. . O

When WRB O
the DT O
aggregates NNS O
were VBD O
not RB O
separated VBN O
from IN O
the DT O
dimers NNS O
, , O
the DT O
protein NN O
readily RB O
aggregated VBD O
within IN O
a DT O
day NN O
. . O

The DT O
dimer NN O
fractions NNS O
were VBD O
concentrated VBN O
to IN O
~ $ O
6 CD O
mg CD O
ml CD O
- HYPH O
1 CD O
concentration NN O
using VBG O
an DT O
YM10 NN O
ultrafiltration NN O
membrane NN O
( , O
Millipore NNP O
- HYPH O
Amicon NNP O
) -RRB- O
and CC O
further RB O
purified VBN O
by IN O
gel NN O
filtration NN O
on IN O
a DT O
HiLoad NNP O
XK NNP O
16 CD O
Superdex NNP O
200 CD O
prep NN O
- HYPH O
grade NN O
column NN O
( , O
GE NNP O
Healthcare NNP O
) -RRB- O
, , O
which WDT O
was VBD O
previously RB O
equilibrated VBN O
with IN O
a DT O
buffer NN O
of IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
, , O
200 CD O
mM NN O
sodium NN O
chloride NN O
, , O
1 CD O
mM NN O
dithiothreitol NN O
and CC O
1 CD O
mM NN O
EDTA NNP O
. . O

The DT O
first JJ O
peak NN O
corresponding VBG O
to IN O
the DT O
high JJ O
molecular JJ O
aggregates NNS O
of IN O
RdgC NNP O
was VBD O
only RB O
a DT O
minor JJ O
component NN O
, , O
and CC O
the DT O
second JJ O
peak NN O
corresponding VBG O
to IN O
RdgC NNP O
dimers NNS O
was VBD O
stable JJ O
for IN O
several JJ O
weeks NNS O
when WRB O
frozen VBN O
at IN O
- HYPH O
70 CD O
degrees NNS O
C NN O
. . O

The DT O
procedure NN O
for IN O
purifying VBG O
the DT O
SeMet NNP O
- HYPH O
substituted VBN O
protein NN O
was VBD O
the DT O
same JJ O
, , O
except IN O
for IN O
the DT O
presence NN O
of IN O
10 CD O
mM NN O
dithiothreitol NN O
in IN O
all DT O
buffers NNS O
used VBN O
during IN O
purification NN O
steps NNS O
. . O

Dynamic JJ O
light JJ O
scattering NN O
experiments NNS O
were VBD O
performed VBN O
at IN O
24 CD O
degrees NNS O
C NN O
, , O
with IN O
the DT O
protein NN O
( , O
at IN O
2 CD O
mg NN O
ml CD O
- HYPH O
1 CD O
concentration NN O
) , O
dissolved VBN O
in IN O
a DT O
buffer NN O
consisting VBG O
of IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
, , O
1 CD O
mM NN O
dithiothreitol NN O
, , O
1 CD O
mM NN O
EDTA NN O
and CC O
200 CD O
mM NN O
sodium NN O
chloride NN O
on IN O
a DT O
Model NNP O
DynaPro NNP O
- HYPH O
801 CD O
instrument NN O
( , O
Wyatt NNP O
, , O
Santa NNP O
Barbara NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
protein NN O
concentration NN O
was VBD O
estimated VBN O
by IN O
measuring VBG O
the DT O
absorbance NN O
at IN O
280 CD O
nm NN O
, , O
employing VBG O
the DT O
calculated VBN O
extinction NN O
coefficient NN O
of IN O
20 CD O
910 CD O
M NN O
- HYPH O
1 CD O
cm NN O
- HYPH O
1 CD O
( HYPH O
SWISS NNP O
- HYPH O
PROT NN O
; : O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
expasy NN O
. . O
ch NN O
/ , O
) -RRB- O
. . O

Mutagenesis NN O
and CC O
electrophoretic JJ O
mobility NN O
shift VBP O
assay NN O

Point NN O
mutants NNS O
were VBD O
prepared VBN O
using VBG O
the DT O
QuikChange NNP O
Site NNP O
- HYPH O
Directed NNP O
Mutagenesis NNP O
kit NN O
( , O
Stratagene NNP O
) -RRB- O
, , O
and CC O
the DT O
mutations NNS O
were VBD O
confirmed VBN O
by IN O
DNA NNP O
sequencing NN O
. . O

The DT O
seven CD O
mutants NNS O
R4A NNP O
, , O
F120A NNP O
, , O
K146A NNP O
, , O
R198A NNP O
, , O
R208A NNP O
, , O
Q212A NNP O
and CC O
R252A NNP O
were VBD O
well RB O
expressed JJ O
and CC O
soluble JJ O
. . O

The DT O
three CD O
mutants NNS O
K70A NNP O
, , O
R81A NNP O
and CC O
R211A NNP O
were VBD O
not RB O
expressed VBN O
, , O
while IN O
R122A NNP O
mutant NN O
was VBD O
expressed VBN O
but CC O
was VBD O
not RB O
soluble JJ O
. . O

Therefore RB O
, , O
we PRP O
mutated VBD O
Lys70 NNP O
, , O
Arg81 NNP O
, , O
Arg122 NNP O
and CC O
Arg211 NNP O
into IN O
aspartate NN O
. . O

The DT O
K70D NNP O
, , O
R81D NNP O
, , O
R122D NNP O
and CC O
R211D NNP O
mutants NNS O
were VBD O
well RB O
expressed JJ O
and CC O
soluble JJ O
. . O

The DT O
soluble JJ O
mutants NNS O
were VBD O
expressed VBN O
and CC O
purified VBN O
under IN O
the DT O
conditions NNS O
identical JJ O
to IN O
those DT O
for IN O
the DT O
wild JJ O
type NN O
, , O
except IN O
that IN O
the DT O
heparin NN O
- HYPH O
Sepharose NNP O
column NN O
step NN O
was VBD O
omitted VBN O
. . O

All DT O
of IN O
the DT O
soluble JJ O
mutants NNS O
had VBD O
similar JJ O
elution NN O
profiles NNS O
as IN O
the DT O
wild JJ O
type NN O
upon IN O
gel NN O
filtration NN O
, , O
and CC O
the DT O
dimer NN O
fractions NNS O
were VBD O
used VBN O
for IN O
DNA NN O
- HYPH O
binding VBG O
assays NNS O
. . O

We PRP O
mixed VBD O
5 CD O
mu NNS O
l NN O
of IN O
RdgC NNP O
( SYM O
1 CD O
. . O
1 CD O
mu NN O
g NN O
mu NN O
l NN O
- HYPH O
1 CD O
) SYM O
and CC O
5 CD O
mu NN O
l NN O
of IN O
a DT O
linear JJ O
dsDNA NN O
with IN O
414 CD O
bp NNS O
( SYM O
63 CD O
ng NN O
mu NNS O
l CC O
- HYPH O
1 CD O
) -RRB- O
, , O
corresponding VBG O
to IN O
the DT O
molar JJ O
ratio NN O
of IN O
64 CD O
: : O
1 CD O
for IN O
RdgC NNP O
dimer NN O
to IN O
dsDNA NNP O
. . O

The DT O
reaction NN O
mixtures NNS O
were VBD O
incubated VBN O
for IN O
10 CD O
min NN O
at IN O
room NN O
temperature NN O
. . O

RdgC NNP O
- HYPH O
DNA NNP O
complexes NNS O
were VBD O
analyzed VBN O
by IN O
1 CD O
. . O
5 CD O
% NN O
( HYPH O
w NN O
/ SYM O
v NN O
) , O
agarose JJ O
gel NN O
electrophoresis NN O
in IN O
1 CD O
x SYM O
TAE NNP O
buffer NN O
( SYM O
45 CD O
mM NN O
Tris NN O
- HYPH O
acetate NN O
at IN O
pH NN O
8 CD O
. . O
3 CD O
, , O
1 CD O
mM NN O
EDTA NNP O
) -RRB- O
. . O

DNA NN O
bands NNS O
were VBD O
visualized VBN O
by IN O
ethidium NN O
bromide NN O
staining VBG O
. . O

For IN O
DNA NN O
- HYPH O
binding VBG O
assays NNS O
, , O
the DT O
protein NN O
concentration NN O
was VBD O
measured VBN O
with IN O
a DT O
Bio NNP O
- HYPH O
Rad NNP O
protein NN O
assay NN O
kit NN O
. . O

Crystallization NN O
and CC O
X NN O
- HYPH O
ray NN O
data NN O
collection NN O

Crystals NNS O
were VBD O
grown VBN O
by IN O
the DT O
hanging NN O
- HYPH O
drop NN O
vapor NN O
diffusion NN O
method NN O
at IN O
24 CD O
degrees NNS O
C NN O
by IN O
mixing VBG O
equal JJ O
volumes NNS O
( : O
2 CD O
mu NNS O
l NN O
each DT O
) -RRB- O
of IN O
the DT O
protein NN O
solution NN O
( , O
at IN O
19 CD O
mg NN O
ml CD O
- HYPH O
1 CD O
concentration NN O
in IN O
a DT O
buffer NN O
consisting VBG O
of IN O
50 CD O
mM NN O
Tris NNP O
- HYPH O
HCl NNP O
( , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
, , O
1 CD O
mM NN O
dithiothreitol NN O
, , O
1 CD O
mM NN O
EDTA NN O
and CC O
200 CD O
mM NN O
sodium NN O
chloride NN O
) -RRB- O
and CC O
the DT O
reservoir NN O
solution NN O
. . O

To TO O
grow VB O
the DT O
native JJ O
crystals NNS O
, , O
we PRP O
used VBD O
a DT O
reservoir NN O
solution NN O
consisting VBG O
of IN O
0 CD O
. . O
1 CD O
M NN O
sodium NN O
HEPES NN O
( : O
pH NN O
7 CD O
. . O
5 CD O
) -RRB- O
, , O
1 CD O
. . O
0 CD O
M NN O
tri NN O
- HYPH O
sodium NN O
citrate NN O
and CC O
1 CD O
% NN O
( , O
w NN O
/ SYM O
v NN O
) SYM O
Anapoe NNP O
( -LRB- O
R NN O
) SYM O
35 CD O
as IN O
the DT O
detergent NN O
. . O

Native JJ O
crystals NNS O
grew VBD O
to IN O
approximate JJ O
dimensions NNS O
of IN O
0 CD O
. . O
2 CD O
mm NN O
x SYM O
0 CD O
. . O
1 CD O
mm NN O
x SYM O
0 CD O
. . O
1 CD O
mm NN O
within IN O
a DT O
few JJ O
days NNS O
. . O

The DT O
SeMet NNP O
- HYPH O
substituted VBN O
protein NN O
was VBD O
crystallized VBN O
under IN O
conditions NNS O
identical JJ O
to IN O
those DT O
for IN O
the DT O
native JJ O
crystals NNS O
except IN O
for IN O
the DT O
presence NN O
of IN O
10 CD O
mM NN O
dithiothreitol NN O
in IN O
the DT O
protein NN O
solution NN O
. . O

A DT O
crystal NN O
of IN O
the DT O
SeMet NNP O
- HYPH O
substituted VBN O
protein NN O
was VBD O
dipped VBN O
into IN O
a DT O
cryoprotectant NN O
solution NN O
for IN O
a DT O
few JJ O
seconds NNS O
and CC O
was VBD O
flash NN O
- HYPH O
cooled VBN O
in IN O
the DT O
cold JJ O
nitrogen NN O
gas NN O
stream NN O
at IN O
100 CD O
K NN O
. . O

The DT O
cryoprotectant NN O
solution NN O
consisted VBD O
of IN O
0 CD O
. . O
1 CD O
M NN O
sodium NN O
HEPES NN O
( : O
pH NN O
7 CD O
. . O
5 CD O
) -RRB- O
, , O
1 CD O
. . O
0 CD O
M NN O
tri NN O
- HYPH O
sodium NN O
citrate NN O
, , O
1 CD O
% NN O
( , O
w NN O
/ SYM O
v NN O
) : O
Anapoe NN O
( -LRB- O
R NN O
) SYM O
35 CD O
as IN O
the DT O
detergent NN O
and CC O
10 CD O
% NN O
( , O
v NN O
/ SYM O
v NN O
) NFP O
glycerol NN O
. . O

A DT O
set NN O
of IN O
Se NNP O
MAD NNP O
data NNS O
was VBD O
collected VBN O
at IN O
100 CD O
K NN O
at IN O
three CD O
different JJ O
wavelengths NNS O
using VBG O
an DT O
Area NNP O
Detector NNP O
System NNP O
Corporation NNP O
Quantum NNP O
210 CD O
charge NN O
- HYPH O
coupled VBN O
device NN O
detector NN O
at IN O
the DT O
beamline NN O
NW12A NNP O
of IN O
Photon NNP O
Factory NNP O
, , O
Tsukuba NNP O
, , O
Japan NNP O
. . O

The DT O
crystal NN O
was VBD O
rotated VBN O
through IN O
a DT O
total NN O
of IN O
180 CD O
degrees NNS O
with IN O
a DT O
1 CD O
degrees NNS O
oscillation NN O
range NN O
per IN O
frame NN O
. . O

The DT O
raw JJ O
data NNS O
were VBD O
processed VBN O
and CC O
scaled VBN O
using VBG O
the DT O
program NN O
suit NN O
HKL2000 NNP O
( SYM O
10 CD O
) -RRB- O
. . O

The DT O
SeMet NNP O
- HYPH O
substituted VBN O
crystal NN O
belongs VBZ O
to IN O
the DT O
space NN O
group NN O
P21212 CD O
, , O
with IN O
unit NN O
cell NN O
parameters NNS O
of IN O
a DT O
= SYM O
87 CD O
. . O
4 CD O
A NN O
, , O
b NN O
= SYM O
115 CD O
. . O
60 CD O
A NN O
and CC O
c NN O
= SYM O
76 CD O
. . O
7 CD O
A NN O
. . O

The DT O
native JJ O
crystals NNS O
were VBD O
soaked VBN O
for IN O
10 CD O
min NN O
in IN O
10 CD O
mM NN O
ethyl NN O
mercury NN O
thiosalicylate NN O
( , O
EMTS NNP O
) -RRB- O
to TO O
collect VB O
a DT O
set NN O
of IN O
Hg NNP O
MAD NNP O
data NNS O
at IN O
four CD O
different JJ O
wavelengths NNS O
. . O

X NN O
- HYPH O
ray NN O
diffraction NN O
data NNS O
from IN O
the DT O
EMTS NNP O
- HYPH O
derivatized VBN O
crystal NN O
, , O
as RB O
well RB O
as IN O
a DT O
native JJ O
crystal NN O
, , O
were VBD O
collected VBN O
on IN O
a DT O
Bruker NNP O
charge NN O
- HYPH O
coupled VBN O
device NN O
detector NN O
at IN O
the DT O
beamline NN O
BL NNP O
- HYPH O
6B NNP O
of IN O
Pohang NNP O
Light NNP O
Source NNP O
, , O
Pohang NNP O
, , O
Korea NNP O
. . O

The DT O
EMTS NNP O
- HYPH O
soaked VBN O
crystal NN O
belongs VBZ O
to IN O
the DT O
space NN O
group NN O
P21212 CD O
, , O
with IN O
unit NN O
cell NN O
parameters NNS O
of IN O
a DT O
= SYM O
87 CD O
. . O
16 CD O
A NN O
, , O
b NN O
= SYM O
116 CD O
. . O
2 CD O
A NN O
and CC O
c NN O
= SYM O
74 CD O
. . O
97 CD O
A NN O
. . O

The DT O
native JJ O
crystal NN O
belongs VBZ O
to IN O
the DT O
space NN O
group NN O
P21212 CD O
, , O
with IN O
unit NN O
cell NN O
parameters NNS O
of IN O
a DT O
= SYM O
87 CD O
. . O
49 CD O
A NN O
, , O
b NN O
= SYM O
116 CD O
. . O
4 CD O
A NN O
and CC O
c NN O
= SYM O
76 CD O
. . O
3 CD O
A NN O
. . O

If IN O
the DT O
presence NN O
of IN O
a DT O
dimeric JJ O
molecule NN O
in IN O
the DT O
asymmetric JJ O
unit NN O
is VBZ O
assumed VBN O
, , O
the DT O
calculated VBN O
crystal NN O
volume NN O
per IN O
protein NN O
mass NN O
( -LRB- O
VM NN O
) -RRB- O
is VBZ O
2 CD O
. . O
75 CD O
A NN O
3 CD O
Da NN O
- HYPH O
1 CD O
and CC O
the DT O
solvent JJ O
content NN O
is VBZ O
55 CD O
. . O
3 CD O
% NN O
. . O

Supplementary JJ O
Table NN O
1 CD O
summarizes VBZ O
the DT O
statistics NNS O
of IN O
X NNP O
- HYPH O
ray NN O
diffraction NN O
data NNS O
collection NN O
. . O

Structure NN O
solution NN O
and CC O
refinement NN O

Heavy JJ O
atom NN O
sites NNS O
were VBD O
located VBN O
with IN O
the DT O
program NN O
SOLVE NNP O
( -LRB- O
11 CD O
) -RRB- O
. . O

Four CD O
Se JJ O
sites NNS O
from IN O
the DT O
SeMet NNP O
- HYPH O
substituted VBN O
crystal NN O
and CC O
two CD O
Hg JJ O
sites NNS O
from IN O
the DT O
EMTS NNP O
- HYPH O
soaked VBN O
crystal NN O
were VBD O
located VBN O
. . O

Two CD O
sets NNS O
of IN O
the DT O
initial JJ O
Se NNP O
and CC O
Hg NNP O
MAD NNP O
phases NNS O
were VBD O
separately RB O
improved VBN O
using VBG O
the DT O
program NN O
RESOLVE NNP O
( SYM O
12 CD O
) -RRB- O
. . O

Two CD O
electron NN O
density NN O
maps NNS O
were VBD O
independently RB O
interpreted VBN O
, , O
and CC O
the DT O
fragments NNS O
of IN O
the DT O
two CD O
models NNS O
were VBD O
combined VBN O
into IN O
a DT O
single JJ O
model NN O
, , O
since IN O
the DT O
two CD O
maps NNS O
were VBD O
complementary JJ O
to IN O
each DT O
other JJ O
. . O

Non JJ O
- HYPH O
crystallographic JJ O
symmetry NN O
( , O
NCS NNP O
) -RRB- O
matrices NNS O
were VBD O
found VBN O
from IN O
a DT O
partial JJ O
model NN O
built VBN O
from IN O
the DT O
initial JJ O
electron NN O
density NN O
map NN O
, , O
and CC O
phases NNS O
were VBD O
further RB O
improved VBN O
by IN O
the DT O
2 CD O
- HYPH O
fold NN O
NCS NNP O
averaging VBG O
, , O
solvent JJ O
flattening NN O
and CC O
histogram NN O
matching NN O
with IN O
the DT O
program NN O
DM NN O
( SYM O
13 CD O
) -RRB- O
. . O

The DT O
model NN O
was VBD O
built VBN O
with IN O
O NNP O
( HYPH O
14 CD O
) -RRB- O
. . O

The DT O
model NN O
was VBD O
refined VBN O
with IN O
the DT O
program NN O
CNS NNP O
( -LRB- O
15 CD O
) -RRB- O
, , O
including VBG O
the DT O
bulk NN O
solvent JJ O
correction NN O
. . O

10 CD O
% NN O
of IN O
the DT O
data NNS O
were VBD O
randomly RB O
set VBN O
aside RB O
as IN O
the DT O
test NN O
data NNS O
for IN O
the DT O
calculation NN O
of IN O
Rfree NNP O
( HYPH O
16 CD O
) -RRB- O
. . O

Several JJ O
rounds NNS O
of IN O
model NN O
building NN O
, , O
simulated VBN O
annealing NN O
, , O
positional JJ O
refinement NN O
and CC O
individual JJ O
B NN O
- HYPH O
factor NN O
refinement NN O
were VBD O
performed VBN O
. . O

Subsequently RB O
, , O
this DT O
model NN O
was VBD O
used VBN O
to TO O
refine VB O
the DT O
structure NN O
of IN O
the DT O
native JJ O
protein NN O
. . O

The DT O
model NN O
has VBZ O
excellent JJ O
stereochemistry NN O
, , O
as IN O
evaluated VBN O
by IN O
the DT O
program NN O
PROCHECK NNP O
( : O
17 CD O
) -RRB- O
. . O

Refinement NN O
statistics NNS O
are VBP O
summarized VBN O
in IN O
Supplementary NNP O
Table NNP O
1 CD O
. . O

RESULTS NNS O
AND CC O
DISCUSSION NN O

Model NN O
quality NN O
and CC O
monomer NN O
structure NN O

The DT O
structure NN O
of IN O
P NNP B-Species
. , I-Species
aeruginosa NN I-Species
RdgC NNP O
was VBD O
solved VBN O
using VBG O
two CD O
sets NNS O
of IN O
MAD NNP O
data NNS O
collected VBN O
from IN O
a DT O
crystal NN O
of IN O
the DT O
selenomethionine NN O
( HYPH O
SeMet NNP O
) -RRB- O
- HYPH O
substituted VBN O
protein NN O
and CC O
from IN O
a DT O
mercury NN O
derivative JJ O
crystal NN O
of IN O
the DT O
native JJ O
protein NN O
( -LRB- O
Supplementary NNP O
Table NNP O
1 CD O
) -RRB- O
. . O

The DT O
model NN O
has VBZ O
subsequently RB O
been VBN O
refined VBN O
using VBG O
the DT O
20 CD O
. . O
0 CD O
- HYPH O
2 CD O
. . O
50 CD O
A NN O
data NN O
from IN O
a DT O
native JJ O
crystal NN O
to IN O
crystallographic JJ O
Rwork NN O
and CC O
Rfree JJ O
values NNS O
of IN O
23 CD O
. . O
4 CD O
and CC O
27 CD O
. . O
9 CD O
% NN O
, , O
respectively RB O
, , O
with IN O
no DT O
sigma NN O
cut VBN O
- HYPH O
off NN O
. . O

The DT O
refined JJ O
model NN O
contains VBZ O
612 CD O
residues NNS O
of IN O
the DT O
two CD O
monomers NNS O
in IN O
the DT O
asymmetric JJ O
unit NN O
of IN O
the DT O
crystal NN O
( , O
residues NNS O
1 CD O
- HYPH O
306 CD O
for IN O
both DT O
chains NNS O
A NN O
and CC O
B NN O
) -RRB- O
and CC O
87 CD O
water NN O
molecules NNS O
. . O

The DT O
C NNP O
- HYPH O
terminal JJ O
eight CD O
- HYPH O
residue NN O
fusion NN O
tag NN O
has VBZ O
no DT O
electron NN O
density NN O
in IN O
both DT O
subunits NNS O
and CC O
has VBZ O
not RB O
been VBN O
modeled VBN O
. . O

Conformations NNS O
of IN O
the DT O
two CD O
monomers NNS O
in IN O
the DT O
asymmetric JJ O
unit NN O
are VBP O
similar JJ O
. . O

The DT O
root NN O
- HYPH O
mean JJ O
- HYPH O
square JJ O
( , O
r UH O
. . O
m UH O
. . O
s NN O
. . O
) -RRB- O
difference NN O
between IN O
the DT O
two CD O
monomers NNS O
is VBZ O
0 CD O
. . O
69 CD O
A NN O
for IN O
306 CD O
C NN O
alpha NN O
atom NN O
pairs NNS O
, , O
with IN O
a DT O
maximum JJ O
deviation NN O
of IN O
8 CD O
. . O
8 CD O
A NN O
for IN O
the DT O
C NN O
alpha NN O
atom NN O
of IN O
Gly305 CD O
. . O

The DT O
residues NNS O
giving VBG O
r DT O
. . O
m UH O
. . O
s NFP O
. . O
differences NNS O
larger JJR O
than IN O
2 CD O
. . O
0 CD O
A NN O
are VBP O
14 CD O
- SYM O
16 CD O
, , O
94 CD O
- HYPH O
96 CD O
, , O
201 CD O
- HYPH O
202 CD O
and CC O
303 CD O
- HYPH O
306 CD O
, , O
which WDT O
correspond VBP O
to IN O
loops NNS O
connecting VBG O
secondary JJ O
structure NN O
elements NNS O
or CC O
the DT O
C NNP O
- HYPH O
terminus NN O
. . O

They PRP O
are VBP O
located VBN O
on IN O
the DT O
surface NN O
of IN O
the DT O
dimer NN O
. . O

Subunit NNP O
A NNP O
has VBZ O
a DT O
better JJR O
map NN O
quality NN O
than IN O
subunit NN O
B NN O
, , O
and CC O
thus RB O
has VBZ O
a DT O
lower JJR O
mean JJ O
B NN O
- HYPH O
factor NN O
than IN O
subunit NN O
B NN O
( : O
40 CD O
. . O
3 CD O
A NN O
2 CD O
versus IN O
. . O
56 CD O
. . O
1 CD O
A NN O
2 CD O
for IN O
all DT O
4788 CD O
atoms NNS O
) -RRB- O
( : O
Supplementary JJ O
Figure NN O
1 CD O
) -RRB- O
. . O

Therefore RB O
, , O
subunit NN O
A NNP O
is VBZ O
chosen VBN O
for IN O
discussions NNS O
, , O
unless IN O
otherwise RB O
stated VBN O
. . O

The DT O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
monomer NN O
is VBZ O
J NN O
- HYPH O
shaped JJ O
and CC O
has VBZ O
approximate JJ O
dimensions NNS O
of IN O
72 CD O
A NN O
x SYM O
60 CD O
A NN O
x SYM O
40 CD O
A NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

It PRP O
can MD O
be VB O
divided VBN O
into IN O
three CD O
structural JJ O
domains NNS O
: : O
center NN O
domain NN O
, , O
tip NN O
domain NN O
and CC O
base NN O
domain NN O
. . O

Center NN O
domain NN O
( : O
residues NNS O
1 CD O
- HYPH O
73 CD O
and CC O
121 CD O
- HYPH O
167 CD O
) -RRB- O
includes VBZ O
a DT O
six CD O
- HYPH O
stranded JJ O
anti JJ O
- HYPH O
parallel JJ O
beta NN O
- HYPH O
sheet NN O
with IN O
two CD O
flanking VBG O
alpha NN O
helices NNS O
( , O
alpha NN O
1 CD O
and CC O
alpha NN O
4 CD O
) -RRB- O
. . O

The DT O
helix NN O
alpha NN O
1 CD O
runs VBZ O
nearly RB O
parallel JJ O
to IN O
the DT O
two CD O
outermost JJ O
strands NNS O
beta NN O
2 CD O
and CC O
beta NN O
3 CD O
, , O
which WDT O
in IN O
turn NN O
lie VBP O
adjacent JJ O
to IN O
beta JJ O
4 CD O
. . O

Strands NNS O
beta JJ O
2 CD O
and CC O
beta NN O
3 CD O
are VBP O
separated VBN O
by IN O
a DT O
loop NN O
. . O

The DT O
helix NN O
alpha NN O
4 CD O
is VBZ O
nearly RB O
orthogonal JJ O
to IN O
the DT O
beta NN O
- HYPH O
strands NNS O
. . O

Tip NN O
domain NN O
( : O
residues NNS O
74 CD O
- HYPH O
120 CD O
) -RRB- O
contains VBZ O
two CD O
alpha NN O
helices NNS O
( , O
alpha NN O
2 CD O
and CC O
alpha NN O
3 CD O
) -RRB- O
and CC O
is VBZ O
inserted VBN O
between IN O
strands NNS O
beta NN O
4 CD O
and CC O
beta NN O
5 CD O
of IN O
the DT O
center NN O
domain NN O
. . O

It PRP O
sticks VBZ O
out RP O
from IN O
the DT O
center NN O
domain NN O
. . O

The DT O
two CD O
connections NNS O
between IN O
the DT O
center NN O
domain NN O
and CC O
the DT O
tip NN O
domain NN O
are VBP O
rich JJ O
in IN O
conserved JJ O
residues NNS O
, , O
hinting VBG O
at IN O
an DT O
important JJ O
functional JJ O
role NN O
of IN O
these DT O
joints NNS O
. . O

They PRP O
could MD O
act VB O
as IN O
a DT O
hinge NN O
for IN O
a DT O
possible JJ O
conformational JJ O
change NN O
. . O

The DT O
C NNP O
- HYPH O
terminal JJ O
region NN O
of IN O
the DT O
polypeptide NN O
chain NN O
is VBZ O
folded VBN O
into IN O
the DT O
base NN O
domain NN O
( , O
residues NNS O
168 CD O
- HYPH O
306 CD O
) -RRB- O
, , O
which WDT O
consists VBZ O
of IN O
a DT O
five CD O
- HYPH O
stranded JJ O
anti JJ O
- HYPH O
parallel JJ O
beta NN O
- HYPH O
sheet NN O
with IN O
four CD O
alpha NN O
- HYPH O
helices NNS O
, , O
three CD O
of IN O
which WDT O
( , O
alpha NN O
5 CD O
, , O
alpha NN O
6 CD O
and CC O
alpha NN O
8 CD O
) -RRB- O
cover VBP O
one CD O
side NN O
of IN O
the DT O
beta NN O
- HYPH O
sheet NN O
. . O

The DT O
long JJ O
helix NN O
alpha NN O
8 CD O
is VBZ O
slightly RB O
bent JJ O
. . O

Structural JJ O
similarity NN O
searches NNS O

When WRB O
we PRP O
searched VBD O
for IN O
structural JJ O
similarity NN O
against IN O
the DT O
Protein NNP O
Data NNP O
Bank NNP O
database NN O
using VBG O
the DT O
program NN O
DALI NNP O
( SYM O
18 CD O
) -RRB- O
, , O
the DT O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
monomer NN O
showed VBD O
no DT O
significant JJ O
similarity NN O
with IN O
a DT O
Z NN O
score NN O
above IN O
5 CD O
. . O

Therefore RB O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
overall JJ O
fold NN O
of IN O
the DT O
RdgC NNP O
polypeptide NN O
chain NN O
is VBZ O
unique JJ O
. . O

When WRB O
we PRP O
elaborated VBD O
the DT O
structural JJ O
comparisons NNS O
with IN O
individual JJ O
domains NNS O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
, , O
only RB O
the DT O
center NN O
domain NN O
gave VBD O
a DT O
Z NN O
score NN O
above IN O
5 CD O
. . O

Using VBG O
the DT O
center NN O
domain NN O
( , O
residues NNS O
1 CD O
- HYPH O
73 CD O
and CC O
121 CD O
- HYPH O
167 CD O
) -RRB- O
alone RB O
, , O
the DT O
highest JJS O
structural JJ O
similarity NN O
is VBZ O
found VBN O
with IN O
the DT O
human JJ B-Species
beta NN O
2 CD O
- HYPH O
adaptin NN O
appendage NN O
domain NN O
( , O
PDB NN O
code NN O
1E+042 CD O
, , O
Z NN O
score NN O
= SYM O
7 CD O
. . O
1 CD O
, , O
r NN O
. . O
m ADD O
. . O
s NFP O
. . O
deviation NN O
= SYM O
2 CD O
. . O
5 CD O
A NN O
for IN O
85 CD O
structurally RB O
aligned VBN O
residues NNS O
, , O
residues NNS O
1 CD O
- HYPH O
12 CD O
, , O
14 CD O
- HYPH O
30 CD O
, , O
44 CD O
- HYPH O
47 CD O
, , O
58 CD O
- HYPH O
72 CD O
, , O
122 CD O
- HYPH O
133 CD O
and CC O
135 CD O
- SYM O
160 CD O
of IN O
P NN B-Species
. , I-Species
aeruginosa NN I-Species
RdgC NN O
chain NN O
A NN O
and CC O
residues NN O
838 CD O
- HYPH O
841 CD O
, , O
848 CD O
- HYPH O
880 CD O
, , O
885 CD O
- HYPH O
906 CD O
and CC O
912 CD O
- HYPH O
967 CD O
of IN O
the DT O
human JJ B-Species
beta NN O
2 CD O
- HYPH O
adaptin NN O
appendage NN O
domain NN O
chain NN O
A NN O
) -RRB- O
( SYM O
19 CD O
) -RRB- O
. . O

There EX O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
any DT O
functional JJ O
relatedness NN O
between IN O
these DT O
two CD O
proteins NNS O
. . O

The DT O
next JJ O
highest JJS O
similarity NN O
is VBZ O
found VBN O
with IN O
the DT O
yeast NN B-Species
TATA NNP O
- HYPH O
box NN O
- HYPH O
binding VBG O
protein NN O
( , O
PDB NNP O
code NN O
1YTB NN O
, , O
Z NN O
score NN O
= SYM O
5 CD O
. . O
7 CD O
, , O
r NN O
. . O
m UH O
. . O
s NFP O
. . O
deviation NN O
= SYM O
2 CD O
. . O
6 CD O
A NN O
for IN O
79 CD O
structurally RB O
aligned VBN O
residues NNS O
, , O
residues NNS O
4 CD O
- HYPH O
12 CD O
, , O
14 CD O
- HYPH O
19 CD O
, , O
21 CD O
- HYPH O
27 CD O
, , O
56 CD O
- HYPH O
70 CD O
, , O
124 CD O
- HYPH O
132 CD O
and CC O
134 CD O
- SYM O
166 CD O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
chain NN O
A NN O
and CC O
residues NNS O
69 CD O
- HYPH O
96 CD O
, , O
100 CD O
- SYM O
126 CD O
and CC O
132 CD O
- HYPH O
155 CD O
of IN O
TATA NNP O
- HYPH O
box NN O
- HYPH O
binding VBG O
protein NN O
, , O
N NNP O
- HYPH O
terminal JJ O
half NN O
of IN O
chain NN O
A NNP O
) -RRB- O
( SYM O
20 CD O
) -RRB- O
. . O

The DT O
TATA NNP O
- HYPH O
box NN O
- HYPH O
binding VBG O
protein NN O
is VBZ O
composed VBN O
of IN O
a DT O
ten CD O
- HYPH O
stranded VBN O
antiparallel JJ O
beta NN O
- HYPH O
sheet NN O
with IN O
four CD O
flanking VBG O
alpha NN O
- HYPH O
helices NNS O
on IN O
the DT O
convex NN O
side NN O
of IN O
the DT O
beta NN O
- HYPH O
sheet NN O
( HYPH O
20 CD O
) -RRB- O
. . O

It PRP O
has VBZ O
an DT O
internal JJ O
quasi JJ O
2 CD O
- HYPH O
fold NN O
symmetry NN O
, , O
and CC O
its PRP$ O
beta NN O
- HYPH O
strands NNS O
are VBP O
involved VBN O
in IN O
DNA NNP O
binding NN O
. . O

There EX O
is VBZ O
, , O
however RB O
, , O
no DT O
structural JJ O
similarity NN O
of IN O
functional JJ O
significance NN O
, , O
because IN O
the DT O
two CD O
center NN O
domains NNS O
of IN O
the DT O
RdgC NNP O
dimer NN O
are VBP O
well RB O
separated VBN O
and CC O
do VBP O
not RB O
associate VB O
into IN O
a DT O
single JJ O
unit NN O
( -LRB- O
Figure NNP O
1C NNP O
and CC O
D NNP O
) -RRB- O
. . O

Using VBG O
the DT O
tip NN O
domain NN O
( , O
residues NNS O
74 CD O
- HYPH O
120 CD O
) -RRB- O
alone RB O
, , O
the DT O
ATPase NNP O
domain NN O
of IN O
bovine JJ B-Species
Hsc70 NNP O
chaperone NN O
shows VBZ O
highest JJS O
structural JJ O
similarity NN O
( , O
PDB NNP O
code NN O
1BA1 NN O
, , O
Z NN O
score NN O
= SYM O
4 CD O
. . O
8 CD O
, , O
r NN O
. . O
m UH O
. . O
s NFP O
. . O
deviation NN O
= SYM O
1 CD O
. . O
7 CD O
A NN O
for IN O
45 CD O
structurally RB O
aligned VBN O
residues NNS O
, , O
residues NNS O
76 CD O
- HYPH O
120 CD O
of IN O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
chain NN O
A NN O
and CC O
residues NNS O
230 CD O
- HYPH O
253 CD O
and CC O
256 CD O
- HYPH O
276 CD O
of IN O
the DT O
Hsc70 NNP O
ATPase NNP O
domain NN O
) -RRB- O
( SYM O
21 CD O
) -RRB- O
. . O

There EX O
does VBZ O
not RB O
seem VB O
to TO O
be VB O
any DT O
significant JJ O
functional JJ O
relationship NN O
between IN O
these DT O
two CD O
proteins NNS O
. . O

The DT O
alpha JJ O
- HYPH O
helix NN O
- HYPH O
loop NN O
- HYPH O
alpha NN O
- HYPH O
helix NN O
structure NN O
of IN O
the DT O
tip NN O
domain NN O
is VBZ O
reminiscent JJ O
of IN O
the DT O
helix NN O
- HYPH O
hairpin NN O
- HYPH O
helix NN O
( , O
HhH NN O
) -RRB- O
DNA NN O
- HYPH O
binding VBG O
motif NN O
that WDT O
is VBZ O
present JJ O
in IN O
a DT O
number NN O
of IN O
DNA NNP O
repair NN O
enzymes NNS O
( , O
22 CD O
- SYM O
25 CD O
) -RRB- O
. . O

The DT O
HhH NNP O
motifs NNS O
are VBP O
characterized VBN O
by IN O
the DT O
conserved VBN O
sequence NN O
motif NN O
hxxhxGhGxxxAxxxhh NNP O
, , O
where WRB O
h NN O
is VBZ O
any DT O
hydrophobic JJ O
residue NN O
( , O
VILMWFYA NNP O
) -RRB- O
and CC O
x NN O
any DT O
residue NN O
( SYM O
23 CD O
) -RRB- O
. . O

Two CD O
conserved VBN O
glycines NNS O
allow VBP O
a DT O
tight JJ O
turn NN O
between IN O
two CD O
alpha NN O
- HYPH O
helices NNS O
. . O

However RB O
, , O
the DT O
tip NN O
domain NN O
of IN O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
protein NN O
does VBZ O
not RB O
have VB O
such PDT O
a DT O
sequence NN O
motif NN O
, , O
and CC O
the DT O
loop NN O
in IN O
the DT O
RdgC NNP O
tip NN O
domain NN O
is VBZ O
much RB O
more RBR O
extended JJ O
than IN O
that DT O
of IN O
the DT O
HhH NNP O
motifs NNS O
. . O

Therefore RB O
, , O
the DT O
RdgC NNP O
tip NN O
domain NN O
is VBZ O
uniquely RB O
folded VBN O
. . O

With IN O
the DT O
base NN O
domain NN O
( , O
residues NNS O
168 CD O
- HYPH O
306 CD O
) -RRB- O
alone RB O
, , O
the DT O
highest JJS O
similarity NN O
is VBZ O
found VBN O
with IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
isochorismate NN O
- HYPH O
pyruvate NN O
lyase NN O
( , O
unpublished JJ O
deposition NN O
; , O
PDB NNP O
code NN O
2H9C NN O
, , O
Z NN O
score NN O
= SYM O
4 CD O
. . O
0 CD O
, , O
r NN O
. . O
m ADD O
. . O
s NFP O
. . O
deviation NN O
= SYM O
4 CD O
. . O
8 CD O
A NN O
for IN O
51 CD O
structurally RB O
aligned VBN O
residues NNS O
, , O
residues NNS O
186 CD O
- HYPH O
191 CD O
, , O
237 CD O
- HYPH O
240 CD O
, , O
257 CD O
- HYPH O
272 CD O
and CC O
274 CD O
- SYM O
298 CD O
of IN O
P NN B-Species
. , I-Species
aeruginosa NN I-Species
RdgC NNP O
chain NN O
A NN O
and CC O
residues NNS O
36 CD O
- HYPH O
41 CD O
, , O
50 CD O
- HYPH O
53 CD O
, , O
55 CD O
- SYM O
66 CD O
and CC O
68 CD O
- SYM O
96 CD O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
isochorismate NN O
- HYPH O
pyruvate NN O
lyase NN O
chain NN O
A NN O
) -RRB- O
. . O

There EX O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
any DT O
functional JJ O
relationship NN O
between IN O
the DT O
two CD O
proteins NNS O
, , O
and CC O
the DT O
base NN O
domain NN O
of IN O
RdgC NNP O
is VBZ O
uniquely RB O
folded VBN O
. . O

The DT O
101 CD O
- HYPH O
residue NN O
chain NN O
of IN O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
isochorismate NN O
- HYPH O
pyruvate NN O
lyase NN O
is VBZ O
folded VBN O
into IN O
three CD O
alpha NN O
- HYPH O
helices NNS O
, , O
two CD O
of IN O
which WDT O
overlap VBP O
with IN O
two CD O
alpha NN O
- HYPH O
helices NNS O
( , O
alpha NN O
2 CD O
and CC O
alpha NN O
3 CD O
) -RRB- O
of IN O
the DT O
base NN O
domain NN O
of IN O
RdgC NNP O
. . O

Ring NN O
- HYPH O
shaped JJ O
dimer NN O
structure NN O
and CC O
inter JJ O
- HYPH O
subunit NN O
interface NN O

Our PRP$ O
structure NN O
reveals VBZ O
that IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
forms VBZ O
a DT O
ring NN O
- HYPH O
shaped JJ O
dimer NN O
of IN O
approximate JJ O
2 CD O
- HYPH O
fold NN O
symmetry NN O
in IN O
the DT O
crystal NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

This DT O
observation NN O
is VBZ O
consistent JJ O
with IN O
the DT O
results NNS O
of IN O
previous JJ O
gel NN O
filtration NN O
and CC O
sedimentation NN O
equilibrium NN O
experiments NNS O
, , O
which WDT O
suggested VBD O
the DT O
presence NN O
of IN O
dimeric JJ O
species NNS O
of IN O
E NN B-Species
. . I-Species
coli NNP I-Species
RdgC NNP O
in IN O
solution NN O
( : O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Depending VBG O
on IN O
the DT O
concentration NN O
, , O
RdgC NNP O
could MD O
also RB O
exist VB O
in IN O
solution NN O
as IN O
monomers NNS O
, , O
tetramers NNS O
and CC O
higher JJR O
oligomers NNS O
( , O
1 CD O
) -RRB- O
. . O

In IN O
the DT O
crystal NN O
lattice NN O
, , O
no DT O
monomeric JJ O
, , O
trimeric JJ O
or CC O
tetrameric JJ O
species NNS O
exist VBP O
. . O

Our PRP$ O
structure NN O
unequivocally RB O
rules VBZ O
out RP O
the DT O
monomer NN O
- HYPH O
trimer NN O
model NN O
, , O
which WDT O
fits VBZ O
the DT O
sedimentation NN O
equilibrium NN O
data NNS O
approximately RB O
, , O
as RB O
well RB O
as IN O
the DT O
monomer NN O
- HYPH O
dimer NN O
- HYPH O
tetramer NN O
model NN O
( , O
1 CD O
) -RRB- O
. . O

The DT O
RdgC NNP O
dimer NN O
has VBZ O
approximate JJ O
dimensions NNS O
of IN O
80 CD O
A NN O
x SYM O
60 CD O
A NN O
x SYM O
40 CD O
A NN O
, , O
with IN O
a DT O
central JJ O
hole NN O
of IN O
~ $ O
30 CD O
A NN O
diameter NN O
. . O

Only RB O
a DT O
moderate JJ O
amount NN O
of IN O
surface NN O
area NN O
is VBZ O
buried VBN O
upon IN O
the DT O
formation NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
. . O

The DT O
monomer NN O
- HYPH O
monomer NN O
interface NN O
buries VBZ O
a DT O
solvent NN O
- HYPH O
accessible JJ O
surface NN O
area NN O
of IN O
~ $ O
1360 CD O
A NN O
2 CD O
per IN O
monomer NN O
, , O
corresponding VBG O
to IN O
~ $ O
8 CD O
% NN O
of IN O
the DT O
total JJ O
surface NN O
area NN O
of IN O
the DT O
monomer NN O
( , O
Protein NN O
- HYPH O
Protein NN O
Interaction NN O
Server NN O
at IN O
http NN O
: : O
/ SYM O
/ SYM O
www ADD O
. . O
biochem NN O
. . O
ucl NN O
. . O
ac ADD O
. . O
uk NN O
/ SYM O
bsm NN O
/ SYM O
PP NN O
/ SYM O
server NN O
/ , O
) -RRB- O
. . O

Polar JJ O
and CC O
nonpolar JJ O
atoms NNS O
in IN O
interface NN O
are VBP O
44 CD O
and CC O
56 CD O
% NN O
, , O
respectively RB O
. . O

The DT O
interface NN O
can MD O
be VB O
divided VBN O
into IN O
two CD O
kinds NNS O
: : O
' `` O
interface VB O
A NN O
' '' O
involving VBG O
both CC O
the DT O
tip NN O
domains NNS O
and CC O
center NN O
domains NNS O
, , O
and CC O
' `` O
interface NN O
B NN O
' '' O
involving VBG O
the DT O
base NN O
domains NNS O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

These DT O
two CD O
interfaces NNS O
have VBP O
significantly RB O
different JJ O
characters NNS O
. . O

The DT O
interface NN O
A NN O
is VBZ O
formed VBN O
largely RB O
by IN O
the DT O
crossing NN O
over IN O
of IN O
the DT O
two CD O
tip NN O
domains NNS O
in IN O
the DT O
dimer NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

This DT O
interface NN O
covers VBZ O
a DT O
surface NN O
area NN O
of IN O
~ $ O
565 CD O
A NN O
2 CD O
and CC O
is VBZ O
largely RB O
nonpolar JJ O
, , O
with IN O
the DT O
polar JJ O
and CC O
nonpolar JJ O
atoms NNS O
in IN O
the DT O
interface NN O
being VBG O
37 CD O
. . O
5 CD O
and CC O
2 CD O
. . O
5 CD O
% NN O
, , O
respectively RB O
. . O

Phe120 NNP O
contributes VBZ O
considerably RB O
to IN O
the DT O
nonpolar JJ O
character NN O
of IN O
the DT O
interface NN O
between IN O
the DT O
tip NN O
domains NNS O
, , O
accounting VBG O
for IN O
~ $ O
150 CD O
A NN O
2 CD O
of IN O
the DT O
interface NN O
area NN O
. . O

Phe120 NNP O
is VBZ O
part NN O
of IN O
a DT O
highly RB O
conserved VBN O
sequence NN O
segment NN O
and CC O
lies VBZ O
at IN O
the DT O
boundary NN O
between IN O
the DT O
tip NN O
domain NN O
and CC O
the DT O
center NN O
domain NN O
. . O

The DT O
aromatic JJ O
ring NN O
of IN O
Phe120 NNP O
' '' O
inserts VBZ O
into IN O
a DT O
hydrophobic JJ O
pocket NN O
, , O
which WDT O
is VBZ O
formed VBN O
by IN O
the DT O
hydrophobic JJ O
residues NNS O
Ile74 NNP O
, , O
Leu75 NNP O
, , O
Pro76 NNP O
, , O
Val79 NNP O
, , O
Leu115 NNP O
, , O
Ala119 NNP O
and CC O
Phe120 NNP O
of IN O
the DT O
neighboring VBG O
monomer NN O
( -LRB- O
Figure NNP O
2B NNP O
) -RRB- O
. . O

The DT O
primed VBN O
residue NN O
belongs VBZ O
to IN O
the DT O
adjacent JJ O
subunit NN O
. . O

These DT O
residues NNS O
are VBP O
well RB O
conserved VBN O
in IN O
the DT O
RdgC NNP O
family NN O
( , O
indicated VBN O
by IN O
green JJ O
triangles NNS O
below IN O
the DT O
aligned VBN O
sequences NNS O
in IN O
Figure NNP O
3 CD O
) -RRB- O
. . O

As IN O
these DT O
hydrophobic JJ O
residues NNS O
are VBP O
located VBN O
near IN O
the DT O
molecular JJ O
2 CD O
- HYPH O
fold NN O
axis NN O
, , O
the DT O
two CD O
clusters NNS O
of IN O
hydrophobic JJ O
side NN O
chains NNS O
are VBP O
merged VBN O
into IN O
a DT O
single JJ O
, , O
large JJ O
cluster NN O
in IN O
the DT O
dimer NN O
( -LRB- O
Figure NNP O
2B NN O
) -RRB- O
. . O

Of IN O
the DT O
16 CD O
hydrogen NN O
bonds NNS O
that WDT O
exist VBP O
between IN O
the DT O
two CD O
subunits NNS O
, , O
only RB O
one CD O
is VBZ O
made VBN O
in IN O
this DT O
interface NN O
between IN O
Arg118 NNP O
and CC O
Arg118 NNP O
' '' O
. . O

The DT O
interface NN O
B NN O
is VBZ O
contributed VBN O
to IN O
exclusively RB O
by IN O
the DT O
two CD O
base NN O
domains NNS O
. . O

This DT O
interface NN O
covers VBZ O
a DT O
surface NN O
area NN O
of IN O
~ $ O
795 CD O
A NN O
2 CD O
. . O

The DT O
polar JJ O
and CC O
nonpolar JJ O
atoms NNS O
in IN O
this DT O
interface NN O
are VBP O
50 CD O
% NN O
each DT O
. . O

The DT O
two CD O
beta NN O
- HYPH O
sheets NNS O
of IN O
the DT O
two CD O
base NN O
domains NNS O
merge VBP O
into IN O
a DT O
single JJ O
ten CD O
- HYPH O
stranded VBN O
antiparallel JJ O
beta NN O
- HYPH O
sheet NN O
in IN O
this DT O
interface NN O
( -LRB- O
Figure NNP O
2A NNP O
) -RRB- O
. . O

Thus RB O
, , O
15 CD O
of IN O
16 CD O
inter JJ O
- HYPH O
subunit NN O
hydrogen NN O
bonds NNS O
are VBP O
clustered VBN O
in IN O
this DT O
interface NN O
. . O

The DT O
hydrogen NN O
bond NN O
networks NNS O
can MD O
be VB O
divided VBN O
into IN O
two CD O
types NNS O
. . O

The DT O
first JJ O
type NN O
involves VBZ O
the DT O
main JJ O
chain NN O
atoms NNS O
of IN O
Val206 NNP O
, , O
Arg208 NNP O
and CC O
Lys210 NNP O
in IN O
strand NN O
beta NN O
9 CD O
; , O
this DT O
strand NN O
associates VBZ O
with IN O
the DT O
equivalent JJ O
strand NN O
from IN O
the DT O
other JJ O
subunit NN O
in IN O
an DT O
antiparallel JJ O
manner NN O
( -LRB- O
Figure NNP O
2C NNP O
) -RRB- O
. . O

The DT O
other JJ O
type NN O
involves VBZ O
both CC O
the DT O
side NN O
chain NN O
and CC O
main JJ O
chain NN O
atoms NNS O
. . O

The DT O
side NN O
chain NN O
of IN O
Arg211 NNP O
' '' O
interacts VBZ O
with IN O
the DT O
backbone NN O
of IN O
Gly204 NNP O
, , O
while IN O
the DT O
side NN O
chain NN O
of IN O
Lys227 NNP O
hydrogen NN O
bonds NNS O
to IN O
those DT O
of IN O
both DT O
Gln212 NNP O
' '' O
and CC O
Glu218 NNP O
( -LRB- O
Figure NNP O
2D NNP O
) -RRB- O
. . O

In IN O
addition NN O
, , O
the DT O
side NN O
chain NN O
of IN O
Gln212 NNP O
' '' O
interacts VBZ O
with IN O
that DT O
of IN O
Asp199 NNP O
and CC O
the DT O
backbone NN O
of IN O
Arg211 NNP O
' '' O
( -LRB- O
Figure NNP O
2D NNP O
) -RRB- O
. . O

Arg211 NNP O
, , O
Gln212 NNP O
, , O
Glu218 NNP O
and CC O
Lys227 NNP O
are VBP O
highly RB O
conserved VBN O
among IN O
the DT O
RdgC NNP O
family NN O
members NNS O
. . O

The DT O
residues NNS O
participating VBG O
in IN O
the DT O
hydrogen NN O
bond NN O
networks NNS O
are VBP O
indicated VBN O
by IN O
red JJ O
circles NNS O
below IN O
the DT O
aligned VBN O
sequences NNS O
in IN O
Figure NNP O
3 CD O
. . O

The DT O
observation NN O
that IN O
conserved VBN O
residues NNS O
play VBP O
important JJ O
roles NNS O
in IN O
forming VBG O
the DT O
dimer NN O
implies VBZ O
that IN O
dimerization NN O
of IN O
RdgC NNP O
is VBZ O
critical JJ O
for IN O
its PRP$ O
function NN O
. . O

If IN O
one CD O
or CC O
both DT O
of IN O
interfaces NNS O
A NN O
and CC O
B NN O
are VBP O
to TO O
be VB O
broken VBN O
for IN O
functional JJ O
reasons NNS O
such JJ O
as IN O
for IN O
allowing VBG O
dsDNA NNP O
to TO O
enter VB O
into IN O
the DT O
central JJ O
hole NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
, , O
we PRP O
can MD O
conceive VB O
of IN O
three CD O
scenarios NNS O
. . O

The DT O
first JJ O
possibility NN O
would MD O
be VB O
a DT O
simultaneous JJ O
breakage NN O
of IN O
the DT O
two CD O
interfaces NNS O
A NN O
and CC O
B NN O
. . O

The DT O
second JJ O
would MD O
be VB O
the DT O
sequential JJ O
disruption NN O
of IN O
the DT O
interfaces NNS O
A NN O
and CC O
B NN O
. . O

The DT O
third JJ O
would MD O
be VB O
the DT O
disruption NN O
of IN O
only RB O
one CD O
of IN O
the DT O
two CD O
interfaces NNS O
A NN O
and CC O
B NN O
. . O

Sedimentation NN O
equilibrium NN O
indicated VBD O
the DT O
presence NN O
of IN O
monomers NNS O
in IN O
solution NN O
( : O
1 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
the DT O
first JJ O
two CD O
scenarios NNS O
. . O

If IN O
the DT O
third JJ O
scenario NN O
holds VBZ O
, , O
RdgC NNP O
dimers NNS O
could MD O
possibly RB O
exist VB O
in IN O
two CD O
conformations NNS O
in IN O
solution NN O
, , O
i PRP O
. . O
e LS O
. . O
a DT O
closed VBN O
form NN O
as IN O
observed VBN O
in IN O
the DT O
present JJ O
crystal NN O
structure NN O
, , O
and CC O
an DT O
open JJ O
form NN O
, , O
in IN O
which WDT O
one CD O
of IN O
the DT O
two CD O
interfaces NNS O
A NN O
and CC O
B NN O
is VBZ O
broken VBN O
. . O

A DT O
model NN O
for IN O
DNA NN O
binding NN O
by IN O
RdgC NNP O
and CC O
DNA NNP O
- HYPH O
binding VBG O
assay NN O

The DT O
net JJ O
charge NN O
of IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NN O
is VBZ O
highly RB O
negative JJ O
, , O
since IN O
each DT O
monomer NN O
contains VBZ O
12 CD O
aspartate NN O
, , O
13 CD O
glutamate NN O
, , O
10 CD O
lysine NN O
, , O
9 CD O
arginine NN O
and CC O
2 CD O
histidine NN O
residues NNS O
. . O

The DT O
net JJ O
charge NN O
of IN O
a DT O
dimer NN O
would MD O
be VB O
- HYPH O
12 CD O
( , O
or CC O
- HYPH O
8 CD O
) -RRB- O
, , O
if IN O
we PRP O
assume VBP O
none NN O
( , O
or CC O
all DT O
) -RRB- O
of IN O
histidines NNS O
to TO O
be VB O
positively RB O
charged VBN O
. . O

The DT O
electrostatic JJ O
potential NN O
at IN O
the DT O
molecular JJ O
surface NN O
of IN O
RdgC NNP O
dimer NN O
shows VBZ O
that IN O
the DT O
charge NN O
distribution NN O
on IN O
the DT O
protein NN O
surface NN O
is VBZ O
highly RB O
nonuniform JJ O
( -LRB- O
Figure NNP O
4A NNP O
) -RRB- O
. . O

Since IN O
the DT O
inner JJ O
surface NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
is VBZ O
rich JJ O
in IN O
conserved JJ O
, , O
positively RB O
charged VBN O
residues NNS O
and CC O
the DT O
diameter NN O
of IN O
the DT O
central JJ O
hole NN O
( , O
~ $ O
30 CD O
A NN O
) -RRB- O
is VBZ O
approximately RB O
similar JJ O
to IN O
that DT O
of IN O
other JJ O
toroidal JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
( SYM O
26 CD O
) -RRB- O
, , O
it PRP O
appears VBZ O
likely JJ O
that IN O
RdgC NNP O
dimers NNS O
bind VBP O
dsDNA NNP O
through IN O
the DT O
central JJ O
hole NN O
. . O

Despite IN O
extensive JJ O
co NN O
- HYPH O
crystallization NN O
and CC O
soaking NN O
trials NNS O
with IN O
linear JJ O
dsDNAs NNS O
of IN O
different JJ O
lengths NNS O
( , O
14 CD O
- HYPH O
mer NN O
, , O
16 CD O
- HYPH O
mer NN O
and CC O
18 CD O
- HYPH O
mer NN O
) -RRB- O
, , O
we PRP O
could MD O
not RB O
locate VB O
the DT O
bound VBN O
DNA NNP O
experimentally RB O
. . O

We PRP O
attribute VBP O
this DT O
difficulty NN O
to IN O
the DT O
nature NN O
of IN O
sequence NN O
- HYPH O
nonspecific JJ O
DNA NN O
binding NN O
by IN O
RdgC NNP O
. . O

Therefore RB O
, , O
we PRP O
built VBD O
a DT O
crude JJ O
model NN O
of IN O
a DT O
DNA NNP O
complex NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
by IN O
fitting VBG O
dsDNA NNP O
into IN O
the DT O
central JJ O
hole NN O
( -LRB- O
Figure NNP O
4B NNP O
) -RRB- O
. . O

This DT O
model NN O
is VBZ O
supported VBN O
by IN O
the DT O
DNA NN O
- HYPH O
binding VBG O
assays NNS O
coupled VBN O
with IN O
mutagenesis NN O
, , O
as IN O
described VBN O
below RB O
. . O

It PRP O
is VBZ O
also RB O
consistent JJ O
with IN O
the DT O
suggested VBN O
binding VBG O
site NN O
size NN O
of IN O
~ $ O
16 CD O
nt NN O
for IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
dimer NN O
( : O
1 CD O
) -RRB- O
and CC O
the DT O
approximate JJ O
thickness NN O
( : O
~ $ O
40 CD O
A NN O
) -RRB- O
of IN O
the DT O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NN O
dimer NN O
. . O

When WRB O
we PRP O
performed VBD O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
for IN O
dsDNA NNP O
binding NN O
, , O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
did VBD O
not RB O
require VB O
Mg2 NNP O
+ SYM O
ions NNS O
( -LRB- O
Supplementary NNP O
Figure NNP O
2 CD O
) -RRB- O
, , O
unlike IN O
Deinococcus NNP B-Species
radiodurans NNS I-Species
RecR NNP O
, , O
which WDT O
required VBD O
high JJ O
concentrations NNS O
of IN O
Mg2 NNP O
+ CC O
ions NNS O
( SYM O
27 CD O
) -RRB- O
. . O

ATP NNP O
was VBD O
not RB O
required VBN O
for IN O
dsDNA NNP O
binding NN O
by IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NN O
, , O
either RB O
( , O
Supplementary NNP O
Figure NNP O
2 CD O
) -RRB- O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
an DT O
apparent JJ O
lack NN O
of IN O
an DT O
ATP NNP O
- HYPH O
binding VBG O
pocket NN O
in IN O
the DT O
RdgC NNP O
dimer NN O
structure NN O
. . O

In IN O
order NN O
to TO O
identify VB O
the DT O
residues NNS O
that WDT O
are VBP O
important JJ O
for IN O
dsDNA NNP O
binding NN O
, , O
we PRP O
carried VBD O
out RP O
mutational JJ O
analyses NNS O
. . O

The DT O
residues NNS O
for IN O
mutagenesis NN O
were VBD O
selected VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
modeled VBN O
complex NN O
between IN O
RdgC NNP O
dimer NN O
and CC O
dsDNA NNP O
, , O
together RB O
with IN O
sequence NN O
conservation NN O
( -LRB- O
Figure NNP O
4C NNP O
) -RRB- O
. . O

We PRP O
prepared VBD O
eleven CD O
point NN O
mutants NNS O
( , O
R4A NNP O
, , O
K70D NNP O
, , O
R81D NNP O
, , O
F120A NNP O
, , O
R122D NNP O
, , O
K146A NNP O
, , O
R198A NNP O
, , O
R208A NNP O
, , O
R211D NNP O
, , O
Q212A NNP O
and CC O
R252A NN O
) -RRB- O
. . O

These DT O
eleven CD O
mutated VBN O
residues NNS O
are VBP O
well RB O
conserved VBN O
among IN O
RdgC NNP O
proteins NNS O
. . O

Eight CD O
mutants NNS O
( , O
R4A NNP O
, , O
K70D NNP O
, , O
R81D NNP O
, , O
R122D NNP O
, , O
K146A NNP O
, , O
R198A NNP O
, , O
R208A NNP O
and CC O
R252A NNP O
) -RRB- O
had VBD O
a DT O
lower JJR O
affinity NN O
for IN O
dsDNA NNP O
than IN O
the DT O
wild JJ O
- HYPH O
type NN O
RdgC NN O
( -LRB- O
Figure NN O
4D NN O
) -RRB- O
. . O

These DT O
eight CD O
mutated VBN O
residues NNS O
are VBP O
indicated VBN O
by IN O
blue JJ O
squares NNS O
below IN O
the DT O
aligned VBN O
sequences NNS O
in IN O
Figure NNP O
3 CD O
. . O

This DT O
result NN O
indicates VBZ O
that IN O
dsDNA NNP O
binds VBZ O
to IN O
the DT O
inside JJ O
surface NN O
around IN O
the DT O
central JJ O
hole NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
, , O
since IN O
the DT O
mutated VBN O
residues NNS O
are VBP O
located VBN O
on IN O
the DT O
inner JJ O
surface NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
. . O

It PRP O
is VBZ O
worth JJ O
mentioning VBG O
that IN O
a DT O
single JJ O
mutation NN O
introduces VBZ O
two CD O
alterations NNS O
per IN O
RdgC NNP O
dimer NN O
. . O

The DT O
three CD O
mutants NNS O
( -LRB- O
F120A NNP O
, , O
R211D NNP O
and CC O
Q212A NNP O
) -RRB- O
were VBD O
prepared VBN O
to TO O
investigate VB O
whether IN O
dimerization NN O
of IN O
RdgC NNP O
is VBZ O
crucial JJ O
for IN O
dsDNA NNP O
binding NN O
. . O

Phe120 NN O
is VBZ O
a DT O
key JJ O
residue NN O
located VBN O
in IN O
the DT O
inter JJ O
- HYPH O
subunit NN O
interface NN O
A NNP O
( -LRB- O
Figure NNP O
2B NNP O
) -RRB- O
, , O
while IN O
Arg211 NNP O
makes VBZ O
hydrogen NN O
bonds NNS O
in IN O
the DT O
interface NN O
B NNP O
( -LRB- O
Figure NNP O
2D NN O
) -RRB- O
and CC O
Gln212 NN O
is VBZ O
involved VBN O
in IN O
both CC O
intra JJ O
- HYPH O
and CC O
inter JJ O
- HYPH O
subunit NN O
interactions NNS O
( -LRB- O
Figure NNP O
2D NNP O
) -RRB- O
. . O

dsDNA NNP O
binding NN O
by IN O
the DT O
F120A NNP O
mutant NN O
is VBZ O
considerably RB O
weakened VBN O
, , O
compared VBN O
to IN O
either CC O
the DT O
R211D NNP O
or CC O
Q212A NN O
mutant NN O
( -LRB- O
Figure NNP O
4D NN O
) -RRB- O
. . O

This DT O
result NN O
suggests VBZ O
that IN O
destabilization NN O
of IN O
the DT O
ring NN O
- HYPH O
shaped JJ O
architecture NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
is VBZ O
deleterious JJ O
for IN O
tight JJ O
dsDNA NN O
binding NN O
and CC O
that IN O
interface NN O
A NN O
is VBZ O
probably RB O
more RBR O
important JJ O
than IN O
interface NN O
B NN O
for IN O
dsDNA NNP O
binding NN O
. . O

dsDNA NNP O
- HYPH O
binding VBG O
affinity NN O
of IN O
the DT O
Q212A NNP O
mutant NN O
was VBD O
lower JJR O
than IN O
the DT O
wild JJ O
type NN O
( -LRB- O
Figure NNP O
4D NNP O
) -RRB- O
, , O
whereas IN O
that DT O
of IN O
the DT O
R211D NNP O
mutant NN O
was VBD O
comparable JJ O
to IN O
the DT O
wild JJ O
type NN O
( -LRB- O
Figure NN O
4D NN O
) -RRB- O
. . O

This DT O
result NN O
suggests VBZ O
that IN O
disruption NN O
of IN O
the DT O
inter JJ O
- HYPH O
subunit NN O
interface NN O
B NN O
is VBZ O
also RB O
detrimental JJ O
for IN O
dsDNA NNP O
binding NN O
but CC O
to IN O
a DT O
smaller JJR O
extent NN O
than IN O
disruption NN O
of IN O
the DT O
interface NN O
A NN O
. . O

It PRP O
further RB O
suggests VBZ O
that IN O
the DT O
side NN O
chain NN O
of IN O
Arg211 NNP O
is VBZ O
not RB O
involved VBN O
in IN O
recognizing VBG O
dsDNA NNP O
. . O

It PRP O
is VBZ O
interesting JJ O
that IN O
the DT O
DNA NN O
complex NN O
for IN O
wild JJ O
type NN O
forms VBZ O
a DT O
distinct JJ O
band NN O
( , O
lane NN O
3 CD O
in IN O
Figure NNP O
4D CD O
) -RRB- O
, , O
as IN O
opposed VBN O
to IN O
a DT O
more RBR O
diffuse JJ O
band NN O
as IN O
one PRP O
would MD O
expect VB O
if IN O
the DT O
complexes NNS O
contained VBD O
different JJ O
numbers NNS O
of IN O
RdgC NNP O
dimers NNS O
. . O

Assuming VBG O
a DT O
binding VBG O
site NN O
size NN O
of IN O
~ $ O
16 CD O
nt CD O
( SYM O
1 CD O
) -RRB- O
, , O
the DT O
414 CD O
- HYPH O
bp NN O
duplex NN O
DNA NNP O
would MD O
bind VB O
~ $ O
25 CD O
RdgC NNP O
dimers NNS O
if IN O
it PRP O
is VBZ O
fully RB O
saturated JJ O
. . O

RdgC NNP O
is VBZ O
unique JJ O
among IN O
ring NN O
- HYPH O
shaped JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O

Pseudomonas NNP B-Species
aeruginosa NN I-Species
RdgC NNP O
adds VBZ O
a DT O
unique JJ O
member NN O
to IN O
the DT O
repertoire NN O
of IN O
toroidal NN O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
( , O
26 CD O
) -RRB- O
such JJ O
as IN O
D NNP B-Species
. , I-Species
radiodurans NNS I-Species
RecR NNP O
( -LRB- O
27 CD O
) -RRB- O
and CC O
DNA NN O
polymerase NN O
processivity NN O
factors NNS O
, , O
including VBG O
the DT O
beta NN O
subunit NN O
of IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
DNA NNP O
polymerase NN O
III NNP O
( , O
28 CD O
) -RRB- O
, , O
gp45 CD O
of IN O
T4 NNP O
DNA NNP O
polymerase NN O
( , O
29 CD O
) -RRB- O
and CC O
PCNA NNP O
of IN O
eukaryotic JJ O
DNA NNP O
polymerase NN O
delta NN O
( SYM O
30 CD O
, , O
31 CD O
) -RRB- O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

These DT O
proteins NNS O
do VBP O
not RB O
have VB O
an DT O
overall JJ O
sequence NN O
similarity NN O
among IN O
themselves PRP O
, , O
and CC O
their PRP$ O
quaternary JJ O
structures NNS O
also RB O
vary VBP O
. . O

P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NN O
and CC O
E NN B-Species
. . I-Species
coli NN I-Species
beta NN O
clamp NN O
are VBP O
homodimers NNS O
, , O
T4 NN O
gp45 CD O
and CC O
eukaryotic JJ O
PCNAs NNS O
are VBP O
homotrimers NNS O
and CC O
D NN B-Species
. . I-Species
radiodurans NNS I-Species
RecR NN O
is VBZ O
a DT O
homotetramer NN O
. . O

In IN O
P NN B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
, , O
the DT O
inner JJ O
surface NN O
of IN O
the DT O
ring NN O
- HYPH O
shaped JJ O
dimer NN O
is VBZ O
largely RB O
formed VBN O
by IN O
beta NN O
- HYPH O
strands NNS O
, , O
while IN O
the DT O
outer JJ O
surface NN O
of IN O
the DT O
ring NN O
is VBZ O
mostly RB O
formed VBN O
by IN O
alpha NN O
- HYPH O
helices NNS O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

The DT O
predicted VBN O
DNA NN O
- HYPH O
binding VBG O
site NN O
of IN O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
RdgC NNP O
dimer NN O
is VBZ O
primarily RB O
formed VBN O
by IN O
beta NN O
- HYPH O
strands NNS O
and CC O
loops NNS O
. . O

In IN O
contrast NN O
, , O
in IN O
other JJ O
ring NN O
- HYPH O
shaped JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
such JJ O
as IN O
the DT O
beta NN O
subunit NN O
of IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
DNA NNP O
polymerase NN O
III NNP O
( , O
28 CD O
) -RRB- O
, , O
gp45 CD O
of IN O
T4 NNP O
DNA NNP O
polymerase NN O
( SYM O
29 CD O
) -RRB- O
, , O
PCNA NNP O
of IN O
eukaryotic JJ O
DNA NNP O
polymerases NNS O
delta NN O
( , O
30 CD O
, , O
31 CD O
) -RRB- O
and CC O
D NN B-Species
. . I-Species
radiodurans NNS I-Species
RecR NNP O
( SYM O
27 CD O
) -RRB- O
, , O
alpha NN O
- HYPH O
helices NNS O
are VBP O
located VBN O
toward IN O
the DT O
center NN O
of IN O
the DT O
ring NN O
and CC O
are VBP O
surrounded VBN O
by IN O
beta NN O
- HYPH O
strands NNS O
in IN O
the DT O
outermost JJ O
side NN O
of IN O
the DT O
ring NN O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Despite IN O
a DT O
superficial JJ O
resemblance NN O
of IN O
the DT O
overall JJ O
ring NN O
- HYPH O
shaped VBN O
architecture NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
with IN O
those DT O
of IN O
other JJ O
toroidal JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
, , O
the DT O
internal JJ O
arrangement NN O
of IN O
the DT O
secondary JJ O
structure NN O
elements NNS O
in IN O
the DT O
RdgC NNP O
dimer NN O
is VBZ O
strikingly RB O
different JJ O
from IN O
those DT O
of IN O
other JJ O
toroidal JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
. . O

Thus RB O
, , O
RdgC NNP O
is VBZ O
unique JJ O
among IN O
ring NN O
- HYPH O
shaped JJ O
DNA NN O
- HYPH O
binding VBG O
proteins NNS O
. . O

A DT O
number NN O
of IN O
other JJ O
proteins NNS O
involved VBN O
in IN O
DNA NN O
metabolism NN O
also RB O
adopt VBP O
a DT O
ring NN O
- HYPH O
shaped VBN O
structure NN O
despite IN O
diversity NN O
in IN O
the DT O
molecular JJ O
functions NNS O
( SYM O
26 CD O
) -RRB- O
. . O

They PRP O
include VBP O
NAD NNP O
+ CC O
- HYPH O
dependent JJ O
DNA NNP O
ligase NN O
( : O
25 CD O
) -RRB- O
, , O
lambda NN O
exonuclease NN O
( , O
32 CD O
) -RRB- O
, , O
hexameric JJ O
helicases NNS O
, , O
topoisomerases NNS O
, , O
the DT O
trp NN O
RNA NN O
- HYPH O
binding VBG O
attenuation NN O
protein NN O
, , O
the DT O
bacteriophage NN O
head NN O
- HYPH O
to IN O
- HYPH O
tail NN O
connector NN O
and CC O
translin NN O
( SYM O
26 CD O
) -RRB- O
. . O

There EX O
are VBP O
also RB O
many JJ O
examples NNS O
of IN O
the DT O
proteins NNS O
in IN O
DNA NN O
recombination NN O
pathways NNS O
that WDT O
assemble VBP O
into IN O
multi JJ O
- HYPH O
subunit NN O
toroids NNS O
containing VBG O
a DT O
central JJ O
channel NN O
( SYM O
26 CD O
) -RRB- O
. . O

Electron NN O
microscopy NN O
showed VBD O
that IN O
the DT O
E NN B-Species
. . I-Species
coli NN I-Species
RuvB NNP O
protein NN O
, , O
in IN O
the DT O
presence NN O
of IN O
ATP NNP O
, , O
forms VBZ O
a DT O
dodecamer NN O
on IN O
double JJ O
- HYPH O
stranded JJ O
DNA NN O
in IN O
which WDT O
two CD O
stacked VBN O
hexameric JJ O
rings NNS O
encircle VBP O
the DT O
DNA NN O
and CC O
are VBP O
oriented VBN O
in IN O
opposite JJ O
directions NNS O
with IN O
D6 NNP O
symmetry NN O
( SYM O
33 CD O
) -RRB- O
. . O

The DT O
human JJ B-Species
RAD52 NNP O
protein NN O
was VBD O
found VBN O
to TO O
assemble VB O
into IN O
heptameric JJ O
rings NNS O
with IN O
a DT O
large JJ O
funnel NN O
- HYPH O
shaped VBN O
channel NN O
, , O
40 CD O
- SYM O
60 CD O
A NN O
in IN O
diameter NN O
( SYM O
34 CD O
) -RRB- O
. . O

The DT O
human JJ B-Species
DMC1 NNP O
protein NN O
has VBZ O
so RB O
far RB O
been VBN O
detected VBN O
only RB O
as IN O
an DT O
octameric JJ O
ring NN O
( SYM O
35 CD O
) -RRB- O
. . O

Inhibition NN O
mechanism NN O
of IN O
RecA NN O
function NN O
by IN O
RdgC NNP O

RdgC NNP O
inhibits VBZ O
RecA NNP O
- HYPH O
promoted VBN O
DNA NN O
strand NN O
exchange NN O
, , O
RecA NNP O
- HYPH O
mediated VBN O
ATPase NNP O
activity NN O
and CC O
RecA NNP O
- HYPH O
dependent JJ O
LexA NNP O
cleavage NN O
( -LRB- O
1 CD O
) -RRB- O
. . O

It PRP O
was VBD O
observed VBN O
that IN O
the DT O
effects NNS O
of IN O
RdgC NNP O
on IN O
RecA NNP O
- HYPH O
promoted VBN O
DNA NNP O
strand NN O
exchange NN O
were VBD O
much RB O
more RBR O
pronounced JJ O
than IN O
the DT O
effects NNS O
of IN O
RdgC NNP O
on IN O
other JJ O
RecA NNP O
functions NNS O
, , O
when WRB O
RdgC NNP O
was VBD O
added VBN O
to IN O
the DT O
reaction NN O
late RB O
( : O
1 CD O
) -RRB- O
. . O

By IN O
examining VBG O
the DT O
effects NNS O
of IN O
the DT O
DinI NNP O
protein NN O
on IN O
RdgC NNP O
- HYPH O
mediated VBN O
inhibition NN O
of IN O
RecA NNP O
activities NNS O
, , O
it PRP O
was VBD O
concluded VBN O
that IN O
the DT O
potent JJ O
effect NN O
of IN O
RdgC NNP O
in IN O
the DT O
inhibition NN O
of IN O
strand NN O
exchange NN O
did VBD O
not RB O
primarily RB O
reflect VB O
a DT O
displacement NN O
of IN O
RecA NNP O
in IN O
the DT O
nucleoprotein NN O
filament NN O
by IN O
RdgC NNP O
, , O
but CC O
instead RB O
a DT O
binding NN O
of IN O
RdgC NNP O
to IN O
the DT O
dsDNA NNP O
substrate NN O
so IN O
as IN O
to TO O
make VB O
it PRP O
unavailable JJ O
to IN O
the DT O
filaments NNS O
for IN O
strand NN O
exchange NN O
( , O
1 CD O
) -RRB- O
. . O

Our PRP$ O
work NN O
contributes VBZ O
to IN O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
inhibition NN O
mechanism NN O
of IN O
RecA NNP O
function NN O
by IN O
RdgC NNP O
. . O

The DT O
ring NN O
- HYPH O
shaped JJ O
architecture NN O
with IN O
a DT O
central JJ O
hole NN O
that WDT O
is VBZ O
suitable JJ O
for IN O
the DT O
binding NN O
of IN O
dsDNA NNP O
lends VBZ O
RdgC NNP O
with IN O
a DT O
capacity NN O
to TO O
hold VB O
dsDNA NNP O
very RB O
tightly RB O
. . O

Therefore RB O
, , O
we PRP O
suggest VBP O
that IN O
RdgC NNP O
dimers NNS O
probably RB O
function VBP O
as IN O
a DT O
tight JJ O
dsDNA NN O
gripper NN O
and CC O
physically RB O
block VBP O
access NN O
to IN O
the DT O
target NN O
dsDNA NNP O
by IN O
RecA NNP O
filaments NNS O
, , O
because IN O
tight JJ O
encircling NN O
of IN O
dsDNA NNP O
by IN O
RdgC NNP O
dimers NNS O
, , O
possibly RB O
as IN O
a DT O
linear JJ O
aggregate NN O
, , O
would MD O
prevent VB O
the DT O
two CD O
strands NNS O
from IN O
dissociating VBG O
. . O

However RB O
, , O
it PRP O
remains VBZ O
unclear JJ O
how WRB O
the DT O
closed JJ O
- HYPH O
ring NN O
structure NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
might MD O
allow VB O
binding NN O
of IN O
a DT O
large JJ O
number NN O
of IN O
RdgC NNP O
dimers NNS O
on IN O
the DT O
duplex JJ O
DNA NNP O
. . O

It PRP O
may MD O
be VB O
conceivable JJ O
that IN O
each DT O
RdgC NNP O
dimer NN O
can MD O
open VB O
temporarily RB O
at IN O
one CD O
or CC O
both DT O
of IN O
its PRP$ O
two CD O
inter JJ O
- HYPH O
subunit NN O
interfaces NNS O
so IN O
that IN O
dsDNA NNP O
can MD O
enter VB O
the DT O
central JJ O
hole NN O
. . O

RdgC NNP O
was VBD O
at IN O
its PRP$ O
highest JJS O
level NN O
during IN O
exponential JJ O
phase NN O
, , O
reaching VBG O
its PRP$ O
maximum NN O
of IN O
~ $ O
1000 CD O
dimers NNS O
per IN O
E NNP B-Species
. . I-Species
coli NN I-Species
cell NN O
. . O

Its PRP$ O
level NN O
decreased VBD O
sharply RB O
to IN O
~ $ O
50 CD O
dimers NNS O
per IN O
cell NN O
in IN O
stationary JJ O
phase NN O
( SYM O
2 CD O
) -RRB- O
. . O

Under IN O
normal JJ O
cellular JJ O
conditions NNS O
, , O
RecA NNP O
is VBZ O
maintained VBN O
at IN O
~ $ O
1000 CD O
molecules NNS O
per IN O
cell NN O
( : O
http NN O
: : O
/ : O
/ SYM O
www ADD O
. . O
els NNS O
. . O
net NN O
/ SYM O
) -RRB- O
. . O

Following VBG O
LexA NNP O
repressor NN O
cleavage NN O
, , O
the DT O
level NN O
of IN O
RecA NNP O
protein NN O
in IN O
the DT O
cell NN O
increases VBZ O
by IN O
as RB O
much JJ O
as IN O
20 CD O
- HYPH O
fold NN O
. . O

RdgC NNP O
inhibition NN O
of IN O
the DT O
RecA NNP O
function NN O
by IN O
a DT O
simple JJ O
competition NN O
mechanism NN O
at IN O
the DT O
cellular JJ O
concentration NN O
of IN O
RdgC NNP O
clearly RB O
requires VBZ O
a DT O
much RB O
higher JJR O
affinity NN O
for IN O
DNA NN O
by IN O
RdgC NNP O
than IN O
RecA NNP O
. . O

Possible JJ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
between IN O
RdgC NNP O
dimers NNS O
might MD O
have VB O
a DT O
profound JJ O
effect NN O
on IN O
the DT O
affinity NN O
for IN O
DNA NN O
, , O
when WRB O
a DT O
large JJ O
number NN O
of IN O
RdgC NNP O
dimers NNS O
are VBP O
bound VBN O
on IN O
a DT O
duplex JJ O
DNA NN O
. . O

If IN O
only RB O
one CD O
of IN O
the DT O
two CD O
inter JJ O
- HYPH O
subunit NN O
interfaces NNS O
can MD O
open VB O
up RP O
and CC O
the DT O
2 CD O
- HYPH O
fold NN O
symmetry NN O
axes NNS O
of IN O
the DT O
RdgC NNP O
dimers NNS O
are VBP O
misaligned VBN O
sufficiently RB O
, , O
the DT O
escape NN O
of IN O
DNA NN O
from IN O
a DT O
linear JJ O
array NN O
of IN O
interacting VBG O
RdgC NNP O
dimers NNS O
would MD O
be VB O
extremely RB O
difficult JJ O
. . O

Alternatively RB O
, , O
both CC O
inter JJ O
- HYPH O
subunit NN O
interfaces NNS O
of IN O
each DT O
dimer NN O
may MD O
open VB O
up RP O
simultaneously RB O
. . O

A DT O
line NN O
of IN O
indirect JJ O
evidence NN O
for IN O
the DT O
possible JJ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
between IN O
RdgC NNP O
dimers NNS O
is VBZ O
provided VBN O
by IN O
the DT O
cooperative JJ O
binding NN O
of IN O
RdgC NNP O
to IN O
DNA NNP O
( : O
7 CD O
) -RRB- O
. . O

Cooperativity NN O
of IN O
RdgC NNP O
binding NN O
may MD O
be VB O
caused VBN O
by IN O
local JJ O
and CC O
distant JJ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
( : O
7 CD O
) -RRB- O
. . O

A DT O
kind NN O
of IN O
side NN O
- HYPH O
by IN O
- HYPH O
side NN O
interaction NN O
between IN O
two CD O
adjacent JJ O
molecules NNS O
of IN O
RdgC NNP O
dimer NN O
is VBZ O
present JJ O
in IN O
the DT O
crystal NN O
, , O
burying VBG O
an DT O
accessible JJ O
surface NN O
area NN O
of IN O
~ $ O
750 CD O
A NN O
2 CD O
at IN O
the DT O
interface NN O
. . O

The DT O
interaction NN O
involves VBZ O
mostly RB O
the DT O
less JJR O
polar JJ O
side NN O
surface NN O
of IN O
the DT O
dimer NN O
( , O
left JJ O
side NN O
of IN O
Figure NNP O
4A NNP O
) -RRB- O
, , O
with IN O
2 CD O
- HYPH O
fold NN O
symmetry NN O
axes NNS O
of IN O
the DT O
two CD O
interacting VBG O
RdgC NNP O
molecules NNS O
making VBG O
an DT O
angle NN O
of IN O
~ $ O
90 CD O
degrees NNS O
when WRB O
viewed VBN O
down IN O
the DT O
central JJ O
holes NNS O
and CC O
~ $ O
15 CD O
degrees NNS O
when WRB O
viewed VBN O
perpendicular JJ O
to IN O
the DT O
holes NNS O
. . O

This DT O
may MD O
explain VB O
the DT O
observed VBN O
DNA NN O
bending NN O
by IN O
RdgC NNP O
, , O
which WDT O
was VBD O
speculated VBN O
to TO O
be VB O
a DT O
necessary JJ O
step NN O
in IN O
the DT O
working VBG O
mechanism NN O
of IN O
RdgC NNP O
, , O
if IN O
one PRP O
can MD O
assume VB O
that IN O
the DT O
strong JJ O
protein NN O
- HYPH O
protein NN O
interactions NNS O
in IN O
the DT O
crystal NN O
were VBD O
relevant JJ O
for IN O
protein NN O
- HYPH O
protein NN O
interactions NNS O
in IN O
solution NN O
( : O
7 CD O
) -RRB- O
. . O

RdgC NNP O
protein NN O
was VBD O
shown VBN O
to TO O
have VB O
a DT O
potent JJ O
effect NN O
on IN O
RecA NNP O
protein NN O
- HYPH O
promoted VBN O
DNA NN O
strand NN O
exchange NN O
in IN O
E NNP B-Species
. . I-Species
coli NNP I-Species
( -LRB- O
1 CD O
) -RRB- O
. . O

In IN O
a DT O
series NN O
of IN O
experiments NNS O
, , O
RdgC NNP O
was VBD O
added VBN O
after IN O
RecA NNP O
filaments NNS O
had VBD O
formed VBN O
on IN O
the DT O
ssDNA NNP O
and CC O
5 CD O
min NN O
after IN O
the DT O
linear JJ O
dsDNA NNP O
was VBD O
added VBN O
. . O

With IN O
3 CD O
mu NNS O
M NNP O
RecA NNP O
, , O
a DT O
sharp JJ O
reduction NN O
in IN O
DNA NN O
strand NN O
exchange NN O
products NNS O
was VBD O
seen VBN O
with IN O
0 CD O
. . O
4 CD O
mu NNS O
M NNP O
RdgC NNP O
, , O
and CC O
the DT O
generation NN O
of IN O
products NNS O
was VBD O
abolished VBN O
at IN O
0 CD O
. . O
8 CD O
mu NN O
M NNP O
RdgC NNP O
( SYM O
1 CD O
) -RRB- O
. . O

This DT O
suggests VBZ O
that IN O
the DT O
binding VBG O
affinity NN O
of IN O
RdgC NNP O
to IN O
dsDNA NNP O
is VBZ O
considerably RB O
higher JJR O
than IN O
that DT O
of IN O
RecA NNP O
. . O

The DT O
high JJ O
affinity NN O
of IN O
RdgC NNP O
could MD O
be VB O
explained VBN O
by IN O
its PRP$ O
ring NN O
shape NN O
and CC O
the DT O
suggested VBN O
mode NN O
of IN O
DNA NNP O
binding NN O
. . O

Tetrameric JJ O
species NN O
of IN O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
, , O
which WDT O
started VBD O
to TO O
form VB O
at IN O
around IN O
2 CD O
micro NN O
M NN O
concentrations NNS O
, , O
were VBD O
speculated VBN O
to TO O
be VB O
the DT O
species NNS O
with IN O
the DT O
most RBS O
potent JJ O
inhibitory JJ O
effect NN O
, , O
possibly RB O
by IN O
having VBG O
a DT O
higher JJR O
affinity NN O
for IN O
DNA NNP O
( : O
1 CD O
) -RRB- O
. . O

Higher JJR O
affinity NN O
for IN O
DNA NN O
of IN O
the DT O
tetrameric JJ O
species NNS O
could MD O
be VB O
understood VBN O
, , O
if IN O
the DT O
formation NN O
of IN O
a DT O
tetramer NN O
in IN O
solution NN O
involves VBZ O
a DT O
protein NN O
- HYPH O
protein NN O
interaction NN O
similar JJ O
to IN O
the DT O
side NN O
- HYPH O
by IN O
- HYPH O
side NN O
interaction NN O
between IN O
two CD O
adjacent JJ O
RdgC NNP O
dimers NNS O
in IN O
the DT O
crystal NN O
, , O
although IN O
there EX O
is VBZ O
no DT O
experimental JJ O
evidence NN O
. . O

Obviously RB O
, , O
there EX O
are VBP O
still RB O
many JJ O
open JJ O
questions NNS O
that WDT O
need VBP O
to TO O
be VB O
addressed VBN O
in IN O
future JJ O
biochemical JJ O
experiments NNS O
. . O

SUMMARY NN O

The DT O
crystal NN O
structure NN O
of IN O
RdgC NNP O
, , O
a DT O
recombination NN O
- HYPH O
associated VBN O
DNA NN O
- HYPH O
binding VBG O
protein NN O
, , O
determined VBN O
in IN O
this DT O
study NN O
reveals VBZ O
that IN O
the DT O
polypeptide NN O
chain NN O
is VBZ O
uniquely RB O
folded VBN O
and CC O
two CD O
monomers NNS O
associate VBP O
to TO O
form VB O
a DT O
ring NN O
- HYPH O
shaped JJ O
dimer NN O
with IN O
a DT O
central JJ O
hole NN O
of IN O
~ $ O
30 CD O
A NN O
diameter NN O
. . O

The DT O
inner JJ O
surface NN O
around IN O
the DT O
central JJ O
hole NN O
is VBZ O
rich JJ O
in IN O
positively RB O
charged VBN O
residues NNS O
. . O

These DT O
structural JJ O
features NNS O
suggest VBP O
that IN O
dsDNA NNP O
runs VBZ O
through IN O
the DT O
central JJ O
hole NN O
when WRB O
it PRP O
binds VBZ O
to IN O
RdgC NNP O
dimers NNS O
. . O

This DT O
idea NN O
is VBZ O
supported VBN O
by IN O
our PRP$ O
mutational JJ O
studies NNS O
, , O
which WDT O
indicate VBP O
that IN O
the DT O
conserved VBN O
, , O
positively RB O
charged VBN O
residues NNS O
around IN O
the DT O
central JJ O
hole NN O
are VBP O
important JJ O
for IN O
dsDNA NNP O
binding NN O
. . O

The DT O
toroidal JJ O
architecture NN O
of IN O
the DT O
RdgC NNP O
dimer NN O
provides VBZ O
a DT O
sound JJ O
framework NN O
for IN O
a DT O
better JJR O
understanding NN O
of IN O
its PRP$ O
role NN O
in IN O
homologous JJ O
recombination NN O
. . O

Coordinates NNS O

Atomic JJ O
coordinates NNS O
and CC O
the DT O
structure NN O
factor NN O
data NNS O
have VBP O
been VBN O
deposited VBN O
in IN O
the DT O
Protein NNP O
Data NNP O
Bank NNP O
( HYPH O
accession NN O
code NN O
2OWY NNP O
) -RRB- O
. . O

SUPPLEMENTARY NNP O
DATA NNP O

Supplementary JJ O
Data NNS O
are VBP O
available JJ O
at IN O
NAR NNP O
Online NNP O
. . O

Supplementary JJ O
Material NN O

Port NN O
site NN O
herniation NN O
of IN O
the DT O
small JJ O
bowel NN O
following VBG O
laparoscopy NN O
- HYPH O
assisted VBN O
distal JJ O
gastrectomy NN O
: : O
a DT O
case NN O
report NN O

Abstract JJ O

Introduction NN O

Port NN O
- HYPH O
site NN O
herniation NN O
is VBZ O
a DT O
rare JJ O
but CC O
potentially RB O
dangerous JJ O
complication NN O
after IN O
laparoscopic JJ O
surgery NN O
. . O

Closure NN O
of IN O
port NN O
sites NNS O
, , O
especially RB O
those DT O
measuring VBG O
10 CD O
mm NNS O
or CC O
more JJR O
, , O
has VBZ O
been VBN O
recommended VBN O
to TO O
avoid VB O
such PDT O
an DT O
event NN O
. . O

Case NN O
presentation NN O

We PRP O
herein RB O
report VBP O
the DT O
only JJ O
case NN O
of IN O
a DT O
port NN O
site NN O
hernia NN O
among IN O
a DT O
series NN O
52 CD O
consecutive JJ O
cases NNS O
of IN O
laparoscopy NN O
- HYPH O
assisted VBN O
distal NN O
gastrectomy NN O
( , O
LADG NNP O
) -RRB- O
carried VBN O
out RP O
by IN O
our PRP$ O
unit NN O
between IN O
July NNP O
2002 CD O
and CC O
March NNP O
2007 CD O
. . O

In IN O
this DT O
case NN O
the DT O
small JJ O
bowel NN O
herniated VBN O
and CC O
incarcerated VBD O
through IN O
the DT O
port NN O
site NN O
on IN O
day NN O
4 CD O
after IN O
LADG NNP O
despite IN O
closure NN O
of IN O
the DT O
fascia NN O
. . O

Initial JJ O
manifestations NNS O
experienced VBN O
by IN O
the DT O
patient NN B-Species
, , O
possibly RB O
due JJ O
to IN O
obstruction NN O
, , O
and CC O
including VBG O
mild JJ O
abdominal JJ O
pain NN O
and CC O
nausea NN O
, , O
occurred VBD O
on IN O
the DT O
third JJ O
day NN O
postoperatively RB O
. . O

The DT O
definitive JJ O
diagnosis NN O
was VBD O
made VBN O
on IN O
day NN O
4 CD O
based VBN O
on IN O
symptoms NNS O
related VBN O
to IN O
leakage NN O
from IN O
the DT O
duodenal JJ O
stump NN O
, , O
which WDT O
was VBD O
considered VBN O
to TO O
have VB O
developed VBN O
after IN O
severe JJ O
obstruction NN O
of IN O
the DT O
bowel NN O
. . O

Re IN O
- HYPH O
operation NN O
for IN O
reduction NN O
of IN O
the DT O
incarcerated JJ O
bowel NN O
and CC O
tube NN O
duodenostomy NN O
with IN O
peritoneal JJ O
drainage NN O
were VBD O
required VBN O
to TO O
manage VB O
this DT O
complication NN O
. . O

Conclusion NN O

We PRP O
present VBP O
this DT O
case NN O
report NN O
and CC O
review NN O
of IN O
literature NN O
to TO O
discuss VB O
further RB O
regarding VBG O
methods NNS O
of IN O
fascial JJ O
closure NN O
after IN O
laparoscopic JJ O
surgery NN O
. . O

Introduction NN O

Bowel NN O
herniation NN O
through IN O
the DT O
fascial JJ O
defect NN O
created VBN O
by IN O
the DT O
entry NN O
of IN O
trocars NNS O
is VBZ O
now RB O
recognized VBN O
as IN O
a DT O
rare JJ O
but CC O
potentially RB O
serious JJ O
complication NN O
of IN O
laparoscopic JJ O
surgery NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Although IN O
port NN O
site NN O
herniation NN O
is VBZ O
an DT O
infrequent JJ O
complication NN O
, , O
there EX O
are VBP O
still RB O
some DT O
reports NNS O
of IN O
port NN O
site NN O
herniation NN O
after IN O
these DT O
procedures NNS O
, , O
even RB O
with IN O
closure NN O
of IN O
trocar NN O
sites NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

The DT O
following VBG O
report NN O
describes VBZ O
a DT O
case NN O
of IN O
a DT O
trocar NN O
site NN O
hernia NN O
that WDT O
evolved VBD O
into IN O
leakage NN O
from IN O
the DT O
duodenal JJ O
stump NN O
after IN O
laparoscopy NN O
- HYPH O
assisted VBN O
distal NN O
gastrectomy NN O
( , O
LADG NNP O
) -RRB- O
. . O

Progression NN O
occurred VBD O
because IN O
of IN O
complete JJ O
obstruction NN O
of IN O
the DT O
incarcerated JJ O
bowel NN O
after IN O
a DT O
Roux NNP O
- HYPH O
en NNP O
- HYPH O
Y NN O
reconstruction NN O
. . O

We PRP O
describe VBP O
the DT O
significance NN O
of IN O
complete JJ O
closure NN O
of IN O
the DT O
fascial JJ O
defect NN O
at IN O
the DT O
trocar NN O
site NN O
including VBG O
the DT O
peritoneum NN O
in IN O
the DT O
prevention NN O
of IN O
this DT O
condition NN O
, , O
as RB O
well RB O
as IN O
the DT O
importance NN O
of IN O
early JJ O
diagnosis NN O
to TO O
avoid VB O
serious JJ O
subsequent JJ O
events NNS O
. . O

Case NN O
presentation NN O

An DT O
80 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
man NN B-Species
was VBD O
found VBN O
to TO O
have VB O
early JJ O
gastric JJ O
cancer NN O
during IN O
his PRP$ O
yearly JJ O
check NN O
- HYPH O
up NN O
by IN O
gastrointestinal JJ O
endoscopy NN O
. . O

He PRP O
was VBD O
158 CD O
cm NNS O
in IN O
height NN O
and CC O
weighed VBD O
62 CD O
kg NNS O
. . O

Gastrointestinal JJ O
endoscopy NN O
showed VBD O
a DT O
depressed JJ O
lesion NN O
that WDT O
was VBD O
diagnosed VBN O
as IN O
early JJ O
gastric JJ O
cancer NN O
by IN O
pathological JJ O
examination NN O
of IN O
biopsy NN O
specimens NNS O
. . O

He PRP O
underwent VBD O
LADG NNP O
with IN O
regional JJ O
lymph JJ O
node NN O
dissection NN O
( , O
D1 NN O
including VBG O
the DT O
nodes NNS O
surrounding VBG O
the DT O
origin NN O
of IN O
left JJ O
gastric JJ O
artery NN O
) -RRB- O
. . O

A DT O
12 CD O
- HYPH O
mm NN O
trocar NN O
for IN O
the DT O
laparoscope NN O
was VBD O
placed VBN O
in IN O
the DT O
umbilicus NN O
. . O

Pneumoperitoneum NN O
was VBD O
then RB O
established VBN O
with IN O
carbon NN O
dioxide NN O
and CC O
the DT O
intraperitoneal JJ O
pressure NN O
was VBD O
maintained VBN O
at IN O
10 CD O
mm NN O
Hg NNP O
. . O

Two CD O
more JJR O
12 CD O
- HYPH O
mm NN O
trocars NNS O
were VBD O
inserted VBN O
in IN O
the DT O
midclavicular JJ O
line NN O
below IN O
the DT O
costal JJ O
margin NN O
and CC O
2 CD O
cm NNS O
above IN O
the DT O
umbilicus NN O
on IN O
each DT O
of IN O
both DT O
flanks NNS O
and CC O
were VBD O
used VBN O
for IN O
active JJ O
surgical JJ O
instruments NNS O
. . O

All DT O
trocars NNS O
used VBN O
were VBD O
the DT O
non AFX O
- HYPH O
bladed JJ O
type NN O
. . O

The DT O
specimen NN O
was VBD O
removed VBN O
through IN O
a DT O
small JJ O
medial JJ O
incision NN O
which WDT O
was VBD O
55 CD O
mm NN O
in IN O
length NN O
placed VBN O
after IN O
resection NN O
of IN O
the DT O
stomach NN O
, , O
and CC O
then RB O
Roux NNP O
- HYPH O
en NNP O
- HYPH O
Y NNP O
reconstruction NN O
( -LRB- O
RY NNP O
) -RRB- O
was VBD O
carried VBN O
out RP O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

A DT O
tubular JJ O
shaped VBN O
drainage NN O
tube NN O
10 CD O
mm NN O
in IN O
diameter NN O
was VBD O
inserted VBN O
and CC O
placed VBN O
through IN O
the DT O
upper JJ O
trocar NN O
site NN O
made VBN O
on IN O
the DT O
right JJ O
flank NN O
. . O

Wound NN O
defect NN O
at IN O
the DT O
umbilical JJ O
port NN O
site NN O
was VBD O
sutured VBN O
completely RB O
including VBG O
the DT O
peritoneum NN O
with IN O
0 CD O
absorbable JJ O
suture NN O
and CC O
fascial JJ O
incisions NNS O
at IN O
all DT O
other JJ O
trocar NN O
insertion NN O
sites NNS O
were VBD O
closed VBN O
with IN O
2 CD O
- HYPH O
0 CD O
absorbable JJ O
sutures NNS O
. . O

Surgical JJ O
duration NN O
was VBD O
263 CD O
min NN O
, , O
and CC O
the DT O
volume NN O
of IN O
blood NN O
loss NN O
was VBD O
less JJR O
than IN O
50 CD O
mL NNS O
with IN O
no DT O
blood NN O
transfusion NN O
. . O

Postoperatively RB O
, , O
the DT O
patient NN B-Species
complained VBD O
of IN O
an DT O
acidic JJ O
feeling NN O
in IN O
his PRP$ O
stomach NN O
; : O
however RB O
, , O
there EX O
were VBD O
no DT O
remarkable JJ O
abnormalities NNS O
on IN O
biochemical JJ O
examination NN O
of IN O
serum NN O
. . O

Radiological JJ O
findings NNS O
did VBD O
not RB O
suggest VB O
bowel NN O
obstruction NN O
until IN O
3 CD O
days NNS O
postoperatively RB O
, , O
although IN O
mild JJ O
symptoms NNS O
such JJ O
as IN O
general JJ O
malaise NN O
and CC O
vague JJ O
abdominal JJ O
pain NN O
were VBD O
reported VBN O
on IN O
day NN O
three CD O
. . O

However RB O
, , O
on IN O
day NN O
4 CD O
, , O
the DT O
patient NN B-Species
started VBD O
to TO O
complain VB O
of IN O
upper JJ O
abdominal JJ O
pain NN O
and CC O
developed VBD O
a DT O
high JJ O
grade NN O
fever NN O
( : O
38 CD O
degrees NNS O
C NN O
) -RRB- O
. . O

Complete JJ O
obstruction NN O
of IN O
the DT O
small JJ O
bowel NN O
and CC O
leakage NN O
of IN O
contrast NN O
media NN O
were VBD O
demonstrated VBN O
by IN O
Gastrografin NNP O
swallow NN O
and CC O
subsequent JJ O
abdominal JJ O
computed VBN O
tomography NN O
( -LRB- O
CT NNP O
) -RRB- O
. . O

CT NNP O
also RB O
showed VBD O
a DT O
mass JJ O
lesion NN O
at IN O
the DT O
trocar NN O
insertion NN O
site NN O
on IN O
the DT O
upper JJ O
left JJ O
flank NN O
, , O
suggesting VBG O
herniation NN O
through IN O
the DT O
port NN O
site NN O
( , O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

Marked JJ O
dilatation NN O
of IN O
the DT O
duodenum NN O
including VBG O
the DT O
horizontal JJ O
part NN O
and CC O
second JJ O
portion NN O
was VBD O
observed VBN O
. . O

A DT O
diagnosis NN O
of IN O
staple JJ O
failure NN O
of IN O
the DT O
stump NN O
of IN O
the DT O
duodenum NN O
and CC O
port NN O
- HYPH O
site NN O
herniation NN O
of IN O
the DT O
small JJ O
bowel NN O
was VBD O
made VBN O
, , O
and CC O
exploratory JJ O
laparotomy NN O
was VBD O
carried VBN O
out RP O
. . O

A DT O
small JJ O
medial JJ O
incision NN O
that WDT O
had VBD O
been VBN O
made VBN O
at IN O
the DT O
initial JJ O
surgery NN O
was VBD O
extended VBN O
downward RB O
to IN O
the DT O
umbilicus NN O
to TO O
open VB O
the DT O
peritoneal JJ O
cavity NN O
. . O

As IN O
we PRP O
expected VBD O
, , O
the DT O
small JJ O
bowel NN O
was VBD O
incarcerated VBN O
into IN O
the DT O
peritoneal JJ O
defect NN O
in IN O
the DT O
abdominal JJ O
wall NN O
created VBN O
by IN O
the DT O
trocar NN O
placed VBN O
in IN O
the DT O
left JJ O
upper JJ O
flank NN O
leading VBG O
to IN O
complete JJ O
obstruction NN O
of IN O
the DT O
bowel NN O
( , O
Fig NNP O
. . O
3 CD O
) -RRB- O
. . O

Part NN O
of IN O
the DT O
jejunum NN O
30 CD O
cm NN O
distal NN O
from IN O
the DT O
ligament NN O
of IN O
Treitz NNP O
herniated VBN O
around IN O
the DT O
fascial JJ O
stitch NN O
, , O
which WDT O
still RB O
existed VBD O
at IN O
the DT O
time NN O
of IN O
the DT O
re NN O
- HYPH O
exploration NN O
. . O

The DT O
peritoneal JJ O
cavity NN O
was VBD O
contaminated VBN O
with IN O
intestinal JJ O
juice NN O
. . O

Close JJ O
examination NN O
after IN O
reduction NN O
of IN O
the DT O
incarcerated JJ O
bowel NN O
did VBD O
not RB O
demonstrate VB O
necrosis NN O
of IN O
the DT O
intestine NN O
, , O
and CC O
thus RB O
, , O
we PRP O
decided VBD O
not RB O
to TO O
resect VB O
this DT O
lesion NN O
. . O

Leakage NN O
of IN O
intestinal JJ O
juice NN O
through IN O
a DT O
pinhole NN O
fistula NN O
at IN O
the DT O
duodenal NN O
stump NN O
was VBD O
also RB O
observed VBN O
. . O

Tube NN O
duodenostomy NN O
was VBD O
performed VBN O
with IN O
an DT O
omental JJ O
patch NN O
used VBN O
for IN O
closure NN O
of IN O
the DT O
fistula NN O
. . O

The DT O
peritoneal JJ O
defect NN O
was VBD O
also RB O
closed VBN O
. . O

The DT O
postoperative JJ O
course NN O
was VBD O
fairly RB O
good JJ O
without IN O
high JJ O
output NN O
of IN O
the DT O
intestinal JJ O
juice NN O
leakage NN O
or CC O
sepsis NNS O
. . O

The DT O
patient NN B-Species
remained VBD O
in IN O
the DT O
intensive JJ O
care NN O
unit NN O
for IN O
5 CD O
days NNS O
after IN O
re NN O
- HYPH O
operation NN O
, , O
and CC O
was VBD O
then RB O
transferred VBN O
to IN O
the DT O
general JJ O
ward NN O
. . O

Discussion NN O

Port NN O
- HYPH O
site NN O
herniation NN O
, , O
which WDT O
is VBZ O
one CD O
of IN O
the DT O
major JJ O
complications NNS O
after IN O
laparoscopic JJ O
procedures NNS O
[ -LRB- O
1 CD O
] -RRB- O
, , O
sometimes RB O
develops VBZ O
into IN O
serious JJ O
complications NNS O
, , O
such JJ O
as IN O
bowel NN O
obstruction NN O
due IN O
to IN O
incarceration NN O
into IN O
the DT O
fascial JJ O
defect NN O
at IN O
the DT O
port NN O
site NN O
. . O

Boughey NNP O
et FW O
al NNP O
. . O
have VBP O
reported VBN O
four CD O
cases NNS O
of IN O
Richter NNP O
' POS O
s NN O
hernia NN O
that WDT O
occurred VBD O
at IN O
a DT O
port NN O
site NN O
after IN O
laparoscopic JJ O
surgery NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

They PRP O
reviewed VBD O
previous JJ O
reports NNS O
and CC O
found VBD O
the DT O
incidence NN O
to TO O
be VB O
0 CD O
. . O
2 CD O
to TO O
3 CD O
% NN O
. . O

A DT O
report NN O
describes VBZ O
the DT O
incidence NN O
of IN O
hernia NN O
as IN O
0 CD O
. . O
23 CD O
% NN O
for IN O
10 CD O
- HYPH O
mm NN O
trocar NN O
use NN O
, , O
rising VBG O
to IN O
3 CD O
. . O
1 CD O
% NN O
for IN O
the DT O
12 CD O
- HYPH O
mm NN O
trocar NN O
[ -LRB- O
2 CD O
] -RRB- O
suggesting VBG O
that IN O
the DT O
wound NN O
created VBN O
by IN O
a DT O
larger JJR O
port NN O
carries VBZ O
a DT O
greater JJR O
risk NN O
of IN O
herniation NN O
. . O

Most JJS O
surgeons NNS O
now RB O
routinely RB O
close VBP O
the DT O
fascia NN O
of IN O
port NN O
sites NNS O
to TO O
prevent VB O
this DT O
complication NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

According VBG O
to IN O
previous JJ O
reports NNS O
, , O
port NN O
site NN O
herniation NN O
apparently RB O
happens VBZ O
more RBR O
often RB O
with IN O
the DT O
use NN O
of IN O
bladed VBN O
type NN O
trocars NNS O
than IN O
non NN O
- HYPH O
bladed JJ O
type NN O
trocars NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Indeed RB O
, , O
Kolata NNP O
demonstrated VBD O
that IN O
the DT O
wounds NNS O
made VBN O
by IN O
the DT O
non NN O
- HYPH O
bladed JJ O
trocar NN O
were VBD O
narrower JJR O
than IN O
those DT O
created VBN O
by IN O
cutting VBG O
tip NN O
trocars NNS O
in IN O
a DT O
pig NN B-Species
experimental JJ O
model NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Several JJ O
reports NNS O
even RB O
concluded VBD O
that IN O
port NN O
sites NNS O
created VBN O
by IN O
non NN O
- HYPH O
bladed JJ O
trocars NNS O
do VBP O
not RB O
require VB O
fascial JJ O
closure NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
current JJ O
case NN O
suggests VBZ O
that IN O
thick JJ O
preperitoneum NN O
is VBZ O
a DT O
potential JJ O
space NN O
that WDT O
allows VBZ O
for IN O
the DT O
development NN O
of IN O
bowel NN O
herniation NN O
even RB O
with IN O
the DT O
use NN O
of IN O
non NN O
- HYPH O
bladed VBN O
type NN O
trocars NNS O
. . O

A DT O
previous JJ O
report NN O
also RB O
described VBD O
port NN O
- HYPH O
site NN O
herniation NN O
, , O
despite IN O
the DT O
closure NN O
of IN O
the DT O
superficial JJ O
layer NN O
of IN O
the DT O
fascial JJ O
defect NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
current JJ O
case NN O
did VBD O
not RB O
demonstrate VB O
any DT O
of IN O
the DT O
risk NN O
factors NNS O
suggested VBN O
previously RB O
[ -LRB- O
6 CD O
] -RRB- O
; , O
1 CD O
) -RRB- O
enlargement NN O
of IN O
a DT O
port NN O
site NN O
to TO O
remove VB O
specimen NN O
; : O
2 CD O
) SYM O
glucose NN O
intolerance NN O
; : O
3 CD O
) SYM O
obesity NN O
; : O
or CC O
4 CD O
) SYM O
extensive JJ O
manipulation NN O
of IN O
the DT O
trocar NN O
during IN O
relatively RB O
prolonged VBN O
surgical JJ O
duration NN O
, , O
which WDT O
might MD O
have VB O
enlarged VBN O
the DT O
trocar NN O
site NN O
and CC O
thus RB O
induced VBN O
bowel NN O
herniation NN O
. . O

Therefore RB O
, , O
we PRP O
recommend VBP O
closing VBG O
the DT O
fascial JJ O
defect NN O
, , O
including VBG O
the DT O
peritoneum NN O
, , O
especially RB O
if IN O
the DT O
trocar NN O
size NN O
is VBZ O
more JJR O
than IN O
10 CD O
- HYPH O
mm NN O
and CC O
in IN O
the DT O
presence NN O
of IN O
any DT O
of IN O
the DT O
risk NN O
factors NNS O
described VBN O
above RB O
. . O

However RB O
, , O
it PRP O
is VBZ O
sometimes RB O
difficult JJ O
to TO O
completely RB O
close VB O
the DT O
defect NN O
, , O
including VBG O
the DT O
peritoneum NN O
, , O
especially RB O
in IN O
obese JJ O
patients NNS B-Species
. . O

Shaher NNP O
reviewed VBD O
different JJ O
wound NN O
closure NN O
techniques NNS O
by IN O
a DT O
literature NN O
search NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

In IN O
this DT O
review NN O
, , O
old JJ O
methods NNS O
using VBG O
classical JJ O
instruments NNS O
including VBG O
Deschamps NNP O
needle NN O
are VBP O
also RB O
useful JJ O
as RB O
well RB O
as IN O
special JJ O
wound NN O
devices NNS O
designed VBN O
for IN O
port NN O
site NN O
closure NN O
. . O

Elashry NNP O
et FW O
al NNP O
. . O
described VBD O
a DT O
prospective JJ O
randomized JJ O
study NN O
demonstrating VBG O
that IN O
the DT O
Carter NNP O
- HYPH O
Thomason NNP O
device NN O
was VBD O
faster JJR O
and CC O
resulted VBD O
in IN O
fewer JJR O
port NN O
- HYPH O
closure NN O
- HYPH O
related VBN O
complications NNS O
among IN O
eight CD O
different JJ O
techniques NNS O
tested VBN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Insertion NN O
of IN O
a DT O
SURGICEL NNP O
plug NN O
into IN O
the DT O
muscular JJ O
layer NN O
of IN O
trocar NN O
wounds NNS O
has VBZ O
also RB O
been VBN O
proposed VBN O
by IN O
Chiu NNP O
et FW O
al NNP O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Alternatively RB O
, , O
tangential JJ O
insertion NN O
of IN O
a DT O
trocar NN O
through IN O
the DT O
abdominal JJ O
wall NN O
might MD O
be VB O
effective JJ O
in IN O
reducing VBG O
the DT O
size NN O
of IN O
fascial JJ O
defects NNS O
. . O

Moreover RB O
, , O
recent JJ O
publications NNS O
have VBP O
demonstrated VBN O
that IN O
radially RB O
expanding VBG O
type NN O
trocars NNS O
could MD O
be VB O
useful JJ O
to TO O
avoid VB O
the DT O
necessity NN O
of IN O
closing VBG O
the DT O
fascial JJ O
defect NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Symptoms NNS O
of IN O
trocar NN O
- HYPH O
site NN O
herniation NN O
vary VBP O
depending VBG O
on IN O
the DT O
severity NN O
of IN O
bowel NN O
obstruction NN O
. . O

Mild JJ O
symptoms NNS O
such JJ O
as IN O
slight JJ O
nausea NN O
and CC O
vague JJ O
abdominal JJ O
pain NN O
, , O
both DT O
of IN O
which WDT O
are VBP O
most RBS O
frequently RB O
seen VBN O
in IN O
the DT O
early JJ O
normal JJ O
postoperative JJ O
course NN O
after IN O
abdominal JJ O
surgery NN O
, , O
could MD O
be VB O
the DT O
first JJ O
and CC O
only JJ O
complaints NNS O
at IN O
the DT O
early JJ O
stage NN O
of IN O
this DT O
complication NN O
. . O

Thus RB O
, , O
the DT O
diagnosis NN O
may MD O
be VB O
delayed VBN O
. . O

In IN O
our PRP$ O
case NN O
, , O
mild JJ O
abdominal JJ O
pain NN O
with IN O
general JJ O
malaise NN O
might MD O
have VB O
been VBN O
symptoms NNS O
related VBN O
to IN O
the DT O
early JJ O
stage NN O
of IN O
the DT O
onset NN O
. . O

Abdominal NNP O
CT NNP O
showing VBG O
the DT O
enlarged JJ O
duodenum NN O
also RB O
suggested VBD O
that IN O
leakage NN O
from IN O
the DT O
duodenal JJ O
stump NN O
occurred VBD O
due IN O
to IN O
the DT O
obstruction NN O
of IN O
the DT O
distal JJ O
bowel NN O
. . O

Thus RB O
, , O
severe JJ O
complication NN O
might MD O
have VB O
been VBN O
avoided VBN O
, , O
if IN O
early JJ O
diagnosis NN O
had VBD O
been VBN O
made VBN O
. . O

Although IN O
the DT O
benefit NN O
of IN O
Roux NNP O
- HYPH O
en NNP O
- HYPH O
Y NNP O
is VBZ O
apparent JJ O
[ -LRB- O
11 CD O
] -RRB- O
, , O
the DT O
duodenal JJ O
stump NN O
could MD O
be VB O
vulnerable JJ O
to IN O
leakage NN O
due IN O
to IN O
increased VBN O
intrabowel JJ O
pressure NN O
. . O

Therefore RB O
, , O
careful JJ O
management NN O
of IN O
the DT O
postoperative JJ O
course NN O
is VBZ O
warranted VBN O
, , O
especially RB O
after IN O
procedures NNS O
involving VBG O
division NN O
of IN O
the DT O
bowel NN O
such JJ O
as IN O
LADG NNP O
. . O

Moreover RB O
, , O
special JJ O
attention NN O
should MD O
be VB O
paid VBN O
in IN O
patients NNS B-Species
with IN O
risk NN O
factors NNS O
for IN O
port NN O
site NN O
hernia NN O
such JJ O
as IN O
obesity NN O
, , O
aggressive JJ O
manipulation NN O
through IN O
the DT O
port NN O
sites NNS O
, , O
and CC O
prolonged VBN O
surgery NN O
. . O

Conclusion NN O

Port NN O
- HYPH O
site NN O
herniation NN O
is VBZ O
a DT O
potentially RB O
dangerous JJ O
complication NN O
after IN O
laparoscopic JJ O
procedures NNS O
. . O

Careful JJ O
management NN O
of IN O
the DT O
postoperative JJ O
course NN O
is VBZ O
recommended VBN O
especially RB O
for IN O
patients NNS B-Species
with IN O
risk NN O
factors NNS O
such JJ O
as IN O
obesity NN O
and CC O
extensive JJ O
manipulation NN O
of IN O
the DT O
trocar NN O
during IN O
prolonged VBN O
surgical JJ O
duration NN O
. . O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Authors NNS O
' POS O
contributions NNS O

TI NNP O
, , O
NF NNP O
, , O
HT NNP O
and CC O
TK NNP O
performed VBD O
the DT O
first JJ O
and CC O
second JJ O
operation NN O
. . O

TI NNP O
and CC O
KK NNP O
were VBD O
responsible JJ O
for IN O
the DT O
postoperative JJ O
management NN O
. . O

TI NNP O
, , O
HT NNP O
, , O
TW NNP O
, , O
and CC O
KN NNP O
were VBD O
involved VBN O
in IN O
editing VBG O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

Consent NN O

Written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
the DT O
patient NN B-Species
for IN O
publication NN O
of IN O
this DT O
case NN O
report NN O
and CC O
any DT O
accompanying JJ O
images NNS O
. . O

A DT O
copy NN O
of IN O
the DT O
written JJ O
consent NN O
is VBZ O
available JJ O
for IN O
review NN O
by IN O
the DT O
Editor NNP O
- HYPH O
in IN O
- HYPH O
Chief NNP O
of IN O
this DT O
journal NN O
. . O

Comparison NN O
of IN O
strategies NNS O
for IN O
identification NN O
of IN O
regulatory JJ O
quantitative JJ O
trait NN O
loci NN O
of IN O
transcript NN O
expression NN O
traits NNS O

Abstract JJ O

In IN O
order NN O
to TO O
identify VB O
regulatory JJ O
genes NNS O
, , O
we PRP O
determined VBD O
the DT O
heritability NN O
of IN O
gene NN O
transcripts NNS O
, , O
performed VBD O
linkage NN O
analysis NN O
to TO O
identify VB O
quantitative JJ O
trait NN O
loci NN O
( , O
QTLs NNP O
) -RRB- O
, , O
and CC O
evaluated VBD O
the DT O
evidence NN O
for IN O
shared VBN O
genetic JJ O
effects NNS O
among IN O
transcripts NNS O
with IN O
co NN O
- HYPH O
localized VBN O
QTLs NNP O
in IN O
non AFX O
- HYPH O
diseased JJ O
participants NNS B-Species
from IN O
14 CD O
CEPH NNP O
( -LRB- O
Centre NNP O
d FW O
' '' O
Etude NNP O
du FW O
Polymorphisme NNP O
Humain NNP O
) , O
Utah NNP O
families NNS O
. . O

Seventy CD O
- HYPH O
six CD O
percent NN O
of IN O
transcripts NNS O
had VBD O
a DT O
significant JJ O
heritability NN O
and CC O
54 CD O
% NN O
of IN O
them PRP O
had VBD O
LOD NN O
score NN O
> : O
= SYM O
1 CD O
. . O
8 CD O
. . O

Bivariate NN O
genetic JJ O
analysis NN O
of IN O
15 CD O
transcripts NNS O
that WDT O
had VBD O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
on IN O
4q28 CD O
. . O
2 CD O
- HYPH O
q31 CD O
. . O
1 CD O
identified VBD O
significant JJ O
genetic JJ O
correlation NN O
among IN O
some DT O
transcripts NNS O
although IN O
no DT O
improvement NN O
in IN O
the DT O
magnitude NN O
of IN O
LOD NNP O
scores NNS O
in IN O
this DT O
region NN O
was VBD O
noted VBN O
. . O

Similar JJ O
results NNS O
were VBD O
found VBN O
in IN O
analysis NN O
of IN O
12 CD O
transcripts NNS O
, , O
that WDT O
had VBD O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
in IN O
the DT O
13q34 CD O
region NN O
. . O

Principal JJ O
- HYPH O
component NN O
analyses NNS O
did VBD O
not RB O
improve VB O
the DT O
ability NN O
to TO O
identify VB O
chromosomal JJ O
regions NNS O
of IN O
co NN O
- HYPH O
localized VBN O
gene NN O
expressions NNS O
. . O

Background NN O

There EX O
is VBZ O
a DT O
breadth NN O
of IN O
information NN O
being VBG O
generated VBN O
by IN O
the DT O
Human NNP B-Species
Genome NNP O
Project NNP O
and CC O
the DT O
interpretation NN O
of IN O
these DT O
data NNS O
has VBZ O
been VBN O
a DT O
major JJ O
area NN O
of IN O
research NN O
. . O

For IN O
simple JJ O
Mendelian JJ O
disorders NNS O
, , O
the DT O
identification NN O
of IN O
genetic JJ O
effects NNS O
is VBZ O
fairly RB O
straightforward JJ O
due IN O
to IN O
understanding VBG O
the DT O
biology NN O
that WDT O
drives VBZ O
these DT O
disorders NNS O
. . O

However RB O
, , O
for IN O
complex JJ O
oligogenic JJ O
or CC O
polygenic JJ O
disorders NNS O
, , O
understanding VBG O
all PDT O
the DT O
interconnections NNS O
between IN O
genes NNS O
influencing VBG O
a DT O
trait NN O
is VBZ O
a DT O
difficult JJ O
task NN O
because IN O
the DT O
understanding NN O
of IN O
the DT O
biology NN O
of IN O
many JJ O
of IN O
these DT O
disorders NNS O
is VBZ O
still RB O
evolving VBG O
. . O

Multiple JJ O
gene NN O
x NN O
gene NN O
and CC O
gene NN O
x NN O
environment NN O
interactions NNS O
can MD O
influence VB O
the DT O
expression NN O
of IN O
phenotypes NNS O
. . O

Genes NNS O
can MD O
interact VB O
by IN O
modifying VBG O
the DT O
expression NN O
of IN O
other JJ O
genes NNS O
and CC O
therefore RB O
function VB O
as IN O
regulatory JJ O
genes NNS O
[ -LRB- O
1 CD O
] -RRB- O
. . O

In IN O
an DT O
effort NN O
to TO O
dissect VB O
some DT O
of IN O
these DT O
complexities NNS O
, , O
we PRP O
performed VBD O
linkage NN O
analysis NN O
of IN O
gene NN O
expression NN O
transcripts NNS O
of IN O
members NNS O
of IN O
Centre NNP O
d NNP O
' POS O
Etude NNP O
du FW O
Polymorphisme NNP O
Humain NNP O
( , O
CEPH NNP O
) -RRB- O
Utah NNP O
families NNS O
to TO O
determine VB O
the DT O
heritability NN O
of IN O
transcripts NNS O
and CC O
the DT O
evidence NN O
for IN O
regulatory JJ O
quantitative JJ O
trait NN O
loci NN O
( -LRB- O
QTLs NNP O
) -RRB- O
and CC O
we PRP O
performed VBD O
pairwise JJ O
bivariate NN O
linkage NN O
analysis NN O
and CC O
principal JJ O
- HYPH O
component NN O
analysis NN O
( , O
PCA NNP O
) -RRB- O
for IN O
data NN O
- HYPH O
reduction NN O
to TO O
evaluate VB O
the DT O
evidence NN O
for IN O
shared VBN O
genetic JJ O
effects NNS O
. . O

The DT O
ability NN O
to TO O
assess VB O
gene NN O
expression NN O
traits NNS O
simultaneously RB O
and CC O
to TO O
link VB O
them PRP O
to IN O
QTLs NNP O
offers VBZ O
the DT O
possibility NN O
of IN O
identifying VBG O
previously RB O
unknown JJ O
underlying VBG O
molecular JJ O
processes NNS O
for IN O
future JJ O
investigation NN O
. . O

Methods NNS O

Population NN O
and CC O
phenotypes NNS O

We PRP O
used VBD O
the DT O
Genetic NNP O
Analysis NNP O
Workshop NNP O
15 CD O
( , O
GAW NNP O
15 CD O
) -RRB- O
Problem NNP O
1 CD O
microarray NN O
gene NN O
expression NN O
profiles NNS O
for IN O
the DT O
analyses NNS O
. . O

Data NNS O
were VBD O
available JJ O
for IN O
14 CD O
three CD O
- HYPH O
generation NN O
CEPH NNP O
Utah NNP O
families NNS O
. . O

Expression NN O
levels NNS O
of IN O
genes NNS O
were VBD O
obtained VBN O
from IN O
lymphoblastoid JJ O
cells NNS O
using VBG O
the DT O
Affymetrix NNP O
Human NNP B-Species
Focus NNP O
Arrays NNPS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

We PRP O
were VBD O
provided VBN O
with IN O
data NNS O
on IN O
3554 CD O
transcripts NNS O
that WDT O
showed VBD O
greater JJR O
variation NN O
between IN O
individuals NNS O
than IN O
within IN O
the DT O
same JJ O
individual NN O
. . O

Family NN O
members NNS O
were VBD O
genotyped VBN O
for IN O
2882 CD O
autosomal NN O
and CC O
X NNP O
- HYPH O
linked VBN O
single JJ O
- HYPH O
nucleotide NN O
polymorphisms NNS O
( -LRB- O
SNP NNP O
) -RRB- O
generated VBN O
by IN O
the DT O
SNP NNP O
Consortium NNP O
. . O

Genetic JJ O
map NN O
positions NNS O
were VBD O
obtained VBN O
using VBG O
the DT O
SNP NNP O
Mapping NNP O
web NN O
application NN O
developed VBN O
by IN O
the DT O
University NNP O
College NNP O
Dublin NNP O
Conway NNP O
Institute NNP O
of IN O
Biomolecular NNP O
and CC O
Biomedical NNP O
Research NNP O
, , O
which WDT O
uses VBZ O
the DT O
Rutgers NNP O
Combined NNP O
Linkage NNP O
- HYPH O
Physical NNP O
Map NNP O
of IN O
the DT O
Human NNP B-Species
Genome NNP O
and CC O
data NNS O
taken VBN O
from IN O
the DT O
NCBI NNP O
dbSNP NNP O
Build NNP O
123 CD O
( , O
in IN O
Kosambi NNP O
centimorgans NNS O
) -RRB- O
. . O

This DT O
information NN O
was VBD O
used VBN O
to TO O
calculate VB O
multipoint JJ O
identity NN O
by IN O
descent NN O
matrices NNS O
( , O
MIBDs NNP O
) -RRB- O
with IN O
Merlin NNP O
and CC O
Minx NNP O
[ -LRB- O
3 CD O
] -RRB- O
, , O
after IN O
removal NN O
of IN O
Mendelian JJ O
inconsistencies NNS O
and CC O
double JJ O
recombinants NNS O
with IN O
Preswalk NNP O
( , O
based VBN O
on IN O
Simwalk NNP O
mistyping NN O
probabilities NNS O
) -RRB- O
[ -LRB- O
4 CD O
] -RRB- O
. . O

MIBDs NNS O
were VBD O
used VBN O
for IN O
linkage NN O
analyses NNS O
. . O

Transcript NN O
distributions NNS O
were VBD O
normalized VBN O
using VBG O
an DT O
inverse JJ O
normalization NN O
transformation NN O
of IN O
z NN O
- HYPH O
scores NNS O
of IN O
individual JJ O
transcripts NNS O
regressed VBN O
on IN O
the DT O
mean JJ O
individual JJ O
transcript NN O
level NN O
. . O

We PRP O
further RB O
adjusted VBD O
for IN O
the DT O
effects NNS O
of IN O
age NN O
, , O
age2 NN O
, , O
sex NN O
, , O
age NN O
x NN O
sex NN O
and CC O
age2 NN O
x NN O
sex NN O
interaction NN O
using VBG O
predictive JJ O
linear JJ O
regression NN O
models NNS O
in IN O
SAS NNP O
9 CD O
. . O
1 CD O
( , O
Cary NNP O
, , O
NC NNP O
) -RRB- O
. . O

We PRP O
generated VBD O
these DT O
residuals NNS O
as IN O
part NN O
of IN O
our PRP$ O
processing NN O
of IN O
the DT O
transcripts NNS O
for IN O
linkage NN O
analyses NNS O
. . O

Heritability NN O
estimation NN O
and CC O
linkage NN O
analysis NN O

Heritability NN O
was VBD O
estimated VBN O
using VBG O
maximum JJ O
likelihood NN O
variance NN O
decomposition NN O
methods NNS O
in IN O
SOLAR NNP O
[ -LRB- O
5 CD O
, , O
6 CD O
] -RRB- O
. . O

Genome NN O
scans NNS O
were VBD O
performed VBN O
using VBG O
multipoint JJ O
variance NN O
- HYPH O
components NNS O
models NNS O
that WDT O
test VBP O
for IN O
linkage NN O
between IN O
traits NNS O
and CC O
genetic JJ O
variants NNS O
by IN O
partitioning VBG O
the DT O
variance NN O
of IN O
the DT O
expression NN O
level NN O
into IN O
its PRP$ O
additive JJ O
genetic JJ O
and CC O
environmental JJ O
variance NN O
components NNS O
[ -LRB- O
7 CD O
] -RRB- O
. . O

For IN O
transcripts NNS O
with IN O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
, , O
we PRP O
performed VBD O
bivariate NN O
linkage NN O
analysis NN O
to TO O
identify VB O
shared VBN O
genetic JJ O
effects NNS O
. . O

The DT O
bivariate JJ O
polygenic JJ O
model NN O
estimates VBZ O
correlations NNS O
caused VBN O
by IN O
residual JJ O
additive JJ O
genetic JJ O
effects NNS O
( , O
rho FW O
G NNP O
) -RRB- O
and CC O
correlations NNS O
caused VBN O
by IN O
random JJ O
environmental JJ O
effects NNS O
( , O
rho FW O
E NN O
) -RRB- O
[ -LRB- O
8 CD O
] -RRB- O
. . O

To TO O
test VB O
for IN O
additive JJ O
genetic JJ O
correlation NN O
among IN O
pairs NNS O
of IN O
traits NNS O
, , O
the DT O
log NN O
likelihood NN O
of IN O
a DT O
model NN O
in IN O
which WDT O
rho NN O
G NN O
is VBZ O
constrained VBN O
to IN O
0 CD O
( HYPH O
null JJ O
hypothesis NN O
, , O
no DT O
correlation NN O
) , O
or CC O
rho NN O
G NN O
= SYM O
1 CD O
( HYPH O
null JJ O
hypothesis NN O
, , O
complete JJ O
shared VBN O
genetic JJ O
effect NN O
) -RRB- O
is VBZ O
compared VBN O
to IN O
that DT O
of IN O
a DT O
model NN O
in IN O
which WDT O
rho NN O
G NN O
is VBZ O
estimated VBN O
for IN O
the DT O
traits NNS O
. . O

Significant JJ O
differences NNS O
among IN O
the DT O
models NNS O
( , O
rho FW O
G NNP O
! . O
= SYM O
0 CD O
) -RRB- O
suggest VBP O
that IN O
some DT O
of IN O
the DT O
same JJ O
genes NNS O
influence VBP O
both DT O
traits NNS O
. . O

We PRP O
also RB O
performed VBD O
linkage NN O
analysis NN O
using VBG O
the DT O
factors NNS O
obtained VBN O
from IN O
the DT O
PCA NNP O
in IN O
a DT O
sample NN O
of IN O
transcripts NNS O
with IN O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
. . O

Principal JJ O
- HYPH O
component NN O
analysis NN O

PCA NNP O
was VBD O
used VBN O
to TO O
reduce VB O
the DT O
number NN O
of IN O
expression NN O
profiles NNS O
into IN O
statistically RB O
meaningful JJ O
groups NNS O
while IN O
retaining VBG O
the DT O
original JJ O
total JJ O
variance NN O
using VBG O
all PDT O
the DT O
expression NN O
profiles NNS O
[ -LRB- O
9 CD O
, , O
10 CD O
] -RRB- O
. . O

We PRP O
selected VBD O
two CD O
different JJ O
chromosomal JJ O
regions NNS O
of IN O
a DT O
length NN O
of IN O
10 CD O
to TO O
12 CD O
MB NN O
in IN O
which WDT O
the DT O
QTLs NNS O
of IN O
at RB O
least RBS O
10 CD O
transcripts NNS O
were VBD O
co RB O
- HYPH O
localized VBN O
. . O

Only JJ O
transcripts NNS O
of IN O
genes NNS O
that WDT O
were VBD O
not RB O
located VBN O
in IN O
these DT O
selected VBN O
chromosomal JJ O
regions NNS O
were VBD O
included VBN O
in IN O
the DT O
analyses NNS O
( , O
trans JJ O
- HYPH O
regulatory JJ O
genes NNS O
) -RRB- O
. . O

Because IN O
of IN O
the DT O
small JJ O
number NN O
of IN O
individuals NNS O
in IN O
the DT O
study NN O
and CC O
concerns NNS O
of IN O
overfitting VBG O
the DT O
model NN O
, , O
a DT O
maximum JJ O
sample NN O
of IN O
50 CD O
transcript NN O
values NNS O
were VBD O
considered VBN O
at IN O
one CD O
time NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

The DT O
number NN O
of IN O
factors NNS O
was VBD O
determined VBN O
using VBG O
the DT O
eigenvalue NN O
- HYPH O
one CD O
requirement NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Factors NNS O
are VBP O
interpreted VBN O
by IN O
examining VBG O
the DT O
varimax NN O
- HYPH O
rotated VBN O
factor NN O
loadings NNS O
, , O
which WDT O
are VBP O
the DT O
correlations NNS O
between IN O
each DT O
phenotype NN O
and CC O
the DT O
factor NN O
in IN O
question NN O
. . O

Factor NN O
loadings NNS O
greater JJR O
than IN O
or CC O
equal JJ O
to IN O
0 CD O
. . O
40 CD O
in IN O
absolute JJ O
value NN O
were VBD O
used VBN O
to TO O
interpret VB O
factors NNS O
and CC O
to TO O
characterize VB O
the DT O
factor NN O
structures NNS O
; , O
this DT O
criterion NN O
ensures VBZ O
that IN O
the DT O
individual JJ O
factor NN O
variables NNS O
share VBP O
at RB O
least RBS O
15 CD O
% NN O
of IN O
their PRP$ O
variance NN O
with IN O
the DT O
given VBN O
factor NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

The DT O
principle JJ O
components NNS O
were VBD O
obtained VBN O
by IN O
calculating VBG O
the DT O
eigenvalues NNS O
of IN O
the DT O
sample NN O
covariance NN O
matrix NN O
, , O
which WDT O
represent VBP O
the DT O
amount NN O
of IN O
variance NN O
contributed VBN O
by IN O
each DT O
factor NN O
. . O

Only RB O
factors NNS O
with IN O
eigenvalues NNS O
higher JJR O
than IN O
1 CD O
were VBD O
considered VBN O
for IN O
linkage NN O
analysis NN O
. . O

Integrating VBG O
data NNS O
from IN O
linkage NN O
analysis NN O
for IN O
gene NN O
co NN O
- HYPH O
expression NN O

Linkage NN O
signals NNS O
of IN O
individual JJ O
transcript NN O
expressions NNS O
were VBD O
recorded VBN O
and CC O
the DT O
location NN O
of IN O
QTLs NNS O
was VBD O
compared VBN O
to IN O
the DT O
location NN O
of IN O
the DT O
transcript NN O
gene NN O
in IN O
order NN O
to TO O
identify VB O
trans JJ O
- HYPH O
regulatory JJ O
sites NNS O
. . O

In IN O
addition NN O
, , O
the DT O
location NN O
and CC O
LOD NN O
scores NNS O
of IN O
QTLs NNS O
identified VBN O
in IN O
single JJ O
individual JJ O
transcript NN O
analysis NN O
( , O
univariate JJ O
analysis NN O
) , O
were VBD O
compared VBN O
with IN O
the DT O
location NN O
of IN O
the DT O
QTLs NNS O
identified VBN O
using VBG O
bivariate NN O
analysis NN O
or CC O
factors NNS O
of IN O
the DT O
PCA NNP O
. . O

This DT O
allowed VBD O
a DT O
determination NN O
of IN O
whether IN O
the DT O
bivariate NN O
analysis NN O
or CC O
PCA NNP O
data NN O
reduction NN O
analysis NN O
improved VBD O
our PRP$ O
evidence NN O
for IN O
linkage NN O
, , O
and CC O
if IN O
so RB O
, , O
a DT O
more JJR O
in IN O
- HYPH O
depth NN O
examination NN O
of IN O
the DT O
transcripts NNS O
included VBN O
in IN O
the DT O
principal JJ O
components NNS O
needs VBZ O
to TO O
be VB O
examined VBN O
for IN O
biologic JJ O
interactions NNS O
on IN O
complex JJ O
disorders NNS O
. . O

Results NNS O

Among IN O
194 CD O
individuals NNS O
from IN O
14 CD O
families NNS O
, , O
17 CD O
individuals NNS O
with IN O
missing VBG O
information NN O
on IN O
age NN O
were VBD O
excluded VBN O
. . O

Seventy CD O
- HYPH O
six CD O
percent NN O
( : O
n CD O
= SYM O
2688 CD O
) -RRB- O
of IN O
the DT O
transcripts NNS O
had VBD O
significant JJ O
heritability NN O
( : O
p NN O
< NN O
0 CD O
. . O
5 CD O
) -RRB- O
and CC O
were VBD O
considered VBN O
for IN O
the DT O
linkage NN O
analysis NN O
. . O

Of IN O
this DT O
, , O
1448 CD O
( SYM O
54 CD O
% NN O
) -RRB- O
transcripts NNS O
displayed VBD O
suggestive JJ O
evidence NN O
of IN O
linkage NN O
( , O
had VBD O
a DT O
maximum JJ O
LOD NN O
score NN O
> NFP O
= SYM O
1 CD O
. . O
8 CD O
[ SYM O
12 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
QTLs NNPS O
of IN O
1661 CD O
transcripts NNS O
( , O
759 CD O
of IN O
which WDT O
with IN O
LOD NNP O
> SYM O
= SYM O
1 CD O
. SYM O
8 CD O
) -RRB- O
were VBD O
localized VBN O
in IN O
a DT O
different JJ O
region NN O
than IN O
the DT O
gene NN O
transcript NN O
( , O
trans JJ O
- HYPH O
regulatory JJ O
sites NNS O
) -RRB- O
. . O

We PRP O
used VBD O
two CD O
different JJ O
chromosomal JJ O
regions NNS O
with IN O
co NN O
- HYPH O
localized VBN O
transcript NN O
QTLs NNS O
, , O
chromosomes NNS O
4q28 CD O
. . O
2 CD O
- SYM O
q31 CD O
. . O
1 CD O
and CC O
13q34 CD O
, , O
for IN O
more JJR O
in IN O
- HYPH O
depth NN O
analyses NNS O
. . O

Chromosome NN O
4q28 CD O
. . O
2 CD O
- SYM O
q31 CD O
. . O
1 CD O
region NN O

Table NN O
1 CD O
reports VBZ O
the DT O
results NNS O
for IN O
the DT O
chromosome NN O
4q28 CD O
. . O
2 CD O
- SYM O
q31 CD O
. . O
1 CD O
region NN O
. . O

Fifteen CD O
transcripts NNS O
co NN O
- HYPH O
localized VBN O
in IN O
this DT O
region NN O
in IN O
the DT O
univariate JJ O
linkage NN O
analysis NN O
, , O
and CC O
the DT O
LOD NNP O
scores NNS O
ranged VBD O
from IN O
1 CD O
. . O
17 CD O
to IN O
3 CD O
. . O
72 CD O
. . O

The DT O
strongest JJS O
linkage NN O
signals NNS O
were VBD O
observed VBN O
for IN O
the DT O
transcripts NNS O
of IN O
the DT O
MX2 NNP O
, , O
NUCB2 NNP O
, , O
and CC O
SNX4 NNP O
genes NNS O
. . O

Using VBG O
PCA NNP O
, , O
we PRP O
obtained VBD O
five CD O
factors NNS O
from IN O
the DT O
15 CD O
transcripts NNS O
with IN O
eigenvalues NNS O
greater JJR O
than IN O
1 CD O
. . O

Only RB O
one CD O
factor NN O
, , O
with IN O
a DT O
high JJ O
positive JJ O
loading NN O
for IN O
the DT O
MX2 NNP O
gene NN O
transcript NN O
, , O
had VBD O
a DT O
significant JJ O
heritability NN O
and CC O
a DT O
LOD NNP O
score NN O
> NFP O
= SYM O
1 CD O
. . O
8 CD O
. . O

The DT O
linkage NN O
analysis NN O
using VBG O
this DT O
factor NN O
identified VBD O
the DT O
chromosome NN O
region NN O
for IN O
the DT O
MX2 NNP O
gene NN O
, , O
but CC O
the DT O
LOD NNP O
score NN O
was VBD O
lower JJR O
than IN O
the DT O
one CD O
obtained VBN O
by IN O
single JJ O
linkage NN O
analysis NN O
of IN O
the DT O
MX2 NNP O
transcript NN O
. . O

We PRP O
then RB O
performed VBD O
bivariate JJ O
analysis NN O
of IN O
all DT O
pairwise JJ O
co NN O
- HYPH O
localized VBN O
transcripts NNS O
on IN O
4q28 CD O
. . O
2 CD O
- HYPH O
q31 CD O
. . O
1 CD O
and CC O
found VBD O
evidence NN O
for IN O
genetic JJ O
correlation NN O
of IN O
co NN O
- HYPH O
localized VBN O
genes NNS O
, , O
although IN O
without IN O
much JJ O
increase NN O
in IN O
the DT O
magnitude NN O
of IN O
the DT O
LOD NNP O
score NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

This DT O
analysis NN O
identified VBD O
two CD O
networks NNS O
of IN O
gene NN O
expressions NNS O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

We PRP O
obtained VBD O
two CD O
factors NNS O
using VBG O
PCA NNP O
of IN O
the DT O
first JJ O
network NN O
( : O
Group NNP O
1 CD O
, , O
SNX4 NNP O
, , O
YWHAQ NNP O
, , O
ASS NNP O
, , O
MX2 NNP O
, , O
and CC O
ISGF3G NNP O
gene NN O
transcripts NNS O
) -RRB- O
. . O

Both DT O
factors NNS O
had VBD O
significant JJ O
heritability NN O
; : O
however RB O
, , O
only RB O
Factor NNP O
1 CD O
, , O
loading VBG O
heavily RB O
on IN O
the DT O
MX2 NNP O
gene NN O
, , O
localized VBN O
to IN O
the DT O
4q28 CD O
. . O
2 CD O
- HYPH O
q31 CD O
. . O
1 CD O
region NN O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
, , O
and CC O
the DT O
magnitude NN O
of IN O
the DT O
LOD NNP O
score NN O
was VBD O
lower JJR O
than IN O
that DT O
of IN O
the DT O
univariate NN O
MX2 NNP O
gene NN O
transcript NN O
analysis NN O
( , O
LOD NNP O
= SYM O
2 CD O
. . O
28 CD O
) -RRB- O
. . O

The DT O
heritability NN O
of IN O
one CD O
factor NN O
obtained VBD O
using VBG O
PCA NNP O
for IN O
Group NNP O
2 CD O
transcripts NNS O
was VBD O
not RB O
significant JJ O
and CC O
further JJ O
analysis NN O
was VBD O
not RB O
performed VBN O
. . O

Chromosome NN O
13q34 CD O
region NN O

We PRP O
performed VBD O
analysis NN O
in IN O
an DT O
additional JJ O
chromosome NN O
region NN O
of IN O
co NN O
- HYPH O
localized VBN O
transcripts NNS O
, , O
13q34 CD O
region NN O
, , O
and CC O
noted VBD O
similar JJ O
results NNS O
. . O

Using VBG O
univariate JJ O
analysis NN O
, , O
12 CD O
transcripts NNS O
co NN O
- HYPH O
localized VBN O
in IN O
this DT O
region NN O
; : O
and CC O
bivariate NN O
analysis NN O
revealed VBD O
an DT O
intricate JJ O
network NN O
of IN O
correlated VBN O
traits NNS O
( -LRB- O
Table NN O
2 CD O
and CC O
Figure NNP O
2 CD O
) -RRB- O
. . O

Using VBG O
PCA NNP O
, , O
we PRP O
obtained VBD O
five CD O
factors NNS O
, , O
three CD O
of IN O
them PRP O
with IN O
significant JJ O
heritability NN O
. . O

Similar JJ O
to IN O
our PRP$ O
previous JJ O
findings NNS O
on IN O
chomosome NN O
4 CD O
, , O
PCA NNP O
factors NNS O
did VBD O
not RB O
improve VB O
the DT O
magnitude NN O
of IN O
the DT O
LOD NNP O
scores NNS O
when WRB O
compared VBN O
to IN O
univariate JJ O
analysis NN O
. . O

Discussion NN O

In IN O
this DT O
study NN O
, , O
we PRP O
identified VBD O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
of IN O
individual JJ O
transcripts NNS O
and CC O
compared VBD O
the DT O
univariate NN O
and CC O
bivariate NN O
linkage NN O
results NNS O
using VBG O
single JJ O
transcripts NNS O
to IN O
those DT O
using VBG O
factors NNS O
obtained VBN O
from IN O
PCA NNP O
. . O

By IN O
using VBG O
factors NNS O
that WDT O
accounted VBD O
for IN O
the DT O
variance NN O
of IN O
multiple JJ O
transcripts NNS O
with IN O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
, , O
we PRP O
attempted VBD O
to TO O
reduce VB O
the DT O
number NN O
of IN O
linkage NN O
analyses NNS O
performed VBN O
as RB O
well RB O
as IN O
possibly RB O
identifying VBG O
previously RB O
unknown JJ O
patterns NNS O
of IN O
associated VBN O
gene NN O
expression NN O
profiles NNS O
. . O

The DT O
PCA NNP O
did VBD O
in IN O
fact NN O
reduce VB O
the DT O
number NN O
of IN O
linkage NN O
analyses NNS O
performed VBN O
, , O
but CC O
it PRP O
did VBD O
not RB O
improve VB O
the DT O
magnitude NN O
of IN O
signals NNS O
in IN O
the DT O
target NN O
QTLs NNS O
as IN O
compared VBN O
with IN O
univariate NN O
or CC O
bivariate NN O
analyses NNS O
. . O

In IN O
fact NN O
, , O
in IN O
at RB O
least RBS O
one CD O
case NN O
, , O
PCA NNP O
was VBD O
unable JJ O
to TO O
detect VB O
a DT O
linkage NN O
signal NN O
for IN O
the DT O
main JJ O
gene NN O
transcript NN O
loading NN O
in IN O
the DT O
factor NN O
( , O
Table NNP O
1 CD O
, , O
Group NNP O
1 CD O
, , O
Factor NNP O
2 CD O
) -RRB- O
. . O

We PRP O
also RB O
performed VBD O
pairwise JJ O
bivariate NN O
genetic JJ O
analysis NN O
on IN O
those DT O
transcripts NNS O
that WDT O
co NN O
- HYPH O
localized VBN O
to IN O
the DT O
same JJ O
genomic JJ O
region NN O
, , O
presumably RB O
because IN O
this DT O
area NN O
of IN O
the DT O
genome NN O
harbored VBD O
genes NNS O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
these DT O
transcripts NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

We PRP O
detected VBD O
significant JJ O
genetic JJ O
correlation NN O
of IN O
these DT O
co NN O
- HYPH O
localized VBN O
transcripts NNS O
, , O
indicating VBG O
potential JJ O
gene NN O
networks NNS O
operating VBG O
in IN O
these DT O
regions NNS O
. . O

However RB O
, , O
in IN O
most JJS O
cases NNS O
, , O
bivariate NN O
linkage NN O
analysis NN O
did VBD O
not RB O
improve VB O
the DT O
magnitude NN O
of IN O
the DT O
LOD NNP O
score NN O
compared VBN O
to IN O
univariate JJ O
analysis NN O
. . O

Most JJS O
traits NNS O
were VBD O
highly RB O
correlated VBN O
( , O
rho FW O
G NNP O
> : O
0 CD O
. . O
60 CD O
) -RRB- O
, , O
and CC O
therefore RB O
they PRP O
may MD O
provide VB O
redundant JJ O
information NN O
that WDT O
may MD O
reduce VB O
the DT O
power NN O
for IN O
detection NN O
of IN O
the DT O
bivariate NN O
signal NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
because IN O
rho `` O
G NN O
is VBZ O
a DT O
test NN O
of IN O
the DT O
overall JJ O
additive JJ O
genetic JJ O
correlation NN O
among IN O
two CD O
traits NNS O
and CC O
not RB O
the DT O
QTL NNP O
- HYPH O
specific JJ O
pleiotropy NN O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
the DT O
co NN O
- HYPH O
localized VBN O
linkage NN O
signals NNS O
are VBP O
not RB O
in IN O
fact NN O
genetically RB O
correlated VBN O
. . O

Further JJ O
analysis NN O
is VBZ O
required VBN O
to TO O
address VB O
these DT O
issues NNS O
. . O

The DT O
chromosome NN O
regions NNS O
selected VBN O
for IN O
detailed JJ O
analyses NNS O
were VBD O
arbitrarily RB O
chosen VBN O
as IN O
we PRP O
identified VBD O
multiple JJ O
other JJ O
regions NNS O
with IN O
co NN O
- HYPH O
localized VBN O
linkage NN O
of IN O
gene NN O
expressions NNS O
. . O

The DT O
results NNS O
from IN O
our PRP$ O
univariate JJ O
genome NN O
scan NN O
differ VBP O
markedly RB O
from IN O
those DT O
reported VBN O
by IN O
Morley NNP O
et FW O
al NNP O
. . O

[ -LRB- O
2 LS O
] -RRB- O
because IN O
we PRP O
included VBD O
a DT O
smaller JJR O
sample NN O
of IN O
individuals NNS O
so IN O
that IN O
adjustment NN O
for IN O
covariate NN O
effects NNS O
of IN O
age NN O
could MD O
be VB O
made VBN O
. . O

Our PRP$ O
analysis NN O
strategy NN O
also RB O
adjusted VBD O
for IN O
the DT O
effects NNS O
of IN O
age NN O
and CC O
sex NN O
, , O
which WDT O
could MD O
also RB O
add VB O
to IN O
the DT O
observed VBN O
differences NNS O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Finally RB O
, , O
our PRP$ O
definition NN O
of IN O
genome NN O
window NN O
size NN O
for IN O
co NN O
- HYPH O
localized VBN O
gene NN O
expressions NNS O
was VBD O
twice RB O
larger JJR O
than IN O
the DT O
one NN O
described VBN O
in IN O
the DT O
study NN O
of IN O
Morley NNP O
et FW O
al NNP O
. . O

Conclusion NN O

We PRP O
identified VBD O
several JJ O
chromosomal JJ O
regions NNS O
of IN O
co NN O
- HYPH O
localized VBN O
trans NN O
- HYPH O
regulatory JJ O
genes NNS O
with IN O
significant JJ O
heritability NN O
. . O

Some DT O
of IN O
these DT O
regulatory JJ O
genes NNS O
displayed VBD O
strong JJ O
additive JJ O
genetic JJ O
correlations NNS O
, , O
and CC O
may MD O
be VB O
part NN O
of IN O
genetic JJ O
networks NNS O
. . O

However RB O
, , O
when WRB O
compared VBN O
to IN O
univariate JJ O
analysis NN O
, , O
linkage NN O
analysis NN O
of IN O
bivariate NN O
phenotypes NNS O
and CC O
factor NN O
scores NNS O
obtained VBN O
from IN O
PCA NNP O
did VBD O
not RB O
improve VB O
the DT O
ability NN O
to TO O
identify VB O
chromosomal JJ O
regions NNS O
of IN O
co NN O
- HYPH O
localized VBN O
gene NN O
expressions NNS O
. . O

List NN O
of IN O
Abbreviations NNS O

CEPH NNP O
: : O
Centre NN O
d NN O
' '' O
Etude NNP O
du FW O
Polymorphisme NNP O
Humain NNP O

GAW NN O
: : O
Genetic JJ O
Analysis NN O
Workshop NN O

H2 NN O
: : O
heritability NN O

LOD NN O
: : O
logarithm NN O
of IN O
the DT O
odds NNS O

MIBD NNP O
: : O
multipoint NN O
identity NN O
- HYPH O
by IN O
- HYPH O
descent NN O
matrices NNS O

N NN O
/ SYM O
A NNP O
: : O
not RB O
apply VB O

NCBI NNP O
: : O
National NNP O
Center NNP O
for IN O
Biotechnology NNP O
Information NNP O

PCA NN O
: : O
principal JJ O
- HYPH O
component NN O
analysis NN O

QTL NN O
: : O
quantitative JJ O
trait NN O
loci NN O

SE NNP O
: : O
standard JJ O
error NN O
of IN O
the DT O
mean NN O

SNP NNP O
: : O
single JJ O
- HYPH O
nucleotide NN O
polymorphism NN O

SOLAR NN O
: : O
Sequential JJ O
Oligogenic JJ O
Linkage NN O
Analysis NN O
Routines NNS O

Competing VBG O
interests NNS O

The DT O
author NN O
( , O
s LS O
) -RRB- O
declare VBP O
that IN O
they PRP O
have VBP O
no DT O
competing VBG O
interests NNS O
. . O

Potentiation NN O
of IN O
Nerve JJ O
Growth NN O
Factor NN O
- HYPH O
Induced VBN O
Neurite JJ O
Outgrowth NN O
by IN O
Fluvoxamine NNP O
: : O
Role NN O
of IN O
Sigma NN O
- HYPH O
1 CD O
Receptors NNS O
, , O
IP3 NN O
Receptors NNS O
and CC O
Cellular JJ O
Signaling NN O
Pathways NNS O

Abstract JJ O

Background NN O

Selective JJ O
serotonin NN O
reuptake NN O
inhibitors NNS O
( -LRB- O
SSRIs NNP O
) -RRB- O
have VBP O
been VBN O
widely RB O
used VBN O
and CC O
are VBP O
a DT O
major JJ O
therapeutic JJ O
advance NN O
in IN O
psychopharmacology NN O
. . O

However RB O
, , O
their PRP$ O
pharmacology NN O
is VBZ O
quite RB O
heterogeneous JJ O
. . O

The DT O
SSRI NNP O
fluvoxamine NN O
, , O
with IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonism NN O
, , O
is VBZ O
shown VBN O
to TO O
potentiate VB O
nerve JJ O
- HYPH O
growth NN O
factor NN O
( , O
NGF NNP O
) -RRB- O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC NN O
12 CD O
cells NNS O
. . O

However RB O
, , O
the DT O
precise JJ O
cellular JJ O
and CC O
molecular JJ O
mechanisms NNS O
underlying VBG O
potentiation NN O
by IN O
fluvoxamine NN O
are VBP O
not RB O
fully RB O
understood VBN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
the DT O
roles NNS O
of IN O
cellular JJ O
signaling NN O
pathways NNS O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
fluvoxamine NN O
and CC O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
. . O

Methods NNS O
and CC O
Findings NNS O

The DT O
effects NNS O
of IN O
three CD O
SSRIs NNS O
( , O
fluvoxamine NN O
, , O
sertraline NN O
, , O
paroxetine NN O
) -RRB- O
and CC O
three CD O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
( , O
SA4503 CD O
, , O
4 CD O
- HYPH O
phenyl NN O
- HYPH O
1 CD O
- HYPH O
( SYM O
4 CD O
- HYPH O
phenylbutyl NN O
) -RRB- O
piperidine NN O
( , O
PPBP NNP O
) -RRB- O
, , O
and CC O
dehydroepiandrostero NN O
( , O
DHEA NN O
) -RRB- O
- HYPH O
sulfate NN O
) -RRB- O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
were VBD O
examined VBN O
. . O

Also RB O
examined VBN O
were VBD O
the DT O
effects NNS O
of IN O
the DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
NE NNP O
- HYPH O
100 CD O
, , O
inositol NN O
1 CD O
, , O
4 CD O
, , O
5 CD O
- HYPH O
triphosphate NN O
( , O
IP3 NN O
) -RRB- O
receptor NN O
antagonist NN O
, , O
and CC O
specific JJ O
inhibitors NNS O
of IN O
signaling VBG O
pathways NNS O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
SA4503 NN O
. . O

Fluvoxamine NNP O
( , O
but CC O
not RB O
sertraline NN O
or CC O
paroxetine NN O
) -RRB- O
and CC O
the DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
SA4503 NNP O
, , O
PPBP NNP O
, , O
and CC O
DHEA NNP O
- HYPH O
sulfate NN O
significantly RB O
potentiated VBN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
. . O

The DT O
potentiation NN O
by IN O
fluvoxamine NN O
and CC O
the DT O
three CD O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
was VBD O
blocked VBN O
by IN O
co NN O
- HYPH O
administration NN O
of IN O
the DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
NE NNP O
- HYPH O
100 CD O
, , O
suggesting VBG O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
play VBP O
a DT O
role NN O
in IN O
blocking VBG O
the DT O
enhancement NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

Moreover RB O
, , O
the DT O
potentiation NN O
by IN O
SA4503 NNP O
was VBD O
blocked VBN O
by IN O
co NN O
- HYPH O
administration NN O
of IN O
the DT O
IP3 NNP O
receptor NN O
antagonist NN O
xestospongin NN O
C NN O
. . O

In IN O
addition NN O
, , O
the DT O
specific JJ O
inhibitors NNS O
of IN O
phospholipase NN O
C NNP O
( HYPH O
PLC NNP O
- HYPH O
gamma NN O
) -RRB- O
, , O
phosphatidylinositol NN O
3 CD O
- HYPH O
kinase NN O
( -LRB- O
PI3K NNP O
) -RRB- O
, , O
p38MAPK NNP O
, , O
c NN O
- HYPH O
Jun NNP O
N NNP O
- HYPH O
terminal JJ O
kinase NN O
( , O
JNK NNP O
) -RRB- O
, , O
and CC O
the DT O
Ras NNP O
/ SYM O
Raf NNP O
/ SYM O
mitogen NN O
- HYPH O
activated VBN O
protein NN O
kinase NN O
( -LRB- O
MAPK NNP O
) -RRB- O
signaling NN O
pathways NNS O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
. . O

Conclusion NN O

These DT O
findings NNS O
suggest VBP O
that IN O
stimulation NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
and CC O
subsequent JJ O
interaction NN O
with IN O
IP3 NNP O
receptors NNS O
, , O
PLC NNP O
- HYPH O
gamma NNP O
, , O
PI3K NNP O
, , O
p38MAPK NNP O
, , O
JNK NNP O
, , O
and CC O
the DT O
Ras NNP O
/ SYM O
Raf NNP O
/ SYM O
MAPK NNP O
signaling NN O
pathways NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanisms NNS O
of IN O
action NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
such JJ O
as IN O
fluvoxamine NN O
and CC O
SA4503 NN O
. . O

Introduction NN O

Selective JJ O
serotonin NN O
( , O
5 CD O
- HYPH O
HT NN O
; : O
5 CD O
- HYPH O
hydroxytryptamine NN O
) , O
reuptake NN O
inhibitors NNS O
( , O
SSRIs NNP O
) -RRB- O
have VBP O
emerged VBN O
as IN O
a DT O
major JJ O
therapeutic JJ O
advance NN O
in IN O
psychopharmacology NN O
. . O

SSRIs NNS O
are VBP O
the DT O
treatment NN O
of IN O
choice NN O
for IN O
many JJ O
indications NNS O
, , O
including VBG O
major JJ O
depressive JJ O
disorder NN O
, , O
dysthymia NN O
, , O
panic NN O
disorder NN O
, , O
obsessive JJ O
- HYPH O
compulsive JJ O
disorder NN O
, , O
eating NN O
disorders NNS O
, , O
and CC O
premenstrual JJ O
dysphoric JJ O
disorder NN O
. . O

In IN O
contrast NN O
, , O
it PRP O
is VBZ O
well RB O
known VBN O
that IN O
their PRP$ O
pharmacology NN O
is VBZ O
quite RB O
heterogeneous JJ O
, , O
although IN O
all DT O
of IN O
them PRP O
block VBP O
5 CD O
- HYPH O
HT NNP O
transporters NNS O
, , O
thus RB O
increasing VBG O
5 CD O
- HYPH O
HT NNP O
levels NNS O
throughout IN O
the DT O
central JJ O
nervous JJ O
system NN O
( -LRB- O
CNS NNP O
) -RRB- O
[ -LRB- O
1 CD O
] -RRB- O
- : O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Accumulating VBG O
evidence NN O
suggests VBZ O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
, , O
which WDT O
are VBP O
intracellular JJ O
endoplasmic JJ O
reticulum NN O
( , O
ER NN O
) -RRB- O
proteins NNS O
, , O
are VBP O
involved VBN O
in IN O
both CC O
the DT O
neuroplasticity NN O
and CC O
pathophysiology NN O
of IN O
neuropsychiatric JJ O
diseases NNS O
such JJ O
as IN O
major JJ O
depressive JJ O
disorder NN O
, , O
anxiety NN O
, , O
schizophrenia NN O
, , O
and CC O
Alzheimer NNP O
' POS O
s POS O
disease NN O
[ -LRB- O
10 CD O
] -RRB- O
- : O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Previously RB O
, , O
we PRP O
reported VBD O
that IN O
some DT O
SSRIs NNPS O
possess VBP O
high JJ O
to IN O
moderate JJ O
affinities NNS O
for IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
in IN O
the DT O
rat NN B-Species
brain NN O
. . O

The DT O
rank NN O
order NN O
of IN O
SSRIs NNP O
affinities NNS O
for IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
is VBZ O
fluvoxamine NN O
( , O
Ki NN O
= SYM O
36 CD O
nM NN O
) -RRB- O
> : O
sertraline NN O
( , O
Ki NN O
= SYM O
57 CD O
nM NN O
) -RRB- O
> NFP O
> SYM O
paroxetine NN O
( -LRB- O
Ki NN O
= SYM O
1893 CD O
nM NN O
) -RRB- O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Recently RB O
, , O
we PRP O
reported VBD O
that IN O
fluvoxamine NN O
, , O
but CC O
not RB O
paroxetine NN O
, , O
significantly RB O
ameliorated VBD O
cognitive JJ O
deficits NNS O
in IN O
mice NNS B-Species
after IN O
repeated JJ O
phencyclidine NN O
administration NN O
, , O
and CC O
that IN O
the DT O
effects NNS O
of IN O
fluvoxamine NN O
were VBD O
antagonized VBN O
by IN O
co NN O
- HYPH O
administration NN O
of IN O
the DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
NE NNP O
- HYPH O
100 CD O
[ -LRB- O
20 CD O
] -RRB- O
, , O
suggesting VBG O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
fluvoxamine NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
it PRP O
has VBZ O
been VBN O
demonstrated VBN O
that IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
including VBG O
fluvoxamine NN O
could MD O
potentiate VB O
nerve JJ O
growth NN O
factor NN O
( -LRB- O
NGF NNP O
) -RRB- O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
, , O
and CC O
that IN O
NE NNP O
- HYPH O
100 CD O
blocked VBD O
the DT O
potentiation NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
, , O
suggesting VBG O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
are VBP O
involved VBN O
in IN O
neuroplasticity NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

However RB O
, , O
the DT O
precise JJ O
cellular JJ O
mechanisms NNS O
underlying VBG O
the DT O
potentiation NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
are VBP O
not RB O
fully RB O
understood VBN O
[ -LRB- O
13 CD O
] -RRB- O
, , O
[ -LRB- O
21 CD O
] -RRB- O
. . O

It PRP O
is VBZ O
therefore RB O
of IN O
great JJ O
interest NN O
to TO O
study VB O
the DT O
precise JJ O
cellular JJ O
mechanisms NNS O
underlying VBG O
the DT O
enhancement NN O
by IN O
fluvoxamine NN O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite NN O
sprouting NN O
in IN O
PC12 NNP O
cells NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
three CD O
SSRIs NNS O
( , O
fluvoxamine NN O
, , O
sertraline NN O
, , O
paroxetine NN O
) -RRB- O
, , O
as RB O
well RB O
as IN O
the DT O
effects NNS O
of IN O
a DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
( , O
4 CD O
- HYPH O
phenyl NN O
- HYPH O
1 CD O
- HYPH O
( SYM O
4 CD O
- HYPH O
phenylbutyl NN O
) -RRB- O
piperidine NN O
( -LRB- O
PPBP NNP O
) -RRB- O
, , O
dehydroepiandrostero NN O
- HYPH O
sulphate NN O
( , O
DHEA NNP O
) -RRB- O
- HYPH O
sulfate NN O
) -RRB- O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
22 CD O
] -RRB- O
- HYPH O
[ -LRB- O
28 CD O
] -RRB- O
and CC O
the DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
SA4503 NNP O
[ -LRB- O
29 CD O
] -RRB- O
, , O
[ -LRB- O
30 CD O
] -RRB- O
, , O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
. . O

Furthermore RB O
, , O
it PRP O
is VBZ O
also RB O
known VBN O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
have VBP O
been VBN O
shown VBN O
to TO O
interact VB O
with IN O
IP3 NNP O
receptors NNS O
( SYM O
17 CD O
, , O
18 CD O
) -RRB- O
. . O

Therefore RB O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
NE NNP O
- HYPH O
100 CD O
and CC O
xestospongin NNP O
C NNP O
( , O
a DT O
selective JJ O
inositol NN O
1 CD O
, , O
4 CD O
, , O
5 CD O
- HYPH O
triphosphate NN O
( , O
IP3 NN O
) -RRB- O
receptor NN O
antagonist NN O
) -RRB- O
[ -LRB- O
31 CD O
] -RRB- O
in IN O
order NN O
to TO O
investigate VB O
the DT O
roles NNS O
of IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
and CC O
IP3 NN O
receptors NNS O
in IN O
the DT O
mechanisms NNS O
underlying VBG O
the DT O
enhancement NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
. . O

Moreover RB O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
specific JJ O
inhibitors NNS O
of IN O
several JJ O
cellular JJ O
signaling NN O
targets NNS O
on IN O
the DT O
enhancement NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
, , O
since IN O
several JJ O
signal NN O
transduction NN O
molecules NNS O
have VBP O
been VBN O
implicated VBN O
in IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Materials NNS O
and CC O
Methods NNS O

Drugs NNS O

The DT O
drugs NNS O
were VBD O
obtained VBN O
from IN O
the DT O
following VBG O
sources NNS O
: : O
fluvoxamine NN O
maleate NN O
( , O
Solvay NNP O
Seiyaku NNP O
K NNP O
. . O
K NNP O
. . O
, , O
Tokyo NNP O
, , O
Japan NNP O
) -RRB- O
; : O
paroxetine NN O
hydrochloride NN O
, , O
dehydroepiandosteron NN O
- HYPH O
sulfate NN O
( , O
DHEA NNP O
- HYPH O
sulfate NNP O
) -RRB- O
, , O
LY294002 NNP O
( , O
Sigma NNP O
- HYPH O
Aldrich NNP O
, , O
St NNP O
Louis NNP O
, , O
MO NNP O
, , O
USA NNP O
) -RRB- O
; , O
sertraline NN O
( , O
Toronto NNP O
Research NNP O
Chemicals NNPS O
Inc NNP O
. . O
, , O
North NNP O
York NNP O
, , O
ON NNP O
, , O
Canada NNP O
) -RRB- O
; : O
SA4503 NNP O
( , O
M NNP O
' POS O
s NNPS O
Science NNP O
Corporation NNP O
, , O
Kobe NNP O
, , O
Japan NNP O
) -RRB- O
; : O
NGF NNP O
( , O
Promega NNP O
, , O
Madison NNP O
, , O
WI NNP O
) -RRB- O
; , O
xestospongin NNP O
C NNP O
, , O
lovastatin NN O
, , O
PD98059 NNP O
, , O
GW5074 NNP O
, , O
SB203580 NNP O
, , O
MEK NNP O
1 CD O
/ SYM O
2 CD O
inhibitor NN O
( -LRB- O
SL327 NNP O
) -RRB- O
, , O
and CC O
SP600125 NN O
( : O
Calbiochem NNP O
- HYPH O
Novabiochem NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
. . O

The DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonists NNS O
NE NNP O
- HYPH O
100 CD O
and CC O
4 CD O
- HYPH O
phenyl NN O
- HYPH O
1 CD O
- HYPH O
( SYM O
4 CD O
- HYPH O
phenylbutyl NN O
) -RRB- O
piperidine NN O
( -LRB- O
PPBP NNP O
) -RRB- O
were VBD O
synthesized VBN O
in IN O
our PRP$ O
laboratory NN O
. . O

Other JJ O
drugs NNS O
were VBD O
purchased VBN O
from IN O
commercial JJ O
sources NNS O
. . O

Cell NN O
culture NN O

PC12 NNP O
sells VBZ O
( , O
RIKEN NNP O
Cell NNP O
Bank NNP O
, , O
Tsukuba NNP O
, , O
Japan NNP O
) -RRB- O
were VBD O
cultured VBN O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
5 CD O
% NN O
CO2 NN O
with IN O
Dulbecco NNP O
' POS O
s NNS O
modified VBN O
Eagle NNP O
' POS O
s NN O
medium NN O
( , O
DMEM NNP O
) -RRB- O
supplemented VBN O
with IN O
5 CD O
% NN O
heat NN O
- HYPH O
inactivated VBN O
fetal JJ O
bovine NN B-Species
serum NN O
( , O
FBS NNP O
) -RRB- O
, , O
10 CD O
% NN O
heat NN O
- HYPH O
inactivated VBN O
horse NN B-Species
serum NN O
, , O
and CC O
1 CD O
% NN O
penicillin NN O
. . O

The DT O
medium NN O
was VBD O
changed VBN O
two CD O
or CC O
three CD O
times NNS O
a DT O
week NN O
. . O

PC12 NN O
cells NNS O
were VBD O
plated VBN O
onto IN O
24 CD O
- HYPH O
well NN O
tissue NN O
culture NN O
plates NNS O
coated VBN O
with IN O
poly JJ O
- HYPH O
D NN O
- HYPH O
lysine NN O
/ SYM O
laminin NN O
. . O

Cells NNS O
were VBD O
plated VBN O
at IN O
relatively RB O
low JJ O
density NN O
( , O
0 CD O
. . O
25 CD O
x SYM O
104 CD O
cells NNS O
/ SYM O
cm2 NN O
) -RRB- O
in IN O
DMEM NNP O
medium NN O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
FBS NN O
, , O
1 CD O
% NN O
penicillin NN O
streptomycin NN O
. . O

Medium NN O
containing VBG O
a DT O
minimal JJ O
level NN O
of IN O
serum NN O
( , O
0 CD O
. . O
5 CD O
% NN O
FBS NNP O
) -RRB- O
was VBD O
used VBN O
, , O
since IN O
serum NN O
is VBZ O
known VBN O
to TO O
contain VB O
steroid NN O
hormones NNS O
that WDT O
bind VBP O
to IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

First RB O
, , O
we PRP O
examined VBD O
the DT O
optimal JJ O
concentration NN O
of IN O
NGF NNP O
for IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
. . O

NGF NNP O
( : O
2 CD O
. . O
5 CD O
, , O
5 CD O
, , O
10 CD O
, , O
20 CD O
, , O
40 CD O
ng CD O
/ SYM O
ml NNP O
) -RRB- O
increased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NN O
cells NNS O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

In IN O
the DT O
subsequent JJ O
studies NNS O
, , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
of IN O
NGF NNP O
was VBD O
used VBN O
to TO O
study VB O
the DT O
potentiating VBG O
effects NNS O
of IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

Twenty CD O
- HYPH O
four CD O
hours NNS O
after IN O
plating VBG O
, , O
the DT O
medium NN O
was VBD O
replaced VBN O
with IN O
DMEM NNP O
medium NN O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
FBS NN O
and CC O
1 CD O
% NN O
penicillin NN O
streptomycin NN O
with IN O
NGF NNP O
( : O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
with IN O
or CC O
without IN O
several JJ O
drugs NNS O
. . O

Quantification NN O
of IN O
neurite NN O
sprouting NN O

Five CD O
days NNS O
after IN O
incubation NN O
with IN O
NGF NNP O
( , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
with IN O
or CC O
without IN O
the DT O
several JJ O
drugs NNS O
, , O
morphometric JJ O
analysis NN O
was VBD O
performed VBN O
on IN O
digitized VBN O
images NNS O
of IN O
live JJ O
cells NNS O
taken VBN O
under IN O
phase NN O
- HYPH O
contrast NN O
illumination NN O
with IN O
an DT O
inverted JJ O
microscope NN O
linked VBN O
to IN O
a DT O
camera NN O
. . O

Images NNS O
of IN O
three CD O
fields NNS O
per IN O
well NN O
were VBD O
taken VBN O
, , O
with IN O
an DT O
average NN O
of IN O
100 CD O
cells NNS O
per IN O
field NN O
. . O

Differentiated VBN O
cells NNS O
were VBD O
counted VBN O
by IN O
visual JJ O
examination NN O
of IN O
the DT O
field NN O
; : O
only RB O
cells NNS O
that WDT O
had VBD O
at RB O
least RBS O
one CD O
neurite NN O
with IN O
a DT O
length NN O
equal JJ O
to IN O
the DT O
cell NN O
body NN O
diameter NN O
were VBD O
counted VBN O
, , O
and CC O
were VBD O
then RB O
expressed VBN O
as IN O
a DT O
percentage NN O
of IN O
the DT O
total JJ O
cells NNS O
in IN O
the DT O
field NN O
. . O

The DT O
counting NN O
was VBD O
performed VBN O
in IN O
a DT O
blinded JJ O
manner NN O
. . O

Immunocytochemistry NN O

Cells NNS O
were VBD O
fixed VBN O
for IN O
30 CD O
min NN O
at IN O
room NN O
temperature NN O
with IN O
4 CD O
% NN O
paraformaldehyde NN O
then RB O
permeabilized VBN O
with IN O
0 CD O
. . O
2 CD O
% NN O
Triton NN O
and CC O
blocked VBN O
with IN O
1 CD O
. . O
5 CD O
% NN O
normal JJ O
goat NN B-Species
serum NN O
, , O
0 CD O
. . O
1 CD O
% NN O
bovine JJ B-Species
serum NN O
albumin NN O
( , O
BSA NN O
) -RRB- O
in IN O
0 CD O
. . O
1 CD O
M NN O
phosphate NN O
- HYPH O
buffer NN O
saline NN O
for IN O
1 CD O
h NN O
to TO O
reduce VB O
nonspecific JJ O
binding NN O
. . O

Cells NNS O
were VBD O
incubated VBN O
overnight RB O
at IN O
4 CD O
degrees NNS O
C NN O
with IN O
anti JJ O
- HYPH O
microtubule NN O
- HYPH O
associated VBN O
protein NN O
2 CD O
( , O
MAP NNP O
- HYPH O
2 CD O
) -RRB- O
antibodies NNS O
( , O
1 CD O
: : O
1000 CD O
dilution NN O
in IN O
blocking NN O
solution NN O
, , O
Chemicon NNP O
International NNP O
, , O
Temecula NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
immunolabeling NN O
was VBD O
visualized VBN O
with IN O
secondary JJ O
antibodies NNS O
conjugated VBN O
to IN O
Alexa NNP O
- HYPH O
488 CD O
( , O
1 CD O
: : O
1000 CD O
; : O
Invitrogen NNP O
, , O
Carlsbad NNP O
, , O
CA NNP O
, , O
USA NNP O
) -RRB- O
. . O

MAP NNP O
- HYPH O
2 CD O
immuncytochemistry NN O
was VBD O
visualized VBN O
with IN O
a DT O
fluorescence NN O
microscope NN O
( , O
Axiovert NNP O
200 CD O
, , O
Carl NNP O
Zeiss NNP O
, , O
Oberkocken NNP O
, , O
Germany NNP O
) -RRB- O
. . O

Statistical JJ O
analysis NN O

Data NNS O
are VBP O
expressed VBN O
as IN O
means NNS O
+ NFP O
/ SYM O
- HYPH O
S NN O
. . O
E NN O
. . O
M NN O
. . O

Statistical JJ O
analysis NN O
was VBD O
performed VBN O
by IN O
using VBG O
one CD O
- HYPH O
way NN O
analysis NN O
of IN O
variance NN O
( -LRB- O
ANOVA NNP O
) -RRB- O
and CC O
the DT O
post FW O
hoc FW O
Bonferroni NNP O
/ SYM O
Dunn NNP O
test NN O
. . O

P NN O
values NNS O
less JJR O
than IN O
0 CD O
. . O
5 CD O
were VBD O
considered VBN O
statistically RB O
significant JJ O
. . O

Results NNS O

Effects NNS O
of IN O
SSRIs NNS O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O

Fluvoxamine NNP O
( : O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
increased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
by IN O
NGF NNP O
( , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
in IN O
PC12 NN O
cells NNS O
, , O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
2 CD O
and CC O
4 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
sertraline NN O
( , O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NN O
) -RRB- O
and CC O
paroxetine NN O
( : O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NN O
) -RRB- O
did VBD O
not RB O
increase VB O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
by IN O
NGF NNP O
( : O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
. . O

A DT O
higher JJR O
concentration NN O
( -LRB- O
10 CD O
micro NN O
M NN O
) -RRB- O
of IN O
paroxetine NN O
and CC O
sertraline NN O
significantly RB O
decreased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
, , O
suggesting VBG O
the DT O
cellular JJ O
toxicity NN O
of IN O
these DT O
drugs NNS O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Role NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite NN O
outgrowth NN O
by IN O
fluvoxamine NN O
and CC O
SA4503 NNP O

The DT O
selective JJ O
and CC O
potent JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
SA4503 NN O
( : O
0 CD O
. . O
1 CD O
, , O
0 CD O
. . O
1 CD O
, , O
or CC O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
increased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
by IN O
NGF NNP O
( , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
in IN O
PC12 NN O
cells NNS O
, , O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
3 CD O
and CC O
4 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
other JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
- : O
PPBP NNP O
( : O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NNP O
) -RRB- O
[ -LRB- O
22 CD O
] -RRB- O
- HYPH O
[ -LRB- O
26 CD O
] -RRB- O
and CC O
DHEA NNP O
- HYPH O
sulphate NN O
( : O
0 CD O
. . O
1 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
10 CD O
micro NN O
M NNP O
) -RRB- O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
27 CD O
] -RRB- O
, , O
[ -LRB- O
28 CD O
] -RRB- O
- , O
significantly RB O
increased VBN O
the DT O
number NN O
of IN O
such JJ O
cells NNS O
, , O
also RB O
in IN O
a DT O
concentration NN O
- HYPH O
dependent JJ O
manner NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

In IN O
the DT O
absence NN O
of IN O
NGF NNP O
, , O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
did VBD O
not RB O
produce VB O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

To TO O
investigate VB O
the DT O
role NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
NE NNP O
- HYPH O
100 CD O
( , O
a DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
) -RRB- O
on IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite NN O
outgrowth NN O
by IN O
fluvoxamine NN O
, , O
SA4503 NNP O
, , O
PPBP NNP O
, , O
and CC O
DHEA NNP O
- HYPH O
sulphate NN O
. . O

Co NNP O
- HYPH O
administration NN O
of IN O
NE NNP O
- HYPH O
100 CD O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
blocked VBD O
such JJ O
potentiation NN O
by IN O
fluvoxamine NN O
( : O
10 CD O
micro NN O
M NNP O
) -RRB- O
, , O
SA4503 NNP O
( , O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
PPBP NNP O
( , O
10 CD O
micro NN O
M NNP O
) -RRB- O
, , O
or CC O
DHEA NN O
- HYPH O
sulphate NN O
( : O
10 CD O
micro NN O
M NN O
) -RRB- O
( -LRB- O
Figure NN O
2 CD O
and CC O
3 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
administration NN O
of IN O
NE NNP O
- HYPH O
100 CD O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
alone RB O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Role NN O
of IN O
IP3 NN O
receptors NNS O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O

Sigma NN O
- HYPH O
1 CD O
receptors NNS O
have VBP O
been VBN O
shown VBN O
to TO O
interact VB O
with IN O
IP3 NNP O
receptors NNS O
( : O
17 CD O
, , O
18 CD O
, , O
33 CD O
- HYPH O
35 CD O
) -RRB- O
. . O

To TO O
investigate VB O
the DT O
role NN O
of IN O
IP3 NN O
receptors NNS O
in IN O
the DT O
effects NNS O
of IN O
SA4503 NN O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
xestospongin NNP O
C NNP O
( , O
a DT O
selective JJ O
, , O
reversible JJ O
, , O
and CC O
membrane NN O
- HYPH O
permeable JJ O
inhibitor NN O
of IN O
IP3 NN O
receptors NNS O
) -RRB- O
[ -LRB- O
31 CD O
] -RRB- O
on IN O
the DT O
effects NNS O
of IN O
SA4503 NN O
on IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

Co NN O
- HYPH O
administration NN O
of IN O
xestospongin NNP O
C NNP O
( , O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 CD O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Furthermore RB O
, , O
administration NN O
of IN O
xestospongin NN O
C NNP O
( , O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
alone RB O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Role NN O
of IN O
signaling VBG O
molecules NNS O
proximal JJ O
to IN O
TrkA NNP O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O

Next RB O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
the DT O
specific JJ O
inhibitors NNS O
of IN O
PLC NNP O
- HYPH O
gamma NN O
, , O
PI3K NNP O
, , O
p38 NN O
MAPK NNP O
, , O
and CC O
c NN O
- HYPH O
Jun NNP O
N NNP O
- HYPH O
terminal JJ O
kinase NN O
( , O
JNK NNP O
) -RRB- O
, , O
since IN O
these DT O
signaling VBG O
molecules NNS O
are VBP O
activated VBN O
upon IN O
the DT O
addition NN O
of IN O
NGF NNP O
[ -LRB- O
36 CD O
] -RRB- O
. . O

The DT O
PLC NNP O
- HYPH O
gamma NN O
inhibitor NN O
( , O
U73122 NNP O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
PI3K NN O
inhibitor NN O
( , O
LY294002 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
p38 NN O
MAPK NNP O
inhibitor NN O
( -LRB- O
SB203580 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
and CC O
JNK NNP O
inhibitor NN O
( : O
SP600125 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
( -LRB- O
Figure NN O
6 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
these DT O
inhibitors NNS O
alone RB O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
6 CD O
) -RRB- O
. . O

Role NNP O
of IN O
Raf NNP O
/ SYM O
Ras NNP O
/ SYM O
ERK NNP O
/ SYM O
MAPK NNP O
pathway NN O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O

The DT O
Raf NNP O
/ SYM O
Ras NNP O
/ SYM O
ERK NNP O
/ SYM O
MAPK NNP O
pathway NN O
is VBZ O
known VBN O
to TO O
be VB O
involved VBN O
in IN O
NGF NNP O
- HYPH O
induced VBN O
outgrowth NN O
[ -LRB- O
32 CD O
] -RRB- O
. . O

Therefore RB O
, , O
we PRP O
examined VBD O
the DT O
effects NNS O
of IN O
this DT O
pathway NN O
' POS O
s NNS O
specific JJ O
inhibitors NNS O
. . O

The DT O
Ras NNP O
inhibitor NN O
( , O
GW5074 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
, , O
Raf NNP O
inhibitor NN O
( , O
lovastatin NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
, , O
MEK1 NNP O
/ SYM O
2 CD O
inhibitor NN O
( , O
SL327 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NNP O
) -RRB- O
, , O
and CC O
MAPK NNP O
inhibitor NN O
( -LRB- O
PD98059 NN O
; : O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
( SYM O
1 CD O
. . O
0 CD O
micro NN O
M NN O
) -RRB- O
( -LRB- O
Figure NN O
7 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
these DT O
inhibitors NNS O
alone RB O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
( -LRB- O
Figure NN O
7 CD O
) -RRB- O
. . O

Discussion NN O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
found VBD O
that IN O
fluvoxamine NN O
( , O
but CC O
not RB O
sertraline NN O
or CC O
paroxetine NN O
) -RRB- O
and CC O
the DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
( , O
SA4503 NNP O
, , O
PPBP NNP O
, , O
DHEA NNP O
- HYPH O
sulfate NN O
) -RRB- O
could MD O
potentiate VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
, , O
and CC O
that IN O
the DT O
effects NNS O
of IN O
these DT O
drugs NNS O
were VBD O
blocked VBN O
by IN O
co NN O
- HYPH O
incubation NN O
with IN O
the DT O
selective JJ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
antagonist NN O
NE NNP O
- HYPH O
100 CD O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
agonism NN O
at IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
for IN O
these DT O
drugs NNS O
is VBZ O
involved VBN O
in IN O
the DT O
mechanisms NNS O
underlying VBG O
the DT O
drugs NNS O
' POS O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

As IN O
shown VBN O
in IN O
Figure NNP O
1 CD O
, , O
NGF NNP O
increased VBD O
the DT O
number NN O
of IN O
cells NNS O
with IN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
, , O
in IN O
a DT O
concentration NN O
dependent JJ O
manner NN O
. . O

To TO O
examine VB O
whether IN O
or CC O
not RB O
the DT O
NGF NNP O
levels NNS O
are VBP O
altered VBN O
by IN O
incubation NN O
with IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
, , O
we PRP O
measured VBD O
the DT O
levels NNS O
of IN O
NGF NNP O
in IN O
PC12 NNP O
cells NNS O
with IN O
or CC O
without IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
SA4503 NN O
. . O

No DT O
differences NNS O
of IN O
NGF NNP O
levels NNS O
were VBD O
shown VBN O
in IN O
the DT O
between IN O
control NN O
group NN O
and CC O
SA4503 NN O
- HYPH O
treated VBN O
group NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

It PRP O
is VBZ O
, , O
therefore RB O
, , O
unlikely JJ O
that IN O
the DT O
potentaition NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
might MD O
be VB O
due IN O
to IN O
increased VBN O
levels NNS O
of IN O
NGF NNP O
. . O

Unlike IN O
fluvoxamine NN O
, , O
sertraline NN O
, , O
which WDT O
has VBZ O
a DT O
moderate JJ O
affinity NN O
for IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
, , O
did VBD O
not RB O
alter VB O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

The DT O
reasons NNS O
underlying VBG O
this DT O
discrepancy NN O
between IN O
these DT O
two CD O
SSRIs NNS O
are VBP O
currently RB O
unclear JJ O
. . O

One CD O
possibility NN O
may MD O
involve VB O
the DT O
difference NN O
in IN O
pharmacological JJ O
actions NNS O
( : O
agonist NN O
vs FW O
. . O
antagonist NN O
) -RRB- O
between IN O
these DT O
SSRIs NNS O
at IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
. . O

Interestingly RB O
, , O
we PRP O
recently RB O
found VBD O
that IN O
, , O
in IN O
a DT O
novel JJ O
object NN O
recognition NN O
test NN O
, , O
phencyclidine NN O
- HYPH O
induced VBN O
cognitive JJ O
deficits NNS O
could MD O
be VB O
significantly RB O
improved VBN O
by IN O
subsequent JJ O
subchronic JJ O
( , O
14 CD O
days NNS O
) -RRB- O
administration NN O
of IN O
fluvoxamine NN O
, , O
but CC O
not RB O
of IN O
sertraline NN O
, , O
suggesting VBG O
that IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonism NN O
is VBZ O
involved VBN O
in IN O
fluvoxamine NN O
' '' O
s NNS O
mechanism NN O
of IN O
action NN O
[ -LRB- O
9 CD O
] -RRB- O
, , O
Ishima NNP O
et FW O
al NNP O
. . O
, , O
submitted VBN O
. . O

Taken VBN O
together RB O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
fluvoxamine NN O
and CC O
sertraline NN O
may MD O
function VB O
as IN O
an DT O
agonist NN O
and CC O
an DT O
antagonist NN O
at IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
, , O
respectively RB O
, , O
although IN O
further JJ O
study NN O
is VBZ O
necessary JJ O
. . O

Another DT O
possibility NN O
may MD O
be VB O
that IN O
other JJ O
pharmacological JJ O
activities NNS O
of IN O
sertraline NN O
mask VBP O
the DT O
effects NNS O
of IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonism NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
also RB O
found VBD O
that IN O
high JJ O
concentration NN O
( , O
10 CD O
micro NN O
M NN O
) -RRB- O
of IN O
paroxetine NN O
and CC O
sertraline NN O
, , O
but CC O
not RB O
fluvoxamine NN O
, , O
showed VBD O
cytotoxicity NN O
in IN O
PC12 NNP O
cells NNS O
, , O
suggesting VBG O
that IN O
fluvoxamine NN O
may MD O
be VB O
a DT O
safe JJ O
drug NN O
than IN O
paroxetine NN O
and CC O
sertraline NN O
. . O

Sigma NN O
- HYPH O
1 CD O
receptors NNS O
have VBP O
been VBN O
shown VBN O
to TO O
affect VB O
intracellular JJ O
Ca2 NN O
+ CC O
signaling NN O
, , O
although IN O
the DT O
precise JJ O
molecular JJ O
and CC O
cellular JJ O
mechanisms NNS O
underlying VBG O
this DT O
effect NN O
are VBP O
unknown JJ O
. . O

Sigma NN O
- HYPH O
1 CD O
receptors NNS O
bind VBP O
to IN O
IP3 NN O
receptors NNS O
in IN O
ER NN O
, , O
and CC O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
regulate VBP O
Ca2 NN O
+ CC O
release NN O
from IN O
intracellular JJ O
Ca2 NN O
+ CC O
storage NN O
sites NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Very RB O
recently RB O
, , O
Hayashi NNP O
and CC O
Su NNP O
[ -LRB- O
17 CD O
] -RRB- O
reported VBD O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
function VBP O
as IN O
novel JJ O
ligand NN O
- HYPH O
operated VBN O
chaperones NNS O
that WDT O
specifically RB O
target VBP O
mitochondrion NN O
- HYPH O
associated VBN O
ER NNP O
membrane NN O
. . O

Furthermore RB O
, , O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
form VBP O
Ca2 NN O
+ SYM O
- HYPH O
sensitive JJ O
chaperone NN O
machinery NN O
with IN O
another DT O
chaperone NN O
, , O
BiP NN O
, , O
and CC O
prolong NN O
Ca2 NN O
+ CC O
signaling NN O
from IN O
ER NN O
into IN O
mitochondria NN O
by IN O
stabilizing VBG O
IP3 NN O
receptors NNS O
at IN O
mitochondrion NN O
- HYPH O
associated VBN O
ER NNP O
membrane NN O
[ -LRB- O
17 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
IP3 NN O
receptor NN O
antagonist NN O
xestospongin NNP O
C NNP O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
, , O
suggesting VBG O
the DT O
role NN O
of IN O
IP3 NN O
receptors NNS O
on IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
- HYPH O
mediated VBN O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
stimulation NN O
at IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
and CC O
subsequent JJ O
interaction NN O
with IN O
IP3 NNP O
receptors NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanism NN O
underlying VBG O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
. . O

NGF NNP O
binds VBZ O
to IN O
the DT O
high JJ O
- HYPH O
affinity NN O
tyrosine NN O
receptor NN O
TrkA NNP O
, , O
initiating VBG O
several JJ O
signaling VBG O
pathways NNS O
affecting VBG O
both CC O
morphological JJ O
and CC O
transcriptional JJ O
targets NNS O
[ -LRB- O
32 CD O
] -RRB- O
, , O
[ -LRB- O
36 CD O
] -RRB- O
, , O
[ -LRB- O
37 CD O
] -RRB- O
. . O

The DT O
signaling VBG O
molecules NNS O
, , O
including VBG O
PLC NNP O
- HYPH O
gamma NNP O
, , O
PI3K NNP O
, , O
p38 NN O
MAPK NNP O
, , O
and CC O
JNK NNP O
, , O
are VBP O
activated VBN O
upon IN O
the DT O
addition NN O
of IN O
NGF NNP O
[ -LRB- O
38 CD O
] -RRB- O
. . O

PLC NNP O
- HYPH O
gamma NN O
catalyzes VBZ O
the DT O
hydrolysis NN O
of IN O
phosphatidylinositol NN O
- HYPH O
4 CD O
, , O
5 CD O
- HYPH O
bisphosphate NN O
( , O
PIP2 NN O
) -RRB- O
to IN O
diacylglycerol NN O
( -LRB- O
DAG NN O
) -RRB- O
and CC O
inositol NN O
triphosphate NN O
( -LRB- O
IP3 NN O
) -RRB- O
. . O

DAG NNP O
activates VBZ O
protein NN O
kinase NN O
C NN O
, , O
and CC O
IP3 NN O
promotes VBZ O
transient JJ O
release NN O
of IN O
Ca2 NNP O
+ CC O
from IN O
the DT O
ER NN O
[ -LRB- O
39 CD O
] -RRB- O
. . O

The DT O
pathway NN O
via IN O
PLC NNP O
- HYPH O
gamma NN O
is VBZ O
responsible JJ O
for IN O
NGF NNP O
- HYPH O
induced VBN O
cell NN O
differentiation NN O
[ -LRB- O
40 CD O
] -RRB- O
and CC O
neurite JJ O
outgrowth NN O
[ -LRB- O
41 CD O
] -RRB- O
. . O

Furthermore RB O
, , O
stimulation NN O
of IN O
PI3K NNP O
is VBZ O
reported VBN O
to TO O
be VB O
involved VBN O
in IN O
the DT O
promotion NN O
of IN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
[ -LRB- O
42 CD O
] -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
PLC NNP O
- HYPH O
gamma NN O
inhibitor NN O
U73122 NNP O
and CC O
the DT O
PI3K NNP O
inhibitor NN O
LY294002 NNP O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
. . O

Moreover RB O
, , O
we PRP O
found VBD O
that IN O
both CC O
the DT O
p38MAPK NNP O
inhibitor NN O
SB203580 NN O
and CC O
the DT O
JNK NNP O
inhibitor NN O
SP600125 NN O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
. . O

In IN O
addition NN O
, , O
it PRP O
is VBZ O
also RB O
interesting JJ O
that IN O
neurite JJ O
outgrowth NN O
induced VBN O
by IN O
low JJ O
concentration NN O
( , O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
of IN O
NGF NNP O
was VBD O
not RB O
blocked VBN O
by IN O
these DT O
inihibitors NNS O
, , O
consistent JJ O
with IN O
a DT O
previous JJ O
report NN O
[ -LRB- O
43 CD O
] -RRB- O
, , O
[ -LRB- O
44 CD O
] -RRB- O
, , O
suggesting VBG O
the DT O
existence NN O
of IN O
novel JJ O
pathway NN O
( , O
s FW O
) -RRB- O
for IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
PLC NNP O
- HYPH O
gamma NN O
, , O
PI3K NNP O
, , O
p38MAPK NNP O
, , O
and CC O
JNK NNP O
signaling NN O
pathways NNS O
are VBP O
involved VBN O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
( -LRB- O
Figure NN O
8 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
specific JJ O
inhibitors NNS O
for IN O
the DT O
Raf NNP O
/ SYM O
Ras NNP O
/ SYM O
MEK NNP O
/ SYM O
MAPK NNP O
pathways NNS O
significantly RB O
blocked VBD O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
SA4503 NNP O
, , O
suggesting VBG O
that IN O
these DT O
pathways NNS O
are VBP O
involved VBN O
in IN O
the DT O
potentiation NN O
of IN O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
by IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
( -LRB- O
Figure NN O
8 CD O
) -RRB- O
. . O

Our PRP$ O
recent JJ O
positron NN O
emission NN O
tomography NN O
( , O
PET NNP O
) -RRB- O
study NN O
demonstrated VBD O
that IN O
, , O
after IN O
a DT O
single JJ O
oral JJ O
administration NN O
, , O
fluvoxamine NN O
bound VBN O
to IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
in IN O
the DT O
living VBG O
human JJ B-Species
brain NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

This DT O
finding NN O
suggests VBZ O
that IN O
sigma NN O
- HYPH O
1 CD O
receptors NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
fluvoxamine NN O
in IN O
the DT O
human JJ B-Species
brain NN O
[ -LRB- O
45 CD O
] -RRB- O
. . O

Taken VBN O
together RB O
, , O
the DT O
past JJ O
and CC O
present JJ O
findings NNS O
suggest VBP O
that IN O
, , O
unlike IN O
paroxetine NN O
and CC O
sertraline NN O
, , O
the DT O
SSRI NNP O
fluvoxamine NN O
, , O
with IN O
its PRP$ O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonistic JJ O
activity NN O
, , O
might MD O
be VB O
a DT O
unique JJ O
therapeutic JJ O
drug NN O
for IN O
neuropsychiatric JJ O
diseases NNS O
. . O

In IN O
conclusion NN O
, , O
the DT O
present JJ O
results NNS O
suggest VBP O
that IN O
, , O
as IN O
a DT O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonist NN O
, , O
fluvoxamine NN O
could MD O
potentiate VB O
the DT O
NGF NNP O
- HYPH O
induced VBN O
neurite JJ O
outgrowth NN O
in IN O
PC12 NNP O
cells NNS O
. . O

Furthermore RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
interaction NN O
with IN O
IP3 NN O
receptors NNS O
and CC O
several JJ O
subsequent JJ O
signaling NN O
molecules NNS O
are VBP O
involved VBN O
in IN O
the DT O
mechanism NN O
underlying VBG O
the DT O
pharmacological JJ O
action NN O
of IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
sigma NN O
- HYPH O
1 CD O
receptor NN O
agonists NNS O
such JJ O
as IN O
fluvoxamine NN O
and CC O
DHEA NNP O
- HYPH O
sulfate NN O
, , O
which WDT O
are VBP O
available JJ O
around IN O
the DT O
world NN O
, , O
would MD O
be VB O
unique JJ O
therapeutic JJ O
drugs NNS O
for IN O
neuropsychiatric JJ O
diseases NNS O
. . O

A DT O
novel JJ O
, , O
non RB O
- HYPH O
invasive JJ O
, , O
online RB O
- HYPH O
monitoring NN O
, , O
versatile JJ O
and CC O
easy JJ O
plant NN O
- HYPH O
based VBN O
probe NN O
for IN O
measuring VBG O
leaf NN O
water NN O
status NN O

Abstract JJ O

A DT O
high JJ O
- HYPH O
precision NN O
pressure NN O
probe NN O
is VBZ O
described VBN O
which WDT O
allows VBZ O
non RB O
- HYPH O
invasive JJ O
online RB O
- HYPH O
monitoring NN O
of IN O
the DT O
water NN O
relations NNS O
of IN O
intact JJ O
leaves NNS O
. . O

Real JJ O
- HYPH O
time NN O
recording NN O
of IN O
the DT O
leaf NN O
water NN O
status NN O
occurred VBD O
by IN O
data NNS O
transfer NN O
to IN O
an DT O
Internet NN O
server NN O
. . O

The DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
measures VBZ O
the DT O
attenuated JJ O
pressure NN O
, , O
Pp NNP O
, , O
of IN O
a DT O
leaf JJ O
patch NN O
in IN O
response NN O
to IN O
a DT O
constant JJ O
clamp NN O
pressure NN O
, , O
Pclamp NNP O
. . O

Pp NN O
is VBZ O
sensed VBN O
by IN O
a DT O
miniaturized JJ O
silicone NN O
pressure NN O
sensor NN O
integrated VBN O
into IN O
the DT O
device NN O
. . O

The DT O
magnitude NN O
of IN O
Pp NNP O
is VBZ O
dictated VBN O
by IN O
the DT O
transfer NN O
function NN O
of IN O
the DT O
leaf NN O
, , O
Tf NNP O
, , O
which WDT O
is VBZ O
a DT O
function NN O
of IN O
leaf NN O
patch NN O
volume NN O
and CC O
ultimately RB O
of IN O
cell NN O
turgor NN O
pressure NN O
, , O
Pc NNP O
, , O
as IN O
shown VBN O
theoretically RB O
. . O

The DT O
power NN O
function NN O
Tf NNP O
= SYM O
f NNP O
( -LRB- O
Pc NN O
) -RRB- O
theoretically RB O
derived VBD O
was VBD O
experimentally RB O
confirmed VBN O
by IN O
concomitant JJ O
Pp NN O
and CC O
Pc NNP O
measurements NNS O
on IN O
intact JJ O
leaflets NNS O
of IN O
the DT O
liana NN O
Tetrastigma NNP B-Species
voinierianum NN I-Species
under IN O
greenhouse NN O
conditions NNS O
. . O

Simultaneous JJ O
Pp NN O
recordings NNS O
on IN O
leaflets NNS O
up IN O
to IN O
10 CD O
m NN O
height NN O
above IN O
ground NN O
demonstrated VBD O
that IN O
changes NNS O
in IN O
Tf NNP O
induced VBN O
by IN O
Pc NNP O
changes NNS O
due IN O
to IN O
changes NNS O
of IN O
microclimate NN O
and CC O
/ SYM O
or CC O
of IN O
the DT O
irrigation NN O
regime NN O
were VBD O
sensitively RB O
reflected VBN O
in IN O
corresponding VBG O
changes NNS O
of IN O
Pp NNP O
. . O

Analysis NN O
of IN O
the DT O
data NNS O
show VBP O
that IN O
transpirational JJ O
water NN O
loss NN O
during IN O
the DT O
morning NN O
hours NNS O
was VBD O
associated VBN O
with IN O
a DT O
transient JJ O
rise NN O
in IN O
turgor NN O
pressure NN O
gradients NNS O
within IN O
the DT O
leaflets NNS O
. . O

Subsequent JJ O
recovery NN O
of IN O
turgescence NN O
during IN O
the DT O
afternoon NN O
was VBD O
much RB O
faster JJR O
than IN O
the DT O
preceding VBG O
transpiration NN O
- HYPH O
induced VBN O
water NN O
loss NN O
if IN O
the DT O
plants NNS O
were VBD O
well RB O
irrigated JJ O
. . O

Our PRP$ O
data NNS O
show VBP O
the DT O
enormous JJ O
potential NN O
of IN O
the DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
for IN O
leaf JJ O
water NN O
studies NNS O
including VBG O
unravelling VBG O
of IN O
the DT O
hydraulic JJ O
communication NN O
between IN O
neighbouring VBG O
leaves NNS O
and CC O
over IN O
long JJ O
distances NNS O
within IN O
tall JJ O
plants NNS O
( , O
trees NNS O
) -RRB- O
. . O

Introduction NN O

Optimum JJ O
water NN O
supply NN O
, , O
particularly RB O
at IN O
peak NN O
needs NNS O
of IN O
the DT O
plants NNS O
, , O
is VBZ O
an DT O
important JJ O
issue NN O
for IN O
greenhouse NN O
and CC O
field NN O
vegetable NN O
production NN O
. . O

In IN O
a DT O
greenhouse NN O
on IN O
a DT O
sunny JJ O
day NN O
, , O
evaporation NN O
and CC O
transpiration NN O
( , O
so RB O
- HYPH O
called VBN O
evapotranspiration NN O
) -RRB- O
can MD O
occur VB O
so RB O
rapidly RB O
that IN O
water NN O
loss NN O
can MD O
cause VB O
plant NN O
damage NN O
before IN O
wilting VBG O
symptoms NNS O
are VBP O
visible JJ O
. . O

Even RB O
at IN O
lower JJR O
temperatures NNS O
the DT O
restricted JJ O
rooting NN O
in IN O
greenhouses NNS O
leads VBZ O
frequently RB O
to IN O
plant NN O
water NN O
deficiency NN O
. . O

Thus RB O
, , O
no RB O
matter RB O
how WRB O
slight JJ O
, , O
drought NN O
stress NN O
will MD O
result VB O
in IN O
a DT O
significant JJ O
reduction NN O
in IN O
growth NN O
and CC O
, , O
in IN O
turn NN O
, , O
of IN O
harvest NN O
yield NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
over IN O
- HYPH O
irrigation NN O
must MD O
be VB O
avoided VBN O
and CC O
the DT O
appropriate JJ O
method NN O
of IN O
watering NN O
must MD O
be VB O
selected VBN O
because IN O
wet JJ O
soils NNS O
and CC O
permanent JJ O
moisture NN O
on IN O
plant NN O
organs NNS O
promote VBP O
the DT O
incidence NN O
of IN O
root NN O
mould NN O
, , O
grey JJ O
mould NN O
( , O
Botrytis NNP O
blight NN O
) -RRB- O
, , O
formation NN O
of IN O
leaf NN O
oedema NN O
, , O
and CC O
other JJ O
plant NN O
diseases NNS O
( , O
Sherf NNP O
and CC O
MacNab NNP O
, , O
1986 CD O
) -RRB- O
. . O

Conservation NN O
of IN O
water NN O
is VBZ O
another DT O
important JJ O
issue NN O
in IN O
semi NN O
- HYPH O
arid JJ O
and CC O
arid JJ O
regions NNS O
where WRB O
water NN O
is VBZ O
scarce JJ O
. . O

The DT O
advent NN O
of IN O
( : O
subsurface NN O
) , O
drip NN O
irrigation NN O
has VBZ O
considerably RB O
reduced VBN O
water NN O
consumption NN O
of IN O
agricultural JJ O
, , O
horticultural JJ O
, , O
and CC O
greenhouse NN O
crops NNS O
, , O
but CC O
has VBZ O
also RB O
highlighted VBN O
the DT O
need NN O
for IN O
sensors NNS O
monitoring VBG O
water NN O
deficiency NN O
of IN O
plants NNS O
directly RB O
and CC O
online RB O
( , O
Jones NNP O
, , O
2004 CD O
) -RRB- O
. . O

In IN O
plant NN O
physiology NN O
and CC O
agriculture NN O
the DT O
pressure NN O
bomb NN O
technique NN O
pioneered VBN O
by IN O
Scholander NNP O
et FW O
al NNP O
. . O

( -LRB- O
1965 CD O
) -RRB- O
is VBZ O
a DT O
widely RB O
accepted VBN O
reference NN O
technique NN O
for IN O
measuring VBG O
leaf NN O
water NN O
status NN O
. . O

However RB O
, , O
the DT O
method NN O
is VBZ O
massively RB O
invasive JJ O
, , O
slow JJ O
, , O
labour NN O
- HYPH O
intensive JJ O
( , O
and CC O
therefore RB O
expensive JJ O
) -RRB- O
, , O
unsuitable JJ O
for IN O
automation NN O
, , O
and CC O
gives VBZ O
only RB O
spot NN O
measurements NNS O
. . O

Furthermore RB O
, , O
interpretation NN O
of IN O
the DT O
data NNS O
is VBZ O
still RB O
a DT O
matter NN O
of IN O
debate NN O
( : O
Zimmermann NNP O
U NNP O
et FW O
al NNP O
. . O
, , O
2004 CD O
; : O
Zimmermann NNP O
D NNP O
et FW O
al NNP O
. . O
, , O
2007 CD O
) -RRB- O
. . O

Leaf JJ O
thickness NN O
is VBZ O
also RB O
sometimes RB O
used VBN O
as IN O
an DT O
indicator NN O
for IN O
water NN O
stress NN O
( , O
Burquez NNP O
, , O
1987 CD O
; : O
McBurney NNP O
, , O
1992 CD O
; : O
Malone NNP O
, , O
1993 CD O
) -RRB- O
. . O

Leaf NN O
thickness NN O
monitoring NN O
devices NNS O
are VBP O
commercially RB O
available JJ O
. . O

They PRP O
are VBP O
non RB O
- HYPH O
invasive JJ O
and CC O
suitable JJ O
for IN O
online JJ O
measurements NNS O
, , O
but CC O
have VBP O
the DT O
disadvantage NN O
that IN O
changes NNS O
in IN O
water NN O
status NN O
are VBP O
frequently RB O
not RB O
reflected VBN O
sensitively RB O
in IN O
changes NNS O
of IN O
leaf NN O
thickness NN O
. . O

The DT O
pressure NN O
probe NN O
technique NN O
pioneered VBN O
by IN O
Zimmermann NNP O
, , O
Tomos NNP O
, , O
and CC O
others NNS O
( , O
Zimmermann NNP O
et FW O
al NNP O
. . O
, , O
1969 CD O
, , O
2004 CD O
; : O
Tomos NNP O
, , O
1988 CD O
; : O
Balling NNP O
and CC O
Zimmermann NNP O
, , O
1990 CD O
) -RRB- O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
is VBZ O
a DT O
well RB O
established VBN O
technology NN O
for IN O
measuring VBG O
turgor NN O
and CC O
xylem NN O
pressure NN O
on IN O
the DT O
levels NNS O
of IN O
individual JJ O
cells NNS O
and CC O
xylem NN O
vessels NNS O
, , O
respectively RB O
. . O

This DT O
technique NN O
is VBZ O
not RB O
suitable JJ O
for IN O
automation NN O
. . O

Moreover RB O
, , O
the DT O
probe NN O
technique NN O
requires VBZ O
rather RB O
sophisticated JJ O
equipment NN O
and CC O
a DT O
high JJ O
level NN O
of IN O
technical JJ O
skill NN O
. . O

These DT O
disadvantages NNS O
are VBP O
also RB O
shared VBN O
by IN O
the DT O
ball NN O
tonometry NN O
, , O
a DT O
method NN O
which WDT O
allows VBZ O
non RB O
- HYPH O
invasive JJ O
monitoring NN O
of IN O
cell NN O
turgor NN O
pressure NN O
by IN O
application NN O
of IN O
an DT O
external JJ O
pressure NN O
( , O
Lintilhac NNP O
et FW O
al NNP O
. . O
, , O
2000 CD O
; : O
Geitmann NNP O
, , O
2006 CD O
) -RRB- O
. . O

Other JJ O
water NN O
stress NN O
monitoring NN O
devices NNS O
are VBP O
described VBN O
in IN O
the DT O
literature NN O
, , O
but CC O
all DT O
of IN O
them PRP O
have VBP O
various JJ O
disadvantages NNS O
which WDT O
prevented VBD O
their PRP$ O
implementation NN O
for IN O
leaf JJ O
water NN O
status NN O
measurements NNS O
in IN O
greenhouses NNS O
or CC O
in IN O
the DT O
field NN O
( , O
see VBP O
, , O
for IN O
example NN O
, , O
the DT O
review NN O
article NN O
of IN O
Jones NNP O
, , O
2004 CD O
, , O
and CC O
also RB O
Grant NNP O
et FW O
al NNP O
. . O
, , O
2007 CD O
) -RRB- O
. . O

In IN O
this DT O
communication NN O
a DT O
novel JJ O
, , O
non RB O
- HYPH O
invasive JJ O
, , O
online JJ O
- HYPH O
monitoring NN O
plant NN O
- HYPH O
based VBN O
probe NN O
is VBZ O
described VBN O
that WDT O
meets VBZ O
the DT O
demands NNS O
of IN O
controlling VBG O
horticultural JJ O
and CC O
agricultural JJ O
water NN O
applications NNS O
. . O

The DT O
probe NN O
is VBZ O
characterized VBN O
by IN O
high JJ O
precision NN O
, , O
operating NN O
convenience NN O
, , O
minimum NN O
costs NNS O
, , O
and CC O
by IN O
automation NN O
suitability NN O
. . O

Data NNS O
can MD O
be VB O
transferred VBN O
wireless RB O
to IN O
a DT O
personal JJ O
computer NN O
or CC O
to IN O
an DT O
Internet NN O
server NN O
via IN O
a DT O
mobile JJ O
phone NN O
network NN O
for IN O
real JJ O
- HYPH O
time NN O
evaluation NN O
and CC O
for IN O
the DT O
automatic JJ O
regulation NN O
of IN O
irrigation NN O
. . O

The DT O
technology NN O
includes VBZ O
a DT O
miniaturized JJ O
silicone NN O
pressure NN O
sensor NN O
integrated VBN O
into IN O
a DT O
spring NN O
clamp NN O
that WDT O
is VBZ O
clamped VBN O
to IN O
a DT O
patch NN O
of IN O
an DT O
intact JJ O
plant NN O
leaf NN O
. . O

The DT O
patch NN O
clamp NN O
pressure NN O
probe NN O
measures VBZ O
the DT O
attenuated VBN O
pressure NN O
response NN O
of IN O
the DT O
leaf JJ O
patch NN O
upon IN O
the DT O
application NN O
of IN O
a DT O
constant JJ O
, , O
clamped VBN O
pressure NN O
. . O

The DT O
attenuation NN O
of IN O
the DT O
applied VBN O
pressure NN O
depends VBZ O
on IN O
the DT O
transfer NN O
function NN O
of IN O
the DT O
leaf NN O
. . O

The DT O
magnitude NN O
of IN O
the DT O
transfer NN O
function NN O
depends VBZ O
on IN O
two CD O
terms NNS O
, , O
a DT O
turgor NN O
pressure NN O
- HYPH O
independent JJ O
term NN O
( , O
related VBN O
to IN O
the DT O
compression NN O
of IN O
the DT O
cuticle NN O
, , O
cell NN O
walls NNS O
, , O
and CC O
other JJ O
structural JJ O
elements NNS O
) -RRB- O
and CC O
a DT O
turgor NN O
pressure NN O
- HYPH O
dependent JJ O
term NN O
. . O

Theory NN O
shows VBZ O
that IN O
the DT O
turgor NN O
pressure NN O
- HYPH O
dependent JJ O
part NN O
of IN O
the DT O
transfer NN O
function NN O
Tf NNP O
is VBZ O
a DT O
power NN O
function NN O
of IN O
the DT O
cell NN O
turgor NN O
pressure NN O
, , O
Pc NNP O
, , O
and CC O
predicts VBZ O
that IN O
Tf NNP O
assumes VBZ O
values NNS O
close JJ O
to IN O
zero CD O
if IN O
Pc NNP O
is VBZ O
high JJ O
and CC O
, , O
vice RB O
versa RB O
, , O
values VBZ O
close RB O
to IN O
unity NN O
if IN O
Pc NNP O
is VBZ O
low JJ O
. . O

This DT O
could MD O
be VB O
verified VBN O
by IN O
combined VBN O
turgor NN O
pressure NN O
probe NN O
and CC O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
measurements NNS O
on IN O
leaflets NNS O
of IN O
the DT O
liana NN O
Tetrastigma NNP B-Species
voinierianum NN I-Species
. . O

The DT O
10 CD O
- HYPH O
m NN O
tall JJ O
liana NN O
growing VBG O
in IN O
a DT O
tropical JJ O
greenhouse NN O
was VBD O
selected VBN O
for IN O
the DT O
first JJ O
studies NNS O
because IN O
a DT O
comprehensive JJ O
data NNS O
set VBN O
about IN O
diurnal JJ O
changes NNS O
in IN O
xylem NN O
and CC O
turgor NN O
pressure NN O
gradients NNS O
under IN O
various JJ O
environmental JJ O
conditions NNS O
existed VBD O
for IN O
this DT O
greenhouse NN O
plant NN O
( , O
Benkert NNP O
et FW O
al NNP O
. . O
, , O
1995 CD O
; , O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O
, , O
1999 CD O
; , O
see VB O
also RB O
Zimmermann NNP O
et FW O
al NNP O
. . O
, , O
2004 CD O
) -RRB- O
. . O

Measurements NNS O
of IN O
diurnal JJ O
changes NNS O
of IN O
the DT O
patch NN O
clamp VBP O
pressure NN O
performed VBN O
here RB O
yielded VBD O
results NNS O
which WDT O
were VBD O
consistent JJ O
with IN O
the DT O
previous JJ O
pressure NN O
probe NN O
work NN O
on IN O
the DT O
liana NN O
. . O

The DT O
data NNS O
also RB O
demonstrated VBD O
that IN O
changes NNS O
in IN O
the DT O
irrigation NN O
regime NN O
and CC O
in IN O
microclimate NN O
can MD O
be VB O
sensed VBN O
by IN O
this DT O
novel JJ O
probe NN O
very RB O
sensitively RB O
and CC O
that IN O
use NN O
of IN O
several JJ O
probes NNS O
allowed VBD O
the DT O
study NN O
of IN O
the DT O
diurnal JJ O
water NN O
transport NN O
at IN O
multiple JJ O
scales NNS O
from IN O
single JJ O
leaves NNS O
to IN O
the DT O
whole JJ O
organism NN O
( , O
Meinzer NNP O
et FW O
al NNP O
. . O
, , O
2001 CD O
) -RRB- O
. . O

This DT O
can MD O
be VB O
done VBN O
without IN O
knowledge NN O
of IN O
the DT O
turgor NN O
pressure NN O
because IN O
the DT O
transfer NN O
function NN O
is VBZ O
a DT O
direct JJ O
measure NN O
of IN O
leaf NN O
water NN O
status NN O
. . O

Materials NNS O
and CC O
methods NNS O

Plant NN O
material NN O

Experiments NNS O
were VBD O
performed VBN O
on IN O
two CD O
specimens NNS O
of IN O
the DT O
liana NN O
Tetrastigma NNP B-Species
voinierianum NN I-Species
, , O
growing VBG O
in IN O
the DT O
c NN O
. . O

12 CD O
m NN O
tall JJ O
tropical JJ O
greenhouse NN O
of IN O
the DT O
University NNP O
of IN O
Salzburg NNP O
, , O
Austria NNP O
. . O

The DT O
ground NN O
ascended VBD O
by IN O
about RB O
5 CD O
m NN O
towards IN O
the DT O
backstage NN O
of IN O
the DT O
greenhouse NN O
. . O

The DT O
height NN O
of IN O
the DT O
plant NN O
in IN O
this DT O
area NN O
was VBD O
about RB O
4 CD O
. . O
5 CD O
m NN O
, , O
whereas IN O
the DT O
height NN O
of IN O
the DT O
plant NN O
in IN O
the DT O
front JJ O
area NN O
reached VBD O
10 CD O
m NNS O
. . O

However RB O
, , O
the DT O
stem NN O
and CC O
the DT O
branches NNS O
of IN O
the DT O
two CD O
plants NNS O
were VBD O
considerably RB O
longer JJR O
, , O
because IN O
the DT O
plants NNS O
had VBD O
grown VBN O
vertically RB O
upwards RB O
and CC O
then RB O
part NN O
of IN O
the DT O
way NN O
downwards RB O
. . O

First JJ O
measurements NNS O
were VBD O
performed VBN O
during IN O
the DT O
last JJ O
week NN O
of IN O
May NNP O
, , O
2007 CD O
. . O

This DT O
week NN O
was VBD O
very RB O
sunny JJ O
and CC O
warm JJ O
. . O

Experiments NNS O
were VBD O
repeated VBN O
during IN O
the DT O
last JJ O
week NN O
of IN O
August NNP O
and CC O
the DT O
first JJ O
week NN O
of IN O
September NNP O
, , O
2007 CD O
. . O

At IN O
this DT O
time NN O
of IN O
the DT O
year NN O
the DT O
weather NN O
conditions NNS O
were VBD O
quite RB O
poor JJ O
. . O

The DT O
weeks NNS O
were VBD O
rainy JJ O
, , O
sunshine NN O
occurred VBD O
only RB O
occasionally RB O
. . O

On IN O
average JJ O
, , O
the DT O
sky NN O
was VBD O
very RB O
cloudy JJ O
. . O

Due IN O
to IN O
the DT O
variable JJ O
weather NN O
conditions NNS O
the DT O
ambient JJ O
temperature NN O
, , O
T NNP O
, , O
in IN O
the DT O
greenhouse NN O
usually RB O
varied VBD O
between IN O
19 CD O
degrees NNS O
C NN O
and CC O
27 CD O
degrees NNS O
C NN O
. . O

By IN O
contrast NN O
, , O
during IN O
the DT O
hot JJ O
week NN O
in IN O
May NNP O
temperatures NNS O
at IN O
the DT O
top NN O
of IN O
the DT O
plants NNS O
could MD O
reach VB O
up IN O
to IN O
44 CD O
degrees NNS O
C NN O
. . O

The DT O
greenhouse NN O
was VBD O
illuminated VBN O
between IN O
7 CD O
. . O
30 CD O
h CD O
and CC O
19 CD O
. . O
0 CD O
h NN O
( , O
CET NNP O
= SYM O
Central NNP O
European NNP O
Time NNP O
) -RRB- O
. . O

During IN O
the DT O
day NN O
- HYPH O
time NN O
, , O
the DT O
artificial JJ O
illumination NN O
was VBD O
switched VBN O
off RP O
automatically RB O
once IN O
the DT O
natural JJ O
irradiance NN O
exceeded VBD O
about IN O
45 CD O
mu NNS O
mol NN O
photons NNS O
m SYM O
- HYPH O
2 CD O
s NNS O
- HYPH O
1 CD O
at IN O
ground NN O
level NN O
. . O

At IN O
full JJ O
sunshine NN O
, , O
the DT O
light JJ O
intensity NN O
was VBD O
limited VBN O
by IN O
automatically RB O
operating VBG O
blinds NNS O
. . O

The DT O
relative JJ O
humidity NN O
( , O
r UH O
. . O
h NN O
. . O
) -RRB- O
of IN O
the DT O
air NN O
was VBD O
regulated VBN O
by IN O
overhead JJ O
misters NNS O
. . O

Despite IN O
attempts NNS O
to TO O
keep VB O
the DT O
r NN O
. . O
h NFP O
. . O
above IN O
60 CD O
- SYM O
70 CD O
% NN O
large JJ O
axial JJ O
r NN O
. . O
h NFP O
. . O
gradients NNS O
along IN O
the DT O
stem NN O
of IN O
the DT O
liana NN O
were VBD O
observed VBN O
during IN O
sunny JJ O
days NNS O
( , O
see VB O
below RB O
) -RRB- O
. . O

The DT O
ambient JJ O
temperature NN O
and CC O
relative JJ O
humidity NN O
at IN O
the DT O
measuring NN O
sites NNS O
were VBD O
determined VBN O
by IN O
using VBG O
thermistors NNS O
( , O
Tinytag NNP O
; : O
RS NNP O
Components NNPS O
GmbH NNP O
, , O
M NNP O
o NNP O
rfelden NNP O
- HYPH O
Walldorf NNP O
, , O
Germany NNP O
) -RRB- O
. . O

Leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
and CC O
data NN O
acquisition NN O

The DT O
pressure NN O
sensor NN O
chip NN O
allows VBZ O
pressure NN O
measurements NNS O
up IN O
to IN O
100 CD O
kPa NN O
. . O

The DT O
sensor NN O
consists VBZ O
of IN O
a DT O
miniature JJ O
piezoresistive JJ O
Wheatstone NNP O
bridge NN O
. . O

The DT O
sensors NNS O
used VBN O
in IN O
this DT O
work NN O
were VBD O
purchased VBN O
from IN O
the DT O
company NN O
' `` O
Raumedic NNP O
' '' O
( : O
Helmbrechts NNP O
, , O
Germany NNP O
) , O
and CC O
from IN O
the DT O
company NN O
' '' O
Keller NNP O
' '' O
( , O
AG NNP O
, , O
Druckmesstechnik NNP O
; : O
Winterthur NNP O
, , O
Switzerland NNP O
) -RRB- O
. . O

However RB O
, , O
it PRP O
has VBZ O
to TO O
be VB O
pointed VBN O
out RP O
that IN O
any DT O
other JJ O
miniaturized VBN O
pressure NN O
or CC O
force NN O
sensor NN O
could MD O
be VB O
used VBN O
. . O

The DT O
sensor NN O
chip NN O
was VBD O
integrated VBN O
into IN O
one CD O
of IN O
the DT O
planar NN O
circular JJ O
pads NNS O
of IN O
a DT O
spring NN O
clamp NN O
shown VBN O
schematically RB O
in IN O
Fig NNP O
. . O

1 LS O
. . O

The DT O
spring NN O
clamp NN O
consisted VBD O
of IN O
two CD O
curved JJ O
arms NNS O
bridged VBN O
by IN O
a DT O
spring NN O
in IN O
the DT O
middle NN O
( , O
Wolfcraft NNP O
GmbH NNP O
; : O
microfix NNP O
S NNP O
( -LRB- O
B3630Fz60 NNP O
) -RRB- O
, , O
Kempenich NNP O
, , O
Germany NNP O
) -RRB- O
. . O

The DT O
clamp NN O
pressure NN O
exerted VBN O
by IN O
the DT O
spring NN O
on IN O
the DT O
leaf NN O
, , O
Pclamp NNP O
, , O
could MD O
be VB O
varied VBN O
by IN O
a DT O
stiff JJ O
strap NN O
( , O
made VBN O
of IN O
synthetic JJ O
material NN O
) , O
spanned VBN O
between IN O
the DT O
arms NNS O
of IN O
the DT O
spring NN O
clip NN O
at IN O
the DT O
handhold NN O
site NN O
( , O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

The DT O
length NN O
of IN O
the DT O
strap NN O
and CC O
thus RB O
the DT O
spring NN O
load NN O
acting VBG O
on IN O
the DT O
leaflet NN O
between IN O
the DT O
two CD O
pads NNS O
could MD O
be VB O
varied VBN O
by IN O
regularly RB O
punched VBN O
holes NNS O
( , O
as IN O
in IN O
a DT O
belt NN O
) -RRB- O
. . O

Calibration NN O
of IN O
the DT O
sensor NN O
chips NNS O
was VBD O
performed VBN O
by IN O
pressurization NN O
in IN O
a DT O
pressure NN O
chamber NN O
equipped VBN O
with IN O
an DT O
integrated VBN O
manometer NN O
( , O
LEO NNP O
1 CD O
, , O
Keller NNP O
AG NNP O
, , O
Winterthur NNP O
, , O
Switzerland NNP O
) -RRB- O
. . O

The DT O
readings NNS O
of IN O
all DT O
sensors NNS O
used VBN O
in IN O
this DT O
study NN O
increased VBD O
linearly RB O
with IN O
pressure NN O
in IN O
the DT O
range NN O
between IN O
0 CD O
kPa NN O
and CC O
100 CD O
kPa NN O
. . O

The DT O
pressure NN O
sensitivity NN O
of IN O
the DT O
various JJ O
sensors NNS O
was VBD O
found VBN O
to TO O
be VB O
almost RB O
identical JJ O
for IN O
all DT O
probes NNS O
. . O

Before IN O
use NN O
the DT O
probes NNS O
were VBD O
also RB O
tested VBN O
for IN O
temperature NN O
- HYPH O
sensitivity NN O
in IN O
an DT O
accessible JJ O
climate NN O
chamber NN O
because IN O
it PRP O
is VBZ O
well RB O
- HYPH O
known VBN O
that IN O
silicone NN O
- HYPH O
embedded VBN O
sensors NNS O
tend VBP O
to TO O
become VB O
temperature NN O
- HYPH O
sensitive JJ O
during IN O
storage NN O
. . O

Probes NNS O
were VBD O
subject JJ O
to IN O
temperature NN O
regimes NNS O
ranging VBG O
from IN O
10 CD O
degrees NNS O
C NN O
to IN O
35 CD O
degrees NNS O
C NN O
. . O

Probes NNS O
were VBD O
not RB O
used VBN O
if IN O
the DT O
temperature NN O
treatment NN O
induced VBD O
a DT O
pressure NN O
change NN O
larger JJR O
than IN O
0 CD O
. . O
5 CD O
kPa NNP O
. . O

The DT O
signals NNS O
of IN O
the DT O
leaf NN O
patch NN O
clamp VBP O
pressure NN O
probe NN O
were VBD O
transmitted VBN O
by IN O
a DT O
telemetry NN O
system NN O
( , O
teleBITcom NN O
gmbh NN O
, , O
Teltow NNP O
, , O
Germany NNP O
) -RRB- O
. . O

The DT O
operating VBG O
distance NN O
between IN O
the DT O
battery NN O
- HYPH O
powered VBN O
wireless JJ O
telemetric JJ O
transmitter NN O
and CC O
the DT O
receiver NN O
base NN O
station NN O
was VBD O
up IN O
to IN O
400 CD O
m NNS O
. . O

Each DT O
transmitter NN O
read VBD O
, , O
amplified VBN O
, , O
and CC O
converted VBN O
the DT O
analogue NN O
signals NNS O
of IN O
the DT O
pressure NN O
sensor NN O
into IN O
digitalized JJ O
signals NNS O
. . O

The DT O
data NNS O
were VBD O
sent VBN O
together RB O
with IN O
the DT O
transmitter NN O
ID NN O
- HYPH O
code NN O
every DT O
90 CD O
s NNS O
via IN O
the DT O
ISM NNP O
band NN O
of IN O
433 CD O
MHz NNP O
to IN O
the DT O
receiver NN O
base NN O
station NN O
which WDT O
logged VBD O
and CC O
transferred VBD O
the DT O
data NNS O
to IN O
a DT O
personal JJ O
computer NN O
or CC O
to IN O
a DT O
GPRS NNP O
modem NN O
linked VBN O
to IN O
an DT O
Internet NN O
server NN O
( , O
NTBB NNP O
Systemtechnik NNP O
GmbH NNP O
, , O
Zeuthen NNP O
, , O
Germany NNP O
) , O
for IN O
analysis NN O
and CC O
archival JJ O
storage NN O
. . O

For IN O
sensor NN O
calibration NN O
and CC O
data NNS O
recording VBG O
the DT O
SENBIT NNP O
software NN O
( -LRB- O
teleBITcom NN O
gmbh NN O
, , O
Teltow NNP O
, , O
Germany NNP O
) -RRB- O
was VBD O
used VBN O
. . O

The DT O
software NN O
allowed VBD O
communication NN O
with IN O
up IN O
to TO O
32 CD O
sensors NNS O
at IN O
regular JJ O
short JJ O
intervals NNS O
( : O
90 CD O
s NNS O
to IN O
5 CD O
min NN O
) -RRB- O
. . O

In IN O
this DT O
study NN O
, , O
up IN O
to TO O
10 CD O
sensor NN O
/ SYM O
transmitter NN O
units NNS O
were VBD O
installed VBN O
at IN O
different JJ O
heights NNS O
on IN O
the DT O
two CD O
lianas NNS O
. . O

Data NNS O
transfer NN O
to IN O
the DT O
Internet NN O
server NN O
operated VBD O
without IN O
any DT O
problem NN O
during IN O
the DT O
entire JJ O
experimental JJ O
period NN O
. . O

However RB O
, , O
for IN O
safety NN O
reasons NNS O
hard RB O
- HYPH O
wired VBN O
conventional JJ O
data NN O
acquisition NN O
was VBD O
also RB O
performed VBN O
using VBG O
dataloggers NNS O
( , O
Raumedic NNP O
, , O
Helmbrechts NNP O
, , O
Germany NNP O
) -RRB- O
. . O

The DT O
dataloggers NNS O
were VBD O
controlled VBN O
by IN O
a DT O
computer NN O
program NN O
that WDT O
provided VBD O
functions NNS O
for IN O
data NN O
storage NN O
and CC O
sensor NN O
calibration NN O
. . O

Data NNS O
were VBD O
transferred VBN O
regularly RB O
from IN O
the DT O
dataloggers NNS O
to IN O
a DT O
personal JJ O
computer NN O
. . O

Cell NN O
turgor NN O
pressure NN O
probe NN O

Turgor NN O
pressure NN O
measurements NNS O
were VBD O
performed VBN O
on IN O
leaflets NNS O
of IN O
the DT O
10 CD O
- HYPH O
m NN O
tall JJ O
liana NN O
at IN O
c NN O
. . O

0 NFP O
. . O
2 CD O
m NN O
height NN O
above IN O
the DT O
roots NNS O
. . O

The DT O
construction NN O
and CC O
function NN O
of IN O
the DT O
cell NN O
turgor NN O
pressure NN O
probe NN O
has VBZ O
been VBN O
described VBN O
elsewhere RB O
( : O
Zimmermann NNP O
et FW O
al NNP O
. . O
, , O
1969 CD O
, , O
2004 CD O
) -RRB- O
. . O

Briefly RB O
, , O
the DT O
microcapillary NN O
was VBD O
filled VBN O
with IN O
oil NN O
up IN O
to IN O
the DT O
very JJ O
tip NN O
and CC O
was VBD O
then RB O
inserted VBN O
into IN O
the DT O
upper JJ O
leaflet NN O
surface NN O
between IN O
the DT O
main JJ O
vein NN O
and CC O
the DT O
leaflet NN O
edge NN O
. . O

Insertion NN O
was VBD O
made VBN O
under IN O
a DT O
small JJ O
overpressure JJ O
( , O
about RB O
20 CD O
kPa NN O
) -RRB- O
achieved VBN O
by IN O
appropriate JJ O
displacement NN O
of IN O
the DT O
metal NN O
rod NN O
in IN O
the DT O
probe NN O
in IN O
order NN O
to TO O
avoid VB O
tip NN O
clogging NN O
. . O

Penetration NN O
was VBD O
stopped VBN O
upon IN O
reaching VBG O
the DT O
mesophyll NN O
cell NN O
layer NN O
and CC O
formation NN O
of IN O
a DT O
stable JJ O
oil NN O
/ SYM O
sap NN O
meniscus NN O
within IN O
the DT O
tip NN O
region NN O
of IN O
the DT O
microcapillary NN O
of IN O
the DT O
probe NN O
. . O

During IN O
the DT O
measurements NNS O
it PRP O
was VBD O
regularly RB O
proved VBN O
whether IN O
the DT O
tip NN O
was VBD O
clogged VBN O
or CC O
not RB O
by IN O
appropriate JJ O
displacement NN O
of IN O
the DT O
metal NN O
rod NN O
. . O

Theoretical JJ O
background NN O

The DT O
input NN O
pressure NN O
, , O
Pin NNP O
, , O
experienced VBN O
by IN O
the DT O
cells NNS O
in IN O
a DT O
leaf JJ O
patch NN O
is VBZ O
equal JJ O
to IN O
the DT O
clamp NN O
pressure NN O
, , O
Pclamp NNP O
, , O
only RB O
if IN O
the DT O
pressure NN O
signal NN O
is VBZ O
transferred VBN O
lossless JJ O
to IN O
the DT O
cells NNS O
in IN O
the DT O
leaves NNS O
. . O

However RB O
, , O
losses NNS O
usually RB O
occur VBP O
due IN O
to IN O
the DT O
compressibility NN O
and CC O
the DT O
deformability NN O
of IN O
the DT O
silicone NN O
of IN O
the DT O
pressure NN O
sensor NN O
as RB O
well RB O
as IN O
of IN O
the DT O
compressibility NN O
of IN O
the DT O
cuticle NN O
and CC O
other JJ O
structural JJ O
elements NNS O
of IN O
the DT O
leaf NN O
. . O

Therefore RB O
, , O
theory NN O
shows VBZ O
that IN O
only RB O
a DT O
fraction NN O
of IN O
Pclamp NNP O
may MD O
arrive VB O
at IN O
the DT O
cells NNS O
, , O
i PRP O
. . O
e NFP O
. . O
that IN O
the DT O
attenuation NN O
factor NN O
, , O
Fa NNP O
= , O
Pin NNP O
/ SYM O
Pclamp NNP O
, , O
is VBZ O
smaller JJR O
than IN O
unity NN O
. . O

Fa NNP O
depends VBZ O
on IN O
the DT O
individual JJ O
leaf NN O
properties NNS O
. . O

Fa NNP O
can MD O
be VB O
assumed VBN O
to TO O
be VB O
constant JJ O
( , O
and CC O
leaf NN O
thickness NN O
changes NNS O
are VBP O
negligible JJ O
) , O
if IN O
the DT O
structural JJ O
elements NNS O
are VBP O
completely RB O
pre NN O
- HYPH O
compressed VBN O
by IN O
application NN O
of IN O
an DT O
appropriate JJ O
Pclamp NNP O
. . O

If IN O
Pclamp NNP O
is VBZ O
kept VBN O
constant JJ O
during IN O
the DT O
following VBG O
experimental JJ O
period NN O
, , O
Pin NNP O
is VBZ O
constant JJ O
and CC O
the DT O
output NN O
pressure NN O
, , O
Pp NNP O
, , O
is VBZ O
only RB O
determined VBN O
by IN O
the DT O
cell NN O
transfer NN O
function NN O
, , O
Tf NNP O
( , O
V NN O
) -RRB- O
, , O
where WRB O
V NN O
is VBZ O
the DT O
leaf NN O
patch NN O
volume NN O
. . O

In IN O
other JJ O
words NNS O
, , O
Tf NNP O
( , O
V NNP O
) -RRB- O
determines VBZ O
the DT O
fraction NN O
of IN O
Pin NN O
sensed VBN O
by IN O
the DT O
probe NN O
. . O

It PRP O
is VBZ O
dimensionless JJ O
and CC O
assumes VBZ O
values NNS O
between IN O
zero CD O
and CC O
unity NN O
: : O
( , O
1 CD O
) -RRB- O
Tf NN O
depends VBZ O
on IN O
the DT O
volume NN O
of IN O
the DT O
leaf NN O
patch NN O
, , O
V NN O
, , O
at IN O
constant JJ O
ambient JJ O
temperature NN O
, , O
T NN O
: : O
( : O
2 CD O
) SYM O
delta NN O
V NN O
depends VBZ O
on IN O
changes NNS O
in IN O
cell NN O
turgor NN O
pressure NN O
, , O
delta NN O
Pc NN O
, , O
as IN O
follows VBZ O
: : O
( : O
3 CD O
) NFP O
where WRB O
op NN O
is VBZ O
the DT O
average JJ O
volumetric JJ O
elastic JJ O
modulus NN O
of IN O
the DT O
clamped VBN O
tissue NN O
( , O
Philip NNP O
, , O
1958 CD O
) -RRB- O
. . O

op UH O
is VBZ O
a DT O
very RB O
complex JJ O
parameter NN O
and CC O
will MD O
be VB O
dictated VBN O
by IN O
the DT O
turgor NN O
pressure NN O
in IN O
the DT O
turgescent JJ O
state NN O
. . O

For IN O
a DT O
first JJ O
approximation NN O
it PRP O
is VBZ O
assumed VBN O
that IN O
op NN O
increases VBZ O
linearly RB O
with IN O
Pc NNP O
( , O
support NN O
for IN O
this DT O
assumption NN O
is VBZ O
given VBN O
by IN O
Zimmermann NNP O
and CC O
Steudle NNP O
, , O
1978 CD O
; : O
Zimmermann NNP O
and CC O
H NN O
u NN O
sken NN O
, , O
1980 CD O
; : O
Wendler NNP O
et FW O
al NNP O
. . O
, , O
1983 CD O
) -RRB- O
: : O
( : O
4 CD O
) -RRB- O
where WRB O
a DT O
and CC O
b NN O
are VBP O
constants NNS O
for IN O
individual JJ O
leaf NN O
properties NNS O
. . O

Because IN O
of IN O
the DT O
viscoelastic JJ O
properties NNS O
of IN O
the DT O
cell NN O
wall NN O
, , O
the DT O
magnitude NN O
of IN O
the DT O
constants NNS O
depends VBZ O
on IN O
the DT O
duration NN O
of IN O
the DT O
external JJ O
pressure NN O
application NN O
( , O
Zimmermann NNP O
and CC O
H NN O
u NN O
sken NN O
, , O
1980 CD O
) -RRB- O
. . O

The DT O
constants NNS O
are VBP O
relatively RB O
large JJ O
if IN O
rapid JJ O
turgor NN O
pressure NN O
changes NNS O
are VBP O
induced VBN O
( , O
e LS O
. . O
g LS O
. . O
by IN O
using VBG O
the DT O
cell NN O
turgor NN O
pressure NN O
probe NN O
) -RRB- O
, , O
whereas IN O
slow JJ O
turgor NN O
pressure NN O
changes VBZ O
( , O
e LS O
. . O
g LS O
. . O
under IN O
transpirational JJ O
conditions NNS O
) -RRB- O
result VBP O
in IN O
small JJ O
values NNS O
. . O

Combining VBG O
equations NNS O
2 CD O
- SYM O
4 CD O
leads NNS O
to IN O
equation NN O
5 CD O
. . O
( : O
5 CD O
) NFP O

Equation NN O
5 CD O
can MD O
be VB O
integrated VBN O
by IN O
assuming VBG O
for IN O
a DT O
first JJ O
approximation NN O
that IN O
at IN O
Pc NN O
= SYM O
0 CD O
Tf NN O
= SYM O
1 CD O
and CC O
that IN O
the DT O
internal JJ O
osmotic JJ O
pressure NN O
of IN O
the DT O
cells NNS O
remained VBD O
constant JJ O
. . O

After IN O
appropriate JJ O
re IN O
- HYPH O
arrangements NNS O
equation NN O
6 CD O
is VBZ O
obtained VBN O
: : O
( : O
6 CD O
) NFP O
and CC O
, , O
respectively RB O
, , O
if IN O
the DT O
denominator NN O
is VBZ O
replaced VBN O
by IN O
equation NN O
4 CD O
: : O
( : O
7 CD O
) NFP O

Introducing VBG O
equation NN O
6 CD O
into IN O
equation NN O
1 CD O
yields VBZ O
the DT O
wanted VBN O
relationship NN O
between IN O
the DT O
parameters NNS O
Pp NN O
and CC O
Pin NN O
: : O
( : O
8 CD O
) NFP O

Equation NN O
8 CD O
can MD O
be VB O
verified VBN O
experimentally RB O
. . O

Inspection NN O
of IN O
the DT O
equation NN O
shows VBZ O
that IN O
the DT O
patch NN O
clamp NN O
pressure NN O
, , O
Pp NNP O
, , O
is VBZ O
a DT O
power NN O
function NN O
of IN O
the DT O
turgor NN O
pressure NN O
, , O
Pc NNP O
. . O

The DT O
exponent NN O
of IN O
the DT O
function NN O
is VBZ O
equal JJ O
to IN O
or CC O
smaller JJR O
than IN O
unity NN O
. . O

If IN O
a DT O
= SYM O
1 CD O
and CC O
b NN O
< CC O
< NN O
Pc NN O
, , O
equation NN O
8 CD O
turns VBZ O
into IN O
Pp NN O
= : O
b NN O
/ SYM O
Pc NN O
, , O
i PRP O
. . O
e -RRB- O
. . O
both DT O
parameters NNS O
are VBP O
directly RB O
reciprocally RB O
coupled VBN O
with IN O
each DT O
other JJ O
. . O

Thus RB O
Tf NNP O
assumes VBZ O
low JJ O
values NNS O
if IN O
Pc NNP O
is VBZ O
high JJ O
and CC O
, , O
vice RB O
versa RB O
, , O
a DT O
value NN O
close JJ O
to IN O
unity NN O
if IN O
Pc NNP O
is VBZ O
close JJ O
to IN O
zero CD O
. . O

Using VBG O
appropriate JJ O
values NNS O
for IN O
a DT O
and CC O
b NN O
for IN O
a DT O
given VBN O
leaf NN O
( , O
see VB O
below RB O
) -RRB- O
it PRP O
can MD O
be VB O
shown VBN O
that IN O
below IN O
Pc NNP O
= SYM O
100 CD O
kPa NN O
, , O
Pp NN O
increases VBZ O
dramatically RB O
. . O

This DT O
means VBZ O
that IN O
the DT O
transfer NN O
function NN O
responds VBZ O
very RB O
sensitively RB O
upon IN O
loss NN O
of IN O
complete JJ O
turgor NN O
pressure NN O
. . O

In IN O
the DT O
derivation NN O
of IN O
equation NN O
8 CD O
it PRP O
was VBD O
assumed VBN O
that IN O
op NN O
is VBZ O
temperature NN O
- HYPH O
independent JJ O
. . O

However RB O
, , O
temperature NN O
effects NNS O
on IN O
cell NN O
elasticity NN O
are VBP O
well RB O
- HYPH O
known VBN O
, , O
although IN O
they PRP O
are VBP O
not RB O
very RB O
large JJ O
in IN O
the DT O
temperature NN O
range NN O
investigated VBN O
here RB O
( , O
see VB O
, , O
for IN O
example NN O
, , O
Petersen NNP O
et FW O
al NNP O
. . O
, , O
1982 CD O
; : O
Niklas NNP O
, , O
1992 CD O
; : O
Hogan NNP O
and CC O
Niklas NNP O
, , O
2004 CD O
; : O
Edelmann NNP O
et FW O
al NNP O
. . O
, , O
2005 CD O
) -RRB- O
. . O

Temperature NN O
effects NNS O
on IN O
op NN O
cannot MD O
be VB O
excluded VBN O
if IN O
different JJ O
values NNS O
for IN O
the DT O
Pclamp NNP O
, , O
and CC O
, , O
in IN O
turn NN O
, , O
for IN O
the DT O
input NN O
pressure NN O
, , O
Pin NNP O
, , O
are VBP O
selected VBN O
, , O
as RB O
well RB O
as IN O
if IN O
significantly RB O
different JJ O
values NNS O
for IN O
the DT O
constants NNS O
a DT O
and CC O
b NN O
are VBP O
assumed VBN O
for IN O
optimum JJ O
fitting NN O
of IN O
the DT O
Pp NNP O
= SYM O
f NN O
( -LRB- O
Pc NN O
) -RRB- O
curves NNS O
. . O

Therefore RB O
, , O
in IN O
the DT O
case NN O
of IN O
large JJ O
temperature NN O
gradients NNS O
as IN O
observed VBN O
here RB O
( , O
see VB O
Figs NNP O
2 CD O
and CC O
3 CD O
) , O
only RB O
the DT O
relative NN O
, , O
but CC O
not RB O
the DT O
absolute JJ O
changes NNS O
in IN O
Pp NNP O
measured VBN O
at IN O
the DT O
different JJ O
heights NNS O
can MD O
be VB O
compared VBN O
with IN O
each DT O
other JJ O
. . O

However RB O
, , O
Pp NN O
values NNS O
measured VBN O
at IN O
the DT O
same JJ O
height NN O
are VBP O
still RB O
comparable JJ O
and CC O
give VB O
information NN O
about IN O
the DT O
turgescence NN O
, , O
i PRP O
. . O
e LS O
. . O
about IN O
the DT O
water NN O
status NN O
of IN O
the DT O
leaf NN O
cells NNS O
. . O

Results NNS O

The DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
was VBD O
clamped VBN O
about RB O
2 CD O
cm NNS O
away RB O
from IN O
the DT O
edge NN O
of IN O
a DT O
leaflet NN O
of IN O
the DT O
compound NN O
leaves NNS O
. . O

Leaflets NNS O
of IN O
similar JJ O
size NN O
( : O
176 CD O
+ SYM O
/ SYM O
- HYPH O
58 CD O
cm2 CD O
, , O
n CD O
= SYM O
12 CD O
) -RRB- O
were VBD O
used VBN O
. . O

Inspection NN O
of IN O
the DT O
leaf NN O
patches NNS O
after IN O
removal NN O
of IN O
the DT O
probes NNS O
under IN O
the DT O
microscope NN O
revealed VBD O
no DT O
changes NNS O
in IN O
leaflet NN O
appearance NN O
beneath IN O
the DT O
pads NNS O
, , O
even RB O
after IN O
several JJ O
weeks NNS O
. . O

Lesions NNS O
on IN O
the DT O
leaves NNS O
were VBD O
never RB O
found VBN O
. . O

Only RB O
occasionally RB O
were VBD O
very RB O
slight JJ O
impressions NNS O
of IN O
the DT O
pads NNS O
on IN O
the DT O
leaflet NN O
surface NN O
observed VBN O
. . O

Clamping VBG O
of IN O
the DT O
leaves NNS O
could MD O
be VB O
performed VBN O
at IN O
any DT O
time NN O
of IN O
the DT O
day NN O
. . O

Clamp NN O
pressures NNS O
, , O
Pclamp NNP O
, , O
applied VBN O
to IN O
the DT O
leaves NNS O
were VBD O
of IN O
the DT O
order NN O
of IN O
80 CD O
- SYM O
200 CD O
kPa NN O
. . O

The DT O
optimum JJ O
value NN O
for IN O
Pclamp NNP O
of IN O
a DT O
given VBN O
leaf NN O
has VBZ O
to TO O
be VB O
found VBN O
empirically RB O
. . O

Experience NN O
shows VBZ O
that IN O
Pclamp NNP O
values NNS O
could MD O
be VB O
considered VBN O
as RB O
optimal JJ O
if IN O
the DT O
output NN O
pressure NN O
Pp NNP O
assumed VBD O
values NNS O
between IN O
10 CD O
kPa NN O
and CC O
25 CD O
kPa NN O
upon IN O
clamping VBG O
in IN O
the DT O
early JJ O
morning NN O
( , O
when WRB O
turgor NN O
pressure NN O
was VBD O
high JJ O
) , O
or CC O
between IN O
50 CD O
kPa NN O
and CC O
70 CD O
kPa NN O
upon IN O
clamping VBG O
around IN O
noon NN O
or CC O
towards IN O
early JJ O
afternoon NN O
( , O
when WRB O
turgor NN O
pressure NN O
was VBD O
usually RB O
low JJ O
) -RRB- O
. . O

The DT O
magnitude NN O
of IN O
Pp NNP O
depended VBD O
on IN O
the DT O
compressibility NN O
and CC O
deformability NN O
properties NNS O
of IN O
the DT O
individual JJ O
leaves NNS O
which WDT O
may MD O
vary VB O
considerably RB O
due IN O
to IN O
age NN O
, , O
morphology NN O
, , O
leaf NN O
thickness NN O
, , O
abiotic JJ O
factors NNS O
etc FW O
. . O

The DT O
magnitude NN O
of IN O
Pclamp NNP O
had VBD O
no DT O
effect NN O
on IN O
the DT O
diurnal JJ O
profiles NNS O
of IN O
Pp NNP O
, , O
in IN O
response NN O
to IN O
changes NNS O
in IN O
microclimate NN O
and CC O
/ SYM O
or CC O
changes NNS O
in IN O
the DT O
irrigation NN O
regime NN O
. . O

Probes NNS O
clamped VBD O
on IN O
the DT O
same JJ O
leaflet NN O
or CC O
nearby JJ O
leaflets NNS O
of IN O
leaves NNS O
responded VBD O
almost RB O
identically RB O
upon IN O
temporary JJ O
changes NNS O
in IN O
transpiration NN O
and CC O
/ SYM O
or CC O
water NN O
supply NN O
even RB O
if IN O
the DT O
Pclamp NNP O
values NNS O
were VBD O
different JJ O
due IN O
to IN O
different JJ O
leaf NN O
thickness NN O
as RB O
well RB O
as IN O
local JJ O
compressibility NN O
and CC O
deformability NN O
properties NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

This DT O
was VBD O
found VBN O
over IN O
the DT O
entire JJ O
height NN O
of IN O
the DT O
plants NNS O
. . O

Screening NN O
experiments NNS O
proved VBD O
further RB O
that IN O
a DT O
high JJ O
surface NN O
roughness NN O
prevented VBD O
a DT O
uniform JJ O
contact NN O
between IN O
the DT O
pads NNS O
of IN O
the DT O
probe NN O
and CC O
the DT O
leaf NN O
. . O

Non NNP O
- HYPH O
uniform JJ O
contact NN O
resulted VBD O
in IN O
a DT O
reduced VBN O
pressure NN O
response NN O
of IN O
the DT O
probe NN O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Thus RB O
, , O
in IN O
order NN O
to TO O
obtain VB O
maximum JJ O
resolution NN O
of IN O
microclimate NN O
- HYPH O
induced VBN O
and CC O
/ SYM O
or CC O
plant NN O
- HYPH O
based VBN O
effects NNS O
on IN O
the DT O
Pp NNP O
values NNS O
, , O
it PRP O
was VBD O
crucial JJ O
that IN O
the DT O
probe NN O
was VBD O
placed VBN O
on IN O
relatively RB O
smooth JJ O
areas NNS O
, , O
i PRP O
. . O
e LS O
. . O
preferentially RB O
between IN O
the DT O
veins NNS O
rather RB O
than IN O
on IN O
the DT O
veins NNS O
in IN O
order NN O
to TO O
guarantee VB O
a DT O
uniform JJ O
pressure NN O
transmission NN O
. . O

It PRP O
also RB O
turned VBD O
out RP O
that IN O
areas NNS O
with IN O
lesions NNS O
or CC O
covered VBN O
with IN O
dust NN O
should MD O
be VB O
avoided VBN O
. . O

Probably RB O
due JJ O
to IN O
the DT O
absence NN O
of IN O
dust NN O
, , O
high JJ O
resolution NN O
results NNS O
were VBD O
obtained VBN O
when WRB O
the DT O
sensor NN O
- HYPH O
containing VBG O
pad NN O
faced VBD O
the DT O
abaxial JJ O
side NN O
, , O
but CC O
not RB O
the DT O
adaxial JJ O
side NN O
of IN O
the DT O
leaf NN O
. . O

Diurnal NNP O
changes VBZ O
in IN O
the DT O
patch NN O
clamp NN O
pressure NN O

Figure NN O
2A NNP O
represents VBZ O
Pp NNP O
recordings NNS O
conducted VBN O
on IN O
the DT O
10 CD O
m NN O
tall JJ O
liana NN O
on IN O
24 CD O
May NNP O
and CC O
25 CD O
May NNP O
, , O
2007 CD O
. . O

The DT O
plant NN O
was VBD O
well RB O
- HYPH O
watered VBN O
before IN O
the DT O
beginning NN O
of IN O
the DT O
measurements NNS O
( , O
22 CD O
May NNP O
) , O
and CC O
was VBD O
also RB O
watered VBN O
regularly RB O
during IN O
the DT O
experimental JJ O
period NN O
. . O

The DT O
sufficient JJ O
supply NN O
of IN O
the DT O
leaves NNS O
with IN O
water NN O
was VBD O
indicated VBN O
by IN O
high JJ O
turgor NN O
pressure NN O
values NNS O
of IN O
c NN O
. . O

500 CD O
kPa NN O
at IN O
predawn NN O
and CC O
guttation NN O
up IN O
to IN O
a DT O
height NN O
of IN O
6 CD O
m NN O
around IN O
sunrise NN O
( , O
see VB O
also RB O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O
, , O
1999 CD O
) -RRB- O
. . O

Diurnal JJ O
changes NNS O
of IN O
the DT O
Pp NN O
values NNS O
were VBD O
recorded VBN O
simultaneously RB O
at IN O
0 CD O
. . O
2 CD O
m CD O
, , O
6 CD O
m NN O
, , O
and CC O
10 CD O
m NN O
height NN O
. . O

The DT O
corresponding VBG O
diurnal JJ O
changes NNS O
in IN O
the DT O
ambient JJ O
temperature NN O
, , O
T NN O
, , O
and CC O
relative JJ O
humidity NN O
, , O
r UH O
. . O
h UH O
. . O
, , O
measured VBN O
close RB O
to IN O
the DT O
sites NNS O
of IN O
the DT O
patch NN O
clamp NN O
pressure NN O
probes NNS O
, , O
are VBP O
given VBN O
in IN O
Fig NNP O
. . O

2B NN O
and CC O
C NN O
. . O

It PRP O
was VBD O
very RB O
sunny JJ O
on IN O
24 CD O
May NNP O
resulting VBG O
in IN O
a DT O
rapid JJ O
heating NN O
- HYPH O
up NN O
of IN O
the DT O
greenhouse NN O
, , O
particularly RB O
in IN O
the DT O
upper JJ O
part NN O
. . O

This DT O
led VBD O
to IN O
the DT O
development NN O
of IN O
large JJ O
vertical JJ O
gradients NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
along IN O
the DT O
stem NN O
of IN O
the DT O
liana NN O
( , O
Fig NNP O
. . O
2B NN O
, , O
C NN O
) -RRB- O
. . O

Because IN O
sunlight NN O
was VBD O
dimmed VBN O
by IN O
operation NN O
of IN O
the DT O
automatic JJ O
blinds NNS O
at IN O
noon NN O
( , O
see VB O
Materials NNPS O
and CC O
methods NNS O
) , O
the DT O
gradients NNS O
did VBD O
not RB O
reach VB O
maximum JJ O
values NNS O
before IN O
the DT O
afternoon NN O
. . O

Between IN O
15 CD O
. . O
30 CD O
h CD O
and CC O
16 CD O
. . O
30 CD O
h NN O
an DT O
ambient JJ O
temperature NN O
of IN O
44 CD O
degrees NNS O
C NN O
and CC O
a DT O
relative JJ O
humidity NN O
of IN O
20 CD O
% NN O
were VBD O
recorded VBN O
at IN O
the DT O
top NN O
of IN O
the DT O
liana NN O
, , O
whereas IN O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
were VBD O
27 CD O
degrees NNS O
C NN O
and CC O
70 CD O
% NN O
, , O
respectively RB O
. . O

The DT O
gradients NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
disappeared VBD O
at IN O
c NN O
. . O

22 CD O
. . O
0 NFP O
h NN O
. . O

Due IN O
to IN O
the DT O
dense JJ O
foliage NN O
of IN O
the DT O
plant NN O
above IN O
c NN O
. . O

7 CD O
m NN O
and CC O
due IN O
to IN O
light NN O
dimming VBG O
by IN O
the DT O
blinds NNS O
, , O
leaves NNS O
closer RBR O
to IN O
the DT O
ground NN O
only RB O
became VBD O
exposed VBN O
to IN O
direct JJ O
sunshine NN O
towards IN O
the DT O
early JJ O
afternoon NN O
. . O

In IN O
contrast NN O
to IN O
24 CD O
May NNP O
, , O
the DT O
following VBG O
day NN O
was VBD O
cloudy JJ O
until IN O
noon NN O
. . O

Thus RB O
, , O
leaves NNS O
in IN O
the DT O
upper JJ O
part NN O
of IN O
the DT O
liana NN O
became VBD O
fully RB O
exposed VBN O
to IN O
bright JJ O
sunshine NN O
first RB O
around IN O
14 CD O
. . O
0 CD O
h NN O
as IN O
indicated VBN O
by IN O
the DT O
rapid JJ O
increase NN O
in IN O
T NN O
and CC O
the DT O
corresponding VBG O
decrease NN O
of IN O
r NN O
. . O
h ADD O
. . O
above IN O
a DT O
height NN O
of IN O
6 CD O
m NN O
( , O
Fig NN O
. . O
2B NN O
, , O
C NN O
) -RRB- O
. . O

Despite IN O
the DT O
strongly RB O
delayed VBN O
exposure NN O
of IN O
the DT O
leaves NNS O
to IN O
sunshine NN O
, , O
comparable JJ O
maximum NN O
values NNS O
for IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
at IN O
the DT O
three CD O
measuring NN O
sites NNS O
, , O
as RB O
well RB O
as IN O
vertical JJ O
gradients NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h LS O
. . O
of IN O
comparable JJ O
size NN O
, , O
were VBD O
measured VBN O
between IN O
15 CD O
. . O
30 CD O
h NN O
and CC O
16 CD O
. . O
30 CD O
h NN O
as IN O
on IN O
the DT O
day NN O
before RB O
. . O

Inspection NN O
of IN O
Fig NNP O
. . O

2 LS O
shows VBZ O
that IN O
the DT O
diurnal JJ O
changes NNS O
of IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
at IN O
the DT O
three CD O
measuring NN O
sites NNS O
are VBP O
reflected VBN O
in IN O
corresponding VBG O
changes NNS O
of IN O
Pp NNP O
. . O

During IN O
the DT O
nights NNS O
the DT O
Pp NNP O
values NNS O
were VBD O
low JJ O
. . O

After IN O
sunrise NN O
at IN O
4 CD O
. . O
24 CD O
h NN O
the DT O
Pp NN O
values NNS O
remained VBD O
low JJ O
for IN O
further JJ O
4 CD O
- SYM O
5 CD O
h NN O
, , O
except IN O
at IN O
6 CD O
m NN O
height NN O
where WRB O
a DT O
slight JJ O
and CC O
continuous JJ O
increase NN O
in IN O
the DT O
Pp NNP O
values NNS O
was VBD O
very RB O
often RB O
recorded VBN O
. . O

After IN O
about RB O
9 CD O
. . O
0 NFP O
h NN O
the DT O
Pp NN O
values NNS O
increased VBD O
over IN O
the DT O
entire JJ O
height NN O
of IN O
the DT O
liana NN O
. . O

Peaking VBG O
of IN O
the DT O
Pp NNP O
values NNS O
occurred VBD O
between IN O
15 CD O
. . O
30 CD O
h CD O
and CC O
16 CD O
. . O
30 CD O
h NN O
at IN O
all DT O
heights NNS O
when WRB O
the DT O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
gradients NNS O
reached VBD O
maximum JJ O
values NNS O
. . O

Towards IN O
the DT O
evening NN O
the DT O
Pp NNP O
values NNS O
decreased VBD O
again RB O
in IN O
order NN O
to TO O
reach VB O
the DT O
original JJ O
low JJ O
values NNS O
at IN O
c NN O
. . O

22 CD O
. . O
0 NFP O
h NN O
. . O

Until IN O
peaking VBG O
in IN O
the DT O
afternoon NN O
, , O
more RBR O
or CC O
less RBR O
pronounced JJ O
fluctuations NNS O
of IN O
the DT O
Pp NNP O
values NNS O
were VBD O
seen VBN O
. . O

A DT O
part NN O
of IN O
these DT O
fluctuations NNS O
seemed VBD O
to TO O
be VB O
correlated VBN O
with IN O
changes NNS O
in IN O
the DT O
local JJ O
ambient JJ O
temperature NN O
, , O
relative JJ O
humidity NN O
and CC O
/ SYM O
or CC O
with IN O
a DT O
temporary JJ O
exposure NN O
of IN O
the DT O
clamped VBN O
leaflet NN O
to IN O
sunshine NN O
( , O
compare VB O
Fig NNP O
. . O
2A NN O
with IN O
Fig NNP O
. . O
2B NN O
, , O
C NNP O
) -RRB- O
. . O

However RB O
, , O
there EX O
was VBD O
also RB O
a DT O
considerable JJ O
number NN O
of IN O
fluctuations NNS O
which WDT O
could MD O
not RB O
be VB O
traced VBN O
back RB O
to IN O
changes NNS O
in IN O
the DT O
microclimate NN O
. . O

An DT O
example NN O
can MD O
be VB O
found VBN O
in IN O
Fig NNP O
. . O

2A NN O
( , O
arrow NN O
) -RRB- O
. . O

The DT O
peaking NN O
of IN O
the DT O
Pp NNP O
value NN O
measured VBN O
at IN O
a DT O
height NN O
of IN O
0 CD O
. . O
2 CD O
m NN O
around IN O
14 CD O
. . O
0 CD O
h NN O
is VBZ O
obviously RB O
not RB O
induced VBN O
by IN O
changes NNS O
in IN O
the DT O
local JJ O
temperature NN O
and CC O
relative JJ O
humidity NN O
or CC O
by IN O
exposure NN O
to IN O
sunshine NN O
. . O

Similar JJ O
diurnal JJ O
changes NNS O
in IN O
Pp NNP O
, , O
T NNP O
, , O
and CC O
r NN O
. . O
h -RRB- O
. . O
were VBD O
also RB O
found VBN O
for IN O
the DT O
4 CD O
. . O
5 CD O
m CD O
tall JJ O
liana NN O
in IN O
the DT O
backstage NN O
of IN O
the DT O
greenhouse NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

Figure NN O
3 CD O
shows VBZ O
long JJ O
- HYPH O
term NN O
Pp NN O
, , O
T NN O
, , O
and CC O
r NN O
. . O
h ADD O
. . O
measurements NNS O
performed VBN O
at IN O
0 CD O
. . O
2 CD O
m NN O
, , O
6 CD O
m NN O
, , O
and CC O
10 CD O
m NN O
height NN O
in IN O
late JJ O
summer NN O
2007 CD O
. . O

In IN O
contrast NN O
to IN O
the DT O
experimental JJ O
conditions NNS O
in IN O
late JJ O
spring NN O
( : O
Fig NNP O
. . O
2 CD O
) , O
the DT O
liana NN O
had VBD O
been VBN O
watered VBN O
only RB O
sporadically RB O
during IN O
the DT O
weeks NNS O
before IN O
the DT O
measurements NNS O
. . O

The DT O
soil NN O
was VBD O
extremely RB O
dry JJ O
and CC O
no DT O
guttation NN O
was VBD O
observed VBN O
at IN O
predawn NN O
, , O
even RB O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
. . O

Turgor NNP O
pressure NN O
measurements NNS O
performed VBN O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
yielded VBD O
values NNS O
below IN O
250 CD O
kPa NNS O
at IN O
predawn NN O
. . O

Continuous JJ O
irrigation NN O
was VBD O
started VBN O
at IN O
10 CD O
. . O
0 CD O
h CD O
on IN O
28 CD O
August NNP O
( : O
c NN O
. . O
400 CD O
l SYM O
d CD O
- HYPH O
1 CD O
) -RRB- O
. . O

Guttation NN O
occurred VBD O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
, , O
but CC O
not RB O
at IN O
6 CD O
m NN O
height NN O
on IN O
1 CD O
September NNP O
. . O

At IN O
sunrise NN O
( , O
5 CD O
. . O
25 CD O
h NN O
) -RRB- O
, , O
turgor NN O
pressures NNS O
of IN O
c NN O
. . O

500 CD O
kPa NNP O
were VBD O
recorded VBN O
at IN O
the DT O
base NN O
of IN O
the DT O
liana NN O
. . O

Guttation NN O
at IN O
6 CD O
m NN O
height NN O
was VBD O
still RB O
not RB O
observed VBN O
on IN O
3 CD O
September NNP O
indicating VBG O
that IN O
the DT O
hydration NN O
state NN O
of IN O
the DT O
plant NN O
was VBD O
still RB O
less JJR O
than IN O
in IN O
the DT O
last JJ O
week NN O
of IN O
May NNP O
. . O

The DT O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
profiles NNS O
during IN O
the DT O
end NN O
of IN O
summer NN O
were VBD O
also RB O
different JJ O
to IN O
those DT O
in IN O
late JJ O
spring NN O
( , O
compare VBP O
Fig NNP O
. . O
2B NN O
, , O
C NN O
with IN O
Fig NNP O
. . O
3B NN O
, , O
C NNP O
) -RRB- O
. . O

On IN O
28 CD O
August NNP O
when WRB O
irrigation NN O
started VBD O
it PRP O
was VBD O
sunny JJ O
. . O

Similarly RB O
to IN O
May NNP O
, , O
peak NN O
values NNS O
of IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
were VBD O
reached VBN O
at IN O
c NN O
. . O

15 CD O
. . O
30 CD O
h NN O
. . O

However RB O
, , O
temperatures NNS O
at IN O
the DT O
top NN O
of IN O
the DT O
plant NN O
did VBD O
not RB O
exceed VB O
35 CD O
degrees NNS O
C NN O
and CC O
r VB O
. . O
h UH O
. . O
did VBD O
not RB O
drop VB O
below IN O
40 CD O
% NN O
. . O

Accordingly RB O
, , O
the DT O
vertical JJ O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
gradients NNS O
were VBD O
smaller JJR O
than IN O
those DT O
measured VBN O
at IN O
the DT O
end NN O
of IN O
May NNP O
. . O

On IN O
29 CD O
August NNP O
, , O
when WRB O
it PRP O
became VBD O
very RB O
rainy JJ O
and CC O
light JJ O
irradiance NN O
dropped VBD O
dramatically RB O
, , O
gradients NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h -RRB- O
. . O
of IN O
slightly RB O
decreased VBN O
size NN O
were VBD O
still RB O
recorded VBN O
. . O

Peaking VBG O
of IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
occurred VBD O
at IN O
c NN O
. . O

14 CD O
. . O
30 CD O
h NN O
. . O

T NN O
and CC O
r NN O
. . O
h UH O
. . O
gradients NNS O
did VBD O
not RB O
develop VB O
in IN O
the DT O
following VBG O
three CD O
days NNS O
which WDT O
were VBD O
very RB O
cloudy JJ O
and CC O
rainy JJ O
. . O

An DT O
almost RB O
constant JJ O
temperature NN O
of IN O
c NN O
. . O

25 CD O
degrees NNS O
C NN O
and CC O
a DT O
relative JJ O
humidity NN O
of IN O
80 CD O
% NN O
were VBD O
measured VBN O
on IN O
the DT O
ground NN O
and CC O
at IN O
the DT O
top NN O
of IN O
the DT O
greenhouse NN O
throughout IN O
the DT O
day NN O
; , O
light JJ O
irradiance NN O
did VBD O
not RB O
exceed VB O
40 CD O
mu NNS O
mol NN O
photons NNS O
m SYM O
- HYPH O
2 CD O
s NN O
- HYPH O
1 CD O
. . O

Only RB O
on IN O
31 CD O
August NNP O
, , O
did VBD O
the DT O
rain NN O
stop VB O
and CC O
the DT O
upper JJ O
part NN O
of IN O
the DT O
liana NN O
was VBD O
exposed VBN O
to IN O
sunshine NN O
for IN O
1 CD O
- SYM O
2 CD O
h NN O
and CC O
thus RB O
small JJ O
T NN O
and CC O
r NN O
. . O
h LS O
. . O
gradients NNS O
developed VBN O
. . O

The DT O
following VBG O
days NNS O
of IN O
2 CD O
and CC O
3 CD O
September NNP O
were VBD O
partly RB O
cloudy JJ O
and CC O
sunny JJ O
and CC O
the DT O
peaking NN O
of IN O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
occurred VBD O
at IN O
c NN O
. . O

13 CD O
. . O
0 NFP O
h NN O
. . O

The DT O
upper JJ O
, , O
but CC O
not RB O
the DT O
lower JJR O
part NN O
of IN O
the DT O
liana NN O
was VBD O
exposed VBN O
to IN O
sunshine NN O
for IN O
several JJ O
hours NNS O
. . O

This DT O
resulted VBD O
in IN O
the DT O
formation NN O
of IN O
T NN O
and CC O
r NN O
. . O
h UH O
. . O
gradients NNS O
. . O

The DT O
size NN O
of IN O
the DT O
gradients NNS O
was VBD O
similar JJ O
to IN O
that DT O
measured VBN O
on IN O
29 CD O
August NNP O
. . O

Inspection NN O
of IN O
Fig NNP O
. . O

3A NN O
indicates VBZ O
that IN O
peaking NN O
of IN O
the DT O
Pp NNP O
values NNS O
coincided VBD O
with IN O
peaking NN O
of IN O
r XX O
. . O
h ADD O
. . O
and CC O
T NN O
in IN O
Fig NN O
. . O

3B NN O
and CC O
C NN O
. . O

Figure NN O
3A NNP O
shows VBZ O
further RBR O
that IN O
the DT O
peak NN O
amplitude NN O
of IN O
the DT O
Pp NNP O
values NNS O
recorded VBN O
at IN O
the DT O
three CD O
measuring VBG O
sites NNS O
decreased VBD O
continuously RB O
from IN O
28 CD O
August NNP O
whereas IN O
the DT O
low JJ O
Pp NN O
values NNS O
at IN O
the DT O
nights NNS O
remained VBD O
unaltered JJ O
. . O

The DT O
peak NN O
amplitude NN O
measured VBN O
on IN O
29 CD O
August NNP O
was VBD O
only RB O
slightly RB O
lower JJR O
than IN O
that DT O
measured VBN O
on IN O
the DT O
day NN O
before RB O
, , O
the DT O
peak NN O
amplitude NN O
was VBD O
rather RB O
low JJ O
on IN O
30 CD O
August NNP O
. . O

It PRP O
remained VBD O
at IN O
this DT O
low JJ O
level NN O
until IN O
2 CD O
September NNP O
, , O
except IN O
that IN O
on IN O
31 CD O
August NNP O
the DT O
peak NN O
amplitude NN O
at IN O
the DT O
three CD O
measuring VBG O
sites NNS O
increased VBD O
slightly RB O
, , O
presumably RB O
because IN O
of IN O
the DT O
short JJ O
- HYPH O
time NN O
exposure NN O
of IN O
the DT O
upper JJ O
leaves NNS O
to IN O
sun NN O
( , O
see VB O
above RB O
) -RRB- O
. . O

Comparison NN O
of IN O
the DT O
diurnal JJ O
changes NNS O
in IN O
the DT O
Pp NNP O
values NNS O
with IN O
the DT O
corresponding JJ O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
changes NNS O
in IN O
Fig NNP O
. . O

3B NN O
and CC O
C NN O
indicates VBZ O
that IN O
part NN O
of IN O
the DT O
changes NNS O
in IN O
the DT O
peak NN O
amplitude NN O
of IN O
the DT O
Pp NNP O
values NNS O
were VBD O
induced VBN O
by IN O
changes NNS O
in IN O
the DT O
environmental JJ O
parameters NNS O
. . O

However RB O
, , O
part NN O
of IN O
the DT O
changes NNS O
must MD O
obviously RB O
be VB O
attributed VBN O
to IN O
irrigation NN O
. . O

This DT O
conclusion NN O
can MD O
be VB O
drawn VBN O
if IN O
, , O
for IN O
example NN O
, , O
the DT O
peaking NN O
of IN O
Pp NNP O
on IN O
2 CD O
and CC O
3 CD O
September NNP O
is VBZ O
compared VBN O
with IN O
the DT O
peaking NN O
of IN O
Pp NNP O
on IN O
29 CD O
August NNP O
. . O

Despite IN O
the DT O
comparable JJ O
size NN O
of IN O
the DT O
T NN O
and CC O
r NN O
. . O
h ADD O
. . O
gradients NNS O
, , O
the DT O
peak NN O
Pp NN O
values NNS O
were VBD O
much RB O
smaller JJR O
, , O
particularly RB O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
, , O
on IN O
2 CD O
and CC O
3 CD O
September NNP O
compared VBN O
with IN O
29 CD O
August NNP O
. . O

Plots NNS O
of IN O
the DT O
Pp NN O
values NNS O
measured VBN O
at IN O
6 CD O
m NN O
and CC O
10 CD O
m NN O
height NN O
on IN O
24 CD O
May NNP O
, , O
28 CD O
August NNP O
, , O
and CC O
2 CD O
September NNP O
against IN O
r NN O
. . O
h ADD O
. . O

( : O
or CC O
against IN O
T NNP O
since IN O
both DT O
parameters NNS O
were VBD O
usually RB O
closely RB O
related VBN O
) , O
also RB O
support VBP O
the DT O
view NN O
that IN O
the DT O
local JJ O
microclimate NN O
is VBZ O
not RB O
the DT O
only JJ O
factor NN O
which WDT O
determined VBD O
the DT O
magnitude NN O
of IN O
the DT O
Pp NNP O
values NNS O
at IN O
the DT O
three CD O
measuring VBG O
sites NNS O
. . O

Figure NN O
4 CD O
shows VBZ O
that IN O
the DT O
Pp NN O
values NNS O
recorded VBN O
at IN O
6 CD O
m CD O
and CC O
10 CD O
m NN O
height NN O
increased VBN O
with IN O
decreasing VBG O
r NN O
. . O
h NFP O
. . O
from IN O
c NN O
. . O

9 CD O
. . O
0 NFP O
h NN O
until IN O
r UH O
. . O
h LS O
. . O
reached VBD O
the DT O
minimum JJ O
value NN O
( : O
and CC O
T NN O
the DT O
maximum JJ O
value NN O
, , O
respectively RB O
) -RRB- O
, , O
when WRB O
with IN O
the DT O
progression NN O
of IN O
the DT O
day NN O
r UH O
. . O
h LS O
. . O
increased VBN O
and CC O
T NN O
decreased VBD O
, , O
Pp NNP O
decreased VBD O
again RB O
. . O

This DT O
decrease NN O
was VBD O
much RB O
faster JJR O
than IN O
expected VBN O
in IN O
the DT O
light NN O
of IN O
the DT O
preceding VBG O
r NN O
. . O
h LS O
. . O
- HYPH O
induced VBN O
increase NN O
of IN O
Pp NNP O
if IN O
the DT O
plant NN O
was VBD O
well RB O
- HYPH O
watered VBN O
( : O
24 CD O
May NNP O
; : O
Fig NNP O
. . O
4A NN O
, , O
B NNP O
) -RRB- O
. . O

Refilling VBG O
of IN O
the DT O
leaf NN O
cells NNS O
was VBD O
apparently RB O
enhanced VBN O
by IN O
the DT O
high JJ O
hydration NN O
state NN O
of IN O
the DT O
plant NN O
. . O

By IN O
contrast NN O
, , O
when WRB O
the DT O
liana NN O
had VBD O
not RB O
been VBN O
irrigated VBN O
well RB O
( : O
28 CD O
August NNP O
, , O
Fig NNP O
. . O
4C NNP O
, , O
D NNP O
) , O
both CC O
kinetics NNS O
of IN O
the DT O
changes NNS O
of IN O
Pp NNP O
with IN O
r XX O
. . O
h ADD O
. . O
were VBD O
comparable JJ O
. . O

The DT O
low JJ O
hydration NN O
state NN O
of IN O
the DT O
plant NN O
apparently RB O
delayed VBD O
cell NN O
refilling NN O
. . O

After IN O
4 CD O
d NN O
irrigation NN O
( , O
2 CD O
September NNP O
) -RRB- O
, , O
the DT O
low JJ O
value NN O
of IN O
Pp NNP O
recovered VBD O
at IN O
relatively RB O
low JJ O
r NN O
. . O
h NFP O
. . O
as IN O
in IN O
May NNP O
at IN O
10 CD O
m NN O
height NN O
( : O
Fig NNP O
. . O
4F CD O
) -RRB- O
, , O
but CC O
not RB O
at IN O
6 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
4E CD O
) -RRB- O
. . O

Recovery NN O
of IN O
the DT O
low JJ O
Pp NN O
values NNS O
at IN O
this DT O
height NN O
occurred VBD O
, , O
however RB O
, , O
at IN O
significantly RB O
lower JJR O
r JJR O
. . O
h LS O
. . O
than IN O
on IN O
28 CD O
August NNP O
, , O
indicating VBG O
that IN O
rehydration NN O
of IN O
the DT O
leaves NNS O
at IN O
this DT O
height NN O
had VBD O
not RB O
been VBN O
completed VBN O
. . O

Evaluation NN O
of IN O
other JJ O
data NNS O
sets NNS O
yielded VBD O
similar JJ O
results NNS O
( , O
not RB O
shown VBN O
) NFP O
. . O

Patch NN O
clamp NN O
pressure NN O
versus IN O
cell NN O
turgor NN O
pressure NN O
measurements NNS O

The DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
measures VBZ O
the DT O
pressure NN O
transfer NN O
function NN O
of IN O
a DT O
defined VBN O
leaflet NN O
area NN O
. . O

The DT O
above JJ O
theoretical JJ O
considerations NNS O
have VBP O
shown VBN O
that IN O
the DT O
transfer NN O
function NN O
is VBZ O
mainly RB O
determined VBN O
by IN O
turgor NN O
pressure NN O
provided VBN O
that IN O
the DT O
structural JJ O
elements NNS O
do VBP O
not RB O
contribute VB O
or CC O
constantly RB O
contribute VB O
to IN O
the DT O
pressure NN O
signal NN O
transfer NN O
. . O

In IN O
order NN O
to TO O
prove VB O
the DT O
theory NN O
parallel JJ O
measurements NNS O
of IN O
leaf NN O
patch NN O
clamp NN O
pressure NN O
( , O
Pp NNP O
) -RRB- O
and CC O
cell NN O
turgor NN O
pressure NN O
( -LRB- O
Pc NN O
) -RRB- O
were VBD O
performed VBN O
on IN O
a DT O
leaflet NN O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
( : O
Fig NNP O
. . O
5A NN O
) -RRB- O
. . O

Simultaneously RB O
, , O
the DT O
Pp NN O
values NNS O
were VBD O
recorded VBN O
at IN O
6 CD O
m NN O
and CC O
10 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
5B NN O
, , O
C NNP O
) -RRB- O
. . O

Measurements NNS O
were VBD O
performed VBN O
after IN O
several JJ O
days NNS O
of IN O
irrigation NN O
. . O

In IN O
these DT O
experiments NNS O
, , O
the DT O
microcapillary NN O
of IN O
the DT O
turgor NN O
pressure NN O
probe NN O
was VBD O
inserted VBN O
into IN O
parenchymal JJ O
cells NNS O
located VBN O
close RB O
to IN O
the DT O
main JJ O
vein NN O
on IN O
the DT O
abaxial JJ O
side NN O
of IN O
a DT O
leaflet NN O
, , O
i PRP O
. . O
e ADD O
. . O
c NN O
. . O

10 CD O
cm NNS O
away RB O
from IN O
the DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
near IN O
the DT O
leaflet NN O
periphery NN O
. . O

Turgor NNP O
pressure NN O
measurements NNS O
on IN O
leaf NN O
cells NNS O
of IN O
T NN B-Species
. . I-Species
voinierianum NN I-Species
were VBD O
difficult JJ O
to TO O
perform VB O
because IN O
of IN O
the DT O
presence NN O
of IN O
mucilage NN O
. . O

Mucilage NN O
resulted VBD O
in IN O
clogging NN O
of IN O
the DT O
tip NN O
of IN O
the DT O
microcapillary NN O
of IN O
the DT O
cell NN O
turgor NN O
pressure NN O
probe NN O
. . O

For IN O
this DT O
reason NN O
, , O
measurements NNS O
with IN O
the DT O
Scholander NNP O
pressure NN O
chamber NN O
were VBD O
not RB O
very RB O
reliable JJ O
. . O

It PRP O
was VBD O
extremely RB O
difficult JJ O
to TO O
determine VB O
exactly RB O
the DT O
balancing VBG O
pressure NN O
at IN O
which WDT O
water NN O
appears VBZ O
at IN O
the DT O
cut VBN O
end NN O
of IN O
the DT O
petiole NN O
of IN O
the DT O
leaf NN O
. . O

In IN O
Fig NNP O
. . O

5A NN O
the DT O
average JJ O
turgor NN O
pressure NN O
values NNS O
are VBP O
plotted VBN O
which WDT O
were VBD O
calculated VBN O
from IN O
3 CD O
- SYM O
8 CD O
min NN O
long JJ O
measurements NNS O
. . O

Inspection NN O
of IN O
Fig NNP O
. . O

5A NNP O
- HYPH O
C NNP O
shows VBZ O
that IN O
Pc NNP O
exhibited VBD O
similar JJ O
diurnal JJ O
changes NNS O
as IN O
the DT O
Pp NN O
values NNS O
at IN O
0 CD O
. . O
2 CD O
m CD O
, , O
6 CD O
m NN O
, , O
and CC O
10 CD O
m NN O
height NN O
. . O

Changes NNS O
in IN O
Pc NNP O
after IN O
sunrise NN O
preceded VBD O
changes NNS O
in IN O
Pp NNP O
, , O
most RBS O
likely JJ O
due IN O
to IN O
the DT O
different JJ O
measuring VBG O
sites NNS O
on IN O
the DT O
leaflets NNS O
. . O

After IN O
the DT O
onset NN O
of IN O
transpiration NN O
the DT O
loss NN O
of IN O
turgor NN O
pressure NN O
of IN O
cells NNS O
located VBN O
at IN O
the DT O
periphery NN O
of IN O
the DT O
leaflets NNS O
( , O
where WRB O
Pp NNP O
is VBZ O
recorded VBN O
) -RRB- O
is VBZ O
apparently RB O
immediately RB O
compensated VBN O
by IN O
water NN O
shifting NN O
from IN O
the DT O
xylem NN O
and CC O
the DT O
cells NNS O
located VBN O
close RB O
to IN O
the DT O
main JJ O
vein NN O
( , O
where WRB O
Pc NNP O
is VBZ O
measured VBN O
) -RRB- O
. . O

Consistent JJ O
with IN O
this DT O
explanation NN O
, , O
towards IN O
the DT O
afternoon NN O
when WRB O
all DT O
cells NNS O
throughout IN O
the DT O
leaflets NNS O
exhibit VBP O
low JJ O
turgor NN O
pressure NN O
, , O
the DT O
increase NN O
in IN O
Pc NN O
and CC O
the DT O
decrease NN O
in IN O
Pp NNP O
occurred VBD O
nearly RB O
concomitantly RB O
. . O

Interestingly RB O
, , O
the DT O
delay NN O
between IN O
the DT O
response NN O
of IN O
Pc NNP O
and CC O
Pp NNP O
upon IN O
changes NNS O
in IN O
T NN O
and CC O
r NN O
. . O
h UH O
. . O
in IN O
the DT O
early JJ O
morning NN O
hours NNS O
decreased VBD O
from IN O
about RB O
2 CD O
. . O
5 CD O
h NN O
at IN O
0 CD O
. . O
2 CD O
m CD O
height NN O
to IN O
1 CD O
. . O
5 CD O
h CD O
at IN O
6 CD O
m CD O
height NN O
, , O
and CC O
to IN O
1 CD O
h NN O
at IN O
10 CD O
m NN O
height NN O
. . O

In IN O
Fig NNP O
. . O

5D NN O
the DT O
Pp NN O
values NNS O
measured VBN O
at IN O
the DT O
three CD O
heights NNS O
are VBP O
plotted VBN O
against IN O
the DT O
corresponding JJ O
Pc NN O
values NNS O
( : O
i PRP O
. . O
e -RRB- O
. . O
neglecting VBG O
the DT O
delayed VBN O
response NN O
of IN O
Pp NNP O
) -RRB- O
. . O

The DT O
curves NNS O
could MD O
be VB O
fitted VBN O
quite RB O
well RB O
by IN O
equation NN O
8 CD O
. . O

Fitting VBG O
of IN O
the DT O
curves NNS O
required VBD O
the DT O
assumption NN O
of IN O
different JJ O
values NNS O
for IN O
the DT O
constants NNS O
a DT O
and CC O
b NN O
in IN O
equation NN O
4 CD O
( , O
see VB O
legend NN O
to IN O
Fig NNP O
. . O
5 CD O
) -RRB- O
indicating VBG O
that IN O
the DT O
elastic JJ O
properties NNS O
of IN O
the DT O
leaves NNS O
were VBD O
different JJ O
, , O
presumably RB O
due IN O
to IN O
changes NNS O
of IN O
the DT O
ambient JJ O
temperature NN O
with IN O
height NN O
( , O
see VB O
above RB O
) -RRB- O
. . O

Turgor NNP O
pressure NN O
measurements NNS O
at IN O
5 CD O
m NN O
height NN O
failed VBD O
because IN O
of IN O
abundant JJ O
mucilage NN O
in IN O
the DT O
leaflet NN O
tissue NN O
at IN O
this DT O
time NN O
of IN O
the DT O
year NN O
. . O

Mucilage NN O
in IN O
the DT O
cells NNS O
and CC O
xylem NN O
vessels NNS O
was VBD O
less RBR O
abundant JJ O
when WRB O
turgor NN O
pressure NN O
measurements NNS O
were VBD O
performed VBN O
during IN O
the DT O
summer NN O
of IN O
1999 CD O
. . O

Plot NN O
of IN O
the DT O
Pc NNP O
data NNS O
measured VBN O
by IN O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) -RRB- O
at IN O
5 CD O
m NN O
height NN O
against IN O
online JJ O
recordings NNS O
of IN O
Pp NNP O
in IN O
May NNP O
2007 CD O
revealed VBD O
very RB O
good JJ O
agreement NN O
between IN O
both DT O
parameters NNS O
, , O
even RB O
though IN O
the DT O
microcapillary NN O
was VBD O
inserted VBN O
into IN O
cells NNS O
located VBN O
on IN O
the DT O
upper JJ O
leaflet NN O
surface NN O
between IN O
the DT O
main JJ O
vein NN O
and CC O
the DT O
leaflet NN O
edge NN O
( , O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

On IN O
both DT O
measuring VBG O
days NNS O
in IN O
1999 CD O
and CC O
2007 CD O
, , O
similar JJ O
environmental JJ O
conditions NNS O
existed VBD O
. . O

Inspection NN O
of IN O
Fig NNP O
. . O

6 CD O
shows VBZ O
that IN O
Pp NNP O
measured VBN O
at IN O
6 CD O
m CD O
height NN O
was VBD O
delayed VBN O
by IN O
c NN O
. . O

1 LS O
. . O
5 CD O
h NN O
. . O

A DT O
plot NN O
of IN O
the DT O
Pp NNP O
values NNS O
against IN O
the DT O
Pc NNP O
values NNS O
according VBG O
to IN O
Fig NNP O
. . O

5D NN O
could MD O
also RB O
be VB O
fitted VBN O
very RB O
well RB O
by IN O
equation NN O
8 CD O
( , O
see VB O
inset NN O
of IN O
Fig NNP O
. . O
6 CD O
) -RRB- O
indicating VBG O
the DT O
validity NN O
of IN O
equation NN O
8 CD O
to TO O
describe VB O
properly RB O
the DT O
relationship NN O
between IN O
Pp NNP O
and CC O
Pc NNP O
. . O

Discussion NN O

The DT O
results NNS O
presented VBN O
here RB O
demonstrate VBP O
that IN O
the DT O
novel JJ O
patch NN O
clamp NN O
pressure NN O
probe NN O
is VBZ O
a DT O
very RB O
sensitive JJ O
, , O
versatile JJ O
, , O
and CC O
easy JJ O
- HYPH O
to TO O
- HYPH O
handle VB O
plant NN O
- HYPH O
based VBN O
tool NN O
for IN O
online JJ O
monitoring NN O
of IN O
the DT O
effects NNS O
of IN O
evapotranspiration NN O
and CC O
/ SYM O
or CC O
of IN O
irrigation NN O
regimes NNS O
on IN O
the DT O
water NN O
relations NNS O
of IN O
leaves NNS O
( : O
Figs NNP O
2 CD O
, , O
3 CD O
) -RRB- O
. . O

The DT O
probe NN O
measures VBZ O
the DT O
output NN O
signal NN O
upon IN O
application NN O
of IN O
a DT O
constantly RB O
clamped VBN O
pressure NN O
, , O
i LS O
. . O
e LS O
. . O
the DT O
pressure NN O
transfer NN O
function NN O
of IN O
leaf NN O
patches NNS O
. . O

Since IN O
the DT O
application NN O
of IN O
the DT O
probe NN O
is VBZ O
not RB O
restricted VBN O
to IN O
special JJ O
leaves NNS O
, , O
patch NN O
clamp NN O
pressure NN O
measurements NNS O
will MD O
readily RB O
show VB O
which WDT O
crop NN O
varieties NNS O
can MD O
be VB O
grown VBN O
with IN O
the DT O
least JJS O
water NN O
for IN O
the DT O
most JJS O
yield NN O
. . O

It PRP O
has VBZ O
also RB O
been VBN O
demonstated VBN O
here RB O
that IN O
the DT O
plant NN O
- HYPH O
based VBN O
data NNS O
can MD O
be VB O
sent VBN O
by IN O
small JJ O
telemetric JJ O
units NNS O
connected VBN O
to IN O
the DT O
patch NN O
clamp NN O
pressure NN O
probes NNS O
to IN O
a DT O
receiver NN O
base NN O
station NN O
which WDT O
logs VBZ O
and CC O
stores VBZ O
the DT O
data NNS O
pending VBG O
transfer NN O
to IN O
a DT O
GPRS NNP O
modem NN O
linked VBN O
to IN O
an DT O
Internet NN O
server NN O
. . O

The DT O
telemetric JJ O
systems NNS O
operated VBD O
faultlessly RB O
. . O

This DT O
is VBZ O
a DT O
very RB O
important JJ O
result NN O
because IN O
there EX O
is VBZ O
agreement NN O
between IN O
scientists NNS O
and CC O
growers NNS O
( , O
Jones NNP O
, , O
2004 CD O
) : O
that IN O
control NN O
of IN O
irrigation NN O
must MD O
be VB O
tied VBN O
to IN O
remote JJ O
sensing NN O
devices NNS O
in IN O
order NN O
to TO O
reduce VB O
manpower NN O
and CC O
to TO O
conserve VB O
water NN O
. . O

The DT O
patch NN O
clamp NN O
pressure NN O
probe NN O
technique NN O
introduced VBN O
here RB O
meets VBZ O
these DT O
demands NNS O
. . O

A DT O
further JJ O
advantage NN O
is VBZ O
that IN O
the DT O
probe NN O
is VBZ O
cheap JJ O
and CC O
easy JJ O
to TO O
handle VB O
. . O

Some DT O
care NN O
is VBZ O
required VBN O
only RB O
when WRB O
clamping VBG O
the DT O
leaf NN O
. . O

Leaves NNS O
must MD O
be VB O
clean JJ O
and CC O
any DT O
rough JJ O
surface NN O
topography NN O
must MD O
be VB O
avoided VBN O
. . O

This DT O
implies VBZ O
that IN O
the DT O
dimensions NNS O
of IN O
the DT O
pads NNS O
of IN O
the DT O
spring NN O
clamp NN O
must MD O
be VB O
adjusted VBN O
to IN O
the DT O
size NN O
of IN O
the DT O
intercostal JJ O
area NN O
since IN O
non JJ O
- HYPH O
uniform JJ O
contact NN O
between IN O
leaf NN O
surface NN O
and CC O
pads NNS O
lowered VBD O
the DT O
output NN O
pressure NN O
signal NN O
. . O

Experience NN O
collected VBN O
with IN O
patch NN O
clamp NN O
pressure NN O
measurements NNS O
on IN O
T NN B-Species
. . I-Species
voinierianum NN I-Species
and CC O
on IN O
preliminary JJ O
results NNS O
of IN O
other JJ O
plants NNS O
( , O
e LS O
. . O
g LS O
. . O
grapevines NNS O
, , O
bananas NNS B-Species
, , O
Eucalyptus NNP O
, , O
and CC O
Arabidopsis NNP O
) , O
showed VBD O
that IN O
a DT O
smooth JJ O
intercostal JJ O
leaf NN O
area NN O
for IN O
clamping NN O
can MD O
readily RB O
be VB O
found VBN O
. . O

Equally RB O
, , O
optimum JJ O
values NNS O
for IN O
the DT O
clamp NN O
pressure NN O
can MD O
also RB O
be VB O
relatively RB O
quickly RB O
selected VBN O
empirically RB O
if IN O
the DT O
guidelines NNS O
mentioned VBN O
above RB O
are VBP O
followed VBN O
. . O

For IN O
many JJ O
purposes NNS O
calibration NN O
of IN O
the DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
against IN O
the DT O
cell NN O
turgor NN O
pressure NN O
probe NN O
is VBZ O
not RB O
stringent JJ O
. . O

It PRP O
may MD O
be VB O
sufficient JJ O
to TO O
know VB O
that IN O
the DT O
transfer NN O
function NN O
assumes VBZ O
small JJ O
values NNS O
at IN O
full JJ O
turgescence NN O
and CC O
is VBZ O
nearly RB O
unity NN O
at IN O
low JJ O
turgescence NN O
. . O

However RB O
, , O
for IN O
scientific JJ O
reasons NNS O
and CC O
for IN O
the DT O
application NN O
of IN O
the DT O
probe NN O
in IN O
basic JJ O
research NN O
, , O
the DT O
dependency NN O
of IN O
the DT O
transfer NN O
function NN O
on IN O
cell NN O
turgor NN O
pressure NN O
might MD O
be VB O
of IN O
great JJ O
interest NN O
. . O

The DT O
theoretical JJ O
considerations NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
relationship NN O
between IN O
the DT O
transfer NN O
function NN O
and CC O
the DT O
turgor NN O
pressure NN O
can MD O
obviously RB O
be VB O
described VBN O
by IN O
equation NN O
8 CD O
, , O
i PRP O
. . O
e LS O
. . O
by IN O
a DT O
power NN O
function NN O
. . O

Concomitant JJ O
measurements NNS O
of IN O
turgor NN O
pressure NN O
and CC O
patch NN O
clamp NN O
pressure NN O
have VBP O
confirmed VBN O
the DT O
theoretical JJ O
considerations NNS O
( : O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

Analogous JJ O
recordings NNS O
of IN O
turgor NN O
pressure NN O
and CC O
patch NN O
clamp NN O
pressure NN O
on IN O
grapevines NNS O
, , O
bananas NNS B-Species
, , O
and CC O
Eucalyptus NNP B-Species
trees NNS O
also RB O
yielded VBD O
results NNS O
( , O
D NNP O
Zimmermann NNP O
, , O
unpublished JJ O
results NNS O
) , O
which WDT O
were VBD O
consistent JJ O
with IN O
the DT O
predictions NNS O
of IN O
equation NN O
8 CD O
. . O

Patch NN O
clamp NN O
pressure NN O
measurements NNS O
allow VBP O
, , O
therefore RB O
, , O
calculation NN O
of IN O
turgor NN O
pressures NNS O
if IN O
the DT O
constants NNS O
a DT O
and CC O
b VBP O
defined VBN O
by IN O
equation NN O
4 CD O
are VBP O
known VBN O
. . O

These DT O
parameters NNS O
can MD O
be VB O
obtained VBN O
by IN O
numerical JJ O
fitting NN O
of IN O
Pp NNP O
versus IN O
Pc NNP O
curves NNS O
. . O

Online JJ O
patch NN O
clamp NN O
pressure NN O
measurements NNS O
open VBP O
up RP O
new JJ O
possibilities NNS O
to TO O
unravel VB O
the DT O
hydraulic JJ O
communication NN O
among IN O
leaves NNS O
, , O
including VBG O
tall JJ O
trees NNS O
. . O

It PRP O
is VBZ O
shown VBN O
here RB O
that IN O
the DT O
patch NN O
clamp NN O
pressure NN O
can MD O
simultaneously RB O
be VB O
monitored VBN O
in IN O
shaded VBN O
or CC O
sun NN O
- HYPH O
exposed VBN O
leaflets NNS O
at IN O
different JJ O
heights NNS O
under IN O
greenhouse NN O
conditions NNS O
by IN O
using VBG O
several JJ O
probes NNS O
. . O

It PRP O
was VBD O
even RB O
possible JJ O
to TO O
measure VB O
the DT O
turgor NN O
pressure NN O
at IN O
different JJ O
sites NNS O
on IN O
the DT O
leaf NN O
. . O

Therefore RB O
, , O
water NN O
shifting VBG O
between IN O
leaf NN O
cells NNS O
via IN O
the DT O
apoplastic JJ O
and CC O
symplastic JJ O
pathways NNS O
can MD O
be VB O
studied VBN O
. . O

Physically RB O
sound JJ O
theories NNS O
are VBP O
available JJ O
( : O
Molz NNP O
and CC O
Ikenberry NNP O
, , O
1974 CD O
; : O
Molz NNP O
et FW O
al NNP O
. . O
, , O
1979 CD O
) -RRB- O
, , O
but CC O
experimental JJ O
facts NNS O
are VBP O
not RB O
available JJ O
or CC O
are VBP O
mainly RB O
based VBN O
on IN O
speculations NNS O
( , O
Steudle NNP O
and CC O
French NNP O
, , O
1996 CD O
) -RRB- O
. . O

The DT O
first JJ O
evidence NN O
for IN O
the DT O
dynamics NNS O
of IN O
the DT O
hydraulic JJ O
communication NN O
between IN O
leaflets NNS O
at IN O
different JJ O
height NN O
and CC O
within IN O
leaflets NNS O
is VBZ O
given VBN O
here RB O
. . O

Th IN O
u NNP O
rmer FW O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) -RRB- O
have VBP O
shown VBN O
by IN O
using VBG O
the DT O
xylem NN O
and CC O
turgor NN O
pressure NN O
probe NN O
that IN O
the DT O
decrease NN O
in IN O
local JJ O
xylem NN O
pressure NN O
after IN O
daybreak NN O
from IN O
positive JJ O
, , O
sub NN O
- HYPH O
atmospheric JJ O
or CC O
slightly RB O
above IN O
- HYPH O
atmospheric JJ O
values NNS O
to IN O
negative JJ O
values NNS O
was VBD O
associated VBN O
with IN O
an DT O
almost RB O
1 CD O
: SYM O
1 CD O
decrease NN O
in IN O
turgor NN O
pressure NN O
of IN O
the DT O
cells NNS O
located VBN O
close RB O
to IN O
the DT O
main JJ O
vein NN O
of IN O
the DT O
leaflets NNS O
( , O
see VB O
also RB O
Zimmermann NNP O
et NN O
al NNP O
. . O
, , O
2004 CD O
) -RRB- O
. . O

Similarly RB O
, , O
in IN O
the DT O
afternoon NN O
, , O
the DT O
increase NN O
of IN O
xylem NN O
pressure NN O
in IN O
non NN O
- HYPH O
cavitated VBN O
vessels NNS O
towards IN O
more JJR O
positive JJ O
values NNS O
correlated VBD O
with IN O
a DT O
1 CD O
: SYM O
1 CD O
increase NN O
in IN O
cell NN O
turgor NN O
pressure NN O
. . O

Obviously RB O
, , O
changes NNS O
in IN O
transpiration NN O
resulted VBD O
in IN O
a DT O
very RB O
rapid JJ O
establishment NN O
of IN O
a DT O
new JJ O
local JJ O
water NN O
equilibrium NN O
state NN O
between IN O
the DT O
xylem NN O
and CC O
the DT O
turgor NN O
pressure NN O
of IN O
the DT O
adjacent JJ O
cells NNS O
. . O

The DT O
turgor NN O
pressure NN O
measurements NNS O
of IN O
Th NNP O
u NNP O
rmer FW O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) -RRB- O
were VBD O
performed VBN O
at IN O
1 CD O
m CD O
and CC O
5 CD O
m NN O
height NN O
. . O

No DT O
significant JJ O
differences NNS O
in IN O
the DT O
turgor NN O
pressure NN O
values NNS O
were VBD O
found VBN O
over IN O
the DT O
day NN O
. . O

The DT O
turgor NN O
pressure NN O
measurements NNS O
at IN O
0 CD O
. . O
2 CD O
m NN O
height NN O
reported VBN O
here RB O
confirmed VBD O
the DT O
finding NN O
of IN O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) : O
that IN O
the DT O
turgor NN O
pressure NN O
in IN O
the DT O
cells NNS O
located VBN O
near IN O
the DT O
main JJ O
vein NN O
dropped VBD O
immediately RB O
upon IN O
daybreak NN O
. . O

However RB O
, , O
our PRP$ O
patch NN O
clamp NN O
pressure NN O
measurements NNS O
at IN O
the DT O
periphery NN O
of IN O
the DT O
leaflets NNS O
imply VBP O
that IN O
the DT O
turgor NN O
pressure NN O
of IN O
these DT O
cells NNS O
apparently RB O
had VBD O
a DT O
significantly RB O
delayed VBN O
response NN O
upon IN O
the DT O
onset NN O
of IN O
transpiration NN O
. . O

This DT O
finding NN O
can MD O
be VB O
taken VBN O
as IN O
evidence NN O
that IN O
turgor NN O
pressure NN O
gradients NNS O
are VBP O
temporarily RB O
generated VBN O
within IN O
the DT O
leaf NN O
during IN O
the DT O
early JJ O
morning NN O
hours NNS O
. . O

This DT O
delay NN O
in IN O
the DT O
response NN O
of IN O
patch NN O
clamp NN O
pressure NN O
after IN O
daybreak NN O
was VBD O
c NN O
. . O

1 CD O
h NN O
for IN O
leaves NNS O
at IN O
the DT O
top NN O
, , O
but CC O
c NN O
. . O

2 LS O
. . O
5 CD O
h NN O
for IN O
leaves NNS O
at IN O
the DT O
base NN O
. . O

The DT O
data NNS O
suggest VBP O
that IN O
with IN O
progression NN O
of IN O
the DT O
day NN O
the DT O
gradients NNS O
collapsed VBD O
first RB O
at IN O
the DT O
top NN O
of IN O
the DT O
liana NN O
, , O
where WRB O
transpiration NN O
was VBD O
high JJ O
, , O
before IN O
it PRP O
occurred VBD O
in IN O
leaves NNS O
further RBR O
down RB O
. . O

During IN O
the DT O
afternoon NN O
hours NNS O
the DT O
increase NN O
in IN O
the DT O
turgor NN O
pressure NN O
values NNS O
measured VBN O
close RB O
to IN O
the DT O
main JJ O
vein NN O
coincided VBN O
with IN O
the DT O
values NNS O
measured VBN O
by IN O
the DT O
patch NN O
clamp NN O
pressure NN O
probe NN O
( , O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

The DT O
unbalanced JJ O
osmotic JJ O
pressure NN O
throughout IN O
the DT O
leaflets NNS O
obviously RB O
favoured VBD O
simultaneous JJ O
turgor NN O
pressure NN O
regeneration NN O
in IN O
all DT O
leaflet NN O
cells NNS O
. . O

The DT O
process NN O
seemed VBD O
to TO O
be VB O
very RB O
similar JJ O
to IN O
the DT O
refilling NN O
of IN O
the DT O
cells NNS O
of IN O
the DT O
resurrection NN O
plant NN O
Myrothamnus NNP B-Species
flabellifolia NNP I-Species
with IN O
water NN O
after IN O
desiccation NN O
( , O
Wagner NNP O
et FW O
al NNP O
. . O
, , O
2000 CD O
) -RRB- O
. . O

Uniform JJ O
radial JJ O
refilling NN O
of IN O
cells NNS O
with IN O
water NN O
in IN O
this DT O
species NN O
is VBZ O
also RB O
driven VBN O
by IN O
the DT O
unbalanced JJ O
osmotic JJ O
pressure NN O
throughout IN O
the DT O
tissue NN O
. . O

As IN O
indicated VBN O
by IN O
Fig NNP O
. . O

4A NN O
and CC O
B NN O
, , O
restoration NN O
of IN O
full JJ O
turgescence NN O
in IN O
T NN B-Species
. . I-Species
voinierianum NN I-Species
was VBD O
faster JJR O
than IN O
the DT O
preceding VBG O
turgor NN O
pressure NN O
loss NN O
if IN O
the DT O
lianas NNS O
were VBD O
well RB O
- HYPH O
watered JJ O
. . O

By IN O
contrast NN O
, , O
limitations NNS O
in IN O
water NN O
supply NN O
resulted VBD O
in IN O
the DT O
coincidence NN O
of IN O
the DT O
phases NNS O
of IN O
turgor NN O
pressure NN O
loss NN O
and CC O
regeneration NN O
. . O

Interestingly RB O
, , O
watering NN O
of IN O
the DT O
lianas NNS O
after IN O
non JJ O
- HYPH O
irrigation NN O
seemed VBD O
to TO O
lead VB O
preferentially RB O
to IN O
water NN O
shifting VBG O
to IN O
the DT O
top NN O
of IN O
the DT O
plant NN O
, , O
because IN O
, , O
after IN O
3 CD O
d NN O
of IN O
irrigation NN O
, , O
turgor NN O
pressure NN O
regeneration NN O
during IN O
the DT O
afternoon NN O
was VBD O
very RB O
fast JJ O
again RB O
at IN O
10 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
4F CD O
) -RRB- O
, , O
but CC O
not RB O
at IN O
5 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
4E CD O
) -RRB- O
. . O

Rapid JJ O
water NN O
movement NN O
to IN O
the DT O
top NN O
is VBZ O
expected VBN O
if IN O
hydrostatic JJ O
pressure NN O
, , O
osmotic JJ O
pressure NN O
, , O
and CC O
/ SYM O
or CC O
gel NN O
- HYPH O
based VBN O
gradients NNS O
throughout IN O
the DT O
vessels NNS O
exist VBP O
or CC O
are VBP O
generated VBN O
rapidly RB O
in IN O
the DT O
afternoon NN O
when WRB O
cavitation NN O
has VBZ O
occurred VBN O
. . O

This DT O
was VBD O
demonstrated VBN O
by IN O
Benkert NNP O
et FW O
al NNP O
. . O

( -LRB- O
1995 CD O
) -RRB- O
and CC O
Th NNP O
u NNP O
rmer NNP O
et FW O
al NNP O
. . O

( -LRB- O
1999 CD O
) -RRB- O
by IN O
using VBG O
the DT O
xylem NN O
pressure NN O
probe NN O
. . O

Continuous JJ O
xylem NN O
pressure NN O
gradients NNS O
during IN O
the DT O
morning NN O
hours NNS O
can MD O
also RB O
explain VB O
why WRB O
changes NNS O
in IN O
Pp NNP O
at IN O
lower JJR O
heights NNS O
were VBD O
frequently RB O
found VBN O
which WDT O
could MD O
not RB O
be VB O
correlated VBN O
with IN O
changes NNS O
in IN O
local JJ O
temperature NN O
or CC O
relative JJ O
humidity NN O
. . O

Water NN O
loss NN O
at IN O
the DT O
top NN O
of IN O
the DT O
plant NN O
induces VBZ O
a DT O
drop NN O
in IN O
xylem NN O
pressure NN O
which WDT O
is VBZ O
transferred VBN O
rapidly RB O
to IN O
the DT O
basal JJ O
leaves NNS O
where WRB O
it PRP O
induces VBZ O
a DT O
temporary JJ O
turgor NN O
pressure NN O
loss NN O
that WDT O
is VBZ O
soon RB O
compensated VBN O
by IN O
water NN O
uptake NN O
from IN O
the DT O
roots NNS O
( , O
arrow NN O
in IN O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

Even RB O
though IN O
more JJR O
work NN O
is VBZ O
required VBN O
, , O
the DT O
present JJ O
study NN O
shows VBZ O
that IN O
the DT O
leaf NN O
patch NN O
clamp NN O
pressure NN O
probe NN O
is VBZ O
a DT O
promising JJ O
tool NN O
to TO O
elucidate VB O
short JJ O
- HYPH O
and CC O
long JJ O
- HYPH O
distance NN O
water NN O
transport NN O
in IN O
T NNP B-Species
. . I-Species
voinierianum NN I-Species
and CC O
other JJ O
plants NNS O
. . O

CHEK2 NN O
Mutations NNS O
Affecting VBG O
Kinase NN O
Activity NN O
Together RB O
With IN O
Mutations NNS O
in IN O
TP53 NN O
Indicate VBP O
a DT O
Functional JJ O
Pathway NN O
Associated VBN O
with IN O
Resistance NN O
to IN O
Epirubicin NN O
in IN O
Primary JJ O
Breast NN O
Cancer NN O

Abstract JJ O

Background NN O

Chemoresistance NN O
is VBZ O
the DT O
main JJ O
obstacle NN O
to IN O
cure NN O
in IN O
most JJS O
malignant JJ O
diseases NNS O
. . O

Anthracyclines NNS O
are VBP O
among IN O
the DT O
main JJ O
drugs NNS O
used VBN O
for IN O
breast NN O
cancer NN O
therapy NN O
and CC O
in IN O
many JJ O
other JJ O
malignant JJ O
conditions NNS O
. . O

Single JJ O
parameter NN O
analysis NN O
or CC O
global JJ O
gene NN O
expression NN O
profiles NNS O
have VBP O
failed VBN O
to TO O
identify VB O
mechanisms NNS O
causing VBG O
in IN O
vivo NN O
resistance NN O
to IN O
anthracyclines NNS O
. . O

While IN O
we PRP O
previously RB O
found VBD O
TP53 NNP O
mutations NNS O
in IN O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domains NNS O
to TO O
be VB O
associated VBN O
with IN O
drug NN O
resistance NN O
, , O
some DT O
tumors NNS O
harboring VBG O
wild JJ O
- HYPH O
type NN O
TP53 NN O
were VBD O
also RB O
therapy NN O
resistant JJ O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
; : O
1 LS O
) -RRB- O
To TO O
explore VB O
alterations NNS O
in IN O
the DT O
TP53 NN O
gene NN O
with IN O
respect NN O
to IN O
resistance NN O
to IN O
a DT O
regular JJ O
dose NN O
epirubicin NN O
regimen NN O
( , O
90 CD O
mg NN O
/ SYM O
m2 CD O
every DT O
3 CD O
week NN O
) , O
in IN O
patients NNS B-Species
with IN O
primary JJ O
, , O
locally RB O
advanced JJ O
breast NN O
cancer NN O
; : O
2 CD O
) SYM O
Identify VB O
critical JJ O
mechanisms NNS O
activating VBG O
p53 NN O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
in IN O
breast NN O
cancer NN O
; : O
3 LS O
) -RRB- O
Evaluate VB O
in IN O
vitro FW O
function NN O
of IN O
Chk2 NNP O
and CC O
p14 NN O
proteins NNS O
corresponding VBG O
to IN O
identified VBN O
mutations NNS O
in IN O
the DT O
CHEK2 NN O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
genes NNS O
; : O
and CC O
4 LS O
) -RRB- O
Explore VB O
potential JJ O
CHEK2 NN O
or CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
germline NN O
mutations NNS O
with IN O
respect NN O
to IN O
family NN O
cancer NN O
incidence NN O
. . O

Methods NNS O
and CC O
Findings NNS O

Snap VB O
- HYPH O
frozen VBN O
biopsies NNS O
from IN O
109 CD O
patients NNS B-Species
collected VBN O
prior RB O
to IN O
epirubicin NN O
( , O
as IN O
preoperative JJ O
therapy NN O
were VBD O
investigated VBN O
for IN O
TP53 NNP O
, , O
CHEK2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
mutations NNS O
by IN O
sequencing VBG O
the DT O
coding VBG O
region NN O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
promoter NN O
methylations NNS O
. . O

TP53 NN O
mutastions NNS O
were VBD O
associated VBN O
with IN O
chemoresistance NN O
, , O
defined VBN O
as IN O
progressive JJ O
disease NN O
on IN O
therapy NN O
( : O
p NN O
= SYM O
0 CD O
. . O
358 CD O
; : O
p NN O
= SYM O
0 CD O
. . O
136 CD O
for IN O
mutations NNS O
affecting VBG O
p53 NN O
loop NN O
domains NNS O
L2 NNP O
/ SYM O
L3 NNP O
) -RRB- O
. . O

Germline NNP O
CHEK2 NNP O
mutations NNS O
( , O
n CD O
= SYM O
3 CD O
) -RRB- O
were VBD O
associated VBN O
with IN O
therapy NN O
resistance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
226 CD O
) -RRB- O
. . O

Combined VBN O
, , O
mutations NNS O
affecting VBG O
either CC O
CHEK2 NNP O
or CC O
TP53 NN O
strongly RB O
predicted VBN O
therapy NN O
resistance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
101 CD O
; : O
TP53 NN O
mutations NNS O
restricted VBN O
to IN O
the DT O
L2 NN O
/ SYM O
L3 CD O
domains NNS O
: : O
p NN O
= SYM O
0 CD O
. . O
32 CD O
) -RRB- O
. . O

Two CD O
patients NNS B-Species
progressing VBG O
on IN O
therapy NN O
harbored VBD O
the DT O
CHEK2 NNP O
mutation NN O
, , O
Arg95Ter NNP O
, , O
completely RB O
abrogating VBG O
Chk2 NNP O
protein NN O
dimerization NN O
and CC O
kinase NN O
activity NN O
. . O

One CD O
patient NN B-Species
( -LRB- O
Epi132 NNP O
) -RRB- O
revealed VBD O
family NN O
cancer NN O
occurrence NN O
resembling VBG O
families NNS O
harboring VBG O
CHEK2 NNP O
mutations NNS O
in IN O
general JJ O
, , O
the DT O
other JJ O
patient NN B-Species
( , O
epi203 CD O
) -RRB- O
was VBD O
non RB O
- HYPH O
conclusive JJ O
. . O

No DT O
mutation NN O
or CC O
promoter NN O
hypermethylation NN O
in IN O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
were VBD O
detected VBN O
. . O

Conclusion NN O

This DT O
study NN O
is VBZ O
the DT O
first JJ O
reporting VBG O
an DT O
association NN O
between IN O
CHEK2 NNP O
mutations NNS O
and CC O
therapy NN O
resistance NN O
in IN O
human JJ B-Species
cancers NNS O
and CC O
to TO O
document VB O
mutations NNS O
in IN O
two CD O
genes NNS O
acting VBG O
direct RB O
up IN O
/ SYM O
down RB O
- HYPH O
stream NN O
to IN O
each DT O
other JJ O
to TO O
cause VB O
therapy NN O
failure NN O
, , O
emphasizing VBG O
the DT O
need NN O
to TO O
investigate VB O
functional JJ O
cascades NNS O
in IN O
future JJ O
studies NNS O
. . O

Introduction NN O

Chemoresistance NN O
is VBZ O
the DT O
main JJ O
obstacle NN O
to IN O
cure NN O
in IN O
most JJS O
malignancies NNS O
, , O
including VBG O
breast NN O
cancer NN O
. . O

While IN O
adjuvant JJ O
chemotherapy NN O
may MD O
reduce VB O
the DT O
hazard NN O
rate NN O
of IN O
relapse NN O
by IN O
about RB O
one CD O
third NN O
in IN O
breast NN O
cancer NN O
patients NNS B-Species
[ -LRB- O
1 CD O
] -RRB- O
, , O
the DT O
majority NN O
among IN O
patients NNS B-Species
harboring VBG O
micro NN O
- HYPH O
metastases NNS O
are VBP O
not RB O
cured VBN O
by IN O
today NN O
' POS O
s NN O
standards NNS O
. . O

Considering VBG O
patients NNS B-Species
harboring VBG O
distant JJ O
metastases NNS O
, , O
resistance NN O
and CC O
therapy NN O
failure NN O
inevitably RB O
occurs VBZ O
, , O
in IN O
general JJ O
over IN O
a DT O
time NN O
period NN O
of IN O
less JJR O
than IN O
one CD O
year NN O
for IN O
each DT O
individual JJ O
regimen NN O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Despite IN O
extensive JJ O
experimental JJ O
research NN O
[ -LRB- O
3 CD O
] -RRB- O
, , O
little JJ O
data NNS O
are VBP O
available JJ O
considering VBG O
chemoresistance NN O
in IN O
vivo NN O
. . O

For IN O
anthracycline NN O
therapy NN O
in IN O
breast NN O
cancer NN O
, , O
topoisomerase NN O
- HYPH O
II NN O
amplifications NNS O
have VBP O
been VBN O
associated VBN O
with IN O
a DT O
dose NN O
- HYPH O
responsiveness NN O
different JJ O
from IN O
what WP O
is VBZ O
observed VBN O
in IN O
non NN O
- HYPH O
amplified VBN O
tumors NNS O
4 CD O
, , O
5 CD O
. . O

Several JJ O
studies NNS O
have VBP O
tried VBN O
to TO O
generate VB O
"""" `` O
prediction NN O
profiles NNS O
"""" '' O
based VBN O
on IN O
gene NN O
expression NN O
microarrays NNS O
[ -LRB- O
6 CD O
] -RRB- O
, , O
[ -LRB- O
7 CD O
] -RRB- O
, , O
[ -LRB- O
8 CD O
] -RRB- O
, , O
however RB O
, , O
none NN O
of IN O
the DT O
different JJ O
profiles NNS O
generated VBN O
expressed VBN O
a DT O
sensitivity NN O
suitable JJ O
for IN O
clinical JJ O
applications NNS O
, , O
or CC O
have VBP O
been VBN O
successfully RB O
reproduced VBN O
by IN O
others NNS O
( , O
see VB O
references NNS O
to IN O
original JJ O
works NNS O
in IN O
[ -LRB- O
9 CD O
] -RRB- O
and CC O
[ -LRB- O
10 CD O
] -RRB- O
) -RRB- O
. . O

p53 NN O
( , O
the DT O
protein NN O
encoded VBN O
by IN O
the DT O
TP53 NN O
gene NN O
) -RRB- O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
executing VBG O
DNA NN O
- HYPH O
damage NN O
induced VBN O
apoptosis NN O
and CC O
growth NN O
arrest NN O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Previously RB O
, , O
our PRP$ O
group NN O
reported VBD O
mutations NNS O
in IN O
the DT O
zink NN O
- HYPH O
binding VBG O
domains NNS O
L2 NNP O
( , O
codons NNS O
163 CD O
- SYM O
195 CD O
) -RRB- O
and CC O
L3 NNP O
( , O
codons NNS O
236 CD O
- HYPH O
251 CD O
) -RRB- O
of IN O
p53 NN O
critical JJ O
to IN O
DNA NN O
binding NN O
[ -LRB- O
12 CD O
] -RRB- O
to TO O
be VB O
associated VBN O
with IN O
but CC O
not RB O
fully RB O
predictive JJ O
for IN O
resistance NN O
to IN O
chemotherapy NN O
with IN O
a DT O
low JJ O
- HYPH O
dose NN O
weekly JJ O
anthracycline NN O
[ -LRB- O
13 CD O
] -RRB- O
or CC O
a DT O
mitomycin NN O
plus CC O
5 CD O
- HYPH O
fluoro NN O
- HYPH O
uracil NN O
containing VBG O
[ -LRB- O
14 CD O
] -RRB- O
regimen NN O
. . O

Similar JJ O
findings NNS O
were VBD O
reported VBN O
by IN O
another DT O
group NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

In IN O
contrast NN O
, , O
others NNS O
reported VBD O
TP53 NN O
mutations NNS O
to TO O
predict VB O
sensitivity NN O
to IN O
a DT O
dose NN O
- HYPH O
dense JJ O
epirubicin NN O
- HYPH O
cyclophosphamide NN O
regimen NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

The DT O
finding NN O
that IN O
some DT O
tumors NNS O
harboring VBG O
wild JJ O
- HYPH O
type NN O
TP53 NNP O
may MD O
be VB O
resistant JJ O
to IN O
anthracycline NN O
therapy NN O
lead VBP O
us PRP O
to TO O
postulate VB O
that IN O
other JJ O
genes NNS O
involved VBN O
in IN O
the DT O
p53 NN O
pathway NN O
could MD O
be VB O
mutated VBN O
in IN O
these DT O
tumors NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

p53 NN O
is VBZ O
activated VBN O
by IN O
post NN O
- HYPH O
translational JJ O
modifications NNS O
, , O
and CC O
the DT O
protein NN O
is VBZ O
phosphorylated VBN O
at IN O
multiple JJ O
amino NN O
acids NNS O
[ -LRB- O
17 CD O
] -RRB- O
. . O

Phosphorylation NN O
at IN O
Ser NNP O
20 CD O
( , O
Ser NNP O
23 CD O
in IN O
mice NNS B-Species
) -RRB- O
by IN O
the DT O
Chk2 NNP O
protein NN O
( , O
coded VBN O
by IN O
the DT O
CHEK2 NNP O
gene NN O
) -RRB- O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
activates VBZ O
p53 NN O
by IN O
inhibiting VBG O
binding NN O
to IN O
, , O
and CC O
deactivation NN O
by IN O
, , O
the DT O
MDM2 NNP O
( -LRB- O
Mouse NNP B-Species
Minute NNP O
2 CD O
homolog NN O
; : O
HDM2 NNP O
) -RRB- O
protein NN O
[ -LRB- O
18 CD O
] -RRB- O
, , O
[ -LRB- O
19 CD O
] -RRB- O
, , O
[ -LRB- O
20 CD O
] -RRB- O
. . O

While IN O
experimental JJ O
studies NNS O
have VBP O
suggested VBN O
a DT O
critical JJ O
role NN O
of IN O
Chk2 NNP O
in IN O
activating VBG O
p53 NN O
apoptotic JJ O
response NN O
to IN O
genotoxic JJ O
stress NN O
[ -LRB- O
21 CD O
] -RRB- O
, , O
[ -LRB- O
22 CD O
] -RRB- O
, , O
others NNS O
claim VBP O
Chk2 NNP O
to TO O
be VB O
dispensable JJ O
for IN O
p53 NN O
activation NN O
with IN O
respect NN O
to IN O
apoptosis NN O
as RB O
well RB O
as IN O
growth NN O
arrest NN O
[ -LRB- O
23 CD O
] -RRB- O
. . O

Following VBG O
an DT O
initial JJ O
report NN O
of IN O
a DT O
CHEK2 NNP O
germline NN O
mutation NN O
in IN O
a DT O
family NN O
filling VBG O
the DT O
characteristics NNS O
of IN O
a DT O
Li NNP O
- HYPH O
Fraumeni NNP O
syndrome NN O
( -LRB- O
LFS NNP O
) -RRB- O
[ -LRB- O
24 CD O
] -RRB- O
, , O
recent JJ O
papers NNS O
have VBP O
suggested VBN O
germline NN O
mutations NNS O
in IN O
CHEK2 NNP O
to TO O
be VB O
associated VBN O
with IN O
a DT O
moderately RB O
increased VBN O
risk NN O
of IN O
breast NN O
and CC O
colon NN O
cancers NNS O
( , O
see VB O
references NNS O
in IN O
[ -LRB- O
25 CD O
] -RRB- O
) -RRB- O
. . O

Recently RB O
, , O
we PRP O
discovered VBD O
a DT O
somatic JJ O
, , O
nonsense NN O
CHEK2 NN O
mutation NN O
in IN O
a DT O
single JJ O
patient NN B-Species
expressing VBG O
resistance NN O
to IN O
doxorubicin NN O
low JJ O
dose NN O
therapy NN O
[ -LRB- O
26 CD O
] -RRB- O
. . O

A DT O
second JJ O
mechanism NN O
of IN O
p53 NN O
activation NN O
is VBZ O
through IN O
p14 NN O
( , O
ARF NNP O
) -RRB- O
( , O
p19 NN O
in IN O
mice NNS B-Species
) -RRB- O
function NN O
. . O

p14 NN O
( , O
ARF NNP O
) -RRB- O
does VBZ O
not RB O
phosphorylate VB O
p53 NN O
, , O
but CC O
inhibits VBZ O
MDM2 NN O
dependent JJ O
p53 NN O
degradation NN O
through IN O
direct JJ O
MDM2 NNP O
binding NN O
. . O

While IN O
p14 NN O
( , O
ARF NNP O
) -RRB- O
- HYPH O
mediated VBN O
p53 NN O
activation NN O
has VBZ O
been VBN O
linked VBN O
to IN O
oncogene NN O
- HYPH O
induced VBN O
p53 NN O
activation NN O
and CC O
, , O
in IN O
general JJ O
, , O
considered VBN O
not RB O
involved VBN O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
( , O
see VB O
references NNS O
in IN O
[ -LRB- O
27 CD O
] -RRB- O
) -RRB- O
, , O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
may MD O
be VB O
activated VBN O
through IN O
the DT O
E2F1 NNP O
/ SYM O
retinoblastoma NN O
pathway NN O
[ -LRB- O
28 CD O
] -RRB- O
. . O

Importantly RB O
, , O
two CD O
recent JJ O
studies NNS O
revealed VBD O
lack NN O
of IN O
p19 NN O
( , O
mouse NN B-Species
homologue NN O
of IN O
human JJ B-Species
p14 NN O
( , O
ARF NN O
) -RRB- O
) , O
function NN O
in IN O
mice NNS B-Species
to TO O
inhibit VB O
p53 NN O
tumor NN O
suppressor NN O
function NN O
in IN O
response NN O
to IN O
ionizing VBG O
radiation NN O
as RB O
well RB O
as IN O
DNA NN O
damaging VBG O
agents NNS O
[ -LRB- O
29 CD O
] -RRB- O
, , O
[ -LRB- O
30 CD O
] -RRB- O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
1 CD O
) -RRB- O
to TO O
explore VB O
alterations NNS O
in IN O
the DT O
TP53 NN O
gene NN O
with IN O
respect NN O
to IN O
resistance NN O
to IN O
a DT O
regular JJ O
dose NN O
epirubicin NN O
regimen NN O
( , O
90 CD O
mg NN O
/ SYM O
m2 NN O
body NN O
surface NN O
every DT O
3 CD O
week NN O
) , O
in IN O
patient NN B-Species
with IN O
primary JJ O
, , O
locally RB O
advanced JJ O
, , O
breast NN O
cancer NN O
; : O
2 LS O
) -RRB- O
To TO O
explore VB O
defects NNS O
in IN O
potential JJ O
mechanisms NNS O
activating VBG O
p53 NN O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
in IN O
breast NN O
cancer NN O
as IN O
a DT O
cause NN O
of IN O
drug NN O
resistance NN O
in IN O
wild JJ O
- HYPH O
type NN O
tumors NNS O
. . O

To TO O
do VB O
so RB O
, , O
we PRP O
sequenced VBD O
the DT O
complete JJ O
coding VBG O
regions NNS O
for IN O
the DT O
CHEK2 NNP O
and CC O
p14 NN O
( , O
ARF NN O
) -RRB- O
genes NNS O
and CC O
analyzed VBN O
for IN O
p14 NN O
( , O
ARF NN O
) -RRB- O
promoter NN O
hypermetylations NNS O
; : O
3 CD O
) SYM O
Evaluate NN O
in IN O
vitro FW O
function NN O
of IN O
potential JJ O
Chk2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
protein NN O
translates VBZ O
corresponding VBG O
to IN O
identified VBN O
mutations NNS O
in IN O
the DT O
CHEK2 NN O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
genes NNS O
; : O
4 CD O
) NFP O
Identify VB O
potential JJ O
TP53 NN O
, , O
CHEK2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
mutations NNS O
to TO O
be VB O
germline NN O
, , O
explore VB O
the DT O
incidence NN O
of IN O
different JJ O
cancers NNS O
among IN O
affected JJ O
relatives NNS O
with IN O
respect NN O
to IN O
specific JJ O
mutations NNS O
. . O

By IN O
comparing VBG O
in FW O
vitro FW O
characteristics NNS O
of IN O
specific JJ O
mutations NNS O
to IN O
drug NN O
sensitivity NN O
and CC O
family NN O
cancer NN O
risk NN O
syndromes NNS O
, , O
this DT O
may MD O
add VB O
to IN O
our PRP$ O
understanding NN O
of IN O
the DT O
importance NN O
of IN O
these DT O
gene NN O
cascades NNS O
executing VBG O
response NN O
to IN O
DNA NN O
damage NN O
versus IN O
tumor NN O
suppression NN O
activity NN O
. . O

Analyzing VBG O
tumor NN O
samples NNS O
from IN O
a DT O
total NN O
of IN O
109 CD O
primary JJ O
locally RB O
advanced JJ O
breast NN O
cancer NN O
patients NNS B-Species
treated VBN O
with IN O
epirubicin NN O
90mg CD O
/ SYM O
3 CD O
weekly RB O
, , O
we PRP O
found VBD O
TP53 NN O
mutations NNS O
affecting VBG O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domains NNS O
or CC O
protein NN O
dimerization NN O
, , O
as RB O
well RB O
as IN O
non JJ O
- HYPH O
functional JJ O
CHEK2 NN O
mutations NNS O
abrogating VBG O
dimerization NN O
and CC O
phosphorylation NN O
, , O
to TO O
be VB O
associated VBN O
with IN O
therapy NN O
resistance NN O
; , O
no DT O
mutation NN O
or CC O
promoter NN O
hypermethylations NNS O
of IN O
the DT O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
gene NN O
was VBD O
discovered VBN O
. . O

Our PRP$ O
findings NNS O
suggest VBP O
a DT O
critical JJ O
role NN O
for IN O
Chk2 NNP O
with IN O
respect NN O
to IN O
DNA NN O
- HYPH O
damage NN O
- HYPH O
dependent JJ O
p53 NN O
activation NN O
and CC O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
in IN O
human JJ B-Species
breast NN O
cancer NN O
. . O

Materials NNS O
and CC O
Methods NNS O

Patients NNS B-Species

A DT O
total NN O
of IN O
223 CD O
patients NNS B-Species
with IN O
locally RB O
advanced VBN O
non JJ O
- HYPH O
inflammatory JJ O
breast NN O
cancer NN O
( -LRB- O
T3 NNP O
- HYPH O
4 CD O
and CC O
/ SYM O
or CC O
N2 CD O
) -RRB- O
were VBD O
randomly RB O
allocated VBN O
to IN O
primary JJ O
treatment NN O
either CC O
with IN O
epirubicin NN O
90 CD O
mg NN O
/ SYM O
m2 NN O
or CC O
paclitaxel NN O
200 CD O
mg NNS O
/ SYM O
m2 CD O
. . O

The DT O
primary JJ O
aim NN O
of IN O
the DT O
study NN O
was VBD O
identification NN O
of IN O
markers NNS O
predicting VBG O
drug NN O
resistance NN O
to IN O
the DT O
regimens NNS O
. . O

Thus RB O
, , O
the DT O
reason NN O
for IN O
randomizing VBG O
patients NNS B-Species
was VBD O
not RB O
for IN O
effect NN O
comparison NN O
, , O
but CC O
to TO O
achieve VB O
similar JJ O
patient JJ B-Species
cohorts NNS O
in IN O
the DT O
two CD O
arms NNS O
. . O

Based VBN O
on IN O
the DT O
findings NNS O
of IN O
a DT O
clinical JJ O
lack NN O
of IN O
cross JJ O
- HYPH O
resistance NN O
between IN O
anthracyclines NNS O
and CC O
taxane NN O
therapies NNS O
in IN O
breast NN O
cancer NN O
[ -LRB- O
31 CD O
] -RRB- O
, , O
we PRP O
hypothesized VBD O
the DT O
mechanisms NNS O
of IN O
resistance NN O
to TO O
be VB O
different JJ O
between IN O
the DT O
two CD O
compounds NNS O
. . O

While IN O
the DT O
analysis NN O
of IN O
tumor NN O
samples NNS O
from IN O
the DT O
paclitaxel NN O
is VBZ O
ongoing VBG O
, , O
we PRP O
here RB O
report VBP O
our PRP$ O
findings NNS O
from IN O
the DT O
patients NNS B-Species
allocated VBN O
to IN O
the DT O
epirubicin NN O
arm NN O
. . O

The DT O
epirubicin NN O
arm NN O
included VBD O
a DT O
total NN O
of IN O
109 CD O
patients NNS B-Species
( , O
age NN O
28 CD O
to TO O
70 CD O
years NNS O
, , O
median JJ O
51 CD O
years NNS O
) -RRB- O
. . O

Two CD O
patients NNS B-Species
were VBD O
analyzed VBN O
for IN O
gene NN O
mutations NNS O
but CC O
omitted VBN O
from IN O
statistical JJ O
analysis NN O
as IN O
protocol NN O
violators NNS O
; , O
histopathological JJ O
examination NN O
revealed VBD O
one CD O
patient NN B-Species
( -LRB- O
Epi089 NN O
) -RRB- O
to TO O
harbor VB O
a DT O
sarcomatoid JJ O
tumor NN O
, , O
while IN O
one CD O
patient NN B-Species
Epi232 NNP O
was VBD O
erroneously RB O
enrolled VBN O
with IN O
stage NN O
II NNP O
disease NN O
. . O

The DT O
study NN O
protocol NN O
was VBD O
approved VBN O
by IN O
the DT O
Regional NNP O
Ethical NNP O
Committee NNP O
( , O
Norwegian NNP O
Health NNP O
Region NNP O
III NNP O
) -RRB- O
, , O
including VBG O
formal JJ O
Biobank NNP O
registration NN O
in IN O
accordance NN O
to IN O
Norwegian JJ O
law NN O
. . O

The DT O
study NN O
and CC O
protocol NN O
is VBZ O
registered VBN O
under IN O
the DT O
Norwegian NNP O
Social NNP O
Science NNP O
Data NNP O
services NNPS O
( , O
( -LRB- O
www NN O
. , O
nsd NNP O
/ SYM O
uib NN O
/ SYM O
personvern NN O
/ SYM O
database NN O
/ SYM O
) NFP O
, , O
University NNP O
of IN O
Bergen NNP O
project NN O
no DT O
16297 CD O
and CC O
Helse NNP O
Bergen NNP O
project NN O
no NN O
13025 CD O
) -RRB- O
. . O

Each DT O
patient NN B-Species
gave VBD O
written VBN O
informed JJ O
consent NN O
. . O

Tissue NNP O
Sampling NNP O

Before IN O
commencing VBG O
chemotherapy NN O
, , O
each DT O
patient NN B-Species
had VBD O
an DT O
incisional JJ O
tumor NN O
biopsy NN O
as IN O
described VBN O
previously RB O
[ -LRB- O
14 CD O
] -RRB- O
. . O

All DT O
tissue NN O
samples NNS O
were VBD O
snap NN O
- HYPH O
frozen VBN O
immediately RB O
on IN O
removal NN O
in IN O
the DT O
theatre NN O
. . O

Treatment NN O
Regime NN O
and CC O
Staging NN O

Primary JJ O
treatment NN O
consisted VBD O
of IN O
epirubicin NN O
( : O
90 CD O
mg NNS O
/ SYM O
m2 CD O
) -RRB- O
administered VBN O
as IN O
a DT O
3 CD O
- HYPH O
weekly JJ O
schedule NN O
. . O

Treatment NN O
was VBD O
scheduled VBN O
for IN O
four CD O
cycles NNS O
unless IN O
progression NN O
occurred VBD O
at IN O
an DT O
earlier JJR O
stage NN O
. . O

Clinical JJ O
response NN O
was VBD O
assessed VBN O
before IN O
each DT O
treatment NN O
cycle NN O
, , O
and CC O
the DT O
final JJ O
response NN O
evaluated VBN O
3 CD O
weeks NNS O
after IN O
the DT O
4th JJ O
cycle NN O
for IN O
overall JJ O
response NN O
classification NN O
. . O

Because IN O
the DT O
protocol NN O
was VBD O
implemented VBN O
by IN O
October NNP O
1997 CD O
with IN O
patients NNS B-Species
enrolled VBN O
between IN O
November NNP O
1997 CD O
and CC O
December NNP O
2003 CD O
, , O
responses NNS O
were VBD O
consistently RB O
graded VBN O
by IN O
the DT O
UICC NNP O
system NN O
[ -LRB- O
32 CD O
] -RRB- O
and CC O
not RB O
the DT O
more RBR O
recently RB O
implemented VBN O
"""" `` O
RECIST NNP O
"""" '' O
criteria NNS O
[ -LRB- O
33 CD O
] -RRB- O
. . O

Thus RB O
, , O
responses NNS O
were VBD O
classified VBN O
as IN O
CR NN O
( -LRB- O
Complete NNP O
Response NNP O
, , O
complete JJ O
disappearance NN O
of IN O
all DT O
tumor NN O
lesions NNS O
) -RRB- O
, , O
PR NN O
( , O
Partial NNP O
Response NNP O
, , O
reduction NN O
> : O
= SYM O
50 CD O
% NN O
in IN O
the DT O
sum NN O
of IN O
all DT O
tumor NN O
lesions NNS O
, , O
calculated VBN O
for IN O
each DT O
as IN O
the DT O
product NN O
of IN O
the DT O
largest JJS O
diameter NN O
and CC O
the DT O
one CD O
perpendicular JJ O
to IN O
it PRP O
) -RRB- O
, , O
PD NN O
( , O
Progressive NNP O
Disease NNP O
, , O
increase NN O
in IN O
the DT O
diameter NN O
product NN O
of IN O
any DT O
individual JJ O
tumor NN O
lesion NN O
by IN O
> SYM O
= SYM O
25 CD O
% NN O
) -RRB- O
, , O
and CC O
SD NN O
( : O
Stable NNP O
Disease NNP O
, , O
anything NN O
between IN O
PR NN O
and CC O
PD NN O
) -RRB- O
. . O

To TO O
analyze VB O
for IN O
the DT O
predictive JJ O
value NN O
of IN O
the DT O
different JJ O
parameters NNS O
, , O
similar JJ O
to IN O
our PRP$ O
previous JJ O
studies NNS O
[ -LRB- O
13 CD O
] -RRB- O
, , O
[ -LRB- O
14 CD O
] -RRB- O
we PRP O
compared VBD O
PD NN O
tumors NNS O
( , O
non JJ O
responders NNS O
) , O
with IN O
the DT O
combined JJ O
group NN O
of IN O
tumors NNS O
classified VBN O
as IN O
SD NNP O
/ SYM O
PR NNP O
/ SYM O
CR NN O
( , O
responders NNS O
) -RRB- O
; : O
the DT O
reason NN O
for IN O
this DT O
approach NN O
is VBZ O
discussed VBN O
in IN O
detail NN O
elsewhere RB O
[ -LRB- O
34 CD O
] -RRB- O
. . O

Median JJ O
follow NN O
- HYPH O
up NN O
time NN O
was VBD O
defined VBN O
from IN O
patient JJ B-Species
inclusion NN O
in IN O
the DT O
study NN O
up IN O
to IN O
October NNP O
31 CD O
, , O
2006 CD O
. . O

Deaths NNS O
attributable JJ O
to IN O
causes NNS O
other JJ O
than IN O
breast NN O
cancer NN O
were VBD O
treated VBN O
as IN O
censored JJ O
observations NNS O
. . O

All DT O
patient JJ B-Species
records NNS O
were VBD O
subject JJ O
to IN O
central JJ O
audit NN O
for IN O
response NN O
classification NN O
( , O
by IN O
E NNP O
. . O
L NNP O
. . O
, , O
B NNP O
. . O
O NN O
. . O
and CC O
P NN O
. . O
E NN O
. . O
L NNP O
. . O
) -RRB- O
. . O

Response NN O
classifications NNS O
were VBD O
completed VBN O
and CC O
approved VBN O
without IN O
any DT O
knowledge NN O
about IN O
result NN O
from IN O
laboratory NN O
analysis NN O
. . O

RNA NNP O
Purification NN O

Total JJ O
RNA NNP O
was VBD O
purified VBN O
by IN O
Trizol NNP O
( : O
Life NNP O
Technologies NNPS O
, , O
Inc NNP O
. . O
) -RRB- O
extraction NN O
from IN O
snap NN O
- HYPH O
frozen VBN O
tissue NN O
samples NNS O
according VBG O
to IN O
manufacturer NN O
' POS O
s NNS O
instructions NNS O
. . O

After IN O
extraction NN O
, , O
the DT O
RNA NNP O
was VBD O
dissolved VBN O
in IN O
100 CD O
micro NN O
l NN O
of IN O
DEPC NNP O
treated VBN O
ddH2O NNP O
. . O

cDNA NNP O
was VBD O
synthesized VBN O
by IN O
reverse JJ O
transcription NN O
using VBG O
Transcriptor NNP O
reverse JJ O
transcriptase NN O
( , O
Roche NNP O
) -RRB- O
, , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

DNA NNP O
Purification NN O

Genomic JJ O
DNA NN O
from IN O
tumor NN O
biopsies NNS O
and CC O
blood NN O
lymphocytes NNS O
was VBD O
isolated VBN O
using VBG O
QIAamp NNP O
DNA NNP O
Mini NNP O
kit NN O
( , O
Qiagen NNP O
, , O
Chatsworth NNP O
, , O
CA NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

Mutation NN O
Analysis NNP O

All DT O
mutational JJ O
analysis NN O
was VBD O
performed VBN O
blinded VBN O
to IN O
clinical JJ O
data NNS O
. . O

Mutations NNS O
in IN O
TP53 NNP O
, , O
CHEK2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
genes NNS O
were VBD O
analyzed VBN O
by IN O
PCR NNP O
( , O
or CC O
nested VBN O
PCR NN O
) -RRB- O
amplification NN O
and CC O
sequencing NN O
of IN O
PCR NNP O
product NN O
, , O
or CC O
by IN O
cloning NN O
of IN O
PCR NN O
products NNS O
and CC O
sequencing NN O
of IN O
the DT O
resulting VBG O
plasmids NNS O
( , O
all DT O
primers NNS O
described VBN O
in IN O
Table NNP O
1 CD O
) -RRB- O
. . O

Cloning NN O
was VBD O
performed VBN O
using VBG O
the DT O
TOPO NNP O
TA NNP O
Cloning NNP O
kit NN O
( : O
Invitrogen NNP O
) -RRB- O
. . O

Sequencing VBG O
of IN O
clones NNS O
was VBD O
performed VBN O
until IN O
at RB O
least RBS O
10 CD O
different JJ O
sequences NNS O
covered VBD O
all DT O
parts NNS O
of IN O
the DT O
CHEK2 NNP O
coding VBG O
sequence NN O
. . O

DNA NN O
sequencing NN O
was VBD O
carried VBN O
out RP O
directly RB O
on IN O
1 CD O
micro NN O
l NNP O
PCR NNP O
product NN O
or CC O
plasmid NN O
using VBG O
Big NNP O
Dye NNP O
terminator NN O
mix NN O
( : O
Applied NNP O
Biosystems NNPS O
) -RRB- O
. . O

Capillary NN O
gel NN O
electrophoresis NN O
, , O
data NN O
collection NN O
, , O
and CC O
sequence NN O
analysis NN O
were VBD O
done VBN O
on IN O
an DT O
automated JJ O
DNA NN O
sequencer NN O
( : O
ABI NNP O
3700 CD O
) -RRB- O
. . O

When WRB O
a DT O
mutation NN O
was VBD O
detected VBN O
, , O
the DT O
relevant JJ O
exon NN O
was VBD O
amplified VBN O
by IN O
PCR NNP O
from IN O
genomic JJ O
tumor NN O
DNA NN O
and CC O
DNA NN O
from IN O
blood NN O
lymphocytes NNS O
and CC O
sequenced VBN O
for IN O
verification NN O
and CC O
germline NN O
detection NN O
. . O

( : O
Primers NNS O
described VBN O
in IN O
Table NNP O
1 CD O
) -RRB- O
. . O

Loss NNP O
of IN O
Heterozygosity NNP O
( -LRB- O
LOH NNP O
) -RRB- O

Loss NN O
of IN O
heterozygosity NN O
( -LRB- O
LOH NNP O
) , O
in IN O
tumors NNS O
with IN O
mutations NNS O
in IN O
CHEK2 NNP O
was VBD O
assessed VBN O
using VBG O
the DT O
microsatellite NN O
marker NN O
, , O
D22S275 NNP O
, , O
which WDT O
maps VBZ O
to IN O
intron NN O
4 CD O
of IN O
CHEK2 NNP O
. . O

LOH NNP O
in IN O
tumors NNS O
with IN O
mutation NN O
in IN O
TP53 NN O
was VBD O
assessed VBN O
using VBG O
two CD O
markers NNS O
, , O
one CD O
variable JJ O
number NN O
tandem NN O
repeat NN O
in IN O
intron NN O
1 CD O
[ -LRB- O
35 CD O
] -RRB- O
and CC O
a DT O
CA NN O
repeat NN O
close RB O
to IN O
the DT O
TP53 NN O
gene NN O
[ -LRB- O
36 CD O
] -RRB- O
. . O

Fluorescently RB O
end NN O
- HYPH O
labeled VBN O
primers NNS O
were VBD O
used VBN O
in IN O
the DT O
PCR NNP O
, , O
and CC O
the DT O
PCR NNP O
products NNS O
were VBD O
analyzed VBN O
on IN O
an DT O
ABI NNP O
3700 CD O
. . O

LOH NNP O
was VBD O
evaluated VBN O
by IN O
comparing VBG O
the DT O
allele JJ O
peak NN O
- HYPH O
height NN O
ratios NNS O
from IN O
blood NN O
DNA NN O
and CC O
tumor NN O
DNA NN O
. . O

A DT O
sample NN O
was VBD O
scored VBN O
as IN O
having VBG O
AI NNP O
( -LRB- O
Allelic NNP O
Imbalance NNP O
) , O
when WRB O
a DT O
reduction NN O
in IN O
peak NN O
height NN O
of IN O
one CD O
allele NN O
in IN O
tumor NN O
sample NN O
was VBD O
at RB O
least RBS O
18 CD O
% NN O
compared VBN O
with IN O
that DT O
of IN O
blood NN O
DNA NN O
from IN O
the DT O
same JJ O
patient NN B-Species
[ -LRB- O
37 CD O
] -RRB- O
. . O

Analysis NN O
of IN O
p14 NN O
( , O
ARF NNP O
) -RRB- O
promoter NN O
methylation NN O

Genomic JJ O
DNA NNP O
was VBD O
subjected VBN O
to IN O
bisulphate NN O
conversion NN O
using VBG O
the DT O
CpGenome NNP O
DNA NNP O
Modification NNP O
Kit NNP O
( -LRB- O
Intergen NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
protocol NN O
. . O

Both CC O
the DT O
unmethylated JJ O
- HYPH O
and CC O
methylated JJ O
- HYPH O
specific JJ O
PCRs NNS O
were VBD O
performed VBN O
in IN O
50 CD O
micro JJ O
l NN O
reaction NN O
mixes NNS O
containing VBG O
2 CD O
. . O
5 CD O
U NN O
AmpliTaq NNP O
Gold NNP O
DNA NNP O
Polymerase NNP O
( , O
Applied NNP O
Biosystems NNPS O
) -RRB- O
, , O
1 CD O
x SYM O
PCR NN O
buffer NN O
, , O
1 CD O
. . O
5 CD O
mM NN O
MgCl2 NN O
, , O
0 CD O
. . O
1 CD O
mM NN O
of IN O
each DT O
deoxynucleotide NN O
triphosphate NN O
, , O
0 CD O
. . O
2 CD O
micro NN O
M NN O
of IN O
each DT O
primer NN O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
and CC O
2 CD O
micro NN O
l NN O
of IN O
modified VBN O
genomic JJ O
DNA NN O
. . O

Thermocycling NN O
conditions NNS O
for IN O
both CC O
the DT O
unmethylated JJ O
- HYPH O
and CC O
methylated VBN O
- HYPH O
specific JJ O
PCRs NNS O
were VBD O
an DT O
initial JJ O
step NN O
of IN O
5 CD O
minutes NNS O
at IN O
95 CD O
degrees NNS O
C NN O
followed VBN O
by IN O
35 CD O
cycles NNS O
of IN O
30 CD O
sec NN O
. . O
at IN O
94 CD O
degrees NNS O
C NN O
, , O
30 CD O
sec NN O
. . O
at IN O
60 CD O
. . O
5 CD O
degrees NNS O
C NN O
and CC O
60 CD O
sec NN O
. . O
at IN O
72 CD O
degrees NNS O
C NN O
before IN O
a DT O
final JJ O
elongation NN O
step NN O
at IN O
72 CD O
degrees NNS O
C NN O
for IN O
7 CD O
min NN O
. . O

Chk2 NNP O
Dimerisation NNP O

Chk2 NNP O
mutant NN O
' '' O
s POS O
ability NN O
to TO O
form VB O
dimers NNS O
with IN O
the DT O
wild JJ O
- HYPH O
type NN O
protein NN O
was VBD O
investigated VBN O
by IN O
immunoprecipitation NN O
. . O

U NN O
- HYPH O
2 CD O
- HYPH O
OS NN O
cells NNS O
were VBD O
co NN O
- HYPH O
transfected VBN O
with IN O
expression NN O
vectors NNS O
expressing VBG O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
with IN O
N NNP O
- HYPH O
terminal JJ O
Xpr NNP O
- HYPH O
tag NNP O
( , O
pcDNA4 NNP O
/ SYM O
HisMax NNP O
, , O
Invitrogen NNP O
) -RRB- O
and CC O
mutated VBN O
Chk2 NNP O
forms NNS O
with IN O
C NN O
- HYPH O
terminal NN O
V5 NNP O
- HYPH O
tag NNP O
( : O
pcDNA3 NNP O
. . O
1 CD O
/ SYM O
V5 CD O
- HYPH O
His NN O
, , O
Invitrogen NNP O
) -RRB- O
. . O

Transfection NN O
was VBD O
performed VBN O
using VBG O
FuGene NNP O
6 CD O
. . O
0 CD O
transfection NN O
reagent NN O
( , O
Roche NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

Cells NNS O
were VBD O
harvested VBN O
in IN O
lysisbuffer NN O
( , O
50 CD O
mM NN O
TrisHCl NN O
pH NN O
8 CD O
. . O
0 CD O
, , O
150 CD O
mM NN O
NaCl NN O
, , O
0 CD O
. . O
5 CD O
% NN O
NP40 CD O
, , O
5 CD O
mM NN O
EDTA NN O
pH NN O
8 CD O
. . O
0 CD O
) SYM O
48 CD O
hours NNS O
after IN O
transfection NN O
. . O

An DT O
aliquote NN O
of IN O
the DT O
cell NN O
lysate NN O
was VBD O
harvested VBN O
for IN O
subsequent JJ O
Chk2 NNP O
- HYPH O
mutant JJ O
- HYPH O
V5 NNP O
transfection NN O
verification NN O
. . O

Samples NNS O
were VBD O
further RB O
incubated VBN O
with IN O
A NN O
/ SYM O
G NNP O
Pluss NNP O
Agarose NNP O
beads NNS O
( , O
Santa NNP O
Cruz NNP O
Biotechnology NNP O
) -RRB- O
at IN O
4 CD O
degrees NNS O
C NN O
for IN O
25 CD O
minutes NNS O
before IN O
the DT O
beads NNS O
were VBD O
removed VBN O
by IN O
centrifugation NN O
at IN O
5000g CD O
for IN O
4 CD O
minutes NNS O
and CC O
the DT O
samples NNS O
were VBD O
incubated VBN O
with IN O
1 CD O
. . O
5 CD O
micro NN O
g NN O
anti AFX O
- HYPH O
V5 NN O
( -LRB- O
Invitrogen NNP O
) -RRB- O
at IN O
4 CD O
degrees NNS O
C NN O
for IN O
90 CD O
minutes NNS O
. . O

Fresh JJ O
A NN O
/ SYM O
G NNP O
Pluss NNP O
Agarose NNP O
beads NNS O
were VBD O
added VBN O
and CC O
the DT O
samples NNS O
were VBD O
incubated VBN O
for IN O
another DT O
90 CD O
minutes NNS O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

The DT O
beads NNS O
were VBD O
washed VBN O
three CD O
times NNS O
with IN O
1 CD O
x SYM O
PBS NN O
, , O
before IN O
being VBG O
separated VBN O
on IN O
a DT O
10 CD O
% NN O
polyacrylamide NN O
gel NN O
and CC O
blotted VBN O
on IN O
to IN O
a DT O
nitrocellulose NN O
membrane NN O
. . O

Chk2 NNP O
- HYPH O
wild JJ O
- HYPH O
type NN O
- HYPH O
Xpr NNP O
co NN O
- HYPH O
precipitated VBN O
with IN O
Chk2 NNP O
- HYPH O
mutant NN O
- HYPH O
V5 NNP O
was VBD O
detected VBN O
through IN O
incubations NNS O
with IN O
anti JJ O
- HYPH O
Xpr NN O
antibody NN O
( , O
Invitrogen NNP O
) -RRB- O
, , O
HRP NN O
- HYPH O
conjugated VBN O
secondary JJ O
antibody NN O
and CC O
ECL NNP O
detection NN O
reagent NN O
( -LRB- O
GE NNP O
Healthcare NNP O
) -RRB- O
. . O

Kinase NNP O
Activity NNP O

Chk2 NNP O
mutant NN O
' '' O
s POS O
ability NN O
to TO O
function VB O
as IN O
kinases NNS O
was VBD O
investigated VBN O
through IN O
an DT O
in FW O
vitro FW O
kinase NN O
assay NN O
. . O

The DT O
V5 NNP O
expression NN O
vectors NNS O
used VBN O
for IN O
the DT O
dimerisation NN O
study NN O
were VBD O
also RB O
used VBN O
to TO O
express VB O
Chk2 NNP O
mutants NNS O
in IN O
the DT O
kinase NN O
assay NN O
. . O

U NN O
- HYPH O
2 CD O
- HYPH O
OS NN O
cells NNS O
were VBD O
transfected VBN O
using VBG O
the DT O
FuGene NNP O
6 CD O
. . O
0 NFP O
transfection NN O
reagent NN O
( , O
Roche NNP O
) -RRB- O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s POS O
instructions NNS O
. . O

Cells NNS O
were VBD O
then RB O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
in IN O
5 CD O
% NN O
CO2 NN O
and CC O
humidified JJ O
atmosphere NN O
. . O

After IN O
24 CD O
hours NNS O
doxorubicin NN O
( -LRB- O
Nycomed NNP O
Pharma NNP O
) -RRB- O
was VBD O
added VBN O
to IN O
the DT O
media NNS O
to IN O
a DT O
final JJ O
concentration NN O
of IN O
50ng CD O
/ SYM O
ml NN O
and CC O
the DT O
cells NNS O
were VBD O
further RBR O
incubated VBN O
for IN O
24 CD O
hours NNS O
before IN O
harvest NN O
. . O

75 CD O
cm2 NN O
of IN O
90 CD O
% NN O
confluent JJ O
cells NNS O
were VBD O
harvested VBN O
in IN O
500 CD O
micro NN O
l NN O
lysis NN O
buffer NN O
( : O
50 CD O
mM NN O
HEPES NNP O
, , O
150 CD O
mM NN O
NaCl NNP O
, , O
10 CD O
% NN O
glycerol NN O
, , O
0 CD O
. . O
5 CD O
% NN O
Triton NNP O
X NNP O
- HYPH O
100 CD O
, , O
2 CD O
mM NN O
MgCl2 NNP O
, , O
5 CD O
mM NN O
EDTA NNP O
) -RRB- O
, , O
and CC O
the DT O
cytosol NN O
was VBD O
incubated VBN O
for IN O
90 CD O
minutes NNS O
at IN O
4 CD O
degrees NNS O
C NN O
with IN O
50 CD O
micro NN O
l NN O
50 CD O
% NN O
Glutathione NNP O
Sepharose NNP O
beads NNS O
( , O
Amersham NNP O
Biosciences NNP O
) -RRB- O
linked VBN O
to IN O
anti JJ O
- HYPH O
V5 NN O
antibody NN O
( , O
Invitrogen NNP O
) -RRB- O
. . O

The DT O
beads NNS O
were VBD O
then RB O
washed VBN O
twice RB O
with IN O
lysisbuffer NN O
containing VBG O
500 CD O
mM NN O
NaCl NNP O
and CC O
twice RB O
with IN O
kinase NN O
assay NN O
buffer NN O
( , O
50 CD O
mM NN O
HEPES NNP O
, , O
10 CD O
mM NN O
MgCl2 NNP O
, , O
5 CD O
mM NN O
MnCl2 NN O
, , O
2 CD O
. . O
5 CD O
mM NN O
EGTA NN O
) -RRB- O
. . O

The DT O
beads NNS O
received VBD O
30 CD O
micro JJ O
l NN O
kinase NN O
assay NN O
buffer NN O
with IN O
7 CD O
. . O
5 CD O
micro NN O
M NN O
cold JJ O
ATP NNP O
, , O
10 CD O
micro JJ O
Ci NN O
32P NN O
- HYPH O
gamma NN O
- HYPH O
ATP NNP O
( -LRB- O
GE NNP O
Healthcare NNP O
) -RRB- O
and CC O
2 CD O
micro NN O
g NN O
isolated VBN O
Cdc25C NN O
peptide NN O
, , O
and CC O
was VBD O
incubated VBN O
at IN O
30 CD O
degrees NNS O
C NN O
for IN O
30 CD O
minutes NNS O
. . O

Samples NNS O
were VBD O
separated VBN O
on IN O
a DT O
12 CD O
. . O
5 CD O
% NN O
polyacrylamide NN O
gel NN O
and CC O
blotted VBN O
on IN O
to IN O
a DT O
nitrocellulose NN O
membrane NN O
. . O

A DT O
radiosensitive JJ O
imaging NN O
plate NN O
was VBD O
exposed VBN O
to IN O
the DT O
membrane NN O
and CC O
the DT O
plate NN O
was VBD O
read VBN O
in IN O
a DT O
FLA200 NN O
imager NN O
( , O
Fuji NNP O
) -RRB- O
. . O

The DT O
kinase NN O
assay NN O
described VBN O
above RB O
was VBD O
also RB O
used VBN O
to TO O
determine VB O
the DT O
Chk2 NNP O
mutants NNS O
' POS O
kinase NN O
activity NN O
after IN O
co NN O
- HYPH O
transfection NN O
of IN O
each DT O
Chk2 NNP O
mutant NN O
and CC O
wild JJ O
- HYPH O
type NN O
Chk2 NN O
in IN O
equal JJ O
amounts NNS O
. . O

Statistical NNP O
Analysis NNP O

Statistical JJ O
analysis NN O
was VBD O
performed VBN O
using VBG O
the DT O
Primer NNP O
of IN O
Biostatistics NNP O
system NN O
, , O
version NN O
5 CD O
. . O
0 CD O
[ -LRB- O
38 CD O
] -RRB- O
. . O

The DT O
differences NNS O
in IN O
the DT O
distribution NN O
of IN O
TP53 NN O
and CC O
CHEK2 NNP O
mutations NNS O
among IN O
patients NNS B-Species
revealing VBG O
a DT O
PD NN O
and CC O
the DT O
responders NNS O
were VBD O
analyzed VBN O
with IN O
use NN O
of IN O
Fisher NNP O
' POS O
s POS O
exact JJ O
test NN O
. . O

P NN O
- HYPH O
values NNS O
are VBP O
reported VBN O
as IN O
accumulated VBN O
two CD O
- HYPH O
sided JJ O
. . O

Because IN O
of IN O
the DT O
limited JJ O
time NN O
of IN O
the DT O
follow NN O
- HYPH O
up NN O
, , O
no DT O
formal JJ O
statistical JJ O
assessment NN O
of IN O
overall JJ O
survival NN O
was VBD O
performed VBN O
. . O

Relapse NN O
- HYPH O
free JJ O
survival NN O
was VBD O
analyzed VBN O
by IN O
the DT O
log NN O
- HYPH O
rank NN O
test NN O
. . O

Details NNS O
regarding VBG O
outcome NN O
in IN O
individual JJ O
patients NNS B-Species
with IN O
mutations NNS O
are VBP O
shown VBN O
in IN O
Table NNP O
2 CD O
and CC O
3 CD O
to TO O
make VB O
them PRP O
available JJ O
to IN O
the DT O
reader NN O
. . O

Results NNS O

TP53 NN O
Mutations NNS O
and CC O
Response NN O
to IN O
Therapy NN O

The DT O
TP53 NNP O
mutations NNS O
identified VBN O
in IN O
the DT O
tumors NNS O
of IN O
the DT O
patients NNS B-Species
treated VBN O
with IN O
epirubicin NN O
together RB O
with IN O
the DT O
clinical JJ O
response NN O
to IN O
therapy NN O
and CC O
follow NN O
- HYPH O
up NN O
data NNS O
are VBP O
presented VBN O
in IN O
Table NNP O
2 CD O
. . O

Somatic JJ O
TP53 NN O
mutations NNS O
were VBD O
identified VBN O
in IN O
23 CD O
( SYM O
21 CD O
. . O
5 CD O
% NN O
) -RRB- O
of IN O
the DT O
patients NNS B-Species
. . O

Normal JJ O
tissue NN O
( -LRB- O
WBC NNP O
) -RRB- O
was VBD O
available JJ O
from IN O
18 CD O
of IN O
these DT O
for IN O
germline NN O
characterization NN O
, , O
revealing VBG O
none NN O
of IN O
the DT O
mutations NNS O
identified VBN O
to TO O
be VB O
germline NN O
alterations NNS O
. . O

Of IN O
the DT O
23 CD O
mutations NNS O
detected VBN O
, , O
20 CD O
were VBD O
missense JJ O
and CC O
3 CD O
were VBD O
nonsense NN O
. . O

One CD O
mutation NN O
( -LRB- O
del483CAT NN O
) -RRB- O
has VBZ O
not RB O
been VBN O
reported VBN O
previously RB O
either CC O
in IN O
breast NN O
cancer NN O
or CC O
in IN O
any DT O
other JJ O
tumor NN O
type NN O
( : O
IARC NNP O
database NN O
: : O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
iarc NNP O
. . O
fr XX O
/ SYM O
p53 CD O
/ , O
) -RRB- O
. . O

Twelve CD O
of IN O
the DT O
mutations NNS O
directly RB O
or CC O
indirectly RB O
affected VBD O
the DT O
L2 NNP O
/ SYM O
L3 CD O
domains NNS O
of IN O
the DT O
p53 NN O
protein NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
previous JJ O
found VBN O
to TO O
predict VB O
a DT O
poor JJ O
prognosis NN O
[ -LRB- O
39 CD O
] -RRB- O
and CC O
drug NN O
resistance NN O
[ -LRB- O
14 CD O
] -RRB- O
, , O
[ -LRB- O
40 CD O
] -RRB- O
. . O

For IN O
statistical JJ O
comparison NN O
, , O
mutation NN O
Gly325Ter NNP O
( -LRB- O
patient NN B-Species
Epi215 NNP O
) -RRB- O
located VBN O
to IN O
the DT O
tetramerization NN O
domain NN O
is VBZ O
grouped VBN O
together RB O
with IN O
the DT O
mutations NNS O
affecting VBG O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domain NN O
, , O
since IN O
this DT O
mutation NN O
leads VBZ O
to IN O
truncation NN O
of IN O
the DT O
protein NN O
and CC O
with IN O
loss NN O
of IN O
tetramerization NN O
and CC O
functional JJ O
defects NNS O
similar JJ O
to IN O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
[ -LRB- O
41 CD O
] -RRB- O
. . O

There EX O
was VBD O
a DT O
statistical JJ O
significant JJ O
correlation NN O
between IN O
TP53 NN O
mutation NN O
status NN O
and CC O
lack NN O
of IN O
treatment NN O
response NN O
( -LRB- O
PD NN O
) -RRB- O
( , O
Table NN O
4 CD O
; : O
p NN O
= SYM O
0 CD O
. . O
358 CD O
; : O
Fisher NNP O
exact JJ O
test NN O
) -RRB- O
. . O

When WRB O
tumors NNS O
harboring VBG O
TP53 NNP O
mutations NNS O
affecting VBG O
the DT O
p53 NN O
L2 NNP O
/ SYM O
L3 NNP O
DNA NN O
- HYPH O
binding VBG O
domains NNS O
were VBD O
compared VBN O
to IN O
those DT O
with IN O
wild JJ O
- HYPH O
type NN O
TP53 NN O
or CC O
TP53 NN O
mutations NNS O
outside IN O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domains NNS O
, , O
this DT O
correlation NN O
was VBD O
further RB O
strengthened VBN O
( : O
p NN O
= SYM O
0 CD O
. . O
136 CD O
) -RRB- O
. . O

The DT O
previously RB O
described VBN O
TP53 NNP O
polymorphism NN O
, , O
Arg72Pro NNP O
[ -LRB- O
42 CD O
] -RRB- O
was VBD O
detected VBN O
in IN O
31 CD O
( SYM O
29 CD O
% NN O
) -RRB- O
of IN O
our PRP$ O
patients NNS B-Species
. . O

No DT O
correlation NN O
was VBD O
found VBN O
between IN O
this DT O
polymorphism NN O
and CC O
lack NN O
of IN O
treatment NN O
response NN O
( , O
p NN O
= SYM O
0 CD O
. . O
2750 CD O
; : O
Fisher NN O
exact JJ O
test NN O
) -RRB- O
or CC O
TP53 NN O
mutational JJ O
status NN O
( : O
p NN O
= SYM O
0 CD O
. . O
2024 CD O
) -RRB- O
. . O

CHEK2 NN O
Mutations NNS O
and CC O
Response NN O
to IN O
Therapy NN O

Table NNP O
3 CD O
presents VBZ O
the DT O
patients NNS B-Species
with IN O
detected VBN O
CHEK2 NNP O
mutations NNS O
together RB O
with IN O
a DT O
description NN O
of IN O
the DT O
clinical JJ O
response NN O
and CC O
follow NN O
up IN O
- HYPH O
data NNS O
. . O

CHEK2 NNP O
mutations NNS O
were VBD O
identified VBN O
in IN O
three CD O
out IN O
of IN O
the DT O
109 CD O
patients NNS B-Species
( , O
2 CD O
. . O
8 CD O
% NN O
) -RRB- O
. . O

Notably RB O
, , O
each DT O
of IN O
the DT O
CHEK2 NNP O
mutations NNS O
identified VBN O
was VBD O
also RB O
present JJ O
in IN O
patient JJ B-Species
lymphocyte NN O
DNA NN O
, , O
confirming VBG O
a DT O
germline NN O
origin NN O
. . O

The DT O
Arg95Ter NNP O
( -LRB- O
C283T NNP O
) -RRB- O
mutation NN O
is VBZ O
novel JJ O
. . O

This DT O
mutation NN O
was VBD O
present JJ O
in IN O
two CD O
patients NNS B-Species
( , O
Epi132 NNP O
and CC O
Epi203 NNP O
) -RRB- O
living VBG O
in IN O
different JJ O
parts NNS O
of IN O
Norway NNP O
with IN O
no DT O
known VBN O
family NN O
relationship NN O
. . O

However RB O
, , O
linkage NN O
analysis NN O
using VBG O
microsatellite NN O
markers NNS O
( -LRB- O
D22S275 NNP O
, , O
D22S272 NNP O
, , O
D22S1172 CD O
and CC O
D22S423 CD O
) -RRB- O
suggested VBD O
a DT O
common JJ O
founder NN O
mutation NN O
( , O
data NNS O
not RB O
shown VBN O
) : O
. . O

The DT O
C283T NNP O
transition NN O
generates VBZ O
a DT O
novel JJ O
stop NN O
codon NN O
in IN O
exon NN O
1 CD O
of IN O
CHEK2 NNP O
, , O
leading VBG O
to IN O
truncation NN O
of IN O
the DT O
Chk2 NNP O
protein NN O
. . O

LOH NNP O
analysis NN O
indicated VBD O
loss NN O
of IN O
the DT O
wild JJ O
- HYPH O
type NN O
CHEK2 NNP O
allele NN O
in IN O
the DT O
both DT O
tumors NNS O
from IN O
the DT O
two CD O
patients NNS B-Species
harboring VBG O
this DT O
mutation NN O
( , O
Epi132 NNP O
and CC O
Epi203 NNP O
) -RRB- O
. . O

Both PDT O
these DT O
tumors NNS O
were VBD O
non RB O
- HYPH O
responsive JJ O
to IN O
epirubicin NN O
therapy NN O
( -LRB- O
PD NN O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
the DT O
third JJ O
patient NN B-Species
with IN O
a DT O
germline NN O
CHEK2 NN O
mutation NN O
( -LRB- O
patient JJ B-Species
Epi151 NN O
; : O
point NN O
mutation NN O
at IN O
T1091C NNP O
, , O
Ile364Thr NNP O
) -RRB- O
had VBD O
a DT O
partial JJ O
response NN O
to IN O
epirubicin NN O
therapy NN O
. . O

This DT O
tumor NN O
was VBD O
non RB O
- HYPH O
informative JJ O
with IN O
respect NN O
to IN O
LOH NNP O
. . O

Taking VBG O
all DT O
CHEK2 NNP O
mutations NNS O
together RB O
, , O
they PRP O
predicted VBD O
resistance NN O
to IN O
epirubicin NN O
( , O
p NN O
= SYM O
0 CD O
. . O
226 CD O
) -RRB- O
. . O

The DT O
previously RB O
described VBN O
silent JJ O
Glu84Glu NNP O
( -LRB- O
A252G NNP O
) -RRB- O
polymorphism NN O
[ -LRB- O
24 CD O
] -RRB- O
, , O
[ -LRB- O
43 CD O
] -RRB- O
in IN O
exon NN O
1 CD O
was VBD O
detected VBN O
in IN O
two CD O
( SYM O
1 CD O
. . O
9 CD O
% NN O
) -RRB- O
patients NNS B-Species
. . O

No DT O
association NN O
between IN O
this DT O
polymorphism NN O
and CC O
treatment NN O
response NN O
was VBD O
recorded VBN O
. . O

One CD O
of IN O
the DT O
tumors NNS O
( -LRB- O
Epi203 NNP O
) -RRB- O
harboring VBG O
the DT O
C283T NNP O
substitution NN O
( , O
Arg95Ter NNP O
) -RRB- O
also RB O
harbored VBD O
a DT O
somatic JJ O
TP53 NN O
mutation NN O
in IN O
codon NN O
175 CD O
, , O
Arg175His NNP O
, , O
located VBN O
in IN O
the DT O
L2 NNP O
domain NN O
of IN O
p53 NN O
( , O
Table NNP O
2 CD O
) -RRB- O
. . O

This DT O
mutation NN O
was VBD O
detected VBN O
in IN O
another DT O
four CD O
of IN O
our PRP$ O
patients NNS B-Species
treated VBN O
with IN O
epirubicin NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

In IN O
addition NN O
, , O
TP53 NNP O
Arg175His NNP O
mutation NN O
was VBD O
recorded VBN O
in IN O
one CD O
patient NN B-Species
of IN O
our PRP$ O
previous JJ O
study NN O
evaluating VBG O
response NN O
to IN O
doxorubicin NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

The DT O
fact NN O
that IN O
none NN O
of IN O
the DT O
Arg175His NNP O
patients NNS B-Species
presented VBN O
here RB O
or CC O
in IN O
our PRP$ O
previous JJ O
study NN O
revealed VBD O
resistance NN O
to IN O
therapy NN O
( -LRB- O
PD NN O
) -RRB- O
suggests VBZ O
this DT O
mutation NN O
may MD O
not RB O
cause VB O
resistance NN O
to IN O
anthracyclines NNS O
in IN O
breast NN O
cancers NNS O
in IN O
vivo NN O
. . O

Omitting VBG O
the DT O
tumor NN O
harboring VBG O
both CC O
a DT O
CHEK2 NN O
and CC O
a DT O
TP53 NN O
mutation NN O
( -LRB- O
patient NN B-Species
Epi203 NNP O
) -RRB- O
from IN O
statistical JJ O
analysis NN O
, , O
Chk2 NNP O
mutations NNS O
( , O
n CD O
= SYM O
2 CD O
) -RRB- O
were VBD O
non NN O
- HYPH O
significantly RB O
associated VBN O
with IN O
therapy NN O
resistance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
1633 CD O
) -RRB- O
. . O

In IN O
a DT O
previous JJ O
study NN O
[ -LRB- O
26 CD O
] -RRB- O
, , O
however RB O
, , O
we PRP O
analyzed VBD O
for IN O
CHEK2 NNP O
mutation NN O
status NN O
in IN O
relation NN O
to IN O
therapy NN O
outcome NN O
in IN O
a DT O
cohort NN O
of IN O
patients NNS B-Species
from IN O
doxorubicin NN O
study NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

In IN O
that DT O
study NN O
[ -LRB- O
26 CD O
] -RRB- O
, , O
we PRP O
detected VBD O
the DT O
previously RB O
identified VBN O
mutation NN O
Ile157Thr NNP O
. . O

In IN O
addition NN O
, , O
we PRP O
detected VBD O
a DT O
novel JJ O
nonsense NN O
somatic JJ O
mutation NN O
( -LRB- O
1368InsA NN O
) -RRB- O
. . O

This DT O
mutation NN O
was VBD O
associated VBN O
with IN O
lack NN O
of IN O
function NN O
in IN O
vitro NN O
; , O
moreover RB O
, , O
it PRP O
was VBD O
associated VBN O
with IN O
drug NN O
resistance NN O
in IN O
vivo NN O
. . O

Analyzing VBG O
our PRP$ O
material NN O
and CC O
this DT O
cohort NN O
[ -LRB- O
26 CD O
] -RRB- O
together RB O
, , O
( , O
n CD O
= SYM O
160 CD O
) -RRB- O
, , O
CHEK2 NNP O
mutations NNS O
( , O
n CD O
= SYM O
5 CD O
in IN O
total NN O
) -RRB- O
predicted VBN O
for IN O
resistance NN O
to IN O
doxorubicin NN O
and CC O
epirubicin NN O
therapy NN O
( : O
p NN O
= SYM O
0 CD O
. . O
123 CD O
) -RRB- O
. . O

Even RB O
though IN O
, , O
excluding VBG O
patient JJ B-Species
Epi203 NNP O
( , O
harboring VBG O
TP53 NNP O
Arg175His NNP O
and CC O
Arg95Ter NNP O
CHEK2 NNP O
mutation NN O
) , O
as RB O
well RB O
as IN O
other JJ O
patients NNS B-Species
harboring VBG O
TP53 NNP O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
( , O
n CD O
= SYM O
129 CD O
) -RRB- O
, , O
CHEK2 NNP O
mutations NNS O
( , O
n CD O
= SYM O
4 CD O
in IN O
total NN O
) -RRB- O
predicted VBN O
for IN O
resistance NN O
to IN O
doxorubicin NN O
and CC O
epirubicin NN O
therapy NN O
( : O
p NN O
= SYM O
0 CD O
. . O
30 CD O
) -RRB- O
. . O

TP53 NN O
and CC O
CHEK2 NN O
Mutations NNS O
Combined VBN O
and CC O
Response NN O
to IN O
Therapy NN O

Assuming VBG O
that IN O
TP53 NN O
and CC O
CHEK2 NNP O
mutations NNS O
may MD O
substitute VB O
for IN O
each DT O
other JJ O
, , O
we PRP O
analyzed VBD O
for IN O
the DT O
predictive JJ O
effect NN O
of IN O
mutations NNS O
in IN O
both DT O
genes NNS O
. . O

The DT O
occurrence NN O
of IN O
a DT O
mutation NN O
affecting VBG O
either CC O
CHEK2 NNP O
or CC O
TP53 NN O
strongly RB O
predicted VBN O
therapy NN O
resistance NN O
( : O
p NN O
= SYM O
0 CD O
. . O
101 CD O
; : O
Fisher NNP O
exact JJ O
test NN O
) -RRB- O
. . O

When WRB O
tumors NNS O
harboring VBG O
TP53 NNP O
- HYPH O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
and CC O
CHEK2 NNP O
mutations NNS O
were VBD O
compared VBN O
with IN O
those DT O
wild JJ O
- HYPH O
type NN O
or CC O
TP53 NN O
mutations NNS O
outside IN O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domain NN O
, , O
the DT O
correlation NN O
was VBD O
further RB O
strengthened VBN O
( : O
p NN O
= SYM O
0 CD O
. . O
32 CD O
; : O
Fisher NNP O
exact JJ O
test NN O
) -RRB- O
. . O

The DT O
significance NN O
was VBD O
preserved VBN O
when WRB O
comparing VBG O
patients NNS B-Species
with IN O
a DT O
PD NN O
to IN O
objective JJ O
responders NNS O
( , O
CR NN O
and CC O
PR NN O
) -RRB- O
excluding VBG O
patients NNS B-Species
with IN O
stable JJ O
disease NN O
( -LRB- O
SD NN O
) -RRB- O
from IN O
the DT O
statistical JJ O
analysis NN O
( -LRB- O
Table NNP O
4 CD O
) -RRB- O
. . O

p14 NN O
( : O
ARF NN O
) -RRB- O
Mutations NNS O
and CC O
Promoter NN O
Methylations NNS O

Neither CC O
mutations NNS O
nor CC O
polymorphisms NNS O
in IN O
the DT O
coding VBG O
region NN O
of IN O
p14 NN O
( -LRB- O
ARF NNP O
) -RRB- O
were VBD O
observed VBN O
among IN O
the DT O
107 CD O
patients NNS B-Species
analyzed VBN O
. . O

Likewise RB O
, , O
no DT O
promoter NN O
methylations NNS O
were VBD O
detected VBN O
. . O

Influence NN O
of IN O
CHEK2 NN O
and CC O
TP53 NN O
Mutation NN O
Status NN O
on IN O
Relapse NN O
- HYPH O
Free JJ O
Survival NN O

Because IN O
of IN O
the DT O
limited JJ O
time NN O
of IN O
the DT O
follow NN O
- HYPH O
up NN O
, , O
no DT O
formal JJ O
statistical JJ O
assessment NN O
of IN O
overall JJ O
survival NN O
was VBD O
performed VBN O
. . O

Details NNS O
regarding VBG O
outcome NN O
for IN O
individual JJ O
patients NNS B-Species
with IN O
mutations NNS O
are VBP O
described VBN O
in IN O
Table NNP O
2 CD O
and CC O
3 CD O
to TO O
make VB O
these DT O
data NNS O
available JJ O
to IN O
the DT O
reader NN O
. . O

Relapse NN O
- HYPH O
free JJ O
survival NN O
is VBZ O
depicted VBN O
in IN O
( : O
Figure NN O
1 CD O
) -RRB- O
. . O

Figure NN O
1A NN O
shows VBZ O
relapse NN O
- HYPH O
free JJ O
survival NN O
for IN O
the DT O
patients NNS B-Species
with IN O
TP53 NNP O
and CC O
CHEK2 NNP O
mutations NNS O
( , O
all DT O
mutations NNS O
found VBN O
) , O
compared VBN O
to IN O
patients NNS B-Species
without IN O
any DT O
TP53 NN O
or CC O
CHEK2 NNP O
mutations NNS O
, , O
no DT O
difference NN O
in IN O
relapse NN O
- HYPH O
free JJ O
survival NN O
was VBD O
observed VBN O
. . O

Similar JJ O
, , O
no DT O
difference NN O
was VBD O
seen VBN O
when WRB O
grouping VBG O
TP53 NN O
mutations NNS O
outside IN O
L2 NNP O
/ SYM O
L3 NNP O
and CC O
CHEK2 NNP O
mutation NN O
not RB O
affecting VBG O
kinase NN O
function NN O
( -LRB- O
Ile364Thr NNP O
) -RRB- O
as IN O
wild JJ O
- HYPH O
type NN O
( -LRB- O
Figure NN O
1B NN O
) -RRB- O
. . O

Grouping VBG O
tumors NNS O
harboring VBG O
a DT O
mutation NN O
in IN O
L2 NNP O
/ SYM O
L3 NNP O
together RB O
with IN O
CHEK2 NNP O
mutations NNS O
affecting VBG O
kinase NN O
domain NN O
( , O
Arg95Ter NNP O
) -RRB- O
in IN O
one CD O
group NN O
, , O
mutations NNS O
outside IN O
TP53 NNP O
L2 NNP O
/ SYM O
L3 NNP O
and CC O
Ile364Thr NNP O
as IN O
one CD O
group NN O
and CC O
tumors NNS O
without IN O
any DT O
found VBN O
mutations NNS O
in IN O
TP53 NN O
and CC O
CHEK2 NNP O
separately RB O
, , O
again RB O
no DT O
noticeably RB O
difference NN O
in IN O
relapse NN O
- HYPH O
free JJ O
survival NN O
were VBD O
seen VBN O
( -LRB- O
Figure NNP O
1C NNP O
) -RRB- O
. . O

Notably RB O
, , O
in IN O
addition NN O
to IN O
a DT O
short JJ O
median JJ O
follow NN O
- HYPH O
up NN O
time NN O
, , O
a DT O
total NN O
of IN O
35 CD O
patients NNS B-Species
with IN O
a DT O
sub NN O
- HYPH O
optimal JJ O
response NN O
to IN O
epirubicin NN O
received VBD O
subsequent JJ O
treatment NN O
with IN O
paclitaxel NN O
, , O
which WDT O
may MD O
have VB O
influenced VBN O
the DT O
outcome NN O
. . O

CHEK2 NNP O
Mutant NNP O
' POS O
s NN O
Capability NN O
to TO O
Form VB O
Dimers NNS O

To TO O
investigate VB O
whether IN O
the DT O
identified VBN O
CHEK2 NNP O
mutations NNS O
affect VBP O
the DT O
ability NN O
of IN O
the DT O
Chk2 NNP O
protein NN O
to TO O
form VB O
dimers NNS O
, , O
co NN O
- HYPH O
transfection NN O
and CC O
immunopresipitation NN O
of IN O
V5 NNP O
- HYPH O
tagged VBN O
mutants NNS O
and CC O
Xpress NNP O
- HYPH O
tagged VBN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
were VBD O
performed VBN O
using VBG O
CHEK2 NNP O
low RB O
- HYPH O
expressing VBG O
U NNP O
- HYPH O
2 CD O
- HYPH O
OS NNP O
cells NNS O
. . O

As IN O
we PRP O
identified VBD O
the DT O
previously RB O
characterized VBN O
CHEK2 NNP O
germline NN O
mutants NNS O
variants NNS O
Arg117His NNP O
( , O
n CD O
= SYM O
2 CD O
and CC O
Ile157Thr NNP O
( , O
n CD O
= SYM O
1 CD O
) -RRB- O
among IN O
patients NNS B-Species
allocated VBN O
to IN O
primary JJ O
treatment NN O
with IN O
paclitaxel NN O
in IN O
our PRP$ O
ongoing JJ O
study NN O
, , O
these DT O
mutants NNS O
were VBD O
evaluated VBN O
together RB O
with IN O
Arg95Ter NNP O
and CC O
Ile364Thr NNP O
. . O

The DT O
results NNS O
presented VBN O
in IN O
Figure NN O
2 CD O
show VBP O
that IN O
all DT O
Chk2 NNP O
variants NNS O
carrying VBG O
a DT O
point NN O
mutation NN O
were VBD O
able JJ O
to TO O
form VB O
dimers NNS O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
, , O
whereas IN O
the DT O
Arg95Ter NNP O
variant NN O
was VBD O
not RB O
. . O

Kinase NNP O
Activity NN O
of IN O
CHEK2 NNP O
Mutants NNPS O

To TO O
investigate VB O
whether IN O
the DT O
identified VBN O
CHEK2 NNP O
mutants NNS O
retained VBD O
the DT O
wild JJ O
- HYPH O
type NN O
kinase NN O
activity NN O
, , O
an DT O
in FW O
vitro FW O
Chk2 NNP O
kinase NN O
assay NN O
with IN O
respect NN O
to IN O
Chk2 NNP O
autophosphorylation NN O
and CC O
Cdc25 NN O
substrate NN O
phosphorylation NN O
was VBD O
performed VBN O
. . O

The DT O
U NNP O
- HYPH O
2 CD O
- HYPH O
OS NNP O
cells NNS O
were VBD O
preferred VBN O
for IN O
this DT O
assay NN O
because IN O
they PRP O
were VBD O
previously RB O
found VBN O
to TO O
express VB O
only RB O
low JJ O
levels NNS O
of IN O
endogenous JJ O
Chk2 NNP O
[ -LRB- O
44 CD O
] -RRB- O
. . O

This DT O
was VBD O
confirmed VBN O
by IN O
us PRP O
using VBG O
an DT O
antibody NN O
recognizing VBG O
endogenous JJ O
protein NN O
( , O
data NNS O
not RB O
shown VBN O
) NFP O
. . O

These DT O
cells NNS O
have VBP O
previously RB O
been VBN O
used VBN O
by IN O
other JJ O
investigators NNS O
to TO O
study VB O
Chk2 NNP O
kinase NN O
activity NN O
[ -LRB- O
44 CD O
] -RRB- O
, , O
[ -LRB- O
45 CD O
] -RRB- O
, , O
[ -LRB- O
46 CD O
] -RRB- O
. . O

The DT O
two CD O
mutants NNS O
Arg117Gly NNP O
and CC O
Ile157Thr NNP O
were VBD O
previously RB O
tested VBN O
for IN O
in FW O
vitro FW O
kinase NN O
activity NN O
[ -LRB- O
47 CD O
] -RRB- O
, , O
but CC O
were VBD O
both DT O
included VBN O
here RB O
, , O
together RB O
with IN O
wild JJ O
- HYPH O
type NN O
CHEK2 NNP O
as IN O
controls NNS O
. . O

Compared VBN O
to IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
, , O
the DT O
Ile157Thr NNP O
mutant NN O
retained VBD O
wild JJ O
- HYPH O
type NN O
kinase NN O
activity NN O
. . O

The DT O
mutant JJ O
Ile364Thr NNP O
showed VBD O
partially RB O
reduced VBN O
kinase NN O
activity NN O
both CC O
in IN O
term NN O
of IN O
Cdc25 NN O
- HYPH O
phosphorylation NN O
and CC O
autophosphorylation NN O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
the DT O
mutant NN O
Arg117Gly NNP O
showed VBD O
strongly RB O
reduced VBN O
kinase NN O
activity NN O
while IN O
the DT O
Arg95Ter NNP O
mutant NN O
was VBD O
totally RB O
devoid JJ O
of IN O
any DT O
Chk2 NNP O
kinase NN O
activity NN O
. . O

The DT O
activity NN O
recorded VBN O
for IN O
Ile157Thr NNP O
and CC O
Arg117Gly NNP O
was VBD O
consistent JJ O
with IN O
previously RB O
reported VBN O
results NNS O
for IN O
these DT O
two CD O
mutants NNS O
[ -LRB- O
47 CD O
] -RRB- O
. . O

Notably RB O
, , O
there EX O
was VBD O
an DT O
internal JJ O
consistency NN O
with IN O
respect NN O
to IN O
percentage NN O
activity NN O
reduction NN O
comparing VBG O
individual JJ O
mutants NNS O
with IN O
respect NN O
to IN O
autophosphorylation NN O
and CC O
phosphorylation NN O
of IN O
Cdc25 NNP O
( -LRB- O
Figure NN O
3 CD O
) -RRB- O
. . O

Since IN O
enzymatically RB O
active JJ O
Chk2 NNP O
exists VBZ O
as IN O
dimers NNS O
, , O
it PRP O
was VBD O
important JJ O
to TO O
determine VB O
the DT O
effect NN O
of IN O
Chk2 NNP O
mutants NNS O
on IN O
wild JJ O
- HYPH O
type NN O
/ SYM O
mutant JJ O
heterodimer NN O
kinase NN O
activity NN O
. . O

The DT O
effect NN O
on IN O
Chk2 NNP O
kinase NN O
activities NNS O
( -LRB- O
Chk2 NNP O
autophosphorylation NN O
and CC O
Cdc25 NN O
substrate NN O
phosphorylation NN O
) -RRB- O
of IN O
the DT O
individual JJ O
mutants NNS O
were VBD O
therefore RB O
determined VBN O
after IN O
co NN O
- HYPH O
transfection NN O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
. . O

The DT O
results NNS O
from IN O
this DT O
co NN O
- HYPH O
transfection NN O
- HYPH O
kinase NN O
assay NN O
( -LRB- O
Figure NNP O
4 CD O
) -RRB- O
were VBD O
similar JJ O
to IN O
those DT O
of IN O
the DT O
single JJ O
- HYPH O
transfection NN O
assay NN O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
except IN O
in IN O
the DT O
case NN O
of IN O
the DT O
Arg117Gly NNP O
mutant NN O
, , O
which WDT O
expressed VBD O
a DT O
substantial JJ O
kinase NN O
activity NN O
when WRB O
complexed VBN O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
previous JJ O
data NNS O
indicating VBG O
that IN O
the DT O
Arg117Gly NNP O
mutant NN O
has VBZ O
neglectable JJ O
kinase NN O
activity NN O
itself PRP O
but CC O
dimerizes VBZ O
efficiently RB O
to IN O
Chk2 NNP O
wild JJ O
- HYPH O
type NN O
without IN O
strongly RB O
affecting VBG O
the DT O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
activity NN O
. . O

Hence RB O
, , O
the DT O
activity NN O
detected VBN O
is VBZ O
probably RB O
caused VBN O
by IN O
the DT O
co NN O
- HYPH O
transfected VBN O
and CC O
co NN O
- HYPH O
precipitated VBN O
wild JJ O
- HYPH O
type NN O
protein NN O
. . O

To TO O
rule VB O
out RP O
the DT O
possibility NN O
that IN O
endogenously RB O
expressed VBN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
contributed VBD O
to IN O
observed JJ O
Arg117Gly NNP O
kinase NN O
activity NN O
shown VBN O
in IN O
Figure NNP O
4 CD O
, , O
we PRP O
compared VBD O
the DT O
Arg117Gly NNP O
variant JJ O
activity NN O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
co NN O
- HYPH O
transfected VBN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
to IN O
the DT O
activities NNS O
of IN O
Arg95Ter NNP O
under IN O
the DT O
same JJ O
conditions NNS O
. . O

The DT O
Arg95Ter NNP O
variant NN O
does VBZ O
not RB O
form VB O
dimers NNS O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
. . O

As IN O
seen VBN O
in IN O
Figure NNP O
5 CD O
, , O
Arg117Gly NNP O
, , O
which WDT O
forms VBZ O
dimers NNS O
with IN O
Chk2 NNP O
wild JJ O
- HYPH O
type NN O
, , O
allows VBZ O
increased JJ O
activity NN O
when WRB O
co NN O
- HYPH O
transfected VBN O
with IN O
wild JJ O
- HYPH O
type NN O
as IN O
compared VBN O
to IN O
the DT O
corresponding VBG O
activity NN O
for IN O
the DT O
Arg95Ter NNP O
mutant NN O
. . O

The DT O
fact NN O
that IN O
Arg117Gly NNP O
, , O
when WRB O
transfected VBN O
alone RB O
, , O
displays VBZ O
very RB O
similar JJ O
activity NN O
as IN O
Arg95Ter NNP O
or CC O
negative JJ O
control NN O
( , O
background NN O
levels NNS O
) -RRB- O
, , O
strongly RB O
indicates VBZ O
that IN O
the DT O
contribution NN O
of IN O
endogenous JJ O
Chk2 NNP O
, , O
which WDT O
, , O
similarly RB O
to IN O
exogenously RB O
expressed VBN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
co NN O
- HYPH O
precipitate NN O
with IN O
Arg117Gly NNP O
is VBZ O
non RB O
- HYPH O
significant JJ O
. . O

Family NN O
Cancer NN O
Incidence NN O
in IN O
Relation NN O
to IN O
CHEK2 NN O
Germline NN O
Mutations NNS O

Following VBG O
an DT O
initial JJ O
report NN O
of IN O
a DT O
family NN O
with IN O
a DT O
CHEK2 NNP O
germline NN O
mutation NN O
expressing VBG O
an DT O
increased JJ O
cancer NN O
incidence NN O
resembling VBG O
the DT O
Li NNP O
- HYPH O
Fraumeni NNP O
syndrome NN O
[ -LRB- O
24 CD O
] -RRB- O
, , O
recent JJ O
studies NNS O
have VBP O
revealed VBN O
the DT O
more RBR O
common JJ O
CHEK2 NN O
mutations NNS O
to TO O
be VB O
associated VBN O
with IN O
a DT O
moderately RB O
increased VBN O
risk NN O
of IN O
breast NN O
and CC O
colorectal JJ O
cancers NNS O
. . O

We PRP O
hypothesized VBD O
that IN O
CHEK2 NNP O
mutations NNS O
having VBG O
a DT O
detrimental JJ O
effect NN O
on IN O
drug NN O
sensitivity NN O
could MD O
be VB O
associated VBN O
with IN O
a DT O
more RBR O
aggressive JJ O
, , O
Li NNP O
- HYPH O
Fraumeni NNP O
or CC O
a DT O
Li NNP O
- HYPH O
Fraumeni NNP O
- HYPH O
like JJ O
( -LRB- O
LFL NNP O
) , O
cancer NN O
syndrome NN O
[ -LRB- O
48 CD O
] -RRB- O
. . O

Except IN O
from IN O
the DT O
patient NN B-Species
harboring VBG O
the DT O
Ile364Thr NNP O
mutation NN O
who WP O
did VBD O
not RB O
have VB O
any DT O
known VBN O
congestion NN O
of IN O
cancer NN O
disease NN O
in IN O
the DT O
family NN O
, , O
a DT O
detailed VBN O
assessment NN O
of IN O
family NN O
cancer NN O
history NN O
was VBD O
performed VBN O
for IN O
each DT O
patient NN B-Species
harboring VBG O
a DT O
germline NN O
CHEK2 NNP O
mutation NN O
. . O

The DT O
family NN O
cancer NN O
pedigrees NNS O
are VBP O
depicted VBN O
in IN O
Figure NNP O
6 CD O
. . O

While IN O
patients NNS B-Species
harboring VBG O
CHEK2 NNP O
germline NN O
mutations NNS O
revealed VBD O
different JJ O
types NNS O
of IN O
cancers NNS O
( , O
mainly RB O
breast NN O
and CC O
tumors NNS O
of IN O
the DT O
gastrointestinal JJ O
area NN O
) , O
in IN O
their PRP$ O
family NN O
, , O
surprisingly RB O
, , O
no DT O
distinct JJ O
pattern NN O
discriminating VBG O
families NNS O
harboring VBG O
the DT O
Arg95Ter NNP O
mutation NN O
from IN O
the DT O
other JJ O
CHEK2 NNP O
mutated VBN O
families NNS O
could MD O
be VB O
identified VBN O
. . O

One CD O
of IN O
them PRP O
( , O
Epi203 NNP O
) -RRB- O
, , O
who WP O
inherited VBD O
the DT O
mutation NN O
from IN O
her PRP$ O
father NN O
' POS O
s NNS O
side NN O
of IN O
the DT O
family NN O
, , O
had VBD O
no DT O
accumulation NN O
of IN O
either CC O
breast NN O
or CC O
colorectal JJ O
cancer NN O
on IN O
that DT O
side NN O
. . O

It PRP O
should MD O
be VB O
noted VBN O
, , O
however RB O
, , O
that IN O
two CD O
brothers NNS O
of IN O
her PRP$ O
fathers NNS O
mother NN O
had VBD O
prostate NN O
cancer NN O
, , O
and CC O
two CD O
siblings NNS O
of IN O
his PRP$ O
father NN O
having VBG O
hepatocellular JJ O
carcinoma NN O
and CC O
bladder NN O
cancer NN O
, , O
respectively RB O
) -RRB- O
, , O
while IN O
the DT O
other JJ O
expressed VBD O
a DT O
disease NN O
pattern NN O
resembling VBG O
what WP O
has VBZ O
been VBN O
seen VBN O
with IN O
the DT O
more RBR O
common JJ O
CHEK2 NNP O
mutations NNS O
, , O
like IN O
del1100C NNP O
[ -LRB- O
25 CD O
] -RRB- O
. . O

Discussion NN O

TP53 NNP O
plays VBZ O
a DT O
key JJ O
role NN O
as IN O
a DT O
tumor NN O
suppressor NN O
gene NN O
. . O

Its PRP$ O
protein NN O
product NN O
activates VBZ O
processes NNS O
such JJ O
as IN O
growth NN O
arrest NN O
, , O
DNA NN O
repair NN O
, , O
apoptosis NN O
and CC O
/ SYM O
or CC O
senescence NN O
in IN O
response NN O
to IN O
genotoxic JJ O
damage NN O
as RB O
well RB O
as IN O
oncogene NN O
activity NN O
[ -LRB- O
49 CD O
] -RRB- O
, , O
[ -LRB- O
50 CD O
] -RRB- O
. . O

Despite IN O
being VBG O
extensively RB O
studied VBN O
, , O
critical JJ O
issues NNS O
regarding VBG O
regulation NN O
of IN O
the DT O
p53 NN O
protein NN O
remain VBP O
poorly RB O
understood VBN O
, , O
and CC O
conflicting VBG O
evidence NN O
obtained VBN O
in IN O
different JJ O
experimental JJ O
systems NNS O
make VBP O
the DT O
clinical JJ O
relevance NN O
of IN O
experimental JJ O
data NNS O
questionable JJ O
. . O

Chemoresistance NN O
is VBZ O
the DT O
main JJ O
obstacle NN O
to IN O
cancer NN O
cure NN O
in IN O
most JJS O
malignancies NNS O
, , O
including VBG O
breast NN O
cancer NN O
. . O

Previously RB O
, , O
we PRP O
found VBD O
TP53 NN O
mutations NNS O
affecting VBG O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
DNA NNP O
binding NN O
domain NN O
to TO O
be VB O
associated VBN O
with IN O
lack NN O
of IN O
responsiveness NN O
to IN O
doxorubicin NN O
monotherapy NN O
[ -LRB- O
13 CD O
] -RRB- O
as RB O
well RB O
as IN O
mitomycin NN O
and CC O
5 CD O
- HYPH O
fluoro NN O
- HYPH O
uracil NN O
in IN O
concert NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

However RB O
, , O
some DT O
tumors NNS O
revealed VBD O
therapy NN O
resistance NN O
despite IN O
harboring VBG O
wild JJ O
- HYPH O
type NN O
TP53 NN O
. . O

Postulating VBG O
that IN O
these DT O
tumors NNS O
may MD O
harbor VB O
genetic JJ O
disturbances NNS O
in IN O
genes NNS O
playing VBG O
a DT O
key JJ O
role NN O
in IN O
the DT O
p53 NN O
pathway NN O
, , O
we PRP O
here RB O
sequenced VBD O
TP53 NNP O
along IN O
with IN O
CHEK2 NNP O
and CC O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
, , O
the DT O
latter JJ O
two CD O
known VBN O
to TO O
play VB O
a DT O
critical JJ O
role NN O
as IN O
p53 NN O
activators NNS O
, , O
in IN O
tumors NNS O
from IN O
109 CD O
patients NNS B-Species
treated VBN O
with IN O
epirubicin NN O
monotherapy NN O
. . O

Our PRP$ O
results NNS O
confirm VBP O
TP53 NN O
mutations NNS O
, , O
in IN O
particular JJ O
those DT O
affecting VBG O
the DT O
L2 NNP O
/ SYM O
L3 NNP O
domains NNS O
, , O
to TO O
be VB O
associated VBN O
with IN O
drug NN O
resistance NN O
. . O

Most RBS O
importantly RB O
, , O
we PRP O
also RB O
found VBD O
CHEK2 NNP O
mutations NNS O
generating VBG O
a DT O
non JJ O
- HYPH O
functional JJ O
protein NN O
in IN O
our PRP$ O
in FW O
vitro FW O
assays NNS O
to TO O
be VB O
associated VBN O
with IN O
drug NN O
resistance NN O
. . O

In IN O
contrast NN O
, , O
none NN O
of IN O
our PRP$ O
tumors NNS O
harbored VBD O
either CC O
mutations NNS O
or CC O
expressed VBN O
promoter NN O
hypermethylations NNS O
affecting VBG O
the DT O
p14 NN O
. . O

Based VBN O
on IN O
in FW O
vitro FW O
assays NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
classify VB O
the DT O
different JJ O
Chk2 NNP O
mutants NNS O
with IN O
respect NN O
to IN O
dimerization NN O
capability NN O
as RB O
well RB O
as IN O
kinase NN O
activity NN O
( , O
Chk2 NN O
autophosphorylation NN O
and CC O
Cdc25 NN O
substrate NN O
phosphorylation NN O
) -RRB- O
. . O

In IN O
addition NN O
, , O
the DT O
kinase NN O
activities NNS O
of IN O
the DT O
Chk2 NNP O
wild JJ O
- HYPH O
type NN O
/ SYM O
mutant JJ O
complexes NNS O
were VBD O
monitored VBN O
in IN O
co NN O
- HYPH O
transfection NN O
experiments NNS O
. . O

Notably RB O
, , O
each DT O
point NN O
mutation NN O
( , O
except IN O
for IN O
Arg117Gly NNP O
) -RRB- O
revealed VBD O
similar JJ O
relative JJ O
kinase NN O
efficacy NN O
whether IN O
co NN O
- HYPH O
transfected VBN O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
or CC O
not RB O
( -LRB- O
Figure NN O
3 CD O
and CC O
4 CD O
) -RRB- O
. . O

Cells NNS O
co NN O
- HYPH O
transfected VBN O
with IN O
Arg117Gly NNP O
and CC O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
revealed VBD O
kinase NN O
activity NN O
, , O
probably RB O
due JJ O
to IN O
the DT O
contribution NN O
of IN O
the DT O
wild JJ O
type NN O
protein NN O
in IN O
Chk2 NNP O
mutant JJ O
- HYPH O
wild JJ O
- HYPH O
type NN O
heterodimers NNS O
. . O

In IN O
contrast NN O
, , O
cells NNS O
transfected VBN O
with IN O
Arg95Ter NNP O
revealed VBD O
no DT O
kinase NN O
activity NN O
whether IN O
co NN O
- HYPH O
transfected VBN O
with IN O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
or CC O
not RB O
, , O
clearly RB O
distinguishing VBG O
this DT O
mutation NN O
from IN O
the DT O
others NNS O
( -LRB- O
Figure NN O
3 CD O
and CC O
5 CD O
) -RRB- O
. . O

All DT O
in IN O
vitro FW O
assays NNS O
were VBD O
based VBN O
on IN O
transfection NN O
of IN O
the DT O
U NNP O
- HYPH O
2 CD O
- HYPH O
OS NNP O
cell NN O
line NN O
, , O
a DT O
cell NN O
line NN O
known VBN O
to TO O
express VB O
wild JJ O
- HYPH O
type NN O
Chk2 NNP O
at IN O
low JJ O
levels NNS O
, , O
and CC O
previously RB O
used VBN O
by IN O
other JJ O
investigators NNS O
to TO O
study VB O
Chk2 NNP O
activity NN O
[ -LRB- O
44 CD O
] -RRB- O
, , O
[ -LRB- O
45 CD O
] -RRB- O
, , O
[ -LRB- O
46 CD O
] -RRB- O
. . O

Since IN O
we PRP O
were VBD O
not RB O
able JJ O
to TO O
obtain VB O
satisfactory JJ O
technical JJ O
quality NN O
of IN O
the DT O
kinase NN O
assay NN O
in IN O
cell NN O
lines NNS O
negative JJ O
for IN O
Chk2 NNP O
( -LRB- O
HCT NNP O
15 CD O
and CC O
HCT NNP O
116 CD O
) -RRB- O
, , O
we PRP O
assessed VBD O
potential JJ O
background NN O
kinase NN O
activity NN O
due IN O
to IN O
endogenous JJ O
Chk2 NNP O
by IN O
performing VBG O
western JJ O
blot NN O
analysis NN O
revealing VBG O
the DT O
endogenous JJ O
levels NNS O
of IN O
Chk2 NNP O
in IN O
U NNP O
- HYPH O
2 CD O
- HYPH O
OS NNP O
cells NNS O
to TO O
be VB O
non RB O
- HYPH O
significant JJ O
compared VBN O
to IN O
the DT O
exogenously RB O
expressed VBN O
Chk2 NNP O
levels NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

We PRP O
also RB O
performed VBD O
a DT O
separate JJ O
kinase NN O
assay NN O
, , O
directly RB O
comparing VBG O
the DT O
effect NN O
of IN O
binding VBG O
partners NNS O
for IN O
the DT O
dimerizing VBG O
Arg117Gly NNP O
and CC O
the DT O
non AFX O
- HYPH O
dimerizing VBG O
Arg95Ter NNP O
. . O

This DT O
assay NN O
also RB O
revealed VBD O
the DT O
contribution NN O
of IN O
endogenous JJ O
Chk2 NNP O
to TO O
be VB O
non RB O
- HYPH O
significant JJ O
( -LRB- O
Figure NN O
5 CD O
) -RRB- O
. . O

Taking VBG O
our PRP$ O
in FW O
vitro FW O
findings NNS O
together RB O
with IN O
in IN O
vivo NN O
observations NNS O
, , O
our PRP$ O
present JJ O
data NNS O
confirm VBP O
that IN O
the DT O
functionally RB O
defective JJ O
CHEK2 NNP O
Arg95Ter NNP O
mutation NN O
, , O
together RB O
with IN O
LOH NNP O
, , O
is VBZ O
associated VBN O
with IN O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
. . O

In IN O
contrast NN O
, , O
the DT O
patient NN B-Species
harboring VBG O
the DT O
Ile364Thr NNP O
mutation NN O
, , O
moderately RB O
reducing VBG O
phosphorylation NN O
activity NN O
, , O
responded VBD O
well RB O
to IN O
therapy NN O
. . O

The DT O
other JJ O
missense NN O
mutations NNS O
; , O
Arg117Gly NNP O
and CC O
Ile157Thr NNP O
were VBD O
observed VBN O
among IN O
patients NNS B-Species
receiving VBG O
paclitaxel NN O
therapy NN O
only RB O
; : O
thus RB O
, , O
their PRP$ O
influence NN O
on IN O
anthracycline NN O
sensitivity NN O
in IN O
vivo NN O
could MD O
not RB O
be VB O
addressed VBN O
. . O

Yet CC O
, , O
based VBN O
on IN O
the DT O
finding NN O
that IN O
the DT O
Arg117Gly NNP O
mutant NN O
expressed VBD O
no DT O
intrinsic JJ O
activity NN O
, , O
but CC O
readily RB O
dimerized VBN O
to IN O
the DT O
wild JJ O
- HYPH O
type NN O
protein NN O
without IN O
abolishing VBG O
its PRP$ O
activity NN O
, , O
we PRP O
hypothesize VBP O
that IN O
this DT O
mutation NN O
and CC O
, , O
probably RB O
, , O
other JJ O
yet CC O
unidentified JJ O
CHEK2 NNP O
mutations NNS O
with IN O
a DT O
similar JJ O
lack NN O
of IN O
intrinsic JJ O
kinase NN O
activity NN O
, , O
may MD O
cause VB O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
if IN O
combined VBN O
with IN O
LOH NNP O
in IN O
breast NN O
cancer NN O
. . O

Our PRP$ O
present JJ O
findings NNS O
have VBP O
two CD O
major JJ O
implications NNS O
. . O

First RB O
, , O
we PRP O
confirm VBP O
that IN O
mutations NNS O
in IN O
genes NNS O
encoding VBG O
proteins NNS O
located VBN O
within IN O
the DT O
same JJ O
functional JJ O
pathway NN O
may MD O
substitute VB O
for IN O
each DT O
other JJ O
with IN O
respect NN O
to IN O
drug NN O
sensitivity NN O
, , O
revealing VBG O
for IN O
the DT O
first JJ O
time NN O
a DT O
functional JJ O
pathway NN O
critical JJ O
to IN O
chemotherapy NN O
response NN O
in IN O
vivo NN O
. . O

Second RB O
, , O
the DT O
identification NN O
of IN O
mutations NNS O
in IN O
the DT O
CHEK2 NNP O
but CC O
not RB O
in IN O
the DT O
p14 NN O
( -LRB- O
ARF NN O
) -RRB- O
gene NN O
in IN O
resistant JJ O
tumors NNS O
suggests VBZ O
that IN O
Chk2 NNP O
mediated VBN O
phosphorylation NN O
of IN O
p53 NN O
is VBZ O
a DT O
critical JJ O
event NN O
in IN O
executing VBG O
anti JJ O
- HYPH O
tumor NN O
effect NN O
as IN O
a DT O
response NN O
to IN O
DNA NN O
damaging JJ O
agents NNS O
in IN O
breast NN O
cancer NN O
. . O

This DT O
adds VBZ O
to IN O
our PRP$ O
understanding NN O
not RB O
only RB O
of IN O
the DT O
function NN O
of IN O
p53 NN O
but CC O
Chk2 NNP O
as RB O
well RB O
. . O

p53 NN O
undergoes VBZ O
phosphorylation NN O
at IN O
multiple JJ O
sites NNS O
by IN O
different JJ O
kinases NNS O
, , O
including VBG O
Chk2 NNP O
[ -LRB- O
51 CD O
] -RRB- O
. . O

While IN O
activation NN O
of IN O
the DT O
ATM NNP O
leading VBG O
to IN O
direct JJ O
( -LRB- O
Ser NNP O
15 CD O
) -RRB- O
and CC O
Chk2 NN O
- HYPH O
mediated VBN O
( -LRB- O
Ser NNP O
20 CD O
) -RRB- O
phosphorylation NN O
of IN O
p53 NN O
is VBZ O
considered VBN O
an DT O
important JJ O
mechanism NN O
for IN O
triggering VBG O
p53 NN O
activation NN O
in IN O
response NN O
to IN O
DNA NN O
damage NN O
[ -LRB- O
52 CD O
] -RRB- O
, , O
some DT O
reports NNS O
suggest VBP O
ATM NNP O
[ -LRB- O
53 CD O
] -RRB- O
and CC O
even RB O
Chk2 NNP O
[ -LRB- O
23 CD O
] -RRB- O
to TO O
be VB O
redundant JJ O
to IN O
this DT O
function NN O
. . O

Importantly RB O
, , O
Chk2 NNP O
has VBZ O
been VBN O
shown VBN O
capable JJ O
of IN O
inducing VBG O
ATM NNP O
- HYPH O
independent JJ O
apoptosis NN O
in IN O
vitro FW O
[ -LRB- O
21 CD O
] -RRB- O
. . O

While IN O
Chk2 NNP O
phosphorylates NNS O
p53 NN O
at IN O
Ser NNP O
20 CD O
, , O
thereby RB O
stabilizing VBG O
p53 NN O
by IN O
preventing VBG O
MDM2 NNP O
binding NN O
[ -LRB- O
19 CD O
] -RRB- O
, , O
Chk2 NNP O
also RB O
phosphorylates VBZ O
p53 NN O
at IN O
six CD O
additional JJ O
sites NNS O
, , O
including VBG O
Ser NNP O
313 CD O
and CC O
Ser NNP O
314 CD O
located VBN O
in IN O
the DT O
nuclear JJ O
localization NN O
signal NN O
domain NN O
of IN O
p53 NN O
[ -LRB- O
51 CD O
] -RRB- O
. . O

In IN O
addition NN O
, , O
Chk2 NNP O
phosphorylates NNS O
other JJ O
important JJ O
targets NNS O
like IN O
BRCA1 NNP O
, , O
Cdc25A NNP O
and CC O
Cdc25C NNP O
involved VBN O
in IN O
DNA NN O
repair NN O
, , O
G1 NNP O
and CC O
G2 NNP O
arrest NN O
, , O
respectively RB O
[ -LRB- O
54 CD O
] -RRB- O
. . O

Despite IN O
the DT O
wide JJ O
range NN O
of IN O
known VBN O
Chk2 NNP O
substrates NNS O
relevant JJ O
for IN O
DNA NN O
repair NN O
and CC O
cell NN O
cycle NN O
control NN O
, , O
our PRP$ O
present JJ O
findings NNS O
that IN O
CHEK2 NNP O
mutations NNS O
leading VBG O
to IN O
non JJ O
- HYPH O
functional JJ O
Chk2 NNP O
protein NN O
may MD O
substitute VB O
for IN O
p53 NN O
mutations NNS O
strongly RB O
advocate VBP O
a DT O
role NN O
for IN O
Chk2 NNP O
with IN O
respect NN O
to IN O
drug NN O
sensitivity NN O
executed VBN O
through IN O
p53 NN O
activation NN O
. . O

Notably RB O
, , O
one CD O
of IN O
the DT O
tumors NNS O
( -LRB- O
Epi203 NNP O
) -RRB- O
with IN O
the DT O
Arg95Ter NNP O
CHEK2 NNP O
mutation NN O
in IN O
addition NN O
harbored VBD O
a DT O
somatic JJ O
TP53 NN O
mutation NN O
, , O
Arg175His NNP O
, , O
with IN O
allelic JJ O
imbalance NN O
for IN O
the DT O
TP53 NN O
gene NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

Importantly RB O
, , O
among IN O
another DT O
four CD O
patients NNS B-Species
in IN O
this DT O
study NN O
( , O
Epi063 NNP O
, , O
Epi071 NNP O
, , O
Epi087 NNP O
, , O
Epi153 NNP O
) -RRB- O
and CC O
one CD O
patient NN B-Species
from IN O
our PRP$ O
previous JJ O
doxorubicin NN O
protocol NN O
[ -LRB- O
13 CD O
] -RRB- O
harboring VBG O
the DT O
Arg175His NNP O
mutation NN O
together RB O
with IN O
allelic JJ O
imbalance NN O
for IN O
TP53 NN O
, , O
all DT O
five CD O
of IN O
these DT O
patients NNS B-Species
responded VBD O
to IN O
anthracycline NN O
therapy NN O
either CC O
with IN O
a DT O
partial JJ O
response NN O
or CC O
stable JJ O
disease NN O
. . O

In IN O
contrast NN O
, , O
Epi132 NNP O
and CC O
the DT O
only JJ O
patient NN B-Species
for IN O
whom WP O
we PRP O
previously RB O
identified VBD O
a DT O
non AFX O
- HYPH O
functional JJ O
CHEK2 NNP O
mutation NN O
( -LRB- O
1368InsA CD O
; : O
coding VBG O
for IN O
a DT O
non JJ O
- HYPH O
functional JJ O
protein NN O
translate NN O
with IN O
cytoplasmic JJ O
location NN O
[ -LRB- O
26 CD O
] -RRB- O
) -RRB- O
expressed VBD O
resistance NN O
to IN O
epirubicin NN O
and CC O
doxorubicin NN O
, , O
respectively RB O
. . O

Arg175His NNP O
is VBZ O
a DT O
p53 NN O
"""" `` O
hot JJ O
- HYPH O
spot NN O
"""" '' O
structural JJ O
mutation NN O
reported VBN O
to TO O
have VB O
defects NNS O
with IN O
respect NN O
to IN O
transcriptional JJ O
activation NN O
and CC O
also RB O
to TO O
negatively RB O
interact VB O
with IN O
wild JJ O
- HYPH O
type NN O
p53 NN O
[ -LRB- O
55 CD O
] -RRB- O
. . O

While IN O
this DT O
mutation NN O
has VBZ O
been VBN O
shown VBN O
to TO O
enhance VB O
chemoresistance NN O
upon IN O
transfection NN O
into IN O
p53 NN O
null NN O
Saos NNP O
- HYPH O
2 CD O
cells NNS O
[ -LRB- O
56 CD O
] -RRB- O
, , O
these DT O
osteosarcoma NN O
- HYPH O
derived VBN O
cells NNS O
may MD O
not RB O
necessarily RB O
be VB O
representative JJ O
for IN O
breast NN O
cancers NNS O
in IN O
vivo NN O
. . O

Recent JJ O
evidence NN O
strongly RB O
support VBP O
p53 NN O
to TO O
be VB O
involved VBN O
also RB O
in IN O
non NN O
- HYPH O
transcriptional JJ O
mediated VBN O
apoptosis NN O
by IN O
interacting VBG O
with IN O
the DT O
Bcl NNP O
- HYPH O
2 CD O
/ SYM O
Bax NNP O
system NN O
[ -LRB- O
57 CD O
] -RRB- O
, , O
and CC O
transcription NN O
- HYPH O
defect NN O
structural JJ O
p53 NN O
mutants NNS O
have VBP O
been VBN O
shown VBN O
to TO O
execute VB O
non JJ O
- HYPH O
transcriptional JJ O
apoptosis NN O
in IN O
experimental JJ O
systems NNS O
[ -LRB- O
58 CD O
] -RRB- O
. . O

Concomitant JJ O
inactivation NN O
of IN O
Chk2 NNP O
and CC O
p53 NN O
in IN O
breast NN O
cancer NN O
has VBZ O
been VBN O
recorded VBN O
by IN O
others NNS O
[ -LRB- O
59 CD O
] -RRB- O
, , O
and CC O
the DT O
finding NN O
that IN O
a DT O
somatic JJ O
mutation NN O
may MD O
generate VB O
a DT O
"""" `` O
growth NN O
advantage NN O
"""" '' O
in IN O
tumor NN O
cells NNS O
already RB O
harboring VBG O
a DT O
germline NN O
CHEK2 NN O
mutation NN O
may MD O
not RB O
implicate VB O
an DT O
effect NN O
on IN O
drug NN O
sensitivity NN O
in IN O
tumors NNS O
not RB O
yet RB O
exposed VBN O
to IN O
cytotoxic JJ O
compounds NNS O
. . O

Rather RB O
, , O
it PRP O
may MD O
indicate VB O
a DT O
growth NN O
advantage NN O
, , O
probably RB O
related VBN O
to IN O
loss NN O
of IN O
p21 NN O
function NN O
. . O

Notably RB O
, , O
in IN O
a DT O
previous JJ O
study NN O
we PRP O
found VBD O
the DT O
p21 NN O
polymorphism NN O
G251A NN O
to TO O
be VB O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
developing VBG O
large JJ O
breast NN O
cancers NNS O
but CC O
to TO O
have VB O
no DT O
effect NN O
on IN O
drug NN O
sensitivity NN O
[ -LRB- O
60 CD O
] -RRB- O
, , O
indicating VBG O
that IN O
growth NN O
rate NN O
and CC O
drug NN O
resistance NN O
may MD O
be VB O
regulated VBN O
independently RB O
. . O

Taken VBN O
together RB O
, , O
we PRP O
believe VBP O
our PRP$ O
findings NNS O
advocate VBP O
a DT O
role NN O
for IN O
Chk2 NNP O
in IN O
executing VBG O
cellular JJ O
response NN O
to IN O
anthracycline NN O
- HYPH O
induced VBN O
DNA NNP O
damage NN O
. . O

As IN O
mentioned VBN O
above RB O
, , O
removing VBG O
TP53 NN O
mutated VBN O
tumors NNS O
including VBG O
the DT O
double RB O
- HYPH O
mutated VBN O
Epi203 NNP O
from IN O
statistical JJ O
analysis NN O
, , O
CHEK2 NNP O
mutation NN O
status NN O
still RB O
predicted VBN O
for IN O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
. . O

In IN O
addition NN O
, , O
removing VBG O
the DT O
tumors NNS O
harboring VBG O
the DT O
Arg175His NNP O
mutation NN O
from IN O
the DT O
p53 NN O
"""" `` O
L2 NNP O
/ SYM O
L3 NNP O
"""" '' O
group NN O
strengthened VBD O
the DT O
correlation NN O
to IN O
lack NN O
of IN O
treatment NN O
response NN O
to IN O
epirubicin NN O
( , O
p NN O
= SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Comparing VBG O
the DT O
effects NNS O
of IN O
mutations NNS O
in IN O
the DT O
CHEK2 NNP O
gene NN O
to IN O
TP53 NN O
mutations NNS O
indirectly RB O
underlines VBZ O
the DT O
importance NN O
of IN O
the DT O
role NN O
of IN O
Chk2 NNP O
to IN O
chemoresistance NN O
. . O

Our PRP$ O
present JJ O
findings NNS O
as RB O
well RB O
as IN O
results NNS O
from IN O
our PRP$ O
previous JJ O
studies NNS O
[ -LRB- O
13 CD O
] -RRB- O
, , O
[ -LRB- O
14 CD O
] -RRB- O
revealed VBD O
that IN O
about RB O
50 CD O
% NN O
of IN O
the DT O
patients NNS B-Species
with IN O
tumors NNS O
harboring VBG O
TP53 NNP O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
to TO O
be VB O
non NN O
- HYPH O
responders NNS O
to IN O
primary JJ O
therapy NN O
. . O

In IN O
contrast NN O
, , O
all PDT O
our PRP$ O
three CD O
patients NNS B-Species
harboring VBG O
a DT O
non AFX O
- HYPH O
functional JJ O
CHEK2 NN O
mutation NN O
( , O
the DT O
two CD O
Arg95Ter NNP O
mutated VBN O
patients NNS B-Species
here RB O
and CC O
our PRP$ O
previous JJ O
patient NN B-Species
harboring VBG O
the DT O
1368InsA NNP O
) -RRB- O
expressed VBD O
primary JJ O
resistance NN O
to IN O
therapy NN O
. . O

We PRP O
previously RB O
hypothesized VBD O
that IN O
therapy NN O
response NN O
in IN O
tumors NNS O
harboring VBG O
TP53 NNP O
L2 NNP O
/ SYM O
L3 NNP O
mutations NNS O
could MD O
be VB O
due IN O
to IN O
redundant JJ O
pathways NNS O
acting VBG O
in IN O
concert NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Although IN O
no DT O
definite JJ O
conclusion NN O
should MD O
be VB O
drawn VBN O
from IN O
a DT O
limited JJ O
number NN O
of IN O
observation NN O
, , O
the DT O
fact NN O
that IN O
Chk2 NNP O
not RB O
only RB O
phosphorylates VBZ O
p53 NN O
but CC O
also RB O
phosphorylates VBZ O
other JJ O
substrates NNS O
such JJ O
as IN O
Cdc25A NNP O
and CC O
Cdc25C NNP O
[ -LRB- O
54 CD O
] -RRB- O
and CC O
E2F1 NN O
in IN O
response NN O
to IN O
etoposide NN O
- HYPH O
induced VBN O
DNA NNP O
damage NN O
[ -LRB- O
61 CD O
] -RRB- O
may MD O
indicate VB O
that IN O
inactivation NN O
of IN O
redundant JJ O
pathways NNS O
could MD O
take VB O
place NN O
in IN O
parallel NN O
. . O

The DT O
literature NN O
remains VBZ O
inconsistent JJ O
with IN O
respect NN O
to IN O
whether IN O
the DT O
border NN O
amino NN O
acids NNS O
163 CD O
, , O
195 CD O
, , O
236 CD O
and CC O
251 CD O
should MD O
be VB O
included VBN O
in IN O
the DT O
p53 NN O
L2 NNP O
and CC O
L3 NNP O
domains NNS O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Taking VBG O
a DT O
conservative JJ O
approach NN O
, , O
we PRP O
classified VBD O
patient JJ B-Species
Epi56 NNP O
, , O
harboring VBG O
a DT O
mutation NN O
in IN O
codon NN O
163 CD O
, , O
as IN O
a DT O
L2 NNP O
/ SYM O
L3 NNP O
mutant NN O
. . O

The DT O
patient NN B-Species
harboring VBG O
this DT O
mutation NN O
responded VBD O
to IN O
therapy NN O
( -LRB- O
PR NN O
) -RRB- O
. . O

If IN O
this DT O
mutation NN O
was VBD O
classified VBN O
as IN O
outside IN O
the DT O
L2 NNP O
domain NN O
, , O
our PRP$ O
p NN O
- HYPH O
value NN O
had VBD O
been VBN O
strengthened VBN O
from IN O
p NN O
= SYM O
0 CD O
. . O
136 CD O
to IN O
p NN O
= SYM O
0 CD O
. . O
96 CD O
. . O

Germline NN O
mutations NNS O
in IN O
TP53 NNP O
cause VBP O
the DT O
Li NNP O
- HYPH O
Fraumeni NNP O
and CC O
Li NNP O
- HYPH O
Fraumeni NNP O
- HYPH O
like JJ O
cancer NN O
disposition NN O
syndromes NNS O
. . O

However RB O
, , O
while IN O
the DT O
germline NN O
and CC O
somatic JJ O
mutations NNS O
associated VBN O
with IN O
these DT O
syndromes NNS O
reveal VBP O
a DT O
preference NN O
for IN O
the DT O
same JJ O
codons NNS O
[ -LRB- O
48 CD O
] -RRB- O
, , O
TP53 NN O
mutations NNS O
affecting VBG O
the DT O
DNA NN O
- HYPH O
binding VBG O
domains NNS O
seem VBP O
associated VBN O
with IN O
a DT O
poor JJ O
prognosis NN O
[ -LRB- O
62 CD O
] -RRB- O
, , O
[ -LRB- O
63 CD O
] -RRB- O
, , O
[ -LRB- O
64 CD O
] -RRB- O
and CC O
, , O
in IN O
particular JJ O
, , O
drug NN O
resistance NN O
[ -LRB- O
14 CD O
] -RRB- O
, , O
[ -LRB- O
40 CD O
] -RRB- O
in IN O
breast NN O
cancer NN O
. . O

Thus RB O
, , O
tumor NN O
suppression NN O
and CC O
tumor NN O
cell NN O
response NN O
to IN O
chemotherapeutics NNS O
may MD O
involve VB O
different JJ O
parts NNS O
of IN O
p53 NN O
protein NN O
function NN O
. . O

Following VBG O
an DT O
initial JJ O
report NN O
identifying VBG O
a DT O
CHEK2 NNP O
mutation NN O
in IN O
a DT O
family NN O
expressing VBG O
characteristics NNS O
of IN O
the DT O
Li NNP O
- HYPH O
Fraumeni NNP O
syndrome NN O
[ -LRB- O
65 CD O
] -RRB- O
, , O
recent JJ O
evidence NN O
has VBZ O
linked VBN O
CHEK2 NNP O
founder NN O
mutations NNS O
to IN O
a DT O
moderately RB O
increased VBN O
risk NN O
of IN O
breast NN O
- HYPH O
and CC O
colorectal JJ O
cancers NNS O
with IN O
some DT O
additional JJ O
disposition NN O
for IN O
other JJ O
malignancies NNS O
as RB O
well RB O
[ -LRB- O
66 CD O
] -RRB- O
. . O

However RB O
, , O
cancer NN O
incidence NN O
and CC O
phenotypes NNS O
did VBD O
not RB O
reveal VB O
an DT O
aggressive JJ O
Li NNP O
- HYPH O
Fraumeni NNP O
or CC O
Li NNP O
- HYPH O
Fraumeni NNP O
- HYPH O
like JJ O
tumor NN O
pattern NN O
. . O

Similar JJ O
to IN O
the DT O
two CD O
patients NNS B-Species
in IN O
our PRP$ O
paclitaxel NN O
treatment NN O
arm NN O
harboring VBG O
the DT O
rare JJ O
but CC O
previously RB O
characterized VBN O
mutation NN O
Arg117Gly NNP O
and CC O
the DT O
patient NN B-Species
with IN O
the DT O
Ile157Thr NNP O
mutation NN O
, , O
they PRP O
expressed VBD O
a DT O
moderately RB O
increased VBN O
risk NN O
of IN O
breast NN O
and CC O
gastrointestinal JJ O
cancers NNS O
( , O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

Thus RB O
, , O
CHEK2 NNP O
resembles VBZ O
TP53 NN O
in IN O
as RB O
much JJ O
as IN O
there EX O
seems VBZ O
to TO O
be VB O
no DT O
direct JJ O
correlation NN O
between IN O
effects NNS O
of IN O
individual JJ O
mutations NNS O
with IN O
respect NN O
to IN O
tumor NN O
suppression NN O
and CC O
drug NN O
resistance NN O
. . O

Our PRP$ O
finding NN O
that IN O
TP53 NNP O
mutations NNS O
located VBN O
to IN O
the DT O
DNA NN O
- HYPH O
binding VBG O
domains NNS O
predicts VBZ O
drug NN O
resistance NN O
may MD O
indicate VB O
transcriptional JJ O
mechanisms NNS O
to TO O
be VB O
involved VBN O
in IN O
drug NN O
- HYPH O
induced VBN O
cell NN O
death NN O
. . O

p53 NN O
induced VBN O
apoptosis NN O
has VBZ O
been VBN O
associated VBN O
with IN O
transcriptional JJ O
induction NN O
of IN O
genes NNS O
including VBG O
Puma NNP O
and CC O
Noxa NNP O
as RB O
well RB O
as IN O
Bax NNP O
in IN O
experimental JJ O
systems NNS O
[ -LRB- O
55 CD O
] -RRB- O
, , O
[ -LRB- O
67 CD O
] -RRB- O
, , O
[ -LRB- O
68 CD O
] -RRB- O
. . O

Yet CC O
, , O
recent JJ O
evidence NN O
has VBZ O
revealed VBN O
p53 NN O
to TO O
induce VB O
apoptosis NN O
through IN O
non JJ O
- HYPH O
transcriptional JJ O
mechanisms NNS O
by IN O
direct JJ O
protein NN O
interactions NNS O
with IN O
members NNS O
of IN O
the DT O
Bcl NNP O
- HYPH O
2 CD O
/ SYM O
Bax NNP O
system NN O
and CC O
mitochondrial JJ O
release NN O
of IN O
cytochrom NN O
c NN O
[ -LRB- O
57 CD O
] -RRB- O
, , O
[ -LRB- O
69 CD O
] -RRB- O
. . O

In IN O
deed NN O
, , O
there EX O
is VBZ O
evidence NN O
that IN O
the DT O
DNA NN O
- HYPH O
binding VBG O
domains NNS O
, , O
in IN O
particular JJ O
the DT O
L3 NNP O
part NN O
of IN O
the DT O
protein NN O
, , O
may MD O
be VB O
critical JJ O
also RB O
to IN O
transcriptional JJ O
- HYPH O
independent JJ O
apoptosis NN O
[ -LRB- O
70 CD O
] -RRB- O
. . O

Of IN O
particular JJ O
note NN O
is VBZ O
the DT O
finding NN O
that IN O
Chk2 NNP O
may MD O
regulate VB O
transcriptional JJ O
- HYPH O
independent JJ O
p53 NN O
- HYPH O
mediated VBN O
apoptosis NN O
in IN O
response NN O
to IN O
DNA NN O
- HYPH O
damage NN O
created VBN O
through IN O
ionizing VBG O
irradiation NN O
[ -LRB- O
71 CD O
] -RRB- O
. . O

Interestingly RB O
, , O
Krajewski NNP O
et FW O
al NNP O
[ -LRB- O
72 CD O
] -RRB- O
reported VBD O
low JJ O
expression NN O
of IN O
Bax NNP O
assessed VBN O
by IN O
immunostaining NN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
low JJ O
response NN O
to IN O
chemotherapy NN O
in IN O
metastatic JJ O
breast NN O
cancer NN O
. . O

Although IN O
no DT O
conclusion NN O
should MD O
be VB O
drawn VBN O
at IN O
this DT O
stage NN O
, , O
together RB O
these DT O
findings NNS O
are VBP O
consistent JJ O
with IN O
the DT O
challenging VBG O
hypothesis NN O
that IN O
transcription NN O
- HYPH O
independent JJ O
activation NN O
of IN O
Bax NNP O
following VBG O
Chk2 NNP O
- HYPH O
phosphorylation NN O
may MD O
represent VB O
a DT O
key JJ O
pathway NN O
in IN O
p53 NN O
dependent JJ O
cell NN O
death NN O
in IN O
breast NN O
cancer NN O
in IN O
vivo NN O
. . O

p14 NN O
acts VBZ O
by IN O
releasing VBG O
p53 NN O
from IN O
MDM2 NNP O
binding NN O
, , O
and CC O
has VBZ O
been VBN O
related VBN O
to IN O
oncogene NN O
- HYPH O
induced VBN O
p53 NN O
activation NN O
[ -LRB- O
73 CD O
] -RRB- O
. . O

Recently RB O
, , O
p14 NN O
was VBD O
shown VBN O
to TO O
affect VB O
p53 NN O
by IN O
additional JJ O
mechanisms NNS O
, , O
including VBG O
acetylations NNS O
[ -LRB- O
74 CD O
] -RRB- O
, , O
response NN O
to IN O
ionizing VBG O
radiation NN O
in IN O
human JJ B-Species
fibroblasts NNS O
[ -LRB- O
75 CD O
] -RRB- O
, , O
and CC O
tumor NN O
- HYPH O
suppression NN O
following VBG O
ionizing VBG O
radiation NN O
in IN O
mice NNS B-Species
[ -LRB- O
76 CD O
] -RRB- O
, , O
[ -LRB- O
77 CD O
] -RRB- O
. . O

These DT O
findings NNS O
further RB O
links VBZ O
the DT O
retinoblastoma NN O
and CC O
p53 NN O
pathways NNS O
[ -LRB- O
28 CD O
] -RRB- O
. . O

As IN O
such JJ O
, , O
we PRP O
believe VBP O
the DT O
negative JJ O
finding NN O
with IN O
respect NN O
to IN O
its PRP$ O
role NN O
in IN O
chemoresistance NN O
adds VBZ O
important JJ O
information NN O
. . O

Contrasting VBG O
earlier JJR O
findings NNS O
by IN O
us PRP O
and CC O
others NNS O
[ -LRB- O
15 CD O
] -RRB- O
, , O
a DT O
recent JJ O
study NN O
revealed VBD O
TP53 NN O
mutations NNS O
to TO O
be VB O
associated VBN O
with IN O
increased VBN O
likelihood NN O
of IN O
having VBG O
a DT O
complete JJ O
response NN O
to IN O
chemotherapy NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

These DT O
results NNS O
may MD O
not RB O
necessarily RB O
be VB O
at IN O
conflict NN O
. . O

In IN O
the DT O
latter JJ O
study NN O
, , O
patients NNS B-Species
received VBD O
treatment NN O
with IN O
a DT O
"""" `` O
dose NN O
- HYPH O
dense JJ O
"""" '' O
chemotherapy NN O
regimen NN O
; : O
if IN O
confirmed VBN O
, , O
the DT O
combined VBN O
data NNS O
may MD O
outline VB O
a DT O
therapeutic JJ O
indication NN O
for IN O
aggressive JJ O
dose NN O
- HYPH O
dense JJ O
therapy NN O
based VBN O
on IN O
tumor NN O
TP53 NNP O
/ SYM O
CHEK2 NN O
status NN O
. . O

So RB O
far RB O
attempts NNS O
to TO O
identify VB O
single JJ O
markers NNS O
and CC O
, , O
more RBR O
recently RB O
, , O
gene NN O
expression NN O
arrays NNS O
predicting VBG O
chemoresistance NN O
have VBP O
not RB O
proved VBN O
successful JJ O
( : O
see VB O
refs NNS O
in IN O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
10 CD O
] -RRB- O
) -RRB- O
. . O

The DT O
findings NNS O
presented VBN O
here RB O
reveal VBP O
for IN O
the DT O
first JJ O
time NN O
defects NNS O
in IN O
a DT O
functional JJ O
gene NN O
cascade NN O
to TO O
be VB O
associated VBN O
with IN O
drug NN O
resistance NN O
in IN O
a DT O
human JJ B-Species
cancer NN O
in IN O
vivo NN O
. . O

Moreover RB O
, , O
the DT O
findings NNS O
are VBP O
made VBN O
in IN O
breast NN O
cancer NN O
, , O
the DT O
most RBS O
frequent JJ O
malignant JJ O
disease NN O
among IN O
women NNS O
in IN O
the DT O
industrialized JJ O
world NN O
, , O
and CC O
relate VBP O
to IN O
resistance NN O
to IN O
anthracyclines NNS O
, , O
the DT O
type NN O
of IN O
cytotoxic JJ O
compounds NNS O
most RBS O
frequently RB O
employed VBN O
for IN O
this DT O
malignancy NN O
. . O

While IN O
the DT O
only JJ O
study NN O
we PRP O
are VBP O
aware JJ O
of IN O
comparing VBG O
TP53 NN O
mutation NN O
status NN O
in IN O
primaries NNS O
and CC O
their PRP$ O
distant JJ O
metastases NNS O
suggested VBD O
an DT O
increasing VBG O
fraction NN O
of IN O
tumors NNS O
to TO O
express VB O
mutated VBN O
TP53 NN O
during IN O
progression NN O
[ -LRB- O
78 CD O
] -RRB- O
, , O
we PRP O
do VBP O
not RB O
know VB O
the DT O
potential JJ O
contribution NN O
of IN O
either CC O
TP53 NN O
or CC O
CHEK2 NN O
mutations NNS O
to IN O
drug NN O
resistance NN O
in IN O
micrometastases NNS O
or CC O
in IN O
metastatic JJ O
disease NN O
. . O

Yet CC O
the DT O
finding NN O
that IN O
one CD O
of IN O
our PRP$ O
non AFX O
- HYPH O
functional JJ O
CHEK2 NNP O
mutations NNS O
associated VBN O
with IN O
chemoresistance NN O
( , O
1368InsA CD O
) -RRB- O
occurred VBD O
as IN O
a DT O
somatic JJ O
, , O
not RB O
germline NN O
mutation NN O
, , O
suggest VBP O
such JJ O
mutations NNS O
may MD O
be VB O
selected VBN O
for IN O
during IN O
tumor NN O
progression NN O
. . O

We PRP O
propose VBP O
the DT O
findings NNS O
presented VBN O
here RB O
provide VBP O
important JJ O
beacons NNS O
identifying VBG O
a DT O
functional JJ O
pathway NN O
[ -LRB- O
3 CD O
] -RRB- O
likely JJ O
to TO O
be VB O
disturbed VBN O
through IN O
different JJ O
mechanisms NNS O
in IN O
relation NN O
to IN O
therapy NN O
resistance NN O
in IN O
advanced JJ O
disease NN O
. . O

In IN O
conclusion NN O
, , O
we PRP O
believe VBP O
our PRP$ O
findings NNS O
here RB O
that IN O
mutations NNS O
in IN O
the DT O
TP53 NNP O
and CC O
CHEK2 NNP O
genes NNS O
each DT O
may MD O
cause VB O
resistance NN O
to IN O
anthracycline NN O
therapy NN O
in IN O
primary JJ O
tumors NNS O
to TO O
have VB O
wide JJ O
implications NNS O
to IN O
future JJ O
research NN O
in IN O
this DT O
area NN O
. . O

While IN O
results NNS O
from IN O
experimental JJ O
systems NNS O
are VBP O
mandatory JJ O
generating VBG O
hypotheses NNS O
, , O
conflicting VBG O
data NNS O
from IN O
in FW O
vitro FW O
studies NNS O
underlines VBZ O
the DT O
pivotal JJ O
role NN O
of IN O
identifying VBG O
defects NNS O
associated VBN O
with IN O
therapy NN O
resistance NN O
in IN O
vivo NN O
. . O

Either CC O
through IN O
mutations NNS O
of IN O
the DT O
genes NNS O
themselves PRP O
, , O
or CC O
inactivation NN O
of IN O
this DT O
functional JJ O
cascade NN O
through IN O
co NN O
- HYPH O
factors NNS O
, , O
we PRP O
believe VBP O
identification NN O
of IN O
the DT O
Chk2 NNP O
- HYPH O
p53 NN O
axis NN O
as IN O
critical JJ O
to IN O
anthracycline NN O
therapy NN O
response NN O
provides VBZ O
a DT O
functional JJ O
clue NN O
for IN O
further JJ O
investigations NNS O
in IN O
this DT O
area NN O
. . O

Host NN O
immunity NN O
in IN O
the DT O
protective JJ O
response NN O
to IN O
vaccination NN O
with IN O
heat NN O
- HYPH O
killed VBN O
Burkholderia NNP B-Species
mallei NN I-Species

Abstract JJ O

Background NN O

We PRP O
performed VBD O
initial JJ O
cell NN O
, , O
cytokine NN O
and CC O
complement NN O
depletion NN O
studies NNS O
to TO O
investigate VB O
the DT O
possible JJ O
role NN O
of IN O
these DT O
effectors NNS O
in IN O
response NN O
to IN O
vaccination NN O
with IN O
heat NN O
- HYPH O
killed VBN O
Burkholderia NNP B-Species
mallei NN I-Species
in IN O
a DT O
susceptible JJ O
BALB NNP O
/ SYM O
c NNP O
mouse NN B-Species
model NN O
of IN O
infection NN O
. . O

Results NNS O

While IN O
protection NN O
with IN O
heat NN O
- HYPH O
killed VBN O
bacilli NN O
did VBD O
not RB O
result VB O
in IN O
sterilizing VBG O
immunity NN O
, , O
limited JJ O
protection NN O
was VBD O
afforded VBN O
against IN O
an DT O
otherwise RB O
lethal JJ O
infection NN O
and CC O
provided VBD O
insight NN O
into IN O
potential JJ O
host NN O
protective JJ O
mechanisms NNS O
. . O

Our PRP$ O
results NNS O
demonstrated VBD O
that IN O
mice NNS B-Species
depleted VBN O
of IN O
either CC O
B NN O
cells NNS O
, , O
TNF NNP O
- HYPH O
alpha NN O
or CC O
IFN NNP O
- HYPH O
gamma NN O
exhibited VBD O
decreased VBN O
survival NN O
rates NNS O
, , O
indicating VBG O
a DT O
role NN O
for IN O
these DT O
effectors NNS O
in IN O
obtaining VBG O
partial JJ O
protection NN O
from IN O
a DT O
lethal JJ O
challenge NN O
by IN O
the DT O
intraperitoneal JJ O
route NN O
. . O

Additionally RB O
, , O
complement VB O
depletion NN O
had VBD O
no DT O
effect NN O
on IN O
immunoglobulin NN O
production NN O
when WRB O
compared VBN O
to IN O
non NN O
- HYPH O
complement NN O
depleted VBN O
controls NNS O
infected VBN O
intranasally RB O
. . O

Conclusion NN O

The DT O
data NNS O
provide VBP O
a DT O
basis NN O
for IN O
future JJ O
studies NNS O
of IN O
protection NN O
via IN O
vaccination NN O
using VBG O
either CC O
subunit NN O
or CC O
whole JJ O
- HYPH O
organism NN O
vaccine NN O
preparations NNS O
from IN O
lethal JJ O
infection NN O
in IN O
the DT O
experimental JJ O
BALB NNP O
/ SYM O
c NN O
mouse NN B-Species
model NN O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
demonstrate VBP O
participation NN O
of IN O
B220 NN O
+ CC O
cells NNS O
and CC O
pro JJ O
- HYPH O
inflammatory JJ O
cytokines NNS O
IFN NNP O
- HYPH O
gamma NN O
and CC O
TNF NNP O
- HYPH O
alpha NN O
in IN O
protection NN O
following VBG O
HK NNP O
vaccination NN O
. . O

Background NN O

Burkholderia NNP B-Species
mallei NNP I-Species
, , O
the DT O
etiologic JJ O
agent NN O
of IN O
glanders NNS O
, , O
is VBZ O
a DT O
gram NN O
- HYPH O
negative JJ O
, , O
capsulated VBN O
, , O
non NN O
- HYPH O
motile NN O
, , O
facultative JJ O
intracelluar JJ O
bacterium NN O
. . O

Most RBS O
known VBN O
members NNS O
of IN O
the DT O
Burkholderiaceae NNP O
are VBP O
resident JJ O
in IN O
the DT O
soil NN O
; : O
however RB O
, , O
B NNP B-Species
. . I-Species
mallei NNP I-Species
is VBZ O
thought VBN O
to TO O
be VB O
an DT O
obligate JJ O
mammalian JJ O
pathogen NN O
. . O

Horses NNS B-Species
are VBP O
highly RB O
susceptible JJ O
to IN O
infection NN O
and CC O
considered VBN O
the DT O
natural JJ O
reservoir NN O
for IN O
infection NN O
, , O
although IN O
mules NNS B-Species
and CC O
donkeys NNS B-Species
are VBP O
also RB O
susceptible JJ O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Clinically RB O
, , O
glanders NNS O
in IN O
solipeds NNS O
can MD O
present VB O
as IN O
either CC O
a DT O
chronic JJ O
( , O
horses NNS B-Species
) , O
or CC O
acute JJ O
( , O
mules NNS B-Species
and CC O
donkeys NNS B-Species
) -RRB- O
form NN O
. . O

Naturally RB O
acquired VBN O
human JJ B-Species
infection NN O
with IN O
B NNP B-Species
. . I-Species
mallei NNP I-Species
, , O
although IN O
not RB O
seen VBN O
in IN O
the DT O
United NNP O
States NNP O
since IN O
1945 CD O
, , O
has VBZ O
occurred VBN O
rarely RB O
and CC O
sporadically RB O
among IN O
laboratory NN O
workers NNS O
and CC O
those DT O
in IN O
direct JJ O
contact NN O
with IN O
infected JJ O
animals NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

However RB O
, , O
glanders NNS O
is VBZ O
endemic JJ O
among IN O
domestic JJ O
animals NNS O
in IN O
Africa NNP O
, , O
Asia NNP O
, , O
the DT O
Middle NNP O
East NNP O
, , O
and CC O
Central NNP O
and CC O
South NNP O
America NNP O
. . O

The DT O
course NN O
of IN O
infection NN O
is VBZ O
dependent JJ O
on IN O
the DT O
route NN O
of IN O
exposure NN O
. . O

Direct JJ O
contact NN O
with IN O
the DT O
skin NN O
can MD O
lead VB O
to IN O
a DT O
systemic JJ O
infection NN O
. . O

Inhalation NN O
of IN O
aerosol NN O
or CC O
dust NN O
containing VBG O
B NN B-Species
. . I-Species
mallei NN I-Species
can MD O
lead VB O
to IN O
septicemic JJ O
, , O
pulmonary JJ O
, , O
or CC O
chronic JJ O
infections NNS O
of IN O
the DT O
muscle NN O
, , O
liver NN O
and CC O
spleen NN O
. . O

The DT O
disease NN O
has VBZ O
a DT O
95 CD O
% NN O
case NN O
fatality NN O
rate NN O
for IN O
untreated JJ O
septicemic JJ O
infections NNS O
and CC O
a DT O
50 CD O
% NN O
case NN O
fatality NN O
rate NN O
in IN O
antibiotic JJ O
- HYPH O
treated VBN O
individuals NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

There EX O
is VBZ O
no DT O
human JJ B-Species
or CC O
animal NN O
vaccine NN O
available JJ O
for IN O
glanders NNS O
, , O
and CC O
development NN O
of IN O
a DT O
partial JJ O
or CC O
fully RB O
protective JJ O
adaptive JJ O
host NN O
response NN O
to IN O
the DT O
organism NN O
has VBZ O
not RB O
been VBN O
well RB O
- HYPH O
defined VBN O
. . O

Previous JJ O
studies NNS O
with IN O
B NNP B-Species
. . I-Species
mallei NN I-Species
and CC O
the DT O
host NN O
response NN O
have VBP O
shown VBN O
that IN O
a DT O
mixed JJ O
immune JJ O
response NN O
consisting VBG O
of IN O
both DT O
Th1 NN O
and CC O
Th2 NNP O
- HYPH O
associated VBN O
cytokines NNS O
with IN O
a DT O
predominant JJ O
IgG1 NNP O
subclass NN O
does VBZ O
not RB O
correlate VB O
with IN O
protection NN O
[ -LRB- O
4 CD O
] -RRB- O
. . O

Additional JJ O
studies NNS O
with IN O
passive JJ O
transfer NN O
of IN O
monoclonal JJ O
antibodies NNS O
specific JJ O
for IN O
B NNP B-Species
. . I-Species
mallei NNS I-Species
have VBP O
correlated VBN O
with IN O
early JJ O
protection NN O
from IN O
infection NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Recent JJ O
studies NNS O
have VBP O
also RB O
shown VBN O
the DT O
Th1 NNP O
cytokine NN O
IL NN O
- HYPH O
12 CD O
to TO O
mediate VB O
partial JJ O
protection NN O
to IN O
non NN O
- HYPH O
viable JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
- HYPH O
vaccinated VBN O
mice NNS B-Species
[ -LRB- O
6 CD O
] -RRB- O
. . O

Thus RB O
, , O
full JJ O
correlates NNS O
of IN O
protection NN O
mediated VBN O
by IN O
the DT O
adaptive JJ O
immune JJ O
system NN O
against IN O
B NNP B-Species
. . I-Species
mallei NNS I-Species
remain VBP O
to TO O
be VB O
fully RB O
elucidated VBN O
. . O

In IN O
this DT O
series NN O
of IN O
studies NNS O
, , O
we PRP O
sought VBD O
to TO O
address VB O
the DT O
impact NN O
of IN O
depletion NN O
of IN O
the DT O
major JJ O
effector NN O
lymphoid NN O
cell NN O
populations NNS O
( , O
B220 NNP O
+ CC O
B NN O
cells NNS O
, , O
CD4 NNP O
+ CC O
or CC O
CD8 NNP O
+ CC O
T NNP O
cells NNS O
) -RRB- O
and CC O
key JJ O
pro JJ O
- HYPH O
inflammatory NN O
/ SYM O
Type NN O
1 CD O
cytokines NNS O
( , O
IFN NNP O
- HYPH O
gamma NN O
or CC O
TNF NNP O
- HYPH O
alpha NN O
) -RRB- O
on IN O
survival NN O
in IN O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
vaccinated VBN O
with IN O
heat NN O
killed VBN O
( , O
HK NNP O
) -RRB- O
bacilli NN O
followed VBN O
by IN O
an DT O
intraperitoneal JJ O
( , O
i CD O
. . O
p NN O
. . O
) -RRB- O
challenge NN O
with IN O
live JJ O
organism NN O
. . O

In IN O
addition NN O
, , O
studies NNS O
investigating VBG O
the DT O
effect NN O
of IN O
complement NN O
on IN O
opsonization NN O
of IN O
organism NN O
and CC O
antibody NN O
production NN O
were VBD O
assessed VBN O
. . O

Heat NN O
killed VBN O
bacteria NNS O
were VBD O
used VBN O
as IN O
a DT O
model NN O
of IN O
vaccination NN O
to TO O
allow VB O
evaluation NN O
of IN O
B NN B-Species
. . I-Species
mallei NN I-Species
specific JJ O
immune JJ O
responses NNS O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
demonstrate VBP O
participation NN O
of IN O
B220 NN O
+ CC O
cells NNS O
and CC O
pro JJ O
- HYPH O
inflammatory JJ O
cytokines NNS O
IFN NNP O
- HYPH O
gamma NN O
and CC O
TNF NNP O
- HYPH O
alpha NN O
in IN O
protection NN O
following VBG O
HK NNP O
vaccination NN O
. . O

Results NNS O

Heat NN O
- HYPH O
killed VBN O
B NNP B-Species
. . I-Species
mallei NN I-Species
vaccination NN O
mediates VBZ O
partial JJ O
protection NN O
from IN O
lethal JJ O
challenge NN O

To TO O
begin VB O
to TO O
address VB O
this DT O
issue NN O
in IN O
an DT O
animal NN O
model NN O
of IN O
acute JJ O
infection NN O
, , O
we PRP O
established VBD O
that IN O
immunologically RB O
naive JJ O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
challenged VBN O
i PRP O
. . O
p UH O
. . O
with IN O
2 CD O
x SYM O
107 CD O
CFU NN O
resulted VBN O
in IN O
death NN O
by IN O
day NN O
4 CD O
- SYM O
6 CD O
, , O
while IN O
i PRP O
. . O
p NN O
. . O
immunization NN O
with IN O
1 CD O
x SYM O
105 CD O
heat NN O
killed VBN O
( -LRB- O
HK NNP O
) -RRB- O
bacteria NNS O
provided VBD O
partial JJ O
protection NN O
against IN O
a DT O
subsequent JJ O
challenge NN O
. . O

Two CD O
independent JJ O
experiments NNS O
resulted VBD O
in IN O
similar JJ O
findings NNS O
of IN O
40 CD O
% NN O
survival NN O
for IN O
HK NNP O
- HYPH O
vaccinated VBN O
mice NNS B-Species
with IN O
a DT O
mean JJ O
survival NN O
time NN O
( -LRB- O
MST NNP O
) -RRB- O
of IN O
8 CD O
days NNS O
versus IN O
4 CD O
days NNS O
in IN O
na FW O
i FW O
ve FW O
mice NNS B-Species
( -LRB- O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

The DT O
administration NN O
of IN O
vaccines NNS O
for IN O
B NNP B-Species
. . I-Species
mallei NN I-Species
during IN O
an DT O
outbreak NN O
would MD O
mandate VB O
relatively RB O
rapid JJ O
onset NN O
of IN O
protection NN O
for IN O
human JJ B-Species
or CC O
veterinary JJ O
use NN O
. . O

Based VBN O
on IN O
non JJ O
- HYPH O
routine JJ O
use NN O
and CC O
vaccine NN O
implementation NN O
in IN O
the DT O
course NN O
of IN O
an DT O
outbreak NN O
, , O
a DT O
14 CD O
day NN O
window NN O
was VBD O
chosen VBN O
for IN O
assessment NN O
of IN O
protection NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
HK NNP O
vaccination NN O
can MD O
afford VB O
partial JJ O
protection NN O
to IN O
an DT O
otherwise RB O
lethal JJ O
challenge NN O
of IN O
B NN B-Species
. . I-Species
mallei NN I-Species
by IN O
the DT O
i NN O
. . O
p UH O
. . O
route NN O
. . O

Effects NNS O
of IN O
cell NN O
depletion NN O
on IN O
HK NNP O
- HYPH O
vaccinated VBN O
survival NN O

To TO O
dissect VB O
the DT O
cellular JJ O
basis NN O
for IN O
protection NN O
mediated VBN O
by IN O
HK NNP O
vaccination NN O
, , O
13 CD O
days NNS O
after IN O
immunization NN O
with IN O
HK NNP O
bacteria NNS O
( : O
day NN O
- HYPH O
1 CD O
) -RRB- O
, , O
and CC O
at IN O
day NN O
of IN O
challenge NN O
, , O
mice NNS B-Species
were VBD O
dosed VBN O
with IN O
antibodies NNS O
to TO O
deplete VB O
CD4 NN O
+ CC O
, , O
CD8 NN O
+ CC O
or CC O
B220 NN O
+ CC O
cells NNS O
. . O

Antibody NN O
depletion NN O
of IN O
CD4 NNP O
+ CC O
, , O
CD8 NNP O
+ CC O
, , O
or CC O
B220 NN O
+ CC O
cells NNS O
in IN O
these DT O
mice NNS B-Species
was VBD O
confirmed VBN O
by IN O
flow NN O
cytometric JJ O
analysis NN O
with IN O
depletion NN O
efficiencies NNS O
for IN O
CD4 NNP O
, , O
CD8 NNP O
, , O
and CC O
B220 NN O
populations NNS O
at IN O
99 CD O
. . O
7 CD O
% NN O
, , O
96 CD O
% NN O
, , O
and CC O
95 CD O
% NN O
, , O
respectively RB O
, , O
relative JJ O
to IN O
mice NNS B-Species
treated VBN O
with IN O
isotype NN O
control NN O
monoclonal JJ O
antibodies NNS O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Our PRP$ O
results NNS O
demonstrated VBD O
decreased VBN O
survival NN O
rates NNS O
in IN O
B220 CD O
( , O
p NN O
= SYM O
0 CD O
. . O
3418 CD O
) -RRB- O
, , O
CD4 NN O
+ CC O
( : O
p NN O
= SYM O
0 CD O
. . O
5417 CD O
) -RRB- O
and CC O
CD8 NN O
+ SYM O
( : O
p NN O
= SYM O
0 CD O
. . O
4684 CD O
) -RRB- O
antibody NN O
depleted VBN O
mice NNS B-Species
, , O
compared VBN O
to IN O
isotype NN O
control NN O
antibody NN O
, , O
a DT O
finding NN O
that WDT O
indicated VBD O
a DT O
possible JJ O
role NN O
for IN O
vaccine NN O
induced VBN O
antibody NN O
production NN O
. . O

When WRB O
challenged VBN O
with IN O
2 CD O
x SYM O
107 CD O
CFU NN O
/ SYM O
mouse NN B-Species
by IN O
the DT O
i NN O
. . O
p NN O
. . O
route NN O
, , O
loss NN O
of IN O
T NN O
cells NNS O
resulted VBD O
in IN O
reduced VBN O
survival NN O
( : O
50 CD O
% NN O
) -RRB- O
relative JJ O
to IN O
the DT O
non AFX O
- HYPH O
specific JJ O
isotype NN O
control NN O
( : O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

In IN O
contrast NN O
to IN O
the DT O
loss NN O
of IN O
T NNP O
cells NNS O
, , O
depletion NN O
of IN O
B220 NN O
+ CC O
cells NNS O
resulted VBD O
in IN O
100 CD O
% NN O
mortality NN O
relative JJ O
to IN O
the DT O
non AFX O
- HYPH O
specific JJ O
isotype NN O
control NN O
( : O
Fig NNP O
. . O
2 CD O
) -RRB- O
. . O

To TO O
further RB O
evaluate VB O
the DT O
necessity NN O
of IN O
these DT O
effector NN O
cells NNS O
in IN O
providing VBG O
protection NN O
following VBG O
HK NNP O
vaccination NN O
, , O
relatively RB O
resistant JJ O
C57BL NNP O
/ SYM O
6 CD O
mice NNS B-Species
, , O
deficient JJ O
in IN O
mature JJ O
B NN O
- HYPH O
cells NNS O
( , O
mu NN O
MT NNP O
) -RRB- O
, , O
CD4 NNP O
T NNP O
- HYPH O
cells NNS O
( -LRB- O
CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
or CC O
CD8 NNP O
T NNP O
- HYPH O
cells NNS O
( -LRB- O
CD8 NN O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
were VBD O
subjected VBN O
to IN O
an DT O
identical JJ O
HK NNP O
vaccination NN O
and CC O
challenge NN O
regimen NN O
. . O

Mature JJ O
, , O
B NN O
- HYPH O
cell NN O
- HYPH O
deficient JJ O
mice NNS B-Species
demonstrated VBD O
a DT O
50 CD O
% NN O
decreased JJ O
survival NN O
( , O
p NN O
= SYM O
0 CD O
. . O
888 CD O
) -RRB- O
compared VBN O
to IN O
the DT O
wild JJ O
- HYPH O
type NN O
mice NNS B-Species
with IN O
an DT O
MST NN O
of IN O
35 CD O
. . O
5 CD O
days NNS O
( : O
Fig NNP O
. . O
3 CD O
) -RRB- O
. . O

CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
and CC O
CD8 NN O
- HYPH O
/ SYM O
- HYPH O
mice NNS B-Species
exhibited VBN O
a DT O
60 CD O
% NN O
( , O
p NN O
= SYM O
0 CD O
. . O
1343 CD O
) -RRB- O
and CC O
0 CD O
% NN O
reduced VBN O
survival NN O
, , O
respectively RB O
( : O
Fig NNP O
. . O
3 CD O
) -RRB- O
. . O

Effects NNS O
of IN O
cytokine NN O
depletion NN O
on IN O
HK NNP O
vaccination NN O

Similar JJ O
studies NNS O
were VBD O
performed VBN O
to TO O
determine VB O
the DT O
role NN O
of IN O
IFN NNP O
- HYPH O
gamma NN O
or CC O
TNF NNP O
- HYPH O
alpha NN O
in IN O
acute JJ O
infection NN O
in IN O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
immunized VBN O
with IN O
HK NNP O
bacteria NNS O
. . O

Six CD O
hours NNS O
before IN O
challenge NN O
, , O
mice NNS B-Species
were VBD O
dosed VBN O
with IN O
antibodies NNS O
that WDT O
neutralize VBP O
IFN NNP O
- HYPH O
gamma NN O
or CC O
TNF NNP O
- HYPH O
alpha NN O
. . O

Individual JJ O
depletion NN O
of IN O
either CC O
TNF NNP O
- HYPH O
alpha NN O
( , O
p NN O
= SYM O
0 CD O
. . O
145 CD O
) -RRB- O
or CC O
IFN NNP O
- HYPH O
gamma NN O
( : O
p NN O
= SYM O
0 CD O
. . O
446 CD O
) -RRB- O
resulted VBD O
in IN O
100 CD O
% NN O
mortality NN O
with IN O
an DT O
MST NNP O
of IN O
3 CD O
and CC O
2 CD O
days NNS O
, , O
respectively RB O
, , O
compared VBN O
to IN O
the DT O
HK NNP O
- HYPH O
vaccinated VBN O
isotype NN O
control NN O
mice NN B-Species
( : O
Fig NNP O
. . O
4 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
40 CD O
% NN O
of IN O
HK NNP O
- HYPH O
vaccinated VBN O
, , O
isotype NN O
control NN O
mice NNS B-Species
survived VBD O
to IN O
at RB O
least RBS O
12 CD O
days NNS O
post NN O
- HYPH O
challenge NN O
( -LRB- O
Fig NNP O
4 CD O
) -RRB- O
. . O

To TO O
further RB O
evaluate VB O
the DT O
host NN O
TNF NNP O
- HYPH O
alpha NN O
response NN O
during IN O
an DT O
established VBN O
B NN B-Species
. . I-Species
mallei NN I-Species
chronic JJ O
infection NN O
, , O
we PRP O
infected VBD O
12 CD O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
by IN O
the DT O
i NN O
. . O
p NN O
. . O
route NN O
with IN O
1 CD O
x SYM O
106 CD O
CFU NN O
B NN B-Species
. . I-Species
mallei NNP I-Species
. . O

One CD O
animal NN O
was VBD O
terminally RB O
ill JJ O
on IN O
day NN O
37 CD O
post NN O
- HYPH O
infection NN O
. . O

On IN O
day NN O
42 CD O
post NN O
- HYPH O
infection NN O
, , O
the DT O
remaining VBG O
11 CD O
mice NNS B-Species
were VBD O
dosed VBN O
with IN O
either CC O
anti JJ O
- HYPH O
TNF NNP O
- HYPH O
alpha NN O
( , O
n CD O
= SYM O
6 CD O
) -RRB- O
, , O
or CC O
control NN O
mAb NN O
( , O
AFRC NNP O
Mac NNP O
49 CD O
) -RRB- O
( : O
n CD O
= SYM O
5 CD O
) -RRB- O
. . O

No DT O
further JJ O
deaths NNS O
were VBD O
observed VBN O
in IN O
the DT O
control NN O
mAb NN O
- HYPH O
treated VBN O
mice NNS B-Species
. . O

Rapid JJ O
mortality NN O
was VBD O
observed VBN O
in IN O
the DT O
anti AFX O
- HYPH O
TNF NNP O
- HYPH O
alpha NN O
- HYPH O
treated VBN O
group NN O
, , O
with IN O
all DT O
mice NNS B-Species
dying VBG O
within IN O
7 CD O
days NNS O
of IN O
treatment NN O
( : O
p NN O
= SYM O
0 CD O
. . O
23 CD O
) -RRB- O
relative JJ O
to IN O
the DT O
isotype NN O
- HYPH O
treated VBN O
controls NNS O
( : O
Fig NNP O
. . O
5 CD O
) -RRB- O
. . O

J774A NNP O
. . O
1 CD O
uptake NN O
of IN O
serum NN O
treated VBN O
B NN B-Species
. . I-Species
mallei NN I-Species

Complement NN O
mediated VBN O
uptake NN O
assays NNS O
were VBD O
performed VBN O
to TO O
evaluate VB O
opsonization NN O
. . O

Results NNS O
indicated VBD O
enhanced VBN O
bacterial JJ O
uptake NN O
in IN O
J774A NNP O
. . O
1 CD O
phagocytes NNS O
inoculated VBN O
with IN O
serum NN O
treated VBN O
B NNP B-Species
. . I-Species
mallei NNP I-Species
( , O
p NN O
= SYM O
. . O
82 CD O
) -RRB- O
, , O
compared VBN O
to IN O
B NN B-Species
. . I-Species
mallei NN I-Species
alone RB O
, , O
while IN O
heat NN O
- HYPH O
inactivated VBN O
serum NN O
produced VBN O
uptake NN O
percentages NNS O
similar JJ O
to IN O
those DT O
prior RB O
to IN O
serum NN O
addition NN O
( : O
Fig NNP O
. . O
6 CD O
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
imply VBP O
an DT O
active JJ O
role NN O
for IN O
complement NN O
components NNS O
in IN O
the DT O
uptake NN O
of IN O
organism NN O
by IN O
macrophages NNS O
. . O

Immunoglobulin NN O
production NN O
in IN O
HK NNP O
vaccinated VBN O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species

We PRP O
further RB O
characterized VBD O
the DT O
ability NN O
of IN O
HK NNP O
vaccination NN O
to TO O
induce VB O
a DT O
predominant JJ O
IgG NN O
isotype NN O
by IN O
determining VBG O
IgG2a NNP O
/ SYM O
IgG1 NNP O
ratios NNS O
in IN O
i CD O
. . O
p LS O
. . O
and CC O
i LS O
. . O
n LS O
. . O
vaccinated VBN O
BALB NN O
/ SYM O
c NN O
mice NNS B-Species
. . O

Pre NNP O
( , O
day NN O
14 CD O
post NN O
vaccination NN O
) -RRB- O
and CC O
post NN O
( HYPH O
day NN O
2 CD O
post NN O
infection NN O
) -RRB- O
exposure NN O
serum NN O
samples NNS O
were VBD O
obtained VBN O
and CC O
evaluated VBN O
for IN O
IgG NN O
isotype NN O
concentrations NNS O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

No DT O
appreciable JJ O
differences NNS O
in IN O
IgG NNP O
pre NN O
- HYPH O
exposure NN O
levels NNS O
were VBD O
seen VBN O
when WRB O
comparing VBG O
i PRP O
. . O
n NFP O
. . O
to IN O
i LS O
. . O
p NN O
. . O
vaccination NN O
. . O

In IN O
addition NN O
, , O
cobra NN O
venom NN O
factor NN O
- HYPH O
treated VBN O
animals NNS O
showed VBD O
no DT O
significant JJ O
differences NNS O
to IN O
non JJ O
- HYPH O
cobra NN O
venom NN O
factor NN O
- HYPH O
treated VBN O
animals NNS O
in IN O
IgG NNP O
pre NN O
- HYPH O
exposure NN O
( HYPH O
challenge NN O
) -RRB- O
levels NNS O
. . O

Conversely RB O
, , O
isotype NN O
switching NN O
in IN O
the DT O
cobra NN O
venom NN O
factor NN O
treated VBD O
animals NNS O
was VBD O
enhanced VBN O
in IN O
post NN O
- HYPH O
exposure NN O
serum NN O
IgG2a NNP O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

Discussion NN O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
a DT O
key JJ O
role NN O
in IN O
protection NN O
from IN O
lethal JJ O
challenge NN O
for IN O
IFN NNP O
- HYPH O
gamma NN O
in IN O
non NN O
- HYPH O
vaccinated VBN O
mice NNS B-Species
from IN O
either CC O
NK NNP O
and CC O
/ SYM O
or CC O
NKT NNP O
cells NNS O
following VBG O
experimental JJ O
exposure NN O
to IN O
B NN B-Species
. . I-Species
mallei NN I-Species
and CC O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
. . O

A DT O
similar JJ O
protective JJ O
role NN O
in IN O
the DT O
innate JJ O
response NN O
to IN O
infection NN O
has VBZ O
been VBN O
demonstrated VBN O
for IN O
TNF NNP O
- HYPH O
alpha NN O
in IN O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
infection NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

The DT O
studies NNS O
presented VBN O
here RB O
are VBP O
consistent JJ O
with IN O
the DT O
essential JJ O
role NN O
of IN O
these DT O
factors NNS O
in IN O
the DT O
relative JJ O
levels NNS O
of IN O
protection NN O
conferred VBN O
by IN O
vaccination NN O
with IN O
heat NN O
- HYPH O
killed VBN O
B NNP B-Species
. . I-Species
pseudomallei NN I-Species
and CC O
would MD O
appear VB O
to TO O
be VB O
viable JJ O
early JJ O
markers NNS O
for IN O
protection NN O
from IN O
lethal JJ O
acute JJ O
infection NN O
[ -LRB- O
9 CD O
] -RRB- O
. . O

Currently RB O
, , O
there EX O
are VBP O
no DT O
fully RB O
protective JJ O
vaccines NNS O
against IN O
B NN B-Species
. . I-Species
mallei NN I-Species
or CC O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
in IN O
a DT O
murine NN B-Species
model NN O
, , O
particularly RB O
for IN O
the DT O
sensitive JJ O
BALB NNP O
/ SYM O
c NN O
versus IN O
C57BL6 NN O
models NNS O
. . O

Previous JJ O
studies NNS O
have VBP O
also RB O
demonstrated VBN O
that IN O
both CC O
the DT O
humoral JJ O
and CC O
cell NN O
- HYPH O
mediated VBN O
arms NNS O
are VBP O
essential JJ O
for IN O
protection NN O
from IN O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
infection NN O
[ -LRB- O
10 CD O
] -RRB- O
. . O

Thus RB O
, , O
loss NN O
or CC O
reduction NN O
of IN O
TNF NNP O
- HYPH O
alpha NN O
and CC O
IFN NNP O
- HYPH O
gamma NN O
levels NNS O
result VBP O
in IN O
significantly RB O
reduced VBN O
survival NN O
rates NNS O
, , O
substantiating VBG O
previous JJ O
reports NNS O
of IN O
the DT O
role NN O
of IN O
these DT O
factors NNS O
in IN O
protection NN O
against IN O
B NNP B-Species
. . I-Species
mallei NN I-Species
[ -LRB- O
7 CD O
] -RRB- O
. . O

Moreover RB O
, , O
we PRP O
demonstrate VBP O
a DT O
role NN O
for IN O
sustained JJ O
TNF NNP O
- HYPH O
alpha NN O
production NN O
in IN O
the DT O
maintenance NN O
of IN O
host NN O
survival NN O
throughout IN O
the DT O
course NN O
of IN O
B NN B-Species
. . I-Species
mallei NN I-Species
infection NN O
. . O

Mice NNS B-Species
with IN O
an DT O
established VBN O
B NN B-Species
. . I-Species
mallei NN I-Species
chronic JJ O
infection NN O
rapidly RB O
lost VBD O
the DT O
ability NN O
to TO O
control VB O
the DT O
growth NN O
of IN O
the DT O
bacillus NN O
upon IN O
neutralization NN O
of IN O
TNF NNP O
- HYPH O
alpha NN O
. . O

This DT O
would MD O
suggest VB O
a DT O
potential JJ O
role NN O
for IN O
TNF NNP O
- HYPH O
alpha NN O
in IN O
the DT O
maintenance NN O
of IN O
productive JJ O
granulomas NNS O
which WDT O
may MD O
limit VB O
the DT O
spread NN O
of IN O
bacteria NNS O
in IN O
chronically RB O
infected JJ O
hosts NNS O
, , O
or CC O
, , O
alternatively RB O
, , O
in IN O
direct JJ O
or CC O
indirect JJ O
microbicidal JJ O
or CC O
bacteriostatic JJ O
activities NNS O
at IN O
the DT O
sites NNS O
of IN O
infection NN O
. . O

Additional JJ O
studies NNS O
are VBP O
underway JJ O
to TO O
determine VB O
more RBR O
precisely RB O
the DT O
role NN O
of IN O
TNF NNP O
- HYPH O
alpha NN O
in IN O
host NN O
protection NN O
to IN O
B NN B-Species
. . I-Species
mallei NN I-Species
. . O

Multiple JJ O
innate JJ O
and CC O
adaptive JJ O
cell NN O
types NNS O
may MD O
contribute VB O
to IN O
the DT O
production NN O
of IN O
IFN NN O
- HYPH O
gamma NN O
in IN O
response NN O
to IN O
infection NN O
with IN O
B NN B-Species
. . I-Species
mallei NN I-Species
following VBG O
vaccination NN O
. . O

Our PRP$ O
results NNS O
with IN O
individual JJ O
depletion NN O
of IN O
CD4 NNP O
+ CC O
and CC O
CD8 NNP O
+ CC O
T NN O
cells NNS O
suggests VBZ O
that IN O
both DT O
cell NN O
types NNS O
may MD O
compensate VB O
for IN O
the DT O
functional JJ O
loss NN O
of IN O
the DT O
other JJ O
effector NN O
cell NN O
type NN O
in IN O
the DT O
production NN O
of IN O
this DT O
key JJ O
cytokine NN O
. . O

The DT O
effector NN O
role NN O
for IN O
IFN NNP O
- HYPH O
gamma NN O
in IN O
mediating VBG O
protection NN O
against IN O
B NNP B-Species
. . I-Species
mallei NN I-Species
may MD O
include VB O
both CC O
immunoregulatory JJ O
and CC O
non JJ O
- HYPH O
regulatory JJ O
functions NNS O
. . O

Regardless RB O
, , O
the DT O
requirement NN O
of IN O
IFN NNP O
- HYPH O
gamma NN O
, , O
as IN O
demonstrated VBN O
by IN O
administration NN O
of IN O
neutralizing VBG O
antibody NN O
prior RB O
to IN O
infection NN O
, , O
indicates VBZ O
that IN O
stimulation NN O
of IN O
IFN NNP O
- HYPH O
gamma NN O
response NN O
is VBZ O
a DT O
desirable JJ O
goal NN O
for IN O
a DT O
B NN B-Species
. . I-Species
mallei NN I-Species
vaccine NN O
. . O

Similarly RB O
, , O
B220 NNP O
- HYPH O
positive JJ O
cells NNS O
appear VBP O
to TO O
play VB O
a DT O
role NN O
in IN O
protection NN O
following VBG O
vaccination NN O
with IN O
heat NN O
- HYPH O
killed VBN O
B NNP B-Species
. . I-Species
mallei NNP I-Species
. . O

Interestingly RB O
, , O
this DT O
protective JJ O
immunity NN O
, , O
occurring VBG O
in IN O
other JJ O
intracellular JJ O
pathogens NNS O
, , O
is VBZ O
not RB O
exclusively RB O
dependent JJ O
on IN O
B NNP O
cells NNS O
[ -LRB- O
11 CD O
] -RRB- O
. . O

Passive JJ O
protection NN O
has VBZ O
been VBN O
demonstrated VBN O
against IN O
acute JJ O
Burkholderia NNP O
infection NN O
by IN O
monoclonal JJ O
antibodies NNS O
[ -LRB- O
5 CD O
, , O
12 CD O
] -RRB- O
. . O

Protection NN O
against IN O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
infection NN O
by IN O
anti JJ O
- HYPH O
LPS NNP O
, , O
capsular NN O
polysaccharide NN O
and CC O
proteins NNS O
has VBZ O
been VBN O
short RB O
- HYPH O
lived VBN O
, , O
suggesting VBG O
that IN O
antibody NN O
production NN O
offers VBZ O
limited JJ O
protection NN O
in IN O
the DT O
initial JJ O
stages NNS O
of IN O
infection NN O
by IN O
an DT O
as IN O
- HYPH O
yet CC O
- HYPH O
undefined JJ O
mechanism NN O
[ -LRB- O
12 CD O
] -RRB- O
. . O

We PRP O
have VBP O
shown VBN O
that IN O
following VBG O
depletion NN O
of IN O
B220 NNP O
+ SYM O
cells NNS O
, , O
survival NN O
rates NNS O
decreased VBD O
as RB O
much JJ O
as IN O
100 CD O
% NN O
relative JJ O
to IN O
non NN O
- HYPH O
depleted VBN O
controls NNS O
and CC O
individual JJ O
CD4 NN O
/ SYM O
CD8 NN O
- HYPH O
depleted VBN O
mice NNS B-Species
via IN O
the DT O
intraperitoneal JJ O
route NN O
. . O

Results NNS O
from IN O
C57BL NNP O
/ SYM O
6 CD O
mice NN B-Species
deficient JJ O
in IN O
mature JJ O
B NN O
- HYPH O
cells NNS O
( , O
mu NN O
MT NNP O
) -RRB- O
, , O
CD4 NNP O
T NNP O
- HYPH O
cells NNS O
( , O
CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
or CC O
CD8 NNP O
T NNP O
- HYPH O
cells NNS O
( -LRB- O
CD8 NNP O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
substantiate VBP O
the DT O
requirement NN O
for IN O
B NN O
- HYPH O
cell NN O
involvement NN O
by IN O
evidence NN O
of IN O
mu NN O
MT NNP O
and CC O
CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
decreased VBN O
survival NN O
. . O

The DT O
lack NN O
of IN O
an DT O
effective JJ O
CTL NNP O
response NN O
to IN O
vaccination NN O
did VBD O
not RB O
appear VB O
to TO O
alter VB O
survival NN O
in IN O
what WP O
would MD O
appear VB O
to TO O
be VB O
a DT O
CD4 NNP O
/ SYM O
B NN O
- HYPH O
cell NN O
( , O
humoral JJ O
) -RRB- O
- HYPH O
driven VBN O
response NN O
. . O

In IN O
CD4 NN O
- HYPH O
deficient JJ O
mice NNS B-Species
, , O
we PRP O
have VBP O
the DT O
additional JJ O
potential JJ O
variable JJ O
that IN O
a DT O
CD4 NN O
- HYPH O
dependent JJ O
antibody NN O
response NN O
might MD O
also RB O
be VB O
inhibited VBN O
during IN O
the DT O
vaccination NN O
phase NN O
relative JJ O
to IN O
mice NNS B-Species
treated VBN O
with IN O
antibody NN O
immediately RB O
prior RB O
to IN O
and CC O
during IN O
the DT O
early JJ O
phases NNS O
of IN O
infection NN O
. . O

Although IN O
not RB O
statistically RB O
significant JJ O
, , O
we PRP O
did VBD O
observe VB O
a DT O
decrease NN O
in IN O
survival NN O
in IN O
mu NNP O
MT NNP O
( , O
mature JJ O
B NN O
cell NN O
) -RRB- O
deficient JJ O
mice NNS B-Species
as RB O
early RB O
as IN O
day NN O
9 CD O
post NN O
challenge NN O
, , O
whereas IN O
CD4 NN O
- HYPH O
deficient JJ O
mice NN B-Species
produced VBD O
similar JJ O
results NNS O
at IN O
day NN O
32 CD O
post NN O
challenge NN O
, , O
indicating VBG O
a DT O
role NN O
for IN O
B NN O
cells NNS O
independent JJ O
of IN O
CD4 NNP O
T NNP O
cell NN O
help NN O
, , O
perhaps RB O
through IN O
a DT O
T NNP O
- HYPH O
independent JJ O
mechanism NN O
of IN O
antibody NN O
production NN O
. . O

Although IN O
CD8 NNP O
- HYPH O
/ SYM O
- HYPH O
C57BL NNP O
/ SYM O
6 CD O
demonstrated VBD O
no DT O
decreased VBN O
survival NN O
in IN O
our PRP$ O
HK NNP O
- HYPH O
vaccinated VBN O
model NN O
, , O
a DT O
lack NN O
of IN O
potential JJ O
endogenous JJ O
protein NN O
production NN O
by IN O
HK NNP O
B NNP B-Species
. . I-Species
mallei NNP I-Species
may MD O
have VB O
contributed VBN O
to IN O
limited JJ O
MHC NNP O
- HYPH O
I PRP O
presentation NN O
. . O

Complement NN O
associated VBN O
studies NNS O
revealed VBD O
increased VBN O
J774A NNP O
. . O
1 CD O
uptake NN O
of IN O
serum NN O
- HYPH O
treated VBN O
B NN B-Species
. . I-Species
mallei NNP I-Species
. . O

Complement NN O
- HYPH O
mediated VBN O
uptake NN O
studies NNS O
of IN O
B NN B-Species
. . I-Species
pseudomallei NN I-Species
by IN O
polymorphonuclear NN O
leukocytes NNS O
( -LRB- O
PMNs NNP O
) -RRB- O
suggest VBP O
that IN O
capsule NN O
production NN O
contributes VBZ O
to IN O
resistance NN O
of IN O
phagocytosis NN O
by IN O
reducing VBG O
C3b NN O
bacterial JJ O
deposition NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Previous JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
a DT O
polysaccharide NN O
capsule NN O
is VBZ O
present JJ O
in IN O
B NN B-Species
. . I-Species
mallei NN I-Species
, , O
[ -LRB- O
14 CD O
, , O
15 CD O
] -RRB- O
although IN O
in IN O
the DT O
present JJ O
study NN O
enhanced VBN O
uptake NN O
with IN O
serum NN O
- HYPH O
treated VBN O
B NNP B-Species
. . I-Species
mallei NNP I-Species
was VBD O
observed VBN O
. . O

Intracellular JJ O
survival NN O
assays NNS O
of IN O
complement NN O
mediated VBN O
uptake NN O
of IN O
organisms NNS O
were VBD O
not RB O
performed VBN O
in IN O
the DT O
present JJ O
study NN O
, , O
thus RB O
, , O
the DT O
role NN O
of IN O
complement NN O
opsonization NN O
on IN O
intracellular JJ O
survival NN O
is VBZ O
not RB O
fully RB O
resolved VBN O
. . O

Previous JJ O
reports NNS O
have VBP O
demonstrated VBN O
the DT O
ability NN O
of IN O
B NN B-Species
. . I-Species
mallei NN I-Species
to TO O
survive VB O
within IN O
macrophage NN O
without IN O
the DT O
aid NN O
of IN O
serum NN O
coating NN O
organisms NNS O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Conversely RB O
, , O
the DT O
idea NN O
of IN O
antibody NN O
mediated VBN O
opsonization NN O
to TO O
facilitate VB O
macrophage NN O
activation NN O
and CC O
clearance NN O
of IN O
intracellular JJ O
organisms NNS O
may MD O
offer VB O
support NN O
to IN O
the DT O
role NN O
of IN O
B NN O
cells NNS O
in IN O
an DT O
effective JJ O
immune JJ O
response NN O
. . O

A DT O
possible JJ O
protective JJ O
mechanism NN O
may MD O
include VB O
HK NNP O
vaccination NN O
induced VBN O
production NN O
of IN O
opsonizing JJ O
antibodies NNS O
which WDT O
may MD O
aid VB O
in IN O
complement NN O
mediated VBN O
uptake NN O
, , O
thereby RB O
limiting VBG O
the DT O
initial JJ O
bacterial JJ O
threshold NN O
below IN O
a DT O
lethal JJ O
level NN O
. . O

Immunoglobulin NN O
responses NNS O
to IN O
HK NNP O
vaccination NN O
resulted VBD O
in IN O
modest JJ O
levels NNS O
of IN O
IgG1 NNP O
following VBG O
2 CD O
weeks NNS O
post NN O
vaccination NN O
, , O
while IN O
post NN O
- HYPH O
exposure NN O
levels NNS O
were VBD O
indicative JJ O
of IN O
efficient JJ O
class NN O
switching NN O
to IN O
a DT O
favorable JJ O
IgG2a NNP O
isotype NN O
. . O

Importantly RB O
, , O
cobra NN O
venom NN O
factor NN O
treatment NN O
of IN O
animals NNS O
at IN O
time NN O
of IN O
vaccination NN O
did VBD O
not RB O
alter VB O
their PRP$ O
ability NN O
to TO O
produce VB O
immunoglobulin NN O
. . O

In IN O
fact NN O
, , O
cobra NN O
venom NN O
factor NN O
treated VBN O
animals NNS O
resulted VBD O
in IN O
higher JJR O
IgG2a NNP O
levels NNS O
when WRB O
compared VBN O
to IN O
non NN O
- HYPH O
treated VBN O
. . O

Complement NN O
activation NN O
can MD O
modulate VB O
both CC O
the DT O
primary JJ O
and CC O
secondary JJ O
immune JJ O
responses NNS O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
enhance VB O
secondary JJ O
immune JJ O
responses NNS O
to IN O
vaccination NN O
[ -LRB- O
17 CD O
] -RRB- O
. . O

The DT O
current JJ O
results NNS O
suggest VBP O
that IN O
cobra NN O
venom NN O
factor NN O
treatment NN O
may MD O
affect VB O
the DT O
modulation NN O
of IN O
the DT O
immune JJ O
response NN O
to IN O
B NN B-Species
. . I-Species
mallei NN I-Species
infection NN O
through IN O
B NN O
cell NN O
activation NN O
and CC O
/ SYM O
or CC O
memory NN O
B NN O
cell NN O
generation NN O
. . O

Conclusion NN O

In IN O
summary NN O
, , O
our PRP$ O
results NNS O
provide VBP O
a DT O
basis NN O
for IN O
future JJ O
studies NNS O
of IN O
protection NN O
via IN O
vaccination NN O
using VBG O
either CC O
subunit NN O
or CC O
whole JJ O
- HYPH O
organism NN O
vaccine NN O
preparations NNS O
from IN O
lethal JJ O
infection NN O
in IN O
the DT O
experimental JJ O
BALB NNP O
/ SYM O
c NN O
mouse NN B-Species
model NN O
. . O

Understanding VBG O
and CC O
defining VBG O
the DT O
role NN O
of IN O
B NN O
cells NNS O
in IN O
adaptive JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
immunity NN O
will MD O
likely RB O
be VB O
fundamental JJ O
to IN O
the DT O
design NN O
of IN O
an DT O
efficacious JJ O
vaccine NN O
and CC O
important JJ O
goals NNS O
of IN O
future JJ O
research NN O
. . O

Methods NNS O

Bacterial JJ O
strain NN O
and CC O
mice NNS B-Species

B NN B-Species
. . I-Species
mallei NN I-Species
strain NN O
ATCC NNP O
23344 CD O
( , O
China NNP O
7 CD O
) -RRB- O
was VBD O
cultured VBN O
on IN O
Luria NNP O
- HYPH O
Bertani NNP O
agar NN O
supplemented VBN O
with IN O
4 CD O
% NN O
glycerol NN O
( , O
LB NN O
+ SYM O
4 CD O
% NN O
G NN O
) -RRB- O
agar NN O
plates NNS O
for IN O
48 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Isolated JJ O
colonies NNS O
were VBD O
sub NN O
- HYPH O
cultured VBN O
to IN O
LB NNP O
+ SYM O
4 CD O
% NN O
G NN O
broth NN O
, , O
and CC O
cultures NNS O
were VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
until IN O
optical JJ O
density NN O
readings NNS O
at IN O
600 CD O
nm NN O
( SYM O
OD600 CD O
) -RRB- O
reached VBD O
an DT O
exponential JJ O
phase NN O
of IN O
growth NN O
. . O

Bacteria NNS O
were VBD O
pelleted VBN O
by IN O
centrifugation NN O
, , O
washed VBN O
and CC O
re NN O
- HYPH O
suspended VBN O
in IN O
sterile JJ O
1 CD O
x NN O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
( , O
PBS NNP O
, , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
to TO O
obtain VB O
the DT O
desired VBN O
CFU NN O
/ SYM O
ml NNP O
. . O

To TO O
obtain VB O
HK NNP O
inoculums NNS O
, , O
bacterial JJ O
suspensions NNS O
were VBD O
incubated VBN O
at IN O
85 CD O
degrees NNS O
C NN O
for IN O
3 CD O
h NN O
and CC O
stored VBN O
at IN O
4 CD O
degrees NNS O
C NN O
until IN O
use NN O
. . O

The DT O
absence NN O
of IN O
live JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
organisms NNS O
in IN O
the DT O
HK NNP O
preparations NNS O
was VBD O
confirmed VBN O
after IN O
plating VBG O
10 CD O
% NN O
of IN O
the DT O
total JJ O
inoculums NNS O
( , O
v NN O
/ SYM O
v NN O
) -RRB- O
and CC O
incubating VBG O
these DT O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
48 CD O
h NNS O
. . O

All DT O
procedures NNS O
were VBD O
performed VBN O
under IN O
a DT O
class NN O
II NNP O
biosafety NN O
cabinet NN O
in IN O
a DT O
biosafety NN O
level NN O
3 CD O
laboratory NN O
. . O

Female JJ O
, , O
6 CD O
- HYPH O
to TO O
8 CD O
- HYPH O
week NN O
- HYPH O
old JJ O
, , O
BALB NNP O
/ SYM O
c NN O
mice NNS B-Species
( : O
n CD O
= SYM O
5 CD O
- HYPH O
7 CD O
) -RRB- O
were VBD O
obtained VBN O
from IN O
Harlan NNP O
Sprague NNP O
Dawley NNP O
, , O
Inc NNP O
. . O

( : O
Indianapolis NNP O
, , O
Indiana NNP O
) -RRB- O
. . O

Female JJ O
, , O
6 CD O
- HYPH O
to TO O
8 CD O
- HYPH O
week NN O
- HYPH O
old JJ O
, , O
C57BL NNP O
/ SYM O
6 CD O
mice NN B-Species
deficient JJ O
in IN O
mature JJ O
B NN O
- HYPH O
cells NNS O
( , O
mu NN O
MT NNP O
) -RRB- O
, , O
CD4 NNP O
T NNP O
- HYPH O
cells NNS O
( , O
CD4 NNP O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
and CC O
CD8 NNP O
T NNP O
- HYPH O
cells NNS O
( -LRB- O
CD8 NN O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
and CC O
wild JJ O
- HYPH O
type NN O
mice NNS B-Species
were VBD O
obtained VBN O
from IN O
The DT O
Jackson NNP O
Laboratory NNP O
( : O
Bar NNP O
Harbor NNP O
, , O
Maine NNP O
) -RRB- O
. . O

Vaccination NN O
and CC O
challenge NN O

BALB NNP O
/ SYM O
c NNP O
and CC O
C57BL NNP O
/ SYM O
6 CD O
mice NNS B-Species
were VBD O
grouped VBN O
and CC O
vaccinated VBN O
with IN O
0 CD O
. . O
5 CD O
mu NN O
g NN O
of IN O
HK NN O
B NN B-Species
. . I-Species
mallei NNP I-Species
( , O
without IN O
adjuvant NN O
) -RRB- O
by IN O
i PRP O
. . O
p NN O
. . O
injection NN O
using VBG O
a DT O
25 CD O
- HYPH O
gauge NN O
syringe NN O
. . O

Two CD O
weeks NNS O
post NN O
HK NNP O
vaccination NN O
mice NNS B-Species
were VBD O
injected VBN O
i PRP O
. . O
p UH O
. . O
with IN O
2 CD O
x SYM O
107 CD O
CFU NN O
/ SYM O
100 CD O
mu NNS O
l NN O
of IN O
live JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
( , O
~ $ O
20 CD O
LD50 CD O
) -RRB- O
[ -LRB- O
18 CD O
] -RRB- O
. . O

Complement VB O
depleted VBN O
animals NNS O
were VBD O
challenged VBN O
with IN O
2 CD O
. . O
5 CD O
x SYM O
104 CD O
CFU NN O
/ SYM O
50 CD O
mu NN O
l NN O
( : O
~ $ O
0 CD O
. . O
25 CD O
LD50 CD O
) -RRB- O
by IN O
intranasal NN O
( : O
i CD O
. . O
n NN O
. . O
) -RRB- O
route NN O
. . O

Aliquots NNS O
from IN O
the DT O
inoculums NNS O
were VBD O
plated VBN O
to TO O
confirm VB O
the DT O
infecting VBG O
dose NN O
. . O

All DT O
procedures NNS O
and CC O
animal NN O
protocols NNS O
used VBN O
in IN O
this DT O
study NN O
were VBD O
approved VBN O
by IN O
the DT O
Biosafety NNP O
and CC O
IACUC NNP O
committees NNS O
at IN O
UTMB NNP O
and CC O
conducted VBN O
in IN O
either CC O
BSL NNP O
- HYPH O
3 CD O
or CC O
ABSL NNP O
- HYPH O
3 CD O
laboratories NNS O
. . O

Cell NN O
and CC O
cytokine NN O
depletions NNS O

Acute NN O
in IN O
vivo NN O
cell NN O
/ SYM O
cytokine NN O
depletion NN O
was VBD O
performed VBN O
with IN O
monoclonal JJ O
rat JJ B-Species
anti JJ O
- HYPH O
mouse NN B-Species
CD4 NNP O
( : O
GK1 NNP O
. . O
5 CD O
) -RRB- O
, , O
CD8 NNP O
alpha NN O
( , O
53 CD O
- SYM O
6 CD O
. . O
7 CD O
) -RRB- O
or CC O
B220 CD O
( SYM O
RA3 NNP O
- HYPH O
6B2 CD O
) -RRB- O
obtained VBN O
from IN O
R NNP O
& CC O
D NNP O
Systems NNPS O
, , O
Inc NNP O
. . O

( -LRB- O
Minneapolis NNP O
, , O
MN NNP O
) -RRB- O
by IN O
methods NNS O
similar JJ O
to IN O
those DT O
we PRP O
have VBP O
previously RB O
described VBN O
[ -LRB- O
19 CD O
] -RRB- O
. . O

Functional JJ O
grade NN O
purified VBN O
rat JJ B-Species
anti JJ O
- HYPH O
mouse NN B-Species
interferon NN O
- HYPH O
gamma NN O
( , O
IFN NNP O
- HYPH O
gamma NN O
, , O
AN NNP O
- HYPH O
18 CD O
) -RRB- O
was VBD O
obtained VBN O
from IN O
eBioscience NNP O
( , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
and CC O
purified JJ O
anti JJ O
- HYPH O
mouse NN B-Species
tumor NN O
necrosis NN O
factor NN O
( , O
TNF NNP O
- HYPH O
alpha NN O
, , O
MP6 NNP O
- HYPH O
XT3 NNP O
) -RRB- O
from IN O
BD NNP O
Pharmingen NNP O
( : O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
. . O

IFN NNP O
- HYPH O
gamma NN O
and CC O
TNF NNP O
- HYPH O
alpha NN O
antibodies NNS O
were VBD O
injected VBN O
i PRP O
. . O
p LS O
. . O

6 CD O
h NN O
prior RB O
to IN O
challenge NN O
, , O
200 CD O
mu NN O
g NN O
per IN O
mouse NN B-Species
in IN O
200 CD O
mu NNS O
l CC O
PBS NN O
or CC O
at IN O
later JJ O
time NN O
points NNS O
as IN O
indicated VBN O
. . O

Rat NNP B-Species
IgG NNP O
isotype NN O
control NN O
was VBD O
obtained VBN O
from IN O
Southern NNP O
Biotech NNP O
( : O
Birmingham NNP O
, , O
AL NNP O
) -RRB- O
and CC O
administered VBN O
i NFP O
. . O
p LS O
. . O
on IN O
day NN O
of IN O
challenge NN O
, , O
200 CD O
mu NN O
g NN O
/ SYM O
mouse NN B-Species
. . O

Rat JJ B-Species
anti JJ O
- HYPH O
mouse NNP B-Species
CD4 NNP O
, , O
CD8 NN O
alpha NN O
and CC O
B220 NN O
were VBD O
injected VBN O
i PRP O
. . O
p LS O
. . O
twice RB O
, , O
1 CD O
day NN O
prior RB O
to IN O
challenge NN O
and CC O
on IN O
day NN O
of IN O
challenge NN O
, , O
with IN O
an DT O
equivalent JJ O
dosage NN O
sufficient JJ O
to TO O
deplete VB O
T NN O
or CC O
B NN O
cells NNS O
from IN O
6 CD O
x SYM O
108 CD O
bone NN O
marrow NN O
cells NNS O
per IN O
injection NN O
. . O

The DT O
efficiency NN O
of IN O
depletion NN O
at IN O
time NN O
of IN O
infection NN O
for IN O
CD4 NNP O
+ CC O
, , O
CD8 NNP O
+ CC O
, , O
and CC O
B220 NNP O
+ CC O
cells NNS O
was VBD O
confirmed VBN O
by IN O
flow NN O
cytometry NN O
analysis NN O
immediately RB O
prior RB O
to IN O
infection NN O
. . O

Complement VB O
depletion NN O
with IN O
cobra NN O
venom NN O
factor NN O

Mice NNS B-Species
, , O
six CD O
to TO O
seven CD O
per IN O
group NN O
, , O
were VBD O
vaccinated VBN O
i PRP O
. . O
p UH O
. . O
with IN O
1 CD O
x SYM O
105 CD O
CFU NN O
of IN O
nonviable JJ O
B NN B-Species
. . I-Species
mallei NN I-Species
cell NN O
preparation NN O
in IN O
a DT O
total JJ O
volume NN O
of IN O
0 CD O
. . O
1 CD O
ml NNS O
. . O

Two CD O
weeks NNS O
later RB O
, , O
24 CD O
h NN O
and CC O
1 CD O
h NN O
before IN O
challenge NN O
, , O
complement VBP O
depleted VBN O
mice NNS B-Species
were VBD O
treated VBN O
i : O
. . O
p UH O
. . O
with IN O
12 CD O
. . O
5 CD O
units NNS O
total JJ O
cobra NN O
venom NN O
factor NN O
( : O
Quidel NNP O
Corporation NNP O
Speciality NNP O
Products NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
in IN O
0 CD O
. . O
1 CD O
ml NNS O
of IN O
PBS NNP O
. . O

Complement NN O
depletion NN O
was VBD O
confirmed VBN O
prior RB O
to IN O
challenge NN O
by IN O
micro JJ O
- HYPH O
titer NN O
hemolytic JJ O
complement NN O
activity NN O
( -LRB- O
CH50 NNP O
) -RRB- O
assay NN O
as IN O
previously RB O
described VBN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

B NN B-Species
. . I-Species
mallei NNP I-Species
J774A NNP O
. . O
1 CD O
uptake NN O
assays NNS O

J774A NNP O
. . O
1 CD O
cells NNS O
were VBD O
seeded VBN O
( : O
5 CD O
x SYM O
105 CD O
) -RRB- O
onto IN O
Corning NN O
costar NN O
24 CD O
well NN O
plates NNS O
( , O
Corning NNP O
, , O
NY NNP O
) -RRB- O
with IN O
DMEM NNP O
and CC O
incubated VBN O
overnight RB O
at IN O
37 CD O
degrees NNS O
C NN O
with IN O
5 CD O
% NN O
CO2 NN O
. . O

Bacterial JJ O
suspensions NNS O
were VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
45 CD O
minutes NNS O
supplemented VBN O
with IN O
2 CD O
% NN O
mouse NN B-Species
serum NN O
from IN O
Sigma NNP O
- HYPH O
Aldrich NNP O
( : O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
. . O
) -RRB- O
, , O
heat NN O
inactivated VBN O
mouse NN B-Species
serum NN O
( , O
56 CD O
degrees NNS O
C NN O
30 CD O
minutes NNS O
) -RRB- O
, , O
or CC O
bacteria NNS O
alone RB O
and CC O
then RB O
added VBN O
at IN O
an DT O
MOI NNP O
of IN O
10 CD O
: : O
1 CD O
to IN O
J774A NN O
. . O
1 CD O
cells NNS O
in IN O
triplicate NN O
. . O

Inoculated JJ O
wells NNS O
were VBD O
centrifuged VBN O
at IN O
800 CD O
g NN O
for IN O
2 CD O
minutes NNS O
and CC O
incubated VBN O
for IN O
2 CD O
hours NNS O
at IN O
37 CD O
degrees NNS O
C NN O
with IN O
5 CD O
% NN O
CO2 NN O
followed VBN O
by IN O
a DT O
PBS NNP O
wash NN O
( : O
x SYM O
2 CD O
) SYM O
and CC O
2 CD O
hour NN O
incubation NN O
with IN O
250 CD O
mu NNS O
g NN O
/ SYM O
ml FW O
kanamycin FW O
. . O

Wells NNS O
were VBD O
washed VBN O
twice RB O
with IN O
PBS NNP O
and CC O
lysed VBN O
with IN O
0 CD O
. . O
1 CD O
% NN O
Triton NNP O
X NNP O
- HYPH O
100 CD O
, , O
followed VBN O
by IN O
serial JJ O
10 CD O
- HYPH O
fold NN O
dilutions NNS O
plated VBN O
on IN O
LBG NNP O
plates NNS O
and CC O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
2 CD O
days NNS O
. . O

Colony NN O
forming VBG O
units NNS O
were VBD O
enumerated VBN O
and CC O
uptake NN O
expressed VBN O
as IN O
a DT O
percentage NN O
of IN O
initial JJ O
inoculating VBG O
dose NN O
+ SYM O
/ SYM O
- HYPH O
SEM NN O
. . O

Antibodies NNS O
and CC O
flow NN O
cytometry NN O

Flow NN O
cytometric JJ O
analysis NN O
was VBD O
performed VBN O
on IN O
0 CD O
. . O
1 CD O
- HYPH O
ml NN O
blood NN O
samples NNS O
transferred VBN O
to IN O
micro NN O
centrifuge NN O
tubes NNS O
containing VBG O
90 CD O
mu NNS O
l NN O
of IN O
acid NN O
citrate NN O
dextrose NN O
( -LRB- O
ACD NN O
) -RRB- O
solution NN O
. . O

Red JJ O
blood NN O
cells NNS O
were VBD O
lysed VBN O
using VBG O
ACK NNP O
- HYPH O
lysing VBG O
buffer NN O
( , O
Biosource NNP O
International NNP O
, , O
Inc NNP O
. . O
, , O
Camarillo NNP O
, , O
CA NNP O
) , O
according VBG O
to IN O
the DT O
manufacturer NN O
' POS O
s NN O
instruction NN O
. . O

Antibodies NNS O
used VBN O
for IN O
analysis NN O
of IN O
surface NN O
markers NNS O
included VBD O
: : O
FITC NNP O
- HYPH O
conjugated VBN O
rat JJ B-Species
anti JJ O
- HYPH O
mouse NNP B-Species
CD45R NNP O
/ SYM O
B220 NNP O
( , O
RA3 NNP O
- HYPH O
6B2 CD O
, , O
BD NNP O
Pharmingen NNP O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
for IN O
B NN O
cells NNS O
; : O
FITC NNP O
- HYPH O
conjugated VBN O
rat JJ B-Species
anti JJ O
- HYPH O
mouse NN B-Species
CD8 NNP O
alpha NN O
( : O
53 CD O
- SYM O
6 CD O
. . O
7 CD O
) -RRB- O
and CC O
CD4 NN O
( : O
GK1 NNP O
. . O
5 CD O
, , O
BD NNP O
Pharmingen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
for IN O
CD8 NN O
+ SYM O
or CC O
CD4 NN O
+ SYM O
cells NNS O
, , O
respectively RB O
. . O

Samples NNS O
evaluated VBN O
for IN O
CD4 NNP O
+ CC O
and CC O
CD8 NNP O
alpha NN O
+ CC O
cells NNS O
were VBD O
also RB O
incubated VBN O
with IN O
biotin NN O
- HYPH O
conjugated VBN O
hamster NN O
anti JJ O
- HYPH O
mouse NN B-Species
CD3e NNP O
( -LRB- O
145 CD O
- SYM O
2C11 CD O
) -RRB- O
monoclonal JJ O
antibody NN O
( , O
BD NNP O
Pharmingen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
and CC O
subsequently RB O
with IN O
streptavidin NN O
APC NNP O
Cy7 NNP O
. . O

Isotype NN O
- HYPH O
matched VBN O
, , O
non NNP O
- HYPH O
specific JJ O
controls NNS O
were VBD O
assayed VBN O
in IN O
parallel NN O
( , O
BD NNP O
Pharmingen NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
) -RRB- O
. . O

Surface NN O
staining NN O
was VBD O
performed VBN O
according VBG O
to IN O
previously RB O
published VBN O
protocols NNS O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Following VBG O
cell NN O
staining NN O
, , O
the DT O
samples NNS O
were VBD O
fixed VBN O
with IN O
2 CD O
% NN O
buffered VBN O
paraformaldehyde NN O
overnight RB O
prior RB O
to IN O
analysis NN O
by IN O
flow NN O
cytometry NN O
. . O

Samples NNS O
were VBD O
analyzed VBN O
using VBG O
a DT O
FACSCalibur NNP O
flow NN O
cytometer NN O
with IN O
BD NNP O
CellQuest NNP O
Pro NNP O
software NN O
. . O

Antibody NN O
assays NNS O

Immunoglobulin NN O
subclass NN O
IgG1 NNP O
and CC O
IgG2a NNP O
titers NNS O
in IN O
mice NNS B-Species
were VBD O
determined VBN O
by IN O
a DT O
whole JJ O
bacterial JJ O
cell NN O
ELISA NNP O
performed VBN O
in IN O
96 CD O
- HYPH O
well NN O
, , O
Immulon NNP O
2 CD O
HB NNP O
, , O
round JJ O
- HYPH O
bottom NN O
plates NNS O
( , O
Dynex NNP O
Technologies NNPS O
) -RRB- O
. . O

B NN B-Species
. . I-Species
mallei NN I-Species
antigen NN O
was VBD O
diluted VBN O
in IN O
0 CD O
. . O
1 CD O
M NN O
carbonate NN O
buffer NN O
( , O
pH NN O
9 CD O
. . O
5 CD O
) -RRB- O
and CC O
50 CD O
mu NNS O
l NN O
of IN O
diluted VBN O
cells NNS O
placed VBN O
into IN O
wells NNS O
. . O

Plates NNS O
were VBD O
stored VBN O
overnight RB O
at IN O
4 CD O
degrees NNS O
C NN O
. . O

The DT O
plates NNS O
were VBD O
washed VBN O
with IN O
washing NN O
solution NN O
( , O
1 CD O
x SYM O
PBS NN O
, , O
0 CD O
. . O
5 CD O
% NN O
Tween NNP O
20 CD O
) -RRB- O
, , O
and CC O
incubated VBN O
with IN O
100 CD O
mu NNS O
l NN O
of IN O
blocking NN O
solution NN O
( , O
1 CD O
x SYM O
PBS NN O
, , O
1 CD O
% NN O
bovine JJ B-Species
serum NN O
albumin NN O
, , O
0 CD O
. . O
5 CD O
% NN O
Tween NNP O
20 CD O
) -RRB- O
for IN O
1 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Dilutions NNS O
of IN O
mouse NNP B-Species
sera NN O
were VBD O
made VBN O
with IN O
blocking NN O
solution NN O
in IN O
duplicate JJ O
and CC O
plates NNS O
were VBD O
incubated VBN O
for IN O
1 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Following VBG O
incubation NN O
, , O
plates NNS O
were VBD O
washed VBN O
and CC O
50 CD O
mu NNS O
l NN O
of IN O
anti JJ O
- HYPH O
Ig NN O
- HYPH O
horseradish JJ B-Species
peroxidase NN O
subclass NN O
conjugate NN O
, , O
diluted VBN O
accordingly RB O
to IN O
manufacturer NN O
' '' O
s NN O
instructions NNS O
( -LRB- O
Southern NNP O
Biotechnology NNP O
Associates NNPS O
, , O
Inc NNP O
. . O
Birmingham NNP O
, , O
Ala NNP O
. . O
) -RRB- O
, , O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
incubated VBN O
for IN O
1 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

After IN O
washing VBG O
, , O
50 CD O
mu NNS O
l NN O
of IN O
2 CD O
, , O
2 CD O
' '' O
- HYPH O
azino NN O
- HYPH O
di NN O
- HYPH O
( , O
3 CD O
- HYPH O
ethylbenzthizoline NN O
) NFP O
- HYPH O
6 CD O
- HYPH O
sulfonate NN O
( , O
ABTS NNP O
) -RRB- O
peroxidase NN O
substrate NN O
( : O
KPL NNP O
, , O
Inc NNP O
. . O
, , O
Gaithersburg NNP O
, , O
Maryland NNP O
) , O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
plates NNS O
incubated VBN O
for IN O
25 CD O
min NN O
at IN O
room NN O
temperature NN O
. . O

The DT O
amount NN O
of IN O
bound JJ O
antibody NN O
was VBD O
determined VBN O
colorimetrically RB O
by IN O
absorbance NN O
at IN O
405 CD O
nm NN O
. . O

Statistical JJ O
analysis NN O

Survival JJ O
curves NNS O
were VBD O
calculated VBN O
by IN O
Kaplan NNP O
Meier NNP O
survival NN O
analysis NN O
with IN O
log NN O
- HYPH O
rank NN O
tests NNS O
between IN O
groups NNS O
using VBG O
GraphPad NNP O
Prism NNP O
( , O
V NNP O
. . O
4 CD O
. . O
3 CD O
for IN O
windows NNS O
) -RRB- O
. . O

Statistical JJ O
analysis NN O
was VBD O
generally RB O
performed VBN O
with IN O
the DT O
paired VBN O
Student NNP O
' '' O
s POS O
t NN O
- HYPH O
test NN O
. . O

P NN O
value NN O
< : O
= SYM O
0 CD O
. . O
5 CD O
was VBD O
considered VBN O
significant JJ O
. . O

Abbreviations NNS O

HK NN O
: : O
Heat NN O
- HYPH O
killed VBN O
; : O
i PRP O
. . O
p NN O
. . O
: : O
intraperitoneal JJ O
; : O
i PRP O
. . O
n LS O
. . O
: : O
intranasal NN O
. . O

Authors NNS O
' POS O
contributions NNS O

GCW NNP O
designed VBD O
and CC O
conducted VBD O
experiments NNS O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

BMJ NNP O
carried VBD O
out RP O
the DT O
immunoassays NNS O
and CC O
animal NN O
work NN O
. . O

SP NNP O
provided VBD O
analysis NN O
of IN O
data NNS O
and CC O
contributed VBD O
to IN O
design NN O
and CC O
animal NN O
work NN O
. . O

RAL NNP O
participated VBD O
in IN O
the DT O
generation NN O
and CC O
analysis NN O
of IN O
chronic JJ O
TNF NNP O
- HYPH O
alpha NN O
data NNS O
. . O

DME NNP O
conceived VBD O
the DT O
study NN O
, , O
and CC O
participated VBD O
in IN O
its PRP$ O
design NN O
and CC O
coordination NN O
and CC O
helped VBD O
to TO O
draft VB O
the DT O
manuscript NN O
. . O

AGT NNP O
participated VBD O
in IN O
the DT O
bacterial JJ O
work NN O
and CC O
drafting NN O
of IN O
the DT O
manuscript NN O
. . O

All DT O
authors NNS O
read VBP O
and CC O
approved VBD O
the DT O
final JJ O
manuscript NN O
. . O

The DT O
ineffectiveness NN O
of IN O
tobramycin NN O
combination NN O
therapy NN O
in IN O
Streptococcus NNP B-Species
faecium NN I-Species
endocarditis NN O
. . O

Abstract JJ O

A DT O
patient NN B-Species
required VBD O
mitral JJ O
valve NN O
replacement NN O
following VBG O
ineffective JJ O
antibiotic JJ O
treatment NN O
of IN O
enterococcal JJ O
endocarditis NN O
caused VBN O
by IN O
Streptococcus NNP B-Species
faecium NN I-Species
. . O

Endocarditis NNP O
had VBD O
relapsed VBN O
despite IN O
therapy NN O
with IN O
ampicillin NN O
and CC O
tobramycin NN O
for IN O
six CD O
weeks NNS O
. . O

A DT O
second JJ O
relapse NN O
had VBD O
occurred VBN O
following VBG O
treatment NN O
with IN O
penicillin NN O
and CC O
gentamicin NN O
. . O

Initial JJ O
failure NN O
of IN O
antibiotic JJ O
therapy NN O
may MD O
be VB O
related VBN O
to IN O
the DT O
known VBN O
lack NN O
of IN O
in FW O
vitro FW O
and CC O
in IN O
vivo NN O
synergy NN O
between IN O
penicillin NN O
and CC O
tobramycin NN O
against IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
. . O

Effective JJ O
therapy NN O
of IN O
enterococcal JJ O
endocarditis NN O
requires VBZ O
considerations NNS O
of IN O
bacterial JJ O
speciation NN O
, , O
determination NN O
of IN O
high JJ O
- HYPH O
level NN O
aminoglycoside NN O
resistance NN O
, , O
and CC O
preferably RB O
adequate JJ O
antibiotic JJ O
synergy NN O
studies NNS O
to TO O
assure VB O
effective JJ O
therapy NN O
. . O

THE DT O
YALE NNP O
JOURNAL NNP O
OF IN O
BIOLOGY NNP O
AND CC O
MEDICINE NNP O
56 CD O
( : O
1983 CD O
) -RRB- O
, , O
243 CD O
- HYPH O
249 CD O

The DT O
Ineffectiveness NN O
of IN O
Tobramycin NN O
Combination NN O
Therapy NN O

in IN O
Streptococcus NN B-Species
Faecium NNP I-Species
Endocarditis NNP O

JUDITH NNP O
A NNP O
. . O

GOLDSTEIN NNP O
, , O
M UH O
. . O
D NNP O
. . O
, , O
a DT O
HOWARD NNP O
COHEN NNP O
, , O
M NNP O
. . O
D NNP O
. . O
, , O
a DT O
AND CC O

FRANK NNP O
J NNP O
. . O

BIA NNP O
, , O
M NNP O
. . O
D NNP O
. . O
, , O
M NNP O
. . O
P NN O
. . O
H NN O
. . O
a DT O
, , O
b NN O

aInfectious NNP O
Disease NNP O
Section NNP O
of IN O
the DT O
Department NNP O
of IN O
Medicine NNP O
, , O
and CC O
bThe NNP O
Department NNP O
of IN O

Laboratory NNP O
Medicine NNP O
, , O
Veterans NNPS O
Administration NNP O
Medical NNP O
Center NNP O
, , O

West NNP O
Haven NNP O
, , O
and CC O
Yale NNP O
University NNP O
School NNP O
of IN O
Medicine NNP O
, , O

New NNP O
Haven NNP O
, , O
Connecticut NNP O

Received VBN O
July NNP O
11 CD O
, , O
1983 CD O

A DT O
patient NN B-Species
required VBD O
mitral JJ O
valve NN O
replacement NN O
following VBG O
ineffective JJ O
antibiotic JJ O
treatment NN O
of IN O
enterococcal JJ O
endocarditis NN O
caused VBN O
by IN O
Streptococcusfaecium NNP B-Species
. . O

Endocarditis NNP O
had VBD O
relapsed VBN O
despite IN O
therapy NN O
with IN O
ampicillin NN O
and CC O
tobramycin NN O
for IN O
six CD O
weeks NNS O
. . O

A DT O
second JJ O
relapse NN O
had VBD O
occurred VBN O
following VBG O
treatment NN O
with IN O
penicillin NN O
and CC O
gentamicin NN O
. . O

Initial JJ O
failure NN O
of IN O
antibiotic JJ O
therapy NN O
may MD O
be VB O
related VBN O
to IN O
the DT O
known VBN O
lack NN O
of IN O
in FW O
vitro FW O
and CC O
in IN O
vivo NN O
synergy NN O
between IN O
penicillin NN O
and CC O
tobramycin NN O
against IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
. . O

Effective JJ O
therapy NN O
of IN O
enterococcal JJ O
endocarditis NN O
requires VBZ O
considerations NNS O
of IN O
bacterial JJ O
speciation NN O
, , O
determination NN O
of IN O
high JJ O
- HYPH O
level NN O
aminoglycoside NN O
resistance NN O
, , O
and CC O
preferably RB O
adequate JJ O
antibiotic JJ O
synergy NN O
studies NNS O
to TO O
assure VB O
effective JJ O
therapy NN O
. . O

INTRODUCTION NN O

Enterococcal JJ O
endocarditis NN O
requires VBZ O
special JJ O
therapeutic JJ O
considerations NNS O
because IN O
the DT O
responsible JJ O
organisms NNS O
are VBP O
relatively RB O
penicillin NN O
- HYPH O
resistant JJ O
streptococci NN O
which WDT O
require VBP O
synergistic JJ O
combinations NNS O
of IN O
antibiotics NNS O
to TO O
achieve VB O
acceptable JJ O
cure NN O
rates NNS O
[ -LRB- O
1 CD O
, , O
2 CD O
] -RRB- O
. . O

The DT O
group NN O
D NNP O
enterococci NNP O
include VBP O
three CD O
main JJ O
species NNS O
S NN B-Species
. . I-Species
faecalis NN I-Species
, , O
S NNP B-Species
. . I-Species
faecium NN I-Species
, , O
and CC O
S NNP B-Species
. . I-Species
durans NNS I-Species
. . O

S NN B-Species
. . I-Species
faecium NN I-Species
cause VBP O
a DT O
minority NN O
of IN O
all DT O
cases NNS O
of IN O
enterococcal JJ O
endocarditis NN O
, , O
in IN O
those DT O
instances NNS O
in IN O
which WDT O
enterococci NNS O
have VBP O
been VBN O
speciated VBN O
[ -LRB- O
3 CD O
] -RRB- O
, , O
but CC O
they PRP O
have VBP O
been VBN O
more RBR O
resistant JJ O
both CC O
to IN O
penicillin NN O
and CC O
penicillin NN O
- HYPH O
aminoglycoside NN O
combinations NNS O
than IN O
S NNP B-Species
. . I-Species
faecalis NNS I-Species
[ -LRB- O
4 CD O
, , O
5 CD O
, , O
6 CD O
] -RRB- O
. . O

We PRP O
describe VBP O
a DT O
64 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
man NN B-Species
with IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
endocarditis NN O
in IN O
whom WP O
a DT O
six CD O
- HYPH O
week NN O
course NN O
of IN O
ampicillin NN O
and CC O
tobramycin NN O
, , O
followed VBN O
by IN O
additional JJ O
courses NNS O
of IN O
penicillin NN O
and CC O
other JJ O
aminoglycosides NNS O
, , O
failed VBD O
to TO O
eradicate VB O
the DT O
organism NN O
from IN O
the DT O
patient NN B-Species
' POS O
s NNS O
mitral JJ O
valve NN O
. . O

This DT O
case NN O
is VBZ O
of IN O
interest NN O
because IN O
therapeutic JJ O
failure NN O
of IN O
ampicillin NN O
and CC O
tobramycin NN O
in IN O
S NN B-Species
. . I-Species
faecium NN I-Species
endocarditis NN O
has VBZ O
not RB O
been VBN O
reported VBN O
previously RB O
, , O
but CC O
might MD O
have VB O
been VBN O
predicted VBN O
on IN O
the DT O
basis NN O
of IN O
previous JJ O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
studies NNS O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Although IN O
the DT O
need NN O
for IN O
both CC O
a DT O
penicillin NN O
derivative NN O
and CC O
an DT O
aminoglycoside NN O
in IN O
the DT O
therapy NN O
of IN O
enterococcal JJ O
endocarditis NN O
is VBZ O
widely RB O
known VBN O
, , O
it PRP O
is VBZ O
important JJ O
to TO O
distinguish VB O
between IN O
the DT O
differing VBG O
efficacies NNS O
of IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
combinations NNS O
for IN O
treating VBG O
various JJ O
species NNS O
of IN O
enterococci NN O
such JJ O
as IN O
S NN B-Species
. . I-Species
faecium NN I-Species
. . O

243 CD O

Address NN O
reprint NN O
requests NNS O
to IN O
: : O
Judith NNP O
A NNP O
. . O
Goldstein NNP O
, , O
M NNP O
. . O
D NNP O
. . O
, , O
Section NNP O
of IN O
Infectious NNP O
Diseases NNPS O
, , O
Department NNP O
of IN O
Medicine NNP O
, , O
Long NNP O
Island NNP O
Jewish NNP O
- HYPH O
Hillside NNP O
Medical NNP O
Center NNP O
, , O
Queen NNP O
' POS O
s POS O
Hosp NNP O
. . O

Center NNP O
Affiliate NNP O
, , O
82 CD O
- HYPH O
68 CD O
164th JJ O
Street NNP O
, , O
Jamaica NNP O
, , O
NY NNP O
11432 CD O

Copyright NN O
c NN O
1983 CD O
by IN O
The DT O
Yale NNP O
Journal NNP O
of IN O
Biology NNP O
and CC O
Medicine NNP O
, , O
Inc NNP O
. . O

All DT O
rights NNS O
of IN O
reproduction NN O
in IN O
any DT O
form NN O
reserved VBN O
. . O

GOLDSTEIN NNP O
ET NNP O
AL NNP O
. . O

CASE NN O
REPORT NN O

A DT O
64 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
male NN O
was VBD O
in IN O
good JJ O
health NN O
until IN O
December NNP O
1980 CD O
, , O
when WRB O
he PRP O
noted VBD O
intermittent JJ O
night NN O
sweats NNS O
, , O
malaise NN O
, , O
fever NN O
, , O
and CC O
fatigue NN O
. . O

He PRP O
received VBD O
oral JJ O
erythromycin NN O
for IN O
14 CD O
days NNS O
with IN O
transient JJ O
improvement NN O
of IN O
symptoms NNS O
. . O

However RB O
, , O
after IN O
completing VBG O
therapy NN O
, , O
symptoms NNS O
reappeared VBD O
and CC O
he PRP O
noted VBD O
a DT O
15 CD O
- HYPH O
pound NN O
weight NN O
loss NN O
with IN O
low JJ O
- HYPH O
grade NN O
fever NN O
( : O
99 CD O
- SYM O
100 CD O
. . O
5 CD O
? . O
F NN O
) -RRB- O
during IN O
the DT O
two CD O
months NNS O
preceding VBG O
admission NN O
. . O

There EX O
was VBD O
no DT O
previous JJ O
history NN O
of IN O
rheumatic JJ O
or CC O
congenital JJ O
heart NN O
disease NN O
. . O

In IN O
March NNP O
1981 CD O
, , O
the DT O
patient NN B-Species
was VBD O
admitted VBN O
to IN O
his PRP$ O
community NN O
hospital NN O
where WRB O
evaluation NN O
revealed VBD O
a DT O
new JJ O
apical JJ O
systolic JJ O
murmur NN O
radiating VBG O
to IN O
the DT O
axilla NN O
. . O

There EX O
were VBD O
no DT O
petechiae NN O
, , O
Janeway NNP O
lesions NNS O
, , O
Osler NNP O
' POS O
s NNS O
nodes NNS O
, , O
Roth NNP O
spots NNS O
, , O
or CC O
splenomegaly NN O
. . O

The DT O
hematocrit NN O
was VBD O
34 CD O
. . O
8 CD O
percent NN O
, , O
WBC NNP O
count NN O
9 CD O
, , O
300 CD O
cells NNS O
per IN O
cu NN O
mm NN O
with IN O
a DT O
differential JJ O
count NN O
of IN O
67 CD O
segmented JJ O
forms NNS O
, , O
9 CD O
bands NNS O
, , O
15 CD O
lymphocytes NNS O
, , O
7 CD O
monocytes NNS O
, , O
1 CD O
eosinophil NN O
, , O
and CC O
1 CD O
basophil NN O
. . O

The DT O
erythrocyte NN O
sedimentation NN O
rate NN O
( -LRB- O
ESR NNP O
) -RRB- O
was VBD O
62 CD O
mm NN O
per IN O
hour NN O
( , O
nl NN O
< SYM O
10 CD O
mm NN O
per IN O
hour NN O
) -RRB- O
and CC O
the DT O
serum JJ O
rheumatoid NN O
factor NN O
titer NN O
was VBD O
1 CD O
: SYM O
320 CD O
. . O

Chest NN O
films NNS O
and CC O
electrocardiogram NN O
were VBD O
reportedly RB O
normal JJ O
. . O

Group NNP O
D NNP O
streptococci NNP O
grew VBD O
from IN O
three CD O
sets NNS O
of IN O
blood NN O
cultures NNS O
. . O

Enterococcal JJ O
endocarditis NN O
was VBD O
diagnosed VBN O
and CC O
he PRP O
was VBD O
treated VBN O
with IN O
six CD O
weeks NNS O
of IN O
parenteral JJ O
ampicillin NN O
( : O
12 CD O
grams NNS O
per IN O
day NN O
) , O
and CC O
tobramycin NN O
( : O
3 CD O
mg NN O
per IN O
kg NN O
per IN O
day NN O
) -RRB- O
. . O

Resolution NN O
of IN O
symptoms NNS O
occurred VBD O
within IN O
several JJ O
days NNS O
after IN O
antibiotics NNS O
were VBD O
begun VBN O
. . O

Serum JJ O
bactericidal JJ O
titers NNS O
against IN O
the DT O
organism NN O
, , O
obtained VBN O
during IN O
peak NN O
antibiotic JJ O
levels NNS O
, , O
were VBD O
1 CD O
: SYM O
8 CD O
or CC O
greater JJR O
on IN O
several JJ O
occasions NNS O
, , O
and CC O
blood NN O
cultures NNS O
were VBD O
negative JJ O
while IN O
the DT O
patient NN B-Species
was VBD O
receiving VBG O
antibiotics NNS O
. . O

M NN O
- HYPH O
mode NN O
echocardiography NN O
demonstrated VBD O
left VBN O
atrial JJ O
enlargement NN O
but CC O
no DT O
definable JJ O
abnormalities NNS O
of IN O
the DT O
mitral JJ O
or CC O
aortic JJ O
valves NNS O
. . O

Intravenous JJ O
pyelogram NN O
, , O
oral JJ O
cholecystogram NN O
, , O
cystoscopy NN O
, , O
liver NN O
- HYPH O
spleen NN O
scan NN O
, , O
and CC O
upper JJ O
and CC O
lower JJ O
gastrointestinal JJ O
series NN O
were VBD O
normal JJ O
except IN O
for IN O
a DT O
few JJ O
sigmoid NN O
diverticuli NNS O
. . O

Flexible JJ O
signoidoscopy NN O
demonstrated VBD O
both CC O
a DT O
small JJ O
perianal JJ O
fissure NN O
and CC O
hemorrhoids NNS O
. . O

Blood NN O
cultures NNS O
two CD O
weeks NNS O
after IN O
therapy NN O
were VBD O
negative JJ O
. . O

Second NNP O
Admission NNP O
( : O
June NNP O
19 CD O
- HYPH O
August NNP O
4 CD O
, , O
1981 CD O
) -RRB- O

In IN O
June NNP O
1981 CD O
, , O
he PRP O
again RB O
noted VBD O
intermittent JJ O
fever NN O
, , O
night NN O
sweats NNS O
, , O
and CC O
fatigue NN O
. . O

Group NN O
D NNP O
streptococci NNP O
grew VBD O
from IN O
three CD O
sets NNS O
of IN O
blood NN O
cultures NNS O
and CC O
he PRP O
was VBD O
admitted VBN O
to IN O
the DT O
West NNP O
Haven NNP O
VA NNP O
Medical NNP O
Center NNP O
for IN O
recurrent JJ O
endocarditis NN O
. . O

On IN O
examination NN O
a DT O
somewhat RB O
louder JJR O
apical JJ O
systolic JJ O
murmur NN O
was VBD O
noted VBN O
. . O

The DT O
ESR NNP O
was VBD O
50 CD O
mm NN O
/ SYM O
hour NN O
and CC O
rheumatoid JJ O
factor NN O
titer NN O
was VBD O
1 CD O
: SYM O
320 CD O
. . O

Serum NN O
complement NN O
levels NNS O
were VBD O
normal JJ O
and CC O
cryoglobulins NNS O
were VBD O
not RB O
detectable JJ O
. . O

Chest NN O
films NNS O
, , O
EKG NNP O
, , O
and CC O
urinalysis NN O
were VBD O
normal JJ O
. . O

Cardiac JJ O
M NN O
- HYPH O
mode NN O
echocardiogram NN O
revealed VBD O
a DT O
globular JJ O
mass NN O
attached VBN O
to IN O
the DT O
posterior JJ O
mitral NN O
valve NN O
leaflet NN O
with IN O
prolapse NN O
into IN O
a DT O
slightly RB O
enlarged VBN O
left JJ O
atrium NN O
. . O

A DT O
twodimensional JJ O
echocardiogram NN O
confirmed VBD O
mitral JJ O
valve NN O
prolapse NN O
and CC O
suggested VBD O
a DT O
posterior JJ O
leaflet NN O
vegetation NN O
. . O

Gallium NNP O
citrate NN O
scan NN O
was VBD O
negative JJ O
. . O

Three CD O
separate JJ O
morphologic JJ O
colony NN O
variants NNS O
were VBD O
isolated VBN O
from IN O
blood NN O
, , O
each DT O
identified VBN O
as IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
by IN O
Dr NNP O
. . O
R NNP O
. . O
R NN O
. . O

Facklam NNP O
( : O
Center NNP O
for IN O
Disease NNP O
Control NNP O
, , O
Atlanta NNP O
, , O
Georgia NNP O
) -RRB- O
. . O

The DT O
patient NN B-Species
received VBD O
intravenous JJ O
penicillin NN O
( : O
20 CD O
million CD O
units NNS O
per IN O
day NN O
) , O
and CC O
gentamicin NN O
( : O
3 CD O
mg NN O
per IN O
kg NN O
per IN O
day NN O
) -RRB- O
for IN O
six CD O
weeks NNS O
with IN O
improvement NN O
. . O

Peak NN O
serum NN O
bactericidal JJ O
titers NNS O
of IN O
1 CD O
: SYM O
8 CD O
or CC O
greater JJR O
were VBD O
achieved VBN O
against IN O
two CD O
of IN O
the DT O
colony NN O
variants NNS O
; : O
however RB O
, , O
against IN O
the DT O
large JJ O
colony NN O
morphotype NN O
, , O
a DT O
titer NN O
of IN O
only RB O
1 CD O
: SYM O
2 CD O
was VBD O
obtained VBN O
. . O

An DT O
enlarged JJ O
left JJ O
atrium NN O
with IN O
intermittent JJ O
fluttering NN O
and CC O
prolapse NN O
of IN O
the DT O
mitral JJ O
valve NN O
was VBD O
noted VBN O
on IN O
echocardiography NN O
three CD O
weeks NNS O
into IN O
therapy NN O
. . O

Multiple JJ O
blood NN O
cultures NNS O
taken VBN O
while IN O
the DT O
patient NN B-Species
was VBD O
receiving VBG O
antibiotics NNS O
were VBD O
negative JJ O
, , O
as IN O
were VBD O
those DT O
obtained VBN O
48 CD O
and CC O
72 CD O
hours NNS O
after IN O
discontinuation NN O
of IN O
antibiotics NNS O
. . O

244 CD O

S UH B-Species
. . I-Species

FAECIUM NNP B-Species
ENDOCARDITIS NNP O

Third NNP O
Admission NNP O
( : O
August NNP O
12 CD O
- : O
October NNP O
4 CD O
, , O
1981 CD O
) -RRB- O

Withing VBG O
a DT O
week NN O
following VBG O
discharge NN O
, , O
the DT O
patient NN B-Species
again RB O
developed VBD O
fever NN O
, , O
nocturnal JJ O
sweats NNS O
, , O
and CC O
malaise NN O
. . O

S NNP B-Species
. . I-Species
faecium NN I-Species
( , O
large JJ O
colony NN O
morphotype NN O
, , O
and CC O
poorly RB O
growing VBG O
small JJ O
colony NN O
morphotype NN O
) -RRB- O
grew VBD O
from IN O
six CD O
sets NNS O
of IN O
blood NN O
cultures NNS O
obtained VBN O
on IN O
admission NN O
. . O

Penicillin NNP O
( : O
30 CD O
million CD O
units NNS O
/ SYM O
day NN O
) -RRB- O
and CC O
gentamicin NN O
( , O
3 CD O
mg NN O
/ SYM O
kg NNS O
/ SYM O
day NN O
) -RRB- O
were VBD O
again RB O
administered VBN O
, , O
initially RB O
achieving VBG O
peak NN O
serum NN O
inhibitory NN O
and CC O
bactericidal JJ O
dilutions NNS O
of IN O
1 CD O
: SYM O
16 CD O
and CC O
1 CD O
: SYM O
8 CD O
against IN O
the DT O
organism NN O
, , O
respectively RB O
. . O

However RB O
, , O
the DT O
organism NN O
had VBD O
a DT O
lowlevel JJ O
resistance NN O
to IN O
streptomycin NN O
( , O
MIC NNP O
< SYM O
125 CD O
/ SYM O
Ag NNP O
/ SYM O
ml NNP O
) -RRB- O
, , O
and CC O
streptomycin NN O
( , O
2 CD O
grams NNS O
per IN O
day NN O
) -RRB- O
was VBD O
substituted VBN O
for IN O
gentamicin NN O
two CD O
weeks NNS O
into IN O
antibiotic JJ O
therapy NN O
. . O

Repeat NN O
echocardiograms NNS O
showed VBD O
irregular JJ O
and CC O
shaggy JJ O
densities NNS O
of IN O
both DT O
mitral JJ O
valve NN O
leaflets NNS O
with IN O
partial JJ O
prolapse NN O
. . O

Cardiac JJ O
catheterization NN O
demonstrated VBD O
marked JJ O
mitral JJ O
valve NN O
prolapse NN O
with IN O
mitral JJ O
regurgitation NN O
. . O

A DT O
radiolucent JJ O
filling NN O
defect NN O
was VBD O
noted VBN O
, , O
suggesting VBG O
a DT O
coronary JJ O
artery NN O
embolus VB O
at IN O
the DT O
origin NN O
of IN O
the DT O
left JJ O
anterior JJ O
descending VBG O
( HYPH O
LAD NNP O
) -RRB- O
artery NN O
, , O
causing VBG O
75 CD O
percent NN O
occlusion NN O
of IN O
the DT O
lumen NN O
. . O

The DT O
patient NN B-Species
underwent VBD O
mitral JJ O
valve NN O
replacement NN O
, , O
receiving VBG O
a DT O
number NN O
31 CD O
porcine NN O
Hancock NNP O
bioprosthesis NN O
and CC O
bypass NN O
graft NN O
to IN O
the DT O
midportion NN O
of IN O
the DT O
LAD NNP O
. . O

The DT O
mitral JJ O
valve NN O
was VBD O
thickened VBN O
with IN O
several JJ O
ruptured VBN O
chordae NN O
of IN O
the DT O
posterior JJ O
leaflet NN O
noted VBN O
, , O
but CC O
no DT O
vegetations NNS O
. . O

The DT O
aortic JJ O
valve NN O
appeared VBD O
normal JJ O
, , O
with IN O
no DT O
visible JJ O
septal NN O
or CC O
ring NN O
abscesses NNS O
. . O

The DT O
occlusion NN O
in IN O
the DT O
LAD NNP O
was VBD O
not RB O
approached VBN O
to TO O
avoid VB O
embolizing VBG O
distal JJ O
fragments NNS O
. . O

Histopathologically RB O
the DT O
mitral JJ O
valve NN O
showed VBD O
mild JJ O
fibrosis NN O
and CC O
myxoid NN O
degeneration NN O
without IN O
inflammatory JJ O
changes NNS O
. . O

Bacterial JJ O
and CC O
fungal JJ O
stains NNS O
were VBD O
negative JJ O
but CC O
S NNP B-Species
. . I-Species
faecium NN I-Species
grew VBD O
from IN O
fragments NNS O
of IN O
the DT O
resected VBN O
valve NN O
. . O

Following VBG O
surgery NN O
the DT O
patient NN B-Species
received VBD O
six CD O
additional JJ O
weeks NNS O
parenteral JJ O
penicillin NN O
and CC O
streptomycin NN O
. . O

Repeat NN O
blood NN O
cultures NNS O
on IN O
this DT O
regimen NN O
and CC O
following VBG O
therapy NN O
were VBD O
negative JJ O
. . O

Evaluation NN O
six CD O
months NNS O
following VBG O
discontinuation NN O
of IN O
antibiotics NNS O
showed VBD O
no DT O
evidence NN O
of IN O
recurrent JJ O
endocarditis NN O
. . O

LABORATORY NN O
EVALUATION NN O

The DT O
minimum JJ O
inhibitory JJ O
and CC O
bactericidal JJ O
concentrations NNS O
of IN O
penicillin NN O
, , O
ampicillin NN O
, , O
and CC O
tobramycin NN O
against IN O
the DT O
S NNP B-Species
. , I-Species
faecium NN I-Species
isolated VBN O
from IN O
the DT O
patient NN B-Species
' POS O
s NN O
blood NN O
cultures NNS O

TABLE NN O
1 CD O

Minimum JJ O
Inhibitory NN O
and CC O
Bactericidal NNP O
Concentrations NNPS O
of IN O
Antibiotics NNPS O
, , O

Against IN O
Streptococcus NN B-Species
faecium NN I-Species
Isolates VBZ O
from IN O
Blood NNP O
Cultures NNPS O

Date NN O
Penicillin NN O
Ampicillin NN O
Tobramycin NN O

Organism NN O
Isolated VBN O
MIC NNP O
MIC NNP O
MBC NNP O
MIC NNP O
MBC NNP O
S NNP B-Species
. . I-Species
faecium NN I-Species
, , O
prior RB O
to IN O
ampicillin NN O
/ , O

tobramycin NN O
therapy NN O
3 CD O
/ SYM O
17 CD O
/ SYM O
81 CD O
2 CD O
1 CD O
2 CD O
> SYM O
32 CD O
> SYM O
32 CD O
S NN B-Species
. . I-Species
faecium NN I-Species
, , O
after IN O
ampicillin NN O
/ , O

tobramycin NN O
therapy NN O

a DT O
. . O

Large JJ O
colony NN O

variant JJ O
6 CD O
/ SYM O
16 CD O
/ SYM O
81 CD O
2 CD O
1 CD O
1 CD O
> SYM O
32 CD O
> SYM O
32 CD O
b NN O
. . O

Medium JJ O
colony NN O

variant NN O
6 CD O
/ SYM O
16 CD O
/ SYM O
81 CD O
2 CD O
1 CD O
2 CD O
32 CD O
32 CD O
c NN O
. . O

Small JJ O
colony NN O

variant NN O
6 CD O
/ SYM O
16 CD O
/ SYM O
81 CD O
4 CD O
2 CD O
4 CD O
> SYM O
32 CD O
> SYM O
32 CD O
aMIC NN O
and CC O
MBC NNP O
are VBP O
minimum JJ O
inhibitory NN O
and CC O
bactericidal JJ O
concentrations NNS O
of IN O
antibiotics NNS O
, , O
respectively RB O
, , O
in IN O
tig NN O
/ SYM O
ml NNP O
. . O

245 CD O

GOLDSTEIN NNP O
ET NNP O
AL NNP O
. . O

FIG NNP O
. . O

1 LS O
. . O

Time NN O
- HYPH O
kill NN O
curve NN O
demonstrat8 NN O
3 CD O
- : O
\ NFP O
"""" '' O
' '' O
' '' O
ing VBG O
the DT O
effects NNS O
of IN O
various JJ O
penicillinO NN O
aminoglycoside NN O
combinations NNS O
on IN O
S NNP O
. . O

{ NFP O
73 CD O
2 CD O
- HYPH O
\ NN O
> NFP O
, , O
faecium NN O
obtained VBN O
from IN O
the DT O
patient NN B-Species
' '' O
s VBZ O

blood NN O
cultures NNS O
immediately RB O
prior RB O
to IN O
mitral JJ O
valve NN O
excision NN O
. . O

Note VB O
the DT O
lack NN O
of IN O
4u CD O
, , O
synergy NN O
between IN O
penicillin NN O
and CC O
tobra25kg NN O
/ SYM O
rm NN O
Streporrrychn NNP O
t NN O
mycin NN O
against IN O
this DT O
organism NN O
when WRB O

/ SYM O
0 CD O
units NNS O
/ SYM O
mI NN O
Penicillin NN O
_ : O
compared VBN O
to IN O
synergistic JJ O
combinations NNS O
0 CD O
4 CD O
8 CD O
12 CD O
6 CD O
20 CD O
24 CD O
of IN O
penicillin NN O
- HYPH O
gentamicin NN O
and CC O
penicillin NN O

HOURS NNS O
streptomycin NN O
. . O

after IN O
initial JJ O
oral JJ O
erythromycin NN O
therapy NN O
, , O
and CC O
prior RB O
to IN O
therapy NN O
for IN O
endocarditis NN O
, , O
are VBP O
shown VBN O
in IN O
Table NNP O
1 CD O
. . O

Following VBG O
combined VBN O
therapy NN O
with IN O
ampicillin NN O
and CC O
tobramycin NN O
and CC O
relapse NN O
of IN O
endocarditis NN O
, , O
three CD O
morphological JJ O
variants NNS O
were VBD O
isolated VBN O
from IN O
blood NN O
cultures NNS O
and CC O
also RB O
evaluated VBN O
. . O

Twenty CD O
- HYPH O
four CD O
hour NN O
time NN O
- HYPH O
kill NN O
curves NNS O
for IN O
penicillin NN O
in IN O
combination NN O
with IN O
various JJ O
aminoglycosides NNS O
were VBD O
performed VBN O
by IN O
Dr NNP O
. . O
Robert NNP O
Moellering NNP O
on IN O
the DT O
S NNP B-Species
. , I-Species
faecium NN I-Species
isolated VBN O
from IN O
the DT O
patient NN B-Species
' POS O
s NN O
blood NN O
immediately RB O
prior RB O
to IN O
mitral JJ O
valve NN O
excision NN O
and CC O
replacement NN O
( : O
Fig NNP O
. . O
1 CD O
) -RRB- O
. . O

Synergy NN O
was VBD O
readily RB O
demonstrable JJ O
against IN O
this DT O
organism NN O
by IN O
penicillin NN O
- HYPH O
streptomycin NN O
and CC O
penicillin NN O
- HYPH O
gentamicin NN O
combinations NNS O
in IN O
vitro NN O
, , O
but CC O
not RB O
by IN O
penicillin NN O
- HYPH O
tobramycin NN O
. . O

DISCUSSION NN O

Among IN O
streptococci NN O
, , O
the DT O
enterococci NNS O
are VBP O
unusual JJ O
in IN O
their PRP$ O
relative JJ O
resistance NN O
to IN O
a DT O
broad JJ O
spectrum NN O
of IN O
antimicrobial JJ O
agents NNS O
, , O
and CC O
single JJ O
- HYPH O
agent NN O
therapy NN O
is VBZ O
rarely RB O
bactericidal JJ O
against IN O
them PRP O
[ -LRB- O
2 CD O
] -RRB- O
. . O

Since IN O
Hunter NNP O
' POS O
s POS O
original JJ O
observations NNS O
in IN O
1947 CD O
, , O
it PRP O
has VBZ O
become VBN O
increasingly RB O
clear JJ O
that IN O
effective JJ O
synergistic JJ O
combinations NNS O
of IN O
antibiotics NNS O
are VBP O
necessary JJ O
to TO O
successfully RB O
treat VB O
enterococcal JJ O
endocarditis NN O
[ -LRB- O
1 CD O
] -RRB- O
. . O

Although IN O
S NNP B-Species
. . I-Species
faecalis NNS I-Species
represents VBZ O
the DT O
majority NN O
of IN O
clinical JJ O
enterococcal JJ O
isolates NNS O
, , O
S NN B-Species
. . I-Species
faecium NN I-Species
nonetheless RB O
comprises VBZ O
5 CD O
- SYM O
10 CD O
percent NN O
of IN O
these DT O
isolates NNS O
in IN O
some DT O
series NN O
[ -LRB- O
3 CD O
, , O
4 CD O
] -RRB- O
. . O

Moreover RB O
, , O
major JJ O
differences NNS O
exist VBP O
in IN O
antimicrobial JJ O
susceptibility NN O
and CC O
resistance NN O
to IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
synergism NN O
between IN O
these DT O
two CD O
enterococcal JJ O
species NNS O
. . O

The DT O
MIC NNP O
of IN O
penicillin NN O
against IN O
S NNP B-Species
. . I-Species
faecium NN I-Species
is VBZ O
higher JJR O
and CC O
this DT O
organism NN O
is VBZ O
more RBR O
resistant JJ O
to IN O
a DT O
number NN O
of IN O
different JJ O
combinations NNS O
of IN O
penicillin NN O
and CC O
various JJ O
aminoglycosides NNS O
than IN O
is VBZ O
S NN B-Species
. . I-Species
faecalis NNS I-Species
[ -LRB- O
6 CD O
] -RRB- O
. . O

The DT O
mechanisms NNS O
of IN O
resistance NN O
exhibited VBN O
by IN O
enterococci NN O
to IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
synergy NN O
have VBP O
been VBN O
investigated VBN O
. . O

Clinically RB O
achievable JJ O
levels NNS O
of IN O
amino NN O

246 CD O

S UH B-Species
. . I-Species

FAECIUM NNP B-Species
ENDOCARDITIS NNP O

glycosides NNS O
are VBP O
generally RB O
ineffective JJ O
against IN O
enterococci NN O
. . O

This DT O
intrinsic JJ O
low JJ O
- HYPH O
level NN O
resistance NN O
( -LRB- O
MIC NNP O
c NN O
250 CD O
isg NN O
/ SYM O
ml NN O
) -RRB- O
is VBZ O
thought VBN O
to TO O
be VB O
the DT O
result NN O
of IN O
poor JJ O
antibiotic JJ O
penetration NN O
of IN O
the DT O
bacterial JJ O
cell NN O
wall NN O
. . O

However RB O
, , O
in IN O
the DT O
presence NN O
of IN O
antibiotics NNS O
that WDT O
interfere VBP O
with IN O
cell NN O
wall NN O
synthesis NN O
, , O
there EX O
is VBZ O
enhanced VBN O
aminoglycoside NN O
uptake NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

In IN O
concert NN O
, , O
these DT O
events NNS O
are VBP O
the DT O
basis NN O
for IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
synergism NN O
. . O

Ribosomal JJ O
resistance NN O
of IN O
the DT O
30S NNP O
subunit NN O
to IN O
streptomycin NN O
and CC O
defective JJ O
uptake NN O
of IN O
gentamicin NN O
in IN O
the DT O
presence NN O
of IN O
penicillin NN O
have VBP O
been VBN O
reported VBN O
mechanisms NNS O
of IN O
resistance NN O
among IN O
enterococcal JJ O
isolates NNS O
[ -LRB- O
8 CD O
, , O
9 CD O
] -RRB- O
. . O

However RB O
, , O
in IN O
the DT O
majority NN O
of IN O
instances NNS O
, , O
failure NN O
of IN O
synergy NN O
involves VBZ O
plasmid NN O
- HYPH O
mediated VBN O
production NN O
of IN O
aminoglycoside NN O
- HYPH O
modifying VBG O
enzymes NNS O
. . O

For IN O
streptomycin NN O
and CC O
kanamycin NN O
, , O
plasmid NN O
- HYPH O
mediated VBN O
enzymatic JJ O
inactivation NN O
confers VBZ O
high JJ O
- HYPH O
level NN O
resistance NN O
( -LRB- O
MIC NNP O
> SYM O
2 CD O
, , O
0 CD O
Ag NN O
/ SYM O
ml NN O
) -RRB- O
and CC O
correlates VBZ O
with IN O
failure NN O
of IN O
these DT O
aminoglycosides NNS O
to TO O
exert VB O
a DT O
synergistic JJ O
effect NN O
when WRB O
combined VBN O
with IN O
penicillin NN O
[ -LRB- O
10 CD O
, , O
11 CD O
] -RRB- O
. . O

Plasmid NN O
- HYPH O
mediated VBN O
modifying VBG O
enzymes NNS O
have VBP O
been VBN O
found VBN O
in IN O
both DT O
S NN B-Species
. . I-Species
faecalis NN I-Species
and CC O
S NN B-Species
. . I-Species
faecium NN I-Species
' '' O
[ -LRB- O
12 CD O
] -RRB- O
. . O

Currently RB O
, , O
approximately RB O
one CD O
- HYPH O
half NN O
of IN O
clinical JJ O
enterococcal JJ O
isolates NNS O
demonstrate VBP O
high JJ O
- HYPH O
level NN O
resistance NN O
to IN O
streptomycin NN O
and CC O
kanamycin NN O
[ -LRB- O
13 CD O
] -RRB- O
. . O

Combinations NNS O
of IN O
penicillin NN O
with IN O
kanamycin NN O
, , O
tobramycin NN O
, , O
sisomicin NN O
, , O
and CC O
netilmicin NN O
have VBP O
consistently RB O
failed VBN O
to TO O
demonstrate VB O
synergistic JJ O
killing NN O
of IN O
S NN B-Species
. . I-Species
faecium NN I-Species
in IN O
vitro FW O
[ -LRB- O
6 CD O
] -RRB- O
. . O

This DT O
failure NN O
of IN O
synergy NN O
occurs VBZ O
even RB O
when WRB O
high JJ O
- HYPH O
level NN O
resistance NN O
to IN O
these DT O
aminoglycosides NNS O
is VBZ O
not RB O
present JJ O
. . O

The DT O
mechanism NN O
of IN O
resistance NN O
appears VBZ O
to TO O
be VB O
related VBN O
to IN O
the DT O
production NN O
of IN O
an DT O
inactivating VBG O
enzyme NN O
that WDT O
acetylates VBZ O
the DT O
aminoglycoside NN O
substrate NN O
at IN O
the DT O
6 CD O
' '' O
position1 NN O
[ -LRB- O
14 CD O
] -RRB- O
. . O

The DT O
genetic JJ O
basis NN O
for IN O
production NN O
of IN O
this DT O
enzyme NN O
has VBZ O
not RB O
been VBN O
well RB O
- HYPH O
defined VBN O
and CC O
plasmid NN O
transfer NN O
experiments NNS O
have VBP O
thus RB O
far RB O
been VBN O
unsucessful JJ O
in IN O
demonstrating VBG O
the DT O
encodement NN O
of IN O
this DT O
enzyme NN O
by IN O
extrachromosomal JJ O
DNA NNP O
[ -LRB- O
14 CD O
] -RRB- O
. . O

Moellering NNP O
et FW O
al NN O
. . O
demonstrated VBN O
in IN O
vivo NN O
, , O
utilizing VBG O
the DT O
rabbit NN B-Species
model NN O
of IN O
endocarditis NN O
, , O
that IN O
penicillin NN O
and CC O
netilmicin NN O
were VBD O
not RB O
efficacious JJ O
in IN O
the DT O
treatment NN O
of IN O
endocarditis NN O
caused VBN O
by IN O
a DT O
low JJ O
- HYPH O
level NN O
aminoglycoside NN O
- HYPH O
resistant JJ O
strain NN O
of IN O
S NN B-Species
. . I-Species
faecium NN I-Species
[ -LRB- O
6 CD O
] -RRB- O
. . O

Although IN O
combinations NNS O
of IN O
penicillin NN O
with IN O
tobramycin NN O
, , O
kanamycin NN O
, , O
or CC O
sisomicin NN O
were VBD O
not RB O
evaluated VBN O
, , O
the DT O
authors NNS O
postulated VBD O
that IN O
the DT O
same JJ O
ineffectual JJ O
result NN O
would MD O
have VB O
occurred VBN O
. . O

In IN O
the DT O
present JJ O
case NN O
, , O
the DT O
recurrence NN O
of IN O
S NNP B-Species
. , I-Species
faecium NN I-Species
endocarditis NN O
after IN O
six CD O
weeks NNS O
of IN O
therapy NN O
with IN O
ampicillin NN O
and CC O
tobramycin NN O
confirms VBZ O
the DT O
therapeutic JJ O
and CC O
clinical JJ O
significance NN O
of IN O
their PRP$ O
data NNS O
, , O
and CC O
emphasizes VBZ O
that IN O
tobramycin NN O
is VBZ O
not RB O
an DT O
aminoglycoside NN O
to TO O
be VB O
used VBN O
for IN O
treatment NN O
of IN O
serious JJ O
S NN B-Species
. . I-Species
faecium NN I-Species
infections NNS O
. . O

Bacterial JJ O
tolerance NN O
has VBZ O
been VBN O
suggested VBN O
as IN O
a DT O
possible JJ O
basis NN O
for IN O
therapeutic JJ O
failures NNS O
, , O
particularly RB O
in IN O
the DT O
treatment NN O
of IN O
infections NNS O
caused VBN O
by IN O
Staphylococcus NNP B-Species
aureus NN I-Species
with IN O
defects NNS O
in IN O
the DT O
production NN O
of IN O
autolysins NNS O
. . O

MBCs NNS O
are VBP O
generally RB O
several JJ O
- HYPH O
fold NN O
higher JJR O
than IN O
MICs NNS O
and CC O
this DT O
phenomenon NN O
appears VBZ O
to TO O
be VB O
associated VBN O
with IN O
the DT O
autolysin NN O
defect NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Lorian NNP O
has VBZ O
also RB O
described VBN O
the DT O
formation NN O
of IN O
numerous JJ O
aberrant JJ O
cross NN O
- HYPH O
walls NNS O
by IN O
S NNP B-Species
. . I-Species
faecalis NNS I-Species
grown VBN O
in IN O
the DT O
presence NN O
of IN O
subinhibitory JJ O
concentrations NNS O
of IN O
penicillin NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

MBCs NNS O
were VBD O
only RB O
slightly RB O
higher JJR O
than IN O
MICs NNS O
for IN O
the DT O
three CD O
S NNS B-Species
. . I-Species
faecium NN I-Species
variants NNS O
obtained VBN O
from IN O
our PRP$ O
patient NN B-Species
, , O
and CC O
they PRP O
did VBD O
not RB O
appear VB O
to TO O
be VB O
tolerant JJ O
strains NNS O
of IN O
S NN B-Species
. . I-Species
faecium NN I-Species
. . O

There EX O
was VBD O
no DT O
evidence NN O
that IN O
any DT O
of IN O
the DT O
morphological JJ O
variants NNS O
isolated VBN O
were VBD O
unusually RB O
resistant JJ O
to IN O
antibiotics NNS O
. . O

Therefore RB O
, , O
subsequent JJ O
failure NN O
of IN O
therapy NN O
could MD O
not RB O
be VB O
explained VBN O
on IN O
the DT O
basis NN O
of IN O
antibiotic JJ O
resistance NN O
patterns NNS O
. . O

The DT O
initial JJ O
failure NN O
of IN O
ampicillin NN O
and CC O
tobramycin NN O
therapy NN O
may MD O
have VB O
allowed VBN O
the DT O
infecting VBG O
organism NN O
to TO O
become VB O
better RBR O
established VBN O
and CC O
more RBR O
difficult JJ O
to TO O
eradicate VB O
from IN O
the DT O
valve NN O
. . O

Alternatively RB O
, , O
a DT O

' '' O
Wennersten NNP O
C NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
: : O
Mechanism NN O
of IN O
resistance NN O
to IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
synergism NN O
in IN O
Streptococcus NN B-Species
faecium NN I-Species
. . O

Proceedings NNS O
of IN O
the DT O
1th JJ O
International NNP O
Congress NNP O
of IN O
Chemotherapy NNP O
and CC O
19th JJ O
Interscience NNP O
Conference NNP O
on IN O
Antimicrobial NNP O
Agents NNPS O
and CC O
Chemotherapy NNP O
1 CD O
: : O
710 CD O
- HYPH O
711 CD O
, , O
1979 CD O

247 CD O

248 CD O
GOLDSTEIN NNP O
ET NNP O
AL NNP O
. . O

persistent JJ O
focus NN O
of IN O
infection NN O
causing VBG O
the DT O
LAD NNP O
lesion NN O
seen VBN O
by IN O
arteriography NN O
may MD O
have VB O
slowly RB O
resolved VBN O
and CC O
accounted VBN O
for IN O
the DT O
apparent JJ O
failure NN O
to TO O
respond VB O
to IN O
synergistic JJ O
combinations NNS O
of IN O
antibiotics NNS O
. . O

In IN O
summary NN O
, , O
our PRP$ O
patient NN B-Species
was VBD O
treated VBN O
for IN O
Streptococcusfaecium NN B-Species
endocarditis NN O
with IN O
both CC O
ampicillin NN O
and CC O
the DT O
aminoglycoside NN O
antibiotic NN O
, , O
tobramycin NN O
. . O

Relapse NN O
of IN O
endocarditis NN O
might MD O
have VB O
been VBN O
anticipated VBN O
on IN O
the DT O
basis NN O
of IN O
previous JJ O
experimental JJ O
data NNS O
showing VBG O
lack NN O
of IN O
synergy NN O
when WRB O
tobramycin NN O
is VBZ O
used VBN O
against IN O
this DT O
organism NN O
. . O

This DT O
case NN O
graphically RB O
illustrates VBZ O
the DT O
relevance NN O
of IN O
synergy NN O
studies NNS O
to IN O
therapeutic JJ O
considerations NNS O
in IN O
the DT O
treatment NN O
of IN O
endocarditis NN O
. . O

However RB O
, , O
subsequent JJ O
therapy NN O
with IN O
synergistic JJ O
combinations NNS O
of IN O
antibiotics NNS O
did VBD O
not RB O
result VB O
in IN O
cure NN O
. . O

The DT O
data NNS O
do VBP O
not RB O
implicate VB O
tolerant JJ O
organisms NNS O
as IN O
a DT O
cause NN O
for IN O
relapses NNS O
. . O

Failure NN O
of IN O
therapy NN O
may MD O
have VB O
been VBN O
related VBN O
to IN O
the DT O
presence NN O
of IN O
protected VBN O
organisms NNS O
in IN O
vegetations NNS O
which WDT O
were VBD O
seen VBN O
on IN O
echocardiograms NNS O
, , O
and CC O
also RB O
suggested VBN O
by IN O
the DT O
presence NN O
of IN O
a DT O
possible JJ O
coronary JJ O
artery NN O
embolus NN O
seen VBN O
on IN O
coronary JJ O
arteriograms NNS O
. . O

In IN O
conclusion NN O
, , O
speciation NN O
of IN O
isolates NNS O
suspected VBN O
of IN O
causing VBG O
endocarditis NN O
and CC O
adequate JJ O
synergy NN O
studies NNS O
of IN O
antibiotic JJ O
combinations NNS O
are VBP O
indicated VBN O
before IN O
a DT O
long JJ O
and CC O
expensive JJ O
course NN O
of IN O
therapy NN O
with IN O
antimicrobial JJ O
agents NNS O
is VBZ O
undertaken VBN O
for IN O
this DT O
disease NN O
. . O

However RB O
, , O
as IN O
this DT O
case NN O
also RB O
illustrates VBZ O
, , O
demonstration NN O
of IN O
synergism NN O
in IN O
vitro FW O
does VBZ O
not RB O
assure VB O
clinical JJ O
cure NN O
. . O

ACKNOWLEDGEMENTS NNS O

Dr NNP O
. . O
Goldstein NNP O
was VBD O
supported VBN O
by IN O
training NN O
grant NN O
Al NNP O
7033 CD O
- HYPH O
5 CD O
from IN O
the DT O
National NNP O
Institute NNP O
of IN O
Allergy NNP O
and CC O
Infectious NNP O
Diseases NNPS O
. . O

The DT O
authors NNS O
gratefully RB O
acknowledge VBP O
the DT O
advice NN O
, , O
laboratory NN O
assistance NN O
, , O
and CC O
careful JJ O
review NN O
of IN O
this DT O
manuscript NN O
by IN O
Dr NNP O
. . O
Robert NNP O
C NNP O
. . O
Moellering NNP O
, , O
Jr NNP O
. . O

The DT O
authors NNS O
also RB O
wish VBP O
to TO O
thank VB O
Dr NNP O
. . O
Howard NNP O
S NNP O
. . O
Forster NNP O
for IN O
referring VBG O
this DT O
patient NN B-Species
to IN O
us PRP O
, , O
Ms NNP O
. . O
Mary NNP O
Murray NNP O
and CC O
Deborah NNP O
Beauvais NNP O
for IN O
manuscript NN O
preparation NN O
, , O
and CC O
Ms NNP O
. , O
Gertrude NNP O
Barden NNP O
, , O
MT NNP O
( , O
ASCP NNP O
) -RRB- O
, , O
MHS NNP O
, , O
for IN O
technical JJ O
assistance NN O
and CC O
advice NN O
in IN O
evaluation NN O
of IN O
this DT O
patient NN B-Species
. . O

REFERENCES NNS O

1 LS O
. . O

Hunter NNP O
TH NNP O
: : O
Use NN O
of IN O
streptomycin NN O
in IN O
the DT O
treatment NN O
of IN O
bacterial JJ O
endocarditis NN O
. . O

Am NNP O
J NNP O
Med NNP O
2 CD O
: : O
436 CD O
- HYPH O
442 CD O
, , O

1947 CD O

2 LS O
. . O

Moellering NNP O
RC NNP O
Jr NNP O
, , O
Krogstad NNP O
DJ NNP O
: : O
Antibiotic JJ O
resistance NN O
in IN O
enterococci NN O
. . O

Microbiology NNP O
293 CD O
- HYPH O
298 CD O
, , O
1979 CD O
3 CD O
. . O

Facklam NNP O
RR NNP O
: : O
Recognition NN O
of IN O
group NN O
D NN O
streptococcal JJ O
species NNS O
of IN O
human JJ B-Species
origin NN O
by IN O
biochemical JJ O
and CC O

physiological JJ O
tests NNS O
. . O

Appl NN O
Microbiol NN O
23 CD O
: : O
1131 CD O
- HYPH O
1139 CD O
, , O
1972 CD O

4 LS O
. . O

Toala NNP O
P NNP O
, , O
McDonald NNP O
A NNP O
, , O
Wilcox NNP O
C NNP O
, , O
et NN O
al NN O
: : O
Susceptibility NN O
of IN O
group NN O
D NN O
streptococcus NN O
( , O
enterococcus NN O
) -RRB- O
to IN O
21 CD O

antibiotics NNS O
in IN O
vitro FW O
, , O
with IN O
special JJ O
reference NN O
to IN O
species NNS O
differences NNS O
. . O

Am NNP O
J NNP O
Med NNP O
Sci NNP O
258 CD O
: : O
416 CD O
- HYPH O
430 CD O
, , O
1969 CD O
5 CD O
. . O

Shungu NNP O
DL NNP O
, , O
Cornett NNP O
JB NNP O
, , O
Shockman NN O
GD NN O
: : O
Morphological JJ O
and CC O
physiological JJ O
study NN O
of IN O
autolytic JJ O

defective JJ O
Streptococcus NNP B-Species
faecium NN I-Species
strains NNS O
. . O

J NNP O
Bacteriol NNP O
138 CD O
: : O
598 CD O
- HYPH O
608 CD O
, , O
1979 CD O

6 LS O
. . O

Moellering NNP O
RC NNP O
Jr NNP O
, , O
Korzeniowski NNP O
OM NNP O
, , O
Sande NNP O
MA NNP O
, , O
et FW O
al NNP O
: : O
Species NNP O
- HYPH O
specific JJ O
resistance NN O
to IN O
antimicrobial JJ O

synergism NN O
in IN O
Streptococcusfaecium NNP B-Species
and CC O
Streptococcusfaecali NNP B-Species
. . O

J NNP O
Infect NNP O
Dis NNP O
140 CD O
: : O
203 CD O
- HYPH O
208 CD O
, , O
1979 CD O

7 LS O
. . O

Moellering NNP O
RC NNP O
Jr NNP O
, , O
Weinberg NNP O
AN NNP O
: : O
Studies NNS O
on IN O
antibiotic JJ O
synergism NN O
against IN O
enterococci NN O
. . O

11 CD O
. . O

Effect NN O
of IN O

various JJ O
antibiotics NNS O
on IN O
the DT O
uptake NN O
of IN O
' `` O
4C NN O
- HYPH O
labelled VBN O
streptomycin NN O
by IN O
enterococci NNP O
. . O

J NNP O
Clin NNP O
Invest NNP O
50 CD O
: : O
2580 CD O
- HYPH O
2584 CD O
, , O
1971 CD O

8 LS O
. . O

Zimmermann NNP O
RA NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
, , O
Weinberg NNP O
AN NNP O
: : O
Mechanisms NNS O
of IN O
resistance NN O
to IN O
antibiotic JJ O

synergism NN O
in IN O
enterococci FW O
. . O

J NNP O
Bacteriol NNP O
105 CD O
: : O
873 CD O
- HYPH O
879 CD O
, , O
1971 CD O

9 LS O
. . O

Moellering NNP O
RC NNP O
Jr NNP O
, , O
Murray NNP O
BE NNP O
, , O
Schoenbaum NNP O
SC NNP O
, , O
et FW O
al NNP O
: : O
A DT O
novel JJ O
mechanism NN O
of IN O
resistance NN O
to IN O
penicillin NN O

gentamicin NN O
synergism NN O
in IN O
S NN B-Species
. . I-Species
faecalis NNS I-Species
. . O

J NNP O
Infect NNP O
Dis NNP O
141 CD O
: : O
81 CD O
- HYPH O
86 CD O
, , O
1980 CD O

10 CD O
. . O

Krogstad NNP O
DJ NNP O
, , O
Korfhagen NNP O
TR NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
, , O
et FW O
al NN O
: : O
Plasmid NNP O
- HYPH O
mediated VBN O
resistance NN O
to IN O
antibiotic JJ O

synergism NN O
in IN O
enterococci FW O
. . O

J NNP O
Clin NNP O
Invest NNP O
61 CD O
: : O
1645 CD O
- HYPH O
1653 CD O
, , O
1978 CD O

11 CD O
. . O

Krogstad NNP O
DJ NNP O
, , O
Korfhagen NNP O
TR NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
, , O
et FW O
al NN O
: : O
Aminoglycoside NN O
- HYPH O
inactivating VBG O
enzymes NNS O
in IN O

clinical JJ O
isolates NNS O
of IN O
Streptococcusfaecali NNP B-Species
: : O
An DT O
explanation NN O
for IN O
resistance NN O
to IN O
antibiotic JJ O
synergism NN O
. . O

J NNP O
Clin NNP O
Invest NNP O
62 CD O
: : O
480 CD O
- HYPH O
486 CD O
, , O
1978 CD O

S UH B-Species
. . I-Species

FAECIUM NN B-Species
ENDOCARDITIS NN O
249 CD O

12 CD O
. . O

Courvalin NNP O
PM NNP O
, , O
Shaw NNP O
WV NNP O
, , O
Jacob NNP O
AE NNP O
: : O
Plasmid NNP O
- HYPH O
mediated VBN O
mechanisms NNS O
of IN O
resistance NN O
to IN O

aminoglycoside NN O
- : O
aminocyclitol NN O
antibiotics NNS O
and CC O
to IN O
chloramphenicol NN O
in IN O
group NN O
D NN O
streptococci NN O
. . O

Antimicrob JJ O
Agents NNS O
Chemother NNP O
13 CD O
: : O
716 CD O
- HYPH O
725 CD O
, , O
1978 CD O

13 CD O
. . O

Calderwood NNP O
SA NNP O
, , O
Wennersten NNP O
C NNP O
, , O
Moellering NNP O
RC NNP O
Jr NNP O
, , O
et FW O
al NN O
: : O
Resistance NN O
to IN O
six CD O
aminoglycosidic NN O

aminocyclitol NN O
antibiotics NNS O
among IN O
enterococci NN O
: : O
Prevalence NN O
, , O
evolution NN O
, , O
and CC O
relationship NN O
to IN O
synergism NN O
with IN O
penicillin NN O
. . O

Antimicrob JJ O
Agents NNS O
Chemother NNP O
12 CD O
: : O
401 CD O
- HYPH O
405 CD O
, , O
1977 CD O

14 CD O
. . O

Bisno NNP O
AL NNP O
: : O
Treatment NN O
of IN O
infective JJ O
endocarditis NN O
. . O

New NNP O
York NNP O
, , O
Grune NNP O
and CC O
Stratton NNP O
, , O
1981 CD O
, , O
p NN O
90 CD O

15 CD O
. . O

Lorian NNP O
V NNP O
: : O
Effects NNS O
of IN O
subminimum JJ O
inhibitory JJ O
concentrations NNS O
of IN O
antibiotics NNS O
on IN O
bacteria NNS O
. . O

In IN O
Antibiotics NNS O

in IN O
Laboratory NNP O
Medicine NNP O
. . O

Edited VBN O
by IN O
V NNP O
Lorian NNP O
. . O

Baltimore NNP O
, , O
Williams NNP O
and CC O
Wilkins NNP O
, , O
1980 CD O
, , O
p NN O
342 CD O

Structural JJ O
organization NN O
of IN O
a DT O
17 CD O
KB NNP O
segment NN O
of IN O
the DT O
alpha NN O
2 CD O
collagen NN O
gene NN O
: : O
evaluation NN O
by IN O
R NN O
loop NN O
mapping NN O
. . O

Abstract JJ O

A DT O
recombinant JJ O
phage NN O
, , O
SpC3 NNP O
, , O
containing VBG O
a DT O
17 CD O
kb NN O
genomic JJ O
DNA NN O
insert NN O
representing VBG O
approximately RB O
60 CD O
% NN O
of IN O
the DT O
3 CD O
' '' O
portion NN O
of IN O
the DT O
sheep NN B-Species
collagen NN O
alpha NN O
2 CD O
gene NN O
, , O
was VBD O
evaluated VBN O
by IN O
electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
. . O

A DT O
minimum NN O
of IN O
17 CD O
intervening VBG O
sequences NNS O
( , O
introns NNS O
) -RRB- O
and CC O
18 CD O
alpha NN O
2 CD O
coding VBG O
sequences NNS O
( , O
exons NNS O
) -RRB- O
were VBD O
mapped VBN O
. . O

With IN O
the DT O
exception NN O
of IN O
the DT O
850 CD O
base NN O
pair NN O
exon NN O
located VBN O
at IN O
the DT O
extreme JJ O
3 CD O
' '' O
end NN O
of IN O
the DT O
insert NN O
, , O
all DT O
exons NNS O
contained VBD O
250 CD O
base NN O
pairs NNS O
or CC O
less JJR O
. . O

The DT O
total JJ O
length NN O
of IN O
all PDT O
the DT O
exons NNS O
in IN O
SpC3 NNP O
was VBD O
3 CD O
, , O
14 CD O
base NN O
pairs NNS O
. . O

The DT O
length NN O
distribution NN O
of IN O
the DT O
17 CD O
introns NNS O
ranged VBD O
from IN O
300 CD O
to IN O
1600 CD O
base NN O
pairs NNS O
; , O
together RB O
, , O
all DT O
of IN O
the DT O
introns NNS O
comprised VBD O
14 CD O
, , O
70 CD O
base NN O
pairs NNS O
of IN O
SpC3 NNP O
DNA NNP O
. . O

Thus RB O
, , O
the DT O
DNA NN O
region NN O
required VBN O
for IN O
coding VBG O
the DT O
interspersed JJ O
3 CD O
kb NN O
of IN O
alpha NN O
2 CD O
collagen NN O
genetic JJ O
information NN O
was VBD O
5 CD O
. . O
6 CD O
fold NN O
longer RBR O
than IN O
the DT O
corresponding JJ O
alpha NN O
2 CD O
mRNA NN O
coding VBG O
sequences NNS O
. . O
Images NNS O

Nucleic NNP O
Acids NNP O
Research NNP O

Structural JJ O
organization NN O
of IN O
a DT O
17 CD O
KB NNP O
segment NN O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
: : O
evaluation NN O
by IN O
R NNP O
loop NN O
mapping NN O
Millie NNP O
P NNP O
. . O
Schafer NNP O
, , O
Charles NNP O
D NNP O
. . O
Boyd NNP O
, , O
Paul NNP O
Tolstoshev NNP O
and CC O
Ronald NNP O
G NNP O
. . O
Crystal NNP O

Pulmonary NNP O
Branch NNP O
, , O
National NNP O
Heart NNP O
, , O
Lung NNP O
and CC O
Blood NNP O
Institute NNP O
, , O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
, , O
Bethesda NNP O
, , O
MD NNP O
20205 CD O
, , O
USA NNP O

Received VBN O
13 CD O
February NNP O
1980 CD O

ABSTRACT NNP O

A DT O
recombinant JJ O
phage NN O
, , O
SpC3 NNP O
, , O
containing VBG O
a DT O
17 CD O
kb NN O
genomic JJ O
DNA NN O
insert NN O
rep NN O

resenting VBG O
approximately RB O
60 CD O
% NN O
of IN O
the DT O
3 CD O
' '' O
portion NN O
of IN O
the DT O
sheep NN B-Species
collagen NN O
a2 NN O
gene NN O
, , O
was VBD O
evaluated VBN O
by IN O
electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
. . O

A DT O
minimum NN O
of IN O
17 CD O
intervening VBG O
sequences NNS O
( , O
introns NNS O
) -RRB- O
and CC O
18 CD O
a2 CD O
coding VBG O
sequences NNS O
( , O
exons NNS O
) -RRB- O
were VBD O

mapped VBN O
. . O

With IN O
the DT O
exception NN O
of IN O
the DT O
850 CD O
base NN O
pair NN O
exon NN O
located VBN O
at IN O
the DT O
extreme JJ O
3 CD O
' '' O
end NN O
of IN O
the DT O
insert NN O
, , O
all DT O
exons NNS O
contained VBD O
250 CD O
base NN O
pairs NNS O
or CC O
less JJR O
. . O

The DT O
total JJ O
length NN O
of IN O
all PDT O
the DT O
exons NNS O
in IN O
SpC3 NNP O
was VBD O
3 CD O
, , O
14 CD O
base NN O
pairs NNS O
. . O

The DT O
length NN O
distribution NN O
of IN O
the DT O
17 CD O
introns NNS O
ranged VBD O
from IN O
300 CD O
to IN O
1600 CD O
base NN O
pairs NNS O
; , O
together RB O
, , O
all DT O
of IN O
the DT O
introns NNS O
comprised VBD O
14 CD O
, , O
70 CD O
base NN O
pairs NNS O
of IN O
SpC3 NNP O
DNA NNP O
. . O

Thus RB O
, , O
the DT O
DNA NNP O
region NN O

required VBN O
for IN O
coding VBG O
the DT O
interspersed JJ O
3 CD O
kb NN O
of IN O
a2 CD O
collagen NN O
genetic JJ O
information NN O
was VBD O
5 CD O
. . O
6 CD O
fold NN O
longer RBR O
than IN O
the DT O
corresponding JJ O
a2 CD O
mRNA NN O
coding VBG O
sequences NNS O
. . O

INTRODUCTION NN O

Type NN O
I NN O
collagen NN O
, , O
composed VBN O
of IN O
two CD O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
one CD O
a2 CD O
polypeptide NN O
chains NNS O
, , O
is VBZ O
the DT O
most RBS O
abundant JJ O
of IN O
the DT O
five CD O
known VBN O
mammalian JJ O
collagen NN O
types NNS O
. . O

It PRP O
is VBZ O
a DT O
major JJ O
extracellular JJ O
constituent NN O
of IN O
tissues NNS O
such JJ O
as IN O
bone NN O
, , O
tendon NN O
, , O
skin NN O
and CC O
lung NN O
where WRB O
, , O
because IN O
of IN O
its PRP$ O
great JJ O
tensile JJ O
strength NN O
, , O
it PRP O
plays VBZ O
an DT O
important JJ O

role NN O
in IN O
tissue NN O
structure NN O
and CC O
function NN O
. . O

The DT O
polypeptides NNS O
comprising VBG O
type NN O
I PRP O

collagen NN O
are VBP O
synthesized VBN O
in IN O
long JJ O
, , O
precursor NN O
forms NNS O
, , O
referred VBN O
to IN O
as IN O
pro FW O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
pro FW O
a2 NN O
chains NNS O
, , O
1 CD O
each DT O
containing VBG O
approximately RB O
1500 CD O
amino NN O
acid NN O
residues NNS O
( , O
1 CD O
) -RRB- O
. . O

1 LS O
The DT O
terminology NN O
for IN O
the DT O
primary JJ O
translation NN O
products NNS O
of IN O
the DT O
various JJ O

collagen NN O
messenger NN O
RNAs NNP O
is VBZ O
still RB O
in IN O
a DT O
state NN O
of IN O
flux NN O
. . O

It PRP O
is VBZ O
known VBN O
that IN O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
a2 NN O
chains NNS O
are VBP O
synthesized VBN O
in IN O
precursor NN O
forms NNS O
; : O
these DT O
are VBP O
currently RB O
termed VBN O
pro JJ O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
pro JJ O
a2 NN O
chains NNS O
( -LRB- O
1 CD O
) -RRB- O
. . O

However RB O
, , O
recent JJ O
studies NNS O
( , O
43 CD O
, , O
44 CD O
) -RRB- O
have VBP O
shown VBN O
that IN O
the DT O
actual JJ O
primary JJ O
translation NN O
product NN O
of IN O
al NNP O
( HYPH O
I NNP O
) -RRB- O
mRNA NNP O
is VBZ O
somewhat RB O
larger JJR O

than IN O
the DT O
pro JJ O
al NNP O
( HYPH O
I NNP O
) -RRB- O
chain NN O
; : O
this DT O
translation NN O
product NN O
has VBZ O
been VBN O
termed VBN O
a DT O
"""" `` O
pre NN O
- HYPH O
pro FW O
al NNP O
( HYPH O
I NNP O
) -RRB- O
chain NN O
. , O
"""" '' O
Although IN O
the DT O
corresponding VBG O
"""" `` O
pre NN O
- HYPH O
pro JJ O
a2 NN O
chain NN O
"""" '' O
likely RB O
exists VBZ O
, , O
it PRP O
has VBZ O
not RB O
yet RB O
been VBN O
characterized VBN O
. . O

For IN O
simplicity NN O
, , O
therefore RB O
, , O
until IN O
the DT O

proper JJ O
terminology NN O
for IN O
the DT O
primary JJ O
translation NN O
product NN O
is VBZ O
clarified VBN O
, , O
we PRP O
have VBP O

chosen VBN O
to TO O
use VB O
the DT O
terms NNS O
"""" `` O
al NNP O
( , O
I NNP O
) -RRB- O
"""" '' O
and CC O
"""" `` O
a2 NN O
"""" '' O
to TO O
refer VB O
to IN O
the DT O
type NN O
I NN O
collagen NN O
mRNAs NNS O
and CC O
collagen NN O
structural JJ O
gene NN O
sequences NNS O
. . O

? . O
) : O
IRL NNP O
Press NNP O
Umited NNP O
, , O
1 CD O
Falconberg NNP O
Court NNP O
, , O
London NNP O
W1V NNP O
5FG NNP O
, , O
U NN O
. . O
K NNP O
. . O

Volurne NNP O
8 CD O
Number NNP O
10 CD O
1980 CD O

2241 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

There EX O
is VBZ O
increasing VBG O
evidence NN O
that IN O
the DT O
quantities NNS O
of IN O
al NNP O
( HYPH O
I NNP O
) -RRB- O
and CC O
a2 NN O

chains NNS O
produced VBN O
by IN O
cells NNS O
may MD O
be VB O
regulated VBN O
, , O
in IN O
part NN O
, , O
at IN O
the DT O
genomic JJ O
level NN O

( : O
1 CD O
) -RRB- O
. . O

However RB O
, , O
to TO O
understand VB O
the DT O
processes NNS O
which WDT O
mediate VBP O
their PRP$ O
expression NN O
, , O

it PRP O
is VBZ O
necessary JJ O
to TO O
understand VB O
the DT O
structural JJ O
organization NN O
of IN O
these DT O
collagen NN O
genes NNS O
and CC O
the DT O
various JJ O
enzymes NNS O
that WDT O
modify VBP O
the DT O
collagen NN O
chains NNS O
after IN O
its PRP$ O

synthesis NN O
( : O
1 CD O
) -RRB- O
. . O

As IN O
an DT O
initial JJ O
approach NN O
to IN O
this DT O
problem NN O
, , O
we PRP O
have VBP O
recently RB O

isolated VBN O
a DT O
recombinant JJ O
bacteriophage NN O
, , O
termed VBN O
SpC3 NNP O
, , O
containing VBG O
approximately RB O
60 CD O
% NN O
of IN O
the DT O
a2 NN O
gene NN O
for IN O
type NN O
I NN O
collagen NN O
. . O

Partial JJ O
characterization NN O
of IN O
this DT O

a2 NN O
gene NN O
demonstrated VBD O
that IN O
, , O
like IN O
most JJS O
other JJ O
structurally RB O
evaluated VBN O
eukaryotic JJ O
genes NNS O
, , O
the DT O
coding VBG O
sequences NNS O
are VBP O
interspersed VBN O
with IN O
intervening VBG O
sequences NNS O
( , O
2 CD O
) -RRB- O
. . O

The DT O
present JJ O
study NN O
further RB O
characterizes VBZ O
this DT O
portion NN O
of IN O
the DT O
a2 NN O

gene NN O
by IN O
utilizing VBG O
electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
to TO O
map VB O
the DT O
coding VBG O
regions NNS O
( , O
exons FW O
) -RRB- O
and CC O
intervening VBG O
sequences NNS O
( , O
introns NNS O
) -RRB- O
contained VBN O
within IN O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
of IN O
SpC3 NNP O
. . O

The DT O
data NNS O
suggests VBZ O
that IN O
the DT O
structural JJ O

organization NN O
of IN O
this DT O
portion NN O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
represents VBZ O
3 CD O
kb NN O
of IN O
coding VBG O
information NN O
that WDT O
is VBZ O
interspersed VBN O
in IN O
a DT O
complex JJ O
fashion NN O
with IN O
17 CD O
introns NNS O
over IN O
17 CD O
kb NN O
of IN O
genome NN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Isolation NN O
and CC O
characterization NN O
of IN O
a2 NN O
collagen NN O
recombinant NN O
clone NN O
, , O
SpC3 NNP O
. . O

The DT O
sheep NN B-Species
a2 NN O
collagen NN O
recombinant NN O
clone NN O
, , O
SpC3 NNP O
, , O
containing VBG O
a DT O
portion NN O
of IN O
the DT O
sheep NN B-Species
a2 NN O
gene NN O
, , O
was VBD O
isolated VBN O
as IN O
previously RB O
described VBN O
( , O
2 CD O
) -RRB- O
. . O

Briefly RB O
, , O

high JJ O
molecular JJ O
weight NN O
fetal JJ O
sheep NN B-Species
liver NN O
DNA NNP O
was VBD O
extracted VBN O
by IN O
the DT O
method NN O
of IN O
Blin NNP O
and CC O
Stafford NNP O
( SYM O
3 CD O
) -RRB- O
, , O
and CC O
15 CD O
- SYM O
20 CD O
kb NN O
DNA NN O
fragments NNS O
, , O
resulting VBG O
from IN O
partial JJ O
Eco NNP O
RI NNP O
digestion NN O
, , O
were VBD O
isolated VBN O
and CC O
ligated VBN O
to IN O
the DT O
left JJ O
and CC O
right JJ O
arms NNS O
of IN O
Charon NNP O
4A NNP O
. . O

The DT O
recombinant JJ O
DNA NNP O
was VBD O
then RB O
packaged VBN O
in IN O
vitro NN O
and CC O
the DT O
sheep NN B-Species

genomic JJ O
library NN O
amplified VBN O
( : O
4 CD O
- HYPH O
6 CD O
) -RRB- O
. . O

Screening NN O
of IN O
the DT O
sheep NN B-Species
genomic JJ O
library NN O
was VBD O

conducted VBN O
utilizing VBG O
[ -LRB- O
32 CD O
P NN O
] -RRB- O
- HYPH O
labeled VBN O
fetal JJ O
sheep NN B-Species
tendon NN O
type NN O
I NN O
collagen NN O
cDNA NNP O
and CC O

several JJ O
positive JJ O
recombinant JJ O
phages NNS O
were VBD O
isolated VBN O
. . O

One CD O
recombinant NN O
, , O
containing VBG O
a DT O
17 CD O
kb NN O
sheep NN B-Species
genomic JJ O
insert NN O
, , O
was VBD O
demonstrated VBN O
to TO O
have VB O
coding VBG O
sequences NNS O
corresponding VBG O
to IN O
60 CD O
% NN O
of IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
a2 CD O
mRNA NN O
. . O

Prior JJ O
studies NNS O
showed VBD O
that IN O
the DT O
insert NN O
in IN O
SpC3 NNP O
was VBD O
not RB O
due JJ O
to IN O
ligation NN O
of IN O
noncontiguous JJ O
restriction NN O
fragments NNS O
and CC O
/ SYM O
or CC O
genetic JJ O
rearrangement NN O
during IN O
the DT O
cloning NN O
process NN O
( , O
2 CD O
) -RRB- O
. . O

Electron NN O
mi NN O
croscopy NN O
. . O

To TO O
visualize VB O
the DT O
recombinant JJ O
bacteriophage NN O
DNA NN O
structure NN O
complementary JJ O
to IN O
a2 CD O
collagen NN O
mRNA NN O
, , O
1 CD O
iig NN O
of IN O
SpC3 NNP O
DNA NNP O
was VBD O
lyophilized VBN O
with IN O
1 CD O
ig NN O
or CC O
100 CD O
ng NNS O
of IN O
mRNA NNP O

to TO O
give VB O
DNA NN O
: : O
mRNA NNP O
ratios NNS O
of IN O
1 CD O
: SYM O
1 CD O
and CC O
10 CD O
: SYM O
1 CD O
, , O
respectively RB O
. . O

These DT O
were VBD O
then RB O
dissolved VBN O
in IN O
10 CD O
i1 CD O
of IN O
R NN O
loop NN O
buffer NN O
[ -LRB- O
70 CD O
% NN O
( HYPH O
v NN O
/ SYM O
v NN O
) -RRB- O
deionized VBN O
formamide NN O
, , O
0 CD O
. . O
1 CD O
N NN O
- HYPH O
[ -LRB- O
tris NN O
( , O
hydroxy NN O

2242 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

methyl NN O
) : O
methyl NN O
] -RRB- O
glycine NN O
( , O
tricine NN O
) NFP O
- HYPH O
NaOH NNP O
, , O
pH NN O
8 CD O
. . O
0 CD O
, , O
0 CD O
. . O
5 CD O
M NN O
NaCl NN O
, , O
and CC O
0 CD O
. . O
1 CD O
M NN O
ethyl NN O

enediaminetetraaceta NNP O
( -LRB- O
EDTA NNP O
) -RRB- O
] -RRB- O
, , O
incubated VBN O
in IN O
sealed VBN O
capillary NN O
tubes NNS O
at IN O
520 CD O
for IN O
14 CD O
hr NNS O
( SYM O
7 CD O
) -RRB- O
, , O
and CC O
then RB O
diluted VBN O
1 CD O
: SYM O
10 CD O
with IN O
R NN O
loop NN O
buffer NN O
. . O

Two CD O
spreading VBG O
methods NNS O
were VBD O
used VBN O
to TO O
subsequently RB O
prepare VB O
the DT O
hybrids NNS O
for IN O
visualization NN O
in IN O
the DT O
electron NN O
microscope NN O
. . O

70 CD O
% NN O
formamide NN O
method NN O
. . O

Immediately RB O
before IN O
spreading VBG O
onto IN O
a DT O
deionized JJ O

water NN O
hypophase NN O
, , O
the DT O
nucleic JJ O
acid NN O
mixtures NNS O
were VBD O
diluted VBN O
an DT O
additional JJ O
10 CD O
- HYPH O
fold NN O
in IN O
R NN O
loop NN O
buffer NN O
and CC O
cytochrome NN O
c NN O
, , O
100 CD O
vg NN O
/ SYM O
ml NNS O
, , O
was VBD O
added VBN O
. . O

Urea NNP O
- HYPH O
formamide NN O
method NN O
. . O

The DT O
nucleic JJ O
acid NN O
solutions NNS O
were VBD O
spread VBN O
using VBG O
a DT O
modification NN O
of IN O
the DT O
method NN O
of IN O
Westphal NNP O
and CC O
Lai NNP O
( , O
8 CD O
, , O
9 CD O
) -RRB- O
. . O

The DT O
hyperphase NN O
contained VBD O
55 CD O
% NN O
formamide NN O
, , O
2 CD O
. . O
6 CD O
M NN O
urea NN O
, , O
0 CD O
. . O
9 CD O
M NN O
EDTA NNP O
, , O
0 CD O
. . O
9 CD O
M NN O
tricine NN O
- HYPH O
NaOH NN O
, , O
pH NN O
8 CD O
. . O
0 CD O
, , O
and CC O
the DT O
nucleic JJ O
acid NN O
mixture NN O
( , O
approximately RB O
0 CD O
. . O
1 CD O
to TO O
1 CD O
. . O
0 CD O
ig NN O
/ SYM O
ml NN O
) -RRB- O
. . O

The DT O
mixture NN O
was VBD O
heated VBN O
at IN O
40 CD O
? , O
for IN O
30 CD O
sec NN O
, , O
placed VBN O
in IN O
ice NN O
water NN O
, , O
and CC O
then RB O
allowed VBN O
to TO O
reach VB O
room NN O
temperature NN O
. . O

Cytochrome NN O
c NN O
, , O
100 CD O
pg NN O
/ SYM O
ml NNS O
, , O
was VBD O
added VBN O
immediately RB O
before IN O
spreading VBG O
onto IN O
a DT O
deionized VBN O
water NN O
hypophase NN O
. . O

The DT O
nucleic JJ O
acid NN O
- HYPH O
protein NN O
films NNS O
from IN O
both DT O
methods NNS O
were VBD O
absorbed VBN O
onto IN O

parlodion NN O
- HYPH O
coated VBN O
grids NNS O
, , O
stained VBN O
with IN O
uranyl NN O
acetate NN O
( , O
10 CD O
) -RRB- O
, , O
dehydrated VBN O
in IN O
90 CD O
% NN O
ethanol NN O
and CC O
rotary NN O
- HYPH O
shadowed VBN O
with IN O
platinum NN O
- HYPH O
palladium NN O
( , O
80 CD O
: SYM O
20 CD O
) -RRB- O
at IN O
an DT O
angle NN O
of IN O
50 CD O
. . O

Micrographs NNS O
were VBD O
taken VBN O
with IN O
a DT O
Siemens NNP O
Elmiskop NNP O
101 CD O
electron NN O
microscope NN O
at IN O
an DT O
original JJ O
magnification NN O
of IN O
10 CD O
, , O
0 CD O
and CC O
an DT O
accelerating VBG O
voltage NN O
of IN O
60 CD O
kv NN O
. . O

Nucleic JJ O
acid NN O
lengths NNS O
were VBD O
measured VBN O
at IN O
a DT O
final JJ O
magnification NN O
of IN O
43 CD O
, , O
0 CD O
with IN O
a DT O

Hewlett NNP O
- HYPH O
Packard NNP O
9810A NN O
calculator NN O
equipped VBN O
with IN O
a DT O
9864A CD O
digitizer NN O
using VBG O
pBR322 NN O
and CC O
fX NN O
- HYPH O
174 CD O
double JJ O
and CC O
single JJ O
stranded VBN O
DNA NN O
, , O
respectively RB O
, , O
as IN O
internal JJ O
length NN O
standards NNS O
. . O

Approximately RB O
10 CD O
, , O
0 CD O
hybrid JJ O
molecules NNS O
were VBD O
screened VBN O
for IN O
these DT O
studies NNS O
; : O
approximately RB O
200 CD O
represented VBN O
molecules NNS O
containing VBG O
unambiguous JJ O
regions NNS O

appropriate JJ O
for IN O
quantitative JJ O
analysis NN O
. . O

The DT O
mean JJ O
lengths NNS O
of IN O
each DT O
intron NN O
and CC O
exon NN O
were VBD O
determined VBN O
for IN O
each DT O
method NN O
and CC O
the DT O
data NNS O
expressed VBN O
as IN O
mean JJ O
? . O

standard JJ O
deviation NN O
. . O

Nucleic JJ O
acid NN O
lengths NNS O
of IN O
< SYM O
50 CD O
base NN O
pairs NNS O
could MD O
not RB O
be VB O

accurately RB O
determined VBN O
using VBG O
the DT O
methods NNS O
outlined VBN O
above RB O
. . O

Thus RB O
, , O
in IN O
the DT O
cases NNS O

where WRB O
introns NNS O
or CC O
exons NNS O
were VBD O
of IN O
this DT O
length NN O
or CC O
less JJR O
, , O
accurate JJ O
error NN O
estimates NNS O
could MD O
not RB O
be VB O
made VBN O
. . O

Bi NNP O
ohazard FW O
precauti FW O
ons NNS O
. . O

The DT O
construction NN O
and CC O
screening NN O
of IN O
the DT O
sheep NN B-Species
genomic JJ O
library NN O
together RB O
with IN O
amplification NN O
of IN O
pCg45 NN O
and CC O
preparation NN O
of IN O
high JJ O
titre NN O
lysates NNS O
of IN O
chimaeric JJ O

Charon NNP O
4A NNP O
were VBD O
performed VBN O
under IN O
the DT O
physical JJ O
and CC O
biological JJ O
containment NN O
levels NNS O
specified VBN O
by IN O
the DT O
NIH NNP O
guidelines NNS O
for IN O
recombinant JJ O
DNA NN O
research NN O
( SYM O
11 CD O
) -RRB- O
. . O

2243 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

RESULTS NNS O

Location NN O
and CC O
orientation NN O
of IN O
the DT O
intervening VBG O
and CC O
a2 CD O
mRNA NN O
coding VBG O
sequences NNS O
in IN O
the DT O
SpC3 NNP O
recombinant JJ O
DNA NN O
. . O

Hybridization NN O
of IN O
fetal JJ O
sheep NN B-Species
tendon NN O
type NN O
I NN O
collagen NN O
mRNA NNP O
to IN O
SpC3 NNP O
DNA NNP O

yielded VBD O
a DT O
complex JJ O
R NN O
loop NN O
pattern NN O
in IN O
the DT O
region NN O
where WRB O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
was VBD O
expected VBN O
to TO O
be VB O
ligated VBN O
to IN O
the DT O
arms NNS O
of IN O
the DT O
lambda NN O
vector NN O
, , O
Charon NNP O
4A NNP O
. . O

To TO O

confirm VB O
that IN O
these DT O
hybridization NN O
events NNS O
were VBD O
restricted VBN O
to IN O
the DT O
inserted VBN O
sheep NN B-Species
DNA NN O
fragment NN O
, , O
duplex JJ O
DNA NN O
strands NNS O
on IN O
both DT O
sides NNS O
of IN O
this DT O
hybridization NN O
area NN O
were VBD O
measured VBN O
. . O

Using VBG O
pBR322 CD O
as IN O
an DT O
internal JJ O
length NN O
standard NN O
, , O
the DT O
left JJ O
arm NN O
of IN O
the DT O
phage NN O
was VBD O
found VBN O
to TO O
contain VB O
21 CD O
, , O
780 CD O
? . O

1500 CD O
bp NN O
, , O
and CC O
the DT O
right JJ O
arm NN O
, , O
11 CD O
, , O
950 CD O
? . O

1030 CD O
bp NN O
, , O
corresponding VBG O
to IN O
the DT O
report NN O
values NNS O
for IN O
the DT O
left JJ O
and CC O
right JJ O
arms NNS O
, , O
respectively RB O
, , O
of IN O
Charon NNP O
4A NNP O
DNA NNP O
( , O
5 CD O
, , O
6 CD O
) -RRB- O
. . O

The DT O
hybridization NN O
of IN O
SpC3 NNP O
to IN O
a2 NN O
mRNA NNP O
resulted VBD O
in IN O
the DT O
destabilization NN O
of IN O

the DT O
inserted VBN O
helical JJ O
duplex JJ O
DNA NN O
fragment NN O
such JJ O
that IN O
one CD O
DNA NN O
strand NN O
was VBD O
displaced VBN O
( : O
Figure NN O
1 CD O
) -RRB- O
. . O

Occasionally RB O
, , O
the DT O
displaced VBN O
DNA NNP O
strand NN O
was VBD O
mostly RB O
absent JJ O
, , O
probably RB O
due JJ O
to IN O
fragmentation NN O
induced VBN O
by IN O
accidental JJ O
mechanical JJ O
shearing NN O
. . O

This DT O
event NN O
considerably RB O
enhanced VBD O
the DT O
visualization NN O
and CC O
ordering NN O
of IN O
the DT O
introns NNS O
. . O

As IN O
the DT O
a2 NN O
mRNA NNP O
annealed VBD O
to IN O
complementary JJ O
DNA NNP O
regions NNS O
present JJ O
in IN O
one CD O

DNA NN O
strand NN O
, , O
numerous JJ O
single JJ O
- HYPH O
stranded JJ O
loops NNS O
resulted VBD O
. . O

These DT O
loops NNS O
, , O
referred VBD O
to IN O
as IN O
introns NNS O
, , O
represented VBD O
DNA NNP O
sequences NNS O
not RB O
complementary JJ O
to IN O
the DT O
mRNA NNP O
. . O

Although IN O
, , O
by IN O
convention NN O
, , O
introns NNS O
are VBP O
usually RB O
sequentially RB O
labeled VBN O
5 CD O
' '' O
to IN O
3 CD O
' '' O
, , O
an DT O
opposite JJ O
order NN O
had VBD O
to TO O
be VB O
employed VBN O
in IN O
this DT O
case NN O
as IN O
SpC3 NNP O
does VBZ O
not RB O
contain VB O
the DT O
sequences NNS O
coding VBG O
for IN O
the DT O
5 CD O
' '' O
end NN O
of IN O
sheep NN B-Species
a2 NN O
mRNA NN O
. . O

Infrequently RB O
, , O
all DT O
introns NNS O

were VBD O
clearly RB O
observed VBN O
within IN O
the DT O
same JJ O
hybrid NN O
molecule NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
largest JJS O
introns NNS O
were VBD O
towards IN O
the DT O
left JJ O
arm NN O
of IN O
Charon NNP O
4A NNP O
and CC O
were VBD O
more RBR O
clustered VBN O
than IN O
the DT O
introns NNS O
at IN O
the DT O
opposite JJ O
end NN O
of IN O
the DT O
hybrid NN O
. . O

Thus RB O
, , O
much JJ O
of IN O
the DT O
genetic JJ O

information NN O
coding VBG O
for IN O
the DT O
a2 NN O
mRNA NN O
was VBD O
contained VBN O
in IN O
that DT O
half NN O
of IN O
the DT O
hybrid NN O
attached VBN O
to IN O
the DT O
right JJ O
arm NN O
. . O

A DT O
small JJ O
non NN O
- HYPH O
hybridized JJ O
tail NN O
was VBD O
consistently RB O
found VBN O
in IN O
the DT O
region NN O
where WRB O

the DT O
right JJ O
arm NN O
of IN O
the DT O
phage NN O
was VBD O
ligated VBN O
to IN O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

This DT O
tail NN O
likely RB O
corresponded VBD O
to IN O
the DT O
3 CD O
' '' O
poly NN O
A DT O
sequence NN O
of IN O
the DT O
a2 NN O
mRNA NNP O
. . O

At IN O

the DT O
extreme JJ O
5 CD O
' '' O
end NN O
of IN O
the DT O
insert NN O
, , O
a DT O
variable JJ O
length NN O
was VBD O
often RB O
observed VBN O
for IN O
the DT O
remaining VBG O
unhybridized JJ O
mRNA NNP O
strand NN O
. . O

This DT O
was VBD O
most RBS O
likely JJ O
due IN O
to IN O
the DT O
size NN O
heterogeneity NN O
of IN O
the DT O
a2 CD O
mRNA NNP O
used VBN O
in IN O
these DT O
studies NNS O
. . O

Size NN O
determination NN O
and CC O
comparative JJ O
analysis NN O
of IN O
SpC3 NNP O
introns NNS O
. . O

Although IN O
localization NN O
of IN O
exon NN O
and CC O
intron NN O
sequences NNS O
was VBD O
possible JJ O
with IN O
both DT O
the DT O
70 CD O
% NN O
formamide NN O
and CC O
urea NN O
- HYPH O
formamide NN O
spreading VBG O
methods NNS O
, , O
the DT O
probability NN O
of IN O

detecting VBG O
unambiguous JJ O
regions NNS O
in IN O
a DT O
hybrid JJ O
molecule NN O
was VBD O
far RB O
greater JJR O
with IN O
the DT O

2244 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

A DT O
B NN O
' '' O
, , O
: : O
' '' O
14 CD O
. . O
0 NFP O
. . O

13 CD O

7 CD O
1 CD O

- SYM O
5 CD O
13 CD O

. . O
. . O

. . O
. . O

, , O
4 CD O
x2 CD O
% NN O
. . O

N1 NNP O

9 CD O

> NFP O
10 CD O
R NN O
4 CD O

Figure NN O
1 CD O
. . O

Electron NN O
microscopic JJ O
visualization NN O
of IN O
all DT O
17 CD O
introns NNS O
and CC O
18 CD O
exons NNS O

from IN O
hybrid JJ O
molecules NNS O
formed VBN O
between IN O
recombinant JJ O
clone NN O
SpC3 NN O
DNA NN O
and CC O
fetal JJ O
sheep NN B-Species

tendon NN O
a2 NN O
mRNA NN O
. . O

( : O
A DT O
, , O
B NNP O
) , O
Shown VBN O
are VBP O
the DT O
double JJ O
- HYPH O
stranded JJ O
segment NN O
of IN O
the DT O
right JJ O
arm NN O
CR NN O
) -RRB- O
of IN O
Charon NNP O
4A NNP O
; : O
double JJ O
- HYPH O
stranded JJ O
segment NN O
of IN O
the DT O
left JJ O
arm NN O
CL NNP O
) -RRB- O
of IN O
Charon NNP O
4A NNP O
; : O
the DT O

displaced VBN O
single JJ O
- HYPH O
stranded JJ O
DNA NN O
segment NN O
of IN O
the DT O
insert NN O
( , O
5 CD O
) -RRB- O
; : O
single JJ O
- HYPH O
stranded VBN O
DNA NNP O
loops NNS O
representing VBG O
introns NNS O
sequentially RB O
labeled VBN O
1 CD O
through IN O
17 CD O
in IN O
the DT O
3 CD O
' '' O
to IN O
5 CD O
' '' O
direction NN O
; : O
and CC O
18 CD O
regions NNS O
of IN O
insert NN O
DNA NN O
sequences NNS O
hybridized VBN O
to IN O
ct2 NNP O
mRNA NNP O

- : O
- : O
- : O
- : O
) -RRB- O
. . O

( : O
C NN O
, , O
D NN O
) : O
Similar JJ O
to IN O
( : O
A NN O
, , O
B NN O
) -RRB- O
but CC O
the DT O
single JJ O
- HYPH O
stranded VBN O
DNA NN O
segment NN O
( -LRB- O
5 CD O
) -RRB- O
of IN O
the DT O
insert NN O
is VBZ O
mostly RB O
absent JJ O
. . O

The DT O
urea NN O
- HYPH O
formamide NN O
spreading VBG O
method NN O
, , O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
, , O
was VBD O
employed VBN O
. . O

2245 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

urea NN O
- HYPH O
formamide JJ O
method NN O
than IN O
with IN O
the DT O
70 CD O
% NN O
formamide NN O
procedure NN O
. . O

For IN O
this DT O
reason NN O
, , O
most JJS O
measurements NNS O
were VBD O
made VBN O
with IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
( -LRB- O
Tables NNP O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

For IN O

example NN O
, , O
the DT O
lowest JJS O
probability NN O
event NN O
, , O
the DT O
detection NN O
of IN O
intron NN O
17 CD O
and CC O
the DT O
surrounding VBG O
small JJ O
exons NNS O
, , O
"""" `` O
q NN O
"""" '' O
and CC O
"""" `` O
r NN O
"""" '' O
, , O
was VBD O
only RB O
observed VBN O
by IN O
way NN O
of IN O
the DT O
ureaformamide NN O
spreading VBG O
procedure NN O
. . O

The DT O
smallest JJS O
introns NNS O
, , O
7 CD O
and CC O
12 CD O
, , O
were VBD O
found VBN O
to TO O
contain VB O
approximately RB O

the DT O
same JJ O
number NN O
of IN O
bases NNS O
. . O

Introns NNP O
1 CD O
through IN O
8 CD O
, , O
representing VBG O
the DT O
DNA NN O
sequences NNS O
which WDT O
split VBD O
the DT O
a2 NN O
coding VBG O
sequence NN O
corresponding VBG O
to IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
the DT O
a2 NN O
mRNA NN O
, , O
varied VBD O
in IN O
length NN O
over IN O
approximately RB O
a DT O
2 CD O
. . O
4 CD O
- HYPH O
fold NN O
range NN O
. . O

With IN O
the DT O
exception NN O
of IN O

Table NN O
1 CD O
. . O

Electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O

present JJ O
in IN O
SpC3 NNP O
DNA1 NNP O
. . O

of IN O
the DT O
sheep NN B-Species
a2 CD O
introns NNS O

SpC3 NN O
was VBD O
hybridized VBN O
to IN O
sheep NN B-Species
a2 IN O
mRNA NN O
as IN O
described VBN O
in IN O
Materials NNPS O
and CC O
Methods NNPS O
; , O
intron NN O
lengths NNS O
were VBD O
determined VBN O
by IN O
comparison NN O
with IN O
* NFP O
X NNP O
- HYPH O
174 CD O
DNA NNP O
lengths NNS O
. . O

2 CD O
Introns NNS O
are VBP O
designated VBN O
sequentially RB O
3 CD O
' '' O
to IN O
5 CD O
' '' O
. . O

3 LS O
All DT O
data NNS O
is VBZ O
presented VBN O
as IN O
mean JJ O
? . O

standard JJ O
deviation NN O
. . O

4 CD O
Intron NNP O
17 CD O
was VBD O
visualized VBN O
only RB O
by IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
. . O

2246 CD O

70 CD O
% NN O
Formamide NNP O
Method NNP O
Urea NNP O
- HYPH O
Formamide NNP O
Method NNP O

Intron2 JJ O
Number NN O
of IN O
Intron NN O
length NN O
Number NN O
of IN O
Intron NNP O
length NN O

introns NNS O
analyzed VBN O
( , O
bases NNS O
) -RRB- O
introns NNS O
analyzed VBN O
( HYPH O
bases NNS O
) -RRB- O

1 CD O
10 CD O
819 CD O
t NN O
63 CD O
35 CD O
806 CD O
t CD O
76 CD O
2 CD O
12 CD O
771 CD O
? . O

89 CD O
46 CD O
757 CD O
t CD O
78 CD O
3 CD O
11 CD O
458 CD O
? . O

58 CD O
47 CD O
464 CD O
? . O

66 CD O
4 CD O
6 CD O
627 CD O
? . O

53 CD O
41 CD O
611 CD O
? . O

73 CD O
5 CD O
5 CD O
554 CD O
? . O

51 CD O
34 CD O
562 CD O
? . O

76 CD O
6 CD O
6 CD O
675 CD O
? . O

19 CD O
40 CD O
684 CD O
? . O

76 CD O
7 CD O
5 CD O
386 CD O
? . O

48 CD O
50 CD O
342 CD O
? . O

54 CD O
8 CD O
7 CD O
771 CD O
? . O

84 CD O
49 CD O
757 CD O
? . O

82 CD O
9 CD O
8 CD O
1 CD O
, , O
181 CD O
? . O

94 CD O
52 CD O
1 CD O
, , O
124 CD O
? , O
122 CD O
10 CD O
8 CD O
1 CD O
, , O
133 CD O
? , O
106 CD O
53 CD O
1 CD O
, , O
124 CD O
? , O
137 CD O
11 CD O
10 CD O
964 CD O
t CD O
? , O
79 CD O
61 CD O
952 CD O
? . O
105 CD O
12 CD O
9 CD O
362 CD O
? . O

77 CD O
62 CD O
342 CD O
? . O

71 CD O
13 CD O
4 CD O
723 CD O
? . O
222 CD O
53 CD O
806 CD O
? . O
105 CD O
14 CD O
4 CD O
1 CD O
, , O
85 CD O
? , O
142 CD O
53 CD O
1 CD O
, , O
75 CD O
? . O
105 CD O
15 CD O
3 CD O
795 CD O
? . O

60 CD O
47 CD O
806 CD O
? . O
100 CD O
16 CD O
2 CD O
1 CD O
, , O
229 CD O
? . O

48 CD O
43 CD O
1 CD O
, , O
319 CD O
? . O
146 CD O
174 CD O
- HYPH O
- HYPH O
12 CD O
1 CD O
, , O
539 CD O
? . O
166 CD O

1 NFP O

Nucleic NNP O
Acids NNP O
Research NNP O

Table NN O
2 CD O
. . O

Electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
of IN O
the DT O
sheep NN B-Species
a2 NN O
exons NNS O

present JJ O
in IN O
SpC3 NNP O
DNA1 NNP O
. . O

70 CD O
% NN O
Formamide NNP O
Method NNP O
Urea NNP O
- HYPH O
Formamide NNP O
Method NNP O

Exon2 NNP O
Number NN O
of IN O
Exon NNP O
length NN O
Number NNP O
of IN O
Exon NNP O
length NN O

exons NNS O
analyzed VBN O
( HYPH O
base NN O
pairs NNS O
) -RRB- O
exons NNS O
analyzed VBN O
( HYPH O
base NN O
pairs NNS O
) -RRB- O

a DT O
7 CD O
807 CD O
? . O

883 CD O
26 CD O
883 CD O
? . O
132 CD O
b NN O
10 CD O
252 CD O
? . O

35 CD O
41 CD O
234 CD O
? . O

49 CD O
c NN O
11 CD O
151 CD O
? . O

25 CD O
48 CD O
182 CD O
? . O

42 CD O
d NN O
6 CD O
252 CD O
? . O

60 CD O
44 CD O
234 CD O
? . O

62 CD O
e NN O
5 CD O
126 CD O
? . O

45 CD O
37 CD O
129 CD O
? . O

47 CD O
f SYM O
5 CD O
126 CD O
? . O

38 CD O
35 CD O
104 CD O
? . O

41 CD O
9 CD O
5 CD O
176 CD O
? . O

48 CD O
40 CD O
182 CD O
? . O

54 CD O
h CD O
5 CD O
100 CD O
? . O

43 CD O
47 CD O
104 CD O
? . O

31 CD O

7 CD O
100 CD O
? . O

35 CD O
50 CD O
104 CD O
? . O

28 CD O
j NN O
7 CD O
126 CD O
? . O

48 CD O
45 CD O
130 CD O
? . O

47 CD O
k NN O
8 CD O
50 CD O
? . O

48 CD O
51 CD O
52 CD O
? . O

39 CD O
1 CD O
9 CD O
75 CD O
? . O

10 CD O
60 CD O
52 CD O
? . O

44 CD O
m NN O
6 CD O
126 CD O
? . O

43 CD O
51 CD O
182 CD O
? . O

54 CD O
n SYM O
4 CD O
100 CD O
? . O

45 CD O
53 CD O
52 CD O
? . O

42 CD O
o CD O
3 CD O
< SYM O
504 CD O
50 CD O
78 CD O
? . O

36 CD O
p NN O
2 CD O
126 CD O
? . O

71 CD O
47 CD O
104 CD O
? . O

36 CD O
q5 CD O
- HYPH O
_ SYM O
33 CD O
130 CD O
? . O
47 CD O
r5 CD O
r NN O
6 CD O
78 CD O
? . O
36 CD O

SpC3 NNP O
was VBD O
hybridized VBN O
to IN O
sheep NN B-Species
a2 NN O
mRNA NN O
as IN O
described VBN O
in IN O
M4aterials NNPS O
and CC O

Methods NNS O
; : O
exon NN O
lengths NNS O
were VBD O
determined VBN O
by IN O
comparison NN O
with IN O
pBR322 CD O
DNA NN O
lengths NNS O
. . O

2 CD O
Exons NNPS O
are VBP O
designated VBN O
sequentially RB O
3 CD O
' '' O
to IN O
5 CD O
' '' O
. . O

3 LS O
All DT O
data NNS O
is VBZ O
presented VBN O
as IN O
mean JJ O
? . O

standard JJ O
deviation NN O
. . O

4 LS O
5 CD O

No DT O
statistical JJ O
evaluation NN O
was VBD O
possible JJ O
because IN O
of IN O
the DT O
size NN O
of IN O
the DT O
exon NN O
( , O
see VB O
( , O
Materials NNPS O
and CC O
Methods NNPS O
) -RRB- O
. . O

Exons NNP O
q NNP O
and CC O
r NN O
were VBD O
only RB O
analyzed VBN O
by IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
. . O

intron NN O
1 CD O
, , O
the DT O
nucleotide NN O
size NN O
of IN O
these DT O
introns NNS O
was VBD O
less JJR O
than IN O
800 CD O
bases NNS O
. . O

In IN O
contrast NN O
, , O
introns NNS O
9 CD O
through IN O
17 CD O
varied VBD O
over IN O
a DT O
4 CD O
. . O
5 CD O
- HYPH O
fold NN O
range NN O
. . O

Except IN O
for IN O
intron NN O
12 CD O
, , O
all DT O
of IN O
the DT O
introns NNS O
9 CD O
through IN O
17 CD O
contained VBD O
800 CD O
bases NNS O
or CC O
more JJR O
. . O

Summation NN O
of IN O
introns NNS O
1 CD O
through IN O
16 CD O
for IN O
the DT O
70 CD O
% NN O
formamide NN O
and CC O
urea NN O

formamide NN O
spreading NN O
methods NNS O
yielded VBD O
12 CD O
, , O
533 CD O
and CC O
12 CD O
, , O
531 CD O
bases NNS O
, , O
respectively RB O
. . O

However RB O
, , O
detection NN O
of IN O
intron NN O
17 CD O
by IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
indicates VBZ O
that DT O

the DT O
actual JJ O
summed JJ O
value NN O
for IN O
the DT O
intervening VBG O
sequences NNS O
of IN O
SpC3 NNP O
is VBZ O
14 CD O
, , O
70 CD O
bases NNS O
. . O

2247 CD O

1 NFP O

Nucleic NNP O
Acids NNP O
Research NNP O

Size NN O
determination NN O
and CC O
the DT O
comparative JJ O
analysis NN O
of IN O
SpC3 NNP O
exons NNS O
. . O

Eighteen CD O
exons NNS O
, , O
"""" `` O
a DT O
"""" '' O
through IN O
"""" `` O
r NN O
"""" '' O
, , O
were VBD O
mapped VBN O
( , O
Table NNP O
2 CD O
) -RRB- O
. . O

The DT O
largest JJS O
exon NN O
, , O
"""" `` O
a DT O
"""" '' O
, , O
located VBN O
on IN O
the DT O
extreme JJ O
3 CD O
' '' O
end NN O
of IN O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
, , O
contained VBN O

approximately RB O
800 CD O
bp NN O
. . O

With IN O
the DT O
exception NN O
of IN O
exon NN O
"""" `` O
m NN O
"""" '' O
, , O
exons NNS O
larger JJR O
than IN O
150 CD O

base NN O
pairs NNS O
were VBD O
confined VBN O
to IN O
the DT O
genetic JJ O
region NN O
corresponding VBG O
to IN O
the DT O
far RB O
3 CD O
' '' O
end NN O
of IN O
the DT O
a2 CD O
mRNA NN O
. . O

Exon NNP O
"""" `` O
a DT O
"""" '' O
and CC O
exon NN O
"""" `` O
b NN O
"""" '' O
, , O
the DT O
two CD O
exons NNS O
situated VBN O
on IN O
either DT O
side NN O
of IN O
intron NN O
1 CD O
, , O
coded VBN O
for IN O
around IN O
1000 CD O
bases NNS O
of IN O
a2 CD O
collagen NN O
information NN O
; : O
these DT O
two CD O

exons NNS O
contained VBD O
one CD O
- HYPH O
third NN O
of IN O
the DT O
mapped VBN O
3 CD O
, , O
14 CD O
DNA NN O
bases NNS O
complementary JJ O
to IN O
a2 CD O
mRNA NN O
Length NN O
distribution NN O
and CC O
organization NN O
of IN O
the DT O
introns NNS O
and CC O
exons NNS O
in IN O
the DT O
sheep NN B-Species
genomi NN O
c NN O
i NN O
nsert UH O
. . O

There EX O
was VBD O
a DT O
sharp JJ O
contrast NN O
in IN O
the DT O
size NN O
distribution NN O
of IN O
the DT O
exons NNS O
and CC O
introns NNS O
contained VBN O
within IN O
SpC3 NNP O
( -LRB- O
Figure NNP O
2 CD O
) -RRB- O
. . O

While IN O
the DT O
intron NN O
sizes NNS O
varied VBD O

considerably RB O
, , O
the DT O
exons NNS O
, , O
in IN O
general JJ O
, , O
showed VBD O
a DT O
very RB O
narrow JJ O
distribution NN O
of IN O

lengths NNS O
, , O
and CC O
thus RB O
tended VBD O
to TO O
cluster VB O
at IN O
the DT O
lowest JJS O
end NN O
of IN O
the DT O
length NN O
distri NN O

A DT O
. . O

( : O
I PRP O
) -RRB- O

z NN O
6 CD O
0 CD O

z LS O

ZL4 NN O
0 CD O

21 CD O

z LS O

10 CD O

B NN O
. . O

8 CD O

z LS O
0 CD O

16 CD O
0 CD O
z NN O

2 LS O

20 CD O
400 CD O
600 CD O
800 CD O
1000 CD O
1200 CD O
1400 CD O
1600 CD O

LENGTH NN O
IN IN O
NUCLEOTIDES NNS O

Figure NN O
2 CD O
. . O

Length NN O
distribution NN O
of IN O
the DT O
intron NN O
and CC O
exon NN O
mean JJ O
lengths NNS O
measured VBN O
from IN O
micrographs NNS O
prepared VBN O
by IN O
the DT O
urea NN O
- HYPH O
formamide NN O
method NN O
. . O

( : O
A DT O
) : O
Introns NN O
; : O
( : O
b LS O
) -RRB- O
Exons NNPS O
. . O

See VB O
Tables NNP O
1 CD O
and CC O
2 CD O
for IN O
details NNS O
. . O

2248 CD O

Nucleic JJ O
Acids NN O
Research NN O
bution NN O
graph NN O
. . O

The DT O
exon NN O
in IN O
the DT O
800 CD O
- SYM O
900 CD O
bp NN O
region NN O
was VBD O
unique JJ O
and CC O
was VBD O
the DT O
only JJ O
exon NN O
which WDT O
exhibited VBD O
length NN O
overlap NN O
with IN O
introns NNS O
. . O

The DT O
maps NNS O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
obtained VBN O
with IN O
both DT O
electron NN O
micro NN O

scopic JJ O
spreading NN O
methods NNS O
were VBD O
almost RB O
identical JJ O
( : O
Figure NNP O
3 CD O
) -RRB- O
, , O
except IN O
that IN O
the DT O

region NN O
at IN O
the DT O
extreme NN O
5 CD O
' '' O
end NN O
of IN O
the DT O
insert NN O
could MD O
only RB O
be VB O
mapped VBN O
with IN O
the DT O
ureaformamide NN O
method NN O
. . O

From IN O
these DT O
measurements NNS O
we PRP O
concluded VBD O
that IN O
the DT O
length NN O
of IN O
the DT O
a2 NN O
collagen NN O
genetic JJ O
regi NN O
? , O
on IN O
in IN O
SpC3 NNP O
was VBD O
17 CD O
, , O
84 CD O
bases NNS O
long JJ O
with IN O
only RB O
3 CD O
, , O
14 CD O
bases NNS O
actually RB O
coding VBG O
for IN O
a2 CD O
mRNA NN O
. . O

Therefore RB O
, , O
only RB O
18 CD O
% NN O
of IN O
the DT O
mapped VBN O
17 CD O
kb NN O
sheep NN B-Species
genetic JJ O
insert NN O
actually RB O
contained VBD O
a2 DT O
structural JJ O
information NN O
. . O

DISCUSSION NN O

The DT O
organizational JJ O
structure NN O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
is VBZ O
complex JJ O
. . O

A DT O
minimum NN O
of IN O
17 CD O
introns NNS O
interrupt VBP O
the DT O
3 CD O
kb NN O
of IN O
ca2 NN O
genetic JJ O
information NN O
interspersed VBN O
as IN O
18 CD O
exons NNS O
over IN O
17 CD O
kb NNS O
of IN O
sheep NN B-Species
DNA NNP O
. . O

With IN O
the DT O
exception NN O
of IN O
exon NN O
"""" `` O
a DT O
"""" '' O
located VBN O
at IN O
the DT O
extreme JJ O
3 CD O
' '' O
end NN O
of IN O
the DT O
inserted VBN O
a2 NN O
gene NN O
, , O
all DT O
other JJ O
mapped VBN O
exons NNS O
are VBP O
rather RB O
small JJ O
, , O
exhibiting VBG O
a DT O
size NN O
distribution NN O
range NN O
of IN O
50 CD O
to IN O
250 CD O
bp NN O
. . O

In IN O

contrast VB O
, , O
the DT O
intron NN O
sizes NNS O
range VBP O
from IN O
340 CD O
to IN O
1540 CD O
bases NNS O
occupying VBG O
a DT O
total JJ O

of IN O
14 CD O
kb NN O
. . O

Thus RB O
, , O
the DT O
DNA NNP O
region NN O
containing VBG O
the DT O
3 CD O
kb NN O
of IN O
a2 CD O
collagen NN O
genetic JJ O
information NN O
is VBZ O
5 CD O
. . O
6 CD O
fold NN O
longer JJR O
than IN O
the DT O
corresponding JJ O
co2 NN O
mRNA NNP O
sequences NNS O
. . O

Although IN O
the DT O
total JJ O
number NN O
of IN O
introns NNS O
present JJ O
within IN O
the DT O
60 CD O
% NN O
3 CD O
' '' O
portion NN O

of IN O
the DT O
a2 CD O
sheep NN B-Species
gene NN O
was VBD O
determined VBN O
to TO O
be VB O
17 CD O
, , O
variation NN O
in IN O
the DT O
precise JJ O
number NN O

TRANSRIPTlO NNP O

A DT O
5w CD O
r NN O

1 CD O
"""" `` O
2a4 CD O
133 CD O
112s CD O
11 CD O
. . O
17 CD O
0 CD O
. . O

3O CD O
2 CD O
715 CD O
6 CD O
. . O
2 CD O
313 CD O
4 CD O
4 CD O
. . O
2B NN O
3 CD O
. . O
51 CD O
2 CD O
. . O
2 CD O
12 CD O

EXON0 NN O
p NN O
o NN O
n NN O
5 CD O
Ik NN O
h CD O
f NN O
d NN O
4 CD O
. . O

b LS O

WPM300 NN O
16 CD O
16 CD O
14 CD O
13 CD O
12 CD O
11 CD O
10 CD O
9 CD O
6 CD O
7 CD O
6 CD O
5 CD O
4 CD O
3 CD O
2 CD O
1 CD O

B NN O

110 CD O
16 CD O
4 CD O
. . O
2 CD O
13111 CD O
112n CD O
1113104 CD O
3 CD O
. . O
6 CD O
gm74 CD O
2 CD O
6 CD O
. . O

4 CD O
4 CD O
2 CD O
3 CD O
. SYM O
2 CD O
22 CD O
in IN O

1 CD O
a1m03 CD O
133 CD O
1 CD O
. . O
2 CD O
11 CD O
10 CD O
1 CD O
341 CD O
6 CD O
. . O

1 CD O
117 CD O
6 CD O
. . O
2 CD O
4 CD O
12 CD O
417 CD O
3I5 CD O
' '' O
m NN O
2 CD O

DM00 NN O
1 CD O
q5 CD O
p NN O
0 CD O
n NN O
m NN O
I PRP O
k VBP O
. . O

j NN O
i NN O
h NN O
g NN O
f NN O
d NN O
c NN O
b NN O
a NN O
147306 CD O
17 CD O
16 CD O
15 CD O
14 CD O
13 CD O
12 CD O
11 CD O
10 CD O
9 CD O
a CD O
7 CD O
6 CD O
5 CD O
4 CD O
3 CD O
2 CD O
1 CD O

175 CD O
17 CD O
. . O
0 CD O
16 CD O
. . O
6 CD O
& SYM O
16 CD O
' '' O
5 CD O
. . O
5 CD O
15 CD O
. . O
0 CD O
14 CD O
. . O
5 CD O
14 CD O
. . O

13 CD O
. . O
5 CD O
13 CD O
. . O
0 CD O
12 CD O
. . O
5 CD O
12 CD O
. . O
0 CD O
11 CD O
. . O
5 CD O
11 CD O
10 CD O
. . O
5M NN O
10 CD O
. . O
0 CD O
9 CD O
. . O
5 CD O
9 CD O
. . O
0 CD O
8 CD O
. . O

5 CD O
. . O
0 CD O
71 CD O
7 CD O
. . O
0 CD O
6 CD O
. . O
5 CD O
6 CD O
. . O

5 CD O
. . O
5 CD O
50 CD O
4 CD O
. . O
5 CD O
4 CD O
. . O
0 CD O
3 CD O
. . O
5 CD O
3 CD O
. . O
0 CD O
2 CD O
. . O
5 CD O
2 CD O
. . O
0 CD O
1 CD O
. . O
5 CD O
1 CD O
. . O
0 NFP O

KILOBASE NNP O

Fiue3 NNP O
Organization NNP O
of IN O
60 CD O
% NN O
of IN O
the DT O
3 CD O
' '' O
end NN O
of IN O
the DT O
sheep NN B-Species
a2 NN O
collagen NN O
gene NN O
. . O

( : O
A DT O
) : O
} : O
The DT O
exon NN O
( , O
) -RRB- O
and CC O
intron NN O
( -LRB- O
CDJ NNP O
) -RRB- O
order NN O
within IN O
the DT O
a2 NN O
gene NN O
as IN O
determined VBN O
by IN O
R NNP O
loop NN O
analysis NN O
of IN O
SpC3 NNP O
DNA NNP O
- HYPH O
a2 CD O
mRNA NNP O
hybrid NN O
molecules NNS O
visualized VBN O
by IN O
the DT O
electron NN O
microscopic JJ O
70 CD O
% NN O
formamide NN O
spreading NN O
method NN O
. . O

( -LRB- O
B NN O
) : O
The DT O
exon NN O
Um UH O
) . O

and CC O
intron NN O
( -LRB- O
Efl NNP O
) -RRB- O
order NN O
within IN O
the DT O
a2 NN O
gene NN O
as IN O
determined VBN O
by IN O
R NNP O
loop NN O
analysis NN O
of IN O
SpC3 NNP O
DNA NNP O
- HYPH O
a2 CD O
mRNA NNP O
hybrid NN O
molecules NNS O
evaluated VBN O
by IN O
the DT O
electron NN O
microscopic JJ O

urea NN O
- HYPH O
formamide NN O
spreading VBG O
method NN O
. . O

Arrows NNS O
represent VBP O
the DT O
approximate JJ O
location NN O
of IN O
intron NN O
- HYPH O
exon NN O
junctions NNS O
. . O

All DT O
values NNS O
are VBP O
presented VBN O
as IN O
kilobase NN O
pairs NNS O
. . O

2249 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

of IN O
introns NNS O
present JJ O
in IN O
individual JJ O
hybrid NN O
molecules NNS O
was VBD O
observed VBN O
. . O

The DT O
reason NN O

for IN O
this DT O
may MD O
be VB O
due IN O
to IN O
size NN O
heterogeneity NN O
of IN O
the DT O
a2 NN O
mRNA NNP O
used VBN O
as IN O
a DT O
complementary JJ O
probe NN O
. . O

Although IN O
the DT O
a2 NN O
mRNA NNP O
was VBD O
extensively RB O
purified VBN O
( : O
2 CD O
) -RRB- O
, , O
some DT O
degradation NN O
was VBD O
likely RB O
present JJ O
. . O

It PRP O
is VBZ O
also RB O
possible JJ O
that IN O
additional JJ O
introns NNS O
exist VBP O
that WDT O
are VBP O
too RB O
small JJ O
to TO O
be VB O
detected VBN O
by IN O
electron NN O
microscopic JJ O
R NN O
loop NN O
analysis NN O
. . O

The DT O
most RBS O
likely JJ O
a2 CD O
genetic JJ O
regions NNS O
containing VBG O
such JJ O
introns NNS O
are VBP O
exons NNS O
"""" `` O
g NN O
"""" '' O
and CC O
"""" `` O
m NN O
"""" '' O
. . O

Small JJ O

"""" `` O
protrusions NNS O
"""" '' O
were VBD O
sometimes RB O
observed VBN O
within IN O
these DT O
exons NNS O
that WDT O
could MD O
represent VB O
small JJ O
introns NNS O
. . O

Very RB O
small JJ O
introns NNS O
have VBP O
been VBN O
reported VBN O
for IN O
tRNA NNP O
genes NNS O
( , O
12 CD O
, , O
13 CD O
) -RRB- O
, , O

and CC O
it PRP O
will MD O
be VB O
necessary JJ O
to TO O
sequence VB O
these DT O
regions NNS O
of IN O
SpC3 NNP O
to TO O
determine VB O
if IN O
such JJ O
introns NNS O
are VBP O
present JJ O
within IN O
the DT O
a2 NN O
sheep NN B-Species
genome NN O
. . O

The DT O
existence NN O
of IN O
mRNAs NNS O
comprised VBN O
of IN O
sequences NNS O
complementary JJ O
to IN O
noncontiguous JJ O
regions NNS O
in IN O
a DT O
DNA NNP O
genome NN O
was VBD O
first RB O
described VBN O
for IN O
adenovirus NN B-Species
( , O
14 CD O
, , O
15 CD O
) -RRB- O
and CC O

simian JJ O
virus NN O
( : O
16 CD O
, , O
17 CD O
) CD O
genes NNS O
. . O

Similar JJ O
observations NNS O
were VBD O
soon RB O
reported VBN O
for IN O
eukaryotic JJ O
genes NNS O
, , O
including VBG O
serum JJ O
albumin NN O
( , O
18 CD O
) FW O
, , O
conalbumin NN O
( , O
19 CD O
) , O
, , O
fibroin NN O
( , O
20 CD O
) -RRB- O
, , O
s NNS O

globin NN O
( : O
21 CD O
, , O
22 CD O
) -RRB- O
, , O
growth NN O
hormones NNS O
( , O
23 CD O
, , O
24 CD O
) NN O
, , O
immunoglobulin NN O
( , O
25 CD O
) -RRB- O
, , O
lysozyme NN O
( , O
26 CD O
) -RRB- O
, , O

ovalbumin NNP O
( : O
27 CD O
- SYM O
29 CD O
) -RRB- O
, , O
ovomucoid JJ O
( , O
30 CD O
) -RRB- O
, , O
rRNA NNP O
( , O
31 CD O
- SYM O
34 CD O
) -RRB- O
, , O
tRNA NNP O
( SYM O
12 CD O
, , O
13 CD O
) -RRB- O
, , O
and CC O
vitellogenin NN O
( SYM O
35 CD O
) -RRB- O
. . O

The DT O
precise JJ O
number NN O
or CC O
occurrence NN O
of IN O
introns NNS O
within IN O
these DT O
genes NNS O
does VBZ O
not RB O
seem VB O
to TO O
follow VB O
any DT O
clear JJ O
pattern NN O
. . O

However RB O
, , O
the DT O
genes NNS O
for IN O
albumin NN O
, , O
conalbumin NN O
, , O

lysozyme NN O
, , O
ovalbumin NN O
, , O
and CC O
ovomucoid NN O
exhibit VBP O
a DT O
structural JJ O
organization NN O
comparable JJ O
to IN O
the DT O
a2 NN O
collagen NN O
gene NN O
. . O

All DT O
of IN O
these DT O
genes NNS O
are VBP O
composed VBN O
of IN O
numerous JJ O
small JJ O

exons NNS O
, , O
usually RB O
less JJR O
than IN O
250 CD O
base NN O
pairs NNS O
, , O
and CC O
introns NNS O
which WDT O
show VBP O
a DT O
large JJ O
size NN O
variation NN O
within IN O
an DT O
individual JJ O
gene NN O
. . O

Within IN O
all DT O
of IN O
these DT O
genomes NNS O
, , O
the DT O
DNA NNP O

regions NNS O
required VBN O
for IN O
coding VBG O
structural JJ O
formation NN O
are VBP O
4 CD O
to TO O
7 CD O
times NNS O
longer JJR O
than IN O
the DT O
corresponding VBG O
mRNA NNP O
coding VBG O
sequences NNS O
. . O

As IN O
with IN O
the DT O
a2 NN O
collagen NN O
gene NN O
, , O
a DT O
large JJ O
unique JJ O
exon NN O
at IN O
the DT O
extreme NN O
3 CD O
' '' O
end NN O

is VBZ O
also RB O
present JJ O
in IN O
the DT O
ovalbumin NN O
gene NN O
( : O
36 CD O
, , O
37 CD O
) -RRB- O
. . O

In IN O
the DT O
a2 CD O
gene NN O
, , O
this DT O
exon NN O
was VBD O
800 CD O
to IN O
900 CD O
nucleotides NNS O
in IN O
length NN O
, , O
while IN O
in IN O
the DT O
ovalbumin NN O
gene NN O
the DT O
exon NN O
contained VBD O
1 CD O
, , O
30 CD O
base NN O
pairs NNS O
. . O

Interestingly RB O
, , O
this DT O
ovalbumin JJ O
exon NN O
contained VBD O
634 CD O
- SYM O
650 CD O
base NN O
pairs NNS O
ot IN O
DNA NN O
sequence NN O
to IN O
the DT O
3 CD O
' '' O
side NN O
of IN O
the DT O
terminator NN O

triplet NN O
, , O
suggesting VBG O
the DT O
ovalbumin NN O
mRNA NNP O
has VBZ O
a DT O
large JJ O
untranslated JJ O
region NN O
at IN O
the DT O
3 CD O
' '' O
end NN O
. . O

The DT O
consistent JJ O
appearance NN O
of IN O
a DT O
small JJ O
non NN O
- HYPH O
hybridized JJ O
tail NN O
, , O
approximately RB O
100 CD O
nucleotides NNS O
in IN O
length NN O
, , O
in IN O
the DT O
region NN O
where WRB O
the DT O
right JJ O
arm NN O
of IN O
the DT O
phage NN O
was VBD O
ligated VBN O
to IN O
the DT O
sheep NN B-Species
genomic JJ O
insert NN O
of IN O
SpC3 NNP O
very RB O
likely RB O
corresponded VBD O
to IN O
the DT O

3 CD O
' POS O
poly NN O
A DT O
sequence NN O
of IN O
the DT O
a2 NN O
mRNA NNP O
. . O

This DT O
would MD O
suggest VB O
that IN O
the DT O
a2 NN O
mRNA NNP O
coding VBG O
sequence NN O
terminates VBZ O
very RB O
near RB O
or CC O
at IN O
this DT O
point NN O
in IN O
the DT O
genome NN O
. . O

Previously RB O
published VBN O
biochemical JJ O
evidence NN O
( , O
2 CD O
) -RRB- O
obtained VBD O
from IN O
restriction NN O
mapping NN O
and CC O
Southern JJ O
blot NN O
analysis NN O
using VBG O
[ -LRB- O
32P NN O
] -RRB- O
- HYPH O
labeled VBN O
chick NN O
a2 NN O
cDNA NN O
probe NN O
supports VBZ O

2250 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

this DT O
observation NN O
. . O

It PRP O
is VBZ O
unclear JJ O
what WDT O
role NN O
introns NNS O
play VBP O
in IN O
genetic JJ O
expression NN O
. . O

However RB O
, , O

it PRP O
is VBZ O
known VBN O
that IN O
these DT O
sequences NNS O
are VBP O
tranncribed VBN O
as IN O
part NN O
of IN O
larger JJR O
precursor NN O
mRNAs NNS O
and CC O
the DT O
introns NNS O
are VBP O
then RB O
excised VBN O
and CC O
the DT O
fragmented JJ O
mRNA NN O
chains NNS O

covalently RB O
rejoined VBN O
( SYM O
38 CD O
) -RRB- O
. . O

Some DT O
evidence NN O
has VBZ O
recently RB O
accumulated VBN O
demonstrating VBG O
the DT O
existence NN O
of IN O
precursor NN O
a2 IN O
mRNAs NNS O
( SYM O
39 CD O
, , O
40 CD O
) -RRB- O
. . O

However RB O
, , O
if IN O
the DT O
introns NNS O
in IN O
the DT O
a2 NN O
gene NN O
are VBP O
transcribed VBN O
in IN O
their PRP$ O
entirety NN O
, , O
as IN O
has VBZ O
been VBN O

demonstrated VBN O
for IN O
the DT O
introns NNS O
in IN O
ovalbumin NN O
and CC O
globin NN O
( SYM O
41 CD O
, , O
42 CD O
) -RRB- O
, , O
much RB O
larger JJR O
precursor NN O
a2 CD O
mRNAs NNS O
may MD O
exist VB O
than IN O
those DT O
reported VBN O
to IN O
date NN O
. . O

For IN O
if IN O
the DT O
re NN O

mainder NN O
of IN O
the DT O
a2 NN O
collagen NN O
gene NN O
has VBZ O
a DT O
structural JJ O
organization NN O
comparable JJ O
to IN O
the DT O
60 CD O
% NN O
3 CD O
' '' O
portion NN O
that WDT O
has VBZ O
been VBN O
analyzed VBN O
, , O
it PRP O
is VBZ O
probable JJ O
that IN O
the DT O
a2 NN O

collagen NN O
gene NN O
in IN O
its PRP$ O
entirety NN O
is VBZ O
dispersed VBN O
throughout IN O
a DT O
30 CD O
kb NN O
DNA NNP O
segment NN O
. . O

ACKNOWLEDGMENTS NNS O

We PRP O
thank VBP O
Dr NNP O
. . O
John NNP O
Dahlberg NNP O
and CC O
Frances NNP O
Loebenstein NNP O
, , O
Laboratory NNP O
of IN O
Cellular NNP O
and CC O
Molecular NNP O
Biology NNP O
, , O
National NNP O
Cancer NNP O
Institute NNP O
, , O
for IN O
the DT O
generous JJ O
use NN O
of IN O
a DT O

Siemens NNP O
Elmiskop NNP O
101 CD O
electron NN O
microscope NN O
; : O
Dr NNP O
. . O
Ursula NNP O
Heine NNP O
and CC O
Benjamin NNP O
Elliott NNP O
, , O
Laboratory NNP O
of IN O
Viral NNP O
Carcinogenesis NNP O
, , O
National NNP O
Cancer NNP O
Institute NNP O
, , O
for IN O
the DT O
use NN O
of IN O
a DT O
Hewlett NNP O
- HYPH O
Packard NNP O
calculator NN O
equipped VBN O
with IN O
a DT O
digitizer NN O
and CC O
a DT O
Denton NNP O
vacuum NN O

evaporator NN O
, , O
and CC O
Drs NNP O
. . O

Victor NNP O
Ferrans NNP O
and CC O
Oichi NNP O
Kawanami NNP O
, , O
Laboratory NNP O
of IN O
Pathology NNP O
, , O

National NNP O
Heart NNP O
, , O
Lung NNP O
, , O
and CC O
Blood NNP O
Institute NNP O
, , O
for IN O
expert JJ O
assistance NN O
with IN O
photography NN O
. . O

We PRP O
are VBP O
also RB O
grateful JJ O
to IN O
Margery NNP O
Sullivan NNP O
, , O
Laboratory NNP O
of IN O
Molecular NNP O
Genetics NNP O
, , O

National NNP O
Institute NNP O
of IN O
Child NNP B-Species
Health NNP O
and CC O
Human NNP B-Species
Development NNP O
, , O
for IN O
helpful JJ O
discussions NNS O
and CC O
to IN O
Dr NNP O
. . O
Helga NNP O
Boedtker NNP O
, , O
Department NNP O
of IN O
Chemistry NNP O
, , O
Harvard NNP O
University NNP O
, , O
for IN O
making VBG O
available JJ O
the DT O
recombinant JJ O
plasmid NN O
pCg45 NN O
. . O

References NNS O

1 LS O
. . O

Prockop NNP O
, , O
D NNP O
. . O

J NNP O
. . O
, , O
Kivirikko NNP O
, , O
k UH O
. . O

I PRP O
. . O
, , O
Tuderman NNP O
, , O
L NNP O
. . O
, , O
and CC O
Guzman NNP O
, , O
N NNP O
. . O

A DT O
. . O

( -LRB- O
1979 CD O
) SYM O
New NNP O
Engl NNP O
. . O

J NNP O
. . O

Med NNP O
. . O

301 CD O
, , O
13 CD O
- HYPH O
23 CD O
and CC O
77 CD O
- HYPH O
85 CD O
. . O

2 LS O
. . O

Boyd NNP O
, , O
C UH O
. . O

D NNP O
. . O
, , O
Tolstoshev NNP O
, , O
P NNP O
. . O
, , O
Schafer NNP O
, , O
M NNP O
. . O

P UH O
. . O
, , O
Trapnell NNP O
, , O
B NNP O
. . O

C UH O
. . O
, , O
Coon NNP O
, , O

H NN O
. . O

C UH O
. . O
, , O
Kretschmer NNP O
, , O
P NN O
. . O

J NNP O
. . O
, , O
Nienhuis NNP O
, , O
A NNP O
. . O

W UH O
. . O
, , O
and CC O
Crystal NNP O
, , O
R NNP O
. . O

G NNP O
. . O

( : O
1980 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O
, , O
in IN O
press NN O
. . O

3 LS O
. . O

Blin NNP O
, , O
N NNP O
. . O
, , O
and CC O
Stafford NNP O
, , O
D NNP O
. . O

W UH O
. . O

( -LRB- O
1976 CD O
) : O
Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

3 CD O
, , O
2303 CD O
- SYM O
2308 CD O
. . O

4 LS O
. . O

Kretschmer NNP O
, , O
P NN O
. . O

J NNP O
. . O
, , O
Kaufman NNP O
, , O
R NNP O
. . O

E UH O
. . O
, , O
Coon NNP O
, , O
H NNP O
. . O

C UH O
. . O
, , O
Chen NNP O
, , O
M NNP O
. . O

JY NNP O
. . O
, , O
Geist NNP O

C NN O
. . O

E NNP O
. . O
, , O
and CC O
Nienhuis NNP O
, , O
A NNP O
. . O

W UH O
. . O

( : O
1980 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O
, , O
in IN O
press NN O
. . O

5 LS O
. . O

Maniatis NNP O
, , O
T NNP O
. . O
, , O
Hardison NNP O
, , O
R NN O
. . O

C UH O
. . O
, , O
Lacey NNP O
, , O
E NNP O
. . O
, , O
Laver NNP O
, , O
H NNP O
. . O
, , O
O UH O
' '' O
Connell NNP O
, , O
C NNP O
. . O
, , O

Quon NNP O
, , O
D NNP O
. . O
, , O
Sim NNP O
, , O
G NNP O
. . O

K UH O
. . O
, , O
and CC O
Efstratiadis NNP O
, , O
A DT O
. . O

( : O
1975 CD O
) SYM O
Cell NNP O
15 CD O
, , O
687 CD O
- HYPH O
701 CD O
. . O

6 LS O
. . O

Blattner NNP O
, , O
F NNP O
. . O

R NNP O
. . O
, , O
Blechl NNP O
, , O
A NNP O
. . O

E UH O
. . O
, , O
Denniston NNP O
- HYPH O
Thompson NNP O
, , O
K NNP O
. . O
, , O
Faber NNP O
, , O
H NNP O
. . O

E UH O
. . O
, , O

Richards NNP O
, , O
J NNP O
. . O

E UH O
. . O
, , O
Slightom NNP O
, , O
H NNP O
. . O

L NNP O
. . O
, , O
Tucker NNP O
, , O
P NN O
. . O

W UH O
. . O
, , O
and CC O
Smithies NNP O
, , O
0 NFP O
. . O

( : O
1978 CD O
) SYM O
Science NNP O
202 CD O
, , O
1279 CD O
- SYM O
1284 CD O
. . O

7 LS O
. . O

Meyer NNP O
, , O
J NNP O
. . O
, , O
Neuwald NNP O
, , O
P NN O
. . O

D NNP O
. . O
, , O
Lai NNP O
, , O
S NNP O
. . O
, , O
Maizel NNP O
, , O
J NNP O
. . O

V NNP O
. . O
, , O
Jr NNP O
. . O
, , O
and CC O
Westphal NNP O
, , O

H NN O
. . O

( : O
1977 CD O
) SYM O
J NN O
. . O

Virol NNP O
. . O

21 CD O
, , O
1010 CD O
- SYM O
1014 CD O
. . O

2251 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

8 LS O
. . O

Westphal NNP O
, , O
H NNP O
. . O
, , O
and CC O
Lai NNP O
, , O
S NNP O
. . O

P NN O
. . O

( : O
1977 CD O
) SYM O
J NN O
. . O

Mol NNP O
. . O

Biol NNP O
. . O

116 CD O
, , O
525 CD O
- HYPH O
548 CD O
. . O

9 LS O
. . O

Schafer NNP O
, , O
M NNP O
. . O

P UH O
. . O
, , O
Rohrmann NNP O
, , O
G NNP O
. . O
, , O
Heine NNP O
, , O
U NNP O
. . O
, , O
and CC O
Beaudreau NNP O
, , O
G NNP O
. . O

S UH O
. . O

( -LRB- O
1979 CD O
) SYM O
Virol NNP O
. . O

95 CD O
, , O
176 CD O
- SYM O
184 CD O
. . O

10 CD O
. . O

Davis NNP O
, , O
R NNP O
. . O

W UH O
. . O
, , O
Simon NNP O
, , O
M NNP O
. . O

M NNP O
. . O
, , O
and CC O
Davison NNP O
, , O
N NNP O
. . O

( -LRB- O
1971 CD O
) -RRB- O
in IN O
Methods NNPS O
in IN O

Enzymology NNP O
( , O
Grossman NNP O
, , O
L NNP O
. . O
and CC O
Moldave NNP O
, , O
K NNP O
. . O
, , O
eds FW O
) -RRB- O
Vol NNP O
. . O

21 CD O
, , O
pp UH O
. . O

413428 CD O
, , O
Academic NNP O
Press NNP O
, , O
New NNP O
York NNP O
. . O

11 CD O
. . O

Federal NNP O
Register NNP O
( : O
1978 CD O
) SYM O
43 CD O
, , O
60108 CD O
- HYPH O
60131 CD O
. . O

12 CD O
. . O

Goodman NNP O
, , O
H NNP O
. . O

M UH O
. . O
, , O
Olson NNP O
, , O
M NNP O
. . O

V NNP O
. . O
, , O
Hall NNP O
, , O
B NNP O
. . O

D NNP O
. . O

( : O
1977 CD O
) : O
Pro NN O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

74 CD O
, , O
5453 CD O
- HYPH O
5457 CD O
. . O

13 CD O
. . O

Valenzuela NNP O
, , O
P NNP O
. . O
, , O
Venegas NNP O
, , O
A NNP O
. . O
, , O
Weinberg NNP O
, , O
F NNP O
. . O
, , O
Bishop NNP O
, , O
R NNP O
. . O
, , O
Rutter NNP O
, , O

W UH O
. . O

J NNP O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
190 CD O
- SYM O
194 CD O
. . O

14 CD O
. . O

Berget NNP O
, , O
S NNP O
. . O

M NNP O
. . O
, , O
Moore NNP O
, , O
C NNP O
. . O
, , O
and CC O
Sharp NNP O
, , O
P NN O
. . O

A DT O
. . O

( -LRB- O
1977 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

74 CD O
, , O
3171 CD O
- HYPH O
3175 CD O
. . O

15 CD O
. . O

Chow NNP O
, , O
L NNP O
. . O

T UH O
. . O
, , O
Gelinas NNP O
, , O
R NNP O
. . O

E NNP O
. . O
, , O
Broker NNP O
, , O
T NNP O
. . O
, , O
and CC O
Roberts NNP O
, , O
R NNP O
. . O

J NNP O
. . O

( -LRB- O
1977 CD O
) NFP O

Cell NNP O
12 CD O
, , O
1 CD O
- SYM O
8 CD O
. . O

16 CD O
. . O

Berk NNP O
, , O
A UH O
. . O

J NNP O
. . O
, , O
and CC O
Sharp NNP O
, , O
P NN O
. . O

A DT O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
1274 CD O
- HYPH O
1278 CD O
. . O

17 CD O
. . O

Bratosin NNP O
, , O
S NNP O
. . O
, , O
Horowitz NNP O
, , O
M NNP O
. . O
, , O
Laub NNP O
, , O
0 CD O
. . O
, , O
and CC O
Aloni NNP O
, , O
Y NNP O
. . O

( -LRB- O
1978 CD O
) NFP O

Cell NNP O
13 CD O
, , O
783 CD O
- HYPH O
790 CD O
. . O

18 CD O
. . O

Sargent NNP O
, , O
T NNP O
. . O

D NNP O
. . O
, , O
Wu NNP O
, , O
J NNP O
. . O

R NNP O
. . O
, , O
Sala NNP O
- HYPH O
Trepat NNP O
, , O
J NNP O
. . O

M UH O
. . O
, , O
Wallace NNP O
, , O
R NNP O
. . O

B UH O
. . O
, , O

Reyes NNP O
, , O
A UH O
. . O

A DT O
. . O
, , O
and CC O
Bonner NNP O
, , O
J NNP O
. . O

( -LRB- O
1979 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

76 CD O
, , O
3256 CD O
- HYPH O
3260 CD O
. . O

19 CD O
. . O

Perrin NNP O
, , O
F NNP O
. . O
, , O
Cochet NNP O
, , O
M NNP O
. . O
, , O
Gerlinger NNP O
, , O
P NNP O
. . O
, , O
Cami NNP O
, , O
B NNP O
. . O
, , O
LePennec NNP O
, , O
J NNP O
. . O

P UH O
. . O
, , O

and CC O
Chambon NNP O
, , O
P NN O
. . O

( -LRB- O
1979 CD O
) : O
Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

6 CD O
2731 CD O
- SYM O
2748 CD O
. . O

20 CD O
. . O

Tsujimoto NNP O
, , O
Y NNP O
. . O
, , O
and CC O
Suzuki NNP O
, , O
Y NNP O
. . O

( : O
1979 CD O
) SYM O
Cell NNP O
16 CD O
425 CD O
- HYPH O
436 CD O
. . O

21 CD O
. . O

Jeffreys NNP O
, , O
A NNP O
. . O

J NNP O
. . O
, , O
and CC O
Flavell NNP O
, , O
R NNP O
. . O

A DT O
. . O

( -LRB- O
1977 CD O
) SYM O
Cell NNP O
12 CD O
, , O
1097 CD O
- SYM O
1108 CD O
. . O

22 CD O
. . O

Tilghman NNP O
, , O
S NNP O
. . O

M UH O
. . O
, , O
Tiemeier NNP O
, , O
D NNP O
. . O

C UH O
. . O
, , O
Seidman NNP O
, , O
J NNP O
. . O

C UH O
. . O
, , O
Matija NNP O
Peterlin NNP O
, , O
B NNP O
. . O
, , O

Sullivan NNP O
, , O
M NNP O
. . O
, , O
Maizel NNP O
, , O
J NNP O
. . O

V NNP O
. . O
, , O
and CC O
Leder NNP O
, , O
P NN O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
725 CD O
- HYPH O
729 CD O
. . O

23 CD O
. . O

Fiddes NNP O
, , O
J NNP O
. . O

C UH O
. . O
, , O
Seeburg NNP O
, , O
P NN O
. . O

H UH O
. . O
, , O
DeNoto NNP O
, , O
F NNP O
. . O

M UH O
. . O
, , O
Hallewell NNP O
, , O
R NNP O
. . O

A UH O
. . O
, , O

Baxter NNP O
, , O
J NNP O
. . O

D NNP O
. . O
, , O
and CC O
Goodman NNP O
, , O
H NNP O
. . O

M UH O
. . O

( -LRB- O
1979 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

76 CD O
, , O
4294 CD O
- HYPH O
4298 CD O
. . O

24 CD O
. . O

Soreq NNP O
, , O
H NNP O
. . O
, , O
Harpold NNP O
, , O
M NNP O
. . O
, , O
Evans NNP O
, , O
R NNP O
. . O
, , O
Darnell NNP O
, , O
Jr NNP O
. . O
, , O
J NNP O
. . O

E UH O
. . O
, , O
and CC O

Bancroft NNP O
, , O
F NNP O
. . O

C NN O
. . O

( -LRB- O
1979 CD O
) : O
Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

6 CD O
, , O
2471 CD O
- HYPH O
2482 CD O
. . O

25 CD O
. . O

Tonegawa NNP O
, , O
S NNP O
. . O
, , O
Maxam NNP O
, , O
A NNP O
. . O

M UH O
. . O
, , O
Tizard NNP O
, , O
R NNP O
. . O
, , O
Bernard NNP O
, , O
0 CD O
. . O
, , O
and CC O
Gilbert NNP O
, , O
W NNP O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
1485 CD O
- HYPH O
1489 CD O
. . O

26 CD O
. . O

Nguyen NNP O
- HYPH O
Huu NNP O
, , O
M NNP O
. . O

C UH O
. . O
, , O
Stratmann NNP O
, , O
M NNP O
. . O
, , O
Groner NNP O
, , O
B NNP O
. . O
, , O
Wurtz NNP O
, , O
T NNP O
. . O
, , O
Land NNP O
, , O
M NNP O
. . O
, , O

Glesecke NNP O
, , O
K NNP O
. . O
, , O
Sippel NNP O
, , O
A NNP O
. . O

F NNP O
. . O
, , O
and CC O
Schutz NNP O
, , O
G NNP O
. . O

( -LRB- O
1979 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

76 CD O
, , O
76 CD O
- SYM O
80 CD O
. . O

27 CD O
. . O

Breathnach NNP O
, , O
R NNP O
. . O
, , O
Mandel NNP O
, , O
J NNP O
. . O

L NNP O
. . O
, , O
and CC O
Chambon NNP O
, , O
P NN O
. . O

( -LRB- O
1977 CD O
) SYM O
Nature NNP O
270 CD O
, , O

314 CD O
- HYPH O
319 CD O
. . O

28 CD O
. . O

Dugaiczyk NNP O
, , O
A NNP O
. . O
, , O
Woo UH O
, , O
S NNP O
. . O

L NN O
. . O

C UH O
. . O
, , O
Lai NNP O
, , O
E NNP O
. . O

C UH O
. . O
, , O
Mace NNP O
, , O
M NNP O
. . O

L NNP O
. . O
, , O
Jr NNP O
. . O
, , O

McReynolds NNP O
, , O
L NNP O
. . O
, , O
and CC O
O NNP O
' '' O
Malley NNP O
, , O
B NNP O
. . O

W UH O
. . O

( : O
1978 CD O
) SYM O
Nature NNP O
274 CD O
, , O
328 CD O
- HYPH O
333 CD O
. . O

29 CD O
. . O

Weinstock NNP O
, , O
R NNP O
. . O
, , O
Sweet NNP O
, , O
R NNP O
. . O
, , O
Weiss NNP O
, , O
M NNP O
. . O
, , O
Cedar NNP O
, , O
M NNP O
. . O
, , O
and CC O
Axel NNP O
, , O
R NNP O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
1299 CD O
- SYM O
1303 CD O
. . O

30 CD O
. . O

Catterall NNP O
, , O
J NNP O
. . O

F NNP O
. . O
, , O
Stein NNP O
, , O
J NNP O
. . O

P UH O
. . O
, , O
Lai NNP O
, , O
E NNP O
. . O

C UH O
. . O
, , O
Woo UH O
, , O
S NNP O
. . O

L NN O
. . O

C UH O
. . O
, , O

Dugaiczyk NNP O
, , O
Mace NNP O
, , O
M NNP O
. . O

L NNP O
. . O
, , O
Means NNP O
, , O
A DT O
. . O

R NNP O
. . O
, , O
and CC O
O UH O
' '' O
Malley NNP O
, , O
B NNP O
. . O

W UH O
. . O

( : O
1979 CD O
) SYM O
Nature NNP O
278 CD O
, , O
323 CD O
- HYPH O
327 CD O
. . O

31 CD O
. . O

White JJ O
, , O
R NNP O
. . O

L NNP O
. . O
, , O
and CC O
Hogness NNP O
, , O
D NNP O
. . O

S UH O
. . O

( : O
1977 CD O
) SYM O
Cell NNP O
10 CD O
, , O
177 CD O
- SYM O
192 CD O
. . O

32 CD O
. . O

Glover NNP O
, , O
D NNP O
. . O

M UH O
. . O
, , O
and CC O
Hogness NNP O
, , O
D NNP O
. . O

S UH O
. . O

( -LRB- O
1977 CD O
) SYM O
Cell NNP O
16 CD O
, , O
167 CD O
- SYM O
176 CD O
. . O

33 CD O
. . O

Wellauer NNP O
, , O
P NN O
. . O

K UH O
. . O
, , O
and CC O
David NNP O
, , O
I PRP O
. . O

B NN O
. . O

( : O
1977 CD O
) SYM O
Cell NNP O
10 CD O
, , O
193 CD O
- HYPH O
212 CD O
. . O

34 CD O
. . O

Pellegrini NNP O
, , O
M NNP O
. . O
, , O
Manning NNP O
, , O
J NNP O
. . O
, , O
and CC O
Davidson NNP O
, , O
N NNP O
. . O

( -LRB- O
1977 CD O
) SYM O
Cell NN O
10 CD O
, , O

213 CD O
- HYPH O
214 CD O
. . O

35 CD O
. . O

Wahli NNP O
, , O
W NNP O
. . O
, , O
David NNP O
, , O
I PRP O
. . O

B NNP O
. . O
, , O
Wyler NNP O
, , O
T NNP O
. . O
, , O
Jaggi NNP O
, , O
R NNP O
. . O

B NNP O
. . O
, , O
Weber NNP O
, , O
R NNP O
. . O
, , O
and CC O

Ryffel NNP O
, , O
G NNP O
. . O

V NN O
. . O

( : O
1979 CD O
) SYM O
Cell NNP O
16 CD O
, , O
535 CD O
- HYPH O
549 CD O
. . O

36 CD O
. . O

McReynolds NNP O
, , O
L NNP O
. . O
, , O
O UH O
' '' O
Malley NNP O
, , O
B NNP O
. . O

W UH O
. . O
, , O
Nisbet NNP O
, , O
A NNP O
. . O

D NNP O
. . O
, , O
Fothergill NNP O
, , O
J NNP O
. . O

E UH O
. . O
, , O

2252 CD O

Nucleic NNP O
Acids NNP O
Research NNP O

Givol NNP O
, , O
D NNP O
. . O
, , O
Fields NNP O
, , O
S NNP O
. . O
, , O
Robertson NNP O
, , O
M NNP O
. . O
, , O
Brownlee NNP O
, , O
G NNP O
. . O

G NNP O
. . O

( : O
1978 CD O
) SYM O
Nature NNP O
273 CD O
, , O
723 CD O
- HYPH O
728 CD O
. . O

37 CD O
. . O

O UH O
' '' O
Hare NNP O
, , O
K NNP O
. . O
, , O
Breathnach NNP O
, , O
R NNP O
. . O
, , O
Benoist NNP O
, , O
C NNP O
. . O
, , O
Chambon NNP O
, , O
P NN O
. . O

( -LRB- O
1979 CD O
) -RRB- O

Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

7 CD O
, , O
321 CD O
- SYM O
334 CD O
. . O

38 CD O
. . O

Abelson NNP O
, , O
J NNP O
. . O

( : O
1979 CD O
) : O
Ann NNP O
. . O

Rev NNP O
. . O

Biochem NNP O
. . O

48 CD O
, , O
1035 CD O
- SYM O
1069 CD O
. . O

39 CD O
. . O

Adams NNP O
, , O
S NNP O
. . O

L NNP O
. . O
, , O
Alwine NNP O
, , O
J NNP O
. . O

C UH O
. . O
, , O
de FW O
Chrombrugghe NNP O
, , O
B NNP O
. . O
, , O
and CC O
Pastan NNP O
, , O
I PRP O
. . O

( : O
1979 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

254 CD O
, , O
4935 CD O
- HYPH O
4938 CD O
, , O

40 CD O
. . O

Rave NNP O
, , O
N NNP O
. . O
, , O
Crkvenjakow NNP O
, , O
R NNP O
. . O
, , O
and CC O
Boedtker NNP O
, , O
H NNP O
. . O

( -LRB- O
1979 CD O
) : O
Nucl NNP O
. . O

Acids NNP O
Res NNP O
. . O

6 CD O
, , O
3559 CD O
- HYPH O
3567 CD O
. . O

41 CD O
. . O

Roop NNP O
, , O
D NNP O
. . O

R NNP O
. . O
, , O
Nordstrom NNP O
, , O
J NNP O
. . O

L NNP O
. . O
, , O
Tsai NNP O
, , O
S NNP O
. . O

Y UH O
. . O
, , O
Tsai NNP O
, , O
M NNP O
. . O

J NNP O
. . O
, , O
and CC O

O UH O
' '' O
Malley NNP O
, , O
B NNP O
. . O

W UH O
. . O

( : O
1978 CD O
) SYM O
Cell NNP O
15 CD O
, , O
671 CD O
- HYPH O
685 CD O
. . O

42 CD O
. . O

Tilghman NNP O
, , O
S NNP O
. . O

M UH O
. . O
, , O
Curtis NNP O
, , O
P NN O
. . O

J NNP O
. . O
, , O
Tiemeier NNP O
, , O
D NNP O
. . O

C UH O
. . O
, , O
Leder NNP O
, , O
P NNP O
. . O
, , O
and CC O

Weissmann NNP O
, , O
C NNP O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NN O
. . O
S NNP O
. . O
A DT O
. . O

75 CD O
, , O
1309 CD O
- HYPH O
1313 CD O
. . O

43 CD O
. . O

Palmiter NNP O
, , O
R NNP O
. . O

D NNP O
. . O
, , O
Davidson NNP O
, , O
J NNP O
. . O

M UH O
. . O
, , O
Gagnon NNP O
, , O
H NNP O
. . O
, , O
Rowe NNP O
, , O
D NNP O
. . O

W UH O
. . O
, , O
and CC O

Bornstein NNP O
, , O
P NN O
. . O

( : O
1979 CD O
) SYM O
J NN O
. . O

Biol NNP O
. . O

Chem NNP O
. . O

254 CD O
, , O
1433 CD O
- HYPH O
1436 CD O
. . O

44 CD O
. . O

Graves NNP O
, , O
P NN O
. . O

N NNP O
. . O
, , O
Olsen NNP O
, , O
B NNP O
. . O

R NNP O
. . O
, , O
Feitzig NNP O
, , O
P NN O
. . O

P UH O
. . O
, , O
Monson NNP O
, , O
J NNP O
. . O

M UH O
. . O
and CC O

Prockop NNP O
, , O
D NNP O
. . O

J NNP O
. . O

( -LRB- O
1979 CD O
) SYM O
Fed NNP O
. . O

Proc NNP O
. . O

38 CD O
, , O
620 CD O
. . O

2253 CD O

Thumb NN O
force NN O
deficit NN O
after IN O
lower JJR O
median JJ O
nerve NN O
block NN O

Abstract JJ O

Purpose NN O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
characterize VB O
thumb NN O
motor NN O
dysfunction NN O
resulting VBG O
from IN O
simulated VBN O
lower JJR O
median JJ O
nerve NN O
lesions NNS O
at IN O
the DT O
wrist NN O
. . O

Methods NNS O

Bupivacaine NN O
hydrochloride NN O
was VBD O
injected VBN O
into IN O
the DT O
carpal NN O
tunnel NN O
of IN O
six CD O
healthy JJ O
subjects NNS O
to TO O
locally RB O
anesthetize VB O
the DT O
median JJ O
nerve NN O
. . O

Motor NN O
function NN O
was VBD O
subsequently RB O
evaluated VBN O
by IN O
measuring VBG O
maximal JJ O
force NN O
production NN O
in IN O
all DT O
directions NNS O
within IN O
the DT O
transverse NN O
plane NN O
perpendicular JJ O
to IN O
the DT O
longitudinal JJ O
axis NN O
of IN O
the DT O
thumb NN O
. . O

Force NN O
envelopes NNS O
were VBD O
constructed VBN O
using VBG O
these DT O
measured VBN O
multidirectional JJ O
forces NNS O
. . O

Results NNS O

Blockage NN O
of IN O
the DT O
median JJ O
nerve NN O
resulted VBD O
in IN O
decreased VBN O
force NN O
magnitudes NNS O
and CC O
thus RB O
smaller JJR O
force NN O
envelopes NNS O
. . O

The DT O
average JJ O
force NN O
decrease NN O
around IN O
the DT O
force NN O
envelope NN O
was VBD O
27 CD O
. . O
9 CD O
% NN O
. . O

A DT O
maximum JJ O
decrease NN O
of IN O
42 CD O
. . O
4 CD O
% NN O
occurred VBD O
in IN O
a DT O
direction NN O
combining VBG O
abduction NN O
and CC O
slight JJ O
flexion NN O
, , O
while IN O
a DT O
minimum JJ O
decrease NN O
of IN O
10 CD O
. . O
5 CD O
% NN O
occurred VBD O
in IN O
a DT O
direction NN O
combining VBG O
adduction NN O
and CC O
slight JJ O
flexion NN O
. . O

Relative JJ O
decreases NNS O
in IN O
adduction NN O
, , O
extension NN O
, , O
abduction NN O
, , O
and CC O
flexion NN O
were VBD O
17 CD O
. . O
3 CD O
% NN O
, , O
21 CD O
. . O
2 CD O
% NN O
, , O
41 CD O
. . O
2 CD O
% NN O
and CC O
33 CD O
. . O
5 CD O
% NN O
, , O
respectively RB O
. . O

Areas NNS O
enclosed VBN O
by IN O
pre JJ O
- HYPH O
and CC O
post JJ O
- HYPH O
block NN O
force NN O
envelopes NNS O
were VBD O
20628 CD O
+ CD O
/ SYM O
- HYPH O
7747 CD O
N CD O
. . O
N NN O
, , O
and CC O
10700 CD O
+ SYM O
/ SYM O
- HYPH O
4474 CD O
N CD O
. . O
N CD O
, , O
respectively RB O
, , O
representing VBG O
an DT O
average JJ O
decrease NN O
of IN O
48 CD O
. . O
1 CD O
% NN O
. . O

Relative JJ O
decreases NNS O
in IN O
the DT O
adduction NN O
, , O
extension NN O
, , O
abduction NN O
, , O
and CC O
flexion NN O
quadrant NN O
areas NNS O
were VBD O
31 CD O
. . O
5 CD O
% NN O
, , O
42 CD O
. . O
3 CD O
% NN O
, , O
60 CD O
. . O
9 CD O
% NN O
, , O
and CC O
52 CD O
. . O
3 CD O
% NN O
, , O
respectively RB O
. . O

Conclusion NN O

Lower JJR O
median JJ O
nerve JJ O
lesion NN O
, , O
simulated VBN O
by IN O
a DT O
nerve NN O
block NN O
at IN O
the DT O
wrist NN O
, , O
compromise VBP O
normal JJ O
motor NN O
function NN O
of IN O
the DT O
thumb NN O
. . O

A DT O
median JJ O
nerve NN O
block NN O
results VBZ O
in IN O
force NN O
deficits NNS O
in IN O
all DT O
directions NNS O
, , O
with IN O
the DT O
most RBS O
severe JJ O
impairment NN O
in IN O
abduction NN O
and CC O
flexion NN O
. . O

From IN O
our PRP$ O
results NNS O
, , O
such PDT O
a DT O
means NN O
of IN O
motor NN O
function NN O
assessment NN O
can MD O
potentially RB O
be VB O
applied VBN O
to TO O
functionally RB O
evaluate VB O
peripheral JJ O
neuropathies NNS O
. . O

Introduction NN O

The DT O
thumb NN O
has VBZ O
unique JJ O
anatomical JJ O
and CC O
biomechanical JJ O
characteristics NNS O
that WDT O
are VBP O
required VBN O
to TO O
perform VB O
many JJ O
manipulative JJ O
tasks NNS O
. . O

Thumb NN O
motor NN O
dysfunction NN O
resulting VBG O
from IN O
neuromuscular JJ O
and CC O
musculoskeletal JJ O
pathologies NNS O
severely RB O
hinders VBZ O
the DT O
performance NN O
of IN O
these DT O
daily JJ O
tasks NNS O
. . O

Clinical JJ O
treatment NN O
, , O
prevention NN O
protocols NNS O
, , O
and CC O
rehabilitation NN O
efficacy NN O
requires VBZ O
a DT O
thorough JJ O
understanding NN O
of IN O
thumb NN O
motor NN O
capabilities NNS O
, , O
as RB O
well RB O
as IN O
its PRP$ O
associated JJ O
functional JJ O
deficit NN O
. . O

Investigations NNS O
of IN O
underlying JJ O
pathological JJ O
mechanism NN O
of IN O
the DT O
thumb NN O
help VBP O
advance VB O
clinical JJ O
treatments NNS O
such JJ O
as IN O
tendon NN O
transfers NNS O
[ -LRB- O
1 CD O
] -RRB- O
, , O
functional JJ O
electrical JJ O
stimulation NN O
[ -LRB- O
2 CD O
] -RRB- O
and CC O
plasticity NN O
suppression NN O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Measurement NN O
of IN O
strength NN O
during IN O
maximum JJ O
voluntary JJ O
contraction NN O
is VBZ O
a DT O
simple JJ O
and CC O
direct JJ O
means NN O
of IN O
assessing VBG O
neuromuscular JJ O
function NN O
. . O

Popular JJ O
instruments NNS O
used VBN O
for IN O
quantitative JJ O
assessment NN O
of IN O
thumb NN O
strength NN O
are VBP O
pinch NN O
dynamometers NNS O
. . O

The DT O
pinch NN O
output NN O
, , O
however RB O
, , O
provides VBZ O
limited JJ O
information NN O
about IN O
thumb NN O
motor NN O
function NN O
in IN O
that IN O
it PRP O
offers VBZ O
a DT O
single JJ O
generic JJ O
force NN O
in IN O
one CD O
specific JJ O
direction NN O
. . O

Each DT O
muscle NN O
/ SYM O
tendon NN O
within IN O
the DT O
thumb NN O
has VBZ O
a DT O
distinct JJ O
anatomical JJ O
origin NN O
and CC O
insertion NN O
, , O
suggesting VBG O
its PRP$ O
external JJ O
force NN O
potential NN O
in IN O
a DT O
particular JJ O
direction NN O
[ -LRB- O
4 CD O
- SYM O
6 CD O
] -RRB- O
. . O

Hence RB O
, , O
evaluation NN O
of IN O
strengths NNS O
in IN O
multiple JJ O
directions NNS O
offers VBZ O
insight NN O
concerning VBG O
the DT O
motor NN O
capacity NN O
of IN O
individual JJ O
muscles NNS O
. . O

Force NN O
production NN O
of IN O
a DT O
digit NN O
has VBZ O
been VBN O
measured VBN O
in IN O
various JJ O
directions NNS O
such JJ O
as IN O
flexion NN O
/ SYM O
extension NN O
[ -LRB- O
7 CD O
, , O
8 CD O
] -RRB- O
, , O
abduction NN O
/ SYM O
adduction NN O
[ -LRB- O
9 CD O
- SYM O
14 CD O
] -RRB- O
, , O
or CC O
in IN O
combined VBN O
directions NNS O
[ -LRB- O
15 CD O
, , O
16 CD O
] -RRB- O
. . O

Bourbonnais NNP O
et FW O
al NNP O
. . O
developed VBD O
an DT O
apparatus NN O
to TO O
measure VB O
thumb NN O
force NN O
production NN O
in IN O
eight CD O
directions NNS O
in IN O
the DT O
transverse JJ O
plane NN O
of IN O
the DT O
thumb NN O
and CC O
investigated VBN O
force NN O
dependence NN O
on IN O
the DT O
direction NN O
of IN O
effort NN O
[ -LRB- O
15 CD O
] -RRB- O
. . O

Yokogawa NNP O
and CC O
Hara NNP O
measured VBD O
index NN O
fingertip NN O
forces NNS O
in IN O
various JJ O
directions NNS O
within IN O
the DT O
flexion NN O
/ SYM O
extension NN O
plane NN O
[ -LRB- O
8 CD O
] -RRB- O
. . O

Recently RB O
, , O
we PRP O
developed VBD O
experimental JJ O
apparatuses NNS O
to TO O
measure VB O
multi JJ O
- HYPH O
directional JJ O
forces NNS O
of IN O
a DT O
digit NN O
in IN O
its PRP$ O
transverse NN O
plane NN O
[ -LRB- O
17 CD O
- HYPH O
19 CD O
] -RRB- O
. . O

From IN O
these DT O
multi JJ O
- HYPH O
directional JJ O
forces NNS O
we PRP O
constructed VBD O
force NN O
envelopes NNS O
representative JJ O
of IN O
the DT O
characteristic JJ O
force NN O
output NN O
pattern NN O
of IN O
a DT O
digit NN O
[ -LRB- O
17 CD O
- SYM O
19 CD O
] -RRB- O
. . O

Disorders NNS O
resulting VBG O
from IN O
traumatic JJ O
injuries NNS O
to IN O
and CC O
various JJ O
diseases NNS O
of IN O
these DT O
nerves NNS O
are VBP O
common JJ O
in IN O
clinical JJ O
practice NN O
. . O

Clinical JJ O
manifestations NNS O
of IN O
hand NN O
dysfunction NN O
are VBP O
distinctive JJ O
depending VBG O
on IN O
the DT O
nerve NN O
involved VBN O
. . O

For IN O
example NN O
, , O
thenar NN O
atrophy NN O
is VBZ O
a DT O
major JJ O
clinical JJ O
observation NN O
affecting VBG O
thumb NN O
function NN O
at IN O
the DT O
later JJ O
stages NNS O
of IN O
compression NN O
neuropathy NN O
of IN O
the DT O
median JJ O
nerve NN O
. . O

Several JJ O
studies NNS O
have VBP O
been VBN O
conducted VBN O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
simulated VBN O
peripheral JJ O
neuropathies NNS O
using VBG O
local JJ O
anesthetization NN O
[ -LRB- O
5 CD O
, , O
16 CD O
, , O
20 CD O
, , O
21 CD O
] -RRB- O
. . O

Kozin NNP O
et FW O
al NNP O
. . O

[ -LRB- O
21 CD O
] -RRB- O
studied VBD O
the DT O
effects NNS O
of IN O
median JJ O
and CC O
ulnar JJ O
nerve NN O
blocks NNS O
on IN O
grip NN O
and CC O
pinch NN O
strength NN O
and CC O
showed VBD O
significant JJ O
decreases NNS O
following VBG O
nerve NN O
blockage NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Boatright NNP O
and CC O
Kiebzak NNP O
[ -LRB- O
20 CD O
] -RRB- O
investigated VBD O
the DT O
effects NNS O
of IN O
median JJ O
nerve NN O
block NN O
on IN O
thumb NN O
abduction NN O
strength NN O
. . O

Kaufman NNP O
et FW O
al NNP O
. . O

[ -LRB- O
5 CD O
] -RRB- O
measured VBN O
isometric JJ O
thumb NN O
forces NNS O
in IN O
eight CD O
directions NNS O
together RB O
with IN O
electromyographic JJ O
signals NNS O
of IN O
thumb NN O
muscles NNS O
after IN O
block NN O
of IN O
the DT O
median JJ O
nerve NN O
. . O

Labosky NNP O
and CC O
Waggy NNP O
[ -LRB- O
22 CD O
] -RRB- O
studied VBD O
the DT O
strength NN O
related VBN O
to IN O
grip NN O
, , O
pinch NN O
, , O
thumb NN O
adduction NN O
, , O
thumb NN O
abduction NN O
, , O
and CC O
finger NN O
flexion NN O
after IN O
radial JJ O
nerve NN O
block NN O
[ -LRB- O
22 CD O
] -RRB- O
. . O

Kuxhaus NNP O
studied VBD O
the DT O
three CD O
dimensional JJ O
feasible JJ O
force NN O
set VBN O
at IN O
the DT O
thumb NN O
- HYPH O
tip NN O
before IN O
and CC O
after IN O
ulnar JJ O
nerve NN O
block NN O
and CC O
reported VBD O
this DT O
to TO O
be VB O
a DT O
reproducible JJ O
and CC O
sensitive JJ O
means NN O
to TO O
detect VB O
impairment NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
utilize VB O
our PRP$ O
developed JJ O
apparatus NN O
and CC O
protocols NNS O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
lower JJR O
median JJ O
nerve NN O
lesion NN O
on IN O
thumb NN O
motor NN O
function NN O
. . O

The DT O
lesion NN O
was VBD O
simulated VBN O
by IN O
blocking VBG O
the DT O
median JJ O
nerve NN O
at IN O
the DT O
wrist NN O
using VBG O
an DT O
anesthetic NN O
. . O

We PRP O
hypothesized VBD O
that IN O
a DT O
median JJ O
nerve NN O
block NN O
would MD O
cause VB O
( : O
1 CD O
) SYM O
a DT O
decrease NN O
in IN O
force NN O
production NN O
, , O
which WDT O
would MD O
be VB O
direction NN O
- HYPH O
dependent JJ O
with IN O
the DT O
most RBS O
severe JJ O
reduction NN O
in IN O
the DT O
abduction NN O
direction NN O
, , O
and CC O
( , O
2 CD O
) , O
a DT O
decrease NN O
in IN O
the DT O
force NN O
envelope NN O
area NN O
and CC O
force NN O
quadrant NN O
area NN O
, , O
with IN O
the DT O
greatest JJS O
decrease NN O
in IN O
the DT O
abduction NN O
quadrant NN O
. . O

Methods NNS O

Subjects NNS O

Six CD O
healthy JJ O
male JJ O
subjects NNS O
( , O
mean JJ O
age NN O
: : O
26 CD O
. . O
9 CD O
+ SYM O
/ SYM O
- HYPH O
5 CD O
. . O
1 CD O
years NNS O
) -RRB- O
participated VBD O
in IN O
this DT O
study NN O
. . O

The DT O
subjects NNS O
had VBD O
no DT O
previous JJ O
history NN O
of IN O
neuromuscular JJ O
or CC O
musculoskeletal JJ O
disorders NNS O
of IN O
the DT O
upper JJ O
extremities NNS O
. . O

Each DT O
subject NN O
signed VBD O
an DT O
informed JJ O
consent NN O
form NN O
approved VBN O
by IN O
the DT O
Institutional NNP O
Review NNP O
Board NNP O
prior RB O
to IN O
participating VBG O
in IN O
the DT O
experiment NN O
. . O

Median JJ O
nerve NN O
block NN O

Injections NNS O
were VBD O
performed VBN O
under IN O
aseptic JJ O
conditions NNS O
while IN O
the DT O
subjects NNS O
sat VBD O
with IN O
the DT O
forearm NN O
supinated VBD O
and CC O
the DT O
wrist NN O
slightly RB O
extended VBD O
. . O

After IN O
the DT O
skin NN O
at IN O
the DT O
palmer NN O
area NN O
of IN O
the DT O
wrist NN O
was VBD O
cleaned VBN O
with IN O
alcohol NN O
, , O
4 CD O
mL NNS O
of IN O
0 CD O
. . O
5 CD O
% NN O
bupivacaine NN O
hydrochloride NN O
( : O
Astra NNP O
Pharmaceuticals NNPS O
, , O
Westborough NNP O
, , O
MA NNP O
, , O
USA NNP O
) -RRB- O
was VBD O
injected VBN O
into IN O
the DT O
carpal JJ O
tunnel NN O
with IN O
a DT O
sterile JJ O
25 CD O
- HYPH O
gauge NN O
short JJ O
- HYPH O
bevel NN O
needle NN O
. . O

The DT O
needle NN O
was VBD O
inserted VBN O
through IN O
the DT O
transverse JJ O
carpal NN O
ligament NN O
in IN O
line NN O
with IN O
the DT O
radial JJ O
border NN O
of IN O
the DT O
fourth JJ O
digit NN O
slightly RB O
ulnar JJ O
to IN O
the DT O
palmaris NN O
longus NN O
tendon NN O
at IN O
the DT O
level NN O
of IN O
the DT O
distal JJ O
wrist NN O
crease NN O
. . O

Forty CD O
minutes NNS O
was VBD O
allowed VBN O
for IN O
the DT O
median JJ O
nerve NN O
block NN O
to TO O
reach VB O
complete JJ O
effectiveness NN O
[ -LRB- O
23 CD O
] -RRB- O
and CC O
was VBD O
verified VBN O
using VBG O
the DT O
Semmes NNP O
- HYPH O
Weinstein NNP O
monofilament NN O
test NN O
. . O

The DT O
average JJ O
monofilament NN O
score NN O
was VBD O
2 CD O
. . O
85 CD O
across IN O
the DT O
five CD O
digits NNS O
before IN O
nerve NN O
block NN O
. . O

About RB O
40 CD O
minutes NNS O
after IN O
nerve NN O
injection NN O
, , O
little JJ O
sensory JJ O
impairment NN O
occurred VBD O
in IN O
the DT O
ulnar JJ O
distribution NN O
( , O
score NN O
= SYM O
3 CD O
. . O
22 CD O
) -RRB- O
, , O
while IN O
the DT O
sensory JJ O
score NN O
in IN O
the DT O
median JJ O
distribution NN O
was VBD O
greater JJR O
than IN O
6 CD O
. . O
15 CD O
. . O

The DT O
effects NNS O
of IN O
nerve NN O
block NN O
lasted VBD O
more JJR O
than IN O
6 CD O
hours NNS O
with IN O
all DT O
subjects NNS O
regaining VBG O
normal JJ O
hand NN O
function NN O
within IN O
12 CD O
hours NNS O
. . O

Testing NN O
apparatus NN O

The DT O
experimental JJ O
apparatus NN O
was VBD O
designed VBN O
and CC O
constructed VBN O
to TO O
measure VB O
maximum JJ O
voluntary JJ O
contraction NN O
forces NNS O
of IN O
any DT O
digit NN O
at IN O
any DT O
point NN O
along IN O
the DT O
digit NN O
. . O

Force NN O
application NN O
was VBD O
possible JJ O
in IN O
any DT O
direction NN O
within IN O
the DT O
transverse JJ O
plane NN O
of IN O
the DT O
longitudinal JJ O
axis NN O
of IN O
the DT O
digit NN O
. . O

The DT O
apparatus NN O
consisted VBD O
of IN O
position NN O
control NN O
accessories NNS O
, , O
a DT O
force NN O
transducer NN O
, , O
and CC O
a DT O
custom RB O
fitted VBN O
aluminum NN O
ring NN O
attached VBN O
to IN O
the DT O
transducer NN O
( -LRB- O
Figure NNP O
1A NNP O
, , O
1B NNP O
) -RRB- O
. . O

The DT O
transducer NN O
( -LRB- O
Mini40 NNP O
, , O
ATI NNP O
Industrial NNP O
Automation NNP O
, , O
NC NNP O
, , O
USA NNP O
) -RRB- O
, , O
capable JJ O
of IN O
measuring VBG O
6 CD O
degrees NNS O
of IN O
freedom NN O
forces NNS O
and CC O
moments NNS O
, , O
was VBD O
attached VBN O
to IN O
a DT O
mounting VBG O
clamp NN O
via IN O
an DT O
aluminum NN O
adapter NN O
plate NN O
while IN O
the DT O
aluminum NN O
ring NN O
was VBD O
secured VBN O
to IN O
the DT O
tool NN O
side NN O
of IN O
the DT O
transducer NN O
using VBG O
a DT O
custom JJ O
adapter NN O
. . O

The DT O
ring NN O
served VBD O
as IN O
a DT O
connection NN O
anchor NN O
for IN O
the DT O
transducer NN O
and CC O
the DT O
digit NN O
. . O

The DT O
force NN O
transducer NN O
and CC O
ring NN O
attachment NN O
were VBD O
positioned VBN O
in IN O
a DT O
desired VBN O
orientation NN O
using VBG O
an DT O
aluminum NN O
slide NN O
rail NN O
, , O
tubing NN O
, , O
and CC O
lockable JJ O
mounting NN O
clamps NNS O
( , O
80 CD O
/ SYM O
20 CD O
Inc NNP O
. . O
, , O
Columbia NNP O
City NNP O
, , O
IN NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
slide NN O
rail NN O
was VBD O
secured VBN O
to IN O
an DT O
aluminum NN O
base NN O
plate NN O
. . O

Foam NN O
padded VBN O
wooden JJ O
blocks NNS O
with IN O
two CD O
locking VBG O
straps NNS O
secured VBD O
the DT O
arm NN O
to IN O
the DT O
base NN O
plate NN O
. . O

The DT O
analog NN O
outputs NNS O
from IN O
the DT O
transducer NN O
were VBD O
digitized VBN O
using VBG O
a DT O
16 CD O
- HYPH O
bit NN O
analog NN O
- HYPH O
to IN O
- HYPH O
digital JJ O
converter NN O
( HYPH O
PCI NNP O
- HYPH O
6031 CD O
, , O
National NNP O
Instruments NNPS O
, , O
TX NNP O
, , O
USA NNP O
) -RRB- O
. . O

The DT O
X NNP O
( HYPH O
abduction NN O
/ SYM O
adduction NN O
) -RRB- O
and CC O
Y NNP O
( HYPH O
flexion NN O
/ SYM O
extension NN O
) -RRB- O
force NN O
components NNS O
in IN O
the DT O
transverse NN O
plane NN O
were VBD O
displayed VBN O
on IN O
the DT O
screen NN O
while IN O
the DT O
subject NN O
performed VBD O
a DT O
force NN O
production NN O
task NN O
. . O

The DT O
resolutions NNS O
of IN O
the DT O
force NN O
transducer NN O
in IN O
its PRP$ O
axial JJ O
( , O
flexion NN O
/ SYM O
extension NN O
) -RRB- O
and CC O
horizontal JJ O
( -LRB- O
abduction NN O
/ SYM O
adduction NN O
) -RRB- O
directions NNS O
were VBD O
0 CD O
. . O
16 CD O
N CD O
and CC O
0 CD O
. . O
8 CD O
N CD O
, , O
respectively RB O
. . O

A DT O
personal JJ O
computer NN O
equipped VBN O
with IN O
LabVIEW NNP O
( -LRB- O
National NNP O
Instrument NNP O
, , O
TX NNP O
, , O
USA NNP O
) -RRB- O
was VBD O
used VBN O
for IN O
force NN O
data NN O
acquisition NN O
, , O
display NN O
, , O
and CC O
processing NN O
. . O

Experimental JJ O
procedures NNS O

Each DT O
subject NN O
was VBD O
tested VBN O
before IN O
and CC O
after IN O
median JJ O
nerve NN O
block NN O
. . O

The DT O
nerve NN O
block NN O
procedures NNS O
were VBD O
performed VBN O
immediately RB O
after IN O
the DT O
completion NN O
of IN O
the DT O
first JJ O
testing NN O
session NN O
. . O

Post NN O
- HYPH O
block NN O
testing NN O
started VBD O
after IN O
the DT O
verification NN O
of IN O
complete JJ O
median JJ O
nerve NN O
block NN O
, , O
approximately RB O
40 CD O
minutes NNS O
after IN O
the DT O
injection NN O
. . O

During IN O
each DT O
test NN O
, , O
the DT O
subject NN O
was VBD O
seated VBN O
in IN O
a DT O
chair NN O
adjacent JJ O
to IN O
the DT O
testing NN O
station NN O
modified VBN O
with IN O
a DT O
wooden JJ O
board NN O
to TO O
align VB O
their PRP$ O
back NN O
vertically RB O
throughout IN O
the DT O
trials NNS O
. . O

The DT O
subjects NNS O
rested VBD O
their PRP$ O
forearm NN O
on IN O
padded VBN O
wooden JJ O
blocks NNS O
positioning VBG O
their PRP$ O
shoulder NN O
in IN O
approximately RB O
60 CD O
degrees NNS O
of IN O
frontal JJ O
plane NN O
abduction NN O
. . O

Nylon NNP O
straps NNS O
fitted VBN O
with IN O
plastic JJ O
snap NN O
locking VBG O
mechanisms NNS O
secured VBD O
the DT O
forearm NN O
and CC O
minimized VBD O
the DT O
intervention NN O
of IN O
the DT O
elbow NN O
and CC O
shoulder NN O
during IN O
thumb NN O
force NN O
application NN O
. . O

Subjects NNS O
grasped VBD O
a DT O
vertical JJ O
dowel NN O
secured VBN O
to IN O
the DT O
distal JJ O
end NN O
of IN O
the DT O
wooden JJ O
blocks NNS O
in IN O
a DT O
midprone JJ O
position NN O
. . O

Formable JJ O
thermoplastic JJ O
braces NNS O
were VBD O
used VBN O
to TO O
fix VB O
the DT O
elbow NN O
in IN O
90 CD O
degrees NNS O
of IN O
flexion NN O
, , O
and CC O
the DT O
wrist NN O
in IN O
20 CD O
degrees NNS O
of IN O
extension NN O
and CC O
0 CD O
degrees NNS O
of IN O
ulnar JJ O
deviation NN O
. . O

A DT O
metallic JJ O
brace NN O
was VBD O
used VBN O
to TO O
fix VB O
the DT O
interphalangeal JJ O
joint NN O
of IN O
the DT O
thumb NN O
in IN O
full JJ O
extension NN O
. . O

The DT O
aluminum NN O
ring NN O
was VBD O
placed VBN O
around IN O
the DT O
middle NN O
of IN O
the DT O
proximal JJ O
phalanx NN O
and CC O
oriented VBN O
to TO O
accommodate VB O
comfortable JJ O
thumb NN O
position NN O
with IN O
the DT O
metacarpophalangeal NN O
joint NN O
flexed VBN O
approximately RB O
15 CD O
degrees NNS O
. . O

Prior RB O
to IN O
testing NN O
, , O
a DT O
line NN O
was VBD O
drawn VBN O
on IN O
the DT O
proximal JJ O
phalange NN O
at IN O
the DT O
midpoint NN O
between IN O
the DT O
interphalangeal JJ O
and CC O
metacarpophalangeal NN O
joints NNS O
. . O

The DT O
alignment NN O
of IN O
the DT O
ring NN O
with IN O
the DT O
circumferential JJ O
line NN O
standardized VBD O
the DT O
location NN O
of IN O
force NN O
application NN O
within IN O
and CC O
between IN O
subjects NNS O
. . O

As IN O
force NN O
application NN O
was VBD O
at IN O
the DT O
middle NN O
of IN O
the DT O
proximal JJ O
phalanx NN O
, , O
mechanical JJ O
action NN O
pertains VBZ O
to IN O
both CC O
the DT O
metacarpophalangeal NN O
and CC O
carpometacarpal NN O
joints NNS O
. . O

We PRP O
chose VBD O
the DT O
terminology NN O
of IN O
flexion NN O
/ SYM O
extension NN O
and CC O
adduction NN O
/ SYM O
adduction NN O
based VBN O
on IN O
the DT O
mechanical JJ O
action NN O
with IN O
respect NN O
to IN O
the DT O
metacarpophalangeal NN O
joint NN O
. . O

With IN O
the DT O
thumb NN O
in IN O
the DT O
ring NN O
( -LRB- O
Figure NNP O
1B NNP O
) -RRB- O
, , O
extension NN O
and CC O
flexion NN O
occurred VBD O
in IN O
parallel NN O
with IN O
the DT O
palm NN O
, , O
and CC O
abduction NN O
and CC O
adduction NN O
occurred VBD O
in IN O
a DT O
plane NN O
perpendicular JJ O
to IN O
the DT O
palm NN O
. . O

Each DT O
subject NN O
performed VBD O
15 CD O
circumferential JJ O
MVC NNP O
trials NNS O
with IN O
randomized VBN O
starting NN O
directions NNS O
( -LRB- O
Figure NNP O
1C NNP O
) -RRB- O
. . O

The DT O
subject NN O
was VBD O
allotted VBN O
15 CD O
seconds NNS O
to TO O
complete VB O
each DT O
circumferential JJ O
trial NN O
, , O
and CC O
was VBD O
instructed VBN O
to TO O
use VB O
the DT O
entire JJ O
time NN O
allotted VBN O
to TO O
traverse VB O
the DT O
perimeter NN O
of IN O
the DT O
ring NN O
once RB O
. . O

A DT O
dot NN O
generated VBN O
on IN O
the DT O
computer NN O
screen NN O
was VBD O
programmed VBN O
to TO O
traverse VB O
a DT O
circle NN O
within IN O
15 CD O
seconds NNS O
to TO O
provide VB O
the DT O
subject NN O
with IN O
directional JJ O
feedback NN O
of IN O
their PRP$ O
force NN O
application NN O
. . O

Subjects NNS O
were VBD O
given VBN O
60 CD O
seconds NNS O
of IN O
rest NN O
between IN O
each DT O
circumferential JJ O
trial NN O
. . O

Each DT O
subject NN O
was VBD O
familiarized VBN O
with IN O
the DT O
task NN O
with IN O
a DT O
few JJ O
practice NN O
trials NNS O
. . O

Data NNS O
were VBD O
collected VBN O
from IN O
each DT O
subject NN O
at IN O
100 CD O
samples NNS O
per IN O
second NN O
producing VBG O
a DT O
total NN O
of IN O
22 CD O
, , O
500 CD O
pairs NNS O
of IN O
force NN O
components NNS O
from IN O
the DT O
15 CD O
circumferential JJ O
trials NNS O
. . O

Our PRP$ O
previous JJ O
study NN O
[ -LRB- O
19 CD O
] -RRB- O
indicated VBD O
that IN O
the DT O
testing NN O
protocol NN O
did VBD O
not RB O
cause VB O
noticeable JJ O
fatigue NN O
. . O

Force NN O
envelope NN O
and CC O
quadrants NNS O

Data NNS O
from IN O
multiple JJ O
circumferential JJ O
trials NNS O
were VBD O
accumulated VBN O
to TO O
construct VB O
a DT O
force NN O
envelope NN O
. . O

The DT O
procedures NNS O
to TO O
generate VB O
a DT O
force NN O
envelope NN O
were VBD O
as IN O
follows VBZ O
: : O

Cartesian JJ O
force NN O
coordinates VBZ O
( , O
Xi NNP O
, , O
Yi NNP O
) -RRB- O
were VBD O
transformed VBN O
into IN O
polar JJ O
coordinates NNS O
( , O
R NNP O
alpha NN O
, , O
alpha NN O
) -RRB- O
, , O
where WRB O
R NN O
alpha NN O
was VBD O
the DT O
force NN O
magnitude NN O
at IN O
an DT O
angular JJ O
position NN O
alpha NN O
. . O

Each DT O
alpha NN O
was VBD O
rounded VBN O
to IN O
the DT O
nearest JJS O
integer NN O
ranging VBG O
from IN O
0 CD O
to IN O
359 CD O
degrees NNS O
. . O

The DT O
maximum JJ O
, , O
F NNP O
alpha NN O
, , O
was VBD O
determined VBN O
from IN O
a DT O
string NN O
of IN O
N NNP O
data NNS O
points NNS O
along IN O
each DT O
radial JJ O
line NN O
defined VBN O
by IN O
alpha NN O
. . O

At IN O
the DT O
completion NN O
of IN O
the DT O
15 CD O
trials NNS O
, , O
there EX O
were VBD O
, , O
on IN O
average JJ O
, , O
N CD O
= SYM O
63 CD O
data NNS O
points NNS O
on IN O
each DT O
radial JJ O
line NN O
of IN O
alpha NN O
based VBN O
on IN O
the DT O
distribution NN O
off IN O
the DT O
22 CD O
, , O
500 CD O
data NNS O
points NNS O
around IN O
360 CD O
degrees NNS O
. . O

A DT O
moving VBG O
average NN O
with IN O
an DT O
interval NN O
of IN O
10 CD O
degrees NNS O
was VBD O
applied VBN O
to IN O
the DT O
maximal JJ O
series NN O
data NN O
F NN O
alpha NN O
( , O
alpha NN O
= SYM O
0 CD O
, , O
1 CD O
, , O
2 CD O
, , O
. . O
. , O
. . O
, , O
359 CD O
) -RRB- O
to TO O
obtain VB O
filtered VBN O
maximal JJ O
forces NNS O
. . O

These DT O
forces NNS O
formed VBD O
a DT O
force NN O
envelope NN O
. . O

The DT O
area NN O
formed VBN O
by IN O
a DT O
force NN O
envelope NN O
was VBD O
divided VBN O
into IN O
adduction NN O
- HYPH O
extension NN O
, , O
extension NN O
- HYPH O
abduction NN O
, , O
abduction NN O
- HYPH O
flexion NN O
, , O
and CC O
flexion NN O
- HYPH O
adduction NN O
quadrants NNS O
by IN O
radial JJ O
lines NNS O
oriented VBN O
at IN O
0 CD O
degrees NNS O
, , O
90 CD O
degrees NNS O
, , O
180 CD O
degrees NNS O
, , O
and CC O
270 CD O
degrees NNS O
A DT O
quadrant JJ O
force NN O
was VBD O
represented VBN O
using VBG O
the DT O
mean JJ O
magnitude NN O
of IN O
the DT O
forces NNS O
in IN O
that DT O
quadrant NN O
. . O

The DT O
areas NNS O
of IN O
the DT O
entire JJ O
envelope NN O
and CC O
each DT O
quadrant NN O
were VBD O
calculated VBN O
by IN O
summing VBG O
the DT O
areas NNS O
of IN O
individual JJ O
arc NN O
sections NNS O
formed VBN O
by IN O
the DT O
polar JJ O
coordinates NNS O
of IN O
the DT O
force NN O
envelope NN O
. . O

( -LRB- O
Figure NN O
2 CD O
) -RRB- O
. . O

Statistical NNP O
Analyses NNPS O

One CD O
- HYPH O
and CC O
two CD O
- HYPH O
factor NN O
repeated VBN O
measures NNS O
analyses NNS O
of IN O
variance NN O
( -LRB- O
ANOVA NNP O
) -RRB- O
were VBD O
used VBN O
to TO O
analyze VB O
outcome NN O
measures NNS O
. . O

The DT O
independent JJ O
variables NNS O
were VBD O
testing NN O
SESSION NN O
( : O
n ADD O
= SYM O
2 CD O
, , O
i LS O
. . O
e -RRB- O
. . O
, , O
pre NN O
- HYPH O
and CC O
post NN O
- HYPH O
block NN O
) -RRB- O
, , O
force NN O
DIRECTION NN O
( : O
n NN O
= SYM O
16 CD O
) -RRB- O
, , O
and CC O
force VB O
QUADRANT NN O
( : O
n NN O
= SYM O
4 CD O
) -RRB- O
, , O
with IN O
SESSION NN O
as IN O
a DT O
repeated JJ O
variable NN O
. . O

Dependent JJ O
variables NNS O
were VBD O
directional JJ O
force NN O
, , O
individual JJ O
quadrant NN O
area NN O
and CC O
force NN O
envelope NN O
area NN O
. . O

Statistical JJ O
analyses NNS O
were VBD O
performed VBN O
using VBG O
SPSS NNP O
11 CD O
( : O
SPSS NNP O
Inc NNP O
. . O
, , O
Illinois NNP O
) -RRB- O
with IN O
statistical JJ O
significance NN O
set VBN O
at IN O
alpha NN O
= SYM O
0 CD O
. . O
5 CD O
. . O

Results NNS O

Force NN O
envelope NN O
and CC O
directional JJ O
forces NNS O

Figure NN O
3 CD O
shows VBZ O
the DT O
force NN O
envelopes NNS O
produced VBN O
by IN O
each DT O
subject NN O
( -LRB- O
A NN O
to IN O
F NNP O
) -RRB- O
before IN O
and CC O
after IN O
median JJ O
nerve NN O
block NN O
. . O

The DT O
post NN O
- HYPH O
block NN O
force NN O
envelope NN O
was VBD O
inside IN O
the DT O
pre JJ O
- HYPH O
block NN O
envelope NN O
for IN O
each DT O
subject NN O
, , O
indicating VBG O
a DT O
decrease NN O
in IN O
force NN O
magnitude NN O
in IN O
all DT O
directions NNS O
after IN O
nerve NN O
block NN O
. . O

Figure NN O
4 CD O
shows VBZ O
the DT O
average JJ O
pre JJ O
- HYPH O
and CC O
post NN O
- HYPH O
block NN O
force NN O
envelope NN O
across IN O
all DT O
subjects NNS O
. . O

Force NN O
magnitudes NNS O
were VBD O
significantly RB O
reduced VBN O
after IN O
nerve NN O
block NN O
( , O
p NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
resulting VBG O
in IN O
significantly RB O
smaller JJR O
force NN O
envelopes NNS O
. . O

The DT O
average JJ O
decrease NN O
across IN O
all DT O
directions NNS O
was VBD O
27 CD O
. . O
9 CD O
% NN O
. . O

A DT O
maximum JJ O
decrease NN O
of IN O
42 CD O
. . O
4 CD O
% NN O
occurred VBD O
at IN O
199 CD O
degrees NNS O
, , O
corresponding VBG O
to IN O
a DT O
combined VBN O
direction NN O
of IN O
abduction NN O
and CC O
slight JJ O
flexion NN O
, , O
while IN O
a DT O
minimum JJ O
decrease NN O
of IN O
10 CD O
. . O
5 CD O
% NN O
occurred VBD O
at IN O
328 CD O
degrees NNS O
corresponding VBG O
to IN O
a DT O
combined VBN O
direction NN O
of IN O
adduction NN O
and CC O
slight JJ O
flexion NN O
. . O

Relative JJ O
decreases NNS O
at IN O
0 CD O
degrees NNS O
( , O
adduction NN O
) -RRB- O
, , O
90 CD O
degrees NNS O
( , O
extension NN O
) -RRB- O
, , O
180 CD O
degrees NNS O
( , O
abduction NN O
) -RRB- O
, , O
and CC O
270 CD O
degrees NNS O
( , O
flexion NN O
) -RRB- O
directions NNS O
were VBD O
17 CD O
. . O
3 CD O
% NN O
, , O
21 CD O
. . O
2 CD O
% NN O
, , O
41 CD O
. . O
2 CD O
% NN O
and CC O
33 CD O
. . O
5 CD O
% NN O
, , O
respectively RB O
. . O

A DT O
single JJ O
force NN O
in IN O
each DT O
quadrant NN O
was VBD O
represented VBN O
using VBG O
the DT O
mean JJ O
magnitude NN O
of IN O
the DT O
forces NNS O
in IN O
that DT O
quadrant NN O
( , O
see VB O
description NN O
in IN O
the DT O
Methods NNPS O
) -RRB- O
. . O

The DT O
average JJ O
quadrant NN O
forces NNS O
were VBD O
significantly RB O
decreased VBN O
after IN O
nerve NN O
block NN O
( , O
p NN O
< SYM O
0 CD O
. . O
1 CD O
; : O
Figure NN O
5 CD O
) -RRB- O
. . O

The DT O
amount NN O
of IN O
decrease NN O
was VBD O
also RB O
different JJ O
between IN O
quadrants NNS O
( , O
p NN O
< SYM O
0 CD O
. . O
5 CD O
) -RRB- O
. . O

Relative JJ O
decreases NNS O
in IN O
mean JJ O
quadrant JJ O
forces NNS O
were VBD O
24 CD O
. . O
5 CD O
% NN O
, , O
38 CD O
. . O
7 CD O
% NN O
, , O
32 CD O
. . O
1 CD O
% NN O
, , O
and CC O
18 CD O
. . O
1 CD O
% NN O
for IN O
extension NN O
, , O
abduction NN O
, , O
flexion NN O
, , O
and CC O
adduction NN O
, , O
respectively RB O
. . O

The DT O
maximal JJ O
decreases NNS O
in IN O
mean JJ O
quadrant JJ O
force NN O
, , O
38 CD O
. . O
7 CD O
% NN O
, , O
occurred VBD O
in IN O
the DT O
abduction NN O
quadrant NN O
. . O

Force NN O
envelope NN O
areas NNS O
and CC O
quadrant NN O
areas NNS O

Areas NNS O
enclosed VBN O
by IN O
the DT O
post NN O
- HYPH O
block NN O
envelopes NNS O
were VBD O
significantly RB O
smaller JJR O
than IN O
the DT O
pre JJ O
- HYPH O
block NN O
envelopes NNS O
( , O
p NN O
< SYM O
0 CD O
. . O
1 CD O
; : O
Figure NN O
4 CD O
) -RRB- O
. . O

Post NN O
- HYPH O
block NN O
force NN O
envelope NN O
area NN O
, , O
10700 CD O
+ CD O
/ SYM O
- HYPH O
4474 CD O
N NNP O
. . O
N NNP O
, , O
was VBD O
51 CD O
. . O
9 CD O
% NN O
of IN O
pre JJ O
- HYPH O
block NN O
force NN O
envelope NN O
area NN O
, , O
20628 CD O
+ CD O
/ SYM O
- HYPH O
7747 CD O
N CD O
. . O
N CD O
. . O

Quadrant NNP O
area NN O
decreased VBD O
significantly RB O
( : O
p NN O
< SYM O
0 CD O
. . O
1 CD O
; : O
Figure NN O
6 CD O
) -RRB- O
. . O

The DT O
maximal JJ O
percentage NN O
decrease NN O
in IN O
area NN O
after IN O
nerve NN O
block NN O
was VBD O
60 CD O
. . O
9 CD O
% NN O
in IN O
the DT O
abduction NN O
quadrant NN O
, , O
followed VBN O
by IN O
a DT O
52 CD O
. . O
3 CD O
% NN O
area NN O
decrease NN O
in IN O
the DT O
flexion NN O
quadrant NN O
. . O

Discussion NN O

In IN O
this DT O
study NN O
we PRP O
simulated VBD O
a DT O
lower JJR O
median JJ O
nerve NN O
lesion NN O
and CC O
evaluated VBD O
the DT O
resultant JJ O
thumb NN O
motor NN O
function NN O
deficit NN O
. . O

Our PRP$ O
internal JJ O
control NN O
via IN O
pre NN O
- HYPH O
and CC O
post NN O
- HYPH O
block NN O
design NN O
offered VBD O
a DT O
particular JJ O
advantage NN O
of IN O
investigating VBG O
the DT O
mechanical JJ O
role NN O
of IN O
muscles NNS O
innervated VBN O
by IN O
a DT O
targeted VBN O
nerve NN O
. . O

The DT O
testing NN O
and CC O
analytical JJ O
methods NNS O
employed VBN O
have VBP O
provided VBN O
advanced JJ O
quantification NN O
of IN O
thumb NN O
motor NN O
function NN O
. . O

The DT O
results NNS O
have VBP O
confirmed VBN O
our PRP$ O
initial JJ O
hypotheses NNS O
that IN O
greatest JJS O
force NN O
decreases NNS O
occurred VBD O
in IN O
directions NNS O
related VBN O
to IN O
abduction NN O
, , O
and CC O
that IN O
the DT O
post JJ O
- HYPH O
block NN O
thumb NN O
force NN O
envelope NN O
area NN O
was VBD O
smaller JJR O
than IN O
the DT O
pre JJ O
- HYPH O
block NN O
force NN O
envelope NN O
area NN O
. . O

Preferential JJ O
force NN O
attenuation NN O
in IN O
the DT O
quadrants NNS O
of IN O
abduction NN O
and CC O
flexion NN O
after IN O
median JJ O
nerve NN O
block NN O
are VBP O
in IN O
agreement NN O
with IN O
anatomical JJ O
and CC O
neuromuscular JJ O
features NNS O
of IN O
the DT O
thumb NN O
. . O

The DT O
median JJ O
nerve NN O
innervates VBZ O
the DT O
abductor NN O
pollicis NN O
brevis NN O
, , O
the DT O
opponens NN O
pollicis NN O
and CC O
superficial JJ O
head NN O
of IN O
the DT O
flexor NN O
pollicis NN O
brevis NN O
, , O
all DT O
of IN O
which WDT O
contribute VBP O
to IN O
the DT O
abduction NN O
and CC O
flexion NN O
of IN O
the DT O
thumb NN O
[ -LRB- O
4 CD O
] -RRB- O
; , O
therefore RB O
, , O
denervation NN O
of IN O
these DT O
muscles NNS O
after IN O
median JJ O
nerve NN O
block NN O
would MD O
cause VB O
the DT O
greatest JJS O
force NN O
deficit NN O
related VBN O
to IN O
median JJ O
nerve NN O
function NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Additionally RB O
, , O
as IN O
force NN O
application NN O
moved VBD O
towards IN O
adduction NN O
, , O
the DT O
force NN O
deficit NN O
decreased VBD O
as IN O
neuromuscular JJ O
control NN O
shifted VBD O
from IN O
the DT O
median JJ O
nerve NN O
to IN O
the DT O
ulnar JJ O
nerve NN O
via IN O
the DT O
first JJ O
dorsal JJ O
interosseous JJ O
and CC O
adductor NN O
pollicis NN O
brevis NN O
. . O

Force NN O
deficit NN O
in IN O
extension NN O
was VBD O
also RB O
comparably RB O
small JJ O
as IN O
extension NN O
forces NNS O
are VBP O
mainly RB O
produced VBN O
by IN O
the DT O
extensors NNS O
pollicis NN O
brevis NN O
and CC O
longus NN O
originating VBG O
in IN O
the DT O
forearm NN O
. . O

Our PRP$ O
reported JJ O
force NN O
decreases VBZ O
following VBG O
a DT O
median JJ O
nerve NN O
block NN O
( : O
40 CD O
. . O
9 CD O
% NN O
in IN O
abduction NN O
, , O
34 CD O
. . O
1 CD O
% NN O
in IN O
flexion NN O
) -RRB- O
were VBD O
smaller JJR O
than IN O
those DT O
reported VBN O
in IN O
the DT O
literature NN O
. . O

Kozin NNP O
et FW O
al NNP O
. . O

[ -LRB- O
21 CD O
] -RRB- O
reported VBD O
a DT O
60 CD O
% NN O
decrease NN O
in IN O
pinch NN O
strength NN O
after IN O
a DT O
median JJ O
nerve NN O
block NN O
using VBG O
mepivicaine NN O
hydrochloride NN O
[ -LRB- O
21 CD O
] -RRB- O
. . O

Boatright NNP O
and CC O
Kiebzak NNP O
[ -LRB- O
20 CD O
] -RRB- O
reported VBD O
an DT O
approximate JJ O
70 CD O
% NN O
decrease NN O
in IN O
thumb NN O
abduction NN O
strength NN O
after IN O
median JJ O
nerve NN O
block NN O
using VBG O
Lidocaine NNP O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Kaufman NNP O
et FW O
al NNP O
. . O

[ -LRB- O
5 CD O
] -RRB- O
stated VBD O
that IN O
a DT O
median JJ O
nerve NN O
block NN O
with IN O
Lidocaine NNP O
almost RB O
completely RB O
diminished VBN O
force NN O
production NN O
in IN O
the DT O
abduction NN O
direction NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

The DT O
discrepancy NN O
may MD O
be VB O
due IN O
to IN O
the DT O
anesthetic JJ O
used VBN O
and CC O
strength NN O
testing NN O
method NN O
. . O

Although IN O
the DT O
sensory JJ O
block NN O
appeared VBD O
to TO O
be VB O
complete JJ O
for IN O
each DT O
method NN O
, , O
the DT O
motor NN O
capabilities NNS O
of IN O
the DT O
muscles NNS O
associated VBN O
with IN O
the DT O
median JJ O
nerve NN O
might MD O
or CC O
might MD O
not RB O
be VB O
completely RB O
eliminated VBN O
. . O

Such PDT O
a DT O
result NN O
is VBZ O
largely RB O
dependent JJ O
on IN O
a DT O
particular JJ O
anesthetic NN O
, , O
its PRP$ O
concentration NN O
and CC O
dosage NN O
, , O
as RB O
well RB O
as IN O
the DT O
efficacy NN O
of IN O
the DT O
injection NN O
technique NN O
at IN O
immersing VBG O
the DT O
nerve NN O
. . O

The DT O
methods NNS O
of IN O
strength NN O
testing NN O
may MD O
also RB O
help VB O
explain VB O
the DT O
different JJ O
magnitudes NNS O
of IN O
strength NN O
deficit NN O
after IN O
the DT O
nerve NN O
block NN O
. . O

All DT O
previous JJ O
results NNS O
were VBD O
based VBN O
on IN O
forces NNS O
obtained VBN O
in IN O
discrete JJ O
direction NN O
( , O
s NNS O
) -RRB- O
, , O
and CC O
focused VBN O
exertions NNS O
, , O
while IN O
the DT O
current JJ O
study NN O
utilized VBD O
a DT O
method NN O
of IN O
force NN O
production NN O
in IN O
a DT O
continuous JJ O
, , O
circumferential JJ O
and CC O
dynamic JJ O
manner NN O
. . O

Furthermore RB O
, , O
thumb NN O
motor NN O
performance NN O
can MD O
be VB O
maintained VBN O
despite IN O
the DT O
absence NN O
of IN O
certain JJ O
individual JJ O
muscles NNS O
. . O

For IN O
example NN O
, , O
Britto NNP O
and CC O
Elliot NNP O
reported VBD O
that IN O
the DT O
loss NN O
of IN O
abductor NN O
pollicis NN O
longus NN O
and CC O
extensor JJ O
pollicis NN O
brevis NNS O
in IN O
their PRP$ O
two CD O
patients NNS B-Species
did VBD O
not RB O
show VB O
functional JJ O
compromise NN O
of IN O
strength NN O
and CC O
grip NN O
strength NN O
[ -LRB- O
24 CD O
] -RRB- O
. . O

In IN O
a DT O
broader JJR O
sense NN O
, , O
the DT O
neuromuscular JJ O
system NN O
has VBZ O
remarkable JJ O
capabilities NNS O
to TO O
accomplish VB O
the DT O
same JJ O
motor NN O
function NN O
goal NN O
using VBG O
different JJ O
effectors NNS O
and CC O
different JJ O
goals NNS O
using VBG O
the DT O
same JJ O
effectors NNS O
, , O
a DT O
phenomenon NN O
so RB O
called VBN O
"""" `` O
motor NN O
equivalence NN O
"""" '' O
[ -LRB- O
25 CD O
] -RRB- O
. . O

An DT O
unexpected JJ O
finding NN O
from IN O
this DT O
study NN O
was VBD O
that IN O
the DT O
force NN O
deficit NN O
occurred VBD O
in IN O
all DT O
directions NNS O
( -LRB- O
Figure NNP O
4 CD O
) -RRB- O
. . O

In IN O
other JJ O
words NNS O
, , O
the DT O
median JJ O
nerve NN O
block NN O
caused VBD O
reduced VBN O
force NN O
production NN O
by IN O
those DT O
muscles NNS O
not RB O
associated VBN O
with IN O
the DT O
median JJ O
nerve NN O
. . O

Several JJ O
potential JJ O
explanations NNS O
exist VBP O
to TO O
describe VB O
such PDT O
a DT O
phenomenon NN O
. . O

First RB O
, , O
the DT O
injection NN O
into IN O
the DT O
carpal NN O
tunnel NN O
at IN O
the DT O
wrist NN O
, , O
although IN O
localized VBN O
, , O
potentially RB O
diffused VBD O
into IN O
the DT O
intrinsic JJ O
fascia NN O
of IN O
the DT O
hand NN O
partially RB O
compromising VBG O
function NN O
of IN O
the DT O
ulnar JJ O
nerve NN O
, , O
which WDT O
innervates VBZ O
the DT O
adductor NN O
pollicis NN O
. . O

Although IN O
Semmes NNP O
- HYPH O
Weinstein NNP O
monofilament NN O
testing NN O
confirmed VBD O
the DT O
continued VBN O
sensation NN O
of IN O
the DT O
digits NNS O
within IN O
the DT O
ulnar JJ O
nerve NN O
distribution NN O
, , O
it PRP O
is VBZ O
not RB O
inconceivable JJ O
that IN O
the DT O
injection NN O
could MD O
have VB O
contaminated VBN O
the DT O
ulnar JJ O
innervated VBN O
muscles NNS O
, , O
the DT O
first JJ O
dorsal JJ O
interosseous JJ O
and CC O
deep JJ O
head NN O
of IN O
the DT O
flexor NN O
pollicis NN O
brevis NN O
[ -LRB- O
20 CD O
] -RRB- O
. . O

Secondly RB O
, , O
thumb NN O
force NN O
in IN O
any DT O
direction NN O
is VBZ O
produced VBN O
by IN O
synergistic JJ O
activation NN O
of IN O
the DT O
many JJ O
intrinsic JJ O
muscles NNS O
, , O
and CC O
as IN O
a DT O
result NN O
, , O
the DT O
muscular JJ O
deficiency NN O
associated VBN O
with IN O
one CD O
direction NN O
may MD O
hinder VB O
the DT O
force NN O
production NN O
in IN O
other JJ O
directions NNS O
by IN O
other JJ O
muscles NNS O
[ -LRB- O
5 CD O
, , O
22 CD O
] -RRB- O
. . O

For IN O
example NN O
, , O
Kaufman NNP O
et FW O
al NNP O
. . O
demonstrated VBD O
that IN O
thumb NN O
muscles NNS O
not RB O
innervated VBN O
by IN O
the DT O
median JJ O
nerve NN O
displayed VBD O
lower JJR O
electromyographical JJ O
activation NN O
and CC O
shifted VBD O
the DT O
direction NN O
of IN O
maximum JJ O
activation NN O
after IN O
a DT O
median JJ O
nerve NN O
block NN O
[ -LRB- O
5 CD O
] -RRB- O
. . O

Labosky NNP O
and CC O
Waggy NNP O
showed VBD O
that IN O
a DT O
radial JJ O
nerve NN O
block NN O
caused VBD O
a DT O
53 CD O
% NN O
decrease NN O
in IN O
thumb NN O
abduction NN O
strength NN O
because IN O
of IN O
the DT O
lack NN O
of IN O
stabilization NN O
of IN O
the DT O
radial JJ O
innervated VBN O
extensor JJ O
muscles NNS O
[ -LRB- O
22 CD O
] -RRB- O
. . O

Consequently RB O
, , O
deficiency NN O
of IN O
median JJ O
innervated VBN O
muscles NNS O
inherently RB O
limits VBZ O
force NN O
production NN O
in IN O
other JJ O
directions NNS O
as IN O
neuromuscular JJ O
switching NN O
is VBZ O
necessary JJ O
to TO O
produce VB O
force NN O
in IN O
changing VBG O
directions NNS O
. . O

The DT O
median JJ O
innervated VBN O
muscles NNS O
are VBP O
the DT O
dominant JJ O
abductors NNS O
of IN O
the DT O
thumb NN O
metacarpophalangeal NN O
and CC O
carpometacarpal NN O
joint NN O
. . O

The DT O
more JJR O
than IN O
50 CD O
% NN O
residual JJ O
abduction NN O
force NN O
found VBN O
in IN O
this DT O
study NN O
suggests VBZ O
that IN O
the DT O
injection NN O
did VBD O
not RB O
totally RB O
block VB O
the DT O
motor NN O
function NN O
of IN O
these DT O
muscles NNS O
, , O
even RB O
though IN O
a DT O
complete JJ O
sensory JJ O
loss NN O
was VBD O
verified VBN O
. . O

This DT O
concurs VBZ O
with IN O
clinical JJ O
observations NNS O
of IN O
median JJ O
compression NN O
neuropathy NN O
. . O

Individuals NNS O
with IN O
carpal JJ O
tunnel NN O
syndrome NN O
complain VBP O
of IN O
sensory JJ O
dysfunction NN O
early RB O
in IN O
the DT O
disease NN O
process NN O
( , O
at IN O
the DT O
beginning NN O
) -RRB- O
, , O
while IN O
motor NN O
signs NNS O
of IN O
thenar NN O
wasting NN O
and CC O
thumb NN O
weakness NN O
occur VBP O
as IN O
the DT O
disease NN O
advances VBZ O
. . O

The DT O
concept NN O
that IN O
the DT O
motor NN O
deficit NN O
is VBZ O
more RBR O
resistant JJ O
to IN O
peripheral JJ O
median JJ O
neuropathy NN O
than IN O
sensory JJ O
loss NN O
has VBZ O
been VBN O
well RB O
documented VBN O
[ -LRB- O
23 CD O
, , O
26 CD O
, , O
27 CD O
] -RRB- O
. . O

Butterworth NNP O
et FW O
al NNP O
. . O
studied VBD O
the DT O
temporal JJ O
effects NNS O
on IN O
sensory NN O
and CC O
motor NN O
blockade NN O
after IN O
injection NN O
of IN O
bupivacaine NN O
or CC O
mepivacaine NN O
, , O
and CC O
found VBD O
that IN O
sensory JJ O
loss NN O
was VBD O
complete JJ O
but CC O
about IN O
a DT O
20 CD O
% NN O
compound NN O
motor NN O
action NN O
potential NN O
remained VBD O
after IN O
40 CD O
minutes NNS O
[ -LRB- O
23 CD O
] -RRB- O
. . O

In IN O
conclusion NN O
, , O
we PRP O
have VBP O
incorporated VBN O
a DT O
method NN O
for IN O
assessing VBG O
thumb NN O
motor NN O
deficit NN O
based VBN O
on IN O
strength NN O
measurement NN O
with IN O
a DT O
standard JJ O
local JJ O
anesthetic NN O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
a DT O
simulated VBN O
median JJ O
neuropathy NN O
on IN O
thumb NN O
motor NN O
function NN O
. . O

Median JJ O
nerve NN O
block NN O
results VBZ O
in IN O
force NN O
deficits NNS O
in IN O
all DT O
directions NNS O
, , O
with IN O
the DT O
most RBS O
severe JJ O
impairment NN O
in IN O
abduction NN O
and CC O
flexion NN O
. . O

Future JJ O
endeavors NNS O
using VBG O
this DT O
methodology NN O
can MD O
potentially RB O
further RB O
elucidate VB O
underlying VBG O
pathomechanisms NNS O
of IN O
peripheral JJ O
neuropathies NNS O
in IN O
all DT O
digits NNS O
of IN O
the DT O
hand NN O
. . O
